{"meta":{"query_hash":"6455bcf056af","filters":{"topic":"Lipoproteins and Cardiovascular Health"},"cohort_total":3195,"direct_labels_cover":13,"predictions_cover":3195,"exported":3195,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/6455bcf056af","api":"https://metacan.xera.ac/api/v1/cohort?topic=Lipoproteins+and+Cardiovascular+Health"},"results":[{"id":"W101917016","doi":"","title":"ISVH – October Newsletter","year":2008,"lang":"en","type":"article","venue":"PubMed Central","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thursday; Library science; Session (web analytics); General partnership; Media studies; Gerontology; Law; Political science; Sociology","score_opus":0.020290660249317343,"score_gpt":0.2214384901957596,"score_spread":0.20114782994644226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W101917016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98098606,0.00076984026,0.0003378322,0.004213181,0.0006451298,0.00063980656,0.0000030910653,0.00009605755,0.012309008],"genre_scores_gemma":[0.98639566,0.0002098201,0.0004543829,0.006801546,0.0026534798,0.00009779568,0.00001619208,0.000024155108,0.0033469542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807686,0.000030746356,0.00015610024,0.00020946717,0.00038370554,0.0011430983],"domain_scores_gemma":[0.9989476,0.0000060774796,0.000024457584,0.00038171388,0.000025400263,0.00061475753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022765817,0.00011017844,0.00023719839,0.00004021178,0.000079118705,0.0000075536946,0.000055325014,0.0000719206,0.00023490755],"category_scores_gemma":[0.000047838046,0.00008740954,0.000241452,0.00011777317,0.00005431853,0.00006116085,0.000020221369,0.00018488406,0.00010713942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025560946,0.00042522384,0.63706905,0.00019266552,0.00055705215,0.0018962801,0.0009920517,0.000010931904,0.0003323779,0.00048629032,0.16506882,0.19271366],"study_design_scores_gemma":[0.0009935088,0.000020508289,0.70778567,0.000006207905,0.000038509803,0.00060719816,0.000008856414,0.0000069816742,0.0007568656,0.000010186122,0.28968552,0.00007996958],"about_ca_topic_score_codex":0.00013772526,"about_ca_topic_score_gemma":0.0000073944216,"teacher_disagreement_score":0.19263369,"about_ca_system_score_codex":0.00014961787,"about_ca_system_score_gemma":0.00014807584,"threshold_uncertainty_score":0.3564458},"labels":[],"label_agreement":null},{"id":"W1113293211","doi":"10.1016/j.jacl.2015.07.011","title":"Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study","year":2015,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal; Hospital for Sick Children; University of British Columbia; Université du Québec à Chicoutimi; University of Toronto","funders":"Pfizer","keywords":"Rosuvastatin; Medicine; Discontinuation; Adverse effect; Familial hypercholesterolemia; Internal medicine; Gastroenterology; Rosuvastatin Calcium; Cholesterol; Endocrinology","score_opus":0.06207042970551783,"score_gpt":0.3633206977396602,"score_spread":0.30125026803414234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1113293211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673045,0.00083602953,0.00002236625,0.0014459044,0.00029331827,0.0006431588,0.000013422474,0.00000282408,0.000012539073],"genre_scores_gemma":[0.9958456,0.0013933831,0.0002529363,0.0006080152,0.0018804366,0.000001376377,0.0000032558764,0.000011451633,0.0000035403662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969247,0.0010133678,0.0013149224,0.000212068,0.00038339666,0.00015154846],"domain_scores_gemma":[0.99832976,0.00045845818,0.0005338673,0.00029477637,0.00016488525,0.00021824347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005331738,0.00011892765,0.0009564438,0.00004898553,0.000022745606,0.000006712466,0.00010890794,0.00014030808,0.0000011131738],"category_scores_gemma":[0.0012071526,0.000060417573,0.00009691349,0.0000825829,0.00021453224,0.000047150723,0.000051259325,0.0007655706,5.1690824e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03135102,0.00079681346,0.88963926,0.0000054398674,0.00024407903,0.0000124766575,0.00089711644,0.0000060416196,0.000020946025,9.933002e-7,0.00010830235,0.07691752],"study_design_scores_gemma":[0.058700703,0.008960526,0.93102396,0.00022622553,0.000115658826,0.0001840702,0.00043599494,0.0000041973917,0.000006581346,0.000017568407,0.00027419886,0.00005029937],"about_ca_topic_score_codex":0.00038593393,"about_ca_topic_score_gemma":0.00009448146,"teacher_disagreement_score":0.07686722,"about_ca_system_score_codex":0.000015433621,"about_ca_system_score_gemma":0.00023134667,"threshold_uncertainty_score":0.33260658},"labels":[],"label_agreement":null},{"id":"W1126452551","doi":"10.71781/31013","title":"Effet de la N-acétylcystéine sur la dysfonction endothéliale des artères coronaires épicardiques associée à une hypertrophie ventriculaire gauche dans un modèle porcin","year":2010,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology","score_opus":0.016923649276962632,"score_gpt":0.2929938706606879,"score_spread":0.2760702213837253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1126452551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95938754,0.011626469,0.0006288375,0.0003108569,0.0013026361,0.0024959152,0.00022023145,0.000024814219,0.024002682],"genre_scores_gemma":[0.97199684,0.004426625,0.005558881,0.00006720488,0.0021819456,0.00039605534,0.0021182147,0.00020951213,0.0130447075],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9942057,0.0017232696,0.0009238992,0.0010835488,0.0010218003,0.0010417794],"domain_scores_gemma":[0.99671584,0.0005869701,0.0005466775,0.0011077478,0.00042276576,0.0006199864],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0032422426,0.0008400027,0.0016995721,0.00019448878,0.00067896844,0.0004080433,0.00064768223,0.0016319517,0.0019887658],"category_scores_gemma":[0.0009948945,0.0007744084,0.0008738745,0.0005127793,0.0005100757,0.00040530664,0.00017440377,0.0016337926,0.00032712513],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008834198,0.0011440474,0.010235366,0.0010777444,0.0020417518,0.0023417512,0.008910942,0.00017647489,0.05814967,0.000093227325,0.0010902985,0.9138553],"study_design_scores_gemma":[0.01035295,0.0013388928,0.44561523,0.004252698,0.0047849193,0.0027424586,0.006761637,0.0006314345,0.28456867,0.00029653375,0.23700511,0.0016494653],"about_ca_topic_score_codex":0.028314134,"about_ca_topic_score_gemma":0.0048232083,"teacher_disagreement_score":0.9122058,"about_ca_system_score_codex":0.0009049284,"about_ca_system_score_gemma":0.0020051817,"threshold_uncertainty_score":0.9996641},"labels":[],"label_agreement":null},{"id":"W1132929002","doi":"10.71781/30796","title":"La PCSK9 humaine, une molécule aux multiples facettes métaboliques et une cible thérapeutique prometteuse : études de régulation in vitro et in vivo","year":2010,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Pfizer","keywords":"Chemistry","score_opus":0.008447573854659824,"score_gpt":0.2386685619260355,"score_spread":0.23022098807137567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1132929002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96418,0.020058006,0.00037495294,0.0025664966,0.000530997,0.0016147157,0.00011240788,0.00013731586,0.010425105],"genre_scores_gemma":[0.98820114,0.0029291008,0.0031175322,0.0004275418,0.00028424634,0.00020112228,0.0008572881,0.000085826076,0.0038962085],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99542475,0.0009286326,0.00082963565,0.00093842,0.0010164296,0.00086211134],"domain_scores_gemma":[0.9978033,0.00025300146,0.00046638664,0.0006932527,0.0003720204,0.00041207825],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017247285,0.00071350305,0.0010681705,0.0010286411,0.0016742914,0.00008805598,0.0003849445,0.0013209097,0.00003142154],"category_scores_gemma":[0.00029409325,0.00079939264,0.0005356086,0.0011895135,0.0003276278,0.0006422391,0.00014762768,0.001930263,0.000012197086],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.003024267,0.0016440892,0.058605887,0.0016991439,0.0008546198,0.0051694554,0.10684847,0.012534704,0.73138195,0.064651646,0.00007786318,0.013507905],"study_design_scores_gemma":[0.0068577826,0.0002398138,0.6864993,0.002521206,0.00068094104,0.001128342,0.049113985,0.006295432,0.19996431,0.00084388757,0.044570684,0.0012843376],"about_ca_topic_score_codex":0.31888744,"about_ca_topic_score_gemma":0.28600812,"teacher_disagreement_score":0.6278934,"about_ca_system_score_codex":0.005199464,"about_ca_system_score_gemma":0.006606983,"threshold_uncertainty_score":0.99997556},"labels":[],"label_agreement":null},{"id":"W1133930063","doi":"10.1038/nrendo.2015.146","title":"Antisenses working overtime in lipids","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Oligonucleotide; Overtime; Clinical trial; Computational biology; Bioinformatics; Pharmacology; Internal medicine; Biochemistry; Gene; Biology","score_opus":0.08729925398709358,"score_gpt":0.4003326883213674,"score_spread":0.31303343433427383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1133930063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000018632107,0.98664826,0.000005332055,0.00014004202,0.001232958,0.0037764309,0.00001086662,0.00008692427,0.008097346],"genre_scores_gemma":[0.000006774694,0.9952999,0.00060347107,0.0007205386,0.0020576776,0.00037108883,0.00017525275,0.00010957586,0.0006557175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99506414,0.001054107,0.001485682,0.00093548355,0.00048412025,0.0009764944],"domain_scores_gemma":[0.9974386,0.000099330544,0.00049383455,0.0015887958,0.000099956116,0.00027947754],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0012064556,0.000761846,0.008125602,0.00061719783,0.000042675503,0.000017430575,0.00033087438,0.0016203917,0.00007640961],"category_scores_gemma":[0.0006773768,0.0005179155,0.0019237896,0.0010038578,0.00008526337,0.000041544146,0.00019631705,0.004263286,0.0004144865],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008930691,0.00005868056,0.000025423018,0.029734671,0.00019344705,0.00075956044,0.000008511611,2.1963643e-8,7.414286e-8,0.00028506308,0.0056677917,0.96325785],"study_design_scores_gemma":[0.0006383033,0.00010835119,0.000023185883,0.04052123,0.0013687599,0.005257174,0.0000024067472,3.0072493e-7,3.8553213e-7,0.00002170075,0.9516823,0.0003758842],"about_ca_topic_score_codex":0.000045360735,"about_ca_topic_score_gemma":0.000023496104,"teacher_disagreement_score":0.9628819,"about_ca_system_score_codex":0.00053927914,"about_ca_system_score_gemma":0.000908137,"threshold_uncertainty_score":0.99972725},"labels":[],"label_agreement":null},{"id":"W117850927","doi":"10.1096/fasebj.22.1_supplement.948.4","title":"Role and regulation of the proprotein convertase subtilisin/kexin type 9 (PCSK9) in the small intestine","year":2008,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"PCSK9; Kexin; Proprotein convertase; Endocrinology; Internal medicine; LDL receptor; Small intestine; Biology; Chemistry; Cholesterol; Biochemistry; Lipoprotein; Medicine","score_opus":0.02483428188332235,"score_gpt":0.2342611459956967,"score_spread":0.20942686411237435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W117850927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948051,0.001635766,0.000049695143,0.0024763914,0.000065915265,0.00057909574,0.0000015953025,0.0000052538057,0.0003812098],"genre_scores_gemma":[0.9988313,0.0001402346,0.00014374846,0.00039623264,0.00023212125,0.0000060117272,0.000001780914,0.000009539989,0.00023908273],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988195,0.00030871018,0.00025931414,0.00008859254,0.0003704931,0.0001533999],"domain_scores_gemma":[0.99924105,0.000050346556,0.00013460242,0.00039452664,0.00012472314,0.000054721386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015570255,0.00008817233,0.00018682501,0.000041344254,0.00020158626,0.000012755825,0.00015613165,0.00004360482,0.000032360676],"category_scores_gemma":[0.00023696394,0.000035832112,0.00010070595,0.00021276157,0.00016797951,0.00003808584,0.000034533095,0.00044812114,0.0000032485166],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029161647,0.0007906325,0.3044997,0.00045357092,0.00048072022,0.00039034945,0.020627463,0.00027201272,0.5524718,0.0013721249,0.0014078293,0.11431762],"study_design_scores_gemma":[0.0025808108,0.00046840342,0.9000751,0.0003425799,0.0001392089,0.010070518,0.0011083045,0.000822924,0.08196453,0.000913732,0.0014084072,0.00010547848],"about_ca_topic_score_codex":0.00034999574,"about_ca_topic_score_gemma":0.00008416712,"teacher_disagreement_score":0.5955754,"about_ca_system_score_codex":0.000029507231,"about_ca_system_score_gemma":0.00022967249,"threshold_uncertainty_score":0.19468883},"labels":[],"label_agreement":null},{"id":"W120848922","doi":"10.1016/j.jacc.2008.08.039","title":"Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments","year":2008,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":421,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; University of British Columbia; University of Toronto; McMaster University","funders":"Medical Research Council; Pfizer UK; London School of Hygiene and Tropical Medicine","keywords":"Medicine; Primary prevention; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Internal medicine; Intensive care medicine; Disease","score_opus":0.038221698425828045,"score_gpt":0.32558317335713577,"score_spread":0.2873614749313077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W120848922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044209175,0.95384175,0.00022886042,0.000020468837,0.00016089917,0.0011987345,0.00012670367,0.0000031724903,0.00021025747],"genre_scores_gemma":[0.0055685635,0.9930296,0.0009238886,0.000016175438,0.00030663458,0.000021026086,0.000008684542,0.000040141593,0.0000852833],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960565,0.0013726599,0.001187791,0.0002472554,0.000913282,0.00022249967],"domain_scores_gemma":[0.995861,0.00010215601,0.0026426597,0.0009113662,0.0003494406,0.00013337989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097060227,0.00032880963,0.00696663,0.0002108919,0.000050357492,0.0000011443365,0.00022848276,0.00012989501,0.0000013448713],"category_scores_gemma":[0.00008926889,0.00017413836,0.0041098036,0.00047565426,0.00052282395,0.000041046056,0.00009209765,0.00040677428,2.5498213e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006672447,0.0002279449,0.008440395,0.01498587,0.09690149,0.0010144258,0.000032466527,0.00009463564,0.0000035161572,0.0000120013965,0.0005899877,0.87703],"study_design_scores_gemma":[0.0047189705,0.006838354,0.07194842,0.013976525,0.052143328,0.0412904,0.00013763615,5.7450626e-7,0.000011748053,0.000045662036,0.80849814,0.00039027559],"about_ca_topic_score_codex":0.00007492728,"about_ca_topic_score_gemma":0.0000015619631,"teacher_disagreement_score":0.8766397,"about_ca_system_score_codex":0.00025032938,"about_ca_system_score_gemma":0.0017916284,"threshold_uncertainty_score":0.7101156},"labels":[],"label_agreement":null},{"id":"W121620060","doi":"","title":"Management of dyslipidemia in primary care.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dyslipidemia; Diabetes mellitus; Hyperlipidemia; Framingham Risk Score; Internal medicine; Cardiology; Heart disease; Disease; Endocrinology","score_opus":0.014475482745625103,"score_gpt":0.223495630934148,"score_spread":0.2090201481885229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W121620060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69270444,0.0060050366,0.00009713541,0.00012979691,0.00017983721,0.001910393,0.0000015140497,0.00002319788,0.29894865],"genre_scores_gemma":[0.99747854,0.00017317067,0.00087481574,0.00019766662,0.000038671275,0.00067125837,0.0000057395882,0.000009871647,0.0005502691],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99917454,0.0000444356,0.00018768989,0.00013450954,0.00023633635,0.0002224674],"domain_scores_gemma":[0.99954885,0.0000057393627,0.000030131372,0.00030817025,0.000024505129,0.000082584826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005811604,0.00005907304,0.00023211999,0.00006300827,0.000009317617,0.0000017725911,0.000033840366,0.000040298153,0.000009078633],"category_scores_gemma":[0.000016032664,0.000050628558,0.00009517242,0.00016958771,0.000015690308,0.000020036283,0.000014759216,0.000078372,0.0000033836568],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049943148,0.000094385,0.03941097,0.002252712,0.00015050778,0.00010308781,0.000106059146,0.000008883451,0.000007856442,0.0020989508,0.00016646412,0.9555502],"study_design_scores_gemma":[0.0015179157,0.000013880198,0.9726486,0.00005562586,0.00005386964,0.0000047453827,0.00016612791,4.290295e-7,0.0005479882,0.000043872024,0.024896245,0.000050690618],"about_ca_topic_score_codex":0.0000245008,"about_ca_topic_score_gemma":0.0000034382958,"teacher_disagreement_score":0.9554995,"about_ca_system_score_codex":0.0001672656,"about_ca_system_score_gemma":0.00003346779,"threshold_uncertainty_score":0.20645727},"labels":[],"label_agreement":null},{"id":"W1224944581","doi":"10.1016/j.jacc.2007.06.063","title":"Statins for Secondary Prevention in Elderly Patients","year":2008,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":347,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Pravastatin; Relative risk; Myocardial infarction; Internal medicine; Placebo; Statin; Stroke (engine); Confidence interval; Number needed to treat; Cholesterol","score_opus":0.025736004041334887,"score_gpt":0.32638927441604265,"score_spread":0.3006532703747078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1224944581","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006596173,0.98995453,0.00022896302,0.00009330431,0.00057562743,0.0019133482,0.0002958728,0.0000027530878,0.00033945034],"genre_scores_gemma":[0.0015172879,0.99670625,0.00089839497,0.00006018738,0.00059255137,0.000042109175,0.000014028175,0.000037118214,0.00013205367],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971786,0.0007508688,0.0012823329,0.00017114817,0.00037871575,0.00023832469],"domain_scores_gemma":[0.99653435,0.00019755759,0.002371985,0.00044213794,0.00036703405,0.00008691238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007247306,0.00022273627,0.0043454613,0.00030977002,0.000040443723,0.0000014639279,0.0002621071,0.00013763036,0.0000029782257],"category_scores_gemma":[0.00031594507,0.00013328886,0.0031903824,0.00043078288,0.00021135993,0.00003385832,0.00005270633,0.0005840434,6.369252e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021276576,0.00006697948,0.00039396723,0.003690359,0.0013683656,0.00008004114,0.000011402322,0.000005824895,3.3320464e-7,0.000011609768,0.0054568066,0.9887015],"study_design_scores_gemma":[0.0020193544,0.003557957,0.0030605616,0.0036589382,0.0011854607,0.0028902602,0.000051865885,4.4217285e-7,9.297207e-7,0.00005392153,0.9834076,0.00011266544],"about_ca_topic_score_codex":0.000011836412,"about_ca_topic_score_gemma":0.0000051124794,"teacher_disagreement_score":0.98858887,"about_ca_system_score_codex":0.00026519687,"about_ca_system_score_gemma":0.0023081983,"threshold_uncertainty_score":0.54353625},"labels":[],"label_agreement":null},{"id":"W1249434025","doi":"10.1161/circ.130.suppl_2.15805","title":"Abstract 15805: PCSK9 R46L, Lower LDL and Cardiovascular Disease Risk in Familial Hypercholesterolemia","year":2014,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PCSK9; Familial hypercholesterolemia; Medicine; Internal medicine; LDL receptor; Apolipoprotein B; Endocrinology; Missense mutation; Kexin; Cohort; Lipoprotein; Mutation; Cholesterol; Genetics; Biology; Gene","score_opus":0.013210702157266963,"score_gpt":0.23493705218110658,"score_spread":0.2217263500238396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1249434025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940126,0.002538119,0.0017971746,0.00010143451,0.00018556521,0.0005677676,0.000006579252,0.00004998248,0.00074080727],"genre_scores_gemma":[0.9988109,0.00025594528,0.00010621556,0.00017770941,0.00054394844,0.000029802548,0.000037921258,0.00002870335,0.000008848799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984352,0.0001296827,0.00026965258,0.0004276484,0.00049449,0.00024335187],"domain_scores_gemma":[0.9988546,0.00002656622,0.00004871679,0.0007484545,0.00006146369,0.00026021345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011146712,0.00015496601,0.00037415014,0.00011194594,0.00007937033,0.000027856262,0.000043149365,0.000121705605,0.000019415535],"category_scores_gemma":[0.00020957533,0.0001456072,0.00032114226,0.00013944089,0.000046671317,0.00013297115,0.00002286486,0.00025156402,0.000033659275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015175653,0.00010008166,0.67306054,0.00028333915,0.00023128607,0.00005304902,0.0001481406,0.0028596602,0.00050136214,0.0000631524,0.000019522517,0.3225281],"study_design_scores_gemma":[0.002306951,0.00003132889,0.9895196,0.00011090518,0.0002769363,0.000018144603,0.00002575098,0.0024728305,0.000019569825,0.00021361603,0.0048570912,0.0001473075],"about_ca_topic_score_codex":0.0006403766,"about_ca_topic_score_gemma":0.000022267412,"teacher_disagreement_score":0.32238078,"about_ca_system_score_codex":0.00008662381,"about_ca_system_score_gemma":0.00006978967,"threshold_uncertainty_score":0.59376895},"labels":[],"label_agreement":null},{"id":"W1252855759","doi":"10.1593/neo.121252","title":"Proprotein Convertase Subtilisin/Kexin Type 9 Deficiency Reduces Melanoma Metastasis in Liver","year":2012,"lang":"en","type":"article","venue":"Neoplasia","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Montreal Clinical Research Institute; Université de Montréal","funders":"Canadian Institutes of Health Research; Bristol-Myers Squibb","keywords":"Kexin; PCSK9; Endocrinology; Proprotein convertase; Internal medicine; Metastasis; LDL receptor; Biology; Cholesterol; Liver X receptor; Cancer research; Medicine; Cancer; Lipoprotein","score_opus":0.025537626333447364,"score_gpt":0.27181861954216513,"score_spread":0.24628099320871777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1252855759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98027724,0.012454555,0.0000342337,0.00028551024,0.0003312766,0.0009809901,0.00000782137,0.000065040455,0.005563304],"genre_scores_gemma":[0.99716425,0.00026599978,0.0013797148,0.00027171758,0.00032390165,0.00006406163,0.000026687812,0.000034071658,0.00046957965],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980759,0.0001434423,0.00032922818,0.00031435722,0.0005225727,0.00061448733],"domain_scores_gemma":[0.99896,0.000027655158,0.00007293221,0.000527994,0.00009785856,0.00031355047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090112136,0.00021133471,0.00046591723,0.00017807978,0.00007155768,0.000018464822,0.000105135354,0.00014982148,0.00048335773],"category_scores_gemma":[0.00017633263,0.0001677243,0.00017250868,0.00044294313,0.00006825626,0.00019830816,0.00004606242,0.0002988957,0.00043521522],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019628785,0.0031085229,0.30087742,0.001870814,0.0005479413,0.0011971241,0.007377866,0.00000980994,0.022254692,0.0033432974,0.006104189,0.65134543],"study_design_scores_gemma":[0.00728205,0.0017488393,0.6816954,0.00049680023,0.0007400578,0.002194029,0.0016385278,0.00020272126,0.20084958,0.000102218146,0.10197916,0.0010706213],"about_ca_topic_score_codex":0.0010438607,"about_ca_topic_score_gemma":0.00011159366,"teacher_disagreement_score":0.6502748,"about_ca_system_score_codex":0.00013239148,"about_ca_system_score_gemma":0.00027579095,"threshold_uncertainty_score":0.68395984},"labels":[],"label_agreement":null},{"id":"W129630785","doi":"","title":"Lipoprotein(a) and the link between atherosclerosis and thrombosis.","year":2004,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Thrombosis; Lipoprotein(a); Lipoprotein; Coronary artery disease; Endothelium; Endothelial dysfunction; Internal medicine; Pathophysiology; Cardiology; Vascular disease; Cholesterol","score_opus":0.030609291064568972,"score_gpt":0.23653539323081402,"score_spread":0.20592610216624505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W129630785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9586351,0.0030392043,0.00023602441,0.033556454,0.00006579741,0.0027396416,0.0000051793336,0.00007090037,0.0016517253],"genre_scores_gemma":[0.9951509,0.0013398895,0.00027917046,0.00084103824,0.0011729504,0.0011016905,0.0000030354493,0.000022272128,0.00008904657],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99892426,0.000056871453,0.00017699815,0.0002451658,0.00028624112,0.00031045813],"domain_scores_gemma":[0.9992783,0.000038442424,0.000045497392,0.00038372312,0.00003260583,0.00022141315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010647214,0.0001257076,0.00038880625,0.0000341161,0.00015108947,0.000043073585,0.000055456218,0.00009297207,0.0000033230617],"category_scores_gemma":[0.0001075051,0.000074244505,0.000115295115,0.00012020086,0.0002550791,0.000056554316,0.00006590157,0.00019924385,0.0000039922998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004689419,0.000013725757,0.01542221,0.00012597,0.0003029993,0.0000014882814,0.00036587712,8.441936e-7,0.000017955444,0.0017521329,0.000024257157,0.98192567],"study_design_scores_gemma":[0.0056627872,0.00004122553,0.98542225,0.00003389084,0.000234845,0.000016061978,0.000041135296,0.0000013001785,0.0005034332,0.0013228732,0.006628339,0.00009184078],"about_ca_topic_score_codex":0.00079548283,"about_ca_topic_score_gemma":0.000020550926,"teacher_disagreement_score":0.9818338,"about_ca_system_score_codex":0.000041705374,"about_ca_system_score_gemma":0.000030514724,"threshold_uncertainty_score":0.3027603},"labels":[],"label_agreement":null},{"id":"W132114997","doi":"10.1016/j.jacc.2014.02.578","title":"2013 ACC/AHA Cholesterol Treatment Guideline","year":2014,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Guideline; Medicine; Intensive care medicine; Blood cholesterol; Statin; National Cholesterol Education Program; Canadian Cardiovascular Society; Family medicine; Cholesterol; Internal medicine; Pathology; Metabolic syndrome; Myocardial infarction","score_opus":0.032018479441545115,"score_gpt":0.3459093765423521,"score_spread":0.313890897100807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W132114997","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043631205,0.99510515,0.00031680593,0.0014154613,0.00090646895,0.0010677045,0.00012488489,0.000007570931,0.0006196258],"genre_scores_gemma":[0.00063332415,0.9938581,0.0007571227,0.00039570738,0.0037803522,0.00002616888,0.0000075926896,0.000065581546,0.00047603875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954348,0.0012965437,0.0020574245,0.0002656624,0.0005911006,0.00035445948],"domain_scores_gemma":[0.9941327,0.00018182887,0.0036313091,0.0013293327,0.0004889618,0.00023589708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001614892,0.00045197588,0.008759641,0.00030025758,0.000060477352,0.0000044797794,0.0005301872,0.00021300375,0.000012438461],"category_scores_gemma":[0.00021396462,0.0002221767,0.0058828862,0.00045362246,0.0003889212,0.000027520438,0.00012117909,0.0005796783,0.000011761763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001377838,0.00005497688,0.00008221709,0.0022554994,0.006302314,0.00024192902,0.0000067320602,0.00003753081,0.0000027537612,0.000015698939,0.03980013,0.95106244],"study_design_scores_gemma":[0.0011480642,0.00243563,0.0001593491,0.0027780153,0.0067069395,0.01664979,0.00003090082,0.0000017793683,0.000003239749,0.000010453259,0.96992224,0.000153603],"about_ca_topic_score_codex":0.00007584279,"about_ca_topic_score_gemma":0.0000055790692,"teacher_disagreement_score":0.95090884,"about_ca_system_score_codex":0.00046266158,"about_ca_system_score_gemma":0.0016371764,"threshold_uncertainty_score":0.9060103},"labels":[],"label_agreement":null},{"id":"W13935130","doi":"10.1007/978-1-4615-1321-6_42","title":"The Atherosclerosis Reversal Clinic: The Way of the Future","year":2001,"lang":"en","type":"article","venue":"Advances in experimental medicine and biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Medicine; Pharmacotherapy; Normalization (sociology); Clinical trial; Drug; Intensive care medicine; Cardiology; Internal medicine; Pharmacology","score_opus":0.026597279550904088,"score_gpt":0.35117924697746544,"score_spread":0.32458196742656137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W13935130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78699493,0.19407675,0.000010178675,0.01478255,0.0008308944,0.0004944853,0.0000014222276,0.000008010381,0.0028007932],"genre_scores_gemma":[0.93847954,0.058492918,0.00003790728,0.0019934434,0.0007828935,0.000036737725,0.0000020474681,0.000006457074,0.00016806588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910104,0.00014697683,0.0002708362,0.0001678608,0.00012606957,0.0001871981],"domain_scores_gemma":[0.9993319,0.00014248457,0.00008973703,0.00037368631,0.000022187063,0.000040027146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005380328,0.00010238015,0.00026921878,0.000016582953,0.00015717595,0.0000018114573,0.00014602381,0.00007136509,0.00004357474],"category_scores_gemma":[0.00006082394,0.000034450175,0.000086654014,0.00016372575,0.0008177266,0.00003188127,0.000069627145,0.00019739849,0.0000014581013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013325824,0.0003783138,0.34362468,0.000107768356,0.00026471197,0.000011543084,0.005445084,0.0000011459315,0.071009204,0.008514355,0.0033070226,0.56600356],"study_design_scores_gemma":[0.0030161277,0.0016003894,0.05739287,0.00020357099,0.00005302845,0.00014647492,0.01836732,0.0000073733563,0.007867763,0.0005987163,0.91064817,0.00009821625],"about_ca_topic_score_codex":0.00012457868,"about_ca_topic_score_gemma":0.00010800808,"teacher_disagreement_score":0.9073411,"about_ca_system_score_codex":0.000023231936,"about_ca_system_score_gemma":0.00002082792,"threshold_uncertainty_score":0.30129477},"labels":[],"label_agreement":null},{"id":"W1423581981","doi":"10.1016/j.jacl.2015.08.006","title":"Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial","year":2015,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":467,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Amarin Corporation; Regeneron Pharmaceuticals; Eli Lilly and Company; AstraZeneca; CSL Behring; Danone; Amarin Pharma; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; Esperion Therapeutics; GlaxoSmithKline","keywords":"Medicine; Alirocumab; Ezetimibe; Statin; Internal medicine; Pharmacology; Cholesterol; Total cholesterol","score_opus":0.0757458802216295,"score_gpt":0.3849540900123038,"score_spread":0.3092082097906743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1423581981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890851,0.00075724855,0.0012023473,0.005302425,0.0013991224,0.0019378101,0.000008838052,0.0000050186027,0.00030208536],"genre_scores_gemma":[0.9905579,0.0020956618,0.0039929748,0.0009518735,0.0023193716,0.00002045875,0.0000064974665,0.000024830026,0.000030444535],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.992326,0.0036595087,0.0027534282,0.00023483869,0.0007700412,0.00025618117],"domain_scores_gemma":[0.992358,0.004532789,0.0017241349,0.00033453008,0.0007263237,0.0003242103],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015595522,0.00018504343,0.0026956073,0.00012633625,0.000030227635,0.000008137894,0.0001619346,0.00018650791,0.000031458312],"category_scores_gemma":[0.009770103,0.00009088758,0.00042505848,0.00013461323,0.00046621708,0.00007282563,0.00005838927,0.0009890324,0.0000015447188],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96381044,0.0012834291,0.0024987478,0.000049178372,0.00076608674,0.000026371557,0.0013318425,0.000049829454,7.29801e-7,0.00020733551,0.00039683422,0.029579157],"study_design_scores_gemma":[0.9595674,0.015999928,0.018230136,0.00028800045,0.00044542702,0.000075522395,0.00035337688,0.00010764295,0.000007681995,0.00073161663,0.004090357,0.00010290187],"about_ca_topic_score_codex":0.0001381907,"about_ca_topic_score_gemma":0.00005648033,"teacher_disagreement_score":0.029476255,"about_ca_system_score_codex":0.000053822947,"about_ca_system_score_gemma":0.000709983,"threshold_uncertainty_score":0.99857104},"labels":[],"label_agreement":null},{"id":"W1481546673","doi":"10.1111/j.1742-1241.2010.02530.x","title":"Attainment of Canadian and European guidelines’ lipid targets with atorvastatin plus ezetimibe vs. doubling the dose of atorvastatin","year":2010,"lang":"en","type":"review","venue":"International Journal of Clinical Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Atorvastatin; Ezetimibe; Medicine; Apolipoprotein B; Internal medicine; National Cholesterol Education Program; Cholesterol; Endocrinology; Lipoprotein; Pharmacology; Gastroenterology; Urology; Metabolic syndrome; Obesity","score_opus":0.1487509727956526,"score_gpt":0.47463867839498486,"score_spread":0.3258877055993322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1481546673","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094150094,0.9750644,0.0006645351,0.015216287,0.00227406,0.0010105004,0.00009311578,0.000006888318,0.004728738],"genre_scores_gemma":[0.0011694181,0.9719457,0.022210164,0.0014112344,0.0030862174,0.0000048145075,0.000020710064,0.000060720613,0.000091018344],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925723,0.0012118627,0.0039500734,0.0002756863,0.0017693607,0.0002206881],"domain_scores_gemma":[0.98711306,0.0025294786,0.005519511,0.0004698748,0.0038521357,0.0005159342],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013971814,0.00028910997,0.0020790484,0.00044604987,0.000052794694,0.000049047794,0.00055000425,0.00020320149,0.00006423665],"category_scores_gemma":[0.013709279,0.0001610795,0.000894565,0.00025858346,0.00023020702,0.00021948869,0.000115567105,0.0019987205,0.000007165709],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008738819,0.00017412854,0.000100785146,0.0012568912,0.0028256846,0.00080946716,0.00013600905,0.00001366892,7.1511505e-7,0.00020303046,0.0023261986,0.99127954],"study_design_scores_gemma":[0.002169723,0.000669977,0.00045913426,0.007165787,0.0020686972,0.0033732383,0.00013712677,0.000016462638,0.0000016583955,0.0000070083534,0.9837965,0.0001346988],"about_ca_topic_score_codex":0.004454546,"about_ca_topic_score_gemma":0.00093323993,"teacher_disagreement_score":0.99114484,"about_ca_system_score_codex":0.00013999706,"about_ca_system_score_gemma":0.004813333,"threshold_uncertainty_score":0.9945987},"labels":[],"label_agreement":null},{"id":"W148228335","doi":"","title":"Are Canadian guidelines for cholesterol lowering in high-risk patients optimal?","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Heart Research Centre","funders":"","keywords":"Pravastatin; Atorvastatin; Medicine; Myocardial infarction; Internal medicine; Unstable angina; Statin; Cholesterol; Cardiology; Revascularization; Hazard ratio; Confidence interval","score_opus":0.036233797148074086,"score_gpt":0.26477345453516266,"score_spread":0.22853965738708856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W148228335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340063,0.00034702875,0.0001424939,0.003518477,0.0002006804,0.0021288954,0.000045740915,0.000027010756,0.00018902277],"genre_scores_gemma":[0.9930918,0.00006230371,0.0012029888,0.0027760034,0.0007564754,0.0018269221,0.00002677102,0.000027419403,0.00022929702],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987656,0.00001643947,0.00028631135,0.00022323958,0.00020132585,0.0005070927],"domain_scores_gemma":[0.9990168,0.000008864927,0.00008301292,0.00029914317,0.00020521341,0.00038692166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005439443,0.00010971624,0.0002673769,0.00015186753,0.000054277087,0.000016065538,0.000066044864,0.000079768775,0.0000069614075],"category_scores_gemma":[0.00049568474,0.00009593997,0.000114089424,0.00011287515,0.000010858963,0.0000731766,0.0000142958825,0.000115713825,0.000007921892],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036007023,0.000045682904,0.24391203,0.00006045351,0.000044721066,0.0000060717443,0.000035243058,0.00039337148,2.8282668e-7,0.0000028255809,0.002190031,0.7532733],"study_design_scores_gemma":[0.0028904092,0.000022375254,0.91569275,0.00003352419,0.00003766324,0.0000023354473,0.000023101042,0.00013733968,0.0000942909,0.0000035179285,0.08096949,0.00009319091],"about_ca_topic_score_codex":0.055719264,"about_ca_topic_score_gemma":0.14874381,"teacher_disagreement_score":0.7531801,"about_ca_system_score_codex":0.00032900216,"about_ca_system_score_gemma":0.000074898446,"threshold_uncertainty_score":0.9505688},"labels":[],"label_agreement":null},{"id":"W1488264686","doi":"10.1111/cge.12201","title":"Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families","year":2013,"lang":"en","type":"article","venue":"Clinical Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Xenon Pharmaceuticals (Canada)","funders":"","keywords":"Internal medicine; Endocrinology; Apolipoprotein B; Mutation; Chemistry; Lipoprotein; High-density lipoprotein; Cholesterol; Medicine; Biochemistry; Gene","score_opus":0.0586219062177426,"score_gpt":0.3603067274898082,"score_spread":0.3016848212720656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1488264686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910093,0.0007441748,0.0017601288,0.0011920974,0.00020469048,0.0031329868,0.000008935923,0.00004755446,0.0019001242],"genre_scores_gemma":[0.98200923,0.0005680382,0.015085089,0.0007237174,0.0006940115,0.00059279974,0.000017608996,0.0000455812,0.00026392762],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975379,0.00019933471,0.0009486371,0.00048992474,0.00038174397,0.00044245814],"domain_scores_gemma":[0.9986516,0.00016819041,0.000119766024,0.0006582172,0.00016787254,0.00023435173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096892705,0.0002082154,0.0006285598,0.00017385278,0.000049421986,0.000025871583,0.00014205325,0.00025678327,0.000093341696],"category_scores_gemma":[0.00061052333,0.00017863678,0.00025908937,0.0004481316,0.00023882437,0.000054573236,0.00008741906,0.0006891705,0.00019270845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001541857,0.0028892069,0.26349056,0.00042922035,0.0002753243,0.00004875244,0.0012933324,0.0007778204,0.004367699,0.0011968517,0.00018620909,0.7248908],"study_design_scores_gemma":[0.007456568,0.0008614517,0.9794865,0.000291245,0.000066625566,0.000026728816,0.0015057696,0.002919036,0.0017137079,0.0028198815,0.0025009867,0.0003514597],"about_ca_topic_score_codex":0.0027870724,"about_ca_topic_score_gemma":0.00096699095,"teacher_disagreement_score":0.7245394,"about_ca_system_score_codex":0.0001242778,"about_ca_system_score_gemma":0.0003646666,"threshold_uncertainty_score":0.72845966},"labels":[],"label_agreement":null},{"id":"W1491374834","doi":"10.1074/jbc.m115.647180","title":"Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other","year":2015,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Fondation Leducq; University of Pennsylvania","keywords":"PCSK9; LDL receptor; Kexin; Proprotein convertase; Amyloid precursor protein; Chemistry; Endosome; Furin; Internalization; Receptor; Cell biology; LRP1; Biochemistry; Biology; Lipoprotein; Internal medicine; Cholesterol; Alzheimer's disease; Enzyme","score_opus":0.024446386814265298,"score_gpt":0.2474732982377835,"score_spread":0.2230269114235182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1491374834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645597,0.00095816905,0.00017884474,0.001568084,0.00006555481,0.00058966625,0.000017002561,0.000024840423,0.0001418573],"genre_scores_gemma":[0.9976181,0.00007605679,0.00086078316,0.00041424928,0.0005285409,0.000022606439,0.000029250508,0.000019116951,0.00043131277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998201,0.00017267995,0.0005300536,0.00027526874,0.00055047905,0.0002705192],"domain_scores_gemma":[0.9982722,0.0000633133,0.00048754452,0.00035231933,0.00042963735,0.00039498226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014600544,0.0002328595,0.00055743917,0.00002651586,0.00007752065,0.00004310098,0.00015696889,0.00027593548,0.00010808789],"category_scores_gemma":[0.0006206057,0.00011263905,0.00018742461,0.000113535985,0.00023312263,0.000089533976,0.000053587868,0.0007139521,0.000010276793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008668049,0.00047265727,0.008206378,0.00036896495,0.00061220274,0.00019448275,0.00031641292,0.0000038223197,0.94548935,0.000005406279,0.00079434115,0.034867935],"study_design_scores_gemma":[0.0043046186,0.0014303608,0.0108817415,0.00063216523,0.00013943714,0.0016568864,0.00056630815,0.000070451715,0.97229695,0.000063345826,0.0076785693,0.00027917896],"about_ca_topic_score_codex":0.00011467138,"about_ca_topic_score_gemma":0.0000055428977,"teacher_disagreement_score":0.034588758,"about_ca_system_score_codex":0.00012570026,"about_ca_system_score_gemma":0.0002544733,"threshold_uncertainty_score":0.4593287},"labels":[],"label_agreement":null},{"id":"W1491620417","doi":"10.1159/000360568","title":"Potential Peptides in Atherosclerosis Therapy","year":2014,"lang":"en","type":"review","venue":"Frontiers of hormone research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Dyslipidemia; Medicine; Scavenger receptor; Macrophage; Myocardial infarction; Disease; Atherosclerotic cardiovascular disease; Stroke (engine); Inflammation; Cholesterol; Lipid metabolism; Lipoprotein; Internal medicine; Bioinformatics; Immunology; Biology","score_opus":0.10359092211148556,"score_gpt":0.40451573660774665,"score_spread":0.3009248144962611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1491620417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051127264,0.9958412,0.00018610834,0.00008457142,0.00015396194,0.0023973098,0.000018693352,0.000022959422,0.0007839254],"genre_scores_gemma":[0.00062422134,0.9966643,0.0011247478,0.000011527624,0.0005501343,0.00027623816,0.00006884641,0.00011180185,0.00056821026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99492484,0.0010316641,0.0008493031,0.0005891503,0.0017960842,0.0008089369],"domain_scores_gemma":[0.9979648,0.000069841524,0.0001851069,0.0012261933,0.00028721517,0.0002668435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005232962,0.0003506073,0.0032004067,0.0010998765,0.00008978444,0.000029459552,0.00042898618,0.00055046874,0.000007146787],"category_scores_gemma":[0.00018045015,0.0002567842,0.0013639338,0.0009697555,0.00029601983,0.000052599135,0.00014199734,0.0014387106,0.00004764375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108519474,0.00020132997,0.000054057375,0.0026381034,0.00050905795,0.0000265016,0.000047988342,2.8409926e-7,0.000013948617,0.00001678619,0.09704218,0.8993412],"study_design_scores_gemma":[0.0013264879,0.0008119431,0.0006373286,0.0015980233,0.00016485366,0.000029699899,0.000074433796,0.0000101729365,0.0000109125895,0.00003705402,0.99509245,0.00020666789],"about_ca_topic_score_codex":0.00066637236,"about_ca_topic_score_gemma":0.0000059520526,"teacher_disagreement_score":0.8991346,"about_ca_system_score_codex":0.00034233596,"about_ca_system_score_gemma":0.0009262601,"threshold_uncertainty_score":0.99998844},"labels":[],"label_agreement":null},{"id":"W1500937011","doi":"10.18433/j33018","title":"Bicarbonate supplementation as a preventive way in statins-induced muscle damage","year":2008,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cerivastatin; Lovastatin; Simvastatin; In vivo; Pharmacology; Statin; Viability assay; Chemistry; Apoptosis; Myocyte; Medicine; Biochemistry; Pravastatin; Internal medicine; Cholesterol; Biology","score_opus":0.09127852001836051,"score_gpt":0.42734605202470133,"score_spread":0.3360675320063408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1500937011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918851,0.00084518344,0.00006700084,0.0039874134,0.00028951003,0.00046301296,0.000004074826,0.000012583502,0.0024461236],"genre_scores_gemma":[0.9952477,0.0018717978,0.0011665989,0.0012830651,0.00034209937,0.000009792955,0.0000017968862,0.000011126929,0.00006597477],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969639,0.0002975429,0.0006936312,0.0002450116,0.00135791,0.00044198305],"domain_scores_gemma":[0.9989204,0.000101830046,0.00024222299,0.00010736346,0.0001849938,0.0004432127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024381368,0.0001556246,0.00039155863,0.00030076675,0.0001816357,0.000027741482,0.00022126845,0.000030461568,0.00076157186],"category_scores_gemma":[0.00015820522,0.00011384229,0.00025561967,0.00078360806,0.00023698683,0.000492005,0.0000522979,0.0005174666,0.00001966175],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016965937,0.002118299,0.106343426,0.00027521426,0.0003763002,0.003985823,0.004161501,0.00014058713,0.38910824,0.00043056477,0.0012701625,0.4900933],"study_design_scores_gemma":[0.038052496,0.0032024933,0.31701463,0.00045764333,0.00067787454,0.0040085427,0.002170151,0.010691227,0.4664717,0.0006536625,0.15589526,0.00070431223],"about_ca_topic_score_codex":0.00026488112,"about_ca_topic_score_gemma":0.000010410847,"teacher_disagreement_score":0.48938897,"about_ca_system_score_codex":0.00016190406,"about_ca_system_score_gemma":0.0006881575,"threshold_uncertainty_score":0.8338678},"labels":[],"label_agreement":null},{"id":"W1503639662","doi":"10.1111/j.1742-4658.2008.06495.x","title":"PCSK9 is phosphorylated by a Golgi casein kinase‐like kinase <i>ex vivo</i> and circulates as a phosphoprotein in humans","year":2008,"lang":"en","type":"article","venue":"FEBS Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Proprotein convertase; PCSK9; Kexin; Phosphorylation; Endoplasmic reticulum; Casein kinase 2; Furin; Kinase; Phosphoprotein; Biology; Golgi apparatus; Protein kinase A; Biochemistry; LDL receptor; Cell biology; Chemistry; Cyclin-dependent kinase 2; Cholesterol; Lipoprotein; Enzyme","score_opus":0.01235361360377333,"score_gpt":0.24400976702781318,"score_spread":0.23165615342403986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1503639662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575527,0.038568627,0.0000668656,0.001828869,0.00024679437,0.000753379,0.000027643664,0.000054022916,0.0009011195],"genre_scores_gemma":[0.98675734,0.0066755116,0.0002772688,0.0032483793,0.0005411044,0.00003675491,0.000017955404,0.000080012236,0.0023656809],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703026,0.00015213787,0.00069332274,0.0005133342,0.0008623598,0.00074860896],"domain_scores_gemma":[0.9983354,0.000024671472,0.00020798763,0.0005356043,0.00018171477,0.0007146107],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00087862136,0.0003843161,0.00078650325,0.00023119115,0.00041069183,0.00007410846,0.00014890866,0.00026626975,0.00095604215],"category_scores_gemma":[0.00007222671,0.00033482505,0.00037168793,0.0004960849,0.00015539018,0.00020702214,0.000062331055,0.0010590084,0.000092441885],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003972458,0.0043041473,0.1978483,0.0014925915,0.003021186,0.11307944,0.020375164,0.000045077173,0.16590717,0.00020937396,0.37109035,0.118654735],"study_design_scores_gemma":[0.027797807,0.0028753632,0.078065544,0.001618308,0.0005571291,0.06389401,0.0016494393,0.00033663723,0.12379975,0.0006488559,0.69705945,0.0016977142],"about_ca_topic_score_codex":0.003081314,"about_ca_topic_score_gemma":0.000052292537,"teacher_disagreement_score":0.3259691,"about_ca_system_score_codex":0.00029783224,"about_ca_system_score_gemma":0.00046564217,"threshold_uncertainty_score":0.9999572},"labels":[],"label_agreement":null},{"id":"W1504080602","doi":"10.3724/sp.j.1263.2011.00001","title":"The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years","year":2011,"lang":"en","type":"article","venue":"Journal of Geriatric Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Atorvastatin; Ezetimibe; Medicine; Statin; Internal medicine; Simvastatin; Coronary heart disease; Urology; Gastroenterology; Lipid profile; Cholesterol; Cardiology; Pharmacology","score_opus":0.05963006212045365,"score_gpt":0.31425482723349096,"score_spread":0.25462476511303733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1504080602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964631,0.00006568318,0.0011376608,0.00010022387,0.00071418495,0.0013074748,0.000045174864,0.0000072399134,0.00015925417],"genre_scores_gemma":[0.9954749,0.000029398869,0.0037572342,0.00015858746,0.00042589102,0.000034984394,0.0000079104475,0.000027571072,0.0000835605],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9969714,0.0006001391,0.0011175812,0.00027994145,0.0006119364,0.00041898058],"domain_scores_gemma":[0.997971,0.00030891644,0.00042863705,0.00043743022,0.00044913363,0.00040486464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016283094,0.00021113874,0.0012559068,0.00047652837,0.000044748384,0.000011443802,0.00024626346,0.00012755294,0.00012623935],"category_scores_gemma":[0.0006909094,0.00014024861,0.00038468078,0.0007565039,0.00004857864,0.000061492225,0.00010560914,0.00026080714,0.000034772183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5760945,0.0016742332,0.104495026,0.00046098535,0.0065451325,0.0019891139,0.124393,0.0034135187,0.013098219,0.00019503785,0.04719409,0.12044714],"study_design_scores_gemma":[0.00737951,0.009669082,0.9775452,0.0000822654,0.00022500035,0.000050008777,0.0016625801,0.0000038962708,0.0007519437,0.00000549037,0.002450994,0.00017404249],"about_ca_topic_score_codex":0.0003090236,"about_ca_topic_score_gemma":0.0002738801,"teacher_disagreement_score":0.87305015,"about_ca_system_score_codex":0.00021703537,"about_ca_system_score_gemma":0.00037620423,"threshold_uncertainty_score":0.57191724},"labels":[],"label_agreement":null},{"id":"W1505196721","doi":"","title":"Statines et prévention primaire (encore...)","year":2014,"lang":"fr","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gynecology; Humanities; Political science; Philosophy","score_opus":0.013033969747370113,"score_gpt":0.2862413436193532,"score_spread":0.27320737387198313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1505196721","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14326856,0.060572267,0.27106592,0.033665817,0.008709219,0.0022171524,0.00002387424,0.00035526347,0.48012194],"genre_scores_gemma":[0.8176057,0.004382887,0.017896207,0.005457039,0.0053085126,0.00006696605,0.0001056014,0.0000818544,0.14909524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980228,0.00033363345,0.0003430236,0.00031621242,0.0005232397,0.0004611109],"domain_scores_gemma":[0.9988719,0.00005300296,0.000082727805,0.00057158835,0.00014017899,0.00028057466],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001968203,0.00018574174,0.00039476712,0.00006112649,0.000084762134,0.00003341986,0.00007042129,0.00015652209,0.0022928289],"category_scores_gemma":[0.00022938504,0.00015482384,0.00031072192,0.00017465175,0.00007950456,0.00015080125,0.00004323844,0.00024602303,0.00079691043],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042569634,0.0002845135,0.0043564043,0.0020330038,0.00021472064,0.00002375189,0.00032155376,0.000022626107,0.0002407778,0.12830682,0.019565947,0.8445873],"study_design_scores_gemma":[0.0026539578,0.0009251639,0.07127691,0.0012079708,0.00037457384,0.00017027173,0.00041007303,0.002318835,0.0013187337,0.003310177,0.91572934,0.0003039749],"about_ca_topic_score_codex":0.0011480014,"about_ca_topic_score_gemma":0.0002877088,"teacher_disagreement_score":0.8961634,"about_ca_system_score_codex":0.00010811606,"about_ca_system_score_gemma":0.000253815,"threshold_uncertainty_score":0.9999811},"labels":[],"label_agreement":null},{"id":"W1509925720","doi":"10.1007/bf03405430","title":"Statin Use in Canadians: Trends, Determinants and Persistence","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Public Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Calgary; Public Health Agency of Canada; University of Ottawa","funders":"Servier; Sanofi; Pfizer; Pfizer Canada; Bristol-Myers Squibb","keywords":"Medicine; Statin; Medical prescription; Comorbidity; Diabetes mellitus; Population; Disease; Physical therapy; Internal medicine; Demography; Environmental health; Endocrinology","score_opus":0.0773016645139017,"score_gpt":0.30189911227668736,"score_spread":0.22459744776278567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1509925720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840184,0.00450391,0.00020481514,0.0104913,0.00019624904,0.00015201695,0.000022639884,0.0000031155173,0.00040754775],"genre_scores_gemma":[0.9941624,0.00022401634,0.0011160811,0.004046372,0.00017172821,9.0658233e-7,0.000003262582,0.00001577654,0.00025944842],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99795246,0.00012805346,0.0005917545,0.00014611398,0.0002762839,0.0009053388],"domain_scores_gemma":[0.99439925,0.000050669285,0.00018927213,0.00020487825,0.00018708849,0.0049688583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004440838,0.00010841186,0.00043126463,0.0011803685,0.000116040865,0.000058561924,0.00008510254,0.000076448014,0.000054444135],"category_scores_gemma":[0.0005918878,0.000097241114,0.0000945249,0.0005056337,0.000086178574,0.00025230355,0.0000043648365,0.000363093,0.0000011951549],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009371583,0.000014606882,0.40150145,0.00008525387,0.00002842877,0.0016621548,0.0024206776,4.557166e-7,0.0000018345427,0.00011681635,0.0012196354,0.5929393],"study_design_scores_gemma":[0.0010266441,0.00037692866,0.8835078,0.00017685143,0.00000975098,0.0023189008,0.0034318503,0.000014894523,0.0000026154307,0.000008110843,0.10903881,0.00008684084],"about_ca_topic_score_codex":0.51636803,"about_ca_topic_score_gemma":0.9523072,"teacher_disagreement_score":0.5928525,"about_ca_system_score_codex":0.0012311601,"about_ca_system_score_gemma":0.013921678,"threshold_uncertainty_score":0.99166846},"labels":[],"label_agreement":null},{"id":"W1512171729","doi":"10.1111/1753-0407.12139","title":"Variable effects of gender and <scp>W</scp>estern diet on lipid and glucose homeostasis in aged <scp>PCSK9</scp>‐deficient <scp>C57BL</scp>/6 mice 性别与西方饮食对CSK9基因缺陷的PC57BL/6老龄小鼠的脂质以及葡萄糖内稳态的不同影响","year":2014,"lang":"en","type":"article","venue":"Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; PCSK9; Endocrinology; Diabetes mellitus; Internal medicine; Cholesterol; LDL receptor; Lipoprotein","score_opus":0.008614441304580398,"score_gpt":0.2236716722274979,"score_spread":0.2150572309229175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1512171729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654056,0.031147465,0.00022240765,0.00007284059,0.0006925684,0.00092202006,0.000025747257,0.0000352736,0.001476082],"genre_scores_gemma":[0.9934533,0.0026528174,0.0015061365,0.0010030931,0.0009489018,0.000035789726,0.000013448091,0.000110862646,0.00027560967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99480456,0.0006962299,0.0013470054,0.00065703614,0.0013744787,0.0011207109],"domain_scores_gemma":[0.9931313,0.0039176545,0.0009842418,0.00075211836,0.00039381563,0.0008208849],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003830096,0.00062622916,0.0020614082,0.0008076754,0.00017760127,0.00012872647,0.0003159823,0.00041961527,0.000004467838],"category_scores_gemma":[0.005771003,0.0005048095,0.00051057007,0.0006906969,0.00021973194,0.00033865302,0.00018731359,0.0011088809,0.000011093275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002798463,0.0072927973,0.5908189,0.02825941,0.006412945,0.00066945725,0.018423617,0.00067724945,0.21481483,0.001050279,0.025914963,0.10538574],"study_design_scores_gemma":[0.019490832,0.011455522,0.7584442,0.0045786337,0.0020980388,0.0002574312,0.002923441,0.0006585331,0.16006108,0.001108593,0.03868067,0.00024302048],"about_ca_topic_score_codex":0.000073170435,"about_ca_topic_score_gemma":0.000010534219,"teacher_disagreement_score":0.16762534,"about_ca_system_score_codex":0.00017174937,"about_ca_system_score_gemma":0.00024497558,"threshold_uncertainty_score":0.99974036},"labels":[],"label_agreement":null},{"id":"W1514423800","doi":"10.5915/33-2-6518","title":"Understanding and Managing Cerbrovascular Disease: Are We Ready to Bring the Tragic Disease to Primetime?","year":2001,"lang":"en","type":"article","venue":"Journal of the Islamic Medical Association of North America","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Disease; Intensive care medicine; Pathology","score_opus":0.026853353873075223,"score_gpt":0.26432917848622633,"score_spread":0.23747582461315112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1514423800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74546367,0.0018912549,0.01746852,0.23382403,0.0003485803,0.0007004707,0.000011301777,0.000015689842,0.00027650964],"genre_scores_gemma":[0.99163985,0.0024237246,0.00019173884,0.0046996856,0.00054298295,0.0000037595855,0.0000016968925,0.000018964805,0.00047759098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637127,0.00026882923,0.00055708573,0.0001637708,0.0023621714,0.0002768573],"domain_scores_gemma":[0.9981393,0.00017157386,0.0005942411,0.0003519668,0.00019429762,0.0005486212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015842662,0.00013291146,0.00048294215,0.00011802612,0.00013974492,0.000023297502,0.0002518283,0.000044197837,0.000051904706],"category_scores_gemma":[0.0018377971,0.000075939075,0.00037598523,0.0005424506,0.000058301674,0.000060621347,0.00009882175,0.0004187452,0.0000062183076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001229974,0.0005225264,0.755821,0.0007081327,0.0028161902,0.0006548845,0.002055353,0.0030739647,0.000045277462,0.00026180458,0.022827813,0.20998311],"study_design_scores_gemma":[0.0013584307,0.00017229225,0.94525236,0.0011913499,0.00087061385,0.000091512986,0.0005508689,0.00073148945,0.000006433194,0.0004515226,0.049171522,0.00015159402],"about_ca_topic_score_codex":0.000058829617,"about_ca_topic_score_gemma":0.000044106415,"teacher_disagreement_score":0.24617621,"about_ca_system_score_codex":0.00053947745,"about_ca_system_score_gemma":0.0003427267,"threshold_uncertainty_score":0.30967057},"labels":[],"label_agreement":null},{"id":"W1516522660","doi":"","title":"Statin induced myopathy presenting as mechanical musculoskeletal pain observed in two chiropractic patients.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Memorial Chiropractic College","funders":"","keywords":"myalgia; Myopathy; Statin; Medicine; Chiropractic; Rhabdomyolysis; Physical therapy; Physical medicine and rehabilitation; Bioinformatics; Internal medicine; Alternative medicine; Pathology","score_opus":0.02993025712979379,"score_gpt":0.2865052620777323,"score_spread":0.2565750049479385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1516522660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460274,0.00003977007,0.000037496255,0.0006408793,0.00048097633,0.0024584811,0.0000029839791,0.00008266591,0.0016539912],"genre_scores_gemma":[0.9967133,0.000009433188,0.00059064757,0.00053941074,0.0004495237,0.001524004,0.000043528893,0.00004739314,0.00008278575],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972219,0.00039390856,0.0004937578,0.0004527127,0.00072109036,0.0007166359],"domain_scores_gemma":[0.9985729,0.00011491133,0.00014659407,0.0006423203,0.00011460138,0.00040867916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039192103,0.00020454297,0.00044006194,0.00013416598,0.00008539058,0.000040124265,0.0001377345,0.0001323008,0.000060280945],"category_scores_gemma":[0.0044764513,0.0001752332,0.00026430486,0.00033751017,0.000027705333,0.0001788941,0.000101124344,0.00097369554,0.000027348693],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012287065,0.0006589642,0.06505544,0.00021767578,0.00009901215,0.00013706578,0.00016092474,0.000001249184,0.0013867766,0.00026157155,0.00004358619,0.93185484],"study_design_scores_gemma":[0.004793515,0.00016834761,0.9896195,0.000024413373,0.00008274352,0.000022408094,0.00009803062,0.0002965909,0.0017578804,0.00025699046,0.0026445673,0.0002350329],"about_ca_topic_score_codex":0.0016117959,"about_ca_topic_score_gemma":0.0005087258,"teacher_disagreement_score":0.9316198,"about_ca_system_score_codex":0.00008952786,"about_ca_system_score_gemma":0.000126252,"threshold_uncertainty_score":0.71458024},"labels":[],"label_agreement":null},{"id":"W1520609538","doi":"10.1056/nejmoa1410489","title":"Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4415,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Ezetimibe; Medicine; Acute coronary syndrome; Statin; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.03614455167931328,"score_gpt":0.3079256884203498,"score_spread":0.2717811367410365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1520609538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96055156,0.01038209,0.0013408208,0.025581095,0.00086716015,0.00039749415,0.0000043118084,0.00001945358,0.0008559993],"genre_scores_gemma":[0.9817266,0.001773135,0.0035421404,0.0062899073,0.0053626006,0.0000065505787,0.000007276094,0.000033813638,0.0012580128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977721,0.00013661222,0.00054601434,0.0001516725,0.0011233183,0.0002702804],"domain_scores_gemma":[0.99778175,0.00005887317,0.00016958466,0.000318873,0.0004015476,0.0012693633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017868795,0.00018224315,0.000776119,0.00021543732,0.000025411757,0.000008288754,0.000118985554,0.000069704154,0.00043907162],"category_scores_gemma":[0.00024565583,0.00010484043,0.00015425283,0.00021932855,0.00005320218,0.0000843248,0.000022345612,0.00035959718,0.000024686604],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012280435,0.00015918186,0.011475965,0.00005441665,0.0013151026,0.0073902765,0.0057907626,0.000021320539,0.001091584,0.000022905278,0.098801546,0.8615965],"study_design_scores_gemma":[0.16634609,0.022500776,0.12500146,0.0011879508,0.0007967766,0.032392018,0.0009637582,0.000014906994,0.0006726215,0.000569554,0.6492581,0.00029603127],"about_ca_topic_score_codex":0.00014041606,"about_ca_topic_score_gemma":0.000012215482,"teacher_disagreement_score":0.86130047,"about_ca_system_score_codex":0.00009212486,"about_ca_system_score_gemma":0.00059259863,"threshold_uncertainty_score":0.48075265},"labels":[],"label_agreement":null},{"id":"W1533565183","doi":"","title":"What role do genes play in abnormal HDL levels","year":2001,"lang":"en","type":"article","venue":"Europe PMC (PubMed Central)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geneticist; Bioinformatics; Medicine; Gerontology; Genetics; Biology","score_opus":0.019672505172637755,"score_gpt":0.23740432677421341,"score_spread":0.21773182160157567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1533565183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97193384,0.017571297,0.000062538486,0.0011722115,0.0010252238,0.0009924571,0.000006137244,0.00010194701,0.0071343365],"genre_scores_gemma":[0.9824813,0.012518887,0.00018472885,0.0009235145,0.0012741359,0.00008702213,0.00001744707,0.000067196546,0.0024457427],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99698746,0.00018382283,0.00041144007,0.00047081267,0.00059628143,0.0013501642],"domain_scores_gemma":[0.99853283,0.000020231773,0.00007085961,0.0006981082,0.00007892002,0.0005990507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008637675,0.00024941636,0.00045143545,0.00013961787,0.000072520896,0.000113951384,0.00018332417,0.00010747306,0.0002794804],"category_scores_gemma":[0.00010127601,0.0002102715,0.00020182521,0.000546486,0.000050925242,0.00040558094,0.00007815207,0.00036039308,0.00016868372],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030820558,0.0003447468,0.1961243,0.00012291639,0.00018097939,0.0021812238,0.004146585,0.00008648357,0.0011182454,0.00019208134,0.0006445538,0.7945497],"study_design_scores_gemma":[0.0019751696,0.000066320594,0.66754705,0.00012060828,0.000048574224,0.00041297305,0.00032610836,0.000019159554,0.002864858,0.000020593488,0.32639247,0.000206109],"about_ca_topic_score_codex":0.00018841059,"about_ca_topic_score_gemma":0.00007396262,"teacher_disagreement_score":0.7943436,"about_ca_system_score_codex":0.00017723041,"about_ca_system_score_gemma":0.0001942697,"threshold_uncertainty_score":0.8574622},"labels":[],"label_agreement":null},{"id":"W1535008806","doi":"10.1161/str.46.suppl_1.wp269","title":"Abstract W P269: High vs. Moderate-intensity Statin Therapy After Ischemic Stroke: Findings from PROSPER","year":2015,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Mace; Statin; Stroke (engine); Hazard ratio; Proportional hazards model; Internal medicine; Physical therapy; Comorbidity; Emergency medicine; Myocardial infarction; Confidence interval","score_opus":0.02018334610404985,"score_gpt":0.25743438655642736,"score_spread":0.23725104045237752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1535008806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993867,0.0013450548,0.00022282112,0.0010521819,0.00034817558,0.00072261464,0.00029150947,0.000112026675,0.0020386402],"genre_scores_gemma":[0.9932375,0.0001586274,0.001835836,0.0014509028,0.0007484764,0.00008629678,0.00012381129,0.000053724056,0.002304857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997917,0.000032936223,0.0003277946,0.00047977266,0.00077273184,0.0004697705],"domain_scores_gemma":[0.99850214,0.000018869805,0.000071819086,0.0006956823,0.00030296814,0.00040853518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043250798,0.0002753352,0.00062963465,0.00006428361,0.000064099295,0.000057089674,0.000109283246,0.00018669371,0.0004383996],"category_scores_gemma":[0.00005748416,0.00021404907,0.0002695204,0.000076734315,0.00006694456,0.00015135002,0.000049124257,0.00047748242,0.0002218305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042245355,0.0019187949,0.5172003,0.0005321439,0.005003406,0.0019351604,0.008417194,0.00009928854,0.20342545,0.00015675626,0.13512588,0.0839403],"study_design_scores_gemma":[0.012489464,0.000873127,0.73955697,0.00018957682,0.00020591868,0.000059342936,0.0005445703,0.00019984115,0.19631138,0.00019425666,0.04871607,0.0006594728],"about_ca_topic_score_codex":0.0030493885,"about_ca_topic_score_gemma":0.00005379965,"teacher_disagreement_score":0.22235669,"about_ca_system_score_codex":0.00016177354,"about_ca_system_score_gemma":0.00029628977,"threshold_uncertainty_score":0.8728668},"labels":[],"label_agreement":null},{"id":"W1539154931","doi":"","title":"Cholesterol lowering for secondary prevention: what statin dose should we use?","year":2007,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Statin; Internal medicine; Coronary artery disease; Cardiology; Placebo; Cholesterol; Acute coronary syndrome; Clinical trial; Myocardial infarction; Pathology","score_opus":0.07317210287646228,"score_gpt":0.306474230416834,"score_spread":0.23330212754037175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1539154931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95959693,0.0046180733,0.02310791,0.003043776,0.0012036319,0.006841377,0.000015657157,0.00017316674,0.0013994967],"genre_scores_gemma":[0.9886579,0.0006764256,0.0016252738,0.0017010814,0.0010546971,0.0019246988,0.000044809993,0.000055029912,0.004260084],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985489,0.000022290045,0.0003038041,0.00027267655,0.00033092417,0.0005213605],"domain_scores_gemma":[0.99911064,0.000054558193,0.000067350215,0.0004036287,0.00007707727,0.0002867513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015696401,0.00013288735,0.00028706453,0.00008714947,0.00007442805,0.00009826703,0.00006164282,0.000101360194,0.000034703953],"category_scores_gemma":[0.00008207542,0.00011615367,0.0002692696,0.00011819199,0.000025098374,0.0004789835,0.00003043467,0.0001938723,0.0000064052983],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017326436,0.00007709606,0.0007411681,0.0003524625,0.0001273009,0.000015699032,0.00012581797,0.000001928449,0.000035054025,0.000028472197,0.00049844355,0.9978233],"study_design_scores_gemma":[0.0054640714,0.0001695728,0.69288456,0.00019329837,0.00016868075,0.00008124701,0.00040997317,0.000011614723,0.0055005993,0.00012053228,0.29477766,0.00021816572],"about_ca_topic_score_codex":0.000029043209,"about_ca_topic_score_gemma":0.00007053795,"teacher_disagreement_score":0.99760514,"about_ca_system_score_codex":0.000107839434,"about_ca_system_score_gemma":0.00006922157,"threshold_uncertainty_score":0.47366092},"labels":[],"label_agreement":null},{"id":"W1542603599","doi":"10.1016/j.jacl.2015.06.012","title":"The apoB-to-PCSK9 ratio: A new index for metabolic risk in humans","year":2015,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Endocrinology; Internal medicine; PCSK9; Apolipoprotein B; Medicine; Kexin; Postprandial; Lipoprotein; Hyperinsulinemia; Insulin resistance; Type 2 diabetes; Insulin; Cholesterol; LDL receptor; Diabetes mellitus","score_opus":0.13075347700927287,"score_gpt":0.4440603937341583,"score_spread":0.3133069167248854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1542603599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8997863,0.0076709865,0.041637752,0.036761865,0.011678351,0.0015538816,0.000006057479,0.000018266202,0.00088656833],"genre_scores_gemma":[0.9470977,0.0017427366,0.0071468307,0.0066181384,0.036115456,0.000026384974,0.000002198546,0.000038398302,0.0012121347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99670136,0.0007105392,0.0016956048,0.00017246774,0.0004050926,0.00031494023],"domain_scores_gemma":[0.9966691,0.0012098623,0.0006299626,0.00040239343,0.00041248035,0.0006761716],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012907507,0.00011412233,0.00110942,0.00012333787,0.00006158875,0.00001672228,0.00021663027,0.00022770252,0.000014035114],"category_scores_gemma":[0.014177864,0.0000648569,0.00069313956,0.00018728555,0.00008654403,0.000057112302,0.000044515888,0.00086047244,0.000020624007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010366591,0.0006154358,0.2245681,0.000038755734,0.0013642075,0.00003883109,0.0007693187,0.00031542737,0.000042433036,0.004121564,0.12530077,0.63245857],"study_design_scores_gemma":[0.009136886,0.0024986477,0.17368947,0.000031958727,0.00024515094,0.00011348104,0.00016698077,0.00009251027,0.000018539275,0.004393107,0.80954105,0.00007222319],"about_ca_topic_score_codex":0.00016242078,"about_ca_topic_score_gemma":0.00042226008,"teacher_disagreement_score":0.6842403,"about_ca_system_score_codex":0.000036573565,"about_ca_system_score_gemma":0.0014484479,"threshold_uncertainty_score":0.99412614},"labels":[],"label_agreement":null},{"id":"W1546107817","doi":"10.1023/a:1024449603891","title":"Lipoprotein disorders and cardiovascular risk","year":2003,"lang":"en","type":"review","venue":"Journal of Inherited Metabolic Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Medicine; Asymptomatic; Disease; Coronary artery disease; Internal medicine; Lipoprotein; Vascular disease; Very low-density lipoprotein; Etiology; Cardiology; Cholesterol; Endocrinology","score_opus":0.02187244829319028,"score_gpt":0.292538090608634,"score_spread":0.2706656423154437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1546107817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023626396,0.99684685,0.00025945297,0.000037216563,0.0004809629,0.001712614,0.00007970089,0.000024897397,0.00032203074],"genre_scores_gemma":[0.000050022143,0.9970495,0.0010519335,0.00013292638,0.0013307284,0.000076900214,0.000019633126,0.00015236996,0.00013595018],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950472,0.0011013339,0.0014872458,0.00049805635,0.0013817823,0.0004843639],"domain_scores_gemma":[0.9957268,0.00004887782,0.0010532018,0.0012767271,0.00031496605,0.001579398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025242288,0.0006842735,0.0053535835,0.0006393267,0.00012914975,0.00007066891,0.00022308686,0.00034399802,0.0000819722],"category_scores_gemma":[0.0007319608,0.00047513633,0.006693987,0.0007692203,0.00013929256,0.00015347725,0.00006804835,0.0013585862,0.000016236381],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007373545,0.00019440734,0.000035980785,0.013135118,0.007597853,0.0003913025,0.00001802278,0.000002195801,7.596906e-8,0.000044176166,0.00031049768,0.9781966],"study_design_scores_gemma":[0.0017700156,0.00012823398,0.00073840417,0.0075451015,0.03958524,0.0008746314,0.000026789223,0.0000012219152,1.7556897e-7,0.00008339855,0.9488577,0.00038906393],"about_ca_topic_score_codex":0.00008748868,"about_ca_topic_score_gemma":0.0000021128733,"teacher_disagreement_score":0.9778076,"about_ca_system_score_codex":0.00007541768,"about_ca_system_score_gemma":0.0017235228,"threshold_uncertainty_score":0.99977005},"labels":[],"label_agreement":null},{"id":"W154753375","doi":"10.1016/s0021-9150(99)00212-9","title":"Coexisting dysbetalipoproteinemia and familial hypercholesterolemia","year":2000,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Medical Research Council Canada","keywords":"Familial hypercholesterolemia; Allele; Internal medicine; Endocrinology; LDL receptor; Population; Medicine; Genetics; Biology; Cholesterol; Lipoprotein; Gene","score_opus":0.01936425720277135,"score_gpt":0.2505551784458535,"score_spread":0.23119092124308216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W154753375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99124134,0.00051810255,0.00005328207,0.00046084492,0.000050782015,0.00048135722,0.000008762453,0.00013397272,0.007051557],"genre_scores_gemma":[0.9944041,0.00061910995,0.0015910158,0.0012971645,0.00038035543,0.00005594608,0.000010872758,0.00004603624,0.0015954168],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986209,0.00005304178,0.00025476114,0.00037642766,0.0003507069,0.0003441484],"domain_scores_gemma":[0.99917686,0.000017536617,0.000033929093,0.00048680545,0.000040841456,0.00024405436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034540117,0.00019152994,0.00037468606,0.00003882427,0.00016451521,0.000038635804,0.00006712462,0.00013567077,0.0004228794],"category_scores_gemma":[0.000029114088,0.00016304011,0.00015808131,0.000150959,0.00010186014,0.00008400069,0.000028962135,0.0002254169,0.00013736574],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014207563,0.00011811071,0.036018368,0.00019442216,0.00015112589,0.000014742669,0.00047461418,0.00000440692,0.04095191,0.00010319485,0.00032254448,0.9215045],"study_design_scores_gemma":[0.005169971,0.00066019385,0.9307526,0.00049760524,0.00030800578,0.00029439345,0.00017100347,0.00024018125,0.0072198026,0.0001085005,0.054070972,0.000506795],"about_ca_topic_score_codex":0.0005893398,"about_ca_topic_score_gemma":0.000013852596,"teacher_disagreement_score":0.9209977,"about_ca_system_score_codex":0.000052480067,"about_ca_system_score_gemma":0.00004387349,"threshold_uncertainty_score":0.6648583},"labels":[],"label_agreement":null},{"id":"W1548034605","doi":"10.1111/j.1542-4758.2012.00687.x","title":"Oxidized low‐density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: Influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene","year":2012,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Internal medicine; Adiponectin; Endocrinology; Apolipoprotein B; Lipoprotein; Medicine; Hemodialysis; Low-density lipoprotein; Kidney disease; Lipid profile; Body mass index; Cholesterol; Obesity; Insulin resistance","score_opus":0.013548352819517669,"score_gpt":0.257273237365772,"score_spread":0.24372488454625435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1548034605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954184,0.0016180653,0.0002435017,0.000980134,0.000083192506,0.0014658187,0.000093405724,0.000013848177,0.00008357673],"genre_scores_gemma":[0.9979433,0.00021759835,0.0006107139,0.0005619314,0.0003078379,0.00022687377,0.00007488396,0.000029165372,0.000027686763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657625,0.00036604697,0.0008963595,0.00047832183,0.0012240442,0.00045895367],"domain_scores_gemma":[0.9981701,0.00010191656,0.0003858007,0.0006948874,0.00027039504,0.00037691864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018029885,0.00031030228,0.0008404723,0.00059193524,0.00006536501,0.000024216219,0.00025648632,0.00016906194,0.00005466246],"category_scores_gemma":[0.0007912392,0.00025066652,0.00028565782,0.00059893006,0.00024862716,0.00031579667,0.00018692201,0.00034764197,0.0000036438078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029028144,0.003526159,0.8189785,0.0018674257,0.0019862163,0.00006903442,0.0049812165,0.0008222488,0.10573395,0.0019709892,0.000065641456,0.057095792],"study_design_scores_gemma":[0.0059692427,0.00011661641,0.9685684,0.00041754733,0.00029615982,0.000024876208,0.000089329274,0.00056723773,0.023197614,0.00042151238,0.000089053916,0.00024242686],"about_ca_topic_score_codex":0.00741457,"about_ca_topic_score_gemma":0.000429059,"teacher_disagreement_score":0.14958988,"about_ca_system_score_codex":0.0003417093,"about_ca_system_score_gemma":0.00039570374,"threshold_uncertainty_score":0.9999946},"labels":[],"label_agreement":null},{"id":"W1553780630","doi":"10.1074/jbc.m102953200","title":"Lipid Association-induced N- and C-terminal Domain Reorganization in Human Apolipoprotein E3","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Terminal (telecommunication); Apolipoprotein B; Association (psychology); Domain (mathematical analysis); Apolipoprotein E; Chemistry; Internal medicine; Endocrinology; Medicine; Cholesterol; Psychology; Computer science; Telecommunications; Disease","score_opus":0.018422818047377307,"score_gpt":0.27172834569544135,"score_spread":0.253305527648064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1553780630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758136,0.00028435647,0.000040137013,0.0009351302,0.000032059463,0.00010982879,8.6874525e-7,0.000009127976,0.0010071343],"genre_scores_gemma":[0.9980521,0.00026412567,0.000301801,0.00016647475,0.0010413205,0.0000025266822,0.0000060156044,0.000007244943,0.00015840027],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989102,0.000061011644,0.00043130547,0.00013190518,0.00027880742,0.0001867559],"domain_scores_gemma":[0.9992796,0.000027549602,0.00028415347,0.00011830958,0.00013847565,0.00015187894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096886157,0.00010037937,0.0003768674,0.000036846024,0.000049560316,0.000015416355,0.00006287698,0.00026164774,0.00010953477],"category_scores_gemma":[0.00040496406,0.00007082613,0.00011597418,0.0001678264,0.00002377297,0.00004319396,0.000026187405,0.00039412276,0.0000015161886],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013162447,0.00017257394,0.16400829,0.00007702231,0.00006381315,0.000377522,0.00006050101,4.806036e-7,0.8300339,0.000014907143,0.000090717855,0.0049686353],"study_design_scores_gemma":[0.006968253,0.0011824828,0.62581676,0.000444186,0.000106097,0.0065870364,0.00047477245,0.000008636313,0.34907404,0.0012845284,0.007697977,0.00035523332],"about_ca_topic_score_codex":0.000022990844,"about_ca_topic_score_gemma":0.0000020534405,"teacher_disagreement_score":0.4809599,"about_ca_system_score_codex":0.00024109284,"about_ca_system_score_gemma":0.00007150928,"threshold_uncertainty_score":0.28882056},"labels":[],"label_agreement":null},{"id":"W1553897441","doi":"10.1111/j.0009-9163.2004.00223.x","title":"The Δ&gt;15 Kb deletion French Canadian founder mutation in familial hypercholesterolemia: rapid polymerase chain reaction‐based diagnostic assay and prevalence in Quebec","year":2004,"lang":"en","type":"article","venue":"Clinical Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University; Centre Hospitalier Universitaire Sainte-Justine","funders":"Health Canada","keywords":"Familial hypercholesterolemia; Alu element; Genetics; Exon; Biology; Population; LDL receptor; Polymerase chain reaction; Breakpoint; Founder effect; Allele; Mutation; Gene; Molecular biology; Human genome; Medicine; Lipoprotein; Genome; Cholesterol; Haplotype; Endocrinology","score_opus":0.025818183999937714,"score_gpt":0.3077423088906813,"score_spread":0.2819241248907436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1553897441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894809,0.004950806,0.0006075879,0.003762366,0.00030263557,0.0007967484,0.000007578319,0.000013407604,0.000077950775],"genre_scores_gemma":[0.99380565,0.0036636759,0.00035671543,0.0016630021,0.00032455,0.000066144145,0.000027574624,0.000018763514,0.00007393764],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99799687,0.00040242597,0.00060962804,0.0003508249,0.00030234043,0.00033789047],"domain_scores_gemma":[0.99842757,0.0006732577,0.00007674755,0.00042268503,0.00007657308,0.00032315255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001980708,0.00013801284,0.00027617917,0.00011690423,0.00010168934,0.00003147754,0.00008070195,0.00026329642,0.0000056649665],"category_scores_gemma":[0.0017509522,0.00011255522,0.00010014533,0.0002272417,0.00017020365,0.000040515948,0.000018079796,0.0004849243,0.000009535384],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011652278,0.00033670172,0.25264037,0.00020011795,0.000045994857,0.0002598801,0.00036753228,0.0008226665,0.00026145976,0.00005372971,0.00006256554,0.74483246],"study_design_scores_gemma":[0.0037168674,0.00035744952,0.9928808,0.00021287097,0.00006452109,0.000025512198,0.00009295486,0.0007657562,0.000094045376,0.00016178265,0.0015029514,0.00012448263],"about_ca_topic_score_codex":0.23689179,"about_ca_topic_score_gemma":0.7818402,"teacher_disagreement_score":0.744708,"about_ca_system_score_codex":0.00038874778,"about_ca_system_score_gemma":0.001232374,"threshold_uncertainty_score":0.7681898},"labels":[],"label_agreement":null},{"id":"W1557641267","doi":"10.1097/01.hco.0000231412.15049.fb","title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","year":2006,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Government of Canada; St. Michael's Hospital; Credit Valley Hospital","funders":"","keywords":"Medicine; Fenofibrate; Fibrate; Clinical trial; Statin; Diabetes mellitus; National Cholesterol Education Program; Internal medicine; Cholesterol; Randomized controlled trial; Subgroup analysis; Observational study; Intensive care medicine; Meta-analysis; Endocrinology; Metabolic syndrome","score_opus":0.7069838768937562,"score_gpt":0.6250334912465941,"score_spread":0.08195038564716206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1557641267","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000027649285,0.97358435,0.00093682087,0.0014201734,0.007362018,0.016122686,0.00036564126,0.000030980562,0.00017455328],"genre_scores_gemma":[0.000008308548,0.96180654,0.00045001824,0.000060667066,0.010767058,0.022983812,0.0038610229,0.00003474707,0.000027860013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99394715,0.0014386978,0.003430233,0.000598346,0.00030341023,0.00028214676],"domain_scores_gemma":[0.99518913,0.0012885109,0.0011782475,0.0006969368,0.0015451746,0.00010202815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005656655,0.00036007212,0.003832071,0.00022061981,0.00007202779,0.0000119430615,0.00020171597,0.00047057026,0.0000072636335],"category_scores_gemma":[0.0024698472,0.0002052145,0.0027579612,0.0003077146,0.00012602545,0.000021588254,0.00004056099,0.0003392384,0.0000049058917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003224004,0.0004739925,0.00016536805,0.005524451,0.0006060766,3.315929e-8,0.000005683638,0.000006186386,2.1053644e-8,0.0003980655,0.02103694,0.9717509],"study_design_scores_gemma":[0.0019884508,0.000403419,0.0017084914,0.0039979625,0.0014116665,0.000082795,0.000011790419,0.00001270141,8.731267e-8,0.000105304,0.9901298,0.00014749312],"about_ca_topic_score_codex":0.00005888034,"about_ca_topic_score_gemma":0.00000532145,"teacher_disagreement_score":0.97160345,"about_ca_system_score_codex":0.00046274374,"about_ca_system_score_gemma":0.0034471338,"threshold_uncertainty_score":0.8368404},"labels":[],"label_agreement":null},{"id":"W1562047291","doi":"","title":"La pravastatine et le risque d’un accident vasculaire cérébral","year":2001,"lang":"fr","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Gynecology; Medicine","score_opus":0.012645583482896012,"score_gpt":0.2768175621889962,"score_spread":0.2641719787061002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1562047291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40294862,0.11936258,0.03913793,0.07793334,0.003060962,0.0026239245,0.000023468705,0.0004409253,0.35446826],"genre_scores_gemma":[0.9388061,0.01629662,0.004825282,0.0036726233,0.0020995792,0.00008056567,0.00006280026,0.00010392098,0.0340525],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996131,0.000879948,0.00058386644,0.0005871509,0.00088983803,0.00092817476],"domain_scores_gemma":[0.99790657,0.00012014417,0.00011482829,0.0010600651,0.00017986506,0.000618535],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0030092318,0.00039081337,0.00076047186,0.00011628259,0.00020585809,0.000086866414,0.00018713267,0.00038246205,0.004186977],"category_scores_gemma":[0.00022051792,0.00034446438,0.00076751015,0.00044250328,0.00015185997,0.00030303994,0.00014981415,0.0007733246,0.00086132786],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014376479,0.0012753725,0.011682257,0.0006195275,0.0016435322,0.0031532065,0.0009822084,0.00015007437,0.00011779976,0.055982586,0.012173663,0.912076],"study_design_scores_gemma":[0.0073461705,0.00047696527,0.11150019,0.00071677915,0.0006466198,0.0048254505,0.002425882,0.0007531022,0.0012302937,0.0006077908,0.86893284,0.0005379225],"about_ca_topic_score_codex":0.013042992,"about_ca_topic_score_gemma":0.0012386771,"teacher_disagreement_score":0.91153806,"about_ca_system_score_codex":0.0002468169,"about_ca_system_score_gemma":0.0009992454,"threshold_uncertainty_score":0.9999166},"labels":[],"label_agreement":null},{"id":"W1563483832","doi":"10.1161/circ.129.suppl_1.mp72","title":"Abstract MP72: Apolipoprotein B and Apolipoprotein B, LDL-C Discordance in Young Adults Are Associated With Coronary Artery Calcification at 25 Year Follow-Up: The Coronary Artery Disease in Young Adults (CARDIA) Study","year":2014,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Apolipoprotein B; Internal medicine; Context (archaeology); Logistic regression; Agatston score; Odds ratio; Cardiology; Risk factor; Cholesterol; Coronary artery disease; Gastroenterology; Coronary artery calcium","score_opus":0.013034871516346828,"score_gpt":0.23659447493928068,"score_spread":0.22355960342293385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1563483832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932343,0.0004415499,0.00012897981,0.00031524608,0.00021488295,0.0053649386,0.00004885461,0.00009019702,0.00016109968],"genre_scores_gemma":[0.99833447,0.000052596217,0.00001987764,0.000067968154,0.00028543317,0.0007658203,0.00034604289,0.00007799959,0.000049795657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964332,0.00046298947,0.00070240384,0.0008708228,0.0009726308,0.00055795396],"domain_scores_gemma":[0.9980346,0.000087638095,0.0003791792,0.0010583522,0.00016365379,0.00027658633],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00112829,0.0004013805,0.00067122106,0.0002236103,0.00024748966,0.00005816698,0.00014782662,0.00018057435,0.000013771008],"category_scores_gemma":[0.0002957919,0.0003220802,0.00017599964,0.00047936646,0.00012762786,0.0003465941,0.00007051761,0.00047761653,0.000018700759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002274738,0.00046981598,0.9844389,0.00020742342,0.00014622514,0.0001663165,0.0016584327,0.00017326388,0.00019190462,0.000021532147,0.0000089837795,0.010242475],"study_design_scores_gemma":[0.009400149,0.00028384602,0.9838513,0.0012329766,0.00015661101,0.00009914959,0.001411957,0.0030945071,0.000015813,0.00007888547,0.0000066058888,0.00036820152],"about_ca_topic_score_codex":0.003701836,"about_ca_topic_score_gemma":0.020673625,"teacher_disagreement_score":0.01697179,"about_ca_system_score_codex":0.000645641,"about_ca_system_score_gemma":0.00013141107,"threshold_uncertainty_score":0.9999231},"labels":[],"label_agreement":null},{"id":"W1564683019","doi":"10.18433/j3hg6q","title":"Relationship between LDL-C Reduction after Coronary Revascularization and Prevention of Recurrence of Cardiovascular Events","year":2010,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Revascularization; Internal medicine; Cardiology; Myocardial infarction; Coronary artery disease; Unstable angina; Restenosis; Angina; Stent","score_opus":0.08281907446213282,"score_gpt":0.3989599116921966,"score_spread":0.31614083723006375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564683019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892626,0.0075272694,0.0018656942,0.00040175015,0.00043800974,0.00040155067,0.0000045036722,0.000005971481,0.00009269826],"genre_scores_gemma":[0.9950888,0.0014038312,0.003021237,0.000020377574,0.00043780231,0.0000055282735,0.0000023670052,0.0000080350765,0.000012011656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973562,0.00028159213,0.000749784,0.00020903829,0.0012134665,0.0001899176],"domain_scores_gemma":[0.9987069,0.000090291345,0.00038732213,0.0001830017,0.0003819894,0.00025051835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004309716,0.00012060034,0.00048110235,0.00021414351,0.00010232484,0.0000104016835,0.00013754575,0.00006742433,0.000068855574],"category_scores_gemma":[0.00034561718,0.00009347611,0.00049632695,0.0005240858,0.0004101966,0.00044524804,0.00004487917,0.0005167072,0.0000011643319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000368372,0.00019010119,0.7288849,0.00058303814,0.00047208637,0.000013067321,0.0001847956,0.000055977496,0.016117511,0.00014547101,0.00001813276,0.25296658],"study_design_scores_gemma":[0.0038148505,0.0005651647,0.9352604,0.00037716827,0.0025353814,0.0008882439,0.000084253195,0.0003047237,0.047326136,0.0010439967,0.007637761,0.00016188885],"about_ca_topic_score_codex":0.000025189765,"about_ca_topic_score_gemma":5.1485694e-7,"teacher_disagreement_score":0.2528047,"about_ca_system_score_codex":0.00003115476,"about_ca_system_score_gemma":0.00030620763,"threshold_uncertainty_score":0.38118455},"labels":[],"label_agreement":null},{"id":"W1567698310","doi":"10.1161/circulationaha.114.013729","title":"Response to Letter Regarding Article, “Proprotein Convertase Subtilisin Kexin Type 9 Promotes Intestinal Overproduction of Triglyceride-Rich Apolipoprotein B Lipoproteins Through Both Low-Density Lipoprotein Receptor–Dependent and –Independent Mechanisms”","year":2015,"lang":"en","type":"letter","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; University of Toronto; Dalhousie University","funders":"National Heart, Lung, and Blood Institute","keywords":"Kexin; Proprotein convertase; Medicine; Subtilisin; Apolipoprotein B; PCSK9; Overproduction; Triglyceride; Internal medicine; Endocrinology; Lipoprotein; LDL receptor; Biochemistry; Cholesterol; Enzyme; Biology","score_opus":0.024010017403474585,"score_gpt":0.25960047625328675,"score_spread":0.23559045884981217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1567698310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8670051,0.00084378215,0.009557227,0.10930943,0.0011921349,0.01153739,0.000091257396,0.0003306546,0.00013299836],"genre_scores_gemma":[0.94452035,0.000046590758,0.010641462,0.03649257,0.0055626445,0.0007100048,0.0006173476,0.00039322124,0.0010157904],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99010444,0.0013896122,0.00176503,0.002214036,0.0033488192,0.0011780433],"domain_scores_gemma":[0.9941239,0.00011980579,0.0010634797,0.0024868732,0.0016845195,0.00052146276],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0050388444,0.0011348306,0.0020902231,0.00075477886,0.00032377773,0.00018139687,0.00035275932,0.0016037786,0.00021415646],"category_scores_gemma":[0.0027806535,0.0010959182,0.0004891729,0.0009984478,0.00023734457,0.00054986466,0.00033464696,0.0025716473,0.00015380874],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025387146,0.001001235,0.001449743,0.008141509,0.0017733651,0.0018004655,0.0036079285,0.0002649602,0.8166786,0.00023911975,0.09896974,0.040686186],"study_design_scores_gemma":[0.014353304,0.005359594,0.021569883,0.0075943177,0.002086209,0.0031943982,0.00050280977,0.00087252585,0.85700864,0.004791682,0.07856683,0.004099805],"about_ca_topic_score_codex":0.006383822,"about_ca_topic_score_gemma":0.00012823317,"teacher_disagreement_score":0.07751524,"about_ca_system_score_codex":0.0014626546,"about_ca_system_score_gemma":0.0011982664,"threshold_uncertainty_score":0.99972945},"labels":[],"label_agreement":null},{"id":"W1567834317","doi":"10.1002/9781444309768.ch75","title":"Secondary Prevention Strategies Post Myocardial Infarction","year":2009,"lang":"en","type":"other","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Myocardial infarction; Secondary prevention; Internal medicine; Cardiology; Medicine","score_opus":0.008820921369918605,"score_gpt":0.26650206147965955,"score_spread":0.25768114010974097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1567834317","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018917654,0.0027434037,0.00071790296,0.00032835858,0.0003866102,0.0008885438,0.000012890018,0.00034731298,0.9943858],"genre_scores_gemma":[0.0030205532,0.0011643466,0.0010787776,0.0010646998,0.0035553558,0.000030094267,0.000486489,0.0002674835,0.9893322],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99893165,0.000053599095,0.00018059002,0.00027367944,0.00036894678,0.00019154829],"domain_scores_gemma":[0.9993048,0.0000024428653,0.00008378113,0.00045475634,0.000050257644,0.000103980376],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018617696,0.00020077608,0.0004501799,0.0002005506,0.00002933706,0.000030675656,0.000041469095,0.00038225186,0.007222543],"category_scores_gemma":[0.00000783489,0.00016303262,0.0004229688,0.00008901281,0.000023773486,0.000055326494,0.000013382726,0.00030495084,0.0002547177],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053457963,0.000090683585,0.000020497957,0.00045192466,0.00077386637,0.000028003962,0.000025718933,4.452511e-7,0.00009814805,0.0011132134,0.5971419,0.4002021],"study_design_scores_gemma":[0.0010372918,0.00048713104,0.008563211,0.00027250242,0.00027175073,0.0001180628,0.0001404968,0.0000010343443,0.000021058257,0.00020033603,0.9887047,0.00018246306],"about_ca_topic_score_codex":0.0014570415,"about_ca_topic_score_gemma":0.0003225863,"teacher_disagreement_score":0.40001962,"about_ca_system_score_codex":0.000059470145,"about_ca_system_score_gemma":0.0007140209,"threshold_uncertainty_score":0.993685},"labels":[],"label_agreement":null},{"id":"W1571139179","doi":"10.1016/j.atherosclerosis.2009.01.023","title":"Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease","year":2009,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia; Pfizer","keywords":"Cardiology; Medicine; Heart failure; Internal medicine; Statin; Coronary heart disease","score_opus":0.01599077788654954,"score_gpt":0.22416081035999869,"score_spread":0.20817003247344915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1571139179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936051,0.00011764006,0.000018619467,0.0036358444,0.000019635992,0.0022686159,0.00015048709,0.00012801749,0.00005603993],"genre_scores_gemma":[0.99339396,0.000013074653,0.00060604693,0.0053231926,0.000035784855,0.00012098003,0.0003257939,0.00006439832,0.00011674824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739873,0.0001863657,0.00034173043,0.0006043498,0.0008841219,0.0005846948],"domain_scores_gemma":[0.9983974,0.000041109342,0.00012737804,0.00061059743,0.0003486062,0.00047490827],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024946503,0.0003792753,0.0007460338,0.000111910034,0.0001435959,0.000037175065,0.00009346993,0.00013359354,0.00008432436],"category_scores_gemma":[0.000072254974,0.00027618,0.00014343504,0.000542226,0.00011329795,0.00016765276,0.000023963441,0.00034738277,0.000034296285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014945056,0.0014577026,0.99372524,0.000034555207,0.00020401849,0.000031912212,0.00026975735,0.000019531673,0.0006289769,0.0000065586773,0.0009805614,0.0011466789],"study_design_scores_gemma":[0.009359124,0.002505064,0.98547244,0.0011332534,0.00018502095,0.0000049770924,0.000067860434,0.000039567723,0.000522045,0.000020503567,0.0003589731,0.0003311775],"about_ca_topic_score_codex":0.00097482157,"about_ca_topic_score_gemma":0.00015214954,"teacher_disagreement_score":0.008252808,"about_ca_system_score_codex":0.00028265218,"about_ca_system_score_gemma":0.00016390414,"threshold_uncertainty_score":0.99996907},"labels":[],"label_agreement":null},{"id":"W1573777214","doi":"10.1111/j.1600-6143.2005.01105.x","title":"Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study","year":2005,"lang":"en","type":"article","venue":"American Journal of Transplantation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":339,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Novartis Pharma; Novartis","keywords":"Fluvastatin; Medicine; Mace; Internal medicine; Clinical endpoint; Adverse effect; Transplantation; Placebo; Statin; Cardiology; Randomized controlled trial; Urology; Surgery; Simvastatin; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.013882608382276422,"score_gpt":0.288234430629107,"score_spread":0.2743518222468306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1573777214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959218,0.00029272784,0.0017921554,0.0011908854,0.0002098856,0.0005257196,0.000010788014,0.000010413263,0.000045616547],"genre_scores_gemma":[0.99674416,0.0017368967,0.00091745856,0.0002759559,0.00025726578,0.000011284255,0.00001215287,0.0000212855,0.000023562536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768466,0.00040933146,0.00070337614,0.00018193788,0.0007741654,0.00024655438],"domain_scores_gemma":[0.9990441,0.00012565339,0.00031398213,0.00025233143,0.00013017215,0.0001337333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015484059,0.00016448296,0.0006429072,0.0002033382,0.00008469579,0.000019099549,0.00011804566,0.000030103802,0.000014950154],"category_scores_gemma":[0.000023301856,0.00010174722,0.00032219695,0.00029147713,0.000070069924,0.00017928361,0.0000029749474,0.00039535473,0.0000042330826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009849502,0.0003373969,0.7573427,0.000026769687,0.00031136247,0.00036632296,0.0075703315,0.0001909934,0.0014245894,0.000001026532,0.000011467578,0.23143212],"study_design_scores_gemma":[0.0025636076,0.0013421131,0.9928552,0.00040942006,0.00051873305,0.0007894398,0.0007208852,0.000019832347,0.0006404368,0.0000016934893,0.000033134125,0.000105521045],"about_ca_topic_score_codex":0.0002565843,"about_ca_topic_score_gemma":0.000216878,"teacher_disagreement_score":0.23551251,"about_ca_system_score_codex":0.00011129945,"about_ca_system_score_gemma":0.00011541117,"threshold_uncertainty_score":0.41491312},"labels":[],"label_agreement":null},{"id":"W1575225075","doi":"10.1016/j.cjca.2015.03.025","title":"Statin Use and Incident Diabetes Explained by Bias Rather Than Biology","year":2015,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Saskatchewan","funders":"","keywords":"Medicine; Diabetes mellitus; Odds ratio; Placebo; Internal medicine; Statin; Randomized controlled trial; Confidence interval; Meta-analysis; Type 2 diabetes; Publication bias; Endocrinology; Pathology","score_opus":0.08882345913238507,"score_gpt":0.31801355021773825,"score_spread":0.22919009108535318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1575225075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037197396,0.99428713,0.00008850096,0.00015216405,0.00067620067,0.0005655556,0.00025734946,0.000005951667,0.00024743166],"genre_scores_gemma":[0.0033048003,0.9941727,0.00013593974,0.00021319113,0.001796327,0.000023821096,0.00014778753,0.000068371875,0.00013705785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968616,0.0011623137,0.00088788127,0.00029489043,0.00018925128,0.0006040864],"domain_scores_gemma":[0.99668944,0.000193848,0.0005811583,0.00045797057,0.00042912015,0.0016484481],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019992616,0.0003824276,0.0040287185,0.00054541265,0.00007057343,0.000039381794,0.00018702204,0.000605822,0.000016255432],"category_scores_gemma":[0.0008616188,0.00026675404,0.00090740685,0.00017892885,0.00025629182,0.00007610824,0.000028646671,0.00077443477,0.00001039685],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001752498,0.0000031439436,0.008275903,0.0024214848,0.0028983366,0.0006447797,0.000102635844,0.0000013720831,0.0000019710897,0.00006438069,0.060849003,0.92471945],"study_design_scores_gemma":[0.000695059,0.0005850764,0.00035184223,0.0014976305,0.0015656436,0.0023859828,0.000045420125,2.6200806e-7,6.4592723e-7,0.000048816673,0.992606,0.00021766062],"about_ca_topic_score_codex":0.001925001,"about_ca_topic_score_gemma":0.00078748085,"teacher_disagreement_score":0.931757,"about_ca_system_score_codex":0.00045466537,"about_ca_system_score_gemma":0.0058794073,"threshold_uncertainty_score":0.9999785},"labels":[],"label_agreement":null},{"id":"W1579991761","doi":"10.1111/febs.13309","title":"β‐Estradiol results in a proprotein convertase subtilisin/kexin type 9‐dependent increase in low‐density lipoprotein receptor levels in human hepatic HuH7 cells","year":2015,"lang":"en","type":"article","venue":"FEBS Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; LDL receptor; Downregulation and upregulation; Kexin; Endocrinology; Internal medicine; Proprotein convertase; Low-density lipoprotein; Lipoprotein; Chemistry; Biology; Cholesterol; Medicine; Biochemistry","score_opus":0.03687735548525903,"score_gpt":0.2840532923355609,"score_spread":0.2471759368503019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1579991761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525845,0.0008632189,0.000039543815,0.00067917985,0.00040964028,0.0022674988,0.00002981133,0.00003449956,0.00041817146],"genre_scores_gemma":[0.9975744,0.00011486432,0.0008105038,0.00025498585,0.00065996824,0.00006002047,0.0000390633,0.00005909632,0.00042712718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99470407,0.0010053437,0.0015047593,0.0006151474,0.0013041837,0.0008664714],"domain_scores_gemma":[0.9975544,0.000045558096,0.0003709341,0.0007858978,0.00034037602,0.0009027888],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006718864,0.0004053052,0.0010881843,0.00072260527,0.00010027749,0.000090580004,0.00028066366,0.00034727287,0.00013153486],"category_scores_gemma":[0.0011042133,0.00035584596,0.00021756132,0.0007377849,0.00009698314,0.00029726975,0.00009606322,0.0019086461,0.000114955525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055554233,0.017616231,0.3596716,0.0056507653,0.0011317991,0.10002654,0.032022595,0.002568444,0.2641357,0.00029134043,0.010629951,0.15070081],"study_design_scores_gemma":[0.09069018,0.00603477,0.6693499,0.010470411,0.00021533789,0.005210803,0.0028678696,0.0016501454,0.20735595,0.0017105092,0.0022904247,0.0021536828],"about_ca_topic_score_codex":0.022268012,"about_ca_topic_score_gemma":0.007258453,"teacher_disagreement_score":0.30967832,"about_ca_system_score_codex":0.0014185464,"about_ca_system_score_gemma":0.0016514974,"threshold_uncertainty_score":0.9998894},"labels":[],"label_agreement":null},{"id":"W1586407206","doi":"10.1023/a:1007079223546","title":"Evaluation of a new apolipoprotein(a) isoform-independent assay for serum Lipoprotein(a)","year":2000,"lang":"en","type":"article","venue":"Molecular and Cellular Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; University of Manitoba; Health Sciences Centre","funders":"","keywords":"Lipoprotein(a); Apolipoprotein B; Gene isoform; Lipoprotein; Clinical chemistry; Monoclonal antibody; Molecular biology; Chemistry; Antibody; PCSK9; Biology; Biochemistry; Immunology; Cholesterol; LDL receptor; Gene","score_opus":0.014572303731873496,"score_gpt":0.264417594510706,"score_spread":0.24984529077883252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1586407206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774104,0.008201212,0.0074944873,0.00050538423,0.00004198381,0.0018628724,0.000025942389,0.00004032666,0.00441739],"genre_scores_gemma":[0.9962491,0.000037837235,0.0017142819,0.00019617654,0.00029127146,0.00015977022,0.000106881715,0.00004638074,0.0011983013],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99724346,0.0000951211,0.00038758156,0.00050179503,0.0013362367,0.00043582884],"domain_scores_gemma":[0.9984235,0.000009352857,0.00010331575,0.0007433516,0.00033059347,0.0003898521],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002255592,0.00025928477,0.00045321984,0.000054178396,0.000083480714,0.000023749599,0.00010996009,0.00028904062,0.0004145295],"category_scores_gemma":[0.000113719114,0.00024542285,0.00041228867,0.00015843035,0.000063940395,0.000038107697,0.000033514338,0.00018200795,0.0000072414105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016191983,0.00010387379,0.000091236,0.0006282605,0.0003581316,0.000017099235,0.00005034107,0.000013892628,0.5802891,0.0000703969,0.00015104223,0.41806468],"study_design_scores_gemma":[0.003936396,0.0002410734,0.0002913296,0.0001529637,0.0009183913,0.000104666506,0.00007719934,0.00056178187,0.99066705,0.00095370825,0.0018496498,0.000245824],"about_ca_topic_score_codex":0.00026579679,"about_ca_topic_score_gemma":0.0000036166457,"teacher_disagreement_score":0.41781887,"about_ca_system_score_codex":0.00011812695,"about_ca_system_score_gemma":0.00064005953,"threshold_uncertainty_score":0.9999998},"labels":[],"label_agreement":null},{"id":"W1588157873","doi":"10.1161/circ.130.suppl_2.17368","title":"Abstract 17368: The Diagnosis of Heterozygous Familial Hypercholesterolemia: Genotype versus Phenotype","year":2014,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Genetic testing; Genotyping; Clinical trial; Genotype; Pediatrics; Internal medicine; Genetics","score_opus":0.031132650401102722,"score_gpt":0.273052164412408,"score_spread":0.24191951401130526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1588157873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584395,0.00049060717,0.00074929243,0.00031938683,0.0004160942,0.0004039532,0.0000029712664,0.000035223227,0.0017385532],"genre_scores_gemma":[0.9989407,0.000055261837,0.00008848123,0.00021460863,0.00061687664,0.000031841242,0.000026886764,0.000020056026,0.000005291362],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998963,0.00006459135,0.00024460806,0.00018584848,0.0003777126,0.00016425949],"domain_scores_gemma":[0.9990992,0.000087314795,0.00009151685,0.00053801853,0.000113505506,0.000070460665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046702445,0.000103625105,0.0002350135,0.000043212818,0.00008310622,0.000011113752,0.00007497524,0.00010919004,0.000039613264],"category_scores_gemma":[0.00015810004,0.00007459176,0.00017964293,0.0001221794,0.000051986357,0.000056554833,0.000018759827,0.0001623979,0.000047706042],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010264757,0.0003171238,0.19823375,0.0006663605,0.00051083986,0.000010912822,0.0014343703,0.0016540767,0.016797144,0.000893795,0.00041594848,0.7780392],"study_design_scores_gemma":[0.0018542126,0.00012257117,0.9928875,0.000048929578,0.00015934336,0.000008027505,0.00006115993,0.00041261592,0.0011979577,0.0000738111,0.0030909223,0.00008295313],"about_ca_topic_score_codex":0.00030738002,"about_ca_topic_score_gemma":0.000027383667,"teacher_disagreement_score":0.7946537,"about_ca_system_score_codex":0.000065397544,"about_ca_system_score_gemma":0.00005103831,"threshold_uncertainty_score":0.30417633},"labels":[],"label_agreement":null},{"id":"W1591229062","doi":"10.1111/j.1755-5922.2010.00142.x","title":"Anacetrapib: Hope for CETP Inhibitors?","year":2010,"lang":"en","type":"review","venue":"Cardiovascular Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cholesterylester transfer protein; Medicine; Pharmacology; Lipoprotein; Cholesterol; Internal medicine","score_opus":0.0712586479161407,"score_gpt":0.3413414175779533,"score_spread":0.27008276966181255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1591229062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006309953,0.9861298,0.0035899992,0.000055814846,0.0020134333,0.0068857116,0.00012351107,0.0002548454,0.00094053533],"genre_scores_gemma":[0.0000104476,0.9900897,0.0023325956,0.0003925174,0.0046567586,0.0010917948,0.00048540125,0.00048796664,0.0004528108],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99505615,0.0003507924,0.0010923854,0.001205881,0.0013174431,0.000977355],"domain_scores_gemma":[0.9945557,0.00012524397,0.00029436644,0.0041108243,0.0004531912,0.00046066978],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00255904,0.0010723255,0.0063913353,0.0004020093,0.00026219254,0.00010420413,0.00044831983,0.0018955993,0.000026305463],"category_scores_gemma":[0.00009035346,0.0008335143,0.019933483,0.00068054354,0.00018223027,0.0000779091,0.00010789834,0.0017883127,0.00011698453],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017003698,0.000081556755,7.1274684e-7,0.024128186,0.016430644,0.000060809318,0.000027672177,7.895952e-7,0.0000026077585,0.000093229646,0.00031500362,0.9588418],"study_design_scores_gemma":[0.0016064739,0.00021962318,0.0000037293491,0.0047953776,0.03577381,0.001052049,0.000016787046,0.0000054028515,0.000020147656,0.000035204655,0.9556643,0.0008070881],"about_ca_topic_score_codex":0.000018451727,"about_ca_topic_score_gemma":0.0000028003087,"teacher_disagreement_score":0.9580347,"about_ca_system_score_codex":0.00030014597,"about_ca_system_score_gemma":0.0013234445,"threshold_uncertainty_score":0.9994116},"labels":[],"label_agreement":null},{"id":"W1595175397","doi":"","title":"Abstract 16194: PCSK9 Inhibitor Alirocumab as Add-on to Atorvastatin versus Other Lipid Treatment Strategies in Patients at High CVD Risk: ODYSSEY OPTIONS I","year":2014,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Alirocumab; Medicine; Atorvastatin; PCSK9; Rosuvastatin; Clinical endpoint; Regimen; Statin; Ezetimibe; Population; Urology; Internal medicine; Tolerability; Randomization; Evolocumab; Randomized controlled trial; Pharmacology; Gastroenterology; Adverse effect; Apolipoprotein B; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.01459777445760022,"score_gpt":0.2761123750888265,"score_spread":0.2615146006312263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1595175397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98317856,0.000044886736,0.00004900715,0.0003363396,0.00048131117,0.0011766126,0.00004874902,0.00009229547,0.014592247],"genre_scores_gemma":[0.9966814,0.00005000626,0.00081836607,0.00036926116,0.00060345273,0.00016054435,0.00007917761,0.000053425,0.0011843459],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979637,0.000118627315,0.0004039736,0.00048206857,0.000591556,0.0004400694],"domain_scores_gemma":[0.9986811,0.000087915854,0.000099630255,0.0006911999,0.00008834118,0.00035178885],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030948652,0.0003002728,0.00048534584,0.00016739912,0.00012981499,0.000042567663,0.0000762038,0.00013504563,0.001034795],"category_scores_gemma":[0.00009471818,0.00022068794,0.00022435964,0.0001847197,0.000030179344,0.000103786115,0.000038481434,0.00016515561,0.0012963746],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027653202,0.012240394,0.099002376,0.00070302805,0.0030245504,0.00011618978,0.0065379404,0.0039991974,0.002624468,0.01923248,0.019702332,0.80516386],"study_design_scores_gemma":[0.03850607,0.014767745,0.80404246,0.0003216067,0.00028706944,0.0000044720064,0.0012472095,0.00004570161,0.010376027,0.00015157822,0.12950508,0.00074495474],"about_ca_topic_score_codex":0.011117446,"about_ca_topic_score_gemma":0.0031688998,"teacher_disagreement_score":0.80441886,"about_ca_system_score_codex":0.0006802599,"about_ca_system_score_gemma":0.00015592962,"threshold_uncertainty_score":0.9998784},"labels":[],"label_agreement":null},{"id":"W1596117146","doi":"10.1096/fasebj.29.1_supplement.248.3","title":"Inter‐relationship Between the <i>In vivo</i> Metabolism of Apolipoprotein B <sub>100</sub> ‐Containing Lipoproteins and LDL Particle Size and LDL Particle Number","year":2015,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Apolipoprotein B; Internal medicine; Endocrinology; Very low-density lipoprotein; Chemistry; Triglyceride; Lipoprotein; In vivo; Catabolism; Adiponectin; Albumin; Cholesterol; Metabolism; Medicine; Biology; Obesity; Insulin resistance","score_opus":0.03926425583138379,"score_gpt":0.28176268883458655,"score_spread":0.24249843300320276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1596117146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915747,0.0030149803,0.00037696655,0.003955812,0.000098737815,0.0007110632,0.000009274128,0.000021725313,0.00023674252],"genre_scores_gemma":[0.99833816,0.00014721183,0.00021875155,0.00041922124,0.00073669525,0.000039328705,9.074638e-7,0.000032480846,0.000067239314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997456,0.00059180823,0.000633319,0.00022507076,0.00061365217,0.0004801615],"domain_scores_gemma":[0.99828076,0.00037607597,0.00025057947,0.0005001483,0.00015144995,0.00044099064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044593387,0.00021019511,0.0005388998,0.000035365414,0.00028656705,0.000090054826,0.00016626668,0.000103428465,0.000025729203],"category_scores_gemma":[0.00086380047,0.00012284874,0.000167302,0.0003221091,0.0002754723,0.00022727693,0.00012393079,0.0007509356,0.000012412896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084374845,0.00018865401,0.8726591,0.00013803742,0.00052848214,0.000096791875,0.011014516,0.00004042965,0.07128921,0.0021017157,0.00021735588,0.04088198],"study_design_scores_gemma":[0.0082588885,0.00055038405,0.5466916,0.00039684676,0.0007649519,0.0015328393,0.0045809015,0.0003874092,0.42981282,0.0057480955,0.00094284,0.0003324374],"about_ca_topic_score_codex":0.0007625099,"about_ca_topic_score_gemma":0.0001222217,"teacher_disagreement_score":0.3585236,"about_ca_system_score_codex":0.00006919727,"about_ca_system_score_gemma":0.0001889386,"threshold_uncertainty_score":0.5009626},"labels":[],"label_agreement":null},{"id":"W1601275300","doi":"10.1096/fasebj.28.1_supplement.782.1","title":"LYCAT, an acyltransferase required for 1‐stearoyl esterification of phosphoinositides, plays a critical role in receptor trafficking dynamics (782.1)","year":2014,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Transferrin receptor; Cell biology; Acyltransferase; Receptor; Transferrin; Gene silencing; Biology; Population; Chemistry; Biochemistry; Gene","score_opus":0.017700533673491312,"score_gpt":0.28107677477942145,"score_spread":0.2633762411059301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1601275300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97024685,0.0003355466,0.026755022,0.0017561691,0.00021559618,0.0005100193,0.000025168189,0.00001961615,0.0001359877],"genre_scores_gemma":[0.99628365,0.00011545684,0.0025776885,0.00021750997,0.0006873636,0.000027834378,0.00004221953,0.000030403693,0.000017884664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99839544,0.00024866042,0.0004959994,0.00018134672,0.00036168547,0.0003168487],"domain_scores_gemma":[0.9989807,0.0001491345,0.00009368578,0.00040664896,0.00016435797,0.0002054808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023631763,0.00013237474,0.0003765499,0.00009605287,0.00016075338,0.000039555252,0.00016111815,0.00009928885,0.00002440525],"category_scores_gemma":[0.00028350565,0.00009555031,0.00023012882,0.00013834397,0.00009560634,0.00015320083,0.000009443961,0.00034606847,0.0000028165327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005225191,0.0012363846,0.004283819,0.00087536237,0.00029930938,0.0000354536,0.0069187386,0.0006715035,0.6731178,0.01042661,0.00020648444,0.2967033],"study_design_scores_gemma":[0.027572114,0.008455673,0.043838676,0.0029677823,0.0013474122,0.004530566,0.013652803,0.15614933,0.7334328,0.0034568973,0.0034269476,0.0011689628],"about_ca_topic_score_codex":0.00012842815,"about_ca_topic_score_gemma":0.00008452305,"teacher_disagreement_score":0.29553437,"about_ca_system_score_codex":0.00014116381,"about_ca_system_score_gemma":0.00018936723,"threshold_uncertainty_score":0.38964286},"labels":[],"label_agreement":null},{"id":"W1609565130","doi":"10.1016/j.jacc.2015.07.020","title":"Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis","year":2015,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":397,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Boniface Hospital; University of Ottawa; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Medicine; Cardiology; Internal medicine; Lipoprotein(a); Apolipoprotein B; Lipoprotein; Stenosis; Clinical endpoint; Aortic valve stenosis; Aortic valve; Aortic valve replacement; Cholesterol; Randomized controlled trial","score_opus":0.02010327529917839,"score_gpt":0.2937392737901399,"score_spread":0.27363599849096154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1609565130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246424,0.0047904374,0.00023152717,0.0011949625,0.0003796097,0.0005274564,0.000020898595,0.0000056439603,0.0003852133],"genre_scores_gemma":[0.9962751,0.0007085559,0.0023596843,0.00012400972,0.00045828274,0.000008689121,5.0048067e-7,0.000020412559,0.000044716744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767566,0.000492115,0.0007579852,0.00015393477,0.0006862188,0.00023408704],"domain_scores_gemma":[0.99722403,0.00007860978,0.0012480798,0.0005202993,0.00067463046,0.0002543549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016667278,0.00015462216,0.0016659586,0.0001434908,0.000042471085,0.000002612555,0.00020417152,0.00007891077,0.0000026371265],"category_scores_gemma":[0.00049529364,0.000089612295,0.0008798335,0.000434854,0.00066498405,0.000045207355,0.00011453795,0.00029961762,5.6799246e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029783174,0.0011081694,0.47623718,0.002214131,0.019065024,0.0009905009,0.0015811832,0.00071450585,0.13651268,0.00089436676,0.03551474,0.29538435],"study_design_scores_gemma":[0.027606834,0.029532366,0.7521406,0.0023545113,0.006625474,0.02076296,0.009130184,0.00017134166,0.098594226,0.0016621199,0.050581787,0.00083759706],"about_ca_topic_score_codex":0.00010283355,"about_ca_topic_score_gemma":0.0000014502765,"teacher_disagreement_score":0.29454675,"about_ca_system_score_codex":0.0000934616,"about_ca_system_score_gemma":0.00063049945,"threshold_uncertainty_score":0.36542833},"labels":[],"label_agreement":null},{"id":"W1615247714","doi":"10.1111/j.1464-5491.2004.01263.x","title":"Statin use in Type 2 diabetes mellitus is associated with a delay in starting insulin","year":2004,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Type 2 Diabetes Mellitus; Diabetes mellitus; Insulin; Type 2 diabetes; Statin; Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Endocrinology","score_opus":0.020266965152646237,"score_gpt":0.258488101760648,"score_spread":0.2382211366080018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1615247714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903127,0.0056543234,0.000049196045,0.002830401,0.000094456605,0.00077482255,0.000006379867,0.00004878622,0.00022893545],"genre_scores_gemma":[0.9948891,0.00051643647,0.00059527054,0.0036665034,0.000113363705,0.000046445493,0.00007448202,0.00004348972,0.000054898686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975067,0.00014000955,0.0006103781,0.00039586404,0.0007065146,0.0006405389],"domain_scores_gemma":[0.9988154,0.00017755607,0.00013336861,0.00044938803,0.00016911971,0.0002551235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014806176,0.00023735885,0.0008684334,0.00031616454,0.00003695051,0.00001110545,0.00007895922,0.00013289027,0.0001233997],"category_scores_gemma":[0.0015616841,0.00016918295,0.00005617962,0.0012030267,0.00013078957,0.00009483509,0.000025598993,0.00046145183,0.000018344503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057149626,0.0012977317,0.9211811,0.00080099906,0.0006460683,0.0020882615,0.013264708,0.00059966376,0.0023155983,0.00027464656,0.00065681274,0.05630293],"study_design_scores_gemma":[0.034327764,0.0039005694,0.9435849,0.008884132,0.00035285912,0.000018992509,0.0012635216,0.00079468807,0.0035691282,0.0011451925,0.001567777,0.0005904861],"about_ca_topic_score_codex":0.0021119749,"about_ca_topic_score_gemma":0.0011486327,"teacher_disagreement_score":0.055712447,"about_ca_system_score_codex":0.00035316005,"about_ca_system_score_gemma":0.000322499,"threshold_uncertainty_score":0.689908},"labels":[],"label_agreement":null},{"id":"W1626807691","doi":"10.1161/circulationaha.105.169180","title":"Managing Abnormal Blood Lipids","year":2005,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WiLAN (Canada)","funders":"","keywords":"Medicine; Multidisciplinary approach; Intensive care medicine; Multidisciplinary team; Health professionals; Health care; Nursing","score_opus":0.03883101174963447,"score_gpt":0.316764694560497,"score_spread":0.2779336828108625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1626807691","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023099967,0.99202293,0.00053745665,0.00004381336,0.00025224354,0.0010977675,0.0000036307804,0.00010430655,0.005914765],"genre_scores_gemma":[0.0004115797,0.9949762,0.00025317993,0.00007815951,0.0036637653,0.00007275752,0.00030159493,0.00006389042,0.0001788776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845326,0.00008627045,0.0004590761,0.00034194725,0.0004052367,0.0002542282],"domain_scores_gemma":[0.99898,0.000015208295,0.00016964036,0.0006470793,0.000054136635,0.00013393532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004425208,0.00025074667,0.0011767054,0.00020132255,0.00007770595,0.000024887799,0.000069445654,0.00029716012,0.00011175407],"category_scores_gemma":[0.000018491586,0.00021276725,0.000893126,0.0002716571,0.00001671743,0.00007217322,0.000027046519,0.0003464505,0.00020917995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000011104255,0.000030398307,0.00003768385,0.0136087155,0.00040196817,0.000024897456,0.000012977154,0.000004874778,1.2051038e-7,0.00012070852,0.00003312482,0.98572344],"study_design_scores_gemma":[0.00037193988,0.000016661,0.00060917804,0.006883328,0.0049125412,0.0007181342,0.0000027347965,0.000043518885,1.8996796e-7,0.000014512808,0.9862308,0.00019644412],"about_ca_topic_score_codex":0.000021804277,"about_ca_topic_score_gemma":0.0000014486646,"teacher_disagreement_score":0.9861977,"about_ca_system_score_codex":0.00016474986,"about_ca_system_score_gemma":0.0002725442,"threshold_uncertainty_score":0.86763966},"labels":[],"label_agreement":null},{"id":"W163994460","doi":"10.2165/00024677-200504050-00004","title":"A New Perspective in the Treatment of Dyslipidemia","year":2005,"lang":"en","type":"review","venue":"Treatments in Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Simvastatin; Atorvastatin; Diabetes mellitus; Endocrinology; Fenofibrate; Triglyceride; Gemfibrozil; Cholesterol; HMG-CoA reductase; Type 2 diabetes; Pharmacology; Reductase; Biology; Biochemistry","score_opus":0.07373907236875694,"score_gpt":0.41299162478854223,"score_spread":0.3392525524197853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W163994460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026513133,0.9909418,0.0000033071083,0.00024115664,0.0001238719,0.0030521469,0.000021921445,0.000017402186,0.00533325],"genre_scores_gemma":[0.00015260647,0.9970883,0.000508036,0.000048620062,0.0004414638,0.00063930266,0.000055497403,0.000038843795,0.0010273199],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975032,0.00046009448,0.0007213057,0.0005249588,0.00024086518,0.00054953265],"domain_scores_gemma":[0.99854374,0.0001716556,0.00020696328,0.00097047683,0.000026448708,0.00008071982],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011959372,0.000467812,0.0029633117,0.00046259107,0.000021528318,0.0000036549907,0.00017884644,0.00026092058,0.00010180308],"category_scores_gemma":[0.000033850985,0.00025379952,0.0009114311,0.00044342587,0.00006839886,0.000022189894,0.000021564965,0.00030363345,0.000048850838],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003799984,0.001096376,0.00023313069,0.000583707,0.0009806693,0.0006610789,0.00088256504,5.178261e-7,2.3536424e-8,0.0009765794,0.00006189682,0.99448544],"study_design_scores_gemma":[0.004420593,0.0017266046,0.0011501787,0.0015449804,0.0021952346,0.00070848054,0.0003392267,3.1666679e-7,0.0000011715813,0.00009494914,0.9876673,0.00015093683],"about_ca_topic_score_codex":0.0039406153,"about_ca_topic_score_gemma":0.0007508483,"teacher_disagreement_score":0.9943345,"about_ca_system_score_codex":0.0023076923,"about_ca_system_score_gemma":0.00078873866,"threshold_uncertainty_score":0.9999914},"labels":[],"label_agreement":null},{"id":"W165002874","doi":"10.1161/circ.128.suppl_22.a18092","title":"Abstract 18092: Statin Use After an Acute In-Hospital Myocardial Infarction Among Medicare Beneficiaries","year":2013,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Myocardial infarction; Statin; Emergency medicine; Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Cardiology; Physical therapy; Intensive care medicine","score_opus":0.009141419300887091,"score_gpt":0.2420185727239159,"score_spread":0.23287715342302878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W165002874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771464,0.00011071196,0.00037505716,0.00034443018,0.0002811104,0.00097075553,0.000010870451,0.00006870423,0.00012369247],"genre_scores_gemma":[0.9986277,0.000039061364,0.00022726043,0.00017194972,0.0004464219,0.00018193759,0.0002711803,0.000027810554,0.0000066468006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985996,0.000051456056,0.00031803685,0.00028862525,0.0004933416,0.0002489367],"domain_scores_gemma":[0.99916047,0.000020029847,0.00008138295,0.0003861771,0.00017745813,0.00017447711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002584594,0.0001401942,0.00026057038,0.00013590422,0.00006315098,0.00008069611,0.000037493497,0.00017118028,0.00019119172],"category_scores_gemma":[0.000081893195,0.0001300072,0.00013571116,0.00017183783,0.00004359866,0.0008926122,0.000016182925,0.00022045693,0.00005342345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048615264,0.00012875997,0.9337466,0.000061438404,0.00015451405,0.000037214155,0.0013949531,0.00016930274,0.0006857784,0.00005938305,0.00006156898,0.063451916],"study_design_scores_gemma":[0.0008100341,0.00009317771,0.9969588,0.000069419075,0.00008733162,0.000009141047,0.00025783243,0.0011752389,0.00003184698,0.00016420166,0.00020203103,0.00014095985],"about_ca_topic_score_codex":0.0039085257,"about_ca_topic_score_gemma":0.00031772457,"teacher_disagreement_score":0.06331096,"about_ca_system_score_codex":0.00015411589,"about_ca_system_score_gemma":0.00008958151,"threshold_uncertainty_score":0.59085476},"labels":[],"label_agreement":null},{"id":"W1656750119","doi":"10.1016/j.taap.2015.09.008","title":"Toxicokinetics and toxicity of atorvastatin in dogs","year":2015,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TransCanada (Canada)","funders":"GlaxoSmithKline","keywords":"Atorvastatin; Toxicokinetics; Toxicity; Pharmacology; Toxicology; Medicine; Internal medicine; Biology","score_opus":0.027746753689589666,"score_gpt":0.3127431620130702,"score_spread":0.2849964083234805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1656750119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933696,0.0010252679,0.000079647405,0.00088794803,0.00012905152,0.0005483454,0.000004569231,0.000019012077,0.0039365804],"genre_scores_gemma":[0.9966561,0.00027831196,0.0010010673,0.0018261414,0.00011802487,0.000055958353,0.000004169633,0.000011085153,0.000049120386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901974,0.00009287399,0.00027375782,0.00024656102,0.000111136935,0.0002559403],"domain_scores_gemma":[0.9994767,0.00006875943,0.00006809485,0.00011744223,0.00003776603,0.00023124037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006169144,0.00012274766,0.0004957942,0.00011047628,0.000025119873,0.0000022039053,0.000042089607,0.00019144581,0.00006959337],"category_scores_gemma":[0.000023589453,0.00011096174,0.00003052112,0.00013648145,0.00026959047,0.000018397088,0.00007884221,0.00024504634,0.0000037414263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029796136,0.0011454396,0.039960094,0.00066219614,0.00037485195,0.00018086909,0.0022715847,0.00007394181,0.87017894,0.011171155,0.0036742326,0.06732706],"study_design_scores_gemma":[0.038530823,0.0038387433,0.19849065,0.000053584045,0.00066115626,0.0009518391,0.001064158,0.000567632,0.72533655,0.0045948345,0.025267744,0.0006422789],"about_ca_topic_score_codex":0.000024618636,"about_ca_topic_score_gemma":0.000019502517,"teacher_disagreement_score":0.15853056,"about_ca_system_score_codex":0.00003419342,"about_ca_system_score_gemma":0.00014421041,"threshold_uncertainty_score":0.4524888},"labels":[],"label_agreement":null},{"id":"W1662671132","doi":"10.1111/1753-0407.12064","title":"Proprotein <scp>C</scp>onvertases <scp>S</scp>ubtilisin/<scp>K</scp>exin <scp>T</scp>ype 9, an enzyme turned escort protein: Hepatic and extra hepatic functions (第9型前蛋白转换酶—枯草溶菌素/蛋白酶K，一种酶转变的护送蛋白：在肝脏与肝外的功能)","year":2013,"lang":"en","type":"review","venue":"Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"LDL receptor; PCSK9; Endocrinology; Furin; Internal medicine; Cholesterol; Receptor; Biology; Lipoprotein; Medicine; Cell biology; Biochemistry; Enzyme","score_opus":0.030211970004211705,"score_gpt":0.2786865298446806,"score_spread":0.2484745598404689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1662671132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34742057,0.63949704,0.00018377212,0.00008109376,0.001358113,0.009682786,0.00028725158,0.00029341897,0.0011959501],"genre_scores_gemma":[0.020012781,0.9463045,0.0046254713,0.0009027207,0.009086435,0.003576619,0.0009812946,0.0014239805,0.013086215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9789113,0.0029546714,0.0064672935,0.0027512696,0.004970585,0.0039449045],"domain_scores_gemma":[0.9783802,0.005060298,0.0062623783,0.0039009948,0.0024650868,0.003931051],"candidate_categories":["metaresearch","metaepi_narrow","scholarly_communication","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.006310541,0.0037006761,0.011473658,0.0025439265,0.0011367246,0.0011886132,0.001925756,0.0026282745,0.00011850726],"category_scores_gemma":[0.02016291,0.0028391366,0.0050387657,0.002711302,0.0009095021,0.0021293785,0.0006343399,0.006046377,0.00045551566],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003865645,0.007916054,0.014979627,0.18476945,0.023476984,0.0023477473,0.0042108055,0.000051209852,0.0028382875,0.00025697306,0.09629727,0.66281694],"study_design_scores_gemma":[0.005205086,0.006541423,0.0031953282,0.04346778,0.013867798,0.0017512795,0.0025582826,0.00029856208,0.0034132225,0.00062152557,0.9185401,0.00053959375],"about_ca_topic_score_codex":0.0005124219,"about_ca_topic_score_gemma":0.00011867205,"teacher_disagreement_score":0.82224286,"about_ca_system_score_codex":0.0011393136,"about_ca_system_score_gemma":0.004401873,"threshold_uncertainty_score":0.99984825},"labels":[],"label_agreement":null},{"id":"W167027724","doi":"10.1016/j.jacc.2013.05.087","title":"High-Density Lipoprotein and Residual Cardiovascular Risk","year":2013,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Residual risk; Residual; Cardiology; Law and economics; Internal medicine; Actuarial science; Algorithm","score_opus":0.009534264038068691,"score_gpt":0.2245931081185995,"score_spread":0.2150588440805308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W167027724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7350854,0.014337895,0.0004361637,0.24595016,0.001744212,0.001735917,0.0003677175,0.000021551046,0.00032098347],"genre_scores_gemma":[0.7848106,0.0175418,0.006798339,0.1377934,0.051283963,0.00006488237,0.000028218954,0.00030174226,0.0013770575],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99420494,0.0021902872,0.0011327146,0.0004326304,0.00151371,0.00052569306],"domain_scores_gemma":[0.9945124,0.0002344222,0.0023147545,0.0018262387,0.000921579,0.000190655],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002482901,0.0004634115,0.0049257,0.0003372305,0.00014750606,0.000011276119,0.0005102608,0.0005680478,0.000009119916],"category_scores_gemma":[0.0006748562,0.00028732323,0.0035109005,0.0004145352,0.001202181,0.00006110214,0.00028973076,0.0034792318,0.0000066755993],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047016182,0.000019339222,0.002202106,0.00048058262,0.017622303,0.0040698093,0.000022238752,0.00012417947,0.00010947266,0.000016004959,0.9577252,0.017138587],"study_design_scores_gemma":[0.0029053835,0.002362524,0.0885952,0.00043982593,0.0088145295,0.027222758,0.00017844324,0.0000032530384,0.000554455,0.0005500542,0.86792105,0.00045254434],"about_ca_topic_score_codex":0.002134275,"about_ca_topic_score_gemma":0.00000907607,"teacher_disagreement_score":0.108156756,"about_ca_system_score_codex":0.00020450511,"about_ca_system_score_gemma":0.0007836908,"threshold_uncertainty_score":0.9999579},"labels":[],"label_agreement":null},{"id":"W1679568657","doi":"10.1161/circ.104.20.e104","title":"Do Statins Reduce the Risk for Diabetes by Improving Exercise Capacity?","year":2001,"lang":"en","type":"letter","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pravastatin; Medicine; Diabetes mellitus; Nova scotia; Internal medicine; Gerontology; Endocrinology; Cholesterol","score_opus":0.02161776102595395,"score_gpt":0.25148955441350035,"score_spread":0.2298717933875464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1679568657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6174825,0.01275839,0.021440802,0.33037868,0.0019831527,0.01348721,0.0010319334,0.0003712728,0.0010660851],"genre_scores_gemma":[0.67438895,0.0014981647,0.0019665905,0.28399912,0.0269611,0.0023833758,0.006734162,0.0004657573,0.0016027795],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980148,0.00012809537,0.00035982905,0.0004789728,0.0005706749,0.00044764802],"domain_scores_gemma":[0.99839395,0.00011621903,0.00031967167,0.00089512643,0.00020347707,0.00007155028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082753686,0.00026790824,0.000516256,0.00008476345,0.00028986536,0.00007340508,0.00011830901,0.0005402553,0.000034829016],"category_scores_gemma":[0.0002180042,0.00019367653,0.00047377674,0.00016221352,0.000059876736,0.00008279125,0.00001848525,0.0009977898,0.000014785004],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002322225,0.00003666024,0.006750863,0.0018014689,0.00035895212,0.000010691504,0.00036449818,0.00003759327,0.0010746772,0.0000071836503,0.78287554,0.20665863],"study_design_scores_gemma":[0.0016631951,0.000093031194,0.016410364,0.0005347682,0.0019832393,0.0000246064,0.000067092755,0.0018621268,0.00068734854,0.000663686,0.97553295,0.00047756842],"about_ca_topic_score_codex":0.00039057864,"about_ca_topic_score_gemma":0.0000031456104,"teacher_disagreement_score":0.20618106,"about_ca_system_score_codex":0.00021995744,"about_ca_system_score_gemma":0.00013880094,"threshold_uncertainty_score":0.78979},"labels":[],"label_agreement":null},{"id":"W1686688666","doi":"10.1007/s11892-015-0661-y","title":"New and Emerging Biomarkers in Cardiovascular Disease","year":2015,"lang":"en","type":"review","venue":"Current Diabetes Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Disease; Intensive care medicine; Biomarker discovery; Diabetes mellitus; Bioinformatics; Risk stratification; Cause of death; Pathology; Internal medicine; Proteomics","score_opus":0.047211944378909666,"score_gpt":0.33664715994961253,"score_spread":0.28943521557070284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1686688666","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002897891,0.9957754,0.000018425062,0.000019873563,0.0013463454,0.0022837324,0.000011407197,0.00007028647,0.00018472808],"genre_scores_gemma":[0.000056493533,0.99829835,0.000096220014,0.000010177057,0.00085663155,0.0002117435,0.00032305464,0.00009445406,0.000052894226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961039,0.00021213606,0.0010506305,0.0010282993,0.0010119796,0.0005930422],"domain_scores_gemma":[0.9965618,0.000022604941,0.00031315416,0.0017643926,0.000092024595,0.0012459969],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020319198,0.00055960997,0.0035134298,0.00043552078,0.000043497315,0.000042252217,0.000081373495,0.00020472285,0.000020268655],"category_scores_gemma":[0.00031084946,0.00044559242,0.0020239898,0.0005661349,0.00005049932,0.000082907274,0.0001554768,0.0005055042,0.0000105325635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002445611,0.000037878384,0.0025189861,0.036009844,0.0020481874,0.001074947,0.000013662397,6.598716e-7,1.2886239e-8,0.000001650595,0.0015069607,0.9567848],"study_design_scores_gemma":[0.00037602338,0.000023372166,0.000515261,0.024989774,0.0063563604,0.00019995295,0.0000042416955,0.00000550191,1.3201907e-7,0.00005065571,0.9670736,0.00040509133],"about_ca_topic_score_codex":0.00007591397,"about_ca_topic_score_gemma":0.0000012214066,"teacher_disagreement_score":0.9655667,"about_ca_system_score_codex":0.00031165028,"about_ca_system_score_gemma":0.002074079,"threshold_uncertainty_score":0.9997996},"labels":[],"label_agreement":null},{"id":"W1688730913","doi":"10.25011/cim.v30i2.981","title":"Exploring patient demographic and clinical characteristics associated with lipid-lowering pharmacotherapy use in primary care","year":2007,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; Dalhousie University; McMaster University; Université de Montréal; St. Joseph’s Healthcare Hamilton","funders":"AstraZeneca","keywords":"Dyslipidemia; Medicine; Medical prescription; Hyperlipidemia; Pharmacotherapy; Pharmacy; Internal medicine; Medical record; Primary care; Population; Family medicine; Diabetes mellitus; Pharmacology; Environmental health; Endocrinology; Disease","score_opus":0.22191550319777342,"score_gpt":0.35372990855724473,"score_spread":0.1318144053594713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1688730913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995619,0.0018781782,0.00009647314,0.0011410821,0.00041512476,0.00066270295,0.000005967199,0.00004961393,0.0001318343],"genre_scores_gemma":[0.98715216,0.0068065496,0.00045245848,0.0045994334,0.0008591264,0.000022247597,0.0000580145,0.000033939286,0.000016056088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719834,0.0002457442,0.0012287531,0.00053885253,0.00041999412,0.00036829012],"domain_scores_gemma":[0.9979354,0.00057349954,0.0002506309,0.000257467,0.00021190586,0.00077109924],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0026348073,0.00025552526,0.0011063188,0.00015657394,0.0000887963,0.000011891876,0.00004906398,0.00016008271,0.0000069442995],"category_scores_gemma":[0.0015745936,0.00016830204,0.000119683384,0.00038134618,0.003566744,0.00020762069,0.000053200492,0.00088629086,6.6141195e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035444112,0.00013906015,0.8315838,0.00014637207,0.00020353937,0.00016428807,0.00078904297,5.7153514e-8,0.0001482527,0.00002757744,0.00001737809,0.1664262],"study_design_scores_gemma":[0.00685487,0.003259798,0.98469245,0.0022123265,0.00022399897,0.000023112552,0.0005993179,0.000018160199,0.0001443714,0.00004169979,0.0017396513,0.00019021476],"about_ca_topic_score_codex":0.00012309317,"about_ca_topic_score_gemma":0.00010750866,"teacher_disagreement_score":0.16623598,"about_ca_system_score_codex":0.00005899022,"about_ca_system_score_gemma":0.00012477284,"threshold_uncertainty_score":0.999145},"labels":[],"label_agreement":null},{"id":"W1720369452","doi":"10.1714/1311.14483","title":"10.1714/1311.14483","year":2000,"lang":"en","type":"review","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clopidogrel; Atorvastatin; Medicine; Pharmacology; Pravastatin; Rosuvastatin; Statin; Percutaneous coronary intervention; CYP2C19; Loading dose; P2Y12; Ticlopidine; Internal medicine; Aspirin; Cholesterol; Myocardial infarction; Cytochrome P450; Metabolism","score_opus":0.0232547904903869,"score_gpt":0.2704393266082416,"score_spread":0.2471845361178547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1720369452","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.079589e-8,0.5271846,2.4850277e-7,0.000033330984,0.000004316412,0.0010972543,0.000022764598,0.0000806922,0.47157678],"genre_scores_gemma":[1.4875022e-9,0.45372155,0.000044833836,0.000050520786,0.00074087287,0.00011785703,0.000115627394,0.000072638846,0.5451361],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977335,0.00015132259,0.00054672034,0.0005310568,0.00056915934,0.00046826762],"domain_scores_gemma":[0.99801314,0.000036319674,0.0001010356,0.0012951157,0.000065918895,0.00048848655],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00050815695,0.0004508509,0.002570947,0.00023557151,0.000068039175,0.000027747463,0.0002166671,0.0004000507,0.96906686],"category_scores_gemma":[0.00005695903,0.0003424014,0.0013418981,0.00044542368,0.00002792049,0.000028328093,0.000066890985,0.0004194308,0.9799045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015692858,0.00003956254,8.956799e-10,0.007567714,0.00031413444,0.000069926646,0.0000017710448,1.1227729e-7,7.621056e-9,5.7979776e-7,0.08461027,0.9073802],"study_design_scores_gemma":[0.00027814807,0.00024382342,1.7410882e-7,0.00889513,0.0019168529,0.00041745795,1.4902493e-7,5.95551e-7,1.020854e-7,5.8564314e-7,0.987924,0.00032297787],"about_ca_topic_score_codex":0.000040721123,"about_ca_topic_score_gemma":1.266445e-7,"teacher_disagreement_score":0.9070572,"about_ca_system_score_codex":0.0001903349,"about_ca_system_score_gemma":0.00065134885,"threshold_uncertainty_score":0.9999028},"labels":[],"label_agreement":null},{"id":"W172152587","doi":"10.1161/circ.114.suppl_18.ii_905-b","title":"Abstract 4193: A Randomized, Double-blind, Double-dummy, Comparison of Efficacy and Tolerability of Fluvastatin XL alone, Ezetimibe alone and the Combination, in Patients with a History of Muscle Related Side Effects with other Statins","year":2006,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"","keywords":"Medicine; Tolerability; Ezetimibe; Fluvastatin; Double blind; Internal medicine; Pharmacology; Adverse effect; Statin; Simvastatin; Placebo","score_opus":0.012988659177298124,"score_gpt":0.2451316857143624,"score_spread":0.23214302653706426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W172152587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388593,0.0010187742,0.0005261252,0.00006239754,0.000025306359,0.0039079227,0.0000037616646,0.000012874179,0.0005568825],"genre_scores_gemma":[0.9994945,0.000007902147,0.00031055402,0.000014539407,0.000008853428,0.00006674684,0.000069376016,0.000019614674,0.000007893868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980916,0.00023852622,0.000783839,0.00024541796,0.00050622533,0.00013439586],"domain_scores_gemma":[0.99833196,0.00034416,0.0006338144,0.00032677178,0.0003159831,0.000047278038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012913104,0.00015740644,0.0010512451,0.0001376639,0.000031988948,0.0000053222866,0.00003646308,0.0000797268,0.0000063360585],"category_scores_gemma":[0.0000682095,0.0001013722,0.00008244994,0.00021594754,0.00045254437,0.00009381164,0.000012264156,0.00016001267,2.0604521e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3930245,0.0022914617,0.58330977,0.0022911725,0.0004424553,0.0000021248204,0.0055515673,0.005009415,0.0007529256,0.00096673006,0.000013303402,0.006344602],"study_design_scores_gemma":[0.37778723,0.000189816,0.6202217,0.00024931,0.00021042072,0.0000012496853,0.000039803614,0.00089109666,0.00027376597,0.00006387433,0.0000053485533,0.00006639169],"about_ca_topic_score_codex":0.005668386,"about_ca_topic_score_gemma":0.00032058242,"teacher_disagreement_score":0.03691195,"about_ca_system_score_codex":0.00012380599,"about_ca_system_score_gemma":0.00013236974,"threshold_uncertainty_score":0.85689414},"labels":[],"label_agreement":null},{"id":"W172350394","doi":"10.2165/11533430-000000000-00000","title":"Efficacy and Safety of Rosuvastatin and Fenofibric Acid Combination Therapy versus Simvastatin Monotherapy in Patients with Hypercholesterolemia and Hypertriglyceridemia","year":2010,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"Merck; AstraZeneca","keywords":"Rosuvastatin; Simvastatin; Fenofibrate; Medicine; Rosuvastatin Calcium; Pharmacology; Statin; Combination therapy; Internal medicine","score_opus":0.005283008122858314,"score_gpt":0.22650469904548856,"score_spread":0.22122169092263025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W172350394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945291,0.0043776785,0.0002836161,0.00014655551,0.00007225133,0.0005386596,0.0000061942087,0.0000072379107,0.000038667033],"genre_scores_gemma":[0.9925577,0.0041708373,0.0030592305,0.00008968526,0.00007161802,0.0000054176808,0.000004878945,0.000038854207,0.0000017830678],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99798137,0.00024847206,0.00052815094,0.0002668029,0.00074654416,0.00022863681],"domain_scores_gemma":[0.99860847,0.00015962833,0.00034357057,0.00037448385,0.0002840945,0.00022974522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013343364,0.00022413723,0.0011463793,0.00024312228,0.000054654858,0.000023793707,0.00007041093,0.000066223234,0.000002808126],"category_scores_gemma":[0.0000962099,0.00016438427,0.00024912372,0.0003218289,0.00040211654,0.00017050454,0.000025690351,0.00044377075,1.6341842e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010029457,0.00015548366,0.083325945,0.000058639143,0.0016782159,0.00001812215,0.001228483,0.000044772485,0.0008888923,0.000013957367,0.0000025149534,0.9025555],"study_design_scores_gemma":[0.051279973,0.0044553475,0.939972,0.00016386107,0.00037874153,0.00018714381,0.0005590365,0.000027273296,0.00081142935,0.000010559595,0.0019502915,0.00020434207],"about_ca_topic_score_codex":0.0001640315,"about_ca_topic_score_gemma":0.000005437517,"teacher_disagreement_score":0.9023512,"about_ca_system_score_codex":0.00004194969,"about_ca_system_score_gemma":0.00013480952,"threshold_uncertainty_score":0.6703396},"labels":[],"label_agreement":null},{"id":"W1735028854","doi":"10.1016/j.ijcard.2015.05.156","title":"Placing HPS2-THRIVE in context using Bayesian analysis","year":2015,"lang":"en","type":"letter","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Niacin; Medicine; Internal medicine; Context (archaeology); Myocardial infarction; Adverse effect","score_opus":0.03338318402007639,"score_gpt":0.3238159211616645,"score_spread":0.2904327371415881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1735028854","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16727,0.019507755,0.11526955,0.6667354,0.015885478,0.0013193674,0.0002568025,0.000054210548,0.01370145],"genre_scores_gemma":[0.80579525,0.00045438792,0.0012417729,0.1605792,0.031486932,0.000005915848,0.0001817773,0.00005977888,0.00019499318],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965959,0.00043794478,0.0010467041,0.00027657655,0.0013252053,0.00031763726],"domain_scores_gemma":[0.9970749,0.00011297023,0.00073954836,0.0003299181,0.0016098525,0.00013279244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013094527,0.00025547014,0.001965237,0.0017867738,0.00001903707,0.000027969707,0.00036558273,0.00070671807,0.00004858893],"category_scores_gemma":[0.00032227742,0.00021349148,0.0016596238,0.0003139955,0.00008961357,0.00009792122,0.00007594735,0.002110995,0.000006841483],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017979951,0.000078832134,0.07646941,0.00024966136,0.108472295,0.13636191,0.0010137816,0.015504899,0.00026503907,0.000070511,0.6216748,0.03804086],"study_design_scores_gemma":[0.004782731,0.00039575106,0.0071962504,0.00058813667,0.00541473,0.022985816,0.00034374604,0.0008108039,0.00003802847,0.00036053822,0.9566968,0.0003866307],"about_ca_topic_score_codex":0.00036051034,"about_ca_topic_score_gemma":0.000038561786,"teacher_disagreement_score":0.63852525,"about_ca_system_score_codex":0.0010243028,"about_ca_system_score_gemma":0.0010139969,"threshold_uncertainty_score":0.917134},"labels":[],"label_agreement":null},{"id":"W1754892304","doi":"10.1016/j.jacl.2015.10.003","title":"JCL roundtable: Apolipoproteins as causative elements in vascular disease","year":2015,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Apolipoprotein B; Medicine; Cholesterol; Lipoprotein; Internal medicine; Disease; Bioinformatics; Endocrinology; Genetics; Computational biology; Biology","score_opus":0.21400066480712102,"score_gpt":0.5073236104021006,"score_spread":0.2933229455949796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1754892304","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032864625,0.9909469,0.00013099916,0.00052156486,0.0055883257,0.0018618184,0.000028065786,0.000014474737,0.00057920645],"genre_scores_gemma":[0.00004168081,0.98075485,0.000848166,0.00079180865,0.016308745,0.00006439693,0.00005337226,0.000096493015,0.0010404624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98750937,0.0034563257,0.006205573,0.0006162024,0.0014954832,0.00071707164],"domain_scores_gemma":[0.99228925,0.00069645396,0.003347806,0.0011448936,0.0008070205,0.0017145965],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.01576871,0.0006023509,0.009248553,0.0006154884,0.00004820397,0.000039819348,0.00049810036,0.0010899986,0.0001919523],"category_scores_gemma":[0.009276341,0.00041000367,0.0043349764,0.0005875001,0.00018730391,0.00024434345,0.0002028372,0.0034370553,0.00017195051],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044496014,0.00092109543,0.00063436467,0.0076047545,0.0025907322,0.0011584604,0.000023604465,0.0000015794508,2.7936453e-8,0.00022876794,0.003959209,0.9824324],"study_design_scores_gemma":[0.0045641973,0.0019995999,0.00067620445,0.011150648,0.0047563775,0.0009633827,0.000024177665,0.0000019406407,4.595498e-8,0.0007454517,0.9748272,0.0002908147],"about_ca_topic_score_codex":0.0001971386,"about_ca_topic_score_gemma":0.000040445077,"teacher_disagreement_score":0.9821416,"about_ca_system_score_codex":0.0007860461,"about_ca_system_score_gemma":0.010159833,"threshold_uncertainty_score":0.9998352},"labels":[],"label_agreement":null},{"id":"W1761705283","doi":"","title":"Do hypertensive patients with average cholesterol levels benefit from atorvastatin therapy?","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Atorvastatin; Medicine; Internal medicine; Cholesterol; Stroke (engine); Cardiology; Randomized controlled trial; Cholesterol lowering; Ldl cholesterol","score_opus":0.023715147412228473,"score_gpt":0.20967067938056486,"score_spread":0.1859555319683364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1761705283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949992,0.0007662223,0.00016620848,0.00015335562,0.00015218301,0.0019200229,0.000052841067,0.00004825487,0.0017417639],"genre_scores_gemma":[0.9961737,0.000059357462,0.0003593965,0.0022061288,0.00014164213,0.00072794815,0.000036770725,0.000045271707,0.00024982027],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983864,0.000068029825,0.00020131051,0.00036022268,0.00056228484,0.00042178098],"domain_scores_gemma":[0.9988344,0.000027327642,0.00007477921,0.00056660676,0.00021185116,0.00028507764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024004934,0.00018872366,0.00040865617,0.000052079224,0.0000722703,0.000033322794,0.000062705825,0.00007872677,0.000085284475],"category_scores_gemma":[0.00006652163,0.00012879337,0.00012763438,0.0001406103,0.000032331278,0.00008853258,0.0000123837635,0.00016704272,0.000023660337],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027499668,0.0003207272,0.25052467,0.000029692708,0.00064033445,0.000043687363,0.0003754929,0.000011879526,0.000017846982,0.000087020926,0.00018545582,0.7474882],"study_design_scores_gemma":[0.0065830313,0.00010783367,0.9780546,0.000024540555,0.00006144798,0.0000082573315,0.00004166819,0.0000013544686,0.00092187646,0.000083745705,0.013953924,0.00015772677],"about_ca_topic_score_codex":0.00020834978,"about_ca_topic_score_gemma":0.000014403223,"teacher_disagreement_score":0.7473304,"about_ca_system_score_codex":0.00007644001,"about_ca_system_score_gemma":0.000059209364,"threshold_uncertainty_score":0.5252041},"labels":[],"label_agreement":null},{"id":"W1764111892","doi":"10.1080/00325481.2015.998987","title":"Safety and efficacy of alirocumab 150 mg every 2 weeks, a fully human proprotein convertase subtilisin/kexin type 9 monoclonal antibody: A Phase II pooled analysis","year":2015,"lang":"en","type":"article","venue":"Postgraduate Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; PCSK9; Medicine; Evolocumab; Kexin; Placebo; Internal medicine; Adverse effect; Gastroenterology; Statin; Pharmacology; Endocrinology; Lipoprotein; Cholesterol; LDL receptor; Pathology","score_opus":0.03230265787129456,"score_gpt":0.33661445635765774,"score_spread":0.3043117984863632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1764111892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983611,0.0074220276,0.0005678821,0.0057648914,0.00016999191,0.0017368267,0.0000618878,0.000103579696,0.0005618996],"genre_scores_gemma":[0.996072,0.00043140142,0.00043949147,0.00056952884,0.00052687986,0.000020962301,0.0010979577,0.000059345584,0.0007824238],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9958027,0.000288091,0.001136128,0.0007435755,0.0014386093,0.00059088826],"domain_scores_gemma":[0.9966486,0.00006847347,0.00039077405,0.0011167373,0.0008467349,0.00092866435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022226407,0.0004771463,0.0020157322,0.00066300866,0.00021354387,0.000014172935,0.00019165133,0.00019119836,0.00017290063],"category_scores_gemma":[0.00078676414,0.0003490107,0.00038656822,0.0013932394,0.0004940014,0.00012349962,0.00014853942,0.00042776007,0.000013968913],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.084946275,0.015517916,0.06557039,0.0060276045,0.0546887,0.005064054,0.02306005,0.00010098649,0.42872545,0.002949589,0.011550209,0.3017988],"study_design_scores_gemma":[0.35088733,0.09054585,0.35868064,0.004653726,0.078861944,0.0025213496,0.0038787962,0.009971608,0.043131713,0.0013309772,0.051922753,0.0036133204],"about_ca_topic_score_codex":0.0060187755,"about_ca_topic_score_gemma":0.0001423344,"teacher_disagreement_score":0.38559374,"about_ca_system_score_codex":0.0001564851,"about_ca_system_score_gemma":0.00052588485,"threshold_uncertainty_score":0.99989617},"labels":[],"label_agreement":null},{"id":"W1772375187","doi":"10.25011/cim.v32i6s.11138","title":"UNE HYPERLIPIDÉMIE SECONDAIRE A NE PAS OMETTRE","year":2009,"lang":"fr","type":"article","venue":"Clinical and investigative medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Gynecology","score_opus":0.13158785948285756,"score_gpt":0.3499798759086471,"score_spread":0.21839201642578954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1772375187","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21407568,0.15390639,0.00020096857,0.60239255,0.0051520066,0.0010963057,0.000027903727,0.00010526999,0.023042906],"genre_scores_gemma":[0.80850935,0.023428332,0.0018608723,0.10378158,0.030528136,0.000029094082,0.000121587735,0.00007054241,0.031670526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947118,0.00079836167,0.0017534827,0.0010398986,0.0007765669,0.0009199034],"domain_scores_gemma":[0.9956751,0.00035775625,0.00033677975,0.0008785128,0.0003301511,0.00242169],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.003586255,0.00059324625,0.0022824076,0.00014185377,0.0002617128,0.000022766355,0.00019792457,0.0006150846,0.0008765849],"category_scores_gemma":[0.0041724485,0.00042236043,0.0004770974,0.00093756674,0.016830392,0.0002550801,0.000080602025,0.0017124391,0.00018912231],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121313045,0.00046026387,0.0108666485,0.0006516365,0.0005535873,0.00042100463,0.0012600364,0.0000010283203,0.000402193,0.045079265,0.05029483,0.88988817],"study_design_scores_gemma":[0.009060992,0.009933382,0.34076002,0.004919149,0.0013097842,0.0003126317,0.0015301107,0.0002443454,0.00019673017,0.060447145,0.5707742,0.00051152124],"about_ca_topic_score_codex":0.00063780777,"about_ca_topic_score_gemma":0.000048140115,"teacher_disagreement_score":0.8893767,"about_ca_system_score_codex":0.00008006812,"about_ca_system_score_gemma":0.0005403078,"threshold_uncertainty_score":0.9998228},"labels":[],"label_agreement":null},{"id":"W1786484934","doi":"10.1016/j.jsha.2015.05.004","title":"Quantifying the impact of using Coronary Artery Calcium Score for risk categorization instead of Framingham Score or European Heart SCORE in lipid lowering algorithms in a Middle Eastern population","year":2015,"lang":"en","type":"article","venue":"Journal of the Saudi Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Framingham Risk Score; Medicine; Categorization; Internal medicine; Population; Cardiology; Framingham Heart Study; Physical therapy; Disease; Artificial intelligence","score_opus":0.1386801031142055,"score_gpt":0.35191235185180464,"score_spread":0.21323224873759913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1786484934","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602616,0.00040522625,0.0019065926,0.00033890633,0.0005193903,0.00077609956,0.000010960411,0.000005414315,0.000011231634],"genre_scores_gemma":[0.99877185,0.000037113736,0.00048235885,0.000045144126,0.00059826864,0.0000031482236,0.000009124232,0.000031300697,0.000021687263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972937,0.000601798,0.0010112409,0.0001387818,0.00070836546,0.00024608054],"domain_scores_gemma":[0.9976826,0.00013034613,0.0013355215,0.0002607158,0.0005099379,0.000080911515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005402543,0.00014867281,0.00063950423,0.0002469637,0.00009072037,0.000019813258,0.00011218011,0.00011680708,0.0000022854656],"category_scores_gemma":[0.0013783753,0.000087071996,0.00042166215,0.00052333175,0.000027604243,0.0002754436,0.00004425051,0.00040390322,5.0981487e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040193697,0.00011188607,0.98384124,0.00014236745,0.00011954813,0.00000383975,0.0016604017,0.008960436,0.0024396502,0.0000012221803,0.000055925455,0.0022615506],"study_design_scores_gemma":[0.0025496231,0.0005542122,0.98135877,0.0016271983,0.00013416907,0.00012471301,0.000544378,0.012598485,0.00034673137,0.0000553902,0.000023679922,0.00008264375],"about_ca_topic_score_codex":0.0032851312,"about_ca_topic_score_gemma":0.00044019445,"teacher_disagreement_score":0.004024168,"about_ca_system_score_codex":0.0011285838,"about_ca_system_score_gemma":0.00040596782,"threshold_uncertainty_score":0.49661574},"labels":[],"label_agreement":null},{"id":"W1793169550","doi":"10.1002/jca.21406","title":"Comparison of two low‐density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Apheresis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Institut sur la Nutrition et les Aliments Fonctionnels; Université Laval","keywords":"Medicine; Familial hypercholesterolemia; Apheresis; LDL apheresis; Apolipoprotein B; Internal medicine; Lipoprotein(a); Lipoprotein; Gastroenterology; Cholesterol; Endocrinology; Ldl cholesterol; Hematocrit; Low-density lipoprotein; Platelet","score_opus":0.06570089489959835,"score_gpt":0.3837548756720295,"score_spread":0.31805398077243113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1793169550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968381,0.0011019851,0.00027189622,0.00014437502,0.00057088514,0.00069954176,0.000007667847,0.000012696879,0.00035286552],"genre_scores_gemma":[0.99690956,0.00005145904,0.0019446991,0.00013257985,0.0008645026,0.0000057996413,0.0000036600827,0.0000371389,0.0000506299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99397373,0.00073750125,0.0028389357,0.0002971179,0.0018025296,0.00035020072],"domain_scores_gemma":[0.9957521,0.00023749829,0.0014083803,0.00063138857,0.0012691915,0.00070141716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003862143,0.0002517583,0.0024560434,0.00017053713,0.000034396428,0.000025258521,0.00025548134,0.00028412655,0.000019327237],"category_scores_gemma":[0.0010531317,0.00016804005,0.0006276195,0.00038115671,0.00016763997,0.00016362997,0.00006764771,0.0009808448,0.000012313835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006210888,0.0022717153,0.93632597,0.0003229865,0.00045443466,0.00017138652,0.00016183408,0.000302966,0.000021790225,0.000008395198,0.0009526344,0.052794974],"study_design_scores_gemma":[0.02289996,0.0050241044,0.96819115,0.0014160523,0.0004346578,0.000074599724,0.0006122032,0.00013138016,0.00021820412,0.00004013969,0.0007503254,0.00020720664],"about_ca_topic_score_codex":0.0017739511,"about_ca_topic_score_gemma":0.00037817148,"teacher_disagreement_score":0.052587766,"about_ca_system_score_codex":0.00014032563,"about_ca_system_score_gemma":0.00067583134,"threshold_uncertainty_score":0.6852474},"labels":[],"label_agreement":null},{"id":"W1793783730","doi":"10.1016/j.cjca.2015.07.001","title":"Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; St. Michael's Hospital; University of Ottawa; University of Toronto; Hamilton Health Sciences; McMaster University; Université Laval; Population Health Research Institute","funders":"Canadian Institutes of Health Research; AstraZeneca","keywords":"Medicine; Baseline (sea); Primary prevention; Disease; Physical therapy; Primary (astronomy); Intensive care medicine; Internal medicine","score_opus":0.13794692789577245,"score_gpt":0.2756992251714949,"score_spread":0.13775229727572247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1793783730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57778925,0.041883174,0.36531264,0.007920716,0.0018540812,0.0041842675,0.00005918673,0.000012454302,0.0009842258],"genre_scores_gemma":[0.99493307,0.0002711624,0.0012810001,0.00035357123,0.0030017588,0.000056371242,0.00002502338,0.000018246094,0.00005980708],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979516,0.0006975693,0.0005060681,0.00017660213,0.0003404128,0.0003277177],"domain_scores_gemma":[0.9980752,0.00008559108,0.000127377,0.00038458806,0.00026049683,0.0010667514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060056644,0.00013228031,0.000753335,0.00016227493,0.000070921014,0.000026101252,0.000106957305,0.00009750457,0.000003543116],"category_scores_gemma":[0.0010865445,0.00009188094,0.00042346,0.00014625116,0.00016662672,0.000085964995,0.00001560031,0.00030849164,0.0000018612782],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.090211235,0.0003730558,0.1270015,0.0012437113,0.024024563,0.01031034,0.0038794174,0.12090882,0.0001734152,0.0024282422,0.025542846,0.5939029],"study_design_scores_gemma":[0.098298706,0.002221516,0.44521007,0.00032853655,0.0042842017,0.0051074503,0.0006737374,0.00173196,0.000019473202,0.00063803623,0.44092503,0.00056125864],"about_ca_topic_score_codex":0.00026057247,"about_ca_topic_score_gemma":0.00009441464,"teacher_disagreement_score":0.5933416,"about_ca_system_score_codex":0.00021996518,"about_ca_system_score_gemma":0.0054218797,"threshold_uncertainty_score":0.96181816},"labels":[],"label_agreement":null},{"id":"W1805934449","doi":"10.1016/j.jacc.2010.11.015","title":"Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease","year":2011,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"Anthera; Amarin Corporation; Schering-Plough; Sanofi; Roche; GlaxoSmithKline; Novartis; Pfizer","keywords":"Medicine; Tolerability; Apolipoprotein B; Internal medicine; Placebo; Coronary artery disease; Statin; Endocrinology; Cholesterol; Atorvastatin; Lipoprotein; Clinical endpoint; Gastroenterology; Adverse effect; Cardiology; Pharmacology; Clinical trial; Pathology","score_opus":0.017313622905909234,"score_gpt":0.2373319743941632,"score_spread":0.22001835148825397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1805934449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985025,0.00022079937,0.00013347116,0.00010560367,0.000041028332,0.0006335968,0.00021223992,0.0000020655898,0.00014867871],"genre_scores_gemma":[0.9982482,0.00010839989,0.0015223665,0.000045568784,0.00003725003,0.000008207612,0.0000013854294,0.000018205892,0.000010388211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982213,0.00034632348,0.0006942868,0.000137705,0.0003984487,0.00020198642],"domain_scores_gemma":[0.99797106,0.00012930964,0.000991578,0.00039860667,0.00036102548,0.00014841821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006114552,0.00014524422,0.0014077239,0.00019383637,0.000023949127,7.5286533e-7,0.00014257521,0.000043957556,0.000007880299],"category_scores_gemma":[0.00026132487,0.000085939624,0.0002551657,0.00037290805,0.00055534084,0.000053213116,0.00006358731,0.00020120648,8.446273e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028362943,0.0006780531,0.9596287,0.00022680662,0.0017572262,0.00016560544,0.00016718972,0.00012802138,0.0015089286,0.000042056632,0.000060949933,0.0072735418],"study_design_scores_gemma":[0.0055327904,0.001958448,0.98960423,0.00036993058,0.0005318993,0.0002279431,0.00031537432,0.000008518909,0.0012858309,0.0000151824615,0.000070921604,0.00007894219],"about_ca_topic_score_codex":0.00037822357,"about_ca_topic_score_gemma":0.000014877243,"teacher_disagreement_score":0.029975541,"about_ca_system_score_codex":0.00006770895,"about_ca_system_score_gemma":0.00042705826,"threshold_uncertainty_score":0.35045162},"labels":[],"label_agreement":null},{"id":"W1816130895","doi":"10.25011/cim.v38i4.24260","title":"Rosuvastatin Lowers Systemic Inflammatory Response in Coronary Artery Bypass Graft Accompanied by Cardiopulmonary Bypass Surgery: A Randomized Controlled Study","year":2015,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Firat Üniversitesi","keywords":"Medicine; Rosuvastatin; Cardiopulmonary bypass; Anesthesia; Systemic inflammatory response syndrome; Systemic inflammation; Acute coronary syndrome; Randomized controlled trial; Coronary artery disease; Artery; Inflammatory response; Interleukin 6; Internal medicine; Gastroenterology; Surgery; Cardiology; Inflammation; Myocardial infarction; Sepsis","score_opus":0.0869393553731982,"score_gpt":0.32622605377252234,"score_spread":0.23928669839932415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1816130895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976794,0.008729824,0.00007742661,0.0076898406,0.00088996405,0.005515411,0.000013636873,0.0001062836,0.00018360233],"genre_scores_gemma":[0.99521846,0.00043424647,0.00005589263,0.0022611625,0.00065397983,0.0008204581,0.000069776426,0.00005778054,0.0004282224],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98497283,0.009087068,0.0032613794,0.00089739903,0.0012171827,0.00056412345],"domain_scores_gemma":[0.99251735,0.0041823965,0.00065155304,0.0007589706,0.00041144746,0.0014782624],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.033081576,0.00056723,0.007134678,0.00035428352,0.00009862259,0.000021577189,0.00016026915,0.00028148553,0.000020542086],"category_scores_gemma":[0.018375441,0.00035765188,0.00073575065,0.00047487335,0.0055528153,0.00018732557,0.00011522361,0.00095839024,0.000017183478],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47916746,0.00074626016,0.50103134,0.00023684115,0.0025933203,0.0021547042,0.0026353567,0.0000066881116,0.00047929454,0.00005287627,0.008880828,0.0020150342],"study_design_scores_gemma":[0.6900056,0.0034604375,0.29177782,0.001725511,0.001360189,0.0005649976,0.008487123,0.00044310768,0.000019234549,0.00089044205,0.00076434837,0.0005011577],"about_ca_topic_score_codex":0.00037807412,"about_ca_topic_score_gemma":0.00002548579,"teacher_disagreement_score":0.21083817,"about_ca_system_score_codex":0.00015514425,"about_ca_system_score_gemma":0.0010580418,"threshold_uncertainty_score":0.9998875},"labels":[],"label_agreement":null},{"id":"W1834572837","doi":"10.1111/joim.12405","title":"Statins and new‐onset diabetes mellitus – a risk lacking in familial hypercholesterolaemia","year":2015,"lang":"en","type":"editorial","venue":"Journal of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Internal medicine; Pediatrics; Cholesterol; Endocrinology","score_opus":0.019131095214514126,"score_gpt":0.30561879098458705,"score_spread":0.28648769577007294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1834572837","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46262208,0.047315884,0.00021193529,0.001226146,0.48762465,0.0004582909,0.00007922594,0.000017412129,0.00044439256],"genre_scores_gemma":[0.06486547,0.016629692,0.0007595832,0.0005270434,0.91659445,0.0000053574204,0.000038256967,0.00010061946,0.00047955435],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99459624,0.00036012547,0.0016382533,0.00035362967,0.0025771018,0.00047463897],"domain_scores_gemma":[0.9957701,0.00064936,0.001263967,0.0004158848,0.000944753,0.0009559661],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004954629,0.0004490145,0.0022146415,0.00073164765,0.000035331166,0.00003620992,0.00029314918,0.0006184432,0.000040102055],"category_scores_gemma":[0.0074709235,0.00029962123,0.0003163734,0.00021385435,0.00018313121,0.00015929241,0.00010011583,0.0038535509,0.000005258069],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015283165,0.00009015215,0.020353565,0.0005405616,0.0007279802,0.0009841023,0.0014155683,0.000003594111,0.00007540704,0.0000010827534,0.90962946,0.06465022],"study_design_scores_gemma":[0.020915622,0.00751857,0.01769833,0.016462285,0.0015223365,0.00092987635,0.00095937325,0.000037053942,0.00004556159,0.00034208523,0.9332048,0.0003640903],"about_ca_topic_score_codex":0.003303384,"about_ca_topic_score_gemma":0.00029735596,"teacher_disagreement_score":0.42896977,"about_ca_system_score_codex":0.00059590215,"about_ca_system_score_gemma":0.0017043329,"threshold_uncertainty_score":0.9999456},"labels":[],"label_agreement":null},{"id":"W1835102699","doi":"10.1016/j.metabol.2015.08.007","title":"The contribution of PCSK9 levels to the phenotypic severity of familial hypercholesterolemia is independent of LDL receptor genotype","year":2015,"lang":"en","type":"article","venue":"Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada; Institut sur la Nutrition et les Aliments Fonctionnels; Université Laval","keywords":"PCSK9; LDL receptor; Kexin; Familial hypercholesterolemia; Internal medicine; Apolipoprotein B; Endocrinology; Genotype; Medicine; Lipoprotein; Cholesterol; Biology; Genetics; Gene","score_opus":0.03012448865358191,"score_gpt":0.27914434667114896,"score_spread":0.24901985801756704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1835102699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903976,0.005337951,0.0009473748,0.0015584978,0.0005629742,0.00086093496,0.000091373906,0.0000099648405,0.00023335843],"genre_scores_gemma":[0.998411,0.0001608495,0.00033527915,0.0004766074,0.0004112748,0.00002371673,0.000008313816,0.000014177989,0.00015876984],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979997,0.00025572485,0.0004840425,0.00017935998,0.00085204886,0.0002290936],"domain_scores_gemma":[0.998093,0.000042367512,0.000192359,0.000781383,0.0007421196,0.00014874579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002361955,0.00012693154,0.000566789,0.000046781486,0.000063652435,0.0000063978955,0.00022382665,0.00011158685,0.000024520878],"category_scores_gemma":[0.00041234886,0.00006990567,0.00022817693,0.00024775582,0.00010526808,0.000042550182,0.00009980087,0.00020568646,0.000019644698],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005970186,0.0009260743,0.020919668,0.0005662225,0.002709419,0.0000063246384,0.022539329,0.00013940949,0.2276776,0.010182581,0.011005374,0.69735783],"study_design_scores_gemma":[0.003978729,0.0002847286,0.5285839,0.00008182506,0.0004829204,0.0000141291675,0.0008008737,0.000033988414,0.1697827,0.00043822973,0.2953721,0.00014587103],"about_ca_topic_score_codex":0.0010728074,"about_ca_topic_score_gemma":0.0000856535,"teacher_disagreement_score":0.6972119,"about_ca_system_score_codex":0.00005214984,"about_ca_system_score_gemma":0.00033165523,"threshold_uncertainty_score":0.28506702},"labels":[],"label_agreement":null},{"id":"W183934126","doi":"10.1016/j.jacc.2009.07.013","title":"Optimal Medical Therapy With or Without Percutaneous Coronary Intervention in Older Patients With Stable Coronary Disease","year":2009,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of British Columbia; McMaster University Medical Centre","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Coronary artery disease; Internal medicine; Myocardial infarction; Revascularization; Cardiology; Unstable angina; Clinical trial; Angina; Stroke (engine)","score_opus":0.007751685587114511,"score_gpt":0.2607990242709928,"score_spread":0.25304733868387824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W183934126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966281,0.0007719155,0.0003896337,0.001356649,0.00009371679,0.00064066297,0.000023157601,0.0000062136405,0.000089946305],"genre_scores_gemma":[0.997696,0.0004520427,0.0008336172,0.0007224396,0.00017689793,0.000005567071,0.0000034608624,0.000020534317,0.000089484856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977113,0.000423981,0.0005087854,0.00017700919,0.00091394025,0.00026497047],"domain_scores_gemma":[0.99846613,0.00005734656,0.00052283355,0.00038311564,0.0003117866,0.0002587625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005830309,0.00017614289,0.001145052,0.00012981337,0.000046413676,0.0000030696933,0.0002261421,0.00005474939,0.000041151205],"category_scores_gemma":[0.00008622078,0.00008284817,0.00036373953,0.0003275539,0.0003850322,0.00007078882,0.000032554773,0.00039784002,4.187692e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060189724,0.00069199846,0.9050079,0.00005272838,0.0008872618,0.00623161,0.00007452987,0.0009963904,0.00003988568,0.000008797016,0.0004995616,0.025319614],"study_design_scores_gemma":[0.0076578795,0.0125938365,0.9639083,0.00043274768,0.00022032215,0.0137959,0.00042131988,0.00006410704,0.000013691514,0.000008760669,0.0007719832,0.000111151836],"about_ca_topic_score_codex":0.00003082622,"about_ca_topic_score_gemma":0.000014039489,"teacher_disagreement_score":0.0589004,"about_ca_system_score_codex":0.00014957313,"about_ca_system_score_gemma":0.00086451916,"threshold_uncertainty_score":0.33784506},"labels":[],"label_agreement":null},{"id":"W184028435","doi":"10.1016/j.jacc.2009.10.062","title":"Intensive Multifactorial Intervention for Stable Coronary Artery Disease","year":2010,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Sudbury Regional Hospital; Libin Cardiovascular Institute of Alberta; Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; McMaster University Medical Centre; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Coronary artery disease; Cardiology; Internal medicine; Intervention (counseling)","score_opus":0.015905948806137812,"score_gpt":0.2754016421762943,"score_spread":0.2594956933701565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W184028435","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38801914,0.0022347255,0.0042726663,0.5777409,0.02208018,0.0035039273,0.001981979,0.000021724796,0.00014474074],"genre_scores_gemma":[0.7280062,0.00053719454,0.0017351846,0.20644264,0.061518975,0.000089955145,0.000118606804,0.00016884386,0.001382415],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974706,0.0004855933,0.0008875685,0.00023434887,0.0005803437,0.000341504],"domain_scores_gemma":[0.99519473,0.000281338,0.0019041568,0.0007681252,0.0016998661,0.00015178729],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008349768,0.00026679633,0.0021973825,0.00021295995,0.00006714347,0.0000051899046,0.00036248815,0.00042177612,0.000012753],"category_scores_gemma":[0.0010416339,0.00016845345,0.0033784974,0.00015420058,0.00051708805,0.00004981261,0.000105566185,0.0026176423,0.0000013265766],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004656967,0.000037736918,0.002132706,0.00052956,0.0035355058,0.0020053368,0.00001734112,0.000020947207,0.0006373005,0.0000061787373,0.98327,0.0031504033],"study_design_scores_gemma":[0.0038198652,0.0023201306,0.016581986,0.00045689475,0.0026559595,0.0057775197,0.00024238907,0.000013677006,0.00016391097,0.00022910125,0.9675387,0.00019982479],"about_ca_topic_score_codex":0.000029646051,"about_ca_topic_score_gemma":0.0000032164962,"teacher_disagreement_score":0.37129828,"about_ca_system_score_codex":0.00019008447,"about_ca_system_score_gemma":0.00086366205,"threshold_uncertainty_score":0.9996834},"labels":[],"label_agreement":null},{"id":"W184776916","doi":"10.1186/1532-429x-17-s1-p137","title":"Use of CMR imaging to assess the effect of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a)","year":2015,"lang":"en","type":"article","venue":"Journal of Cardiovascular Magnetic Resonance","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Imperial College London; National Institute for Health and Care Research; Royal Brompton and Harefield NHS Foundation Trust","keywords":"Medicine; Lipoprotein(a); Cardiology; Internal medicine; Apheresis; Lipoprotein; Percutaneous coronary intervention; Angina; Angiology; Canadian Cardiovascular Society; Refractory (planetary science); Medical therapy; Percutaneous; Thrombosis; Cholesterol; Myocardial infarction","score_opus":0.016634042541456256,"score_gpt":0.23710313362130608,"score_spread":0.22046909107984983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W184776916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87938225,0.118296646,0.00035209185,0.00012828858,0.00009596386,0.0015862064,0.0000057049597,0.0000062424283,0.0001465888],"genre_scores_gemma":[0.99577445,0.0010744304,0.0027928785,0.000057338395,0.00017539292,0.00003921933,0.000001217432,0.000048917394,0.00003614817],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99562955,0.00077901076,0.0008066876,0.0002990749,0.0021400899,0.00034556643],"domain_scores_gemma":[0.9972427,0.00014813285,0.0003762558,0.0010722036,0.00085306476,0.00030767036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040549715,0.00028237124,0.0015201153,0.0002951147,0.000037440226,0.000030809326,0.00022187187,0.000096596115,0.000006996842],"category_scores_gemma":[0.0010092271,0.00016825076,0.00076580583,0.00063742,0.0001750836,0.00023982397,0.000087379885,0.0004226333,8.6396864e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038770535,0.0001357698,0.11775204,0.0005630672,0.0007118661,0.00020370346,0.00027052502,0.00034056543,0.00015171529,0.0000057025964,0.00018966138,0.87579834],"study_design_scores_gemma":[0.011831135,0.0063667037,0.9009901,0.001653016,0.00090777595,0.0002242263,0.00009093844,0.00005495649,0.0032340612,0.000010330298,0.07440239,0.00023433201],"about_ca_topic_score_codex":0.00066234183,"about_ca_topic_score_gemma":0.000011668516,"teacher_disagreement_score":0.875564,"about_ca_system_score_codex":0.000118094445,"about_ca_system_score_gemma":0.00026507114,"threshold_uncertainty_score":0.6861067},"labels":[],"label_agreement":null},{"id":"W1852373983","doi":"10.1517/14656566.2010.512006","title":"Mipomersen as a potential adjunctive therapy for hypercholesterolemia","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Apolipoprotein B; Population; Gastroenterology; Lipoprotein(a); Lipoprotein; Endocrinology; Cholesterol","score_opus":0.07210830279709016,"score_gpt":0.43681410121708286,"score_spread":0.36470579841999273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1852373983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024352366,0.9864957,0.00020651313,0.00063155656,0.004291121,0.007326369,0.000118063675,0.00018048912,0.0007258551],"genre_scores_gemma":[0.000006400247,0.9787675,0.00059830496,0.007482825,0.008714111,0.0029293604,0.00060245313,0.00035642163,0.0005426266],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641037,0.00030217343,0.0007510436,0.0010689386,0.0008061063,0.00066135847],"domain_scores_gemma":[0.9978187,0.00010687412,0.00034307397,0.001074637,0.0001797501,0.00047696257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060781225,0.000917844,0.0025993895,0.00036079093,0.00021161097,0.0000624631,0.0003435912,0.0008151151,0.000581427],"category_scores_gemma":[0.00002253836,0.0006489622,0.0027990474,0.00026233346,0.00009655805,0.000089644556,0.000026263531,0.0012145145,0.0001693086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010089477,0.0004309955,1.217215e-7,0.0012478613,0.0011531224,0.000017783414,0.0001586929,1.4726723e-7,0.00036650253,0.000065362896,0.0073604537,0.98819],"study_design_scores_gemma":[0.008115917,0.0014506917,0.0000013938517,0.0032805789,0.00010657885,0.00034336222,0.00002245122,0.0000068134127,0.0004415215,0.000022401751,0.98560274,0.00060555525],"about_ca_topic_score_codex":0.00005420174,"about_ca_topic_score_gemma":3.86886e-7,"teacher_disagreement_score":0.9875845,"about_ca_system_score_codex":0.00022613125,"about_ca_system_score_gemma":0.00089710695,"threshold_uncertainty_score":0.9995962},"labels":[],"label_agreement":null},{"id":"W185387885","doi":"10.1016/j.jacc.2014.01.060","title":"The Severe Hypercholesterolemia Phenotype","year":2014,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"National Heart, Lung, and Blood Institute; European Atherosclerosis Society","keywords":"Familial hypercholesterolemia; PCSK9; Medicine; Apolipoprotein B; Microsomal triglyceride transfer protein; Internal medicine; Coronary artery disease; Proprotein convertase; Lipoprotein; LDL receptor; Endocrinology; Cholesterol; Bioinformatics; Very low-density lipoprotein; Biology","score_opus":0.02198567268709946,"score_gpt":0.31125842976476376,"score_spread":0.2892727570776643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W185387885","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004927683,0.9954276,0.00007548539,0.0008197832,0.0010169934,0.0006338865,0.000046474637,0.0000051600286,0.0014818532],"genre_scores_gemma":[0.0016542368,0.9947724,0.00017900999,0.00030511187,0.0026571082,0.000011976555,0.0000014416357,0.00005260198,0.00036613332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958431,0.001728662,0.0012568062,0.00019226232,0.0006410476,0.0003381367],"domain_scores_gemma":[0.9950407,0.00053301797,0.0025862101,0.0012757756,0.00040666826,0.00015763119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025192653,0.00031595607,0.0053119683,0.00012856312,0.00014444487,0.0000068421696,0.0008013233,0.00018240712,0.000002793161],"category_scores_gemma":[0.0005288013,0.00013465133,0.0040456997,0.00047996498,0.00069031323,0.000021189348,0.000176019,0.0011379138,0.000007719614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017676884,0.000012064523,0.00007816531,0.0026378583,0.0032837754,0.00011583457,0.000005871796,0.000010998576,0.0000017094342,0.000101585734,0.01199167,0.9815837],"study_design_scores_gemma":[0.0004568335,0.00069331424,0.0003579281,0.0028623748,0.0035668048,0.016382651,0.00005801356,4.375684e-7,6.1763956e-7,0.000047262565,0.9754555,0.000118243704],"about_ca_topic_score_codex":0.000008224718,"about_ca_topic_score_gemma":0.0000025179215,"teacher_disagreement_score":0.98146546,"about_ca_system_score_codex":0.00021897344,"about_ca_system_score_gemma":0.0015425864,"threshold_uncertainty_score":0.5490922},"labels":[],"label_agreement":null},{"id":"W1857205731","doi":"10.1194/jlr.m061952","title":"PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice","year":2015,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"LDL receptor; PCSK9; Receptor; Endocrinology; Internal medicine; Very low-density lipoprotein; Chemistry; Cholesterol; Biology; Lipoprotein; Medicine","score_opus":0.07570067223715204,"score_gpt":0.3477162476810117,"score_spread":0.2720155754438597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1857205731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98347723,0.013522349,0.000100838784,0.0018947426,0.00020560012,0.00031749482,0.0000031939699,0.0000019597653,0.00047660543],"genre_scores_gemma":[0.99696004,0.0022170644,0.00012123827,0.000012962682,0.00042389217,0.0000023812777,0.0000016716345,0.000009169383,0.00025160098],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99746853,0.0004951823,0.0004112699,0.00013495758,0.0012239479,0.0002661008],"domain_scores_gemma":[0.9987527,0.00009056444,0.00012234693,0.00022705703,0.0005563055,0.0002509994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007347577,0.00007614459,0.00032590356,0.00016969562,0.00007441671,0.000022897038,0.00012385228,0.00009240377,0.000009702303],"category_scores_gemma":[0.00053640467,0.000046231104,0.00007751893,0.00053355313,0.00022816005,0.000077988225,0.00009523605,0.0006931501,0.000001846475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003837406,0.0020285584,0.36347672,0.002672351,0.0003656933,0.00046781867,0.013711986,0.00007390105,0.14807928,0.00240029,0.047603775,0.41528222],"study_design_scores_gemma":[0.012163078,0.0054500266,0.19946586,0.0017982025,0.000119072414,0.003291016,0.0114009185,0.00020037135,0.100939825,0.0011975825,0.6636242,0.00034980293],"about_ca_topic_score_codex":0.00015460054,"about_ca_topic_score_gemma":0.000012040268,"teacher_disagreement_score":0.6160205,"about_ca_system_score_codex":0.00017136539,"about_ca_system_score_gemma":0.00039993736,"threshold_uncertainty_score":0.30114308},"labels":[],"label_agreement":null},{"id":"W1858324018","doi":"","title":"Évolution des lignes directrices sur le traitement de la dyslipidémie Les données pourraient vous libérer","year":2014,"lang":"fr","type":"article","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Humanities; Medicine; Gynecology; Art","score_opus":0.019684510438404683,"score_gpt":0.22762391089269576,"score_spread":0.20793940045429107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1858324018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7368643,0.1117785,0.0013035861,0.0031368188,0.0020947638,0.0010015216,0.00015105857,0.00013248151,0.14353696],"genre_scores_gemma":[0.97333664,0.0020376015,0.0005098212,0.015692567,0.0064134523,0.000093177565,0.00005556425,0.00011030862,0.001750856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961808,0.00075359875,0.00042549527,0.0005861112,0.00050014304,0.0015538943],"domain_scores_gemma":[0.99735105,0.00017958513,0.0001376682,0.0006618869,0.00020458926,0.0014652448],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014353624,0.0004519691,0.00069143274,0.00032371827,0.0006984211,0.00016416851,0.0002663722,0.00034909087,0.000014232283],"category_scores_gemma":[0.000114189796,0.0004752533,0.00048303383,0.00046639235,0.00059250253,0.0002683042,0.000030206247,0.00043612902,0.00016321111],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022673119,0.0003151552,0.0011231855,0.0008708021,0.00040807214,0.00007926954,0.00085156254,0.00032684702,0.0032410407,0.0098009985,0.012476523,0.9704839],"study_design_scores_gemma":[0.0016877241,0.00036658032,0.1719159,0.0011955807,0.00044495435,0.00001582019,0.00166459,0.0018693384,0.0015002874,0.0014630598,0.8172879,0.000588269],"about_ca_topic_score_codex":0.49730557,"about_ca_topic_score_gemma":0.11013154,"teacher_disagreement_score":0.9698956,"about_ca_system_score_codex":0.002054728,"about_ca_system_score_gemma":0.003205984,"threshold_uncertainty_score":0.9997699},"labels":[],"label_agreement":null},{"id":"W1861059114","doi":"10.12968/npre.2011.9.4.180","title":"Lipid-lowering therapies: a prescribing guide","year":2011,"lang":"en","type":"article","venue":"Nurse Prescribing","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Residual risk; Statin; Disease; Diabetes mellitus; Internal medicine; Population; Intensive care medicine; Endocrinology; Environmental health","score_opus":0.04614263925551796,"score_gpt":0.27782086549515383,"score_spread":0.23167822623963588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1861059114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7888121,0.004057916,0.005324761,0.00049799134,0.0011988644,0.0016005317,0.0000058802393,0.0006924436,0.1978095],"genre_scores_gemma":[0.98920995,0.00017975719,0.006907672,0.0006674941,0.0009076262,0.0000970445,0.000006848341,0.00008984548,0.0019337329],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977624,0.000074541604,0.00045888947,0.0005173862,0.000548042,0.00063873525],"domain_scores_gemma":[0.9983838,0.00002222332,0.00009572551,0.0010474849,0.000138762,0.0003119904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074076926,0.0002757161,0.00048525524,0.00014704965,0.00019327561,0.00004216737,0.00020256771,0.00015033147,0.0004643752],"category_scores_gemma":[0.00012881354,0.00023942585,0.0003850158,0.00021215007,0.00007093263,0.00025235603,0.000068055524,0.00037368253,0.00009734799],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015579409,0.001558134,0.09806163,0.0016301447,0.002856188,0.0010460174,0.06265177,0.000028944336,0.08566711,0.004767143,0.012588201,0.7275868],"study_design_scores_gemma":[0.016776439,0.002524708,0.16886854,0.0064216857,0.0022365937,0.0022053323,0.018590575,0.002358367,0.24958771,0.0011183169,0.5260871,0.0032246492],"about_ca_topic_score_codex":0.0014022925,"about_ca_topic_score_gemma":0.000029293555,"teacher_disagreement_score":0.72436213,"about_ca_system_score_codex":0.00012787104,"about_ca_system_score_gemma":0.00014966809,"threshold_uncertainty_score":0.97635025},"labels":[],"label_agreement":null},{"id":"W1874730789","doi":"","title":"Evolution of lipid management guidelines: evidence might set you free.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Medicine; Psychological intervention; Framingham Risk Score; Intervention (counseling); Cohort; Intensive care medicine; Disease; Family medicine; Internal medicine","score_opus":0.049787412763462484,"score_gpt":0.2769846298186574,"score_spread":0.2271972170551949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1874730789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7817403,0.034358613,0.06592097,0.031458303,0.003587348,0.013602842,0.000045318335,0.0005699171,0.06871636],"genre_scores_gemma":[0.99315274,0.0005645037,0.0020236657,0.00053982984,0.0010940545,0.00077361526,0.000006782896,0.000017808667,0.0018269928],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984446,0.00007744886,0.00037176567,0.00024345794,0.0005704362,0.000292279],"domain_scores_gemma":[0.9985971,0.00002137998,0.00009438518,0.0009265517,0.00019988911,0.00016073606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018846248,0.00010403648,0.00029423056,0.000100827325,0.00003517436,0.0000069854163,0.00015050083,0.000060873663,0.000023683482],"category_scores_gemma":[0.0006266582,0.00008238531,0.00018779273,0.00021634033,0.000035202305,0.00007438756,0.00008500998,0.00007992891,0.000017652712],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021633718,0.00012798824,0.015158372,0.002100343,0.0004202656,0.000015695565,0.00009065985,0.000057373232,0.000065788525,0.0037335055,0.059440296,0.9185734],"study_design_scores_gemma":[0.002035257,0.00010319276,0.7204561,0.00037662667,0.0003448566,0.000025635243,0.00009854448,0.0004154048,0.0006979088,0.0004577956,0.2748165,0.0001721182],"about_ca_topic_score_codex":0.000267364,"about_ca_topic_score_gemma":0.000013236084,"teacher_disagreement_score":0.91840124,"about_ca_system_score_codex":0.00013846782,"about_ca_system_score_gemma":0.00003121595,"threshold_uncertainty_score":0.33595756},"labels":[],"label_agreement":null},{"id":"W1881471613","doi":"","title":"Did the major clinical trials of statins affect prescribing behaviour?","year":2001,"lang":"en","type":"letter","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Randomized controlled trial; Medicine; Affect (linguistics); Coronary heart disease; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Clinical trial; Statin; Coronary disease; Cholesterol lowering; Disease; Intensive care medicine; Cholesterol; Alternative medicine; Internal medicine; Pharmacology; Bioinformatics; Pathology; Psychology; Biology","score_opus":0.17101785482544268,"score_gpt":0.3787281392049625,"score_spread":0.20771028437951983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1881471613","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07812879,0.009942231,0.000480429,0.87164575,0.0046759336,0.028009087,0.0005994562,0.0002297651,0.006288586],"genre_scores_gemma":[0.113554604,0.0029851515,0.00049575255,0.7732409,0.07429497,0.01566612,0.0013136076,0.00044659228,0.018002301],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923824,0.0032025198,0.0019212209,0.0005491907,0.0011959487,0.00074869767],"domain_scores_gemma":[0.9957073,0.001505383,0.00092089287,0.0015151686,0.00014936693,0.00020193096],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.022274831,0.00033864912,0.0024342712,0.00012895925,0.00008189625,0.000035769648,0.00030555393,0.0008758544,0.00009676553],"category_scores_gemma":[0.0044688745,0.00019368978,0.0022707495,0.00020240173,0.00017073,0.000038625112,0.00009836851,0.0024923051,0.000011333594],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013362379,0.0000917614,0.004729301,0.00051495543,0.0011374973,0.00038325036,0.00003288363,2.0263468e-7,9.656507e-7,0.00000346267,0.7095634,0.28340873],"study_design_scores_gemma":[0.003199054,0.00017052268,0.1866742,0.00019463606,0.0036553321,0.00010864835,0.000023338369,0.0000023857167,0.00009359258,0.000021538213,0.8056186,0.00023815442],"about_ca_topic_score_codex":0.00064238533,"about_ca_topic_score_gemma":0.00001875823,"teacher_disagreement_score":0.28317055,"about_ca_system_score_codex":0.00010052309,"about_ca_system_score_gemma":0.00024558153,"threshold_uncertainty_score":0.99980897},"labels":[],"label_agreement":null},{"id":"W1883433817","doi":"10.1186/1471-2261-3-12","title":"Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects","year":2003,"lang":"en","type":"article","venue":"BMC Cardiovascular Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"Fondazione Cariplo","keywords":"Overweight; Medicine; Interquartile range; Internal medicine; Lipoprotein(a); Apolipoprotein B; Lipoprotein; Obesity; Angiology; Endocrinology; Gastroenterology; Cardiology; Cholesterol","score_opus":0.019083902624961346,"score_gpt":0.24582726525352971,"score_spread":0.22674336262856837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1883433817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9377675,0.05602483,0.0014130886,0.00048078343,0.00014852308,0.0022705728,0.000018598254,0.00011774055,0.0017583409],"genre_scores_gemma":[0.99725676,0.00040429746,0.0012880417,0.00027076193,0.00021898336,0.00022357017,0.00003795381,0.00008987812,0.00020976795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962915,0.0006836847,0.0004710364,0.00081895135,0.0010547289,0.0006800964],"domain_scores_gemma":[0.99755096,0.00026728812,0.000060197006,0.0014328072,0.000052656505,0.00063610525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016570826,0.0003936191,0.0010113121,0.00023680867,0.00020939672,0.000036916284,0.00009871895,0.00022739008,0.000042274398],"category_scores_gemma":[0.0012237517,0.00038825654,0.0013557621,0.00060904864,0.0001764847,0.00018478306,0.00005981428,0.00045823056,0.000034595058],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011137114,0.0000984854,0.99533486,0.00042812148,0.00034923293,0.0000560987,0.000087864006,0.00009842806,0.000005554376,0.0010622625,0.00006225756,0.0023054846],"study_design_scores_gemma":[0.004698962,0.00010014554,0.97670734,0.00011325698,0.0007350828,0.00010059646,0.000118918186,0.000013171468,0.000029644505,0.0024581985,0.014504539,0.00042012945],"about_ca_topic_score_codex":0.0011692074,"about_ca_topic_score_gemma":0.00014331548,"teacher_disagreement_score":0.059489224,"about_ca_system_score_codex":0.00017781001,"about_ca_system_score_gemma":0.0005166285,"threshold_uncertainty_score":0.99985695},"labels":[],"label_agreement":null},{"id":"W1885069791","doi":"10.1155/2015/742408","title":"Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality","year":2015,"lang":"en","type":"article","venue":"Journal of Lipids","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Douglas Mental Health University Institute","funders":"Canadian Institutes of Health Research","keywords":"Abdominal obesity; Apolipoprotein E; Very low-density lipoprotein; Internal medicine; Cholesterol; Lipoprotein; Medicine; Endocrinology; Obesity; Triglyceride; Apolipoprotein B; High-density lipoprotein; Genotype; Waist; Biology; Genetics; Disease; Gene","score_opus":0.019416834502476277,"score_gpt":0.2907383458167557,"score_spread":0.27132151131427945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1885069791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964112,0.00050275703,0.000044172648,0.0009633707,0.00020006599,0.0015552953,0.000012280177,0.000006847122,0.00030398372],"genre_scores_gemma":[0.9985547,0.000024759154,0.00024259476,0.00013948353,0.00094822556,0.000044279754,0.0000013985125,0.000019427189,0.000025099382],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99548954,0.0013755957,0.0010551333,0.00019873686,0.0015793795,0.00030162698],"domain_scores_gemma":[0.997254,0.00021339016,0.00083022175,0.0009189544,0.0004907511,0.00029266582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011424587,0.00022887887,0.0009782803,0.00015604433,0.00006736593,0.000015814052,0.0004160649,0.00014215629,0.000023748144],"category_scores_gemma":[0.0016419622,0.00010939585,0.0004308004,0.0004318672,0.00023994896,0.00016818108,0.000072040726,0.0008083676,0.0000038012624],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06443172,0.0065745083,0.3297443,0.010819953,0.004052427,0.00075593597,0.024510752,0.01684634,0.09945769,0.002276233,0.00412069,0.43640944],"study_design_scores_gemma":[0.0127536645,0.026353244,0.44694778,0.0030830295,0.00062908075,0.0007267704,0.0026126746,0.00041252424,0.5024014,0.00039402462,0.0032828958,0.00040290377],"about_ca_topic_score_codex":0.0016391098,"about_ca_topic_score_gemma":0.00008712569,"teacher_disagreement_score":0.43600655,"about_ca_system_score_codex":0.00021363967,"about_ca_system_score_gemma":0.00064572826,"threshold_uncertainty_score":0.44610333},"labels":[],"label_agreement":null},{"id":"W1897095777","doi":"","title":"Use of lipid-lowering agents (statins) during pregnancy.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pregnancy; Hyperlipidemia; Medicine; Statin; Drug; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Bioinformatics; Intensive care medicine; Pharmacology; Internal medicine; Endocrinology; Biology","score_opus":0.04634718492975992,"score_gpt":0.24697341600273762,"score_spread":0.2006262310729777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1897095777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933184,0.000762237,0.00012801446,0.00005205824,0.00022485742,0.001119656,0.0000036302015,0.000043926826,0.00434722],"genre_scores_gemma":[0.9969627,0.00026300878,0.00046187747,0.00005665976,0.00008645235,0.00046316322,0.0000024634626,0.000023806339,0.0016798477],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99887705,0.00004216014,0.00023405184,0.00018581233,0.0003203149,0.0003406113],"domain_scores_gemma":[0.9992711,0.000013944907,0.00006664607,0.0004099201,0.000055186196,0.00018319912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020090374,0.00009641076,0.00026677107,0.00006768469,0.000041477226,0.000010643537,0.000038377166,0.000050422605,0.000039860504],"category_scores_gemma":[0.00030564165,0.00008482562,0.00016313788,0.00015582122,0.000021986429,0.00009379887,0.00001991123,0.000100090765,0.000004798623],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027394708,0.00078295683,0.17617056,0.004638442,0.0012858326,0.00058146706,0.0010111335,0.00017059143,0.002318473,0.0006486087,0.00060966745,0.8115083],"study_design_scores_gemma":[0.0016464447,0.000029630195,0.9391296,0.00022631032,0.00008627581,0.00008395772,0.00003439361,0.000007608517,0.041337907,0.0000105097915,0.017277215,0.00013015069],"about_ca_topic_score_codex":0.00006475621,"about_ca_topic_score_gemma":0.000004742355,"teacher_disagreement_score":0.8113782,"about_ca_system_score_codex":0.000060632323,"about_ca_system_score_gemma":0.000037745285,"threshold_uncertainty_score":0.34590882},"labels":[],"label_agreement":null},{"id":"W1898399486","doi":"10.1016/j.jacc.2015.08.857","title":"Next Steps in Primary Prevention of Coronary Heart Disease","year":2015,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; Women's College Hospital; McMaster University; Canadian Heart Research Centre; University of Toronto","funders":"","keywords":"Medicine; Primary prevention; Coronary heart disease; Cardiology; Primary (astronomy); Internal medicine; Secondary prevention; Disease; Intensive care medicine","score_opus":0.04003427810530365,"score_gpt":0.33355193630524776,"score_spread":0.29351765819994413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1898399486","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008114517,0.9895651,0.000028237222,0.00028246478,0.00040983147,0.0011149852,0.00010628398,0.0000027580438,0.00037584963],"genre_scores_gemma":[0.009303966,0.9893276,0.00036581964,0.00012676949,0.00065502175,0.000018443712,0.000008821442,0.00003734731,0.00015622578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957373,0.0016962294,0.0014642861,0.0001846545,0.0006911913,0.00022630006],"domain_scores_gemma":[0.99618936,0.00012954394,0.002327167,0.0007625827,0.0003738388,0.00021750364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022080382,0.00024532597,0.0058384845,0.000329874,0.000018943134,0.0000015574798,0.00033477994,0.00012531104,0.00000420795],"category_scores_gemma":[0.00024405742,0.00014778053,0.002881357,0.00060806744,0.0003994394,0.00005172929,0.00014397955,0.00061259675,0.0000013110558],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021670093,0.00027266121,0.004718767,0.022157287,0.0034191776,0.0011526719,0.000017749848,0.00007074864,0.000012472873,0.000041998057,0.010718052,0.9552514],"study_design_scores_gemma":[0.0013817275,0.0018344604,0.026233166,0.010388806,0.004026857,0.0067845606,0.00010044777,6.74339e-7,7.1068433e-7,0.000107641215,0.9489888,0.00015216069],"about_ca_topic_score_codex":0.000015976442,"about_ca_topic_score_gemma":0.0000010968016,"teacher_disagreement_score":0.9550992,"about_ca_system_score_codex":0.00042963948,"about_ca_system_score_gemma":0.004849865,"threshold_uncertainty_score":0.8603452},"labels":[],"label_agreement":null},{"id":"W19080722","doi":"10.1007/s11883-009-0002-1","title":"Golden Retriever x Newfoundland Puppies For Sale","year":2011,"lang":"en","type":"article","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business; Geography","score_opus":0.08436568383947086,"score_gpt":0.29683948112252273,"score_spread":0.21247379728305188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W19080722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98467875,0.005652525,0.0023571814,0.000112843016,0.0022221175,0.002151426,0.000015587657,0.0002126467,0.0025969215],"genre_scores_gemma":[0.99525374,0.00071171887,0.0015374037,0.000115265844,0.0008569107,0.0002966011,0.000054913045,0.00006872674,0.001104746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808615,0.000028847167,0.00051899074,0.00050071697,0.00044756208,0.00041772108],"domain_scores_gemma":[0.9984076,0.000018446803,0.00021096942,0.0008942743,0.00020625102,0.0002624383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006473676,0.00022565655,0.00049283664,0.0000745492,0.00013463783,0.000029849949,0.000072917996,0.00012083728,0.00021201928],"category_scores_gemma":[0.0001577029,0.0001826498,0.00050395215,0.0001834569,0.00007484188,0.00012213836,0.000048878537,0.00016907802,0.000026568294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030201668,0.001024446,0.8124521,0.00090183585,0.00042462072,0.000071675306,0.0025931862,4.451103e-7,0.0037338804,0.00036524687,0.0162974,0.16183315],"study_design_scores_gemma":[0.0014585699,0.00035374166,0.60950804,0.00032516257,0.00030332297,0.00025991895,0.000056806184,0.000011639295,0.0028492876,0.00048679148,0.38407108,0.00031567432],"about_ca_topic_score_codex":0.00019842987,"about_ca_topic_score_gemma":0.000022764034,"teacher_disagreement_score":0.36777368,"about_ca_system_score_codex":0.0001261118,"about_ca_system_score_gemma":0.00015990502,"threshold_uncertainty_score":0.7448243},"labels":[],"label_agreement":null},{"id":"W1914018054","doi":"10.18433/j34307","title":"Statins Reduce Mortality After Non-severe but Not After Severe Pneumonia: A Systematic Review and Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pneumonia; Confidence interval; Meta-analysis; Odds ratio; Internal medicine; Confounding; Subgroup analysis; Systematic review; Statin; MEDLINE; Intensive care medicine","score_opus":0.2271059141311043,"score_gpt":0.4839727625842117,"score_spread":0.25686684845310737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1914018054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040187623,0.99419254,0.000029777215,0.0012509708,0.00018770169,0.003511358,0.00023532863,0.000017711423,0.00017274487],"genre_scores_gemma":[0.005512566,0.9889941,0.00042404648,0.0039355196,0.00037203694,0.00041857085,0.000006392224,0.000045248384,0.00029149101],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9899243,0.0017590949,0.003282414,0.0008460085,0.003405701,0.0007824903],"domain_scores_gemma":[0.9946629,0.0002788621,0.0018467811,0.0007100766,0.0008269251,0.001674481],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012597931,0.00088258734,0.013016964,0.00055458874,0.00015950063,0.00019362285,0.00068921753,0.0001699928,0.0011922814],"category_scores_gemma":[0.00037211468,0.00046917782,0.00711619,0.0020890422,0.00049586134,0.0005344011,0.00025364145,0.001586477,0.000043322558],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008824807,0.00022641062,0.00004069985,0.81999975,0.15422827,0.0011885867,0.000073137046,0.0000016656195,0.000001956643,0.0000025009706,0.00028877502,0.023859994],"study_design_scores_gemma":[0.0006393769,0.00013259744,0.000021212869,0.01905002,0.7958624,0.004234008,0.000025217714,0.00003081911,0.0000057464417,0.0000049734413,0.17955908,0.00043457796],"about_ca_topic_score_codex":0.00006586187,"about_ca_topic_score_gemma":0.000006059361,"teacher_disagreement_score":0.80094975,"about_ca_system_score_codex":0.00031971498,"about_ca_system_score_gemma":0.0020222312,"threshold_uncertainty_score":0.999776},"labels":[],"label_agreement":null},{"id":"W1918902660","doi":"10.1111/j.1464-5491.2011.03360.x","title":"Persistent lipid abnormalities in statin‐treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study","year":2011,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Merck","keywords":"Medicine; Metabolic syndrome; Diabetes mellitus; Simvastatin; Ezetimibe; Statin; Internal medicine; Cholesterol; Triglyceride; Endocrinology; National Cholesterol Education Program","score_opus":0.013043162674212955,"score_gpt":0.20856799356584588,"score_spread":0.19552483089163292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1918902660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642074,0.0004405471,3.5311234e-7,0.00049992005,0.00017216634,0.000883436,0.00002200369,0.0000057924694,0.0015550331],"genre_scores_gemma":[0.99948686,0.0000575093,0.000023050447,0.00021680798,0.00006248181,0.00002970392,0.000030320103,0.000013756312,0.00007951476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998174,0.00017498476,0.00049499073,0.00023690995,0.000678508,0.0002405803],"domain_scores_gemma":[0.9991008,0.00006553648,0.00013121883,0.00035125847,0.00024468105,0.000106519976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007056863,0.00014462185,0.00045128583,0.0001220951,0.000025196456,0.0000024423102,0.000112964655,0.000029899687,0.00003023669],"category_scores_gemma":[0.00040066024,0.00007969938,0.00002652648,0.00030927075,0.00014186185,0.000034385568,0.00005371258,0.00018162612,2.630703e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022691896,0.00026682636,0.99193513,0.00011028128,0.00013712906,0.000019539359,0.004665428,0.0000028455092,0.000009179738,0.000009605704,0.00008729508,0.002529841],"study_design_scores_gemma":[0.008653005,0.0009973298,0.98559296,0.0006247154,0.000111327456,0.0000012790371,0.0034976131,0.000032560212,0.00015021137,0.0000019026384,0.00026016243,0.00007695212],"about_ca_topic_score_codex":0.36702427,"about_ca_topic_score_gemma":0.18999119,"teacher_disagreement_score":0.1770331,"about_ca_system_score_codex":0.00013708127,"about_ca_system_score_gemma":0.00023221446,"threshold_uncertainty_score":0.82478935},"labels":[],"label_agreement":null},{"id":"W191921423","doi":"10.1016/j.ecl.2014.08.002","title":"Lipoprotein(a)","year":2014,"lang":"en","type":"review","venue":"Endocrinology and Metabolism Clinics of North America","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Medicine; Lipoprotein(a); Lipoprotein; Coronary heart disease; Mechanism (biology); Plasma lipoprotein; Risk factor; Atherosclerotic cardiovascular disease; Intensive care medicine; Internal medicine; Disease; Bioinformatics; Cholesterol; Biology","score_opus":0.03159264937173644,"score_gpt":0.3418810939057533,"score_spread":0.3102884445340168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W191921423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023320212,0.99656916,0.00019186916,0.00007087072,0.0005870923,0.0012834582,0.000062006206,0.000064862186,0.00093748467],"genre_scores_gemma":[0.000078383615,0.99571574,0.0019822835,0.00043941365,0.001031764,0.00017347203,0.00017274868,0.00007448252,0.0003317121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965838,0.00041672157,0.0013377942,0.0007101376,0.000340685,0.0006108294],"domain_scores_gemma":[0.9971173,0.00025478174,0.0008973627,0.0012559933,0.00014395783,0.0003306422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035020668,0.0005336165,0.006048684,0.00032493623,0.000087426146,0.0000067949622,0.00023683328,0.00034598607,0.000049549384],"category_scores_gemma":[0.00045647967,0.00040207017,0.0015185894,0.00036802847,0.0005260528,0.000035720113,0.00019834518,0.0010882693,0.000083924475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023183078,0.00008486013,0.000056503464,0.011050346,0.00094848295,0.000048868354,0.000014551315,1.175856e-7,1.3263438e-8,0.00024669338,0.00013884198,0.98738754],"study_design_scores_gemma":[0.0007755408,0.00027005724,0.0011426498,0.0012561058,0.0046715746,0.00048616968,0.000005407563,0.0000010604595,3.9050292e-7,0.000034122746,0.9910595,0.00029741987],"about_ca_topic_score_codex":0.00012431774,"about_ca_topic_score_gemma":0.00001110753,"teacher_disagreement_score":0.99092066,"about_ca_system_score_codex":0.000014604322,"about_ca_system_score_gemma":0.0005213839,"threshold_uncertainty_score":0.9998431},"labels":[],"label_agreement":null},{"id":"W1934277520","doi":"10.1016/j.jacl.2015.08.005","title":"Familial hypercholesterolemia: PCSK9 InsLEU genetic variant and prediabetes/diabetes risk","year":2015,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; McGill University","funders":"Fondation Leducq","keywords":"PCSK9; Prediabetes; Medicine; Internal medicine; Diabetes mellitus; Familial hypercholesterolemia; Endocrinology; Impaired fasting glucose; Glucose homeostasis; Impaired glucose tolerance; Type 2 diabetes; Cholesterol; LDL receptor; Lipoprotein; Insulin resistance","score_opus":0.06823566948672859,"score_gpt":0.3567780784363165,"score_spread":0.2885424089495879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1934277520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900518,0.0034678753,0.00038313784,0.0014843444,0.004015118,0.00022756943,0.0000073273563,0.000015249237,0.00034760186],"genre_scores_gemma":[0.96936125,0.0018427196,0.010121339,0.0025577238,0.016018359,0.0000046815153,0.0000020670545,0.000029335546,0.00006249999],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961474,0.0010388365,0.0016804677,0.00027184037,0.00049106457,0.00037037831],"domain_scores_gemma":[0.99689865,0.00060733664,0.0007088355,0.00040576182,0.00045411754,0.0009252986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062882397,0.0001764643,0.0014043814,0.00012708297,0.000043955497,0.000017375392,0.0001523297,0.0004576728,0.000017109329],"category_scores_gemma":[0.005310807,0.0001240033,0.00047982985,0.00011144766,0.0002685321,0.00009107296,0.00009938056,0.0012965197,0.000021625556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073392235,0.00036085997,0.75741935,0.000091380105,0.0006735635,0.00012863257,0.00012444341,0.000021623386,0.00015963562,0.000019457224,0.0040422454,0.2362249],"study_design_scores_gemma":[0.010325374,0.007039931,0.91070116,0.00011520198,0.0009236062,0.0012985859,0.00008279461,0.00025442336,0.00005972887,0.001106276,0.067939855,0.00015307158],"about_ca_topic_score_codex":0.000023175257,"about_ca_topic_score_gemma":0.0000041311573,"teacher_disagreement_score":0.23607184,"about_ca_system_score_codex":0.000039017687,"about_ca_system_score_gemma":0.00077255967,"threshold_uncertainty_score":0.63579154},"labels":[],"label_agreement":null},{"id":"W1938592689","doi":"","title":"Le point sur les statines","year":2002,"lang":"fr","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Humanities; Medicine; Philosophy","score_opus":0.030422056967199396,"score_gpt":0.24167771241423797,"score_spread":0.21125565544703856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1938592689","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06577551,0.39620507,0.01024363,0.113805786,0.0028412105,0.0010355642,0.00003010343,0.00020678573,0.40985632],"genre_scores_gemma":[0.81294024,0.009889661,0.001873943,0.001493698,0.0023274266,0.000017545415,0.0000074524705,0.000039350405,0.17141068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984596,0.000121347126,0.00029352042,0.00025710696,0.00037905105,0.00048940995],"domain_scores_gemma":[0.9989847,0.000045208617,0.000042546777,0.00050149247,0.00014566502,0.00028039026],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000489909,0.00016349577,0.00037743422,0.00004995018,0.00012296067,0.00002434086,0.00006709142,0.0001316654,0.014973086],"category_scores_gemma":[0.00015046507,0.0001403265,0.0002855634,0.00016163437,0.00009616578,0.00015018319,0.00003598691,0.00021394662,0.0013616483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010338235,0.0003689682,0.00077408855,0.0007786343,0.00024695293,0.00016330223,0.00040872305,0.000008666572,0.00013355068,0.039008602,0.07435633,0.88374186],"study_design_scores_gemma":[0.002563116,0.00035948775,0.0074657956,0.00041546073,0.00017706658,0.00026934867,0.0014915471,0.002290955,0.0013345082,0.000231066,0.98313755,0.00026411275],"about_ca_topic_score_codex":0.019385042,"about_ca_topic_score_gemma":0.0006788925,"teacher_disagreement_score":0.9087812,"about_ca_system_score_codex":0.000058973,"about_ca_system_score_gemma":0.00013407857,"threshold_uncertainty_score":0.99941593},"labels":[],"label_agreement":null},{"id":"W1938634875","doi":"10.1161/jaha.114.001758","title":"Comparing Guidelines for Statin Treatment in Canada and the United States","year":2015,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Statistics Canada; Institute for Clinical Evaluative Sciences; Ottawa Hospital; Bruyère; Libin Cardiovascular Institute of Alberta; University of Ottawa","funders":"","keywords":"Medicine; Statin; Population; Disease; Kidney disease; Family medicine; Canadian Cardiovascular Society; Gerontology; Internal medicine; Environmental health; Myocardial infarction","score_opus":0.05817792075756788,"score_gpt":0.33053569544980904,"score_spread":0.27235777469224115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1938634875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97370154,0.00026047602,0.000051295327,0.02561118,0.00009476327,0.00026937688,0.0000033724243,0.0000013090071,0.0000066989746],"genre_scores_gemma":[0.99618995,0.0001995792,0.00072379934,0.0026336869,0.00017931091,0.0000071101613,0.0000021007772,0.0000053862527,0.000059051687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990148,0.00021996253,0.00029366,0.000038336228,0.00033050188,0.00010276318],"domain_scores_gemma":[0.9988381,0.0002191096,0.00033891894,0.00008383522,0.00045839365,0.000061622435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001729656,0.000047960842,0.00039451552,0.00003507267,0.000038529302,0.000009892471,0.000031165553,0.000007669208,3.0295283e-7],"category_scores_gemma":[0.0009965632,0.000022522263,0.00009781722,0.00016222842,0.000019122124,0.000021173084,0.000008534662,0.00007376468,8.210034e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034125304,0.00002181929,0.9833777,0.0000074100753,0.00019784093,0.0000014691979,0.0006067894,0.0019228982,0.000009983869,0.000006508508,0.01053657,0.002969772],"study_design_scores_gemma":[0.008638525,0.000495324,0.9269755,0.000078617384,0.00024619728,0.000060549388,0.005959417,0.013366422,0.00011419746,0.00021184946,0.04378786,0.000065575594],"about_ca_topic_score_codex":0.8901762,"about_ca_topic_score_gemma":0.52391416,"teacher_disagreement_score":0.366262,"about_ca_system_score_codex":0.0017642409,"about_ca_system_score_gemma":0.0010152503,"threshold_uncertainty_score":0.48477316},"labels":[],"label_agreement":null},{"id":"W1939039978","doi":"10.2147/vhrm.s3748","title":"Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience","year":2008,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Hospital Edmonton; University of Alberta Hospital","funders":"University of Alberta","keywords":"Medicine; Lipid profile; Cholesterol; Internal medicine; Medical record; Retrospective cohort study; Lipoprotein","score_opus":0.0219923866325342,"score_gpt":0.2726773774479245,"score_spread":0.25068499081539025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1939039978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9164774,0.07155483,0.007502928,0.00011100532,0.00056184095,0.002813995,0.000035358375,0.00011667512,0.0008259765],"genre_scores_gemma":[0.6389879,0.34285325,0.01513192,0.00025072249,0.0004547371,0.00029835626,0.00002497148,0.0000779585,0.0019201975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959239,0.00040725473,0.0008928582,0.00096446194,0.0010331081,0.0007784668],"domain_scores_gemma":[0.99716586,0.000022831528,0.00043131897,0.0016318583,0.00013092665,0.00061721564],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026330913,0.00035199008,0.0012624945,0.00019456555,0.00073823857,0.000012416375,0.00015777523,0.00013627089,0.000069838614],"category_scores_gemma":[0.0001234614,0.00029287607,0.0015749326,0.00046748464,0.00018658342,0.00012776331,0.00020543872,0.00034691687,0.0000323032],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016378693,0.0009856059,0.06406499,0.0068527246,0.016628861,0.0003773125,0.011565372,0.0002519686,0.00009043946,0.00014878319,0.0056402497,0.8917558],"study_design_scores_gemma":[0.022319088,0.0028098535,0.16362263,0.0015474034,0.0029877585,0.0005824616,0.0077696014,0.0008013008,0.00049200223,0.00008870003,0.79574484,0.0012343366],"about_ca_topic_score_codex":0.0024031631,"about_ca_topic_score_gemma":0.00002961619,"teacher_disagreement_score":0.89052147,"about_ca_system_score_codex":0.00029636413,"about_ca_system_score_gemma":0.00020384224,"threshold_uncertainty_score":0.9999523},"labels":[],"label_agreement":null},{"id":"W1947682983","doi":"10.1111/j.1368-504x.2004.00390.x","title":"A review of the efficacy of rosuvastatin in patients with type 2 diabetes","year":2004,"lang":"en","type":"review","venue":"International Journal of Clinical Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; AstraZeneca (Canada); St. Michael's Hospital","funders":"","keywords":"Rosuvastatin; Atorvastatin; Medicine; Type 2 diabetes; Statin; Type 2 Diabetes Mellitus; Internal medicine; Diabetes mellitus; Rosuvastatin Calcium; Pharmacology; Gastroenterology; Endocrinology","score_opus":0.06474233357697969,"score_gpt":0.4704350403109191,"score_spread":0.4056927067339394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1947682983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007466851,0.9966913,0.000008558427,0.0006407489,0.00089630455,0.0006734769,0.000012307048,0.0000012961938,0.00032934087],"genre_scores_gemma":[0.0005531825,0.9968198,0.0013363899,0.0008428362,0.00040140102,0.0000025150996,0.000011425122,0.000021135194,0.000011327247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99436164,0.0007948993,0.0030940627,0.00014381122,0.0015025014,0.00010310675],"domain_scores_gemma":[0.9889765,0.0023446686,0.005586455,0.0003628011,0.0026400327,0.00008956303],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00456368,0.0001580505,0.0022347427,0.0001152338,0.000007756775,0.000006282087,0.00042713116,0.0001361481,0.00003968882],"category_scores_gemma":[0.03062527,0.00007926063,0.0012247141,0.00031149611,0.000094385214,0.00013811384,0.00007507098,0.0011110478,0.0000040181103],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052478706,0.0014502072,0.00202374,0.036882795,0.002212422,0.00003758123,0.000010425431,0.0000019907827,1.6773022e-8,0.000032450287,0.0002561605,0.9565674],"study_design_scores_gemma":[0.002461861,0.0007706191,0.009820322,0.33225858,0.002145856,0.00008437996,0.0000027726587,1.1994595e-7,3.5136134e-7,0.000008686183,0.65238726,0.000059166003],"about_ca_topic_score_codex":0.000017995491,"about_ca_topic_score_gemma":8.8356535e-7,"teacher_disagreement_score":0.9565083,"about_ca_system_score_codex":0.00011761881,"about_ca_system_score_gemma":0.0024906988,"threshold_uncertainty_score":0.9775402},"labels":[],"label_agreement":null},{"id":"W1948458971","doi":"10.1111/bcp.12339","title":"Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review","year":2014,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Statin; Discontinuation; Observational study; Internal medicine; MEDLINE; Population; Disease; Adverse effect; Intensive care medicine; Risk of mortality; Environmental health","score_opus":0.13532234234406884,"score_gpt":0.5122336009521217,"score_spread":0.37691125860805286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948458971","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001830037,0.993511,0.000050019567,0.000028798875,0.00077116466,0.0036438894,0.000120511664,0.000009275212,0.000035290814],"genre_scores_gemma":[0.0007532958,0.99730915,0.00006151672,0.00073453656,0.0009528916,0.00009168397,0.000017656137,0.000052969066,0.000026322172],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98703915,0.005208964,0.0058332877,0.00045754595,0.0011214692,0.00033958556],"domain_scores_gemma":[0.9925533,0.0014000656,0.0036313203,0.0007367429,0.000600339,0.0010782667],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.013749735,0.00043617075,0.01734627,0.0001285518,0.000042203043,0.00001736508,0.0003305905,0.00031962508,0.00013726384],"category_scores_gemma":[0.006406223,0.00030064103,0.013229835,0.00020396755,0.00023341448,0.000057361744,0.00008120552,0.0016948008,0.000011912662],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005325213,0.0003385215,0.00017663186,0.66462135,0.022444207,0.0018188251,0.0000012887206,0.0000013557088,1.0075052e-8,9.708696e-7,0.0015325024,0.30901107],"study_design_scores_gemma":[0.003264227,0.0020757017,0.005711221,0.81281626,0.12879191,0.005217778,0.0000014480132,0.0000035421199,2.324264e-8,0.0000125254355,0.041826732,0.00027861394],"about_ca_topic_score_codex":0.00011177192,"about_ca_topic_score_gemma":0.0000013201321,"teacher_disagreement_score":0.30873245,"about_ca_system_score_codex":0.0001179533,"about_ca_system_score_gemma":0.0020137157,"threshold_uncertainty_score":0.99994457},"labels":[],"label_agreement":null},{"id":"W1951400892","doi":"10.1111/j.1399-0004.2005.0453a.x","title":"Common inactivating mutations in PCSK9 cause low LDL cholesterol","year":2005,"lang":"en","type":"article","venue":"Clinical Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Bulletin of Medical History; Pacific Centre for Reproductive Medicine","funders":"","keywords":"PCSK9; Familial hypercholesterolemia; Cholesterol; Citation; LDL receptor; Medicine; Internal medicine; Library science; Genetics; Lipoprotein; Biology; Computer science","score_opus":0.06882083302523588,"score_gpt":0.39966075245426425,"score_spread":0.33083991942902835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1951400892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608064,0.0004712428,0.00032983025,0.0015316478,0.00014088693,0.00043152308,0.0000030965655,0.000033898385,0.0009772503],"genre_scores_gemma":[0.9922715,0.00031281408,0.003763021,0.0024980358,0.00094027683,0.000021786584,0.000017211965,0.000024255995,0.00015109593],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99843097,0.00014369284,0.0006836903,0.00024847282,0.00025060624,0.00024256196],"domain_scores_gemma":[0.99897027,0.00014988596,0.00008903468,0.00051910715,0.00006468407,0.00020703321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007645598,0.000107169195,0.00038843782,0.000055382512,0.000047078873,0.000013966814,0.000078025994,0.00016916383,0.000029610137],"category_scores_gemma":[0.0003100662,0.00009753205,0.00018119837,0.00017687,0.00007886544,0.00003230673,0.000047803336,0.00046961452,0.000078047415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038401144,0.00055045594,0.41456547,0.000079314814,0.00007700057,0.000036146168,0.00020244038,0.00040416277,0.00015617909,0.000020291202,0.00016630847,0.5837038],"study_design_scores_gemma":[0.003115412,0.0003537632,0.97267306,0.00016806326,0.00009531609,0.00003840201,0.00011364243,0.0024960246,0.001212184,0.00005466973,0.01953323,0.00014625814],"about_ca_topic_score_codex":0.000048802056,"about_ca_topic_score_gemma":0.00021224371,"teacher_disagreement_score":0.58355755,"about_ca_system_score_codex":0.0000725116,"about_ca_system_score_gemma":0.00013506628,"threshold_uncertainty_score":0.39772418},"labels":[],"label_agreement":null},{"id":"W1962272706","doi":"10.1093/eurheartj/ehv370","title":"ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia","year":2015,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":534,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Kowa Company; Esperion Therapeutics; Regeneron Pharmaceuticals; Valeant Pharmaceuticals International; Sanofi; Servier; Amgen; Pfizer; Janssen Pharmaceuticals; AstraZeneca; Eli Lilly and Company","keywords":"Alirocumab; Medicine; Placebo; Discontinuation; Internal medicine; PCSK9; Gastroenterology; Clinical endpoint; Adverse effect; Randomized controlled trial; Endocrinology; Cholesterol; Apolipoprotein B; Lipoprotein; LDL receptor; Pathology","score_opus":0.040324910078964764,"score_gpt":0.26401324998363046,"score_spread":0.2236883399046657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1962272706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549913,0.00047203855,0.000027303322,0.0007396586,0.0001316373,0.0005602891,0.000013039786,0.000032605356,0.002524298],"genre_scores_gemma":[0.9969835,0.00012611352,0.0011487951,0.0005843187,0.00061588694,0.000005626977,0.000020871357,0.000068936795,0.00044589565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997606,0.00045852028,0.00040471985,0.00036660105,0.0007204165,0.00044376162],"domain_scores_gemma":[0.99854606,0.0000163461,0.00011385147,0.0004240981,0.00017960396,0.0007200219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096577284,0.0002702637,0.00049239106,0.00015270815,0.00019050378,0.00008016564,0.00007405961,0.000046007557,0.0000050241083],"category_scores_gemma":[0.00005277466,0.00016330197,0.00009162908,0.00014955382,0.00007748555,0.00018563835,0.0000536304,0.0004592846,0.000026393573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015893681,0.0024057773,0.87741035,0.00009959398,0.00059556944,0.006194454,0.008544797,0.00015669255,0.00015470984,0.000003733267,0.0041221594,0.084418476],"study_design_scores_gemma":[0.032051094,0.015228171,0.8926262,0.0004056449,0.00011732971,0.0045119934,0.00031170374,0.000013110078,0.00005010099,0.000002485373,0.054447867,0.00023427517],"about_ca_topic_score_codex":0.00020644798,"about_ca_topic_score_gemma":0.000100195015,"teacher_disagreement_score":0.0841842,"about_ca_system_score_codex":0.0002865301,"about_ca_system_score_gemma":0.0002673272,"threshold_uncertainty_score":0.6659261},"labels":[],"label_agreement":null},{"id":"W1963603728","doi":"10.1016/j.atherosclerosis.2012.08.026","title":"Aortic calcification: Novel insights from familial hypercholesterolemia and potential role for the low-density lipoprotein receptor","year":2012,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; McGill University","funders":"","keywords":"Calcification; Internal medicine; LDL receptor; Medicine; Lipoprotein; Endocrinology; PCSK9; Receptor; Cholesterol; Cardiology","score_opus":0.05105932255632736,"score_gpt":0.2868575550356863,"score_spread":0.2357982324793589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963603728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015120576,0.97652805,0.0024749779,0.00015106886,0.00068968517,0.004647061,0.0002798666,0.000084540676,0.00002419763],"genre_scores_gemma":[0.013877088,0.97910076,0.0011791756,0.0002692485,0.0035556927,0.0013161384,0.0003654972,0.00016398837,0.00017240559],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971979,0.0001691713,0.0007567675,0.00078581437,0.0005878563,0.0005024482],"domain_scores_gemma":[0.9975113,0.00017718975,0.00034943738,0.0014645028,0.00015336281,0.00034418455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051216164,0.00059457304,0.0018604046,0.000077513156,0.00040543906,0.000095545,0.00029382127,0.0006919117,0.000037993435],"category_scores_gemma":[0.00007222148,0.00037361102,0.0011086178,0.0002122589,0.00017003421,0.00011216472,0.00014948621,0.0006246081,0.00009472866],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041742653,0.00015931677,0.000015036563,0.002943732,0.0006856254,3.28868e-7,0.00020766436,1.1478584e-7,0.0012931334,0.000031114392,0.00006363662,0.9945586],"study_design_scores_gemma":[0.001836104,0.00017083404,0.006780808,0.005934783,0.007373477,0.000028947985,0.00012851862,0.000035993373,0.00022057472,0.00002770897,0.97686034,0.0006019182],"about_ca_topic_score_codex":0.0015414017,"about_ca_topic_score_gemma":0.00004303589,"teacher_disagreement_score":0.9939566,"about_ca_system_score_codex":0.00020277053,"about_ca_system_score_gemma":0.0002546485,"threshold_uncertainty_score":0.9998716},"labels":[],"label_agreement":null},{"id":"W1963777356","doi":"10.1016/j.pharmthera.2012.03.004","title":"Novel HDL-based therapeutic agents","year":2012,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cholesterylester transfer protein; Apolipoprotein B; Cholesterol; Pharmacology; Medicine; Mechanism of action; Lipoprotein; Therapeutic approach; Reverse cholesterol transport; High-density lipoprotein; Mechanism (biology); Disease; Bioinformatics; Internal medicine; Chemistry; Biology; Biochemistry","score_opus":0.20972457457453705,"score_gpt":0.4332547411128237,"score_spread":0.22353016653828664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963777356","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010215954,0.9920882,0.0011533244,0.00046511032,0.0023225874,0.0030095004,0.00006110323,0.00019709783,0.0006928659],"genre_scores_gemma":[0.00018742979,0.9749477,0.00048400112,0.020604648,0.0023243197,0.0005255781,0.00020469846,0.00025732073,0.00046431285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99637145,0.00047980904,0.00083420996,0.00063965644,0.0006190405,0.0010558652],"domain_scores_gemma":[0.997872,0.00017316893,0.00042568808,0.00094280107,0.00014850336,0.00043783776],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009245043,0.0008419403,0.0028782848,0.0003164344,0.00017655217,0.000022845476,0.00040799828,0.0008558884,0.0010450287],"category_scores_gemma":[0.0000020960185,0.0006349901,0.0018636457,0.000483778,0.00019664102,0.00005496971,0.00008499197,0.0013969349,0.00054903823],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052103554,0.0007722275,0.000010373107,0.011267279,0.0066445027,0.00003519149,0.000036688212,8.1541e-7,0.00006383183,0.000016459877,0.0002549257,0.98084563],"study_design_scores_gemma":[0.0021222797,0.00018942944,0.000035435143,0.0010957905,0.04987362,0.0003804774,0.0000050828085,0.00004529093,0.000057918907,0.0000042187235,0.94569314,0.00049730926],"about_ca_topic_score_codex":0.000023737348,"about_ca_topic_score_gemma":0.0000015093057,"teacher_disagreement_score":0.9803483,"about_ca_system_score_codex":0.00043933652,"about_ca_system_score_gemma":0.0013178047,"threshold_uncertainty_score":0.99986815},"labels":[],"label_agreement":null},{"id":"W1964008507","doi":"10.1161/strokeaha.110.595132","title":"Response to Letter by Hadjiev et al","year":2010,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Rosuvastatin; Atorvastatin; Adverse effect; Stroke (engine); Population; Statin; Internal medicine; Clinical trial; Gerontology","score_opus":0.008682948647915543,"score_gpt":0.27760943274111055,"score_spread":0.26892648409319503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964008507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85862386,0.000065176464,0.00039099774,0.13679482,0.00032361734,0.00028080947,0.0000306029,0.0000456569,0.003444459],"genre_scores_gemma":[0.82363474,0.0000069816765,0.0020155287,0.1652206,0.00028840688,0.00003186728,0.000012017113,0.000023089717,0.008766789],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911547,0.00006471338,0.00010357671,0.00018563707,0.00031628928,0.00021431493],"domain_scores_gemma":[0.9992214,0.000022454416,0.000014337742,0.00049048406,0.000037277703,0.00021406126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086010166,0.00008039644,0.00016401846,0.00004498442,0.000037555565,0.000014029549,0.00005576973,0.000054262982,0.00021906181],"category_scores_gemma":[0.00013158147,0.00006474348,0.00012191836,0.00005888107,0.000020722971,0.000028224236,0.000027861164,0.0003157718,0.00025718226],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050669455,0.000031153682,0.0008625134,0.000006711987,0.000036450867,0.000033613112,0.00007943211,1.466244e-7,0.44424936,0.0000474006,0.5454892,0.008657333],"study_design_scores_gemma":[0.0007939472,0.00019158522,0.013853711,0.000009421816,0.000014378718,0.000043968932,0.00001381612,0.0000020436682,0.018151358,0.0000035400226,0.9668544,0.000067854904],"about_ca_topic_score_codex":0.0001316304,"about_ca_topic_score_gemma":0.000029403307,"teacher_disagreement_score":0.426098,"about_ca_system_score_codex":0.000017610182,"about_ca_system_score_gemma":0.00008395425,"threshold_uncertainty_score":0.33056435},"labels":[],"label_agreement":null},{"id":"W1964229597","doi":"10.1161/jaha.114.001208","title":"Statin Use Following Hospitalization Among Medicare Beneficiaries With a Secondary Discharge Diagnosis of Acute Myocardial Infarction","year":2015,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"Amgen","keywords":"Medicine; Percutaneous coronary intervention; Myocardial infarction; Internal medicine; Statin; Cardiology; Coronary artery disease; Emergency medicine","score_opus":0.009407927409029366,"score_gpt":0.2548362244004045,"score_spread":0.2454282969913751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964229597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657625,0.00013987592,0.00034302834,0.0022345977,0.00036257022,0.0002919483,0.000020150299,0.000010254043,0.00002135274],"genre_scores_gemma":[0.9983009,0.00013242589,0.00076185906,0.0004064885,0.00032945737,0.000011490623,0.000008788002,0.00001959442,0.000028966451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770206,0.00030866868,0.0004438075,0.00009730366,0.00127869,0.00016946162],"domain_scores_gemma":[0.9979183,0.0001116484,0.0010213396,0.0001962576,0.0006085684,0.00014389779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013972068,0.000105461906,0.0006567043,0.00010398622,0.000083606115,0.00003203213,0.00006546011,0.00005238051,0.000003849463],"category_scores_gemma":[0.000861381,0.00006699829,0.0004753247,0.00044249222,0.00004882064,0.00039900298,0.00002646174,0.00026837667,6.3408845e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001484159,0.00005507878,0.9939816,0.000013164242,0.0014670752,0.000004413045,0.0009706374,0.00007635481,0.00009868899,0.0000061348546,0.0014076431,0.0017707833],"study_design_scores_gemma":[0.0012715426,0.0009133287,0.99382484,0.00017180758,0.0010988532,0.000026399961,0.0010039238,0.00005309872,0.00045174512,0.000026981284,0.0010828231,0.00007466981],"about_ca_topic_score_codex":0.0012087496,"about_ca_topic_score_gemma":0.00010720097,"teacher_disagreement_score":0.0018281091,"about_ca_system_score_codex":0.00051893754,"about_ca_system_score_gemma":0.00049735943,"threshold_uncertainty_score":0.2732111},"labels":[],"label_agreement":null},{"id":"W1964240590","doi":"10.1016/j.cjca.2013.09.023","title":"Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; McGill University; University of Toronto; McMaster University; University of British Columbia; University of Alberta; Robarts Clinical Trials; Université Laval; University of British Columbia Hospital","funders":"Canadian Cardiovascular Society","keywords":"Medicine; Statin; Adverse effect; Diabetes mellitus; Intensive care medicine; Cataracts; Disease; Cognition; Type 2 diabetes; Physical therapy; Internal medicine; Psychiatry; Endocrinology","score_opus":0.00924961441609574,"score_gpt":0.2316546824870373,"score_spread":0.22240506807094157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964240590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98248935,0.013771255,0.00024788352,0.0013225088,0.0003372499,0.00066213956,0.0000073230112,0.0000025413897,0.0011597582],"genre_scores_gemma":[0.99537396,0.0029045762,0.0011134731,0.00031242054,0.00022834461,0.000025658475,0.0000044683466,0.000012850974,0.000024257666],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989166,0.00016780617,0.00033590375,0.00013919186,0.00011467296,0.00032581112],"domain_scores_gemma":[0.9984825,0.000040642422,0.00013747072,0.00017227227,0.00014960897,0.0010175008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055760815,0.00011274536,0.00054492377,0.0002720206,0.00007870487,0.000010516212,0.000054614833,0.00009368646,0.000020276562],"category_scores_gemma":[0.000048241323,0.00010026379,0.00012759869,0.0001049937,0.00016029003,0.000037142072,0.000010258094,0.00018544555,0.000002382238],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057046283,0.000005872417,0.45179865,0.0013948993,0.002219881,0.0021633592,0.00036656964,0.00008272229,0.000039594477,0.0012532905,0.010879852,0.52973825],"study_design_scores_gemma":[0.0021997092,0.0003159089,0.91475654,0.0008660913,0.00038172468,0.0012663334,0.00041141047,0.000007101436,0.000031914835,0.0004076729,0.07923466,0.0001209583],"about_ca_topic_score_codex":0.07369464,"about_ca_topic_score_gemma":0.07786403,"teacher_disagreement_score":0.5296173,"about_ca_system_score_codex":0.00013778955,"about_ca_system_score_gemma":0.00059137424,"threshold_uncertainty_score":0.9389625},"labels":[],"label_agreement":null},{"id":"W1964286975","doi":"10.1159/000127442","title":"Efficacy and Tolerability of Rosuvastatin and Atorvastatin when Force-Titrated in Patients with Primary Hypercholesterolemia","year":2008,"lang":"en","type":"article","venue":"Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"AstraZeneca","keywords":"Rosuvastatin; Atorvastatin; Tolerability; Medicine; Rosuvastatin Calcium; Statin; Internal medicine; Pharmacology; Randomized controlled trial; Urology; Endocrinology; Gastroenterology; Adverse effect","score_opus":0.011594959441913506,"score_gpt":0.21976866115414673,"score_spread":0.20817370171223323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964286975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982339,0.0005302147,0.00016620339,0.000053038693,0.000022724143,0.00065543794,0.000013123774,0.000014874631,0.00031048837],"genre_scores_gemma":[0.99861914,0.00008907608,0.000993816,0.00017252125,0.00003424801,0.00001944084,0.00004222052,0.00001451493,0.000014995361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889284,0.00017086211,0.00028028368,0.0002907084,0.00016037916,0.00020490611],"domain_scores_gemma":[0.9993779,0.000059524697,0.000058547226,0.00029154186,0.00010186025,0.00011061766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003193017,0.00012509701,0.00074064656,0.00006451215,0.000034375993,0.000002216077,0.00002990427,0.0000994749,0.000003140578],"category_scores_gemma":[0.00006520229,0.00009484669,0.000049231312,0.0000836099,0.00027413288,0.00004343657,0.000035822814,0.00017225707,6.156853e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064514426,0.00005319275,0.9851913,0.00018232508,0.00009321492,0.000035863417,0.00048010817,0.000012631528,0.000267871,0.0000065346703,0.00002872342,0.013003128],"study_design_scores_gemma":[0.0070625544,0.00084052054,0.9914385,0.00005490581,0.000047270652,0.00014003493,0.00004583833,0.000004912802,0.00009017346,0.000019324678,0.00017176445,0.000084202846],"about_ca_topic_score_codex":0.00009874243,"about_ca_topic_score_gemma":0.00000777855,"teacher_disagreement_score":0.012918924,"about_ca_system_score_codex":0.000045485685,"about_ca_system_score_gemma":0.00011486762,"threshold_uncertainty_score":0.3867736},"labels":[],"label_agreement":null},{"id":"W1964421675","doi":"10.1016/j.cjca.2012.04.019","title":"Regional and National Familial Hypercholesterolemia Registries: Present International Application, Importance, and Needs for Canada","year":2012,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Providence Health Care","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Environmental health; Pediatrics; Internal medicine; Cholesterol","score_opus":0.04430705817459283,"score_gpt":0.30047930930844585,"score_spread":0.256172251133853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964421675","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011081331,0.99509823,0.00064643053,0.0012758798,0.00066486927,0.00068776746,0.00030229765,0.0000023634002,0.0012113394],"genre_scores_gemma":[0.0034692658,0.9864393,0.00022113445,0.00045330694,0.008800923,0.00008991509,0.00028033022,0.000036749792,0.00020908292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838907,0.00009028754,0.0006626892,0.00019709612,0.00035041745,0.00031042995],"domain_scores_gemma":[0.9978137,0.00011542442,0.00041294476,0.00020501047,0.00062826026,0.00082463096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000823624,0.00022459465,0.0013791261,0.00034884966,0.000094894225,0.000019762978,0.00015737898,0.00028924696,0.0000038277676],"category_scores_gemma":[0.00015636956,0.0001851493,0.0003557175,0.00010871704,0.000170934,0.000060933897,0.000017584613,0.00039363353,3.8314167e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047357153,0.0000026691475,0.003307357,0.0033086773,0.0020925005,0.000060644627,0.00004709194,0.000006532997,2.5878688e-7,0.0013377725,0.07439291,0.9153962],"study_design_scores_gemma":[0.000595862,0.00005957318,0.0012621835,0.00051095773,0.00081286236,0.0073923958,0.00004827063,0.0000016367171,4.9926218e-8,0.00006578676,0.98911476,0.00013565586],"about_ca_topic_score_codex":0.04080115,"about_ca_topic_score_gemma":0.07304505,"teacher_disagreement_score":0.91526055,"about_ca_system_score_codex":0.0008290497,"about_ca_system_score_gemma":0.014438359,"threshold_uncertainty_score":0.9911489},"labels":[],"label_agreement":null},{"id":"W1965676778","doi":"10.1517/14728220802600715","title":"PCSK9 as a therapeutic target of dyslipidemia","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Dyslipidemia; Proprotein convertase; Medicine; Pharmacology; Internal medicine; Cholesterol; Disease; LDL receptor; Lipoprotein","score_opus":0.07195171311946463,"score_gpt":0.38167704167601885,"score_spread":0.3097253285565542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965676778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.7406577e-7,0.9909759,0.0002922903,0.00033301537,0.0020402942,0.002896266,0.000037327456,0.00017813648,0.0032460073],"genre_scores_gemma":[0.00006258914,0.9930178,0.0006089295,0.002516408,0.0021100426,0.00051244523,0.00036190802,0.00028534277,0.0005245391],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99442977,0.0007255845,0.0015324636,0.0010685856,0.0014057617,0.00083785783],"domain_scores_gemma":[0.9962703,0.0002584258,0.00076080405,0.0020787593,0.00019487827,0.0004368065],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061672076,0.0010998483,0.0047180527,0.0004991194,0.00019328047,0.000018805687,0.0004863013,0.0009910499,0.0008413171],"category_scores_gemma":[0.00008264106,0.0007818529,0.0030148788,0.0005783422,0.00021756774,0.000074130585,0.00008464288,0.0010963707,0.00048455998],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012865648,0.00043476527,0.0000019702754,0.0040022586,0.0020955869,0.00003834536,0.00040482255,7.634312e-7,0.000007742922,0.0007610261,0.0022093311,0.9899147],"study_design_scores_gemma":[0.0012513079,0.0011524851,0.000012912547,0.007959394,0.00016951197,0.00050876394,0.000052706404,0.000007843058,0.000100995894,0.00018218614,0.98794323,0.00065865065],"about_ca_topic_score_codex":0.00006523613,"about_ca_topic_score_gemma":3.715294e-7,"teacher_disagreement_score":0.9892561,"about_ca_system_score_codex":0.00038332553,"about_ca_system_score_gemma":0.0015345749,"threshold_uncertainty_score":0.99946326},"labels":[],"label_agreement":null},{"id":"W1966307825","doi":"10.14797/mdcj-10-1-7","title":"Genetics of Coronary Artery Disease: An Update","year":2014,"lang":"en","type":"review","venue":"Methodist DeBakey Cardiovascular Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Webcast; MEDLINE; Coronary artery disease; Medical education; Cardiology; World Wide Web","score_opus":0.05531380399304284,"score_gpt":0.35188303074683014,"score_spread":0.2965692267537873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966307825","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040752908,0.93646413,0.060289845,0.000025630701,0.001111531,0.0015637951,0.000101280966,0.00006379998,0.000339255],"genre_scores_gemma":[0.00005845618,0.9725027,0.022761997,0.00013653998,0.0036888407,0.00008929192,0.0003754269,0.0002972894,0.00008944447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98752433,0.0056916713,0.002218819,0.001020569,0.0026489794,0.0008956052],"domain_scores_gemma":[0.9923436,0.00013843535,0.0008917331,0.0041401354,0.0006101488,0.0018759257],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.011515218,0.0010463359,0.0087049045,0.0005919891,0.0003021654,0.00011842987,0.0007043,0.00065725885,0.0001403332],"category_scores_gemma":[0.0004228878,0.0007928671,0.017442374,0.0005666505,0.00024325581,0.00014944677,0.0001810489,0.0019733345,0.00006431783],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006440039,0.00014597908,0.000030110199,0.023747321,0.01484446,0.0021431705,0.000018460263,0.000037642723,4.518345e-7,0.00003186988,0.00030415886,0.958632],"study_design_scores_gemma":[0.0013607014,0.0002568474,0.00035269101,0.007896517,0.03820081,0.026534218,0.0000140602215,0.000027543454,0.0000028115437,0.00009254487,0.9245722,0.00068900484],"about_ca_topic_score_codex":0.000012184372,"about_ca_topic_score_gemma":0.000001238234,"teacher_disagreement_score":0.95794296,"about_ca_system_score_codex":0.0003710517,"about_ca_system_score_gemma":0.0022792271,"threshold_uncertainty_score":0.99945223},"labels":[],"label_agreement":null},{"id":"W1966550321","doi":"10.1016/s0021-9150(99)00282-8","title":"Governance of the concentration of plasma LDL: a reevaluation of the LDL receptor paradigm","year":2000,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Pravastatin; Lovastatin; Simvastatin; Medicine; Internal medicine; Coronary heart disease; Myocardial infarction; Statin; Cholesterol lowering; Cardiology; Cholesterol","score_opus":0.05127466318083752,"score_gpt":0.29897814008600243,"score_spread":0.24770347690516492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966550321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017056657,0.97846645,0.000012152238,0.00022429468,0.00038134458,0.0030007004,0.00021680484,0.000011357054,0.00063026045],"genre_scores_gemma":[0.025280546,0.973975,0.00007253621,0.000046353638,0.00014559623,0.00009848709,0.000019905146,0.00004184313,0.00031970415],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971661,0.00046952692,0.0009450334,0.00027434688,0.0009621442,0.00018286971],"domain_scores_gemma":[0.99714416,0.00008656933,0.0013156733,0.0013013165,0.0001100055,0.000042287313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075558067,0.00024568386,0.0014581833,0.000017054786,0.000059399696,0.0000064216406,0.00033309974,0.00027153382,0.00010333664],"category_scores_gemma":[0.00015338183,0.00012893061,0.0013907981,0.00049917883,0.0001972096,0.000053076878,0.00004946733,0.00026724316,0.0000064662486],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034027682,0.00014848034,0.00022047527,0.010722876,0.0004695975,5.122731e-8,0.00025359337,0.000005613413,0.00031111145,0.00079332304,0.0004347704,0.98660606],"study_design_scores_gemma":[0.0013161045,0.00024568522,0.007850035,0.045537837,0.0030050268,0.000009626006,0.000019385876,0.000022822845,0.003687985,0.000030016581,0.9380597,0.00021579336],"about_ca_topic_score_codex":0.00029533933,"about_ca_topic_score_gemma":0.000016679549,"teacher_disagreement_score":0.9863903,"about_ca_system_score_codex":0.00016432932,"about_ca_system_score_gemma":0.00070563954,"threshold_uncertainty_score":0.52576375},"labels":[],"label_agreement":null},{"id":"W1966747907","doi":"10.1007/s11095-012-0858-6","title":"Inhibition of Cholesterol Absorption: Targeting the Intestine","year":2012,"lang":"en","type":"review","venue":"Pharmaceutical Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Cholesterol; Medicine; Coronary artery disease; Cholesterol lowering; Gastrointestinal tract; Pharmacology; Internal medicine; Bioinformatics; Biology","score_opus":0.39239691532684723,"score_gpt":0.5312233324568828,"score_spread":0.13882641713003557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966747907","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000926715,0.99421656,0.00007679036,0.0005245512,0.00013086344,0.0022460453,0.000012823423,0.000029047702,0.0026706539],"genre_scores_gemma":[0.0041283923,0.9929624,0.000095010924,0.00009028436,0.0020472722,0.00031341825,0.000078644356,0.000058559035,0.00022602473],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952199,0.001282171,0.000699669,0.0003350046,0.0017259996,0.0007372975],"domain_scores_gemma":[0.9976372,0.0006839712,0.00012017064,0.0006396114,0.00048637885,0.0004326839],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009675684,0.00023730315,0.0011595243,0.00023282447,0.00015532454,0.000026504174,0.00020423393,0.00023928081,0.0004603517],"category_scores_gemma":[0.0009642397,0.00013192005,0.0006715327,0.0008247407,0.0003776283,0.000059223872,0.00028757923,0.0026836905,0.0003947208],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002489408,0.0001363031,0.000010174884,0.03353921,0.00017148501,0.000013392327,0.000036439807,4.0278906e-8,0.00003660473,0.00019823693,0.00045246203,0.9653807],"study_design_scores_gemma":[0.00040542017,0.00009173862,0.000016291102,0.0077417097,0.0008311468,0.00018980086,0.00002402731,0.000018018096,0.00019716815,0.000024170724,0.99035585,0.00010466596],"about_ca_topic_score_codex":0.00004029203,"about_ca_topic_score_gemma":6.368553e-7,"teacher_disagreement_score":0.9899034,"about_ca_system_score_codex":0.00021874653,"about_ca_system_score_gemma":0.0005109419,"threshold_uncertainty_score":0.99961716},"labels":[],"label_agreement":null},{"id":"W1966941449","doi":"10.1074/jbc.m705831200","title":"Dual Mechanisms for the Fibrate-mediated Repression of Proprotein Convertase Subtilisin/Kexin Type 9","year":2008,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"PCSK9; Proprotein convertase; Furin; Kexin; LDL receptor; Chemistry; Endocrinology; Internal medicine; Biology; Cholesterol; Biochemistry; Medicine; Lipoprotein; Enzyme","score_opus":0.0442787762413653,"score_gpt":0.2759647750626708,"score_spread":0.2316859988213055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966941449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954395,0.0022610053,0.0010331769,0.0006510457,0.000098475095,0.00038847586,0.000015260142,0.000011114206,0.00010189005],"genre_scores_gemma":[0.9972796,0.00064750644,0.0013316325,0.00015152652,0.00039812794,0.00000895074,0.000018923729,0.000008751784,0.00015500479],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988373,0.000043442502,0.00048494077,0.00013941985,0.00032440966,0.00017048961],"domain_scores_gemma":[0.9987018,0.00014376944,0.00035614654,0.00026703914,0.00038831908,0.00014293456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007509347,0.000114460105,0.00045132881,0.0000150574715,0.00007604926,0.0000037601926,0.000113390946,0.00021983356,0.00017154508],"category_scores_gemma":[0.0010702594,0.000053179912,0.00033746698,0.00009968913,0.00013382081,0.000027027732,0.000034095567,0.00029786318,0.0000018984563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020177963,0.0001811504,0.0006650987,0.0002184667,0.0001829093,0.00016461684,0.000043925735,0.0000056800386,0.9939134,0.00001180503,0.0008956144,0.0016995257],"study_design_scores_gemma":[0.0019513187,0.001034211,0.0036307408,0.0001376813,0.000079520796,0.0014151625,0.00011762307,0.00008763476,0.98887277,0.00018553548,0.002407719,0.00008007974],"about_ca_topic_score_codex":0.000009716467,"about_ca_topic_score_gemma":1.0489848e-7,"teacher_disagreement_score":0.0050406377,"about_ca_system_score_codex":0.00003098617,"about_ca_system_score_gemma":0.00024274545,"threshold_uncertainty_score":0.2168614},"labels":[],"label_agreement":null},{"id":"W1967200037","doi":"10.1016/j.ahj.2007.04.031","title":"Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: Insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials","year":2007,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Aspirin; Internal medicine; Acute coronary syndrome; Cardiology; Myocardial infarction","score_opus":0.15317350809939587,"score_gpt":0.3595408054119653,"score_spread":0.20636729731256945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967200037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96216697,0.0038314622,0.0020741923,0.028567696,0.00031438645,0.0029488495,0.000067727844,0.000024928626,0.0000037626262],"genre_scores_gemma":[0.98871654,0.00087672856,0.0027531257,0.006796076,0.0006545942,0.00010624145,0.000029182804,0.00004676703,0.00002076992],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957674,0.00091006764,0.0012305799,0.0004717946,0.0011055503,0.0005145973],"domain_scores_gemma":[0.99408484,0.004151762,0.0004836715,0.0007078009,0.00021293778,0.00035899514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038084695,0.00035198155,0.0015873432,0.00027360997,0.00028887807,0.000052939715,0.0002451534,0.00013735415,0.000056911962],"category_scores_gemma":[0.0015694577,0.00018587908,0.0004800547,0.0005770443,0.00030621237,0.00037209352,0.000055038523,0.0007622187,0.0000043764812],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036037236,0.0009773122,0.24082795,0.00034118112,0.005729569,0.0016272638,0.005531574,0.00006843114,0.22981374,0.000011765959,0.024711177,0.45432281],"study_design_scores_gemma":[0.003210774,0.018771155,0.94891477,0.004403658,0.0012034568,0.0038880243,0.0021108775,0.00005294659,0.004444698,0.0002460772,0.012410232,0.000343358],"about_ca_topic_score_codex":0.00881673,"about_ca_topic_score_gemma":0.0002464406,"teacher_disagreement_score":0.7080868,"about_ca_system_score_codex":0.00015387607,"about_ca_system_score_gemma":0.00045773765,"threshold_uncertainty_score":0.99778366},"labels":[],"label_agreement":null},{"id":"W1967461471","doi":"10.1592/phco.26.7.939","title":"Key Articles, Guidelines, and Consensus Papers Relative to the Treatment of Dyslipidemias—2005","year":2006,"lang":"en","type":"review","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Key (lock); Relevance (law); Coronary heart disease; Medicine; Intensive care medicine; Political science; Computer science; Internal medicine","score_opus":0.08457198349057203,"score_gpt":0.41602229251225814,"score_spread":0.3314503090216861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967461471","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02286403,0.96854055,0.000011928019,0.0057685953,0.00043691954,0.002207899,0.000028770452,0.000013798846,0.00012750825],"genre_scores_gemma":[0.0011829612,0.99217117,0.000133433,0.003394037,0.0022340927,0.000059496128,0.000004849415,0.00007225705,0.0007477097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99565977,0.001714885,0.0015312221,0.00027701905,0.00041092766,0.00040618444],"domain_scores_gemma":[0.99722964,0.00071494165,0.0011484944,0.0003389259,0.0002787399,0.00028927243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002734349,0.00054259173,0.002236184,0.00024543615,0.0003512919,0.000016626134,0.00026221861,0.00016445623,0.00021130557],"category_scores_gemma":[0.000014239102,0.00024473647,0.0007751248,0.00023505237,0.00039209967,0.00004414664,0.000024061783,0.00064148294,0.0000028534866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011756312,0.0004518488,0.00002226072,0.00058624696,0.0051481663,0.00005614249,0.0019038595,0.00001393893,0.0029132233,0.000035979247,0.03369226,0.9540004],"study_design_scores_gemma":[0.0065740114,0.0014940178,0.00003044202,0.0006815764,0.00416052,0.0009703088,0.00010924718,0.000006582267,0.0010422161,0.00006230726,0.98465395,0.00021482297],"about_ca_topic_score_codex":0.000102438884,"about_ca_topic_score_gemma":0.000019173616,"teacher_disagreement_score":0.9537856,"about_ca_system_score_codex":0.00015996791,"about_ca_system_score_gemma":0.000374246,"threshold_uncertainty_score":0.99800634},"labels":[],"label_agreement":null},{"id":"W1967710053","doi":"10.1016/j.metabol.2007.10.014","title":"Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus","year":2008,"lang":"en","type":"article","venue":"Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canada Research Chairs; Heart and Stroke Foundation of Canada; Pfizer","keywords":"Fenofibrate; Internal medicine; Endocrinology; Atorvastatin; Inflammation; Hypertriglyceridemia; Type 2 Diabetes Mellitus; Diabetes mellitus; Cell adhesion molecule; Medicine; Triglyceride; Lipoprotein; Soluble cell adhesion molecules; Chemistry; Cholesterol; Cell adhesion; Immunology; Cell; Biochemistry","score_opus":0.0035050498942777435,"score_gpt":0.1829011693156746,"score_spread":0.17939611942139685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967710053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784905,0.0009412968,0.000014430415,0.000019551542,0.00007005008,0.0010434486,0.0000062366503,0.000019065323,0.000036882582],"genre_scores_gemma":[0.998822,0.0005168618,0.00048669026,0.000017851715,0.00006372832,0.000020107276,0.00003466103,0.000024500432,0.00001364865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857616,0.00025993006,0.00025429102,0.00027707356,0.0004208658,0.00021169781],"domain_scores_gemma":[0.9993737,0.00005166839,0.00012246687,0.00024879433,0.00008418048,0.00011921919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002225462,0.00020280182,0.0006309981,0.00013263075,0.00006413013,0.000009683364,0.00003157627,0.000094159564,0.000012714738],"category_scores_gemma":[0.00006518648,0.00013967874,0.000060040686,0.0001576824,0.0000780959,0.00007208448,0.000035525696,0.00014239272,0.0000027086485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026131677,0.00072511885,0.53151417,0.0048046336,0.00061464525,0.00009964593,0.0014690361,0.000022429758,0.19582509,0.00006855519,0.000070933034,0.23865408],"study_design_scores_gemma":[0.0067955744,0.0007956804,0.65101635,0.0001226074,0.00010333393,0.0000016712406,0.000005426639,0.00008468415,0.34092307,0.0000056383146,0.00004549037,0.00010046959],"about_ca_topic_score_codex":0.00017690304,"about_ca_topic_score_gemma":0.00001045706,"teacher_disagreement_score":0.23855361,"about_ca_system_score_codex":0.000017107193,"about_ca_system_score_gemma":0.000030000943,"threshold_uncertainty_score":0.56959337},"labels":[],"label_agreement":null},{"id":"W1968044964","doi":"10.1007/s11886-012-0285-7","title":"Regression of Atherosclerosis","year":2012,"lang":"en","type":"review","venue":"Current Cardiology Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Surrogate endpoint; Myocardial infarction; Atherosclerotic cardiovascular disease; Clinical trial; Disease; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.134612191783665,"score_gpt":0.3919604565998126,"score_spread":0.2573482648161476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968044964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013017666,0.9935375,0.000066542976,0.0000037630148,0.0037186467,0.0013676703,0.000016743692,0.000055859797,0.0011031078],"genre_scores_gemma":[0.00052714755,0.99661964,0.000058057394,0.0000052416613,0.002094313,0.00020470044,0.000313368,0.00007117065,0.00010634857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689037,0.00037318948,0.0012753743,0.0005727225,0.00044141614,0.0004469241],"domain_scores_gemma":[0.99668926,0.00004609832,0.0010804626,0.0017642562,0.00015100087,0.00026892565],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013867547,0.00047429325,0.005354891,0.00019104932,0.000047736106,0.000003416792,0.000088834815,0.00063853763,0.00003984627],"category_scores_gemma":[0.00012810531,0.00028820854,0.0033216719,0.00023841044,0.00014148485,0.00003128698,0.00013321057,0.0006750891,0.000027678956],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003171276,0.0000450375,0.0012128882,0.030214062,0.00072306197,0.000114078364,0.000011339025,4.9625555e-8,8.36001e-7,0.0000075832477,0.0007809711,0.96688694],"study_design_scores_gemma":[0.00012822024,0.00006299473,0.0005240091,0.019220369,0.006430421,0.008465857,0.0000024426984,3.205314e-8,0.0000027592087,0.000007879564,0.9649439,0.00021113928],"about_ca_topic_score_codex":0.000008985316,"about_ca_topic_score_gemma":1.2348124e-7,"teacher_disagreement_score":0.96667576,"about_ca_system_score_codex":0.00013609308,"about_ca_system_score_gemma":0.00055846194,"threshold_uncertainty_score":0.999957},"labels":[],"label_agreement":null},{"id":"W1968779439","doi":"10.1358/dot.2005.41.4.908565","title":"Statin-associated neuromyotoxicity","year":2005,"lang":"en","type":"article","venue":"Drugs of today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Geranylgeranyl pyrophosphate; Myopathy; Rhabdomyolysis; Statin; Mevalonate pathway; Disease; Bioinformatics; Internal medicine; Prenylation; Biochemistry; Biology","score_opus":0.010485788395464093,"score_gpt":0.259453654406713,"score_spread":0.24896786601124887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968779439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98429143,0.00029583104,0.00005756308,0.0028736196,0.000067758534,0.00029597798,0.000013768445,0.00005528802,0.01204878],"genre_scores_gemma":[0.9965099,0.00005627337,0.0008568357,0.0012541418,0.00017986468,0.000008153416,0.000014579012,0.000015442249,0.001104808],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99900305,0.000051948347,0.00022303264,0.00014501218,0.00038505846,0.00019191382],"domain_scores_gemma":[0.99936146,0.000025886993,0.00007986093,0.00032272204,0.0000958337,0.000114247974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043433555,0.00008347995,0.0002954575,0.000046731195,0.000033965338,0.0000041347753,0.00005921962,0.00005775137,0.000162804],"category_scores_gemma":[0.00013125794,0.00007009818,0.00019095531,0.00012584537,0.000030350671,0.0000454839,0.00002411394,0.00013278688,0.000040543768],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043130765,0.002497696,0.02472533,0.0007753531,0.0012130127,0.0000861166,0.0046695205,0.00015346083,0.029923862,0.0020005754,0.045693267,0.8878305],"study_design_scores_gemma":[0.010136113,0.0010852912,0.46906304,0.00038830002,0.00045306975,0.00005817467,0.0005209312,0.0010020473,0.17197447,0.00028850426,0.34447032,0.0005597337],"about_ca_topic_score_codex":0.00021154097,"about_ca_topic_score_gemma":0.000015641304,"teacher_disagreement_score":0.88727075,"about_ca_system_score_codex":0.000056278663,"about_ca_system_score_gemma":0.00008972387,"threshold_uncertainty_score":0.28585204},"labels":[],"label_agreement":null},{"id":"W1968930649","doi":"10.1016/j.cjca.2012.10.012","title":"Effectiveness of Statin Prescribing on Reducing Mortality in South Asian, Chinese, and White Patients With Diabetes","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Calgary; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Diabetes mellitus; Hazard ratio; Statin; Internal medicine; Confidence interval; Medical prescription; Comorbidity; Proportional hazards model; Population; Demography; Environmental health; Endocrinology; Pharmacology","score_opus":0.00796982730305505,"score_gpt":0.2219456260740603,"score_spread":0.21397579877100525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968930649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983358,0.00030231057,0.00009062846,0.000059959108,0.00010888924,0.00043521821,0.000011627482,0.0000016143373,0.0006539483],"genre_scores_gemma":[0.99971616,0.000004172321,0.000095228104,0.000032390628,0.00012284207,0.000008671716,0.0000046418963,0.0000131803745,0.000002718649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988065,0.000346811,0.00029004295,0.00013567467,0.00016208133,0.0002589326],"domain_scores_gemma":[0.9990038,0.00005086657,0.00014444688,0.00019319038,0.0002542093,0.00035348677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008540101,0.00011045129,0.0006908084,0.00025366244,0.000030930925,0.000008412304,0.000050352573,0.00007399571,0.0000049437313],"category_scores_gemma":[0.00022951914,0.00007532995,0.00010149082,0.00013883479,0.00009738257,0.0000711335,0.0000064995793,0.00025124548,5.504756e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060456117,0.000003718788,0.99441147,0.00025767015,0.00024053593,0.000026693304,0.00033465412,0.0005790304,0.00007292338,0.000005900722,0.00001563645,0.0039912905],"study_design_scores_gemma":[0.0018428947,0.00074995967,0.99639696,0.0005947671,0.00006722699,0.000018185232,0.00010330916,0.000007988607,0.000074773154,0.000047566304,0.000029739836,0.00006665984],"about_ca_topic_score_codex":0.0017571845,"about_ca_topic_score_gemma":0.00038390473,"teacher_disagreement_score":0.003924631,"about_ca_system_score_codex":0.00010207566,"about_ca_system_score_gemma":0.00048060695,"threshold_uncertainty_score":0.30718663},"labels":[],"label_agreement":null},{"id":"W1968949098","doi":"10.1016/s0140-6736(10)60284-x","title":"Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial","year":2010,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":906,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"University of California, San Diego","keywords":"Medicine; Placebo; Familial hypercholesterolemia; Internal medicine; Apolipoprotein B; Gastroenterology; Clinical endpoint; Cholesterol; Clinical trial; Intention-to-treat analysis; Endocrinology; Pathology","score_opus":0.023982290103411363,"score_gpt":0.2774385225148751,"score_spread":0.25345623241146376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968949098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815436,0.000032134336,0.00017084996,0.00050236593,0.0003362345,0.017128855,0.000046592417,0.000042814,0.0001965332],"genre_scores_gemma":[0.9935922,0.000011456121,0.00039319223,0.00019968988,0.0019544875,0.0037447745,0.00003404356,0.00004573572,0.000024409941],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978912,0.00014110778,0.00062323845,0.000347423,0.00051654736,0.0004804918],"domain_scores_gemma":[0.9982127,0.000193638,0.00023593279,0.0010130773,0.00018261852,0.00016201884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016050012,0.00025516565,0.001410778,0.00011216898,0.00012527537,0.000044859928,0.00024197256,0.00019468603,0.000015043503],"category_scores_gemma":[0.00026293346,0.00015530646,0.00028278216,0.00017508888,0.00014757429,0.00015758621,0.000028010947,0.00052338175,0.0000026096725],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9889086,0.0005830217,0.0030514644,0.00014939008,0.00024754126,0.0000039317556,0.00047637452,0.000026281461,0.002422776,0.000027669392,0.00002459186,0.004078367],"study_design_scores_gemma":[0.987693,0.001136379,0.005645267,0.00018538913,0.00033813267,0.000011997694,0.00009103147,0.00007180194,0.004318603,0.000011938626,0.00031890013,0.0001775258],"about_ca_topic_score_codex":0.00034657764,"about_ca_topic_score_gemma":0.0007800068,"teacher_disagreement_score":0.013384081,"about_ca_system_score_codex":0.000055417135,"about_ca_system_score_gemma":0.00022202951,"threshold_uncertainty_score":0.6333214},"labels":[],"label_agreement":null},{"id":"W1969297657","doi":"10.1136/ebm.13.3.87","title":"Review: lower total cholesterol is associated with reduced risk of death from ischaemic heart disease but not stroke","year":2008,"lang":"en","type":"letter","venue":"Evidence-Based Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ischaemic heart disease; Cardiology; Stroke (engine); Internal medicine; Ischaemic stroke; Disease; Cholesterol; Total cholesterol; Ischemia; Engineering","score_opus":0.03856417535949831,"score_gpt":0.2816885644542661,"score_spread":0.2431243890947678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969297657","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14164892,0.1799862,0.0001412048,0.6716199,0.00070420577,0.0045490623,0.0011296782,0.00015143819,0.000069410366],"genre_scores_gemma":[0.055489548,0.06589377,0.00023355873,0.8640815,0.009817623,0.0004065715,0.0016384599,0.00022957011,0.0022094208],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99153215,0.00089062314,0.0015062592,0.0014195925,0.0037376627,0.00091369223],"domain_scores_gemma":[0.993242,0.0008627871,0.0012545086,0.0028875768,0.000933789,0.0008193233],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016322393,0.0010250858,0.003771456,0.00036869972,0.00016216995,0.000012718109,0.00039200016,0.0008092865,0.00077332],"category_scores_gemma":[0.0038480593,0.0006890488,0.0010964354,0.00052035175,0.000562373,0.00019078425,0.00007110016,0.003424379,0.000057638917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016506744,0.00017728673,0.005004895,0.004577782,0.0014479286,0.002486109,0.0000829844,0.000004982015,0.0005725768,1.10724535e-7,0.9823535,0.0016411664],"study_design_scores_gemma":[0.01776013,0.006559357,0.117259294,0.47254127,0.022435935,0.00043510724,0.000031872445,0.00010273618,0.0026240959,0.000007817654,0.35854748,0.0016949017],"about_ca_topic_score_codex":0.004827122,"about_ca_topic_score_gemma":0.000013864144,"teacher_disagreement_score":0.623806,"about_ca_system_score_codex":0.0005388749,"about_ca_system_score_gemma":0.0025485742,"threshold_uncertainty_score":0.99955606},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W1969536582","doi":"10.1503/cmaj.150030","title":"Is there a clinically relevant interaction between clarithromycin and statins not metabolized by cytochrome P450 3A4?","year":2015,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Clarithromycin; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medicine; CYP3A4; Atorvastatin; Pharmacology; Cytochrome P450; Internal medicine; Bioinformatics; Biology; Metabolism","score_opus":0.026022177886832865,"score_gpt":0.30947869115420973,"score_spread":0.28345651326737686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969536582","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02977367,0.0023128022,0.00016450763,0.96462476,0.0007742178,0.00062816485,0.000799008,0.00003666365,0.0008862045],"genre_scores_gemma":[0.013492902,0.0033015742,0.00044744537,0.9541442,0.025307762,0.00003011723,0.00067559996,0.0001231469,0.0024772848],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919203,0.0009810604,0.0014638124,0.0005166804,0.004190785,0.00092739466],"domain_scores_gemma":[0.9940709,0.00041028037,0.00093173306,0.0003902863,0.0010732528,0.0031235707],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0064719715,0.0004087743,0.0015704391,0.00031801977,0.00028320847,0.00020297796,0.00024750887,0.0031090428,0.0023336653],"category_scores_gemma":[0.0030449976,0.00034038885,0.00053760194,0.0002324594,0.000089083136,0.00016176503,0.000038962397,0.009869579,0.0001534412],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002864122,0.000016643187,0.0026805135,0.00009348811,0.0014092965,0.0011198358,0.00018417607,4.5679087e-8,0.000010185899,0.000001950306,0.96646786,0.027987361],"study_design_scores_gemma":[0.0033213743,0.0003539307,0.022595676,0.00047708803,0.0007756207,0.0010849471,0.0001795222,0.000017862976,0.0000048506945,0.00010949983,0.97075963,0.00031998393],"about_ca_topic_score_codex":0.01365607,"about_ca_topic_score_gemma":0.0026954652,"teacher_disagreement_score":0.027667377,"about_ca_system_score_codex":0.0025449235,"about_ca_system_score_gemma":0.010083491,"threshold_uncertainty_score":0.9999048},"labels":[],"label_agreement":null},{"id":"W1969851920","doi":"10.2174/157489007782418937","title":"Genetics of Cholesterol and Lipoprotein Metabolism","year":2007,"lang":"en","type":"review","venue":"Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Biology; Computational biology; Gene; Context (archaeology); Phenotype; Genetics; Disease; Bioinformatics; Medicine; Internal medicine","score_opus":0.032440921896360865,"score_gpt":0.3085307830238931,"score_spread":0.2760898611275322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969851920","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025940703,0.978575,0.0013905469,0.000043651155,0.0028977292,0.01151788,0.0006092059,0.00017118877,0.002200747],"genre_scores_gemma":[0.00095146237,0.99332565,0.0005089183,0.00014907896,0.0014910091,0.0011554967,0.0011202582,0.00078743394,0.0005106929],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9775363,0.0024056563,0.004831754,0.0046023834,0.0076719294,0.002951958],"domain_scores_gemma":[0.9884593,0.0002954331,0.0015311899,0.007830098,0.0007940347,0.0010899586],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"category_scores_codex":[0.008677994,0.0035691247,0.017230786,0.002497553,0.00035277804,0.0004887805,0.0014555829,0.0013664945,0.000033576725],"category_scores_gemma":[0.00040997603,0.00296187,0.020473743,0.0037737566,0.0008403232,0.002847471,0.00092789123,0.0032014875,0.00006966732],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003850654,0.0008499868,0.00013499307,0.029659212,0.024535619,0.00048615344,0.00013048951,0.0012755052,0.0000013960565,0.00009062161,0.00005177244,0.9423992],"study_design_scores_gemma":[0.0069131674,0.0002888082,0.00041794227,0.023377867,0.020499853,0.00072721863,0.000312206,0.000012192234,0.00031118465,0.00006729968,0.9444978,0.0025744266],"about_ca_topic_score_codex":0.00046553437,"about_ca_topic_score_gemma":0.00011444338,"teacher_disagreement_score":0.9444461,"about_ca_system_score_codex":0.001807646,"about_ca_system_score_gemma":0.0016277095,"threshold_uncertainty_score":0.99992996},"labels":[],"label_agreement":null},{"id":"W1970932673","doi":"10.1097/01.ogx.0000358018.78512.a1","title":"Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin Trial","year":2009,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Rosuvastatin; Hazard ratio; Unstable angina; Internal medicine; Placebo; Rosuvastatin Calcium; Myocardial infarction; Cardiology; Cholesterol; Population; C-reactive protein; Randomized controlled trial; Confidence interval; Inflammation","score_opus":0.11504546854678374,"score_gpt":0.3687973482790047,"score_spread":0.2537518797322209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970932673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802935,0.000328589,0.0009798501,0.000046999845,0.000111658934,0.0182027,0.000027715074,0.000007959296,0.000001023422],"genre_scores_gemma":[0.9979365,0.000016460048,0.00055942836,0.000007273329,0.000054135526,0.0013827482,0.000025214891,0.000011207819,0.0000070153974],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9940362,0.0033722443,0.0011856948,0.0005003194,0.0006992473,0.00020630485],"domain_scores_gemma":[0.99722606,0.0011344466,0.0005997557,0.00045285065,0.000523043,0.000063821935],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0054880865,0.00019070152,0.0008333217,0.0001560358,0.00007850098,0.000029268705,0.000086152024,0.00015719506,0.000005016513],"category_scores_gemma":[0.011072745,0.00011975178,0.00028449565,0.0007825479,0.00012459783,0.00022821841,0.000056308083,0.00031649895,6.600725e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30221197,0.015900778,0.06972959,0.0005565242,0.00058319926,0.0000061647365,0.004729482,0.0008826776,0.0034273977,0.00004128786,0.000001392193,0.60192955],"study_design_scores_gemma":[0.0887272,0.01731029,0.8893468,0.00018177985,0.00021407969,0.000002569247,0.0012355739,0.0010497144,0.0016497634,0.00018427038,8.4465995e-7,0.000097160475],"about_ca_topic_score_codex":0.002470935,"about_ca_topic_score_gemma":0.0012218053,"teacher_disagreement_score":0.81961715,"about_ca_system_score_codex":0.00017093256,"about_ca_system_score_gemma":0.00011817026,"threshold_uncertainty_score":0.9972574},"labels":[],"label_agreement":null},{"id":"W1970965401","doi":"10.1016/j.amjcard.2007.02.086","title":"Relation of Age, the Apolipoprotein B/Apolipoprotein A-I Ratio, and the Risk of Fatal Myocardial Infarction and Implications for the Primary Prevention of Cardiovascular Disease","year":2007,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Decile; Apolipoprotein B; Myocardial infarction; Medicine; Risk factor; Internal medicine; Disease; Apolipoprotein E; Cardiology; Cholesterol","score_opus":0.013071167238204912,"score_gpt":0.27139961503500265,"score_spread":0.25832844779679776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970965401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8473829,0.015212542,0.13244916,0.002700128,0.00011451782,0.0020331456,0.000030000965,0.000004409681,0.00007317837],"genre_scores_gemma":[0.9924133,0.0061953687,0.0005055394,0.00009442525,0.00069468847,0.00006575969,0.000006401448,0.000016571783,0.000007961256],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99725026,0.001188083,0.0007942536,0.00015046244,0.00042398126,0.00019297577],"domain_scores_gemma":[0.99664295,0.00080260204,0.001252492,0.0008189889,0.00040107867,0.000081906874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009017919,0.00014298648,0.000988512,0.00009783836,0.0002234667,0.0000073975557,0.0001929781,0.000047891597,6.272309e-7],"category_scores_gemma":[0.0006291763,0.00006275997,0.0011522712,0.0002747592,0.0018858373,0.000062950814,0.00006737878,0.00033424026,8.045633e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013094462,0.000071089824,0.017943462,0.00033007015,0.020009868,0.000005957595,0.0016173148,0.0070606424,0.005358659,0.0058156596,0.00012020651,0.9285726],"study_design_scores_gemma":[0.0032613878,0.0010218524,0.98255956,0.00006580541,0.0057247705,0.0004297519,0.00085935736,0.00008723532,0.000444647,0.0029062303,0.0025609198,0.000078473546],"about_ca_topic_score_codex":0.00074767973,"about_ca_topic_score_gemma":0.0000070257183,"teacher_disagreement_score":0.9646161,"about_ca_system_score_codex":0.00004192286,"about_ca_system_score_gemma":0.0002069512,"threshold_uncertainty_score":0.6948446},"labels":[],"label_agreement":null},{"id":"W1971175832","doi":"10.1161/01.cir.0000057982.50167.6e","title":"Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease","year":2003,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":270,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Aarne ja Aili Turusen Säätiö; Helsingin ja Uudenmaan Sairaanhoitopiiri; AstraZeneca","keywords":"Fenofibrate; Medicine; Internal medicine; Coronary artery disease; Apolipoprotein B; Placebo; Diabetes mellitus; Triglyceride; Lipoprotein; Endocrinology; Cholesterol; Cardiology; Gastroenterology; Pathology","score_opus":0.025644170377393066,"score_gpt":0.26076874578475256,"score_spread":0.2351245754073595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971175832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99595207,0.0007958899,0.0012371163,0.00024863088,0.000054900644,0.001472969,0.0000075349813,0.00006807327,0.000162789],"genre_scores_gemma":[0.9986008,0.000031613763,0.001033259,0.000028924813,0.00014159616,0.00006405416,0.000040939012,0.000025931562,0.000032881257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824864,0.00029364854,0.00039966233,0.00033172514,0.0004986128,0.00022771006],"domain_scores_gemma":[0.99876446,0.000085702304,0.00015272736,0.0005019425,0.0001365061,0.0003586837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090060115,0.00015367962,0.000339305,0.00005498193,0.00019332275,0.00001611079,0.00003328728,0.00014266837,0.000030043344],"category_scores_gemma":[0.00072724407,0.00014170163,0.00013164354,0.00022941927,0.000092720875,0.0001714109,0.000021698504,0.00023774951,0.00001396995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015943396,0.00014398983,0.9454971,0.0004443402,0.00008752039,0.000034561057,0.00019772892,0.000026835389,0.0035630895,0.00076494965,0.0000082760125,0.049072187],"study_design_scores_gemma":[0.0015715352,0.0000917074,0.9885046,0.0002918995,0.00019411749,0.00005440739,0.00006061145,0.00051288836,0.0074239615,0.0010224958,0.00013028058,0.0001415317],"about_ca_topic_score_codex":0.00003730992,"about_ca_topic_score_gemma":0.000007373739,"teacher_disagreement_score":0.048930656,"about_ca_system_score_codex":0.00006766316,"about_ca_system_score_gemma":0.00014037153,"threshold_uncertainty_score":0.57784253},"labels":[],"label_agreement":null},{"id":"W1971357885","doi":"10.1016/j.metabol.2007.09.008","title":"Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia","year":2008,"lang":"en","type":"article","venue":"Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Pfizer","keywords":"Fenofibrate; Internal medicine; Endocrinology; Apolipoprotein B; Hypertriglyceridemia; Atorvastatin; Very low-density lipoprotein; Triglyceride; Chemistry; Lipoprotein; Low-density lipoprotein; Cholesterol; Medicine","score_opus":0.0075435509605645415,"score_gpt":0.21845406629283307,"score_spread":0.2109105153322685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971357885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935466,0.005266242,0.000012996567,0.000040941428,0.000045969802,0.0009078807,0.000011141544,0.000011646498,0.00015655805],"genre_scores_gemma":[0.9979257,0.0012045682,0.0006542148,0.000037899892,0.00006678048,0.000032890333,0.0000053471995,0.000035220357,0.000037404116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998446,0.00022916624,0.00032787543,0.00029774682,0.00040119982,0.00029803102],"domain_scores_gemma":[0.9992688,0.00009057032,0.00012441822,0.00032633918,0.000060955004,0.00012895101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029625656,0.00023762598,0.0010640924,0.00024341773,0.000022662307,0.000005334679,0.000047216818,0.000099261306,0.000020947122],"category_scores_gemma":[0.00006821913,0.0001493342,0.000052858348,0.00041370204,0.00020459107,0.00004701815,0.000028192926,0.00019773674,4.994763e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021498391,0.0010096024,0.5530046,0.0054867216,0.0009970192,0.0004376174,0.0025655883,0.00005533915,0.3633768,0.0004281999,0.00006947633,0.051070612],"study_design_scores_gemma":[0.0082175005,0.0021979327,0.62087667,0.00041406738,0.00017663809,0.000045055098,0.000023348533,0.00006821091,0.36756918,0.000011282096,0.00023611759,0.00016402776],"about_ca_topic_score_codex":0.0009448213,"about_ca_topic_score_gemma":0.0001389709,"teacher_disagreement_score":0.06787202,"about_ca_system_score_codex":0.000020567762,"about_ca_system_score_gemma":0.000072707546,"threshold_uncertainty_score":0.6089672},"labels":[],"label_agreement":null},{"id":"W1971423903","doi":"10.1016/j.cjca.2012.03.025","title":"Lifetime Risk of Cardiovascular Disease: The Next Generation in Risk Prediction","year":2012,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Public Health Agency","keywords":"Medicine; Internal medicine; Disease; Atherosclerotic cardiovascular disease; Cardiology","score_opus":0.05647405757028041,"score_gpt":0.2719810187961988,"score_spread":0.2155069612259184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971423903","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004039425,0.9958247,0.00086064264,0.000043137476,0.0012719557,0.0009677169,0.00030463652,0.0000037044554,0.0003195428],"genre_scores_gemma":[0.014762034,0.9756253,0.00005471903,0.000018468192,0.009334275,0.000038628696,0.00009551871,0.0000516896,0.000019380055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949541,0.0025559955,0.0012583033,0.0002582321,0.00048709006,0.00048629584],"domain_scores_gemma":[0.9966457,0.00009803435,0.00087718444,0.0010901056,0.0003242254,0.0009647506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052801035,0.00032351786,0.0032881238,0.0006139906,0.00012495731,0.00001704559,0.00026096788,0.0004742982,0.000020151192],"category_scores_gemma":[0.0006768098,0.00020554126,0.004179977,0.00038624753,0.00019101422,0.000096706375,0.000018964307,0.0013781895,0.000011603856],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016589463,0.000003910481,0.0022381875,0.0019587446,0.008456344,0.00017386583,0.00005223616,0.0026884775,9.164064e-8,0.000016104936,0.0013642497,0.9830312],"study_design_scores_gemma":[0.00050713104,0.00012886636,0.0039303065,0.0014188054,0.024546875,0.001214616,0.00002043041,0.00002459054,1.845718e-7,0.000013108976,0.96805865,0.0001364381],"about_ca_topic_score_codex":0.006720096,"about_ca_topic_score_gemma":0.0005172888,"teacher_disagreement_score":0.9828948,"about_ca_system_score_codex":0.00055641966,"about_ca_system_score_gemma":0.0053860997,"threshold_uncertainty_score":0.99989426},"labels":[],"label_agreement":null},{"id":"W1972148567","doi":"10.1016/s0002-9343(01)01042-7","title":"Insert art title here:","year":2002,"lang":"en","type":"article","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal; McGill University","funders":"","keywords":"Medicine; Statin; Scopus; Lovastatin; Cancer; Internal medicine; MEDLINE; Oncology; Cholesterol; Biochemistry","score_opus":0.02113064321521364,"score_gpt":0.2728692321287135,"score_spread":0.25173858891349987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972148567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5332956,0.023436654,0.001018029,0.18653363,0.0011097651,0.00032308858,0.0000011593762,0.000040030147,0.2542421],"genre_scores_gemma":[0.98616934,0.0015227288,0.00017356954,0.0065107574,0.0016931894,6.0221726e-7,2.8511678e-7,0.000010440655,0.0039191004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933964,0.000044149157,0.00016684158,0.000037815087,0.000325644,0.00008590252],"domain_scores_gemma":[0.99947906,0.00002351242,0.00014107075,0.00019536678,0.00006503454,0.00009597914],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004569493,0.000047437457,0.000274641,0.000043645647,0.00002121917,0.0000015106416,0.000070570495,0.000008842267,0.0012185225],"category_scores_gemma":[0.00007340612,0.000022385793,0.00008529359,0.00015502599,0.00019560316,0.000012494512,0.000006625144,0.00018231738,0.00028914277],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006658715,0.000036585025,0.00056001387,0.0000143725665,0.00015160946,0.000120237746,0.0002589679,5.785448e-7,0.00022470899,0.00010274456,0.28620434,0.7122593],"study_design_scores_gemma":[0.0011873238,0.0017796337,0.004117049,0.00017693563,0.00017359889,0.0030198046,0.00075979874,0.000031565243,0.00006320778,0.000092941555,0.9885521,0.00004604875],"about_ca_topic_score_codex":0.000026093912,"about_ca_topic_score_gemma":5.5523947e-7,"teacher_disagreement_score":0.7122132,"about_ca_system_score_codex":0.000022048882,"about_ca_system_score_gemma":0.000025296205,"threshold_uncertainty_score":0.9996945},"labels":[],"label_agreement":null},{"id":"W1972642505","doi":"10.1016/j.athoracsur.2011.04.107","title":"Statin Therapy and Saphenous Vein Graft Disease After Coronary Bypass Surgery: Analysis From the CASCADE Randomized Trial","year":2011,"lang":"en","type":"article","venue":"The Annals of Thoracic Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Physicians' Services Incorporated Foundation","keywords":"Medicine; Randomized controlled trial; Surgery; Statin; Saphenous vein graft; Vein; Disease; Coronary artery disease; Cardiology; Bypass surgery; Coronary disease; Internal medicine; Artery; Coronary heart disease","score_opus":0.11572380064779718,"score_gpt":0.3426084720422465,"score_spread":0.2268846713944493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972642505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9554426,0.038923893,0.000102604405,0.003905951,0.00023436118,0.0011573901,0.0001350138,0.000040149836,0.00005800254],"genre_scores_gemma":[0.98476857,0.011725912,0.00005171841,0.002486616,0.00042825972,0.00029907565,0.000101666345,0.00003847293,0.000099733974],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9950972,0.0025248027,0.0008323268,0.000378232,0.0007456131,0.00042182577],"domain_scores_gemma":[0.9934085,0.0044363374,0.0004002127,0.0012698361,0.00019069885,0.0002943883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009083619,0.0002907417,0.0019383812,0.0002077911,0.0001534477,0.000030085102,0.00016176802,0.00009580777,0.0004394337],"category_scores_gemma":[0.00093561545,0.00014414394,0.0022917762,0.0006145801,0.00042202108,0.000100774596,0.0000672546,0.00023974516,0.0000076110996],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8470953,0.00032179407,0.020475058,0.00005736867,0.007201635,0.00017786365,0.0010687393,0.0000013648942,0.000010284139,0.000010299233,0.0019910464,0.12158925],"study_design_scores_gemma":[0.1359863,0.00029053004,0.8358648,0.0005151606,0.013380758,0.00004773036,0.00085115613,0.00022061466,0.0028969347,0.0033351441,0.0056553297,0.00095554075],"about_ca_topic_score_codex":0.004808659,"about_ca_topic_score_gemma":0.000076113596,"teacher_disagreement_score":0.81538975,"about_ca_system_score_codex":0.000011885904,"about_ca_system_score_gemma":0.00029714024,"threshold_uncertainty_score":0.72692865},"labels":[],"label_agreement":null},{"id":"W1973224273","doi":"10.1586/14779072.4.3.283","title":"Colesevelam hydrochloride in the management of dyslipidemia","year":2006,"lang":"en","type":"review","venue":"Expert Review of Cardiovascular Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Medicine; Ezetimibe; Internal medicine; Statin; Bile acid; Enterohepatic circulation; Pharmacology; Adverse effect; Fluvastatin; Gastroenterology; Disease; Simvastatin","score_opus":0.04004055584142992,"score_gpt":0.35968438684510623,"score_spread":0.3196438310036763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973224273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000044867197,0.98705965,0.00023149485,0.00008125974,0.0002520004,0.007994214,0.000014807098,0.000024122402,0.0043379813],"genre_scores_gemma":[0.0000049160585,0.99601305,0.0008715256,0.0005255959,0.0006956754,0.001534923,0.00016489468,0.000114030256,0.00007538391],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99275064,0.001397511,0.0023366036,0.0007229527,0.002305788,0.0004864896],"domain_scores_gemma":[0.9949326,0.00009604105,0.00066711043,0.0040239524,0.0001842949,0.00009598784],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0072522922,0.00075648463,0.008768215,0.0002577306,0.000045996458,0.000009668003,0.0008070113,0.00035211482,0.000040408002],"category_scores_gemma":[0.00003098347,0.00043185128,0.013095938,0.0013460587,0.00013590114,0.000051698426,0.000089512236,0.0006148434,0.000014312307],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010395334,0.00012828516,4.774783e-7,0.2507825,0.008272308,0.00011469352,0.000030293815,0.0000010833267,1.12743386e-7,0.00009594539,0.0013419318,0.739222],"study_design_scores_gemma":[0.00092789554,0.000087421904,0.00001649649,0.22849788,0.0035618725,0.00016830876,0.00002259276,2.2654987e-7,0.0000063411817,0.000007749168,0.7664312,0.00027201595],"about_ca_topic_score_codex":0.00018137596,"about_ca_topic_score_gemma":0.0000011295411,"teacher_disagreement_score":0.7650893,"about_ca_system_score_codex":0.0002027454,"about_ca_system_score_gemma":0.00036299738,"threshold_uncertainty_score":0.9998133},"labels":[],"label_agreement":null},{"id":"W1973355122","doi":"10.1056/nejmoa070635","title":"Effect of Torcetrapib on the Progression of Coronary Atherosclerosis","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":965,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Coronary atherosclerosis; Coronary heart disease","score_opus":0.016790286342933485,"score_gpt":0.3077157874240596,"score_spread":0.2909255010811261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973355122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920281,0.0031963324,0.00032358558,0.0023588156,0.00035202166,0.00034620374,7.306812e-7,0.000004528003,0.0013896758],"genre_scores_gemma":[0.9966468,0.0006419285,0.00013102463,0.00022943405,0.0022749105,7.713833e-7,0.0000010871248,0.000013532171,0.000060493097],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979433,0.00020194234,0.00060127804,0.00008087263,0.0010125878,0.00016001191],"domain_scores_gemma":[0.99831784,0.0005797766,0.0004457168,0.00027417878,0.00017220782,0.00021026301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070797135,0.000120471275,0.00067006715,0.00012718601,0.000030649917,0.0000011753066,0.000106899184,0.00007060428,0.000117387055],"category_scores_gemma":[0.0005509123,0.000050020142,0.00021779092,0.00018336778,0.00013183634,0.000024253983,0.000012128527,0.0003402834,8.337231e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005898946,0.00011785462,0.02535008,0.00034115074,0.00030485616,0.000084063424,0.00072859105,0.0000039850083,0.035521545,0.00013790044,0.0015665892,0.92994446],"study_design_scores_gemma":[0.13145453,0.1037636,0.4300522,0.011946631,0.0014499488,0.002607837,0.0004636553,0.00001648745,0.28843623,0.000100504316,0.029526027,0.00018235917],"about_ca_topic_score_codex":0.00005978,"about_ca_topic_score_gemma":0.000003342031,"teacher_disagreement_score":0.92976207,"about_ca_system_score_codex":0.000027159589,"about_ca_system_score_gemma":0.000100857884,"threshold_uncertainty_score":0.24537015},"labels":[],"label_agreement":null},{"id":"W1973401559","doi":"10.1016/s0828-282x(08)70648-2","title":"The 2006 Canadian dyslipidemia guidelines will prevent more deaths while treating fewer people – but should they be further modified?","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Dyslipidemia; Guideline; Population; Statin; Coronary artery disease; Medical prescription; Environmental health; Disease; Internal medicine; Pathology; Pharmacology","score_opus":0.05257972269919429,"score_gpt":0.28922591463973496,"score_spread":0.23664619194054068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973401559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87079436,0.023614198,0.0011246162,0.076043285,0.0024109015,0.0011476566,0.00023143011,0.000027939685,0.024605641],"genre_scores_gemma":[0.98957735,0.00095758354,0.00029258366,0.0030654634,0.004726716,0.000022431592,0.000017797076,0.00005692637,0.001283116],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997175,0.00033310562,0.0008373448,0.00026732613,0.00040717126,0.0009800897],"domain_scores_gemma":[0.9960695,0.00011752105,0.00025263496,0.0006869339,0.0009387286,0.0019346767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017408729,0.00028349255,0.0010098941,0.00030962648,0.00067365624,0.000027732674,0.00033032964,0.00032234922,0.00004429292],"category_scores_gemma":[0.00088351034,0.0001877384,0.0007549905,0.00018783766,0.00019128635,0.00010498857,0.000017143104,0.00068147504,0.00000798618],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002837067,0.000017165212,0.31401572,0.0001344884,0.0047535677,0.0061265915,0.005855122,0.029844599,0.00020663075,0.0009697917,0.56090325,0.07688937],"study_design_scores_gemma":[0.0015518034,0.00037691853,0.092705674,0.0001370067,0.00046177433,0.012487727,0.001684133,0.00017689978,0.000047831207,0.0002012435,0.8898169,0.00035210353],"about_ca_topic_score_codex":0.44693056,"about_ca_topic_score_gemma":0.7233097,"teacher_disagreement_score":0.32891363,"about_ca_system_score_codex":0.0007730593,"about_ca_system_score_gemma":0.008375729,"threshold_uncertainty_score":0.99724585},"labels":[],"label_agreement":null},{"id":"W1973433464","doi":"10.2174/1568006043586215","title":"Editorial Statins: [Hot Topic: Statins: Effects Beyond Cholesterol Lowering (Guest Editor: Garry X. Shen)]","year":2005,"lang":"en","type":"editorial","venue":"Current Drug Targets - Cardiovascular & Hematological Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Diabetes Association","keywords":"Medicine; Cholesterol; Internal medicine","score_opus":0.006920575980873129,"score_gpt":0.26629564288013635,"score_spread":0.2593750668992632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973433464","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090847735,0.12557693,0.0019396985,0.00020563349,0.8649163,0.004660409,0.0004030265,0.0007607102,0.0006287761],"genre_scores_gemma":[0.0021460867,0.031762954,0.0005631671,0.00011744168,0.95982087,0.0014985179,0.003529052,0.00042400998,0.000137894],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98195213,0.001148029,0.002308697,0.003460686,0.008412734,0.0027177143],"domain_scores_gemma":[0.9919805,0.0009688396,0.00073120656,0.0037856805,0.0010125736,0.0015212093],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0031113632,0.0024866476,0.0062628062,0.000518733,0.00066113955,0.00033796323,0.0012146037,0.0028191644,0.000103758655],"category_scores_gemma":[0.0037361612,0.0021192622,0.007878014,0.00067763205,0.0005808876,0.000502055,0.0007377129,0.006032263,0.00033408264],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033436686,0.0010606063,0.00012471445,0.0075105624,0.004649246,0.00015122825,0.00040835215,0.00009214325,0.000005649809,0.000014687872,0.9347169,0.05093156],"study_design_scores_gemma":[0.0088710375,0.00046706235,0.00021235956,0.00181404,0.003568708,0.000041991567,0.00015097467,0.000030301988,0.00009985992,0.00013824172,0.9825463,0.0020591218],"about_ca_topic_score_codex":0.0003098176,"about_ca_topic_score_gemma":0.00010682066,"teacher_disagreement_score":0.09490454,"about_ca_system_score_codex":0.0009911996,"about_ca_system_score_gemma":0.0015076414,"threshold_uncertainty_score":0.998787},"labels":[],"label_agreement":null},{"id":"W1973638150","doi":"10.1136/bmj.g1792","title":"Authors' reply to Davis and Dietrich","year":2014,"lang":"en","type":"letter","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; York University","funders":"","keywords":"Rosuvastatin; Myocardial infarction; Medicine; Internal medicine; Meta-analysis; Disease; Cardiology","score_opus":0.028127981444061208,"score_gpt":0.3099887049694762,"score_spread":0.281860723525415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973638150","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006804836,0.0009406495,0.00036590965,0.9858193,0.00052804884,0.0013876953,0.000009819797,0.00007500314,0.0101931365],"genre_scores_gemma":[0.00060821866,0.000070461414,0.0015463596,0.9562922,0.020812826,0.00012429678,0.00009742777,0.00006517582,0.020382995],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811965,0.00010871182,0.00030537267,0.00048754434,0.00063495245,0.00034376982],"domain_scores_gemma":[0.9984168,0.000041395906,0.0000823699,0.0011474964,0.00009546855,0.00021650792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010045631,0.00021272767,0.0006584261,0.00018172155,0.00005695235,0.000030065019,0.000085681924,0.00048294078,0.00006378793],"category_scores_gemma":[0.0003759695,0.00016867596,0.00022310675,0.00019749843,0.000023399038,0.00001534463,0.00007615675,0.0009671939,0.00020633117],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017114746,0.000005643815,0.00016546586,0.0005497431,0.00012299436,0.0004932238,0.000044082277,6.815709e-8,0.000003619725,0.000005398692,0.97752976,0.021062898],"study_design_scores_gemma":[0.00043426466,0.00025373246,0.0031059603,0.00025817225,0.00019828111,0.00048767295,0.0000046540895,0.0000037416899,0.000015321579,0.000021137714,0.995019,0.000198024],"about_ca_topic_score_codex":0.00046235218,"about_ca_topic_score_gemma":0.0000024791648,"teacher_disagreement_score":0.029527014,"about_ca_system_score_codex":0.000060703882,"about_ca_system_score_gemma":0.000116326504,"threshold_uncertainty_score":0.68784064},"labels":[],"label_agreement":null},{"id":"W1974413521","doi":"10.2147/ijwh.s38133","title":"Dyslipidemia in women: etiology and management","year":2014,"lang":"en","type":"review","venue":"International Journal of Women s Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Dyslipidemia; Medicine; Internal medicine; Myocardial infarction; Physical therapy; Intensive care medicine; Disease","score_opus":0.025746879845314728,"score_gpt":0.3781852793922534,"score_spread":0.3524383995469387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974413521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010149257,0.99506336,0.00013773952,0.0017595607,0.0010423311,0.0005892796,0.0000072148687,0.000007001559,0.00037860568],"genre_scores_gemma":[0.00024662053,0.9948408,0.00059102767,0.002681332,0.0013830934,0.00007366108,0.000010511256,0.000031372456,0.00014158413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965527,0.00043009093,0.0015697961,0.00024337978,0.00069816684,0.00050587684],"domain_scores_gemma":[0.997899,0.0000903006,0.0010989698,0.00023516585,0.0001664327,0.0005101543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005671352,0.00023891049,0.0025672826,0.00085583964,0.000025889767,0.000020908497,0.00026342276,0.0001726498,0.00006336267],"category_scores_gemma":[0.00010266135,0.00017677927,0.0003344375,0.00015499188,0.00004459442,0.00005275303,0.00009297145,0.00071174005,0.000013905748],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009509145,0.00007468464,0.00003388252,0.013196979,0.0009508564,0.0002345918,0.00037418253,6.482327e-7,1.3284506e-8,0.00052679406,0.0005919773,0.9839203],"study_design_scores_gemma":[0.0014784271,0.0005595533,0.0004017208,0.013461649,0.00006316006,0.001886231,0.00015853868,0.0000013192594,1.3052411e-8,0.00016960154,0.9817129,0.000106935506],"about_ca_topic_score_codex":0.000029286957,"about_ca_topic_score_gemma":0.0000043750983,"teacher_disagreement_score":0.98381335,"about_ca_system_score_codex":0.0046738684,"about_ca_system_score_gemma":0.0010990438,"threshold_uncertainty_score":0.999147},"labels":[],"label_agreement":null},{"id":"W1974455801","doi":"10.1016/s0828-282x(06)70916-3","title":"A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NEPTUNE) II survey","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"National Cholesterol Education Program; Medicine; Cholesterol; Coronary artery disease; National Health and Nutrition Examination Survey; Dyslipidemia; Internal medicine; Risk factor; Disease; Environmental health; Population","score_opus":0.33586135630450403,"score_gpt":0.45797673065916855,"score_spread":0.12211537435466452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974455801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807169,0.0035578597,0.003531198,0.0066339723,0.00061008864,0.0037079751,0.0005927654,0.0000075869157,0.00064168434],"genre_scores_gemma":[0.9851337,0.000054193075,0.012705519,0.00032023198,0.0012636968,0.00007153392,0.00042765005,0.000015444886,0.000008019114],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984805,0.00017519902,0.0005813793,0.0002161033,0.00028030807,0.00026648675],"domain_scores_gemma":[0.99713796,0.00005687037,0.00036667872,0.00033871704,0.0019196556,0.00018008529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027176598,0.00011487727,0.0005295757,0.000785647,0.00018838026,0.000019425162,0.00023116708,0.00009600986,0.0000017108628],"category_scores_gemma":[0.00066192215,0.000090786736,0.000094036855,0.0005035159,0.00020242605,0.000067202825,0.000029261388,0.00016313701,1.3570573e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011278898,0.00005010971,0.42045656,0.00009881415,0.0013771529,0.0000038263047,0.00020148465,0.0019032136,0.00032593752,0.0003168236,0.05844619,0.5167071],"study_design_scores_gemma":[0.0013887222,0.00041209042,0.5764136,0.00015466759,0.00062826776,0.00023802738,0.0013676119,0.0054315096,0.000027556638,0.00008938403,0.41372836,0.00012023698],"about_ca_topic_score_codex":0.54356205,"about_ca_topic_score_gemma":0.65326357,"teacher_disagreement_score":0.5165869,"about_ca_system_score_codex":0.00034053606,"about_ca_system_score_gemma":0.0066100433,"threshold_uncertainty_score":0.99902153},"labels":[],"label_agreement":null},{"id":"W1974518982","doi":"10.1136/ebn.4.3.86","title":"Aspirin but not vitamin E prevented cardiovascular events in patients at risk","year":2001,"lang":"en","type":"article","venue":"Evidence-Based Nursing","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Aspirin; Internal medicine; Web of science; Gastroenterology","score_opus":0.025884051184775124,"score_gpt":0.27825867962254247,"score_spread":0.25237462843776737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974518982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898538,0.005043379,0.0019332686,0.00064706197,0.00047900275,0.0017188614,0.000009818265,0.00009650541,0.00021832559],"genre_scores_gemma":[0.9974646,0.0006474825,0.0006381066,0.00041452475,0.0003532223,0.00008540919,0.00004835814,0.000062754065,0.00028552412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99558187,0.00080513285,0.0005959378,0.0007291957,0.001570328,0.0007175264],"domain_scores_gemma":[0.99793607,0.000110778186,0.00016651937,0.0012609136,0.00018728868,0.00033840394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023036855,0.00033325254,0.00081767596,0.00032593773,0.00020823693,0.000015526022,0.00017843212,0.00020212092,0.000075470045],"category_scores_gemma":[0.0005449124,0.00031234344,0.00094628194,0.0006794102,0.000084619394,0.000276264,0.000043008884,0.00045109092,0.00011388073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013043185,0.00067528716,0.6943017,0.00026153066,0.00029587164,0.00013506348,0.00016765892,0.0008169237,0.00023449809,0.000002182976,0.00014502801,0.3016599],"study_design_scores_gemma":[0.007251672,0.000715153,0.97582424,0.008018868,0.0005862372,0.00004251778,0.000057024215,0.0005740807,0.004414876,0.000022316808,0.0021353075,0.0003577045],"about_ca_topic_score_codex":0.0010864579,"about_ca_topic_score_gemma":0.000040571867,"teacher_disagreement_score":0.30130222,"about_ca_system_score_codex":0.0016738122,"about_ca_system_score_gemma":0.0002758977,"threshold_uncertainty_score":0.9999329},"labels":[],"label_agreement":null},{"id":"W1974768421","doi":"10.1161/circulationaha.108.838466","title":"Lipid Treatment Assessment Project 2","year":2009,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":308,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Canada; Pfizer","keywords":"Medicine; Internal medicine; Diabetes mellitus; Cholesterol; Statin; Coronary heart disease; National Cholesterol Education Program; Cohort; Risk factor; Lipid profile; Endocrinology","score_opus":0.032893094645665914,"score_gpt":0.3337644596426032,"score_spread":0.3008713649969373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974768421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971565,0.0002827415,0.004354702,0.0012211682,0.00012164154,0.0011691016,0.0000013755655,0.00011137732,0.021172892],"genre_scores_gemma":[0.9978933,0.000054900855,0.0010793568,0.00028090356,0.0005045221,0.000024680183,0.0000550705,0.0000064160154,0.00010088207],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99936783,0.000028053573,0.000118865115,0.00015027028,0.0002169059,0.00011809553],"domain_scores_gemma":[0.9996031,0.0000037073664,0.000029722181,0.00027053567,0.00004134739,0.000051594896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013564921,0.00007234372,0.00015592064,0.00005439141,0.000052073738,0.000011260081,0.000013903494,0.000044728677,0.000025743757],"category_scores_gemma":[0.000007507523,0.000055871744,0.00013226218,0.00011130466,0.000005518927,0.000043957854,0.000001938808,0.00004243615,0.000016966816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032820037,0.00036884527,0.04250944,0.000038934413,0.00010527645,0.000023818027,0.00022075437,0.00008428515,0.004448626,0.0016619159,0.00023804829,0.95026726],"study_design_scores_gemma":[0.0012216371,0.00035468786,0.9778499,0.000025056315,0.00009049316,0.000054894066,0.000025010988,0.0011014639,0.00036065123,0.00011132899,0.018738272,0.000066582856],"about_ca_topic_score_codex":0.00006824926,"about_ca_topic_score_gemma":0.0000018111003,"teacher_disagreement_score":0.9502007,"about_ca_system_score_codex":0.0002902883,"about_ca_system_score_gemma":0.00017680306,"threshold_uncertainty_score":0.22783837},"labels":[],"label_agreement":null},{"id":"W1974896569","doi":"10.1186/cc14060","title":"Early phases of sepsis: effects of simvastatin on mitochondrial enzyme activities in kidney tissue in rats","year":2014,"lang":"en","type":"article","venue":"Critical Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Children's Health Foundation; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina; Financiadora de Estudos e Projetos; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Japan Society for the Promotion of Science; Russian Foundation for Basic Research; London Health Sciences Centre","keywords":"Simvastatin; Medicine; Kidney; Sepsis; Pharmacology; Enzyme; Acute kidney injury; Bioinformatics; Intensive care medicine; Internal medicine; Physiology; Biochemistry; Biology","score_opus":0.011307757814881221,"score_gpt":0.3061016790809757,"score_spread":0.29479392126609444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974896569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665475,0.00086378725,0.00016885578,0.00027765133,0.00025641284,0.00051621534,0.00002394484,0.000013551394,0.0012248558],"genre_scores_gemma":[0.9989935,0.000009737986,0.00033897316,0.0003115979,0.0002524062,0.000048189504,0.000012027444,0.000016596072,0.00001695207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986836,0.00021547177,0.0002752507,0.00020847762,0.0003800679,0.00023718204],"domain_scores_gemma":[0.9989404,0.00047462527,0.000026228563,0.0002974773,0.00009317087,0.00016808407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014913802,0.00012028454,0.000551443,0.00014494504,0.000014202896,0.00000575234,0.000054945605,0.000108247295,0.000027891498],"category_scores_gemma":[0.0025576532,0.000105157385,0.000118912605,0.00015615615,0.00011442052,0.000048788563,0.000020356092,0.00020476467,0.0000027932367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054236837,0.004024489,0.018808786,0.073073685,0.0002843522,0.0012708607,0.025464848,0.00007271281,0.57877487,0.016524177,0.0025469058,0.27373064],"study_design_scores_gemma":[0.006021501,0.0037268137,0.017575223,0.0038831637,0.00010155867,0.0000057186085,0.0015308864,0.000032024367,0.96549976,0.00026500726,0.0011595458,0.00019880862],"about_ca_topic_score_codex":0.00047732933,"about_ca_topic_score_gemma":0.00004510186,"teacher_disagreement_score":0.3867249,"about_ca_system_score_codex":0.000054693337,"about_ca_system_score_gemma":0.00013174479,"threshold_uncertainty_score":0.42881936},"labels":[],"label_agreement":null},{"id":"W1975206078","doi":"10.1177/1715163514561256","title":"Updated guidelines for the management of dyslipidemia and prevention of cardiovascular disease by pharmacists","year":2014,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Montreal Heart Institute; University of Calgary; Université de Montréal; University of Alberta; University of British Columbia","funders":"","keywords":"Dyslipidemia; Medicine; Disease; Intensive care medicine; Disease management; Pharmacist; Cause of death; Kidney disease; Family medicine; Internal medicine; Pharmacy","score_opus":0.05142072502019094,"score_gpt":0.3147054579671812,"score_spread":0.26328473294699023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975206078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8789033,0.0845965,0.024611786,0.0013774543,0.0029863333,0.005111664,0.0017290486,0.000044446748,0.00063945155],"genre_scores_gemma":[0.9760184,0.020435821,0.0011841335,0.0010457848,0.00069612736,0.00006490028,0.00008448872,0.000052821088,0.00041747856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973053,0.00018102917,0.00085692934,0.00035889674,0.00071489933,0.0005829854],"domain_scores_gemma":[0.99639946,0.00006264891,0.0003110985,0.0005152448,0.0011555508,0.0015559894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002402315,0.00029007473,0.0006668492,0.00016289177,0.00039110254,0.000033722,0.0003119474,0.00004680435,0.00009850594],"category_scores_gemma":[0.000154153,0.00023395095,0.000588488,0.00035272053,0.00018479927,0.0001261687,0.00004009778,0.00027290927,5.4051736e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005387128,0.00006365657,0.0004425015,0.003755087,0.008228764,0.0021641129,0.00013776353,0.0032873035,0.0010108512,0.00011544632,0.07147718,0.9087786],"study_design_scores_gemma":[0.015229458,0.00021753628,0.00020978606,0.0003536574,0.012025009,0.051527746,0.00003600068,0.029776815,0.0070114345,0.00027008264,0.8825391,0.00080338796],"about_ca_topic_score_codex":0.0049840864,"about_ca_topic_score_gemma":0.00080512126,"teacher_disagreement_score":0.90797526,"about_ca_system_score_codex":0.0004900413,"about_ca_system_score_gemma":0.0013415961,"threshold_uncertainty_score":0.9540243},"labels":[],"label_agreement":null},{"id":"W1975259720","doi":"10.1161/01.cir.102.7.722","title":"Cost-Effectiveness of Treating Hyperlipidemia in the Presence of Diabetes","year":2000,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Medicine; Simvastatin; Hyperlipidemia; Diabetes mellitus; Life expectancy; Confidence interval; Type 2 diabetes; Internal medicine; Disease; Coronary artery disease; Cost effectiveness; Population; Endocrinology; Environmental health","score_opus":0.03375585770290528,"score_gpt":0.3010732392748883,"score_spread":0.26731738157198304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975259720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723476,0.00039119803,0.0001263235,0.00003129677,0.000014510894,0.00071347767,0.0000011565985,0.0000051190045,0.0014821633],"genre_scores_gemma":[0.99980253,0.000015268155,0.000058137837,0.00002001599,0.00004397486,0.000043051103,0.000009414431,0.0000043004857,0.0000032788532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992423,0.00023820758,0.00016509785,0.000084355444,0.00019172719,0.00007831322],"domain_scores_gemma":[0.9994964,0.00018522337,0.000042394302,0.00022104017,0.00004033721,0.000014610672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001123476,0.000041000058,0.00018632233,0.000032279277,0.000016068649,0.0000016180651,0.000033898534,0.00003754972,0.000024594216],"category_scores_gemma":[0.00012941725,0.000028324022,0.00007438109,0.00018897773,0.000026972997,0.00004018315,0.000002738342,0.0000568375,0.0000013992411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026259744,0.000053746284,0.8332114,0.00044555226,0.000021479564,6.7759e-7,0.00042033987,0.0019352515,0.009385835,0.00011919381,0.0000015389937,0.1543787],"study_design_scores_gemma":[0.0005713022,0.000032664,0.9927048,0.0002626714,0.00003089796,0.0000025222625,0.00005898209,0.002290195,0.0038555574,0.000120460296,0.00004545049,0.000024484005],"about_ca_topic_score_codex":0.00018399526,"about_ca_topic_score_gemma":0.000003412531,"teacher_disagreement_score":0.15949337,"about_ca_system_score_codex":0.000026730315,"about_ca_system_score_gemma":0.000031291736,"threshold_uncertainty_score":0.11550201},"labels":[],"label_agreement":null},{"id":"W1975346339","doi":"10.1016/s0828-282x(08)71035-3","title":"Treatment of low high-density lipoprotein cholesterol","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; High-density lipoprotein; Cholesterol; Internal medicine","score_opus":0.018089097179796756,"score_gpt":0.22987992707870886,"score_spread":0.2117908298989121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975346339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941898,0.001831907,0.0012118929,0.0008011153,0.00046634153,0.0002770528,0.000013427949,0.000004283527,0.0012042008],"genre_scores_gemma":[0.9971109,0.0005259452,0.00028708667,0.0001237632,0.0017990891,0.000004276782,0.0000045800925,0.000016278795,0.00012806138],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988084,0.00013805536,0.00041454908,0.000129797,0.00019910828,0.0003101206],"domain_scores_gemma":[0.9983557,0.000017426597,0.00017911827,0.00038077906,0.00032908187,0.0007379218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023955092,0.0001345503,0.0009939498,0.00024547376,0.000080854974,0.0000029782284,0.000082810795,0.00015457308,0.000019371613],"category_scores_gemma":[0.000069112226,0.00010341903,0.0005638107,0.00011248149,0.00020433104,0.000039019014,0.0000044346743,0.00016056884,0.000009775851],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012145706,0.00011433198,0.28197062,0.000498918,0.0072157024,0.025902772,0.0024367806,0.0013739436,0.005311483,0.0004441722,0.0086872745,0.66482943],"study_design_scores_gemma":[0.004862316,0.0035570734,0.88140655,0.000091103895,0.00030882412,0.028200751,0.000079791986,0.000002672484,0.007544434,0.00008092732,0.07371953,0.00014605149],"about_ca_topic_score_codex":0.022373935,"about_ca_topic_score_gemma":0.0025837487,"teacher_disagreement_score":0.6646834,"about_ca_system_score_codex":0.00031705303,"about_ca_system_score_gemma":0.0021789279,"threshold_uncertainty_score":0.98413616},"labels":[],"label_agreement":null},{"id":"W1975421074","doi":"10.1016/j.jval.2011.02.210","title":"PCV22 META REGRESSION ANALYSIS TO INDIRECTLY COMPARE THE SAFETY AND EFFICACY OF DALTEPARIN TO ENOXAPARIN IN PATIENTS WITH UNSTABLE CORONARY ARTERY DISEASE","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Enoxaparin sodium; Unstable angina; Internal medicine; Low molecular weight heparin; Meta-analysis; Randomized controlled trial; Relative risk; Angina; Heparin; Cardiology; Confidence interval; Myocardial infarction","score_opus":0.042920077049483044,"score_gpt":0.27334860265593436,"score_spread":0.23042852560645133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975421074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538374,0.0013387514,0.0001853642,0.0006877239,0.000035110406,0.0021580562,0.000038977818,0.000015145736,0.00015713232],"genre_scores_gemma":[0.99797684,0.00013329882,0.0010353603,0.0006942888,0.00001882849,0.000056142155,0.000042936725,0.000018571489,0.0000237622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975837,0.0004959797,0.0006048486,0.00041286126,0.000522197,0.00038039984],"domain_scores_gemma":[0.9983819,0.00009087685,0.00014650148,0.0007778577,0.00007024186,0.00053258514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014864889,0.00018765299,0.0009914153,0.00042762718,0.000088488676,0.000006132678,0.00012129979,0.000035637375,0.000031818217],"category_scores_gemma":[0.0000902016,0.000107648484,0.00013852167,0.0013317696,0.000042096148,0.00005198942,0.00009319081,0.00020778754,0.0000027066433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041157897,0.0006193242,0.9778347,0.00028050508,0.00079957093,0.00002268031,0.0022927495,0.0030049782,8.459418e-7,0.00009181775,0.000038350165,0.0108987],"study_design_scores_gemma":[0.0023201571,0.0006337008,0.9951537,0.00033015155,0.00060213055,0.0000020307239,0.00013676457,0.00029146703,0.000011681152,0.000014469024,0.00039658893,0.00010710554],"about_ca_topic_score_codex":0.019788487,"about_ca_topic_score_gemma":0.0014110709,"teacher_disagreement_score":0.018377418,"about_ca_system_score_codex":0.00018482647,"about_ca_system_score_gemma":0.00039757244,"threshold_uncertainty_score":0.9867388},"labels":[],"label_agreement":null},{"id":"W1975636428","doi":"10.1016/j.ahj.2013.06.004","title":"Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience","year":2013,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Physical therapy; Family medicine; Gerontology; Intensive care medicine; Internal medicine","score_opus":0.016939004683886826,"score_gpt":0.3061610777397571,"score_spread":0.2892220730558703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975636428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766743,0.00017550366,0.00011142348,0.001188755,0.00005357308,0.0005040849,0.0000011420441,0.000008875883,0.00028923474],"genre_scores_gemma":[0.9974389,0.00017666905,0.0014223626,0.0006707752,0.00014413959,0.00006519545,0.0000015645172,0.000012635903,0.00006774435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881136,0.00013038934,0.00026674752,0.00014120787,0.0003729541,0.00027735817],"domain_scores_gemma":[0.99933803,0.000039732542,0.00010007185,0.0002531935,0.0001082693,0.00016071959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017259993,0.000116494004,0.00033864714,0.00004651448,0.00012098231,0.00006821171,0.000055492113,0.000017200566,0.00022064743],"category_scores_gemma":[0.000017240107,0.000055831068,0.00009229864,0.0001968963,0.00019649528,0.00015372846,0.000009030808,0.0002490853,0.00004379788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016695523,0.00018381,0.8822071,0.0000060192865,0.00006658655,0.000016583153,0.0023747457,0.000010374855,0.000014449523,0.000004143989,0.00020619856,0.11474303],"study_design_scores_gemma":[0.0018811568,0.002631446,0.98511237,0.00004604949,0.00001741047,0.00013150036,0.0067585995,0.000017775845,0.00002145019,0.000022177488,0.003286369,0.00007371977],"about_ca_topic_score_codex":0.0024150047,"about_ca_topic_score_gemma":0.00005756764,"teacher_disagreement_score":0.11466931,"about_ca_system_score_codex":0.0001132791,"about_ca_system_score_gemma":0.00030161926,"threshold_uncertainty_score":0.36507806},"labels":[],"label_agreement":null},{"id":"W1975674908","doi":"10.1007/s12325-010-0033-6","title":"Systematic review on evidence of the effectiveness of cholesterol-lowering drugs","year":2010,"lang":"en","type":"review","venue":"Advances in Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regina Qu'Appelle Health Region","funders":"","keywords":"Medicine; Intensive care medicine; MEDLINE; Coronary heart disease; Diabetes mellitus; Disease; Population; Internal medicine; Environmental health; Endocrinology","score_opus":0.024738024962558287,"score_gpt":0.3738771809146772,"score_spread":0.3491391559521189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975674908","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014414561,0.99215645,0.000013803224,0.00000982656,0.00033053066,0.0071722483,0.000003059389,0.000008586627,0.00016133815],"genre_scores_gemma":[0.0006360652,0.99844253,0.000020312682,0.00010203917,0.000058085618,0.00068994425,0.0000017504492,0.000037527534,0.000011754288],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967687,0.00123342,0.0009694153,0.00029215403,0.0005724198,0.0001638981],"domain_scores_gemma":[0.99658644,0.0009368224,0.0007722369,0.0015785538,0.00008760916,0.000038314134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004242352,0.00029302877,0.0040758224,0.00008659802,0.000020248104,0.0000030870337,0.00038838582,0.00015380759,0.0000048075512],"category_scores_gemma":[0.000539014,0.00014320167,0.0010849524,0.00045021359,0.00008915195,0.00008551762,0.000036352947,0.00055898767,0.000003095755],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022884798,0.000031602885,0.0000037883824,0.6410847,0.000084107094,9.613804e-7,0.000012165114,3.6439704e-7,0.000003074114,0.000020433681,1.4426944e-7,0.35873583],"study_design_scores_gemma":[0.00031949225,0.00020165618,0.000027204245,0.9536014,0.00058793783,0.00003225051,0.0000028874251,8.462941e-8,0.00014658186,0.000020267664,0.044955842,0.000104349914],"about_ca_topic_score_codex":0.000015149077,"about_ca_topic_score_gemma":0.00000271501,"teacher_disagreement_score":0.3586315,"about_ca_system_score_codex":0.00008876191,"about_ca_system_score_gemma":0.00019771908,"threshold_uncertainty_score":0.58395946},"labels":[],"label_agreement":null},{"id":"W1975748249","doi":"10.1161/circoutcomes.113.000769","title":"How Do the 2013 Cholesterol Guidelines Compare With Previous Cholesterol Guideline Reports?","year":2014,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Institute for Clinical Evaluative Sciences; Western University","funders":"","keywords":"Guideline; Pharmacy; Medicine; Blood cholesterol; Veterans Affairs; Family medicine; Cholesterol; Clinical pharmacy; Health care; Political science; Internal medicine; Pathology","score_opus":0.05892219782359559,"score_gpt":0.3259377713309381,"score_spread":0.2670155735073425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975748249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7980263,0.018420301,0.13368842,0.04512184,0.0004924568,0.003381335,0.000014884292,0.00032719815,0.0005272108],"genre_scores_gemma":[0.9921005,0.00048358808,0.0014514922,0.004738934,0.000796795,0.000116767034,0.00009715383,0.00005952169,0.00015527711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99529624,0.0007438744,0.0011196393,0.0008101922,0.0016079694,0.00042207623],"domain_scores_gemma":[0.9957251,0.00009503449,0.00036878366,0.0026426534,0.00087816204,0.00029024718],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0063945428,0.0004345244,0.0015112387,0.000105679675,0.00038959278,0.00029619157,0.00014845286,0.0001634625,0.00001190832],"category_scores_gemma":[0.00055800914,0.00025647253,0.0013536615,0.00026371417,0.00019773902,0.0002749787,0.000082941275,0.0003345748,0.000007162945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099241064,0.000118517746,0.7626538,0.0010520244,0.0066789,0.00005717559,0.0005311745,0.0045742453,0.000052880427,0.00070742966,0.001975539,0.22149904],"study_design_scores_gemma":[0.002519376,0.00007602309,0.77417266,0.00014347499,0.0011733195,0.0010045813,0.0002918411,0.00047339252,0.00003415534,0.00013656265,0.21962757,0.00034701498],"about_ca_topic_score_codex":0.00073692284,"about_ca_topic_score_gemma":0.00008327439,"teacher_disagreement_score":0.22115202,"about_ca_system_score_codex":0.00007215705,"about_ca_system_score_gemma":0.00009423248,"threshold_uncertainty_score":0.99998873},"labels":[],"label_agreement":null},{"id":"W1976068831","doi":"10.1016/j.ijcard.2013.08.127","title":"Real-life effectiveness of statins in the prevention of first acute coronary syndrome in France: A prospective observational study","year":2013,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"AstraZeneca","keywords":"Medicine; Rosuvastatin; Acute coronary syndrome; Atorvastatin; Pravastatin; Internal medicine; Statin; Odds ratio; Hazard ratio; Confidence interval; Fluvastatin; Incidence (geometry); Observational study; Simvastatin; Myocardial infarction; Cholesterol","score_opus":0.027477342964606064,"score_gpt":0.3330023025388908,"score_spread":0.3055249595742847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976068831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972643,0.00019513996,0.0006389992,0.00034431228,0.00026175525,0.0010904869,0.000011712161,0.0000018105967,0.00019148499],"genre_scores_gemma":[0.9994051,0.00018676833,0.00014488016,0.00003208649,0.00011357248,0.00009129025,0.0000098406,0.000007335488,0.000009161986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780065,0.0005984633,0.0006936352,0.00011905153,0.0006819761,0.000106203544],"domain_scores_gemma":[0.9983081,0.0003037747,0.00038156798,0.00015193484,0.0008204658,0.000034155397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020944935,0.00008942185,0.0006296479,0.00023040274,0.000012281573,0.00000438678,0.0002127606,0.0000647669,0.000016527012],"category_scores_gemma":[0.00023878131,0.00006141645,0.0002492618,0.00017851144,0.00006801939,0.00014039146,0.000033534674,0.00025725013,0.0000011077668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059821847,0.00035661695,0.99465626,0.00007167238,0.0013794022,0.00036110167,0.0005314278,0.00076904165,0.00047816645,0.00031193695,0.00001654005,0.00046963646],"study_design_scores_gemma":[0.004350054,0.0017729443,0.9904124,0.00029026726,0.00008957816,0.0012609187,0.0006654201,0.00003613333,0.00006870429,0.0009941984,0.000016478418,0.000042893065],"about_ca_topic_score_codex":0.00041612337,"about_ca_topic_score_gemma":0.000025613908,"teacher_disagreement_score":0.004243829,"about_ca_system_score_codex":0.00014236417,"about_ca_system_score_gemma":0.00027513257,"threshold_uncertainty_score":0.25044903},"labels":[],"label_agreement":null},{"id":"W1976126931","doi":"10.1097/hpc.0b013e318053d1a1","title":"An Annual, Prospective, International Study of Outpatients With Cardiovascular Disease or Risk Factors","year":2007,"lang":"en","type":"article","venue":"Critical Pathways in Cardiology A Journal of Evidence-Based Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Disease; Dyslipidemia; Observational study; Medical diagnosis; Diabetes mellitus; Demographics; Medical history; Emergency medicine; Risk factor; Internal medicine; Physical therapy; Intensive care medicine; Family medicine; Pediatrics; Demography; Pathology","score_opus":0.10164885452939758,"score_gpt":0.3686031807492203,"score_spread":0.26695432621982274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976126931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97596645,0.0053129303,0.016383138,0.00041016558,0.0007601398,0.0010502165,0.000030186935,0.000018144725,0.00006860909],"genre_scores_gemma":[0.9973959,0.00045359458,0.0006761461,0.0001707433,0.0012389716,0.00002106267,0.0000069313323,0.000033706347,0.0000029683597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945645,0.000889778,0.0013789665,0.00050128886,0.0021755118,0.00048995716],"domain_scores_gemma":[0.99447733,0.0013308635,0.00035283837,0.000932585,0.0020650062,0.0008413461],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0078113363,0.00032855518,0.0019102,0.00070736697,0.00008730367,0.000006958597,0.00034498534,0.0001719987,0.000041343414],"category_scores_gemma":[0.012096533,0.0001725758,0.0005554424,0.00054873695,0.0007867983,0.00036214697,0.000038784383,0.0009482932,7.921452e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014653499,0.0014595208,0.9635308,0.0002859733,0.0018808871,0.007929867,0.0013767246,0.002244104,0.00010934015,0.000048090034,0.000034849236,0.006446379],"study_design_scores_gemma":[0.012853127,0.028377986,0.941962,0.0029844553,0.0027238422,0.00051036436,0.00967716,0.00008180795,0.00023771396,0.00011982342,0.0002465894,0.00022513639],"about_ca_topic_score_codex":0.00026003784,"about_ca_topic_score_gemma":0.000026919697,"teacher_disagreement_score":0.026918465,"about_ca_system_score_codex":0.00034082527,"about_ca_system_score_gemma":0.0008761978,"threshold_uncertainty_score":0.996225},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W1976199573","doi":"10.1016/j.jacl.2014.08.004","title":"The Risk-Benefit Paradigm vs the Causal Exposure Paradigm: LDL as a primary cause of vascular disease","year":2014,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Disease; Atherosclerotic cardiovascular disease; Primary prevention; Intensive care medicine; Statin; Blood pressure; Vascular disease; Risk assessment; Cardiology; Cardiovascular event; Internal medicine; Physical therapy","score_opus":0.03317201517271609,"score_gpt":0.3407055560705636,"score_spread":0.30753354089784746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976199573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632918,0.009842464,0.0010105161,0.020635035,0.004066804,0.0006089989,0.000009285283,0.00001720122,0.0005178955],"genre_scores_gemma":[0.9702508,0.01287213,0.00025637177,0.0043198816,0.012061924,0.000015267491,0.0000043168384,0.00003920625,0.00018011751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937208,0.0021945352,0.0023270466,0.00028865327,0.001013395,0.00045556534],"domain_scores_gemma":[0.9921956,0.0037606887,0.001680903,0.0013730675,0.0002932241,0.0006964991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01296663,0.00023651498,0.0015733624,0.00007006256,0.00023905201,0.000023670811,0.00049495907,0.0002962253,0.00005012956],"category_scores_gemma":[0.0068703135,0.0001119148,0.0019393254,0.0001734541,0.00061947264,0.00007764419,0.00010572393,0.0015231023,0.00003048419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019345053,0.00221937,0.6784992,0.0006252516,0.010144678,0.0003433136,0.00045921598,0.00053432886,0.000042485823,0.041916665,0.01957166,0.22629876],"study_design_scores_gemma":[0.004444021,0.0033792022,0.69213635,0.00011970551,0.0017964176,0.00048341646,0.000031381725,0.00007309756,0.000009512217,0.009636672,0.28776744,0.00012280467],"about_ca_topic_score_codex":0.00008288383,"about_ca_topic_score_gemma":0.000031900596,"teacher_disagreement_score":0.26819578,"about_ca_system_score_codex":0.000045100507,"about_ca_system_score_gemma":0.0008885448,"threshold_uncertainty_score":0.82249033},"labels":[],"label_agreement":null},{"id":"W1976280770","doi":"10.1007/s11883-008-0016-0","title":"Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes","year":2008,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"British Heart Foundation","keywords":"Medicine; Angiology; Diabetes mellitus; Coronary atherosclerosis; Internal medicine; Cardiology; Acute coronary syndrome; Intensive care medicine; Coronary heart disease; Myocardial infarction; Endocrinology","score_opus":0.0352330996061857,"score_gpt":0.2896371737807499,"score_spread":0.2544040741745642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976280770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19980416,0.79593915,0.00000941111,0.000002333179,0.00025112522,0.003872096,0.000023491564,0.000036511577,0.00006173514],"genre_scores_gemma":[0.012625238,0.98585016,0.00029575705,0.0000060480756,0.00006705807,0.00061700214,0.00035035406,0.00012871293,0.00005969125],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9959857,0.00016929267,0.0014345868,0.00096432865,0.00095606945,0.00049001456],"domain_scores_gemma":[0.99729246,0.00003130867,0.001193382,0.0011141639,0.00015339625,0.00021529273],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038433174,0.00066111,0.0027686874,0.00028322972,0.000082304134,0.00001876365,0.000108488544,0.00027584707,0.00002159695],"category_scores_gemma":[0.000016982736,0.00049082027,0.00077943335,0.00052941515,0.00017321356,0.00011349842,0.00016671649,0.00043416364,0.000004207305],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015252696,0.00090852584,0.15124781,0.027208544,0.00070528756,0.000027872524,0.0000664727,3.2203388e-7,3.283734e-7,0.0000034974178,0.00004791715,0.8197682],"study_design_scores_gemma":[0.002649247,0.00096982793,0.6893491,0.15250675,0.002787741,0.000086599845,0.00001936605,6.873116e-7,0.000007839159,0.000008982173,0.1508883,0.00072553364],"about_ca_topic_score_codex":0.00001110467,"about_ca_topic_score_gemma":0.0000021956005,"teacher_disagreement_score":0.8190426,"about_ca_system_score_codex":0.00027764696,"about_ca_system_score_gemma":0.00025211964,"threshold_uncertainty_score":0.99975437},"labels":[],"label_agreement":null},{"id":"W1976478146","doi":"10.1139/y03-042","title":"Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia","year":2003,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pravastatin; Simvastatin; Chemistry; Internal medicine; Cholesterol; Endocrinology; Lipid peroxidation; Erythrocyte membrane; Membrane fluidity; Medicine; Membrane; Antioxidant; Biochemistry","score_opus":0.005966199450535479,"score_gpt":0.23449108401095578,"score_spread":0.2285248845604203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976478146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917364,0.0003335068,0.0000043467426,0.000059947874,0.00014873571,0.00023661971,0.000004774194,7.06567e-7,0.000037716374],"genre_scores_gemma":[0.9993597,0.00013283349,0.00017279986,0.0002744853,0.000040440133,0.0000020678854,0.0000040933055,0.000007767867,0.0000057978627],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.999125,0.0003013742,0.00024266331,0.000101066136,0.000074621945,0.0001552835],"domain_scores_gemma":[0.9992911,0.00012937187,0.00017103773,0.000054824843,0.00015268782,0.00020097522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028066034,0.00008767775,0.00040452796,0.00018771338,0.00002953018,0.0000011650789,0.000028059509,0.000078415294,0.000055670374],"category_scores_gemma":[0.00007225446,0.000066990855,0.000029369508,0.00010147134,0.00015271685,0.000038757862,0.0000031863763,0.00025709262,3.30978e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041746036,0.00032380575,0.093485154,0.002354122,0.0006316043,0.000106287625,0.0017447739,0.00023410353,0.8863267,0.00016284006,0.00020006523,0.010255999],"study_design_scores_gemma":[0.011570586,0.0063479664,0.622609,0.000211928,0.00023582378,0.000072858216,0.00008494182,0.000013912098,0.35814065,0.000047967686,0.00056964875,0.0000946833],"about_ca_topic_score_codex":0.00019758454,"about_ca_topic_score_gemma":0.00022143916,"teacher_disagreement_score":0.5291239,"about_ca_system_score_codex":0.000030798168,"about_ca_system_score_gemma":0.00044811188,"threshold_uncertainty_score":0.27318078},"labels":[],"label_agreement":null},{"id":"W1976531866","doi":"10.1136/bmj.g3244","title":"Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases","year":2014,"lang":"en","type":"article","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Saskatchewan Health Quality Council; University of Calgary; McGill University; University of Victoria; Institute for Clinical Evaluative Sciences; Manitoba Health; Jewish General Hospital; York University; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Potency; Diabetes mellitus; Confidence interval; Internal medicine; Confounding; Population; Incidence (geometry); Logistic regression; Cohort; Endocrinology; Environmental health; Mathematics","score_opus":0.12088442784400327,"score_gpt":0.368559957888882,"score_spread":0.24767553004487874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976531866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968095,0.0003701156,0.00019357992,0.0008116879,0.000050506784,0.0011415774,0.000043606957,0.0000062230024,0.0005732274],"genre_scores_gemma":[0.99726444,0.000054373373,0.0019545222,0.00015625865,0.00019547256,0.000023379132,0.000018311319,0.0000065058266,0.00032670674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989378,0.00022612893,0.00028407515,0.00012256514,0.00034033234,0.0000891055],"domain_scores_gemma":[0.99903107,0.0002477032,0.00018876616,0.0003624496,0.00010476952,0.00006522455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079643773,0.00006990509,0.00030024524,0.00001780486,0.000036562506,0.0000029151183,0.000042085845,0.000016362666,0.000043642573],"category_scores_gemma":[0.0005563901,0.00003981476,0.00006275868,0.000076532735,0.000068706184,0.000036572575,0.000029274508,0.000074431686,0.0000011225641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006839408,0.0009310771,0.9516608,0.0003337101,0.0011105507,0.0000035475286,0.004147927,0.000021812031,0.000108658256,0.0032092605,0.0032155921,0.034573104],"study_design_scores_gemma":[0.0069646914,0.00053933664,0.9871693,0.000064699525,0.00035914453,9.545887e-7,0.0014533091,0.0002702899,0.00020569233,0.00010330142,0.0028230562,0.00004618944],"about_ca_topic_score_codex":0.0022731456,"about_ca_topic_score_gemma":0.00018225072,"teacher_disagreement_score":0.035508517,"about_ca_system_score_codex":0.0000061006335,"about_ca_system_score_gemma":0.00012819466,"threshold_uncertainty_score":0.34363315},"labels":[],"label_agreement":null},{"id":"W1976691226","doi":"10.1073/pnas.0903849106","title":"A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates","year":2009,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":415,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"Basic Energy Sciences; Office of Science; Amgen; U.S. Department of Energy","keywords":"PCSK9; Kexin; LDL receptor; Proprotein convertase; Subtilisin; Chemistry; Internal medicine; Endocrinology; Cholesterol; Antibody; Biochemistry; Lipoprotein; Biology; Medicine; Enzyme; Immunology","score_opus":0.03466682914151578,"score_gpt":0.3359034658393262,"score_spread":0.3012366366978104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976691226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917544,0.00064198487,1.0590121e-7,0.0061242795,0.000009693114,0.00052643777,0.0000034731172,0.000010373603,0.00092921755],"genre_scores_gemma":[0.9986025,0.000121271674,0.0006025053,0.0005565363,0.00006568246,0.000004986255,2.6727926e-7,0.0000037377092,0.000042474025],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984221,0.000009015084,0.0003095743,0.00025194167,0.00082953594,0.00017782797],"domain_scores_gemma":[0.99950624,0.000018070252,0.00021218507,0.0000113720835,0.00019967265,0.000052490082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015461147,0.00009866277,0.00024888778,0.00017662911,0.000108843305,0.00002501443,0.00023044838,0.000078717414,0.0000036233619],"category_scores_gemma":[0.00021198668,0.000063996114,0.000060041297,0.0005376231,0.00036569647,0.00033599712,0.000044908673,0.00018905757,4.6256312e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007099469,0.00010063935,0.02875011,0.00035548361,0.000017092718,7.4980235e-8,0.00044864317,0.000004685379,0.96372163,0.0033601956,0.000040848845,0.0031295777],"study_design_scores_gemma":[0.00044038336,0.00016762032,0.5401995,0.0003786985,0.000016350012,0.000036074965,0.000152732,0.00016906923,0.45593384,0.0024055864,0.000041014307,0.00005913175],"about_ca_topic_score_codex":0.00004191827,"about_ca_topic_score_gemma":2.7730553e-7,"teacher_disagreement_score":0.5114494,"about_ca_system_score_codex":0.00003087951,"about_ca_system_score_gemma":0.00006569637,"threshold_uncertainty_score":0.26096857},"labels":[],"label_agreement":null},{"id":"W1977016172","doi":"10.1111/j.1744-9987.2008.00574.x","title":"Low‐density Lipoprotein Apheresis in Children With Familial Hypercholesterolemia: Follow‐up to 21 Years","year":2008,"lang":"en","type":"article","venue":"Therapeutic Apheresis and Dialysis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Familial hypercholesterolemia; LDL apheresis; Internal medicine; Cholesterol; Angina; Gastroenterology; Bradykinin; Cardiology; Surgery; Myocardial infarction","score_opus":0.01454090773415688,"score_gpt":0.2324080406785344,"score_spread":0.21786713294437754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977016172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632937,0.0014095252,0.00036780396,0.0003386014,0.000046298308,0.0011211707,0.000009495221,0.000070667375,0.00030707842],"genre_scores_gemma":[0.9961069,0.0008266758,0.0006652158,0.0015592107,0.00027679183,0.00010582439,0.000015724814,0.00006158038,0.00038203876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751097,0.00019163058,0.00039527696,0.0006696572,0.0006932954,0.00053914124],"domain_scores_gemma":[0.99856913,0.000042058397,0.0000773607,0.00082823366,0.00008680164,0.00039643334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046945046,0.00034104352,0.0009466348,0.0002276875,0.00017107965,0.000033773722,0.0001467461,0.00021535452,0.000119311015],"category_scores_gemma":[0.000036419628,0.00026858345,0.0003170229,0.0007631413,0.00014235554,0.00009409983,0.00007511539,0.0003103748,0.000050314204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024949557,0.00047381455,0.51396775,0.00010185966,0.0022273704,0.00020274898,0.0037709915,0.00004257537,0.005294151,0.000049233415,0.00018697261,0.47118756],"study_design_scores_gemma":[0.005078017,0.00047854136,0.9892165,0.000113335176,0.00057358475,0.0001864902,0.0004262753,0.000015457128,0.0028900362,0.000041990927,0.00059737597,0.00038237302],"about_ca_topic_score_codex":0.008221293,"about_ca_topic_score_gemma":0.0018007645,"teacher_disagreement_score":0.47524875,"about_ca_system_score_codex":0.00012723444,"about_ca_system_score_gemma":0.00016150842,"threshold_uncertainty_score":0.99997663},"labels":[],"label_agreement":null},{"id":"W1977275173","doi":"10.1016/s0002-9149(00)01508-3","title":"High apolipoprotein B with low high-density lipoprotein cholesterol and normal plasma triglycerides and cholesterol","year":2001,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Cholesterol; Medicine; Internal medicine; Lipoprotein; Scopus; Coronary heart disease; Disease; Low-density lipoprotein; Endocrinology; High-density lipoprotein; Apolipoprotein E; MEDLINE; Chemistry; Biochemistry","score_opus":0.006595535373727967,"score_gpt":0.22372969175137924,"score_spread":0.21713415637765127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977275173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99344647,0.0006019966,0.0020441688,0.0031378206,0.0001167885,0.0005471101,0.000005085554,0.00002256684,0.00007797273],"genre_scores_gemma":[0.99481195,0.0015686937,0.0010195482,0.00097209256,0.0015243975,0.000020096657,0.0000020704897,0.00004065517,0.00004050841],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99771637,0.00049577927,0.0005221071,0.00030137037,0.00048854214,0.00047582938],"domain_scores_gemma":[0.99816257,0.000088142726,0.00058893836,0.0005610872,0.00023271555,0.00036654322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012645569,0.00030332463,0.001565602,0.00017466022,0.00017318876,0.000040242252,0.00017751282,0.00008855123,0.0000057927846],"category_scores_gemma":[0.000068733636,0.0001747287,0.00022266524,0.00025796582,0.0011062882,0.00014288472,0.00008969033,0.0006872473,0.000003754063],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008848998,0.000054761826,0.021418275,0.000108190194,0.0018341636,0.0010037313,0.00031597776,0.00023790669,0.0027495848,0.00008025153,0.00007912805,0.96326905],"study_design_scores_gemma":[0.008166997,0.008892637,0.8958101,0.0002483229,0.00079823576,0.078662984,0.00064136897,0.000023648494,0.0036570732,0.00019243393,0.002579306,0.00032687903],"about_ca_topic_score_codex":0.002710258,"about_ca_topic_score_gemma":0.000083365914,"teacher_disagreement_score":0.9629421,"about_ca_system_score_codex":0.00006452918,"about_ca_system_score_gemma":0.00015173003,"threshold_uncertainty_score":0.712523},"labels":[],"label_agreement":null},{"id":"W1977598347","doi":"10.1038/ejhg.2012.30","title":"Clinical utility gene card for: Abetalipoproteinaemia","year":2012,"lang":"en","type":"article","venue":"European Journal of Human Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"Ontario Genomics Institute; Canadian Institutes of Health Research; Ontario Genomics; Genome Canada; Heart and Stroke Foundation of Canada; Pfizer","keywords":"Genetics; Gene; Biology; Computational biology; Report card; Psychology","score_opus":0.07465990671551737,"score_gpt":0.35217774364315546,"score_spread":0.2775178369276381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977598347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803272,0.0095966,0.0053860014,0.00011760397,0.000774172,0.00041676016,0.0000070144906,0.000016408942,0.0033582598],"genre_scores_gemma":[0.9778557,0.00043363724,0.0143949585,0.0003143982,0.0067105554,0.0000014806693,0.000006927442,0.00005884045,0.00022351008],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973462,0.0005582562,0.0010560292,0.00015193781,0.0005005022,0.00038704128],"domain_scores_gemma":[0.9980463,0.000027303598,0.00040998126,0.0005772846,0.00037165897,0.000567464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068662576,0.00016149633,0.00057276053,0.00007380462,0.00012178014,0.000017816325,0.00018920578,0.000055677738,0.00004094743],"category_scores_gemma":[0.00014934286,0.00012815163,0.0008385068,0.00006793983,0.00010295636,0.00005539467,0.000061110426,0.00042185423,0.000028404644],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005313567,0.0011308842,0.29940715,0.00053544453,0.0016895366,0.00041791837,0.00087255077,0.00000961746,0.010048915,0.00016328154,0.013675296,0.671518],"study_design_scores_gemma":[0.003913051,0.0027461944,0.73598045,0.000104156985,0.00069585594,0.0009044865,0.000083295105,0.0000112233,0.005171039,0.000051124138,0.2501322,0.00020689367],"about_ca_topic_score_codex":0.0000017850014,"about_ca_topic_score_gemma":6.0700603e-7,"teacher_disagreement_score":0.67131114,"about_ca_system_score_codex":0.000042089003,"about_ca_system_score_gemma":0.00010662391,"threshold_uncertainty_score":0.5225872},"labels":[],"label_agreement":null},{"id":"W1977713662","doi":"10.1016/j.amjcard.2007.04.023","title":"Comparison of Utilization of Statin Therapy at Hospital Discharge and Six-Month Outcomes in Patients With an Acute Coronary Syndrome and Serum Low-Density Lipoprotein ≥100 mg/dl Versus &lt;100 mg/dl","year":2007,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canadian Heart Research Centre; McMaster University","funders":"","keywords":"Medicine; Acute coronary syndrome; Statin; Internal medicine; Myocardial infarction; Confidence interval; Odds ratio; Cardiology; Clinical endpoint; Clinical trial","score_opus":0.017078003310132022,"score_gpt":0.30120463739801634,"score_spread":0.2841266340878843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977713662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978182,0.0008445286,0.00036469885,0.00018099033,0.00012112897,0.0006152497,0.000029061075,0.0000062872923,0.000019894702],"genre_scores_gemma":[0.998974,0.00049448403,0.00036777495,0.00006308997,0.000054808002,0.0000032284959,0.000013570566,0.000024319655,0.000004673084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792176,0.00041058997,0.0006582104,0.00020820565,0.0004999447,0.0003012959],"domain_scores_gemma":[0.99819946,0.00013201752,0.00086435076,0.00037211922,0.00025943498,0.00017260216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011354443,0.00020953358,0.0016432804,0.00016091757,0.000066387496,0.0000048055367,0.00012341102,0.00006605717,0.0000041909625],"category_scores_gemma":[0.00004659446,0.00012624066,0.00016580049,0.00021902137,0.00062034186,0.00010784703,0.00006204071,0.000288376,2.6973126e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011434754,0.00019111822,0.9432136,0.00003605571,0.0011017248,0.000081944796,0.00091956614,0.000033837678,0.00036379282,0.000009276255,0.0000064889555,0.042607863],"study_design_scores_gemma":[0.0075539374,0.022860236,0.9671995,0.00007072087,0.00023912353,0.00026935257,0.0012004826,0.00002172422,0.0004279447,0.000012121752,0.000022064833,0.00012279503],"about_ca_topic_score_codex":0.00025233583,"about_ca_topic_score_gemma":0.00006101058,"teacher_disagreement_score":0.042485066,"about_ca_system_score_codex":0.00009195855,"about_ca_system_score_gemma":0.000096229174,"threshold_uncertainty_score":0.51479447},"labels":[],"label_agreement":null},{"id":"W1978239396","doi":"10.1038/ki.2014.31","title":"KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient","year":2014,"lang":"en","type":"review","venue":"Kidney International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":658,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Guideline; Kidney disease; Ezetimibe; Statin; Dialysis; Clinical Practice; Intensive care medicine; Renal function; Internal medicine; Cholesterol; Urology; Physical therapy; Pathology","score_opus":0.10159645832194135,"score_gpt":0.4904585491459416,"score_spread":0.38886209082400025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978239396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020887424,0.70013994,0.121529646,0.053685103,0.0116530955,0.030386025,0.0018516582,0.000074851116,0.080658786],"genre_scores_gemma":[0.0000064004125,0.9248429,0.061269365,0.0084834695,0.0014102797,0.0004959073,0.0031778016,0.000035461395,0.0002784033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953091,0.00060126657,0.0028094787,0.0005273772,0.00056625454,0.0001865153],"domain_scores_gemma":[0.9976287,0.000438931,0.00085092086,0.00047226,0.00035087075,0.00025830124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007925513,0.0002233498,0.0012034822,0.00018749802,0.000033438962,0.00002382391,0.0002336584,0.00018846792,0.000026781307],"category_scores_gemma":[0.0030499261,0.0001478789,0.0006056582,0.00013227922,0.000038304104,0.00008497843,0.00023725435,0.00038444123,0.000011893292],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011568871,0.0005333375,0.000036599722,0.0026178567,0.0012891588,0.0000015745435,0.000018182383,7.3402674e-7,2.9066736e-9,0.00030406556,0.15769142,0.8373914],"study_design_scores_gemma":[0.0017578247,0.0003608742,0.000054349468,0.0026410827,0.0010675142,0.000023802375,0.000056104378,0.00030871408,4.600772e-8,0.000016713504,0.9935887,0.00012426957],"about_ca_topic_score_codex":0.000060400325,"about_ca_topic_score_gemma":0.000004295154,"teacher_disagreement_score":0.8372671,"about_ca_system_score_codex":0.00016026212,"about_ca_system_score_gemma":0.00031032288,"threshold_uncertainty_score":0.60303265},"labels":[],"label_agreement":null},{"id":"W1979643646","doi":"10.1185/030079906x148364","title":"Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia","year":2006,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"American Heart Association","keywords":"Rosuvastatin; Ezetimibe; Medicine; Simvastatin; Statin; Atorvastatin; Combination therapy; Pharmacology; Ldl cholesterol; Fixed-dose combination; Cholesterol; Internal medicine; Urology","score_opus":0.07781500923638612,"score_gpt":0.3735728337994214,"score_spread":0.2957578245630353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979643646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5131946,0.021584503,0.0005929579,0.44784656,0.004625769,0.008298183,0.00051648705,0.00019787367,0.0031430288],"genre_scores_gemma":[0.33914417,0.040220503,0.0054482017,0.32597518,0.115641534,0.005451042,0.15926737,0.0028007682,0.0060512363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99158275,0.0005524963,0.0005473409,0.0008280759,0.0052628024,0.0012265042],"domain_scores_gemma":[0.99778676,0.00045923598,0.00009188073,0.0006013541,0.00043409286,0.00062669715],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019497179,0.000363717,0.00079487235,0.00051499985,0.00012954058,0.00008518644,0.00022661843,0.0006904387,0.00017142676],"category_scores_gemma":[0.000789655,0.00026318713,0.00011152005,0.0005325854,0.00046903288,0.00009022449,0.0001934735,0.0056187683,0.000040354113],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009899271,0.0006898019,0.011921223,0.002357678,0.0000667219,0.0002410796,0.000054350672,4.107721e-7,7.485539e-7,0.0000069341,0.6905048,0.2931663],"study_design_scores_gemma":[0.013264606,0.0035450999,0.043005325,0.004586679,0.00002598532,0.00001007095,0.000021376021,0.000032614083,0.0000062113563,0.00004188109,0.93515474,0.00030539566],"about_ca_topic_score_codex":0.00041305512,"about_ca_topic_score_gemma":0.00006183085,"teacher_disagreement_score":0.29286093,"about_ca_system_score_codex":0.00038238685,"about_ca_system_score_gemma":0.0010034499,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W1979744384","doi":"10.1007/s11606-008-0825-4","title":"Discussing Coronary Risk with Patients to Improve Blood Pressure Treatment: Secondary Results from the CHECK-UP Study","year":2008,"lang":"en","type":"article","venue":"Journal of General Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); McGill University; McGill University Health Centre","funders":"Pfizer Canada; Sanofi; AstraZeneca; Pfizer","keywords":"Medicine; Blood pressure; Intensive care medicine; Emergency medicine; Internal medicine","score_opus":0.015662651679086273,"score_gpt":0.26406860732251114,"score_spread":0.24840595564342488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979744384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918798,0.003112872,0.00011036521,0.0022765668,0.0010578692,0.0008908763,0.0000974214,0.000011217212,0.000562967],"genre_scores_gemma":[0.9894943,0.0005165516,0.00048957247,0.0008289697,0.0047250767,0.000011566054,0.000018948624,0.00003680762,0.0038781748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971102,0.00024575487,0.0009163175,0.00031355143,0.0011314205,0.00028273978],"domain_scores_gemma":[0.9978277,0.00010186589,0.0006485485,0.00056726334,0.00041620928,0.00043838855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006830938,0.00028784745,0.0008429416,0.000108028136,0.00019728013,0.000015322481,0.0002325775,0.000064415144,0.00007677034],"category_scores_gemma":[0.0002779293,0.00011714132,0.00024405311,0.00015539918,0.000120180324,0.00012200754,0.00005858873,0.00062844955,0.000004342897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02883528,0.0033924235,0.730676,0.000051169463,0.016003273,0.004585175,0.02656724,0.00009971785,0.002437202,0.0000018022599,0.017786901,0.16956383],"study_design_scores_gemma":[0.037887182,0.036402296,0.9036015,0.0006590746,0.004420948,0.0016082551,0.0013447306,0.000034032775,0.0014551936,0.000008353024,0.0124183325,0.00016006346],"about_ca_topic_score_codex":0.0070269327,"about_ca_topic_score_gemma":0.00023819914,"teacher_disagreement_score":0.17292555,"about_ca_system_score_codex":0.000094434945,"about_ca_system_score_gemma":0.00028272308,"threshold_uncertainty_score":0.9995854},"labels":[],"label_agreement":null},{"id":"W1980022077","doi":"10.1136/bmj.d3400","title":"Trial of niacin alongside statin is stopped early","year":2011,"lang":"en","type":"article","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Niacin; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medicine; Computer science; Bioinformatics; Internal medicine; Biology","score_opus":0.054235130344225314,"score_gpt":0.3140408285385132,"score_spread":0.25980569819428784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980022077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98160285,0.00013938441,0.00024115163,0.00051218225,0.00018914421,0.0011581794,0.000009053444,0.000025717978,0.016122349],"genre_scores_gemma":[0.99415207,0.000018508714,0.0034294254,0.0004018696,0.00045762653,0.000046265966,0.0000038869375,0.000016151478,0.0014741817],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989962,0.000060073184,0.00029439564,0.00013882258,0.00035129272,0.00015922275],"domain_scores_gemma":[0.99924713,0.000011545422,0.00009151292,0.00047104486,0.00007410346,0.0001046526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064551545,0.00007456295,0.00031418016,0.000046003355,0.000019387835,0.0000025953084,0.000047917252,0.00006186929,0.00035988798],"category_scores_gemma":[0.0000896919,0.000058863163,0.00019849095,0.00008872801,0.000029321602,0.000030230014,0.000018447561,0.000092662536,0.00006855324],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16276807,0.0030239332,0.0319108,0.001834124,0.0029835773,0.0014833926,0.035479948,8.475328e-7,0.0058889715,0.0036652435,0.10348292,0.64747816],"study_design_scores_gemma":[0.27361423,0.011834727,0.56152946,0.00048672876,0.00092884566,0.00032349446,0.0012744899,0.000039079874,0.08729333,0.0013619786,0.060622007,0.00069162477],"about_ca_topic_score_codex":0.002407426,"about_ca_topic_score_gemma":0.000022297369,"teacher_disagreement_score":0.6467866,"about_ca_system_score_codex":0.000016568525,"about_ca_system_score_gemma":0.00015219113,"threshold_uncertainty_score":0.39405212},"labels":[],"label_agreement":null},{"id":"W1980307116","doi":"10.1111/j.1582-4934.2005.tb00382.x","title":"Pharmacological basis of different targets for the treatment of atherosclerosis","year":2005,"lang":"en","type":"review","venue":"Journal of Cellular and Molecular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Inflammation; Medicine; Nitric oxide; Blockade; Platelet; Coronary atherosclerosis; Oxidative stress; Platelet activation; Drug; Pharmacology; Immunology; Internal medicine; Coronary artery disease; Receptor","score_opus":0.055041097171059386,"score_gpt":0.34734140354532117,"score_spread":0.2923003063742618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980307116","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012815746,0.99126554,0.005099281,0.00047750346,0.00026327893,0.0015540121,0.000016211769,0.0000029780601,0.000039636143],"genre_scores_gemma":[0.005219728,0.9931697,0.00033892036,0.0001003002,0.0010122895,0.00004518906,0.000017072887,0.00004017057,0.00005659269],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974602,0.00018462318,0.0012937366,0.000193135,0.0006478111,0.00022051221],"domain_scores_gemma":[0.9978532,0.00023357556,0.0010775262,0.000336356,0.00026419046,0.00023514229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007716113,0.00036312183,0.0034788947,0.0001845101,0.000043530974,0.000003237029,0.00014570518,0.00021431188,0.00007167773],"category_scores_gemma":[0.000082387174,0.00015289434,0.0019642126,0.00013464974,0.00020229493,0.000014279127,0.000019349904,0.00023596626,2.2738611e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012744112,0.00055754435,0.0000043228656,0.0063793934,0.0038698642,0.000051372615,0.00014236361,7.1109696e-7,0.0044014435,0.000038850398,0.00014015412,0.98428655],"study_design_scores_gemma":[0.004639339,0.0069625108,0.000035022294,0.0067891027,0.026825504,0.00027902052,0.00005531494,0.00001128,0.0064574517,0.000012539864,0.94780374,0.0001291968],"about_ca_topic_score_codex":0.000012800999,"about_ca_topic_score_gemma":5.4896924e-7,"teacher_disagreement_score":0.9841573,"about_ca_system_score_codex":0.000104076375,"about_ca_system_score_gemma":0.000195867,"threshold_uncertainty_score":0.623485},"labels":[],"label_agreement":null},{"id":"W1980311708","doi":"10.1177/0091270009334376","title":"Statin Effects on LDL and HDL Cholesterol in South Asian and White Populations","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; William Osler Health System; Canadian Respiratory Research Network; St. Michael's Hospital","funders":"","keywords":"Statin; Ldl cholesterol; Medicine; Cholesterol; White (mutation); Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Atorvastatin; Pharmacology; Endocrinology; Biology; Biochemistry","score_opus":0.05706845570309015,"score_gpt":0.43436605115318583,"score_spread":0.37729759545009567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980311708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97961646,0.00048618802,0.000095893505,0.018897468,0.0003699483,0.00030599546,9.3777396e-7,0.000004203542,0.0002228714],"genre_scores_gemma":[0.98815125,0.0004442955,0.00023184321,0.010171901,0.0009619245,0.0000011656816,4.2896608e-7,0.0000062654653,0.00003091074],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982481,0.0007099788,0.00062124734,0.000091933536,0.00017893233,0.00014982489],"domain_scores_gemma":[0.9991169,0.000284226,0.0002463293,0.00010363839,0.000047698242,0.00020119385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027512435,0.00008213447,0.0004928025,0.0000812872,0.000044211523,0.0000056977615,0.000054478427,0.00008255591,0.000015069906],"category_scores_gemma":[0.00023009827,0.0000482762,0.00010016721,0.00007584059,0.000068134876,0.00003982792,0.00001504007,0.0007121319,0.0000023499178],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053394674,0.00070520904,0.15793002,0.0001492191,0.00035785933,0.00035951502,0.0025428508,0.00010597605,0.0011634899,0.00006990406,0.003361477,0.827915],"study_design_scores_gemma":[0.007358492,0.0028617089,0.9874649,0.00008594663,0.00029419377,0.00023661395,0.00007863453,0.00008591937,0.00009974348,0.000388802,0.0009994864,0.000045542478],"about_ca_topic_score_codex":0.000005440769,"about_ca_topic_score_gemma":0.0000061271326,"teacher_disagreement_score":0.8295349,"about_ca_system_score_codex":0.0000151634395,"about_ca_system_score_gemma":0.000066701345,"threshold_uncertainty_score":0.30938983},"labels":[],"label_agreement":null},{"id":"W1980426514","doi":"10.1016/s0021-9150(00)80348-2","title":"Replacement of usual lipid lowering treatment by atorvastatin: Effect on plasma lipid levels","year":2000,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Atorvastatin; Plasma levels; Chemistry; Internal medicine; Medicine","score_opus":0.02221127139796813,"score_gpt":0.2679634557569221,"score_spread":0.24575218435895396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980426514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601275,0.00014804077,0.000041261548,0.0001924975,0.00016036314,0.0009543194,0.00007404738,0.000080036196,0.0023366914],"genre_scores_gemma":[0.9965541,0.00043339015,0.00019968949,0.0003023785,0.00030341404,0.00015665827,0.000026353746,0.00006343847,0.0019606287],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980335,0.00011203562,0.00041268373,0.0004620891,0.00057612313,0.0004035615],"domain_scores_gemma":[0.9987716,0.00008814971,0.000098573015,0.0007843412,0.000035318164,0.00022203256],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045007275,0.0003073701,0.00070972904,0.000052685697,0.00010172197,0.000016374031,0.00008432342,0.000117492214,0.0010609952],"category_scores_gemma":[0.000023967248,0.0002321746,0.00042180865,0.00016630146,0.000054976674,0.000049243194,0.000017860093,0.00012626729,0.00016832752],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021050626,0.0015445938,0.015164949,0.0003934558,0.0011857296,0.000006776682,0.001299247,0.00007497463,0.105759025,0.000020876623,0.0034839744,0.86896133],"study_design_scores_gemma":[0.014424839,0.026771614,0.0426552,0.0009055179,0.00048452083,0.000024603805,0.000096012685,0.00011943393,0.82812065,0.0000022701458,0.08589262,0.0005027384],"about_ca_topic_score_codex":0.00045453318,"about_ca_topic_score_gemma":0.000009178164,"teacher_disagreement_score":0.8684586,"about_ca_system_score_codex":0.0002852494,"about_ca_system_score_gemma":0.00006649452,"threshold_uncertainty_score":0.9998522},"labels":[],"label_agreement":null},{"id":"W1980467489","doi":"10.1194/jlr.d008888","title":"Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?","year":2010,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Secretion; Apolipoprotein B; Very low-density lipoprotein; Microsomal triglyceride transfer protein; Lipoprotein; Cell culture; Chemistry; Cell biology; Biochemistry; Endocrinology; Biology; Cholesterol","score_opus":0.10869899024855181,"score_gpt":0.4089490566576766,"score_spread":0.30025006640912477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980467489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766685,0.00032289326,0.0013343003,0.01951283,0.00024992102,0.0014193064,0.0000074152094,0.000009649422,0.00047520918],"genre_scores_gemma":[0.98883957,0.00023907155,0.0036081206,0.0007341722,0.004738821,0.00007085643,0.0000015626538,0.00004819743,0.0017196196],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965741,0.0002608628,0.00057213084,0.0002558084,0.0017634603,0.0005736268],"domain_scores_gemma":[0.996854,0.00026293896,0.00018455197,0.00060769846,0.0017205299,0.00037027991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010064805,0.00015944101,0.00049014913,0.00029895487,0.0007131078,0.00014880579,0.0003131956,0.0001832333,0.0000953639],"category_scores_gemma":[0.00042505361,0.00008557865,0.0002785199,0.0003618021,0.00015062006,0.0001580169,0.00012968849,0.0020476412,0.0000062621707],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031575558,0.0011675452,0.006254202,0.0025588048,0.0020145548,0.00016167042,0.009036806,0.000076884986,0.8311676,0.001009272,0.06400158,0.07939356],"study_design_scores_gemma":[0.05365166,0.02554757,0.07520164,0.003799923,0.0021536849,0.007534009,0.0144078825,0.10570029,0.2553802,0.0112807285,0.44294286,0.0023995503],"about_ca_topic_score_codex":0.00013332088,"about_ca_topic_score_gemma":0.0001526184,"teacher_disagreement_score":0.57578737,"about_ca_system_score_codex":0.000081800106,"about_ca_system_score_gemma":0.0007327479,"threshold_uncertainty_score":0.88960963},"labels":[],"label_agreement":null},{"id":"W1980504238","doi":"10.1038/nrendo.2014.90","title":"Progress in reducing vascular complications of diabetes","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Diabetes mellitus; Intensive care medicine; Endocrinology","score_opus":0.035090839331891555,"score_gpt":0.37020957726691384,"score_spread":0.3351187379350223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980504238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017373788,0.9941932,0.000013743399,0.00017284771,0.00025635064,0.004419118,0.000015132169,0.00004112543,0.00087113923],"genre_scores_gemma":[0.00006188116,0.99621755,0.001506673,0.00020206576,0.00038767475,0.0012826173,0.00024585394,0.0000681628,0.000027545077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957668,0.00094630726,0.001623528,0.00072086893,0.0003138602,0.0006286123],"domain_scores_gemma":[0.9969316,0.00012409323,0.00076474855,0.0019106544,0.00013425617,0.00013460792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010519825,0.0005008466,0.006815852,0.00053292274,0.000039953757,0.0000062849426,0.00036704348,0.00089988613,0.000023915602],"category_scores_gemma":[0.00038486265,0.00034938942,0.0021083925,0.0007731016,0.00017016915,0.000026375486,0.00012624318,0.0022354466,0.00005316274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[7.5888545e-7,0.00008421649,0.00014832884,0.10208277,0.00027914502,0.00000894556,0.0000068422155,3.8424147e-8,1.6280313e-7,0.0008692374,0.0003219919,0.89619756],"study_design_scores_gemma":[0.00037297574,0.000091398324,0.0004364756,0.04320001,0.0016034907,0.00016706124,0.0000011719155,0.0000011546158,0.0000017605914,0.000017381079,0.95388097,0.00022614175],"about_ca_topic_score_codex":0.000013434918,"about_ca_topic_score_gemma":0.0000044006124,"teacher_disagreement_score":0.953559,"about_ca_system_score_codex":0.00016875073,"about_ca_system_score_gemma":0.0003297143,"threshold_uncertainty_score":0.9998958},"labels":[],"label_agreement":null},{"id":"W1980743246","doi":"10.1016/j.cjca.2011.09.014","title":"Perceptions of Canadian Primary Care Physicians Towards Cardiovascular Risk Assessment and Lipid Management","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; William Osler Health System; Canadian Respiratory Research Network; St. Michael's Hospital","funders":"AstraZeneca","keywords":"Medicine; Primary care; Risk assessment; Family medicine; Risk management; Intensive care medicine; Management","score_opus":0.012857122912171145,"score_gpt":0.24720386852633944,"score_spread":0.2343467456141683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980743246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8228868,0.043083053,0.006560256,0.00092984113,0.0020228794,0.0010566215,0.00029147507,0.0000127275,0.12315635],"genre_scores_gemma":[0.9912428,0.0043921755,0.0017960859,0.00027450288,0.0021751432,0.000011636845,0.000041124822,0.000029371899,0.00003712568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981045,0.00030151667,0.000420429,0.00017562465,0.00035026215,0.0006476733],"domain_scores_gemma":[0.9973734,0.000013279105,0.00015114422,0.0005344369,0.00040670898,0.0015210462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011555576,0.00018570166,0.0010576535,0.0010077948,0.00018274921,0.000013049089,0.00013091769,0.00016797334,0.000021645892],"category_scores_gemma":[0.000026212436,0.00016886847,0.00095853495,0.0003227152,0.00018952736,0.000113032795,0.000020113723,0.00043650795,0.0000031869213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027887798,0.000009954072,0.5025367,0.00072878733,0.007388043,0.00039451857,0.0018658682,0.0007547671,0.000058013225,0.00046041768,0.0031032532,0.48267177],"study_design_scores_gemma":[0.00075821264,0.0001789952,0.68906343,0.000095421536,0.0014383445,0.0007143158,0.002173221,0.0000012435191,0.00000901041,0.00001027833,0.30544508,0.00011244117],"about_ca_topic_score_codex":0.12162661,"about_ca_topic_score_gemma":0.04569228,"teacher_disagreement_score":0.48255932,"about_ca_system_score_codex":0.0010235128,"about_ca_system_score_gemma":0.0025679357,"threshold_uncertainty_score":0.97172135},"labels":[],"label_agreement":null},{"id":"W1980777417","doi":"10.1016/j.spinee.2005.10.017","title":"The use of simvastatin in rabbit posterolateral lumbar intertransverse process spine fusion","year":2006,"lang":"en","type":"article","venue":"The Spine Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"Merck","keywords":"Medicine; Palpation; Spinal fusion; Simvastatin; Lumbar; Radiography; Iliac crest; Nuclear medicine; Radiology; Surgery; Internal medicine","score_opus":0.018602476987592223,"score_gpt":0.26962816880131024,"score_spread":0.25102569181371803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980777417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936306,0.0009716703,0.0010479541,0.003598057,0.00016864826,0.00041491553,0.000002013189,0.00001001595,0.00015614551],"genre_scores_gemma":[0.9975162,0.000533662,0.00041710015,0.0003137391,0.0004972331,0.0000058907344,0.0000040617165,0.000019781195,0.00069229177],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99845636,0.00014389082,0.00053543644,0.00010843356,0.0004718369,0.00028405825],"domain_scores_gemma":[0.99927336,0.000006478426,0.00017808862,0.00030610024,0.00016102062,0.000074950956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010471551,0.00012818316,0.00029447107,0.00007919646,0.00016359559,0.00004740906,0.00014423426,0.000048099188,0.00004551964],"category_scores_gemma":[0.00007507483,0.000061366016,0.00021978999,0.00020567907,0.0000802416,0.00012592088,0.000028435996,0.00049737404,0.000003996887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019126453,0.0023569525,0.013779595,0.0018113601,0.0012103246,0.0017226414,0.0067047044,0.0116263935,0.3896161,0.00074971485,0.007802476,0.5607071],"study_design_scores_gemma":[0.008070284,0.0014361155,0.9619446,0.0012372235,0.00024509715,0.0026776774,0.0004450142,0.0027981848,0.008279309,0.0004549914,0.012167587,0.00024391976],"about_ca_topic_score_codex":0.00041839093,"about_ca_topic_score_gemma":0.00021555425,"teacher_disagreement_score":0.948165,"about_ca_system_score_codex":0.00005712748,"about_ca_system_score_gemma":0.000117289164,"threshold_uncertainty_score":0.25024334},"labels":[],"label_agreement":null},{"id":"W1981220884","doi":"10.2147/dddt.s34976","title":"Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib","year":2012,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Cholesterylester transfer protein; Dyslipidemia; Medicine; Cholesterol; Pharmacology; Lipoprotein; Bioinformatics; Internal medicine; Disease; Biology","score_opus":0.09489177903714113,"score_gpt":0.3135815514196455,"score_spread":0.21868977238250437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981220884","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036528826,0.98363423,0.004677007,0.00016994287,0.00030535983,0.010585745,0.000009799307,0.000089964306,0.0001626702],"genre_scores_gemma":[0.00028863002,0.9884125,0.004203196,0.00030902828,0.0012462912,0.0038499078,0.00011806632,0.00019438256,0.0013779731],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968942,0.00029502832,0.00088724017,0.00069448224,0.0005358881,0.00069318095],"domain_scores_gemma":[0.99876016,0.00013431661,0.00013668403,0.00052843615,0.00007370159,0.00036669805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021235764,0.0007879022,0.002264749,0.0003144383,0.00020578966,0.00005980023,0.00014848985,0.00053307484,0.000030292],"category_scores_gemma":[0.000012205533,0.00052402524,0.0007352885,0.00022765723,0.000054340315,0.00009711752,0.000018493227,0.00055137073,0.00004044919],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001678596,0.00015791805,0.0000035336557,0.007169389,0.00081943447,0.00000845012,0.00048128518,2.844087e-8,0.0000069798725,0.000092308226,0.00024488143,0.99084795],"study_design_scores_gemma":[0.0025248288,0.00025120593,0.000013413446,0.008517007,0.00043914642,0.000040234696,0.000013754971,2.9358992e-7,0.0016938719,0.000045965433,0.9858505,0.00060977624],"about_ca_topic_score_codex":0.000004643248,"about_ca_topic_score_gemma":0.0000014061005,"teacher_disagreement_score":0.99023813,"about_ca_system_score_codex":0.00017300251,"about_ca_system_score_gemma":0.0007581651,"threshold_uncertainty_score":0.9997211},"labels":[],"label_agreement":null},{"id":"W1981305314","doi":"10.1016/s1567-5688(00)00004-0","title":"Mechanisms of acute coronary syndromes and the potential role of statins","year":2001,"lang":"en","type":"review","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Thrombus; Medicine; Fibrous cap; Pathogenesis; Inflammation; Acute coronary syndrome; Cardiology; Internal medicine; Platelet; Thrombosis; Cholesterol; Myocardial infarction","score_opus":0.02722466437500633,"score_gpt":0.3009512421395457,"score_spread":0.2737265777645394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981305314","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015990282,0.99370027,0.00036794247,0.000044661876,0.000119734126,0.0029142036,0.0011556501,0.000017477207,0.000081055325],"genre_scores_gemma":[0.008104569,0.9899885,0.000982357,0.000048997725,0.0000426369,0.0002222717,0.00039317194,0.000076948054,0.00014053646],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99726045,0.00028390653,0.0009672987,0.00037881717,0.00076863717,0.00034086496],"domain_scores_gemma":[0.9983034,0.000056406894,0.0006107382,0.000816679,0.00009183755,0.00012093032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074963894,0.00038136847,0.0025824946,0.00010801807,0.00008588474,0.000012302822,0.00023694264,0.00020193681,0.00038468404],"category_scores_gemma":[0.0000135019345,0.00022860769,0.0010363548,0.00024747726,0.00020322742,0.000044725177,0.0002097488,0.00024783073,0.000006902937],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111992755,0.0002682356,0.000099603094,0.009926974,0.007031093,0.000013651427,0.00017914087,1.4350204e-7,0.00017717392,0.0010457342,0.00018320607,0.98096305],"study_design_scores_gemma":[0.02351379,0.0029106897,0.004130793,0.032530762,0.056766056,0.0015603892,0.0010684527,0.000032184806,0.0004905479,0.002725056,0.8730802,0.0011910943],"about_ca_topic_score_codex":0.00050048967,"about_ca_topic_score_gemma":0.000006882475,"teacher_disagreement_score":0.979772,"about_ca_system_score_codex":0.000056267058,"about_ca_system_score_gemma":0.00020659195,"threshold_uncertainty_score":0.9322351},"labels":[],"label_agreement":null},{"id":"W1981367722","doi":"10.1016/s0021-9150(00)00640-7","title":"A novel TC deletion resulting in Pro260→Stop in the human LCAT gene is associated with a dominant effect on HDL-cholesterol","year":2001,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Proband; Biology; Apolipoprotein B; Sterol O-acyltransferase; Genetics; Molecular biology; Allele; Cholesterol; Stop codon; Mutation; Gene; Lipoprotein; Biochemistry","score_opus":0.030227474615664947,"score_gpt":0.27515403545363043,"score_spread":0.2449265608379655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981367722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967006,0.00007517462,0.00008344358,0.000952994,0.000030526906,0.0018102853,0.0000075734497,0.000033310564,0.00030610923],"genre_scores_gemma":[0.9974585,0.00006304133,0.00008433223,0.0017143652,0.00010943299,0.00039914646,0.00002343055,0.000047666137,0.000100049685],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99777335,0.00029942574,0.00037678008,0.0004480979,0.00063280016,0.00046956263],"domain_scores_gemma":[0.9989903,0.00010698735,0.00014459669,0.00062854326,0.00005386808,0.000075710064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023568503,0.00024776513,0.0005045882,0.00014165687,0.00015135959,0.000041126063,0.00014381223,0.00016501154,0.000008115402],"category_scores_gemma":[0.00015052703,0.00015053293,0.0001656026,0.00060277345,0.000050245362,0.00006695622,0.000025828587,0.00044423423,0.000011643125],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014440713,0.003104465,0.40681416,0.00024478827,0.0003924892,0.00020091332,0.0141324,0.00009436896,0.5197481,0.000047517264,0.00016664466,0.05361009],"study_design_scores_gemma":[0.011986573,0.0021043797,0.9686012,0.0015827247,0.00011039748,0.000080963255,0.00022543348,0.00019489988,0.014627604,0.000006072234,0.00025563405,0.00022407413],"about_ca_topic_score_codex":0.0031820196,"about_ca_topic_score_gemma":0.0011951829,"teacher_disagreement_score":0.5617871,"about_ca_system_score_codex":0.00031717189,"about_ca_system_score_gemma":0.000045445537,"threshold_uncertainty_score":0.6138554},"labels":[],"label_agreement":null},{"id":"W1981455226","doi":"10.1139/cjpp-2014-0478","title":"Niacin as antidyslipidemic drug","year":2015,"lang":"en","type":"review","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Niacin; Statin; Medicine; Triglyceride; Internal medicine; Cholesterol; Lipoprotein; Endocrinology; Drug; Pharmacology","score_opus":0.04102402340731116,"score_gpt":0.3639853214094562,"score_spread":0.32296129800214507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981455226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025433348,0.9939325,6.789994e-7,0.00035743802,0.002162474,0.00046617747,0.000029372644,0.0000069491607,0.0005010933],"genre_scores_gemma":[0.0010282524,0.9941054,0.000042038948,0.0013607967,0.0030258757,0.000011616792,0.00002928193,0.000036824233,0.0003598928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978291,0.0006467861,0.0006860002,0.0002501152,0.00011861212,0.00046938122],"domain_scores_gemma":[0.99739337,0.0000948614,0.00049474114,0.00020040326,0.00026153817,0.0015550632],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011477461,0.00030693144,0.0028075778,0.0004752846,0.0001039819,0.0000058318165,0.0001857821,0.0004462224,0.001056996],"category_scores_gemma":[0.000060009545,0.00022547526,0.0006339864,0.00018515228,0.00028738103,0.00004779601,0.000022584789,0.0012956457,0.000072333176],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092374576,0.000041029445,0.000027291071,0.020714158,0.0029891431,0.0020484924,0.00021348133,0.0000011446218,0.0002303198,0.00009810416,0.1644599,0.8090846],"study_design_scores_gemma":[0.00090044504,0.00033822606,0.000018756087,0.001282201,0.0029405435,0.007704356,0.000016725406,7.6398493e-7,0.000032307496,0.000249099,0.9863465,0.00017007244],"about_ca_topic_score_codex":0.0012873175,"about_ca_topic_score_gemma":0.00029464948,"teacher_disagreement_score":0.8218866,"about_ca_system_score_codex":0.00022022141,"about_ca_system_score_gemma":0.010613491,"threshold_uncertainty_score":0.9998562},"labels":[],"label_agreement":null},{"id":"W1981655248","doi":"10.1016/j.amjcard.2010.09.006","title":"Impact of Smoking on Cardiovascular Events in Patients With Coronary Disease Receiving Contemporary Medical Therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] Trials)","year":2010,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Myocardial infarction; Atorvastatin; Cardiology; Confidence interval; Simvastatin","score_opus":0.019082931751570404,"score_gpt":0.2993462072579819,"score_spread":0.2802632755064115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981655248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928362,0.004323413,0.00019785448,0.0013341808,0.00018551707,0.0010646356,0.000016923848,0.0000044253557,0.000036898313],"genre_scores_gemma":[0.9972944,0.00096549356,0.00010806197,0.0007450753,0.00082856143,0.000019983137,0.0000079107085,0.000029952113,5.566551e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948859,0.0026657586,0.00086580886,0.0002577236,0.0010063839,0.00031837678],"domain_scores_gemma":[0.99635375,0.0015347829,0.0009700065,0.0006376679,0.00012121649,0.0003825846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006749774,0.00025789507,0.001948562,0.000108932676,0.000092048336,0.000009332961,0.0003267887,0.00006133464,0.000017478007],"category_scores_gemma":[0.003406544,0.00010611116,0.0008779932,0.00027956374,0.00048004443,0.000088312314,0.000101791215,0.0008733766,3.2180535e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025767587,0.00007104831,0.8733627,0.000005640424,0.0029517263,0.00026483188,0.0014379893,0.0002953161,0.000039827803,0.0000030995361,0.000047502417,0.095752686],"study_design_scores_gemma":[0.015088831,0.0018878041,0.9810677,0.00058478606,0.00027711072,0.0002540918,0.0005110259,0.0000092344735,0.000027776257,0.00009833157,0.0000835504,0.00010971343],"about_ca_topic_score_codex":0.0067366045,"about_ca_topic_score_gemma":0.00006149295,"teacher_disagreement_score":0.107705005,"about_ca_system_score_codex":0.00012673323,"about_ca_system_score_gemma":0.0009219644,"threshold_uncertainty_score":0.99987763},"labels":[],"label_agreement":null},{"id":"W1981718233","doi":"10.1016/s0749-3797(03)00204-6","title":"Patients' achievement of cholesterol targets","year":2003,"lang":"en","type":"article","venue":"American Journal of Preventive Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Cholesterol; Lipid profile; Psychological intervention; HMG-CoA reductase; Lower risk; Disease; Reductase; Confidence interval; Biology","score_opus":0.007937679400072246,"score_gpt":0.2675864967537913,"score_spread":0.2596488173537191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981718233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885161,0.0015487535,0.0066722366,0.0008936421,0.0003037448,0.0003840795,0.0000026474142,0.0000046171594,0.0016741902],"genre_scores_gemma":[0.99679565,0.00030627055,0.0019536624,0.00053583755,0.00023521032,0.000003584317,0.0000033239835,0.000017668914,0.00014879444],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99774665,0.0002997644,0.0007642432,0.00013287367,0.0008469381,0.00020953112],"domain_scores_gemma":[0.9979357,0.00004423648,0.0009012594,0.00027616852,0.00058391213,0.0002587235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014408266,0.0001447335,0.00091434334,0.00019410726,0.000028208598,0.0000016480919,0.00009458479,0.000023544586,0.0001586395],"category_scores_gemma":[0.00040519284,0.00009400031,0.00029436857,0.0003057352,0.0003333962,0.00006089225,0.000015165196,0.00024874602,0.0000029198109],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093539525,0.0023615975,0.3864422,0.0004193908,0.0027360518,0.00010849614,0.00304247,0.000009429468,0.004619673,0.00062348216,0.002388611,0.5963132],"study_design_scores_gemma":[0.0147967,0.025390116,0.89319783,0.0017118825,0.0012407161,0.00034891616,0.0032089052,0.0000022021068,0.009881276,0.00028204048,0.049715415,0.00022397438],"about_ca_topic_score_codex":0.000065571476,"about_ca_topic_score_gemma":0.0000016389954,"teacher_disagreement_score":0.59608924,"about_ca_system_score_codex":0.00008283191,"about_ca_system_score_gemma":0.00015711422,"threshold_uncertainty_score":0.38332212},"labels":[],"label_agreement":null},{"id":"W1981819062","doi":"10.1016/j.jacl.2010.05.001","title":"Complete Apo AI Deficiency in an Iraqi Mandaean Family: Case studies and review of the literature","year":2010,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital; St. Paul's Hospital","funders":"","keywords":"Medicine; Internal medicine; Apolipoprotein B; Nonsense mutation; Nonsense; Genotype; Pediatrics; Endocrinology; Phenotype; Cholesterol; Missense mutation; Gene; Genetics","score_opus":0.19020067112110933,"score_gpt":0.49957950437791115,"score_spread":0.3093788332568018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981819062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001718343,0.99305654,0.0000036015556,0.0010584663,0.0031665016,0.0008966364,0.000024673674,0.000003218746,0.000072035444],"genre_scores_gemma":[0.00011121084,0.99194324,0.0004966222,0.0034178316,0.0039637806,0.000008625928,0.00000652125,0.000026568268,0.000025577336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922843,0.0027243341,0.0039538904,0.00032896863,0.00044357625,0.00026492117],"domain_scores_gemma":[0.99479717,0.0010655161,0.0023477713,0.00084577326,0.0006900495,0.00025373517],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010121851,0.00032498714,0.00696808,0.00018299936,0.000058469755,0.000010754171,0.00030333802,0.000729081,0.000010644426],"category_scores_gemma":[0.004332123,0.00015398001,0.0020647093,0.00040435372,0.00046677035,0.000068913454,0.00016635677,0.00407902,0.0000015788478],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044618864,0.00016363652,0.00020187593,0.12840272,0.0002860275,0.00082058494,0.00005779313,2.3029699e-8,3.2660907e-7,0.00010774557,0.00086656114,0.86904806],"study_design_scores_gemma":[0.0008997055,0.0011528238,0.00034209978,0.15916736,0.0022202604,0.03824102,0.000027897231,3.0266523e-7,2.576245e-8,0.00014865458,0.79768574,0.000114076625],"about_ca_topic_score_codex":0.0000057940097,"about_ca_topic_score_gemma":0.00003520145,"teacher_disagreement_score":0.868934,"about_ca_system_score_codex":0.00003990016,"about_ca_system_score_gemma":0.0009229872,"threshold_uncertainty_score":0.9982186},"labels":[],"label_agreement":null},{"id":"W1982020498","doi":"10.1016/j.atherosclerosissup.2008.09.410","title":"Effect of fatty acids on enterocytic beta-amyloid abundance: Possible aetiology in Alzheimer’s disease","year":2008,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada","keywords":"Cholesterol; HMG-CoA reductase; Disease; Stroke (engine); Incidence (geometry); Etiology; Medicine; Reductase; Clinical trial; Internal medicine; Pharmacology; Enzyme; Endocrinology; Biochemistry; Chemistry","score_opus":0.0333379303454366,"score_gpt":0.30272140585041957,"score_spread":0.269383475504983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982020498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968983,0.00080561737,0.000048516406,0.0002360099,0.0001804772,0.0014774151,0.00012385132,0.000037625505,0.00019220271],"genre_scores_gemma":[0.99797803,0.00073531474,0.00015789604,0.00046730693,0.000108889035,0.000273746,0.00014651293,0.000047807815,0.00008449168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974227,0.0003294917,0.0005641554,0.0004984775,0.0006415162,0.00054364896],"domain_scores_gemma":[0.9986311,0.00007406799,0.00013891124,0.0008144733,0.00005347699,0.0002879281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065211434,0.0003032193,0.000820339,0.00017090763,0.00011261647,0.0000069942835,0.00017711533,0.000111776426,0.0004540508],"category_scores_gemma":[0.000049711853,0.00024085422,0.00042695933,0.00025643804,0.00014142312,0.000077001285,0.00007498647,0.00023609672,0.00008195594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011075841,0.00055759004,0.986614,0.00022493325,0.0003898689,0.000036335732,0.00023911246,0.00002070698,0.0058165407,0.000029587403,0.00046738592,0.004496394],"study_design_scores_gemma":[0.00916586,0.0031826687,0.92124355,0.00029011033,0.00036287968,0.000015616077,0.000021102835,0.000038720766,0.06391151,0.000010178787,0.0015491935,0.00020861534],"about_ca_topic_score_codex":0.00037553252,"about_ca_topic_score_gemma":0.000022230153,"teacher_disagreement_score":0.06537042,"about_ca_system_score_codex":0.00015991577,"about_ca_system_score_gemma":0.000121802645,"threshold_uncertainty_score":0.982175},"labels":[],"label_agreement":null},{"id":"W1982107006","doi":"10.1016/j.amjmed.2009.01.032","title":"Effect of Statin Adherence on Cerebrovascular Disease in Primary Prevention","year":2009,"lang":"en","type":"article","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Primary prevention; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Secondary prevention; Disease; Atherosclerotic cardiovascular disease; Intensive care medicine; Internal medicine; Cardiology; Physical therapy","score_opus":0.008437234890812597,"score_gpt":0.2999986992312377,"score_spread":0.29156146434042507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982107006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99277747,0.0017739355,0.0003666832,0.0043352824,0.00006458085,0.00038751616,6.843275e-7,0.0000046971318,0.00028915016],"genre_scores_gemma":[0.9976104,0.0007183221,0.00014600763,0.0011245267,0.00035215478,0.0000029120768,0.000002219855,0.000008801798,0.000034680044],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977571,0.00060201174,0.0005193666,0.00010376804,0.0008586251,0.00015912407],"domain_scores_gemma":[0.9986191,0.00015750251,0.00055361784,0.00038265306,0.00009794819,0.00018917612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033679283,0.000120571414,0.00083219016,0.00016149208,0.000020570156,0.0000017082288,0.00013383913,0.000014175739,0.00002970107],"category_scores_gemma":[0.00040176115,0.00005912612,0.0002576575,0.00037201933,0.00024262155,0.000035537858,0.000008553379,0.0003243618,0.0000018998229],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064244187,0.00022356646,0.008275381,0.00022577435,0.0001739597,0.00014615855,0.00034269565,0.0001032534,0.0019477105,0.000035465455,0.00025708598,0.98184454],"study_design_scores_gemma":[0.010180517,0.07205019,0.9104881,0.003767371,0.00076199055,0.00025937543,0.00023072025,0.00004030183,0.0013663837,0.00035041381,0.0004028969,0.000101720674],"about_ca_topic_score_codex":0.00009225217,"about_ca_topic_score_gemma":8.783216e-7,"teacher_disagreement_score":0.9817428,"about_ca_system_score_codex":0.00008812354,"about_ca_system_score_gemma":0.00018444283,"threshold_uncertainty_score":0.24110931},"labels":[],"label_agreement":null},{"id":"W1982623119","doi":"10.1016/j.cjca.2013.03.003","title":"Impactful Clinical Trials of 2012: What Clinicians Need to Know","year":2013,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Respiratory Research Network","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Clinical trial; Internal medicine; Prasugrel; Clopidogrel; Warfarin; Cardiology; Intensive care medicine; Acute coronary syndrome; Randomized controlled trial; Aspirin; Myocardial infarction; Atrial fibrillation","score_opus":0.20649577375818193,"score_gpt":0.46820594283642275,"score_spread":0.26171016907824085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982623119","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000061958475,0.98957294,0.00042157448,0.0013165247,0.005496009,0.001957227,0.0001077566,0.0000049936043,0.0010610163],"genre_scores_gemma":[0.00015167843,0.9855528,0.00030053323,0.0005699383,0.0130110895,0.000026583108,0.000032102318,0.000082519226,0.00027278825],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98741657,0.00519891,0.0058675893,0.00036882254,0.0003884903,0.0007596266],"domain_scores_gemma":[0.9904059,0.0013273045,0.0027335521,0.0010893466,0.00094456214,0.0034993286],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0230613,0.000480954,0.015515218,0.0011520544,0.000055873865,0.000049904374,0.0004962549,0.0014043911,0.00021112534],"category_scores_gemma":[0.00843346,0.00032359778,0.009693278,0.00040840247,0.00023985382,0.00017354422,0.000033494834,0.0016974971,0.00015140924],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003447111,0.0000041567228,0.000071988106,0.0020489844,0.003215734,0.00028561757,0.000022155315,0.000004013021,1.8320861e-7,0.000016330077,0.12717006,0.8671263],"study_design_scores_gemma":[0.0010495511,0.0013982422,0.00014753708,0.013045524,0.006018745,0.0033995083,0.0001411713,1.2829044e-7,3.285327e-7,0.000019771684,0.97454494,0.00023455337],"about_ca_topic_score_codex":0.0013380005,"about_ca_topic_score_gemma":0.00068504235,"teacher_disagreement_score":0.86689174,"about_ca_system_score_codex":0.000400705,"about_ca_system_score_gemma":0.018374939,"threshold_uncertainty_score":0.9999216},"labels":[],"label_agreement":null},{"id":"W1982900042","doi":"10.2165/00129784-200606060-00003","title":"Intensive Reduction of Low-Density Lipoprotein-Cholesterol","year":2006,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Cholesterol; Statin; Coronary artery disease; Internal medicine; Randomized controlled trial; Pharmacotherapy; Placebo; Disease; Clinical trial; Cardiology; Intensive care medicine; Pathology","score_opus":0.014788466981190329,"score_gpt":0.28239048422067486,"score_spread":0.2676020172394845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982900042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031567805,0.9930286,0.0012062417,0.000051476825,0.0007256966,0.0014580924,0.000018681627,0.00002825862,0.00032619262],"genre_scores_gemma":[0.0061027515,0.9897876,0.0009345204,0.000061343,0.0028070365,0.000030747462,0.0000352003,0.00016883234,0.00007201567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928194,0.0010988924,0.0023992092,0.00060075807,0.0025387332,0.0005429943],"domain_scores_gemma":[0.99175155,0.000082516824,0.002986809,0.0020082302,0.0027320099,0.00043888122],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0031152682,0.0007561749,0.010119535,0.00084804016,0.000079971265,0.000031967676,0.00040955737,0.00033565992,0.000009610073],"category_scores_gemma":[0.00033457426,0.00057802204,0.016591499,0.0011550373,0.00062905817,0.00015721154,0.000116613955,0.0015493724,0.000018194334],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081252256,0.000097458375,0.0000015175483,0.011155806,0.016193131,0.00027546397,0.00014343493,0.000031137366,0.0000028051727,0.0000032919631,0.0003129571,0.97170174],"study_design_scores_gemma":[0.0015400684,0.001128154,0.00008142395,0.026230656,0.026599806,0.019469885,0.00065699604,8.987939e-7,0.0001656633,0.000010955377,0.92358917,0.0005263218],"about_ca_topic_score_codex":0.0016028218,"about_ca_topic_score_gemma":0.000001894903,"teacher_disagreement_score":0.97117543,"about_ca_system_score_codex":0.0005187837,"about_ca_system_score_gemma":0.0015583928,"threshold_uncertainty_score":0.9996671},"labels":[],"label_agreement":null},{"id":"W1983031803","doi":"10.1111/j.1751-7141.2008.00014.x","title":"Control of Lipids at Baseline in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial","year":2009,"lang":"en","type":"article","venue":"Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute","keywords":"Medicine; Diabetes mellitus; Internal medicine; Cholesterol; Triglyceride; Coronary artery disease; Randomization; Angioplasty; Revascularization; Cardiology; Lipoprotein; Randomized controlled trial; Endocrinology; Myocardial infarction","score_opus":0.012097294693928456,"score_gpt":0.251612646753441,"score_spread":0.23951535205951258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983031803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845955,0.0017002872,0.009273698,0.0014995605,0.00024942926,0.0021928842,0.000018305114,0.000021581058,0.00044874955],"genre_scores_gemma":[0.9975242,0.00011374593,0.00015021377,0.0010633563,0.000820239,0.00011793273,0.00015868575,0.000009748032,0.000041874242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969997,0.0016813689,0.00045470116,0.00028835752,0.00031698094,0.0002589306],"domain_scores_gemma":[0.9989664,0.00017990495,0.00015297039,0.00046527764,0.00017071984,0.00006476076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032509295,0.00014547264,0.00073070824,0.00011202655,0.00005455393,0.0000048498555,0.00009526289,0.00017653019,0.000014008817],"category_scores_gemma":[0.00065070787,0.00010162769,0.00050448073,0.00028628684,0.00010052418,0.00005279406,0.00002106399,0.0001975936,0.0000055253995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041502133,0.0014767967,0.64376116,0.0013758254,0.0070450264,0.00024348823,0.0033929853,0.0030592207,0.09648756,0.009183965,0.0075869365,0.18488492],"study_design_scores_gemma":[0.067338474,0.0032628241,0.91369486,0.00022483798,0.00140831,0.000080643906,0.00017687237,0.0011191871,0.0051541543,0.002087382,0.0051403283,0.0003121476],"about_ca_topic_score_codex":0.000027824133,"about_ca_topic_score_gemma":0.00000899084,"teacher_disagreement_score":0.2699337,"about_ca_system_score_codex":0.00009243081,"about_ca_system_score_gemma":0.00010005683,"threshold_uncertainty_score":0.41442567},"labels":[],"label_agreement":null},{"id":"W1983033342","doi":"10.1016/j.amjcard.2006.10.003","title":"The Editor’s Roundtable: Statin Therapy in Acute Coronary Syndrome","year":2006,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Cardiology; Acute coronary syndrome; Internal medicine; Statin; Myocardial infarction","score_opus":0.009746654596816168,"score_gpt":0.27142708050563424,"score_spread":0.26168042590881807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983033342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98759943,0.0048397235,0.00086853054,0.004893964,0.0012344525,0.00024478056,0.0000038270978,0.0000081015305,0.0003071901],"genre_scores_gemma":[0.99048716,0.004423157,0.00016394419,0.0006164978,0.00402254,0.000011972633,0.0000020913005,0.000020006066,0.0002526093],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979506,0.0006892184,0.0004813411,0.00011460471,0.00040779755,0.00035643307],"domain_scores_gemma":[0.9986621,0.0002717881,0.00039636594,0.0004369201,0.00015933416,0.000073450756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020872825,0.00013261505,0.0008284573,0.00007595939,0.000121825746,0.000022825263,0.00025122697,0.000038103975,0.0000037023094],"category_scores_gemma":[0.00003904057,0.000062329986,0.00035995626,0.00028975154,0.00039537487,0.00007792615,0.00002906163,0.0005123201,0.000004226129],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011763688,0.00021595997,0.27499723,0.00003471378,0.008162829,0.010600603,0.00052408664,0.003382124,0.0039064228,0.0011101225,0.08867686,0.5966253],"study_design_scores_gemma":[0.0020271814,0.0039445404,0.8496476,0.000031903386,0.00017188962,0.03172053,0.00062285806,0.000008171713,0.00004619805,0.000804317,0.11086493,0.000109881716],"about_ca_topic_score_codex":0.00042918161,"about_ca_topic_score_gemma":0.000012684159,"teacher_disagreement_score":0.5965155,"about_ca_system_score_codex":0.0001712928,"about_ca_system_score_gemma":0.00032189972,"threshold_uncertainty_score":0.25417432},"labels":[],"label_agreement":null},{"id":"W1983294552","doi":"10.2217/14796678.4.1.5","title":"Understanding How Statins Work: the Path to Better Treatments for Heart Disease and More","year":2007,"lang":"en","type":"editorial","venue":"Future Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Medicine; HMG-CoA reductase; Specialty; Cholesterol; Coronary heart disease; Reductase; Apolipoprotein B; Statin; Internal medicine; Pharmacology; Pathology; Enzyme","score_opus":0.03265604153420752,"score_gpt":0.3008288554628251,"score_spread":0.2681728139286176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983294552","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051654335,0.009261517,0.018689364,0.044111148,0.9145916,0.0061642616,0.0017108028,0.000111108064,0.0001947848],"genre_scores_gemma":[0.004860775,0.00057764474,0.0008053635,0.0031782587,0.9882544,0.00044509943,0.0012435018,0.000097375516,0.0005375355],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99773103,0.00016728441,0.00021844535,0.0006487496,0.0006142417,0.00062026555],"domain_scores_gemma":[0.9981091,0.00039487204,0.00008118206,0.0007864577,0.00017965339,0.00044876023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008237539,0.00039339723,0.001110207,0.00011730171,0.00024722918,0.000039477087,0.00010735576,0.00072627165,0.0000037780162],"category_scores_gemma":[0.00034172492,0.00024072679,0.0005725303,0.0001470974,0.0001125991,0.000024543166,0.000072758645,0.00069115934,0.0000034481716],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073637173,0.000011196307,0.0007588294,0.00026514416,0.0012483975,0.0001587119,0.00022375699,0.0000018328425,0.0000020550033,0.000026472593,0.9944614,0.0021058111],"study_design_scores_gemma":[0.001757967,0.00043099484,0.010143222,0.00015013375,0.0017670289,0.000029904386,0.0006640938,7.91637e-7,9.144895e-7,0.000086113316,0.98473525,0.00023361019],"about_ca_topic_score_codex":0.00001741126,"about_ca_topic_score_gemma":0.0000059056765,"teacher_disagreement_score":0.07366286,"about_ca_system_score_codex":0.00044058528,"about_ca_system_score_gemma":0.00037235694,"threshold_uncertainty_score":0.98165536},"labels":[],"label_agreement":null},{"id":"W1983519839","doi":"10.1016/j.cjca.2010.12.013","title":"Reply to Letters from Dr Maria Luz Fernandez, Eddie Vos, and Dr Niva Shapira","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Prostacyclin; Internal medicine; Enos; Cholesterol; Endocrinology; Nitric oxide; Fibrinogen; Nitric oxide synthase","score_opus":0.027336893879321075,"score_gpt":0.2305061382721279,"score_spread":0.2031692443928068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983519839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96425253,0.005269159,0.0023802824,0.018128151,0.0016500729,0.00036775516,0.000051908388,0.000011849016,0.007888315],"genre_scores_gemma":[0.9843751,0.00017573008,0.0009499728,0.011265513,0.0030313097,0.000004701594,0.0000068149116,0.000030904386,0.00015993568],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985651,0.0001540088,0.0004067113,0.00024057332,0.0001847417,0.0004488596],"domain_scores_gemma":[0.9977257,0.000029625398,0.00012637764,0.00042543357,0.00016986983,0.0015229671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006818693,0.00016340462,0.00079797464,0.0002729604,0.00009187473,0.000017309792,0.00015602502,0.00013609305,0.00011276543],"category_scores_gemma":[0.00020651138,0.00013786081,0.00032001082,0.000108354994,0.0001192345,0.00006484034,0.000022888355,0.00037620537,0.000021860253],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009117923,0.000011345836,0.34737885,0.000115916744,0.004606211,0.012351083,0.0035304285,0.000083196195,0.0033913692,0.00057687017,0.52346337,0.103579566],"study_design_scores_gemma":[0.0011834695,0.0004093753,0.4362148,0.000086140004,0.0002820456,0.0017322055,0.0001371521,0.000001694349,0.00012863362,0.0001859198,0.55949366,0.000144911],"about_ca_topic_score_codex":0.031583514,"about_ca_topic_score_gemma":0.003038101,"teacher_disagreement_score":0.10343465,"about_ca_system_score_codex":0.00019233096,"about_ca_system_score_gemma":0.0009056851,"threshold_uncertainty_score":0.97486526},"labels":[],"label_agreement":null},{"id":"W1984346612","doi":"10.1016/s2213-8587(14)70026-9","title":"Inducing thyrotoxicosis in the liver to treat raised cholesterol","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ezetimibe; Cholesterol; Internal medicine; Statin; Familial hypercholesterolemia; Population; Endocrinology; Pediatrics","score_opus":0.047250953375664276,"score_gpt":0.2867011758288138,"score_spread":0.23945022245314956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984346612","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29518652,0.0017964182,0.000012602237,0.6970925,0.00026422378,0.0023361915,0.000024928808,0.000093829636,0.0031928162],"genre_scores_gemma":[0.19153814,0.0004999028,0.00006156738,0.7956814,0.010653144,0.0011232285,0.00009272142,0.00007628025,0.00027358593],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950231,0.0011570901,0.0004417572,0.00065935915,0.0005616449,0.0021570732],"domain_scores_gemma":[0.99673253,0.0004801727,0.00014620615,0.0025030763,0.000058299123,0.00007973429],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012555833,0.0004817012,0.0015961796,0.00025014082,0.0001403601,0.000056500365,0.0009543651,0.0004956804,0.000087285436],"category_scores_gemma":[0.00016990943,0.000257868,0.00040103582,0.0003212398,0.00016292755,0.000035806446,0.00018360329,0.0031199483,0.00025559418],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061248335,0.00006236214,0.0063168383,0.0007571114,0.00035541577,0.0006628183,0.0009831727,0.0000056437616,0.0004332852,0.00006276384,0.95022786,0.040071476],"study_design_scores_gemma":[0.002374736,0.00042972527,0.033067424,0.00028339066,0.0003259713,0.0002532161,0.000041911662,0.0000105318795,0.0011523815,0.00008938506,0.96166414,0.00030719722],"about_ca_topic_score_codex":0.0003912654,"about_ca_topic_score_gemma":0.00004327804,"teacher_disagreement_score":0.103648394,"about_ca_system_score_codex":0.00014022675,"about_ca_system_score_gemma":0.000082869294,"threshold_uncertainty_score":0.99998736},"labels":[],"label_agreement":null},{"id":"W1984535742","doi":"10.1177/1479164111406457","title":"Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes","year":2011,"lang":"en","type":"review","venue":"Diabetes and Vascular Disease Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Kowa Company","keywords":"Ezetimibe; Medicine; Statin; Diabetes mellitus; Internal medicine; Ldl cholesterol; Cholesterol; Endocrinology","score_opus":0.08150820742353419,"score_gpt":0.345835272576522,"score_spread":0.2643270651529878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984535742","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39781436,0.59751904,0.0000030098013,0.000047393667,0.000017508273,0.0044131638,0.00014874463,0.000015897693,0.00002087648],"genre_scores_gemma":[0.039114628,0.9585113,0.00060310937,0.00003554993,0.00006095693,0.0010858998,0.00041240724,0.00015136466,0.000024776664],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9948244,0.0011689968,0.0006857015,0.0010214386,0.001318762,0.0009807127],"domain_scores_gemma":[0.997219,0.00024416627,0.00025166504,0.0010048065,0.00040370642,0.0008766442],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025298402,0.00066073245,0.0025980764,0.0005809584,0.00018477417,0.00008125074,0.0001737751,0.00021578447,0.00003573271],"category_scores_gemma":[0.00014663949,0.0004220423,0.00026432902,0.00061839685,0.00045575184,0.0001283441,0.00023106784,0.00080804713,0.0000016571853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015353675,0.0009633816,0.119416416,0.028242787,0.0027456996,0.0000074744844,0.00019177012,1.524183e-7,9.392866e-7,0.00004301481,0.000015282143,0.8468377],"study_design_scores_gemma":[0.075558566,0.019979628,0.7412753,0.053897876,0.0040112627,0.0000014793446,0.00028572493,0.00006356235,0.000050962997,0.00012796916,0.10269753,0.0020501034],"about_ca_topic_score_codex":0.00024384413,"about_ca_topic_score_gemma":0.000035278717,"teacher_disagreement_score":0.8447876,"about_ca_system_score_codex":0.0001054015,"about_ca_system_score_gemma":0.00057875074,"threshold_uncertainty_score":0.99982315},"labels":[],"label_agreement":null},{"id":"W1984716394","doi":"10.1016/j.ahj.2004.09.057","title":"Association between lipid testing and statin therapy in acute myocardial infarction patients","year":2005,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Canadian Heart Research Centre; University of Toronto","funders":"","keywords":"Medicine; Myocardial infarction; Statin; Medical prescription; Internal medicine; Emergency medicine; Intensive care medicine; Physical therapy; Pharmacology","score_opus":0.01808532139178743,"score_gpt":0.2903972953526615,"score_spread":0.2723119739608741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984716394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966922,0.00011279568,0.00004214358,0.002708906,0.00008152982,0.00022191624,0.000004353922,0.00001627416,0.000119888566],"genre_scores_gemma":[0.9906877,0.0006697077,0.0053466875,0.001430722,0.001812005,0.0000067043666,0.000004986589,0.000016003138,0.000025453644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986857,0.00017769102,0.00029295433,0.00013008219,0.00044895435,0.00026460286],"domain_scores_gemma":[0.9993079,0.000102928556,0.00017205886,0.00009478168,0.00015125165,0.00017110958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084975327,0.00009267279,0.00035185032,0.000120517994,0.00011175049,0.000033925153,0.000023260678,0.000039784114,0.000012436875],"category_scores_gemma":[0.0002432868,0.00007919688,0.00009373051,0.00027047304,0.000029688894,0.00013383926,0.000012059055,0.00040254934,0.0000075637745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025720487,0.000024578996,0.6366201,0.0000017075414,0.00013855325,0.0000014202712,0.00012419144,0.000003079009,0.00010808148,1.4250448e-7,0.00028263536,0.36266977],"study_design_scores_gemma":[0.0015913846,0.00089270447,0.9842699,0.000031012944,0.00006214378,0.00006881065,0.000060275626,0.000036607318,0.00007196706,0.000009291993,0.012829982,0.000075908865],"about_ca_topic_score_codex":0.00056369434,"about_ca_topic_score_gemma":0.000011542968,"teacher_disagreement_score":0.36259386,"about_ca_system_score_codex":0.0003178083,"about_ca_system_score_gemma":0.00012026676,"threshold_uncertainty_score":0.3229555},"labels":[],"label_agreement":null},{"id":"W1984790513","doi":"10.1111/j.1524-4733.2009.00531.x","title":"Economic Evaluation of Atorvastatin for Prevention of Recurrent Stroke Based on the SPARCL Trial","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Atorvastatin; Stroke (engine); Life expectancy; Quality-adjusted life year; Emergency medicine; Clinical trial; Cost–benefit analysis; Economic evaluation; Health care; Cost effectiveness; Internal medicine; Environmental health; Population","score_opus":0.11316720568272373,"score_gpt":0.3796711519156389,"score_spread":0.2665039462329152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984790513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895691,0.00051005813,0.0009309283,0.00314356,0.0002529299,0.0053537525,0.000031580796,0.000006230695,0.00020182048],"genre_scores_gemma":[0.9984635,0.000071714116,0.00094717613,0.00018264464,0.00018179884,0.000113263486,0.000023355831,0.0000071520544,0.000009358889],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980429,0.00061236107,0.000584818,0.00015590127,0.00044999723,0.00015404235],"domain_scores_gemma":[0.99906796,0.00015180148,0.00030685184,0.00033306112,0.00008751701,0.000052825984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007848544,0.000070835864,0.00034002066,0.00010257431,0.00002914106,0.0000022210766,0.00004595363,0.000041046656,0.000028250499],"category_scores_gemma":[0.0002948864,0.00005202259,0.00019989841,0.00007338937,0.000014640841,0.000017873399,0.0000029974253,0.0000916974,0.0000011620185],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024756417,0.0013616727,0.000584431,0.001295051,0.00007658257,2.9445764e-7,0.0004942375,0.038480163,0.00014904338,0.006992514,0.00060292287,0.92520666],"study_design_scores_gemma":[0.17591561,0.04026055,0.06453483,0.003195317,0.0003405956,0.000003538325,0.0003761456,0.6984204,0.005735763,0.008704368,0.002255776,0.00025710696],"about_ca_topic_score_codex":0.000547959,"about_ca_topic_score_gemma":0.000032549444,"teacher_disagreement_score":0.9249496,"about_ca_system_score_codex":0.0003520187,"about_ca_system_score_gemma":0.0012809348,"threshold_uncertainty_score":0.27201644},"labels":[],"label_agreement":null},{"id":"W1984898976","doi":"10.2174/187152906779010764","title":"Novel Insights Into Lp(a) Physiology and Pathogenicity: More Questions Than Answers?","year":2006,"lang":"en","type":"review","venue":"Cardiovascular & Haematological Disorders - Drug Targets","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lipoprotein(a); Kringle domain; Lipoprotein; Apolipoprotein B; Glycoprotein; In vitro; Biochemistry; In vivo; Chemistry; Biology; Genetics; Recombinant DNA; Cholesterol; Gene","score_opus":0.019991049186071603,"score_gpt":0.28526047121689135,"score_spread":0.26526942203081977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984898976","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011950971,0.98933864,0.0035273419,0.00017861741,0.000482406,0.004157969,0.00006837794,0.00039962694,0.0006519398],"genre_scores_gemma":[0.0037463752,0.99147123,0.0015063642,0.00020838404,0.00057194504,0.0009979906,0.0011730173,0.00021804268,0.00010665396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99258333,0.0010777516,0.001441625,0.0023834065,0.0013009885,0.0012128742],"domain_scores_gemma":[0.99573725,0.00019031759,0.00040037648,0.0027160824,0.00024268866,0.0007133085],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010093901,0.0015832345,0.009215422,0.00048599287,0.0005740617,0.000073919306,0.0005154849,0.0015758402,0.000029668632],"category_scores_gemma":[0.000379568,0.0011401047,0.009430751,0.00089020684,0.00092600845,0.00015421644,0.0005172138,0.0016305743,0.000075818854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050151513,0.0010038285,0.000055981942,0.04764542,0.014529424,0.0012842186,0.00035441882,0.000037521673,0.000010704103,0.0014362468,0.0013979981,0.9321941],"study_design_scores_gemma":[0.0016845394,0.0001258165,0.0006992755,0.0038233087,0.009709571,0.0024245149,0.00011437835,0.00003155237,0.0000050682293,0.00079508434,0.97929466,0.0012922586],"about_ca_topic_score_codex":0.0007832793,"about_ca_topic_score_gemma":0.00009250243,"teacher_disagreement_score":0.97789663,"about_ca_system_score_codex":0.0002521453,"about_ca_system_score_gemma":0.0005346105,"threshold_uncertainty_score":0.99972034},"labels":[],"label_agreement":null},{"id":"W1984973133","doi":"10.1097/01.hco.0000245741.85829.06","title":"The effect of statins on preservation of kidney function in patients with coronary artery disease","year":2006,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Renal function; Pravastatin; Atorvastatin; Internal medicine; Kidney disease; Urology; Kidney; Post-hoc analysis; Urinalysis; Proteinuria; Cardiology; Albuminuria; Coronary artery disease; Endocrinology; Cholesterol; Urinary system","score_opus":0.03608296918959757,"score_gpt":0.33576136659314,"score_spread":0.2996783974035424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984973133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043128286,0.9892947,0.000073060124,0.000020328062,0.0023624557,0.0036704445,0.00019206778,0.000009244004,0.00006487663],"genre_scores_gemma":[0.005002251,0.9908836,0.0000029872103,0.0000069079197,0.0003876732,0.0005202915,0.003159927,0.000030548756,0.0000058320525],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724215,0.0010831389,0.0007315616,0.0003285324,0.00039754977,0.00021706498],"domain_scores_gemma":[0.99853516,0.00027906647,0.00038129295,0.0006066516,0.00008610391,0.00011173615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079438643,0.00025635198,0.0017035583,0.00022947793,0.000025067193,0.0000025480788,0.00009483548,0.00015656176,0.0000018850757],"category_scores_gemma":[0.000269954,0.00014291432,0.0004420753,0.00028361063,0.00009503416,0.00003565753,0.000036705365,0.00040664116,0.0000019787954],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012749921,0.00010935708,0.17989066,0.04067407,0.00022572267,0.000002037974,0.0000055400465,0.00005224601,1.0079852e-8,0.000040548584,0.0015952254,0.7761296],"study_design_scores_gemma":[0.0028481851,0.0023315814,0.35007703,0.019201897,0.00039709196,0.000003573587,0.0000014836587,0.0000052846103,7.555523e-8,0.000010428671,0.625007,0.000116368574],"about_ca_topic_score_codex":0.000022014145,"about_ca_topic_score_gemma":0.0000012938775,"teacher_disagreement_score":0.7760132,"about_ca_system_score_codex":0.00016640166,"about_ca_system_score_gemma":0.00048283703,"threshold_uncertainty_score":0.58278763},"labels":[],"label_agreement":null},{"id":"W1985051814","doi":"10.1503/cmaj.050532","title":"UK decision to sell statins over the counter criticized","year":2005,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Over-the-counter; Agency (philosophy); Simvastatin; Regulatory agency; Medicine; Statin; Family medicine; Political science; Pharmacology; Public administration; Medical prescription; Internal medicine; Sociology","score_opus":0.006542462402953117,"score_gpt":0.26959333271554864,"score_spread":0.2630508703125955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985051814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7678923,0.0007554233,0.002543931,0.22132973,0.0010249979,0.000497939,0.000034853532,0.000021374055,0.005899469],"genre_scores_gemma":[0.8254371,0.00025751765,0.0010194698,0.16623533,0.0059727067,0.000011991339,0.0000059428726,0.000022394135,0.00103749],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966031,0.00014005578,0.00039258559,0.00013378059,0.0022443198,0.00048620746],"domain_scores_gemma":[0.9968668,0.00017115212,0.00007719612,0.0001920492,0.00045082954,0.0022419726],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033351087,0.00009964022,0.00024482457,0.00011973169,0.0003044235,0.00008588999,0.0001445333,0.00020592724,0.008384522],"category_scores_gemma":[0.002574432,0.00006524626,0.00018701612,0.00021187583,0.000019265366,0.00006002179,0.000012883489,0.0008036824,0.00044523727],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037360453,0.00003223793,0.013089848,0.000007880849,0.00019554417,0.00028692535,0.0006125675,0.000013639639,0.000010791701,0.00017059353,0.63795286,0.34758973],"study_design_scores_gemma":[0.0015363932,0.00006540917,0.07885123,0.000094442286,0.00004906618,0.00047255665,0.00018567954,0.00023938966,0.000010365983,0.00006105137,0.91835606,0.00007834747],"about_ca_topic_score_codex":0.0031788545,"about_ca_topic_score_gemma":0.044624973,"teacher_disagreement_score":0.34751138,"about_ca_system_score_codex":0.0016052467,"about_ca_system_score_gemma":0.0029987455,"threshold_uncertainty_score":0.99252194},"labels":[],"label_agreement":null},{"id":"W1985114767","doi":"10.1001/archneurol.2011.228","title":"Statins and Intracerebral Hemorrhage","year":2011,"lang":"en","type":"article","venue":"Archives of Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Interquartile range; Intracerebral hemorrhage; Internal medicine; Statin; Hazard ratio; Stroke (engine); Confidence interval; Emergency department; Population; Subarachnoid hemorrhage","score_opus":0.01926051244555277,"score_gpt":0.2345582635528105,"score_spread":0.21529775110725774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985114767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984851,0.0002197593,0.0004892255,0.0005058098,0.00004328625,0.00014895486,0.000003262965,0.000016311309,0.013722364],"genre_scores_gemma":[0.9934393,0.000106337684,0.0054062135,0.000929989,0.00004799491,0.000004610974,0.000002273908,0.000008983416,0.000054282802],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99948454,0.00006012991,0.00011814905,0.00013989003,0.00006026499,0.00013701145],"domain_scores_gemma":[0.9996293,0.000038419454,0.000033421667,0.0002098345,0.000006888805,0.00008212943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005726625,0.000056756562,0.00019504881,0.000055196142,0.000018361967,7.7034315e-7,0.000035974517,0.000026549016,0.000049096852],"category_scores_gemma":[0.000030541647,0.0000464329,0.000058956786,0.000027269884,0.0001598816,0.000015956663,0.000043142496,0.00012615886,0.000003180654],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022801897,0.00042829898,0.14290202,0.0007055326,0.00022881477,0.00094224163,0.0070298077,8.274138e-7,0.016037386,0.009364142,0.00008859604,0.8199921],"study_design_scores_gemma":[0.0014128383,0.0022749668,0.9867097,0.0000075836037,0.00006162768,0.0010469207,0.00004626364,0.00026872428,0.0036223975,0.003079027,0.0014048406,0.00006511578],"about_ca_topic_score_codex":0.00012852761,"about_ca_topic_score_gemma":0.000011257771,"teacher_disagreement_score":0.8438077,"about_ca_system_score_codex":5.29331e-7,"about_ca_system_score_gemma":0.000024957508,"threshold_uncertainty_score":0.18934786},"labels":[],"label_agreement":null},{"id":"W1985252547","doi":"10.1136/bmj.f3156","title":"Statins and the risk of developing diabetes","year":2013,"lang":"en","type":"letter","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pravastatin; Rosuvastatin; Medicine; Diabetes mellitus; Atorvastatin; Fluvastatin; Statin; Observational study; Internal medicine; Simvastatin; Lovastatin; Type 2 diabetes; Epidemiology; Cholesterol; Endocrinology","score_opus":0.015726308266791438,"score_gpt":0.26356227714295777,"score_spread":0.24783596887616632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985252547","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049716566,0.0045443987,0.00018727152,0.9409767,0.0002037889,0.0020761394,0.000032512475,0.000022256327,0.0022403847],"genre_scores_gemma":[0.007338415,0.0031038108,0.0070818677,0.96977997,0.00893535,0.00043161592,0.00012520142,0.000081938495,0.0031218473],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988524,0.00019803448,0.00026645875,0.00015270914,0.0003462052,0.00018424176],"domain_scores_gemma":[0.9990588,0.00016241665,0.00019804675,0.00046200602,0.00009158115,0.000027185248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008730252,0.00012327814,0.000537582,0.000040457606,0.000047311074,0.000011369856,0.00005998974,0.00020517394,0.00003318647],"category_scores_gemma":[0.00024972728,0.00006427566,0.00017849509,0.000054494758,0.000126971,0.00001519979,0.00004484966,0.00062696595,0.000015019993],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008653547,0.0000024716435,0.0019761298,0.0011197316,0.0006146224,0.0000149209745,0.00013912712,1.2226597e-7,0.0000022214745,0.000054492983,0.97694397,0.019123554],"study_design_scores_gemma":[0.0015978871,0.000046124376,0.019898523,0.0004602974,0.0004888389,0.00002092334,0.000035736062,0.000030452782,0.000087269415,0.00040427828,0.9768053,0.00012433394],"about_ca_topic_score_codex":0.0006131664,"about_ca_topic_score_gemma":0.0000043881887,"teacher_disagreement_score":0.04237815,"about_ca_system_score_codex":0.00002034309,"about_ca_system_score_gemma":0.00016742767,"threshold_uncertainty_score":0.272389},"labels":[],"label_agreement":null},{"id":"W1985544005","doi":"10.1517/14728214.2013.811487","title":"Inflammation and the heart – prime time for new therapeutic approaches","year":2013,"lang":"en","type":"letter","venue":"Expert Opinion on Emerging Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Coronary artery disease; Inflammation; Disease; Intensive care medicine; Clinical trial; Atherosclerotic cardiovascular disease; Cardiology; Internal medicine","score_opus":0.037059422539979,"score_gpt":0.2852610698547764,"score_spread":0.24820164731479738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985544005","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017327158,0.018162861,0.000778452,0.97536117,0.00077043584,0.0035898245,0.0000039521533,0.00011739818,0.0010426186],"genre_scores_gemma":[0.0012408658,0.00572525,0.0021921813,0.90695584,0.05943813,0.002075645,0.001151481,0.00033244654,0.020888172],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796385,0.00019691004,0.00036789247,0.00048178068,0.0006129267,0.00037662845],"domain_scores_gemma":[0.9986771,0.0002290485,0.00015490914,0.00077458046,0.00006456554,0.00009982387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067406043,0.0003484789,0.00070066936,0.00012637308,0.00020339926,0.00007086136,0.00012905532,0.00043255245,0.00008969975],"category_scores_gemma":[0.000064923996,0.00021447112,0.0004358703,0.00009030716,0.00010140773,0.00007494906,0.000040513736,0.0006966548,0.00009248178],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014378915,0.000012562523,0.0000015595866,0.00018376116,0.0003126197,7.557344e-7,0.0018424938,0.0000019831498,0.00005802911,0.00026032276,0.83031505,0.16686709],"study_design_scores_gemma":[0.0030116164,0.0001357418,0.0000394522,0.00031826503,0.0000363905,0.000025975287,0.000094668605,0.0013276122,0.00031683492,0.00023258083,0.9942217,0.00023914776],"about_ca_topic_score_codex":0.00026464247,"about_ca_topic_score_gemma":1.7866343e-7,"teacher_disagreement_score":0.16662794,"about_ca_system_score_codex":0.00008042729,"about_ca_system_score_gemma":0.00018332913,"threshold_uncertainty_score":0.87458783},"labels":[],"label_agreement":null},{"id":"W1985623563","doi":"10.1016/j.jns.2009.02.352","title":"Therapeutic potential of statins in Alzheimer's disease","year":2009,"lang":"en","type":"review","venue":"Journal of the Neurological Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Dementia; Disease; Pathogenesis; Clinical trial; Alzheimer's disease; Statin; Cholesterol; Vascular dementia; Bioinformatics; Internal medicine; Biology","score_opus":0.0799386093077143,"score_gpt":0.3611373165224609,"score_spread":0.2811987072147466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985623563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040203086,0.99394715,0.0000069677726,0.0012471311,0.00028815042,0.00039929245,0.000003038203,0.0000026090097,0.00008538181],"genre_scores_gemma":[0.019673754,0.979331,0.00007537787,0.0006579695,0.00024994984,0.0000019905833,2.1491729e-7,0.0000049085725,0.0000047980943],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728185,0.00063503784,0.0007351115,0.00017493503,0.00095718715,0.00021585432],"domain_scores_gemma":[0.99870634,0.00009504269,0.0007498701,0.00023197744,0.000056513178,0.00016026547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016903547,0.00015463254,0.0012146824,0.00012815329,0.000064696134,0.000016612597,0.0005554948,0.00009856934,0.000025849691],"category_scores_gemma":[0.00020092918,0.000059597925,0.0012379504,0.00052885845,0.0002953347,0.00004652182,0.000062782696,0.00061922707,0.0000012448577],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049526203,0.00015000408,0.00020741638,0.00033576755,0.00007001651,0.00018231849,0.0000045162797,0.000037692604,7.1770455e-7,0.000047358513,0.000027703645,0.99888694],"study_design_scores_gemma":[0.0012944988,0.0075599495,0.07917651,0.008472974,0.007865435,0.0029414298,0.000017719163,0.0001059579,0.0000028476086,0.0032036097,0.88901234,0.000346704],"about_ca_topic_score_codex":0.0000058717624,"about_ca_topic_score_gemma":8.153763e-7,"teacher_disagreement_score":0.9985403,"about_ca_system_score_codex":0.000016072541,"about_ca_system_score_gemma":0.00069535594,"threshold_uncertainty_score":0.2690268},"labels":[],"label_agreement":null},{"id":"W1985705515","doi":"10.1016/j.jacl.2011.04.006","title":"Can conclusions that seem discordant be concordant after all?","year":2011,"lang":"en","type":"letter","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Scopus; Medicine; Disease; Internal medicine; MEDLINE","score_opus":0.14278335019877653,"score_gpt":0.3949998836364707,"score_spread":0.2522165334376942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985705515","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028224872,0.0025646915,0.0002782343,0.94539076,0.021378925,0.0007516827,0.000107535474,0.000030114868,0.0012731707],"genre_scores_gemma":[0.02595078,0.004033488,0.0017190913,0.87338626,0.09197069,0.000025365991,0.0000731613,0.000120603625,0.0027205609],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99237347,0.0015953906,0.0033815883,0.00058557035,0.0012274926,0.0008365144],"domain_scores_gemma":[0.99377805,0.0012542217,0.0024348486,0.0012111821,0.0005764342,0.00074524176],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0043778974,0.0005451619,0.004414764,0.00028058162,0.000065194465,0.000022704193,0.00051805546,0.0017745068,0.0011878493],"category_scores_gemma":[0.0014779784,0.00034462646,0.0035762952,0.000111990565,0.0006314155,0.00007728423,0.00031653664,0.008711871,0.00005378359],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013879384,0.0002664207,0.0084894905,0.00031692107,0.0025060105,0.010737208,0.00014389207,1.5180987e-7,0.00000922017,0.00003494403,0.97110647,0.005001319],"study_design_scores_gemma":[0.0037074944,0.0036425327,0.010265236,0.00052940665,0.0022726492,0.01016949,0.0000533397,0.000001594767,0.000014279027,0.00042783152,0.96857786,0.00033830586],"about_ca_topic_score_codex":0.00023053872,"about_ca_topic_score_gemma":0.00008921709,"teacher_disagreement_score":0.07200451,"about_ca_system_score_codex":0.00013848172,"about_ca_system_score_gemma":0.002148519,"threshold_uncertainty_score":0.9999006},"labels":[],"label_agreement":null},{"id":"W1985903341","doi":"10.1186/cc7496","title":"Evolution of inflammation in non-ICU patients with infections: pilot prospective cohort study","year":2009,"lang":"en","type":"article","venue":"Critical Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prospective cohort study; Inflammation; Intensive care medicine; Organ dysfunction; Cohort; Systemic inflammation; Cohort study; Internal medicine; Emergency medicine; Sepsis","score_opus":0.006909885788163565,"score_gpt":0.27419984661241864,"score_spread":0.2672899608242551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985903341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995468,0.00011672039,0.00040804566,0.00006174188,0.00004345315,0.0021812264,0.0000036714036,0.00002364552,0.0016934759],"genre_scores_gemma":[0.9996712,0.0000016247942,0.000082378414,0.00002097287,0.00009160268,0.00010506096,0.000016604095,0.000007205027,0.0000033440488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989998,0.00006381457,0.00020424188,0.00018748357,0.00040451036,0.00014018618],"domain_scores_gemma":[0.99903315,0.000020043595,0.00002178932,0.0002302468,0.00062534545,0.00006941083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019746719,0.00008300967,0.0002484013,0.00010026443,0.000052035808,0.0000063666826,0.000022947861,0.000041036423,0.000008514906],"category_scores_gemma":[0.00031851954,0.00006556182,0.000043321605,0.0002724822,0.00004066153,0.000093660456,0.0000084878175,0.00017171404,0.0000037653992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015327014,0.00076531037,0.9957816,0.00013915545,0.000018897781,0.000006665028,0.0005175333,0.000008777742,0.00003086474,0.00038855794,0.0000022334787,0.0021871552],"study_design_scores_gemma":[0.0025432082,0.0057884073,0.98955435,0.00012594622,0.00011436972,0.0000026649407,0.0014934924,0.000015367374,0.00015742167,0.00013285536,0.0000039305123,0.00006796379],"about_ca_topic_score_codex":0.00027751934,"about_ca_topic_score_gemma":0.0001233758,"teacher_disagreement_score":0.006227206,"about_ca_system_score_codex":0.00036216382,"about_ca_system_score_gemma":0.00009547909,"threshold_uncertainty_score":0.26735336},"labels":[],"label_agreement":null},{"id":"W1986028233","doi":"10.1016/s0895-4356(01)00436-x","title":"Utilization of lipid-lowering drugs in men and women","year":2002,"lang":"en","type":"article","venue":"Journal of Clinical Epidemiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Ministry of Health, British Columbia","keywords":"Medicine; Medical prescription; Statin; Coronary heart disease; Randomized controlled trial; Population; Internal medicine; Physical therapy; Pharmacology; Environmental health","score_opus":0.20595149103292024,"score_gpt":0.45689016587011694,"score_spread":0.2509386748371967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986028233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167496,0.002593445,0.0006822126,0.0030481927,0.0002355964,0.000109465356,4.426495e-7,0.0000031042694,0.0016525949],"genre_scores_gemma":[0.98680496,0.010315347,0.0011447257,0.0009815414,0.0006685723,0.0000017663939,2.9064105e-7,0.0000071805835,0.00007563185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957977,0.0010428304,0.0026661048,0.00012811825,0.00015384595,0.00021142191],"domain_scores_gemma":[0.99590534,0.0025873268,0.0009831571,0.00017226419,0.00010926093,0.0002426435],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.020536704,0.00007244222,0.0018718782,0.00010989302,0.0000116001775,0.0000010037935,0.000057275356,0.00019919197,0.00012098432],"category_scores_gemma":[0.018149268,0.00005093853,0.00029291425,0.00010538732,0.0001089127,0.000049363396,0.000027344702,0.0004734076,0.0000022543702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004896173,0.0002940362,0.63974124,0.0002219619,0.00021988097,0.00003205901,0.00073317287,0.000043246066,0.000034196735,0.00031850702,0.001050077,0.35682198],"study_design_scores_gemma":[0.005102338,0.0019525089,0.9773998,0.00029771443,0.000060497463,0.0002611375,0.00041200707,0.0022088524,0.00003569938,0.0016975407,0.010495255,0.0000766335],"about_ca_topic_score_codex":0.000023861605,"about_ca_topic_score_gemma":0.0000013462463,"teacher_disagreement_score":0.35674536,"about_ca_system_score_codex":0.000038237846,"about_ca_system_score_gemma":0.00005768028,"threshold_uncertainty_score":0.9901213},"labels":[],"label_agreement":null},{"id":"W1986029658","doi":"10.1586/14779072.2013.839204","title":"PCSK9 and resistin at the crossroads of the atherogenic dyslipidemia","year":2013,"lang":"en","type":"review","venue":"Expert Review of Cardiovascular Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dyslipidemia; Medicine; Resistin; Internal medicine; Very low-density lipoprotein; Endocrinology; PCSK9; Apolipoprotein B; Lipoprotein; Type 2 diabetes; Diabetes mellitus; Insulin resistance; Cholesterol; LDL receptor; Adipokine","score_opus":0.044376546479020854,"score_gpt":0.3499799227529357,"score_spread":0.3056033762739149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986029658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000076988945,0.9910588,0.000025976857,0.00033331307,0.0003772781,0.00760167,0.000026069318,0.00002583963,0.00047406636],"genre_scores_gemma":[0.0000057147536,0.99625593,0.00017367171,0.00088291307,0.0008052206,0.0010463594,0.000033076452,0.00015228183,0.00064484484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928655,0.0023198319,0.0017801796,0.00077374274,0.0017857435,0.00047501508],"domain_scores_gemma":[0.99264926,0.00021478433,0.0009338862,0.005648026,0.00037017342,0.00018386792],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0052723153,0.00079865416,0.0073680594,0.00007959883,0.00023361635,0.000019751937,0.0007754626,0.00044608,0.00024065947],"category_scores_gemma":[0.00034329813,0.0003434804,0.015185042,0.0006721244,0.0006312565,0.00004963009,0.00035878978,0.0006547507,0.000030450987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010361332,0.000032244614,0.0000027418646,0.08284059,0.009155168,0.0000040055947,0.00006074619,1.4467584e-7,0.000007855189,0.000021082173,0.00366939,0.90419567],"study_design_scores_gemma":[0.00066311605,0.000079333724,0.000027913258,0.09307846,0.004144861,0.0004295032,0.0000103320635,2.0276991e-7,0.00013582486,0.000005189363,0.90113956,0.00028568102],"about_ca_topic_score_codex":0.00024051343,"about_ca_topic_score_gemma":0.0000028346592,"teacher_disagreement_score":0.90391,"about_ca_system_score_codex":0.00020430746,"about_ca_system_score_gemma":0.00064338575,"threshold_uncertainty_score":0.9999017},"labels":[],"label_agreement":null},{"id":"W1986202747","doi":"10.1016/s0828-282x(06)70313-0","title":"The clinical effect and tolerability of ezetimibe in high-risk patients managed in a specialty cardiovascular risk reduction clinic","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta; University of Alberta Hospital","funders":"","keywords":"Medicine; Ezetimibe; Tolerability; Internal medicine; Cholesterol; Dose; Concomitant; Gastroenterology; Adverse effect","score_opus":0.009692581862497123,"score_gpt":0.25575230605937355,"score_spread":0.2460597241968764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986202747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252915,0.0050601326,0.00009892816,0.0001510739,0.0009942153,0.00062460615,0.0000147013425,0.0000022805223,0.0005249295],"genre_scores_gemma":[0.9957726,0.0026413752,0.00008059791,0.000013843078,0.0014550613,0.000007702841,0.0000050410667,0.000014334054,0.000009465125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947223,0.003070201,0.0012995768,0.00026001543,0.00028092758,0.00036697823],"domain_scores_gemma":[0.99820316,0.00031776068,0.0004242795,0.00053695514,0.00021546522,0.00030238746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011377589,0.00014824497,0.0015132091,0.00027103414,0.000098697776,0.000009926093,0.000119728924,0.00025466387,0.0000035843577],"category_scores_gemma":[0.0014844191,0.00010472059,0.0009326518,0.00025728863,0.00038194115,0.00004894939,0.000016792403,0.0009654434,0.0000016879849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031360125,0.000011659855,0.90907645,0.000039604758,0.000429428,0.00009322125,0.000029005218,0.0007060751,5.3670084e-7,0.0000098352375,0.0004021459,0.08888845],"study_design_scores_gemma":[0.0049422127,0.0010766683,0.98206776,0.00006602039,0.00043183638,0.00013586831,0.000051670086,0.0000056956524,0.000009053399,0.0004274867,0.010705008,0.00008069253],"about_ca_topic_score_codex":0.037689235,"about_ca_topic_score_gemma":0.022988401,"teacher_disagreement_score":0.08880776,"about_ca_system_score_codex":0.0002798256,"about_ca_system_score_gemma":0.0006969787,"threshold_uncertainty_score":0.9948395},"labels":[],"label_agreement":null},{"id":"W1986416204","doi":"10.1097/00005344-200001000-00022","title":"Effect of Micronized Fenofibrate on Plasma Lipoprotein Levels and Hemostatic Parameters of Hypertriglyceridemic Patients with Low Levels of High-Density Lipoprotein Cholesterol in the Fed and Fasted State","year":2000,"lang":"en","type":"article","venue":"Journal of Cardiovascular Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Centre Hospitalier de l’Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Fenofibrate; Internal medicine; Endocrinology; Triglyceride; Postprandial; Apolipoprotein B; Cholesterol; Hypertriglyceridemia; Placebo; Lipoprotein; Chemistry; Medicine; Low-density lipoprotein; Insulin","score_opus":0.007987513069321307,"score_gpt":0.24159215750104474,"score_spread":0.23360464443172343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986416204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521124,0.0020275796,0.00014494143,0.00016394297,0.0000973862,0.002288699,0.000047937818,0.000005660698,0.0000126097475],"genre_scores_gemma":[0.99855834,0.00044285264,0.00069668423,0.00016775115,0.000056498146,0.00002618005,0.0000035550465,0.00003938932,0.000008731661],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953637,0.0017959365,0.0011052388,0.0003299852,0.0010344164,0.0003707213],"domain_scores_gemma":[0.9979947,0.00034747366,0.00067884166,0.00047361446,0.00032950813,0.00017585455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036987967,0.00035337405,0.0023554608,0.0003193265,0.000052065167,0.000011775432,0.00018570937,0.0001556505,0.000023026209],"category_scores_gemma":[0.000104411694,0.00021799968,0.0006494122,0.00037090064,0.00034357602,0.00013962442,0.000033288205,0.00058240973,7.882348e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03381007,0.0006888983,0.0044787745,0.0033791615,0.0117283445,0.00046505348,0.0013103202,0.003295177,0.052075658,0.0000010210135,0.000027165457,0.88874036],"study_design_scores_gemma":[0.06138205,0.014453865,0.2488826,0.0011472554,0.0036131558,0.0011342873,0.000084200336,0.00016965788,0.6686619,0.000017286728,0.00014770548,0.00030603725],"about_ca_topic_score_codex":0.00068531546,"about_ca_topic_score_gemma":0.000014269466,"teacher_disagreement_score":0.8884343,"about_ca_system_score_codex":0.00008071638,"about_ca_system_score_gemma":0.00018503092,"threshold_uncertainty_score":0.88897693},"labels":[],"label_agreement":null},{"id":"W1986605894","doi":"10.1016/j.atherosclerosissup.2004.03.005","title":"Insights from apoB: from better diagnosis &amp; therapy to the Medusa Hypothesis","year":2004,"lang":"en","type":"review","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Disease; Adipose tissue; Apolipoprotein B; Endothelial dysfunction; Bioinformatics; Pathophysiology; Inflammation; Medicine; Vascular disease; Biology; Internal medicine; Endocrinology; Cholesterol","score_opus":0.10276722608868231,"score_gpt":0.32635403247978917,"score_spread":0.22358680639110684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986605894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047223535,0.98317724,0.00014512446,0.0019540326,0.00088337425,0.005932848,0.0030100173,0.00012289885,0.00005211385],"genre_scores_gemma":[0.0004949631,0.980142,0.0033659607,0.0051772953,0.0023860065,0.0052436544,0.002685332,0.00034543587,0.00015933375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941615,0.0005777444,0.0013256897,0.001466332,0.0016371406,0.00083160296],"domain_scores_gemma":[0.9951153,0.00047078796,0.00044377032,0.0032919147,0.00011241231,0.00056581834],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00034485187,0.0011614762,0.0032608751,0.00021414994,0.0003872531,0.0001801711,0.0010029675,0.00060849264,0.0034322632],"category_scores_gemma":[0.00009257301,0.0006883983,0.0022367989,0.0005850187,0.0000855636,0.00010708247,0.00031894693,0.00078061223,0.0034570077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023849218,0.0004139872,0.0004272707,0.0010266409,0.0030426746,0.0000076235474,0.0006078387,3.973234e-7,0.000021451433,0.000006130566,0.017958865,0.97646326],"study_design_scores_gemma":[0.0018910115,0.00016523131,0.0022285513,0.013392073,0.0023905886,0.0000022565212,0.000035346635,9.231671e-8,0.00012701111,0.00017297447,0.97892123,0.00067360065],"about_ca_topic_score_codex":0.010730175,"about_ca_topic_score_gemma":0.0009399733,"teacher_disagreement_score":0.97578967,"about_ca_system_score_codex":0.00069442025,"about_ca_system_score_gemma":0.00048402703,"threshold_uncertainty_score":0.9995567},"labels":[],"label_agreement":null},{"id":"W1986892557","doi":"10.4021//jmc.v2i2.124","title":"Successful Treatment of Statin Resistant Hypercholesterolemia by an Inhibitor of Cholesterol Absorption, Ezetimibe","year":2011,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Rosuvastatin; Pitavastatin; Medicine; Familial hypercholesterolemia; Cholesterol; Statin; HMG-CoA reductase; Internal medicine; Endocrinology; Reductase; Diabetes mellitus; Pharmacology; Simvastatin; Biochemistry; Chemistry; Enzyme","score_opus":0.04133261160080861,"score_gpt":0.3091890316363279,"score_spread":0.2678564200355193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986892557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962855,0.0023676725,0.00026708248,0.00058963214,0.00014140134,0.00020454497,0.000038096154,0.0000066273205,0.00009942403],"genre_scores_gemma":[0.9969931,0.0015731527,0.00074977684,0.00020002935,0.0004149863,0.000004960825,0.000009641177,0.000020043193,0.000034268913],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99669385,0.00020768661,0.0010579362,0.00014649611,0.0016965464,0.00019751379],"domain_scores_gemma":[0.99805963,0.000076373384,0.0005471386,0.00034028332,0.00036823412,0.00060831284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011633054,0.0001538343,0.0008122538,0.0001366017,0.0000276529,0.0000061612786,0.00014749198,0.00016836516,0.00039730847],"category_scores_gemma":[0.00029389214,0.00009897046,0.0003138652,0.00011786024,0.00017257968,0.00012731567,0.000018337549,0.000215078,0.00000172145],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01883857,0.023802815,0.15489478,0.0039908304,0.0031523027,0.009504085,0.014603414,0.000008968401,0.08216318,0.00014808707,0.012041231,0.67685175],"study_design_scores_gemma":[0.04545519,0.098261915,0.37448737,0.005937687,0.0029768904,0.015931314,0.009388109,0.000088062036,0.41300258,0.00017430622,0.033565667,0.00073090516],"about_ca_topic_score_codex":0.0009978897,"about_ca_topic_score_gemma":0.00007658565,"teacher_disagreement_score":0.6761208,"about_ca_system_score_codex":0.00010116237,"about_ca_system_score_gemma":0.0004830659,"threshold_uncertainty_score":0.43502492},"labels":[],"label_agreement":null},{"id":"W1987039235","doi":"10.1139/y09-085","title":"Atorvastatin mediates increases in intralesional BAX and BAK expression in human end-stage abdominal aortic aneurysms","year":2009,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Pfizer Canada; Jewish General Hospital","keywords":"Atorvastatin; Apoptosis; Endoplasmic reticulum; Bcl-2-associated X protein; Statin; Biology; Population; Cytochrome c; Unfolded protein response; Endocrinology; Internal medicine; Medicine; Cell biology; Programmed cell death; Caspase 3; Biochemistry","score_opus":0.012391080108539537,"score_gpt":0.29160198584268915,"score_spread":0.27921090573414964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987039235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957109,0.003261218,0.0000024088356,0.00070585124,0.00011491571,0.00015667842,0.00001023748,0.0000020833477,0.000035674082],"genre_scores_gemma":[0.9976736,0.0004551858,0.00011743538,0.0013973761,0.00032268473,0.0000040710215,0.000009308206,0.000006571495,0.000013816885],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987754,0.00027983048,0.00037135213,0.0001661554,0.00008118488,0.00032608217],"domain_scores_gemma":[0.99913985,0.00009269873,0.000117625656,0.000062248415,0.000045490655,0.0005421169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047978194,0.00012309746,0.00046106463,0.00034041784,0.0000769154,0.00000461337,0.00006151146,0.00012239335,0.00079757127],"category_scores_gemma":[0.000043307024,0.00010281778,0.00005611135,0.00008553105,0.00019512199,0.00007990635,0.000009859442,0.0004550756,8.0083845e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041700964,0.00011497934,0.041465554,0.0001432312,0.000040407114,0.0019288921,0.0004154518,0.000017757757,0.94831824,0.0000832944,0.0004949996,0.0065601678],"study_design_scores_gemma":[0.0043019457,0.001179555,0.945868,0.00012041852,0.00006694477,0.00096011197,0.00014692111,0.00006453707,0.04546848,0.0010049865,0.00068524794,0.00013282934],"about_ca_topic_score_codex":0.0017094776,"about_ca_topic_score_gemma":0.0018861758,"teacher_disagreement_score":0.9044025,"about_ca_system_score_codex":0.00006702365,"about_ca_system_score_gemma":0.0005718382,"threshold_uncertainty_score":0.87328464},"labels":[],"label_agreement":null},{"id":"W1987071918","doi":"10.1016/s0828-282x(10)70393-7","title":"Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Lakeridge Health; McGill University; Jewish General Hospital; University of British Columbia; McMaster University; Canadian Heart Research Centre; University of Toronto; Western University; St. Michael's Hospital","funders":"Novo Nordisk Canada; Novartis Pharmaceuticals Canada; Bristol-Myers Squibb Canada; Merck Canada; AstraZeneca Canada; Servier; Pfizer Canada; Sanofi; Eli Lilly Canada; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Internal medicine; Cholesterol; Guideline; Blood pressure; Pharmacotherapy; Type 2 Diabetes Mellitus; Endocrinology","score_opus":0.006081310363725994,"score_gpt":0.1899872989936979,"score_spread":0.1839059886299719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987071918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972229,0.0013485219,0.0000027885437,0.00007297669,0.00030918737,0.0004112265,0.000015694637,5.472889e-7,0.000616127],"genre_scores_gemma":[0.9995065,0.00029525135,0.00004562596,0.000028757187,0.00009584501,0.000006956464,0.000007792753,0.000010987427,0.000002314633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863815,0.00023350418,0.00036040982,0.00012941088,0.00029108513,0.000347443],"domain_scores_gemma":[0.99913776,0.00003266608,0.00010543963,0.00040459665,0.000107314365,0.00021219907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000661299,0.00012917336,0.0007581039,0.00027749914,0.000022355884,0.0000037511033,0.00013626259,0.00007115325,0.000005849669],"category_scores_gemma":[0.000034387893,0.00007639376,0.00021620482,0.00031395853,0.000055428663,0.000028407632,0.0000054892366,0.00039187644,3.0439838e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004138811,0.000007632989,0.98776394,0.000032444532,0.00096318085,0.00047457026,0.0001364584,0.0024704132,8.741213e-7,0.000010355659,0.000032535052,0.008066214],"study_design_scores_gemma":[0.0026910873,0.00045178662,0.9807196,0.000060947095,0.00026470653,0.000024453917,0.0004895871,0.0000029902455,0.000019505022,0.000009385939,0.015196902,0.00006899677],"about_ca_topic_score_codex":0.87481004,"about_ca_topic_score_gemma":0.9529978,"teacher_disagreement_score":0.07818775,"about_ca_system_score_codex":0.00072237704,"about_ca_system_score_gemma":0.002574484,"threshold_uncertainty_score":0.45670244},"labels":[],"label_agreement":null},{"id":"W1987262643","doi":"10.1016/j.cjca.2014.07.068","title":"CLINICAL PROFILE OF STATIN INTOLERANCE IN THE PHASE 3 GAUSS-2 STUDY","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors","score_opus":0.03534119369283804,"score_gpt":0.35550170844529827,"score_spread":0.3201605147524602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987262643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247897,0.0006584202,0.001776403,0.0008189404,0.00039022954,0.00046013386,0.000007837045,0.000001328216,0.0034077505],"genre_scores_gemma":[0.99806273,0.00003591176,0.00020435076,0.0004336286,0.0012304984,0.0000072077464,0.0000019975503,0.000008305254,0.00001538025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761915,0.0011164205,0.00070986187,0.00011219553,0.00020800007,0.00023435593],"domain_scores_gemma":[0.9987736,0.00013991362,0.00020791653,0.00036246786,0.00021662506,0.0002995206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055359825,0.000081411345,0.00080653594,0.0001623825,0.00003344752,0.0000050320023,0.00017670095,0.000082703715,0.00001669765],"category_scores_gemma":[0.00068882405,0.000051368934,0.00029472174,0.00016000135,0.00014259238,0.00002755573,0.0000056449003,0.00047502507,0.0000035247858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004077596,0.000106179104,0.64308405,0.00009276207,0.0005936908,0.00093526085,0.0020380563,0.00018846674,0.00005049904,0.00029040335,0.007494772,0.3447181],"study_design_scores_gemma":[0.010077963,0.0065420144,0.82833415,0.00009561966,0.00023118498,0.0010856473,0.0023003987,0.000050169045,0.000024203831,0.00015948636,0.15100026,0.000098886114],"about_ca_topic_score_codex":0.0017086706,"about_ca_topic_score_gemma":0.0026717873,"teacher_disagreement_score":0.3446192,"about_ca_system_score_codex":0.000049553553,"about_ca_system_score_gemma":0.00120626,"threshold_uncertainty_score":0.25830102},"labels":[],"label_agreement":null},{"id":"W1987486422","doi":"10.1371/journal.pone.0010682","title":"A Locked Nucleic Acid Antisense Oligonucleotide (LNA) Silences PCSK9 and Enhances LDLR Expression In Vitro and In Vivo","year":2010,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Locked nucleic acid; LDL receptor; Kexin; Proprotein convertase; In vivo; Biology; Lipoprotein; Cholesterol; Molecular biology; Chemistry; Pharmacology; Endocrinology; Oligonucleotide; Biochemistry; Gene","score_opus":0.01574817355262743,"score_gpt":0.2320700317735856,"score_spread":0.21632185822095817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987486422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965331,0.001959211,0.000003385838,0.00048712172,0.000041914394,0.00054972013,0.0000057647553,0.00003346871,0.00038632358],"genre_scores_gemma":[0.9942294,0.0014001478,0.0039257263,0.00017338738,0.00016032635,0.00003655531,0.0000025403374,0.000019400082,0.000052517826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99872065,0.00006446112,0.00023653192,0.00034298826,0.00035561327,0.00027973708],"domain_scores_gemma":[0.999406,0.0000383482,0.000055086926,0.0002989989,0.000035200923,0.0001663892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041444058,0.00014331976,0.0004814113,0.00015083296,0.0000533999,0.00002388097,0.000052368272,0.00011872852,0.000050197094],"category_scores_gemma":[0.00014319846,0.00011902791,0.000040635205,0.00016729473,0.00011263619,0.00012542866,0.000059966696,0.00035173094,0.0000058475093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023574836,0.0003980647,0.0115139,0.00035877674,0.00003286116,0.00008283783,0.00044628268,4.5495906e-8,0.9821914,0.000004868439,0.00001070412,0.0047244974],"study_design_scores_gemma":[0.0016769766,0.0001164594,0.049951326,0.000716632,0.000052009233,0.00003029288,0.00022915755,0.00014760524,0.9467626,0.000073693394,0.000109262444,0.00013396166],"about_ca_topic_score_codex":0.0002475691,"about_ca_topic_score_gemma":0.00030249316,"teacher_disagreement_score":0.038437426,"about_ca_system_score_codex":0.00001619254,"about_ca_system_score_gemma":0.000047420053,"threshold_uncertainty_score":0.48538172},"labels":[],"label_agreement":null},{"id":"W1988024888","doi":"10.1517/13543784.2013.822485","title":"Current Phase II proprotein convertase subtilisin/kexin 9 inhibitor therapies for dyslipidemia","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Ezetimibe; Alirocumab; Proprotein convertase; Evolocumab; Pharmacology; Tolerability; Kexin; Niacin; Medicine; Statin; Familial hypercholesterolemia; Dyslipidemia; Adverse effect; Internal medicine; Cholesterol; Endocrinology; Apolipoprotein B; Lipoprotein; LDL receptor; Disease; Apolipoprotein A1","score_opus":0.09729688680475103,"score_gpt":0.4063385413648205,"score_spread":0.3090416545600695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988024888","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072096234,0.9844021,0.00016260995,0.0020126642,0.0023424805,0.010339938,0.00038832935,0.00016202629,0.000117746036],"genre_scores_gemma":[0.000017791783,0.97182864,0.0021371932,0.001413322,0.007823632,0.010527184,0.005626117,0.00018305234,0.00044303972],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951373,0.0004010095,0.0014189885,0.0010971404,0.0013376297,0.0006079596],"domain_scores_gemma":[0.9967956,0.00036112915,0.0006347814,0.0010321714,0.0004429064,0.00073339633],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010141691,0.00090676465,0.0024449648,0.0003942066,0.0004646463,0.00007370433,0.00029425218,0.0005712226,0.0002917562],"category_scores_gemma":[0.0006984058,0.0006552871,0.0015684587,0.00030929036,0.00032471598,0.00019084412,0.00010389981,0.00086626364,0.0002178936],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007295289,0.0005412515,5.8203165e-7,0.010326036,0.00038221112,0.0000014115355,0.0004927114,2.913446e-7,0.0000107474825,0.0048232106,0.0724687,0.9108799],"study_design_scores_gemma":[0.003429172,0.0011063238,0.0000018386374,0.022287123,0.0001020055,0.000025003346,0.000055918048,0.00005983491,0.00019816039,0.00063524925,0.9714728,0.00062654994],"about_ca_topic_score_codex":0.000060048314,"about_ca_topic_score_gemma":4.5703146e-7,"teacher_disagreement_score":0.91025335,"about_ca_system_score_codex":0.0005220485,"about_ca_system_score_gemma":0.0026367242,"threshold_uncertainty_score":0.99958986},"labels":[],"label_agreement":null},{"id":"W1988370388","doi":"10.1007/s100380170051","title":"Single nucleotide polymorphisms of the very low density lipoprotein receptor (VLDLR) gene","year":2001,"lang":"en","type":"article","venue":"Journal of Human Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Single-nucleotide polymorphism; Genetics; Exon; Coding region; Biology; Intron; Gene; SNP; Allele; Genotype","score_opus":0.01905596594998663,"score_gpt":0.24615323749693574,"score_spread":0.22709727154694911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988370388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421924,0.0037854677,0.00017687473,0.000587804,0.0005541832,0.00030031774,0.0000028517984,0.000008053629,0.00036521134],"genre_scores_gemma":[0.9948308,0.00064924237,0.0019521754,0.00037415503,0.001744207,0.000001202388,0.0000013985796,0.000034842964,0.0004119694],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794704,0.00012271797,0.0006867869,0.00013676306,0.00084975926,0.00025691575],"domain_scores_gemma":[0.9982126,0.000015400201,0.00054259435,0.00062871707,0.0004031037,0.00019760073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068068376,0.00015587565,0.00051985605,0.000105886,0.00013319025,0.000017275403,0.00023948844,0.000112116766,0.00012437256],"category_scores_gemma":[0.00006966656,0.000106145366,0.0005868943,0.00020516098,0.00012706169,0.00004317931,0.00007751373,0.0003600408,0.000008759787],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025243565,0.0006251035,0.015558294,0.0001378971,0.00043315848,0.00017220409,0.0003747191,0.000051611023,0.9352587,0.000022530441,0.002027705,0.04508563],"study_design_scores_gemma":[0.002574206,0.0018449408,0.17162643,0.00048970286,0.00043140873,0.0017040928,0.00014200012,0.000017321905,0.806824,0.00025969883,0.013883193,0.00020295102],"about_ca_topic_score_codex":0.000076900345,"about_ca_topic_score_gemma":0.000032078246,"teacher_disagreement_score":0.15606815,"about_ca_system_score_codex":0.00013549619,"about_ca_system_score_gemma":0.00022312197,"threshold_uncertainty_score":0.43284824},"labels":[],"label_agreement":null},{"id":"W1988921227","doi":"10.7326/0003-4819-155-12-201112200-02006","title":"Review: Insufficient evidence exists to determine the benefits and risks of statins for acute ischemic stroke or TIA","year":2011,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stroke (engine); Neurology; Internal medicine; Randomized controlled trial; Statin; Psychiatry","score_opus":0.22087353050521535,"score_gpt":0.42363898181723963,"score_spread":0.20276545131202428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988921227","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07294058,0.3417626,0.00063945947,0.57826746,0.0006100593,0.0045805224,0.0005873546,0.000024585226,0.0005873554],"genre_scores_gemma":[0.012251492,0.20813431,0.0007069967,0.7738092,0.0028168678,0.00025400158,0.00006473293,0.000080413716,0.0018819914],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969369,0.00010124294,0.0011736316,0.0004777335,0.0008897035,0.00042076575],"domain_scores_gemma":[0.99646366,0.00046812574,0.000776187,0.0010083735,0.0010680273,0.00021563166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016509673,0.0003914076,0.0017435212,0.00021052994,0.00003901321,0.0000047200024,0.00044285777,0.0002410641,0.000120405326],"category_scores_gemma":[0.0019728937,0.0002009463,0.00039749968,0.00018020935,0.00026695864,0.00004997538,0.00015907663,0.0007727166,0.00000404086],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008996481,0.000045386616,0.00010777735,0.0098346,0.001081985,0.00010733806,0.00041140296,1.59289e-7,0.00061934715,0.000003933945,0.8968047,0.09008371],"study_design_scores_gemma":[0.0012937699,0.008576345,0.0011335446,0.1170034,0.0023289013,0.0005733053,0.000052527026,0.000011553868,0.010013445,0.000007873417,0.8587495,0.00025583632],"about_ca_topic_score_codex":0.0014607961,"about_ca_topic_score_gemma":0.000040513223,"teacher_disagreement_score":0.19554172,"about_ca_system_score_codex":0.00002592477,"about_ca_system_score_gemma":0.0001944321,"threshold_uncertainty_score":0.81943524},"labels":[],"label_agreement":null},{"id":"W1989006105","doi":"10.1007/s11883-009-0009-7","title":"High-density lipoprotein/apolipoprotein A-I infusion therapy","year":2008,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Apolipoprotein B; Clinical trial; Lipoprotein; Cholesterylester transfer protein; Coronary artery disease; Pharmacology; Internal medicine; Cholesterol; High-density lipoprotein; Bioinformatics; Endocrinology","score_opus":0.0767801848661572,"score_gpt":0.33318334563057633,"score_spread":0.25640316076441916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989006105","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004488562,0.983512,0.0000911685,0.000044460892,0.0030211005,0.008141717,0.00003405106,0.00051067286,0.00015630438],"genre_scores_gemma":[0.00046886358,0.9927152,0.00041789762,0.000096044,0.003439688,0.0015230317,0.000636936,0.00039840947,0.0003039267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914668,0.00047834957,0.0026389065,0.0020361783,0.0022131742,0.0011665547],"domain_scores_gemma":[0.9926795,0.000053560507,0.0019732884,0.0040537775,0.0004057194,0.00083416846],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010658752,0.0016084239,0.006031718,0.0005053003,0.00052017893,0.00010390799,0.00034017378,0.0011377197,0.00026654385],"category_scores_gemma":[0.00024348094,0.0011973897,0.004368519,0.0010123276,0.0002568693,0.0001679119,0.00033120014,0.0019461953,0.00026901963],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022269136,0.0005735199,0.00003919853,0.008615158,0.0005178422,0.00031422116,0.000075673786,1.7230653e-7,0.000015012534,0.000011556099,0.002655943,0.98715943],"study_design_scores_gemma":[0.0008939236,0.00033555293,0.0008175242,0.026236497,0.0008095047,0.003932648,0.0000036430833,5.5468144e-7,0.0001475728,0.00003775564,0.96575266,0.001032185],"about_ca_topic_score_codex":0.0017087932,"about_ca_topic_score_gemma":0.000016119466,"teacher_disagreement_score":0.98612726,"about_ca_system_score_codex":0.0007323619,"about_ca_system_score_gemma":0.00172702,"threshold_uncertainty_score":0.99966633},"labels":[],"label_agreement":null},{"id":"W1989110922","doi":"10.2165/11319800-000000000-00000","title":"Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination","year":2009,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Rosuvastatin; Medicine; Simvastatin; Atorvastatin; Combination therapy; Statin; Internal medicine; Pharmacology; Pharmacotherapy; Rosuvastatin Calcium; Fenofibrate; Gastroenterology; Population","score_opus":0.04619729645364628,"score_gpt":0.3819313796049937,"score_spread":0.3357340831513474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989110922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939228,0.00015895172,0.0014252891,0.0029064997,0.00008653057,0.00047441144,0.0000034100942,0.00003388391,0.0009881947],"genre_scores_gemma":[0.987886,0.00014285551,0.010644815,0.0010290578,0.00013250833,0.000007491424,0.000065118154,0.000008763824,0.00008338536],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985553,0.00023498693,0.00053156586,0.00022488451,0.00033656252,0.00011670171],"domain_scores_gemma":[0.9991569,0.00007417823,0.00016464852,0.0002544885,0.00015328405,0.00019648693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015192216,0.000087699205,0.0003494577,0.000054648946,0.000048032696,0.00001431925,0.000033571807,0.000068262794,0.000009853901],"category_scores_gemma":[0.00027646282,0.000076515964,0.000098942706,0.00014634801,0.00011739662,0.00009707012,0.000015225022,0.00019438432,0.0000046504315],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004875079,0.0014809084,0.36804435,0.00082793174,0.00033807705,0.00002820016,0.0012650554,0.00023204152,0.016104337,0.07586209,0.0031406544,0.53218883],"study_design_scores_gemma":[0.004092711,0.00066904,0.963661,0.00013445593,0.000099695724,0.000006334614,0.00007441845,0.0130971465,0.0035804457,0.014334185,0.00015091032,0.00009961861],"about_ca_topic_score_codex":0.000051974763,"about_ca_topic_score_gemma":0.0000038780704,"teacher_disagreement_score":0.5956167,"about_ca_system_score_codex":0.000037626036,"about_ca_system_score_gemma":0.00022026066,"threshold_uncertainty_score":0.31202304},"labels":[],"label_agreement":null},{"id":"W1989133590","doi":"10.1007/s00228-005-0980-z","title":"Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease","year":2005,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Dyslipidemia; Statin; Cohort; Medical prescription; Persistence (discontinuity); Proportional hazards model; Internal medicine; Coronary artery disease; Cohort study; Diabetes mellitus; Disease; Endocrinology; Pharmacology","score_opus":0.09092833399569246,"score_gpt":0.3528317980808257,"score_spread":0.26190346408513326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989133590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171096,0.007056779,0.0000875258,0.00016526469,0.0004429156,0.00030346418,0.000013928891,0.0000045220304,0.0002146158],"genre_scores_gemma":[0.9918673,0.0057983915,0.0009637094,0.0004500638,0.0008668208,9.618194e-7,0.0000011839293,0.000025364981,0.00002621627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564296,0.0018187414,0.0015939113,0.00019942281,0.0005511601,0.00019382499],"domain_scores_gemma":[0.9976772,0.00019833777,0.0008487941,0.000372819,0.0004223429,0.0004805078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004752222,0.00013614412,0.0010677761,0.00009084615,0.000035091256,0.0000034240722,0.00023173414,0.000039858183,0.0000701808],"category_scores_gemma":[0.0006870579,0.00010053216,0.0010537079,0.00008596884,0.00037194375,0.0000930019,0.000081316786,0.0004105683,0.0000023377984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042906892,0.0014502425,0.5472039,0.00034200962,0.0032345287,0.0007597775,0.00041874894,0.00017579172,0.00035787682,8.594826e-7,0.0012982736,0.44046733],"study_design_scores_gemma":[0.01622303,0.0023230065,0.9704521,0.00018031671,0.0010991469,0.00003552567,0.00004542575,0.00009615393,0.0008182609,0.0000040431105,0.008630936,0.000092083035],"about_ca_topic_score_codex":0.0000072185862,"about_ca_topic_score_gemma":7.566405e-7,"teacher_disagreement_score":0.44037524,"about_ca_system_score_codex":0.000015591544,"about_ca_system_score_gemma":0.00015947042,"threshold_uncertainty_score":0.40995824},"labels":[],"label_agreement":null},{"id":"W1989660004","doi":"10.1074/jbc.m109.037085","title":"Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation","year":2009,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; Université de Sherbrooke; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Bristol-Myers Squibb","keywords":"PCSK9; Endogeny; LDL receptor; Receptor; Degradation (telecommunications); Cell biology; Chemistry; Lipoprotein; Cholesterol; Biochemistry; Biology; Computer science","score_opus":0.03693823842091521,"score_gpt":0.23310074409497816,"score_spread":0.19616250567406296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989660004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848276,0.00053883414,0.00021694464,0.00020000024,0.00008917481,0.00018854957,0.0000038295743,0.000006879267,0.00027299733],"genre_scores_gemma":[0.9991298,0.000107860404,0.0003211195,0.00004803301,0.00036577883,0.0000011620004,0.000005798042,0.000004426918,0.000016060716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987539,0.00007577739,0.0005363168,0.00011753036,0.00037991744,0.00013652603],"domain_scores_gemma":[0.99873936,0.00002377331,0.0005660042,0.00027364813,0.00029388614,0.000103348946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006374468,0.00010897648,0.000447696,0.000018401433,0.00004649358,0.0000036836777,0.00012663353,0.00021534522,0.000046972018],"category_scores_gemma":[0.0003792815,0.000059044578,0.00048520416,0.0001521169,0.000052351614,0.000027665486,0.000020265526,0.00034657144,6.23301e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023038553,0.00024698104,0.0011792808,0.00011249036,0.00005536825,0.000015941929,0.000029187342,0.0000018243716,0.97765815,0.000004879763,0.00001059865,0.02045491],"study_design_scores_gemma":[0.000628257,0.0006298607,0.022245998,0.00017222975,0.000058222417,0.0004421761,0.000097282566,0.0000043585064,0.9755022,0.000106577136,0.000056447232,0.000056425903],"about_ca_topic_score_codex":0.000021665654,"about_ca_topic_score_gemma":3.815304e-7,"teacher_disagreement_score":0.021066716,"about_ca_system_score_codex":0.000080337275,"about_ca_system_score_gemma":0.00013330302,"threshold_uncertainty_score":0.24077679},"labels":[],"label_agreement":null},{"id":"W1989813792","doi":"10.1016/j.atherosclerosis.2014.07.010","title":"PCSK9 levels in abdominally obese men: Association with cardiometabolic risk profile and effects of a one-year lifestyle modification program","year":2014,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Medicine; PCSK9; Lifestyle modification; Association (psychology); Internal medicine; Metabolic syndrome; Obesity; Effect modification; Endocrinology; Psychology; Cholesterol; LDL receptor; Lipoprotein; Confidence interval","score_opus":0.011933532960859325,"score_gpt":0.245791314392594,"score_spread":0.23385778143173466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989813792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964935,0.00029829648,0.00052861066,0.00014057943,0.000028424603,0.001824923,0.0000093091785,0.000054613458,0.00062172924],"genre_scores_gemma":[0.994019,0.0003932342,0.004819402,0.000047715133,0.0001152932,0.00047154055,0.0000086918735,0.00003384008,0.00009131609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835074,0.00028423214,0.00026744386,0.00030402822,0.00052805914,0.00026547423],"domain_scores_gemma":[0.99899286,0.00009697655,0.00023270593,0.00041957697,0.00014333651,0.00011453515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013300265,0.00015014502,0.00057045725,0.00012015099,0.0000553858,0.000021847914,0.000056683264,0.00014029285,0.0000048105185],"category_scores_gemma":[0.00030590317,0.00012177981,0.00011453635,0.00040235417,0.00004208617,0.00008595247,0.000023564864,0.00018552551,0.000008307557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013904428,0.0006490624,0.8039595,0.00087571854,0.0004507291,6.4105893e-7,0.0010265786,0.000012891091,0.024826972,0.00015000139,0.00003577926,0.16787308],"study_design_scores_gemma":[0.0037193228,0.00083739567,0.9776242,0.0003265412,0.0003443023,0.000001528051,0.000066170476,0.00039775408,0.016145946,0.00002504976,0.00038593286,0.00012585439],"about_ca_topic_score_codex":0.0007857834,"about_ca_topic_score_gemma":0.000046457862,"teacher_disagreement_score":0.1736647,"about_ca_system_score_codex":0.00011561575,"about_ca_system_score_gemma":0.00007387994,"threshold_uncertainty_score":0.49660367},"labels":[],"label_agreement":null},{"id":"W1989993335","doi":"10.1016/j.cjca.2010.12.025","title":"The Effect of the Change in the Framingham Risk Score Calculator Between the 2006 and 2009 Canadian Lipid Guidelines","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Medicine; Framingham Risk Score; Statin; Internal medicine; Framingham Heart Study; Population; Lipid profile; Psychological intervention; Cholesterol; Disease; Environmental health","score_opus":0.03968264880836317,"score_gpt":0.2717036082334827,"score_spread":0.23202095942511955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989993335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96834123,0.021163182,0.000024858313,0.007080621,0.00064879464,0.00095914304,0.0000721959,0.0000018108441,0.0017081861],"genre_scores_gemma":[0.99558026,0.0005313285,0.000011507123,0.0009647269,0.0028536308,0.000018638355,0.0000014411579,0.0000154549,0.000022995695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752825,0.0011105248,0.00047665887,0.0001254262,0.00024112684,0.00051799783],"domain_scores_gemma":[0.9981963,0.00024283158,0.00023666745,0.0006240213,0.0002402569,0.00045994626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052592726,0.0001559533,0.00058204116,0.00015215512,0.00040673997,0.0000183216,0.00046049408,0.00017278234,0.0000062228746],"category_scores_gemma":[0.001012438,0.00005907185,0.00038818456,0.00025894115,0.00041464495,0.000038468555,0.000020676047,0.00071093073,0.0000015437812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027169108,4.8298324e-7,0.95293397,0.000024253566,0.0003229394,0.00009972949,0.0008127754,0.000009470925,0.0000016776934,0.00010089799,0.0070675374,0.03859908],"study_design_scores_gemma":[0.00050704455,0.0003228025,0.83156824,0.0000741247,0.0003272394,0.0006179668,0.00023624553,0.0000041680883,0.000023729024,0.00005847916,0.1662037,0.00005628763],"about_ca_topic_score_codex":0.56993425,"about_ca_topic_score_gemma":0.48441884,"teacher_disagreement_score":0.15913615,"about_ca_system_score_codex":0.00012744602,"about_ca_system_score_gemma":0.0013492383,"threshold_uncertainty_score":0.5249892},"labels":[],"label_agreement":null},{"id":"W1990037063","doi":"10.1097/hcr.0b013e31825d29ee","title":"Evidence for Cholesterol Hyperabsorbers and Hyperproducers Based on Comparative Low-Density Lipoprotein Reductions Achieved by Ezetimibe Versus Statins","year":2012,"lang":"en","type":"article","venue":"Journal of Cardiopulmonary Rehabilitation and Prevention","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ezetimibe; Statin; Medicine; Cholesterol; Internal medicine; Ldl cholesterol; Gastroenterology","score_opus":0.06045044467762806,"score_gpt":0.3474489737033685,"score_spread":0.28699852902574047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990037063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887396,0.0033077328,0.0033657772,0.0027356967,0.0004511145,0.0012760303,0.000013833395,0.000014218887,0.00009600661],"genre_scores_gemma":[0.98924875,0.0002829037,0.009786045,0.00010591646,0.00041693242,0.000057095767,0.000019796678,0.000016115016,0.00006647154],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982407,0.00042965217,0.0004647998,0.0002181715,0.00045476918,0.00019191935],"domain_scores_gemma":[0.99851084,0.0004359462,0.0002763178,0.0002276577,0.00029287272,0.0002563768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021540837,0.00016025438,0.0004900653,0.00014294789,0.0001714226,0.000024373561,0.000035181252,0.00008870606,0.0000059073013],"category_scores_gemma":[0.0005553653,0.0001368966,0.0003501215,0.00013012123,0.00010930141,0.0004666408,0.000010487309,0.00023458072,9.3238003e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05820512,0.0027587533,0.035545,0.0045113917,0.002239877,0.000012418476,0.009876315,0.0018754285,0.051217366,0.00026242377,0.006652273,0.8268436],"study_design_scores_gemma":[0.016463695,0.020178545,0.93594724,0.0031550587,0.0019205315,0.0005094891,0.006403079,0.0014749664,0.004767494,0.00034961465,0.008244358,0.000585946],"about_ca_topic_score_codex":0.000029450808,"about_ca_topic_score_gemma":0.0000025930487,"teacher_disagreement_score":0.90040225,"about_ca_system_score_codex":0.00015721846,"about_ca_system_score_gemma":0.00011870206,"threshold_uncertainty_score":0.55824816},"labels":[],"label_agreement":null},{"id":"W1990092121","doi":"10.1016/j.jacl.2011.07.005","title":"Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists","year":2011,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":266,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institutes of Health; National Lipid Association; Abbott Laboratories; Merck; AstraZeneca; Genzyme; Pfizer","keywords":"Medicine; National Cholesterol Education Program; Hypertriglyceridemia; Residual risk; Apolipoprotein B; Internal medicine; Population; Cholesterol; Lipoprotein; Biomarker; Intensive care medicine; Metabolic syndrome; Physical therapy; Obesity; Environmental health; Triglyceride","score_opus":0.17471571907754718,"score_gpt":0.40713855426934764,"score_spread":0.23242283519180046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990092121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323326,0.001000085,0.00020640105,0.00028939912,0.0028843759,0.00039647552,0.000012574675,0.00001925792,0.0019581912],"genre_scores_gemma":[0.9489412,0.0016116541,0.039020687,0.00069332664,0.009672121,0.0000042912434,0.000003825708,0.000031840413,0.00002105433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.992282,0.0017221681,0.004670077,0.0004248372,0.0005883895,0.0003125776],"domain_scores_gemma":[0.9929637,0.0018984004,0.0026725659,0.0008322588,0.000932642,0.0007004526],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009484801,0.00023301157,0.0025426648,0.000136145,0.000036087356,0.000003928756,0.00030106906,0.0006124723,0.00031366025],"category_scores_gemma":[0.011552996,0.00017952279,0.00085259514,0.0001706849,0.00086353865,0.00018287094,0.0001275552,0.0011007271,0.0000030440647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010673196,0.0013803687,0.5201083,0.00020225701,0.0006279821,0.00006718009,0.00032306276,4.0772474e-7,0.0005679124,0.000045497763,0.0005959196,0.4654079],"study_design_scores_gemma":[0.0061716344,0.0062955683,0.9722731,0.00038476114,0.00027133964,0.00019017806,0.00027203938,0.00007089712,0.0004980322,0.00047740978,0.012944395,0.0001506058],"about_ca_topic_score_codex":0.00050562504,"about_ca_topic_score_gemma":0.0000697204,"teacher_disagreement_score":0.46525732,"about_ca_system_score_codex":0.000016812768,"about_ca_system_score_gemma":0.00074659585,"threshold_uncertainty_score":0.9967731},"labels":[],"label_agreement":null},{"id":"W1990237691","doi":"10.1126/scitranslmed.3008782","title":"PCSK9 is a critical regulator of the innate immune response and septic shock outcome","year":2014,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":370,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Septic shock; Regulator; Innate immune system; Immune system; Medicine; Shock (circulatory); Sepsis; Immunology; Biology; Intensive care medicine; Internal medicine","score_opus":0.023590841726594182,"score_gpt":0.3282403711257987,"score_spread":0.3046495293992045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990237691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92135614,0.000794958,0.0016072742,0.074928045,0.00018771795,0.00033123902,0.0000042024903,0.000013463499,0.0007769669],"genre_scores_gemma":[0.9970518,0.0000083869345,0.00094860926,0.0016214969,0.00016434546,0.0000063102716,8.7851294e-7,0.000007678245,0.00019051092],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997782,0.00011323463,0.00037016728,0.00025707707,0.0012640803,0.00021344221],"domain_scores_gemma":[0.998876,0.00021004464,0.00004799379,0.00045438876,0.00023418419,0.00017744003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004121869,0.00009800179,0.00030568376,0.00013114746,0.00018293371,0.000005937111,0.00014862651,0.000038000573,0.000094926916],"category_scores_gemma":[0.0016160312,0.000055669654,0.000092389666,0.0005820888,0.00199995,0.00007042397,0.000025025116,0.00014732113,0.0000029792886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031183723,0.00029469014,0.15339011,0.0014628313,0.00017455939,0.000015294894,0.0075868936,0.000053738542,0.6770751,0.09075206,0.00031965648,0.06575669],"study_design_scores_gemma":[0.0016167556,0.00032336722,0.98874193,0.0002712082,0.00009048418,0.00011420624,0.000103587365,0.0016940251,0.003382244,0.0015758505,0.0020151755,0.00007118993],"about_ca_topic_score_codex":0.000044730536,"about_ca_topic_score_gemma":0.000002202596,"teacher_disagreement_score":0.8353518,"about_ca_system_score_codex":0.000021110915,"about_ca_system_score_gemma":0.00028263923,"threshold_uncertainty_score":0.73688996},"labels":[],"label_agreement":null},{"id":"W1990300258","doi":"10.1097/fjc.0b013e3181e7fd74","title":"Effects of Ezetimibe Add-on to Statin Therapy on Adipokine Production in Patients With Metabolic Syndrome and Stable Vascular Disease","year":2010,"lang":"en","type":"article","venue":"Journal of Cardiovascular Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; St. Michael's Hospital; Canadian Respiratory Research Network","funders":"","keywords":"Ezetimibe; Adipokine; Adiponectin; Medicine; Metabolic syndrome; Internal medicine; Statin; Endocrinology; Atorvastatin; Cholesterol; Leptin; Gastroenterology; Insulin resistance; Obesity","score_opus":0.004845781750131126,"score_gpt":0.24049802456164,"score_spread":0.23565224281150887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990300258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98804533,0.008795292,0.00011906094,0.00026207848,0.00078952196,0.001952775,0.000006507735,0.0000105923855,0.000018823155],"genre_scores_gemma":[0.9963512,0.0020948998,0.00051444955,0.0004761494,0.00043418,0.00006387767,0.0000045531933,0.000048844544,0.000011890418],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971346,0.00045537067,0.000505322,0.00036354328,0.0011917977,0.00034935764],"domain_scores_gemma":[0.99828666,0.00006559553,0.00022197727,0.0004815334,0.00046541827,0.00047880723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017461985,0.0002663436,0.0013283927,0.00055871136,0.000049112296,0.000009571687,0.00011889157,0.000097890035,0.000034267203],"category_scores_gemma":[0.00018259707,0.00018634509,0.00069238106,0.00042162096,0.00007972769,0.00012369656,0.00002798211,0.0006834872,0.000003108485],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060127135,0.01363475,0.10002771,0.0043945014,0.07579546,0.0058281203,0.0016724918,0.0338226,0.05361811,0.0001359505,0.002311422,0.64863175],"study_design_scores_gemma":[0.02191292,0.0047056885,0.90166444,0.000271554,0.0028753267,0.0001979546,0.000010705547,0.00000949203,0.043423146,0.000013685151,0.024677498,0.0002375963],"about_ca_topic_score_codex":0.00003807376,"about_ca_topic_score_gemma":0.000002080719,"teacher_disagreement_score":0.8016367,"about_ca_system_score_codex":0.00006274019,"about_ca_system_score_gemma":0.00024062826,"threshold_uncertainty_score":0.75989324},"labels":[],"label_agreement":null},{"id":"W1990686245","doi":"10.1007/s11883-005-0006-4","title":"Genetic lipoprotein disorders and coronary atherosclerosis","year":2005,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Medicine; Coronary artery disease; Familial hypercholesterolemia; Disease; Coronary atherosclerosis; Lipoprotein; Genetic predisposition; Bioinformatics; Angiology; Internal medicine; Cholesterol; Biology","score_opus":0.05202555971377034,"score_gpt":0.328964448063002,"score_spread":0.2769388883492317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990686245","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029177533,0.9899916,0.00009948602,0.000050962597,0.0012116367,0.0051494865,0.00004697649,0.00029453027,0.00023755619],"genre_scores_gemma":[0.0012145399,0.994063,0.000741131,0.00005918078,0.0016196762,0.001404398,0.00017549093,0.00039173602,0.00033081823],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99344856,0.0002991335,0.0020792903,0.00191607,0.0012364708,0.0010204654],"domain_scores_gemma":[0.99541557,0.00006302692,0.0011693668,0.002426503,0.00012048008,0.0008050805],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00085931824,0.0013413654,0.0040272526,0.000341897,0.00031873124,0.00013381695,0.00023686164,0.0007756284,0.00022716704],"category_scores_gemma":[0.00012147127,0.001086517,0.00228684,0.00057420594,0.00029981253,0.00014137272,0.00033389413,0.0012151287,0.000100004734],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000063147595,0.00035782982,0.0011653412,0.0127102295,0.00045006396,0.000026518072,0.00007471089,3.8366807e-7,0.0000030431954,0.000005374775,0.00046466934,0.98473555],"study_design_scores_gemma":[0.00059035054,0.00023148203,0.015738692,0.022770017,0.0030725996,0.0013243553,0.000009538417,0.000003945425,0.0000013832789,0.000022295844,0.9552886,0.00094674504],"about_ca_topic_score_codex":0.00013497724,"about_ca_topic_score_gemma":0.000028874196,"teacher_disagreement_score":0.9837888,"about_ca_system_score_codex":0.00045755834,"about_ca_system_score_gemma":0.00072138535,"threshold_uncertainty_score":0.9999337},"labels":[],"label_agreement":null},{"id":"W1990858269","doi":"10.1016/s0828-282x(06)70994-1","title":"PROVE-IT proves that lower is better: A contrary view","year":2006,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Medicine; Statin; C-reactive protein; Cholesterol; Ldl cholesterol; Internal medicine; Clinical trial; Lipoprotein; Epidemiology; Low-density lipoprotein; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Endocrinology; Cardiology; Inflammation","score_opus":0.03900676759280975,"score_gpt":0.295952301011685,"score_spread":0.25694553341887527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990858269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017316157,0.98358476,0.00018265223,0.0015922283,0.0015081946,0.0013937716,0.0001411624,0.000008912826,0.0115709985],"genre_scores_gemma":[0.0003015802,0.9892098,0.00013025054,0.0023376762,0.0071285553,0.000048059304,0.000056998888,0.00010063089,0.00068650267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99672556,0.0004871282,0.0011997952,0.000390191,0.0003969331,0.0008003893],"domain_scores_gemma":[0.9968712,0.000073670395,0.00073353975,0.0007857008,0.00031426433,0.0012216294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011757162,0.0005341403,0.005639082,0.0006062416,0.0001039579,0.000044424218,0.0003584458,0.0008040136,0.00007910181],"category_scores_gemma":[0.00011096161,0.0003799566,0.0036939185,0.00024105735,0.00022479096,0.00008531611,0.000020590844,0.0013433505,0.000050455925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000113000615,0.000003599548,0.00010446719,0.007866731,0.002113861,0.0030184733,0.000018024812,4.9269227e-7,8.156333e-8,0.000019291589,0.10682907,0.8800146],"study_design_scores_gemma":[0.0007306557,0.00042807794,0.00013723878,0.009611231,0.0037347397,0.016050551,0.000010720689,1.1773202e-7,4.877722e-7,0.000040522595,0.96895146,0.00030417743],"about_ca_topic_score_codex":0.0013302178,"about_ca_topic_score_gemma":0.00061248714,"teacher_disagreement_score":0.87971044,"about_ca_system_score_codex":0.0005784674,"about_ca_system_score_gemma":0.012022874,"threshold_uncertainty_score":0.99986523},"labels":[],"label_agreement":null},{"id":"W1991220810","doi":"10.1016/s0828-282x(07)70875-9","title":"Effects of an enhanced secondary prevention program for patients with heart disease: A prospective randomized trial","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Medical prescription; Randomized controlled trial; Intervention (counseling); Secondary prevention; Emergency medicine; Physical therapy; Internal medicine; Pediatrics; Nursing","score_opus":0.004291537052717207,"score_gpt":0.2591834876183248,"score_spread":0.2548919505656076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991220810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786175,0.0007301012,0.012662571,0.000066674125,0.0004467325,0.007190101,0.000011875801,0.000006236041,0.00026823446],"genre_scores_gemma":[0.9967799,0.0000078125295,0.0018247518,0.000062855695,0.0010941203,0.00016718035,0.000022999779,0.000018489003,0.000021878743],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986326,0.00026559585,0.0004484898,0.00014553936,0.00020454664,0.0003031958],"domain_scores_gemma":[0.99808145,0.0001328874,0.00025483858,0.00017160743,0.00062061165,0.00073862885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016377878,0.00011555476,0.0011261045,0.00020571183,0.000054298544,0.000006517628,0.00005612378,0.00009538643,0.0000035257208],"category_scores_gemma":[0.00056537654,0.00008109731,0.00060131744,0.00010214691,0.0001578903,0.0000743656,0.0000028297604,0.00018185024,2.3436266e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9413692,0.00008897652,0.0029215747,0.00038757164,0.0010923905,0.00005207779,0.00011409635,0.00001585249,0.000057193974,0.000063225634,0.00013266683,0.0537052],"study_design_scores_gemma":[0.8501183,0.01257512,0.13159189,0.00019470991,0.0010428899,0.000055342425,0.000028562696,0.00000181712,0.0007118461,0.00043941647,0.0031352956,0.000104808525],"about_ca_topic_score_codex":0.00012865622,"about_ca_topic_score_gemma":0.00024760392,"teacher_disagreement_score":0.12867032,"about_ca_system_score_codex":0.0001456243,"about_ca_system_score_gemma":0.002285402,"threshold_uncertainty_score":0.4054205},"labels":[],"label_agreement":null},{"id":"W1991611671","doi":"10.1161/atvbaha.114.304200","title":"The Effects of Diet on Occlusive Coronary Artery Atherosclerosis and Myocardial Infarction in Scavenger Receptor Class B, Type 1/Low-Density Lipoprotein Receptor Double Knockout Mice","year":2014,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"LDL receptor; Knockout mouse; Internal medicine; Scavenger receptor; Endocrinology; Apolipoprotein E; Cholesterol; Lipoprotein; Foam cell; Apolipoprotein B; Receptor; Biology; Medicine","score_opus":0.013438084671212398,"score_gpt":0.24893156877525588,"score_spread":0.23549348410404347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991611671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639505,0.00040690566,0.00004062251,0.0007426394,0.00080946065,0.0014933865,0.000009244063,0.000038953494,0.000063761465],"genre_scores_gemma":[0.9844969,0.014170432,0.0001505216,0.00060255406,0.00031232304,0.00018105148,0.000036848036,0.000043970933,0.000005429006],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99748206,0.0005986473,0.0004962958,0.00066062785,0.00027764644,0.0004846927],"domain_scores_gemma":[0.9984545,0.00032082247,0.0001842728,0.00070348626,0.0001443221,0.0001925752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011305009,0.0003517515,0.0009402168,0.0001237739,0.00031634606,0.00003653386,0.00012162707,0.00037261666,0.000014725914],"category_scores_gemma":[0.00019098422,0.0002546538,0.0003665078,0.0002489903,0.0004702539,0.000101337966,0.00015701442,0.00034907382,0.0000214683],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074767333,0.00055654347,0.1445788,0.00070129987,0.0018278479,1.9392694e-7,0.0012593261,0.000002257327,0.8220972,0.0008140786,0.00030451527,0.027110256],"study_design_scores_gemma":[0.004311086,0.0037575925,0.98114073,0.00055718503,0.00021200556,0.0000021429914,0.000119403965,0.000037196627,0.005158338,0.000035746165,0.0043996414,0.00026895094],"about_ca_topic_score_codex":0.00058779685,"about_ca_topic_score_gemma":0.00015547275,"teacher_disagreement_score":0.8365619,"about_ca_system_score_codex":0.00008946569,"about_ca_system_score_gemma":0.00005059049,"threshold_uncertainty_score":0.9999906},"labels":[],"label_agreement":null},{"id":"W1991781200","doi":"10.1016/s0140-6736(00)00016-7","title":"Role of WHO-MONICA Project in unravelling of the cardiovascular puzzle","year":2000,"lang":"en","type":"letter","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Medicine; Multidisciplinary approach; Epidemiology; Population; Disease; Psychological intervention; Estimation; Coronary heart disease; Demography; Gerontology; Intensive care medicine; Internal medicine; Environmental health","score_opus":0.02519266474720109,"score_gpt":0.25703434935295083,"score_spread":0.23184168460574975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991781200","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20353876,0.17213286,0.000045125726,0.5400002,0.0007017575,0.010297109,0.00039230063,0.00012032922,0.07277156],"genre_scores_gemma":[0.51953566,0.04431573,0.00092310604,0.38094765,0.047383446,0.00066742103,0.00025234293,0.0005332573,0.005441404],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974594,0.00043329847,0.00045721448,0.0002965661,0.00094426353,0.00040922267],"domain_scores_gemma":[0.99679583,0.000053993048,0.00017581575,0.0028885715,0.00006637404,0.000019401643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013966946,0.00022372665,0.0017717059,0.000088374036,0.000049854778,0.0000075795997,0.0005807406,0.00038214386,0.000028718887],"category_scores_gemma":[0.000050792387,0.000116313466,0.0012525534,0.00038810048,0.00014438914,0.000017773842,0.000082644896,0.0015733364,0.000005758202],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011310558,0.00029776778,0.005697463,0.018911587,0.0150732,0.0005037849,0.008166522,0.00159623,0.0012653668,0.00025936193,0.8016509,0.14544679],"study_design_scores_gemma":[0.0011915106,0.000048040125,0.0033035376,0.0010651929,0.00053141994,0.00006569224,0.00004782617,0.0000352897,0.0013578405,0.0001346234,0.99209434,0.00012470043],"about_ca_topic_score_codex":0.0028482971,"about_ca_topic_score_gemma":0.000050574698,"teacher_disagreement_score":0.3159969,"about_ca_system_score_codex":0.000065416534,"about_ca_system_score_gemma":0.00034104075,"threshold_uncertainty_score":0.6835451},"labels":[],"label_agreement":null},{"id":"W1991965498","doi":"10.1542/peds.113.6.1723","title":"Usefulness of the American Academy of Pediatrics Recommendations for Identifying Youths With Hypercholesterolemia","year":2004,"lang":"en","type":"article","venue":"PEDIATRICS","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Family history; Overweight; Population; Familial hypercholesterolemia; Predictive value; Internal medicine; Diabetes mellitus; Pediatrics; Positive predicative value; Cholesterol; Obesity; Endocrinology; Environmental health","score_opus":0.060364441455133616,"score_gpt":0.33245563763995967,"score_spread":0.272091196184826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991965498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98640364,0.00039790012,0.00961291,0.0024120526,0.00012909777,0.0008347939,0.00012139799,0.000023645365,0.00006457615],"genre_scores_gemma":[0.98928714,0.0005621089,0.009001887,0.0004061596,0.0006072869,0.000054996253,0.000014058315,0.00002940866,0.00003698285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862975,0.000043775955,0.0003985005,0.00020793382,0.00048749073,0.00023253838],"domain_scores_gemma":[0.99887717,0.00008627289,0.00041373784,0.00033304316,0.0001876991,0.00010207251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005215586,0.00012826841,0.00042128612,0.00014626479,0.00009697573,0.000007696985,0.000171559,0.00007093834,0.0000026413293],"category_scores_gemma":[0.00015856158,0.000086166096,0.0002486697,0.0009430802,0.00010069251,0.0000709617,0.000054869615,0.00025500736,0.000001230612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012755028,0.0016278991,0.8667666,0.011841057,0.0004966649,0.000008085278,0.008760991,0.001983938,0.0012485539,0.0040258938,0.002289687,0.09967518],"study_design_scores_gemma":[0.018470453,0.0020981121,0.9272981,0.000485968,0.007469636,0.00022156087,0.005632832,0.00004889895,0.022254888,0.0018394568,0.013157344,0.0010226965],"about_ca_topic_score_codex":0.00020232928,"about_ca_topic_score_gemma":0.000014187953,"teacher_disagreement_score":0.09865248,"about_ca_system_score_codex":0.00008479975,"about_ca_system_score_gemma":0.00031233463,"threshold_uncertainty_score":0.35137513},"labels":[],"label_agreement":null},{"id":"W1992338633","doi":"10.1016/s0021-9150(00)00528-1","title":"Coronary artery disease in patients at low risk — apolipoprotein AI as an independent risk factor","year":2001,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"Medical Research Council Canada","keywords":"Medicine; Coronary artery disease; Internal medicine; Risk factor; Blood pressure; Cardiology; Apolipoprotein B; Diabetes mellitus; Lipoprotein(a); Cholesterol; Family history; Endocrinology","score_opus":0.01275576141399245,"score_gpt":0.24308887470034624,"score_spread":0.23033311328635378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992338633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971728,0.00024224808,0.00006220813,0.00014690786,0.00020486863,0.001715364,0.00024817424,0.00011815238,0.000089275425],"genre_scores_gemma":[0.9966055,0.0013220051,0.00007286096,0.0010026966,0.00028674473,0.00018370827,0.000104458944,0.000093954965,0.00032805433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967203,0.00035737487,0.000496142,0.0007433141,0.0010103692,0.0006724722],"domain_scores_gemma":[0.9975424,0.000026162737,0.0001962103,0.0012685743,0.00010630614,0.0008603586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043585352,0.00036948535,0.0005577864,0.00015141512,0.00024132479,0.000041197927,0.00018944389,0.00021391749,0.00072093407],"category_scores_gemma":[0.00013167942,0.00032172003,0.00038061888,0.00028653612,0.00007928288,0.0002645087,0.00012707846,0.0005445465,0.00041813956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008383192,0.0010846818,0.9541617,0.00004664031,0.00012341951,0.000046258596,0.00041706892,0.00002220511,0.00023229574,0.000004771699,0.00005669769,0.042965945],"study_design_scores_gemma":[0.005686608,0.0008336093,0.99141943,0.00016949834,0.00015849028,0.00000883906,0.000055128432,0.00013948658,0.00034384552,0.000111665504,0.0007376833,0.00033570515],"about_ca_topic_score_codex":0.0048680725,"about_ca_topic_score_gemma":0.0006009761,"teacher_disagreement_score":0.04263024,"about_ca_system_score_codex":0.0005224454,"about_ca_system_score_gemma":0.0001514527,"threshold_uncertainty_score":0.99992347},"labels":[],"label_agreement":null},{"id":"W1992798646","doi":"10.1161/circulationaha.111.055269","title":"Statins and Intracerebral Hemorrhage","year":2011,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research; Pfizer","keywords":"Medicine; Intracerebral hemorrhage; Confidence interval; Randomized controlled trial; Observational study; Relative risk; Internal medicine; Cohort study; Cohort; Absolute risk reduction; Rate ratio; Subarachnoid hemorrhage","score_opus":0.05589297333374839,"score_gpt":0.3172509071915789,"score_spread":0.2613579338578305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992798646","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023860323,0.99602765,0.0006422514,0.000008230809,0.00011894105,0.0010320094,0.000009390129,0.00004863371,0.001874294],"genre_scores_gemma":[0.0009011296,0.99757355,0.0006908135,0.00003806521,0.00040967963,0.00004996002,0.00021899206,0.00004262607,0.00007515969],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903286,0.000076134274,0.0003031968,0.00027459505,0.00015826143,0.00015493794],"domain_scores_gemma":[0.9993035,0.000013814736,0.00013454922,0.0003823755,0.000040237584,0.00012550094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027068792,0.00018583424,0.00092878356,0.000101894315,0.000048795227,0.000014741354,0.00003078964,0.00022183672,0.00010455502],"category_scores_gemma":[0.00003844353,0.000147317,0.00030087784,0.00012482212,0.000026324482,0.00004859161,0.000021124584,0.00023779376,0.00006379597],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000015407828,0.000013656558,0.000059353897,0.019700827,0.00008644997,0.000016669666,0.000041603766,3.466169e-8,1.04870495e-7,0.00031274377,0.000019412171,0.9797476],"study_design_scores_gemma":[0.00030824062,0.000029919798,0.002366732,0.003284718,0.0015463915,0.0007507264,0.000008124529,0.00003128094,2.4239606e-7,0.00007655689,0.99141514,0.00018191128],"about_ca_topic_score_codex":0.000051776387,"about_ca_topic_score_gemma":0.000002413986,"teacher_disagreement_score":0.9913958,"about_ca_system_score_codex":0.000086754735,"about_ca_system_score_gemma":0.00020139023,"threshold_uncertainty_score":0.60074127},"labels":[],"label_agreement":null},{"id":"W1992908766","doi":"10.2165/10061630-000000000-00000","title":"Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus","year":2010,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"AstraZeneca","keywords":"Dyslipidemia; Medicine; Atorvastatin; Statin; Rosuvastatin; Simvastatin; Internal medicine; Pharmacology; Type 2 Diabetes Mellitus; Fixed-dose combination; Combination therapy; Gastroenterology; Fenofibrate; Adverse effect; Diabetes mellitus; Endocrinology","score_opus":0.005073515122734928,"score_gpt":0.22884284159155013,"score_spread":0.2237693264688152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992908766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534893,0.0035641731,0.00021542418,0.0000779179,0.00007627732,0.0006303882,0.000011339141,0.000009242319,0.00006630198],"genre_scores_gemma":[0.99474883,0.00086138176,0.004116411,0.00008533811,0.00011064991,0.0000059316253,0.000010847309,0.0000532164,0.0000074033806],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99728066,0.000323193,0.0006674279,0.00032816295,0.0010271963,0.00037336594],"domain_scores_gemma":[0.997897,0.00014154267,0.0004643863,0.0006074776,0.0004917487,0.00039783897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014957091,0.00029142576,0.0018112854,0.00023570996,0.00006253614,0.000027309794,0.000106507236,0.00007438054,0.000008667318],"category_scores_gemma":[0.00017868417,0.00017990364,0.00029494133,0.00051526056,0.0005081293,0.00015272427,0.000035408117,0.00051652367,6.690672e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029406205,0.00050374685,0.1638466,0.0007347428,0.009880019,0.00021686786,0.0019856228,0.0004880213,0.00061487715,0.0000101494,0.000026531425,0.79228663],"study_design_scores_gemma":[0.031906173,0.0100609,0.9468952,0.0009766356,0.0021098503,0.00027732342,0.0009544776,0.00008678041,0.0036535591,0.000006922575,0.002583256,0.0004889457],"about_ca_topic_score_codex":0.00007691649,"about_ca_topic_score_gemma":0.000012162397,"teacher_disagreement_score":0.7917977,"about_ca_system_score_codex":0.000051138763,"about_ca_system_score_gemma":0.00047012442,"threshold_uncertainty_score":0.7336257},"labels":[],"label_agreement":null},{"id":"W1993223193","doi":"10.1111/ijcp.12503","title":"Comparative effectiveness of cardioprotective drugs in elderly individuals with type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"International Journal of Clinical Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval; Université du Québec à Rimouski","funders":"","keywords":"Medicine; Stroke (engine); Cohort; Diabetes mellitus; Internal medicine; Myocardial infarction; Type 2 diabetes; Odds ratio; Cohort study; Population; Endocrinology","score_opus":0.03606829206788894,"score_gpt":0.41763439906802236,"score_spread":0.38156610700013344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993223193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99163336,0.0004202703,0.0012250505,0.0007959921,0.0005987851,0.00031388315,0.0000027137482,0.0000043428427,0.0050055953],"genre_scores_gemma":[0.9947898,0.00011187465,0.0041900966,0.0002551889,0.0006262494,0.0000050780322,0.0000024523276,0.0000104847895,0.000008780106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603736,0.0015596456,0.0009673097,0.00015840132,0.0011562844,0.00012100924],"domain_scores_gemma":[0.9918258,0.00442844,0.0010424596,0.0001798188,0.0024035147,0.00011994197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010586434,0.00010707217,0.0009682345,0.00016241679,0.000014767615,0.00001694406,0.00018372033,0.00010055673,0.000012736102],"category_scores_gemma":[0.0077788644,0.000074162344,0.00027591156,0.00018596352,0.00010978647,0.00034048475,0.000035187528,0.0007433157,0.0000065385548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03751945,0.0043093064,0.6913275,0.0005136826,0.018149883,0.00043732885,0.0020912217,0.001137603,0.0011604638,0.0023304075,0.00023872394,0.24078445],"study_design_scores_gemma":[0.010437164,0.007851543,0.956371,0.0015848692,0.00055198744,0.0004289177,0.0006061883,0.00009711875,0.004016741,0.00075554923,0.01714663,0.00015227658],"about_ca_topic_score_codex":0.00007304315,"about_ca_topic_score_gemma":0.0000032175633,"teacher_disagreement_score":0.26504353,"about_ca_system_score_codex":0.00007191812,"about_ca_system_score_gemma":0.00041659025,"threshold_uncertainty_score":0.9312589},"labels":[],"label_agreement":null},{"id":"W1993417780","doi":"10.1016/j.jcjd.2014.01.006","title":"Effect of Atorvastatin on Pancreatic Beta-Cell Function and Insulin Resistance in Type 2 Diabetes Mellitus Patients: A Randomized Pilot Study","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Atorvastatin; Insulin resistance; Type 2 Diabetes Mellitus; Internal medicine; BETA (programming language); Beta cell; Type 2 diabetes; Diabetes mellitus; Endocrinology; Pancreatic function; Insulin; Gastroenterology; Pancreas; Islet","score_opus":0.006279266096487289,"score_gpt":0.2096849861137375,"score_spread":0.2034057200172502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993417780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98734283,0.011161834,0.0000036428803,0.00008308492,0.00019274784,0.00094920205,0.0000052997602,0.0000032390012,0.00025811684],"genre_scores_gemma":[0.99959385,0.000060401417,0.00005836582,0.00012806809,0.000098564306,0.000018426801,0.00000466886,0.00002145635,0.00001621588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763846,0.0010141649,0.0005907599,0.00015573976,0.00031264932,0.00028822094],"domain_scores_gemma":[0.9982124,0.0006223494,0.0003053003,0.00022898517,0.00022259839,0.00040835835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003439879,0.00016589029,0.0011935992,0.0003584184,0.00004778661,0.000017885624,0.00006544409,0.000042147236,0.000023847811],"category_scores_gemma":[0.0012850752,0.00011888348,0.00013388853,0.00024920117,0.000111368616,0.000063545565,0.000005501373,0.00023305682,0.0000026473633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008850092,0.00039027524,0.95773613,0.0010904022,0.00055761106,0.0000074759387,0.00043333473,0.00001214508,0.00010761907,0.000065789754,0.000112624824,0.030636474],"study_design_scores_gemma":[0.1852842,0.03689112,0.7733557,0.0012711328,0.0011831867,3.26662e-7,0.00010971966,0.000042475072,0.0010227432,0.00022846818,0.00040280883,0.00020812143],"about_ca_topic_score_codex":0.0005942841,"about_ca_topic_score_gemma":0.0028128577,"teacher_disagreement_score":0.18438046,"about_ca_system_score_codex":0.00010798108,"about_ca_system_score_gemma":0.0002621916,"threshold_uncertainty_score":0.48479277},"labels":[],"label_agreement":null},{"id":"W1994045865","doi":"10.1016/j.cca.2015.03.036","title":"Relationship between testosterone, estradiol and circulating PCSK9: Cross-sectional and interventional studies in humans","year":2015,"lang":"en","type":"article","venue":"Clinica Chimica Acta","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Ottawa Hospital; University of Ottawa","funders":"Heart and Stroke Foundation of Canada","keywords":"PCSK9; Internal medicine; Testosterone (patch); Endocrinology; Medicine; Sex steroid; Sex hormone-binding globulin; Hormone; Cholesterol; Androgen; Lipoprotein; LDL receptor; Steroid","score_opus":0.3112241717604299,"score_gpt":0.4488359585329868,"score_spread":0.13761178677255692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994045865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753064,0.00094385224,0.000010631701,0.0005707133,0.00014799286,0.00032604273,0.000011059868,0.000032436452,0.00042661084],"genre_scores_gemma":[0.9984435,0.00003576568,0.00064733205,0.00010235302,0.000565696,0.000022807959,0.00003946018,0.00001696675,0.00012611602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984615,0.000117104486,0.0006137136,0.0003568365,0.00026895144,0.00018191707],"domain_scores_gemma":[0.99883157,0.0004915233,0.00012752449,0.0002485664,0.0001022624,0.00019853548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016284531,0.0001277583,0.0004021708,0.000105793944,0.00011573288,0.000034730394,0.000051228868,0.00013628592,0.000007558571],"category_scores_gemma":[0.0019612354,0.000114872084,0.00011796327,0.00010884029,0.00027071623,0.0001317461,0.000088253146,0.0004027058,0.000003663056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003569992,0.000054134092,0.9987619,0.00015540565,0.00009209103,0.000005891258,0.00031166512,6.6953555e-7,0.00003322424,0.000115300696,0.00006498804,0.0003690096],"study_design_scores_gemma":[0.0023187732,0.0002796238,0.99493045,0.00018638509,0.000061765844,0.000106620806,0.00016324186,0.000025804902,0.000005954898,0.0014981122,0.00031823287,0.00010504137],"about_ca_topic_score_codex":0.00002431942,"about_ca_topic_score_gemma":0.000023329441,"teacher_disagreement_score":0.0038314776,"about_ca_system_score_codex":0.00008836044,"about_ca_system_score_gemma":0.000117711475,"threshold_uncertainty_score":0.46843475},"labels":[],"label_agreement":null},{"id":"W1994083200","doi":"10.1111/j.1464-5491.2011.03452.x","title":"Persistent lipid abnormalities in diabetes; are we approaching the treatment optimally?","year":2011,"lang":"en","type":"letter","venue":"Diabetic Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ezetimibe; Statin; Diabetes mellitus; Simvastatin; Cholesterol; Type 2 diabetes; Internal medicine; Disease; Intensive care medicine; Endocrinology","score_opus":0.044486423881824395,"score_gpt":0.24915994987887918,"score_spread":0.2046735259970548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994083200","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049608532,0.04517095,0.000028106571,0.8899661,0.0014450252,0.0033689,0.000036751473,0.00012817545,0.010247458],"genre_scores_gemma":[0.06627017,0.021087013,0.00041615748,0.8579807,0.03675403,0.0022307117,0.0011490072,0.0003971389,0.013715034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99539435,0.00048867485,0.00088542816,0.00082541374,0.0012325643,0.0011735677],"domain_scores_gemma":[0.9971934,0.00023825908,0.00034895114,0.0018396768,0.00011940741,0.0002602846],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014589834,0.0007828747,0.0021270867,0.00040635638,0.00016871419,0.000025038202,0.00038091108,0.00072446384,0.0005187816],"category_scores_gemma":[0.00012762642,0.00042211192,0.00088690553,0.00031214193,0.00046602642,0.00005026128,0.00007116137,0.0021797186,0.000053861906],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012661352,0.00074025523,0.013734121,0.008595413,0.004409767,0.0023067223,0.021908803,0.000029053137,0.000017410242,0.00007518596,0.9013678,0.04668888],"study_design_scores_gemma":[0.0040603597,0.00224457,0.0034878065,0.0044896295,0.0021871328,0.000105708976,0.0030186984,0.00019578659,0.00004179472,0.000044893055,0.97959673,0.0005268624],"about_ca_topic_score_codex":0.0010956771,"about_ca_topic_score_gemma":0.000030391424,"teacher_disagreement_score":0.07822898,"about_ca_system_score_codex":0.0005750893,"about_ca_system_score_gemma":0.00024790925,"threshold_uncertainty_score":0.9998231},"labels":[],"label_agreement":null},{"id":"W1994178659","doi":"10.1016/s0021-9150(00)81118-1","title":"Gender differences in serum levels of Lp(a) in coronary artery disease patients","year":2000,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Coronary artery disease; Internal medicine; Cardiology; Medicine; Disease","score_opus":0.04391036858423551,"score_gpt":0.2483054490134142,"score_spread":0.2043950804291787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994178659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848914,0.00030962582,0.000004423525,0.0001108186,0.000046152352,0.0004647206,0.00007407954,0.000016130101,0.0004849069],"genre_scores_gemma":[0.99894196,0.00042462023,0.00005934516,0.00031226844,0.00003485009,0.000039224713,0.000007494566,0.000019820442,0.00016039344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987027,0.00008751751,0.00032598554,0.00025335784,0.00036586454,0.00026456348],"domain_scores_gemma":[0.99939793,0.000018937943,0.000041100415,0.0003699759,0.000028036624,0.00014401114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018296271,0.00012958239,0.00037940365,0.00010631166,0.000025692758,0.0000079972,0.00007709226,0.00006988515,0.00088457606],"category_scores_gemma":[0.000016832328,0.00011194354,0.00014289064,0.00023291497,0.0000572778,0.00007173496,0.000020224781,0.0001238286,0.000028056524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009858857,0.0004180276,0.9201386,0.00009101748,0.000030229128,0.000007472623,0.0003587593,0.0000040690265,0.00014691638,0.000007946929,0.000012194672,0.07868617],"study_design_scores_gemma":[0.0023773212,0.00013217759,0.9968111,0.00022437921,0.000029034089,0.0000010732249,0.000052100815,0.000044591667,0.00008186255,0.00007175947,0.00006958225,0.00010502988],"about_ca_topic_score_codex":0.00039966486,"about_ca_topic_score_gemma":0.00012383843,"teacher_disagreement_score":0.07858114,"about_ca_system_score_codex":0.00007822133,"about_ca_system_score_gemma":0.00009513861,"threshold_uncertainty_score":0.9685487},"labels":[],"label_agreement":null},{"id":"W1994201240","doi":"10.1371/journal.pmed.1000196","title":"Measuring hsCRP—An Important Part of a Comprehensive Risk Profile or a Clinically Redundant Practice?","year":2010,"lang":"en","type":"article","venue":"PLoS Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Rosuvastatin; C-reactive protein; Medicine; Internal medicine; Jupiter (rocket family); Intensive care medicine; Clinical Practice; Clinical trial; Physical therapy; Inflammation; Physics; Spacecraft","score_opus":0.08348866371430289,"score_gpt":0.3445362045266701,"score_spread":0.26104754081236725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994201240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98848504,0.0011016112,0.000097102486,0.0034325873,0.0007702693,0.0019032351,0.000028237851,0.00013430078,0.004047629],"genre_scores_gemma":[0.97941434,0.0022626207,0.012278041,0.0017881093,0.0036258074,0.00014027188,0.0000634927,0.00008453921,0.00034276574],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99597037,0.00027931118,0.0013954814,0.0005209694,0.0014033774,0.000430485],"domain_scores_gemma":[0.9957232,0.00043507337,0.0008110462,0.0013892404,0.0010001896,0.0006412748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002803828,0.00026645997,0.0011990627,0.00013436237,0.000115927025,0.000007717389,0.00017777349,0.0002038544,0.00081115315],"category_scores_gemma":[0.0070871236,0.0001620137,0.00021847017,0.00031690902,0.00034863868,0.00014221392,0.00006377065,0.0011410976,0.00002792994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03315772,0.0145261185,0.09763635,0.008762618,0.012272869,0.0064040665,0.014560042,0.0000069095145,0.5154499,0.0017425326,0.017309336,0.27817157],"study_design_scores_gemma":[0.058391914,0.050103787,0.15850282,0.010024543,0.017759446,0.0089345975,0.022588909,0.003636391,0.054036487,0.00068625517,0.61314094,0.0021939275],"about_ca_topic_score_codex":0.0007634896,"about_ca_topic_score_gemma":0.000117906304,"teacher_disagreement_score":0.5958316,"about_ca_system_score_codex":0.000037555015,"about_ca_system_score_gemma":0.00068065687,"threshold_uncertainty_score":0.8881558},"labels":[],"label_agreement":null},{"id":"W199464482","doi":"","title":"Expected versus observed survival in 3 large population studies with HMG-CoA reductase inhibitors.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Pravastatin; Simvastatin; Placebo; Medicine; HMG-CoA reductase; Internal medicine; Cholesterol; Population; Hydroxymethylglutaryl-CoA reductase; Endocrinology; Reductase; Cardiology; Biology; Pathology","score_opus":0.0633797568477532,"score_gpt":0.276595338617481,"score_spread":0.21321558176972777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W199464482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994101,0.0024114044,0.0000015753711,0.0005747616,0.00035142983,0.0013812464,0.000007743846,0.00009541171,0.0010754127],"genre_scores_gemma":[0.99747694,0.00027374143,0.00010037685,0.00008241671,0.00054150046,0.0009495522,0.000087564724,0.000027395694,0.00046052234],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983008,0.00012723732,0.00028842056,0.00032033867,0.00047624373,0.00048696125],"domain_scores_gemma":[0.99927396,0.000029674282,0.000049342125,0.0004030161,0.00007650938,0.00016747542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006848273,0.00015995055,0.00045132267,0.00009604335,0.000072607436,0.000013746755,0.000047814876,0.00007705889,0.0000475168],"category_scores_gemma":[0.00016422757,0.00012251972,0.000104476065,0.00045026088,0.000031992295,0.00011572818,0.00001835095,0.00017928466,0.000009923645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013160988,0.0013830408,0.34312418,0.0007092527,0.0018126725,0.0008074268,0.0029875385,0.00013168024,0.00006780375,0.00024378892,0.00153017,0.6340415],"study_design_scores_gemma":[0.009064442,0.00012160006,0.9864131,0.00005726621,0.000104477345,0.0000118481485,0.0007274987,0.000010260423,0.00030577855,0.000013278956,0.00300624,0.00016416347],"about_ca_topic_score_codex":0.00085176295,"about_ca_topic_score_gemma":0.00095160154,"teacher_disagreement_score":0.64328897,"about_ca_system_score_codex":0.00023358193,"about_ca_system_score_gemma":0.000044412285,"threshold_uncertainty_score":0.4996209},"labels":[],"label_agreement":null},{"id":"W1994927664","doi":"10.1155/2013/341632","title":"Human Serum PCSK9 Is Elevated at Parturition in Comparison to Nonpregnant Subjects While Serum PCSK9 from Umbilical Cord Blood is Lower Compared to Maternal Blood","year":2013,"lang":"en","type":"article","venue":"ISRN Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Heart and Stroke Foundation of Canada","keywords":"PCSK9; Umbilical cord; Medicine; Pregnancy; Internal medicine; Cord blood; Endocrinology; Blood lipids; Lipoprotein; Cohort; Cholesterol; LDL receptor; Immunology; Biology","score_opus":0.0265228299546421,"score_gpt":0.2871994247170334,"score_spread":0.2606765947623913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994927664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901807,0.00044342264,0.000029271,0.0057007144,0.00045717403,0.002239504,0.00025665242,0.00019018214,0.0005023837],"genre_scores_gemma":[0.99120843,0.000046648453,0.0005360383,0.0059427503,0.00041055173,0.00040995402,0.00012791905,0.00007757488,0.0012401455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955705,0.00024524645,0.00094671623,0.001104863,0.0006228867,0.0015098344],"domain_scores_gemma":[0.9976601,0.000049074868,0.00014792301,0.0012407753,0.00022697376,0.0006751446],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00015871732,0.0004849866,0.0013709201,0.00031153928,0.00017821346,0.000055496897,0.00034467917,0.00029045247,0.00453252],"category_scores_gemma":[0.00003854232,0.0004583962,0.000300041,0.0003975501,0.00010028715,0.00011029489,0.00037351184,0.00060925575,0.0026918582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009768982,0.002640749,0.8481254,0.00028834364,0.001230111,0.0013658695,0.0013268684,0.000027715038,0.11873395,0.000085847256,0.016497603,0.008700629],"study_design_scores_gemma":[0.007203154,0.00164481,0.7791326,0.00035468684,0.0003290373,0.000493105,0.00020376657,0.00009073909,0.20025697,0.00012670869,0.0096856225,0.00047876855],"about_ca_topic_score_codex":0.012266451,"about_ca_topic_score_gemma":0.0042758,"teacher_disagreement_score":0.08152303,"about_ca_system_score_codex":0.00021565004,"about_ca_system_score_gemma":0.000092776136,"threshold_uncertainty_score":0.9997868},"labels":[],"label_agreement":null},{"id":"W1994966497","doi":"10.1016/j.atherosclerosis.2014.06.003","title":"Treatment of dyslipidemia: The problem of reaching the goal","year":2014,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Dyslipidemia; Medicine; Diabetes mellitus; Intensive care medicine; Endocrinology","score_opus":0.03625466422936963,"score_gpt":0.2628960937418888,"score_spread":0.2266414295125192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994966497","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05496347,0.0036728405,0.00034727252,0.9312653,0.00032627262,0.004076236,0.000079922094,0.00007530814,0.0051934063],"genre_scores_gemma":[0.4493676,0.0038128213,0.0026449016,0.5202741,0.016664516,0.0011719399,0.00026323533,0.00043416262,0.005366708],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975,0.00042994582,0.00061939686,0.0003459258,0.00074359105,0.00036113727],"domain_scores_gemma":[0.99738276,0.00029695767,0.00049854023,0.0016599433,0.00011496909,0.000046858328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087038585,0.0003349492,0.0010848145,0.00004879692,0.0001399282,0.000012978757,0.00029413332,0.0005272552,0.00003377567],"category_scores_gemma":[0.00003000777,0.0001454498,0.0010349092,0.00015595535,0.00023738056,0.000020127587,0.000047605186,0.00080047944,0.000013874072],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014272203,0.00053942576,0.007210039,0.0033594053,0.0054766955,0.000018578552,0.005544281,0.000021307973,0.0063310736,0.00043421102,0.8024604,0.16846187],"study_design_scores_gemma":[0.0013109756,0.0010746694,0.006080445,0.00058824907,0.0014003952,0.00002955034,0.00008001632,0.000017187855,0.0015577789,0.00008244535,0.9876086,0.00016969316],"about_ca_topic_score_codex":0.0016852854,"about_ca_topic_score_gemma":0.000016263659,"teacher_disagreement_score":0.41099116,"about_ca_system_score_codex":0.00015967507,"about_ca_system_score_gemma":0.00015199196,"threshold_uncertainty_score":0.5931271},"labels":[],"label_agreement":null},{"id":"W1995818130","doi":"10.1016/j.cjca.2015.03.019","title":"New Hope for Lipid-Lowering Beyond Statins: Effect of IMPROVE-IT on Understanding and Implementation of Atherosclerosis Prevention","year":2015,"lang":"en","type":"editorial","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Residual risk; Statin; Internal medicine; Pravastatin; Cholesterol; Lipoprotein; Pharmacology; Cardiology; Endocrinology","score_opus":0.026494402398878517,"score_gpt":0.31983747004913965,"score_spread":0.29334306765026114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995818130","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11314693,0.006505594,0.069937944,0.0007761293,0.8012085,0.005460509,0.0017660744,0.000013288589,0.0011850391],"genre_scores_gemma":[0.4416025,0.0012610543,0.0009186143,0.00003969201,0.5556641,0.000033787008,0.00023501454,0.0001123159,0.0001329252],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819213,0.00019462133,0.0007030866,0.00019607697,0.00042066834,0.00029341827],"domain_scores_gemma":[0.9977644,0.00029446193,0.00075086264,0.0002277208,0.00043978167,0.00052277517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025047006,0.00020730056,0.0014081051,0.00037917995,0.00005134233,0.000012694124,0.0000948863,0.00042342744,0.000007733433],"category_scores_gemma":[0.00061531685,0.00017613446,0.0005258747,0.00008642686,0.00006627798,0.000060444312,0.000011080981,0.00037930894,1.8429581e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009317542,0.0000030721224,0.0009695328,0.0021007927,0.0023766132,0.000013785302,0.0005174834,0.00007751914,0.0010414653,0.00006651762,0.9193379,0.07256356],"study_design_scores_gemma":[0.022077104,0.036692522,0.0013480093,0.002659556,0.0041490053,0.00010162551,0.00167796,0.0000040031027,0.0031211425,0.00073177327,0.9269913,0.00044600535],"about_ca_topic_score_codex":0.0033233764,"about_ca_topic_score_gemma":0.0026034142,"teacher_disagreement_score":0.32845557,"about_ca_system_score_codex":0.00076880306,"about_ca_system_score_gemma":0.0051683527,"threshold_uncertainty_score":0.9168436},"labels":[],"label_agreement":null},{"id":"W1995826500","doi":"10.1016/j.jtcvs.2007.05.039","title":"Patterns and predictors of statin use after coronary artery bypass graft surgery","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Pfizer","keywords":"Medicine; Odds ratio; Coronary artery disease; Coronary artery bypass surgery; Statin; Retrospective cohort study; Internal medicine; Surgery; Cardiology; Diabetes mellitus; Artery; Propensity score matching; Myocardial infarction; Derivation","score_opus":0.01891761634561216,"score_gpt":0.2616796680431347,"score_spread":0.24276205169752255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995826500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94901294,0.044983644,0.0050034923,0.00007222129,0.00062286516,0.00024643948,0.000025384405,0.00001595317,0.000017040802],"genre_scores_gemma":[0.9867915,0.011888585,0.00035882494,0.00016907172,0.0006963319,0.000005760045,0.000009604293,0.00004781041,0.00003253704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99637026,0.00035852197,0.0012204892,0.00030363604,0.0013022078,0.00044486378],"domain_scores_gemma":[0.997405,0.0006740183,0.00040501117,0.00059069006,0.0004108199,0.0005144851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008479657,0.00028853203,0.0018714992,0.0005539949,0.000065716245,0.000039684113,0.000055620247,0.00019844424,0.00002251712],"category_scores_gemma":[0.0003242951,0.00022662155,0.002484965,0.00025609793,0.0001338527,0.00038600888,0.00006104117,0.0004092096,8.911735e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010931604,0.00009856339,0.79486346,0.0008694899,0.0052772914,0.0040358542,0.000183171,0.000004587716,0.0000562759,0.0000010630573,0.00041020263,0.19310689],"study_design_scores_gemma":[0.00044886552,0.0001290203,0.98127025,0.0008424104,0.0019233648,0.009496789,0.0003762933,0.0000036432903,0.0007842219,0.000012311041,0.0044898223,0.00022299385],"about_ca_topic_score_codex":0.00010928205,"about_ca_topic_score_gemma":0.000009654187,"teacher_disagreement_score":0.1928839,"about_ca_system_score_codex":0.00004916874,"about_ca_system_score_gemma":0.00026894876,"threshold_uncertainty_score":0.92413586},"labels":[],"label_agreement":null},{"id":"W1995958361","doi":"10.1179/1077352512z.0000000008","title":"Rosuvastatin and the JUPITER trial: critical appraisal of a lifeless planet in the galaxy of primary prevention","year":2012,"lang":"en","type":"article","venue":"International Journal of Occupational and Environmental Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rosuvastatin; Jupiter (rocket family); Medicine; Randomized controlled trial; Clinical trial; Placebo; Primary prevention; Internal medicine; Alternative medicine; Astronomy; Pathology; Physics","score_opus":0.030159558858642337,"score_gpt":0.35451964837011074,"score_spread":0.3243600895114684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995958361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944783,0.0024927766,0.0004188357,0.0019875397,0.00024200528,0.00026621172,0.00005721294,7.105037e-7,0.00005642972],"genre_scores_gemma":[0.997645,0.0007826592,0.00063187635,0.00047525295,0.0003905418,0.0000068155264,0.00005885905,0.0000042253823,0.000004763069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983675,0.00022254529,0.0005488453,0.000058119265,0.00070537615,0.000097615804],"domain_scores_gemma":[0.99916327,0.00039694493,0.00028238897,0.000064508844,0.000022266808,0.000070627946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018791768,0.000063702595,0.00025869362,0.000067714376,0.000027588878,0.000006338497,0.000069566115,0.000028935907,0.00002846966],"category_scores_gemma":[0.000074035706,0.0000351671,0.00007870449,0.00002409408,0.00019280653,0.00011388304,0.000026818754,0.00014895534,3.957639e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14341709,0.0048146457,0.6306863,0.0010496303,0.000924003,0.000033679356,0.0138898725,0.00005590498,0.00052878645,0.015804933,0.0011426908,0.18765248],"study_design_scores_gemma":[0.01634161,0.00061980117,0.9802529,0.000116396885,0.000038666294,0.00061538524,0.00071645906,0.00003963511,0.000026428253,0.00019156691,0.001005814,0.000035321824],"about_ca_topic_score_codex":0.00009535109,"about_ca_topic_score_gemma":0.0000040654236,"teacher_disagreement_score":0.34956664,"about_ca_system_score_codex":0.00005361187,"about_ca_system_score_gemma":0.000101856,"threshold_uncertainty_score":0.14340727},"labels":[],"label_agreement":null},{"id":"W1995965477","doi":"10.1016/s0828-282x(07)70882-6","title":"Missed opportunities for the secondary prevention of cardiovascular disease in Canada","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; Canadian Heart Research Centre; University of Toronto; St. Michael's Hospital; Western University","funders":"Canadian Institutes of Health Research; Sanofi; University of Toronto; AstraZeneca; Pfizer","keywords":"Medicine; Guideline; Internal medicine; Coronary artery disease; Disease; Antithrombotic; Blood pressure; Cardiology; Statin; Intensive care medicine; Body mass index; Dosing; Clinical trial; Physical therapy; Pathology","score_opus":0.045407606417743024,"score_gpt":0.24841123786630415,"score_spread":0.20300363144856112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995965477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8858689,0.07710939,0.026319528,0.004314453,0.0017999002,0.0013697584,0.000117838805,0.0000033017898,0.0030969027],"genre_scores_gemma":[0.9984147,0.0004134331,0.00008820102,0.00028001823,0.0007159971,0.0000070761266,0.000008137542,0.000013106473,0.000059356928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987459,0.000116623356,0.0004801605,0.00009560629,0.00024201244,0.00031970732],"domain_scores_gemma":[0.99849653,0.00011223272,0.00013030609,0.00034437195,0.00030610195,0.00061047706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002419865,0.00009254579,0.0006284822,0.00019477305,0.000055138567,0.000004152326,0.000120028264,0.000058556398,0.000010983328],"category_scores_gemma":[0.00022233423,0.0000680888,0.0007440327,0.00009996808,0.00008522453,0.000035162026,0.000005084162,0.00021792583,1.03256546e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010909251,0.00000951936,0.054287482,0.000862455,0.009786452,0.0061568655,0.00027398873,0.018156491,0.00006081753,0.0006664706,0.015827863,0.89282066],"study_design_scores_gemma":[0.0018664604,0.00019341156,0.20626533,0.000116132775,0.0008818369,0.0005069325,0.0015317713,0.000027587363,0.00007871067,0.00013235096,0.7883069,0.000092569746],"about_ca_topic_score_codex":0.69911814,"about_ca_topic_score_gemma":0.746042,"teacher_disagreement_score":0.8927281,"about_ca_system_score_codex":0.0005155001,"about_ca_system_score_gemma":0.023571279,"threshold_uncertainty_score":0.9819642},"labels":[],"label_agreement":null},{"id":"W1996626325","doi":"10.1371/journal.pone.0106294","title":"Plasma PCSK9 Levels Are Elevated with Acute Myocardial Infarction in Two Independent Retrospective Angiographic Studies","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; McGill University; Canadian Heart Research Centre; University of Ottawa","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health; Canadian Institutes of Health Research; National Center for Research Resources; University of Ottawa; Taibah University; Emory University","keywords":"PCSK9; Medicine; Coronary artery disease; Myocardial infarction; Internal medicine; Cardiology; Stenosis; Cholesterol; LDL receptor; Lipoprotein","score_opus":0.03760705702361972,"score_gpt":0.27170319861033343,"score_spread":0.2340961415867137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996626325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971501,0.00048130436,0.00007451172,0.00063602615,0.00006487494,0.00095117645,0.0000136663575,0.000103040205,0.00052524713],"genre_scores_gemma":[0.99783117,0.0003839534,0.0007930719,0.00027826673,0.0004329327,0.00015568268,0.00001584886,0.0000366275,0.000072475465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978853,0.00014200399,0.0002670391,0.0004078275,0.0009460177,0.0003518119],"domain_scores_gemma":[0.99889964,0.000027906723,0.00012382625,0.00046486364,0.00035164523,0.00013212892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006366365,0.00020820013,0.00079265283,0.00032038242,0.00009030941,0.00001631029,0.00006330405,0.00008821296,0.000013366315],"category_scores_gemma":[0.00013278011,0.00016301499,0.00021427916,0.0006815928,0.000082365535,0.00010347137,0.000045673958,0.00040702085,0.000020127252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010658678,0.0013759083,0.9597062,0.00038220588,0.02430314,0.00019316723,0.0009745188,0.000018242476,0.009678044,0.00036104335,0.000054545984,0.001887136],"study_design_scores_gemma":[0.0066901497,0.0009908072,0.9816313,0.00082480465,0.0017882036,0.00005751157,0.00033596333,0.00011633838,0.006948497,0.00032220283,0.000053483964,0.00024074994],"about_ca_topic_score_codex":0.00029687845,"about_ca_topic_score_gemma":0.0006375144,"teacher_disagreement_score":0.022514937,"about_ca_system_score_codex":0.00024874596,"about_ca_system_score_gemma":0.0000735646,"threshold_uncertainty_score":0.6647559},"labels":[],"label_agreement":null},{"id":"W1996819821","doi":"10.1111/j.1365-2796.2005.01528.x","title":"Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review","year":2005,"lang":"en","type":"review","venue":"Journal of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":582,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nicotinic agonist; Niacin; Medicine; Pharmacology; Endocrinology; Internal medicine; Receptor","score_opus":0.032264300723476746,"score_gpt":0.3517637627351707,"score_spread":0.31949946201169394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996819821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006249423,0.97541136,0.00009274028,0.017518282,0.0020990933,0.001331967,0.000007806208,0.00002106414,0.0035114533],"genre_scores_gemma":[0.000020760304,0.96860695,0.00011620741,0.007844609,0.0207895,0.000017164582,0.000010867016,0.000096681324,0.0024972402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935169,0.00065163086,0.0029567676,0.00038695225,0.0019527874,0.00053495116],"domain_scores_gemma":[0.99463713,0.000266622,0.0029166862,0.0011327701,0.00042281076,0.0006239666],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0048935623,0.0006985099,0.0059644924,0.0004906666,0.00009405135,0.000019426807,0.0009802099,0.00025037854,0.0013902927],"category_scores_gemma":[0.00095956394,0.00031739494,0.003331688,0.0006148832,0.00025596263,0.00013226752,0.00015076909,0.0033468022,0.00013596572],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006943119,0.00007746579,0.0000036802096,0.030964598,0.0017828511,0.0006857118,0.00008268321,4.4945985e-8,5.164352e-7,0.000014954972,0.1364041,0.829914],"study_design_scores_gemma":[0.0010942869,0.00081981334,0.000012301705,0.30517155,0.0070883883,0.024501216,0.000055889803,5.072106e-7,0.000001329653,0.0000065224535,0.66108584,0.00016239159],"about_ca_topic_score_codex":0.00011135025,"about_ca_topic_score_gemma":0.00001190386,"teacher_disagreement_score":0.82975155,"about_ca_system_score_codex":0.0006288664,"about_ca_system_score_gemma":0.0013598492,"threshold_uncertainty_score":0.9999278},"labels":[],"label_agreement":null},{"id":"W1997224822","doi":"10.1016/j.cjca.2012.03.021","title":"Statin Use and the Risk of Incident Diabetes Mellitus: A Review of the Literature","year":2012,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Diabetes mellitus; Statin; Adverse effect; Internal medicine; Incidence (geometry); Intensive care medicine; Clinical trial; Randomized controlled trial; Disease; Placebo; Endocrinology; Alternative medicine","score_opus":0.024227483165561284,"score_gpt":0.2726595038459784,"score_spread":0.24843202068041714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997224822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035182954,0.9975712,0.000011598406,0.00028543043,0.00044281626,0.0010064127,0.00022360194,8.128266e-7,0.00010635731],"genre_scores_gemma":[0.0019299055,0.99670154,0.00005266248,0.00030021006,0.00094310753,0.000015399195,0.00001181777,0.000024647317,0.000020734866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99544525,0.00268057,0.0011386558,0.00012859948,0.0002960475,0.000310886],"domain_scores_gemma":[0.9962541,0.0004293715,0.0015736124,0.00074769394,0.00057355955,0.0004216829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047346335,0.00024400468,0.004018312,0.00017905605,0.00006363935,0.000012586549,0.0002792642,0.00026973418,0.0000092875825],"category_scores_gemma":[0.0018120026,0.00010293931,0.0023018022,0.00031327092,0.00047671443,0.000052548286,0.000035836256,0.0010411398,6.7297447e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016455411,0.0000023254556,0.0026318836,0.12541607,0.004346542,0.00004309808,0.00027450663,0.0000012044445,9.917321e-8,0.00019457389,0.0027718716,0.8643014],"study_design_scores_gemma":[0.00044549897,0.00007716747,0.0018925393,0.097408,0.009424133,0.0012617811,0.000015960752,5.8248663e-8,4.6556258e-7,0.000034174678,0.8893661,0.00007415375],"about_ca_topic_score_codex":0.0008789599,"about_ca_topic_score_gemma":0.0002367202,"teacher_disagreement_score":0.8865942,"about_ca_system_score_codex":0.00012261777,"about_ca_system_score_gemma":0.0028019287,"threshold_uncertainty_score":0.49705014},"labels":[],"label_agreement":null},{"id":"W1997586556","doi":"10.1161/circulationaha.105.598987","title":"Vascular Biomarkers and Surrogates in Cardiovascular Disease","year":2006,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Biomarker; Disease; Drug development; Intensive care medicine; Population; Biomarker discovery; Surrogate endpoint; Bioinformatics; Drug; Pathology; Pharmacology; Environmental health","score_opus":0.01070778247733023,"score_gpt":0.2248941570753525,"score_spread":0.21418637459802228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997586556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771765,0.019971693,0.0010631982,0.00016181021,0.000058199978,0.0005702755,0.0000021715773,0.000050607345,0.00094557396],"genre_scores_gemma":[0.99931484,0.0001707428,0.00017218958,0.000030258845,0.00018148126,0.000031675245,0.000070733055,0.000018703104,0.000009353813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988458,0.00007605025,0.00019626021,0.0003021714,0.00038942206,0.00019029708],"domain_scores_gemma":[0.9993405,0.000011119495,0.000024359917,0.00045308235,0.00004906832,0.00012186641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000599094,0.00010978814,0.00028094178,0.00013934296,0.000051506453,0.000018136147,0.0000229323,0.000065185865,0.000014170292],"category_scores_gemma":[0.000043158154,0.00010480614,0.0003118541,0.00024900478,0.00004048033,0.00008801811,0.000013959494,0.000072332,0.000008401304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039322167,0.00007315511,0.97537345,0.0002711193,0.00039353262,0.00007985147,0.000035549623,0.0018958955,0.0004467278,0.00051070953,0.000025192272,0.020855485],"study_design_scores_gemma":[0.0014730258,0.00000803947,0.99220884,0.00006680707,0.00022568989,0.000020254958,0.000023437962,0.0024026698,0.000056912373,0.0004941782,0.002909081,0.00011106252],"about_ca_topic_score_codex":0.0011512317,"about_ca_topic_score_gemma":0.000022239004,"teacher_disagreement_score":0.02213839,"about_ca_system_score_codex":0.00008745686,"about_ca_system_score_gemma":0.0000619662,"threshold_uncertainty_score":0.42738703},"labels":[],"label_agreement":null},{"id":"W1997799057","doi":"10.1111/j.1365-2125.2008.03269.x","title":"Impact of adherence to statins on chronic heart failure in primary prevention","year":2008,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Statin; Disease; Cardiology; Primary prevention; Coronary artery disease; Intensive care medicine; Cohort; Physical therapy","score_opus":0.06455398163581318,"score_gpt":0.4485935559888676,"score_spread":0.3840395743530544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997799057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695826,0.0013114501,0.00011195076,0.0005239273,0.0004455103,0.00045803413,0.000008611577,0.0000051212537,0.00017716202],"genre_scores_gemma":[0.99360305,0.0028309193,0.0012533382,0.00097230583,0.0012435206,0.0000069466946,0.000003153459,0.0000134632955,0.00007328528],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99731684,0.0005063545,0.001379564,0.0001682205,0.00038614808,0.0002428504],"domain_scores_gemma":[0.9987002,0.00019371667,0.00040173536,0.000112931106,0.00025419524,0.0003371956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018764534,0.00009181124,0.0009650392,0.0001200038,0.000029203049,0.0000033551416,0.00010471398,0.00013088867,0.00040924762],"category_scores_gemma":[0.00039039948,0.000086806256,0.0007602052,0.00019512938,0.00009488761,0.000077136865,0.000028255236,0.0008416471,0.000013261906],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006262955,0.0057577053,0.19478618,0.00049057824,0.0012365576,0.005480845,0.0001276825,0.001073887,0.01103429,0.0000031970314,0.12715928,0.64658684],"study_design_scores_gemma":[0.009468727,0.02215913,0.9581173,0.00065592886,0.00009299406,0.005264324,0.000008023898,0.000010606729,0.0003611952,0.000019160978,0.003764397,0.000078231344],"about_ca_topic_score_codex":0.00015685066,"about_ca_topic_score_gemma":0.00005912114,"teacher_disagreement_score":0.7633311,"about_ca_system_score_codex":0.00021580039,"about_ca_system_score_gemma":0.00188477,"threshold_uncertainty_score":0.44809744},"labels":[],"label_agreement":null},{"id":"W1997930387","doi":"10.1592/phco.23.4.506.32129","title":"The Importance of In‐Hospital Statin Therapy for Patients with Acute Coronary Syndromes","year":2003,"lang":"en","type":"review","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université Laval; Centre hospitalier universitaire de Québec; University of Alberta; Sunnybrook Health Science Centre; St. Michael's Hospital; Institute for Clinical Evaluative Sciences; University of Saskatchewan; Royal Columbian Hospital; Hamilton Health Sciences; Toronto General Hospital; University of Toronto; University Health Network; Health Sciences Centre","funders":"","keywords":"Medicine; Acute coronary syndrome; Statin; Internal medicine; Cardiology; Intensive care medicine; Myocardial infarction","score_opus":0.023915234890380204,"score_gpt":0.36399560597273317,"score_spread":0.34008037108235295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997930387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21315944,0.782187,0.000009480804,0.00034950086,0.0004610629,0.0037699768,0.00004206828,0.000007706125,0.000013786282],"genre_scores_gemma":[0.00639422,0.99165654,0.000081369595,0.0010718914,0.00031117778,0.00021738217,0.000017188004,0.00011934551,0.0001308844],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961081,0.001128373,0.0014213076,0.00029402983,0.00054509944,0.00050306757],"domain_scores_gemma":[0.9964218,0.000747508,0.0019011878,0.00036914545,0.00039097283,0.00016937875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028091054,0.0005866025,0.0022634068,0.00022469588,0.00038461006,0.000021680025,0.000513329,0.00015778875,0.00012630761],"category_scores_gemma":[0.000006353826,0.00026334525,0.00078044616,0.0002838383,0.00046950602,0.00013398974,0.00002147838,0.0009851477,5.427197e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0090972455,0.0023396828,0.0033170448,0.0017677635,0.014842279,0.00012376242,0.0013933091,0.0000019732227,0.0001593986,0.00004788435,0.006727492,0.9601822],"study_design_scores_gemma":[0.029482927,0.0077382983,0.0011183749,0.0011611914,0.0025541566,0.00060228293,0.00011213083,0.0000016547206,0.00025238004,0.00022006148,0.95631623,0.00044028112],"about_ca_topic_score_codex":0.0000063472994,"about_ca_topic_score_gemma":0.0000028333875,"teacher_disagreement_score":0.9597419,"about_ca_system_score_codex":0.00011370211,"about_ca_system_score_gemma":0.0006360829,"threshold_uncertainty_score":0.9999819},"labels":[],"label_agreement":null},{"id":"W1998053144","doi":"10.1016/j.cjca.2014.07.002","title":"The Effect of Infrequent Low-Dose Rosuvastatin on the Lipid Profile","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Rosuvastatin; Medicine; Statin; Lipid profile; Internal medicine; Cholesterol; Rosuvastatin Calcium; Low-density lipoprotein; Gastroenterology; Endocrinology; Urology","score_opus":0.007257704182183672,"score_gpt":0.2285723540062208,"score_spread":0.22131464982403715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998053144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97326726,0.0013262708,0.00051552366,0.0058517912,0.0012020932,0.0006699153,0.000012429374,0.0000043299688,0.017150404],"genre_scores_gemma":[0.99761343,0.000069483576,0.000023505223,0.00041698432,0.00176099,0.000013496203,0.0000018011771,0.000014653617,0.00008563809],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813205,0.0008529881,0.00036516317,0.00009253307,0.00023890485,0.00031834628],"domain_scores_gemma":[0.9982871,0.00048555102,0.00020345152,0.00046225503,0.00018355343,0.00037809502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003515948,0.00011351138,0.00056524534,0.00009538753,0.00015820688,0.000012198198,0.0001909618,0.000085659005,0.000017878727],"category_scores_gemma":[0.0012596654,0.000051773994,0.00046178623,0.00010506551,0.00023198579,0.000017645989,0.000008469558,0.00041370513,0.000013998287],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019672199,0.000011804212,0.072507374,0.00065335893,0.0041518267,0.0005654042,0.00086133985,0.0030109906,0.0032834082,0.011646482,0.15015742,0.7511834],"study_design_scores_gemma":[0.00398299,0.008985132,0.12310648,0.0004117917,0.0004506316,0.0020708528,0.0002043656,0.00006866698,0.007150781,0.00029878857,0.8530776,0.00019191581],"about_ca_topic_score_codex":0.0006744409,"about_ca_topic_score_gemma":0.00039775405,"teacher_disagreement_score":0.75099146,"about_ca_system_score_codex":0.00011683797,"about_ca_system_score_gemma":0.00086164154,"threshold_uncertainty_score":0.21112822},"labels":[],"label_agreement":null},{"id":"W1998602867","doi":"10.7326/0003-4819-159-2-201307160-02003","title":"Meta-analysis: Atorvastatin reduces CV events and increases new-onset diabetes in patients with coronary disease","year":2013,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Atorvastatin; Diabetes mellitus; Internal medicine; Type 2 diabetes; Meta-analysis; Cardiology; Disease; Coronary heart disease; Endocrinology","score_opus":0.05217344141865606,"score_gpt":0.30410949677011795,"score_spread":0.2519360553514619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998602867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8154347,0.016453624,0.0000067743845,0.16681197,0.00007150059,0.0009631272,0.00019370769,0.000017267475,0.000047351794],"genre_scores_gemma":[0.6988693,0.00060767564,0.0001189392,0.29645905,0.0010006488,0.00012232995,0.0009789165,0.00007317736,0.0017699555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959112,0.00033708118,0.0010010076,0.00065185083,0.0016006769,0.0004981744],"domain_scores_gemma":[0.99732167,0.0002185595,0.00063068024,0.00078269857,0.0004828448,0.0005635232],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006556981,0.0005479356,0.0031931554,0.00078586396,0.000029265278,0.0000111832205,0.00023813301,0.00022732318,0.0010695958],"category_scores_gemma":[0.00034947848,0.00032068393,0.00089391705,0.00041196955,0.00024501167,0.00013275599,0.00009759243,0.00087309617,0.000009904888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006956789,0.00021595723,0.49282378,0.00073676277,0.12641379,0.0002370305,0.00008780555,0.0000010970226,0.0000018790453,6.386248e-7,0.37716657,0.0016190269],"study_design_scores_gemma":[0.0026080348,0.0018738396,0.87287015,0.0013723184,0.113343485,0.000009857944,0.00003567729,0.0000084116855,0.00004019599,0.00009731889,0.007427901,0.0003127931],"about_ca_topic_score_codex":0.007616908,"about_ca_topic_score_gemma":0.00005259947,"teacher_disagreement_score":0.3800464,"about_ca_system_score_codex":0.00003177811,"about_ca_system_score_gemma":0.00022696074,"threshold_uncertainty_score":0.99992454},"labels":[],"label_agreement":null},{"id":"W1998764524","doi":"10.3821/1913-701x-142.6.280","title":"Assessment of Muscle Pain Associated with Statins — A Tool for Pharmacists","year":2009,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Physical medicine and rehabilitation; Physical therapy","score_opus":0.025663647879756137,"score_gpt":0.29677070410703893,"score_spread":0.2711070562272828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998764524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901709,0.0006895693,0.0041555334,0.0003268317,0.00061226514,0.0018593922,0.001039251,0.00004368205,0.0011025786],"genre_scores_gemma":[0.9907377,0.0010079185,0.0018938711,0.0051347725,0.0006417599,0.000050408846,0.00013613066,0.00006658542,0.00033087056],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9963003,0.0003272996,0.0008185183,0.00043956042,0.0009300154,0.0011843162],"domain_scores_gemma":[0.9955927,0.00017515538,0.00045010902,0.00036632948,0.0012824527,0.0021332162],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002853111,0.0004168539,0.0008332397,0.00036143503,0.0005810547,0.00008522537,0.00031839008,0.00008087889,0.00030174703],"category_scores_gemma":[0.00045482547,0.00038028602,0.00038061055,0.00069984765,0.00012558915,0.00022786939,0.000012350011,0.0006584041,7.1450046e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006705139,0.000638508,0.0076527474,0.0012852849,0.002440932,0.066244714,0.0010161102,0.0017049417,0.014954155,0.00017737503,0.032692425,0.87052226],"study_design_scores_gemma":[0.06845146,0.005647499,0.019395705,0.000972192,0.0049874936,0.6794852,0.000101823935,0.056007963,0.014999759,0.00040155312,0.14540155,0.0041478104],"about_ca_topic_score_codex":0.004534059,"about_ca_topic_score_gemma":0.01401837,"teacher_disagreement_score":0.8663745,"about_ca_system_score_codex":0.0033765275,"about_ca_system_score_gemma":0.011232142,"threshold_uncertainty_score":0.99986494},"labels":[],"label_agreement":null},{"id":"W1998838799","doi":"10.1016/j.atherosclerosis.2005.10.037","title":"Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia","year":2005,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Université Laval; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Familial hypercholesterolemia; Fenofibrate; Apolipoprotein B; Apolipoprotein E; Kinetics; Internal medicine; Medicine; Endocrinology; Cholesterol; Physics","score_opus":0.006981403828672059,"score_gpt":0.21076719211339154,"score_spread":0.2037857882847195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998838799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976466,0.0001751007,0.00006470379,0.00014615963,0.000039511404,0.0017021892,0.0000120568575,0.00004753398,0.00016617063],"genre_scores_gemma":[0.99648416,0.000055973753,0.0026005784,0.0004663684,0.00016371184,0.000101522906,0.000014375638,0.00007000846,0.0000433273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800235,0.00010258844,0.00042838536,0.0004479887,0.00059669954,0.00042195918],"domain_scores_gemma":[0.9990252,0.000051579198,0.00015069611,0.00049136986,0.00008915496,0.00019198406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023556223,0.00030721197,0.00064590416,0.00014386272,0.000058279562,0.000020979858,0.00009373887,0.00016816531,0.000006238075],"category_scores_gemma":[0.000065137734,0.00023980509,0.00010946119,0.00024558575,0.0001260689,0.00009237436,0.00005662757,0.00027896982,0.000008734137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002843098,0.0030444965,0.43540326,0.0028418098,0.00042472506,0.000023368448,0.0014602455,0.00016951116,0.20743361,0.00012182667,0.000045896406,0.34618816],"study_design_scores_gemma":[0.008781349,0.0027841425,0.9184487,0.0010806896,0.00009962776,0.0000047386343,0.000018659004,0.000039185314,0.068356544,0.0000068275376,0.00014530287,0.00023423639],"about_ca_topic_score_codex":0.00041144853,"about_ca_topic_score_gemma":0.00006191493,"teacher_disagreement_score":0.48304543,"about_ca_system_score_codex":0.0001329006,"about_ca_system_score_gemma":0.000034095054,"threshold_uncertainty_score":0.97789675},"labels":[],"label_agreement":null},{"id":"W1999226510","doi":"10.1002/clc.4960261106","title":"Differential effects of simvastatin and atorvastatin on high‐density lipoprotein cholesterol and apolipoprotein A‐I are consistent across hypercholesterolemic patient subgroups","year":2003,"lang":"en","type":"review","venue":"Clinical Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Simvastatin; Atorvastatin; Medicine; Apolipoprotein B; Internal medicine; Cholesterol; Endocrinology; Lipoprotein; High-density lipoprotein","score_opus":0.0477641335476208,"score_gpt":0.36390662271061053,"score_spread":0.3161424891629897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999226510","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5053687,0.48990372,0.00009380975,0.000035447658,0.0006762622,0.0037050797,0.00015579496,0.000041161966,0.000020030151],"genre_scores_gemma":[0.17635784,0.82156247,0.00020695054,0.00046189898,0.0006834713,0.00043950317,0.00012412595,0.00013408942,0.000029688634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910419,0.003391994,0.0024238215,0.0016408374,0.0006320817,0.0008693849],"domain_scores_gemma":[0.99487346,0.0013284573,0.0012799433,0.0015469822,0.00022507852,0.0007460471],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013563005,0.000997046,0.008643148,0.00016859098,0.00016199404,0.000038583028,0.00018335524,0.0015124216,0.000007658017],"category_scores_gemma":[0.0012040382,0.00075057696,0.0018553416,0.000191599,0.0010588017,0.000040235667,0.00038160477,0.0019673135,0.00001937379],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022409933,0.00022098007,0.001310059,0.028792808,0.001480898,0.00036676164,0.000053881166,2.9830792e-7,0.000007353649,0.000036754358,0.000059934013,0.96744615],"study_design_scores_gemma":[0.031642463,0.028077178,0.29222444,0.085876234,0.020706069,0.009220942,0.00046618094,0.000008196962,0.0003657078,0.00035417845,0.5266397,0.004418693],"about_ca_topic_score_codex":0.00033274427,"about_ca_topic_score_gemma":0.000040796655,"teacher_disagreement_score":0.9630275,"about_ca_system_score_codex":0.0001448368,"about_ca_system_score_gemma":0.00026755236,"threshold_uncertainty_score":0.9997838},"labels":[],"label_agreement":null},{"id":"W1999320125","doi":"10.1136/bmj.f2610","title":"Risk of incident diabetes among patients treated with statins: population based study","year":2013,"lang":"en","type":"article","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":408,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canada Research Chairs; Toronto General Hospital; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; St. Michael's Hospital","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Pravastatin; Rosuvastatin; Medicine; Fluvastatin; Atorvastatin; Hazard ratio; Diabetes mellitus; Internal medicine; Population; Statin; Confidence interval; Type 2 diabetes; Absolute risk reduction; Proportional hazards model; Simvastatin; Relative risk; Cohort study; Endocrinology; Cholesterol; Environmental health","score_opus":0.008710156137039808,"score_gpt":0.2511902698017296,"score_spread":0.24248011366468977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999320125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967826,0.000019410889,0.000028525808,0.00003061364,0.00001932175,0.0029725996,0.000008252233,0.00002713831,0.00011151151],"genre_scores_gemma":[0.9992058,0.0000013822869,0.00035593292,0.000045375036,0.000045177545,0.000220381,0.00007383909,0.000015773074,0.0000363097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886334,0.00013913566,0.00026337046,0.00014430069,0.00045823323,0.00013162848],"domain_scores_gemma":[0.9991598,0.000020315712,0.00018288805,0.0003498561,0.00020556968,0.00008156282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031028135,0.00008866139,0.0002673506,0.00006375304,0.00003699476,0.000007727611,0.000028524868,0.000030931336,0.00006184543],"category_scores_gemma":[0.000108033026,0.000057645946,0.00006491766,0.00013527318,0.000011893149,0.00006924279,0.000010399257,0.00006661155,0.00000910707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033211334,0.0003910684,0.9915666,0.000053188593,0.00015210835,0.0000017365026,0.00009767853,0.000033427503,0.000009198432,3.170684e-7,0.00010331847,0.0075581735],"study_design_scores_gemma":[0.0028694668,0.0013060913,0.9946529,0.00007782306,0.0002052371,1.2404423e-7,0.0001444673,0.00044451733,0.00022243905,0.0000033847002,0.000007520807,0.00006597745],"about_ca_topic_score_codex":0.014353904,"about_ca_topic_score_gemma":0.00026686644,"teacher_disagreement_score":0.014087037,"about_ca_system_score_codex":0.000049695824,"about_ca_system_score_gemma":0.00003481885,"threshold_uncertainty_score":0.9922096},"labels":[],"label_agreement":null},{"id":"W1999597525","doi":"10.2147/vhrm.1.1.29.58937","title":"Ongoing clinical trials of the pleiotropic effects of statins","year":2005,"lang":"en","type":"review","venue":"Vascular Health and Risk Management","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Montreal Clinical Research Institute","funders":"AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Clinical trial; Tolerability; Statin; Stroke (engine); Internal medicine; Randomized controlled trial; Physical therapy; Disease; Atorvastatin; Bioinformatics; Intensive care medicine; Adverse effect","score_opus":0.08106946811989335,"score_gpt":0.43532799523453297,"score_spread":0.3542585271146396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999597525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018710851,0.99054813,0.0006150669,0.000050395804,0.0004768668,0.007907698,0.000032720818,0.00001916682,0.00016281405],"genre_scores_gemma":[0.000010324542,0.9966719,0.0022612466,0.00021722667,0.00050516933,0.00014928225,0.000031957807,0.000049586946,0.00010327542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99024534,0.0047911545,0.0031860874,0.0005235702,0.00083896663,0.00041486195],"domain_scores_gemma":[0.9950566,0.0005860937,0.0024255356,0.0014644545,0.00006221151,0.00040506042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0128738135,0.00037406397,0.0057256003,0.00022107863,0.00014254171,0.000009376674,0.00021092233,0.00025036262,0.000010639853],"category_scores_gemma":[0.00092037645,0.00019917866,0.0035661587,0.000382261,0.00011524442,0.000020073778,0.00021642666,0.00064812397,0.0000051293855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011403628,0.0001446668,0.00013121631,0.17829368,0.0029483894,0.0000049740474,0.00004592524,7.1869243e-7,2.2544981e-9,0.00027598705,0.0003155212,0.8178275],"study_design_scores_gemma":[0.0022366252,0.0004467905,0.0009377206,0.027516289,0.00758908,0.0000076164424,0.00003758789,0.0000059944537,2.4682504e-7,0.00001749836,0.96106666,0.0001378701],"about_ca_topic_score_codex":0.0004048775,"about_ca_topic_score_gemma":0.00002812403,"teacher_disagreement_score":0.9607512,"about_ca_system_score_codex":0.00011741983,"about_ca_system_score_gemma":0.00081386865,"threshold_uncertainty_score":0.812227},"labels":[],"label_agreement":null},{"id":"W1999948102","doi":"10.2174/157016106777698388","title":"Statins for Diabetic Cardiovascular Complications","year":2006,"lang":"en","type":"review","venue":"Current Vascular Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Diabetes Association; American Diabetes Association","keywords":"Medicine; Diabetes mellitus; Dyslipidemia; Internal medicine; Coronary artery disease; Insulin resistance; Fluvastatin; Endocrinology; Simvastatin","score_opus":0.09527128724237102,"score_gpt":0.4154425884756741,"score_spread":0.32017130123330306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999948102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008173854,0.97339183,0.012791595,0.000052533,0.0023823641,0.010419564,0.00044633244,0.0002044197,0.00030318034],"genre_scores_gemma":[0.000006048542,0.9844575,0.000845746,0.00012002542,0.0029502397,0.0074894484,0.0038124507,0.00022481022,0.000093755145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951969,0.0006413713,0.0011930793,0.0012537049,0.0007293425,0.0009856402],"domain_scores_gemma":[0.9969574,0.00019637389,0.0003574354,0.0016524844,0.0003894343,0.00044682255],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012617725,0.00084228686,0.0048533184,0.00045239992,0.00028574545,0.000033546537,0.00041277654,0.0004820175,0.00009499715],"category_scores_gemma":[0.000060311442,0.00072258554,0.009723414,0.000575883,0.00017809295,0.000053055344,0.00014213771,0.00095946575,0.00020796218],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000049631626,0.0004260474,0.0000024533012,0.060930636,0.00737652,0.000014231762,0.000009570667,0.000012971983,9.752232e-7,0.000114942704,0.017544588,0.9135621],"study_design_scores_gemma":[0.0025535396,0.00012955492,0.000027314905,0.0027948825,0.03919699,0.0001379624,0.0000024501155,0.00005176769,0.000003967107,0.0000309514,0.95447814,0.0005924853],"about_ca_topic_score_codex":0.000033206547,"about_ca_topic_score_gemma":0.000001604329,"teacher_disagreement_score":0.9369335,"about_ca_system_score_codex":0.0005226078,"about_ca_system_score_gemma":0.00129885,"threshold_uncertainty_score":0.9995225},"labels":[],"label_agreement":null},{"id":"W2000257366","doi":"10.1517/14656566.1.4.683","title":"Pharmacotherapy of hypercholesterolaemia: statins in clinical practice","year":2000,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Adverse effect; Gemfibrozil; Pharmacology; Statin; Cerivastatin; Lovastatin; Atorvastatin; Bezafibrate; Clinical trial; Internal medicine; Cholesterol; Pravastatin","score_opus":0.1386396925910737,"score_gpt":0.5305010941545557,"score_spread":0.39186140156348204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000257366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047444795,0.99122053,0.000033958313,0.00054996484,0.001567643,0.0033302833,0.00007224971,0.000093180344,0.0030847595],"genre_scores_gemma":[0.0000073230235,0.98499066,0.001362363,0.009701821,0.002869941,0.00046222907,0.00017066252,0.00025412315,0.00018087441],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928163,0.0018820495,0.0025607946,0.0010184436,0.0011235275,0.00059886987],"domain_scores_gemma":[0.99689186,0.0006386649,0.0008026515,0.0011107249,0.00013667037,0.00041942307],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002414763,0.00080105796,0.0039395457,0.00054182514,0.00005943008,0.000026734066,0.00039737418,0.00064666825,0.0011060198],"category_scores_gemma":[0.000079557125,0.0006188209,0.001939702,0.00067659334,0.0001342149,0.000190337,0.000025320554,0.0018883713,0.00013020674],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011459163,0.0019800514,0.0000045848988,0.0026765005,0.0009863127,0.000082685714,0.00029331664,0.0000010778884,0.000019431014,0.000027419828,0.0063139265,0.9864688],"study_design_scores_gemma":[0.007639203,0.001017834,0.000009349154,0.009783038,0.00012452055,0.00024246423,0.000033579036,0.000009011852,0.000095063384,0.0000035850512,0.9805679,0.0004744575],"about_ca_topic_score_codex":0.00013022618,"about_ca_topic_score_gemma":7.4749653e-7,"teacher_disagreement_score":0.98599434,"about_ca_system_score_codex":0.00029374255,"about_ca_system_score_gemma":0.0011149052,"threshold_uncertainty_score":0.9998071},"labels":[],"label_agreement":null},{"id":"W2000386177","doi":"10.1016/j.jvs.2007.10.065","title":"Regarding “Does simvastatin save lives; If so, when and in whom?”","year":2008,"lang":"en","type":"letter","venue":"Journal of Vascular Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Simvastatin; Medicine; Arterial disease; Clinical endpoint; Disease; Internal medicine; Cholesterol; Scopus; Clinical trial; Randomized controlled trial; Vascular disease; Cardiology; MEDLINE","score_opus":0.018266559051111506,"score_gpt":0.23764797726737802,"score_spread":0.2193814182162665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000386177","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5894045,0.08062238,0.00078598445,0.32436374,0.0030148297,0.001295833,0.00002748403,0.000061542705,0.00042368402],"genre_scores_gemma":[0.096336395,0.16793078,0.008864437,0.65998435,0.0615622,0.00007758564,0.00024448877,0.00089887984,0.004100862],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950014,0.0006185312,0.0015085485,0.00044081805,0.0017739799,0.0006567426],"domain_scores_gemma":[0.9971288,0.00057854824,0.0009035787,0.00070935563,0.00039886727,0.00028084978],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0034869888,0.0004783397,0.0026817943,0.0011686542,0.00014929555,0.00011371579,0.00015140761,0.00067665876,0.000080244215],"category_scores_gemma":[0.0008027163,0.0003330492,0.0023533676,0.00025648024,0.000191845,0.00022795948,0.00007690338,0.003300558,0.000008305075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001762094,0.00011478419,0.020686522,0.0023661538,0.0027263875,0.046556063,0.0010979275,0.0000131594725,0.000047826503,6.684853e-7,0.8965779,0.02963642],"study_design_scores_gemma":[0.0015823558,0.00011764568,0.016212672,0.003813988,0.0006400621,0.008211719,0.00017977094,0.000013420414,0.00009180205,0.000079947786,0.9686213,0.0004352997],"about_ca_topic_score_codex":0.00027983318,"about_ca_topic_score_gemma":0.000020148396,"teacher_disagreement_score":0.49306813,"about_ca_system_score_codex":0.00027092683,"about_ca_system_score_gemma":0.0014275775,"threshold_uncertainty_score":0.99991214},"labels":[],"label_agreement":null},{"id":"W2000440477","doi":"10.2174/1871529x11202020133","title":"Human Apolipoprotein C-III – A New Intrahepatic Protein Factor Promoting Assembly and Secretion of Very Low Density Lipoproteins","year":2012,"lang":"en","type":"review","venue":"Cardiovascular & Haematological Disorders - Drug Targets","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Very low-density lipoprotein; Apolipoprotein B; Secretion; Endocrinology; Lipid droplet; Biology; Internal medicine; Intracellular; Lipoprotein; Biochemistry; Cholesterol; Medicine","score_opus":0.029529948098763494,"score_gpt":0.2825634351056642,"score_spread":0.2530334870069007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000440477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050705582,0.932626,0.0018411035,0.00007613109,0.0002462346,0.013950754,0.000043099466,0.0003294186,0.00018167049],"genre_scores_gemma":[0.12454796,0.8713094,0.0011799532,0.000038309467,0.0008228301,0.0012995965,0.00036553483,0.00029485242,0.0001415624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898732,0.0018026382,0.0023745734,0.0019931868,0.0022439163,0.0017125366],"domain_scores_gemma":[0.99435574,0.00009686333,0.0011422201,0.0027628853,0.0003047059,0.0013375623],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0026917658,0.0017995973,0.010605603,0.0005553971,0.00047737334,0.00010058332,0.00057363324,0.0016739395,0.00010958965],"category_scores_gemma":[0.0006697022,0.0013942833,0.007704413,0.000912334,0.0005299998,0.00032067677,0.0006112256,0.0019899916,0.00005413238],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049661518,0.0005754116,0.000065773,0.08540445,0.007275558,0.00025542054,0.00048899266,0.0000010461436,0.000050808732,0.00027404804,0.000070778835,0.9054881],"study_design_scores_gemma":[0.01416675,0.0019908312,0.0026930207,0.10675653,0.05053779,0.0058927652,0.00043319332,0.00010468092,0.00278897,0.0021087166,0.8040978,0.008428965],"about_ca_topic_score_codex":0.0025495042,"about_ca_topic_score_gemma":0.00012103712,"teacher_disagreement_score":0.8970591,"about_ca_system_score_codex":0.0003714321,"about_ca_system_score_gemma":0.0008752398,"threshold_uncertainty_score":0.9996221},"labels":[],"label_agreement":null},{"id":"W2000584537","doi":"10.1016/j.cjca.2015.03.033","title":"A Reappraisal of the Safety and Cost-Effectiveness of Statin Therapy in Primary Prevention","year":2015,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Primary prevention; Secondary prevention; Statin; Intensive care medicine; Internal medicine; Disease","score_opus":0.05827216173028854,"score_gpt":0.3535930552516667,"score_spread":0.29532089352137814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000584537","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013912983,0.99482137,0.00017814137,0.000026270502,0.00032276142,0.0014818636,0.000062818326,7.316005e-7,0.0017147744],"genre_scores_gemma":[0.0069379476,0.99265623,0.000046243673,0.000013244565,0.00027329434,0.000017167866,0.000018578108,0.000021486145,0.000015811038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99651265,0.0021550867,0.0007964429,0.00013025098,0.00021183435,0.00019372007],"domain_scores_gemma":[0.9982824,0.00017586634,0.00064228376,0.00032451274,0.00031474332,0.00026022247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044912375,0.00016271084,0.002935017,0.0002877813,0.000019409115,0.000002461955,0.00013936704,0.00027196962,0.0000025735185],"category_scores_gemma":[0.0002568599,0.00009868373,0.00077174057,0.0002322252,0.00019618639,0.000027085789,0.000015077618,0.00049330865,1.7230734e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016803828,0.000003985534,0.0011256386,0.006558471,0.00071238994,0.000050531467,0.000048957387,0.00001559643,0.0000016876189,0.000066050554,0.00008492571,0.99116373],"study_design_scores_gemma":[0.0018076114,0.00062953524,0.025981,0.009546211,0.0005604232,0.0017942043,0.000024320103,1.2194357e-7,0.0000017375828,0.000047628422,0.9595307,0.000076523094],"about_ca_topic_score_codex":0.0011840365,"about_ca_topic_score_gemma":0.0004288474,"teacher_disagreement_score":0.9910872,"about_ca_system_score_codex":0.00029109148,"about_ca_system_score_gemma":0.010244612,"threshold_uncertainty_score":0.9953664},"labels":[],"label_agreement":null},{"id":"W2000857749","doi":"10.1007/s10557-012-6373-5","title":"ApoA-I Induction as a Potential Cardioprotective Strategy: Rationale for the SUSTAIN and ASSURE Studies","year":2012,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Resverlogix (Canada)","funders":"","keywords":"Medicine; Intensive care medicine; Pharmacology","score_opus":0.032372533228771955,"score_gpt":0.2947657922874573,"score_spread":0.2623932590586854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000857749","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47089922,0.5213515,0.0034724637,0.00083460356,0.00030972983,0.0028915545,0.00000894489,0.000039515868,0.00019244726],"genre_scores_gemma":[0.9560112,0.040645994,0.00015937805,0.00026256935,0.002050593,0.0006210033,0.000012130022,0.00003622979,0.0002009124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841046,0.00019138242,0.00018964447,0.00033106838,0.00051693054,0.0003604969],"domain_scores_gemma":[0.998906,0.0000660283,0.000050881397,0.0004908346,0.00033057568,0.00015564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024568292,0.00022573331,0.0006184846,0.00006219724,0.0004921946,0.000052513937,0.000046694247,0.00013392195,0.0000053675135],"category_scores_gemma":[0.00007371727,0.00014133185,0.00082608906,0.00014182186,0.00016856923,0.00017688306,0.000033515524,0.0002178545,0.0000018230224],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044442405,0.00007040293,0.0002856861,0.0002885271,0.020967903,0.000010336067,0.0040369234,0.00015561935,0.00043252922,0.0019634503,0.0002444219,0.9710998],"study_design_scores_gemma":[0.025289707,0.0019040557,0.06804675,0.00021554227,0.007406669,0.0031665366,0.09138768,0.00037525862,0.007346305,0.00588555,0.7875993,0.001376648],"about_ca_topic_score_codex":0.00017308723,"about_ca_topic_score_gemma":0.000001095653,"teacher_disagreement_score":0.9697231,"about_ca_system_score_codex":0.000060039383,"about_ca_system_score_gemma":0.00011153195,"threshold_uncertainty_score":0.5763346},"labels":[],"label_agreement":null},{"id":"W2000868686","doi":"10.5414/cp201687","title":"Single-dose, 2-way crossover, bioequivalence study of two rosuvastatin formulations in normal healthy subjects under fasting conditions","year":2012,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada); Pharmaxis (Canada)","funders":"","keywords":"Bioequivalence; Rosuvastatin; Pharmacokinetics; Medicine; Tolerability; Crossover study; Confidence interval; Pharmacology; Rosuvastatin Calcium; Adverse effect; Dosing; Internal medicine; Placebo","score_opus":0.1491367167304826,"score_gpt":0.49789304087878067,"score_spread":0.34875632414829805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000868686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408185,0.00076192437,0.0009983672,0.0013275121,0.0024006485,0.00027353523,0.00001106309,0.000005337594,0.00013978386],"genre_scores_gemma":[0.9951023,0.00044124504,0.0005087724,0.002502376,0.0014129503,0.000004187432,0.000003894386,0.000010514853,0.000013760896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977256,0.00031132865,0.0012229639,0.000106633415,0.00042012066,0.00021337077],"domain_scores_gemma":[0.9979703,0.000693384,0.0006194048,0.00008037054,0.00046326857,0.00017329896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001866024,0.000100888545,0.000440431,0.0001796653,0.000059266302,0.000009988028,0.0001171335,0.00008298607,0.0000684755],"category_scores_gemma":[0.000104967614,0.000083488,0.0001676588,0.00012126274,0.00014882088,0.00022770227,0.000046308487,0.0005253133,0.0000013795495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033399486,0.0077300407,0.9446516,0.000045962806,0.0018692681,0.00005569212,0.0014040029,0.00052295154,0.005074001,0.00093470386,0.000052082723,0.03431974],"study_design_scores_gemma":[0.02245419,0.0027127955,0.97032255,0.0000786955,0.00045204343,0.00038073672,0.0006417916,0.0003836027,0.0006991672,0.0005548526,0.0012112301,0.000108357206],"about_ca_topic_score_codex":0.000043030683,"about_ca_topic_score_gemma":0.000033409724,"teacher_disagreement_score":0.034211382,"about_ca_system_score_codex":0.00005693725,"about_ca_system_score_gemma":0.00019835027,"threshold_uncertainty_score":0.34045416},"labels":[],"label_agreement":null},{"id":"W2001019694","doi":"10.1016/j.cjca.2014.07.151","title":"IMPROVING DYSLIPIDEMIA MANAGEMENT IN THE COMMUNITY: A RANDOMIZED TRIAL OF PHARMACIST PRESCRIBING, THE RxACT STUDY","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Dyslipidemia; Pharmacist; Randomized controlled trial; Internal medicine; Pharmacy; Physical therapy; Disease; Family medicine","score_opus":0.03634760537195704,"score_gpt":0.3010146118314606,"score_spread":0.2646670064595036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001019694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98282915,0.00082768453,0.0016867312,0.0013067317,0.00089714816,0.0031095925,0.0000029173277,0.0000029414928,0.009337075],"genre_scores_gemma":[0.9980019,0.000060535072,0.00005705636,0.00060178374,0.0011956253,0.00005027538,0.0000013908178,0.000011261501,0.000020171567],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9916665,0.006934259,0.00073132955,0.000088028995,0.00029532227,0.00028455214],"domain_scores_gemma":[0.99816334,0.0005560897,0.00032656614,0.00063553004,0.00012996067,0.0001885173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025785262,0.000121129546,0.0011682734,0.00022156246,0.00019448575,0.000017566177,0.00042167548,0.00006337143,0.0000051972775],"category_scores_gemma":[0.0012211001,0.00006172491,0.0005968568,0.00016557265,0.00020876496,0.00003395471,0.000026061018,0.0010232994,0.0000011220993],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57250106,0.00022255794,0.01334586,0.0005660692,0.011615805,0.0011430592,0.019233715,0.001649258,0.00009322883,0.0017012667,0.011940994,0.36598712],"study_design_scores_gemma":[0.9256384,0.0018075703,0.007065257,0.00007933189,0.0018477567,0.00059302396,0.007023146,0.00013013143,0.000012039352,0.00026494768,0.055427328,0.000111107416],"about_ca_topic_score_codex":0.008656616,"about_ca_topic_score_gemma":0.0024414505,"teacher_disagreement_score":0.36587602,"about_ca_system_score_codex":0.000111229885,"about_ca_system_score_gemma":0.00046421943,"threshold_uncertainty_score":0.99794483},"labels":[],"label_agreement":null},{"id":"W2001067466","doi":"10.1016/j.clinthera.2008.12.023","title":"Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: Results of the CAP (Comparative Atorvastatin Pleiotropic effects) study","year":2008,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University of Ottawa","funders":"Pfizer Canada","keywords":"Atorvastatin; Medicine; C-reactive protein; Coronary artery disease; Internal medicine; Triglyceride; National Cholesterol Education Program; Gastroenterology; Statin; Clinical endpoint; Lipoprotein; Cholesterol; Endocrinology; Inflammation; Cardiology; Randomized controlled trial; Metabolic syndrome; Obesity","score_opus":0.06857215870727022,"score_gpt":0.3439261744786169,"score_spread":0.27535401577134666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001067466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99236465,0.00015567691,0.000051699615,0.00006533994,0.00030645932,0.0068339114,0.00012309237,0.000027391909,0.00007180964],"genre_scores_gemma":[0.99920243,0.000014717663,0.00025478553,0.00012530043,0.00010568015,0.00014736492,0.000046998583,0.000038129623,0.000064572654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99385,0.0028374458,0.0010776399,0.00065233925,0.0011677128,0.00041486084],"domain_scores_gemma":[0.9943813,0.002956651,0.0008461712,0.0011276257,0.00044755993,0.0002406648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009132398,0.00041572517,0.001753683,0.0000904592,0.00013435817,0.000007145896,0.00016628044,0.0001393757,0.0000056872786],"category_scores_gemma":[0.0004224844,0.00026518173,0.00033688731,0.00046569048,0.0006281428,0.00009066623,0.000090685426,0.00074227125,0.000009205266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1545165,0.028761946,0.79599243,0.00094603427,0.005678362,0.0004886724,0.00779801,0.00032051574,0.00091685005,0.00011297543,0.0001637456,0.0043039653],"study_design_scores_gemma":[0.035989948,0.014309369,0.9432295,0.00064162875,0.00048119112,0.0000015802202,0.00036917214,0.00013779433,0.004508748,0.000019746803,0.00007318687,0.00023815627],"about_ca_topic_score_codex":0.00019049496,"about_ca_topic_score_gemma":0.00012244262,"teacher_disagreement_score":0.14723705,"about_ca_system_score_codex":0.00018986572,"about_ca_system_score_gemma":0.00054502574,"threshold_uncertainty_score":0.99998003},"labels":[],"label_agreement":null},{"id":"W2001099147","doi":"10.1016/s1098-3015(10)70638-0","title":"PCV50 UP-TITRATION OF STATIN THERAPY TO MEET CANADIAN TARGET LIPID GOALS: ECONOMIC IMPACT OFTITRATION ASSOCIATED WITH COMPARATIVE EFFICACY OF ROSUVASTATIN, ATORVASTATIN, SIMVASTATIN AND PRAVASTATIN","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Pravastatin; Simvastatin; Atorvastatin; Statin; Medicine; Pharmacology; Internal medicine; Cholesterol","score_opus":0.053754054396429926,"score_gpt":0.3198960244048216,"score_spread":0.2661419700083917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001099147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946698,0.0006555292,0.00076478365,0.0005419542,0.00007058993,0.0026194733,0.00049581274,0.000025708789,0.00015633008],"genre_scores_gemma":[0.99071276,0.000332543,0.008202241,0.00033617613,0.000062234445,0.000060357423,0.00022732481,0.00004478465,0.000021551841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964634,0.0007780594,0.0012049034,0.00045538266,0.0005132595,0.00058499654],"domain_scores_gemma":[0.99757934,0.00040972815,0.00068818027,0.0003738118,0.0003019813,0.0006469692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019427899,0.00031269074,0.0011850528,0.00046987567,0.00014705324,0.000015148894,0.00008598704,0.000099711855,0.000047521622],"category_scores_gemma":[0.0002829268,0.0002661914,0.00012489092,0.0005437629,0.00014030012,0.00016719048,0.000012446179,0.00021368919,0.000003145875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007960299,0.002045158,0.44189337,0.0022543448,0.0024626702,0.0001222036,0.20910113,0.28775856,0.0056849895,0.003150459,0.008741212,0.02882561],"study_design_scores_gemma":[0.014567234,0.011145043,0.9446616,0.0013460617,0.000055446726,0.00007999516,0.003604549,0.016471727,0.006741632,0.00015941546,0.0005461816,0.00062109815],"about_ca_topic_score_codex":0.31690118,"about_ca_topic_score_gemma":0.074787244,"teacher_disagreement_score":0.5027682,"about_ca_system_score_codex":0.0010028512,"about_ca_system_score_gemma":0.0066916444,"threshold_uncertainty_score":0.999979},"labels":[],"label_agreement":null},{"id":"W2001157930","doi":"10.1016/s0149-2918(02)80022-4","title":"Efficacy and tolerability of a “suprabioavailable” formulation of fenofibrate in patients with dyslipidemia: a pooled analysis of two open-label trials","year":2002,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Fenofibrate; Medicine; Tolerability; Dyslipidemia; Internal medicine; Gastroenterology; Adverse effect; Triglyceride; Cholesterol; Endocrinology; Obesity","score_opus":0.2215697994329045,"score_gpt":0.4352190506748764,"score_spread":0.21364925124197187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001157930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997308,0.00060457294,0.0003018255,0.00016009464,0.000031879386,0.0014294487,0.000027190685,0.000005709278,0.00013125507],"genre_scores_gemma":[0.9966551,0.00027209258,0.0027977931,0.00018711733,0.000028344744,0.000008860929,0.000020207417,0.0000129629025,0.000017500523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963197,0.0007667396,0.0020885018,0.00029584792,0.00036858016,0.0001606337],"domain_scores_gemma":[0.9970414,0.0010267714,0.00083759194,0.00067378586,0.0003238295,0.00009662174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054395837,0.00013596535,0.0023536335,0.00015593448,0.000019435625,0.0000067152855,0.0001204499,0.00016653306,0.0000613998],"category_scores_gemma":[0.00072894426,0.00009187704,0.00024515323,0.00087427406,0.00016050243,0.00007850519,0.00006307546,0.0001987148,4.9076556e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003953738,0.004457175,0.88437057,0.00021024478,0.00525544,6.3222944e-7,0.00018953881,0.000067859706,0.00024868702,0.00013964169,0.0000046354403,0.101101816],"study_design_scores_gemma":[0.03726061,0.0029975555,0.94609404,0.0001684385,0.006380374,2.3419325e-7,0.000019774121,0.0063783927,0.00040770503,0.00011264989,0.000072590505,0.000107635016],"about_ca_topic_score_codex":0.00008971711,"about_ca_topic_score_gemma":0.000028281995,"teacher_disagreement_score":0.10099418,"about_ca_system_score_codex":0.000026588765,"about_ca_system_score_gemma":0.000070531845,"threshold_uncertainty_score":0.37466368},"labels":[],"label_agreement":null},{"id":"W2001375687","doi":"10.1016/j.amjcard.2008.09.076","title":"Efficacy and Safety of Ezetimibe Added on to Atorvastatin (40 mg) Compared With Uptitration of Atorvastatin (to 80 mg) in Hypercholesterolemic Patients at High Risk of Coronary Heart Disease","year":2008,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Atorvastatin; Ezetimibe; Apolipoprotein B; Cholesterol; Medicine; Internal medicine; Tolerability; Lipoprotein; Pharmacology; Endocrinology; Chemistry; Adverse effect","score_opus":0.012156153070157442,"score_gpt":0.25222536645115806,"score_spread":0.24006921338100062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001375687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823654,0.0001417571,0.0004011921,0.00044173707,0.000042271564,0.00063873065,0.00007721354,0.0000034395628,0.00001714399],"genre_scores_gemma":[0.99796695,0.0002215296,0.0012742215,0.00042149768,0.00007425938,0.0000084149915,0.000010612008,0.000020004718,0.0000025250795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975447,0.0008368227,0.0007398269,0.00018085598,0.0004900432,0.00020772083],"domain_scores_gemma":[0.99811363,0.0002483836,0.0006632647,0.00039699694,0.00030572666,0.00027202506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074510125,0.00015939906,0.0013211141,0.00018713136,0.000046229394,0.0000011879554,0.00011292395,0.00002760387,0.0000040504565],"category_scores_gemma":[0.00017591064,0.000103454106,0.0001767815,0.0002860567,0.00041472694,0.00003138036,0.00004757779,0.00022806782,0.0000014160354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0673389,0.00021703,0.90169024,0.00008083968,0.0005986222,0.000069240734,0.00199218,0.012127916,0.0049723205,0.000007707546,0.00023708906,0.010667901],"study_design_scores_gemma":[0.0053283693,0.0077313953,0.98536456,0.000243925,0.00022584491,0.00024102636,0.00025726287,0.000012463171,0.00038337967,0.0000075892917,0.00011975364,0.00008443166],"about_ca_topic_score_codex":0.00025184618,"about_ca_topic_score_gemma":0.000010749362,"teacher_disagreement_score":0.08367431,"about_ca_system_score_codex":0.00009786743,"about_ca_system_score_gemma":0.00021361736,"threshold_uncertainty_score":0.4218736},"labels":[],"label_agreement":null},{"id":"W2001976096","doi":"10.1159/000221835","title":"Long-Term Statin Therapy and CSF Cholesterol Levels: Implications for Alzheimer’s Disease","year":2009,"lang":"en","type":"article","venue":"Dementia and Geriatric Cognitive Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Canadian Institutes of Health Research; Wellcome Trust","keywords":"Lathosterol; Internal medicine; Cholesterol; Endocrinology; Medicine; Simvastatin; Atorvastatin; Cerebrospinal fluid; Apolipoprotein B; Asymptomatic; Apolipoprotein E; Statin; Gastroenterology; Disease","score_opus":0.033155723450041016,"score_gpt":0.3164477260296255,"score_spread":0.2832920025795845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001976096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94703764,0.033881094,0.012150533,0.003920634,0.00004341094,0.002569488,0.00018050335,0.00004047998,0.00017619548],"genre_scores_gemma":[0.9911483,0.0064703343,0.00018210332,0.0016299712,0.00010034556,0.00023701125,0.00019155246,0.00001680616,0.000023588662],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99905354,0.000038644594,0.0001902792,0.000348751,0.000120682,0.0002481094],"domain_scores_gemma":[0.99938047,0.00004431353,0.00006495811,0.00015914405,0.00011999036,0.00023111905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016498871,0.00016267746,0.00022826697,0.00008492837,0.0001982499,0.000044971315,0.00003195278,0.00004248032,0.00002541979],"category_scores_gemma":[0.000035910878,0.00014254215,0.00012733822,0.00012778271,0.00005264913,0.000091146416,0.00001466511,0.00006497946,0.0000015802912],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002543992,0.00018505433,0.14470075,0.000054601653,0.00042876476,0.0000012510224,0.0001626292,1.0077381e-7,0.00005146761,0.00012218648,0.00007531702,0.8539635],"study_design_scores_gemma":[0.0051524257,0.00039368085,0.9913994,0.000030313528,0.0010510301,0.0000053708486,0.00010942614,0.000012802374,0.000032599357,0.0009153835,0.00073653384,0.00016104197],"about_ca_topic_score_codex":0.000019570343,"about_ca_topic_score_gemma":0.0000147199935,"teacher_disagreement_score":0.85380244,"about_ca_system_score_codex":0.0000064882356,"about_ca_system_score_gemma":0.00007243187,"threshold_uncertainty_score":0.58127},"labels":[],"label_agreement":null},{"id":"W2002468528","doi":"10.1016/j.amjcard.2005.07.135","title":"Association Between Time of Statin Initiation After Hospital Discharge from Acute Myocardial Infarction and Risk of Recurrence and Mortality in Patients ≥65 Years of Age","year":2005,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University","funders":"","keywords":"Medicine; Confidence interval; Hazard ratio; Myocardial infarction; Statin; Proportional hazards model; Propensity score matching; Retrospective cohort study; Internal medicine; Cohort; Medical prescription; Cardiology","score_opus":0.00593663273833006,"score_gpt":0.2504136844690944,"score_spread":0.24447705173076434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002468528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991731,0.00021621243,0.00014581822,0.0000844326,0.000044631706,0.00015617617,0.00016486086,0.0000010912255,0.000013658924],"genre_scores_gemma":[0.99828815,0.0012303091,0.00022655392,0.000018366687,0.00021433707,0.00000211361,0.000014416975,0.0000050152157,7.404537e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986022,0.0005112378,0.00044628663,0.00007817452,0.00027090975,0.00009119158],"domain_scores_gemma":[0.9985592,0.00013143716,0.0009945865,0.00012386509,0.00015018729,0.00004075417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010775656,0.000061462364,0.0007119083,0.00007508002,0.000009399446,0.0000017703647,0.00003768666,0.000040423354,0.0000017624872],"category_scores_gemma":[0.00018645223,0.000046337078,0.00013343312,0.00010286765,0.00015554964,0.00007012411,0.000024047298,0.00018157176,2.5254514e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026740564,0.000016247863,0.9537267,0.00000736209,0.0012557264,0.0000016576389,0.0007693882,0.000012935503,0.000114446084,5.6309506e-7,0.000009137309,0.043818407],"study_design_scores_gemma":[0.0011184944,0.0011132994,0.9965793,0.000038393642,0.0008058992,0.0000031420864,0.000092528346,0.0000060570073,0.00011402382,0.00006405716,0.000027910537,0.00003690962],"about_ca_topic_score_codex":0.00033981114,"about_ca_topic_score_gemma":0.000004380004,"teacher_disagreement_score":0.043781497,"about_ca_system_score_codex":0.000050718703,"about_ca_system_score_gemma":0.00004480948,"threshold_uncertainty_score":0.18895712},"labels":[],"label_agreement":null},{"id":"W2003839321","doi":"10.1111/j.0889-7204.2003.01176.x","title":"Understanding the Essentials of Blood Lipid Metabolism","year":2003,"lang":"en","type":"review","venue":"Progress in Cardiovascular Nursing","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Dyslipidemia; Medicine; Lipid metabolism; Context (archaeology); Intensive care medicine; Disease; Intervention (counseling); Internal medicine; Nursing; Biology","score_opus":0.10825915062800771,"score_gpt":0.3567934972238932,"score_spread":0.24853434659588547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003839321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000081465605,0.99138755,0.0019779708,0.000043368847,0.0012373487,0.0036094834,0.000012824724,0.000056371216,0.001666936],"genre_scores_gemma":[0.0011149312,0.996398,0.0009069398,0.000017115719,0.001002792,0.00031645023,0.000039280774,0.00018497031,0.000019572457],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934749,0.0016082845,0.0013958793,0.00088708795,0.00182087,0.00081299857],"domain_scores_gemma":[0.9964485,0.00011287972,0.0004825963,0.0026205808,0.00014481423,0.0001906293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005120379,0.000715712,0.0062727984,0.0005525202,0.00018225051,0.00006997828,0.0004027163,0.0006178676,0.000018148125],"category_scores_gemma":[0.00011117889,0.00047744796,0.008085874,0.0014680438,0.000567091,0.0000877695,0.00007527168,0.0011054443,0.000006637393],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010774473,0.00022186968,0.000015112444,0.022435455,0.011159544,0.00015360567,0.00016434675,0.000006055821,7.850598e-8,0.0010320027,0.000033358792,0.9647678],"study_design_scores_gemma":[0.0017651,0.000062506726,0.000022753093,0.06022189,0.05594518,0.002389699,0.00024134455,0.0000047566805,0.00002005394,0.00022202404,0.87854266,0.0005620367],"about_ca_topic_score_codex":0.000018176492,"about_ca_topic_score_gemma":9.3019673e-7,"teacher_disagreement_score":0.96420574,"about_ca_system_score_codex":0.00046682858,"about_ca_system_score_gemma":0.00080159405,"threshold_uncertainty_score":0.9997677},"labels":[],"label_agreement":null},{"id":"W2004195771","doi":"10.1016/j.jacc.2008.09.002","title":"Efficacy and Safety of Coadministration of Ezetimibe and Simvastatin in Adolescents With Heterozygous Familial Hypercholesterolemia","year":2008,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Ezetimibe; Simvastatin; Medicine; Placebo; Familial hypercholesterolemia; Randomized controlled trial; Internal medicine; Pharmacology; Gastroenterology; Cholesterol; Urology; Endocrinology","score_opus":0.012571108016584169,"score_gpt":0.25567614955287715,"score_spread":0.24310504153629298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004195771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876857,0.00039035524,0.00019158931,0.00024141162,0.000040545277,0.0002856356,0.000022116845,0.0000011324994,0.00005864753],"genre_scores_gemma":[0.99855363,0.0007379994,0.00054338283,0.00007529617,0.000074733674,0.0000011597754,3.919157e-7,0.000008775695,0.000004623362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986289,0.00029184186,0.0005659379,0.000102025195,0.0002928479,0.00011844094],"domain_scores_gemma":[0.9988454,0.00005221758,0.0006474339,0.0002098399,0.00017263784,0.00007247868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004508608,0.00009792151,0.0010482309,0.00010484733,0.000025336805,6.50457e-7,0.000076787706,0.00004234624,2.9689778e-7],"category_scores_gemma":[0.00009201896,0.000060965955,0.00014718987,0.00018503587,0.0007261644,0.000028672379,0.000034411594,0.00020052907,2.7272595e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017645653,0.00018433451,0.95316786,0.0004610294,0.0005661403,0.00042781568,0.00038216144,0.00075959926,0.017713444,0.000013887626,0.00006969679,0.008608402],"study_design_scores_gemma":[0.0053088637,0.0035825712,0.9823734,0.00046688106,0.00015049023,0.006134887,0.00042822745,0.0000143421585,0.0013894177,0.0000054601273,0.000093734234,0.00005167906],"about_ca_topic_score_codex":0.000055540724,"about_ca_topic_score_gemma":0.000012639112,"teacher_disagreement_score":0.029205611,"about_ca_system_score_codex":0.00003200416,"about_ca_system_score_gemma":0.000266054,"threshold_uncertainty_score":0.26755828},"labels":[],"label_agreement":null},{"id":"W2004326207","doi":"10.1503/cmaj.050236","title":"Are the benefits of statins a class effect?","year":2005,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mistake; Medicine; Hormone replacement therapy (female-to-male); Cohort; Coronary artery disease; Hormone replacement; Class (philosophy); Intensive care medicine; Bioinformatics; Internal medicine; Computer science; Hormone; Artificial intelligence","score_opus":0.008575964513897121,"score_gpt":0.23475800553851126,"score_spread":0.22618204102461414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004326207","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013099671,0.0024571652,0.000008730268,0.98078215,0.00096080743,0.00044725594,0.00014965673,0.000012246007,0.0020823157],"genre_scores_gemma":[0.006907107,0.0006406087,0.00003062566,0.9516785,0.03911024,0.000021379132,0.00007005589,0.00005352877,0.0014879272],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939406,0.0005905859,0.0006680333,0.00020058769,0.0039096097,0.00069060555],"domain_scores_gemma":[0.9965672,0.00033441238,0.00097568845,0.00034840175,0.000668255,0.0011060727],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0037588074,0.00023285301,0.0008261448,0.00023146754,0.00023983643,0.000051766332,0.0002893733,0.0017019878,0.0015262272],"category_scores_gemma":[0.0030380355,0.00014926746,0.00060106174,0.00024457392,0.000059889528,0.00004065611,0.000016623313,0.0063292705,0.000087434724],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005598023,0.0000076247093,0.004906017,0.00012532432,0.0005577364,0.001005507,0.00006225886,0.0000021821243,1.3611796e-7,0.000006637157,0.9289656,0.064355366],"study_design_scores_gemma":[0.0011092633,0.00011734376,0.022038955,0.00061517884,0.00030665426,0.0012523236,0.000066431814,0.000017182292,0.000004068025,0.000008099297,0.9743366,0.00012784867],"about_ca_topic_score_codex":0.0035951715,"about_ca_topic_score_gemma":0.018167779,"teacher_disagreement_score":0.06422752,"about_ca_system_score_codex":0.0018336674,"about_ca_system_score_gemma":0.0055027637,"threshold_uncertainty_score":0.9997481},"labels":[],"label_agreement":null},{"id":"W2004431776","doi":"10.1111/j.1365-2796.2006.01734.x","title":"Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools","year":2007,"lang":"en","type":"review","venue":"Journal of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Risk assessment; Intensive care medicine; Pathology","score_opus":0.044806452021201676,"score_gpt":0.3869055478177581,"score_spread":0.3420990957965564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004431776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071322364,0.9796343,0.010166382,0.00040938536,0.0003436368,0.0021602958,0.00012393584,0.000004233692,0.000025637699],"genre_scores_gemma":[0.0069621676,0.9871668,0.004373974,0.00024012077,0.0010398932,0.00012505685,0.00004658553,0.00004202264,0.000003358453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964477,0.00024900198,0.0018350127,0.00033663493,0.0008512565,0.00028043656],"domain_scores_gemma":[0.9965791,0.0014636249,0.0008224051,0.0003293942,0.0003345433,0.00047094692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003457295,0.000370748,0.0034987957,0.000864748,0.000032102693,0.000020278228,0.00015714759,0.0001321957,0.000023870938],"category_scores_gemma":[0.0032845247,0.0002379332,0.0010338726,0.00028543163,0.0001360345,0.00009839537,0.00007509447,0.00066315243,2.3624844e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025070604,0.00011190464,0.0047989544,0.0099961525,0.0025596484,0.00023676825,0.00009219321,3.3214357e-7,0.0000072411544,0.0000048567676,0.0009838657,0.9809574],"study_design_scores_gemma":[0.0136714475,0.006591323,0.04589,0.32697892,0.03186966,0.0034948552,0.0013162295,0.000054615874,0.00006422613,0.00008033594,0.5693753,0.00061309617],"about_ca_topic_score_codex":0.0008714733,"about_ca_topic_score_gemma":0.000019578842,"teacher_disagreement_score":0.9803443,"about_ca_system_score_codex":0.00044738172,"about_ca_system_score_gemma":0.00026169536,"threshold_uncertainty_score":0.9702634},"labels":[],"label_agreement":null},{"id":"W2004683380","doi":"10.1042/cs20140755","title":"Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9","year":2015,"lang":"en","type":"review","venue":"Clinical Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PCSK9; Proprotein convertase; Kexin; Familial hypercholesterolemia; Medicine; Bioinformatics; Genetic testing; Statin; Lipoprotein; Internal medicine; LDL receptor; Cholesterol; Biology","score_opus":0.20049737758610803,"score_gpt":0.44410149905887614,"score_spread":0.2436041214727681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004683380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025652926,0.97232205,0.00001911106,0.000102058606,0.0001560861,0.001649131,0.000011185455,0.0000020968316,0.00008537265],"genre_scores_gemma":[0.25668246,0.7431974,0.000035979134,0.000027544025,0.000036489415,0.000011493555,0.0000024058504,0.000004363906,0.0000018786941],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978315,0.000582449,0.00071034225,0.00032742668,0.00040333273,0.0001449297],"domain_scores_gemma":[0.99852467,0.00026957446,0.00042735133,0.00049143203,0.00022444513,0.000062524494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004371526,0.00011987955,0.0009845386,0.000057645688,0.000046362453,0.000005328047,0.0002495891,0.00017384245,0.0000014158568],"category_scores_gemma":[0.00074854,0.000055054148,0.00012265418,0.0005759789,0.0021718624,0.000045030454,0.0000797755,0.0003161172,1.2255481e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046915244,0.000032149273,0.0019104372,0.003355004,0.000012171575,4.0935976e-7,0.00023443272,4.2152652e-7,0.000032477143,0.00046203652,8.612969e-7,0.9939127],"study_design_scores_gemma":[0.0058393073,0.0062685576,0.06655193,0.036162753,0.0023972057,0.00014320333,0.007703198,0.0001481979,0.00034146948,0.0060980325,0.8675807,0.00076544244],"about_ca_topic_score_codex":0.000049292168,"about_ca_topic_score_gemma":0.000033239525,"teacher_disagreement_score":0.99314725,"about_ca_system_score_codex":0.000092241025,"about_ca_system_score_gemma":0.0010681893,"threshold_uncertainty_score":0.80023175},"labels":[],"label_agreement":null},{"id":"W2004696591","doi":"10.1016/j.amjmed.2007.06.033","title":"Statin Therapy in Stroke Prevention: A Meta-analysis Involving 121,000 Patients","year":2008,"lang":"en","type":"review","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; McMaster University; University of Toronto","funders":"Pfizer UK","keywords":"Medicine; Relative risk; Statin; Internal medicine; Stroke (engine); Meta-analysis; Randomized controlled trial; Incidence (geometry); Confidence interval; Clinical trial","score_opus":0.11345019502752249,"score_gpt":0.3837879876554343,"score_spread":0.2703377926279118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004696591","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013952097,0.9963593,0.00016292457,0.00088472804,0.000109160566,0.0009549088,0.000019274501,0.0000076754595,0.000106818006],"genre_scores_gemma":[0.00096204696,0.99664265,0.00037035815,0.0007860154,0.0008085389,0.00004259438,0.000030995063,0.00005370993,0.0003030857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935313,0.001827866,0.0021573252,0.00029414176,0.0018272903,0.00036206623],"domain_scores_gemma":[0.9945702,0.00036468435,0.0034493683,0.0009074203,0.0004251465,0.0002831641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032761672,0.00047868185,0.009970249,0.0011106187,0.000078656776,0.000009156587,0.00044317613,0.00008062916,0.00038119283],"category_scores_gemma":[0.00029517658,0.00020925084,0.005450609,0.0022326494,0.00048323703,0.000062563435,0.000042827472,0.001217311,0.000004594317],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010691842,0.00016331821,0.00009527539,0.00050296803,0.12993535,0.00016501984,0.0003779327,0.000004102156,1.2292432e-7,0.0000024921146,0.00042712124,0.8682194],"study_design_scores_gemma":[0.0032073387,0.0062112208,0.0009682295,0.002880177,0.3789618,0.0012024562,0.0005094812,0.0000032308183,3.6674834e-7,0.000022092678,0.6057663,0.00026732474],"about_ca_topic_score_codex":0.000529996,"about_ca_topic_score_gemma":0.00002058832,"teacher_disagreement_score":0.86795205,"about_ca_system_score_codex":0.00023420517,"about_ca_system_score_gemma":0.0006782956,"threshold_uncertainty_score":0.85330015},"labels":[],"label_agreement":null},{"id":"W2004773312","doi":"10.1016/j.cjca.2012.01.018","title":"Local Delivery of Pravastatin Inhibits Intimal Formation in a Mouse Vein Graft Model","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pravastatin; Intimal hyperplasia; Internal medicine; Cardiology; Smooth muscle","score_opus":0.018538185340974574,"score_gpt":0.2407315214798694,"score_spread":0.22219333613889483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004773312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94697845,0.0018381419,0.049667303,0.0002828716,0.0001327858,0.00017550398,0.000015572383,0.0000022955721,0.00090708025],"genre_scores_gemma":[0.9983316,0.000083966384,0.0010199071,0.00017820252,0.00034083286,0.0000033821452,0.0000072533026,0.000012567541,0.000022275766],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987271,0.00015575152,0.0004986312,0.00006623402,0.00017928885,0.00037298657],"domain_scores_gemma":[0.99885166,0.000018785431,0.00016919103,0.00016135421,0.00025042184,0.00054858864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010722465,0.00009319534,0.0005604897,0.0004225475,0.000025354306,0.0000035515188,0.00006622357,0.00013754588,0.0000057584257],"category_scores_gemma":[0.00011199002,0.000081835795,0.00023954488,0.00013312722,0.00009807124,0.00020722534,0.000009258622,0.0003190818,0.000003535051],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025237305,0.00016475315,0.2024675,0.002347392,0.0029637474,0.0021295578,0.01770353,0.2879987,0.046063296,0.005363797,0.02781175,0.40246224],"study_design_scores_gemma":[0.05549482,0.010632085,0.4294413,0.0033064848,0.0030096094,0.06789963,0.017212385,0.055585496,0.18189818,0.0020967643,0.17035498,0.003068289],"about_ca_topic_score_codex":0.0016957105,"about_ca_topic_score_gemma":0.0016471433,"teacher_disagreement_score":0.39939395,"about_ca_system_score_codex":0.00026989167,"about_ca_system_score_gemma":0.001225591,"threshold_uncertainty_score":0.3337167},"labels":[],"label_agreement":null},{"id":"W2004882814","doi":"10.1016/j.ijcard.2004.12.011","title":"Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study","year":2005,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Rosuvastatin; Atorvastatin; Pravastatin; Simvastatin; Medicine; Internal medicine; Apolipoprotein B; Endocrinology; Statin; Cholesterol; Pharmacology","score_opus":0.010725440533402334,"score_gpt":0.30163953454593073,"score_spread":0.2909140940125284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004882814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944545,0.00064350734,0.0010565576,0.0026657926,0.00029879934,0.0004507788,0.0000014596362,0.0000024786664,0.00042611343],"genre_scores_gemma":[0.9970133,0.00022734137,0.00024311765,0.00060708844,0.0018821504,0.000011885447,8.092841e-7,0.0000072146036,0.000007103375],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99841297,0.00037604282,0.0004350627,0.000097359276,0.0005731613,0.000105426174],"domain_scores_gemma":[0.999187,0.00023145242,0.00020571501,0.0001298355,0.00020189492,0.000044132747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014546649,0.00008550737,0.0004182184,0.00020675833,0.000019222653,0.0000092158525,0.0001554364,0.000046753885,0.000003074287],"category_scores_gemma":[0.00032703235,0.00005255055,0.00016726428,0.000059267055,0.000030002659,0.000064288135,0.000025474064,0.00032765052,0.0000014307193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003917448,0.0015407145,0.17829959,0.0002673649,0.0056504803,0.0030415626,0.013830217,0.0028926725,0.025315767,0.0030264258,0.0009448604,0.7612729],"study_design_scores_gemma":[0.011094872,0.004580554,0.9606538,0.00035020866,0.0003163331,0.003962252,0.002132139,0.00009301468,0.0044484246,0.0003346576,0.011885499,0.00014823761],"about_ca_topic_score_codex":0.00006724255,"about_ca_topic_score_gemma":0.000018350413,"teacher_disagreement_score":0.78235424,"about_ca_system_score_codex":0.00006717724,"about_ca_system_score_gemma":0.00009199719,"threshold_uncertainty_score":0.21429491},"labels":[],"label_agreement":null},{"id":"W2004932296","doi":"10.1038/nrcardio.2014.209","title":"Advances in the prevention of cardiovascular disease","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cancer Society; University of British Columbia","funders":"","keywords":"Medicine; Disease; Cardiovascular health; Intensive care medicine; Disease prevention; Atherosclerotic cardiovascular disease; Secondary prevention; Environmental health; Internal medicine","score_opus":0.03176647835504837,"score_gpt":0.36853929892341025,"score_spread":0.3367728205683619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004932296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.344175e-7,0.99049854,0.00046062344,0.000043019416,0.0004731615,0.005709672,0.000017104288,0.000016823222,0.002780437],"genre_scores_gemma":[0.000041463532,0.9965746,0.00015807092,0.00014464611,0.0016958553,0.0010342605,0.00026951963,0.000049379996,0.000032209733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922134,0.004669033,0.0013365151,0.0007191956,0.0006688496,0.0003929866],"domain_scores_gemma":[0.99630874,0.00017475625,0.0005257763,0.002752486,0.00010165192,0.00013655984],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0070409793,0.0005320114,0.009065307,0.00024672685,0.000042160464,0.0000064191786,0.00044473636,0.001037327,0.000008525511],"category_scores_gemma":[0.0008801928,0.00027599753,0.010183633,0.0007055421,0.00011925903,0.00005325424,0.00006978257,0.0019628487,0.000036465077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000987479,0.000022093474,0.0000063824214,0.08885748,0.00081431214,0.00007751646,0.000005295762,0.000004550329,7.2753403e-9,0.0003830767,0.00031889064,0.90950054],"study_design_scores_gemma":[0.0003405861,0.00010697273,0.00003346059,0.024001786,0.01158065,0.0005296865,0.0000036577537,4.5896567e-7,2.7175984e-8,0.000110121815,0.96307963,0.00021293724],"about_ca_topic_score_codex":0.0000065855047,"about_ca_topic_score_gemma":0.0000022031911,"teacher_disagreement_score":0.96276075,"about_ca_system_score_codex":0.00011492043,"about_ca_system_score_gemma":0.000544032,"threshold_uncertainty_score":0.99996924},"labels":[],"label_agreement":null},{"id":"W2005127456","doi":"10.1136/bmj.g3047","title":"Taking a longer term view of cardiovascular risk: the causal exposure paradigm","year":2014,"lang":"en","type":"article","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Cardiovascular event; Disease; Term (time); Medicine; Intervention (counseling); Event (particle physics); Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.021245787679237814,"score_gpt":0.27939505963694866,"score_spread":0.25814927195771087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005127456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92396617,0.047759194,0.009709624,0.0017969415,0.0005750519,0.002580909,0.000011285252,0.00009741975,0.013503432],"genre_scores_gemma":[0.99709594,0.000745563,0.00035907977,0.00028152872,0.0013071329,0.000083984145,0.0000054151305,0.000027813127,0.00009353815],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99812037,0.00036019564,0.00034849113,0.0002422609,0.0006688682,0.00025983228],"domain_scores_gemma":[0.99814355,0.00005172058,0.00017670193,0.001453322,0.00006991131,0.000104802195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028418526,0.0001435715,0.0006033165,0.00003863284,0.00010194237,0.000012332096,0.00012561749,0.00009292863,0.00006913826],"category_scores_gemma":[0.00025881964,0.00008593419,0.0008496683,0.0001571942,0.000075617245,0.000033612807,0.000045076325,0.00023983444,0.000032225373],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093895476,0.0001127618,0.028064987,0.000947764,0.004142985,0.00009049246,0.0011357388,0.00021967945,0.00012368034,0.0011953943,0.0019122388,0.9619604],"study_design_scores_gemma":[0.0031121573,0.00049462623,0.5818166,0.00056828244,0.0024370933,0.0005450417,0.0001465091,0.00021859644,0.0010293984,0.00021147166,0.40910816,0.00031203448],"about_ca_topic_score_codex":0.0005250596,"about_ca_topic_score_gemma":0.000017173163,"teacher_disagreement_score":0.96164834,"about_ca_system_score_codex":0.00002883048,"about_ca_system_score_gemma":0.00009650418,"threshold_uncertainty_score":0.35042948},"labels":[],"label_agreement":null},{"id":"W2005158100","doi":"10.1016/s1098-3015(10)70028-0","title":"CA4 THE EARLY CLINICAL AND ECONOMIC BENEFITS OF ATORVASTATIN IN A CANADIAN SETTING","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Economics; Medicine; Internal medicine","score_opus":0.052219693821782334,"score_gpt":0.3114592046918989,"score_spread":0.2592395108701166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005158100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196637,0.0031421734,0.0000013732937,0.0040225484,0.00009505243,0.0005680502,0.000014343629,0.0000051989196,0.00018492117],"genre_scores_gemma":[0.996806,0.0017787104,0.00034027622,0.00089082203,0.00014594506,0.000011731567,0.0000023421571,0.000012216057,0.000011942299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984062,0.00029519605,0.00061721075,0.00019291294,0.0001235219,0.00036496023],"domain_scores_gemma":[0.99916995,0.00012620278,0.000094141666,0.00027079353,0.000016509586,0.00032240473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032182708,0.000073973126,0.0003835583,0.00012561264,0.000069024456,0.0000030513934,0.000050714767,0.00006708801,0.0000061029327],"category_scores_gemma":[0.0001321794,0.00005766991,0.00006526051,0.000117815565,0.00008027759,0.000026818232,0.000015514657,0.0002835208,0.000004707842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019994557,0.000018450452,0.9742586,0.0001256128,0.000011975028,0.000021686776,0.0015826309,0.00041356852,2.8336225e-7,0.00059022923,0.00007264129,0.022884345],"study_design_scores_gemma":[0.0010592534,0.00019718688,0.99565744,0.0002342029,0.0000037679238,0.00008904785,0.00013183783,0.0012203484,0.0000038021903,0.000036223064,0.0013198198,0.000047063793],"about_ca_topic_score_codex":0.9437766,"about_ca_topic_score_gemma":0.43819812,"teacher_disagreement_score":0.50557846,"about_ca_system_score_codex":0.00024375047,"about_ca_system_score_gemma":0.0027852408,"threshold_uncertainty_score":0.5720533},"labels":[],"label_agreement":null},{"id":"W2005240611","doi":"10.1016/j.ahj.2005.04.003","title":"Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention","year":2006,"lang":"en","type":"review","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Pravastatin; Medicine; Atorvastatin; Simvastatin; Statin; Relative risk; Internal medicine; Placebo; Randomized controlled trial; Rosuvastatin; Cholesterol; Confidence interval; Pathology","score_opus":0.18114014910960793,"score_gpt":0.4355266389626152,"score_spread":0.25438648985300727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005240611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014054405,0.9464652,0.04343728,0.00010767175,0.00017936259,0.0072517903,0.0011115163,0.000037227197,0.0000045207225],"genre_scores_gemma":[0.00024780244,0.96885383,0.028401839,0.00008032237,0.0011070367,0.0007210238,0.00036213425,0.00015142921,0.00007456078],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9844794,0.00856604,0.0040410464,0.0008041991,0.0015072669,0.0006020384],"domain_scores_gemma":[0.9845621,0.007265114,0.005584067,0.0009559806,0.0008412418,0.00079148903],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.017243678,0.00074564316,0.016171614,0.00041129402,0.00022321224,0.00011375548,0.00016737921,0.00016038187,0.000065919325],"category_scores_gemma":[0.018081628,0.00052175875,0.011718051,0.0005177184,0.0005199256,0.00017773606,0.00006409054,0.0007296112,0.000004350753],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008439104,0.00017637383,0.00010071852,0.015914844,0.014346292,0.00012655869,0.00010647185,0.000032461056,0.0000026418516,0.000006959371,0.0018740479,0.9588735],"study_design_scores_gemma":[0.06619111,0.0012861864,0.00046479751,0.09293013,0.09797639,0.0005732303,0.00048068204,0.00016152933,0.000009048895,0.0004214188,0.7384208,0.0010846672],"about_ca_topic_score_codex":0.0018242653,"about_ca_topic_score_gemma":0.000014645698,"teacher_disagreement_score":0.9577889,"about_ca_system_score_codex":0.00020538119,"about_ca_system_score_gemma":0.0022159931,"threshold_uncertainty_score":0.9997234},"labels":[],"label_agreement":null},{"id":"W2005425566","doi":"10.2174/156800705774322085","title":"Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - CNS & Neurological Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pathogenesis; Disease; Apolipoprotein E; Alzheimer's disease; Medicine; Cholesterol; Apolipoprotein B; Bioinformatics; Immunology; Internal medicine; Biology","score_opus":0.0708535222575065,"score_gpt":0.36555977612965285,"score_spread":0.29470625387214633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005425566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018240174,0.9901867,0.0003523927,0.0016652031,0.0007802644,0.006227213,0.00031941946,0.00019378729,0.000092606024],"genre_scores_gemma":[0.00044827088,0.9946439,0.00027621587,0.0013592126,0.0008523142,0.0013728909,0.0008288443,0.00015349568,0.00006480492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99565107,0.00039870007,0.0008937321,0.0014225111,0.00061649433,0.00101752],"domain_scores_gemma":[0.9975373,0.00020234236,0.00034144154,0.000940348,0.000082126884,0.00089644326],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005025479,0.0010176013,0.0026832605,0.00021440451,0.000263823,0.000069829046,0.00035794746,0.0003682233,0.00007956435],"category_scores_gemma":[0.00015242313,0.00070629286,0.002023655,0.000289147,0.00032366722,0.00009456018,0.00019330886,0.0012289921,0.000034847857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011403079,0.00055510626,0.00010759311,0.008288805,0.0005072811,0.000009228569,0.000029599745,0.0000032232153,2.5741196e-8,0.000074278505,0.0013257621,0.98898506],"study_design_scores_gemma":[0.0015744772,0.00042524087,0.00055911334,0.001082692,0.0049502067,0.00002350451,0.000006402131,0.00016764706,6.613209e-8,0.00023450966,0.99034387,0.0006322993],"about_ca_topic_score_codex":0.0000044130425,"about_ca_topic_score_gemma":0.000003968717,"teacher_disagreement_score":0.9890181,"about_ca_system_score_codex":0.00004992681,"about_ca_system_score_gemma":0.00036790402,"threshold_uncertainty_score":0.99953884},"labels":[],"label_agreement":null},{"id":"W2005515914","doi":"10.1016/j.cjca.2012.10.010","title":"Genetics 101 for Cardiologists: Rare Genetic Variants and Monogenic Cardiovascular Disease","year":2012,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Disease; Familial hypercholesterolemia; Genetics; Mutation; Gene; Bioinformatics; Inheritance (genetic algorithm); Phenotype; Atherosclerotic cardiovascular disease; Biology; Internal medicine; Cholesterol","score_opus":0.059889600268017006,"score_gpt":0.29101167676479295,"score_spread":0.23112207649677594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005515914","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010050965,0.99045676,0.0050975825,0.000051826006,0.00160366,0.001981428,0.00042655604,0.000010140059,0.0002715435],"genre_scores_gemma":[0.0031509872,0.9856139,0.0010473023,0.000080548445,0.009675699,0.00013271777,0.000099441575,0.000143937,0.000055479046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99600095,0.0007837505,0.001207362,0.00055721076,0.00037643887,0.0010742992],"domain_scores_gemma":[0.99430084,0.00013023005,0.00046399306,0.0013677015,0.00051195145,0.0032253088],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019082482,0.0006371363,0.0059689097,0.0006243629,0.0001907073,0.000039571885,0.00035903556,0.0008177048,0.000010708483],"category_scores_gemma":[0.00039945074,0.000505633,0.0062407204,0.00022841422,0.000317062,0.00005516776,0.000048284426,0.000763831,0.000010487259],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034086603,0.0000025890185,0.00057191186,0.00914564,0.013960125,0.0012576232,0.000019940107,0.00014467051,9.313025e-8,0.00002457285,0.0011797376,0.97365904],"study_design_scores_gemma":[0.0009957465,0.0002776109,0.0025625622,0.0016819983,0.0336476,0.013762375,0.000016827991,0.0000025632175,9.891453e-8,0.000054755,0.9465829,0.00041492344],"about_ca_topic_score_codex":0.0003303152,"about_ca_topic_score_gemma":0.000052294057,"teacher_disagreement_score":0.9732441,"about_ca_system_score_codex":0.0005733741,"about_ca_system_score_gemma":0.007944436,"threshold_uncertainty_score":0.9997395},"labels":[],"label_agreement":null},{"id":"W2005738707","doi":"10.1016/j.cmet.2005.04.006","title":"Dual regulation of the LDL receptor—Some clarity and new questions","year":2005,"lang":"en","type":"review","venue":"Cell Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"CLARITY; Receptor; LDL receptor; Dual (grammatical number); Medicine; Biology; Computational biology; Internal medicine; Cholesterol; Biochemistry; Philosophy; Lipoprotein","score_opus":0.04235695690033611,"score_gpt":0.3085857253429634,"score_spread":0.26622876844262733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005738707","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010366759,0.99667287,0.00002586391,0.00023948128,0.0006912276,0.0012680704,0.00002799604,0.000027223208,0.0009435828],"genre_scores_gemma":[0.00003881639,0.9910773,0.0010117335,0.000094783856,0.0032605957,0.000029074066,0.000054662865,0.00004274801,0.0043903072],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981791,0.00031192933,0.00054637337,0.00032390197,0.00043433593,0.00020436445],"domain_scores_gemma":[0.9984368,0.000034014844,0.0003260562,0.00092429284,0.00007887902,0.00019992066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006140013,0.00026965857,0.0016236242,0.00010358513,0.00008892937,0.000014392315,0.000107309206,0.00041433264,0.00009982551],"category_scores_gemma":[0.00009389476,0.00016577085,0.00079566496,0.00028662954,0.00008279029,0.00006774305,0.00008613509,0.00056308304,0.000026677822],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028095096,0.000037338512,0.0000015253236,0.004866375,0.000119163065,5.624853e-7,0.000037581583,2.617608e-7,0.000011137871,0.0018191087,0.0017843341,0.9913198],"study_design_scores_gemma":[0.00041560884,0.000013718868,0.0011515016,0.0024695445,0.0029067614,0.00005398065,0.000004037477,8.442016e-7,0.00002701679,0.00015244444,0.9926657,0.0001388575],"about_ca_topic_score_codex":0.00025142627,"about_ca_topic_score_gemma":0.0000068853583,"teacher_disagreement_score":0.99118096,"about_ca_system_score_codex":0.00005709836,"about_ca_system_score_gemma":0.0007750192,"threshold_uncertainty_score":0.6759939},"labels":[],"label_agreement":null},{"id":"W2006623674","doi":"10.1164/rccm.201003-0423oc","title":"A Randomized Clinical Trial of Hydroxymethylglutaryl– Coenzyme A Reductase Inhibition for Acute Lung Injury (The HARP Study)","year":2010,"lang":"en","type":"article","venue":"American Journal of Respiratory and Critical Care Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":213,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Public Health Agency","keywords":"Medicine; Randomized controlled trial; HARP; Reductase; Coenzyme A; Intensive care medicine; Internal medicine; Enzyme; Biology","score_opus":0.027881957435235458,"score_gpt":0.4030214702643269,"score_spread":0.3751395128290914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006623674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98827034,0.002570996,0.0014642916,0.0047324994,0.00088893296,0.0020046383,0.000017178678,0.000009545239,0.000041560423],"genre_scores_gemma":[0.9933673,0.00015777466,0.00065294164,0.0022186243,0.0035000523,0.00007287808,0.0000036096496,0.000023570678,0.0000032535063],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958576,0.0011451826,0.0016626761,0.00026249298,0.0008109275,0.00026114561],"domain_scores_gemma":[0.9955624,0.0018779852,0.00055071886,0.0004483078,0.0010666648,0.0004939243],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.010455899,0.00020525164,0.0021456678,0.00018810213,0.00013208111,0.000011098937,0.000118023185,0.00009682932,0.000033902437],"category_scores_gemma":[0.008626148,0.000112764064,0.00070073246,0.00028432682,0.0029572025,0.00008311925,0.00003551319,0.0009812317,3.158672e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8365839,0.00077126094,0.0006798151,0.00028059285,0.0013883378,0.00028383013,0.0018252496,1.2483314e-7,0.0037376503,0.0006850998,0.0014082838,0.15235585],"study_design_scores_gemma":[0.88741386,0.08046256,0.00074126455,0.00045948764,0.009805163,0.0005944397,0.011719856,0.000030464205,0.0016018957,0.00033614156,0.0065991017,0.00023574801],"about_ca_topic_score_codex":0.00005165473,"about_ca_topic_score_gemma":0.000004925592,"teacher_disagreement_score":0.15212011,"about_ca_system_score_codex":0.000025357442,"about_ca_system_score_gemma":0.0004304892,"threshold_uncertainty_score":0.99975616},"labels":[],"label_agreement":null},{"id":"W2007060398","doi":"10.1111/j.1365-2125.2007.02905.x","title":"Risk of congenital anomalies in pregnant users of statin drugs","year":2007,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Pregnancy; Statin; Population; Fibrate; Incidence (geometry); Obstetrics; Medical prescription; Pharmacoepidemiology; Pediatrics; Internal medicine; Pharmacology; Environmental health","score_opus":0.03017067945937453,"score_gpt":0.3922372569742992,"score_spread":0.36206657751492466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007060398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907184,0.0072210226,0.0002517507,0.00014062354,0.0008868049,0.0002953406,0.000027590397,0.000003605931,0.00045483114],"genre_scores_gemma":[0.9860213,0.011230104,0.0017434421,0.00030800657,0.000634555,0.0000014375428,0.0000016774803,0.0000139075055,0.00004559273],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99616617,0.00054068695,0.0024363569,0.00013946966,0.0004257768,0.00029154654],"domain_scores_gemma":[0.997209,0.00078464,0.0011997274,0.0001061255,0.00045144392,0.0002490307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008485017,0.00008968937,0.001153319,0.00014241457,0.00001902129,0.0000029757678,0.00012960918,0.00015967934,0.00014429422],"category_scores_gemma":[0.0010469311,0.00008678504,0.0005881513,0.00016831676,0.00032438507,0.00007492553,0.00003747182,0.00086472376,0.000001369139],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004330158,0.0019733668,0.2963057,0.00033249627,0.0018082851,0.0033486183,0.0003154473,0.00004139771,0.0016918167,0.000019230329,0.0019277771,0.6879057],"study_design_scores_gemma":[0.01804113,0.0027724805,0.9659436,0.0005721509,0.0008138651,0.002075329,0.0006990544,0.000035636447,0.005802202,0.00013423745,0.00299581,0.00011451794],"about_ca_topic_score_codex":0.00050715415,"about_ca_topic_score_gemma":0.00015293655,"teacher_disagreement_score":0.68779117,"about_ca_system_score_codex":0.00003579254,"about_ca_system_score_gemma":0.00049197336,"threshold_uncertainty_score":0.37568426},"labels":[],"label_agreement":null},{"id":"W2007954957","doi":"10.1016/s1567-5688(01)00013-7","title":"Environmental modulation of atherosclerosis end points in familial hypercholesterolemia","year":2002,"lang":"en","type":"review","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Merck Canada; Canada Research Chairs","keywords":"Familial hypercholesterolemia; Medicine; Internal medicine; Disease; Coronary heart disease; Population; Coronary atherosclerosis; Cholesterol; Endocrinology; Cardiology","score_opus":0.05649060139234793,"score_gpt":0.30063894688821696,"score_spread":0.24414834549586903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007954957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07713392,0.9165879,0.00003542317,0.000034317232,0.00032811327,0.0043220557,0.0013445292,0.000057391935,0.00015636685],"genre_scores_gemma":[0.07306957,0.92438424,0.0005690593,0.00009796921,0.00022958829,0.00042270633,0.00087365287,0.00020637515,0.00014682006],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946422,0.00041223026,0.0018702497,0.0010046106,0.001288819,0.00078186614],"domain_scores_gemma":[0.9975837,0.00006275701,0.0006218285,0.00142803,0.000028916853,0.00027480593],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00076733244,0.00083165173,0.0031919363,0.00043704204,0.000088480425,0.000029164377,0.00036313632,0.0006552486,0.0013622795],"category_scores_gemma":[0.000030126985,0.0007388458,0.0014908192,0.0004398588,0.00014338644,0.00016282796,0.00022034248,0.000660502,0.00019499507],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020459114,0.00092346,0.009942323,0.006092561,0.00050108787,0.0000045222578,0.0002754004,0.0000016668623,0.00042609617,0.0000050348835,0.00014995455,0.98165745],"study_design_scores_gemma":[0.008803399,0.0010404958,0.11640257,0.027898487,0.0027512468,0.000060700055,0.00014244129,0.000057075722,0.00014259567,0.00001516749,0.84134555,0.0013402933],"about_ca_topic_score_codex":0.0003749906,"about_ca_topic_score_gemma":0.000034486653,"teacher_disagreement_score":0.9803171,"about_ca_system_score_codex":0.0008576702,"about_ca_system_score_gemma":0.00012854583,"threshold_uncertainty_score":0.9995506},"labels":[],"label_agreement":null},{"id":"W2008879022","doi":"10.1097/hco.0b013e328353adc1","title":"Triglycerides","year":2012,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Traditional medicine","score_opus":0.21389566928939688,"score_gpt":0.4411056216963154,"score_spread":0.22720995240691852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008879022","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013960489,0.9809805,0.000101380334,0.000021064065,0.016194493,0.0015797332,0.000035112465,0.000054475557,0.0010318458],"genre_scores_gemma":[0.000013992865,0.98869145,0.000039830913,0.000008827117,0.010034129,0.00051983475,0.00060122134,0.000060427723,0.000030312125],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997236,0.000573064,0.0008001422,0.0005185632,0.00027487808,0.0005973582],"domain_scores_gemma":[0.9985346,0.00009290477,0.00019826464,0.0008882628,0.000050846804,0.00023508986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001033486,0.00042546814,0.0039986507,0.00039777101,0.00003552886,0.0000074031905,0.00015737858,0.0005741644,0.00005420304],"category_scores_gemma":[0.000080510355,0.0003152593,0.0018209233,0.00036791107,0.00008706818,0.00003738048,0.00011073245,0.0010173407,0.00031167557],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008651084,0.0000336967,0.00014355347,0.048539862,0.00022717565,0.0000065525746,0.000008850544,1.9414342e-7,6.408165e-9,0.00017715538,0.0016352364,0.94921905],"study_design_scores_gemma":[0.00056607893,0.00006912836,0.00020100364,0.013028199,0.0007218055,0.0013379611,0.000004561015,3.175998e-7,2.200054e-8,0.000014813289,0.9837965,0.0002596373],"about_ca_topic_score_codex":0.000011963837,"about_ca_topic_score_gemma":2.4169066e-7,"teacher_disagreement_score":0.9821612,"about_ca_system_score_codex":0.00032449342,"about_ca_system_score_gemma":0.0005940469,"threshold_uncertainty_score":0.99992996},"labels":[],"label_agreement":null},{"id":"W2009075342","doi":"10.1016/j.jacl.2014.03.006","title":"Dramatic lowering of very high Lp(a) in response to niacin","year":2014,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Niacin; Medicine; Lipoprotein(a); Myocardial infarction; Statin; Internal medicine; Cardiology; Lipoprotein; Gastroenterology; Pharmacology; Endocrinology; Cholesterol","score_opus":0.04193391566992468,"score_gpt":0.38808481098635605,"score_spread":0.3461508953164314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009075342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99000823,0.00013430143,0.0018517175,0.005349695,0.0022592922,0.00016270654,6.808775e-7,0.0000049526793,0.00022841344],"genre_scores_gemma":[0.9918389,0.00010272671,0.0033672245,0.0016191578,0.0029678978,0.0000018579672,3.0344683e-7,0.00001392686,0.000088058674],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9964135,0.00090283336,0.0019433029,0.00014508057,0.0003719174,0.00022336062],"domain_scores_gemma":[0.99677604,0.0018274423,0.0005224628,0.00038537747,0.00019543554,0.00029324403],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013409125,0.00009323688,0.0014142412,0.0003263828,0.000015081967,0.0000050860754,0.00013889388,0.00021216967,0.00007489527],"category_scores_gemma":[0.013388774,0.00007212037,0.00048015124,0.00021401099,0.000088895235,0.00004118616,0.00005211497,0.00060049753,0.000025285824],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09924435,0.003148796,0.24451114,0.0015155529,0.0013844764,0.00049586693,0.0011013038,0.0010390313,0.029388541,0.00091135397,0.009322523,0.60793704],"study_design_scores_gemma":[0.008446564,0.009618436,0.9169004,0.00075164257,0.00016184436,0.0005332245,0.000065472945,0.00005881432,0.000739145,0.0007036112,0.061891936,0.00012889097],"about_ca_topic_score_codex":0.00007491924,"about_ca_topic_score_gemma":0.000033111693,"teacher_disagreement_score":0.67238927,"about_ca_system_score_codex":0.000048877075,"about_ca_system_score_gemma":0.00037180202,"threshold_uncertainty_score":0.99492186},"labels":[],"label_agreement":null},{"id":"W2009093201","doi":"10.1016/j.acvd.2008.05.010","title":"Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design","year":2008,"lang":"en","type":"article","venue":"Archives of cardiovascular diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Rosuvastatin; Medicine; Atorvastatin; Apolipoprotein B; Acute coronary syndrome; Placebo; Internal medicine; Statin; Randomized controlled trial; Simvastatin; Percutaneous coronary intervention; HMG-CoA reductase; Cardiology; Gastroenterology; Cholesterol; Myocardial infarction; Reductase; Pathology","score_opus":0.009029003872686271,"score_gpt":0.21230240801663022,"score_spread":0.20327340414394396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009093201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858102,0.004824282,0.001802095,0.00008354267,0.000048936272,0.0072936183,0.00007757075,0.000028147551,0.000031580956],"genre_scores_gemma":[0.99732476,0.00076252955,0.0010254064,0.00010157528,0.00007248835,0.00058998796,0.000050477287,0.00005941259,0.000013347816],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957091,0.0014545539,0.00052525493,0.000506375,0.0013812534,0.00042346222],"domain_scores_gemma":[0.9975652,0.0005550453,0.0002103301,0.0013329214,0.000080261096,0.0002562329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005565015,0.00036380359,0.0011253136,0.00017732814,0.00022261305,0.000015099295,0.0002637637,0.00006003982,0.0000066702337],"category_scores_gemma":[0.00023190306,0.00020186686,0.0008120871,0.0003019758,0.00073946395,0.00012694213,0.000090380745,0.00027467805,0.0000013860016],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39820635,0.012613325,0.114307985,0.005282739,0.04706169,0.0040532593,0.008261911,0.0051318216,0.0009958076,0.0019284488,0.00016235896,0.40199432],"study_design_scores_gemma":[0.048144005,0.008880756,0.93584716,0.0005415144,0.0018962118,0.0001399166,0.00017110736,0.00011907336,0.0036607832,0.00024155538,0.00006456189,0.0002933352],"about_ca_topic_score_codex":0.0005842741,"about_ca_topic_score_gemma":0.0000063849225,"teacher_disagreement_score":0.8215392,"about_ca_system_score_codex":0.000032868396,"about_ca_system_score_gemma":0.00034160475,"threshold_uncertainty_score":0.8231892},"labels":[],"label_agreement":null},{"id":"W2009098521","doi":"10.2165/00044011-200019030-00007","title":"LIPI-WATCH, a Belgian/Luxembourg Survey on Achievement of European Atherosclerosis Society Lipid Goals","year":2000,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"European Atherosclerosis Society","keywords":"Medicine; Body mass index; Internal medicine; Diabetes mellitus; Coronary heart disease; Lipid profile; Risk factor; Cholesterol; Endocrinology","score_opus":0.07260013807781045,"score_gpt":0.3247633831257585,"score_spread":0.252163245047948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009098521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930681,0.000085620944,0.00003971117,0.0039781844,0.00022943597,0.00067778764,0.000042309086,0.00008421774,0.001794606],"genre_scores_gemma":[0.9879802,0.0011602333,0.00104762,0.0063614124,0.0011234893,0.000018830928,0.00023571111,0.0000584665,0.0020140547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99603057,0.0013565188,0.0011366932,0.0005066014,0.00066658214,0.00030301345],"domain_scores_gemma":[0.99798495,0.00032225632,0.0002525043,0.00082939886,0.00017856275,0.000432316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070804553,0.00021473563,0.0006522722,0.000026980235,0.000118595024,0.00001989751,0.00015862013,0.00015328257,0.00020942815],"category_scores_gemma":[0.000600879,0.00017846933,0.0006765706,0.0003154994,0.00033501445,0.0000712565,0.000044536562,0.00048344786,0.0002959515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005014716,0.0017208594,0.69009614,0.0004875055,0.0008347196,0.0000053876674,0.0017971678,0.00013831124,0.0020108104,0.00022851842,0.062557526,0.2396216],"study_design_scores_gemma":[0.0021564164,0.00059301953,0.98277736,0.00040897544,0.00011896228,0.000001297686,0.000037538863,0.00014687289,0.0018801825,0.00007943282,0.011628896,0.00017107656],"about_ca_topic_score_codex":0.0006688391,"about_ca_topic_score_gemma":0.000041558404,"teacher_disagreement_score":0.2926812,"about_ca_system_score_codex":0.0000739705,"about_ca_system_score_gemma":0.000186976,"threshold_uncertainty_score":0.72777677},"labels":[],"label_agreement":null},{"id":"W2009383197","doi":"10.1371/journal.pone.0049006","title":"Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy","year":2012,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Bayer HealthCare; Kowa Company; Sanofi; Pfizer","keywords":"Internal medicine; Gastroenterology; Medicine; Familial hypercholesterolemia; Placebo; Apolipoprotein B; Adverse effect; Endocrinology; Cholesterol; Pathology","score_opus":0.02427780878028109,"score_gpt":0.23221186985484674,"score_spread":0.20793406107456563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009383197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004394,0.00040222396,0.000017053313,0.00010487453,0.00009622013,0.0074899034,0.0000029903895,0.00003869656,0.0018040923],"genre_scores_gemma":[0.99758714,0.00028508424,0.0009929453,0.00014469525,0.00038363077,0.00044390353,0.000019318126,0.000046873483,0.000096413074],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975886,0.00034523738,0.00061492884,0.00022988916,0.00080183387,0.00041953576],"domain_scores_gemma":[0.99885565,0.00014145894,0.00020518356,0.00043645932,0.00018304186,0.00017817954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018453557,0.00022156545,0.0018164251,0.00017616003,0.000037655813,0.000012633562,0.00007806694,0.00013267688,0.00006811211],"category_scores_gemma":[0.0002769475,0.00015141808,0.00025021358,0.00023382208,0.000049427905,0.00016314909,0.000024439374,0.0002877144,0.000008418097],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.961257,0.0035514957,0.028940175,0.000167378,0.001527452,0.000002499431,0.0005281009,0.0000041684443,0.0006042056,0.0000027414687,0.0000024950912,0.0034123175],"study_design_scores_gemma":[0.979815,0.0009034671,0.016626056,0.0007137971,0.00041616464,0.0000026332496,0.00004061586,0.000030915817,0.0012681893,0.0000018593344,0.000014928786,0.0001663957],"about_ca_topic_score_codex":0.00014143047,"about_ca_topic_score_gemma":0.000014364807,"teacher_disagreement_score":0.018558007,"about_ca_system_score_codex":0.00010010805,"about_ca_system_score_gemma":0.00011420511,"threshold_uncertainty_score":0.617465},"labels":[],"label_agreement":null},{"id":"W2009560883","doi":"10.1159/000188578","title":"Comparison of Lp(a) Concentrations and Some Potential Effects in Hemodialysis, CAPD, Transplantation, and Control Groups, and Review of the Literature","year":2008,"lang":"en","type":"article","venue":"˜The œNephron journals/Nephron journals","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Internal medicine; Continuous ambulatory peritoneal dialysis; Hemodialysis; Lipoprotein(a); Cardiology; Urology; Transplantation; Coronary artery disease; Peritoneal dialysis; Diabetes mellitus; Gastroenterology; Endocrinology; Apolipoprotein B; Cholesterol","score_opus":0.012161051908069478,"score_gpt":0.28630024456890196,"score_spread":0.2741391926608325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009560883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56432354,0.43020675,0.0010181072,0.003411555,0.00009760176,0.0008951285,0.000025983383,0.000005044003,0.00001626754],"genre_scores_gemma":[0.7185672,0.2796294,0.000115971285,0.0013762753,0.00026117545,0.000014237037,0.000004980263,0.000016331642,0.0000144329915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964173,0.0009356678,0.0012109942,0.00025453203,0.0008465631,0.0003349293],"domain_scores_gemma":[0.9980572,0.00019848377,0.00075597555,0.00038802205,0.00032853681,0.00027180705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020498466,0.00027249873,0.0012718998,0.00017527849,0.00036423796,0.000055006778,0.00014645286,0.00015804698,0.000039108403],"category_scores_gemma":[0.00010235575,0.0001608851,0.00033225695,0.0004346065,0.0003656176,0.00028125566,0.000028497974,0.0007884944,4.7311846e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030444874,0.0019415927,0.64801896,0.058164377,0.005934475,0.00123342,0.035350937,0.0007287315,0.149644,0.0008047602,0.008289016,0.08684524],"study_design_scores_gemma":[0.0131254345,0.00058917794,0.9369387,0.027766522,0.0025426184,0.012302993,0.0005076641,0.00064723147,0.003045631,0.00049483444,0.0016757486,0.00036341045],"about_ca_topic_score_codex":0.00005470742,"about_ca_topic_score_gemma":0.000041819832,"teacher_disagreement_score":0.28891978,"about_ca_system_score_codex":0.000056327008,"about_ca_system_score_gemma":0.00024227187,"threshold_uncertainty_score":0.65607035},"labels":[],"label_agreement":null},{"id":"W2009681469","doi":"10.1074/jbc.m112.394023","title":"The M2 Module of the Cys-His-rich Domain (CHRD) of PCSK9 Protein Is Needed for the Extracellular Low-density Lipoprotein Receptor (LDLR) Degradation Pathway","year":2012,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"LDL receptor; PCSK9; Extracellular; Chemistry; Receptor; Degradation (telecommunications); Low-density lipoprotein; Domain (mathematical analysis); Cell biology; Lipoprotein; Biochemistry; Cholesterol; Biology; Computer science; Telecommunications","score_opus":0.022348416224829432,"score_gpt":0.2424618245242434,"score_spread":0.22011340829941395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009681469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866624,0.0074805077,0.0016781931,0.0028256935,0.00015852685,0.0010695887,0.000021736654,0.0000075004014,0.00009585589],"genre_scores_gemma":[0.9968071,0.00022726804,0.0013586343,0.000114163086,0.00095922145,0.000047827012,0.0000053822896,0.0000148909385,0.000465532],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978795,0.00017871332,0.0008117874,0.00015862868,0.00062312605,0.00034825635],"domain_scores_gemma":[0.99762565,0.00020440866,0.0009361766,0.0006240377,0.00045404732,0.00015570362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033150213,0.00019200014,0.0005378552,0.000015334286,0.00023412664,0.000014133101,0.0003908965,0.0002936601,0.000076140095],"category_scores_gemma":[0.0009140767,0.00007606364,0.00075735943,0.00020161604,0.0002829873,0.00005655069,0.00008765659,0.0004550767,0.0000015378597],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005990038,0.0002630656,0.0008648201,0.00029946168,0.000236223,0.0000016410111,0.0001335509,0.0000024578344,0.9834057,0.000067852474,0.00040544945,0.01372078],"study_design_scores_gemma":[0.001094085,0.00026139052,0.003305201,0.00019576291,0.00009982492,0.00010080272,0.000748947,0.000024976725,0.9858582,0.0002846506,0.007929154,0.000097007854],"about_ca_topic_score_codex":0.00005106181,"about_ca_topic_score_gemma":0.0000012829046,"teacher_disagreement_score":0.013623772,"about_ca_system_score_codex":0.00009661811,"about_ca_system_score_gemma":0.00018431564,"threshold_uncertainty_score":0.31017852},"labels":[],"label_agreement":null},{"id":"W2010093681","doi":"10.1136/bmj.326.7403.1348-b","title":"Statins cut cardiovascular events by a quarter in people with diabetes","year":2003,"lang":"en","type":"article","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Diabetes mellitus; Medicine; Internal medicine; Cardiology; History; Endocrinology","score_opus":0.007693492401792234,"score_gpt":0.24321847407762792,"score_spread":0.2355249816758357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010093681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904574,0.002738539,0.00056097266,0.00059444143,0.00007273476,0.0012130666,0.000008984353,0.00003451859,0.004319305],"genre_scores_gemma":[0.9979078,0.000056996218,0.0008306275,0.00042239338,0.00009726122,0.00023373456,0.00002244446,0.000030204437,0.00039849762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838793,0.00017739463,0.00022380562,0.0002766908,0.0005740144,0.00036018813],"domain_scores_gemma":[0.99911696,0.00001564052,0.000036669026,0.0006349049,0.00005156616,0.00014428231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091214804,0.00014112874,0.00048966607,0.00006309636,0.000037400165,0.00000842618,0.000044344037,0.000065339,0.000058085756],"category_scores_gemma":[0.00006549494,0.000105723746,0.00026353565,0.00026053717,0.00001708176,0.000055062497,0.000008484132,0.00015648782,0.00004085026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119993885,0.0005601661,0.9500712,0.0006795996,0.0023603602,0.00018837483,0.0013027245,0.0000925262,0.00029705503,0.00015022384,0.028280146,0.01589761],"study_design_scores_gemma":[0.015542155,0.0013976162,0.6326805,0.00062593183,0.0007667797,0.0002377702,0.0015013152,0.00014198832,0.004207072,0.00013981233,0.34192684,0.00083221344],"about_ca_topic_score_codex":0.00034592487,"about_ca_topic_score_gemma":0.00016939353,"teacher_disagreement_score":0.3173907,"about_ca_system_score_codex":0.00007999207,"about_ca_system_score_gemma":0.0001722489,"threshold_uncertainty_score":0.43112892},"labels":[],"label_agreement":null},{"id":"W2010427428","doi":"10.1054/plef.2002.0432","title":"Lovastatin does not accentuate but is rather additive to palmitate-induced apoptosis in cardiomyocytes","year":2002,"lang":"en","type":"article","venue":"Prostaglandins Leukotrienes and Essential Fatty Acids","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lovastatin; Apoptosis; Palmitic acid; Lipotoxicity; Fatty acid metabolism; Biochemistry; Biology; Fatty acid; Carnitine O-palmitoyltransferase; Chemistry; Endocrinology; Cholesterol; Beta oxidation","score_opus":0.022329985959432662,"score_gpt":0.26327895417369473,"score_spread":0.24094896821426207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010427428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935642,0.00066881906,0.0005837622,0.0023311533,0.00035834988,0.0014494968,0.0002374705,0.00007910937,0.00072762364],"genre_scores_gemma":[0.99514,0.0018550407,0.0005154783,0.0010488856,0.00051596476,0.00021691975,0.000051618426,0.000058013087,0.0005980517],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972819,0.000107679276,0.0005063023,0.00075386814,0.00062498037,0.00072525063],"domain_scores_gemma":[0.99874526,0.000055199052,0.000094313225,0.0005145255,0.00015537921,0.00043529493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000415191,0.00039279606,0.00081851915,0.00031060437,0.0002048126,0.00012833318,0.00012382554,0.00019120758,0.00035712463],"category_scores_gemma":[0.00010627188,0.0002855563,0.00028934036,0.0005592537,0.00008442299,0.00021276386,0.00014886554,0.0003024351,0.00008099831],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041788504,0.0013408375,0.22740665,0.0016679297,0.00281093,0.0007456666,0.025113223,0.000026579353,0.22549686,0.00061089545,0.0025774988,0.5080241],"study_design_scores_gemma":[0.009006901,0.00095660525,0.06475396,0.0004129147,0.0004655276,0.00012748937,0.0029030927,0.00049913925,0.90177345,0.000085111984,0.018031495,0.0009842963],"about_ca_topic_score_codex":0.0009506935,"about_ca_topic_score_gemma":0.000090535126,"teacher_disagreement_score":0.6762766,"about_ca_system_score_codex":0.00012170533,"about_ca_system_score_gemma":0.000069129805,"threshold_uncertainty_score":0.99995965},"labels":[],"label_agreement":null},{"id":"W2010561405","doi":"10.1111/j.1744-9987.2005.00324_9.x","title":"Lp(a) apheresis for the treatment of severe CHD patients with Lp(a) hyperlipidemia","year":2005,"lang":"en","type":"article","venue":"Therapeutic Apheresis and Dialysis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Apheresis Group","funders":"","keywords":"Medicine; Lipoprotein(a); Apheresis; Hyperlipidemia; Internal medicine; Lipoprotein; Cardiology; Coronary artery disease; Gastroenterology; LDL apheresis; Cholesterol; Urology; Endocrinology; Platelet","score_opus":0.016073021205000412,"score_gpt":0.25396852305967416,"score_spread":0.23789550185467373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010561405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797297,0.015736578,0.0007214403,0.0013525918,0.00004563657,0.0015747737,0.000037714533,0.0000348665,0.0007666587],"genre_scores_gemma":[0.99329764,0.0034160174,0.0014120192,0.0005961863,0.0004080129,0.00020094267,0.000022524282,0.000042190488,0.00060445146],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99853516,0.000078677615,0.00033572764,0.00033050412,0.00040652056,0.00031344173],"domain_scores_gemma":[0.9986033,0.0002686364,0.00014619142,0.0006734343,0.00016569771,0.00014276872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002665907,0.00025404562,0.0007267469,0.00005795835,0.00020412795,0.000020603731,0.00008612323,0.00010646783,0.00022811879],"category_scores_gemma":[0.000016879952,0.00012943195,0.00046963233,0.00023895323,0.000118838616,0.00005457612,0.000012105021,0.000057092017,0.0000052399873],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013917949,0.000707568,0.05572123,0.00011637409,0.0035489784,7.3702444e-7,0.00083945,0.000071406976,0.00013328154,0.00013551838,0.00020312142,0.9371305],"study_design_scores_gemma":[0.023386259,0.0051254965,0.676235,0.00015065137,0.0127223,0.000014985647,0.0015301314,0.0008033178,0.003057847,0.00021197241,0.2760444,0.0007175888],"about_ca_topic_score_codex":0.00036078313,"about_ca_topic_score_gemma":0.00023914054,"teacher_disagreement_score":0.93641293,"about_ca_system_score_codex":0.000082178405,"about_ca_system_score_gemma":0.00008239874,"threshold_uncertainty_score":0.5278082},"labels":[],"label_agreement":null},{"id":"W2010683229","doi":"10.1067/mcp.2000.105152","title":"Growth in use of statins after trials is not targeted to most appropriate patients","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Medicine; Simvastatin; Population; Statin; Clinical trial; Coronary heart disease; Ezetimibe; Defined daily dose; Internal medicine; Medical prescription; Environmental health; Pharmacology","score_opus":0.13488067877343987,"score_gpt":0.42747636411346634,"score_spread":0.29259568534002645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010683229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99151367,0.00018228454,0.00006424291,0.0056481706,0.00058128283,0.001806243,0.00012722786,0.00002883944,0.000048037367],"genre_scores_gemma":[0.8209698,0.001750368,0.0013366381,0.17520152,0.0003722795,0.00010185704,0.000025265377,0.000038210095,0.00020403141],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960235,0.0011673251,0.0016068817,0.00042821997,0.00037039173,0.00040370264],"domain_scores_gemma":[0.9982728,0.0006125681,0.00020274955,0.00035324797,0.00027146688,0.0002872055],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021371145,0.00021269302,0.0012695113,0.00011362072,0.00003052466,0.000008270467,0.00013109476,0.00028681563,0.0014329801],"category_scores_gemma":[0.00016577322,0.00016705816,0.00043662888,0.00036605206,0.0001530403,0.00006408198,0.00004506294,0.0005150193,0.00009620192],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037912972,0.008145217,0.4041103,0.00033712634,0.004702343,0.00014260365,0.0020798342,0.000057886402,0.005063631,0.0000067614556,0.013035621,0.5244057],"study_design_scores_gemma":[0.024035208,0.0032655916,0.81660587,0.00009095312,0.0022453892,0.000003994761,0.000025588717,0.00033981906,0.015905397,0.00008422538,0.13699771,0.00040025567],"about_ca_topic_score_codex":0.000088375375,"about_ca_topic_score_gemma":0.000005873012,"teacher_disagreement_score":0.5240054,"about_ca_system_score_codex":0.000058954527,"about_ca_system_score_gemma":0.00021410141,"threshold_uncertainty_score":0.99947983},"labels":[],"label_agreement":null},{"id":"W2010945123","doi":"10.1016/j.atherosclerosis.2013.10.031","title":"Simvastatin treatment upregulates intestinal lipid secretion pathways in a rodent model of the metabolic syndrome","year":2013,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Heart and Stroke Foundation of Canada","keywords":"Chylomicron; Simvastatin; Internal medicine; Endocrinology; Statin; ABCA1; Postprandial; Cholesterol; Metabolic syndrome; Ezetimibe; Reverse cholesterol transport; Medicine; Hyperlipidemia; Chemistry; Lipoprotein; Very low-density lipoprotein; Biochemistry; Diabetes mellitus; Transporter","score_opus":0.030981504385071076,"score_gpt":0.23126457791744476,"score_spread":0.20028307353237368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010945123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738455,0.00043383546,0.0003849485,0.00041545546,0.00005657177,0.0011405578,0.000012022071,0.000032193966,0.00013985364],"genre_scores_gemma":[0.9975997,0.00035562733,0.0013549369,0.00013347884,0.000041579628,0.00031550424,0.0000070609303,0.00002982954,0.00016227554],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986406,0.00010122231,0.0003640436,0.0002583364,0.0003629995,0.00027279215],"domain_scores_gemma":[0.99906564,0.00002800922,0.000115780145,0.0006041627,0.0000842229,0.00010216005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025249846,0.00018454126,0.00047826656,0.00006298137,0.000054141317,0.000015586023,0.00010717075,0.0000757414,0.000078146535],"category_scores_gemma":[0.000043352506,0.00011167434,0.00032448707,0.00025533367,0.000067503686,0.00007984655,0.000051610732,0.00011558652,0.000024265257],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118595955,0.0023751885,0.28212866,0.00042014703,0.0005786413,0.0000061651785,0.0072847484,0.008900869,0.55889297,0.001891741,0.00010684049,0.13729541],"study_design_scores_gemma":[0.0019390916,0.00046585142,0.94140244,0.00043630748,0.00017440558,0.000040917977,0.00025111064,0.028877879,0.025766008,0.00042874692,0.00006429925,0.00015293938],"about_ca_topic_score_codex":0.0032627012,"about_ca_topic_score_gemma":0.000089361485,"teacher_disagreement_score":0.65927374,"about_ca_system_score_codex":0.00013111888,"about_ca_system_score_gemma":0.00012552972,"threshold_uncertainty_score":0.49322498},"labels":[],"label_agreement":null},{"id":"W2011098763","doi":"10.1115/sbc2009-206539","title":"Fluid Shear Stress Reduces Simvastatin Induced Adhesion Molecule Expression in Cytokine Activated Endothelial Cells","year":2009,"lang":"en","type":"article","venue":"ASME 2009 Summer Bioengineering Conference, Parts A and B","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Heart Institute","funders":"National Research Council Canada; Canadian Institutes of Health Research; National Research Foundation","keywords":"Cell adhesion molecule; Simvastatin; Cell biology; Endothelial stem cell; Intercellular Adhesion Molecule-1; Cell adhesion; VCAM-1; Statin; ICAM-1; E-selectin; Adhesion; Tumor necrosis factor alpha; Chemistry; Soluble cell adhesion molecules; Cytokine; Biology; Cell; Biochemistry; Immunology; Pharmacology; In vitro","score_opus":0.022083431295162183,"score_gpt":0.25909059651892485,"score_spread":0.23700716522376267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011098763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975528,0.0004597767,0.00039315177,0.00033395962,0.00012833062,0.0005251249,0.000035814868,0.000093136914,0.000477866],"genre_scores_gemma":[0.9982953,0.0004354549,0.00076016894,0.00014029648,0.00018067443,0.000022168764,0.00004282805,0.000024901343,0.00009821452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983625,0.000057176057,0.00035028305,0.0004242433,0.00034437413,0.00046144365],"domain_scores_gemma":[0.9992704,0.000021027265,0.000060675764,0.00031535674,0.00007555173,0.0002570068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021214529,0.00028749372,0.0004910358,0.00022912468,0.00006476386,0.00005051234,0.00008168252,0.00016759873,0.000052329142],"category_scores_gemma":[0.000029918538,0.00023619585,0.000096828255,0.00024612443,0.000029038816,0.0001255587,0.00003036287,0.00029961782,0.00000822697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001308544,0.00015048486,0.00022555939,0.00007109507,0.000025427558,0.000091197224,0.00022432495,0.00006197386,0.98193395,0.000039630893,0.00012638581,0.016919088],"study_design_scores_gemma":[0.0018009933,0.0005075677,0.013240742,0.00065723545,0.000034891662,0.000023691258,0.00012920982,0.0011614775,0.9805427,0.000012441123,0.0016111668,0.00027783556],"about_ca_topic_score_codex":0.0001567758,"about_ca_topic_score_gemma":0.000006825848,"teacher_disagreement_score":0.016641254,"about_ca_system_score_codex":0.000037368558,"about_ca_system_score_gemma":0.00010503144,"threshold_uncertainty_score":0.96317875},"labels":[],"label_agreement":null},{"id":"W2011103783","doi":"10.1111/j.1600-6143.2004.00445.x","title":"Fluvastatin Prevents Cardiac Death and Myocardial Infarction in Renal Transplant Recipients: Post-Hoc Subgroup Analyses of the ALERT Study","year":2004,"lang":"en","type":"article","venue":"American Journal of Transplantation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Fluvastatin; Myocardial infarction; Internal medicine; Cardiology; Transplantation; Placebo; Clinical endpoint; Kidney disease; Randomized controlled trial; Pathology","score_opus":0.015839831544099285,"score_gpt":0.2967017219743357,"score_spread":0.2808618904302364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011103783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976688,0.00039771464,0.0010240522,0.000204305,0.00015027968,0.0004963112,0.000033911994,0.00000410769,0.00002053756],"genre_scores_gemma":[0.9971793,0.0019151584,0.0006965543,0.00007705298,0.000095205,0.000007955274,0.000013641237,0.000012977651,0.0000021373858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981043,0.0003534736,0.000606786,0.00014641674,0.0006327635,0.00015627567],"domain_scores_gemma":[0.99920195,0.000041469113,0.00035319716,0.0001629217,0.00014334726,0.000097095486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007951504,0.00013037151,0.0005496188,0.00021331767,0.000050895018,0.000008588981,0.000075029486,0.000031388925,0.0000026325654],"category_scores_gemma":[0.000017600592,0.000087935296,0.00035508955,0.0003706973,0.00008319745,0.00014285193,0.000004257692,0.00024501575,2.4900712e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074248738,0.00096695666,0.84851056,0.00020048746,0.0024710502,0.0002218238,0.02005528,0.0020046444,0.04047363,0.000018841238,0.0000028417724,0.07764901],"study_design_scores_gemma":[0.004261169,0.0034583483,0.9851964,0.0005411539,0.0012729468,0.00046353735,0.0013738065,0.000003985591,0.003317095,0.000020598514,0.000008275073,0.00008267813],"about_ca_topic_score_codex":0.0022362636,"about_ca_topic_score_gemma":0.00013133544,"teacher_disagreement_score":0.13668585,"about_ca_system_score_codex":0.00009811932,"about_ca_system_score_gemma":0.0001997555,"threshold_uncertainty_score":0.3585897},"labels":[],"label_agreement":null},{"id":"W2011175975","doi":"10.1016/j.cjca.2013.03.004","title":"Regional Distribution and Metabolic Effect of PCSK9 insLEU and R46L Gene Mutations and apoE Genotype","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Medicine; Genetics; Genotype; Insulin resistance; Population; Apolipoprotein E; Single-nucleotide polymorphism; Kexin; Internal medicine; Gene; Cholesterol; Obesity; Biology; LDL receptor; Lipoprotein; Disease","score_opus":0.00950248843647717,"score_gpt":0.2293963119019513,"score_spread":0.21989382346547415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011175975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766694,0.021016598,0.001021578,0.0008045043,0.000097476724,0.00022591848,0.000025161331,0.0000017167372,0.0001376819],"genre_scores_gemma":[0.9982159,0.0010414274,0.00017897972,0.000105460036,0.00041287948,0.000005647761,0.000021233984,0.000007356357,0.000011096461],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99925435,0.00016282173,0.00022130436,0.00009915504,0.00009248429,0.00016987188],"domain_scores_gemma":[0.9990442,0.000053559655,0.0000946562,0.00011054036,0.00019322569,0.0005038546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047926363,0.000085611195,0.0005363119,0.00012613337,0.00006915863,0.0000098816745,0.000027758615,0.0000977608,0.0000056034833],"category_scores_gemma":[0.00015101765,0.00006519397,0.00010165811,0.00007532848,0.00022592324,0.000058696263,0.000007753993,0.00015572585,9.2691806e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033133655,0.000007529505,0.48613346,0.0006383292,0.003627147,0.00042607225,0.000699712,0.00017822055,0.008662508,0.0018798007,0.0067504765,0.4906654],"study_design_scores_gemma":[0.0019471205,0.00070351927,0.9431877,0.000040549865,0.0005225589,0.0063284175,0.00005718857,0.000024876063,0.0006647114,0.00028589205,0.046154078,0.00008334969],"about_ca_topic_score_codex":0.0027118074,"about_ca_topic_score_gemma":0.00019136947,"teacher_disagreement_score":0.49058205,"about_ca_system_score_codex":0.00003458669,"about_ca_system_score_gemma":0.00044335666,"threshold_uncertainty_score":0.40994596},"labels":[],"label_agreement":null},{"id":"W2011478889","doi":"10.1139/g06-147","title":"Genetic susceptibility to heart disease in Canada: lessons from patients with familial hypercholesterolemia","year":2006,"lang":"en","type":"review","venue":"Genome","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Familial hypercholesterolemia; Genetics; LDL receptor; Biology; Copy-number variation; PCSK9; Mendelian inheritance; Mutation; Population; Gene; Lipoprotein; Endocrinology; Medicine; Genome; Cholesterol","score_opus":0.022546099591630224,"score_gpt":0.27182048486746924,"score_spread":0.249274385275839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011478889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21729407,0.77862483,0.000012305796,0.00010041429,0.00012001015,0.0026378175,0.0011663608,0.000015042657,0.000029180965],"genre_scores_gemma":[0.05499887,0.93749785,0.0007886319,0.0014228867,0.0012993996,0.00060474797,0.0030270666,0.00021738546,0.00014316903],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997182,0.00019429307,0.0005929266,0.00079467933,0.00071918435,0.0005168884],"domain_scores_gemma":[0.9978912,0.00002513644,0.00008819902,0.0012639521,0.00007790274,0.000653641],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015949467,0.00041716208,0.0018974578,0.000121255594,0.00004640641,0.000015019405,0.00017164691,0.00013091904,0.000036107136],"category_scores_gemma":[0.000025492565,0.00031225823,0.00030328025,0.00029994256,0.000026273876,0.000019633302,0.000084738975,0.00041799012,0.000044840162],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018364654,0.00035398515,0.12690611,0.0144756185,0.0002830816,0.00041864224,0.000048694114,0.000066753164,0.0000012958449,7.339425e-7,0.00033014268,0.85693127],"study_design_scores_gemma":[0.0005076037,0.000057059733,0.5563893,0.0016193023,0.00042436807,0.0000020912803,0.000002895607,1.8155625e-7,1.6625865e-8,0.0000015120539,0.44079897,0.00019673951],"about_ca_topic_score_codex":0.8862545,"about_ca_topic_score_gemma":0.84505963,"teacher_disagreement_score":0.8567346,"about_ca_system_score_codex":0.0024771597,"about_ca_system_score_gemma":0.0069812876,"threshold_uncertainty_score":0.99993294},"labels":[],"label_agreement":null},{"id":"W2011760617","doi":"10.1111/j.1463-1326.2011.01383.x","title":"Lipid‐altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials","year":2011,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Ezetimibe; Statin; Medicine; Internal medicine; Diabetes mellitus; Population; Placebo; Gastroenterology; Cholesterol; Lipid profile; Endocrinology; Pharmacology","score_opus":0.059020171091089264,"score_gpt":0.3252401634328464,"score_spread":0.26621999234175714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011760617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962558,0.001658434,0.0001870104,0.000019875586,0.000036820296,0.0013969872,0.0004203048,0.000015182972,0.000009553403],"genre_scores_gemma":[0.9922593,0.0017819669,0.005136122,0.00012728057,0.000041125175,0.000018243867,0.0006071121,0.00002518309,0.0000036719189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705976,0.00093418907,0.00085622765,0.0005466244,0.00036459567,0.00023857839],"domain_scores_gemma":[0.9981447,0.00026384406,0.0005122708,0.0007160476,0.00016968734,0.00019343429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033767796,0.0002327112,0.0020027112,0.00025271953,0.000051467974,0.000019354584,0.00011895783,0.00011469086,0.00003156469],"category_scores_gemma":[0.00021011126,0.00015565813,0.00008178747,0.00035638546,0.00020425854,0.0002700927,0.000060419592,0.00017614666,1.3685805e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025263329,0.0011347325,0.9368174,0.00010379167,0.0022973116,3.56407e-7,0.0013406407,0.0000014300487,0.00021906504,0.000025085636,0.0000013126784,0.055532537],"study_design_scores_gemma":[0.020581013,0.0013327139,0.9723524,0.00016637407,0.0021538993,5.6883273e-8,0.000103809354,0.0013404143,0.001726215,0.000026729542,0.00004490641,0.00017145659],"about_ca_topic_score_codex":0.00066924404,"about_ca_topic_score_gemma":0.00013066371,"teacher_disagreement_score":0.05536108,"about_ca_system_score_codex":0.000006941192,"about_ca_system_score_gemma":0.000069072405,"threshold_uncertainty_score":0.63475543},"labels":[],"label_agreement":null},{"id":"W2011790546","doi":"10.1016/j.lfs.2013.03.002","title":"Statin therapy influences endothelial cell morphology and F-actin cytoskeleton structure when exposed to static and laminar shear stress conditions","year":2013,"lang":"en","type":"article","venue":"Life Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Cytoskeleton; Shear stress; Actin; Statin; Laminar flow; Morphology (biology); Actin cytoskeleton; Materials science; Biophysics; Cell; Chemistry; Medicine; Internal medicine; Cell biology; Composite material; Biology; Mechanics; Physics; Biochemistry; Genetics","score_opus":0.019296029304474153,"score_gpt":0.2779584062695333,"score_spread":0.2586623769650591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011790546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515015,0.00080801453,0.00007155045,0.002747973,0.00009237699,0.00080403505,0.00009069014,0.000027011443,0.00020818523],"genre_scores_gemma":[0.9920133,0.0003162088,0.0049531935,0.0024169409,0.00012502687,0.000050407853,0.000007946535,0.000008616451,0.0001083728],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986576,0.0001161582,0.00019807217,0.0003554187,0.0003716328,0.00030111766],"domain_scores_gemma":[0.99928784,0.000092194634,0.00006543305,0.00018537781,0.00006300924,0.00030614465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027505594,0.00013595793,0.00027646957,0.00011130371,0.0002580705,0.00007717526,0.000099575474,0.000057519348,0.0003548021],"category_scores_gemma":[0.000083208026,0.00009351787,0.000032653254,0.00016737344,0.00041517775,0.00019801046,0.000037036792,0.00011768243,0.000012062777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021278227,0.00028080732,0.1458778,0.0006530344,0.00019988608,0.00007264429,0.023224272,0.00020779223,0.7405617,0.00077046314,0.005590536,0.08234824],"study_design_scores_gemma":[0.006370829,0.007259955,0.80321205,0.00025251202,0.00011206439,0.00024071871,0.025715167,0.00054558483,0.14091009,0.0055019506,0.009028871,0.0008502069],"about_ca_topic_score_codex":0.0014415038,"about_ca_topic_score_gemma":0.000044332217,"teacher_disagreement_score":0.65733427,"about_ca_system_score_codex":0.0000119879505,"about_ca_system_score_gemma":0.00018060005,"threshold_uncertainty_score":0.3884834},"labels":[],"label_agreement":null},{"id":"W2011796546","doi":"10.1016/s0002-9149(01)02258-5","title":"Tolerability of statin-fibrate and statin-niacin combination therapy in dyslipidemic patients at high risk for cardiovascular events","year":2002,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Fibrate; Tolerability; Niacin; Statin; Medicine; Pharmacology; Internal medicine; Adverse effect","score_opus":0.016460674958883675,"score_gpt":0.2553707960491489,"score_spread":0.23891012109026524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011796546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405056,0.0025545845,0.0020264327,0.00039108348,0.00015570792,0.000754054,0.000037481972,0.000004604143,0.000025463421],"genre_scores_gemma":[0.9942451,0.004486739,0.00090754876,0.00014119601,0.00016292911,0.00002127053,0.000006534411,0.000019871686,0.000008822555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699026,0.0014039674,0.0007325215,0.00019669891,0.00041569542,0.00026083083],"domain_scores_gemma":[0.9978972,0.00035649442,0.00080666906,0.00044476273,0.00039123264,0.000103657505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030426863,0.00015633676,0.0015068515,0.00012618974,0.00006987177,0.0000029939565,0.000117009826,0.00004961446,0.000006545205],"category_scores_gemma":[0.00035155885,0.00010058531,0.0007291908,0.00021102431,0.00028348452,0.000057897163,0.00003479996,0.00027145972,8.490474e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022550116,0.00013530294,0.63166875,0.00008943603,0.002820963,0.000010204675,0.00083628774,0.0018444322,0.0002049844,0.000048082806,0.00016760165,0.35991895],"study_design_scores_gemma":[0.008936406,0.0063108583,0.9805372,0.0000547538,0.0004316436,0.00015122812,0.00026819267,0.00023707096,0.00026190275,0.001064774,0.0016198937,0.00012610937],"about_ca_topic_score_codex":0.00030414455,"about_ca_topic_score_gemma":0.000004657477,"teacher_disagreement_score":0.35979286,"about_ca_system_score_codex":0.00014188823,"about_ca_system_score_gemma":0.000051812527,"threshold_uncertainty_score":0.410175},"labels":[],"label_agreement":null},{"id":"W2011950080","doi":"10.1016/j.jacl.2009.10.001","title":"Acquired severe hypercholesterolemia and hypoalphalipoproteinemia","year":2009,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"McGill University Health Centre","keywords":"Medicine; Body mass index; Diabetes mellitus; Obesity; Myocardial infarction; Pediatrics; Internal medicine; Coronary artery disease; Family history; Nephropathy; Endocrinology","score_opus":0.05398766015217993,"score_gpt":0.3847052830784341,"score_spread":0.3307176229262542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011950080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825408,0.0020127736,0.00030351168,0.012285163,0.0013254976,0.0002323392,0.000001326573,0.000017565517,0.0012810563],"genre_scores_gemma":[0.97700584,0.0011880579,0.0053961235,0.0070923697,0.009069932,0.0000012416797,0.000001407207,0.000013923238,0.00023113427],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997239,0.00036594397,0.0014983559,0.00022101059,0.00039672933,0.00027899336],"domain_scores_gemma":[0.9980916,0.00024741457,0.0005137899,0.00036379023,0.0002775774,0.0005058474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034537404,0.00015227562,0.0012658754,0.00010631834,0.000045982088,0.000013717766,0.00012458744,0.00036815036,0.00007001064],"category_scores_gemma":[0.0016060475,0.000106769876,0.0005556518,0.000108724824,0.00014208053,0.00011129551,0.000033313765,0.00062068173,0.000014701731],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027382362,0.0004903396,0.038179632,0.000089327485,0.00039181046,0.0002609668,0.000081289145,0.0000040709897,0.0020477027,0.0003396876,0.0074977945,0.94787914],"study_design_scores_gemma":[0.00975173,0.007914661,0.8525669,0.00021868479,0.00043332248,0.0135017345,0.00005979529,0.000020868536,0.00019397314,0.0019418373,0.11321146,0.00018500458],"about_ca_topic_score_codex":0.0000069088305,"about_ca_topic_score_gemma":0.0000019077736,"teacher_disagreement_score":0.9476941,"about_ca_system_score_codex":0.000026525253,"about_ca_system_score_gemma":0.00028732885,"threshold_uncertainty_score":0.43539494},"labels":[],"label_agreement":null},{"id":"W2012406449","doi":"10.1161/01.atv.0000216750.09611.ec","title":"Effect of Ezetimibe on the In Vivo Kinetics of ApoB-48 and ApoB-100 in Men With Primary Hypercholesterolemia","year":2006,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada","keywords":"Ezetimibe; Apolipoprotein B; Very low-density lipoprotein; Internal medicine; Chemistry; Endocrinology; Triglyceride; Lipoprotein; Cholesterol; Intermediate-density lipoprotein; Biochemistry; Medicine","score_opus":0.013332005837052486,"score_gpt":0.2516957814302731,"score_spread":0.2383637755932206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012406449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978338,0.000318544,0.000026286127,0.00040209628,0.0000188699,0.00075359666,0.000010078205,0.0000079273905,0.0006287932],"genre_scores_gemma":[0.9978276,0.0016703712,0.00012619545,0.00024191596,0.00003688523,0.000062816885,0.0000112341095,0.000020605203,0.0000023785415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843806,0.00039855886,0.000390333,0.00033453744,0.00017951267,0.00025898908],"domain_scores_gemma":[0.99922913,0.00013313131,0.0001026167,0.00044984304,0.000032483942,0.000052809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008873984,0.00021068614,0.0008520809,0.00013484817,0.000029030276,0.000007865504,0.00007772549,0.00016143816,0.000012458573],"category_scores_gemma":[0.00001890868,0.00012186957,0.00012796107,0.00020271892,0.00030133934,0.000029352332,0.000058708352,0.00017225948,6.5916987e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009788875,0.00031462676,0.5414836,0.00049168844,0.0001910378,4.1566219e-7,0.00023366108,0.0000087409235,0.4544117,0.00023096251,0.00005394302,0.002481759],"study_design_scores_gemma":[0.003536691,0.002757224,0.975118,0.0004168185,0.00013170377,0.0000025108575,0.000052175674,0.000032149743,0.017578568,0.000017607857,0.00024049603,0.00011606835],"about_ca_topic_score_codex":0.00093193236,"about_ca_topic_score_gemma":0.00017240731,"teacher_disagreement_score":0.4368331,"about_ca_system_score_codex":0.000035979003,"about_ca_system_score_gemma":0.000020266143,"threshold_uncertainty_score":0.49696967},"labels":[],"label_agreement":null},{"id":"W2012810123","doi":"10.1016/s0828-282x(10)70003-9","title":"Achieving cholesterol targets by individualizing starting doses of statin according to baseline low-density lipoprotein cholesterol and coronary artery disease risk category: The CANadians Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (CanACTFAST) study","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Pfizer (Canada); University of Toronto; University of British Columbia","funders":"Pfizer Canada; Pfizer","keywords":"Medicine; Atorvastatin; Statin; Cholesterol; Internal medicine; Regimen; Dosing; Coronary artery disease; Ezetimibe; Lipoprotein; Gastroenterology; Endocrinology; Pharmacology","score_opus":0.008721634211898328,"score_gpt":0.2310545071114291,"score_spread":0.22233287289953077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012810123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909666,0.00029907533,0.0046905074,0.0014184194,0.00029685188,0.0018339729,0.00044448389,0.000013643906,0.0000363993],"genre_scores_gemma":[0.99785626,0.00002623779,0.00042048199,0.00080870965,0.000696633,0.000050585215,0.0000609156,0.00006929002,0.000010873171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961096,0.0009961791,0.0010118865,0.00051152945,0.0005894154,0.0007813791],"domain_scores_gemma":[0.9959338,0.00016383805,0.0007573795,0.00068543945,0.00049207406,0.0019674746],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031987417,0.00043089184,0.0011331822,0.00041800534,0.00051630987,0.00012717847,0.00030065258,0.00015973454,0.000009243782],"category_scores_gemma":[0.0005528931,0.00032477497,0.0002094063,0.00028001948,0.0002639997,0.0003196098,0.00004517465,0.0013280038,0.0000014812705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076091365,0.000059191807,0.89620036,0.00021287701,0.0013718847,0.0005623278,0.0058869706,0.0015109354,0.007770309,0.000008613129,0.00047468476,0.085180946],"study_design_scores_gemma":[0.003190365,0.0018634183,0.98176295,0.0002469954,0.0007196755,0.0005835243,0.00998199,0.00007642106,0.0006402843,0.00001877566,0.000561197,0.00035441117],"about_ca_topic_score_codex":0.07185722,"about_ca_topic_score_gemma":0.33072877,"teacher_disagreement_score":0.25887156,"about_ca_system_score_codex":0.00021040248,"about_ca_system_score_gemma":0.0024628635,"threshold_uncertainty_score":0.9999204},"labels":[],"label_agreement":null},{"id":"W2012880565","doi":"10.1136/bmj.38849.487546.de","title":"Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study","year":2006,"lang":"en","type":"article","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Institute for Work & Health; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Guideline; Coronary heart disease; Population; Cause of death; Statin; Disease; Medical emergency; Family medicine; Emergency medicine; Environmental health; Internal medicine; Pathology","score_opus":0.04609360954958184,"score_gpt":0.351194015014077,"score_spread":0.30510040546449513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012880565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98258084,0.001899004,0.011178614,0.00015758144,0.0000541028,0.0040375097,0.000051763058,0.000020824024,0.00001978632],"genre_scores_gemma":[0.99727046,0.000022915337,0.0019247622,0.00002341944,0.0002333437,0.00040593027,0.000042809694,0.00001847687,0.000057858826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988818,0.00010480286,0.00032469525,0.00027344568,0.00026519303,0.00015005865],"domain_scores_gemma":[0.99936074,0.00013267351,0.00006955439,0.00027613636,0.00008574285,0.000075154945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003943695,0.0001363271,0.00039996413,0.000036132493,0.00006960582,0.000006708861,0.000023522312,0.000024459552,0.000002950783],"category_scores_gemma":[0.00003907006,0.000093667455,0.00014660844,0.00003690407,0.0000137836305,0.000015846179,0.000015772699,0.00003085318,4.794327e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071221567,0.014350159,0.8210095,0.0025036307,0.0011550802,0.00012345568,0.00072216475,0.03504499,0.00321462,0.00038429617,0.00036479623,0.11400515],"study_design_scores_gemma":[0.0069485274,0.0029455535,0.9644419,0.0006113365,0.0005445713,0.000004364578,0.00015967256,0.021472517,0.0019843655,0.0005819128,0.00015870467,0.0001465993],"about_ca_topic_score_codex":0.0011057146,"about_ca_topic_score_gemma":0.00001500871,"teacher_disagreement_score":0.14343236,"about_ca_system_score_codex":0.0000632895,"about_ca_system_score_gemma":0.00006146817,"threshold_uncertainty_score":0.38196477},"labels":[],"label_agreement":null},{"id":"W2013818621","doi":"10.1016/j.jacc.2014.09.088","title":"Underutilization of High-Intensity Statin Therapy After Hospitalization for Coronary Heart Disease","year":2015,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Statin; Rosuvastatin; Atorvastatin; Internal medicine; Medical prescription; Intensity (physics); Myocardial infarction; Simvastatin; Cardiology; Coronary artery disease; Physical therapy; Pharmacology","score_opus":0.020651289878995782,"score_gpt":0.279934056297611,"score_spread":0.2592827664186152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013818621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823152,0.0012166562,0.012527462,0.002902625,0.00039036555,0.0005292016,0.000092494454,0.000003621687,0.000022402453],"genre_scores_gemma":[0.99738324,0.00022940051,0.0012803234,0.00073775224,0.00030901362,0.000009588251,0.000004856324,0.000014886618,0.000030970354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987654,0.0002422196,0.00042371647,0.00009513354,0.00035078323,0.0001227093],"domain_scores_gemma":[0.99784595,0.000054516106,0.00057180075,0.00030778683,0.0010825836,0.00013737925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006650102,0.00009002573,0.0008581341,0.00007941546,0.000023699982,0.0000013135511,0.00009015317,0.000032854223,0.0000021442206],"category_scores_gemma":[0.00029195964,0.000056904086,0.00045599518,0.00021077992,0.0002577473,0.000042876465,0.000027024918,0.00008124239,1.8403566e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05436539,0.0003781699,0.89099044,0.00036196393,0.0026482677,0.00019039423,0.00028775886,0.005665291,0.0022846528,0.0009872472,0.03426682,0.007573633],"study_design_scores_gemma":[0.0033936773,0.003712208,0.98351556,0.00008636195,0.0003647567,0.0005244905,0.0005730753,0.00010510801,0.0008761639,0.0017855903,0.0049801343,0.000082851024],"about_ca_topic_score_codex":0.000030832583,"about_ca_topic_score_gemma":0.0000015814165,"teacher_disagreement_score":0.09252517,"about_ca_system_score_codex":0.00008647129,"about_ca_system_score_gemma":0.0005795711,"threshold_uncertainty_score":0.23204812},"labels":[],"label_agreement":null},{"id":"W2014291253","doi":"10.1111/cge.12483","title":"Beneficial metabolic phenotypes caused by loss‐of‐function <i><scp>APOC3</scp></i> mutations","year":2014,"lang":"en","type":"letter","venue":"Clinical Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Loss function; Phenotype; Mutation; Genetics; Medicine; Internal medicine; Function (biology); Endocrinology; Biology; Gene","score_opus":0.03686416086635697,"score_gpt":0.3163928186436344,"score_spread":0.2795286577772774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014291253","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46198815,0.13020545,0.03781812,0.32336044,0.020912668,0.009494077,0.001738956,0.00086182234,0.013620317],"genre_scores_gemma":[0.048700802,0.0121844765,0.002633944,0.87176055,0.054768644,0.00016406493,0.004728383,0.00044122274,0.004617889],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956533,0.00045054543,0.0015679053,0.00075269217,0.0010229299,0.0005526589],"domain_scores_gemma":[0.99653643,0.0007481976,0.00060680835,0.0013477815,0.0004849642,0.0002758389],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001103876,0.00044164358,0.0017279696,0.0001326177,0.00010754027,0.000028109209,0.0002540477,0.0018445244,0.000049023543],"category_scores_gemma":[0.0009372816,0.00039322567,0.0012218832,0.00029098178,0.00033495872,0.00002212041,0.00007833011,0.0021076542,0.00017253355],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022721419,0.00023013227,0.0026717267,0.0006542886,0.0012361226,0.00005227156,0.00004163017,0.000028221586,0.00008945385,0.000046045123,0.96730924,0.027618134],"study_design_scores_gemma":[0.001725331,0.0007134621,0.0055938438,0.00010072436,0.0030900978,0.00002155552,0.000013346979,0.00006082482,0.00041976708,0.00034714895,0.987751,0.00016288615],"about_ca_topic_score_codex":0.00006293269,"about_ca_topic_score_gemma":0.000009810578,"teacher_disagreement_score":0.5484001,"about_ca_system_score_codex":0.000033316428,"about_ca_system_score_gemma":0.00050168467,"threshold_uncertainty_score":0.99985194},"labels":[],"label_agreement":null},{"id":"W2014505829","doi":"10.1046/j.1524-4733.2000.36006.x","title":"Predictors of Long-term Persistence on Statins in a Subsidized Clinical Population","year":2000,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pravastatin; Cohort; Statin; Persistence (discontinuity); Population; Medical record; Demography; Pediatrics; Internal medicine; Environmental health","score_opus":0.07645816296236467,"score_gpt":0.35671550069685415,"score_spread":0.28025733773448946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014505829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997187,0.0006932616,0.000014766599,0.0006814886,0.00014062684,0.0009792892,0.000008482774,0.00002228749,0.000272773],"genre_scores_gemma":[0.996953,0.0019258551,0.0003931325,0.00044835635,0.00015308776,0.000017945667,0.00002940186,0.00001613412,0.0000630803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974025,0.00057109544,0.00096543937,0.00029867733,0.00045788544,0.0003044133],"domain_scores_gemma":[0.99912655,0.0001096975,0.00013909397,0.00040658296,0.000027972692,0.00019007592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024499246,0.00010754374,0.0005986897,0.00016298237,0.000028011196,0.0000032434727,0.00006215999,0.000106736414,0.00008944152],"category_scores_gemma":[0.00016287748,0.000094642084,0.00017410032,0.00033991062,0.000039675822,0.000041171763,0.000007804248,0.000324353,0.000010788354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004804444,0.0004101858,0.9436663,0.00064534025,0.000020608635,0.00003628778,0.00051131693,0.0010509376,0.0000023447267,0.0000622916,0.000010585523,0.053103402],"study_design_scores_gemma":[0.0028907189,0.0010984209,0.99331385,0.0010313715,0.0000115848,0.000015687796,0.00004701613,0.0014334234,0.0000110783385,0.000022270533,0.00006016256,0.00006441517],"about_ca_topic_score_codex":0.010800065,"about_ca_topic_score_gemma":0.0004345043,"teacher_disagreement_score":0.05303899,"about_ca_system_score_codex":0.00026605185,"about_ca_system_score_gemma":0.00039234382,"threshold_uncertainty_score":0.9957871},"labels":[],"label_agreement":null},{"id":"W2014558113","doi":"10.1016/j.ahj.2009.09.017","title":"Rationale and design of the dal-OUTCOMES trial: Efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome","year":2009,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":183,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; University of Toronto; Université de Montréal; St. Michael's Hospital","funders":"National Institute of General Medical Sciences","keywords":"Medicine; Acute coronary syndrome; Intensive care medicine; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.017730038884224242,"score_gpt":0.27303773750933347,"score_spread":0.2553076986251092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014558113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678236,0.00031831575,0.00013430226,0.0017066171,0.00003419715,0.0010061078,0.000004837743,0.000002741317,0.000010490177],"genre_scores_gemma":[0.99682516,0.00078987924,0.0018750731,0.00047208418,0.000016698938,0.0000029837659,0.0000017501407,0.000007049183,0.000009301979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882144,0.0001920275,0.00033056774,0.00010735317,0.00041656254,0.00013203877],"domain_scores_gemma":[0.99937344,0.00007562926,0.00017597557,0.00018454729,0.00008889456,0.00010150435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005289923,0.00008675761,0.00049194816,0.000066835266,0.000058752015,0.0000055390965,0.00003917628,0.000021051732,0.000010980842],"category_scores_gemma":[0.00006321111,0.00004894237,0.00006442872,0.00021678364,0.00015998303,0.000051361156,0.000012967833,0.00018275139,1.2683144e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02371603,0.0006557164,0.90293837,0.000025810614,0.00044098575,0.0000311796,0.00032577862,0.00005517332,0.00020220448,0.00001738513,0.000114996554,0.0714764],"study_design_scores_gemma":[0.022441162,0.0044148015,0.9721265,0.000107225904,0.0000956793,0.000494607,0.000052172007,0.0000056913573,0.000034910478,0.000013738379,0.000163974,0.000049562466],"about_ca_topic_score_codex":0.000030198398,"about_ca_topic_score_gemma":0.0000012725301,"teacher_disagreement_score":0.07142684,"about_ca_system_score_codex":0.00003532658,"about_ca_system_score_gemma":0.00018387729,"threshold_uncertainty_score":0.19958119},"labels":[],"label_agreement":null},{"id":"W2014561045","doi":"10.1016/j.ahj.2014.07.028","title":"Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial","year":2014,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":411,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian VIGOUR Centre","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Alirocumab; PCSK9; Monoclonal; Monoclonal antibody; Term (time); Internal medicine; Intensive care medicine; Antibody; Immunology; Cholesterol; LDL receptor; Lipoprotein","score_opus":0.022613826288382623,"score_gpt":0.3292959977167019,"score_spread":0.30668217142831933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014561045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271774,0.00047893156,0.0038191802,0.00074896816,0.00041296476,0.001780579,0.000008055753,0.000014497889,0.00001906799],"genre_scores_gemma":[0.99767244,0.00007336736,0.0012803683,0.00067133753,0.00016910164,0.000040422314,0.000004702487,0.00003667897,0.00005161055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99622095,0.0011552346,0.00060657645,0.000299428,0.0013773043,0.0003404951],"domain_scores_gemma":[0.9980738,0.0005718302,0.00023816979,0.0007225974,0.00010038668,0.0002931962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031494321,0.00027764778,0.0018344196,0.00017707457,0.00019936931,0.000025416222,0.00016972309,0.000061736086,0.000013555701],"category_scores_gemma":[0.0004983211,0.00016261863,0.001860475,0.00027412781,0.00016637084,0.00008347458,0.00007336098,0.000344058,0.000004449973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005751569,0.00019126685,0.9490718,0.00015219905,0.0075675542,0.0001280169,0.00021139442,0.00037413178,0.0022988697,0.00001239309,0.0001083029,0.034132447],"study_design_scores_gemma":[0.017948408,0.008878299,0.9677626,0.00030327274,0.0016687164,0.0013286454,0.00003934313,0.000041952666,0.0015868924,0.000008624695,0.00024433344,0.00018891049],"about_ca_topic_score_codex":0.00014052351,"about_ca_topic_score_gemma":0.0000017657003,"teacher_disagreement_score":0.033943538,"about_ca_system_score_codex":0.00007710645,"about_ca_system_score_gemma":0.00021776267,"threshold_uncertainty_score":0.6631395},"labels":[],"label_agreement":null},{"id":"W2014594637","doi":"10.1016/j.amjmed.2008.09.033","title":"Reduced Efficacy of Rosuvastatin by St. John's Wort","year":2009,"lang":"en","type":"article","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Medicine; Pravastatin; Simvastatin; Hyperlipidemia; Cholesterol; Statin; Reductase; Internal medicine; Pharmacology; Traditional medicine; Endocrinology; Biochemistry; Enzyme","score_opus":0.011289441881785222,"score_gpt":0.29483964209631375,"score_spread":0.28355020021452854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014594637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.950583,0.0035283004,0.0008316595,0.04382598,0.0001359473,0.00022996266,0.0000029310474,0.000010505667,0.00085175043],"genre_scores_gemma":[0.99353045,0.0010817356,0.00071194104,0.0034595772,0.0010561474,8.310419e-7,0.0000035442658,0.00001561832,0.00014012691],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977269,0.00020006493,0.0007317199,0.00011490682,0.0009873472,0.00023902698],"domain_scores_gemma":[0.9979177,0.0001343952,0.00092995574,0.00047068618,0.00027573074,0.00027149517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021307308,0.00014477564,0.0010420658,0.00013226682,0.000046243207,0.0000030808642,0.00021658312,0.000022161432,0.000089075525],"category_scores_gemma":[0.00044849204,0.000073794065,0.00025743738,0.00051291584,0.00053115544,0.000036290836,0.000012056227,0.00041799204,0.000002146281],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021571866,0.0002856987,0.00029881796,0.00003415966,0.0004540833,0.00013553588,0.0011470851,0.000013769257,0.054666523,0.000055612996,0.04702406,0.8937275],"study_design_scores_gemma":[0.05223046,0.10125154,0.6296625,0.0059039877,0.0050654397,0.014716806,0.0138658285,0.00009545221,0.03458363,0.0011918874,0.14057225,0.00086022343],"about_ca_topic_score_codex":0.00013365025,"about_ca_topic_score_gemma":5.1178495e-7,"teacher_disagreement_score":0.89286727,"about_ca_system_score_codex":0.000054355238,"about_ca_system_score_gemma":0.00021198986,"threshold_uncertainty_score":0.30092347},"labels":[],"label_agreement":null},{"id":"W2014604947","doi":"10.1111/j.1399-0004.2001.590602.2.x","title":"Treatment of severe hypercholesterolemia in apolipoprotein E‐deficient mice by intramuscular injection of plasmid DNA","year":2001,"lang":"en","type":"article","venue":"Clinical Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre","funders":"","keywords":"Medicine; Citation; Apolipoprotein B; Pediatrics; Genetics; Library science; Family medicine; Internal medicine; Biology; Cholesterol; Computer science","score_opus":0.03639543131869122,"score_gpt":0.33405863394604496,"score_spread":0.29766320262735374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014604947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519324,0.0029960468,0.00023906573,0.00021779852,0.00016013336,0.00079219724,0.00001752462,0.000013773146,0.00037020724],"genre_scores_gemma":[0.993566,0.004906429,0.0010053522,0.00013379387,0.00018756784,0.000027327838,0.000027420914,0.000023054294,0.00012308586],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99787456,0.00017754124,0.0009840151,0.00032964136,0.0003795854,0.00025466087],"domain_scores_gemma":[0.9989212,0.000071545386,0.00017616224,0.0005490981,0.000109352135,0.00017261975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005215512,0.00016230515,0.0007151657,0.000083640865,0.000018906278,0.0000038821386,0.00008234005,0.00026571247,0.000022608017],"category_scores_gemma":[0.000112310634,0.0001346223,0.00037004251,0.0002619775,0.0001344123,0.000015874744,0.000030214092,0.00017573441,0.000008139904],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013005637,0.005896277,0.3393961,0.0005338358,0.00048340668,0.00007572106,0.0005832033,0.0009849658,0.023358844,0.000030141624,0.00032597897,0.62703097],"study_design_scores_gemma":[0.0338782,0.03000055,0.72650397,0.00081496657,0.0011965866,0.0010194056,0.0011134576,0.0021817146,0.10720136,0.00022592665,0.09498247,0.00088138547],"about_ca_topic_score_codex":0.00040304317,"about_ca_topic_score_gemma":0.00005398109,"teacher_disagreement_score":0.6261496,"about_ca_system_score_codex":0.00011837836,"about_ca_system_score_gemma":0.00015900962,"threshold_uncertainty_score":0.54897386},"labels":[],"label_agreement":null},{"id":"W2014707843","doi":"10.1016/j.ejim.2013.07.005","title":"Attainment of normal lipid levels among high cardiovascular risk patients: Pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada","year":2013,"lang":"en","type":"article","venue":"European Journal of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Internal medicine; Odds ratio; Body mass index; Confidence interval; Lipid profile; Risk factor; Logistic regression; Observational study; Diabetes mellitus; National Cholesterol Education Program; Framingham Risk Score; Cholesterol; Endocrinology; Disease; Obesity; Metabolic syndrome","score_opus":0.043152712112247846,"score_gpt":0.2618206469069361,"score_spread":0.21866793479468827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014707843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99416876,0.0028226604,0.0012828809,0.0009818817,0.0003708277,0.00026035478,0.000045395784,0.0000031931204,0.00006406768],"genre_scores_gemma":[0.997586,0.0005028706,0.00030086984,0.0007443166,0.0007987299,0.0000018630492,0.000023237677,0.000020987809,0.00002110403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99574417,0.001018819,0.0013248748,0.00017453013,0.0015527863,0.000184848],"domain_scores_gemma":[0.99622256,0.0003960364,0.0011271441,0.00042450542,0.0016151785,0.00021458938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031979973,0.00020116389,0.0012944107,0.00028060866,0.00006565694,0.000007817908,0.00024673797,0.000023450219,0.00013972797],"category_scores_gemma":[0.0014792996,0.000109470144,0.0004899556,0.00044135997,0.00026454724,0.000091085334,0.000103690094,0.0003875689,5.9613654e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021664547,0.00007905591,0.936494,0.000096321135,0.047393467,0.0001273338,0.0011278949,0.0009179858,0.0001617954,0.000016004185,0.0021012966,0.011268215],"study_design_scores_gemma":[0.0035708754,0.0007903958,0.9818098,0.0010623105,0.008996565,0.0000189952,0.0014643058,0.00016202853,0.00018743167,0.000005186179,0.0018450887,0.00008700524],"about_ca_topic_score_codex":0.51487064,"about_ca_topic_score_gemma":0.012615091,"teacher_disagreement_score":0.50225556,"about_ca_system_score_codex":0.00015435628,"about_ca_system_score_gemma":0.00013636933,"threshold_uncertainty_score":0.70395166},"labels":[],"label_agreement":null},{"id":"W2014725150","doi":"10.1016/j.ahj.2004.01.020","title":"Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial","year":2004,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Hôtel-Dieu de Québec","funders":"","keywords":"Medicine; Rosuvastatin; Atorvastatin; Coronary heart disease; Randomized controlled trial; Internal medicine; Cardiology; Cholesterol; Ldl cholesterol; Statin","score_opus":0.0049347817264238,"score_gpt":0.24300555258494197,"score_spread":0.23807077085851816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014725150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954649,0.0011303097,0.00014918219,0.00049794046,0.00002853911,0.0026966345,0.000023774612,0.000005013585,0.0000036558363],"genre_scores_gemma":[0.99582446,0.00080043887,0.0030426292,0.00021059354,0.000060102437,0.000036198006,0.0000038518165,0.000019164312,0.0000025531328],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99774784,0.0006244882,0.0007306941,0.00020671141,0.00047500653,0.0002152647],"domain_scores_gemma":[0.9985958,0.0003658561,0.00038355996,0.00017279066,0.00012123431,0.00036076427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001514432,0.00016948949,0.0020055897,0.00013964972,0.000070186274,0.000013700241,0.00002489507,0.000028821974,0.0000057472225],"category_scores_gemma":[0.00040792438,0.000109144654,0.00016189158,0.00014142964,0.0005999834,0.00007124711,0.000025337473,0.0003045046,1.6179268e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7357943,0.00026821083,0.25567082,0.000052055348,0.0002700376,0.000013668331,0.00026931253,0.000028245364,0.000019895211,0.00000756525,0.0000037795498,0.0076021412],"study_design_scores_gemma":[0.50032943,0.0020212901,0.49689442,0.00021894019,0.0002758007,0.00007424969,0.0000819749,0.0000071860663,0.0000037964294,0.000028190056,0.0000104555465,0.00005426729],"about_ca_topic_score_codex":0.00086581055,"about_ca_topic_score_gemma":0.000014188381,"teacher_disagreement_score":0.2412236,"about_ca_system_score_codex":0.00004016412,"about_ca_system_score_gemma":0.00029642298,"threshold_uncertainty_score":0.44507897},"labels":[],"label_agreement":null},{"id":"W2015015053","doi":"10.1194/jlr.r400002-jlr200","title":"Genetics of LDL particle heterogeneity","year":2004,"lang":"en","type":"review","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Genetic architecture; Heritability; Genome-wide association study; Biology; Trait; Genetic epidemiology; Disease; Genetic linkage; Genetics; Missing heritability problem; Candidate gene; Quantitative trait locus; Genetic association; Genetic model; Family aggregation; Genetic heterogeneity; Evolutionary biology; Gene; Genetic variants; Medicine; Single-nucleotide polymorphism; Genotype; Phenotype; Pathology","score_opus":0.2511238374373066,"score_gpt":0.4966084185549865,"score_spread":0.2454845811176799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015015053","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002393275,0.9963363,0.000035487363,0.00012488142,0.00024106809,0.00063192676,0.0000069338043,0.0000032863604,0.00022683915],"genre_scores_gemma":[0.00084328826,0.99613184,0.0005833775,0.000010522577,0.0022385046,0.0000085112815,0.0000023123328,0.000043023425,0.000138642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99514,0.00074857514,0.0012308605,0.00017934969,0.0022521156,0.00044906174],"domain_scores_gemma":[0.99710065,0.00013361912,0.0004952425,0.00068259094,0.0011432394,0.0004446669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006548758,0.00017723828,0.0021215267,0.00035574447,0.00006315814,0.000020158346,0.0003160626,0.00027171586,0.00006798121],"category_scores_gemma":[0.00043864755,0.00011296198,0.0016122741,0.0006225484,0.00015905047,0.000036446254,0.0001212728,0.001537542,0.00003165167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045791727,0.00026156593,0.00006229391,0.04158382,0.0008077832,0.00021873452,0.000033836302,0.000002997159,0.000021531068,0.00002318601,0.00039671903,0.9565417],"study_design_scores_gemma":[0.00080743694,0.0012128553,0.000095359064,0.022295462,0.00057629804,0.0018007306,0.00002005759,0.0000013626217,0.00043299887,0.000021390626,0.97264856,0.00008750368],"about_ca_topic_score_codex":0.000023170527,"about_ca_topic_score_gemma":0.0000022451388,"teacher_disagreement_score":0.97225183,"about_ca_system_score_codex":0.00037520516,"about_ca_system_score_gemma":0.0037478092,"threshold_uncertainty_score":0.667994},"labels":[],"label_agreement":null},{"id":"W2015073683","doi":"10.7326/0003-4819-140-11-200406010-00014","title":"Observational Studies of Treatment Effectiveness: Some Cautions","year":2004,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Statin; Observational study; Myocardial infarction; Randomized controlled trial; Atorvastatin; Ezetimibe; Acute coronary syndrome; Simvastatin; Internal medicine; Rosuvastatin; Clinical trial; Placebo; Polypill; Disease; Cardiology; Alternative medicine; Pathology","score_opus":0.1828583143948832,"score_gpt":0.41373698093522854,"score_spread":0.23087866654034533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015073683","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08472729,0.06328152,0.00014500572,0.8482329,0.0012190329,0.0013873568,0.00015644818,0.000038666596,0.00081175135],"genre_scores_gemma":[0.201531,0.026072763,0.00029405262,0.7488228,0.019507209,0.00032455797,0.0007114149,0.00012990863,0.0026063165],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974835,0.00016101268,0.00085311587,0.00033781095,0.0008755911,0.0002889516],"domain_scores_gemma":[0.9974256,0.00037520909,0.00048386963,0.0005812057,0.001038223,0.00009585121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070584775,0.00035222422,0.0019653388,0.000324265,0.000036474252,0.0000017463624,0.00013947317,0.000310162,0.00008383941],"category_scores_gemma":[0.0005906757,0.00022395585,0.0006836064,0.00017143106,0.0004574105,0.00005751396,0.000041725598,0.00055689114,0.000007527946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010949301,0.0006442956,0.003261755,0.02044981,0.026320787,0.0018709553,0.0014761366,0.000053975975,0.0022270828,0.002649186,0.9261217,0.013829356],"study_design_scores_gemma":[0.011358249,0.025950598,0.046595648,0.06145109,0.0037259595,0.00078508374,0.0003726022,0.000009142693,0.026226463,0.010387483,0.81249774,0.00063995755],"about_ca_topic_score_codex":0.002912243,"about_ca_topic_score_gemma":0.000011153757,"teacher_disagreement_score":0.116803706,"about_ca_system_score_codex":0.00030270338,"about_ca_system_score_gemma":0.00057949405,"threshold_uncertainty_score":0.91326547},"labels":[],"label_agreement":null},{"id":"W2015544933","doi":"10.1097/mol.0b013e3283587522","title":"Familial hypercholesterolemia in children and adolescents","year":2012,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Disease; Observational study; Statin; Genetic testing; Intensive care medicine; Pediatrics; Cholesterol; Internal medicine","score_opus":0.09112676473320178,"score_gpt":0.3867461450627223,"score_spread":0.2956193803295205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015544933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059584406,0.97530377,0.000008381732,0.000023092933,0.022093657,0.0019021435,0.000028398254,0.000023788927,0.000020910767],"genre_scores_gemma":[0.00020341965,0.9794891,0.000028286575,0.000029079363,0.019603265,0.00017932341,0.00041152,0.000050096132,0.0000059509143],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971816,0.00057614263,0.00081815163,0.0005962668,0.00024665712,0.0005811951],"domain_scores_gemma":[0.99899,0.00003275691,0.00017262355,0.0005521885,0.000023190149,0.0002292712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008153528,0.00041683082,0.0022184337,0.0005359995,0.000024667575,0.0000092019545,0.00015036853,0.0005957578,0.000015097146],"category_scores_gemma":[0.00005840026,0.00034382142,0.00034698326,0.0002980858,0.0001041996,0.000061156155,0.00017881746,0.0013366975,0.000064001],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016394875,0.00018958242,0.04378451,0.024137557,0.000042126027,1.2557628e-7,0.000036196867,4.716533e-8,3.2500118e-8,0.000027669701,0.00047566794,0.9312901],"study_design_scores_gemma":[0.0015694855,0.00007246145,0.1054313,0.02897017,0.00019252804,0.00043130683,0.00000367461,5.6759995e-7,9.026585e-9,0.0000060905254,0.8630878,0.00023462727],"about_ca_topic_score_codex":0.000081171165,"about_ca_topic_score_gemma":0.000005905878,"teacher_disagreement_score":0.9310555,"about_ca_system_score_codex":0.00021804625,"about_ca_system_score_gemma":0.00027594014,"threshold_uncertainty_score":0.99990135},"labels":[],"label_agreement":null},{"id":"W2015561885","doi":"10.1016/s0828-282x(06)70292-6","title":"Surveillance and treatment of dyslipidemia in the post-infarct patient: Can a nurse-led management approach make a difference?","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Heart and Stroke Foundation of Canada; Heart And Stroke Foundation Of Quebec; AstraZeneca","keywords":"Medicine; Dyslipidemia; Intensive care medicine; Nursing; Internal medicine","score_opus":0.008818821598036701,"score_gpt":0.21626185485592422,"score_spread":0.20744303325788752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015561885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98507065,0.0034163932,0.00011831202,0.0016108071,0.0001426973,0.0005324935,0.000029843715,0.000001877072,0.009076931],"genre_scores_gemma":[0.99900514,0.00015191294,0.0001821429,0.00021093225,0.0003681161,0.000018756557,0.0000147937835,0.000009531897,0.00003868259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986337,0.00032431583,0.00041332663,0.00014114345,0.00017879733,0.0003087591],"domain_scores_gemma":[0.99920297,0.000041230905,0.0001454783,0.00028571152,0.00011349487,0.00021112477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005203079,0.00013203708,0.00071396516,0.0002448241,0.000045808607,0.0000082208435,0.00008869545,0.00008448441,0.0000024826377],"category_scores_gemma":[0.000027096447,0.000081226724,0.00023671093,0.00014957052,0.00012494554,0.0000102904905,0.0000040957284,0.00013804388,2.5549144e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002577698,0.000046478675,0.7564642,0.00016599557,0.0009171056,0.0014039194,0.0018830576,0.00044988826,0.00004825804,0.001448762,0.00065974984,0.23625483],"study_design_scores_gemma":[0.0021143833,0.00097067206,0.97394866,0.00003972478,0.00012678612,0.0011848236,0.0010504016,0.000012043038,0.000006920894,0.00010571427,0.020363774,0.00007611544],"about_ca_topic_score_codex":0.011035427,"about_ca_topic_score_gemma":0.019848559,"teacher_disagreement_score":0.23617871,"about_ca_system_score_codex":0.00024112518,"about_ca_system_score_gemma":0.0004471783,"threshold_uncertainty_score":0.9980366},"labels":[],"label_agreement":null},{"id":"W2015846619","doi":"10.1016/j.amjcard.2006.06.032","title":"Non–High-Density Lipoprotein and Very-Low-Density Lipoprotein Cholesterol and Their Risk Predictive Values in Coronary Heart Disease","year":2006,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":276,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Cholesterol; Internal medicine; Medicine; Triglyceride; Very low-density lipoprotein; Framingham Risk Score; Framingham Heart Study; Lipoprotein; Endocrinology; High-density lipoprotein; Risk factor; Cardiology; Disease","score_opus":0.00486048532372321,"score_gpt":0.2200436477464174,"score_spread":0.2151831624226942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015846619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937032,0.0025187468,0.0011928463,0.0015923975,0.0001244145,0.0007787468,0.000024161665,0.000018543904,0.00004695336],"genre_scores_gemma":[0.9968182,0.0010091885,0.00022379197,0.00061203504,0.0012658123,0.000021694892,0.000004254108,0.000031063293,0.000013971515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973049,0.0010217058,0.00054723176,0.00034975857,0.00036672511,0.0004096385],"domain_scores_gemma":[0.99827576,0.00015393768,0.00048302085,0.00056490686,0.0002078723,0.0003144807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020799239,0.0002922921,0.0015053311,0.00017101914,0.00017175608,0.000021737447,0.0001397623,0.00008401925,0.0000018797396],"category_scores_gemma":[0.0001429038,0.00018242492,0.00032978997,0.00022045452,0.0010684918,0.00010975175,0.0001360515,0.0008166752,0.000002191485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014414083,0.00023113479,0.6808822,0.00020296099,0.0015337325,0.0013041688,0.0009742438,0.0010654739,0.0042727366,0.000036544036,0.0005031021,0.29457963],"study_design_scores_gemma":[0.0022265813,0.002064888,0.98866075,0.00016089834,0.00032297455,0.0031137667,0.00054905243,0.000089231806,0.0006288975,0.0018797874,0.00014059937,0.00016255595],"about_ca_topic_score_codex":0.0075284657,"about_ca_topic_score_gemma":0.00009754395,"teacher_disagreement_score":0.30777857,"about_ca_system_score_codex":0.00010802852,"about_ca_system_score_gemma":0.00021210374,"threshold_uncertainty_score":0.9990805},"labels":[],"label_agreement":null},{"id":"W2015895269","doi":"10.1517/14656566.2011.555398","title":"Lipid modification in the elderly using the combination of a statin and a cholesterol absorption inhibitor","year":2011,"lang":"en","type":"letter","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Ezetimibe; Medicine; Atorvastatin; Simvastatin; Tolerability; Statin; Combination therapy; Internal medicine; Pharmacology; Randomized controlled trial; Adverse effect","score_opus":0.07858964624462204,"score_gpt":0.3646761405947508,"score_spread":0.28608649435012873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015895269","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30733898,0.014449925,0.0030252445,0.66287994,0.0025564793,0.009137798,0.000059097536,0.00009449543,0.00045805037],"genre_scores_gemma":[0.29483536,0.03091479,0.00043705906,0.66280204,0.009557392,0.0008202257,0.0003641864,0.00016661061,0.00010233925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978983,0.0005390264,0.0004192542,0.0003176237,0.0006230265,0.00020279436],"domain_scores_gemma":[0.99902,0.00007362132,0.00028365903,0.000500217,0.000090938105,0.00003155993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078643736,0.00023956267,0.00035996962,0.00018260487,0.00008710036,0.000029715142,0.00015245972,0.00025785723,0.000037483347],"category_scores_gemma":[0.000009797144,0.00013956998,0.00015194851,0.00017798432,0.00008316906,0.000080778715,0.00000984276,0.0008239069,0.00000259453],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012525164,0.0011127625,0.0001532973,0.0008561132,0.00048694594,0.000020514692,0.029477458,0.000013815008,0.04593903,0.0002834308,0.31159824,0.6088059],"study_design_scores_gemma":[0.0074807936,0.0015184005,0.0016924564,0.00085140124,0.00003389016,0.000089447916,0.00046640035,0.001164663,0.013811387,0.00012331997,0.9724441,0.00032372057],"about_ca_topic_score_codex":0.00054192124,"about_ca_topic_score_gemma":0.0000018231976,"teacher_disagreement_score":0.6608459,"about_ca_system_score_codex":0.000087666565,"about_ca_system_score_gemma":0.00008530332,"threshold_uncertainty_score":0.56914985},"labels":[],"label_agreement":null},{"id":"W2016164662","doi":"10.1194/jlr.d300041-jlr200","title":"Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE","year":2004,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Apolipoprotein E; Human plasma; Lipoprotein; Plasma lipoprotein; Chemistry; Distribution (mathematics); Plasma; Cholesterol; Biochemistry; Internal medicine; Chromatography; Medicine; Physics; Mathematics","score_opus":0.07582341087895525,"score_gpt":0.38404893894604725,"score_spread":0.308225528067092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016164662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942568,0.0004310637,0.0008478293,0.0036337518,0.000041978215,0.0005709131,0.000013753633,0.0000016959477,0.0002021967],"genre_scores_gemma":[0.99882317,0.00015117173,0.0004026975,0.00003226649,0.0005247969,0.00001234596,0.0000073087954,0.000007860701,0.000038371007],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99755406,0.00032819272,0.00055734423,0.00010668788,0.0012237766,0.00022993809],"domain_scores_gemma":[0.9987602,0.00010717575,0.00014049854,0.00029046126,0.0005626181,0.00013901383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055915974,0.000072854826,0.0003750359,0.00029936375,0.0001191685,0.000020918576,0.00015618949,0.00006639592,0.000015006714],"category_scores_gemma":[0.0005238966,0.000046193913,0.00013522667,0.00051912747,0.00013964501,0.000083651656,0.000047499056,0.0005802379,0.0000011906434],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006024775,0.00547667,0.027855096,0.0044745924,0.0009907061,0.00077684363,0.034702923,0.0032919433,0.774727,0.032775406,0.007189743,0.10171429],"study_design_scores_gemma":[0.023009457,0.020866953,0.639539,0.0051550437,0.00022794132,0.0023847998,0.012176683,0.00009742318,0.27782226,0.0032201516,0.015073432,0.0004268642],"about_ca_topic_score_codex":0.0012406448,"about_ca_topic_score_gemma":0.00028040042,"teacher_disagreement_score":0.6116839,"about_ca_system_score_codex":0.0001443522,"about_ca_system_score_gemma":0.0003593202,"threshold_uncertainty_score":0.2520877},"labels":[],"label_agreement":null},{"id":"W2016466191","doi":"10.1097/01.hjh.0000420074.89790.e9","title":"318 VALIDATION OF THE FRAMINGHAM GENERAL CARDIOVASCULAR RISK PREDICTION SCORE IN A MULTI-ETHNIC PRIMARY CARE COHORT","year":2012,"lang":"en","type":"article","venue":"Journal of Hypertension","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wycliffe College","funders":"","keywords":"Medicine; Framingham Risk Score; Cohort; Retrospective cohort study; Population; Chart; Cohort study; Internal medicine; Disease; Statistics; Environmental health","score_opus":0.04194226212589168,"score_gpt":0.2556620473871847,"score_spread":0.21371978526129298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016466191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95807374,0.039686173,0.000811354,0.000047138165,0.0007819385,0.0005324312,0.000005995849,0.0000076937185,0.000053515912],"genre_scores_gemma":[0.9948391,0.0025858139,0.0016590969,0.00011722656,0.0007437363,0.000005371673,0.000011954595,0.00002243889,0.000015277214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977078,0.0003268576,0.0006052163,0.00013056617,0.00100559,0.00022400884],"domain_scores_gemma":[0.9984746,0.000021055497,0.00035663904,0.0005060044,0.00051175035,0.00012992974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020456668,0.00013037516,0.00065467827,0.0001585458,0.00006958245,0.000005022727,0.00008758776,0.0001575583,0.0000045246898],"category_scores_gemma":[0.00021391147,0.00007880282,0.0008884652,0.00027861906,0.000041494503,0.00018824698,0.000045743178,0.00051465654,0.0000014318497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001693688,0.00027853824,0.9492476,0.00036092525,0.00073802244,0.000041417483,0.000744833,0.0012343389,0.011843112,0.0000015092069,0.00013026022,0.035210047],"study_design_scores_gemma":[0.0027304704,0.00018841276,0.9850477,0.00055001146,0.0011907874,0.0010325069,0.00025150282,0.00023174607,0.0077812225,0.0000027254496,0.0009216894,0.000071243674],"about_ca_topic_score_codex":0.00030827845,"about_ca_topic_score_gemma":0.000004916308,"teacher_disagreement_score":0.03710036,"about_ca_system_score_codex":0.00027360875,"about_ca_system_score_gemma":0.00020476207,"threshold_uncertainty_score":0.32134858},"labels":[],"label_agreement":null},{"id":"W2016808531","doi":"10.1016/j.atherosclerosis.2015.01.002","title":"Low-density lipoprotein cholesterol was inversely associated with 3-year all-cause mortality among Chinese oldest old: Data from the Chinese Longitudinal Healthy Longevity Survey","year":2015,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"National Institute on Aging; Centers for Disease Control and Prevention; Peking University","keywords":"Hazard ratio; Confounding; Medicine; Confidence interval; Demography; Proportional hazards model; Internal medicine; Cohort study; Prospective cohort study; Cohort; Risk factor; Cholesterol","score_opus":0.13225906080428818,"score_gpt":0.32466511197867237,"score_spread":0.1924060511743842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016808531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485856,0.00025150052,0.00016599723,0.0008518262,0.0003361982,0.0021779106,0.0010389651,0.00025004204,0.000068979054],"genre_scores_gemma":[0.9945541,0.00026793522,0.00012840773,0.0017640799,0.00069926,0.000096807504,0.0022691095,0.00014013263,0.00008016985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936023,0.0013935667,0.00074943824,0.0014213583,0.001928465,0.000904871],"domain_scores_gemma":[0.99284285,0.00031154114,0.0004971584,0.0048073493,0.00053593644,0.001005152],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0061731185,0.00072376704,0.0013439339,0.0000687396,0.00036791823,0.00019790769,0.0008473019,0.00038810848,0.00006797217],"category_scores_gemma":[0.0019973593,0.00043466687,0.00029295115,0.0011206705,0.0004481909,0.0006210985,0.0006423165,0.0010144897,0.000119374636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052166946,0.0007600798,0.9940672,0.00005326372,0.002252974,0.00003715449,0.00057019683,0.000010768743,0.00010104316,0.0000019010611,0.0011475675,0.00047619708],"study_design_scores_gemma":[0.0058528795,0.0005220238,0.9914373,0.000332517,0.0007950675,0.000013785995,0.00012562919,0.0003185893,0.00007299503,0.000024859046,0.000038906368,0.0004654516],"about_ca_topic_score_codex":0.19210291,"about_ca_topic_score_gemma":0.1994048,"teacher_disagreement_score":0.007301885,"about_ca_system_score_codex":0.00041198652,"about_ca_system_score_gemma":0.00048241092,"threshold_uncertainty_score":0.9998105},"labels":[],"label_agreement":null},{"id":"W2016893082","doi":"10.1097/00045415-200201000-00011","title":"Genetics and Prevention: A New Look at High-Density Lipoprotein Cholesterol","year":2002,"lang":"en","type":"review","venue":"Cardiology in Review","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Lipoprotein; High-density lipoprotein; Cholesterol; Internal medicine; Endocrinology; Medicine; Apolipoprotein E; Apolipoprotein C2; Lipoprotein particle; Apolipoprotein B; Very low-density lipoprotein; Disease","score_opus":0.06453903624380337,"score_gpt":0.34202365631520826,"score_spread":0.2774846200714049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016893082","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004426114,0.99232286,0.0000842269,0.00025522773,0.00028785414,0.006355345,0.000012823611,0.00004817579,0.00058924255],"genre_scores_gemma":[0.000004529404,0.9945492,0.00044520712,0.000739792,0.0013137516,0.00050648826,0.00015073013,0.00008486417,0.0022054492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957111,0.0011414608,0.0012617465,0.0009957555,0.00035782883,0.0005321237],"domain_scores_gemma":[0.99737066,0.0000590046,0.00040339772,0.0016877288,0.00007804068,0.00040119645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013690863,0.0006674761,0.007427681,0.0001648773,0.00006945872,0.0000121248,0.00020736843,0.0008445457,0.00014667945],"category_scores_gemma":[0.00016283222,0.00051591964,0.001753101,0.000382528,0.00014532694,0.000031850606,0.0002904342,0.000924689,0.0003011967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003177967,0.00001163199,0.00002536429,0.12983513,0.00048868585,0.00037859118,0.000004178049,9.512734e-8,3.6744417e-8,0.00000706257,0.003599117,0.86564696],"study_design_scores_gemma":[0.0007077694,0.00018445545,0.0004548896,0.1216119,0.004765361,0.008807067,7.809447e-7,2.0157901e-7,2.4456568e-7,0.000029434157,0.86310124,0.00033662544],"about_ca_topic_score_codex":0.00011892368,"about_ca_topic_score_gemma":0.000038077404,"teacher_disagreement_score":0.8653103,"about_ca_system_score_codex":0.00038337347,"about_ca_system_score_gemma":0.00044430952,"threshold_uncertainty_score":0.9997292},"labels":[],"label_agreement":null},{"id":"W2017096727","doi":"10.1194/jlr.m500455-jlr200","title":"Apolipoprotein C-III isoforms: kinetics and relative implication in lipid metabolism","year":2006,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Lipid metabolism; Gene isoform; Apolipoprotein B; Kinetics; Chemistry; Metabolism; Biochemistry; Cholesterol; Gene","score_opus":0.03441946356073319,"score_gpt":0.35160971667825053,"score_spread":0.31719025311751736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017096727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808639,0.0066037294,0.000587234,0.0062599005,0.00015462576,0.0007876238,0.0000026907712,0.000009045393,0.0047312225],"genre_scores_gemma":[0.99179584,0.0016817945,0.0021166352,0.000065472144,0.0035543384,0.000021219295,0.0000032791622,0.000025601348,0.0007358428],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970252,0.00029816173,0.0007201535,0.00019328964,0.0013029772,0.0004602056],"domain_scores_gemma":[0.99833614,0.00011319321,0.00020299328,0.00033779506,0.00077845313,0.00023141848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004584417,0.00012442685,0.00052224996,0.0007076487,0.00009672707,0.00004099668,0.00013126576,0.00015821465,0.000035680656],"category_scores_gemma":[0.0003740665,0.00008931674,0.0001773056,0.0006879901,0.00015401556,0.0002295909,0.00007630573,0.0011401849,0.00000968499],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005819878,0.004167656,0.043605145,0.0020770833,0.0012314288,0.0007994121,0.00448165,0.00015318536,0.35789266,0.040797222,0.02621388,0.5127608],"study_design_scores_gemma":[0.01167978,0.0023600683,0.70609903,0.0007968647,0.00014368903,0.001996911,0.0011059325,0.00017869749,0.0361494,0.008460176,0.2307041,0.00032537585],"about_ca_topic_score_codex":0.0008939434,"about_ca_topic_score_gemma":0.000062269166,"teacher_disagreement_score":0.6624939,"about_ca_system_score_codex":0.00022044101,"about_ca_system_score_gemma":0.00031445172,"threshold_uncertainty_score":0.49535996},"labels":[],"label_agreement":null},{"id":"W2017251234","doi":"10.1186/1472-6904-12-13","title":"Statin therapy in critical illness: an international survey of intensive care physicians’ opinions, attitudes and practice","year":2012,"lang":"en","type":"article","venue":"BMC Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Medical Research Council; Canadian Institutes of Health Research; Intensive Care Society","keywords":"Medicine; Statin; Family medicine; Medical prescription; Computer-assisted web interviewing; Intensive care medicine; Critically ill; Emergency medicine; Internal medicine; Nursing","score_opus":0.19982661155150072,"score_gpt":0.5455252710660071,"score_spread":0.3456986595145064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017251234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914185,0.0030699398,0.00024577795,0.0021331324,0.0023721294,0.0005029925,0.00006162285,0.000016079672,0.00017982557],"genre_scores_gemma":[0.98570746,0.0022235226,0.0014005019,0.009379209,0.0011230254,0.000035657027,0.000110531364,0.000015388561,0.000004681864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969274,0.0018085847,0.00054150424,0.0002552476,0.00022297056,0.00024428454],"domain_scores_gemma":[0.99488324,0.0032676035,0.00011629124,0.0001888609,0.0013563201,0.00018766675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028714715,0.00010753749,0.0004898918,0.00006173228,0.000030168498,0.0000052619785,0.00009162446,0.0001285799,0.000086188214],"category_scores_gemma":[0.008300774,0.000092255636,0.000098677,0.00010384533,0.00029231183,0.00023815085,0.000062999155,0.00036494186,0.0000056605777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028221137,0.0013188096,0.9323388,0.00015217105,0.00024266435,0.000014042214,0.0011869444,0.0000023981936,0.00023069399,0.0002234949,0.001085508,0.060382385],"study_design_scores_gemma":[0.0039635063,0.00075013586,0.98576427,0.000042477794,0.00006746269,0.000036898466,0.0026165592,0.00006260405,0.00016233322,0.0000088268125,0.006426075,0.0000988536],"about_ca_topic_score_codex":0.0007389932,"about_ca_topic_score_gemma":0.00011956529,"teacher_disagreement_score":0.060283534,"about_ca_system_score_codex":0.000038458027,"about_ca_system_score_gemma":0.00019272546,"threshold_uncertainty_score":0.99374014},"labels":[],"label_agreement":null},{"id":"W2017648468","doi":"10.1097/med.0b013e328329135a","title":"Approach to the diagnosis and management of lipoprotein disorders","year":2009,"lang":"en","type":"review","venue":"Current Opinion in Endocrinology Diabetes and Obesity","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Rosuvastatin; Internal medicine; Intensive care medicine; Metabolic syndrome; Family history; Statin; Disease; Coronary artery disease; Hyperlipidemia; C-reactive protein; Framingham Risk Score; Cardiology; Inflammation; Obesity; Diabetes mellitus; Endocrinology","score_opus":0.05968471438211563,"score_gpt":0.34479190554452505,"score_spread":0.2851071911624094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017648468","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014387789,0.9940116,0.000031178304,0.00022313747,0.0005364503,0.0035305466,0.000022343367,0.000018982373,0.00018702046],"genre_scores_gemma":[0.00049992657,0.9979375,0.0002238728,0.000026241025,0.00017606924,0.0010428625,0.00006466565,0.000019184066,0.000009668536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804544,0.00021342542,0.0005022605,0.00055926427,0.00021995134,0.00045967265],"domain_scores_gemma":[0.9990802,0.000048723487,0.00014770543,0.00056396105,0.000023598595,0.00013584613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003416819,0.00033738575,0.0015439013,0.00022083567,0.00008182426,0.000012668604,0.00016680513,0.00013828743,0.0000032013854],"category_scores_gemma":[0.0000227893,0.00021978002,0.00029959978,0.0003187572,0.00015195775,0.000026351652,0.00026226358,0.0004519935,0.000003376058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000031244897,0.00029559623,0.0047587776,0.05344617,0.00017433192,5.9858985e-7,0.000034029326,4.232456e-7,3.0837735e-9,0.0011812522,0.00024425957,0.9398614],"study_design_scores_gemma":[0.0005227615,0.00018141499,0.034413096,0.013267734,0.00044193715,0.000011827377,0.00003221624,0.000004371082,4.27834e-7,0.00010352967,0.95081896,0.00020170787],"about_ca_topic_score_codex":0.00004917566,"about_ca_topic_score_gemma":0.000005308055,"teacher_disagreement_score":0.9505747,"about_ca_system_score_codex":0.000047954287,"about_ca_system_score_gemma":0.000039880535,"threshold_uncertainty_score":0.8962369},"labels":[],"label_agreement":null},{"id":"W2017849679","doi":"10.1016/s0021-9150(00)80885-0","title":"Macrophage LPL production is increased in patients with heterozygous familial hypercholesterolemia","year":2000,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Familial hypercholesterolemia; Production (economics); Macrophage; Medicine; Internal medicine; Genetics; Biology; Cholesterol; Economics","score_opus":0.007952447687029865,"score_gpt":0.20902699538558225,"score_spread":0.20107454769855237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017849679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980451,0.00007105692,0.0000069694174,0.00024305836,0.000076754535,0.0009823515,0.000017957607,0.00007370448,0.00048308793],"genre_scores_gemma":[0.9973137,0.00012544681,0.00033595267,0.0013399724,0.00019274987,0.00008271437,0.000033975237,0.000056014323,0.0005195027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822325,0.00009075877,0.00027905608,0.00048793503,0.00054301013,0.00037601154],"domain_scores_gemma":[0.99902993,0.000006380494,0.000045569857,0.0006745381,0.000072984985,0.00017059722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024739405,0.00021861884,0.00038599357,0.00008009155,0.00008712606,0.000023308028,0.00008403608,0.00012675182,0.00028822667],"category_scores_gemma":[0.00001558607,0.00017004975,0.00013259248,0.00030931813,0.00006444958,0.00013394172,0.00001653598,0.00025211065,0.00014083786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009982453,0.0007565028,0.8547668,0.00009889525,0.00010155869,0.000007989092,0.00065520615,0.000015453172,0.002896685,9.710066e-7,0.00030542162,0.13939627],"study_design_scores_gemma":[0.0050284457,0.0006308556,0.98974484,0.00021041483,0.00006966,0.000008391865,0.00002184094,0.00001101769,0.0024157674,0.0000034912325,0.0016762832,0.0001790081],"about_ca_topic_score_codex":0.0016165081,"about_ca_topic_score_gemma":0.000056290904,"teacher_disagreement_score":0.13921726,"about_ca_system_score_codex":0.00016585393,"about_ca_system_score_gemma":0.00005758511,"threshold_uncertainty_score":0.69344276},"labels":[],"label_agreement":null},{"id":"W2018037691","doi":"10.1038/ki.2009.323","title":"Results of a randomized controlled trial on statin use in dialysis patients had no influence on statin prescription","year":2009,"lang":"en","type":"article","venue":"Kidney International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Medical prescription; Statin; Dialysis; Hemodialysis; Randomized controlled trial; Population; Internal medicine; Retrospective cohort study; Cohort; Intensive care medicine; Diabetes mellitus; Emergency medicine; Pharmacology","score_opus":0.011082112228961112,"score_gpt":0.2731969701187343,"score_spread":0.2621148578897732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018037691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896646,0.000009561151,0.00008490606,0.0014534618,0.000539786,0.003910335,0.0002051823,0.000020845055,0.0041113137],"genre_scores_gemma":[0.9955468,0.000050074043,0.00054435316,0.0020738982,0.00024430364,0.00024558036,0.00043881603,0.00001029166,0.00084584876],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968323,0.00041750836,0.0011078061,0.00029141823,0.0011835033,0.0001674575],"domain_scores_gemma":[0.99823743,0.00033354486,0.0004392634,0.00029636757,0.0005343504,0.00015901877],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0016170364,0.00016110137,0.0010829804,0.00034088694,0.000022824652,0.000028693705,0.00010262542,0.00008007072,0.00006808796],"category_scores_gemma":[0.018235097,0.000117715004,0.00050223776,0.00012984274,0.000038367885,0.00013810898,0.000012299986,0.00019935338,0.000025949425],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99185115,0.0011954788,0.00046725268,0.000013654483,0.0004162501,0.000008188962,0.00028777754,0.00019543568,0.00026862233,0.0004170216,0.0016514753,0.0032276679],"study_design_scores_gemma":[0.9744998,0.0014977381,0.020046946,0.0003109997,0.00013460437,5.0646685e-7,0.000007645639,0.0012933247,0.00035243627,0.00012556309,0.0016335075,0.00009692816],"about_ca_topic_score_codex":0.0006394374,"about_ca_topic_score_gemma":0.000014197791,"teacher_disagreement_score":0.019579692,"about_ca_system_score_codex":0.00017654445,"about_ca_system_score_gemma":0.00020360958,"threshold_uncertainty_score":0.9900347},"labels":[],"label_agreement":null},{"id":"W2018327621","doi":"10.1016/j.clinbiochem.2003.12.007","title":"Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models","year":2004,"lang":"en","type":"review","venue":"Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Apolipoprotein B; Lipoprotein(a); Lipoprotein; Antifibrinolytic; Familial hypercholesterolemia; Low-density lipoprotein receptor-related protein 8; Animal studies; PCSK9; LDL receptor; Genetically modified mouse; Transgene; Biology; Immunology; Medicine; Pharmacology; Cholesterol; Very low-density lipoprotein; Internal medicine; Biochemistry; Gene; Surgery","score_opus":0.11706296302031494,"score_gpt":0.3958568927887796,"score_spread":0.2787939297684647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018327621","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008122254,0.9856929,0.0009043466,0.0000355572,0.0002306346,0.002942457,0.0018206921,0.00012800097,0.00012314075],"genre_scores_gemma":[0.01142038,0.9825039,0.0027772181,0.00013723403,0.0019381726,0.0005894956,0.00038517907,0.00016274948,0.00008569581],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956586,0.00016855671,0.0015546213,0.0016182085,0.0005305103,0.00046952243],"domain_scores_gemma":[0.9963595,0.00050026097,0.00071853684,0.0015081615,0.0001595697,0.00075391633],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00050022796,0.0007759928,0.00399576,0.00004987246,0.00018315791,0.000070322945,0.0002934514,0.0019789771,0.000072255025],"category_scores_gemma":[0.0011391612,0.00058582425,0.0026208884,0.00016658075,0.00023225309,0.00005082386,0.00019338465,0.0012511917,0.000045355697],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120425975,0.00051020866,0.000006408633,0.044397,0.0029735789,0.000013625752,0.00004662965,1.2841255e-7,0.00013493864,0.00014378177,0.00005521676,0.95159805],"study_design_scores_gemma":[0.01784817,0.0068035116,0.00043526333,0.22243021,0.051626272,0.00023345502,0.00020175963,0.0002046751,0.003865488,0.02321048,0.6677899,0.005350855],"about_ca_topic_score_codex":0.00026377893,"about_ca_topic_score_gemma":0.0000037538005,"teacher_disagreement_score":0.9462472,"about_ca_system_score_codex":0.0002383663,"about_ca_system_score_gemma":0.0014622912,"threshold_uncertainty_score":0.9996593},"labels":[],"label_agreement":null},{"id":"W2018455877","doi":"10.1194/jlr.m300420-jlr200","title":"Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemia","year":2004,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"","keywords":"Cholesterylester transfer protein; Familial hypercholesterolemia; Ldl cholesterol; Chemistry; Cholesterol; Cholesteryl ester; Internal medicine; Biochemistry; Lipoprotein; Medicine","score_opus":0.12836164106901132,"score_gpt":0.3920508434710486,"score_spread":0.2636892024020373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018455877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944814,0.00066432985,0.00032445084,0.0036018374,0.000063025545,0.00070752075,0.0000032714506,0.0000068647805,0.00014734169],"genre_scores_gemma":[0.99785876,0.00008467488,0.0005365932,0.000103092985,0.0013085639,0.000016515985,0.000002115911,0.000026709726,0.00006295388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688953,0.00045938094,0.00066609675,0.00022675905,0.0013119408,0.00044626644],"domain_scores_gemma":[0.9988776,0.00009233178,0.00005173806,0.0003256641,0.00031230826,0.0003403963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053305775,0.00013692497,0.00050484226,0.0005710264,0.00011309572,0.000056088313,0.00014535099,0.00020845374,0.0000059451145],"category_scores_gemma":[0.00032981875,0.000104156854,0.00020504775,0.0004198781,0.00015567208,0.0002556744,0.00004827648,0.0017554889,0.000011272876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005360481,0.00022304928,0.97613186,0.00046309174,0.00007901013,0.00024924913,0.00077924144,0.000025982632,0.006115936,0.00007684199,0.000019643932,0.015300032],"study_design_scores_gemma":[0.0060175364,0.0010926963,0.9860728,0.0006625644,0.00003246818,0.00049327384,0.0001516954,0.0000014240779,0.0038361072,0.00027811792,0.0012667688,0.00009456726],"about_ca_topic_score_codex":0.00010565895,"about_ca_topic_score_gemma":0.000059407743,"teacher_disagreement_score":0.015205464,"about_ca_system_score_codex":0.00029956014,"about_ca_system_score_gemma":0.0004601489,"threshold_uncertainty_score":0.7626823},"labels":[],"label_agreement":null},{"id":"W2018608508","doi":"10.1007/s11883-010-0123-6","title":"The Influence of PCSK9 Polymorphisms on Serum Low-Density Lipoprotein Cholesterol and Risk of Atherosclerosis","year":2010,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; Kexin; Proprotein convertase; Ezetimibe; LDL receptor; Medicine; Lipoprotein; Rosuvastatin; Cholesterol; Subtilisin; Furin; Internal medicine; Pharmacology; Endocrinology; Chemistry; Biochemistry","score_opus":0.026782435125799028,"score_gpt":0.2952267203596998,"score_spread":0.2684442852339008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018608508","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47377828,0.52315044,0.000005963127,0.000014284525,0.00054342917,0.002356858,0.000087204244,0.000044537792,0.000019019319],"genre_scores_gemma":[0.09161461,0.90741193,0.000053982043,0.00001727392,0.00032797933,0.0003277759,0.000030063171,0.00015829869,0.000058074842],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99351984,0.0005098718,0.002550663,0.0012000082,0.0015230445,0.0006965808],"domain_scores_gemma":[0.99157196,0.00024752744,0.003850656,0.003470846,0.00041792277,0.00044106154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002796344,0.0009727929,0.003780671,0.00023623521,0.00036921626,0.00006969692,0.00037718166,0.00078629784,0.000014622746],"category_scores_gemma":[0.0006970676,0.0006160413,0.0019502778,0.00055209274,0.00073666486,0.00010803809,0.00031804884,0.0019393066,0.000011931058],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024370087,0.0003379741,0.0048009204,0.009505315,0.0005313701,0.0000050735566,0.00010857768,0.0000015289552,0.0002867267,0.00001347765,0.000020788602,0.98436385],"study_design_scores_gemma":[0.0013952141,0.00092793757,0.3451215,0.09110518,0.0060812547,0.0004303997,0.000022748072,0.0000033690724,0.0024049461,0.00006305779,0.551307,0.0011374096],"about_ca_topic_score_codex":0.00074896344,"about_ca_topic_score_gemma":0.00006720126,"teacher_disagreement_score":0.9832265,"about_ca_system_score_codex":0.00014393742,"about_ca_system_score_gemma":0.0005702951,"threshold_uncertainty_score":0.9996291},"labels":[],"label_agreement":null},{"id":"W2018824336","doi":"10.3109/00207454.2013.778846","title":"Role of statins in Alzheimer's disease: a retrospective meta-analysis for commonly investigated clinical parameters in RCTs","year":2013,"lang":"en","type":"review","venue":"International Journal of Neuroscience","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Meta-analysis; Placebo; Medicine; Clinical Global Impression; Disease; Clinical trial; MEDLINE; Randomized controlled trial; Physical therapy; Alzheimer's disease; Forest plot; Internal medicine; Alternative medicine; Pathology","score_opus":0.2758667506638966,"score_gpt":0.4578028522481711,"score_spread":0.18193610158427448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018824336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008553633,0.9890144,0.00017547488,0.00041601594,0.00039461732,0.0012276184,0.00019534852,0.0000041863887,0.000018708906],"genre_scores_gemma":[0.049691953,0.94775933,0.0018274147,0.00044834995,0.00012061347,0.00008820195,0.000021565746,0.000026284957,0.000016256738],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954025,0.0005480735,0.0021276977,0.00038966048,0.0013169622,0.0002150914],"domain_scores_gemma":[0.99646336,0.0004138135,0.0017811019,0.0003500486,0.00068381353,0.0003078908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024223267,0.00024000707,0.0034292988,0.0011503389,0.000016578373,0.00004025656,0.00066185254,0.00010687837,0.000008097723],"category_scores_gemma":[0.0023064304,0.00016238207,0.0039030025,0.0010477065,0.00023281024,0.0001873352,0.00008256334,0.00063495844,0.0000010412573],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008097595,0.0037817387,0.03339968,0.0028684258,0.21022317,0.0019161251,0.00035608196,0.0012399945,0.00010144723,0.000926745,0.0002933447,0.74408346],"study_design_scores_gemma":[0.0045530386,0.0023777012,0.3242528,0.005144439,0.4577465,0.0006473469,0.00008440997,0.0030961027,0.000024516665,0.0018735364,0.19930452,0.0008950585],"about_ca_topic_score_codex":0.00018066485,"about_ca_topic_score_gemma":0.000045554436,"teacher_disagreement_score":0.74318844,"about_ca_system_score_codex":0.00016470226,"about_ca_system_score_gemma":0.0012125822,"threshold_uncertainty_score":0.6621749},"labels":[],"label_agreement":null},{"id":"W2019294138","doi":"10.1542/peds.2012-3818d","title":"Author's Response Universal Lipid Screening: In Response to Ongoing Debate","year":2013,"lang":"en","type":"letter","venue":"PEDIATRICS","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine","score_opus":0.026202664757166504,"score_gpt":0.2779966710091049,"score_spread":0.25179400625193843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019294138","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24175559,0.00090171245,0.0010419664,0.75300664,0.00086004694,0.0018863389,0.000054550062,0.00018500464,0.0003081652],"genre_scores_gemma":[0.017660301,0.00051146664,0.015086391,0.83922315,0.044132307,0.00032516784,0.00031640485,0.0006214181,0.0821234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946217,0.0014103152,0.00065893796,0.0008673712,0.0014013316,0.0010403303],"domain_scores_gemma":[0.9967607,0.00086420565,0.00020437679,0.0014077612,0.00027722731,0.00048572005],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0044357106,0.0005162801,0.0010323355,0.0017757459,0.00011714141,0.00007920137,0.0003505107,0.0013111436,0.00013118885],"category_scores_gemma":[0.0026787343,0.0005014702,0.0004994211,0.0013774061,0.000043852473,0.00011433088,0.00023549428,0.0029739717,0.0005189704],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050389064,0.000038312253,0.0015381034,0.0004007814,0.00007049539,0.0059609124,0.0004643558,0.000025537012,0.000047755446,0.0000016459414,0.9809118,0.0055013797],"study_design_scores_gemma":[0.0017335489,0.0005324941,0.021212727,0.00019036802,0.00029092006,0.00022597486,0.00009386302,0.000047842084,0.000014573749,0.0000058480086,0.97513694,0.000514887],"about_ca_topic_score_codex":0.0009341323,"about_ca_topic_score_gemma":0.000019666426,"teacher_disagreement_score":0.2240953,"about_ca_system_score_codex":0.0005625134,"about_ca_system_score_gemma":0.0014158182,"threshold_uncertainty_score":0.99998534},"labels":[],"label_agreement":null},{"id":"W2019342207","doi":"10.1016/j.ejphar.2010.09.016","title":"Laminar shear stress prevents simvastatin-induced adhesion molecule expression in cytokine activated endothelial cells","year":2010,"lang":"en","type":"article","venue":"European Journal of Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Heart Institute","funders":"Canadian Institutes of Health Research","keywords":"Simvastatin; Cell adhesion molecule; VCAM-1; Endothelial stem cell; Intercellular Adhesion Molecule-1; HMG-CoA reductase; Cell adhesion; ICAM-1; Hydroxymethylglutaryl-CoA reductase; Cell biology; Chemistry; Reductase; Biology; Cell; Endocrinology; Biochemistry; In vitro; Enzyme","score_opus":0.01581968719475129,"score_gpt":0.2937180078919018,"score_spread":0.2778983206971505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019342207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710494,0.00007315071,0.00015713197,0.0003046453,0.0012069854,0.0003675404,0.000012003308,0.00001592182,0.0007576677],"genre_scores_gemma":[0.99666536,0.00012109784,0.0013966647,0.00037189273,0.0012706699,0.0000026407592,0.0000045208467,0.000051298775,0.00011583345],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974313,0.0010341594,0.0006058425,0.00020744519,0.00039737576,0.00032390465],"domain_scores_gemma":[0.9989955,0.000054519594,0.00036507458,0.00018916263,0.00014671074,0.00024906223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014885322,0.0001766195,0.0004462839,0.00023644096,0.000054353262,0.0000103787115,0.00019951616,0.00006199886,0.00039048272],"category_scores_gemma":[0.000069996626,0.000138248,0.00020267164,0.0001593229,0.00003911503,0.000109219036,0.00007724315,0.0011058334,0.000034186345],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009372648,0.00047264548,0.00019843447,0.000070177244,0.000076273536,0.00308346,0.00027818652,0.00002875594,0.9828738,8.7009334e-7,0.0009601015,0.0110200625],"study_design_scores_gemma":[0.007484948,0.0011840134,0.006080909,0.0001785695,0.00009885862,0.00043043072,0.00006412389,0.000033939392,0.9768486,0.0000019895783,0.0074816244,0.00011199086],"about_ca_topic_score_codex":0.000008307637,"about_ca_topic_score_gemma":0.0000013008054,"teacher_disagreement_score":0.010908071,"about_ca_system_score_codex":0.000052632175,"about_ca_system_score_gemma":0.0001602421,"threshold_uncertainty_score":0.56375897},"labels":[],"label_agreement":null},{"id":"W2019834813","doi":"10.1016/j.clinthera.2005.02.011","title":"Long-term safety and, tolerability profiles andlipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: A multicenter, randomized, double-blind, placebo-controlled, 48-week extension study","year":2005,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Ezetimibe; Tolerability; Simvastatin; Statin; Placebo; Pharmacology; Cholesterol; Adverse effect; Internal medicine","score_opus":0.11742829436053269,"score_gpt":0.40376317560047476,"score_spread":0.28633488123994205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019834813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98193383,0.0019173046,0.0014950691,0.0005961867,0.00018196608,0.01359212,0.00001334977,0.000073360636,0.00019683925],"genre_scores_gemma":[0.99401206,0.0020244343,0.002560293,0.00043410299,0.00040002918,0.00024273213,0.000031193114,0.00006634039,0.00022879308],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943638,0.0013424702,0.0022976522,0.00085562567,0.0006552435,0.00048523623],"domain_scores_gemma":[0.9947972,0.0026703742,0.0007101,0.0011219775,0.0003301634,0.00037018055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0045586964,0.0005012664,0.0034571092,0.000105997926,0.00019112772,0.00005327747,0.00013873263,0.00023944842,0.000041574225],"category_scores_gemma":[0.0003253741,0.00030506065,0.0009082975,0.0001775537,0.0005300441,0.00010630968,0.00008102468,0.00046227901,0.000010438955],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7858847,0.008511444,0.046431884,0.00018840679,0.0027934364,0.000037127877,0.001122881,0.000059915874,0.000033034325,0.0000115657,8.2631084e-7,0.15492482],"study_design_scores_gemma":[0.9480624,0.0056267404,0.037399437,0.00042157562,0.003840893,0.00004831719,0.00042769406,0.0034339773,0.00021200105,0.000003164302,0.00020993235,0.00031383778],"about_ca_topic_score_codex":0.000058112393,"about_ca_topic_score_gemma":0.00011171696,"teacher_disagreement_score":0.16217777,"about_ca_system_score_codex":0.000145527,"about_ca_system_score_gemma":0.00031528948,"threshold_uncertainty_score":0.99994016},"labels":[],"label_agreement":null},{"id":"W2020158846","doi":"10.1111/j.1463-1326.2009.01152.x","title":"Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither","year":2009,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Merck","keywords":"Atorvastatin; Ezetimibe; Metabolic syndrome; Medicine; Tolerability; Internal medicine; Type 2 diabetes; Type 2 Diabetes Mellitus; Diabetes mellitus; Endocrinology; Gastroenterology; Acute coronary syndrome; Dyslipidemia; National Cholesterol Education Program; Cholesterol; Adverse effect; Pharmacology; Myocardial infarction","score_opus":0.009547110710946228,"score_gpt":0.22572039570497007,"score_spread":0.21617328499402386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020158846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892407,0.0056064287,0.000057242196,0.0008837779,0.000093252806,0.003715167,0.00032153836,0.00007422411,0.000007651578],"genre_scores_gemma":[0.9915834,0.00019371267,0.0039078235,0.003460993,0.00013161037,0.00039054084,0.00017298595,0.00006431559,0.00009463713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99694556,0.00029785212,0.00045808553,0.000709601,0.00070653146,0.0008823514],"domain_scores_gemma":[0.9979397,0.00018504463,0.00018139141,0.0007546134,0.00022245153,0.000716805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008781971,0.00047737182,0.0012997417,0.00019086941,0.00038694032,0.00007968893,0.0001704886,0.000090079935,0.000038964878],"category_scores_gemma":[0.00012253788,0.00026924515,0.00018141326,0.0005744912,0.00013451066,0.00021711788,0.000075103126,0.00028946722,0.000010251349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034758814,0.00084241515,0.9793307,0.00025113742,0.00049457245,0.000024668014,0.00075729075,0.00015701987,0.000054079126,0.0001635854,0.00021533406,0.014233299],"study_design_scores_gemma":[0.010098901,0.0009804545,0.98126143,0.00025226126,0.0009882072,0.000003690802,0.00007627638,0.00012536875,0.0004045138,0.0001418329,0.0052583013,0.00040879037],"about_ca_topic_score_codex":0.00021152657,"about_ca_topic_score_gemma":0.00011506028,"teacher_disagreement_score":0.013824508,"about_ca_system_score_codex":0.00005781663,"about_ca_system_score_gemma":0.00018144996,"threshold_uncertainty_score":0.999976},"labels":[],"label_agreement":null},{"id":"W2020990745","doi":"10.1080/07853890310011969","title":"Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients","year":2003,"lang":"en","type":"article","venue":"Annals of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Montreal Heart Institute","funders":"","keywords":"Fenofibrate; Atorvastatin; Triglyceride; Internal medicine; Hypertriglyceridemia; Endocrinology; Apolipoprotein B; Chemistry; Cholesterol; Hyperlipidemia; Lipoprotein; Lipoprotein lipase; Medicine; Pharmacology; Diabetes mellitus; Adipose tissue","score_opus":0.04068290887959714,"score_gpt":0.31166887177782754,"score_spread":0.2709859628982304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020990745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927119,0.0014023666,0.00004783647,0.0039832876,0.00015620398,0.0015763324,0.000018805313,0.00000702335,0.00009622021],"genre_scores_gemma":[0.9984761,0.00060374144,0.00004231542,0.0006489799,0.00011965314,0.00003367179,0.000015599046,0.000017436734,0.00004253038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977806,0.0006076584,0.0006472936,0.00023614205,0.00048450206,0.00024376214],"domain_scores_gemma":[0.99867177,0.0002541139,0.00029452585,0.000379798,0.00028556777,0.000114228984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031394507,0.00018123625,0.0009253619,0.00014691982,0.000031842854,0.0000017159283,0.00006217166,0.00008830674,0.000039973762],"category_scores_gemma":[0.001356039,0.000100725876,0.00012683556,0.00028411968,0.00015402467,0.000039968403,0.0000118274165,0.00014344482,0.0000012735313],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050148197,0.0013153296,0.21724242,0.00220929,0.0018246633,0.000025215892,0.00997064,0.0000897928,0.506274,0.00054391136,0.007535346,0.20282121],"study_design_scores_gemma":[0.019962559,0.01178013,0.43996352,0.0012387545,0.000096750155,0.000016943759,0.00013606447,0.0000073401175,0.5252361,0.000105457395,0.0013488203,0.000107542415],"about_ca_topic_score_codex":0.0004833321,"about_ca_topic_score_gemma":0.000011292535,"teacher_disagreement_score":0.2227211,"about_ca_system_score_codex":0.00002724148,"about_ca_system_score_gemma":0.000062818835,"threshold_uncertainty_score":0.4107482},"labels":[],"label_agreement":null},{"id":"W2021054770","doi":"10.1007/s10067-011-1921-0","title":"Managing cardiovascular risk in patients with chronic inflammatory diseases","year":2012,"lang":"en","type":"review","venue":"Clinical Rheumatology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University Health Network; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Disease; Context (archaeology); Intensive care medicine; Inflammation; Risk factor; Pathogenesis; Systemic inflammation; Risk assessment; Internal medicine; Bioinformatics","score_opus":0.03163628111836555,"score_gpt":0.3298901184053057,"score_spread":0.29825383728694016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021054770","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003010215,0.9933334,0.00008609082,0.000014243123,0.00072311814,0.002591094,0.00003266575,0.000093877774,0.00011528282],"genre_scores_gemma":[0.0025968954,0.9962331,0.000056785822,0.000033585897,0.00034904166,0.00030184962,0.00026565,0.00014248851,0.000020613405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937834,0.0016346595,0.001983478,0.0009594798,0.0006500809,0.000988889],"domain_scores_gemma":[0.99597216,0.0004788353,0.00065173133,0.002209105,0.00010843667,0.0005797616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022953243,0.0006180749,0.007043376,0.00030463398,0.000081137325,0.000013125942,0.0002913241,0.0009159085,0.00006951665],"category_scores_gemma":[0.0005685291,0.00042286408,0.0033980825,0.00035438666,0.0003318377,0.00008116138,0.00021238216,0.0018988347,0.0003210125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058754555,0.00022882006,0.23455049,0.02087806,0.0031068712,0.00006449309,0.000004958091,0.0000011785551,1.2160497e-11,0.000054502027,0.000036742404,0.74101514],"study_design_scores_gemma":[0.0040770094,0.00032959256,0.08020789,0.012787512,0.008791932,0.000104002596,0.000003373218,0.0000021913402,1.5502944e-9,0.000025642184,0.89325124,0.00041961178],"about_ca_topic_score_codex":0.00015644981,"about_ca_topic_score_gemma":0.000039218474,"teacher_disagreement_score":0.8932145,"about_ca_system_score_codex":0.00042156037,"about_ca_system_score_gemma":0.0014802365,"threshold_uncertainty_score":0.9998223},"labels":[],"label_agreement":null},{"id":"W2021089740","doi":"10.1503/cmaj.1041427","title":"The analysis by Manuel and colleagues creates controversy with headlines, not data","year":2005,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Coronary artery disease; Medicine; CAD; Coronary disease; Data science; Disease; Computer science; Intensive care medicine; Coronary heart disease; Pathology; Internal medicine; Engineering","score_opus":0.009353486840683448,"score_gpt":0.2400977776736917,"score_spread":0.23074429083300824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021089740","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008864521,0.00719548,0.00008130167,0.9898551,0.00023601674,0.00031367625,0.00082733866,0.00001327358,0.0005913363],"genre_scores_gemma":[0.002683586,0.009003749,0.00010254531,0.9613771,0.015280181,0.000013763491,0.0017232643,0.000050873405,0.009764945],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950868,0.00034359086,0.0005582007,0.0003830551,0.0029181587,0.00071022444],"domain_scores_gemma":[0.9965846,0.00044417632,0.00041593667,0.0006361071,0.00050106447,0.0014180955],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0034773264,0.00025606636,0.0008605581,0.00023286275,0.0006505161,0.0002973928,0.00041425083,0.0010450957,0.00048198245],"category_scores_gemma":[0.0013984147,0.00015402457,0.0002407028,0.00036964868,0.00011685434,0.00010308308,0.00003590107,0.0034894436,0.000016877726],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022662894,0.000006490617,0.0043021115,0.000019427895,0.0048568496,0.0010489204,0.000021054684,3.662836e-7,1.0705049e-7,0.0000019484469,0.9707888,0.018931272],"study_design_scores_gemma":[0.0015396606,0.00007245468,0.005925383,0.000100358215,0.0026710015,0.0008279751,0.000082746155,0.00025322186,5.251259e-7,0.000003236609,0.9883501,0.00017332144],"about_ca_topic_score_codex":0.017956946,"about_ca_topic_score_gemma":0.08049674,"teacher_disagreement_score":0.06253979,"about_ca_system_score_codex":0.0011257777,"about_ca_system_score_gemma":0.0048145885,"threshold_uncertainty_score":0.9988096},"labels":[],"label_agreement":null},{"id":"W2021355783","doi":"10.2174/1568006043586189","title":"Statins and Thrombin","year":2005,"lang":"en","type":"review","venue":"Current Drug Targets - Cardiovascular & Hematological Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; McMaster University","funders":"","keywords":"Mevalonic acid; Thrombin; Cerivastatin; Chemistry; Downregulation and upregulation; Prenylation; Biochemistry; Tissue factor; Pravastatin; Cholesterol; Biology; Reductase; Coagulation; Enzyme; Platelet; Internal medicine; Medicine; Immunology","score_opus":0.04469971474881169,"score_gpt":0.3397548690855078,"score_spread":0.2950551543366961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021355783","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054270324,0.9920212,0.0008939769,0.00013934862,0.0007499883,0.004516596,0.00009463077,0.00035161234,0.001178364],"genre_scores_gemma":[0.00019498044,0.99668944,0.00073003164,0.00007404357,0.0006328232,0.0007666386,0.0006459368,0.00019204397,0.00007407288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992661,0.0009636651,0.0014486489,0.0019566617,0.0016838784,0.0012861184],"domain_scores_gemma":[0.9963086,0.00016217264,0.0003438913,0.0021883764,0.00013699307,0.00085994444],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0016552578,0.0014301665,0.008372004,0.00034831357,0.00032856208,0.00009173093,0.0004128295,0.0007179995,0.00018112198],"category_scores_gemma":[0.00034467372,0.0010165952,0.009523678,0.0006579279,0.0004695296,0.00014380898,0.0004107232,0.0018407071,0.00026363472],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000101465075,0.00037345372,0.000023984016,0.032923967,0.004477676,0.00010029162,0.000067784014,0.0000030726112,1.7323927e-8,0.00049753883,0.0023880603,0.959134],"study_design_scores_gemma":[0.0014957098,0.00008150736,0.000058330006,0.006721328,0.009096237,0.0011762397,0.000068898866,0.000014241872,4.6796345e-7,0.00023121512,0.98001087,0.0010449674],"about_ca_topic_score_codex":0.00004833986,"about_ca_topic_score_gemma":0.000011497131,"teacher_disagreement_score":0.9776228,"about_ca_system_score_codex":0.00025477403,"about_ca_system_score_gemma":0.00053818803,"threshold_uncertainty_score":0.99984485},"labels":[],"label_agreement":null},{"id":"W2021836074","doi":"10.1503/cmaj.1041490","title":"Should a statin be routinely prescribed for primary prevention of cardiovascular disease in diabetes mellitus?","year":2004,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; League; Match play; Physical therapy","score_opus":0.017255268605222373,"score_gpt":0.2570552259128296,"score_spread":0.23979995730760723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021836074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96195626,0.009843672,0.0030820288,0.022939226,0.00038999933,0.001343582,0.000112161404,0.000018753602,0.00031433607],"genre_scores_gemma":[0.99267805,0.0009927799,0.0011652948,0.0037260763,0.0011090364,0.000088669956,0.00009895311,0.00003302717,0.000108133645],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965152,0.00019658078,0.00063371134,0.00020344958,0.0019344672,0.0005165586],"domain_scores_gemma":[0.99753904,0.000063975946,0.00018618448,0.00023100858,0.00040455695,0.0015752051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041676494,0.00012956564,0.0005646682,0.0002216756,0.000095754294,0.000024339404,0.00011094369,0.0002494397,0.00012685392],"category_scores_gemma":[0.0021793863,0.00011858685,0.0007124857,0.00024996462,0.000031206015,0.00011122636,0.000010884448,0.00053301646,0.0000028788277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005525105,0.0012023044,0.24873151,0.0027161024,0.010032706,0.0014343866,0.0020566932,0.0047392827,0.00012675513,0.0016835678,0.008597208,0.71812695],"study_design_scores_gemma":[0.024352588,0.00078063575,0.6400331,0.002162747,0.0018539577,0.00009738182,0.0004814349,0.00064204284,0.0003366014,0.0035440447,0.32514587,0.0005696053],"about_ca_topic_score_codex":0.0048855976,"about_ca_topic_score_gemma":0.0036991725,"teacher_disagreement_score":0.7175574,"about_ca_system_score_codex":0.0017725917,"about_ca_system_score_gemma":0.007299438,"threshold_uncertainty_score":0.99832827},"labels":[],"label_agreement":null},{"id":"W2022305048","doi":"10.1016/j.amjcard.2005.10.062","title":"Does Low-Density Lipoprotein Size Add to Atherogenic Particle Number in Predicting the Risk of Fatal Myocardial Infarction?","year":2006,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Myocardial infarction; Internal medicine; Cardiology; Medicine; Low-density lipoprotein; Lipoprotein; Cholesterol","score_opus":0.0051480323046724005,"score_gpt":0.24255967584685517,"score_spread":0.23741164354218278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022305048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962499,0.00020389605,0.0008015689,0.0018621224,0.00025654133,0.0004272551,0.000010426716,0.000010203501,0.00017806128],"genre_scores_gemma":[0.99713695,0.0001553409,0.0002981697,0.0003576906,0.0019964825,0.000016581003,6.0906086e-7,0.000019418654,0.000018743447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711543,0.0012566667,0.0006624377,0.00016372174,0.00046299916,0.0003387301],"domain_scores_gemma":[0.9981998,0.00034575356,0.0005757939,0.0005440079,0.00022648952,0.000108154185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032973576,0.00014669086,0.0009366244,0.00003761242,0.00010220173,0.000008614547,0.00020806106,0.00004277251,0.000014682332],"category_scores_gemma":[0.00049852283,0.000064780885,0.000669863,0.0004214936,0.00041674683,0.000044901713,0.000077891986,0.0005354204,0.000009257885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022804507,0.00006146267,0.9381336,0.000023106883,0.0015496121,0.00010779582,0.0008110266,0.004026704,0.0056894547,0.000048330938,0.00033058503,0.046937857],"study_design_scores_gemma":[0.0011983615,0.00081377453,0.9906884,0.000049237464,0.00039325975,0.001147837,0.0012263582,0.000032140357,0.0030381035,0.00024871255,0.0010774886,0.00008633976],"about_ca_topic_score_codex":0.0037293264,"about_ca_topic_score_gemma":0.00009983698,"teacher_disagreement_score":0.052554775,"about_ca_system_score_codex":0.000089460314,"about_ca_system_score_gemma":0.00017387827,"threshold_uncertainty_score":0.5637651},"labels":[],"label_agreement":null},{"id":"W2022456102","doi":"10.1097/00001573-200011000-00004","title":"Lipid lowering and coronary bypass graft surgery","year":2000,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Hyperlipidemia; Cardiology; Internal medicine; Bypass surgery; Artery; Coronary artery disease; Coronary artery bypass surgery; Clinical trial; Revascularization; Statin; Coronary heart disease; Surgery; Myocardial infarction; Diabetes mellitus; Endocrinology","score_opus":0.11330344014151914,"score_gpt":0.3860143831721196,"score_spread":0.2727109430306005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022456102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058610683,0.9887514,0.000037151047,0.000037541453,0.009443155,0.0012310963,0.000046636673,0.000059260736,0.00033513497],"genre_scores_gemma":[0.000074418625,0.9940158,0.000012305008,0.00001678362,0.00481176,0.00032615144,0.000653889,0.00006712168,0.00002175794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970089,0.00048947526,0.00090806815,0.00077078154,0.00027300094,0.00054972904],"domain_scores_gemma":[0.99854416,0.00026422896,0.00017244191,0.0007464038,0.00003741938,0.00023535],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000991182,0.00048678558,0.004322855,0.00046245244,0.000055848643,0.00001275665,0.00011272096,0.00055755477,0.000044454297],"category_scores_gemma":[0.00008214846,0.00040154665,0.0013680169,0.00030946766,0.00013448522,0.00004185542,0.00011865448,0.0009786608,0.00005787259],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019427102,0.000026569953,0.00095867063,0.034921613,0.00027993837,0.000044554377,0.000008566902,7.4696044e-7,9.166607e-9,0.000011945409,0.0035994153,0.96012855],"study_design_scores_gemma":[0.00040141467,0.000066639936,0.0014124643,0.021547768,0.00036643536,0.0029794767,0.000004226845,9.7187e-7,2.3124777e-8,0.000008962302,0.97288895,0.00032267062],"about_ca_topic_score_codex":0.00001814604,"about_ca_topic_score_gemma":5.243924e-7,"teacher_disagreement_score":0.96928954,"about_ca_system_score_codex":0.00020273865,"about_ca_system_score_gemma":0.0006484721,"threshold_uncertainty_score":0.99984366},"labels":[],"label_agreement":null},{"id":"W2022499233","doi":"10.1016/j.atherosclerosis.2005.05.010","title":"Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia","year":2005,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Windsor; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Rosuvastatin; Internal medicine; Endocrinology; Apolipoprotein B; Dyslipidemia; Insulin resistance; Very low-density lipoprotein; Triglyceride; Chemistry; Cholesterol; Insulin; Fructose; Lipoprotein; Medicine; Diabetes mellitus; Biochemistry","score_opus":0.019517089291528372,"score_gpt":0.27701340664981466,"score_spread":0.25749631735828626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022499233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966344,0.0013353465,0.00013103303,0.00018756521,0.000029562047,0.0015682203,0.000019434146,0.000025949905,0.0000684563],"genre_scores_gemma":[0.9940706,0.00030902386,0.0051926696,0.000047416343,0.00013360534,0.00015323724,0.000006768888,0.00004909401,0.00003759597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974817,0.00036910028,0.0008372861,0.0004521566,0.00055566523,0.00030408672],"domain_scores_gemma":[0.9985572,0.000073842784,0.00041596254,0.00070488156,0.00012290018,0.00012520747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022701013,0.0002558293,0.0011383273,0.00023805525,0.000042255328,0.000005630152,0.0001053385,0.00014990379,0.0000063850994],"category_scores_gemma":[0.0003966611,0.00021638321,0.00019116368,0.00039753874,0.00014676785,0.00017669218,0.00003657476,0.0002545186,9.2394083e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003940245,0.00061029464,0.03269535,0.0020657848,0.00015286864,7.35248e-7,0.0024878483,0.0016891311,0.84187055,0.0006497473,0.000006131355,0.11383133],"study_design_scores_gemma":[0.003995105,0.004213781,0.13003118,0.0014272165,0.00020704487,0.0000020028542,0.00010997288,0.005511896,0.8542135,0.000059612685,0.000022572802,0.00020614448],"about_ca_topic_score_codex":0.0009774604,"about_ca_topic_score_gemma":0.0005783643,"teacher_disagreement_score":0.113625176,"about_ca_system_score_codex":0.00007466005,"about_ca_system_score_gemma":0.00010664652,"threshold_uncertainty_score":0.88238513},"labels":[],"label_agreement":null},{"id":"W2022756739","doi":"10.1373/clinchem.2003.023689","title":"Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions","year":2003,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":285,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Lipoprotein(a); Coronary artery disease; Disease; Risk factor; Population; Lung disease; Lipoprotein; Internal medicine; Intensive care medicine; Cardiology; Lung; Cholesterol; Environmental health","score_opus":0.025535795865976874,"score_gpt":0.32403103057474303,"score_spread":0.29849523470876616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022756739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81182164,0.17989096,0.000010304187,0.0034634506,0.00031705407,0.0005195391,0.000014109458,0.000027120863,0.0039358186],"genre_scores_gemma":[0.83393747,0.16151436,0.0006179986,0.00066845905,0.0022551513,0.00009271897,0.000020092377,0.00002952924,0.0008642357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985011,0.00007463112,0.00037447643,0.00042583203,0.0004920646,0.00013190297],"domain_scores_gemma":[0.9989459,0.00006278289,0.00008580387,0.0004974535,0.00013922484,0.00026881887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010486788,0.00012966782,0.00039938855,0.000011446234,0.00013142804,0.000012002269,0.000036183552,0.00014517776,0.000017398315],"category_scores_gemma":[0.0014763635,0.00009016864,0.00028794163,0.0001310758,0.00030904607,0.00004618585,0.000041678453,0.0003522682,1.8944858e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008370051,0.0024473565,0.38832188,0.0076262783,0.007781916,0.0005931978,0.0001243693,0.00005594533,0.0004948227,0.0009328589,0.0038119627,0.5869724],"study_design_scores_gemma":[0.001329426,0.000029751218,0.058196556,0.00022901711,0.0005597217,0.00072552427,0.000032331143,0.0000062971485,0.0010743414,0.00012723662,0.9375753,0.00011452306],"about_ca_topic_score_codex":0.000004367762,"about_ca_topic_score_gemma":0.0000013273409,"teacher_disagreement_score":0.9337633,"about_ca_system_score_codex":0.000016850636,"about_ca_system_score_gemma":0.00021930636,"threshold_uncertainty_score":0.36769706},"labels":[],"label_agreement":null},{"id":"W2022771791","doi":"10.2174/138945009789108783","title":"Role of Statins in Peri-Operative Medicine","year":2009,"lang":"en","type":"review","venue":"Current Drug Targets","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital","funders":"","keywords":"Medicine; Statin; Perioperative; Coronary artery disease; HMG-CoA reductase; Atorvastatin; Cholesterol; Disease; Inflammation; Stroke (engine); Internal medicine; Reductase; Intensive care medicine; Cardiology; Surgery; Enzyme","score_opus":0.03945160345725738,"score_gpt":0.3820370272393232,"score_spread":0.3425854237820658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022771791","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000055075532,0.99532706,0.000010759882,0.000094435214,0.00035865372,0.0020403755,0.000056878805,0.000028879751,0.002027874],"genre_scores_gemma":[0.0001568884,0.998149,0.00013775856,0.000030895695,0.0007286931,0.00012684846,0.000482336,0.000047981564,0.00013963104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99698734,0.0003263302,0.0010948016,0.0005121723,0.0006722515,0.0004070832],"domain_scores_gemma":[0.9985178,0.000057205063,0.00035516606,0.0006836378,0.0001513667,0.00023484265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008288821,0.0004776133,0.003654792,0.00038510672,0.00003864321,0.000005094066,0.00017906523,0.00016270384,0.00020116472],"category_scores_gemma":[0.00017323636,0.0003195811,0.00069668697,0.0004779348,0.00010579414,0.00004850561,0.000051992993,0.00082502665,0.000038199716],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008575451,0.00021228724,0.000009122088,0.018520048,0.00013338625,0.000019568282,0.00091092574,3.949124e-7,0.0000010600621,0.00014191266,0.0011513064,0.97889143],"study_design_scores_gemma":[0.0008632161,0.00017043203,0.00008997188,0.039212797,0.0007275726,0.000032391847,0.00016878977,0.0000074365225,0.0000062335143,0.000064718784,0.9584178,0.00023868211],"about_ca_topic_score_codex":0.00013087962,"about_ca_topic_score_gemma":0.000025012256,"teacher_disagreement_score":0.9786527,"about_ca_system_score_codex":0.00025242366,"about_ca_system_score_gemma":0.000819383,"threshold_uncertainty_score":0.9999256},"labels":[],"label_agreement":null},{"id":"W2022935004","doi":"10.1016/j.biocel.2013.05.021","title":"Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin αVβ3 and RhoA/ROCK-mediated mechanisms","year":2013,"lang":"en","type":"article","venue":"The International Journal of Biochemistry & Cell Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"British Heart Foundation; University of Windsor","keywords":"RHOA; Vascular smooth muscle; Cell biology; Integrin; Biology; Motility; Signal transduction; Chemistry; Cell; Biochemistry; Endocrinology; Smooth muscle","score_opus":0.006886202777151342,"score_gpt":0.24461447678628404,"score_spread":0.23772827400913268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022935004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222946,0.0007144704,0.0015623501,0.0035351883,0.0003785172,0.0004468522,0.000010188614,0.000017599445,0.0011053816],"genre_scores_gemma":[0.9956477,0.00029450655,0.0009040815,0.001869685,0.0009007373,0.000025631982,0.000036232017,0.000025517402,0.0002958727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982211,0.00007010178,0.0005506464,0.00028926609,0.00056018564,0.0003087145],"domain_scores_gemma":[0.9982387,0.000054927463,0.00034353117,0.0004036048,0.0005989451,0.00036031497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007090668,0.00023426938,0.00043564587,0.00011630929,0.00007864352,0.00004455976,0.0005182978,0.0002056284,0.0005932308],"category_scores_gemma":[0.00011577179,0.00015369845,0.00029470326,0.000095438074,0.00008073039,0.00004919031,0.00022049637,0.0004799065,0.00013104646],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000789861,0.00013455382,0.000026940064,0.00004497222,0.0003079778,0.000039247305,0.00012739626,0.0000062740714,0.9898298,0.000040158167,0.0005697269,0.008794002],"study_design_scores_gemma":[0.0016457711,0.0005275662,0.0007192836,0.00010680708,0.00010300879,0.00024781667,0.000339242,0.000060642993,0.98033875,0.0010013949,0.014732474,0.00017724329],"about_ca_topic_score_codex":0.0006962227,"about_ca_topic_score_gemma":0.000003999114,"teacher_disagreement_score":0.014162748,"about_ca_system_score_codex":0.00016985167,"about_ca_system_score_gemma":0.00018417882,"threshold_uncertainty_score":0.64954615},"labels":[],"label_agreement":null},{"id":"W2023270721","doi":"10.3821/1913-701x-141.sp2.s4","title":"Cardiovascular Risk Assessment and Stratification","year":2008,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Risk stratification; Stratification (seeds); Risk assessment; Medicine; Environmental science; Internal medicine; Cardiology; Computer science; Biology","score_opus":0.03623644449799246,"score_gpt":0.27939675024663824,"score_spread":0.24316030574864578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023270721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875947,0.0077939313,0.000736278,0.00014822865,0.0008664781,0.0006343682,0.00015697094,0.000028747832,0.0020402689],"genre_scores_gemma":[0.95584047,0.040949557,0.0008164192,0.00092044077,0.0011596122,0.000022978322,0.00003085944,0.00004629467,0.00021338736],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99731445,0.0002483383,0.00048297533,0.0004190765,0.0007991785,0.000735982],"domain_scores_gemma":[0.9959676,0.000030495408,0.00016212078,0.00046642305,0.0005648568,0.0028084759],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0011615604,0.00029262644,0.00055537495,0.0002575958,0.0013546044,0.00008625291,0.00017871692,0.00007039884,0.00022008129],"category_scores_gemma":[0.00009611973,0.00028633262,0.0003816622,0.00039219036,0.0001942504,0.0002456179,0.000020492755,0.0008451279,0.0000052233136],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013386742,0.00011213323,0.046604533,0.0006540165,0.004051318,0.23213506,0.0013489142,0.0012555756,0.00124325,0.000106637184,0.016982602,0.6953721],"study_design_scores_gemma":[0.0029631327,0.00007610933,0.0050580897,0.000020740123,0.0007572428,0.90792686,0.000014436004,0.0016623305,0.0006389336,0.00003439351,0.080444634,0.00040307475],"about_ca_topic_score_codex":0.071297854,"about_ca_topic_score_gemma":0.024522545,"teacher_disagreement_score":0.694969,"about_ca_system_score_codex":0.0024017307,"about_ca_system_score_gemma":0.008414466,"threshold_uncertainty_score":0.9999589},"labels":[],"label_agreement":null},{"id":"W2023283451","doi":"10.1074/jbc.m112.399725","title":"Loss- and Gain-of-function PCSK9 Variants","year":2012,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Montreal Clinical Research Institute; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Endoplasmic reticulum; PCSK9; LDL receptor; Mutant; Secretion; Proprotein convertase; Zymogen; Biochemistry; Biology; ER retention; Endosome; Cell biology; Chemistry; Receptor; Enzyme; Cholesterol; Gene","score_opus":0.030055133931804392,"score_gpt":0.2730551539445232,"score_spread":0.24300002001271878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023283451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345094,0.004399392,0.00041937747,0.00016096431,0.00008858197,0.000040835694,0.000001420919,0.00000414564,0.001434338],"genre_scores_gemma":[0.9979973,0.00043331936,0.0004389014,0.000119919605,0.0009523256,6.067798e-7,0.0000017390907,0.0000033618624,0.00005257027],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993603,0.000022941393,0.00025867127,0.000058658454,0.00016464134,0.0001347889],"domain_scores_gemma":[0.99942625,0.000026691954,0.00016479376,0.00010162942,0.00009043915,0.00019020894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006588658,0.000064318076,0.00028546088,0.000012084043,0.000019092031,0.0000028055542,0.000033224682,0.00013853474,0.00015164739],"category_scores_gemma":[0.00019788677,0.000037336802,0.00015133085,0.00004932172,0.000059675203,0.0000375898,0.000019877347,0.00020653945,0.0000016081713],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008518002,0.00048678633,0.19237408,0.00048571278,0.00042363367,0.00007766541,0.00006591747,9.961024e-7,0.7642304,0.00007375013,0.0003907871,0.040538512],"study_design_scores_gemma":[0.0028560364,0.0010060933,0.6506324,0.00024497064,0.00030139048,0.0056410544,0.00021744447,0.000006787224,0.32172897,0.00039901093,0.016797347,0.00016853758],"about_ca_topic_score_codex":0.0000020293942,"about_ca_topic_score_gemma":1.1343777e-8,"teacher_disagreement_score":0.45825827,"about_ca_system_score_codex":0.000022267592,"about_ca_system_score_gemma":0.000038014245,"threshold_uncertainty_score":0.16604325},"labels":[],"label_agreement":null},{"id":"W2023394318","doi":"10.1016/s0002-9343(03)00303-6","title":"Evaluating the benefits of treating dyslipidemia: the importance of diabetes as a risk factor","year":2003,"lang":"en","type":"article","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Dyslipidemia; Diabetes mellitus; Risk factor; Intensive care medicine; Environmental health; Internal medicine; Endocrinology","score_opus":0.03575257149675726,"score_gpt":0.34316956160203393,"score_spread":0.3074169901052767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023394318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786947,0.012736452,0.00006832988,0.0075946366,0.00012282305,0.00033110986,0.0000045287425,0.0000040551977,0.00044340262],"genre_scores_gemma":[0.99639416,0.0010299217,0.00046400505,0.0013527251,0.00070418854,0.0000053833487,3.4195187e-7,0.000019780116,0.000029505109],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99646693,0.0009786602,0.0009873477,0.000115160845,0.0011973623,0.0002545051],"domain_scores_gemma":[0.9947404,0.001342178,0.002674542,0.00068285665,0.00044398155,0.000115988856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008813049,0.00015865268,0.0010109139,0.000067524554,0.00014882299,0.000003143871,0.00029384132,0.000026547998,0.00009104547],"category_scores_gemma":[0.005951331,0.00005549882,0.00032238258,0.00052820856,0.00091738347,0.000034519602,0.000024922427,0.00061953533,8.7417334e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045274894,0.00010598183,0.3001759,0.00015313896,0.00181048,0.000008136729,0.0074494584,0.00055695575,0.0086475,0.00050865073,0.00032448355,0.67980653],"study_design_scores_gemma":[0.008334699,0.024756609,0.910321,0.0032299322,0.004813384,0.00094962085,0.032849215,0.0005641491,0.011007114,0.0017491174,0.0011570455,0.00026811057],"about_ca_topic_score_codex":0.00022153648,"about_ca_topic_score_gemma":0.000008722057,"teacher_disagreement_score":0.6795384,"about_ca_system_score_codex":0.000046721565,"about_ca_system_score_gemma":0.0002889401,"threshold_uncertainty_score":0.7124729},"labels":[],"label_agreement":null},{"id":"W2023401935","doi":"10.1111/ijs.12136","title":"Review of Lipid and Lipoprotein(a) Abnormalities in Childhood Arterial Ischemic Stroke","year":2013,"lang":"en","type":"review","venue":"International Journal of Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Institute on Aging","keywords":"Medicine; Ischemic stroke; Stroke (engine); Cardiology; Internal medicine; Lipoprotein; Cholesterol; Ischemia","score_opus":0.021702582510213207,"score_gpt":0.3126769291890936,"score_spread":0.2909743466788804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023401935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011842259,0.995227,0.000018161056,0.0002542386,0.00090249855,0.0008953231,0.00015225339,0.0000052323526,0.001361096],"genre_scores_gemma":[0.00024968176,0.995634,0.00052903226,0.00023057971,0.0029974612,0.00004006297,0.000039261715,0.000036360034,0.00024355252],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996467,0.00015457973,0.0018729777,0.0002077278,0.0010834482,0.00021429743],"domain_scores_gemma":[0.99734885,0.00006807804,0.0014853523,0.00028579438,0.0006386858,0.0001732702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010977065,0.00032144625,0.0025493358,0.00050808955,0.00001463667,0.000032713255,0.00036440816,0.00021692988,0.0002843784],"category_scores_gemma":[0.00027894706,0.00023317561,0.0011711572,0.00009714429,0.00007654207,0.00019672894,0.000107958695,0.0007874131,0.000009408796],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003896117,0.00013096342,0.000023905328,0.049998146,0.001390857,0.000088457644,0.00004156532,6.4431205e-8,0.000020962274,0.000029055436,0.0012982695,0.9469388],"study_design_scores_gemma":[0.001226096,0.0002019407,0.00011821892,0.20023938,0.0006176315,0.0033411118,0.000026509346,2.7163222e-7,0.000046324312,0.000004826619,0.79403967,0.00013802685],"about_ca_topic_score_codex":0.000101426755,"about_ca_topic_score_gemma":0.0000030183248,"teacher_disagreement_score":0.94680077,"about_ca_system_score_codex":0.00018506082,"about_ca_system_score_gemma":0.0007906852,"threshold_uncertainty_score":0.9508626},"labels":[],"label_agreement":null},{"id":"W2024110748","doi":"10.1002/hep.22354","title":"Proprotein convertase subtilisin/kexin type 9 (PCSK9)","year":2008,"lang":"en","type":"article","venue":"Hepatology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":400,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal","funders":"Canadian Institutes of Health Research; Pfizer Canada; McGill University; Pfizer","keywords":"Kexin; Proprotein convertase; PCSK9; Subtilisin; Hepatocyte; LDL receptor; Chemistry; Cell biology; Internal medicine; Endocrinology; Lipoprotein; Cholesterol; Biology; Biochemistry; Medicine; Enzyme","score_opus":0.03639240097985095,"score_gpt":0.27231627315586265,"score_spread":0.2359238721760117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024110748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045604,0.0022880551,0.00015191922,0.0014763336,0.00034136703,0.0007208537,0.0000038034113,0.00012832173,0.0044333283],"genre_scores_gemma":[0.99502677,0.00032107916,0.0007667939,0.0018934532,0.00025633772,0.000046461668,0.0000351297,0.000028973993,0.0016250318],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865735,0.00010683791,0.00025468576,0.0003235013,0.00027440424,0.00038320245],"domain_scores_gemma":[0.99893296,0.000018092578,0.00005204004,0.0006211751,0.00015829172,0.00021744391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022232365,0.00015241335,0.0005062012,0.00008747039,0.00011779106,0.0000032472838,0.00007556245,0.00019632338,0.00055145175],"category_scores_gemma":[0.00013693764,0.0001245239,0.00016705584,0.00018454836,0.00017334541,0.000038920967,0.000036594243,0.00025697163,0.00070227915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018227758,0.00082585897,0.89158946,0.0007995123,0.00065410795,0.012150754,0.00097224716,0.0000011470348,0.006406644,0.0038689908,0.031127151,0.049781322],"study_design_scores_gemma":[0.007445535,0.0021104042,0.09042796,0.00009990644,0.0002683059,0.025421714,0.00010718673,0.00087479927,0.04731808,0.00042544163,0.8248411,0.0006595958],"about_ca_topic_score_codex":0.0008617322,"about_ca_topic_score_gemma":0.00006490503,"teacher_disagreement_score":0.8011615,"about_ca_system_score_codex":0.00006421885,"about_ca_system_score_gemma":0.000500847,"threshold_uncertainty_score":0.9026612},"labels":[],"label_agreement":null},{"id":"W2024166279","doi":"10.1097/01.jom.0000205997.18143.6c","title":"Partners in Lowering Cholesterol: Comparison of a Multidisciplinary Educational Program, Monetary Incentives, or Usual Care in the Treatment of Dyslipidemia Identified Among Employees","year":2006,"lang":"en","type":"article","venue":"Journal of Occupational and Environmental Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Dyslipidemia; Multidisciplinary approach; Incentive; Medicine; Ldl cholesterol; Family medicine; Gerontology; Environmental health; Cholesterol; Internal medicine; Economics; Sociology; Disease","score_opus":0.03258119822384277,"score_gpt":0.3625719021919245,"score_spread":0.3299907039680817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024166279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427295,0.0048829014,0.000012408507,0.00026381327,0.000072368544,0.0004547549,0.000011037259,0.0000012512794,0.000028496172],"genre_scores_gemma":[0.9988958,0.0003707602,0.0002898776,0.0000146490165,0.0002696002,0.000023591374,0.00011241961,0.000006688767,0.000016599924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983709,0.00007220411,0.0007682436,0.000117040545,0.0005568484,0.00011479281],"domain_scores_gemma":[0.9993913,0.00009401016,0.0003297571,0.00010622738,0.0000204649,0.00005825268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030299192,0.00011817647,0.0004739882,0.0001622538,0.00003152522,0.0000027982487,0.000054913147,0.00004819932,0.000025049601],"category_scores_gemma":[0.000016689723,0.00006600267,0.00009567081,0.000112904054,0.0002404769,0.0000893033,0.000013644793,0.00012116947,1.6587416e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001125764,0.0018968171,0.97882164,0.00012541875,0.000059909184,0.00002057796,0.003840412,0.0003101468,0.0006566461,0.0000037047837,0.00003101362,0.013107927],"study_design_scores_gemma":[0.004150174,0.003012102,0.9853348,0.00043660306,0.000100601406,0.000041705014,0.006245542,0.00012064341,0.00036175761,0.000016735466,0.0001281873,0.00005111041],"about_ca_topic_score_codex":0.00047868455,"about_ca_topic_score_gemma":0.00036807708,"teacher_disagreement_score":0.0130568165,"about_ca_system_score_codex":0.00016463023,"about_ca_system_score_gemma":0.00006979306,"threshold_uncertainty_score":0.26915106},"labels":[],"label_agreement":null},{"id":"W2024423016","doi":"10.1016/j.jacl.2010.08.018","title":"Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology?","year":2010,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Atheroma; Clinical endpoint; Antithrombotic; Placebo; Internal medicine; Acute coronary syndrome; Apolipoprotein B; Cardiology; Lipoprotein; Endothelium; Clinical trial; Urology; Cholesterol; Gastroenterology; Endocrinology; Myocardial infarction; Pathology","score_opus":0.06535762871334946,"score_gpt":0.3973418951462419,"score_spread":0.33198426643289247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024423016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97456366,0.0011251704,0.0019019134,0.016218022,0.005590116,0.00043123728,0.0000015562262,0.000013102204,0.00015520955],"genre_scores_gemma":[0.9710121,0.0015369053,0.012807877,0.0023884024,0.012162616,0.0000054419975,0.0000017876516,0.00002172687,0.00006313077],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9945746,0.0015457554,0.0028694351,0.00024646052,0.0004083935,0.00035532741],"domain_scores_gemma":[0.99318624,0.0030488453,0.0020194785,0.00077741774,0.000669358,0.0002986621],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.025430953,0.00017244816,0.0018690242,0.000116643285,0.00011243036,0.000004298435,0.0003063715,0.0005153189,0.00022715794],"category_scores_gemma":[0.018922875,0.00009159741,0.0011240438,0.00017009032,0.000534638,0.00006955818,0.00010214172,0.0024146994,0.000010321692],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003343119,0.0006820475,0.08830141,0.00022748591,0.0012219037,0.000044990233,0.00044040737,0.000028608625,0.012591326,0.0028834394,0.0026394431,0.88759583],"study_design_scores_gemma":[0.008671514,0.0052283634,0.78870136,0.00040605894,0.0007906865,0.0019847911,0.00035277577,0.00022880535,0.0027665936,0.01294228,0.17765133,0.00027542503],"about_ca_topic_score_codex":0.00028332177,"about_ca_topic_score_gemma":0.00008065211,"teacher_disagreement_score":0.8873204,"about_ca_system_score_codex":0.000015638263,"about_ca_system_score_gemma":0.00043695082,"threshold_uncertainty_score":0.99988675},"labels":[],"label_agreement":null},{"id":"W2024624676","doi":"10.1016/j.atherosclerosis.2013.03.029","title":"Beyond LDL-C lowering: Distinct molecular sphingolipids are good indicators of proprotein convertase subtilisin/kexin type 9 (PCSK9) deficiency","year":2013,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"H2020 European Research Council; Sydäntutkimussäätiö; Canadian Institutes of Health Research; Emil Aaltosen Säätiö","keywords":"PCSK9; Kexin; Proprotein convertase; Lipidome; Lactosylceramide; Chemistry; Sphingolipid; Cholesterol; Biochemistry; Endocrinology; Biology; Lipid metabolism; LDL receptor; Lipoprotein; Enzyme","score_opus":0.011452311472809758,"score_gpt":0.23304648474706668,"score_spread":0.22159417327425693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024624676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942604,0.0010852438,0.00035409108,0.0003788045,0.00022095807,0.001734788,0.000025517304,0.00011633503,0.0018238967],"genre_scores_gemma":[0.9983664,0.000065392596,0.0006086748,0.0003533632,0.00012981852,0.00016521102,0.000029339102,0.000091910224,0.0001898662],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9972628,0.0000904834,0.0006050354,0.0005841468,0.0008611572,0.0005963792],"domain_scores_gemma":[0.99780804,0.00002950311,0.00032292324,0.0011802787,0.00026172266,0.00039754552],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005072258,0.00036143392,0.0007744637,0.00019372597,0.00012979833,0.00004398811,0.00027149086,0.0002405272,0.0005114726],"category_scores_gemma":[0.00023022977,0.00029806973,0.00040595286,0.0007206503,0.0002304803,0.00014424823,0.00012426259,0.00033787923,0.00019894644],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002648204,0.002252935,0.44230577,0.0030783073,0.0007615734,0.00007239619,0.0015566845,0.000016507955,0.5037114,0.0017480535,0.00092011824,0.04331142],"study_design_scores_gemma":[0.0028597403,0.0012292744,0.6352915,0.0006132756,0.00036259493,0.00003637576,0.00042047148,0.00005979013,0.3565355,0.00030211444,0.0016786056,0.0006107349],"about_ca_topic_score_codex":0.0016310455,"about_ca_topic_score_gemma":0.000016925016,"teacher_disagreement_score":0.19298576,"about_ca_system_score_codex":0.00012054912,"about_ca_system_score_gemma":0.00020711325,"threshold_uncertainty_score":0.99994713},"labels":[],"label_agreement":null},{"id":"W2024930123","doi":"10.1016/s0140-6736(14)61399-4","title":"PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial","year":2014,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":751,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal","funders":"Ipsen; Novo Nordisk; Otsuka America; Novartis; AbbVie; Genzyme; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Pfizer; Bayer HealthCare; Meso Scale Diagnostics; Sanofi; Merck; Abbott Laboratories","keywords":"Evolocumab; Ezetimibe; Medicine; Placebo; PCSK9; Familial hypercholesterolemia; Cholesterol; Statin; Alirocumab; Internal medicine; Clinical trial; Dosing; Ldl cholesterol; Gastroenterology; Endocrinology; Lipoprotein; LDL receptor; Pathology","score_opus":0.0287132061087211,"score_gpt":0.2783745620263545,"score_spread":0.24966135591763342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024930123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842386,0.00022446133,0.00035195216,0.0019332651,0.0002751553,0.007825378,0.0000043542514,0.00009924794,0.0050475704],"genre_scores_gemma":[0.9925932,0.000067089844,0.00016341738,0.0014246306,0.0039168443,0.0015227327,0.000025151305,0.000047800087,0.00023911192],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99736595,0.00053464476,0.0005103787,0.00038494667,0.00065335544,0.00055070093],"domain_scores_gemma":[0.9983709,0.00015900738,0.00015709831,0.0010960901,0.000078264915,0.00013863991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033744704,0.00027944747,0.0015474219,0.00011528828,0.00012625205,0.000058741585,0.00018349574,0.00017978673,0.000033830893],"category_scores_gemma":[0.0001354858,0.00015303877,0.00031282354,0.00021609214,0.000102724254,0.00010205618,0.000040994564,0.0006119015,0.000052261727],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9930336,0.000149113,0.00027302984,0.00008690015,0.00020072803,0.000027749249,0.00044545115,0.00009545617,0.0003454407,0.000061521125,0.00016366167,0.00511739],"study_design_scores_gemma":[0.9934524,0.0013754846,0.00069601345,0.00019462993,0.00026497524,0.00013843707,0.00007415765,0.00053073216,0.00027833256,0.00008847237,0.0027165366,0.00018982413],"about_ca_topic_score_codex":0.00044254062,"about_ca_topic_score_gemma":0.00031257368,"teacher_disagreement_score":0.008354607,"about_ca_system_score_codex":0.00012756087,"about_ca_system_score_gemma":0.00015705582,"threshold_uncertainty_score":0.624074},"labels":[],"label_agreement":null},{"id":"W2025041596","doi":"10.1016/j.amjcard.2008.09.075","title":"Efficacy and Safety of Ezetimibe Added on to Atorvastatin (20 mg) Versus Uptitration of Atorvastatin (to 40 mg) in Hypercholesterolemic Patients at Moderately High Risk for Coronary Heart Disease††Conflicts of interest: Dr. Conard served as a consultant and advisor for Merck &amp; Company and Merck/Schering-Plough. Dr. Bays received research grants from Amylin, San Diego, California, Amgen, Thousand Oaks, California, J&amp;J, Langhorne, Pennsylvania, Aegerion, Bridgewater, New Jersey, Abbott, Chicago, Illinois, Arena Pharmaceuticals, San Diego, California, GlaxoSmithKline (Glaxo), London, UK, Hoffmann LaRoche, Nutley, New Jersey, Merck, Whitehouse Station, New Jersey, MSP, Kenilworth, New Jersey, Metabolex, San Jose, California, Schering-Plough, Kenilworth, New Jersey, Orexigen, San Diego, California, Reliant, Liberty Corner, New Jersey, Sciele, Atlanta, Georgia, Takeda, Osaka, Japan, TAP, Lake Forest, Illinois, and Vivus, Mountain View, California; received speakers' honoraria from Abbott, Daiichi Sankyo, Tokyo, Japan, GlaxoSmithKline, Reliant, Merck &amp; Company, Merck/Schering-Plough, and Schering-Plough; received honoraria from Abbott, AstraZeneca, London, UK (Wilmington, Delaware, US Headquarters), Daiichi Sankyo, GlaxoSmithKline, Reliant, Merck &amp; Company, Merck/Schering-Plough, and Schering-Plough; and served as a consultant and advisor for Abbott, GlaxoSmithKline, Metabolex, San Jose, California, Reliant, Takeda, AstraZeneca, and Essentialis, Carlsbad, California. Dr. Leiter received grants and speakers' honoraria from and served as a consultant and advisor for AstraZeneca, Merck &amp; Company, Merck/Schering-Plough, and Pfizer, New York, New York. Mr. Bird, Mr. Rubino, and Drs. Lowe, Tomassini, and Tershakovec are employees of Merck &amp; Company and may own stock and/or hold stock options in the company.","year":2008,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Atorvastatin; Ezetimibe; Medicine; Apolipoprotein B; Internal medicine; Cholesterol; National Cholesterol Education Program; Lipoprotein; Cardiology; Gastroenterology; Endocrinology; Pharmacology; Urology; Metabolic syndrome","score_opus":0.06648491516254833,"score_gpt":0.30640628763707795,"score_spread":0.2399213724745296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025041596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89595056,0.051475856,0.0061694547,0.0024743674,0.00038711424,0.010682158,0.032649033,0.00020797616,0.0000035101627],"genre_scores_gemma":[0.8736442,0.049051486,0.069429465,0.0010710969,0.0008595998,0.0004243668,0.0043839384,0.0009404696,0.0001954182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97950095,0.0029895497,0.0069515724,0.0051966333,0.002063903,0.0032973906],"domain_scores_gemma":[0.98018795,0.0050557987,0.004460398,0.0023608138,0.0018602499,0.0060747736],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","sts","research_integrity"],"category_scores_codex":[0.0042739455,0.0040892614,0.00962394,0.0015371025,0.0017358421,0.0010121828,0.0011450932,0.0014731426,0.00011106075],"category_scores_gemma":[0.0028828972,0.003505021,0.0006607743,0.0020034474,0.004696035,0.0010652409,0.0013172654,0.003043288,0.000010151467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1614848,0.0015626149,0.68281543,0.0032778971,0.0112749245,0.00022018334,0.021756401,0.0021610556,0.071982585,0.000028046741,0.026470596,0.01696551],"study_design_scores_gemma":[0.10426246,0.00778202,0.75283045,0.0070996815,0.010253642,0.0014859746,0.0057013403,0.0066892332,0.0011174404,0.0006573011,0.09628955,0.005830883],"about_ca_topic_score_codex":0.10396345,"about_ca_topic_score_gemma":0.22751892,"teacher_disagreement_score":0.123555474,"about_ca_system_score_codex":0.00041744465,"about_ca_system_score_gemma":0.002403653,"threshold_uncertainty_score":0.99982315},"labels":[],"label_agreement":null},{"id":"W2025353591","doi":"10.3810/pgm.2011.01.2252","title":"C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians","year":2011,"lang":"en","type":"review","venue":"Postgraduate Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; C-reactive protein; Rosuvastatin; Internal medicine; Dyslipidemia; Statin; Rheumatology; Physical therapy; Disease; Intensive care medicine; Inflammation","score_opus":0.09395065103393752,"score_gpt":0.3688902101136504,"score_spread":0.2749395590797129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025353591","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026115992,0.96891606,0.0010171462,0.0018139805,0.00047781225,0.023688914,0.00039986635,0.00026559937,0.0008090518],"genre_scores_gemma":[0.0040416787,0.9812531,0.0025278595,0.0006328299,0.0042414004,0.0037611271,0.002137947,0.0004720672,0.000931989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936445,0.0010125047,0.0015822405,0.0018136987,0.00086028443,0.0010867801],"domain_scores_gemma":[0.9949502,0.00025253827,0.0011574626,0.0018799101,0.00073411537,0.0010257821],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0038180365,0.0013574652,0.0064975964,0.0005456509,0.00029416132,0.00003176118,0.0002407662,0.00085373886,0.00004421305],"category_scores_gemma":[0.0010641252,0.0009238375,0.0010239439,0.0005232855,0.00064632617,0.00026213712,0.00014678342,0.0015273067,0.000062062034],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055960513,0.00046863107,0.0000046011387,0.024500953,0.0016963471,0.00037627516,0.00034357276,1.1690526e-8,0.000083530875,0.0017783633,0.00019736691,0.96999073],"study_design_scores_gemma":[0.004597119,0.0060545555,0.00009527312,0.03904452,0.00854102,0.0017067641,0.000177641,0.000013325644,0.00020238054,0.0010774826,0.9373959,0.0010940427],"about_ca_topic_score_codex":0.0036318137,"about_ca_topic_score_gemma":0.00018262604,"teacher_disagreement_score":0.9688967,"about_ca_system_score_codex":0.00035312065,"about_ca_system_score_gemma":0.0010197333,"threshold_uncertainty_score":0.9999176},"labels":[],"label_agreement":null},{"id":"W2025410214","doi":"10.3810/pgm.2014.11.2832","title":"Impact of Statins in Outcomes of Septic Patients: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"Postgraduate Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Randomized controlled trial; Sepsis; Intensive care medicine; Confounding; Cohort study; Pneumonia; Cohort; Internal medicine; Odds ratio; MEDLINE; Systematic review; Septic shock; Emergency medicine; Physical therapy","score_opus":0.0402829607094772,"score_gpt":0.3956751313356326,"score_spread":0.3553921706261554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025410214","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002958539,0.990964,0.000015868338,0.00013464068,0.00011654748,0.008120221,0.00007359472,0.000019144465,0.00026015172],"genre_scores_gemma":[0.0008072667,0.9980382,0.000053501197,0.00018120953,0.00007125102,0.0002495065,0.00040554215,0.00008555073,0.000108012544],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9934796,0.0008213063,0.0036434226,0.00041429116,0.0012420792,0.00039929218],"domain_scores_gemma":[0.99522007,0.000393403,0.002081156,0.0015664081,0.00048517215,0.00025380545],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0027007223,0.00064055016,0.01580968,0.00061879633,0.000014515943,0.0000018623751,0.00026036004,0.00019104198,0.000071646704],"category_scores_gemma":[0.0038061987,0.0003231144,0.0022698313,0.0009161951,0.0001488133,0.00003206971,0.00005911731,0.0004567317,0.000023394427],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007833084,0.00020527148,0.00088579924,0.92873317,0.0016396696,0.000015016172,0.00007412711,4.6712316e-8,7.20998e-8,0.000012090883,0.00023570105,0.068191215],"study_design_scores_gemma":[0.0019115157,0.0018533755,0.0025104347,0.9725165,0.016272403,0.000067404624,0.000010008978,0.0000021540832,9.2471936e-8,0.0000073602278,0.004624374,0.00022442252],"about_ca_topic_score_codex":0.001221792,"about_ca_topic_score_gemma":0.000016894226,"teacher_disagreement_score":0.0679668,"about_ca_system_score_codex":0.0003326542,"about_ca_system_score_gemma":0.00056832976,"threshold_uncertainty_score":0.9999221},"labels":[],"label_agreement":null},{"id":"W2025499067","doi":"10.1016/j.amjcard.2009.03.048","title":"Is Measuring C-Reactive Protein Useful for Guiding Treatment in Women ≥60 Years and Men ≥50 Years of Age?","year":2009,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; C-reactive protein; National Health and Nutrition Examination Survey; Internal medicine; Statin; Kidney disease; Metabolic syndrome; Demographics; Physical therapy; Obesity; Inflammation; Demography","score_opus":0.03528297023231108,"score_gpt":0.28690943921356654,"score_spread":0.25162646898125546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025499067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975123,0.0007798381,0.00024515635,0.0006913953,0.000023822327,0.00049274554,0.000003275374,0.0000034295656,0.00024804074],"genre_scores_gemma":[0.99848884,0.0003202703,0.0006636913,0.00019802032,0.00027452008,0.000021712609,3.1873523e-7,0.00001106978,0.000021581016],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99892145,0.00021326749,0.00032233307,0.00011683953,0.00018901026,0.00023711984],"domain_scores_gemma":[0.99923426,0.000066639856,0.00030881763,0.00022093835,0.00007680957,0.000092561226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012233371,0.00009451957,0.0009094485,0.00013302774,0.000020738811,0.000004256346,0.00007931092,0.00003135538,0.0000012478548],"category_scores_gemma":[0.00006942112,0.00006501239,0.00024875902,0.00012502223,0.00014250877,0.000032279055,0.000013207619,0.00010746524,3.3689855e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005511611,0.0000986252,0.006398015,0.000047940932,0.0025075437,0.00077990285,0.012123672,0.00020296493,0.0464224,0.000052584543,0.00014032437,0.92571443],"study_design_scores_gemma":[0.0052346718,0.011714802,0.95953745,0.00022191639,0.00034821857,0.0014278342,0.0062958603,0.000012722994,0.00400794,0.0009188506,0.010115159,0.00016456273],"about_ca_topic_score_codex":0.00013735969,"about_ca_topic_score_gemma":0.0000011203399,"teacher_disagreement_score":0.9531394,"about_ca_system_score_codex":0.00023028319,"about_ca_system_score_gemma":0.00014158642,"threshold_uncertainty_score":0.26511285},"labels":[],"label_agreement":null},{"id":"W2025707427","doi":"10.1194/jlr.m300043-jlr200","title":"Effect of apoC-III gene polymorphisms on the lipoprotein-lipid profile of viscerally obese men","year":2003,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Ottawa; Montreal Heart Institute; McGill Genome Centre; Université Laval","funders":"","keywords":"Internal medicine; Endocrinology; Hypertriglyceridemia; Apolipoprotein B; Triglyceride; Insulin; Insulin resistance; Postprandial; Chemistry; Lipoprotein; Cholesterol; Adipose tissue; Biology; Medicine","score_opus":0.03388813542271892,"score_gpt":0.34491442081684986,"score_spread":0.31102628539413096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025707427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748539,0.0024314173,0.000055827215,0.0022189561,0.00028812958,0.0018160619,0.00000567409,0.000007380763,0.018322658],"genre_scores_gemma":[0.9955395,0.00080689735,0.00045285234,0.00008103558,0.0015268782,0.00004409354,0.0000016202914,0.00004611294,0.001500994],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99238926,0.0024525332,0.00096882146,0.00023650246,0.003358603,0.00059430336],"domain_scores_gemma":[0.9964152,0.0006687836,0.0004728005,0.0009260218,0.0011583854,0.000358802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020370083,0.00021405073,0.0010189046,0.0005064229,0.00016608555,0.000027696613,0.00042115917,0.00017272928,0.00061048823],"category_scores_gemma":[0.002145938,0.000113423295,0.0007170569,0.0007656857,0.00029529762,0.000102429214,0.000082594146,0.0013726918,0.000028441631],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014404276,0.002184657,0.0040154466,0.0030857786,0.0029614768,0.0006063877,0.0014172037,0.00006916505,0.79783934,0.0026271376,0.027304614,0.14348453],"study_design_scores_gemma":[0.005733271,0.015603001,0.003507855,0.0010938593,0.00014359357,0.00081426714,0.00020418278,0.000045324352,0.96087176,0.00008337866,0.01176177,0.00013771349],"about_ca_topic_score_codex":0.00022773437,"about_ca_topic_score_gemma":0.0000029799705,"teacher_disagreement_score":0.16303246,"about_ca_system_score_codex":0.00018300969,"about_ca_system_score_gemma":0.0010160531,"threshold_uncertainty_score":0.7059905},"labels":[],"label_agreement":null},{"id":"W2025776975","doi":"10.1016/j.amjcard.2011.07.064","title":"Frequency of Intensive Statin Therapy in Patients With Acute Coronary Syndrome Admitted to a Tertiary Care Center","year":2011,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Medicine; Acute coronary syndrome; Statin; Retrospective cohort study; Population; Emergency medicine; Internal medicine; Tertiary care; Pediatrics; Myocardial infarction","score_opus":0.010929175752338129,"score_gpt":0.24655690082816908,"score_spread":0.23562772507583096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025776975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984909,0.0003639279,0.00024264991,0.00024832383,0.000093524504,0.0004517481,0.00001855062,0.000004253324,0.00008610118],"genre_scores_gemma":[0.99711597,0.00015960581,0.00084611593,0.0017839908,0.00005624878,0.000009447897,0.0000057524885,0.000020478374,0.000002414569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857295,0.00037537498,0.0004078819,0.00012843167,0.0002803493,0.0002350077],"domain_scores_gemma":[0.9981697,0.000027298142,0.00036631958,0.000367056,0.0009373046,0.00013227276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028435764,0.00013541133,0.00093431084,0.0001683479,0.000019312924,0.0000014145263,0.00017199904,0.000029719871,0.000013865822],"category_scores_gemma":[0.00004123504,0.00007188444,0.00023391675,0.00022422435,0.00024634035,0.000039609375,0.000032212345,0.000284646,0.0000020965315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027032078,0.000045798668,0.9680084,0.000011147444,0.0013877235,0.00083469966,0.0028570252,0.00000611892,0.00013469734,0.0000022372787,0.00005190008,0.023957023],"study_design_scores_gemma":[0.0027773208,0.008905964,0.98202944,0.00010829328,0.00014467721,0.002859769,0.002950886,1.9086185e-7,0.00009452666,0.000019857382,0.000034555396,0.00007455107],"about_ca_topic_score_codex":0.0002226136,"about_ca_topic_score_gemma":0.000004558295,"teacher_disagreement_score":0.023882471,"about_ca_system_score_codex":0.00007599922,"about_ca_system_score_gemma":0.00019819118,"threshold_uncertainty_score":0.29313624},"labels":[],"label_agreement":null},{"id":"W2025857343","doi":"10.7326/0003-4819-152-12-201006150-02007","title":"Review: Statin use increases risk for diabetes","year":2010,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Statin; Internal medicine; Diabetes mellitus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Family medicine; Traditional medicine; Endocrinology","score_opus":0.05158405665553322,"score_gpt":0.3488658570891094,"score_spread":0.29728180043357616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025857343","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013596404,0.12291287,0.00022084326,0.858998,0.00082794443,0.0023676145,0.0006858721,0.000054316908,0.00033611845],"genre_scores_gemma":[0.00048690653,0.09038776,0.0006771408,0.89427465,0.011490116,0.00018521995,0.00068083324,0.00009960711,0.0017177492],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99667305,0.00020646624,0.0011307562,0.00049453694,0.0009417475,0.00055345846],"domain_scores_gemma":[0.99558234,0.00083511986,0.0009491053,0.0011377395,0.0012416933,0.0002540053],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019906613,0.00045353817,0.0021987548,0.0002732524,0.000047582165,0.000009656373,0.00029849,0.0007660473,0.00040081842],"category_scores_gemma":[0.007610636,0.00029845885,0.0009099447,0.00014340383,0.00028503453,0.00008221459,0.00006561231,0.0031853493,0.000014657865],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011386188,0.00005202751,0.0012860381,0.013779002,0.001011953,0.0001027717,0.000021816628,2.7395306e-8,0.00012801698,0.0000029786247,0.96243465,0.02106686],"study_design_scores_gemma":[0.0012929923,0.00166065,0.001066556,0.039539848,0.0013813198,0.00007295552,0.00000660309,0.000007229617,0.0013052895,0.00011910522,0.9533199,0.00022752266],"about_ca_topic_score_codex":0.0040604444,"about_ca_topic_score_gemma":0.000041671712,"teacher_disagreement_score":0.035276655,"about_ca_system_score_codex":0.000020963627,"about_ca_system_score_gemma":0.00018035581,"threshold_uncertainty_score":0.9999468},"labels":[],"label_agreement":null},{"id":"W2026019878","doi":"10.1186/1472-6904-8-10","title":"Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study","year":2008,"lang":"en","type":"article","venue":"BMC Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; University of British Columbia Hospital","funders":"Heart and Stroke Foundation of Canada","keywords":"Fenofibrate; Simvastatin; Crossover study; Medicine; Apolipoprotein B; Lipoprotein particle; Internal medicine; Lipoprotein; Cholesterol; Endocrinology; Pharmacology; Hyperlipidemia; Lipid profile; Very low-density lipoprotein; Diabetes mellitus; Pathology","score_opus":0.0773770374530317,"score_gpt":0.39997367127848155,"score_spread":0.32259663382544984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026019878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98506874,0.00064006005,0.0011888635,0.0022289369,0.0010876097,0.009569311,0.000025455394,0.0001398222,0.000051218816],"genre_scores_gemma":[0.9845215,0.00026483237,0.00056466967,0.009957009,0.0019336425,0.0014275064,0.000006102862,0.00006948523,0.0012552723],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9936937,0.002482422,0.0016100617,0.0008436046,0.000614469,0.00075571],"domain_scores_gemma":[0.9960313,0.0019055977,0.00031214993,0.0009228063,0.00025920576,0.0005689348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054810336,0.000361001,0.0017433256,0.000050823728,0.00041572523,0.00003181367,0.0003426195,0.00020988962,0.000714507],"category_scores_gemma":[0.0016380997,0.00022584687,0.0012381222,0.0003650631,0.00059189124,0.000090619236,0.00022752438,0.0006977217,0.0005543665],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.550177,0.020152157,0.1735258,0.00044904553,0.015662361,0.0015329629,0.00896559,0.0009548946,0.18903483,0.00046361497,0.017009525,0.022072228],"study_design_scores_gemma":[0.72461504,0.0069223493,0.13192675,0.00003950612,0.0036289333,0.00041603312,0.0010174876,0.006385959,0.11817752,0.00013114534,0.005768816,0.0009704572],"about_ca_topic_score_codex":0.00067974685,"about_ca_topic_score_gemma":0.00011240418,"teacher_disagreement_score":0.17443804,"about_ca_system_score_codex":0.00007621883,"about_ca_system_score_gemma":0.00075322826,"threshold_uncertainty_score":0.9209768},"labels":[],"label_agreement":null},{"id":"W2026436971","doi":"10.1046/j.1492-7535.2003.01243.x","title":"Lipoprotein (a) in CRF: Effect of Maintenance Hemodialysis","year":2003,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Hemodialysis; Lipoprotein(a); Internal medicine; Uremia; Lipoprotein; Chronic renal failure; Intima-media thickness; Coronary artery disease; Cardiology; Gastroenterology; Endocrinology; Carotid arteries; Cholesterol","score_opus":0.008607264813784977,"score_gpt":0.262996067536431,"score_spread":0.254388802722646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026436971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95935935,0.00042131066,0.002654853,0.0004772163,0.00033794687,0.00061083655,0.000012190453,0.00003266003,0.03609366],"genre_scores_gemma":[0.9963524,0.000159153,0.0020333296,0.00017919541,0.00019799909,0.00011523505,0.00003692869,0.00002413516,0.00090163614],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767005,0.00025712364,0.0005504069,0.0003871239,0.000851251,0.00028405793],"domain_scores_gemma":[0.998875,0.00009758997,0.00015957371,0.00055093894,0.00019700795,0.00011983841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001337975,0.00019665262,0.00074147875,0.00043490337,0.00003094494,0.000014311021,0.00016244243,0.00012571609,0.0005939454],"category_scores_gemma":[0.0009211745,0.00016300386,0.0006465882,0.0005399924,0.000069888534,0.000090259266,0.00003485846,0.00022346582,0.000047977195],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029592987,0.0016915743,0.5717427,0.0011227742,0.0049150004,0.00087030657,0.0008888849,0.0016627999,0.02554931,0.013882804,0.0025963632,0.37211815],"study_design_scores_gemma":[0.044379976,0.0018970179,0.22642897,0.0014137966,0.0021015173,0.0011075641,0.00030748372,0.008607873,0.59300345,0.002801989,0.11628958,0.0016607638],"about_ca_topic_score_codex":0.00048250548,"about_ca_topic_score_gemma":0.00006952424,"teacher_disagreement_score":0.56745416,"about_ca_system_score_codex":0.00024148358,"about_ca_system_score_gemma":0.00012989229,"threshold_uncertainty_score":0.66471046},"labels":[],"label_agreement":null},{"id":"W2026737636","doi":"10.2165/00129784-200808020-00001","title":"Long-Term Safety and Efficacy of a Combination of Niacin Extended Release and Simvastatin in Patients with Dyslipidemia","year":2008,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Niacin; Simvastatin; Medicine; Dyslipidemia; Tolerability; Internal medicine; Triglyceride; Lovastatin; Pharmacology; Gastroenterology; Urology; Adverse effect; Endocrinology; Cholesterol; Obesity","score_opus":0.004725128016476281,"score_gpt":0.22181609393772764,"score_spread":0.21709096592125135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026737636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384123,0.0043569673,0.001206628,0.000059831993,0.000029098896,0.00044118153,0.0000052214573,0.0000044782983,0.000055332832],"genre_scores_gemma":[0.996724,0.0020516673,0.0011037684,0.000035893125,0.000047201356,0.0000021660064,0.0000062091995,0.00002480523,0.0000043020186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974421,0.0003483522,0.00076633313,0.00021009555,0.0010321566,0.00020092553],"domain_scores_gemma":[0.9981911,0.000119100565,0.0005898796,0.00041161617,0.00047175723,0.00021653129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012869833,0.00017635112,0.0015093946,0.00028216306,0.00003941616,0.0000037023783,0.000068332134,0.000045419074,0.000002920161],"category_scores_gemma":[0.00022516242,0.00013424481,0.00051436515,0.00042091892,0.0004605515,0.00011888877,0.00003180794,0.0002720181,1.6862654e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033833352,0.00048273287,0.52995586,0.0003329862,0.0029347138,0.00014660304,0.0014831006,0.00020621842,0.000038948743,0.000014408836,0.0000055561977,0.46101552],"study_design_scores_gemma":[0.014900809,0.002206686,0.9806134,0.00048534616,0.00072977284,0.00032388823,0.00026441127,0.000015369927,0.0002500963,0.0000042112906,0.0000832384,0.00012273113],"about_ca_topic_score_codex":0.00016159302,"about_ca_topic_score_gemma":0.0000020428906,"teacher_disagreement_score":0.4608928,"about_ca_system_score_codex":0.000073110656,"about_ca_system_score_gemma":0.00022159927,"threshold_uncertainty_score":0.54743445},"labels":[],"label_agreement":null},{"id":"W2026759872","doi":"10.1016/j.ahj.2005.06.034","title":"Missed opportunities in the secondary prevention of myocardial infarction: An assessment of the effects of statin underprescribing on mortality","year":2006,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Myocardial infarction; Statin; Cardiology; Secondary prevention; Internal medicine; Emergency medicine; Intensive care medicine","score_opus":0.046465855376918025,"score_gpt":0.3546074128039486,"score_spread":0.30814155742703053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026759872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770385,0.0001312012,0.00020506351,0.00063210924,0.00011301345,0.00038206836,0.000004850954,0.000002914546,0.00082495186],"genre_scores_gemma":[0.99893326,0.00007140879,0.00038387676,0.00042267094,0.00015791092,0.000008091552,0.000003826174,0.000007549226,0.000011403531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978667,0.00085681205,0.00043271756,0.00008489449,0.0006323198,0.00012657206],"domain_scores_gemma":[0.9990991,0.00011365621,0.00032558668,0.0003201562,0.00009593746,0.000045579232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014030295,0.000078422745,0.00038426364,0.000077007586,0.000063545696,0.000008450326,0.00007510522,0.000022964334,0.000014415114],"category_scores_gemma":[0.00004965674,0.000046818368,0.00027896388,0.00018367055,0.00018295906,0.00006198167,0.000012953821,0.00031805033,5.3900273e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004408283,0.0025956742,0.74369824,0.0015938771,0.0011211105,0.000076850985,0.0027621705,0.00085667125,0.051960964,0.0019858978,0.0017573931,0.19115032],"study_design_scores_gemma":[0.00072969205,0.0015679528,0.99209994,0.00029479884,0.00011018476,0.000110741596,0.0021667066,0.000046032423,0.0022298382,0.00023302944,0.00036946774,0.000041620337],"about_ca_topic_score_codex":0.0027825772,"about_ca_topic_score_gemma":0.00005576724,"teacher_disagreement_score":0.24840169,"about_ca_system_score_codex":0.00005720113,"about_ca_system_score_gemma":0.00058570906,"threshold_uncertainty_score":0.4206443},"labels":[],"label_agreement":null},{"id":"W2026885891","doi":"10.1016/s0828-282x(09)70159-x","title":"Economic evaluation of high-dose (80mg/day) atorvastatin treatment compared with standard-dose (20mg/day to 40mg/day) simvastatin treatment in Canada based on the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) trial","year":2009,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Inro Consultants (Canada)","funders":"Pfizer Canada; Pfizer","keywords":"Medicine; Atorvastatin; Simvastatin; Myocardial infarction; Quality-adjusted life year; Cost effectiveness; Internal medicine","score_opus":0.02673513593338558,"score_gpt":0.2782888167672072,"score_spread":0.2515536808338216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026885891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934759,0.0004080526,0.00021032144,0.0021747437,0.0004703839,0.0025488893,0.00028062286,0.000003630358,0.0004274469],"genre_scores_gemma":[0.998364,0.000057369525,0.00031171428,0.00054430455,0.0005170235,0.000112722504,0.000057755973,0.000030386125,0.000004769537],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99575263,0.0015097277,0.0010428645,0.00037905548,0.0006742722,0.0006414234],"domain_scores_gemma":[0.9973432,0.00038069667,0.00060072885,0.00054475834,0.00026876174,0.00086186914],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00284619,0.00037856968,0.0015455794,0.00045560437,0.00010060427,0.000020358519,0.00016994143,0.00009401112,0.00012599347],"category_scores_gemma":[0.00051769975,0.00025825144,0.00029477297,0.00025950646,0.00008468317,0.00007733734,0.000008117128,0.00026108208,0.0000023058753],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.07619851,0.00031348586,0.05688095,0.00006459394,0.0029438986,0.008734333,0.006579532,0.5570283,0.000270043,0.00027620548,0.002574658,0.28813553],"study_design_scores_gemma":[0.38834542,0.04393523,0.5301473,0.0022231287,0.0022718818,0.00089747756,0.006293516,0.0033013327,0.005644211,0.00031750364,0.015335542,0.0012874365],"about_ca_topic_score_codex":0.7979776,"about_ca_topic_score_gemma":0.9456872,"teacher_disagreement_score":0.5537269,"about_ca_system_score_codex":0.018841295,"about_ca_system_score_gemma":0.036310963,"threshold_uncertainty_score":0.99998695},"labels":[],"label_agreement":null},{"id":"W2027098893","doi":"10.1136/ebm.8.4.106","title":"Pravastatin was not better than usual care in reducing all cause mortality or CHD events","year":2003,"lang":"en","type":"article","venue":"Evidence-Based Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pravastatin; Internal medicine; Web of science; Cholesterol; Meta-analysis","score_opus":0.10563602947340137,"score_gpt":0.36984822506006143,"score_spread":0.2642121955866601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027098893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798103,0.0061292984,0.00040618205,0.010873095,0.00055410934,0.0016786506,0.000010673072,0.00008186993,0.00045583365],"genre_scores_gemma":[0.9893743,0.0007452041,0.0012077788,0.007045325,0.0009869298,0.00015998907,0.00007014522,0.000060738923,0.00034963002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99538505,0.0006316356,0.0008636844,0.0007632564,0.001612571,0.00074378616],"domain_scores_gemma":[0.99749905,0.00030361203,0.00020835748,0.0011960065,0.00026192397,0.0005310305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031273249,0.0003956955,0.0009950264,0.0002919591,0.000096539734,0.000011767914,0.00016847409,0.00019489224,0.00061479653],"category_scores_gemma":[0.00324854,0.00027077927,0.0002213109,0.00061324745,0.00015648814,0.00021066217,0.00003097097,0.0006396443,0.000034397992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057963817,0.0011822515,0.8270559,0.010557637,0.0023517178,0.008713122,0.015081399,0.00039474748,0.016748162,0.00026686033,0.009839428,0.10201244],"study_design_scores_gemma":[0.027637586,0.006870821,0.8449094,0.031113338,0.0029732222,0.00043811486,0.006338708,0.00029156837,0.04226414,0.00007771044,0.035815857,0.0012695162],"about_ca_topic_score_codex":0.0039898767,"about_ca_topic_score_gemma":0.0007711814,"teacher_disagreement_score":0.10074293,"about_ca_system_score_codex":0.0005182024,"about_ca_system_score_gemma":0.0013566867,"threshold_uncertainty_score":0.9999744},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2027877088","doi":"10.1517/14656566.2015.1041504","title":"Ezetimibe plus simvastatin for the treatment of hypercholesterolemia","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Ezetimibe; Simvastatin; Medicine; Pharmacology; Clinical trial; Pharmacodynamics; Combination therapy; Statin; Internal medicine; Pharmacokinetics","score_opus":0.19812055944903947,"score_gpt":0.48447515919048406,"score_spread":0.2863545997414446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027877088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003924099,0.9916635,0.00037054298,0.00045630816,0.001273372,0.0058472734,0.00013736708,0.000049560924,0.00019812358],"genre_scores_gemma":[0.0000018833958,0.99248606,0.00049744494,0.0010177039,0.0027857376,0.002402886,0.00021681617,0.0001452196,0.00044623367],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977589,0.00022850701,0.000656975,0.00046029183,0.0005653497,0.00032997457],"domain_scores_gemma":[0.9982015,0.00026436572,0.00029982344,0.0008722759,0.0001405965,0.00022146532],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050072453,0.00052265543,0.0021862246,0.00012697025,0.00008984692,0.000017309398,0.0002069234,0.00021160262,0.00010949257],"category_scores_gemma":[0.000010254461,0.00026815987,0.0016107786,0.00017249101,0.000067423956,0.000026670295,0.0000094619745,0.00018644935,0.0000245363],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036656918,0.00038347227,1.105906e-7,0.0019006777,0.0011485292,0.000002859408,0.00063540577,0.000003621007,0.0000075740404,0.000024381947,0.010445713,0.9850811],"study_design_scores_gemma":[0.0060236296,0.0022672745,4.052363e-7,0.0027322418,0.00021687117,0.000043463468,0.000049766386,0.00005018607,0.00014384466,0.0000041288436,0.98824376,0.00022441646],"about_ca_topic_score_codex":0.000067124536,"about_ca_topic_score_gemma":4.867955e-7,"teacher_disagreement_score":0.98485667,"about_ca_system_score_codex":0.000564316,"about_ca_system_score_gemma":0.00081782107,"threshold_uncertainty_score":0.99997705},"labels":[],"label_agreement":null},{"id":"W2028219942","doi":"10.1016/s0828-282x(06)70310-5","title":"Canadian Cardiovascular Society position statement – Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":309,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Dyslipidemia; Coronary artery disease; Disease; Randomized controlled trial; Clinical trial; Internal medicine; Intensive care medicine; Cholesterol; Lipid profile; Physical therapy","score_opus":0.028520461123940615,"score_gpt":0.272852395648948,"score_spread":0.24433193452500737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028219942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6069821,0.33798158,0.033516712,0.015339225,0.00087902526,0.004018455,0.0009772354,0.000008196163,0.00029749112],"genre_scores_gemma":[0.9878028,0.010287143,0.0009331653,0.00005979342,0.0007096109,0.00009972466,0.000065217915,0.000018436103,0.000024118262],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985806,0.00021205576,0.00053397747,0.00018254171,0.00020230342,0.00028856413],"domain_scores_gemma":[0.9983844,0.00009332437,0.00017365973,0.0004003967,0.00037335305,0.00057487004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001316033,0.00014533642,0.0008693389,0.00017564523,0.00018187483,0.000010948139,0.00005728363,0.00010291357,0.00000531105],"category_scores_gemma":[0.00006243789,0.00010775025,0.0017342275,0.000112749556,0.00015619704,0.000060014892,0.000005976452,0.000086781256,1.1971196e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028348266,0.000051785082,0.13243426,0.0009233349,0.058931723,0.00016633772,0.0008771723,0.028323349,0.00006134644,0.0011812187,0.022230078,0.7545359],"study_design_scores_gemma":[0.0035573775,0.0010787137,0.15756497,0.00017826508,0.009863263,0.00023529374,0.00048826367,0.00011332886,0.00017077426,0.00057098793,0.8260162,0.00016259236],"about_ca_topic_score_codex":0.16537388,"about_ca_topic_score_gemma":0.03523172,"teacher_disagreement_score":0.8037861,"about_ca_system_score_codex":0.00058563787,"about_ca_system_score_gemma":0.002039317,"threshold_uncertainty_score":0.98237276},"labels":[],"label_agreement":null},{"id":"W2028329289","doi":"10.4061/2011/597163","title":"Effectiveness of Ezetimibe in Reducing the Estimated Risk for Fatal Cardiovascular Events in Hypercholesterolaemic Patients with Inadequate Lipid Control While on Statin Monotherapy as Measured by the SCORE Model","year":2010,"lang":"en","type":"article","venue":"Advances in Preventive Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); TransCanada (Canada); McGill University","funders":"","keywords":"Medicine; Ezetimibe; Statin; Internal medicine; Prospective cohort study; Framingham Risk Score; Coronary heart disease; Relative risk; Cohort study; Disease; Confidence interval","score_opus":0.012810970761476543,"score_gpt":0.282130477562241,"score_spread":0.2693195068007645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028329289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770872,0.004449379,0.012158654,0.00015044736,0.00017686492,0.005866675,0.000060183003,0.000013191247,0.000037401984],"genre_scores_gemma":[0.9976734,0.00073760515,0.00028608856,0.000102276026,0.000059158116,0.0010157956,0.00006802399,0.000048758146,0.0000088955385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967242,0.0009378466,0.0005792143,0.0005201814,0.00083852117,0.00040002953],"domain_scores_gemma":[0.99808586,0.000587751,0.00025394006,0.00077599304,0.00021824257,0.000078228986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050578834,0.00030383465,0.0010094707,0.00017814078,0.00007994319,0.000003880049,0.0002476255,0.000104107196,0.0000038805224],"category_scores_gemma":[0.000821292,0.00015979975,0.00019468725,0.00046255474,0.0002636748,0.00018584439,0.00002410403,0.00078731193,6.127735e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019412413,0.0014241772,0.5274913,0.0014126576,0.0011706452,0.000015889873,0.003833839,0.105721965,0.0054308986,0.000096404765,0.000013883388,0.33397594],"study_design_scores_gemma":[0.08291734,0.0044071465,0.8766961,0.00910153,0.00068418856,0.000019132625,0.000558536,0.015803091,0.0070941816,0.0019555464,0.00028924586,0.0004739444],"about_ca_topic_score_codex":0.0012496547,"about_ca_topic_score_gemma":0.0003475373,"teacher_disagreement_score":0.34920484,"about_ca_system_score_codex":0.00016454095,"about_ca_system_score_gemma":0.00013813323,"threshold_uncertainty_score":0.65164447},"labels":[],"label_agreement":null},{"id":"W2028427382","doi":"10.2147/dddt.s10812","title":"Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease &amp;ndash; a perspective","year":2010,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Medicine; C-reactive protein; Dyslipidemia; Rosuvastatin Calcium; Internal medicine; Statin; Risk factor; Disease; Inflammation; Asymptomatic; Cardiology","score_opus":0.045768458980056353,"score_gpt":0.300191932783629,"score_spread":0.25442347380357266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028427382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044303136,0.9842217,0.0043866113,0.00003968914,0.000067239205,0.0066777035,0.000011740753,0.000050263392,0.00011471341],"genre_scores_gemma":[0.00009315552,0.9836301,0.013953589,0.000019517836,0.00023217121,0.0011664359,0.00021233014,0.00008477667,0.00060789887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997021,0.00048608432,0.0007414524,0.00070183986,0.00074986904,0.00029970953],"domain_scores_gemma":[0.9981709,0.000067751076,0.00041350964,0.00065689796,0.00039314642,0.0002977822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017534931,0.000552031,0.002092563,0.00030753098,0.00016797011,0.00004843228,0.00010293778,0.0002438963,0.000015337415],"category_scores_gemma":[0.000073716765,0.00041757428,0.00072440115,0.0002704564,0.00013619765,0.0001482474,0.000059822665,0.0004765922,0.0000059732615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018131419,0.00010974228,0.000007582882,0.0068069226,0.003658938,0.00001893153,0.0017480416,2.596942e-7,0.000028435228,0.00007968301,0.00001646741,0.98734367],"study_design_scores_gemma":[0.0017521268,0.00008844176,0.00021759914,0.006521402,0.001418265,0.00005794282,0.000074031355,8.04283e-7,0.00028285035,0.00033484862,0.9887944,0.00045728395],"about_ca_topic_score_codex":0.00004498191,"about_ca_topic_score_gemma":0.0000023521154,"teacher_disagreement_score":0.98877794,"about_ca_system_score_codex":0.0001871481,"about_ca_system_score_gemma":0.0020234254,"threshold_uncertainty_score":0.9998276},"labels":[],"label_agreement":null},{"id":"W2028562744","doi":"10.1016/j.ahj.2014.01.014","title":"Impact of the ENHANCE Trial on the use of ezetimibe in the United States and Canada","year":2014,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; University Health Network; Health Sciences Centre","funders":"National Institute on Aging; Health Canada; Canada Research Chairs; National Heart, Lung, and Blood Institute; Heart and Stroke Foundation of Canada; Ontario Ministry of Health and Long-Term Care; Western University of Health Sciences; Yale University; Canadian Institutes of Health Research; American Federation for Aging Research","keywords":"Ezetimibe; Medicine; Simvastatin; Population; Medical prescription; Demography; Statin; Internal medicine; Environmental health; Pharmacology","score_opus":0.02784854461833734,"score_gpt":0.30214731164910374,"score_spread":0.2742987670307664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028562744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382246,0.000046198977,0.000016769987,0.005751388,0.000050860046,0.00028254723,0.000005165748,9.823975e-7,0.000023659017],"genre_scores_gemma":[0.99683225,0.00022779351,0.000041849646,0.0027430907,0.000134895,0.0000032697542,7.321252e-7,0.000006063062,0.000010025451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984829,0.0006475263,0.00022812157,0.00006344427,0.00042820617,0.00014980174],"domain_scores_gemma":[0.9989271,0.00045390587,0.00015817833,0.0003244514,0.00007275881,0.000063606014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010214781,0.00006967039,0.00027483152,0.000039598577,0.000078660334,0.000011828353,0.0000868644,0.000012228893,0.00001365655],"category_scores_gemma":[0.00039849707,0.000025873307,0.00014753187,0.0002679792,0.00018481187,0.000018082752,0.000013174761,0.0003280464,1.366764e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028498633,0.0011130123,0.72663987,0.00017038915,0.0018628609,0.00006389391,0.008372942,0.006000971,0.0036156354,0.00033046096,0.10353191,0.11979941],"study_design_scores_gemma":[0.0050144815,0.0034051142,0.9631822,0.00018726007,0.00008057819,0.00032371364,0.0010791317,0.0005122853,0.0006682824,0.000029796112,0.025434306,0.00008283931],"about_ca_topic_score_codex":0.7260781,"about_ca_topic_score_gemma":0.047429066,"teacher_disagreement_score":0.678649,"about_ca_system_score_codex":0.000057406596,"about_ca_system_score_gemma":0.00047645147,"threshold_uncertainty_score":0.9699529},"labels":[],"label_agreement":null},{"id":"W2028606045","doi":"10.1139/o05-155","title":"Expression and localization of PCSK9 in rat hepatic cells","year":2006,"lang":"en","type":"article","venue":"Biochemistry and Cell Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health","keywords":"PCSK9; Subcellular localization; Proprotein convertase; LDL receptor; Biology; Kexin; Golgi apparatus; Cell fractionation; Clathrin; Cell biology; Blot; Western blot; Molecular biology; Cholesterol; Biochemistry; Receptor; Endocytosis; Cytoplasm; Endoplasmic reticulum; Lipoprotein; Enzyme","score_opus":0.005018282919673611,"score_gpt":0.21622694843838072,"score_spread":0.21120866551870712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028606045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99320763,0.0051358654,0.0002607571,0.000020818703,0.000023794493,0.00009907615,0.0000026360535,0.0000052300798,0.0012442074],"genre_scores_gemma":[0.99910474,0.00042421345,0.0001446943,0.000038454713,0.00006155958,0.0000048082206,0.000040678642,0.0000034210361,0.00017743082],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999578,0.000023456465,0.00013509787,0.00014160332,0.000035898356,0.000085922096],"domain_scores_gemma":[0.99979246,0.000010280836,0.000036920126,0.00011010961,0.000016405294,0.000033799974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010269965,0.00005841432,0.00016143767,0.000017749007,0.000015754265,0.0000015683852,0.000014068043,0.00012447305,0.000010782959],"category_scores_gemma":[0.0000062620243,0.00004624591,0.000020191459,0.000044198725,0.000063781976,0.000006910635,0.000017512693,0.000045758872,4.1281754e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034639652,0.00005296171,0.01626979,0.00041293123,0.000002369239,0.000003132616,0.000012266176,0.000002062453,0.98107255,0.000007807588,0.00005346708,0.0020760384],"study_design_scores_gemma":[0.000879736,0.000070069545,0.0007934576,0.000052435298,0.000012678908,0.000008727013,0.00003192317,0.00009162698,0.9956746,0.000061982115,0.002277235,0.000045531957],"about_ca_topic_score_codex":0.00012732211,"about_ca_topic_score_gemma":0.0000022273937,"teacher_disagreement_score":0.015476332,"about_ca_system_score_codex":0.0000079196325,"about_ca_system_score_gemma":0.000022960106,"threshold_uncertainty_score":0.18858534},"labels":[],"label_agreement":null},{"id":"W2028948892","doi":"10.1016/s0140-6736(09)60357-3","title":"Lipid lowering for primary prevention","year":2009,"lang":"en","type":"review","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Primary prevention; Primary (astronomy); Medicine; Internal medicine; Physics","score_opus":0.07340227639589911,"score_gpt":0.3631998989512172,"score_spread":0.28979762255531805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028948892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004458872,0.9928221,0.000672387,0.0003431105,0.00022193813,0.0024454135,0.000016619382,0.000061703584,0.0034122698],"genre_scores_gemma":[0.0000013409156,0.98780507,0.00068858353,0.0004745686,0.009240025,0.00023998572,0.00015903967,0.00003476771,0.0013566024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900514,0.000066610744,0.00027263767,0.00019967362,0.00020178166,0.0002541404],"domain_scores_gemma":[0.99885184,0.000036800426,0.00013163588,0.00090216345,0.000027899345,0.000049682072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009489979,0.00017512351,0.0019244618,0.00003327815,0.00006335271,0.000016492999,0.000168812,0.000137478,0.000014084271],"category_scores_gemma":[0.000042327803,0.000095751806,0.00093883433,0.00009757913,0.000014364091,0.000018781053,0.00002731602,0.00027595603,0.000030866082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001861593,0.000018341469,2.394212e-7,0.029336065,0.00017921843,0.0000024890637,0.000008223119,5.9379357e-8,1.3617249e-7,0.000049087874,0.0032716685,0.9671159],"study_design_scores_gemma":[0.00054351875,0.00013652025,0.000035318062,0.012866653,0.0012937835,0.00010681291,0.0000010711532,3.4901612e-7,4.77513e-7,0.0000929323,0.98482424,0.00009829618],"about_ca_topic_score_codex":0.0000040876944,"about_ca_topic_score_gemma":0.0000010771722,"teacher_disagreement_score":0.9815526,"about_ca_system_score_codex":0.00010644919,"about_ca_system_score_gemma":0.00025155404,"threshold_uncertainty_score":0.39046454},"labels":[],"label_agreement":null},{"id":"W2029059422","doi":"10.1016/j.ccl.2015.02.008","title":"Statins and Cognitive Side Effects","year":2015,"lang":"en","type":"review","venue":"Cardiology Clinics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute for Aging; McMaster University; University of Waterloo","funders":"","keywords":"Medicine; Cognition; Statin; Adverse effect; Atherosclerotic cardiovascular disease; Disease; Primary prevention; Intensive care medicine; Clinical trial; Internal medicine; Psychiatry","score_opus":0.07656785285912429,"score_gpt":0.41866116703865625,"score_spread":0.3420933141795319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029059422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007150025,0.99113655,0.00030890392,0.00001564665,0.00082473486,0.0022657716,0.00009938609,0.000066836124,0.0052106795],"genre_scores_gemma":[0.000052472715,0.996706,0.0001786965,0.00038497394,0.0017178563,0.00022664781,0.0003921395,0.00008191945,0.00025930573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970294,0.0009895337,0.00067475287,0.0006481694,0.00025968897,0.00039845778],"domain_scores_gemma":[0.9973309,0.0010871456,0.0002684501,0.00063064025,0.00026377675,0.00041907313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020389312,0.00042947402,0.0054286015,0.0001245026,0.000059157446,0.000009948905,0.0000821954,0.0009961113,0.0000022342265],"category_scores_gemma":[0.0018356199,0.0003140614,0.0012504574,0.00016017948,0.0002501369,0.00002170952,0.00013264129,0.001034207,0.00013191879],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001822162,0.000012183489,0.000040753857,0.019584997,0.0021471342,0.00069221825,0.000021475285,3.8545558e-8,6.780417e-9,0.000033866185,0.00053383945,0.97691524],"study_design_scores_gemma":[0.0013391076,0.00064075686,0.00014613438,0.0076897694,0.011543324,0.0020979247,0.0000330505,8.6080723e-7,6.475883e-8,0.00007114053,0.97616893,0.00026891025],"about_ca_topic_score_codex":0.000006448026,"about_ca_topic_score_gemma":9.0108676e-7,"teacher_disagreement_score":0.97664636,"about_ca_system_score_codex":0.00009054815,"about_ca_system_score_gemma":0.0013728639,"threshold_uncertainty_score":0.99993116},"labels":[],"label_agreement":null},{"id":"W2029154036","doi":"10.1074/jbc.m100326200","title":"Interaction of Lecithin:Cholesterol Acyltransferase (LCAT)·α2-Macroglobulin Complex with Low Density Lipoprotein Receptor-related Protein (LRP)","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; McGill University; Royal Victoria Hospital","funders":"Canadian Institutes of Health Research; Pfizer","keywords":"Phosphatidylcholine; Chemistry; High-density lipoprotein; Sterol O-acyltransferase; Lipoprotein lipase; Lipoprotein; Lecithin; Cholesterol; Acyltransferase; Biochemistry; Enzyme; Phospholipid","score_opus":0.022119893712112,"score_gpt":0.2634464292440467,"score_spread":0.2413265355319347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029154036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652797,0.000329429,0.00091877696,0.0010071739,0.0000653417,0.0005324377,0.000008195287,0.000032120905,0.00057856063],"genre_scores_gemma":[0.99727374,0.00023724533,0.0016799023,0.00017617135,0.00040026265,0.0000120164505,0.00003461177,0.000020145279,0.00016589154],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773866,0.0001341015,0.00094031723,0.0002907963,0.00057735527,0.00031878395],"domain_scores_gemma":[0.99816006,0.000035162153,0.00056103076,0.00037352036,0.00052369747,0.00034651198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082756864,0.00026944868,0.0008903284,0.000052802596,0.00007239693,0.000020224777,0.00019084036,0.0003698288,0.000569178],"category_scores_gemma":[0.00021719429,0.0001679568,0.00046932776,0.00028054698,0.0002059472,0.00010603857,0.00003447773,0.0009805344,0.000009916616],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035113718,0.000700014,0.004643719,0.00035387208,0.00042028097,0.00032729784,0.00007406506,0.000017410845,0.96545804,0.0000027460608,0.00009879877,0.024392368],"study_design_scores_gemma":[0.004964698,0.0019231456,0.02474328,0.0012053865,0.00015502829,0.0054954453,0.00023756574,0.000030559204,0.9571584,0.000057388403,0.0037652245,0.00026389028],"about_ca_topic_score_codex":0.00008458401,"about_ca_topic_score_gemma":0.000004282071,"teacher_disagreement_score":0.024128478,"about_ca_system_score_codex":0.00016401873,"about_ca_system_score_gemma":0.0001684553,"threshold_uncertainty_score":0.6849079},"labels":[],"label_agreement":null},{"id":"W2029204624","doi":"10.1177/0891988714522702","title":"Long-Term Statin Use and Dementia Risk in Taiwan","year":2014,"lang":"en","type":"article","venue":"Journal of Geriatric Psychiatry and Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Dementia; Medicine; Odds ratio; Confidence interval; Population; Internal medicine; Cohort; Statin; Cohort study; Disease; Environmental health","score_opus":0.008699990197897146,"score_gpt":0.2455891943301801,"score_spread":0.23688920413228295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029204624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909704,0.004981274,0.00055916846,0.002606747,0.0006935459,0.00013883096,0.0000018901479,0.0000047915323,0.00004335589],"genre_scores_gemma":[0.99382216,0.0033315776,0.0010297225,0.0011122229,0.00068255514,0.000001390332,7.898177e-7,0.000011734901,0.000007843312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873805,0.0003154911,0.00043346258,0.00016211555,0.00015588719,0.00019501754],"domain_scores_gemma":[0.9992624,0.00004920221,0.00030438768,0.0001613059,0.00004866443,0.00017406877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089996454,0.00010761812,0.00040461944,0.00022180611,0.000053611082,0.00001889807,0.000044104414,0.00010231689,0.000014401975],"category_scores_gemma":[0.00010591629,0.00008322369,0.00009905083,0.00013099978,0.00004699926,0.000104290215,0.00002579435,0.0004510835,8.514724e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071349205,0.000104532715,0.98210627,0.000101544334,0.00010385794,0.00006772894,0.00005093341,0.0000031369486,0.000058358408,0.00009748744,0.00016352796,0.016429124],"study_design_scores_gemma":[0.0037707435,0.00220985,0.98984283,0.00002041894,0.00027940597,0.0021586095,0.000010400084,0.00003119667,0.0000053072094,0.00039795414,0.0012077958,0.00006549464],"about_ca_topic_score_codex":0.000027440627,"about_ca_topic_score_gemma":0.000052203533,"teacher_disagreement_score":0.01636363,"about_ca_system_score_codex":0.000004854796,"about_ca_system_score_gemma":0.000086990556,"threshold_uncertainty_score":0.33937636},"labels":[],"label_agreement":null},{"id":"W2029255258","doi":"10.1016/j.rec.2014.05.008","title":"Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology Position Statement on Dyslipidemia Management. Differences Between the European and American Guidelines","year":2014,"lang":"en","type":"article","venue":"Revista Española de Cardiología (English Edition)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Medicine; Dyslipidemia; Position statement; Disease; Intensive care medicine; Family medicine; Position paper; Canadian Cardiovascular Society; Statin; Population; Physical therapy; Internal medicine; Environmental health; Pathology; Myocardial infarction","score_opus":0.0239648524441203,"score_gpt":0.29643744019205337,"score_spread":0.2724725877479331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029255258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6766579,0.010289732,0.28093678,0.016385624,0.0010497208,0.008956792,0.00061636645,0.00026938284,0.0048376857],"genre_scores_gemma":[0.9896946,0.0021754915,0.0014298366,0.0005908138,0.0054119527,0.0003329758,0.0002894429,0.00004411518,0.00003074678],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9955117,0.0023179476,0.0007091203,0.00058102363,0.0004603873,0.000419826],"domain_scores_gemma":[0.9975686,0.0005034671,0.00030924912,0.0009844428,0.00041128055,0.00022293931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007853304,0.0003151498,0.0012570426,0.00005710539,0.00044080883,0.00007693935,0.00021042771,0.0000808831,0.0000014666094],"category_scores_gemma":[0.00040685092,0.00019253134,0.0015102427,0.00015526482,0.00083467265,0.000071701885,0.00030396055,0.00030966726,9.894892e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030336452,0.0001916364,0.187554,0.009094524,0.041578926,0.00006302907,0.0019267915,0.0013942723,0.000049226717,0.060206797,0.1391383,0.55576885],"study_design_scores_gemma":[0.006865144,0.0012258444,0.8521685,0.0010887252,0.0093080755,0.000056211076,0.003707745,0.00062093855,0.000015758262,0.0047787563,0.11964589,0.0005184124],"about_ca_topic_score_codex":0.000018697261,"about_ca_topic_score_gemma":7.612806e-7,"teacher_disagreement_score":0.6646145,"about_ca_system_score_codex":0.00012703707,"about_ca_system_score_gemma":0.00005125196,"threshold_uncertainty_score":0.78512007},"labels":[],"label_agreement":null},{"id":"W2029459374","doi":"10.1074/jbc.m112.421370","title":"Low Density Lipoprotein Binds to Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK9) in Human Plasma and Inhibits PCSK9-mediated Low Density Lipoprotein Receptor Degradation","year":2013,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Kexin; PCSK9; Proprotein convertase; LDL receptor; Subtilisin; Lipoprotein; Chemistry; Biochemistry; Low-density lipoprotein; Familial hypercholesterolemia; Biology; Cholesterol; Enzyme","score_opus":0.016790344136763526,"score_gpt":0.24304817816008134,"score_spread":0.2262578340233178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029459374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652684,0.000381418,0.00007324146,0.001157711,0.00010604741,0.0016095631,0.000013119287,0.000048221835,0.00008387003],"genre_scores_gemma":[0.9970131,0.00010621171,0.0014696495,0.00040696564,0.0005975647,0.000061672,0.000088024324,0.000033130844,0.000223666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967222,0.00021661501,0.0011349035,0.00058708066,0.00073625694,0.00060292706],"domain_scores_gemma":[0.99729395,0.000076255266,0.0005146036,0.00049242267,0.0007756192,0.00084715727],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014996977,0.00043391704,0.0011279522,0.00016002949,0.0001465025,0.000076356984,0.00022824992,0.0007241969,0.00042514395],"category_scores_gemma":[0.0017201696,0.00031265797,0.00028146547,0.0004933577,0.00020632849,0.00019359283,0.00016161262,0.0011837373,0.00007197873],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087982113,0.0005023999,0.008092205,0.000481328,0.00010655017,0.00020639318,0.00009271554,0.00000289283,0.9565079,0.0000029912842,0.00031920878,0.03280559],"study_design_scores_gemma":[0.0031142684,0.0011448957,0.050080057,0.0007664487,0.000045267414,0.00049532583,0.00017490207,0.000058821377,0.94322306,0.000079360194,0.00044841293,0.00036919018],"about_ca_topic_score_codex":0.0010238346,"about_ca_topic_score_gemma":0.00008313589,"teacher_disagreement_score":0.04198785,"about_ca_system_score_codex":0.00034503892,"about_ca_system_score_gemma":0.0003073588,"threshold_uncertainty_score":0.9999325},"labels":[],"label_agreement":null},{"id":"W2029465901","doi":"10.1161/strokeaha.113.001529","title":"Extended-Release Niacin Therapy and Risk of Ischemic Stroke in Patients With Cardiovascular Disease","year":2013,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University Hospital; McMaster University Medical Centre","funders":"National Heart, Lung, and Blood Institute; Pfizer","keywords":"Medicine; Niacin; Stroke (engine); Ischemic stroke; Disease; Internal medicine; Cardiology; Ischemia","score_opus":0.006204224266948148,"score_gpt":0.2027473245753171,"score_spread":0.19654310030836897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029465901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99103963,0.0067609525,0.000070991744,0.000037896298,0.000032408134,0.001269995,0.00011457049,0.00002180406,0.0006517648],"genre_scores_gemma":[0.99716485,0.0019640813,0.0004286788,0.000050845192,0.000073588446,0.00009269337,0.000028042363,0.000029127494,0.0001680793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983865,0.00009932513,0.00023713433,0.00033396768,0.00065994594,0.00028311694],"domain_scores_gemma":[0.9986486,0.000014735483,0.00007339126,0.0008133447,0.0001410722,0.0003088642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028426616,0.00018238678,0.00051834935,0.00010633054,0.000037725764,0.000010944531,0.000060604172,0.000063581,0.000051131094],"category_scores_gemma":[0.00004943,0.00012781742,0.0003045784,0.00011451037,0.00008676114,0.000102740574,0.000028840906,0.00022070961,0.000008707087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045258683,0.0002757461,0.8593634,0.00012241055,0.0010921594,0.000011910663,0.00006330086,0.000016557278,0.000112712216,0.0000051864813,0.00011480062,0.13836925],"study_design_scores_gemma":[0.008570751,0.0003830222,0.9871171,0.00008324222,0.00026656452,0.0000027567473,0.00006591293,0.000046076013,0.000502065,0.0000065438185,0.0028206888,0.00013526065],"about_ca_topic_score_codex":0.0016264674,"about_ca_topic_score_gemma":0.000009619897,"teacher_disagreement_score":0.13823399,"about_ca_system_score_codex":0.000037990016,"about_ca_system_score_gemma":0.000105841085,"threshold_uncertainty_score":0.52122426},"labels":[],"label_agreement":null},{"id":"W2029564213","doi":"10.1592/phco.21.9.807.34553","title":"Cholesterol Risk Management: A Systematic Examination of the Gap from Evidence to Practice","year":2001,"lang":"en","type":"review","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Intensive care medicine; Cholesterol; Coronary heart disease; Ldl cholesterol; Disease; Risk factor; Cardiovascular event; Internal medicine","score_opus":0.06496945932366377,"score_gpt":0.40884898092524674,"score_spread":0.34387952160158297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029564213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008614545,0.98446614,0.0001525812,0.00069223135,0.0009210678,0.0049726097,0.000014204198,0.000013870118,0.00015272625],"genre_scores_gemma":[0.004582282,0.9904975,0.00012044061,0.0031829337,0.0010689815,0.00014292874,0.0000017742409,0.00007447016,0.00032866813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98986214,0.0071321717,0.0015542397,0.00029319632,0.0008510768,0.00030717623],"domain_scores_gemma":[0.99437326,0.0014359204,0.0030220516,0.0006183059,0.0003514433,0.00019901423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008213528,0.00048639346,0.002268686,0.00032193982,0.00034846558,0.000034969078,0.00082082424,0.0001462431,0.0002012458],"category_scores_gemma":[0.00006524412,0.0002356997,0.0009159288,0.00054185995,0.00017246619,0.0002370228,0.00008697659,0.0012185884,0.0000074213635],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009353277,0.00057811185,0.00001839168,0.03782231,0.011485918,0.000052556632,0.0039310795,0.0000095959795,0.0008358114,0.00001684335,0.0022828518,0.9420312],"study_design_scores_gemma":[0.006816832,0.00083286985,0.00020255735,0.0628358,0.028984305,0.0015354911,0.0005165021,0.000007808568,0.00071749545,0.000071939794,0.8970919,0.000386501],"about_ca_topic_score_codex":0.00006571438,"about_ca_topic_score_gemma":0.0000027236954,"teacher_disagreement_score":0.9416447,"about_ca_system_score_codex":0.00015934883,"about_ca_system_score_gemma":0.00016508186,"threshold_uncertainty_score":0.9611555},"labels":[],"label_agreement":null},{"id":"W2029647281","doi":"10.1016/j.cardfail.2008.10.026","title":"Statin Therapy and Clinical Outcomes in Heart Failure: A Propensity-Matched Analysis","year":2008,"lang":"en","type":"article","venue":"Journal of Cardiac Failure","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; Health Sciences Centre; Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto; Toronto General Hospital; Canadian Institutes of Health Research; Sunnybrook Health Science Centre; Heart and Stroke Foundation","funders":"","keywords":"Medicine; Ejection fraction; Internal medicine; Propensity score matching; Hazard ratio; Cardiology; Coronary artery disease; Statin; Heart failure; Proportional hazards model; Confidence interval","score_opus":0.03286644191140062,"score_gpt":0.3132395744392437,"score_spread":0.2803731325278431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029647281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98745084,0.002370099,0.00007084722,0.009505192,0.00012831988,0.00041972808,0.0000053955523,0.000010661593,0.000038930873],"genre_scores_gemma":[0.98762566,0.002777316,0.00830963,0.0007907844,0.00039176786,0.0000050407552,0.0000037449597,0.000020885056,0.00007520158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973676,0.0004574941,0.0009230641,0.00021949582,0.0007736254,0.00025871562],"domain_scores_gemma":[0.99856013,0.00012703626,0.00028788156,0.00038608108,0.00032327027,0.00031559824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024246373,0.00018354972,0.00215847,0.00035901344,0.0000658289,0.000022733033,0.00007448075,0.00016749447,0.000027661023],"category_scores_gemma":[0.00023327665,0.00012036074,0.0017519689,0.000598873,0.000101324375,0.00015037128,0.000029255694,0.0006988218,0.0000047227595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021998724,0.00016150657,0.9872532,0.000025229047,0.0038534286,0.00019163494,0.0002935243,0.000008920079,0.00017333229,0.0000052595005,0.0036300723,0.004183928],"study_design_scores_gemma":[0.002605511,0.00051090267,0.9480651,0.00004176281,0.0007757091,0.00041176775,0.00030116658,0.000008995192,0.00010387596,0.000012756847,0.047042135,0.00012032308],"about_ca_topic_score_codex":0.00012899289,"about_ca_topic_score_gemma":0.00007447568,"teacher_disagreement_score":0.043412063,"about_ca_system_score_codex":0.000062247665,"about_ca_system_score_gemma":0.00037314068,"threshold_uncertainty_score":0.49081686},"labels":[],"label_agreement":null},{"id":"W2029972606","doi":"10.1016/j.amjcard.2011.02.058","title":"AS-033 Validation of British Columbia-Percutaneous Coronary Intervention (BC PCI) Risk Score Using the Singapore Cardiac Data Bank","year":2011,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Conventional PCI; Percutaneous coronary intervention; Medicine; Cohort; Cardiology; Internal medicine; Emergency medicine; Medical emergency; Myocardial infarction","score_opus":0.0471621196290293,"score_gpt":0.2899644996349567,"score_spread":0.24280238000592738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029972606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993626,0.0025778734,0.0023715615,0.00009678886,0.00048936676,0.00034644257,0.000096793075,0.000010036544,0.0003851682],"genre_scores_gemma":[0.9962027,0.0019391242,0.000809755,0.00012245198,0.00083526026,0.000002278706,0.000026163843,0.000027979773,0.00003428776],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968732,0.0015404706,0.0006701539,0.00021426791,0.00044930467,0.00025263053],"domain_scores_gemma":[0.99713945,0.0001316559,0.0011440468,0.0010914194,0.00038877223,0.000104666215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033392939,0.00011589425,0.001069943,0.00005221824,0.00014585984,0.000022506749,0.0004979341,0.00006077791,0.000041505537],"category_scores_gemma":[0.000280695,0.00009419732,0.0006886116,0.0002313849,0.00080886704,0.0001101058,0.00017375968,0.0005178129,0.0000026839712],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001603792,0.00012190897,0.27621236,0.00011897017,0.00629458,0.0015588574,0.0010048511,0.00042265895,0.0022428166,0.000010990172,0.0034757722,0.7069324],"study_design_scores_gemma":[0.0023943225,0.008244801,0.729665,0.0009098099,0.008242788,0.22972709,0.011944858,0.00024753434,0.00042381868,0.0009957149,0.0067591807,0.00044508142],"about_ca_topic_score_codex":0.03039099,"about_ca_topic_score_gemma":0.00016709726,"teacher_disagreement_score":0.70648736,"about_ca_system_score_codex":0.000084890904,"about_ca_system_score_gemma":0.0002647948,"threshold_uncertainty_score":0.9760657},"labels":[],"label_agreement":null},{"id":"W2030056062","doi":"10.1161/circulationaha.104.531582","title":"Impact of the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22/Reversal of Atherosclerosis With Aggressive Lipid Lowering Trials on Trends in Intensive Versus Moderate Statin Therapy in Ontario, Canada","year":2005,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Pravastatin; Medicine; Simvastatin; TIMI; Myocardial infarction; Internal medicine; Statin; Medical prescription; Rosuvastatin; Acute coronary syndrome; Cardiology; Thrombolysis; Pharmacology; Cholesterol","score_opus":0.06720133195696522,"score_gpt":0.33190744530063965,"score_spread":0.26470611334367444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030056062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983457,0.00009117086,0.00007098389,0.00009034652,0.00011216205,0.001245066,0.000011382972,0.000005172003,0.000028053571],"genre_scores_gemma":[0.9995348,0.00015875178,0.000058272526,0.000039302777,0.000054338925,0.00008836761,0.000043482305,0.000019992467,0.0000027024985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763393,0.00063383277,0.0006547919,0.0002714718,0.00062122004,0.00018472916],"domain_scores_gemma":[0.99859864,0.00016958472,0.00061454374,0.00024857037,0.00032363573,0.000045028468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001650413,0.00018623837,0.0006622904,0.0003428315,0.000036807156,0.000011920819,0.00003100559,0.0000928449,0.00008700491],"category_scores_gemma":[0.00041125278,0.00012103947,0.00014649371,0.00065937836,0.00004096719,0.00016355093,0.000009221244,0.0002459281,1.01099445e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008029627,0.00015132938,0.6529414,0.000019419722,0.0003300158,0.0000016923799,0.0052062958,0.12063351,0.005343314,0.0000019966642,0.000009215998,0.20733221],"study_design_scores_gemma":[0.013789529,0.00082195067,0.9768895,0.0003159392,0.00006802664,0.0000039827323,0.00027290927,0.0058599324,0.0018562829,0.000007930615,0.000004474497,0.00010954472],"about_ca_topic_score_codex":0.83460516,"about_ca_topic_score_gemma":0.89673126,"teacher_disagreement_score":0.32394812,"about_ca_system_score_codex":0.0018910656,"about_ca_system_score_gemma":0.0014113779,"threshold_uncertainty_score":0.49450707},"labels":[],"label_agreement":null},{"id":"W2030071481","doi":"10.1016/j.jtcvs.2008.12.001","title":"Highlights from the 2008 American Heart Association Scientific Session","year":2009,"lang":"en","type":"editorial","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Heart Institute; University of Ottawa","funders":"","keywords":"Medicine; Session (web analytics); Association (psychology); MEDLINE; Cardiology; Internal medicine; World Wide Web","score_opus":0.01160103172926245,"score_gpt":0.278942450386709,"score_spread":0.26734141865744654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030071481","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07306363,0.23849978,0.00041468,0.0025586386,0.6846311,0.00056953076,0.00010461849,0.00004809623,0.00010991377],"genre_scores_gemma":[0.022474622,0.041736152,0.00044170948,0.00033528614,0.9339672,0.000010672609,0.00020319976,0.00009554663,0.0007356101],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913056,0.0013754878,0.0010732927,0.000556695,0.00518484,0.0005040662],"domain_scores_gemma":[0.9943237,0.0015457587,0.0010395374,0.0012506953,0.001448619,0.00039171378],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.014452686,0.00043127738,0.0032109688,0.00032971348,0.00045370305,0.00031540083,0.00022486143,0.00066683674,0.000018285744],"category_scores_gemma":[0.0025554697,0.00026433924,0.0058823107,0.0006210504,0.00017987961,0.00021558059,0.00007163914,0.001714624,0.0000147423725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019981644,0.000058214784,0.0012308416,0.00011133186,0.0045238733,0.00024307326,0.000067446796,0.000005899846,0.000017842081,3.0508488e-7,0.8590112,0.13453016],"study_design_scores_gemma":[0.00035197753,0.000116719646,0.011434652,0.0012189721,0.0044387113,0.0002199526,0.000091746806,0.0000027322744,0.00012936261,0.000031232674,0.98168916,0.0002747701],"about_ca_topic_score_codex":0.0005545069,"about_ca_topic_score_gemma":0.000013280958,"teacher_disagreement_score":0.2493361,"about_ca_system_score_codex":0.0004234691,"about_ca_system_score_gemma":0.0018669688,"threshold_uncertainty_score":0.99998087},"labels":[],"label_agreement":null},{"id":"W2030076333","doi":"10.1016/j.atherosclerosis.2008.09.008","title":"Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial","year":2008,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Pfizer","keywords":"Stroke (engine); Medicine; Baseline (sea); Internal medicine; Blood pressure; Cholesterol; Cardiology; Reduction (mathematics); Biology","score_opus":0.0159537265310155,"score_gpt":0.23785442608775256,"score_spread":0.22190069955673705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030076333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004525,0.006483828,0.00011190966,0.00036057085,0.000059589962,0.002878028,0.00004640309,0.0000114289205,0.0000030162514],"genre_scores_gemma":[0.98347896,0.01588471,0.0001330978,0.000065711734,0.00014646882,0.00021092601,0.000010930155,0.000020233543,0.0000489313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731976,0.0011112009,0.00047346985,0.00038776407,0.000489498,0.00021832433],"domain_scores_gemma":[0.99894065,0.00011592633,0.00033869845,0.0004765407,0.000058121026,0.00007009055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028257174,0.00020001752,0.0006039247,0.0000798722,0.00016342763,0.000014655943,0.00008488378,0.00014685706,0.0000042661286],"category_scores_gemma":[0.00031027096,0.00012058806,0.00015272235,0.00018662863,0.00028495246,0.00012585722,0.000057077697,0.00033356415,2.7753595e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.087474726,0.009884676,0.4936218,0.0038437808,0.008996716,0.000051122814,0.03254835,0.00015688776,0.07459379,0.00022340484,0.00041353318,0.28819123],"study_design_scores_gemma":[0.0984884,0.0008634247,0.8872448,0.00066227425,0.0011763936,0.00008409693,0.00028767015,0.0001283803,0.010658904,0.00017823614,0.00006559986,0.00016181174],"about_ca_topic_score_codex":0.0067423284,"about_ca_topic_score_gemma":0.00021290813,"teacher_disagreement_score":0.39362302,"about_ca_system_score_codex":0.000014651134,"about_ca_system_score_gemma":0.000043074382,"threshold_uncertainty_score":0.99987185},"labels":[],"label_agreement":null},{"id":"W2030710600","doi":"10.1021/bi049536d","title":"Identification of Sequences in Apolipoprotein(a) that Maintain Its Closed Conformation:  A Novel Role for Apo(a) Isoform Size in Determining the Efficiency of Covalent Lp(a) Formation","year":2004,"lang":"en","type":"article","venue":"Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Chemistry; Conformational change; Gene isoform; Covalent bond; Kringle domain; Biochemistry; Lysine; Apolipoprotein B; Stereochemistry; Amino acid; Recombinant DNA; Cholesterol","score_opus":0.01937456279594067,"score_gpt":0.2745378805771685,"score_spread":0.2551633177812278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030710600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429387,0.00038296045,0.0034008785,0.00032832628,0.000035758087,0.0013210467,0.00003939557,0.000010698144,0.00018709029],"genre_scores_gemma":[0.9991172,0.000051412244,0.0004891982,0.000050761024,0.000047368067,0.00016783971,0.000049521597,0.000008353062,0.00001832777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862057,0.000013798589,0.00062203355,0.0001512387,0.00039090612,0.00020147878],"domain_scores_gemma":[0.99908096,0.00004790804,0.0003604389,0.00031163,0.00015899049,0.00004010552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010698315,0.00011200144,0.00026807544,0.00006633705,0.0000438578,0.000008676691,0.00013306392,0.00011679078,0.000003627418],"category_scores_gemma":[0.00033370467,0.00008814383,0.00013112633,0.00023156288,0.00006726657,0.00013200578,0.000023525503,0.000101993515,9.724431e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002442539,0.00036017637,0.0019037867,0.0035483735,0.000035908844,0.0000012539529,0.0020887894,0.00027888044,0.98369026,0.0005270587,0.0000061457176,0.0073150853],"study_design_scores_gemma":[0.003401916,0.00010071512,0.013334657,0.00040164051,0.000025772337,0.000019892886,0.0020914644,0.0017304003,0.9786077,0.00016901582,0.00002745734,0.000089335444],"about_ca_topic_score_codex":0.00010186318,"about_ca_topic_score_gemma":0.000021738037,"teacher_disagreement_score":0.011430871,"about_ca_system_score_codex":0.00022639708,"about_ca_system_score_gemma":0.00027231543,"threshold_uncertainty_score":0.35944012},"labels":[],"label_agreement":null},{"id":"W2030765516","doi":"10.1016/j.cjca.2014.11.007","title":"The New Dyslipidemia Guidelines: What Is the Debate?","year":2014,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; Population Health Research Institute; Université de Montréal; University of British Columbia; Montreal Heart Institute; Libin Cardiovascular Institute of Alberta; McGill University Health Centre; University of Calgary","funders":"","keywords":"Dyslipidemia; Medicine; Psychological intervention; Statin; Intensive care medicine; Disease; Aspirin; Risk factor; Internal medicine","score_opus":0.059039017810287774,"score_gpt":0.34615868978598624,"score_spread":0.2871196719756985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030765516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.3704706e-7,0.9752353,0.0009950818,0.017365417,0.0043355026,0.00064581534,0.00000826383,0.0000046863365,0.0014092075],"genre_scores_gemma":[0.000011930779,0.9734961,0.0000718687,0.003963908,0.021244965,0.000013939005,0.000009094594,0.00006475557,0.0011234634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960475,0.0009930684,0.0015986335,0.00026093537,0.0003915207,0.00070834445],"domain_scores_gemma":[0.9953174,0.00045712388,0.00083001645,0.0013006874,0.00070467836,0.0013901013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050229765,0.00040023838,0.0035835053,0.00022739862,0.00036480895,0.00013914227,0.00079076807,0.0006059979,0.000030855892],"category_scores_gemma":[0.0013577909,0.00017514898,0.0034552272,0.00027038498,0.0002684087,0.000075343116,0.00003128743,0.0014850162,0.000082223145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028713803,1.2563986e-7,0.0000036364188,0.0005153986,0.0011098026,0.000098474324,0.000019557925,0.000004552806,8.090133e-9,0.00007941444,0.32013893,0.6780272],"study_design_scores_gemma":[0.000305886,0.00013531178,0.000013028939,0.006055546,0.0028278278,0.008415681,0.000097755204,8.4003426e-7,1.00582255e-7,0.00015632731,0.9818331,0.00015858914],"about_ca_topic_score_codex":0.0013383587,"about_ca_topic_score_gemma":0.0015200353,"teacher_disagreement_score":0.67786866,"about_ca_system_score_codex":0.00046755598,"about_ca_system_score_gemma":0.017664062,"threshold_uncertainty_score":0.98790485},"labels":[],"label_agreement":null},{"id":"W2031070761","doi":"10.1007/s11883-009-0054-2","title":"ApoB versus non-HDL-C: What to do when they disagree","year":2009,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Apolipoprotein B; Medicine; Argument (complex analysis); Internal medicine; Clinical Practice; Cholesterol; Endocrinology; Family medicine","score_opus":0.09717390846045247,"score_gpt":0.37234890799242093,"score_spread":0.27517499953196844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031070761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033101172,0.9863871,0.00014720786,0.00013504487,0.0070740897,0.0050295833,0.000021132899,0.00017436946,0.00070046674],"genre_scores_gemma":[0.00029290287,0.99501276,0.00025360577,0.00012910951,0.00273464,0.0006984274,0.0003243146,0.00023141262,0.00032284114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99342644,0.0002100467,0.0018877733,0.0017516497,0.0016988692,0.0010252341],"domain_scores_gemma":[0.9940075,0.000075503674,0.0010109539,0.0036408538,0.00023245523,0.0010327179],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014027347,0.0011763744,0.0043424144,0.00033960215,0.00020877851,0.00029635878,0.00037356446,0.0006060572,0.00015816125],"category_scores_gemma":[0.00025017836,0.0008729637,0.0032777316,0.0004904149,0.000063414656,0.00030344914,0.00026469873,0.0010571156,0.00038413837],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027873375,0.0003679467,0.000024863102,0.0078006242,0.00046937508,0.0000976627,0.00030973772,4.665192e-7,9.2070894e-7,0.0000062653257,0.003805613,0.9870887],"study_design_scores_gemma":[0.0008428067,0.00041222785,0.00031653157,0.06417859,0.0027225555,0.00030940704,0.000039742536,4.4278747e-7,0.000002803245,0.000031368778,0.93036515,0.000778389],"about_ca_topic_score_codex":0.00009286172,"about_ca_topic_score_gemma":0.000020536732,"teacher_disagreement_score":0.98631024,"about_ca_system_score_codex":0.0007658401,"about_ca_system_score_gemma":0.00087010843,"threshold_uncertainty_score":0.9993721},"labels":[],"label_agreement":null},{"id":"W2031310514","doi":"10.1016/s0009-9120(01)00231-4","title":"Lecithin:cholesterol acyl transferase G30S: association with atherosclerosis, hypoalphalipoproteinemia and reduced in vivo enzyme activity","year":2001,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Western University","funders":"","keywords":"Apolipoprotein B; Cholesterol; Lecithin; Internal medicine; Endocrinology; Lecithin—cholesterol acyltransferase; Heterozygote advantage; Transferase; Mutation; Sterol O-acyltransferase; Biology; Enzyme; Medicine; Gene; Biochemistry; Genotype; Lipoprotein","score_opus":0.024852331654634453,"score_gpt":0.30384811152308683,"score_spread":0.27899577986845236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031310514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618256,0.0003338735,0.00009358695,0.002171927,0.00007035,0.00060054555,0.00001619146,0.00006980074,0.0004611673],"genre_scores_gemma":[0.9968698,0.00086052465,0.0002763442,0.0006110052,0.00054068177,0.00007588717,0.000012581501,0.000034468412,0.0007186858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977716,0.00013733895,0.0005287301,0.00066007057,0.0005033452,0.00039889992],"domain_scores_gemma":[0.99863696,0.00013730214,0.00014543408,0.00061431236,0.0000977132,0.00036828092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001488425,0.0002464271,0.0006618144,0.000035546156,0.000068912224,0.000036548918,0.00009558355,0.0005320969,0.000042390217],"category_scores_gemma":[0.00047732372,0.00020305061,0.00022018563,0.0002489101,0.00011180722,0.00008854083,0.00003121062,0.00076780794,0.0000062191766],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011594506,0.0009109532,0.22457218,0.00031588512,0.00025376165,0.00006970328,0.00009212561,9.644533e-7,0.73976606,0.00000158938,0.00039649292,0.032460842],"study_design_scores_gemma":[0.00942304,0.0005852157,0.38503978,0.0005321708,0.00020867956,0.0001290736,0.00006636739,0.00004508022,0.6018435,0.000013958824,0.0017539144,0.00035923783],"about_ca_topic_score_codex":0.00023175137,"about_ca_topic_score_gemma":0.000043498156,"teacher_disagreement_score":0.1604676,"about_ca_system_score_codex":0.00022811753,"about_ca_system_score_gemma":0.00023584021,"threshold_uncertainty_score":0.82801634},"labels":[],"label_agreement":null},{"id":"W2031347540","doi":"10.1016/j.atherosclerosis.2006.12.001","title":"Efficacy and safety of rosuvastatin 40mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: Results of the POLARIS study","year":2007,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Rosuvastatin; Atorvastatin; Medicine; Internal medicine; Pharmacology","score_opus":0.012695874464681978,"score_gpt":0.24364116493316545,"score_spread":0.23094529046848347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031347540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979442,0.00007606007,0.000058848356,0.00006179354,0.000086573695,0.0015789741,0.00011809467,0.000014292251,0.00006117951],"genre_scores_gemma":[0.99904877,0.000063212785,0.000747379,0.00004066081,0.00003058582,0.0000122149595,0.000010055617,0.00003540262,0.000011722763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770075,0.0002378503,0.0006953827,0.00035170765,0.00070845097,0.00030582794],"domain_scores_gemma":[0.9983848,0.0002464897,0.00034705293,0.00075224665,0.00015305346,0.00011635713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015986274,0.00019883821,0.0005595259,0.00008988296,0.00008273624,0.000007919577,0.00012625752,0.000099023135,0.0000038383782],"category_scores_gemma":[0.00026825466,0.00012607097,0.00010138001,0.0004698979,0.0001451771,0.00006010923,0.00009156391,0.00032908548,0.0000011259463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007544355,0.0010783487,0.9632526,0.000059442667,0.00019985795,0.0000012743466,0.0032502625,0.000013250175,0.0006789272,0.000007289083,0.000008348333,0.023906054],"study_design_scores_gemma":[0.04471756,0.0024968178,0.9495851,0.00026458988,0.00021711476,5.785194e-7,0.001085747,0.0000026679616,0.0014797045,0.0000018238561,0.000041795858,0.00010650858],"about_ca_topic_score_codex":0.00639287,"about_ca_topic_score_gemma":0.0014478985,"teacher_disagreement_score":0.037173204,"about_ca_system_score_codex":0.00008770886,"about_ca_system_score_gemma":0.00007384856,"threshold_uncertainty_score":0.966415},"labels":[],"label_agreement":null},{"id":"W2031618774","doi":"10.1080/03639040500272058","title":"The Effects of Competitive Displacement on Haloperidol's Plasma Distribution in Normolipidemic and Hyperlipidemic Plasma","year":2005,"lang":"en","type":"article","venue":"Drug Development and Industrial Pharmacy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Riverview Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Chemistry; Haloperidol; Lipoprotein; Warfarin Sodium; Pharmacokinetics; Plasma protein binding; Pharmacology; Endocrinology; Internal medicine; Chromatography; Warfarin; Cholesterol; Biochemistry; Dopamine; Medicine","score_opus":0.02104285925937638,"score_gpt":0.2734665277498485,"score_spread":0.2524236684904721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031618774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955682,0.0007713675,0.0000050715503,0.0018005265,0.0003710615,0.0010640967,0.000008377325,0.00001546689,0.00039578936],"genre_scores_gemma":[0.9972853,0.0015469901,0.000064684966,0.00019982355,0.0005067281,0.00008180104,0.00006172935,0.000012769115,0.00024019534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984994,0.00014151208,0.0004653829,0.00026077818,0.00032999387,0.00030296223],"domain_scores_gemma":[0.999231,0.00032232958,0.000110445726,0.0001352724,0.000039998104,0.00016100291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009620761,0.0001942562,0.0003895178,0.000064992724,0.00017601317,0.000018757619,0.000062560015,0.000067454916,0.0000068562285],"category_scores_gemma":[0.00022637879,0.0001325176,0.000054774242,0.00014491769,0.000098080964,0.00008275701,0.00006453698,0.0003905554,0.000006483151],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002630566,0.00026109227,0.04194403,0.0002839101,0.00031422052,0.000018860179,0.0014403489,0.0000146108,0.001741178,0.0010295829,0.0043523093,0.9459693],"study_design_scores_gemma":[0.026982494,0.00025620032,0.03852921,0.0010603387,0.00014378899,0.00004682517,0.00048202995,0.00089381495,0.16676839,0.000009196583,0.7644474,0.00038033474],"about_ca_topic_score_codex":0.00008987328,"about_ca_topic_score_gemma":0.00004332045,"teacher_disagreement_score":0.94558895,"about_ca_system_score_codex":0.00020680577,"about_ca_system_score_gemma":0.00024252251,"threshold_uncertainty_score":0.5403911},"labels":[],"label_agreement":null},{"id":"W2031835748","doi":"10.1007/s12170-011-0206-0","title":"CETP Inhibitors: Will They Live up to Their Promise?","year":2011,"lang":"en","type":"article","venue":"Current Cardiovascular Risk Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Cholesterylester transfer protein; Medicine; Clinical trial; Cholesterol; Lipoprotein; Pharmacology; Bioinformatics; Internal medicine; Biology","score_opus":0.03154084679285167,"score_gpt":0.25560395073470904,"score_spread":0.22406310394185736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031835748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9138807,0.06768155,0.003330471,0.000059517974,0.00602695,0.0049937596,0.000030537074,0.0004943043,0.003502232],"genre_scores_gemma":[0.9921418,0.003866972,0.0007441501,0.00007435892,0.0023564051,0.00048522418,0.000054342174,0.00013706187,0.00013973133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948283,0.00038850703,0.0009899315,0.0013282335,0.0016029115,0.00086212694],"domain_scores_gemma":[0.99438787,0.000019518182,0.0003185291,0.0037871988,0.0005271253,0.0009597926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034977854,0.00058930845,0.0015568584,0.00026377052,0.00025542697,0.000047336343,0.00019170904,0.00023452226,0.00012413488],"category_scores_gemma":[0.00050744077,0.00044684677,0.0041714096,0.00040544543,0.000086358195,0.00022652632,0.00024671337,0.0007412067,0.00018248292],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025754893,0.00056197844,0.07506586,0.00081654487,0.008796806,0.0029000088,0.011529847,0.00006079849,0.000090422815,0.00004937129,0.004440369,0.89543045],"study_design_scores_gemma":[0.0028614851,0.00066991255,0.086493835,0.0011835225,0.004477596,0.006594137,0.0011525435,0.00001741688,0.0081603,0.0009859159,0.88602936,0.0013739711],"about_ca_topic_score_codex":0.0018310609,"about_ca_topic_score_gemma":0.00003884828,"teacher_disagreement_score":0.8940565,"about_ca_system_score_codex":0.0002503233,"about_ca_system_score_gemma":0.0004411633,"threshold_uncertainty_score":0.99979836},"labels":[],"label_agreement":null},{"id":"W2033435813","doi":"10.1517/13543784.12.11.1855","title":"Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growth","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Probucol; Restenosis; Medicine; Internal medicine; Endocrinology; Lipoprotein; Cholesterol; Stent","score_opus":0.16570150015299992,"score_gpt":0.43428749972595293,"score_spread":0.26858599957295304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033435813","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018039314,0.9927738,0.00002443542,0.0010597282,0.0011551789,0.0042657936,0.000023098666,0.000056283665,0.00046134114],"genre_scores_gemma":[0.00012584924,0.9914713,0.00090416626,0.0034252612,0.0015124638,0.0019360123,0.00028966402,0.00009625081,0.00023906805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99483234,0.0014081299,0.0010047797,0.0009478457,0.0014229316,0.00038395025],"domain_scores_gemma":[0.9975439,0.00063451706,0.0004576095,0.00076430023,0.00019715459,0.00040256712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001668705,0.00067619194,0.0020780286,0.00014629003,0.00040639978,0.00005578086,0.00023969622,0.00040206884,0.00004472474],"category_scores_gemma":[0.0006460256,0.00040674862,0.0011990442,0.00029600732,0.0008118152,0.0001328856,0.00017481904,0.0008212353,0.0000377563],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013604181,0.0020412838,0.0004091001,0.021517375,0.018941287,0.00006375169,0.008462123,0.0000013087359,0.0000078453995,0.028967092,0.08855631,0.8308965],"study_design_scores_gemma":[0.0012160626,0.00038165148,0.00012747859,0.012056906,0.00018687123,0.00012375397,0.0007849767,0.000004769533,0.00007658917,0.00033833933,0.98427504,0.00042754656],"about_ca_topic_score_codex":0.000025586998,"about_ca_topic_score_gemma":2.2654187e-7,"teacher_disagreement_score":0.89571875,"about_ca_system_score_codex":0.00036705926,"about_ca_system_score_gemma":0.0009694178,"threshold_uncertainty_score":0.9998384},"labels":[],"label_agreement":null},{"id":"W2033552895","doi":"10.1016/s0828-282x(10)70452-9","title":"Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Conventional PCI; Medicine; Atorvastatin; Mace; Percutaneous coronary intervention; Cardiology; Internal medicine; Acute coronary syndrome; Creatine; Troponin I; Loading dose; Myocardial infarction","score_opus":0.01078339631298866,"score_gpt":0.2800835338466453,"score_spread":0.26930013753365667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033552895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99701965,0.00062652567,0.0004665293,0.0001271046,0.0010430255,0.0004536204,0.00007446076,0.0000032722342,0.00018582199],"genre_scores_gemma":[0.9993013,0.00007426595,0.00014676926,0.00003558533,0.0003624391,0.00000771067,0.000016704456,0.000021929824,0.000033302993],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987026,0.00022071355,0.0005027915,0.0001302955,0.0001812362,0.00026240599],"domain_scores_gemma":[0.9986107,0.00024125424,0.00028871684,0.00025065456,0.00022253963,0.00038614502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081279536,0.00014807492,0.0010794463,0.0002731264,0.00004751392,0.000003841899,0.00011899872,0.00015382978,0.000032617252],"category_scores_gemma":[0.00025211534,0.00010903725,0.00088235986,0.000055809047,0.00015364768,0.000031180734,0.000009414661,0.00034668043,0.0000010906646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00930093,0.00007249129,0.28137767,0.0033322203,0.013763465,0.007982937,0.0007069296,0.0002986767,0.13306305,0.0009167401,0.0033946096,0.54579026],"study_design_scores_gemma":[0.015270172,0.0761671,0.6663739,0.0021507542,0.006209502,0.17099242,0.0004879034,0.00007733382,0.050592285,0.00046208283,0.010641538,0.0005750207],"about_ca_topic_score_codex":0.0003167351,"about_ca_topic_score_gemma":0.00035779618,"teacher_disagreement_score":0.54521525,"about_ca_system_score_codex":0.000115514595,"about_ca_system_score_gemma":0.0004168565,"threshold_uncertainty_score":0.44464102},"labels":[],"label_agreement":null},{"id":"W2033556017","doi":"10.1373/clinchem.2011.172932","title":"Rosuvastatin, Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations, and LDL Cholesterol Response: the JUPITER Trial","year":2011,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; King Abdulaziz University; AstraZeneca","keywords":"Kexin; Rosuvastatin; Proprotein convertase; Subtilisin; PCSK9; Internal medicine; Medicine; Cholesterol; Endocrinology; Ldl cholesterol; Chemistry; Biochemistry; Lipoprotein; LDL receptor; Enzyme","score_opus":0.08444340419603803,"score_gpt":0.3505605077529023,"score_spread":0.2661171035568643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033556017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581635,0.00066818093,0.000029633004,0.0014168606,0.00020445678,0.0011114569,0.000012441719,0.00004691844,0.0006937116],"genre_scores_gemma":[0.99549633,0.0001309273,0.0002949574,0.001404135,0.0007590827,0.00007487716,0.000027136803,0.000023516546,0.0017890146],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99818575,0.00025885485,0.00062299194,0.0003838982,0.00029791868,0.00025059513],"domain_scores_gemma":[0.99846023,0.0002031487,0.00013813487,0.00075639086,0.00015342499,0.0002886826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002118559,0.00016068203,0.00039969134,0.00000864682,0.000104487684,0.000029733977,0.00011797222,0.00023266056,0.0003299731],"category_scores_gemma":[0.001551168,0.000103618644,0.00020222661,0.000084309046,0.00038546554,0.000047456186,0.000055784138,0.0005236359,0.000035430734],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6242033,0.004275041,0.18523435,0.0022654247,0.0018569503,0.0007820969,0.0032781353,4.1697322e-7,0.02605484,0.00016433054,0.024917828,0.12696728],"study_design_scores_gemma":[0.22562309,0.006197317,0.3127339,0.0007562788,0.0014179461,0.0007737403,0.0013127693,0.00019987793,0.25680923,0.00038487825,0.19252081,0.0012701657],"about_ca_topic_score_codex":0.00003354847,"about_ca_topic_score_gemma":0.0000022040927,"teacher_disagreement_score":0.39858022,"about_ca_system_score_codex":0.000025875508,"about_ca_system_score_gemma":0.00038704587,"threshold_uncertainty_score":0.42254457},"labels":[],"label_agreement":null},{"id":"W2033701020","doi":"10.1016/j.cjca.2014.07.074","title":"THE RELATIONSHIP BETWEEN LOW-DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) AND APOLIPOPROTEIN B 100 IN SOUTH ASIANS","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Apolipoprotein B; Internal medicine; Triglyceride; Cholesterol; Cohort; Endocrinology; Diabetes mellitus; Gastroenterology; Apolipoprotein A1","score_opus":0.02380561859860848,"score_gpt":0.25036474591059876,"score_spread":0.2265591273119903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033701020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993,0.0010535239,0.002757564,0.0039884704,0.00023895559,0.00047973034,0.000007233484,0.00000696994,0.0015375516],"genre_scores_gemma":[0.9972046,0.000024472623,0.00011100737,0.0002669518,0.002263547,0.000010635152,0.0000034353313,0.000024462164,0.000090865986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978755,0.0006036449,0.00055646064,0.00020292262,0.00024685066,0.0005146051],"domain_scores_gemma":[0.9981247,0.00022153751,0.00020555261,0.0004714391,0.0001649837,0.000811789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029650205,0.00016894082,0.0007418013,0.00031854995,0.0002676483,0.000041660576,0.00016633948,0.00025890765,0.000002380308],"category_scores_gemma":[0.0014521029,0.00012286963,0.00026397256,0.0002035972,0.00028291252,0.00006962757,0.0000187699,0.0008491242,0.000010394395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055956778,0.0000015627708,0.92210925,0.00006702634,0.00016324551,0.000105862724,0.0005395827,0.000046709214,0.000018825618,0.0006623647,0.00023514949,0.0759945],"study_design_scores_gemma":[0.001447949,0.00030291127,0.97146726,0.00014536698,0.00010182918,0.00074087316,0.0002141135,0.000005508302,0.000047872323,0.0010882227,0.024325423,0.00011264596],"about_ca_topic_score_codex":0.007584185,"about_ca_topic_score_gemma":0.014278678,"teacher_disagreement_score":0.07588185,"about_ca_system_score_codex":0.00020245345,"about_ca_system_score_gemma":0.00097218336,"threshold_uncertainty_score":0.9990244},"labels":[],"label_agreement":null},{"id":"W2034306651","doi":"10.1016/j.cjca.2015.04.007","title":"Cardiovascular Risk Factors and In-hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Canadian VIGOUR Centre; University of Alberta Hospital; McGill University Health Centre; Vancouver General Hospital; University of British Columbia; Canadian Heart Research Centre; University of Toronto; Toronto General Hospital; St. Michael's Hospital","funders":"Heart and Stroke Foundation of Canada; Sanofi","keywords":"Medicine; Acute coronary syndrome; Myocardial infarction; Logistic regression; Risk factor; Internal medicine; Statin; Emergency medicine; Framingham Risk Score; Intensive care medicine; Cardiology; Disease","score_opus":0.020265537215141648,"score_gpt":0.2539307930622109,"score_spread":0.23366525584706924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034306651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98305583,0.014171067,0.00003601714,0.00037970854,0.0008790501,0.0004632846,0.00060620747,0.0000033221872,0.0004054925],"genre_scores_gemma":[0.9983827,0.001064428,0.000054438362,0.00011532416,0.00029224597,0.0000062568715,0.000058931935,0.000020816553,0.0000048680035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972844,0.00064873695,0.0006950624,0.00031943884,0.00050051586,0.0005518596],"domain_scores_gemma":[0.99697673,0.000051181014,0.00025744239,0.0007854343,0.00027684667,0.0016523828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010871694,0.00027022176,0.0014976173,0.00024244332,0.000100772566,0.000014415067,0.0003366808,0.0003771743,0.00000482598],"category_scores_gemma":[0.00023237744,0.00019554915,0.0006846835,0.00033173183,0.00034832428,0.00013340794,0.000036742054,0.000737985,0.0000018777887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008097023,0.000006180453,0.9842719,0.00001316858,0.005788685,0.007473905,0.00046243393,0.0004464316,0.0000012915832,0.000018177621,0.00055632286,0.0008805559],"study_design_scores_gemma":[0.0023723762,0.0004530639,0.985435,0.00011797559,0.001426375,0.0028030165,0.00078457827,0.00000768574,0.0000043860596,0.0005300521,0.0058938838,0.00017162247],"about_ca_topic_score_codex":0.7806133,"about_ca_topic_score_gemma":0.72290194,"teacher_disagreement_score":0.057711415,"about_ca_system_score_codex":0.0015644883,"about_ca_system_score_gemma":0.007890652,"threshold_uncertainty_score":0.9977337},"labels":[],"label_agreement":null},{"id":"W2034588349","doi":"10.1016/j.jacl.2010.01.005","title":"When is equal not equal?","year":2010,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Royal Victoria Regional Health Centre; McGill University Health Centre; Royal Victoria Hospital","funders":"","keywords":"Medicine; Apolipoprotein B; Converse; Cholesterol; Hazard ratio; Disease; Hazard; Internal medicine; Lipoprotein; Confidence interval; Biology","score_opus":0.28010152918002335,"score_gpt":0.5100878414208259,"score_spread":0.22998631224080252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034588349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003692508,0.9795424,0.0007799233,0.0018224376,0.016008904,0.0006579205,0.000023878354,0.000017790882,0.0011098178],"genre_scores_gemma":[0.000012309507,0.9315821,0.003244153,0.0046571656,0.059689917,0.00001020031,0.000013431648,0.00008317894,0.00070756703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904038,0.0016660545,0.0059115067,0.00048638473,0.0009829781,0.0005493035],"domain_scores_gemma":[0.99117434,0.0023906704,0.00378676,0.0011576777,0.000588286,0.00090228097],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01210827,0.00048428608,0.009743629,0.00025692594,0.000058907768,0.000022713984,0.0005679871,0.00268301,0.0010749137],"category_scores_gemma":[0.006258039,0.000298952,0.0075967945,0.00017095344,0.0003011767,0.00007334927,0.00017124349,0.0068840147,0.0004018385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019248121,0.00025429105,0.000022342536,0.0051354114,0.0013471899,0.0001521832,0.000023952103,1.1936122e-8,2.692826e-7,0.00025279287,0.02650105,0.96611804],"study_design_scores_gemma":[0.0019874368,0.002234632,0.00003100082,0.004855354,0.004740895,0.005247264,0.0000043326554,6.790787e-7,7.4244895e-7,0.0007455317,0.97990865,0.00024350813],"about_ca_topic_score_codex":0.000012451368,"about_ca_topic_score_gemma":0.00000453605,"teacher_disagreement_score":0.9658745,"about_ca_system_score_codex":0.00007238307,"about_ca_system_score_gemma":0.0035552825,"threshold_uncertainty_score":0.99994624},"labels":[],"label_agreement":null},{"id":"W2034776370","doi":"10.1093/eurheartj/ehn346","title":"Discontinuation of statin therapy following an acute myocardial infarction: a population-based study","year":2008,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Statin; Hazard ratio; Discontinuation; Myocardial infarction; Internal medicine; Cohort; Population; Proportional hazards model; Medical prescription; Cohort study; Confidence interval; Pharmacology","score_opus":0.048958598438493525,"score_gpt":0.3261254695084405,"score_spread":0.277166871069947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034776370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761957,0.00020000614,0.00077046524,0.00029127873,0.00030799588,0.000497907,0.0000023993598,0.000031803516,0.00027857316],"genre_scores_gemma":[0.99706334,0.000044676868,0.0014369301,0.00035196287,0.0009871162,0.000003631905,0.000019794421,0.00003616136,0.000056399862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977406,0.0008202824,0.00040859586,0.00016409945,0.0006890483,0.00017734744],"domain_scores_gemma":[0.9992188,0.000019339363,0.00014007001,0.00031148634,0.00012226269,0.00018802413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001593269,0.00011870708,0.00034296155,0.00013351532,0.0003002265,0.000026526432,0.0000576713,0.000020564496,0.00005063042],"category_scores_gemma":[0.000047856574,0.00009364799,0.00037596628,0.00017394817,0.000014653864,0.00018791287,0.0000102158165,0.00027045258,0.000009537793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002802816,0.00053923344,0.9812676,0.000004878593,0.0005187922,0.00035260827,0.0015014358,0.00015353416,0.0012191099,0.000002156297,0.00020910267,0.013951304],"study_design_scores_gemma":[0.0039131767,0.002293338,0.99146515,0.00003857785,0.00010176547,0.00045128525,0.00024940932,0.00006643433,0.00009082374,0.0000027743886,0.0012384474,0.000088795656],"about_ca_topic_score_codex":0.000088143934,"about_ca_topic_score_gemma":0.0000044498647,"teacher_disagreement_score":0.013862509,"about_ca_system_score_codex":0.000051648578,"about_ca_system_score_gemma":0.00017142778,"threshold_uncertainty_score":0.3818854},"labels":[],"label_agreement":null},{"id":"W2034800204","doi":"10.1016/s0828-282x(06)70979-5","title":"Introduction to the symposium: Advances in Vascular Biology","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine","score_opus":0.005194996905357373,"score_gpt":0.2280750616002605,"score_spread":0.22288006469490312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034800204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6794962,0.077068195,0.03081396,0.1775535,0.007927371,0.0015127214,0.00002490176,0.000020270309,0.025582839],"genre_scores_gemma":[0.9852877,0.00069258484,0.00018959113,0.000541188,0.013217993,0.000008021856,0.0000058300593,0.000010476965,0.00004656459],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.998917,0.00021147972,0.00032102765,0.00013929342,0.00009947045,0.00031172746],"domain_scores_gemma":[0.9991972,0.00001875759,0.0000698161,0.0002899158,0.00017006801,0.00025425927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011074772,0.00008586612,0.0004524945,0.00031278143,0.000060493792,0.0000071648183,0.00011285555,0.00009841757,0.000014692299],"category_scores_gemma":[0.00011179504,0.000056514993,0.00025432731,0.00025126943,0.00008139113,0.000051084764,0.0000063445377,0.0002712644,0.000014944008],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003924562,0.000023895558,0.37705207,0.0002057711,0.0012367785,0.001193551,0.0006124015,0.13936532,0.0057118055,0.020085113,0.22501959,0.22910126],"study_design_scores_gemma":[0.00048277355,0.0002486393,0.07034316,0.000015508287,0.000057359503,0.0007750809,0.000056480836,0.0000025573406,0.000054862416,0.00036167525,0.9275484,0.00005350889],"about_ca_topic_score_codex":0.0035732456,"about_ca_topic_score_gemma":0.009308845,"teacher_disagreement_score":0.70252883,"about_ca_system_score_codex":0.00021467666,"about_ca_system_score_gemma":0.00072489074,"threshold_uncertainty_score":0.5401702},"labels":[],"label_agreement":null},{"id":"W2035099895","doi":"10.1194/jlr.m800027-jlr200","title":"Plasma PCSK9 preferentially reduces liver LDL receptors in mice","year":2008,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"PCSK9; LDL receptor; Receptor; Chemistry; Internal medicine; Endocrinology; Biochemistry; Cholesterol; Biology; Medicine; Lipoprotein","score_opus":0.11090230728134726,"score_gpt":0.3631126001877802,"score_spread":0.25221029290643293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035099895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99113846,0.0018722545,0.000013529682,0.0016240297,0.00051253015,0.00032330395,9.160242e-7,0.0000071382533,0.0045078504],"genre_scores_gemma":[0.98615783,0.007242694,0.0011247343,0.000050501218,0.0028422028,0.0000065692125,0.0000015253091,0.000024298748,0.0025496113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99623793,0.0005521306,0.00058630446,0.00018245749,0.0019651162,0.00047604533],"domain_scores_gemma":[0.9983052,0.00013488691,0.0001361789,0.00024718005,0.00082283164,0.00035372213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043490287,0.000109238295,0.0004729005,0.0006810648,0.00013587625,0.000021280555,0.00023501371,0.00014362573,0.00037134194],"category_scores_gemma":[0.0006447323,0.000079303834,0.0002826854,0.00059729913,0.00015508669,0.0001676832,0.0000753868,0.0014447205,0.00007315216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012193831,0.004884446,0.059489805,0.0019823664,0.0021372775,0.008557069,0.013726138,0.00015755264,0.11955946,0.00023877811,0.23708847,0.5399848],"study_design_scores_gemma":[0.014590678,0.0065386673,0.16930191,0.0025038042,0.00012400078,0.010662846,0.002302502,0.00019030683,0.18174541,0.00009349629,0.61145175,0.00049464905],"about_ca_topic_score_codex":0.00018989647,"about_ca_topic_score_gemma":0.000032568823,"teacher_disagreement_score":0.53949016,"about_ca_system_score_codex":0.00025630806,"about_ca_system_score_gemma":0.0012357399,"threshold_uncertainty_score":0.62766725},"labels":[],"label_agreement":null},{"id":"W2035256553","doi":"10.1097/hco.0b013e32832ebf92","title":"When statin therapy stops: implications for the patient","year":2009,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Discontinuation; Statin; Myocardial infarction; Disease; Intensive care medicine; Stroke (engine); Internal medicine; Physical therapy","score_opus":0.18548718006548273,"score_gpt":0.4437878992943537,"score_spread":0.258300719228871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035256553","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013791412,0.9859805,0.003013449,0.0008052862,0.0037001402,0.006137189,0.0002185402,0.000035397603,0.00010813492],"genre_scores_gemma":[0.000008138549,0.9925338,0.0001752351,0.00009485,0.002437092,0.0037813126,0.00091639726,0.00004197246,0.000011214086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976813,0.00043696637,0.0007636886,0.0005299215,0.00017741295,0.00041071884],"domain_scores_gemma":[0.9979863,0.00040021032,0.00026433874,0.0011142609,0.00013331026,0.000101558515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007739516,0.00034762124,0.0020792899,0.00016812442,0.00011121497,0.000013717069,0.00023167409,0.0002924218,0.000009764944],"category_scores_gemma":[0.00011496392,0.0002031868,0.0014478111,0.00021018082,0.00007463973,0.000020065248,0.000046088368,0.00058196054,0.000013342699],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015321313,0.00004483229,0.000033929588,0.0040126145,0.00026166832,3.2523545e-7,0.00005703606,0.0000031257275,1.9253772e-8,0.00058312743,0.016028037,0.97896],"study_design_scores_gemma":[0.0007276386,0.00033664482,0.00068742805,0.0033007734,0.00025441148,0.00013622835,0.000017944842,0.0000020983055,2.9812156e-8,0.0003918353,0.9939587,0.00018625686],"about_ca_topic_score_codex":0.000012970926,"about_ca_topic_score_gemma":6.3684087e-7,"teacher_disagreement_score":0.9787737,"about_ca_system_score_codex":0.00023644963,"about_ca_system_score_gemma":0.00066864653,"threshold_uncertainty_score":0.82857174},"labels":[],"label_agreement":null},{"id":"W2035355827","doi":"10.1007/s10238-001-8022-3","title":"Effect of low-density lipoprotein buoyant density and cholesterol content on the formation of lipoprotein(a) particles","year":2001,"lang":"en","type":"article","venue":"Clinical and Experimental Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Apolipoprotein B; Lipoprotein; Chemistry; Cholesterol; Low-density lipoprotein; Lipoprotein(a); Lipoprotein particle; Intermediate-density lipoprotein; Covalent bond; Biochemistry; Internal medicine; Very low-density lipoprotein; Medicine; Organic chemistry","score_opus":0.05235672860571391,"score_gpt":0.34229283035381863,"score_spread":0.28993610174810475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035355827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99387586,0.0018040783,0.00006934017,0.0026774195,0.00012548789,0.001305972,0.0000014372042,0.000017286671,0.0001231004],"genre_scores_gemma":[0.99830174,0.0005181091,0.000036326986,0.00075942406,0.00029813783,0.000044060358,0.000004596173,0.000010926743,0.000026664195],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981134,0.00031424063,0.00069232803,0.0002566466,0.0004395888,0.00018379933],"domain_scores_gemma":[0.99882007,0.00027686832,0.00020031548,0.0003974609,0.00007786779,0.00022740866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021547033,0.00017408794,0.00079870236,0.000038492497,0.00008585955,0.0000047669687,0.000056293076,0.00010827387,0.000024329653],"category_scores_gemma":[0.0004951863,0.000089030545,0.00014971606,0.000090877475,0.0007401014,0.000054363925,0.00007146221,0.0002267602,0.0000031739128],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015688794,0.0017557871,0.059276268,0.0021436755,0.00053399865,0.00011810618,0.0024462931,0.0000010541116,0.30041885,0.000787454,0.00036769235,0.616462],"study_design_scores_gemma":[0.008075484,0.012873397,0.11757809,0.0012582996,0.00016984814,0.00017797931,0.0008167626,0.00025022848,0.858477,0.000052332107,0.00016336478,0.000107211745],"about_ca_topic_score_codex":0.0006562266,"about_ca_topic_score_gemma":0.000016290423,"teacher_disagreement_score":0.6163548,"about_ca_system_score_codex":0.00001729469,"about_ca_system_score_gemma":0.000015217948,"threshold_uncertainty_score":0.36305603},"labels":[],"label_agreement":null},{"id":"W2035380893","doi":"10.7326/0003-4819-158-12-201306180-00004","title":"Statin Toxicity From Macrolide Antibiotic Coprescription","year":2013,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Canadian Institutes of Health Research","keywords":"Clarithromycin; Medicine; Azithromycin; Erythromycin; Rhabdomyolysis; Statin; Internal medicine; Relative risk; Atorvastatin; Population; Adverse effect; Pharmacology; Gastroenterology; Confidence interval; Antibiotics","score_opus":0.03953436323036993,"score_gpt":0.3244158554487694,"score_spread":0.2848814922183995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035380893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806902,0.002376683,0.0010690993,0.008270503,0.00032822543,0.00045750645,0.000015612708,0.00003524171,0.00675693],"genre_scores_gemma":[0.99096066,0.000594423,0.0005320173,0.006394424,0.0008402504,0.000007560402,0.000027926813,0.00001936329,0.00062337826],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99830234,0.00007488591,0.00052331,0.00023511531,0.00060312665,0.00026123345],"domain_scores_gemma":[0.9986616,0.000059712216,0.00017598743,0.0004374963,0.00040090294,0.00026433112],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044569015,0.00015465078,0.0005960589,0.00011455526,0.000025739966,0.00000760905,0.000121268735,0.00007895365,0.0015561663],"category_scores_gemma":[0.00038294803,0.000106617525,0.00017435955,0.000119293996,0.00014067497,0.00010477746,0.000040447194,0.0002205399,0.00013214452],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009907577,0.0005878414,0.06949251,0.0008434914,0.0016019515,0.00023216369,0.0016629107,0.0000052683145,0.420236,0.0005433725,0.17724313,0.32656062],"study_design_scores_gemma":[0.004004071,0.0030067493,0.6655117,0.003583171,0.00021075807,0.00013603085,0.0007961722,0.00039108912,0.30863816,0.0028090815,0.010664489,0.0002485235],"about_ca_topic_score_codex":0.023437357,"about_ca_topic_score_gemma":0.00004054194,"teacher_disagreement_score":0.5960192,"about_ca_system_score_codex":0.000020964118,"about_ca_system_score_gemma":0.000044081375,"threshold_uncertainty_score":0.99935657},"labels":[],"label_agreement":null},{"id":"W2035721719","doi":"10.1046/j.1440-1681.2002.03733.x","title":"Old and new risk factors for atherosclerosis and development of treatment recommendations","year":2002,"lang":"en","type":"review","venue":"Clinical and Experimental Pharmacology and Physiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Ethnic group; Abdominal obesity; Obesity; Medicine; Waist; Risk factor; Familial hypercholesterolemia; Population; Genetic predisposition; Chinese population; Environmental health; Demography; Gerontology; Internal medicine; Cholesterol; Genetics; Genotype; Disease; Biology; Gene","score_opus":0.22832257777466577,"score_gpt":0.46533280872081717,"score_spread":0.2370102309461514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035721719","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19337495,0.80517805,0.00000814743,0.00005257899,0.0002565663,0.0010484416,0.00006103941,0.000009883512,0.000010342333],"genre_scores_gemma":[0.006519111,0.9916769,0.00091994024,0.0001560106,0.00029654583,0.00017430927,0.00011237059,0.00002004708,0.00012475133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841934,0.00022212228,0.00064144627,0.00048472182,0.000034503657,0.00019788853],"domain_scores_gemma":[0.9989015,0.00044649295,0.00022972701,0.000113228336,0.00001492055,0.0002941473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019984464,0.00029125472,0.0017685207,0.000047487538,0.0001791815,0.0000044853855,0.00003173883,0.00034728684,0.000097307275],"category_scores_gemma":[0.000016179529,0.000193801,0.00023347697,0.00003264243,0.00035675796,0.000022784372,0.00008361128,0.00020200301,0.0000013437711],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116651856,0.00039659426,0.00041050478,0.0015947971,0.0014553677,3.7081983e-7,0.00050859805,2.2077392e-8,0.00021078419,0.000017668297,0.0005113618,0.99477726],"study_design_scores_gemma":[0.0047090487,0.0028069133,0.0019997242,0.00042513153,0.0018250658,0.000024850266,0.00016339487,0.000008547987,0.00045523446,0.000027463908,0.98731285,0.00024176946],"about_ca_topic_score_codex":0.00005997637,"about_ca_topic_score_gemma":0.0000018382606,"teacher_disagreement_score":0.9945355,"about_ca_system_score_codex":0.0000311788,"about_ca_system_score_gemma":0.00010768366,"threshold_uncertainty_score":0.7902975},"labels":[],"label_agreement":null},{"id":"W2035937593","doi":"10.1503/cmaj.1050121","title":"Questioning the benefits of statins","year":2005,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Dyslipidemia; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Alternative medicine; Medicine; Reflection (computer programming); Family medicine; Computer science; Statin; Pathology; Internal medicine","score_opus":0.009595965568063174,"score_gpt":0.23909530030723997,"score_spread":0.2294993347391768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035937593","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002375064,0.0025277326,0.00004022654,0.99045116,0.0008118371,0.0002314269,0.000067695684,0.000010622185,0.0034842382],"genre_scores_gemma":[0.0030894761,0.0011900512,0.000177695,0.95104545,0.04214914,0.0000101413,0.0000902405,0.00004043304,0.00220734],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99509656,0.00031799226,0.00062496244,0.00015142276,0.0032729523,0.0005360986],"domain_scores_gemma":[0.9975043,0.00017043491,0.00048723398,0.0002532453,0.0007568829,0.0008279034],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003205747,0.00016094673,0.0005023089,0.00019549941,0.00026089497,0.00004936365,0.00021684096,0.0012549767,0.0023242002],"category_scores_gemma":[0.002032248,0.000110528556,0.0003771055,0.00019610171,0.00004763132,0.00004545278,0.000012047946,0.005233961,0.0000622307],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000017480019,0.0000054180996,0.001208806,0.000044000968,0.00031846657,0.0003580674,0.000104892904,0.0000050002313,1.0625418e-7,0.00003667433,0.9088157,0.089101106],"study_design_scores_gemma":[0.0005342231,0.000054905588,0.00889193,0.00046649523,0.00017725832,0.0013532158,0.00005603107,0.00002457979,0.000002208255,0.00002285351,0.9883174,0.00009893373],"about_ca_topic_score_codex":0.008475722,"about_ca_topic_score_gemma":0.014491926,"teacher_disagreement_score":0.08900218,"about_ca_system_score_codex":0.0015384145,"about_ca_system_score_gemma":0.009339701,"threshold_uncertainty_score":0.9985878},"labels":[],"label_agreement":null},{"id":"W2035982665","doi":"10.1016/s0002-9149(01)02151-8","title":"Treating lipid abnormalities in patients with type 2 diabetes mellitus","year":2001,"lang":"en","type":"review","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Fenofibrate; Diabetes mellitus; Internal medicine; Type 2 Diabetes Mellitus; Type 2 diabetes; Lipid profile; Macrovascular disease; Cholesterol; Lipoprotein; Disease; Endocrinology; Placebo; Cardiology; Pathology","score_opus":0.018031619159253616,"score_gpt":0.28316604939984724,"score_spread":0.26513443024059363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035982665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050397314,0.9483074,0.000015625508,0.000040027422,0.00020732943,0.00041566303,0.0000053195786,0.0000069209136,0.00060442823],"genre_scores_gemma":[0.009519185,0.9885143,0.00012195522,0.00012052516,0.0016261024,0.000011692131,0.000014780604,0.00004712275,0.000024355695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99713004,0.0010915358,0.0007999884,0.00017397868,0.00039651187,0.00040794452],"domain_scores_gemma":[0.9977331,0.00023729618,0.001129234,0.000507021,0.00026712043,0.00012620303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013215658,0.00030129476,0.0044111866,0.00026372232,0.000045904075,0.000010022977,0.00022859719,0.00009017855,0.000008062146],"category_scores_gemma":[0.00011871502,0.00014314415,0.0008571124,0.0006330038,0.00034667735,0.000039244238,0.000038743085,0.00079202914,0.000006512663],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017351916,0.000016554124,0.009614874,0.00088402285,0.0015423911,0.00008458879,0.00005789759,0.000013453197,1.5946164e-8,0.0000039080164,0.00006738373,0.9875414],"study_design_scores_gemma":[0.0011202258,0.0050150272,0.01437844,0.0062354784,0.0031858152,0.001493243,0.00026688018,2.9981408e-7,1.5923293e-7,0.000007952811,0.9680644,0.00023206616],"about_ca_topic_score_codex":0.000050646046,"about_ca_topic_score_gemma":0.0000013137743,"teacher_disagreement_score":0.98730934,"about_ca_system_score_codex":0.00018676846,"about_ca_system_score_gemma":0.0005298857,"threshold_uncertainty_score":0.5837249},"labels":[],"label_agreement":null},{"id":"W2036075350","doi":"10.1097/mol.0b013e32835111d8","title":"Lipoprotein(a)","year":2012,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"Canadian Institutes of Health Research","keywords":"Lipoprotein(a); Mendelian randomization; Mechanism (biology); Lipoprotein; Medicine; Apolipoprotein B; Pathogenesis; Risk factor; Disease; Internal medicine; Endocrinology; Cholesterol; Biology; Biochemistry; Gene","score_opus":0.2181485786523582,"score_gpt":0.4393749560159972,"score_spread":0.22122637736363898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036075350","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.144817e-7,0.89871037,0.000082054365,0.00006361412,0.09816623,0.002292085,0.000018061182,0.00007260263,0.0005946641],"genre_scores_gemma":[7.400475e-7,0.9201326,0.00015014384,0.000021637446,0.07828661,0.00076502975,0.0004781637,0.00008184853,0.00008323687],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99656665,0.000593633,0.0010253005,0.00063602126,0.00039748542,0.00078090624],"domain_scores_gemma":[0.99807864,0.00009397513,0.0003267164,0.0011081711,0.00006101836,0.00033149126],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001161722,0.00053062494,0.0032139844,0.00056923804,0.000047820806,0.000011178695,0.00022835465,0.000748507,0.00030661648],"category_scores_gemma":[0.00013091473,0.00041453753,0.0011663332,0.0005367611,0.000105789084,0.0000635937,0.00017073925,0.0014662484,0.00080475945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009099513,0.00018835739,0.000033758603,0.07926081,0.00010079133,2.0052232e-7,0.000022755139,3.441392e-8,1.15521095e-8,0.0006816485,0.0064201034,0.91328245],"study_design_scores_gemma":[0.00061539205,0.00012181589,0.00008587633,0.023713304,0.00046860645,0.0004858683,0.000004372203,6.29695e-7,2.3440021e-8,0.000032524396,0.9741428,0.00032880367],"about_ca_topic_score_codex":0.00004336792,"about_ca_topic_score_gemma":0.0000021796818,"teacher_disagreement_score":0.96772265,"about_ca_system_score_codex":0.00030718325,"about_ca_system_score_gemma":0.00070512004,"threshold_uncertainty_score":0.99997324},"labels":[],"label_agreement":null},{"id":"W2036088862","doi":"10.1097/ede.0b013e31829eef0a","title":"Statin Use and Fracture Risk","year":2013,"lang":"en","type":"review","venue":"Epidemiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Confounding; Observational study; Medicine; Relative risk; Information bias; Confidence interval; Statin; Selection bias; Meta-analysis; Randomized controlled trial; Internal medicine; Pathology","score_opus":0.14684506924110197,"score_gpt":0.407626784583187,"score_spread":0.26078171534208505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036088862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048528327,0.9968716,0.000790016,0.00038593676,0.00017329914,0.0015229456,0.000048035115,0.00004717934,0.00011247151],"genre_scores_gemma":[0.0000018963856,0.9904283,0.005390249,0.0022570263,0.0008603056,0.00019640227,0.00020888945,0.000054738593,0.0006021919],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99585176,0.002240968,0.00081818114,0.0005508938,0.000100522986,0.0004376934],"domain_scores_gemma":[0.9957369,0.0025194315,0.00053194736,0.0008356502,0.000059659116,0.00031639647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025807722,0.0003663288,0.0044043516,0.00010862174,0.000066842884,0.000007441424,0.00007467701,0.0008377638,0.00022530078],"category_scores_gemma":[0.006473393,0.00021842185,0.0007325746,0.000091134876,0.00010979775,0.00004566256,0.000066207795,0.0012052407,0.00023663683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002820114,0.0000109156945,0.00054821663,0.0077705914,0.0004597148,0.000019679595,0.000010321367,1.970604e-7,5.5136775e-9,0.00011745914,0.019822046,0.971238],"study_design_scores_gemma":[0.00021817083,0.000120659264,0.0012018004,0.0023713238,0.0015219057,0.0005926459,0.0000035153753,0.000004443303,1.7987237e-8,0.0003081916,0.9934845,0.0001728121],"about_ca_topic_score_codex":0.0017088093,"about_ca_topic_score_gemma":0.000009622726,"teacher_disagreement_score":0.9736625,"about_ca_system_score_codex":0.00006673806,"about_ca_system_score_gemma":0.00022717446,"threshold_uncertainty_score":0.89069843},"labels":[],"label_agreement":null},{"id":"W2036304437","doi":"10.1097/mol.0000000000000114","title":"PCSK9 and LDLR degradation","year":2014,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":363,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"PCSK9; Proprotein convertase; Kexin; LDL receptor; Cholesterol; Sterol regulatory element-binding protein; Apolipoprotein B; Lipoprotein; Biology; Endocrinology; Cell biology; Lipidology; Internal medicine; Chemistry; Medicine; Sterol","score_opus":0.14162422646524078,"score_gpt":0.42824137708230564,"score_spread":0.28661715061706483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036304437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000030498431,0.9626591,0.00038284203,0.000099780606,0.035536326,0.0011262331,0.00000845838,0.000034471224,0.00014972911],"genre_scores_gemma":[0.0000011985979,0.97907996,0.00013252105,0.000027399297,0.019944673,0.00020567834,0.00052777503,0.000035970053,0.000044811113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99783045,0.0004823171,0.00066429994,0.0005121318,0.00020603306,0.00030473876],"domain_scores_gemma":[0.9989402,0.00012079698,0.00022752825,0.00051938294,0.00004373457,0.00014832609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087044504,0.00030159435,0.002057697,0.00035252463,0.000037820853,0.000011105562,0.00009115753,0.00040638875,0.000039406186],"category_scores_gemma":[0.00019792163,0.0002350757,0.00037209483,0.0002350932,0.00008191799,0.000033365355,0.0000824645,0.00065754977,0.00007845012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005286876,0.00004203554,0.00006136144,0.053621437,0.0000444768,6.966454e-8,0.000011835212,4.4148273e-8,1.6418682e-8,0.0009259782,0.0062174983,0.93907],"study_design_scores_gemma":[0.00060976035,0.00013108434,0.00013808026,0.01696063,0.00020618086,0.00025306444,0.000003575616,0.0000066443276,1.8216742e-8,0.000055916145,0.9814519,0.00018312747],"about_ca_topic_score_codex":0.000020499445,"about_ca_topic_score_gemma":0.0000021993148,"teacher_disagreement_score":0.9752344,"about_ca_system_score_codex":0.00011271568,"about_ca_system_score_gemma":0.00030221615,"threshold_uncertainty_score":0.9586109},"labels":[],"label_agreement":null},{"id":"W2036394293","doi":"10.1016/j.amjcard.2008.07.035","title":"Longitudinal Evaluation and Assessment of Cardiovascular Disease in Patients With Homozygous Familial Hypercholesterolemia","year":2008,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"National Center for Research Resources","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Cardiology; Coronary artery disease; Regurgitation (circulation); Stenosis; Disease; Aortic valve; Cholesterol","score_opus":0.022118323999444772,"score_gpt":0.2891733368307203,"score_spread":0.26705501283127553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036394293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962327,0.0020608115,0.0010163151,0.00012248101,0.0000618167,0.00039108453,0.00000399924,0.0000025759261,0.00010822244],"genre_scores_gemma":[0.9982656,0.000969132,0.00044011587,0.00006788842,0.00023065477,0.000009707231,0.0000033090578,0.000012557692,0.0000010306478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775064,0.00068206066,0.00036244057,0.00015241498,0.00087636424,0.00017606096],"domain_scores_gemma":[0.99866295,0.000045404693,0.00026765894,0.00043470977,0.00045067983,0.00013857099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017312887,0.00011758316,0.0009912945,0.00012963169,0.00004718251,0.0000025614452,0.00008836798,0.000024287565,0.0000013338012],"category_scores_gemma":[0.00007158317,0.00006781583,0.0003533313,0.00019356204,0.0005121402,0.00005112827,0.000029294628,0.00029791778,2.2424082e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011674595,0.000045768153,0.9355525,0.000022166356,0.0014613122,0.00020614931,0.000089536545,0.006781104,0.000009374876,0.000003345348,0.000008046307,0.054653287],"study_design_scores_gemma":[0.0037424096,0.0020688681,0.9913559,0.000056850204,0.001188946,0.0010485279,0.00008670864,0.00008827611,0.0000030124356,0.00001184805,0.00028367835,0.00006498266],"about_ca_topic_score_codex":0.00013041482,"about_ca_topic_score_gemma":0.000001087198,"teacher_disagreement_score":0.05580344,"about_ca_system_score_codex":0.00011288439,"about_ca_system_score_gemma":0.000497572,"threshold_uncertainty_score":0.27654493},"labels":[],"label_agreement":null},{"id":"W2036440924","doi":"10.1185/03007995.2013.856287","title":"Statin–fibrate combination therapy is safe and effective in normalizing lipid profile and in keeping cardiovascular event rates low","year":2013,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Fibrate; Medicine; Cardiovascular event; Statin; Lipid profile; Dyslipidemia; Cardiology; Internal medicine; Intensive care medicine; Pharmacology; Cholesterol; Disease","score_opus":0.05354596407779159,"score_gpt":0.3889355457778891,"score_spread":0.33538958170009747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036440924","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52092195,0.30181295,0.0003493429,0.16450664,0.0011086678,0.010974887,0.000040311912,0.000041984313,0.00024329122],"genre_scores_gemma":[0.24272391,0.71896744,0.000116940304,0.02600973,0.007127006,0.003191712,0.001562945,0.00017134355,0.00012894756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994367,0.001315215,0.0004880813,0.00075805065,0.0022933218,0.0007783382],"domain_scores_gemma":[0.99839073,0.0005019123,0.000072699106,0.000366407,0.0002453601,0.0004228975],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0054861936,0.000298276,0.00093249045,0.00058902975,0.00013832035,0.0000924448,0.000105656116,0.00056806573,0.0000719383],"category_scores_gemma":[0.00066272845,0.00023304053,0.00014928599,0.0003998682,0.000327214,0.00016478055,0.00019510619,0.0033670259,0.000008755891],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001999309,0.00017831809,0.0054203477,0.007217305,0.00024345862,0.00013721101,0.0007035081,3.642059e-7,0.000014054244,0.000024664128,0.028528273,0.95733255],"study_design_scores_gemma":[0.016161345,0.0022431514,0.1276254,0.021415683,0.00004245447,0.000139969,0.0002640539,0.00416903,0.0005498659,0.00050982187,0.8261583,0.00072094647],"about_ca_topic_score_codex":0.0012248966,"about_ca_topic_score_gemma":0.000015247848,"teacher_disagreement_score":0.95661163,"about_ca_system_score_codex":0.00019189178,"about_ca_system_score_gemma":0.00044001642,"threshold_uncertainty_score":0.99893224},"labels":[],"label_agreement":null},{"id":"W2037010020","doi":"10.1016/j.cjca.2013.07.680","title":"Characteristics and Evidence-Based Management of Stable Coronary Artery Disease Patients in Canada Compared With the Rest of the World: Insights From the CLARIFY Registry","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Vancouver General Hospital; University of British Columbia; Montreal Heart Institute; McGill University Health Centre; Université Laval; Queen Elizabeth II Health Sciences Centre; Université de Montréal; St. Michael's Hospital; Dalhousie University; University of Toronto","funders":"","keywords":"Medicine; Guideline; Coronary artery disease; Percutaneous coronary intervention; Body mass index; Internal medicine; Observational study; Cohort; Risk factor; Emergency medicine; Intensive care medicine; Cardiology; Physical therapy; Myocardial infarction","score_opus":0.015346196282131325,"score_gpt":0.20312646188345385,"score_spread":0.18778026560132252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037010020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916777,0.0029890928,0.000026015066,0.0044779363,0.00017785873,0.0004833823,0.000049411905,4.90566e-7,0.00011812144],"genre_scores_gemma":[0.99875754,0.00015973893,0.000022988548,0.00088697847,0.00012478897,0.000009596441,0.000007569256,0.000007795441,0.000023008688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987973,0.00030582014,0.00034077794,0.00009966667,0.00027735124,0.00017907837],"domain_scores_gemma":[0.99858993,0.00013530061,0.00028499722,0.0004896727,0.00022507309,0.00027499883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022972278,0.0000951615,0.00042454837,0.00005416749,0.00007165496,0.000008301358,0.00021169952,0.000040503848,0.000008729888],"category_scores_gemma":[0.000049257174,0.00004409407,0.00008863869,0.00015147594,0.00023425122,0.000043958433,0.0000190448,0.00036711546,1.7368349e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018785792,0.0000037906557,0.99374413,0.00009139671,0.0003023403,0.00020099162,0.00006164566,0.0002633917,0.00000584062,0.000027461625,0.0036406326,0.0014705439],"study_design_scores_gemma":[0.00088648516,0.00006749234,0.99213505,0.00089599384,0.00022323825,0.00002173105,0.00033160206,0.000024067613,0.000006998313,0.000023814717,0.005337739,0.00004580818],"about_ca_topic_score_codex":0.61761713,"about_ca_topic_score_gemma":0.8083692,"teacher_disagreement_score":0.19075206,"about_ca_system_score_codex":0.00026662997,"about_ca_system_score_gemma":0.003915627,"threshold_uncertainty_score":0.6946154},"labels":[],"label_agreement":null},{"id":"W2037150431","doi":"10.1038/labinvest.3780331","title":"Advances in Experimental Dyslipidemia and Atherosclerosis","year":2001,"lang":"en","type":"review","venue":"Laboratory Investigation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Dyslipidemia; Medicine; Cardiology; Internal medicine; Arteriosclerosis; Obesity","score_opus":0.041141309397977194,"score_gpt":0.3343891358020324,"score_spread":0.2932478264040552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037150431","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027903304,0.9956852,0.000005073878,0.000029922232,0.00014844773,0.0009713593,0.000013794441,0.000048833546,0.00030702096],"genre_scores_gemma":[0.00013610114,0.9983884,0.00037061214,0.00027590143,0.00038595093,0.00027093664,0.00009400621,0.000048805294,0.000029296849],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840873,0.00023762627,0.00047913985,0.00039579414,0.00027222582,0.00020646503],"domain_scores_gemma":[0.9991735,0.00003052637,0.00018925045,0.00035377668,0.000047823367,0.00020513062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047002637,0.0002783694,0.0011770044,0.00016079478,0.000050232775,0.000020604204,0.00005220017,0.00031286487,0.000022707814],"category_scores_gemma":[0.00007623943,0.00023184213,0.00014370072,0.0006680878,0.000111448455,0.00020227987,0.000026221362,0.00034388897,0.000020219886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000043198816,0.000036783473,0.00093521393,0.012387988,0.00004248514,0.000013684141,0.0001447548,2.9591175e-7,0.000035976464,0.00025299744,0.00010547563,0.98604],"study_design_scores_gemma":[0.00043002528,0.000080586,0.00025448352,0.011499214,0.00020458642,0.000017703745,0.000060252954,0.0000026853795,0.00007240103,0.000030313417,0.9871376,0.0002101292],"about_ca_topic_score_codex":0.000023664708,"about_ca_topic_score_gemma":0.000013298475,"teacher_disagreement_score":0.9870321,"about_ca_system_score_codex":0.00026162833,"about_ca_system_score_gemma":0.00044134748,"threshold_uncertainty_score":0.9454248},"labels":[],"label_agreement":null},{"id":"W2037224159","doi":"10.1053/j.ajkd.2009.09.018","title":"AURORA: Is There a Role for Statin Therapy in Dialysis Patients?","year":2009,"lang":"en","type":"letter","venue":"American Journal of Kidney Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Pfizer","keywords":"Medicine; Statin; Dialysis; Dialysis Therapy; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive care medicine; Internal medicine; Oncology","score_opus":0.007850588627548415,"score_gpt":0.2590432486516554,"score_spread":0.251192660024107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037224159","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16125825,0.012639385,0.0002000107,0.8216377,0.0003615187,0.0020471343,0.0015421227,0.00003217403,0.0002817243],"genre_scores_gemma":[0.040217884,0.0033446446,0.00087600935,0.9504185,0.0043707583,0.00006401232,0.00036941835,0.00010680405,0.00023201207],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727744,0.00025520468,0.0007644259,0.0003054697,0.00094944664,0.00044803892],"domain_scores_gemma":[0.9971934,0.00010163535,0.0009950448,0.0004899357,0.00047466386,0.0007452955],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025314055,0.000348977,0.001564182,0.00040093705,0.000050651186,0.000036669913,0.0002320688,0.00013516092,0.00013087578],"category_scores_gemma":[0.0006541424,0.0002511537,0.0014593095,0.0003884369,0.00012616931,0.000089119625,0.000014615671,0.00078427885,0.000004083256],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064881716,0.00035182855,0.017248835,0.00012943425,0.00078926136,0.0002253486,0.00020316808,8.262915e-7,0.0000034145132,3.780782e-7,0.64691794,0.33348078],"study_design_scores_gemma":[0.0048400145,0.0048882924,0.053188264,0.00062277337,0.000963672,0.000026528487,0.00022012166,0.000005327904,0.00002177874,0.00017455568,0.9347444,0.000304273],"about_ca_topic_score_codex":0.00024775387,"about_ca_topic_score_gemma":0.0000013091927,"teacher_disagreement_score":0.3331765,"about_ca_system_score_codex":0.00019185379,"about_ca_system_score_gemma":0.0018671677,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W2037248554","doi":"10.1165/rcmb.2010-0052oc","title":"The Mevalonate Cascade as a Target to Suppress Extracellular Matrix Synthesis by Human Airway Smooth Muscle","year":2010,"lang":"en","type":"article","venue":"American Journal of Respiratory Cell and Molecular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; Research Manitoba; Canadian Institutes of Health Research","funders":"Canadian Institutes of Health Research","keywords":"Simvastatin; RHOA; Fibronectin; Cell biology; Farnesyltransferase; Extracellular matrix; HMG-CoA reductase; Biology; Endocrinology; Internal medicine; Signal transduction; Chemistry; Biochemistry; Medicine; Reductase; Enzyme; Prenylation","score_opus":0.005117199370105772,"score_gpt":0.27274720482008236,"score_spread":0.26763000544997656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037248554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840637,0.01247487,0.0011479735,0.0015026854,0.00018901797,0.00027832264,0.000010541835,0.000011446182,0.0003214814],"genre_scores_gemma":[0.9964702,0.00024072318,0.001294227,0.0015194848,0.00022247195,0.000018889477,0.0000020120763,0.000037514907,0.00019443399],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981524,0.00039583372,0.00046918268,0.00027886752,0.0002930534,0.0004107007],"domain_scores_gemma":[0.99841535,0.00008967413,0.0003349931,0.00047706618,0.00017682882,0.0005060914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013552615,0.00020965718,0.00057866453,0.00012808373,0.0002238332,0.000029267318,0.00024798035,0.00011828393,0.00004616626],"category_scores_gemma":[0.00018004273,0.0001348937,0.00030919665,0.00017242889,0.00044571617,0.000029684994,0.00006749517,0.0005791293,0.000008929432],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012719662,0.00006033167,0.00034289397,0.000020118474,0.00011991521,0.0002167629,0.000070628616,0.0000015041021,0.94230384,0.00016228073,0.0008191938,0.05575533],"study_design_scores_gemma":[0.0006530965,0.0023940804,0.0006822869,0.000021077723,0.00015167706,0.00023109069,0.00025322914,0.0000023567839,0.27424073,0.000082225015,0.7211147,0.00017347607],"about_ca_topic_score_codex":0.00019076251,"about_ca_topic_score_gemma":0.000009753363,"teacher_disagreement_score":0.7202955,"about_ca_system_score_codex":0.000025397645,"about_ca_system_score_gemma":0.00019034235,"threshold_uncertainty_score":0.55008054},"labels":[],"label_agreement":null},{"id":"W2037377195","doi":"10.1038/nrendo.2010.50","title":"Diagnosis and treatment of apolipoprotein B dyslipoproteinemias","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; McGill University; Royal Victoria Hospital","funders":"","keywords":"Apolipoprotein B; Triglyceride; Cholesterol; Lipoprotein; Medicine; Internal medicine; Familial hypercholesterolemia; Endocrinology","score_opus":0.051906218929220795,"score_gpt":0.37140747478260555,"score_spread":0.31950125585338474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037377195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048191894,0.98847824,0.000003566718,0.00022242978,0.00048369562,0.009853289,0.000087290246,0.00006518133,0.0007581212],"genre_scores_gemma":[0.000008692624,0.9913567,0.0019029396,0.0001334972,0.0013951189,0.0045094537,0.00018253824,0.000118426295,0.00039263992],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957516,0.0005185286,0.00157076,0.0010111893,0.00038718848,0.0007607239],"domain_scores_gemma":[0.9964501,0.00015392044,0.00090460776,0.0020095434,0.00013067074,0.00035113236],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00041881698,0.0009866885,0.008755374,0.00048433023,0.0000815879,0.000012681054,0.00024239576,0.0022001527,0.0001336576],"category_scores_gemma":[0.00045309294,0.0006121369,0.0024454575,0.00047515138,0.00025719235,0.00003912264,0.00011884518,0.0022391349,0.000060198756],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012538467,0.0002156172,0.000017677872,0.040347293,0.0005088739,0.00014994177,0.00001417668,1.6776298e-9,0.0000015377555,0.00050131255,0.00025263164,0.9579784],"study_design_scores_gemma":[0.0009378793,0.0008293605,0.000026390231,0.012693005,0.004463911,0.003346539,0.0000022349457,6.983404e-8,0.000068584086,0.000023389066,0.97721636,0.0003922695],"about_ca_topic_score_codex":0.00026818056,"about_ca_topic_score_gemma":0.00006440713,"teacher_disagreement_score":0.97696376,"about_ca_system_score_codex":0.00022737501,"about_ca_system_score_gemma":0.0004957396,"threshold_uncertainty_score":0.999633},"labels":[],"label_agreement":null},{"id":"W2037492221","doi":"10.1007/s11883-005-0077-2","title":"Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis","year":2005,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Trimetazidine; Beta oxidation; Internal medicine; Medicine; Fatty acid; Glycolysis; Carbohydrate metabolism; Endocrinology; Chemistry; Metabolism; Pharmacology; Biochemistry","score_opus":0.08419413671541766,"score_gpt":0.3567961729155779,"score_spread":0.27260203620016027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037492221","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030425657,0.99126416,0.00031124277,0.00004809978,0.00044379223,0.004462424,0.000034353812,0.00003815814,0.00035519336],"genre_scores_gemma":[0.02000772,0.9778116,0.00038154144,0.000012610816,0.00033596047,0.0010323671,0.0003225612,0.00008052826,0.000015126616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950282,0.0002776938,0.0024320125,0.00072851515,0.0011242124,0.00040939345],"domain_scores_gemma":[0.99548835,0.000044836615,0.0019221904,0.0022729784,0.00016056556,0.00011109573],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016297258,0.0005318536,0.002202528,0.00029541194,0.00008765416,0.000022388014,0.00033260917,0.00028051596,0.000040638904],"category_scores_gemma":[0.000024999734,0.0003659009,0.0015738996,0.0010547143,0.00016859238,0.00008539171,0.00013947433,0.00054395164,0.000013256338],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000023909688,0.0008243832,0.00036140418,0.026022023,0.00035682227,0.0000031326067,0.0001648842,0.0000023794985,0.00008365088,0.00008488719,0.00014273195,0.9719513],"study_design_scores_gemma":[0.00062817696,0.00016479363,0.018053167,0.068921,0.0027794968,0.00010250686,0.00006627738,0.000004450407,0.0002191405,0.000013886774,0.90865684,0.00039025696],"about_ca_topic_score_codex":0.000047039906,"about_ca_topic_score_gemma":0.000010290042,"teacher_disagreement_score":0.9715611,"about_ca_system_score_codex":0.00053527125,"about_ca_system_score_gemma":0.0003584193,"threshold_uncertainty_score":0.9998793},"labels":[],"label_agreement":null},{"id":"W2037641512","doi":"10.1007/s11883-004-0113-7","title":"The cardioprotective effects of statins","year":2004,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Myocardial infarction; Cardiology; Pharmacology; Animal studies; Reperfusion injury; Ischemia; Internal medicine","score_opus":0.03670949166181044,"score_gpt":0.33848935319889467,"score_spread":0.30177986153708425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037641512","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013974945,0.9915798,0.0002340268,0.000008306376,0.002070528,0.0057296627,0.00001656498,0.00007610478,0.00014527928],"genre_scores_gemma":[0.00045672874,0.99746805,0.00007049769,0.0000043355485,0.0004894907,0.001240156,0.000049809532,0.00012934284,0.000091568465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99593645,0.0002937462,0.0014257026,0.0007217455,0.0011045578,0.0005177883],"domain_scores_gemma":[0.9958755,0.00018568877,0.0014077915,0.0020337773,0.00025366206,0.00024362447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011320722,0.00059919985,0.003131635,0.00011965462,0.00024150898,0.000038867038,0.00017234881,0.00031027134,0.000006080177],"category_scores_gemma":[0.0005293491,0.00034343332,0.0030123347,0.0004928446,0.00021038216,0.000041089686,0.00012687244,0.00085998053,0.00001585153],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000040732066,0.00012690517,0.000014453369,0.07544308,0.0008186286,0.000050945215,0.00009204041,3.3891388e-7,0.0000029946116,0.000029047922,0.00008103755,0.92333645],"study_design_scores_gemma":[0.00036498794,0.00021193597,0.0003167226,0.08395708,0.0030853678,0.000397591,0.00000851818,1.3767406e-7,0.00007443467,0.0000643603,0.9112327,0.00028614083],"about_ca_topic_score_codex":0.00009626594,"about_ca_topic_score_gemma":0.0000022643176,"teacher_disagreement_score":0.9230503,"about_ca_system_score_codex":0.0005657696,"about_ca_system_score_gemma":0.0016912975,"threshold_uncertainty_score":0.9999018},"labels":[],"label_agreement":null},{"id":"W2037742324","doi":"10.1054/ebcm.2001.0362","title":"There was a significant association between plasma concentration of Lp(a) and the risk of CHD","year":2001,"lang":"en","type":"article","venue":"Evidence-based Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Association (psychology); Plasma concentration; Internal medicine; Chemistry; Medicine; Philosophy; Epistemology","score_opus":0.027705455005497606,"score_gpt":0.2589302395618323,"score_spread":0.23122478455633472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037742324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9007669,0.08511515,0.0057117804,0.0053560194,0.00018786264,0.0020078775,0.000016379756,0.00004429692,0.0007937471],"genre_scores_gemma":[0.976916,0.021590851,0.00017533201,0.00017882638,0.0009540554,0.00006165349,0.000022816641,0.000027970576,0.00007245343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99486166,0.0013026507,0.0008387004,0.00041147854,0.002243725,0.00034181104],"domain_scores_gemma":[0.9962393,0.0012502068,0.00058101595,0.0011351483,0.00059822894,0.00019606706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010717533,0.00025956688,0.0017305493,0.000109122964,0.00012371254,0.000009624152,0.00016092407,0.00020359468,0.00007545952],"category_scores_gemma":[0.0036904025,0.00015251758,0.0011810056,0.0005805662,0.00053761515,0.0001208419,0.000031310425,0.0003864542,0.0000044917538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00241069,0.0001227001,0.7995234,0.0018473901,0.01797971,0.0000997435,0.001463091,0.0007846768,0.0018675269,0.00043663516,0.00072870095,0.17273572],"study_design_scores_gemma":[0.042941403,0.0022349241,0.87975365,0.007104956,0.027971493,0.00011652376,0.0011726925,0.0027860433,0.01872232,0.00029211774,0.016377615,0.00052624603],"about_ca_topic_score_codex":0.0025716315,"about_ca_topic_score_gemma":0.000011197885,"teacher_disagreement_score":0.17220947,"about_ca_system_score_codex":0.00019563231,"about_ca_system_score_gemma":0.00035706317,"threshold_uncertainty_score":0.6219486},"labels":[],"label_agreement":null},{"id":"W2037782056","doi":"10.1038/ncpcardio0599","title":"Can ACAT inhibition limit the progression of atherosclerosis in patients with coronary artery disease?","year":2006,"lang":"en","type":"letter","venue":"Nature Clinical Practice Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Cardiology; Coronary artery disease; Internal medicine; Medicine; Disease; Coronary atherosclerosis; Limit (mathematics)","score_opus":0.02062264725835844,"score_gpt":0.31516826925088154,"score_spread":0.2945456219925231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037782056","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06657242,0.07081725,0.00010812709,0.85046583,0.0020798657,0.0082730595,0.00014886577,0.00013028398,0.0014042915],"genre_scores_gemma":[0.5222243,0.0031379496,0.00060046546,0.45533776,0.013810751,0.00033414658,0.004116836,0.00029145592,0.0001463086],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98823845,0.0024502696,0.0019226356,0.0013803451,0.0052807406,0.00072757725],"domain_scores_gemma":[0.9921095,0.0017411845,0.001072839,0.0033525827,0.0013763612,0.00034752756],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0067969915,0.00078507443,0.0030339833,0.00029761443,0.00014334587,0.000022579343,0.00035429824,0.0028058034,0.00003563638],"category_scores_gemma":[0.0051471563,0.0004293945,0.0023184388,0.0008413806,0.00093829917,0.00022072339,0.00015250323,0.011999986,0.000009519375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004704367,0.0022702902,0.16052948,0.0035205625,0.013997438,0.006051596,0.00014717989,0.000034788452,0.0000029624723,0.000021813665,0.7040897,0.104629815],"study_design_scores_gemma":[0.00865524,0.0015075346,0.53648937,0.0036519314,0.00788163,0.00010312203,0.000039354116,0.0000030303027,0.000002738655,0.000022763816,0.44131672,0.00032653994],"about_ca_topic_score_codex":0.00021431428,"about_ca_topic_score_gemma":0.000016044934,"teacher_disagreement_score":0.45565188,"about_ca_system_score_codex":0.00027229273,"about_ca_system_score_gemma":0.0007741503,"threshold_uncertainty_score":0.99981576},"labels":[],"label_agreement":null},{"id":"W2037903021","doi":"10.1503/cmaj.1040162","title":"Is regression of coronary atherosclerosis possible by infusing recombinant apolipoprotein A-I?","year":2004,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Observational study; Internal medicine; Apolipoprotein B; Coronary atherosclerosis; Recombinant DNA; Cardiology; Randomized controlled trial; Acute coronary syndrome; Coronary heart disease; Myocardial infarction; Cholesterol; Biology; Genetics","score_opus":0.013120773452366905,"score_gpt":0.24641091263965056,"score_spread":0.23329013918728367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037903021","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033537805,0.0035432982,0.00003427312,0.958834,0.0017821778,0.0006441228,0.000214637,0.000028032742,0.0013816394],"genre_scores_gemma":[0.009491642,0.0023500312,0.00033079373,0.9712205,0.010023543,0.000025587464,0.00038354154,0.00014445813,0.0060298895],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99269944,0.00035544412,0.0010319352,0.00035462005,0.004652396,0.0009061733],"domain_scores_gemma":[0.99568725,0.000057082172,0.000899965,0.0004149248,0.0009581102,0.0019826978],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002912349,0.00036548666,0.001123291,0.00037401405,0.00029972976,0.00006612076,0.00028917377,0.002866435,0.0023411745],"category_scores_gemma":[0.000983804,0.0002913326,0.000645956,0.00037406987,0.00008686977,0.00010444111,0.000033250828,0.005228447,0.000067715475],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000011719341,0.000036281253,0.003889677,0.00020099059,0.0004089657,0.00087602204,0.00017088673,2.6458565e-7,0.000029113044,0.0000017365751,0.962551,0.03182335],"study_design_scores_gemma":[0.0027061934,0.00030984674,0.0033125882,0.0034581,0.00019688798,0.0015542343,0.000091770205,0.00000855216,0.00018754626,0.00019531346,0.9876778,0.00030113303],"about_ca_topic_score_codex":0.0283314,"about_ca_topic_score_gemma":0.0016261429,"teacher_disagreement_score":0.031522214,"about_ca_system_score_codex":0.0056188363,"about_ca_system_score_gemma":0.018160885,"threshold_uncertainty_score":0.99995387},"labels":[],"label_agreement":null},{"id":"W2038036962","doi":"10.1002/humu.1205","title":"Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent","year":2001,"lang":"en","type":"article","venue":"Human Mutation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Robarts Clinical Trials","funders":"Heart and Stroke Foundation of Canada","keywords":"LDL receptor; Familial hypercholesterolemia; Biology; Genetics; Gene; Descent (aeronautics); Mutation; Low-density lipoprotein; Lipoprotein; Internal medicine; Endocrinology; Cholesterol; Medicine","score_opus":0.01788581730759691,"score_gpt":0.2506410720139998,"score_spread":0.2327552547064029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038036962","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769944,0.00006938778,0.0005084637,0.00020732149,0.00006379221,0.0010326369,0.000017750384,0.000027895521,0.00037332508],"genre_scores_gemma":[0.9977823,0.000022153068,0.0012369719,0.00024515382,0.00018899652,0.00005781497,0.00027121656,0.000028126722,0.00016726024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841225,0.00010710492,0.00035312626,0.00030251502,0.00045168583,0.00037331827],"domain_scores_gemma":[0.9989924,0.000013519674,0.00009889835,0.00035627582,0.00023984177,0.00029907882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044670724,0.000158078,0.00033286258,0.00032047843,0.00012199623,0.0000168695,0.00006470184,0.00012590706,0.000063133986],"category_scores_gemma":[0.00006189175,0.00014882523,0.00008775223,0.00033300018,0.00007391616,0.00010261282,0.000009954998,0.00022583197,0.000027619883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001168006,0.0015264822,0.37453744,0.0016012582,0.00055512943,0.002411251,0.013803765,0.0019018168,0.35855,0.0004226051,0.00022689332,0.24329534],"study_design_scores_gemma":[0.0028825474,0.00045990854,0.9147551,0.0002593702,0.000083302446,0.00018369485,0.00034191695,0.00015041915,0.08049983,0.000045977587,0.00015676733,0.00018114687],"about_ca_topic_score_codex":0.5462787,"about_ca_topic_score_gemma":0.6710566,"teacher_disagreement_score":0.5402177,"about_ca_system_score_codex":0.00053188956,"about_ca_system_score_gemma":0.00068424834,"threshold_uncertainty_score":0.6068917},"labels":[],"label_agreement":null},{"id":"W2038614269","doi":"10.1074/jbc.m110.154815","title":"Effects of the Prosegment and pH on the Activity of PCSK9","year":2010,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Endosome; Internalization; LDL receptor; Biochemistry; Chemistry; Kexin; Proprotein convertase; Endocytosis; Furin; Cell biology; Evolocumab; Zymogen; Enzyme; Receptor; Biology; Cholesterol; Lipoprotein","score_opus":0.01251704916602094,"score_gpt":0.24514907619049106,"score_spread":0.2326320270244701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038614269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982327,0.00027125824,0.000006855703,0.00090504554,0.00005470699,0.00014848019,0.0000011578693,0.000001347713,0.000378415],"genre_scores_gemma":[0.9995527,0.00008811689,0.00004127241,0.000095423755,0.00019214675,0.0000021568137,8.6535735e-8,0.0000020969355,0.000025972015],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994605,0.000040577463,0.00015821907,0.000058319863,0.00021117029,0.00007121356],"domain_scores_gemma":[0.99936265,0.00012954258,0.00021893198,0.00016949933,0.00006479701,0.000054579115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005491589,0.000057671867,0.00024125853,0.00000445694,0.00002514685,0.0000021030291,0.00008427228,0.00009877,0.000021226206],"category_scores_gemma":[0.00047386187,0.000020202937,0.00019791943,0.000040697592,0.00014368934,0.0000071872023,0.000035518708,0.0004362827,1.2740978e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013847799,0.00014901646,0.002558296,0.00020730497,0.000059602553,0.0000047503695,0.000013953765,1.1770711e-7,0.9897246,0.0000115282455,0.000029540051,0.007102813],"study_design_scores_gemma":[0.00046985515,0.00025099778,0.103318535,0.0001006068,0.000037389575,0.00010580855,0.000013038674,0.0000011033648,0.8952257,0.00005673605,0.00040050308,0.000019706964],"about_ca_topic_score_codex":0.0000029924188,"about_ca_topic_score_gemma":1.0833871e-7,"teacher_disagreement_score":0.10076024,"about_ca_system_score_codex":0.000010470747,"about_ca_system_score_gemma":0.00004980214,"threshold_uncertainty_score":0.18954554},"labels":[],"label_agreement":null},{"id":"W2038854968","doi":"10.1016/j.amjmed.2014.10.016","title":"Ezetimibe Use Remains Common Among Medical Inpatients","year":2014,"lang":"en","type":"article","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Ezetimibe; Medicine; Simvastatin; Cohort; Statin; Internal medicine; Prospective cohort study; Coronary artery disease; Cohort study","score_opus":0.014632733459186628,"score_gpt":0.2864505952010625,"score_spread":0.27181786174187583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038854968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715742,0.0003172511,0.0020062237,0.024686566,0.00033822033,0.00019354372,6.565812e-7,0.000016841877,0.0008665184],"genre_scores_gemma":[0.9859391,0.0006212114,0.00036749282,0.010613785,0.0023257688,0.0000025210009,0.0000026826845,0.00002802129,0.00009945046],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961216,0.0006093685,0.00075941463,0.00013653091,0.002071091,0.00030200643],"domain_scores_gemma":[0.99725485,0.00037198974,0.0007768671,0.000651196,0.00028859638,0.00065647694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046245065,0.0001687298,0.0010785138,0.00016174198,0.000098897195,0.000008612998,0.00032204346,0.000049065235,0.0001441795],"category_scores_gemma":[0.0021051578,0.000082231796,0.0002527588,0.0004069253,0.0013917614,0.00008462645,0.000055708362,0.0007742924,0.0000091364955],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016646858,0.0003203202,0.2152946,0.000104632585,0.00087592273,0.000550618,0.0019296919,0.000023684597,0.00028886454,0.00037942338,0.017814737,0.7607528],"study_design_scores_gemma":[0.008117971,0.011504481,0.9228734,0.002134127,0.0008353304,0.004883704,0.0012925222,0.00057709654,0.00013879605,0.00030365505,0.047128536,0.00021039743],"about_ca_topic_score_codex":0.00061673427,"about_ca_topic_score_gemma":0.00003675196,"teacher_disagreement_score":0.7605424,"about_ca_system_score_codex":0.00007598123,"about_ca_system_score_gemma":0.00017632317,"threshold_uncertainty_score":0.5128003},"labels":[],"label_agreement":null},{"id":"W2038924345","doi":"10.1161/circresaha.108.178756","title":"Enhanced Cellular Uptake of Remnant High-Density Lipoprotein Particles","year":2008,"lang":"en","type":"article","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Heart, Lung, and Blood Institute","keywords":"High-density lipoprotein; Lipoprotein; Chemistry; Cell biology; Biophysics; Cholesterol; Biology; Biochemistry","score_opus":0.08649145520145111,"score_gpt":0.33517189172000084,"score_spread":0.2486804365185497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038924345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932614,0.0005612747,0.0037704287,0.0005049368,0.00006145057,0.0009407239,0.0000022702711,0.000045187026,0.000852324],"genre_scores_gemma":[0.99842495,0.00015395832,0.000735196,0.000031895073,0.00027291922,0.00004675736,0.00001922702,0.000022177206,0.00029290744],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971095,0.0002479994,0.00039452067,0.00032639434,0.0015137711,0.00040785206],"domain_scores_gemma":[0.99809164,0.00004792903,0.00006849583,0.00078609353,0.00078735535,0.00021848225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002036873,0.00009997946,0.00035525524,0.00019139772,0.00025183093,0.000009657342,0.000091217604,0.00012316457,0.00015668548],"category_scores_gemma":[0.0004176748,0.000087822766,0.00017758503,0.00061868096,0.00022156267,0.000077743134,0.00005328578,0.0003282854,0.00010404386],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003003022,0.00036401974,0.006002379,0.00045365343,0.00016211711,0.00019769854,0.0008750172,0.00022944414,0.87155104,0.001690848,0.00031199778,0.11786151],"study_design_scores_gemma":[0.0010912359,0.00015238041,0.57136816,0.00008158421,0.000019037734,0.00004210307,0.000100561374,0.0006638319,0.4253858,0.0004712358,0.0005430014,0.00008109232],"about_ca_topic_score_codex":0.002402751,"about_ca_topic_score_gemma":0.000042698313,"teacher_disagreement_score":0.56536573,"about_ca_system_score_codex":0.000112394664,"about_ca_system_score_gemma":0.00037697746,"threshold_uncertainty_score":0.36322567},"labels":[],"label_agreement":null},{"id":"W2039114947","doi":"10.1007/s11883-005-0052-y","title":"Lipoprotein(a) and atherosclerosis: New perspectives on the mechanism of action of an enigmatic lipoprotein","year":2005,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lipoprotein(a); Apolipoprotein B; Lipoprotein; Medicine; Kringle domain; Internal medicine; Risk factor; In vivo; PCSK9; Cholesterol; Endocrinology; LDL receptor; Biology; Biochemistry; Genetics; Recombinant DNA","score_opus":0.11593119617857894,"score_gpt":0.3632278353737354,"score_spread":0.24729663919515643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039114947","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017132293,0.9757198,0.00023638744,0.00009269014,0.0005141728,0.0060310257,0.000033392756,0.000103945924,0.00013626917],"genre_scores_gemma":[0.016304692,0.9810633,0.0004834935,0.000022928536,0.0011478873,0.0006107496,0.000047420122,0.00019992374,0.00011959884],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939698,0.00056175917,0.0021104624,0.0012453749,0.0015712695,0.0005413169],"domain_scores_gemma":[0.99396694,0.00011807019,0.002504416,0.002695984,0.0002711609,0.0004434074],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021016856,0.0009408408,0.003553353,0.00035370287,0.00019567995,0.00006083774,0.00029843237,0.00061158335,0.00015140459],"category_scores_gemma":[0.0003593239,0.0006095574,0.0017222622,0.00060046837,0.00025912983,0.00018232237,0.00015146464,0.0010996747,0.00001023943],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028386134,0.00064814097,0.000004580707,0.009610543,0.00059693074,0.0000035443634,0.0010092952,5.667351e-7,0.00019968137,0.0007102535,0.000075037125,0.98711306],"study_design_scores_gemma":[0.002569361,0.0043180496,0.0014265593,0.16182572,0.010064224,0.001099703,0.0017809334,0.000049146623,0.0053642965,0.0008368983,0.8083435,0.0023215702],"about_ca_topic_score_codex":0.000538487,"about_ca_topic_score_gemma":0.000027416487,"teacher_disagreement_score":0.98479146,"about_ca_system_score_codex":0.00026200485,"about_ca_system_score_gemma":0.0008470629,"threshold_uncertainty_score":0.9996356},"labels":[],"label_agreement":null},{"id":"W2039357029","doi":"10.1016/j.jacl.2013.06.010","title":"Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia","year":2013,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia; McMaster University; University of Toronto; Hospital for Sick Children","funders":"AstraZeneca","keywords":"Medicine; Rosuvastatin; Familial hypercholesterolemia; Baseline (sea); Pediatrics; Internal medicine; Physical therapy; Cholesterol","score_opus":0.1438911063031317,"score_gpt":0.4072582887311235,"score_spread":0.26336718242799184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039357029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917415,0.0005013122,0.0059464076,0.0007675906,0.0003522518,0.0006713545,0.0000028155996,0.0000032924158,0.000013468981],"genre_scores_gemma":[0.97592777,0.00067990314,0.02006567,0.00043445767,0.0028565058,0.0000053071503,0.0000025260372,0.000014324315,0.000013543221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961609,0.0013646904,0.0016713316,0.0002389939,0.00037677967,0.0001872768],"domain_scores_gemma":[0.9971676,0.0011993657,0.0005778783,0.0005397448,0.000290714,0.00022473182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009582103,0.00011268162,0.0011663997,0.00016297029,0.00001414473,0.0000066382,0.00019586044,0.0001308228,0.000032305037],"category_scores_gemma":[0.0020522794,0.00006957103,0.00009167235,0.00017214501,0.00010151855,0.00013628021,0.000103672166,0.0006699095,0.0000036321203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029254013,0.0015954325,0.915253,0.00009988791,0.00024012133,0.00009036263,0.00016728452,0.000056513476,0.000074375304,0.000001861552,0.0011542279,0.07834156],"study_design_scores_gemma":[0.013268264,0.01385744,0.9704427,0.000059683127,0.00044643608,0.00045118932,0.0003995922,0.00056276744,0.0000053053395,0.00003860817,0.0003879661,0.00008003683],"about_ca_topic_score_codex":0.00014409386,"about_ca_topic_score_gemma":0.000035846097,"teacher_disagreement_score":0.078261524,"about_ca_system_score_codex":0.000011391981,"about_ca_system_score_gemma":0.00046138026,"threshold_uncertainty_score":0.33209848},"labels":[],"label_agreement":null},{"id":"W2039988386","doi":"10.1097/00041433-200404000-00009","title":"Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity","year":2004,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Apolipoprotein B; Lipoprotein(a); Lipoprotein; Biochemistry; Apolipoprotein C2; Apolipoprotein E; Chemistry; Biology; Cholesterol; Very low-density lipoprotein; Internal medicine; Medicine; Disease","score_opus":0.09038556450124627,"score_gpt":0.3691722169174359,"score_spread":0.2787866524161896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039988386","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004362214,0.9745413,0.0005982659,0.000095454874,0.019625988,0.004552651,0.000019966894,0.000079205136,0.000050942297],"genre_scores_gemma":[0.0012627402,0.98603374,0.00048928795,0.000022502712,0.010575888,0.0007607697,0.0007431903,0.000100897836,0.0000110102055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942193,0.0015497099,0.0016857724,0.0013043657,0.00056421256,0.00067666254],"domain_scores_gemma":[0.9977563,0.00018595599,0.0005610357,0.0010579297,0.0001112907,0.00032747517],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001263277,0.000795347,0.0031032162,0.0014482248,0.0001701965,0.000035558078,0.00022224698,0.0014478691,0.0000317527],"category_scores_gemma":[0.00060941844,0.0006772614,0.0005779592,0.0012031533,0.00019982088,0.00018260533,0.00021635696,0.0031784398,0.00003756572],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070031594,0.00020516006,0.000290496,0.060404837,0.000113453185,0.0000019127795,0.0002782569,0.0000068365384,0.0000021900314,0.0037592063,0.00013993273,0.93472767],"study_design_scores_gemma":[0.0022606421,0.00040189677,0.0037435703,0.036552943,0.00033020193,0.00029986232,0.00003608484,0.000014515654,9.4453134e-7,0.0048134145,0.95093834,0.0006075782],"about_ca_topic_score_codex":0.0007405423,"about_ca_topic_score_gemma":0.00040249372,"teacher_disagreement_score":0.9507984,"about_ca_system_score_codex":0.0010086331,"about_ca_system_score_gemma":0.0014043229,"threshold_uncertainty_score":0.9998485},"labels":[],"label_agreement":null},{"id":"W2040005083","doi":"10.1185/03007995.2012.657302","title":"Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Rosuvastatin; Medicine; Tolerability; Internal medicine; Statin; Adverse effect; Simvastatin; Atorvastatin; Rosuvastatin Calcium; Gastroenterology; Diabetes mellitus; Endocrinology","score_opus":0.33369323085718666,"score_gpt":0.49896020723159556,"score_spread":0.1652669763744089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040005083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912951,0.006332997,0.00009918134,0.0007902796,0.00030742056,0.0011279971,0.000007766849,0.000011791024,0.000027489517],"genre_scores_gemma":[0.9933078,0.0056879176,0.0000705348,0.0001402642,0.00048059048,0.00014032586,0.00015215269,0.000012493349,0.000007916274],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965096,0.00051481515,0.00033855304,0.00028927156,0.0018584278,0.000489328],"domain_scores_gemma":[0.99848264,0.00015570193,0.00003194161,0.00022127664,0.00022088437,0.0008875517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041435286,0.00011684072,0.00027103123,0.00017181772,0.0001054982,0.000031897223,0.000080268976,0.00006508615,0.000091751775],"category_scores_gemma":[0.0008543574,0.00008182904,0.000031180774,0.00022723581,0.0001572376,0.00019862373,0.00011415522,0.0006522139,0.0000046974596],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019245467,0.0017737374,0.47241154,0.000088754256,0.0000135964465,0.0000026546427,0.00145315,1.813342e-8,0.0000051141396,0.000082967126,0.00027689093,0.5236991],"study_design_scores_gemma":[0.0052429833,0.0026970892,0.9795051,0.00030784617,0.0000025830432,0.000004580735,0.0011415101,0.0002624553,0.000007532245,0.00007829153,0.010669845,0.00008018243],"about_ca_topic_score_codex":0.0003025779,"about_ca_topic_score_gemma":0.00004131368,"teacher_disagreement_score":0.52361894,"about_ca_system_score_codex":0.0000713971,"about_ca_system_score_gemma":0.00024635455,"threshold_uncertainty_score":0.33368915},"labels":[],"label_agreement":null},{"id":"W2040096459","doi":"10.1016/s0140-6736(03)12663-3","title":"Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment","year":2003,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":461,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Statin; Cholesterol; Medicine; Internal medicine; Disease; Body mass index; Endocrinology","score_opus":0.03285945471394589,"score_gpt":0.31021263934197574,"score_spread":0.2773531846280298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040096459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98856115,0.005267374,0.0000966679,0.00066890987,0.00014623256,0.0012693086,0.00009267691,0.000024727422,0.0038729254],"genre_scores_gemma":[0.99412256,0.0026718273,0.0019308702,0.00024450754,0.00052737835,0.00014822152,0.000019941237,0.000018094575,0.00031658725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913794,0.000111159,0.00015328622,0.00016075792,0.00020068184,0.0002361764],"domain_scores_gemma":[0.99921113,0.000104306506,0.000096074065,0.0004637866,0.000038250084,0.00008647093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053259515,0.0001156378,0.00045691317,0.000026680076,0.00010358497,0.0000074652035,0.000058205507,0.00005138332,0.000057182722],"category_scores_gemma":[0.00019097193,0.000068132074,0.000111412126,0.000063224405,0.00007296509,0.000024971452,0.000012800788,0.000085223415,0.000011065492],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022673082,0.0015603699,0.07499353,0.002189616,0.006114006,0.00010097765,0.016046194,0.000051077877,0.0021831987,0.04159922,0.006021127,0.82646763],"study_design_scores_gemma":[0.05221281,0.016835243,0.12178424,0.00020297336,0.0015388686,0.00021837355,0.0024813486,0.00006589724,0.03146011,0.008812397,0.76396424,0.00042353055],"about_ca_topic_score_codex":0.0018046059,"about_ca_topic_score_gemma":0.00009656494,"teacher_disagreement_score":0.8260441,"about_ca_system_score_codex":0.0000482633,"about_ca_system_score_gemma":0.00014390978,"threshold_uncertainty_score":0.27783453},"labels":[],"label_agreement":null},{"id":"W2040332234","doi":"10.1016/j.reprotox.2008.06.009","title":"Prenatal exposure to HMG-CoA reductase inhibitors: Effects on fetal and neonatal outcomes","year":2008,"lang":"en","type":"article","venue":"Reproductive Toxicology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"HMG-CoA reductase; Fetus; Medicine; Reductase; Prenatal exposure; Pregnancy; Obstetrics; Biology; Gestation; Genetics; Enzyme; Biochemistry","score_opus":0.01357683956489394,"score_gpt":0.26793055190600834,"score_spread":0.2543537123411144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040332234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98884356,0.0016416352,0.00003455099,0.006382098,0.00077388086,0.0017238386,0.000013329601,0.00010396698,0.00048314294],"genre_scores_gemma":[0.9941272,0.00006701807,0.0011105419,0.0014211566,0.0019457159,0.00016166738,0.000018782128,0.000038987033,0.0011088933],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99761766,0.00019191131,0.0002762944,0.0010438117,0.00042794528,0.00044238556],"domain_scores_gemma":[0.99839836,0.000086888016,0.000068118716,0.0009697419,0.00013135262,0.00034552088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050189416,0.00026830946,0.00068099936,0.00018664704,0.0001765569,0.0000074734767,0.00007495799,0.00019865498,0.000032880067],"category_scores_gemma":[0.0011416103,0.00021430908,0.00018941307,0.00022743271,0.00018039084,0.00008805443,0.00012064424,0.00040162675,0.000078881014],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073853196,0.0028163095,0.1431483,0.002263723,0.0031626704,0.011706647,0.011851878,0.00006891794,0.11796253,0.0014344482,0.025177801,0.67302144],"study_design_scores_gemma":[0.004860511,0.008621588,0.45756552,0.0001700126,0.00018045265,0.0070772534,0.00025371186,0.000002437623,0.506419,0.00010617792,0.014252775,0.00049056736],"about_ca_topic_score_codex":0.00007329602,"about_ca_topic_score_gemma":0.0000069448533,"teacher_disagreement_score":0.6725309,"about_ca_system_score_codex":0.00014708722,"about_ca_system_score_gemma":0.00017720358,"threshold_uncertainty_score":0.87392706},"labels":[],"label_agreement":null},{"id":"W2040419430","doi":"10.1016/s1098-3015(10)63173-7","title":"CV3 COST-EFFECTIVENESSS OF INTENSIVE STATIN THERAPY COMPARED TO MODERATE STATIN THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: ANALYSIS FROM CANADA, GERMANY AND THE UK","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acute coronary syndrome; Medicine; Statin; Internal medicine; Cardiology; Physical therapy; Myocardial infarction","score_opus":0.01443540087236686,"score_gpt":0.25798223398127923,"score_spread":0.24354683310891237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040419430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918089,0.0017997595,0.00043683578,0.001380262,0.00004981674,0.004176671,0.0003309155,0.000009261093,0.0000075737335],"genre_scores_gemma":[0.99563414,0.00053706375,0.00042307022,0.0029414357,0.000016223972,0.0002082596,0.00020572025,0.000026383485,0.0000077333725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706006,0.00088519324,0.0006333834,0.00039738658,0.00063080265,0.00039314994],"domain_scores_gemma":[0.99840134,0.00035702222,0.0002430715,0.00046883913,0.00036891986,0.0001608289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009207345,0.00022854428,0.0012121312,0.00023746707,0.000080952195,0.000012827862,0.00009562297,0.000050187053,0.000014634654],"category_scores_gemma":[0.0000329197,0.00014489381,0.000088730754,0.00083271053,0.00008964368,0.00004029483,0.00002489862,0.0002516946,3.8485985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010670838,0.00026984385,0.94941837,0.000095701354,0.0013845739,0.00012605145,0.002375221,0.02659316,0.000013330854,0.000046057135,0.00012866843,0.008878178],"study_design_scores_gemma":[0.014567414,0.0008206758,0.9792339,0.00019568641,0.00007979475,0.0000075418116,0.00036698644,0.0044022617,0.000059905764,0.00009127408,0.000038622074,0.00013591096],"about_ca_topic_score_codex":0.9565663,"about_ca_topic_score_gemma":0.364183,"teacher_disagreement_score":0.59238327,"about_ca_system_score_codex":0.00047627705,"about_ca_system_score_gemma":0.0011093533,"threshold_uncertainty_score":0.64741904},"labels":[],"label_agreement":null},{"id":"W2040637030","doi":"10.1161/circulationaha.110.954016","title":"Letter by Vos et al Regarding Article, “Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia: Results From the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and Meta-Analysis of Women From Primary Prevention Trials”","year":2010,"lang":"en","type":"letter","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Dyslipidemia; Primary prevention; C-reactive protein; Sensitivity (control systems); Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Statin; Cardiology; Endocrinology; Physical therapy; Gerontology; Inflammation; Disease","score_opus":0.14883586482229194,"score_gpt":0.35807536970550563,"score_spread":0.2092395048832137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040637030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8760183,0.0003636958,0.09327674,0.011180619,0.00010266076,0.017034194,0.0020084095,0.000015055524,3.4793317e-7],"genre_scores_gemma":[0.9676836,0.000053141488,0.006703939,0.004819794,0.0004799782,0.008111108,0.012002707,0.00009965381,0.000046056277],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9878077,0.0066443156,0.002806552,0.00092457107,0.0014044851,0.00041240707],"domain_scores_gemma":[0.98879915,0.0054330993,0.0036649848,0.0013490621,0.0006977133,0.000055959757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02515378,0.00042584364,0.0028709034,0.00032734408,0.00014178465,0.000055525135,0.0001714664,0.0005312388,0.000017531638],"category_scores_gemma":[0.003780247,0.00024375335,0.001589421,0.00076082064,0.00013058634,0.00056370266,0.000055795037,0.0010674708,9.857059e-8],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27337855,0.0031246732,0.0013113809,0.0033687993,0.372195,0.000010623469,0.021580452,0.027707309,0.07123702,0.00001880806,0.003335245,0.22273213],"study_design_scores_gemma":[0.14671841,0.0059593944,0.4096699,0.0018112686,0.38563263,0.000006097045,0.002200117,0.034465503,0.0050145346,0.001588518,0.0057675163,0.0011660971],"about_ca_topic_score_codex":0.0046980176,"about_ca_topic_score_gemma":0.0010731986,"teacher_disagreement_score":0.4083585,"about_ca_system_score_codex":0.0006815046,"about_ca_system_score_gemma":0.00043832255,"threshold_uncertainty_score":0.99399734},"labels":[],"label_agreement":null},{"id":"W2040908456","doi":"10.1194/jlr.m014118","title":"PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke","year":2011,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; LDL receptor; Kexin; Apolipoprotein E; Endocrinology; Neurogenesis; Internal medicine; Dentate gyrus; Hippocampus; Receptor; Cholesterol; Biology; Medicine; Neuroscience; Lipoprotein","score_opus":0.07569935338107231,"score_gpt":0.3244067743245073,"score_spread":0.248707420943435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040908456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952572,0.0009969926,0.0000034986176,0.0025591468,0.000062282284,0.0006112716,0.0000027639214,0.0000020432012,0.00050479284],"genre_scores_gemma":[0.99582857,0.00006452022,0.0010255773,0.00004059735,0.0003677969,0.000032881286,8.3067235e-8,0.000014977304,0.0026249897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99752116,0.00042696347,0.00049462495,0.00012356248,0.0011270031,0.00030667215],"domain_scores_gemma":[0.99904156,0.000058341484,0.00014928059,0.0003025929,0.0003217219,0.00012651006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057896893,0.00008799481,0.0002821487,0.0001961852,0.00010307962,0.000015477175,0.0002330973,0.000074568314,0.00011044455],"category_scores_gemma":[0.0004991011,0.000042577634,0.00012812717,0.00025400217,0.00017698781,0.00008416156,0.00015840204,0.0009246291,0.0000031002612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013379707,0.00023265945,0.01806515,0.0005345069,0.00025258414,0.000046851794,0.008835451,5.664276e-7,0.9466189,0.000013229132,0.00057896704,0.023483155],"study_design_scores_gemma":[0.0010646634,0.0001654391,0.1852155,0.00058326346,0.000006459893,0.000111401074,0.0011819376,8.862149e-7,0.80504954,0.000006955233,0.0065673837,0.000046567526],"about_ca_topic_score_codex":0.00006335358,"about_ca_topic_score_gemma":0.00002378347,"teacher_disagreement_score":0.16715035,"about_ca_system_score_codex":0.00012615831,"about_ca_system_score_gemma":0.0006495257,"threshold_uncertainty_score":0.40171048},"labels":[],"label_agreement":null},{"id":"W2041128703","doi":"10.1016/j.jpeds.2015.02.043","title":"Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia","year":2015,"lang":"en","type":"article","venue":"The Journal of Pediatrics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Quebec - Clinical Research Organization in Cancer","funders":"","keywords":"Ezetimibe; Medicine; Tolerability; Placebo; Familial hypercholesterolemia; Internal medicine; Lipid profile; Gastroenterology; Cholesterol; Randomized controlled trial; Adverse effect; Endocrinology","score_opus":0.018935174673588285,"score_gpt":0.26473425973600095,"score_spread":0.24579908506241266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041128703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965421,0.0021934407,0.00042878263,0.00027731992,0.00008256073,0.00041631912,0.000005883892,0.000004782589,0.000048822778],"genre_scores_gemma":[0.99261725,0.005228658,0.00088654633,0.00022341842,0.0009975344,0.0000010354032,0.0000012276216,0.000021369191,0.000022946066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984859,0.00016369084,0.0004765137,0.000090036716,0.00060651294,0.00017731696],"domain_scores_gemma":[0.9990371,0.00007172372,0.00025579077,0.00025875575,0.00018491462,0.00019173093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015985387,0.00012850472,0.00046881207,0.00014530483,0.000028697945,0.000007242737,0.00013184425,0.00008182796,0.000002636281],"category_scores_gemma":[0.00009767621,0.00006410682,0.00007781155,0.00025254555,0.000077923105,0.0000703589,0.000028110038,0.0003912727,8.536248e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06069446,0.00080635253,0.8423519,0.00026992257,0.00034198686,0.00017411148,0.00620597,0.0017106164,0.0005012376,0.000008003653,0.0006650923,0.08627032],"study_design_scores_gemma":[0.03086841,0.005242231,0.9583686,0.00009327153,0.0006808118,0.0036340116,0.00042969015,0.000023281227,0.00016802707,0.000019420007,0.0003209325,0.00015129187],"about_ca_topic_score_codex":0.00019682507,"about_ca_topic_score_gemma":0.000026892283,"teacher_disagreement_score":0.11601669,"about_ca_system_score_codex":0.0000708161,"about_ca_system_score_gemma":0.00044524527,"threshold_uncertainty_score":0.26142},"labels":[],"label_agreement":null},{"id":"W2041239330","doi":"10.1111/j.1463-1326.2011.01404.x","title":"High‐density lipoprotein‐cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive","year":2011,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Eli Lilly and Company","keywords":"Pioglitazone; Medicine; Internal medicine; Blood pressure; Myocardial infarction; Post-hoc analysis; Type 2 diabetes; Cholesterol; Placebo; Cardiology; Stroke (engine); Diabetes mellitus; Endocrinology","score_opus":0.018707300552375503,"score_gpt":0.22895393290745122,"score_spread":0.21024663235507574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041239330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916198,0.005514488,0.00003357272,0.00023904417,0.00023886758,0.0018281819,0.000016133854,0.00009330332,0.000416563],"genre_scores_gemma":[0.9966193,0.00063466135,0.001479566,0.00079246535,0.00013118908,0.00013933984,0.000010517828,0.000040930827,0.00015206888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974555,0.0002682908,0.0004525055,0.00073593255,0.0005079232,0.0005798491],"domain_scores_gemma":[0.99849933,0.000024923253,0.00007121352,0.00077824807,0.00012946152,0.0004968348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016468255,0.00034514308,0.0014073018,0.00026402698,0.00014514911,0.000034227356,0.00010207855,0.00026675384,0.000016437933],"category_scores_gemma":[0.00016089738,0.00029556485,0.0003608275,0.00036645148,0.00011635653,0.00021533167,0.00017542056,0.00048751163,0.000024471306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003546482,0.0006779708,0.49529034,0.0010032672,0.0036389704,0.00021796855,0.005862459,0.000005459772,0.004676931,0.0015645394,0.000022373048,0.48668507],"study_design_scores_gemma":[0.0025433232,0.00011538355,0.9536745,0.0000951464,0.00070281624,0.000025279816,0.00008109479,0.000009267999,0.040102735,0.0003427687,0.0019950664,0.0003125994],"about_ca_topic_score_codex":0.0062900046,"about_ca_topic_score_gemma":0.00013067917,"teacher_disagreement_score":0.48637247,"about_ca_system_score_codex":0.0000497236,"about_ca_system_score_gemma":0.00004860981,"threshold_uncertainty_score":0.99994963},"labels":[],"label_agreement":null},{"id":"W2041308690","doi":"10.1016/j.amjcard.2005.08.006","title":"Assessment of Reaching Goal in Patients with Combined Hyperlipidemia: Low-Density Lipoprotein Cholesterol, Non–High-Density Lipoprotein Cholesterol, or Apolipoprotein B","year":2005,"lang":"en","type":"review","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre","funders":"","keywords":"Hyperlipidemia; Apolipoprotein B; Cholesterol; Internal medicine; Medicine; Lipoprotein; Triglyceride; High-density lipoprotein; Endocrinology; Diabetes mellitus","score_opus":0.01740008909863322,"score_gpt":0.306078113812704,"score_spread":0.2886780247140708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041308690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83688504,0.15386662,0.0015941527,0.00041944376,0.000545611,0.0064271446,0.00006286451,0.000047052767,0.00015206754],"genre_scores_gemma":[0.55991924,0.43355107,0.0027088306,0.00044292893,0.0028546718,0.00017731005,0.00006437825,0.0002353992,0.000046189336],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9887797,0.0037866489,0.0033870593,0.0009396294,0.0019382377,0.0011686869],"domain_scores_gemma":[0.9901395,0.0003767498,0.0055894707,0.0024742146,0.0008555983,0.0005645104],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006293537,0.001259949,0.012382843,0.0008867914,0.00019839483,0.000047233847,0.0011193566,0.0006104807,0.000012566947],"category_scores_gemma":[0.0003855459,0.0007040149,0.0022263518,0.0011680571,0.00112187,0.00023538034,0.00039308905,0.004539378,0.000009981206],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002310413,0.0003421851,0.002631041,0.0032832008,0.0028432095,0.00025307285,0.00009432961,0.00009792186,0.000011378299,0.000009465864,0.00004575573,0.988078],"study_design_scores_gemma":[0.0181933,0.024611868,0.8613339,0.034446392,0.008850691,0.006211522,0.00029860938,0.000015184444,0.000052143798,0.000036204314,0.044225994,0.0017241903],"about_ca_topic_score_codex":0.00526475,"about_ca_topic_score_gemma":0.00035091568,"teacher_disagreement_score":0.9863538,"about_ca_system_score_codex":0.0011937388,"about_ca_system_score_gemma":0.0022228754,"threshold_uncertainty_score":0.9995411},"labels":[],"label_agreement":null},{"id":"W2042318705","doi":"10.1681/asn.2006010012","title":"Statins for Improving Renal Outcomes","year":2006,"lang":"en","type":"review","venue":"Journal of the American Society of Nephrology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":480,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Albuminuria; Renal function; Proteinuria; Statin; Confidence interval; Internal medicine; Kidney disease; Meta-analysis; Randomized controlled trial; Urology; Kidney","score_opus":0.034868211435477504,"score_gpt":0.3487114160353412,"score_spread":0.3138432045998637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042318705","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011507958,0.9938114,0.0021080202,0.0017752065,0.00018658717,0.0008815373,0.00005227986,0.000006968655,0.000027162432],"genre_scores_gemma":[0.00004682428,0.9769662,0.018032046,0.0034293395,0.0012084652,0.00001910915,0.000006980341,0.000053725613,0.00023729038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767697,0.00022817143,0.0011494431,0.00017026084,0.0004585132,0.0003166462],"domain_scores_gemma":[0.9948343,0.00028203707,0.0040003634,0.00050500274,0.0002825591,0.00009572704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011355106,0.0002648164,0.0037647157,0.000068021574,0.000081003374,0.000006236251,0.0003437665,0.00016149938,0.00000532257],"category_scores_gemma":[0.00009443109,0.00014020041,0.007084936,0.00026159352,0.0004482106,0.000027987739,0.00008282286,0.00068858097,6.1853837e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049588903,0.000080813385,0.000047181427,0.007277385,0.002370543,0.0000044946723,0.000047143214,0.0000020716943,0.000053260886,0.000008519768,0.031089028,0.95896995],"study_design_scores_gemma":[0.0007991844,0.00097067945,0.0011683503,0.00088660425,0.0040634573,0.0007337505,0.00007459458,0.0000065074246,0.0000021912206,0.00003162961,0.99115443,0.00010862445],"about_ca_topic_score_codex":0.00023969972,"about_ca_topic_score_gemma":0.0000053691574,"teacher_disagreement_score":0.9600654,"about_ca_system_score_codex":0.0001957533,"about_ca_system_score_gemma":0.0012318467,"threshold_uncertainty_score":0.71453476},"labels":[],"label_agreement":null},{"id":"W2042546999","doi":"10.1136/bcr.12.2011.5369","title":"Use of once-weekly statin in combination with ezetimibe in a patient with mitochondrial disease: Table 1","year":2012,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Ezetimibe; Rosuvastatin; Medicine; Statin; Internal medicine; Coronary artery disease; Disease; Adverse effect; Family history; Regimen; Cardiology; Rosuvastatin Calcium; Physical therapy; Endocrinology","score_opus":0.02332189957901208,"score_gpt":0.2792599657859518,"score_spread":0.2559380662069397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042546999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689037,0.00026826083,0.0002078917,0.00011915105,0.00009955893,0.0022366296,0.0000067148617,0.000015180287,0.00015626845],"genre_scores_gemma":[0.9960724,0.000012972363,0.0033599054,0.00005031967,0.00007192845,0.00022192096,0.000048865688,0.000023565024,0.00013809868],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9982783,0.00009947862,0.0005099801,0.00022803772,0.0005955543,0.00028860223],"domain_scores_gemma":[0.99878895,0.000029834271,0.0002827547,0.00052465714,0.00013535749,0.00023842131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039121186,0.0001311614,0.0003803127,0.00013642554,0.000023172659,0.000009506833,0.0000101030255,0.000049326554,0.000024011093],"category_scores_gemma":[0.00017448225,0.00009309062,0.00005257741,0.00034177062,0.000039092352,0.00021652864,0.00001766188,0.00013300021,8.268795e-7],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002472798,0.0022047132,0.37702847,0.00068375963,0.00011258193,0.5960062,0.0014241158,0.00073562906,0.00024859366,0.000051566793,0.00037292248,0.01865865],"study_design_scores_gemma":[0.014251268,0.0038652276,0.50392956,0.0037586426,0.0006276297,0.452229,0.0015766849,0.0009694264,0.004721634,0.000044381646,0.013109873,0.0009166724],"about_ca_topic_score_codex":0.0044899452,"about_ca_topic_score_gemma":0.0007826007,"teacher_disagreement_score":0.14377722,"about_ca_system_score_codex":0.00012381501,"about_ca_system_score_gemma":0.0005089926,"threshold_uncertainty_score":0.67874837},"labels":[],"label_agreement":null},{"id":"W2042573312","doi":"10.1089/gte.2008.0013","title":"Ethnic Differences in the Frequency of the Cardioprotective C679X PCSK9 Mutation in a West African Population","year":2008,"lang":"en","type":"article","venue":"Genetic Testing","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Ottawa Hospital","funders":"","keywords":"PCSK9; Allele frequency; Mutation; Ethnic group; Population; Genetics; Loss of heterozygosity; Biology; Apolipoprotein B; Internal medicine; Allele; LDL receptor; Endocrinology; Gene; Cholesterol; Medicine; Lipoprotein; Environmental health","score_opus":0.06216401517141777,"score_gpt":0.27092252705424946,"score_spread":0.20875851188283168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042573312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969874,0.0010869347,0.00015315726,0.00018603366,0.000043507487,0.00087808777,0.0000014618727,0.000011485062,0.00065191195],"genre_scores_gemma":[0.998311,0.000013703774,0.0014278664,0.000049817874,0.00009395682,0.00008895084,0.0000016123207,0.0000080784785,0.0000050230174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987433,0.00027053387,0.00028059396,0.00016393409,0.00037522745,0.00016641407],"domain_scores_gemma":[0.9993906,0.000107906526,0.00010911801,0.00031000175,0.000060001614,0.000022391907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005408634,0.00008419749,0.00022278227,0.0000721812,0.00007729777,0.0000035423582,0.000098354736,0.00005152206,0.0000029304317],"category_scores_gemma":[0.0006720321,0.000049218146,0.00007987098,0.00077373296,0.000056577624,0.000021233885,0.000019072892,0.00021899598,9.878047e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005405734,0.00003261116,0.9377214,0.000058055277,0.000012126737,0.000030992305,0.004258252,0.00021560778,0.00089338236,0.0000127853145,4.0164923e-7,0.056759022],"study_design_scores_gemma":[0.00041422545,0.00009549194,0.9972281,0.00015720261,0.000024319503,0.00022235088,0.0007994267,0.00039922047,0.00015318932,0.00045412028,9.985824e-7,0.000051348536],"about_ca_topic_score_codex":0.016791519,"about_ca_topic_score_gemma":0.0011601686,"teacher_disagreement_score":0.05950675,"about_ca_system_score_codex":0.000075432385,"about_ca_system_score_gemma":0.000116334675,"threshold_uncertainty_score":0.98975575},"labels":[],"label_agreement":null},{"id":"W2042767008","doi":"10.1016/s0149-2918(08)80061-6","title":"Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective","year":2008,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Vancouver General Hospital","funders":"AstraZeneca Canada","keywords":"Pravastatin; Medicine; Rosuvastatin; Atorvastatin; Simvastatin; Perspective (graphical); Statin; Pharmacology; Internal medicine; Cholesterol","score_opus":0.1808289121573606,"score_gpt":0.43496613499180087,"score_spread":0.2541372228344403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042767008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846157,0.004168095,0.0071568675,0.0006896455,0.00034069622,0.0017845485,0.0007808502,0.00007334116,0.0003902942],"genre_scores_gemma":[0.9922202,0.0014217561,0.004992923,0.00092898833,0.00016180491,0.00005092965,0.0001572457,0.000047939437,0.000018164501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960427,0.0011787707,0.0010619287,0.0006394662,0.0005677786,0.00050932827],"domain_scores_gemma":[0.9957365,0.0016859149,0.00042835486,0.00071112585,0.00060392014,0.0008341935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021707916,0.00028165925,0.0017307318,0.00031240538,0.00023164747,0.000016467759,0.00011097187,0.00018691251,0.000027189459],"category_scores_gemma":[0.00034731792,0.00024757558,0.0006178575,0.0009753173,0.0003939323,0.000055518685,0.000037849684,0.00046725082,0.0000067740866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0096414415,0.0017949658,0.48775238,0.0012674188,0.073357604,0.0008015275,0.023243492,0.0006479633,0.00019598592,0.0075946855,0.00041168288,0.39329085],"study_design_scores_gemma":[0.010280041,0.0026256794,0.9621945,0.0002889715,0.004482916,0.000036424233,0.010064403,0.006010258,0.00011484718,0.00006309372,0.003421891,0.00041698574],"about_ca_topic_score_codex":0.12586704,"about_ca_topic_score_gemma":0.021551603,"teacher_disagreement_score":0.47444212,"about_ca_system_score_codex":0.00059798494,"about_ca_system_score_gemma":0.0021077336,"threshold_uncertainty_score":0.9999977},"labels":[],"label_agreement":null},{"id":"W2042818572","doi":"10.1016/j.ahj.2005.12.013","title":"Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II","year":2006,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Rosuvastatin; Atorvastatin; Simvastatin; Medicine; Apolipoprotein B; Internal medicine; Rosuvastatin Calcium; Cholesterol; National Cholesterol Education Program; Endocrinology; Statin; Lipoprotein; Gastroenterology; Urology; Metabolic syndrome","score_opus":0.014798172581111052,"score_gpt":0.2682330529048457,"score_spread":0.2534348803237347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042818572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956532,0.0005824044,0.0010743226,0.00070289255,0.00023815122,0.0016652972,0.000022002936,0.000037444137,0.000024277868],"genre_scores_gemma":[0.9928722,0.00028717332,0.0052479147,0.0005288017,0.0008363675,0.00010504303,0.000008914232,0.00009944798,0.000014172117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99580723,0.0008450397,0.0010048804,0.0006365541,0.0008017682,0.0009045223],"domain_scores_gemma":[0.99839425,0.00006229262,0.00049220776,0.000489691,0.00019155607,0.0003699926],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018490786,0.00046513538,0.0011933355,0.00075856346,0.0005513114,0.00013844432,0.00013457752,0.00012748306,0.0000125653705],"category_scores_gemma":[0.00012868785,0.0004208916,0.00027823276,0.0008634846,0.00025576816,0.00058240944,0.000092776674,0.0015587184,0.00000391123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020099878,0.00058721565,0.8598274,0.00005973759,0.000125074,0.000029222916,0.00092833093,0.0011672437,0.008253598,0.0000013089289,0.000030684,0.12878919],"study_design_scores_gemma":[0.0068308357,0.0013688175,0.9866369,0.0007333389,0.00006120542,0.00058883236,0.0004692934,0.00020241686,0.0023649603,0.000042754218,0.0003409408,0.00035974063],"about_ca_topic_score_codex":0.035927583,"about_ca_topic_score_gemma":0.00065716886,"teacher_disagreement_score":0.12842944,"about_ca_system_score_codex":0.00061738025,"about_ca_system_score_gemma":0.00022322983,"threshold_uncertainty_score":0.9998243},"labels":[],"label_agreement":null},{"id":"W2042953537","doi":"10.1016/j.jacl.2012.12.004","title":"Counterpoint: Statins do reduce fatal events","year":2013,"lang":"en","type":"letter","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Royal Victoria Hospital; Royal Victoria Regional Health Centre; McGill University Health Centre","funders":"","keywords":"Medicine; Simvastatin; Scopus; Statin; Placebo; Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Meta-analysis; Cholesterol lowering; MEDLINE; Cholesterol; Alternative medicine; Pathology","score_opus":0.08235070885245235,"score_gpt":0.41377649927365573,"score_spread":0.33142579042120335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042953537","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04860043,0.0026054669,0.00055908394,0.91228646,0.031943552,0.0009832791,0.000068802095,0.000031799336,0.0029211284],"genre_scores_gemma":[0.0059941662,0.0031304252,0.003326399,0.7653154,0.21858796,0.000015308287,0.0000938678,0.0001238202,0.0034126395],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924633,0.0013336631,0.0037907504,0.00046316138,0.001327535,0.00062158954],"domain_scores_gemma":[0.9938036,0.0011261733,0.0027180086,0.00092201214,0.0009782987,0.00045186485],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0048206323,0.0003945086,0.0033754308,0.00026194903,0.000054445336,0.000026067424,0.0004543946,0.0021699918,0.0016468543],"category_scores_gemma":[0.0031350446,0.0002741555,0.0025013487,0.00012338367,0.00025470345,0.0001217358,0.00011964859,0.008218472,0.00039602682],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039304164,0.00019057454,0.0012122117,0.00035201813,0.001358935,0.00078596425,0.00002923576,5.040523e-7,0.000007794314,0.000011735788,0.9721528,0.023505166],"study_design_scores_gemma":[0.0039013056,0.0031555179,0.0067332326,0.0006721897,0.0008010839,0.0054272413,0.00003436203,0.0000047844464,0.00000690383,0.00050178973,0.97853523,0.00022633155],"about_ca_topic_score_codex":0.000048018406,"about_ca_topic_score_gemma":0.0000015503063,"teacher_disagreement_score":0.18664442,"about_ca_system_score_codex":0.0001263983,"about_ca_system_score_gemma":0.0015582365,"threshold_uncertainty_score":0.9999711},"labels":[],"label_agreement":null},{"id":"W2043026852","doi":"10.1007/s11883-013-0360-6","title":"Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator","year":2013,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Lipoprotein(a); Medicine; Apolipoprotein B; Lipoprotein; PCSK9; Mendelian randomization; Mediator; Risk factor; Internal medicine; Bioinformatics; Pharmacology; LDL receptor; Cholesterol; Biochemistry; Biology; Gene; Genetic variants","score_opus":0.058921319808885105,"score_gpt":0.32500377985063633,"score_spread":0.26608246004175123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043026852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044289436,0.9859517,0.000041743056,0.000020485311,0.001997807,0.006922773,0.00014083313,0.00024972245,0.00024595094],"genre_scores_gemma":[0.0005884922,0.9946988,0.00014039475,0.000045242825,0.001924609,0.0019273292,0.00020828149,0.00031873665,0.00014811242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99277043,0.0005647481,0.0017288872,0.0019841648,0.0020629133,0.00088886917],"domain_scores_gemma":[0.99371535,0.00007774755,0.0013014211,0.0036365467,0.00022718152,0.0010417375],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0014374985,0.0013163168,0.005546853,0.0003710109,0.00027899997,0.00016865267,0.0002108497,0.00080034055,0.00039142923],"category_scores_gemma":[0.00058501516,0.00093335495,0.0048435535,0.00046052987,0.00017166967,0.00013727315,0.00024574544,0.0017173832,0.00064624817],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005822601,0.00017142044,0.00009670394,0.013792759,0.002472791,0.00011169618,0.000059272712,1.6654731e-7,7.2046413e-7,0.00001103547,0.0005671416,0.9827105],"study_design_scores_gemma":[0.00055906497,0.00026495598,0.0005769748,0.019241584,0.005988189,0.00083770294,0.000007759282,0.0000010191407,0.000016902932,0.000025410796,0.9716593,0.0008211051],"about_ca_topic_score_codex":0.00027783736,"about_ca_topic_score_gemma":0.0000018723492,"teacher_disagreement_score":0.98188937,"about_ca_system_score_codex":0.0003910261,"about_ca_system_score_gemma":0.00078108313,"threshold_uncertainty_score":0.9999588},"labels":[],"label_agreement":null},{"id":"W2043201007","doi":"10.1016/s0828-282x(06)70969-2","title":"Forging the shield","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Disease; Risk factor; Coronary artery disease; Face shield; Intensive care medicine; Cardiology; Pathology; Health care","score_opus":0.011546888724841995,"score_gpt":0.22752622070437997,"score_spread":0.21597933197953798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043201007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7719507,0.015893169,0.013441958,0.023687731,0.0021448454,0.0004370833,0.0000095094065,0.000012511408,0.1724225],"genre_scores_gemma":[0.9947189,0.000036866175,0.0001107275,0.0006878961,0.0042283353,0.0000015648932,0.0000014799152,0.000009108693,0.00020510811],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992635,0.0000788753,0.00022127661,0.000060858067,0.00012042989,0.00025503643],"domain_scores_gemma":[0.99931014,0.000029082856,0.0000703796,0.0002130179,0.00012279693,0.00025460476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069658365,0.000062041254,0.0003190439,0.000113577335,0.000101499696,0.000010790631,0.00009348447,0.00007451148,0.00001766792],"category_scores_gemma":[0.00007777032,0.000037757163,0.0003440964,0.000094068004,0.00009048184,0.000026231548,0.0000040374184,0.00026972496,0.00000706859],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002023635,0.000007438116,0.35948753,0.00016447804,0.0022295061,0.0069229696,0.0005588667,0.006166043,0.0009322806,0.025650818,0.3859576,0.21172011],"study_design_scores_gemma":[0.0005791183,0.00014263831,0.12030221,0.000027646116,0.00013972427,0.0064740595,0.00013761724,0.000004814081,0.00009038904,0.0007458843,0.87130344,0.000052481228],"about_ca_topic_score_codex":0.004400624,"about_ca_topic_score_gemma":0.002502495,"teacher_disagreement_score":0.48534584,"about_ca_system_score_codex":0.00009752634,"about_ca_system_score_gemma":0.0011456043,"threshold_uncertainty_score":0.66524565},"labels":[],"label_agreement":null},{"id":"W2043353709","doi":"10.1161/circulationaha.109.900027","title":"Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis","year":2010,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":795,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Hamilton Health Sciences; St. Boniface Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Rosuvastatin; Stenosis; Cardiology; Internal medicine; Rosuvastatin Calcium","score_opus":0.007700103448535075,"score_gpt":0.2782680641903546,"score_spread":0.27056796074181955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043353709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980685,0.000024305607,0.000708911,0.00002952927,0.000085906686,0.00061020843,9.905575e-7,0.000019563444,0.000452068],"genre_scores_gemma":[0.9995345,0.0000029852222,0.00030126504,0.000008363564,0.000103159786,0.000021768712,0.0000102603335,0.000014239292,0.0000034760571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992224,0.000036941692,0.00017533032,0.00012499474,0.0003484793,0.000091831556],"domain_scores_gemma":[0.9994269,0.000036075493,0.00011854898,0.0002876937,0.0000795931,0.0000511786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044895618,0.00007290299,0.00024332157,0.00006478021,0.000023368566,0.0000028374973,0.000022702763,0.000054887223,0.000021017458],"category_scores_gemma":[0.000074839634,0.000048430844,0.00008612145,0.00013138523,0.000032056934,0.000033817756,0.0000062621166,0.000114600654,0.0000023463272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004928027,0.000104698185,0.3813308,0.001289142,0.00007480899,0.0000035378189,0.0001616204,0.00012961346,0.23743032,0.000040921965,0.000003151747,0.37893862],"study_design_scores_gemma":[0.0014426665,0.00142386,0.7306372,0.0004947296,0.000107665175,0.000008911493,0.0000083767745,0.00068882894,0.26510638,0.000004417036,0.000022860986,0.00005408931],"about_ca_topic_score_codex":0.000023980405,"about_ca_topic_score_gemma":0.0000014862497,"teacher_disagreement_score":0.37888452,"about_ca_system_score_codex":0.000016334727,"about_ca_system_score_gemma":0.000039194576,"threshold_uncertainty_score":0.19749525},"labels":[],"label_agreement":null},{"id":"W2043491118","doi":"10.1002/mus.22115","title":"Association of common variants in the human eyes shut ortholog (EYS) with statin‐induced myopathy: Evidence for additional functions of EYS","year":2011,"lang":"en","type":"article","venue":"Muscle & Nerve","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute","keywords":"Myopathy; Genome-wide association study; Single-nucleotide polymorphism; Statin; Medicine; Genetic association; Genetics; Internal medicine; Biology; Bioinformatics; Gene; Genotype","score_opus":0.08459980962018912,"score_gpt":0.3117753405524847,"score_spread":0.22717553093229556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043491118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970383,0.00008017508,0.000419449,0.000243729,0.00004829082,0.00077900523,0.00027080008,0.0000128996535,0.0011073706],"genre_scores_gemma":[0.9986285,0.000009581363,0.0006309119,0.00010929433,0.00010538728,0.00021645748,0.00018742646,0.000012268254,0.000100200006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873054,0.00019723423,0.00033867738,0.00016146991,0.0004049893,0.0001670687],"domain_scores_gemma":[0.9988767,0.00023985036,0.0002764778,0.00033267605,0.00023765408,0.000036637353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014299816,0.00008738957,0.0002882793,0.000070446025,0.000083111125,0.0000048730867,0.00008567359,0.000074651696,0.00032380197],"category_scores_gemma":[0.00027600804,0.000059634494,0.00013129777,0.0002013439,0.000030129679,0.000100667276,0.000015262258,0.00014311074,0.0000023443852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019659086,0.005405531,0.8069035,0.002716579,0.0019263165,0.00015664582,0.024161626,0.00006305057,0.037865344,0.01094332,0.015697937,0.09219426],"study_design_scores_gemma":[0.0013012679,0.0009863095,0.9948923,0.00028359346,0.00017077099,0.0000068716863,0.00073889404,0.000027317561,0.0009759705,0.0002521648,0.00029841647,0.000066139684],"about_ca_topic_score_codex":0.0016254577,"about_ca_topic_score_gemma":0.001158031,"teacher_disagreement_score":0.1879888,"about_ca_system_score_codex":0.00006677166,"about_ca_system_score_gemma":0.00014000614,"threshold_uncertainty_score":0.35454047},"labels":[],"label_agreement":null},{"id":"W2043626423","doi":"10.1517/14656566.2011.563506","title":"Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Fenofibrate; Fibrate; Medicine; Dyslipidemia; Metabolic syndrome; Internal medicine; Statin; Type 2 Diabetes Mellitus; Insulin resistance; Combination therapy; Type 2 diabetes; Simvastatin; Diabetes mellitus; Population; Endocrinology; Insulin; Obesity","score_opus":0.03170774920635816,"score_gpt":0.31567765092331695,"score_spread":0.2839699017169588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043626423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030387633,0.96614254,0.0000074111153,0.00006206385,0.00013406038,0.0030700883,0.0000412034,0.00006340348,0.000091605994],"genre_scores_gemma":[0.0024138498,0.9956478,0.000266519,0.0005945763,0.000078404184,0.00036408423,0.00038609206,0.00016762913,0.00008107362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972501,0.0005599032,0.0005113107,0.00069985184,0.0005560487,0.00042281038],"domain_scores_gemma":[0.99863297,0.00011265308,0.0004382188,0.00041006814,0.00018044046,0.00022566739],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053603,0.00064077764,0.0021062933,0.00033044594,0.00010053274,0.00004070156,0.000103375954,0.00023140402,0.000053903088],"category_scores_gemma":[0.000014325819,0.00036879108,0.00009698757,0.00067145884,0.000125262,0.00018676442,0.000013295255,0.0005052407,0.00000271808],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021729143,0.0007418188,0.0020408784,0.0013782679,0.0018928846,0.00001495177,0.00047035163,2.736354e-7,0.000001270223,0.00016363813,0.00016339659,0.99095935],"study_design_scores_gemma":[0.01799845,0.004283634,0.018029347,0.013961302,0.000114385424,0.000008174126,0.000013660566,0.0000040835835,0.00003296551,0.0000151100385,0.94489163,0.00064724125],"about_ca_topic_score_codex":0.00003870481,"about_ca_topic_score_gemma":0.00000901331,"teacher_disagreement_score":0.9903121,"about_ca_system_score_codex":0.00011909675,"about_ca_system_score_gemma":0.00028969717,"threshold_uncertainty_score":0.9998764},"labels":[],"label_agreement":null},{"id":"W2043699066","doi":"10.1159/000158128","title":"Resolution of Lipid-Containing Atherosclerotic Lesions Induced by Injury","year":2008,"lang":"en","type":"article","venue":"Blood Vessels","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Fatty streak; Lesion; Aorta; Fibrous cap; Medicine; Pathology; Foam cell; Internal medicine; Cholesterol; Lipoprotein","score_opus":0.03593703027903791,"score_gpt":0.272933245140433,"score_spread":0.23699621486139508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043699066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689084,0.00087529526,0.000225143,0.00019185759,0.000094152194,0.00045266814,0.000010568368,0.00006247103,0.0011970032],"genre_scores_gemma":[0.9984312,0.00031223774,0.0004955839,0.00021585902,0.00028163975,0.000031250078,0.000015061536,0.000027088754,0.00019004833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998754,0.00008152732,0.0003108166,0.00022395543,0.00037629338,0.0002533601],"domain_scores_gemma":[0.99915123,0.000024713603,0.00010095305,0.00047221076,0.00009770395,0.00015317346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035638796,0.00012229764,0.00039095446,0.00007640081,0.00013129841,0.0000037126176,0.00007362603,0.00013121108,0.00003863423],"category_scores_gemma":[0.00011722233,0.000108215,0.00017677326,0.00023329238,0.00005437886,0.00006394718,0.00003240823,0.00020010621,0.000015677015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033030324,0.0013475072,0.012087569,0.00041112656,0.00064373366,0.00004997362,0.0017028946,0.0000056329286,0.9637312,0.00056532235,0.0026313462,0.016493352],"study_design_scores_gemma":[0.012744218,0.0059848037,0.277574,0.0013978222,0.0010947415,0.00062043726,0.000799345,0.00011679392,0.68421465,0.00014031833,0.014532367,0.000780501],"about_ca_topic_score_codex":0.00019035954,"about_ca_topic_score_gemma":0.0000017155386,"teacher_disagreement_score":0.2795166,"about_ca_system_score_codex":0.00002957053,"about_ca_system_score_gemma":0.00021619406,"threshold_uncertainty_score":0.44128796},"labels":[],"label_agreement":null},{"id":"W2043985436","doi":"10.1016/j.jclinepi.2006.04.007","title":"Case selection for statins was similar in two Canadian provinces: BC and Ontario","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Epidemiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; York University","funders":"","keywords":"Medicine; Medical prescription; Statin; Diabetes mellitus; Acute coronary syndrome; Prescription drug; Population; Demographics; Coronary heart disease; Demography; Epidemiology; Gerontology; Family medicine; Emergency medicine; Internal medicine; Environmental health; Myocardial infarction","score_opus":0.14716003098186264,"score_gpt":0.458713128138894,"score_spread":0.31155309715703133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043985436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903689,0.00043046573,0.0019251752,0.006179029,0.000312649,0.00041783374,0.00000476156,0.0000036364954,0.0003575425],"genre_scores_gemma":[0.9793846,0.00014082556,0.015959112,0.0029214835,0.0013811773,0.000008431935,0.0000050751573,0.000011370831,0.00018789523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99616057,0.00094125123,0.0022602838,0.00019134974,0.00009818725,0.0003483315],"domain_scores_gemma":[0.99549526,0.0030642268,0.00068823696,0.0001212752,0.00019762566,0.00043339917],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017375046,0.0001016219,0.001534771,0.00014472644,0.00005693443,0.000003848448,0.000039339597,0.00018682214,0.000028095561],"category_scores_gemma":[0.0088238465,0.000073234085,0.00038851448,0.00007274661,0.000082658815,0.00005591508,0.000007799966,0.00073151535,9.940234e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005023336,0.00010526449,0.9685917,0.000069117435,0.00010118951,0.0010580276,0.000048509803,0.00023532647,0.0000022107472,0.0008082751,0.0020712307,0.026406817],"study_design_scores_gemma":[0.008197875,0.003224381,0.8473145,0.0001397219,0.00025279747,0.016973974,0.00008936426,0.0021929212,0.000008292736,0.009909814,0.11154871,0.00014764856],"about_ca_topic_score_codex":0.8445712,"about_ca_topic_score_gemma":0.98546004,"teacher_disagreement_score":0.14088884,"about_ca_system_score_codex":0.0003520597,"about_ca_system_score_gemma":0.00265045,"threshold_uncertainty_score":0.99952525},"labels":[],"label_agreement":null},{"id":"W2044066251","doi":"10.1016/s0828-282x(09)70480-5","title":"Efficacy of alternate day versus daily dosing of rosuvastatin","year":2009,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; Western University","funders":"","keywords":"Rosuvastatin; Dosing; Medicine; Regimen; Dyslipidemia; Crossover study; Rosuvastatin Calcium; Urology; Internal medicine; Pharmacology; Placebo","score_opus":0.020895914949405524,"score_gpt":0.2746305549843993,"score_spread":0.2537346400349938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044066251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847221,0.0034571597,0.0020770852,0.00073346106,0.0008720028,0.00016640757,0.000016131893,0.0000030462159,0.007952625],"genre_scores_gemma":[0.9982472,0.00013649123,0.0005518577,0.00011791929,0.0009108073,3.4377274e-7,0.0000037490627,0.000010403237,0.000021213506],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99869096,0.00016376593,0.0005386171,0.00010393049,0.00021714678,0.00028557476],"domain_scores_gemma":[0.99852705,0.00007156058,0.00030210937,0.00029313902,0.0003096782,0.00049645663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092264876,0.000102016376,0.0008312164,0.00028140252,0.000032674616,0.0000041936873,0.00013142683,0.00009744307,0.000013977341],"category_scores_gemma":[0.0003577984,0.00008651527,0.0004832099,0.00014588961,0.00011844565,0.00004153735,0.0000050011304,0.00024798443,0.0000016260612],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048285313,0.00004590671,0.04034272,0.00035595556,0.004960621,0.0036583554,0.0021877824,0.009249255,0.024876064,0.0028135588,0.010276552,0.8964047],"study_design_scores_gemma":[0.027966537,0.008187237,0.8311357,0.00078346854,0.0014842969,0.004545702,0.0005163216,0.000037357062,0.011604978,0.00049286743,0.11285368,0.00039186538],"about_ca_topic_score_codex":0.0012901049,"about_ca_topic_score_gemma":0.00019968588,"teacher_disagreement_score":0.89601284,"about_ca_system_score_codex":0.00011693514,"about_ca_system_score_gemma":0.0014950462,"threshold_uncertainty_score":0.35279903},"labels":[],"label_agreement":null},{"id":"W2044079910","doi":"10.1016/j.tcm.2014.10.008","title":"A genetic basis for coronary artery disease","year":2014,"lang":"en","type":"review","venue":"Trends in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Mendelian randomization; Coronary artery disease; CAD; Medicine; Bioinformatics; Disease; Genome-wide association study; Clinical trial; Cholesterol; Genetic predisposition; Genetics; Biology; Internal medicine; Genetic variants; Single-nucleotide polymorphism; Gene","score_opus":0.049553499938065924,"score_gpt":0.33520465285615414,"score_spread":0.28565115291808824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044079910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010487032,0.99195665,0.0021838038,0.00024182508,0.00095129147,0.0031216023,0.00009118828,0.00013844241,0.0013047082],"genre_scores_gemma":[0.0002188476,0.9886081,0.00087626633,0.0003717546,0.005499809,0.002350035,0.0009199305,0.0003079206,0.00084731245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99330825,0.0007009484,0.0016867096,0.0015951634,0.0017125078,0.0009963978],"domain_scores_gemma":[0.9943824,0.00027384557,0.00027939738,0.0039318963,0.0001645834,0.00096786977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003193335,0.0011069672,0.009655926,0.0015634893,0.00010768152,0.000016017699,0.00040004565,0.0006126525,0.00026482402],"category_scores_gemma":[0.0005209836,0.00080164825,0.00984236,0.0012851548,0.0002700289,0.00004716132,0.00011056107,0.00083551696,0.00005314746],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008080647,0.00009064944,0.000041273168,0.041616943,0.0062597217,0.0013203755,0.00003451864,0.000008292811,3.2461376e-8,0.000023285762,0.0023822559,0.9481419],"study_design_scores_gemma":[0.0040958133,0.00044331996,0.0031877374,0.031213982,0.030364119,0.0018150487,0.000014774886,0.000033171644,4.6390216e-8,0.000027560267,0.9281613,0.0006430835],"about_ca_topic_score_codex":0.000101044374,"about_ca_topic_score_gemma":0.000012831302,"teacher_disagreement_score":0.94749874,"about_ca_system_score_codex":0.00058451947,"about_ca_system_score_gemma":0.0006551758,"threshold_uncertainty_score":0.9994434},"labels":[],"label_agreement":null},{"id":"W2044690891","doi":"10.1016/j.jacc.2009.11.046","title":"Rosuvastatin Prevents Conduit Artery Endothelial Dysfunction Induced by Ischemia and Reperfusion by a Cyclooxygenase-2–Dependent Mechanism","year":2010,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Rosuvastatin; Medicine; Placebo; Rosuvastatin Calcium; Ischemia; Urology; Statin; Cyclooxygenase; Celecoxib; Endothelial dysfunction; Internal medicine; Anesthesia; Cardiology; Pharmacology; Enzyme; Pathology; Biochemistry","score_opus":0.0072483170612576905,"score_gpt":0.23965178745642302,"score_spread":0.23240347039516532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044690891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676853,0.00025103652,0.0006217204,0.00090336945,0.0007091606,0.0004007375,0.00013339642,0.0000068926015,0.00020517719],"genre_scores_gemma":[0.9980937,0.0002744898,0.00043684998,0.0003861621,0.0005065281,0.000009551925,0.0000033981225,0.00002316891,0.00026611084],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981638,0.00032064432,0.000565063,0.00020497285,0.0005168132,0.00022866715],"domain_scores_gemma":[0.99828523,0.00007261999,0.00083495287,0.00043413552,0.00019485243,0.00017817748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011494706,0.00016639855,0.0009513005,0.000085259526,0.00008544765,0.0000052704695,0.0001581864,0.000117960975,0.0000148854915],"category_scores_gemma":[0.00018403264,0.00010892375,0.00041245113,0.00014952886,0.00019263849,0.000058225276,0.00008365462,0.00064141216,9.3820347e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000599222,0.000043746757,0.0011418996,0.000028401939,0.00043260283,0.00005423203,0.000032230644,0.0000016249684,0.9869732,0.000034531717,0.006016662,0.004641594],"study_design_scores_gemma":[0.009294327,0.004943598,0.00905682,0.00016266039,0.0010641047,0.018722458,0.001083265,0.000040929197,0.92827517,0.0005434908,0.026457774,0.00035537765],"about_ca_topic_score_codex":0.00010872003,"about_ca_topic_score_gemma":0.000005965932,"teacher_disagreement_score":0.058698054,"about_ca_system_score_codex":0.000060371614,"about_ca_system_score_gemma":0.00027261945,"threshold_uncertainty_score":0.44417816},"labels":[],"label_agreement":null},{"id":"W2045054080","doi":"10.1111/j.1365-2796.2006.01616.x","title":"Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel","year":2006,"lang":"en","type":"article","venue":"Journal of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":471,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Université Laval; St. Paul's Hospital; University of British Columbia; McGill University Health Centre; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Apolipoprotein B; Cholesterol; Lipoprotein; Guideline; Internal medicine; Epidemiology; Vascular disease; Endocrinology; Disease; Clinical trial; Risk factor; Pathology","score_opus":0.03484046279699392,"score_gpt":0.2789458719316743,"score_spread":0.24410540913468037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045054080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802751,0.015999086,0.00080262264,0.0009378304,0.0009878227,0.00029111278,0.0000012514897,0.000004600498,0.00070057495],"genre_scores_gemma":[0.9963884,0.00085241534,0.0009824923,0.00018376525,0.0015361956,0.000003640507,8.1292796e-7,0.000021307203,0.000030990475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713135,0.00020811835,0.0011413821,0.00018922654,0.0010974084,0.00023252214],"domain_scores_gemma":[0.99838674,0.00011697364,0.0007617731,0.0004289995,0.00020837745,0.00009715106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004364999,0.00018014919,0.0009773377,0.00027557535,0.000038420745,0.000009396114,0.00016960733,0.00010112172,0.000011184668],"category_scores_gemma":[0.0010096177,0.00010011564,0.0003880815,0.0002952152,0.00014095158,0.0001031126,0.000037619444,0.00063760264,2.481795e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029536274,0.00027443736,0.8868618,0.0005468981,0.0018778723,0.005491259,0.0021841011,0.002256659,0.0044695004,0.00002381839,0.0006642573,0.09239576],"study_design_scores_gemma":[0.024000045,0.0012397545,0.9431928,0.0077721765,0.0006248328,0.014591724,0.0019191948,0.0014851202,0.0016938252,0.000113133974,0.003184333,0.00018309188],"about_ca_topic_score_codex":0.007134667,"about_ca_topic_score_gemma":0.00014165108,"teacher_disagreement_score":0.09221267,"about_ca_system_score_codex":0.00017597889,"about_ca_system_score_gemma":0.00013766995,"threshold_uncertainty_score":0.9994769},"labels":[],"label_agreement":null},{"id":"W2045066425","doi":"10.1016/j.cjca.2014.07.476","title":"THE ROLE OF RGS5 IN MEDIATING THE PLEIOTROPIC EFFECTS OF STATINS IN VASCULAR SMOOTH MUSCLE CELLS","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Fluvastatin; Vascular smooth muscle; Apolipoprotein E; Statin; Medicine; Endocrinology; Internal medicine; Downregulation and upregulation; Pharmacology; Biology; Biochemistry; Smooth muscle","score_opus":0.0037478752466235422,"score_gpt":0.20070117772730814,"score_spread":0.1969533024806846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045066425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99035585,0.007306022,0.00031127606,0.00038405284,0.00033627948,0.0002963457,0.0000032713303,0.0000010482289,0.001005877],"genre_scores_gemma":[0.99892133,0.00045109336,0.00008198814,0.00009272303,0.0004313236,0.0000057397197,8.4576607e-7,0.000012150222,0.0000027823123],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99811995,0.00070696924,0.0005258331,0.00009162718,0.00023228848,0.00032334815],"domain_scores_gemma":[0.99862295,0.00043470855,0.00024287203,0.0003499524,0.00014126116,0.00020826065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023007372,0.00009147946,0.00065918005,0.0001921474,0.000049832903,0.0000042572256,0.00019418556,0.00009533856,0.0000022358504],"category_scores_gemma":[0.00081326667,0.000053740965,0.00030243074,0.00020078706,0.00017059347,0.000023748269,0.00001239484,0.0003888939,6.852248e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013904058,0.000026037042,0.2801109,0.0008101801,0.0011848777,0.0004033228,0.005897571,0.012698063,0.03167186,0.0027589865,0.00051862374,0.66378057],"study_design_scores_gemma":[0.0023829434,0.00060279435,0.9186291,0.00023241129,0.00013919767,0.000035643123,0.0010627423,0.00015862664,0.0028308458,0.0007484234,0.073090926,0.00008630966],"about_ca_topic_score_codex":0.008462687,"about_ca_topic_score_gemma":0.011059001,"teacher_disagreement_score":0.66369426,"about_ca_system_score_codex":0.00011735817,"about_ca_system_score_gemma":0.00096644514,"threshold_uncertainty_score":0.99814004},"labels":[],"label_agreement":null},{"id":"W2045439469","doi":"10.5551/jat1994.8.33","title":"A Comparison of Low Versus Standard Dose Pravastatin Therapy for the Prevention of Cardiovascular Events in the Elderly : The Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE)","year":2001,"lang":"en","type":"article","venue":"Journal of Atherosclerosis and Thrombosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Defence Medical Centre","funders":"","keywords":"Pravastatin; Medicine; Confidence interval; Incidence (geometry); Internal medicine; Randomized controlled trial; Gastroenterology; Cholesterol","score_opus":0.09273850827625886,"score_gpt":0.3625495436740829,"score_spread":0.26981103539782403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045439469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872778,0.00541536,0.0014450483,0.0018084513,0.00037151456,0.0036232343,0.000024631605,0.0000049285,0.000029014862],"genre_scores_gemma":[0.98279953,0.016308324,0.0003015114,0.00009845557,0.00027123227,0.0001713327,0.000004088176,0.000039008275,0.0000065428057],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9947361,0.0013890546,0.0015102376,0.00028988265,0.0016575427,0.00041722046],"domain_scores_gemma":[0.9965993,0.0009740184,0.001112222,0.00088356907,0.00036241292,0.000068441965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009886756,0.00032538432,0.0014082917,0.00014374616,0.0002710867,0.00006902169,0.00058256945,0.00016882946,0.000017569937],"category_scores_gemma":[0.00027589808,0.00014311515,0.0014040519,0.00070046674,0.00023238675,0.00017997964,0.000038680075,0.00064903835,3.7723385e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.086826,0.013285608,0.1314639,0.0013399547,0.015827268,0.000009207823,0.08843572,0.0020343307,0.022894422,0.0005612079,0.0017815222,0.6355409],"study_design_scores_gemma":[0.11698094,0.036705665,0.80847216,0.0016753924,0.0021058384,0.000030671315,0.02579859,0.00022442662,0.0028139115,0.00026590674,0.0045846454,0.00034187306],"about_ca_topic_score_codex":0.0005063556,"about_ca_topic_score_gemma":0.00019175668,"teacher_disagreement_score":0.6770083,"about_ca_system_score_codex":0.00007845982,"about_ca_system_score_gemma":0.0002619723,"threshold_uncertainty_score":0.58360666},"labels":[],"label_agreement":null},{"id":"W2045536496","doi":"10.1016/s0021-9150(00)80341-x","title":"Fluvastatin extended-release formulation is effective in treating primary hypercholesterolaemia","year":2000,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Fitness and Lifestyle Research Institute","funders":"","keywords":"Fluvastatin; Medicine; Pharmacology; Simvastatin","score_opus":0.011422530182344884,"score_gpt":0.2523433362759499,"score_spread":0.24092080609360503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045536496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99380004,0.0002743843,0.00014648118,0.0002494787,0.00003002473,0.0010869761,0.000011636931,0.00007997109,0.004321006],"genre_scores_gemma":[0.9954766,0.00025402592,0.0014264692,0.0018899436,0.00014236309,0.0002022679,0.000031606454,0.000049075235,0.0005276284],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99839824,0.00012934003,0.00033145165,0.00039328143,0.0003832796,0.00036438194],"domain_scores_gemma":[0.999228,0.00005983661,0.000053970303,0.0004619933,0.000042189535,0.00015403345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004655625,0.00020292387,0.00042840588,0.000093526476,0.00009882195,0.000027169315,0.000063023945,0.00013087956,0.00037791426],"category_scores_gemma":[0.000033691576,0.0001774639,0.00023465496,0.0003111212,0.000028071576,0.00018438992,0.000017501572,0.0002561777,0.00014150678],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001811051,0.00029547836,0.040078525,0.00014330039,0.00006563545,0.000008008977,0.0015276906,0.0000318563,0.012608946,0.000015162035,0.00008358038,0.9449607],"study_design_scores_gemma":[0.0034901581,0.00033720164,0.98982745,0.00035964674,0.00007943803,0.000020310517,0.00007998945,0.00045370692,0.0039118235,0.00005544402,0.0012072129,0.00017760275],"about_ca_topic_score_codex":0.0007842227,"about_ca_topic_score_gemma":0.00003012013,"teacher_disagreement_score":0.94974893,"about_ca_system_score_codex":0.00029768972,"about_ca_system_score_gemma":0.00006443955,"threshold_uncertainty_score":0.72367674},"labels":[],"label_agreement":null},{"id":"W2045899836","doi":"10.1179/016164103101202039","title":"The risk of dementia in relation to statins and other lipid lowering agents","year":2003,"lang":"en","type":"review","venue":"Neurological Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Dementia; Epidemiology; Medicine; Disease; Clinical trial; Alzheimer's disease; Lipid metabolism; Bioinformatics; Intensive care medicine; Neuroscience; Pharmacology; Psychology; Internal medicine; Biology","score_opus":0.19330091540164465,"score_gpt":0.45332758634662146,"score_spread":0.2600266709449768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045899836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012253151,0.98406684,0.00003341703,0.000103324826,0.00005643706,0.001996924,0.000009557248,0.0000073209894,0.0014730244],"genre_scores_gemma":[0.0013852228,0.99807054,0.00008698704,0.0001089273,0.0000741258,0.00013301101,0.0000023634211,0.000022302087,0.000116540534],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641186,0.0016078544,0.0004219932,0.0003567833,0.000804802,0.00039669],"domain_scores_gemma":[0.99845713,0.0007583925,0.000081343176,0.00046143055,0.000077403674,0.00016430486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005212501,0.00013219638,0.0006860712,0.00016828549,0.00011604397,0.000020026648,0.00013162704,0.00020080015,0.00004817235],"category_scores_gemma":[0.0023982537,0.00006952227,0.00019027949,0.0005091622,0.00009722308,0.000011843124,0.00014492092,0.001216271,0.000024106945],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005684519,0.000050567996,0.0022898947,0.0019194179,0.000087532295,0.000032952277,0.00002196159,0.0000012407438,5.342184e-7,0.00009183543,0.00011956971,0.99532765],"study_design_scores_gemma":[0.00023590303,0.000691956,0.011918043,0.000714163,0.00010793313,0.000015140484,0.000004699093,0.000009060498,4.523129e-7,0.000043590724,0.98620814,0.000050921462],"about_ca_topic_score_codex":0.0001017692,"about_ca_topic_score_gemma":0.000024639696,"teacher_disagreement_score":0.99527675,"about_ca_system_score_codex":0.000035431833,"about_ca_system_score_gemma":0.00014713654,"threshold_uncertainty_score":0.528416},"labels":[],"label_agreement":null},{"id":"W2046003236","doi":"10.1074/jbc.m113.541094","title":"Annexin A2 Reduces PCSK9 Protein Levels via a Translational Mechanism and Interacts with the M1 and M2 Domains of PCSK9","year":2014,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Montreal Clinical Research Institute; Université de Sherbrooke","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Annexin A2; Kexin; Proprotein convertase; Gene knockdown; Annexin; LDL receptor; Cell biology; Biology; Proprotein Convertases; Transfection; Molecular biology; Gene silencing; Chemistry; Cell culture; Biochemistry; Cholesterol; Flow cytometry; Lipoprotein","score_opus":0.020066256499730616,"score_gpt":0.2510830495427761,"score_spread":0.23101679304304548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046003236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398607,0.0008911912,0.002152336,0.0024862522,0.000012198345,0.00017201554,0.000005008258,0.0000046308865,0.00029027287],"genre_scores_gemma":[0.9977316,0.000034743385,0.00177541,0.00012848135,0.00027796926,0.0000047020803,0.00000198203,0.0000057929747,0.00003927073],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99912,0.00006892508,0.00029124215,0.00013040769,0.0002615086,0.00012789716],"domain_scores_gemma":[0.999319,0.0000696494,0.0002326147,0.0001143467,0.00012515765,0.00013923703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000831251,0.00011286252,0.00036917423,0.0000170842,0.000050895396,0.000011383466,0.00007161663,0.0001211696,0.000040391085],"category_scores_gemma":[0.00010712384,0.00005194716,0.00010855799,0.000057027246,0.00016812116,0.00003970794,0.000020506353,0.0002469928,1.9564443e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005027126,0.000082553626,0.0003497851,0.00016996043,0.00016973495,0.000023565928,0.00013795694,0.0000011697857,0.98545295,0.0001278418,0.000012917165,0.012968871],"study_design_scores_gemma":[0.00251991,0.0013628508,0.019378088,0.00042003058,0.00011587528,0.0023809357,0.0002683147,0.000055444027,0.9691175,0.0029000829,0.0013469149,0.00013404667],"about_ca_topic_score_codex":0.0000045327743,"about_ca_topic_score_gemma":5.8843847e-7,"teacher_disagreement_score":0.019028304,"about_ca_system_score_codex":0.0000123662385,"about_ca_system_score_gemma":0.00006316493,"threshold_uncertainty_score":0.21183437},"labels":[],"label_agreement":null},{"id":"W2046545146","doi":"10.1016/j.amjcard.2007.01.028","title":"Comparison of Rosuvastatin Versus Atorvastatin in South-Asian Patients at Risk of Coronary Heart Disease (from the IRIS Trial)","year":2007,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; McMaster University","funders":"","keywords":"Rosuvastatin; Atorvastatin; Medicine; Internal medicine; Statin; Cholesterol; National Cholesterol Education Program; Adverse effect; Gastroenterology; HMG-CoA reductase; Endocrinology; Cardiology; Urology; Metabolic syndrome; Chemistry; Reductase; Biochemistry","score_opus":0.024201283304384986,"score_gpt":0.3184056236713792,"score_spread":0.2942043403669942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046545146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666435,0.001267202,0.0006323418,0.0004645409,0.00034592778,0.00047075987,0.00007627322,0.000003444729,0.000075140684],"genre_scores_gemma":[0.9988313,0.00011274473,0.0004314206,0.00016681758,0.00042273093,0.0000040139716,0.000009859034,0.000018043003,0.0000031167378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966953,0.0012903314,0.0010147865,0.00014325825,0.00057534757,0.0002810144],"domain_scores_gemma":[0.9967619,0.0008927201,0.0014045207,0.0005339056,0.00022229926,0.00018465707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026177282,0.00014562727,0.0014001852,0.00009211781,0.00006279168,0.0000023662344,0.00021320407,0.000036431065,0.000009946082],"category_scores_gemma":[0.0005633897,0.00008103241,0.0006049201,0.0002710905,0.00063188275,0.000024686886,0.00006949156,0.00041964257,0.0000024991132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11064909,0.00009396302,0.85605896,0.000012101856,0.00063141255,0.0000338295,0.0021076018,0.00031190988,0.000090061345,0.0000040352306,0.00034853295,0.029658485],"study_design_scores_gemma":[0.019737259,0.0045988937,0.9691091,0.000054016407,0.0005612187,0.00002260632,0.004790067,0.000009263675,0.000081275524,0.00003557586,0.0009319554,0.00006873249],"about_ca_topic_score_codex":0.00041984554,"about_ca_topic_score_gemma":0.000028986015,"teacher_disagreement_score":0.113050155,"about_ca_system_score_codex":0.00011956124,"about_ca_system_score_gemma":0.00023702199,"threshold_uncertainty_score":0.3304406},"labels":[],"label_agreement":null},{"id":"W2046707901","doi":"10.1016/j.atherosclerosis.2012.04.006","title":"Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia","year":2012,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"PCSK9; Identification (biology); Gain of function; Familial hypercholesterolemia; Genetics; Gene; Function (biology); Biology; Mutation; Computational biology; LDL receptor; Endocrinology; Cholesterol; Lipoprotein","score_opus":0.03692533704113632,"score_gpt":0.2805347693621342,"score_spread":0.24360943232099785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046707901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986281,0.0001744408,0.012129351,0.0004831608,0.000088934554,0.00080800656,0.000016688451,0.000007280788,0.000011153422],"genre_scores_gemma":[0.99871165,0.00010470224,0.00068010844,0.00011908535,0.00013278844,0.000095915166,0.00005736962,0.000013701248,0.00008466087],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99917686,0.00008632337,0.0003015729,0.000116624615,0.00018201453,0.00013661769],"domain_scores_gemma":[0.9994264,0.000051279436,0.00013439344,0.00027215757,0.00006644936,0.00004929101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009591154,0.00007199877,0.00018948114,0.00008141377,0.000051493287,0.00000912875,0.000042139596,0.00006700516,0.0000044913572],"category_scores_gemma":[0.000069965245,0.000053220923,0.000082136576,0.00019409865,0.000034850425,0.00013784443,0.000009919786,0.000055236433,0.0000016001113],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013367514,0.0001010527,0.017968336,0.00009031943,0.000025066745,3.261152e-8,0.0021364293,0.0000018139265,0.96434885,0.0003128857,0.000008791934,0.01487272],"study_design_scores_gemma":[0.0010059186,0.00014034119,0.8055346,0.00006709938,0.00012476952,0.000005358985,0.00021455088,0.00007647573,0.19236743,0.000061854036,0.00036083962,0.000040732033],"about_ca_topic_score_codex":0.000101631784,"about_ca_topic_score_gemma":0.0000073983397,"teacher_disagreement_score":0.7875663,"about_ca_system_score_codex":0.000026044356,"about_ca_system_score_gemma":0.00007287701,"threshold_uncertainty_score":0.21702862},"labels":[],"label_agreement":null},{"id":"W2046727692","doi":"10.1016/j.atherosclerosis.2014.05.022","title":"Effect of rosuvastatin therapy on carotid intima media thickness in children with familial hypercholesterolemia: Findings from the charon study","year":2014,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia; McMaster University; University of Toronto","funders":"","keywords":"Rosuvastatin; Familial hypercholesterolemia; Intima-media thickness; Medicine; Internal medicine; Carotid arteries; Cholesterol","score_opus":0.011799629650303744,"score_gpt":0.24372713005044913,"score_spread":0.2319275004001454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046727692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718887,0.00007832689,0.000039228147,0.0002034783,0.00008653982,0.0022988946,0.000027312346,0.000039588904,0.000037791513],"genre_scores_gemma":[0.99872816,0.000116812786,0.00006275544,0.00052641204,0.0002476125,0.00022111223,0.00002900699,0.0000619892,0.000006118804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973399,0.0007786568,0.00033892202,0.0004636858,0.00076047494,0.00031833135],"domain_scores_gemma":[0.9984347,0.00042346556,0.00010276427,0.00089279254,0.000050202238,0.00009606588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019727477,0.00030155852,0.00074112776,0.00006987067,0.000092397044,0.00002423999,0.00024401938,0.00013096121,0.000019529363],"category_scores_gemma":[0.00012779667,0.00016073705,0.00017709866,0.00027951782,0.000116479605,0.00005606044,0.000046418252,0.0004895899,0.000015496815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006073081,0.00033548963,0.96024483,0.000019512387,0.00019637801,5.324991e-7,0.004220654,0.00001316474,0.006460327,0.000004669957,0.000017720282,0.02787941],"study_design_scores_gemma":[0.010256448,0.005373781,0.96827525,0.0002838557,0.00013993285,0.0000039820916,0.00024089409,0.000010445334,0.015251013,0.0000040434447,0.000014427733,0.00014591869],"about_ca_topic_score_codex":0.005330001,"about_ca_topic_score_gemma":0.00033462053,"teacher_disagreement_score":0.027733492,"about_ca_system_score_codex":0.00006601358,"about_ca_system_score_gemma":0.000045144803,"threshold_uncertainty_score":0.8057403},"labels":[],"label_agreement":null},{"id":"W2046758304","doi":"10.1681/asn.2014090952","title":"We Don’t Prescribe Statins to Lower Cholesterol","year":2014,"lang":"en","type":"letter","venue":"Journal of the American Society of Nephrology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ldl cholesterol; Cholesterol; Medicine; Internal medicine","score_opus":0.018780358520540306,"score_gpt":0.27821573536950917,"score_spread":0.25943537684896883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046758304","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10586986,0.00044640718,0.0011697031,0.89151484,0.00040701087,0.00046865543,0.000018572166,0.0000097269885,0.00009521257],"genre_scores_gemma":[0.008479462,0.0009294005,0.0049936776,0.97619003,0.008492693,0.000009008382,0.000003964015,0.0000700284,0.00083171367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969017,0.00045018055,0.00084676157,0.00026300095,0.0010425005,0.00049589336],"domain_scores_gemma":[0.996326,0.00013568281,0.0019565441,0.0010184854,0.00038148297,0.00018177144],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000877313,0.00030899444,0.0018371856,0.00008859873,0.00007097311,0.000012269797,0.00061430846,0.00034953345,0.000056099354],"category_scores_gemma":[0.000058177888,0.00019241724,0.0025047292,0.00028155273,0.000606976,0.000038229613,0.00016168956,0.0025486476,0.000010009424],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019172936,0.000058727397,0.00013859906,0.00026993838,0.0014389806,0.000049528247,0.0005182566,0.00001753429,0.0019910643,5.713423e-7,0.98740315,0.007921943],"study_design_scores_gemma":[0.001039117,0.002680977,0.0066922167,0.00025536897,0.0006970838,0.00153064,0.00020594816,0.00000948935,0.000082891616,0.000032629378,0.9866239,0.0001497664],"about_ca_topic_score_codex":0.000330723,"about_ca_topic_score_gemma":0.0000057654847,"teacher_disagreement_score":0.09739039,"about_ca_system_score_codex":0.00018051322,"about_ca_system_score_gemma":0.00046032568,"threshold_uncertainty_score":0.9997525},"labels":[],"label_agreement":null},{"id":"W2046851330","doi":"10.5114/aoms.2011.25550","title":"Effectiveness and tolerability of ezetimibe co-administered with statins versus statin dose-doubling in high-risk patients with persistent hyperlipidemia: The EZE(STAT)2 trial","year":2011,"lang":"en","type":"article","venue":"Archives of Medical Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; GDI Integrated Facility Services (Canada); Merck Canada Inc. (Canada); Cambridge Cardiac Care Centre","funders":"","keywords":"Medicine; Ezetimibe; Statin; Hyperlipidemia; Internal medicine; Tolerability; Adverse effect; Gastroenterology; Incidence (geometry); Cholesterol; Endocrinology; Diabetes mellitus","score_opus":0.03371286860930814,"score_gpt":0.29812626858272995,"score_spread":0.26441339997342184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046851330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759144,0.000060373215,0.0005028003,0.00015428971,0.00008102256,0.0012234262,0.000019659654,0.000007680753,0.00035930178],"genre_scores_gemma":[0.997156,0.00006324676,0.0026793235,0.000027782731,0.000023313303,0.00003702012,0.0000041314574,0.0000079316205,0.0000012515189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672496,0.00042245042,0.00039375023,0.00040126182,0.0017397904,0.0003177913],"domain_scores_gemma":[0.997981,0.00096292753,0.0002114268,0.0004311832,0.0000873788,0.00032609017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034430092,0.0001340449,0.000506406,0.00009608667,0.000121974386,0.0000085534775,0.00028807606,0.00004433069,0.000019464673],"category_scores_gemma":[0.0011958224,0.00006781841,0.00007984583,0.0003348844,0.002688057,0.00008715308,0.00009740839,0.00033785377,2.4241146e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1533619,0.0016300626,0.6133169,0.00083972415,0.00025300856,0.000025103967,0.012381216,0.000031461565,0.00011008495,0.0005415416,0.0000019630556,0.21750703],"study_design_scores_gemma":[0.058689576,0.009037406,0.9295386,0.00043412324,0.00010173996,0.000004632031,0.0011479285,0.00032457156,0.00055383844,0.000062909596,0.0000121725625,0.000092481656],"about_ca_topic_score_codex":0.0024081275,"about_ca_topic_score_gemma":0.00018838997,"teacher_disagreement_score":0.31622174,"about_ca_system_score_codex":0.000036404697,"about_ca_system_score_gemma":0.0008165621,"threshold_uncertainty_score":0.99042577},"labels":[],"label_agreement":null},{"id":"W2046879146","doi":"10.1016/j.pharmthera.2012.03.005","title":"Novel therapeutic agents for lowering low density lipoprotein cholesterol","year":2012,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Kexin; PCSK9; Proprotein convertase; Tolerability; Pharmacology; Microsomal triglyceride transfer protein; Residual risk; Medicine; Apolipoprotein B; Apolipoprotein C2; Lipoprotein; Drug; Cholesterol; Endocrinology; LDL receptor; Internal medicine; Very low-density lipoprotein; Adverse effect","score_opus":0.14946259615083912,"score_gpt":0.40724969414004886,"score_spread":0.25778709798920973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046879146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020831129,0.98168844,0.007129574,0.0002606109,0.0025459698,0.007813487,0.000080113045,0.0001846789,0.00008880364],"genre_scores_gemma":[0.00089745026,0.98410517,0.0006132088,0.008156701,0.0035960283,0.0016180258,0.0001601059,0.0003193362,0.00053394714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99623847,0.00024268102,0.00095163495,0.00081140443,0.0005169011,0.0012389186],"domain_scores_gemma":[0.99769115,0.00016370924,0.00051992724,0.00095915864,0.00022445727,0.00044158616],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001191856,0.0009374399,0.0031029242,0.00026330748,0.00026482114,0.00003906149,0.00043611895,0.00093157176,0.00016611308],"category_scores_gemma":[0.000004820538,0.00076002436,0.0019790009,0.00032068166,0.00016515506,0.00010010726,0.00015104338,0.0012198639,0.00014764087],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011022628,0.0006372825,0.000006124176,0.021443235,0.0067939414,0.000014357616,0.00008882862,5.952875e-7,0.00040873518,0.000009278571,0.000078588404,0.9704088],"study_design_scores_gemma":[0.0028899673,0.00027316724,0.00007042023,0.0020008853,0.03225595,0.00057116506,0.000007867306,0.000029523428,0.0006879703,0.000009170423,0.9606027,0.0006011904],"about_ca_topic_score_codex":0.000048621518,"about_ca_topic_score_gemma":0.000008048981,"teacher_disagreement_score":0.9698076,"about_ca_system_score_codex":0.00048447042,"about_ca_system_score_gemma":0.00065002096,"threshold_uncertainty_score":0.9994851},"labels":[],"label_agreement":null},{"id":"W2047229407","doi":"10.1016/s0828-282x(08)70597-x","title":"How many cardiovascular events can be prevented with optimal management of high-risk Canadians?","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Canadian Heart Research Centre; University of Toronto","funders":"","keywords":"Medicine; Statin; Population; Disease; Diabetes mellitus; Clinical trial; Health care; Intensive care medicine; Cardiovascular health; Disease management; Emergency medicine; Internal medicine; Environmental health","score_opus":0.012291484427324927,"score_gpt":0.20416025389796452,"score_spread":0.1918687694706396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047229407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98018706,0.006183039,0.008971002,0.0019792528,0.0004861105,0.00071243383,0.00013682357,0.000008722172,0.0013355783],"genre_scores_gemma":[0.9947744,0.001590382,0.00221005,0.00014403342,0.0007173038,0.000015145045,0.000021067766,0.0000465253,0.0004811182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761003,0.00031907938,0.000478873,0.00029309804,0.0006248784,0.00067404995],"domain_scores_gemma":[0.99700236,0.000016436605,0.00029923784,0.0007985805,0.00049843045,0.0013849579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008434354,0.00026313055,0.0014866729,0.00046216065,0.00017752711,0.000008754247,0.0002555957,0.00018452147,0.00001288232],"category_scores_gemma":[0.00004745781,0.00021358178,0.0010661008,0.00033279447,0.00025911967,0.00007939435,0.000017506449,0.00048249328,0.0000012510523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019621328,0.000083503546,0.46586958,0.002381225,0.1526721,0.11342416,0.0024742582,0.07301681,0.00008717307,0.0021774054,0.028679488,0.15717217],"study_design_scores_gemma":[0.010281289,0.0025381306,0.6356525,0.00058374327,0.0057829535,0.033348963,0.0016047031,0.000015430085,0.0003232518,0.00006165903,0.30924073,0.00056663115],"about_ca_topic_score_codex":0.07859962,"about_ca_topic_score_gemma":0.014234838,"teacher_disagreement_score":0.28056124,"about_ca_system_score_codex":0.0005138787,"about_ca_system_score_gemma":0.0027434623,"threshold_uncertainty_score":0.9275361},"labels":[],"label_agreement":null},{"id":"W2047553180","doi":"10.1159/000111583","title":"Lipid-Lowering Agents and the Risk of Cognitive Impairment That Does Not Meet Criteria for Dementia, in Relation to Apolipoprotein E Status","year":2007,"lang":"en","type":"article","venue":"Neuroepidemiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of Calgary; University of Victoria; University of Ottawa; Dalhousie University","funders":"","keywords":"Medicine; Dementia; Cognitive impairment; Apolipoprotein E; Cognition; Relation (database); Gerontology; Psychiatry; Internal medicine; Disease","score_opus":0.03558401534749396,"score_gpt":0.33778128326813467,"score_spread":0.3021972679206407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047553180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98461527,0.00032116362,0.009930441,0.0018719017,0.00030528574,0.0027925067,0.000045267923,0.000016926251,0.000101212056],"genre_scores_gemma":[0.9943803,0.00056164054,0.0015680686,0.0030386895,0.00021191558,0.0001853267,0.000014443515,0.000020600673,0.000019022391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784565,0.00056578155,0.00057704246,0.00035534622,0.00017131948,0.0004848429],"domain_scores_gemma":[0.99786025,0.0014034957,0.00022115179,0.0002809474,0.000075129945,0.0001590315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005459184,0.00015203565,0.0006406215,0.00014485008,0.00007677322,0.000004379351,0.00005511086,0.000103791645,0.000014597439],"category_scores_gemma":[0.003164029,0.00009154708,0.00017499774,0.000109442866,0.00011685433,0.00004128885,0.00007448501,0.00018558398,0.0000013234171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014970954,0.00026410283,0.9230577,0.0006361409,0.0007675707,0.000033755696,0.0033757559,0.00008004438,0.0052845087,0.000926631,0.00044875086,0.050154135],"study_design_scores_gemma":[0.0060804537,0.0007207874,0.9855553,0.00013615596,0.0002562525,0.0000179626,0.0002767259,0.00037940874,0.004961622,0.0004674278,0.0010550007,0.000092900314],"about_ca_topic_score_codex":0.0021959906,"about_ca_topic_score_gemma":0.00057151425,"teacher_disagreement_score":0.062497653,"about_ca_system_score_codex":0.000047952537,"about_ca_system_score_gemma":0.000037776652,"threshold_uncertainty_score":0.37878668},"labels":[],"label_agreement":null},{"id":"W2047577097","doi":"10.1002/phar.1340","title":"Impact of the <scp>JUPITER</scp> Trial on Statin Prescribing for Primary Prevention","year":2013,"lang":"en","type":"article","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto; Health Sciences Centre; Public Health Ontario; University of British Columbia","funders":"","keywords":"Rosuvastatin; Statin; Medicine; Population; Medical prescription; Internal medicine; Rosuvastatin Calcium; Physical therapy; Pharmacology; Environmental health","score_opus":0.03193045022874066,"score_gpt":0.3651402715023314,"score_spread":0.3332098212735908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047577097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98843384,0.006426811,0.00013585648,0.00079778326,0.00059204304,0.003453605,0.0000092034015,0.00001192701,0.00013893207],"genre_scores_gemma":[0.9883912,0.0065482585,0.00008558394,0.0028421893,0.0014033125,0.00010479666,0.0000026360133,0.000044014207,0.0005779651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757904,0.00088142924,0.0006711612,0.00015363288,0.0003978692,0.00031686248],"domain_scores_gemma":[0.99809784,0.00046986956,0.0007676628,0.00023422543,0.00028901975,0.00014135864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023250922,0.00023576389,0.0005740966,0.0001306561,0.00031151716,0.000022658256,0.00028862705,0.00007091683,0.00026780617],"category_scores_gemma":[0.000022134505,0.00011392193,0.0007737073,0.00012933326,0.00017560404,0.00017682582,0.000022621985,0.0005104902,0.0000013148042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020505136,0.00141847,0.001651759,0.00011987617,0.0032435707,0.0000032008693,0.0034523928,0.00010528113,0.8724856,0.00002617895,0.030483596,0.06650494],"study_design_scores_gemma":[0.40988663,0.027479911,0.07776432,0.00036322768,0.0020264613,0.0003951265,0.00060940627,0.00025426943,0.4497646,0.004161125,0.027018428,0.00027648246],"about_ca_topic_score_codex":0.00004588478,"about_ca_topic_score_gemma":6.960043e-7,"teacher_disagreement_score":0.42272097,"about_ca_system_score_codex":0.000089605375,"about_ca_system_score_gemma":0.0002499058,"threshold_uncertainty_score":0.46456015},"labels":[],"label_agreement":null},{"id":"W2047601746","doi":"10.1185/03007990903512396","title":"Undertreatment of hypercholesterolemia","year":2009,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Intensive care medicine; Internal medicine; Pharmacology","score_opus":0.1455126765897489,"score_gpt":0.4490897593131414,"score_spread":0.30357708272339246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047601746","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048455163,0.082557864,0.00012694893,0.9080226,0.00088229036,0.0015389128,0.00003211034,0.000039806524,0.0019539949],"genre_scores_gemma":[0.03573057,0.5596209,0.00037999524,0.33712915,0.05840054,0.00044845915,0.0055781924,0.00023761002,0.0024745837],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99424595,0.00033300486,0.00039529364,0.00047306623,0.0039293505,0.00062334724],"domain_scores_gemma":[0.9982456,0.00020714101,0.00005832496,0.0005968274,0.00029266428,0.00059944694],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018229,0.0002090473,0.0006922169,0.00029493112,0.00008274114,0.000019275258,0.0001659587,0.00075468613,0.0001516834],"category_scores_gemma":[0.0005832,0.00014504096,0.00021346282,0.00021827329,0.00037746163,0.000027610185,0.00012229985,0.0037613753,0.000027493952],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047222187,0.00014739555,0.00012022508,0.0018382604,0.000067203364,0.00012549569,0.000022885077,4.2656954e-9,0.0000024947888,0.000039012546,0.51232713,0.4852627],"study_design_scores_gemma":[0.0014739261,0.001455613,0.0019407682,0.0037851078,0.000031243264,0.00013326068,0.0000124362405,0.000011610136,0.00004001022,0.00048255714,0.990529,0.0001044655],"about_ca_topic_score_codex":0.00009929119,"about_ca_topic_score_gemma":0.000002222314,"teacher_disagreement_score":0.5708934,"about_ca_system_score_codex":0.00016038708,"about_ca_system_score_gemma":0.0011481692,"threshold_uncertainty_score":0.998537},"labels":[],"label_agreement":null},{"id":"W2047723707","doi":"10.2165/00003495-200262170-00002","title":"Statins and Menopause","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Menopause; Pravastatin; Fluvastatin; Internal medicine; Clinical trial; Hormone replacement therapy (female-to-male); Lovastatin; Placebo; Cholesterol; Endocrinology; Simvastatin; Lipoprotein; Statin; Physiology; Testosterone (patch)","score_opus":0.03733087280325366,"score_gpt":0.32604547079497603,"score_spread":0.2887145979917224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047723707","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009753067,0.9907524,0.0000052843816,0.000045682995,0.0000831586,0.000852361,0.000027117649,0.000043509586,0.008180758],"genre_scores_gemma":[0.000003477737,0.9958142,0.00021652569,0.00013809116,0.00039361446,0.0000684806,0.00006322455,0.00004875084,0.003253642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988917,0.00007439882,0.00027306267,0.0002757394,0.00028131405,0.00020375787],"domain_scores_gemma":[0.9991829,0.000038689708,0.000085313804,0.00048081737,0.000025662259,0.00018665598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025988062,0.0002148948,0.0013991671,0.000085306165,0.000043101605,0.000015422913,0.00004660083,0.00015635096,0.00014488121],"category_scores_gemma":[0.000034441564,0.00014897785,0.00027712705,0.00012901342,0.000030058218,0.000019231806,0.00003759539,0.00029235473,0.0001589002],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.142458e-7,0.000018447774,3.946537e-7,0.02202197,0.00019652197,0.000045621906,0.00009065144,1.6051361e-9,1.565159e-8,0.00005769363,0.0015293473,0.9760385],"study_design_scores_gemma":[0.0002916083,0.00006774745,0.0000032563619,0.005698317,0.0013122035,0.00024682764,0.00001764542,6.633429e-7,1.2670564e-7,0.0000056674326,0.992223,0.00013291887],"about_ca_topic_score_codex":0.000054771583,"about_ca_topic_score_gemma":0.0000010770608,"teacher_disagreement_score":0.9906937,"about_ca_system_score_codex":0.00006551102,"about_ca_system_score_gemma":0.00013725624,"threshold_uncertainty_score":0.607514},"labels":[],"label_agreement":null},{"id":"W2047861227","doi":"10.1073/pnas.0712064105","title":"Molecular basis for LDL receptor recognition by PCSK9","year":2008,"lang":"en","type":"article","venue":"Proceedings of the National Academy of Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":414,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; University of Chicago; Canadian Institutes of Health Research; Welch Foundation; Howard Hughes Medical Institute; Argonne National Laboratory; Foundation for the National Institutes of Health","keywords":"Kexin; PCSK9; LDL receptor; Proprotein convertase; Subtilisin; C2 domain; EGF-like domain; Receptor; Epidermal growth factor; Chemistry; Binding domain; Binding site; Biochemistry; Cell biology; Biology; Lipoprotein; Cholesterol; Enzyme","score_opus":0.053163446424618975,"score_gpt":0.3039674863607629,"score_spread":0.2508040399361439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047861227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98943466,0.00045154456,0.000013391594,0.00597895,0.000017820616,0.0004986736,0.00004172135,0.000011181569,0.0035520473],"genre_scores_gemma":[0.9937967,0.00013578065,0.004927071,0.0008443021,0.00011385496,0.000042557695,9.3597674e-7,0.000005008131,0.00013379617],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836075,0.0000042599077,0.00022868307,0.00018513261,0.0010957735,0.00012537527],"domain_scores_gemma":[0.9992901,0.000040774557,0.00019638884,0.000007758261,0.00041897706,0.000046002617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011797053,0.00006532508,0.00017067252,0.0000852428,0.00017167335,0.0000047548924,0.00019560147,0.000074354306,0.000016765825],"category_scores_gemma":[0.0007300004,0.000043297212,0.00017893045,0.0004307213,0.00036669566,0.00015979605,0.000028715775,0.000094742696,0.0000016836904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083103136,0.00012229812,0.0018635121,0.00035221424,0.00008373357,1.1771207e-8,0.00016927686,0.0000045634106,0.9700342,0.0031552888,0.014852551,0.00927926],"study_design_scores_gemma":[0.00046780214,0.00015188954,0.006911869,0.0001536294,0.00003761416,0.000035400273,0.00009002046,0.00011090126,0.9815908,0.005326106,0.0050533614,0.000070622285],"about_ca_topic_score_codex":0.000008052045,"about_ca_topic_score_gemma":6.8290174e-9,"teacher_disagreement_score":0.011556597,"about_ca_system_score_codex":0.000038125003,"about_ca_system_score_gemma":0.00006176874,"threshold_uncertainty_score":0.17656091},"labels":[],"label_agreement":null},{"id":"W2047908832","doi":"10.1016/j.bbrc.2007.07.029","title":"Plasma PCSK9 levels correlate with cholesterol in men but not in women","year":2007,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University of Ottawa; Ottawa Hospital","funders":"","keywords":"PCSK9; Cholesterol; Internal medicine; Chemistry; Endocrinology; LDL receptor; Biology; Biochemistry; Medicine; Lipoprotein","score_opus":0.07382601229435996,"score_gpt":0.36722845804364074,"score_spread":0.29340244574928076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047908832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306166,0.00023238578,0.000019249917,0.0038296734,0.0000045358415,0.00054620695,0.0000114210125,0.000017563316,0.0022772956],"genre_scores_gemma":[0.9984832,0.00037817794,0.0005880935,0.00016890824,0.00005734764,0.00012259044,0.000018363773,0.000013665432,0.00016964388],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981422,0.00015530169,0.00026657435,0.00027830555,0.0005854573,0.0005721498],"domain_scores_gemma":[0.9981519,0.00033304348,0.000024640794,0.0010085606,0.00013282252,0.00034900667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001794589,0.00011360543,0.00029212865,0.00019167949,0.0001058176,0.000024611016,0.0003067189,0.00013023331,0.000009327686],"category_scores_gemma":[0.00020708912,0.000083246545,0.000046714147,0.00073173636,0.0005741219,0.00005487284,0.00029105635,0.0010078955,0.000018964456],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002516872,0.0024973438,0.0057972684,0.000291588,0.00011955751,0.000081704486,0.0015450919,6.6403624e-7,0.8639619,0.002839102,0.00020402965,0.1201449],"study_design_scores_gemma":[0.007063038,0.00095827837,0.8521277,0.0006670886,0.000020712907,0.000059685706,0.0017077442,0.0010850979,0.1293941,0.0005422692,0.0060356623,0.00033866471],"about_ca_topic_score_codex":0.00079916784,"about_ca_topic_score_gemma":0.00010639173,"teacher_disagreement_score":0.8463304,"about_ca_system_score_codex":0.00024129212,"about_ca_system_score_gemma":0.00015137678,"threshold_uncertainty_score":0.43788603},"labels":[],"label_agreement":null},{"id":"W2048027661","doi":"10.1017/s0317167100007630","title":"Metabolic Myopathies Discovered During Investigations of Statin Myopathy","year":2008,"lang":"en","type":"letter","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Rhabdomyolysis; myalgia; Statin; Myopathy; Medicine; Internal medicine; Creatine kinase; Prenylation; Ezetimibe; Pharmacology; Endocrinology; Biology; Biochemistry; Enzyme","score_opus":0.035763546243003826,"score_gpt":0.2581033016107238,"score_spread":0.22233975536772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048027661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.889407,0.006646736,0.000011354895,0.101808086,0.00091203046,0.00034174602,0.00008698186,0.000015162702,0.0007709302],"genre_scores_gemma":[0.86492705,0.0047007184,0.0027178088,0.12465871,0.0028319792,0.000008401114,0.0000050162535,0.000043430162,0.00010686684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9919333,0.0016293216,0.0017856105,0.0007427669,0.0021375848,0.0017714591],"domain_scores_gemma":[0.9941985,0.00042684795,0.0019703624,0.0003924418,0.00094318774,0.0020686467],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["sts"],"category_scores_codex":[0.003893122,0.00059304887,0.0016869819,0.0020756559,0.0026618624,0.0003606336,0.0018477819,0.00065756973,0.0001231736],"category_scores_gemma":[0.003528029,0.00039360873,0.00097420276,0.001908086,0.0117461365,0.0008026338,0.0000918938,0.0047575184,0.000002945453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025348552,0.00010823933,0.7828367,0.00045144153,0.00036918122,0.1284677,0.0020068726,0.002263702,0.00020978559,0.0003853551,0.078835346,0.0038122192],"study_design_scores_gemma":[0.0018438351,0.10392242,0.37374038,0.0008363067,0.000852738,0.34120077,0.00050543866,0.0002655038,0.0010580744,0.009700438,0.16465162,0.00142248],"about_ca_topic_score_codex":0.004164718,"about_ca_topic_score_gemma":0.013607537,"teacher_disagreement_score":0.4090963,"about_ca_system_score_codex":0.00028142173,"about_ca_system_score_gemma":0.013682647,"threshold_uncertainty_score":0.9998516},"labels":[],"label_agreement":null},{"id":"W2048422420","doi":"10.1503/cmaj.112-2036","title":"Statins for primary prevention","year":2012,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alberta Kidney Disease Network; Alberta Health; University of Calgary; University of Alberta; University of Ottawa; University of British Columbia","funders":"","keywords":"Primary prevention; Adverse effect; Medicine; Section (typography); Hydroxymethylglutaryl-CoA Reductase Inhibitors; Secondary prevention; Alternative medicine; Intensive care medicine; Bioinformatics; Statin; Computer science; Pharmacology; Internal medicine; Pathology; Disease","score_opus":0.01253458567939407,"score_gpt":0.26010172848520396,"score_spread":0.24756714280580988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048422420","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006264708,0.00162367,0.0010764397,0.9889088,0.002453195,0.00088388653,0.00015236445,0.000024730685,0.0042504375],"genre_scores_gemma":[0.00018732002,0.000385115,0.0008302025,0.91859794,0.06873759,0.000069821705,0.0008475626,0.000069499816,0.010274938],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953346,0.0002507091,0.0005981383,0.00020307317,0.0026930475,0.0009203856],"domain_scores_gemma":[0.99679214,0.0001329839,0.00042129276,0.00021853975,0.0006623056,0.0017727459],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0036287922,0.00020639587,0.00062008516,0.0002567591,0.00025827787,0.00006554934,0.00014670134,0.0020791127,0.002633315],"category_scores_gemma":[0.0012745728,0.0001831983,0.0006726087,0.00012294146,0.00002142744,0.00009328391,0.000009933511,0.0039444473,0.00012592295],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000056348194,0.000014348585,0.0009465683,0.00023560227,0.00046627028,0.00037963892,0.000038988554,4.3051006e-8,3.9060254e-7,0.000007765471,0.9013254,0.09657932],"study_design_scores_gemma":[0.0013464146,0.00012567035,0.005056968,0.00028923096,0.00036600072,0.0011664272,0.000023374243,0.0000039382176,0.0000010691244,0.00010796131,0.9913402,0.00017274916],"about_ca_topic_score_codex":0.00125225,"about_ca_topic_score_gemma":0.0023667223,"teacher_disagreement_score":0.09640657,"about_ca_system_score_codex":0.003770065,"about_ca_system_score_gemma":0.0137788225,"threshold_uncertainty_score":0.9992164},"labels":[],"label_agreement":null},{"id":"W2048499068","doi":"10.1503/cmaj.112-2051","title":"Statins: the good, the bad and the ugly","year":2012,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medicine; Bioinformatics; Computer science; Pharmacology; Intensive care medicine; Data science; Cholesterol; Internal medicine; Biology","score_opus":0.007432141392050943,"score_gpt":0.22611674548127325,"score_spread":0.2186846040892223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048499068","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006268626,0.008158324,0.00002927456,0.9843408,0.0014110046,0.0006174143,0.00003736443,0.000009130494,0.004769832],"genre_scores_gemma":[0.0042300816,0.0021459502,0.000014776202,0.94820714,0.041907378,0.00004243651,0.00003090782,0.0000371434,0.0033841785],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99411064,0.0013214776,0.00050170877,0.00016255165,0.0031232717,0.0007803395],"domain_scores_gemma":[0.99709684,0.00082001905,0.00039044037,0.00042476284,0.00033799914,0.0009299598],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0105105,0.00021391334,0.0004964841,0.000074113304,0.0009988066,0.00019244415,0.00038430854,0.0009654322,0.0014735431],"category_scores_gemma":[0.0025643369,0.00008400174,0.00040059126,0.00017474327,0.00026966553,0.00005489742,0.000032498534,0.007818217,0.00009823664],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006481134,0.0000031147936,0.0008878286,0.000022553842,0.00056554005,0.0002812464,0.00047987216,6.2187226e-8,2.7256005e-8,0.00017771086,0.95464545,0.042930122],"study_design_scores_gemma":[0.0015354579,0.000024616647,0.0073261233,0.00010810257,0.00041356008,0.0024730635,0.0003416105,0.000018508134,1.4623147e-7,0.0001742803,0.9874832,0.00010133993],"about_ca_topic_score_codex":0.012602738,"about_ca_topic_score_gemma":0.011600075,"teacher_disagreement_score":0.04282878,"about_ca_system_score_codex":0.00083039963,"about_ca_system_score_gemma":0.0047917925,"threshold_uncertainty_score":0.99943924},"labels":[],"label_agreement":null},{"id":"W2048760408","doi":"10.1056/nejmoa0706628","title":"Effects of Torcetrapib in Patients at High Risk for Coronary Events","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Hazard ratio; Myocardial infarction; Unstable angina; Atorvastatin; Cholesterylester transfer protein; Angina; Confidence interval; Cholesterol; Lipoprotein","score_opus":0.006796091399624439,"score_gpt":0.25270668052826695,"score_spread":0.2459105891286425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048760408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936304,0.0027312248,0.0017488216,0.00042729737,0.0007979939,0.00058779767,0.0000025863828,0.0000036036975,0.00007028089],"genre_scores_gemma":[0.99608034,0.0006842166,0.0005418081,0.0002052379,0.002343627,0.0000014965096,0.000007681232,0.00001694527,0.00011866462],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99817026,0.00008026346,0.0006902539,0.000108124405,0.0007185184,0.00023257732],"domain_scores_gemma":[0.9985972,0.00028050542,0.0004204722,0.00015867184,0.00022789,0.00031524312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023667277,0.00012230588,0.0006979232,0.00023078186,0.00002695045,6.536373e-7,0.00007433764,0.00008488628,0.00003109033],"category_scores_gemma":[0.0007039087,0.00007808199,0.00016645521,0.00014815103,0.000037095117,0.000041048846,0.000015250722,0.00025449434,8.4287365e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008561076,0.0003136735,0.4704899,0.00057688716,0.000324566,0.00017493147,0.00060852617,0.000010801703,0.0009635665,0.000020111194,0.0012693267,0.5166867],"study_design_scores_gemma":[0.13517459,0.006420629,0.8494492,0.0008437107,0.00033524295,0.00014486116,0.000026221744,0.0000040946893,0.0018417126,0.00017933547,0.005523032,0.000057356105],"about_ca_topic_score_codex":0.0004029758,"about_ca_topic_score_gemma":0.00005473612,"teacher_disagreement_score":0.5166293,"about_ca_system_score_codex":0.0001492398,"about_ca_system_score_gemma":0.00010600752,"threshold_uncertainty_score":0.31840912},"labels":[],"label_agreement":null},{"id":"W2048857395","doi":"10.1016/j.acvd.2010.01.005","title":"Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: Results of the CENTAURUS study","year":2010,"lang":"en","type":"article","venue":"Archives of cardiovascular diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"AstraZeneca","keywords":"Medicine; Rosuvastatin; Atorvastatin; Apolipoprotein B; Acute coronary syndrome; Internal medicine; Cardiology; Metabolic syndrome; Cholesterol; Obesity; Myocardial infarction","score_opus":0.010129334419067113,"score_gpt":0.2657575086327395,"score_spread":0.2556281742136724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048857395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932711,0.0011663834,0.000030813673,0.000036831138,0.00018776844,0.0048850444,0.0003184027,0.000011598152,0.00009207073],"genre_scores_gemma":[0.9991873,0.00003508103,0.0005340681,0.0000049232326,0.000031753745,0.000106680265,0.000046185974,0.00004627,0.000007761506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950792,0.00086921576,0.0013393735,0.000519984,0.0017974055,0.0003947957],"domain_scores_gemma":[0.9962784,0.0002875087,0.0006968345,0.002429615,0.0001601352,0.00014747465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007105621,0.0003308944,0.0016916286,0.00026232467,0.0000764193,0.000006817282,0.00053251284,0.00007413103,0.000005333806],"category_scores_gemma":[0.00064358267,0.00020858103,0.0013280874,0.00077269314,0.0006400118,0.00009128792,0.00029174736,0.00049857417,3.1277773e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012001936,0.0049964045,0.92981243,0.00081582105,0.004857294,0.00003463684,0.0038672995,0.0042930376,0.0013566448,0.000045867644,0.0000066520915,0.037911985],"study_design_scores_gemma":[0.02500657,0.0014248331,0.9590548,0.0008844249,0.0015005827,0.000008589436,0.0009982348,0.00007747946,0.010824876,0.000020135782,0.000019642852,0.00017978734],"about_ca_topic_score_codex":0.0050720554,"about_ca_topic_score_gemma":0.00046199549,"teacher_disagreement_score":0.0377322,"about_ca_system_score_codex":0.000045386427,"about_ca_system_score_gemma":0.0005792932,"threshold_uncertainty_score":0.8505688},"labels":[],"label_agreement":null},{"id":"W2048874580","doi":"10.1016/j.ijcard.2010.08.043","title":"Influence of age, gender, and race on the efficacy of adding ezetimibe to atorvastatin vs. atorvastatin up-titration in patients at moderately high or high risk for coronary heart disease","year":2010,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Merck","keywords":"Atorvastatin; Ezetimibe; Medicine; Internal medicine; Apolipoprotein B; Cholesterol; Population; Endocrinology; Gastroenterology; Cardiology","score_opus":0.01963148941756463,"score_gpt":0.2997468813010876,"score_spread":0.28011539188352297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048874580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974171,0.00004788333,0.00077261374,0.0006419537,0.00043059955,0.0005418408,0.00013139892,0.0000030525844,0.000013581363],"genre_scores_gemma":[0.9975797,0.0000772813,0.0015489358,0.0004579735,0.0002645787,0.000020472808,0.000023033474,0.000014291488,0.000013737909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839985,0.00019418629,0.00058868906,0.00016252682,0.00051424344,0.00014052317],"domain_scores_gemma":[0.99804497,0.0005422809,0.00037942053,0.00017313854,0.00072513643,0.0001350654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085343886,0.00011671295,0.0004857693,0.00016185569,0.00004063019,0.00000805646,0.00013627418,0.00006754467,0.000012345796],"category_scores_gemma":[0.0014048405,0.000077414785,0.00017420664,0.00006922914,0.00008401688,0.00007500496,0.000052095187,0.00025493384,0.0000010962373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06846439,0.00041205826,0.82804686,0.0002130463,0.00176779,0.00022314751,0.0012670782,0.066423245,0.009566829,0.0036429113,0.001967381,0.018005254],"study_design_scores_gemma":[0.0042407205,0.0009940597,0.99222875,0.000113524446,0.000088569,0.00007149398,0.000031322663,0.00009145742,0.0012107837,0.00033248242,0.000529454,0.00006741],"about_ca_topic_score_codex":0.00007319931,"about_ca_topic_score_gemma":0.000013882894,"teacher_disagreement_score":0.16418186,"about_ca_system_score_codex":0.00008322898,"about_ca_system_score_gemma":0.000210272,"threshold_uncertainty_score":0.31568834},"labels":[],"label_agreement":null},{"id":"W2048992545","doi":"10.1038/nrendo.2012.22","title":"Niacin: another look at an underutilized lipid-lowering medication","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Niacin; Medicine; Pharmacology; Dyslipidemia; Adverse effect; Tolerability; Clinical trial; B vitamins; Lipoprotein(a); Internal medicine; Apolipoprotein B; Cholesterol; Diabetes mellitus; Endocrinology","score_opus":0.07639929665962882,"score_gpt":0.38450584052409714,"score_spread":0.30810654386446834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048992545","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000049392147,0.9887874,0.00010624565,0.00024424164,0.0017148013,0.004484821,0.000021430937,0.00018759273,0.004448525],"genre_scores_gemma":[0.000017891129,0.99083185,0.0006540197,0.0015084983,0.003783345,0.00074333674,0.000648712,0.00018753452,0.0016248323],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946669,0.0010559926,0.0014609589,0.0010719341,0.0006026655,0.0011415591],"domain_scores_gemma":[0.99590087,0.000102035716,0.00081677345,0.0026124178,0.00010497978,0.00046295233],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0012732256,0.000901528,0.005942958,0.00038058712,0.00015550847,0.000015513166,0.0004518837,0.0019370539,0.0009850856],"category_scores_gemma":[0.00026855827,0.0006074234,0.0020408987,0.00044941992,0.00014709837,0.000114245,0.00023242405,0.0028117313,0.0009542183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016518447,0.00010548949,0.0000092844175,0.030792758,0.00042885685,0.000052845713,0.000021027274,6.7388526e-9,0.000002451793,0.0002753812,0.0018038031,0.9664916],"study_design_scores_gemma":[0.0007505356,0.00013406291,0.00002367841,0.008624006,0.004547516,0.0040400927,0.0000035244789,2.2221889e-7,0.000008004619,0.0000060369016,0.98139936,0.000462984],"about_ca_topic_score_codex":0.000027120373,"about_ca_topic_score_gemma":0.000036212066,"teacher_disagreement_score":0.97959554,"about_ca_system_score_codex":0.00077509857,"about_ca_system_score_gemma":0.0004781397,"threshold_uncertainty_score":0.9999282},"labels":[],"label_agreement":null},{"id":"W2049133873","doi":"10.1139/y07-043","title":"Effect of pioglitazone and its combination with statins in coronary artery disease patients with hyperinsulinemia","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pioglitazone; Hyperinsulinemia; Internal medicine; Medicine; Atorvastatin; Endocrinology; Diabetes mellitus; Insulin; Hyperlipidemia; Placebo; Coronary artery disease; Apolipoprotein B; Insulin resistance; Type 2 diabetes; Cholesterol; Pathology","score_opus":0.004826479508478425,"score_gpt":0.24711825790409875,"score_spread":0.24229177839562033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049133873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982374,0.0011836261,0.000009124676,0.00013620786,0.00008883532,0.0003121574,0.000013672405,0.0000011990606,0.000017783836],"genre_scores_gemma":[0.99953747,0.00007984101,0.000025881498,0.00026888345,0.00006103617,0.000003086912,0.000011636505,0.000007330968,0.0000048062775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993253,0.00013103234,0.00019081963,0.00009614538,0.00007184655,0.00018487858],"domain_scores_gemma":[0.9991826,0.00008632337,0.0001097199,0.000046776306,0.00013146315,0.00044313527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039447943,0.00008726387,0.00033030595,0.00017843128,0.000037852413,0.000001096295,0.000026898666,0.000050293544,0.000045305183],"category_scores_gemma":[0.000017404882,0.00005839685,0.000025321104,0.00008605482,0.00013714707,0.000051247043,0.00000447858,0.00020042554,2.2604942e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013702308,0.0001929172,0.9448815,0.0010797068,0.00044872766,0.0013316551,0.00046192828,0.000036573376,0.025823973,0.00005869691,0.000062510844,0.011919523],"study_design_scores_gemma":[0.009559679,0.006051578,0.97932506,0.00007038733,0.00019462097,0.00016758821,0.000024588251,0.000021735184,0.0044192662,0.000018081868,0.00008857603,0.000058835707],"about_ca_topic_score_codex":0.00015003032,"about_ca_topic_score_gemma":0.00045209937,"teacher_disagreement_score":0.034443583,"about_ca_system_score_codex":0.00004303836,"about_ca_system_score_gemma":0.0003693725,"threshold_uncertainty_score":0.23813546},"labels":[],"label_agreement":null},{"id":"W2049614740","doi":"10.1177/14746514050050020201","title":"Review: Defining the role of statins in diabetes","year":2005,"lang":"en","type":"article","venue":"The British Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"AstraZeneca","keywords":"Medicine; Atorvastatin; Rosuvastatin; Fibrate; Diabetes mellitus; Statin; Internal medicine; Niacin; Type 2 diabetes; Clinical trial; Cardiology; Pharmacology; Endocrinology","score_opus":0.006331942314054844,"score_gpt":0.23865852464461082,"score_spread":0.23232658233055598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049614740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5784599,0.41927463,9.713449e-7,0.0015981128,0.000026656295,0.00015025138,0.000004293268,0.0000027398758,0.00048240297],"genre_scores_gemma":[0.9559676,0.04093719,0.00036635136,0.0024019354,0.00028263917,0.000007949301,0.0000017132842,0.00001534656,0.000019247465],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99847007,0.00022413113,0.0005847905,0.000072574774,0.00039729002,0.0002511204],"domain_scores_gemma":[0.9990527,0.00017211727,0.00031007538,0.000229145,0.00016597842,0.00006997728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002972994,0.00008135552,0.0005005358,0.00003860571,0.000104003666,0.00003230839,0.00019866118,0.000031682237,0.000038972656],"category_scores_gemma":[0.0004980654,0.000050152517,0.00028297972,0.0001995779,0.00008826852,0.00009358838,0.000033211796,0.00040667527,0.0000050460258],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000068797676,0.00011303447,0.060144197,0.00050439744,0.00022118134,0.000010203204,0.00019160443,0.000026556214,0.00068013516,0.00006313696,0.0027520717,0.9352866],"study_design_scores_gemma":[0.0054884925,0.0013538249,0.68914425,0.062334634,0.0015223748,0.0010138903,0.0017164404,0.0004269261,0.032338116,0.0028603775,0.20132558,0.00047508403],"about_ca_topic_score_codex":0.00007710049,"about_ca_topic_score_gemma":0.000057605223,"teacher_disagreement_score":0.93481153,"about_ca_system_score_codex":0.00003542128,"about_ca_system_score_gemma":0.00011371235,"threshold_uncertainty_score":0.20451604},"labels":[],"label_agreement":null},{"id":"W2050121625","doi":"10.1097/01.mca.0000131571.06897.da","title":"Emphasis on pleiotropic effects, a new paradigm shift?","year":2004,"lang":"en","type":"editorial","venue":"Coronary Artery Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; University hospital; Research centre; Library science; Family medicine","score_opus":0.008044352780678247,"score_gpt":0.2542328672366509,"score_spread":0.24618851445597265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050121625","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01459942,0.025040958,0.0004117165,0.002988217,0.9515339,0.0038449056,0.00047832722,0.00050797884,0.00059454015],"genre_scores_gemma":[0.05484291,0.0016234259,0.000060297472,0.0013265021,0.9370924,0.00028704194,0.0025126133,0.00021312457,0.0020416442],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957651,0.00018393366,0.00048019583,0.0010968285,0.0017568334,0.000717121],"domain_scores_gemma":[0.9955229,0.00023840475,0.00015293546,0.0019920692,0.00004431305,0.0020493506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018370454,0.0007207578,0.0011927935,0.0002070474,0.0001719425,0.00006337112,0.00028652776,0.0006311647,0.00023174661],"category_scores_gemma":[0.00032022852,0.0006357003,0.0011591886,0.00017974286,0.00009023271,0.00011565506,0.00008280492,0.0010605823,0.00073476613],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00245737,0.000669261,0.00027751995,0.0026875432,0.0007666558,0.008724919,0.00007409252,0.000012767653,0.0000010776503,0.00015356993,0.94339323,0.040781964],"study_design_scores_gemma":[0.0070992894,0.0015835249,0.06201715,0.0024520794,0.0018607005,0.000040035495,0.0000032001512,0.0000033571325,0.0000047405138,0.0016542872,0.9226616,0.0006200494],"about_ca_topic_score_codex":0.00013444561,"about_ca_topic_score_gemma":0.000012040095,"teacher_disagreement_score":0.06173963,"about_ca_system_score_codex":0.00072333054,"about_ca_system_score_gemma":0.0054356246,"threshold_uncertainty_score":0.9996094},"labels":[],"label_agreement":null},{"id":"W2050214825","doi":"10.1186/1476-511x-12-112","title":"Decreased APOE-containing HDL subfractions and cholesterol efflux capacity of serum in mice lacking Pcsk9","year":2013,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Center for Research Resources; National Institute of General Medical Sciences; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"LDL receptor; Apolipoprotein E; Cholesterol; PCSK9; Endocrinology; Internal medicine; Knockout mouse; Apolipoprotein B; Lipidology; Biology; Fatty streak; Lipoprotein; Chemistry; Receptor; Medicine","score_opus":0.021534417476965738,"score_gpt":0.2786354689662753,"score_spread":0.25710105148930956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050214825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947489,0.0016838623,0.000051098985,0.002264456,0.0000880054,0.0010158516,0.000019911968,0.000021122863,0.00010681028],"genre_scores_gemma":[0.99586946,0.00040647146,0.0002971421,0.003111996,0.00016765478,0.00010036259,0.000012188432,0.000014827651,0.000019914422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846286,0.00021766381,0.00045184436,0.0002872764,0.0002051959,0.0003751462],"domain_scores_gemma":[0.99818677,0.00010751885,0.000103883904,0.00026041616,0.000050405,0.0012910048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006911366,0.00013726958,0.00043142962,0.00017665782,0.00009412439,0.000018308514,0.000035649035,0.00006930407,0.00002569701],"category_scores_gemma":[0.0005338359,0.00012592755,0.00006367892,0.00019469326,0.000070042224,0.00015570533,0.000029793146,0.00029138188,0.0000029081916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001471566,0.00015929398,0.9688513,0.002484879,0.000014204269,0.000003710561,0.0007966981,0.000007922814,0.000035966805,0.000121691686,0.00002961442,0.027347531],"study_design_scores_gemma":[0.003136317,0.00020035788,0.99345815,0.00067624607,0.000019296043,0.000013543454,0.00090474804,0.0008114121,0.000018989324,0.00023605039,0.0004225879,0.00010227341],"about_ca_topic_score_codex":0.014726476,"about_ca_topic_score_gemma":0.00064885046,"teacher_disagreement_score":0.027245259,"about_ca_system_score_codex":0.00009178818,"about_ca_system_score_gemma":0.00051296357,"threshold_uncertainty_score":0.9918345},"labels":[],"label_agreement":null},{"id":"W2050348933","doi":"10.1371/journal.pone.0041865","title":"Annexin A2 Is a Natural Extrahepatic Inhibitor of the PCSK9-Induced LDL Receptor Degradation","year":2012,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Montreal Clinical Research Institute","funders":"Institute of Nutrition, Metabolism and Diabetes; Canadian Institutes of Health Research; State University of New York; SUNY Downstate Medical Center; Heart and Stroke Foundation of Canada","keywords":"PCSK9; LDL receptor; Biology; Endocrinology; Kexin; Internal medicine; Proprotein convertase; Annexin A2; Cholesterol; Lipoprotein; Annexin; Molecular biology; Medicine","score_opus":0.04892088453730945,"score_gpt":0.24928329526505,"score_spread":0.20036241072774055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050348933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956125,0.0016231152,0.000009460767,0.0013579804,0.00022385597,0.0007757505,0.000007368659,0.00003036909,0.000359596],"genre_scores_gemma":[0.9965001,0.000050109644,0.0015501275,0.0005048676,0.00077771157,0.000040593008,0.00001330546,0.000021205366,0.0005420088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986168,0.00009142834,0.0002423732,0.00013547321,0.00066651317,0.00024738116],"domain_scores_gemma":[0.9991184,0.000023482453,0.00010367309,0.00050430425,0.0001308219,0.00011931447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039310424,0.00010784862,0.0003133915,0.000033737848,0.00006313881,0.00000582872,0.00007602699,0.00008488283,0.0001265038],"category_scores_gemma":[0.0001998378,0.0000703786,0.0001801428,0.00021722716,0.000031069794,0.00011208923,0.00003421501,0.00022434477,0.000051533396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001947588,0.0028495647,0.059693843,0.0013279347,0.0010614954,0.0000013339958,0.0022195287,4.2749726e-8,0.9002909,0.00017641955,0.0011537856,0.031030368],"study_design_scores_gemma":[0.0012542504,0.000210042,0.08375451,0.0006823231,0.0005190282,0.000008298074,0.0001802634,0.0000746227,0.9123346,0.000022017968,0.00082003005,0.00013996693],"about_ca_topic_score_codex":0.00017721303,"about_ca_topic_score_gemma":0.000009914369,"teacher_disagreement_score":0.030890401,"about_ca_system_score_codex":0.00008053376,"about_ca_system_score_gemma":0.00007243355,"threshold_uncertainty_score":0.2869956},"labels":[],"label_agreement":null},{"id":"W2050402762","doi":"10.1152/japplphysiol.00158.2011","title":"Endotoxin-induced cardiovascular dysfunction in mice: effect of simvastatin","year":2011,"lang":"en","type":"article","venue":"Journal of Applied Physiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Simvastatin; Medicine; Pharmacology; Internal medicine; Cardiology; Endocrinology","score_opus":0.015196786108658598,"score_gpt":0.24084562003204635,"score_spread":0.22564883392338775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050402762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963077,0.00053235795,0.00013211336,0.000010841853,0.00022629646,0.00044773225,9.20277e-7,0.000006477291,0.0023355766],"genre_scores_gemma":[0.99889374,0.00011822727,0.0005508103,0.000060912287,0.0003341184,0.000016757838,0.0000024537724,0.000018965695,0.0000040142613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985208,0.00017382384,0.00057469535,0.00016753183,0.00033958655,0.00022358091],"domain_scores_gemma":[0.99908614,0.00006396271,0.00031788918,0.00031782693,0.00011127383,0.00010293101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001349711,0.00014964996,0.0011435556,0.00021237928,0.000019297173,0.0000014183695,0.00009243954,0.00013949387,0.00005245629],"category_scores_gemma":[0.00004872194,0.00010607823,0.0006956337,0.00020710002,0.000046336387,0.000037962487,0.000024791792,0.00040045855,0.000008690247],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004908342,0.00019857015,0.00037335284,0.00045557387,0.001379846,0.000082015926,0.0005193933,0.00008671299,0.93983954,0.00013970716,0.000050764276,0.051966168],"study_design_scores_gemma":[0.010157972,0.0033336687,0.13201655,0.0001299329,0.00066587824,0.00031893927,0.00021528761,0.000021705806,0.85178804,0.0004651944,0.0007370053,0.00014980031],"about_ca_topic_score_codex":0.000103846345,"about_ca_topic_score_gemma":0.000002140654,"teacher_disagreement_score":0.13164319,"about_ca_system_score_codex":0.00006817191,"about_ca_system_score_gemma":0.00012344676,"threshold_uncertainty_score":0.43257445},"labels":[],"label_agreement":null},{"id":"W2050802974","doi":"10.1503/cmaj.1060001","title":"An evaluation of class effect","year":2006,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Pravastatin; Atorvastatin; Observational study; Randomized controlled trial; Medicine; Computer science; Internal medicine; Cholesterol","score_opus":0.00788710623827011,"score_gpt":0.27320869543256876,"score_spread":0.26532158919429866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050802974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98505497,0.0005238253,0.00009101822,0.0050635473,0.0003900639,0.0002630275,0.0000060340285,0.000009826567,0.008597675],"genre_scores_gemma":[0.99619406,0.000020578374,0.000058749658,0.0012100852,0.0024104228,0.000006774995,0.000021189038,0.000009986616,0.00006812467],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9954951,0.0005396288,0.0003372693,0.00009709992,0.0032662898,0.00026463266],"domain_scores_gemma":[0.9978485,0.00004324235,0.00015606737,0.00014353456,0.0008583388,0.0009503236],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010415922,0.00006962581,0.0002515151,0.00014507466,0.00010232988,0.000020152193,0.00006905354,0.00026682887,0.0015177628],"category_scores_gemma":[0.0010846586,0.000057103796,0.00015992348,0.00017303607,0.000018207997,0.00007099366,0.0000023651985,0.00043920308,0.000026447404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033475902,0.000115733594,0.29496437,0.000061683095,0.00032325677,0.00021159418,0.00009040913,0.00009216002,0.00028203567,0.00043796326,0.033990126,0.6693972],"study_design_scores_gemma":[0.006789689,0.00066215126,0.83728355,0.00017855984,0.0005784007,0.001051032,0.000111713845,0.005687238,0.00068838877,0.0004308031,0.14636737,0.00017108627],"about_ca_topic_score_codex":0.010901617,"about_ca_topic_score_gemma":0.019971251,"teacher_disagreement_score":0.6692261,"about_ca_system_score_codex":0.0012810893,"about_ca_system_score_gemma":0.0048596854,"threshold_uncertainty_score":0.999395},"labels":[],"label_agreement":null},{"id":"W2050927931","doi":"10.1074/jbc.m309705200","title":"The Apolipoprotein(a) Component of Lipoprotein(a) Stimulates Actin Stress Fiber Formation and Loss of Cell-Cell Contact in Cultured Endothelial Cells","year":2004,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Myosin light-chain kinase; Cytoskeleton; Stress fiber; Cell biology; Actin cytoskeleton; Focal adhesion; Actin; Intracellular; Rho kinase inhibitor; Biology; Rho-associated protein kinase; Phosphorylation; Cell; Biochemistry","score_opus":0.0129899072844852,"score_gpt":0.24294408728766978,"score_spread":0.22995418000318457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050927931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996848,0.0020552946,0.000075068034,0.00023090043,0.00003560993,0.00037302406,0.000030406472,0.0000046090013,0.00034711175],"genre_scores_gemma":[0.9978589,0.0010681798,0.0008024225,0.000021528043,0.00018859337,0.0000047386625,0.000007490536,0.0000079780775,0.00004019491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840873,0.00006580003,0.00078279985,0.00013106897,0.00039080664,0.00022076021],"domain_scores_gemma":[0.9986806,0.00008526853,0.0006904351,0.0002113719,0.00019399317,0.00013834822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006366394,0.00016230949,0.00059052,0.000029742241,0.000046029556,0.000011621289,0.00014241092,0.00022036236,0.000029091041],"category_scores_gemma":[0.000072709205,0.000088299435,0.00027358095,0.000093302115,0.00013456005,0.00005895466,0.000048811355,0.00041982476,0.0000010101909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008558841,0.00037877855,0.0006867819,0.00066526444,0.00006561469,0.00004396225,0.00014841309,0.00013354525,0.99511313,0.00000505457,0.0000072374655,0.0018963441],"study_design_scores_gemma":[0.004403538,0.0005536978,0.003259143,0.00034981457,0.00005706796,0.00016103346,0.00037998677,0.000014962288,0.99025446,0.00010389799,0.00037265837,0.000089723144],"about_ca_topic_score_codex":0.00016393806,"about_ca_topic_score_gemma":0.0000042124575,"teacher_disagreement_score":0.0048586433,"about_ca_system_score_codex":0.000092445676,"about_ca_system_score_gemma":0.000100982936,"threshold_uncertainty_score":0.36007464},"labels":[],"label_agreement":null},{"id":"W2051160165","doi":"10.1161/circulationaha.106.624890","title":"Risks Associated With Statin Therapy","year":2006,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":483,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive care medicine; Internal medicine","score_opus":0.10813984120844791,"score_gpt":0.3645392576216039,"score_spread":0.256399416413156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051160165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045635476,0.9954156,0.0005997437,0.000009814196,0.00006368515,0.0017689385,0.000020080292,0.00009110037,0.0015746838],"genre_scores_gemma":[0.0020661943,0.99523866,0.00007555388,0.00004013122,0.0003572727,0.00012293892,0.0019107335,0.000073724754,0.00011479769],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984792,0.00018772404,0.00035917552,0.0002972442,0.0004755154,0.00020114362],"domain_scores_gemma":[0.9990232,0.00004102071,0.00030287073,0.0004429639,0.000117920885,0.00007199544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043904292,0.00024541683,0.0012184462,0.00011528749,0.00006744465,0.000021063797,0.000042953685,0.00028981705,0.00003805309],"category_scores_gemma":[0.000041149415,0.00016443392,0.00046460333,0.00035025974,0.000022720098,0.000034713685,0.000005597547,0.00028824614,0.00002945624],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004574738,0.000052122432,0.00042791135,0.0023438814,0.0004219233,0.000017960492,0.000010590193,0.0000071781164,1.00910526e-7,0.000020183577,0.000120303885,0.99657327],"study_design_scores_gemma":[0.0009809238,0.00007414675,0.0267315,0.0075938595,0.0011660537,0.000059873935,0.000002506793,0.000020734797,2.6384757e-7,0.000020063077,0.9631219,0.00022817009],"about_ca_topic_score_codex":0.00021126319,"about_ca_topic_score_gemma":0.000013035212,"teacher_disagreement_score":0.9963451,"about_ca_system_score_codex":0.00029780366,"about_ca_system_score_gemma":0.00045433495,"threshold_uncertainty_score":0.67054206},"labels":[],"label_agreement":null},{"id":"W2051204145","doi":"10.1007/s11883-004-0086-6","title":"Diet and low-density lipoprotein particle size","year":2004,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Phenotype; Medicine; Atherosclerotic cardiovascular disease; Low-density lipoprotein; Lipoprotein; Trait; Disease; Internal medicine; Cholesterol; Endocrinology; Biology; Genetics; Gene; Computer science","score_opus":0.050550951295501634,"score_gpt":0.3235282818773882,"score_spread":0.27297733058188656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051204145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011033476,0.98463005,0.000029035877,0.000036661917,0.00091682706,0.003096544,0.000014967291,0.00018159744,0.00006082116],"genre_scores_gemma":[0.005946989,0.99235654,0.0001258782,0.0000331353,0.0007435689,0.000449522,0.000061008017,0.00013988861,0.00014348436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99592537,0.00016290353,0.0012827567,0.001141977,0.00084828184,0.0006387044],"domain_scores_gemma":[0.9968132,0.000055281824,0.0007194345,0.001684453,0.000133482,0.0005941904],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010188668,0.0006995341,0.002924313,0.000067648834,0.00019221687,0.000088897854,0.00009837264,0.0004144862,0.00007852276],"category_scores_gemma":[0.00038424323,0.00053372444,0.001403367,0.0003660889,0.000158959,0.00008967534,0.00020037979,0.00078729866,0.000057659207],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013106095,0.00029459642,0.00015576834,0.040548448,0.00026654065,0.00015529597,0.000073637595,8.990513e-8,0.00000865661,0.000014667319,0.000101220314,0.958368],"study_design_scores_gemma":[0.0006973645,0.000310471,0.0028428605,0.07230637,0.0024638597,0.001226061,0.000008148318,0.0000010764526,0.00006225734,0.00007334026,0.9193345,0.00067368784],"about_ca_topic_score_codex":0.0001946401,"about_ca_topic_score_gemma":0.000007831862,"teacher_disagreement_score":0.9576943,"about_ca_system_score_codex":0.0003771136,"about_ca_system_score_gemma":0.0008020942,"threshold_uncertainty_score":0.99971145},"labels":[],"label_agreement":null},{"id":"W2051336160","doi":"10.1007/s10557-009-6190-7","title":"How Can We Improve the Management of Vascular Risk in Type 2 Diabetes: Insights from FIELD","year":2009,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Fenofibrate; Medicine; Fibrate; Dyslipidemia; Type 2 diabetes; Internal medicine; Diabetes mellitus; Metabolic syndrome; Diabetic retinopathy; Relative risk; Type 2 Diabetes Mellitus; Endocrinology; Statin","score_opus":0.015093042608351374,"score_gpt":0.24898470169554268,"score_spread":0.2338916590871913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051336160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022761303,0.99372166,0.00004956329,0.00015548084,0.00034791487,0.0031086225,0.000027023549,0.000031889776,0.00028169173],"genre_scores_gemma":[0.0015579689,0.99710953,0.00016365171,0.00016756837,0.00056470954,0.0001996017,0.00007920649,0.000085951135,0.000071820155],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965474,0.00064713,0.000606953,0.0008407455,0.0009179872,0.00043980897],"domain_scores_gemma":[0.9967977,0.00009789967,0.000265596,0.002554461,0.00011120683,0.0001731458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010543362,0.00064420525,0.003737886,0.00020340101,0.00011325068,0.00007200436,0.00033257357,0.0004717199,0.0000075049866],"category_scores_gemma":[0.00001895791,0.00037651058,0.004244562,0.0006294814,0.000092062444,0.000054220167,0.000095800184,0.00080640323,0.0000029780338],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018649851,0.000057543566,0.000007387505,0.0049822386,0.018573772,0.00005848396,0.00024017993,0.0000013167922,4.2598865e-7,0.00005384821,0.000025649188,0.9759805],"study_design_scores_gemma":[0.002115769,0.0002559246,0.0001629303,0.007781825,0.006670188,0.000007756565,0.00023085438,0.0000049176247,0.000024868432,0.0003319882,0.9820188,0.0003941765],"about_ca_topic_score_codex":0.00062684447,"about_ca_topic_score_gemma":0.00000951714,"teacher_disagreement_score":0.98199314,"about_ca_system_score_codex":0.00009827638,"about_ca_system_score_gemma":0.00018157603,"threshold_uncertainty_score":0.9998687},"labels":[],"label_agreement":null},{"id":"W2051756878","doi":"10.1136/bmj.332.7553.1330","title":"Should we lower cholesterol as much as possible?","year":2006,"lang":"en","type":"review","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Computer science; Cholesterol; Data science; Text mining; World Wide Web; Medicine; Bioinformatics; Internal medicine; Data mining; Biology","score_opus":0.07461327130243554,"score_gpt":0.3982081066712758,"score_spread":0.32359483536884026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051756878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001750525,0.92717755,0.000023482375,0.000928082,0.0007231829,0.0035338106,0.000020518464,0.00011520575,0.06746066],"genre_scores_gemma":[0.0000129266655,0.9619111,0.00014585433,0.0010908927,0.004420737,0.00043250195,0.00018019136,0.00014475381,0.031661067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967359,0.00020046177,0.00087494095,0.0006432046,0.001015407,0.0005301176],"domain_scores_gemma":[0.997568,0.000036392743,0.00028985317,0.0016739396,0.0001018236,0.0003299662],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00089358154,0.0005523107,0.0026650021,0.00021795706,0.00008213363,0.000055464185,0.00023077049,0.0007621746,0.0004647475],"category_scores_gemma":[0.00007975073,0.00038723345,0.0019874768,0.0003692141,0.000050331066,0.00005122842,0.000092299604,0.0008779122,0.0029985134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011079963,0.00009976692,0.000004732004,0.018052781,0.0004027757,0.00048650475,0.000011112923,6.568501e-8,6.951295e-8,0.0000666295,0.03672313,0.9441413],"study_design_scores_gemma":[0.00066570455,0.00024721073,0.000042619387,0.020349333,0.0018949419,0.002509944,0.000008061694,3.4544237e-7,0.0000021198675,0.000038028676,0.97387844,0.00036326697],"about_ca_topic_score_codex":0.00068739284,"about_ca_topic_score_gemma":0.000023142618,"teacher_disagreement_score":0.9437781,"about_ca_system_score_codex":0.0002195076,"about_ca_system_score_gemma":0.0013674333,"threshold_uncertainty_score":0.99985796},"labels":[],"label_agreement":null},{"id":"W2051794682","doi":"10.3821/1913-701x(2007)140[300:hthpmt]2.0.co;2","title":"How to help patients manage their dyslipidemia: A primary care physician–pharmacist team intervention","year":2007,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primary care; Dyslipidemia; Pharmacist; Medicine; Primary care physician; Intervention (counseling); Family medicine; Clinical pharmacy; Nursing; Pharmacy; Internal medicine; Disease","score_opus":0.019077887879377364,"score_gpt":0.26079967845401997,"score_spread":0.2417217905746426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051794682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98229986,0.003205475,0.0013048141,0.00034803612,0.004024592,0.0019597758,0.00066367735,0.00007693867,0.006116803],"genre_scores_gemma":[0.98085886,0.00094373897,0.0003748734,0.012883733,0.0034610108,0.000040361025,0.0002784316,0.00013375963,0.0010252108],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99523604,0.00020994525,0.0008764718,0.0007077344,0.0011583746,0.0018114421],"domain_scores_gemma":[0.99272835,0.000055290595,0.00035185934,0.0005769449,0.0013120669,0.0049755042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015347514,0.0006333184,0.0008752174,0.00076137553,0.00094126497,0.00029585644,0.0006226229,0.00013083122,0.0000965061],"category_scores_gemma":[0.00015310668,0.00061071187,0.0007068888,0.0010669071,0.0001273348,0.0004743001,0.00010398979,0.0012586963,0.000024735698],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056404254,0.00017253148,0.005296894,0.0018664235,0.0007072532,0.026263941,0.0018075214,0.00007355816,0.0016931008,0.000009776881,0.03307393,0.928471],"study_design_scores_gemma":[0.01538824,0.00055882067,0.002822999,0.00046912,0.0009961688,0.1257527,0.00044943872,0.00031800554,0.013253052,0.00002638875,0.83816147,0.0018035688],"about_ca_topic_score_codex":0.010840625,"about_ca_topic_score_gemma":0.05095488,"teacher_disagreement_score":0.92666745,"about_ca_system_score_codex":0.009761688,"about_ca_system_score_gemma":0.0024570501,"threshold_uncertainty_score":0.99963444},"labels":[],"label_agreement":null},{"id":"W2052269816","doi":"10.1016/s1567-5688(05)80429-5","title":"W16-P-033 Direct statin comparison of LDL-Cvalues: An evaluation of rosuvastatin therapy (discovery — Canada)","year":2005,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Statin; Medicine; Internal medicine","score_opus":0.07838923376061507,"score_gpt":0.3598021456357078,"score_spread":0.2814129118750927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052269816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637043,0.00090564706,0.00022518777,0.00025528943,0.0001157049,0.0013571715,0.00036880656,0.000020323398,0.00038146295],"genre_scores_gemma":[0.9964705,0.00027898978,0.002313441,0.00025450543,0.00013716982,0.0001044135,0.00032997876,0.000047547906,0.00006342371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99560267,0.00041343056,0.0008630966,0.00036881262,0.0023818398,0.00037012613],"domain_scores_gemma":[0.9981819,0.000051388764,0.00039803007,0.000768329,0.00044163753,0.00015876169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019158375,0.00023337032,0.0007400094,0.00008398725,0.00008802589,0.000017889606,0.00015992415,0.00007092429,0.0005411783],"category_scores_gemma":[0.00007337585,0.00020279741,0.00019212911,0.00022829499,0.00006261953,0.00023165181,0.00003363375,0.00012793233,0.0000022696468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005458894,0.0031029196,0.4765028,0.00033279386,0.0013042389,8.7583004e-7,0.005519576,0.0022668764,0.1300708,0.00008295557,0.009461467,0.3708088],"study_design_scores_gemma":[0.011108476,0.0016893272,0.5805331,0.0002899752,0.0005020038,0.000001873141,0.0026869418,0.005461688,0.38836053,0.00002674196,0.008974628,0.0003647248],"about_ca_topic_score_codex":0.2031468,"about_ca_topic_score_gemma":0.14639251,"teacher_disagreement_score":0.3704441,"about_ca_system_score_codex":0.0003568023,"about_ca_system_score_gemma":0.0010921551,"threshold_uncertainty_score":0.8691836},"labels":[],"label_agreement":null},{"id":"W2052275573","doi":"10.1007/s11883-007-0031-6","title":"The strengths and limitations of the ApoB/ApoA-I ratio to predict the risk of vascular disease: a hegelian analysis","year":2007,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre","funders":"","keywords":"Angiology; Medicine; Hegelianism; Apolipoprotein B; Internal medicine; Disease; Cardiology; Epistemology; Cholesterol; Philosophy","score_opus":0.06160193629691712,"score_gpt":0.3399515003699717,"score_spread":0.27834956407305456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052275573","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044843424,0.9904626,0.00050530385,0.0001121678,0.00053167215,0.0036716731,0.00015637165,0.000023833749,0.000052057258],"genre_scores_gemma":[0.017544074,0.98152304,0.00004396098,0.00001856638,0.00026553476,0.0003967308,0.00008507782,0.00005441279,0.000068613335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99518514,0.00065881,0.0017320806,0.0006263469,0.001421417,0.00037620944],"domain_scores_gemma":[0.9935565,0.0008889063,0.0016825162,0.0031780247,0.00036102431,0.00033300743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032350505,0.00045646995,0.0018876195,0.00021554407,0.00046998548,0.000054507742,0.0003321902,0.00016221667,0.000008630295],"category_scores_gemma":[0.0028449006,0.00019695424,0.0035782317,0.0020397946,0.00033579234,0.000039442184,0.00021763076,0.0005770871,0.0000016778995],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007495069,0.00014833937,0.00430815,0.0030547502,0.004446706,0.0000021432288,0.00023760565,0.000029204522,0.0000011585386,0.00003308658,0.00027079866,0.98746055],"study_design_scores_gemma":[0.00017034543,0.00005663484,0.05728575,0.0056499355,0.0317335,0.000012307085,0.00006584332,0.000029370034,0.000005105917,0.000014506365,0.9047898,0.00018689515],"about_ca_topic_score_codex":0.00013382119,"about_ca_topic_score_gemma":0.000119334036,"teacher_disagreement_score":0.9872737,"about_ca_system_score_codex":0.00010770414,"about_ca_system_score_gemma":0.0006857978,"threshold_uncertainty_score":0.8031561},"labels":[],"label_agreement":null},{"id":"W2052672877","doi":"10.1016/s0021-9150(00)80215-4","title":"Efficacy of pravastatin in reducing plasma LDL-cholesterol and LDL-apo B concentrations in mixed hyperlipidemias of different genetic causes","year":2000,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université du Québec à Chicoutimi","funders":"","keywords":"Pravastatin; Apolipoprotein B; Ldl cholesterol; Hyperlipidemia; Cholesterol; Internal medicine; Chemistry; Endocrinology; Medicine; Diabetes mellitus","score_opus":0.022311142100986316,"score_gpt":0.25859300687766856,"score_spread":0.23628186477668225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052672877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851316,0.00041035344,0.000016620375,0.00018832232,0.00003718903,0.0007297042,0.000013207668,0.00001238005,0.000079087724],"genre_scores_gemma":[0.9978135,0.0012798732,0.0006809122,0.000068355526,0.000038145,0.00004731509,0.000007996863,0.000024576191,0.000039332062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839693,0.00017001566,0.0006186004,0.00028828921,0.0002676863,0.00025845],"domain_scores_gemma":[0.9992468,0.00012557271,0.000113145754,0.0003734756,0.000035422472,0.00010561607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027396344,0.0001602551,0.00059216714,0.00009739311,0.000027591967,0.000008069266,0.00006136033,0.000102705526,0.00006667635],"category_scores_gemma":[0.00009003353,0.00013851344,0.00010831088,0.0002192347,0.00010727929,0.000045959532,0.000019730038,0.00017030376,0.0000022498893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025721747,0.000913839,0.66044825,0.00045425878,0.00014105618,0.000005003659,0.003936918,0.00046040723,0.20172684,0.000051983538,0.00002169961,0.13158254],"study_design_scores_gemma":[0.004481147,0.00026723515,0.96155614,0.00074512715,0.00007305148,0.000007665428,0.000203506,0.0003784943,0.03211955,0.0000102471995,0.000055679706,0.00010215694],"about_ca_topic_score_codex":0.0014390387,"about_ca_topic_score_gemma":0.00052237074,"teacher_disagreement_score":0.3011079,"about_ca_system_score_codex":0.000061580904,"about_ca_system_score_gemma":0.00007338127,"threshold_uncertainty_score":0.5648414},"labels":[],"label_agreement":null},{"id":"W2052867812","doi":"10.1016/j.cjca.2012.03.003","title":"Utility of Biomarkers and Imaging in the Development of Drugs for the Treatment of Coronary Atherosclerosis","year":2012,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ezetimibe; Clinical trial; Rimonabant; Niacin; Drug development; Internal medicine; Cholesterylester transfer protein; Cholesterol; Cardiology; Lipoprotein; Drug; Pharmacology; Cannabinoid receptor; Receptor","score_opus":0.07800721323232034,"score_gpt":0.3161472918992581,"score_spread":0.23814007866693776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052867812","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004972,0.9933289,0.00018782988,0.000086971326,0.0001941804,0.0009828017,0.0000639355,4.247138e-7,0.00018292715],"genre_scores_gemma":[0.18156223,0.8178939,0.00027263025,0.000013701029,0.00020154372,0.000030028763,0.000008417315,0.000014191932,0.0000033071626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982624,0.00035262888,0.00088681065,0.00010524517,0.00015103054,0.00024186229],"domain_scores_gemma":[0.9984971,0.00030677218,0.00054836477,0.00033304316,0.00014584386,0.00016883836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002180461,0.00016882872,0.0019041738,0.00019978448,0.000047626556,0.0000021824599,0.00015528775,0.00012020363,0.000004525981],"category_scores_gemma":[0.000046622237,0.00008308533,0.00086876994,0.00011943989,0.00026836008,0.000016520407,0.0000073078027,0.00012477899,9.4191066e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028090284,0.000008489158,0.0067011355,0.0023067878,0.0013746631,0.0000042623715,0.001017604,3.3499714e-7,9.586e-7,0.000007984325,0.000057439087,0.98849225],"study_design_scores_gemma":[0.0008454433,0.00023431925,0.06404152,0.0017115122,0.0024909144,0.00042742796,0.00077640434,6.613337e-7,0.000007112009,0.0000063160387,0.92939067,0.00006767771],"about_ca_topic_score_codex":0.0010574603,"about_ca_topic_score_gemma":0.00077129784,"teacher_disagreement_score":0.9884246,"about_ca_system_score_codex":0.00016581191,"about_ca_system_score_gemma":0.0031213835,"threshold_uncertainty_score":0.55372006},"labels":[],"label_agreement":null},{"id":"W2052967530","doi":"10.1016/j.cjca.2014.03.006","title":"Risk Stratification and Selection for Statin Therapy: Going Beyond Framingham","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa; Libin Cardiovascular Institute of Alberta; Montreal Heart Institute; University of British Columbia; University of Toronto; University of Calgary; St. Michael's Hospital","funders":"","keywords":"Medicine; Dyslipidemia; Framingham Risk Score; Statin; Disease; Internal medicine; Coronary artery disease; Risk stratification; Framingham Heart Study; Atherosclerotic cardiovascular disease; Cardiology; Observational study; Physical therapy; Intensive care medicine","score_opus":0.01176705729596469,"score_gpt":0.24763348316968,"score_spread":0.2358664258737153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052967530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83444965,0.0023081803,0.15975684,0.0008621672,0.0003155855,0.0003920404,0.00001382324,0.000005896617,0.0018958384],"genre_scores_gemma":[0.9957535,0.00028268492,0.0022779542,0.0002014601,0.0014271799,0.0000067116544,0.000005144565,0.000011838563,0.000033488053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992646,0.00015531674,0.00022095561,0.00009931003,0.000077979654,0.00018184513],"domain_scores_gemma":[0.9991448,0.00006941941,0.00014567995,0.000088975794,0.00024047114,0.00031067122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012298533,0.000068091154,0.00032236573,0.00013808912,0.00012273956,0.000015794067,0.000032329637,0.00009482891,0.00000381496],"category_scores_gemma":[0.00030269823,0.00005651408,0.00013605035,0.000060916984,0.00004936623,0.0000420505,0.000001253274,0.00018728613,6.242058e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016961887,0.0000027321348,0.106812626,0.00007583608,0.00062645966,0.000007518577,0.0004308941,0.0005197721,0.0021822893,0.001739663,0.0041500893,0.8832825],"study_design_scores_gemma":[0.0034305553,0.0025502965,0.35744396,0.000049334296,0.0003026844,0.00138755,0.00025893043,0.00083227607,0.0008675336,0.0041278866,0.6285807,0.00016829878],"about_ca_topic_score_codex":0.0007271305,"about_ca_topic_score_gemma":0.0012188208,"teacher_disagreement_score":0.8831142,"about_ca_system_score_codex":0.000075634314,"about_ca_system_score_gemma":0.0006277068,"threshold_uncertainty_score":0.23045774},"labels":[],"label_agreement":null},{"id":"W2053019417","doi":"10.1002/fps.77","title":"Raising HDL‐C through cholesteryl ester transfer protein inhibition","year":2011,"lang":"en","type":"article","venue":"Future Prescriber","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Cholesterylester transfer protein; Apolipoprotein B; Medicine; Cholesterol; Reverse cholesterol transport; Pharmacology; Cholesteryl ester; Lipoprotein; High-density lipoprotein; Internal medicine; Chemistry; Endocrinology","score_opus":0.04782104924778665,"score_gpt":0.25910195088601773,"score_spread":0.21128090163823107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053019417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9464009,0.0016226899,0.009669146,0.0017255499,0.0005955097,0.0021417984,0.000011999605,0.00022162599,0.03761079],"genre_scores_gemma":[0.99003327,0.000057187455,0.0037049851,0.0021592644,0.0025999572,0.00017156408,0.00003706273,0.00006424247,0.001172496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983649,0.00009450828,0.00030465476,0.00039917196,0.00044753822,0.0003891839],"domain_scores_gemma":[0.999053,0.0000037324587,0.000029859557,0.00064186583,0.00010988551,0.00016166808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002815117,0.00023460123,0.00036743248,0.000057081357,0.000107706925,0.000028655902,0.000066734254,0.00023322464,0.0005741267],"category_scores_gemma":[0.000011037476,0.00018077537,0.00031630017,0.00015683414,0.000054081844,0.00034495277,0.000030858228,0.00039153968,0.000117810305],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005560461,0.0037522812,0.005362844,0.006201323,0.0026949588,0.0022838735,0.11025444,0.0000049677874,0.18436967,0.019750785,0.024512172,0.63525224],"study_design_scores_gemma":[0.009380346,0.0009646446,0.07596941,0.0015413229,0.00070817623,0.0010148807,0.0009816953,0.000008054988,0.36918494,0.002350023,0.53685206,0.0010444039],"about_ca_topic_score_codex":0.00023876641,"about_ca_topic_score_gemma":0.00002964915,"teacher_disagreement_score":0.63420784,"about_ca_system_score_codex":0.000050170547,"about_ca_system_score_gemma":0.00007273644,"threshold_uncertainty_score":0.73718053},"labels":[],"label_agreement":null},{"id":"W2053222771","doi":"10.1016/j.ahj.2007.09.004","title":"Class effects of statins in elderly patients with congestive heart failure: A population-based analysis","year":2007,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; University of British Columbia; Centre for Advancing Health Outcomes; Jewish General Hospital; Sunnybrook Health Science Centre; McGill University Health Centre; Institute for Clinical Evaluative Sciences; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pravastatin; Atorvastatin; Lovastatin; Simvastatin; Heart failure; Internal medicine; Fluvastatin; Statin; Population; Medical prescription; Coronary artery disease; Cardiology; Cholesterol; Pharmacology","score_opus":0.004955683897328223,"score_gpt":0.26340799305490664,"score_spread":0.25845230915757844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053222771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953842,0.00008695748,0.0033542234,0.0006444869,0.000038216644,0.00045461845,0.000005285862,0.0000121940275,0.000019816467],"genre_scores_gemma":[0.99060214,0.0000051677757,0.008501623,0.0007522205,0.000086325825,0.000006956758,0.000020545425,0.00001991711,0.0000051002303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980236,0.00019770509,0.0004574614,0.00020410228,0.0007503713,0.0003667094],"domain_scores_gemma":[0.9986271,0.00023916588,0.00024628788,0.0002770776,0.00029947422,0.00031089174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078216015,0.00015051794,0.00082614715,0.0005344212,0.000073485666,0.0000140184275,0.00004465981,0.00004207494,0.000023897559],"category_scores_gemma":[0.00017533217,0.0001135833,0.00031054398,0.0014994369,0.00011055896,0.00006862752,0.000007251149,0.0003848662,0.000002306035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033510826,0.00023538714,0.9890836,0.000052706026,0.00047764025,0.000040310806,0.00011475583,0.00031546943,0.00007834339,0.0000041265207,0.00007783389,0.009184749],"study_design_scores_gemma":[0.002511289,0.0027043233,0.99291253,0.0001520486,0.0004711144,0.000031282147,0.000205958,0.00011861866,0.00034902708,0.0000043250725,0.00042417087,0.00011532027],"about_ca_topic_score_codex":0.0038319484,"about_ca_topic_score_gemma":0.0011913513,"teacher_disagreement_score":0.009069429,"about_ca_system_score_codex":0.00018801598,"about_ca_system_score_gemma":0.00027890867,"threshold_uncertainty_score":0.5792785},"labels":[],"label_agreement":null},{"id":"W2053324564","doi":"10.1161/circulationaha.110.961201","title":"The Johns Hopkins Textbook of DyslipidemiaKwiterovichPeter O.Jr MD, ed. The Johns Hopkins Textbook of Dyslipidemia 303 pages. Philadelphia, USA: Lippincott Willams and Wilkins, 2010. $99.95. ISBN 0-7817-8265-4","year":2010,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Gerontology","score_opus":0.014637183166358477,"score_gpt":0.2495092434965127,"score_spread":0.23487206033015423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053324564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9598623,0.008718872,0.0028434019,0.00893805,0.0027792624,0.0045866948,0.00009212667,0.00017578717,0.012003508],"genre_scores_gemma":[0.9707078,0.025371952,0.00036365815,0.0010501223,0.002071752,0.000114700335,0.000074969765,0.00011119194,0.00013389128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99540746,0.0003881579,0.0014166705,0.0007884072,0.0012284523,0.00077085895],"domain_scores_gemma":[0.99539614,0.00054218405,0.0008990851,0.0022861464,0.0005159187,0.00036052914],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028394463,0.0005617385,0.0011065354,0.0004230904,0.00054522144,0.000083263716,0.00046155087,0.00061185355,0.00020631214],"category_scores_gemma":[0.000636424,0.00036038022,0.00068042456,0.00075025694,0.0008307719,0.00034790565,0.00020689251,0.0012325287,0.00007178553],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081263675,0.00083452795,0.2861732,0.0026112592,0.0031194359,0.000062866486,0.006020425,0.00041755024,0.08740175,0.007312385,0.081382,0.523852],"study_design_scores_gemma":[0.0026942017,0.00026389834,0.48765627,0.0004045542,0.0006898466,0.00014111608,0.0001853017,0.0018071365,0.0022748252,0.00021731893,0.5031487,0.0005168236],"about_ca_topic_score_codex":0.0018180065,"about_ca_topic_score_gemma":0.0015237926,"teacher_disagreement_score":0.52333516,"about_ca_system_score_codex":0.00015185503,"about_ca_system_score_gemma":0.0004850964,"threshold_uncertainty_score":0.99988484},"labels":[],"label_agreement":null},{"id":"W2053390057","doi":"10.1016/j.atherosclerosis.2006.03.019","title":"Effect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets: The Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study","year":2006,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; University of Toronto; St. Michael's Hospital; Pfizer (Canada)","funders":"Pfizer","keywords":"Atorvastatin; Statin; Ldl cholesterol; Medicine; Cholesterol; Internal medicine; Washout; Urology; Gastroenterology","score_opus":0.018338805966737932,"score_gpt":0.2825080487898484,"score_spread":0.2641692428231105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053390057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880833,0.000070635484,0.0068177045,0.0003034946,0.000086285814,0.004301677,0.00016982568,0.00009034106,0.0000767241],"genre_scores_gemma":[0.9973202,0.000008631448,0.0013549398,0.0004899585,0.00024576584,0.00036102894,0.000057476114,0.00013118105,0.000030814143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944953,0.0012456628,0.0013202055,0.0007812359,0.0014798534,0.00067774754],"domain_scores_gemma":[0.9970783,0.0005489607,0.00082574313,0.0010809567,0.00025584994,0.0002101773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035367105,0.00061833777,0.0012410711,0.0002626895,0.0003342492,0.00013212988,0.00032402444,0.0001370264,0.000017064272],"category_scores_gemma":[0.00026681693,0.00040675118,0.00030925212,0.0006555571,0.000114158975,0.0003242014,0.00011714146,0.0005376034,0.0000076617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002010548,0.0017586864,0.5505086,0.0011830385,0.0009709484,0.000007996863,0.010598366,0.0036864248,0.35284784,0.000022377746,0.00007633297,0.076328784],"study_design_scores_gemma":[0.008055429,0.01268631,0.7603997,0.0019682553,0.0006677902,0.000008421033,0.005886652,0.0002065639,0.2096164,0.00000602383,0.000035443558,0.00046300492],"about_ca_topic_score_codex":0.0017779302,"about_ca_topic_score_gemma":0.0006967522,"teacher_disagreement_score":0.20989108,"about_ca_system_score_codex":0.00014342919,"about_ca_system_score_gemma":0.00012758588,"threshold_uncertainty_score":0.9998384},"labels":[],"label_agreement":null},{"id":"W2053534708","doi":"10.1016/j.jalz.2010.05.609","title":"P1‐061: HMG‐CoA reductase as a risk factor and modulator of Alzheimer pathology","year":2010,"lang":"en","type":"article","venue":"Alzheimer s & Dementia","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Genotype; Allele; Apolipoprotein E; Population; Single-nucleotide polymorphism; Biology; Genetics; Lathosterol; Disease; Internal medicine; Alzheimer's disease; Pathological; Reductase; Medicine; Biochemistry; Gene; Enzyme","score_opus":0.01817271993467959,"score_gpt":0.27742150069410276,"score_spread":0.25924878075942315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053534708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9073614,0.09020505,0.000052973457,0.00032150067,0.0005639643,0.00075915497,0.00007384295,0.000055507397,0.00060664694],"genre_scores_gemma":[0.99436677,0.00059149886,0.0041759275,0.0003530719,0.00037319137,0.00004578815,0.00003295829,0.000051480794,0.000009301693],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99801606,0.00012027295,0.00048576738,0.0005163484,0.0004349031,0.0004266597],"domain_scores_gemma":[0.99828506,0.000026228965,0.00022405575,0.00096988515,0.00014238688,0.00035236304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054475165,0.00026685392,0.0006075031,0.0001321771,0.00012365344,0.000016940625,0.00011743721,0.00023984959,0.0008086456],"category_scores_gemma":[0.0000864973,0.00022606082,0.0002777058,0.0001531766,0.00022523373,0.00010800856,0.000116992866,0.0004838416,0.000075924625],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033932968,0.00067653845,0.03554192,0.00007935868,0.061327267,0.00030357108,0.0013356563,0.000001598889,0.18411402,0.0014087146,0.0023435308,0.71252847],"study_design_scores_gemma":[0.006684374,0.0013951428,0.38390127,0.000072838375,0.09307235,0.0013885577,0.00029300665,0.0001326983,0.4516543,0.0010475798,0.059436236,0.00092166866],"about_ca_topic_score_codex":0.00086583983,"about_ca_topic_score_gemma":0.00005640563,"teacher_disagreement_score":0.7116068,"about_ca_system_score_codex":0.0000027163842,"about_ca_system_score_gemma":0.0001669838,"threshold_uncertainty_score":0.92184925},"labels":[],"label_agreement":null},{"id":"W2053548898","doi":"10.1007/s11096-009-9339-3","title":"Statin prescribing in Northern Ireland and England pre and post introduction of the quality and outcomes framework","year":2009,"lang":"en","type":"article","venue":"Pharmacy World & Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"National Science Foundation","keywords":"Quality and Outcomes Framework; Medicine; Northern ireland; Pharmacoepidemiology; Defined daily dose; Primary care; Medical prescription; Emergency medicine; Family medicine; Nursing","score_opus":0.025183154960595353,"score_gpt":0.3506175141524323,"score_spread":0.32543435919183694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053548898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905684,0.0010493591,0.000030187413,0.007824439,0.000069698595,0.0003796095,0.0000030313606,0.000008808615,0.000066440785],"genre_scores_gemma":[0.9987749,0.00018040367,0.0004021741,0.00048698345,0.000102626465,0.000003501148,5.643328e-7,0.0000032036667,0.000045669254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989402,0.00007609783,0.00020548343,0.00026381158,0.00034727325,0.00016712419],"domain_scores_gemma":[0.99948716,0.000057797726,0.00007119897,0.00021897806,0.00007012838,0.00009473874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014375562,0.00008034594,0.00020316514,0.00008193494,0.00012997408,0.000028427992,0.00006512997,0.0000038013397,0.000003044959],"category_scores_gemma":[0.00037037864,0.000049675145,0.000024352285,0.00038432743,0.00027099915,0.00016093228,0.000054223252,0.00019893656,1.2176382e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006503404,0.000029340183,0.9382825,0.000058930214,0.0000063502753,0.000001035402,0.0012446364,0.000004322172,0.0053095147,0.00023846017,0.0000029095602,0.05475697],"study_design_scores_gemma":[0.0010333814,0.00001697604,0.996162,0.000059375117,0.000022437378,0.000019085908,0.000077917466,0.000116668365,0.0017328057,0.00024751556,0.000456713,0.000055116067],"about_ca_topic_score_codex":0.0016510594,"about_ca_topic_score_gemma":0.0015200772,"teacher_disagreement_score":0.05787951,"about_ca_system_score_codex":0.000024839706,"about_ca_system_score_gemma":0.00007925846,"threshold_uncertainty_score":0.2495919},"labels":[],"label_agreement":null},{"id":"W2053653961","doi":"10.1371/journal.pone.0060095","title":"Evidence from a Randomized Trial That Simvastatin, but Not Ezetimibe, Upregulates Circulating PCSK9 Levels","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Ezetimibe; PCSK9; Simvastatin; Internal medicine; Medicine; Endocrinology; Statin; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.135254597491851,"score_gpt":0.27659963809525734,"score_spread":0.14134504060340633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053653961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98858804,0.002249696,0.0011509814,0.0017554944,0.00011799358,0.0055466047,0.000020236928,0.00016389361,0.00040704838],"genre_scores_gemma":[0.97947377,0.00023681078,0.01703078,0.0007389401,0.0011463315,0.0007411933,0.000030156782,0.0000562625,0.00054575026],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965462,0.00046424763,0.00065337576,0.00052738923,0.001341723,0.00046706226],"domain_scores_gemma":[0.9971068,0.001180154,0.00025280545,0.0008617405,0.00029223424,0.00030626528],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014389979,0.00028135555,0.0016930032,0.00008471318,0.0001356942,0.00009758983,0.00015530185,0.00016773792,0.0016346117],"category_scores_gemma":[0.00267547,0.00021757557,0.00056759437,0.00015801741,0.00011857883,0.0002968363,0.000084925734,0.00033292544,0.00032030596],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5144943,0.003085912,0.0034172703,0.0018267364,0.011212953,0.00015751424,0.003370696,0.00003265286,0.40594062,0.0000912424,0.00040401024,0.055966098],"study_design_scores_gemma":[0.8383177,0.00037076202,0.01108737,0.004152799,0.0023712295,0.000014545317,0.00021399617,0.0046531805,0.13733771,0.0009979046,0.000012087004,0.0004707164],"about_ca_topic_score_codex":0.004059215,"about_ca_topic_score_gemma":0.000012477292,"teacher_disagreement_score":0.3238234,"about_ca_system_score_codex":0.000089767185,"about_ca_system_score_gemma":0.00018268438,"threshold_uncertainty_score":0.999278},"labels":[],"label_agreement":null},{"id":"W2054331554","doi":"10.1097/01.prs.0000371878.18825.87","title":"144B: ACTIVATED PROTEIN C AND OVEREXPRESSION OF ITS RECEPTOR INHIBIT TUMOR METASTASIS","year":2010,"lang":"en","type":"article","venue":"Plastic & Reconstructive Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Metastasis; Receptor; Cancer research; Internal medicine; Cancer","score_opus":0.014484571298006803,"score_gpt":0.23682653788824493,"score_spread":0.2223419665902381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054331554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976502,0.00028802443,0.00006680964,0.000056858422,0.0006184592,0.0007493757,0.0000902486,0.000053430016,0.00042661215],"genre_scores_gemma":[0.9972858,0.000043497024,0.0022393656,0.000026247746,0.00022408801,0.00007662436,0.000020088984,0.00003537919,0.000048901205],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818134,0.00012590882,0.00048935384,0.00042691448,0.0004310338,0.00034546093],"domain_scores_gemma":[0.9979932,0.0007918836,0.00028932688,0.0003523064,0.00028247482,0.00029082113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006890625,0.00023948679,0.0008169264,0.0002710053,0.00008924672,0.000015211881,0.000046888184,0.00014051855,0.00058039266],"category_scores_gemma":[0.003241977,0.00019251954,0.0002614169,0.00029518732,0.00022731216,0.00018825803,0.00006083791,0.0004930201,0.000017926925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050264894,0.00009458841,0.009012454,0.000612014,0.0002806912,0.000016840819,0.00006336368,2.2604131e-7,0.93259084,0.0001593482,0.00014740441,0.056519553],"study_design_scores_gemma":[0.00095648103,0.000114824164,0.027621351,0.0012888291,0.00013203494,0.00042426863,0.00014960908,0.000024476716,0.96738106,0.000087368666,0.0015768514,0.0002428547],"about_ca_topic_score_codex":0.00005858546,"about_ca_topic_score_gemma":0.0000052447854,"teacher_disagreement_score":0.0562767,"about_ca_system_score_codex":0.000036962698,"about_ca_system_score_gemma":0.00038212392,"threshold_uncertainty_score":0.78507185},"labels":[],"label_agreement":null},{"id":"W2054400785","doi":"10.1016/j.cjca.2015.02.001","title":"The New Pooled Cohort Equations Risk Calculator","year":2015,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Framingham Risk Score; Cohort; Myocardial infarction; Internal medicine; Risk assessment; Framingham Heart Study; Population; Stroke (engine); Calculator; National Cholesterol Education Program; Atherosclerotic cardiovascular disease; Kidney disease; Cohort study; Disease; Metabolic syndrome; Environmental health; Obesity","score_opus":0.0418402521167865,"score_gpt":0.31889288361008594,"score_spread":0.27705263149329945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054400785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000041385724,0.9904762,0.0033034952,0.00043068352,0.0017213133,0.0008175415,0.000055487595,0.0000055379232,0.0031856315],"genre_scores_gemma":[0.00023141167,0.9909472,0.0000772695,0.00008196491,0.007915553,0.000016047918,0.00003130608,0.00005216281,0.0006471194],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970561,0.00085666083,0.0009610584,0.00020332335,0.00039295098,0.0005298611],"domain_scores_gemma":[0.99543405,0.00020855624,0.00068351533,0.0007904904,0.00059822766,0.0022851734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035257738,0.00028781837,0.0030653637,0.00032572803,0.00025007423,0.00003882743,0.0003334366,0.0004937798,0.000015977708],"category_scores_gemma":[0.00166135,0.00016692562,0.002230028,0.00028717757,0.00016537723,0.000032174554,0.000016848331,0.0012580758,0.00006572516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005766142,4.936439e-7,0.00014450896,0.00031411115,0.0036593874,0.00029177373,0.000013919851,0.000037006143,6.2475425e-9,0.00019372559,0.07088525,0.92445403],"study_design_scores_gemma":[0.00045791277,0.0001600658,0.00020675878,0.0010726147,0.00874415,0.0046852184,0.000019035475,0.0000013735978,2.3248557e-8,0.00012466496,0.98438656,0.00014161816],"about_ca_topic_score_codex":0.00429955,"about_ca_topic_score_gemma":0.0024033515,"teacher_disagreement_score":0.9243124,"about_ca_system_score_codex":0.000938749,"about_ca_system_score_gemma":0.03985593,"threshold_uncertainty_score":0.9655872},"labels":[],"label_agreement":null},{"id":"W2054446527","doi":"10.1016/s1473-3099(07)70004-x","title":"Statins and sepsis: panacea or Pandora's box? – Authors' reply","year":2007,"lang":"en","type":"article","venue":"The Lancet Infectious Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Panacea (medicine); Sepsis; Intensive care medicine; Medicine; Pharmacology; Alternative medicine; Internal medicine","score_opus":0.022360838263625026,"score_gpt":0.3085046448211168,"score_spread":0.2861438065574918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054446527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861037,0.004158826,0.00088831293,0.0024491113,0.00023556362,0.0008297105,0.000058099587,0.0004283642,0.004848273],"genre_scores_gemma":[0.9910421,0.0012054367,0.00009898673,0.005605793,0.0013731068,0.000042831547,0.000017935155,0.000028280834,0.0005855346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986879,0.00010542212,0.00022197702,0.00024943287,0.00032729062,0.00040793745],"domain_scores_gemma":[0.99875706,0.0001478028,0.000078306344,0.0006518685,0.00007740337,0.00028756913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008723749,0.00015581313,0.00045306023,0.00005844074,0.0002310581,0.000041066214,0.000066812754,0.000050605748,0.00008719233],"category_scores_gemma":[0.00038758683,0.00008672029,0.00014393042,0.0002334637,0.000106336374,0.00005880325,0.000048198675,0.00020022529,0.000019864505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026991728,0.0005897444,0.718361,0.0011296917,0.0012277893,0.0005686975,0.0012097383,0.000013752878,0.00016085507,0.0014214938,0.032864157,0.23975389],"study_design_scores_gemma":[0.0049621384,0.0007050046,0.84657645,0.00017998047,0.0007947821,0.0004513843,0.0005799109,0.000035679856,0.00024334258,0.0011079948,0.14410101,0.00026231652],"about_ca_topic_score_codex":0.00060509343,"about_ca_topic_score_gemma":0.00024441635,"teacher_disagreement_score":0.23949157,"about_ca_system_score_codex":0.000061018152,"about_ca_system_score_gemma":0.00013609596,"threshold_uncertainty_score":0.35363507},"labels":[],"label_agreement":null},{"id":"W2054761779","doi":"10.1136/bmj.g4890","title":"Author's reply to Phillips and Brugts","year":2014,"lang":"en","type":"letter","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Computer science; Data science; World Wide Web","score_opus":0.033149970733222386,"score_gpt":0.3090515760372676,"score_spread":0.27590160530404517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054761779","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007237807,0.000743441,0.00025979267,0.9875973,0.0005012045,0.0014330323,0.000009764176,0.000081226455,0.008650454],"genre_scores_gemma":[0.0005399338,0.000034724162,0.0013443163,0.95123565,0.025931494,0.00011678869,0.00009300899,0.00007041683,0.020633671],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807686,0.00012828955,0.00031306254,0.00050080655,0.0006262218,0.00035474106],"domain_scores_gemma":[0.99838305,0.00003219129,0.00008791345,0.0011865449,0.00009061325,0.00021971564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010923807,0.0002303455,0.0006813012,0.00012428287,0.000057981113,0.000027643275,0.00008420949,0.00046562208,0.000069444126],"category_scores_gemma":[0.00021581117,0.00018500652,0.0002401205,0.00009864206,0.00003075793,0.000016707394,0.00006542128,0.00091092393,0.00026756377],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016771934,0.000005023449,0.000074544674,0.00054258894,0.00012918492,0.0005388109,0.000036970574,1.2872988e-7,0.0000050642543,0.000012410795,0.9820388,0.016599722],"study_design_scores_gemma":[0.00045097084,0.00018607877,0.0019946557,0.00037216602,0.00017985358,0.0009129465,0.00000412278,0.0000035837786,0.000020435924,0.000058294936,0.9956004,0.00021647353],"about_ca_topic_score_codex":0.00033198335,"about_ca_topic_score_gemma":0.0000034646046,"teacher_disagreement_score":0.036361657,"about_ca_system_score_codex":0.000056051584,"about_ca_system_score_gemma":0.00013624116,"threshold_uncertainty_score":0.7544347},"labels":[],"label_agreement":null},{"id":"W2055105660","doi":"10.1016/j.ahj.2003.12.037","title":"Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors","year":2004,"lang":"en","type":"review","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University; Québec Science (Canada)","funders":"","keywords":"Cerivastatin; Rhabdomyolysis; Medicine; Statin; Myopathy; Clinical trial; Pharmacology; HMG-CoA reductase; Drug; Adverse effect; Internal medicine; Cholesterol; Pravastatin; Reductase; Biochemistry; Enzyme; Biology","score_opus":0.02698371638237842,"score_gpt":0.32412107600731976,"score_spread":0.29713735962494137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055105660","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011026075,0.9966481,0.000067918525,0.00051898084,0.00027832758,0.0011208745,0.000039545055,0.000098274184,0.00012541591],"genre_scores_gemma":[0.00038338237,0.99392307,0.0029968563,0.00048008686,0.001690212,0.00007594328,0.00010285985,0.00021459206,0.00013302482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995007,0.0006251771,0.0012259699,0.0006626496,0.0015236567,0.0009555853],"domain_scores_gemma":[0.9964446,0.00013949524,0.0010898914,0.00092546875,0.00027772645,0.0011228434],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016560198,0.00077490276,0.0052941265,0.0006652517,0.0003563433,0.00009968857,0.00021487451,0.00027297827,0.00014569968],"category_scores_gemma":[0.00039250086,0.0005134558,0.0028761753,0.001999947,0.0004695667,0.00011742068,0.00006016884,0.0026216076,0.00009275354],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056381785,0.00032298182,0.00004954659,0.0033767365,0.00453986,0.00196716,0.000096405616,0.0000044537533,0.0000023122204,0.0000038792186,0.004471435,0.98510885],"study_design_scores_gemma":[0.0010263607,0.0017193899,0.00006099592,0.03873821,0.0066735568,0.027506344,0.000108507345,0.0000012431601,0.0000064538763,0.000011153593,0.92354053,0.0006072343],"about_ca_topic_score_codex":0.0007949353,"about_ca_topic_score_gemma":0.000015763642,"teacher_disagreement_score":0.9845016,"about_ca_system_score_codex":0.0014890305,"about_ca_system_score_gemma":0.005068892,"threshold_uncertainty_score":0.9997317},"labels":[],"label_agreement":null},{"id":"W2055757953","doi":"10.1016/j.atherosclerosis.2005.03.027","title":"Genotype of the mutant LDL receptor allele is associated with LDL particle size heterogeneity in familial hypercholesterolemia","year":2005,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canada Research Chairs","keywords":"LDL receptor; Familial hypercholesterolemia; Internal medicine; Endocrinology; Genotype; Allele; Heterozygote advantage; Receptor; Apolipoprotein E; Apolipoprotein B; Mutant; Biology; Chemistry; Cholesterol; Medicine; Lipoprotein; Genetics; Gene; Disease","score_opus":0.02081010438345485,"score_gpt":0.24233036389569004,"score_spread":0.2215202595122352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055757953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972718,0.0002485407,0.000011567254,0.0015918657,0.000056529116,0.0006355295,0.000033847155,0.00003886252,0.000111484616],"genre_scores_gemma":[0.99671596,0.00017843777,0.0003049691,0.0024339398,0.00012313608,0.000048344686,0.0000047153526,0.000043814623,0.0001466814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980999,0.00018194692,0.0003937509,0.00033750845,0.000578727,0.0004081456],"domain_scores_gemma":[0.9988332,0.000053702173,0.00013266703,0.00074000953,0.000106445856,0.00013398126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000596044,0.00019610704,0.00047865784,0.000022093847,0.00008845017,0.000013941744,0.00017319444,0.0001360562,0.00011853886],"category_scores_gemma":[0.00013745627,0.00012658242,0.00025114804,0.00038178457,0.00011585048,0.00007722848,0.00006631698,0.00025934583,0.00003005081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004986829,0.00095137267,0.57422286,0.00006897675,0.000452609,0.0000029519033,0.0025055073,0.00010142968,0.40403128,0.000015919448,0.00027399347,0.016874403],"study_design_scores_gemma":[0.003583589,0.00043260798,0.82791203,0.00020325107,0.00011385075,0.00000616599,0.00011412967,0.00012387196,0.16560914,0.0000044374287,0.0017438226,0.00015308395],"about_ca_topic_score_codex":0.00054013147,"about_ca_topic_score_gemma":0.0011267323,"teacher_disagreement_score":0.25368917,"about_ca_system_score_codex":0.0002299412,"about_ca_system_score_gemma":0.00012944314,"threshold_uncertainty_score":0.51618814},"labels":[],"label_agreement":null},{"id":"W2056089577","doi":"10.1016/j.cjca.2014.08.019","title":"Doctor My Eyes: A Statin-Cataract Connection?","year":2014,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Connection (principal bundle); Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Optometry; Ophthalmology; Internal medicine","score_opus":0.02176987023970247,"score_gpt":0.26248021714337033,"score_spread":0.24071034690366785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056089577","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068449955,0.007025356,0.007082163,0.94658107,0.007612365,0.00096583756,0.00021838822,0.000029225426,0.02364061],"genre_scores_gemma":[0.10760512,0.0004566309,0.00030784786,0.79736453,0.0917826,0.000019827248,0.00029719685,0.00013761639,0.0020286094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728477,0.0005196708,0.00074712833,0.0003018225,0.0004133965,0.0007332315],"domain_scores_gemma":[0.99720144,0.00013229152,0.00047144963,0.0006802445,0.000681626,0.00083292974],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011296925,0.00032752586,0.0018903523,0.00068131497,0.0001249323,0.00003204191,0.00025625332,0.0010294686,0.00015968934],"category_scores_gemma":[0.0003332329,0.0002711368,0.0012656595,0.00014796181,0.00026932367,0.000055185177,0.000009394855,0.0029590353,0.00010866612],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028636125,7.591671e-7,0.001117412,0.00021564295,0.0015594852,0.0059061074,0.000049293798,0.000025415287,0.000007878858,0.000026312406,0.9872147,0.0038483678],"study_design_scores_gemma":[0.0010728746,0.00064169243,0.0020162626,0.00020007318,0.0008624246,0.017815888,0.00003990189,0.0000013595077,0.000010689832,0.00009766148,0.97701186,0.00022929545],"about_ca_topic_score_codex":0.0038748535,"about_ca_topic_score_gemma":0.00062561623,"teacher_disagreement_score":0.1492165,"about_ca_system_score_codex":0.00056524616,"about_ca_system_score_gemma":0.0063670143,"threshold_uncertainty_score":0.9999741},"labels":[],"label_agreement":null},{"id":"W2056224752","doi":"10.1016/j.carpath.2012.03.001","title":"Cardiovascular risk and atherosclerosis prevention","year":2012,"lang":"en","type":"review","venue":"Cardiovascular Pathology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Medicine; Lipoprotein(a); Risk factor; Coronary artery disease; Biomarker; Apolipoprotein B; Diabetes mellitus; Disease; Lipoprotein; Risk assessment; CAD; Internal medicine; Intensive care medicine; Cholesterol; Endocrinology; Computer science; Biology","score_opus":0.057925972205852,"score_gpt":0.3009034128657599,"score_spread":0.2429774406599079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056224752","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021673713,0.98899984,0.004977508,0.000005262788,0.00086050265,0.003865296,0.00008509243,0.00023769654,0.00075208367],"genre_scores_gemma":[0.0002163353,0.99410874,0.0014654822,0.000037332786,0.0023655924,0.0009709094,0.00028584403,0.00033558937,0.00021419133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.991636,0.0030631935,0.0011322029,0.001720472,0.0012604988,0.0011876738],"domain_scores_gemma":[0.9939741,0.00008408643,0.0003738146,0.004675215,0.00019781919,0.0006949884],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0064808168,0.0011608052,0.00911995,0.00048984087,0.0003116847,0.000053441945,0.00027986715,0.0017312184,0.000054636246],"category_scores_gemma":[0.00022471955,0.0009497781,0.021311875,0.000625998,0.00032997548,0.0001409834,0.000365314,0.0015832185,0.00031366938],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000070834285,0.00008860525,0.00006891471,0.016815307,0.024081297,0.00025916597,0.000054834083,0.0000022629774,2.2162936e-7,0.000031501684,0.00003465751,0.9585562],"study_design_scores_gemma":[0.0013378203,0.00020044665,0.00050162146,0.003339448,0.09610699,0.00923809,0.000021920827,8.7149715e-7,0.0000016574206,0.000023238697,0.8884981,0.0007297396],"about_ca_topic_score_codex":0.000092974056,"about_ca_topic_score_gemma":0.0000023271436,"teacher_disagreement_score":0.95782644,"about_ca_system_score_codex":0.00032665473,"about_ca_system_score_gemma":0.00045143237,"threshold_uncertainty_score":0.99956477},"labels":[],"label_agreement":null},{"id":"W2056359850","doi":"10.2165/00002018-200124130-00008","title":"Lipid Abnormalities Induced by Novel Antipsychotic Drugs","year":2001,"lang":"en","type":"letter","venue":"Drug Safety","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Medicine; Antipsychotic; Pharmacology; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.01615402993544175,"score_gpt":0.25292363784840977,"score_spread":0.23676960791296803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056359850","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01165147,0.005006414,0.0004222119,0.9370901,0.0032117385,0.0022965919,0.00059110235,0.0004350878,0.039295264],"genre_scores_gemma":[0.009796783,0.0033019152,0.00035783937,0.914376,0.02588285,0.00010929963,0.0034961428,0.00029277673,0.04238639],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958623,0.0001741676,0.0007784384,0.0008239225,0.0013911702,0.00096997124],"domain_scores_gemma":[0.9975748,0.000097796874,0.0002522429,0.0016483789,0.00018175736,0.00024502628],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00094988086,0.0006383316,0.0013774147,0.00021817684,0.000199599,0.00005206582,0.0003167261,0.001051177,0.0005142189],"category_scores_gemma":[0.000047805086,0.0005553247,0.0008679014,0.0003528858,0.00009956187,0.00010982712,0.00007906143,0.0030907746,0.00028588704],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011526128,0.000100081976,0.000040560823,0.0009877192,0.000521335,0.0001872488,0.00062057347,3.6760218e-7,0.000092933864,0.000026879949,0.9901447,0.0071623246],"study_design_scores_gemma":[0.00268352,0.0000820955,0.0004945358,0.0005177186,0.00036782262,0.00035461845,0.00028380766,0.0000069014213,0.0001424348,0.000019316853,0.9944791,0.0005681325],"about_ca_topic_score_codex":0.002103539,"about_ca_topic_score_gemma":0.000009888388,"teacher_disagreement_score":0.022714114,"about_ca_system_score_codex":0.00030550122,"about_ca_system_score_gemma":0.00041221874,"threshold_uncertainty_score":0.9996898},"labels":[],"label_agreement":null},{"id":"W2056390664","doi":"10.1371/journal.pone.0114469","title":"Peptide-Based Anti-PCSK9 Vaccines - An Approach for Long-Term LDLc Management","year":2014,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Magistrat der Stadt Wien; University of Alberta","keywords":"PCSK9; LDL receptor; Kexin; Proprotein convertase; Medicine; Peptide vaccine; Immunology; Antibody; Cholesterol; Monoclonal antibody; Immune system; Familial hypercholesterolemia; Pharmacology; Lipoprotein; Internal medicine; Epitope","score_opus":0.044967135866043936,"score_gpt":0.2590793950103107,"score_spread":0.21411225914426674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056390664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94258964,0.00026479692,0.049541645,0.00048475564,0.00004251465,0.0024112384,0.0000074736913,0.00016347716,0.004494436],"genre_scores_gemma":[0.94338095,0.000049370115,0.053361207,0.0008801941,0.0008677033,0.00038369853,0.00025521024,0.000056849396,0.00076481764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846995,0.000058584985,0.00023488431,0.0003991398,0.00049360225,0.00034385582],"domain_scores_gemma":[0.9987265,0.000017078928,0.000061723,0.00086438406,0.00011540185,0.0002149203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006054192,0.00017267182,0.0005036852,0.0001049318,0.00010214184,0.000027537055,0.00012333895,0.00007924138,0.000042611184],"category_scores_gemma":[0.00003305175,0.00014478143,0.0001995752,0.00012072957,0.00001908202,0.00006605257,0.000029541516,0.00010671153,0.000021285032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021107367,0.04193466,0.6158659,0.062321097,0.0104389265,0.00014663099,0.00043468,0.00017372519,0.016551845,0.00515662,0.0017225444,0.24314265],"study_design_scores_gemma":[0.018500285,0.002637318,0.9270706,0.0012014429,0.004467214,0.000024696747,0.00010199807,0.014924273,0.028146317,0.00021468438,0.0018293465,0.00088178366],"about_ca_topic_score_codex":0.000022630496,"about_ca_topic_score_gemma":0.0000045239326,"teacher_disagreement_score":0.31120476,"about_ca_system_score_codex":0.000044898832,"about_ca_system_score_gemma":0.00003268993,"threshold_uncertainty_score":0.59040153},"labels":[],"label_agreement":null},{"id":"W2056702861","doi":"10.1016/j.ijcard.2008.12.213","title":"Effect of atorvastatin on circulating hsCRP concentrations: A sub-study of the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study","year":2009,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Pfizer (Canada); University of Toronto","funders":"","keywords":"Atorvastatin; Medicine; Internal medicine; Statin; C-reactive protein; Metabolic syndrome; Gastroenterology; Cholesterol; Diabetes mellitus; Endocrinology; Inflammation","score_opus":0.010273151434871465,"score_gpt":0.29519353132513426,"score_spread":0.2849203798902628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056702861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601436,0.000063596046,0.0017575832,0.00026637342,0.0003373218,0.0012238503,0.000012760425,0.0000066695948,0.00031751062],"genre_scores_gemma":[0.99933535,0.000010993864,0.000081435246,0.000103367856,0.00043049394,0.000013806131,0.000006779014,0.000013131207,0.00000463575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675494,0.0009046048,0.0008694935,0.00019097704,0.0011228506,0.00015714536],"domain_scores_gemma":[0.9977736,0.00018824723,0.00087504945,0.0002994473,0.0007879347,0.000075708616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014414103,0.00018155306,0.0007579922,0.0001510214,0.0000553334,0.00001744357,0.00022613806,0.000064414824,0.00000528606],"category_scores_gemma":[0.00024852215,0.00010898612,0.00030708357,0.00015226372,0.00006732104,0.00011084857,0.000020286712,0.00036861593,6.927413e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012182199,0.002774344,0.7928831,0.00014531595,0.008671758,0.0007041038,0.008500502,0.025443623,0.054853704,0.000396896,0.00013082106,0.09331362],"study_design_scores_gemma":[0.012302682,0.032511637,0.93658626,0.00032712266,0.0005766527,0.00089368684,0.0024157898,0.0001405975,0.014046665,0.000038665,0.000029980669,0.00013027442],"about_ca_topic_score_codex":0.00003838492,"about_ca_topic_score_gemma":0.000025978843,"teacher_disagreement_score":0.14370313,"about_ca_system_score_codex":0.00011473534,"about_ca_system_score_gemma":0.00024370069,"threshold_uncertainty_score":0.4444325},"labels":[],"label_agreement":null},{"id":"W2057238157","doi":"10.1097/01.hco.0000184529.52832.e6","title":"Optimal goals for statin use in patients with coronary artery disease","year":2005,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Statin; Coronary artery disease; Intensive care medicine; Disease; Atherosclerotic cardiovascular disease; Expert opinion; Clinical trial; Internal medicine; Cardiology","score_opus":0.09609227831924626,"score_gpt":0.381715940371846,"score_spread":0.2856236620525997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057238157","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011046929,0.98956025,0.0004122004,0.000021994478,0.0023231301,0.005828802,0.00071228296,0.000027444697,0.000009202364],"genre_scores_gemma":[0.0002242908,0.9905912,0.00041653172,0.000022521283,0.001508741,0.0017957154,0.005349249,0.00007808883,0.000013648288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996935,0.00049138186,0.00089051016,0.0007710123,0.00033307326,0.000579016],"domain_scores_gemma":[0.99841434,0.0002034107,0.00023750527,0.0007502599,0.00011668943,0.00027779597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000546059,0.00047991987,0.0029420252,0.00039580878,0.000033422795,0.000013788603,0.0001386244,0.00028939248,0.000010941842],"category_scores_gemma":[0.00014332548,0.00035685528,0.00081984693,0.00024144138,0.00008869861,0.000092357805,0.000074263975,0.0006212281,0.00001563948],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004567418,0.00022237588,0.037158765,0.020275977,0.0002728022,0.000021535234,0.000014236953,0.00008400697,8.1990803e-10,0.00002679085,0.0013039991,0.9401628],"study_design_scores_gemma":[0.0038493192,0.00042555336,0.09284871,0.013791974,0.00039458546,0.00004195947,0.0000047734115,0.0000092535465,1.8562446e-9,0.0000030373028,0.88830656,0.00032426388],"about_ca_topic_score_codex":0.0000072988655,"about_ca_topic_score_gemma":0.000002114518,"teacher_disagreement_score":0.9398385,"about_ca_system_score_codex":0.00043879592,"about_ca_system_score_gemma":0.00086872326,"threshold_uncertainty_score":0.99988836},"labels":[],"label_agreement":null},{"id":"W2057416509","doi":"10.2174/13816128113199990313","title":"Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors in the Treatment of Hypercholesterolemia and other Pathologies","year":2013,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Core Research for Evolutional Science and Technology; Canadian Institutes of Health Research; Pfizer","keywords":"PCSK9; Kexin; Proprotein convertase; Subtilisin; Familial hypercholesterolemia; Medicine; LDL receptor; Proprotein Convertases; Pharmacology; Cholesterol; Chemistry; Endocrinology; Biochemistry; Lipoprotein; Enzyme","score_opus":0.2804797153982914,"score_gpt":0.4420727696308272,"score_spread":0.16159305423253578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057416509","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013510186,0.98922354,0.00015262344,0.000087718945,0.00022325947,0.008834194,0.00004597924,0.000032432414,0.00004924611],"genre_scores_gemma":[0.0006942348,0.99688625,0.00023261186,0.000100515485,0.0003107037,0.0016615803,0.00003283462,0.000056229517,0.000025062673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961129,0.0014538079,0.0008725103,0.0005746626,0.000515767,0.00047034826],"domain_scores_gemma":[0.9985332,0.00029371388,0.0001999768,0.0006879349,0.000056704936,0.00022848348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011952132,0.00056800304,0.0020464899,0.00019589429,0.00004796069,0.00004003907,0.0001934939,0.0003017653,0.000053709056],"category_scores_gemma":[0.00008873308,0.00029018088,0.0005986502,0.00025457246,0.00031666292,0.000054444026,0.00004178829,0.00063286745,0.00004925959],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055392808,0.0007820087,0.00007046871,0.014074654,0.0001336419,0.00006242326,0.0002758175,1.3597726e-7,0.00001199534,0.000030674775,0.00015508606,0.9843477],"study_design_scores_gemma":[0.0018726351,0.00086212426,0.000042100153,0.0069347327,0.0015462422,0.0002035091,0.00005095871,0.000028848333,0.00028984016,0.0000242244,0.9878772,0.000267596],"about_ca_topic_score_codex":0.000039942075,"about_ca_topic_score_gemma":9.755499e-7,"teacher_disagreement_score":0.9877221,"about_ca_system_score_codex":0.00019668507,"about_ca_system_score_gemma":0.0003314793,"threshold_uncertainty_score":0.99995506},"labels":[],"label_agreement":null},{"id":"W2058093970","doi":"10.1517/14656560802532640","title":"Effect of omega-3-acid ethyl esters on the steady-state plasma pharmacokinetics of rosuvastatin in healthy adults","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council Canada","keywords":"Rosuvastatin; Medicine; Pharmacokinetics; Cmax; Crossover study; Pharmacology; Bioequivalence; Concomitant; Dosing; Statin; Adverse effect; Rosuvastatin Calcium; Area under the curve; Internal medicine","score_opus":0.02710743316397679,"score_gpt":0.34600241506513363,"score_spread":0.31889498190115684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058093970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903375,0.004222495,0.000057916874,0.0022642012,0.000723856,0.0019133176,0.000031120075,0.000042270163,0.00040732726],"genre_scores_gemma":[0.9604143,0.034588438,0.00012434968,0.004298859,0.00027805907,0.00018157107,0.000017444216,0.00006614004,0.00003083],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702036,0.00069674035,0.0006610858,0.00038527272,0.0008433084,0.00039320867],"domain_scores_gemma":[0.9986019,0.0003457428,0.0002613966,0.0005223473,0.00008181358,0.00018679687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009773672,0.0003223715,0.0007315229,0.00023009513,0.00007989711,0.0000043951336,0.00018742617,0.00007954946,0.00011667557],"category_scores_gemma":[0.000038863906,0.00020912234,0.00031445525,0.00038658766,0.00015129814,0.000049279584,0.00001751039,0.00042776825,0.0000130605395],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12411016,0.0021476718,0.0016160031,0.0011605637,0.00068889424,0.000106803964,0.018634923,0.0006432703,0.2132574,0.000113870025,0.006691941,0.6308285],"study_design_scores_gemma":[0.029124621,0.013627762,0.0011107941,0.0006878559,0.000008264106,0.00005112202,0.00015629883,0.0012686097,0.91770804,0.000003576648,0.036005154,0.00024792325],"about_ca_topic_score_codex":0.00022618606,"about_ca_topic_score_gemma":0.0000021064081,"teacher_disagreement_score":0.7044506,"about_ca_system_score_codex":0.00010361805,"about_ca_system_score_gemma":0.00014929098,"threshold_uncertainty_score":0.85277617},"labels":[],"label_agreement":null},{"id":"W2058186456","doi":"10.1016/j.atherosclerosis.2003.10.016","title":"Effect of fibrates on postprandial remnant-like particles in patients with combined hyperlipidemia","year":2003,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Otsuka Pharmaceutical; Otsuka America; Otsuka America Pharmaceutical","keywords":"Postprandial; Gemfibrozil; Fenofibrate; Internal medicine; Hyperlipidemia; Medicine; Area under the curve; Endocrinology; Gastroenterology; Cholesterol; Diabetes mellitus","score_opus":0.007494601663420119,"score_gpt":0.22300564950048435,"score_spread":0.21551104783706423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058186456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863976,0.000057897996,0.0000065764193,0.00006667145,0.00008272775,0.0008186351,0.00000567536,0.000026272985,0.00029578025],"genre_scores_gemma":[0.99946856,0.000032206277,0.00016582722,0.00021078935,0.000023802035,0.00004112696,0.000009781491,0.000032462925,0.000015428403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850845,0.00029962545,0.00026850158,0.00024881828,0.00039186163,0.00028274697],"domain_scores_gemma":[0.9991907,0.00013149645,0.000083048326,0.0004285153,0.0000524783,0.00011375932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069287844,0.00017309359,0.0005305038,0.00006538994,0.000043031643,0.000007808608,0.00005054973,0.0000905781,0.000032974116],"category_scores_gemma":[0.00015863166,0.000111372414,0.00014049021,0.000253096,0.000057620888,0.000050460734,0.000009782196,0.00014005404,0.000016091244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004863042,0.00036225992,0.9862537,0.00015107758,0.00009513003,0.0000016202531,0.000121831516,0.000014067673,0.0022305977,0.0001253356,0.00003512702,0.0057462174],"study_design_scores_gemma":[0.013271915,0.017156158,0.92419857,0.00039893453,0.000100202924,0.0000010063123,0.000015493162,0.000010898756,0.044587705,0.000011519113,0.000119530625,0.00012804464],"about_ca_topic_score_codex":0.00012081363,"about_ca_topic_score_gemma":0.000010011229,"teacher_disagreement_score":0.0620551,"about_ca_system_score_codex":0.00005287886,"about_ca_system_score_gemma":0.000047854865,"threshold_uncertainty_score":0.45416352},"labels":[],"label_agreement":null},{"id":"W2058341307","doi":"10.1016/j.cjca.2010.12.024","title":"Statin-Associated Rhabdomyolysis: Is There a Dose-Response Relationship?","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"Health Canada; McMaster University","keywords":"Medicine; Rhabdomyolysis; Statin; Internal medicine; Atorvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Cardiology","score_opus":0.03992960343957567,"score_gpt":0.258365702165929,"score_spread":0.21843609872635336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058341307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823974,0.003304805,0.00093029387,0.0015850159,0.0004225865,0.00022457271,0.00003267791,0.000010629419,0.011092032],"genre_scores_gemma":[0.99805975,0.0000640315,0.00039226725,0.000635289,0.00043894746,0.0000052607807,0.000003837505,0.00002358677,0.00037705814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818945,0.0006255268,0.00045543408,0.00013732494,0.00020988309,0.00038237494],"domain_scores_gemma":[0.99807256,0.00010240108,0.00022776717,0.00034395375,0.00043051364,0.0008228004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020261155,0.00012985361,0.00065525953,0.00034592696,0.0001252167,0.000009562332,0.00012965864,0.00021512184,0.0002074604],"category_scores_gemma":[0.0009777274,0.000106294545,0.00056472834,0.0002483563,0.00011908119,0.000066459084,0.000006818093,0.00045567172,0.000038543043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024568858,0.000022706314,0.9153088,0.00007385264,0.0052310033,0.0050961715,0.007543326,0.00007796329,0.00025245995,0.0008133019,0.04139191,0.021731652],"study_design_scores_gemma":[0.0017087391,0.00067140616,0.92557746,0.000074555915,0.0004233057,0.001465509,0.0006174842,0.0000033720048,0.00007337706,0.0005374494,0.06873478,0.000112541995],"about_ca_topic_score_codex":0.00285855,"about_ca_topic_score_gemma":0.001165183,"teacher_disagreement_score":0.027342875,"about_ca_system_score_codex":0.00029839156,"about_ca_system_score_gemma":0.0031843537,"threshold_uncertainty_score":0.5648907},"labels":[],"label_agreement":null},{"id":"W2058444692","doi":"10.1016/j.amjcard.2009.10.029","title":"Safety and Efficacy of Ezetimibe Added to Atorvastatin Versus Up Titration of Atorvastatin to 40 mg in Patients ≥65 Years of Age (from the ZETia in the ELDerly [ZETELD] Study)","year":2009,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Atorvastatin; Ezetimibe; Medicine; Hyperlipidemia; Cholesterol; Internal medicine; Apolipoprotein B; Lipoprotein; Endocrinology; Gastroenterology; Diabetes mellitus","score_opus":0.015041863180423741,"score_gpt":0.2880394761515975,"score_spread":0.27299761297117375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058444692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792254,0.00014446441,0.00022584693,0.00079442596,0.00009596604,0.0007179917,0.000015775968,0.0000015903895,0.00008139661],"genre_scores_gemma":[0.9991185,0.000090431735,0.00034303695,0.0003199991,0.00011142162,0.000003704052,0.0000028645443,0.00000848511,0.0000015495264],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99740756,0.0011357906,0.0007148402,0.00013133387,0.0004350464,0.00017544575],"domain_scores_gemma":[0.9983051,0.0005822531,0.0004764457,0.00041904292,0.00014879186,0.00006840967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020115816,0.000109833905,0.0009002121,0.000118230106,0.000022433696,0.0000039602296,0.00024022683,0.000028918415,0.0000031896454],"category_scores_gemma":[0.00044276597,0.0000617057,0.00018110206,0.00044297113,0.00016520351,0.000025662233,0.0000326328,0.00025947086,6.7598256e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033395104,0.0004185705,0.091160364,0.00002450734,0.0010321109,0.00009769981,0.03625375,0.002211468,0.0025964556,0.00007223094,0.00043662835,0.83230114],"study_design_scores_gemma":[0.0044249073,0.012030727,0.9769753,0.00007005225,0.00014963168,0.000014000469,0.005874608,0.000002469759,0.00008899634,0.00002420634,0.00029186378,0.000053210995],"about_ca_topic_score_codex":0.0005899289,"about_ca_topic_score_gemma":0.000064564556,"teacher_disagreement_score":0.88581496,"about_ca_system_score_codex":0.00004272004,"about_ca_system_score_gemma":0.0001191596,"threshold_uncertainty_score":0.25162855},"labels":[],"label_agreement":null},{"id":"W2058451295","doi":"10.7326/m13-1921","title":"<i>N</i>-of-1 (Single-Patient) Trials for Statin-Related Myalgia","year":2014,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"myalgia; Medicine; Statin; Placebo; Discontinuation; Internal medicine; Visual analogue scale; Physical therapy; Pathology","score_opus":0.0965059449467259,"score_gpt":0.3663289738589935,"score_spread":0.2698230289122676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058451295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579881,0.0048460625,0.014569732,0.009481429,0.0011168895,0.0016878657,0.00004194836,0.00004689265,0.010221071],"genre_scores_gemma":[0.99580944,0.00015658113,0.0010947743,0.002049176,0.00046853622,0.000027261829,0.00002698051,0.000029846422,0.00033741535],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971913,0.00022643596,0.0014850867,0.00022599717,0.0006079655,0.00026321583],"domain_scores_gemma":[0.99722564,0.00059167115,0.0007642688,0.0004389031,0.00076883857,0.00021068448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039225304,0.00017423676,0.001471059,0.00019236152,0.000023701761,0.00000256885,0.00012255597,0.00010170478,0.00019455975],"category_scores_gemma":[0.0059107896,0.00011437475,0.00052095216,0.00016219793,0.0001688335,0.000041849038,0.000027210875,0.0001419422,0.0000039553033],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004945302,0.0007195032,0.0018581281,0.0032215116,0.002681719,0.000022771175,0.002317447,0.000014091518,0.123417966,0.006402738,0.04852594,0.80587286],"study_design_scores_gemma":[0.021328257,0.040291715,0.0055260146,0.009562879,0.0012949064,0.0002117942,0.00092730764,0.0006338972,0.6990335,0.0058243107,0.21492408,0.00044132603],"about_ca_topic_score_codex":0.00038138416,"about_ca_topic_score_gemma":0.0000042254796,"teacher_disagreement_score":0.80543154,"about_ca_system_score_codex":0.00001412316,"about_ca_system_score_gemma":0.00006595188,"threshold_uncertainty_score":0.7076194},"labels":[],"label_agreement":null},{"id":"W2059094096","doi":"10.1097/mol.0b013e32832ca1d6","title":"Targets for LDL-lowering therapy","year":2009,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Royal Victoria Regional Health Centre; McGill University Health Centre","funders":"","keywords":"Medicine","score_opus":0.18736531841869894,"score_gpt":0.4498452065195394,"score_spread":0.26247988810084044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059094096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.583661e-7,0.93735605,0.00080102327,0.00011592031,0.058102686,0.00342074,0.000024261932,0.00005934958,0.000119318545],"genre_scores_gemma":[4.9786223e-7,0.9591976,0.0002851137,0.00006163944,0.038930282,0.0008364489,0.0005863999,0.00006172963,0.000040332157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99751586,0.00020825413,0.00084758736,0.00063754467,0.00022698815,0.000563796],"domain_scores_gemma":[0.99868935,0.00013452,0.00025756308,0.0006862241,0.000074061296,0.00015826512],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008706761,0.0004405333,0.002731847,0.00038359035,0.000054825992,0.0000112952075,0.00019255494,0.00050179387,0.00005022582],"category_scores_gemma":[0.00013866636,0.00034067477,0.0012473376,0.00027658342,0.000049470287,0.000036248213,0.00004325093,0.00069295714,0.000039014994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033971668,0.00015278775,0.000007336968,0.026924733,0.000100848534,1.4184732e-7,0.000022581844,2.7575223e-7,7.708751e-8,0.0002742987,0.01521844,0.9572645],"study_design_scores_gemma":[0.0014955425,0.00044849844,0.00004418801,0.015851751,0.000107192085,0.00010840081,0.0000029551497,0.0000026460407,1.7519626e-7,0.00010969668,0.98155355,0.00027540379],"about_ca_topic_score_codex":0.0000071709173,"about_ca_topic_score_gemma":6.9096075e-7,"teacher_disagreement_score":0.9663351,"about_ca_system_score_codex":0.00019864681,"about_ca_system_score_gemma":0.0005629351,"threshold_uncertainty_score":0.9999045},"labels":[],"label_agreement":null},{"id":"W2059634850","doi":"10.2165/00003495-200464190-00003","title":"Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"U.S. Department of Veterans Affairs","keywords":"Medicine; Fibrate; Internal medicine; Bezafibrate; Fenofibrate; Metabolic syndrome; Abdominal obesity; Hypertriglyceridemia; Diabetes mellitus; Risk factor; Cholesterol; Gemfibrozil; Endocrinology; Triglyceride; Obesity","score_opus":0.0231935526228265,"score_gpt":0.30793954816706903,"score_spread":0.2847459955442425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059634850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052337246,0.99143,0.00002698669,0.000024116995,0.000032107568,0.002923339,0.00020316061,0.0000074379245,0.00011913031],"genre_scores_gemma":[0.026684942,0.97245395,0.00029943587,0.000021750568,0.00005459086,0.00024350191,0.00019494862,0.000027336157,0.000019554944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986981,0.00013957097,0.00042483318,0.00021498116,0.0003530026,0.00016948776],"domain_scores_gemma":[0.9989963,0.00010948441,0.00021519406,0.00057995185,0.000030361822,0.000068719004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044035044,0.00019497835,0.0011590014,0.00009908137,0.000027313925,0.0000029353703,0.00013644983,0.000070974806,0.000010005474],"category_scores_gemma":[0.00003527881,0.00011316825,0.00085362146,0.00023708427,0.000048477967,0.000020848162,0.00004140187,0.00014669244,0.0000018644233],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056240573,0.00022544399,0.00031923567,0.121682234,0.0007168959,0.000009667682,0.0012057311,0.0000027150859,3.5183007e-7,0.00040181944,0.000037921203,0.8753418],"study_design_scores_gemma":[0.0016927919,0.00026746918,0.050302096,0.04469386,0.0053693224,0.000011478136,0.0036138028,0.00000165179,0.00001751061,0.0006876826,0.893041,0.00030134968],"about_ca_topic_score_codex":0.000120095785,"about_ca_topic_score_gemma":8.809466e-7,"teacher_disagreement_score":0.89300305,"about_ca_system_score_codex":0.00007547737,"about_ca_system_score_gemma":0.00022606371,"threshold_uncertainty_score":0.46148676},"labels":[],"label_agreement":null},{"id":"W2059775717","doi":"10.1002/ejlt.200800196","title":"A novel mutation of the LDL receptor gene leading to familial hypercholesterolemia","year":2009,"lang":"en","type":"article","venue":"European Journal of Lipid Science and Technology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fondation des Etoiles; National Natural Science Foundation of China; Stars Foundation","keywords":"Familial hypercholesterolemia; Proband; Genetics; Exon; Loss of heterozygosity; Mutation; LDL receptor; Biology; Compound heterozygosity; Allele; Gene; Lipoprotein; Endocrinology; Cholesterol","score_opus":0.01638080829534625,"score_gpt":0.2589667790891798,"score_spread":0.24258597079383357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059775717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98901135,0.00013778938,0.0016502679,0.008221436,0.00021304034,0.00012009661,7.1474545e-7,0.000009852711,0.00063545635],"genre_scores_gemma":[0.99373484,0.000040031857,0.005212967,0.0007341674,0.0002415183,2.3502535e-7,6.4175055e-8,0.0000048910424,0.000031308817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989734,0.000041340638,0.00028539746,0.00012534081,0.00041765938,0.00015684844],"domain_scores_gemma":[0.9991467,0.000006083733,0.00015297321,0.0002282812,0.00037013466,0.00009585011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020891177,0.00006094276,0.00019657062,0.00032526476,0.00010449128,0.000012332179,0.00025931283,0.000024587782,0.0000018142275],"category_scores_gemma":[0.00047937973,0.00003758508,0.000056730623,0.0008728244,0.00027112602,0.000087475855,0.000056129782,0.00022295502,0.0000041745056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024293447,0.000028266284,0.00057425594,0.000005834153,0.000007157893,0.0000127597805,0.00020831499,0.000004896448,0.8047176,0.00012171157,0.00008052316,0.1942144],"study_design_scores_gemma":[0.0048612664,0.00812634,0.30387652,0.00089499913,0.00014669287,0.010839748,0.0015158359,0.00006255424,0.633986,0.0001583287,0.0352452,0.000286539],"about_ca_topic_score_codex":0.0000016234327,"about_ca_topic_score_gemma":4.145922e-7,"teacher_disagreement_score":0.30330226,"about_ca_system_score_codex":0.000044015593,"about_ca_system_score_gemma":0.00018889164,"threshold_uncertainty_score":0.1532675},"labels":[],"label_agreement":null},{"id":"W2059870401","doi":"10.1016/j.cjca.2012.11.032","title":"2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult","year":2013,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":774,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; Population Health Research Institute; University of Toronto; St. Michael's Hospital; Institut universitaire de cardiologie et de pneumologie de Québec; St. Paul's Hospital; Montreal Clinical Research Institute; Centre Hospitalier Universitaire de Sherbrooke; Montreal Heart Institute; University of British Columbia; Centre hospitalier universitaire de Québec; McGill University; McGill University Health Centre; University of Ottawa; Libin Cardiovascular Institute of Alberta; Université Laval; McMaster University; Robarts Clinical Trials; Université de Montréal; University of Calgary","funders":"","keywords":"Medicine; Dyslipidemia; Disease; Framingham Risk Score; Intensive care medicine; Statin; Risk assessment; Population; Kidney disease; Physical therapy; Internal medicine; Environmental health","score_opus":0.10612945360490865,"score_gpt":0.34349592613779667,"score_spread":0.237366472532888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059870401","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026182187,0.9879022,0.0010097007,0.0028406323,0.0006812523,0.006671688,0.0006082434,0.0000013061194,0.000023133221],"genre_scores_gemma":[0.008366739,0.98784953,0.0002077327,0.00019844876,0.0020228412,0.0012342732,0.00003835906,0.00005388518,0.000028204578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99591607,0.0010868895,0.0015615239,0.00032158362,0.0005512638,0.0005626418],"domain_scores_gemma":[0.9944832,0.00076956564,0.0008217867,0.0018295672,0.0016140098,0.00048188714],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0054164925,0.00042483956,0.0037781852,0.00020859852,0.00031167475,0.000020228663,0.0006757423,0.0004054003,0.000005264416],"category_scores_gemma":[0.0011527067,0.00017558128,0.013239787,0.0003467857,0.00054372684,0.000059396865,0.000025871812,0.00038688435,3.3172012e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027587135,0.000009710932,0.0006287927,0.0043482,0.03370852,0.000012140711,0.00021532566,0.0022832078,7.249677e-8,0.00016285737,0.012092353,0.9465112],"study_design_scores_gemma":[0.001275136,0.00026824116,0.001590894,0.002062227,0.032444753,0.00017136514,0.00025314157,0.00003675849,0.0000016832453,0.00007842215,0.96167284,0.00014456527],"about_ca_topic_score_codex":0.14486887,"about_ca_topic_score_gemma":0.09167848,"teacher_disagreement_score":0.9495805,"about_ca_system_score_codex":0.0005700341,"about_ca_system_score_gemma":0.008279895,"threshold_uncertainty_score":0.9973422},"labels":[],"label_agreement":null},{"id":"W2059872519","doi":"10.7326/0003-4819-156-8-201204170-02007","title":"Review: Statins reduce mortality and cardiovascular (CV) morbidity in patients with low CV risk","year":2012,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Primary prevention; Kidney disease; Disease; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Statin; Atorvastatin","score_opus":0.050992282745779514,"score_gpt":0.33361396569333923,"score_spread":0.28262168294755974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059872519","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58723694,0.31314203,0.00012626639,0.09418979,0.000736384,0.0030864356,0.00028857088,0.000042270225,0.0011512738],"genre_scores_gemma":[0.19168973,0.21611677,0.00019903525,0.58165723,0.008917645,0.0001491096,0.0007099451,0.00019520178,0.00036534594],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9949132,0.0005323299,0.0011549055,0.00069501577,0.002049064,0.0006554745],"domain_scores_gemma":[0.9964996,0.00009664999,0.0006667586,0.0016269147,0.00077767926,0.0003324112],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0031175811,0.0005644844,0.00287284,0.00028265393,0.00003879735,0.000006282272,0.00024287785,0.00041237735,0.00016930443],"category_scores_gemma":[0.000845299,0.00036661926,0.0006381955,0.0002861419,0.000376167,0.0001211398,0.000102646125,0.0023058099,0.0000082365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033037987,0.00022229354,0.19465503,0.01786587,0.004897994,0.00040772077,0.00018414082,0.0000010684629,0.000003266873,0.0000012319906,0.7538744,0.027556596],"study_design_scores_gemma":[0.004058143,0.0015486446,0.61683184,0.042039562,0.0025160888,0.00008920518,0.000025339905,0.0000026451742,0.000092690985,0.000018770203,0.3323906,0.00038646534],"about_ca_topic_score_codex":0.017245669,"about_ca_topic_score_gemma":0.000055296903,"teacher_disagreement_score":0.48746744,"about_ca_system_score_codex":0.00006652482,"about_ca_system_score_gemma":0.00016193833,"threshold_uncertainty_score":0.9999959},"labels":[],"label_agreement":null},{"id":"W2059904775","doi":"10.1016/s0828-282x(06)70995-3","title":"Current and future challenges in cardiology: An introduction","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Excellence; Canadian Cardiovascular Society; Library science; Internal medicine; Cardiology; Family medicine; Myocardial infarction; Political science; Angina","score_opus":0.019404064151559923,"score_gpt":0.25126236736710345,"score_spread":0.23185830321554352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059904775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82410467,0.1459331,0.00025717082,0.023572486,0.002994884,0.00026776383,0.00000824867,0.000008125501,0.0028535537],"genre_scores_gemma":[0.96005774,0.007848941,0.00008603128,0.000045148587,0.03193193,0.0000035057797,0.000009304512,0.000011926018,0.000005464033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886966,0.00025069952,0.00029704208,0.00018360616,0.0001032894,0.00029568045],"domain_scores_gemma":[0.9991373,0.000009241338,0.00007799107,0.00023660778,0.00015459617,0.0003842598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091127906,0.00010813652,0.0006516773,0.000359637,0.0000449193,0.000006961586,0.00005793524,0.00016159103,0.0000044330795],"category_scores_gemma":[0.000035396057,0.00009022929,0.00016359753,0.00009229834,0.00010415781,0.0000728982,0.000005072982,0.00041661295,0.0000011541669],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015618645,0.000008833796,0.17177927,0.00018112698,0.00033182505,0.0014755083,0.0002695856,0.0008541378,0.0001484267,0.007628226,0.010722514,0.80644435],"study_design_scores_gemma":[0.00061489356,0.00023163822,0.4209779,0.000011691104,0.0000557502,0.004752744,0.0002122067,0.0000016940206,0.0000057476805,0.0003187797,0.5727617,0.000055289835],"about_ca_topic_score_codex":0.0007677403,"about_ca_topic_score_gemma":0.0035725082,"teacher_disagreement_score":0.8063891,"about_ca_system_score_codex":0.00016631954,"about_ca_system_score_gemma":0.0006791476,"threshold_uncertainty_score":0.36794436},"labels":[],"label_agreement":null},{"id":"W2059908741","doi":"10.1016/j.amjmed.2005.09.014","title":"Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22) trial","year":2005,"lang":"en","type":"article","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Medicine; Pravastatin; Atorvastatin; Myocardial infarction; Internal medicine; TIMI; Acute coronary syndrome; Statin; Cardiology; Cholesterol; Thrombolysis","score_opus":0.03333023584024435,"score_gpt":0.3400795919159844,"score_spread":0.30674935607574005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059908741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976422,0.0005531752,0.00047259714,0.020587483,0.00049338763,0.0014121511,0.000022393284,0.000015219839,0.000021602582],"genre_scores_gemma":[0.9925671,0.0018477379,0.0007882058,0.0026562503,0.002007035,0.00006028797,0.000022846603,0.00003675183,0.0000137634],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99634117,0.0008569561,0.0009690162,0.00030267023,0.0012539449,0.00027622032],"domain_scores_gemma":[0.9969056,0.00053431164,0.0010827569,0.00052142603,0.0007700818,0.00018578838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005061582,0.00027025896,0.0010458336,0.00017791032,0.00012281461,0.000029359071,0.00011810783,0.000053912314,0.0000708405],"category_scores_gemma":[0.0010821938,0.00012304207,0.0001526647,0.00046496163,0.000515255,0.0002806441,0.00003424687,0.0006598251,8.7091394e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5863398,0.00008485141,0.0022060804,0.000009367568,0.0018100438,0.000076953285,0.0074506295,0.00013062217,0.0007405466,4.994343e-7,0.0003057966,0.40084484],"study_design_scores_gemma":[0.38792336,0.14178914,0.42206305,0.0010306044,0.0057111233,0.0020084123,0.033377863,0.0017425157,0.00043941714,0.000039327526,0.003340231,0.00053494476],"about_ca_topic_score_codex":0.0018389398,"about_ca_topic_score_gemma":0.0004636117,"teacher_disagreement_score":0.41985697,"about_ca_system_score_codex":0.00037384822,"about_ca_system_score_gemma":0.00047569862,"threshold_uncertainty_score":0.501751},"labels":[],"label_agreement":null},{"id":"W2060137921","doi":"10.1182/asheducation-2005.1.436","title":"Pathogenesis of Atherosclerosis","year":2005,"lang":"en","type":"article","venue":"Hematology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Pathogenesis; Medicine; Immunology","score_opus":0.01956480063932185,"score_gpt":0.2660671877416919,"score_spread":0.24650238710237007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060137921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934561,0.0019276639,0.00054094923,0.00109518,0.000044623634,0.00017232435,0.0000023411028,0.00003212924,0.002728634],"genre_scores_gemma":[0.9951338,0.00017733804,0.0039596977,0.00045474197,0.000101700134,0.000016341446,0.000002525827,0.000011464626,0.00014235379],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994033,0.000029578387,0.00018198388,0.00011800695,0.00012493956,0.00014220766],"domain_scores_gemma":[0.9995134,0.000013339777,0.00004261149,0.00031839203,0.000046593854,0.00006568717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015185935,0.00005890956,0.00033922587,0.00004169291,0.000018480636,8.2107977e-7,0.000033856286,0.000079846715,0.0001930264],"category_scores_gemma":[0.000027642523,0.000047543796,0.00015498066,0.0000809256,0.000039361646,0.000014305617,0.000016219838,0.000047405498,0.00007117578],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030204622,0.0014105471,0.3289863,0.0020541055,0.0009038904,0.00008876667,0.0011942313,0.00001697522,0.15242212,0.056145065,0.005186815,0.45128915],"study_design_scores_gemma":[0.0053250585,0.00065839716,0.49954408,0.0002753494,0.00044918084,0.0031500272,0.00027812377,0.00019737225,0.36014667,0.0002697719,0.12934992,0.00035603915],"about_ca_topic_score_codex":0.00002723845,"about_ca_topic_score_gemma":0.000009021492,"teacher_disagreement_score":0.45093313,"about_ca_system_score_codex":0.00001497943,"about_ca_system_score_gemma":0.00004735567,"threshold_uncertainty_score":0.21135037},"labels":[],"label_agreement":null},{"id":"W2060615057","doi":"10.1016/s0140-6736(08)60313-x","title":"Age as a modifiable risk factor for cardiovascular disease","year":2008,"lang":"en","type":"review","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Medicine; Disease; Guideline; Myocardial infarction; Risk factor; Middle age; Intensive care medicine; Cause of death; Dilemma; Blood pressure; Stroke (engine); Secondary prevention; Age groups; Internal medicine; Pathology; Demography","score_opus":0.08893180537040173,"score_gpt":0.33519380660610754,"score_spread":0.2462620012357058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060615057","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022379105,0.9920808,0.00042894005,0.000085971544,0.00026971794,0.004850848,0.00133344,0.000117935466,0.0008099714],"genre_scores_gemma":[0.000025641037,0.99087316,0.00035080788,0.000194292,0.0060410844,0.0010695482,0.00021162411,0.00012174357,0.0011121152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997396,0.0003506503,0.00040624265,0.0005439148,0.000707137,0.0005960703],"domain_scores_gemma":[0.99585015,0.00011338508,0.00017564387,0.0034605074,0.00007115512,0.0003291808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072094565,0.0004480419,0.004358689,0.0000679022,0.00025629558,0.000034472898,0.00040689838,0.00021815038,0.00005200753],"category_scores_gemma":[0.0003474177,0.0002440407,0.0068046357,0.00021281408,0.00008413353,0.000030463572,0.00007857941,0.00061853527,0.00018336532],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007156009,0.000033530312,0.0000015928683,0.020966524,0.0061941496,0.00022327069,0.000054185697,0.000017944374,1.0663715e-8,0.00007686332,0.0047471873,0.96761316],"study_design_scores_gemma":[0.0012934102,0.000069018744,0.00002091392,0.0037193296,0.008743588,0.00023358855,0.0000036793283,0.000017491217,1.2296692e-7,0.0001281237,0.9855013,0.00026946995],"about_ca_topic_score_codex":0.00053341314,"about_ca_topic_score_gemma":0.0000013637334,"teacher_disagreement_score":0.9807541,"about_ca_system_score_codex":0.00015112515,"about_ca_system_score_gemma":0.00075681007,"threshold_uncertainty_score":0.9951691},"labels":[],"label_agreement":null},{"id":"W2060635573","doi":"10.1016/j.taap.2003.08.009","title":"Lovastatin-induced cardiac toxicity involves both oncotic and apoptotic cell death with the apoptotic component blunted by both caspase-2 and caspase-3 inhibitors","year":2003,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Heart and Stroke Foundation of British Columbia and Yukon; Heart and Stroke Foundation of Canada","keywords":"Lovastatin; Apoptosis; Programmed cell death; Propidium iodide; Caspase; Biology; Caspase 3; Cell biology; Pharmacology; Chemistry; Biochemistry; Cholesterol","score_opus":0.01387126220769876,"score_gpt":0.25577199727017463,"score_spread":0.24190073506247586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060635573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99129254,0.003085516,0.00013188407,0.0014317435,0.000252775,0.0021592677,0.000025198939,0.0000719932,0.0015490893],"genre_scores_gemma":[0.99432373,0.0006677363,0.00042907748,0.0039003189,0.00019780056,0.00023699993,0.000026611258,0.00005568243,0.00016204044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972621,0.0005377147,0.00039651367,0.00076796557,0.00027198117,0.0007636799],"domain_scores_gemma":[0.9985545,0.00036936632,0.00018210139,0.0003246166,0.000048099875,0.0005212825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008823522,0.00047768123,0.0010195307,0.000121608966,0.00050173764,0.000033784727,0.00009109924,0.0003311728,0.00007919004],"category_scores_gemma":[0.000016712549,0.00033493634,0.00009500952,0.00022457073,0.0006206908,0.000057475445,0.000094930874,0.000846033,0.000006874638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011959035,0.00093340507,0.003787367,0.0007666478,0.001320827,0.00018146809,0.0015604645,0.000038622944,0.9783639,0.002018157,0.0065344907,0.0032988035],"study_design_scores_gemma":[0.02674859,0.0056320056,0.031429484,0.00010504208,0.00522579,0.0018111268,0.004362427,0.00044474288,0.9011204,0.00024223949,0.021198248,0.0016798697],"about_ca_topic_score_codex":0.00015247377,"about_ca_topic_score_gemma":0.000044162698,"teacher_disagreement_score":0.07724341,"about_ca_system_score_codex":0.00010790081,"about_ca_system_score_gemma":0.0002721439,"threshold_uncertainty_score":0.9999103},"labels":[],"label_agreement":null},{"id":"W2060762426","doi":"10.1016/s0021-9150(01)00700-6","title":"A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus","year":2002,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; McGill University; Bristol-Myers Squibb (Canada); St. Paul's Hospital; St. Michael's Hospital; Centre Hospitalier Universitaire de Sherbrooke; Jewish General Hospital","funders":"","keywords":"Gemfibrozil; Pravastatin; Internal medicine; Triglyceride; Endocrinology; Apolipoprotein B; Cholesterol; Medicine; Diabetes mellitus; Chemistry","score_opus":0.019798071702330812,"score_gpt":0.2506397749979261,"score_spread":0.2308417032955953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060762426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967559,0.0016044528,0.000009874203,0.00009019644,0.000012744739,0.001372597,0.000103158156,0.0000053899166,0.00004567949],"genre_scores_gemma":[0.99872607,0.00062664517,0.00041496486,0.00003562958,0.000015850706,0.00012357646,0.000034976627,0.000015645881,0.0000066218313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855036,0.00010989973,0.00042449855,0.00022588647,0.00045708127,0.00023227034],"domain_scores_gemma":[0.99923575,0.00005840679,0.00015689193,0.0004367146,0.000055958015,0.00005625743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002771958,0.00016501489,0.0006178629,0.00009139885,0.000025876421,0.000007406629,0.000069684946,0.00006912404,0.000021795133],"category_scores_gemma":[0.000017762777,0.000097328935,0.00008320143,0.00026869576,0.00008098414,0.000039045226,0.000012430025,0.00009624777,0.0000016796171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116922216,0.0025931178,0.94616616,0.0001890592,0.000089175475,0.0000012653124,0.004540605,0.000016754131,0.0009033034,0.0000041435273,0.000025610494,0.045353893],"study_design_scores_gemma":[0.007303111,0.0039107734,0.9808757,0.00028256094,0.00009275842,3.8981847e-7,0.0003944617,0.000168456,0.006733521,0.0000044668886,0.00013903574,0.000094789364],"about_ca_topic_score_codex":0.001236241,"about_ca_topic_score_gemma":0.00022973283,"teacher_disagreement_score":0.045259103,"about_ca_system_score_codex":0.00006783715,"about_ca_system_score_gemma":0.000018725625,"threshold_uncertainty_score":0.3968959},"labels":[],"label_agreement":null},{"id":"W2060770632","doi":"10.7326/0003-4819-143-7-200510040-00025","title":"Interaction between Simvastatin and <scp>l</scp>-Thyroxine","year":2005,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Simvastatin; Liraglutide; Tel aviv; Internal medicine; Endocrinology; Pediatrics; Library science; Diabetes mellitus","score_opus":0.04940601831966284,"score_gpt":0.3444389901896203,"score_spread":0.29503297186995747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060770632","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.109085836,0.014061212,0.0006645521,0.8570035,0.0009187233,0.000995468,0.00009417576,0.00009348301,0.01708304],"genre_scores_gemma":[0.086573765,0.005416628,0.00042213316,0.84615755,0.049241614,0.000041065254,0.0005592656,0.00016571155,0.0114222765],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964387,0.00016160555,0.0011023122,0.0005573682,0.0012071024,0.00053294445],"domain_scores_gemma":[0.99719894,0.0006403883,0.00066396984,0.0006709874,0.000528993,0.00029672773],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010334261,0.00049031124,0.0017716382,0.000539206,0.000043119308,0.000014510994,0.00021061208,0.0005934209,0.0001892685],"category_scores_gemma":[0.0012984178,0.00035693374,0.00040209194,0.00019395907,0.00028839658,0.00011415066,0.00010292997,0.0023238023,0.000036378206],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041649055,0.00003232238,0.0012007899,0.0011323739,0.0010611363,0.0004530522,0.00036989985,3.4882396e-7,0.00017651398,0.0000063686625,0.92788076,0.06764475],"study_design_scores_gemma":[0.0015760323,0.001975091,0.0051605394,0.0046988493,0.0005531694,0.00057262677,0.00023150996,0.000013952795,0.0025259436,0.00008713827,0.9824901,0.00011500322],"about_ca_topic_score_codex":0.0011647941,"about_ca_topic_score_gemma":0.000010723447,"teacher_disagreement_score":0.06752975,"about_ca_system_score_codex":0.00005171433,"about_ca_system_score_gemma":0.000102287646,"threshold_uncertainty_score":0.9999779},"labels":[],"label_agreement":null},{"id":"W2060775238","doi":"10.1016/s0021-9150(99)00381-0","title":"Glycation amplifies lipoprotein(a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells","year":2000,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Canadian Diabetes Association","keywords":"Glycation; Umbilical vein; Plasminogen activator; Internal medicine; Endocrinology; Plasminogen activator inhibitor-1; Chemistry; Tissue plasminogen activator; Lipoprotein; Medicine; Diabetes mellitus; Biochemistry; Cholesterol; In vitro","score_opus":0.043484367917543745,"score_gpt":0.26382896100755965,"score_spread":0.22034459309001592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060775238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765766,0.00020089987,0.00015160207,0.0002770742,0.000075006574,0.0010626611,0.000029584526,0.00003399191,0.0005115361],"genre_scores_gemma":[0.99810034,0.00018830349,0.00041848104,0.0002827518,0.00059559505,0.00015819169,0.0000921408,0.000030127117,0.00013404553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982359,0.00020376378,0.00047093522,0.00032323506,0.00053856685,0.0002276212],"domain_scores_gemma":[0.9988487,0.000039194536,0.00009925673,0.00088827655,0.00006380944,0.00006080952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004305963,0.00017369843,0.00034844704,0.00007739505,0.00017812732,0.000044844528,0.00014305818,0.0001281375,0.00034820277],"category_scores_gemma":[0.000023702933,0.00013154659,0.00027524182,0.00027072412,0.000052385654,0.00011586901,0.000013253922,0.00016459153,0.00003778323],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030763258,0.00022933827,0.0012033099,0.000041241085,0.000121530094,0.0000012099673,0.002806088,0.0001439279,0.9699766,0.00036799212,0.00010408051,0.024973907],"study_design_scores_gemma":[0.0030245425,0.00046103014,0.33144665,0.00025165707,0.0002854935,0.0000054552575,0.00042714714,0.0006778471,0.6609239,0.00032635688,0.0018726101,0.0002973075],"about_ca_topic_score_codex":0.008599457,"about_ca_topic_score_gemma":0.00039258474,"teacher_disagreement_score":0.33024332,"about_ca_system_score_codex":0.000073599505,"about_ca_system_score_gemma":0.00006435777,"threshold_uncertainty_score":0.99800235},"labels":[],"label_agreement":null},{"id":"W2061063355","doi":"10.14740/jocmr2113w","title":"Cross-Sectional Study of Patients With Onset of Acute Coronary Syndrome During Statin Therapy","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Acute coronary syndrome; Triglyceride; Atorvastatin; Percutaneous coronary intervention; Statin; Body mass index; Gastroenterology; Aspirin; Cholesterol; Cardiology; Myocardial infarction","score_opus":0.2249231192941771,"score_gpt":0.527820899272869,"score_spread":0.30289777997869194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061063355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801093,0.0004557173,0.000014101444,0.00032993802,0.0002596805,0.00082293677,0.000012267429,0.000003826004,0.0000906176],"genre_scores_gemma":[0.9987511,0.00043129863,0.00019967802,0.00003530979,0.0004259142,0.000006288243,0.0000061515684,0.000022054934,0.00012219866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913306,0.0009968228,0.0022175752,0.00021189848,0.0049478803,0.00029518837],"domain_scores_gemma":[0.9928432,0.00078603375,0.0007768951,0.00045815526,0.00449773,0.0006379981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016098445,0.0001244006,0.0012973589,0.00037628086,0.000059195307,0.0000059008044,0.0002352662,0.00011871841,0.00014181621],"category_scores_gemma":[0.0022556672,0.00006818367,0.0002261002,0.00049037294,0.0005721949,0.0001054659,0.000071791685,0.0013199308,0.0000023453501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01730804,0.0031052812,0.9733338,0.0001238828,0.0015747845,0.00072746025,0.00036001927,0.0000073905853,0.000019367635,0.0000015401957,0.00019494991,0.0032435316],"study_design_scores_gemma":[0.03297957,0.06087348,0.9042392,0.00033513864,0.000104234576,0.0005956321,0.0006411938,0.0000037325192,0.00004905522,0.000034120585,0.00009621757,0.000048477374],"about_ca_topic_score_codex":0.0002014696,"about_ca_topic_score_gemma":0.0000057699895,"teacher_disagreement_score":0.069094606,"about_ca_system_score_codex":0.00008973192,"about_ca_system_score_gemma":0.0011922207,"threshold_uncertainty_score":0.5734516},"labels":[],"label_agreement":null},{"id":"W2061147297","doi":"10.1016/s0828-282x(10)71058-8","title":"Lipoprotein-associated phospholipase A2: A new therapeutic target","year":2010,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Lipoprotein-associated phospholipase A2; Phospholipase A2; Apolipoprotein B; Proinflammatory cytokine; Medicine; Apolipoprotein E; Lipoprotein; Enzyme; Phospholipase; Foam cell; Cholesterol; Internal medicine; Endocrinology; Pharmacology; Biochemistry; Inflammation; Disease; Biology","score_opus":0.03606575771406723,"score_gpt":0.29706191756229855,"score_spread":0.2609961598482313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061147297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021608063,0.9919773,0.00051649695,0.00036908814,0.0024367943,0.0010587205,0.00007459201,0.000015735995,0.003529666],"genre_scores_gemma":[0.0004663573,0.9895316,0.00033345373,0.00045465725,0.008085848,0.00002397579,0.00007754163,0.00013753165,0.00088907627],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99639,0.00058917166,0.0012725618,0.00037636727,0.00043391084,0.00093801494],"domain_scores_gemma":[0.9948474,0.000093256895,0.00092803786,0.0009057906,0.00046454,0.0027609498],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018281401,0.00057516305,0.005546453,0.0007536812,0.00014402233,0.000044210403,0.00047192696,0.0015571658,0.0001849687],"category_scores_gemma":[0.0006974779,0.000431634,0.003751506,0.00047769258,0.00018963973,0.000060473936,0.000021951068,0.0030452865,0.00008342518],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017094657,0.0000037874404,0.00003523069,0.0011923495,0.0027040853,0.0016801873,0.000032785247,0.0000030586154,6.1832884e-7,0.000066835695,0.009752624,0.9845113],"study_design_scores_gemma":[0.0010701208,0.00046273883,0.00012562792,0.0039369226,0.0038861437,0.010498138,0.000011070438,2.887527e-7,0.0000017978613,0.00019328269,0.9794749,0.00033898972],"about_ca_topic_score_codex":0.0058644195,"about_ca_topic_score_gemma":0.0021830422,"teacher_disagreement_score":0.98417234,"about_ca_system_score_codex":0.00080735347,"about_ca_system_score_gemma":0.03129227,"threshold_uncertainty_score":0.99981356},"labels":[],"label_agreement":null},{"id":"W2061382536","doi":"10.1097/00005373-200104000-00014","title":"Major Trauma in Elderly Adults Receiving Lipid-Lowering Medications","year":2001,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Emergency medicine; Internal medicine","score_opus":0.013686931300009772,"score_gpt":0.2702215328030111,"score_spread":0.25653460150300134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061382536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9513361,0.0005655518,0.0019580827,0.003536031,0.00015417497,0.00047511535,6.790279e-7,0.00010715153,0.04186711],"genre_scores_gemma":[0.9953247,0.00044734046,0.0015358317,0.0004979468,0.00044495118,0.000060067498,0.000009079729,0.00001875182,0.0016613416],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988523,0.000027183634,0.00027500256,0.00023755615,0.00032539503,0.00028254002],"domain_scores_gemma":[0.9992859,0.00002533935,0.000030041834,0.00042661018,0.000047970345,0.00018418128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004909957,0.00009796977,0.0002472833,0.00013187231,0.000058244506,0.000010208205,0.00006917831,0.00008504451,0.000644717],"category_scores_gemma":[0.00009204455,0.000081039725,0.00012002953,0.00035171793,0.000020796817,0.00007413391,0.000017966511,0.00019889708,0.00007066173],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103961844,0.00021602536,0.021582086,0.00016066738,0.00009277583,0.0001262275,0.0008030803,0.0000042409765,0.00036065662,0.00017492211,0.0006035935,0.9757718],"study_design_scores_gemma":[0.009067096,0.0006808092,0.89469,0.0013940671,0.00015180066,0.0008483729,0.0020950793,0.000624422,0.00273131,0.00012158166,0.087156914,0.00043854324],"about_ca_topic_score_codex":0.0017420106,"about_ca_topic_score_gemma":0.0015553719,"teacher_disagreement_score":0.9753332,"about_ca_system_score_codex":0.00008476507,"about_ca_system_score_gemma":0.00008648124,"threshold_uncertainty_score":0.7059199},"labels":[],"label_agreement":null},{"id":"W2061592066","doi":"10.1007/s00228-009-0673-0","title":"Impact of better adherence to statin agents in the primary prevention of coronary artery disease","year":2009,"lang":"en","type":"article","venue":"European Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Coronary artery disease; Statin; Diabetes mellitus; Cohort; Logistic regression; Surgery; Endocrinology","score_opus":0.10771605853810795,"score_gpt":0.46211172206242085,"score_spread":0.3543956635243129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061592066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672765,0.00029550758,0.00029120015,0.0014809741,0.00027783055,0.00037481973,0.000005751962,0.0000021428605,0.00054411497],"genre_scores_gemma":[0.99322,0.00023206961,0.0004960585,0.005365004,0.0006471783,8.5520645e-7,0.0000030495437,0.000008595533,0.000027210008],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99568427,0.0022942608,0.0014089528,0.0001151846,0.00034595528,0.00015139506],"domain_scores_gemma":[0.9986313,0.00017871431,0.00060527347,0.00018553055,0.00014678594,0.00025237686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047572358,0.00008846583,0.00055987015,0.00008866983,0.000012183195,0.0000024800809,0.00020004106,0.000021918819,0.00017569421],"category_scores_gemma":[0.0002396302,0.00005356063,0.00061449886,0.00012654303,0.00006434545,0.000057337544,0.00002691617,0.0004337966,0.000009048046],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012751715,0.0041874624,0.21017437,0.00016458542,0.00072830304,0.004523026,0.0004590655,0.00020424252,0.005019939,0.0000031895584,0.025601642,0.73618245],"study_design_scores_gemma":[0.004706461,0.010333529,0.98360425,0.00014349831,0.00023313268,0.00011352042,0.000013861092,0.000009934158,0.00003600866,0.00004386567,0.0007198496,0.00004206303],"about_ca_topic_score_codex":0.0000020341445,"about_ca_topic_score_gemma":1.9906733e-7,"teacher_disagreement_score":0.77342993,"about_ca_system_score_codex":0.000028363633,"about_ca_system_score_gemma":0.00031097315,"threshold_uncertainty_score":0.21841392},"labels":[],"label_agreement":null},{"id":"W2061967749","doi":"10.1016/s1878-6480(13)71184-4","title":"253: The effect of statins on the risk of first non-fatal myocardial infarction: A population-based observational study using the PGRx information system","year":2013,"lang":"en","type":"article","venue":"Archives of Cardiovascular Diseases Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Rosuvastatin; Myocardial infarction; Internal medicine; Statin; Observational study; Logistic regression; Odds ratio; Population; Propensity score matching; Medical record; Physical therapy","score_opus":0.014922164010870334,"score_gpt":0.25228535108095324,"score_spread":0.23736318707008291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061967749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99023485,0.00030743418,0.0026293027,0.00014435672,0.00013288757,0.005677688,0.0007730007,0.000014871513,0.000085600615],"genre_scores_gemma":[0.99868625,0.000037778485,0.0001321705,0.000041513806,0.00015337448,0.0005033001,0.00042430693,0.000019812891,0.0000014713289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959878,0.0010740679,0.000746459,0.00020465584,0.0017529803,0.00023408451],"domain_scores_gemma":[0.9971071,0.0007567729,0.00044663026,0.0014118087,0.00018964068,0.00008808647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011754268,0.0002364199,0.0007147649,0.00012946359,0.0003729348,0.000028689197,0.0002833091,0.00003268413,0.000037019097],"category_scores_gemma":[0.0003046155,0.00011639957,0.0017872204,0.0002986638,0.00015391118,0.00017798878,0.00009777151,0.00017108652,0.0000027855647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045128324,0.0001333454,0.9502881,0.00085780973,0.008866608,0.0000011879356,0.0007960703,0.03390851,0.000009179273,0.00006538225,0.0000634102,0.004559104],"study_design_scores_gemma":[0.0038286576,0.0007844236,0.97774595,0.00024826187,0.0032983522,0.000004571481,0.001721983,0.011632578,0.0002339345,0.000019008436,0.0003759664,0.00010630351],"about_ca_topic_score_codex":0.008198058,"about_ca_topic_score_gemma":0.000023148003,"teacher_disagreement_score":0.027457848,"about_ca_system_score_codex":0.00006153952,"about_ca_system_score_gemma":0.0001554358,"threshold_uncertainty_score":0.9984064},"labels":[],"label_agreement":null},{"id":"W2062025000","doi":"10.1001/archinte.163.21.2576","title":"In-Hospital Initiation of Lipid-Lowering Therapy After Coronary Intervention as a Predictor of Long-term Utilization","year":2003,"lang":"en","type":"article","venue":"Archives of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Confidence interval; Relative risk; Percutaneous coronary intervention; Internal medicine; Confounding; Retrospective cohort study; Randomized controlled trial; Cardiology; Myocardial infarction","score_opus":0.01516841562411602,"score_gpt":0.29555946436089436,"score_spread":0.28039104873677834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062025000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886777,0.0027865118,0.0055272765,0.00013845158,0.00034301312,0.00048783747,0.000004604983,0.000007611133,0.0020270373],"genre_scores_gemma":[0.99809957,0.0013555958,0.00016448779,0.00010014185,0.00015315262,0.000024548466,0.000015707525,0.000016632683,0.00007018527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854475,0.0000957523,0.00069310644,0.00016700038,0.00037022113,0.00012919027],"domain_scores_gemma":[0.99922174,0.00007046945,0.0002887,0.0002473705,0.000085724,0.00008600996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031444462,0.0001213603,0.00045545812,0.0002772803,0.0000073851224,0.0000011194155,0.000078595265,0.000045430945,0.00038640795],"category_scores_gemma":[0.0003225177,0.000094052826,0.00019864559,0.00012481546,0.00015626255,0.00009487274,0.0000249996,0.00013123502,8.709199e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039498173,0.001270861,0.87156534,0.0018397863,0.0004705437,0.00012774847,0.0062208087,0.000005824143,0.023546528,0.00044202813,0.000021465057,0.09053924],"study_design_scores_gemma":[0.0060154907,0.0051665134,0.91917247,0.0053138114,0.000054445187,0.000089544716,0.00023955581,0.000043283282,0.063395105,0.00035278735,0.000084990155,0.000071987255],"about_ca_topic_score_codex":0.00019511097,"about_ca_topic_score_gemma":0.0000139251715,"teacher_disagreement_score":0.09046725,"about_ca_system_score_codex":0.00002248703,"about_ca_system_score_gemma":0.00006252014,"threshold_uncertainty_score":0.4230896},"labels":[],"label_agreement":null},{"id":"W2062442341","doi":"10.1177/0091270011420253","title":"The Seduction of Biomarkers in the Practice of Medicine and the Tyranny of Power in the Drug Approval Process: Lessons From Niacin","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Psychological intervention; Diligence; Medicine; Due diligence; Intensive care medicine; Psychology; Psychiatry; Business; Social psychology","score_opus":0.08051743857832007,"score_gpt":0.4551217575855924,"score_spread":0.37460431900727237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062442341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88128185,0.0070986706,0.00003651841,0.10888256,0.00061113166,0.0007917938,0.0000027944177,0.0000013984582,0.0012932537],"genre_scores_gemma":[0.9892681,0.0069487137,0.00006732858,0.003118538,0.00057195546,0.0000100115685,4.155751e-7,0.000008302723,0.000006588833],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99179435,0.0056291027,0.0016508787,0.00011301345,0.000636801,0.00017586729],"domain_scores_gemma":[0.98943686,0.008221469,0.0015790467,0.00036846427,0.0003422225,0.00005194516],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.039112445,0.00011446257,0.00077638665,0.00006785903,0.00007489229,0.0000026504258,0.00054210884,0.000095231335,0.000041009956],"category_scores_gemma":[0.003100027,0.000035486482,0.00024412092,0.0003324092,0.0019739717,0.000080236314,0.00004493159,0.0011276148,4.3307912e-7],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29903722,0.010729376,0.023391526,0.0012231683,0.01842766,0.000344954,0.394559,0.00014044748,0.013507793,0.0050507775,0.046837214,0.18675087],"study_design_scores_gemma":[0.11214826,0.009699477,0.44324002,0.0013159855,0.015608983,0.0034638692,0.34569883,0.0006303404,0.007204026,0.021685863,0.03891347,0.0003908673],"about_ca_topic_score_codex":0.0009502766,"about_ca_topic_score_gemma":0.000053009117,"teacher_disagreement_score":0.4198485,"about_ca_system_score_codex":0.000013046012,"about_ca_system_score_gemma":0.00028720067,"threshold_uncertainty_score":0.989436},"labels":[],"label_agreement":null},{"id":"W2062531980","doi":"10.1021/bi002141j","title":"Cholesterol Mobilization by Free and Lipid-Bound ApoAI<sub>Milano</sub> and ApoAI<sub>Milano</sub>−ApoAII Heterodimers","year":2001,"lang":"en","type":"article","venue":"Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cholesterol; Apolipoprotein B; Sterol O-acyltransferase; Chemistry; Phospholipid; Reverse cholesterol transport; Internal medicine; Biochemistry; Endocrinology; Lipoprotein; Biology; Medicine; Membrane","score_opus":0.007381734019990811,"score_gpt":0.22255308044938202,"score_spread":0.2151713464293912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062531980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98910457,0.0078085116,0.00027795392,0.00073691073,0.00020492243,0.0007783002,0.00009826991,0.00016256217,0.0008280261],"genre_scores_gemma":[0.98990583,0.006855025,0.0000903436,0.0011392058,0.0009891308,0.00010474359,0.00055795,0.000098825774,0.00025894007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969443,0.00008064953,0.00055262144,0.001019846,0.00070295454,0.000699647],"domain_scores_gemma":[0.9976792,0.00004429146,0.0001925734,0.0012614127,0.00015544196,0.00066711626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005093544,0.00052526756,0.0006996136,0.00009720407,0.00026703402,0.00013124915,0.00020491231,0.00054782437,0.000023283348],"category_scores_gemma":[0.00017499915,0.0005084569,0.00022513936,0.0003050013,0.00029948127,0.00015089671,0.00018869722,0.00043893812,0.000020297564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014385728,0.00017404526,0.0071189147,0.0007955578,0.00021274184,0.000033011187,0.00010388083,0.0000018635878,0.9643295,0.000002112209,0.0075380467,0.019546486],"study_design_scores_gemma":[0.004312966,0.00024432217,0.008076528,0.00031945115,0.0002964459,0.00066036085,0.00017029398,0.00010940829,0.97614765,0.00002792459,0.009058585,0.00057607907],"about_ca_topic_score_codex":0.00012068576,"about_ca_topic_score_gemma":0.000028657247,"teacher_disagreement_score":0.018970408,"about_ca_system_score_codex":0.00017252415,"about_ca_system_score_gemma":0.00017596208,"threshold_uncertainty_score":0.9997367},"labels":[],"label_agreement":null},{"id":"W2062532304","doi":"10.1007/s11606-011-1939-7","title":"Statins and Sepsis – Scientifically Interesting but Clinically Inconsequential","year":2011,"lang":"en","type":"letter","venue":"Journal of General Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Intensive care medicine; Sepsis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MEDLINE; Internal medicine; Statin","score_opus":0.06218382978558007,"score_gpt":0.34269273871098005,"score_spread":0.2805089089254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062532304","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29276225,0.0061400086,0.0070089707,0.670541,0.011837195,0.00089836493,0.00005549623,0.00005767638,0.010699036],"genre_scores_gemma":[0.042780396,0.0026634112,0.01798603,0.81755084,0.089386836,0.000012117483,0.0000780856,0.00022336916,0.029318947],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943771,0.00036761363,0.0025913522,0.0004916056,0.0016360547,0.00053627434],"domain_scores_gemma":[0.9956251,0.00022225811,0.0018581982,0.00054646074,0.0011805419,0.000567459],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0031858163,0.00047157428,0.0019399094,0.0006831083,0.000093482566,0.00005777762,0.00043522494,0.0006239681,0.0005961392],"category_scores_gemma":[0.0016343414,0.00030608877,0.0007014577,0.00017900587,0.0007377997,0.00012640371,0.00019062421,0.0043709883,0.000014329506],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008238856,0.00007986081,0.0017394897,0.0007499199,0.0015344888,0.012563825,0.00037047442,4.3280698e-7,0.0038543548,0.0000137064335,0.9483789,0.02989066],"study_design_scores_gemma":[0.007896553,0.010199857,0.0049145413,0.011596409,0.003111798,0.034845017,0.00020097541,0.000101360034,0.0009732493,0.0005852201,0.92496717,0.000607874],"about_ca_topic_score_codex":0.0013133755,"about_ca_topic_score_gemma":0.00001890949,"teacher_disagreement_score":0.24998185,"about_ca_system_score_codex":0.0001893928,"about_ca_system_score_gemma":0.0006713353,"threshold_uncertainty_score":0.99993914},"labels":[],"label_agreement":null},{"id":"W2062778217","doi":"10.1139/h07-186","title":"Plasma lipoprotein (a), homocysteine, and other cardiovascular disease (CVD) risk factors in Nigerians with CVD","year":2008,"lang":"en","type":"article","venue":"Applied Physiology Nutrition and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Nigerians; Medicine; Anthropometry; Homocysteine; Internal medicine; Blood pressure; Body mass index; Waist–hip ratio; Endocrinology; Waist; Lipoprotein; Lipoprotein(a); Cardiology; Cholesterol","score_opus":0.011764922092345993,"score_gpt":0.21212201289649193,"score_spread":0.20035709080414593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062778217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851855,0.012666192,0.0000886506,0.00009522218,0.000058570746,0.0014807167,0.00006477903,0.00006474919,0.00029563648],"genre_scores_gemma":[0.9901377,0.008071847,0.00051091035,0.0003051278,0.0003769185,0.0004500252,0.000061564526,0.00004535827,0.000040543604],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99834603,0.00014758785,0.00023918481,0.00059701555,0.0002955794,0.0003745993],"domain_scores_gemma":[0.99895024,0.000027687973,0.00007621621,0.0005555633,0.000040723386,0.00034957955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022780274,0.0003007618,0.0009090171,0.00017052711,0.00019970123,0.000009890323,0.000053875527,0.0001705769,0.000020171852],"category_scores_gemma":[0.000017026181,0.00022550071,0.00021803504,0.00023411341,0.0003031533,0.000060980645,0.00003549208,0.00032574916,0.000007183533],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032846533,0.016691983,0.1321348,0.014919163,0.035327427,0.0034432637,0.020651951,0.0012557029,0.3169034,0.056146227,0.0034761154,0.36620343],"study_design_scores_gemma":[0.01644506,0.000084684085,0.85623544,0.00011114815,0.0007081778,0.00018429129,0.00039466596,0.00005334776,0.003713364,0.0005064638,0.121113665,0.00044971227],"about_ca_topic_score_codex":0.0008715866,"about_ca_topic_score_gemma":0.000025314821,"teacher_disagreement_score":0.72410065,"about_ca_system_score_codex":0.000019839792,"about_ca_system_score_gemma":0.00007370739,"threshold_uncertainty_score":0.91956526},"labels":[],"label_agreement":null},{"id":"W2062834072","doi":"10.1016/j.jacl.2007.12.006","title":"Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice","year":2008,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Ezetimibe; Apolipoprotein B; Internal medicine; Percentile; Cholesterol; Population; Endocrinology; Lipoprotein; Statistics; Environmental health; Mathematics","score_opus":0.24887842144101638,"score_gpt":0.47160715150342325,"score_spread":0.22272873006240687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062834072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982162,0.0011287167,0.0069537633,0.008248014,0.0007726881,0.00070732087,0.000008991584,0.000007303562,0.000011186124],"genre_scores_gemma":[0.98669815,0.0036316148,0.0061148494,0.0012201428,0.0022639264,0.000020583251,6.3106864e-7,0.000022930779,0.000027192875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99564314,0.0010081393,0.0025418068,0.00023761982,0.00033841733,0.0002308934],"domain_scores_gemma":[0.9943032,0.0027186424,0.0011697001,0.00049488415,0.00092035317,0.00039319939],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0073805666,0.00012912952,0.0013447677,0.00008510858,0.00006219072,0.000004386108,0.00015801955,0.00025125846,0.000012914791],"category_scores_gemma":[0.014452192,0.00009471985,0.0008848559,0.00013349109,0.00025434425,0.00008543337,0.000055874436,0.00042702007,0.000001399304],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.105847605,0.006617084,0.29294848,0.00024323982,0.004024495,0.000023453453,0.0010092255,0.000017888004,0.09992061,0.0002857302,0.0018877774,0.48717442],"study_design_scores_gemma":[0.008758325,0.012377447,0.9428693,0.00009866931,0.0003879448,0.0008079982,0.0000632807,0.000009437625,0.0070563117,0.00008890477,0.027384052,0.00009831773],"about_ca_topic_score_codex":0.000016853135,"about_ca_topic_score_gemma":0.000005793607,"teacher_disagreement_score":0.6499208,"about_ca_system_score_codex":0.000016462514,"about_ca_system_score_gemma":0.0004905536,"threshold_uncertainty_score":0.9938495},"labels":[],"label_agreement":null},{"id":"W2062912605","doi":"10.1194/jlr.d800050-jlr200","title":"Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR","year":2008,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of Victoria; University of Windsor; Western University","funders":"","keywords":"Genotyping; Copy-number variation; genomic DNA; Genetics; Biology; DNA; Computational biology; Genotype; Genome; Gene","score_opus":0.08925039594815166,"score_gpt":0.37280372150176294,"score_spread":0.2835533255536113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062912605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905887,0.00042688026,0.0067082974,0.0002378911,0.00032120978,0.00046239563,0.000006342232,0.000010099168,0.0012381738],"genre_scores_gemma":[0.9692594,0.0006661165,0.0263642,0.00003630669,0.0034152337,0.0000057528096,0.0000060139855,0.000042083753,0.00020491134],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99606776,0.00050277566,0.0008864067,0.00023838879,0.0019014612,0.00040323313],"domain_scores_gemma":[0.99709266,0.00015714152,0.0004743861,0.0004804251,0.001544403,0.0002509692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038692888,0.00014183998,0.00060899474,0.00028672555,0.00026605485,0.000027120604,0.00018570044,0.00019135351,0.00051811436],"category_scores_gemma":[0.000592184,0.0001209086,0.00036252363,0.0004597679,0.00012132616,0.0002613582,0.000093921,0.0008024311,0.00003984376],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026011388,0.0010619211,0.156225,0.00094656943,0.0010996382,0.0011702259,0.0055031595,0.00019856801,0.7378782,0.00011873588,0.0010523672,0.09214449],"study_design_scores_gemma":[0.009528703,0.0014696375,0.67401737,0.0025176064,0.00052365445,0.010721659,0.0008666315,0.0053141206,0.28118312,0.00121822,0.011998286,0.0006410119],"about_ca_topic_score_codex":0.0014866902,"about_ca_topic_score_gemma":0.000012465565,"teacher_disagreement_score":0.51779234,"about_ca_system_score_codex":0.0005843357,"about_ca_system_score_gemma":0.0009162594,"threshold_uncertainty_score":0.56729895},"labels":[],"label_agreement":null},{"id":"W2062993935","doi":"10.1111/j.1742-4658.2005.05089.x","title":"Replacement of helix 1′ enhances the lipid binding activity of apoE3 N‐terminal domain","year":2006,"lang":"en","type":"article","venue":"FEBS Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa","funders":"National Heart, Lung, and Blood Institute","keywords":"Guanidine; Helix (gastropod); Denaturation (fissile materials); Apolipoprotein B; Chemistry; Biochemistry; Mutant; LDL receptor; Lipoprotein; Helix bundle; Biophysics; Conformational change; Wild type; Triple helix; Protein structure; Biology; Stereochemistry; Cholesterol; Gene","score_opus":0.013121622006605195,"score_gpt":0.2741144913838998,"score_spread":0.2609928693772946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062993935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417984,0.00069553027,0.0023452104,0.0006301677,0.00025333327,0.00021497007,0.000004573709,0.0000056037993,0.0016707845],"genre_scores_gemma":[0.99714637,0.0001869164,0.001189722,0.000044704822,0.0011811479,0.000004771748,0.0000013696005,0.000009668083,0.00023534292],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985652,0.00012470364,0.00036281522,0.000108782486,0.0006310884,0.0002074058],"domain_scores_gemma":[0.9991462,0.00003319403,0.00034538648,0.0002947573,0.000108035354,0.00007238319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017642599,0.00009439149,0.0003397024,0.00008159698,0.00013114208,0.000013683459,0.000096119205,0.000048552185,0.00012327451],"category_scores_gemma":[0.00003099062,0.00005596019,0.00029523013,0.00013872042,0.00007661021,0.000066254404,0.000028797956,0.0002808373,0.000003961142],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025744198,0.0009782203,0.016321026,0.0009451896,0.00086820865,0.0002065121,0.00096798467,0.00006164137,0.8328066,0.000603262,0.006537968,0.13712898],"study_design_scores_gemma":[0.005603314,0.002402712,0.10922095,0.001180657,0.0004442571,0.005059052,0.000967161,0.00006345269,0.84327495,0.0010819484,0.030438876,0.0002626935],"about_ca_topic_score_codex":0.000183424,"about_ca_topic_score_gemma":0.000018225986,"teacher_disagreement_score":0.13686629,"about_ca_system_score_codex":0.00007397832,"about_ca_system_score_gemma":0.0001807123,"threshold_uncertainty_score":0.22819902},"labels":[],"label_agreement":null},{"id":"W2063431469","doi":"10.1161/strokeaha.108.546135","title":"Relative and Cumulative Effects of Lipid and Blood Pressure Control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trial","year":2009,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Yorkville University; University of Alberta; Dalhousie University","funders":"","keywords":"Medicine; Stroke (engine); Blood pressure; Atorvastatin; Hazard ratio; Internal medicine; Cholesterol; Placebo; Cardiology; Confidence interval; Endocrinology","score_opus":0.01058869453339159,"score_gpt":0.2768111563081317,"score_spread":0.26622246177474007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063431469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913033,0.004915207,0.0001675095,0.00053450867,0.000072083116,0.0027675263,0.00003298045,0.0000071731724,0.00019970768],"genre_scores_gemma":[0.9991528,0.0002052428,0.000054645654,0.00007271227,0.0001900365,0.0000665612,0.0000064298047,0.000006575598,0.00024503033],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986279,0.0004259589,0.00027383954,0.00023086926,0.00028235,0.00015909155],"domain_scores_gemma":[0.9994271,0.00009578321,0.00020277507,0.00018644446,0.00004062859,0.000047305894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006212922,0.00012233415,0.0004007777,0.000089599765,0.000034698827,0.000010941287,0.000036123667,0.000118500335,0.000002107468],"category_scores_gemma":[0.0001908355,0.00008643031,0.00008108278,0.000093620285,0.00006111223,0.0001348501,0.000008809312,0.0002888276,1.5884555e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08786889,0.00737342,0.04030205,0.003549952,0.005915079,0.00029303032,0.049171906,0.0001782721,0.24076858,0.0019561038,0.00074122404,0.5618815],"study_design_scores_gemma":[0.29631653,0.013123628,0.6610037,0.0018680551,0.00210563,0.00016756564,0.0010682107,0.00027716983,0.022433298,0.0008082024,0.0005185525,0.00030941734],"about_ca_topic_score_codex":0.00008731542,"about_ca_topic_score_gemma":0.000011733682,"teacher_disagreement_score":0.6207017,"about_ca_system_score_codex":0.000014198974,"about_ca_system_score_gemma":0.00004013894,"threshold_uncertainty_score":0.35245258},"labels":[],"label_agreement":null},{"id":"W2063463656","doi":"10.1016/j.ymeth.2015.03.003","title":"A semi-automated mass spectrometric immunoassay coupled to selected reaction monitoring (MSIA–SRM) reveals novel relationships between circulating PCSK9 and metabolic phenotypes in patient cohorts","year":2015,"lang":"en","type":"article","venue":"Methods","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital du Sacré-Cœur de Montréal; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Kexin; PCSK9; Proprotein convertase; Subtilisin; Chemistry; Immunoassay; Furin; Phosphorylation; Target peptide; Cysteine; LDL receptor; Biochemistry; Peptide; Computational biology; Cholesterol; Lipoprotein; Biology; Enzyme; Antibody; Genetics","score_opus":0.07249555039177327,"score_gpt":0.3587186101889999,"score_spread":0.2862230597972266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063463656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486815,0.0032571885,0.045896057,0.000118684715,0.0002427448,0.0012207712,0.000006986992,0.00028906862,0.000287052],"genre_scores_gemma":[0.805754,0.00004355767,0.19369954,0.000020300677,0.000294921,0.00008837487,0.000030415631,0.000044654294,0.00002426397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966997,0.0010437954,0.0007119072,0.000483552,0.00060671614,0.0004543653],"domain_scores_gemma":[0.99816066,0.00038055307,0.00020243782,0.0005046958,0.0003626209,0.0003890079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068932655,0.00024602,0.00089976046,0.000790063,0.00013394089,0.000041870473,0.00006649499,0.00021472499,0.0000032346013],"category_scores_gemma":[0.0041916044,0.00023140275,0.00009817109,0.0033500355,0.000019683202,0.00014301154,0.00005538147,0.00057865784,0.0000057676802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105765794,0.000115626324,0.5038073,0.00015304436,0.00045858065,0.00003437185,0.0018159687,0.0002941721,0.4401064,0.00005193989,0.000017133088,0.053039674],"study_design_scores_gemma":[0.0016821551,0.00019330242,0.9777417,0.00021073673,0.00031945464,0.00010027867,0.0004419219,0.003827552,0.014583469,0.00012370414,0.00053369015,0.00024202587],"about_ca_topic_score_codex":0.0011588988,"about_ca_topic_score_gemma":0.000006719273,"teacher_disagreement_score":0.47393438,"about_ca_system_score_codex":0.00045680132,"about_ca_system_score_gemma":0.00018729574,"threshold_uncertainty_score":0.943633},"labels":[],"label_agreement":null},{"id":"W2063997003","doi":"10.1016/j.ahj.2013.12.008","title":"Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry","year":2013,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Patient registry; Disease; Family medicine; Demographics; Intensive care medicine; Pediatrics; Internal medicine; Cholesterol","score_opus":0.038729439551625465,"score_gpt":0.29477022744541054,"score_spread":0.2560407878937851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063997003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9385987,0.00020336529,0.059654288,0.00060358364,0.000094110816,0.000827565,0.000005643525,0.000006341924,0.0000064153965],"genre_scores_gemma":[0.9911207,0.00017172226,0.007940587,0.00033485715,0.00033764748,0.00004506695,0.0000024892877,0.000017571,0.000029352857],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99874485,0.00019658322,0.00037379304,0.00016989138,0.0003399267,0.0001749634],"domain_scores_gemma":[0.9990448,0.0001121731,0.00023665304,0.00021647343,0.00026266818,0.00012726305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006537956,0.00011449882,0.0003791163,0.00007380345,0.00022836323,0.000031264473,0.000056717945,0.000060881364,0.0000038587386],"category_scores_gemma":[0.00016822529,0.00008272442,0.00013421601,0.00012792659,0.00030042388,0.00016584902,0.000029731895,0.00024821542,4.0628754e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004991836,0.00005121383,0.08280285,0.0002305691,0.00016816008,0.0000014577714,0.00053039,0.00022311817,0.5376808,0.0000063329803,0.00012788242,0.377678],"study_design_scores_gemma":[0.0023234258,0.0009733811,0.96814114,0.0002675758,0.00019195015,0.0017780741,0.0013026117,0.0028199807,0.020707501,0.00008360958,0.001275001,0.00013572561],"about_ca_topic_score_codex":0.001417318,"about_ca_topic_score_gemma":0.00002670766,"teacher_disagreement_score":0.8853383,"about_ca_system_score_codex":0.000046010657,"about_ca_system_score_gemma":0.00019850166,"threshold_uncertainty_score":0.3373404},"labels":[],"label_agreement":null},{"id":"W2064225033","doi":"10.1016/s0002-9149(02)02994-6","title":"Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease","year":2003,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Core Research for Evolutional Science and Technology; AstraZeneca","keywords":"Rosuvastatin; Atorvastatin; Medicine; Internal medicine; Cardiology","score_opus":0.008757274877726743,"score_gpt":0.27125135795355726,"score_spread":0.2624940830758305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064225033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986705,0.00051957637,0.00024640022,0.00008174875,0.000048560672,0.00039512385,0.000016382597,0.0000022200272,0.000019475501],"genre_scores_gemma":[0.99935454,0.00013716315,0.00028927406,0.00012209828,0.000073966985,0.000008874268,0.0000014953381,0.00001151529,0.0000010812314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983677,0.0008553729,0.0002580141,0.00013220616,0.000190188,0.00019647989],"domain_scores_gemma":[0.998974,0.00019316343,0.00035142273,0.00018337216,0.00014190172,0.00015611449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005347322,0.00013975351,0.0010996283,0.000052840664,0.000040123898,0.000006765722,0.000045834287,0.00002033754,4.772237e-7],"category_scores_gemma":[0.00008618962,0.00007363027,0.00008952989,0.00010979179,0.00070345035,0.000053020904,0.000020185851,0.00022382067,1.3246063e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020061195,0.000100623874,0.9113965,0.00014018174,0.0011264897,0.00007221131,0.008368716,0.0000671004,0.0015342097,0.000017417224,0.000009864341,0.057105508],"study_design_scores_gemma":[0.0069785984,0.002709839,0.98697037,0.00013139202,0.00016603906,0.00017237781,0.0021074,0.000002182876,0.0005595516,0.000040844978,0.00008920161,0.0000721852],"about_ca_topic_score_codex":0.00001941169,"about_ca_topic_score_gemma":0.0000036667277,"teacher_disagreement_score":0.07557391,"about_ca_system_score_codex":0.000029225497,"about_ca_system_score_gemma":0.00011190506,"threshold_uncertainty_score":0.3002555},"labels":[],"label_agreement":null},{"id":"W2064344939","doi":"10.1016/j.cjca.2014.01.009","title":"Are the ACC/AHA Guidelines on the Treatment of Blood Cholesterol a Game Changer? A Perspective From the Canadian Cardiovascular Society Dyslipidemia Panel","year":2014,"lang":"en","type":"editorial","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; Population Health Research Institute; University of Toronto; St. Michael's Hospital; University of Calgary; Institut universitaire de cardiologie et de pneumologie de Québec; St. Paul's Hospital; Montreal Clinical Research Institute; Centre Hospitalier Universitaire de Sherbrooke; University of British Columbia; Montreal Heart Institute; Centre hospitalier universitaire de Québec; Université Laval; McMaster University; Robarts Clinical Trials; Université de Montréal; McGill University Health Centre; University of Ottawa; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Dyslipidemia; Perspective (graphical); Ldl cholesterol; Blood cholesterol; Intensive care medicine; Internal medicine; Cholesterol; Obesity; Artificial intelligence","score_opus":0.05945447597772801,"score_gpt":0.28790067165354477,"score_spread":0.22844619567581675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064344939","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027450096,0.1817929,0.00020301926,0.08404225,0.69520986,0.0049766432,0.0040507996,0.000028827857,0.002245606],"genre_scores_gemma":[0.14149567,0.0057796175,0.000030731342,0.0032761435,0.8489196,0.00012758048,0.000086467655,0.00012314081,0.00016108442],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99459,0.0015088391,0.0010594769,0.0005827214,0.001289233,0.000969765],"domain_scores_gemma":[0.9914081,0.0011150929,0.001092243,0.0023662737,0.0028808948,0.0011373695],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0040231897,0.0006721065,0.003010132,0.00022140825,0.00060151826,0.00008422784,0.0009876601,0.0013656301,0.00002303731],"category_scores_gemma":[0.0030638322,0.0003139659,0.005638029,0.00028134734,0.00067929964,0.000036155277,0.00002635253,0.0020414887,0.0000117366135],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073281495,0.000010900307,0.00071721314,0.00004303465,0.02602617,0.0002838668,0.0022245606,0.00045518973,0.0000022903776,0.00004073083,0.96616316,0.0039596157],"study_design_scores_gemma":[0.0022683642,0.0010493718,0.0042834375,0.00047296757,0.007828238,0.0003134015,0.0029634633,0.0000072374232,0.000012544564,0.0001041754,0.9804355,0.0002613269],"about_ca_topic_score_codex":0.6199108,"about_ca_topic_score_gemma":0.6206209,"teacher_disagreement_score":0.17601329,"about_ca_system_score_codex":0.0024235044,"about_ca_system_score_gemma":0.012617537,"threshold_uncertainty_score":0.9999312},"labels":[],"label_agreement":null},{"id":"W2064508165","doi":"10.1016/j.atherosclerosis.2015.03.014","title":"The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia – A post-hoc analysis of a Phase 3, single-arm, open-label trial","year":2015,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi; Western University","funders":"National Center for Research Resources; Aegerion Pharmaceuticals","keywords":"Open label; Post-hoc analysis; Medicine; Familial hypercholesterolemia; Post hoc; Apheresis; Internal medicine; Clinical trial; Cholesterol; Platelet","score_opus":0.027241668845493353,"score_gpt":0.2739147305378492,"score_spread":0.24667306169235587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064508165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565506,0.0005085124,0.000088512876,0.000069869995,0.00018497597,0.0032807246,0.00013015147,0.000029851619,0.00005235928],"genre_scores_gemma":[0.9991074,0.00006046648,0.00021308406,0.00014852035,0.00006464891,0.0002351535,0.00008004241,0.000062199535,0.000028480134],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970105,0.0004405515,0.00067215395,0.000517059,0.00090740685,0.0004523079],"domain_scores_gemma":[0.99736553,0.00033478186,0.0004874041,0.0009727416,0.00056349515,0.00027605816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091478805,0.00033818267,0.0014595195,0.00023443034,0.000095911695,0.000050792183,0.00036494856,0.00018481274,0.0000050090002],"category_scores_gemma":[0.000621395,0.00022174965,0.0003093652,0.001589555,0.00017618648,0.00018528964,0.00016014384,0.00026456357,0.0000017415182],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5192238,0.05598093,0.13627468,0.0010350023,0.019542728,0.000039669118,0.0058126803,0.00008255754,0.08391149,0.00001314835,0.0009898546,0.17709348],"study_design_scores_gemma":[0.5897796,0.06381249,0.32121032,0.0014787451,0.00696286,0.0000022385927,0.0010107973,0.00019644089,0.014712591,0.000007712917,0.00018598448,0.0006402437],"about_ca_topic_score_codex":0.002146033,"about_ca_topic_score_gemma":0.0008049698,"teacher_disagreement_score":0.18493563,"about_ca_system_score_codex":0.00029205185,"about_ca_system_score_gemma":0.0002323844,"threshold_uncertainty_score":0.9042688},"labels":[],"label_agreement":null},{"id":"W2064877075","doi":"10.1016/j.amjcard.2005.10.060","title":"Apolipoprotein-B, Low-Density Lipoprotein Cholesterol, and the Long-Term Risk of Coronary Heart Disease in Men","year":2006,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Apolipoprotein B; Coronary heart disease; Cholesterol; Term (time); Lipoprotein(a); Risk factor","score_opus":0.006204080812394525,"score_gpt":0.2418497755340197,"score_spread":0.2356456947216252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064877075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150866,0.0038958057,0.0004324136,0.0031919728,0.00007083221,0.000731622,0.000007835668,0.000007034008,0.00015384241],"genre_scores_gemma":[0.9974826,0.0010270965,0.000093473056,0.0004733932,0.0008601407,0.000018377297,0.0000019785748,0.0000212123,0.00002173075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686337,0.0015359628,0.00065695273,0.00018783266,0.00044307605,0.00031280992],"domain_scores_gemma":[0.9981303,0.00019085119,0.0006939319,0.0006593452,0.00016219952,0.0001633286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002937868,0.0001869167,0.0013969877,0.00012250787,0.00008969589,0.000009888457,0.00020736488,0.000046987,0.00000331252],"category_scores_gemma":[0.000151548,0.00009678115,0.0005206172,0.00022174709,0.0016056969,0.000052408504,0.000091945054,0.00059315277,0.000001962964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011811192,0.00009582797,0.9092139,0.00012936509,0.0008262047,0.00044225305,0.00021355016,0.0005958752,0.0009032735,0.00013309995,0.00017480378,0.07546064],"study_design_scores_gemma":[0.0041115573,0.0007168645,0.9910209,0.00012370393,0.0004804517,0.0021781763,0.00012593516,0.000020030364,0.00024201947,0.00081050396,0.000079624646,0.000090223766],"about_ca_topic_score_codex":0.004383225,"about_ca_topic_score_gemma":0.000052668252,"teacher_disagreement_score":0.081806995,"about_ca_system_score_codex":0.000065366934,"about_ca_system_score_gemma":0.00019580011,"threshold_uncertainty_score":0.6626154},"labels":[],"label_agreement":null},{"id":"W2064954699","doi":"10.1111/j.1541-9215.2006.05537.x","title":"Personalized Genomic Medicine: A Future Prerequisite for the Prevention of Coronary Artery Disease","year":2006,"lang":"en","type":"review","venue":"The American Heart Hospital Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Heart Institute; University of Ottawa","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Coronary artery disease; Occult; Disease; Personalized medicine; Asymptomatic; Internal medicine; Family history; Cardiology; Intensive care medicine; Bioinformatics; Pathology; Alternative medicine","score_opus":0.02189394601748053,"score_gpt":0.32687427520074425,"score_spread":0.30498032918326373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064954699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038768752,0.98852354,0.00040648857,0.0030269965,0.0005795462,0.0034705924,0.00006722526,0.000018975574,0.000029767363],"genre_scores_gemma":[0.00115693,0.9893915,0.0002252514,0.00042674676,0.007946502,0.00022366353,0.000068424546,0.00008720703,0.00047378297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971229,0.0004842294,0.00089862634,0.00030393343,0.00077078264,0.00041952168],"domain_scores_gemma":[0.9973384,0.00026129407,0.001073841,0.000845584,0.00019103897,0.00028985422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014757732,0.00040744065,0.0023938376,0.00011877803,0.00033191763,0.00002797001,0.00034773542,0.00007731969,0.000072801864],"category_scores_gemma":[0.00007010428,0.00018286794,0.0028129267,0.00030776128,0.000709072,0.000054562788,0.000061599916,0.0007990624,0.000010892367],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003309717,0.00014038279,0.00012951811,0.0044949474,0.0017180034,0.000058879883,0.00015563736,0.0000012082194,0.0000022365098,0.000040521045,0.0105565805,0.9823711],"study_design_scores_gemma":[0.0010849554,0.0020053019,0.0112068,0.005724272,0.007713572,0.0030339865,0.00039315457,0.000008231108,9.329556e-8,0.0001101065,0.9685003,0.00021918159],"about_ca_topic_score_codex":0.000057684636,"about_ca_topic_score_gemma":0.0000014515143,"teacher_disagreement_score":0.9821519,"about_ca_system_score_codex":0.0002168913,"about_ca_system_score_gemma":0.0012176693,"threshold_uncertainty_score":0.7457138},"labels":[],"label_agreement":null},{"id":"W2065030731","doi":"10.1016/j.amjcard.2013.04.041","title":"Trends in the Prevalence, Awareness, Treatment and Control of High Low Density Lipoprotein-Cholesterol Among United States Adults From 1999–2000 Through 2009–2010","year":2013,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Heart and Stroke Foundation; Ted Rogers Centre for Heart Research","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Amgen","keywords":"Medicine; Cholesterol; Ldl cholesterol; National Cholesterol Education Program; High cholesterol; National Health and Nutrition Examination Survey; Young adult; Internal medicine; Demography; Gerontology; Environmental health; Population; Metabolic syndrome; Obesity","score_opus":0.0089954567685335,"score_gpt":0.2431866114735303,"score_spread":0.2341911547049968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065030731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99399203,0.0024457057,0.00063553744,0.0021953268,0.00010527627,0.0005389458,0.000053420477,0.0000068234935,0.000026932554],"genre_scores_gemma":[0.99504334,0.0035207947,0.00011201403,0.00076345174,0.00046471297,0.000039360577,0.00001668134,0.000016461074,0.000023198816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974059,0.0011772276,0.0005750387,0.00020547083,0.00033036055,0.0003060123],"domain_scores_gemma":[0.9981234,0.0002830386,0.00063309143,0.00060790614,0.00024517727,0.00010735528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079255714,0.0002182508,0.0013133223,0.00017483854,0.00007244578,0.00001522959,0.0002264562,0.00006902148,0.000021271162],"category_scores_gemma":[0.00004962009,0.00010530652,0.00034687782,0.00040089645,0.0008060708,0.00009953995,0.000027666318,0.00035063474,0.0000021953708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004164122,0.00030220815,0.5214901,0.00014431211,0.0035051543,0.00026580525,0.007582435,0.00153347,0.0007492004,0.000017166938,0.00058033934,0.4596657],"study_design_scores_gemma":[0.0041798386,0.0029535468,0.98886913,0.00016091998,0.00058060454,0.000598168,0.0014662556,0.000092280185,0.00031050848,0.00019923213,0.00049010094,0.000099408644],"about_ca_topic_score_codex":0.0719757,"about_ca_topic_score_gemma":0.00023437261,"teacher_disagreement_score":0.46737903,"about_ca_system_score_codex":0.000080781974,"about_ca_system_score_gemma":0.0001259099,"threshold_uncertainty_score":0.9342041},"labels":[],"label_agreement":null},{"id":"W2065252540","doi":"10.1016/s0828-282x(06)70319-1","title":"Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study – the Ezetrol® Add-On Study","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University; Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Tolerability; Ezetimibe; Statin; Ldl cholesterol; Prospective cohort study; Internal medicine; Pharmacology; Cholesterol; Adverse effect","score_opus":0.010935473775216033,"score_gpt":0.23187356625561814,"score_spread":0.2209380924804021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065252540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994476,0.00012710528,0.00002637492,0.00039558977,0.0000630145,0.003761144,0.00019687705,0.00000417113,0.00094971474],"genre_scores_gemma":[0.99914664,0.000005753956,0.00010726718,0.00041998742,0.00016767028,0.00005537294,0.000020093881,0.000043775566,0.000033435063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967562,0.0010137944,0.0006998398,0.000428817,0.0005396838,0.000561653],"domain_scores_gemma":[0.9977187,0.0001943688,0.00034373952,0.00060864625,0.0004957189,0.0006388243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013767768,0.00032177943,0.0012967363,0.00040327152,0.00015322813,0.000035057186,0.00018434286,0.00010862992,0.000015278672],"category_scores_gemma":[0.000116339885,0.00019799905,0.0001127205,0.00027530608,0.0002399142,0.00007276986,0.000012015958,0.0006702473,0.0000010684146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008254941,0.00034914265,0.98051465,0.000028654262,0.00077917596,0.00031144384,0.0036770375,0.0019678927,0.0000039428364,0.0000069008906,0.00020172413,0.003904514],"study_design_scores_gemma":[0.022292893,0.022269396,0.95154953,0.00012264555,0.00022852328,0.00004480051,0.0022921627,0.000006427859,0.000009665679,0.0000068754966,0.0010005871,0.00017649487],"about_ca_topic_score_codex":0.062190466,"about_ca_topic_score_gemma":0.3073156,"teacher_disagreement_score":0.24512511,"about_ca_system_score_codex":0.000877239,"about_ca_system_score_gemma":0.002618814,"threshold_uncertainty_score":0.9440545},"labels":[],"label_agreement":null},{"id":"W2065349361","doi":"10.1136/bmj.g1523","title":"Authors' reply to Huffman and colleagues","year":2014,"lang":"en","type":"letter","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; York University","funders":"","keywords":"Huffman coding; Computer science; Data science; World Wide Web; Artificial intelligence","score_opus":0.026993995055075413,"score_gpt":0.30615093009863154,"score_spread":0.2791569350435561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065349361","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010607782,0.0006604981,0.00014163498,0.98249316,0.0004808655,0.001683144,0.00001244238,0.00008555292,0.013381925],"genre_scores_gemma":[0.0004475627,0.000056100067,0.001471515,0.94114757,0.021492515,0.00013716644,0.0000958953,0.00006432416,0.035087343],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981852,0.00012733355,0.0003189346,0.00048574296,0.0005575675,0.0003252094],"domain_scores_gemma":[0.9985296,0.000035165176,0.00008693777,0.0010501161,0.00009010027,0.00020808837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010209181,0.00021720628,0.00070581626,0.00013247892,0.00007124853,0.000030308378,0.00008123414,0.00047279618,0.00006506315],"category_scores_gemma":[0.00022715787,0.00017335513,0.0002259132,0.000106617284,0.000034218014,0.00001454397,0.00006481421,0.0008211484,0.00019173537],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002168743,0.0000055398527,0.00008932098,0.0004948387,0.00013545966,0.0005016664,0.00006736944,7.218371e-8,0.0000058579103,0.00001339927,0.9924156,0.006249196],"study_design_scores_gemma":[0.00048807636,0.0002752563,0.0016398232,0.00038264194,0.00018105618,0.0005434182,0.000010181827,0.000003100703,0.000030693223,0.000042691612,0.99619913,0.00020395577],"about_ca_topic_score_codex":0.0004900668,"about_ca_topic_score_gemma":0.000007870159,"teacher_disagreement_score":0.041345578,"about_ca_system_score_codex":0.000055640146,"about_ca_system_score_gemma":0.00014293937,"threshold_uncertainty_score":0.7069217},"labels":[],"label_agreement":null},{"id":"W2065363615","doi":"10.1016/j.vph.2010.10.001","title":"Does atorvastatin induce aortic smooth muscle cell apoptosis in vivo?","year":2010,"lang":"en","type":"article","venue":"Vascular Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research; Pfizer Canada; Heart and Stroke Foundation of Canada","keywords":"Atorvastatin; Amlodipine; Apoptosis; In vivo; Medicine; Pharmacology; Statin; Aorta; Internal medicine; Endocrinology; Chemistry; Biology; Blood pressure; Biochemistry","score_opus":0.00962919112437694,"score_gpt":0.27686268491713945,"score_spread":0.2672334937927625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065363615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942496,0.00028187144,0.000110015644,0.0008607677,0.0019303664,0.001018225,0.000008212761,0.00009733674,0.0014435935],"genre_scores_gemma":[0.9951608,0.00038905375,0.0011874544,0.0018925441,0.0008366722,0.0002190126,0.000009525024,0.00005799894,0.00024694513],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977486,0.0002273943,0.00042190508,0.0005381312,0.00042901348,0.00063492794],"domain_scores_gemma":[0.9988225,0.000056187484,0.00009180225,0.00059019023,0.000097066586,0.0003422507],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010093662,0.00025068133,0.0005868201,0.00024802698,0.00008977194,0.000015223336,0.00018033052,0.00026192385,0.002264605],"category_scores_gemma":[0.000050571896,0.00017391396,0.0003978717,0.00042237097,0.000106448984,0.00008993741,0.00008736084,0.0009017404,0.00011596981],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005725969,0.0006182157,0.006068628,0.00031216696,0.00020726095,0.00009192455,0.00041893037,0.000011999627,0.9579573,0.000035192246,0.0017268189,0.03249429],"study_design_scores_gemma":[0.009337263,0.0002767247,0.06367814,0.00003626538,0.0006293749,0.00002146008,0.00022771212,0.00038660725,0.6198755,0.00009353383,0.30495393,0.0004834995],"about_ca_topic_score_codex":0.00075585785,"about_ca_topic_score_gemma":0.00012385352,"teacher_disagreement_score":0.33808184,"about_ca_system_score_codex":0.00008600936,"about_ca_system_score_gemma":0.00029681163,"threshold_uncertainty_score":0.99864745},"labels":[],"label_agreement":null},{"id":"W2065408044","doi":"10.1016/j.jacl.2008.04.006","title":"Elevated atherogenic lipoproteins in childhood: Risk, prevention, and treatment","year":2008,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Ezetimibe; Overweight; Childhood obesity; Internal medicine; Obesity; Insulin resistance; Endocrinology; Pediatrics; Cholesterol","score_opus":0.06556603295755499,"score_gpt":0.370928531869825,"score_spread":0.30536249891227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065408044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952099,0.0025901897,0.00011940254,0.0009106613,0.0006477865,0.00041304334,0.0000018426326,0.00000980894,0.00009741253],"genre_scores_gemma":[0.975494,0.017948084,0.0023703333,0.00030441638,0.0036229833,0.000008016228,0.0000021003316,0.00001777704,0.00023224075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969994,0.000754552,0.0015364161,0.00021110424,0.00026218605,0.00023633474],"domain_scores_gemma":[0.9984034,0.00021303026,0.0006679727,0.0002902354,0.0001331209,0.0002922846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026113244,0.00014105604,0.0011665035,0.00014601194,0.00006152658,0.00000343378,0.00006947316,0.00026433598,0.0000728687],"category_scores_gemma":[0.001276711,0.00009555863,0.0006530592,0.00015661801,0.0001474808,0.000058021244,0.000024008343,0.0006382131,0.000012055756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016690857,0.0028216771,0.70944226,0.000026121166,0.0010884552,0.0002874477,0.00037518446,0.000010211391,0.00009525449,0.000062296014,0.0003861502,0.28373587],"study_design_scores_gemma":[0.011218426,0.0072127148,0.9620365,0.00008332564,0.00024223223,0.0037354631,0.000035080036,0.000013650757,0.00011529486,0.0004441901,0.0147795705,0.00008357318],"about_ca_topic_score_codex":0.00012599622,"about_ca_topic_score_gemma":0.00013187176,"teacher_disagreement_score":0.2836523,"about_ca_system_score_codex":0.00006150788,"about_ca_system_score_gemma":0.0006494772,"threshold_uncertainty_score":0.3896768},"labels":[],"label_agreement":null},{"id":"W2065751246","doi":"10.3109/02813432.2014.869410","title":"High LDL cholesterol and statin use were independently associated with lower eight-year mortality in a cohort free from terminal illness, cardiovascular disease, and diabetes at baseline","year":2014,"lang":"en","type":"editorial","venue":"Scandinavian Journal of Primary Health Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Family Medicine","funders":"","keywords":"Medicine; Cholesterol; Disease; Statin; Diabetes mellitus; Internal medicine; Cohort; Atherosclerotic cardiovascular disease; Cohort study; Risk factor; Cardiology; Endocrinology","score_opus":0.0067780331912840955,"score_gpt":0.23290212280221942,"score_spread":0.22612408961093533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065751246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9138305,0.029985335,0.000028195813,0.00025350662,0.0502482,0.0015422546,0.0040766196,0.000023353152,0.000012023432],"genre_scores_gemma":[0.74380744,0.014838926,0.00079279864,0.0010843667,0.2303511,0.0001236418,0.008480512,0.0003815683,0.00013965636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99193126,0.0012903876,0.0014891672,0.00097575487,0.003467856,0.00084558857],"domain_scores_gemma":[0.99452364,0.00037968758,0.0012601607,0.0013652522,0.00089416147,0.0015771027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003740648,0.0007509898,0.003604501,0.0003853249,0.00027488766,0.0001386671,0.00030447546,0.0007075209,0.000031416144],"category_scores_gemma":[0.0009413365,0.00059411715,0.0006303263,0.00023778545,0.0002482553,0.00034647126,0.00023723353,0.0021884514,0.0000011068722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023692292,0.00019939042,0.8882232,0.004106987,0.0047670202,0.0020741718,0.00035715816,0.000011957057,0.000001552331,8.912213e-7,0.09067849,0.0072099566],"study_design_scores_gemma":[0.014424755,0.0017481488,0.9350304,0.007661246,0.0035410263,0.00005994165,0.00012959693,0.0000053195085,0.0000032552327,0.00003241733,0.03671947,0.0006444295],"about_ca_topic_score_codex":0.0049803546,"about_ca_topic_score_gemma":0.0020321272,"teacher_disagreement_score":0.18010291,"about_ca_system_score_codex":0.00270383,"about_ca_system_score_gemma":0.003210963,"threshold_uncertainty_score":0.999651},"labels":[],"label_agreement":null},{"id":"W2065904318","doi":"10.1345/aph.1k140","title":"Dyslipidemia: Reduction in Estimated Risk for Coronary Artery Disease After Use of Ezetimibe with a Statin","year":2007,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); McGill University","funders":"","keywords":"Medicine; Ezetimibe; Dyslipidemia; Statin; Coronary artery disease; Cardiology; Internal medicine; Disease","score_opus":0.07247510997399895,"score_gpt":0.3836821258122315,"score_spread":0.3112070158382325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065904318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922298,0.0021729658,0.0036368724,0.00055122765,0.00006300633,0.0011981672,0.000115258794,0.00002149043,0.000011205947],"genre_scores_gemma":[0.9916969,0.0021188583,0.004927865,0.0009053742,0.00013870496,0.0000913063,0.000029645902,0.000035615183,0.000055725937],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987381,0.000077406105,0.00042250438,0.00021324083,0.00028077158,0.00026799052],"domain_scores_gemma":[0.9990546,0.000078072546,0.00019401316,0.00025733275,0.0002284036,0.0001875627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094579515,0.00013817356,0.00037988578,0.00015955111,0.000020347112,0.0000037273132,0.00003802609,0.000051420207,0.00006505632],"category_scores_gemma":[0.00003640805,0.00010874807,0.00017619376,0.0002063269,0.00007693042,0.00013624535,0.0000050339468,0.00013455066,7.6996633e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.122813135,0.0024684155,0.25686938,0.0017129992,0.0020946052,0.0003252052,0.001603949,0.0013755105,0.1540391,0.000039829134,0.005019928,0.45163795],"study_design_scores_gemma":[0.010117325,0.0015553765,0.77872825,0.00058045576,0.00031111078,0.000040578616,0.00010240452,0.0013794035,0.20256044,0.00016437074,0.0042071785,0.00025313668],"about_ca_topic_score_codex":0.00017590678,"about_ca_topic_score_gemma":0.000014659179,"teacher_disagreement_score":0.5218588,"about_ca_system_score_codex":0.00001984276,"about_ca_system_score_gemma":0.00012757267,"threshold_uncertainty_score":0.44346178},"labels":[],"label_agreement":null},{"id":"W2066450795","doi":"10.1161/circulationaha.113.006720","title":"Proprotein Convertase Subtilisin Kexin Type 9 Promotes Intestinal Overproduction of Triglyceride-Rich Apolipoprotein B Lipoproteins Through Both Low-Density Lipoprotein Receptor–Dependent and –Independent Mechanisms","year":2014,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Saint John Regional Hospital; Dalhousie University","funders":"National Heart, Lung, and Blood Institute","keywords":"Kexin; Proprotein convertase; PCSK9; Subtilisin; Medicine; Apolipoprotein B; Overproduction; Internal medicine; Triglyceride; Lipoprotein; Endocrinology; Apolipoprotein C2; LDL receptor; Very low-density lipoprotein; Biochemistry; Cholesterol; Biology; Gene; Enzyme","score_opus":0.014659496713158056,"score_gpt":0.2430266661463432,"score_spread":0.22836716943318514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066450795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535665,0.00058507075,0.03841541,0.0005992948,0.00050083734,0.0056998283,0.000015405685,0.00023713133,0.0003805312],"genre_scores_gemma":[0.9888823,0.00007287628,0.009424707,0.00012856042,0.000792138,0.00024625822,0.00016252327,0.000112250294,0.00017838604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9948316,0.00048356198,0.0011221349,0.001265282,0.001627497,0.000669912],"domain_scores_gemma":[0.99675035,0.00005181312,0.0006767009,0.0014083087,0.0007660094,0.00034681798],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024079664,0.0005923922,0.00114235,0.00028950506,0.00030785272,0.000081120954,0.00019147967,0.00046431305,0.00021692757],"category_scores_gemma":[0.0011838265,0.0005501836,0.0002856233,0.0006080823,0.0002290672,0.00047750992,0.00014918095,0.0006666391,0.000058033318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029932996,0.0013242925,0.009192931,0.0041748714,0.0005422306,0.000049437007,0.0015537256,0.00019216735,0.80360365,0.009701357,0.0000756309,0.16659641],"study_design_scores_gemma":[0.006070046,0.0020865258,0.114271596,0.0013115003,0.00046708994,0.0007125043,0.0003001744,0.0034039505,0.86102504,0.0088685565,0.00049272535,0.0009902671],"about_ca_topic_score_codex":0.006787625,"about_ca_topic_score_gemma":0.00022160643,"teacher_disagreement_score":0.16560614,"about_ca_system_score_codex":0.00038175995,"about_ca_system_score_gemma":0.00041049882,"threshold_uncertainty_score":0.99982625},"labels":[],"label_agreement":null},{"id":"W2066651815","doi":"10.1016/j.amjcard.2009.05.009","title":"Acute Effects of Statin Therapy on Coronary Atherosclerosis Following an Acute Coronary Syndrome","year":2009,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Acute coronary syndrome; Medicine; Cardiology; Internal medicine; Coronary atherosclerosis; Statin; Myocardial infarction; Coronary heart disease","score_opus":0.013118080743532181,"score_gpt":0.28543049890762484,"score_spread":0.2723124181640927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066651815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640113,0.0011842002,0.00075315684,0.0008538081,0.0002925369,0.00040435573,0.000007264945,0.000017630027,0.000085941014],"genre_scores_gemma":[0.9935555,0.0031108647,0.00065331376,0.0023672013,0.00025580951,0.0000065132053,0.0000043100245,0.000029917523,0.000016594317],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99759597,0.0008350445,0.0004971819,0.00019436542,0.0005287353,0.00034870158],"domain_scores_gemma":[0.99827296,0.00020653356,0.0005639007,0.00063302263,0.000120798715,0.00020281084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010196345,0.00022192064,0.0016090301,0.00012853816,0.00008696516,0.0000062988815,0.00028867347,0.00006120004,0.0000045463535],"category_scores_gemma":[0.000033628035,0.00013159035,0.0009913868,0.00024299251,0.00026217673,0.00007984404,0.000020977708,0.00044579242,0.0000034634556],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011590684,0.00041592517,0.029726183,0.000043199438,0.019347603,0.008134866,0.0016766764,0.00041365903,0.17207818,0.000108121654,0.0004733664,0.7559915],"study_design_scores_gemma":[0.0034220638,0.051844615,0.92771006,0.00015344673,0.0011032039,0.012703998,0.00022527584,0.000005830372,0.002300846,0.00017011876,0.00021602956,0.00014452019],"about_ca_topic_score_codex":0.000019328652,"about_ca_topic_score_gemma":1.6222853e-7,"teacher_disagreement_score":0.89798385,"about_ca_system_score_codex":0.00008126823,"about_ca_system_score_gemma":0.00017862955,"threshold_uncertainty_score":0.5366099},"labels":[],"label_agreement":null},{"id":"W2066698059","doi":"10.1186/cvm-2-4-165","title":"The role of dyslipidemia and statins in venous thromboembolism","year":2001,"lang":"en","type":"article","venue":"Trials","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Dyslipidemia; Hyperlipidemia; Venous thromboembolism; Medicine; Epidemiology; HMG-CoA reductase; Simvastatin; Intensive care medicine; Internal medicine; Bioinformatics; Reductase; Thrombosis; Endocrinology; Biology; Diabetes mellitus; Obesity; Enzyme","score_opus":0.05337682013613263,"score_gpt":0.36033108824542387,"score_spread":0.3069542681092912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066698059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830744,0.011788095,0.000024941712,0.00056244066,0.00009485379,0.0008050879,0.0000042415368,0.000011175639,0.0036347394],"genre_scores_gemma":[0.9969228,0.0023437324,0.00018461345,0.00011112419,0.0003226535,0.000025245457,0.0000020517255,0.000008834534,0.000078946076],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988639,0.00027357263,0.00042168202,0.00010003742,0.00018828893,0.00015251382],"domain_scores_gemma":[0.9992444,0.0003077739,0.00010527424,0.00025561728,0.000030992876,0.000055950997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042133485,0.000058704398,0.00064884033,0.00003286153,0.00004142146,0.000006362036,0.00003707171,0.000050135735,0.000022955584],"category_scores_gemma":[0.000880503,0.00003416774,0.00009312925,0.000101629426,0.000041786374,0.000019147932,0.000015651032,0.00009178885,0.0000042370534],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064966304,0.00019547007,0.014511719,0.00009968938,0.00028640107,0.000025192281,0.0014914174,0.000004534934,0.0099581545,0.0048231757,0.0002869534,0.96766764],"study_design_scores_gemma":[0.013435697,0.0011573151,0.6443429,0.00034416138,0.0004928544,0.00012409358,0.0028660856,0.00013951398,0.01246638,0.021909138,0.30245465,0.00026720949],"about_ca_topic_score_codex":0.00049230916,"about_ca_topic_score_gemma":0.00009140779,"teacher_disagreement_score":0.96740043,"about_ca_system_score_codex":0.00001983117,"about_ca_system_score_gemma":0.00009263357,"threshold_uncertainty_score":0.14602709},"labels":[],"label_agreement":null},{"id":"W2066939517","doi":"10.1016/j.jacc.2013.07.050","title":"Effect of Treatment for 12 Weeks With Rilapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, on Arterial Inflammation as Assessed With 18F-Fluorodeoxyglucose-Positron Emission Tomography Imaging","year":2013,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; Canadian Heart Research Centre; University of Toronto","funders":"National Institutes of Health; NIHR Cambridge Biomedical Research Centre; Academy of Medical Sciences; British Heart Foundation; Roche; GlaxoSmithKline","keywords":"Medicine; Lipoprotein-associated phospholipase A2; Phospholipase A2; Positron emission tomography; Inflammation; Biomarker; Fluorodeoxyglucose; Internal medicine; Lipoprotein; Pharmacology; Nuclear medicine; Enzyme; Biochemistry; Cholesterol","score_opus":0.005669484849105013,"score_gpt":0.24140229898198698,"score_spread":0.23573281413288197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066939517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708281,0.00035721692,0.00019492864,0.023841482,0.00056240195,0.0037314834,0.00019342982,0.000019793717,0.0002711287],"genre_scores_gemma":[0.98900145,0.00015771342,0.00054743135,0.004561017,0.005040193,0.0002854731,0.000081779515,0.00013961007,0.00018534921],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99575585,0.0012832546,0.0010256617,0.00040699696,0.0010082093,0.000520015],"domain_scores_gemma":[0.9941707,0.0004979527,0.0034958592,0.00087619375,0.0007906774,0.00016859338],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011449346,0.0006144692,0.0035584383,0.00046937974,0.00013099752,0.000016853111,0.00029779845,0.00029406016,0.000005609237],"category_scores_gemma":[0.00022097088,0.00031754567,0.0017289197,0.00045250892,0.0004599317,0.000091793394,0.000040662944,0.00096640596,8.1035813e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22391671,0.0010573572,0.020139042,0.0061320085,0.056398403,0.006950267,0.00044197586,0.0014476876,0.16833302,0.000027484046,0.43815282,0.077003226],"study_design_scores_gemma":[0.07452173,0.27919182,0.0170439,0.011861613,0.022163568,0.014228853,0.00037683704,0.00013506511,0.39433768,0.00010334001,0.18428928,0.0017462953],"about_ca_topic_score_codex":0.00045572687,"about_ca_topic_score_gemma":0.000009093595,"teacher_disagreement_score":0.27813447,"about_ca_system_score_codex":0.0007113869,"about_ca_system_score_gemma":0.0011397128,"threshold_uncertainty_score":0.99992764},"labels":[],"label_agreement":null},{"id":"W2066961152","doi":"10.1016/j.ijcard.2011.01.033","title":"Updated evidence on early statin therapy for acute coronary syndromes: Meta-analysis of 18 randomized trials involving over 14,000 patients","year":2011,"lang":"en","type":"review","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McGill University; McMaster University","funders":"Gottfried und Julia Bangerter-Rhyner-Stiftung; Bristol-Myers Squibb; American Heart Association","keywords":"Medicine; Internal medicine; Randomized controlled trial; Myocardial infarction; Statin; Unstable angina; Acute coronary syndrome; Angina; Clinical endpoint; Confidence interval; Placebo; Stroke (engine); Meta-analysis; Cardiology; Pathology","score_opus":0.2813145696158715,"score_gpt":0.4568529220619448,"score_spread":0.1755383524460733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066961152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00232573,0.99051464,0.0022830837,0.000054761607,0.0012939996,0.0026416248,0.00078984123,0.000008110304,0.00008819923],"genre_scores_gemma":[0.006631668,0.99127364,0.00054738834,0.00023537417,0.0005611064,0.00021485011,0.00037963066,0.000051791518,0.000104528226],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9901075,0.0041919514,0.0038212053,0.0003923482,0.0012307554,0.00025626685],"domain_scores_gemma":[0.9875941,0.0040766494,0.0049469476,0.0005270842,0.002697721,0.00015747905],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0115421275,0.00047663465,0.019735878,0.0014869242,0.000031602478,0.000024172474,0.00062098925,0.00040040608,0.0006112066],"category_scores_gemma":[0.0032206678,0.00026856913,0.024615731,0.00032137844,0.00014070164,0.00014971563,0.00006417782,0.0005337975,0.0000040740574],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030928016,0.0000844517,0.00007465582,0.00035650912,0.85527354,0.00013595322,0.00005930326,0.000019762887,0.000001150878,0.00009609707,0.0009958724,0.111974664],"study_design_scores_gemma":[0.045503236,0.0017328514,0.0007162748,0.0017228363,0.78776276,0.0004223788,0.0000058538167,0.0000047973076,0.0000046358505,0.00014163656,0.16172805,0.00025465872],"about_ca_topic_score_codex":0.00006154623,"about_ca_topic_score_gemma":9.916041e-7,"teacher_disagreement_score":0.16073218,"about_ca_system_score_codex":0.00024541497,"about_ca_system_score_gemma":0.00064604747,"threshold_uncertainty_score":0.99997663},"labels":[],"label_agreement":null},{"id":"W2066991839","doi":"10.1021/bi048156p","title":"Baboon Lipoprotein(a) Binds Very Weakly to Lysine−Agarose and Fibrin Despite the Presence of a Strong Lysine-Binding Site in Apolipoprotein(a) Kringle IV Type 10","year":2004,"lang":"en","type":"article","venue":"Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Baboon; Lysine; Kringle domain; Lipoprotein(a); Biology; Biochemistry; Plasmin; Molecular biology; Binding site; Apolipoprotein B; Amino acid; Cholesterol; Enzyme","score_opus":0.012906330109032966,"score_gpt":0.2568211320348122,"score_spread":0.24391480192577925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066991839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949094,0.0020555733,0.00004321989,0.0007510038,0.000064174405,0.00095568626,0.000034794135,0.000044913468,0.0011412367],"genre_scores_gemma":[0.99654704,0.00011908971,0.00093515584,0.00009465698,0.0003546265,0.00008191724,0.000049547587,0.00004384872,0.001774106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977897,0.000044247063,0.00045202326,0.000571276,0.0006234801,0.00051929394],"domain_scores_gemma":[0.99836624,0.00003437898,0.00014908968,0.0010183726,0.00014251673,0.00028940119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006320785,0.00029603933,0.0005283129,0.00013183813,0.00012699324,0.000035874556,0.00020461947,0.0002159626,0.00006676247],"category_scores_gemma":[0.00035218714,0.00023931426,0.00017812909,0.0006948478,0.00014767318,0.000077727615,0.00028422734,0.00029537323,0.00003548864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065897265,0.00016005793,0.003315815,0.00093503745,0.00012478871,0.00007363506,0.00035501766,0.00014145087,0.9853013,0.000028744054,0.00023904307,0.008666151],"study_design_scores_gemma":[0.0019713035,0.00040438498,0.012838191,0.0011637163,0.00010756576,0.00016363894,0.00018462967,0.00006234788,0.98024386,0.000026334857,0.0024977105,0.000336303],"about_ca_topic_score_codex":0.0015191457,"about_ca_topic_score_gemma":0.00012517936,"teacher_disagreement_score":0.009522377,"about_ca_system_score_codex":0.00032586374,"about_ca_system_score_gemma":0.00031512667,"threshold_uncertainty_score":0.9758953},"labels":[],"label_agreement":null},{"id":"W2067554343","doi":"10.1161/circresaha.109.203596","title":"Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins","year":2009,"lang":"en","type":"article","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Toxicity; Drug; Pharmacology; Skeletal muscle; Transporter; Medicine; Chemistry; Internal medicine; Biochemistry","score_opus":0.04565521786074492,"score_gpt":0.35230789967039144,"score_spread":0.30665268180964655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067554343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960741,0.0003359732,0.0017196692,0.0005163262,0.000013094704,0.0005113067,0.0000058030205,0.000020723452,0.0008030346],"genre_scores_gemma":[0.999557,0.000025639409,0.00013670836,0.0000716496,0.00008842327,0.00000814415,0.000027028404,0.000009673357,0.00007572389],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983608,0.00013207662,0.00025676377,0.00022294432,0.00077842653,0.00024898545],"domain_scores_gemma":[0.9992386,0.00002369817,0.000034811343,0.00031099803,0.00021845597,0.00017341446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012166131,0.00007622062,0.00023523514,0.00015719545,0.00012724592,0.000011610922,0.00004849817,0.00006487794,0.00006439629],"category_scores_gemma":[0.00003254731,0.000069217655,0.00010096854,0.00024459226,0.00015511576,0.00007376819,0.000008810423,0.00023759114,0.0000023823445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007260626,0.0004843078,0.041702602,0.0007688436,0.00009994981,0.00012610294,0.0024711485,0.00028175255,0.18504137,0.00077485864,0.00020200471,0.76797444],"study_design_scores_gemma":[0.0012419852,0.00036273006,0.99336225,0.00006644993,0.00002073358,0.000017415665,0.0002773406,0.0007971323,0.0033470073,0.0002441892,0.00019572406,0.00006703063],"about_ca_topic_score_codex":0.00022778701,"about_ca_topic_score_gemma":0.000054181997,"teacher_disagreement_score":0.9516597,"about_ca_system_score_codex":0.00005528485,"about_ca_system_score_gemma":0.00009606182,"threshold_uncertainty_score":0.2822614},"labels":[],"label_agreement":null},{"id":"W2067957381","doi":"10.1091/mbc.e12-08-0637","title":"Apolipoprotein(a) stimulates nuclear translocation of β-catenin: a novel pathogenic mechanism for lipoprotein(a)","year":2012,"lang":"en","type":"article","venue":"Molecular Biology of the Cell","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Queen's University","funders":"","keywords":"Biology; Proinflammatory cytokine; Phosphorylation; Apolipoprotein B; Cell biology; Catenin; Umbilical vein; Signal transduction; Molecular biology; Biochemistry; Wnt signaling pathway; Inflammation; Immunology","score_opus":0.014994035714576887,"score_gpt":0.25908265805199066,"score_spread":0.24408862233741377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067957381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93768793,0.0027644425,0.056383036,0.00054690585,0.0002088573,0.0021659706,0.0000484812,0.000026124597,0.00016825505],"genre_scores_gemma":[0.9864461,0.000056781148,0.012839354,0.00030820238,0.000122027726,0.0000925681,0.000025033572,0.000047700207,0.000062228755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986255,0.000110508634,0.0004150081,0.00023901659,0.00021771055,0.0003922588],"domain_scores_gemma":[0.9986835,0.000023275918,0.00025084632,0.0007154132,0.00020955734,0.00011737881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007206869,0.00019095466,0.0005186904,0.000078455334,0.000073601164,0.0000024119784,0.00022646868,0.00029336836,0.000015459445],"category_scores_gemma":[0.00008018851,0.00013546829,0.0006695394,0.00016990131,0.00015002738,0.000029585857,0.000059992926,0.00016556845,0.0000045130105],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013971343,0.00028373912,0.000082815386,0.0003924788,0.00017735692,3.387931e-7,0.00020078264,0.000011757971,0.98020715,0.014103141,0.0000063474404,0.004394384],"study_design_scores_gemma":[0.002102701,0.00047329612,0.00048452005,0.00007574212,0.00030459912,0.00003149798,0.000055966804,0.0002274612,0.9940368,0.0016140388,0.0004592523,0.0001341459],"about_ca_topic_score_codex":0.00023416722,"about_ca_topic_score_gemma":0.0000022621707,"teacher_disagreement_score":0.04875818,"about_ca_system_score_codex":0.00003284134,"about_ca_system_score_gemma":0.00008629656,"threshold_uncertainty_score":0.55242366},"labels":[],"label_agreement":null},{"id":"W2068003690","doi":"10.4330/wjc.v1.i1.41","title":"Key questions resulting from the JUPITER trial assessing cardiovascular disease intervention with rosuvastatin","year":2009,"lang":"en","type":"article","venue":"World Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Rosuvastatin; Medicine; Statin; Clinical endpoint; Internal medicine; Rosuvastatin Calcium; Randomized controlled trial; Disease; Atorvastatin; Clinical trial; Cholesterol; Intensive care medicine; Physical therapy","score_opus":0.022650575315197364,"score_gpt":0.2995238911462479,"score_spread":0.2768733158310505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068003690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8905634,0.026465008,0.07184478,0.0069243526,0.0011619346,0.00094583974,0.000016798866,0.00004389099,0.0020339848],"genre_scores_gemma":[0.9918599,0.0002460187,0.0024497802,0.00048141828,0.0048329304,0.000009138876,0.000017428474,0.000018989105,0.000084365434],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972344,0.0009487151,0.0006676738,0.00022797954,0.00064814766,0.00027309172],"domain_scores_gemma":[0.99829817,0.0001598789,0.00033788453,0.0006259959,0.00034979093,0.00022830252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002752389,0.00017288968,0.0008809873,0.00014960923,0.00016645629,0.000064566746,0.00014279404,0.000059935603,0.000013822178],"category_scores_gemma":[0.0004315999,0.000099229954,0.0015815697,0.00026338582,0.00009084864,0.00017317635,0.000022827366,0.0006086539,0.0000033761273],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065159895,0.0003675791,0.026404642,0.00011315201,0.01585195,0.0051609883,0.00083406136,0.01398636,0.0004915727,0.0007163096,0.0054384028,0.86547506],"study_design_scores_gemma":[0.08069374,0.0024380982,0.7233009,0.0018953228,0.007416667,0.00200546,0.0005861899,0.00013549732,0.00007650085,0.001150671,0.17990917,0.0003917896],"about_ca_topic_score_codex":0.000083318104,"about_ca_topic_score_gemma":0.000010991292,"teacher_disagreement_score":0.8650833,"about_ca_system_score_codex":0.00011446298,"about_ca_system_score_gemma":0.00026643064,"threshold_uncertainty_score":0.404648},"labels":[],"label_agreement":null},{"id":"W2068136793","doi":"10.1016/j.atherosclerosis.2006.02.023","title":"Association of heterozygous familial hypercholesterolemia with smaller HDL particle size","year":2006,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"Canada Research Chairs; Université Laval","keywords":"Internal medicine; Familial hypercholesterolemia; Hypertriglyceridemia; Apolipoprotein B; Endocrinology; Heterozygote advantage; Cholesterol; Medicine; Biology; Allele; Triglyceride; Genetics; Gene","score_opus":0.010661561254194455,"score_gpt":0.21539780608187967,"score_spread":0.2047362448276852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068136793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977335,0.00012369569,0.00016217287,0.0006536839,0.00006121833,0.0003734296,0.000010338732,0.00006654583,0.00081544864],"genre_scores_gemma":[0.9970562,0.000058471305,0.0008465412,0.00040775002,0.00023530633,0.000043335684,0.0000067779592,0.000036921472,0.0013087018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985123,0.00007239736,0.0002973386,0.00024274472,0.00055977225,0.00031544312],"domain_scores_gemma":[0.9991661,0.0000554379,0.00013576714,0.00041456032,0.00013796434,0.00009018088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003749705,0.0001456352,0.00038051218,0.000021042442,0.00006291546,0.000016762946,0.000063350024,0.00012413044,0.000050101167],"category_scores_gemma":[0.000044780238,0.000111854286,0.00019029023,0.00018030997,0.000042301668,0.000070461516,0.000021471307,0.00013666015,0.000028692166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002854348,0.0005369759,0.79311967,0.00014016077,0.0003587122,0.0000062275712,0.00027743637,0.00007237666,0.19592847,0.00006339069,0.001068541,0.008142612],"study_design_scores_gemma":[0.0032843288,0.0004919864,0.9501691,0.00010512096,0.00021845486,0.00001053728,0.000062487175,0.000041170086,0.04343464,0.000022094651,0.0020268436,0.00013322338],"about_ca_topic_score_codex":0.0019011578,"about_ca_topic_score_gemma":0.00025304002,"teacher_disagreement_score":0.15704946,"about_ca_system_score_codex":0.00015564372,"about_ca_system_score_gemma":0.000057207246,"threshold_uncertainty_score":0.45612854},"labels":[],"label_agreement":null},{"id":"W2068395978","doi":"10.1159/000175768","title":"Small Dense Low-Density Lipoproteins and Associated Risk Factors in Patients with Stroke","year":2008,"lang":"en","type":"article","venue":"Cerebrovascular Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Stroke (engine); Internal medicine; Stroke risk; Cardiology; Ischemic stroke","score_opus":0.009190524467167211,"score_gpt":0.1907323095323787,"score_spread":0.18154178506521151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068395978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718195,0.0010672775,0.000074433905,0.000024307437,0.000055491062,0.0013174937,0.00012532703,0.000114062525,0.000039653907],"genre_scores_gemma":[0.9987316,0.0005738208,0.00013531049,0.00009610825,0.00007719936,0.000038666392,0.00020446848,0.000057059202,0.00008572464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997573,0.00022859704,0.0003041833,0.0005887342,0.0008126899,0.0004928062],"domain_scores_gemma":[0.998312,0.000041135583,0.00013113754,0.0007712487,0.00021703767,0.0005274685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022979727,0.00033317736,0.0007366721,0.00017420437,0.00027176566,0.00002339458,0.000087611574,0.00015916236,0.000035910063],"category_scores_gemma":[0.00041733438,0.00025356223,0.00040585714,0.00029989795,0.00017012464,0.00010946102,0.000073441974,0.00033776808,0.00001009222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021638314,0.00085562584,0.99557877,0.00012507924,0.00069170125,0.00007438458,0.00017222819,0.0000138387595,0.0000053864937,0.0000028763413,0.000024082521,0.0022396352],"study_design_scores_gemma":[0.007632838,0.0004142169,0.9903882,0.00016780286,0.00061864284,0.000014097935,0.000059686663,0.000024172265,0.00026655474,0.000013478381,0.000101119236,0.00029917463],"about_ca_topic_score_codex":0.0029022053,"about_ca_topic_score_gemma":0.00048164336,"teacher_disagreement_score":0.007416455,"about_ca_system_score_codex":0.00018438514,"about_ca_system_score_gemma":0.00021035694,"threshold_uncertainty_score":0.99999166},"labels":[],"label_agreement":null},{"id":"W2068550771","doi":"10.1016/j.cjca.2014.04.030","title":"Is Plant-Based Cardioprotection Evidence-Based?","year":2014,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cardioprotection; Cardiology; Internal medicine; Ischemia","score_opus":0.04881845985279231,"score_gpt":0.25811697603723255,"score_spread":0.20929851618444023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068550771","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010178086,0.013487738,0.026091577,0.95067966,0.0044581145,0.0010425197,0.00019210283,0.00003052845,0.0029999404],"genre_scores_gemma":[0.15378131,0.00022188052,0.00037243354,0.7877767,0.05726521,0.000036267662,0.00013408023,0.0001276142,0.00028447827],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963607,0.00079200557,0.00080922665,0.00042952527,0.00075905514,0.0008494869],"domain_scores_gemma":[0.9965029,0.00017959764,0.00055224856,0.0010222958,0.0008317853,0.0009111801],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0019557343,0.0004367037,0.002228373,0.0011168448,0.0001673217,0.000044367276,0.0003376977,0.001731221,0.000095108066],"category_scores_gemma":[0.0005040126,0.0003717348,0.0023267656,0.00023526252,0.00024638977,0.00006992798,0.0000076738825,0.0035448414,0.000057213118],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087590575,6.93265e-7,0.0018636145,0.0006183612,0.0009064141,0.0058964505,0.0000123775835,0.00069271564,0.000012204609,0.0000020306031,0.98482156,0.005085978],"study_design_scores_gemma":[0.0011938837,0.0010009211,0.0011597672,0.0015944027,0.0011751388,0.009218623,0.0000070833967,0.000038990118,0.00014375824,0.000026024296,0.98412967,0.00031173148],"about_ca_topic_score_codex":0.0058762827,"about_ca_topic_score_gemma":0.000315905,"teacher_disagreement_score":0.16290294,"about_ca_system_score_codex":0.0009872549,"about_ca_system_score_gemma":0.012063489,"threshold_uncertainty_score":0.99987346},"labels":[],"label_agreement":null},{"id":"W2068583214","doi":"10.1016/j.cjca.2013.08.003","title":"Incremental Lowering of Low-Density Lipoprotein Cholesterol With Ezetimibe 20 mg vs 10 mg Daily in Patients Receiving Concomitant Statin Therapy","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Ezetimibe; Medicine; Concomitant; Internal medicine; Statin; Cholesterol; Dyslipidemia; Pharmacology; Creatine kinase; Dosing; Endocrinology; Gastroenterology","score_opus":0.009031915555709143,"score_gpt":0.21239198068816018,"score_spread":0.20336006513245103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068583214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972247,0.0003908798,0.00025072478,0.00034537108,0.00021275315,0.00076133345,0.00001451786,0.0000044356266,0.0007952753],"genre_scores_gemma":[0.998829,0.000083864135,0.00031368536,0.0003393021,0.00035098768,0.000012454183,0.0000096456715,0.0000320118,0.00002901892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803734,0.00022905349,0.0006772275,0.0002103819,0.00035397874,0.00049202907],"domain_scores_gemma":[0.99812484,0.000036493064,0.0003426178,0.00036002003,0.00051498937,0.0006210393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083981745,0.00020412056,0.0010411454,0.00032872515,0.00006199138,0.000020177127,0.00016595263,0.00015455305,0.000103339735],"category_scores_gemma":[0.00012232685,0.00015966994,0.00023578585,0.00017724033,0.0001658449,0.00015340601,0.000018370652,0.0004783106,0.000008395351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011360183,0.0000312808,0.87830055,0.00016261687,0.00078372983,0.00034196686,0.0006816976,0.00027683872,0.0044994378,0.0000037957152,0.0013795221,0.11240257],"study_design_scores_gemma":[0.0075691985,0.0026759955,0.98417366,0.00045622737,0.000048699523,0.00028113963,0.00025595256,0.000009780553,0.0025888032,0.000013140764,0.0017636161,0.00016381058],"about_ca_topic_score_codex":0.018107839,"about_ca_topic_score_gemma":0.011588491,"teacher_disagreement_score":0.11223876,"about_ca_system_score_codex":0.00033792816,"about_ca_system_score_gemma":0.0011810341,"threshold_uncertainty_score":0.9884307},"labels":[],"label_agreement":null},{"id":"W2069990241","doi":"10.1016/j.ahj.2007.07.015","title":"Statin use and recurrence of atrial fibrillation after successful cardioversion","year":2007,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Heart Institute; University of Toronto; University of Calgary; University of Ottawa; Libin Cardiovascular Institute of Alberta; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Atrial fibrillation; Statin; Internal medicine; Concomitant; Cardiology; Confounding; Cardioversion; Population; Odds ratio; Logistic regression","score_opus":0.017752010595091808,"score_gpt":0.29958317379793664,"score_spread":0.28183116320284485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069990241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611807,0.0018787447,0.001470912,0.000164679,0.00014870985,0.00015630962,0.0000053839462,0.0000070461356,0.000050139555],"genre_scores_gemma":[0.9933158,0.0010503366,0.004568039,0.00013462715,0.00090623484,2.7784031e-7,0.0000017428973,0.000009475367,0.0000134500615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885714,0.0000948153,0.00028513663,0.00012292051,0.0004409076,0.0001990696],"domain_scores_gemma":[0.9992232,0.00009447365,0.0001327247,0.000160775,0.00016777376,0.00022106116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010105472,0.0000785831,0.00035781888,0.00010467283,0.000061553255,0.000021069081,0.000019314954,0.000028868897,0.000028785962],"category_scores_gemma":[0.00016488989,0.000063765576,0.0002589347,0.00019588058,0.00012130997,0.00015064645,0.000018357265,0.00018629256,0.0000023204523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000843256,0.0000061366472,0.7738726,0.00003276116,0.00008759821,0.000050124316,0.00018898679,0.0000130843555,0.00037917518,0.0000031523255,0.00024002214,0.22428308],"study_design_scores_gemma":[0.00085365574,0.0007295491,0.96490145,0.00012157417,0.00010985135,0.0014152657,0.00033158163,0.000027965218,0.00062329986,0.000010255821,0.030791482,0.00008409664],"about_ca_topic_score_codex":0.00067812426,"about_ca_topic_score_gemma":0.000016763459,"teacher_disagreement_score":0.224199,"about_ca_system_score_codex":0.000052909956,"about_ca_system_score_gemma":0.00012113383,"threshold_uncertainty_score":0.26002845},"labels":[],"label_agreement":null},{"id":"W2069993714","doi":"10.1074/jbc.m708098200","title":"The Proprotein Convertase PCSK9 Induces the Degradation of Low Density Lipoprotein Receptor (LDLR) and Its Closest Family Members VLDLR and ApoER2","year":2007,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":492,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; LDL receptor; Proprotein convertase; Low-density lipoprotein receptor-related protein 8; Familial hypercholesterolemia; Apolipoprotein B; Biology; Lipoprotein; Internalization; Kexin; Endocrinology; Internal medicine; Receptor; Cell biology; Chemistry; Cholesterol; Biochemistry; Very low-density lipoprotein; Medicine","score_opus":0.023120677137099564,"score_gpt":0.2587097415515454,"score_spread":0.23558906441444585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069993714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99107516,0.007214984,0.000047845217,0.0010343406,0.00006108896,0.00040888603,0.0000054277657,0.0000073215447,0.00014496958],"genre_scores_gemma":[0.9974643,0.001641389,0.0002454842,0.00017421496,0.00035631665,0.000005303387,0.0000046889595,0.0000073156957,0.000100993944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858147,0.000089537854,0.00053728995,0.00016837945,0.0004017874,0.00022152519],"domain_scores_gemma":[0.9986871,0.0001754201,0.00043539147,0.00020449808,0.000298289,0.00019930785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025991802,0.00015049586,0.0003919098,0.000018103161,0.00016837975,0.000022752616,0.00012658144,0.0002296002,0.000019358356],"category_scores_gemma":[0.0007848781,0.0000668992,0.00015713101,0.00010367858,0.00028539286,0.000050121947,0.000058910693,0.00053081283,7.2203426e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010181916,0.00011058889,0.0023127166,0.00031917496,0.00019703546,0.000048101672,0.00007661732,3.472793e-7,0.9239376,0.000027729555,0.00009718541,0.07185468],"study_design_scores_gemma":[0.0011842415,0.00044048956,0.043788616,0.0001935222,0.000082538936,0.00048866315,0.00083422335,0.000010724885,0.9501936,0.00007052819,0.002599192,0.0001137065],"about_ca_topic_score_codex":0.00005112487,"about_ca_topic_score_gemma":0.0000052676055,"teacher_disagreement_score":0.07174097,"about_ca_system_score_codex":0.000046031462,"about_ca_system_score_gemma":0.00012025548,"threshold_uncertainty_score":0.27280703},"labels":[],"label_agreement":null},{"id":"W2070340117","doi":"10.1038/sj.jhh.1002036","title":"Effect of pravastatin on blood pressure in people with cardiovascular disease","year":2006,"lang":"en","type":"article","venue":"Journal of Human Hypertension","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Provincial Laboratory of Public Health; University of Alberta","funders":"","keywords":"Pravastatin; Medicine; Blood pressure; Placebo; Internal medicine; Cardiology; Pulse pressure; Post-hoc analysis; Myocardial infarction; Cholesterol","score_opus":0.007160726769809988,"score_gpt":0.22793059503210703,"score_spread":0.22076986826229703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070340117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98779935,0.011416954,0.000022936247,0.000093538714,0.00004927966,0.00044422076,0.0000023464868,0.0000072518474,0.00016409619],"genre_scores_gemma":[0.99930966,0.00012219176,0.00011429045,0.000051801664,0.0003085349,0.0000048751776,0.000005461648,0.000026560212,0.000056603552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793094,0.0002609812,0.00042980822,0.00017003926,0.0010279076,0.00018030943],"domain_scores_gemma":[0.9988747,0.00006585193,0.00020869954,0.00047617752,0.00023353577,0.00014102057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013307834,0.00015552324,0.00090861326,0.00022006348,0.000045889192,0.000007830504,0.000063978296,0.000058061738,0.000013737902],"category_scores_gemma":[0.000109022745,0.000092211936,0.00059088477,0.00016821487,0.000032199438,0.000063281994,0.0000144656715,0.0002887258,0.0000012606887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03510438,0.011069329,0.59834516,0.019315189,0.024201477,0.047086846,0.0009801224,0.041593168,0.16156788,0.0005078509,0.0052705253,0.054958053],"study_design_scores_gemma":[0.026984619,0.022132823,0.89641964,0.0042278906,0.0154181225,0.0027182945,0.00007173166,0.00016169905,0.02951756,0.000038647133,0.0019824628,0.0003265135],"about_ca_topic_score_codex":0.00035785412,"about_ca_topic_score_gemma":0.000026071908,"teacher_disagreement_score":0.29807445,"about_ca_system_score_codex":0.00002106922,"about_ca_system_score_gemma":0.00013202555,"threshold_uncertainty_score":0.37602937},"labels":[],"label_agreement":null},{"id":"W2070344375","doi":"10.1161/circulationaha.107.181946","title":"Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents","year":2007,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":419,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Hyperlipidemia; Drug; Clinical trial; Statin; Pharmacotherapy; Intensive care medicine; Physical therapy; Pediatrics; Internal medicine; Cholesterol; Pharmacology; Endocrinology; Diabetes mellitus","score_opus":0.007410076710482558,"score_gpt":0.23453158339889865,"score_spread":0.2271215066884161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070344375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769497,0.0012960292,0.00046697646,0.00003075542,0.000045347537,0.00038537596,0.0000026016735,0.000013603839,0.000064334854],"genre_scores_gemma":[0.9990069,0.0006241587,0.00008379666,0.00005923451,0.00019033904,0.0000022897561,0.000020527825,0.000008290087,0.0000044459616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936897,0.00003719295,0.00018613388,0.00010991166,0.0001875304,0.0001102374],"domain_scores_gemma":[0.9996872,0.00000745585,0.00006152976,0.00016282356,0.00003653036,0.00004448429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006748148,0.000056781028,0.00016207705,0.00009219616,0.000023420822,0.0000034979535,0.000017553912,0.000045472767,0.000006208567],"category_scores_gemma":[0.000016330836,0.00005003644,0.000047864374,0.00010382666,0.00002443657,0.00005107898,0.0000064409624,0.0000816869,0.000001273217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005055454,0.00003691062,0.9240692,0.000035015426,0.000025117282,8.326631e-7,0.00039198296,0.000016881138,0.00014769989,0.00008407498,0.000004311036,0.075137414],"study_design_scores_gemma":[0.0018525639,0.000020880712,0.99666893,0.0000861415,0.000013491773,0.000016924578,0.00007371219,0.00002663702,0.0010548657,0.00011166522,0.00002867982,0.000045530156],"about_ca_topic_score_codex":0.0030764602,"about_ca_topic_score_gemma":0.000060948907,"teacher_disagreement_score":0.07509188,"about_ca_system_score_codex":0.000030539177,"about_ca_system_score_gemma":0.000022428587,"threshold_uncertainty_score":0.4650708},"labels":[],"label_agreement":null},{"id":"W2070496500","doi":"10.1007/s11883-013-0379-8","title":"Clinical and Biological Relevance of Statin-Mediated Changes in HDL Metabolism","year":2013,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"","keywords":"Medicine; Cholesterol; Statin; Internal medicine; Angiology; Reverse cholesterol transport; Clinical significance; Lipoprotein; Endocrinology","score_opus":0.16637575544642025,"score_gpt":0.4026178753069959,"score_spread":0.23624211986057564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070496500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021485904,0.97475415,0.000011258834,0.000027247926,0.001000982,0.0026006575,0.000040205672,0.000048144273,0.000031433116],"genre_scores_gemma":[0.00083703856,0.9975073,0.0003494295,0.000028348359,0.0004898106,0.00049737626,0.0001911806,0.00006586009,0.000033663524],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99535054,0.0005274222,0.0022091712,0.00094263116,0.0005268706,0.00044333754],"domain_scores_gemma":[0.99687904,0.0002784764,0.0013580684,0.0010095064,0.00015501982,0.00031987097],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021967227,0.00051552535,0.004526359,0.00020798936,0.000033886015,0.000017677105,0.00010883563,0.0005817668,0.000073321986],"category_scores_gemma":[0.0012609363,0.00033535447,0.0008691636,0.00042069893,0.00030968932,0.00004641776,0.00015796689,0.0008942396,0.000015226259],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005158486,0.00024702665,0.0043598018,0.009518535,0.0001634822,0.000025923577,0.00003758658,1.335858e-8,0.0000052745463,0.000007361437,0.00017835964,0.98545146],"study_design_scores_gemma":[0.00051979383,0.00015636584,0.024063433,0.01784907,0.0006265406,0.00013371269,0.000009477933,0.0000013542676,0.0000036069644,0.000020088255,0.9563182,0.00029838627],"about_ca_topic_score_codex":0.00008198001,"about_ca_topic_score_gemma":0.000011032409,"teacher_disagreement_score":0.9851531,"about_ca_system_score_codex":0.00005690981,"about_ca_system_score_gemma":0.00034759284,"threshold_uncertainty_score":0.9999099},"labels":[],"label_agreement":null},{"id":"W2070580285","doi":"10.1503/cmaj.051313","title":"Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease","year":2006,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University","funders":"Genome Canada; Heart and Stroke Foundation of Canada","keywords":"Familial hypercholesterolemia; Medicine; Proband; Coronary artery disease; LDL receptor; Internal medicine; Disease; Cardiology; Bioinformatics; Lipoprotein; Cholesterol; Mutation; Genetics; Gene; Biology","score_opus":0.03424842832426117,"score_gpt":0.2970418995444079,"score_spread":0.26279347122014673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070580285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027982912,0.9941658,0.00007514058,0.00032352525,0.00108109,0.00093478936,0.0002485222,0.000030880637,0.00034198913],"genre_scores_gemma":[0.0007222046,0.9920803,0.00006692479,0.00080579,0.0056646485,0.00004682501,0.00028137176,0.00011474311,0.00021720387],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917247,0.0012583872,0.0015022585,0.0005062287,0.0041345204,0.0008738597],"domain_scores_gemma":[0.992467,0.00009693737,0.0005895868,0.0008235105,0.000666081,0.0053569004],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0040233484,0.00048610425,0.0031883763,0.0005430407,0.00022590534,0.00009329881,0.0003755402,0.0014967105,0.000281089],"category_scores_gemma":[0.0009525585,0.00040347368,0.003391695,0.0004351067,0.000079122525,0.00014582883,0.000030950814,0.0026998098,0.000076627875],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000141222545,0.000074915675,0.0005098563,0.0025707972,0.0038497276,0.0032066938,0.000028850558,0.0000020087625,1.5751311e-8,0.000004371215,0.002402359,0.9873363],"study_design_scores_gemma":[0.0017272739,0.00015964269,0.0017910262,0.0050619296,0.0063951756,0.0020059394,0.000020701978,0.000007261119,5.700915e-8,0.000013403679,0.98248106,0.0003365205],"about_ca_topic_score_codex":0.01712739,"about_ca_topic_score_gemma":0.0066916747,"teacher_disagreement_score":0.98699975,"about_ca_system_score_codex":0.0027461578,"about_ca_system_score_gemma":0.01934413,"threshold_uncertainty_score":0.9998417},"labels":[],"label_agreement":null},{"id":"W2070600062","doi":"10.1016/j.bbrc.2006.10.134","title":"Simvastatin inhibits lipopolysaccharide-induced tumor necrosis factor-α expression in neonatal rat cardiomyocytes: The role of reactive oxygen species","year":2006,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Heart and Stroke Foundation","funders":"","keywords":"Simvastatin; Tumor necrosis factor alpha; Reactive oxygen species; NADPH oxidase; Lipopolysaccharide; Chemistry; Pharmacology; Molecular biology; Biochemistry; Biology; Endocrinology","score_opus":0.044843640109895125,"score_gpt":0.32639618208317334,"score_spread":0.2815525419732782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070600062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943666,0.002335681,0.000013084305,0.001803241,0.000009754233,0.00064661127,0.00004644923,0.000018371536,0.0007602359],"genre_scores_gemma":[0.9989162,0.00034331763,0.00030190518,0.000029410865,0.00015009868,0.0001226666,0.00006701318,0.0000145878375,0.000054764358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99795747,0.0003315232,0.00032810326,0.0002840149,0.00075025717,0.000348605],"domain_scores_gemma":[0.99772894,0.00053987675,0.00006481177,0.0012062645,0.00031133188,0.0001487732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005409154,0.00014038642,0.00036020103,0.000115228926,0.00024948534,0.000035238227,0.00039418842,0.00009171567,0.000008729214],"category_scores_gemma":[0.00037781894,0.00009014335,0.00018090554,0.0005111998,0.0006475256,0.000074176394,0.00052566215,0.0007133833,0.000005634977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010603365,0.00024736652,0.0005331242,0.00004225545,0.000023393097,0.000002080256,0.0002542478,9.184242e-8,0.99006456,0.0013379926,0.000109253524,0.007279617],"study_design_scores_gemma":[0.0005211384,0.00012616921,0.014876505,0.00017277556,0.00001733192,0.000007442313,0.0008470794,0.00011655508,0.97879547,0.0014125268,0.0030098248,0.000097201126],"about_ca_topic_score_codex":0.002589907,"about_ca_topic_score_gemma":0.000050998595,"teacher_disagreement_score":0.014343382,"about_ca_system_score_codex":0.000102639206,"about_ca_system_score_gemma":0.00017982248,"threshold_uncertainty_score":0.3915182},"labels":[],"label_agreement":null},{"id":"W2070622687","doi":"10.1016/j.amjmed.2006.06.008","title":"Does Statin Therapy Decrease the Risk for Bleeding in Patients Who Are Receiving Warfarin?","year":2007,"lang":"en","type":"article","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; McMaster University; St. Michael's Hospital; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Warfarin; Major bleeding; Internal medicine; Statin; Atrial fibrillation","score_opus":0.0144390265373935,"score_gpt":0.29372537901689527,"score_spread":0.2792863524795018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070622687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833057,0.0013199176,0.0020199416,0.012378191,0.0002723633,0.0006156754,0.0000030779975,0.000006797849,0.00007832234],"genre_scores_gemma":[0.99173355,0.0028465583,0.0005711907,0.0033299152,0.0014475514,0.000006933777,0.0000013193329,0.000026339652,0.000036654863],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99785936,0.0002469187,0.0006659221,0.00012915206,0.0007570835,0.00034157542],"domain_scores_gemma":[0.99733615,0.0006039136,0.0011025374,0.00036485947,0.0003452616,0.00024726702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0081659695,0.00015209576,0.0007453648,0.00015900978,0.00015152586,0.000008010876,0.00022610591,0.000023691802,0.000024826191],"category_scores_gemma":[0.0016426047,0.00005057586,0.00019938423,0.00041778936,0.0003730852,0.000051179897,0.000020657666,0.0005239294,5.6813167e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036034726,0.00011886333,0.2891272,0.000031776966,0.00031709185,0.000028959088,0.004062135,0.00001441503,0.00009679316,0.000012596856,0.0007203719,0.7018663],"study_design_scores_gemma":[0.008379802,0.003833776,0.9663391,0.00093143305,0.00022933453,0.00006744161,0.01439972,0.00004147051,0.00019019464,0.0002913111,0.0052053216,0.00009105614],"about_ca_topic_score_codex":0.0007385179,"about_ca_topic_score_gemma":0.000063690495,"teacher_disagreement_score":0.70177525,"about_ca_system_score_codex":0.000114033755,"about_ca_system_score_gemma":0.00011945182,"threshold_uncertainty_score":0.28301784},"labels":[],"label_agreement":null},{"id":"W2070820990","doi":"10.1056/nejmc1311039","title":"Safety Profile of Extended-Release Niacin in the AIM-HIGH Trial","year":2014,"lang":"en","type":"letter","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Niacin; Medicine; Discontinuation; Adverse effect; Statin; Triglyceride; Clinical trial; Internal medicine; Drug; Metabolic syndrome; Cholesterol; Pharmacology","score_opus":0.01869848979158145,"score_gpt":0.2739852988622542,"score_spread":0.25528680907067275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070820990","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020779086,0.0059183594,0.0008609079,0.9648126,0.0024454778,0.0018452851,0.000015724387,0.000011330212,0.0033112816],"genre_scores_gemma":[0.18774486,0.003451513,0.0006943146,0.5483397,0.257202,0.000024553114,0.00022805098,0.00013052046,0.0021844702],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994321,0.00097265793,0.0017338333,0.00025358165,0.0023165299,0.00040240903],"domain_scores_gemma":[0.99693924,0.0005381688,0.0011432777,0.0008036693,0.0003391165,0.00023650606],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006691513,0.00035940693,0.0022053937,0.00045320226,0.00004429321,0.000007877176,0.00039534192,0.000518983,0.00046363467],"category_scores_gemma":[0.0011734108,0.00017562238,0.0005287012,0.00032313223,0.00016990326,0.000048383627,0.000024515655,0.0036265657,0.0000067779947],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020860914,0.00011898114,0.000060529524,0.0007251467,0.0004109235,0.002969289,0.0006158911,0.000005476495,0.000036898775,0.00004366071,0.83567375,0.13847853],"study_design_scores_gemma":[0.26799184,0.0055065486,0.0009299137,0.001974589,0.0008731105,0.0034908971,0.00008445038,0.000006064379,0.000024765639,0.00027559444,0.7187166,0.00012557459],"about_ca_topic_score_codex":0.00092419004,"about_ca_topic_score_gemma":0.000029546385,"teacher_disagreement_score":0.41647282,"about_ca_system_score_codex":0.00011002403,"about_ca_system_score_gemma":0.0009476996,"threshold_uncertainty_score":0.9986721},"labels":[],"label_agreement":null},{"id":"W2070970918","doi":"10.1016/j.amjmed.2009.03.030","title":"Effect of Fibrates on Lipid Profiles and Cardiovascular Outcomes: A Systematic Review","year":2009,"lang":"en","type":"review","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Centre hospitalier de l'Université Laval; McGill University Health Centre; McGill University; Institut Universitaire de Cardiologie et de Pneumologie de Québec; Jewish General Hospital","funders":"","keywords":"Medicine; Fibrate; Internal medicine; Odds ratio; Placebo; Myocardial infarction; Confidence interval; Hypertriglyceridemia; Gemfibrozil; Statin; Cholesterol; Fenofibrate; Cardiology; Triglyceride; Pathology","score_opus":0.019463484071405808,"score_gpt":0.33638366651788093,"score_spread":0.31692018244647513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070970918","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012403504,0.994617,0.00001776328,0.0011816857,0.00012606871,0.0038174358,0.000004319649,0.000010361971,0.000101320125],"genre_scores_gemma":[0.00017035898,0.99775535,0.000044449218,0.0010053245,0.0008746832,0.00005697201,0.000005021266,0.00005217929,0.000035665296],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99253005,0.0031604648,0.0020940818,0.00025468785,0.0016916828,0.00026902065],"domain_scores_gemma":[0.993857,0.0012216509,0.0029515168,0.0014635976,0.0002319106,0.00027427662],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0125969015,0.0005685429,0.017927708,0.00031575552,0.000050293904,0.0000060428556,0.00036918055,0.000078454155,0.000013338839],"category_scores_gemma":[0.00266059,0.00020485959,0.0032194408,0.00064555166,0.0005462463,0.000029763469,0.000036450616,0.00084093283,0.000005205307],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045779976,0.0000151103195,0.0000014794148,0.5174315,0.0038567982,0.00007517288,0.000023929779,1.2103752e-7,1.585238e-7,0.0000032707346,0.00028544964,0.47826123],"study_design_scores_gemma":[0.0010793322,0.0133346375,0.00001508533,0.87332255,0.061448894,0.0062500453,0.000057783698,3.2389147e-7,0.0000023934726,0.000002569211,0.044341017,0.00014535135],"about_ca_topic_score_codex":0.000032849945,"about_ca_topic_score_gemma":8.5609635e-8,"teacher_disagreement_score":0.4781159,"about_ca_system_score_codex":0.00008344663,"about_ca_system_score_gemma":0.00029900245,"threshold_uncertainty_score":0.9966522},"labels":[],"label_agreement":null},{"id":"W2071834419","doi":"10.1016/j.diabres.2005.03.025","title":"Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus","year":2005,"lang":"en","type":"article","venue":"Diabetes Research and Clinical Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Blood Services; University of Manitoba","funders":"Health Sciences Centre Foundation; Canadian Diabetes Association","keywords":"Simvastatin; Medicine; Internal medicine; Endocrinology; Plasminogen activator; Fibrinolysis; Diabetes mellitus; Plasminogen activator inhibitor-1; Factor VII; Cholesterol; Lipoprotein; Type 2 Diabetes Mellitus; Coagulation","score_opus":0.07241458923617126,"score_gpt":0.46643767192765595,"score_spread":0.39402308269148467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071834419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98843426,0.007429329,5.811286e-7,0.0024333897,0.000027553917,0.00053215004,0.000009243645,0.000011561905,0.0011219379],"genre_scores_gemma":[0.99385655,0.004636503,0.00085185096,0.00038829725,0.00015516179,0.000010595886,0.000011389431,0.000020691647,0.00006897049],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99705786,0.00069707754,0.0005754966,0.0003867286,0.00071027514,0.0005725754],"domain_scores_gemma":[0.99340487,0.0052696792,0.00010827083,0.00044050103,0.00033950503,0.00043717292],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005444062,0.00013660714,0.00056378305,0.00018049544,0.00006472781,0.000035244284,0.00006889184,0.00013122242,0.000050550567],"category_scores_gemma":[0.012072564,0.000101423044,0.00013244421,0.0004598021,0.0003481342,0.00020532869,0.00008502756,0.0008011849,0.000023423287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000990732,0.0012711547,0.37915927,0.00037679743,0.00050466094,0.000030632804,0.00012970164,0.000011614552,0.00018617297,0.00019673533,0.0009665693,0.61617595],"study_design_scores_gemma":[0.0032290535,0.011018363,0.973229,0.00040405014,0.000103380786,0.000006065052,0.00021430942,0.0023423983,0.00067489565,0.00048604835,0.008117684,0.00017475066],"about_ca_topic_score_codex":0.00014154494,"about_ca_topic_score_gemma":0.000012388558,"teacher_disagreement_score":0.6160012,"about_ca_system_score_codex":0.00008306225,"about_ca_system_score_gemma":0.00027239803,"threshold_uncertainty_score":0.99624914},"labels":[],"label_agreement":null},{"id":"W2072263451","doi":"10.1111/j.1744-9987.2005.00314.x","title":"Direct Adsorption of Lipoproteins from Whole Blood by Direct Adsorption of Lipoprotein Apheresis: First Experience in Two Hypercholesterolemic Children","year":2005,"lang":"en","type":"article","venue":"Therapeutic Apheresis and Dialysis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Nutrition, Metabolism and Diabetes","funders":"","keywords":"Medicine; Familial hypercholesterolemia; LDL apheresis; Apheresis; Lipoprotein; Very low-density lipoprotein; Cholesterol; Extracorporeal; Internal medicine; Gastroenterology; Endocrinology; Platelet","score_opus":0.014355345553104013,"score_gpt":0.26243729476252753,"score_spread":0.2480819492094235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072263451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97423387,0.023521783,0.00016902456,0.00029910303,0.000031193496,0.0010472928,0.000109731984,0.000057269786,0.000530718],"genre_scores_gemma":[0.99505115,0.0033412871,0.00063357863,0.0002113278,0.00027740048,0.00021125357,0.00009356682,0.000057698613,0.00012273563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996914,0.0002997367,0.0009231149,0.0007039635,0.0007252706,0.00043387874],"domain_scores_gemma":[0.99826515,0.00010025374,0.00037497704,0.0009479837,0.000108675806,0.0002029814],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066837313,0.00039281446,0.0012940173,0.00023203519,0.00007639453,0.000030065004,0.00021129531,0.00020791804,0.00030841105],"category_scores_gemma":[0.000056391735,0.00033780042,0.00045924945,0.0006355779,0.0001973095,0.000222558,0.00007009688,0.00023367244,0.0000107918695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010145375,0.00160657,0.08659796,0.00024130751,0.0017296567,0.0000030450474,0.0050765057,0.00014133294,0.65967256,0.000015703563,0.00004783431,0.24385302],"study_design_scores_gemma":[0.011183074,0.000730622,0.33641607,0.0011008927,0.0025955425,0.000019168287,0.0010187645,0.00045626055,0.6433319,0.00009886303,0.0022535904,0.00079528143],"about_ca_topic_score_codex":0.02385292,"about_ca_topic_score_gemma":0.0033799268,"teacher_disagreement_score":0.2498181,"about_ca_system_score_codex":0.000077594734,"about_ca_system_score_gemma":0.00007137802,"threshold_uncertainty_score":0.9999074},"labels":[],"label_agreement":null},{"id":"W2073040540","doi":"10.1016/j.amjcard.2007.09.072","title":"Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein","year":2007,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":125,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Rosuvastatin; Medicine; Statin; Internal medicine; C-reactive protein; Placebo; Cholesterol; Rosuvastatin Calcium; Randomized controlled trial; Interquartile range; Gastroenterology; Inflammation; Pathology","score_opus":0.01272281938868915,"score_gpt":0.27576757103328686,"score_spread":0.26304475164459773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073040540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862126,0.00010865548,0.0051039835,0.0002982906,0.00007100835,0.008176332,0.000012910457,0.000005632076,0.000010570895],"genre_scores_gemma":[0.99865496,0.00016253388,0.0003197246,0.00017693063,0.0004941057,0.00015567134,0.00000875648,0.000022312792,0.0000049915184],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.988836,0.008273148,0.0015757353,0.00021397088,0.00073525315,0.0003659061],"domain_scores_gemma":[0.9942478,0.0017274708,0.0029739193,0.0004688698,0.00047176404,0.00011021072],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.031352032,0.0002554189,0.0038428141,0.00022191605,0.00005190936,0.000013346194,0.00013325614,0.00009394456,0.0000020890795],"category_scores_gemma":[0.001414909,0.00012218018,0.0005662068,0.00031212904,0.0010240794,0.00009114863,0.00003007496,0.0005956209,1.8655669e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95509714,0.00034718987,0.0015895009,0.00005332038,0.0020413394,0.00009453818,0.00086103135,0.000019632396,0.0077076936,0.0000044886688,0.0000015800834,0.032182567],"study_design_scores_gemma":[0.7833102,0.008488242,0.20102926,0.00031591757,0.0008212809,0.0001643102,0.00048684693,0.000023002547,0.0051926496,0.000055237037,0.000004204582,0.00010887648],"about_ca_topic_score_codex":0.00050750375,"about_ca_topic_score_gemma":0.00003238948,"teacher_disagreement_score":0.19943975,"about_ca_system_score_codex":0.00005912465,"about_ca_system_score_gemma":0.0003418396,"threshold_uncertainty_score":0.9974269},"labels":[],"label_agreement":null},{"id":"W2073252878","doi":"10.1194/jlr.m600510-jlr200","title":"Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages","year":2007,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of British Columbia and Yukon; Heart and Stroke Foundation of Canada","keywords":"Atorvastatin; Lipoprotein lipase; Endocrinology; Internal medicine; Chemistry; Simvastatin; Liver X receptor; Biology; Biochemistry; Medicine; Adipose tissue; Nuclear receptor; Transcription factor","score_opus":0.04994967058178814,"score_gpt":0.39857594645045397,"score_spread":0.34862627586866585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073252878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928923,0.0044778027,0.00030709553,0.0005972908,0.00016389671,0.00062235445,0.000005672207,0.000011694827,0.000921842],"genre_scores_gemma":[0.99235564,0.0011280557,0.002396235,0.000094046394,0.0034842542,0.000012522966,0.0000024860335,0.000040380302,0.00048635443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99569273,0.000556837,0.00084478135,0.00027198443,0.0019302688,0.0007034212],"domain_scores_gemma":[0.99770904,0.00033037504,0.0002092668,0.0004047061,0.00056720705,0.00077938236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011411365,0.00017873353,0.00059615227,0.0009426707,0.00022496108,0.000065991946,0.00018525594,0.00015968218,0.00017948223],"category_scores_gemma":[0.0012393169,0.00012942367,0.00023193182,0.0004990734,0.00020695331,0.00023058229,0.00013609856,0.0013485467,0.000009668192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004094174,0.0012757502,0.01958245,0.00095829344,0.0001635024,0.0076033813,0.0014981675,0.00000526542,0.78922457,0.00019937358,0.002926661,0.1724684],"study_design_scores_gemma":[0.014115322,0.0046155206,0.12485272,0.003478364,0.000071795155,0.0031554408,0.0024216787,0.000023187642,0.80686116,0.00064539094,0.03939438,0.00036505962],"about_ca_topic_score_codex":0.00064236484,"about_ca_topic_score_gemma":0.00014252108,"teacher_disagreement_score":0.17210333,"about_ca_system_score_codex":0.00019923325,"about_ca_system_score_gemma":0.00046011485,"threshold_uncertainty_score":0.5858839},"labels":[],"label_agreement":null},{"id":"W2074098680","doi":"10.1016/j.jss.2003.10.011","title":"Novel cardioprotective effects of pravastatin in human ventricular cardiomyocytes subjected to hypoxia and reoxygenation: beneficial effects of statins independent of endothelial cells1","year":2004,"lang":"en","type":"article","venue":"Journal of Surgical Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital","funders":"","keywords":"Pravastatin; Hypoxia (environmental); Cardiology; Medicine; Pharmacology; Chemistry; Internal medicine; Oxygen; Cholesterol","score_opus":0.020894462459563785,"score_gpt":0.3278851693255687,"score_spread":0.30699070686600494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074098680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949877,0.0022302382,0.00086689385,0.0001206166,0.000094938965,0.0015845144,0.000018338595,0.0000032033,0.00009354189],"genre_scores_gemma":[0.9984246,0.00041814885,0.00082011084,0.0000047808594,0.00027338142,0.000025642474,0.0000021333406,0.000021842834,0.000009396716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952313,0.00053937396,0.00089994876,0.00023898466,0.002700972,0.0003894324],"domain_scores_gemma":[0.9964621,0.0007334142,0.0003425373,0.00026882926,0.0018808286,0.00031229606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040685483,0.00015845984,0.0011639781,0.0008959981,0.000057847683,0.000010994194,0.00014735872,0.0001573439,0.000005269951],"category_scores_gemma":[0.001976477,0.00012466038,0.00038111905,0.0009858871,0.00015092161,0.00007237391,0.0001086017,0.00078262505,5.3224915e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026998569,0.0014974017,0.0029888533,0.0054620486,0.0009558039,0.0040864157,0.0019798994,0.00077592424,0.9619472,0.00050870335,0.000011194379,0.017086675],"study_design_scores_gemma":[0.013991405,0.005342083,0.13520588,0.001780559,0.00012110122,0.00039232272,0.00028557147,0.000005946406,0.8423754,0.00024618252,0.00014378632,0.000109789384],"about_ca_topic_score_codex":0.0015368316,"about_ca_topic_score_gemma":0.0000344422,"teacher_disagreement_score":0.13221702,"about_ca_system_score_codex":0.00032121938,"about_ca_system_score_gemma":0.0007056618,"threshold_uncertainty_score":0.50835025},"labels":[],"label_agreement":null},{"id":"W2074209817","doi":"10.1042/cs20030375","title":"Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice","year":2004,"lang":"en","type":"article","venue":"Clinical Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Forskningsrådet om Hälsa, Arbetsliv och Välfärd; University of Ottawa; American Heart Association","keywords":"Endocrinology; Internal medicine; Long-term potentiation; Apolipoprotein B; LDL receptor; Apolipoprotein E; C57BL/6; Biology; Chemistry; Receptor; Messenger RNA; Pathogenesis; Lipoprotein; Cholesterol; Gene; Medicine; Biochemistry; Disease","score_opus":0.04903481713252936,"score_gpt":0.32843845495474805,"score_spread":0.27940363782221866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074209817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982146,0.000008630572,0.00023501371,0.00052348134,0.00007241771,0.0008060425,0.000013388272,0.000046988785,0.00007945919],"genre_scores_gemma":[0.9973374,0.000014759116,0.0017957934,0.00073644955,0.00006738974,0.000023039622,0.0000027631747,0.000014434467,0.00000795295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974811,0.000107495,0.00050411973,0.0007747327,0.00063049997,0.00050207356],"domain_scores_gemma":[0.9983484,0.00022759939,0.00016250336,0.0004539431,0.00014203668,0.0006655286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029022025,0.00017938354,0.00058509264,0.00007932436,0.00019382285,0.00005827659,0.00018977236,0.00015715139,0.000010239049],"category_scores_gemma":[0.0032780415,0.00013106344,0.000099511555,0.0009227431,0.000524715,0.00021147651,0.00012830803,0.0004323639,0.0000092404225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004990828,0.0005712294,0.9343002,0.000056798406,0.000036829846,0.000039294737,0.00056132243,0.00008808996,0.049847938,0.000003779213,0.0000020412033,0.01399342],"study_design_scores_gemma":[0.00435904,0.000842997,0.9814537,0.00045718226,0.000009207745,0.000008789117,0.0001839404,0.0002652231,0.012218755,0.000007747978,0.00002730366,0.00016610102],"about_ca_topic_score_codex":0.0009477191,"about_ca_topic_score_gemma":0.0007232866,"teacher_disagreement_score":0.04715354,"about_ca_system_score_codex":0.0003289951,"about_ca_system_score_gemma":0.000511789,"threshold_uncertainty_score":0.5344612},"labels":[],"label_agreement":null},{"id":"W2074306342","doi":"10.1046/j.1538-7836.2003.t01-1-00199.x-i1","title":"Talking about …","year":2003,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"World Federation of Science Journalists","funders":"","keywords":"Food and drug administration; General partnership; Intellect; Genius; Medicine; Autism; Psychology; Sociology; Psychoanalysis; Psychiatry; Law; Philosophy; Epistemology; Political science; Pharmacology; Developmental psychology","score_opus":0.04459177613330179,"score_gpt":0.3214871587668439,"score_spread":0.27689538263354213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074306342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837275,0.009096679,0.00055931346,0.0014171229,0.00023719117,0.00013148121,0.0000019360607,0.0000071789186,0.004821562],"genre_scores_gemma":[0.98832226,0.0062871687,0.0044461824,0.0006760547,0.00020465392,0.0000011054178,4.2894837e-7,0.000014251791,0.00004787051],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990032,0.000057417576,0.00033242986,0.0000926126,0.0003532918,0.00016109933],"domain_scores_gemma":[0.99927646,0.000020394333,0.0001749207,0.00016792049,0.00016037471,0.00019995112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008215992,0.00009280854,0.000453586,0.00009285815,0.000089499634,0.000028830447,0.000036500925,0.000060494916,0.00014871017],"category_scores_gemma":[0.00010994783,0.000065491135,0.00027760526,0.000120225486,0.00003889969,0.00009538353,0.000011353354,0.00018953202,0.0000036037513],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037448612,0.0009763653,0.14601217,0.0011511524,0.0051619005,0.00041712972,0.0023005705,0.000015114973,0.0072204014,0.009182186,0.026293911,0.8008946],"study_design_scores_gemma":[0.008118775,0.0015718607,0.47473505,0.001094173,0.001834854,0.0051669874,0.0016374285,0.00001583607,0.020959271,0.0010696885,0.48340368,0.00039238963],"about_ca_topic_score_codex":0.000019054925,"about_ca_topic_score_gemma":0.0000017910802,"teacher_disagreement_score":0.80050224,"about_ca_system_score_codex":0.000042036037,"about_ca_system_score_gemma":0.0001122653,"threshold_uncertainty_score":0.26706508},"labels":[],"label_agreement":null},{"id":"W2074552018","doi":"10.1016/j.ejim.2012.08.014","title":"Lipoprotein (a) is independently correlated with coronary artery calcification","year":2012,"lang":"en","type":"article","venue":"European Journal of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lipoprotein(a); Internal medicine; Cardiology; Risk factor; Diabetes mellitus; Coronary artery disease; Chest pain; Lipoprotein; Cholesterol; Endocrinology","score_opus":0.019914195608667584,"score_gpt":0.26037071312961424,"score_spread":0.24045651752094666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074552018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9577383,0.005717349,0.01375874,0.0040648403,0.0011070232,0.00038250833,0.0000022611969,0.000031847132,0.01719717],"genre_scores_gemma":[0.9927571,0.00021567919,0.0006828965,0.002063164,0.0031918022,0.0000015778214,0.000004342173,0.000055694283,0.001027743],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973372,0.00032831734,0.0008097151,0.00015124549,0.0010503412,0.00032315866],"domain_scores_gemma":[0.99798536,0.000031678257,0.0005735339,0.00038319788,0.00043017417,0.0005960427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021856122,0.00020795722,0.0005330239,0.00024258609,0.00005327748,0.000010697517,0.00019051484,0.000042733627,0.00052866864],"category_scores_gemma":[0.0001501615,0.00012342661,0.00017938705,0.00019188806,0.00013271662,0.0002203332,0.00003374877,0.0007785842,0.00012392165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0128037855,0.0014665258,0.22568221,0.000539659,0.0048991754,0.022666007,0.012316176,0.000014165447,0.024318814,0.00022902564,0.03820754,0.6568569],"study_design_scores_gemma":[0.012506719,0.00918069,0.7990599,0.0043435227,0.0008650217,0.108058,0.0013819496,0.000041480795,0.0034676662,0.000012265657,0.060787138,0.00029562673],"about_ca_topic_score_codex":0.00004076381,"about_ca_topic_score_gemma":9.736523e-7,"teacher_disagreement_score":0.6565613,"about_ca_system_score_codex":0.00011801019,"about_ca_system_score_gemma":0.00008795948,"threshold_uncertainty_score":0.5788551},"labels":[],"label_agreement":null},{"id":"W2074985728","doi":"10.1503/cmaj.090917","title":"The Enhancing Secondary Prevention in Coronary Artery Disease trial","year":2009,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Calgary; University of Alberta; Foothills Medical Centre; University of Ottawa; Royal Alexandra Hospital","funders":"Eli Lilly Canada; Fondation pour la Recherche Médicale; W. Garfield Weston Foundation; Boston Scientific Corporation; Pfizer; Heart and Stroke Foundation of Canada; Pfizer Canada; Sanofi; Alberta Heritage Foundation for Medical Research; University of Alberta; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Statin; Coronary artery disease; Guideline; Randomized controlled trial; Odds ratio; Internal medicine; Cardiac catheterization; Clinical endpoint; Physical therapy; Pathology","score_opus":0.007108351548822551,"score_gpt":0.24928205886000707,"score_spread":0.2421737073111845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074985728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9145228,0.002108499,0.000117295014,0.07872339,0.001274028,0.00064568705,0.0000048216843,0.000015268142,0.00258817],"genre_scores_gemma":[0.98566186,0.00047205566,0.000025330502,0.009836525,0.003244212,0.000011177646,0.000010877591,0.000007932377,0.00073002203],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99755114,0.00027240263,0.0004448674,0.00011497015,0.0012118404,0.00040479738],"domain_scores_gemma":[0.9979534,0.00007392901,0.00011977502,0.0001367134,0.00012214597,0.0015940089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038337535,0.00007932427,0.00019826638,0.00010267033,0.0002927587,0.000057817346,0.000088791676,0.00017087389,0.0005743979],"category_scores_gemma":[0.001442569,0.00005812624,0.00020240713,0.00015117876,0.000016017559,0.000092616785,0.0000044147914,0.00097481045,0.000031023665],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016236583,0.00010095477,0.00805815,0.000012720263,0.00013618408,0.002500431,0.00014898083,0.0000015183991,0.0000069915886,0.00017940227,0.019595003,0.967636],"study_design_scores_gemma":[0.033341996,0.0005366717,0.74832606,0.00028545843,0.000079940255,0.00087391573,0.00032076758,0.00011266248,0.0000057219822,0.0016229065,0.21434525,0.0001486285],"about_ca_topic_score_codex":0.00031729636,"about_ca_topic_score_gemma":0.01799983,"teacher_disagreement_score":0.9674874,"about_ca_system_score_codex":0.001196368,"about_ca_system_score_gemma":0.007891597,"threshold_uncertainty_score":0.9999191},"labels":[],"label_agreement":null},{"id":"W2075147537","doi":"10.1016/j.amjcard.2007.03.024","title":"Evolution of the Lipid Trial Protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial","year":2007,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"National Heart, Lung, and Blood Institute","keywords":"Diabetes mellitus; Action (physics); Medicine; Protocol (science); Internal medicine; Bioinformatics; Endocrinology; Biology; Alternative medicine; Pathology","score_opus":0.014158791518525737,"score_gpt":0.2921162745077262,"score_spread":0.2779574829892005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075147537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95995754,0.00021434178,0.003827913,0.00049188687,0.00096913736,0.034390345,0.000005508629,0.0000042003585,0.00013912872],"genre_scores_gemma":[0.99486715,0.000029526638,0.00006685408,0.00013123384,0.0032778182,0.001605587,1.293711e-7,0.000016552522,0.000005146102],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9951225,0.0025748562,0.001018119,0.0001569806,0.0007995204,0.00032805416],"domain_scores_gemma":[0.99698555,0.0003093219,0.0013124049,0.0009548279,0.0003462671,0.00009160308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0100857625,0.0001552492,0.001600524,0.00015964003,0.00008249584,0.0000038658713,0.0003923426,0.00008210688,0.0000024631763],"category_scores_gemma":[0.0012337877,0.00006990556,0.002312601,0.00070472946,0.0004688161,0.000039012175,0.00006519041,0.00064162945,7.3938054e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6650598,0.00022319876,0.07957151,0.00012167082,0.0060467054,0.000014280617,0.0004321804,0.01266364,0.0058101667,0.000073196185,0.0003252862,0.22965835],"study_design_scores_gemma":[0.27774787,0.013476159,0.684457,0.00024516974,0.0025672894,0.00031950854,0.0013676418,0.000040089748,0.0040908735,0.00023302366,0.015264003,0.00019137542],"about_ca_topic_score_codex":0.00041700312,"about_ca_topic_score_gemma":0.00001916275,"teacher_disagreement_score":0.60488546,"about_ca_system_score_codex":0.00024452622,"about_ca_system_score_gemma":0.0004929874,"threshold_uncertainty_score":0.34955442},"labels":[],"label_agreement":null},{"id":"W2075259688","doi":"10.1038/ncpneph0203","title":"Atorvastatin has no beneficial effect on cardiovascular outcomes in patients with advanced chronic kidney disease","year":2006,"lang":"en","type":"article","venue":"Nature Clinical Practice Nephrology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Atorvastatin; Medicine; Kidney disease; Intensive care medicine; Cardiology; Internal medicine; Disease","score_opus":0.008079605344764576,"score_gpt":0.31184550532411864,"score_spread":0.30376589997935405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075259688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837959,0.0038928348,0.000056366433,0.007147158,0.0011633489,0.0026064906,0.000039469844,0.00010344638,0.0011950111],"genre_scores_gemma":[0.9763864,0.00010310864,0.0011370165,0.020013984,0.0018743721,0.00012357424,0.0002333028,0.00007539612,0.00005279514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949723,0.0013263766,0.00084679306,0.0009747422,0.0012246812,0.0006551048],"domain_scores_gemma":[0.995508,0.0019120616,0.00030398247,0.0013443594,0.00040123213,0.00053035363],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0025619552,0.00041148826,0.0015590886,0.00014720588,0.00013031482,0.000026473537,0.00016842363,0.00082205,0.000054016196],"category_scores_gemma":[0.011438431,0.00028769052,0.0009362121,0.00031083362,0.00021703196,0.00022484233,0.00006673208,0.002940396,0.00015619746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057451613,0.005977317,0.8240069,0.00058593793,0.0035732454,0.0016514502,0.000016595988,0.00081495993,0.000012949391,0.00064727594,0.009813907,0.09544781],"study_design_scores_gemma":[0.016372204,0.006382029,0.6445666,0.000074849166,0.00090353406,0.000009548714,0.0000018525492,0.00002118745,0.0000042736815,0.000027809461,0.3314252,0.0002109308],"about_ca_topic_score_codex":0.00017563453,"about_ca_topic_score_gemma":0.00004591577,"teacher_disagreement_score":0.3216113,"about_ca_system_score_codex":0.00028447417,"about_ca_system_score_gemma":0.000902878,"threshold_uncertainty_score":0.9999575},"labels":[],"label_agreement":null},{"id":"W2075397711","doi":"10.1177/1740774511407939","title":"A tale of three labels: translating the JUPITER trial data into regulatory claims","year":2011,"lang":"en","type":"article","venue":"Clinical Trials","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Medicine; Clinical endpoint; Unstable angina; Clinical trial; Myocardial infarction; Placebo; Randomized controlled trial; Population; Internal medicine; Statin; Rosuvastatin Calcium; Physical therapy; Cardiology; Alternative medicine; Environmental health; Pathology","score_opus":0.5731594950753952,"score_gpt":0.49455147749572415,"score_spread":0.07860801757967106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075397711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804345,0.005003308,0.002077297,0.0019725626,0.0022518868,0.004606952,0.00004701122,0.00007790058,0.003528633],"genre_scores_gemma":[0.9891483,0.00032331646,0.0045388523,0.00095844746,0.0047791493,0.000057284564,0.00003938191,0.00003830547,0.000116961244],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99419576,0.0019962948,0.002537524,0.0004926305,0.0005483806,0.00022943527],"domain_scores_gemma":[0.9945007,0.0017425568,0.00058434805,0.00286717,0.00011067663,0.00019455628],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.039514184,0.00015501758,0.0016194965,0.000039649673,0.00008340842,0.0000111181635,0.00049867,0.0002895109,0.00029472553],"category_scores_gemma":[0.008339661,0.000085467385,0.0009530289,0.00017121433,0.00031936326,0.00009376126,0.00015738982,0.00045236235,0.00002992913],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04487319,0.0011977677,0.0035044332,0.00038786672,0.0022170225,0.00003196039,0.0014012151,2.905307e-7,0.0005930818,0.0014544497,0.005168857,0.9391699],"study_design_scores_gemma":[0.6283627,0.0142636895,0.097804196,0.002071531,0.011497218,0.00009107488,0.0016047332,0.0011132769,0.004214967,0.058182128,0.17939715,0.001397296],"about_ca_topic_score_codex":0.00016051251,"about_ca_topic_score_gemma":0.000078581565,"teacher_disagreement_score":0.9377726,"about_ca_system_score_codex":0.00001270527,"about_ca_system_score_gemma":0.00036079716,"threshold_uncertainty_score":0.9983956},"labels":[],"label_agreement":null},{"id":"W2075487117","doi":"10.1016/j.atherosclerosis.2007.02.026","title":"Two new large deletions in the low density lipoprotein receptor (LDLR) gene not revealed by PCR-based molecular diagnosis of familial hypercholesterolemia","year":2007,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"LDL receptor; Familial hypercholesterolemia; Gene; Genetics; Medicine; Biology; Lipoprotein; Internal medicine; Cholesterol","score_opus":0.018098157085221767,"score_gpt":0.26486068141909647,"score_spread":0.2467625243338747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075487117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864486,0.0006042709,0.009173164,0.0018350021,0.000113833994,0.0015825788,0.00009296575,0.000055982597,0.00009362461],"genre_scores_gemma":[0.98953146,0.0002991966,0.004112071,0.0054133898,0.00026535252,0.00017410908,0.00008775132,0.00006663978,0.000050004885],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99678314,0.00033007443,0.0007049909,0.00053172297,0.00096061244,0.0006894751],"domain_scores_gemma":[0.9980368,0.00014745111,0.00018257716,0.0011844402,0.0001542075,0.000294498],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026107095,0.00032333157,0.00068703864,0.00014196621,0.00014208986,0.000026032629,0.0003142322,0.00025055537,0.00007517937],"category_scores_gemma":[0.00023375334,0.00025615533,0.0005175623,0.0006728048,0.00010190967,0.00007148205,0.00005976433,0.0004922503,0.000038249294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004945917,0.00162071,0.1292238,0.0002448141,0.00021190991,0.000034472672,0.0009188701,0.000030838713,0.82819563,0.00012564343,0.0028379872,0.03606075],"study_design_scores_gemma":[0.008053435,0.0004988637,0.3881997,0.0004847708,0.00023977486,0.000012093595,0.00024561826,0.00003868546,0.5980014,0.000025809602,0.0038458463,0.00035402234],"about_ca_topic_score_codex":0.0066085598,"about_ca_topic_score_gemma":0.00090381555,"teacher_disagreement_score":0.2589759,"about_ca_system_score_codex":0.0001999378,"about_ca_system_score_gemma":0.00022213743,"threshold_uncertainty_score":0.9999891},"labels":[],"label_agreement":null},{"id":"W2075543662","doi":"10.1001/jama.291.15.1864","title":"Lipid-Lowering Therapy With Statins in High-Risk Elderly Patients","year":2004,"lang":"en","type":"article","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":412,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Medical prescription; Statin; Internal medicine; Odds ratio; Confidence interval; Cohort; Retrospective cohort study; Cohort study; Diabetes mellitus; Physical therapy","score_opus":0.007739531869359798,"score_gpt":0.23278832648154307,"score_spread":0.22504879461218327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075543662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975289,0.00020623735,0.0005125206,0.00052470044,0.00009001436,0.0005259024,0.000006798811,0.00004106095,0.0005638409],"genre_scores_gemma":[0.9972517,0.00039944248,0.001449228,0.0005035994,0.0002762494,0.000035629928,0.00001646585,0.000025347548,0.000042373336],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990287,0.000028151031,0.00016233641,0.00019602134,0.00035201546,0.0002328092],"domain_scores_gemma":[0.9994439,0.00001015698,0.000051844123,0.00031986978,0.00007237826,0.00010188424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021360462,0.00010760818,0.00023594906,0.000067972156,0.00004342927,0.000017646737,0.000045854536,0.000064376036,0.000024992736],"category_scores_gemma":[0.000035452074,0.00007472835,0.000064090076,0.00018276987,0.000018969346,0.0000837414,0.000010561729,0.00023137222,0.000019388308],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005481279,0.00046085392,0.19716349,0.00006435548,0.00011601456,0.00007818358,0.0011172688,0.00017817486,0.00007552922,0.000089354864,0.00006301788,0.8000456],"study_design_scores_gemma":[0.021913575,0.002520516,0.9675549,0.00020054218,0.000021967044,0.000009884462,0.00011672586,0.0000043017412,0.0018642154,0.000114367365,0.0055459607,0.00013302515],"about_ca_topic_score_codex":0.004371787,"about_ca_topic_score_gemma":0.0003969887,"teacher_disagreement_score":0.7999126,"about_ca_system_score_codex":0.00011379146,"about_ca_system_score_gemma":0.00012765545,"threshold_uncertainty_score":0.66088635},"labels":[],"label_agreement":null},{"id":"W2075578416","doi":"10.1001/archinte.161.2.183","title":"Use of the Statins in Patients After Acute Myocardial Infarction","year":2001,"lang":"en","type":"article","venue":"Archives of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Pravastatin; Medicine; Simvastatin; Statin; Myocardial infarction; Internal medicine; Cardiology; Cholesterol","score_opus":0.011453071875713256,"score_gpt":0.2563705157910447,"score_spread":0.24491744391533143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075578416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966744,0.00011562945,0.0003107968,0.00076895865,0.0002585196,0.0003655902,0.000010633016,0.0000049253995,0.0014905086],"genre_scores_gemma":[0.9983343,0.00030294104,0.00027172294,0.0006988451,0.0001657397,0.000012079586,0.0000061924434,0.0000106861335,0.0001974773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880785,0.00008764854,0.00040298112,0.00012755948,0.00043010755,0.00014384161],"domain_scores_gemma":[0.99933016,0.000073956704,0.00012948044,0.00033952997,0.00005553213,0.000071324976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013766029,0.00009384942,0.00035099592,0.00014654614,0.000011474467,0.0000014081371,0.00008687135,0.000026843736,0.000046031164],"category_scores_gemma":[0.00019990963,0.000053384763,0.00017302665,0.00014139814,0.00020953243,0.00005252569,0.00006357841,0.0001883261,0.0000011245925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001962208,0.00012678708,0.93803334,0.000063819665,0.00028477728,0.000017322176,0.0012915835,0.0000049057257,0.0012308792,0.000031403437,0.000103918166,0.05684903],"study_design_scores_gemma":[0.0026919977,0.0008584651,0.9917672,0.00093823,0.00011659882,0.00002121648,0.000058842554,0.00005509507,0.00071470905,0.000101271326,0.002635312,0.000041050233],"about_ca_topic_score_codex":0.00191172,"about_ca_topic_score_gemma":0.00006690468,"teacher_disagreement_score":0.05680798,"about_ca_system_score_codex":0.000020543821,"about_ca_system_score_gemma":0.00003893783,"threshold_uncertainty_score":0.28899616},"labels":[],"label_agreement":null},{"id":"W2075715279","doi":"10.1016/j.amjcard.2004.07.052","title":"Is there value in liver function test and creatine phosphokinase monitoring with statin use?","year":2004,"lang":"en","type":"review","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Harm; Intensive care medicine; Statin; Disease; Mechanism (biology); Internal medicine","score_opus":0.03170078242743387,"score_gpt":0.30167946300911075,"score_spread":0.2699786805816769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075715279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02245733,0.9763762,0.00039705852,0.000097686665,0.00010427482,0.00045461737,0.000010745743,0.000006858636,0.000095266376],"genre_scores_gemma":[0.027954709,0.97036695,0.00055507186,0.00007784547,0.00094612443,0.00001752745,0.0000027907502,0.00004838716,0.000030577416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804705,0.00054813665,0.00057963346,0.00021888423,0.00033581918,0.00027046286],"domain_scores_gemma":[0.9980019,0.00040031815,0.0008765827,0.00042366845,0.00015810659,0.00013942282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010469818,0.00029598983,0.0029111335,0.00017424082,0.00005432391,0.00001762362,0.000119238975,0.00009285725,0.00000500534],"category_scores_gemma":[0.00012957722,0.00014852706,0.00053626933,0.00036896122,0.0003205676,0.00005829435,0.000036772424,0.00090275845,0.0000027822246],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032726515,0.000020513535,0.004978461,0.0018191607,0.0013131945,0.0008214597,0.00012327905,0.00006077423,8.828793e-7,0.000010104622,0.00002490672,0.9905],"study_design_scores_gemma":[0.003620113,0.013537094,0.08570323,0.041207045,0.011272348,0.046182353,0.0011963752,0.000003889429,0.000008856367,0.000059520113,0.79662025,0.0005889306],"about_ca_topic_score_codex":0.0006250868,"about_ca_topic_score_gemma":0.0000017297414,"teacher_disagreement_score":0.9899111,"about_ca_system_score_codex":0.0002595277,"about_ca_system_score_gemma":0.00072499964,"threshold_uncertainty_score":0.60567576},"labels":[],"label_agreement":null},{"id":"W2075827622","doi":"10.1139/y02-136","title":"Stereospecific disposition of fluvastatin in streptozotocin-induced diabetic rats","year":2002,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Streptozotocin; Pharmacokinetics; Enantiomer; Fluvastatin; Chemistry; Stereoselectivity; Pharmacology; Diabetes mellitus; High-performance liquid chromatography; Area under the curve; Endocrinology; Chromatography; Medicine; Stereochemistry; Biochemistry","score_opus":0.022340951008354013,"score_gpt":0.26892380382671327,"score_spread":0.24658285281835926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075827622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965602,0.0020882483,0.0000061876235,0.0006298882,0.00033734055,0.00021477218,0.0000052205537,0.0000013862827,0.00015675256],"genre_scores_gemma":[0.9989972,0.00019536466,0.000045115703,0.00046781692,0.00025307902,0.0000052340724,0.0000027094486,0.000007596395,0.000025898045],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99905616,0.00020049933,0.00033558407,0.00010936899,0.00006463451,0.00023375964],"domain_scores_gemma":[0.99927795,0.000046984114,0.0001478338,0.000085359046,0.00011647766,0.0003253837],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002513114,0.00008674559,0.00042641093,0.00023501556,0.00004186067,0.0000020568987,0.000053429274,0.00009656785,0.0013009628],"category_scores_gemma":[0.000017003704,0.000075184485,0.00008510506,0.00014867572,0.00011515845,0.0000452782,0.000005435575,0.00030893224,0.0000038819394],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013072586,0.00008379233,0.007666922,0.00027457517,0.00019048117,0.00031580264,0.0007469333,0.00002802741,0.9793408,0.00006575761,0.0010231462,0.010133067],"study_design_scores_gemma":[0.008750156,0.0034989482,0.5648223,0.00029372828,0.0004166833,0.00083708396,0.00038268924,0.00039862134,0.4175014,0.00068351795,0.0021366365,0.00027826073],"about_ca_topic_score_codex":0.000520118,"about_ca_topic_score_gemma":0.0005089727,"teacher_disagreement_score":0.5618394,"about_ca_system_score_codex":0.000063177235,"about_ca_system_score_gemma":0.00025469318,"threshold_uncertainty_score":0.999612},"labels":[],"label_agreement":null},{"id":"W2075998991","doi":"10.1002/pds.1314","title":"The impact of over‐the‐counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database","year":2006,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medical prescription; Medicine; Statin; Simvastatin; Pharmacoepidemiology; Over-the-counter; Quarter (Canadian coin); Family medicine; Internal medicine; Pharmacology","score_opus":0.11112886930976043,"score_gpt":0.4753157445552493,"score_spread":0.3641868752454889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075998991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93455064,0.0038031342,0.00020562364,0.05816058,0.00008279474,0.0014405258,0.00034613747,0.000008211571,0.0014023558],"genre_scores_gemma":[0.989269,0.0034896424,0.00014369909,0.006381624,0.0003727501,0.00012744011,0.00013500702,0.000014869304,0.0000659555],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9838551,0.014281409,0.0007012603,0.00026477902,0.0004680684,0.00042937964],"domain_scores_gemma":[0.968422,0.030135175,0.00029056516,0.0008807102,0.00021832885,0.00005322378],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029472185,0.00017138642,0.0004007834,0.0000423862,0.00059169426,0.000015511278,0.0003738566,0.000058913727,0.00014575916],"category_scores_gemma":[0.0042589917,0.000056621087,0.00021222029,0.0004998657,0.0007271546,0.00008309908,0.00012306162,0.0012160402,0.000007600614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01330102,0.0020437005,0.2102892,0.00032743096,0.0034457007,0.00009512281,0.010825406,0.004360337,0.002781848,0.15962705,0.5738239,0.0190793],"study_design_scores_gemma":[0.0038460584,0.00019479825,0.6609502,0.00028399553,0.00053806335,0.00009997715,0.0031932506,0.008848642,0.00018650503,0.0041910047,0.31748518,0.00018234413],"about_ca_topic_score_codex":0.10962813,"about_ca_topic_score_gemma":0.0006894336,"teacher_disagreement_score":0.45066097,"about_ca_system_score_codex":0.000057864007,"about_ca_system_score_gemma":0.00020373105,"threshold_uncertainty_score":0.99936265},"labels":[],"label_agreement":null},{"id":"W2076369490","doi":"10.1016/s0828-282x(10)71064-3","title":"Genomics in coronary artery disease: Past, present and future","year":2010,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Coronary artery disease; Genomics; Disease; Internal medicine; Cardiology; Genome; Gene; Genetics","score_opus":0.020279982068880514,"score_gpt":0.26961691516532893,"score_spread":0.24933693309644842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076369490","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030413995,0.9959785,0.000018898381,0.0010931483,0.0013603553,0.00059402885,0.00006791617,0.0000022745996,0.0005807367],"genre_scores_gemma":[0.00027776734,0.9724264,0.00006312135,0.00012036598,0.02696999,0.000015061171,0.00003917756,0.000041626143,0.000046468736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827784,0.00029638084,0.0006403817,0.00022591779,0.00015218939,0.0004072944],"domain_scores_gemma":[0.99758095,0.000039957587,0.00024516374,0.0004435355,0.000107017666,0.0015833718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006850936,0.0002634941,0.0024979096,0.00049875,0.000046917954,0.000015346053,0.00015342733,0.0005217662,0.000014550476],"category_scores_gemma":[0.000024922796,0.00019969817,0.0008929735,0.000114225084,0.0001424593,0.00003465923,0.000019040546,0.0013955908,0.0000045243683],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018620432,0.0000014953274,0.00084260025,0.0023937472,0.0004599553,0.006039664,0.000018656901,0.000002194769,5.758385e-8,0.000019807794,0.003920032,0.9862832],"study_design_scores_gemma":[0.00046817065,0.00010674776,0.010882867,0.0014272964,0.0011458228,0.020489596,0.000020882295,2.6875043e-7,9.50196e-9,0.000026608037,0.9652842,0.00014752784],"about_ca_topic_score_codex":0.00015208343,"about_ca_topic_score_gemma":0.00035648327,"teacher_disagreement_score":0.98613566,"about_ca_system_score_codex":0.00033808328,"about_ca_system_score_gemma":0.007376493,"threshold_uncertainty_score":0.9982508},"labels":[],"label_agreement":null},{"id":"W2076648603","doi":"10.1194/jlr.m900273-jlr200","title":"A new method for measurement of total plasma PCSK9: clinical applications","year":2009,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre; Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; Kexin; Ezetimibe; Endocrinology; Familial hypercholesterolemia; LDL receptor; Internal medicine; Chemistry; Proprotein convertase; Cholesterol; Medicine; Lipoprotein","score_opus":0.21490033170071707,"score_gpt":0.5178683211423347,"score_spread":0.3029679894416176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076648603","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06058872,0.0048160814,0.89349043,0.03131477,0.00058806967,0.004145078,0.000009422183,0.000019222653,0.0050281906],"genre_scores_gemma":[0.53152436,0.00089909876,0.45068315,0.0002932047,0.014994229,0.000054472865,0.0000026337998,0.000038112783,0.0015107674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99628973,0.00035723072,0.0008714958,0.00014579188,0.0020460873,0.00028968148],"domain_scores_gemma":[0.99654055,0.00026141782,0.0002242392,0.00035905468,0.0021576835,0.0004570662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019120231,0.00007417018,0.0005562228,0.00024813248,0.00007533163,0.000014039033,0.00014893808,0.00010972329,0.00004147752],"category_scores_gemma":[0.0011752705,0.000052451767,0.0006460817,0.00032824706,0.00003919408,0.000049233655,0.00002375752,0.0006630369,0.000005632565],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001295791,0.0005718283,0.00037096898,0.0001890215,0.00039610543,0.000010079827,0.00008033249,0.000018341376,0.010597384,0.00063408597,0.022544341,0.9632917],"study_design_scores_gemma":[0.01975201,0.020720756,0.055428095,0.0009563075,0.00055653177,0.0016133913,0.0005778773,0.000968083,0.03989442,0.002840083,0.85642695,0.00026550144],"about_ca_topic_score_codex":0.000022927572,"about_ca_topic_score_gemma":0.0000024963379,"teacher_disagreement_score":0.9630262,"about_ca_system_score_codex":0.00013649961,"about_ca_system_score_gemma":0.0018299053,"threshold_uncertainty_score":0.6626729},"labels":[],"label_agreement":null},{"id":"W2076671893","doi":"10.1002/jcb.21938","title":"HDL<sub>3</sub> reduces the association and modulates the metabolism of oxidized LDL by osteoblastic cells: A protection against cell death","year":2008,"lang":"en","type":"article","venue":"Journal of Cellular Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Association (psychology); Metabolism; Programmed cell death; Chemistry; Cell biology; Internal medicine; Biochemistry; Biology; Medicine; Apoptosis; Psychology","score_opus":0.0073128186730637415,"score_gpt":0.19200822878762216,"score_spread":0.18469541011455842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076671893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98510516,0.0133048,0.0003926159,0.0005421727,0.00013276629,0.00034062308,0.0000063778443,0.000008079916,0.00016741834],"genre_scores_gemma":[0.9965407,0.0025271373,0.00012411694,0.0000749784,0.0005022532,0.000009611741,0.0000051498064,0.000020943111,0.00019506796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826205,0.00014440097,0.0005306797,0.00015844563,0.00069908693,0.00020535798],"domain_scores_gemma":[0.9984469,0.00007107544,0.00080684863,0.00028351427,0.00027073632,0.0001209467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010299922,0.00016869743,0.00043913952,0.000042194715,0.00018724473,0.000020417148,0.00013035985,0.00017824804,0.0000028700056],"category_scores_gemma":[0.00018039769,0.00009578306,0.0003583694,0.0001651057,0.000091653405,0.000052588144,0.00003265089,0.0004743794,0.0000010217692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012494824,0.00009665544,0.00003983593,0.000168507,0.0002303814,0.000013961524,0.00019201777,0.000018003435,0.9972211,4.5879332e-7,0.00038024335,0.0015138825],"study_design_scores_gemma":[0.0014795917,0.000104536244,0.00025102406,0.000112219845,0.0003741171,0.00021482121,0.00020065965,0.00013286069,0.99636847,0.00001717598,0.0006526921,0.00009182055],"about_ca_topic_score_codex":0.000015290636,"about_ca_topic_score_gemma":2.0833679e-7,"teacher_disagreement_score":0.011435595,"about_ca_system_score_codex":0.00008765183,"about_ca_system_score_gemma":0.00022508658,"threshold_uncertainty_score":0.390592},"labels":[],"label_agreement":null},{"id":"W2076695593","doi":"10.1074/jbc.c700095200","title":"Catalytic Activity Is Not Required for Secreted PCSK9 to Reduce Low Density Lipoprotein Receptors in HepG2 Cells","year":2007,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; National Institutes of Health","keywords":"PCSK9; LDL receptor; Receptor; Chemistry; Low-density lipoprotein; Lipoprotein; Cell biology; Biochemistry; Biology; Cholesterol","score_opus":0.033142085676179,"score_gpt":0.29478302809900436,"score_spread":0.2616409424228254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076695593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662405,0.00015280336,0.0010400855,0.0012404929,0.00017852461,0.000532519,0.000011125291,0.000016335744,0.00020406989],"genre_scores_gemma":[0.9958603,0.000056785877,0.0022667148,0.00065121305,0.00094620534,0.000008625763,0.0000068252884,0.000015071752,0.0001882902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815965,0.00004217154,0.00062313874,0.00031791793,0.00040185484,0.00045526004],"domain_scores_gemma":[0.9984591,0.00011559717,0.00030158737,0.0003452381,0.0002757438,0.0005027453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023666355,0.00020113052,0.0007420143,0.0000662042,0.000053278094,0.000014344569,0.00016810205,0.00040886726,0.000054126675],"category_scores_gemma":[0.0008535074,0.00014378315,0.00048362362,0.00029053062,0.000068473906,0.000055528384,0.000055053326,0.00055674044,0.0000063756656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003055489,0.00020798366,0.0006154461,0.00025102586,0.00008342933,0.00015673439,0.0000739293,0.0000018711842,0.94981354,4.803286e-7,0.00045183362,0.045288205],"study_design_scores_gemma":[0.0017246553,0.0005655318,0.011864348,0.00023526199,0.000042991258,0.0002744257,0.00009907676,0.000009823862,0.98245496,0.00002682603,0.0025385064,0.00016362159],"about_ca_topic_score_codex":0.00009295007,"about_ca_topic_score_gemma":0.000005569599,"teacher_disagreement_score":0.045124583,"about_ca_system_score_codex":0.0003830744,"about_ca_system_score_gemma":0.00021626831,"threshold_uncertainty_score":0.58633065},"labels":[],"label_agreement":null},{"id":"W2076756427","doi":"10.1016/s0828-282x(06)70941-2","title":"Profound regression of coronary atherosclerosis with statins","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Atorvastatin; Intravascular ultrasound; Coronary artery disease; Lesion; Coronary atherosclerosis; Artery; Stenosis; Statin; Acute coronary syndrome; Myocardial infarction; Surgery","score_opus":0.01465805579926824,"score_gpt":0.23379214700500686,"score_spread":0.21913409120573862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076756427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899423,0.0016458331,0.0020102344,0.0005213696,0.00019418987,0.00020876946,0.000017903552,0.0000029025903,0.005456505],"genre_scores_gemma":[0.99812275,0.00007524429,0.00082434685,0.000088038985,0.00071494543,0.0000026538742,0.0000069649786,0.0000173582,0.00014767634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900156,0.00011000427,0.0003317621,0.00009817931,0.00020812807,0.00025039085],"domain_scores_gemma":[0.99887514,0.000022201539,0.00021204673,0.00022797275,0.00033278193,0.0003298471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043192654,0.00010222499,0.00061362784,0.00016773865,0.000055425855,0.000004409009,0.00007232096,0.00009732085,0.000019251083],"category_scores_gemma":[0.000035557852,0.000064425396,0.0002304858,0.00012024628,0.00017323116,0.000042035008,0.000004424191,0.0002071194,0.0000017532074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004917023,0.00001474941,0.95624423,0.00021775556,0.00089226157,0.0010837822,0.00020731144,0.0010297268,0.0047029415,0.00066364923,0.013704447,0.020747421],"study_design_scores_gemma":[0.0020731895,0.0015327389,0.92835766,0.00031295323,0.00024108429,0.003659807,0.000183475,0.000002587288,0.0009982014,0.00013358059,0.062409125,0.00009558684],"about_ca_topic_score_codex":0.004128755,"about_ca_topic_score_gemma":0.0022402408,"teacher_disagreement_score":0.04870468,"about_ca_system_score_codex":0.00013988673,"about_ca_system_score_gemma":0.0019273779,"threshold_uncertainty_score":0.624147},"labels":[],"label_agreement":null},{"id":"W2076775794","doi":"10.1111/j.1524-6175.2006.05636.x","title":"Efficacy and Safety of Coadministered Amlodipine and Atorvastatin in Patients With Hypertension and Dyslipidemia: Results of the AVALON Trial","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Hypertension","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Atorvastatin; Amlodipine; Medicine; Dyslipidemia; Placebo; Blood pressure; Lisinopril; Pharmacology; Internal medicine; Adverse effect; Randomized controlled trial; Angiotensin-converting enzyme; Disease","score_opus":0.035929172242855204,"score_gpt":0.3058003046269861,"score_spread":0.2698711323841309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076775794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736124,0.0006691019,0.000009444782,0.0010846638,0.00020692013,0.00062734267,0.0000079394695,0.00000225976,0.00003107862],"genre_scores_gemma":[0.9981699,0.0004969161,0.0008372789,0.0002201325,0.0002472068,5.6391247e-7,0.0000037020354,0.000012788907,0.000011495991],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99679846,0.0003636797,0.0019257179,0.00020489993,0.0005724735,0.00013476332],"domain_scores_gemma":[0.9974411,0.0006750748,0.0010218384,0.00027462604,0.00044231734,0.00014505506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002698034,0.00013298851,0.0012594797,0.00007977872,0.000041077823,0.0000049865857,0.00004786217,0.0001744249,0.0000010568907],"category_scores_gemma":[0.0019753424,0.000067146895,0.00016244977,0.00013348981,0.00023551905,0.000061833416,0.00006101324,0.00042173307,8.594892e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4940098,0.002476963,0.40231007,0.00035278336,0.0002517132,0.000102841055,0.000076371514,0.000011910969,0.0010093809,0.000021172715,0.00069594465,0.09868106],"study_design_scores_gemma":[0.16283253,0.005521367,0.82953703,0.00095448364,0.00026610473,0.00011733394,0.000025058967,0.000054488253,0.000112953625,0.000020340756,0.0004984562,0.000059827285],"about_ca_topic_score_codex":0.000095823205,"about_ca_topic_score_gemma":0.000022225342,"teacher_disagreement_score":0.427227,"about_ca_system_score_codex":0.0000132277555,"about_ca_system_score_gemma":0.00014203048,"threshold_uncertainty_score":0.2738171},"labels":[],"label_agreement":null},{"id":"W2077434204","doi":"10.1016/j.atherosclerosis.2013.12.030","title":"Chronic kidney disease on hemodialysis is associated with decreased serum PCSK9 levels","year":2014,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"PCSK9; Internal medicine; Kidney disease; Hemodialysis; Medicine; Endocrinology; Population; Cholesterol; Gastroenterology; Lipoprotein; LDL receptor","score_opus":0.021432142307020632,"score_gpt":0.24051617506113443,"score_spread":0.2190840327541138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077434204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915933,0.00017682542,0.0007602436,0.0042737783,0.000099683464,0.00077212194,0.0001789141,0.00022446299,0.0019206594],"genre_scores_gemma":[0.9884771,0.000049978145,0.00014085176,0.009436618,0.00046385432,0.00010795027,0.0000791476,0.000090556954,0.0011539068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753475,0.00019722639,0.0002786559,0.00057993445,0.00085532444,0.0005541366],"domain_scores_gemma":[0.9974231,0.00007036781,0.00013224094,0.0011396062,0.00014031965,0.0010943316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006328187,0.00032228857,0.0006404727,0.000095754236,0.00021720419,0.00004629985,0.00014360387,0.000120264536,0.00063797826],"category_scores_gemma":[0.00042304312,0.00024124725,0.00046765668,0.00042534037,0.000086086475,0.00007462358,0.000033810764,0.00023539539,0.00028385324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002467061,0.004261931,0.6306286,0.0016065586,0.010247722,0.00013163603,0.0013840789,0.0002910232,0.025587844,0.0013949259,0.029130543,0.2928681],"study_design_scores_gemma":[0.009011552,0.0012322494,0.9583709,0.0012046023,0.0012656895,0.000003707828,0.000021166366,0.0010140088,0.011155127,0.00008764427,0.016121708,0.00051159423],"about_ca_topic_score_codex":0.00020934692,"about_ca_topic_score_gemma":0.000025135007,"teacher_disagreement_score":0.3277424,"about_ca_system_score_codex":0.00039585246,"about_ca_system_score_gemma":0.000494973,"threshold_uncertainty_score":0.98377776},"labels":[],"label_agreement":null},{"id":"W2077518579","doi":"10.1016/j.amjmed.2005.09.005","title":"What impact will current trial data have on future guideline recommendations?","year":2005,"lang":"en","type":"article","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pravastatin; Guideline; Myocardial infarction; Intensive care medicine; Canadian Cardiovascular Society; Atorvastatin; Clinical trial; Disease; Risk assessment; Internal medicine; Cholesterol; Pathology; Angina","score_opus":0.060185414539153,"score_gpt":0.42015340334866713,"score_spread":0.35996798880951414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077518579","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25735548,0.024951804,0.0013361088,0.71163887,0.0036939126,0.0007906169,0.000021505635,0.000021215512,0.00019048601],"genre_scores_gemma":[0.7553785,0.09046729,0.0028653857,0.030515755,0.12022407,0.000009466307,0.00024808687,0.00008378705,0.00020764813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715596,0.00035076184,0.000980054,0.0002001511,0.00104572,0.00026735826],"domain_scores_gemma":[0.99687845,0.00013453169,0.00096190535,0.0013361968,0.00033614237,0.00035280164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047771516,0.0002003194,0.0009190966,0.00018386822,0.00009750547,0.000021855958,0.0005003938,0.000027176087,0.00038769317],"category_scores_gemma":[0.00043168612,0.0000911946,0.00027024272,0.00029992597,0.00028276475,0.00036374835,0.00006936238,0.0007780728,0.000012247278],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010293056,0.00014854307,0.000034745295,0.0000070260376,0.0002757716,0.000013639686,0.00029948424,0.000020855688,0.000024391122,0.0000106919515,0.16206282,0.826809],"study_design_scores_gemma":[0.03663287,0.010372379,0.0011657532,0.00086218806,0.0006367461,0.0013246253,0.0041259117,0.00030762932,0.000021160658,0.000054281827,0.9443776,0.000118862445],"about_ca_topic_score_codex":0.000079516874,"about_ca_topic_score_gemma":0.000010256779,"teacher_disagreement_score":0.82669014,"about_ca_system_score_codex":0.00018683591,"about_ca_system_score_gemma":0.00035891388,"threshold_uncertainty_score":0.42449683},"labels":[],"label_agreement":null},{"id":"W2077542093","doi":"10.1016/j.ddmec.2004.09.006","title":"How more effective diagnosis of familial combined hyperlipidemia could lead to more effective therapy","year":2004,"lang":"en","type":"article","venue":"Drug Discovery Today Disease Mechanisms","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Very low-density lipoprotein; Hyperlipidemia; Lipoprotein; Apolipoprotein B; Abnormality; Familial hypercholesterolemia; Internal medicine; Medicine; Triglyceride; Cholesterol; Endocrinology; Diabetes mellitus","score_opus":0.008583668148935306,"score_gpt":0.2573658034514275,"score_spread":0.2487821353024922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077542093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682384,0.0020288806,0.014050071,0.006673729,0.00066632405,0.0076454566,0.00046408057,0.00015488757,0.000078134064],"genre_scores_gemma":[0.99151206,0.000396362,0.000564077,0.0034536757,0.0004174332,0.0030441668,0.00018154619,0.00012311526,0.00030753497],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99631274,0.00029019263,0.000422395,0.00095147407,0.0013241142,0.0006990644],"domain_scores_gemma":[0.99727553,0.00021452669,0.00017987487,0.0012230425,0.00025477415,0.0008522535],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006343165,0.0006116682,0.0013255076,0.00024104088,0.00019163649,0.000084398554,0.00027823518,0.0001862586,0.000017401047],"category_scores_gemma":[0.00044457387,0.00048564735,0.001339199,0.00055668026,0.00015632309,0.00040703188,0.00013748214,0.00039907757,0.000023016639],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072702244,0.024277816,0.048810773,0.010664929,0.017035967,0.0051111137,0.020317946,0.015539249,0.16248913,0.07676483,0.0059212325,0.5403648],"study_design_scores_gemma":[0.043140635,0.0069536963,0.2803443,0.0034406383,0.003053997,0.000052008738,0.0055718175,0.0004443528,0.6389748,0.012904717,0.0026161002,0.002502963],"about_ca_topic_score_codex":0.0007054883,"about_ca_topic_score_gemma":0.000020210671,"teacher_disagreement_score":0.5378618,"about_ca_system_score_codex":0.0004797954,"about_ca_system_score_gemma":0.00044258984,"threshold_uncertainty_score":0.9997595},"labels":[],"label_agreement":null},{"id":"W2077682985","doi":"10.1016/j.jpeds.2013.09.050","title":"Improving Recognition of Cardiovascular Risk in Children","year":2013,"lang":"en","type":"letter","venue":"The Journal of Pediatrics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institute of General Medical Sciences","keywords":"Medicine; Hypertriglyceridemia; Dyslipidemia; Apolipoprotein B; Internal medicine; Cholesterol; Scopus; National Cholesterol Education Program; Lipoprotein; Endocrinology; Metabolic syndrome; MEDLINE; Triglyceride; Obesity","score_opus":0.01127885784916781,"score_gpt":0.21408038187579362,"score_spread":0.2028015240266258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077682985","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8705802,0.09920586,0.0017705038,0.025302976,0.00097164785,0.0018508317,0.00009074643,0.000016445223,0.00021076723],"genre_scores_gemma":[0.22696266,0.44069737,0.007710462,0.12328406,0.19985962,0.000050751165,0.00035001323,0.0006306209,0.00045443527],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99659806,0.000600748,0.00095297006,0.00014520936,0.0013984897,0.00030454612],"domain_scores_gemma":[0.99720955,0.0001383139,0.0013032976,0.00070645,0.0005625357,0.00007984049],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0042801322,0.00022932538,0.0011250246,0.0004885709,0.000044668785,0.000012969451,0.0002693588,0.00053803134,0.000028008417],"category_scores_gemma":[0.00048591988,0.00014255525,0.001321566,0.00038422618,0.000049116967,0.00009230265,0.000055002376,0.003480733,0.00001643892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000250782,0.00021249536,0.02884499,0.0050690332,0.0035518848,0.0006021244,0.00057579164,0.0003584821,0.000025460757,3.9266507e-7,0.5406249,0.41988367],"study_design_scores_gemma":[0.044755228,0.009090214,0.3832383,0.0036493747,0.20965938,0.032645106,0.0010126876,0.0001705303,0.0013296362,0.0020808766,0.3082745,0.0040941606],"about_ca_topic_score_codex":0.0024621887,"about_ca_topic_score_gemma":0.0000022503948,"teacher_disagreement_score":0.6436176,"about_ca_system_score_codex":0.00015342514,"about_ca_system_score_gemma":0.00046294238,"threshold_uncertainty_score":0.9988183},"labels":[],"label_agreement":null},{"id":"W2077876793","doi":"10.1016/j.clinbiochem.2004.03.008","title":"Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with β-quantification in a large population","year":2004,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université Laval; Heart and Stroke Foundation of Canada","keywords":"Chemistry; Triglyceride; Cholesterol; Internal medicine; Lipoprotein; Quartile; Population; Ldl cholesterol; Endocrinology; Medicine; Confidence interval; Biochemistry","score_opus":0.031052692566150196,"score_gpt":0.33382851476714187,"score_spread":0.3027758222009917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077876793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98650044,0.00006261933,0.011307277,0.0008096316,0.000053076754,0.0012220254,0.000016829797,0.000009104627,0.000018978519],"genre_scores_gemma":[0.998807,0.0000156211,0.00081604655,0.00008189706,0.00010350735,0.000059841692,0.00009113588,0.000009898798,0.000015056936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987276,0.00004878167,0.0005988724,0.00021286315,0.0002946281,0.000117231946],"domain_scores_gemma":[0.99867964,0.000094882766,0.00036163817,0.0006190647,0.00020649306,0.000038283724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001222272,0.000088220535,0.0002939348,0.000019290741,0.00005959687,0.0000063421608,0.00010826488,0.00014790797,0.0000016466965],"category_scores_gemma":[0.00044185456,0.000051213046,0.00021084986,0.00015637749,0.00008638048,0.000037834976,0.00002587142,0.00015655301,3.7004256e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00599007,0.0058022793,0.35236317,0.009472901,0.0005190804,0.00000597226,0.0010939661,0.0008197843,0.35423368,0.0009099565,0.000058395242,0.26873076],"study_design_scores_gemma":[0.0031334076,0.00010405611,0.4010163,0.00039274985,0.00008748579,0.000005489521,0.0000821015,0.0005101913,0.5944593,0.0001398585,0.000016375583,0.00005267169],"about_ca_topic_score_codex":0.0002249347,"about_ca_topic_score_gemma":0.00007576504,"teacher_disagreement_score":0.2686781,"about_ca_system_score_codex":0.000059654427,"about_ca_system_score_gemma":0.00011908946,"threshold_uncertainty_score":0.20884074},"labels":[],"label_agreement":null},{"id":"W2078119823","doi":"10.1016/j.jclinepi.2012.02.019","title":"A survey of physicians show a one-third reduction in harmful outcomes to be a clinically important difference for statin therapy","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Epidemiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; St. Joseph's Hospital; McMaster University","funders":"Ministerul Cercetării, Inovării şi Digitalizării; McMaster University","keywords":"Medicine; Minimal clinically important difference; Statin; Physical therapy; Myocardial infarction; Internal medicine; Revascularization; Emergency medicine; Intensive care medicine; Randomized controlled trial","score_opus":0.40530651812770707,"score_gpt":0.5264035812660307,"score_spread":0.12109706313832364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078119823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97036254,0.0010285877,0.009130373,0.017679185,0.0009911599,0.000754652,0.000027894477,0.0000063606544,0.000019241159],"genre_scores_gemma":[0.96534574,0.0040434264,0.01888138,0.010583481,0.0010469633,0.000026737758,0.000009488041,0.000022271155,0.00004051619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98724437,0.004217713,0.007411198,0.00026613154,0.0003405117,0.00052009034],"domain_scores_gemma":[0.9792216,0.015637897,0.0035691166,0.0004663168,0.0006676521,0.0004374178],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0777198,0.00018126008,0.004406083,0.00020202417,0.000024216737,0.0000023965997,0.00018155976,0.00033973408,0.000015840937],"category_scores_gemma":[0.08473557,0.000120759985,0.0013252094,0.0002727646,0.00015047399,0.00007009545,0.000034456905,0.00086747285,0.0000015514912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003826883,0.0013130858,0.90771663,0.000060620125,0.00043950428,0.000003512805,0.00017455236,0.000008004392,0.00016315887,0.00012695808,0.0011776299,0.084989436],"study_design_scores_gemma":[0.0042195227,0.004829928,0.9882344,0.0001596698,0.000099750905,0.0000349548,0.00008217861,0.00007251067,0.0000389751,0.0007178907,0.0014074317,0.00010278914],"about_ca_topic_score_codex":0.00052281516,"about_ca_topic_score_gemma":0.00012628095,"teacher_disagreement_score":0.08488665,"about_ca_system_score_codex":0.000041577005,"about_ca_system_score_gemma":0.00042008064,"threshold_uncertainty_score":0.9496816},"labels":[],"label_agreement":null},{"id":"W2078480719","doi":"10.2217/clp.09.64","title":"Lipid-altering gene variants and cardiovascular risk in the older population","year":2009,"lang":"en","type":"article","venue":"Clinical Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Single-nucleotide polymorphism; SNP; Triglyceride; Internal medicine; Genome-wide association study; Quartile; Population; Endocrinology; Biology; Allele; Medicine; Genotype; Genetics; Cholesterol; Gene","score_opus":0.0421610341525381,"score_gpt":0.34559409933595586,"score_spread":0.3034330651834178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078480719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923028,0.0025654314,0.0013755236,0.0015983379,0.0010035142,0.0006357726,0.000002525337,0.000035089706,0.00048105133],"genre_scores_gemma":[0.98872,0.002092002,0.0011267887,0.0031199052,0.0048814807,0.000014929868,0.000015009268,0.000011995883,0.00001786303],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973922,0.000996897,0.00059786066,0.00044422987,0.00026173476,0.00030708703],"domain_scores_gemma":[0.99869,0.00023759702,0.0000819268,0.00082681456,0.000036735706,0.0001269124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049377577,0.00013731819,0.0007141976,0.00006962247,0.000085457534,0.000014160239,0.000103299644,0.00026420312,0.000018746054],"category_scores_gemma":[0.0008991131,0.0000921747,0.00045688573,0.00016890904,0.00007363668,0.00004720838,0.000035540965,0.0005549432,0.00001473217],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021835961,0.00034364357,0.33169207,0.00005814081,0.00040770337,0.0000741015,0.0002698661,0.00006149332,0.00004926992,0.00051146036,0.0005241508,0.6657897],"study_design_scores_gemma":[0.0023142362,0.00048036705,0.987722,0.000032296724,0.00024365792,0.00026128447,0.000039714858,0.0001570176,0.00000561096,0.00053001544,0.008116654,0.00009718845],"about_ca_topic_score_codex":0.00029762625,"about_ca_topic_score_gemma":0.000021694575,"teacher_disagreement_score":0.66569257,"about_ca_system_score_codex":0.000020104037,"about_ca_system_score_gemma":0.000039724393,"threshold_uncertainty_score":0.3758775},"labels":[],"label_agreement":null},{"id":"W2078524991","doi":"10.1053/meta.2001.19452","title":"Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins","year":2001,"lang":"en","type":"article","venue":"Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Very low-density lipoprotein; Apolipoprotein B; Internal medicine; Intermediate-density lipoprotein; Lipoprotein; Endocrinology; Cholesterol; Triglyceride; Chemistry; Apolipoprotein E; High-density lipoprotein; Apolipoprotein C2; Lipoprotein particle; Biology; Medicine","score_opus":0.022250631851636178,"score_gpt":0.26812664615719684,"score_spread":0.24587601430556066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078524991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856811,0.0064624143,0.0013392216,0.0025818108,0.00015568828,0.0034060343,0.000050956645,0.000031123844,0.0002916438],"genre_scores_gemma":[0.99729025,0.0008203436,0.00059141364,0.00007051133,0.00032614192,0.0003478981,0.000027579214,0.000029932782,0.0004959185],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99705446,0.00029520915,0.00088187755,0.00044431302,0.00086682977,0.00045728713],"domain_scores_gemma":[0.998224,0.00010552396,0.00026528773,0.00089637574,0.0002809104,0.00022790428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020842336,0.00025422082,0.00085164874,0.00024324328,0.0001189611,0.000015579102,0.00022453655,0.0001921264,0.000027694436],"category_scores_gemma":[0.001208046,0.00017867201,0.0001945099,0.0013934006,0.00010115806,0.00014685774,0.00013363014,0.00041653952,0.0000130659655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009286487,0.002147215,0.044160645,0.0026985386,0.00090406893,0.00026190473,0.011618683,0.0015670174,0.058437627,0.07684128,0.0010666345,0.7910099],"study_design_scores_gemma":[0.006891311,0.0005618058,0.83764774,0.000791964,0.00036034887,0.00030512718,0.0005598081,0.0013802028,0.09351116,0.0008097775,0.056710552,0.00047023845],"about_ca_topic_score_codex":0.0044181487,"about_ca_topic_score_gemma":0.0005663823,"teacher_disagreement_score":0.7934871,"about_ca_system_score_codex":0.00006503988,"about_ca_system_score_gemma":0.00019973189,"threshold_uncertainty_score":0.7286033},"labels":[],"label_agreement":null},{"id":"W2078626644","doi":"10.1155/2013/146579","title":"Comparison of Efficacy and Safety of Rosuvastatin, Atorvastatin and Pravastatin among Dyslipidemic Diabetic Patients","year":2013,"lang":"en","type":"article","venue":"ISRN Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Queen's University; Queen's University Belfast; Hamad Medical Corporation","keywords":"Rosuvastatin; Pravastatin; Atorvastatin; Medicine; Internal medicine; Pharmacology; Cholesterol","score_opus":0.01431034864734134,"score_gpt":0.32277401977558257,"score_spread":0.30846367112824125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078626644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997101,0.0007488499,0.00015485288,0.0001839831,0.00014912897,0.0014466163,0.000023329441,0.000018485402,0.00017374026],"genre_scores_gemma":[0.9982556,0.00019074274,0.0011447122,0.00021269286,0.00006261692,0.00005446568,0.000023035016,0.000020254289,0.00003589682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982648,0.00024600764,0.0006710525,0.00026812076,0.00025165145,0.0002983824],"domain_scores_gemma":[0.99877036,0.0002760146,0.00032724105,0.00017707588,0.00023243163,0.00021688375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041332832,0.00016229773,0.00080330455,0.00010219188,0.00004755987,0.0000044518856,0.00005600193,0.000090237256,0.00019689818],"category_scores_gemma":[0.00012538071,0.00014030377,0.00006853736,0.00013128853,0.00032579445,0.000075187585,0.00007825022,0.00022414402,0.000005925228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026093103,0.00046054175,0.8774311,0.000820145,0.0003261559,0.000002290512,0.001131709,0.000012459982,0.033019666,0.000040693812,0.0018003033,0.08469402],"study_design_scores_gemma":[0.0074154506,0.00091254193,0.97214174,0.000089861234,0.00029682074,0.0000044576177,0.0002460354,0.00062972854,0.017569035,0.00002637633,0.00054999837,0.00011792531],"about_ca_topic_score_codex":0.0003109951,"about_ca_topic_score_gemma":0.0000117950785,"teacher_disagreement_score":0.094710685,"about_ca_system_score_codex":0.000027069384,"about_ca_system_score_gemma":0.00007379883,"threshold_uncertainty_score":0.5721422},"labels":[],"label_agreement":null},{"id":"W2078768557","doi":"10.1016/j.clinbiochem.2014.04.023","title":"Marked effects of extreme levels of lipoprotein(a) on estimation of low-density lipoprotein cholesterol","year":2014,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of British Columbia; Providence Health Care","funders":"","keywords":"Lipoprotein; Internal medicine; Endocrinology; Lipoprotein(a); Chemistry; Low-density lipoprotein; Cholesterol; Ldl cholesterol; Medicine","score_opus":0.026289373879789486,"score_gpt":0.30992894576302243,"score_spread":0.28363957188323297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078768557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956798,0.0001851194,0.0021730438,0.00015754752,0.00014373158,0.0008233798,0.000014576738,0.000030081228,0.0007927531],"genre_scores_gemma":[0.997053,0.00003296222,0.0021945676,0.0001544156,0.000343327,0.000025014215,0.000019470128,0.000026662236,0.00015052629],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972292,0.00020924688,0.0011833821,0.0004627662,0.0006843889,0.0002309985],"domain_scores_gemma":[0.99711424,0.00039753667,0.0006262836,0.0013544587,0.00027367027,0.00023382553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001972554,0.00022189577,0.0011261496,0.000052738815,0.000026618576,0.000003847654,0.00017782475,0.0004419546,0.000035988305],"category_scores_gemma":[0.004143913,0.00019053249,0.00063898927,0.00017622088,0.00031780766,0.000028460918,0.00008020341,0.0003842783,0.000009247419],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008850283,0.0012875731,0.0018719817,0.012884801,0.0003220616,0.000008850706,0.000032021082,0.000012856051,0.34960973,0.000038755206,0.00010502514,0.6329413],"study_design_scores_gemma":[0.0030722339,0.0009798022,0.1327411,0.002144764,0.00015410187,0.000008867857,0.0000071317004,0.00034823403,0.8602725,0.00010953683,0.000032647775,0.00012908144],"about_ca_topic_score_codex":0.00012375518,"about_ca_topic_score_gemma":0.0000018743796,"teacher_disagreement_score":0.6328122,"about_ca_system_score_codex":0.000034517765,"about_ca_system_score_gemma":0.00015911032,"threshold_uncertainty_score":0.77696896},"labels":[],"label_agreement":null},{"id":"W2078872459","doi":"10.1111/j.1600-0404.2006.00688.x","title":"Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease","year":2006,"lang":"en","type":"review","venue":"Acta Neurologica Scandinavica","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research; Dalhousie Medical Research Foundation","keywords":"Observational study; Dementia; Confounding; Epidemiology; Medicine; Disease; Clinical trial; Alzheimer's disease; Intensive care medicine; Psychology; Psychiatry; Internal medicine","score_opus":0.2772907918783111,"score_gpt":0.498824549440296,"score_spread":0.22153375756198485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078872459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012985795,0.9869479,0.000051252708,0.00094682275,0.00020704785,0.010060241,0.00028290154,0.00008214282,0.0001230957],"genre_scores_gemma":[0.005981896,0.9893256,0.0004861347,0.0009082537,0.00089565426,0.002008678,0.000263847,0.00006830152,0.0000616578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9862438,0.007645559,0.0031674427,0.001676585,0.00043337623,0.00083323155],"domain_scores_gemma":[0.9845524,0.012243006,0.0013407224,0.0010169327,0.00009976721,0.000747185],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.014774618,0.0007641151,0.007701982,0.00021052403,0.00014346068,0.00005094132,0.00035188886,0.0009015947,0.00004868208],"category_scores_gemma":[0.021084653,0.00046116076,0.0031386826,0.00034760262,0.00032419444,0.000101745354,0.00024331638,0.0013496698,0.000009356748],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010449403,0.00045019272,0.0041686296,0.0040788963,0.00058956345,0.0002977344,0.0000064349265,3.3437766e-7,1.7691166e-7,0.00007864165,0.0016006245,0.98768383],"study_design_scores_gemma":[0.0018161308,0.0026402057,0.05660932,0.008506599,0.010028539,0.00012985777,0.0000041967965,0.00005265304,7.3372235e-8,0.0005720469,0.91915524,0.000485141],"about_ca_topic_score_codex":0.00013715666,"about_ca_topic_score_gemma":0.000020959093,"teacher_disagreement_score":0.9871987,"about_ca_system_score_codex":0.00008373787,"about_ca_system_score_gemma":0.0006855135,"threshold_uncertainty_score":0.999784},"labels":[],"label_agreement":null},{"id":"W2078894409","doi":"10.1007/s11897-004-0003-x","title":"Do statins prevent heart failure in patients after myocardial infarction?","year":2004,"lang":"en","type":"review","venue":"Current Heart Failure Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Cardiology; Myocardial infarction; Internal medicine; Coronary artery disease; Simvastatin; Heart failure; Ventricular remodeling; Statin; Dyslipidemia; Disease","score_opus":0.01825134359177577,"score_gpt":0.3175003461796219,"score_spread":0.29924900258784615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078894409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015780241,0.9885614,0.000017918534,0.00045080684,0.0021379075,0.007004903,0.00008101453,0.00012929928,0.000038718543],"genre_scores_gemma":[0.004743081,0.9883188,0.0011659723,0.00012583566,0.0020411373,0.001928405,0.0013566486,0.00025157913,0.00006852166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927424,0.00047176972,0.0023753222,0.0015371364,0.0018657092,0.0010076445],"domain_scores_gemma":[0.99622554,0.000037901835,0.00065137655,0.002066125,0.0003322562,0.0006868006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013182801,0.0010076904,0.004027818,0.0006392628,0.0001224552,0.00009811833,0.00011469574,0.00072132156,0.00025089542],"category_scores_gemma":[0.00020887691,0.00082403957,0.0026875725,0.0008563703,0.00009071786,0.00020081272,0.00019296522,0.0019738018,0.00016291716],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059282018,0.0021162264,0.04193107,0.07904597,0.0010151732,0.0006498092,0.00019373669,0.000008232779,1.326658e-7,0.000013162356,0.03321834,0.84174883],"study_design_scores_gemma":[0.00093487574,0.00025074327,0.010132573,0.04043457,0.0011151686,0.0010554763,0.000012167324,1.15760386e-7,4.6485448e-7,0.00003127151,0.9453802,0.0006523365],"about_ca_topic_score_codex":0.00013701065,"about_ca_topic_score_gemma":0.00006201216,"teacher_disagreement_score":0.9121619,"about_ca_system_score_codex":0.0013081431,"about_ca_system_score_gemma":0.0031506089,"threshold_uncertainty_score":0.99942106},"labels":[],"label_agreement":null},{"id":"W2079102359","doi":"10.1016/j.jacl.2011.05.004","title":"Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement","year":2011,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Medicine; Reliability (semiconductor); Cholesterol; Lipoprotein; Apolipoprotein C2; Internal medicine; High-density lipoprotein; Endocrinology; Very low-density lipoprotein","score_opus":0.10932544190154245,"score_gpt":0.382787442917427,"score_spread":0.2734620010158846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079102359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10624868,0.8789832,0.0010363334,0.0004857074,0.0062178364,0.0066657197,0.00005256702,0.00006735932,0.00024262829],"genre_scores_gemma":[0.041213587,0.9429147,0.0036304162,0.0004923302,0.011314717,0.00010433803,0.00001876448,0.00020110024,0.000109994086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98103505,0.004139256,0.009766889,0.0015488627,0.0023883805,0.0011215736],"domain_scores_gemma":[0.9836138,0.00064568984,0.008204986,0.003023838,0.0029239806,0.0015877379],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.027626162,0.0013627278,0.015023499,0.0006898358,0.00017608801,0.00004983839,0.00096435903,0.0030577106,0.00011151517],"category_scores_gemma":[0.0079149585,0.000978268,0.005219223,0.00054542674,0.0012736936,0.00030741643,0.0006874495,0.005659027,0.00006352794],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012553873,0.0015068742,0.00028127572,0.031639557,0.0019123502,0.000086503365,0.000065786226,4.06648e-7,0.000026371756,0.00003465206,0.00041485045,0.962776],"study_design_scores_gemma":[0.016090369,0.015784457,0.13086618,0.07153944,0.014012344,0.0068612825,0.00006128743,0.0000055027285,0.0006185586,0.0013139368,0.7408543,0.0019923216],"about_ca_topic_score_codex":0.005041089,"about_ca_topic_score_gemma":0.0005815685,"teacher_disagreement_score":0.96078366,"about_ca_system_score_codex":0.00042149378,"about_ca_system_score_gemma":0.0030782132,"threshold_uncertainty_score":0.9999124},"labels":[],"label_agreement":null},{"id":"W2079134517","doi":"10.1111/j.1365-2125.2005.02355.x","title":"Persistence and determinants of statin therapy among middle‐aged patients for primary and secondary prevention","year":2005,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Social Sciences and Humanities Research Council of Canada; Canadian Institutes of Health Research","keywords":"Medicine; Cohort; Statin; Proportional hazards model; Hazard ratio; Internal medicine; Persistence (discontinuity); Medical prescription; Cohort study; Pharmacology; Confidence interval","score_opus":0.06394352163721083,"score_gpt":0.38344855217609464,"score_spread":0.3195050305388838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079134517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156815,0.0073223277,0.00008083568,0.000114253744,0.00029647304,0.0005397202,0.00001675743,0.000002908463,0.000058566628],"genre_scores_gemma":[0.9832154,0.012413638,0.0026942205,0.0009929646,0.00059721177,0.000007826699,0.0000038311146,0.000011476057,0.00006343425],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99825317,0.00027024883,0.0009967582,0.0001457838,0.00018760336,0.00014645253],"domain_scores_gemma":[0.998687,0.00024147672,0.0005578837,0.000053548833,0.00026592487,0.0001941333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019067989,0.00007297919,0.0006592781,0.000042422806,0.00005222707,0.000008002694,0.000052623673,0.000104512335,0.00004336339],"category_scores_gemma":[0.00020843302,0.00007032214,0.00027024985,0.000032143078,0.0001962719,0.00014091002,0.000023119874,0.00032082488,1.5562021e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011486484,0.00049957144,0.11566903,0.00025910477,0.00020450787,0.000038054382,0.00005654856,5.1412405e-7,0.00024962064,2.1044146e-7,0.0011159906,0.8807582],"study_design_scores_gemma":[0.017578688,0.0029279815,0.97454125,0.000289419,0.00022625361,0.0005798775,0.00003863143,0.000042222946,0.0005794208,0.000029061068,0.0031022455,0.00006492588],"about_ca_topic_score_codex":0.000010785403,"about_ca_topic_score_gemma":0.000017514201,"teacher_disagreement_score":0.88069326,"about_ca_system_score_codex":0.000017327042,"about_ca_system_score_gemma":0.0001913631,"threshold_uncertainty_score":0.28676537},"labels":[],"label_agreement":null},{"id":"W2079422707","doi":"10.1016/j.accreview.2005.04.005","title":"Statin Use and Survival Outcomes in Elderly Patients With Heart Failure","year":2005,"lang":"en","type":"article","venue":"ACC Current Journal Review","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Hazard ratio; Heart failure; Myocardial infarction; Internal medicine; Cardiology; Ejection fraction; Coronary artery disease; Stroke (engine); Statin; Retrospective cohort study; Population; Confidence interval; Cause of death; Cohort; Disease","score_opus":0.030482993774085348,"score_gpt":0.32254612415556766,"score_spread":0.2920631303814823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079422707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82829493,0.1638154,0.00005647779,0.006888372,0.00012238113,0.0007930246,0.000005892627,0.000009719257,0.000013805247],"genre_scores_gemma":[0.6049339,0.38769034,0.0038695878,0.0028405215,0.00047569792,0.000039911472,0.000031271826,0.00005270631,0.00006602781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842006,0.00016362971,0.00043372746,0.0001637514,0.0005709078,0.0002479411],"domain_scores_gemma":[0.9992083,0.000042367752,0.00012854207,0.00023238325,0.00014122119,0.00024720782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007860275,0.00015560674,0.00069154816,0.00006867363,0.000055740093,0.000046554418,0.00005126266,0.000027297874,0.00007768741],"category_scores_gemma":[0.00021462531,0.00009179538,0.00015206875,0.00015116387,0.00001851285,0.00028797606,0.000022495664,0.00047557673,0.000015228453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017066917,0.00014239733,0.6699629,0.0009356245,0.000039666935,0.0000055689648,0.000020203375,2.9373788e-7,3.3095196e-7,0.000010738145,0.0016763278,0.32718888],"study_design_scores_gemma":[0.0019071783,0.00022118111,0.5840551,0.0055054706,0.000121601886,0.00008360035,0.000007080691,0.0000010002254,9.906273e-7,0.0000057700427,0.40799516,0.000095820455],"about_ca_topic_score_codex":0.000021963158,"about_ca_topic_score_gemma":0.00008488546,"teacher_disagreement_score":0.40631884,"about_ca_system_score_codex":0.0000712933,"about_ca_system_score_gemma":0.00012234501,"threshold_uncertainty_score":0.3743307},"labels":[],"label_agreement":null},{"id":"W2079438318","doi":"10.1016/j.amjcard.2004.09.012","title":"Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease","year":2005,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; McMaster University; Pfizer (Canada); Queen Elizabeth II Health Sciences Centre; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Vancouver General Hospital; Jewish General Hospital; Libin Cardiovascular Institute of Alberta; McGill University; McGill University Health Centre","funders":"","keywords":"Amlodipine; Atorvastatin; Medicine; Blood pressure; Aspirin; Internal medicine; Cholesterol; Placebo; Coronary artery disease; Statin; High-density lipoprotein; Cardiology; Endocrinology; Pharmacology","score_opus":0.006059544943594858,"score_gpt":0.22992239191251224,"score_spread":0.22386284696891737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079438318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325895,0.0012336009,0.00027262748,0.0047855563,0.000035774672,0.0003347506,0.0000051862553,0.0000074797645,0.000066061126],"genre_scores_gemma":[0.9971117,0.00013917463,0.0013535707,0.0010557642,0.000300564,0.000005831698,0.0000068414015,0.000018574694,0.000007994292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985549,0.00052338437,0.00027573056,0.0001409796,0.00029895885,0.00020606443],"domain_scores_gemma":[0.9990564,0.00007072561,0.00029592073,0.00024500908,0.00015827826,0.00017368032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076837477,0.00012726596,0.0006589427,0.00009634295,0.000060622348,0.0000073398364,0.00007012956,0.000020491105,0.0000029577138],"category_scores_gemma":[0.000054310334,0.00006963831,0.0000831906,0.00013175776,0.0001793387,0.00008814571,0.00002278306,0.00036163957,5.0306096e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007091682,0.0001760665,0.92987984,0.00004013902,0.0010534695,0.000084077226,0.00040793294,0.00067578454,0.000033339995,0.000025541085,0.00026087076,0.060271263],"study_design_scores_gemma":[0.00509638,0.004642057,0.98510957,0.000103212486,0.00069476524,0.00071086374,0.000198496,0.000020465279,0.00001032408,0.00002238581,0.0033020421,0.00008941089],"about_ca_topic_score_codex":0.000029537585,"about_ca_topic_score_gemma":0.0000033086974,"teacher_disagreement_score":0.060181852,"about_ca_system_score_codex":0.000032640568,"about_ca_system_score_gemma":0.0001368426,"threshold_uncertainty_score":0.28397676},"labels":[],"label_agreement":null},{"id":"W2079884939","doi":"10.1016/s1388-1981(00)00023-8","title":"Analysis of low-density lipoprotein catabolism by primary cultures of hepatic cells from normal and low-density lipoprotein receptor knockout mice","year":2000,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"Medical Research Council; Natural Sciences and Engineering Research Council of Canada","keywords":"LDL receptor; Hepatocyte; Catabolism; Low-density lipoprotein; Lipoprotein; Chemistry; Receptor; Knockout mouse; Familial hypercholesterolemia; Internal medicine; Endocrinology; Biochemistry; Biology; Cholesterol; Metabolism; In vitro; Medicine","score_opus":0.003423940519925158,"score_gpt":0.2126102200235384,"score_spread":0.20918627950361326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079884939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941573,0.0034615188,0.00007410457,0.00029068542,0.00009060706,0.0008996197,0.0007276221,0.000034885445,0.00026365928],"genre_scores_gemma":[0.99396485,0.0030995896,0.0011079382,0.00050193607,0.00016530916,0.000024543535,0.0010066072,0.000042441003,0.000086801076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967474,0.00048085046,0.00092424056,0.00091120676,0.0004609221,0.0004753934],"domain_scores_gemma":[0.9978547,0.00007719785,0.00053013547,0.0009971701,0.00022589782,0.0003148873],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046390772,0.000524844,0.0020277745,0.00024951578,0.00010239312,0.000015321517,0.0002722487,0.00054674695,0.00008225092],"category_scores_gemma":[0.00003344225,0.0004494889,0.0007551198,0.0006204686,0.00091036165,0.00008286688,0.00018746851,0.00041414332,0.000005160839],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007654786,0.0006543652,0.00011433187,0.00075973733,0.0018716969,0.000005173091,0.0005997475,0.0000022625466,0.9856937,0.000010399144,0.00014594513,0.009377182],"study_design_scores_gemma":[0.0017514845,0.0006651432,0.01663067,0.00017473247,0.0022822248,0.000004386133,0.00009379619,0.00007013945,0.97764045,0.000031694268,0.0002571509,0.00039812207],"about_ca_topic_score_codex":0.008635642,"about_ca_topic_score_gemma":0.00005840838,"teacher_disagreement_score":0.016516337,"about_ca_system_score_codex":0.00003413656,"about_ca_system_score_gemma":0.00016773977,"threshold_uncertainty_score":0.9997957},"labels":[],"label_agreement":null},{"id":"W2080443045","doi":"10.1074/jbc.m114.611988","title":"Lipoprotein(a) Catabolism Is Regulated by Proprotein Convertase Subtilisin/Kexin Type 9 through the Low Density Lipoprotein Receptor","year":2015,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Ontario Ministry of Research and Innovation; Fondation Leducq; Canadian Institutes of Health Research; Sanofi; University of Ottawa; Heart and Stroke Foundation of Canada","keywords":"Kexin; Proprotein convertase; Subtilisin; LDL receptor; Catabolism; PCSK9; Lipoprotein; Endocrinology; Chemistry; Internal medicine; Low-density lipoprotein; Low-density lipoprotein receptor-related protein 8; Biochemistry; Medicine; Very low-density lipoprotein; Cholesterol; Metabolism; Enzyme","score_opus":0.031051568423443258,"score_gpt":0.26892930878382487,"score_spread":0.23787774036038162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080443045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98306316,0.009424963,0.00016634953,0.0055135987,0.00028794736,0.00089422223,0.000038045822,0.00005496583,0.00055672036],"genre_scores_gemma":[0.99321556,0.0006648293,0.0012993633,0.0017125347,0.0017863453,0.000025166248,0.0000755782,0.000038537863,0.0011820908],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99681646,0.00022185693,0.0009185606,0.00044065205,0.0010643909,0.0005380845],"domain_scores_gemma":[0.99665356,0.000047274392,0.00064389524,0.00086830324,0.0011613747,0.00062562205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017172394,0.00038690868,0.0009863074,0.00002560103,0.000153812,0.00005477294,0.00044286417,0.0006323746,0.00043818326],"category_scores_gemma":[0.0013035499,0.00021013604,0.0005125004,0.00036498578,0.00038825968,0.00013663394,0.00013647159,0.0012287223,0.00006139532],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053628054,0.0010810982,0.00097142323,0.0005737441,0.00086780003,0.00049632526,0.00086820195,0.000004229914,0.8432509,0.000025106134,0.11136996,0.035128463],"study_design_scores_gemma":[0.0028736102,0.0008041466,0.0008200248,0.00026876532,0.00012958201,0.0012467323,0.00040012697,0.000014173033,0.89594555,0.00042465047,0.09677467,0.00029797116],"about_ca_topic_score_codex":0.0006175518,"about_ca_topic_score_gemma":0.0000028041143,"teacher_disagreement_score":0.05269471,"about_ca_system_score_codex":0.00024737226,"about_ca_system_score_gemma":0.00068139087,"threshold_uncertainty_score":0.85690993},"labels":[],"label_agreement":null},{"id":"W2080731610","doi":"10.1016/j.crvasa.2014.01.006","title":"Use of ezetimibe results in more patients reaching lipid targets without side effects","year":2014,"lang":"en","type":"article","venue":"Cor et Vasa","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Ezetimibe; Internal medicine; Physics; Cholesterol; Medicine; Endocrinology","score_opus":0.020759258958609868,"score_gpt":0.2761902926802657,"score_spread":0.2554310337216558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080731610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966476,0.00012703698,0.0005496348,0.00031234205,0.00024582035,0.00076281634,0.000010794458,0.000040666735,0.0013032893],"genre_scores_gemma":[0.996136,0.00007025117,0.002484775,0.0008757847,0.00016833497,0.00002416428,0.00007372802,0.000031043655,0.00013592234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983929,0.0002566777,0.00036573564,0.00029435026,0.00043000389,0.00026037],"domain_scores_gemma":[0.99880195,0.0001659121,0.0001294031,0.00065064814,0.000106284664,0.00014581466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009202611,0.00014933241,0.0005020845,0.00011255959,0.00003096048,0.000010479958,0.00007019627,0.00010323521,0.0000023702173],"category_scores_gemma":[0.0017559809,0.00012063618,0.0001557947,0.0001434109,0.00003554319,0.000099124045,0.0000553971,0.0002728056,0.000010466225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023002746,0.0011556472,0.6676432,0.0025822099,0.00030072118,0.00008568189,0.0052899327,0.0003809798,0.005311769,0.0002475147,0.003263532,0.31143853],"study_design_scores_gemma":[0.0059919716,0.0006640703,0.973313,0.0009214539,0.00008429144,0.000007864599,0.000024302764,0.0006740251,0.004926214,0.00002384473,0.013198475,0.00017048602],"about_ca_topic_score_codex":0.0009310003,"about_ca_topic_score_gemma":0.00007722535,"teacher_disagreement_score":0.31126803,"about_ca_system_score_codex":0.00006517525,"about_ca_system_score_gemma":0.000065378794,"threshold_uncertainty_score":0.49194005},"labels":[],"label_agreement":null},{"id":"W2081628048","doi":"10.1007/s10439-010-0145-9","title":"Differential Response of Endothelial Cells to Simvastatin When Conditioned with Steady, Non-Reversing Pulsatile or Oscillating Shear Stress","year":2010,"lang":"en","type":"article","venue":"Annals of Biomedical Engineering","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Pulsatile flow; Reversing; Shear stress; Simvastatin; Mechanics; Physics; Materials science; Internal medicine; Medicine; Composite material","score_opus":0.017042563193651196,"score_gpt":0.2752505578063644,"score_spread":0.2582079946127132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081628048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850943,0.000011503915,0.013347254,0.00052355044,0.0002345729,0.00044159056,0.00028650498,0.000031504864,0.00002919663],"genre_scores_gemma":[0.9899405,0.000006131098,0.009576407,0.00009451971,0.00024211999,0.000013783747,0.000035214867,0.000032693708,0.000058624362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981939,0.000049117385,0.00040873123,0.00022201224,0.00079635147,0.00032985807],"domain_scores_gemma":[0.99886835,0.00020980666,0.00010493724,0.0003301131,0.00012403289,0.00036275457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006485387,0.00015808194,0.0004977617,0.00025137007,0.000060682272,0.000008726648,0.00010676022,0.00009168624,0.0007518765],"category_scores_gemma":[0.00034752712,0.000119512115,0.00013586333,0.0002653917,0.000083804145,0.00005237247,0.00006359048,0.0002993446,0.0000025117188],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023897723,0.00020764781,0.00009105291,0.0006982063,0.0002236077,0.00007145606,0.0010083123,0.0006028382,0.9860332,0.000018117713,0.00025461792,0.00840115],"study_design_scores_gemma":[0.0040629655,0.0034292398,0.009584127,0.0010086817,0.00013179037,0.00008267518,0.000647489,0.0074470215,0.96521586,0.0000047449917,0.008016261,0.00036914254],"about_ca_topic_score_codex":0.00018718792,"about_ca_topic_score_gemma":0.000006382363,"teacher_disagreement_score":0.02081736,"about_ca_system_score_codex":0.000016651436,"about_ca_system_score_gemma":0.00017413269,"threshold_uncertainty_score":0.823252},"labels":[],"label_agreement":null},{"id":"W2081702953","doi":"10.1016/s0009-3084(02)00167-6","title":"A more detailed fatty acid composition of human lipoprotein(a)—a comparison with low density lipoprotein","year":2003,"lang":"en","type":"article","venue":"Chemistry and Physics of Lipids","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cape Breton University","funders":"","keywords":"Chemistry; Sphingomyelin; Triglyceride; Phospholipid; Palmitic acid; Fatty acid; Linoleic acid; Lipoprotein; Ethanolamine; Composition (language); Biochemistry; Chromatography; Cholesterol; Membrane","score_opus":0.011731375470079039,"score_gpt":0.256284624423445,"score_spread":0.24455324895336597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081702953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431163,0.00043736972,0.0030411626,0.000047350124,0.000019885603,0.00048892945,0.000011769509,0.000027895396,0.0016139813],"genre_scores_gemma":[0.9966766,0.000018672226,0.0028539791,0.000031246775,0.00026091063,0.000029389204,0.00006951378,0.000024163213,0.000035497727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986184,0.00004586676,0.00037310144,0.00030736142,0.00043287576,0.00022239411],"domain_scores_gemma":[0.998722,0.000013989893,0.00025278816,0.00059169333,0.00024590179,0.00017362974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025567424,0.000228963,0.00077255623,0.000010943668,0.00010944096,0.00000997743,0.00007495791,0.00014527503,0.000026488407],"category_scores_gemma":[0.000018263594,0.00019465218,0.00019151118,0.00018373644,0.00026409418,0.00006630484,0.000030188037,0.0002816401,8.740704e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003094616,0.0006430328,0.01658796,0.003962306,0.0003065658,0.000007854204,0.00035934983,0.000013907464,0.96822065,0.00031952717,0.000019630821,0.0092497775],"study_design_scores_gemma":[0.0021391124,0.00033258557,0.0120707825,0.00055956823,0.00021626789,0.000047195066,0.0001754991,0.00006909955,0.9839089,0.00024607847,0.000045149016,0.00018975344],"about_ca_topic_score_codex":0.00012664881,"about_ca_topic_score_gemma":0.000004169818,"teacher_disagreement_score":0.015688282,"about_ca_system_score_codex":0.00003252632,"about_ca_system_score_gemma":0.00010822926,"threshold_uncertainty_score":0.7937685},"labels":[],"label_agreement":null},{"id":"W2081710182","doi":"10.1097/hco.0b013e3283229afb","title":"The role of statins in chronic heart failure","year":2009,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Rosuvastatin; Heart failure; Internal medicine; Cardiology; Post-hoc analysis; Randomized controlled trial; Statin","score_opus":0.05493186539815796,"score_gpt":0.39341504867088717,"score_spread":0.3384831832727292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081710182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012778998,0.9963195,0.000015072514,0.00010933059,0.0016696606,0.0016284533,0.000031221018,0.000013657633,0.0002003683],"genre_scores_gemma":[0.00015003208,0.9976198,0.000029573313,0.000005358923,0.0016980963,0.00025564554,0.00020980313,0.000026507207,0.0000051976986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970997,0.00081127184,0.0009349919,0.00041530165,0.00028099795,0.00045773527],"domain_scores_gemma":[0.99865466,0.00017034724,0.00022192439,0.00080983486,0.00005896086,0.00008426835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012411043,0.0002971411,0.0028291296,0.00025654116,0.000037190766,0.0000059798235,0.00019492813,0.00036487944,0.0000061488986],"category_scores_gemma":[0.00011003243,0.0001909993,0.0010178636,0.00042115676,0.0001119841,0.000019561774,0.00007040051,0.0010331367,0.00001939983],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000076118677,0.000020903526,0.00020788853,0.010235606,0.00009147721,0.0000018272732,0.000016669268,0.0000074408035,1.8547632e-7,0.00035448023,0.0012706089,0.9877853],"study_design_scores_gemma":[0.00055460556,0.00021319016,0.00066060387,0.014056727,0.00010399889,0.00016122637,0.000030717943,0.000004415017,2.8136628e-7,0.00011231795,0.98396045,0.00014145921],"about_ca_topic_score_codex":0.000050654005,"about_ca_topic_score_gemma":0.000020915411,"teacher_disagreement_score":0.98764384,"about_ca_system_score_codex":0.00058271067,"about_ca_system_score_gemma":0.0016346618,"threshold_uncertainty_score":0.77887255},"labels":[],"label_agreement":null},{"id":"W2081823054","doi":"10.1016/j.cjca.2014.04.001","title":"Comparison of Cardiovascular Risk Assessment Algorithms to Determine Eligibility for Statin Therapy: Implications for Practice in Canada","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Framingham Risk Score; Internal medicine; Risk assessment; Statin; Cohort; Diabetes mellitus; Disease; Endocrinology","score_opus":0.04118908365054416,"score_gpt":0.37070217293718694,"score_spread":0.3295130892866428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081823054","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4309965,0.0059768567,0.55308247,0.005194115,0.00070431473,0.0029479363,0.00046559368,0.000004077448,0.00062815595],"genre_scores_gemma":[0.9775402,0.0002107819,0.021056758,0.0004720676,0.0005692703,0.00011122907,0.000016810189,0.000020273512,0.000002627462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804115,0.00040045116,0.0007450766,0.00021818785,0.0002094179,0.00038568844],"domain_scores_gemma":[0.9968151,0.00060010795,0.00032508324,0.0005548919,0.0011036017,0.00060124404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003378696,0.0001331332,0.0012911574,0.00019503543,0.00008149939,0.0000077967015,0.00015375149,0.000084446045,0.0000016303914],"category_scores_gemma":[0.0020125818,0.00011659529,0.0005933175,0.0001622829,0.000041409443,0.00004899779,0.0000073296997,0.00023589391,1.3651801e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029054427,0.000020056248,0.24436373,0.00015318778,0.0026142236,0.000013948789,0.00025614223,0.02951883,0.000093727285,0.0001446373,0.0054739057,0.71705705],"study_design_scores_gemma":[0.0030382874,0.0013447352,0.38492623,0.00003958919,0.00053262676,0.000157486,0.00040540137,0.0004413233,0.00017536474,0.00021595,0.6085912,0.00013179025],"about_ca_topic_score_codex":0.728095,"about_ca_topic_score_gemma":0.71349764,"teacher_disagreement_score":0.71692526,"about_ca_system_score_codex":0.00094378775,"about_ca_system_score_gemma":0.009749851,"threshold_uncertainty_score":0.995864},"labels":[],"label_agreement":null},{"id":"W2081834793","doi":"10.1016/j.jacl.2007.07.006","title":"Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B","year":2007,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université Laval; Royal Victoria Hospital; Royal Victoria Regional Health Centre; McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Medicine; Internal medicine; Triglyceride; Lipoprotein; Cholesterol; Endocrinology; Gastroenterology","score_opus":0.04868595796761922,"score_gpt":0.36678412956928524,"score_spread":0.31809817160166604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081834793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927131,0.0021168862,0.00032209762,0.0014124467,0.0026316706,0.00042087142,0.000008418396,0.000013406878,0.00036108826],"genre_scores_gemma":[0.9836495,0.0010553581,0.005173008,0.00068169774,0.009242165,0.000004943311,0.0000047557187,0.000031570988,0.00015702275],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957464,0.0002980955,0.0026635684,0.000306349,0.0006026626,0.00038295903],"domain_scores_gemma":[0.9961819,0.0010689909,0.0012106365,0.0004719647,0.00048601328,0.00058046536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050469725,0.00022074804,0.0019398966,0.00020400998,0.000046217865,0.000009969017,0.00016348074,0.0005456189,0.00024204013],"category_scores_gemma":[0.0028610402,0.00016388859,0.00066945824,0.00022608948,0.0003293357,0.000110910056,0.00009285508,0.0010382228,0.000014602473],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012699456,0.0009277615,0.27181053,0.00020190136,0.0011882526,0.00019450222,0.00016626473,0.000007248474,0.002424242,0.00011583099,0.00226253,0.7080015],"study_design_scores_gemma":[0.020144729,0.008744033,0.9151137,0.00044478558,0.000892952,0.0019850044,0.0001900544,0.000039641014,0.008760451,0.0004326693,0.04296479,0.00028720917],"about_ca_topic_score_codex":0.0006293494,"about_ca_topic_score_gemma":0.00008093542,"teacher_disagreement_score":0.70771426,"about_ca_system_score_codex":0.000042526925,"about_ca_system_score_gemma":0.00038087723,"threshold_uncertainty_score":0.6683183},"labels":[],"label_agreement":null},{"id":"W2081986126","doi":"10.2174/157016111206141210121017","title":"Different Patterns of Statin Use in Patients with Acute Myocardial Infarction","year":2014,"lang":"en","type":"article","venue":"Current Vascular Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Montreal General Hospital; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Statin; Discontinuation; Myocardial infarction; Hazard ratio; Medical prescription; Internal medicine; Proportional hazards model; Cohort; Emergency medicine; Cardiology; Confidence interval; Pharmacology","score_opus":0.013178219550426406,"score_gpt":0.27991116210870337,"score_spread":0.26673294255827695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081986126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944668,0.00019909126,0.0033338552,0.000054400003,0.00081801135,0.0010602413,0.00002713401,0.000026612799,0.000013901976],"genre_scores_gemma":[0.9987372,0.00044745763,0.000080285216,0.0001725378,0.0002518682,0.00009560956,0.00018250573,0.0000272158,0.000005321083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815947,0.00034292194,0.00035081574,0.00032603423,0.00048959913,0.0003311544],"domain_scores_gemma":[0.9991848,0.0000354111,0.000121969446,0.00033519568,0.00016145853,0.0001611522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031210558,0.00019873302,0.00059736404,0.00019187029,0.000032132597,0.0000070442734,0.00007606836,0.00007668828,0.000085304426],"category_scores_gemma":[0.000021951308,0.00014835518,0.00025445386,0.0001469764,0.000046690053,0.000090354486,0.000054276694,0.00032051915,0.000007011271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051017397,0.0009025039,0.94596946,0.00026768696,0.0010876018,0.0000056260897,0.000121777615,0.000054248427,0.00047505612,0.000037090882,0.00017517415,0.050393596],"study_design_scores_gemma":[0.012396211,0.0007117092,0.97685456,0.00008349986,0.0007961178,0.0000042145803,0.000006884777,0.00017876706,0.0010726007,0.0000064683204,0.007739867,0.00014907008],"about_ca_topic_score_codex":0.000111521746,"about_ca_topic_score_gemma":0.000017879882,"teacher_disagreement_score":0.05024453,"about_ca_system_score_codex":0.000107367116,"about_ca_system_score_gemma":0.00006681333,"threshold_uncertainty_score":0.60497487},"labels":[],"label_agreement":null},{"id":"W2082220423","doi":"10.1016/j.clinthera.2007.09.022","title":"A population-based analysis of statin utilization in British Columbia","year":2007,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; University of British Columbia; Health Sciences Centre","funders":"","keywords":"Rosuvastatin; Medicine; Statin; Atorvastatin; Simvastatin; Internal medicine; Medical prescription; Population; Diabetes mellitus; Pharmacology; Endocrinology; Environmental health","score_opus":0.10823144287888131,"score_gpt":0.41742397133131004,"score_spread":0.3091925284524287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082220423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867939,0.0003887391,0.012231669,0.000063529034,0.00007869602,0.0002906038,0.000012524029,0.000019386825,0.000120999764],"genre_scores_gemma":[0.99619323,0.00018730525,0.0020643065,0.0012860199,0.00006493756,0.0000030446597,0.00012610295,0.000012164945,0.000062898594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983798,0.00012578521,0.0008396378,0.00018544051,0.00030945247,0.0001598558],"domain_scores_gemma":[0.9990323,0.00027956543,0.00014681119,0.00031931247,0.00013645718,0.00008551443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002415828,0.000048699534,0.0005431741,0.00010112754,0.000024554969,0.000016505719,0.000045125395,0.00014438714,0.000110768655],"category_scores_gemma":[0.00018179229,0.00006765712,0.00037760028,0.0010526314,0.00004631995,0.000017513214,0.0000074130785,0.00016002331,9.20103e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003910021,0.00026337977,0.7963748,0.000028244865,0.00040687795,0.000009660005,0.000014406916,0.000083676576,0.000006015595,0.00000804761,0.000006127961,0.2027597],"study_design_scores_gemma":[0.0013477915,0.0001731583,0.9883927,0.000048871952,0.00089199864,0.0000011051894,0.00004659276,0.007993592,0.000012251805,0.000068723944,0.0009627008,0.000060478626],"about_ca_topic_score_codex":0.009874501,"about_ca_topic_score_gemma":0.07883421,"teacher_disagreement_score":0.20269921,"about_ca_system_score_codex":0.000047470563,"about_ca_system_score_gemma":0.00011085008,"threshold_uncertainty_score":0.9967188},"labels":[],"label_agreement":null},{"id":"W2082249487","doi":"10.2174/1874082001004010013","title":"Neuroprotective Role of Statins in Alzheimer`s Disease: Anti-Apoptotic Signaling~!2009-02-06~!2010-04-04~!2010-06-22~!","year":2010,"lang":"en","type":"article","venue":"The Open Neuroscience Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Neuroprotection; Disease; Medicine; Neuroscience; Pharmacology; Psychology; Internal medicine","score_opus":0.03081232559617069,"score_gpt":0.3037935791291769,"score_spread":0.27298125353300623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082249487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936729,0.00051915995,0.0001640699,0.0021465784,0.0009950895,0.0018157646,0.000029291974,0.000023155915,0.000633956],"genre_scores_gemma":[0.99736565,0.00024556002,0.00038063576,0.0012284898,0.00039414296,0.000025319248,0.0000024711221,0.00005028703,0.0003074294],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99596196,0.0005354589,0.0007556999,0.0005823856,0.0014103085,0.0007541807],"domain_scores_gemma":[0.9973228,0.000107219756,0.00050938915,0.0011129279,0.0002774428,0.0006702371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035364707,0.00031137525,0.0006749114,0.00025589633,0.0006052483,0.0003244137,0.0014903672,0.00008881338,0.00015671026],"category_scores_gemma":[0.0009628961,0.0002051124,0.00030757725,0.0009470273,0.00054783083,0.0006270209,0.00043292218,0.0019456965,0.00003337489],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047956334,0.0010108685,0.024547813,0.0000616859,0.00007995157,0.0005978168,0.0010233584,0.001181853,0.94989514,0.000437827,0.0007107298,0.019973382],"study_design_scores_gemma":[0.0034686741,0.0009861315,0.93837315,0.0003162364,0.00043285702,0.0022087614,0.0005853039,0.0035992775,0.041391224,0.0014798238,0.0066491454,0.00050939975],"about_ca_topic_score_codex":0.0005163428,"about_ca_topic_score_gemma":0.00003463462,"teacher_disagreement_score":0.91382533,"about_ca_system_score_codex":0.000042667834,"about_ca_system_score_gemma":0.0010998374,"threshold_uncertainty_score":0.84531915},"labels":[],"label_agreement":null},{"id":"W2082270778","doi":"10.1016/j.clinbiochem.2014.03.022","title":"The effect of insulin on circulating PCSK9 in postmenopausal obese women","year":2014,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Université de Montréal; King Abdulaziz University","keywords":"PCSK9; Internal medicine; Endocrinology; Hyperinsulinemia; Insulin; Kexin; LDL receptor; Medicine; Cholesterol; Insulin resistance; Lipoprotein","score_opus":0.011592691463162969,"score_gpt":0.3221827764082404,"score_spread":0.31059008494507745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082270778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590915,0.0004840804,0.0000051504317,0.00030386893,0.00011122077,0.00026209193,0.0000019553356,0.00001862237,0.0029038847],"genre_scores_gemma":[0.99898493,0.00006424364,0.00003294453,0.00027154534,0.0004915623,0.000032985383,0.00000774188,0.000014226363,0.000099793804],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983357,0.00023202205,0.00057390315,0.00028651243,0.00029965586,0.00027218185],"domain_scores_gemma":[0.9979647,0.0009767113,0.000121163444,0.0007231765,0.000037873397,0.00017642186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041165096,0.000121845354,0.00047964172,0.00001603971,0.000046419416,0.000007297541,0.000119080396,0.00019821864,0.000013668114],"category_scores_gemma":[0.004188164,0.00007414219,0.00019370034,0.00012810215,0.00014092667,0.000008359413,0.000050736235,0.00044993628,0.0000187472],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025626477,0.0005182314,0.18886247,0.0015730428,0.00032570332,0.00006280701,0.00009706866,0.0000107786655,0.0523763,0.000071721974,0.00022672206,0.7533125],"study_design_scores_gemma":[0.025295254,0.017400678,0.42882696,0.0019668795,0.00022331266,0.00011472379,0.00028680442,0.0007369681,0.51104695,0.00038024236,0.013053056,0.00066819304],"about_ca_topic_score_codex":0.000017211245,"about_ca_topic_score_gemma":6.2528244e-7,"teacher_disagreement_score":0.7526443,"about_ca_system_score_codex":0.000074118994,"about_ca_system_score_gemma":0.000083866886,"threshold_uncertainty_score":0.5013926},"labels":[],"label_agreement":null},{"id":"W2082860703","doi":"10.1016/j.cjca.2011.07.255","title":"091 Statins prevent expansive remodeling in arterialized vein grafts","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Expansive; Cardiology; Internal medicine; Composite material","score_opus":0.03945796474568465,"score_gpt":0.25831721143325037,"score_spread":0.21885924668756573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082860703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850497,0.0018554734,0.004249684,0.00043602,0.0008492266,0.0003462627,0.0000115332405,0.0000051945026,0.0071968967],"genre_scores_gemma":[0.99738467,0.00018039838,0.0011441874,0.00031796796,0.000897387,0.0000065562476,0.0000044404223,0.0000189202,0.00004549045],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985149,0.0002750458,0.00051921915,0.00014297478,0.0001527977,0.0003950877],"domain_scores_gemma":[0.9986688,0.000015945443,0.00014697507,0.00026895653,0.0002482925,0.00065106817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009852016,0.00011852214,0.0007389132,0.00035652836,0.000041068695,0.0000066356147,0.00010658252,0.00013531865,0.00005149413],"category_scores_gemma":[0.00019646352,0.00010215169,0.00032286698,0.00012652054,0.00007152977,0.0000618729,0.0000073641017,0.0003217683,0.000006878609],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005470736,0.00017328895,0.20466371,0.0011347805,0.0080280695,0.052594945,0.050116688,0.008037243,0.013541402,0.00474044,0.03278231,0.6187164],"study_design_scores_gemma":[0.023355983,0.0055509433,0.5605166,0.0015365003,0.0012356023,0.02280779,0.0062292237,0.00022382305,0.0032313943,0.008193844,0.36595532,0.001162968],"about_ca_topic_score_codex":0.0064660395,"about_ca_topic_score_gemma":0.0044144327,"teacher_disagreement_score":0.6175534,"about_ca_system_score_codex":0.00025360612,"about_ca_system_score_gemma":0.0022932864,"threshold_uncertainty_score":0.9774761},"labels":[],"label_agreement":null},{"id":"W2083000884","doi":"10.1016/s0828-282x(07)70889-9","title":"Surgical strategies for severe calcifications of the aorta (porcelain aorta) in two patients with homozygous familial hypercholesterolemia","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Royal Victoria Hospital","funders":"","keywords":"Medicine; Ascending aorta; Aorta; Familial hypercholesterolemia; Stenosis; Cardiology; Surgery; Artery; Internal medicine; Genetic disorder; Pathological; Disease; Cholesterol","score_opus":0.013280145569217269,"score_gpt":0.2722082420537221,"score_spread":0.2589280964845049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083000884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505794,0.00030917904,0.0013325505,0.00030516688,0.00026614303,0.0004894136,0.000050213406,0.00000201649,0.0021874008],"genre_scores_gemma":[0.99911016,0.000014720457,0.00019305771,0.000104721505,0.0005138537,0.000006626868,0.000012018982,0.00001559709,0.000029250832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986727,0.000118382566,0.0004971109,0.00013027727,0.00022187004,0.00035961365],"domain_scores_gemma":[0.99866605,0.00007350721,0.00017934258,0.00031865903,0.00040631345,0.0003561447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009951175,0.000113497554,0.00056036335,0.00019873364,0.00007368808,0.000008000821,0.00015730162,0.00011106241,0.0000037708792],"category_scores_gemma":[0.0000768496,0.000072703995,0.0003049174,0.00019607464,0.00020220889,0.00005421415,0.000006961602,0.00034363737,4.205803e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045438667,0.00001505035,0.9839089,0.00006692493,0.00032362493,0.0003420057,0.0003803179,0.0016648764,0.00004031007,0.0008180776,0.00049059995,0.011494911],"study_design_scores_gemma":[0.005628243,0.00047532577,0.9608125,0.00010609993,0.00017174042,0.0015135502,0.00096941506,0.0000048607308,0.000023932293,0.00014889764,0.03004196,0.00010349445],"about_ca_topic_score_codex":0.003235146,"about_ca_topic_score_gemma":0.019034889,"teacher_disagreement_score":0.02955136,"about_ca_system_score_codex":0.00019997724,"about_ca_system_score_gemma":0.002540549,"threshold_uncertainty_score":0.9988652},"labels":[],"label_agreement":null},{"id":"W2083006110","doi":"10.1111/j.1471-4159.2006.03928.x","title":"Implication of the proprotein convertase NARC‐1/PCSK9 in the development of the nervous system","year":2006,"lang":"en","type":"article","venue":"Journal of Neurochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Université du Québec à Montréal; McGill University Health Centre; Royal Victoria Regional Health Centre; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Proprotein convertase; Proprotein Convertases; Nervous system; Kexin; Central nervous system; Neuroscience; Biology; Endocrinology; LDL receptor; Cholesterol; Lipoprotein","score_opus":0.008788603739075838,"score_gpt":0.22877147588056737,"score_spread":0.21998287214149154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083006110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975251,0.0003737777,0.0000404991,0.0010770467,0.00006523494,0.0003938873,0.0000019234858,0.0000023330974,0.0005202272],"genre_scores_gemma":[0.99954724,0.0000044500066,0.00012709848,0.00008639715,0.00016249728,0.000010926052,7.6061343e-7,0.0000079336105,0.000052715728],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840206,0.000097391916,0.00065840484,0.00008326672,0.00064697576,0.000111914596],"domain_scores_gemma":[0.9986735,0.00002477841,0.0005943574,0.00047973378,0.00019753583,0.000030073008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074304064,0.00008525683,0.0002486509,0.000020566325,0.000056116238,0.000005536039,0.00031727907,0.000055776793,0.0000026159735],"category_scores_gemma":[0.00008321663,0.000037242033,0.00023779307,0.00017795207,0.00005473779,0.000019948298,0.00003985932,0.0003134154,3.1632382e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009996305,0.00021345772,0.0066919094,0.0015461423,0.000055467295,0.000023522072,0.00046743068,0.0000314744,0.98675853,0.00003321894,0.00026843438,0.0038104753],"study_design_scores_gemma":[0.000816862,0.00004326732,0.2739105,0.000556105,0.000068109715,0.0011540373,0.000519508,0.000013762771,0.7216115,0.000017403798,0.001247301,0.000041628304],"about_ca_topic_score_codex":0.000043603326,"about_ca_topic_score_gemma":0.0000055915216,"teacher_disagreement_score":0.2672186,"about_ca_system_score_codex":0.00008011587,"about_ca_system_score_gemma":0.00047961547,"threshold_uncertainty_score":0.1518686},"labels":[],"label_agreement":null},{"id":"W2083123036","doi":"10.1038/ejhg.2013.270","title":"Genealogical analysis as a new approach for the investigation of drug intolerance heritability","year":2013,"lang":"en","type":"article","venue":"European Journal of Human Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Social Sciences and Humanities Research Council of Canada; Canadian Institutes of Health Research","keywords":"Heritability; Genetics; Missing heritability problem; Drug; Computational biology; Biology; Medicine; Pharmacology; Genetic variants; Genotype; Gene","score_opus":0.04038969653286845,"score_gpt":0.27574761497439404,"score_spread":0.2353579184415256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083123036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609075,0.0028838858,0.034306366,0.00065217505,0.000039992152,0.0004593133,0.0000011290826,0.00000490522,0.0007446988],"genre_scores_gemma":[0.97713166,0.00014127248,0.02156757,0.00035428774,0.00057781267,0.0000028012812,0.0000046111927,0.000016212914,0.00020374004],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984488,0.0003382557,0.00059018977,0.00012863275,0.00036658978,0.00012751484],"domain_scores_gemma":[0.9985792,0.00003789857,0.00033818214,0.0004154274,0.00038788188,0.00024139242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018709737,0.00009507528,0.00037261908,0.00007276393,0.00008354252,0.00002442263,0.00019567927,0.000019205152,0.00008627824],"category_scores_gemma":[0.00012530932,0.000057194306,0.0004951396,0.00022093658,0.00010994199,0.00003248861,0.00003138792,0.00018028382,0.000005285232],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008785705,0.0013150548,0.2389443,0.0021564085,0.018235728,0.000103269915,0.032997802,0.0262026,0.09271089,0.00073890784,0.040815584,0.5449009],"study_design_scores_gemma":[0.0028386656,0.0013675535,0.97934,0.000059645165,0.002457951,0.00013029952,0.0010298643,0.0031450007,0.004835551,0.00078741537,0.0038258752,0.00018216776],"about_ca_topic_score_codex":0.000045791203,"about_ca_topic_score_gemma":0.000003096908,"teacher_disagreement_score":0.7403957,"about_ca_system_score_codex":0.000025477295,"about_ca_system_score_gemma":0.00013536887,"threshold_uncertainty_score":0.2332316},"labels":[],"label_agreement":null},{"id":"W2083147006","doi":"10.1097/00005768-200405001-00645","title":"Adult Treatment Panel III Guidelines and Cardiovascular Disease Mortality","year":2004,"lang":"en","type":"article","venue":"Medicine & Science in Sports & Exercise","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cardiorespiratory fitness; Internal medicine; Framingham Risk Score; Proportional hazards model; Diabetes mellitus; Cholesterol; Disease; Endocrinology","score_opus":0.04569901161306603,"score_gpt":0.31424836196632516,"score_spread":0.2685493503532591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083147006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989469,0.005633277,0.00016072713,0.0022728941,0.00039323367,0.001391697,0.0000034728616,0.00007756795,0.00059815124],"genre_scores_gemma":[0.98597294,0.0120262,0.00058931945,0.0005949102,0.00048364513,0.00014193094,0.00001354137,0.00002284634,0.00015465723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953838,0.000023757135,0.0007219631,0.0009846014,0.0022455852,0.0006402901],"domain_scores_gemma":[0.99688286,0.000008883322,0.00008875389,0.0015628348,0.00044824797,0.0010084471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002660536,0.00033579944,0.0010828666,0.00033508803,0.0002258472,0.000021404052,0.00018043543,0.00006823582,0.00006162934],"category_scores_gemma":[0.00035503315,0.00022214987,0.00030695123,0.0009989981,0.0010842626,0.00023393483,0.00007214714,0.00016113,0.0000055073133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016133944,0.0003356626,0.58074236,0.00020605804,0.00002319904,0.0032688128,0.0014792627,0.0006126449,0.00005986161,0.000053081174,0.00009006429,0.41296768],"study_design_scores_gemma":[0.0052028624,0.00023788333,0.98813426,0.0012399739,0.0008508652,0.00016773486,0.0010397007,0.00015869479,0.00004330054,0.00045562725,0.0022187394,0.00025035162],"about_ca_topic_score_codex":0.013649074,"about_ca_topic_score_gemma":0.00010403769,"teacher_disagreement_score":0.41271734,"about_ca_system_score_codex":0.00033876006,"about_ca_system_score_gemma":0.0010408082,"threshold_uncertainty_score":0.99291915},"labels":[],"label_agreement":null},{"id":"W2083187187","doi":"10.1155/2015/610239","title":"Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial","year":2015,"lang":"en","type":"article","venue":"International Journal of Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Astellas Pharma; Ministry of Education, India; Novo Nordisk; BD; McGill University; Saint Louis University; Case Western Reserve University; University of Minnesota; National Institutes of Health; Ohio State University; GlaxoSmithKline; Astellas Pharma US; Medical Center, University of Pittsburgh; University of Pittsburgh; National Institute of Diabetes and Digestive and Kidney Diseases; Johns Hopkins University; National Heart, Lung, and Blood Institute; Novartis Pharmaceuticals Corporation; Pfizer; Brown University; Eli Lilly and Company; Bristol-Myers Squibb; Abbott Laboratories","keywords":"Medicine; Blood pressure; Internal medicine; Diabetes mellitus; Hyperlipidemia; Guideline; Metformin; Type 2 diabetes; Pharmacotherapy; Disease; Endocrinology; Insulin","score_opus":0.05961103596118276,"score_gpt":0.35307122339266633,"score_spread":0.29346018743148355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083187187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94846916,0.014560675,0.00023859087,0.034308158,0.0010577913,0.00049431424,0.000013694395,0.000008862804,0.00084874284],"genre_scores_gemma":[0.9921993,0.0018405971,0.0015269447,0.0024960842,0.0017539534,0.000011562017,0.000011998931,0.000011305088,0.00014826054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980706,0.00039582525,0.0006428061,0.00017002334,0.00052982883,0.00019090643],"domain_scores_gemma":[0.99856514,0.00021384566,0.00053797296,0.00016566378,0.00039353804,0.00012383705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020807895,0.00011396425,0.00034253168,0.00017693719,0.000032011754,0.000036477613,0.00018675339,0.00006165924,0.00002859749],"category_scores_gemma":[0.001413997,0.0000748772,0.00008033673,0.000042809763,0.00004940189,0.00018772158,0.00012776052,0.00039959545,0.0000010396305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15739481,0.0068033594,0.18837899,0.0004522672,0.02282465,0.023351759,0.010448037,0.00053621957,0.005689399,0.0038063908,0.069970034,0.5103441],"study_design_scores_gemma":[0.1663432,0.0039860816,0.016825456,0.00020994281,0.0017766153,0.07763588,0.0018726968,0.000661492,0.0025487563,0.0007012996,0.72716653,0.00027208848],"about_ca_topic_score_codex":0.00029671035,"about_ca_topic_score_gemma":0.00009616444,"teacher_disagreement_score":0.65719646,"about_ca_system_score_codex":0.000031519812,"about_ca_system_score_gemma":0.00013199045,"threshold_uncertainty_score":0.30534038},"labels":[],"label_agreement":null},{"id":"W2083366489","doi":"10.1056/nejmsa0801461","title":"Use of Ezetimibe in the United States and Canada","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Ezetimibe; Medicine; Cholesterol; Environmental health; Internal medicine","score_opus":0.03210317907467643,"score_gpt":0.2505619419919191,"score_spread":0.2184587629172427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083366489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984136,0.0021292034,0.00006632809,0.013385276,0.00009941699,0.000105331215,0.0000016276698,0.0000011970535,0.00007566077],"genre_scores_gemma":[0.9893436,0.0071771494,0.00018999586,0.0023721796,0.0008323575,3.3575017e-7,0.0000066487287,0.000005853745,0.00007190051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987704,0.00011989306,0.00036633937,0.00005153109,0.0005816382,0.00011016492],"domain_scores_gemma":[0.9992029,0.00021205745,0.00014095478,0.00014252473,0.00014343683,0.0001581043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089621765,0.00007073274,0.00037732787,0.00013555695,0.00002582705,0.0000016176913,0.000052829877,0.000025301792,0.00002158617],"category_scores_gemma":[0.0003449823,0.000034022807,0.000034450873,0.00018827233,0.00008207472,0.000033508997,0.000006419983,0.00025907846,5.164175e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035609119,0.00028846084,0.54837066,0.0006256966,0.00087860745,0.012483781,0.023608657,0.00091873953,0.0011029388,0.00022430105,0.20382221,0.20411505],"study_design_scores_gemma":[0.04672968,0.0022168783,0.47654966,0.0008569898,0.0002707103,0.018913954,0.0017473139,0.00015121631,0.00024536529,0.00008948676,0.45213133,0.00009741063],"about_ca_topic_score_codex":0.70381856,"about_ca_topic_score_gemma":0.14201833,"teacher_disagreement_score":0.56180024,"about_ca_system_score_codex":0.000033111177,"about_ca_system_score_gemma":0.0005410912,"threshold_uncertainty_score":0.8736376},"labels":[],"label_agreement":null},{"id":"W2083760766","doi":"10.1016/j.clinthera.2007.04.009","title":"Prevalence and treatment of dyslipidemia in canadian primary care: A retrospective cohort analysis","year":2007,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); Western University","funders":"","keywords":"Medicine; Dyslipidemia; Retrospective cohort study; Cohort; Internal medicine; Coronary artery disease; Cohort study; Hyperlipidemia; Risk factor; Medical prescription; Pediatrics; Disease; Diabetes mellitus; Endocrinology","score_opus":0.04291699522430418,"score_gpt":0.36856929925565995,"score_spread":0.32565230403135575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083760766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98952067,0.0074181715,0.00010870961,0.00015683197,0.00007658341,0.00061738666,0.000016446776,0.0000098340215,0.0020753657],"genre_scores_gemma":[0.99296254,0.0055151423,0.0006093194,0.00063674024,0.00015793688,0.00000831347,0.000015766918,0.000010960381,0.0000832902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985046,0.00010001039,0.000572401,0.00029520533,0.00023405175,0.00029374933],"domain_scores_gemma":[0.99886036,0.00014661012,0.00008875178,0.00046112307,0.00011860164,0.0003245324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016738742,0.00011185303,0.00076408323,0.00017390799,0.000028683407,0.0000037410173,0.000044288772,0.00018651811,0.000012609758],"category_scores_gemma":[0.00005417181,0.0000874756,0.000334184,0.0004559298,0.00013853096,0.000016950025,0.000009731812,0.00016145282,0.0000011030149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010239418,0.00010913355,0.92753685,0.000067938585,0.0012579809,0.000026526553,0.00022559428,0.000001245575,0.0000063311145,0.000046124533,0.000001105248,0.0706188],"study_design_scores_gemma":[0.0012180582,0.0007703637,0.9933265,0.000035691166,0.0018932503,0.0000031718155,0.00005644469,0.000050605417,0.00004404078,0.000023027804,0.00250371,0.000075161624],"about_ca_topic_score_codex":0.025018942,"about_ca_topic_score_gemma":0.07728946,"teacher_disagreement_score":0.07054364,"about_ca_system_score_codex":0.00079494796,"about_ca_system_score_gemma":0.00048075616,"threshold_uncertainty_score":0.98147357},"labels":[],"label_agreement":null},{"id":"W2083791045","doi":"10.2165/00019053-200624080-00007","title":"Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Merck Canada Inc. (Canada)","funders":"","keywords":"Ezetimibe; Atorvastatin; Quality of Life Research; Health economics; Medicine; Public health; Ldl cholesterol; Pharmacotherapy; Cholesterol; Cost effectiveness; Intensive care medicine; Internal medicine; Risk analysis (engineering)","score_opus":0.021071013579764025,"score_gpt":0.29399228974178526,"score_spread":0.2729212761620212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083791045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772125,0.00007761513,0.000007598323,0.00007562025,0.00015533785,0.0016831098,0.00009566193,0.0000053901986,0.00017839114],"genre_scores_gemma":[0.999007,0.00009467942,0.00006873551,0.00047966128,0.00006199424,0.00018727685,0.00006174472,0.000024011484,0.000014888189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989182,0.000108108536,0.0003513254,0.00024211816,0.00012003121,0.00026023385],"domain_scores_gemma":[0.9995363,0.000065607004,0.00007212131,0.00018495039,0.00002844363,0.000112581656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030030304,0.0001489942,0.00045322668,0.00009624192,0.000019621199,0.000004566583,0.000053172545,0.00002755349,0.000032718377],"category_scores_gemma":[0.000004923239,0.00014043528,0.000078361496,0.000084956024,0.000009417297,0.000041932934,0.000022813892,0.000072865456,0.0000064927513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016443356,0.00028940543,0.9231113,0.00009533914,0.00007253715,0.000014214158,0.000111025045,0.004497523,0.0019710762,0.0000047645904,0.0000776362,0.06811083],"study_design_scores_gemma":[0.01310254,0.00023768951,0.91365546,0.000066168184,0.000015567924,0.0000019787024,0.00001734574,0.0002650176,0.06980085,0.0000012914845,0.0027196677,0.00011643193],"about_ca_topic_score_codex":0.7440121,"about_ca_topic_score_gemma":0.49300653,"teacher_disagreement_score":0.25100556,"about_ca_system_score_codex":0.0042310087,"about_ca_system_score_gemma":0.0004886613,"threshold_uncertainty_score":0.9995916},"labels":[],"label_agreement":null},{"id":"W2084676572","doi":"10.1155/2012/103728","title":"A Randomized Trial Assessing the Effectiveness of Ezetimibe in South Asian Canadians with Coronary Artery Disease or Diabetes: The INFINITY Study","year":2012,"lang":"en","type":"article","venue":"Advances in Preventive Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); The Scarborough Hospital; Toronto East General Hospital; McGill University; Health Sciences Centre; TransCanada (Canada); Sunnybrook Health Science Centre","funders":"Merck Canada; Merck","keywords":"Medicine; Ezetimibe; Coronary artery disease; Diabetes mellitus; Randomized controlled trial; Internal medicine; Cardiology; Cholesterol; Endocrinology","score_opus":0.015947889261968537,"score_gpt":0.32168764372606223,"score_spread":0.3057397544640937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084676572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806513,0.007970234,0.00043776643,0.00035060928,0.0003431454,0.009364657,0.0000061813,0.000011534451,0.0008645644],"genre_scores_gemma":[0.9979305,0.00014277184,0.000036299156,0.00018051766,0.00032885524,0.0013009309,0.00001116566,0.000022595721,0.00004636685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937742,0.004345852,0.0005695058,0.0002685635,0.0006157757,0.00042613174],"domain_scores_gemma":[0.9968395,0.002056443,0.00023118775,0.0005956758,0.00007974948,0.00019743713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01078837,0.00023300054,0.0012215244,0.00014730488,0.000093795905,0.000006519233,0.00016221839,0.000040234023,0.000035907433],"category_scores_gemma":[0.0019491073,0.0000937711,0.00015025631,0.00057959656,0.0006488185,0.00026654298,0.00004308978,0.00040735776,6.9172535e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48278207,0.0009871221,0.49463612,0.0005617835,0.00047222042,0.00013434036,0.009236374,0.00003517789,0.0000052564847,0.000084084735,0.0000022998968,0.011063172],"study_design_scores_gemma":[0.46798566,0.0010833128,0.51833904,0.0017862347,0.0006325385,0.000009331817,0.009754558,0.000020290727,0.000009384458,0.00018329182,0.000095922675,0.00010043383],"about_ca_topic_score_codex":0.0008102132,"about_ca_topic_score_gemma":0.0017875988,"teacher_disagreement_score":0.023702927,"about_ca_system_score_codex":0.00014374813,"about_ca_system_score_gemma":0.0004018065,"threshold_uncertainty_score":0.38238743},"labels":[],"label_agreement":null},{"id":"W2084820152","doi":"10.1016/j.cjca.2013.11.031","title":"Use and Misuse of Ezetimibe: Analysis of Use and Cost in Saskatchewan, a Canadian Jurisdiction With Broad Access","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Saskatchewan Health Quality Council; University of Manitoba; University of Saskatchewan","funders":"","keywords":"Ezetimibe; Formulary; Medicine; Statin; Emergency medicine; Family medicine; Internal medicine","score_opus":0.023311273672203533,"score_gpt":0.25861086802296906,"score_spread":0.23529959435076553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084820152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976573,0.0010818349,0.00020278279,0.00048153478,0.000055962304,0.0003447978,0.00005821024,0.0000012683942,0.00011631281],"genre_scores_gemma":[0.9989724,0.00044802713,0.0002282911,0.00020864815,0.00008784347,0.000006266094,0.000010870747,0.000012959658,0.000024684361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875575,0.00016951445,0.0004488435,0.00015748662,0.0001527077,0.00031567947],"domain_scores_gemma":[0.9978343,0.00006751765,0.00021005783,0.00026903205,0.00055352156,0.0010655219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048189002,0.00012478353,0.0010207633,0.0014517951,0.00003945789,0.000036930014,0.0000796159,0.00015416094,0.000020305462],"category_scores_gemma":[0.00015875514,0.000100126905,0.00017929087,0.00058180676,0.00023511105,0.00030769722,0.000008995981,0.00024760608,2.1702294e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000727287,0.0000027972499,0.98809993,0.00005807887,0.0018892376,0.00021638413,0.0004632983,0.0007555855,0.00010975647,0.0000079903675,0.00061150396,0.00771269],"study_design_scores_gemma":[0.0011266525,0.00027077115,0.9912729,0.000101160374,0.0013078456,0.00060714653,0.0005458095,0.00007782877,0.000060881484,0.00000789903,0.004534656,0.00008639392],"about_ca_topic_score_codex":0.8569229,"about_ca_topic_score_gemma":0.92424655,"teacher_disagreement_score":0.06732363,"about_ca_system_score_codex":0.00020621062,"about_ca_system_score_gemma":0.0026758201,"threshold_uncertainty_score":0.47467902},"labels":[],"label_agreement":null},{"id":"W2085013428","doi":"10.1517/14728214.13.2.363","title":"Emerging antidyslipidemic drugs","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Emerging Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Ezetimibe; Tolerability; Adverse effect; Intensive care medicine; Coronary heart disease; Niacin; Pharmacology; Statin; Internal medicine","score_opus":0.04300957262493703,"score_gpt":0.3725274129698519,"score_spread":0.3295178403449149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085013428","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000792055,0.9839692,0.0000730006,0.0008322928,0.00475935,0.0019424385,0.00001757065,0.0004694248,0.007928778],"genre_scores_gemma":[0.000017396307,0.9884592,0.0003680525,0.0013355273,0.0075817793,0.00041112772,0.0005188676,0.00035661907,0.00095139723],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936939,0.00047557385,0.0015778614,0.0014549814,0.0016922778,0.0011053985],"domain_scores_gemma":[0.9962808,0.00021670481,0.00060902914,0.0021525938,0.00014496711,0.00059589936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00081371295,0.0011841344,0.0042156484,0.00084586727,0.00049535034,0.00003756418,0.0004601792,0.00070917443,0.0002711324],"category_scores_gemma":[0.00021599547,0.00095535285,0.0032059448,0.0009457857,0.00012270395,0.00013144688,0.00018516296,0.001505572,0.0006922972],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002105182,0.00014085647,0.0000015824018,0.0049148155,0.0005518671,0.000043507538,0.0012507688,0.000001446893,4.6638476e-7,0.0001656332,0.042917963,0.94999003],"study_design_scores_gemma":[0.00094457885,0.00016412558,0.0000025043378,0.030368272,0.00010223675,0.00044934914,0.00029983945,0.000025851694,0.000005348135,0.000006311101,0.96678007,0.0008514896],"about_ca_topic_score_codex":0.00029092177,"about_ca_topic_score_gemma":4.58541e-7,"teacher_disagreement_score":0.9491385,"about_ca_system_score_codex":0.00059358275,"about_ca_system_score_gemma":0.0009397188,"threshold_uncertainty_score":0.9992897},"labels":[],"label_agreement":null},{"id":"W2085073662","doi":"10.1016/s0828-282x(08)71029-8","title":"Advances in vascular biology: Underlying mechanisms for cardiovascular therapies on the horizon","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Obesity; Disease; Gerontology; Library science; Internal medicine","score_opus":0.04298836316028651,"score_gpt":0.2727399957586026,"score_spread":0.22975163259831607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085073662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44509557,0.21109274,0.32246715,0.0068511,0.0033111977,0.0030213583,0.00004627103,0.00003238295,0.008082241],"genre_scores_gemma":[0.9909445,0.0067807445,0.00080255995,0.00046921964,0.0009175389,0.000043335225,0.0000046261985,0.000028237677,0.000009236272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830705,0.0003727802,0.00039010102,0.00021648791,0.00022321683,0.00049033796],"domain_scores_gemma":[0.9986891,0.00015006472,0.000110798246,0.0004976417,0.00023540793,0.00031698294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002072501,0.00017936937,0.0009803625,0.00034468205,0.000240731,0.000008116691,0.0002014575,0.00019691406,0.000007830342],"category_scores_gemma":[0.00031803935,0.00011489673,0.0016993915,0.00020492358,0.00021255578,0.00006994128,0.000007218385,0.00041443037,0.000003516056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010825234,0.000051598203,0.038621288,0.0005983497,0.024408692,0.003424506,0.0030139447,0.019458437,0.0022451782,0.19609296,0.005525906,0.7054766],"study_design_scores_gemma":[0.003936095,0.0030226246,0.021543898,0.00019120715,0.0005405677,0.0021894444,0.0010726408,0.00002058029,0.0002032006,0.01792105,0.9490475,0.0003111649],"about_ca_topic_score_codex":0.0005597425,"about_ca_topic_score_gemma":0.00044389957,"teacher_disagreement_score":0.9435216,"about_ca_system_score_codex":0.00023499483,"about_ca_system_score_gemma":0.0012544898,"threshold_uncertainty_score":0.46853527},"labels":[],"label_agreement":null},{"id":"W2085084256","doi":"10.1016/j.ejmech.2015.01.022","title":"LDL-R promoting activity of peptides derived from human PCSK9 catalytic domain (153–421): Design, synthesis and biochemical evaluation","year":2015,"lang":"en","type":"article","venue":"European Journal of Medicinal Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Health Sciences Centre","funders":"Saudi Arabian Cultural Bureau; Ottawa Hospital Research Institute","keywords":"Kexin; Chemistry; LDL receptor; PCSK9; Proprotein convertase; Reductase; Statin; Cholesterol; Biochemistry; Low-density lipoprotein; HMG-CoA reductase; Enzyme; Pharmacology; Lipoprotein; Biology","score_opus":0.05408838699581983,"score_gpt":0.2897067651186447,"score_spread":0.23561837812282485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085084256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943668,0.002464253,0.0013646334,0.0003877862,0.000049061586,0.00020473491,0.0000036896365,0.000010716374,0.0011482848],"genre_scores_gemma":[0.99612516,0.000038215792,0.0028023145,0.000032416894,0.0009499684,0.000002445152,0.0000069729763,0.00003100291,0.000011525745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99727124,0.00051699474,0.0006035448,0.00022182848,0.0011894044,0.00019696588],"domain_scores_gemma":[0.9980078,0.00012317458,0.0005853923,0.00031035903,0.0004811778,0.00049212656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068443087,0.0001816196,0.0005904944,0.00005150608,0.000054735814,0.000013230866,0.00014710358,0.000060833696,0.000044371005],"category_scores_gemma":[0.0017916467,0.00014116307,0.00016380675,0.000090554175,0.00018682319,0.000077185345,0.000056912737,0.00042549794,0.000002466258],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038012594,0.0001261295,0.000711631,0.00034167527,0.0002760204,0.0003151031,0.000921233,0.0000048855413,0.9698376,1.8955485e-7,0.00021168038,0.026873732],"study_design_scores_gemma":[0.00353584,0.00047832978,0.012987712,0.0015786593,0.0008740313,0.0012631194,0.001013372,0.00012230051,0.9778627,0.000062663814,0.00008162238,0.00013965857],"about_ca_topic_score_codex":0.000034439443,"about_ca_topic_score_gemma":3.172014e-7,"teacher_disagreement_score":0.026734075,"about_ca_system_score_codex":0.00016142103,"about_ca_system_score_gemma":0.00041176504,"threshold_uncertainty_score":0.5756463},"labels":[],"label_agreement":null},{"id":"W2085216936","doi":"10.1074/jbc.m005732200","title":"Structural Characterization of a Low Density Lipoprotein Receptor-active Apolipoprotein E Peptide, ApoE3-(126–183)","year":2000,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health; National Heart, Lung, and Blood Institute; Alberta Heritage Foundation for Medical Research; Fondation pour la Recherche Médicale; Heart and Stroke Foundation of Canada","keywords":"Apolipoprotein B; Apolipoprotein C2; Low-density lipoprotein receptor-related protein 8; Lipoprotein; LDL receptor; Peptide; Apolipoprotein E; Chemistry; Low-density lipoprotein; Receptor; Internal medicine; Endocrinology; Biochemistry; Medicine; Very low-density lipoprotein; Cholesterol","score_opus":0.015386673782082791,"score_gpt":0.2435436481549405,"score_spread":0.2281569743728577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085216936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828666,0.0002414681,0.00008308524,0.00027060884,0.000073630465,0.00034482885,0.00003114182,0.000021970869,0.00064659456],"genre_scores_gemma":[0.99697936,0.00047058606,0.00086683256,0.00014376722,0.0012096727,0.000007912848,0.00006367641,0.000016942618,0.00024127279],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99799365,0.00009980439,0.000797146,0.00025717285,0.0005438645,0.00030836184],"domain_scores_gemma":[0.9984037,0.000027860702,0.0005737113,0.00034381964,0.00034859337,0.0003022804],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059722265,0.0002390802,0.0008570796,0.00004062198,0.00007208949,0.000014205808,0.0001769162,0.0003728496,0.0020442873],"category_scores_gemma":[0.00022926115,0.00016165608,0.00055841845,0.00021616524,0.00016908757,0.00010893357,0.00003623628,0.00060939806,0.0000112843245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013784867,0.00013097104,0.0008083127,0.00028429806,0.00018355322,0.00005170488,0.00005954456,0.0000026921075,0.8394848,0.0000028551244,0.000026275458,0.15758651],"study_design_scores_gemma":[0.0016828189,0.0005949072,0.063197374,0.00038906583,0.00007293621,0.000891109,0.000074093485,0.00002931225,0.9314083,0.0001265417,0.0013321018,0.00020147847],"about_ca_topic_score_codex":0.00006351085,"about_ca_topic_score_gemma":6.8761767e-7,"teacher_disagreement_score":0.15738504,"about_ca_system_score_codex":0.00014858355,"about_ca_system_score_gemma":0.00018596399,"threshold_uncertainty_score":0.998868},"labels":[],"label_agreement":null},{"id":"W2085237214","doi":"10.1161/circulationaha.111.057406","title":"Gene Inactivation of Proprotein Convertase Subtilisin/Kexin Type 9 Reduces Atherosclerosis in Mice","year":2012,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Kexin; PCSK9; Internal medicine; Endocrinology; Proprotein convertase; Apolipoprotein B; LDL receptor; Cholesterol; Medicine; Lipoprotein; Familial hypercholesterolemia; Genetically modified mouse; Knockout mouse; Subtilisin; Receptor; Apolipoprotein E; Transgene; Chemistry; Biochemistry; Enzyme; Gene","score_opus":0.0353667355824985,"score_gpt":0.27363805539220193,"score_spread":0.23827131980970342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085237214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978572,0.0006594792,0.000277523,0.00012501744,0.0001250089,0.0007316635,0.0000020642558,0.000021007087,0.00020105274],"genre_scores_gemma":[0.9991545,0.000039469476,0.00043562037,0.000055755387,0.00019471908,0.000027077287,0.000058312715,0.000016345717,0.000018191025],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990877,0.0000740856,0.00025886833,0.00013839427,0.0002689598,0.00017197515],"domain_scores_gemma":[0.9994652,0.00001231164,0.000109105946,0.00021582244,0.000125581,0.00007197869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005503615,0.00008388058,0.00021956273,0.00010653441,0.000026736048,0.000004509382,0.000028775914,0.00010010235,0.000038028953],"category_scores_gemma":[0.00011728573,0.00007741084,0.00006877866,0.00028861818,0.000025778649,0.00018668936,0.000009468909,0.000090738264,0.000013118192],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009485145,0.00017892961,0.2583109,0.00015412933,0.000030963132,5.155704e-7,0.0007274925,0.000028926032,0.72358954,0.00009547048,0.000010873186,0.016777413],"study_design_scores_gemma":[0.00058535545,0.00003331567,0.66100866,0.000077564866,0.000027424372,0.000006284592,0.000075289834,0.00018186099,0.33785143,0.000023642777,0.000074334035,0.000054869648],"about_ca_topic_score_codex":0.00057388714,"about_ca_topic_score_gemma":0.0000067112355,"teacher_disagreement_score":0.4026977,"about_ca_system_score_codex":0.00014831974,"about_ca_system_score_gemma":0.000084794396,"threshold_uncertainty_score":0.31567225},"labels":[],"label_agreement":null},{"id":"W2085269115","doi":"10.1016/j.cardfail.2004.06.308","title":"Effect of statin use and smoking status on two-year mortality in an unselected heart failure population","year":2004,"lang":"en","type":"article","venue":"Journal of Cardiac Failure","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Dyslipidemia; Heart failure; Myocardial infarction; Hazard ratio; Internal medicine; Statin; Population; Medical prescription; Cardiology; Disease; Environmental health; Confidence interval","score_opus":0.011108672684037618,"score_gpt":0.293272217927937,"score_spread":0.2821635452438994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085269115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998786,0.00036256548,0.000027014965,0.00022592003,0.000105755826,0.00045457593,0.000016546743,0.000009715074,0.000011915111],"genre_scores_gemma":[0.99801004,0.00006995461,0.0015282927,0.000059959555,0.00027303616,0.0000035714882,0.000028935456,0.000024961344,0.0000012726183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780375,0.000511649,0.00050786167,0.00017481625,0.00074587256,0.0002560809],"domain_scores_gemma":[0.99890006,0.00007397093,0.00025467825,0.00029446834,0.00023854407,0.00023827022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016540581,0.00016569886,0.0008314499,0.00024203541,0.000038243797,0.000033299097,0.00003738985,0.00011863611,0.000004450433],"category_scores_gemma":[0.0002676418,0.00012745232,0.0003168934,0.0002904108,0.000029628318,0.00026217074,0.0000116753545,0.0004884915,4.110152e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006636854,0.00007597931,0.98924524,0.00024629457,0.00027567058,0.000037589598,0.0002549966,0.001118262,0.0049291393,0.00008452201,0.000081508486,0.0029871268],"study_design_scores_gemma":[0.004577081,0.0029508523,0.9840906,0.0004899519,0.0002965543,0.00008097891,0.0001769326,0.00000671844,0.006530325,0.000046300946,0.00064174744,0.000111932684],"about_ca_topic_score_codex":0.0011426192,"about_ca_topic_score_gemma":0.00028651394,"teacher_disagreement_score":0.0051546013,"about_ca_system_score_codex":0.00018701806,"about_ca_system_score_gemma":0.000186218,"threshold_uncertainty_score":0.5197355},"labels":[],"label_agreement":null},{"id":"W2085329543","doi":"10.1161/strokeaha.111.645978","title":"Association of Statins and Statin Discontinuation With Poor Outcome and Survival After Intracerebral Hemorrhage","year":2012,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Toronto; Toronto General Hospital; Institute for Clinical Evaluative Sciences; University of Calgary; University of Ottawa","funders":"","keywords":"Medicine; Discontinuation; Intracerebral hemorrhage; Statin; Stroke (engine); Internal medicine; Surgery; Subarachnoid hemorrhage","score_opus":0.009212690030310187,"score_gpt":0.2538008083266343,"score_spread":0.24458811829632413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085329543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99752337,0.0003586674,0.00080266496,0.00050902145,0.00005966005,0.00028370408,0.000067012996,0.000011426551,0.00038447377],"genre_scores_gemma":[0.9946415,0.000019785903,0.00395926,0.00007562888,0.00014102343,0.000016393895,0.000017838734,0.000011212128,0.0011173793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919444,0.000059707898,0.00016851879,0.000099329925,0.00029678768,0.00018121049],"domain_scores_gemma":[0.99960715,0.000031949898,0.00009859579,0.000104976054,0.000055673514,0.0001016534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058552943,0.00007746735,0.00024002914,0.000033857115,0.00002412763,0.000010191294,0.000010702459,0.000042173997,0.000033944547],"category_scores_gemma":[0.00007054734,0.00005580736,0.000032530552,0.000040897434,0.00002459096,0.00012627158,0.000014678753,0.00009274125,0.0000013765471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012140527,0.00004548252,0.9792947,0.00013303489,0.00008881257,0.0000023543068,0.00050271576,1.0895897e-7,0.0002893006,0.00007395907,0.000011799372,0.019436322],"study_design_scores_gemma":[0.0016405911,0.00022396077,0.99638367,0.000020568916,0.00017033641,0.000010258231,0.0005705703,0.000033184384,0.0005878898,0.00000535569,0.0002881375,0.00006546416],"about_ca_topic_score_codex":0.00016628923,"about_ca_topic_score_gemma":0.00016176894,"teacher_disagreement_score":0.019370858,"about_ca_system_score_codex":0.00004128918,"about_ca_system_score_gemma":0.000024804252,"threshold_uncertainty_score":0.22757581},"labels":[],"label_agreement":null},{"id":"W2085670902","doi":"10.1136/ebn.8.3.86","title":"Review: statins reduce non-fatal and fatal strokes in patients with and without coronary heart disease","year":2005,"lang":"en","type":"letter","venue":"Evidence-Based Nursing","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Medicine; Web of science; Internal medicine; Placebo; Coronary heart disease; Cochrane Library; Randomized controlled trial; Gastroenterology; Meta-analysis; Pathology","score_opus":0.020852913877133037,"score_gpt":0.29488644659329827,"score_spread":0.2740335327161652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085670902","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4427682,0.18563719,0.00012886616,0.3666069,0.00023546646,0.004335769,0.00018208376,0.000066368884,0.000039179242],"genre_scores_gemma":[0.37454736,0.01215586,0.0043774378,0.6025714,0.0039247083,0.00026878715,0.001611884,0.00026086427,0.0002816403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678344,0.00030081364,0.00048299946,0.00085147505,0.0010088031,0.00057246146],"domain_scores_gemma":[0.9984464,0.00009819313,0.00019560942,0.00073927135,0.00014916169,0.00037135818],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00055526046,0.00048676165,0.0010492551,0.00022343585,0.0001299288,0.00005501585,0.00009655354,0.00023081232,0.000023181661],"category_scores_gemma":[0.00016762043,0.0003904589,0.00014212853,0.00020519868,0.0003259442,0.00035660327,0.000028969966,0.001257223,0.000004492179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031356157,0.00044683932,0.4566864,0.024656909,0.00019086279,0.0006285188,0.00026910944,0.000011725017,0.000021118256,5.718333e-7,0.34463382,0.16931853],"study_design_scores_gemma":[0.0048176656,0.0013172243,0.7317027,0.22387306,0.0008906557,0.00010231783,0.000037610345,0.000078418474,0.000024619005,0.0000042895817,0.036468063,0.00068340584],"about_ca_topic_score_codex":0.00015020944,"about_ca_topic_score_gemma":0.0000057133366,"teacher_disagreement_score":0.30816573,"about_ca_system_score_codex":0.00036498404,"about_ca_system_score_gemma":0.0007945554,"threshold_uncertainty_score":0.99985474},"labels":[],"label_agreement":null},{"id":"W2085762854","doi":"10.1021/bi061814g","title":"Nuclear Magnetic Resonance (NMR) Solution Structure, Dynamics, and Binding Properties of the Kringle IV Type 8 Module of Apolipoprotein(a)<sup>,</sup>","year":2007,"lang":"en","type":"article","venue":"Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto","funders":"","keywords":"Lysine; Chemistry; Kringle domain; Stereochemistry; Lipoprotein; Apolipoprotein B; Lipoprotein(a); Covalent bond; Plasma protein binding; Crystallography; Biochemistry; Amino acid; Plasmin; Cholesterol; Organic chemistry","score_opus":0.009185002285815752,"score_gpt":0.20969491708805565,"score_spread":0.2005099148022399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085762854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924625,0.006653118,0.0000125943625,0.00009155294,0.000038328883,0.0003090416,0.000024247469,0.000017808123,0.00039077832],"genre_scores_gemma":[0.998773,0.0001036949,0.00046378793,0.000028194694,0.00014019957,0.0000019981987,0.000007873412,0.000021618576,0.00045965833],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898607,0.000016928707,0.0002581117,0.00020597236,0.00031675008,0.00021616895],"domain_scores_gemma":[0.9992172,0.0000048792394,0.00009818186,0.00048955274,0.00011664997,0.00007349482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027267425,0.00011963295,0.0002427923,0.000030557538,0.00007395834,0.0000059092913,0.00010409185,0.00014468562,0.000022176402],"category_scores_gemma":[0.00010945066,0.00008542416,0.00009279605,0.00017675823,0.00020410615,0.000023248405,0.00008679803,0.00016028939,8.2739814e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022974926,0.000062294035,0.0046039633,0.0016347305,0.000046777328,0.000003354584,0.00020469741,0.000008086122,0.96149313,0.00011658721,0.00007968814,0.03151696],"study_design_scores_gemma":[0.00057716784,0.00011624825,0.009493704,0.00049372937,0.000066368855,0.00007592306,0.0003338502,0.0023862694,0.985993,0.000024294406,0.0003244965,0.00011493439],"about_ca_topic_score_codex":0.00029904564,"about_ca_topic_score_gemma":0.000009917039,"teacher_disagreement_score":0.03140203,"about_ca_system_score_codex":0.00009340619,"about_ca_system_score_gemma":0.00009345422,"threshold_uncertainty_score":0.3483496},"labels":[],"label_agreement":null},{"id":"W2085828681","doi":"10.1001/jama.288.4.462","title":"Adherence With Statin Therapy in Elderly Patients With and Without Acute Coronary Syndromes","year":2002,"lang":"en","type":"article","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1085,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Statin; Coronary artery disease; Medical prescription; Internal medicine; Acute coronary syndrome; Cohort; Population; Cohort study; Physical therapy; Myocardial infarction; Pharmacology","score_opus":0.016729764297087918,"score_gpt":0.24805822942350103,"score_spread":0.2313284651264131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085828681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972316,0.00087201333,0.000038845337,0.00039487603,0.0000153317,0.0007300367,0.000007901906,0.000027149898,0.00068223424],"genre_scores_gemma":[0.99716127,0.0005705886,0.0012984354,0.0005803996,0.000028052664,0.000053411277,0.0000115378425,0.000022183624,0.00027414065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904406,0.00004111014,0.00012489027,0.00023016227,0.00035346765,0.00020628826],"domain_scores_gemma":[0.99949425,0.000010866115,0.000046094112,0.00026443665,0.000074604926,0.00010974928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087267545,0.00012906505,0.0002848722,0.000051319024,0.00003734822,0.00002000627,0.000039549053,0.00005322463,0.000085668114],"category_scores_gemma":[0.0000084462445,0.00007726085,0.00002486171,0.00014278515,0.00005761999,0.00011795555,0.00001033735,0.00016981122,0.0000073172573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055367476,0.00014943522,0.6731359,0.000039444367,0.00015592485,0.00010809643,0.0004841739,7.5579123e-7,0.000013524643,0.000005310738,0.00010083027,0.32525298],"study_design_scores_gemma":[0.012412531,0.005985148,0.9801859,0.00022116772,0.000042000993,0.00018328996,0.00010859929,0.000039627997,0.00006885695,0.00000714878,0.0006208751,0.00012480943],"about_ca_topic_score_codex":0.00022074497,"about_ca_topic_score_gemma":0.000055276858,"teacher_disagreement_score":0.32512817,"about_ca_system_score_codex":0.000022033226,"about_ca_system_score_gemma":0.00003709282,"threshold_uncertainty_score":0.3150606},"labels":[],"label_agreement":null},{"id":"W2085912966","doi":"10.1016/s0828-282x(06)70999-0","title":"Prevention challenges: The era of atherosclerosis regression","year":2006,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Regression; Internal medicine; Statistics","score_opus":0.0790666907225826,"score_gpt":0.3238646923500262,"score_spread":0.24479800162744358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085912966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005098181,0.9953588,0.00016140477,0.0003497283,0.00065858406,0.00053422246,0.000020237356,0.000002648487,0.0028633683],"genre_scores_gemma":[0.0012899134,0.99560934,0.00006532512,0.00002611705,0.0028155744,0.000014716732,0.000017529053,0.000039238672,0.00012222763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758035,0.0007593161,0.0009094481,0.00017190592,0.00027035162,0.0003086235],"domain_scores_gemma":[0.9978452,0.00007499657,0.0008546735,0.00059907354,0.00027942978,0.000346625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016344255,0.0002422075,0.0028368488,0.00023731637,0.0000786762,0.000007112664,0.00025183495,0.00048075762,0.000013169414],"category_scores_gemma":[0.00013271523,0.00013000879,0.002518169,0.00016603098,0.00016320805,0.000028735512,0.000013629874,0.00096276205,0.0000050993244],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000051795178,0.0000022451704,0.000022331364,0.0037237748,0.00081251556,0.00005146732,0.000030354,0.0000052840883,2.3346234e-7,0.00007126911,0.0034140232,0.99186134],"study_design_scores_gemma":[0.000339161,0.00034033007,0.00067847024,0.016022893,0.0022111698,0.002228094,0.00003748933,1.002111e-7,6.359418e-7,0.000053400978,0.9779938,0.00009446419],"about_ca_topic_score_codex":0.00084246445,"about_ca_topic_score_gemma":0.0006942434,"teacher_disagreement_score":0.99176687,"about_ca_system_score_codex":0.00027974937,"about_ca_system_score_gemma":0.004538288,"threshold_uncertainty_score":0.8050728},"labels":[],"label_agreement":null},{"id":"W2085942677","doi":"10.1016/j.amjmed.2005.11.015","title":"Contemporary Management of Dyslipidemia in High-Risk Patients: Targets Still Not Met","year":2006,"lang":"en","type":"article","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Canadian Heart Research Centre","funders":"Canadian Institutes of Health Research; Sanofi; Pfizer","keywords":"Medicine; Dyslipidemia; Internal medicine; Diabetes mellitus; Statin; Coronary artery disease; Cholesterol; Ambulatory; National Cholesterol Education Program; Lipid profile; Cardiology; Disease; Endocrinology; Metabolic syndrome","score_opus":0.010795008521497411,"score_gpt":0.2573532529925356,"score_spread":0.24655824447103816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085942677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895605,0.0035148072,0.000531056,0.004780347,0.00023126719,0.0003699317,0.0000068503723,0.0000066128573,0.0009986442],"genre_scores_gemma":[0.9958934,0.0008357448,0.0013482367,0.0011603714,0.0006693178,0.0000042236834,0.0000070671144,0.000019686038,0.000061920626],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972922,0.00034579475,0.0010395745,0.0001321594,0.000971333,0.0002189469],"domain_scores_gemma":[0.99776614,0.00011832767,0.0013251093,0.0004156816,0.00024607158,0.00012869391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029193957,0.00015471625,0.0011167508,0.00021986087,0.000026898299,0.000001900767,0.00019537573,0.000025052384,0.00003234198],"category_scores_gemma":[0.00012694114,0.000081538914,0.00018839614,0.0004595001,0.00045147564,0.000051915882,0.00003746456,0.00040199986,0.0000022583818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006657256,0.0010884352,0.34969395,0.0005935875,0.002291872,0.0008514208,0.0011990594,0.00028276688,0.00060081354,0.0008311662,0.030159548,0.60575014],"study_design_scores_gemma":[0.012050046,0.0053716204,0.96905774,0.0011253275,0.0005822714,0.00006150265,0.0018263186,0.0000172608,0.00032816757,0.0003864081,0.009083644,0.000109695204],"about_ca_topic_score_codex":0.0027724733,"about_ca_topic_score_gemma":0.000007966099,"teacher_disagreement_score":0.6193638,"about_ca_system_score_codex":0.000100863705,"about_ca_system_score_gemma":0.00009000739,"threshold_uncertainty_score":0.41911688},"labels":[],"label_agreement":null},{"id":"W2086019168","doi":"10.3821/1913-701x(2008)141[170:acorrm]2.0.co;2","title":"A case of rosuvastatin-induced rhabdomyolysis: More is not better","year":2008,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Rhabdomyolysis; Medicine; Internal medicine","score_opus":0.054244746628720704,"score_gpt":0.28850828375018633,"score_spread":0.23426353712146564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086019168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963501,0.00079231116,0.000065251494,0.0005769579,0.00078163075,0.0005126352,0.0004264315,0.000020007066,0.00047465035],"genre_scores_gemma":[0.98476374,0.0017496899,0.0005722308,0.011218923,0.0012005703,0.000021621443,0.00001844853,0.00007823036,0.0003765518],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9966305,0.00015495927,0.00087732705,0.00045017296,0.00081229146,0.0010747393],"domain_scores_gemma":[0.9948544,0.000050009075,0.00033024402,0.00054503256,0.0009027133,0.0033176118],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00066067313,0.00041053107,0.00084283354,0.000492805,0.00085111364,0.000041717623,0.0002925533,0.00009633882,0.0009301608],"category_scores_gemma":[0.00013055293,0.00039956006,0.00053988304,0.0007612134,0.00022721995,0.00022796824,0.00003405748,0.0008794483,0.000010177934],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017833238,0.00006188789,0.0017335464,0.00043893536,0.00084372045,0.85671645,0.0031136896,0.00004741996,0.0073376596,0.0000044005806,0.017059255,0.1124647],"study_design_scores_gemma":[0.0033543447,0.000088795336,0.000102991784,0.000037800113,0.00044631085,0.9551469,0.000036711754,0.0007478034,0.025400614,0.000004722629,0.0142517015,0.00038129603],"about_ca_topic_score_codex":0.12838006,"about_ca_topic_score_gemma":0.03774323,"teacher_disagreement_score":0.112083405,"about_ca_system_score_codex":0.0017207954,"about_ca_system_score_gemma":0.008353615,"threshold_uncertainty_score":0.99998313},"labels":[],"label_agreement":null},{"id":"W2086031899","doi":"10.1111/j.1742-1241.2009.02154.x","title":"Le bon et le mauvais: nouvelles connaissances sur le cholestérol alimentaire, la maîtrise des lipides et le risque de maladies cardiovasculaires depuis la<i>Harvard Egg Study</i>","year":2009,"lang":"fr","type":"article","venue":"International Journal of Clinical Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Gynecology","score_opus":0.04898465484159227,"score_gpt":0.4099373077961376,"score_spread":0.3609526529545453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086031899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5695049,0.1457106,0.010120306,0.20718566,0.006171597,0.0015286711,0.00009179399,0.00011894844,0.059567533],"genre_scores_gemma":[0.93925005,0.043618735,0.00523156,0.0068878713,0.004348997,0.000018595752,0.000010469276,0.00006555478,0.0005681781],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98718673,0.006882081,0.002654713,0.0005667085,0.0021079783,0.0006017957],"domain_scores_gemma":[0.98913026,0.005813484,0.0018528238,0.0005631026,0.0020215646,0.0006187446],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.024013877,0.00045812654,0.001592205,0.00024421574,0.0002972499,0.00045169177,0.0007741166,0.00042565336,0.00005004307],"category_scores_gemma":[0.014510592,0.00042943485,0.0019043657,0.0002289287,0.00067051576,0.0024602173,0.00018823877,0.0021801942,0.00005177016],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012833466,0.037921153,0.054355606,0.0005665744,0.038207866,0.018551515,0.0045349314,0.007918964,0.00027476772,0.06746393,0.028951157,0.7284201],"study_design_scores_gemma":[0.01885384,0.002282053,0.21014583,0.002326025,0.00209317,0.0082335165,0.011744267,0.00022788283,0.0006877001,0.0017266386,0.74117434,0.000504724],"about_ca_topic_score_codex":0.009727958,"about_ca_topic_score_gemma":0.00053541095,"teacher_disagreement_score":0.72791535,"about_ca_system_score_codex":0.00023025087,"about_ca_system_score_gemma":0.007692034,"threshold_uncertainty_score":0.99981576},"labels":[],"label_agreement":null},{"id":"W2086048382","doi":"10.1016/j.atherosclerosis.2014.12.017","title":"On the function and homeostasis of PCSK9: Reciprocal interaction with LDLR and additional lipid effects","year":2014,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"PCSK9; LDL receptor; Kexin; Proprotein convertase; Internal medicine; Endocrinology; Lipoprotein; Cholesterol; Triglyceride; Chemistry; Low-density lipoprotein; Receptor; Biology; Biochemistry; Medicine","score_opus":0.02894416697093795,"score_gpt":0.27295901682571855,"score_spread":0.2440148498547806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086048382","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047357227,0.9916504,0.00033490182,0.000170392,0.00024402977,0.0022307313,0.00018080368,0.00004541656,0.0004076225],"genre_scores_gemma":[0.004900095,0.99350214,0.00012541158,0.00027957966,0.00042096488,0.000450163,0.00019371111,0.000060715272,0.00006724785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985583,0.00024258383,0.00029556174,0.00036482033,0.0003762896,0.00016247306],"domain_scores_gemma":[0.9984928,0.0006582593,0.00026402812,0.00041704014,0.000064882784,0.00010304093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004460125,0.0002896911,0.0011503528,0.00009815427,0.00011316101,0.000025092055,0.00004740651,0.00020832592,0.00017234596],"category_scores_gemma":[0.00013768153,0.00015232786,0.00028829795,0.00017862929,0.000121871846,0.000045362238,0.00003307739,0.00038024288,0.000016541644],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008157257,0.0000569345,0.000013517518,0.009803894,0.00046676162,3.3966012e-7,0.000021303285,8.429892e-8,0.000002896732,0.0004191789,0.0011141557,0.98801935],"study_design_scores_gemma":[0.0009330108,0.0023803655,0.004294757,0.041056443,0.0025901715,0.00008407193,0.000027005559,0.000004304175,0.0000151716395,0.00006420491,0.94831157,0.00023891304],"about_ca_topic_score_codex":0.00003834697,"about_ca_topic_score_gemma":0.0000065482213,"teacher_disagreement_score":0.98778045,"about_ca_system_score_codex":0.00006590761,"about_ca_system_score_gemma":0.00008173683,"threshold_uncertainty_score":0.621175},"labels":[],"label_agreement":null},{"id":"W2086225735","doi":"10.1177/1715163513481319","title":"Putting cardiovascular risk into perspective","year":2013,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Perspective (graphical); Medicine; Computer science; Artificial intelligence","score_opus":0.01668321531454299,"score_gpt":0.24996484198323496,"score_spread":0.23328162666869195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086225735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682138,0.020518728,0.0009491535,0.0005612547,0.0024912297,0.0017259138,0.00012653849,0.000082796694,0.00533056],"genre_scores_gemma":[0.9825154,0.009638906,0.0018763811,0.0023606773,0.003015673,0.000065188906,0.000015410375,0.00010106533,0.00041129396],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9959599,0.00035286436,0.00063599495,0.00061720697,0.0010523207,0.0013817076],"domain_scores_gemma":[0.9928445,0.000052340365,0.00022620359,0.0006674456,0.0017156336,0.004493869],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014661025,0.00046307777,0.0008319486,0.00044954513,0.0014109653,0.0002431392,0.0004097537,0.000106505584,0.0013155161],"category_scores_gemma":[0.00050064176,0.00044632025,0.00096521777,0.0007568831,0.00019354794,0.00044380713,0.000051004594,0.0013809879,0.00008695213],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000061603714,0.000064328575,0.0048677973,0.0004609657,0.004563508,0.08525577,0.0028651117,0.0011714083,0.0007951791,0.00007047827,0.02407406,0.87574977],"study_design_scores_gemma":[0.0050653103,0.00012466108,0.00055274693,0.00006973477,0.0016209957,0.82606333,0.00019049681,0.0034530042,0.001572955,0.00056827907,0.15982592,0.0008925775],"about_ca_topic_score_codex":0.5922585,"about_ca_topic_score_gemma":0.072569296,"teacher_disagreement_score":0.8748572,"about_ca_system_score_codex":0.0070652,"about_ca_system_score_gemma":0.0074919914,"threshold_uncertainty_score":0.9998891},"labels":[],"label_agreement":null},{"id":"W2086247967","doi":"10.2147/dddt.s36984","title":"The biology of PCSK9 from the endoplasmic reticulum to lysosomes: new and emerging therapeutics to control low-density lipoprotein cholesterol","year":2013,"lang":"en","type":"review","venue":"Drug Design Development and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Institut de Cardiologie de Montréal; Fondation Institut de Cardiologie de Montréal; Heart and Stroke Foundation of Canada","keywords":"PCSK9; LDL receptor; Kexin; Proprotein convertase; Cholesterol; Lipoprotein; Low-density lipoprotein; Endocrinology; Medicine; Internal medicine; Pharmacology; Biology","score_opus":0.0452173383743127,"score_gpt":0.2978546919823394,"score_spread":0.2526373536080267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086247967","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01488606,0.97229475,0.0039511644,0.0018932935,0.00020568425,0.0067080846,0.000009277459,0.000032608667,0.000019094497],"genre_scores_gemma":[0.0019446356,0.9923994,0.0025830823,0.0018127285,0.00035867718,0.00051876146,0.000021397993,0.000067925444,0.00029341746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99718434,0.0006208083,0.00078362314,0.00057066325,0.0003710259,0.00046952846],"domain_scores_gemma":[0.9980151,0.0005257933,0.0002799602,0.00075219554,0.0001222505,0.000304695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014485525,0.00054401025,0.0017257663,0.000111613364,0.00032308107,0.00009055024,0.00031744788,0.00022787214,0.000016117916],"category_scores_gemma":[0.000046115223,0.000264372,0.00025754765,0.00026077344,0.00010617226,0.0000337666,0.00009626775,0.00038141786,0.000028338432],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009917734,0.000023417242,0.000031753683,0.0003377556,0.001315315,0.0000027622466,0.0015930105,1.5685515e-7,0.00008672068,0.00003422635,0.0002251218,0.99625057],"study_design_scores_gemma":[0.0016007219,0.0001668994,0.00032025986,0.0026736772,0.0003475884,0.000027850661,0.00012824147,0.0000037493724,0.0018845098,0.00012445176,0.99239445,0.00032763244],"about_ca_topic_score_codex":0.0006431204,"about_ca_topic_score_gemma":0.000055839366,"teacher_disagreement_score":0.9959229,"about_ca_system_score_codex":0.000059495003,"about_ca_system_score_gemma":0.0006837782,"threshold_uncertainty_score":0.99998087},"labels":[],"label_agreement":null},{"id":"W2086435918","doi":"10.1016/j.amjcard.2014.01.418","title":"Risk and the Physics of Clinical Prediction","year":2014,"lang":"en","type":"review","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University Health Centre; McGill University","keywords":"Physics","score_opus":0.041809410350901494,"score_gpt":0.37682349324646525,"score_spread":0.3350140828955638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086435918","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009923909,0.99254304,0.0050340206,0.0001682242,0.00045091685,0.00044212182,0.000015128169,0.0000040191544,0.00035011684],"genre_scores_gemma":[0.0051707523,0.9880189,0.00013591656,0.00012646153,0.0065050963,0.000007978852,0.0000024113235,0.00002286249,0.000009660614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99298793,0.004993006,0.0013951026,0.00014162372,0.00032627385,0.00015608025],"domain_scores_gemma":[0.99434775,0.001323404,0.0033487298,0.00066386705,0.00021431493,0.00010195982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010072803,0.00018338754,0.00624195,0.00005007612,0.000057122732,0.0000040505283,0.00022167768,0.00010955006,0.0000010837367],"category_scores_gemma":[0.00075207837,0.000069982234,0.0029440552,0.00017826573,0.0018826826,0.000013545504,0.00006134261,0.0012574077,0.000002161653],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028669313,0.0000058959254,0.0002874987,0.00067355396,0.0030186125,0.000007633501,0.000023474207,0.000006626455,1.950126e-8,0.00008848266,0.0002751109,0.9953264],"study_design_scores_gemma":[0.0014393828,0.0016218888,0.0018133386,0.0014096005,0.012190997,0.004816244,0.000059989317,0.0000075548996,6.445402e-8,0.00022483587,0.97635305,0.000063078],"about_ca_topic_score_codex":0.000032741915,"about_ca_topic_score_gemma":1.653781e-7,"teacher_disagreement_score":0.99526334,"about_ca_system_score_codex":0.000021734537,"about_ca_system_score_gemma":0.00041320254,"threshold_uncertainty_score":0.69368225},"labels":[],"label_agreement":null},{"id":"W2087492770","doi":"10.1186/1741-7015-11-58","title":"Do statins lower testosterone and does it matter?","year":2013,"lang":"en","type":"letter","venue":"BMC Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Testosterone (patch); Confidence interval; Drug; Diabetes mellitus; Internal medicine; Intensive care medicine; Pharmacology; Endocrinology","score_opus":0.024412064223158503,"score_gpt":0.2750408317652989,"score_spread":0.2506287675421404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087492770","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015184877,0.006109632,0.00042241157,0.9641885,0.0015794466,0.0022283827,0.000047968413,0.00011167841,0.0101270955],"genre_scores_gemma":[0.0019148542,0.0010628565,0.0018795796,0.9311749,0.020530079,0.00021116786,0.00044900982,0.00017594185,0.042601623],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640226,0.00016383616,0.0007001135,0.0008443457,0.001237372,0.00065203937],"domain_scores_gemma":[0.9974683,0.00021135944,0.0002425345,0.0015342707,0.00019850694,0.0003450585],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067698857,0.0005662645,0.0015391404,0.00026275084,0.00008766633,0.000035122728,0.00017071083,0.000708734,0.00622963],"category_scores_gemma":[0.00021988164,0.00031258797,0.00020560404,0.00015284428,0.00033844748,0.00007131318,0.00010894611,0.0016107555,0.0006466143],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035215337,0.000027007489,0.0029269455,0.003309018,0.00020759819,0.00053436175,0.0002498511,6.8271355e-8,0.000057380927,0.0000033917581,0.9878346,0.004814608],"study_design_scores_gemma":[0.0031044479,0.0007881327,0.0110962475,0.0026920938,0.0007351272,0.00069912645,0.00021646182,0.0000074136333,0.000014182445,0.00007772998,0.98019344,0.00037562737],"about_ca_topic_score_codex":0.0009403182,"about_ca_topic_score_gemma":0.000042968255,"teacher_disagreement_score":0.03301362,"about_ca_system_score_codex":0.00010337441,"about_ca_system_score_gemma":0.0002257242,"threshold_uncertainty_score":0.99993265},"labels":[],"label_agreement":null},{"id":"W2087693041","doi":"10.1016/j.ijcard.2007.10.055","title":"Changing trends (1986–2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: A community-based perspective","year":2008,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Myocardial infarction; Regimen; Observational study; Medical record; Population; Internal medicine; Emergency medicine; Intensive care medicine","score_opus":0.02847540593631132,"score_gpt":0.2908016021722462,"score_spread":0.2623261962359349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087693041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946754,0.000050904408,0.0026715668,0.0014512894,0.0005184006,0.0001699736,0.000009123214,0.0000041929347,0.000449177],"genre_scores_gemma":[0.9983223,0.00016947457,0.00036182435,0.000565026,0.00052249065,0.000013281441,0.00002937556,0.000009885653,0.0000063436823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981674,0.00045133234,0.000431221,0.000090680405,0.0007097267,0.00014966345],"domain_scores_gemma":[0.99829584,0.000072940384,0.00028358077,0.00020746786,0.001094942,0.000045235854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009747233,0.000102236576,0.00046775222,0.00074406696,0.000045731715,0.0000066591524,0.00019497,0.00007871209,0.0000052308983],"category_scores_gemma":[0.00022284636,0.00006888219,0.00021306521,0.00046366305,0.00013077527,0.00014085532,0.000027936063,0.00052885286,4.3097867e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064192475,0.00047434578,0.9648833,0.000026350888,0.0035109858,0.0009960267,0.008319745,0.005159796,0.000106721905,0.00017290183,0.00042697668,0.009503587],"study_design_scores_gemma":[0.0069894637,0.0012569726,0.986401,0.00014777495,0.00010996186,0.0014118302,0.00046690347,0.00006389696,0.000064637876,0.000013815551,0.0030017798,0.00007196613],"about_ca_topic_score_codex":0.00021947251,"about_ca_topic_score_gemma":0.000008932917,"teacher_disagreement_score":0.021517683,"about_ca_system_score_codex":0.00030818116,"about_ca_system_score_gemma":0.0002736384,"threshold_uncertainty_score":0.28089342},"labels":[],"label_agreement":null},{"id":"W2087836969","doi":"10.1007/s11886-014-0479-2","title":"The Role of Genetic Risk Factors in Coronary Artery Disease","year":2014,"lang":"en","type":"review","venue":"Current Cardiology Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Mendelian randomization; Medicine; Coronary artery disease; Genome-wide association study; Myocardial infarction; Disease; Mendelian inheritance; Genetic association; PCSK9; Population; Internal medicine; Clinical trial; Familial hypercholesterolemia; Bioinformatics; Cardiology; Genetic variants; Single-nucleotide polymorphism; Genetics; Genotype; Cholesterol; Gene; LDL receptor","score_opus":0.025009448098352927,"score_gpt":0.3119017345472293,"score_spread":0.2868922864488764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087836969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008664629,0.98747456,0.000031547657,0.000003088521,0.0017966481,0.0017996134,0.000033071392,0.000025586027,0.00017127737],"genre_scores_gemma":[0.024321036,0.9743629,0.00000596499,0.000003069797,0.00074747123,0.00026547164,0.00022632841,0.00004879286,0.00001896807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99616903,0.0009160717,0.0014718461,0.0006282498,0.0003850266,0.00042979812],"domain_scores_gemma":[0.99660933,0.00019903993,0.0009627662,0.0018609377,0.0000853777,0.0002825255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013299442,0.00041470933,0.0033479566,0.00015128966,0.000083049206,0.0000065667086,0.00013601467,0.0002903648,0.000005609306],"category_scores_gemma":[0.0004571506,0.00023908948,0.0022384478,0.00017102367,0.00021632343,0.000014408925,0.00011195449,0.0007880289,0.000007577367],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010376728,0.000026135194,0.12956834,0.0045404006,0.0005641199,0.00077944715,0.000009651308,0.0000036453682,2.8827044e-8,0.0000040059977,0.000104683015,0.8643892],"study_design_scores_gemma":[0.0001340877,0.000062373954,0.08644234,0.003220047,0.0028567612,0.002582109,0.000009434002,0.0000020297039,1.1705106e-7,0.00015961101,0.9043465,0.0001845589],"about_ca_topic_score_codex":0.0000371661,"about_ca_topic_score_gemma":0.0000030776873,"teacher_disagreement_score":0.90424186,"about_ca_system_score_codex":0.00012946354,"about_ca_system_score_gemma":0.0009066929,"threshold_uncertainty_score":0.9749786},"labels":[],"label_agreement":null},{"id":"W2088083980","doi":"10.1016/j.cjca.2012.05.003","title":"Clinical Value of Drugs Targeting Inflammation for the Management of Coronary Artery Disease","year":2012,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Inflammation; Coronary artery disease; Disease; Cause of death; Arterial wall; Clinical trial; Coronary atherosclerosis; Vulnerable plaque; Immunology; Cardiology; Internal medicine","score_opus":0.050156886337765265,"score_gpt":0.33738614177291976,"score_spread":0.2872292554351545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088083980","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002476292,0.99457526,0.002117707,0.00015700051,0.0012646124,0.0012250962,0.000067020905,0.0000015728243,0.0003441149],"genre_scores_gemma":[0.013268145,0.98184496,0.0005061843,0.00003642527,0.004196246,0.00003404287,0.00004918414,0.00003124708,0.000033560904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973134,0.0004889429,0.0015260207,0.00013433064,0.0002312205,0.00030609884],"domain_scores_gemma":[0.9973044,0.00027182457,0.0010509014,0.00045204564,0.0002971331,0.000623731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004102637,0.00018206761,0.0023064492,0.00019730927,0.000056462875,0.0000035822397,0.00022184446,0.00022197238,0.000008910717],"category_scores_gemma":[0.00013049398,0.000114034934,0.0025016484,0.000103032005,0.00018039721,0.0000357943,0.00002086446,0.0003946476,0.000001887732],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051592524,0.0000027224376,0.0004598123,0.016029896,0.0045414437,0.00010418199,0.000026287753,0.000037268437,4.145321e-8,0.00039752762,0.000763743,0.9775855],"study_design_scores_gemma":[0.0006021603,0.00016212172,0.0045606936,0.004540192,0.011446081,0.00037190778,0.00008096586,0.0000030890508,1.3081596e-7,0.00004741621,0.9780983,0.00008695048],"about_ca_topic_score_codex":0.00006951984,"about_ca_topic_score_gemma":0.000010746526,"teacher_disagreement_score":0.97749853,"about_ca_system_score_codex":0.00015261504,"about_ca_system_score_gemma":0.0026055572,"threshold_uncertainty_score":0.46502095},"labels":[],"label_agreement":null},{"id":"W2088531744","doi":"10.1016/j.ahj.2003.10.004","title":"Effects of switching statins on achievement of lipid goals: measuring effective reductions in cholesterol using rosuvastatin therapy (MERCURY I) study","year":2004,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Rosuvastatin; Cholesterol; Mercury (programming language); Atorvastatin; Pharmacology; Internal medicine","score_opus":0.02669005245890768,"score_gpt":0.32484490924110704,"score_spread":0.29815485678219933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088531744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617755,0.0003228086,0.0015531768,0.00023479217,0.00014920963,0.001537113,0.0000017043196,0.000011456864,0.000012176826],"genre_scores_gemma":[0.9969568,0.00018058869,0.002366304,0.00016852772,0.00025798837,0.000035352048,3.8933075e-7,0.0000329516,0.0000010968427],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99759656,0.00057047,0.00058884674,0.00022625837,0.0007125507,0.00030533003],"domain_scores_gemma":[0.9989659,0.00012431626,0.00034975534,0.00026382497,0.00012938002,0.00016680427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014427692,0.00018152571,0.00079926144,0.0003534981,0.00012380384,0.000013761417,0.000067028865,0.000026234615,0.000003239725],"category_scores_gemma":[0.00013850741,0.00014788481,0.0002564611,0.00048319693,0.00008297059,0.00009449957,0.00002112877,0.0005751945,9.005296e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015087212,0.0072216187,0.21848357,0.00042395596,0.0013831449,0.00013195378,0.018276788,0.011460405,0.4754364,0.000011178109,0.000005972763,0.26565632],"study_design_scores_gemma":[0.00712234,0.009315045,0.8997814,0.0013452519,0.00011965643,0.00029779677,0.005393519,0.000029541497,0.07638838,0.000022588833,0.00003110298,0.00015338206],"about_ca_topic_score_codex":0.0032708854,"about_ca_topic_score_gemma":0.000038018265,"teacher_disagreement_score":0.68129784,"about_ca_system_score_codex":0.00035060465,"about_ca_system_score_gemma":0.00029186773,"threshold_uncertainty_score":0.6030567},"labels":[],"label_agreement":null},{"id":"W2088663756","doi":"10.3315/jdcr.2009.1026","title":"Erythromelalgia accompanying rosuvastatin-associated myopathy","year":2009,"lang":"en","type":"article","venue":"Journal of Dermatological Case Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Erythromelalgia; Medicine; Rosuvastatin; Discontinuation; Myopathy; Dermatology; Statin; Drug; Pharmacology; Internal medicine","score_opus":0.021129894807822982,"score_gpt":0.29080272813531904,"score_spread":0.2696728333274961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088663756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946587,0.0021741912,0.00039324406,0.0014466888,0.00023288747,0.00022522762,0.0000012602225,0.0000443537,0.0008234218],"genre_scores_gemma":[0.9972661,0.00010979931,0.0014517821,0.00093883806,0.00019482132,0.0000014964724,0.0000038666785,0.000011150915,0.000022155233],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9973663,0.00014369238,0.0012425495,0.00018646804,0.00072438363,0.00033658787],"domain_scores_gemma":[0.99784774,0.000054544533,0.0009641615,0.00031246338,0.00041108334,0.00041001808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012444301,0.00017527999,0.0009492496,0.00013471405,0.00012203491,0.000036227622,0.00003721719,0.00017702348,0.00006591835],"category_scores_gemma":[0.00078057667,0.00011584624,0.0006383151,0.0002588496,0.000039481503,0.00014170239,0.000019950137,0.0005367984,0.000004267057],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007086481,0.0005160765,0.012370625,0.000044322158,0.00016950605,0.9643048,0.00009890343,0.000010030556,0.0005021922,0.000022315913,0.001366535,0.020523818],"study_design_scores_gemma":[0.0010350839,0.0003935889,0.11762064,0.00015383464,0.0002153143,0.877983,0.0001371316,0.000025792682,0.0007079774,0.0004907329,0.0011234389,0.00011346752],"about_ca_topic_score_codex":0.000009090705,"about_ca_topic_score_gemma":0.0000011245099,"teacher_disagreement_score":0.105250016,"about_ca_system_score_codex":0.00012545123,"about_ca_system_score_gemma":0.0002285995,"threshold_uncertainty_score":0.47240725},"labels":[],"label_agreement":null},{"id":"W2088824227","doi":"10.1161/circulationaha.108.824151","title":"Statin Adherence and Risk of Accidents","year":2009,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"B.C. Women's Hospital & Health Centre; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Bristol-Myers Squibb; National Institute on Aging; Ministry of Health, British Columbia; AstraZeneca; Amgen","keywords":"Medicine; Hazard ratio; Confidence interval; Statin; Proportional hazards model; Population; Prospective cohort study; Internal medicine; Cohort study; Cohort; Physical therapy; Environmental health","score_opus":0.01728059941232416,"score_gpt":0.28270576628845323,"score_spread":0.26542516687612905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088824227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962362,0.0005179272,0.0024521889,0.000041600942,0.000019810643,0.00018951268,0.0000013397223,0.000011286115,0.00053011836],"genre_scores_gemma":[0.9991704,0.0001866046,0.0005345072,0.00004349892,0.000043236592,0.0000015908687,0.0000070583064,0.0000024934911,0.000010563022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958915,0.000024337547,0.00010425041,0.00007929781,0.00014930128,0.000053642885],"domain_scores_gemma":[0.99971765,0.0000065234053,0.000054156175,0.00013553948,0.00004673515,0.000039365787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018452691,0.000032844335,0.000104394414,0.000026164838,0.000021021346,0.0000032851851,0.000010962727,0.000027422539,0.000015347146],"category_scores_gemma":[0.000059551337,0.00002874679,0.000035855744,0.00006214603,0.000008537637,0.00003893715,0.0000028719476,0.00004196574,0.0000031532531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019081179,0.000022226057,0.6491014,0.0000363107,0.000027714646,0.0000017143971,0.0001626972,0.000024270636,0.0022930221,0.00015421023,0.000017027167,0.34814033],"study_design_scores_gemma":[0.0005371478,0.000071807364,0.99740136,0.000035066467,0.000058517555,0.000009983889,0.000023334238,0.00042772302,0.00065191824,0.00070093916,0.00005637972,0.000025827283],"about_ca_topic_score_codex":0.00013092833,"about_ca_topic_score_gemma":0.0000034747695,"teacher_disagreement_score":0.34829995,"about_ca_system_score_codex":0.000013013079,"about_ca_system_score_gemma":0.000022746986,"threshold_uncertainty_score":0.11722601},"labels":[],"label_agreement":null},{"id":"W2089110021","doi":"10.1186/1476-511x-9-136","title":"Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?","year":2010,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Atorvastatin; Ezetimibe; Apolipoprotein B; Internal medicine; Lipidology; Triglyceride; Medicine; Cholesterol; Lipoprotein; Endocrinology; Clinical chemistry; Subclass; Low-density lipoprotein; Population; Clinical nutrition; Gastroenterology; Immunology","score_opus":0.02353752791081993,"score_gpt":0.3167509830031022,"score_spread":0.2932134550922823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089110021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873977,0.0024688598,0.00019434879,0.0079903975,0.00045192067,0.0012803655,0.000062955696,0.00007897558,0.000074478114],"genre_scores_gemma":[0.9892748,0.0004865774,0.000308313,0.008487443,0.0010257185,0.00009710201,0.000086639026,0.000032475702,0.00020091662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977173,0.00018930125,0.00048592736,0.0005641845,0.00043251595,0.0006107303],"domain_scores_gemma":[0.99624336,0.000038061058,0.0001965315,0.00076344603,0.00012249725,0.0026361053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005107319,0.0002799424,0.00066260743,0.00019199155,0.00023403302,0.000042832307,0.000075354175,0.00012504452,0.00007291426],"category_scores_gemma":[0.00051876565,0.0002236326,0.00027585303,0.00020293008,0.0000888113,0.00007981042,0.000047819532,0.0004186816,0.000025064293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014379196,0.0013858629,0.6397353,0.0040714005,0.00016989451,0.00084907556,0.00055561186,0.0000062605372,0.00081894774,0.00006658263,0.0003652512,0.3505379],"study_design_scores_gemma":[0.004274133,0.0007601499,0.9852144,0.0005202559,0.00014936717,0.00006276736,0.0004970938,0.00028586222,0.00024765116,0.00015762047,0.007490326,0.0003403324],"about_ca_topic_score_codex":0.009972344,"about_ca_topic_score_gemma":0.004059924,"teacher_disagreement_score":0.35019758,"about_ca_system_score_codex":0.00013551224,"about_ca_system_score_gemma":0.0010508982,"threshold_uncertainty_score":0.99662036},"labels":[],"label_agreement":null},{"id":"W2089293158","doi":"10.1016/j.atherosclerosis.2004.06.022","title":"Comparison of the impact of atorvastatin and simvastatin on apoA-I kinetics in men","year":2004,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Simvastatin; Atorvastatin; Chemistry; Internal medicine; Endocrinology; Kinetics; Cholesterol; Pharmacology; Medicine; Biochemistry","score_opus":0.03398946462915428,"score_gpt":0.33321612013970164,"score_spread":0.2992266555105474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089293158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863875,0.00017349621,0.000051716994,0.00018233627,0.000017560264,0.00041178294,0.000015536909,0.000006742788,0.00050207373],"genre_scores_gemma":[0.9993813,0.000057910842,0.0004576046,0.000043615146,0.000019338917,0.0000092879745,0.000001960813,0.00001693777,0.000012026109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902713,0.0000599743,0.00032105396,0.00013993192,0.00029567696,0.00015620576],"domain_scores_gemma":[0.999356,0.000039450733,0.00013535429,0.0003619496,0.000044294527,0.00006299619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024099868,0.0001098244,0.00042059924,0.00004681097,0.000021060208,0.000003816994,0.00006476996,0.000055706198,0.000013957088],"category_scores_gemma":[0.00006199654,0.0000670254,0.00018738265,0.0002261405,0.00008964586,0.00001758035,0.000031581694,0.0001294944,0.0000014333231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024641978,0.0015822134,0.7725813,0.00030477357,0.0002516631,0.0000010666259,0.0059732357,0.0041985684,0.19294022,0.0004505951,0.00013408758,0.021335876],"study_design_scores_gemma":[0.0022114618,0.0009822849,0.95044905,0.00034544815,0.000034532044,0.0000012054766,0.000317889,0.00010262522,0.0453963,0.0000878445,0.0000140932525,0.000057244386],"about_ca_topic_score_codex":0.002166801,"about_ca_topic_score_gemma":0.000054073225,"teacher_disagreement_score":0.1778678,"about_ca_system_score_codex":0.00009170632,"about_ca_system_score_gemma":0.00007720756,"threshold_uncertainty_score":0.32755694},"labels":[],"label_agreement":null},{"id":"W2089749592","doi":"10.1371/journal.pone.0072113","title":"PCSK9 Prosegment Chimera as Novel Inhibitors of LDLR Degradation","year":2013,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Institute for Biological Sciences; Montreal Clinical Research Institute; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Proprotein Convertases; PCSK9; Furin; Kexin; LDL receptor; Proprotein convertase; Zymogen; Biochemistry; Protein precursor; Proteases; Chemistry; Enzyme; Cell biology; Biology; Cholesterol; Lipoprotein","score_opus":0.034315566450491976,"score_gpt":0.23281274753020892,"score_spread":0.19849718107971695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089749592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413323,0.00037102116,0.00011753196,0.0010200028,0.000035220273,0.0013817996,0.000002986675,0.00003746446,0.0029007343],"genre_scores_gemma":[0.99016255,0.00007355412,0.00788298,0.0002956509,0.00029678326,0.00015347522,0.00003113963,0.000020420677,0.0010834654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987991,0.00001757002,0.00024322906,0.0001638746,0.00061411696,0.00016211582],"domain_scores_gemma":[0.9992776,0.000008648504,0.00007738285,0.00034628477,0.00016960055,0.000120491015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018953178,0.000089983005,0.00029830966,0.00006118647,0.000032883505,0.000008394598,0.000040015722,0.00006095171,0.00022042288],"category_scores_gemma":[0.000068019835,0.00007267587,0.00010066723,0.00012761602,0.00002629963,0.00007837032,0.00002416107,0.00011090955,0.00016745213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006496709,0.00507903,0.012437418,0.0013014678,0.0010878323,0.0000034297273,0.00035238944,9.213105e-7,0.946697,0.00052832096,0.00035408806,0.03209312],"study_design_scores_gemma":[0.0024812,0.000766227,0.062265605,0.00072356616,0.00041688568,0.000013348526,0.00012949441,0.00013495446,0.9323055,0.00013473384,0.0004697033,0.00015874612],"about_ca_topic_score_codex":0.0008054809,"about_ca_topic_score_gemma":0.0000044121684,"teacher_disagreement_score":0.049828187,"about_ca_system_score_codex":0.000052301533,"about_ca_system_score_gemma":0.00009669776,"threshold_uncertainty_score":0.2963636},"labels":[],"label_agreement":null},{"id":"W2089910283","doi":"10.1016/s0140-6736(09)60448-7","title":"Bringing JUPITER down to earth","year":2009,"lang":"en","type":"letter","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"","keywords":"Rosuvastatin; Medicine; Asymptomatic; C-reactive protein; Statin; Internal medicine; Cholesterol; Inflammation","score_opus":0.025841687960545236,"score_gpt":0.2728586018730871,"score_spread":0.24701691391254185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089910283","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029313376,0.0013088031,0.00011255261,0.9708371,0.00029253386,0.000710661,0.000018691115,0.000121149336,0.023667153],"genre_scores_gemma":[0.0021713385,0.00012364499,0.00061101007,0.9354374,0.05133326,0.000026553134,0.00006553603,0.000041425345,0.0101898685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984101,0.000078291334,0.00017421371,0.0002838171,0.0005228917,0.0005306724],"domain_scores_gemma":[0.99828875,0.00002151167,0.000047423287,0.0015222025,0.00004260672,0.000077480974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005263671,0.00020089155,0.00080418284,0.00006965941,0.00007529584,0.000046457757,0.00025636845,0.00023993992,0.00015953643],"category_scores_gemma":[0.000033747845,0.00011980438,0.00028033898,0.0001399139,0.000019989257,0.000017734688,0.00005340324,0.0014114158,0.0005371495],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025916102,0.0000042427027,0.000034678185,0.00017114582,0.000105088926,0.0003215312,0.00012085831,0.00000158288,0.00001854904,0.000012796035,0.9685801,0.030603468],"study_design_scores_gemma":[0.00056516245,0.000088837056,0.00621838,0.00037060474,0.00011999669,0.00020843017,0.000003103227,0.000003522466,0.00005525702,0.000050758434,0.992168,0.00014793915],"about_ca_topic_score_codex":0.00012333579,"about_ca_topic_score_gemma":0.0000070843867,"teacher_disagreement_score":0.051040728,"about_ca_system_score_codex":0.000040963518,"about_ca_system_score_gemma":0.00007020223,"threshold_uncertainty_score":0.6904149},"labels":[],"label_agreement":null},{"id":"W2090080740","doi":"10.1177/2047487314567001","title":"Treat-to-target versus dose-adapted statin treatment of cholesterol to reduce cardiovascular risk","year":2015,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Sanofi","keywords":"Medicine; Guideline; Statin; Atherosclerotic cardiovascular disease; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive care medicine; Cholesterol; Disease; Clinical Practice; Internal medicine; Physical therapy; Pathology","score_opus":0.05503551656018065,"score_gpt":0.30596824324177035,"score_spread":0.2509327266815897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090080740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631126,0.008722758,0.017061608,0.00026753792,0.0010532297,0.0011179958,0.00006798365,0.000022669597,0.008573654],"genre_scores_gemma":[0.9892639,0.00078006345,0.007922083,0.00007273397,0.0015583895,0.0000128912125,0.0000128433085,0.00006910461,0.00030799795],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942897,0.003415728,0.00085681153,0.00037957315,0.0006574159,0.00040074618],"domain_scores_gemma":[0.99693495,0.00007103004,0.00040922017,0.0008326992,0.0008939608,0.00085812836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003620914,0.00030214305,0.0017309058,0.0003224905,0.000050464074,0.000010729052,0.00021180857,0.00005983885,0.000014745952],"category_scores_gemma":[0.0006634708,0.00022852172,0.0017272042,0.0003094979,0.000074251686,0.00006706244,0.000076612174,0.00024727147,0.0000829285],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020843394,0.0010209123,0.010658104,0.00017859164,0.03604439,0.011820573,0.00877284,0.019952238,0.0041196113,0.00003693477,0.007256801,0.8792956],"study_design_scores_gemma":[0.04964327,0.05144939,0.3493285,0.0004158717,0.006488305,0.004168961,0.0022725242,0.000011326363,0.008238702,0.00004088592,0.52732587,0.00061641866],"about_ca_topic_score_codex":0.000074244505,"about_ca_topic_score_gemma":0.0000021852745,"teacher_disagreement_score":0.8786792,"about_ca_system_score_codex":0.00034869576,"about_ca_system_score_gemma":0.0003437504,"threshold_uncertainty_score":0.9318845},"labels":[],"label_agreement":null},{"id":"W2090156484","doi":"10.1016/s0735-1097(13)61950-6","title":"CLINICAL DETERMINANTS OF INCIDENT AORTIC STENOSIS IN STATIN–TREATED STABLE CORONARY PATIENTS","year":2013,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Stenosis; Cardiology; Internal medicine; Statin","score_opus":0.017642931770738734,"score_gpt":0.3031594064019107,"score_spread":0.28551647463117197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090156484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986543,0.00018626779,0.00002050541,0.00017489919,0.00024096288,0.0005548747,0.000035960245,0.000002215653,0.00013000047],"genre_scores_gemma":[0.99866194,0.00047317072,0.0005004341,0.00018016987,0.000114215014,0.000008974463,9.0386567e-7,0.000015554726,0.000044661756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690574,0.0007855834,0.0014384118,0.00013748358,0.00048492814,0.00024785494],"domain_scores_gemma":[0.99699616,0.00020866786,0.0015660817,0.00044369441,0.0006490841,0.000136288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011383423,0.00012632702,0.0017877056,0.00015654188,0.000024780536,0.0000015669333,0.00022682954,0.000067557135,0.000016215157],"category_scores_gemma":[0.00049101084,0.00007739025,0.00066353125,0.00037477494,0.0003948624,0.0000647928,0.00010388492,0.0003012848,0.0000020558894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051552535,0.00014747005,0.97965866,0.000056212324,0.0003737825,0.00008515622,0.000022045508,0.000047201058,0.00019672947,0.0000014098159,0.0008395973,0.018056216],"study_design_scores_gemma":[0.0024438158,0.0029299436,0.9929433,0.00015287366,0.00024013227,0.00021829581,0.0003696091,0.000040164115,0.00036329936,0.000037015274,0.00019784745,0.000063688676],"about_ca_topic_score_codex":0.0005464046,"about_ca_topic_score_gemma":0.000014509738,"teacher_disagreement_score":0.017992528,"about_ca_system_score_codex":0.00012321676,"about_ca_system_score_gemma":0.00040450905,"threshold_uncertainty_score":0.31558827},"labels":[],"label_agreement":null},{"id":"W2090231128","doi":"10.1016/s0022-3476(03)00186-0","title":"Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial","year":2003,"lang":"en","type":"article","venue":"The Journal of Pediatrics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":268,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Atorvastatin; Medicine; Placebo; Apolipoprotein B; Hyperlipidemia; Familial hypercholesterolemia; Internal medicine; Cholesterol; Gastroenterology; Randomized controlled trial; Endocrinology; Ldl cholesterol; Diabetes mellitus","score_opus":0.007877797298202196,"score_gpt":0.24607958548845518,"score_spread":0.23820178819025298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090231128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99333626,0.0028046644,0.00020351389,0.0000987197,0.00013708776,0.0033907958,0.000004459936,0.0000037692514,0.000020745714],"genre_scores_gemma":[0.99228406,0.0063703605,0.00061467063,0.00011414687,0.00056957867,0.000008620422,7.274499e-7,0.000020305664,0.000017553986],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970778,0.0010737929,0.0009448293,0.00013066303,0.0005525554,0.00022034829],"domain_scores_gemma":[0.99835324,0.0005470657,0.0005692607,0.00020402257,0.00014672602,0.00017969996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005304826,0.00018629826,0.0013944443,0.00015906843,0.000053916323,0.000010832774,0.00008414323,0.00010845286,0.0000031222828],"category_scores_gemma":[0.0014964854,0.000089318826,0.00017553105,0.00018660752,0.00012105592,0.0000755353,0.000025406003,0.00055761373,3.4208284e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96285087,0.0002480334,0.03422371,0.00017575095,0.00013273483,0.00001667489,0.00045913213,0.000048877868,0.00001799465,0.0000027828632,0.000021505568,0.0018019216],"study_design_scores_gemma":[0.9564216,0.0011539937,0.03924051,0.00023329344,0.0017209072,0.00089600746,0.00019831896,0.000016905835,0.000010558244,0.0000054206544,0.000010472582,0.000091981245],"about_ca_topic_score_codex":0.000059494636,"about_ca_topic_score_gemma":0.00001443414,"teacher_disagreement_score":0.006429248,"about_ca_system_score_codex":0.000052603413,"about_ca_system_score_gemma":0.00035506897,"threshold_uncertainty_score":0.3642316},"labels":[],"label_agreement":null},{"id":"W2090738000","doi":"10.2165/00003495-200262120-00001","title":"Who Should Receive HMG CoA Reductase Inhibitors?","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McMaster University","funders":"Merck Canada","keywords":"Medicine; Myocardial infarction; Internal medicine; Pharmacotherapy; Diabetes mellitus; Statin; Cholesterol; Cardiology; HMG-CoA reductase; Dyslipidemia; Placebo; Disease; Endocrinology; Reductase; Alternative medicine","score_opus":0.06530291621394826,"score_gpt":0.34205484533847247,"score_spread":0.2767519291245242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090738000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012045296,0.97634226,0.0000032421447,0.00032605094,0.0007645118,0.0020853458,0.00008456406,0.00012629374,0.020255674],"genre_scores_gemma":[0.00000781015,0.9858924,0.00012152254,0.00041378572,0.0039922846,0.00021540833,0.0003734645,0.00014517884,0.008838115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968498,0.00026007317,0.00078497815,0.0007113327,0.0008651918,0.0005286234],"domain_scores_gemma":[0.9976249,0.00007166508,0.00028580189,0.0014518175,0.00012101778,0.0004448291],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00073321216,0.00056181516,0.0031149618,0.000246557,0.00010957456,0.000036106383,0.0001929261,0.0006667931,0.0005111086],"category_scores_gemma":[0.00017369857,0.0004181868,0.0018997553,0.00053420546,0.000086485874,0.000056686593,0.00008873313,0.0011399336,0.00088684424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004896364,0.00006342041,4.5501335e-7,0.019103339,0.0003860403,0.0001483726,0.00014494649,2.6353828e-8,1.1155921e-7,0.0000436955,0.07041476,0.90968996],"study_design_scores_gemma":[0.0004935448,0.00009787429,0.0000010331646,0.022641059,0.0021711926,0.0004616741,0.000052715517,0.0000010264928,0.000006525091,0.0000096388985,0.9736879,0.000375835],"about_ca_topic_score_codex":0.00016685169,"about_ca_topic_score_gemma":0.0000021081394,"teacher_disagreement_score":0.9093141,"about_ca_system_score_codex":0.00035490547,"about_ca_system_score_gemma":0.0005356872,"threshold_uncertainty_score":0.9998911},"labels":[],"label_agreement":null},{"id":"W2090796532","doi":"10.1016/s0002-9149(03)00262-5","title":"Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk","year":2003,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":224,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université Laval; McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Internal medicine; Medicine; Cholesterol; Concordance; Endocrinology; Cohort; Lipoprotein; Risk factor; High-density lipoprotein; Population; Residual risk; Cardiology","score_opus":0.018596625588540645,"score_gpt":0.2673793534622345,"score_spread":0.24878272787369388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090796532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910064,0.0017778801,0.005484366,0.0008626799,0.00011912125,0.0004704616,0.000012469117,0.0000054659836,0.00026116002],"genre_scores_gemma":[0.9974627,0.0010608031,0.00051617937,0.00029442046,0.0006115912,0.000012884988,2.8225756e-7,0.000022000693,0.000019124633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968309,0.0017093578,0.00063420704,0.00015622821,0.00037916636,0.00029017884],"domain_scores_gemma":[0.99756503,0.0004342262,0.0011290992,0.00056727405,0.00017462851,0.00012972028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035690714,0.00017708441,0.0015791884,0.00007238226,0.00011589709,0.000009825568,0.00023560604,0.000046318408,0.0000035287267],"category_scores_gemma":[0.0004504898,0.00008530073,0.00047700718,0.00022507911,0.0021387984,0.00004663128,0.000041718362,0.00061807025,0.0000018372049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028240036,0.00003741865,0.7197689,0.00012960612,0.005126854,0.00004791245,0.001811116,0.000601942,0.0021162657,0.0017239437,0.00011888463,0.26569316],"study_design_scores_gemma":[0.007604507,0.0023503269,0.97739065,0.00017274823,0.0011241942,0.0032559682,0.0011539676,0.000009143182,0.0024180843,0.0017119,0.0026516654,0.00015684916],"about_ca_topic_score_codex":0.00023940716,"about_ca_topic_score_gemma":0.0000039856022,"teacher_disagreement_score":0.2655363,"about_ca_system_score_codex":0.00003791854,"about_ca_system_score_gemma":0.00020064687,"threshold_uncertainty_score":0.7880492},"labels":[],"label_agreement":null},{"id":"W2091200828","doi":"10.1111/j.1523-1755.2005.00398.x","title":"Biomarkers of inflammation and progression of chronickidney disease","year":2005,"lang":"en","type":"article","venue":"Kidney International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":363,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Renal function; Medicine; Pravastatin; Kidney disease; Internal medicine; C-reactive protein; Inflammation; Interquartile range; Kidney; Urology; Gastroenterology; Creatinine; Endocrinology; Systemic inflammation; Cholesterol","score_opus":0.008357800000023716,"score_gpt":0.2854282200118025,"score_spread":0.2770704200117788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091200828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776658,0.00072543183,0.00040534043,0.015916822,0.00017584591,0.0004080273,0.00006579969,0.000020820149,0.004616152],"genre_scores_gemma":[0.99674875,0.00014617549,0.0024200038,0.00015245647,0.0002958679,0.000012179341,0.000103435545,0.000006493933,0.00011464544],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992255,0.000016314507,0.00021868583,0.00010225404,0.0003719287,0.00006531773],"domain_scores_gemma":[0.99939567,0.0000074944214,0.000101025624,0.00013860062,0.00013324541,0.00022395673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019944772,0.000054500193,0.00012242427,0.00008936503,0.000013367369,0.0000035421806,0.000042985906,0.000030630752,0.00015728208],"category_scores_gemma":[0.0002673807,0.00004459523,0.00007947515,0.000050814913,0.000056910398,0.000080879545,0.000027937836,0.000040611365,0.0000031666568],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013152765,0.0004858727,0.13335322,0.0015276665,0.0014138964,0.000016970544,0.00049573364,0.000021900032,0.076276794,0.0063173156,0.011108908,0.76766646],"study_design_scores_gemma":[0.0094480915,0.0004272616,0.5439413,0.0022318938,0.0003792735,0.00008108617,0.00008034333,0.013667523,0.15688501,0.00040837232,0.2721757,0.0002741083],"about_ca_topic_score_codex":0.000020919986,"about_ca_topic_score_gemma":0.0000011312912,"teacher_disagreement_score":0.76739234,"about_ca_system_score_codex":0.00004685739,"about_ca_system_score_gemma":0.00026647563,"threshold_uncertainty_score":0.18185405},"labels":[],"label_agreement":null},{"id":"W2091367263","doi":"10.1016/s0140-6736(14)62115-2","title":"Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study","year":2015,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Merck","keywords":"Medicine; Placebo; Internal medicine; Familial hypercholesterolemia; Cholesterylester transfer protein; Statin; Clinical trial; Cholesterol; Gastroenterology; Lipoprotein","score_opus":0.0628419643297945,"score_gpt":0.3356787810479516,"score_spread":0.2728368167181571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091367263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98698807,0.0006334978,0.000049464477,0.000619386,0.00021404364,0.01032716,0.000010053825,0.000088760185,0.0010695604],"genre_scores_gemma":[0.99605376,0.0001364367,0.0000602786,0.0013381277,0.0013089393,0.00093719305,0.000032167496,0.000055589975,0.00007748727],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969241,0.00053762726,0.00049067225,0.0004411769,0.0010157266,0.0005907163],"domain_scores_gemma":[0.9980713,0.00007508404,0.00015080592,0.00123773,0.00018076612,0.00028430222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002709106,0.00033394364,0.001597049,0.00014452027,0.00011633934,0.0000736636,0.00031109803,0.00011292453,0.00001797031],"category_scores_gemma":[0.00008781415,0.00017917673,0.00021388147,0.0003182185,0.00007351412,0.00013465065,0.000048756356,0.0005438118,0.00002965136],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9317115,0.0018980288,0.047701776,0.000036565205,0.00067759014,0.00007861418,0.0040649786,0.0000677974,0.000025338175,0.0000050135022,0.00029540635,0.013437409],"study_design_scores_gemma":[0.9762311,0.0054692496,0.015347392,0.00008712174,0.00020366756,0.00003176757,0.0008306718,0.00008783859,0.000026902337,0.000013768154,0.0014498093,0.00022068841],"about_ca_topic_score_codex":0.0016862269,"about_ca_topic_score_gemma":0.00021878026,"teacher_disagreement_score":0.04451964,"about_ca_system_score_codex":0.0001679724,"about_ca_system_score_gemma":0.00025458215,"threshold_uncertainty_score":0.7306615},"labels":[],"label_agreement":null},{"id":"W2091645704","doi":"10.1054/ebcm.2000.0309","title":"A large proportion of dyslipidemic patients receiving lipid-lowering therapy did not reach NCEP LDL-C goals","year":2000,"lang":"en","type":"article","venue":"Evidence-based Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Internal medicine; Medicine; Physical therapy; Cardiology","score_opus":0.03763329581741006,"score_gpt":0.286707400090709,"score_spread":0.24907410427329893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091645704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92829823,0.060599487,0.0035519446,0.0018969376,0.0007585816,0.0032753716,0.00001554722,0.0002663379,0.0013375548],"genre_scores_gemma":[0.97921056,0.015196818,0.000441635,0.0018757989,0.002465441,0.00025658196,0.00011850606,0.00012570033,0.00030897942],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9914607,0.00074303255,0.0016131955,0.0011813183,0.0040007383,0.0010010275],"domain_scores_gemma":[0.99517757,0.00023642687,0.00038729873,0.0027761643,0.0008607355,0.0005618354],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008967464,0.0006387667,0.0025622747,0.0004049893,0.00024347454,0.000020479023,0.0003815203,0.00036109897,0.0013194613],"category_scores_gemma":[0.0018773697,0.0004855882,0.0023124123,0.0011305312,0.00030700967,0.00042027255,0.00005360619,0.00071350933,0.000078850324],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024933042,0.0007234637,0.060910333,0.0021923305,0.0038570282,0.00018048804,0.0010191234,0.0005882022,0.0060823737,0.000025745172,0.0017487862,0.92017883],"study_design_scores_gemma":[0.042811573,0.006913443,0.6144838,0.027817678,0.0048043504,0.00026633294,0.00035630696,0.0009069136,0.045204286,0.00004702482,0.25452623,0.001862086],"about_ca_topic_score_codex":0.0007329179,"about_ca_topic_score_gemma":0.000009007498,"teacher_disagreement_score":0.9183167,"about_ca_system_score_codex":0.00041827344,"about_ca_system_score_gemma":0.0005482973,"threshold_uncertainty_score":0.99975955},"labels":[],"label_agreement":null},{"id":"W2091908988","doi":"10.1016/s1499-2671(08)24105-5","title":"Well Controlled T2DM: Low Prevalence of Elevated ApoB Levels.","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Dyslipidemia; Apolipoprotein B; Internal medicine; Disease; Endocrinology; Gastroenterology; Cholesterol","score_opus":0.015079647474507567,"score_gpt":0.22088784802369185,"score_spread":0.20580820054918428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091908988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98859906,0.009196022,0.000015315283,0.0005968112,0.00022984057,0.0003276727,0.000024234645,0.0000048730694,0.0010061972],"genre_scores_gemma":[0.9982155,0.00015294545,0.00022383752,0.0003786771,0.000393072,0.0000036657068,0.0000016228304,0.000019124032,0.00061155984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984661,0.000092943315,0.0005729465,0.000112299706,0.000372417,0.00038332018],"domain_scores_gemma":[0.99792075,0.000056984998,0.00030005837,0.0003029205,0.0005456557,0.0008736257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070602144,0.00013109179,0.0007898536,0.00028042527,0.00008490743,0.000007912109,0.00015710416,0.00009276325,0.0004834253],"category_scores_gemma":[0.0004508158,0.00010236578,0.00044013746,0.00021227764,0.00015161937,0.000086316904,0.0000052088244,0.00026011944,0.00001429394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018046831,0.00014974836,0.9582342,0.0025924568,0.0024674686,0.0007684689,0.0009571705,0.00010282659,0.010868536,0.00013145003,0.009153267,0.014393935],"study_design_scores_gemma":[0.016023416,0.0012948386,0.94833714,0.0014197265,0.00066626933,0.00032182134,0.00009571182,0.00014746546,0.022376899,0.000097252385,0.008945103,0.00027433736],"about_ca_topic_score_codex":0.00052885985,"about_ca_topic_score_gemma":0.00035297216,"teacher_disagreement_score":0.015842948,"about_ca_system_score_codex":0.00012215972,"about_ca_system_score_gemma":0.0027648823,"threshold_uncertainty_score":0.5293168},"labels":[],"label_agreement":null},{"id":"W2091969238","doi":"10.1016/j.ijcard.2008.12.122","title":"Statin therapy in women: Concerns and caution","year":2009,"lang":"en","type":"letter","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Medicine; Statin; Coronary heart disease; Incidence (geometry); Primary prevention; Disease; Population; Adverse effect; Heart failure; Secondary prevention; Intensive care medicine; Internal medicine; Environmental health","score_opus":0.0218996899707218,"score_gpt":0.31267274948511503,"score_spread":0.29077305951439325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091969238","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23521441,0.009330949,0.00082396274,0.7494462,0.002657808,0.00041743545,0.00004084402,0.000013091169,0.0020552755],"genre_scores_gemma":[0.3578383,0.018255787,0.00029188397,0.5885615,0.03467032,0.000016704122,0.00006888868,0.000035286437,0.00026136043],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982339,0.00023442002,0.00053013506,0.00016419479,0.00061604247,0.00022131704],"domain_scores_gemma":[0.99894726,0.00006597913,0.0003261022,0.00014344552,0.000450402,0.00006679546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077571353,0.00015699676,0.0008246875,0.0003694341,0.000011851037,0.00001712132,0.00014963483,0.000409755,0.000029626352],"category_scores_gemma":[0.00008747686,0.00012253768,0.0002821732,0.000049043123,0.00007160148,0.000056459266,0.000019955758,0.0013272295,0.0000026099005],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013659991,0.000031978696,0.0037092974,0.00006350504,0.0030904762,0.019684354,0.00052494457,0.00007899029,0.00020089076,0.000054941098,0.6385356,0.33265898],"study_design_scores_gemma":[0.003175188,0.0009214221,0.022409981,0.00017101922,0.000036922596,0.0064130644,0.00005432604,0.000003940031,0.000022640676,0.00063466537,0.9660503,0.00010647931],"about_ca_topic_score_codex":0.00003354993,"about_ca_topic_score_gemma":0.0000010373046,"teacher_disagreement_score":0.33255252,"about_ca_system_score_codex":0.00044114937,"about_ca_system_score_gemma":0.00035773823,"threshold_uncertainty_score":0.57662255},"labels":[],"label_agreement":null},{"id":"W2091977091","doi":"10.1016/s0003-9861(03)00032-8","title":"A role for apolipoprotein(a) in protection of the low-density lipoprotein component of lipoprotein(a) from copper-mediated oxidation","year":2003,"lang":"en","type":"article","venue":"Archives of Biochemistry and Biophysics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Copper; Quenching (fluorescence); Chemistry; Tryptophan; Apolipoprotein B; Lipoprotein; Lipoprotein(a); Low-density lipoprotein; Lysine; Biochemistry; Fluorescence; Cholesterol; Amino acid; Organic chemistry","score_opus":0.007756278222914159,"score_gpt":0.21129880482452815,"score_spread":0.20354252660161398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091977091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653393,0.00043553428,0.00067400414,0.00013817461,0.000030414043,0.0018708865,0.000100515914,0.000010245143,0.00020631672],"genre_scores_gemma":[0.9977207,0.00008305275,0.0018729947,0.000019433144,0.00008382994,0.000113799564,0.000068602945,0.000015999249,0.00002156016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863344,0.00008959121,0.00046952977,0.00030278647,0.00031153957,0.0001931014],"domain_scores_gemma":[0.99887675,0.00006222306,0.00035854723,0.00053402386,0.00009154946,0.0000768982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002208239,0.00017969449,0.00051613734,0.000051350788,0.000056560657,0.00000431519,0.00010732177,0.00012812445,0.0000026564767],"category_scores_gemma":[0.00019539277,0.00013922845,0.00027546202,0.00022865304,0.00029640077,0.00003535252,0.00005497518,0.00018529773,2.3815659e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049338717,0.00036372597,0.00056905416,0.0013180905,0.00010066297,4.8275416e-7,0.00023668898,0.0000040493587,0.9719316,0.00014472166,0.0000014040083,0.024836184],"study_design_scores_gemma":[0.0019222489,0.00023420368,0.023424098,0.00069615146,0.00007016028,0.0000055064293,0.00021605245,0.00023655735,0.9706929,0.0023418898,0.000039611125,0.0001206431],"about_ca_topic_score_codex":0.0024308658,"about_ca_topic_score_gemma":0.000032742664,"teacher_disagreement_score":0.02471554,"about_ca_system_score_codex":0.000021042653,"about_ca_system_score_gemma":0.00013601477,"threshold_uncertainty_score":0.5677571},"labels":[],"label_agreement":null},{"id":"W2092214145","doi":"10.1016/j.atherosclerosis.2003.11.011","title":"Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutation","year":2003,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University","funders":"","keywords":"Internal medicine; Endocrinology; Chylomicron; Apolipoprotein B; LDL receptor; Familial hypercholesterolemia; Catabolism; Heterozygote advantage; Biology; Lipoprotein; Very low-density lipoprotein; Ketogenesis; Allele; Cholesterol; Medicine; Genetics; Gene; Metabolism; Ketone bodies","score_opus":0.10476951993167634,"score_gpt":0.3121200849315239,"score_spread":0.20735056499984755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092214145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970785,0.00023259173,0.00021593351,0.00027081236,0.00021349422,0.0018985018,0.000043765194,0.000024557135,0.000021895417],"genre_scores_gemma":[0.9963325,0.00016895763,0.002578727,0.00040292984,0.00011502494,0.00026246023,0.00003807662,0.00005498277,0.000046320907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981016,0.00018748932,0.00043363785,0.00039185598,0.00052250637,0.0003628906],"domain_scores_gemma":[0.99875563,0.0001210529,0.00017452911,0.000620294,0.00022178133,0.00010669884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000686569,0.00021305284,0.0004757145,0.00007082621,0.00010997593,0.00002066581,0.00013379409,0.00012923774,0.000009991004],"category_scores_gemma":[0.00029363288,0.00013294531,0.00017558341,0.0002714268,0.00009087001,0.00013930077,0.000021267606,0.00019544722,0.0000067227847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004883976,0.0014710433,0.57740337,0.001466632,0.00076146197,0.000004818974,0.016638992,0.00079527375,0.29707864,0.00014903735,0.00048248982,0.09886427],"study_design_scores_gemma":[0.010736256,0.0013521551,0.8997782,0.0011375671,0.00026920985,0.000010451363,0.0005441726,0.00008235031,0.08485625,0.000025032203,0.00087486475,0.00033349244],"about_ca_topic_score_codex":0.00071332307,"about_ca_topic_score_gemma":0.000077972196,"teacher_disagreement_score":0.32237482,"about_ca_system_score_codex":0.00016931116,"about_ca_system_score_gemma":0.0001527616,"threshold_uncertainty_score":0.54213524},"labels":[],"label_agreement":null},{"id":"W2092426758","doi":"10.1074/jbc.m104789200","title":"Identification of a Critical Lysine Residue in Apolipoprotein B-100 That Mediates Noncovalent Interaction with Apolipoprotein(a)","year":2001,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Ottawa Heart Institute; Queen's University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Apolipoprotein B; Lysine; Chemistry; Biochemistry; Peptide; Amino acid; Peptide sequence; Covalent bond; Sepharose; Residue (chemistry); Alanine; Enzyme; Cholesterol","score_opus":0.03351372202820236,"score_gpt":0.31258766087537615,"score_spread":0.2790739388471738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092426758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548936,0.0012658462,0.0007298194,0.0018201751,0.000068532034,0.0002662874,0.0000048400243,0.000013057897,0.00034210514],"genre_scores_gemma":[0.99791694,0.0006622889,0.0006133469,0.00008272221,0.00062393345,0.000019641153,0.000010049268,0.000013401442,0.000057696518],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978754,0.000097516386,0.00088980584,0.00023591341,0.00062581396,0.00027553394],"domain_scores_gemma":[0.9985067,0.00009741962,0.0005082231,0.00032488955,0.0003491921,0.0002135685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012129687,0.00018073726,0.0006796778,0.00010792628,0.000033826833,0.000015549858,0.00014849147,0.00025018546,0.00016096846],"category_scores_gemma":[0.0007692721,0.00011298958,0.00027718925,0.00030400677,0.00019690744,0.00012093908,0.000035048495,0.00057436986,0.0000032129255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041158814,0.0016688376,0.044967808,0.0011548005,0.0002604455,0.0008774523,0.00019534516,0.000043169563,0.9310579,0.00003564019,0.000074755924,0.015548003],"study_design_scores_gemma":[0.0024851519,0.0009951766,0.0634672,0.00075468706,0.00013706808,0.0035258355,0.0007412302,0.00005925737,0.926816,0.00032815363,0.0005066454,0.00018362727],"about_ca_topic_score_codex":0.00012196159,"about_ca_topic_score_gemma":0.000010924829,"teacher_disagreement_score":0.018499391,"about_ca_system_score_codex":0.00018931215,"about_ca_system_score_gemma":0.00016199959,"threshold_uncertainty_score":0.46075815},"labels":[],"label_agreement":null},{"id":"W2093086607","doi":"10.1159/000045979","title":"Apolipoprotein(a) Phenotype, Albumin Clearance, and Plasma Levels of Lipoprotein(a) in Peritoneal Dialysis","year":2001,"lang":"en","type":"article","venue":"˜The œNephron journals/Nephron journals","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lipoprotein(a); Internal medicine; Albumin; Medicine; Apolipoprotein B; Peritoneal dialysis; Endocrinology; Lipoprotein; Phenotype; Population; Serum albumin; Renal function; Plasma lipoprotein; Cholesterol; Biology; Biochemistry; Gene","score_opus":0.029965801568012217,"score_gpt":0.2943420028797348,"score_spread":0.26437620131172257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093086607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581404,0.03025405,0.0013221643,0.005692249,0.00036870167,0.0018449656,0.000037672173,0.000063619416,0.0022762076],"genre_scores_gemma":[0.98145443,0.012315373,0.0014329739,0.0012043501,0.002397736,0.000100649944,0.000005172893,0.00015036865,0.0009389158],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9920595,0.00094647513,0.0023562722,0.000792894,0.00239657,0.0014482734],"domain_scores_gemma":[0.99563605,0.00019213273,0.0012056668,0.0014145991,0.0005908157,0.0009607479],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0059448783,0.00076023134,0.0021563969,0.0010107873,0.00058437395,0.00024379944,0.00061702507,0.0005053683,0.0017223097],"category_scores_gemma":[0.000267021,0.0005632243,0.0009710592,0.0017343095,0.0005218811,0.0006037847,0.00021516414,0.0021468077,0.00006726917],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036730766,0.0010997672,0.017660845,0.00072637404,0.0021986852,0.0012939255,0.0033997355,0.0005516071,0.060361393,0.00019905389,0.0017931487,0.9070424],"study_design_scores_gemma":[0.020498099,0.0023140854,0.825512,0.0045631006,0.0016673265,0.015702216,0.0033997884,0.0025354456,0.011725477,0.0023639156,0.10783858,0.0018799412],"about_ca_topic_score_codex":0.0013919855,"about_ca_topic_score_gemma":0.0010056227,"teacher_disagreement_score":0.90516245,"about_ca_system_score_codex":0.0003846299,"about_ca_system_score_gemma":0.00063161284,"threshold_uncertainty_score":0.99968195},"labels":[],"label_agreement":null},{"id":"W2093236229","doi":"10.1016/j.brainres.2005.01.105","title":"Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke","year":2005,"lang":"en","type":"article","venue":"Brain Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Simvastatin; Medicine; Neuroprotection; Ischemia; Stroke (engine); Perfusion; Anesthesia; Saline; Brain ischemia; Internal medicine; Cardiology","score_opus":0.0689801595087661,"score_gpt":0.39431138794617243,"score_spread":0.32533122843740636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093236229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99096686,0.00071067474,0.0000798059,0.0056456705,0.000008213293,0.00075466005,0.000020657284,0.000019181707,0.0017943097],"genre_scores_gemma":[0.9961167,0.00017636461,0.0018671007,0.00037487404,0.00015791679,0.000043893135,0.000018146935,0.00003052676,0.0012144798],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974575,0.0003751136,0.00032706087,0.0003815292,0.0009552026,0.00050361006],"domain_scores_gemma":[0.99877006,0.0001661532,0.000035917445,0.00054300297,0.00021697795,0.00026788173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039906567,0.00011946837,0.00036215415,0.00043749972,0.00008056367,0.00001812839,0.00012257046,0.00013989172,0.000044287204],"category_scores_gemma":[0.00072640396,0.00010609187,0.000075933676,0.00040042063,0.0001338397,0.00011701528,0.00012653459,0.00058646715,0.0000087834405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038029283,0.00023618025,0.0013593818,0.00023847731,0.000015412801,0.000010142496,0.001512302,0.0001844041,0.7752517,0.000203429,0.0029963772,0.21761192],"study_design_scores_gemma":[0.015673285,0.004712698,0.10318448,0.0014139873,0.00005789256,0.00021391777,0.006303397,0.37544188,0.48027602,0.00071990886,0.01102088,0.0009816748],"about_ca_topic_score_codex":0.00043552375,"about_ca_topic_score_gemma":0.00017615655,"teacher_disagreement_score":0.37525746,"about_ca_system_score_codex":0.00010425321,"about_ca_system_score_gemma":0.000474589,"threshold_uncertainty_score":0.43263012},"labels":[],"label_agreement":null},{"id":"W2093455197","doi":"10.1016/j.hlc.2011.10.013","title":"Lipid Management in High Risk Coronary Patients: How Effective are We at Secondary Intervention?","year":2011,"lang":"en","type":"article","venue":"Heart Lung and Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Cardiovascular Society; American Heart Association","keywords":"Secondary prevention; Medicine; Intervention (counseling); Internal medicine; Risk management; Percutaneous coronary intervention; Cardiology; Myocardial infarction; Business; Nursing","score_opus":0.010743079350095469,"score_gpt":0.23458435565837593,"score_spread":0.22384127630828046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093455197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964727,0.001141451,0.00027193283,0.0001859611,0.00017603053,0.0011329687,0.000007948586,0.000032786305,0.0005782077],"genre_scores_gemma":[0.9990299,0.00031866372,0.00015462108,0.000103622806,0.000078702345,0.000103503655,0.000058611746,0.000014253311,0.0001381312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991052,0.00014674937,0.00015522852,0.00025249226,0.00019239628,0.00014790756],"domain_scores_gemma":[0.99958146,0.000011144786,0.00007115416,0.00021384077,0.00004596104,0.00007645549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031140997,0.0001012807,0.00021325308,0.000100774385,0.00008994901,0.000009081962,0.00001707864,0.00006900517,0.00008271913],"category_scores_gemma":[0.0000102192525,0.000093123395,0.0001132045,0.00009854933,0.000021182934,0.00010305311,0.00003699934,0.0001356715,0.000010820293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013309425,0.0001672086,0.90159535,0.00047924562,0.00013177711,0.000014606964,0.00034926648,0.000003917774,0.000006240064,0.00005015433,0.00026741065,0.09680173],"study_design_scores_gemma":[0.0029965024,0.00018419225,0.9944962,0.00028594965,0.00013154584,0.000020013431,0.00017798116,0.0001853048,0.000036369544,0.00017312774,0.0012211351,0.000091670634],"about_ca_topic_score_codex":0.00029103586,"about_ca_topic_score_gemma":0.000071551636,"teacher_disagreement_score":0.096710056,"about_ca_system_score_codex":0.00017088177,"about_ca_system_score_gemma":0.0000075066546,"threshold_uncertainty_score":0.37974617},"labels":[],"label_agreement":null},{"id":"W2093515825","doi":"10.1097/00001756-200109170-00036","title":"3-Hydroxy-3-methylglutaryl-coenzyme A reductase mRNA in Alzheimer and control brain","year":2001,"lang":"en","type":"article","venue":"Neuroreport","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Reductase; Hydroxymethylglutaryl-CoA reductase; Coenzyme A; HMG-CoA reductase; Cholesterol synthesis; Alzheimer's disease; Cholesterol; Endocrinology; Statin; Degenerative disease; Enzyme; Internal medicine; Biology; Medicine; Disease; Pharmacology; Biochemistry","score_opus":0.020364296008962515,"score_gpt":0.28193135085103116,"score_spread":0.26156705484206866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093515825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98452175,0.0043441523,0.000081834536,0.0075020264,0.00017510819,0.00082061713,0.0000047332583,0.000069294314,0.002480513],"genre_scores_gemma":[0.9931544,0.00024352438,0.00018830849,0.0058311233,0.00036050664,0.00004723961,0.000013146986,0.000030891653,0.00013083497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982114,0.00008243624,0.00044949618,0.00046554903,0.0004233909,0.00036775897],"domain_scores_gemma":[0.99890685,0.000043353826,0.00009815229,0.000619599,0.0000497668,0.000282275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081797334,0.00018199027,0.00049093703,0.00014579188,0.000048308557,0.000016332066,0.000050539245,0.000097756696,0.00007958145],"category_scores_gemma":[0.0002788858,0.0001574509,0.00015348008,0.00026998494,0.00007060174,0.00008882011,0.000029302113,0.00032825934,0.00001537582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023114753,0.0014311348,0.45893493,0.00030447176,0.0018980781,0.11109792,0.0010385484,0.000044807406,0.10430137,0.00046796765,0.029413352,0.28875592],"study_design_scores_gemma":[0.013314708,0.001095395,0.6214634,0.00015314203,0.0008681601,0.03813526,0.00009610167,0.00072539644,0.0064120074,0.00051037694,0.31659868,0.0006273237],"about_ca_topic_score_codex":0.0008813563,"about_ca_topic_score_gemma":0.000033477827,"teacher_disagreement_score":0.2881286,"about_ca_system_score_codex":0.000028043789,"about_ca_system_score_gemma":0.00017567564,"threshold_uncertainty_score":0.6420661},"labels":[],"label_agreement":null},{"id":"W2093767555","doi":"10.1093/qjmed/94.6.301","title":"Are patients suffering from stable angina receiving optimal medical treatment?","year":2001,"lang":"en","type":"article","venue":"QJM","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Health Canada","keywords":"Medicine; Medical prescription; Angina; Internal medicine; Aspirin; Adverse effect; Drug class; Calcium channel blocker; Stable angina; Drug; Cardiology; Coronary heart disease; Myocardial infarction; Pharmacology; Calcium","score_opus":0.018964866474003444,"score_gpt":0.2625464514173774,"score_spread":0.24358158494337398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093767555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951316,0.0009663839,0.00032288936,0.000445002,0.00020319299,0.0002785767,0.00001257052,0.00007892546,0.002560829],"genre_scores_gemma":[0.99709153,0.00035150765,0.00063143775,0.00033604738,0.0006382944,0.000026796506,0.00006834986,0.000026649623,0.00082939945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987031,0.000039894698,0.00016643418,0.00024419767,0.0005349086,0.00031142178],"domain_scores_gemma":[0.99922585,0.00002371361,0.000054630214,0.00036068656,0.000050972416,0.00028414314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001614552,0.00012728568,0.00032627076,0.000043068892,0.00008213238,0.000015329515,0.000057336067,0.00010573319,0.00087479124],"category_scores_gemma":[0.00012143769,0.00009868887,0.00015159484,0.00011886258,0.000019550043,0.00006380133,0.000029765257,0.00012144405,0.0000854977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013939156,0.0004264649,0.83863425,0.000041504267,0.00028334372,0.00059485075,0.0002892277,0.00000865031,0.00004832728,0.000007986217,0.0010909234,0.1584351],"study_design_scores_gemma":[0.004165519,0.00038672722,0.91798806,0.00029794368,0.00013521903,0.000043822816,0.00019812306,0.0003894398,0.00055185903,0.000011567334,0.07565995,0.0001717487],"about_ca_topic_score_codex":0.0018318571,"about_ca_topic_score_gemma":0.00011546038,"teacher_disagreement_score":0.15826336,"about_ca_system_score_codex":0.00020634985,"about_ca_system_score_gemma":0.00009187878,"threshold_uncertainty_score":0.957835},"labels":[],"label_agreement":null},{"id":"W2093774639","doi":"10.1016/s1474-4422(14)70095-x","title":"Are statins to be STASHed in subarachnoid haemorrhage?","year":2014,"lang":"en","type":"letter","venue":"The Lancet Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Simvastatin; Subarachnoid hemorrhage; Modified Rankin Scale; Subarachnoid haemorrhage; Neurology; Neurovascular bundle; Randomized controlled trial; Statin; Clinical trial; Aneurysm; Ischemia; Anesthesia; Surgery; Internal medicine; Ischemic stroke","score_opus":0.052902818737815244,"score_gpt":0.2939375126166353,"score_spread":0.24103469387882007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093774639","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12823817,0.00020170113,0.00008852337,0.86861074,0.00041940893,0.0011106869,0.000067003304,0.0000927347,0.0011710217],"genre_scores_gemma":[0.04205823,0.00005425316,0.00011243086,0.9474143,0.009344636,0.00017870599,0.00013303771,0.00009012138,0.0006143327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968588,0.00077744806,0.00038119644,0.0006074265,0.00049176614,0.0008833919],"domain_scores_gemma":[0.9974994,0.00017482467,0.00022676591,0.0019340513,0.000064447515,0.00010052108],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00096122036,0.0003354881,0.0015105823,0.00019223179,0.000065550405,0.000018308063,0.00046128232,0.00055989344,0.000087909335],"category_scores_gemma":[0.00028001834,0.00022700423,0.00021929033,0.00024510286,0.00009921449,0.000016818038,0.00013769479,0.003627962,0.00018634762],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003147154,0.000021962138,0.0017828075,0.0005332132,0.000054951935,0.0049813036,0.00014674665,0.000022024584,0.00001959116,0.00002213684,0.9892395,0.0028610523],"study_design_scores_gemma":[0.0013799038,0.00046573268,0.027587423,0.000028405793,0.00010627445,0.0006540387,0.000007960019,0.00005817473,0.000022147082,0.000117635704,0.9693779,0.0001944009],"about_ca_topic_score_codex":0.00039670066,"about_ca_topic_score_gemma":0.0003126162,"teacher_disagreement_score":0.08617994,"about_ca_system_score_codex":0.00004434409,"about_ca_system_score_gemma":0.000101965765,"threshold_uncertainty_score":0.9986707},"labels":[],"label_agreement":null},{"id":"W2093987460","doi":"10.1053/meta.2002.30510","title":"Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes","year":2002,"lang":"en","type":"article","venue":"Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; SickKids Foundation; Chrysler (Canada); Hospital for Sick Children; University of Toronto","funders":"","keywords":"Atorvastatin; Dyslipidemia; Internal medicine; Apolipoprotein B; Endocrinology; Triglyceride; Medicine; Type 2 diabetes; Lipoprotein; Hypertriglyceridemia; Cholesterol; Low-density lipoprotein; Placebo; Diabetes mellitus","score_opus":0.010237649707840312,"score_gpt":0.2043649806827037,"score_spread":0.1941273309748634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093987460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226224,0.0045006517,0.000011751128,0.0005009133,0.000070903916,0.0025394533,0.000020766358,0.000065841,0.000027475973],"genre_scores_gemma":[0.99772954,0.00019890696,0.0011500078,0.00036857807,0.00019097923,0.00024163835,0.000023339431,0.000050662005,0.000046323774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768114,0.0003147666,0.0004345421,0.0005131733,0.00048264288,0.00057376095],"domain_scores_gemma":[0.99876726,0.000113116614,0.00015569913,0.00054719637,0.00013411243,0.00028261536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062922976,0.00035125445,0.00079128105,0.0000881796,0.00022248288,0.000068623885,0.00007570118,0.00010000174,0.00004677659],"category_scores_gemma":[0.00028904155,0.0002138469,0.000100518155,0.00035629323,0.00015206556,0.00015582798,0.00008203976,0.00021817433,0.0000092137525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077623327,0.0009844183,0.5237439,0.00023074575,0.00041603917,0.000035841542,0.0013407812,0.00001039109,0.0014654933,0.00007007757,0.000036214486,0.47088984],"study_design_scores_gemma":[0.007330768,0.0011942362,0.9808464,0.00019047584,0.00029727537,0.0000059471595,0.000113798276,0.001329671,0.008165314,0.000037904785,0.00021446975,0.00027370872],"about_ca_topic_score_codex":0.0032293883,"about_ca_topic_score_gemma":0.00052887236,"teacher_disagreement_score":0.4706161,"about_ca_system_score_codex":0.00008864312,"about_ca_system_score_gemma":0.00006181066,"threshold_uncertainty_score":0.87204236},"labels":[],"label_agreement":null},{"id":"W2094039427","doi":"10.1136/ebn.7.3.82","title":"Cholesterol lowering with simvastatin reduced stroke in patients with, or at risk of, vascular disease","year":2004,"lang":"en","type":"letter","venue":"Evidence-Based Nursing","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Simvastatin; Internal medicine; IMG; Stroke (engine); Incidence (geometry); Gastroenterology","score_opus":0.01638481864920227,"score_gpt":0.25750460299252986,"score_spread":0.2411197843433276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094039427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96139264,0.0020291386,0.0018859934,0.030957485,0.00025675778,0.003264073,0.00010725368,0.00008240515,0.000024269073],"genre_scores_gemma":[0.95876443,0.00024653054,0.002502814,0.035894617,0.0014381444,0.00021121876,0.00043846178,0.00030714239,0.00019665388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948882,0.00039295855,0.00070177106,0.0009821157,0.002243554,0.00079140376],"domain_scores_gemma":[0.9970739,0.00017988024,0.0005673639,0.001523399,0.00030419073,0.00035129293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006861776,0.0006456251,0.0013258242,0.0005170502,0.0001426309,0.0000444751,0.00022157247,0.00038166626,0.000072283525],"category_scores_gemma":[0.00028554568,0.00044330413,0.00045835026,0.0005543059,0.00027948877,0.00024595062,0.000028439777,0.0016226326,0.000008830095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033492174,0.0023751552,0.7968945,0.022232141,0.002552077,0.005151113,0.0014957796,0.0125779845,0.00017222196,8.8957876e-7,0.01208391,0.11097205],"study_design_scores_gemma":[0.022111105,0.0044437856,0.7867903,0.17578955,0.004246043,0.000029715651,0.000072494004,0.00011111379,0.0018381351,0.000009866084,0.0032002302,0.0013576677],"about_ca_topic_score_codex":0.0005188559,"about_ca_topic_score_gemma":0.00003966242,"teacher_disagreement_score":0.1535574,"about_ca_system_score_codex":0.0017718887,"about_ca_system_score_gemma":0.0018236074,"threshold_uncertainty_score":0.9998019},"labels":[],"label_agreement":null},{"id":"W2094108957","doi":"10.1074/jbc.m110.192104","title":"In Vivo Evidence That Furin from Hepatocytes Inactivates PCSK9","year":2010,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; U.S. Public Health Service; Vlaamse regering","keywords":"Furin; PCSK9; Proprotein convertase; Kexin; Proprotein Convertases; LDL receptor; In vivo; Biology; Biochemistry; Receptor; Cell biology; Molecular biology; Chemistry; Cholesterol; Enzyme; Lipoprotein; Genetics","score_opus":0.043141555962494464,"score_gpt":0.2920955114232382,"score_spread":0.24895395546074373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094108957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613935,0.0021176194,0.000023892797,0.0010767488,0.00013108041,0.00007794758,0.0000036537165,0.000008985771,0.00042069997],"genre_scores_gemma":[0.9970623,0.0007345166,0.0007920782,0.0002873117,0.0010576224,0.0000035031082,0.0000011396794,0.00000608348,0.00005542958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990142,0.000033898836,0.00032899145,0.00015624247,0.00028239275,0.00018429378],"domain_scores_gemma":[0.99908656,0.0001676162,0.00024490815,0.0002313965,0.000076649325,0.00019289971],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00058866275,0.00011718759,0.00044241562,0.000021728622,0.000022668324,0.000013163912,0.00015015183,0.00025898102,0.0011694058],"category_scores_gemma":[0.00092584494,0.00007004316,0.0002556792,0.00007912641,0.00006580803,0.00009466503,0.000045174907,0.0008637986,0.000005146343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024139164,0.0001020569,0.11315076,0.00004442868,0.000043025113,0.00030273636,0.000020294536,2.0898321e-7,0.88374317,0.0000024586566,0.0001601152,0.0021893696],"study_design_scores_gemma":[0.0006982171,0.00014026031,0.060368445,0.00025200282,0.000023658122,0.00055370055,0.00008696805,0.0000044166245,0.9314302,0.00028151248,0.0060755922,0.00008502756],"about_ca_topic_score_codex":0.000095432224,"about_ca_topic_score_gemma":0.0000028731106,"teacher_disagreement_score":0.05278232,"about_ca_system_score_codex":0.00006209686,"about_ca_system_score_gemma":0.000115472336,"threshold_uncertainty_score":0.99974364},"labels":[],"label_agreement":null},{"id":"W2094140885","doi":"10.1007/s40261-013-0071-3","title":"Pharmacokinetic and Pharmacodynamic Profile of Rosuvastatin in Patients with End-Stage Renal Disease on Chronic Haemodialysis","year":2013,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"AstraZeneca","keywords":"Rosuvastatin; Medicine; Pharmacokinetics; Pharmacodynamics; Rosuvastatin Calcium; End stage renal disease; Urology; Dialysis; Population; Area under the curve; Internal medicine; Kidney disease; Pharmacology; Hemodialysis","score_opus":0.017598463046620848,"score_gpt":0.29924447481007505,"score_spread":0.2816460117634542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094140885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974766,0.00015032367,0.0000446955,0.00060194917,0.000057786558,0.0015143141,0.000035588066,0.000022543523,0.00009619274],"genre_scores_gemma":[0.9982352,0.00009753993,0.00050638494,0.00047520202,0.0001301419,0.00013126986,0.0002371732,0.000021682887,0.0001653538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981571,0.00026763603,0.0005943215,0.0003483558,0.00043536766,0.00019723774],"domain_scores_gemma":[0.99886984,0.00011406413,0.0001983159,0.00028577022,0.00012923178,0.0004027777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005815259,0.00014401195,0.00039634304,0.000112360874,0.000033369535,0.000010240298,0.000053270953,0.00004150309,0.00020807292],"category_scores_gemma":[0.0001977975,0.000108369335,0.00010675462,0.00023478351,0.00026888028,0.00011670783,0.000027452737,0.00028351913,0.000021926026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000677358,0.0005919596,0.8088542,0.00092844706,0.00017033111,0.000013725757,0.00016393515,0.0004386245,0.0006392575,0.000060021102,0.00032446906,0.18713765],"study_design_scores_gemma":[0.0065609044,0.00062191533,0.97834307,0.00036895342,0.000182793,3.6306733e-7,0.0000133554995,0.012638899,0.00095357344,0.00008079084,0.00011478223,0.000120601515],"about_ca_topic_score_codex":0.00022088662,"about_ca_topic_score_gemma":0.000017119432,"teacher_disagreement_score":0.18701705,"about_ca_system_score_codex":0.00008138236,"about_ca_system_score_gemma":0.000274257,"threshold_uncertainty_score":0.44191733},"labels":[],"label_agreement":null},{"id":"W2094174361","doi":"10.1016/j.atherosclerosis.2007.05.017","title":"Lipid management in cardiovascular disease prevention guidelines: Strategies and tactics for implementation","year":2007,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Business; Intensive care medicine; Disease prevention; Medicine; Environmental health","score_opus":0.1799230946286993,"score_gpt":0.43750550173583497,"score_spread":0.25758240710713565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094174361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002157543,0.9878729,0.0056442036,0.000039769428,0.0001682886,0.005870977,0.000046244997,0.000044392164,0.0000974627],"genre_scores_gemma":[0.00013702491,0.9931095,0.004344441,0.00007168916,0.00049483,0.0013182757,0.00032605656,0.00009253108,0.00010565664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99745816,0.0001225719,0.00089206785,0.0006141233,0.00052784185,0.00038520686],"domain_scores_gemma":[0.99866843,0.000034773013,0.00019102913,0.00079429947,0.00011851186,0.00019293801],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016635314,0.0003865517,0.0015443362,0.0002527502,0.00008083668,0.00008603115,0.00009039454,0.00019309846,0.000014292893],"category_scores_gemma":[0.000028195693,0.00032604407,0.0015256626,0.00030282547,0.000030882504,0.00015382718,0.00006105918,0.00017332716,0.0000053258536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017630731,0.000052437415,0.000024869885,0.025501618,0.0017453631,0.0000065263976,0.00002625113,0.0000027958527,2.1264381e-7,0.00029033574,0.00009577141,0.9722362],"study_design_scores_gemma":[0.0017280208,0.00016294504,0.0010083143,0.008755856,0.008383768,0.00000942956,0.0004957393,0.000008396931,7.887513e-7,0.00008587249,0.9790584,0.00030246007],"about_ca_topic_score_codex":0.00016424255,"about_ca_topic_score_gemma":0.000032062773,"teacher_disagreement_score":0.97896266,"about_ca_system_score_codex":0.000252167,"about_ca_system_score_gemma":0.00030190405,"threshold_uncertainty_score":0.9999192},"labels":[],"label_agreement":null},{"id":"W2094222285","doi":"10.1038/nrd3699","title":"The biology and therapeutic targeting of the proprotein convertases","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Drug Discovery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":841,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Proprotein Convertases; Kexin; Furin; PCSK9; Proprotein convertase; Subtilisin; Proteases; Serine; Biology; Biochemistry; LDL receptor; Enzyme; Cholesterol; Lipoprotein","score_opus":0.027939725287207413,"score_gpt":0.34247334962035714,"score_spread":0.31453362433314974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094222285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018248626,0.9926054,0.000005661428,0.00037845358,0.0005471557,0.0061732447,0.00004551248,0.000012758261,0.00021355237],"genre_scores_gemma":[0.00037833722,0.9972432,0.00003860862,0.00039794677,0.00076792104,0.0004117611,0.000047618294,0.000055814253,0.0006587719],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964918,0.0013489183,0.0009718137,0.00040832697,0.00035356026,0.00042559722],"domain_scores_gemma":[0.9974143,0.00025358514,0.00087932864,0.0012835471,0.00007258189,0.00009667468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028376656,0.00049136975,0.0029393584,0.000049243405,0.0002338208,0.000036546175,0.0003775226,0.0005818158,0.000012228863],"category_scores_gemma":[0.00039182208,0.00017291147,0.0017087751,0.00035724964,0.00030996,0.000064593754,0.00020692259,0.001793386,0.000011424926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000063389984,0.000029223313,0.000032081585,0.04181087,0.0004018366,9.01938e-7,0.000020554045,3.2454859e-9,0.0000017614832,0.0014726867,0.00040814118,0.9558156],"study_design_scores_gemma":[0.00014981776,0.000024863908,0.000025225801,0.010046417,0.004775872,0.00009075896,0.00001437103,1.5223742e-7,0.000012292715,0.000061031216,0.9846168,0.00018238065],"about_ca_topic_score_codex":0.00004321034,"about_ca_topic_score_gemma":0.000010113156,"teacher_disagreement_score":0.9842087,"about_ca_system_score_codex":0.00008160496,"about_ca_system_score_gemma":0.00047744688,"threshold_uncertainty_score":0.7791469},"labels":[],"label_agreement":null},{"id":"W2094828564","doi":"10.1016/s0021-9150(02)00034-5","title":"Does correction of the friedewald formula using lipoprotein(a) change our estimation of ischemic heart disease risk? The Quebec Cardiovascular Study","year":2002,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Université Laval","funders":"","keywords":"Medicine; Coronary heart disease; Internal medicine; Confidence interval; Myocardial infarction; Cholesterol; Cardiology; Ldl cholesterol; Relative risk","score_opus":0.040672504367708806,"score_gpt":0.26048832569789565,"score_spread":0.21981582133018684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094828564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379784,0.0015835289,0.00039584757,0.0005739168,0.0005582983,0.0029970724,0.000020987536,0.000038231414,0.000034269488],"genre_scores_gemma":[0.9987018,0.00020129727,0.00014853926,0.00012527844,0.00040430806,0.0002207937,0.0000026248504,0.000042807522,0.00015252166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772835,0.00033610113,0.00042546485,0.0003247149,0.00093120115,0.0002541404],"domain_scores_gemma":[0.9978903,0.00002967118,0.00027169439,0.0015472835,0.00015353244,0.00010749697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009961188,0.0002135171,0.000558568,0.000047419697,0.00028970762,0.000019380519,0.00017459979,0.0000899919,0.000017149028],"category_scores_gemma":[0.00021755905,0.000101427126,0.0009253761,0.00043614325,0.000076645585,0.00014242368,0.00008851277,0.0002568192,0.0000048115503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005865936,0.004619137,0.46733734,0.0018974484,0.006261144,0.000006234434,0.023497501,0.009908465,0.032910123,0.000023211986,0.0022095938,0.4507432],"study_design_scores_gemma":[0.0028713674,0.00037794252,0.9314959,0.0008210075,0.0035897018,0.000009891403,0.003463222,0.027176669,0.028223516,0.000018364924,0.0016375062,0.00031493173],"about_ca_topic_score_codex":0.043156262,"about_ca_topic_score_gemma":0.00068855146,"teacher_disagreement_score":0.46415854,"about_ca_system_score_codex":0.000123745,"about_ca_system_score_gemma":0.000058062,"threshold_uncertainty_score":0.9632155},"labels":[],"label_agreement":null},{"id":"W2094964401","doi":"10.1016/s0149-2918(01)80122-3","title":"Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: A one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness","year":2001,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"Bayer Canada","keywords":"Medicine; Pravastatin; Cerivastatin; Randomization; Adverse effect; Randomized controlled trial; Internal medicine; Cholesterol; Pharmacology","score_opus":0.20848785641586248,"score_gpt":0.44190961746479573,"score_spread":0.23342176104893325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094964401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98526776,0.002897739,0.000029627001,0.00027296148,0.00008293741,0.010223392,0.00001936478,0.000003806877,0.0012023905],"genre_scores_gemma":[0.9911427,0.007598551,0.0004897406,0.00040890256,0.00002901856,0.00027087063,0.000037004684,0.000019550214,0.000003662869],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99225533,0.005209793,0.0013415574,0.00039481398,0.0005347807,0.00026372555],"domain_scores_gemma":[0.9896801,0.009168776,0.000354435,0.0005495821,0.00016377207,0.00008334806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040620305,0.00022916928,0.0022211226,0.00008593789,0.00003383544,0.000015110558,0.00020492922,0.000103990766,0.0000027457863],"category_scores_gemma":[0.0002655169,0.00015696167,0.00009625068,0.0004171027,0.00019044764,0.00008291044,0.00007287305,0.00043430287,3.150093e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5769469,0.017834963,0.08968961,0.00031979903,0.0011776013,0.00018243228,0.024008466,0.0001394397,0.000052644467,0.000024167888,0.0000012253903,0.28962275],"study_design_scores_gemma":[0.49554598,0.005627086,0.4813512,0.0002910983,0.00045764464,0.000009303899,0.01579698,0.00006129742,0.000021155882,0.000006841392,0.00070796127,0.00012343917],"about_ca_topic_score_codex":0.1879433,"about_ca_topic_score_gemma":0.30986327,"teacher_disagreement_score":0.39166158,"about_ca_system_score_codex":0.00087008276,"about_ca_system_score_gemma":0.0017691482,"threshold_uncertainty_score":0.8174643},"labels":[],"label_agreement":null},{"id":"W2095210977","doi":"10.1038/sj.ki.5002240","title":"Evidence mounts for a role of the kidney in lipoprotein(a) catabolism","year":2007,"lang":"en","type":"letter","venue":"Kidney International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lipoprotein(a); Lipoprotein; Catabolism; Apolipoprotein B; Kidney; Hemodialysis; Chemistry; Internal medicine; Endocrinology; Biochemistry; Biology; Medicine; Cholesterol; Metabolism","score_opus":0.025652931678336016,"score_gpt":0.29638018160847646,"score_spread":0.2707272499301404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095210977","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019138955,0.0019168342,0.00036053747,0.9836229,0.0027958022,0.0030725244,0.0010729858,0.000033883163,0.005210615],"genre_scores_gemma":[0.012080482,0.0003344908,0.0017385028,0.96513605,0.012674549,0.0005267091,0.0009725249,0.0000955276,0.0064411713],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99698174,0.00007309184,0.00061820884,0.00045778853,0.0014721177,0.0003970636],"domain_scores_gemma":[0.9980797,0.000094343915,0.000312756,0.0008392477,0.00045829767,0.00021566705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091047696,0.00027294207,0.00056291535,0.0003140414,0.00004595877,0.000023615456,0.0006279495,0.0005991477,0.0002284052],"category_scores_gemma":[0.0029613823,0.00020226942,0.0006309079,0.00021907454,0.000100117,0.000099584104,0.00014016652,0.001220408,0.000019205772],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001340668,0.00006803997,0.0013505658,0.0007557024,0.00035094967,0.000042323194,0.00017130133,0.0000011550171,0.00055980403,0.00019563381,0.9884794,0.007891096],"study_design_scores_gemma":[0.0014251032,0.000052897023,0.004597413,0.0035696144,0.00013126475,0.000096020325,0.000015726026,0.00010166443,0.0028231766,0.00043891362,0.98656595,0.00018226056],"about_ca_topic_score_codex":0.0022638808,"about_ca_topic_score_gemma":0.000038209473,"teacher_disagreement_score":0.01848688,"about_ca_system_score_codex":0.0003760177,"about_ca_system_score_gemma":0.0017067186,"threshold_uncertainty_score":0.8248308},"labels":[],"label_agreement":null},{"id":"W2095254917","doi":"10.1016/j.cjca.2013.01.008","title":"Western Database of Lipid Variants (WDLV): A Catalogue of Genetic Variants in Monogenic Dyslipidemias","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Dyslipidemia; Medicine; Genetics; Mutation; DNA sequencing; Gene; Disease; Bioinformatics; Computational biology; Biology; Internal medicine","score_opus":0.02000758257958358,"score_gpt":0.24810415572349412,"score_spread":0.22809657314391055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095254917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896414,0.005929659,0.0020855237,0.00040358145,0.000699192,0.00045885472,0.000118232594,0.0000023937678,0.0006611414],"genre_scores_gemma":[0.99723214,0.00038751718,0.000903823,0.00018355904,0.0012111434,0.00000990114,0.000024679126,0.000025152856,0.000022059014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997678,0.00035723182,0.0010212054,0.00017997592,0.00023510985,0.0005285196],"domain_scores_gemma":[0.99769866,0.000070242815,0.0003959279,0.00059837545,0.00036240485,0.0008744105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012135167,0.00016826068,0.0012851014,0.0005495023,0.000025498495,0.0000050553185,0.00023278121,0.00021908966,0.00007976243],"category_scores_gemma":[0.00036671295,0.00014623096,0.0003795522,0.0002734984,0.00016256545,0.0001261747,0.000027602933,0.00039847588,0.000016868893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014467533,0.00003128186,0.96636176,0.000592878,0.0014414678,0.0009002212,0.00070887845,0.00081831496,0.0064212848,0.00009675347,0.0040896125,0.018392848],"study_design_scores_gemma":[0.0021776895,0.00041170313,0.98803616,0.0002921833,0.00027154246,0.0035786368,0.00017560534,0.000023705697,0.0003539878,0.00006208274,0.004482882,0.0001338168],"about_ca_topic_score_codex":0.026744233,"about_ca_topic_score_gemma":0.004234541,"teacher_disagreement_score":0.022509692,"about_ca_system_score_codex":0.0001771525,"about_ca_system_score_gemma":0.0024325456,"threshold_uncertainty_score":0.97973675},"labels":[],"label_agreement":null},{"id":"W2095350074","doi":"10.1016/s1047-2797(03)00178-9","title":"Adherence to guidelines for lipid-lowering therapy after coronary artery bypass grafting (CABG): Canadian off-pump CABG registry","year":2003,"lang":"en","type":"article","venue":"Annals of Epidemiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bypass grafting; Artery; Cardiology; Internal medicine; Grafting","score_opus":0.22729568685232782,"score_gpt":0.41998866603571156,"score_spread":0.19269297918338374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095350074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94840723,0.018709216,0.0026854936,0.026517792,0.0006628737,0.0015502771,0.00008262504,0.00004661922,0.0013378607],"genre_scores_gemma":[0.9283481,0.0033064168,0.007740406,0.05856383,0.0008794103,0.00038889272,0.000043801814,0.000053388932,0.0006757467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968826,0.00034772104,0.0010765578,0.000544351,0.00015541079,0.0009933132],"domain_scores_gemma":[0.9968937,0.00048265353,0.00023538363,0.0008988289,0.0007684496,0.0007209541],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00539964,0.0002631774,0.0011138936,0.00017171627,0.00010096681,0.0000047870253,0.00016517601,0.00028308592,0.00012985707],"category_scores_gemma":[0.0092240125,0.00022172793,0.0004920193,0.00017472154,0.00009477713,0.000060454036,0.0000250183,0.00021999117,0.000017675004],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020920767,0.00021132277,0.2359998,0.00072756,0.0018153056,0.00032284512,0.0006061888,0.00035586857,0.0021918719,0.0018945566,0.18917231,0.5646103],"study_design_scores_gemma":[0.0022072094,0.0025525063,0.097069725,0.00055110484,0.000086174965,0.0005286801,0.00026167792,0.00016191222,0.0031448472,0.0014984896,0.8914039,0.0005337787],"about_ca_topic_score_codex":0.024632318,"about_ca_topic_score_gemma":0.012968354,"teacher_disagreement_score":0.7022316,"about_ca_system_score_codex":0.000051931795,"about_ca_system_score_gemma":0.0006112142,"threshold_uncertainty_score":0.9991217},"labels":[],"label_agreement":null},{"id":"W2095375351","doi":"10.1203/00006450-200206000-00009","title":"A Randomized Crossover Trial of Combination Pharmacologic Therapy in Children with Familial Hyperlipidemia","year":2002,"lang":"en","type":"article","venue":"Pediatric Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children; St. Joseph’s Healthcare Hamilton; University of Toronto; SickKids Foundation; St. Joseph's Hospital","funders":"","keywords":"Medicine; Regimen; Pravastatin; Adverse effect; Crossover study; Bile acid; Combination therapy; Internal medicine; Pill; Randomized controlled trial; Hyperlipidemia; Familial hypercholesterolemia; Gastroenterology; Pharmacology; Cholesterol; Endocrinology","score_opus":0.07697314941281047,"score_gpt":0.3789741773776821,"score_spread":0.3020010279648716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095375351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896599,0.002926998,0.000015904068,0.0003790662,0.000079002806,0.005183213,0.0000028771528,0.00001984384,0.0017331956],"genre_scores_gemma":[0.9839396,0.014103946,0.00008531722,0.00006142245,0.0010775808,0.00038530197,0.000007944776,0.000017905633,0.000321013],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99646646,0.0010200295,0.0004294605,0.00028736028,0.0013846748,0.00041200494],"domain_scores_gemma":[0.998793,0.00038340382,0.00008771686,0.00031813848,0.00029571023,0.00012201964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058031883,0.00011728605,0.000720899,0.0004490268,0.000074404554,0.000015437281,0.00012798907,0.00012542141,0.00024144913],"category_scores_gemma":[0.0006086028,0.00007498284,0.00021945553,0.0010525346,0.0001738711,0.0000691197,0.000034178316,0.00058321113,0.000023069977],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86717784,0.0018914103,0.10480258,0.00009737022,0.00026262668,0.000020350295,0.0003285618,0.0000097800985,0.000101018166,0.00010442141,0.001394432,0.023809612],"study_design_scores_gemma":[0.9538866,0.0018123784,0.043347824,0.000007905587,0.00007132735,0.000015060581,0.000017274673,0.00038320967,0.00016250787,0.00008480727,0.00012788946,0.00008316135],"about_ca_topic_score_codex":0.0007590386,"about_ca_topic_score_gemma":0.0000038542853,"teacher_disagreement_score":0.086708814,"about_ca_system_score_codex":0.000101985825,"about_ca_system_score_gemma":0.00019438381,"threshold_uncertainty_score":0.30577114},"labels":[],"label_agreement":null},{"id":"W2095889878","doi":"10.1345/aph.1q620","title":"Is Statin-Associated Cognitive Impairment Clinically Relevant? A Narrative Review and Clinical Recommendations","year":2012,"lang":"en","type":"review","venue":"Annals of Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Research Institute for Aging; McMaster University; University of Waterloo","funders":"","keywords":"Medicine; Statin; Cognition; Observational study; Adverse effect; Rosuvastatin; Dementia; Discontinuation; Randomized controlled trial; Placebo; Pravastatin; Delirium; Physical therapy; Internal medicine; Psychiatry; Cholesterol; Alternative medicine; Pathology","score_opus":0.25459982469441106,"score_gpt":0.5560120183798378,"score_spread":0.30141219368542677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095889878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007221561,0.9892195,0.000014436566,0.004844939,0.00022972126,0.0046074437,0.0006563013,0.0000418899,0.00031359575],"genre_scores_gemma":[0.000032622487,0.9762967,0.0002235131,0.021827692,0.00044080094,0.00026560726,0.00040028675,0.00009049278,0.00042224556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99395037,0.0018528884,0.0026232149,0.0005914213,0.0004945635,0.00048756672],"domain_scores_gemma":[0.9956783,0.00082126283,0.0017695801,0.0004516113,0.00074382185,0.0005354468],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005970118,0.00052269094,0.0045281188,0.00013002973,0.000104840416,0.000012817988,0.00014430992,0.00036266618,0.0012996356],"category_scores_gemma":[0.00034124037,0.00038616618,0.0022109773,0.00040756454,0.000182835,0.00010276361,0.000055036784,0.0009726141,0.000045710785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090152695,0.0009598723,0.000043931057,0.025317665,0.00706101,0.0000068125396,0.00039404113,6.56005e-10,3.282817e-7,0.00000360209,0.032378934,0.93374366],"study_design_scores_gemma":[0.002169754,0.001368822,0.000094375115,0.061154988,0.010316483,0.000038816837,0.00006780983,6.619614e-7,0.0000076022366,0.000016941009,0.92442966,0.00033406078],"about_ca_topic_score_codex":0.000036276568,"about_ca_topic_score_gemma":0.0000022785107,"teacher_disagreement_score":0.9334096,"about_ca_system_score_codex":0.000046239107,"about_ca_system_score_gemma":0.00078639196,"threshold_uncertainty_score":0.99985904},"labels":[],"label_agreement":null},{"id":"W2096331435","doi":"10.1016/j.jacl.2013.01.007","title":"Point: Why statins have failed to reduce mortality in just about anybody","year":2013,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Scopus; Medicine; Statin; Cholesterol; Event (particle physics); Meta-analysis; Clinical trial; Internal medicine; MEDLINE","score_opus":0.11087970980585737,"score_gpt":0.4464494420404469,"score_spread":0.3355697322345895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096331435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775431,0.00026651655,0.0009125057,0.016402371,0.0025449083,0.00063292583,0.0000041128383,0.000011519098,0.001682032],"genre_scores_gemma":[0.9761651,0.00036005612,0.0039872197,0.01190227,0.007260785,0.000017554668,0.000003253285,0.000024426301,0.0002793022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953125,0.00085750205,0.0025647583,0.00029620196,0.00053420424,0.00043483448],"domain_scores_gemma":[0.9969611,0.00052815623,0.0006603215,0.00055487547,0.00055058126,0.0007449709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005938969,0.00017026381,0.0016144449,0.00020357389,0.00003454824,0.00001981865,0.00020612538,0.00032289667,0.000702115],"category_scores_gemma":[0.0049922015,0.00012303586,0.00067960395,0.00019474534,0.0001336818,0.00015340671,0.00007323594,0.0012037636,0.00013445846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017188364,0.0017403488,0.76137495,0.0002584727,0.0009211122,0.00032962853,0.00074671116,0.000063691004,0.0009435516,0.00034656626,0.13527961,0.09627654],"study_design_scores_gemma":[0.0043806145,0.0022671109,0.95223004,0.00017716606,0.00014769916,0.00027506545,0.0004203503,0.000052322586,0.00010101104,0.00055290724,0.03926925,0.00012644616],"about_ca_topic_score_codex":0.00069334614,"about_ca_topic_score_gemma":0.00024962242,"teacher_disagreement_score":0.19085513,"about_ca_system_score_codex":0.00007796417,"about_ca_system_score_gemma":0.00052014925,"threshold_uncertainty_score":0.7687667},"labels":[],"label_agreement":null},{"id":"W2096343612","doi":"10.1194/jlr.p011668","title":"Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography","year":2011,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":295,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Internal medicine; Coronary angiography; Cholesterol; Cardiology; Medicine; Lipoprotein; Angiography; Lipoprotein(a); Coronary atherosclerosis; Coronary heart disease; Myocardial infarction","score_opus":0.05305976849847666,"score_gpt":0.30342630202074555,"score_spread":0.2503665335222689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096343612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979252,0.00083946716,0.000046297926,0.00030305164,0.00004375171,0.00048298316,0.0000020295945,0.0000047028693,0.00035250155],"genre_scores_gemma":[0.9980703,0.0010450282,0.0005654266,0.000036360747,0.00015522298,0.000010027503,5.0646344e-7,0.000022072776,0.00009504475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812263,0.00019179574,0.00036125517,0.00017202552,0.0009114726,0.00024079149],"domain_scores_gemma":[0.9988044,0.0000990376,0.00017509388,0.00027018716,0.00039645875,0.00025483183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022512889,0.000110806344,0.00036746354,0.00041560957,0.000081854014,0.000017739127,0.000094298746,0.00011407116,0.00002604693],"category_scores_gemma":[0.00010306868,0.00007332181,0.00015884754,0.00034610057,0.00025539644,0.000115464354,0.000039486626,0.0006164743,0.0000018191129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012950026,0.0006774554,0.7843132,0.0009798753,0.0017635836,0.00021185557,0.0047455383,0.000004154413,0.027925275,0.00015535823,0.00016834101,0.1661053],"study_design_scores_gemma":[0.0032366607,0.0055992305,0.98114353,0.00065739005,0.000079874524,0.0014872659,0.00038468768,0.000020905929,0.006906974,0.000037407026,0.00037374327,0.00007232684],"about_ca_topic_score_codex":0.00011861684,"about_ca_topic_score_gemma":0.000009242628,"teacher_disagreement_score":0.1968303,"about_ca_system_score_codex":0.00003163289,"about_ca_system_score_gemma":0.0001535995,"threshold_uncertainty_score":0.29899767},"labels":[],"label_agreement":null},{"id":"W2096458247","doi":"10.1016/j.amjcard.2007.03.025","title":"Recruitment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial","year":2007,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Eye Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute on Aging; Centers for Disease Control and Prevention","keywords":"Diabetes mellitus; Action (physics); Medicine; Control (management); Internal medicine; Environmental health; Endocrinology; Economics","score_opus":0.04009415865112355,"score_gpt":0.3291097978140728,"score_spread":0.28901563916294926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096458247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98726445,0.0023455163,0.0067136637,0.0014051489,0.00040668572,0.0014095451,0.0000020140621,0.0000058783867,0.00044709948],"genre_scores_gemma":[0.99598056,0.0009022367,0.00014313284,0.0008946576,0.0020039475,0.000059050355,6.4257796e-7,0.000013663458,0.0000020881905],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99621654,0.002006305,0.00064303307,0.00016303321,0.0005482964,0.0004228265],"domain_scores_gemma":[0.9984064,0.0004404522,0.00034548374,0.0005848451,0.00011937907,0.00010343989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01456719,0.00015063788,0.0012988655,0.0002564772,0.000057763475,0.00001730129,0.000248202,0.000053193005,0.0000020690845],"category_scores_gemma":[0.00031475865,0.00007727516,0.00093009055,0.0005320599,0.00018307654,0.000060618477,0.000019961306,0.00071211514,0.000003767683],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04950786,0.00012011463,0.046764992,0.000029780247,0.004269093,0.0007803001,0.0018112196,0.015464643,0.0006980689,0.00013998483,0.00028040996,0.8801335],"study_design_scores_gemma":[0.04042787,0.009992989,0.88979024,0.00009165095,0.0012853454,0.0012818726,0.021577371,0.000017406286,0.00017725816,0.0005533217,0.034583095,0.00022156586],"about_ca_topic_score_codex":0.00041764358,"about_ca_topic_score_gemma":0.000059272705,"teacher_disagreement_score":0.87991196,"about_ca_system_score_codex":0.00018428886,"about_ca_system_score_gemma":0.00022535276,"threshold_uncertainty_score":0.5048726},"labels":[],"label_agreement":null},{"id":"W2096790749","doi":"10.1093/qjmed/hcr158","title":"Adverse events associated with individual statin treatments for cardiovascular disease: an indirect comparison meta-analysis","year":2011,"lang":"en","type":"review","venue":"QJM","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Pravastatin; Rosuvastatin; Medicine; Atorvastatin; Fluvastatin; Internal medicine; Pitavastatin; Adverse effect; Statin; Simvastatin; Relative risk; Rosuvastatin Calcium; Meta-analysis; Pharmacology; Cholesterol; Confidence interval","score_opus":0.2512903936136423,"score_gpt":0.3835831391842445,"score_spread":0.13229274557060222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096790749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015333401,0.99067414,0.0006233747,0.0000045365264,0.000068667665,0.005589545,0.0026885401,0.00010899194,0.0000888802],"genre_scores_gemma":[0.0005703193,0.9750453,0.0016331228,0.000048900223,0.00020143934,0.0034142153,0.017846335,0.00021370215,0.0010266228],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9946682,0.0011128223,0.0009516547,0.0011412943,0.0014811091,0.0006449458],"domain_scores_gemma":[0.99607587,0.0000996143,0.0006886645,0.0021611548,0.00024104495,0.0007336746],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0019435773,0.0008711141,0.011040872,0.0005395405,0.00018585061,0.000018878514,0.00030506216,0.00038090436,0.00020469571],"category_scores_gemma":[0.00012567847,0.00054268335,0.020771472,0.0010948398,0.000051511455,0.00010986849,0.0000559619,0.00039474858,0.000028025546],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054799406,0.0005502306,0.0003178698,0.0025677476,0.7842955,0.00005873016,0.000094398885,0.000016275699,1.0097311e-9,0.000004960893,0.000071672235,0.2119678],"study_design_scores_gemma":[0.0011709678,0.00037733093,0.001225017,0.00044105062,0.670674,0.0000054185266,0.000020270267,0.000006242421,1.3880766e-7,0.0000049643454,0.3257166,0.00035795933],"about_ca_topic_score_codex":0.00044415836,"about_ca_topic_score_gemma":0.00009912441,"teacher_disagreement_score":0.32564494,"about_ca_system_score_codex":0.00037647053,"about_ca_system_score_gemma":0.00087694864,"threshold_uncertainty_score":0.99970245},"labels":[],"label_agreement":null},{"id":"W2096990833","doi":"10.7748/nop2004.12.16.9.37.c2352","title":"Lipid-lowering drugs","year":2004,"lang":"en","type":"article","venue":"Nursing Older People","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Cause of death; Gerontology; Intensive care medicine; Internal medicine; Disease","score_opus":0.009988476375632186,"score_gpt":0.27284762154357073,"score_spread":0.26285914516793857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096990833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96953565,0.0010707887,0.0069674114,0.005356795,0.0008650541,0.00045564683,0.0000014973848,0.00022548121,0.015521675],"genre_scores_gemma":[0.9964615,0.000048090344,0.0015802161,0.0005834026,0.0008568218,0.000015653444,0.000010532126,0.000035631747,0.0004081307],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988378,0.000012903383,0.00016479439,0.00025498643,0.00038631583,0.00034320098],"domain_scores_gemma":[0.9992543,0.000007551867,0.000031148673,0.00045890364,0.000053966392,0.00019416194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020496137,0.00012646608,0.0002867792,0.00007382188,0.00012997916,0.00002341387,0.000057170106,0.0000833379,0.00008392652],"category_scores_gemma":[0.000022300956,0.000114641996,0.00020025899,0.00023681181,0.000033220338,0.00007037826,0.000011216585,0.00018527631,0.00010366408],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025227162,0.0019883788,0.0070798644,0.0011070763,0.00040367708,0.00016017385,0.057450112,0.00039792855,0.009788101,0.0029647793,0.006047125,0.9123605],"study_design_scores_gemma":[0.028287789,0.0015064614,0.7979259,0.009211431,0.0011956533,0.002758136,0.0083931815,0.00017960659,0.08922621,0.0035374607,0.05596959,0.0018085802],"about_ca_topic_score_codex":0.00035818943,"about_ca_topic_score_gemma":0.000024737781,"teacher_disagreement_score":0.9105519,"about_ca_system_score_codex":0.00027166135,"about_ca_system_score_gemma":0.00019713877,"threshold_uncertainty_score":0.46749648},"labels":[],"label_agreement":null},{"id":"W2097092357","doi":"10.1370/afm.1641","title":"Cardiovascular Risk and Statin Use in the United States","year":2014,"lang":"en","type":"article","venue":"The Annals of Family Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; University of Michigan","keywords":"Medicine; Statin; Coronary artery disease; Internal medicine; Hyperlipidemia; Diabetes mellitus; Logistic regression; Population; Medical prescription; Cardiology; Physical therapy; Environmental health; Endocrinology","score_opus":0.1515693441460471,"score_gpt":0.35581367288242094,"score_spread":0.20424432873637383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097092357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97929734,0.011672644,0.00090284477,0.0070167896,0.00005229122,0.0005978456,0.000010125561,0.000017369504,0.00043273176],"genre_scores_gemma":[0.96927017,0.020787649,0.00010905227,0.009435349,0.0002810989,0.000021147483,0.00003996877,0.000018173328,0.000037367216],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99742377,0.0009165846,0.00037730802,0.00020254792,0.0008067899,0.00027301282],"domain_scores_gemma":[0.9979468,0.0005861143,0.00010939839,0.0010561942,0.00019945765,0.00010202873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007766786,0.00015657522,0.00062342064,0.00016205423,0.00008628115,0.000008932883,0.00016345449,0.000054288987,0.0000062352533],"category_scores_gemma":[0.0010143329,0.00006971983,0.00019024678,0.00052178785,0.0003493231,0.000046381323,0.000036482306,0.0003339005,0.0000027455535],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002547036,0.00075452303,0.1075712,0.002432165,0.0067429887,0.00029406132,0.051732168,0.0030407882,0.0011112111,0.0069621424,0.05945079,0.75736094],"study_design_scores_gemma":[0.0042009205,0.0013090349,0.7413016,0.00050822936,0.00069226517,0.00006694811,0.0064076823,0.0014300062,0.00020449024,0.0016329011,0.24208982,0.00015609218],"about_ca_topic_score_codex":0.018919243,"about_ca_topic_score_gemma":0.00006680261,"teacher_disagreement_score":0.75720483,"about_ca_system_score_codex":0.0000073299925,"about_ca_system_score_gemma":0.00003196415,"threshold_uncertainty_score":0.98761386},"labels":[],"label_agreement":null},{"id":"W2097123269","doi":"","title":"Dyslipidemia in Type 2 Diabetes: What's the Role of Combination Drugs?","year":2005,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Internal medicine; Endocrinology; Very low-density lipoprotein; Dyslipidemia; Diabetes mellitus; Medicine; Type 2 diabetes; Cholesterol; Lipoprotein; Metabolic syndrome; Triglyceride","score_opus":0.007040787182577602,"score_gpt":0.2467382213180674,"score_spread":0.2396974341354898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097123269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97727424,0.007011009,0.000008491579,0.0037621437,0.000083277024,0.00033802234,1.8891015e-7,0.00001726283,0.01150538],"genre_scores_gemma":[0.9979895,0.00041441096,0.00014990097,0.0010197894,0.00015238895,0.000010746769,0.000004725065,0.0000072078733,0.00025136402],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993276,0.00005253666,0.00017888591,0.000090044,0.00022292869,0.00012799795],"domain_scores_gemma":[0.9995337,0.000041727755,0.00003420418,0.00028520465,0.0000675767,0.00003754963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006861321,0.00005235641,0.00017900752,0.00004461733,0.000018287263,0.000009153804,0.000049710376,0.000048708287,0.00012070087],"category_scores_gemma":[0.000069382295,0.000031549444,0.00007087657,0.00019049022,0.000023662282,0.00013421605,0.000016416137,0.00010861848,0.000030301857],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028281565,0.00016962166,0.022784783,0.000066918015,0.00006392738,4.9222905e-7,0.00082762324,0.000020594352,0.0010174792,0.004461875,0.0004720885,0.97008634],"study_design_scores_gemma":[0.007007192,0.00085190346,0.49125898,0.0007313566,0.0002276594,0.000008436131,0.013256461,0.012374021,0.087171435,0.0036388917,0.38309813,0.00037556535],"about_ca_topic_score_codex":0.000099221426,"about_ca_topic_score_gemma":0.00004366681,"teacher_disagreement_score":0.96971077,"about_ca_system_score_codex":0.000049598464,"about_ca_system_score_gemma":0.0000585158,"threshold_uncertainty_score":0.13215898},"labels":[],"label_agreement":null},{"id":"W2097833361","doi":"10.1161/circgenetics.109.907642","title":"Comprehensive Analysis of Genomic Variation in the <i>LPA</i> Locus and Its Relationship to Plasma Lipoprotein(a) in South Asians, Chinese, and European Caucasians","year":2009,"lang":"en","type":"article","venue":"Circulation Cardiovascular Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Copy-number variation; Genetics; Linkage disequilibrium; Single-nucleotide polymorphism; Biology; Genetic variation; Lipoprotein(a); Haplotype; Gene; Apolipoprotein B; Allele; Genotype; Genome; Endocrinology; Cholesterol","score_opus":0.020191983510545623,"score_gpt":0.2500522920927273,"score_spread":0.22986030858218165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097833361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98111737,0.011898082,0.0046895724,0.0003696372,0.000034771394,0.0014768913,0.00001481442,0.00001706162,0.00038177552],"genre_scores_gemma":[0.9986508,0.0003050544,0.0005734122,0.00026001554,0.00011754593,0.000019886917,0.0000460808,0.000023032759,0.0000042007355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975153,0.0006368093,0.00054482213,0.0004609918,0.00060434174,0.00023770421],"domain_scores_gemma":[0.9988112,0.00005380839,0.00010540389,0.00075131183,0.00015590305,0.00012235796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015113648,0.00021283429,0.0007280467,0.00067214086,0.00008500202,0.000035106124,0.00009671569,0.00012016024,0.0000023163507],"category_scores_gemma":[0.00012626879,0.00018266878,0.00044215002,0.0016336922,0.000031203057,0.000054940847,0.000032589138,0.00023363765,0.0000039574675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001571523,0.00021189907,0.48430735,0.00045372298,0.004518587,0.00019256913,0.02723775,0.37662506,0.007220356,0.00047053344,0.0000064827254,0.09859851],"study_design_scores_gemma":[0.0014504077,0.00008365086,0.98772573,0.000041480424,0.0014290438,0.00006653702,0.0003532765,0.008316601,0.000030484405,0.000062161525,0.00027142302,0.00016921543],"about_ca_topic_score_codex":0.00010490004,"about_ca_topic_score_gemma":0.0000689298,"teacher_disagreement_score":0.5034184,"about_ca_system_score_codex":0.00008225883,"about_ca_system_score_gemma":0.00006198248,"threshold_uncertainty_score":0.74490166},"labels":[],"label_agreement":null},{"id":"W2098230963","doi":"10.1056/nejmoa0902604","title":"Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1646,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"British Heart Foundation; Wellcome Trust","keywords":"Lipoprotein(a); Medicine; Coronary artery disease; Lipoprotein; Risk factor; Disease; Internal medicine; Genetic variants; Atherosclerotic cardiovascular disease; Cardiology; Genetics; Cholesterol; Gene; Genotype; Biology","score_opus":0.02224901186022214,"score_gpt":0.2553915572722287,"score_spread":0.23314254541200655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098230963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97193956,0.010805756,0.0022434897,0.014040526,0.00015799311,0.00035789312,0.000003855463,0.000016876258,0.0004340301],"genre_scores_gemma":[0.9925138,0.0010624772,0.0011957878,0.0017259603,0.0030862754,0.00000107551,0.0000055833325,0.000017860839,0.00039118895],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981712,0.00011672787,0.00043468634,0.00016516706,0.00086541835,0.00024677845],"domain_scores_gemma":[0.99829096,0.000057995556,0.0002469978,0.00024124309,0.00022616345,0.0009366614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009926348,0.0001782514,0.0006408276,0.00014308996,0.000064369924,0.0000091944785,0.00007491447,0.00006550585,0.00007865575],"category_scores_gemma":[0.0005328026,0.00010322798,0.000082823804,0.00017752315,0.00008233468,0.0000724085,0.000010007895,0.0003649418,0.0000012191579],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00361448,0.00020954157,0.028013496,0.00008030457,0.00051064236,0.0058385087,0.0005502261,0.000023182956,0.0008955351,0.000069082496,0.0023632108,0.9578318],"study_design_scores_gemma":[0.053120006,0.005199687,0.93056846,0.0013848384,0.0007022616,0.0048381127,0.000038819937,0.00005010501,0.00002707027,0.00081297726,0.0031443732,0.00011331733],"about_ca_topic_score_codex":0.000116055,"about_ca_topic_score_gemma":0.000027182117,"teacher_disagreement_score":0.9577185,"about_ca_system_score_codex":0.00006447945,"about_ca_system_score_gemma":0.00046063153,"threshold_uncertainty_score":0.4209515},"labels":[],"label_agreement":null},{"id":"W2098702712","doi":"10.4021/jocmr1371w","title":"Ezetimibe in Combination With a Statin Does Not Reduce All-Cause Mortality","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Medicine; Statin; Internal medicine; Population; Univariate analysis; Logistic regression; Cohort; Multivariate analysis; Environmental health","score_opus":0.3142990876718596,"score_gpt":0.5563979210360243,"score_spread":0.24209883336416466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098702712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94274974,0.00034328245,0.00013301315,0.05417565,0.00024482928,0.0009202137,9.962857e-7,0.000007918138,0.0014243518],"genre_scores_gemma":[0.99354637,0.0024289284,0.0011023711,0.0008543061,0.0015748055,0.000027999478,0.0000034769635,0.000023459996,0.00043830997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925587,0.0014416536,0.0019518329,0.00026995962,0.0032991965,0.00047861543],"domain_scores_gemma":[0.9945184,0.0015979653,0.0004429568,0.0005480087,0.002132997,0.0007596602],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.025676252,0.00013765348,0.0011370074,0.00042707054,0.000045197135,0.000021671298,0.00021791352,0.00017162236,0.00043431672],"category_scores_gemma":[0.008994063,0.000066218876,0.00020058753,0.00055609643,0.0005338192,0.00020073484,0.0000544421,0.0023914382,0.000026394886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006997889,0.005141239,0.52679986,0.0015010956,0.004084515,0.003784223,0.0016866007,0.0000146254815,0.0035332367,0.001039777,0.029276622,0.41614032],"study_design_scores_gemma":[0.016463218,0.010947928,0.96134096,0.0018157219,0.0002885524,0.00031882152,0.0016206951,0.00024850183,0.00084941235,0.0015060737,0.0044774297,0.00012270399],"about_ca_topic_score_codex":0.0014759231,"about_ca_topic_score_gemma":0.0000977027,"teacher_disagreement_score":0.43454108,"about_ca_system_score_codex":0.00013500616,"about_ca_system_score_gemma":0.00093148387,"threshold_uncertainty_score":0.99991006},"labels":[],"label_agreement":null},{"id":"W2099483046","doi":"10.1007/s00270-006-0183-8","title":"Lipid-Altering Therapies and the Progression of Atherosclerotic Disease","year":2007,"lang":"en","type":"review","venue":"CardioVascular and Interventional Radiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"GlaxoSmithKline; Pfizer","keywords":"Medicine; Cardiology; Internal medicine; Intravascular ultrasound; Ezetimibe; Coronary atherosclerosis; Stenosis; Disease; Statin; Lipid profile; Coronary artery disease; Cholesterol","score_opus":0.054148993685701405,"score_gpt":0.3553134258734259,"score_spread":0.3011644321877245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099483046","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005432729,0.9959844,0.0014020562,0.000051086707,0.00026525973,0.0015628043,0.000018664465,0.000019889232,0.00015258437],"genre_scores_gemma":[0.0034463205,0.9953264,0.00016644283,0.000039375805,0.0006464622,0.00018967528,0.0000655263,0.000043007003,0.00007678341],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974597,0.00073048775,0.000689953,0.00046359864,0.00039732753,0.00025892866],"domain_scores_gemma":[0.99866563,0.00015153404,0.00020419367,0.00069663214,0.00009676306,0.0001852242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028131388,0.00033030892,0.002707915,0.00016332345,0.00010350003,0.00001668932,0.00012035005,0.00023587469,0.000024298079],"category_scores_gemma":[0.00016020275,0.00018055168,0.004923982,0.00012683305,0.0007668223,0.000035820154,0.00014343447,0.00037510728,0.0000025885263],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014550747,0.000044011074,0.00004400837,0.021869445,0.0068053636,0.000032823977,0.000039258808,5.465548e-7,1.8040826e-7,0.002102677,0.000024796374,0.9688914],"study_design_scores_gemma":[0.0025077038,0.00027113638,0.0014493169,0.015232225,0.0064832643,0.0018866126,0.000024437268,0.000010297689,5.707861e-7,0.00012391324,0.9718117,0.00019883254],"about_ca_topic_score_codex":0.000016978705,"about_ca_topic_score_gemma":4.91463e-7,"teacher_disagreement_score":0.9717869,"about_ca_system_score_codex":0.000034940476,"about_ca_system_score_gemma":0.00012790847,"threshold_uncertainty_score":0.73626834},"labels":[],"label_agreement":null},{"id":"W2099654648","doi":"10.1161/circresaha.114.301621","title":"PCSK9","year":2014,"lang":"en","type":"review","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":586,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Centre for Heart Rhythm Disorders, University of Adelaide; Canadian Institutes of Health Research","keywords":"PCSK9; Kexin; LDL receptor; Proprotein convertase; Cholesterol; Endosome; Biology; Familial hypercholesterolemia; Receptor; Lipoprotein; Pharmacology; Endocrinology; Biochemistry","score_opus":0.29125760893604985,"score_gpt":0.5140535183381166,"score_spread":0.22279590940206678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099654648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000055878913,0.9786218,0.00028813188,0.00007863326,0.00012060806,0.0020294471,0.0000036318825,0.000055665514,0.018796485],"genre_scores_gemma":[0.00013766454,0.99589485,0.00007479516,0.00003380507,0.0014861338,0.00025455814,0.00020861521,0.00006963868,0.0018399652],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962761,0.00082073326,0.00045775957,0.00046443724,0.0015231068,0.00045790046],"domain_scores_gemma":[0.9978723,0.00017326575,0.000083171726,0.0011801356,0.00041215305,0.0002790075],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043288446,0.00019031923,0.001474479,0.00055271195,0.00012572514,0.00005379285,0.00014936528,0.0004185744,0.00025470735],"category_scores_gemma":[0.0004716943,0.00014531007,0.0008676831,0.0008366157,0.00008468988,0.000032323824,0.00007406467,0.0010649622,0.0018658905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018144198,0.00002180668,0.000012003482,0.033469502,0.00013498604,0.000019583355,0.00000696541,7.3217075e-7,1.0867738e-7,0.00038991802,0.0014036432,0.96453893],"study_design_scores_gemma":[0.00021190669,0.000043968525,0.00013983675,0.007713082,0.0002486017,0.0001557242,0.000003105677,0.000038282058,9.209927e-8,0.000092824266,0.99123245,0.00012010635],"about_ca_topic_score_codex":0.00008951741,"about_ca_topic_score_gemma":0.0000027413844,"teacher_disagreement_score":0.9898288,"about_ca_system_score_codex":0.0003313044,"about_ca_system_score_gemma":0.0010293805,"threshold_uncertainty_score":0.99891126},"labels":[],"label_agreement":null},{"id":"W2099686878","doi":"10.1136/bcr.06.2009.2028","title":"A patient’s informative mistake: niacin is very effective in correcting dyslipidaemia: Table 1","year":2010,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Niacin; Ezetimibe; Fenofibrate; Medicine; Internal medicine; Atorvastatin; Cholesterol; Endocrinology; High-density lipoprotein; Lipoprotein","score_opus":0.009237478110243775,"score_gpt":0.2770326237235706,"score_spread":0.26779514561332685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099686878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866653,0.00014680234,0.00010886214,0.000088013265,0.0010454638,0.0024900076,0.000004868385,0.00006497479,0.009385689],"genre_scores_gemma":[0.9979992,0.0000043722043,0.0006737706,0.0004408794,0.00032274998,0.00033240748,0.000014429513,0.000026921867,0.00018527477],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9980008,0.0000762477,0.00071083795,0.00034685215,0.0004667069,0.00039857498],"domain_scores_gemma":[0.99839395,0.00008534467,0.00035512034,0.00073083857,0.00020934941,0.00022539092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016126523,0.00020296578,0.0005341567,0.00015984067,0.00012329734,0.00002846916,0.000017580254,0.00020379397,0.000106064224],"category_scores_gemma":[0.0009719384,0.00017535198,0.0001982863,0.00038907572,0.00004249518,0.00020521233,0.000052756215,0.00077468995,0.000019128947],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021801992,0.00022460334,0.028791491,0.000726633,0.00021572672,0.63964194,0.0068668285,0.000016586215,0.0015605445,0.000011293418,0.002891849,0.31883445],"study_design_scores_gemma":[0.0014510402,0.00031630258,0.011464588,0.00045867616,0.00011763989,0.9407727,0.0022799827,0.0002519382,0.023447268,0.00003925015,0.019064482,0.00033613434],"about_ca_topic_score_codex":0.0032808648,"about_ca_topic_score_gemma":0.00049374637,"teacher_disagreement_score":0.31849834,"about_ca_system_score_codex":0.00018614685,"about_ca_system_score_gemma":0.00045276675,"threshold_uncertainty_score":0.71506464},"labels":[],"label_agreement":null},{"id":"W2099697702","doi":"10.1161/circgenetics.114.000663","title":"Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib","year":2015,"lang":"en","type":"article","venue":"Circulation Cardiovascular Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Medicine; Cardiology; Internal medicine; Pharmacology","score_opus":0.02917991054956236,"score_gpt":0.2660842926172692,"score_spread":0.2369043820677068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099697702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89617133,0.09585881,0.0049396176,0.000014873047,0.00084581826,0.00173742,0.000009580433,0.000032780532,0.00038979028],"genre_scores_gemma":[0.9976348,0.0010527258,0.00072026625,0.000052651034,0.00040224136,0.000043236432,0.000008859826,0.00006549682,0.00001969632],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996035,0.00046332972,0.00070831965,0.00045666491,0.0019830957,0.0003536228],"domain_scores_gemma":[0.9961991,0.00003760947,0.00021748472,0.0025959988,0.00067186006,0.00027798192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017837058,0.0002829332,0.0013430974,0.0001522103,0.000075841264,0.000009982096,0.0002844272,0.00020885175,0.000004916969],"category_scores_gemma":[0.00025693353,0.00022461783,0.0045185043,0.00063548586,0.00020143008,0.000055544562,0.0001327775,0.00020773023,0.000008761089],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001967965,0.0005479605,0.37993088,0.00821302,0.035669047,0.0001925712,0.0016589091,0.09325503,0.02710514,0.00009589333,0.00023439365,0.45290035],"study_design_scores_gemma":[0.011176536,0.00026770929,0.6358792,0.00047951104,0.012170068,0.00076863804,0.00015963145,0.0032906397,0.3099714,0.00014765169,0.025112238,0.000576788],"about_ca_topic_score_codex":0.00013066355,"about_ca_topic_score_gemma":0.0000017524198,"teacher_disagreement_score":0.4523236,"about_ca_system_score_codex":0.00015599004,"about_ca_system_score_gemma":0.0005564931,"threshold_uncertainty_score":0.9159649},"labels":[],"label_agreement":null},{"id":"W2099833118","doi":"10.1097/med.0b013e32835ed9cb","title":"Update on the detection and treatment of atherogenic low-density lipoproteins","year":2013,"lang":"en","type":"review","venue":"Current Opinion in Endocrinology Diabetes and Obesity","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Lipoprotein; Medicine; Epidemiology; Internal medicine; Cholesterol; Coronary artery disease; Disease; Risk factor; Apolipoprotein A1; Prospective cohort study; Cardiology; Endocrinology","score_opus":0.05682372322229171,"score_gpt":0.3246804057604331,"score_spread":0.2678566825381414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099833118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17820995,0.8188736,0.000004398805,0.00006364354,0.0006971226,0.002104596,0.000019447469,0.000019677582,0.000007581434],"genre_scores_gemma":[0.012297146,0.9868929,0.000010155672,0.000012531757,0.0002988655,0.00041729322,0.00003884882,0.000023757408,0.000008504716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981174,0.0003367,0.00047570578,0.0004964882,0.00017323531,0.00040051062],"domain_scores_gemma":[0.99891436,0.000108014974,0.00023908574,0.0005760025,0.00004922118,0.00011329274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019548855,0.0003844593,0.0016501285,0.0001816056,0.0001106038,0.000013275455,0.000078232275,0.00020772337,0.00001980685],"category_scores_gemma":[0.000039927967,0.00022420032,0.00041156256,0.00015716418,0.00023365548,0.000030281279,0.00008949339,0.0003861326,0.00001929187],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007765156,0.00028864137,0.0026384725,0.008427646,0.00022465619,0.0000011913149,0.000027729884,4.0600003e-8,0.0000016211919,0.00024430518,0.000011014588,0.98812693],"study_design_scores_gemma":[0.0015883313,0.0013595189,0.019321848,0.010362941,0.00075779855,0.00008281572,0.000026593292,0.00001969747,0.00023802671,0.00017034693,0.9656909,0.00038118294],"about_ca_topic_score_codex":0.0001102306,"about_ca_topic_score_gemma":0.000015226169,"teacher_disagreement_score":0.98774576,"about_ca_system_score_codex":0.000134104,"about_ca_system_score_gemma":0.00008429618,"threshold_uncertainty_score":0.9142624},"labels":[],"label_agreement":null},{"id":"W2099962778","doi":"","title":"Primary prevention of CVD: treating dyslipidaemia.","year":2008,"lang":"en","type":"review","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; University of Ottawa","funders":"","keywords":"Medicine; Ezetimibe; Cochrane Library; Context (archaeology); Observational study; Systematic review; Psychological intervention; MEDLINE; Niacin; Statin; Environmental health; Intensive care medicine; Family medicine; Internal medicine; Randomized controlled trial; Psychiatry","score_opus":0.05436544728935718,"score_gpt":0.29932215905078163,"score_spread":0.24495671176142444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099962778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000056999896,0.9808456,0.000034389857,0.000009844903,0.00017840156,0.004055443,0.000010718699,0.000049070168,0.014759557],"genre_scores_gemma":[0.00002215672,0.9929227,0.00031001298,0.000026323376,0.00092520646,0.003115858,0.00020297134,0.00006097703,0.0024137483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785006,0.00018042042,0.0007600589,0.0003385855,0.0005111398,0.00035973248],"domain_scores_gemma":[0.9985937,0.000046759953,0.00045267638,0.0006644416,0.0000660934,0.00017634181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005739652,0.00027184308,0.002400929,0.00018871401,0.00004574625,0.0000055884025,0.000099492056,0.00030272486,0.000013210267],"category_scores_gemma":[0.00013030067,0.00020428776,0.0015756557,0.0003230289,0.00004032166,0.0000433101,0.000050574363,0.00033588838,0.000011432297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000062558333,0.00006841641,0.0000097542525,0.040443286,0.0004424911,0.000021054104,0.000010075931,5.5624657e-8,3.1967268e-8,0.0000070938177,0.00025246234,0.95873904],"study_design_scores_gemma":[0.0005302076,0.000041090647,0.0019945158,0.006842158,0.0016013875,0.00038892805,0.0000032855326,1.6891006e-7,0.0000025442807,0.000003817195,0.98843,0.00016187268],"about_ca_topic_score_codex":0.000037663438,"about_ca_topic_score_gemma":0.0000012515665,"teacher_disagreement_score":0.98817754,"about_ca_system_score_codex":0.00030761072,"about_ca_system_score_gemma":0.0004823608,"threshold_uncertainty_score":0.83306134},"labels":[],"label_agreement":null},{"id":"W2100115047","doi":"10.1016/j.cjca.2012.05.002","title":"Lifetime Risk Prediction in Cardiovascular Prevention: Wave of the Future?","year":2012,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.012298586052476291,"score_gpt":0.21390931904168925,"score_spread":0.20161073298921295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100115047","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054566894,0.47169355,0.0034858075,0.39889008,0.041850004,0.0054172636,0.0010199595,0.000032919106,0.02304355],"genre_scores_gemma":[0.68338704,0.0063796863,0.00047158977,0.053812053,0.2537596,0.000065599415,0.0001839158,0.00024213022,0.0016984026],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996151,0.0013740781,0.0009562281,0.000241916,0.00067249883,0.0006043367],"domain_scores_gemma":[0.997402,0.000041936102,0.0006266609,0.001102563,0.00042780375,0.00039900126],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027607195,0.00028078942,0.0019577488,0.0005408931,0.00008606251,0.000008833141,0.00027087133,0.0012697482,0.00005905058],"category_scores_gemma":[0.00019487606,0.00019604497,0.0034971465,0.00031397573,0.0002144816,0.00006787541,0.000025272073,0.003362111,0.0000075517946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052452073,0.0000049385126,0.05155778,0.00051168445,0.0077311643,0.0014766213,0.00018775687,0.00057384337,0.0000036408576,0.000011709537,0.90658814,0.03130025],"study_design_scores_gemma":[0.0010842973,0.0001994267,0.120448224,0.00033069146,0.0022910447,0.005372061,0.00004871053,0.0000016314784,0.000011073331,0.00008294596,0.8700091,0.00012079857],"about_ca_topic_score_codex":0.0022071411,"about_ca_topic_score_gemma":0.000580684,"teacher_disagreement_score":0.6288201,"about_ca_system_score_codex":0.0005693243,"about_ca_system_score_gemma":0.0039026244,"threshold_uncertainty_score":0.9989372},"labels":[],"label_agreement":null},{"id":"W2100134754","doi":"10.1258/jrsm.97.10.461","title":"The case for statins: has it really been made?","year":2004,"lang":"en","type":"article","venue":"Journal of the Royal Society of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Athabasca University","funders":"","keywords":"Computer science; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Data science; Information retrieval; Medicine; Statin; Internal medicine","score_opus":0.02723718966258624,"score_gpt":0.2949565682510145,"score_spread":0.26771937858842826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100134754","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22322689,0.013741926,0.0181244,0.7413744,0.001235558,0.0015347896,0.00001950555,0.000015658288,0.0007269082],"genre_scores_gemma":[0.9796585,0.001527783,0.0071990914,0.0065946607,0.0034871912,0.000010561123,0.0000020535774,0.000035927926,0.0014842595],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807435,0.000068797824,0.00070907536,0.0000997829,0.0008010213,0.00024695505],"domain_scores_gemma":[0.9981585,0.00019219484,0.00060313975,0.00037927058,0.0004857289,0.00018115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035521423,0.00012928483,0.0005400593,0.000017524422,0.00037964055,0.000009976031,0.00022968375,0.000093665185,0.000020834304],"category_scores_gemma":[0.0005257645,0.000055124256,0.00095560885,0.0001261867,0.00044750454,0.000030738338,0.000040654366,0.00043757126,6.606952e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001823412,0.0005769442,0.0006050202,0.002258502,0.0057166,0.0006996686,0.01733758,0.0020221274,0.0023454933,0.001662709,0.83018625,0.13476571],"study_design_scores_gemma":[0.07884718,0.013782652,0.019273842,0.0076205162,0.0063595017,0.02623873,0.04875417,0.0020344863,0.004816942,0.01211808,0.7795956,0.00055828586],"about_ca_topic_score_codex":0.0007368148,"about_ca_topic_score_gemma":0.000047673897,"teacher_disagreement_score":0.7564316,"about_ca_system_score_codex":0.00017692124,"about_ca_system_score_gemma":0.00057319424,"threshold_uncertainty_score":0.29199263},"labels":[],"label_agreement":null},{"id":"W2100192039","doi":"10.1002/acr.20662","title":"Rarity of anti–3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase antibodies in statin users, including those with self‐limited musculoskeletal side effects","year":2011,"lang":"en","type":"article","venue":"Arthritis Care & Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Amgen","keywords":"Statin; Medicine; Antibody; Internal medicine; Myopathy; Familial hypercholesterolemia; Immunosuppression; HMG-CoA reductase; Reductase; Cholesterol; Immunology; Enzyme; Biochemistry; Biology","score_opus":0.05163177281449354,"score_gpt":0.3545031532893936,"score_spread":0.30287138047490003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100192039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765124,0.018446898,0.000034631907,0.0001258133,0.00007152262,0.0020322483,0.000042203963,0.0000852606,0.002649049],"genre_scores_gemma":[0.98908293,0.003866581,0.0065776673,0.000047188434,0.00014165704,0.00014137254,0.00006985095,0.00005873118,0.0000140056045],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9950888,0.0009873001,0.0005383436,0.0007067163,0.0016446371,0.0010342082],"domain_scores_gemma":[0.9974791,0.00026488845,0.000099469275,0.0010023011,0.0007673631,0.0003869221],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002567406,0.00030253365,0.00094280957,0.0007759613,0.00024411529,0.000028679584,0.00022822189,0.00019036361,0.000037421105],"category_scores_gemma":[0.0004900536,0.0002583336,0.00026514247,0.0013780475,0.00043611997,0.00026285052,0.00026691172,0.0010672021,0.000016987256],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00270384,0.0026966438,0.33356684,0.013662202,0.0014815185,0.015584693,0.09160216,0.000012633431,0.05919405,0.0015135766,0.0010087143,0.47697312],"study_design_scores_gemma":[0.026546862,0.010394679,0.653029,0.0102263605,0.0002948058,0.0007688133,0.026272919,0.00014558226,0.26793,0.0006230445,0.0024838562,0.0012840398],"about_ca_topic_score_codex":0.011104568,"about_ca_topic_score_gemma":0.00233683,"teacher_disagreement_score":0.47568905,"about_ca_system_score_codex":0.00021846221,"about_ca_system_score_gemma":0.00069610914,"threshold_uncertainty_score":0.9999869},"labels":[],"label_agreement":null},{"id":"W2100194310","doi":"10.1136/jmg.2008.059980","title":"A <i>PCSK9</i> variant and familial combined hyperlipidaemia","year":2008,"lang":"en","type":"article","venue":"Journal of Medical Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; LDL receptor; Internal medicine; Endocrinology; Genetics; Cholesterol; Biology; Mutation; Phenotype; Loss function; Lipoprotein; Gene; Medicine","score_opus":0.018925228899417817,"score_gpt":0.2637908628099249,"score_spread":0.2448656339105071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100194310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98556596,0.007015824,0.0020415578,0.004237561,0.0005140562,0.00013426956,0.0000010775298,0.000008361679,0.00048130978],"genre_scores_gemma":[0.97674704,0.014658885,0.0038395687,0.0024612981,0.0021728424,0.0000012804477,0.0000010545747,0.000018276902,0.00009975053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735177,0.00007542272,0.00050217344,0.00010710667,0.0017623955,0.00020111981],"domain_scores_gemma":[0.9987184,0.00004754211,0.00013284237,0.0001955185,0.00017079485,0.0007349224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011240252,0.0001041566,0.0004763651,0.00006889008,0.00006806778,0.000006941545,0.000117132564,0.00019026283,0.00008081173],"category_scores_gemma":[0.0003591145,0.00007255496,0.00018931954,0.00010748897,0.00014746691,0.000022724693,0.00005101264,0.0005172508,0.0000047076014],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022797538,0.001977256,0.06530187,0.0010681204,0.0021557221,0.040089976,0.002728193,0.000031523807,0.0073918523,0.0007187878,0.04082673,0.8354302],"study_design_scores_gemma":[0.0383494,0.0087365955,0.30045515,0.0012498398,0.0012391068,0.21031933,0.0005471054,0.0030954203,0.0036134657,0.00043005068,0.4313526,0.00061194215],"about_ca_topic_score_codex":0.000017047367,"about_ca_topic_score_gemma":0.0000017623547,"teacher_disagreement_score":0.83481824,"about_ca_system_score_codex":0.000033034947,"about_ca_system_score_gemma":0.0007565368,"threshold_uncertainty_score":0.29587057},"labels":[],"label_agreement":null},{"id":"W2100696393","doi":"","title":"Abaissement intensif du cholestérol LDL par l'atorvastatine chez des patients atteints de maladie coronarienne stable : commentaires relatifs à l'étude TNT","year":2005,"lang":"fr","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Gynecology; Medicine; Coronary heart disease; Internal medicine","score_opus":0.01171837363706156,"score_gpt":0.24469754909308444,"score_spread":0.23297917545602287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100696393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588541,0.014932884,0.0039221905,0.015526477,0.0010285871,0.0020849751,0.00009437001,0.00017504558,0.003381369],"genre_scores_gemma":[0.9695079,0.0035665906,0.008589393,0.008323335,0.001831694,0.00018049747,0.0002268984,0.00015028186,0.0076234234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942765,0.00044700038,0.0012418292,0.00084968016,0.0011264614,0.0020585053],"domain_scores_gemma":[0.9965092,0.00012854768,0.00030579887,0.001121497,0.0006105925,0.0013243911],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002220387,0.0007168244,0.0010991992,0.00015880707,0.00053396414,0.00009900641,0.00031388729,0.0003295832,0.004911689],"category_scores_gemma":[0.0003671577,0.0006549307,0.00049701723,0.00036141506,0.000507954,0.00049446075,0.00032351696,0.00074354897,0.00094599894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003570795,0.0028647857,0.5425364,0.00088196015,0.0012518655,0.00015887644,0.0069067464,0.00024764767,0.00030875625,0.0011269698,0.03029279,0.41306612],"study_design_scores_gemma":[0.008383045,0.0012413957,0.7075078,0.0014598197,0.00071395736,0.00013569916,0.0021272998,0.001992026,0.0053023836,0.000095923024,0.27036643,0.00067423965],"about_ca_topic_score_codex":0.0077195866,"about_ca_topic_score_gemma":0.0030353758,"teacher_disagreement_score":0.4123919,"about_ca_system_score_codex":0.003047759,"about_ca_system_score_gemma":0.0004720571,"threshold_uncertainty_score":0.99983186},"labels":[],"label_agreement":null},{"id":"W2100730128","doi":"10.1186/cc10063","title":"Statins do not prevent acute organ failure in ventilated ICU patients: single-centre retrospective cohort study","year":2011,"lang":"en","type":"article","venue":"Critical Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institute for Health and Care Research","keywords":"Medicine; Retrospective cohort study; Emergency medicine; Intensive care medicine; Cohort study; Cohort; Internal medicine","score_opus":0.017705176289017542,"score_gpt":0.2744915317643848,"score_spread":0.25678635547536727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100730128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953815,0.000114878356,0.000020331894,0.00018183357,0.00020887986,0.0023758502,0.00008945379,0.00007258493,0.0015546981],"genre_scores_gemma":[0.99913883,0.0000046204514,0.0002994881,0.00019680765,0.00010033044,0.0000787477,0.00008887029,0.00004339287,0.000048903268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977084,0.00016955196,0.00038323255,0.00053702015,0.00074811745,0.00045367135],"domain_scores_gemma":[0.9983417,0.000019561097,0.00003713332,0.00056867435,0.0007422124,0.0002907628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024664454,0.000214537,0.0005604007,0.00009028634,0.000084568404,0.00002611719,0.00010068816,0.00013743741,0.00044446994],"category_scores_gemma":[0.00041115002,0.00018601598,0.00017723469,0.00030943882,0.00008105615,0.00009442515,0.00008456186,0.00040630126,0.000040405524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000196484,0.0026157238,0.98557115,0.00022474055,0.00023672551,0.00049149856,0.008463889,7.963684e-8,0.000089195804,0.00020446068,0.00014517551,0.0017608554],"study_design_scores_gemma":[0.0020961496,0.0019186777,0.983391,0.00018663851,0.0006142829,0.000009098776,0.009379077,0.0000020648204,0.0019462936,0.000055635246,0.00018619481,0.00021492674],"about_ca_topic_score_codex":0.00021120078,"about_ca_topic_score_gemma":0.0002996562,"teacher_disagreement_score":0.00375735,"about_ca_system_score_codex":0.0005875698,"about_ca_system_score_gemma":0.00011387346,"threshold_uncertainty_score":0.7585511},"labels":[],"label_agreement":null},{"id":"W2101005910","doi":"10.1161/circoutcomes.111.000015","title":"Diabetes Mellitus and Cardiovascular Events in Older Patients With Myocardial Infarction Prescribed Intensive-Dose and Moderate-Dose Statins","year":2013,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Myocardial infarction; Acute coronary syndrome; Internal medicine; Diabetes mellitus; Statin; Intensive care; Propensity score matching; Mortality rate; Cardiology; Intensive care medicine","score_opus":0.021560007775829757,"score_gpt":0.2594259311827571,"score_spread":0.23786592340692733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101005910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98200655,0.013008615,0.0012994627,0.00035316986,0.00014496641,0.0030355128,0.000019859122,0.00007564954,0.000056223376],"genre_scores_gemma":[0.99734396,0.0011007213,0.0003308459,0.000678109,0.00010120895,0.00025003182,0.00012567575,0.00005855064,0.000010928363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99575496,0.0008085309,0.000709026,0.00093864766,0.0012497175,0.0005391354],"domain_scores_gemma":[0.99769866,0.0001149777,0.00012287522,0.0010048514,0.0006762978,0.0003823192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019082635,0.0004660504,0.0017842122,0.00026946308,0.00023156052,0.0000953611,0.00006203523,0.00025783773,0.000012878092],"category_scores_gemma":[0.00036448316,0.00037853426,0.00086878863,0.0002990977,0.00018851216,0.00060362084,0.000107251784,0.00035955774,0.0000055799155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009309851,0.00009402558,0.93344086,0.00053707464,0.0052665733,0.000006313638,0.00076023734,0.0005950835,0.0000178221,0.000073195464,0.000007597026,0.05910814],"study_design_scores_gemma":[0.010360114,0.00009957063,0.9860197,0.00014799238,0.0010776984,0.000022257018,0.00050608953,0.0006664995,0.000018415887,0.0003328943,0.00029266975,0.00045614428],"about_ca_topic_score_codex":0.0020527327,"about_ca_topic_score_gemma":0.000026494718,"teacher_disagreement_score":0.058652,"about_ca_system_score_codex":0.00011306797,"about_ca_system_score_gemma":0.00008753777,"threshold_uncertainty_score":0.99986666},"labels":[],"label_agreement":null},{"id":"W2101094196","doi":"10.1503/cmaj.101280","title":"Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis","year":2011,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Merck Canada; Pfizer; Amgen","keywords":"Medicine; Statin; Meta-analysis; Relative risk; Internal medicine; Myocardial infarction; Randomized controlled trial; Confidence interval; Stroke (engine); Placebo; Coronary artery disease; Clinical trial; Physical therapy; Alternative medicine; Pathology","score_opus":0.04163824445622174,"score_gpt":0.30817985294966815,"score_spread":0.26654160849344644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101094196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003522959,0.9960235,0.000764964,0.00015826376,0.00020423923,0.0018957402,0.00035023323,0.000008664957,0.00024213259],"genre_scores_gemma":[0.00011128124,0.99722373,0.00047147134,0.00023064781,0.0007370508,0.00021801615,0.00040832194,0.000057238693,0.00054220995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99335706,0.0014613796,0.0018163758,0.000433354,0.0022835173,0.0006483066],"domain_scores_gemma":[0.99545,0.0003912956,0.0014457966,0.0005977708,0.0005728996,0.0015421966],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.011360478,0.0003632633,0.0067793233,0.0010977545,0.0001662899,0.000024195248,0.00026008594,0.0010229782,0.0018022035],"category_scores_gemma":[0.0028066293,0.00027740686,0.016778935,0.0012453572,0.000029745575,0.00006298199,0.000031972904,0.0013954398,0.00002438124],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000015932434,0.000098715944,0.00054272293,0.0042026695,0.33430007,0.000087102315,0.00016437843,0.0000067692354,4.494261e-9,0.000009078214,0.0010096296,0.65956295],"study_design_scores_gemma":[0.0012498436,0.00007701707,0.0029268377,0.00059136003,0.339717,0.000129653,0.000016884314,0.000004625662,7.231676e-8,0.000008395146,0.6551145,0.00016386631],"about_ca_topic_score_codex":0.012384024,"about_ca_topic_score_gemma":0.069359876,"teacher_disagreement_score":0.65939903,"about_ca_system_score_codex":0.004525808,"about_ca_system_score_gemma":0.011671181,"threshold_uncertainty_score":0.9999678},"labels":[],"label_agreement":null},{"id":"W2101269662","doi":"10.25011/cim.v34i1.14908","title":"The relationship between lipoprotein(a) and coronary artery disease, as well as its variable nature following myocardial infarction","year":2011,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Myocardial infarction; Coronary artery disease; Cardiology; Lipoprotein(a); Unstable angina; Body mass index; Diabetes mellitus; Angina; Lipoprotein; Stable angina; Cholesterol; Endocrinology","score_opus":0.12555068088853613,"score_gpt":0.33745966113848674,"score_spread":0.2119089802499506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101269662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632783,0.009156884,0.000055293567,0.016709851,0.0007836843,0.0011085417,0.0000052893447,0.00006341821,0.008838738],"genre_scores_gemma":[0.99063915,0.00074159197,0.00027643426,0.0045825066,0.0021245168,0.00006168429,0.00004821147,0.000026013946,0.001499919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976167,0.00043363206,0.0006471605,0.0004922267,0.00051390793,0.00029634676],"domain_scores_gemma":[0.9975605,0.0007543062,0.00015301413,0.00042887,0.00013218784,0.0009711301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024205518,0.00023479387,0.0006249632,0.000060126666,0.00048191572,0.000017065886,0.000090685506,0.00031862373,0.00007028692],"category_scores_gemma":[0.007662348,0.00013968829,0.00018311512,0.00025041876,0.0026747654,0.00019372746,0.000094426185,0.0012085125,0.000060396356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002807641,0.000041193558,0.9691191,0.00011411293,0.00047054995,0.00007593792,0.00027796178,5.6632746e-8,0.000027169346,0.020620646,0.0013075975,0.0076649273],"study_design_scores_gemma":[0.0021480562,0.0011507414,0.8732859,0.0005086825,0.00065131846,0.00005564667,0.00020826602,0.000011104047,0.000025558826,0.100717165,0.021098716,0.0001388453],"about_ca_topic_score_codex":0.0001826809,"about_ca_topic_score_gemma":0.000005264033,"teacher_disagreement_score":0.09583318,"about_ca_system_score_codex":0.00002337354,"about_ca_system_score_gemma":0.00028003557,"threshold_uncertainty_score":0.98552847},"labels":[],"label_agreement":null},{"id":"W2101333957","doi":"10.1161/01.atv.0000154144.73236.f4","title":"Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men","year":2004,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":426,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Medicine; Internal medicine; Myocardial infarction; Angina; Cardiology; Unstable angina; Lipoprotein; Cohort; Disease; Cholesterol; Population; Low-density lipoprotein","score_opus":0.01584256978895911,"score_gpt":0.2666882123977634,"score_spread":0.2508456426088043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101333957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557036,0.0009067753,0.00032688992,0.0021591124,0.000048190625,0.0009113946,0.000015355821,0.000021521051,0.00004041721],"genre_scores_gemma":[0.9874606,0.0117427055,0.00017300528,0.00040444612,0.00008448848,0.00009636623,0.000018573535,0.000018169107,0.0000016313252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985324,0.00026203875,0.00035619645,0.0004062437,0.00015876858,0.00028436587],"domain_scores_gemma":[0.9989895,0.000050497438,0.000110667956,0.00060450775,0.000058439917,0.00018637933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008628607,0.0001955093,0.00070299685,0.00008465808,0.00016654335,0.000017840961,0.000068979076,0.00013498896,0.000016337013],"category_scores_gemma":[0.000091210844,0.00012977404,0.00029927935,0.00016481089,0.0005298917,0.00006960682,0.000098348406,0.00024843204,0.000004497011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008942516,0.0003369332,0.9582385,0.00023652062,0.00050958054,4.7042252e-7,0.0004702405,0.000004594887,0.03818158,0.00039327706,0.00002032263,0.001518599],"study_design_scores_gemma":[0.0056901006,0.00017484066,0.99184144,0.00022229129,0.00038721587,0.0000030983185,0.00006883143,0.000018069895,0.0011878392,0.00019583202,0.00007797667,0.0001324708],"about_ca_topic_score_codex":0.003864192,"about_ca_topic_score_gemma":0.00034428973,"teacher_disagreement_score":0.03699374,"about_ca_system_score_codex":0.00004168163,"about_ca_system_score_gemma":0.00007458096,"threshold_uncertainty_score":0.5841528},"labels":[],"label_agreement":null},{"id":"W2101809660","doi":"10.1016/s0002-9149(02)03290-3","title":"Optimizing lipid management in patients with acute coronary syndromes","year":2003,"lang":"en","type":"review","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acute coronary syndrome; Statin; Guideline; Myocardial infarction; Cholesterol; Internal medicine; Unstable angina; Cardiology; National Cholesterol Education Program; Canadian Cardiovascular Society; Angina; Regimen; Intensive care medicine; Metabolic syndrome; Pathology","score_opus":0.020223669540691384,"score_gpt":0.29425524547108955,"score_spread":0.2740315759303982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101809660","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049616913,0.99231917,0.00033114033,0.000059908074,0.00028910371,0.0010134917,0.000006888678,0.000006926306,0.0010117088],"genre_scores_gemma":[0.0014181379,0.99619555,0.0017297528,0.00021497019,0.00029700383,0.00002890365,0.000011183808,0.00005604305,0.000048438425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714696,0.0009764604,0.0007772585,0.00023122565,0.0004857844,0.00038229214],"domain_scores_gemma":[0.9979553,0.000073317955,0.0010511489,0.0006543394,0.00012519858,0.00014066986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011115947,0.0003347996,0.0043705925,0.0003324027,0.00004493869,0.000008147715,0.00029609373,0.00008047642,0.00000610686],"category_scores_gemma":[0.000011605039,0.00016682278,0.0010845922,0.00047013361,0.0002885344,0.000035446225,0.0000675924,0.00082135404,0.0000076226975],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003089659,0.00002779306,0.0005007804,0.0009093226,0.008657056,0.0017822362,0.000021546619,0.000034996363,6.2414838e-9,0.000011498276,0.00015195522,0.9875938],"study_design_scores_gemma":[0.0020263158,0.003845969,0.008718758,0.0049704346,0.010117326,0.021188622,0.00012604137,1.834058e-7,2.4398451e-8,0.0000064165924,0.9487375,0.00026238672],"about_ca_topic_score_codex":0.0000050314325,"about_ca_topic_score_gemma":1.6589642e-7,"teacher_disagreement_score":0.98733145,"about_ca_system_score_codex":0.00026762547,"about_ca_system_score_gemma":0.00034746213,"threshold_uncertainty_score":0.68028355},"labels":[],"label_agreement":null},{"id":"W2101843081","doi":"10.1186/1472-6963-9-198","title":"The impact of statins on health services utilization and mortality in older adults discharged from hospital with ischemic heart disease: a cohort study","year":2009,"lang":"en","type":"article","venue":"BMC Health Services Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Capital District Health Authority; Nova Scotia Health Authority; Dalhousie University","funders":"College of Pharmacy, Dalhousie University; Dalhousie University; Nova Scotia Health Research Foundation","keywords":"Medicine; Hazard ratio; Emergency medicine; Confidence interval; Proportional hazards model; Statin; Population; Cohort study; Relative risk; Internal medicine; Intensive care medicine; Environmental health","score_opus":0.026028824063753727,"score_gpt":0.4077111685811848,"score_spread":0.38168234451743105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101843081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98443687,0.006326937,0.000009061485,0.0012315976,0.000023922259,0.0077793533,0.0001274948,0.000033449145,0.00003133975],"genre_scores_gemma":[0.99690425,0.0018523433,0.00006952032,0.000565521,0.00011420533,0.00020804178,0.00024499273,0.000030866708,0.000010270552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945741,0.0011799487,0.0007085953,0.0007229629,0.0019204713,0.00089386356],"domain_scores_gemma":[0.99725837,0.00018760096,0.0002257379,0.0011106532,0.0003809056,0.00083676557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041131475,0.0002574546,0.00077733473,0.0001934762,0.0004343973,0.000066685134,0.00021420271,0.00006767746,0.000014312313],"category_scores_gemma":[0.000024099381,0.00015349308,0.00009650084,0.0008981142,0.0000801969,0.00016253712,0.00007065382,0.00054956076,0.0000038820363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020545395,0.0016330599,0.98081255,0.0024236096,0.000091606096,0.000007811448,0.0072476696,0.000013631776,0.000004549929,0.000007162428,0.000026691656,0.005677111],"study_design_scores_gemma":[0.003788433,0.005034527,0.9767371,0.0021885831,0.000016935302,0.0000017985083,0.010679331,0.0013584311,0.000011146775,0.00002837575,0.00003925156,0.00011609175],"about_ca_topic_score_codex":0.08799407,"about_ca_topic_score_gemma":0.013742533,"teacher_disagreement_score":0.07425154,"about_ca_system_score_codex":0.0003792148,"about_ca_system_score_gemma":0.002083421,"threshold_uncertainty_score":0.9180791},"labels":[],"label_agreement":null},{"id":"W2101979622","doi":"10.1373/clinchem.2011.165191","title":"Novel Loss-of-Function PCSK9 Variant Is Associated with Low Plasma LDL Cholesterol in a French-Canadian Family and with Impaired Processing and Secretion in Cell Culture","year":2011,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; Montreal Clinical Research Institute; University of Ottawa","funders":"Canadian Institutes of Health Research; Fondation Jean-Louis Lévesque; AstraZeneca; Pfizer","keywords":"PCSK9; Secretion; Internal medicine; Cholesterol; Function (biology); Endocrinology; Ldl cholesterol; Kexin; LDL receptor; Medicine; Biology; Genetics; Lipoprotein","score_opus":0.025825351815409757,"score_gpt":0.25412422119525796,"score_spread":0.2282988693798482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101979622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981952,0.00025990963,0.00009855767,0.00006392054,0.000013672213,0.00027793372,0.000012782168,0.000012408884,0.0010656513],"genre_scores_gemma":[0.99906963,0.000055336706,0.00034784965,0.00031347817,0.000057163732,0.000016759259,0.000033065655,0.000016496238,0.0000902123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988557,0.000026311896,0.00036701083,0.00034816875,0.0001836946,0.00021912636],"domain_scores_gemma":[0.9992846,0.000019857856,0.00014376247,0.00018982748,0.00009303303,0.0002688822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051483,0.00014544526,0.0004168511,0.000034870565,0.000030782194,0.0000124284725,0.000038989187,0.00033438305,0.000008027678],"category_scores_gemma":[0.000079525205,0.0001064041,0.000044293873,0.00019666438,0.00014005187,0.00006760032,0.000014409566,0.00043624797,3.5251674e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091769086,0.0007961896,0.9787781,0.0016558493,0.0001504789,0.00024107455,0.0016023011,0.000002193462,0.004828216,9.271106e-7,0.000040472907,0.010986469],"study_design_scores_gemma":[0.008993083,0.0006101133,0.9845609,0.0016304251,0.0001452496,0.000114063216,0.00038180556,0.00069950626,0.0025733889,0.0000134404,0.00008661014,0.00019141851],"about_ca_topic_score_codex":0.0043437895,"about_ca_topic_score_gemma":0.0033275243,"teacher_disagreement_score":0.01079505,"about_ca_system_score_codex":0.00007516814,"about_ca_system_score_gemma":0.00041823072,"threshold_uncertainty_score":0.65665394},"labels":[],"label_agreement":null},{"id":"W2102238081","doi":"10.1016/s0140-6736(12)61731-0","title":"Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study","year":2012,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":740,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi; Western University","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources","keywords":"Microsomal triglyceride transfer protein; Triglyceride; Medicine; Internal medicine; Endocrinology; Chemistry; Pharmacology; Cholesterol; Lipoprotein; Very low-density lipoprotein","score_opus":0.0370874989909164,"score_gpt":0.2948776957138069,"score_spread":0.2577901967228905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102238081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993272,0.00033117086,0.00002376496,0.00023008433,0.000049550414,0.0059223524,0.000040848317,0.00001971013,0.00011052348],"genre_scores_gemma":[0.9989341,0.000012823089,0.000218633,0.00021348022,0.00040805276,0.00014748517,0.00001392083,0.000029818802,0.000021670532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842125,0.00022329683,0.00035067098,0.00023550149,0.0003641371,0.00040511278],"domain_scores_gemma":[0.9991295,0.000027256034,0.000050306953,0.0006028398,0.00005906337,0.0001310785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085829856,0.00018367424,0.00081978645,0.000051334664,0.00007492386,0.00002654367,0.00018592532,0.000069445414,0.000007007239],"category_scores_gemma":[0.000033300923,0.00010731056,0.000034412344,0.00020858459,0.00010335644,0.0001541397,0.00007961185,0.00032076452,0.0000019816189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27311343,0.10158762,0.32805994,0.0011282751,0.00125499,0.00013556135,0.027448025,0.0000030283097,0.057416596,0.000053705393,0.00015245292,0.20964636],"study_design_scores_gemma":[0.37809893,0.01808113,0.5951643,0.00062662753,0.0003571324,0.00006401479,0.0005646205,0.000003618971,0.0049167704,0.0000039131896,0.0018115976,0.0003073327],"about_ca_topic_score_codex":0.00037070015,"about_ca_topic_score_gemma":0.00006384392,"teacher_disagreement_score":0.26710436,"about_ca_system_score_codex":0.00006357854,"about_ca_system_score_gemma":0.00008122339,"threshold_uncertainty_score":0.43759975},"labels":[],"label_agreement":null},{"id":"W2102602093","doi":"10.1067/mhj.2001.115588","title":"Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women’s Atorvastatin Trial on Cholesterol (WATCH)","year":2001,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; University of Ottawa","funders":"","keywords":"Atorvastatin; Medicine; Dyslipidemia; National Cholesterol Education Program; Internal medicine; Cholesterol; Risk factor; Disease; Population; Endocrinology; Lipoprotein; Obesity; Metabolic syndrome; Environmental health","score_opus":0.01723296695595285,"score_gpt":0.28944942277345614,"score_spread":0.2722164558175033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102602093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910749,0.0013421243,0.00039206186,0.00064752775,0.00014758387,0.006304637,0.000049699604,0.000035921996,0.0000055325218],"genre_scores_gemma":[0.9951604,0.00056598056,0.0008541576,0.0004276162,0.0007944355,0.002072511,0.000020640953,0.00008365308,0.000020633264],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99453175,0.001158755,0.0008875839,0.000726756,0.001834598,0.00086053053],"domain_scores_gemma":[0.99708635,0.0003362493,0.0003937124,0.00088212255,0.0003269608,0.00097460835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004417487,0.00045878583,0.0014773977,0.00030678333,0.000298456,0.000099378965,0.00018556892,0.00008035801,0.000017241427],"category_scores_gemma":[0.0013778119,0.00029955318,0.00088429754,0.0007299732,0.00030453995,0.00028179694,0.000055435925,0.000879797,0.0000016525559],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.101444624,0.0026951723,0.20762038,0.000641157,0.0043504676,0.00011472524,0.004508385,0.008513341,0.000019327486,0.0000065772497,0.000109618755,0.66997623],"study_design_scores_gemma":[0.032056313,0.002906303,0.9521008,0.000697763,0.00053316884,0.00017497732,0.003213639,0.00018004651,0.000016206768,0.00004593531,0.0076683364,0.00040649838],"about_ca_topic_score_codex":0.0017845022,"about_ca_topic_score_gemma":0.00008180072,"teacher_disagreement_score":0.74448043,"about_ca_system_score_codex":0.0009656171,"about_ca_system_score_gemma":0.001880869,"threshold_uncertainty_score":0.99994564},"labels":[],"label_agreement":null},{"id":"W2103298184","doi":"10.1136/ebn.11.2.52","title":"Primary prevention with pravastatin for 5 years continued to prevent coronary events in the next 10 yearsCommentary","year":2008,"lang":"en","type":"letter","venue":"Evidence-Based Nursing","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Pravastatin; Medicine; Myocardial infarction; Blinding; Placebo; Coronary heart disease; Internal medicine; Randomized controlled trial; Physical therapy; Cholesterol; Alternative medicine","score_opus":0.05977019848349098,"score_gpt":0.31993012848854746,"score_spread":0.2601599300050565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103298184","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19602758,0.006903145,0.004592685,0.7749591,0.0006116408,0.016569648,0.000058356964,0.00009573027,0.0001821251],"genre_scores_gemma":[0.044124592,0.00045818958,0.017606884,0.9230109,0.0058903834,0.0027931775,0.0022862942,0.00031324453,0.003516333],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99610263,0.0007900479,0.0005434226,0.0006610618,0.0012854178,0.0006174207],"domain_scores_gemma":[0.9982129,0.000394953,0.00025996807,0.00089823897,0.00012145309,0.00011253752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015393952,0.0003801117,0.00075070595,0.00027274174,0.00012489327,0.000033828517,0.00029969757,0.00032239011,0.000058286932],"category_scores_gemma":[0.00011637632,0.00029101825,0.00042241797,0.00035516117,0.00008766083,0.00020908925,0.000022034406,0.0010326725,0.000023920444],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016760589,0.0006101635,0.0007698565,0.0014350937,0.00021285073,0.0008657148,0.0010627183,0.000058522637,0.00007632404,7.5126576e-7,0.8580706,0.13516134],"study_design_scores_gemma":[0.009050554,0.009474284,0.156527,0.08618485,0.0016771583,0.00085470197,0.0005891241,0.000079647805,0.0003489751,0.00011778846,0.7338151,0.0012808673],"about_ca_topic_score_codex":0.00016122007,"about_ca_topic_score_gemma":0.00001714752,"teacher_disagreement_score":0.15575714,"about_ca_system_score_codex":0.0008815167,"about_ca_system_score_gemma":0.0011143755,"threshold_uncertainty_score":0.9999542},"labels":[],"label_agreement":null},{"id":"W2103403372","doi":"","title":"Prevalence of dyslipidaemia in patients treated with lipid-modifying drugs in the Netherlands. Part of the dyslipidaemia international survey.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lipid profile; Cohort; Internal medicine; Statin; Residual risk; Population; Cholesterol; Cohort study; Environmental health","score_opus":0.013719692988753734,"score_gpt":0.22872954174263485,"score_spread":0.21500984875388113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103403372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99669915,0.000061265746,0.0000023470957,0.00020764675,0.00027852863,0.0014707694,0.00002294541,0.0000072520074,0.0012500851],"genre_scores_gemma":[0.9991761,0.00003296385,0.000019239667,0.00009180027,0.0001687211,0.00038664008,0.000015597801,0.000014515131,0.00009443237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814075,0.0002866329,0.0004073261,0.00021381491,0.0006805152,0.00027094694],"domain_scores_gemma":[0.99889445,0.0001220319,0.00019733414,0.0005847806,0.00014718565,0.000054211327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024922881,0.00012414069,0.0002959061,0.00009831661,0.000026579177,0.000008910675,0.0003221554,0.00009213391,0.000016356658],"category_scores_gemma":[0.00036855732,0.00006438907,0.00009701023,0.0004225627,0.00010427914,0.0000699281,0.000050898037,0.00041155683,5.072848e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024750418,0.00017102507,0.96743315,0.00015131343,0.00004548988,8.2272754e-7,0.00044971178,0.00001132857,0.000023760724,0.000012466306,0.00005500712,0.031398397],"study_design_scores_gemma":[0.0025870244,0.00004316163,0.9960187,0.00012330168,0.000035956327,0.0000027959843,0.00005806631,0.000036579833,0.00071997225,0.0000035276832,0.00030418328,0.00006674302],"about_ca_topic_score_codex":0.0013871219,"about_ca_topic_score_gemma":0.00092557387,"teacher_disagreement_score":0.03133165,"about_ca_system_score_codex":0.00006478969,"about_ca_system_score_gemma":0.00007995914,"threshold_uncertainty_score":0.26257098},"labels":[],"label_agreement":null},{"id":"W2103565597","doi":"10.3174/ajnr.a4257","title":"Statin Therapy Does Not Affect the Radiographic and Clinical Profile of Patients with TIA and Minor Stroke","year":2015,"lang":"en","type":"article","venue":"American Journal of Neuroradiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Genome Canada; Heart and Stroke Foundation of Canada; National Institutes of Health; Pfizer; National Institute of Neurological Disorders and Stroke; American Heart Association","keywords":"Medicine; Interquartile range; Stroke (engine); Statin; Internal medicine; Aspirin; Cardiology","score_opus":0.019756536456952942,"score_gpt":0.2932444269308604,"score_spread":0.2734878904739074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103565597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978749,0.00067148206,0.000058100242,0.0009323,0.00011106829,0.00031655264,0.000016749773,0.0000035376968,0.000015289559],"genre_scores_gemma":[0.9971544,0.0012090626,0.0007589765,0.00069622,0.00015496026,0.0000028863742,0.0000017266841,0.000013644562,0.000008131628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984291,0.0006383154,0.0003841907,0.00014325645,0.000251499,0.00015363246],"domain_scores_gemma":[0.9986309,0.0002467642,0.00049060356,0.00021082688,0.00020547623,0.00021542788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090037397,0.00010845801,0.00068574556,0.00009585777,0.000027764529,0.0000054656894,0.000074513475,0.000031704723,0.0000031941],"category_scores_gemma":[0.0001393758,0.000046964687,0.00012669565,0.00013116351,0.0008893414,0.000037579794,0.000016757227,0.00029505463,1.9771338e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023448325,0.000108339766,0.8905977,0.000013807918,0.00038915552,0.000032908458,0.00021157713,7.2923956e-7,0.00014137145,0.000005492262,0.00010674889,0.10604734],"study_design_scores_gemma":[0.004092582,0.020955155,0.9728558,0.000018797491,0.0001479798,0.00047822445,0.00028728836,0.000007776524,0.0000825564,0.000009467214,0.0010092694,0.000055091634],"about_ca_topic_score_codex":0.00007155653,"about_ca_topic_score_gemma":0.000005096158,"teacher_disagreement_score":0.10599225,"about_ca_system_score_codex":0.0000073393157,"about_ca_system_score_gemma":0.00013890649,"threshold_uncertainty_score":0.32768154},"labels":[],"label_agreement":null},{"id":"W2104298482","doi":"10.1161/circgenetics.112.963264","title":"Exome Sequencing Identifies 2 Rare Variants for Low High-Density Lipoprotein Cholesterol in an Extended Family","year":2012,"lang":"en","type":"article","venue":"Circulation Cardiovascular Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Victoria Hospital","funders":"National Human Genome Research Institute; National Heart, Lung, and Blood Institute; McGill University Health Centre; Canadian Institutes of Health Research; National Institutes of Health; American Heart Association","keywords":"Exome sequencing; Nonsynonymous substitution; Exome; Genetics; Biology; Gene; Mutation; Genome","score_opus":0.036949176856538764,"score_gpt":0.27329484407692306,"score_spread":0.2363456672203843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104298482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90705717,0.009792762,0.07937154,0.00003467535,0.0007286669,0.0028154454,0.000022540667,0.00011459313,0.00006260571],"genre_scores_gemma":[0.9930827,0.00026573602,0.0040323185,0.0002512183,0.0017073165,0.00029559492,0.00022991573,0.00010936069,0.00002582027],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99627215,0.00037683858,0.000683236,0.00071039645,0.0011465626,0.0008108422],"domain_scores_gemma":[0.99708253,0.000028157538,0.00013540832,0.0018673362,0.00044337797,0.00044321563],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026435144,0.00037613756,0.0010251497,0.00030066163,0.00020702321,0.00009156718,0.00017128217,0.0003701621,0.000013033638],"category_scores_gemma":[0.00014513389,0.00039576623,0.0011518685,0.00044184653,0.0000700122,0.00042732313,0.000069581176,0.00029600455,0.000026316038],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042804828,0.0010364613,0.07015383,0.004091509,0.0060821767,0.0002490867,0.0043140445,0.0371203,0.13542,0.00044425743,0.00008438637,0.7405759],"study_design_scores_gemma":[0.003804527,0.00010489799,0.98148495,0.00018386733,0.00074846693,0.0002214864,0.00040455628,0.0022622624,0.009448011,0.00026883918,0.00060339586,0.0004647284],"about_ca_topic_score_codex":0.00073637225,"about_ca_topic_score_gemma":0.000073175695,"teacher_disagreement_score":0.9113311,"about_ca_system_score_codex":0.00050350034,"about_ca_system_score_gemma":0.00026236195,"threshold_uncertainty_score":0.99984944},"labels":[],"label_agreement":null},{"id":"W2104299102","doi":"10.1093/eurheartj/ehv157","title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","year":2015,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":870,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Novo Nordisk Fonden; British Heart Foundation; Regeneron Pharmaceuticals; Sanofi; Kowa Company; Danone; F. Hoffmann-La Roche; Valeant Pharmaceuticals International; Amgen; National Heart, Lung, and Blood Institute; Pfizer; European Atherosclerosis Society; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Familial hypercholesterolemia; Family history; Life expectancy; Pediatrics; Genetic testing; Internal medicine; Newborn screening; Cholesterol; Statin; Population","score_opus":0.05696708090533539,"score_gpt":0.3242105512169354,"score_spread":0.2672434703116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104299102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07348145,0.9257378,0.0000330844,0.000013954816,0.000073182826,0.0005668836,0.000010200255,0.000011152047,0.000072319155],"genre_scores_gemma":[0.015744206,0.9830442,0.00034056196,0.00006157992,0.00071453856,0.0000036858319,0.000010647743,0.00006582688,0.00001476123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977541,0.0008259092,0.0006005632,0.000277981,0.00029618907,0.00024526755],"domain_scores_gemma":[0.99906576,0.0000152835,0.00022289055,0.0002045259,0.000049073595,0.00044245197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016123973,0.00027822074,0.0013945282,0.00023104477,0.0000781522,0.000049411236,0.00005180678,0.00010772441,0.0000018092745],"category_scores_gemma":[0.00007589354,0.00020156437,0.00026301912,0.0001160384,0.000050107774,0.00007807392,0.000052665502,0.0006689198,0.000003329133],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038052065,0.000050551105,0.006667889,0.0010553327,0.0001877174,0.00003080318,0.00010342355,7.4635193e-7,0.000007673747,6.135206e-8,0.00006987384,0.99178785],"study_design_scores_gemma":[0.008928629,0.0021595096,0.09563236,0.048294026,0.0019267426,0.02264278,0.00016156676,0.000013545402,0.000007522611,8.5379696e-7,0.8196495,0.0005829151],"about_ca_topic_score_codex":0.00004694599,"about_ca_topic_score_gemma":0.0000023497862,"teacher_disagreement_score":0.991205,"about_ca_system_score_codex":0.00020011474,"about_ca_system_score_gemma":0.00024031966,"threshold_uncertainty_score":0.8219556},"labels":[],"label_agreement":null},{"id":"W2104352098","doi":"10.1515/cclm.2003.082","title":"Lipoprotein Lipase Gene Polymorphisms in Croatian Patients with Coronary Artery Disease","year":2003,"lang":"en","type":"article","venue":"Clinical Chemistry and Laboratory Medicine (CCLM)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Science and Technology, Croatia; Université de Genève; Heart and Stroke Foundation of Canada","keywords":"Lipoprotein lipase; Internal medicine; Coronary artery disease; Triglyceride; Medicine; Endocrinology; Lipoprotein; Cholesterol; Lipid profile; Apolipoprotein E; High-density lipoprotein; Disease; Adipose tissue","score_opus":0.016232855637956286,"score_gpt":0.27563263715052344,"score_spread":0.25939978151256715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104352098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926204,0.004230883,0.000044245066,0.0010806907,0.00015995676,0.00072864274,0.000044185166,0.0000544924,0.001036482],"genre_scores_gemma":[0.99524534,0.00036085016,0.0002934351,0.002673302,0.0007800171,0.00007534659,0.00013680034,0.000048229005,0.00038666304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971668,0.00021979821,0.00084206293,0.00072255975,0.0006056621,0.0004431082],"domain_scores_gemma":[0.99731475,0.0001224545,0.00017695937,0.0008638635,0.0002339277,0.0012880267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001273818,0.00034527757,0.00086290255,0.000041421947,0.000099719466,0.000011487483,0.00010163976,0.00026066325,0.00041422262],"category_scores_gemma":[0.0011639214,0.00025013986,0.00011857747,0.0003971957,0.0005846083,0.00009137153,0.000034593922,0.0007214789,0.000010135391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021153684,0.0014768454,0.9803256,0.0006683714,0.00025614235,0.0019488856,0.00011769989,0.0000022354052,0.0010463946,0.00003926912,0.0013923713,0.010610833],"study_design_scores_gemma":[0.016601302,0.000961036,0.959316,0.00086425897,0.00036887533,0.000068277994,0.00011722078,0.00001279191,0.0021510434,0.00007772517,0.019010508,0.0004509306],"about_ca_topic_score_codex":0.000028437473,"about_ca_topic_score_gemma":0.000006080613,"teacher_disagreement_score":0.021009553,"about_ca_system_score_codex":0.00006590944,"about_ca_system_score_gemma":0.0006327527,"threshold_uncertainty_score":0.9999951},"labels":[],"label_agreement":null},{"id":"W2104666672","doi":"10.1016/j.clinthera.2005.04.009","title":"Quantifying the use of the statin antilipemic drugs: Comparisons and contrasts between Nova Scotia, Canada, and Queensland, Australia","year":2005,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Nova scotia; Medical prescription; Statin; Public health; Pharmaceutical Benefits Scheme; Environmental health; Family medicine; Internal medicine; Pharmacology; Geography; Nursing","score_opus":0.28831103401476077,"score_gpt":0.41656768573180314,"score_spread":0.12825665171704237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104666672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925423,0.0011925049,0.00029414988,0.0052149883,0.0001706133,0.0005098781,0.000052509524,0.000008543132,0.000014464508],"genre_scores_gemma":[0.9958733,0.00034340506,0.0009467563,0.002401488,0.00030584043,0.0000013250715,0.00000490703,0.000015733047,0.00010728905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826646,0.00029832678,0.0006295481,0.00021573866,0.00034693014,0.00024302478],"domain_scores_gemma":[0.99821466,0.00086469646,0.00018209466,0.0005143625,0.00009000371,0.00013416998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009722226,0.00014024561,0.0005372928,0.000014620825,0.00010010428,0.000024885405,0.000104878294,0.00011617254,0.000011211618],"category_scores_gemma":[0.00010630687,0.00007537474,0.00014012367,0.00010530621,0.0004173755,0.000036082383,0.00005714393,0.00050173845,0.0000012849348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058599562,0.000046378154,0.95188844,0.00006084736,0.00038945818,0.0000014643416,0.00017262391,0.000009913276,0.000048878665,0.00007070862,0.00093143753,0.04632124],"study_design_scores_gemma":[0.0014348682,0.0000969437,0.9442345,0.000112714144,0.00044308198,0.0000131651295,0.00016372705,0.0006064476,0.00024528382,0.00000870779,0.05254678,0.00009379449],"about_ca_topic_score_codex":0.14994216,"about_ca_topic_score_gemma":0.2907082,"teacher_disagreement_score":0.14076605,"about_ca_system_score_codex":0.000028022223,"about_ca_system_score_gemma":0.00029063158,"threshold_uncertainty_score":0.85571843},"labels":[],"label_agreement":null},{"id":"W2104761168","doi":"10.1001/archinte.166.21.2307","title":"Primary Prevention of Cardiovascular Diseases With Statin Therapy","year":2006,"lang":"en","type":"review","venue":"Archives of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":353,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Aging","keywords":"Medicine; Internal medicine; Relative risk; Statin; Population; Adverse effect; Randomized controlled trial; Meta-analysis; Confidence interval","score_opus":0.022966582948033665,"score_gpt":0.31078594611938626,"score_spread":0.2878193631713526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104761168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002591979,0.98911816,0.0036555452,0.000022644525,0.000099326615,0.0016051527,0.000058219073,0.000022156657,0.0051595704],"genre_scores_gemma":[0.00024595764,0.99692076,0.0011591306,0.000036922866,0.0006573028,0.00008926664,0.00031962112,0.000071174836,0.00049984053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996935,0.00031672744,0.0010683928,0.00040331692,0.0010372468,0.00023931683],"domain_scores_gemma":[0.9978934,0.00020771529,0.000665432,0.00097178115,0.000093795396,0.00016790857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003608811,0.00040645583,0.0042897826,0.0003836256,0.000021163472,0.0000024829226,0.00023591917,0.0000870356,0.00004253452],"category_scores_gemma":[0.00006726478,0.0002236095,0.002077238,0.00021184553,0.0004521948,0.00003313103,0.000055331693,0.0003470857,0.0000014599433],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030968245,0.00021828874,0.00009156249,0.043973543,0.006316179,0.00008710645,0.0000762886,0.0000022904505,0.0000038836483,0.000029783358,0.00012533207,0.94876605],"study_design_scores_gemma":[0.0033044445,0.0034743028,0.0014013399,0.11654288,0.007174969,0.0003340065,0.00002915519,0.0000017341016,0.00002225474,0.00009831476,0.8674137,0.00020290771],"about_ca_topic_score_codex":0.0009523159,"about_ca_topic_score_gemma":0.000004202019,"teacher_disagreement_score":0.94856316,"about_ca_system_score_codex":0.000042338506,"about_ca_system_score_gemma":0.0005028339,"threshold_uncertainty_score":0.9118531},"labels":[],"label_agreement":null},{"id":"W2104874383","doi":"10.1016/j.amjcard.2009.05.019","title":"Usefulness of Statin–Ezetimibe Combination to Reduce the Care Gap in Dyslipidemia Management in Patients With a High Risk of Atherosclerotic Disease","year":2009,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; University of British Columbia; Canadian Heart Research Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Ezetimibe; Dyslipidemia; Medicine; Statin; Atherosclerotic cardiovascular disease; Disease; Internal medicine; Intensive care medicine; Cardiology","score_opus":0.0107991305851359,"score_gpt":0.2550470221831312,"score_spread":0.2442478915979953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104874383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748284,0.0001684053,0.0006403965,0.0008758602,0.000054342567,0.0006943359,0.0000090647545,0.0000021451576,0.00007261185],"genre_scores_gemma":[0.99915236,0.00011366422,0.0003768779,0.00027072025,0.000058954254,0.000012132912,0.0000027157973,0.000010050464,0.0000024966882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794585,0.00084660144,0.000490984,0.00011782684,0.00041380068,0.00018494432],"domain_scores_gemma":[0.99854785,0.00008616935,0.00059323094,0.0004259556,0.0002570293,0.00008975901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011267595,0.00010794371,0.0007671219,0.00016579237,0.000025805526,0.0000023490613,0.0001844161,0.000018120603,0.000001463002],"category_scores_gemma":[0.00011000001,0.000055808418,0.00016125481,0.00043907642,0.00018230284,0.000027915145,0.00002649399,0.00024879538,3.680047e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008327347,0.00023928165,0.7004752,0.00012621084,0.00078718207,0.000059543057,0.002921058,0.025206497,0.000045618308,0.00034490484,0.000076760974,0.2613904],"study_design_scores_gemma":[0.0029618547,0.00278031,0.99155426,0.00019873642,0.00030842618,0.000008067296,0.001820601,0.000007788922,0.000051676132,0.0002226381,0.000030982126,0.000054681703],"about_ca_topic_score_codex":0.00016186129,"about_ca_topic_score_gemma":0.0000051549114,"teacher_disagreement_score":0.29107904,"about_ca_system_score_codex":0.000120512486,"about_ca_system_score_gemma":0.00009954106,"threshold_uncertainty_score":0.22758013},"labels":[],"label_agreement":null},{"id":"W2105042387","doi":"10.1161/01.atv.0000170819.57945.03","title":"An Apolipoprotein(a) Peptide Delays Chylomicron Remnant Clearance and Increases Plasma Remnant Lipoproteins and Atherosclerosis In Vivo","year":2005,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Heart, Lung, and Blood Institute; University of Cincinnati; University of Washington","keywords":"Chylomicron; Apolipoprotein B; Plasma lipoprotein; In vivo; Apolipoprotein C2; Internal medicine; Endocrinology; Chemistry; Lipoprotein; Very low-density lipoprotein; Cholesterol; Biology; Medicine","score_opus":0.022250430171263123,"score_gpt":0.2746792243335636,"score_spread":0.2524287941623005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105042387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588764,0.0013809134,0.00013401151,0.0010374287,0.000058041405,0.001295597,0.000047905367,0.000095075135,0.00006336635],"genre_scores_gemma":[0.96434665,0.030532569,0.003510783,0.0009643197,0.0003396457,0.00019560417,0.000023030792,0.000080314596,0.000007105051],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996626,0.00036976917,0.00069537293,0.0012030134,0.00027677257,0.0008290487],"domain_scores_gemma":[0.9982244,0.00004754201,0.0001735938,0.00093799655,0.00007978808,0.0005366809],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011410706,0.00054072536,0.0012561921,0.0002465262,0.00034343987,0.000102909486,0.00015286978,0.0004419011,0.000054271342],"category_scores_gemma":[0.00006253576,0.00045350898,0.00023886604,0.000245024,0.00050040515,0.00031231518,0.00018075475,0.00037677516,0.000008982854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000963376,0.0006902836,0.27905098,0.00030656363,0.0004225276,0.0000010413668,0.00110279,0.000004915015,0.681813,0.000460667,0.00004551122,0.036005385],"study_design_scores_gemma":[0.0042713387,0.0014711783,0.9804934,0.0005101107,0.00021431454,0.00003222088,0.00027125253,0.0008491942,0.0052736797,0.000041632986,0.006025387,0.00054624246],"about_ca_topic_score_codex":0.0054577244,"about_ca_topic_score_gemma":0.002537111,"teacher_disagreement_score":0.7014425,"about_ca_system_score_codex":0.000109330584,"about_ca_system_score_gemma":0.000066521716,"threshold_uncertainty_score":0.9997917},"labels":[],"label_agreement":null},{"id":"W2105161966","doi":"10.1016/s0828-282x(08)70669-x","title":"Ischemic stroke: A cardiovascular risk equivalent? Lessons learned from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; Atorvastatin; Stroke (engine); Internal medicine; Cardiology; Coronary artery disease; Incidence (geometry); Statin; Revascularization; Population; Myocardial infarction","score_opus":0.06988041107876844,"score_gpt":0.29799243973799816,"score_spread":0.22811202865922972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105161966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974231,0.017648835,0.0025088706,0.002517032,0.0014039659,0.0008171621,0.00029114663,0.00000831144,0.00057366805],"genre_scores_gemma":[0.9899042,0.0047228946,0.000103646715,0.000084748994,0.0048109074,0.00003327007,0.00003708873,0.000034003533,0.00026923962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965826,0.0012555239,0.00070798956,0.0003569887,0.00053809816,0.00055874913],"domain_scores_gemma":[0.99783456,0.00007675238,0.00054903125,0.00072188396,0.0002528946,0.00056490325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002004728,0.00023379383,0.0012073022,0.0002484655,0.00024464304,0.000021942282,0.0002647242,0.00032951296,0.000025462825],"category_scores_gemma":[0.00064649666,0.00018051942,0.0015439152,0.00019451874,0.0002740954,0.0001399253,0.000022562548,0.001192701,0.000008719611],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019034905,0.00012241783,0.06194851,0.0001386542,0.029768486,0.004819771,0.0046446957,0.010415398,0.01301854,0.000032051656,0.16048412,0.69557244],"study_design_scores_gemma":[0.11496617,0.0029169002,0.15668848,0.0006648999,0.0039794547,0.011648714,0.0021782469,0.000024324443,0.003923383,0.00021982302,0.70209503,0.0006945788],"about_ca_topic_score_codex":0.01140082,"about_ca_topic_score_gemma":0.0013187986,"teacher_disagreement_score":0.69487786,"about_ca_system_score_codex":0.0005021034,"about_ca_system_score_gemma":0.0024937398,"threshold_uncertainty_score":0.99518234},"labels":[],"label_agreement":null},{"id":"W2105534196","doi":"10.1136/bmj.f880","title":"Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases","year":2013,"lang":"en","type":"review","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Dalhousie University; Université de Montréal; University of Manitoba; McGill University; Institute for Clinical Evaluative Sciences; University of Calgary; Jewish General Hospital; Manitoba Health; Saskatchewan Health Quality Council; University of British Columbia","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Medicine; Acute kidney injury; Kidney disease; Atorvastatin; Retrospective cohort study; Statin; Internal medicine; Potency; Rosuvastatin; Observational study; Database; Confounding; Population; Propensity score matching; Environmental health","score_opus":0.23799641069775773,"score_gpt":0.4685544749111764,"score_spread":0.23055806421341868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105534196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011874474,0.90422213,0.0018351807,0.0003699093,0.0001981467,0.011682806,0.06974996,0.000021186881,0.00004623572],"genre_scores_gemma":[0.0011440055,0.96702766,0.02389381,0.000048211456,0.000096192176,0.00027042275,0.007246456,0.000029693012,0.00024351699],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776375,0.00016663893,0.0010966075,0.0003596678,0.00046416387,0.00014918392],"domain_scores_gemma":[0.9968617,0.00022261025,0.0013131684,0.00059354905,0.0008052166,0.00020378424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046043217,0.000257442,0.002953409,0.00030278944,0.000031257918,0.000006528673,0.00007760363,0.00013023113,0.00008465838],"category_scores_gemma":[0.001622104,0.00017894231,0.0008036713,0.0005655489,0.00009619144,0.00013019731,0.000062226645,0.00013572387,3.6068775e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013803472,0.0014868869,0.010066158,0.11052625,0.085292995,0.000020342639,0.00037628374,0.0000011822206,0.00025584007,0.0024800606,0.017481918,0.77063173],"study_design_scores_gemma":[0.003999878,0.004087715,0.09387819,0.045238897,0.15799583,0.000027546901,0.00019666474,0.0004682038,0.0021854574,0.000073261785,0.6909512,0.00089711946],"about_ca_topic_score_codex":0.0012394885,"about_ca_topic_score_gemma":0.000015300937,"teacher_disagreement_score":0.7697346,"about_ca_system_score_codex":0.00006330879,"about_ca_system_score_gemma":0.0012228969,"threshold_uncertainty_score":0.7297056},"labels":[],"label_agreement":null},{"id":"W2105962383","doi":"10.1016/j.jacc.2009.10.042","title":"Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia","year":2010,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Université Laval","funders":"","keywords":"Rosuvastatin; Familial hypercholesterolemia; Medicine; Placebo; Rosuvastatin Calcium; Adverse effect; Internal medicine; Gastroenterology; Endocrinology; Cholesterol; Pathology","score_opus":0.008331859322635811,"score_gpt":0.2604597920823167,"score_spread":0.2521279327596809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105962383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723446,0.0002867548,0.000654451,0.0008945987,0.00013699631,0.00063530647,0.00008057389,0.0000024782814,0.000074395335],"genre_scores_gemma":[0.9953227,0.00041254342,0.0035278986,0.00021292162,0.00048527433,0.000004843858,0.0000010710764,0.000017058668,0.000015669399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890256,0.00015469137,0.00041989982,0.00011078695,0.00025841477,0.00015367493],"domain_scores_gemma":[0.9985323,0.00013596035,0.00060853525,0.0003483699,0.00028638382,0.000088463385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079205574,0.00011089329,0.0010407278,0.00007547631,0.00004555944,0.0000015628284,0.00015102232,0.000050053433,0.000001314841],"category_scores_gemma":[0.00012885805,0.000058902344,0.00037228322,0.00015414832,0.0005796979,0.000024724974,0.000028941442,0.00030500363,5.9663776e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04312028,0.00024855178,0.6183806,0.00014729684,0.006605758,0.000048539194,0.00028565005,0.0003551988,0.15199664,0.00033098302,0.0018749337,0.17660554],"study_design_scores_gemma":[0.00846789,0.0043396363,0.97638726,0.0000519367,0.00028804972,0.0035514429,0.00014931249,0.0000037962595,0.0030780435,0.00003314105,0.0035826655,0.00006682644],"about_ca_topic_score_codex":0.000028156088,"about_ca_topic_score_gemma":0.0000061528895,"teacher_disagreement_score":0.35800663,"about_ca_system_score_codex":0.000016298853,"about_ca_system_score_gemma":0.00031030303,"threshold_uncertainty_score":0.24019678},"labels":[],"label_agreement":null},{"id":"W2106238465","doi":"10.2174/187152811796117771","title":"Lipoprotein-Associated Phospholipase A2: How Effective as a Risk Marker of Cardiovascular Disease and as a Therapeutic Target?","year":2011,"lang":"en","type":"review","venue":"Inflammation & Allergy - Drug Targets","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Lipoprotein-associated phospholipase A2; Biomarker; Lipoprotein; Phospholipase A2; Medicine; Very low-density lipoprotein; Disease; Lipoprotein(a); Inflammation; Proinflammatory cytokine; Internal medicine; Immunology; Biology; Enzyme; Cholesterol; Biochemistry","score_opus":0.01413730237020527,"score_gpt":0.25465942237509476,"score_spread":0.24052212000488948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106238465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002840501,0.9872925,0.00019149108,0.00011149877,0.00033869105,0.007903025,0.00013194823,0.00018453118,0.0010057967],"genre_scores_gemma":[0.006376636,0.9886672,0.00024276899,0.000053774213,0.0005951736,0.002290795,0.00056050596,0.00024356741,0.000969567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99322253,0.0020457827,0.0012107303,0.0012484578,0.001487811,0.0007846981],"domain_scores_gemma":[0.9949381,0.00021317581,0.0013475926,0.0020191418,0.000640473,0.0008415269],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029212313,0.0011551585,0.004377404,0.0004830627,0.00027394271,0.00007628071,0.00031794488,0.00069363863,0.00031545825],"category_scores_gemma":[0.0012250806,0.00093636377,0.003899373,0.0006065439,0.00023047124,0.00027533408,0.00020839954,0.0010451453,0.00015227395],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040269218,0.00022502347,0.000018898778,0.014122204,0.03409367,0.0003098801,0.0007100122,0.000021629408,0.0000018100579,0.00024835276,0.00015998288,0.9496859],"study_design_scores_gemma":[0.002709404,0.0002805562,0.00076138054,0.0089101,0.011583234,0.000092105,0.00006212391,0.00006531237,0.00012671364,0.0007561873,0.973755,0.00089789345],"about_ca_topic_score_codex":0.0032883545,"about_ca_topic_score_gemma":0.00003767805,"teacher_disagreement_score":0.973595,"about_ca_system_score_codex":0.00042587103,"about_ca_system_score_gemma":0.0012255113,"threshold_uncertainty_score":0.9993087},"labels":[],"label_agreement":null},{"id":"W2106470271","doi":"10.1096/fj.05-4857fje","title":"Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac‐1 integrin","year":2006,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institutes of Health; National Cancer Institute; University of Pennsylvania; Novartis Foundation; Heart and Stroke Foundation of Canada","keywords":"Lipoprotein(a); Chemistry; Integrin; Apolipoprotein B; Lipoprotein; Proinflammatory cytokine; Kringle domain; Cell adhesion; Inflammation; Cell biology; Cancer research; Immunology; Cell; Medicine; Biochemistry; Biology; Cholesterol; Plasmin","score_opus":0.01919682490322006,"score_gpt":0.2524490733671701,"score_spread":0.23325224846395004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106470271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917169,0.0006413581,0.0019389667,0.0008141319,0.0002722799,0.00075738865,0.0000017676339,0.00004300683,0.00381416],"genre_scores_gemma":[0.99649394,0.0002895528,0.0011069643,0.00031363123,0.0011722462,0.000037762675,0.0000040189607,0.00003958774,0.00054230454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822503,0.00023717726,0.00043234945,0.00019142043,0.0005518516,0.00036215334],"domain_scores_gemma":[0.999152,0.00004089342,0.00020348537,0.00039858802,0.0001073885,0.00009763581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010283046,0.00019893494,0.00034484724,0.00010872307,0.00016890506,0.00007512641,0.00014445967,0.0000957968,0.000121503545],"category_scores_gemma":[0.000024453633,0.00011197271,0.00017946343,0.00021781342,0.00008591417,0.00024910062,0.000030617957,0.0010807293,0.00005370935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075793,0.0019906233,0.047049407,0.0011518073,0.001571067,0.004443252,0.011121356,0.0070134136,0.6759814,0.0033571124,0.006412414,0.23232882],"study_design_scores_gemma":[0.012504966,0.0024123893,0.12048643,0.0049699526,0.0004964783,0.012587066,0.004603182,0.00072640035,0.8105477,0.0030592724,0.026693482,0.00091270107],"about_ca_topic_score_codex":0.0012961389,"about_ca_topic_score_gemma":0.00055246137,"teacher_disagreement_score":0.23141612,"about_ca_system_score_codex":0.00029168391,"about_ca_system_score_gemma":0.00020933889,"threshold_uncertainty_score":0.4695291},"labels":[],"label_agreement":null},{"id":"W2107026184","doi":"10.1177/0003319713505897","title":"Nicotinic Acid","year":2013,"lang":"en","type":"editorial","venue":"Angiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Niacin; Statin; Nicotinic agonist; Internal medicine; Medical prescription; Cholesterol; Endocrinology; Cardiology; Pharmacology","score_opus":0.009420901171413252,"score_gpt":0.2755844955840265,"score_spread":0.2661635944126132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107026184","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013222548,0.01084044,0.000040324747,0.00044495906,0.9794351,0.00059501035,0.000027794558,0.000104690174,0.0071894643],"genre_scores_gemma":[0.0012765952,0.0017715599,0.00022878622,0.00046695187,0.9886724,0.0001163263,0.0008846128,0.00005990551,0.0065228646],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833506,0.000116977,0.0002964852,0.00043526816,0.00038487036,0.00043133696],"domain_scores_gemma":[0.9985061,0.00012320075,0.0001115346,0.00086403714,0.00022252239,0.00017257099],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003870512,0.00023626864,0.0009229819,0.000099252386,0.000043837506,0.000008574805,0.0001436259,0.0015818429,0.000698986],"category_scores_gemma":[0.00059465965,0.00018291989,0.00057587615,0.0000826497,0.0000804669,0.00002139057,0.00007818313,0.00088123046,0.002010001],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026334408,0.000026872049,0.00003111217,0.00015442404,0.00036233736,0.00004067459,0.000015742724,2.9915938e-8,0.000060163962,0.00003729567,0.9885101,0.0107349595],"study_design_scores_gemma":[0.0008335186,0.00047710756,0.0002779067,0.000070061215,0.0002651661,0.00004845198,0.000008163399,9.51384e-7,0.0000667602,0.00008625121,0.99770725,0.00015838607],"about_ca_topic_score_codex":0.00048253316,"about_ca_topic_score_gemma":0.000016768741,"teacher_disagreement_score":0.010576574,"about_ca_system_score_codex":0.00008072622,"about_ca_system_score_gemma":0.00062937324,"threshold_uncertainty_score":0.9997143},"labels":[],"label_agreement":null},{"id":"W2107089384","doi":"10.1016/j.jval.2015.09.802","title":"Burden of Dyslipidaemia in Patients at High Risk for Cardiovascular (Cv) Events: Results of a Canadian Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Amgen (Canada); Université de Montréal","funders":"","keywords":"Medicine; Statin; Internal medicine; Cohort; Body mass index; Risk factor; Medical prescription; Diabetes mellitus; Cohort study; Ezetimibe; Obesity; Endocrinology; Pharmacology","score_opus":0.039038384304523714,"score_gpt":0.27406148344453884,"score_spread":0.23502309914001512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107089384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924475,0.002020362,0.000015253226,0.00031081997,0.00028739666,0.0045773555,0.00023260417,0.000009370931,0.000099370576],"genre_scores_gemma":[0.998521,0.00026856686,0.0007559627,0.000049372607,0.0001648046,0.000104720304,0.00006894418,0.000032371747,0.00003430245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634844,0.0007014508,0.0011408067,0.00041031642,0.00086616754,0.00053281046],"domain_scores_gemma":[0.9978249,0.00006998511,0.00029999224,0.00095630524,0.00030215818,0.0005466457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066193305,0.00016872761,0.0011352256,0.0008245538,0.00004612477,0.0000020166617,0.00013183845,0.00012208929,0.0000021087512],"category_scores_gemma":[0.0009357129,0.00015529922,0.00036203722,0.0008627331,0.00002604656,0.00004416631,0.000047051963,0.00022103496,0.0000027226254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024362656,0.0009937218,0.9327652,0.0018736778,0.00090098317,0.000024491825,0.011109594,0.027074378,0.0000017627286,0.00005771413,0.00075178547,0.022010436],"study_design_scores_gemma":[0.045275163,0.0054746983,0.9366451,0.0009575946,0.00022462057,0.00000502167,0.0021729826,0.0007631544,0.000046771725,0.00016885033,0.008031869,0.00023417361],"about_ca_topic_score_codex":0.96460027,"about_ca_topic_score_gemma":0.15834643,"teacher_disagreement_score":0.80625385,"about_ca_system_score_codex":0.0015583652,"about_ca_system_score_gemma":0.001726279,"threshold_uncertainty_score":0.85701156},"labels":[],"label_agreement":null},{"id":"W2107224392","doi":"10.5339/gcsp.2014.3","title":"The expanding role of lipoprotein apheresis in the treatment of raised lipoprotein(a) in ischaemic heart disease and refractory angina","year":2014,"lang":"en","type":"review","venue":"Global Cardiology Science and Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Imperial College London; National Institute for Health and Care Research; Royal Brompton and Harefield NHS Foundation Trust","keywords":"Medicine; Angina; Lipoprotein(a); Internal medicine; Apheresis; Cardiology; Lipoprotein; Canadian Cardiovascular Society; Risk factor; Refractory (planetary science); Cholesterol; Myocardial infarction; Platelet","score_opus":0.03149086573236971,"score_gpt":0.36434135454575434,"score_spread":0.33285048881338464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107224392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012228617,0.98255384,0.000006573091,0.0006359766,0.000093276045,0.0023275549,0.000025105453,0.000006401376,0.0021226527],"genre_scores_gemma":[0.06122242,0.9380811,0.00009670161,0.00012949854,0.00018593307,0.00026110554,0.0000053802005,0.000009624502,0.000008241488],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960408,0.0016999171,0.00058881997,0.0005564716,0.0006688529,0.00044508767],"domain_scores_gemma":[0.99737424,0.0010163599,0.0003946932,0.00089367526,0.00015522711,0.0001657797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075990707,0.00029069555,0.0017003675,0.00015228678,0.00020482735,0.000032820903,0.00026472117,0.00020340378,0.0000013272772],"category_scores_gemma":[0.002534431,0.00015144114,0.00031821834,0.0009524448,0.0010893252,0.00018993118,0.000081089645,0.00029147175,0.0000017732065],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030623862,0.00008910568,0.000692496,0.0014813277,0.00014621856,0.000059738948,0.00021375171,0.0000011728062,0.000012221475,0.00030952596,0.000038595583,0.9966496],"study_design_scores_gemma":[0.00087084674,0.00097386865,0.010408691,0.001717689,0.0009762319,0.00089271925,0.0010495075,0.0000048233933,0.0000027697045,0.00017579575,0.98274827,0.0001788086],"about_ca_topic_score_codex":0.0014881461,"about_ca_topic_score_gemma":0.000051548435,"teacher_disagreement_score":0.9964708,"about_ca_system_score_codex":0.0002593211,"about_ca_system_score_gemma":0.0011495582,"threshold_uncertainty_score":0.6175591},"labels":[],"label_agreement":null},{"id":"W2107420451","doi":"10.1016/s0828-282x(06)70928-x","title":"The use of lipid-lowering therapy for secondary prevention in patients undergoing percutaneous coronary intervention","year":2006,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; University Health Network; Toronto East General Hospital","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Internal medicine; Angiotensin-converting enzyme; Lipid profile; Myocardial infarction; Cardiology; Cholesterol; Blood pressure","score_opus":0.02016501492925075,"score_gpt":0.24841862336698955,"score_spread":0.22825360843773881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107420451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944418,0.0019888044,0.0022404774,0.00016857726,0.00054560043,0.0004170687,0.000009773994,0.0000017850291,0.00018612487],"genre_scores_gemma":[0.9989522,0.00024421874,0.00018376195,0.000045113036,0.0004714651,0.0000050309923,0.00001420428,0.000012968819,0.00007101656],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990239,0.00013098739,0.00045034877,0.000081829756,0.000104705774,0.00020822384],"domain_scores_gemma":[0.9992537,0.000098020035,0.00018539984,0.0001443368,0.00021319425,0.00010537289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005775424,0.00007335003,0.00034078062,0.00015247973,0.00007079271,0.0000112274665,0.00006313712,0.000083277024,0.0000055460378],"category_scores_gemma":[0.00012072277,0.000054821263,0.00042282845,0.000062092055,0.00005712491,0.00007211619,0.000004836022,0.0001673639,2.6524918e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015099037,0.000034638022,0.39146996,0.0002119476,0.00076012564,0.00021275449,0.00014066159,0.0039796014,0.00028897618,0.00017253368,0.0035096083,0.5977093],"study_design_scores_gemma":[0.005208799,0.0029046647,0.888625,0.00030075922,0.000078953,0.0012761038,0.000119189164,0.000024017587,0.00010471806,0.00041454722,0.100849725,0.00009352259],"about_ca_topic_score_codex":0.0011479023,"about_ca_topic_score_gemma":0.0063952133,"teacher_disagreement_score":0.5976158,"about_ca_system_score_codex":0.00022034194,"about_ca_system_score_gemma":0.0007795818,"threshold_uncertainty_score":0.3568679},"labels":[],"label_agreement":null},{"id":"W2107753684","doi":"10.1155/2014/380316","title":"Cholesterol Assimilation by<i>Lactobacillus</i>Probiotic Bacteria: An<i>In Vitro</i>Investigation","year":2014,"lang":"en","type":"article","venue":"BioMed Research International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Probiotic; Assimilation (phonology); Microbiology; Cholesterol; In vitro; Lactobacillus; Bacteria; Biology; Food science; Biochemistry","score_opus":0.04597753379401377,"score_gpt":0.344522582368815,"score_spread":0.29854504857480124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107753684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865164,0.000044711574,0.0010573843,0.008306794,0.00078343955,0.00081281184,0.000054221167,0.00006709396,0.0023571008],"genre_scores_gemma":[0.995124,0.000045422115,0.0013811481,0.00054242305,0.0010859529,0.000089475805,0.0011187345,0.000028762192,0.00058407895],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968131,0.0004692572,0.00036205314,0.00045013285,0.0014696061,0.00043581368],"domain_scores_gemma":[0.9986705,0.0000714023,0.00006602848,0.00043914764,0.00041876157,0.00033411672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003258535,0.0001400774,0.00023830651,0.00055493735,0.00010080207,0.00010860342,0.00022745495,0.00016631842,0.00013647514],"category_scores_gemma":[0.00038638682,0.00012348195,0.000096531534,0.00044547502,0.0001645267,0.0003124247,0.000070301256,0.000438384,0.00010629346],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003572939,0.00031132597,0.006289217,0.00010096029,0.0000917601,0.0000088438965,0.00018778154,0.000003985756,0.9094694,0.00027317958,0.004378364,0.07852787],"study_design_scores_gemma":[0.008244189,0.00089501473,0.4887952,0.00032464016,0.0000329726,0.00012655006,0.00015918192,0.010832489,0.2800823,0.0007400572,0.20931776,0.0004496908],"about_ca_topic_score_codex":0.00032481964,"about_ca_topic_score_gemma":0.000030220934,"teacher_disagreement_score":0.62938714,"about_ca_system_score_codex":0.00045024705,"about_ca_system_score_gemma":0.00017982411,"threshold_uncertainty_score":0.50354475},"labels":[],"label_agreement":null},{"id":"W2107989308","doi":"10.1161/01.cir.0000038303.84249.4a","title":"Effect of Atorvastatin on High-Density Lipoprotein Apolipoprotein A-I Production and Clearance in the New Zealand White Rabbit","year":2002,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Pfizer Canada; National Institutes of Health; National Center for Research Resources; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Atorvastatin; Apolipoprotein B; Internal medicine; Endocrinology; Medicine; Cholesterol; Placebo; HMG-CoA reductase; Lipoprotein; Reductase; Enzyme; Biology; Biochemistry","score_opus":0.010837660265080071,"score_gpt":0.23664716953914736,"score_spread":0.2258095092740673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107989308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949803,0.00041785123,0.00015139946,0.0023218482,0.000090465604,0.0018574568,0.0000012058864,0.000027784567,0.00015173481],"genre_scores_gemma":[0.9990902,0.00005994548,0.00011236697,0.00011454903,0.00041458753,0.0000432502,0.000008282469,0.000017618877,0.00013922469],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984344,0.00033078878,0.00026540042,0.00030561688,0.00048136743,0.00018239875],"domain_scores_gemma":[0.9992572,0.000038419592,0.00011605035,0.00047755838,0.00004056148,0.000070215545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012288386,0.00014303421,0.00033557278,0.000109048044,0.00006680342,0.000015196808,0.000046262965,0.0000946452,0.00003016327],"category_scores_gemma":[0.0002473859,0.00010098918,0.000086633285,0.00028026538,0.00004493978,0.00008590407,0.000010193299,0.00022689269,0.000017573404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012937785,0.00023356674,0.11645612,0.0010837169,0.00010088685,0.000031640142,0.0031263693,0.0007049633,0.008343334,0.00030811442,0.001278935,0.86703855],"study_design_scores_gemma":[0.001958401,0.00059646735,0.9821895,0.00032867675,0.00007235165,0.00007979892,0.00003382305,0.0005313801,0.0136535745,0.0001618936,0.0002794542,0.00011472409],"about_ca_topic_score_codex":0.002351443,"about_ca_topic_score_gemma":0.00015381152,"teacher_disagreement_score":0.86692387,"about_ca_system_score_codex":0.000061054125,"about_ca_system_score_gemma":0.000020409681,"threshold_uncertainty_score":0.4118219},"labels":[],"label_agreement":null},{"id":"W2108475045","doi":"10.1136/bmj.b92","title":"Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis","year":2009,"lang":"en","type":"review","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":490,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Canadian College of Naturopathic Medicine; Western University; McMaster University","funders":"Ontario Ministry of Health and Long-Term Care; Pfizer","keywords":"Medicine; Myocardial infarction; Internal medicine; Cholesterol; Meta-analysis; Meta-regression; High-density lipoprotein; Lipoprotein; Cardiology","score_opus":0.0951130876038194,"score_gpt":0.3659013835580902,"score_spread":0.2707882959542708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108475045","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026439896,0.984464,0.000022347607,0.00041099594,0.000023975945,0.0122702345,0.00012232643,0.000035988203,0.0000061302976],"genre_scores_gemma":[0.003150993,0.9941217,0.00005572544,0.00030158757,0.0003516917,0.0016663662,0.00025313688,0.00003934601,0.00005946692],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9943516,0.0019761634,0.0012676875,0.000916632,0.0011357171,0.0003521477],"domain_scores_gemma":[0.99698526,0.00009656087,0.0007706221,0.0015474204,0.00012394549,0.0004762109],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0070721433,0.00064356724,0.012528659,0.00036761176,0.00009393264,0.000063367486,0.00009355288,0.0004134361,0.000008095616],"category_scores_gemma":[0.0006619408,0.000404431,0.0025771756,0.000769058,0.000036595782,0.00013443976,0.00013327046,0.0004943564,0.0000029382024],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000021168375,0.000027036787,0.0027074798,0.7755404,0.068779334,0.00009623478,0.000014856658,7.973907e-8,4.158359e-9,0.000001374683,0.000019932007,0.15281112],"study_design_scores_gemma":[0.00039437364,0.00003472932,0.12475993,0.12712649,0.7429709,0.000042132084,0.000002473439,0.000004110871,1.0122659e-7,0.000010211359,0.0043090037,0.00034560135],"about_ca_topic_score_codex":0.0057673515,"about_ca_topic_score_gemma":0.00030222686,"teacher_disagreement_score":0.67419153,"about_ca_system_score_codex":0.00023937727,"about_ca_system_score_gemma":0.00011423359,"threshold_uncertainty_score":0.99984074},"labels":[],"label_agreement":null},{"id":"W2108488063","doi":"10.1016/s0890-8508(03)00050-1","title":"Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory element","year":2003,"lang":"en","type":"article","venue":"Molecular and Cellular Probes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biology; Linkage disequilibrium; Genetics; Haplotype; Allele; Allele frequency; Promoter; Population; LDL receptor; Gene; Polymorphism (computer science); Lipoprotein; Cholesterol; Endocrinology; Gene expression; Demography","score_opus":0.013557546214560812,"score_gpt":0.22180922173087,"score_spread":0.2082516755163092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108488063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876994,0.002396272,0.0077643064,0.00052530505,0.00003202945,0.0011935018,0.0000017784223,0.000004492807,0.0003829292],"genre_scores_gemma":[0.9989722,0.00012413798,0.0005893347,0.00017528542,0.000028744636,0.00006996243,0.000015188154,0.000012795573,0.000012374425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744534,0.0011093474,0.0004230912,0.000274894,0.0005538768,0.0001934214],"domain_scores_gemma":[0.998834,0.000023816729,0.00017413554,0.00086494716,0.00007085615,0.0000322262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027544007,0.00013266927,0.0003418471,0.0001520597,0.000071404334,0.000018948485,0.00017216423,0.00008274875,0.0000131973175],"category_scores_gemma":[0.00004801809,0.000069750335,0.00023645884,0.00090807903,0.000059187234,0.000040758692,0.000023049215,0.00019434936,2.3848426e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040524645,0.0028315526,0.0073530683,0.0009256685,0.0027407564,0.0005818458,0.06336076,0.0017978059,0.85723686,0.026353428,0.00007784575,0.03633513],"study_design_scores_gemma":[0.0072854958,0.0019382415,0.28915596,0.0005931338,0.0046566785,0.00044935688,0.018332383,0.0042569833,0.6488008,0.0026004023,0.020947417,0.0009831451],"about_ca_topic_score_codex":0.00026043932,"about_ca_topic_score_gemma":0.000050053975,"teacher_disagreement_score":0.2818029,"about_ca_system_score_codex":0.00004033202,"about_ca_system_score_gemma":0.00007121907,"threshold_uncertainty_score":0.2844336},"labels":[],"label_agreement":null},{"id":"W2108493094","doi":"10.1161/atvbaha.110.220988","title":"Circulating Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Regulates VLDLR Protein and Triglyceride Accumulation in Visceral Adipose Tissue","year":2011,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":241,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Kexin; Adipose tissue; Endocrinology; Internal medicine; Proprotein convertase; LDL receptor; Adipocyte; Triglyceride; Biology; Chemistry; Lipoprotein; Cholesterol; Medicine","score_opus":0.07613237329694497,"score_gpt":0.30867574164331235,"score_spread":0.23254336834636738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108493094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963627,0.00059349975,0.00022702772,0.00031715896,0.00007566375,0.0022108266,0.00001026437,0.00008202636,0.00012081839],"genre_scores_gemma":[0.99666494,0.00046949624,0.0020091007,0.0003313716,0.00013795274,0.00026422643,0.000060984763,0.000053695312,0.000008208782],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99744856,0.00028795382,0.0006456073,0.0008206948,0.00022110315,0.00057605625],"domain_scores_gemma":[0.998839,0.000024478042,0.00017416316,0.00063101825,0.00009754487,0.00023376729],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092615094,0.0003860544,0.00093593757,0.00023832651,0.00019349092,0.000050860337,0.00009824971,0.00036136422,0.00013187177],"category_scores_gemma":[0.0000955123,0.00032688148,0.00020168225,0.00024168169,0.00028688673,0.00024112087,0.0001225692,0.00027923737,0.0000128094725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100140816,0.00041085668,0.2604455,0.00059278467,0.0005051352,0.0000058185383,0.0019358982,0.0000013749252,0.7150919,0.0010606094,0.000010709686,0.019839253],"study_design_scores_gemma":[0.003455786,0.0008081534,0.97944826,0.0003831323,0.0001811613,0.000016756056,0.00014968208,0.0005180443,0.013756582,0.00039437582,0.0005046665,0.0003833992],"about_ca_topic_score_codex":0.0027286527,"about_ca_topic_score_gemma":0.00030473285,"teacher_disagreement_score":0.7190027,"about_ca_system_score_codex":0.00007106933,"about_ca_system_score_gemma":0.00007355761,"threshold_uncertainty_score":0.99991834},"labels":[],"label_agreement":null},{"id":"W2108688501","doi":"10.1016/s0828-282x(10)71061-8","title":"C-reactive protein: Risk factor, biomarker and/or therapeutic target?","year":2010,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Rosuvastatin; Medicine; C-reactive protein; Biomarker; Dyslipidemia; Mendelian randomization; Internal medicine; Inflammation; Lipoprotein; Adipose tissue; Gastroenterology; Cholesterol; Disease; Genotype","score_opus":0.04781724965357957,"score_gpt":0.3127525978410595,"score_spread":0.26493534818747994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108688501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019477445,0.995231,0.00047477573,0.00012687514,0.00095413794,0.0012901411,0.00018939907,0.0000074534473,0.0015314623],"genre_scores_gemma":[0.003055312,0.99338996,0.00030147546,0.00009545571,0.0028059736,0.00003963069,0.000015955078,0.000087301385,0.00020893916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972671,0.0007508615,0.00080708956,0.00032979422,0.0002593359,0.0005857866],"domain_scores_gemma":[0.9967995,0.0001177607,0.00074975006,0.0005891424,0.00033302847,0.0014108098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011588978,0.00045017857,0.0038421794,0.00065370946,0.0001457471,0.000031273346,0.00022451213,0.0010199713,0.00009766147],"category_scores_gemma":[0.00044713207,0.00027482884,0.0016883598,0.000231733,0.0002930279,0.00006399147,0.000018578508,0.0022339928,0.000017291515],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004147797,0.0000019805366,0.00017844286,0.001835118,0.0026530293,0.000885339,0.00003227566,1.4235879e-7,0.000002429281,0.000025636848,0.00025434728,0.9940898],"study_design_scores_gemma":[0.0005952894,0.00046134397,0.0011605397,0.0024268865,0.0024950723,0.013246333,0.000022688308,2.723918e-7,0.0000018080573,0.00007507352,0.9792624,0.0002523009],"about_ca_topic_score_codex":0.0011133762,"about_ca_topic_score_gemma":0.0007360634,"teacher_disagreement_score":0.9938375,"about_ca_system_score_codex":0.00034221253,"about_ca_system_score_gemma":0.010039966,"threshold_uncertainty_score":0.9999704},"labels":[],"label_agreement":null},{"id":"W2108829860","doi":"10.3138/ptc.2012-65","title":"Statin-Induced Rhabdomyolysis: A Comprehensive Review of Case Reports","year":2013,"lang":"en","type":"review","venue":"Physiotherapy Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rhabdomyolysis; myalgia; Statin; Myopathy; Physical therapy; Simvastatin; Concomitant; Rehabilitation; Muscle disorder; Muscle weakness; Internal medicine","score_opus":0.039899718342701215,"score_gpt":0.35582764913445686,"score_spread":0.31592793079175563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108829860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008969294,0.9949956,0.00000514955,0.00010865936,0.0003116536,0.0041714674,0.000063657,0.000024323643,0.00022977807],"genre_scores_gemma":[0.000017056493,0.9964194,0.00026733032,0.0019483452,0.00036803624,0.00049080455,0.00015522858,0.000121683086,0.00021209018],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963161,0.0003068194,0.0014191719,0.0005884015,0.0009795261,0.00039002058],"domain_scores_gemma":[0.9960522,0.00009414644,0.0011821255,0.0018295053,0.00049584074,0.000346152],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026728975,0.0005689094,0.005015346,0.00012532662,0.00006832851,0.000009304647,0.000096795426,0.00015129846,0.0005304709],"category_scores_gemma":[0.000039491635,0.00040694862,0.0013470706,0.00060527486,0.000033396464,0.00003854883,0.00003351225,0.0004197766,0.000005924802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000022638476,0.000030399902,1.00084165e-7,0.32951355,0.0013033987,0.006436141,0.000007729805,3.085188e-8,0.0000063903394,0.000002215815,0.011995929,0.6507018],"study_design_scores_gemma":[0.0002215522,0.000094147195,8.8091e-7,0.13194619,0.0016567273,0.016899046,0.00002030218,6.657587e-7,0.0000108723325,0.0000023911064,0.8488579,0.0002893401],"about_ca_topic_score_codex":0.7694586,"about_ca_topic_score_gemma":0.040556405,"teacher_disagreement_score":0.83686197,"about_ca_system_score_codex":0.00055411324,"about_ca_system_score_gemma":0.008375733,"threshold_uncertainty_score":0.99983823},"labels":[],"label_agreement":null},{"id":"W2109548714","doi":"10.1016/j.amjcard.2012.04.025","title":"Comparison of Coronary Calcium Screening Versus Broad Statin Therapy for Patients at Intermediate Cardiovascular Risk","year":2012,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Coronary artery calcium; Statin; Internal medicine; Cardiology; Coronary artery disease","score_opus":0.045945664512982265,"score_gpt":0.34280597205310004,"score_spread":0.2968603075401178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109548714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754272,0.010813979,0.012265669,0.00007406713,0.00077869603,0.00051551696,0.000035961624,0.000008083914,0.00008079807],"genre_scores_gemma":[0.99534637,0.0017318517,0.0014434722,0.00010305171,0.0013045716,0.000017615073,0.000014505422,0.000033328863,0.0000052368077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973001,0.00088529574,0.00067287346,0.0001411214,0.00055628095,0.00044435047],"domain_scores_gemma":[0.9974035,0.00042093892,0.0009952041,0.000541789,0.0004186354,0.00021992065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002367801,0.00018611518,0.0018014421,0.00010586071,0.00011261171,0.0000033536487,0.0002074563,0.000056693876,0.0000073201577],"category_scores_gemma":[0.00025951577,0.00011492321,0.0016561833,0.00015290001,0.00045988298,0.00006247082,0.00006965157,0.00036117283,0.0000025496859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010744404,0.00007569842,0.51715094,0.00002504077,0.0061900276,0.0000055379573,0.00067483087,0.00048674524,0.00011328187,0.0000039547203,0.0005899349,0.46393964],"study_design_scores_gemma":[0.0089916615,0.009437805,0.94977677,0.000043478965,0.0015062747,0.0002204426,0.00135161,0.000044332653,0.0006669068,0.000008209572,0.02780462,0.00014787591],"about_ca_topic_score_codex":0.00009297125,"about_ca_topic_score_gemma":7.7342884e-7,"teacher_disagreement_score":0.46379176,"about_ca_system_score_codex":0.00012066529,"about_ca_system_score_gemma":0.0000964275,"threshold_uncertainty_score":0.46864325},"labels":[],"label_agreement":null},{"id":"W2109770394","doi":"10.1373/clinchem.2014.231365","title":"Refinement of Variant Selection for the LDL Cholesterol Genetic Risk Score in the Diagnosis of the Polygenic Form of Clinical Familial Hypercholesterolemia and Replication in Samples from 6 Countries","year":2014,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; Agency for Healthcare Research and Quality; Department of Health Research, India; National Institutes of Health; Athens University of Economics and Business; Health and Safety Executive; University College London; British Heart Foundation; National Institute for Health and Care Research; Agency for Health Care Policy and Research; Medical Research Council; John D. and Catherine T. MacArthur Foundation","keywords":"Single-nucleotide polymorphism; SNP; Familial hypercholesterolemia; Apolipoprotein B; Genetics; PCSK9; Biology; Allele; Allele frequency; LDL receptor; Internal medicine; Medicine; Genotype; Cholesterol; Lipoprotein; Gene","score_opus":0.05691960960916297,"score_gpt":0.3526156645771,"score_spread":0.295696054967937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109770394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971012,0.00062853587,0.00020653408,0.001146892,0.000064144086,0.0007769933,0.000056875997,0.0000035162816,0.000015344007],"genre_scores_gemma":[0.9972693,0.0015433424,0.0003063853,0.00033681386,0.0003620705,0.00015471867,0.0000119439455,0.000010050996,0.000005425674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758846,0.00025763293,0.0014000623,0.00032451277,0.00029724895,0.00013211383],"domain_scores_gemma":[0.9963466,0.0019878673,0.00053035957,0.0009852243,0.00010702084,0.000042905587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042289416,0.00010499983,0.0005362009,0.000011860962,0.000042758853,0.0000055907612,0.00022194315,0.00021347312,0.000005111498],"category_scores_gemma":[0.0030582205,0.000054667078,0.00029990147,0.00011705594,0.00029291617,0.000014010872,0.000061276216,0.00038439652,1.4024391e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030282588,0.00021158792,0.9531906,0.0002505287,0.000076138516,1.0599252e-7,0.00015344674,0.000007963887,0.00031705256,0.000008519759,0.000044279957,0.045436937],"study_design_scores_gemma":[0.0027756605,0.0002728213,0.98840934,0.0002347637,0.00028233955,0.000004767347,0.0001483217,0.0005403222,0.006018246,0.0002598431,0.001004683,0.000048878566],"about_ca_topic_score_codex":0.0011764581,"about_ca_topic_score_gemma":0.00040928135,"teacher_disagreement_score":0.04538806,"about_ca_system_score_codex":0.00002225549,"about_ca_system_score_gemma":0.00013845529,"threshold_uncertainty_score":0.36611965},"labels":[],"label_agreement":null},{"id":"W2110390656","doi":"10.1002/pds.1602","title":"The safety of rosuvastatin in comparison with other statins in over 25 000 statin users in the Saskatchewan Health Databases","year":2008,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ministry of Health","funders":"Ministry of Health, Saskatchewan; AstraZeneca","keywords":"Rosuvastatin; Medicine; Rhabdomyolysis; Statin; Incidence (geometry); Internal medicine; Confidence interval; Relative risk","score_opus":0.04505512817734338,"score_gpt":0.36260470249092763,"score_spread":0.31754957431358427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110390656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97942525,0.006102818,0.0014138395,0.011009239,0.00006562111,0.0014484819,0.00020422475,0.000017012657,0.0003135214],"genre_scores_gemma":[0.985934,0.005944769,0.0016671433,0.0061884155,0.00005572417,0.00006712259,0.000075347416,0.000021332333,0.000046105746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99374115,0.0037454828,0.00122084,0.00039670637,0.00029461877,0.0006011831],"domain_scores_gemma":[0.9962697,0.0027867605,0.0003381063,0.00044474646,0.000033748165,0.0001269568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010553419,0.00023321134,0.0010052491,0.0001231618,0.00020316339,0.0000028197155,0.00015140239,0.000054029548,0.00003808033],"category_scores_gemma":[0.00033241426,0.00012761411,0.000081876824,0.00042074837,0.00044405172,0.00008967855,0.000048084486,0.0007766615,0.000001440762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028835922,0.0003000349,0.9597414,0.00019397392,0.00008653041,0.00004212692,0.013933713,0.00075962924,0.000027155804,0.00045419406,0.0020644993,0.019513166],"study_design_scores_gemma":[0.00661428,0.00019333903,0.95539355,0.00020787059,0.00002937163,0.000069787005,0.008843607,0.0014495515,0.00005473744,0.000053121286,0.026938364,0.00015243964],"about_ca_topic_score_codex":0.03921792,"about_ca_topic_score_gemma":0.04530744,"teacher_disagreement_score":0.024873864,"about_ca_system_score_codex":0.000118753,"about_ca_system_score_gemma":0.0004885605,"threshold_uncertainty_score":0.9721132},"labels":[],"label_agreement":null},{"id":"W2110406725","doi":"10.2174/138161211798220891","title":"Statin Discontinuation in High-Risk Patients: A Systematic Review of the Evidence","year":2011,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Discontinuation; Medicine; Statin; Cochrane Library; Intensive care medicine; Disease; Internal medicine; Meta-analysis; MEDLINE; Clinical trial","score_opus":0.1928732473728073,"score_gpt":0.42416716336243265,"score_spread":0.23129391598962534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110406725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006598942,0.9824871,0.0017302529,0.000023929857,0.0005143448,0.01516352,0.000040869207,0.000017849741,0.000015559397],"genre_scores_gemma":[0.00007148033,0.99828094,0.00014582853,0.0000931412,0.00009202084,0.0012200639,0.000037033642,0.000042668747,0.000016840457],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9922155,0.004228592,0.0019178385,0.00045339586,0.00084357074,0.00034108578],"domain_scores_gemma":[0.9968701,0.0005675201,0.0010858134,0.0010419548,0.00024529741,0.00018931375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042211213,0.00041662494,0.003513024,0.00012324072,0.000041535095,0.000011158195,0.00038132674,0.00013703351,0.000075251526],"category_scores_gemma":[0.004000059,0.00021689961,0.0010997067,0.0006916683,0.00009137762,0.00009486247,0.000114041955,0.00097163854,0.00005662105],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008569021,0.00019865095,0.000021801581,0.59219253,0.00012116997,0.0000010742999,0.000017200917,3.515811e-8,1.3428484e-8,0.000057446698,0.000120258046,0.40726128],"study_design_scores_gemma":[0.00055597955,0.00013445182,0.00007163441,0.9468723,0.012769581,0.000007655065,0.0000018064184,0.000016074433,0.0000024834649,0.000018601397,0.039356433,0.00019301895],"about_ca_topic_score_codex":0.000022376456,"about_ca_topic_score_gemma":5.891967e-7,"teacher_disagreement_score":0.40706825,"about_ca_system_score_codex":0.000284754,"about_ca_system_score_gemma":0.0006114162,"threshold_uncertainty_score":0.88449097},"labels":[],"label_agreement":null},{"id":"W2110938969","doi":"10.1161/circgenetics.114.000646","title":"Common Low-Density Lipoprotein Receptor p.G116S Variant Has a Large Effect on Plasma Low-Density Lipoprotein Cholesterol in Circumpolar Inuit Populations","year":2014,"lang":"en","type":"article","venue":"Circulation Cardiovascular Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Center for Research Resources; National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Circumpolar star; Lipoprotein; Cholesterol; Low-density lipoprotein; Internal medicine; LDL receptor; Plasma lipoprotein; High-density lipoprotein; Endocrinology; Biology; Genetics; Medicine; Oceanography","score_opus":0.018691905093089507,"score_gpt":0.24731384689532065,"score_spread":0.22862194180223114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110938969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717317,0.0014478135,0.0196595,0.0003033644,0.0008845726,0.0053753774,0.00005870769,0.00030346093,0.00023550051],"genre_scores_gemma":[0.9956992,0.00009700888,0.0011101954,0.0005317052,0.0015761529,0.00033336846,0.00039942627,0.00021911757,0.00003382161],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99108356,0.0021338605,0.0013472192,0.001643749,0.002564663,0.001226959],"domain_scores_gemma":[0.99449027,0.00012190842,0.00034951576,0.0039015051,0.00044051677,0.00069626106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005545551,0.00090646435,0.0023177317,0.00066917227,0.00065471156,0.00021765838,0.00038308572,0.000927986,0.00006842474],"category_scores_gemma":[0.00065269915,0.0009327134,0.0024022632,0.0011122732,0.00017904873,0.00020268816,0.00021619213,0.0012873064,0.000352578],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009141625,0.0020238396,0.10276152,0.0037365747,0.0050585074,0.00053969095,0.0029684503,0.04770306,0.013001773,0.0009865201,0.00022642378,0.82007945],"study_design_scores_gemma":[0.012082632,0.00091480074,0.9436947,0.0011938794,0.0012557104,0.00041172118,0.00007312235,0.018281559,0.014188848,0.00032963874,0.0062728766,0.001300527],"about_ca_topic_score_codex":0.0027876892,"about_ca_topic_score_gemma":0.0016634315,"teacher_disagreement_score":0.84093314,"about_ca_system_score_codex":0.0010031302,"about_ca_system_score_gemma":0.00036862574,"threshold_uncertainty_score":0.99931234},"labels":[],"label_agreement":null},{"id":"W2110947798","doi":"10.1161/circulationaha.114.012477","title":"Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":409,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Heart, Lung, and Blood Institute; Agency for Healthcare Research and Quality","keywords":"Medicine; Hazard ratio; Hyperlipidemia; Internal medicine; Confidence interval; Offspring; Statin; Framingham Risk Score; Cohort; Young adult; Cohort study; Cardiology; Disease; Endocrinology; Diabetes mellitus; Pregnancy","score_opus":0.024466378168482992,"score_gpt":0.2759108272700555,"score_spread":0.2514444491015725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110947798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968543,0.001965042,0.00031494373,0.00011495386,0.00007138474,0.0005453788,0.000010803956,0.00002995445,0.0000932301],"genre_scores_gemma":[0.99934405,0.00004384664,0.00014834164,0.0001275008,0.00021613917,0.000023301563,0.000074393196,0.00001570435,0.000006709881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988571,0.000167715,0.0002717883,0.0001891865,0.0003682767,0.00014593753],"domain_scores_gemma":[0.9990856,0.00002730336,0.00008329108,0.00038215314,0.00012993178,0.0002917079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005788254,0.00008847772,0.00027863015,0.00009458075,0.000022528026,0.0000048050006,0.000033292054,0.000067030946,0.000012053403],"category_scores_gemma":[0.0003958422,0.00008149289,0.00012696742,0.00016913968,0.00003058813,0.0001063035,0.000016955786,0.000119439086,0.000019160305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023638173,0.00013959929,0.99266475,0.00012884192,0.000028800048,0.000026789168,0.00014774383,0.00014180355,0.000102943326,0.00002922338,0.000030431529,0.0063226772],"study_design_scores_gemma":[0.0019751273,0.00008019128,0.99693257,0.00017203641,0.00013227256,0.000028845581,0.000033614953,0.00032185033,0.000033740576,0.00018450944,0.0000290799,0.00007618739],"about_ca_topic_score_codex":0.0010839395,"about_ca_topic_score_gemma":0.000021220887,"teacher_disagreement_score":0.00624649,"about_ca_system_score_codex":0.00011641838,"about_ca_system_score_gemma":0.00026296693,"threshold_uncertainty_score":0.3323184},"labels":[],"label_agreement":null},{"id":"W2111157937","doi":"10.1016/s0002-9149(02)02633-4","title":"How, when, and why to use apolipoprotein B in clinical practice","year":2002,"lang":"en","type":"review","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Royal Victoria Hospital","funders":"","keywords":"Apolipoprotein B; Medicine; Cholesterol; Soundness; Lipoprotein; Internal medicine; Statin; Clinical Practice; Coronary artery disease; Intensive care medicine; Computer science; Physical therapy","score_opus":0.08691237582598496,"score_gpt":0.38972829011420784,"score_spread":0.30281591428822285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111157937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007899482,0.98981494,0.00093899696,0.0068066358,0.00033642174,0.0010767909,0.000007256811,0.000007939443,0.00022106153],"genre_scores_gemma":[0.00036282733,0.9898556,0.0033374804,0.0032958116,0.002958603,0.000030277899,0.0000017644649,0.00005717239,0.000100461024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932709,0.003999881,0.0014338011,0.00034879576,0.00051260984,0.00043404324],"domain_scores_gemma":[0.9953659,0.001306658,0.0016747648,0.0009162564,0.0003137116,0.0004226853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056312704,0.00035923696,0.006068296,0.00036558247,0.00004607346,0.00005082117,0.00031936888,0.0002101441,0.0000033791987],"category_scores_gemma":[0.0040581194,0.0001995628,0.0016356234,0.0004557164,0.00049151125,0.00012726182,0.00013587919,0.0019233638,0.000010466301],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020620094,0.000023091414,0.0000785117,0.0005690951,0.0013806077,0.0009079987,0.00005744894,0.0000010553,1.3018365e-7,0.000024251216,0.0030319446,0.99371964],"study_design_scores_gemma":[0.0005346304,0.0023249707,0.00052277825,0.002410231,0.0026750138,0.032533266,0.00017900432,3.596549e-7,5.7413008e-8,0.000019012898,0.958628,0.00017267534],"about_ca_topic_score_codex":0.0002151209,"about_ca_topic_score_gemma":0.0000046118494,"teacher_disagreement_score":0.99354696,"about_ca_system_score_codex":0.00015279673,"about_ca_system_score_gemma":0.0004437414,"threshold_uncertainty_score":0.8356165},"labels":[],"label_agreement":null},{"id":"W2111262883","doi":"10.1016/j.bbalip.2009.08.001","title":"Absence of stearoyl-CoA desaturase-1 does not promote DSS-induced acute colitis","year":2009,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Colitis; Inflammation; Inflammatory bowel disease; Medicine; Gastroenterology; Ulcerative colitis; Internal medicine; Immunology; Feces; Disease; Biology","score_opus":0.009120542021880493,"score_gpt":0.2574881989576279,"score_spread":0.24836765693574742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111262883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959633,0.00034694895,0.0000630861,0.0017128796,0.00016136814,0.0007905648,0.0001149959,0.000049492162,0.0007973678],"genre_scores_gemma":[0.9966259,0.0007071314,0.0012746563,0.0009891572,0.00018008631,0.000016698474,0.000098964345,0.000029906585,0.000077526456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977696,0.00022148014,0.00056914013,0.00063615077,0.00032514744,0.0004785006],"domain_scores_gemma":[0.998407,0.000037592516,0.00031507836,0.0008108235,0.0001756292,0.00025384175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036283175,0.00037020672,0.0009978516,0.00015008442,0.000076696655,0.00001440387,0.00023260167,0.00036381878,0.000012052138],"category_scores_gemma":[0.000036673337,0.0002697552,0.00048910064,0.00026918392,0.0003459248,0.000059827675,0.00009490115,0.00034177824,0.000004081897],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004297017,0.00031829797,0.000015964915,0.00022563411,0.00034188526,0.000022226192,0.00020022313,1.3011854e-7,0.9921455,0.00037966593,0.000030298483,0.005890505],"study_design_scores_gemma":[0.0016376948,0.0024665452,0.009828043,0.00013012801,0.00036186332,0.000033504097,0.000056999615,0.000019068584,0.98465765,0.00026814174,0.00025244252,0.00028793918],"about_ca_topic_score_codex":0.00013861741,"about_ca_topic_score_gemma":0.0000022895704,"teacher_disagreement_score":0.009812078,"about_ca_system_score_codex":0.000026439935,"about_ca_system_score_gemma":0.00021079916,"threshold_uncertainty_score":0.99997544},"labels":[],"label_agreement":null},{"id":"W2111818022","doi":"10.1053/meta.2003.50084","title":"Disodium ascorbyl phytostanyl phosphate reduces plasma cholesterol concentrations and atherosclerotic lesion formation in apolipoprotein E-deficient mice","year":2003,"lang":"en","type":"article","venue":"Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Apolipoprotein B; Cholesterol; Lesion; Chemistry; Phosphate; Internal medicine; Endocrinology; Biochemistry; Medicine; Pathology","score_opus":0.02062915568108436,"score_gpt":0.25431611486808325,"score_spread":0.2336869591869989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111818022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99011445,0.0060867146,0.00081236317,0.00045362613,0.00025672256,0.0014693594,0.000010588368,0.00004997845,0.00074621954],"genre_scores_gemma":[0.99716043,0.001140785,0.0009434411,0.00029368702,0.00011836191,0.00014183654,0.000017447119,0.000028328086,0.00015567672],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982333,0.00018220603,0.00042372794,0.00033684584,0.00042153362,0.00040234666],"domain_scores_gemma":[0.9992661,0.000017414855,0.000117582415,0.00034340651,0.00007244646,0.00018303243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061269617,0.00020994322,0.00044436607,0.0001263578,0.00014461618,0.000057033674,0.000060286766,0.00010962566,0.000026296373],"category_scores_gemma":[0.00009996862,0.00017789679,0.00011641051,0.00030135177,0.00006931304,0.0002729409,0.000022167738,0.00023010011,0.000024973919],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008227817,0.0024169656,0.009218926,0.0019925379,0.00044102088,0.00015172825,0.0152912885,0.00068802654,0.6709529,0.022393141,0.00070294156,0.2749277],"study_design_scores_gemma":[0.013771821,0.00028599412,0.20416673,0.0006935252,0.00040734588,0.0005040257,0.0018641714,0.0017031695,0.72519207,0.0004116513,0.05028172,0.00071780547],"about_ca_topic_score_codex":0.0002316893,"about_ca_topic_score_gemma":0.000071473216,"teacher_disagreement_score":0.27420992,"about_ca_system_score_codex":0.00007926025,"about_ca_system_score_gemma":0.00008094787,"threshold_uncertainty_score":0.72544205},"labels":[],"label_agreement":null},{"id":"W2112083652","doi":"10.1016/j.ahj.2014.09.001","title":"Reducing the burden of disease and death from familial hypercholesterolemia: A call to action","year":2014,"lang":"en","type":"editorial","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institutes of Health","keywords":"Medicine; Familial hypercholesterolemia; Call to action; Summit; Disease; Public health; Population; Ethnic group; Health care; Gerontology; Action (physics); Family medicine; Environmental health; Pediatrics; Economic growth; Cholesterol; Nursing; Internal medicine","score_opus":0.01827532968643962,"score_gpt":0.30972389521220683,"score_spread":0.2914485655257672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112083652","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74338317,0.0014428134,0.00047271614,0.005221093,0.24839687,0.00089057547,0.00011311313,0.000026041702,0.000053624663],"genre_scores_gemma":[0.115876816,0.0012280558,0.00079867017,0.0005343167,0.8813272,0.000025457319,0.000031868454,0.0000568607,0.00012073396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739665,0.00034637618,0.00044426354,0.0003430379,0.0011586915,0.00031096567],"domain_scores_gemma":[0.99790347,0.0002786834,0.000256967,0.0005822259,0.00026899492,0.0007096524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091552327,0.00023809077,0.0009243666,0.00011694967,0.00017985556,0.00005483937,0.00013365339,0.0001604291,0.00001213923],"category_scores_gemma":[0.0007500243,0.00015637784,0.00036634543,0.00012630841,0.00012691255,0.00004624809,0.00007491032,0.00149151,0.000008115039],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011607616,0.000040352774,0.00071782403,0.00014898571,0.00049214397,0.00004550789,0.00073818304,0.000058804053,0.0012393885,4.3816334e-7,0.93012494,0.065232664],"study_design_scores_gemma":[0.0009725476,0.0010498186,0.012258308,0.0009018954,0.0009799819,0.00013794599,0.00042788193,0.000048096124,0.00004150123,0.000016569846,0.98296285,0.00020258706],"about_ca_topic_score_codex":0.017278584,"about_ca_topic_score_gemma":0.000026833906,"teacher_disagreement_score":0.63293034,"about_ca_system_score_codex":0.00017845888,"about_ca_system_score_gemma":0.000866084,"threshold_uncertainty_score":0.98926544},"labels":[],"label_agreement":null},{"id":"W2112121119","doi":"10.1161/atvbaha.107.141291","title":"A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease","year":2007,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Single-nucleotide polymorphism; Coronary artery disease; Odds ratio; Internal medicine; Apolipoprotein B; SNP; Lipoprotein(a); Case-control study; Confidence interval; Medicine; Allele; Biology; Gastroenterology; Endocrinology; Genotype; Genetics; Cholesterol; Gene","score_opus":0.02453749920111532,"score_gpt":0.26312463765313976,"score_spread":0.23858713845202445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112121119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578536,0.00044086316,0.00033607797,0.0014352334,0.000052199957,0.0017479899,0.000046470126,0.00003108597,0.00012470211],"genre_scores_gemma":[0.9959682,0.0005485756,0.0003127649,0.0028167225,0.00009164118,0.0001563967,0.00006698233,0.00003379404,0.000004897564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768573,0.00032985766,0.0004932247,0.0005150632,0.00040956034,0.00056654064],"domain_scores_gemma":[0.99862003,0.000074575255,0.0001714519,0.0008046088,0.000086546905,0.00024276962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017646325,0.00030144208,0.00076446007,0.00015811938,0.00015064458,0.000018326722,0.00016032858,0.00020859748,0.000052965752],"category_scores_gemma":[0.000039249902,0.00018937943,0.00033090945,0.00038428575,0.00036537106,0.00007735868,0.00006464005,0.00026892274,0.000004058055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021207271,0.0012796243,0.9637164,0.00026609757,0.0016340934,0.000019615518,0.0025440627,6.104231e-7,0.025405483,0.00063785515,0.0001588862,0.0041252063],"study_design_scores_gemma":[0.0035475625,0.0009456762,0.992978,0.0003590143,0.00028801546,0.000026760601,0.00054732995,0.000009355292,0.000097230935,0.0001775948,0.00078543695,0.00023806051],"about_ca_topic_score_codex":0.0004159294,"about_ca_topic_score_gemma":0.00021000106,"teacher_disagreement_score":0.02926157,"about_ca_system_score_codex":0.00006429545,"about_ca_system_score_gemma":0.000120977675,"threshold_uncertainty_score":0.7722669},"labels":[],"label_agreement":null},{"id":"W2112129124","doi":"10.1161/circresaha.114.304163","title":"Clearance of Plasma Proprotein Convertase Subtilisin/Kexin 9 by Low-Density Lipoprotein Apheresis","year":2014,"lang":"en","type":"letter","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Université Laval","funders":"Canadian Institutes of Health Research; Cancer Research UK","keywords":"PCSK9; Kexin; Proprotein convertase; Evolocumab; Internal medicine; Endocrinology; Lipoprotein; Apolipoprotein B; LDL receptor; Medicine; Chemistry; Cholesterol; Apolipoprotein A1","score_opus":0.05096728062989743,"score_gpt":0.3261986491800286,"score_spread":0.2752313685501312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112129124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67233455,0.0032873342,0.0014607382,0.30336803,0.0004180967,0.01353442,0.00021180809,0.00027622812,0.005108778],"genre_scores_gemma":[0.9423676,0.00019807834,0.00029879925,0.04546048,0.0042093005,0.0005868762,0.0014141183,0.00027454307,0.00519019],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907682,0.0015452988,0.0009695686,0.0011928697,0.004410719,0.0011133583],"domain_scores_gemma":[0.9948975,0.00024282461,0.00036867074,0.0023565271,0.0018043111,0.0003301654],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0042573893,0.00048485727,0.0014370108,0.0005730599,0.0003001542,0.00008808259,0.00043890125,0.0016877368,0.00060293253],"category_scores_gemma":[0.0009207916,0.00045115565,0.00066069467,0.00078021403,0.0005950122,0.00012650272,0.00014165866,0.004132727,0.0004054694],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006886398,0.00024476464,0.0009233866,0.011354768,0.00055161066,0.0005066983,0.00015732294,0.000028567696,0.0077819866,0.000045329798,0.93693227,0.04078463],"study_design_scores_gemma":[0.007473283,0.0010601277,0.021926075,0.00438734,0.00037076868,0.0002624395,0.00010791481,0.0044792304,0.063367315,0.0005649568,0.89457756,0.001423014],"about_ca_topic_score_codex":0.0072877198,"about_ca_topic_score_gemma":0.00007937598,"teacher_disagreement_score":0.27003306,"about_ca_system_score_codex":0.000418942,"about_ca_system_score_gemma":0.0009068749,"threshold_uncertainty_score":0.999794},"labels":[],"label_agreement":null},{"id":"W2112283571","doi":"10.1016/j.jacl.2015.03.005","title":"Successful reintroduction of statin therapy after statin-associated rhabdomyolysis","year":2015,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Regional Laboratory Medicine Program; McMaster University","funders":"","keywords":"Rhabdomyolysis; Medicine; Statin; Adverse effect; Incidence (geometry); Internal medicine; Intensive care medicine; Physical therapy","score_opus":0.09571902363080367,"score_gpt":0.41072969575694734,"score_spread":0.31501067212614364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112283571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891206,0.0015359037,0.00089622336,0.0047318134,0.0032831964,0.00019839656,0.0000062161703,0.000010142789,0.00021748734],"genre_scores_gemma":[0.98679477,0.0014593651,0.0036188927,0.0010212604,0.0068830606,0.0000046689993,0.0000060055063,0.000021462683,0.0001904965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954652,0.0012396139,0.002155602,0.00019420529,0.00070242194,0.00024292895],"domain_scores_gemma":[0.9958194,0.0004981283,0.001487342,0.00036603273,0.0014567815,0.00037232088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008729507,0.00013233496,0.001490066,0.00015358023,0.000020039359,0.0000067591195,0.00011998487,0.00026466156,0.00020494609],"category_scores_gemma":[0.006091945,0.000090665475,0.0007674196,0.00024378872,0.00017913738,0.000102971644,0.000027656111,0.00068198296,0.000011284926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02719589,0.0031148319,0.55146086,0.00015663338,0.0044404212,0.00016744898,0.0010236467,0.00011229582,0.00094077253,0.00013559563,0.034848075,0.37640354],"study_design_scores_gemma":[0.03383539,0.023468096,0.79409385,0.00028335553,0.0011544671,0.0007841949,0.001127524,0.00009948286,0.0015865859,0.0024265298,0.14079739,0.0003431493],"about_ca_topic_score_codex":0.00008839029,"about_ca_topic_score_gemma":0.0000197599,"teacher_disagreement_score":0.3760604,"about_ca_system_score_codex":0.0000643663,"about_ca_system_score_gemma":0.00078018516,"threshold_uncertainty_score":0.72930676},"labels":[],"label_agreement":null},{"id":"W2112345742","doi":"10.1161/atvbaha.112.250043","title":"Proprotein Convertase Subtilisin/Kexin Type 9 Interacts With Apolipoprotein B and Prevents Its Intracellular Degradation, Irrespective of the Low-Density Lipoprotein Receptor","year":2012,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Heart, Lung, and Blood Institute","keywords":"PCSK9; Kexin; Apolipoprotein B; LDL receptor; Proprotein convertase; Endocrinology; Internal medicine; Lipoprotein; Chemistry; Cholesterol; Low-density lipoprotein; Biology; Medicine","score_opus":0.024716979980259134,"score_gpt":0.2643236015072898,"score_spread":0.23960662152703066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112345742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954235,0.0011195748,0.00021306674,0.0005346047,0.00020434674,0.0024196855,0.000022071932,0.0000353455,0.000027784634],"genre_scores_gemma":[0.9972957,0.0012041737,0.0008114965,0.00026089067,0.00019407015,0.00013206775,0.00003613746,0.000044503417,0.000020977612],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976647,0.00047007197,0.0004662324,0.0005314657,0.00034421,0.000523325],"domain_scores_gemma":[0.9983475,0.00003642114,0.00027230798,0.0007736999,0.00027236424,0.0002976688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009125215,0.00035897628,0.00081067975,0.0000981923,0.00023538103,0.000029124842,0.00014072336,0.00025457228,0.00007929796],"category_scores_gemma":[0.00016809456,0.00022518921,0.00021000579,0.000288769,0.0003807299,0.00021871351,0.00018798762,0.00032703846,0.000012214225],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021475907,0.0007985126,0.19268121,0.00077169394,0.0014259359,2.6703805e-7,0.0019336028,3.2261931e-7,0.7932643,0.0007475602,0.00006852571,0.008093272],"study_design_scores_gemma":[0.0017645515,0.00092652877,0.8088011,0.0005358479,0.0003078043,0.000009825622,0.00025134822,0.000019532534,0.18640858,0.000028349064,0.00068761455,0.00025891248],"about_ca_topic_score_codex":0.0010551681,"about_ca_topic_score_gemma":0.00014823322,"teacher_disagreement_score":0.6161199,"about_ca_system_score_codex":0.00007492291,"about_ca_system_score_gemma":0.00011300461,"threshold_uncertainty_score":0.91829497},"labels":[],"label_agreement":null},{"id":"W2112878915","doi":"10.1161/01.str.0000222979.34697.bf","title":"Lipoprotein(a)","year":2006,"lang":"es","type":"review","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Lipoprotein(a); Internal medicine; Lipoprotein; Cardiology; Cholesterol","score_opus":0.02589316887847482,"score_gpt":0.3065874109795369,"score_spread":0.2806942421010621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112878915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000694952,0.9051836,0.0001920418,0.00015372214,0.0013536629,0.0035429678,0.00039630898,0.00014913797,0.08895904],"genre_scores_gemma":[0.00028183148,0.95349735,0.0005188753,0.0001715601,0.010878334,0.0004125744,0.0005417164,0.00021491553,0.033482827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99448603,0.00041376846,0.0012748643,0.0010767494,0.0015877844,0.001160826],"domain_scores_gemma":[0.99634695,0.00006973506,0.00051922136,0.0023543423,0.00020028223,0.0005094776],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012952542,0.0009873094,0.0040242663,0.00034175385,0.00023526092,0.000108552485,0.0004252298,0.0010031392,0.0007317922],"category_scores_gemma":[0.0001405393,0.00078049744,0.0033746476,0.00046687308,0.00016082713,0.00007419442,0.00017649985,0.0015005918,0.0033028158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013938984,0.00012827656,0.000041182702,0.03854583,0.0010184406,0.00027284506,0.000009318197,3.8976117e-7,0.0000030189556,0.0005404317,0.0057956683,0.9536307],"study_design_scores_gemma":[0.0010139599,0.00034622673,0.00037242682,0.015641896,0.0037233767,0.000285295,0.000016257865,0.000002694092,0.000023550128,0.000021219417,0.97791207,0.00064104825],"about_ca_topic_score_codex":0.0028081303,"about_ca_topic_score_gemma":0.000048716145,"teacher_disagreement_score":0.9721164,"about_ca_system_score_codex":0.0004458512,"about_ca_system_score_gemma":0.0014030883,"threshold_uncertainty_score":0.9994646},"labels":[],"label_agreement":null},{"id":"W2112976905","doi":"10.1016/s0828-282x(08)70179-x","title":"Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: Resolved and unresolved issues","year":2008,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Island Health; Canadian Heart Research Centre; Western University; St. Michael's Hospital; Université de Montréal; University of Toronto; University of Ottawa; Jewish General Hospital","funders":"","keywords":"Medicine; Primary prevention; Adverse effect; Statin; Intensive care medicine; Risk assessment; Rhabdomyolysis; Clinical trial; Randomized controlled trial; Psychological intervention; Diabetes mellitus; Internal medicine; Physical therapy; Disease","score_opus":0.18156359686426227,"score_gpt":0.43537539220387245,"score_spread":0.2538117953396102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112976905","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05326134,0.9452855,0.00013162062,0.00018566732,0.00013930374,0.0007836842,0.00012554122,0.000001160423,0.000086157735],"genre_scores_gemma":[0.05539372,0.9431317,0.001140256,0.000038099006,0.00020970705,0.0000070418687,0.000050092167,0.000023049703,0.000006366167],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99539393,0.0015810173,0.0021681453,0.0002573411,0.00027945742,0.00032011876],"domain_scores_gemma":[0.9969215,0.00019778362,0.0015323306,0.0003112584,0.00030573405,0.00073141704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003384988,0.00022458044,0.0046039885,0.00063591567,0.000037841626,0.0000032024273,0.00010374356,0.00036953448,0.0000029844346],"category_scores_gemma":[0.0002841876,0.00018460874,0.00055182754,0.00018421476,0.0004364139,0.00006078351,0.00003998734,0.00063790154,3.4981802e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029736426,0.000019223788,0.13203025,0.008400312,0.00087122625,0.000065342116,0.00006412803,0.0000033841084,1.8758766e-7,0.000046942005,0.00011219749,0.8583571],"study_design_scores_gemma":[0.0025970906,0.002820581,0.74827623,0.010583495,0.0006533243,0.0027492372,0.00013290822,0.0000016483709,1.3168538e-7,0.000037701324,0.23200443,0.00014323264],"about_ca_topic_score_codex":0.0030736711,"about_ca_topic_score_gemma":0.0017352243,"teacher_disagreement_score":0.85821384,"about_ca_system_score_codex":0.00021059441,"about_ca_system_score_gemma":0.009737486,"threshold_uncertainty_score":0.9958764},"labels":[],"label_agreement":null},{"id":"W2113275926","doi":"10.1093/eurheartj/ehr310","title":"Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials","year":2011,"lang":"en","type":"letter","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; C-reactive protein; Framingham Risk Score; Fibrinogen; Atorvastatin; Framingham Heart Study; Internal medicine; Prospective cohort study; Inflammation; Blood pressure; Disease","score_opus":0.046874475745108495,"score_gpt":0.29875174421468687,"score_spread":0.25187726846957836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113275926","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13487905,0.046403997,0.00021251195,0.7565381,0.0011633744,0.038272124,0.00024493865,0.00011348845,0.02217239],"genre_scores_gemma":[0.3083862,0.002209301,0.0063044894,0.61320895,0.06275658,0.0016319557,0.000109865025,0.0010324429,0.0043601952],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907457,0.005104253,0.0016458583,0.0005876079,0.0012585927,0.0006579479],"domain_scores_gemma":[0.9970105,0.00023725201,0.0010438268,0.0010126141,0.00047294563,0.00022283944],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.012299851,0.00052059937,0.0016871211,0.00028214697,0.0003856409,0.00019125782,0.0003305324,0.0002663569,0.000086587774],"category_scores_gemma":[0.0016372938,0.0002869247,0.000774449,0.00032407622,0.00015063817,0.00015770944,0.000117779724,0.0041355905,0.000023086437],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030870663,0.00041764433,0.0023584361,0.0026999484,0.002212428,0.0033113994,0.03886477,0.0000023974449,0.020965084,0.000037001693,0.9135808,0.012463039],"study_design_scores_gemma":[0.0030986634,0.0019667123,0.006459576,0.0035378619,0.00045814665,0.004727477,0.0045759194,0.000002651459,0.0008438964,0.000043154687,0.9739443,0.00034165365],"about_ca_topic_score_codex":0.0016046648,"about_ca_topic_score_gemma":0.00009101616,"teacher_disagreement_score":0.17350714,"about_ca_system_score_codex":0.00022823534,"about_ca_system_score_gemma":0.0005806741,"threshold_uncertainty_score":0.9999583},"labels":[],"label_agreement":null},{"id":"W2113485385","doi":"10.2337/db14-1059","title":"Statin-Induced Insulin Resistance Through Inflammasome Activation: Sailing Between Scylla and Charybdis","year":2014,"lang":"en","type":"letter","venue":"Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Statin; Insulin resistance; Type 2 diabetes; Internal medicine; Population; Risk factor; Clinical trial; Disease; Diabetes mellitus; Insulin; Endocrinology; Environmental health","score_opus":0.02894998339451775,"score_gpt":0.26372810683110004,"score_spread":0.23477812343658228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113485385","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7058614,0.002692047,0.000058614056,0.28797662,0.00017951067,0.0010701435,0.00005555575,0.00014530361,0.0019607937],"genre_scores_gemma":[0.2895547,0.00074977183,0.0032983737,0.666462,0.033440407,0.000333321,0.002659422,0.00034512582,0.0031569211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972276,0.00019232302,0.0005176089,0.0006784609,0.0007717014,0.00061228196],"domain_scores_gemma":[0.99822867,0.0003021758,0.00028408386,0.0008859266,0.00017307563,0.00012607555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005799098,0.0004318728,0.0011767377,0.00013375375,0.0001759302,0.000071317525,0.00014351938,0.0007715587,0.000048994018],"category_scores_gemma":[0.00026402145,0.00038259648,0.0002465999,0.00022499509,0.00008721018,0.00015514759,0.00007053297,0.0015465667,0.000047191206],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009682564,0.00007294662,0.04177163,0.02147792,0.003905863,0.00029474052,0.0020786372,0.0000010683476,0.006727832,0.00020867365,0.8099165,0.11344737],"study_design_scores_gemma":[0.0013884229,0.00016142527,0.015197378,0.0016066374,0.0003452076,0.0000026889936,0.000027849173,0.000004220923,0.013522703,0.0005349293,0.966693,0.00051553396],"about_ca_topic_score_codex":0.000072450464,"about_ca_topic_score_gemma":0.0000028045613,"teacher_disagreement_score":0.41630673,"about_ca_system_score_codex":0.00012280715,"about_ca_system_score_gemma":0.00018762065,"threshold_uncertainty_score":0.9998626},"labels":[],"label_agreement":null},{"id":"W2113799074","doi":"10.1016/j.cjca.2011.05.007","title":"Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of a Canadian Working Group Consensus Conference","year":2011,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; Robarts Clinical Trials; Université Laval; University of Toronto; McMaster University; McGill University; University of British Columbia","funders":"","keywords":"Medicine; Statin; Subspecialty; Adverse effect; Intensive care medicine; Referral; Consensus conference; Internal medicine; Family medicine","score_opus":0.043796676430726524,"score_gpt":0.2820553570697035,"score_spread":0.238258680638977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113799074","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006107718,0.9899272,0.00002280193,0.000043479184,0.00024998165,0.0012228698,0.000030441433,0.0000019254514,0.0023935824],"genre_scores_gemma":[0.04632143,0.9526193,0.0007258156,0.000022562106,0.00020305911,0.000048435842,0.0000071826457,0.00002625624,0.000025950078],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829113,0.00013758507,0.00081914826,0.00023818751,0.00014623893,0.0003676969],"domain_scores_gemma":[0.99772173,0.00006154616,0.0007090602,0.00016455316,0.00035732082,0.0009857963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010038012,0.000257176,0.0025443889,0.0010639916,0.00005526877,0.000008000746,0.00012280635,0.0002838689,0.000008200017],"category_scores_gemma":[0.000087789274,0.00021714641,0.00043912735,0.0003164699,0.00030053925,0.000028244425,0.000020097237,0.0003986344,4.088257e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021879032,0.0000034488191,0.003638388,0.04457964,0.0022462122,0.00044145668,0.00020380381,2.5435665e-7,2.5455316e-7,0.0015746607,0.0008521618,0.94643784],"study_design_scores_gemma":[0.0010748956,0.00049902755,0.013266905,0.04751485,0.0034938732,0.0023762307,0.00023036706,1.8997558e-7,0.0000014960843,0.0001023264,0.9312559,0.00018396569],"about_ca_topic_score_codex":0.03382352,"about_ca_topic_score_gemma":0.03385307,"teacher_disagreement_score":0.9462539,"about_ca_system_score_codex":0.00018415747,"about_ca_system_score_gemma":0.0022881716,"threshold_uncertainty_score":0.98377657},"labels":[],"label_agreement":null},{"id":"W2114234310","doi":"","title":"Practical use of the Framingham risk score in primary prevention: Canadian perspective.","year":2011,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Statin; Journal club; Randomized controlled trial; Framingham Risk Score; Family medicine; Primary prevention; Guideline; MEDLINE; Canadian Cardiovascular Society; Disease; Clinical trial; Physical therapy; Internal medicine; Pathology; Angina","score_opus":0.07416136381576269,"score_gpt":0.2636378059863205,"score_spread":0.18947644217055779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114234310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98249155,0.00045183106,0.0000745118,0.001288831,0.00017685005,0.0020264473,0.0000087366,0.000013724056,0.01346754],"genre_scores_gemma":[0.9980867,0.00007189768,0.0007343706,0.00029502573,0.00009555284,0.00028831928,0.000001503642,0.000011495228,0.00041513308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902296,0.00013855583,0.00016380494,0.00016005099,0.0002474969,0.00026711618],"domain_scores_gemma":[0.9991831,0.000021412707,0.00006911738,0.0004360311,0.00008839967,0.00020191725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006483811,0.00006774812,0.00018813349,0.00007978672,0.000042511365,0.0000061152255,0.00005525393,0.00007788495,0.000034808636],"category_scores_gemma":[0.00065168965,0.000046603287,0.00015163243,0.000217668,0.00006347304,0.00009512061,0.000027271191,0.00028348173,0.0000026083708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014457283,0.0003263567,0.9147227,0.00010123922,0.00022851751,0.00008675961,0.0012718892,0.000001004658,0.0000024012477,0.002430761,0.00069051277,0.07999329],"study_design_scores_gemma":[0.0004981765,0.000027982413,0.99628127,0.000029347171,0.00008833349,0.000036571404,0.00017808336,0.0000030207898,0.00011294206,0.00026042995,0.0024367964,0.00004707041],"about_ca_topic_score_codex":0.23736529,"about_ca_topic_score_gemma":0.06754323,"teacher_disagreement_score":0.16982205,"about_ca_system_score_codex":0.00038044236,"about_ca_system_score_gemma":0.0006154907,"threshold_uncertainty_score":0.94947165},"labels":[],"label_agreement":null},{"id":"W2114331323","doi":"10.1093/eurheartj/ehs168","title":"Is it important to measure or reduce C-reactive protein in people at risk of cardiovascular disease?","year":2012,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"British Heart Foundation","keywords":"Rosuvastatin; Medicine; C-reactive protein; Internal medicine; Placebo; Rosuvastatin Calcium; Statin; Disease; Cholesterol; Inflammation; Pathology","score_opus":0.05408039129696574,"score_gpt":0.2993835515236969,"score_spread":0.24530316022673115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114331323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98700786,0.008436424,0.00013721231,0.0015072727,0.00020601173,0.0011345873,0.00002476577,0.000018103585,0.0015277724],"genre_scores_gemma":[0.9959578,0.00041201708,0.00090929633,0.0004811989,0.0013924525,0.000017864179,0.000003176219,0.00007418845,0.00075202534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99620104,0.0010484768,0.00061836356,0.00029954335,0.001236142,0.00059640984],"domain_scores_gemma":[0.99755347,0.00002350367,0.00018417081,0.0008625943,0.00020489968,0.0011713913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061122915,0.00022779807,0.00072574784,0.00019597517,0.00016157878,0.000020150344,0.00012637327,0.000045765057,0.0002994076],"category_scores_gemma":[0.0006710432,0.00016283471,0.0009571199,0.00041074166,0.00003337755,0.00015827763,0.000105990504,0.00062207674,0.00016230559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004606626,0.001020893,0.93291676,0.00054282555,0.0044181095,0.0016785205,0.010061284,0.00014104898,0.0082047,0.000011017955,0.017549673,0.018848553],"study_design_scores_gemma":[0.0018983248,0.00032926892,0.8169812,0.000625125,0.0005713258,0.0015444699,0.00039389185,0.000008973774,0.0031886303,0.0000028208083,0.1742411,0.0002148696],"about_ca_topic_score_codex":0.00023177025,"about_ca_topic_score_gemma":0.00002196246,"teacher_disagreement_score":0.15669143,"about_ca_system_score_codex":0.00033403648,"about_ca_system_score_gemma":0.00036376264,"threshold_uncertainty_score":0.66402066},"labels":[],"label_agreement":null},{"id":"W2114389547","doi":"10.1016/j.ymgme.2003.11.001","title":"The c.419-420insA in the MTP gene is associated with abetalipoproteinemia among French-Canadians","year":2003,"lang":"en","type":"article","venue":"Molecular Genetics and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Chicoutimi; McGill University and Génome Québec Innovation Centre; Montreal Heart Institute; Université Laval","funders":"Université Laval","keywords":"Microsomal triglyceride transfer protein; Apolipoprotein B; Triglyceride; Haplotype; Genetics; Biology; Apolipoprotein E; Cholesterol; Gene; Internal medicine; Endocrinology; Lipoprotein; Medicine; Disease; Very low-density lipoprotein; Genotype","score_opus":0.00580174473377316,"score_gpt":0.2063785143344599,"score_spread":0.20057676960068674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114389547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538772,0.04127516,0.0004173984,0.00091885496,0.00008934667,0.0010214656,0.0000130889775,0.000012584503,0.002374891],"genre_scores_gemma":[0.99434674,0.0020495632,0.0005327291,0.0025233112,0.00008238009,0.00012254746,0.000013702181,0.00004042898,0.00028862886],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979496,0.00029478458,0.00027666707,0.00034294848,0.0006198648,0.0005161111],"domain_scores_gemma":[0.9987611,0.000028298904,0.00008610209,0.000796782,0.00011439499,0.00021330405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011401704,0.00023668876,0.00038270693,0.00007134112,0.00025432534,0.00008655127,0.00016064424,0.00013919723,0.000013553078],"category_scores_gemma":[0.00011675795,0.00013071917,0.000155685,0.00041668824,0.00017598328,0.000020668476,0.000022870521,0.00032989378,0.0000023646899],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039726653,0.002825238,0.14988476,0.00080559275,0.016092405,0.014789982,0.03423556,0.0009894778,0.09903656,0.07062317,0.011187367,0.5991326],"study_design_scores_gemma":[0.0059588393,0.00031142842,0.63888645,0.0001237683,0.0012204751,0.00045319254,0.00065460394,0.0003537356,0.021528788,0.001615073,0.3282012,0.0006924496],"about_ca_topic_score_codex":0.002598468,"about_ca_topic_score_gemma":0.0022089705,"teacher_disagreement_score":0.5984402,"about_ca_system_score_codex":0.00003259654,"about_ca_system_score_gemma":0.00023762358,"threshold_uncertainty_score":0.5330573},"labels":[],"label_agreement":null},{"id":"W2114867402","doi":"10.1177/107602960000600103","title":"State-of-the-Art-Review : Statins Induce Hypothrombotic States?","year":2000,"lang":"en","type":"review","venue":"Clinical and Applied Thrombosis/Hemostasis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Manitoba","funders":"","keywords":"Mevalonic acid; Cholesterol; Downregulation and upregulation; Chemistry; Thrombin; Squalene; HMG-CoA reductase; Terpenoid; Biochemistry; Pharmacology; Reductase; Medicine; Internal medicine; Platelet; Enzyme","score_opus":0.10955130325887133,"score_gpt":0.39635937400694976,"score_spread":0.28680807074807846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114867402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007136389,0.9906126,0.000021256688,0.00057200255,0.00031547222,0.0050475104,0.0003236217,0.00008198506,0.0023118986],"genre_scores_gemma":[0.00008630054,0.9951659,0.0006532673,0.002650728,0.0002841686,0.00032149992,0.0002821926,0.0001655353,0.00039039756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99302185,0.00058106397,0.0033285937,0.0012818625,0.0010208505,0.0007657772],"domain_scores_gemma":[0.9952999,0.00067352835,0.0011116336,0.002120697,0.00013324255,0.00066104054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020960341,0.00095094705,0.0077970712,0.00010898897,0.00021783603,0.000039559778,0.00050171645,0.00058116426,0.0004779487],"category_scores_gemma":[0.00022148612,0.0005842481,0.0026889956,0.0009767683,0.00087998214,0.00005537193,0.00034080102,0.0017655945,0.00028388374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016519978,0.0003930595,0.000020581321,0.069771506,0.0012400036,0.0000056679737,0.000025760195,2.4958518e-7,2.119306e-7,0.00005977857,0.0073838583,0.9210828],"study_design_scores_gemma":[0.0010484927,0.00024730724,0.00044967706,0.048048507,0.0076439246,0.000056807643,0.000016304843,9.309694e-7,0.00000868066,0.0002948144,0.94161993,0.00056463626],"about_ca_topic_score_codex":0.000027416727,"about_ca_topic_score_gemma":0.000007810174,"teacher_disagreement_score":0.93423605,"about_ca_system_score_codex":0.00008939715,"about_ca_system_score_gemma":0.001140068,"threshold_uncertainty_score":0.9996609},"labels":[],"label_agreement":null},{"id":"W2115199512","doi":"10.1139/y11-118","title":"Influence of atorvastatin and carboxymethylated glucan on the serum lipoprotein profile and MMP activity of mice with lipemia induced by poloxamer 407","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Poloxamer 407; Chemistry; Triglyceride; Hyperlipidemia; Very low-density lipoprotein; Endocrinology; Lipoprotein; Internal medicine; Cholesterol; Poloxamer; Biochemistry; Medicine","score_opus":0.011637446719103623,"score_gpt":0.2611647604494968,"score_spread":0.2495273137303932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115199512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962437,0.0022246542,0.0000010778696,0.0010650876,0.00006747447,0.00032781018,0.00003396504,0.0000015712859,0.000034653032],"genre_scores_gemma":[0.998974,0.00018549334,0.00003393826,0.00065996055,0.000117296106,0.000007678668,0.0000012830801,0.000010136456,0.000010196956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989768,0.00032439982,0.00021378705,0.00011771622,0.00008707176,0.00028022085],"domain_scores_gemma":[0.9989265,0.00012708621,0.00027529162,0.000100678306,0.00013967288,0.0004307273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005406076,0.00012569824,0.00045705034,0.000089627734,0.00008212337,0.000002023085,0.000058070218,0.00012917664,0.00007947371],"category_scores_gemma":[0.000043545573,0.000079655525,0.000038990787,0.00010508525,0.00042493397,0.00007109525,0.000013555141,0.0004531595,2.7750468e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049914105,0.000037807695,0.008181691,0.00019678618,0.00035650373,0.00000818701,0.00067596626,0.0000044013177,0.98627883,0.000039618517,0.00015621042,0.0035648814],"study_design_scores_gemma":[0.0014288416,0.0015001354,0.33237913,0.00006719819,0.00019942249,0.00017091786,0.000108782726,0.000008615409,0.6635763,0.000029211142,0.00045073716,0.00008067199],"about_ca_topic_score_codex":0.008480243,"about_ca_topic_score_gemma":0.0005128219,"teacher_disagreement_score":0.32419744,"about_ca_system_score_codex":0.000032432657,"about_ca_system_score_gemma":0.00059614854,"threshold_uncertainty_score":0.9981224},"labels":[],"label_agreement":null},{"id":"W2115261928","doi":"10.1016/j.jacl.2013.11.005","title":"A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy","year":2013,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Proband; Internal medicine; Endocrinology; Tangier disease; Cholesterol; Apolipoprotein B; High-density lipoprotein; Lipoprotein; Familial hypercholesterolemia; Mutation; Genetics; Gene; Biology","score_opus":0.036607715937194175,"score_gpt":0.32325980414142286,"score_spread":0.28665208820422866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115261928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893727,0.0009075891,0.000660753,0.0072329124,0.000879929,0.000746541,0.000010679622,0.000019779929,0.00016915609],"genre_scores_gemma":[0.9853387,0.0016164414,0.005468311,0.0039907168,0.0032814182,0.000018644167,0.0000071562913,0.000030008036,0.00024861647],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99656916,0.00078225834,0.0013097058,0.00032083952,0.000620709,0.00039735425],"domain_scores_gemma":[0.9969361,0.0005179323,0.00073718245,0.00044157746,0.0005688181,0.00079838885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027845455,0.00021516859,0.0013336783,0.000110126195,0.00009385844,0.00003713908,0.0001465212,0.00022191614,0.00030926758],"category_scores_gemma":[0.0010016685,0.00013539218,0.00036915467,0.00014625826,0.00047630828,0.0001513267,0.00005282729,0.00087586907,0.000012637395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016850466,0.0014994332,0.39136767,0.00033188987,0.0010552735,0.0004701577,0.00023919521,0.0000064390806,0.00022065415,0.00043616715,0.011083962,0.57643867],"study_design_scores_gemma":[0.0082813185,0.004930823,0.9781437,0.00013627135,0.00017874602,0.00034460414,0.000119080025,0.00003838417,0.000041403746,0.00095691305,0.0066710934,0.00015767303],"about_ca_topic_score_codex":0.0005771726,"about_ca_topic_score_gemma":0.000062648236,"teacher_disagreement_score":0.586776,"about_ca_system_score_codex":0.000035090758,"about_ca_system_score_gemma":0.000727718,"threshold_uncertainty_score":0.5521133},"labels":[],"label_agreement":null},{"id":"W2115598649","doi":"10.1136/hrt.2010.205781.40","title":"BAS/BSCR29 Apolipoprotein(a) impairs adaptive remodelling in human saphenous vein endothelial and smooth muscle cells","year":2010,"lang":"en","type":"article","venue":"Heart","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Medicine; Artery; Apolipoprotein B; Cardiology; Chemotaxis; Internal medicine; Wound healing; Motility; Vascular remodelling in the embryo; Vasa vasorum; Endocrinology; Cell biology; Immunology; Biology; Receptor; Cholesterol","score_opus":0.015530649477876225,"score_gpt":0.25552382367614873,"score_spread":0.2399931741982725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115598649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994666,0.0004158986,0.00035084056,0.0004662542,0.00022666398,0.0010754521,0.000013817242,0.00008237756,0.0027026897],"genre_scores_gemma":[0.99373966,0.000066372224,0.0045558163,0.00050627044,0.0007800785,0.000050757913,0.0000072055136,0.00005310474,0.00024071011],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981973,0.00008988659,0.0003262149,0.0004502467,0.0004148066,0.00052150746],"domain_scores_gemma":[0.998942,0.000029021565,0.000051991206,0.00060113706,0.00006554516,0.00031031217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089053035,0.00021466726,0.0005011387,0.00015895329,0.00016025298,0.000028257826,0.00007060955,0.00019601504,0.000103223516],"category_scores_gemma":[0.000032719094,0.00019585366,0.00017607858,0.00017071048,0.000109663175,0.00008956049,0.000050608323,0.000710205,0.00003434488],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031086258,0.00059108867,0.0035943964,0.000382898,0.000094987365,0.0002931764,0.0023073026,0.00007802047,0.9292069,0.0020977336,0.0005819572,0.060460653],"study_design_scores_gemma":[0.027867388,0.005976798,0.340278,0.0013517283,0.0005482503,0.0010203292,0.0025356926,0.01048534,0.23029824,0.005886544,0.3708161,0.0029355849],"about_ca_topic_score_codex":0.0063807596,"about_ca_topic_score_gemma":0.0010863638,"teacher_disagreement_score":0.6989087,"about_ca_system_score_codex":0.00006987169,"about_ca_system_score_gemma":0.00016090008,"threshold_uncertainty_score":0.96458423},"labels":[],"label_agreement":null},{"id":"W2115633652","doi":"10.1042/bst0320116","title":"Scavenger receptor class B type I in high-density lipoprotein metabolism, atherosclerosis and heart disease: lessons from gene-targeted mice","year":2004,"lang":"en","type":"review","venue":"Biochemical Society Transactions","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Scavenger receptor; Apolipoprotein B; Endocrinology; Knockout mouse; Internal medicine; Lipoprotein; Bone marrow; Cholesterol; Receptor; In vivo; Apolipoprotein E; Foam cell; Macrophage; Reverse cholesterol transport; Biology; Transplantation; LDL receptor; Chemistry; Medicine; Disease; In vitro; Biochemistry","score_opus":0.029578480682095155,"score_gpt":0.2886276927345357,"score_spread":0.2590492120524405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115633652","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012480203,0.98240155,0.00072799606,0.0012867664,0.00032604652,0.0017283567,0.00091500813,0.00013119425,0.0000028784611],"genre_scores_gemma":[0.0061364197,0.98559755,0.0059630517,0.0003207009,0.0005920722,0.000308727,0.0008800239,0.00012495398,0.00007650548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970707,0.00019410241,0.0006487649,0.0010054747,0.0005466535,0.0005342859],"domain_scores_gemma":[0.9982762,0.000076762284,0.00013483324,0.00074816577,0.00011514536,0.000648944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033027475,0.0005949429,0.0021589524,0.000065610075,0.00019959723,0.000042825603,0.0001478062,0.0010800746,0.00017434878],"category_scores_gemma":[0.000042164178,0.000521063,0.0018671865,0.00071106903,0.0002095208,0.00006909998,0.000026818832,0.0013467415,0.000048268394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003832553,0.0035598502,0.000038960607,0.056977578,0.00815765,0.000025399017,0.0010695062,0.000010909262,0.034992572,0.00007115038,0.0030062208,0.89170694],"study_design_scores_gemma":[0.003271915,0.00008926748,0.0041679307,0.01583075,0.008865771,0.000036661877,0.00010727253,0.0000106248,0.004064095,0.000064630854,0.96211994,0.0013711747],"about_ca_topic_score_codex":0.0032490408,"about_ca_topic_score_gemma":0.000033668435,"teacher_disagreement_score":0.95911366,"about_ca_system_score_codex":0.00056850846,"about_ca_system_score_gemma":0.0009000319,"threshold_uncertainty_score":0.9997241},"labels":[],"label_agreement":null},{"id":"W2115647563","doi":"10.1038/clpt.2014.82","title":"Pharmacogenomics, Lipid Disorders, and Treatment Options","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenomics; Clinical pharmacology; Pharmacodynamics; Pharmacology; Medicine; Bioinformatics; Pharmacogenetics; Adverse effect; Pharmacokinetics; Intensive care medicine; Biology; Gene; Genetics; Genotype","score_opus":0.15900569609211934,"score_gpt":0.4827303659860899,"score_spread":0.3237246698939706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115647563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012398743,0.9907002,0.000067277055,0.0026846149,0.0031474256,0.0028760512,0.00006682845,0.00010871379,0.0002249348],"genre_scores_gemma":[0.000011494238,0.9788252,0.0003421013,0.013927066,0.0056960057,0.00028282078,0.000168953,0.00013130104,0.0006150528],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99608815,0.0010988087,0.0012919303,0.0008108456,0.00018729418,0.0005229783],"domain_scores_gemma":[0.99785495,0.0005453529,0.00039152757,0.00062911224,0.000067268,0.00051180355],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010331634,0.00062663056,0.0035584415,0.00013654666,0.00019136607,0.000020006062,0.0001970956,0.0007854294,0.00019184093],"category_scores_gemma":[0.000010359159,0.0004525216,0.0019844233,0.00016343768,0.00048104822,0.000025377576,0.00011021301,0.0010333572,0.00019830378],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006953435,0.0006454059,0.00003330883,0.0021972707,0.006672689,0.0000137253965,0.000022446502,1.9459637e-7,0.0000015327056,0.000009892562,0.0032046519,0.98712933],"study_design_scores_gemma":[0.0033865767,0.0010942691,0.000025905694,0.0005039432,0.029908089,0.00013944489,0.000004066783,0.000044301913,0.0000011978906,0.000012981082,0.96452975,0.0003494535],"about_ca_topic_score_codex":0.000009994358,"about_ca_topic_score_gemma":0.0000046463265,"teacher_disagreement_score":0.98677987,"about_ca_system_score_codex":0.00021857096,"about_ca_system_score_gemma":0.0007272298,"threshold_uncertainty_score":0.99979264},"labels":[],"label_agreement":null},{"id":"W2115770054","doi":"10.1016/j.cjca.2014.07.152","title":"UTILITY OF A LDL CHOLESTEROL GENETIC RISK SCORE TO PREDICT RECURRENT CARDIOVASCULAR EVENTS AFTER ACUTE CORONARY SYNDROME","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Myocardial infarction; Clopidogrel; Aspirin; Cohort; Cardiology; Statin; Coronary artery disease","score_opus":0.01211461722165945,"score_gpt":0.22911104732459003,"score_spread":0.21699643010293057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115770054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98226374,0.0062383087,0.009197954,0.00019679626,0.0010240499,0.0006615561,0.00013092386,0.000007042313,0.0002796543],"genre_scores_gemma":[0.9979809,0.00044065865,0.00048104924,0.00023216757,0.0007770186,0.00002416514,0.000008074746,0.00003570647,0.000020286921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970043,0.00074674847,0.00078679004,0.00033837665,0.0005452416,0.00057858025],"domain_scores_gemma":[0.99667025,0.00003206794,0.00023888385,0.0010189888,0.00045539212,0.0015844374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018010411,0.00024768364,0.0016313017,0.00039866453,0.00007300915,0.0000078711355,0.00026479378,0.00023244102,0.000035756264],"category_scores_gemma":[0.00026941445,0.00021040933,0.0016053721,0.00022199909,0.00014852948,0.000057701756,0.000038391856,0.00054064527,0.000016175927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038539572,0.000010073228,0.89032525,0.00018491808,0.005637999,0.0013638923,0.00014787883,0.00064824073,0.000014610935,0.0000025991135,0.0010538374,0.100225314],"study_design_scores_gemma":[0.0017357387,0.0016937477,0.9362259,0.00027366614,0.0019129162,0.011470585,0.000022003378,0.00002173571,0.000024247507,0.000054765016,0.046416834,0.00014785571],"about_ca_topic_score_codex":0.0014990902,"about_ca_topic_score_gemma":0.0006494755,"teacher_disagreement_score":0.10007746,"about_ca_system_score_codex":0.0001679774,"about_ca_system_score_gemma":0.0013325561,"threshold_uncertainty_score":0.85802436},"labels":[],"label_agreement":null},{"id":"W2115913745","doi":"10.1194/jlr.m300448-jlr200","title":"Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation","year":2004,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Apolipoprotein B; Internal medicine; Endocrinology; Familial hypercholesterolemia; LDL receptor; Catabolism; Very low-density lipoprotein; Heterozygote advantage; Cholesterol; Chemistry; Lipoprotein; Null allele; Biology; Gene; Medicine; Allele; Metabolism; Biochemistry","score_opus":0.04602409882673814,"score_gpt":0.33704136648916727,"score_spread":0.29101726766242914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115913745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940008,0.0006601104,0.0000859471,0.0041294885,0.00026757468,0.0007224037,0.0000017593985,0.000005810352,0.00012611352],"genre_scores_gemma":[0.99588364,0.0004567743,0.0012759767,0.00007605661,0.0022030363,0.000016307209,0.000004454634,0.000025149935,0.000058576545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964528,0.00059749937,0.00055454887,0.0001944378,0.0018507701,0.00034993995],"domain_scores_gemma":[0.99809456,0.000088493565,0.00021153329,0.00037566994,0.0010565079,0.00017322435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067762886,0.00011353836,0.00042269795,0.00047458638,0.00011905536,0.000024162391,0.00016276685,0.00010091912,0.000012701648],"category_scores_gemma":[0.0007774064,0.000066393215,0.00015027636,0.00082234124,0.00017105213,0.00017449495,0.000033111402,0.0011111588,0.000005312775],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011112024,0.001336704,0.0428312,0.0013774817,0.00063487276,0.00051316706,0.010078023,0.003635119,0.8728512,0.000058122005,0.00067559024,0.054896478],"study_design_scores_gemma":[0.020584553,0.008659469,0.4145392,0.0039475947,0.00022411332,0.0054724272,0.0093709035,0.00006070236,0.5327315,0.0002533511,0.0038136279,0.00034260488],"about_ca_topic_score_codex":0.0017515299,"about_ca_topic_score_gemma":0.00018177253,"teacher_disagreement_score":0.37170798,"about_ca_system_score_codex":0.0005248599,"about_ca_system_score_gemma":0.0014084027,"threshold_uncertainty_score":0.48274937},"labels":[],"label_agreement":null},{"id":"W2115993317","doi":"10.1161/atvbaha.110.209064","title":"Dyslipidemia of Mothers With Familial Hypercholesterolemia Deteriorates Lipids in Adult Offspring","year":2010,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cégep de Chicoutimi","funders":"Canadian Institutes of Health Research; Canada Research Chairs; AstraZeneca Canada","keywords":"Offspring; Dyslipidemia; Apolipoprotein B; Familial hypercholesterolemia; Internal medicine; Endocrinology; Pregnancy; Cholesterol; Medicine; Fetus; Cohort; Biology; Genetics; Diabetes mellitus","score_opus":0.018573715111283598,"score_gpt":0.2692932443916603,"score_spread":0.2507195292803767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115993317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987596,0.000037987906,0.00015309271,0.00029865053,0.00015193943,0.0004342818,0.00000819478,0.00003157366,0.00012464942],"genre_scores_gemma":[0.9962937,0.0006866365,0.002328786,0.00043200457,0.00016008836,0.000056115623,0.0000113651595,0.000030208796,0.000001088373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838126,0.00014959594,0.0004362429,0.00047360323,0.00017116172,0.00038811227],"domain_scores_gemma":[0.99897224,0.00004024109,0.00010801235,0.0006035106,0.00011021784,0.00016575422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064446154,0.00024876583,0.0008303278,0.00014755256,0.00007606988,0.000016414093,0.00010970745,0.0002819731,0.000024820218],"category_scores_gemma":[0.000057464564,0.00018206613,0.00020502527,0.00020071889,0.00031934612,0.00008401428,0.0000494608,0.00043443157,0.0000035072333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015288972,0.00008003967,0.50159293,0.00009993608,0.00015902965,1.500303e-7,0.00029447125,9.518454e-7,0.49295807,0.00011680418,0.0000028433792,0.0046794834],"study_design_scores_gemma":[0.0025606852,0.0006824237,0.9921748,0.000209407,0.00012771563,0.000004324952,0.0002629785,0.00009283973,0.0033705544,0.000013637437,0.00030699247,0.00019364458],"about_ca_topic_score_codex":0.00069545594,"about_ca_topic_score_gemma":0.0007275551,"teacher_disagreement_score":0.49058187,"about_ca_system_score_codex":0.000024313738,"about_ca_system_score_gemma":0.00007047626,"threshold_uncertainty_score":0.7424441},"labels":[],"label_agreement":null},{"id":"W2116407135","doi":"10.1016/s1499-2671(11)52076-3","title":"Population-based lipid screening in the era of a childhood obesity epidemic: The importance of non-HDL cholesterol assessment","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Overweight; Obesity; Childhood obesity; Cholesterol; Population; Environmental health; Internal medicine; Lipid profile; Pediatrics; Endocrinology","score_opus":0.01895416340086608,"score_gpt":0.257064997215191,"score_spread":0.2381108338143249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116407135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969855,0.0011106908,0.000120643635,0.0011827354,0.0000787055,0.00034181017,0.000012222052,0.0000012350762,0.00016649133],"genre_scores_gemma":[0.99738306,0.000008757293,0.0011519943,0.0012567886,0.00017620917,0.0000061214487,0.000004465607,0.000011363157,0.0000012135971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985358,0.00018880307,0.0006097508,0.0000911112,0.000321172,0.0002533265],"domain_scores_gemma":[0.9986636,0.00009499225,0.00047086948,0.00038457641,0.00016002163,0.00022595645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002384954,0.00010381615,0.00047292607,0.00013367574,0.00007040883,0.000008290786,0.00023849405,0.000059337974,0.000037071397],"category_scores_gemma":[0.00019185338,0.000060384453,0.00026739028,0.0002300675,0.000065260894,0.00007434926,0.000006002172,0.00046394172,2.5831653e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000026278135,0.00005141268,0.98996973,0.000058569705,0.00010298214,0.000006840831,0.0006233977,0.00004339456,0.000019806745,0.000021472753,0.000043741842,0.009055996],"study_design_scores_gemma":[0.0008461236,0.00022294339,0.9973554,0.0005373482,0.00012896494,0.0000098651035,0.00029912672,0.00012734665,0.00029366877,0.0000744361,0.000051544717,0.00005321034],"about_ca_topic_score_codex":0.010378675,"about_ca_topic_score_gemma":0.015646275,"teacher_disagreement_score":0.009002785,"about_ca_system_score_codex":0.00006145368,"about_ca_system_score_gemma":0.0011112489,"threshold_uncertainty_score":0.9962113},"labels":[],"label_agreement":null},{"id":"W2116646125","doi":"10.1177/1741826711400545","title":"Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada","year":2011,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ldl cholesterol; Statin; Primary care; Internal medicine; Cholesterol; Clinical Practice; Physical therapy; Intensive care medicine; Pediatrics; Family medicine","score_opus":0.019220850133135146,"score_gpt":0.26058875239820684,"score_spread":0.24136790226507168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116646125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632734,0.0011596234,0.000019965304,0.000087164146,0.00022425942,0.00034939384,0.000012776339,0.0000016215689,0.0018178358],"genre_scores_gemma":[0.99773353,0.0016798789,0.00024240329,0.00018181499,0.000113914444,0.0000018817492,0.0000048988577,0.000016654254,0.000025021602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994513,0.0036628696,0.0011465903,0.00020143454,0.00025814594,0.0002179633],"domain_scores_gemma":[0.9987673,0.00013743885,0.00045945088,0.00014909945,0.0003339569,0.00015273475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041457647,0.00013605783,0.00072262884,0.00017470132,0.00001442586,0.000003890336,0.00007876081,0.00003742233,0.000003531165],"category_scores_gemma":[0.0009860091,0.00011028279,0.00012209355,0.00011762336,0.0001262497,0.0001120351,0.00009465345,0.00046217506,3.2580675e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008174941,0.00021475663,0.9870004,0.00008010188,0.00038480735,0.0012680045,0.0018763081,0.0000112802945,0.000013448216,0.0000042687975,0.00008276816,0.008246368],"study_design_scores_gemma":[0.0051697236,0.0024601195,0.98777634,0.00027633188,0.00015377998,0.0002883776,0.0018261643,0.0000017431408,0.000017274384,0.0000012176658,0.0019530662,0.000075886106],"about_ca_topic_score_codex":0.017901657,"about_ca_topic_score_gemma":0.007480054,"teacher_disagreement_score":0.010421603,"about_ca_system_score_codex":0.000089059344,"about_ca_system_score_gemma":0.00025669456,"threshold_uncertainty_score":0.9886382},"labels":[],"label_agreement":null},{"id":"W2116732628","doi":"10.2337/diacare.24.1.45","title":"How Cost-Effective Is the Treatment of Dyslipidemia in Patients With Diabetes but Without Cardiovascular Disease?","year":2001,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Dyslipidemia; Simvastatin; Diabetes mellitus; Myocardial infarction; Internal medicine; Disease; Life expectancy; Cost effectiveness; Endocrinology; Environmental health; Population","score_opus":0.008390766646319395,"score_gpt":0.22301857150096105,"score_spread":0.21462780485464167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116732628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97867644,0.015019941,0.000008728161,0.0002848417,0.00009210634,0.0055973744,0.00014786342,0.000034695902,0.00013800764],"genre_scores_gemma":[0.99746007,0.0002224202,0.000043925753,0.0002503528,0.00020719833,0.0015524613,0.00015634026,0.000050756833,0.000056470893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784315,0.00020195181,0.00021504563,0.00046400196,0.000755706,0.00052017625],"domain_scores_gemma":[0.99808,0.00007148042,0.000085439715,0.0012204025,0.0003066613,0.00023602572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017827725,0.0003154483,0.00092610234,0.00010396389,0.00008577571,0.00002611966,0.00010996537,0.00009435653,0.00000842187],"category_scores_gemma":[0.00006111687,0.0001787067,0.00073570217,0.00034995723,0.00012986957,0.000091019625,0.000024539058,0.00013981233,0.000007768489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001012661,0.00020586805,0.85426193,0.0002444738,0.0014509257,0.000008543848,0.0005703739,0.000037904898,0.000009148267,0.0000018767291,0.00002442716,0.14308327],"study_design_scores_gemma":[0.0054650884,0.0012651219,0.96301764,0.0002887103,0.0012297702,1.8143592e-7,0.000635806,0.00004174716,0.0016725959,0.00000545763,0.026187647,0.00019021425],"about_ca_topic_score_codex":0.00006130191,"about_ca_topic_score_gemma":0.000019354908,"teacher_disagreement_score":0.14289306,"about_ca_system_score_codex":0.00035961065,"about_ca_system_score_gemma":0.00009843548,"threshold_uncertainty_score":0.72874475},"labels":[],"label_agreement":null},{"id":"W2117011155","doi":"10.1172/jci29383","title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and inlivers of parabiotic mice","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":671,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; University of Texas Southwestern Medical Center","keywords":"PCSK9; Kexin; LDL receptor; Proprotein convertase; Endocytosis; Biology; Receptor; Cell biology; Endocytic cycle; Internal medicine; Endocrinology; Molecular biology; Cholesterol; Lipoprotein; Biochemistry","score_opus":0.04176156610301236,"score_gpt":0.34578452085656836,"score_spread":0.304022954753556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117011155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746245,0.0007184354,0.000038714275,0.0013664099,0.00010755903,0.00017301121,0.0000011724297,0.0000024589638,0.00012978016],"genre_scores_gemma":[0.9974335,0.000401345,0.0016295088,0.0002432788,0.00026314845,9.10934e-7,0.000003324459,0.0000065400964,0.000018474944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794567,0.00034780242,0.0011684092,0.000085820524,0.00036617808,0.00008614802],"domain_scores_gemma":[0.9981226,0.0005257188,0.0008303314,0.00013413126,0.00026548497,0.00012177905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024631484,0.00007126543,0.00052603305,0.000058786485,0.000018045968,0.000005037036,0.000057592988,0.000113249196,0.00001956654],"category_scores_gemma":[0.001485622,0.000044767025,0.00022760376,0.00018803221,0.00031014692,0.00009312202,0.0000139062595,0.00028372984,9.801355e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002601145,0.000104211314,0.99224275,0.00015182172,0.000095468415,0.000010724641,0.00010416839,0.000034117056,0.00080346974,0.00022406016,0.00042105548,0.005548032],"study_design_scores_gemma":[0.0025228155,0.00039342398,0.98559624,0.00061456655,0.00024651305,0.00012080179,0.00023775971,0.00037956677,0.0073220264,0.0017993101,0.0007081747,0.00005879043],"about_ca_topic_score_codex":0.000860102,"about_ca_topic_score_gemma":0.000054698397,"teacher_disagreement_score":0.0066465056,"about_ca_system_score_codex":0.000023125625,"about_ca_system_score_gemma":0.00027998912,"threshold_uncertainty_score":0.18255462},"labels":[],"label_agreement":null},{"id":"W2117173168","doi":"10.1093/eurheartj/ehu492","title":"Frontiers in lipid research","year":2015,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myocardial infarction; Internal medicine; Cardiology; Cholesterol","score_opus":0.16541118968849539,"score_gpt":0.38457776109978986,"score_spread":0.21916657141129448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117173168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8799577,0.006192989,0.00082547934,0.00841294,0.0016887313,0.00041461876,8.398892e-7,0.00004389453,0.10246283],"genre_scores_gemma":[0.9841899,0.00038739017,0.0075263935,0.0009598276,0.004816902,0.000001972309,0.0000017111566,0.00005286674,0.002062989],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971414,0.0012054063,0.00023218238,0.00015014053,0.0008623728,0.00040849627],"domain_scores_gemma":[0.99880075,0.000013323384,0.000025491196,0.00030101725,0.0002242323,0.00063516735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010894927,0.000073970536,0.0002360759,0.0003087796,0.000102719365,0.00005255358,0.00009479844,0.00002796507,0.00004117168],"category_scores_gemma":[0.00040447825,0.000058243753,0.00013038618,0.00033515098,0.000053574397,0.000085078886,0.000052245206,0.0010729476,0.0003449389],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030483428,0.0001614078,0.20772088,0.000041936186,0.00006830219,0.0029041604,0.0010689169,0.000021550206,0.00021578518,0.000036710193,0.72471285,0.06274266],"study_design_scores_gemma":[0.0022009166,0.00044439413,0.20004377,0.00014711429,0.000008745634,0.0034639875,0.00073057093,0.00003713974,0.000067420224,0.00007921398,0.79270405,0.00007270956],"about_ca_topic_score_codex":0.000023748287,"about_ca_topic_score_gemma":0.0000019537415,"teacher_disagreement_score":0.10423227,"about_ca_system_score_codex":0.00019472682,"about_ca_system_score_gemma":0.00038548282,"threshold_uncertainty_score":0.46614832},"labels":[],"label_agreement":null},{"id":"W2117184830","doi":"10.1161/circoutcomes.8.suppl_2.338","title":"Abstract 338: Patterns of Lipid Lowering Medication Use among Patients with Atherosclerotic Cardiovascular Disease","year":2015,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Discontinuation; Atherosclerotic cardiovascular disease; Internal medicine; Cohort; Canadian Cardiovascular Society; Retrospective cohort study; Combination therapy; Disease; Cardiovascular health; Cohort study; Physical therapy; Myocardial infarction; Angina","score_opus":0.058670238637512334,"score_gpt":0.28129444287657496,"score_spread":0.22262420423906262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117184830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800014,0.0024945806,0.015597606,0.000093385715,0.00022449491,0.0013843292,0.00004508743,0.00009617342,0.00006296016],"genre_scores_gemma":[0.9989551,0.00020971609,0.00018618924,0.000119735196,0.00018846648,0.00006183185,0.00020618529,0.000058753154,0.000014046535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99545395,0.0003087107,0.00075841584,0.00066756783,0.0024529716,0.00035839996],"domain_scores_gemma":[0.99651766,0.00008264395,0.00023205404,0.0018375467,0.00061070046,0.00071937236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028248185,0.00035162942,0.001384648,0.00016958351,0.00012200572,0.0000591723,0.00011004807,0.00017272322,0.000014840431],"category_scores_gemma":[0.0006183331,0.00028127985,0.0018043008,0.00023083761,0.00015777476,0.00049882877,0.00006430135,0.00023656787,0.000005686252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010820225,0.0001495942,0.9775645,0.0007683325,0.0055662734,0.000015156685,0.0002499367,0.0031429399,0.000004856878,0.000059109898,0.0000037543632,0.012367358],"study_design_scores_gemma":[0.0052107316,0.000051855495,0.9910458,0.00026753842,0.001855382,0.000006182896,0.00012981826,0.00007431326,0.000034724922,0.000024076464,0.0009696316,0.00032999358],"about_ca_topic_score_codex":0.0014906253,"about_ca_topic_score_gemma":0.0000119966,"teacher_disagreement_score":0.018953694,"about_ca_system_score_codex":0.00016371049,"about_ca_system_score_gemma":0.00019833446,"threshold_uncertainty_score":0.99996394},"labels":[],"label_agreement":null},{"id":"W2117216433","doi":"10.1185/030079905x59102","title":"Statins and LDL‐cholesterol lowering: an overview","year":2005,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Society of Cardiology; University of Waterloo; Merck KGaA","keywords":"Medicine; Ldl cholesterol; Cholesterol; Cholesterol lowering; Ezetimibe; Pharmacology; Atorvastatin; Statin; Internal medicine","score_opus":0.4106502170329484,"score_gpt":0.5698913529223524,"score_spread":0.15924113588940397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117216433","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007416317,0.9973798,0.00004968795,0.00037458623,0.00041788872,0.0015014155,0.000030850133,0.000025914896,0.00014572994],"genre_scores_gemma":[0.000020784886,0.99648327,0.000036393198,0.000048746155,0.0027548033,0.00017000764,0.0003742765,0.00004718186,0.00006451053],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99483925,0.0005520947,0.000590163,0.000732124,0.0025652868,0.0007210521],"domain_scores_gemma":[0.9966877,0.00022915729,0.00008185736,0.00059817545,0.0001652088,0.0022379088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040976596,0.00032983336,0.001543142,0.00030400185,0.00018095272,0.00008682888,0.00020194358,0.00041615072,0.00027236147],"category_scores_gemma":[0.0009027829,0.0002235218,0.00024450617,0.00033062795,0.0003629225,0.000106673535,0.00031330687,0.0022005176,0.000053308897],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013840602,0.00019565334,0.000008617588,0.04120529,0.00006331667,0.000020503725,0.00003545636,1.3731476e-9,2.0450804e-8,0.00018863729,0.0007237546,0.9575449],"study_design_scores_gemma":[0.0007913074,0.00074857636,0.00012855373,0.048659418,0.00008254467,0.00026095365,0.000015358599,0.000014561228,1.1681865e-7,0.00003490875,0.94909036,0.000173317],"about_ca_topic_score_codex":0.00006040617,"about_ca_topic_score_gemma":0.000016505242,"teacher_disagreement_score":0.9573716,"about_ca_system_score_codex":0.00013111791,"about_ca_system_score_gemma":0.0014954244,"threshold_uncertainty_score":0.9560276},"labels":[],"label_agreement":null},{"id":"W2117248462","doi":"10.1016/j.amjmed.2006.02.007","title":"Clinical Perspectives of Statin-Induced Rhabdomyolysis","year":2006,"lang":"en","type":"review","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":242,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Rhabdomyolysis; Medicine; Statin; Hyperlipidemia; Hypertriglyceridemia; Myopathy; Internal medicine; Incidence (geometry); Intensive care medicine; Cholesterol; Diabetes mellitus; Endocrinology; Triglyceride","score_opus":0.06690634831753256,"score_gpt":0.43004118104905403,"score_spread":0.3631348327315215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117248462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029968552,0.9935,0.00023643978,0.001766211,0.00028852726,0.0005443733,0.000006508821,0.000008609053,0.0006524942],"genre_scores_gemma":[0.002408324,0.99171627,0.0007126212,0.00023629391,0.0047196387,0.000006204619,0.000006047774,0.00005941378,0.00013521036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993978,0.0014029476,0.0027012627,0.0002552838,0.0013720458,0.0002904157],"domain_scores_gemma":[0.99216133,0.0008391443,0.0051024635,0.00094007887,0.00066148833,0.000295474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064215977,0.0003756127,0.0075446405,0.00040080003,0.000053404863,0.0000041520893,0.00044480723,0.00010531598,0.0000730174],"category_scores_gemma":[0.0010554802,0.00016785681,0.0024751618,0.00095029804,0.0014531675,0.00002981841,0.00005021505,0.0014712656,0.0000054987113],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001416033,0.0001414995,0.000025819063,0.0023123096,0.0023799322,0.00013272148,0.00032715758,2.1645234e-7,0.0000020617233,0.00002690776,0.0015651231,0.99294466],"study_design_scores_gemma":[0.0024887568,0.009158901,0.00073661545,0.026092293,0.017154092,0.0039905845,0.005105516,0.0000011719864,0.0000013009819,0.000040940635,0.9350142,0.00021562353],"about_ca_topic_score_codex":0.00040258747,"about_ca_topic_score_gemma":0.0000028888003,"teacher_disagreement_score":0.992729,"about_ca_system_score_codex":0.00015888191,"about_ca_system_score_gemma":0.0013006084,"threshold_uncertainty_score":0.6845002},"labels":[],"label_agreement":null},{"id":"W2117276735","doi":"10.1016/s0140-6736(07)60084-1","title":"Are lipid-lowering guidelines evidence-based?","year":2007,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Coronary heart disease; Primary prevention; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Coronary disease; Disease; Internal medicine; Physical therapy; Gerontology","score_opus":0.14558027595613016,"score_gpt":0.36992762195351653,"score_spread":0.22434734599738637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117276735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91621387,0.0135722635,0.008068345,0.057738196,0.0006104181,0.0005630547,0.0000043466152,0.00021160107,0.0030179264],"genre_scores_gemma":[0.9681871,0.0005130709,0.001787201,0.01891663,0.010202826,0.000011721416,0.0000019649667,0.000019583134,0.00035989672],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894804,0.000027296346,0.00021072078,0.00014526269,0.00036189982,0.00030679585],"domain_scores_gemma":[0.99878126,0.000073493335,0.000080500395,0.00083637453,0.00013880685,0.00008958681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025110082,0.00009009341,0.0003467657,0.00003086368,0.00008397299,0.000015506264,0.00014777115,0.000046201807,0.000061240804],"category_scores_gemma":[0.0006628271,0.0000516706,0.00014749354,0.00015181923,0.000035227138,0.00004070185,0.000029647308,0.00017385959,0.00006367895],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002280382,0.00016883029,0.22767644,0.001937003,0.0005074227,0.0007311027,0.00055495027,0.00041483773,0.0073897955,0.00067903573,0.22325492,0.5344053],"study_design_scores_gemma":[0.0019165345,0.00012295108,0.34785044,0.0018686248,0.00013098153,0.00011210613,0.00018264391,0.00019887406,0.008285775,0.000079544676,0.63907164,0.00017986116],"about_ca_topic_score_codex":0.0001342411,"about_ca_topic_score_gemma":0.000052128904,"teacher_disagreement_score":0.5342254,"about_ca_system_score_codex":0.00004568076,"about_ca_system_score_gemma":0.0000627063,"threshold_uncertainty_score":0.21070658},"labels":[],"label_agreement":null},{"id":"W2117326539","doi":"10.1161/atvbaha.107.144980","title":"Apolipoprotein A-V Genetic Variation and Plasma Lipoprotein Response to Fibrates","year":2007,"lang":"en","type":"letter","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Ontario Genomics; Ontario Genomics Institute; Genome Canada; Heart and Stroke Foundation of Canada","keywords":"Apolipoprotein B; Lipoprotein(a); Apolipoprotein C2; Genetic variation; Lipoprotein; Plasma lipoprotein; Variation (astronomy); Genetics; Internal medicine; Biology; Medicine; Cholesterol; Very low-density lipoprotein; Gene","score_opus":0.0283865065477484,"score_gpt":0.2802764421957543,"score_spread":0.25188993564800594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117326539","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8192749,0.00061907875,0.0013517241,0.17562322,0.00029004997,0.0025787717,0.00008552804,0.00012680642,0.000049884406],"genre_scores_gemma":[0.36442453,0.008177387,0.017246375,0.601443,0.006607822,0.0010123076,0.00051974604,0.00040164686,0.00016715996],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99566525,0.0007182588,0.0007664584,0.0013862964,0.0004901681,0.0009735624],"domain_scores_gemma":[0.9977852,0.00015522359,0.00022253304,0.0012408745,0.00017379233,0.00042234757],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001561981,0.0007314501,0.0015773425,0.000547519,0.00030406352,0.00012626898,0.00018358215,0.001724684,0.00010183863],"category_scores_gemma":[0.00019002795,0.0006339205,0.00046513992,0.00035623123,0.00026190485,0.000077135905,0.00025324436,0.0010451755,0.00006641825],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091970654,0.00068745477,0.029633837,0.0058470606,0.011413579,0.000061138366,0.0053206375,0.000006538975,0.6884871,0.00018562718,0.17529215,0.08214518],"study_design_scores_gemma":[0.0015413875,0.0016055689,0.71991163,0.00040415916,0.0005072682,0.00002338976,0.000027869371,0.00003233539,0.00039408135,0.000046535788,0.2749238,0.00058195385],"about_ca_topic_score_codex":0.0016794002,"about_ca_topic_score_gemma":0.00006513729,"teacher_disagreement_score":0.6902778,"about_ca_system_score_codex":0.00013124157,"about_ca_system_score_gemma":0.00016429152,"threshold_uncertainty_score":0.9996112},"labels":[],"label_agreement":null},{"id":"W2117341106","doi":"10.1002/iub.299","title":"Rare genetic causes of autosomal dominant or recessive hypercholesterolaemia","year":2010,"lang":"en","type":"review","venue":"IUBMB Life","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Tellabs (Canada)","funders":"","keywords":"PCSK9; LDL receptor; Kexin; Proprotein convertase; LRP1B; Apolipoprotein B; Receptor; Endocrinology; Internal medicine; Familial hypercholesterolemia; Biology; Cholesterol; Mutation; Lipoprotein; Gene; Genetics; Medicine","score_opus":0.05205450004841808,"score_gpt":0.34573652191927184,"score_spread":0.2936820218708538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117341106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024307035,0.99419194,0.000022194532,0.00006514552,0.00069745845,0.0020269323,0.00010645979,0.000048232665,0.0004109308],"genre_scores_gemma":[0.00020296666,0.99536246,0.001062927,0.0002457549,0.001834673,0.00027358817,0.0000828386,0.00012788268,0.0008068922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996925,0.00025716767,0.001078177,0.00058087177,0.00069818704,0.00046061963],"domain_scores_gemma":[0.99716175,0.00012313819,0.0005566641,0.001473526,0.00017817639,0.0005067477],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004520019,0.00051762024,0.0036334784,0.0002123934,0.00007104848,0.000023597995,0.00030563108,0.0008640788,0.0002034225],"category_scores_gemma":[0.00062863814,0.00031292296,0.0011909262,0.00034531765,0.00013537526,0.00004896612,0.00012623041,0.0010657663,0.000100526835],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056192926,0.000081819104,0.000053808093,0.04049824,0.00042844785,0.00034976023,0.000054208354,8.465844e-8,0.000008306212,0.000007194876,0.0005488342,0.9579131],"study_design_scores_gemma":[0.0009523108,0.0002733271,0.0005052949,0.018696742,0.0029403786,0.001515312,0.000019107225,5.822006e-7,0.000041158328,0.0000025076054,0.9747434,0.00030985326],"about_ca_topic_score_codex":0.000105520194,"about_ca_topic_score_gemma":0.00003979177,"teacher_disagreement_score":0.9741946,"about_ca_system_score_codex":0.000108549706,"about_ca_system_score_gemma":0.0032931482,"threshold_uncertainty_score":0.9999323},"labels":[],"label_agreement":null},{"id":"W2117385776","doi":"10.1016/j.jvs.2008.04.057","title":"Suboptimal use of statin therapy in elderly patients with atherosclerosis: A population-based study","year":2008,"lang":"en","type":"article","venue":"Journal of Vascular Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; St. Michael's Hospital; Toronto General Hospital; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Statin; Coronary artery disease; Internal medicine; Population; Adverse effect; Disease","score_opus":0.037737452187129254,"score_gpt":0.2490222753366739,"score_spread":0.21128482314954464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117385776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854285,0.00045307737,0.00027689245,0.000033020464,0.000080444486,0.0006015649,0.0000034547027,0.000007194952,0.0000014964346],"genre_scores_gemma":[0.99831295,0.00023969018,0.001231922,0.000091970694,0.00006780073,0.000010128764,0.000008848493,0.0000331158,0.000003545819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972452,0.00030646575,0.0008483817,0.00015414933,0.0012305974,0.0002152201],"domain_scores_gemma":[0.9982999,0.00016663311,0.0005016601,0.00037941834,0.00051577366,0.00013660421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001249125,0.00016236685,0.0009037932,0.0004022527,0.0000484601,0.000010963675,0.000057273322,0.00006327002,0.0000244281],"category_scores_gemma":[0.00017148301,0.0001103177,0.0005902738,0.00041382082,0.000026754053,0.00020361238,0.000006769831,0.00023914354,6.2820146e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078304106,0.002187767,0.98927873,0.00004410331,0.00046968347,0.000096078504,0.00029016277,0.0007345087,0.000030443802,2.725016e-7,0.000033244847,0.006051952],"study_design_scores_gemma":[0.0059435354,0.0020381156,0.9911948,0.0003079377,0.000093796305,0.000018092496,0.00008336682,0.000026415079,0.00009336283,8.0697436e-7,0.000093036055,0.00010673903],"about_ca_topic_score_codex":0.0008367634,"about_ca_topic_score_gemma":0.00004219009,"teacher_disagreement_score":0.005945213,"about_ca_system_score_codex":0.000089970184,"about_ca_system_score_gemma":0.00045350732,"threshold_uncertainty_score":0.4498625},"labels":[],"label_agreement":null},{"id":"W2117423403","doi":"10.1212/01.wnl.0000208403.18885.0e","title":"Statin treatment and adherence to national cholesterol guidelines after ischemic stroke","year":2006,"lang":"en","type":"article","venue":"Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Statin; Guideline; National Cholesterol Education Program; Internal medicine; Stroke (engine); Cholesterol; Cohort; Physical therapy; Univariate analysis; Coronary artery disease; Multivariate analysis; Pathology; Metabolic syndrome","score_opus":0.028345198644833473,"score_gpt":0.3093173626940967,"score_spread":0.28097216404926323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117423403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99305266,0.00039956594,0.00011589438,0.0047331206,0.00006525985,0.00031628163,0.000021890646,0.000022993618,0.0012723309],"genre_scores_gemma":[0.98984885,0.000042806216,0.00083958625,0.007955527,0.0004090302,0.00013068835,0.000012096845,0.0000108961995,0.00075050216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926436,0.000031077412,0.00016867153,0.0002261306,0.00015419541,0.0001555854],"domain_scores_gemma":[0.9996315,0.000015875657,0.00002280783,0.00014680508,0.000105120744,0.0000778602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092696646,0.00008968755,0.00017538546,0.0000491499,0.000021586395,0.000006337393,0.00002216636,0.000055773635,0.00004857098],"category_scores_gemma":[0.000028077222,0.00006971868,0.00004989352,0.000040372677,0.00002315114,0.000018912779,0.00001836274,0.00006493331,0.000033215376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005329731,0.0010907635,0.48131555,0.00027218656,0.00042484072,0.00065704354,0.00051219907,0.00029839177,0.07024466,0.0004878044,0.048311014,0.39105582],"study_design_scores_gemma":[0.0034191445,0.0052264524,0.60316926,0.000013057308,0.000069483904,0.0005144807,0.0000050211374,0.00012961795,0.0027974609,0.00006819413,0.3844545,0.00013336792],"about_ca_topic_score_codex":0.0008120401,"about_ca_topic_score_gemma":0.00028856666,"teacher_disagreement_score":0.39092246,"about_ca_system_score_codex":0.000018800623,"about_ca_system_score_gemma":0.00006649836,"threshold_uncertainty_score":0.2843045},"labels":[],"label_agreement":null},{"id":"W2117518342","doi":"10.1016/j.jcjd.2012.07.045","title":"Rosuvastatin Drug Levels in Non-Daily Rosuvastatin Regimen","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Medicine; Dosing; Tolerability; Regimen; Drug; Pharmacology; Statin; Internal medicine; Adverse effect","score_opus":0.014446614675502602,"score_gpt":0.2432869717330872,"score_spread":0.2288403570575846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117518342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99020064,0.006313056,0.00003349998,0.0014625163,0.0004306814,0.0002384265,0.00002231556,0.0000045687207,0.0012943215],"genre_scores_gemma":[0.9965044,0.000015736567,0.0014580463,0.0008910062,0.0007600078,0.000006837471,0.0000046209934,0.000034508997,0.00032480768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811685,0.00010912901,0.0005222957,0.00011618846,0.0003370928,0.00079842395],"domain_scores_gemma":[0.9977501,0.000058151414,0.0002009904,0.0002726417,0.00017220914,0.0015458808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018075965,0.00016043145,0.00054489914,0.00044339933,0.00007163732,0.000033352586,0.00013131104,0.00007373601,0.00019784184],"category_scores_gemma":[0.00025614232,0.00013815798,0.00023350678,0.00031026514,0.0000680464,0.00026804753,0.000009320848,0.00041570727,0.000032011354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000075336416,0.00006286317,0.9332548,0.00019865535,0.00021095149,0.000114271505,0.0038145082,0.000019506571,0.00071625586,0.0000824424,0.011691492,0.049826715],"study_design_scores_gemma":[0.0019114382,0.00016733051,0.97993696,0.0004579249,0.0000856294,0.00005346029,0.0008831023,0.00002011504,0.0021009722,0.000101926336,0.014101593,0.00017955354],"about_ca_topic_score_codex":0.0023294059,"about_ca_topic_score_gemma":0.0049581616,"teacher_disagreement_score":0.04964716,"about_ca_system_score_codex":0.0003228598,"about_ca_system_score_gemma":0.0015287236,"threshold_uncertainty_score":0.56339186},"labels":[],"label_agreement":null},{"id":"W2117628687","doi":"10.1345/aph.1h394","title":"Clopidogrel-Precipitated Rhabdomyolysis in a Stable Heart Transplant Patient","year":2007,"lang":"en","type":"article","venue":"Annals of Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University of Alberta","funders":"","keywords":"Clopidogrel; Medicine; Rhabdomyolysis; Atorvastatin; Internal medicine; Loading dose; Creatine kinase; Myopathy; Cardiology; Gastroenterology; Anesthesia; Pharmacology; Aspirin","score_opus":0.04213127585444113,"score_gpt":0.3632283509999171,"score_spread":0.321097075145476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117628687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898492,0.0060175024,0.00040187204,0.0018589917,0.00011873484,0.000640992,0.000018440083,0.000036693782,0.0010575907],"genre_scores_gemma":[0.98974025,0.004648504,0.000454497,0.004890449,0.00012761333,0.000020356605,0.0000133860685,0.000028660403,0.000076279815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827003,0.00008402216,0.0005071673,0.00023366536,0.00045972524,0.0004453925],"domain_scores_gemma":[0.9992491,0.000043123837,0.00008178387,0.00028253952,0.00014010999,0.00020332052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012201713,0.00015357556,0.0004967143,0.00023992703,0.000030446465,0.00000497472,0.000067149565,0.00007337629,0.00031686132],"category_scores_gemma":[0.0000083918885,0.00013029137,0.00032330974,0.00047178246,0.00003986958,0.00007071,0.000006169971,0.00018487134,0.000011013189],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004624922,0.0015745008,0.033363692,0.00038871448,0.0008997889,0.00024298197,0.0037354985,0.00006766803,0.5772963,0.00007364281,0.004657234,0.37307504],"study_design_scores_gemma":[0.0034345265,0.0006336278,0.028126037,0.00017754154,0.000045100107,0.000037310318,0.0001046597,0.00005408447,0.8861566,0.000048562542,0.08101773,0.00016421489],"about_ca_topic_score_codex":0.0007464356,"about_ca_topic_score_gemma":0.00004239497,"teacher_disagreement_score":0.3729108,"about_ca_system_score_codex":0.000024795492,"about_ca_system_score_gemma":0.00009094255,"threshold_uncertainty_score":0.5313128},"labels":[],"label_agreement":null},{"id":"W2117730865","doi":"10.1016/j.jacl.2014.11.008","title":"Familial hypercholesterolemia mutations in the Middle Eastern and North African region: A need for a national registry","year":2014,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Saint Joseph University","keywords":"Medicine; Middle East; Mendelian inheritance; Disease; Familial hypercholesterolemia; Environmental health; Demography; Internal medicine; Genetics; Geography; Gene","score_opus":0.2850544005155663,"score_gpt":0.44188718749210476,"score_spread":0.15683278697653846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117730865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056732697,0.98538196,0.0006310718,0.003732716,0.0021902947,0.001668274,0.00003014354,0.000007922886,0.0006843469],"genre_scores_gemma":[0.0029598952,0.9747919,0.0009712988,0.0021351168,0.018761102,0.00008736685,0.000042504984,0.000036208643,0.00021462106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952138,0.0013368098,0.0024379343,0.00027576822,0.0004946027,0.0002410876],"domain_scores_gemma":[0.994741,0.002778294,0.0015252361,0.0003657825,0.00038625958,0.00020341025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005569454,0.00022693172,0.0029562328,0.00017691136,0.000056016193,0.000020909638,0.00027940376,0.0005250128,0.000003485429],"category_scores_gemma":[0.0039851223,0.00013024244,0.0015166854,0.00020260578,0.00023847824,0.000042884963,0.000039592367,0.0014428056,0.000003824927],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042614498,0.0002706954,0.0014773571,0.007720776,0.0005596956,0.00006126112,0.00018913085,0.0000012170874,2.2577966e-8,0.00018028036,0.0042541353,0.9848593],"study_design_scores_gemma":[0.002538872,0.0011871392,0.003363974,0.0028684812,0.0010696749,0.004899219,0.00011489566,0.000011558189,2.9289426e-9,0.00018996821,0.9836505,0.000105727835],"about_ca_topic_score_codex":0.000008175206,"about_ca_topic_score_gemma":0.000096030635,"teacher_disagreement_score":0.98475355,"about_ca_system_score_codex":0.000062342,"about_ca_system_score_gemma":0.0013894514,"threshold_uncertainty_score":0.6268352},"labels":[],"label_agreement":null},{"id":"W2117752747","doi":"10.1016/j.jacc.2012.01.078","title":"Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism","year":2012,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Fondation pour la Recherche Médicale; Academy of Finland; European Commission; National Institute for Health and Care Research; British Heart Foundation; Wellcome Trust; National Institute of Neurological Disorders and Stroke; American Heart Association","keywords":"Medicine; Coronary atherosclerosis; Venous thromboembolism; Apolipoprotein B; Cardiology; Internal medicine; Genetic variants; Coronary heart disease; Genetics; Thrombosis; Gene; Genotype; Cholesterol","score_opus":0.04115519755526842,"score_gpt":0.27820034052928405,"score_spread":0.23704514297401563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117752747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2680336,0.72885567,0.0001329642,0.00009689201,0.0002843351,0.0022097589,0.000304462,0.000016379248,0.000065958775],"genre_scores_gemma":[0.37606606,0.62243754,0.00043003034,0.00007279549,0.0007730062,0.000041959906,0.0000034726463,0.00010952663,0.00006560363],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99517643,0.001584223,0.0012079887,0.00040312487,0.0009912326,0.000636984],"domain_scores_gemma":[0.9942157,0.0002561754,0.003643325,0.0010676645,0.00048464432,0.00033244805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013477424,0.00061949674,0.0075770947,0.00022585651,0.00014343279,0.0000115600515,0.0005485172,0.00031337695,0.0000043649698],"category_scores_gemma":[0.00014264262,0.00032612373,0.001141441,0.00066550175,0.0011513898,0.00006826349,0.00015577876,0.0009967871,0.0000025601134],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029371371,0.0007918399,0.016174063,0.04552735,0.090061195,0.0034608068,0.0008484296,0.0005290165,0.0016647732,0.00015670415,0.00030667117,0.837542],"study_design_scores_gemma":[0.010005572,0.025256485,0.29813996,0.12456224,0.086361006,0.39063087,0.0011478045,0.000017916236,0.000047549827,0.000047054305,0.061479248,0.0023042988],"about_ca_topic_score_codex":0.0001694072,"about_ca_topic_score_gemma":0.000005647523,"teacher_disagreement_score":0.83523774,"about_ca_system_score_codex":0.00053381594,"about_ca_system_score_gemma":0.0018852621,"threshold_uncertainty_score":0.99991906},"labels":[],"label_agreement":null},{"id":"W2117848894","doi":"10.1161/01.cir.0000143892.84582.60","title":"Effect of Pravastatin on Cardiovascular Events in People With Chronic Kidney Disease","year":2004,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":384,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Pravastatin; Kidney disease; Disease; Intensive care medicine; Cardiology; Internal medicine; Cholesterol","score_opus":0.013563920760864646,"score_gpt":0.2914310505143405,"score_spread":0.27786712975347583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117848894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039743357,0.99036294,0.00035622757,0.0000110463,0.000102289836,0.0050508888,0.000027391283,0.000031088442,0.00008376906],"genre_scores_gemma":[0.07076939,0.92743254,0.000023116485,0.000013458898,0.0002699625,0.00050420046,0.0008784985,0.00009710226,0.000011720362],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99713826,0.0005805747,0.0005239527,0.0005306953,0.0009456414,0.00028086812],"domain_scores_gemma":[0.99822706,0.000057286623,0.00024625356,0.0011049303,0.00006186228,0.000302603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011843212,0.000391116,0.0024339557,0.00031133127,0.00003490629,0.000004874061,0.00008266242,0.00020490085,0.000018402507],"category_scores_gemma":[0.00020702681,0.0002753138,0.0015318098,0.00060253975,0.000025201038,0.00004967083,0.000018808978,0.00036221292,0.000029268112],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115637915,0.00009148877,0.002550888,0.19106503,0.0011337907,0.000068503,0.000027398823,0.0010602816,2.3803202e-7,0.000024397536,0.0000032423054,0.8038591],"study_design_scores_gemma":[0.017743753,0.00291458,0.11754975,0.4544971,0.027399559,0.00029272115,0.000004840601,0.00014977845,0.0000161501,0.00003233596,0.3780443,0.0013551479],"about_ca_topic_score_codex":0.00027567096,"about_ca_topic_score_gemma":0.00001158054,"teacher_disagreement_score":0.80250394,"about_ca_system_score_codex":0.0012293642,"about_ca_system_score_gemma":0.0025352347,"threshold_uncertainty_score":0.9999699},"labels":[],"label_agreement":null},{"id":"W2117860932","doi":"10.1161/atvbaha.107.143644","title":"Summary of the American Heart Association’s Scientific Statement on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents","year":2007,"lang":"en","type":"editorial","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Family medicine; Pediatrics; Asymptomatic; Internal medicine","score_opus":0.011072406695924568,"score_gpt":0.26868790019741384,"score_spread":0.25761549350148927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117860932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656529,0.0005314489,0.000002609057,0.0001529121,0.03236686,0.0008627215,0.00041643446,0.000010578141,0.000003579743],"genre_scores_gemma":[0.9386563,0.042679146,0.00005002427,0.00016008169,0.018199781,0.000033088243,0.00017971931,0.000034354085,0.0000075224707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678665,0.0007160928,0.00072519935,0.00058533245,0.0007840599,0.00040266936],"domain_scores_gemma":[0.9981169,0.00016557825,0.0006735673,0.0007209192,0.00022588632,0.00009716823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032829188,0.00031300238,0.0014687274,0.00023876163,0.0001570313,0.00002986103,0.00015972072,0.0003077211,0.000006034629],"category_scores_gemma":[0.00015153116,0.00021416222,0.0004328051,0.00029283547,0.00053995586,0.00003941822,0.00013249496,0.00054284395,8.804411e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038095506,0.00032371748,0.95290005,0.00016165426,0.0010328395,1.8576916e-8,0.0004373063,7.376939e-7,0.00091086945,0.000008022973,0.042632602,0.0015540863],"study_design_scores_gemma":[0.002256764,0.00063731184,0.97814995,0.0006897635,0.0001881111,1.299553e-7,0.00012441071,8.8551815e-7,0.00029452163,0.000009880654,0.017470432,0.00017781697],"about_ca_topic_score_codex":0.011627959,"about_ca_topic_score_gemma":0.00055112055,"teacher_disagreement_score":0.042147696,"about_ca_system_score_codex":0.00016859337,"about_ca_system_score_gemma":0.00019573212,"threshold_uncertainty_score":0.9949537},"labels":[],"label_agreement":null},{"id":"W2118152092","doi":"10.1002/hep.22911","title":"PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression #","year":2009,"lang":"en","type":"article","venue":"Hepatology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"CD81; LDL receptor; PCSK9; Scavenger receptor; Hepatitis C virus; Biology; Hepatocyte; Receptor; Virology; Lipoprotein; Virus; Cholesterol; In vitro; Endocrinology; Biochemistry","score_opus":0.011744251400392659,"score_gpt":0.2563861944610229,"score_spread":0.24464194306063025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118152092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956579,0.0028444016,0.00030758607,0.00032084738,0.00008909832,0.00028891972,0.0000022927923,0.00005274938,0.00043617375],"genre_scores_gemma":[0.99256134,0.006191938,0.00045903618,0.0005968454,0.00011336501,0.000018861587,0.00001469809,0.000009484852,0.0000344166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991209,0.00009953123,0.00018663726,0.00024113154,0.000120771554,0.00023103361],"domain_scores_gemma":[0.99958974,0.00002059439,0.00003955212,0.00022006893,0.000033120377,0.00009689403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017635683,0.00011087981,0.00034884503,0.00013153485,0.000053165095,0.0000073912634,0.000021726071,0.0001667115,0.000039036237],"category_scores_gemma":[0.00005053574,0.00009444172,0.00007478801,0.000109380046,0.000038344737,0.00007109781,0.000021280004,0.00016875891,0.000014262773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028718662,0.00015123643,0.698016,0.00010472035,0.000027302747,0.0003497677,0.00024430352,0.0000021804863,0.11471816,0.00011971065,0.0001569535,0.1858225],"study_design_scores_gemma":[0.0015273417,0.00041688525,0.8403581,0.00007582237,0.00004283014,0.0007934061,0.000007341414,0.002089103,0.1501656,0.0005784644,0.0037944315,0.00015066756],"about_ca_topic_score_codex":0.01075383,"about_ca_topic_score_gemma":0.0011614311,"teacher_disagreement_score":0.18567184,"about_ca_system_score_codex":0.0000553367,"about_ca_system_score_gemma":0.000041067753,"threshold_uncertainty_score":0.99583364},"labels":[],"label_agreement":null},{"id":"W2118158038","doi":"10.1177/1074248407299839","title":"Lipid-Lowering Therapy and Outcomes in Heart Failure","year":2007,"lang":"en","type":"article","venue":"Journal of Cardiovascular Pharmacology and Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Hospital and Health Sciences Centre; University of British Columbia; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"","keywords":"Medicine; Heart failure; Dyslipidemia; Internal medicine; Cardiology; Hazard ratio; Coronary artery disease; Diabetes mellitus; Concomitant; Stenosis; Myocardial infarction; Confidence interval; Disease; Endocrinology","score_opus":0.021738335565247763,"score_gpt":0.31398682746413464,"score_spread":0.2922484918988869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118158038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9195808,0.07682911,0.0010590918,0.001702759,0.0004391073,0.0003054734,6.415369e-7,0.000010181888,0.000072800896],"genre_scores_gemma":[0.9746003,0.021390578,0.0011003271,0.0022378506,0.00063115597,0.0000028474058,3.7384928e-7,0.000023095285,0.000013434087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985212,0.00014349395,0.000458894,0.00016725517,0.0004012837,0.00030784795],"domain_scores_gemma":[0.99929565,0.000088515706,0.000098623284,0.00018942512,0.00013885922,0.00018893249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033949672,0.00017626616,0.0009142588,0.00024911412,0.000067764704,0.000014189096,0.00006191487,0.00017236035,0.000013437374],"category_scores_gemma":[0.000012602763,0.000129964,0.00065869145,0.00015700274,0.00010858322,0.000100956815,0.000027726654,0.0005639562,7.8635867e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022727023,0.00067267596,0.2878713,0.00032466793,0.029887093,0.0016374547,0.0013717011,0.00015720067,0.031609725,0.00011015082,0.00023431086,0.643851],"study_design_scores_gemma":[0.015747434,0.0009817873,0.3613255,0.0000841187,0.0017631731,0.005835752,0.00037671684,0.000026015516,0.020691818,0.00011597871,0.5927717,0.00027998307],"about_ca_topic_score_codex":0.00001297194,"about_ca_topic_score_gemma":0.0000037166214,"teacher_disagreement_score":0.643571,"about_ca_system_score_codex":0.000048006143,"about_ca_system_score_gemma":0.00009505792,"threshold_uncertainty_score":0.5299778},"labels":[],"label_agreement":null},{"id":"W2118242699","doi":"10.1161/atvbaha.115.306032","title":"PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver","year":2015,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Institut de Cardiologie de Montréal; Université du Québec à Montréal","keywords":"CD36; PCSK9; Triglyceride; Endocrinology; Internal medicine; LDL receptor; Fatty acid; Biology; Lipoprotein; Proprotein convertase; Kexin; Scavenger receptor; Fatty acid metabolism; Lipid metabolism; Chemistry; Biochemistry; Cholesterol; Receptor; Medicine","score_opus":0.048568761305577184,"score_gpt":0.279089592920953,"score_spread":0.2305208316153758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118242699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886714,0.010009486,0.00012319606,0.00037644504,0.00006933543,0.0006959092,0.000010743686,0.00002603414,0.000017430211],"genre_scores_gemma":[0.97525024,0.023486104,0.0007218766,0.00033603478,0.00007555683,0.000076176744,0.000026947362,0.000024390642,0.0000026859043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825144,0.00031983183,0.00032258648,0.0005857594,0.00015391922,0.00036646865],"domain_scores_gemma":[0.99924916,0.00004513746,0.0000805053,0.00029673023,0.0000441948,0.0002842963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010957336,0.00027429312,0.0008398636,0.0002390046,0.00007977634,0.000052424843,0.000049059716,0.0002709891,0.00000605374],"category_scores_gemma":[0.00010196565,0.00022229805,0.00008271512,0.00018690046,0.00023700898,0.00018473671,0.00011596091,0.00021359055,0.0000014237584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085880994,0.00025754617,0.7354767,0.0003371112,0.0004959747,0.0000037281231,0.0022930112,0.0000011183515,0.21810658,0.00034596425,0.000023664408,0.04257274],"study_design_scores_gemma":[0.004522269,0.00037616826,0.9903595,0.00012383118,0.00015176565,0.000012626444,0.00033655323,0.00013657559,0.0032455022,0.000044661807,0.00046163675,0.00022894933],"about_ca_topic_score_codex":0.0010771897,"about_ca_topic_score_gemma":0.0012119891,"teacher_disagreement_score":0.25488278,"about_ca_system_score_codex":0.00003987433,"about_ca_system_score_gemma":0.000049344482,"threshold_uncertainty_score":0.90650517},"labels":[],"label_agreement":null},{"id":"W2118243287","doi":"10.1503/cmaj.1041403","title":"Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect","year":2005,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Arthritis Society; McGill University","keywords":"Atorvastatin; Pravastatin; Medicine; Fluvastatin; Statin; Hazard ratio; Myocardial infarction; Simvastatin; Internal medicine; Lovastatin; Proportional hazards model; Retrospective cohort study; Confidence interval; Cholesterol","score_opus":0.006923060561124125,"score_gpt":0.2843781653171143,"score_spread":0.27745510475599017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118243287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972982,0.00016315251,0.00022544074,0.0005474452,0.0003546014,0.0011477475,0.000057286474,0.0000037360055,0.00020239523],"genre_scores_gemma":[0.9987722,0.00003110725,0.00014999713,0.00023173519,0.0005846531,0.000114439696,0.00009253617,0.000013394501,0.000009906678],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960601,0.0012084398,0.0005296672,0.00014226949,0.0018050533,0.00025452132],"domain_scores_gemma":[0.9978146,0.00014276919,0.00026877047,0.00012037676,0.0011371996,0.00051626615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010845926,0.00009746728,0.00040675144,0.0002504681,0.00005445795,0.000011354898,0.000057210415,0.00028267837,0.00031583302],"category_scores_gemma":[0.00112067,0.00008879404,0.0002427455,0.00018504327,0.000021457936,0.00020226178,0.000005046389,0.00040687624,0.000002352604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052019896,0.00016195327,0.24571799,0.000232482,0.000628144,0.0000069761145,0.00026597976,0.00005232581,0.000055950957,0.000013922182,0.00027092034,0.75207317],"study_design_scores_gemma":[0.011706465,0.0018202468,0.98102754,0.00034593677,0.00041601248,0.000024253359,0.000043861124,0.0007361121,0.0003156674,0.000101404556,0.0033785638,0.00008390349],"about_ca_topic_score_codex":0.00086523884,"about_ca_topic_score_gemma":0.008372474,"teacher_disagreement_score":0.75198925,"about_ca_system_score_codex":0.0016214779,"about_ca_system_score_gemma":0.003970042,"threshold_uncertainty_score":0.70426834},"labels":[],"label_agreement":null},{"id":"W2118416292","doi":"10.1016/s1474-4422(05)70248-9","title":"Cholesterol in Alzheimer's disease","year":2005,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":328,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pathogenesis; Disease; Alzheimer's disease; Dementia; Cholesterol; Amyloid beta; Medicine; Amyloid (mycology); Lipid metabolism; Amyloid precursor protein; Biochemistry of Alzheimer's disease; Neuroscience; Bioinformatics; Biology; Internal medicine; Pathology","score_opus":0.09434395617123283,"score_gpt":0.3676350615179319,"score_spread":0.2732911053466991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118416292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001196107,0.99147165,0.0000013267355,0.005855149,0.00024171882,0.0014159377,0.000018063638,0.000051808067,0.00082472485],"genre_scores_gemma":[0.00019949085,0.9868716,0.0000071476206,0.008766658,0.0037586926,0.00025748284,0.000042406395,0.00005680814,0.00003968946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793047,0.0006012544,0.00038801343,0.000396166,0.00021417774,0.0004699251],"domain_scores_gemma":[0.99822545,0.00007920955,0.00012738309,0.0013949667,0.000014433448,0.000158582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005778554,0.00028087743,0.0021971143,0.00010521618,0.000036025034,0.000009448597,0.00031084334,0.00022280941,0.000051429513],"category_scores_gemma":[0.000046444457,0.00015970091,0.0005381929,0.00019274978,0.000084594816,0.000018685278,0.000100101184,0.0011362219,0.00023851384],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060170267,0.00003781714,0.000065022934,0.0015857404,0.00015724763,0.00019829949,0.000009771589,0.0000018201183,5.4947455e-9,0.00006507476,0.00079591124,0.9970231],"study_design_scores_gemma":[0.0006798808,0.00009062707,0.002402191,0.00081498787,0.0015246018,0.0004907736,3.2567524e-7,0.0000063265916,1.8543433e-8,0.00001558287,0.99386144,0.00011325166],"about_ca_topic_score_codex":0.000040437844,"about_ca_topic_score_gemma":0.000030253193,"teacher_disagreement_score":0.99690986,"about_ca_system_score_codex":0.000021337171,"about_ca_system_score_gemma":0.00027148883,"threshold_uncertainty_score":0.6512414},"labels":[],"label_agreement":null},{"id":"W2118459143","doi":"","title":"WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE).","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":289,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Blood pressure; Stroke (engine); Myocardial infarction; Diabetes mellitus; Aspirin; Internal medicine; Cross-sectional study; Blood sugar","score_opus":0.026287391478797793,"score_gpt":0.2730137696494265,"score_spread":0.24672637817062867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118459143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941612,0.0006125951,0.000029502811,0.00019383681,0.00009212009,0.0016080077,0.0000062852346,0.000012127625,0.0032843093],"genre_scores_gemma":[0.998748,0.00023527846,0.00004213406,0.000026164078,0.0002942582,0.0002786084,0.0000031075201,0.000006371458,0.00036609144],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989743,0.000092104085,0.0002472372,0.00015935286,0.00039031493,0.0001366932],"domain_scores_gemma":[0.99949485,0.00001605979,0.000104960935,0.00023355513,0.00007037248,0.00008019267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081565935,0.00007284205,0.0003191863,0.00008918278,0.000023696817,0.0000042892984,0.000032214473,0.000047659905,0.000006492875],"category_scores_gemma":[0.0000895767,0.000059876525,0.00012051755,0.00010037938,0.000034664863,0.000058936614,0.000018562987,0.00009133341,6.040235e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022351305,0.0003334247,0.061720077,0.000103568775,0.0002645749,5.9238306e-7,0.00033560133,0.000009676658,0.000056101886,0.00003128241,0.000095397045,0.93682617],"study_design_scores_gemma":[0.0018616003,0.00052856654,0.99325544,0.000048930724,0.0001825249,0.0000034963755,0.00026934984,0.0000141606415,0.0017366013,0.000017767126,0.002032775,0.000048782935],"about_ca_topic_score_codex":0.00008566565,"about_ca_topic_score_gemma":0.000018843704,"teacher_disagreement_score":0.9367774,"about_ca_system_score_codex":0.000032629,"about_ca_system_score_gemma":0.000032231277,"threshold_uncertainty_score":0.24416938},"labels":[],"label_agreement":null},{"id":"W2118584914","doi":"10.1016/j.cjca.2010.12.010","title":"Use of a Treatment Optimization Algorithm Involving Statin-Ezetimibe Combination Aids in Achievement of Guideline-Based Low-Density Lipoprotein Targets in Patients With Dyslipidemia at High Vascular Risk Guideline-Based Undertaking to Improve Dyslipidemia Management in Canada (GUIDANC)","year":2011,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Canadian Heart Research Centre; University of Toronto","funders":"","keywords":"Medicine; Ezetimibe; Guideline; Statin; Dyslipidemia; Internal medicine; Algorithm; Physical therapy; Intensive care medicine; Disease; Pathology","score_opus":0.014033732269530315,"score_gpt":0.21528516190711297,"score_spread":0.20125142963758266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118584914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89944065,0.00019837801,0.09791594,0.0001582722,0.00027863996,0.0019009134,0.00008156275,0.0000039251295,0.000021742855],"genre_scores_gemma":[0.8998193,0.000026763373,0.09945873,0.00040392106,0.000070694034,0.00004846472,0.00012825437,0.000040740975,0.000003090464],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99541855,0.0007280595,0.0022413922,0.00041728097,0.0005881584,0.0006065895],"domain_scores_gemma":[0.9968452,0.00008820048,0.0009868304,0.0005832476,0.0009687839,0.0005277771],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022671001,0.0003474544,0.0014917669,0.001165588,0.000056934645,0.0000069894268,0.00017407247,0.00017786857,0.000017372246],"category_scores_gemma":[0.0003911234,0.00030405706,0.00024369943,0.0006194693,0.00006676909,0.00011012158,0.00003180179,0.00032602955,2.738976e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00057819,0.00006499806,0.45372224,0.00012308182,0.0004353933,0.00018226102,0.00014177509,0.5178074,0.000022149117,0.000012884194,0.00011952726,0.026790056],"study_design_scores_gemma":[0.017281124,0.0032164187,0.9478557,0.00086047733,0.0004407914,0.000004856967,0.0003185616,0.027764237,0.0013699462,0.000028929766,0.00046537034,0.00039357523],"about_ca_topic_score_codex":0.90190375,"about_ca_topic_score_gemma":0.8622822,"teacher_disagreement_score":0.49413347,"about_ca_system_score_codex":0.008082292,"about_ca_system_score_gemma":0.0057400125,"threshold_uncertainty_score":0.9999412},"labels":[],"label_agreement":null},{"id":"W2118667643","doi":"10.1001/jama.287.24.3215","title":"Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention&lt;SUBTITLE&gt;A Randomized Controlled Trial&lt;/SUBTITLE&gt;","year":2002,"lang":"en","type":"article","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":714,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novartis Pharma","keywords":"Medicine; Mace; Conventional PCI; Fluvastatin; Percutaneous coronary intervention; Myocardial infarction; Placebo; Internal medicine; Randomized controlled trial; Cardiology; Angina; Surgery; Simvastatin","score_opus":0.013767579806589261,"score_gpt":0.2682617631400416,"score_spread":0.2544941833334523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118667643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96587294,0.009798386,0.0021804636,0.0007613253,0.001784554,0.015435049,0.000062046085,0.00010353513,0.0040016836],"genre_scores_gemma":[0.98710316,0.00084293116,0.0010929876,0.00008787333,0.00078338216,0.0014700884,0.00013461923,0.00007183909,0.008413126],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99627566,0.00065697485,0.0013434908,0.0004519884,0.0008488918,0.00042299266],"domain_scores_gemma":[0.9978085,0.0005957225,0.0005137922,0.0006079303,0.00028689,0.00018713338],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031287961,0.0003194149,0.002710797,0.0001920126,0.0001695106,0.00003619298,0.00016229616,0.00024321691,0.0009358364],"category_scores_gemma":[0.0015925628,0.00025499944,0.0047870316,0.00019489187,0.000061584346,0.00016514576,0.00005274884,0.00020799619,0.000063179104],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8600018,0.0015649267,0.00025410915,0.0015448069,0.007132721,0.00012396766,0.0007754622,0.000024319113,0.0022128678,0.00026032055,0.0062661036,0.119838566],"study_design_scores_gemma":[0.98097104,0.0012702409,0.00043756448,0.0008593804,0.002748685,0.00009725746,0.00012274706,0.001685485,0.0004805541,0.000263167,0.010777335,0.00028655076],"about_ca_topic_score_codex":0.00012605355,"about_ca_topic_score_gemma":0.000053581447,"teacher_disagreement_score":0.120969206,"about_ca_system_score_codex":0.00016747863,"about_ca_system_score_gemma":0.00007881318,"threshold_uncertainty_score":0.9999902},"labels":[],"label_agreement":null},{"id":"W2118882750","doi":"10.1161/atvbaha.115.306442","title":"Nonstatin Low-Density Lipoprotein–Lowering Therapy and Cardiovascular Risk Reduction—Statement From <i>ATVB</i> Council","year":2015,"lang":"en","type":"review","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Western University","funders":"National Heart, Lung, and Blood Institute; National Institute of Dental and Craniofacial Research; Canadian Institutes of Health Research","keywords":"Ezetimibe; PCSK9; Niacin; Statin; Medicine; Cholesterol; Bile acid; Internal medicine; Familial hypercholesterolemia; Clinical trial; LDL receptor; Endocrinology; Bioinformatics; Lipoprotein; Pharmacology; Biology","score_opus":0.1300980820685477,"score_gpt":0.31956369866344736,"score_spread":0.18946561659489966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118882750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06559678,0.9298517,0.00035917136,0.000053746488,0.00057345885,0.0030450064,0.00030482293,0.00013467298,0.0000806241],"genre_scores_gemma":[0.0050969445,0.9916977,0.0011016647,0.00013530412,0.00088018976,0.000548984,0.00037168415,0.00016188105,0.0000055899254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99403673,0.0010533518,0.0012621342,0.0018649289,0.0009908557,0.00079196825],"domain_scores_gemma":[0.99623954,0.00007283243,0.0005097966,0.0020781644,0.00047539384,0.0006242619],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039670854,0.0010864851,0.005423347,0.00017091479,0.00044270334,0.0001348712,0.00022058107,0.00089370547,0.00006268933],"category_scores_gemma":[0.00011013161,0.0008301196,0.0023500158,0.00033289444,0.00046439265,0.00013213251,0.0003109433,0.000842364,0.0000419574],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012560569,0.00020286001,0.00032089284,0.002940172,0.012795198,0.0000022860625,0.0004332595,5.297319e-7,0.00012923813,0.000013578561,0.0003433228,0.9828061],"study_design_scores_gemma":[0.0031213872,0.00069844397,0.01586659,0.0048562842,0.006821068,0.00003722401,0.00017705421,0.0000068863314,0.000014882825,0.00005731454,0.9673639,0.0009789416],"about_ca_topic_score_codex":0.0069495696,"about_ca_topic_score_gemma":0.000097482516,"teacher_disagreement_score":0.98182714,"about_ca_system_score_codex":0.00047156322,"about_ca_system_score_gemma":0.00090241816,"threshold_uncertainty_score":0.99966323},"labels":[],"label_agreement":null},{"id":"W2119028588","doi":"10.1017/s1047951102000240","title":"Impact of the characteristics of patients and their clinical management on outcomes in children with homozygous familial hypercholesterolemia","year":2002,"lang":"en","type":"article","venue":"Cardiology in the Young","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Plasmapheresis; Familial hypercholesterolemia; Internal medicine; Lipoprotein; Cholesterol; Aorta; Cardiology; Pediatrics; Immunology","score_opus":0.0169002406677176,"score_gpt":0.27546040631657015,"score_spread":0.25856016564885254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119028588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984975,0.00011095864,0.0000045756997,0.00006822184,0.00007824735,0.00078240555,0.000034726087,0.0000032924138,0.0004200998],"genre_scores_gemma":[0.99935853,0.00035561252,0.000009397735,0.00017336506,0.00005919575,0.000019298719,0.000007220181,0.000009119952,0.000008260108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987998,0.00036877167,0.0003419172,0.00016687498,0.0001591677,0.00016349215],"domain_scores_gemma":[0.99925834,0.000059184837,0.00009766163,0.0005274178,0.000029492623,0.000027874989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064904086,0.00012069658,0.0006251979,0.00005586274,0.000021961492,0.0000023556051,0.00013821459,0.00009412074,0.0000012894086],"category_scores_gemma":[0.000052314394,0.00005032514,0.00024338468,0.000102189944,0.0001895448,0.0000132757295,0.000051525287,0.0002864106,7.376684e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107395696,0.00013327286,0.9905055,0.000017288297,0.00040984782,0.000030135327,0.00030086146,0.000007915014,0.000002492782,0.000009472252,0.000015195003,0.008460581],"study_design_scores_gemma":[0.0023998613,0.0006892308,0.99639267,0.000045923232,0.000091085705,0.00022753382,0.00008290199,0.000007764563,0.0000023183793,0.000009105114,0.000004458099,0.000047159134],"about_ca_topic_score_codex":0.00007361425,"about_ca_topic_score_gemma":0.0000062655777,"teacher_disagreement_score":0.008413422,"about_ca_system_score_codex":0.00003957846,"about_ca_system_score_gemma":0.000013206643,"threshold_uncertainty_score":0.20521995},"labels":[],"label_agreement":null},{"id":"W2119276496","doi":"10.1016/j.atherosclerosis.2015.09.021","title":"Familial hypercholesterolaemia: A global call to arms","year":2015,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Apolipoprotein B; LDL receptor; Internal medicine; Coronary artery disease; Familial hypercholesterolemia; Population; Disease; PCSK9; Cholesterol; Bioinformatics; Lipoprotein; Endocrinology; Biology","score_opus":0.05242052260115248,"score_gpt":0.29714267136992706,"score_spread":0.24472214876877457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119276496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910506,0.0002020395,0.0012379002,0.0028731255,0.00035009504,0.0006223388,0.00002461209,0.00014413387,0.0034951682],"genre_scores_gemma":[0.9895664,0.000036174322,0.0031729778,0.0061504776,0.00058830803,0.00007885342,0.000008854944,0.00003228242,0.00036569627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982874,0.00005999308,0.00023356479,0.00037518423,0.00062891503,0.00041495916],"domain_scores_gemma":[0.9982828,0.000007618097,0.000030722564,0.00067856605,0.00015076748,0.0008495134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005005085,0.00018430057,0.00039888217,0.00003463828,0.000049244805,0.000033221335,0.00013167379,0.00014849445,0.000015546917],"category_scores_gemma":[0.00012111775,0.00015009123,0.00022826354,0.00032021737,0.000038077294,0.00006800346,0.00008447543,0.00016527204,0.0005892365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012771013,0.0013483532,0.6275035,0.00026618072,0.0008024306,0.000104702376,0.0058542877,0.000114333154,0.02855824,0.00062922534,0.06257773,0.2709639],"study_design_scores_gemma":[0.0065533086,0.0016366385,0.9055466,0.00022229123,0.0002557273,0.00016328676,0.00063855347,0.000051798837,0.0018589275,0.0001536482,0.08245073,0.00046850805],"about_ca_topic_score_codex":0.0012702951,"about_ca_topic_score_gemma":0.000087260836,"teacher_disagreement_score":0.27804306,"about_ca_system_score_codex":0.00036513005,"about_ca_system_score_gemma":0.00021017643,"threshold_uncertainty_score":0.757364},"labels":[],"label_agreement":null},{"id":"W2119832165","doi":"10.1586/erc.12.94","title":"Update on guidelines for management of hypercholesterolemia","year":2012,"lang":"en","type":"review","venue":"Expert Review of Cardiovascular Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Nice; Coronary heart disease; Intensive care medicine; Primary care; Atherosclerotic cardiovascular disease; Risk factor; Familial hypercholesterolemia; Disease; Cardiology; Family medicine; Internal medicine; Cholesterol","score_opus":0.16346063211794667,"score_gpt":0.43552137651458445,"score_spread":0.27206074439663774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119832165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.222918e-7,0.98851275,0.0012041088,0.00016974936,0.0005163116,0.008933509,0.000058926576,0.000039657698,0.0005641645],"genre_scores_gemma":[5.202108e-7,0.985594,0.0086713275,0.0016830502,0.0014602097,0.0019811313,0.00032509412,0.00020020043,0.00008450677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99447125,0.00052298943,0.0021908004,0.0007140361,0.0015918124,0.00050911366],"domain_scores_gemma":[0.9944745,0.000052680018,0.00067439565,0.0037592018,0.00081127073,0.00022796271],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0047161356,0.000817128,0.008969305,0.0002152617,0.000048878464,0.0000074735367,0.00047397186,0.00035530076,0.000066204026],"category_scores_gemma":[0.00005846298,0.0005281045,0.017266788,0.00042870847,0.00008140315,0.000057587567,0.000080569735,0.00029385052,0.000029642124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026992135,0.00010053645,5.866115e-8,0.29413226,0.015907044,0.000007962447,0.000007679513,3.4614553e-7,2.5820498e-7,0.00008153486,0.0022802532,0.68745506],"study_design_scores_gemma":[0.0011352868,0.00019442617,0.0000011842675,0.2501783,0.008062871,0.00010785619,0.000006169735,1.3656934e-7,0.000024680368,0.000003261974,0.73998356,0.000302254],"about_ca_topic_score_codex":0.00001804501,"about_ca_topic_score_gemma":5.621401e-8,"teacher_disagreement_score":0.7377033,"about_ca_system_score_codex":0.000139159,"about_ca_system_score_gemma":0.00022154224,"threshold_uncertainty_score":0.99971706},"labels":[],"label_agreement":null},{"id":"W2120043292","doi":"10.1136/jmedgenet-2014-102405","title":"Whole exome sequencing of familial hypercholesterolaemia patients negative for <i>LDLR</i>/<i>APOB</i>/<i>PCSK9</i> mutations","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"Medical Research Council; National Institute for Health and Care Research; University College London; British Heart Foundation; Wellcome Trust","keywords":"PCSK9; Apolipoprotein B; Familial hypercholesterolemia; Genetics; Exome sequencing; LDL receptor; Exome; Biology; Genome-wide association study; Locus (genetics); SNP; Allele; Gene; Mutation; Single-nucleotide polymorphism; Cholesterol; Lipoprotein; Genotype; Endocrinology","score_opus":0.022344873815874015,"score_gpt":0.2920521837679291,"score_spread":0.26970730995205505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120043292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736561,0.000515998,0.022816675,0.0015978471,0.0006179143,0.00046780412,0.00003003023,0.00000880768,0.00028881824],"genre_scores_gemma":[0.9840312,0.00026685742,0.0121209975,0.0020322856,0.001437241,0.000010579596,0.000018538405,0.000034852947,0.00004744307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963839,0.00015660877,0.0009878628,0.00016725944,0.0020123252,0.0002920536],"domain_scores_gemma":[0.99747133,0.00024499258,0.00047423245,0.0002963325,0.00094003615,0.00057308364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019461814,0.0001606067,0.0006873949,0.00013387954,0.00007154126,0.000013848088,0.00024374286,0.00023687331,0.000022890988],"category_scores_gemma":[0.0019646925,0.00012281428,0.00043955614,0.00017817727,0.00015791378,0.00006624139,0.00005074006,0.0004745145,0.0000039948823],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017256936,0.00221517,0.045936022,0.0033827203,0.002102665,0.00014843838,0.0059788614,0.0011691586,0.035895478,0.00042445087,0.011015429,0.8900059],"study_design_scores_gemma":[0.11693256,0.033872407,0.29666287,0.008123841,0.0058477605,0.0025523982,0.0041244165,0.01902461,0.10204349,0.0084380545,0.40043423,0.0019433665],"about_ca_topic_score_codex":0.000021916276,"about_ca_topic_score_gemma":0.00000840962,"teacher_disagreement_score":0.88806254,"about_ca_system_score_codex":0.00012509864,"about_ca_system_score_gemma":0.0008027672,"threshold_uncertainty_score":0.50082207},"labels":[],"label_agreement":null},{"id":"W2120295140","doi":"10.1016/s0828-282x(06)70993-x","title":"PROVE-IT proved it: Lower is better – Pro","year":2006,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"AstraZeneca; Pfizer","keywords":"Medicine; Epidemiology; Internal medicine; Cholesterol; Coronary artery disease; Randomized controlled trial; Clinical trial; Cardiology; Lipoprotein","score_opus":0.03919368901226076,"score_gpt":0.3068216908513075,"score_spread":0.2676280018390467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120295140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015325078,0.973763,0.00020813441,0.0035181665,0.0016800079,0.0015969782,0.00010441394,0.000007904335,0.019106075],"genre_scores_gemma":[0.00018441191,0.9817529,0.00024495606,0.0030336631,0.012042036,0.0000698682,0.00006623969,0.00012986608,0.0024760726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99650645,0.00040398448,0.0013940603,0.00041894536,0.00041851547,0.00085801375],"domain_scores_gemma":[0.9966276,0.000049520102,0.00071676186,0.0008578086,0.00052950124,0.0012187947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012906739,0.00052546425,0.004763595,0.00068407797,0.00010645922,0.00004056506,0.00035853471,0.00092401373,0.00010754583],"category_scores_gemma":[0.00018671139,0.00037806845,0.0033652626,0.00029874986,0.000197436,0.000068882764,0.000022640197,0.0015201968,0.000087205124],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013350704,0.000003885339,0.00007100662,0.006031087,0.0018423977,0.0024547502,0.000026314836,0.0000013633695,2.0355843e-7,0.000009127943,0.26269695,0.72684956],"study_design_scores_gemma":[0.0006606165,0.00048641974,0.00007836464,0.0056874095,0.0031797662,0.011557439,0.000011090062,2.4683106e-7,6.917065e-7,0.000025738727,0.977997,0.0003152275],"about_ca_topic_score_codex":0.0013358366,"about_ca_topic_score_gemma":0.00096931093,"teacher_disagreement_score":0.7265343,"about_ca_system_score_codex":0.0007936996,"about_ca_system_score_gemma":0.014179697,"threshold_uncertainty_score":0.99986714},"labels":[],"label_agreement":null},{"id":"W2120508542","doi":"10.1161/01.str.0000221315.60282.ca","title":"Statin Use and Sex-Specific Stroke Outcomes in Patients With Vascular Disease","year":2006,"lang":"en","type":"review","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Duke Clinical Research Institute; Stroke Association","keywords":"Medicine; Stroke (engine); Hazard ratio; Internal medicine; Statin; Aspirin; Proportional hazards model; Poisson regression; Vascular disease; Cardiology; Confidence interval; Population","score_opus":0.024159430491111196,"score_gpt":0.2747988866891482,"score_spread":0.250639456198037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120508542","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016790474,0.97844034,0.000042591404,0.000010910944,0.00009678639,0.0029825687,0.0014556806,0.00004730861,0.0001333542],"genre_scores_gemma":[0.0004429521,0.99578446,0.0005659965,0.00004622904,0.00015551611,0.0001889325,0.0010479192,0.000114934286,0.0016530794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970529,0.00021377773,0.0006190557,0.00069263164,0.00093236193,0.00048927934],"domain_scores_gemma":[0.9982048,0.00006699363,0.00019051101,0.0010698754,0.00007953936,0.00038828093],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030257922,0.00055374665,0.002476405,0.00030006893,0.00006267795,0.000070792645,0.000104700855,0.00019314897,0.000022051361],"category_scores_gemma":[0.00003979388,0.00036382026,0.00068784296,0.00018014328,0.00007767927,0.000113733615,0.000067655856,0.0005417118,0.0000129260325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004029183,0.00034191756,0.26261702,0.00933444,0.00060381676,0.00013033347,0.000014216981,6.8490954e-7,7.874788e-9,0.000022841092,0.00015690198,0.7267375],"study_design_scores_gemma":[0.0029848123,0.00016811168,0.18798561,0.0029742944,0.000863364,0.0000037570555,0.0000073885717,4.4969372e-7,4.2410168e-8,0.0000013553356,0.8046997,0.0003110809],"about_ca_topic_score_codex":0.00024504535,"about_ca_topic_score_gemma":0.00004297667,"teacher_disagreement_score":0.80454284,"about_ca_system_score_codex":0.00020321413,"about_ca_system_score_gemma":0.0003320241,"threshold_uncertainty_score":0.9998814},"labels":[],"label_agreement":null},{"id":"W2120991468","doi":"10.1016/j.atherosclerosis.2013.01.023","title":"PCSK9 plays a significant role in cholesterol homeostasis and lipid transport in intestinal epithelial cells","year":2013,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Sherbrooke; Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Université Laval; Canadian Institutes of Health Research","funders":"Canadian Institutes of Health Research; Diabète Québec","keywords":"Homeostasis; PCSK9; Cholesterol; Chemistry; Cell biology; Biology; Biochemistry; LDL receptor; Lipoprotein","score_opus":0.014114385570782598,"score_gpt":0.21998694235133529,"score_spread":0.2058725567805527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120991468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975982,0.00028047827,0.00017830117,0.00047225208,0.0000624886,0.0011055346,0.000018877015,0.000041380168,0.00024249226],"genre_scores_gemma":[0.99781364,0.0005951966,0.0005992487,0.0004870039,0.00014048461,0.0002625316,0.000012607562,0.000044572127,0.000044718305],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982302,0.00008387128,0.0004450547,0.0004465167,0.00032636095,0.00046796855],"domain_scores_gemma":[0.9992107,0.000039715578,0.00006433232,0.00040315336,0.00004514956,0.0002369367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049884245,0.00023405465,0.0005485817,0.0001774648,0.000041959138,0.000028158567,0.00010012605,0.00014437042,0.00012905586],"category_scores_gemma":[0.000024129744,0.00020050009,0.00014475238,0.00031073028,0.00008723661,0.00014039455,0.00002858888,0.00034317136,0.00007564192],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013325675,0.00058475055,0.3964823,0.0002588978,0.00006374036,0.000022629552,0.0026576112,0.000021776312,0.47590405,0.000029381887,0.000037530084,0.12380409],"study_design_scores_gemma":[0.0032177411,0.0003672689,0.9660028,0.00035583833,0.000044877972,0.000017761797,0.00049779494,0.00018127407,0.02838617,0.00004669249,0.0006612017,0.00022056853],"about_ca_topic_score_codex":0.00821117,"about_ca_topic_score_gemma":0.00044488115,"teacher_disagreement_score":0.56952053,"about_ca_system_score_codex":0.00009744971,"about_ca_system_score_gemma":0.00007817262,"threshold_uncertainty_score":0.99839324},"labels":[],"label_agreement":null},{"id":"W2121236575","doi":"10.17269/cjph.104.3783","title":"Dyslipidemia Prevalence, Treatment, Control, and Awareness in the Canadian Health Measures Survey","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Public Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; Agricultural Research Institute of Ontario; University of Ottawa; Statistics Canada; Simon Fraser University","funders":"","keywords":"Dyslipidemia; Medicine; Population; Internal medicine; Lipid profile; Environmental health; Disease; Cholesterol","score_opus":0.08997527391740552,"score_gpt":0.3149688296816439,"score_spread":0.2249935557642384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121236575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74179745,0.03979294,0.00022147316,0.21453437,0.00047867768,0.0023590724,0.0002129246,0.00000869548,0.00059439254],"genre_scores_gemma":[0.98155653,0.0015172296,0.0000794699,0.016331563,0.00035648484,0.000027213613,0.000021183238,0.00002185062,0.00008847737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99499834,0.0022114632,0.0008207816,0.0002214466,0.0004693988,0.0012786001],"domain_scores_gemma":[0.99247336,0.00015877925,0.00033150017,0.000435364,0.00049289624,0.00610809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014464274,0.00020143809,0.0008276104,0.0007657894,0.00053108606,0.00018749616,0.00022573452,0.0001227183,0.00007762006],"category_scores_gemma":[0.001000317,0.00013056371,0.00014110663,0.0005258918,0.00013354681,0.00023819515,0.0000033784747,0.0004928084,0.000007765279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000059306,0.00002992851,0.8517994,0.0001579777,0.00011410209,0.00006576497,0.0017840455,0.0000028128125,2.2457962e-7,0.00021119478,0.012528818,0.13329977],"study_design_scores_gemma":[0.0017531756,0.00073759205,0.9168848,0.00013088208,0.000013749506,0.0005377802,0.00052201573,0.000018009874,1.4317679e-7,0.000042369287,0.07927008,0.00008942059],"about_ca_topic_score_codex":0.9909056,"about_ca_topic_score_gemma":0.9980879,"teacher_disagreement_score":0.23975907,"about_ca_system_score_codex":0.003442363,"about_ca_system_score_gemma":0.089363836,"threshold_uncertainty_score":0.9157986},"labels":[],"label_agreement":null},{"id":"W2121424621","doi":"10.1080/08941930152024183","title":"Surgical Management of Dyslipidemia: Clinical and Experimental Evidence","year":2001,"lang":"en","type":"review","venue":"Journal of Investigative Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Dyslipidemia; Coronary artery disease; Cholesterol; Apolipoprotein B; Hyperlipidemia; Familial hypercholesterolemia; Internal medicine; Myocardial infarction; Diabetes mellitus; Lipoprotein; Endocrinology; Cardiology; Surgery; Gastroenterology","score_opus":0.25714280422836594,"score_gpt":0.44681789181382126,"score_spread":0.18967508758545532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121424621","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008484021,0.98996204,0.000009805239,0.00015533327,0.0005680846,0.00053712283,0.0000042263655,0.0000068323443,0.00027254596],"genre_scores_gemma":[0.00062243576,0.9966572,0.0012114479,0.0000868998,0.0012372239,0.00001474701,0.000004251384,0.00004013229,0.0001256454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99429524,0.0011201096,0.003047912,0.00032467293,0.0009410683,0.00027101437],"domain_scores_gemma":[0.9950831,0.0014277527,0.0021625264,0.00040906723,0.00028302823,0.0006345228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071065584,0.00037068207,0.005181065,0.0003333951,0.00004159547,0.000013600605,0.00013583095,0.00036567013,0.000058912225],"category_scores_gemma":[0.0007121679,0.00024463472,0.002731174,0.00046914406,0.00081095414,0.00015164388,0.0001199828,0.0010707978,0.0000053267236],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013521414,0.00025037123,0.0019130692,0.033660695,0.0033995465,0.004692013,0.000037835518,1.8686809e-7,7.5763046e-7,0.00012843458,0.0040826094,0.95169926],"study_design_scores_gemma":[0.00076047616,0.0004564666,0.0009748607,0.18399063,0.003272136,0.004728196,0.00014482191,5.3842217e-7,0.00004618293,0.00005704068,0.80529886,0.00026980942],"about_ca_topic_score_codex":0.000007005548,"about_ca_topic_score_gemma":1.6025803e-7,"teacher_disagreement_score":0.9514295,"about_ca_system_score_codex":0.00013719758,"about_ca_system_score_gemma":0.0010679459,"threshold_uncertainty_score":0.9975914},"labels":[],"label_agreement":null},{"id":"W2121958467","doi":"10.1016/s0828-282x(10)70413-x","title":"Utilization patterns of extended-release niacin in Canada: Analysis of an administrative claims database","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Discontinuation; Medical prescription; Persistence (discontinuity); Niacin; Cohort; Pediatrics; Retrospective cohort study; Database; Internal medicine; Demography; Pharmacology","score_opus":0.03251749360598377,"score_gpt":0.29392626811277045,"score_spread":0.2614087745067867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121958467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690276,0.00026830815,0.0015677401,0.00015681983,0.00026270867,0.00014246738,0.00036869413,8.574376e-7,0.0003296348],"genre_scores_gemma":[0.99933213,0.000060396756,0.0001708253,0.00009173458,0.00022872815,0.0000020471307,0.00009869284,0.000009392251,0.0000060244943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985168,0.00021402069,0.0006295403,0.00014425733,0.00025053584,0.00024482686],"domain_scores_gemma":[0.99811625,0.00003979349,0.00030899508,0.00043262859,0.0004081618,0.00069418637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075300166,0.00010662586,0.0009872973,0.00067484705,0.000023128867,0.0000026841224,0.00013087623,0.00010360089,0.00007293013],"category_scores_gemma":[0.00021234083,0.000093620256,0.0002861426,0.00045464202,0.000079748424,0.00007033493,0.0000065025865,0.0003856873,1.5101323e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026612522,0.00002467525,0.9403724,0.00016634405,0.0033647758,0.0021502746,0.00038261278,0.002914606,0.0026004347,0.00051697536,0.00027126633,0.046969485],"study_design_scores_gemma":[0.0009966597,0.00036179886,0.99213094,0.000053051914,0.0011974627,0.0004051061,0.00094152754,0.00022113002,0.0016773846,0.000025169691,0.001899178,0.00009059562],"about_ca_topic_score_codex":0.8660827,"about_ca_topic_score_gemma":0.9946356,"teacher_disagreement_score":0.12855287,"about_ca_system_score_codex":0.0002622862,"about_ca_system_score_gemma":0.014077583,"threshold_uncertainty_score":0.9915117},"labels":[],"label_agreement":null},{"id":"W2122864632","doi":"10.1074/jbc.m409699200","title":"NARC-1/PCSK9 and Its Natural Mutants","year":2004,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":625,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Montreal Clinical Research Institute","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"PCSK9; LDL receptor; Missense mutation; Mutant; Biology; Chemistry; Endocrinology; Lipoprotein; Molecular biology; Internal medicine; Mutation; Cholesterol; Biochemistry; Gene; Medicine","score_opus":0.021380470131645585,"score_gpt":0.27248324591945927,"score_spread":0.2511027757878137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122864632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98833394,0.0100196805,0.000016321253,0.0009728204,0.00007193386,0.000057681023,0.0000017551986,0.0000091952425,0.00051665877],"genre_scores_gemma":[0.997926,0.00072565,0.00035597084,0.00030162217,0.0006186718,7.468099e-7,0.0000017176995,0.0000044618755,0.00006515452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992591,0.000012746902,0.0002530748,0.00010495108,0.0002164516,0.00015364091],"domain_scores_gemma":[0.9994626,0.0000146759,0.00011339102,0.000090529895,0.000116321295,0.00020246154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029961983,0.00008900848,0.000315105,0.000012968257,0.00003429225,0.0000075963276,0.000060127848,0.00013641953,0.000060823884],"category_scores_gemma":[0.00024103203,0.000050722672,0.0001854627,0.000063385516,0.000045855602,0.0000310136,0.000027972359,0.00039090775,0.0000031775342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038260274,0.0001800738,0.0020552585,0.00022555224,0.00020981148,0.0010737391,0.000044838544,0.0000029704818,0.98095804,0.000029882356,0.00005625018,0.014780993],"study_design_scores_gemma":[0.004878,0.0007192922,0.038564086,0.00033697093,0.00010241998,0.018386014,0.00017386435,0.000007613076,0.930697,0.0006618088,0.005282212,0.00019069343],"about_ca_topic_score_codex":0.000001599757,"about_ca_topic_score_gemma":6.812282e-8,"teacher_disagreement_score":0.050261002,"about_ca_system_score_codex":0.000058122816,"about_ca_system_score_gemma":0.00009404997,"threshold_uncertainty_score":0.20684105},"labels":[],"label_agreement":null},{"id":"W2122955674","doi":"10.1194/jlr.d045963","title":"LipidSeq: a next-generation clinical resequencing panel for monogenic dyslipidemias","year":2014,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Sanger sequencing; Exome sequencing; Dyslipidemia; Concordance; Genetics; Computational biology; Exome; DNA sequencing; Biology; Bioinformatics; Medicine; Mutation; Gene; Disease; Internal medicine","score_opus":0.5409540244862475,"score_gpt":0.4939419183266643,"score_spread":0.04701210615958323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122955674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97647196,0.002085754,0.008190565,0.009468571,0.001684961,0.0010651179,0.0000027673377,0.000019597786,0.0010106753],"genre_scores_gemma":[0.9463605,0.0014393409,0.009628105,0.00057003973,0.040924598,0.000037695936,0.0000067419255,0.000051721996,0.0009811998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943984,0.001530585,0.0013829077,0.0003134871,0.0017335955,0.0006410014],"domain_scores_gemma":[0.9951669,0.0010388084,0.00034175994,0.0006299532,0.0021803593,0.0006422217],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.040207855,0.0001475964,0.00081925164,0.0004487542,0.00028098995,0.00008684091,0.00028318813,0.00023300039,0.00005321989],"category_scores_gemma":[0.0088874595,0.00010694312,0.0009027277,0.00041102772,0.00014728232,0.00023046111,0.00007385961,0.001508683,0.00003193667],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036425842,0.00096250896,0.015749458,0.0014008391,0.0014464619,0.00011233727,0.0008841934,0.00020167175,0.15341814,0.0019777515,0.25560588,0.5645982],"study_design_scores_gemma":[0.017374916,0.012514329,0.019038165,0.0013258036,0.00048902887,0.0020355165,0.0013311752,0.022951635,0.023935836,0.0016546606,0.8967869,0.00056199287],"about_ca_topic_score_codex":0.000054875727,"about_ca_topic_score_gemma":0.000015957676,"teacher_disagreement_score":0.64118105,"about_ca_system_score_codex":0.00028739474,"about_ca_system_score_gemma":0.0012218083,"threshold_uncertainty_score":0.9994611},"labels":[],"label_agreement":null},{"id":"W2123185320","doi":"10.1016/s0828-282x(10)71060-6","title":"The role of lipoprotein(a) in the formation of arterial plaques, stenoses and occlusions","year":2010,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Stenosis; Lipoprotein(a); Cardiology; Internal medicine; Thrombosis; Thrombolysis; Occlusion; Lipoprotein; Apolipoprotein B; Risk factor; Fibrinolysis; Logistic regression; Cholesterol; Myocardial infarction","score_opus":0.019137383858717185,"score_gpt":0.27465985748465344,"score_spread":0.2555224736259363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123185320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015158117,0.99572456,0.00003665442,0.00017982222,0.0003789038,0.00072480156,0.00004922993,8.243675e-7,0.0013893765],"genre_scores_gemma":[0.0331961,0.9654222,0.00004147417,0.000026172831,0.0012668336,0.000015557785,0.000012198331,0.00001415139,0.0000052969644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980527,0.00056576956,0.0008457987,0.00008759791,0.00021531731,0.0002328032],"domain_scores_gemma":[0.9983981,0.00017758313,0.00062210974,0.00040111385,0.00020079405,0.00020025698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020645258,0.00015041095,0.0016336519,0.00027008273,0.00010030605,0.000012000496,0.00024613767,0.00032871505,0.0000027843437],"category_scores_gemma":[0.00033975675,0.00007512081,0.0006053906,0.00014742446,0.00024915993,0.000041994874,0.000017637618,0.00074011047,5.4420855e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002069184,0.0000016698839,0.000024180115,0.0010566008,0.00017989501,0.000050775074,0.00018947093,0.0000011735749,0.000005657208,0.00034010003,0.00020100299,0.9979288],"study_design_scores_gemma":[0.00035526912,0.00024882413,0.00037221386,0.0018300754,0.00060159503,0.0043686074,0.00029777398,6.979931e-7,0.0000052016976,0.00020648642,0.9916547,0.000058574988],"about_ca_topic_score_codex":0.0020071839,"about_ca_topic_score_gemma":0.0059509734,"teacher_disagreement_score":0.9978702,"about_ca_system_score_codex":0.000074501535,"about_ca_system_score_gemma":0.002636894,"threshold_uncertainty_score":0.46777365},"labels":[],"label_agreement":null},{"id":"W2123303862","doi":"10.1016/j.jacl.2010.03.005","title":"Why is non−high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?","year":2010,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; Royal Victoria Hospital; McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Medicine; Internal medicine; Cholesterol; Lipoprotein; Triglyceride; Endocrinology; Apolipoprotein C2; High-density lipoprotein; Intermediate-density lipoprotein; Very low-density lipoprotein","score_opus":0.035347692485231653,"score_gpt":0.3470390448419356,"score_spread":0.3116913523567039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123303862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43482676,0.5465089,0.00074431865,0.0034047198,0.008896119,0.005294395,0.00024294792,0.000029539191,0.00005232799],"genre_scores_gemma":[0.01765111,0.9602572,0.0013900623,0.004459412,0.015794624,0.00006705357,0.000024104542,0.00021361726,0.00014284527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9831624,0.005331715,0.007280069,0.0010674192,0.0023167161,0.00084166863],"domain_scores_gemma":[0.9824032,0.0010787757,0.009689876,0.0041344548,0.0014670618,0.0012265847],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.013678411,0.0010755373,0.011159524,0.00045065783,0.00016960561,0.0000371602,0.0014790421,0.0025351862,0.00018901944],"category_scores_gemma":[0.005558124,0.0006283468,0.012991285,0.00059083174,0.0012202533,0.0001800014,0.00073483214,0.007843572,0.00003921108],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011313282,0.001332288,0.008779346,0.016423684,0.004966444,0.00008054133,0.00005803272,0.0000010264097,0.000013005885,0.0000049649734,0.0025147786,0.96469456],"study_design_scores_gemma":[0.0053702854,0.0015030807,0.36589867,0.020062368,0.015055325,0.000626143,0.000009953263,0.0000062286517,0.000098806675,0.00022387605,0.59060323,0.00054201693],"about_ca_topic_score_codex":0.0023737573,"about_ca_topic_score_gemma":0.0005199256,"teacher_disagreement_score":0.9641525,"about_ca_system_score_codex":0.00011165785,"about_ca_system_score_gemma":0.002104059,"threshold_uncertainty_score":0.9996168},"labels":[],"label_agreement":null},{"id":"W2123447133","doi":"10.1586/erc.12.176","title":"What do high blood resistin levels mean for patients on statin therapy?","year":2013,"lang":"en","type":"editorial","venue":"Expert Review of Cardiovascular Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Resistin; Statin; Internal medicine; Cardiology; Obesity; Adipokine","score_opus":0.020948129288833498,"score_gpt":0.31155480512997324,"score_spread":0.29060667584113975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123447133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005710284,0.745609,0.00013424683,0.00021539458,0.24384695,0.009189065,0.00024442794,0.00007632046,0.000113590424],"genre_scores_gemma":[0.00006814837,0.7112829,0.0012675078,0.0011500258,0.28205007,0.0023242019,0.0013066327,0.00029292156,0.00025756902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98946923,0.0011481202,0.0017424275,0.0015750403,0.0052107,0.00085450517],"domain_scores_gemma":[0.99082714,0.000500397,0.00078390463,0.00473605,0.0027581225,0.0003943595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0044134404,0.0012360284,0.0057776086,0.00025629223,0.00018677804,0.00013718665,0.00070191105,0.0010645883,0.0003194267],"category_scores_gemma":[0.0010115776,0.0008820428,0.008748789,0.00038159968,0.0001433303,0.00026579172,0.00007298984,0.00091152114,0.000043550433],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034800722,0.0005373467,0.0000014632992,0.007593192,0.013578231,0.000012845311,0.00016585413,9.792323e-7,0.000014829567,0.0000143675825,0.47691232,0.5008206],"study_design_scores_gemma":[0.012173541,0.0028404703,0.000052406827,0.034897454,0.0013149962,0.0000066650596,0.00004161216,3.3551706e-7,0.001054665,0.000040501043,0.9467904,0.0007869411],"about_ca_topic_score_codex":0.00048654168,"about_ca_topic_score_gemma":0.0000013565444,"teacher_disagreement_score":0.5000336,"about_ca_system_score_codex":0.0002415027,"about_ca_system_score_gemma":0.0008279159,"threshold_uncertainty_score":0.999363},"labels":[],"label_agreement":null},{"id":"W2123546084","doi":"10.1097/hco.0b013e328353fed5","title":"Low-density lipoprotein-lowering strategies","year":2012,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine","score_opus":0.12372649285921765,"score_gpt":0.4006311519462659,"score_spread":0.27690465908704825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123546084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035130644,0.98107743,0.000678361,0.000017282107,0.014790447,0.0022971623,0.000026562806,0.000105095794,0.00097249803],"genre_scores_gemma":[0.00049427035,0.9888601,0.000047362577,0.0000075144994,0.0095154345,0.0005264042,0.0004471283,0.00008525677,0.000016543601],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963844,0.000539674,0.0010041923,0.0007791701,0.00043010304,0.00086247263],"domain_scores_gemma":[0.9979744,0.00008025285,0.00029443618,0.0012436981,0.000101162965,0.00030604907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013431135,0.0006439983,0.0044298866,0.00041814492,0.00007549323,0.000028557148,0.00023768585,0.0007968293,0.000040001345],"category_scores_gemma":[0.00007643255,0.000519473,0.0018244776,0.00041294875,0.00013813807,0.000110620516,0.00022888734,0.0016083666,0.00023795782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012475216,0.000057721878,0.00005107591,0.06946319,0.00028834405,0.000017850622,0.000026523183,0.0000016087291,1.3919089e-7,0.00022719125,0.00028276068,0.9295711],"study_design_scores_gemma":[0.0005327748,0.00009456084,0.00048143402,0.021722963,0.00058554596,0.0010198022,0.000031269326,6.133195e-7,6.685473e-7,0.000039763123,0.97506255,0.00042805402],"about_ca_topic_score_codex":0.00007914058,"about_ca_topic_score_gemma":0.0000033499725,"teacher_disagreement_score":0.9747798,"about_ca_system_score_codex":0.00043330772,"about_ca_system_score_gemma":0.001040269,"threshold_uncertainty_score":0.9997257},"labels":[],"label_agreement":null},{"id":"W2123573411","doi":"10.1517/14728222.2014.920326","title":"Lipoprotein(a) as a therapeutic target in cardiovascular disease","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Targets","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Canadian Institutes of Health Research","keywords":"Disease; Medicine; Lipoprotein; Atherosclerotic cardiovascular disease; Bioinformatics; Pharmacology; Cholesterol; Intensive care medicine; Internal medicine; Biology","score_opus":0.049954008884343266,"score_gpt":0.35039131917059474,"score_spread":0.3004373102862515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123573411","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.3698876e-7,0.98900974,0.00073229836,0.00048132287,0.0018783655,0.0060430667,0.000029661955,0.00026729965,0.0015574086],"genre_scores_gemma":[0.00024686017,0.9897751,0.0002663322,0.002778754,0.0030310387,0.0026126776,0.00051385176,0.00043335275,0.0003419915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99165714,0.0015430483,0.001448736,0.0019266944,0.0021448762,0.0012794907],"domain_scores_gemma":[0.99443984,0.00016722376,0.00038286683,0.0039540716,0.00013436381,0.00092166296],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0020019242,0.0015007975,0.0059428792,0.0007879329,0.00021325765,0.000084956744,0.0006178117,0.0008974539,0.00051098433],"category_scores_gemma":[0.00013706657,0.0011317082,0.0056117903,0.00078360987,0.00015606609,0.00010608567,0.00012772191,0.0015016458,0.0009478441],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021475817,0.0004711301,0.0000023107477,0.00696904,0.0036768643,0.00018382705,0.00017514601,0.000013734697,6.3120365e-7,0.000882708,0.0002867241,0.98712313],"study_design_scores_gemma":[0.002049154,0.000635116,0.00004137501,0.01261656,0.0005390742,0.00018222068,0.000032529853,0.0000500322,0.000007945518,0.0004702049,0.98227787,0.0010979436],"about_ca_topic_score_codex":0.0003436706,"about_ca_topic_score_gemma":0.0000018293987,"teacher_disagreement_score":0.98602515,"about_ca_system_score_codex":0.00072484894,"about_ca_system_score_gemma":0.0014367603,"threshold_uncertainty_score":0.99983},"labels":[],"label_agreement":null},{"id":"W2123817827","doi":"10.1186/1476-511x-13-65","title":"Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort","year":2014,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Medicine; Family history; Diabetes mellitus; Internal medicine; Risk factor; Familial hypercholesterolemia; Cohort; Disease; Lipidology; Hazard ratio; Proportional hazards model; Cholesterol; Endocrinology; Confidence interval","score_opus":0.016160661216454354,"score_gpt":0.2846797953238884,"score_spread":0.268519134107434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123817827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729717,0.000800724,0.00048835087,0.00018025577,0.000049986975,0.0011076698,0.00003064084,0.000011321833,0.000033883352],"genre_scores_gemma":[0.99802226,0.00043534435,0.0006347125,0.0006656748,0.00006722688,0.0000727761,0.000081562364,0.000011045993,0.000009426544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985926,0.00028157362,0.00038412135,0.0002571535,0.0002623029,0.00022225505],"domain_scores_gemma":[0.9988124,0.0000357626,0.00010634306,0.000344689,0.000049231487,0.00065157114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007981248,0.00009997979,0.0003229706,0.00010336404,0.000036683283,0.000003863277,0.00003355773,0.000048412163,0.0000031349464],"category_scores_gemma":[0.00035880055,0.00007801628,0.000039264072,0.00016830662,0.00005186226,0.00004915896,0.000011568904,0.00020392738,0.0000011421753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007324164,0.00034182542,0.9523167,0.0008812759,0.0000072993475,8.62761e-7,0.00025903436,0.000019527995,0.0000015087465,0.000038755195,0.000007272928,0.045393527],"study_design_scores_gemma":[0.004878848,0.00041079495,0.99320203,0.00024526456,0.000022913897,3.0634246e-7,0.000089887835,0.0008849755,0.0000014673766,0.000049940838,0.00014706001,0.00006652258],"about_ca_topic_score_codex":0.0014450795,"about_ca_topic_score_gemma":0.0003477337,"teacher_disagreement_score":0.045327004,"about_ca_system_score_codex":0.00006189903,"about_ca_system_score_gemma":0.00040624556,"threshold_uncertainty_score":0.31814116},"labels":[],"label_agreement":null},{"id":"W2123972340","doi":"10.1177/1074248413492906","title":"Lipid-Lowering Agents","year":2013,"lang":"en","type":"review","venue":"Journal of Cardiovascular Pharmacology and Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Proprotein convertase; Ezetimibe; Pharmacology; Kexin; Cholesterylester transfer protein; Clinical trial; Familial hypercholesterolemia; PCSK9; Internal medicine; Lipoprotein; Statin; Cholesterol; LDL receptor","score_opus":0.06883229877380961,"score_gpt":0.371990948099154,"score_spread":0.3031586493253444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123972340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020403568,0.9957083,0.0005132651,0.00006309856,0.0020619587,0.0010870567,0.0000045934507,0.000018983501,0.00033870386],"genre_scores_gemma":[0.00012519115,0.9951604,0.0003022476,0.0004932352,0.0036552176,0.000036296788,0.0000058475744,0.00009470711,0.00012687623],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99689716,0.0005450282,0.0010828683,0.0003091268,0.0007480302,0.00041775792],"domain_scores_gemma":[0.9981105,0.0000855786,0.00058281457,0.00050985476,0.000348839,0.00036242587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019720236,0.0004960971,0.0043847165,0.00036674883,0.00011089017,0.000036151196,0.00022766094,0.0005940811,0.00012391957],"category_scores_gemma":[0.00001623049,0.0003424547,0.005694862,0.000248205,0.00013176893,0.00011233469,0.000093827206,0.00142723,0.000030205723],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002696772,0.00008419228,0.0000027785236,0.008836988,0.0502621,0.00049656833,0.00003526219,0.000005249583,0.0000038731655,0.0000048654615,0.00049925264,0.9397419],"study_design_scores_gemma":[0.0018026667,0.0003046168,0.000009122994,0.0024420843,0.054168977,0.010474884,0.000013326559,0.0000049837863,0.000027079976,0.000010321644,0.93048555,0.00025638746],"about_ca_topic_score_codex":0.0000048514366,"about_ca_topic_score_gemma":5.6678434e-8,"teacher_disagreement_score":0.9394855,"about_ca_system_score_codex":0.000158779,"about_ca_system_score_gemma":0.00063553033,"threshold_uncertainty_score":0.9999027},"labels":[],"label_agreement":null},{"id":"W2123993085","doi":"","title":"Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Interior Health","funders":"","keywords":"Dyslipidemia; Medicine; Fenofibrate; Internal medicine; Metabolic syndrome; Diabetes mellitus; Obesity; Endocrinology; Cholesterol; Framingham Risk Score; National Cholesterol Education Program; Triglyceride; Niacin; Disease","score_opus":0.025196814726934608,"score_gpt":0.22739428313695975,"score_spread":0.20219746841002514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123993085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98661226,0.0098827155,0.00037050302,0.00040876004,0.000037632304,0.0018143385,0.0000017225478,0.000027724847,0.00084432866],"genre_scores_gemma":[0.9964103,0.00030843628,0.0015107855,0.0004833264,0.000074099196,0.001095015,0.000001416749,0.000014188697,0.000102411606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989219,0.00006183885,0.00020272614,0.00026910217,0.0002127523,0.00033171257],"domain_scores_gemma":[0.9992633,0.000023685667,0.00005360092,0.00029847864,0.00005828481,0.0003026865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008655974,0.00010511452,0.00041944327,0.0000893941,0.000050460647,0.000024795272,0.000051863237,0.000056015797,0.0000036503704],"category_scores_gemma":[0.00011292115,0.00008713563,0.00007530481,0.00016895377,0.00007814863,0.00009728041,0.00008609043,0.00011589095,0.0000030376793],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019436708,0.00012200383,0.18738434,0.0018446838,0.00066622876,0.000011113716,0.0005801574,0.0000034017266,0.0021574527,0.00088399404,0.00014457948,0.8061826],"study_design_scores_gemma":[0.00060806726,0.000012451529,0.9961831,0.000031586034,0.00017526108,0.000045304656,0.00012916162,0.000097822,0.0019206333,0.0002822205,0.00041663495,0.00009775922],"about_ca_topic_score_codex":0.00035353214,"about_ca_topic_score_gemma":0.0000035484823,"teacher_disagreement_score":0.80879873,"about_ca_system_score_codex":0.000021431537,"about_ca_system_score_gemma":0.000020237669,"threshold_uncertainty_score":0.3553288},"labels":[],"label_agreement":null},{"id":"W2124076488","doi":"10.1111/j.1745-7599.2010.00545.x","title":"Heterozygous familial hypercholesterolemia case study","year":2010,"lang":"en","type":"article","venue":"Journal of the American Academy of Nurse Practitioners","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Etiology; MEDLINE; Disease; Intensive care medicine; Primary care; Epidemiology; Pediatrics; Physical therapy; Internal medicine; Family medicine; Cholesterol","score_opus":0.020345601672611548,"score_gpt":0.34838695632165023,"score_spread":0.32804135464903866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124076488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138916,0.00006677581,0.000023588407,0.007413398,0.00042439427,0.00039120234,0.000003930774,0.0000089608975,0.000278622],"genre_scores_gemma":[0.99641144,0.000059631468,0.00091996277,0.0017602409,0.0007612457,0.000005113913,2.0499287e-7,0.000021802873,0.000060371025],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980631,0.00025773564,0.00057996163,0.0001385204,0.0007737941,0.0001868759],"domain_scores_gemma":[0.99801964,0.00007019706,0.001265643,0.00029288637,0.00013881674,0.00021283118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011304683,0.00013628298,0.0005650743,0.00015300278,0.000106402804,0.000013337566,0.00020828389,0.00006584868,0.00001920607],"category_scores_gemma":[0.00024182606,0.00008572572,0.00045940006,0.00030636566,0.00035130564,0.00021939559,0.000031896816,0.0016523147,0.0000045716033],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064449976,0.008578712,0.124454245,0.00029419927,0.006533033,0.009645942,0.010493908,0.00039843333,0.3856296,0.000125118,0.013282264,0.43411955],"study_design_scores_gemma":[0.009544969,0.0050628236,0.50392675,0.00026742334,0.003689935,0.37707132,0.06088159,0.00005598699,0.0075179185,0.0001080972,0.031422082,0.0004511102],"about_ca_topic_score_codex":0.00032037587,"about_ca_topic_score_gemma":0.000010796412,"teacher_disagreement_score":0.43366843,"about_ca_system_score_codex":0.000062132975,"about_ca_system_score_gemma":0.00018279934,"threshold_uncertainty_score":0.71785766},"labels":[],"label_agreement":null},{"id":"W2124110862","doi":"10.1161/strokeaha.114.006736","title":"Guideline-Directed Low-Density Lipoprotein Management in High-Risk Patients With Ischemic Stroke","year":2014,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; St. Michael's Hospital","funders":"","keywords":"Medicine; Stroke (engine); Internal medicine; Guideline; Coronary artery disease; National Cholesterol Education Program; Cardiology; Vascular disease; Concomitant; Risk factor; Metabolic syndrome; Obesity; Pathology","score_opus":0.004347673033842494,"score_gpt":0.21341251971003142,"score_spread":0.20906484667618894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124110862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98982096,0.00009600033,0.0016024684,0.00021305631,0.0001533151,0.0014351115,0.000043354255,0.00017823298,0.006457519],"genre_scores_gemma":[0.9861306,0.00006167549,0.011469731,0.00036292357,0.00030718706,0.00008534002,0.00012319582,0.000049030517,0.0014103272],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99752396,0.0001329463,0.00047431697,0.00052468496,0.0008459236,0.00049816986],"domain_scores_gemma":[0.99845237,0.000016402964,0.00015345249,0.000945518,0.00021120232,0.00022107482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072101003,0.00026946978,0.00056169834,0.00018649996,0.000084392435,0.000019752335,0.00013192596,0.00012656178,0.000069039495],"category_scores_gemma":[0.000085591404,0.00021060315,0.00016452928,0.00024158478,0.000049248425,0.000071298105,0.000090165435,0.0003993086,0.00006735456],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015781679,0.0009124783,0.41874814,0.0006204793,0.0010958834,0.00012697265,0.00014140614,0.0000925696,0.000682341,0.0001729286,0.007909527,0.56791914],"study_design_scores_gemma":[0.015293184,0.000781397,0.9458346,0.00030007263,0.00037532975,0.000008448469,0.00008759908,0.0004765506,0.0054169106,0.000032550703,0.030965174,0.0004281983],"about_ca_topic_score_codex":0.003843892,"about_ca_topic_score_gemma":0.000601987,"teacher_disagreement_score":0.56749094,"about_ca_system_score_codex":0.00015894262,"about_ca_system_score_gemma":0.00005637224,"threshold_uncertainty_score":0.8588147},"labels":[],"label_agreement":null},{"id":"W2124151558","doi":"10.1046/j.1492-7535.2003.00057.x","title":"Lipoprotein (a) in Chronic Renal Failure: Effect of Maintenance Hemodialysis","year":2003,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Hemodialysis; Kidney disease; Uremia; Internal medicine; Stage (stratigraphy); Lipoprotein(a); Coronary artery disease; End stage renal disease; Cardiology; Lipoprotein; Gastroenterology; Urology; Cholesterol","score_opus":0.007543390078034148,"score_gpt":0.2562893133920372,"score_spread":0.24874592331400305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124151558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98115176,0.00073116476,0.004856521,0.0007400732,0.00022900788,0.0008277935,0.000017258888,0.000043565557,0.011402845],"genre_scores_gemma":[0.996395,0.00013588191,0.0021679273,0.000108130254,0.00038201705,0.00015000145,0.000058237798,0.000028886889,0.0005739336],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973056,0.00029406036,0.00062034116,0.00046007434,0.00096480583,0.00035514738],"domain_scores_gemma":[0.9987565,0.000093018796,0.00019552938,0.0006179885,0.00020028475,0.00013664788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017619384,0.00023678964,0.0008093037,0.0004717112,0.00003928046,0.000018227107,0.00019811747,0.0001543858,0.0007332723],"category_scores_gemma":[0.00066770345,0.00019731163,0.0007270542,0.000630855,0.00008908424,0.00011027929,0.000043117994,0.00029918048,0.000051986564],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035451902,0.0014751597,0.12417623,0.0019414739,0.0087513365,0.0013223611,0.0008996505,0.0073581166,0.34092122,0.016335614,0.005114659,0.48815897],"study_design_scores_gemma":[0.031559996,0.0017691884,0.05021482,0.0012691497,0.001430724,0.00082092296,0.00010346611,0.009925058,0.80162925,0.0011286637,0.09901346,0.0011353188],"about_ca_topic_score_codex":0.00037765395,"about_ca_topic_score_gemma":0.00027589404,"teacher_disagreement_score":0.48702368,"about_ca_system_score_codex":0.00075712235,"about_ca_system_score_gemma":0.0003392751,"threshold_uncertainty_score":0.8046135},"labels":[],"label_agreement":null},{"id":"W2124286731","doi":"10.1046/j.1526-0968.2002.00345.x","title":"Comparison of Different Treatment Regimens in a Case of Homozygous Familial Hypercholesterolemia","year":2002,"lang":"en","type":"article","venue":"Therapeutic Apheresis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Atorvastatin; LDL apheresis; Cholesterol; Apheresis; Medicine; Ldl cholesterol; Familial hypercholesterolemia; Internal medicine; Endocrinology; Platelet","score_opus":0.06588016152482269,"score_gpt":0.3324622797415718,"score_spread":0.2665821182167491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124286731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992516,0.0056772847,0.00005351857,0.00016152991,0.000040295436,0.00058604404,0.000008663236,0.000018826795,0.0009378491],"genre_scores_gemma":[0.9988806,0.00051771296,0.00015536336,0.00006786895,0.000051210332,0.00003561371,0.0000027602225,0.000022766939,0.00026607246],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987159,0.00013884687,0.00045730761,0.00020762593,0.000248653,0.00023167211],"domain_scores_gemma":[0.99911565,0.00005120073,0.00011385331,0.00058351946,0.000042002783,0.000093763614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011873196,0.00017554605,0.000835888,0.00009923822,0.000027047454,0.00000291464,0.000058153266,0.00010273917,0.00020002644],"category_scores_gemma":[0.0000061333476,0.00012553344,0.00026507617,0.00017008767,0.000082599334,0.00001874435,0.000015791373,0.00011049477,0.0000067857345],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065372215,0.0047866423,0.15640047,0.00056312745,0.0011154512,0.0011046692,0.009014366,0.000027685739,0.013654259,0.00012478106,0.000080273414,0.81247455],"study_design_scores_gemma":[0.050753564,0.019497309,0.73590595,0.0016772412,0.0046141553,0.006951084,0.017722927,0.0065230276,0.1501519,0.00039387247,0.0044173314,0.0013916297],"about_ca_topic_score_codex":0.0015662007,"about_ca_topic_score_gemma":0.00048120288,"teacher_disagreement_score":0.8110829,"about_ca_system_score_codex":0.00013613122,"about_ca_system_score_gemma":0.000026424414,"threshold_uncertainty_score":0.5119105},"labels":[],"label_agreement":null},{"id":"W2124575119","doi":"10.1053/j.ajkd.2005.03.002","title":"Nonfasting Non-High-Density Lipoprotein Cholesterol Is Adequate for Lipid Management in Hemodialysis Patients","year":2005,"lang":"en","type":"article","venue":"American Journal of Kidney Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Hemodialysis; Cholesterol; Triglyceride; Endocrinology; Dialysis; Kidney disease; High-density lipoprotein; Lipid profile; Diabetes mellitus; Lipoprotein; Gastroenterology","score_opus":0.0062568605239604995,"score_gpt":0.2508776154135385,"score_spread":0.244620754889578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124575119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920718,0.00014874569,0.0029243312,0.0036512653,0.00015688354,0.0008633209,0.000059388545,0.000013851238,0.00011041273],"genre_scores_gemma":[0.985084,0.00014749139,0.0066480082,0.0068456717,0.0010743125,0.00005511414,0.000022916758,0.00003678761,0.00008568228],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978522,0.00008443173,0.0006934733,0.00027965032,0.00068656774,0.00040365415],"domain_scores_gemma":[0.99760884,0.00003512792,0.0005534375,0.00039140857,0.00029176543,0.0011194374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040489796,0.00021715213,0.0008125055,0.00032037558,0.000080313686,0.000030548814,0.00015949109,0.000033233333,0.000045922396],"category_scores_gemma":[0.00032969104,0.0001821948,0.0005890941,0.0003860693,0.000089826055,0.00018254275,0.000052479056,0.00018534526,0.0000123762275],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087029097,0.0007963785,0.035378292,0.00020368038,0.0006901965,0.000045275912,0.00032629812,0.000052405223,0.00002890212,0.000003569126,0.0025855317,0.9590192],"study_design_scores_gemma":[0.013497814,0.0023563365,0.9675961,0.0010474166,0.0019032689,0.000047502377,0.00085892313,0.00042173653,0.0011786725,0.000036967882,0.010631602,0.00042367118],"about_ca_topic_score_codex":0.0005343997,"about_ca_topic_score_gemma":0.00001019344,"teacher_disagreement_score":0.9585955,"about_ca_system_score_codex":0.00020904434,"about_ca_system_score_gemma":0.0002830412,"threshold_uncertainty_score":0.7429688},"labels":[],"label_agreement":null},{"id":"W2125439260","doi":"10.1161/circulationaha.105.548198","title":"Revised Adult Treatment Panel III Guidelines and Cardiovascular Disease Mortality in Men Attending a Preventive Medical Clinic","year":2005,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Canadian Institutes of Health Research; Institute of Gender and Health; National Institute on Aging; National Institutes of Health; Heart and Stroke Foundation of Canada","keywords":"Medicine; Cardiorespiratory fitness; Disease; Internal medicine; Proportional hazards model; Drug; Risk factor; Pharmacology","score_opus":0.07588537643514527,"score_gpt":0.3503964042895219,"score_spread":0.27451102785437664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125439260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98684233,0.0087723,0.0012153507,0.0010777916,0.00005565894,0.0013037638,0.0000052326022,0.00004708328,0.0006804797],"genre_scores_gemma":[0.9955329,0.0029400273,0.00023092848,0.0002680022,0.0007303016,0.00012286782,0.00007934085,0.000019272506,0.000076418786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978058,0.00019019157,0.00057288114,0.00044763423,0.00076039904,0.0002231423],"domain_scores_gemma":[0.99883515,0.000025846583,0.000072841525,0.0005746305,0.000151207,0.00034033065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013784993,0.00016460154,0.00054236373,0.000087266766,0.00006573802,0.000013380267,0.00003957733,0.00011434337,0.00012485124],"category_scores_gemma":[0.0004322266,0.00013582187,0.00045599637,0.00015861208,0.000041474737,0.000108019805,0.000024220442,0.00010991683,0.000015005589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001550683,0.00027490698,0.6206861,0.00031254016,0.0014189016,0.00016836515,0.00035482278,0.0003935037,0.000038430324,0.00008998606,0.00013704655,0.3759703],"study_design_scores_gemma":[0.005217107,0.00004043719,0.97737765,0.0004291146,0.000881082,0.000036732214,0.00011349765,0.013444523,0.000019481624,0.00006227763,0.0022290475,0.0001490715],"about_ca_topic_score_codex":0.0007884683,"about_ca_topic_score_gemma":0.000056465396,"teacher_disagreement_score":0.37582123,"about_ca_system_score_codex":0.0002496499,"about_ca_system_score_gemma":0.00023025191,"threshold_uncertainty_score":0.55386555},"labels":[],"label_agreement":null},{"id":"W2125656906","doi":"10.1186/1476-511x-8-56","title":"Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia","year":2009,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital; Hotel Dieu Hospital; Women's College Hospital; University of Toronto","funders":"Queen's University","keywords":"Fenofibrate; Atorvastatin; Ezetimibe; Combination therapy; Medicine; Dyslipidemia; Internal medicine; Pharmacology; Statin; Gastroenterology; Endocrinology","score_opus":0.05190796566337931,"score_gpt":0.37641309925429217,"score_spread":0.3245051335909129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125656906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925807,0.0046198145,0.00003493404,0.001498685,0.000088908535,0.001096184,0.000015949317,0.00000341985,0.00006139978],"genre_scores_gemma":[0.9989222,0.0005800201,0.00016951984,0.00024685994,0.000042274118,0.000019604337,0.000009413751,0.000005766512,0.000004302412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984304,0.00032482969,0.0006785143,0.00013342751,0.00027732403,0.00015550831],"domain_scores_gemma":[0.9989011,0.00020054373,0.0003161513,0.00037720788,0.000035243087,0.00016973673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050206936,0.00010011942,0.0005647151,0.00007773468,0.000031559914,0.0000020317052,0.00006804902,0.000036180383,0.0000031258924],"category_scores_gemma":[0.00014402236,0.000060742615,0.0001325983,0.0002443987,0.00007264639,0.000021993546,0.0000073368014,0.000072598756,6.525043e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033944074,0.008157294,0.629824,0.0065371613,0.00013440195,0.000005903888,0.039139584,0.0010446972,0.0003772093,0.0035646542,0.00009920144,0.27717185],"study_design_scores_gemma":[0.018864172,0.006120555,0.9693146,0.0007280712,0.000058925893,5.765793e-7,0.0017701536,0.0019377833,0.0006098378,0.00017238906,0.00035127118,0.00007166],"about_ca_topic_score_codex":0.00040811652,"about_ca_topic_score_gemma":0.000031400563,"teacher_disagreement_score":0.33949062,"about_ca_system_score_codex":0.00008464375,"about_ca_system_score_gemma":0.00057073345,"threshold_uncertainty_score":0.2477012},"labels":[],"label_agreement":null},{"id":"W2125673037","doi":"10.1016/j.jacc.2015.09.017","title":"American College of Cardiology","year":2015,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Learning Partnership","funders":"","keywords":"Medicine; Reimbursement; Cardiology; Family medicine; Internal medicine; Medical education; Health care","score_opus":0.036325029589330704,"score_gpt":0.3336512545915049,"score_spread":0.2973262250021742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125673037","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019519217,0.9897744,0.0002114243,0.00058816967,0.0014449351,0.001489905,0.0016205818,0.000012789062,0.002905838],"genre_scores_gemma":[0.010368867,0.9848794,0.0009626045,0.0001618047,0.0031798568,0.000030218866,0.000009902897,0.0001112764,0.00029610813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99183273,0.0031993217,0.0026879096,0.00044359957,0.0011975889,0.00063884805],"domain_scores_gemma":[0.9891513,0.00047596186,0.0066316645,0.0018478413,0.0014619922,0.00043125474],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.003579971,0.00065160485,0.016857097,0.0006908682,0.00007272784,0.000002214396,0.0011168576,0.00033452048,0.0000061285355],"category_scores_gemma":[0.0008458786,0.00038739463,0.007121541,0.0018958758,0.0026046806,0.00004343591,0.00035833035,0.0013930275,0.0000058722485],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018481101,0.00014476865,0.0019344685,0.013756306,0.03299106,0.004180478,0.000042099582,0.00022889202,0.00003419519,0.0006060788,0.12575844,0.8184751],"study_design_scores_gemma":[0.0011329199,0.0033451437,0.00056676724,0.002482972,0.00756746,0.031006187,0.00044017416,9.95923e-7,0.0000058536853,0.00006621344,0.9531009,0.0002844042],"about_ca_topic_score_codex":0.000072053,"about_ca_topic_score_gemma":0.0000043400323,"teacher_disagreement_score":0.82734245,"about_ca_system_score_codex":0.00058821647,"about_ca_system_score_gemma":0.005499917,"threshold_uncertainty_score":0.9998578},"labels":[],"label_agreement":null},{"id":"W2125923881","doi":"10.1016/s0149-2918(07)80089-0","title":"A Model for Assessing the Cost-Effectiveness of Atorvastatin and Simvastatin in Achieving Canadian Low-Density Lipoprotein Cholesterol Targets","year":2007,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McMaster University; Pfizer (Canada); Université de Montréal","funders":"","keywords":"Atorvastatin; Medicine; Simvastatin; Statin; Dosing; Cohort; Internal medicine; Population; Cost effectiveness; Pharmacology; Cholesterol; Environmental health","score_opus":0.12112275625688401,"score_gpt":0.42868644523898336,"score_spread":0.30756368898209935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125923881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9053203,0.00051125616,0.09123107,0.00039795175,0.00009356863,0.0023603803,0.000013393261,0.000013041567,0.000059060818],"genre_scores_gemma":[0.9937682,0.000113370486,0.00442348,0.0014580985,0.0001287891,0.000053819946,0.00000930904,0.000033382516,0.000011536772],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99795777,0.00037884587,0.00068255037,0.0003077446,0.00024878982,0.00042429983],"domain_scores_gemma":[0.99770194,0.0012874566,0.00015754729,0.00041399235,0.00017970506,0.00025938434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00987561,0.00016207129,0.00059701095,0.00008517343,0.00012054537,0.00002610139,0.00009747067,0.0001943214,0.0000013508628],"category_scores_gemma":[0.00041407047,0.00011683138,0.00021805782,0.0001695097,0.00018820868,0.00006301926,0.000033368524,0.0004609588,5.311867e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061160506,0.00029594457,0.11939971,0.00084584224,0.00027414566,0.00002283594,0.0007067739,0.00030276255,0.0018216042,0.00025960445,0.0000038132353,0.8754554],"study_design_scores_gemma":[0.003990347,0.0002899716,0.93981653,0.00058490166,0.00016282192,0.000016916836,0.00032223732,0.051935665,0.0016433251,0.0005693569,0.0004855186,0.00018237683],"about_ca_topic_score_codex":0.00568983,"about_ca_topic_score_gemma":0.019065754,"teacher_disagreement_score":0.875273,"about_ca_system_score_codex":0.000120346944,"about_ca_system_score_gemma":0.00050759484,"threshold_uncertainty_score":0.9988337},"labels":[],"label_agreement":null},{"id":"W2125968725","doi":"10.1016/j.atherosclerosis.2005.01.020","title":"Cholesterol ester transfer protein (CETP) Taq1B polymorphism influences the effect of a standardized cardiac rehabilitation program on lipid risk markers","year":2005,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Genotype; Cholesterylester transfer protein; Internal medicine; Lipoprotein; Hepatic lipase; Endocrinology; Coronary artery disease; Medicine; Polymorphism (computer science); Cholesterol; Lipid profile; Biology; Genetics; Gene","score_opus":0.006949622397684195,"score_gpt":0.25251392129454875,"score_spread":0.24556429889686454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125968725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907056,0.0003297327,0.000087252236,0.001923247,0.00011252569,0.0063272184,0.00006766107,0.00013232212,0.00031444637],"genre_scores_gemma":[0.9965081,0.00015557061,0.00088890415,0.00023087377,0.0003697059,0.0016992992,0.000008486932,0.00006387947,0.00007518597],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966254,0.00096917106,0.00053768756,0.00047011455,0.00097492925,0.00042265982],"domain_scores_gemma":[0.9983084,0.00025483352,0.0001306202,0.0010287461,0.00011101243,0.00016637848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025605776,0.00033461538,0.00079656526,0.000097532764,0.00018994202,0.00004775509,0.00018025517,0.00018889617,0.000047006906],"category_scores_gemma":[0.00025026329,0.00019805346,0.00087949727,0.00034007366,0.00027762927,0.00014807192,0.000026360378,0.00039805364,0.000028126728],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032669872,0.0005371478,0.11085564,0.0006736299,0.0011487677,6.2981513e-7,0.002195699,0.000074916716,0.03526594,0.000038949667,0.00031512664,0.8456266],"study_design_scores_gemma":[0.008640143,0.01425015,0.8723527,0.001134934,0.00092194404,0.0000039257766,0.0001913489,0.00006397102,0.08657516,0.000007733734,0.015501472,0.0003564892],"about_ca_topic_score_codex":0.00048959797,"about_ca_topic_score_gemma":0.000026914006,"teacher_disagreement_score":0.8452701,"about_ca_system_score_codex":0.00014808618,"about_ca_system_score_gemma":0.00008130946,"threshold_uncertainty_score":0.8076386},"labels":[],"label_agreement":null},{"id":"W2126100780","doi":"10.1503/cmaj.111017","title":"The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial","year":2012,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Rosuvastatin; Pneumonia; Jupiter (rocket family); Medicine; Computer science; Intensive care medicine; Internal medicine; Astronomy; Physics; Spacecraft","score_opus":0.007557131518692629,"score_gpt":0.25297529489799475,"score_spread":0.2454181633793021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126100780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9329606,0.0007022672,0.000014952097,0.0627924,0.0018580458,0.00048542244,0.000053141575,0.0000063384246,0.001126789],"genre_scores_gemma":[0.98718435,0.00017353792,0.000009695678,0.005040279,0.0073645087,0.000014811709,0.000015202625,0.000012164002,0.00018543254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958951,0.0009358053,0.00053400086,0.00009494728,0.0020891177,0.00045102197],"domain_scores_gemma":[0.99623346,0.0016917598,0.00031663428,0.0002557505,0.00013887213,0.0013635458],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011731418,0.000100965764,0.00028785848,0.00004200478,0.00040212026,0.00004456709,0.00016400668,0.00020960126,0.00021529896],"category_scores_gemma":[0.0122010745,0.000047541114,0.00027583557,0.00013086745,0.000044236374,0.00004595263,0.000012817885,0.0009953697,0.000057680496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0130392,0.00011272183,0.12303648,0.000024963343,0.001706554,0.00027852354,0.0032590262,0.000006428627,0.000037014146,0.00020660325,0.32613477,0.5321577],"study_design_scores_gemma":[0.043139376,0.001176189,0.3328973,0.0001681719,0.0002280645,0.00018879608,0.0003354148,0.000031104737,0.00015152378,0.000039266968,0.6215321,0.00011271642],"about_ca_topic_score_codex":0.009665491,"about_ca_topic_score_gemma":0.009778324,"teacher_disagreement_score":0.532045,"about_ca_system_score_codex":0.0008040685,"about_ca_system_score_gemma":0.001491908,"threshold_uncertainty_score":0.9969292},"labels":[],"label_agreement":null},{"id":"W2126107340","doi":"10.1136/hrt.2006.112508","title":"Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials","year":2007,"lang":"en","type":"review","venue":"Heart","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Mace; Atorvastatin; Internal medicine; Statin; Rosuvastatin; Simvastatin; Acute coronary syndrome; Meta-analysis; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.26814777598270223,"score_gpt":0.44522319802952615,"score_spread":0.17707542204682392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126107340","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030383645,0.9817735,0.00004099448,0.0002730134,0.00006928033,0.014085744,0.0006436722,0.000026506585,0.00004890583],"genre_scores_gemma":[0.002723218,0.99300605,0.00038882112,0.0010223495,0.00005155139,0.0016131819,0.0006307864,0.00005687375,0.00050716306],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99061275,0.0041902675,0.0030057947,0.0007581711,0.0009373916,0.0004956442],"domain_scores_gemma":[0.99334884,0.0037652722,0.00096618646,0.0009231339,0.0005585558,0.00043802243],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.009045615,0.000733066,0.036950238,0.0010923618,0.00006944024,0.00002656008,0.00010442923,0.0002804444,0.00069179316],"category_scores_gemma":[0.0007187069,0.00042528004,0.011035274,0.0011026236,0.00019686256,0.000077980556,0.0000548982,0.00054026087,0.000009915216],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036737747,0.00048029117,0.00022363209,0.0059217564,0.9156138,0.0006780574,0.00037067404,0.000008217229,0.000005057286,0.000024321896,0.0019241113,0.03801236],"study_design_scores_gemma":[0.061105777,0.00070903363,0.0027700528,0.0013145817,0.7319318,0.00027597722,0.00021026978,0.000036803307,0.0000022410488,0.000014125548,0.20121393,0.00041541885],"about_ca_topic_score_codex":0.00028749966,"about_ca_topic_score_gemma":0.000027491087,"teacher_disagreement_score":0.19928981,"about_ca_system_score_codex":0.00013525854,"about_ca_system_score_gemma":0.001093527,"threshold_uncertainty_score":0.9998199},"labels":[],"label_agreement":null},{"id":"W2126147349","doi":"10.1093/eurheartj/ehu171","title":"Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial","year":2014,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":252,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal","keywords":"Medicine; Atheroma; Placebo; Cardiology; Coronary atherosclerosis; Internal medicine; Intravascular ultrasound; Randomized controlled trial; Coronary artery disease; Pathology","score_opus":0.012321791230382824,"score_gpt":0.22734674307045463,"score_spread":0.2150249518400718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126147349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951874,0.00012999895,0.00007815728,0.0003425932,0.00060948974,0.0034365857,0.0000037696484,0.000023123714,0.00018885374],"genre_scores_gemma":[0.99822116,0.000095188465,0.00033510814,0.0007179376,0.00036359546,0.000025287638,0.000005891468,0.000070390655,0.00016545864],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99404866,0.0035564995,0.000611718,0.00030869336,0.0010920775,0.00038238155],"domain_scores_gemma":[0.9984405,0.00023312606,0.00032557733,0.00061197905,0.00012573974,0.00026306667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031908767,0.00027868772,0.0011478065,0.00013317226,0.00019055852,0.000028935592,0.00018943324,0.000063796455,0.000051345804],"category_scores_gemma":[0.00030427705,0.0001531798,0.00055910746,0.00021311252,0.0001632979,0.00006421543,0.00009297538,0.00073431263,0.0000463421],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9424604,0.0030744758,0.02355415,0.00034534643,0.0016528569,0.00050271914,0.0003982241,0.000036281686,0.0006652893,0.000030756404,0.0008281942,0.026451271],"study_design_scores_gemma":[0.41816822,0.0036831677,0.5762092,0.0007358079,0.00032353247,0.00024762307,0.000004150828,0.0000072799944,0.00030661633,0.000010329012,0.00019894754,0.000105134626],"about_ca_topic_score_codex":0.00012983018,"about_ca_topic_score_gemma":0.0000048207635,"teacher_disagreement_score":0.55265504,"about_ca_system_score_codex":0.00013681014,"about_ca_system_score_gemma":0.00011468757,"threshold_uncertainty_score":0.6246491},"labels":[],"label_agreement":null},{"id":"W2126315888","doi":"10.1177/0091270009335766","title":"Iatrogenic Severe Depression of High‐Density Lipoprotein Cholesterol","year":2009,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Health Sciences Centre","funders":"","keywords":"Fibrate; Fenofibrate; Medicine; Cholesterol; Internal medicine; Drug; Depression (economics); Statin; Endocrinology; Pharmacology","score_opus":0.035605492307966544,"score_gpt":0.3924006890397838,"score_spread":0.35679519673181725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126315888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98991203,0.0019038032,0.00038695842,0.0061973147,0.0010108956,0.00040257614,0.0000015235482,0.000009900397,0.00017499585],"genre_scores_gemma":[0.98943585,0.001477666,0.0004337491,0.005622405,0.0029567417,0.0000010460341,6.916105e-7,0.000010793329,0.00006106394],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99681056,0.0009356851,0.0013884602,0.00012805137,0.00050810154,0.0002291345],"domain_scores_gemma":[0.99779826,0.0002989264,0.00094090507,0.00033675024,0.00035075902,0.0002743847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049625477,0.00012768082,0.0010063645,0.000065332875,0.000060665156,0.0000030143106,0.00025909624,0.00019241213,0.00015428055],"category_scores_gemma":[0.00028697576,0.0000718638,0.0009136919,0.00012638875,0.00013477293,0.000068232875,0.000052198673,0.0010393899,0.000012710779],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018564548,0.002324667,0.0100520635,0.00019281526,0.0027394646,0.00033318953,0.000218345,0.00025577054,0.04591349,0.000034824905,0.024318596,0.8950522],"study_design_scores_gemma":[0.018201854,0.0059426716,0.8977279,0.00019472378,0.0033925902,0.005173297,0.000048047783,0.00006110335,0.06312701,0.0012292637,0.004736165,0.0001653807],"about_ca_topic_score_codex":0.00008781034,"about_ca_topic_score_gemma":0.0000049035953,"teacher_disagreement_score":0.89488685,"about_ca_system_score_codex":0.000029872248,"about_ca_system_score_gemma":0.0002909475,"threshold_uncertainty_score":0.45156893},"labels":[],"label_agreement":null},{"id":"W2127053988","doi":"10.1161/atvbaha.112.300090","title":"Atorvastatin Delays Murine Platelet Activation In Vivo Even in the Absence of Endothelial NO Synthase","year":2012,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Enos; Atorvastatin; Platelet activation; Thrombin; In vivo; Chemistry; Platelet; Agonist; Endothelial activation; Pharmacology; Internal medicine; Endocrinology; Receptor; Medicine; Endothelium; Biology; Nitric oxide synthase; Nitric oxide","score_opus":0.03154714932851155,"score_gpt":0.2884612002672401,"score_spread":0.25691405093872854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127053988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986148,0.00010716417,0.00021130877,0.00024949491,0.00009120724,0.00054645026,0.00001996204,0.000009980316,0.00014967],"genre_scores_gemma":[0.9974624,0.0014373823,0.00038849362,0.00043314783,0.00016004161,0.00008624942,0.00001611197,0.000015038429,0.000001135225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985386,0.00029488225,0.0003810306,0.00024085495,0.00017964502,0.00036499556],"domain_scores_gemma":[0.9992892,0.00009492285,0.000098635894,0.00039558846,0.00004246217,0.00007916021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012179299,0.00016209329,0.00050192676,0.000114552255,0.000050365474,0.000007824127,0.00009181854,0.00013513722,0.000079640675],"category_scores_gemma":[0.000086113665,0.00011110734,0.00015978357,0.00020638962,0.00011119672,0.000109161265,0.000044083517,0.00016967578,0.00000809225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029438763,0.0005642267,0.5012839,0.00017647403,0.0001787393,2.3116463e-7,0.0020936364,0.0000019925194,0.49245572,0.0006148372,0.000057960486,0.0025428657],"study_design_scores_gemma":[0.00176117,0.00030218944,0.99022424,0.00015948276,0.00003122866,0.0000024927326,0.000312984,0.00004448629,0.004892456,0.000020538708,0.0021304297,0.00011830606],"about_ca_topic_score_codex":0.0010511051,"about_ca_topic_score_gemma":0.00008683096,"teacher_disagreement_score":0.48894036,"about_ca_system_score_codex":0.00003881497,"about_ca_system_score_gemma":0.00003542136,"threshold_uncertainty_score":0.4530826},"labels":[],"label_agreement":null},{"id":"W2127091643","doi":"10.1136/hrt.2005.066050","title":"Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targets","year":2006,"lang":"en","type":"review","venue":"Heart","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"School of Medicine, New York University; York University","keywords":"Medicine; Cholesterol; Lipoprotein; High-density lipoprotein; Internal medicine; Homeostasis; Statin; Cardiology; Clinical trial; Fibrous cap; Endocrinology; Bioinformatics; Biology","score_opus":0.04900464778781647,"score_gpt":0.33742702055548807,"score_spread":0.2884223727676716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127091643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002158371,0.99155957,0.00013101439,0.00017313405,0.0001448401,0.005574361,0.000036747122,0.00007701669,0.00014496713],"genre_scores_gemma":[0.0010334658,0.9930711,0.0028420144,0.00060476584,0.0008168079,0.0009647463,0.00008479781,0.00016919003,0.00041313996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975404,0.00024126118,0.0005959868,0.00070679974,0.00040538626,0.00051017606],"domain_scores_gemma":[0.9988106,0.00006275409,0.00019783509,0.0007261977,0.0000607756,0.00014186144],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008866382,0.00048636232,0.0023275707,0.00013769664,0.00014638877,0.00003233042,0.00007455762,0.00044144448,0.000030296833],"category_scores_gemma":[0.00005883483,0.00033855173,0.0006213639,0.00028200922,0.0000641215,0.000065833075,0.00006239516,0.0004603862,0.000015601488],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007450182,0.00022792947,0.00040208953,0.032702338,0.00021046319,0.000022086495,0.00011823763,1.6735929e-7,0.000023311377,0.00025248478,0.0010751704,0.9648912],"study_design_scores_gemma":[0.0013996623,0.00019337935,0.0016007198,0.019032164,0.0005886748,0.00011108848,0.000010962814,0.000004853349,0.000050362927,0.00026489588,0.97639745,0.0003457877],"about_ca_topic_score_codex":0.006436389,"about_ca_topic_score_gemma":0.0002832645,"teacher_disagreement_score":0.9753223,"about_ca_system_score_codex":0.00019755996,"about_ca_system_score_gemma":0.00025374492,"threshold_uncertainty_score":0.99990666},"labels":[],"label_agreement":null},{"id":"W2127110427","doi":"10.1016/s0828-282x(10)70454-2","title":"Prevalence of dyslipidemia in statin-treated patients in Canada: Results of the DYSlipidemia International Study (DYSIS)","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University; University of British Columbia; University of Ottawa; Merck Canada Inc. (Canada); St. Michael's Hospital; Canadian Heart Research Centre; University of Toronto","funders":"","keywords":"Medicine; Dyslipidemia; Interquartile range; Rosuvastatin; Observational study; Statin; Atorvastatin; Internal medicine; Cholesterol; Guideline; Obesity; Pathology","score_opus":0.009628994290845277,"score_gpt":0.24055604711757467,"score_spread":0.2309270528267294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127110427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967433,0.00010605531,0.0000047400094,0.00043030977,0.0011189653,0.00042697004,0.000119652,6.7644606e-7,0.0010493192],"genre_scores_gemma":[0.99955463,0.000018732231,0.00004550812,0.000081137645,0.00025324893,0.0000044472567,0.000004423386,0.0000096123085,0.00002826738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976851,0.0004006873,0.0010833412,0.00015631296,0.00040168376,0.00027292848],"domain_scores_gemma":[0.9981311,0.00012225557,0.00050202565,0.0003968247,0.0005770632,0.0002707626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001726197,0.00011390111,0.0007238333,0.00030468387,0.00002103976,0.0000023363234,0.00032691006,0.000103901926,0.000015063288],"category_scores_gemma":[0.0020209565,0.00008151401,0.00017611042,0.00027250475,0.0001031174,0.0000507848,0.000024520905,0.000690928,2.7814357e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015856589,0.000013575774,0.99441904,0.000047119254,0.00017240888,0.00007363755,0.00024014861,0.0006525632,0.00009691589,0.000011165125,0.0008105791,0.0033042722],"study_design_scores_gemma":[0.0035308888,0.00023389625,0.9936101,0.00013258471,0.00007741615,0.000034356974,0.00032072345,0.000016701078,0.00013877636,0.000015080184,0.0018316703,0.00005779882],"about_ca_topic_score_codex":0.8149825,"about_ca_topic_score_gemma":0.97682935,"teacher_disagreement_score":0.16184686,"about_ca_system_score_codex":0.00067553564,"about_ca_system_score_gemma":0.008038949,"threshold_uncertainty_score":0.9975845},"labels":[],"label_agreement":null},{"id":"W2127572026","doi":"10.1016/j.cjca.2015.06.010","title":"Incident Diabetes With Statins: Biology, Artifact, or Both?","year":2015,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pravastatin; Rosuvastatin; Diabetes mellitus; Internal medicine; Randomized controlled trial; Type 2 diabetes; Residual risk; Incidence (geometry); Placebo; Statin; Intensive care medicine; Cholesterol; Endocrinology; Alternative medicine","score_opus":0.028548843103370213,"score_gpt":0.2633594775046239,"score_spread":0.2348106344012537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127572026","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08551607,0.027385172,0.002255445,0.8605974,0.005911668,0.0023076187,0.0007623154,0.000058009377,0.015206334],"genre_scores_gemma":[0.21342734,0.00071781134,0.0017123432,0.7156347,0.06542436,0.000066981534,0.0005836339,0.000295256,0.0021375464],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970876,0.0005186089,0.00071176625,0.00032466144,0.00041034946,0.00094700616],"domain_scores_gemma":[0.99664676,0.00010415641,0.00053103134,0.00067094003,0.00086198084,0.0011851345],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013290145,0.00038788642,0.0021423972,0.00066411676,0.00008671551,0.000031542528,0.00029466383,0.0010121794,0.00008704423],"category_scores_gemma":[0.00045714655,0.00023962444,0.00056355563,0.00019948087,0.00042390169,0.00006468201,0.000019226976,0.0025942274,0.000029269273],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089281595,0.0000012502194,0.014043684,0.00018354793,0.0020368553,0.009681448,0.0000664001,0.0000347137,0.000007579419,0.000005493498,0.9668464,0.007003333],"study_design_scores_gemma":[0.0014436672,0.0023849322,0.0037018307,0.00029537163,0.0008156836,0.0069385855,0.00007740256,9.667046e-7,0.0000131344195,0.00013267744,0.98392665,0.00026911285],"about_ca_topic_score_codex":0.002905001,"about_ca_topic_score_gemma":0.0030201764,"teacher_disagreement_score":0.14496264,"about_ca_system_score_codex":0.0007623548,"about_ca_system_score_gemma":0.015148013,"threshold_uncertainty_score":0.9997068},"labels":[],"label_agreement":null},{"id":"W2127729207","doi":"10.1194/jlr.m003566","title":"Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters","year":2010,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":260,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Center for Complementary and Integrative Health; National Center for Complementary and Alternative Medicine; National Institutes of Health; U.S. Department of Veterans Affairs","keywords":"PCSK9; Rosuvastatin; LDL receptor; Internal medicine; Endocrinology; Rosuvastatin Calcium; Apolipoprotein B; Hamster; Cholesterol; Statin; Chemistry; Biology; Lipoprotein; Medicine","score_opus":0.04880353330455143,"score_gpt":0.3863875213842239,"score_spread":0.33758398807967244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127729207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967385,0.00038701584,0.0071190554,0.0013236131,0.00038931167,0.001053653,0.0000060951797,0.0000025694562,0.00004481242],"genre_scores_gemma":[0.993989,0.00026338556,0.004909397,0.000031086027,0.0006978282,0.000034165023,6.6405556e-7,0.00002104432,0.00005346048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99762434,0.00030912203,0.00060766796,0.0001698711,0.0009862192,0.00030277128],"domain_scores_gemma":[0.99811244,0.0005602765,0.00025996796,0.00037023594,0.0005572276,0.00013986524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007831581,0.0001053282,0.0005017148,0.0002661685,0.00009273501,0.000017053795,0.00016749793,0.000111653106,0.000007650249],"category_scores_gemma":[0.0012886038,0.00006366496,0.00015617149,0.0002666114,0.000096886135,0.00016386097,0.000077045086,0.0009081356,3.079506e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019749615,0.000058969556,0.0022957767,0.00085139385,0.000087610875,0.000006419744,0.0010832576,0.000055538236,0.9822818,0.00007757699,0.00023525702,0.010991437],"study_design_scores_gemma":[0.0037316063,0.002264659,0.011857538,0.0013552197,0.000051517847,0.00007430549,0.0007977612,0.00007186426,0.97847784,0.00016509333,0.001082845,0.00006973177],"about_ca_topic_score_codex":0.000099861696,"about_ca_topic_score_gemma":0.00009526672,"teacher_disagreement_score":0.0109217055,"about_ca_system_score_codex":0.000077654724,"about_ca_system_score_gemma":0.00016931277,"threshold_uncertainty_score":0.3945448},"labels":[],"label_agreement":null},{"id":"W2128030263","doi":"10.1016/s0140-6736(12)60771-5","title":"Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial","year":2012,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":579,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"PCSK9; Ezetimibe; Medicine; Evolocumab; Alirocumab; Placebo; Internal medicine; Statin; Gastroenterology; Population; Familial hypercholesterolemia; Tolerability; Clinical endpoint; Cholesterol; Apolipoprotein B; Endocrinology; Lipoprotein; Randomized controlled trial; Adverse effect; LDL receptor","score_opus":0.019894253757779305,"score_gpt":0.32070901116168743,"score_spread":0.3008147574039081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128030263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97385114,0.00006083779,0.00020862807,0.00036586932,0.00015736283,0.025154922,0.000055912074,0.000058864636,0.00008647004],"genre_scores_gemma":[0.9949511,0.000015121375,0.0006187915,0.0015366157,0.0009365202,0.0017256036,0.00004747171,0.00008353688,0.00008520903],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99545884,0.0013473158,0.00064561015,0.0005272451,0.0011413397,0.0008796516],"domain_scores_gemma":[0.9974591,0.0002730632,0.000278852,0.0013764154,0.00017587042,0.00043671226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035417008,0.00050453393,0.0027225062,0.00018223048,0.000110762645,0.000046250258,0.00028967575,0.00013179537,0.000018860786],"category_scores_gemma":[0.00032679006,0.00023645011,0.00021942853,0.0004274237,0.00009223168,0.00014593227,0.00005844322,0.0005195392,0.00001494239],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95510656,0.0016635386,0.0117202,0.00017801824,0.00041415772,0.000020687896,0.0016626206,0.00006329618,0.0038711277,6.849937e-7,0.000071145136,0.025227945],"study_design_scores_gemma":[0.89905417,0.035976827,0.049894772,0.0007910571,0.00023193902,0.000020872001,0.000045350214,0.000034414254,0.013460558,8.265345e-7,0.0001932411,0.00029597443],"about_ca_topic_score_codex":0.000960269,"about_ca_topic_score_gemma":0.000122008,"teacher_disagreement_score":0.056052413,"about_ca_system_score_codex":0.00016029621,"about_ca_system_score_gemma":0.00020716376,"threshold_uncertainty_score":0.9642156},"labels":[],"label_agreement":null},{"id":"W2128170302","doi":"10.1001/archinte.163.3.333","title":"The Importance of Indirect Costs in Primary Cardiovascular Disease Prevention","year":2003,"lang":"en","type":"article","venue":"Archives of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Indirect costs; Life expectancy; Medicine; Productivity; Environmental health; Cost–benefit analysis; Cost effectiveness; Economic cost; Business; Economics; Population; Risk analysis (engineering); Biology; Economic growth","score_opus":0.011827892892135794,"score_gpt":0.2651900897868011,"score_spread":0.25336219689466527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128170302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9270554,0.0438407,0.00128626,0.00040271963,0.0001837761,0.00070987426,0.000003338211,0.0000100391535,0.026507894],"genre_scores_gemma":[0.9960881,0.002981444,0.00035340985,0.00014506675,0.00010927852,0.000027708451,0.000007055413,0.000014103419,0.0002738617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982605,0.00023210366,0.00053713034,0.00019655362,0.0005853957,0.00018830856],"domain_scores_gemma":[0.9988317,0.0001729653,0.00015931368,0.0006459297,0.00004467114,0.0001454016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011501415,0.00011556173,0.00056452386,0.00012629236,0.00002658574,0.000001529263,0.0001272849,0.000023752607,0.000018073519],"category_scores_gemma":[0.00070820475,0.000069398724,0.0004224032,0.00015434272,0.00029006132,0.000030072539,0.00003093649,0.00018887159,7.799139e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001843127,0.00034029057,0.62273204,0.0012519795,0.0022289837,0.00025499467,0.0008282615,0.000029126559,0.0027846876,0.0026705912,0.00016575625,0.36487013],"study_design_scores_gemma":[0.0046480238,0.0007434051,0.975274,0.0034281118,0.0004243658,0.0001028487,0.00028705288,0.00004902324,0.0035841633,0.0020935845,0.009259346,0.00010604876],"about_ca_topic_score_codex":0.00024235887,"about_ca_topic_score_gemma":0.00003255297,"teacher_disagreement_score":0.3647641,"about_ca_system_score_codex":0.00004781312,"about_ca_system_score_gemma":0.00017443352,"threshold_uncertainty_score":0.28299978},"labels":[],"label_agreement":null},{"id":"W2129246977","doi":"10.1161/circresaha.114.304800","title":"Gene Therapy for Hypercholesterolemia","year":2014,"lang":"en","type":"letter","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Familial hypercholesterolemia; Medicine; Cholesterol; Allele; Genetic enhancement; LDL receptor; Gerontology; Internal medicine; Genetics; Gene; Lipoprotein; Biology","score_opus":0.16974874143016136,"score_gpt":0.4093148572630959,"score_spread":0.23956611583293455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129246977","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038809147,0.0027239807,0.004506481,0.94390655,0.00035784222,0.0065394146,0.00003412607,0.00012641818,0.0029960326],"genre_scores_gemma":[0.11965276,0.0006530761,0.00089333014,0.83687675,0.0328167,0.001634685,0.002859975,0.00027194485,0.004340803],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99627024,0.0004385293,0.00032322528,0.0005999569,0.0016924709,0.0006755813],"domain_scores_gemma":[0.99738765,0.00022805425,0.000063852625,0.001215318,0.00096689246,0.00013825449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030955106,0.00020531287,0.00054192205,0.00040903196,0.00023503456,0.00008472418,0.00018552356,0.00095160987,0.00010993455],"category_scores_gemma":[0.00019874296,0.00017482569,0.0004667014,0.00026558855,0.00010261861,0.000042403604,0.00003148266,0.002020281,0.00015906502],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008396155,0.000031909924,0.0007572498,0.0008781105,0.0002295043,0.00006202543,0.00005294419,0.000015816442,0.0008340779,0.000016059616,0.9334374,0.06360094],"study_design_scores_gemma":[0.0019166756,0.0002363483,0.00933918,0.000120046905,0.000035796005,0.000104135885,0.0000057983743,0.00033128052,0.0002864911,0.00032865687,0.98712957,0.00016604285],"about_ca_topic_score_codex":0.00012552014,"about_ca_topic_score_gemma":0.0000016211274,"teacher_disagreement_score":0.10702983,"about_ca_system_score_codex":0.00025825377,"about_ca_system_score_gemma":0.00048732117,"threshold_uncertainty_score":0.8777228},"labels":[],"label_agreement":null},{"id":"W2129496524","doi":"10.1194/jlr.d400030-jlr200","title":"Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia","year":2004,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Multiplex ligation-dependent probe amplification; Familial hypercholesterolemia; LDL receptor; Genetics; Exon; OMIM : Online Mendelian Inheritance in Man; Biology; Missense mutation; Mutation; Nonsense mutation; Point mutation; Molecular biology; Gene; Lipoprotein; Cholesterol; Phenotype; Endocrinology","score_opus":0.05763217528731816,"score_gpt":0.3734093919008277,"score_spread":0.31577721661350955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129496524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99311215,0.0013360172,0.0030482244,0.0015918114,0.00013284203,0.00059052877,0.000005237453,0.000004396176,0.00017880552],"genre_scores_gemma":[0.9936443,0.0017543271,0.0039004805,0.000041120074,0.00057626,0.000031613363,0.000003304243,0.000018649329,0.000029951303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962733,0.00025579554,0.0008460056,0.00016919155,0.0021884602,0.00026727296],"domain_scores_gemma":[0.99716866,0.000088709516,0.00036872417,0.00040597917,0.0017878274,0.0001800783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003688116,0.00010215093,0.0005011363,0.00040267187,0.000059922295,0.000014888354,0.00022620824,0.000121436664,0.000023759085],"category_scores_gemma":[0.0007608889,0.00007757904,0.00032245726,0.0004173366,0.00016399051,0.00012956322,0.00005277227,0.0005905217,0.000006205143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005531802,0.00093150634,0.01979968,0.0009740461,0.00032887168,0.000054384294,0.0010316594,0.00037133953,0.94403154,0.00023573988,0.00010909356,0.031578977],"study_design_scores_gemma":[0.003315137,0.0016346554,0.07489327,0.0010174388,0.00007674184,0.00012873136,0.0007007419,0.000014333663,0.91685396,0.00038477287,0.00090153,0.000078669946],"about_ca_topic_score_codex":0.00030326692,"about_ca_topic_score_gemma":0.000014038797,"teacher_disagreement_score":0.05509359,"about_ca_system_score_codex":0.00020214007,"about_ca_system_score_gemma":0.0007028932,"threshold_uncertainty_score":0.31635812},"labels":[],"label_agreement":null},{"id":"W2129575029","doi":"10.1681/asn.2005070779","title":"Effect of Pravastatin in People with Diabetes and Chronic Kidney Disease","year":2005,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Heart Foundation of Australia; Wake Forest University; Canadian Institutes of Health Research; Bristol-Myers Squibb","keywords":"Pravastatin; Kidney disease; Medicine; Diabetes mellitus; Internal medicine; Type 2 diabetes; Endocrinology; Intensive care medicine; Cholesterol","score_opus":0.0037922627696746515,"score_gpt":0.24649638321651857,"score_spread":0.24270412044684392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129575029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886542,0.0016517335,0.00004301248,0.009413151,0.000013055034,0.00021039226,0.0000037470136,0.000001875472,0.000008820514],"genre_scores_gemma":[0.9948231,0.0005467483,0.0011593376,0.003248389,0.000197578,0.000003555509,5.162174e-7,0.000010070166,0.000010711683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989708,0.00023406486,0.0002841523,0.00008225176,0.00026043292,0.00016828094],"domain_scores_gemma":[0.99889934,0.00011318725,0.00056107505,0.00020593622,0.0000702591,0.00015021398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007915993,0.000088214256,0.00066462986,0.000033629538,0.000021747777,0.0000017175231,0.00008598997,0.000024837753,0.000008697014],"category_scores_gemma":[0.000070518654,0.000048106955,0.00032571593,0.00021105421,0.00044663993,0.000037571648,0.00003503384,0.00022998391,1.756918e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030332536,0.00033998003,0.78531325,0.0017092944,0.0016526558,0.0000122695365,0.0018117347,0.00031251053,0.08513247,0.000009428781,0.008943572,0.1117296],"study_design_scores_gemma":[0.004723623,0.007279298,0.9763454,0.00027608773,0.00052893924,0.00009630404,0.00020553143,0.00061722595,0.0037560647,0.000010558813,0.0060869046,0.00007402712],"about_ca_topic_score_codex":0.000068792535,"about_ca_topic_score_gemma":0.000016440805,"teacher_disagreement_score":0.19103222,"about_ca_system_score_codex":0.00007375662,"about_ca_system_score_gemma":0.00040798017,"threshold_uncertainty_score":0.19617447},"labels":[],"label_agreement":null},{"id":"W2129748178","doi":"10.2217/clp.11.15","title":"Controlling lipids after acute coronary syndromes: what is the best strategy?","year":2011,"lang":"en","type":"article","venue":"Clinical Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Rosuvastatin; Atorvastatin; Medicine; Acute coronary syndrome; Internal medicine; Cardiology; Intensive care medicine; Myocardial infarction","score_opus":0.0985879360251023,"score_gpt":0.36062115678344364,"score_spread":0.26203322075834135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129748178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688627,0.012045748,0.0003793901,0.007098848,0.007381385,0.001348504,0.000017698292,0.00010713461,0.0027585684],"genre_scores_gemma":[0.96637845,0.008762695,0.0004938743,0.018637905,0.0044171386,0.00013972714,0.0000125383185,0.00004371395,0.0011139498],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99710673,0.00053932366,0.000920948,0.0005806149,0.00029522704,0.0005571766],"domain_scores_gemma":[0.9976714,0.00046392586,0.00015773236,0.0012030475,0.00015371104,0.00035017065],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0020312348,0.00025156,0.001021512,0.000049301998,0.00011917737,0.000032877346,0.00025861542,0.000502319,0.0012483627],"category_scores_gemma":[0.00018412333,0.00015210418,0.00085037947,0.00013475843,0.00059030106,0.00017557651,0.00012510382,0.0008544234,0.0008772565],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010880927,0.0030328217,0.26491675,0.0004156618,0.009764189,0.0016129748,0.0021385485,0.0000023887826,0.000099343684,0.0027357463,0.011774041,0.6926266],"study_design_scores_gemma":[0.017919702,0.017450035,0.7501696,0.0008341227,0.005822092,0.0059065577,0.0042472878,0.00028937357,0.00014883587,0.0056131617,0.19049679,0.0011024605],"about_ca_topic_score_codex":0.00007512592,"about_ca_topic_score_gemma":0.000015912163,"teacher_disagreement_score":0.69152415,"about_ca_system_score_codex":0.000030470344,"about_ca_system_score_gemma":0.00024794068,"threshold_uncertainty_score":0.9999007},"labels":[],"label_agreement":null},{"id":"W2130101433","doi":"10.1161/strokeaha.108.533018","title":"Applying the Evidence","year":2009,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; Canadian Heart Research Centre; University of Toronto; St. Michael's Hospital","funders":"Sanofi","keywords":"Medicine; Intensive care medicine","score_opus":0.03192985012744218,"score_gpt":0.300483775577362,"score_spread":0.26855392544991985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130101433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83353287,0.031751912,0.0047584306,0.032681275,0.00052615284,0.0055493494,0.0000052025516,0.00029749662,0.09089729],"genre_scores_gemma":[0.99471307,0.00021513642,0.00036568512,0.002882169,0.00044816636,0.00007869865,6.0071096e-7,0.0000037463963,0.0012927306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99941134,0.000022056087,0.000074458076,0.00009714261,0.0002603232,0.00013469082],"domain_scores_gemma":[0.99951524,0.000017138462,0.000015518863,0.00037069392,0.000026576077,0.000054819007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034950447,0.00004656145,0.00010344534,0.00001421079,0.00007519986,0.000010467241,0.000054861644,0.000023560458,0.000035327663],"category_scores_gemma":[0.00006638563,0.000026112028,0.00011382215,0.00006424404,0.00001536403,0.000031206324,0.000008444478,0.00012090584,0.000048169797],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003984519,0.000022176768,0.0019758395,0.000030285139,0.00004066695,0.000028702465,0.00009289776,0.0000031125942,0.004666051,0.0010803158,0.0017896466,0.99023044],"study_design_scores_gemma":[0.0015121495,0.0008862294,0.32860908,0.0005357136,0.0002762378,0.00039993678,0.00050092774,0.0001790995,0.009865615,0.0006664051,0.6563353,0.00023330186],"about_ca_topic_score_codex":0.00003922776,"about_ca_topic_score_gemma":0.000001956355,"teacher_disagreement_score":0.98999715,"about_ca_system_score_codex":0.000021355318,"about_ca_system_score_gemma":0.000050097344,"threshold_uncertainty_score":0.10648176},"labels":[],"label_agreement":null},{"id":"W2130249599","doi":"10.4065/83.11.1299","title":"Is Carotid Intima-Media Thickness a Reliable Clinical Predictor?","year":2008,"lang":"en","type":"letter","venue":"Mayo Clinic Proceedings","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Simvastatin; Ezetimibe; Intima-media thickness; Internal medicine; Cardiology; Familial hypercholesterolemia; Stenosis; Randomized controlled trial; Clinical trial; Statin; Carotid arteries; Cholesterol","score_opus":0.0557987194912783,"score_gpt":0.3246391550059041,"score_spread":0.26884043551462583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130249599","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039202135,0.0042246045,0.00005993861,0.88220936,0.009781207,0.0062627085,0.0002837214,0.0015355124,0.05644082],"genre_scores_gemma":[0.0028455795,0.010302501,0.002339504,0.89283323,0.060091726,0.00046548553,0.00050443294,0.00047188342,0.03014565],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907247,0.00008373427,0.00274732,0.0022110397,0.0026956731,0.0015375342],"domain_scores_gemma":[0.99521714,0.00034219926,0.0010188061,0.0014634847,0.001280875,0.0006775123],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00369583,0.0010421583,0.0034400658,0.0004092051,0.0002911815,0.00010943148,0.0008039152,0.004771677,0.0010428125],"category_scores_gemma":[0.0020763823,0.0008934927,0.0026160243,0.0007093993,0.0006611146,0.00023311195,0.00041020894,0.010363424,0.0018381809],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015031894,0.00016452347,0.028220985,0.0023973628,0.00079355336,0.0005466688,0.0005473126,1.5876529e-8,0.0000023520017,0.0000050065696,0.9657549,0.0014169796],"study_design_scores_gemma":[0.003726719,0.00083514355,0.012030297,0.0017402072,0.0012532107,0.0016119194,0.00010695691,0.000019873643,0.000035935496,0.00018327445,0.9776198,0.000836639],"about_ca_topic_score_codex":0.00022331075,"about_ca_topic_score_gemma":0.0000016594992,"teacher_disagreement_score":0.050310522,"about_ca_system_score_codex":0.00033258516,"about_ca_system_score_gemma":0.0018193998,"threshold_uncertainty_score":0.99987036},"labels":[],"label_agreement":null},{"id":"W2130306028","doi":"10.1017/s0007114507781461","title":"Comparison of a dietary portfolio diet of cholesterol-lowering foods and a statin on LDL particle size phenotype in hypercholesterolaemic participants","year":2007,"lang":"en","type":"article","venue":"British Journal Of Nutrition","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Université Laval","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Canada; Australian Government; Almond Board of California; PepsiCo","keywords":"Internal medicine; Cholesterol; Apolipoprotein B; Endocrinology; Statin; Ldl cholesterol; Psyllium; Chemistry; Medicine; Food science; Dietary fiber","score_opus":0.04441357511445654,"score_gpt":0.34005464984691663,"score_spread":0.2956410747324601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130306028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429744,0.005060978,0.00013447908,0.00010077241,0.00006810008,0.00028120677,0.000009988726,0.000005196569,0.00004180528],"genre_scores_gemma":[0.9975854,0.0013163673,0.0008513725,0.00009457641,0.00012712233,0.0000044129933,0.000003004372,0.000015379384,0.0000023601976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981344,0.000078866564,0.0009455664,0.00012768588,0.00044774916,0.00026572903],"domain_scores_gemma":[0.9990772,0.000094709525,0.00035129447,0.00012887713,0.00016879554,0.00017914205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00137824,0.00009483426,0.00063331396,0.00010526522,0.00002672521,0.00001311041,0.000051340445,0.00007565633,0.000009383754],"category_scores_gemma":[0.00021804383,0.00010280101,0.00013478001,0.00018539625,0.00006415275,0.00014649967,0.000018006665,0.00030224686,3.4999192e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072736614,0.008982852,0.53858197,0.002855808,0.00035589578,0.0010980852,0.0017984862,0.000057637022,0.11178382,0.000015483309,0.00018371797,0.3270126],"study_design_scores_gemma":[0.0062111006,0.003514911,0.9653655,0.0038293106,0.00011217464,0.0006303607,0.0007225939,0.00004929828,0.019339332,0.00008287786,0.000060865877,0.00008163124],"about_ca_topic_score_codex":0.0002164484,"about_ca_topic_score_gemma":0.00013335267,"teacher_disagreement_score":0.4267836,"about_ca_system_score_codex":0.000055324534,"about_ca_system_score_gemma":0.00004505762,"threshold_uncertainty_score":0.41921034},"labels":[],"label_agreement":null},{"id":"W2130760108","doi":"10.1161/01.cir.0000131517.20177.5a","title":"Beneficial Cardiovascular Pleiotropic Effects of Statins","year":2004,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":945,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Pharmacology; Nitric oxide; Drug; Mechanism of action; Endothelial dysfunction; HMG-CoA reductase; Mechanism (biology); Disease; Bioavailability; Reductase; Internal medicine; Enzyme; Biology; Biochemistry","score_opus":0.025690546848103468,"score_gpt":0.29661215055077994,"score_spread":0.2709216037026765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130760108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052833837,0.99320376,0.0029324638,0.000003303808,0.00037893435,0.0026785713,0.00001378105,0.000055471915,0.0002053676],"genre_scores_gemma":[0.0057584657,0.9926552,0.0003158262,0.000009296178,0.0007212327,0.00012017073,0.0003299075,0.00008081601,0.000009068023],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765986,0.00017899541,0.00066014234,0.000430077,0.00081130496,0.00025959508],"domain_scores_gemma":[0.99837774,0.000050358984,0.0002831726,0.0010243789,0.00013629704,0.0001280376],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000342635,0.00033119242,0.0027580245,0.00024395673,0.000057523826,0.000010338031,0.00008707913,0.0004129814,0.000014797774],"category_scores_gemma":[0.00013835472,0.00028024055,0.0030988664,0.0004115316,0.00003800742,0.00004354766,0.000028635044,0.00031455522,0.000034409713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000025666302,0.00004929001,0.000023334424,0.16772923,0.001636298,0.00004060421,0.000032979955,0.00007610765,0.0000013458795,0.00025931085,0.0000029056735,0.830146],"study_design_scores_gemma":[0.0019312596,0.0001585261,0.0048510716,0.056235652,0.017092861,0.00025904953,0.0000061059845,0.000011365428,0.000021156855,0.0001350608,0.918832,0.00046590637],"about_ca_topic_score_codex":0.00021909505,"about_ca_topic_score_gemma":0.0000019398851,"teacher_disagreement_score":0.9188291,"about_ca_system_score_codex":0.0004552286,"about_ca_system_score_gemma":0.0009801923,"threshold_uncertainty_score":0.99996495},"labels":[],"label_agreement":null},{"id":"W2131548964","doi":"10.1373/clinchem.2005.055228","title":"Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia","year":2005,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Pfizer","keywords":"Medicine; Hazard ratio; Internal medicine; Risk factor; Confidence interval; Familial hypercholesterolemia; Proportional hazards model; Lipoprotein(a); Population; Gastroenterology; Cholesterol; Lipoprotein; Endocrinology","score_opus":0.050233442046532954,"score_gpt":0.3389431140917171,"score_spread":0.28870967204518416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131548964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447864,0.002682167,0.00045344076,0.00044483264,0.00015550246,0.0012680383,0.00029586328,0.00009381748,0.0001277027],"genre_scores_gemma":[0.9929028,0.0006683638,0.0011613296,0.0009288034,0.0036645064,0.00023110367,0.00006753845,0.00007015687,0.00030538943],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965159,0.0001483498,0.00095091504,0.0010322912,0.0007881858,0.00056434434],"domain_scores_gemma":[0.99672365,0.000080376805,0.00012993108,0.0018780705,0.000136719,0.0010512422],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015378905,0.00032752313,0.0009975509,0.000036082245,0.00009100994,0.000035312198,0.00025652448,0.0004947242,0.0001254493],"category_scores_gemma":[0.00065677305,0.000296403,0.002233815,0.000111801186,0.00012273293,0.00012621061,0.00009092084,0.0009481131,0.000034698267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018145662,0.0015446899,0.14892435,0.0010302505,0.0014519109,0.00019997964,0.00020359969,0.00019388291,0.00063208176,0.0000016609725,0.00017675772,0.8438263],"study_design_scores_gemma":[0.035036623,0.0011528035,0.735323,0.00063498237,0.002845748,0.00014943734,0.00022257381,0.004378765,0.019000638,0.0002427448,0.19926298,0.0017497205],"about_ca_topic_score_codex":0.00017066533,"about_ca_topic_score_gemma":0.000020463762,"teacher_disagreement_score":0.84207654,"about_ca_system_score_codex":0.00020984965,"about_ca_system_score_gemma":0.00034062675,"threshold_uncertainty_score":0.9999488},"labels":[],"label_agreement":null},{"id":"W2131833043","doi":"10.1067/mhj.2002.125329","title":"Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial","year":2002,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Intravascular ultrasound; Medicine; Cardiology; Internal medicine; Clinical endpoint; Coronary atherosclerosis; Placebo; Coronary artery disease; Population; Randomized controlled trial; Pathology","score_opus":0.05966051073731534,"score_gpt":0.3621463927898446,"score_spread":0.3024858820525293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131833043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908001,0.005720153,0.0011894678,0.0009906143,0.00023519881,0.00092462753,0.0000050820536,0.000011536846,0.0001232119],"genre_scores_gemma":[0.9892198,0.004060638,0.005808478,0.00043391445,0.00038333875,0.000009625178,0.0000013313877,0.000021293166,0.0000616004],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971933,0.0009566912,0.0006584586,0.00020123522,0.0007433611,0.0002469912],"domain_scores_gemma":[0.9983754,0.00037675112,0.00038557645,0.00043187258,0.00016353185,0.00026687185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018559083,0.00014317677,0.00079292513,0.000054167507,0.00017317533,0.000016927686,0.0001207657,0.00008920861,0.000082908555],"category_scores_gemma":[0.0005024918,0.00008414078,0.0004870566,0.00024338141,0.00066491455,0.00006417801,0.000036949077,0.0006568936,0.000001237987],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015825301,0.002670147,0.052458968,0.00019209596,0.0018269127,0.00009464143,0.0008230195,0.0000345098,0.028569555,0.000031241805,0.077813886,0.8196597],"study_design_scores_gemma":[0.08118835,0.029864935,0.8295503,0.0014121879,0.001989324,0.015388344,0.0023250224,0.00042110222,0.0180496,0.0001337243,0.019028906,0.0006481969],"about_ca_topic_score_codex":0.00009756319,"about_ca_topic_score_gemma":0.0000015277974,"teacher_disagreement_score":0.8190115,"about_ca_system_score_codex":0.000035933,"about_ca_system_score_gemma":0.00025167663,"threshold_uncertainty_score":0.34311616},"labels":[],"label_agreement":null},{"id":"W2132022166","doi":"10.1186/1745-6215-12-70","title":"A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial","year":2011,"lang":"en","type":"article","venue":"Trials","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Public Health Agency; Public Health Agency of Canada","keywords":"Medicine; Randomized controlled trial; Observational study; Informed consent; Clinical trial; Neuraminidase inhibitor; Pharmacy; Intensive care medicine; Intensive care unit; Internal medicine; Alternative medicine; Family medicine; Disease; Infectious disease (medical specialty); Coronavirus disease 2019 (COVID-19)","score_opus":0.1198126686263749,"score_gpt":0.4323051490535987,"score_spread":0.3124924804272238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132022166","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030084401,0.00070551306,0.0009653557,0.0010791342,0.00082322094,0.96555454,0.0005629257,0.000030380133,0.00019454036],"genre_scores_gemma":[0.36223638,0.00003500806,0.0013247817,0.000062162115,0.00084594847,0.6353543,0.00007093614,0.000037182126,0.000033284996],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98329854,0.011747151,0.00304435,0.0006062146,0.0008523721,0.00045137104],"domain_scores_gemma":[0.99140716,0.005128897,0.0012524828,0.0004959313,0.0014904174,0.00022511878],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02496097,0.0004675044,0.0077631054,0.00049409893,0.00020764445,0.00012836145,0.0001723499,0.00018586323,0.0000371005],"category_scores_gemma":[0.014923208,0.00022687133,0.0008310077,0.00047506444,0.00016882017,0.00014838642,0.000023690674,0.00014150864,4.6571938e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9752156,0.0011416029,0.000017769567,0.00009559637,0.0047272756,0.000038414775,0.016122784,0.00000213257,0.00007362283,0.0004137224,0.00012391453,0.0020275302],"study_design_scores_gemma":[0.90733117,0.05824323,0.000009719517,0.00012113284,0.0066519757,0.0000059217687,0.026392559,0.000041293697,0.00041983245,0.0000643494,0.00051297643,0.00020585053],"about_ca_topic_score_codex":0.03537252,"about_ca_topic_score_gemma":0.08572267,"teacher_disagreement_score":0.33215198,"about_ca_system_score_codex":0.00080918905,"about_ca_system_score_gemma":0.00693525,"threshold_uncertainty_score":0.9986945},"labels":[],"label_agreement":null},{"id":"W2132069074","doi":"10.1194/jlr.m034132","title":"Rare APOA5 promoter variants associated with paradoxical HDL cholesterol decrease in response to fenofibric acid therapy","year":2013,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Dyslipidemia; Medicine; Internal medicine; Cholesterol; Endocrinology; Cholesterylester transfer protein; Fenofibrate; Combination therapy; Pharmacology; Lipoprotein; Obesity","score_opus":0.05570764879638716,"score_gpt":0.351594409564137,"score_spread":0.29588676076774983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132069074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98721355,0.00042356094,0.000071560855,0.010594187,0.00007344763,0.0014050798,0.000002482439,0.000010642357,0.00020548023],"genre_scores_gemma":[0.99730694,0.00015520534,0.0005285783,0.00067976944,0.00064891763,0.000063838415,0.0000020701596,0.000041669886,0.0005729846],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9943955,0.0019114664,0.0005795092,0.00026079427,0.0021454587,0.00070730376],"domain_scores_gemma":[0.9969512,0.00025353272,0.00013369166,0.0004943393,0.0010868568,0.0010803436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009251923,0.00016941964,0.0006312807,0.00075054326,0.000105749474,0.0001079081,0.00025867423,0.00017209486,0.00033471797],"category_scores_gemma":[0.0022662973,0.0001027688,0.00019584435,0.0010405421,0.0000822353,0.00023574391,0.00006478985,0.0011910488,0.00008359932],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093728736,0.0077333758,0.19699079,0.00037630173,0.0023791627,0.0076164706,0.006974356,0.000050469225,0.3700874,0.00001927741,0.020020373,0.29402328],"study_design_scores_gemma":[0.008854045,0.006583444,0.97321576,0.00097561994,0.00001916275,0.0009743032,0.00017012272,0.000043989385,0.0047380514,0.000050134524,0.004227578,0.00014778481],"about_ca_topic_score_codex":0.00016979137,"about_ca_topic_score_gemma":0.000020492316,"teacher_disagreement_score":0.776225,"about_ca_system_score_codex":0.00036930095,"about_ca_system_score_gemma":0.0012644007,"threshold_uncertainty_score":0.517458},"labels":[],"label_agreement":null},{"id":"W2132196134","doi":"10.1186/1475-2840-13-26","title":"Residual macrovascular risk in 2013: what have we learned?","year":2014,"lang":"en","type":"review","venue":"Cardiovascular Diabetology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Royal Victoria Regional Health Centre; Montreal Clinical Research Institute; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"H. Lundbeck A/S; Servier; Astellas Pharma; Novo Nordisk; International Atherosclerosis Society; Québec Consortium for Drug Discovery; Anthera; Regeneron Pharmaceuticals; Amarin Corporation; Boston Scientific Corporation; Genentech; Valeant Pharmaceuticals International; Daiichi Sankyo Europe; Kowa Company; Halozyme; Sanofi; GlaxoSmithKline; Eli Lilly and Company; AstraZeneca; Amylin Pharmaceuticals; Amgen; Pfizer","keywords":"Ezetimibe; Medicine; Residual risk; PCSK9; Metabolic syndrome; Internal medicine; Statin; Niacin; Type 2 diabetes; Diabetes mellitus; Endocrinology; Intensive care medicine; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.03707531681915845,"score_gpt":0.3160759821856446,"score_spread":0.27900066536648616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132196134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001047643,0.9924113,0.0006144089,0.00032133196,0.0013682995,0.0042578187,0.00004502122,0.0002071955,0.00066984317],"genre_scores_gemma":[0.000043038603,0.9942719,0.00042517215,0.00017078492,0.0025361166,0.001062975,0.0006406831,0.00043454152,0.00041481058],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.986239,0.00525531,0.002095964,0.0026570635,0.0017578315,0.00199483],"domain_scores_gemma":[0.99155575,0.00034445158,0.0006025648,0.0064946823,0.00027320746,0.0007293148],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"category_scores_codex":[0.007989009,0.0016072622,0.015470941,0.0013051243,0.00021606634,0.00016327096,0.0007900544,0.0027706062,0.0001656154],"category_scores_gemma":[0.00067703717,0.0013617286,0.01610921,0.0009566196,0.0004504876,0.0002830645,0.00047006167,0.0035411322,0.0013009884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020424723,0.00010508853,0.00012625294,0.02742445,0.0155177545,0.0011209274,0.00007138397,0.00005633346,4.6385402e-8,0.00004677698,0.0014332781,0.9540773],"study_design_scores_gemma":[0.003052695,0.00015759835,0.00009709209,0.017159998,0.020297518,0.0021630607,0.00011964764,0.000017085591,0.000002743912,0.00010804763,0.95568323,0.0011412954],"about_ca_topic_score_codex":0.00056247076,"about_ca_topic_score_gemma":0.00016567143,"teacher_disagreement_score":0.9542499,"about_ca_system_score_codex":0.0006973044,"about_ca_system_score_gemma":0.0011455399,"threshold_uncertainty_score":0.9996675},"labels":[],"label_agreement":null},{"id":"W2132610854","doi":"10.1001/jama.295.17.2046","title":"Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes","year":2006,"lang":"en","type":"review","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Randomized controlled trial; Myocardial infarction; Stroke (engine); Clinical trial; Acute coronary syndrome; Confidence interval; Placebo; Physical therapy","score_opus":0.048281224969694704,"score_gpt":0.3797420027216252,"score_spread":0.3314607777519305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132610854","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15146765,0.8441987,0.0000056616664,0.000038362297,0.00015014016,0.0037227971,0.00008292298,0.00003412304,0.00029963168],"genre_scores_gemma":[0.0045234323,0.99354535,0.00023008516,0.00007653604,0.00018738654,0.00038275038,0.00018559617,0.000080069905,0.0007887986],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99732316,0.0003564563,0.0009446932,0.0005025796,0.0005482442,0.00032489808],"domain_scores_gemma":[0.9983246,0.00044888424,0.00024553444,0.0007577336,0.000057828507,0.00016543265],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037061784,0.00047550775,0.0043337694,0.00019974908,0.00002201219,0.000012477995,0.000111239555,0.00040583528,0.000007838263],"category_scores_gemma":[0.000039933166,0.00026040524,0.0013368975,0.00018750112,0.00007301518,0.000035468147,0.000030383882,0.0004776159,0.00002233842],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014414219,0.00091648777,0.03168946,0.013462538,0.0027428411,0.0036257675,0.000022400507,8.3633495e-8,3.9988887e-8,0.0000078113235,0.000058143374,0.9473303],"study_design_scores_gemma":[0.007507905,0.017292159,0.70853275,0.032869134,0.009029091,0.00060692226,0.0000053047274,3.3855687e-7,0.0000038145995,0.00000277056,0.22370988,0.00043990483],"about_ca_topic_score_codex":0.00038387053,"about_ca_topic_score_gemma":0.00004752245,"teacher_disagreement_score":0.94689035,"about_ca_system_score_codex":0.00030840075,"about_ca_system_score_gemma":0.0005873853,"threshold_uncertainty_score":0.9999848},"labels":[],"label_agreement":null},{"id":"W2132627628","doi":"10.1161/circulationaha.104.517565","title":"Effect of Pravastatin on Rate of Kidney Function Loss in People With or at Risk for Coronary Disease","year":2005,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"Pravastatin; Medicine; Renal function; Kidney disease; Internal medicine; Urology; Placebo; Post-hoc analysis; Kidney; Cardiology; Endocrinology; Cholesterol; Pathology","score_opus":0.020509770815520592,"score_gpt":0.31230502130738647,"score_spread":0.2917952504918659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132627628","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055922184,0.9326881,0.0015709362,0.000029533325,0.00014079669,0.0092833135,0.00029502236,0.000025012994,0.000045071527],"genre_scores_gemma":[0.07420493,0.9227364,0.00007095965,0.000051299947,0.0002590304,0.00063668087,0.0018834113,0.000073554176,0.00008369684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828744,0.00045789237,0.00050582265,0.0003148009,0.0002814415,0.00015261665],"domain_scores_gemma":[0.9984694,0.00025572884,0.0005521371,0.00044840793,0.000087974084,0.00018634585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011199617,0.00023418642,0.0014067234,0.00017829376,0.000035018504,0.0000026344833,0.000036076457,0.00014229152,0.00003657806],"category_scores_gemma":[0.0004999518,0.00014794996,0.0004437502,0.00028484777,0.0000266527,0.000040872423,0.00001113023,0.00015033258,0.000005515359],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040073097,0.000098486154,0.013368149,0.076751396,0.0002747625,0.000009368466,0.000028742605,0.00016495431,0.0000013500965,0.000012374011,0.00006283886,0.90522027],"study_design_scores_gemma":[0.016164359,0.0070540668,0.34599707,0.07387272,0.018420951,0.00010137191,0.000010536131,0.0011701268,0.00002837136,0.000020497591,0.5364505,0.0007094567],"about_ca_topic_score_codex":0.00006783252,"about_ca_topic_score_gemma":0.000035242912,"teacher_disagreement_score":0.9045108,"about_ca_system_score_codex":0.00030589648,"about_ca_system_score_gemma":0.00077259145,"threshold_uncertainty_score":0.60332245},"labels":[],"label_agreement":null},{"id":"W2132673088","doi":"10.1016/j.atherosclerosis.2009.09.077","title":"The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles","year":2009,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Apolipoprotein B; Apolipoprotein C2; Chemistry; Apolipoprotein E; Internal medicine; Medicine; Biochemistry; Very low-density lipoprotein; Cholesterol; Lipoprotein","score_opus":0.019392589453894604,"score_gpt":0.24698684245616287,"score_spread":0.22759425300226827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132673088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991377,0.0005429277,0.0001447634,0.0046741855,0.000076504,0.0018335402,0.000041115658,0.00016964204,0.0011403286],"genre_scores_gemma":[0.99485666,0.00033920546,0.0004798676,0.0035828657,0.00022534649,0.00018183175,0.000016001775,0.00007287348,0.00024537658],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963348,0.00028935724,0.00066423166,0.000562388,0.0013262564,0.00082296703],"domain_scores_gemma":[0.9972755,0.00016623369,0.00038588693,0.0015208407,0.00027670944,0.00037484913],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015094654,0.00042962408,0.00091499096,0.00009159474,0.00044005085,0.00006909518,0.00030649203,0.00024418693,0.00008412942],"category_scores_gemma":[0.00038654867,0.00026177286,0.00049686077,0.0007355942,0.00024983945,0.00009425109,0.00004037666,0.00040921362,0.00003990708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011847854,0.009105299,0.012305176,0.00041448363,0.006383243,0.00012687112,0.0046749846,0.00006372188,0.61487156,0.019929143,0.008246427,0.3120312],"study_design_scores_gemma":[0.015014149,0.0068532815,0.34530005,0.0015468468,0.000844742,0.000046384946,0.00032749615,0.00032520946,0.6224045,0.0013761586,0.005175821,0.00078533666],"about_ca_topic_score_codex":0.0027397964,"about_ca_topic_score_gemma":0.00009440279,"teacher_disagreement_score":0.33299488,"about_ca_system_score_codex":0.00020854031,"about_ca_system_score_gemma":0.00027480526,"threshold_uncertainty_score":0.99998343},"labels":[],"label_agreement":null},{"id":"W2133043280","doi":"10.1016/j.jacl.2014.03.004","title":"An assessment by the Statin Muscle Safety Task Force: 2014 update","year":2014,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":484,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; myalgia; Adverse effect; Statin; Muscle biopsy; Physical medicine and rehabilitation; Physical therapy; Referral; Intensive care medicine; Internal medicine; Biopsy; Family medicine","score_opus":0.02842061362033824,"score_gpt":0.4207495266566056,"score_spread":0.3923289130362673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133043280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74780625,0.0013137838,0.16334191,0.07215295,0.009968334,0.00085113256,0.000037223694,0.00004645827,0.0044819373],"genre_scores_gemma":[0.9590835,0.0016151252,0.010038427,0.015762405,0.013131727,0.000005332159,0.000024592056,0.000033076332,0.00030582113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952306,0.0019605614,0.0017200338,0.000218748,0.0005560998,0.0003139135],"domain_scores_gemma":[0.9968205,0.0009305544,0.00085114414,0.000666472,0.00029999125,0.0004313578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014405653,0.00013908905,0.0010361546,0.000045294797,0.0001069697,0.000017915758,0.00028035484,0.00022692575,0.00030770816],"category_scores_gemma":[0.0011093543,0.00007648402,0.0006225007,0.00007583978,0.00019074239,0.00009578908,0.00004481472,0.0011285925,0.000037974478],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001364305,0.0009997783,0.02006176,0.000078077384,0.000713631,0.00002088382,0.00009568332,0.00008101011,0.0010993001,0.0025112212,0.27674806,0.6962263],"study_design_scores_gemma":[0.0042194496,0.0039918954,0.19349943,0.000032310283,0.00025848663,0.0002851647,0.000079546466,0.00061293034,0.000019708046,0.0011243257,0.79578257,0.00009417583],"about_ca_topic_score_codex":0.000029000134,"about_ca_topic_score_gemma":0.000012868612,"teacher_disagreement_score":0.6961321,"about_ca_system_score_codex":0.000040654737,"about_ca_system_score_gemma":0.00039297456,"threshold_uncertainty_score":0.49927408},"labels":[],"label_agreement":null},{"id":"W2133612265","doi":"10.1016/j.jacl.2010.03.004","title":"Should we use apoB for risk assessment and as a target for treatment?","year":2010,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Apolipoprotein B; Component (thermodynamics); Cholesterol; Lipoprotein; Feeling; Ldl cholesterol; Clinical Practice; Risk assessment; Internal medicine; Family medicine; Computer science; Psychology; Social psychology","score_opus":0.17666316196760606,"score_gpt":0.49987003720800327,"score_spread":0.3232068752403972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133612265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654146,0.00050534157,0.011976667,0.015259888,0.0054785945,0.0011840936,0.000044702647,0.000012128731,0.0001240291],"genre_scores_gemma":[0.692276,0.0063750795,0.26945147,0.00299758,0.027898543,0.000101897545,0.00001627873,0.000059239144,0.0008239064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796104,0.00022323633,0.0011297455,0.00022038867,0.00020408211,0.00026150158],"domain_scores_gemma":[0.99572694,0.0025334298,0.00065368554,0.00030214564,0.0003752865,0.00040852232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003981016,0.00014323772,0.0012372489,0.000079501726,0.00008264335,0.000020888818,0.00007229026,0.0003750673,0.000053496333],"category_scores_gemma":[0.0040285876,0.00008933603,0.0010066467,0.000040072173,0.00012248165,0.0000921362,0.000020615427,0.0005345568,0.0000021343803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012127715,0.00210081,0.2777332,0.0002605638,0.0032827505,0.00004056024,0.00011355079,0.0000066730954,0.0008261131,0.004661948,0.018545438,0.68030065],"study_design_scores_gemma":[0.016625838,0.019897157,0.08966198,0.00003989517,0.0011180422,0.0007115029,0.000042269232,0.00024832724,0.00012519513,0.0068494393,0.8645692,0.00011119817],"about_ca_topic_score_codex":0.00003265759,"about_ca_topic_score_gemma":0.000043552616,"teacher_disagreement_score":0.84602374,"about_ca_system_score_codex":0.000031164407,"about_ca_system_score_gemma":0.0007121127,"threshold_uncertainty_score":0.4822887},"labels":[],"label_agreement":null},{"id":"W2134120087","doi":"10.1016/s0140-6736(11)60739-3","title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","year":2011,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2466,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Medical Research Council; Medical Research Council; National Health and Medical Research Council; British Heart Foundation","keywords":"Simvastatin; Ezetimibe; Medicine; Kidney disease; Placebo; Internal medicine; Cholesterol; Statin; Ldl cholesterol; Cardiology; Kidney; Pathology","score_opus":0.010228170005904582,"score_gpt":0.2256971879316843,"score_spread":0.21546901792577972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134120087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844546,0.00016616701,0.00006440167,0.00012902688,0.000049641472,0.015085002,0.0000028421168,0.000012590276,0.000035744175],"genre_scores_gemma":[0.99839514,0.000019530049,0.000027670198,0.00006192305,0.00015453991,0.0013074941,0.0000016283747,0.000016588221,0.00001545362],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99866205,0.00031113048,0.0002766058,0.000168577,0.00037600868,0.0002056472],"domain_scores_gemma":[0.9990399,0.00011146614,0.00016499667,0.0005147535,0.000059544338,0.00010935893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008618787,0.00013197566,0.00079470954,0.00003938794,0.00007691264,0.00000870077,0.000080553844,0.000023594781,0.0000039615625],"category_scores_gemma":[0.00023923231,0.00005614299,0.000071196344,0.00011901482,0.000091966176,0.000033144053,0.00002459977,0.0001777852,3.1765575e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9838603,0.00043120523,0.0124049205,0.0004432713,0.00037397342,0.0000054478833,0.0013823673,0.000025955324,0.0000847512,0.0000012260783,0.000018083398,0.0009684727],"study_design_scores_gemma":[0.791451,0.0055831023,0.20176964,0.00046846678,0.00028143707,0.0000016761599,0.000044614608,0.00008380464,0.0002268402,0.0000042883403,0.00002524549,0.00005989785],"about_ca_topic_score_codex":0.00037953357,"about_ca_topic_score_gemma":0.00012276492,"teacher_disagreement_score":0.19240934,"about_ca_system_score_codex":0.00004176621,"about_ca_system_score_gemma":0.00021396812,"threshold_uncertainty_score":0.22894447},"labels":[],"label_agreement":null},{"id":"W2134159541","doi":"10.1093/eurheartj/ehv043","title":"Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","year":2015,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1420,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Western University","funders":"Servier; Regeneron Pharmaceuticals; Danone; F. Hoffmann-La Roche; Genentech; Valeant Pharmaceuticals International; Kowa Company; Sanofi; Quest Diagnostics; Amgen; Pfizer; European Atherosclerosis Society; AstraZeneca; Eli Lilly and Company; Esperion Therapeutics; GlaxoSmithKline","keywords":"Medicine; Statin; myalgia; Discontinuation; Myopathy; Internal medicine; Atorvastatin; Physical therapy; Intensive care medicine; Cardiology","score_opus":0.1672324787928071,"score_gpt":0.40839338961158284,"score_spread":0.24116091081877575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134159541","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0296556,0.9529505,0.000091379814,0.0004860617,0.0007277827,0.0041030427,0.00046572677,0.00019802894,0.011321896],"genre_scores_gemma":[0.0018975432,0.99429023,0.0007980158,0.0012018434,0.00070401665,0.000024152381,0.00021162271,0.000316229,0.00055634923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.988282,0.007585924,0.0013258321,0.00076906447,0.001160936,0.0008762349],"domain_scores_gemma":[0.9969682,0.00018312453,0.0009832374,0.0008087633,0.00022922028,0.0008274744],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011251771,0.0008590982,0.0022641404,0.00023291411,0.00042743172,0.00020983019,0.0002306608,0.00013051007,0.00015087142],"category_scores_gemma":[0.00005883213,0.00056326506,0.0015441477,0.00026039375,0.00013985415,0.00004389567,0.00015328059,0.0017704573,0.00019610075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060598664,0.00053404795,0.00022492907,0.0017191664,0.0038495907,0.0004910999,0.0003366274,0.000013635927,0.0000041395756,0.000014008947,0.037605874,0.95514625],"study_design_scores_gemma":[0.004281426,0.0043555773,0.05481583,0.008766233,0.00090479304,0.0005120774,0.00020195579,0.000009612287,2.5497778e-7,0.0000057145485,0.92564386,0.00050266925],"about_ca_topic_score_codex":0.00002100434,"about_ca_topic_score_gemma":8.431203e-7,"teacher_disagreement_score":0.9546436,"about_ca_system_score_codex":0.0012449083,"about_ca_system_score_gemma":0.0005667171,"threshold_uncertainty_score":0.9996819},"labels":[],"label_agreement":null},{"id":"W2134166090","doi":"10.1016/j.cjca.2014.07.008","title":"Cholesterol End Points Predict Outcome in Patients With Coronary Disease: Quality Improvement Metrics from The Enhancing Secondary Prevention in Coronary Artery Disease (ESP-CAD) Trial","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alliance for Canadian Health Outcomes Research in Diabetes; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Myocardial infarction; Coronary artery disease; Cardiology; Stroke (engine); Statin; Cohort; Confidence interval","score_opus":0.01680456130134217,"score_gpt":0.25877834503744207,"score_spread":0.2419737837360999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134166090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951682,0.0007722873,0.0010033522,0.0007494105,0.0007854937,0.0012536051,0.00018055635,0.000004641159,0.00008244171],"genre_scores_gemma":[0.99775445,0.000031501553,0.0000434665,0.0009538285,0.0010105746,0.00003624957,0.00012992801,0.000024617659,0.000015404108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967232,0.0010199733,0.0010040192,0.00029655313,0.00050951843,0.0004467672],"domain_scores_gemma":[0.99774814,0.00018111515,0.00035074505,0.00053577445,0.0001585082,0.0010257139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025551785,0.00020976891,0.00086977956,0.00032745037,0.00007716618,0.00002081694,0.00019684632,0.00011851927,0.000034351888],"category_scores_gemma":[0.00062236324,0.00014618128,0.00036203014,0.00020457218,0.000119325254,0.00015793146,0.00002758194,0.0006566547,0.0000026290154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008466384,0.00003718998,0.9483734,0.00005922758,0.00028186754,0.00020823663,0.00007494559,0.00009616908,0.0000034817635,0.000008796545,0.00009653803,0.042293794],"study_design_scores_gemma":[0.037686672,0.0014405189,0.9582183,0.00019269416,0.00027039897,0.00002309583,0.00008052114,0.000010059064,0.0000023663779,0.00015311237,0.0017872683,0.00013503303],"about_ca_topic_score_codex":0.0017303936,"about_ca_topic_score_gemma":0.006564152,"teacher_disagreement_score":0.04215876,"about_ca_system_score_codex":0.0006031848,"about_ca_system_score_gemma":0.0022589662,"threshold_uncertainty_score":0.59611},"labels":[],"label_agreement":null},{"id":"W2134498866","doi":"","title":"Recommendations for management of dyslipidemia in high cardiovascular risk patients.","year":2008,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Dyslipidemia; Coronary artery disease; Intensive care medicine; Atherosclerotic cardiovascular disease; Disease; Statin; Cholesterol; Clinical trial; Internal medicine; Cardiology","score_opus":0.031907652333302984,"score_gpt":0.23666540957968152,"score_spread":0.20475775724637854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134498866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98809874,0.0015622987,0.0021595869,0.0006231025,0.00036436116,0.005237802,0.000060557933,0.00003723134,0.0018563092],"genre_scores_gemma":[0.9902209,0.0013586603,0.0040353416,0.000112216374,0.00012258002,0.0038278291,0.00008798297,0.000020364505,0.00021410923],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987329,0.00007393701,0.00034883324,0.00023101215,0.0003195845,0.00029369662],"domain_scores_gemma":[0.9991672,0.0000251448,0.00008026225,0.0005252445,0.00009610132,0.00010606148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010135958,0.0000954472,0.00043186112,0.00011352294,0.000059929305,0.0000019492336,0.00006234362,0.00005997038,0.0000074206946],"category_scores_gemma":[0.00007911247,0.0000855083,0.0004563762,0.00023107772,0.00002866194,0.00004519566,0.000030859974,0.000104125465,0.0000024788894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009982873,0.00027232856,0.10483136,0.00041638868,0.001391936,0.000010781753,0.00007638641,0.00008317052,1.153134e-7,0.00029443362,0.0026627963,0.88986045],"study_design_scores_gemma":[0.0045765387,0.000040460247,0.9240027,0.000030473264,0.000318086,0.0000018546873,0.000035705107,0.000010558845,0.00006957285,0.00009055336,0.07074392,0.00007959442],"about_ca_topic_score_codex":0.00032764644,"about_ca_topic_score_gemma":0.000007847456,"teacher_disagreement_score":0.8897809,"about_ca_system_score_codex":0.00012577836,"about_ca_system_score_gemma":0.000022221257,"threshold_uncertainty_score":0.34869272},"labels":[],"label_agreement":null},{"id":"W2135142672","doi":"10.1038/ncpendmet0982","title":"A diagnostic algorithm for the atherogenic apolipoprotein B dyslipoproteinemias","year":2008,"lang":"en","type":"review","venue":"Nature Clinical Practice Endocrinology &#38 Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval","funders":"","keywords":"Apolipoprotein B; Medicine; Lipoprotein; Algorithm; Triglyceride; Clinical Practice; Intensive care medicine; Cholesterol; Bioinformatics; Internal medicine; Computer science; Physical therapy; Biology","score_opus":0.062193138261551296,"score_gpt":0.43651354003862103,"score_spread":0.3743204017770697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135142672","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000034403972,0.96888083,0.0030608787,0.0039255866,0.0067334706,0.016125295,0.00024455384,0.0003217991,0.0007041618],"genre_scores_gemma":[0.0000053863373,0.93700266,0.02941084,0.005100907,0.02065959,0.00603665,0.00027624404,0.00040201988,0.0011057158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98709714,0.0031402525,0.0037207815,0.0023959447,0.0015933337,0.0020525325],"domain_scores_gemma":[0.95845085,0.03304328,0.0023873735,0.004226342,0.0011272522,0.00076491607],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0041559506,0.001642231,0.008169293,0.00041101655,0.00077510584,0.0000829403,0.0014424212,0.0048826523,0.00014126902],"category_scores_gemma":[0.07666631,0.0009990148,0.008162114,0.0010409105,0.000971541,0.00028834154,0.00055269466,0.014816304,0.0005063115],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017271675,0.00065852806,8.4665515e-7,0.0026304997,0.0072191353,0.0011216366,0.000018550882,1.716609e-7,7.621816e-8,0.0015120738,0.009657805,0.977008],"study_design_scores_gemma":[0.0038681345,0.000521699,0.00005832122,0.0018389742,0.022063123,0.01921219,0.000047250396,0.00001506718,0.0000036419335,0.00011559105,0.951417,0.0008389655],"about_ca_topic_score_codex":0.00023567227,"about_ca_topic_score_gemma":0.000011987894,"teacher_disagreement_score":0.976169,"about_ca_system_score_codex":0.00024415815,"about_ca_system_score_gemma":0.003928556,"threshold_uncertainty_score":0.9996325},"labels":[],"label_agreement":null},{"id":"W2135256854","doi":"10.1002/path.4630","title":"Local effects of human <scp>PCSK9</scp> on the atherosclerotic lesion","year":2015,"lang":"en","type":"article","venue":"The Journal of Pathology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"PCSK9; Lesion; Kexin; Medicine; LDL receptor; Internal medicine; Pathology; Lipoprotein; Cholesterol","score_opus":0.04138753946837025,"score_gpt":0.2929651882022028,"score_spread":0.25157764873383254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135256854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943385,0.0014918346,0.0020053594,0.0008514271,0.00027852075,0.00030291697,4.4152353e-7,0.000006012804,0.000724949],"genre_scores_gemma":[0.99857926,0.000113803995,0.000055398443,0.000742677,0.00035630565,0.0000024938665,3.4804677e-7,0.00001612873,0.00013357933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981634,0.0007842972,0.0003311487,0.00007119567,0.00046165555,0.00018832272],"domain_scores_gemma":[0.9985969,0.00036410082,0.00029914017,0.00042801525,0.0001887281,0.00012310172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033673798,0.000102586426,0.00041749192,0.000065980435,0.00007324753,0.0000032705814,0.00019092133,0.00009331916,0.000005394601],"category_scores_gemma":[0.00057368487,0.000044876597,0.00021553232,0.00010095822,0.000211169,0.000022162241,0.000042368785,0.000456309,0.000020932895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014897978,0.003013143,0.008764013,0.001673737,0.0019411356,0.008350602,0.030646874,0.0009867983,0.7897912,0.011787197,0.032015655,0.10953982],"study_design_scores_gemma":[0.025992652,0.060275603,0.34825945,0.003255339,0.0035529013,0.043702077,0.012546227,0.00021141155,0.47285315,0.015265307,0.013791593,0.00029429208],"about_ca_topic_score_codex":0.000021880436,"about_ca_topic_score_gemma":0.0000033321862,"teacher_disagreement_score":0.33949545,"about_ca_system_score_codex":0.000056688077,"about_ca_system_score_gemma":0.00011991702,"threshold_uncertainty_score":0.19824609},"labels":[],"label_agreement":null},{"id":"W2135519094","doi":"10.1177/14746514030030031001","title":"DAIS: how it relates to other lipid intervention studies in diabetes","year":2003,"lang":"en","type":"article","venue":"The British Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Fenofibrate; Medicine; Diabetes mellitus; Internal medicine; Context (archaeology); Type 2 diabetes; Coronary artery disease; Lipid profile; Gemfibrozil; Intervention (counseling); Physical therapy; Endocrinology; Cholesterol","score_opus":0.027544386205953834,"score_gpt":0.2899654756054223,"score_spread":0.26242108939946845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135519094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9427623,0.052082,0.000010927647,0.0040506613,0.00037902,0.00029170682,0.0000023391447,0.000010267371,0.00041077207],"genre_scores_gemma":[0.9964794,0.0010348904,0.00036127315,0.0012314378,0.0004240739,0.000018270592,6.104704e-7,0.00002611152,0.00042393067],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99833286,0.00034769598,0.0004404497,0.00013168143,0.0004226152,0.00032469066],"domain_scores_gemma":[0.9990941,0.00012019949,0.00019335203,0.00020757716,0.00026164835,0.00012309031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033335863,0.00012091375,0.0005476797,0.00011029669,0.00017453487,0.00014281983,0.00013242786,0.00006423481,0.000032524476],"category_scores_gemma":[0.0015749192,0.00009089967,0.00036076966,0.0002605183,0.00009539294,0.00015564008,0.00003258173,0.00040191368,0.00001022349],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009786244,0.0013184,0.45781216,0.0020093806,0.0057179704,0.00043088372,0.0044482113,0.00012927465,0.0052484693,0.00033156,0.059666257,0.4627896],"study_design_scores_gemma":[0.020508973,0.006886742,0.6153903,0.056278195,0.0022917225,0.002256876,0.018163202,0.00006886134,0.06631256,0.008038948,0.20232815,0.0014754523],"about_ca_topic_score_codex":0.000042464955,"about_ca_topic_score_gemma":0.00021173884,"teacher_disagreement_score":0.46131414,"about_ca_system_score_codex":0.000119266835,"about_ca_system_score_gemma":0.00005498752,"threshold_uncertainty_score":0.3706781},"labels":[],"label_agreement":null},{"id":"W2135604540","doi":"10.1093/qjmed/hcp049","title":"Towards a more inclusive vision of the medical sciences","year":2009,"lang":"en","type":"article","venue":"QJM","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Transformative learning; Medical research; Ask price; Public relations; Psychology; Engineering ethics; Medical education; Medicine; Political science; Pedagogy; Engineering; Business","score_opus":0.014725287355708558,"score_gpt":0.3409664596459956,"score_spread":0.32624117229028704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135604540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9372131,0.0012104178,0.00013656393,0.04575582,0.00012096472,0.00026005873,0.0000011639611,0.000016145594,0.015285726],"genre_scores_gemma":[0.9968374,0.00005539143,0.0002456133,0.0025816562,0.000187648,0.0000016889961,5.436133e-7,0.0000022260467,0.00008788278],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99866235,0.000033535187,0.00011540003,0.000105485815,0.0009727905,0.000110425826],"domain_scores_gemma":[0.9996004,0.000008028298,0.000030915584,0.00023928173,0.000038283757,0.00008307074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006500444,0.000044557964,0.00015016472,0.00002541843,0.00008847504,0.0000035179294,0.00012591502,0.000053769723,0.00008430381],"category_scores_gemma":[0.00018623058,0.000022142392,0.0001299887,0.00022337427,0.00015197399,0.000021935777,0.000054887303,0.00010358758,0.0000040574932],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045762226,0.00022955748,0.0017492468,0.000097698416,0.000048285296,0.0000808355,0.0009882161,0.0000056284257,0.0012438635,0.0063056215,0.003092952,0.98611236],"study_design_scores_gemma":[0.0037340182,0.0027976478,0.899874,0.001245751,0.00017522289,0.00086684927,0.00080833456,0.0011223124,0.024014061,0.0056178593,0.059510123,0.00023383669],"about_ca_topic_score_codex":0.00014613502,"about_ca_topic_score_gemma":0.000005691159,"teacher_disagreement_score":0.98587847,"about_ca_system_score_codex":0.000023737302,"about_ca_system_score_gemma":0.00042520542,"threshold_uncertainty_score":0.09230676},"labels":[],"label_agreement":null},{"id":"W2135648839","doi":"10.1185/030079903125002405","title":"Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial","year":2003,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca","keywords":"Rosuvastatin; Medicine; Pravastatin; Atorvastatin; Simvastatin; Pharmacology; Statin; Rosuvastatin Calcium; Internal medicine; Cholesterol","score_opus":0.17612580238412012,"score_gpt":0.47144030552235,"score_spread":0.2953145031382299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135648839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98454046,0.0114361225,0.00015013061,0.0014008959,0.0006935757,0.0015442533,0.00006720264,0.000006636962,0.00016073161],"genre_scores_gemma":[0.99497616,0.004340578,0.00020984143,0.000018232044,0.00035606287,0.000027022548,0.00005040919,0.000014776565,0.0000069354896],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994148,0.0018341461,0.00090573274,0.00038047743,0.0023082031,0.00042343317],"domain_scores_gemma":[0.9926787,0.0059773135,0.0002280454,0.0005268216,0.00023549638,0.00035364248],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007508124,0.00014991204,0.0005730429,0.00008861449,0.00015477953,0.000023521805,0.00019578297,0.000110955676,0.000029516485],"category_scores_gemma":[0.027347367,0.00008371905,0.00011042998,0.0005046825,0.000653847,0.00004324728,0.00017290223,0.0010506471,0.0000014003001],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045311727,0.0016609684,0.037724648,0.00093552377,0.00017920462,0.0000062084196,0.0067137307,0.0000070356677,0.00023716195,0.0013402014,0.0037530633,0.90213054],"study_design_scores_gemma":[0.43403497,0.01173767,0.35972458,0.012185828,0.00017630644,0.00001613329,0.016065098,0.0029331935,0.0053228154,0.00060158974,0.15658098,0.0006208248],"about_ca_topic_score_codex":0.00047202993,"about_ca_topic_score_gemma":0.000111109286,"teacher_disagreement_score":0.9015097,"about_ca_system_score_codex":0.000043393455,"about_ca_system_score_gemma":0.00079958414,"threshold_uncertainty_score":0.9808457},"labels":[],"label_agreement":null},{"id":"W2135905495","doi":"10.1038/clpt.2014.76","title":"The Ebbs and Flows in the Development of Cholesterol-Lowering Drugs: Prospects for the Future","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Clinical pharmacology; Medicine; Cholesterol; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.09926709391705164,"score_gpt":0.46066391303830856,"score_spread":0.36139681912125693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135905495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012133634,0.98771137,0.00015424394,0.003954423,0.0018576679,0.00504888,0.0000053223275,0.000015240452,0.0000394854],"genre_scores_gemma":[0.00044549129,0.98526156,0.00022097374,0.0101489425,0.0029530334,0.0008637415,0.000009736268,0.000050451734,0.000046082263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99674296,0.00073498,0.0014192426,0.00039190095,0.00030973632,0.00040119575],"domain_scores_gemma":[0.9957736,0.0029178776,0.00045696629,0.00066832296,0.00009874723,0.00008444665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071071447,0.00034006604,0.0016633214,0.00004076973,0.00032739382,0.00002573412,0.0005561059,0.00044447096,0.000004611755],"category_scores_gemma":[0.000032925716,0.00013515221,0.00075948786,0.00017703559,0.00034896604,0.000015958849,0.00012062093,0.0013384816,0.000004246148],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008882878,0.00012206334,0.000029133977,0.0036811803,0.0016153244,0.0000018028417,0.00044934175,2.6477923e-7,9.399425e-7,0.000013379933,0.0004018306,0.9935959],"study_design_scores_gemma":[0.0016962069,0.00023628319,0.0005049227,0.0008617728,0.004106425,0.000027126724,0.00017024447,0.000034905937,0.0000039461875,0.000021252683,0.9922028,0.0001340769],"about_ca_topic_score_codex":0.0000012090497,"about_ca_topic_score_gemma":0.000024886958,"teacher_disagreement_score":0.99346185,"about_ca_system_score_codex":0.000060889026,"about_ca_system_score_gemma":0.0006460751,"threshold_uncertainty_score":0.5815111},"labels":[],"label_agreement":null},{"id":"W2136080736","doi":"10.1503/cmaj.060627","title":"Sex differences in the effectiveness of statins after myocardial infarction","year":2007,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Royal Victoria Hospital","funders":"Institute of Circulatory and Respiratory Health; Canadian Institutes of Health Research; McGill University; Heart and Stroke Foundation of Canada","keywords":"Medicine; Hazard ratio; Myocardial infarction; Confidence interval; Statin; Internal medicine; Cause of death; Proportional hazards model; Disease","score_opus":0.006331775329685052,"score_gpt":0.24309311331404057,"score_spread":0.23676133798435553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136080736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948791,0.00018268105,0.0003742506,0.0022933763,0.00031951873,0.00022265234,0.000005823991,0.0000032251398,0.0017193487],"genre_scores_gemma":[0.9967415,0.00007777979,0.000026117033,0.0022230423,0.0008962824,0.000008889795,0.0000034740408,0.0000055510686,0.0000174158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714726,0.00067392713,0.00032399377,0.00008309666,0.001468681,0.000303015],"domain_scores_gemma":[0.9987355,0.00039750888,0.000094320756,0.000095757525,0.0001815112,0.0004954026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014276426,0.000067627676,0.00026047466,0.0001677996,0.00006943435,0.000017524417,0.0000764417,0.00019968471,0.00021257358],"category_scores_gemma":[0.0013186978,0.00004463967,0.00014072545,0.00025273283,0.000030971594,0.00004590568,0.000004522629,0.00067825906,0.0000063592724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088170746,0.000032918113,0.9594926,0.000039417566,0.00013513277,0.00030467595,0.00061615603,4.7405362e-7,0.000012769542,0.00008545482,0.00029529055,0.038896933],"study_design_scores_gemma":[0.0010201695,0.00010101532,0.991616,0.0001141641,0.00003085701,0.0002546644,0.0006149549,0.000008827056,0.000025680814,0.00010586563,0.006063515,0.000044281904],"about_ca_topic_score_codex":0.0075527476,"about_ca_topic_score_gemma":0.020290323,"teacher_disagreement_score":0.03885265,"about_ca_system_score_codex":0.0006150722,"about_ca_system_score_gemma":0.0015638979,"threshold_uncertainty_score":0.99905604},"labels":[],"label_agreement":null},{"id":"W2136137463","doi":"","title":"Statin myopathies: pathophysiologic and clinical perspectives.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Pathophysiology; Medicine; Statin; Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors","score_opus":0.035353173146704844,"score_gpt":0.2900770496731586,"score_spread":0.2547238765264538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136137463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902237,0.0034964702,0.00012898323,0.0010062084,0.000105611325,0.00090334663,0.000002747439,0.000068433415,0.004064488],"genre_scores_gemma":[0.992533,0.004853837,0.00035067025,0.0007338535,0.00057589525,0.00035116108,0.000003605681,0.000012389801,0.00058553],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989237,0.00011166652,0.0002072405,0.00028780193,0.00018658832,0.00028300914],"domain_scores_gemma":[0.99931586,0.000045432425,0.000042521217,0.00029050207,0.00006194772,0.00024374807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095940934,0.00009005046,0.00030961863,0.000036768324,0.000053837644,0.000011662581,0.000034550318,0.00007911605,0.00002348851],"category_scores_gemma":[0.00038435668,0.00006548041,0.00015666908,0.000114877505,0.00010388487,0.000038445873,0.00003366168,0.00020088472,0.000011668365],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016688349,0.00018205967,0.037915427,0.000045191187,0.000112648995,0.00015567821,0.00022591185,3.345538e-7,0.000009763272,0.00023241287,0.00039258495,0.9605611],"study_design_scores_gemma":[0.0012703084,0.00015093513,0.9862508,0.0000079899055,0.00006405275,0.0000748248,0.00078275695,0.000019054552,0.000007217985,0.00023894689,0.011054581,0.000078531106],"about_ca_topic_score_codex":0.0000630993,"about_ca_topic_score_gemma":0.000004497434,"teacher_disagreement_score":0.9604826,"about_ca_system_score_codex":0.00004216747,"about_ca_system_score_gemma":0.000036948026,"threshold_uncertainty_score":0.26702136},"labels":[],"label_agreement":null},{"id":"W2136226268","doi":"10.2217/pgs.12.204","title":"Institutional Profile: The Beaulieu-Saucier Université de Montréal Pharmacogenomics Centre at the Montreal Heart Institute","year":2013,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Excellence; Center of excellence; General partnership; Commercialization; Best practice; Library science; Medicine; Management; Engineering management; Engineering; Political science; Computer science; Pharmacology","score_opus":0.010586392611145417,"score_gpt":0.22750573106969857,"score_spread":0.21691933845855316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136226268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96741956,0.006467453,0.00008296595,0.017134756,0.0005638222,0.002139883,0.00010899923,0.00008278283,0.005999798],"genre_scores_gemma":[0.97737527,0.0038291698,0.00040720907,0.008777101,0.0014750947,0.00012889128,0.00016893506,0.00006541337,0.007772925],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978931,0.0001465652,0.00034912562,0.0004287896,0.00048894976,0.00069344783],"domain_scores_gemma":[0.9986003,0.000049855105,0.000116273375,0.0006326222,0.00016604654,0.00043487822],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0005664727,0.00031934291,0.00035112683,0.00005873724,0.0016716968,0.000038885526,0.0003459891,0.000109374785,0.0008063996],"category_scores_gemma":[0.00002176388,0.00020158106,0.00040585274,0.00022097981,0.00035690106,0.00015233512,0.0005568405,0.00047318792,0.0005537058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037385523,0.001384549,0.0415506,0.00057346496,0.0065226094,0.00097220077,0.011506493,0.018087955,0.37972116,0.0013226686,0.33111843,0.2035013],"study_design_scores_gemma":[0.0043652295,0.000045760084,0.016699906,0.00002165665,0.0007492923,0.0014711003,0.0002597964,0.0096390825,0.025559284,0.000046358455,0.9408035,0.00033903128],"about_ca_topic_score_codex":0.0076427315,"about_ca_topic_score_gemma":0.00075235515,"teacher_disagreement_score":0.60968506,"about_ca_system_score_codex":0.0017599177,"about_ca_system_score_gemma":0.00062203285,"threshold_uncertainty_score":0.999628},"labels":[],"label_agreement":null},{"id":"W2136837197","doi":"10.1161/circulationaha.105.583336","title":"Apolipoprotein B Versus Non–High-Density Lipoprotein Cholesterol","year":2005,"lang":"en","type":"letter","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Hypertriglyceridemia; Apolipoprotein B; Cholesterol; Lipoprotein; Internal medicine; Disease; Endocrinology; Triglyceride","score_opus":0.02209955940999242,"score_gpt":0.2599135595560186,"score_spread":0.23781400014602616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136837197","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38593167,0.0012782249,0.005337211,0.5870603,0.0038182826,0.00979741,0.00008466516,0.0008016939,0.0058905585],"genre_scores_gemma":[0.72407836,0.000079565296,0.001065768,0.22628085,0.044564437,0.00037518397,0.0021850218,0.00026368795,0.0011071346],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956217,0.00018221202,0.00071104936,0.0010460789,0.0016377555,0.00080123625],"domain_scores_gemma":[0.9970084,0.00003747311,0.0003835862,0.0020104295,0.00032181997,0.00023829674],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0005889346,0.00064989453,0.0011856082,0.00036712692,0.00022379667,0.000095027346,0.00022042391,0.0019110785,0.00027121644],"category_scores_gemma":[0.00011496032,0.0006452232,0.0007892121,0.00034977755,0.00009785245,0.00019467667,0.00008282508,0.0025949273,0.00080001424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006502757,0.00021934246,0.0005134569,0.0032109304,0.0017455219,0.0010749946,0.00027279268,0.00014971443,0.0015213931,0.000040962317,0.37218288,0.61841774],"study_design_scores_gemma":[0.009941838,0.0003568447,0.2192734,0.000913618,0.00146604,0.00040662615,0.000018830624,0.00041783197,0.0027376716,0.0001505364,0.7630154,0.0013013664],"about_ca_topic_score_codex":0.0067732558,"about_ca_topic_score_gemma":0.00019440426,"teacher_disagreement_score":0.6171164,"about_ca_system_score_codex":0.0008168182,"about_ca_system_score_gemma":0.00040858673,"threshold_uncertainty_score":0.999978},"labels":[],"label_agreement":null},{"id":"W2136948346","doi":"10.1373/clinchem.2009.142653","title":"Statin Therapy for Low-LDL, High-hsCRP Patients: From JUPITER to CORONA","year":2010,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novartis; Merck; AstraZeneca","keywords":"Rosuvastatin; Medicine; Internal medicine; Statin; Myocardial infarction; Simvastatin; Rosuvastatin Calcium; Cardiology; Placebo; National Cholesterol Education Program; Acute coronary syndrome; Cholesterol; Metabolic syndrome; Obesity","score_opus":0.02174594595316229,"score_gpt":0.3449899689581586,"score_spread":0.3232440230049963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136948346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996431,0.000088215726,0.00026194833,0.0012545796,0.0006052137,0.0007335167,0.00018101856,0.00005622895,0.0003883113],"genre_scores_gemma":[0.9859858,0.00006217539,0.0046021356,0.0051198876,0.0028054353,0.00013230284,0.00046177104,0.000043459946,0.000787028],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837416,0.000022754899,0.0005501642,0.00046738843,0.00030572948,0.0002797808],"domain_scores_gemma":[0.9981659,0.0002521127,0.00009465294,0.0008033622,0.00022190678,0.0004620798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004878221,0.00016297273,0.0004907597,0.00000852132,0.000051072446,0.000018258175,0.00014544059,0.0003011946,0.0006982243],"category_scores_gemma":[0.00080815505,0.00012854468,0.00038282305,0.000057103058,0.00007046416,0.000028222858,0.000044267705,0.00048846885,0.00007272257],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036093998,0.0033444609,0.24671485,0.0005299041,0.00076943875,0.000028976121,0.0001667787,8.4341775e-7,0.038101617,0.000040394396,0.053617757,0.6530756],"study_design_scores_gemma":[0.020129755,0.0010998955,0.41851476,0.00017478375,0.0001601836,0.0000037999746,0.00004946724,0.000033503646,0.09689693,0.00059322827,0.4618047,0.0005389913],"about_ca_topic_score_codex":0.000059929385,"about_ca_topic_score_gemma":0.000004988081,"teacher_disagreement_score":0.6525366,"about_ca_system_score_codex":0.000025064523,"about_ca_system_score_gemma":0.00014931962,"threshold_uncertainty_score":0.76450664},"labels":[],"label_agreement":null},{"id":"W2137023766","doi":"10.1016/j.clinthera.2014.10.008","title":"Critical Appraisal of the SHARP Trial: The Results May Be Dull","year":2014,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kelowna General Hospital; Vancouver General Hospital","funders":"","keywords":"Medicine; Ezetimibe; Kidney disease; Critical appraisal; Context (archaeology); Intensive care medicine; Clinical trial; Medical prescription; Statin; Disease; Dialysis; Alternative medicine; Internal medicine; Pharmacology; Pathology","score_opus":0.15218081481931708,"score_gpt":0.45601327067003666,"score_spread":0.3038324558507196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137023766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70468265,0.002322478,0.0028869573,0.2475066,0.011440844,0.003410227,0.00007997487,0.0001762988,0.027493965],"genre_scores_gemma":[0.9849068,0.00030008002,0.00040856109,0.011503733,0.0025024542,0.000019424333,0.0000047105273,0.000029690356,0.00032457217],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99677277,0.0010270347,0.0009804015,0.000294851,0.0006412006,0.0002837241],"domain_scores_gemma":[0.99380815,0.003911387,0.00017232794,0.0017389101,0.00021769729,0.0001515084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058363485,0.00014429732,0.0005592593,0.000015282345,0.000126814,0.000019226447,0.00035308648,0.00024812127,0.000029968038],"category_scores_gemma":[0.006903004,0.00006645839,0.000866443,0.00017516143,0.00072159956,0.000022984264,0.00010923088,0.0007020401,0.000016498592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07800665,0.004909172,0.010641,0.0006184732,0.0023419028,0.00001971857,0.0014041753,0.00001791554,0.000328219,0.11127735,0.017779617,0.7726558],"study_design_scores_gemma":[0.032922298,0.001974359,0.026973637,0.000105779596,0.00072050246,0.000025995238,0.00012242088,0.00056200946,0.0002833888,0.0010767401,0.9350858,0.0001470827],"about_ca_topic_score_codex":0.000021510261,"about_ca_topic_score_gemma":0.0000050857525,"teacher_disagreement_score":0.9173062,"about_ca_system_score_codex":0.000013655407,"about_ca_system_score_gemma":0.00018092133,"threshold_uncertainty_score":0.8264039},"labels":[],"label_agreement":null},{"id":"W2137170302","doi":"10.1586/erc.12.84","title":"Cardiovascular biomarkers and surrogate end points: key initiatives and clinical trial challenges","year":2012,"lang":"en","type":"review","venue":"Expert Review of Cardiovascular Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Clinical trial; Biomarker; Intensive care medicine; Clinical Practice; Disease; Biomarker discovery; Surrogate endpoint; Internal medicine; Physical therapy","score_opus":0.1304923372789049,"score_gpt":0.40546919536800247,"score_spread":0.27497685808909755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137170302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023866822,0.9880878,0.000079452606,0.00017682718,0.0010155223,0.00934302,0.00004149016,0.00009133224,0.0011406998],"genre_scores_gemma":[0.000015893747,0.99411964,0.0009687615,0.00036671307,0.0032519733,0.0008647334,0.00013770435,0.0002640513,0.0000105083145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98656243,0.005851669,0.0028475432,0.0016950093,0.0021929017,0.00085043727],"domain_scores_gemma":[0.993479,0.00045194253,0.0007911302,0.004078213,0.0003919487,0.0008077673],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.018022342,0.0014097939,0.016133253,0.00036147796,0.00014941834,0.000039839597,0.0003867797,0.0010060808,0.00008039027],"category_scores_gemma":[0.0005568244,0.0009831926,0.022788007,0.0004982256,0.00070052623,0.0002831702,0.00025684346,0.0009762574,0.000019069419],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044423688,0.0001938177,0.0000014696436,0.10544375,0.083259724,0.00006972173,0.0001028697,9.854369e-9,4.7415792e-8,0.00004654189,0.00006566631,0.8103721],"study_design_scores_gemma":[0.018835861,0.0007508879,0.00004563015,0.079698004,0.020668507,0.0009596387,0.000051092436,1.5431704e-7,0.000002003546,0.00000590983,0.8782096,0.0007726971],"about_ca_topic_score_codex":0.00011064583,"about_ca_topic_score_gemma":0.0000010549545,"teacher_disagreement_score":0.87814397,"about_ca_system_score_codex":0.0001338038,"about_ca_system_score_gemma":0.000632281,"threshold_uncertainty_score":0.99986523},"labels":[],"label_agreement":null},{"id":"W2137575025","doi":"10.3109/10408363.2013.847897","title":"ApoB versus non-HDL-cholesterol: Diagnosis and cardiovascular risk management","year":2013,"lang":"en","type":"review","venue":"Critical Reviews in Clinical Laboratory Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Apolipoprotein B; Cholesterol; Medicine; Internal medicine; Lipoprotein; Endocrinology","score_opus":0.19893423733760315,"score_gpt":0.48195752390051316,"score_spread":0.28302328656291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137575025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009630822,0.991676,0.00006636677,0.00011909002,0.0015306235,0.004630497,0.000045762266,0.000038308157,0.0017970774],"genre_scores_gemma":[0.000029582277,0.9920232,0.004491141,0.00050951313,0.00085102103,0.0020104924,0.000009317766,0.00005102906,0.000024699484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9900416,0.0029415668,0.0029742133,0.0019144292,0.0012768187,0.00085138396],"domain_scores_gemma":[0.9939125,0.002658744,0.00034454552,0.0019389619,0.0001995875,0.00094562856],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.020817965,0.00070940226,0.00654167,0.0002895324,0.00026259373,0.00019185155,0.0006188125,0.000676626,0.00011344611],"category_scores_gemma":[0.01067208,0.0004651045,0.002794779,0.0016106513,0.0019417242,0.00025412042,0.00040381373,0.0016919663,0.0005179668],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005735538,0.00016351466,0.00046518206,0.029545072,0.0003847209,0.00009166771,0.0000049471937,9.521408e-8,1.0369543e-9,0.00039017235,0.00092489086,0.968024],"study_design_scores_gemma":[0.00085296686,0.0005198041,0.0005853883,0.031887073,0.004745338,0.00001291287,0.000032826323,0.000004002359,6.464301e-8,0.00007263111,0.96084034,0.00044667258],"about_ca_topic_score_codex":0.00007505737,"about_ca_topic_score_gemma":0.000013882386,"teacher_disagreement_score":0.96757734,"about_ca_system_score_codex":0.00011986594,"about_ca_system_score_gemma":0.0005657968,"threshold_uncertainty_score":0.99978006},"labels":[],"label_agreement":null},{"id":"W2137677480","doi":"10.1016/j.cjca.2012.03.017","title":"Drugs Targeting High-Density Lipoprotein Cholesterol for Coronary Artery Disease Management","year":2012,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of Manitoba","funders":"","keywords":"Medicine; Cholesterylester transfer protein; Cholesterol; Internal medicine; Residual risk; Coronary artery disease; Statin; Cardiology; Lipoprotein; Disease; Atherosclerotic cardiovascular disease; Clinical trial","score_opus":0.028208082735622902,"score_gpt":0.2732385306924185,"score_spread":0.2450304479567956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137677480","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021179527,0.99241084,0.0019297742,0.00024297548,0.0021182557,0.0024468778,0.00014258792,0.000011575605,0.00048534526],"genre_scores_gemma":[0.014149569,0.9732485,0.00075824495,0.0003256976,0.010742834,0.00017110957,0.0002312185,0.00012050473,0.00025232713],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99685323,0.00045339827,0.0010844136,0.0003684725,0.00033928044,0.0009012247],"domain_scores_gemma":[0.99587566,0.00006603669,0.00062173774,0.0007108455,0.00029706917,0.0024286804],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019724807,0.00047493764,0.0034750632,0.00058064586,0.00018188919,0.000028746803,0.00030285396,0.00041720195,0.00002215228],"category_scores_gemma":[0.00009270021,0.00038085267,0.0025992428,0.00015401149,0.00013479,0.00008899517,0.000040241805,0.0007792945,0.000030681793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005665457,0.0000048130323,0.0000560714,0.013687096,0.0027460959,0.0013513382,0.000023382718,0.000005290272,6.179088e-8,0.00008510516,0.0039305435,0.97805357],"study_design_scores_gemma":[0.0010499555,0.00020096537,0.0025437877,0.004439173,0.008637339,0.0029755482,0.000035861853,2.9088807e-7,2.3856944e-7,0.000065710454,0.9797494,0.00030176016],"about_ca_topic_score_codex":0.00060475594,"about_ca_topic_score_gemma":0.00015737143,"teacher_disagreement_score":0.9777518,"about_ca_system_score_codex":0.0007585625,"about_ca_system_score_gemma":0.0028718137,"threshold_uncertainty_score":0.99986434},"labels":[],"label_agreement":null},{"id":"W2137693160","doi":"10.1016/s0021-9150(01)00711-0","title":"A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients","year":2002,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Cegep de Sainte Foy","funders":"Pfizer","keywords":"Fenofibrate; Pravastatin; Internal medicine; Dyslipidemia; Medicine; Endocrinology; Cholesterol; Gastroenterology","score_opus":0.0430658334335685,"score_gpt":0.24844014843728693,"score_spread":0.20537431500371844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137693160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682015,0.0012232179,0.000006216149,0.00040306954,0.00010797457,0.0006491123,0.000012032394,0.00008093496,0.0006973016],"genre_scores_gemma":[0.99599606,0.0016705238,0.00020519752,0.000969739,0.00015440126,0.000093681985,0.00001265655,0.00004547486,0.00085229316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983334,0.00013887703,0.0003621488,0.00036899623,0.0003364245,0.00046015825],"domain_scores_gemma":[0.9989509,0.00008713669,0.00007724179,0.00055847125,0.00007330038,0.00025297562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022292697,0.0002222987,0.00048891467,0.00004534222,0.0000886505,0.00002331593,0.00007457669,0.000103418,0.00080162997],"category_scores_gemma":[0.00018290944,0.00017478023,0.00021686395,0.0004166468,0.000047328707,0.00010135206,0.00003425489,0.00010583777,0.0003792725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021140577,0.0034126316,0.92899513,0.00006651445,0.00024009052,0.000010692554,0.0006355404,0.000010190537,0.0042313533,0.000037850827,0.0013578681,0.06079073],"study_design_scores_gemma":[0.006894106,0.0024474121,0.9797092,0.00019953035,0.00019247318,0.0000065649315,0.00009198005,0.00033441852,0.0044388035,0.000039174254,0.005378771,0.00026754077],"about_ca_topic_score_codex":0.0034130428,"about_ca_topic_score_gemma":0.00018792236,"teacher_disagreement_score":0.060523186,"about_ca_system_score_codex":0.0003988711,"about_ca_system_score_gemma":0.000045552624,"threshold_uncertainty_score":0.8777286},"labels":[],"label_agreement":null},{"id":"W2137885383","doi":"10.1517/13543784.15.12.1479","title":"Can statins put the brakes on Alzheimer’s disease?","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Biological Sciences","funders":"","keywords":"Disease; Medicine; Alzheimer's disease; Neuroscience; Intensive care medicine; Pharmacology; Psychology; Internal medicine","score_opus":0.0906705833483172,"score_gpt":0.37082078246105105,"score_spread":0.28015019911273387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137885383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000045389934,0.9812988,0.0000072639514,0.011610753,0.0009822546,0.0021379062,0.00037691105,0.0001016612,0.0034798898],"genre_scores_gemma":[0.000039591247,0.9809234,0.00017617164,0.0079372525,0.0043210536,0.0010304335,0.004823052,0.00011866837,0.00063038425],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99597925,0.00047532356,0.0007418288,0.00071219367,0.0016896087,0.00040178222],"domain_scores_gemma":[0.9974448,0.00044457472,0.0003302279,0.0010929733,0.00012331389,0.000564121],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004998179,0.000591915,0.0011994889,0.0002099778,0.00036030228,0.00006492537,0.000286701,0.00023549375,0.00009698944],"category_scores_gemma":[0.0002097434,0.00035853818,0.0010336089,0.0003530572,0.00028389832,0.000045963392,0.000051820894,0.0007024602,0.00021199146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025881704,0.00016410956,0.0000057008447,0.0017089006,0.0005208524,0.000013840384,0.00020611324,0.000014421363,7.6911235e-8,0.024023967,0.12234044,0.8509757],"study_design_scores_gemma":[0.00040123626,0.00013062407,0.00024300232,0.009636169,0.00016696572,0.000022495422,0.000028529117,0.000020888412,0.0000027303277,0.0006249228,0.98837143,0.00035102278],"about_ca_topic_score_codex":0.0004023615,"about_ca_topic_score_gemma":0.000004466736,"teacher_disagreement_score":0.866031,"about_ca_system_score_codex":0.00029926197,"about_ca_system_score_gemma":0.0025054524,"threshold_uncertainty_score":0.99988663},"labels":[],"label_agreement":null},{"id":"W2137914533","doi":"10.1111/j.1600-6135.2004.0355.x","title":"Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative","year":2004,"lang":"en","type":"article","venue":"American Journal of Transplantation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":315,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Kidney disease; Dyslipidemia; Population; Intensive care medicine; Randomized controlled trial; Kidney transplantation; Nephrology; Disease; Internal medicine; National Cholesterol Education Program; Transplantation; Obesity; Metabolic syndrome; Environmental health","score_opus":0.06160611836800406,"score_gpt":0.4009687983152501,"score_spread":0.33936267994724606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137914533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61476535,0.00068540324,0.10028039,0.27599606,0.002111616,0.004160635,0.0017583462,0.00004793021,0.00019425793],"genre_scores_gemma":[0.94252807,0.0015465403,0.007824293,0.045954697,0.00083771214,0.00009367753,0.0011641397,0.000045393896,0.0000054689212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933028,0.0011749325,0.0031372604,0.0004673735,0.0015416219,0.00037597475],"domain_scores_gemma":[0.993311,0.0013002803,0.002517125,0.00046475415,0.0013593158,0.00104756],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006624515,0.00032041935,0.00096443977,0.00024373103,0.00015475725,0.000035331697,0.00032043614,0.00008206303,0.000013303267],"category_scores_gemma":[0.019868137,0.00021189195,0.00078061776,0.0007360614,0.00027494197,0.00065162824,0.000020324054,0.00069144956,0.0000013534992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011555606,0.0009951208,0.9568113,0.0012322012,0.0011756448,0.00027943647,0.0029360366,0.0027864147,0.000042454238,0.00067327847,0.0017112251,0.01980128],"study_design_scores_gemma":[0.01229933,0.00031445984,0.9729555,0.0063974266,0.0015651525,0.00005096679,0.00067960424,0.0003200144,0.000017771992,0.0023944934,0.0027260396,0.00027922154],"about_ca_topic_score_codex":0.0013734108,"about_ca_topic_score_gemma":0.00011804364,"teacher_disagreement_score":0.32776272,"about_ca_system_score_codex":0.00083361904,"about_ca_system_score_gemma":0.004584404,"threshold_uncertainty_score":0.98838794},"labels":[],"label_agreement":null},{"id":"W2137959339","doi":"10.1161/strokeaha.109.573618","title":"Recent Nationwide Trends in Discharge Statin Treatment of Hospitalized Patients With Stroke","year":2010,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Foothills Medical Centre","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Stroke (engine); Statin; Medical prescription; Emergency medicine; Ischemic stroke; Internal medicine; Hospital discharge; Clinical trial; Ischemia","score_opus":0.008621909991581814,"score_gpt":0.2600447198614677,"score_spread":0.2514228098698859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137959339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571586,0.00014678884,0.000017805467,0.00031235025,0.00014688887,0.0005057514,0.00020311563,0.000018824247,0.0029326426],"genre_scores_gemma":[0.9967103,0.00017464305,0.0012042114,0.000028651884,0.00007622774,0.000044467244,0.0002061924,0.00001956943,0.0015357586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988136,0.000032952288,0.00025716855,0.00020926828,0.00046541498,0.00022155726],"domain_scores_gemma":[0.9992728,0.000011673884,0.000093135954,0.00037829025,0.00012612021,0.00011793485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013031323,0.00013603515,0.0003692861,0.00017949159,0.000027353373,0.0000061930205,0.000040440544,0.000060918923,0.00028500808],"category_scores_gemma":[0.000026020984,0.000090126545,0.00012013856,0.00018021931,0.000038014587,0.000051406216,0.000009010882,0.000115794624,0.0000042781026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031104757,0.001035995,0.7565527,0.000025061003,0.00015367224,0.000006904523,0.0003183707,0.0000018391299,0.00051411585,0.000110077715,0.000041296917,0.24092892],"study_design_scores_gemma":[0.0098241335,0.0016660749,0.968438,0.000023243278,0.0000751205,0.0000017998577,0.00005995384,0.000014452443,0.0024139374,0.0000058513715,0.017382512,0.00009489184],"about_ca_topic_score_codex":0.00037290086,"about_ca_topic_score_gemma":0.0005576698,"teacher_disagreement_score":0.24083403,"about_ca_system_score_codex":0.00007578792,"about_ca_system_score_gemma":0.00009110201,"threshold_uncertainty_score":0.3675254},"labels":[],"label_agreement":null},{"id":"W2137983259","doi":"10.1056/nejmoa0807646","title":"Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6637,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Rosuvastatin; Medicine; Hazard ratio; C-reactive protein; Rosuvastatin Calcium; Internal medicine; Myocardial infarction; Confidence interval; Statin; Placebo; Unstable angina; Cardiology; Endocrinology; Gastroenterology; Inflammation; Pathology","score_opus":0.010903832264070391,"score_gpt":0.24794585755644963,"score_spread":0.23704202529237925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137983259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940754,0.0009558081,0.00062559085,0.0031229123,0.00004225706,0.00088516716,7.305375e-7,0.000007860359,0.0002842792],"genre_scores_gemma":[0.99687964,0.00026730658,0.0011780217,0.00033971187,0.0009526976,0.000021343349,0.0000019151369,0.00002280987,0.00033658423],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99799055,0.00016478829,0.000487734,0.00017965378,0.0008770992,0.00030018756],"domain_scores_gemma":[0.9987114,0.000037825146,0.00019045985,0.00021037424,0.00019051773,0.0006594144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017562031,0.0001710929,0.0007477062,0.00027291148,0.000041668267,0.0000021089277,0.00006872099,0.000052680378,0.000050798815],"category_scores_gemma":[0.0002630532,0.000100071964,0.00004872911,0.00032698258,0.00005168169,0.000082700615,0.00001902286,0.00038258912,0.0000017776392],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036672533,0.0022871348,0.12612675,0.0011020271,0.0044470225,0.010550211,0.10494752,0.00032573362,0.09491721,0.000088900146,0.003440298,0.61509466],"study_design_scores_gemma":[0.2107551,0.02498557,0.7076876,0.0048964107,0.00037766524,0.0132549135,0.0036040542,0.000037809885,0.0063309176,0.00046075016,0.02716831,0.0004409091],"about_ca_topic_score_codex":0.00051325606,"about_ca_topic_score_gemma":0.000032311207,"teacher_disagreement_score":0.61465377,"about_ca_system_score_codex":0.00019288684,"about_ca_system_score_gemma":0.00041156603,"threshold_uncertainty_score":0.40808162},"labels":[],"label_agreement":null},{"id":"W2138438666","doi":"10.1161/jaha.112.001800","title":"Prevalence of Dyslipidemia and Lipid Goal Attainment in Statin‐Treated Subjects From 3 Data Sources: A Retrospective Analysis","year":2012,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"American College of Cardiology Foundation; American Diabetes Association","keywords":"Medicine; Dyslipidemia; Statin; National Cholesterol Education Program; Internal medicine; National Health and Nutrition Examination Survey; Population; Retrospective cohort study; Medical record; Disease; Ezetimibe; Environmental health; Obesity","score_opus":0.015286900207694213,"score_gpt":0.29100890549908615,"score_spread":0.27572200529139196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138438666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980371,0.0007830152,0.00010737103,0.00073927356,0.00006904197,0.00018378133,0.00006261614,0.0000032777862,0.000014543178],"genre_scores_gemma":[0.9982703,0.00028110616,0.0008084332,0.0002113884,0.00037724196,0.0000017725039,0.00000716779,0.0000077352115,0.000034877638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979146,0.0005641932,0.00047055498,0.00012640978,0.00072745635,0.0001967542],"domain_scores_gemma":[0.99809957,0.00022267697,0.0010010778,0.00040641418,0.00016504232,0.00010522616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031778147,0.000085165135,0.00079300744,0.00012957597,0.000038510552,0.000008765987,0.000115663046,0.000039190083,0.000013026973],"category_scores_gemma":[0.0011750658,0.00005742445,0.00023791628,0.00066912075,0.000046458317,0.00016778958,0.00007478257,0.0002583965,6.839481e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090085065,0.000091844144,0.9958583,0.000026766538,0.0011354766,7.0043757e-7,0.0006791866,0.000019492802,0.0011744327,8.316186e-7,0.00018139566,0.00074145576],"study_design_scores_gemma":[0.00061439094,0.00019263293,0.99628115,0.00009027545,0.0015583053,0.0000049576947,0.0004238383,0.00020796646,0.0004253645,0.000009339751,0.00014242905,0.000049357473],"about_ca_topic_score_codex":0.0016081778,"about_ca_topic_score_gemma":0.00009471159,"teacher_disagreement_score":0.0020027487,"about_ca_system_score_codex":0.00069254765,"about_ca_system_score_gemma":0.00010739867,"threshold_uncertainty_score":0.24310945},"labels":[],"label_agreement":null},{"id":"W2138558959","doi":"","title":"Statins and cognitive impairment.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dementia; Cognitive impairment; Cognition; Medicine; Affect (linguistics); Cognitive decline; Food and drug administration; Psychiatry; Psychology; Pharmacology; Disease; Internal medicine","score_opus":0.013008528793102044,"score_gpt":0.23283349193456856,"score_spread":0.21982496314146652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138558959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98265547,0.00045952905,0.00077654445,0.00070696993,0.00006389539,0.0010974323,0.0000050711865,0.000045902205,0.014189199],"genre_scores_gemma":[0.997501,0.00004655262,0.00011806624,0.0010356888,0.0002079957,0.0005641999,0.0000072620965,0.000009469945,0.0005097282],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9993911,0.000038382586,0.00007904188,0.00012948191,0.00015893814,0.00020306332],"domain_scores_gemma":[0.9996141,0.00002539283,0.00001936867,0.000115155985,0.000036508616,0.00018943206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047113915,0.000055696593,0.00014651858,0.00002927151,0.000035661924,0.000009719631,0.000013070522,0.000027550715,0.000012746922],"category_scores_gemma":[0.00011800112,0.00004324907,0.000047781603,0.000050287836,0.000030637282,0.000026731692,0.000016313063,0.000065427696,0.000008567612],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005322764,0.00004165725,0.012085997,0.00008192504,0.00008937614,0.0000065459767,0.00009173244,5.855723e-8,0.0000031967943,0.00017235875,0.00029413938,0.9870798],"study_design_scores_gemma":[0.0018749903,0.00009067064,0.9845685,0.000013999067,0.00010066668,0.00003394282,0.00007791517,0.000025048823,0.00023674192,0.00009326945,0.012828546,0.000055717443],"about_ca_topic_score_codex":0.000057680045,"about_ca_topic_score_gemma":0.0000056610193,"teacher_disagreement_score":0.98702407,"about_ca_system_score_codex":0.000014761844,"about_ca_system_score_gemma":0.000015380141,"threshold_uncertainty_score":0.17636459},"labels":[],"label_agreement":null},{"id":"W2138660129","doi":"10.1111/j.1524-4733.2009.00583.x","title":"Relationship between Adherence Level to Statins, Clinical Issues and Health-Care Costs in Real-Life Clinical Setting","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Dyslipidemia; Confidence interval; Internal medicine; Odds ratio; Cohort; Coronary artery disease; Health care; Statin; Disease; Physical therapy; Emergency medicine; Intensive care medicine","score_opus":0.3191217327825773,"score_gpt":0.5003246325631929,"score_spread":0.1812028997806156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138660129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9341754,0.007781367,0.00028933358,0.05496609,0.00020211433,0.0022757216,0.000043539232,0.00007299354,0.0001934974],"genre_scores_gemma":[0.97067505,0.0032887743,0.013559093,0.0114629725,0.00085401506,0.000026898346,0.00006631222,0.00002772666,0.0000391579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99327916,0.0020672348,0.0025923827,0.0007411034,0.0005856379,0.00073447725],"domain_scores_gemma":[0.996757,0.00093682326,0.00035690868,0.0006364038,0.00010265196,0.001210213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014044775,0.00022046821,0.0012809923,0.00024517524,0.00015635733,0.000023467543,0.0001227574,0.0002648082,0.0000047728136],"category_scores_gemma":[0.0029295294,0.00021149188,0.00015411525,0.00056860154,0.00005921389,0.0000872707,0.00005348431,0.0011717187,0.000024606652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007971189,0.000094636685,0.7922097,0.00041727332,0.000008489856,0.000015258108,0.0012387414,0.000022731278,8.1580815e-8,0.0006607061,0.0009572934,0.2042954],"study_design_scores_gemma":[0.002588687,0.0027811653,0.9897308,0.001368249,0.000010500802,0.000008656708,0.0008605496,0.000111896974,6.045073e-7,0.00023372035,0.002143061,0.00016213689],"about_ca_topic_score_codex":0.03262768,"about_ca_topic_score_gemma":0.0013810634,"teacher_disagreement_score":0.20413326,"about_ca_system_score_codex":0.0006160375,"about_ca_system_score_gemma":0.0026476954,"threshold_uncertainty_score":0.97381413},"labels":[],"label_agreement":null},{"id":"W2139543283","doi":"10.1503/cmaj.070675","title":"The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials","year":2008,"lang":"en","type":"review","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Internal medicine; Randomized controlled trial; Statin; Coronary artery disease; Discontinuation; Myocardial infarction; Odds ratio; Meta-analysis; Confidence interval; Relative risk","score_opus":0.09036814506838814,"score_gpt":0.3661399650594396,"score_spread":0.27577181999105144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139543283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021888321,0.99343896,0.00006633073,0.0043698624,0.00018451521,0.0016103499,0.00016350021,0.0000029984503,0.00014158976],"genre_scores_gemma":[0.000033421795,0.9977927,0.000055239492,0.0013625416,0.00049805635,0.000048446997,0.000046241737,0.000021291333,0.00014206876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9866845,0.0070463326,0.003424064,0.00019651462,0.0023143042,0.00033426844],"domain_scores_gemma":[0.98232895,0.010255522,0.003609198,0.00032523976,0.002382833,0.0010982344],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.034925286,0.000267904,0.015210963,0.00058507704,0.00021172366,0.00002634046,0.00018558792,0.00057374977,0.00088708923],"category_scores_gemma":[0.0746597,0.0001242656,0.010765126,0.00081453467,0.000203927,0.000022969582,0.000014882224,0.0011455424,0.0000022801055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006006817,0.000011471472,0.0000021743695,0.00020967628,0.4075903,0.00004746202,0.00014100283,2.551585e-7,8.5569e-9,0.000040027735,0.0035874376,0.5877695],"study_design_scores_gemma":[0.01893452,0.00004391528,0.000023368011,0.00037803416,0.28390244,0.00021940596,0.0000780801,0.0000058159644,9.49017e-8,0.000008870188,0.69633096,0.00007452575],"about_ca_topic_score_codex":0.0034886112,"about_ca_topic_score_gemma":0.002482806,"teacher_disagreement_score":0.6927435,"about_ca_system_score_codex":0.00044844067,"about_ca_system_score_gemma":0.00935183,"threshold_uncertainty_score":0.99940926},"labels":[],"label_agreement":null},{"id":"W2139664471","doi":"10.1681/asn.2013090965","title":"Effects of Lowering LDL Cholesterol on Progression of Kidney Disease","year":2014,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; University of Oxford; National Health and Medical Research Council; British Heart Foundation","keywords":"Ezetimibe; Simvastatin; Medicine; Kidney disease; Placebo; Internal medicine; Dialysis; Urology; Renal function; Gastroenterology; Statin; Endocrinology; Pathology","score_opus":0.006845269216219316,"score_gpt":0.27303036954420173,"score_spread":0.2661851003279824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139664471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332094,0.0003003977,0.0005935465,0.0054075243,0.00010269311,0.00023961277,0.0000019739398,0.0000035173384,0.000029785706],"genre_scores_gemma":[0.9904275,0.00029213284,0.0010862726,0.007859646,0.0003056292,0.0000026371529,3.646436e-7,0.000014066829,0.0000117465715],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986239,0.00019740705,0.0004326236,0.00009725298,0.00048693313,0.00016187567],"domain_scores_gemma":[0.9978388,0.00010788003,0.0012696033,0.00036368385,0.0001713948,0.0002486177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006414806,0.000103473394,0.00075835886,0.00003946046,0.000030588148,0.000001415336,0.00018239592,0.000045554956,0.000004004353],"category_scores_gemma":[0.00027235536,0.000061230385,0.00096423057,0.00016347709,0.00049365126,0.000027230506,0.000060389015,0.00026684275,3.8720782e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004457939,0.001510732,0.035694048,0.0039640605,0.002160622,0.0000160797,0.0011854911,0.00014928644,0.7600596,0.000041735395,0.019640144,0.17112027],"study_design_scores_gemma":[0.004703733,0.007333193,0.9123969,0.0015518601,0.0008245223,0.00011628762,0.00014229157,0.00019767725,0.056526333,0.00010090049,0.015998214,0.000108072476],"about_ca_topic_score_codex":0.000035581834,"about_ca_topic_score_gemma":2.0496819e-7,"teacher_disagreement_score":0.87670285,"about_ca_system_score_codex":0.000035105917,"about_ca_system_score_gemma":0.00022132149,"threshold_uncertainty_score":0.24969028},"labels":[],"label_agreement":null},{"id":"W2139835433","doi":"10.1161/circoutcomes.111.960740","title":"Effectiveness of Preprocedural Statin Therapy on Clinical Outcomes for Patients With Stable Coronary Artery Disease After Percutaneous Coronary Interventions","year":2011,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Percutaneous coronary intervention; Conventional PCI; Hazard ratio; Acute coronary syndrome; Coronary artery disease; Myocardial infarction; Cardiology; Statin; Confidence interval; Propensity score matching","score_opus":0.08130933264933053,"score_gpt":0.35139207940425554,"score_spread":0.270082746754925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139835433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98943293,0.0017232622,0.0051803337,0.000035227076,0.00018095522,0.0031875244,0.00017161424,0.000055953744,0.000032177548],"genre_scores_gemma":[0.9983841,0.000116703006,0.000666248,0.0002270502,0.000034861925,0.00030363616,0.00020183857,0.000044059692,0.000021473126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677986,0.00083992165,0.00079426426,0.00060582656,0.00070684566,0.0002732762],"domain_scores_gemma":[0.99779564,0.00042988124,0.00018450606,0.0009516488,0.0003786568,0.0002596527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024715618,0.00029336897,0.0012802638,0.000101536054,0.000121047,0.000016071934,0.00007502743,0.00012606013,0.00003537475],"category_scores_gemma":[0.00032516854,0.00021003216,0.002498008,0.000100673766,0.00017380301,0.00016088769,0.000034224042,0.00016400253,0.0000030961894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00557128,0.0010170767,0.97163504,0.0019665228,0.005594167,0.00004319132,0.00023735312,0.000051509825,0.0000023197265,0.00017135375,0.0000018615932,0.0137083335],"study_design_scores_gemma":[0.00710749,0.0008855045,0.9899351,0.00034137227,0.001004906,0.00003227732,0.00007857172,0.000013293003,0.000009848875,0.00028814134,0.00004608826,0.00025743587],"about_ca_topic_score_codex":0.00009574745,"about_ca_topic_score_gemma":0.00000530699,"teacher_disagreement_score":0.01830004,"about_ca_system_score_codex":0.00007139243,"about_ca_system_score_gemma":0.00013439065,"threshold_uncertainty_score":0.85648626},"labels":[],"label_agreement":null},{"id":"W2139848588","doi":"10.1185/030079904125004484","title":"Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre","funders":"American Heart Association","keywords":"Atorvastatin; Medicine; Quartile; Internal medicine; Coronary heart disease; National Cholesterol Education Program; Cholesterol; Guideline; Cardiology; Metabolic syndrome; Confidence interval","score_opus":0.4358632798930135,"score_gpt":0.5607694194324756,"score_spread":0.12490613953946211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139848588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818338,0.008845159,0.00010167279,0.0067549814,0.0001256183,0.0022976745,0.000014317994,0.000009393437,0.000017374005],"genre_scores_gemma":[0.9976768,0.0015288694,0.00004777734,0.00011309348,0.00047522318,0.00009541762,0.00004814582,0.000011088807,0.000003615275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99509263,0.0012182469,0.0005255906,0.00048149654,0.0022915152,0.00039052224],"domain_scores_gemma":[0.9972011,0.0013338779,0.00004564331,0.00030847618,0.00015880975,0.00095212145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01825543,0.00013702449,0.00037125134,0.00015785865,0.00028392702,0.00005383144,0.000077943834,0.00012055554,0.000013866464],"category_scores_gemma":[0.0059809336,0.000090352434,0.000045611992,0.0002591115,0.0004838527,0.000105295796,0.00016104025,0.0011360216,0.0000044608987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012385934,0.0002831021,0.8300807,0.00024839074,0.0000151396,0.00002314456,0.00047638227,7.5393686e-8,1.5169124e-7,0.00011959773,0.00007172589,0.16855773],"study_design_scores_gemma":[0.0068523567,0.0012789677,0.98801774,0.00039398577,0.00005873695,0.00003472221,0.0007534293,0.00016611359,1.6032989e-7,0.0018099705,0.00054807117,0.000085737505],"about_ca_topic_score_codex":0.00026851043,"about_ca_topic_score_gemma":0.00009419437,"teacher_disagreement_score":0.16847199,"about_ca_system_score_codex":0.0000656294,"about_ca_system_score_gemma":0.00061049894,"threshold_uncertainty_score":0.7160168},"labels":[],"label_agreement":null},{"id":"W2140020230","doi":"10.1016/j.ejphar.2004.05.041","title":"Treatment of type IIb familial combined hyperlipidemia with the combination pravastatin-piperazine sultosilate","year":2004,"lang":"en","type":"article","venue":"European Journal of Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Pravastatin; Hyperlipidemia; Triglyceride; Internal medicine; Medicine; Apolipoprotein B; Endocrinology; Cholesterol; Statin; Diabetes mellitus","score_opus":0.018912369692608656,"score_gpt":0.29049633576127054,"score_spread":0.27158396606866186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140020230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908451,0.00085856544,0.00047915248,0.0061239866,0.00048100526,0.0004058703,0.0000024704025,0.000010362385,0.00079350715],"genre_scores_gemma":[0.9972471,0.0007702485,0.0006702786,0.00062786316,0.00053401774,0.0000018142189,0.0000050282288,0.0000266683,0.00011695861],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984972,0.00050834875,0.00042618063,0.000106934116,0.0002873371,0.00017402848],"domain_scores_gemma":[0.99889946,0.00004852725,0.00036933558,0.00014163162,0.00043196022,0.00010908895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081629754,0.00013183035,0.00042348195,0.00008237135,0.00006765564,0.0000052638393,0.000101047815,0.000020904676,0.00004649263],"category_scores_gemma":[0.00002887842,0.00007009591,0.00015508787,0.0001772153,0.0001107946,0.000049225946,0.000014294203,0.00020668482,0.00001527817],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023467477,0.005264248,0.0044773365,0.0003116866,0.0057501188,0.0064121247,0.0062418585,0.005124686,0.7925739,0.00077304745,0.006170312,0.14343318],"study_design_scores_gemma":[0.21431288,0.14870581,0.25935155,0.00037834776,0.0061968653,0.009638792,0.001161735,0.00029985505,0.20826603,0.00007911623,0.15099014,0.0006188616],"about_ca_topic_score_codex":0.000020772643,"about_ca_topic_score_gemma":0.0000017669325,"teacher_disagreement_score":0.5843079,"about_ca_system_score_codex":0.00012253907,"about_ca_system_score_gemma":0.00029119648,"threshold_uncertainty_score":0.28584284},"labels":[],"label_agreement":null},{"id":"W2140272923","doi":"10.1007/s00125-014-3374-x","title":"Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"Diabetologia","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Weill Cornell Medical College","keywords":"Diabetes mellitus; Meta-analysis; Medicine; Human physiology; Internal medicine; Type 2 diabetes; MEDLINE; Intensive care medicine; Endocrinology; Biology","score_opus":0.03667936860217352,"score_gpt":0.31766462103157167,"score_spread":0.28098525242939815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140272923","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006172186,0.9915027,0.00007893181,0.00014845566,0.000008151572,0.007950573,0.00017569812,0.000036627276,0.00003714024],"genre_scores_gemma":[0.00049496075,0.9940441,0.00021718565,0.001947573,0.00001816468,0.0030239,0.00014367614,0.000050369483,0.000060069247],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953948,0.0015265382,0.0013654217,0.0007561153,0.0004695138,0.00048757752],"domain_scores_gemma":[0.99716234,0.0005655004,0.0008162524,0.0011207103,0.00009135532,0.00024382354],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0036422587,0.0006501986,0.023363534,0.00049823715,0.00004665784,0.000043547774,0.00015465822,0.0003273266,0.00004366762],"category_scores_gemma":[0.00050321897,0.0003345108,0.0017621092,0.0009852496,0.00012627504,0.000046039724,0.000058970585,0.00053706847,0.0000109292205],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[6.930298e-7,0.000022814791,0.0006858243,0.81632096,0.18036143,0.00001492521,0.000013143172,7.7202266e-8,3.6354113e-9,0.000017687751,0.000026349733,0.002536062],"study_design_scores_gemma":[0.0005698882,0.0001796867,0.00011785092,0.06710874,0.9186518,0.000040176405,0.0000063744624,0.0000049522396,2.5515616e-8,0.000004730133,0.012995044,0.00032069036],"about_ca_topic_score_codex":0.000031322525,"about_ca_topic_score_gemma":0.000026223588,"teacher_disagreement_score":0.7492122,"about_ca_system_score_codex":0.0000673144,"about_ca_system_score_gemma":0.0001846336,"threshold_uncertainty_score":0.9999107},"labels":[],"label_agreement":null},{"id":"W2140314387","doi":"10.1161/jaha.113.000759","title":"Relations of Change in Plasma Levels of LDL‐C, Non‐HDL‐C and apoB With Risk Reduction From Statin Therapy: A Meta‐Analysis of Randomized Trials","year":2014,"lang":"en","type":"review","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill Genome Centre; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Apolipoprotein B; Internal medicine; Statin; Placebo; Meta-analysis; Randomized controlled trial; Ezetimibe; Frequentist inference; Cholesterol; Relative risk; Cardiology; Endocrinology; Bayesian probability; Confidence interval; Bayesian inference; Statistics; Pathology","score_opus":0.1255929035056525,"score_gpt":0.3855896434425562,"score_spread":0.2599967399369037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140314387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14447467,0.8520967,0.00028554298,0.0004235668,0.0000996704,0.0022960769,0.00031118156,0.0000027945098,0.000009834662],"genre_scores_gemma":[0.08408281,0.91364765,0.0019002106,0.000026677822,0.00022424472,0.000058936846,0.0000129915,0.000023827915,0.000022643859],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9891007,0.0071533034,0.002530032,0.00015820704,0.00093059335,0.00012717309],"domain_scores_gemma":[0.9825478,0.003154336,0.013373797,0.0003440584,0.0005199673,0.000059993614],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.018749975,0.00020961819,0.014867975,0.0006947254,0.00003547591,0.0000072502066,0.00008980341,0.00013283566,0.000026462381],"category_scores_gemma":[0.0030891974,0.00010751331,0.00538919,0.0013571144,0.000109423774,0.000075294636,0.000016968099,0.0004465196,2.1049773e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0090953065,0.00030747784,0.0061108125,0.0016096552,0.56926405,0.0000011002456,0.0023671954,0.00013192046,0.000082447616,0.0000056687536,0.00008999901,0.41093436],"study_design_scores_gemma":[0.03922206,0.0009998133,0.045424446,0.0037671376,0.9035196,0.000024156963,0.00027091568,0.00021269181,0.00010665194,0.000062432824,0.006160549,0.00022960208],"about_ca_topic_score_codex":0.0055801948,"about_ca_topic_score_gemma":0.00012932147,"teacher_disagreement_score":0.41070476,"about_ca_system_score_codex":0.00023210935,"about_ca_system_score_gemma":0.00041504856,"threshold_uncertainty_score":0.99975735},"labels":[],"label_agreement":null},{"id":"W2141484423","doi":"10.1093/eurheartj/ehu342","title":"Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)","year":2014,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute for Health and Care Research","keywords":"Medicine; Ejection fraction; Heart failure; Rosuvastatin; Cardiology; Internal medicine; Angina; Myocardial infarction","score_opus":0.021319624860650383,"score_gpt":0.28230638536598124,"score_spread":0.2609867605053309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141484423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960854,0.000037449474,0.00014177745,0.0028680484,0.00007989869,0.0007449945,0.000007902462,0.000010439341,0.00002409063],"genre_scores_gemma":[0.9978392,0.0000015903387,0.0016567897,0.00011415532,0.0003171729,0.000007075553,0.000018999024,0.000021947304,0.000023031975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969939,0.0014850503,0.0005083651,0.00024296723,0.0005766182,0.0001931014],"domain_scores_gemma":[0.99896187,0.00025859533,0.00021485222,0.00024477544,0.00016569014,0.00015420948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025094897,0.0001521431,0.00073540333,0.00044253195,0.00020022954,0.00005238932,0.000044373606,0.000058457645,0.00001717723],"category_scores_gemma":[0.0005936085,0.000099707875,0.00020748179,0.00052246655,0.000057744106,0.00022055404,0.000022556924,0.00056200067,0.0000010159041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019744195,0.00012119961,0.9972367,0.000013190855,0.00014476191,0.0000010979238,0.00012285152,0.000096809075,0.000035188303,0.000009683324,0.00007719701,0.00016688336],"study_design_scores_gemma":[0.043609682,0.000785872,0.9540802,0.000062334715,0.00033834562,0.000020396403,0.0001579666,0.0001667662,0.000008356055,0.000008500564,0.00066776905,0.000093804236],"about_ca_topic_score_codex":0.00008486308,"about_ca_topic_score_gemma":0.00015848584,"teacher_disagreement_score":0.043156512,"about_ca_system_score_codex":0.0000949759,"about_ca_system_score_gemma":0.00007778245,"threshold_uncertainty_score":0.40659693},"labels":[],"label_agreement":null},{"id":"W2141701463","doi":"10.1503/cmaj.050418","title":"Does intensified cholesterol lowering provide greater protection from cardiovascular events among patients with stable coronary artery disease?","year":2005,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Coronary artery disease; Medicine; Atorvastatin; Cholesterol; Cardiology; Internal medicine; Disease; Cholesterol lowering","score_opus":0.005920956991740945,"score_gpt":0.18502965153849787,"score_spread":0.17910869454675693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141701463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232453,0.00016184275,0.00071684783,0.00518193,0.00057178386,0.00088346296,0.000044181088,0.000035224166,0.00008017517],"genre_scores_gemma":[0.9943188,0.000045092198,0.00008172643,0.0027647289,0.0023504002,0.000060477163,0.00006006736,0.000040053397,0.00027869784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960966,0.00018203899,0.0004333139,0.0003219559,0.0023912673,0.0005748169],"domain_scores_gemma":[0.99663025,0.000015425518,0.00016795537,0.00032747,0.00055984635,0.0022990305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010712334,0.00020347795,0.0004484481,0.00015410988,0.0002791013,0.00007513764,0.00011238695,0.0002575757,0.00055354345],"category_scores_gemma":[0.00036183922,0.00012707507,0.0003430438,0.00014382978,0.00003463562,0.00034968558,0.000018080293,0.0009010929,0.000049216098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001214533,0.000061325074,0.89371604,0.00003000763,0.0013916335,0.0003532796,0.000151627,0.000034070457,0.0000018190171,2.6624664e-7,0.0006574022,0.10348106],"study_design_scores_gemma":[0.0034508884,0.00009014432,0.94681555,0.00039610302,0.0002974961,0.0000720732,0.00007838121,0.000142727,0.00002178158,0.000009656778,0.048450667,0.00017455353],"about_ca_topic_score_codex":0.0067849183,"about_ca_topic_score_gemma":0.011832547,"teacher_disagreement_score":0.10330651,"about_ca_system_score_codex":0.0018851748,"about_ca_system_score_gemma":0.0015549558,"threshold_uncertainty_score":0.999829},"labels":[],"label_agreement":null},{"id":"W2142138762","doi":"10.1074/jbc.m212855200","title":"A Ligand-induced Conformational Change in Apolipoprotein(a) Enhances Covalent Lp(a) Formation","year":2003,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Covalent bond; Chemistry; Conformational change; Apolipoprotein B; Biophysics; Lipoprotein; Ligand (biochemistry); Lipoprotein(a); Stereochemistry; Crystallography; Biochemistry; Cholesterol; Receptor; Biology; Organic chemistry","score_opus":0.056062547148842366,"score_gpt":0.30276297090410803,"score_spread":0.24670042375526566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142138762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995725,0.0011697687,0.00016006405,0.0004546212,0.000072319206,0.00023886022,0.0000024426274,0.000008712951,0.0021682107],"genre_scores_gemma":[0.9982144,0.0005273278,0.0004053466,0.00038202276,0.00042104983,0.000020711968,0.000008416565,0.000004341263,0.000016354843],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987372,0.00004821843,0.0005477883,0.000092991366,0.0003707365,0.00020302722],"domain_scores_gemma":[0.9992472,0.000020129848,0.00029838076,0.00012308842,0.00016126611,0.00014996144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009443488,0.00011301672,0.00037963054,0.000045555927,0.00003489957,0.000012509039,0.00007070792,0.0001876913,0.00012562615],"category_scores_gemma":[0.0003006345,0.00007359776,0.0002221252,0.0001326781,0.000030780328,0.00014547931,0.000012550144,0.0003353338,0.0000064200317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005240797,0.0005091361,0.0073409625,0.0008066872,0.00011696277,0.00019434774,0.00051913457,0.0000036100516,0.9611318,0.0002776752,0.00012747372,0.02844812],"study_design_scores_gemma":[0.0023836365,0.00044773275,0.019375924,0.00029171826,0.00002644284,0.0019513335,0.00029739327,0.000031872976,0.9691293,0.00022499767,0.0057043275,0.00013527702],"about_ca_topic_score_codex":0.00000978344,"about_ca_topic_score_gemma":9.257983e-7,"teacher_disagreement_score":0.028312843,"about_ca_system_score_codex":0.00013200259,"about_ca_system_score_gemma":0.00012734105,"threshold_uncertainty_score":0.30012295},"labels":[],"label_agreement":null},{"id":"W2142164422","doi":"10.1001/jama.295.2.180","title":"International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis","year":2006,"lang":"en","type":"article","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1616,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fuwai Hospital, Chinese Academy of Medical Sciences; Debreceni Egyetem; Universitas Indonesia; University of Ioannina; National Taiwan University Hospital; Cleveland Clinic; Brigham and Women's Hospital; University of Toronto; Erasmus Medisch Centrum; Keio University; Huashan Hospital; National Taiwan University; University of Minnesota; Minneapolis Heart Institute Foundation; University of South Carolina; Monash University; Minneapolis Heart Institute; Northwestern University","keywords":"Medicine; Overweight; Risk factor; Internal medicine; Coronary artery disease; Diabetes mellitus; Obesity; Disease; Endocrinology","score_opus":0.02009840025255288,"score_gpt":0.23667735313990992,"score_spread":0.21657895288735704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142164422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995605,0.0010567722,0.000097177326,0.000030663334,0.00003168836,0.00047416848,0.000062282576,0.000018363784,0.0026238977],"genre_scores_gemma":[0.99688673,0.0021497891,0.00059271185,0.000006106544,0.000112829024,0.000038991202,0.00004555777,0.000018216077,0.00014908994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992501,0.000044198736,0.00014677962,0.00016912822,0.00029542288,0.00009437466],"domain_scores_gemma":[0.99962527,0.00000967391,0.000056765548,0.00020626637,0.000063735795,0.00003826374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011515483,0.000087673645,0.00026828205,0.00009439098,0.000015254341,0.000006179324,0.000021892998,0.000048386584,0.000029694356],"category_scores_gemma":[0.000013968272,0.00005957244,0.00013766899,0.000091451235,0.00003481979,0.000046355646,0.000006696167,0.000038155922,0.0000018432779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009465882,0.00032083155,0.8945695,0.0000832778,0.0007497521,0.000010045469,0.00026545778,0.000023237355,0.000015347527,0.000003484744,0.00003635729,0.10382803],"study_design_scores_gemma":[0.0057966313,0.00060581724,0.9825882,0.00016449804,0.000344342,0.000010734493,0.00009453279,0.000018707804,0.0015100718,0.000026723375,0.008760878,0.000078900135],"about_ca_topic_score_codex":0.012677055,"about_ca_topic_score_gemma":0.00011302868,"teacher_disagreement_score":0.10374913,"about_ca_system_score_codex":0.000070045004,"about_ca_system_score_gemma":0.000021326974,"threshold_uncertainty_score":0.9938976},"labels":[],"label_agreement":null},{"id":"W2142267986","doi":"10.1194/jlr.m044156","title":"Internalized PCSK9 dissociates from recycling LDL receptors in PCSK9-resistant SV-589 fibroblasts","year":2013,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; LDL receptor; Receptor; Chemistry; Cell biology; Cholesterol; Biochemistry; Biology; Lipoprotein","score_opus":0.051174424653949266,"score_gpt":0.3673534352426206,"score_spread":0.3161790105886713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142267986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887091,0.0029467028,0.000068303234,0.005555504,0.00066164834,0.0005829776,0.000004511314,0.000014321654,0.0014569158],"genre_scores_gemma":[0.9922489,0.001334719,0.0016111982,0.00012886687,0.0030264335,0.000025365425,0.000006055578,0.00005109101,0.0015673623],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.994765,0.00093911716,0.0011131442,0.00028675486,0.0021700726,0.0007259381],"domain_scores_gemma":[0.99713534,0.0005518261,0.00032131147,0.00045357435,0.0009903633,0.0005475569],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0059330445,0.00018757071,0.0008681242,0.00066016003,0.0001265495,0.00013063652,0.00037019158,0.00020919181,0.0015707068],"category_scores_gemma":[0.0020719874,0.00013404357,0.0005142917,0.0006495303,0.00012304801,0.00029546325,0.00015369915,0.0018565259,0.00017401564],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008228643,0.002245384,0.26178086,0.0012750182,0.0031068267,0.0015051515,0.0075262273,0.000068382804,0.24145994,0.00013654583,0.073056035,0.399611],"study_design_scores_gemma":[0.027593328,0.0066193566,0.53963023,0.016105603,0.0002695175,0.00050311035,0.011247948,0.0007662079,0.067792885,0.005822633,0.32253757,0.001111609],"about_ca_topic_score_codex":0.0037429577,"about_ca_topic_score_gemma":0.00015570245,"teacher_disagreement_score":0.39849937,"about_ca_system_score_codex":0.00062694144,"about_ca_system_score_gemma":0.000458152,"threshold_uncertainty_score":0.99934196},"labels":[],"label_agreement":null},{"id":"W2142823158","doi":"10.1080/03639040500529010","title":"Assessing Lipid Lowering and Plasma Cholesteryl Ester Transfer Protein Activity of Simvastatin Following Administration to Rabbits Fed a High Fat/Cholesterol Diet","year":2006,"lang":"en","type":"article","venue":"Drug Development and Industrial Pharmacy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Simvastatin; Cholesterol; Cholesterylester transfer protein; Triglyceride; Chemistry; Endocrinology; Internal medicine; Apolipoprotein B; Cholesteryl ester; Blood plasma; Biochemistry; Biology; Lipoprotein; Medicine","score_opus":0.043309253685401984,"score_gpt":0.30287491039413966,"score_spread":0.25956565670873766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142823158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649185,0.00004640165,0.00065798766,0.0007861717,0.0002224516,0.0015933554,0.00000579794,0.0000413446,0.00015465588],"genre_scores_gemma":[0.99813247,0.0000054501133,0.0008307493,0.000106643995,0.0005414901,0.00010198079,0.00003385118,0.00003072416,0.00021666042],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981968,0.00009566096,0.0005101228,0.00040418297,0.0004663832,0.00032684184],"domain_scores_gemma":[0.9994571,0.00003491356,0.00008345433,0.00014553787,0.00005319356,0.00022576665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006951597,0.00026587222,0.00051688385,0.00014407777,0.00017255556,0.00015591278,0.000053630665,0.000093878676,0.000010961774],"category_scores_gemma":[0.000034006614,0.00024064032,0.000095468415,0.0002042506,0.00003209362,0.00049257,0.00004683474,0.0003220653,0.0000022800382],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004790113,0.00060780346,0.023062715,0.00064801454,0.00049382536,0.00011005526,0.0023421212,0.000017297434,0.25373834,0.000020407584,0.00032582812,0.71384346],"study_design_scores_gemma":[0.014878737,0.00031472687,0.044078905,0.0008953819,0.00018034554,0.00002491691,0.00019051637,0.000059077036,0.9287476,0.0000044204266,0.01017442,0.00045094674],"about_ca_topic_score_codex":0.0002600873,"about_ca_topic_score_gemma":0.000046415338,"teacher_disagreement_score":0.7133925,"about_ca_system_score_codex":0.0000756443,"about_ca_system_score_gemma":0.00032723657,"threshold_uncertainty_score":0.9813028},"labels":[],"label_agreement":null},{"id":"W2143003213","doi":"10.2174/1381612820666140620162629","title":"Statin Treatment Non-adherence and Discontinuation: Clinical Implications and Potential Solutions","year":2014,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Montreal General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Discontinuation; Statin; Cochrane Library; CINAHL; MEDLINE; Intensive care medicine; Psychological intervention; Physical therapy; Clinical trial; Population; Randomized controlled trial; Internal medicine; Nursing","score_opus":0.3723562909771418,"score_gpt":0.5180654013359534,"score_spread":0.14570911035881157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143003213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017084654,0.910737,0.08497332,0.00029628223,0.00042610551,0.0033524456,0.000072610455,0.000046238554,0.00007894256],"genre_scores_gemma":[0.0009288924,0.9954864,0.0014872921,0.000044987264,0.0010039072,0.0007188384,0.00019129986,0.000043350432,0.000095068026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679303,0.0007473916,0.0009652366,0.0007552836,0.00028392725,0.00045510445],"domain_scores_gemma":[0.9980259,0.0003619399,0.00022540118,0.00053683587,0.000101764366,0.00074817427],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001283359,0.00044115676,0.0018639253,0.0000997895,0.00023478891,0.000072280556,0.00009645673,0.00023578257,0.00004935887],"category_scores_gemma":[0.00013657892,0.00031195296,0.0006121105,0.00017540723,0.0002917772,0.00006163646,0.00009827524,0.0005888342,0.000061953564],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017970317,0.00040918824,0.000027628555,0.0037466127,0.00032557524,0.000008083727,0.000011680227,1.9509554e-7,4.0920372e-7,0.0004718879,0.000590737,0.99439],"study_design_scores_gemma":[0.001875791,0.0007989411,0.00039002064,0.0032061473,0.0063373456,0.00036801584,0.0000035311257,0.0005995662,9.893732e-7,0.00011422734,0.98597646,0.00032897535],"about_ca_topic_score_codex":0.0000053482113,"about_ca_topic_score_gemma":3.7509736e-7,"teacher_disagreement_score":0.99406105,"about_ca_system_score_codex":0.0001259714,"about_ca_system_score_gemma":0.0006257792,"threshold_uncertainty_score":0.99993324},"labels":[],"label_agreement":null},{"id":"W2143265673","doi":"10.1038/ncpcardio1005","title":"Genetic determinants of plasma lipoproteins","year":2007,"lang":"en","type":"review","venue":"Nature Clinical Practice Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Plasma lipoprotein; Genetics; Phenotype; Biology; Genetic variation; Lipoprotein; Gene; Bioinformatics; Computational biology; Cholesterol; Endocrinology","score_opus":0.09680426123079668,"score_gpt":0.46644890764668084,"score_spread":0.3696446464158842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143265673","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050277595,0.9840654,0.00052302674,0.00019025811,0.003787554,0.0053118076,0.00003166363,0.00014132679,0.005898678],"genre_scores_gemma":[0.00012590294,0.9761328,0.0087450715,0.0011330603,0.013046206,0.00014452971,0.00010656418,0.00033105188,0.0002347793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98340875,0.0026727957,0.005817679,0.0020884993,0.00490698,0.0011053229],"domain_scores_gemma":[0.98416936,0.004515198,0.0024553866,0.005874105,0.001737114,0.0012488422],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"category_scores_codex":[0.0233421,0.0013841022,0.015843738,0.0008215472,0.00014746342,0.000019841189,0.00083036005,0.0059442488,0.00012681364],"category_scores_gemma":[0.043921288,0.00094474055,0.01414947,0.0018252503,0.0009737075,0.00019654966,0.00033211344,0.009454957,0.00015575677],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023109674,0.0004040105,0.000031931464,0.036499683,0.0147762485,0.00430636,0.000022286968,5.8641984e-7,8.3567016e-8,0.000023635113,0.0013731772,0.9423309],"study_design_scores_gemma":[0.0037630866,0.0015209418,0.0004605986,0.0313833,0.06283953,0.011026757,0.00006109681,0.000005113031,0.0000024231338,0.000009601182,0.8882624,0.00066514406],"about_ca_topic_score_codex":0.00031976582,"about_ca_topic_score_gemma":0.000013676634,"teacher_disagreement_score":0.94166577,"about_ca_system_score_codex":0.0003316018,"about_ca_system_score_gemma":0.0022011597,"threshold_uncertainty_score":0.9998909},"labels":[],"label_agreement":null},{"id":"W2143340286","doi":"10.1161/01.cir.102.16.1886","title":"VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial","year":2000,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":490,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Internal medicine; Very low-density lipoprotein; Medicine; Apolipoprotein B; Endocrinology; Cholesterol; Myocardial infarction; Triglyceride; Lipoprotein; Cardiology","score_opus":0.018519344804351627,"score_gpt":0.27513544776980636,"score_spread":0.25661610296545473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143340286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926556,0.004915428,0.000026740101,0.00010647975,0.00009050054,0.0020831292,0.000013396171,0.000009411235,0.000099351055],"genre_scores_gemma":[0.99601614,0.003616875,0.000038220925,0.000044812157,0.00015768658,0.000070151975,0.000039262453,0.000011137883,0.0000057128286],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986501,0.00026194638,0.00031456992,0.00026346202,0.00035797872,0.0001519704],"domain_scores_gemma":[0.99946815,0.000028234344,0.000102470854,0.00028193486,0.00003804575,0.00008115205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066480186,0.00012588564,0.00028189036,0.00007439904,0.00008045807,0.000007343201,0.000037105085,0.000090161695,0.00001534869],"category_scores_gemma":[0.00004540749,0.00009430218,0.000069000176,0.000117885946,0.000044713135,0.000084440864,0.000018593892,0.00018804762,0.0000012936755],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022696592,0.0001461593,0.3150634,0.00023592896,0.00006281018,0.000002185682,0.0015382029,0.000010011186,0.000027988064,0.00001639856,0.0000041866992,0.68062305],"study_design_scores_gemma":[0.01798447,0.00043605114,0.979959,0.00024866915,0.00015620352,0.000062436186,0.00016666533,0.00023613249,0.000013056579,0.00025675463,0.00039573098,0.00008484537],"about_ca_topic_score_codex":0.00046787536,"about_ca_topic_score_gemma":0.00008271683,"teacher_disagreement_score":0.68053824,"about_ca_system_score_codex":0.00004835134,"about_ca_system_score_gemma":0.000040134517,"threshold_uncertainty_score":0.38455313},"labels":[],"label_agreement":null},{"id":"W2143615821","doi":"10.1016/j.atherosclerosis.2013.12.050","title":"Comment to the position paper on global recommendations for the management of dyslipidemia developed by the International Atherosclerosis Society (IAS)","year":2014,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Guideline; Medicine; Position paper; Task force; Atherosclerotic cardiovascular disease; Disease; Canadian Cardiovascular Society; Clinical Practice; Family medicine; Internal medicine; Political science; Pathology; Public administration; Myocardial infarction","score_opus":0.04915631876913222,"score_gpt":0.300612096892179,"score_spread":0.25145577812304676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143615821","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005020313,0.00017369348,0.011803258,0.98114526,0.0010516526,0.0038429608,0.0007553336,0.00005060585,0.00067518424],"genre_scores_gemma":[0.0058412035,0.001146354,0.003054869,0.9834596,0.0021672172,0.0024127185,0.000822529,0.000094732255,0.0010007808],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967799,0.00023950895,0.0007029377,0.0005997291,0.0011679141,0.0005099741],"domain_scores_gemma":[0.9972508,0.0004488723,0.0003833317,0.0015785375,0.00025472164,0.00008372898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002012533,0.0004556237,0.00056295237,0.00002518736,0.00069527846,0.000114740425,0.0010219561,0.0003900242,0.00015895953],"category_scores_gemma":[0.000035424935,0.00022983701,0.0010904553,0.00029513804,0.00012251025,0.000050298426,0.00024957457,0.00078096916,0.00006046302],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004767289,0.0000883894,0.000075766984,0.00014298438,0.0022390648,1.54423e-7,0.00025518858,0.00001287541,0.00007545869,0.00049264275,0.9697112,0.026858589],"study_design_scores_gemma":[0.0012725333,0.00023526013,0.0040857126,0.00069617026,0.0009656246,0.0000034009927,0.00032998263,0.00009210881,0.00018923597,0.000077725876,0.9918099,0.00024236037],"about_ca_topic_score_codex":0.00028764262,"about_ca_topic_score_gemma":0.000024924424,"teacher_disagreement_score":0.026616229,"about_ca_system_score_codex":0.00070339185,"about_ca_system_score_gemma":0.00007829167,"threshold_uncertainty_score":0.9372481},"labels":[],"label_agreement":null},{"id":"W2143741651","doi":"10.1161/circulationaha.112.104125","title":"Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia","year":2012,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":300,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Apolipoprotein B; Internal medicine; Ldl cholesterol; Endocrinology; Cholesterol","score_opus":0.018817536131046864,"score_gpt":0.24726006017207214,"score_spread":0.22844252404102527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143741651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963842,0.00029412803,0.0011037566,0.0002034236,0.00007893578,0.00076313387,0.0000027581616,0.000057547553,0.0011121206],"genre_scores_gemma":[0.9985774,0.000016660659,0.00045617812,0.00021415437,0.0005202366,0.00014076658,0.00003206265,0.000030622778,0.000011925902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873054,0.00009526227,0.00023085716,0.00020836286,0.00039366062,0.00034130577],"domain_scores_gemma":[0.9993786,0.00001724865,0.000058129495,0.00033917036,0.00004759904,0.00015924568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046747338,0.00013712091,0.0002726869,0.00016928307,0.000052877185,0.000012768352,0.000023646342,0.00012789822,0.000027469734],"category_scores_gemma":[0.000049931514,0.000116054565,0.000094893985,0.00024144765,0.000034922992,0.00024790852,0.000011785906,0.00016993242,0.00005275355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003354609,0.0003620244,0.82779694,0.000388158,0.00010095634,0.00005023756,0.0011037316,0.00021442886,0.033233635,0.00017977308,0.000023615792,0.13621104],"study_design_scores_gemma":[0.0013696543,0.000050901697,0.990923,0.00023707024,0.00008353229,0.000259774,0.00015322592,0.00016294955,0.006129238,0.000022988632,0.0004533767,0.00015428658],"about_ca_topic_score_codex":0.0005480201,"about_ca_topic_score_gemma":0.00005764802,"teacher_disagreement_score":0.16312605,"about_ca_system_score_codex":0.000254011,"about_ca_system_score_gemma":0.000054971257,"threshold_uncertainty_score":0.47325677},"labels":[],"label_agreement":null},{"id":"W2144790234","doi":"10.1111/j.1463-1326.2007.00725.x","title":"Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus*","year":2007,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Ezetimibe; Simvastatin; Medicine; Atorvastatin; Type 2 diabetes; Pharmacology; Apolipoprotein B; Internal medicine; Statin; Cholesterol; Endocrinology; Diabetes mellitus","score_opus":0.006956152334018997,"score_gpt":0.218371969766574,"score_spread":0.211415817432555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144790234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917189,0.006862519,0.000027213393,0.00004775482,0.000057631652,0.000920288,0.000048440823,0.000035197707,0.00028208015],"genre_scores_gemma":[0.9968451,0.0001967018,0.0023328974,0.0001871104,0.000091995746,0.000013624746,0.00016178178,0.000039656847,0.00013110577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977749,0.00012782769,0.00044295337,0.00046148416,0.0005812894,0.000611564],"domain_scores_gemma":[0.99857634,0.00015541601,0.00018583718,0.00042285692,0.00030333851,0.00035617943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093515764,0.0003197419,0.0010725338,0.00021822455,0.00009875218,0.000026821499,0.000085234766,0.000117232536,0.000081314145],"category_scores_gemma":[0.000103065526,0.00023163338,0.000080962316,0.00049840123,0.0002441846,0.00014198716,0.000060311504,0.00024104766,0.0000069924295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013167332,0.00083824975,0.9681737,0.00067970995,0.00043799618,0.000010779087,0.00072301016,0.0000130089875,0.0005562815,0.00006849221,0.00013768536,0.02704438],"study_design_scores_gemma":[0.0097571425,0.0005956346,0.9793847,0.0003066574,0.0003694189,8.5128283e-7,0.000091193375,0.00005120531,0.003568857,0.000024565783,0.005573783,0.0002759475],"about_ca_topic_score_codex":0.00008833657,"about_ca_topic_score_gemma":0.000081594895,"teacher_disagreement_score":0.026768433,"about_ca_system_score_codex":0.000024816823,"about_ca_system_score_gemma":0.00009942215,"threshold_uncertainty_score":0.9445735},"labels":[],"label_agreement":null},{"id":"W2144896295","doi":"10.1016/s0140-6736(09)60447-5","title":"Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial","year":2009,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1020,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"AstraZeneca","keywords":"Rosuvastatin; Medicine; Internal medicine; Rosuvastatin Calcium; Cholesterol; Reduction (mathematics); Ldl cholesterol; Cardiology; Prospective cohort study; C-reactive protein; Jupiter (rocket family); Cardiovascular event; Inflammation; Disease; Physics","score_opus":0.01833056986093243,"score_gpt":0.2832555200015539,"score_spread":0.26492495014062145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144896295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421,0.00079360284,0.000015611697,0.0005305743,0.000038320853,0.0043365667,0.00000493696,0.00000601175,0.00006435604],"genre_scores_gemma":[0.99930626,0.000033173124,0.00003403445,0.000050827613,0.0003179229,0.00024092791,0.0000010372072,0.0000068098047,0.000009012613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988508,0.0003116988,0.00023589206,0.00017798225,0.00031057544,0.000113009046],"domain_scores_gemma":[0.99932754,0.000011646829,0.00010349031,0.00046247136,0.00007319023,0.0000216735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009907914,0.0000918512,0.0005117102,0.000040415627,0.000032513602,0.000009544324,0.00004661705,0.000037965932,0.0000015488919],"category_scores_gemma":[0.00006152349,0.000049974864,0.000100481164,0.00015318488,0.00005604533,0.00006798501,0.000025037787,0.00016694832,1.4006415e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20107058,0.006535248,0.37137562,0.0019445006,0.005660689,0.000057249847,0.18572472,0.00028851876,0.031655893,0.00038248935,0.00009710722,0.19520737],"study_design_scores_gemma":[0.033926927,0.00147831,0.95719624,0.00020827103,0.00020655169,0.000025568153,0.0015829254,0.000014774253,0.004918732,0.0003550928,0.0000305757,0.000056052264],"about_ca_topic_score_codex":0.00027967046,"about_ca_topic_score_gemma":0.00003535557,"teacher_disagreement_score":0.5858206,"about_ca_system_score_codex":0.00003163732,"about_ca_system_score_gemma":0.000036546306,"threshold_uncertainty_score":0.20379157},"labels":[],"label_agreement":null},{"id":"W2145123193","doi":"10.1001/archneur.59.2.223","title":"Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly People","year":2002,"lang":"en","type":"article","venue":"Archives of Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":518,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Dementia; Medicine; Gerontology; Cohort study; Cohort; Disease; Demography; Internal medicine","score_opus":0.039127964964720895,"score_gpt":0.2508281916604904,"score_spread":0.21170022669576952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145123193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976312,0.0011005129,0.0003343214,0.00044909728,0.000026833915,0.00028069742,0.0000045528795,0.0000042103193,0.0001686073],"genre_scores_gemma":[0.99303883,0.0065146224,0.00027136458,0.00013661793,0.000017364431,0.0000064153805,0.0000035536889,0.0000075074017,0.0000037352158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998677,0.00071396795,0.00030636747,0.00008889514,0.00010550013,0.000108230626],"domain_scores_gemma":[0.99860114,0.0007706001,0.0002095611,0.00037659428,0.0000130657145,0.00002903859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046121425,0.00006059331,0.00032052235,0.00013225268,0.000045511955,0.0000017171782,0.000085241816,0.000033435714,0.000010245524],"category_scores_gemma":[0.00027297606,0.00004485358,0.00009426884,0.00009749029,0.00022686097,0.000027671613,0.00007134951,0.0003072513,2.9702312e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075723755,0.00036743208,0.8798945,0.00057031127,0.00037263473,0.0000048159804,0.014345059,0.0005116453,0.0027399855,0.00031416482,0.000017410297,0.1001048],"study_design_scores_gemma":[0.0020854878,0.0007295524,0.991312,0.000050122733,0.00014776368,0.000022811295,0.00010836564,0.0037712597,0.0009795942,0.00025777883,0.0004996817,0.000035559875],"about_ca_topic_score_codex":0.0019958431,"about_ca_topic_score_gemma":0.00028508596,"teacher_disagreement_score":0.111417525,"about_ca_system_score_codex":0.0000010368199,"about_ca_system_score_gemma":0.00000972499,"threshold_uncertainty_score":0.3017131},"labels":[],"label_agreement":null},{"id":"W2145233209","doi":"10.1017/s0317167100007514","title":"A Neuromuscular Approach to Statin-Related Myotoxicity","year":2008,"lang":"en","type":"review","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Statin; Medicine; Myopathy; Intensive care medicine; Pharmacogenomics; Adverse effect; Exacerbation; Inflammatory myopathy; Myotoxin; Bioinformatics; Internal medicine; Pharmacology","score_opus":0.06793900412125199,"score_gpt":0.3109052264063921,"score_spread":0.24296622228514014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145233209","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14449461,0.84732074,0.00004426737,0.0008117233,0.0011008013,0.0011819382,0.000031207288,0.000037362006,0.0049773515],"genre_scores_gemma":[0.013977611,0.9779224,0.003932613,0.0033112986,0.0007118331,0.000020303545,0.0000024639432,0.00005838378,0.00006308983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98924935,0.0026826477,0.0023643353,0.0012321959,0.0021063832,0.002365103],"domain_scores_gemma":[0.99044234,0.0004555375,0.001626895,0.0005082235,0.000712559,0.0062544593],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["sts"],"category_scores_codex":[0.0062468145,0.0009187143,0.0034003025,0.0026253571,0.0032432615,0.0006111564,0.002824845,0.0006983581,0.000099594276],"category_scores_gemma":[0.0036788587,0.00056447467,0.002205266,0.0040317457,0.005750196,0.00056093757,0.0001459879,0.003992686,0.000019033736],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014091279,0.0003579249,0.014394045,0.0019515903,0.00057929434,0.07311936,0.00095412356,0.0017202889,0.0000014045058,0.00096738583,0.0061437287,0.89966995],"study_design_scores_gemma":[0.00038094437,0.056320038,0.002583898,0.0011485841,0.00050976593,0.32515705,0.00006489672,0.00010650304,0.000001018503,0.0006481736,0.61242074,0.00065837783],"about_ca_topic_score_codex":0.0014435656,"about_ca_topic_score_gemma":0.0037545252,"teacher_disagreement_score":0.89901155,"about_ca_system_score_codex":0.00069456955,"about_ca_system_score_gemma":0.019166222,"threshold_uncertainty_score":0.9996807},"labels":[],"label_agreement":null},{"id":"W2145307924","doi":"10.21101/cejph.a3422","title":"Reaching Target Lipid Levels in Patients at High Risk of Cardiovascular Event: The Experience of a Canadian Tertiary Care Lipid Clinic","year":2007,"lang":"en","type":"article","venue":"Central European Journal of Public Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Health Evaluation and Outcome Sciences; St. Paul's Hospital","funders":"","keywords":"Medicine; Tertiary care; Cardiovascular event; Event (particle physics); Internal medicine; Disease","score_opus":0.029576611232677432,"score_gpt":0.2649816965933513,"score_spread":0.23540508536067387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145307924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899867,0.0063059162,0.0010053399,0.0008203083,0.0007432189,0.0006128692,0.00005427909,0.0000068908394,0.00046446567],"genre_scores_gemma":[0.99606586,0.0019169723,0.0006946951,0.00057172636,0.0006703191,0.000001073908,0.000017964994,0.00004511032,0.00001629023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930748,0.0025631106,0.0019225809,0.00026781514,0.0011422919,0.0010294351],"domain_scores_gemma":[0.9961951,0.00007072496,0.0010469409,0.0007659339,0.0005231662,0.0013981588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015535434,0.00021467304,0.0009500309,0.00065766886,0.00018499153,0.000015340136,0.00040342417,0.000063243984,0.000055448072],"category_scores_gemma":[0.0007923583,0.00014929243,0.0008517818,0.00068086653,0.00013063152,0.00017520667,0.00008100856,0.0007951056,0.000004079317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013199878,0.00028197397,0.6807543,0.00056103553,0.0008032338,0.00019016831,0.029784806,0.00016430324,0.000014788168,0.000019025538,0.00045468737,0.28683963],"study_design_scores_gemma":[0.0029474655,0.00065756374,0.9370622,0.00039277054,0.00007977309,0.000076574644,0.0027571816,0.000005743859,0.00009570656,0.000001185764,0.055813216,0.00011063031],"about_ca_topic_score_codex":0.04927151,"about_ca_topic_score_gemma":0.0046476535,"teacher_disagreement_score":0.286729,"about_ca_system_score_codex":0.0010869809,"about_ca_system_score_gemma":0.0020182703,"threshold_uncertainty_score":0.9570595},"labels":[],"label_agreement":null},{"id":"W2145695259","doi":"10.1016/s0828-282x(08)70649-4","title":"The Canadian lipid guidelines are difficult to model quantitatively","year":2008,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine","score_opus":0.07447477488998785,"score_gpt":0.2993704851970203,"score_spread":0.22489571030703245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145695259","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001146985,0.007567638,0.0010931997,0.9812387,0.0020987405,0.0007095809,0.00022217276,0.000009267221,0.0059136786],"genre_scores_gemma":[0.031143654,0.0018750238,0.0012153026,0.9085242,0.0508364,0.000042760275,0.000090549904,0.00016163333,0.006110469],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640226,0.00031461858,0.00097644137,0.000346609,0.00061261235,0.0013474562],"domain_scores_gemma":[0.9927226,0.000100889934,0.00042774103,0.0007870091,0.003635119,0.0023266643],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012034527,0.000412952,0.0016505484,0.0008625706,0.0008242374,0.00007512818,0.0005805386,0.0010758246,0.000008290665],"category_scores_gemma":[0.001927821,0.0002761236,0.0010709661,0.00034428993,0.00031021543,0.000049730683,0.000020756352,0.0027030227,0.00005349109],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019535748,3.5932234e-7,0.00023878577,0.000046292887,0.000771148,0.008143285,0.0001578,0.002151041,0.0000018199728,0.000050764676,0.9867449,0.0016742777],"study_design_scores_gemma":[0.00045730156,0.00022901529,0.0029307404,0.0002061091,0.0002915999,0.007552183,0.00013539754,0.000035527835,0.0000018358637,0.000037639817,0.9878508,0.00027185935],"about_ca_topic_score_codex":0.279812,"about_ca_topic_score_gemma":0.64032584,"teacher_disagreement_score":0.36051384,"about_ca_system_score_codex":0.0015308014,"about_ca_system_score_gemma":0.026901409,"threshold_uncertainty_score":0.99996907},"labels":[],"label_agreement":null},{"id":"W2146126282","doi":"10.1194/jlr.m041129","title":"Characterization of the role of EGF-A of low density lipoprotein receptor in PCSK9 binding","year":2013,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; LDL receptor; Kexin; Proprotein convertase; Chemistry; Epidermal growth factor; Subtilisin; Receptor; Biochemistry; Lipoprotein; Familial hypercholesterolemia; Cholesterol; Enzyme","score_opus":0.024050684826637154,"score_gpt":0.3021375110177335,"score_spread":0.27808682619109637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146126282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788266,0.00023589424,0.000024005873,0.0008215717,0.00013527133,0.0006742248,0.0000038575345,0.0000014469485,0.0002210351],"genre_scores_gemma":[0.99884295,0.00028952965,0.00024208613,0.000011765947,0.00045638072,0.000007041929,0.0000016038184,0.0000132030555,0.00013540848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99692553,0.0004970483,0.0007607062,0.00009851125,0.0014786578,0.00023953037],"domain_scores_gemma":[0.99755967,0.00007203677,0.00048700173,0.00037123257,0.0013959755,0.00011405966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043354365,0.00007430681,0.00051371596,0.00042126136,0.000041695494,0.000008311913,0.00022035668,0.00010949327,0.00016677311],"category_scores_gemma":[0.0007195043,0.000046242352,0.00026180668,0.0007173139,0.00013505678,0.00013758849,0.00009551944,0.00063652126,0.000006787411],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001842007,0.00021463947,0.033725932,0.00044434765,0.00007133817,0.0000020067796,0.00040431344,0.0000021452322,0.9314624,0.00002728796,0.000043305863,0.033418052],"study_design_scores_gemma":[0.0008372332,0.0004145435,0.24958904,0.0010880174,0.000012229854,0.000029713774,0.0004334735,0.0000477596,0.7468106,0.000053787935,0.0006502762,0.00003330818],"about_ca_topic_score_codex":0.0007099184,"about_ca_topic_score_gemma":0.000016749682,"teacher_disagreement_score":0.21586311,"about_ca_system_score_codex":0.0001133303,"about_ca_system_score_gemma":0.0004919248,"threshold_uncertainty_score":0.27654037},"labels":[],"label_agreement":null},{"id":"W2146150377","doi":"10.1038/tpj.2010.92","title":"Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin","year":2011,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; Child and Family Research Institute","keywords":"SLCO1B1; Myopathy; Simvastatin; Atorvastatin; Statin; Medicine; Internal medicine; Pharmacogenetics; Genotype; Biology; Genetics; Gene","score_opus":0.018236187336917984,"score_gpt":0.24660974491264137,"score_spread":0.2283735575757234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146150377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982929,0.00027335665,0.00021259864,0.00017435834,0.00017806113,0.0005362289,0.000013453727,0.000006577918,0.00031241679],"genre_scores_gemma":[0.99927497,0.00024334523,0.000045387376,0.00021837988,0.00015506297,0.0000094544885,0.0000013886578,0.000026534077,0.00002549224],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983533,0.0005837566,0.0003118251,0.00013340257,0.0003612251,0.00025646627],"domain_scores_gemma":[0.9992102,0.00013637873,0.00025154543,0.00022204318,0.00005419659,0.00012564822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014906856,0.00016143855,0.00036944656,0.00007025415,0.00014490858,0.000014986892,0.00014961824,0.0000384729,0.0000905417],"category_scores_gemma":[0.00007756635,0.00007181771,0.00015888513,0.00016586088,0.000096429896,0.000029867027,0.000050014336,0.0006064853,0.0000019503896],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036109474,0.003396102,0.317656,0.0008842005,0.00986755,0.0036378258,0.034465067,0.0005973181,0.2115864,0.0012419677,0.00090966735,0.37964842],"study_design_scores_gemma":[0.035232756,0.0047410973,0.81613547,0.0011317582,0.0028658782,0.005329113,0.00049728184,0.0028887247,0.12962003,0.0006485785,0.0003435066,0.0005658061],"about_ca_topic_score_codex":0.000079968595,"about_ca_topic_score_gemma":0.000014356535,"teacher_disagreement_score":0.49847946,"about_ca_system_score_codex":0.00010642701,"about_ca_system_score_gemma":0.0001224547,"threshold_uncertainty_score":0.2928641},"labels":[],"label_agreement":null},{"id":"W2146295187","doi":"10.1194/jlr.m400396-jlr200","title":"Wild-type PCSK9 inhibits LDL clearance but does not affect apoB-containing lipoprotein production in mouse and cultured cells","year":2005,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; Kexin; Apolipoprotein B; LDL receptor; Proprotein convertase; Endocrinology; Very low-density lipoprotein; Internal medicine; Lipoprotein; Biology; Chemistry; Cholesterol; Medicine","score_opus":0.04314014238592557,"score_gpt":0.34433234228231463,"score_spread":0.30119219989638907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146295187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98978424,0.002229368,0.000012974424,0.0065403217,0.0003238545,0.00089966075,0.0000019206584,0.00001526333,0.00019237025],"genre_scores_gemma":[0.9884218,0.0022707013,0.0015938663,0.00014694578,0.0051031224,0.000013729501,0.000001027479,0.0000343717,0.0024144477],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99638414,0.0005803518,0.0006090823,0.00032691096,0.0015500749,0.0005494351],"domain_scores_gemma":[0.9982563,0.00007150475,0.00019047776,0.0003629513,0.00079600106,0.00032275546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075757424,0.00016828332,0.00058965024,0.00052244216,0.0001662984,0.00007099953,0.00014000728,0.00017640997,0.00002685497],"category_scores_gemma":[0.001000234,0.00010802559,0.00016965794,0.0005500408,0.00013345432,0.00035246622,0.0000755437,0.0016451977,0.000019617797],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004392963,0.00038451044,0.0029115933,0.000599529,0.00017188677,0.00015736673,0.0019677898,0.00014559421,0.8477717,0.000014936987,0.0008506745,0.14063145],"study_design_scores_gemma":[0.0031695173,0.0017722257,0.006232396,0.00086568826,0.00003019953,0.00055188756,0.0009741429,0.00007264459,0.97283125,0.000017565211,0.013320908,0.00016155533],"about_ca_topic_score_codex":0.0002670119,"about_ca_topic_score_gemma":0.00016765283,"teacher_disagreement_score":0.1404699,"about_ca_system_score_codex":0.00029957594,"about_ca_system_score_gemma":0.00038231534,"threshold_uncertainty_score":0.7147657},"labels":[],"label_agreement":null},{"id":"W2146311281","doi":"10.1097/01.asn.0000068461.45784.2f","title":"Effect of Pravastatin on Loss of Renal Function in People with Moderate Chronic Renal Insufficiency and Cardiovascular Disease","year":2003,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pravastatin; Renal function; Medicine; Placebo; Internal medicine; Kidney disease; Urology; Endocrinology; Cardiology; Cholesterol","score_opus":0.005971577136522137,"score_gpt":0.23607063585026342,"score_spread":0.23009905871374128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146311281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941575,0.0028075483,0.0023162311,0.00035880329,0.00002437789,0.00030619628,0.000003813383,0.000001966401,0.000023575487],"genre_scores_gemma":[0.99820745,0.00094389974,0.00045580306,0.0002954051,0.00007354035,0.0000045917386,5.6044456e-7,0.000012989061,0.0000057374614],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99800956,0.00064090017,0.00043510905,0.0001519033,0.0005727262,0.00018977847],"domain_scores_gemma":[0.99856466,0.00010478865,0.00069275044,0.00037741556,0.0001632961,0.000097104705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001752381,0.00013117745,0.000993244,0.00006757367,0.000037724207,0.0000020418,0.0000837456,0.000043075783,0.000005187662],"category_scores_gemma":[0.00007917242,0.00007625634,0.0007606182,0.0003928356,0.00053390826,0.00003925031,0.00002239868,0.00032185152,9.891081e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09629739,0.0047181603,0.19857705,0.0077652787,0.032057397,0.00027934767,0.0069142417,0.23558076,0.24494031,0.0005064813,0.0028495623,0.16951403],"study_design_scores_gemma":[0.01802352,0.05923782,0.8965665,0.0009028702,0.0037293707,0.0010361709,0.0007451848,0.00238045,0.013961229,0.0001083786,0.003032852,0.00027566936],"about_ca_topic_score_codex":0.00021735672,"about_ca_topic_score_gemma":0.000010713532,"teacher_disagreement_score":0.69798946,"about_ca_system_score_codex":0.000081015816,"about_ca_system_score_gemma":0.00051381625,"threshold_uncertainty_score":0.31096435},"labels":[],"label_agreement":null},{"id":"W2146324261","doi":"10.1517/14740338.1.3.269","title":"A safety look at currently available statins","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Drug Safety","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Medicine; Tolerability; Statin; Adverse effect; Discontinuation; Gemfibrozil; Intensive care medicine; Drug; Pharmacology; Dyslipidemia; Internal medicine; Cholesterol; Disease","score_opus":0.06159846988091728,"score_gpt":0.3495888478837957,"score_spread":0.2879903780028784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146324261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.5293977e-7,0.9580513,0.00007727806,0.0005278517,0.0025630738,0.0032269512,0.000345215,0.00023953621,0.034968525],"genre_scores_gemma":[4.519379e-7,0.96740514,0.00039030527,0.00077250437,0.0027893889,0.00037080637,0.0019079664,0.00022860966,0.026134804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939239,0.00066224096,0.0016280018,0.0013836364,0.001472211,0.00092998595],"domain_scores_gemma":[0.9960125,0.00022471865,0.00054777093,0.002376436,0.00014242208,0.00069613056],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0011242885,0.0010420206,0.0038563637,0.000319491,0.00044886596,0.00003776779,0.0003781158,0.0005472928,0.0074975844],"category_scores_gemma":[0.00014061312,0.00078366173,0.0023725468,0.0005406204,0.00011191735,0.00009801513,0.00026537527,0.0011378411,0.008672331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011072132,0.0002663343,0.0000013023621,0.006568552,0.00041545372,0.000034697478,0.00022084714,6.3402445e-7,6.651781e-8,0.00014207287,0.19322486,0.79901445],"study_design_scores_gemma":[0.0018713322,0.00021565957,0.000004506437,0.024108935,0.00014105276,0.0002696047,0.00003822569,0.000018018689,0.000002266114,0.0000019265603,0.9726163,0.0007121413],"about_ca_topic_score_codex":0.00017187679,"about_ca_topic_score_gemma":0.00000890901,"teacher_disagreement_score":0.7983023,"about_ca_system_score_codex":0.00194485,"about_ca_system_score_gemma":0.00081902114,"threshold_uncertainty_score":0.9994614},"labels":[],"label_agreement":null},{"id":"W2146409845","doi":"10.1111/j.1365-2125.2011.04139.x","title":"Pleiotropic effects of pitavastatin","year":2011,"lang":"en","type":"review","venue":"British Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Pitavastatin; Statin; Cholesterol; Pharmacology; Medicine; Oxidative stress; Cerivastatin; Pharmacodynamics; Lipoprotein; Inflammation; HMG-CoA reductase; Reductase; Pravastatin; Internal medicine; Chemistry; Biochemistry; Enzyme; Pharmacokinetics","score_opus":0.09507817803110909,"score_gpt":0.4643784277813571,"score_spread":0.369300249750248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146409845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009350548,0.99249274,0.000107755535,0.000027826845,0.0050311135,0.0009956367,0.000013997701,0.000009707312,0.0003861991],"genre_scores_gemma":[0.00014376531,0.9929536,0.0009574039,0.00043992893,0.0052586356,0.000017284035,0.00000737113,0.00006194621,0.00016006936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99311334,0.0018229588,0.00399871,0.00028828744,0.00042874384,0.00034798394],"domain_scores_gemma":[0.9945106,0.0012564086,0.0029570828,0.00024680077,0.0004850893,0.0005440441],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0030043665,0.000274318,0.0067804167,0.00018731652,0.000033739434,0.000007822775,0.00033481393,0.00062076387,0.00048739207],"category_scores_gemma":[0.0014906893,0.00023816996,0.0041226055,0.00019729292,0.00025986476,0.00005376688,0.00008522863,0.0023957214,0.000030980354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010356235,0.0006356838,0.000016920745,0.034923244,0.0028246145,0.0048107347,0.0000068234413,4.9927298e-8,8.6255415e-7,0.000007811438,0.015537219,0.9411325],"study_design_scores_gemma":[0.0044741705,0.0022490632,0.00071914814,0.023652457,0.00989667,0.01568214,0.0000022189267,2.7929585e-7,0.000007364151,0.00003150869,0.9431268,0.00015820279],"about_ca_topic_score_codex":0.000048457816,"about_ca_topic_score_gemma":0.000002198987,"teacher_disagreement_score":0.9409743,"about_ca_system_score_codex":0.000055773682,"about_ca_system_score_gemma":0.0018937802,"threshold_uncertainty_score":0.99990577},"labels":[],"label_agreement":null},{"id":"W2146533248","doi":"10.1016/s0828-282x(08)70180-6","title":"Statins and primary prevention: Is all the evidence in?","year":2008,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University","funders":"","keywords":"Medicine; Primary prevention; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Primary (astronomy); Intensive care medicine; Statin; Internal medicine; Disease","score_opus":0.052833395374701754,"score_gpt":0.2806254263184567,"score_spread":0.22779203094375497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146533248","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016365975,0.06778019,0.00021748408,0.9105593,0.00091022026,0.0006553007,0.00003163077,0.0000035621256,0.0034763257],"genre_scores_gemma":[0.049288463,0.021908265,0.0002641895,0.90873575,0.018496763,0.000019360585,0.000026262505,0.000056833636,0.0012041042],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813384,0.0004550806,0.00049281504,0.00019798287,0.00031081992,0.0004094858],"domain_scores_gemma":[0.99869263,0.00012557786,0.00023851915,0.00042179113,0.00020783584,0.0003136682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000995472,0.00017770659,0.000970023,0.00029291058,0.00007294735,0.000015344775,0.00018391486,0.00048353773,0.000024336437],"category_scores_gemma":[0.00017753475,0.000120321674,0.00045752502,0.000109102075,0.00024816953,0.00006152729,0.000015638963,0.0020885395,0.000004726393],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018929295,5.3813784e-7,0.0045155445,0.00018831194,0.000516022,0.007864846,0.00026859203,0.000006378693,0.0000017809589,0.000002202607,0.97532105,0.011295819],"study_design_scores_gemma":[0.00048644035,0.00031946978,0.05241427,0.00048684233,0.00027587093,0.019338641,0.000029716799,3.1679866e-7,0.0000013543699,0.00008309667,0.9264664,0.00009759828],"about_ca_topic_score_codex":0.0022844195,"about_ca_topic_score_gemma":0.00090932014,"teacher_disagreement_score":0.048854653,"about_ca_system_score_codex":0.00035749795,"about_ca_system_score_gemma":0.0052490206,"threshold_uncertainty_score":0.9311537},"labels":[],"label_agreement":null},{"id":"W2146922855","doi":"10.1016/j.atherosclerosis.2013.09.007","title":"APOE p.Leu167del mutation in familial hypercholesterolemia","year":2013,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Royal Victoria Hospital; Université de Montréal; Royal Victoria Regional Health Centre; McGill University Health Centre","funders":"National Heart, Lung, and Blood Institute; King Abdulaziz University","keywords":"PCSK9; Kexin; Proband; Apolipoprotein E; LDL receptor; Genetics; Apolipoprotein B; Exome sequencing; Familial hypercholesterolemia; Mutation; Biology; Candidate gene; Lipoprotein; Gene; Molecular biology; Cholesterol; Internal medicine; Endocrinology; Medicine","score_opus":0.01969686184882035,"score_gpt":0.24814889698539422,"score_spread":0.22845203513657386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146922855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960815,0.0001798183,0.0002522291,0.0008872797,0.00011101736,0.0007727636,0.0000026492646,0.00006842122,0.0016443641],"genre_scores_gemma":[0.9965348,0.00014786291,0.0009724573,0.0015602042,0.00019104815,0.00021261552,0.000014612359,0.00003414089,0.00033222037],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987443,0.00006344385,0.0002743234,0.0002784538,0.0003317925,0.00030765243],"domain_scores_gemma":[0.9992993,0.000018210403,0.00004062812,0.0004268069,0.00007015206,0.00014492442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027391672,0.00014142835,0.00029681594,0.000089099485,0.000047618374,0.000030243766,0.000072597,0.00012940592,0.00017965908],"category_scores_gemma":[0.000039756582,0.000120559955,0.00015882259,0.00022132769,0.000039128798,0.00015846457,0.000027745797,0.00020418651,0.0005164817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100000994,0.0006777038,0.29224288,0.00030082872,0.00017482595,0.000022954551,0.002433743,0.0000701366,0.15632144,0.0002329538,0.0018143816,0.54560816],"study_design_scores_gemma":[0.002442694,0.0001974949,0.99318844,0.00012241057,0.00003337727,0.0000214621,0.00026398024,0.00032713916,0.0021874737,0.00012998379,0.00094718457,0.00013833042],"about_ca_topic_score_codex":0.0029735009,"about_ca_topic_score_gemma":0.00007023009,"teacher_disagreement_score":0.70094556,"about_ca_system_score_codex":0.0001272306,"about_ca_system_score_gemma":0.000059375285,"threshold_uncertainty_score":0.66385},"labels":[],"label_agreement":null},{"id":"W2146992856","doi":"10.1161/01.cir.102.14.1629","title":"Lipoprotein Lipase Activity Is Associated With Severity of Angina Pectoris","year":2000,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Rijksuniversiteit Groningen; University of Washington","keywords":"Medicine; Angina; Lipoprotein lipase; Internal medicine; Lipase; Cardiology; Myocardial infarction; Enzyme; Biochemistry; Adipose tissue","score_opus":0.014225742474993672,"score_gpt":0.24408262693694927,"score_spread":0.2298568844619556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146992856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964641,0.00013194716,0.00052348326,0.00020319188,0.00002695984,0.00055940007,0.000012915868,0.000059088157,0.0020189597],"genre_scores_gemma":[0.9994309,0.00001695838,0.00009006165,0.00007641687,0.00013478084,0.000019006648,0.00003118198,0.000017628154,0.00018308118],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989821,0.00006688041,0.00014154521,0.00020376821,0.00044062664,0.00016512309],"domain_scores_gemma":[0.9993103,0.0000122458505,0.00008216336,0.0003758259,0.00012978668,0.000089672416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003018518,0.00010404724,0.0002968748,0.000051202587,0.00006261558,0.0000071758755,0.00002992452,0.000107971304,0.0004911188],"category_scores_gemma":[0.000044513166,0.000089495996,0.0001396525,0.00032363884,0.000033133463,0.00010464856,0.000005086353,0.00012881838,0.000016302447],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069024117,0.0007768584,0.3864463,0.00040937003,0.00074721157,0.00006627523,0.0011696047,0.00022903873,0.00812378,0.000047277576,0.00025734436,0.60103667],"study_design_scores_gemma":[0.0012132023,0.00011383625,0.9906819,0.00011756912,0.00013135349,0.0000276691,0.000010038033,0.00083084113,0.0061555463,0.00003949034,0.00057766214,0.00010092657],"about_ca_topic_score_codex":0.00095009577,"about_ca_topic_score_gemma":0.000054808886,"teacher_disagreement_score":0.6042356,"about_ca_system_score_codex":0.000141737,"about_ca_system_score_gemma":0.00011839407,"threshold_uncertainty_score":0.5377407},"labels":[],"label_agreement":null},{"id":"W2147048440","doi":"10.1212/wnl.0b013e318228bf11","title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","year":2011,"lang":"en","type":"article","venue":"Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; Health Sciences, University of Arizona; National Institute on Aging; Medical Center, University of Rochester; University of California, Irvine; University of California, San Diego; University of California, Davis; Mitsubishi Tanabe Pharma Corporation; Elan; AstraZeneca; Genentech; University of Oxford; Baxter International; Lewy Body Dementia Association; National Center for Research Resources; National Alliance for Research on Schizophrenia and Depression; Myriad Genetics; SUNY Downstate Medical Center; Marinus Pharmaceuticals; Georgetown University; Demensförbundet; Otsuka Pharmaceutical; National Institutes of Health; BioMarin Pharmaceutical; Avid Radiopharmaceuticals; University of Pittsburgh; University of California, Los Angeles; Pfizer; University of Washington; U.S. Department of Defense; American Health Assistance Foundation; Eli Lilly and Company; State University of New York; University of Pennsylvania; University of South Carolina; Astellas Pharma; University of Southern California; Eisai; Medpace; Brown University; Daiichi Sankyo Europe; Yale University; Astellas Foundation for Research on Metabolic Disorders; Dainippon Sumitomo Pharma; Emory University; Alzheimer's Association; Brigham and Women's Hospital; York University; University of Rochester; Northwestern University; GlaxoSmithKline; Shire; Forest Laboratories; Bristol-Myers Squibb; Sanofi; Case Western Reserve University; American Federation for Aging Research; Rush University; Amgen","keywords":"Simvastatin; Medicine; Placebo; Randomized controlled trial; Double blind; Alzheimer's disease; Disease; Internal medicine; Pathology; Alternative medicine","score_opus":0.052798591535851695,"score_gpt":0.30459960112368084,"score_spread":0.25180100958782914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147048440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788335,0.00048825343,0.00021989908,0.0014801453,0.00041045787,0.010680763,0.000005027198,0.00004709481,0.007834872],"genre_scores_gemma":[0.99533945,0.00005617768,0.00018779052,0.0021937322,0.00040698043,0.0016052348,0.000008041945,0.00003195958,0.00017064504],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99792844,0.0005333303,0.0005524141,0.00035433765,0.00031411598,0.00031733786],"domain_scores_gemma":[0.99853665,0.00020282053,0.0001409613,0.00061538024,0.0001001238,0.0004040795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009666966,0.00018729293,0.0014937392,0.0001719935,0.00003503607,0.0000035174262,0.000098357676,0.000113911374,0.00032541752],"category_scores_gemma":[0.00025434143,0.00012997535,0.0007273646,0.00013309623,0.00010841462,0.000027139848,0.000041822226,0.00019155788,0.00006642702],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9956256,0.00040923586,0.000050802333,0.000029540974,0.0004431713,0.00015558429,0.00023942007,0.000006147129,0.00003253989,0.000391758,0.00012251818,0.0024936527],"study_design_scores_gemma":[0.9936475,0.0029992107,0.00016385714,0.000006538572,0.0020133932,0.00002917066,0.0000041286576,0.000045877798,0.00029120245,0.000107882996,0.0005998458,0.0000913481],"about_ca_topic_score_codex":0.00052678824,"about_ca_topic_score_gemma":0.000017652721,"teacher_disagreement_score":0.016505951,"about_ca_system_score_codex":0.0000060170582,"about_ca_system_score_gemma":0.00018588862,"threshold_uncertainty_score":0.5300241},"labels":[],"label_agreement":null},{"id":"W2147281279","doi":"10.1161/circimaging.109.909655","title":"Carotid Atherosclerosis Progression in Familial Hypercholesterolemia Patients","year":2010,"lang":"en","type":"article","venue":"Circulation Cardiovascular Imaging","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Simvastatin; Statin; Confidence interval; Internal medicine; Intima-media thickness; Randomized controlled trial; Familial hypercholesterolemia; Cardiology; Cholesterol; Carotid arteries","score_opus":0.011039138482294576,"score_gpt":0.25464489222278397,"score_spread":0.2436057537404894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147281279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470913,0.0005678584,0.0013744077,0.0001403417,0.00067730737,0.0013236221,0.0000051172524,0.00013290017,0.0010692923],"genre_scores_gemma":[0.9977488,0.00005042662,0.0011465795,0.00024356709,0.0005301303,0.00011939673,0.000084234096,0.000069298796,0.0000075842763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971597,0.00015958645,0.000453257,0.00062591635,0.0011341212,0.00046738435],"domain_scores_gemma":[0.99823123,0.000015917763,0.00007401826,0.0011879891,0.0002644851,0.00022636018],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012801768,0.0002625925,0.00062043685,0.0002600049,0.00014379434,0.00006131087,0.00011966268,0.00015841136,0.000024221807],"category_scores_gemma":[0.00016558908,0.00024913024,0.0010567018,0.00042266434,0.000083197694,0.00027667644,0.000066504654,0.0006359032,0.0000407485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012788002,0.00010507108,0.86015785,0.00008719286,0.00015681436,0.000008914618,0.00015408688,0.00018426782,0.0063535455,0.000013462839,0.000012260768,0.13275376],"study_design_scores_gemma":[0.0041223466,0.000022161503,0.9899954,0.00016671381,0.0002075675,0.00007833797,0.000045885645,0.00068417896,0.00084160623,0.000018469975,0.0035681247,0.00024917544],"about_ca_topic_score_codex":0.00023047953,"about_ca_topic_score_gemma":0.000017028904,"teacher_disagreement_score":0.13250458,"about_ca_system_score_codex":0.00018374878,"about_ca_system_score_gemma":0.00012739329,"threshold_uncertainty_score":0.99999607},"labels":[],"label_agreement":null},{"id":"W2147667766","doi":"10.1016/s0828-282x(08)70695-0","title":"Preventing cardiovascular disease among Canadians: Is the treatment of hypertension or dyslipidemia cost-effective?","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Dyslipidemia; Blood pressure; Diabetes mellitus; Disease; Cost effectiveness; Internal medicine; Physical therapy; Intensive care medicine; Endocrinology","score_opus":0.036317023488238544,"score_gpt":0.2482569885340169,"score_spread":0.21193996504577836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147667766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614087,0.032883152,0.00059367,0.0013034553,0.0007627318,0.002140629,0.000051427593,0.0000067347623,0.0008495241],"genre_scores_gemma":[0.9947499,0.002626591,0.00007313711,0.00036030635,0.0018576887,0.00007716884,0.0000069145844,0.000031726056,0.00021655607],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785805,0.00048186095,0.0005413659,0.00024131933,0.00035839487,0.0005190266],"domain_scores_gemma":[0.99701405,0.0001302847,0.00020735065,0.00078597985,0.00045874759,0.001403594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008861363,0.00021974918,0.0013257291,0.00026067975,0.00026888077,0.000006860763,0.0001559221,0.00015288837,0.000030374245],"category_scores_gemma":[0.00037571677,0.00012861638,0.0018949154,0.00024843778,0.000380566,0.00006641969,0.000007270811,0.00025324427,0.000003916078],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084170874,0.000046414436,0.5646448,0.00031141858,0.020356659,0.020838207,0.0022597974,0.0076456214,0.00007369242,0.00004923934,0.020768818,0.3621636],"study_design_scores_gemma":[0.0022496637,0.0008402773,0.45149228,0.00015280841,0.0019583895,0.004201777,0.00020805158,0.000044434626,0.00010271252,0.000016540629,0.5385971,0.00013596518],"about_ca_topic_score_codex":0.04515548,"about_ca_topic_score_gemma":0.00780033,"teacher_disagreement_score":0.5178283,"about_ca_system_score_codex":0.0006425749,"about_ca_system_score_gemma":0.0041124984,"threshold_uncertainty_score":0.9612029},"labels":[],"label_agreement":null},{"id":"W2148546401","doi":"10.1503/cmaj.081785","title":"Association between statin-associated myopathy and skeletal muscle damage","year":2009,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Muscle biopsy; Myopathy; Medicine; Creatine kinase; Muscle weakness; Biopsy; Statin; Internal medicine; Skeletal muscle; myalgia; Discontinuation; Pathology","score_opus":0.006770107706791896,"score_gpt":0.2372958379516253,"score_spread":0.2305257302448334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148546401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.940985,0.0004030785,0.000083910396,0.05446937,0.00034026537,0.00026306137,0.00005594773,0.000046923262,0.003352405],"genre_scores_gemma":[0.98414487,0.00035600175,0.00014445178,0.011690316,0.00256339,0.0000035593778,0.000056150257,0.000020981215,0.0010202943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99574155,0.000355993,0.0005547898,0.00022174753,0.0023860661,0.00073982764],"domain_scores_gemma":[0.9962834,0.00015617347,0.0003771799,0.00014529996,0.000557386,0.0024805656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005094316,0.00016925314,0.0004990171,0.0002085569,0.00040059298,0.000121551915,0.00010611565,0.00062798586,0.0007157847],"category_scores_gemma":[0.0047030104,0.00015935702,0.00021804591,0.0003294906,0.000019641571,0.00016714197,0.000010854365,0.0013659522,0.000058819456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000069155303,0.00008952982,0.506853,0.000022006816,0.00086389267,0.0006442623,0.0005412587,8.9070375e-7,0.000036741385,0.0001081557,0.06623595,0.42459738],"study_design_scores_gemma":[0.0020097028,0.00023933082,0.88245285,0.00008736932,0.00020086963,0.00008481753,0.00016211986,0.00006015967,0.000007598567,0.00022674286,0.11431704,0.00015139929],"about_ca_topic_score_codex":0.0021636162,"about_ca_topic_score_gemma":0.0052610375,"teacher_disagreement_score":0.424446,"about_ca_system_score_codex":0.003003202,"about_ca_system_score_gemma":0.002492455,"threshold_uncertainty_score":0.78532684},"labels":[],"label_agreement":null},{"id":"W2149787086","doi":"10.12968/indn.2005.1.9.74121","title":"Q&amp;A: Lipid management","year":2005,"lang":"en","type":"article","venue":"Independent Nurse","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Fibrate; Medicine; Statin; Internal medicine","score_opus":0.01654227456883097,"score_gpt":0.28554218499078804,"score_spread":0.2689999104219571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149787086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71719635,0.0017026373,0.0020897605,0.007204409,0.0009897413,0.0016285129,0.0000065352624,0.00032749426,0.26885453],"genre_scores_gemma":[0.9701883,0.00020416992,0.0035870178,0.0016802767,0.0016398663,0.000060696762,0.000020316238,0.000031793203,0.022587525],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846804,0.000029968538,0.00021733464,0.000282258,0.000685495,0.00031690625],"domain_scores_gemma":[0.9990035,0.0000047888307,0.0000391009,0.0006852174,0.00004710462,0.00022024289],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035797624,0.00013568043,0.00023696799,0.00010446981,0.00006703628,0.000018770726,0.00009643065,0.0000880544,0.0006964086],"category_scores_gemma":[0.000008559171,0.000115048635,0.00022035645,0.00012417872,0.000025847483,0.000070970396,0.00003114056,0.00020567776,0.0018244586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018967426,0.0007133171,0.0043392163,0.00021888275,0.0005612846,0.0002444544,0.00041822117,0.000047553967,0.00028165436,0.0037613348,0.024634428,0.96458995],"study_design_scores_gemma":[0.0024722756,0.00007764349,0.03764731,0.00007998188,0.00019114508,0.00029723928,0.00019707039,0.000025060315,0.0006234414,0.00006020364,0.95816565,0.00016298637],"about_ca_topic_score_codex":0.000041560495,"about_ca_topic_score_gemma":0.00003975358,"teacher_disagreement_score":0.964427,"about_ca_system_score_codex":0.00016098126,"about_ca_system_score_gemma":0.000042403397,"threshold_uncertainty_score":0.99895275},"labels":[],"label_agreement":null},{"id":"W2149976566","doi":"10.1016/s0021-9150(01)00584-6","title":"Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia","year":2002,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Wilfrid Laurier University","funders":"","keywords":"Simvastatin; Familial hypercholesterolemia; Endocrinology; Internal medicine; LDL receptor; Cholesterol; Apolipoprotein B; HMG-CoA reductase; Reductase; Biology; Heterozygote advantage; Lipoprotein; Hydroxymethylglutaryl-CoA reductase; Genotype; Genetics; Medicine; Gene; Biochemistry; Enzyme","score_opus":0.016674718099812184,"score_gpt":0.22979374991413332,"score_spread":0.21311903181432112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149976566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772346,0.00012289104,0.00008130389,0.00042917824,0.000028142716,0.0015044374,0.000039233008,0.000054950513,0.00001637824],"genre_scores_gemma":[0.9974833,0.00016203715,0.0011106431,0.0007405066,0.00008594087,0.0001993562,0.000006987545,0.000059866732,0.00015132179],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980293,0.00021239986,0.00035895014,0.00049756747,0.0005566599,0.00034514075],"domain_scores_gemma":[0.9987876,0.000033254895,0.00012960883,0.00061844086,0.000101798345,0.00032929884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002961738,0.00029548584,0.0004987382,0.00014781849,0.00010481585,0.000023355055,0.00007897915,0.00012295155,0.000016713944],"category_scores_gemma":[0.0000688498,0.00022495766,0.000122031204,0.00025467458,0.00011549256,0.00009516687,0.000029275476,0.00013876488,0.00004075701],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007802012,0.0012859018,0.079981945,0.00027407368,0.00032138842,0.000065616776,0.0061979108,0.0012913322,0.7669191,0.0000028024544,0.000054303375,0.13580361],"study_design_scores_gemma":[0.005187603,0.006872467,0.89451605,0.0012335674,0.000120653734,0.00003833789,0.00009922824,0.000074348194,0.09146276,0.0000014221041,0.00015113218,0.00024240953],"about_ca_topic_score_codex":0.0018226971,"about_ca_topic_score_gemma":0.00006325639,"teacher_disagreement_score":0.8145341,"about_ca_system_score_codex":0.00022581291,"about_ca_system_score_gemma":0.000038020327,"threshold_uncertainty_score":0.9173507},"labels":[],"label_agreement":null},{"id":"W2150155488","doi":"10.1161/01.atv.21.6.979","title":"Determinants of Lipid Level Variability in French-Canadian Children With Familial Hypercholesterolemia","year":2001,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Apolipoprotein B; Familial hypercholesterolemia; Internal medicine; Endocrinology; LDL receptor; Apolipoprotein E; Genotype; Lipoprotein; Cholesterol; Allele; Low-density lipoprotein; Biology; Chemistry; Genetics; Gene; Medicine","score_opus":0.03645899357234227,"score_gpt":0.2754586810389869,"score_spread":0.23899968746664463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150155488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987395,0.000058720434,0.00015972953,0.00017812153,0.00006272707,0.0005984345,0.000044679146,0.000015968792,0.0001421466],"genre_scores_gemma":[0.9968003,0.0019384813,0.00065556186,0.00038828666,0.000111712216,0.000046199664,0.00003410098,0.000023457269,0.0000018849045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815446,0.0002602655,0.00041884396,0.0005214748,0.00016266397,0.0004822698],"domain_scores_gemma":[0.9988893,0.000027478287,0.00007789528,0.000637207,0.00007524027,0.00029285255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009642191,0.00023649377,0.00082291994,0.0001849458,0.00008728533,0.000012812459,0.00011448416,0.00025126553,0.0000548751],"category_scores_gemma":[0.00004593126,0.00018046856,0.00018862047,0.0002535613,0.0002494789,0.00007404808,0.000049924456,0.00019643221,0.000005301686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006823373,0.00012605239,0.98343074,0.00003776734,0.00016025793,3.167166e-7,0.00013963968,5.6965814e-7,0.0044244453,0.00001917995,0.000006041709,0.011648157],"study_design_scores_gemma":[0.0023107775,0.00062549295,0.9958639,0.00014661011,0.00012549164,0.0000152063685,0.000033599903,0.00003887498,0.00013590007,0.000018400697,0.00049629435,0.00018942883],"about_ca_topic_score_codex":0.06486525,"about_ca_topic_score_gemma":0.056248058,"teacher_disagreement_score":0.012433173,"about_ca_system_score_codex":0.00007931223,"about_ca_system_score_gemma":0.00018915228,"threshold_uncertainty_score":0.96097296},"labels":[],"label_agreement":null},{"id":"W2150730869","doi":"10.1139/y04-040","title":"Chronic treatment with bark infusion from<i>Croton cajucara</i>lowers plasma triglyceride levels in genetic hyperlipidemic mice","year":2004,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Hyperlipidemia; Endocrinology; Cholesterol; Internal medicine; Chemistry; Very low-density lipoprotein; Triglyceride; LDL receptor; Lipoprotein; Apolipoprotein E; Pharmacology; Medicine; Diabetes mellitus","score_opus":0.013663432937549338,"score_gpt":0.25989650235853423,"score_spread":0.24623306942098488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150730869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99021745,0.007679971,0.000018069308,0.0010864579,0.00048270877,0.00043342347,0.00002080342,0.000003903063,0.00005721772],"genre_scores_gemma":[0.99590385,0.0016536654,0.00030033238,0.0011134946,0.00096247357,0.000020675627,0.0000063858843,0.000017970606,0.00002117198],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998742,0.00015795909,0.00035850971,0.00022967374,0.000082772,0.00042909378],"domain_scores_gemma":[0.9989758,0.000058597518,0.0001497708,0.00012639069,0.000074167176,0.0006152866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017276168,0.00019224125,0.00063939084,0.00024012793,0.00010022323,0.00000422429,0.00008316505,0.00017632279,0.00039390827],"category_scores_gemma":[0.00000951246,0.00014200274,0.00012253843,0.00013949229,0.00021041106,0.000053805812,0.00000753455,0.00038719695,0.0000069223825],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011929135,0.00008122389,0.009863428,0.00012903106,0.0007747397,0.0020539341,0.00092241395,0.002208112,0.95830315,0.000010623603,0.00015423165,0.024306169],"study_design_scores_gemma":[0.0575952,0.015952753,0.57043564,0.00056937186,0.0014573194,0.005652817,0.0003033113,0.00014305892,0.30745554,0.00071094104,0.039092235,0.0006318035],"about_ca_topic_score_codex":0.020153098,"about_ca_topic_score_gemma":0.021619,"teacher_disagreement_score":0.6508477,"about_ca_system_score_codex":0.0008016136,"about_ca_system_score_gemma":0.0038308394,"threshold_uncertainty_score":0.9962339},"labels":[],"label_agreement":null},{"id":"W2151046062","doi":"10.1136/eb-2013-101610","title":"Basic learning concepts in EBM: the bidimentional hierarchy of evidence","year":2013,"lang":"en","type":"article","venue":"Evidence-Based Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Hierarchy; Computer science; Political science","score_opus":0.11946972544049474,"score_gpt":0.3631294642438161,"score_spread":0.24365973880332137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151046062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86156607,0.0442526,0.0013660399,0.08934313,0.00034693902,0.002292701,9.287813e-7,0.000063900865,0.0007676838],"genre_scores_gemma":[0.9930762,0.0018885605,0.0003993236,0.0028327294,0.0007109993,0.00021285292,0.00000796401,0.000021749582,0.00084962073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666995,0.0005270312,0.0006628526,0.0003710995,0.0013760228,0.0003930744],"domain_scores_gemma":[0.99716556,0.0013672,0.00021255466,0.0006552322,0.0003781916,0.00022125567],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0036197992,0.00020408626,0.0006190857,0.00024224224,0.00010186981,0.00001031257,0.00022105504,0.00009536268,0.0021610255],"category_scores_gemma":[0.004000593,0.00010744085,0.00021004028,0.0007554192,0.0005451503,0.00028761197,0.000047465655,0.00058832206,0.00009081982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014137086,0.00052707567,0.5092784,0.004315377,0.0004861498,0.00025630856,0.003715938,0.0013065466,0.06997432,0.0018186532,0.017252106,0.38965538],"study_design_scores_gemma":[0.006377251,0.0034100038,0.9245868,0.034521893,0.00037176642,0.00009913722,0.0014206702,0.0027127862,0.009327087,0.00042978744,0.016399514,0.00034331164],"about_ca_topic_score_codex":0.0030657365,"about_ca_topic_score_gemma":0.000028887442,"teacher_disagreement_score":0.41530836,"about_ca_system_score_codex":0.00015785899,"about_ca_system_score_gemma":0.000652226,"threshold_uncertainty_score":0.99875116},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"gpt","categories":[],"domain":null,"study_design":"theoretical_or_conceptual","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2151189172","doi":"10.1016/j.ahj.2004.08.024","title":"The benefit of cholesterol-lowering medications after coronary revascularization: A population study","year":2005,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Myocardial infarction; Internal medicine; Percutaneous coronary intervention; Revascularization; Hazard ratio; Cardiology; Coronary artery disease; Population; Confidence interval","score_opus":0.011180749840927826,"score_gpt":0.29379658343620707,"score_spread":0.28261583359527925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151189172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99347705,0.0012488974,0.0005654919,0.0040793964,0.00009497597,0.00044773406,0.0000012492576,0.000016212454,0.00006901066],"genre_scores_gemma":[0.9973013,0.00042434098,0.0008342578,0.00062029506,0.00068164075,0.000036806952,0.0000033226088,0.000018034985,0.000080014055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998468,0.00009888571,0.00044497728,0.00013588685,0.00065583223,0.00019646116],"domain_scores_gemma":[0.9990347,0.00003522925,0.00016835993,0.00043550943,0.00015198776,0.00017419487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009218834,0.00009461558,0.00030798282,0.00007417851,0.00027193112,0.000027229307,0.00007742537,0.000023232378,0.00005386501],"category_scores_gemma":[0.000053603013,0.0000639053,0.00021748578,0.00026650037,0.00009576478,0.00010766517,0.000027986993,0.00026284237,0.000009139556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113977534,0.00025728406,0.7448022,0.000014467928,0.00035410863,0.0000124105545,0.0005804367,0.000105735846,0.000099343815,0.000012622827,0.00010270257,0.25354472],"study_design_scores_gemma":[0.0006421353,0.0004924023,0.98999435,0.00006269031,0.00017368798,0.0008946574,0.00059682276,0.000067404406,0.000037379956,0.000011450222,0.00696656,0.00006047127],"about_ca_topic_score_codex":0.0002649212,"about_ca_topic_score_gemma":0.00010655996,"teacher_disagreement_score":0.25348425,"about_ca_system_score_codex":0.00009390968,"about_ca_system_score_gemma":0.00009598524,"threshold_uncertainty_score":0.26059824},"labels":[],"label_agreement":null},{"id":"W2151332328","doi":"10.1016/s0828-282x(06)70305-1","title":"Combination of statin and ezetimibe for the treatment of dyslipidemias and the prevention of coronary artery disease","year":2006,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Ezetimibe; Coronary artery disease; Internal medicine; Statin; Cardiology; Cholesterol","score_opus":0.036194053801134635,"score_gpt":0.3092443512788322,"score_spread":0.2730502974776976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151332328","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002101976,0.99493396,0.00084917794,0.0002568309,0.00017101632,0.0014610188,0.0001633187,5.247306e-7,0.00006219322],"genre_scores_gemma":[0.038941834,0.96051574,0.00006318912,0.000014054753,0.000317884,0.000041372346,0.000043812488,0.000013591554,0.000048530103],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847203,0.00046605302,0.0007180333,0.00009609142,0.00012029835,0.00012746741],"domain_scores_gemma":[0.99818486,0.00044681094,0.00074005,0.00023621453,0.00021438384,0.00017765227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010746821,0.00013524288,0.0018460476,0.0001433323,0.00004449252,0.0000027474953,0.000062259576,0.000112466565,0.0000018614655],"category_scores_gemma":[0.00012675433,0.00006746177,0.00084645126,0.00006108421,0.00037484977,0.000017049548,0.0000044454914,0.000107781125,3.6666304e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019021067,0.000011483572,0.00046611016,0.0049951742,0.001858988,0.00002126475,0.000081610124,0.000022145423,1.86132e-7,0.0004135068,0.0005070038,0.9914323],"study_design_scores_gemma":[0.0059838584,0.0024537998,0.015977181,0.0035476189,0.012765414,0.0010755088,0.00011660125,0.000017123637,0.0000016245209,0.0007473241,0.95721054,0.000103378705],"about_ca_topic_score_codex":0.00054180686,"about_ca_topic_score_gemma":0.00027269372,"teacher_disagreement_score":0.99132895,"about_ca_system_score_codex":0.00010542577,"about_ca_system_score_gemma":0.0016798017,"threshold_uncertainty_score":0.2979896},"labels":[],"label_agreement":null},{"id":"W2151385565","doi":"10.1161/atvbaha.107.160408","title":"Vascular Calcifications in Homozygote Familial Hypercholesterolemia","year":2008,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Heart Institute; Royal Victoria Hospital; University of Alberta","funders":"","keywords":"Medicine; Calcification; Cardiology; Internal medicine; Stenosis; Aortic valve; Aorta; Familial hypercholesterolemia; Calcinosis; Aortic valve stenosis; Cholesterol; Radiology","score_opus":0.05584035102014817,"score_gpt":0.29798685041111056,"score_spread":0.2421464993909624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151385565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968843,0.00053754996,0.0007496836,0.0007167727,0.00013872527,0.00062239484,0.0000143887555,0.00007148839,0.0002646944],"genre_scores_gemma":[0.9803579,0.017146433,0.0010733543,0.0009802717,0.00018973077,0.00014183836,0.00006539036,0.00003782566,0.00000725551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978736,0.00023252176,0.00048111402,0.0006613558,0.00023728017,0.000514116],"domain_scores_gemma":[0.9987088,0.000029170826,0.000065219596,0.00086184026,0.00008176973,0.00025322428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000537305,0.0002820378,0.000808154,0.00020475699,0.00026082332,0.000017432754,0.0001258484,0.00030053526,0.000048084003],"category_scores_gemma":[0.000042042433,0.00024222251,0.00044200328,0.0003248374,0.00033506218,0.000100429505,0.00008949628,0.00030730022,0.000048838425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009234692,0.0005214784,0.88195556,0.00011677927,0.0005913166,0.00000214366,0.0010928791,0.000004488443,0.11058561,0.00057462737,0.00016854588,0.0043773283],"study_design_scores_gemma":[0.002505741,0.0002962719,0.9860106,0.00008096043,0.00013446757,0.00001570751,0.0001203203,0.000072506395,0.00014272642,0.00003217685,0.010342672,0.00024581153],"about_ca_topic_score_codex":0.0007588234,"about_ca_topic_score_gemma":0.000108493055,"teacher_disagreement_score":0.11044288,"about_ca_system_score_codex":0.00007985754,"about_ca_system_score_gemma":0.000101313766,"threshold_uncertainty_score":0.9877547},"labels":[],"label_agreement":null},{"id":"W2151969158","doi":"10.1093/ndt/gfm866","title":"Progressive kidney disease in three sisters with elevated lipoprotein(a)","year":2008,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Lipoprotein(a); Nephrosclerosis; Renal function; Internal medicine; Kidney disease; Lipoprotein; Apolipoprotein B; Disease; Endocrinology; Kidney; Cholesterol","score_opus":0.012016873401688017,"score_gpt":0.23878611163798422,"score_spread":0.2267692382362962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151969158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345076,0.0003715905,0.0030368406,0.0015576013,0.000037208927,0.0012061023,0.000023153876,0.00009932482,0.0002174056],"genre_scores_gemma":[0.99559975,0.00038947025,0.0011165525,0.0017406296,0.00015201946,0.00037551066,0.0005666563,0.000029210589,0.000030196241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983264,0.00013487264,0.00031844067,0.0004269431,0.0004373258,0.00035598245],"domain_scores_gemma":[0.99903804,0.000027384125,0.000094590214,0.00039415853,0.00010069167,0.00034513505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021758093,0.00020429284,0.00047523854,0.0002639582,0.000116771276,0.000007297,0.00007056436,0.00014196712,0.00007706419],"category_scores_gemma":[0.000028048236,0.0001613469,0.00018404388,0.00051777664,0.00017747126,0.0001230592,0.000004880453,0.00023567646,0.00002247957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027485015,0.0013369899,0.9144552,0.001599286,0.002126269,0.020832026,0.003792332,0.0014296982,0.010920936,0.00028477376,0.00017678659,0.015560701],"study_design_scores_gemma":[0.008566054,0.0005613724,0.9858508,0.00018203333,0.001279481,0.0006729623,0.000019731184,0.00042791842,0.0016771754,0.000104707826,0.0004001247,0.00025762848],"about_ca_topic_score_codex":0.0005377533,"about_ca_topic_score_gemma":0.00046481343,"teacher_disagreement_score":0.07139562,"about_ca_system_score_codex":0.000068356654,"about_ca_system_score_gemma":0.00039089515,"threshold_uncertainty_score":0.65795356},"labels":[],"label_agreement":null},{"id":"W2151984251","doi":"","title":"Façons d’identifier et de prendre en charge la dyslipidémie athérogène: Une conséquence métabolique de l’obésité et du diabète","year":2013,"lang":"fr","type":"article","venue":"Europe PMC (PubMed Central)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Gynecology; Humanities; Philosophy","score_opus":0.008338295385010281,"score_gpt":0.24196413702047997,"score_spread":0.2336258416354697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151984251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8754272,0.03137553,0.0023895982,0.044676602,0.00481782,0.0043481067,0.0002943605,0.00038110552,0.036289703],"genre_scores_gemma":[0.91063017,0.045102183,0.0010911832,0.0075165634,0.0046521295,0.0008081376,0.00011702045,0.00028545625,0.029797185],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9890997,0.0042232745,0.00088614493,0.0010821872,0.00091599283,0.0037927034],"domain_scores_gemma":[0.9950599,0.0004278538,0.00029281183,0.0015260885,0.00034549183,0.0023478593],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0055190306,0.00074551883,0.001037503,0.00017010231,0.00023662648,0.00034763492,0.0006676574,0.0005288416,0.0010477898],"category_scores_gemma":[0.00215092,0.00072846276,0.0005806922,0.00082525465,0.00041949766,0.00063599006,0.00034415943,0.0017852413,0.0015349062],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035011486,0.0038572792,0.287588,0.0049718283,0.0036844597,0.0068701594,0.07295334,0.00033239662,0.020758357,0.14670171,0.14365323,0.30827913],"study_design_scores_gemma":[0.0019922622,0.00007718504,0.52549094,0.0006266573,0.00040046815,0.0009409488,0.00016961768,0.00014068822,0.004234048,0.00021050606,0.46520007,0.0005165927],"about_ca_topic_score_codex":0.005404884,"about_ca_topic_score_gemma":0.00020548806,"teacher_disagreement_score":0.32154685,"about_ca_system_score_codex":0.00081195345,"about_ca_system_score_gemma":0.0023342317,"threshold_uncertainty_score":0.9998654},"labels":[],"label_agreement":null},{"id":"W2152059213","doi":"10.1586/14779072.2014.954551","title":"Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction","year":2014,"lang":"en","type":"review","venue":"Expert Review of Cardiovascular Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"PCSK9; Alirocumab; Medicine; Ezetimibe; LDL receptor; Proprotein convertase; Kexin; Familial hypercholesterolemia; Cholesterol; Evolocumab; Internal medicine; Endocrinology; Pharmacology; Lipoprotein","score_opus":0.04405893607552818,"score_gpt":0.36993396826347574,"score_spread":0.32587503218794756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152059213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013498997,0.98287016,0.0029890991,0.00014799839,0.0013452345,0.012165373,0.000032311586,0.00011612164,0.00033236394],"genre_scores_gemma":[0.0000013178047,0.98541015,0.0017907247,0.0008061734,0.0070153964,0.003981831,0.00049581355,0.00032689338,0.00017169527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99318427,0.0010930412,0.0021935173,0.0012113615,0.0016867258,0.0006311034],"domain_scores_gemma":[0.9940913,0.00007195874,0.00081348093,0.0040855473,0.0005984967,0.00033922456],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0049127494,0.0010645713,0.011664745,0.00028966513,0.0001304543,0.000030827847,0.0004478884,0.0006845112,0.00006429706],"category_scores_gemma":[0.00020702372,0.00074843346,0.024028633,0.0005580251,0.00013307341,0.000110730005,0.000065800385,0.0005463047,0.000047024736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002212453,0.00007764136,3.023573e-8,0.23983723,0.008612431,0.0000044462045,0.000023608263,1.8718211e-7,0.0000019897032,0.00001500219,0.0043707825,0.74703455],"study_design_scores_gemma":[0.0017331048,0.00038283737,4.8182534e-7,0.19696435,0.005049924,0.0007600152,0.0000058989376,3.9621128e-7,0.000065677435,0.0000047232206,0.7945192,0.00051341194],"about_ca_topic_score_codex":0.00006200282,"about_ca_topic_score_gemma":2.1163827e-7,"teacher_disagreement_score":0.7901484,"about_ca_system_score_codex":0.00029361612,"about_ca_system_score_gemma":0.00066592556,"threshold_uncertainty_score":0.99949664},"labels":[],"label_agreement":null},{"id":"W2152065402","doi":"10.1503/cmaj.1040202","title":"The 2003 Canadian recommendations for dyslipidemia management: Revisions are needed","year":2005,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Heart and Stroke Foundation of Canada","keywords":"Dyslipidemia; Medicine; Clinical Practice; Statin; Intensive care medicine; Family medicine; Pathology; Internal medicine","score_opus":0.013000960451293439,"score_gpt":0.2742800416902822,"score_spread":0.26127908123898874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152065402","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014930785,0.0016813347,0.00048193944,0.97693205,0.0015320728,0.0009646084,0.000096468764,0.000023035922,0.016795438],"genre_scores_gemma":[0.18335564,0.015400577,0.013781537,0.69567037,0.040410936,0.00059070095,0.00042592565,0.0002232953,0.05014101],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974474,0.00016573399,0.00051322137,0.00016134267,0.0009274858,0.0007848732],"domain_scores_gemma":[0.99508125,0.00012914471,0.00019980625,0.0002521338,0.00080392946,0.0035337624],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043734945,0.00012102421,0.00025916586,0.00022365314,0.0016068483,0.00012465521,0.00020022676,0.00028817597,0.0017009461],"category_scores_gemma":[0.003290252,0.00009119028,0.00021898387,0.00044954912,0.000026158961,0.00009261031,0.000009266277,0.00080218876,0.00015193425],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003556051,0.0000065016475,0.0008581804,0.00000955934,0.00019528382,0.000032941403,0.000044214514,0.0000014509397,8.875489e-8,0.0009474885,0.7199479,0.27795285],"study_design_scores_gemma":[0.0011244335,0.000024958223,0.0066499934,0.00015059172,0.000104082275,0.00016191098,0.0010273026,0.00025626578,0.0000011527055,0.00007914025,0.9903233,0.00009686783],"about_ca_topic_score_codex":0.051157556,"about_ca_topic_score_gemma":0.76797414,"teacher_disagreement_score":0.7168166,"about_ca_system_score_codex":0.0032742245,"about_ca_system_score_gemma":0.005517759,"threshold_uncertainty_score":0.9996929},"labels":[],"label_agreement":null},{"id":"W2152478871","doi":"10.1258/acb.2009.200918","title":"Apolipoprotein B, Diabetes and Medical Consensus","year":2009,"lang":"en","type":"letter","venue":"Annals of Clinical Biochemistry International Journal of Laboratory Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Consensus conference; Diabetes mellitus; Medicine; Apolipoprotein B; Internal medicine; Intensive care medicine; Endocrinology; Cholesterol","score_opus":0.06299249827965608,"score_gpt":0.4199424749030354,"score_spread":0.3569499766233793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152478871","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19490491,0.012634547,0.0000070621213,0.7903034,0.001234921,0.00018098365,0.00009133544,0.000013402603,0.00062942767],"genre_scores_gemma":[0.09704427,0.012829854,0.00041093896,0.837231,0.051929634,0.0000042978186,0.0001601795,0.00005656367,0.0003332742],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914199,0.00033335364,0.0034896755,0.00042050955,0.003975236,0.0003613087],"domain_scores_gemma":[0.9902112,0.0008347804,0.002580556,0.00056644285,0.005090137,0.0007169096],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.006249888,0.0003987851,0.0024495479,0.00026904454,0.000027437267,0.00001429197,0.00060945627,0.0016225723,0.00038838474],"category_scores_gemma":[0.015242474,0.00028675536,0.0007617881,0.00019657028,0.0010934212,0.00004618366,0.000090251575,0.0035891854,0.000003583352],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046932942,0.00022998523,0.0016346306,0.00070827396,0.002710767,0.0043255924,0.000022837701,1.1987618e-7,0.0010108983,0.000009837877,0.94847333,0.040404394],"study_design_scores_gemma":[0.0065190145,0.0026480844,0.0024225046,0.009242691,0.00072824943,0.001257192,0.0000617618,0.000011027289,0.024612604,0.00035584028,0.95175654,0.00038451757],"about_ca_topic_score_codex":0.000016688211,"about_ca_topic_score_gemma":4.4757007e-7,"teacher_disagreement_score":0.09786065,"about_ca_system_score_codex":0.000036322315,"about_ca_system_score_gemma":0.0022425246,"threshold_uncertainty_score":0.99995846},"labels":[],"label_agreement":null},{"id":"W2152683287","doi":"10.1161/circulationaha.108.790733","title":"Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis","year":2008,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Pfizer Canada; Pfizer Pharmaceuticals; Cleveland Clinic; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Cholesterylester transfer protein; Coronary atherosclerosis; Lipoprotein; Internal medicine; Cardiology; Coronary heart disease; High-density lipoprotein; Cholesterol","score_opus":0.02694456011912999,"score_gpt":0.2504793621932922,"score_spread":0.2235348020741622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152683287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917164,0.00032526106,0.0058233654,0.00025044463,0.000043295055,0.0017038499,0.000004539817,0.00006448753,0.00006834648],"genre_scores_gemma":[0.9988875,0.000055632754,0.00062338414,0.00009721952,0.00014997467,0.00007874029,0.00004982615,0.000030005227,0.000027759383],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986014,0.00008860834,0.00034441985,0.00031103124,0.00047520795,0.00017933878],"domain_scores_gemma":[0.99928176,0.0000074481445,0.00007366832,0.0003493118,0.00016696028,0.00012086405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031782236,0.00015359207,0.00035131548,0.000089852474,0.00015429854,0.000009850256,0.000024839055,0.0001614067,0.00002678316],"category_scores_gemma":[0.000024850602,0.00013455465,0.00012908604,0.00016346225,0.00013940062,0.00017794027,0.000018555238,0.00014667706,0.00000566239],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038446934,0.00047091226,0.26649192,0.001068794,0.00013737174,0.000050754225,0.0015709101,0.000019678067,0.56518096,0.00028359686,0.000026260508,0.16431437],"study_design_scores_gemma":[0.0020844478,0.0001820018,0.9011454,0.0005701817,0.000058013327,0.00023380751,0.000015375508,0.00003677803,0.095362,0.00013050622,0.000058590802,0.0001229192],"about_ca_topic_score_codex":0.00025252483,"about_ca_topic_score_gemma":0.000010372197,"teacher_disagreement_score":0.63465345,"about_ca_system_score_codex":0.000057954487,"about_ca_system_score_gemma":0.00007877312,"threshold_uncertainty_score":0.54869795},"labels":[],"label_agreement":null},{"id":"W2152753361","doi":"10.1016/j.amjcard.2012.01.352","title":"Temporal Patterns of Lipid Testing and Statin Therapy in Acute Coronary Syndrome Patients (from the Canadian GRACE Experience)","year":2012,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Heart Research Centre; Cégep de Lévis; McMaster University; Thrombosis and Atherosclerosis Research Institute; Vancouver General Hospital; Surrey Memorial Hospital; University of British Columbia; Canadian VIGOUR Centre; University of Toronto; St. Michael's Hospital","funders":"Heart and Stroke Foundation of Canada; Bristol-Myers Squibb","keywords":"Medicine; Acute coronary syndrome; Statin; Internal medicine; Confidence interval; Confounding; Odds ratio; Prospective cohort study; Population; Cardiology; Myocardial infarction","score_opus":0.023228300168799523,"score_gpt":0.27551618757048457,"score_spread":0.25228788740168506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152753361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980827,0.0009100951,0.000038175967,0.0005419588,0.00015462305,0.00021925235,0.00002306533,0.000002216345,0.000027904796],"genre_scores_gemma":[0.99838996,0.00042508062,0.0003055819,0.00062062516,0.00023418285,0.0000063070092,0.0000032723906,0.0000125539,0.0000024167996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984936,0.00051386806,0.00035500294,0.00008602172,0.00025176507,0.0002997467],"domain_scores_gemma":[0.9988045,0.00024550577,0.0003696238,0.00026065193,0.00012758758,0.00019212405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096121675,0.000106243424,0.0006351821,0.00006876148,0.00007680065,0.0000052995247,0.00015252491,0.000030171816,0.0000060229327],"category_scores_gemma":[0.000114410286,0.00005466847,0.00012667598,0.00016490323,0.0003058941,0.0000613317,0.000029065302,0.0003013403,5.631632e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015221238,0.000012132793,0.96048605,0.0000027263782,0.0002632074,0.00006382026,0.0019000613,0.000007800529,0.00006845513,0.0000017755281,0.000018679022,0.037023094],"study_design_scores_gemma":[0.0007866937,0.0014086013,0.9934292,0.000046112244,0.000061189974,0.0017849364,0.0020086304,0.0000031272398,0.000022596249,0.000014796877,0.0003789987,0.000055127206],"about_ca_topic_score_codex":0.060831096,"about_ca_topic_score_gemma":0.0012451179,"teacher_disagreement_score":0.05958598,"about_ca_system_score_codex":0.00008225211,"about_ca_system_score_gemma":0.00024386619,"threshold_uncertainty_score":0.9454229},"labels":[],"label_agreement":null},{"id":"W2153063103","doi":"","title":"The use of cholesterol-lowering medications after coronary revascularization.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Revascularization; Medical prescription; Internal medicine; Coronary artery disease; Cardiology; Percutaneous coronary intervention; Diabetes mellitus; Logistic regression; Myocardial infarction","score_opus":0.030246489663332324,"score_gpt":0.22972165522103727,"score_spread":0.19947516555770495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153063103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97333175,0.008149443,0.008567502,0.0029000759,0.0005773721,0.0038855849,0.000010028756,0.000087748886,0.0024904849],"genre_scores_gemma":[0.9958265,0.00076781976,0.00035147215,0.00050596456,0.000073082534,0.0016090677,0.000006409386,0.000016352355,0.00084333506],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989785,0.000076028584,0.00023011342,0.00013773696,0.00036046823,0.00021715034],"domain_scores_gemma":[0.9990548,0.00004578367,0.00005574652,0.0006120087,0.00009778366,0.00013387077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066223147,0.00007113097,0.00015898069,0.000035839286,0.00008632527,0.000017205151,0.000051955165,0.000050364266,0.000017310555],"category_scores_gemma":[0.0003557534,0.000047133577,0.00014596165,0.00016924705,0.000075273725,0.000080888945,0.000017702607,0.00010133967,0.000004439918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017307197,0.00031006182,0.15062808,0.00037285977,0.0013472841,0.00003970918,0.00031622118,0.000086611755,0.00006889012,0.0019332861,0.0015191031,0.8432048],"study_design_scores_gemma":[0.0005411475,0.000011140514,0.83199817,0.000019603718,0.00012263792,0.0000420226,0.000014387004,0.000008571145,0.00033107385,0.000023293936,0.16684225,0.000045697638],"about_ca_topic_score_codex":0.000026504682,"about_ca_topic_score_gemma":0.0000111283125,"teacher_disagreement_score":0.84315914,"about_ca_system_score_codex":0.000039606515,"about_ca_system_score_gemma":0.00006430335,"threshold_uncertainty_score":0.19220515},"labels":[],"label_agreement":null},{"id":"W2153282617","doi":"10.1136/bmj.38849.517257.de","title":"Cardiovascular risk estimation: important but may be inaccurate","year":2006,"lang":"en","type":"letter","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Estimation; Data science; Medicine; Engineering","score_opus":0.02218711936601631,"score_gpt":0.2821164366433253,"score_spread":0.259929317277309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153282617","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064588487,0.034801103,0.0035223945,0.9266347,0.0021987376,0.006484788,0.0006323794,0.00054106035,0.01872598],"genre_scores_gemma":[0.0074634254,0.004875959,0.0138210105,0.8594893,0.07131609,0.0015734861,0.008154326,0.00066375884,0.03264259],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951435,0.00033996947,0.0010242442,0.00081956724,0.0019785005,0.0006942751],"domain_scores_gemma":[0.9963287,0.000047321053,0.00047063964,0.0027471934,0.00024177512,0.0001643358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002044061,0.0005615371,0.0016564255,0.00016497613,0.00017499947,0.000065071,0.00020528019,0.0011509256,0.00015119354],"category_scores_gemma":[0.00018695704,0.0004665685,0.0025220208,0.0002750824,0.000092875,0.000076263736,0.000079449586,0.0022800975,0.00021836784],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015100297,0.000022887982,0.0005634319,0.00076031033,0.0023533932,0.0073013646,0.000014988767,0.000097603006,9.0025253e-7,0.0000071035724,0.97474056,0.014122359],"study_design_scores_gemma":[0.0013707306,0.00011014984,0.0036600058,0.00026864625,0.0028909808,0.0010457997,0.000010793341,0.00021470424,0.00006419351,0.00010837336,0.9897375,0.00051814143],"about_ca_topic_score_codex":0.004263612,"about_ca_topic_score_gemma":0.000017981934,"teacher_disagreement_score":0.06911736,"about_ca_system_score_codex":0.00028644488,"about_ca_system_score_gemma":0.00068943866,"threshold_uncertainty_score":0.9997786},"labels":[],"label_agreement":null},{"id":"W2153437086","doi":"10.1016/j.jval.2015.09.896","title":"Economic Evaluation Of A Pharmacogenomic Test For Statin-Induced Myopathy In Cardiovascular High-Risk Patients Initiating A Statin","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Université de Montréal","funders":"","keywords":"Medicine; Statin; Myopathy; Pharmacogenomics; Rhabdomyolysis; Physical therapy; Test (biology); Internal medicine; Intensive care medicine; Pharmacology","score_opus":0.08329011053762649,"score_gpt":0.3353127573321463,"score_spread":0.25202264679451986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153437086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158317,0.0026108094,0.00020730997,0.00012931728,0.00034574128,0.0048089176,0.000225255,0.000021806509,0.000067664725],"genre_scores_gemma":[0.99549776,0.00025695795,0.0032365313,0.00014834144,0.00022170077,0.00044948034,0.00013513646,0.0000524826,0.0000015987665],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995773,0.0011830293,0.001206929,0.0004743533,0.00085065316,0.0005120416],"domain_scores_gemma":[0.99806273,0.00026737113,0.00048224156,0.0005266838,0.00037040364,0.0002905937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014690424,0.00020854498,0.0009781312,0.0003585901,0.000055336463,0.000009980365,0.000096357675,0.0000939244,0.000008222672],"category_scores_gemma":[0.0016505498,0.00021178486,0.00027392033,0.0002671868,0.000022119351,0.00011183384,0.00003486441,0.00027926936,0.000008836715],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005889585,0.0009953157,0.44907534,0.0023048,0.00047760608,0.000010082619,0.007928424,0.08665741,0.00015692275,0.00009172574,0.00012822422,0.4515852],"study_design_scores_gemma":[0.09381771,0.0063727237,0.64682084,0.001533352,0.0008744802,0.000022157474,0.0029524826,0.24206384,0.0019747852,0.0020079466,0.0008080536,0.0007516223],"about_ca_topic_score_codex":0.050934143,"about_ca_topic_score_gemma":0.00039758914,"teacher_disagreement_score":0.45083356,"about_ca_system_score_codex":0.002216092,"about_ca_system_score_gemma":0.0037023588,"threshold_uncertainty_score":0.95538574},"labels":[],"label_agreement":null},{"id":"W2153817984","doi":"10.1161/jaha.114.000784","title":"The Incidence of Kidney Injury for Patients Treated With a High‐Potency Versus Moderate‐Potency Statin Regimen After an Acute Coronary Syndrome","year":2014,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Atorvastatin; Pravastatin; Simvastatin; Internal medicine; Regimen; Acute coronary syndrome; Creatinine; Statin; Acute kidney injury; Randomized controlled trial; Potency; Incidence (geometry); Renal function; Myocardial infarction; Cholesterol","score_opus":0.0061533082121992926,"score_gpt":0.2551835032601392,"score_spread":0.24903019504793994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153817984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683905,0.000030509438,0.00018798339,0.002190903,0.00017248336,0.00052030873,0.000038568982,0.000007500894,0.000012668075],"genre_scores_gemma":[0.99748015,0.00008935221,0.0013902271,0.0007057535,0.000111708185,0.000026811302,0.000007226431,0.000022092901,0.00016665451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979309,0.00043383654,0.0004460609,0.00012637349,0.0008281024,0.00023475906],"domain_scores_gemma":[0.99748695,0.0001774867,0.0010155258,0.00034586372,0.0007846448,0.00018950469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013090773,0.00012347971,0.00058023765,0.00005544564,0.00016238922,0.00002132083,0.00013271447,0.000045700195,0.0000029920122],"category_scores_gemma":[0.00084093044,0.000065076325,0.00025844967,0.0002446247,0.00007081657,0.00017971621,0.000024033287,0.00021281488,0.0000010533738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025416965,0.0005981928,0.93774563,0.00008130967,0.0025409157,0.00001555841,0.00076023146,0.000059298152,0.0011756679,0.000023434099,0.004363741,0.02721905],"study_design_scores_gemma":[0.003369426,0.01296285,0.98114145,0.00016531338,0.00068884075,0.000060098413,0.0000963142,0.0002746042,0.00042386676,0.00012254104,0.0005899818,0.000104742794],"about_ca_topic_score_codex":0.0005842923,"about_ca_topic_score_gemma":0.000016628224,"teacher_disagreement_score":0.043395784,"about_ca_system_score_codex":0.0004326211,"about_ca_system_score_gemma":0.00041172362,"threshold_uncertainty_score":0.26537356},"labels":[],"label_agreement":null},{"id":"W2154636208","doi":"10.1586/14737167.3.3.273","title":"Costs of dyslipidemia","year":2003,"lang":"en","type":"article","venue":"Expert Review of Pharmacoeconomics & Outcomes Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Dyslipidemia; Medicine; Intensive care medicine; Cost effectiveness; Population; Cost–benefit analysis; Disease; Risk analysis (engineering); Environmental health; Internal medicine","score_opus":0.05206509620023147,"score_gpt":0.5243368935090683,"score_spread":0.47227179730883684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154636208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12422374,0.8027009,0.00015848431,0.0076071685,0.00079735357,0.004482401,0.000034301156,0.00003956139,0.059956133],"genre_scores_gemma":[0.30149364,0.6818816,0.0045998995,0.009934806,0.00037877707,0.0002834216,0.00002637927,0.00008987979,0.0013115691],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694395,0.0006422221,0.0009791141,0.00033202433,0.00063757587,0.00046511187],"domain_scores_gemma":[0.9978308,0.0003067433,0.0001872736,0.0008924019,0.00047255144,0.00031020097],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006885584,0.00017839778,0.0013330419,0.00020885508,0.000057318764,0.000006015216,0.0002524748,0.000077689176,0.001568556],"category_scores_gemma":[0.0009876408,0.00013941864,0.00067713676,0.00029945295,0.00016029837,0.00008182287,0.00008523017,0.00044616,0.00009140541],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033607826,0.0016339275,0.047903936,0.068668984,0.0034405407,0.00007980525,0.00075367576,0.00000727613,0.026097918,0.027615927,0.20639469,0.6170672],"study_design_scores_gemma":[0.0032376451,0.0002657545,0.002225337,0.005383031,0.000112515394,0.000045581848,0.00017944309,0.000046759615,0.04897232,0.000084450076,0.9391808,0.00026636833],"about_ca_topic_score_codex":0.00017616755,"about_ca_topic_score_gemma":0.0000028966438,"teacher_disagreement_score":0.7327861,"about_ca_system_score_codex":0.00032498306,"about_ca_system_score_gemma":0.0006233846,"threshold_uncertainty_score":0.99934417},"labels":[],"label_agreement":null},{"id":"W2154668549","doi":"10.3132/dvdr.2007.067","title":"Atherosclerosis in type 2 diabetes: a role for fibrate therapy?","year":2007,"lang":"en","type":"review","venue":"Diabetes and Vascular Disease Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Fibrate; Diabetes mellitus; Type 2 diabetes; Internal medicine; Disease; Vascular disease; Atherosclerotic cardiovascular disease; Cardiology; Statin; Endocrinology","score_opus":0.14669510979138098,"score_gpt":0.41677606774462755,"score_spread":0.2700809579532466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154668549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011653824,0.9825352,0.000004859687,0.00004485725,0.000075843425,0.005459947,0.00009972901,0.000042008363,0.0000837274],"genre_scores_gemma":[0.0005319145,0.9965919,0.00008752934,0.000108351065,0.00048340092,0.0015032134,0.00040961886,0.0001754897,0.00010854587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99525917,0.00063063763,0.0006014707,0.00096293335,0.0010965198,0.0014492437],"domain_scores_gemma":[0.9970282,0.00040979707,0.00008702166,0.0011937795,0.00035238193,0.00092886033],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005259781,0.0004993577,0.002187328,0.00075214653,0.00022094983,0.00012747492,0.00024759385,0.00042384214,0.000055292923],"category_scores_gemma":[0.00038318025,0.00036983375,0.0015453893,0.0012434808,0.00018214146,0.00008099238,0.000164081,0.0008113484,0.000036543617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035962137,0.00024412964,0.0017112014,0.033919886,0.00090084533,0.000006854404,0.00003560021,2.4213304e-7,0.000003766333,0.000051632665,0.00013133265,0.9629586],"study_design_scores_gemma":[0.0015372006,0.0004244524,0.0031115767,0.01371386,0.0006030179,4.454806e-7,0.000033533466,0.00009422052,0.000006254788,0.00013893397,0.9799433,0.00039320684],"about_ca_topic_score_codex":0.000037184964,"about_ca_topic_score_gemma":0.000004365891,"teacher_disagreement_score":0.97981197,"about_ca_system_score_codex":0.00019933036,"about_ca_system_score_gemma":0.0009863275,"threshold_uncertainty_score":0.99987537},"labels":[],"label_agreement":null},{"id":"W2155417522","doi":"10.1186/1476-511x-13-13","title":"Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years","year":2014,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Atorvastatin; Ezetimibe; Medicine; Dyslipidemia; Internal medicine; Apolipoprotein B; PCSK9; Endocrinology; Pharmacology; Gastroenterology; Statin; Cholesterol; Urology; Lipoprotein; LDL receptor; Disease","score_opus":0.012017835198133327,"score_gpt":0.26853622594169596,"score_spread":0.25651839074356264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155417522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939023,0.0015018511,0.0003175681,0.002373292,0.00030361168,0.0011129862,0.00011233144,0.000021791353,0.0003542682],"genre_scores_gemma":[0.99327993,0.0005537108,0.0022966396,0.0031230773,0.00048125288,0.000039024668,0.0001418375,0.00003414984,0.00005039606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974118,0.0005812229,0.0007019019,0.00042208668,0.00035634026,0.0005266683],"domain_scores_gemma":[0.9966865,0.00009223552,0.00013845379,0.00039276856,0.00006955548,0.0026204719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020751944,0.00018718773,0.00046946472,0.00028601286,0.00009175108,0.000018016035,0.00006229347,0.000052206437,0.00004587711],"category_scores_gemma":[0.001255236,0.00018668339,0.000057730736,0.0002632855,0.00004967437,0.00005782273,0.000042723335,0.00020806897,0.0000135271375],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018012187,0.0006876868,0.4210789,0.008206434,0.00019613175,0.0004077539,0.01558186,0.002181803,0.00008568458,0.003303922,0.024171697,0.50608593],"study_design_scores_gemma":[0.013568444,0.0020429192,0.92091864,0.00059746875,0.00006552981,0.0000041965714,0.0010688726,0.0030652476,0.000012680113,0.00012758741,0.058139667,0.0003887308],"about_ca_topic_score_codex":0.09680885,"about_ca_topic_score_gemma":0.04279117,"teacher_disagreement_score":0.5056972,"about_ca_system_score_codex":0.00031974222,"about_ca_system_score_gemma":0.0015346892,"threshold_uncertainty_score":0.9746754},"labels":[],"label_agreement":null},{"id":"W2155478202","doi":"10.1186/cc8135","title":"Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: a systematic review","year":2009,"lang":"en","type":"review","venue":"Critical Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Health Sciences Centre; McGill University Health Centre; University of Alberta Hospital; University of Alberta","funders":"McGill University Health Centre; McGill University","keywords":"Medicine; Statin; Cardiopulmonary bypass; Intensive care medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammatory response; MEDLINE; Inflammation; Internal medicine","score_opus":0.0225996661300605,"score_gpt":0.3398628821886875,"score_spread":0.317263216058627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155478202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007283807,0.99183965,0.000012226471,0.00007372499,0.00026492157,0.0068886983,0.00005821251,0.00011951663,0.0007357597],"genre_scores_gemma":[0.00029032584,0.9970606,0.00020205686,0.0005118475,0.00050605915,0.001111501,0.0001732196,0.0001088468,0.000035523393],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9952469,0.00087045017,0.0013949552,0.0007450029,0.0011782043,0.00056452357],"domain_scores_gemma":[0.99735093,0.00029624184,0.00015817927,0.0012428577,0.00027251596,0.0006792704],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010962356,0.0006643911,0.006907496,0.00017400723,0.0001403873,0.000050363135,0.00018111551,0.0005260875,0.000014150058],"category_scores_gemma":[0.003131378,0.00046322032,0.0025177212,0.00034929588,0.00010761161,0.00008092949,0.000098219236,0.00093663536,0.00005441093],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000015234178,0.000011833304,0.0000018855397,0.7516905,0.00028486675,0.0011619215,0.00004555784,1.705374e-9,1.5671048e-8,0.000076822056,0.00004578779,0.24667928],"study_design_scores_gemma":[0.00021207666,0.000280681,0.000004864107,0.8446278,0.020188775,0.0008558613,0.00024772953,1.9675404e-7,9.4658404e-8,0.000011590078,0.13313773,0.00043257888],"about_ca_topic_score_codex":0.000010036463,"about_ca_topic_score_gemma":0.0000010853212,"teacher_disagreement_score":0.2462467,"about_ca_system_score_codex":0.00037270845,"about_ca_system_score_gemma":0.0008965083,"threshold_uncertainty_score":0.99978197},"labels":[],"label_agreement":null},{"id":"W2155481867","doi":"10.1016/s0002-9149(00)00942-5","title":"Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels","year":2000,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Simvastatin; Cholesterol; National Cholesterol Education Program; Medicine; Apolipoprotein B; Internal medicine; High-density lipoprotein; Lipoprotein; Endocrinology; Atorvastatin; Metabolic syndrome; Obesity","score_opus":0.020894804772806582,"score_gpt":0.31203643093341743,"score_spread":0.29114162616061084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155481867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972143,0.0007570228,0.00069269346,0.00050043967,0.00014768679,0.00050457794,0.0000075375106,0.000008014962,0.00016771359],"genre_scores_gemma":[0.9981706,0.00021262908,0.0009731443,0.0001650503,0.00042902978,0.000008106066,0.0000011394538,0.0000244861,0.000015798956],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973079,0.0009013209,0.00075844844,0.00018851731,0.000556223,0.00028758845],"domain_scores_gemma":[0.9977016,0.0004755639,0.00089835556,0.0005292527,0.00022129441,0.00017395601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011688061,0.00020864056,0.0019778193,0.00013354603,0.000058144866,0.0000051574193,0.0001767703,0.00006417863,0.000013683002],"category_scores_gemma":[0.00023143172,0.00013538169,0.0003983135,0.00023564772,0.000748286,0.000038548314,0.000035402278,0.00047982807,0.0000040411583],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073515903,0.00010585099,0.0031393035,0.00030229168,0.0013949367,0.00007612719,0.00068739423,0.00055509765,0.012493166,0.000088051915,0.00008826123,0.9737179],"study_design_scores_gemma":[0.009483198,0.026235774,0.8541163,0.0006212369,0.00096777384,0.0008845696,0.0009102455,0.000035086538,0.10546983,0.00023081231,0.00079563184,0.0002494907],"about_ca_topic_score_codex":0.0010034224,"about_ca_topic_score_gemma":0.000009925115,"teacher_disagreement_score":0.9734684,"about_ca_system_score_codex":0.0000526288,"about_ca_system_score_gemma":0.00014434464,"threshold_uncertainty_score":0.55207056},"labels":[],"label_agreement":null},{"id":"W2156106918","doi":"10.1093/eurheartj/eht022","title":"C-reactive protein and cholesterol are equally strong predictors of cardiovascular risk and both are important for quality clinical care","year":2013,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; C-reactive protein; Cholesterol; Intensive care medicine; Internal medicine; Inflammation","score_opus":0.052936487421769846,"score_gpt":0.331730120212436,"score_spread":0.27879363279066616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156106918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865273,0.009888281,0.0011007607,0.00020328657,0.0001544678,0.0018602167,0.000065789995,0.00002644864,0.00017343473],"genre_scores_gemma":[0.99643713,0.0007031378,0.001334468,0.000115003866,0.0012848115,0.000026418233,0.000006133102,0.000060833496,0.000032046137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962665,0.0013845693,0.0009607511,0.00041358598,0.0006157031,0.00035891443],"domain_scores_gemma":[0.9977277,0.00007886934,0.00062266784,0.00055463734,0.00043512424,0.00058100565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00517295,0.00023162106,0.0010141535,0.000082399856,0.0002234242,0.000074155316,0.00008360855,0.00009273106,0.000009667652],"category_scores_gemma":[0.00061823026,0.00017489916,0.0008005877,0.000066436136,0.00015774163,0.00017911603,0.00008073868,0.0007359938,0.0000031292968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020135386,0.00010909758,0.9681408,0.00065668,0.0016997011,0.00006269948,0.00065953826,0.000007655891,0.00020402462,0.0000072118846,0.00032188508,0.027929362],"study_design_scores_gemma":[0.0039200126,0.00096188305,0.97898215,0.0005340698,0.00050450704,0.00035502473,0.0024882092,0.000017931014,0.00015201209,0.0000127390185,0.011903389,0.0001680561],"about_ca_topic_score_codex":0.0001936318,"about_ca_topic_score_gemma":0.000012274679,"teacher_disagreement_score":0.027761305,"about_ca_system_score_codex":0.000052003612,"about_ca_system_score_gemma":0.00014079468,"threshold_uncertainty_score":0.7132181},"labels":[],"label_agreement":null},{"id":"W2156193257","doi":"10.1093/eurheartj/ehr035","title":"Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of &gt;40 000 patients","year":2011,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Relative risk; Dosing; Internal medicine; Confidence interval; Randomized controlled trial; Meta-analysis; Myocardial infarction; Statin; Clinical endpoint; Clinical trial","score_opus":0.2223559716187636,"score_gpt":0.3662374348236046,"score_spread":0.143881463204841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156193257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011306329,0.9874655,0.008601179,0.000008421075,0.00009100124,0.0023968543,0.00015983985,0.0000118891785,0.0001346974],"genre_scores_gemma":[0.0029074857,0.99228644,0.0040404946,0.000065882974,0.00018012355,0.00004786807,0.00022956847,0.00014319907,0.00009894825],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99435675,0.0023901698,0.001540263,0.000441834,0.00093144446,0.00033955113],"domain_scores_gemma":[0.99533874,0.00006929898,0.0014201131,0.0009367942,0.002005226,0.00022980021],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0033519166,0.00047325777,0.007531337,0.0006617553,0.00012214055,0.000023484796,0.00018946131,0.000087044304,0.00011008545],"category_scores_gemma":[0.00010404175,0.0002845108,0.013930941,0.00063814246,0.00006084084,0.000098901175,0.00004361484,0.0004923263,0.0000035010771],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005497951,0.00031139026,0.000035734884,0.0042415694,0.6866952,0.00002373447,0.00036230386,0.00016561152,7.4204286e-7,0.0000039813763,0.0001720695,0.30743787],"study_design_scores_gemma":[0.002525835,0.0012964729,0.0006220515,0.003076817,0.55025524,0.00018662644,0.000047321897,0.00002742479,0.000009747675,0.000006233142,0.44168112,0.00026508988],"about_ca_topic_score_codex":0.000046125828,"about_ca_topic_score_gemma":0.000002195985,"teacher_disagreement_score":0.44150904,"about_ca_system_score_codex":0.00009251092,"about_ca_system_score_gemma":0.0003022056,"threshold_uncertainty_score":0.9999607},"labels":[],"label_agreement":null},{"id":"W2156560844","doi":"10.1136/bmj.f6123","title":"Should people at low risk of cardiovascular disease take a statin?","year":2013,"lang":"en","type":"article","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; York University","funders":"","keywords":"Statin; Disease; Medicine; Primary prevention; Cardiovascular health; Atherosclerotic cardiovascular disease; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Population; Intensive care medicine; Physical therapy; Gerontology; Environmental health; Internal medicine","score_opus":0.01916449500861442,"score_gpt":0.2686625973261427,"score_spread":0.2494981023175283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156560844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884044,0.006159061,0.0009065222,0.0007988192,0.00013628315,0.0020917412,0.00005518368,0.000055990866,0.00139202],"genre_scores_gemma":[0.99616486,0.000688591,0.0009692901,0.00023687501,0.00045816772,0.000299962,0.000039243318,0.000035949237,0.0011070883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980152,0.00014434363,0.00034108153,0.0002994993,0.0009029481,0.00029687615],"domain_scores_gemma":[0.99788815,0.000030853105,0.00010115808,0.0013751795,0.00019068178,0.0004139737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079763815,0.00015240663,0.0005897624,0.000057826433,0.00007409982,0.000010015894,0.00008043863,0.00007089443,0.0006572155],"category_scores_gemma":[0.00031175534,0.000117636344,0.0009846655,0.00017972635,0.000044570843,0.00006134626,0.000071730035,0.00015149023,0.00022554128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010714381,0.0013663106,0.44478756,0.0063918293,0.021429358,0.00058879063,0.0032259598,0.0044573448,0.0012074905,0.00021913997,0.15988415,0.3553706],"study_design_scores_gemma":[0.0035780307,0.00022987674,0.9230769,0.0002243105,0.0023804063,0.00006725603,0.00029635875,0.0014431766,0.00089188037,0.00012768249,0.067361936,0.00032217472],"about_ca_topic_score_codex":0.0050267978,"about_ca_topic_score_gemma":0.00004870286,"teacher_disagreement_score":0.47828934,"about_ca_system_score_codex":0.00008449885,"about_ca_system_score_gemma":0.00018820702,"threshold_uncertainty_score":0.7599048},"labels":[],"label_agreement":null},{"id":"W2156785734","doi":"10.1016/j.thromres.2004.01.002","title":"Apolipoprotein (a) mediates the lipoprotein (a)-induced biphasic shift in human platelet cyclic AMP","year":2003,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cape Breton University","funders":"","keywords":"Platelet; Lipoprotein(a); Internal medicine; Endocrinology; Apolipoprotein B; Chemistry; Lipoprotein; Basal (medicine); Adenosine; Cyclic adenosine monophosphate; Biochemistry; Cholesterol; Biology; Receptor; Medicine","score_opus":0.1267789703543314,"score_gpt":0.4111192552006188,"score_spread":0.2843402848462874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156785734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806967,0.0014405496,0.00003124463,0.0046864585,0.00011922134,0.0037246544,0.000006277826,0.000105955696,0.00918894],"genre_scores_gemma":[0.997136,0.00042239678,0.00019195539,0.00028883238,0.0005236745,0.0009917677,0.00002705096,0.00010315759,0.00031517097],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99226034,0.0018644955,0.00070358365,0.000820993,0.0026985332,0.0016520825],"domain_scores_gemma":[0.9968314,0.00028128922,0.00009394673,0.00206835,0.00024915865,0.00047586582],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009953175,0.00037319332,0.00088735064,0.00071110844,0.0007277012,0.00012854433,0.0005620468,0.00036767518,0.00081447273],"category_scores_gemma":[0.0011575294,0.00025791477,0.00035877217,0.0021696698,0.00043600134,0.00015995318,0.00018414065,0.002158492,0.00053197006],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006132991,0.00330034,0.041972835,0.0024358544,0.0020241716,0.000916625,0.012189987,0.000029961135,0.72881156,0.050852846,0.0068758735,0.14997663],"study_design_scores_gemma":[0.011885495,0.0021918074,0.5093806,0.0011380176,0.00014308274,0.0002880066,0.0023091235,0.00004416236,0.38137624,0.022064053,0.067836806,0.0013426376],"about_ca_topic_score_codex":0.01387128,"about_ca_topic_score_gemma":0.0031010148,"teacher_disagreement_score":0.46740773,"about_ca_system_score_codex":0.0004530682,"about_ca_system_score_gemma":0.0005794182,"threshold_uncertainty_score":0.9999873},"labels":[],"label_agreement":null},{"id":"W2156862231","doi":"10.1503/cmaj.111674","title":"The efficacy and cost-effectiveness of statins in low-risk patients","year":2011,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medicine; Clinical trial; Alternative medicine; Clinical Practice; Health care; Intensive care medicine; Family medicine; Statin; Internal medicine; Political science; Pathology","score_opus":0.0090625433208056,"score_gpt":0.24243641081088924,"score_spread":0.23337386749008363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156862231","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.666743,0.0029935816,0.00007199808,0.3202057,0.003019172,0.0037980904,0.00036869643,0.000017851602,0.002781927],"genre_scores_gemma":[0.37115002,0.012138056,0.00009811863,0.5993392,0.015585645,0.00019945254,0.0004673308,0.00021400079,0.0008081942],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958698,0.0011915253,0.0005536597,0.0001768083,0.0016952653,0.0005129182],"domain_scores_gemma":[0.99728376,0.0007882061,0.00045788698,0.00019618381,0.00051491475,0.00075907167],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0053116507,0.0001602109,0.00054520986,0.00019788177,0.00019448019,0.000032278513,0.0001470372,0.0009338853,0.0001586694],"category_scores_gemma":[0.004640943,0.00011004595,0.00016636825,0.00016989151,0.0000757787,0.00003696317,0.00001666738,0.003908105,0.000010588226],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000948995,0.00007673974,0.31524745,0.00045460384,0.0007818907,0.001061139,0.00035170733,6.670549e-7,1.9733211e-7,0.000014563266,0.46252817,0.21938798],"study_design_scores_gemma":[0.003223968,0.00013970325,0.4799345,0.0007639886,0.00009463686,0.000064740365,0.000026854954,0.000006912091,0.000001766705,0.000049804054,0.5156004,0.00009271552],"about_ca_topic_score_codex":0.015912553,"about_ca_topic_score_gemma":0.014265801,"teacher_disagreement_score":0.29559296,"about_ca_system_score_codex":0.0012522365,"about_ca_system_score_gemma":0.003927525,"threshold_uncertainty_score":0.9983899},"labels":[],"label_agreement":null},{"id":"W2156879211","doi":"10.1016/j.diabres.2004.09.012","title":"What do we (not) know about apoB, type 2 diabetes and obesity?","year":2004,"lang":"en","type":"letter","venue":"Diabetes Research and Clinical Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Regional Health Centre; McGill University Health Centre; Royal Victoria Hospital; McGill University","funders":"","keywords":"Dyslipidemia; Medicine; Apolipoprotein B; Diabetes mellitus; Type 2 diabetes; Internal medicine; Endocrinology; Obesity; Cholesterol","score_opus":0.07220044205135388,"score_gpt":0.4311491234127244,"score_spread":0.3589486813613705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156879211","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08484204,0.27232674,0.0000012713679,0.638815,0.0009823092,0.0015455104,0.00002497383,0.00007129995,0.001390881],"genre_scores_gemma":[0.005787411,0.64274323,0.0005585644,0.33614802,0.010562648,0.000099393525,0.00018331352,0.00014127922,0.0037761084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9915029,0.0020677592,0.0009943744,0.0014260807,0.0023851038,0.001623801],"domain_scores_gemma":[0.98729175,0.0085899485,0.0002863483,0.0014540476,0.0014785462,0.000899332],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.010821869,0.0004908892,0.0015800536,0.00030426955,0.00041235675,0.00088739925,0.0003229411,0.0018159695,0.00016323803],"category_scores_gemma":[0.015887324,0.00039336845,0.0004183154,0.0005576484,0.0011373229,0.0009790487,0.0005315404,0.009733472,0.00032124337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037181526,0.0007686446,0.009473314,0.004701828,0.002386545,0.0011368094,0.000116731004,9.896122e-8,0.000019835097,0.000109778426,0.48265868,0.49825594],"study_design_scores_gemma":[0.001916858,0.003037782,0.0052346084,0.0034245462,0.0005872063,0.000031789736,0.00024413817,0.000012872315,0.000051818475,0.0012697222,0.9837889,0.0003997534],"about_ca_topic_score_codex":0.000087649685,"about_ca_topic_score_gemma":0.000005460868,"teacher_disagreement_score":0.5011302,"about_ca_system_score_codex":0.00016801282,"about_ca_system_score_gemma":0.0011111242,"threshold_uncertainty_score":0.9998518},"labels":[],"label_agreement":null},{"id":"W2156880046","doi":"10.1016/s0140-6736(03)13638-0","title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial","year":2003,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":925,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"Merck Sharp and Dohme; Novartis Pharma; Novartis","keywords":"Fluvastatin; Medicine; Clinical endpoint; Myocardial infarction; Placebo; Internal medicine; Population; Cardiology; Adverse effect; Randomized controlled trial; Simvastatin","score_opus":0.012974105490414757,"score_gpt":0.28261950422775395,"score_spread":0.26964539873733917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156880046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98889405,0.00040342263,0.00003053806,0.00032639556,0.0004115799,0.0071176128,0.000019069617,0.000020791464,0.0027765392],"genre_scores_gemma":[0.9984111,0.00019840951,0.00007857597,0.00018826485,0.0003369912,0.00055287563,0.000009267876,0.000017312597,0.00020720273],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968162,0.0017852228,0.00043035916,0.00019269034,0.00045478396,0.00032072133],"domain_scores_gemma":[0.9981386,0.0010641345,0.00011002019,0.00058949034,0.000024361316,0.000073362586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049161534,0.00017494964,0.0019345217,0.000066559354,0.000039181876,0.0000070308793,0.0000969297,0.000067544206,0.000038004695],"category_scores_gemma":[0.0009346077,0.00008680385,0.00059141556,0.000118870325,0.00003512886,0.00001839099,0.0000054209413,0.00027175262,0.000012920392],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9894357,0.00016700248,0.005170138,0.00010267649,0.00058199203,0.000027500368,0.00056206866,0.00005565919,0.00025722574,0.00006845523,0.00016939144,0.003402196],"study_design_scores_gemma":[0.9905866,0.0013998506,0.00330082,0.00022818992,0.0004527698,0.0000058431474,0.00002016274,0.000054959797,0.002948449,0.000009494595,0.0009038218,0.0000890508],"about_ca_topic_score_codex":0.000100279474,"about_ca_topic_score_gemma":0.000014440617,"teacher_disagreement_score":0.0095170485,"about_ca_system_score_codex":0.000052432228,"about_ca_system_score_gemma":0.000068205496,"threshold_uncertainty_score":0.3539758},"labels":[],"label_agreement":null},{"id":"W2157246422","doi":"10.1136/bmjopen-2013-003475","title":"The comparative risk of new-onset diabetes after prescription of drugs for cardiovascular risk prevention in primary care: a national cohort study","year":2013,"lang":"en","type":"article","venue":"BMJ Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"University of Otago","keywords":"Medicine; Medical prescription; Primary care; Diabetes mellitus; Primary prevention; Cohort study; Epidemiology; Cohort; Family medicine; Alternative medicine; Intensive care medicine; Internal medicine; Disease; Pharmacology; Pathology; Endocrinology","score_opus":0.034825105611031464,"score_gpt":0.34261038356951795,"score_spread":0.3077852779584865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157246422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9582769,0.00198459,0.0002090312,0.000038632053,0.00007031819,0.038776137,0.000065722044,0.0000057006664,0.00057292543],"genre_scores_gemma":[0.9878053,0.00008926081,0.001028368,0.000021578135,0.00009749714,0.010656141,0.00007330622,0.000013239,0.00021527828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976327,0.00059944735,0.00051175617,0.00025539115,0.00083403796,0.00016670798],"domain_scores_gemma":[0.9984535,0.000099586345,0.00027015476,0.0006234763,0.00049412233,0.000059167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004221709,0.00011914198,0.0006754763,0.00006405176,0.00007621403,0.000030514582,0.0001733033,0.000055859433,0.000014634738],"category_scores_gemma":[0.000180357,0.000081747305,0.00050538796,0.00015626455,0.000048702026,0.00017791415,0.00012767839,0.00012581512,0.0000046187497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068617746,0.0002983742,0.9756229,0.0003574391,0.003000582,3.4471637e-7,0.0033619797,0.0001401724,0.000015228455,0.000008993714,0.001134097,0.015373706],"study_design_scores_gemma":[0.0043738433,0.0005421079,0.9905499,0.00019146221,0.00072815473,9.934699e-7,0.0020520547,0.0001396032,0.00021544655,0.00041116387,0.00070681376,0.00008843539],"about_ca_topic_score_codex":0.0062588477,"about_ca_topic_score_gemma":0.00038218644,"teacher_disagreement_score":0.029528387,"about_ca_system_score_codex":0.00015223162,"about_ca_system_score_gemma":0.0005024025,"threshold_uncertainty_score":0.9461548},"labels":[],"label_agreement":null},{"id":"W2157987028","doi":"10.1016/j.amjcard.2007.12.006","title":"The Editor’s Roundtable: Expanded Versus Standard Lipid Panels in Assessing and Managing Cardiovascular Risk","year":2008,"lang":"en","type":"review","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Engineering; Medical education","score_opus":0.036663271736393784,"score_gpt":0.33566805177716047,"score_spread":0.2990047800407667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157987028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010956933,0.9921937,0.0016921475,0.00025113858,0.0037971465,0.0006483913,0.000010048618,0.000013893173,0.00029785704],"genre_scores_gemma":[0.0019564084,0.9802541,0.00018762964,0.00004043017,0.017427303,0.00003305843,0.0000035390485,0.00007404937,0.000023469049],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99300927,0.0037921562,0.0011909839,0.0003827057,0.00097328285,0.00065160304],"domain_scores_gemma":[0.9954799,0.001306832,0.0014968694,0.0012234107,0.00026780777,0.00022518788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060179704,0.00048304975,0.006068848,0.0002714415,0.00041475028,0.000120830504,0.00045408504,0.00018170738,0.0000011163621],"category_scores_gemma":[0.0005977229,0.00024197763,0.0029737514,0.0005706956,0.00080188335,0.0001361932,0.00015551831,0.0021114354,0.000002428978],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047459922,0.0000044861104,0.0000617069,0.00045221864,0.0066364137,0.0004973788,0.00006687968,0.00007215018,6.473837e-8,0.00000566713,0.0007646682,0.99096376],"study_design_scores_gemma":[0.0016444706,0.0010161569,0.00033636554,0.002098377,0.0049352893,0.013861672,0.0007502825,0.0000013671398,1.8851263e-7,0.000022658329,0.97510535,0.00022783857],"about_ca_topic_score_codex":0.00020457027,"about_ca_topic_score_gemma":0.000003896463,"teacher_disagreement_score":0.99073595,"about_ca_system_score_codex":0.00070181227,"about_ca_system_score_gemma":0.0011699498,"threshold_uncertainty_score":0.98675615},"labels":[],"label_agreement":null},{"id":"W2158036133","doi":"10.1093/jnci/djp048","title":"Response: Re: The Influence of Statin Medications on Prostate-Specific Antigen Levels","year":2009,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto","funders":"","keywords":"Prostate-specific antigen; Statin; Medicine; Antigen; Prostate; Internal medicine; Immunology; Cancer","score_opus":0.059529817693518505,"score_gpt":0.3618025468085995,"score_spread":0.302272729115081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158036133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9413108,0.001172039,0.000085479514,0.056061637,0.00043767074,0.00038621842,0.000063307314,0.0000049836162,0.00047786103],"genre_scores_gemma":[0.9939141,0.0006418603,0.00038837653,0.0042753173,0.00056895363,0.000009022527,0.0000015416426,0.000006120479,0.00019469572],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99739844,0.00014923728,0.0005117276,0.00009840628,0.0017173816,0.00012482503],"domain_scores_gemma":[0.9979435,0.00010044697,0.0004934792,0.0002447119,0.0011385721,0.00007924096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021727686,0.00009082733,0.00022510508,0.000110623296,0.00018299077,0.000012967336,0.00028356584,0.00004732118,0.000032518208],"category_scores_gemma":[0.0006834581,0.000046436002,0.00020028582,0.00041410624,0.00016036943,0.0001533477,0.000017070584,0.0003695891,0.000003012897],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026358126,0.0018513547,0.011275824,0.00041334357,0.003270236,0.00016598891,0.011681827,0.2337433,0.307455,0.042984802,0.18130672,0.1794935],"study_design_scores_gemma":[0.0013205914,0.0003574448,0.8151931,0.00047165086,0.000051755498,0.00011959576,0.000050742008,0.000015849495,0.0068651205,0.001142262,0.17434825,0.0000636169],"about_ca_topic_score_codex":0.000036755093,"about_ca_topic_score_gemma":0.000013511696,"teacher_disagreement_score":0.8039173,"about_ca_system_score_codex":0.00032942463,"about_ca_system_score_gemma":0.0020366788,"threshold_uncertainty_score":0.36129805},"labels":[],"label_agreement":null},{"id":"W2158042027","doi":"10.1177/089686080602600503","title":"Statins for Treatment of Dyslipidemia in Chronic Kidney Disease","year":2006,"lang":"en","type":"article","venue":"Peritoneal Dialysis International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Dyslipidemia; Kidney disease; Peritoneal dialysis; Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Dialysis; Disease; Intensive care medicine; Statin","score_opus":0.014602750916294384,"score_gpt":0.30706454260512783,"score_spread":0.29246179168883346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158042027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903409,0.000968652,0.0021408529,0.0028951748,0.00038168553,0.0008358713,0.00049997185,0.00002551883,0.001911406],"genre_scores_gemma":[0.9951188,0.00010435704,0.00121261,0.00011204129,0.001480579,0.0002826676,0.0009062161,0.000015138298,0.00076761853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989034,0.000027275322,0.00035638153,0.0002161252,0.00033427452,0.00016252005],"domain_scores_gemma":[0.99942535,0.000035441797,0.0000779624,0.00021066645,0.000114102506,0.00013648497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014877788,0.00010523638,0.0003404011,0.00015482355,0.000024453971,0.000008850623,0.000059707338,0.000038936007,0.0001890168],"category_scores_gemma":[0.000097029224,0.00008909678,0.00039030387,0.000104715415,0.000036316236,0.000043846354,0.000011146991,0.000027286476,0.0000050573703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00411041,0.0059384108,0.6845663,0.001303562,0.003175005,0.00017870213,0.0009921773,0.005574186,0.028404,0.016850237,0.007574747,0.24133222],"study_design_scores_gemma":[0.0134917945,0.0008300493,0.72634506,0.00019505432,0.0006525491,0.000006739418,0.000056921705,0.026224054,0.0068084435,0.00095173117,0.22412695,0.00031063345],"about_ca_topic_score_codex":0.0014923618,"about_ca_topic_score_gemma":0.00032150713,"teacher_disagreement_score":0.24102159,"about_ca_system_score_codex":0.000784725,"about_ca_system_score_gemma":0.0004964546,"threshold_uncertainty_score":0.36332613},"labels":[],"label_agreement":null},{"id":"W2158223991","doi":"10.1161/01.atv.0000062990.62034.64","title":"Gemfibrozil Reduces Plasma C-Reactive Protein Levels in Abdominally Obese Men With the Atherogenic Dyslipidemia of the Metabolic Syndrome","year":2003,"lang":"en","type":"letter","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Ottawa","funders":"Pfizer","keywords":"Dyslipidemia; Metabolic syndrome; Medicine; Internal medicine; Diabetes mellitus; Gerontology; Endocrinology","score_opus":0.028223968536954868,"score_gpt":0.2594121025125839,"score_spread":0.23118813397562904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158223991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9183124,0.0012388751,0.00001770202,0.077235095,0.00011021102,0.0028041338,0.000056248315,0.000021935843,0.0002034222],"genre_scores_gemma":[0.957461,0.0011354304,0.00031702104,0.0395837,0.00042087393,0.00081169285,0.000043824784,0.00013294128,0.000093543465],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99535835,0.0015811493,0.0007493169,0.00096268003,0.00056511717,0.00078336376],"domain_scores_gemma":[0.9974536,0.00013333245,0.0005413055,0.0016063758,0.0001559726,0.000109459994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015744834,0.0006902742,0.0021835363,0.00017907683,0.00023271794,0.000039040104,0.00048174447,0.0010013363,0.00005586364],"category_scores_gemma":[0.00007591878,0.00034533642,0.00091846794,0.00051124673,0.0008242371,0.000085224914,0.00018392853,0.0015885279,0.00000824028],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028175843,0.0018469879,0.1375162,0.0048258044,0.05342914,0.000043928747,0.0078420965,0.00001611905,0.70553005,0.0010961052,0.07894581,0.00862603],"study_design_scores_gemma":[0.0030022175,0.00084115664,0.90646803,0.0010863015,0.0017224079,0.00006248178,0.00032896744,0.000009891982,0.0031726684,0.00004960812,0.08270198,0.00055431353],"about_ca_topic_score_codex":0.0006204034,"about_ca_topic_score_gemma":0.00014543923,"teacher_disagreement_score":0.76895183,"about_ca_system_score_codex":0.00010552227,"about_ca_system_score_gemma":0.0004433213,"threshold_uncertainty_score":0.99989986},"labels":[],"label_agreement":null},{"id":"W2158834648","doi":"10.1016/s0140-6736(10)60713-1","title":"HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial","year":2010,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"AstraZeneca","keywords":"Rosuvastatin; Medicine; Internal medicine; Rosuvastatin Calcium; Hazard ratio; Placebo; Clinical endpoint; Cholesterol; Statin; Myocardial infarction; Quartile; Stroke (engine); Diabetes mellitus; Gastroenterology; Randomized controlled trial; Endocrinology; Confidence interval; Pathology","score_opus":0.018717963129473023,"score_gpt":0.25863533109280545,"score_spread":0.23991736796333243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158834648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952228,0.0021392843,0.0001013294,0.0011516929,0.00006483086,0.0010838584,0.00019697464,0.00001669463,0.00002252151],"genre_scores_gemma":[0.99588776,0.001795546,0.0003447006,0.00027224474,0.001444899,0.00015848408,0.000052843458,0.000019919005,0.000023592822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984289,0.00036489908,0.00020549573,0.00028002914,0.00050907745,0.00021163333],"domain_scores_gemma":[0.9979185,0.00006771039,0.0000976727,0.0017745291,0.000054788048,0.000086805405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010679231,0.00016929115,0.00079827977,0.00003400837,0.000115053175,0.000026483538,0.00012884155,0.00006375838,0.00003672861],"category_scores_gemma":[0.000016601187,0.0000676486,0.00041274642,0.00014944465,0.00009447007,0.000042715128,0.00002554504,0.00022635791,0.00000248105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04579152,0.00044884463,0.7877123,0.000033121483,0.031037731,0.00003335216,0.0065599317,0.000115746,0.00007028983,0.000004698273,0.00006483349,0.12812763],"study_design_scores_gemma":[0.04033974,0.0012579167,0.9432942,0.000023437013,0.0050916895,0.000009461276,0.00020457423,0.00007478918,0.00018353113,0.000036712798,0.009387928,0.00009600173],"about_ca_topic_score_codex":0.009444418,"about_ca_topic_score_gemma":0.0047569266,"teacher_disagreement_score":0.1555819,"about_ca_system_score_codex":0.000021551445,"about_ca_system_score_gemma":0.000042539872,"threshold_uncertainty_score":0.9971518},"labels":[],"label_agreement":null},{"id":"W2158870651","doi":"10.1194/jlr.m033969","title":"PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population","year":2012,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PCSK9; Proprotein convertase; Kexin; Single-nucleotide polymorphism; SNP; Cholesterol; Medicine; Internal medicine; Population; Bioinformatics; Effects of sleep deprivation on cognitive performance; Oncology; Endocrinology; Cognition; Psychology; LDL receptor; Biology; Genetics; Lipoprotein; Gene; Psychiatry; Genotype","score_opus":0.1646535447075103,"score_gpt":0.4336805409716388,"score_spread":0.26902699626412846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158870651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998048,0.00027756076,0.00018094515,0.0003051782,0.000169428,0.00091528066,0.000010349305,0.0000104634855,0.00008280807],"genre_scores_gemma":[0.9967995,0.0002926767,0.00025175585,0.00024635802,0.0020797017,0.000022869897,0.000013517112,0.000054043336,0.0002395508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99325085,0.0015037098,0.0008931909,0.00029616273,0.0032329822,0.00082310144],"domain_scores_gemma":[0.99659866,0.00025518445,0.00035648077,0.00044924003,0.0016688403,0.00067157415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015056553,0.00021671546,0.0010094503,0.0004643421,0.00016726858,0.000037248774,0.00019964341,0.00026053062,0.00006601329],"category_scores_gemma":[0.0007486358,0.00012869222,0.00033987808,0.00075888896,0.00013325547,0.0008431422,0.000049819388,0.001929033,0.000019557097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007071857,0.0011050486,0.92322713,0.00023237083,0.0011352992,0.00017684941,0.00063730666,0.000020285737,0.00009497948,6.296016e-7,0.000040418756,0.06625781],"study_design_scores_gemma":[0.010997542,0.00781523,0.9752969,0.0028141616,0.00021610355,0.00084016414,0.0005064811,0.000112343965,0.0010216584,0.0000012518707,0.00020936641,0.00016878269],"about_ca_topic_score_codex":0.000113324415,"about_ca_topic_score_gemma":0.00007789324,"teacher_disagreement_score":0.066089034,"about_ca_system_score_codex":0.00034588162,"about_ca_system_score_gemma":0.0007835554,"threshold_uncertainty_score":0.8380796},"labels":[],"label_agreement":null},{"id":"W2158901329","doi":"10.1161/circoutcomes.110.959247","title":"A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk","year":2011,"lang":"en","type":"review","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":643,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"McGill University Health Centre; McGill University","keywords":"Medicine; Apolipoprotein B; Relative risk; Internal medicine; Meta-analysis; Cholesterol; Percentile; Population; Lipoprotein; Endocrinology; High-density lipoprotein; Confidence interval","score_opus":0.1035239007971395,"score_gpt":0.33477283574794886,"score_spread":0.23124893495080937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158901329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.087002076,0.90022564,0.004454455,0.000036948673,0.0001983019,0.007390194,0.00045940073,0.00012050699,0.00011247546],"genre_scores_gemma":[0.1967874,0.8007312,0.00083924085,0.00011312672,0.00023872036,0.0006039893,0.0003981127,0.0002222062,0.000066004046],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9834561,0.004920391,0.0043190513,0.002807305,0.0034770435,0.0010201448],"domain_scores_gemma":[0.988018,0.00036965552,0.0027039442,0.0069719222,0.0010522694,0.0008842226],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.015318651,0.002006312,0.02713087,0.001839319,0.00041522513,0.0001223474,0.0005620443,0.0018295636,0.000095000316],"category_scores_gemma":[0.00090513297,0.001628737,0.043161478,0.002241236,0.00086011365,0.0004138696,0.00059164106,0.0015690995,0.000020305608],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088760586,0.00016633549,0.0005917584,0.02577491,0.5199994,0.00003181395,0.0002121871,0.00010032154,0.0000018031028,0.0000904332,0.0000015396274,0.45294073],"study_design_scores_gemma":[0.0027488156,0.00022477354,0.21122627,0.0015152064,0.7666391,0.00019750115,0.00011028104,0.000024601673,0.0001260254,0.00017200806,0.015649287,0.0013660999],"about_ca_topic_score_codex":0.12526281,"about_ca_topic_score_gemma":0.00068787625,"teacher_disagreement_score":0.45157462,"about_ca_system_score_codex":0.00028706194,"about_ca_system_score_gemma":0.0005842706,"threshold_uncertainty_score":0.9994663},"labels":[],"label_agreement":null},{"id":"W2158905078","doi":"10.1161/circoutcomes.110.938118","title":"Rosuvastatin for Primary Prevention Among Individuals With Elevated High-Sensitivity C-Reactive Protein and 5% to 10% and 10% to 20% 10-Year Risk","year":2010,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Rosuvastatin; Medicine; Hazard ratio; Confidence interval; Internal medicine; Framingham Risk Score; Population; Statin; C-reactive protein; Placebo; Absolute risk reduction; Relative risk; Rosuvastatin Calcium; Lower risk; Physical therapy; Disease; Environmental health; Pathology","score_opus":0.020158032244451524,"score_gpt":0.28905765510508447,"score_spread":0.26889962286063296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158905078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975409,0.000231888,0.018819882,0.0005222468,0.00005337489,0.0046580518,0.00014315972,0.00008495485,0.00007747592],"genre_scores_gemma":[0.9900975,0.00001403939,0.008477412,0.0002107623,0.00017472396,0.00037336236,0.0001973443,0.000049597827,0.0004052557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969153,0.0006003523,0.0004856891,0.00081551593,0.0008129419,0.0003702],"domain_scores_gemma":[0.9979837,0.00019774822,0.00018605938,0.0007619624,0.00041402297,0.00045653593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00520226,0.00033465395,0.0011619694,0.00019638226,0.00031523537,0.000109590364,0.000044870583,0.00023181569,0.000030801253],"category_scores_gemma":[0.0009788973,0.00028041317,0.00045587117,0.00027704437,0.00012677387,0.0002637858,0.000081362574,0.0002752464,0.000008174421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011057889,0.00022557282,0.8568841,0.0015108987,0.0063343835,0.0000217809,0.0014895981,0.0002763428,0.00862123,0.0006709788,0.00008524714,0.12277404],"study_design_scores_gemma":[0.0041547506,0.00028083666,0.9888169,0.00011402454,0.00092634547,0.000037114616,0.00019788834,0.000034036857,0.0013207804,0.00025035985,0.0034882352,0.0003787012],"about_ca_topic_score_codex":0.00079793786,"about_ca_topic_score_gemma":0.00024468263,"teacher_disagreement_score":0.1319328,"about_ca_system_score_codex":0.000072025294,"about_ca_system_score_gemma":0.00012745649,"threshold_uncertainty_score":0.99996483},"labels":[],"label_agreement":null},{"id":"W2159449551","doi":"10.1056/nejmoa040583","title":"Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes","year":2004,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4942,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Bristol-Myers Squibb","keywords":"Medicine; Atorvastatin; Pravastatin; Hazard ratio; Acute coronary syndrome; Unstable angina; Myocardial infarction; Liter; Internal medicine; Confidence interval; Regimen; Clinical endpoint; Statin; Cardiology; Cholesterol; Randomized controlled trial","score_opus":0.01850458348222359,"score_gpt":0.27174939322422287,"score_spread":0.25324480974199925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159449551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98103195,0.002549705,0.0061092735,0.008939137,0.0008269143,0.00022646796,0.0000028798506,0.000017883307,0.00029581078],"genre_scores_gemma":[0.99204266,0.0013155494,0.0019017997,0.0013703957,0.003161731,0.0000030736246,0.0000055205123,0.000032358203,0.00016689888],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99829954,0.000036877118,0.00044131183,0.00016066305,0.0007846344,0.00027699355],"domain_scores_gemma":[0.99841565,0.00005389254,0.00020709797,0.00025269887,0.0005567665,0.0005139234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052003184,0.00019955233,0.0007465488,0.00016470779,0.00004629632,0.000009597518,0.000077936675,0.00006130949,0.000118509925],"category_scores_gemma":[0.00014913223,0.00011269726,0.00013026939,0.00015845573,0.00010675281,0.00013346507,0.000020338912,0.0005053135,0.000005739478],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20479563,0.00048486755,0.010496564,0.00079997536,0.013313289,0.11145353,0.02149447,0.0028075527,0.004126109,0.00020744377,0.0038716658,0.6261489],"study_design_scores_gemma":[0.68313813,0.057974227,0.077242814,0.008778239,0.005583242,0.13661413,0.003691532,0.00006573594,0.003240692,0.0007417074,0.022215663,0.00071391417],"about_ca_topic_score_codex":0.00019403998,"about_ca_topic_score_gemma":0.000055225657,"teacher_disagreement_score":0.625435,"about_ca_system_score_codex":0.00015229694,"about_ca_system_score_gemma":0.00057374476,"threshold_uncertainty_score":0.4595661},"labels":[],"label_agreement":null},{"id":"W2159801354","doi":"10.1001/archinte.165.1.62","title":"Statin Use and Survival Outcomes in Elderly Patients With Heart Failure","year":2005,"lang":"en","type":"article","venue":"Archives of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Hazard ratio; Myocardial infarction; Heart failure; Internal medicine; Stroke (engine); Statin; Cardiology; Coronary artery disease; Retrospective cohort study; Cohort; Population; Confidence interval; Cause of death; Cohort study; Proportional hazards model; Disease","score_opus":0.009789572405753295,"score_gpt":0.2571323778453047,"score_spread":0.2473428054395514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159801354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456865,0.00017652569,0.00040513524,0.0040054005,0.00004317862,0.00032698517,0.000007802579,0.000011141275,0.00045516616],"genre_scores_gemma":[0.9931898,0.00004270874,0.0058524013,0.0006000838,0.00011181617,0.000006998933,0.000009877655,0.000015343803,0.0001709646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988454,0.0000633199,0.00032078335,0.00018694735,0.00039775716,0.00018578766],"domain_scores_gemma":[0.9993037,0.00019156303,0.00007201726,0.00023470711,0.000045602883,0.00015238789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016878512,0.00013161045,0.00054521475,0.00016837867,0.00001542385,0.0000043069226,0.000056228324,0.00002421525,0.00003440864],"category_scores_gemma":[0.00019238422,0.00007769839,0.000057891455,0.00006517994,0.00018378362,0.00008820041,0.0000320132,0.00020213342,0.0000014610221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047177623,0.00013097136,0.9706167,0.000094165815,0.000098607044,0.0000098633245,0.00074859237,0.000002092868,0.00024496994,0.00006467613,0.00010235987,0.02741522],"study_design_scores_gemma":[0.006638584,0.0020076407,0.98635304,0.00083442486,0.00004354778,0.000018097291,0.0002448844,0.000032476448,0.0002188721,0.000035652498,0.0035005002,0.00007229905],"about_ca_topic_score_codex":0.0016551428,"about_ca_topic_score_gemma":0.00079432764,"teacher_disagreement_score":0.02734292,"about_ca_system_score_codex":0.0000136361705,"about_ca_system_score_gemma":0.000032508935,"threshold_uncertainty_score":0.31684485},"labels":[],"label_agreement":null},{"id":"W2160294555","doi":"10.1016/j.cjca.2012.12.015","title":"Efficacy and Plasma Drug Concentrations With Nondaily Dosing of Rosuvastatin","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Rosuvastatin; Medicine; Tolerability; Statin; Dosing; Internal medicine; Urology; Pharmacology; Endocrinology; Rosuvastatin Calcium; Adverse effect","score_opus":0.009028940162423022,"score_gpt":0.21978186511858697,"score_spread":0.21075292495616393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160294555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386793,0.0010756145,0.0010910688,0.0010788381,0.00010959381,0.0002530841,0.0000070580554,0.0000021732421,0.0025146287],"genre_scores_gemma":[0.9984415,0.00006655152,0.0009363657,0.00013034031,0.00035369932,0.0000027951373,0.000002594592,0.000010134941,0.000055975477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992195,0.00009011956,0.00027273945,0.0000836312,0.000119784476,0.00021424556],"domain_scores_gemma":[0.9988646,0.00005097187,0.00012804185,0.00014438563,0.0002743153,0.00053770875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029127166,0.00007767148,0.00048397612,0.00012600062,0.000060212962,0.00001287615,0.000045190063,0.000051271316,0.00002308575],"category_scores_gemma":[0.00007637927,0.0000565576,0.00010037104,0.000083260915,0.00019982338,0.000062457824,0.0000035433693,0.00018682693,0.0000022568445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007272428,0.000030868352,0.5764573,0.00062326225,0.0055608796,0.0017306143,0.0077674175,0.0060541728,0.010873336,0.0026192104,0.0386937,0.34886196],"study_design_scores_gemma":[0.012200759,0.002035069,0.87031025,0.0005153328,0.0007688337,0.012060061,0.002303733,0.000116894116,0.0024891386,0.00014193107,0.096752174,0.00030584302],"about_ca_topic_score_codex":0.002950537,"about_ca_topic_score_gemma":0.0007923376,"teacher_disagreement_score":0.34855613,"about_ca_system_score_codex":0.000055927405,"about_ca_system_score_gemma":0.0013993607,"threshold_uncertainty_score":0.4460349},"labels":[],"label_agreement":null},{"id":"W2160296653","doi":"10.1016/j.mayocp.2014.06.016","title":"A Summary and Critical Assessment of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Disease Risk in Adults: Filling the Gaps","year":2014,"lang":"en","type":"article","venue":"Mayo Clinic Proceedings","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Medicine; Statin; Atherosclerotic cardiovascular disease; Intensive care medicine; Canadian Cardiovascular Society; Internal medicine; Evidence-based medicine; Cholesterol; Physical therapy; Disease; Alternative medicine; Pathology; Myocardial infarction","score_opus":0.024197294096231732,"score_gpt":0.3112004124890999,"score_spread":0.2870031183928682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160296653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850087,0.002360124,0.00008009278,0.009828226,0.000119579585,0.002279066,0.000026844345,0.000017389906,0.00027996473],"genre_scores_gemma":[0.99401385,0.0039488045,0.0003117573,0.00096277735,0.0003632827,0.00030349364,0.0000026840667,0.000034128316,0.00005923566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740344,0.00018489215,0.0008073187,0.00049195817,0.0007860316,0.0003263661],"domain_scores_gemma":[0.9980727,0.00033581004,0.00018761789,0.0009333885,0.0002652998,0.00020517218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033559047,0.00024629862,0.00070647965,0.00006360713,0.00014481183,0.000025249743,0.00025659788,0.00009292297,0.000016785458],"category_scores_gemma":[0.0012720263,0.00011405327,0.00064794294,0.0002642878,0.00020966012,0.00004475234,0.000100462305,0.00031298588,0.0000029561536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003811477,0.0100586815,0.62683564,0.006101566,0.008658055,0.000028414648,0.0121078845,0.00066587963,0.0019807094,0.0023234994,0.0060851313,0.32134306],"study_design_scores_gemma":[0.011138358,0.00498835,0.93982327,0.0054853684,0.005116551,0.000032396165,0.0023416323,0.0047580614,0.0021912383,0.0005350206,0.023155289,0.0004344888],"about_ca_topic_score_codex":0.000920944,"about_ca_topic_score_gemma":0.000017013157,"teacher_disagreement_score":0.32090858,"about_ca_system_score_codex":0.000068260735,"about_ca_system_score_gemma":0.00012553067,"threshold_uncertainty_score":0.46509573},"labels":[],"label_agreement":null},{"id":"W2160695292","doi":"10.1016/s0021-9150(02)00385-4","title":"Effects of atorvastatin on electrophoretic characteristics of LDL particles among subjects with heterozygous familial hypercholesterolemia","year":2003,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Université Laval","funders":"Canada Research Chairs; Université Laval","keywords":"Atorvastatin; Internal medicine; Endocrinology; Apolipoprotein B; Triglyceride; Familial hypercholesterolemia; Cholesterol; Chemistry; Reductase; HMG-CoA reductase; LDL receptor; Medicine; Lipoprotein; Biochemistry; Enzyme","score_opus":0.007854099740028521,"score_gpt":0.21004600186004227,"score_spread":0.20219190212001376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160695292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986701,0.00013811755,0.00024316167,0.000017441096,0.000063873464,0.00072186254,0.000008614598,0.000032056792,0.00010478998],"genre_scores_gemma":[0.9988524,0.00021027018,0.00058481697,0.0001580431,0.000047424317,0.00006348213,0.0000045035445,0.00005780811,0.000021264734],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99820334,0.00019434419,0.00039240657,0.00030344364,0.00053467945,0.00037179518],"domain_scores_gemma":[0.9988773,0.000103493694,0.00020378607,0.00052105536,0.00012301707,0.00017136573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002958077,0.00022913539,0.00068343576,0.00007283093,0.000049206068,0.000009613271,0.000078972465,0.00010854272,0.000010539674],"category_scores_gemma":[0.0001393774,0.00017288495,0.0002053555,0.00024238096,0.00018996764,0.00004102084,0.000013278083,0.0001971023,0.0000069329844],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067565526,0.000809752,0.28674355,0.0012624876,0.00037917634,0.0000263821,0.00090002746,0.0000065548766,0.6972637,0.00030206126,0.000019469684,0.011611151],"study_design_scores_gemma":[0.0019555814,0.0021651215,0.56856614,0.00046293502,0.00018446853,0.00001032265,0.000041041443,0.000009313593,0.42645296,0.000012180107,0.0000300237,0.000109886394],"about_ca_topic_score_codex":0.00014845718,"about_ca_topic_score_gemma":0.000010838832,"teacher_disagreement_score":0.28182262,"about_ca_system_score_codex":0.00006466748,"about_ca_system_score_gemma":0.000104939085,"threshold_uncertainty_score":0.70500433},"labels":[],"label_agreement":null},{"id":"W2160761735","doi":"10.1186/1476-511x-7-22","title":"Plasma PCSK9 levels are significantly modified by statins and fibrates in humans","year":2008,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Queen's University; Ottawa Hospital","funders":"Canadian Stroke Network; Canadian Institutes of Health Research; University of Ottawa","keywords":"PCSK9; Fenofibrate; LDL receptor; Internal medicine; Endocrinology; Kexin; Lipidology; HMG-CoA reductase; Cholesterol; Clinical chemistry; Atorvastatin; Gemfibrozil; Lipoprotein; Medicine; Biology; Chemistry; Reductase; Biochemistry","score_opus":0.03716039431697274,"score_gpt":0.28580312268375935,"score_spread":0.2486427283667866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160761735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879946,0.008140815,0.000070054586,0.0025709928,0.00006217608,0.00082035654,0.00017391809,0.00003200786,0.00013504123],"genre_scores_gemma":[0.9938238,0.002479197,0.00018466769,0.003033927,0.0001411249,0.000076115786,0.00005578605,0.00001948325,0.00018584979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983045,0.0001815331,0.00042077905,0.0003887727,0.0002608738,0.0004435485],"domain_scores_gemma":[0.9981135,0.00007443771,0.00008006675,0.00027063955,0.000024548175,0.0014368023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040621017,0.00016719494,0.00046200003,0.00013040802,0.00016960735,0.000013094163,0.00003879771,0.00006694436,0.000017138647],"category_scores_gemma":[0.00026610252,0.00014821031,0.000050350747,0.00018103086,0.00010487821,0.00008313412,0.000026376587,0.00025310053,0.0000024152337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015125005,0.0006836656,0.9612725,0.0056570745,0.000035490375,0.00041977782,0.0045614466,0.00006619174,0.00006327454,0.0005654747,0.004738164,0.020424442],"study_design_scores_gemma":[0.008609468,0.00064153434,0.9798208,0.0007397544,0.000022239441,0.000027475187,0.0020183094,0.0018573968,0.00003853986,0.00063425256,0.005235498,0.00035472953],"about_ca_topic_score_codex":0.0010465117,"about_ca_topic_score_gemma":0.00017542385,"teacher_disagreement_score":0.020069713,"about_ca_system_score_codex":0.00006849965,"about_ca_system_score_gemma":0.00071946206,"threshold_uncertainty_score":0.60438406},"labels":[],"label_agreement":null},{"id":"W2160812379","doi":"10.1056/nejmoa1315665","title":"Application of New Cholesterol Guidelines to a Population-Based Sample","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":615,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cholesterol; Statin; Internal medicine; Population; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive care medicine; Family medicine; Cardiology; Environmental health","score_opus":0.030345611499228167,"score_gpt":0.32593694374094767,"score_spread":0.2955913322417195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160812379","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36591926,0.00068380305,0.59498334,0.037575234,0.00030013866,0.0003812907,0.00000178951,0.000013291566,0.00014183974],"genre_scores_gemma":[0.9679329,0.00004042996,0.019269474,0.003685736,0.008959371,0.0000018284724,0.000015677124,0.000016229178,0.00007836318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982469,0.00006080958,0.0007591806,0.000111743204,0.00069295807,0.00012840224],"domain_scores_gemma":[0.9982773,0.000119765,0.00033721738,0.0003186543,0.00045154287,0.0004955214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016326447,0.00010734505,0.0005794245,0.00020359097,0.000023111637,0.0000033197418,0.000093160554,0.00005301659,0.000052093346],"category_scores_gemma":[0.0017622903,0.00006859026,0.00012386305,0.00021168259,0.000014641091,0.000034823373,0.000007969332,0.00014634898,0.0000026929288],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042619472,0.000032859953,0.044996098,0.00010270352,0.00006762733,0.0000027229687,0.00021264964,0.0007938108,0.0018034967,0.000105137864,0.005718496,0.9457382],"study_design_scores_gemma":[0.07557228,0.0043883626,0.37314174,0.0015271001,0.00059284084,0.000434588,0.0000725769,0.0020864108,0.0014867857,0.0014317388,0.539092,0.00017354942],"about_ca_topic_score_codex":0.0058351434,"about_ca_topic_score_gemma":0.0001479916,"teacher_disagreement_score":0.9455646,"about_ca_system_score_codex":0.000040274357,"about_ca_system_score_gemma":0.0002402813,"threshold_uncertainty_score":0.882103},"labels":[],"label_agreement":null},{"id":"W2160823290","doi":"10.1093/qjmed/hcr043","title":"The missing ethnicity in primary cardiovascular trials","year":2011,"lang":"en","type":"letter","venue":"QJM","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Stroke (engine); Incidence (geometry); Ethnic group; Disease; Diabetes mellitus; Myocardial infarction; Internal medicine; Demography; Gerontology","score_opus":0.07626151079524808,"score_gpt":0.2971175485871824,"score_spread":0.22085603779193436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160823290","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001898522,0.26056474,0.0007367207,0.67195624,0.0028515186,0.005701998,0.000037123016,0.00021376692,0.056039352],"genre_scores_gemma":[0.0010652363,0.010251882,0.0009852776,0.9503083,0.029091436,0.00040323718,0.00033432938,0.00028048063,0.007279822],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99511594,0.001606125,0.0008741722,0.00056001,0.0011995253,0.00064421026],"domain_scores_gemma":[0.9970602,0.0003208023,0.00022244986,0.0021821174,0.00010710345,0.00010736001],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009980515,0.00036287244,0.0022965136,0.00013775978,0.00016388866,0.000045971625,0.00027575417,0.0010347066,0.00006303732],"category_scores_gemma":[0.0007583107,0.00021859958,0.002778831,0.00021906407,0.00011831717,0.00004016867,0.00008505292,0.0028495768,0.00007687755],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009056957,0.000026938738,0.00007163498,0.000960792,0.002199288,0.0017444729,0.00012653708,7.7442496e-7,0.000016887016,0.000007746007,0.71708435,0.27767],"study_design_scores_gemma":[0.0014003065,0.000060786835,0.0035843258,0.000432517,0.0010073782,0.00018370927,0.000010687336,0.0000017327773,0.00008461324,0.00018094228,0.99281675,0.0002362268],"about_ca_topic_score_codex":0.0017312999,"about_ca_topic_score_gemma":0.000015499256,"teacher_disagreement_score":0.27835205,"about_ca_system_score_codex":0.00035511144,"about_ca_system_score_gemma":0.0006769731,"threshold_uncertainty_score":0.99945086},"labels":[],"label_agreement":null},{"id":"W2160950385","doi":"10.1161/atvbaha.108.169292","title":"Lipoprotein(a) Is Associated Differentially With Carotid Stenosis, Occlusion, and Total Plaque Area","year":2008,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Thrombosis and Atherosclerosis Research Institute; Queen's University; Western University","funders":"","keywords":"Medicine; Stenosis; Occlusion; Lipoprotein(a); Cardiology; Internal medicine; Fibrinolysis; Thrombosis; Stroke (engine); Risk factor; Logistic regression; Lipoprotein; Cholesterol","score_opus":0.027666129334680392,"score_gpt":0.24665036500877335,"score_spread":0.21898423567409298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160950385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968107,0.00034619833,0.00043141376,0.0011560537,0.00009005569,0.0009133915,0.00004476158,0.00009569384,0.00011175041],"genre_scores_gemma":[0.9881511,0.009870877,0.00047550604,0.0011261646,0.00013079979,0.0000881943,0.00008797094,0.000050990064,0.000018418257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977649,0.00019083661,0.00038693508,0.0007637207,0.00034289894,0.000550701],"domain_scores_gemma":[0.99870384,0.000032722513,0.00013638478,0.0006078014,0.00016285205,0.00035641418],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000326758,0.00040356492,0.0010834436,0.000119324766,0.00052766874,0.000037029455,0.00008591937,0.00034223462,0.00010560381],"category_scores_gemma":[0.000031458076,0.00028976885,0.00029196797,0.00020603124,0.00040496574,0.000096779215,0.00016231503,0.00027327752,0.0000073803594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003800961,0.00051495555,0.9192914,0.00015896026,0.00271255,0.000004312085,0.0015842397,6.720172e-7,0.07401392,0.00012414843,0.00044491087,0.0011119352],"study_design_scores_gemma":[0.0035365282,0.0015634334,0.99232084,0.00021637784,0.00041986536,0.00007213831,0.00011450386,0.00004187442,0.0008370068,0.000015992568,0.0004995195,0.0003619287],"about_ca_topic_score_codex":0.0009392078,"about_ca_topic_score_gemma":0.00012356041,"teacher_disagreement_score":0.07317691,"about_ca_system_score_codex":0.000058781894,"about_ca_system_score_gemma":0.00010228605,"threshold_uncertainty_score":0.9999555},"labels":[],"label_agreement":null},{"id":"W2161293986","doi":"10.1161/strokeaha.111.640789","title":"Ezetimibe and Regression of Carotid Atherosclerosis","year":2012,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Ezetimibe; Medicine; Cholesterol; Internal medicine; Cardiology; Gastroenterology; Urology; Endocrinology","score_opus":0.021309448767669784,"score_gpt":0.26946692382086085,"score_spread":0.24815747505319108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161293986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942929,0.0015325245,0.000074633295,0.00014341263,0.000099220066,0.00018748228,0.000008269159,0.000015591604,0.003645969],"genre_scores_gemma":[0.9976621,0.0003424175,0.0011070933,0.00007996629,0.00022537091,0.000007636997,0.0000027254423,0.000009900785,0.0005627796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994422,0.000025028314,0.0001014259,0.000078519784,0.00019566971,0.00015712003],"domain_scores_gemma":[0.9995644,0.000008405539,0.000034577675,0.0002326889,0.000028393595,0.00013153939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025036346,0.00006271565,0.00020330901,0.000027753887,0.000027892027,0.0000020176585,0.000019110897,0.00004934083,0.00004516846],"category_scores_gemma":[0.000023866101,0.00004150757,0.00009142079,0.000040275467,0.00003568581,0.000037034548,0.000023474135,0.00007017609,0.0000053428653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035994384,0.00010111914,0.9145945,0.00028529117,0.00010528498,4.6289068e-7,0.00056144403,1.8730633e-7,0.05936851,0.0002619418,0.0005779164,0.024107378],"study_design_scores_gemma":[0.0009964494,0.00016792805,0.9263673,0.00017201176,0.00009734143,0.000028356098,0.00018098149,0.0000033459812,0.06486287,0.000005519282,0.007052828,0.00006507893],"about_ca_topic_score_codex":0.000098418204,"about_ca_topic_score_gemma":0.0000013626486,"teacher_disagreement_score":0.024042299,"about_ca_system_score_codex":0.000013857602,"about_ca_system_score_gemma":0.00001923133,"threshold_uncertainty_score":0.16926296},"labels":[],"label_agreement":null},{"id":"W2162030247","doi":"10.1503/cmaj.101281","title":"Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk","year":2011,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Alberta Kidney Disease Network","funders":"Merck Canada; Pfizer; Amgen","keywords":"Medicine; Rosuvastatin; Potency; Pravastatin; Fluvastatin; Atorvastatin; Cost effectiveness; Statin; Quality-adjusted life year; Simvastatin; Pharmacology; Internal medicine; Cholesterol; Risk analysis (engineering)","score_opus":0.02075356727471986,"score_gpt":0.22907718528649262,"score_spread":0.20832361801177277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162030247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796104,0.0006143623,0.00024404551,0.00027563638,0.00026480932,0.0004989847,0.000056723482,0.0000028919976,0.00008149006],"genre_scores_gemma":[0.998501,0.0009067193,0.00013620798,0.00025688272,0.00013937322,0.000012045705,0.0000040376053,0.000012990282,0.00003076867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969603,0.000908241,0.00041808872,0.00013666967,0.0012821843,0.0002945453],"domain_scores_gemma":[0.99827904,0.00017457167,0.00024622545,0.00025469586,0.0003613005,0.0006841648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040460858,0.00009629377,0.0005217756,0.00012849746,0.00010891536,0.000007682725,0.00009421082,0.0002313886,0.00022218775],"category_scores_gemma":[0.002611138,0.00006875983,0.00031914236,0.00029322563,0.000063087384,0.00007367118,0.000027042273,0.0005894648,0.0000025801771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067850335,0.00007367666,0.9515926,0.0003022834,0.00081946363,0.00013601576,0.0013174855,0.000051169558,0.00001860077,0.000051950377,0.0002982619,0.04527062],"study_design_scores_gemma":[0.0021676596,0.000071695256,0.9936418,0.00048849505,0.00015848875,0.00014490787,0.00014275781,0.00008245658,0.00029243328,0.000042005588,0.0027003826,0.00006692677],"about_ca_topic_score_codex":0.1077121,"about_ca_topic_score_gemma":0.07817473,"teacher_disagreement_score":0.045203693,"about_ca_system_score_codex":0.0010110718,"about_ca_system_score_gemma":0.0020208387,"threshold_uncertainty_score":0.9386462},"labels":[],"label_agreement":null},{"id":"W2162616212","doi":"10.1042/cs20110449","title":"The causal exposure model of vascular disease","year":2011,"lang":"en","type":"article","venue":"Clinical Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Disease; Risk factor; Vascular disease; Diabetes mellitus; Arterial tree; Intensive care medicine; Apolipoprotein B; Internal medicine; Cardiology; Cholesterol; Endocrinology","score_opus":0.10643521501767796,"score_gpt":0.3624568424428975,"score_spread":0.25602162742521956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162616212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991701,0.000943467,0.00255107,0.0004183004,0.00026239717,0.00032334996,0.0000023109365,0.000022050455,0.0037760718],"genre_scores_gemma":[0.9977487,0.00043758244,0.0012477469,0.00029107174,0.00011516555,0.000009057071,2.941314e-7,0.0000046873756,0.00014571466],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984569,0.000053982985,0.00034315413,0.0002550464,0.00065438164,0.0002365405],"domain_scores_gemma":[0.99841213,0.000056129487,0.00006497093,0.0008426787,0.00016978716,0.00045428195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039763893,0.000058177615,0.00019543679,0.00001792063,0.00017553655,0.000008036867,0.00027772214,0.00003700351,0.000016602788],"category_scores_gemma":[0.0011741015,0.000030943633,0.0002844964,0.00023411152,0.0012262048,0.00006302011,0.00009447045,0.00014903372,0.000014535434],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011221194,0.0021768808,0.4130952,0.00032284483,0.00034296006,0.000109096414,0.0010645012,0.0002648388,0.0018129444,0.06467823,0.0010447981,0.5139656],"study_design_scores_gemma":[0.0012183767,0.00057983724,0.97293305,0.00007542696,0.00019849939,0.0000050110666,0.000081637714,0.01672046,0.0005941252,0.0043936693,0.003061796,0.00013808922],"about_ca_topic_score_codex":0.000052217085,"about_ca_topic_score_gemma":0.000003337648,"teacher_disagreement_score":0.5598379,"about_ca_system_score_codex":0.000015878079,"about_ca_system_score_gemma":0.0007544698,"threshold_uncertainty_score":0.45180026},"labels":[],"label_agreement":null},{"id":"W2162638570","doi":"10.1016/j.cjca.2013.06.013","title":"Management of Risk Factors Among Ambulatory Patients at High Cardiovascular Risk in Canada: A Follow-up Study","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; St. Michael's Hospital; Canadian Heart Research Centre; University of Toronto","funders":"Sanofi; AstraZeneca","keywords":"Medicine; Guideline; Ambulatory; Internal medicine; Diabetes mellitus; Coronary artery disease; Population; Blood pressure; Heart failure; Statin; Cardiology; Physical therapy; Endocrinology","score_opus":0.007737874065485228,"score_gpt":0.18828240991171524,"score_spread":0.18054453584623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162638570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953173,0.0018691812,0.000056436176,0.000016860715,0.0011661332,0.0011124491,0.00006350758,0.0000031622617,0.00039500793],"genre_scores_gemma":[0.99927884,0.00033419064,0.000039746024,0.000020443078,0.00023227283,0.000022157186,0.000011100674,0.000033646502,0.000027623712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687994,0.00067756325,0.00086197915,0.00029008463,0.00069860043,0.0005918349],"domain_scores_gemma":[0.9973844,0.00005064496,0.00042184268,0.00075759494,0.00044311277,0.0009423896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011294088,0.00025021654,0.001600732,0.0004201353,0.0001106924,0.000008055484,0.00023019651,0.0001324729,0.000047449525],"category_scores_gemma":[0.00014987652,0.00020615569,0.0008899512,0.0002791935,0.000100569414,0.000085689026,0.000044702418,0.00052309467,0.000004713918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041865667,0.000010070371,0.98132974,0.000049658684,0.0048701265,0.00062303536,0.00028356447,0.002775774,3.6692435e-7,0.0000030203817,0.0008614759,0.009151298],"study_design_scores_gemma":[0.0049241697,0.00036231172,0.9877755,0.000076494885,0.0013410049,0.000036173005,0.0021100175,0.0000044824164,0.000012004921,0.000019500198,0.0031747462,0.00016356309],"about_ca_topic_score_codex":0.9865673,"about_ca_topic_score_gemma":0.93937635,"teacher_disagreement_score":0.04719094,"about_ca_system_score_codex":0.0024411688,"about_ca_system_score_gemma":0.0023911984,"threshold_uncertainty_score":0.8406785},"labels":[],"label_agreement":null},{"id":"W2162802105","doi":"10.1093/eurheartj/ehm411","title":"Cardiovascular disease on a global scale: defining the path forward for research and practice","year":2007,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Globe; Global health; Psychological intervention; Disease; Health care; Scale (ratio); Cardiovascular health; Realm; Global Leadership; Public health; Economic growth; Gerontology; Public relations; Environmental health; Nursing","score_opus":0.08212663424395934,"score_gpt":0.3894104235598268,"score_spread":0.3072837893158675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162802105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6897066,0.09651268,0.031348825,0.043654446,0.001499812,0.0048820614,0.0000689222,0.00017341766,0.13215321],"genre_scores_gemma":[0.98923343,0.0008545715,0.004483685,0.0026795065,0.0025495547,0.00000863473,0.0000040988607,0.000052697596,0.00013382998],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964447,0.0010448934,0.00027972047,0.00029698716,0.00132878,0.00060493755],"domain_scores_gemma":[0.9976594,0.00048007502,0.000055851022,0.00062141084,0.00044458025,0.0007387114],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02894994,0.00013316346,0.0002792495,0.000075028445,0.00089564815,0.00014333785,0.0001133603,0.000027233524,0.0000062107465],"category_scores_gemma":[0.0024431716,0.00008585714,0.0005038671,0.0002545813,0.00013240395,0.00010559712,0.00007850461,0.0007171678,0.000049497285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019375762,0.001293713,0.044484705,0.0008614531,0.005672322,0.013619292,0.0016985683,0.00021446752,0.00013502929,0.020242846,0.07854693,0.81385493],"study_design_scores_gemma":[0.0020838047,0.0010363903,0.189612,0.00025829382,0.0003374886,0.009345676,0.00075479574,0.000021475413,0.000015337886,0.00018990837,0.7962292,0.0001156316],"about_ca_topic_score_codex":0.000022171487,"about_ca_topic_score_gemma":0.000002323696,"teacher_disagreement_score":0.8137393,"about_ca_system_score_codex":0.00012813666,"about_ca_system_score_gemma":0.00028856873,"threshold_uncertainty_score":0.9999004},"labels":[],"label_agreement":null},{"id":"W2162960564","doi":"10.1161/circgenetics.114.000776","title":"Exome Sequencing in Suspected Monogenic Dyslipidemias","year":2015,"lang":"en","type":"article","venue":"Circulation Cardiovascular Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; University of California, San Francisco; Saint Joseph University; Fondation Leducq; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Agence Nationale de la Recherche; Perelman School of Medicine, University of Pennsylvania; Kanazawa University; European Commission; Broad Institute; Università Degli Studi di Modena e Reggio Emila; McGill University; McGill University Health Centre; Institut National de la Santé et de la Recherche Médicale; Donovan Family Foundation; University of Washington; University of Pennsylvania; Università degli Studi di Palermo; King Abdulaziz University; Massachusetts General Hospital","keywords":"Exome sequencing; Exome; Medicine; Genetics; Computational biology; Biology; Mutation; Gene","score_opus":0.06660301113450388,"score_gpt":0.27958764212788,"score_spread":0.2129846309933761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162960564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94942385,0.03264882,0.013270387,0.00010683882,0.0004197101,0.0011822386,0.000003478094,0.00014886529,0.0027958215],"genre_scores_gemma":[0.9955074,0.00045132864,0.0027934643,0.00019878575,0.00080569036,0.000059641974,0.00006455658,0.00006988653,0.000049236085],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99672484,0.00031493668,0.00059478416,0.000590017,0.001272654,0.00050276256],"domain_scores_gemma":[0.9975416,0.000021656408,0.000079966776,0.0014806277,0.0004170966,0.0004590474],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022719319,0.0002661172,0.0008438251,0.00031365707,0.00006258218,0.000033385237,0.00012328397,0.00027077977,0.000020650568],"category_scores_gemma":[0.00031381365,0.0002753996,0.0010888235,0.00087536284,0.000056310728,0.000093074486,0.00006122151,0.0003376194,0.000089024405],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019280694,0.00018780342,0.2969555,0.00069640594,0.00603024,0.0013390024,0.0032232297,0.5593011,0.0062177465,0.00066753064,0.0005440598,0.12464458],"study_design_scores_gemma":[0.015187056,0.00031782128,0.8659423,0.0003192128,0.002147689,0.0026162,0.002007278,0.05276522,0.0047308984,0.0014615955,0.05106268,0.0014420764],"about_ca_topic_score_codex":0.0002790541,"about_ca_topic_score_gemma":0.000021873595,"teacher_disagreement_score":0.5689868,"about_ca_system_score_codex":0.0015393705,"about_ca_system_score_gemma":0.0010371772,"threshold_uncertainty_score":0.99996984},"labels":[],"label_agreement":null},{"id":"W2162997873","doi":"10.1067/mhj.2001.118739","title":"Effectiveness of a planned strategy using cardiac rehabilitation nurses for the management of dyslipidemia in patients with coronary artery disease","year":2001,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grey Nuns Community Hospital","funders":"","keywords":"Medicine; Dyslipidemia; Coronary artery disease; Rehabilitation; Internal medicine; Prospective cohort study; Intervention (counseling); Percutaneous coronary intervention; Physical therapy; Lipoprotein; Cholesterol; Cardiology; Disease; Myocardial infarction; Nursing","score_opus":0.012630177870429218,"score_gpt":0.29503508184174504,"score_spread":0.28240490397131585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162997873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975485,0.00033655527,0.00068116846,0.000090485744,0.00008083555,0.0012359106,0.000011580839,0.000003162623,0.000011775769],"genre_scores_gemma":[0.9983819,0.00004439193,0.0014404301,0.000025391577,0.00005271371,0.00003451813,0.000005655602,0.000012545272,0.0000024168592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889284,0.00024820754,0.000261207,0.000114096314,0.00032072404,0.0001629309],"domain_scores_gemma":[0.9991842,0.00023588419,0.00013841347,0.00020525118,0.00013994476,0.000096293625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000824334,0.00008266178,0.00039733507,0.00007382948,0.00005292119,0.0000043371015,0.000036309215,0.000013221053,0.000003071166],"category_scores_gemma":[0.000027993354,0.000051806983,0.0001811843,0.00020979445,0.0001357749,0.000057617097,0.000007988866,0.00010092742,1.4396481e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067157666,0.00022312852,0.96440846,0.0004802305,0.00041955145,0.000012839768,0.00007398065,0.0012696584,0.00005539534,0.000014353899,0.000013870028,0.026312778],"study_design_scores_gemma":[0.001938898,0.0025759633,0.99297345,0.000800713,0.00028163745,0.00001630934,0.0010906279,0.0001452298,0.000017231694,0.00003083587,0.00007646591,0.00005263974],"about_ca_topic_score_codex":0.000094539086,"about_ca_topic_score_gemma":0.0000017404492,"teacher_disagreement_score":0.028565,"about_ca_system_score_codex":0.00009545986,"about_ca_system_score_gemma":0.00012590749,"threshold_uncertainty_score":0.21126273},"labels":[],"label_agreement":null},{"id":"W2163014518","doi":"10.1093/qjmed/hcq165","title":"Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials","year":2010,"lang":"en","type":"review","venue":"QJM","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":342,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Medical Research Council","keywords":"Medicine; Internal medicine; Statin; Relative risk; Confidence interval; Randomized controlled trial; Myocardial infarction; Placebo; Adverse effect; Meta-analysis","score_opus":0.1644538583562329,"score_gpt":0.3866278166607835,"score_spread":0.22217395830455058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163014518","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012302182,0.9790027,0.0016676727,0.000016103611,0.00015242473,0.0148708075,0.0041298764,0.000014794151,0.0000225907],"genre_scores_gemma":[0.0001267999,0.99032134,0.0028889035,0.00001717987,0.00040386227,0.0019311144,0.004165961,0.00006793469,0.000076894656],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922823,0.0030230784,0.002757634,0.0007252772,0.0008957969,0.00031596224],"domain_scores_gemma":[0.9922515,0.0036264912,0.0015555889,0.0019303221,0.0002997971,0.00033630396],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0077118217,0.0006076108,0.034900155,0.0002627452,0.00006272412,0.000012939538,0.00012929612,0.00033017146,0.00015486278],"category_scores_gemma":[0.0022247152,0.00033081011,0.050789278,0.0005146854,0.00011912934,0.0000231298,0.000045401157,0.00018728847,0.000001443238],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008358049,0.00018813946,0.0000031141972,0.0033003965,0.54321545,0.000002648381,0.000025137695,0.00002983445,1.6204105e-8,0.00001990794,0.00003705265,0.44482026],"study_design_scores_gemma":[0.06444854,0.00010917183,0.000030334446,0.00044899152,0.5608238,3.072898e-7,0.0000013070355,0.000012180753,3.5287493e-7,0.000020066132,0.37397233,0.00013260513],"about_ca_topic_score_codex":0.00089000864,"about_ca_topic_score_gemma":0.000019097368,"teacher_disagreement_score":0.44468766,"about_ca_system_score_codex":0.000087856206,"about_ca_system_score_gemma":0.0004996183,"threshold_uncertainty_score":0.9999144},"labels":[],"label_agreement":null},{"id":"W2163106819","doi":"10.1016/s0828-282x(09)70715-9","title":"2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult – 2009 recommendations","year":2009,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":773,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta; Population Health Research Institute; University of Toronto; St. Michael's Hospital; University of Calgary; McMaster University; Robarts Clinical Trials; University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke; Montreal Clinical Research Institute; Centre hospitalier universitaire de Québec; McGill University; McGill University Health Centre; University of Ottawa; Libin Cardiovascular Institute of Alberta; St. Paul's Hospital","funders":"","keywords":"Medicine; Dyslipidemia; Disease; Canadian Cardiovascular Society; Intensive care medicine; Atherosclerotic cardiovascular disease; Internal medicine; Myocardial infarction","score_opus":0.10265293675386601,"score_gpt":0.3532965011903117,"score_spread":0.2506435644364457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163106819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013960798,0.9906719,0.00029782727,0.0044871666,0.00034787506,0.003048952,0.0008909607,0.0000021400617,0.00011358732],"genre_scores_gemma":[0.0029813873,0.9941395,0.0004344289,0.0003478653,0.0016036129,0.00028982406,0.00013638729,0.000045614514,0.00002137999],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961313,0.0009451846,0.0014505028,0.00041334308,0.000369398,0.00069025106],"domain_scores_gemma":[0.99556303,0.0003415555,0.0004502399,0.0011289794,0.0010474824,0.0014686998],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003800262,0.00046565302,0.0038491404,0.00076205906,0.0002760809,0.000029969646,0.00031750594,0.0004709069,0.0000066459497],"category_scores_gemma":[0.0009191534,0.00028607456,0.0059353015,0.000474609,0.0002652687,0.000069835456,0.000009323123,0.0004198906,4.7934304e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010790405,0.0000056112976,0.0004937561,0.0012856958,0.0109916255,0.000099894634,0.00015215199,0.00047574457,1.1044628e-8,0.00005605792,0.010659899,0.97576874],"study_design_scores_gemma":[0.0011393273,0.0005000341,0.0023059489,0.0027919589,0.01858599,0.00052682665,0.00026453286,0.000015712782,1.753079e-7,0.000083094244,0.97357136,0.00021503441],"about_ca_topic_score_codex":0.59024256,"about_ca_topic_score_gemma":0.5969575,"teacher_disagreement_score":0.97555375,"about_ca_system_score_codex":0.0009962149,"about_ca_system_score_gemma":0.012785746,"threshold_uncertainty_score":0.9999591},"labels":[],"label_agreement":null},{"id":"W2163232672","doi":"10.1002/clc.22032","title":"Statin and Aspirin Therapy for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus","year":2012,"lang":"en","type":"review","venue":"Clinical Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Servier; Sanofi; Bayer HealthCare; Duke Clinical Research Institute; Novo Nordisk; Teva Pharmaceutical Industries; Medicines Company; Eisai; Boston VA Research Institute; Gilead Sciences; Canadian Institutes of Health Research; American Heart Association; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca","keywords":"Medicine; Bristol-Myers; Family medicine; Management; Internal medicine","score_opus":0.09696046609354177,"score_gpt":0.3888155771596494,"score_spread":0.2918551110661076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163232672","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013522976,0.9809639,0.0001861387,0.000009868464,0.00044739692,0.004804799,0.000031221432,0.000009857534,0.000023828481],"genre_scores_gemma":[0.008140841,0.99034786,0.00017304777,0.000039276256,0.0006129348,0.00038890177,0.00022613145,0.000054816795,0.000016186734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965195,0.001284854,0.0010281132,0.0004737523,0.00031342945,0.00038031724],"domain_scores_gemma":[0.99754316,0.0008168935,0.00034201035,0.00096573326,0.00020850395,0.00012371766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043916455,0.00030435855,0.004085598,0.00008304502,0.000038623126,0.0000025791214,0.0001396407,0.0005154201,0.000004898392],"category_scores_gemma":[0.00028060414,0.00015887365,0.0020731334,0.00019933764,0.00019258882,0.000027817201,0.000063208274,0.00048771448,0.0000035576168],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016949643,0.00010810225,0.033552103,0.004663214,0.0059686927,0.0000010842199,0.0000066863536,0.000002196256,3.9100994e-9,0.000008143694,0.000014331328,0.95550597],"study_design_scores_gemma":[0.0035929608,0.0024311629,0.122898966,0.0018553614,0.0059600966,0.000006279845,0.0000051065563,8.8280063e-7,1.3050477e-7,0.000030794235,0.8630456,0.00017271173],"about_ca_topic_score_codex":0.000017391569,"about_ca_topic_score_gemma":0.0000020263672,"teacher_disagreement_score":0.95533323,"about_ca_system_score_codex":0.000047138878,"about_ca_system_score_gemma":0.00029823964,"threshold_uncertainty_score":0.6478679},"labels":[],"label_agreement":null},{"id":"W2163238468","doi":"10.1016/j.amjcard.2014.05.060","title":"Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials)","year":2014,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"Amgen","keywords":"Alirocumab; PCSK9; Medicine; Placebo; Internal medicine; Lipoprotein(a); Kexin; Evolocumab; Lipoprotein; Dosing; Endocrinology; Gastroenterology; Cholesterol; LDL receptor; Apolipoprotein A1; Pathology","score_opus":0.01740808616805861,"score_gpt":0.3518448448536979,"score_spread":0.33443675868563927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163238468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97969073,0.0011531337,0.017151715,0.00055177824,0.00020197123,0.0009846969,0.00012005764,0.000012835453,0.00013310273],"genre_scores_gemma":[0.99784184,0.00021383703,0.00047516997,0.00026280267,0.0010756952,0.000022078344,0.0000725254,0.000029874667,0.00000616553],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9906371,0.0061390027,0.0016592105,0.000320292,0.00086259196,0.00038179653],"domain_scores_gemma":[0.9940186,0.0017518433,0.0025736021,0.0009378388,0.0004681452,0.00024997923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008939464,0.00032514072,0.0048189843,0.00049213256,0.000100384554,0.000014210884,0.00031723507,0.00009896291,0.000048317695],"category_scores_gemma":[0.0017405752,0.00019285838,0.002455873,0.0007903111,0.0008221452,0.000074066775,0.000046005902,0.0005599286,0.0000027391102],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045517147,0.0004348484,0.016097607,0.00020556658,0.052724916,0.00026821226,0.0006875194,0.0058313115,0.43424222,0.00026866066,0.00016082666,0.44356117],"study_design_scores_gemma":[0.08214559,0.09137772,0.13948157,0.0016581743,0.12851897,0.001825074,0.0012262492,0.011891951,0.53695124,0.00066167524,0.002990223,0.0012715551],"about_ca_topic_score_codex":0.0019533422,"about_ca_topic_score_gemma":0.000012768808,"teacher_disagreement_score":0.44228962,"about_ca_system_score_codex":0.00010056021,"about_ca_system_score_gemma":0.00037700418,"threshold_uncertainty_score":0.78645366},"labels":[],"label_agreement":null},{"id":"W2163257864","doi":"10.1111/j.1365-2753.2008.01002.x","title":"Goal attainment for multiple cardiovascular risk factors in community‐based clinical practice (a Canadian experience)","year":2009,"lang":"en","type":"article","venue":"Journal of Evaluation in Clinical Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Framingham Risk Score; Dyslipidemia; Blood pressure; Risk factor; Internal medicine; Medical prescription; National Cholesterol Education Program; Population; Psychological intervention; Family history; Physical therapy; Disease; Metabolic syndrome; Environmental health; Obesity; Nursing","score_opus":0.14773541617357938,"score_gpt":0.49484865416718515,"score_spread":0.34711323799360577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163257864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800419,0.0019402256,0.003947782,0.008930134,0.0012995427,0.0024883084,0.000011287907,0.00001023473,0.0013305929],"genre_scores_gemma":[0.9683545,0.0011300826,0.02306649,0.006475532,0.00088935497,0.000035692552,0.00001992836,0.00002231724,0.00000605511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98208296,0.011410745,0.0035151183,0.00033656982,0.0022159242,0.00043866827],"domain_scores_gemma":[0.97726727,0.017010577,0.0017216987,0.0009462151,0.0023519255,0.00070234534],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.1186723,0.00022153757,0.0012274345,0.000364793,0.00020784851,0.000053372554,0.00023451871,0.000421227,0.00003611498],"category_scores_gemma":[0.25759533,0.00018712501,0.001459928,0.0004592842,0.00010193383,0.0008318301,0.000022373868,0.0031026832,0.000006836758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010579475,0.010999464,0.5034588,0.00016034995,0.0026031218,0.0007187525,0.0036888993,0.021460747,0.000011686834,0.00007518888,0.0024853444,0.4437582],"study_design_scores_gemma":[0.019954301,0.0046405974,0.71920425,0.00023708578,0.0023289183,0.00020698873,0.007515638,0.008658522,0.000020200634,0.0001893367,0.23679027,0.00025389207],"about_ca_topic_score_codex":0.028409323,"about_ca_topic_score_gemma":0.0063667195,"teacher_disagreement_score":0.4435043,"about_ca_system_score_codex":0.0010815113,"about_ca_system_score_gemma":0.0033639583,"threshold_uncertainty_score":0.9991972},"labels":[],"label_agreement":null},{"id":"W2163521556","doi":"10.1016/j.atherosclerosis.2005.04.002","title":"Fibrates and coronary risk reduction","year":2005,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Coronary artery disease; Cardiology; Coronary heart disease; Internal medicine; Intensive care medicine","score_opus":0.049843495571792046,"score_gpt":0.3161322082979395,"score_spread":0.2662887127261474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163521556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00078663963,0.9974194,0.00001199939,0.000049192735,0.00016791516,0.001102431,0.000045826,0.000095432464,0.00032112966],"genre_scores_gemma":[0.00016349346,0.99699026,0.0007130417,0.000044185246,0.0010862183,0.0001477384,0.00007841482,0.00009556271,0.0006810589],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983955,0.00016983571,0.0004060152,0.0004861212,0.0002746226,0.0002679253],"domain_scores_gemma":[0.998875,0.00003280392,0.0002251648,0.0006376322,0.000036897378,0.00019248694],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040383864,0.00034938377,0.001515473,0.00009277573,0.00013704733,0.000030937263,0.000069885114,0.00037411114,0.00011435951],"category_scores_gemma":[0.000031926018,0.00025779655,0.0006863928,0.00019785223,0.00007806725,0.000067209774,0.00005673159,0.00045216936,0.00012086541],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000045926586,0.00003720461,0.000047889655,0.004034908,0.00033881332,0.0000015832605,0.000031935237,6.551578e-8,0.0000018496937,0.000010891745,0.00044112233,0.9950491],"study_design_scores_gemma":[0.00036536212,0.000170191,0.0013316852,0.007676257,0.0026710979,0.00038086768,0.000018760926,0.0000015505299,0.0000029896937,0.000008060809,0.98713785,0.00023533362],"about_ca_topic_score_codex":0.0001343103,"about_ca_topic_score_gemma":0.0000027252518,"teacher_disagreement_score":0.9948138,"about_ca_system_score_codex":0.00012899902,"about_ca_system_score_gemma":0.00017363479,"threshold_uncertainty_score":0.9999874},"labels":[],"label_agreement":null},{"id":"W2163771711","doi":"10.1017/s1462399411001931","title":"Statins and myocardial remodelling: cell and molecular pathways","year":2011,"lang":"en","type":"review","venue":"Expert Reviews in Molecular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Leeds; Institute of Genetics; British Heart Foundation","keywords":"Heart failure; Medicine; Extracellular matrix; Prenylation; Statin; Fibroblast; Internal medicine; Cardiology; Pharmacology; Bioinformatics; Biology; Cell biology; Cell culture","score_opus":0.0643454891570115,"score_gpt":0.33522243616329817,"score_spread":0.2708769470062867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163771711","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029458857,0.9865619,0.00420255,0.00014048621,0.0002676073,0.004675992,0.000007871069,0.00004807211,0.00406606],"genre_scores_gemma":[0.000017001652,0.98966527,0.0069012693,0.0019616177,0.0005054132,0.0005443525,0.0001377877,0.00019128113,0.00007601548],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944636,0.0010265269,0.0018503468,0.0013043004,0.00067008607,0.00068513793],"domain_scores_gemma":[0.9970364,0.00007295781,0.0005135948,0.0016144009,0.00009045577,0.00067218946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026284046,0.0010498937,0.006612255,0.0004816522,0.00007127978,0.000018602499,0.00023743161,0.000609579,0.00006481719],"category_scores_gemma":[0.0003932702,0.0007172917,0.00088584376,0.0005483273,0.00030730906,0.00005416998,0.00019808213,0.0011271278,0.000025309233],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012906674,0.00007057232,0.0000016023153,0.030017143,0.00017819327,0.0010955589,0.0006332552,6.7914854e-8,0.0001375199,0.00040775994,0.0005085773,0.9669368],"study_design_scores_gemma":[0.0013996946,0.0004369993,0.0000019211866,0.04406786,0.0014069715,0.00077109784,0.000052498748,0.000009867853,0.000032079617,0.000104137696,0.9511498,0.0005670766],"about_ca_topic_score_codex":0.0002734541,"about_ca_topic_score_gemma":0.0000034736051,"teacher_disagreement_score":0.96636975,"about_ca_system_score_codex":0.0001566964,"about_ca_system_score_gemma":0.00035060005,"threshold_uncertainty_score":0.9995278},"labels":[],"label_agreement":null},{"id":"W2164103877","doi":"10.1373/clinchem.2009.126987","title":"Plasma PCSK9 Is Associated with Age, Sex, and Multiple Metabolic Markers in a Population-Based Sample of Children and Adolescents","year":2009,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Pfizer Canada; AstraZeneca Canada","keywords":"PCSK9; Internal medicine; Endocrinology; Body mass index; Population; Cholesterol; Insulin resistance; LDL receptor; Lipoprotein; Medicine; Kexin; Insulin","score_opus":0.016804655899340784,"score_gpt":0.2910573696571725,"score_spread":0.2742527137578317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164103877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991862,0.0002722501,0.000008681315,0.00015015667,0.000007716026,0.00026609257,0.000039381874,0.000017174552,0.000052320134],"genre_scores_gemma":[0.99897164,0.000060351766,0.0003159881,0.000417082,0.000062504725,0.0000025928132,0.00013059835,0.000010737009,0.00002853003],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988899,0.000048808015,0.00039325262,0.00028212095,0.00022291533,0.00016296758],"domain_scores_gemma":[0.9992836,0.00014297491,0.00011867186,0.00024578092,0.000035325094,0.00017363884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005193454,0.000117242285,0.0005449216,0.00001990277,0.000023921666,0.000006766177,0.000038149286,0.00017713578,0.000010205139],"category_scores_gemma":[0.00088331645,0.00009654254,0.0001013415,0.000119343036,0.000073270225,0.00001899835,0.00001367659,0.00024885839,1.8046745e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026445603,0.0002414169,0.9875751,0.000080866215,0.00008737005,0.000009640424,0.000012275206,0.0000020619418,0.0000838718,2.951419e-7,0.00002055261,0.011622066],"study_design_scores_gemma":[0.006949139,0.00010561899,0.9899733,0.0003396896,0.00011491899,0.000008294718,0.000009014815,0.00036152164,0.0019987514,0.000015045123,0.000028018654,0.00009670583],"about_ca_topic_score_codex":0.00022061118,"about_ca_topic_score_gemma":0.000020883494,"teacher_disagreement_score":0.01152536,"about_ca_system_score_codex":0.000019385943,"about_ca_system_score_gemma":0.00007069395,"threshold_uncertainty_score":0.39368907},"labels":[],"label_agreement":null},{"id":"W2164445076","doi":"10.1194/jlr.m200016-jlr200","title":"Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia","year":2002,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; McGill University; Thrombosis and Atherosclerosis Research Institute","funders":"National Center for Research Resources","keywords":"Internal medicine; Very low-density lipoprotein; Atorvastatin; Endocrinology; Hyperlipidemia; Apolipoprotein E; Chemistry; Triglyceride; Cholesterol; Apolipoprotein B; Lipoprotein; Medicine; Diabetes mellitus","score_opus":0.028241972394515463,"score_gpt":0.32395583815178874,"score_spread":0.29571386575727326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164445076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970901,0.0003316552,0.000004403848,0.0005247993,0.00016873874,0.00063350843,0.000002894524,0.0000039971137,0.0012398949],"genre_scores_gemma":[0.99884754,0.0001586017,0.00024024757,0.000045738474,0.00049275765,0.000009012921,0.0000015050441,0.000027082504,0.00017749796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953278,0.0011033247,0.0006044218,0.00015996053,0.0023975302,0.00040698992],"domain_scores_gemma":[0.9979507,0.00052915904,0.00021680298,0.00036280527,0.0006576839,0.00028290262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00628067,0.00013775821,0.00085767603,0.00064057077,0.0000538549,0.000012189183,0.00016284041,0.00009903537,0.00014601213],"category_scores_gemma":[0.0010365739,0.00008008879,0.00022821377,0.00063784036,0.00010421917,0.000090562724,0.000035443532,0.0011666929,0.000022344022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03723743,0.0038677887,0.64227223,0.0022671001,0.0013258605,0.0004110703,0.0012246934,0.00019559704,0.0015771965,0.0002292909,0.01279265,0.2965991],"study_design_scores_gemma":[0.057312407,0.049895544,0.85944384,0.002109553,0.00019086958,0.00011008132,0.00012788235,0.00038499536,0.016937848,0.000018833774,0.013225233,0.00024290914],"about_ca_topic_score_codex":0.000038757305,"about_ca_topic_score_gemma":0.0000028799575,"teacher_disagreement_score":0.29635617,"about_ca_system_score_codex":0.00014695794,"about_ca_system_score_gemma":0.00013001033,"threshold_uncertainty_score":0.5068765},"labels":[],"label_agreement":null},{"id":"W2164884234","doi":"10.1161/circgenetics.113.000099","title":"Clinical and Pharmacogenetic Predictors of Circulating Atorvastatin and Rosuvastatin Concentrations in Routine Clinical Care","year":2013,"lang":"en","type":"article","venue":"Circulation Cardiovascular Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Rosuvastatin; Atorvastatin; Pharmacogenetics; Medicine; Pharmacology; Internal medicine; Statin; Intensive care medicine; Genotype; Biology; Genetics","score_opus":0.03229371699196361,"score_gpt":0.32705573242371955,"score_spread":0.29476201543175595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164884234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9630987,0.029941732,0.004569049,0.000055631775,0.00026303154,0.0018415271,0.000015834858,0.000036166963,0.00017830795],"genre_scores_gemma":[0.9901575,0.0036318793,0.005474647,0.00012528394,0.0004367789,0.00006314536,0.000059841062,0.00004704198,0.0000038870567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99614906,0.00071184494,0.0014761636,0.00064403407,0.00067629473,0.00034258966],"domain_scores_gemma":[0.99811774,0.00014463073,0.00021092368,0.0006929928,0.00045565903,0.0003780753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018529415,0.00024975347,0.0010603792,0.00013658455,0.000088512345,0.000036626767,0.000069349626,0.00024415515,0.0000222381],"category_scores_gemma":[0.00029728116,0.00025144042,0.00071393634,0.0003177088,0.00035670243,0.00008876998,0.00007906979,0.00034675887,0.0000048662578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011134301,0.000053879165,0.83826816,0.0003092469,0.000736568,0.000013190351,0.00044386106,0.0014768328,0.0003232366,0.000021920561,0.000011193628,0.15833078],"study_design_scores_gemma":[0.0048043984,0.00013921614,0.9832196,0.00013014536,0.0007452097,0.00009897512,0.0006606767,0.009013608,0.00019268057,0.000035928835,0.0007415185,0.00021802644],"about_ca_topic_score_codex":0.0001491097,"about_ca_topic_score_gemma":0.000010127594,"teacher_disagreement_score":0.15811275,"about_ca_system_score_codex":0.000051001636,"about_ca_system_score_gemma":0.00026790443,"threshold_uncertainty_score":0.9999938},"labels":[],"label_agreement":null},{"id":"W2165214661","doi":"","title":"Are patients with hyperlipidemia undertreated? Study of patients admitted to hospital with coronary events.","year":2007,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Victoria General Hospital","funders":"","keywords":"Medicine; Acute coronary syndrome; Hyperlipidemia; Myocardial infarction; Unstable angina; Confidence interval; Internal medicine; Angina; Coronary artery disease; Retrospective cohort study; Coronary care unit; Emergency medicine; Diabetes mellitus","score_opus":0.01209280929001888,"score_gpt":0.21987814436509706,"score_spread":0.20778533507507818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165214661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289364,0.000035729376,0.000056324327,0.00007244148,0.00011411058,0.0064926473,0.000017048586,0.00005166956,0.0002664163],"genre_scores_gemma":[0.998724,0.0000017042188,0.0001030155,0.00028661103,0.000074559044,0.0005988636,0.000050236376,0.000048595586,0.000112404894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766636,0.000054726137,0.00035442488,0.00039338405,0.0010065639,0.00052454206],"domain_scores_gemma":[0.9982671,0.000024445177,0.0002258969,0.00056991284,0.00042867794,0.00048395552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038220838,0.0002210903,0.0005276497,0.00014737612,0.00006294319,0.000004898197,0.00009755879,0.00007501861,0.000008308451],"category_scores_gemma":[0.00009402066,0.00014507811,0.000077182536,0.00045327708,0.000028538303,0.000077510056,0.00004821882,0.00016291422,0.000004663414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018987579,0.0035102202,0.94163364,0.00005912617,0.00046211982,0.00004007196,0.0002274051,0.000008878429,1.2137599e-7,7.074979e-7,0.00008626228,0.05207269],"study_design_scores_gemma":[0.011199849,0.003860652,0.9834317,0.000060073715,0.00026812588,0.0000022315473,0.00068722543,4.5199243e-7,0.000032241725,0.0000010669382,0.0002720737,0.00018431101],"about_ca_topic_score_codex":0.00023546646,"about_ca_topic_score_gemma":0.00020916252,"teacher_disagreement_score":0.051888376,"about_ca_system_score_codex":0.0001970914,"about_ca_system_score_gemma":0.000046514488,"threshold_uncertainty_score":0.5916114},"labels":[],"label_agreement":null},{"id":"W2165412221","doi":"10.1016/s0140-6736(00)04257-4","title":"Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study","year":2001,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":315,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Acute coronary syndrome; Hazard ratio; Confounding; Observational study; Medical prescription; Internal medicine; Cardiology; Myocardial infarction; Confidence interval; Pharmacology","score_opus":0.1016237926992361,"score_gpt":0.36750468897447325,"score_spread":0.26588089627523714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165412221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99801826,0.0002426351,0.000011609101,0.0002957024,0.00011918602,0.0010272712,0.000013178864,0.00004312249,0.00022904678],"genre_scores_gemma":[0.9981715,0.0002013337,0.000017975077,0.00062767306,0.00076597685,0.00011883819,0.000012352085,0.000017391396,0.00006696683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987738,0.00022629547,0.00017092227,0.00017945636,0.00045894829,0.00019058079],"domain_scores_gemma":[0.99891186,0.000052481617,0.000047930404,0.0008907821,0.000036938123,0.00005998073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013011447,0.000120964876,0.00050287676,0.000022736656,0.000050256866,0.000010190129,0.00013728971,0.000038330807,0.000088610104],"category_scores_gemma":[0.000016581567,0.00006681263,0.00012914989,0.0001192887,0.00003364594,0.00006227265,0.000022539876,0.00016534417,0.0000115959965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003320814,0.00029200778,0.9823102,0.000055473938,0.00071533554,0.00016821809,0.000714804,0.000008785604,0.00030291826,0.000010096496,0.00005234259,0.012049034],"study_design_scores_gemma":[0.0032359383,0.0051112613,0.99037623,0.000056405224,0.00011642622,0.000059749662,0.00002230675,0.00001468201,0.0003002311,0.000014669211,0.0006267953,0.00006530543],"about_ca_topic_score_codex":0.00025388665,"about_ca_topic_score_gemma":0.000014965586,"teacher_disagreement_score":0.011983729,"about_ca_system_score_codex":0.000027965725,"about_ca_system_score_gemma":0.000032154014,"threshold_uncertainty_score":0.272454},"labels":[],"label_agreement":null},{"id":"W2165527478","doi":"10.14740/jocmr2178e","title":"Effect of Atorvastatin and Pioglitazone on Plasma Levels of Adhesion Molecules in Non-Diabetic Patients With Hypertension or Stable Angina or Both","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pioglitazone; Atorvastatin; Medicine; Internal medicine; Angina; Statin; Pharmacology; Urology; Endocrinology; Diabetes mellitus; Gastroenterology; Myocardial infarction; Type 2 diabetes","score_opus":0.15418842632338947,"score_gpt":0.4565116885140493,"score_spread":0.3023232621906598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165527478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772406,0.00049260084,0.000033894106,0.0007135835,0.00010863221,0.00074487255,0.0000047847834,0.0000022772647,0.00017532484],"genre_scores_gemma":[0.9982962,0.00041266673,0.0008438767,0.0000657119,0.0002748054,0.000004875091,0.0000017186663,0.000021505242,0.000078628895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99405235,0.0013331919,0.001408423,0.00021897478,0.0026462711,0.00034079884],"domain_scores_gemma":[0.99375653,0.003525642,0.0004474799,0.00034224463,0.001326034,0.000602063],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01918378,0.00015056362,0.0016978731,0.0005006729,0.000027019592,0.0000037078605,0.00012079584,0.00014594001,0.000039819617],"category_scores_gemma":[0.0149152065,0.000065677385,0.00012377343,0.00059226697,0.000387718,0.00007243721,0.00005951024,0.00091220334,0.0000015359186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12739898,0.0024193116,0.5344492,0.004146012,0.00052395475,0.0015282959,0.00057476625,0.00001956402,0.0015411727,0.000015722422,0.0023978464,0.32498515],"study_design_scores_gemma":[0.05272441,0.20062554,0.729843,0.009009968,0.00022499017,0.00012687448,0.00053202355,0.00036790594,0.0060717543,0.000025506659,0.00033827272,0.000109753484],"about_ca_topic_score_codex":0.00016216117,"about_ca_topic_score_gemma":0.000015023303,"teacher_disagreement_score":0.32487538,"about_ca_system_score_codex":0.00007554118,"about_ca_system_score_gemma":0.0008322877,"threshold_uncertainty_score":0.9933826},"labels":[],"label_agreement":null},{"id":"W2165624352","doi":"10.1093/eurheartj/eht273","title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society","year":2013,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2737,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute; Novo Nordisk Fonden; Kowa Company; Regeneron Pharmaceuticals; Sanofi; AstraZeneca; British Heart Foundation; F. Hoffmann-La Roche; Amgen","keywords":"Medicine; Coronary heart disease; Statement (logic); Population; Intensive care medicine; Consensus conference; Disease; Atherosclerotic cardiovascular disease; Internal medicine; Cardiology; Environmental health","score_opus":0.05715482428218869,"score_gpt":0.32552574737395756,"score_spread":0.26837092309176885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165624352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728795,0.0005256954,0.00011285308,0.024481429,0.00015069202,0.00165458,0.000031826046,0.000012288111,0.00015112113],"genre_scores_gemma":[0.98278725,0.00016113954,0.0013434354,0.01494175,0.00049306505,0.00002094764,0.000006773086,0.000045094308,0.00020051487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687415,0.001548532,0.00059832545,0.00024893697,0.00043352498,0.0002965316],"domain_scores_gemma":[0.99896526,0.00009243057,0.00013207197,0.00045585216,0.00011934442,0.00023501768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027364474,0.00016480261,0.000295542,0.000030330613,0.0002737374,0.00006436721,0.00014172593,0.000025076783,0.000017672884],"category_scores_gemma":[0.000083839725,0.000098148776,0.00036328158,0.00013297,0.000076572214,0.000050875027,0.00007921752,0.0002887217,0.000011221201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024240397,0.0006079021,0.85766387,0.00023706604,0.0002612454,0.000031915602,0.0033279157,0.00032775733,0.003926827,0.000021764079,0.120283335,0.013067989],"study_design_scores_gemma":[0.0017579491,0.00033163972,0.98801166,0.00031821837,0.000081503305,0.00014510223,0.00039714546,0.000100549216,0.00003997945,0.000038641407,0.008677571,0.00010005933],"about_ca_topic_score_codex":0.00014135892,"about_ca_topic_score_gemma":0.000015282783,"teacher_disagreement_score":0.13034776,"about_ca_system_score_codex":0.00009867469,"about_ca_system_score_gemma":0.00010206608,"threshold_uncertainty_score":0.40023908},"labels":[],"label_agreement":null},{"id":"W2165692718","doi":"10.1681/asn.2012080870","title":"Association between LDL-C and Risk of Myocardial Infarction in CKD","year":2013,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Provincial Laboratory of Public Health; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Myocardial infarction; Internal medicine; Hazard ratio; Renal function; Kidney disease; Cardiology; Proportional hazards model; Population; Confidence interval; Cohort; Incidence (geometry)","score_opus":0.008744125372053938,"score_gpt":0.2506266100747258,"score_spread":0.24188248470267187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165692718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926857,0.00031838138,0.000102857004,0.006642137,0.000049201783,0.00016468205,0.0000031658744,0.0000017849412,0.000032102744],"genre_scores_gemma":[0.99423975,0.0027555581,0.0012781834,0.0012992173,0.0004009198,0.000001908565,4.0731197e-7,0.000006424628,0.000017613436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880344,0.00027313357,0.00041192202,0.00006451629,0.0003158526,0.0001311428],"domain_scores_gemma":[0.99814016,0.00012737466,0.0013217006,0.0001482307,0.00021094308,0.000051583404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001144,0.00006246657,0.0006035873,0.000042691496,0.000027563996,0.0000024468952,0.00006794478,0.000075332624,0.000008530302],"category_scores_gemma":[0.00011825589,0.000041795058,0.00058363436,0.00020795607,0.00019797261,0.000056182696,0.000036026362,0.00035546144,5.8761236e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006316771,0.000036557904,0.9563412,0.000032446143,0.00195541,2.711007e-7,0.00051976024,0.000017449984,0.007912559,0.0000016971594,0.005788548,0.027330946],"study_design_scores_gemma":[0.0010335692,0.0005789094,0.9935114,0.000023119528,0.00048468055,0.000031964442,0.00048303025,0.000033716602,0.00017753216,0.00018284858,0.003428998,0.000030232297],"about_ca_topic_score_codex":0.0028316777,"about_ca_topic_score_gemma":0.000011668421,"teacher_disagreement_score":0.037170213,"about_ca_system_score_codex":0.00011317949,"about_ca_system_score_gemma":0.00010061403,"threshold_uncertainty_score":0.42806685},"labels":[],"label_agreement":null},{"id":"W2165791625","doi":"10.1093/eurheartj/ehu274","title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","year":2014,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1053,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novo Nordisk Fonden; British Heart Foundation; Ontario Genomics Institute; Ontario Genomics; Regeneron Pharmaceuticals; F. Hoffmann-La Roche; Genome Canada; Canadian Institutes of Health Research; Danone; National Heart, Lung, and Blood Institute; Pfizer; Heart and Stroke Foundation of Canada; Valeant Pharmaceuticals International; Kowa Company; Sanofi; Amgen; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Position paper; Familial hypercholesterolemia; Position (finance); Atherosclerotic cardiovascular disease; Intensive care medicine; Internal medicine; Pathology; Cholesterol; Disease","score_opus":0.044206965458717724,"score_gpt":0.2913438002459289,"score_spread":0.24713683478721116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165791625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916367,0.00027911528,0.0021341576,0.0034198076,0.00075436773,0.0010441688,0.00002499629,0.000029214772,0.00067749125],"genre_scores_gemma":[0.98004097,0.00048891106,0.001995712,0.013898943,0.0033600065,0.0000055570476,0.0000026281955,0.00007431906,0.0001329313],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9962093,0.0018574042,0.0007331607,0.00047344342,0.0004215345,0.00030512727],"domain_scores_gemma":[0.99837846,0.00030114345,0.00022661168,0.0006387095,0.0001225103,0.0003325634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035895617,0.00024260745,0.0004452282,0.00003367739,0.0005131406,0.00010996901,0.00019098932,0.0000941915,0.0000018258447],"category_scores_gemma":[0.00026271315,0.00014613497,0.00051707367,0.0001053735,0.00018421392,0.00007050359,0.00016329673,0.0007946309,0.0000115983885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019348789,0.00037970234,0.032987535,0.00019026849,0.0009505761,0.000046788577,0.0031878762,0.000028381854,0.07884594,0.000038130987,0.009317832,0.87209207],"study_design_scores_gemma":[0.005177798,0.0015523903,0.9627278,0.00048034353,0.0003813201,0.00032901595,0.00033161434,0.00009970494,0.00023912136,0.00004823427,0.028471636,0.00016104148],"about_ca_topic_score_codex":0.00008569408,"about_ca_topic_score_gemma":0.00004687555,"teacher_disagreement_score":0.92974025,"about_ca_system_score_codex":0.000057935118,"about_ca_system_score_gemma":0.00005114463,"threshold_uncertainty_score":0.5959211},"labels":[],"label_agreement":null},{"id":"W2165802538","doi":"10.1136/heartjnl-2012-302917","title":"Effectiveness of alternative strategies to define index case phenotypes to aid genetic diagnosis of familial hypercholesterolaemia","year":2012,"lang":"en","type":"article","venue":"Heart","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Atheroma","score_opus":0.020487673042044716,"score_gpt":0.2990179384922977,"score_spread":0.27853026545025295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165802538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628633,0.000807827,0.0014314613,0.000091508475,0.00017079861,0.0009573905,0.000022060562,0.000014823895,0.00021779678],"genre_scores_gemma":[0.9976535,0.000030980493,0.0016783486,0.00020657782,0.00024575822,0.00015302807,0.0000027954763,0.000021776988,0.000007270053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987885,0.00018728255,0.00024148324,0.00018479863,0.00032467552,0.00027326474],"domain_scores_gemma":[0.9990491,0.00010652213,0.00003620332,0.0003760806,0.00015229778,0.0002797927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005909612,0.00012977596,0.00049155165,0.00011768308,0.000029080928,0.000005903314,0.000049425358,0.000066502165,0.000022938206],"category_scores_gemma":[0.00010037567,0.000108905995,0.00013948177,0.00021180953,0.00003758829,0.00007509393,0.00005440814,0.00010518552,0.000025250169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011841169,0.0006266198,0.94075686,0.0023799478,0.00037268872,0.00016903986,0.002951867,0.00069619925,0.02786638,0.00025184333,0.00016254796,0.022581877],"study_design_scores_gemma":[0.0012111986,0.00087910023,0.92557293,0.00037163985,0.00011127523,0.0004946528,0.00038214863,0.000008395955,0.06969145,0.000033037082,0.0011263209,0.00011782242],"about_ca_topic_score_codex":0.003781359,"about_ca_topic_score_gemma":0.00007679731,"teacher_disagreement_score":0.04182507,"about_ca_system_score_codex":0.00006022477,"about_ca_system_score_gemma":0.00010221464,"threshold_uncertainty_score":0.5716309},"labels":[],"label_agreement":null},{"id":"W2165828459","doi":"10.1136/thoraxjnl-2012-201823","title":"Statins and the risk of interstitial lung disease: a cohort study","year":2013,"lang":"en","type":"article","venue":"Thorax","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital","funders":"Canadian Institutes of Health Research; McGill University","keywords":"Medicine; Cohort; Incidence (geometry); Confounding; Cohort study; Interstitial lung disease; Statin; Internal medicine; Disease; Lung","score_opus":0.006161315819891349,"score_gpt":0.2637377541740236,"score_spread":0.2575764383541323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165828459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473333,0.0011468546,0.00054340746,0.0003566899,0.00005424458,0.0022165321,0.000009924009,0.000016256665,0.0009227826],"genre_scores_gemma":[0.99915546,0.00021568705,0.00008553815,0.000089622816,0.000117293246,0.00012796349,0.0000035171338,0.000008864317,0.00019607376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991615,0.00019348082,0.00015023285,0.0001252528,0.00026653009,0.000103046266],"domain_scores_gemma":[0.99936,0.000042824315,0.00005237448,0.00036667543,0.00006654562,0.000111554786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007593376,0.00006660359,0.0002578499,0.000022570228,0.00005278408,0.000011373124,0.000042309326,0.000015146102,0.00011130307],"category_scores_gemma":[0.00012016834,0.000035647325,0.0000885003,0.000060434566,0.00011094598,0.0000318158,0.000044077653,0.00010862785,0.000009521933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052873587,0.00019093911,0.97059625,0.00016569864,0.00073910784,0.000015209761,0.0014890579,0.000002398727,0.000016317672,0.00026898563,0.0008906205,0.02509667],"study_design_scores_gemma":[0.0025152885,0.00014173445,0.9944452,0.00003736477,0.0007015704,0.0000051740053,0.00088158,0.0008558871,0.000012458178,0.00013961567,0.00022077363,0.000043335593],"about_ca_topic_score_codex":0.0029965392,"about_ca_topic_score_gemma":0.000029518244,"teacher_disagreement_score":0.025053335,"about_ca_system_score_codex":0.000015461852,"about_ca_system_score_gemma":0.00005007397,"threshold_uncertainty_score":0.45298907},"labels":[],"label_agreement":null},{"id":"W2166280499","doi":"10.1373/clinchem.2014.225946","title":"Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9): Lessons Learned from Patients with Hypercholesterolemia","year":2014,"lang":"en","type":"review","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"PCSK9; Kexin; Proprotein convertase; Subtilisin; Familial hypercholesterolemia; Medicine; Internal medicine; Endocrinology; Cholesterol; LDL receptor; Chemistry; Biochemistry; Lipoprotein; Enzyme","score_opus":0.1318128230743596,"score_gpt":0.4097449191305346,"score_spread":0.277932096056175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166280499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027606493,0.9682616,0.000017123199,0.00027924063,0.00030851542,0.0022073952,0.0002599234,0.00015983601,0.00089989783],"genre_scores_gemma":[0.0015738965,0.98918617,0.00036019302,0.00042177326,0.0022133263,0.00017769175,0.0040782983,0.00022661207,0.0017620417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99515134,0.00036515496,0.0016191895,0.0014298111,0.00086556445,0.00056891306],"domain_scores_gemma":[0.99534345,0.0003329937,0.00068132003,0.0024646532,0.0003595285,0.0008180654],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0011124355,0.00075681775,0.004391058,0.000035291723,0.00009173111,0.000053010444,0.00043254785,0.0015703805,0.00035360112],"category_scores_gemma":[0.0012226801,0.00051031425,0.0014113549,0.00022730566,0.00032277685,0.000044953245,0.00018034392,0.0024442924,0.0004230312],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026692418,0.00048336788,0.0016497425,0.021058727,0.0008328273,0.00007402524,0.0000055492665,3.7721215e-8,0.0000014454289,0.0000010654393,0.00070665753,0.9749196],"study_design_scores_gemma":[0.003354223,0.00035814286,0.000402843,0.016558867,0.0029817303,0.000024600871,0.000005167329,0.0000016461578,0.000054659118,0.000013402196,0.9756851,0.0005596274],"about_ca_topic_score_codex":0.000071454466,"about_ca_topic_score_gemma":0.000004287705,"teacher_disagreement_score":0.97497845,"about_ca_system_score_codex":0.00018782928,"about_ca_system_score_gemma":0.0014726712,"threshold_uncertainty_score":0.9998571},"labels":[],"label_agreement":null},{"id":"W2166344883","doi":"10.1194/jlr.p800061-jlr200","title":"Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia","year":2009,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Heart and Stroke Foundation of Canada","keywords":"Simvastatin; Apolipoprotein B; Ezetimibe; Endocrinology; Chemistry; Internal medicine; Hyperlipidemia; Very low-density lipoprotein; Triglyceride; Cholesterol; Placebo; Pharmacology; Medicine; Lipoprotein","score_opus":0.027314254880433035,"score_gpt":0.3387878557750659,"score_spread":0.3114736008946329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166344883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204266,0.0037368715,0.000054502078,0.0028513372,0.00006883952,0.0006713498,0.0000011640199,0.0000046053374,0.00056866603],"genre_scores_gemma":[0.99514276,0.0009637323,0.0027476368,0.000169208,0.0008218794,0.000008537571,5.7420954e-7,0.0000190922,0.00012660425],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99655765,0.0006572312,0.0005502038,0.00019062814,0.0016130969,0.00043118952],"domain_scores_gemma":[0.9983367,0.00039481546,0.00019290257,0.00028038275,0.00047776016,0.00031748545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047219335,0.00014614002,0.0008167748,0.0007162878,0.000056240267,0.00001859384,0.00013132741,0.00011243152,0.000013171195],"category_scores_gemma":[0.0009235339,0.00009100131,0.00015783258,0.00055329874,0.00014380971,0.00009552824,0.000027968841,0.0010928195,0.0000027368515],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016812718,0.003268444,0.019197695,0.004733991,0.0009935787,0.0030017227,0.0024131362,0.00031072905,0.1848568,0.0026494158,0.0030185468,0.7587432],"study_design_scores_gemma":[0.010284971,0.008962262,0.8573976,0.0027583968,0.00011440185,0.0006202679,0.00043028517,0.00007654878,0.113267966,0.00040572486,0.005498932,0.00018261741],"about_ca_topic_score_codex":0.00011818205,"about_ca_topic_score_gemma":0.0000131863035,"teacher_disagreement_score":0.8381999,"about_ca_system_score_codex":0.00008506768,"about_ca_system_score_gemma":0.00038665536,"threshold_uncertainty_score":0.47478178},"labels":[],"label_agreement":null},{"id":"W2166726135","doi":"10.1186/1476-511x-10-146","title":"Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients","year":2011,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Ezetimibe; Medicine; Statin; Internal medicine; Apolipoprotein B; Placebo; Clinical nutrition; Lipidology; Gastroenterology; Clinical chemistry; Odds ratio; Endocrinology; Cholesterol","score_opus":0.024380632228223547,"score_gpt":0.30307483968087456,"score_spread":0.278694207452651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166726135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946447,0.0015416503,0.0006301499,0.0011135632,0.00007962479,0.001459141,0.00044783644,0.000034629895,0.000048727397],"genre_scores_gemma":[0.9799757,0.0005838716,0.0024839274,0.016060289,0.00005378178,0.00018111352,0.00016962657,0.000037065223,0.00045464176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684185,0.0008377121,0.00084752147,0.0004832492,0.00047644155,0.0005132396],"domain_scores_gemma":[0.996672,0.00019840692,0.00019690994,0.000624751,0.00009976261,0.0022082094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016209611,0.00022368133,0.0009482771,0.000497655,0.000086968364,0.000008285661,0.000093357026,0.00007304522,0.00022408772],"category_scores_gemma":[0.0011511521,0.00017671312,0.00019446501,0.0009711256,0.0000560432,0.000060771712,0.000039611776,0.00018392575,0.000004643286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.097307675,0.0017591006,0.7687673,0.0021570816,0.0011853311,0.000055187462,0.016636966,0.000103759856,0.00007177494,0.000053057058,0.009942885,0.10195989],"study_design_scores_gemma":[0.013562452,0.004870409,0.9622752,0.0004383206,0.001028166,0.0000019058259,0.0019493256,0.0027768675,0.000062174586,0.00011459083,0.012446527,0.0004740311],"about_ca_topic_score_codex":0.002762716,"about_ca_topic_score_gemma":0.00007887992,"teacher_disagreement_score":0.19350794,"about_ca_system_score_codex":0.0001876465,"about_ca_system_score_gemma":0.001479104,"threshold_uncertainty_score":0.7206152},"labels":[],"label_agreement":null},{"id":"W2166790944","doi":"10.2174/157016110793563825","title":"Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia","year":2010,"lang":"en","type":"review","venue":"Current Vascular Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Orlistat; Medicine; Rimonabant; Internal medicine; Endocrinology; Statin; Overweight; Niacin; Metabolic syndrome; Sibutramine; Lipid profile; Obesity; Lipoprotein; Pharmacology; Weight loss; Cholesterol; Antagonist; Receptor","score_opus":0.011373107795417106,"score_gpt":0.33457398616706296,"score_spread":0.32320087837164585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166790944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40089768,0.59318817,0.00003929434,0.00000619143,0.0020129008,0.0037515445,0.000033637298,0.000028458508,0.000042116164],"genre_scores_gemma":[0.020899959,0.97758573,0.000041274932,0.00002127262,0.00066723686,0.00039579836,0.0002851147,0.0000978271,0.0000057588936],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966506,0.0007341975,0.00074470235,0.00076395465,0.0005753652,0.0005312097],"domain_scores_gemma":[0.99822813,0.00027359728,0.00044237793,0.0006293527,0.00013304685,0.00029349522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014811568,0.00063255784,0.0033024617,0.00052878365,0.00009724782,0.000011985276,0.00017346292,0.00042858,0.000060021815],"category_scores_gemma":[0.000071326234,0.00045481353,0.0008155091,0.00047437922,0.00014897609,0.00007000569,0.00011732017,0.0020134083,0.000023514342],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013569651,0.00065863907,0.0031346267,0.03977433,0.0007452244,0.000015222953,0.000045208497,0.0000028180632,0.000011910031,0.0000012275045,0.00012609603,0.955349],"study_design_scores_gemma":[0.014296254,0.0021101085,0.016980793,0.016392853,0.009215481,0.00003244523,0.0000056087615,0.000021915514,0.00044777495,3.7291053e-7,0.9397643,0.00073209684],"about_ca_topic_score_codex":0.000036418907,"about_ca_topic_score_gemma":0.000005120199,"teacher_disagreement_score":0.9546169,"about_ca_system_score_codex":0.00021613346,"about_ca_system_score_gemma":0.0003664785,"threshold_uncertainty_score":0.9997904},"labels":[],"label_agreement":null},{"id":"W2166900112","doi":"10.1161/atvbaha.115.306172","title":"Association of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) With Cardiovascular Risk in Primary Prevention","year":2015,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Pfizer Canada; Alberta Innovates; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Kexin; PCSK9; Proprotein convertase; Subtilisin; Medicine; Proprotein Convertases; Primary prevention; Evolocumab; Internal medicine; LDL receptor; Endocrinology; Cholesterol; Disease; Biology; Lipoprotein; Biochemistry; Enzyme","score_opus":0.03444687818941301,"score_gpt":0.2684118075212237,"score_spread":0.23396492933181068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166900112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965439,0.0012557802,0.00051858526,0.00019595049,0.00010295235,0.0011688116,0.000015072272,0.0000346096,0.00016432861],"genre_scores_gemma":[0.99471503,0.003589629,0.0012640407,0.0001144849,0.0000897966,0.0000884721,0.00009253403,0.00003183473,0.000014155759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976092,0.00058403466,0.00046813098,0.00050330727,0.00047336722,0.00036195046],"domain_scores_gemma":[0.99854714,0.000028400238,0.00023694802,0.0006881245,0.00030944418,0.00018992073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024675739,0.00023825568,0.0010613948,0.00015239335,0.000059638278,0.000016572649,0.0000789002,0.00028438168,0.000018168757],"category_scores_gemma":[0.00015410662,0.00018302118,0.00038511443,0.00032244434,0.00011648583,0.00011549807,0.00006140266,0.00024108033,0.000008918185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008251394,0.0003572137,0.9824999,0.00026055568,0.002442276,5.790313e-7,0.00042489092,0.000014677957,0.0076263295,0.000041339557,0.0000594215,0.0061903344],"study_design_scores_gemma":[0.005504309,0.0017891616,0.98690224,0.00022513232,0.00087025797,0.0000025060879,0.00016192936,0.000042053947,0.0008416607,0.000060998944,0.0033891785,0.00021056391],"about_ca_topic_score_codex":0.0014691664,"about_ca_topic_score_gemma":0.00024321229,"teacher_disagreement_score":0.0067846687,"about_ca_system_score_codex":0.00022576915,"about_ca_system_score_gemma":0.0002509718,"threshold_uncertainty_score":0.7463387},"labels":[],"label_agreement":null},{"id":"W2166934777","doi":"10.1210/jc.2015-1520","title":"Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial","year":2015,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":221,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Université de Montréal","funders":"Amarin Corporation; Ipsen; Regeneron Pharmaceuticals; Eisai; Daiichi Sankyo Europe; Sanofi; Genentech; Bristol-Myers Squibb; AstraZeneca; Daiichi-Sankyo; Amgen; Pfizer","keywords":"Alirocumab; Atorvastatin; PCSK9; Ezetimibe; Rosuvastatin; Medicine; Pharmacology; Regimen; Internal medicine; Statin; Urology; Cholesterol; Apolipoprotein B; Lipoprotein; LDL receptor","score_opus":0.13736516701518553,"score_gpt":0.44899707666682553,"score_spread":0.31163190965164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166934777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710103,0.0039906595,0.0005806521,0.011478281,0.005674857,0.0020078975,0.000008626537,0.0000389049,0.005209785],"genre_scores_gemma":[0.9664902,0.0070768436,0.002520369,0.005315993,0.017073438,0.00013060065,0.0000047750186,0.00007936563,0.0013083973],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99331385,0.003119323,0.0020049177,0.00025183044,0.00081158394,0.0004985203],"domain_scores_gemma":[0.99518126,0.0020814675,0.0007673869,0.00078007893,0.0004504915,0.00073928403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005975616,0.00029601026,0.0026369826,0.00018024459,0.0000993231,0.000028509266,0.00030484577,0.00017090047,0.00022779137],"category_scores_gemma":[0.0043813,0.00015079201,0.0015356588,0.00018926377,0.00031498086,0.00010007636,0.00005172009,0.0007738237,0.00025418933],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9445079,0.0007558228,0.0000055437363,0.0000053291983,0.0024773146,0.000088751156,0.0005687975,0.0001458107,0.000018444793,0.008716271,0.0017203073,0.040989704],"study_design_scores_gemma":[0.7287447,0.007948002,0.00020947811,0.000033742188,0.0022692813,0.00030223475,0.0009866239,0.00000767685,0.00014616613,0.0009463197,0.25829116,0.00011465918],"about_ca_topic_score_codex":0.0004148121,"about_ca_topic_score_gemma":0.00003269148,"teacher_disagreement_score":0.25657085,"about_ca_system_score_codex":0.00009092382,"about_ca_system_score_gemma":0.001603,"threshold_uncertainty_score":0.614912},"labels":[],"label_agreement":null},{"id":"W2167045683","doi":"10.1056/nejmoa0804602","title":"Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1622,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Ezetimibe; Simvastatin; Internal medicine; Cardiology; Hazard ratio; Stenosis; Myocardial infarction; Aortic valve replacement; Placebo; Unstable angina; Percutaneous coronary intervention; Surgery; Statin; Confidence interval","score_opus":0.019022644188249428,"score_gpt":0.2563299669981456,"score_spread":0.23730732280989617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167045683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98932934,0.0025244933,0.0010371563,0.0064321766,0.00015881273,0.00017398866,3.4683111e-7,0.000006987928,0.00033670818],"genre_scores_gemma":[0.99251133,0.0032246718,0.00089001487,0.0011742151,0.0020718456,0.0000012159437,0.0000011379336,0.00001769069,0.000107881344],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986123,0.00005226528,0.00045781548,0.00012706297,0.00054827175,0.00020227885],"domain_scores_gemma":[0.99887836,0.00009765532,0.00017825134,0.0001547449,0.00031763263,0.000373338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007273315,0.00013460164,0.0006756346,0.00023828553,0.000037226597,0.0000032750338,0.000045166104,0.000044308857,0.00005776748],"category_scores_gemma":[0.00043416885,0.00007648681,0.00005730681,0.00021564784,0.00012511983,0.00006876785,0.000013877029,0.0004123527,0.0000010112956],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045908038,0.00014627242,0.36229405,0.0003931928,0.00057814375,0.0098208375,0.0128284125,0.00011082707,0.0030721135,0.000018947178,0.0036941185,0.6024523],"study_design_scores_gemma":[0.14371122,0.009809818,0.7885677,0.00471434,0.0005951899,0.035094887,0.0032527274,0.00012659632,0.0011141639,0.000101392325,0.012622373,0.00028957042],"about_ca_topic_score_codex":0.00034990502,"about_ca_topic_score_gemma":0.00003311618,"teacher_disagreement_score":0.6021627,"about_ca_system_score_codex":0.000050911316,"about_ca_system_score_gemma":0.00023244222,"threshold_uncertainty_score":0.31190416},"labels":[],"label_agreement":null},{"id":"W2167206949","doi":"10.1016/j.jval.2010.10.033","title":"The Association between Statin use and Outcomes Potentially Attributable to an Unhealthy Lifestyle in Older Adults","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; Canadian Institutes of Health Research","keywords":"Medicine; Statin; Hazard ratio; Adverse effect; Incidence (geometry); Proportional hazards model; Regimen; Physical therapy; Gerontology; Internal medicine; Confidence interval","score_opus":0.04563419773232072,"score_gpt":0.2963434746695832,"score_spread":0.2507092769372625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167206949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99210536,0.0006217912,0.00017317054,0.0049603074,0.00014944308,0.0018785816,0.000031096944,0.00003609958,0.000044125372],"genre_scores_gemma":[0.9946118,0.00071934133,0.0022957898,0.001989628,0.00013298061,0.00006848688,0.00002652266,0.00002891309,0.00012653868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703115,0.00074168434,0.00068387866,0.00035348596,0.00051080395,0.00067898445],"domain_scores_gemma":[0.9985126,0.00028169068,0.00018712849,0.00044659237,0.0001103886,0.00046154583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005016353,0.0001489211,0.0005524832,0.00016364567,0.00017184303,0.000036566744,0.00008894316,0.0001228294,0.0000059780486],"category_scores_gemma":[0.0006766746,0.00011079598,0.000062732805,0.00037338395,0.00001611361,0.00017323121,0.000035994566,0.00034912696,0.000010526111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115141185,0.00012692477,0.9703948,0.00022076408,0.000030765033,0.000009155722,0.0032749344,0.00002296155,9.3229664e-7,0.00017744189,0.000082409155,0.025543807],"study_design_scores_gemma":[0.0021216704,0.0005495804,0.99467856,0.00027286925,0.000015333544,0.0000038672483,0.00044039148,0.000112932,0.0000150276555,0.000097873846,0.0015912127,0.00010066041],"about_ca_topic_score_codex":0.12222059,"about_ca_topic_score_gemma":0.0049264147,"teacher_disagreement_score":0.11729418,"about_ca_system_score_codex":0.0006039795,"about_ca_system_score_gemma":0.00059367093,"threshold_uncertainty_score":0.8836246},"labels":[],"label_agreement":null},{"id":"W2167830683","doi":"10.1016/j.cll.2006.07.007","title":"Apolipoprotein A1 and B","year":2006,"lang":"en","type":"review","venue":"Clinics in Laboratory Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Lipoprotein; Medicine; Internal medicine; Apolipoprotein C2; Cholesterol; Lipoprotein(a); Endocrinology; Very low-density lipoprotein","score_opus":0.0559453600169334,"score_gpt":0.39688861339880926,"score_spread":0.34094325338187587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167830683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000087110995,0.9942207,0.000016140968,0.00027021318,0.0007334841,0.0022851224,0.00005550645,0.00008084679,0.0022509259],"genre_scores_gemma":[0.000016185099,0.99432546,0.00030404484,0.0006922194,0.0035384684,0.00023577239,0.00021874743,0.00013265117,0.0005364758],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995687,0.0004324343,0.0018074703,0.0008470388,0.0007078252,0.0005182293],"domain_scores_gemma":[0.9972788,0.00028467644,0.00048246694,0.0013507716,0.000203065,0.00040022386],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003488702,0.0006230136,0.004757294,0.00055306696,0.00006408407,0.000011538481,0.00018472361,0.00092616223,0.00008241933],"category_scores_gemma":[0.00092819094,0.00043970346,0.00037479287,0.0011702443,0.0004379948,0.000050791707,0.0000980581,0.0016337798,0.00004794975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013611712,0.00008817091,0.000086052,0.03501762,0.0001562028,0.00041018962,0.0000273265,4.963679e-8,1.430535e-7,0.0004220154,0.002365546,0.9614131],"study_design_scores_gemma":[0.0018622787,0.0003801661,0.00012399335,0.033808332,0.0013809127,0.00014418978,0.000028697546,0.0000022169909,2.1459535e-7,0.00008141885,0.9618554,0.00033214036],"about_ca_topic_score_codex":0.00018920017,"about_ca_topic_score_gemma":0.00004722424,"teacher_disagreement_score":0.9610809,"about_ca_system_score_codex":0.00027117552,"about_ca_system_score_gemma":0.0015063504,"threshold_uncertainty_score":0.99980545},"labels":[],"label_agreement":null},{"id":"W2168103583","doi":"10.25011/cim.v33i5.14357","title":"Effects of statin use on total oxidant and antoxidant capacity and ceruloplasmin activity","year":2010,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Medicine; Ceruloplasmin; Antioxidant capacity; Statin; Coronary artery disease; Internal medicine; Oxidative stress; Antioxidant; Gastroenterology; Pharmacology; Endocrinology; Cardiology; Biochemistry; Chemistry","score_opus":0.08904232113867684,"score_gpt":0.32141080523425763,"score_spread":0.2323684840955808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168103583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455917,0.00028571105,0.000045015713,0.004130804,0.0002461922,0.00061939086,0.000010046276,0.000019350997,0.00008430358],"genre_scores_gemma":[0.99695116,0.00058931403,0.0011171818,0.0008745196,0.00035128207,0.000013286689,0.0000030347203,0.000014233828,0.00008596504],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99838716,0.00022878339,0.00042878435,0.0004274934,0.0003240388,0.0002037629],"domain_scores_gemma":[0.9979667,0.000822858,0.0001591115,0.00025970646,0.000100535406,0.00069109735],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0010231414,0.00020717226,0.0008900457,0.000065502085,0.00007674828,0.000007755445,0.000029545485,0.00016155385,0.000009642255],"category_scores_gemma":[0.004748099,0.00012775582,0.00007015887,0.00010760247,0.0070960717,0.000106671774,0.000060414404,0.00075060944,9.3754517e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000883166,0.00072645035,0.29717,0.0028783805,0.0004999954,0.00019530069,0.0020431867,1.3964714e-7,0.5574634,0.007745924,0.0005403331,0.12985368],"study_design_scores_gemma":[0.0044933986,0.003261935,0.9444862,0.0006169466,0.00020394851,0.00011959378,0.00006250672,0.000104897874,0.04450247,0.0015321972,0.0004868533,0.00012906584],"about_ca_topic_score_codex":0.0005853961,"about_ca_topic_score_gemma":0.000048968104,"teacher_disagreement_score":0.64731616,"about_ca_system_score_codex":0.000006989034,"about_ca_system_score_gemma":0.00007288399,"threshold_uncertainty_score":0.99560606},"labels":[],"label_agreement":null},{"id":"W2168135916","doi":"10.25011/cim.v32i4.6619","title":"Effect of simvastatin on plasma interleukin-6 in patients with unstable angina","year":2009,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Simvastatin; Placebo; Unstable angina; Medicine; Internal medicine; Angina; Gastroenterology; Cardiology; Myocardial infarction","score_opus":0.039862718601534154,"score_gpt":0.3182521209406227,"score_spread":0.27838940233908854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168135916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933377,0.00012774166,0.000012740201,0.0040844064,0.00007639526,0.0006698508,0.0000029646885,0.000014582469,0.0016736551],"genre_scores_gemma":[0.997574,0.00003209441,0.0001877336,0.0019511068,0.00013194492,0.0000075836138,0.00002514006,0.0000097582015,0.00008069489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983448,0.00027114598,0.00052192324,0.00029920132,0.0003669059,0.00019606498],"domain_scores_gemma":[0.9990053,0.00023761494,0.00012841917,0.00025017705,0.000093835995,0.0002846395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013300604,0.00017378955,0.0008860939,0.000106189924,0.00002412992,0.0000020575646,0.00004724907,0.0000817464,0.000022138485],"category_scores_gemma":[0.0012228736,0.00009129024,0.00007110572,0.0002650744,0.0018405702,0.000051896768,0.000013791853,0.00036659738,0.0000032685202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025852174,0.00035572375,0.8241427,0.00026487795,0.00009797871,0.000034354754,0.0002752769,0.0000047849226,0.000056871573,0.0011226664,0.0006568366,0.1704027],"study_design_scores_gemma":[0.015982943,0.056768868,0.92215383,0.0020041396,0.000107051485,0.0000025124232,0.000042213083,0.000075899196,0.0013196567,0.00055236206,0.00088989036,0.00010063425],"about_ca_topic_score_codex":0.00006309589,"about_ca_topic_score_gemma":0.0000056704635,"teacher_disagreement_score":0.17030208,"about_ca_system_score_codex":0.000022610733,"about_ca_system_score_gemma":0.00007021998,"threshold_uncertainty_score":0.6781658},"labels":[],"label_agreement":null},{"id":"W2168435321","doi":"10.1001/archinte.167.21.2296","title":"Patient Knowledge of Coronary Risk Profile Improves the Effectiveness of Dyslipidemia Therapy","year":2007,"lang":"en","type":"article","venue":"Archives of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University","funders":"","keywords":"Dyslipidemia; Medicine; Odds ratio; Confidence interval; Lipid profile; Internal medicine; Pharmacotherapy; Cholesterol; Obesity","score_opus":0.00860318217537573,"score_gpt":0.28355903310128716,"score_spread":0.2749558509259114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168435321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754684,0.008985642,0.002634697,0.00006893773,0.00028418182,0.0009794513,0.000011951909,0.000010072604,0.011556688],"genre_scores_gemma":[0.99852395,0.0006222347,0.00043906484,0.00006531022,0.00025081955,0.000018634017,0.0000062590275,0.000018503119,0.00005521919],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99818736,0.0003979117,0.0006773929,0.0001867194,0.00034739834,0.0002032198],"domain_scores_gemma":[0.9971152,0.0017219719,0.00040547783,0.0005072973,0.00014112283,0.00010891942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022731896,0.00015333522,0.0007051136,0.00014775353,0.000028829032,5.8880045e-7,0.00017289926,0.000045009787,0.00003493606],"category_scores_gemma":[0.0005610382,0.00007835384,0.00028771427,0.00013858234,0.00065071613,0.000022405593,0.00007214069,0.00028517004,0.0000011249474],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007633322,0.00036638483,0.06487971,0.0011998581,0.00078356464,0.000010350036,0.0036746943,0.0000015783633,0.22343469,0.00038431145,0.000058119414,0.6975734],"study_design_scores_gemma":[0.0032609454,0.0054798145,0.7465652,0.002515621,0.00011855355,0.000038820883,0.0007495257,0.000055207795,0.2398747,0.00050804595,0.00077221927,0.0000613332],"about_ca_topic_score_codex":0.0009827245,"about_ca_topic_score_gemma":0.0000151007625,"teacher_disagreement_score":0.6975121,"about_ca_system_score_codex":0.000018861747,"about_ca_system_score_gemma":0.00009277473,"threshold_uncertainty_score":0.3195177},"labels":[],"label_agreement":null},{"id":"W2168556156","doi":"10.1681/asn.v132461","title":"Apolipoprotein A-IV Serum Concentrations Are Elevated in Patients with Mild and Moderate Renal Failure","year":2002,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Aging","funders":"","keywords":"Renal function; Internal medicine; Medicine; Creatinine; Endocrinology; Apolipoprotein B; Dialysis; Odds ratio; Logistic regression; Kidney disease; Lipoprotein(a); Gastroenterology; Cholesterol","score_opus":0.011381517364749086,"score_gpt":0.2262199810707064,"score_spread":0.21483846370595733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168556156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854226,0.00031043962,0.000109012166,0.013829403,0.000013323052,0.00029155007,0.000008139436,0.000003877134,0.000011656811],"genre_scores_gemma":[0.99238425,0.00025511006,0.0022298368,0.004972208,0.000114929215,0.0000030626811,8.3032154e-7,0.0000120751565,0.000027690508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988389,0.00014006013,0.000349612,0.00011388637,0.0003398647,0.00021767525],"domain_scores_gemma":[0.99874043,0.000022126147,0.000691416,0.00022497108,0.00022468044,0.00009637823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023454093,0.00011090359,0.00057430356,0.000036666715,0.00006884633,0.000005952849,0.000093922405,0.00005832584,0.00002252684],"category_scores_gemma":[0.000017322332,0.00006712368,0.00023315086,0.0002588358,0.00042127294,0.00006315332,0.00002852439,0.0003942219,5.1380044e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040106014,0.0016716513,0.8828315,0.00034394133,0.004046068,0.000047006,0.004949762,0.0011726922,0.03269905,0.0000744401,0.04427119,0.0238821],"study_design_scores_gemma":[0.0045930194,0.001296054,0.9889466,0.00010999932,0.00014562586,0.000114574126,0.00054975215,0.00080806663,0.0003500447,0.000035847163,0.0029681765,0.00008220033],"about_ca_topic_score_codex":0.00013889611,"about_ca_topic_score_gemma":0.000043094908,"teacher_disagreement_score":0.10611514,"about_ca_system_score_codex":0.00006478744,"about_ca_system_score_gemma":0.00007479971,"threshold_uncertainty_score":0.2737224},"labels":[],"label_agreement":null},{"id":"W2168747536","doi":"10.1016/s0828-282x(07)70786-9","title":"Preventing cardiovascular disease among Canadians: What are the potential benefits of treating hypertension or dyslipidemia?","year":2007,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Medicine; Dyslipidemia; Life expectancy; Diabetes mellitus; Disease; Population; Framingham Heart Study; Framingham Risk Score; Gerontology; Physical therapy; Internal medicine; Environmental health; Endocrinology","score_opus":0.019329419156379077,"score_gpt":0.22940947787306132,"score_spread":0.21008005871668223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168747536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94838303,0.04677435,0.0017527225,0.00096507027,0.0012264856,0.00048631497,0.000020070653,0.000006759306,0.00038521804],"genre_scores_gemma":[0.99497694,0.0009869433,0.0001454975,0.00037064744,0.0034073615,0.0000046844843,0.0000082923625,0.000037640668,0.00006198789],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99737227,0.00033233565,0.00081716327,0.00025306386,0.00051531335,0.00070985936],"domain_scores_gemma":[0.99650824,0.00012259059,0.0004181543,0.00072217215,0.0006764079,0.0015524162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037257404,0.00021903309,0.0012207688,0.0003740722,0.00026182513,0.000034113567,0.00023365596,0.00020560098,0.0000149804355],"category_scores_gemma":[0.0010099593,0.00014105908,0.0015426882,0.0003177693,0.00025121836,0.00020930199,0.000020905132,0.00050669984,0.0000016210016],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008415566,0.000017054193,0.3298616,0.0006433863,0.010895944,0.014837329,0.0006603266,0.07736717,0.00017531058,0.00013187053,0.0028599007,0.5617085],"study_design_scores_gemma":[0.0020870909,0.00029198392,0.9566387,0.0014057745,0.003108102,0.0045496556,0.0048255366,0.00009860495,0.00010123344,0.00004310071,0.026603399,0.0002467968],"about_ca_topic_score_codex":0.023049539,"about_ca_topic_score_gemma":0.023679622,"teacher_disagreement_score":0.6267771,"about_ca_system_score_codex":0.00031264662,"about_ca_system_score_gemma":0.0024731231,"threshold_uncertainty_score":0.9941357},"labels":[],"label_agreement":null},{"id":"W2168837399","doi":"10.1016/s0828-282x(07)70742-0","title":"Should cholesterol-lowering medications be available in Canada without a prescription?","year":2007,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Medical prescription; Pharmacology; Intensive care medicine","score_opus":0.0776728497864182,"score_gpt":0.32724297002289754,"score_spread":0.24957012023647934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168837399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000111295274,0.989545,0.00027793317,0.0003170556,0.0013066647,0.00064778223,0.000052908126,0.0000040204495,0.0077373697],"genre_scores_gemma":[0.0020218927,0.99463356,0.00008962965,0.0005703124,0.0021666563,0.000029813416,0.00004306031,0.00006008124,0.00038502147],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99707407,0.00025453093,0.0012348997,0.00028531507,0.00045512145,0.0006960919],"domain_scores_gemma":[0.99718213,0.00006674617,0.00044132234,0.0006249249,0.0002566856,0.0014281662],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017535426,0.00032026187,0.003146653,0.00087899074,0.00007645888,0.0000167762,0.0003146726,0.00043610463,0.000116842144],"category_scores_gemma":[0.00022527,0.00026412556,0.0007513895,0.00039911421,0.000100933146,0.00006332654,0.000018120008,0.0015010096,0.00001583204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018292341,0.0000044020676,0.007394169,0.006817248,0.0023983577,0.0035977166,0.00006629995,0.00006938188,3.3136112e-7,0.000019545947,0.059426256,0.920188],"study_design_scores_gemma":[0.0005279776,0.000075826014,0.0011889288,0.0050548404,0.001173282,0.0073645147,0.0000439301,7.686643e-7,2.5888357e-7,0.0000023323946,0.98438483,0.00018248147],"about_ca_topic_score_codex":0.85992527,"about_ca_topic_score_gemma":0.9709563,"teacher_disagreement_score":0.9249586,"about_ca_system_score_codex":0.0037598968,"about_ca_system_score_gemma":0.06555175,"threshold_uncertainty_score":0.9999811},"labels":[],"label_agreement":null},{"id":"W2168876694","doi":"10.1161/01.cir.0000018744.58460.62","title":"Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial Hypercholesterolemia","year":2002,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":483,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"Université de Montréal","keywords":"Ezetimibe; Atorvastatin; Simvastatin; Medicine; Statin; Tolerability; Rosuvastatin; Internal medicine; Familial hypercholesterolemia; Cholesterol; Pharmacology; Gastroenterology; Adverse effect","score_opus":0.018135208733422555,"score_gpt":0.23637191747030784,"score_spread":0.21823670873688528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168876694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980586,0.00006643603,0.0005209711,0.00005871888,0.000018789433,0.0010331435,0.000013053186,0.000019968978,0.00021030112],"genre_scores_gemma":[0.9986706,0.000018268192,0.0010842578,0.000085643995,0.00002581606,0.00001680043,0.000053574993,0.000024951756,0.000020137357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987965,0.000071530005,0.00030458882,0.0002509814,0.00040130626,0.00017506196],"domain_scores_gemma":[0.9993516,0.000045663022,0.00011007963,0.00028389992,0.000106396124,0.000102342296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015795726,0.00013577164,0.00034923528,0.00009137821,0.00004134535,0.000009883213,0.000029520585,0.00006428056,0.000034616274],"category_scores_gemma":[0.000045223584,0.00009282437,0.000030808143,0.00022528399,0.00007145471,0.00008220938,0.000011616265,0.00011897733,0.0000029601924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039207255,0.00040715127,0.8942229,0.00030276948,0.00008449954,0.00004441507,0.0013274198,0.00027506036,0.000093628856,0.000013713882,0.0000105008685,0.09929722],"study_design_scores_gemma":[0.014482134,0.00089301396,0.9833312,0.0003249329,0.00007599679,0.000039266262,0.00009316758,0.0005187161,0.000035274737,0.0000024739568,0.00008968395,0.000114152244],"about_ca_topic_score_codex":0.0000635678,"about_ca_topic_score_gemma":0.000049902785,"teacher_disagreement_score":0.09918307,"about_ca_system_score_codex":0.00006825774,"about_ca_system_score_gemma":0.00005429775,"threshold_uncertainty_score":0.37852678},"labels":[],"label_agreement":null},{"id":"W2168949724","doi":"10.1161/circgenetics.113.000395","title":"<i>CKM</i> and <i>LILRB5</i> Are Associated With Serum Levels of Creatine Kinase","year":2014,"lang":"en","type":"article","venue":"Circulation Cardiovascular Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Montreal Heart Institute; Université du Québec à Montréal","funders":"","keywords":"Statin; Medicine; Internal medicine; Biomarker; Population; Creatine kinase; Genome-wide association study; Biobank; Bioinformatics; Endocrinology; Pharmacology; Genetics; Genotype; Single-nucleotide polymorphism; Gene; Biology","score_opus":0.018057835681450356,"score_gpt":0.22419986030795935,"score_spread":0.206142024626509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168949724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96441084,0.009852328,0.023323951,0.00012474314,0.00008281928,0.00081281154,0.00005535449,0.000076751276,0.0012604169],"genre_scores_gemma":[0.9977553,0.00028253053,0.0012902975,0.00025945614,0.00024799508,0.00002151598,0.000034730278,0.00006354154,0.000044662967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975469,0.00023614144,0.0004089604,0.00046388624,0.0010294018,0.00031471555],"domain_scores_gemma":[0.9978904,0.00005144138,0.00019651726,0.0011076182,0.00051646604,0.0002375652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012934898,0.00025793718,0.00095869176,0.00011511515,0.000115655246,0.000023697154,0.00007405681,0.00019673462,0.000018388362],"category_scores_gemma":[0.0002347825,0.00022555863,0.0006278914,0.00039348498,0.00013873537,0.000053564116,0.00004385854,0.00017713373,0.0000037299678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015612348,0.0004034453,0.5357786,0.001907678,0.012605199,0.000116730254,0.00052039576,0.02566546,0.0063760118,0.00048835314,0.00010740248,0.41587463],"study_design_scores_gemma":[0.00398764,0.00022674672,0.9818873,0.00032236727,0.0017902694,0.00016044051,0.00006942788,0.0021084184,0.0041906,0.00006918633,0.004892743,0.0002948884],"about_ca_topic_score_codex":0.000028665852,"about_ca_topic_score_gemma":0.00001354081,"teacher_disagreement_score":0.4461087,"about_ca_system_score_codex":0.00006805352,"about_ca_system_score_gemma":0.00011589287,"threshold_uncertainty_score":0.9198014},"labels":[],"label_agreement":null},{"id":"W2169353688","doi":"10.1113/jp270260","title":"Uncovering the mechanisms for statin‐mediated dysglycaemia: role of Rac1?","year":2015,"lang":"en","type":"letter","venue":"The Journal of Physiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Statin; RAC1; Skeletal muscle; Cholesterol; Farnesyl pyrophosphate; Chemistry; Pharmacology; Diabetes mellitus; Internal medicine; Prediabetes; Glucose uptake; Insulin; Medicine; Endocrinology; Biochemistry; Type 2 diabetes; Enzyme; ATP synthase; Signal transduction","score_opus":0.01655560470587357,"score_gpt":0.2630688693317038,"score_spread":0.24651326462583023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169353688","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27243915,0.020507107,0.0063107405,0.69025606,0.004356291,0.004849423,0.0003954765,0.00005003627,0.0008356936],"genre_scores_gemma":[0.28765574,0.0032386016,0.0034369132,0.6650092,0.03869097,0.00010119308,0.00036190433,0.00034583794,0.0011596401],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979211,0.00044232135,0.00062709814,0.00011903272,0.00056733773,0.00032311364],"domain_scores_gemma":[0.99714077,0.00053462107,0.0010435354,0.00057536695,0.00063937664,0.000066338274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022308344,0.00020875403,0.0010414498,0.00008367088,0.00006931784,0.000004196506,0.00039191372,0.0003943002,0.000034085824],"category_scores_gemma":[0.0003127881,0.00009443152,0.0005281243,0.000104946856,0.00012361174,0.00003236865,0.00007024207,0.001675951,0.0000051262923],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016851343,0.00006749244,0.0000025622664,0.000926264,0.002379876,0.000048562484,0.000973153,0.00026620956,0.23861468,0.00007950619,0.74971896,0.0052375947],"study_design_scores_gemma":[0.005042627,0.004653281,0.0003927185,0.00050601794,0.0026854079,0.0013500302,0.0016619919,0.00011945694,0.017430225,0.047122087,0.91874254,0.0002936172],"about_ca_topic_score_codex":0.00010647987,"about_ca_topic_score_gemma":0.0000036546007,"teacher_disagreement_score":0.22118446,"about_ca_system_score_codex":0.00009974247,"about_ca_system_score_gemma":0.0006455608,"threshold_uncertainty_score":0.7281266},"labels":[],"label_agreement":null},{"id":"W2169462852","doi":"10.1161/atvbaha.112.251306","title":"Mechanisms of Lipoprotein(a) Pathogenicity","year":2012,"lang":"en","type":"letter","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"","keywords":"Population; Windsor; Medicine; Biology; Ecology; Environmental health","score_opus":0.04016024672363234,"score_gpt":0.276569595928038,"score_spread":0.23640934920440565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169462852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6547648,0.0061451127,0.013257329,0.31308568,0.0027919954,0.0072675343,0.0008322805,0.00044534807,0.001409962],"genre_scores_gemma":[0.7004043,0.010947051,0.004156762,0.27966255,0.0033360599,0.00034589705,0.00090222195,0.00021913022,0.000026068034],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967951,0.0004007074,0.0007240886,0.00079842034,0.00046833113,0.0008133215],"domain_scores_gemma":[0.9979017,0.00004743621,0.0002517233,0.0013999764,0.00017625274,0.00022293915],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.000917579,0.00057878974,0.0020481092,0.00021323765,0.00014070517,0.000021047104,0.00020235346,0.0017537033,0.00026224228],"category_scores_gemma":[0.00004209896,0.0004660337,0.0012249346,0.00019037517,0.00030735377,0.00006817488,0.0002133659,0.0010841818,0.000034132983],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003347682,0.001240016,0.027982064,0.009604356,0.016869335,0.0000068408212,0.0008344452,2.836544e-7,0.7779052,0.0035526804,0.13884722,0.023124062],"study_design_scores_gemma":[0.001863097,0.0012560057,0.64463913,0.00057403866,0.0024371496,0.0000165704,0.000038980954,0.0000070435494,0.0020163658,0.00046295067,0.34593,0.0007586458],"about_ca_topic_score_codex":0.0005681466,"about_ca_topic_score_gemma":0.000012708056,"teacher_disagreement_score":0.77588886,"about_ca_system_score_codex":0.00006351506,"about_ca_system_score_gemma":0.00011342152,"threshold_uncertainty_score":0.99977916},"labels":[],"label_agreement":null},{"id":"W2169545592","doi":"10.1177/089686080202200408","title":"Apolipoprotein(a) Phenotype and Lipoprotein(a) Level Predict Peritoneal Dialysis Patient Mortality","year":2002,"lang":"en","type":"article","venue":"Peritoneal Dialysis International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Peritoneal dialysis; Medicine; Lipoprotein(a); Apolipoprotein B; Lipoprotein; Internal medicine; Phenotype; Intensive care medicine; Cholesterol; Biology; Biochemistry","score_opus":0.03752144414438678,"score_gpt":0.27405328288337116,"score_spread":0.23653183873898437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169545592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98063266,0.0020165886,0.00090414676,0.0033797997,0.00087373116,0.0011468289,0.00029933435,0.0001966981,0.010550232],"genre_scores_gemma":[0.99157685,0.00080880214,0.0023681123,0.00087619753,0.002688116,0.00039836677,0.000257084,0.00007240552,0.0009540591],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99527514,0.00017954629,0.00087977335,0.0009736071,0.0020738542,0.0006180802],"domain_scores_gemma":[0.99771285,0.000047290585,0.00025718182,0.0009624941,0.0004480319,0.0005721229],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057635986,0.0004766723,0.0009480436,0.0003759037,0.0003228837,0.00017006708,0.00029971713,0.0002733361,0.0020189693],"category_scores_gemma":[0.00037002366,0.00043735787,0.0007744724,0.00044939868,0.00028091113,0.00030843954,0.00025664544,0.00049849704,0.00013411569],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006257093,0.0024242299,0.063280106,0.0004889118,0.00817318,0.00045675877,0.004802033,0.00013773951,0.0065677306,0.0016059842,0.003305601,0.908132],"study_design_scores_gemma":[0.009753912,0.0017959041,0.76994324,0.0004384707,0.003981416,0.00081892073,0.0008569511,0.045186765,0.0117750075,0.00073875167,0.15221675,0.0024938916],"about_ca_topic_score_codex":0.0055953115,"about_ca_topic_score_gemma":0.00033773176,"teacher_disagreement_score":0.9056381,"about_ca_system_score_codex":0.00032819956,"about_ca_system_score_gemma":0.00009424021,"threshold_uncertainty_score":0.99980783},"labels":[],"label_agreement":null},{"id":"W2169881636","doi":"10.1186/1476-511x-12-70","title":"Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations","year":2013,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; Fondation Jean-Louis Lévesque; Heart and Stroke Foundation of Canada","keywords":"PCSK9; Kexin; Lipidology; Clinical chemistry; Proprotein convertase; LDL receptor; Allele frequency; Internal medicine; Apolipoprotein B; Allele; Biology; Cholesterol; Endocrinology; Lipoprotein; Medicine; Genetics; Gene","score_opus":0.016291548656771494,"score_gpt":0.2605607572672483,"score_spread":0.24426920861047682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169881636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950106,0.0011888654,0.000034640452,0.0022195864,0.00021744905,0.001160654,0.000060602586,0.000006826109,0.000100744786],"genre_scores_gemma":[0.9988061,0.00016923565,0.000049200105,0.000701663,0.00015882798,0.00005466407,0.000020754142,0.0000123636855,0.000027182865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871784,0.00016759352,0.0003605154,0.00025004047,0.00018133192,0.0003226843],"domain_scores_gemma":[0.99810517,0.000049246664,0.0000797805,0.00023525918,0.000037031037,0.0014935221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017814619,0.00012933534,0.00040855986,0.00030200533,0.00008195038,0.000009923757,0.00002426364,0.00007216495,0.000029807616],"category_scores_gemma":[0.00024621404,0.000113757,0.00004070958,0.00019216741,0.0000705493,0.00006990774,0.000018894021,0.0001564771,6.849103e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003527181,0.00024091997,0.912687,0.0059499242,0.000029296396,0.000018711458,0.0010624746,0.000004572837,0.000031654956,0.0016206317,0.00006471835,0.07793736],"study_design_scores_gemma":[0.0022411002,0.0005032595,0.99532706,0.0005494148,0.000032870823,0.0000046847495,0.00022615712,0.00026393597,0.00000738563,0.0006110229,0.00014904329,0.00008408157],"about_ca_topic_score_codex":0.14366381,"about_ca_topic_score_gemma":0.026237128,"teacher_disagreement_score":0.117426686,"about_ca_system_score_codex":0.00007440145,"about_ca_system_score_gemma":0.0007161367,"threshold_uncertainty_score":0.9915315},"labels":[],"label_agreement":null},{"id":"W2170127099","doi":"10.1161/circulationaha.109.906479","title":"Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia","year":2010,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":327,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Rosuvastatin; Hazard ratio; Internal medicine; Confidence interval; Dyslipidemia; Randomized controlled trial; Placebo; Relative risk; Statin; Rosuvastatin Calcium; C-reactive protein; Disease; Inflammation; Pathology","score_opus":0.033762774735044465,"score_gpt":0.30438313198833583,"score_spread":0.27062035725329137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170127099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09461718,0.86267245,0.018126106,0.000030675346,0.00019122183,0.024183324,0.000092564274,0.000056554567,0.00002990912],"genre_scores_gemma":[0.15365368,0.83092505,0.0024925782,0.000051360694,0.0010863355,0.009951577,0.0014017393,0.00030120925,0.00013650474],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969185,0.00064362405,0.0007813768,0.00053515396,0.00075446593,0.00036685204],"domain_scores_gemma":[0.9976432,0.00025534973,0.0006483763,0.0010491011,0.00030805072,0.00009597549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036129707,0.000371518,0.0023938012,0.00020837723,0.000086726206,0.000008006035,0.00009051312,0.0004598659,0.0000085120155],"category_scores_gemma":[0.00036395554,0.00021615658,0.00083040545,0.0005817595,0.00005981175,0.000119674536,0.000030272644,0.00064659363,0.0000026751325],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044637744,0.00015136368,0.00008985368,0.021672502,0.002430427,0.000010028734,0.000113266586,0.000091059774,0.00006574428,0.000029761339,0.0000017973399,0.9748978],"study_design_scores_gemma":[0.013363284,0.0015349622,0.17607474,0.06514987,0.01775813,0.00036986874,0.00022741962,0.00030077336,0.00015341265,0.00048055983,0.72306454,0.0015224138],"about_ca_topic_score_codex":0.00031459247,"about_ca_topic_score_gemma":0.00007063359,"teacher_disagreement_score":0.9733754,"about_ca_system_score_codex":0.00083655695,"about_ca_system_score_gemma":0.0015225357,"threshold_uncertainty_score":0.88146096},"labels":[],"label_agreement":null},{"id":"W2170230186","doi":"10.1016/j.mehy.2007.03.018","title":"Of PCSK9, cholesterol homeostasis and parasitic infections: Possible survival benefits of loss-of-function PCSK9 genetic polymorphisms","year":2007,"lang":"en","type":"article","venue":"Medical Hypotheses","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University of Ottawa; Ottawa Hospital","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"PCSK9; LDL receptor; Biology; Hypocholesterolemia; Single-nucleotide polymorphism; Endocrinology; Internal medicine; Cholesterol; Genetics; Lipoprotein; Medicine; Genotype; Gene","score_opus":0.025818844292359422,"score_gpt":0.2766818092275677,"score_spread":0.25086296493520827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170230186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870787,0.008675378,0.0030400872,0.0002330096,0.00021196021,0.00035007708,0.000016498505,0.000023954643,0.0003703211],"genre_scores_gemma":[0.9980482,0.0011883982,0.00033446835,0.00013640363,0.00022223231,0.00001032151,0.000005719406,0.000023565202,0.000030684114],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977227,0.000089698115,0.00062512606,0.0002343374,0.0010486232,0.00027950405],"domain_scores_gemma":[0.99865544,0.00028587342,0.00018014271,0.00039390603,0.00017115969,0.00031347226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012331827,0.00015399665,0.0006453574,0.00023511927,0.000046608213,0.0000045401575,0.000080769256,0.00020245383,0.00018092987],"category_scores_gemma":[0.0007282499,0.00012273082,0.00019377579,0.00035727845,0.00038620105,0.00005203694,0.000033500633,0.0001835302,0.0000034636748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031818447,0.00074601686,0.33685574,0.0010412105,0.00040628336,0.000028712844,0.0002102572,0.000009902907,0.0017827105,0.0005682125,0.000013774679,0.658019],"study_design_scores_gemma":[0.0017909368,0.0013150624,0.97189385,0.00054127496,0.00030323607,0.00021549246,0.00013386551,0.000016694554,0.023012796,0.0001773705,0.0004893678,0.00011008365],"about_ca_topic_score_codex":0.00081928645,"about_ca_topic_score_gemma":0.00012323503,"teacher_disagreement_score":0.6579089,"about_ca_system_score_codex":0.000027179341,"about_ca_system_score_gemma":0.00018591354,"threshold_uncertainty_score":0.5004818},"labels":[],"label_agreement":null},{"id":"W2170388163","doi":"10.1161/01.cir.102.15.1748","title":"Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis","year":2000,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":276,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); University of Alberta Hospital; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Medicine; Enalapril; Simvastatin; Placebo; Internal medicine; Myocardial infarction; Cardiology; Angiotensin-converting enzyme; ACE inhibitor; Endocrinology; Blood pressure; Pathology","score_opus":0.012292542793604562,"score_gpt":0.23421711786574967,"score_spread":0.2219245750721451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170388163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839073,0.00038174013,0.00044005702,0.000077823264,0.00005700991,0.0005119995,8.492927e-7,0.000038739156,0.00010103388],"genre_scores_gemma":[0.9994135,0.00010428189,0.00003479646,0.00024687318,0.00013610061,0.000010102547,0.000021144791,0.00001955257,0.000013670544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923855,0.000033233337,0.00018734492,0.00019545159,0.00021560585,0.00012982894],"domain_scores_gemma":[0.99959797,0.00002137711,0.00005686669,0.0002180899,0.00003671477,0.000068988986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014886659,0.00009711623,0.0002121072,0.000055616973,0.000056636945,0.000008693678,0.000012938169,0.000083555045,0.000029479692],"category_scores_gemma":[0.000017374769,0.00009318015,0.00009896193,0.00008454248,0.000029104276,0.0000848574,0.000007138471,0.00008308265,0.000010665107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010592178,0.00011029994,0.4691095,0.0007384274,0.00008395651,0.000020706024,0.0003798798,0.00011473664,0.17553116,0.000010840729,0.0000057525453,0.3537888],"study_design_scores_gemma":[0.0014430896,0.00013897287,0.9451042,0.0008014898,0.00007624447,0.00005712115,0.0000033589963,0.0002502143,0.05203535,0.000008426287,0.000007806455,0.00007374584],"about_ca_topic_score_codex":0.000030123445,"about_ca_topic_score_gemma":0.0000016814013,"teacher_disagreement_score":0.47599468,"about_ca_system_score_codex":0.000055211014,"about_ca_system_score_gemma":0.00001522052,"threshold_uncertainty_score":0.3799776},"labels":[],"label_agreement":null},{"id":"W2170411600","doi":"10.1093/clinchem/48.3.484","title":"Can Measurement of Serum Apolipoprotein B Replace the Lipid Profile Monitoring of Patients with Lipoprotein Disorders?","year":2002,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; St. Paul's Hospital; McGill University; University of British Columbia","funders":"","keywords":"Apolipoprotein B; Concordance; Hypertriglyceridemia; Medicine; Internal medicine; Cholesterol; Lipid profile; Risk factor; Lipoprotein; Ldl cholesterol; Disease; Gastroenterology; Endocrinology; Triglyceride","score_opus":0.032335654558409754,"score_gpt":0.27398886671829553,"score_spread":0.24165321215988578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170411600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487704,0.00074127695,0.000015673959,0.0011540422,0.000105585976,0.0011609623,0.00003306109,0.00003280701,0.0018795271],"genre_scores_gemma":[0.9981407,0.00014127875,0.00044036258,0.000037474998,0.0006103096,0.00009488029,0.000006600769,0.000034728742,0.00049366575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971587,0.00009192758,0.0008411586,0.0003925437,0.0012044379,0.00031121026],"domain_scores_gemma":[0.9976706,0.000055965545,0.0004034021,0.001243977,0.0004167056,0.00020937884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012313876,0.00020547728,0.0006393325,0.000016071208,0.00007107654,0.0000066144703,0.00021326648,0.00019189814,0.00021081552],"category_scores_gemma":[0.0007236452,0.00012916992,0.0003539132,0.00021289324,0.00025171996,0.000029828747,0.00007589088,0.00049643347,0.000004410005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004912823,0.0016402748,0.85801727,0.0023610038,0.00059585844,0.000004065486,0.00014762706,0.00000441923,0.00094263913,0.0000056182485,0.0004511867,0.13533878],"study_design_scores_gemma":[0.008850007,0.0014424714,0.6931512,0.0016006427,0.0005063497,0.000008743007,0.0003819661,0.00006582692,0.28790364,0.00003540359,0.005611844,0.00044194807],"about_ca_topic_score_codex":0.00015183479,"about_ca_topic_score_gemma":0.000011493625,"teacher_disagreement_score":0.28696102,"about_ca_system_score_codex":0.000080471604,"about_ca_system_score_gemma":0.00013691078,"threshold_uncertainty_score":0.52673966},"labels":[],"label_agreement":null},{"id":"W2170827802","doi":"10.1161/atvbaha.113.301814","title":"Genomic Medicine for Improved Prediction and Primordial Prevention of Cardiovascular Disease","year":2013,"lang":"en","type":"letter","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institutes of Health","keywords":"Medicine; Framingham Risk Score; Framingham Heart Study; Disease; Family medicine; Gerontology; Library science; Internal medicine","score_opus":0.04058469650060293,"score_gpt":0.2755712713744934,"score_spread":0.23498657487389046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170827802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7911683,0.02229172,0.011406214,0.15910207,0.0016642822,0.013219871,0.0008707067,0.00019577678,0.000081074686],"genre_scores_gemma":[0.5154345,0.27020684,0.0060307942,0.16496952,0.02563964,0.005552318,0.01125535,0.0007434775,0.00016754435],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99716413,0.00028981265,0.0007517196,0.0010131169,0.00027820747,0.0005029863],"domain_scores_gemma":[0.9980269,0.00006403166,0.00028135447,0.0011423756,0.00023967384,0.0002456714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000873946,0.00050299795,0.002018272,0.0002219161,0.00016204269,0.000023555547,0.00011758086,0.0008588709,0.000047886242],"category_scores_gemma":[0.00008425026,0.00039624862,0.001274911,0.00010540913,0.00047926538,0.00008015583,0.00011908797,0.00046977136,0.000002284908],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003488273,0.0012390824,0.06928632,0.037833206,0.13363104,0.0000035885257,0.0015304238,0.0000140341035,0.2338339,0.00057362614,0.33966905,0.18203689],"study_design_scores_gemma":[0.0044476567,0.0019716714,0.57523614,0.00064388855,0.008174549,0.000003794065,0.000027756034,0.00027005209,0.00002987822,0.00022612468,0.40859047,0.00037800797],"about_ca_topic_score_codex":0.0005657003,"about_ca_topic_score_gemma":0.0000037860607,"teacher_disagreement_score":0.50594985,"about_ca_system_score_codex":0.00007033653,"about_ca_system_score_gemma":0.00013757811,"threshold_uncertainty_score":0.99984896},"labels":[],"label_agreement":null},{"id":"W2171837479","doi":"10.1517/14712598.2012.727618","title":"Letter to the Editor: The ezetimibe ‘controversy' is a misunderstanding","year":2012,"lang":"en","type":"letter","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Ezetimibe; Medicine; Intensive care medicine; Internal medicine; Statin","score_opus":0.0470890939153772,"score_gpt":0.3500374663059719,"score_spread":0.3029483723905947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171837479","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012466532,0.017532256,0.0007166292,0.9500475,0.027007584,0.0026018703,0.000052767165,0.000115164126,0.0019137532],"genre_scores_gemma":[0.00016392887,0.00766835,0.00006156211,0.6779149,0.31179047,0.0003900634,0.00005424517,0.00014295791,0.0018135488],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99584025,0.00044004552,0.0004352952,0.0006582505,0.0016970789,0.0009290599],"domain_scores_gemma":[0.99770933,0.00023023132,0.00017993078,0.001545434,0.00009287993,0.0002422055],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009196822,0.000624338,0.00070674624,0.00015279604,0.00047333268,0.00011792049,0.0005593306,0.00056721806,0.0017876228],"category_scores_gemma":[0.000018989998,0.00031792704,0.00093148404,0.00023739832,0.000099422745,0.00008323518,0.00005389096,0.0025176625,0.00052818964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027855797,0.000056668156,0.0000029300224,0.000048891492,0.00071334786,0.000020235153,0.0024066523,0.0000012104317,0.00036609455,0.000014796946,0.9822316,0.013858983],"study_design_scores_gemma":[0.002393696,0.00023721122,0.000008180261,0.00022011205,0.0000405061,0.00004944409,0.00009233003,0.00001840863,0.0017087848,0.000009701968,0.99482745,0.00039420382],"about_ca_topic_score_codex":0.00016728188,"about_ca_topic_score_gemma":7.8118535e-7,"teacher_disagreement_score":0.2847829,"about_ca_system_score_codex":0.00044885074,"about_ca_system_score_gemma":0.00015551575,"threshold_uncertainty_score":0.9999273},"labels":[],"label_agreement":null},{"id":"W2172198715","doi":"10.1177/0091270011407196","title":"Low‐Density Lipoprotein Cholesterol and High‐Sensitivity C‐Reactive Protein Lowering With Atorvastatin in Patients of South Asian Compared With European Origin: Insights From the Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration (ACTFAST) Study","year":2011,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; Université Laval; Canadian Respiratory Research Network; McMaster University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Atorvastatin; Internal medicine; Body mass index; Medicine; Cholesterol; C-reactive protein; Simvastatin; Endocrinology; Gastroenterology; Inflammation","score_opus":0.03404934312411262,"score_gpt":0.3015063388714265,"score_spread":0.2674569957473139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172198715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518156,0.000018559642,0.0014790555,0.00022210382,0.00012521393,0.0028714084,0.00001862514,0.000013389995,0.0000700574],"genre_scores_gemma":[0.99870056,0.000006555722,0.00057252817,0.00031366802,0.0003319028,0.000017390303,0.00000744194,0.000046088215,0.0000038721964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99408597,0.0032572204,0.0012470277,0.00035872243,0.0007516681,0.00029942225],"domain_scores_gemma":[0.99696195,0.00028647218,0.0015512999,0.00041270952,0.000521993,0.00026559486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003037056,0.00033587374,0.0011694329,0.00008845166,0.00013345186,0.00002220208,0.00020312906,0.00008437712,0.000016555603],"category_scores_gemma":[0.000081102,0.00016113537,0.00010625474,0.0002166375,0.00047180548,0.00024904992,0.00007532367,0.0013703009,0.0000027020183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13350102,0.010568392,0.75091785,0.00025238557,0.0053326613,0.0012011421,0.05082451,0.00025679852,0.010254622,0.000010313497,0.000026783746,0.036853537],"study_design_scores_gemma":[0.020343387,0.011839484,0.95458764,0.00038808648,0.00068899256,0.000058314687,0.0030228405,0.00004212342,0.008836704,0.000013711934,0.000005424093,0.00017326501],"about_ca_topic_score_codex":0.0012460466,"about_ca_topic_score_gemma":0.002393727,"teacher_disagreement_score":0.20366983,"about_ca_system_score_codex":0.000059267506,"about_ca_system_score_gemma":0.00033140372,"threshold_uncertainty_score":0.6570909},"labels":[],"label_agreement":null},{"id":"W2173047527","doi":"10.5339/gcsp.2015.28","title":"High prevalence of raised lipoprotein(a) in patients with refractory angina","year":2015,"lang":"en","type":"article","venue":"Global Cardiology Science and Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute for Health and Care Research","keywords":"Medicine; Refractory (planetary science); Angina; Internal medicine; Lipoprotein(a); Prospective cohort study; Canadian Cardiovascular Society; Quartile; Cohort; Risk factor; Lipoprotein; Cohort study; Epidemiology; Cholesterol; Confidence interval; Myocardial infarction","score_opus":0.018511342704227562,"score_gpt":0.28989462057997045,"score_spread":0.2713832778757429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173047527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98525363,0.0013549135,0.00014477163,0.00064482645,0.00016926853,0.00061214203,0.000015586138,0.000016422751,0.011788444],"genre_scores_gemma":[0.99753076,0.00012773306,0.0017863595,0.00043940742,0.00007833385,0.00001430745,0.0000029250418,0.0000042361658,0.00001591589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997941,0.00025170797,0.00019686733,0.00038379736,0.00090917014,0.0003174335],"domain_scores_gemma":[0.99816006,0.00007141666,0.00013330327,0.00045135332,0.00094099075,0.00024289922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039736005,0.00011466663,0.00038676127,0.00008311676,0.000059862017,0.000011608559,0.00013065772,0.00008925018,0.00000316926],"category_scores_gemma":[0.0031439175,0.00008343077,0.000039644605,0.00074380345,0.0006916102,0.0005575528,0.000076592376,0.00016810509,0.0000054478505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035025321,0.0002175937,0.95968384,0.0002567155,0.00012295973,0.00012849887,0.00022733051,0.00006383088,0.0000835663,0.00096386846,0.00047126765,0.03427802],"study_design_scores_gemma":[0.0029070538,0.0017956572,0.98888576,0.000054286997,0.000108632674,0.00027388058,0.00020184283,0.000004077788,0.000026999607,0.000098372795,0.0055402163,0.000103198705],"about_ca_topic_score_codex":0.0005017424,"about_ca_topic_score_gemma":0.00000405885,"teacher_disagreement_score":0.034174822,"about_ca_system_score_codex":0.00020147188,"about_ca_system_score_gemma":0.0010158252,"threshold_uncertainty_score":0.376379},"labels":[],"label_agreement":null},{"id":"W2173852847","doi":"10.1007/978-1-60761-424-1_4","title":"Lipoproteins and Cardiovascular Disease Risk","year":2015,"lang":"en","type":"book-chapter","venue":"Contemporary Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Atherosclerotic cardiovascular disease; Medicine; Cardiology; Internal medicine","score_opus":0.05736592745889675,"score_gpt":0.2614716984263696,"score_spread":0.20410577096747284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173852847","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012019526,0.44517425,0.00017028801,0.0006395574,0.0005422307,0.0024597505,0.00032371367,0.00028818985,0.54920006],"genre_scores_gemma":[0.37104172,0.05021975,0.0004570633,0.0009521881,0.0042374744,0.00035287256,0.00083410996,0.0005284195,0.57137644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996628,0.00014582592,0.0006002728,0.0012123756,0.00084818737,0.0005653309],"domain_scores_gemma":[0.99581593,0.00003722521,0.00022888156,0.0025527303,0.000305037,0.0010602166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058066833,0.00067747576,0.0019754714,0.0003147567,0.00013687937,0.000023620754,0.00018106743,0.00047179282,0.0002115333],"category_scores_gemma":[0.00018681328,0.00060871005,0.0013083591,0.00004019624,0.00043111466,0.00008984824,0.0003039263,0.001194025,0.00018807083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024999606,0.00023623889,0.005020294,0.0029798897,0.03226024,0.035861827,0.00026023737,0.000014076727,0.000010054948,0.09017828,0.06574431,0.7649346],"study_design_scores_gemma":[0.003017868,0.00046198478,0.0010879971,0.00027102474,0.001922339,0.0009770036,0.000019176237,0.000009589394,0.000008599428,0.0068364423,0.98485583,0.00053212367],"about_ca_topic_score_codex":0.0006539901,"about_ca_topic_score_gemma":0.000009310078,"teacher_disagreement_score":0.91911155,"about_ca_system_score_codex":0.00012694889,"about_ca_system_score_gemma":0.0011060234,"threshold_uncertainty_score":0.9996364},"labels":[],"label_agreement":null},{"id":"W2175088494","doi":"10.7326/acpjc-2007-147-3-080","title":"High-dose statins are cost-effective compared with conventional-dose statins in patients with acute coronary syndromes","year":2007,"lang":"en","type":"article","venue":"ACP Journal Club","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Statin; Coronary artery disease; Acute coronary syndrome; Internal medicine; Cardiology; Atorvastatin; Cost effectiveness; Myocardial infarction","score_opus":0.013444089760533306,"score_gpt":0.2781396488194419,"score_spread":0.2646955590589086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175088494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937442,0.00026629458,0.002420173,0.00031517216,0.0001957317,0.0027838089,0.00010793755,0.000035710873,0.00013096556],"genre_scores_gemma":[0.9958302,0.00008298129,0.0029187023,0.0005543411,0.00014149683,0.00008037199,0.00018040395,0.000058411588,0.0001531222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970522,0.0002015429,0.0005579958,0.00034092925,0.0012413757,0.00060595176],"domain_scores_gemma":[0.9979684,0.00013092755,0.00044105123,0.0003504394,0.0006112723,0.0004979532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010094228,0.00030955326,0.0007663533,0.00026773778,0.00022553891,0.000044563785,0.00013025009,0.000093003044,0.00011911256],"category_scores_gemma":[0.000053590167,0.00020965084,0.00015677638,0.0004180859,0.00012709021,0.00027652492,0.00004092563,0.0008290635,0.00002252408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01288384,0.0016247346,0.9413602,0.00017847178,0.0023423792,0.00738228,0.0007709929,0.0001700718,0.000030877778,0.00010799173,0.0008199691,0.032328222],"study_design_scores_gemma":[0.024807546,0.0033417256,0.96653026,0.00070330745,0.00034037099,0.0019926077,0.00080147124,0.000016355325,0.00007373253,0.000093601535,0.001038829,0.00026019564],"about_ca_topic_score_codex":0.0002129866,"about_ca_topic_score_gemma":0.000439313,"teacher_disagreement_score":0.032068025,"about_ca_system_score_codex":0.00052012346,"about_ca_system_score_gemma":0.00036965925,"threshold_uncertainty_score":0.85493135},"labels":[],"label_agreement":null},{"id":"W2177226967","doi":"10.1016/j.jacc.2015.08.042","title":"Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease","year":2015,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Ezetimibe; Medicine; Niacin; Fibrate; Internal medicine; Statin; Bile acid; Endocrinology","score_opus":0.027838556871882268,"score_gpt":0.2709811439455473,"score_spread":0.243142587073665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2177226967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766624,0.00032246698,0.00007735855,0.0013524368,0.00014935379,0.00029048268,0.000043679313,0.0000021760138,0.00009578193],"genre_scores_gemma":[0.99870145,0.00008342388,0.00040439735,0.00057617266,0.00018627844,0.0000063165526,0.0000018828023,0.000014592096,0.000025492913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980685,0.00058551366,0.00045958,0.00010355027,0.00060291716,0.00017991915],"domain_scores_gemma":[0.9983379,0.00012863333,0.00058021536,0.00048613342,0.00032460436,0.00014247585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008214516,0.00011944937,0.00089041854,0.00017585703,0.00002838707,0.0000027650992,0.00019760871,0.000027256287,0.0000026187213],"category_scores_gemma":[0.00015800416,0.000056325076,0.00042392925,0.0005288917,0.0004733559,0.000074383584,0.00003767957,0.00025179717,1.5187726e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004358218,0.00012218623,0.9837589,0.0000136721565,0.00033602412,0.00012826407,0.00013349009,0.0014568209,0.000038411392,0.00000654411,0.0035648232,0.006082598],"study_design_scores_gemma":[0.0029542367,0.0024818182,0.9871542,0.00008962347,0.00013582273,0.00027920754,0.00042332266,0.000013412549,0.000026401063,0.000009788234,0.006373555,0.000058636153],"about_ca_topic_score_codex":0.00011370479,"about_ca_topic_score_gemma":0.000010079362,"teacher_disagreement_score":0.0060239616,"about_ca_system_score_codex":0.00006774953,"about_ca_system_score_gemma":0.00035536994,"threshold_uncertainty_score":0.22968699},"labels":[],"label_agreement":null},{"id":"W2179697345","doi":"10.1186/s12944-015-0154-7","title":"The associations between proprotein convertase subtilisin/kexin type 9 E670G polymorphism and the risk of coronary artery disease and serum lipid levels: a meta-analysis","year":2015,"lang":"en","type":"review","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Jiangsu University","keywords":"Meta-analysis; PCSK9; Internal medicine; Publication bias; Odds ratio; Coronary artery disease; Lipidology; Proprotein convertase; Confidence interval; Kexin; Medicine; Allele; Clinical nutrition; Subgroup analysis; Gastroenterology; Genetic model; Lipid profile; Oncology; Clinical chemistry; Genetics; Biology; Cholesterol; Lipoprotein; LDL receptor; Gene","score_opus":0.10747399687436605,"score_gpt":0.3534559537209733,"score_spread":0.24598195684660729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2179697345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017139472,0.98594743,0.000015091519,0.0032338388,0.00011101301,0.0049443007,0.0039964938,0.000024421555,0.000013456637],"genre_scores_gemma":[0.01676341,0.980659,0.000054072312,0.00073948177,0.00050285005,0.00050650677,0.00048842083,0.000050144426,0.00023611746],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9930362,0.0033673102,0.0014952921,0.00072077144,0.0008112289,0.0005692165],"domain_scores_gemma":[0.9939357,0.0010599182,0.0009774935,0.0012730479,0.00019861759,0.002555203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006162395,0.00054162747,0.0046665673,0.00028388196,0.0005269343,0.00007257419,0.00018222079,0.00020467586,0.00002087155],"category_scores_gemma":[0.0021927813,0.00027422767,0.0014935957,0.00074290583,0.0005710913,0.00008774478,0.00017795633,0.00077629194,0.0000028526713],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019222093,0.00036503325,0.054275773,0.046726305,0.10038682,0.00007211299,0.0009815386,0.0000019767272,7.454551e-9,0.0007484978,0.00081773876,0.793702],"study_design_scores_gemma":[0.0058300886,0.00049723417,0.10502497,0.0018697231,0.57975596,0.000024363879,0.00033471963,0.0001333895,3.3404916e-8,0.0017261392,0.30404627,0.0007570891],"about_ca_topic_score_codex":0.0015385051,"about_ca_topic_score_gemma":0.00015241372,"teacher_disagreement_score":0.7929449,"about_ca_system_score_codex":0.00014570195,"about_ca_system_score_gemma":0.004253649,"threshold_uncertainty_score":0.999971},"labels":[],"label_agreement":null},{"id":"W2181753001","doi":"10.82308/23952","title":"An interaction between statins and clopidogrel : a pharmacoepidemiology cohort study with survival time analysis","year":2007,"lang":"en","type":"article","venue":"eScholarship@McGill (McGill)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Pharmacoepidemiology; Clopidogrel; Medicine; Cohort study; Survival analysis; Cohort; Internal medicine; Pharmacology; Aspirin; Medical prescription","score_opus":0.023392742661842006,"score_gpt":0.3192239889641438,"score_spread":0.2958312463023018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181753001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99366903,0.00007066243,0.000051535473,0.000040075825,0.00012668113,0.001660642,0.00016653404,0.00020462701,0.0040102135],"genre_scores_gemma":[0.99775213,0.0000640767,0.0011616951,0.0003341269,0.00017091788,0.00006196378,0.00020682182,0.00007866195,0.00016960944],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953308,0.0011476966,0.0008678879,0.0010656497,0.0008498875,0.0007380771],"domain_scores_gemma":[0.99719244,0.00042163054,0.0003167139,0.0009267569,0.00032836793,0.00081410614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008469857,0.00044256478,0.0014742,0.00058512285,0.00056355086,0.000031796877,0.00017655834,0.00022198149,0.0001598873],"category_scores_gemma":[0.0003178245,0.00036368813,0.00031174597,0.0011742845,0.00010255864,0.00048034333,0.000092524555,0.0009961021,0.00005207327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000987014,0.00071210874,0.83356065,0.000072832896,0.007388903,0.00027527,0.00001939052,0.000045839643,0.002764107,0.00037576596,0.000001120358,0.153797],"study_design_scores_gemma":[0.003565321,0.0026793242,0.97905743,0.000041687428,0.006437651,0.000111610585,0.0004915562,0.00015836027,0.0019836628,0.00011508043,0.0048644454,0.0004938509],"about_ca_topic_score_codex":0.002628196,"about_ca_topic_score_gemma":0.001407953,"teacher_disagreement_score":0.15330315,"about_ca_system_score_codex":0.0004159828,"about_ca_system_score_gemma":0.00004310849,"threshold_uncertainty_score":0.9998815},"labels":[],"label_agreement":null},{"id":"W2182786851","doi":"10.1016/s0022-2275(20)31990-8","title":"Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity","year":2000,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lipoprotein(a); Lipoprotein; Lysine; Chemistry; Recombinant DNA; Size-exclusion chromatography; Apolipoprotein B; Ultracentrifuge; Biochemistry; Fibronectin; Chromatography; Low-density lipoprotein; Cholesterol; Enzyme; Amino acid; Cell","score_opus":0.055516024492785976,"score_gpt":0.35081843125131257,"score_spread":0.2953024067585266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182786851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966597,0.00023038268,0.000036482565,0.0018065561,0.00011837842,0.0003870058,0.00000733652,0.0000025083216,0.00075162813],"genre_scores_gemma":[0.99753094,0.000745981,0.00016613815,0.000031569478,0.00090203056,0.0000039188963,0.0000018810366,0.000015395657,0.0006021468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967327,0.0004988405,0.00065376575,0.000107082175,0.0017618076,0.00024578857],"domain_scores_gemma":[0.99821687,0.00004644753,0.00029220612,0.00045926802,0.00084869505,0.00013650725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004430543,0.00007947508,0.00045381015,0.00025125346,0.00009793287,0.000010852375,0.00023380585,0.00009016206,0.0003879533],"category_scores_gemma":[0.00027560987,0.000047423182,0.00045513205,0.0007084517,0.00013387333,0.00010201392,0.00004920751,0.00053657533,0.0000070198344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005465001,0.0002757733,0.009100406,0.00044640273,0.00027775686,0.0000146783,0.00023554276,0.000010221415,0.8669716,0.000021851798,0.000099435994,0.12199979],"study_design_scores_gemma":[0.0012044114,0.00061338866,0.14351259,0.00066070864,0.000062931016,0.000230312,0.00006579223,0.0000324293,0.84485817,0.000014015934,0.008696251,0.000049028098],"about_ca_topic_score_codex":0.000118793665,"about_ca_topic_score_gemma":0.000006428653,"teacher_disagreement_score":0.13441218,"about_ca_system_score_codex":0.00009325852,"about_ca_system_score_gemma":0.0004167085,"threshold_uncertainty_score":0.42478165},"labels":[],"label_agreement":null},{"id":"W2182803990","doi":"10.25011/cim.v38i6.26200","title":"Sex/Gender -Based Pharmacology and Statin Utilization Amongst Elderly Patients with Diabetes","year":2015,"lang":"en","type":"article","venue":"Clinical and investigative medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Queen's University; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Diabetes mellitus; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Gerontology; Internal medicine; Endocrinology","score_opus":0.1735107532454738,"score_gpt":0.36337958208725574,"score_spread":0.18986882884178194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182803990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909305,0.000981259,0.00034135825,0.00648895,0.00020713967,0.000651466,0.0000069864655,0.000037090966,0.00035525937],"genre_scores_gemma":[0.9907141,0.00007040773,0.0009857689,0.007541944,0.00043862386,0.000030810468,0.0001108897,0.000018900942,0.000088580266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983292,0.0002834176,0.00042352,0.00036856634,0.0003759364,0.00021933914],"domain_scores_gemma":[0.9984123,0.00012697862,0.00012706986,0.00016424706,0.00033503573,0.000834353],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0010250252,0.0001747759,0.0006103613,0.00006063284,0.00006511677,0.0000061673227,0.00003501877,0.00010335765,0.000036134905],"category_scores_gemma":[0.00078407483,0.000102985294,0.000034684555,0.00017054786,0.004294454,0.000080573045,0.000026846348,0.0002757157,0.000002755183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013191343,0.00013980224,0.9722701,0.00016284827,0.00015125364,0.000008238734,0.00036880927,9.394685e-7,0.000040835377,0.00017028114,0.0034566221,0.023098372],"study_design_scores_gemma":[0.016907182,0.007745665,0.96415037,0.00022905538,0.00044189143,0.0000021438727,0.00036409672,0.0007265745,0.000535398,0.0022738294,0.0064559905,0.00016781523],"about_ca_topic_score_codex":0.000039269366,"about_ca_topic_score_gemma":0.0000058935025,"teacher_disagreement_score":0.022930557,"about_ca_system_score_codex":0.000017740404,"about_ca_system_score_gemma":0.00020565056,"threshold_uncertainty_score":0.9984153},"labels":[],"label_agreement":null},{"id":"W2184482023","doi":"10.1016/j.jacl.2015.10.013","title":"A lipidologist perspective of global lipid guidelines and recommendations, part 1: Lipid treatment targets and risk assessment","year":2015,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amarin Corporation; Regeneron Pharmaceuticals; Sanofi; American Heart Association","keywords":"Medicine; Canadian Cardiovascular Society; Lipidology; Atherosclerotic cardiovascular disease; Perspective (graphical); Excellence; Internal medicine; Intensive care medicine; Family medicine; Cholesterol; Disease; Angina; Political science","score_opus":0.2637324996754211,"score_gpt":0.5382023141137132,"score_spread":0.2744698144382921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184482023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024527163,0.98776436,0.00021059014,0.0042384067,0.00556409,0.0011146552,0.0001881317,0.000015572903,0.00065890234],"genre_scores_gemma":[0.000033916123,0.96421546,0.012623957,0.00024097161,0.02263476,0.00003144026,0.000034630364,0.000037786198,0.00014707114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99005187,0.0031942858,0.0051159323,0.0006362441,0.0005698097,0.0004318813],"domain_scores_gemma":[0.9899727,0.0013975713,0.004879981,0.0006677996,0.0022956165,0.0007863489],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011344249,0.0005732065,0.007935234,0.00018912027,0.00009797622,0.000027665857,0.00020710388,0.00095677713,0.00006082976],"category_scores_gemma":[0.008327188,0.00035519834,0.0020128125,0.0002626474,0.0005351562,0.00011072596,0.00020804502,0.0012423446,0.000005265431],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002973725,0.00062121387,0.0037040384,0.0018092032,0.0038214216,0.000029566925,0.000030515794,4.046463e-7,2.5357574e-8,0.00071738305,0.024331799,0.96463704],"study_design_scores_gemma":[0.0038012543,0.007872319,0.0013526946,0.0032586956,0.0081779715,0.0024362586,0.00029796615,0.0000050026474,6.965333e-8,0.00047333457,0.9720838,0.00024061442],"about_ca_topic_score_codex":0.00027498862,"about_ca_topic_score_gemma":0.000061076455,"teacher_disagreement_score":0.9643964,"about_ca_system_score_codex":0.00062109163,"about_ca_system_score_gemma":0.0039151465,"threshold_uncertainty_score":0.99989},"labels":[],"label_agreement":null},{"id":"W2185972109","doi":"","title":"Preventing heart disease with ASA","year":2003,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Framingham Risk Score; Framingham Heart Study; Dyslipidemia; Guideline; Coronary artery disease; Blood pressure; Disease; Family medicine; Internal medicine; Pathology","score_opus":0.011623151702506393,"score_gpt":0.2534019008471474,"score_spread":0.24177874914464104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185972109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8655375,0.0016307596,0.0043684533,0.0024774263,0.00007536314,0.0009512666,9.714548e-7,0.00014401779,0.124814205],"genre_scores_gemma":[0.987082,0.000008718224,0.004569197,0.0012148279,0.000079838734,0.000018863011,0.0000022464153,0.000011945962,0.0070123565],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993913,0.00003293462,0.00007294342,0.00012957213,0.00022171579,0.00015151709],"domain_scores_gemma":[0.99945104,0.0000047041917,0.000010579665,0.0002857766,0.000031667,0.00021623462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018642932,0.000056666773,0.00012787415,0.000018775489,0.000042866202,0.0000072700054,0.000012948996,0.000015322385,0.00039735742],"category_scores_gemma":[0.0000419404,0.00003560122,0.000079512065,0.000081658625,0.000012593357,0.000028668686,0.000004546578,0.0000603828,0.00006477925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077108055,0.0013835445,0.8976268,0.002129863,0.0008545798,0.00119514,0.00023337711,0.000037710826,0.0012352221,0.034958094,0.022057483,0.037517086],"study_design_scores_gemma":[0.0047254935,0.0005385823,0.38897827,0.00034225915,0.00042881258,0.00073155545,0.00023580945,0.000052248553,0.0038719294,0.0005372203,0.59920764,0.00035016102],"about_ca_topic_score_codex":0.0000338762,"about_ca_topic_score_gemma":0.0000037754307,"teacher_disagreement_score":0.57715017,"about_ca_system_score_codex":0.000016107564,"about_ca_system_score_gemma":0.0001489686,"threshold_uncertainty_score":0.43507853},"labels":[],"label_agreement":null},{"id":"W2186029089","doi":"","title":"Évolution des lignes directrices sur le traitement de la dyslipidémie","year":2014,"lang":"fr","type":"article","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Humanities; Philosophy; Art","score_opus":0.015426360957290214,"score_gpt":0.2310270143594886,"score_spread":0.2156006534021984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186029089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48130012,0.10847854,0.0015448892,0.0022926577,0.0024495677,0.0009608105,0.00012903541,0.00011561128,0.40272877],"genre_scores_gemma":[0.964476,0.0012990205,0.00045085404,0.024864096,0.006610809,0.00006732615,0.000047752044,0.000084384155,0.002099783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687845,0.00063476065,0.00032095064,0.000451009,0.00037713815,0.0013376883],"domain_scores_gemma":[0.9976515,0.0001389163,0.00009331003,0.00058486656,0.00014744907,0.001383968],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014436718,0.00033191746,0.0005578341,0.00024158301,0.00045971826,0.00011195721,0.00019949814,0.00027722286,0.0000090949825],"category_scores_gemma":[0.00010311818,0.00036738382,0.0003736044,0.00051564083,0.0004500586,0.00023973978,0.000017881184,0.00034415213,0.00017844077],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013396849,0.00017623606,0.0005629532,0.00065693463,0.0003057086,0.000057879344,0.00041830522,0.00016174008,0.0031174382,0.012689948,0.01391275,0.9679267],"study_design_scores_gemma":[0.0013343252,0.00025636016,0.14863524,0.00080434605,0.00032814805,0.000009225902,0.00076228846,0.0019076209,0.0012545182,0.00176144,0.84252954,0.0004169277],"about_ca_topic_score_codex":0.51471925,"about_ca_topic_score_gemma":0.09656907,"teacher_disagreement_score":0.9675098,"about_ca_system_score_codex":0.0020988013,"about_ca_system_score_gemma":0.0037057663,"threshold_uncertainty_score":0.9998778},"labels":[],"label_agreement":null},{"id":"W2188021679","doi":"10.1016/j.phrs.2015.12.001","title":"Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"Pharmacological Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Fibrate; Medicine; Fenofibrate; Internal medicine; Meta-analysis; Confidence interval; Subgroup analysis; Randomized controlled trial; Bezafibrate; Fibrinogen; Gastroenterology; Pharmacology; Statin","score_opus":0.6418095105344255,"score_gpt":0.6131023437342582,"score_spread":0.028707166800167272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188021679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023214173,0.98760617,0.000009628524,0.000455635,0.000027113532,0.011262214,0.00013419203,0.000020396234,0.00025250585],"genre_scores_gemma":[0.0018055218,0.9948854,0.0004224603,0.00009173376,0.000052125157,0.0024503076,0.00011563164,0.000027310552,0.00014955367],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9903226,0.004595098,0.0019374506,0.0007584111,0.00171833,0.0006681448],"domain_scores_gemma":[0.99550515,0.0020756368,0.0003856245,0.00065548357,0.00069088367,0.0006872082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0094082905,0.00039553977,0.011895275,0.0006713762,0.00009287359,0.000042104683,0.00032547544,0.0002385393,0.00047908034],"category_scores_gemma":[0.0028924078,0.00023489642,0.0017508254,0.0032669844,0.00016334973,0.00005769407,0.00026355055,0.0011818308,0.000051038183],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011794692,0.00027942535,0.000005487659,0.8949672,0.09038458,0.000077359386,0.000109998604,0.00001917568,0.0000050104027,0.000030282934,0.00065347797,0.013350041],"study_design_scores_gemma":[0.0012362641,0.001257792,0.000005175223,0.03971874,0.91703284,0.000030803567,0.00013208154,0.0002924269,0.000028460941,0.0000062980944,0.039936807,0.00032230938],"about_ca_topic_score_codex":0.00033444038,"about_ca_topic_score_gemma":0.000058493726,"teacher_disagreement_score":0.85524845,"about_ca_system_score_codex":0.00045158557,"about_ca_system_score_gemma":0.001074882,"threshold_uncertainty_score":0.9578798},"labels":[],"label_agreement":null},{"id":"W2188311092","doi":"10.1016/j.jacl.2015.11.006","title":"A lipidologist perspective of global lipid guidelines and recommendations, part 2: Lipid treatment goals","year":2015,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Nottingham; Amarin Corporation; Johnson and Johnson; Alnylam Pharmaceuticals; American Heart Association","keywords":"Medicine; Canadian Cardiovascular Society; Lipidology; Guideline; Position paper; Atherosclerotic cardiovascular disease; Excellence; National Cholesterol Education Program; Family medicine; Internal medicine; Intensive care medicine; Cholesterol; Disease; Pathology; Political science; Angina; Metabolic syndrome","score_opus":0.3604827061725882,"score_gpt":0.5472279023520266,"score_spread":0.18674519617943836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188311092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008122294,0.98247796,0.00008607328,0.0065267375,0.008368242,0.0011171525,0.00013772034,0.000019844772,0.0011850253],"genre_scores_gemma":[0.000015926995,0.95240015,0.0049399654,0.0005098317,0.041588053,0.000030330259,0.000037077727,0.000045341498,0.00043333953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98888826,0.0027027621,0.0066474103,0.0006239964,0.00064208946,0.00049547513],"domain_scores_gemma":[0.9888548,0.0014569728,0.0049459287,0.0008782946,0.0030367693,0.0008272056],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010462627,0.00061400287,0.009915482,0.0002214528,0.00006921186,0.000021935182,0.0003244357,0.0012244004,0.00011991021],"category_scores_gemma":[0.013054179,0.00037941165,0.003583911,0.00040544936,0.0005409434,0.000103800056,0.00018847724,0.0010764137,0.00002547766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042277848,0.00066673156,0.00044056214,0.0022108888,0.003039396,0.00003881578,0.000027967379,3.347943e-7,3.7813077e-8,0.0011013127,0.060117956,0.9319332],"study_design_scores_gemma":[0.0034572915,0.0074411803,0.00014248348,0.005665169,0.0062301233,0.0037764194,0.00026716015,0.0000011411554,1.5753102e-7,0.00038225553,0.9723868,0.00024981893],"about_ca_topic_score_codex":0.00015480572,"about_ca_topic_score_gemma":0.000037929403,"teacher_disagreement_score":0.9316834,"about_ca_system_score_codex":0.0007056876,"about_ca_system_score_gemma":0.0051390426,"threshold_uncertainty_score":0.9998658},"labels":[],"label_agreement":null},{"id":"W2189151867","doi":"10.1111/hdi.2001.5.1.66","title":"Arterial Hypertension Is Associated with Increased Serum Lipoprotein(a) Levels in End‐Stage Renal Disease Patients","year":2001,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Continuous ambulatory peritoneal dialysis; Hemodialysis; Internal medicine; Peritoneal dialysis; End stage renal disease; Lipoprotein(a); Blood pressure; Dialysis; Lipoprotein; Gastroenterology; Ambulatory blood pressure; Cardiology; Endocrinology; Cholesterol","score_opus":0.018948944960768682,"score_gpt":0.24505005371452837,"score_spread":0.2261011087537597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189151867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645203,0.000034518645,0.00030113847,0.0009602034,0.00022603462,0.0005632109,0.00025113506,0.00005467379,0.0011570487],"genre_scores_gemma":[0.99598676,0.000028517712,0.00022548746,0.0016613352,0.00052194955,0.00007686188,0.0007583104,0.00003480131,0.0007059745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973036,0.00012793452,0.0004228098,0.0004788861,0.0013320976,0.00033468616],"domain_scores_gemma":[0.9986654,0.00003730832,0.00016143396,0.0004335149,0.00039762873,0.00030472703],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044073016,0.00022957288,0.00047512868,0.0003007529,0.00008054704,0.000045912606,0.00014384958,0.00011544645,0.0017965976],"category_scores_gemma":[0.0003398125,0.0001884406,0.0002778007,0.00036242764,0.000053872853,0.000176024,0.00005858146,0.00022058989,0.0000419154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00415915,0.002824921,0.94075125,0.000053377007,0.0017086864,0.0018517621,0.00031542903,0.00012511451,0.0020809527,0.00009804742,0.00087009906,0.04516118],"study_design_scores_gemma":[0.009283423,0.00013906196,0.981992,0.00022037629,0.00020077472,0.000023663857,0.00001940589,0.0023644394,0.00068623235,0.00005094948,0.004787577,0.000232113],"about_ca_topic_score_codex":0.00075911003,"about_ca_topic_score_gemma":0.00025882505,"teacher_disagreement_score":0.04492907,"about_ca_system_score_codex":0.0003834257,"about_ca_system_score_gemma":0.00025373002,"threshold_uncertainty_score":0.9991159},"labels":[],"label_agreement":null},{"id":"W2189713131","doi":"10.1194/jlr.m060210","title":"Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a)","year":2015,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Canadian Institutes of Health Research","keywords":"Apolipoprotein B; Lipoprotein(a); Biology; Molecular biology; Transactivation; Reporter gene; Proinflammatory cytokine; Receptor; Gene expression; Chemistry; Biochemistry; Inflammation; Gene; Immunology; Cholesterol","score_opus":0.1465407727459629,"score_gpt":0.4114506250913887,"score_spread":0.2649098523454258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189713131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869447,0.0028786324,0.006171754,0.0014450009,0.00053413224,0.0011904353,0.0000032491891,0.000013371562,0.00081871974],"genre_scores_gemma":[0.9906263,0.00031996993,0.0065876385,0.000043326414,0.002137747,0.000059023463,0.0000051409065,0.0000338531,0.00018702858],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959974,0.00041098802,0.00077646796,0.00022110959,0.002229974,0.00036404387],"domain_scores_gemma":[0.9948609,0.00016286447,0.00035993414,0.00056924357,0.0034364373,0.00061064615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005958627,0.00013576842,0.0006860147,0.00047476648,0.00013297447,0.000028333925,0.00028013144,0.00018136649,0.000024020906],"category_scores_gemma":[0.0020526017,0.000094761046,0.00037075666,0.00047518543,0.000070678965,0.00015595721,0.00008131344,0.0006173071,0.000011400472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028488128,0.00040987495,0.00003589433,0.00043419044,0.00016638762,0.000021256306,0.0018128128,0.000013201582,0.979929,0.0007930703,0.0028002493,0.010735262],"study_design_scores_gemma":[0.008538072,0.004009038,0.00032499112,0.0006934002,0.000107306645,0.00018057282,0.0026912186,0.00095505675,0.93360656,0.0075830393,0.041164864,0.00014585309],"about_ca_topic_score_codex":0.000104720784,"about_ca_topic_score_gemma":0.0000043255736,"teacher_disagreement_score":0.0463224,"about_ca_system_score_codex":0.00030067205,"about_ca_system_score_gemma":0.0015310325,"threshold_uncertainty_score":0.38642433},"labels":[],"label_agreement":null},{"id":"W2189986260","doi":"10.1161/circ.132.suppl_3.16863","title":"Abstract 16863: Alirocumab Effect on Glycemic Measures in Patients Without Diabetes at Baseline","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Ezetimibe; Glycemic; Alirocumab; Placebo; Diabetes mellitus; Adverse effect; Internal medicine; Statin; Endocrinology; Cholesterol; Lipoprotein","score_opus":0.020860067805682805,"score_gpt":0.2621246699150939,"score_spread":0.2412646021094111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189986260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751097,0.00030426992,0.000040182942,0.00008268526,0.0001821394,0.00079166505,0.0000033077733,0.000052578376,0.0010321992],"genre_scores_gemma":[0.99928904,0.0000043762325,0.000024905077,0.0002081414,0.0002218881,0.000036023423,0.00017490129,0.00002637416,0.000014368763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850917,0.00011741724,0.00022199535,0.0002590644,0.00067107513,0.00022125215],"domain_scores_gemma":[0.99924856,0.000035125857,0.00007417569,0.00036976457,0.00010574623,0.00016662324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009976492,0.00014029031,0.00031245936,0.00011915533,0.000039669845,0.000010219808,0.000037177237,0.000109805,0.000018948953],"category_scores_gemma":[0.00037129098,0.00011559892,0.00011557112,0.00014328302,0.000016939963,0.00007442668,0.0000141785495,0.00013937669,0.000102383485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005809827,0.00009494504,0.9587327,0.00010256201,0.000036833004,0.0000036888998,0.00007022424,0.00034475318,0.0007633982,0.000004447472,0.00011661228,0.039148856],"study_design_scores_gemma":[0.0063903723,0.0003789167,0.99006724,0.00018217333,0.000052215557,0.0000018172899,0.00000531674,0.0006109147,0.0014724804,0.000024847086,0.0006972281,0.00011646535],"about_ca_topic_score_codex":0.00010230863,"about_ca_topic_score_gemma":0.00002147551,"teacher_disagreement_score":0.039032392,"about_ca_system_score_codex":0.0004976275,"about_ca_system_score_gemma":0.00006484295,"threshold_uncertainty_score":0.47139874},"labels":[],"label_agreement":null},{"id":"W2192792368","doi":"10.1016/j.atherosclerosis.2015.12.015","title":"Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey","year":2015,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"European Atherosclerosis Society; Amgen","keywords":"Medicine; Statin; Identification (biology); Clinical Practice; Intensive care medicine; Internal medicine; Physical therapy","score_opus":0.05296722094097026,"score_gpt":0.3462701070052699,"score_spread":0.2933028860642996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192792368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985385,0.000116462295,0.000116827156,0.00012660901,0.000083460895,0.0008005872,0.000027493777,0.000016884804,0.00017320958],"genre_scores_gemma":[0.9984597,0.00043638467,0.00071605016,0.00018861724,0.000016887498,0.0000319137,0.00007182634,0.000021082746,0.00005753362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797916,0.00041976105,0.00063507207,0.00027146252,0.00052892667,0.00016564019],"domain_scores_gemma":[0.9986684,0.00012262676,0.0003247279,0.00036993946,0.00037038382,0.00014393678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004276771,0.00010065433,0.00037422258,0.000049313763,0.000022909446,0.000014087091,0.000052980045,0.00008765982,0.000002924801],"category_scores_gemma":[0.0005140927,0.000079848935,0.00005974955,0.0002976353,0.0000669777,0.00010596608,0.000037074304,0.0001316449,0.00000609416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003636439,0.0008382373,0.9778352,0.00006123724,0.00028890127,0.0000016631177,0.00021283627,0.0000013584842,0.0000028296283,0.000029088522,0.000091849855,0.02027316],"study_design_scores_gemma":[0.006200023,0.00072229473,0.9920716,0.00021464993,0.00017853273,3.414302e-7,0.00025915942,0.000028311653,0.000011386593,0.000009865892,0.00022468908,0.00007914416],"about_ca_topic_score_codex":0.000733086,"about_ca_topic_score_gemma":0.00022686331,"teacher_disagreement_score":0.020194016,"about_ca_system_score_codex":0.00007615226,"about_ca_system_score_gemma":0.00007216608,"threshold_uncertainty_score":0.3256145},"labels":[],"label_agreement":null},{"id":"W2194053990","doi":"10.1093/eurheartj/ehv637","title":"Prognostic value of PCSK9 levels in patients with acute coronary syndromes","year":2015,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Hôpitaux Universitaires de Genève; Schweizerische Herzstiftung; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Reuter Foundation","keywords":"Medicine; PCSK9; Internal medicine; Cardiology; Value (mathematics); Acute coronary syndrome; Myocardial infarction; Cholesterol; LDL receptor; Lipoprotein","score_opus":0.046205377105899316,"score_gpt":0.28190150842405265,"score_spread":0.23569613131815334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2194053990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972092,0.00040008142,0.00010307433,0.00024900117,0.00014081472,0.0003681129,0.000005571611,0.000014403436,0.0015097728],"genre_scores_gemma":[0.9975114,0.000014717321,0.0019096332,0.00023218036,0.00015764491,0.0000013030959,0.0000051400866,0.000036913734,0.0001310683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982781,0.0003547903,0.00030870573,0.00014090035,0.0006688267,0.00024866787],"domain_scores_gemma":[0.9990905,0.000015428492,0.000099016994,0.00024745893,0.00020674843,0.00034086296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012190529,0.00011711044,0.000350232,0.00012193228,0.00004111325,0.000015048329,0.000076063036,0.00002352332,0.000030249124],"category_scores_gemma":[0.0000960154,0.000080347505,0.00010713199,0.00016725337,0.00004668565,0.00010530795,0.000039400093,0.00035370069,0.000045552584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027507456,0.00023304786,0.99244666,0.000041526764,0.00019542943,0.0012925534,0.0002573162,0.000028999797,0.000021561753,0.0000109712855,0.0007215435,0.004475336],"study_design_scores_gemma":[0.0043880697,0.0020996095,0.98662496,0.00039046805,0.00010246761,0.0037129906,0.000052387408,0.000009361795,0.00003297317,0.000011285992,0.0024880539,0.000087397486],"about_ca_topic_score_codex":0.000009990878,"about_ca_topic_score_gemma":7.575822e-7,"teacher_disagreement_score":0.0058217044,"about_ca_system_score_codex":0.000073986834,"about_ca_system_score_gemma":0.0003136651,"threshold_uncertainty_score":0.3276476},"labels":[],"label_agreement":null},{"id":"W2200386228","doi":"10.1051/medsci/20153112014","title":"L’intolérance musculaire aux statines","year":2015,"lang":"fr","type":"review","venue":"médecine/sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Wilfrid Laurier University; Centre hospitalier de l'Université Laval","funders":"","keywords":"Medicine; Gynecology","score_opus":0.10549467582612221,"score_gpt":0.39413395196460865,"score_spread":0.28863927613848644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2200386228","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00083104457,0.9543397,0.00040773224,0.0020026031,0.004712037,0.0023968208,0.00009938214,0.00014004933,0.035070617],"genre_scores_gemma":[0.0009138375,0.9823435,0.0031054062,0.0006932467,0.0066516427,0.00025905122,0.00007470117,0.00010507874,0.0058535496],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905574,0.0009052824,0.001637665,0.0018040232,0.0032862646,0.0018094104],"domain_scores_gemma":[0.99597985,0.00032734752,0.0006878485,0.0014304155,0.0005963411,0.0009781944],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008396879,0.0011282975,0.004097131,0.00045557678,0.001072894,0.00022005194,0.0012450698,0.0005943497,0.0011182753],"category_scores_gemma":[0.0011266671,0.00078885735,0.0016377995,0.0027127797,0.0022915257,0.00036466226,0.00031260127,0.0009336827,0.0024802801],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010786591,0.0002448087,0.0006373595,0.019162998,0.0003306715,0.00017594491,0.00016367559,0.00004578399,0.0000016110754,0.005409097,0.0073660836,0.96645117],"study_design_scores_gemma":[0.0015380463,0.0011391323,0.0008594559,0.02243343,0.0014837941,0.00068413105,0.00047210473,0.00021164399,0.00000346909,0.00072714966,0.9696214,0.00082625076],"about_ca_topic_score_codex":0.0015395716,"about_ca_topic_score_gemma":0.00011631503,"teacher_disagreement_score":0.9656249,"about_ca_system_score_codex":0.0005599898,"about_ca_system_score_gemma":0.008636104,"threshold_uncertainty_score":0.99979484},"labels":[],"label_agreement":null},{"id":"W2200388925","doi":"10.7555/jbr.29.20150052","title":"PCSK9 and triglyceride-rich lipoprotein metabolism","year":2015,"lang":"en","type":"review","venue":"Journal of Biomedical Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"PCSK9; Endocrinology; Internal medicine; Triglyceride; Kexin; LDL receptor; Lipoprotein; Apolipoprotein B; Postprandial; Lipid metabolism; Proprotein convertase; Chemistry; Biology; Cholesterol; Medicine; Insulin","score_opus":0.2065980058303717,"score_gpt":0.4877766635946856,"score_spread":0.2811786577643139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2200388925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000107749824,0.9962417,0.00006036116,0.0009831549,0.00046798095,0.0013103497,0.000018839015,0.000011983811,0.00079790107],"genre_scores_gemma":[0.000025261701,0.9923564,0.0009973289,0.000045103152,0.005487532,0.000045351917,0.0000188668,0.0000782625,0.00094587944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98918825,0.0014581117,0.0017237043,0.00042073097,0.006365564,0.0008436266],"domain_scores_gemma":[0.99419796,0.00039937315,0.00054886896,0.000728863,0.0017057323,0.0024192045],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.023873577,0.00037882314,0.004331545,0.0018651363,0.00012911302,0.000089774476,0.00047851328,0.00085791573,0.00019161576],"category_scores_gemma":[0.0041042073,0.00021861517,0.001140544,0.0018291465,0.0006611686,0.0001042111,0.00032889153,0.0042763264,0.00009381047],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001206534,0.00018681845,3.3120227e-7,0.014050443,0.0008185403,0.0013388857,0.000043810316,3.3384049e-9,0.0000022820816,0.000047878137,0.012481343,0.970909],"study_design_scores_gemma":[0.0017948187,0.0012425614,0.000010657575,0.012579233,0.0011850031,0.007029957,0.00006422113,0.0000014837642,0.0000030562976,0.00017420985,0.975743,0.00017179635],"about_ca_topic_score_codex":0.00010430068,"about_ca_topic_score_gemma":0.0000014349235,"teacher_disagreement_score":0.9707372,"about_ca_system_score_codex":0.00046241214,"about_ca_system_score_gemma":0.007994231,"threshold_uncertainty_score":0.9980208},"labels":[],"label_agreement":null},{"id":"W2205130180","doi":"10.1016/j.jacc.2009.03.011","title":"Arginine and Old MACE","year":2009,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Mace; Medicine; Arginine; Cardiology; Internal medicine; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.0106867393580264,"score_gpt":0.2559909417439813,"score_spread":0.2453042023859549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205130180","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11319216,0.006640174,0.00010158853,0.8753123,0.00091371825,0.00057818927,0.00011763781,0.000009291624,0.0031349051],"genre_scores_gemma":[0.2176648,0.0054301242,0.0015573074,0.7466005,0.02428017,0.0000072708317,0.00000782768,0.00009599331,0.004355999],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99769455,0.000503192,0.00067519036,0.00019470543,0.00062764314,0.00030473535],"domain_scores_gemma":[0.9973475,0.00012517734,0.0013854667,0.000701749,0.0003357615,0.000104347164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008004598,0.00024360129,0.0025843515,0.00022159192,0.000046158693,0.0000034258062,0.00029322432,0.00026400262,0.000006281693],"category_scores_gemma":[0.00018192001,0.00014439733,0.0012610197,0.00029560403,0.00053903175,0.00002316265,0.0000799042,0.0018303602,0.0000010563722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003371057,0.000010455553,0.0017967607,0.00016402951,0.00181549,0.0032791628,0.000009506566,0.000016874495,0.00016613591,0.00001790629,0.98638344,0.00600312],"study_design_scores_gemma":[0.0011954963,0.0019473293,0.022254,0.00024013556,0.0011921225,0.03075392,0.00004669817,0.0000018321986,0.00007228337,0.00012035465,0.94204235,0.00013347002],"about_ca_topic_score_codex":0.000024449137,"about_ca_topic_score_gemma":6.8427914e-7,"teacher_disagreement_score":0.1287118,"about_ca_system_score_codex":0.00010416329,"about_ca_system_score_gemma":0.00047620398,"threshold_uncertainty_score":0.79521054},"labels":[],"label_agreement":null},{"id":"W2205630783","doi":"10.1016/j.clinthera.2015.10.002","title":"Lipid-modifying Therapy: The Clinician’s Perspective","year":2015,"lang":"en","type":"editorial","venue":"Clinical Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Task force; Position paper; Atherosclerotic cardiovascular disease; Canadian Cardiovascular Society; Scopus; Disease; Internal medicine; Cardiology; Family medicine; Intensive care medicine; MEDLINE; Myocardial infarction; Pathology","score_opus":0.17595069695128174,"score_gpt":0.46742499645707564,"score_spread":0.2914742995057939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205630783","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059351337,0.039662577,0.00014629148,0.0056658303,0.94258523,0.0021185,0.00009357966,0.0002356889,0.008898803],"genre_scores_gemma":[0.0011124733,0.0408418,0.0002666553,0.006910119,0.9476548,0.00009207741,0.00011789077,0.00022313168,0.0027810403],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928887,0.0012598466,0.0016001917,0.0010842752,0.002445192,0.00072177843],"domain_scores_gemma":[0.99032813,0.0033608237,0.0006704291,0.0028457588,0.0023039016,0.0004909745],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.009542753,0.00065025035,0.0020821684,0.00008883333,0.00027302638,0.000112870905,0.0007407631,0.0027238026,0.00007776303],"category_scores_gemma":[0.003222202,0.0003824817,0.002240552,0.00033848378,0.00065467897,0.00005620567,0.00019506902,0.005680328,0.00022288543],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009880601,0.0005143797,0.0001378493,0.000071219656,0.002814992,0.00004011847,0.00044463214,0.0000012052126,0.0000011192211,0.00014198152,0.8633383,0.13150613],"study_design_scores_gemma":[0.0048105223,0.0017638954,0.00019481349,0.0002192986,0.0011326275,0.000012895474,0.00070141186,0.00005358563,0.000004151736,0.0011246843,0.98955995,0.0004221839],"about_ca_topic_score_codex":0.00022513153,"about_ca_topic_score_gemma":0.000024028355,"teacher_disagreement_score":0.13108394,"about_ca_system_score_codex":0.0004991577,"about_ca_system_score_gemma":0.0042595644,"threshold_uncertainty_score":0.99986273},"labels":[],"label_agreement":null},{"id":"W2207184445","doi":"10.1016/j.jacc.2014.06.1185","title":"Primary Prevention of Atherosclerotic Cardiovascular Disease","year":2014,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; Canadian Heart Research Centre; University of Toronto","funders":"","keywords":"Medicine; Atherosclerotic cardiovascular disease; Primary prevention; Disease; Clinical Practice; Intensive care medicine; Internal medicine; Cardiology; Family medicine","score_opus":0.017249172585755035,"score_gpt":0.24929841776487244,"score_spread":0.2320492451791174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2207184445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52050817,0.040328234,0.011183493,0.41285482,0.005045619,0.00546638,0.00063579145,0.000046137895,0.003931363],"genre_scores_gemma":[0.8464933,0.0048581194,0.0018706867,0.12476606,0.020419905,0.000044639077,0.00003965584,0.00023261552,0.0012750026],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948756,0.0017246647,0.0012295491,0.00029006228,0.0015276372,0.0003524881],"domain_scores_gemma":[0.99469435,0.00015209695,0.0024639282,0.001824352,0.00070922653,0.00015606178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020647736,0.0003260738,0.0041789473,0.00027961822,0.000050145245,0.0000028125098,0.0005540741,0.0002767284,0.0000071168083],"category_scores_gemma":[0.00033104097,0.00020992168,0.0073610763,0.00040224378,0.00077195646,0.00003740807,0.00013449272,0.0013814227,0.0000018492091],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024277265,0.00016558464,0.010078241,0.0062976703,0.04776497,0.0033312032,0.00003558642,0.0026303136,0.0009729691,0.000042050815,0.90935606,0.016897602],"study_design_scores_gemma":[0.0025044593,0.0021308768,0.057487726,0.0013449091,0.011642252,0.0047359224,0.000043103395,0.0000075509383,0.00014012048,0.00027164898,0.9194066,0.00028482932],"about_ca_topic_score_codex":0.0000285435,"about_ca_topic_score_gemma":2.3794276e-7,"teacher_disagreement_score":0.32598516,"about_ca_system_score_codex":0.00023049646,"about_ca_system_score_gemma":0.0013591003,"threshold_uncertainty_score":0.85603577},"labels":[],"label_agreement":null},{"id":"W2208874718","doi":"10.1016/j.gheart.2014.02.002","title":"Atherosclerosis: A Longue Durée Approach","year":2014,"lang":"fr","type":"editorial","venue":"Global Heart","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian Heart Research Centre","funders":"","keywords":"Checklist; Medicine; Strengthening the reporting of observational studies in epidemiology; Observational study; Global health; Download; Medical education; Epidemiology; Family medicine; Systematic review; Public health; MEDLINE; Political science; Pathology; Psychology; World Wide Web","score_opus":0.012213564902081206,"score_gpt":0.27111815676033285,"score_spread":0.25890459185825165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2208874718","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039523947,0.027408348,0.0031341217,0.0009275953,0.9277745,0.002648492,0.000899885,0.00030794347,0.032946717],"genre_scores_gemma":[0.016144387,0.0014741393,0.0029786546,0.0010548752,0.97318035,0.00025989942,0.0008137166,0.0001492065,0.003944767],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99187493,0.0007489646,0.0010114677,0.0015410214,0.0028722563,0.0019513697],"domain_scores_gemma":[0.9955104,0.00013461972,0.00024760407,0.0023115908,0.00048094726,0.0013148215],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026241804,0.0010025958,0.0024254317,0.000077453835,0.0003586116,0.0001419978,0.00047981227,0.0025935709,0.00037552672],"category_scores_gemma":[0.0008065868,0.0009287087,0.0017602217,0.0006092469,0.00036506142,0.00010694051,0.00025838544,0.0016841406,0.004204666],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017702428,0.0005180302,0.0019160932,0.003033935,0.00069066015,0.000028431105,0.000074068805,0.000024361769,0.000013249487,0.0010107099,0.9797374,0.01277601],"study_design_scores_gemma":[0.0035751811,0.00082485186,0.011391355,0.001993488,0.0010341513,0.00026712223,0.00010157841,0.0002016147,0.000014686514,0.00010911749,0.9797243,0.0007625667],"about_ca_topic_score_codex":0.005476584,"about_ca_topic_score_gemma":0.000100289886,"teacher_disagreement_score":0.045405854,"about_ca_system_score_codex":0.0020129234,"about_ca_system_score_gemma":0.0020454007,"threshold_uncertainty_score":0.99931633},"labels":[],"label_agreement":null},{"id":"W2211406338","doi":"10.1016/j.cjca.2015.08.020","title":"Tribulations of Recent Cardiology Trials, the Audacity of Hope, and HOPE-3","year":2015,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cholesterylester transfer protein; Internal medicine; Clinical trial; Disease; Scopus; Cholesterol; Cardiology; Lipoprotein; MEDLINE","score_opus":0.07388744055041653,"score_gpt":0.2994320913525285,"score_spread":0.225544650802112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2211406338","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021726241,0.09790145,0.004361319,0.84686434,0.006920952,0.003138261,0.0017155595,0.000013060546,0.017358793],"genre_scores_gemma":[0.7841673,0.021961764,0.0006716952,0.121863596,0.06975522,0.00005920125,0.000566556,0.00021303275,0.0007416501],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949322,0.00240006,0.0015107188,0.0002386541,0.00044256606,0.0004758078],"domain_scores_gemma":[0.99531823,0.00041864862,0.0012107976,0.00076699146,0.001764739,0.00052057026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007130083,0.00027608022,0.0040196595,0.0005314441,0.0000823379,0.000009170066,0.00028938064,0.001043018,0.000035431192],"category_scores_gemma":[0.0030290498,0.00017671885,0.0011674097,0.00026075996,0.0006689952,0.000036294827,0.000029779978,0.0018360555,0.000001667736],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013023817,0.0000013893743,0.0025294013,0.00017128141,0.0031584736,0.0007101549,0.000096648495,0.00017491078,0.000020329313,0.000038967046,0.9785276,0.01444059],"study_design_scores_gemma":[0.0017709353,0.00063036865,0.009616635,0.00011576064,0.0019656238,0.004952088,0.00007413176,0.0000012874216,0.000022073353,0.00025577762,0.98046356,0.00013177114],"about_ca_topic_score_codex":0.0029720897,"about_ca_topic_score_gemma":0.00051453005,"teacher_disagreement_score":0.76244104,"about_ca_system_score_codex":0.00028276624,"about_ca_system_score_gemma":0.0078348955,"threshold_uncertainty_score":0.99778974},"labels":[],"label_agreement":null},{"id":"W2211782531","doi":"10.1007/978-1-4615-1321-6_43","title":"Lipid Clinics/Cardiovascular Risk Reduction Clinics Current State and Future Consideration","year":2001,"lang":"en","type":"article","venue":"Advances in experimental medicine and biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Current (fluid); Medicine; Reduction (mathematics); Intensive care medicine; Engineering; Mathematics; Electrical engineering","score_opus":0.03153235092780681,"score_gpt":0.377307527780663,"score_spread":0.3457751768528562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2211782531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6177786,0.37964234,0.00022677086,0.0004905295,0.00118514,0.0003925216,0.000002668532,0.000016746704,0.00026470327],"genre_scores_gemma":[0.5955734,0.40174204,0.00035590408,0.00022298918,0.0020238948,0.000033100565,0.000030660092,0.000008907492,0.000009075278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845964,0.00020795286,0.00050148304,0.0004503405,0.00014250225,0.00023807804],"domain_scores_gemma":[0.99934906,0.000061682455,0.00012266716,0.00027505623,0.000049114537,0.00014243473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008315144,0.00018080573,0.0006094489,0.00010882968,0.00009864973,0.0000050034096,0.000030165562,0.00010380787,0.000027826478],"category_scores_gemma":[0.00010645761,0.00012847321,0.000108530374,0.00013755557,0.00034966346,0.00013178868,0.00003740063,0.00031860793,0.000002834408],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002915917,0.00010256701,0.025514923,0.00005052983,0.00010068473,0.000018196964,0.0005383289,0.0000031634884,0.0005993552,0.00018029984,0.000042264008,0.9725581],"study_design_scores_gemma":[0.00933487,0.003996479,0.020279443,0.00031999042,0.00025214112,0.0012578598,0.0041831164,0.00013201886,0.0017393511,0.0019240713,0.9562363,0.0003443464],"about_ca_topic_score_codex":0.00006303529,"about_ca_topic_score_gemma":0.000012336431,"teacher_disagreement_score":0.97221375,"about_ca_system_score_codex":0.000043285523,"about_ca_system_score_gemma":0.000037146387,"threshold_uncertainty_score":0.52389854},"labels":[],"label_agreement":null},{"id":"W2215742785","doi":"10.1186/s12876-015-0371-6","title":"Decreased PCSK9 expression in human hepatocellular carcinoma","year":2015,"lang":"en","type":"article","venue":"BMC Gastroenterology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; McGill University; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Canadian Association of Gastroenterology","keywords":"Hepatocellular carcinoma; Medicine; Cirrhosis; PCSK9; Hepatology; Immunohistochemistry; Internal medicine; Carcinoma; Tissue microarray; Gastroenterology; Pathology; Cholesterol; LDL receptor; Lipoprotein","score_opus":0.0385205292777877,"score_gpt":0.27411970033069544,"score_spread":0.23559917105290773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215742785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99572647,0.00028364675,0.0027410716,0.00016458644,0.00012540647,0.00048589878,0.0000020305301,0.000043574804,0.00042729458],"genre_scores_gemma":[0.99694896,0.0000028795196,0.0019820891,0.00059862767,0.00024202789,0.00006980214,0.00004510946,0.000024037134,0.0000864729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983867,0.00026332735,0.0003015063,0.00032154773,0.00028062856,0.00044630474],"domain_scores_gemma":[0.99893904,0.000007975105,0.00006105265,0.0005378311,0.000066606415,0.00038749908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057312386,0.00014911446,0.0004336558,0.00015410202,0.00003245693,0.000006284438,0.000097326825,0.000112689464,0.00004642822],"category_scores_gemma":[0.00006223899,0.00012891922,0.00015703944,0.000079526086,0.000055320346,0.000041196272,0.000070111346,0.0002053011,0.000027370295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006352079,0.000167111,0.9917061,0.000059005768,0.00001246366,0.00022864022,0.0000899049,0.0000070486,0.0065408926,0.000018377996,0.0004083214,0.00012695907],"study_design_scores_gemma":[0.011002775,0.0017623457,0.9784705,0.000077965335,0.000051637697,0.00049304665,0.0001957029,0.00051986123,0.00530472,0.00009586772,0.0019325698,0.00009302967],"about_ca_topic_score_codex":0.0004275907,"about_ca_topic_score_gemma":0.00021760417,"teacher_disagreement_score":0.0132355895,"about_ca_system_score_codex":0.00012193913,"about_ca_system_score_gemma":0.00012345075,"threshold_uncertainty_score":0.5257173},"labels":[],"label_agreement":null},{"id":"W2217122343","doi":"10.1016/j.jacc.2008.04.023","title":"We Must Prevent Disease, Not Predict Events⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.","year":2008,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cardiology; Disease; Internal medicine","score_opus":0.03632074427851752,"score_gpt":0.3150799285193645,"score_spread":0.278759184240847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2217122343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54372716,0.01022761,0.00019808451,0.41771364,0.010464687,0.00956208,0.007417749,0.000014332302,0.0006746476],"genre_scores_gemma":[0.9431002,0.02585029,0.00014144157,0.014292679,0.015833935,0.00018665621,0.00000937675,0.00015224611,0.0004331803],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9578053,0.030454258,0.005880327,0.0008114149,0.0038877504,0.0011609899],"domain_scores_gemma":[0.9648026,0.006783986,0.020538071,0.005415276,0.0021793637,0.00028069093],"candidate_categories":["metaepi_narrow","sts","open_science","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.018924693,0.001156543,0.010806212,0.00064530206,0.0005527409,0.000016742199,0.00616666,0.00054757576,0.000015029894],"category_scores_gemma":[0.007122381,0.00037727653,0.006254437,0.004027378,0.011586265,0.00015495798,0.001337852,0.005201954,3.7963324e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016751606,0.00022476361,0.026242437,0.00081145734,0.013617562,0.0007972693,0.0011051132,0.0028202578,0.0013359565,0.000056411118,0.9344295,0.0018076237],"study_design_scores_gemma":[0.004746568,0.0070513436,0.2290613,0.0016042112,0.009652534,0.015178976,0.010843356,0.000024594941,0.0006398998,0.00030588135,0.72028494,0.00060637185],"about_ca_topic_score_codex":0.00075173675,"about_ca_topic_score_gemma":0.00014065296,"teacher_disagreement_score":0.40342095,"about_ca_system_score_codex":0.0005040038,"about_ca_system_score_gemma":0.005520566,"threshold_uncertainty_score":0.9998679},"labels":[],"label_agreement":null},{"id":"W2217129485","doi":"10.1016/j.cjca.2015.08.011","title":"suPAR: A Cardiac Biomarker With a Future?","year":2015,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Coronary artery disease; Disease; Biomarker; Framingham Risk Score; Scopus; Cardiology; Intensive care medicine; MEDLINE","score_opus":0.019778669928825227,"score_gpt":0.23947620137987033,"score_spread":0.2196975314510451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2217129485","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034386746,0.04449013,0.00072331494,0.9013549,0.00869118,0.0011574794,0.00034612007,0.00002564179,0.039772544],"genre_scores_gemma":[0.058906198,0.0015080305,0.0011232086,0.6345806,0.29916736,0.00006223895,0.00061617664,0.00043585539,0.0036003222],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970015,0.00048153359,0.00056545547,0.00032260577,0.00067085226,0.0009580009],"domain_scores_gemma":[0.99620384,0.00003576584,0.00033663577,0.0008301652,0.0012062285,0.0013873607],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014722737,0.00039964874,0.0023776984,0.00073325785,0.00008861462,0.00003336918,0.00026779203,0.0012838141,0.000038693397],"category_scores_gemma":[0.000097106655,0.0002796549,0.0012346609,0.0002660763,0.0002620102,0.000058492216,0.000015330053,0.0026120045,0.000030722],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099039054,6.293073e-7,0.002302841,0.00014665411,0.0031028255,0.016640691,0.00005391973,0.000008480224,0.0000025365018,0.000005673055,0.9703553,0.00728141],"study_design_scores_gemma":[0.0012656095,0.0007468841,0.003417002,0.00019005722,0.0014372276,0.019207818,0.000114882336,3.579612e-7,0.0000028991492,0.000031260974,0.97330856,0.00027741527],"about_ca_topic_score_codex":0.0022950815,"about_ca_topic_score_gemma":0.00060338405,"teacher_disagreement_score":0.29047617,"about_ca_system_score_codex":0.0007683411,"about_ca_system_score_gemma":0.0154168615,"threshold_uncertainty_score":0.99996555},"labels":[],"label_agreement":null},{"id":"W2218614179","doi":"10.1016/j.jacc.2007.10.033","title":"The Yin and Yang of High-Density Lipoprotein Cholesterol⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.","year":2008,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Cholesterol","score_opus":0.04581554373052283,"score_gpt":0.3396601069690545,"score_spread":0.2938445632385317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2218614179","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.496483,0.46431303,0.00013153075,0.019953806,0.005854486,0.010248641,0.0025420946,0.00001057848,0.00046283932],"genre_scores_gemma":[0.49392676,0.5022614,0.00010605317,0.0003349839,0.0031378435,0.00008894458,0.0000021758617,0.00007851039,0.00006330794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9579084,0.031505622,0.0062732017,0.00071266654,0.0026575471,0.00094257534],"domain_scores_gemma":[0.9610702,0.007825779,0.023764677,0.004907658,0.0022047574,0.00022693277],"candidate_categories":["metaepi_narrow","metaepi_broad","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.026198883,0.0010993516,0.014796299,0.0005253123,0.0006798284,0.000022952285,0.005088896,0.00047340753,0.000003888357],"category_scores_gemma":[0.0070955437,0.000342097,0.005564846,0.004162948,0.014860815,0.00013811795,0.0014401925,0.003557718,2.4650848e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04554413,0.0011522486,0.039896928,0.014621575,0.093223356,0.0012873455,0.007380169,0.0037842488,0.0065619117,0.0020002443,0.30739725,0.4771506],"study_design_scores_gemma":[0.005018233,0.007878626,0.14810437,0.0051018745,0.013011902,0.029411456,0.016262433,0.000010215781,0.00087448943,0.0004588588,0.77312464,0.00074292324],"about_ca_topic_score_codex":0.0026353577,"about_ca_topic_score_gemma":0.00053921645,"teacher_disagreement_score":0.47640768,"about_ca_system_score_codex":0.00034609457,"about_ca_system_score_gemma":0.0035885333,"threshold_uncertainty_score":0.9999031},"labels":[],"label_agreement":null},{"id":"W2229975202","doi":"","title":"Dyslipidemia and coronary artery disease.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Dyslipidemia; Diabetes mellitus; Disease; Coronary artery disease; Obesity; Atherosclerotic cardiovascular disease; Internal medicine; Intensive care medicine; Cardiology; Endocrinology","score_opus":0.014850713718150181,"score_gpt":0.2177976676743938,"score_spread":0.2029469539562436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2229975202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827972,0.0039820555,0.000010658478,0.0021708815,0.00008086814,0.0009006971,0.0000056698805,0.000068828056,0.009983134],"genre_scores_gemma":[0.992147,0.0004607008,0.00005025591,0.001932397,0.00045752758,0.00059990725,0.000011549556,0.000013843276,0.0043267687],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99921125,0.000031238887,0.00011640668,0.00018660282,0.00019436723,0.000260157],"domain_scores_gemma":[0.99922484,0.000011619477,0.0000117903755,0.00029195182,0.000013159135,0.00044662057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027088635,0.000077457524,0.00017967401,0.000025478079,0.000045299283,0.000009689482,0.000026729253,0.00003807823,0.00020430463],"category_scores_gemma":[0.000027083146,0.00006240453,0.00008702588,0.000058667825,0.00003971605,0.000049430906,0.000011148327,0.00009223381,0.000036275756],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014057549,0.000032398733,0.029128337,0.0000651337,0.00006390713,0.000113580616,0.000013856703,8.908691e-7,0.0000012999639,0.00003331034,0.0016547984,0.9687519],"study_design_scores_gemma":[0.00076063734,0.000014739289,0.9092494,0.000010699006,0.000080504724,0.00007729604,0.000005671037,0.000019568748,0.000006551025,0.000093959155,0.08961799,0.00006297887],"about_ca_topic_score_codex":0.000012889437,"about_ca_topic_score_gemma":0.0000015176624,"teacher_disagreement_score":0.9686889,"about_ca_system_score_codex":0.000029908868,"about_ca_system_score_gemma":0.00003258628,"threshold_uncertainty_score":0.25447828},"labels":[],"label_agreement":null},{"id":"W2231293475","doi":"","title":"Abstract 15052: Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy: Effect of Baseline Risk Factors for Diabetes","year":2012,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Atorvastatin; Simvastatin; Internal medicine; Diabetes mellitus; Myocardial infarction; Risk factor; Odds ratio; Statin; Type 2 diabetes; Cardiology; Endocrinology","score_opus":0.019826877751672696,"score_gpt":0.2677364193937805,"score_spread":0.24790954164210782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2231293475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99065703,0.0058173887,0.0010231566,0.000025967514,0.0007491582,0.001608952,0.000037676025,0.00007057854,0.000010095397],"genre_scores_gemma":[0.99811655,0.00018375214,0.00021775291,0.0000051969,0.0010682133,0.000090964364,0.00026072835,0.000052280357,0.000004538374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981347,0.00022679073,0.00040106833,0.00028617063,0.00052856037,0.0004227222],"domain_scores_gemma":[0.9986445,0.00023036046,0.00021923363,0.0005683145,0.00011527272,0.00022235513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020833975,0.00023276724,0.00062139425,0.00013487224,0.0001368533,0.000011399295,0.00004875206,0.00014239628,0.00003515773],"category_scores_gemma":[0.0005291625,0.0001923113,0.0010051652,0.0001940302,0.000031524185,0.00021017336,0.00001211003,0.00015281541,0.0000056735744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044479308,0.000105130945,0.90044415,0.00085834885,0.0021678486,2.5300628e-7,0.0004001277,0.0017785169,0.02837844,0.0000033066337,0.000051303006,0.06536776],"study_design_scores_gemma":[0.0044888966,0.00021809174,0.84591824,0.00009494225,0.00067247025,0.000001663153,0.00004415958,0.00029426144,0.14775093,0.0000104433875,0.000347328,0.00015856118],"about_ca_topic_score_codex":0.00019998635,"about_ca_topic_score_gemma":9.945281e-7,"teacher_disagreement_score":0.11937249,"about_ca_system_score_codex":0.0001764016,"about_ca_system_score_gemma":0.00006960906,"threshold_uncertainty_score":0.7842227},"labels":[],"label_agreement":null},{"id":"W2234206893","doi":"10.1194/jlr.r060582","title":"Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?","year":2015,"lang":"en","type":"review","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":298,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University; University of Windsor","funders":"Canadian HIV Trials Network, Canadian Institutes of Health Research; Canadian Institutes of Health Research; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Lipoprotein(a); Lipoprotein; Medicine; Disease; Internal medicine; Cardiology; Cholesterol","score_opus":0.2007136487093822,"score_gpt":0.43912076062221694,"score_spread":0.23840711191283476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2234206893","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001451125,0.99185014,0.00001907819,0.00019422351,0.00054218725,0.00564317,0.000034556684,0.000020811105,0.001550716],"genre_scores_gemma":[0.0002370389,0.9921491,0.00023434297,0.000012513996,0.0060482468,0.00033383354,0.00001534892,0.00017896715,0.00079056487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98541224,0.0037906573,0.002045241,0.0006959319,0.0068968427,0.0011591088],"domain_scores_gemma":[0.99374604,0.00024377425,0.0005395888,0.0019828458,0.0017964885,0.0016912365],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.019892536,0.0006027883,0.0070157717,0.0022831198,0.00011679487,0.00011718538,0.0007458295,0.0005801154,0.00012646434],"category_scores_gemma":[0.0027728963,0.00039464404,0.00543597,0.0021122652,0.00022474512,0.00020369168,0.00025680926,0.0045643896,0.00013469093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018301728,0.00037634856,0.00004235784,0.041064247,0.0033155836,0.002683817,0.000087654356,0.000007131913,4.3463848e-7,0.0000060943175,0.0013734945,0.95085984],"study_design_scores_gemma":[0.0017715539,0.0008505377,0.00029358355,0.04098095,0.001571549,0.0011008974,0.00004061614,0.0000052585647,0.0000016850912,0.00002941412,0.95303464,0.00031928392],"about_ca_topic_score_codex":0.00029985962,"about_ca_topic_score_gemma":0.0000082189545,"teacher_disagreement_score":0.95166117,"about_ca_system_score_codex":0.002158198,"about_ca_system_score_gemma":0.012640452,"threshold_uncertainty_score":0.9998506},"labels":[],"label_agreement":null},{"id":"W2234429261","doi":"10.1007/s10557-015-6637-y","title":"Pharmacogenomics to Revive Drug Development in Cardiovascular Disease","year":2016,"lang":"en","type":"review","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Pharmacogenomics; Medicine; Drug development; Drug; Clinical trial; Disease; Intensive care medicine; Pharmacogenetics; Bioinformatics; Pharmacology; Internal medicine; Genetics","score_opus":0.032088515893481134,"score_gpt":0.29952753485543415,"score_spread":0.267439018961953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2234429261","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005288232,0.9914737,0.00031801808,0.000079539255,0.0004637716,0.0065511186,0.00006203894,0.000104304745,0.0004187031],"genre_scores_gemma":[0.00012357521,0.9953917,0.00043486917,0.00035920864,0.0013536543,0.0015648329,0.00010935915,0.00029341137,0.00036936437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934649,0.0008266889,0.001210551,0.0018864977,0.0016014065,0.0010099558],"domain_scores_gemma":[0.99516255,0.00007122647,0.00015296826,0.0030859986,0.00019947352,0.0013277731],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00427641,0.0011871096,0.0068185716,0.00068138493,0.00020129861,0.00008286717,0.00039014185,0.00034644525,0.000044819466],"category_scores_gemma":[0.000063389656,0.0008311489,0.009357049,0.0007353697,0.00010427108,0.00010502163,0.0002491325,0.00064928865,0.00020897509],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008032267,0.000076026176,0.000008361904,0.009123738,0.021945523,0.0005053998,0.00028702206,0.0000075507896,3.0772838e-7,0.000022791924,0.00013141433,0.9678115],"study_design_scores_gemma":[0.003193701,0.000036385034,0.00005365978,0.015636645,0.0042627677,0.00019879031,0.000028353024,8.518595e-7,0.000010797661,0.000012364975,0.97556347,0.0010022116],"about_ca_topic_score_codex":0.00009740886,"about_ca_topic_score_gemma":0.0000011028052,"teacher_disagreement_score":0.97543204,"about_ca_system_score_codex":0.0006574798,"about_ca_system_score_gemma":0.0015989003,"threshold_uncertainty_score":0.9994139},"labels":[],"label_agreement":null},{"id":"W2235916715","doi":"10.1016/j.jacc.2015.10.055","title":"Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification","year":2016,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging","keywords":"Medicine; Apolipoprotein B; Internal medicine; Context (archaeology); Body mass index; Cholesterol; Odds ratio; Agatston score; Cohort; Apolipoprotein A1; Cardiology; Risk factor; Lipoprotein; Endocrinology; Coronary artery disease; Coronary artery calcium","score_opus":0.011096879028356463,"score_gpt":0.252945683673166,"score_spread":0.24184880464480954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2235916715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939471,0.00047607438,0.0010375901,0.0037167969,0.00017060003,0.00046677137,0.00006332065,0.0000044904295,0.00011728863],"genre_scores_gemma":[0.9983572,0.00061387394,0.00023996699,0.000088665634,0.0006184849,0.000012837932,6.8307304e-7,0.00001555724,0.00005277582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825996,0.00038366354,0.00060836994,0.00017206755,0.00035247623,0.00022347293],"domain_scores_gemma":[0.99852115,0.00010579092,0.0006483125,0.00044719136,0.00015235759,0.00012518169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068069395,0.000129202,0.0009751652,0.00014304217,0.00003530694,0.0000021059873,0.00017252236,0.000058813344,0.0000011237427],"category_scores_gemma":[0.00018127565,0.00006889197,0.0002838538,0.00022742854,0.0004697062,0.0000856263,0.000065226384,0.00022392318,7.614168e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013498157,0.000027767062,0.94861245,0.00006833356,0.000360604,0.00015507994,0.00005907781,0.0000066064167,0.004725237,0.000029810684,0.00021036746,0.044394866],"study_design_scores_gemma":[0.0027383673,0.0012106075,0.98897964,0.00046252244,0.00013473693,0.0048620813,0.00021179355,0.000004163117,0.0006800464,0.00011306283,0.00053110387,0.00007185798],"about_ca_topic_score_codex":0.00008831088,"about_ca_topic_score_gemma":0.00003234281,"teacher_disagreement_score":0.044323005,"about_ca_system_score_codex":0.00011935034,"about_ca_system_score_gemma":0.00019271894,"threshold_uncertainty_score":0.2809333},"labels":[],"label_agreement":null},{"id":"W2238462784","doi":"10.1159/000442976","title":"Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis","year":2016,"lang":"en","type":"review","venue":"Journal of Innate Immunity","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; National Sanitarium Association","keywords":"Sepsis; PCSK9; Medicine; Internal medicine; Immune system; Immunology; Lipoprotein; LDL receptor; Cholesterol","score_opus":0.030254480830088634,"score_gpt":0.29332818589682536,"score_spread":0.2630737050667367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2238462784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41119826,0.58763075,0.000013946354,0.00015744168,0.00007545182,0.0008046574,0.000043747157,0.000011582367,0.00006413796],"genre_scores_gemma":[0.16224305,0.83697486,0.00046123218,0.000026271513,0.00012274977,0.000021087142,0.000008345944,0.00006112097,0.00008129893],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962324,0.0010772351,0.0014311562,0.00017174322,0.0007853487,0.00030214756],"domain_scores_gemma":[0.99568975,0.00022504764,0.002778868,0.0005280724,0.000600267,0.00017800678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033875688,0.00038701054,0.0030029279,0.00026389663,0.00026519582,0.000030139016,0.00032930842,0.00025621263,0.000025186286],"category_scores_gemma":[0.0006188993,0.00017813644,0.0006179537,0.00038315804,0.00021573485,0.00010890209,0.00012798424,0.0012402897,0.0000020658101],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029294218,0.00036297567,0.0002017716,0.01845634,0.031150464,0.00038081224,0.0018179162,3.586968e-7,0.0012337845,0.000012199758,0.00004932333,0.9434046],"study_design_scores_gemma":[0.05698242,0.0013573281,0.13110662,0.5592121,0.02196685,0.011034698,0.0010315411,0.000002912727,0.02743718,0.00003545798,0.1880277,0.0018052141],"about_ca_topic_score_codex":0.000054523916,"about_ca_topic_score_gemma":0.000019398349,"teacher_disagreement_score":0.9415994,"about_ca_system_score_codex":0.00037337933,"about_ca_system_score_gemma":0.0015740264,"threshold_uncertainty_score":0.72641927},"labels":[],"label_agreement":null},{"id":"W2250040605","doi":"10.1074/jbc.m115.642991","title":"Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9","year":2015,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Institut National de la Recherche Scientifique","funders":"Canadian Institutes of Health Research","keywords":"Kexin; PCSK9; LDL receptor; Proprotein convertase; Tetraspanin; Biology; Cell biology; Chemistry; Biochemistry; Cholesterol; Lipoprotein; Cell","score_opus":0.04209304433900273,"score_gpt":0.25597402115886847,"score_spread":0.21388097681986573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2250040605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393696,0.004209555,0.000020853715,0.0010517121,0.00006117583,0.00052179705,0.00004880842,0.000030830208,0.00011832706],"genre_scores_gemma":[0.9979876,0.0002541565,0.0007521847,0.00018566975,0.00041474137,0.000009127832,0.000028199185,0.000023713546,0.00034455454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797535,0.00012736981,0.00055073365,0.0004044811,0.0005744501,0.0003676208],"domain_scores_gemma":[0.9977732,0.000058188984,0.00045419188,0.00026633084,0.0006284613,0.000819636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009943843,0.00032374362,0.0009711692,0.00003693055,0.0000944598,0.000043320346,0.00013775291,0.00038131647,0.00010619129],"category_scores_gemma":[0.0008746109,0.00019698833,0.00012587475,0.00016342867,0.0002553718,0.00013895807,0.00007578821,0.0007170475,0.0000056440463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029066282,0.00026437276,0.0026491382,0.0006612033,0.00026633387,0.00033014067,0.00008595762,0.0000012007965,0.98808795,0.0000035705436,0.0009534727,0.003790027],"study_design_scores_gemma":[0.004680233,0.0016368732,0.006367347,0.0005735977,0.00011529259,0.0030410415,0.0004133463,0.00003812605,0.98047966,0.00003279543,0.0023213269,0.00030034347],"about_ca_topic_score_codex":0.00005415606,"about_ca_topic_score_gemma":0.0000066527305,"teacher_disagreement_score":0.0076082777,"about_ca_system_score_codex":0.0001128543,"about_ca_system_score_gemma":0.000312719,"threshold_uncertainty_score":0.8032951},"labels":[],"label_agreement":null},{"id":"W2253019483","doi":"10.1093/ehjqcco/qcv002","title":"Primary prevention of cardiovascular disease: global cardiovascular risk assessment and management in clinical practice","year":2015,"lang":"en","type":"article","venue":"European Heart Journal - Quality of Care and Clinical Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Toronto; St. Michael's Hospital; Conestoga College; McMaster University; Canadian Respiratory Research Network","funders":"AstraZeneca Canada; AstraZeneca","keywords":"Medicine; Framingham Risk Score; Risk assessment; Guideline; Risk stratification; Statin; Disease; Primary care; Risk management tools; Diabetes mellitus; Audit; Physical therapy; Intensive care medicine; Internal medicine; Family medicine; Pathology","score_opus":0.13755955011333462,"score_gpt":0.4801529920584831,"score_spread":0.3425934419451485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2253019483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9159177,0.075299494,0.0014973807,0.0007332564,0.00045446155,0.0008863363,0.000023574325,0.000019406478,0.005168416],"genre_scores_gemma":[0.91811603,0.064146586,0.016535336,0.00065114675,0.00047173648,0.0000041628746,0.0000140973325,0.000029708115,0.000031218755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9872608,0.007629311,0.0025684093,0.0004998603,0.0017756401,0.00026595895],"domain_scores_gemma":[0.9965307,0.00052133424,0.00057700207,0.0009919682,0.0005865205,0.000792442],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.034229554,0.00022814747,0.0020506196,0.00007523523,0.000074264404,0.000036174704,0.00012726891,0.00010396031,0.0000032087194],"category_scores_gemma":[0.0027772195,0.00017959544,0.0038117848,0.00016812053,0.00024969818,0.00021092902,0.00023746683,0.00070973946,0.0000029790822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005707075,0.00043709285,0.71796167,0.0007149542,0.0077379667,0.00027030046,0.000074068914,0.00003987614,6.244268e-8,0.00010605494,0.000114854876,0.27197236],"study_design_scores_gemma":[0.006983217,0.0011081476,0.92988217,0.00032588493,0.004316565,0.00011234891,0.0010691459,0.000004470291,2.0266602e-7,0.00012253359,0.055915523,0.00015979174],"about_ca_topic_score_codex":0.00022157816,"about_ca_topic_score_gemma":0.000007205237,"teacher_disagreement_score":0.27181256,"about_ca_system_score_codex":0.0001352968,"about_ca_system_score_gemma":0.00039918587,"threshold_uncertainty_score":0.9944639},"labels":[],"label_agreement":null},{"id":"W2253062697","doi":"10.1016/j.cjca.2016.02.033","title":"Proprietary Considerations in the Use of Cardiovascular Genetic Data","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Sanofi; Amgen","keywords":"OMIM : Online Mendelian Inheritance in Man; Medicine; Mutation; Database; Table (database); Genetics; Inheritance (genetic algorithm); dbSNP; Genetic data; Bioinformatics; Gene; Computer science; Genotype; Biology; Population; Single-nucleotide polymorphism","score_opus":0.10906914635404798,"score_gpt":0.2665894396417527,"score_spread":0.15752029328770473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2253062697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8895866,0.05349388,0.034016524,0.017839402,0.0015341295,0.001738955,0.0003273899,0.000008596882,0.0014544826],"genre_scores_gemma":[0.9968582,0.0006309244,0.0013050191,0.00042293844,0.00075153576,0.0000037891207,0.0000048526676,0.000010547426,0.000012186395],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839556,0.0004928081,0.00045020744,0.0001478832,0.00026733777,0.000246189],"domain_scores_gemma":[0.99801975,0.00014574672,0.000099710174,0.0012172797,0.00026812532,0.0002493727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014705771,0.000088490204,0.0006381161,0.00021043052,0.000046902293,0.000009975026,0.00021773748,0.00009979126,0.00001661935],"category_scores_gemma":[0.0009281455,0.000046367375,0.00040385718,0.0001263319,0.00021803942,0.000111269175,0.000018446195,0.00020023817,0.000002993041],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020278881,0.00003388124,0.42070618,0.00036639065,0.015205543,0.01781258,0.0012989632,0.012910688,0.0010946651,0.0017273839,0.12929341,0.39934754],"study_design_scores_gemma":[0.0015375589,0.00026255418,0.28480148,0.00013086147,0.00070920744,0.010401165,0.000085832,0.00000944055,0.000045779936,0.00027414586,0.7016508,0.00009115676],"about_ca_topic_score_codex":0.0037522789,"about_ca_topic_score_gemma":0.002321044,"teacher_disagreement_score":0.5723574,"about_ca_system_score_codex":0.000074617135,"about_ca_system_score_gemma":0.002641667,"threshold_uncertainty_score":0.5672348},"labels":[],"label_agreement":null},{"id":"W2253702257","doi":"10.1016/j.cjca.2016.01.003","title":"Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)","year":2016,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":252,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; University of Alberta; Université Laval; University of Toronto; McMaster University; McGill University; University of British Columbia","funders":"","keywords":"Medicine; Statin; Exercise intolerance; Adverse effect; Intensive care medicine; Physical therapy; Internal medicine; Heart failure","score_opus":0.0196398374674926,"score_gpt":0.2843271982962924,"score_spread":0.2646873608287998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2253702257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007049511,0.9963759,0.00014004095,0.00020824444,0.00067109993,0.001119518,0.00006378312,0.0000028973222,0.00071353384],"genre_scores_gemma":[0.006998705,0.99166876,0.00041709054,0.00009013281,0.00065603916,0.00005228507,0.000019002155,0.00004098038,0.00005702334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976617,0.000529504,0.000818947,0.00029232082,0.00017928627,0.00051825604],"domain_scores_gemma":[0.9973533,0.00012751867,0.0005299616,0.00035818372,0.0001614564,0.001469572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012746335,0.00030879313,0.002551609,0.0006660421,0.00009903325,0.000011659026,0.0001265392,0.0003235521,0.000016075977],"category_scores_gemma":[0.00009138983,0.00022857136,0.00057217485,0.00016395762,0.00025989584,0.00002884797,0.000022941149,0.0003997356,0.0000040431164],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001188212,0.0000014065868,0.00090055086,0.013552996,0.002139199,0.0017865053,0.00002355294,5.884893e-7,4.5499625e-8,0.0002234069,0.0025304458,0.97882944],"study_design_scores_gemma":[0.0011817546,0.00020452286,0.003985998,0.043528438,0.002305053,0.0027637628,0.000034986013,8.469511e-8,2.465652e-7,0.00007523265,0.9457368,0.00018307983],"about_ca_topic_score_codex":0.013647378,"about_ca_topic_score_gemma":0.034271263,"teacher_disagreement_score":0.97864634,"about_ca_system_score_codex":0.0004329245,"about_ca_system_score_gemma":0.003347399,"threshold_uncertainty_score":0.9929208},"labels":[],"label_agreement":null},{"id":"W2256630453","doi":"10.21542/gcsp.2017.2","title":"The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol","year":2017,"lang":"en","type":"review","venue":"Global Cardiology Science and Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Fondation Leducq","keywords":"Ezetimibe; Medicine; Familial hypercholesterolemia; Simvastatin; PCSK9; Cholesterol; Statin; Internal medicine; Disease; Incidence (geometry); Lipoprotein; LDL receptor","score_opus":0.06475592584950879,"score_gpt":0.4073453454190859,"score_spread":0.3425894195695771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256630453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023092327,0.9866443,0.00027582742,0.006820863,0.0005764895,0.0016783501,0.000027034013,0.0000120139275,0.0037341793],"genre_scores_gemma":[0.006512703,0.9918027,0.00024473105,0.00081840856,0.00046691776,0.00009421761,0.000004060415,0.000008494127,0.000047747482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99650675,0.0014218063,0.00040515568,0.0005428093,0.0007334857,0.00038999735],"domain_scores_gemma":[0.99691564,0.000605276,0.0005127487,0.0012517705,0.00053656474,0.000178011],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.013769412,0.00024576075,0.0013653288,0.0000596553,0.0011430338,0.00014476059,0.00046884833,0.00021350857,7.8303196e-7],"category_scores_gemma":[0.0060827327,0.00011600111,0.00037441961,0.00034736618,0.0032874194,0.00022137944,0.00021693789,0.00038117287,0.000007304936],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034504558,0.0000066929474,0.0000111025765,0.00063948386,0.00028647901,0.000018130659,0.000032523956,0.0000014301924,0.0000028325244,0.000528319,0.0003522409,0.99777573],"study_design_scores_gemma":[0.0007598458,0.00022052198,0.0012703487,0.00077001954,0.0019744823,0.0036621096,0.00020122727,0.0000047031613,5.616674e-7,0.000087021814,0.9909324,0.00011673511],"about_ca_topic_score_codex":0.00034508234,"about_ca_topic_score_gemma":0.00000779759,"teacher_disagreement_score":0.99765897,"about_ca_system_score_codex":0.00012365197,"about_ca_system_score_gemma":0.0016279056,"threshold_uncertainty_score":0.99942505},"labels":[],"label_agreement":null},{"id":"W2258338427","doi":"10.7555/jbr.29.20150067","title":"Hypercholesterolemia, low density lipoprotein receptor andproprotein convertase subtilisin/kexin-type 9","year":2015,"lang":"en","type":"review","venue":"Journal of Biomedical Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"PCSK9; Kexin; LDL receptor; Proprotein convertase; Internal medicine; Familial hypercholesterolemia; Endocrinology; Lipoprotein; Medicine; Cholesterol; Receptor; Chemistry","score_opus":0.1797146325779665,"score_gpt":0.4618655458276021,"score_spread":0.2821509132496356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258338427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026295243,0.9922907,0.00006706346,0.0008996708,0.0010307787,0.0028013457,0.000047532616,0.000030630876,0.00020279738],"genre_scores_gemma":[0.00024358889,0.991679,0.0010616534,0.00013219459,0.005355266,0.00005009381,0.00014737538,0.00015254538,0.0011782434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9843064,0.002637911,0.0024633599,0.00076071883,0.008469926,0.0013616959],"domain_scores_gemma":[0.9891869,0.00041097743,0.00085739966,0.0015336452,0.004574435,0.0034366439],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.025358165,0.0006637979,0.005079695,0.001751799,0.00021849266,0.00014094907,0.0009732217,0.0016402657,0.00052996736],"category_scores_gemma":[0.0062982724,0.00042561226,0.0018292457,0.0020535951,0.0011039438,0.00018528038,0.00045551936,0.0070612463,0.00075433654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006185981,0.00060823053,0.0000032878731,0.023115242,0.0007682176,0.0024360544,0.000071748305,1.3850266e-8,0.000067016364,0.0000061606866,0.026287513,0.9460179],"study_design_scores_gemma":[0.0022793575,0.0035537223,0.000012594873,0.032016225,0.0007062323,0.004302807,0.000089275105,0.0000032124153,0.00010745453,0.000058675134,0.95653796,0.00033245265],"about_ca_topic_score_codex":0.00039585005,"about_ca_topic_score_gemma":0.000011386574,"teacher_disagreement_score":0.94568545,"about_ca_system_score_codex":0.0016908753,"about_ca_system_score_gemma":0.014200598,"threshold_uncertainty_score":0.9998196},"labels":[],"label_agreement":null},{"id":"W2258632417","doi":"","title":"Familial hypercholesterolemia: Review of diagnosis, screening, and treatment.","year":2016,"lang":"en","type":"review","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; University of Alberta; University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Randomized controlled trial; Observational study; Epidemiology; Pediatrics; Disease; Intensive care medicine; Internal medicine; Cholesterol","score_opus":0.06790738127009238,"score_gpt":0.3163505623495441,"score_spread":0.24844318107945174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258632417","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008941954,0.99250174,0.000007837757,0.0002317697,0.00011381829,0.0060454444,0.00011436064,0.00003054156,0.00094552664],"genre_scores_gemma":[0.0000031001691,0.9863013,0.00007266074,0.00029299388,0.0006657763,0.011935724,0.00007201383,0.000058799353,0.0005976043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978961,0.00021954745,0.0006854379,0.00044422704,0.00037394257,0.00038076862],"domain_scores_gemma":[0.9984241,0.000097650365,0.00029190184,0.0007979783,0.000066809305,0.00032152078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007642761,0.00037967553,0.0032488154,0.00011902233,0.00003104027,0.0000073649335,0.000097695345,0.00027149645,0.000027719525],"category_scores_gemma":[0.0002004431,0.0002089973,0.0011426987,0.00015590026,0.000089261164,0.000040141866,0.00006149495,0.00018511867,0.000011220791],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000044954527,0.000042000258,0.000050545965,0.14324847,0.00051134394,0.000018762506,0.0000019576112,2.3865726e-10,3.2860965e-9,0.000004677786,0.000641793,0.85547596],"study_design_scores_gemma":[0.0007271502,0.00007877044,0.00090364367,0.152575,0.0033307637,0.00013954306,7.3814397e-7,6.3033117e-9,7.103821e-7,9.70855e-7,0.84210086,0.0001418396],"about_ca_topic_score_codex":0.00006576656,"about_ca_topic_score_gemma":0.000002846383,"teacher_disagreement_score":0.8553341,"about_ca_system_score_codex":0.00015670854,"about_ca_system_score_gemma":0.00017878358,"threshold_uncertainty_score":0.85226625},"labels":[],"label_agreement":null},{"id":"W2259733357","doi":"10.2217/clp.15.36","title":"The value of apoA-I in predicting heart disease and myocardial infarction","year":2015,"lang":"en","type":"article","venue":"Clinical Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Myocardial infarction; Internal medicine; Medicine; Cardiology; Apolipoprotein B; Cholesterol; Disease; Coronary heart disease; Ldl cholesterol","score_opus":0.060482855204112146,"score_gpt":0.3708215923715872,"score_spread":0.31033873716747506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2259733357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98803896,0.0017876202,0.00005189359,0.007401514,0.0018744959,0.00038467316,0.0000022821134,0.000018121778,0.0004404334],"genre_scores_gemma":[0.994993,0.0003135915,0.0001762204,0.001360118,0.0030872722,0.000019399116,0.000004130746,0.000008482076,0.00003783685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984068,0.0005345184,0.0004966476,0.0001971235,0.0001846134,0.00018028961],"domain_scores_gemma":[0.9987308,0.0004989738,0.00007209553,0.00033124685,0.000076129785,0.0002907494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00324605,0.00006563338,0.00038402303,0.000032060027,0.000038208407,0.000004066922,0.000043560474,0.0001233137,0.0000021999208],"category_scores_gemma":[0.0041366615,0.00004349254,0.0001454953,0.00008892008,0.0002808237,0.000025510444,0.000068426074,0.00029445713,0.0000056172903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094759587,0.00009568652,0.97946596,0.000042027434,0.000080075406,0.0000031317584,0.00007562452,0.000014070467,0.000015487989,0.000960552,0.0019294806,0.016370282],"study_design_scores_gemma":[0.0023283833,0.00062466465,0.9571847,0.00003680823,0.000093160954,0.000030739928,0.00011721732,0.0003952141,0.0000035761295,0.0013845932,0.037756905,0.00004408326],"about_ca_topic_score_codex":0.00014547571,"about_ca_topic_score_gemma":0.00001539868,"teacher_disagreement_score":0.035827424,"about_ca_system_score_codex":0.000021625276,"about_ca_system_score_gemma":0.00027555594,"threshold_uncertainty_score":0.4952269},"labels":[],"label_agreement":null},{"id":"W2261721173","doi":"10.1136/bmj.39038.515521.1f","title":"Statins and outcomes in patients with pneumonia","year":2006,"lang":"en","type":"letter","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Confounding; Pneumonia; Intensive care medicine; Medicine; Internal medicine","score_opus":0.008277056008363738,"score_gpt":0.25188876541821525,"score_spread":0.24361170940985152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2261721173","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5916246,0.00018000488,0.000012980843,0.4034695,0.0001322761,0.0021814874,0.00007693274,0.0000366875,0.0022855245],"genre_scores_gemma":[0.07035875,0.000029976107,0.0019835054,0.91198486,0.0028448028,0.00027904843,0.0015183114,0.00018113799,0.010819617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986739,0.000049196493,0.00023823562,0.00025809172,0.0005346518,0.000245929],"domain_scores_gemma":[0.99939775,0.000018852881,0.000083799314,0.000407068,0.00004936493,0.000043149543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001547715,0.00018220671,0.00056426995,0.0001064059,0.000020721249,0.000012569283,0.00003573337,0.00024319346,0.0000138222385],"category_scores_gemma":[0.00001661074,0.000120063145,0.00007871057,0.00006815546,0.00002968138,0.000022882941,0.000020760895,0.00063314306,0.000011589565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018083316,0.00004042114,0.6170818,0.00033123072,0.00009511567,0.0003392549,0.000020619871,2.8998355e-7,1.35003e-7,9.459059e-7,0.3783674,0.003704685],"study_design_scores_gemma":[0.0017966896,0.00017399559,0.73423684,0.00014135819,0.00006445346,0.0000072563184,0.0000024928372,6.4698196e-7,5.38499e-7,0.0000070344972,0.26345375,0.000114948],"about_ca_topic_score_codex":0.0008362264,"about_ca_topic_score_gemma":0.00009008023,"teacher_disagreement_score":0.52126586,"about_ca_system_score_codex":0.00006368829,"about_ca_system_score_gemma":0.00010567832,"threshold_uncertainty_score":0.48960328},"labels":[],"label_agreement":null},{"id":"W2262823270","doi":"10.1007/978-1-84882-927-5_23","title":"The Genetic Challenge of Coronary Artery Disease","year":2009,"lang":"en","type":"book-chapter","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Coronary artery disease; Cardiology; Myocardial infarction; Angina; Sudden cardiac death; Internal medicine; Cause of death; Disease; Epidemiology; Thrombus; Sudden death","score_opus":0.01867252303219324,"score_gpt":0.2368297864958582,"score_spread":0.21815726346366496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2262823270","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020628217,0.06451519,0.00004579331,0.0024277177,0.0001445729,0.0010190911,0.00001468454,0.000043152344,0.9315835],"genre_scores_gemma":[0.044410896,0.037789527,0.00016398169,0.0008450919,0.00095982075,0.000018810108,0.000036710106,0.00006470807,0.91571045],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872035,0.000014736568,0.00031228983,0.00023966853,0.00053273974,0.00018021221],"domain_scores_gemma":[0.99852514,0.000023503158,0.00009219158,0.0010285977,0.00008809986,0.00024244489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016681351,0.00020404259,0.00044529952,0.00004245713,0.00006122034,0.0000052040964,0.00009728995,0.00014839256,0.00029218776],"category_scores_gemma":[0.000008920585,0.00012053248,0.0005349588,0.000009391601,0.00009332,0.000010011692,0.00003235535,0.00023314398,0.00006983812],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002077209,0.0000528042,0.00002400245,0.00035783133,0.0005346517,0.0006032856,0.000019621988,5.8651875e-7,0.000001681418,0.03793417,0.0027023808,0.95756125],"study_design_scores_gemma":[0.0009321578,0.0006400769,0.020762425,0.00050292566,0.00079875166,0.00014614641,0.0000103034745,0.000013310705,0.000003462775,0.016530577,0.95941335,0.00024650857],"about_ca_topic_score_codex":0.000008960199,"about_ca_topic_score_gemma":0.000009438328,"teacher_disagreement_score":0.9573147,"about_ca_system_score_codex":0.000040212126,"about_ca_system_score_gemma":0.00026739854,"threshold_uncertainty_score":0.49151722},"labels":[],"label_agreement":null},{"id":"W2265816617","doi":"10.1161/atvb.34.suppl_1.417","title":"Abstract 417: Structural Characterization of 20 kDa Fragments of Apolipoprotein B100","year":2014,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Chemistry; Circular dichroism; Apolipoprotein B; Protein secondary structure; Helix (gastropod); Aqueous solution; Lipoprotein; Nuclear magnetic resonance spectroscopy; Biochemistry; Stereochemistry; Crystallography; Cholesterol; Organic chemistry; Biology","score_opus":0.021775743374350277,"score_gpt":0.27344042841259164,"score_spread":0.25166468503824135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2265816617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983195,0.00006612314,0.0005865368,0.00020064822,0.00014265369,0.00050176354,0.000041665407,0.000022523247,0.00011855587],"genre_scores_gemma":[0.9979611,0.0010206157,0.00043151597,0.00021162089,0.00016081135,0.000027809061,0.00015974339,0.000024394005,0.0000023893574],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984703,0.00012749055,0.00054026995,0.0003549863,0.00022614222,0.00028078348],"domain_scores_gemma":[0.99889743,0.000019848712,0.00026746048,0.00055760617,0.0001248245,0.00013282632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049385417,0.00020994716,0.0008465086,0.000110349996,0.00007708503,0.000009590876,0.000096785516,0.00020740277,0.00012415895],"category_scores_gemma":[0.0000351255,0.00016714566,0.00032465198,0.00013726066,0.00019693038,0.000078912795,0.00006456418,0.000119975564,0.0000044695994],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008559125,0.0000729622,0.10075832,0.00033899996,0.00037776976,1.8648135e-8,0.00013193021,4.678986e-7,0.8906868,0.00035630263,0.000004544226,0.0072632837],"study_design_scores_gemma":[0.0014575792,0.0005350828,0.97797734,0.00019435538,0.00016339267,9.176953e-7,0.000027529035,0.00008635973,0.018507957,0.00006763632,0.00083589915,0.00014598093],"about_ca_topic_score_codex":0.00037374685,"about_ca_topic_score_gemma":0.000015456038,"teacher_disagreement_score":0.87721896,"about_ca_system_score_codex":0.000019811408,"about_ca_system_score_gemma":0.00003515835,"threshold_uncertainty_score":0.6816002},"labels":[],"label_agreement":null},{"id":"W2267476953","doi":"10.1056/jw200603030000003","title":"Statins Might Prevent Sepsis in Older Patients with Atherosclerosis","year":2006,"lang":"en","type":"article","venue":"Journal watch","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Antithrombotic; Sepsis; Inflammation; Endothelium; Intensive care medicine; Cardiology; Pharmacology; Internal medicine","score_opus":0.005813709320431223,"score_gpt":0.22587807448186303,"score_spread":0.22006436516143182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267476953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955876,0.00017341749,0.0002457666,0.0030278563,0.00008485722,0.00041224013,0.0000052934865,0.000012374982,0.00045061077],"genre_scores_gemma":[0.99631476,0.00020606544,0.0014954695,0.0003073817,0.0003230492,0.00001538086,0.000012275225,0.000029007368,0.0012966029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985413,0.000071535665,0.00031851075,0.00015228416,0.0006234692,0.00029288008],"domain_scores_gemma":[0.99939847,0.000010734068,0.00010679247,0.00021260092,0.00013127904,0.00014012151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003574645,0.0001240421,0.0002943285,0.00006285319,0.000086451786,0.000029601524,0.000053232103,0.000060285787,0.00014725579],"category_scores_gemma":[0.000010952536,0.000077783705,0.00014864223,0.00019450134,0.000017052962,0.00008836746,0.000013932168,0.00031687127,0.000014878503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012198246,0.0012737125,0.9782679,0.0000851592,0.00011585979,0.00005503308,0.00046218763,0.000057293284,0.00014357404,0.000009259894,0.008655217,0.010752811],"study_design_scores_gemma":[0.0042943493,0.00033418526,0.9840166,0.00030448777,0.00007160069,0.000046320725,0.000060808532,0.000010143969,0.00046940023,0.00006599386,0.01021736,0.000108767184],"about_ca_topic_score_codex":0.0004419669,"about_ca_topic_score_gemma":0.00018012399,"teacher_disagreement_score":0.010644045,"about_ca_system_score_codex":0.00025054367,"about_ca_system_score_gemma":0.00010039827,"threshold_uncertainty_score":0.31719273},"labels":[],"label_agreement":null},{"id":"W2267561229","doi":"10.1161/jaha.115.002497","title":"Overcoming Challenges With Statin Therapy","year":2016,"lang":"en","type":"review","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Statin; Medicine; Intensive care medicine; Internal medicine","score_opus":0.04035948452243843,"score_gpt":0.3371612838321391,"score_spread":0.2968017993097007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267561229","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00092927617,0.99584275,0.000017569708,0.002404004,0.0001972317,0.0004580132,0.0000063834714,0.000007888157,0.00013689273],"genre_scores_gemma":[0.00016972901,0.99756026,0.0003445279,0.00034801807,0.0012671661,0.000009648587,5.9864624e-7,0.00004259269,0.00025742658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974036,0.0007411295,0.0005415441,0.00012592779,0.000969154,0.00021860452],"domain_scores_gemma":[0.99684346,0.00030954988,0.002131802,0.00035064307,0.0002691141,0.000095453666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021000504,0.00019336959,0.0023666741,0.00010870751,0.00007025174,0.0000170934,0.00012772584,0.00008306431,0.000010888316],"category_scores_gemma":[0.00027802706,0.00008039165,0.0013321049,0.00022854008,0.000035881574,0.00006197844,0.000019974688,0.00049876893,0.000009834356],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004163583,0.00003646313,0.00058273313,0.0006584616,0.0012379132,0.0000057508596,0.000057425492,9.82819e-8,0.0000017121366,0.00000429006,0.0010067484,0.99636674],"study_design_scores_gemma":[0.0005524911,0.0006050905,0.0036668826,0.010136448,0.0006381843,0.00037586674,0.00004198362,1.1577411e-7,0.0000026497137,0.000010412063,0.9838705,0.00009937696],"about_ca_topic_score_codex":0.000031327854,"about_ca_topic_score_gemma":0.0000036350536,"teacher_disagreement_score":0.9962674,"about_ca_system_score_codex":0.0010227463,"about_ca_system_score_gemma":0.0008529244,"threshold_uncertainty_score":0.32782763},"labels":[],"label_agreement":null},{"id":"W2272000616","doi":"10.1161/atvb.34.suppl_1.243","title":"Abstract 243: Canadian Familial Hypercholesterolemia Registry","year":2014,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Robarts Clinical Trials; St. Paul's Hospital; McGill University","funders":"","keywords":"Biobank; Disease registry; Medicine; Family medicine; Patient registry; Disease; Primary care; Familial hypercholesterolemia; Pediatrics; Pathology; Bioinformatics","score_opus":0.028508873311539323,"score_gpt":0.27229365754006357,"score_spread":0.24378478422852426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2272000616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937711,0.00012871348,0.00023995538,0.001582226,0.0002500987,0.00035633732,0.000027244734,0.00006170092,0.0035826473],"genre_scores_gemma":[0.99385124,0.0017635622,0.00056969863,0.0031850825,0.00045855506,0.000042236094,0.00008230466,0.000036532834,0.0000108088925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823153,0.00013211247,0.0003269127,0.00055866805,0.00017310015,0.0005776688],"domain_scores_gemma":[0.9984075,0.000027478249,0.00006578107,0.0008262899,0.00007360512,0.00059934886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007204126,0.0002608583,0.00064576865,0.00012746031,0.00024659315,0.000046569952,0.00012516629,0.00033934522,0.000108530374],"category_scores_gemma":[0.00006426449,0.0002180295,0.00033479574,0.00011660186,0.00019910715,0.00006789605,0.000050336617,0.00027055113,0.000070186354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013910945,0.0002104711,0.6748486,0.0004298635,0.0012756531,0.0000010719449,0.00047432663,0.0000026615162,0.25268668,0.0022750879,0.0016215728,0.0661601],"study_design_scores_gemma":[0.0012297797,0.00026414898,0.9058663,0.00009103331,0.00013320136,0.0000047985723,0.00006352004,0.000034175246,0.00009011588,0.00003954316,0.09197074,0.00021262684],"about_ca_topic_score_codex":0.037497323,"about_ca_topic_score_gemma":0.012567856,"teacher_disagreement_score":0.25259656,"about_ca_system_score_codex":0.000085569016,"about_ca_system_score_gemma":0.0001428227,"threshold_uncertainty_score":0.96891207},"labels":[],"label_agreement":null},{"id":"W2273636061","doi":"10.1007/978-1-59745-385-1_8","title":"Biomarkers and Surrogates in Clinical Studies","year":2008,"lang":"en","type":"review","venue":"Methods in molecular biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"History","score_opus":0.1747216621043565,"score_gpt":0.567863579266352,"score_spread":0.39314191716199554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2273636061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010720012,0.99236715,0.005675147,0.00006708351,0.0003549939,0.0012032925,0.0000046067103,0.000019639145,0.00020087088],"genre_scores_gemma":[7.016873e-7,0.7529822,0.2465979,0.00012934174,0.000086441076,0.0001296451,0.000024587274,0.000034464487,0.00001472809],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99033403,0.0070487773,0.0013127989,0.00078406045,0.00010629691,0.00041403357],"domain_scores_gemma":[0.9980328,0.00092549063,0.00021762218,0.00065161806,0.0000500409,0.00012240796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006183981,0.00039102577,0.0043823794,0.00049641787,0.000025428166,0.0000035995486,0.00012860497,0.00087918836,0.000004555701],"category_scores_gemma":[0.002809529,0.0002801867,0.00085619575,0.00053725106,0.00048329236,0.000009490008,0.00020325414,0.0008348319,0.000004129656],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014089682,0.000052690015,0.000903626,0.0048908256,0.0009106179,0.0004939903,0.000022508431,2.6432435e-8,0.0000068205145,0.00010246938,0.000016616588,0.9925857],"study_design_scores_gemma":[0.0011989232,0.000343741,0.00034573692,0.005640574,0.0005271235,0.0010630032,0.00004330058,0.0000025655927,0.000014005452,0.00046223187,0.9900221,0.00033668216],"about_ca_topic_score_codex":0.00009327563,"about_ca_topic_score_gemma":0.000023272072,"teacher_disagreement_score":0.992249,"about_ca_system_score_codex":0.00011927158,"about_ca_system_score_gemma":0.00033436675,"threshold_uncertainty_score":0.999965},"labels":[],"label_agreement":null},{"id":"W2274836352","doi":"10.1056/nejmoa1506930","title":"Pioglitazone after Ischemic Stroke or Transient Ischemic Attack","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge; Western University; Hôpital Charles-Le Moyne","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Yale University; National Cancer Institute; National Institute for Health and Care Research; National Institute of Neurological Disorders and Stroke","keywords":"Medicine; Pioglitazone; Hazard ratio; Internal medicine; Insulin resistance; Stroke (engine); Diabetes mellitus; Placebo; Myocardial infarction; Cardiology; Confidence interval; Type 2 diabetes; Insulin; Endocrinology; Pathology","score_opus":0.020811518045200324,"score_gpt":0.2790570959854299,"score_spread":0.25824557794022956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2274836352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95412135,0.0087930495,0.004222792,0.027019361,0.000702809,0.00027867922,0.000007685936,0.000021829745,0.004832439],"genre_scores_gemma":[0.97664076,0.0026771298,0.00092848885,0.0013242309,0.010417791,0.0000045866386,0.0000020748237,0.00003528316,0.007969659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756575,0.00007840856,0.0007598488,0.00020383579,0.0010304278,0.00036172924],"domain_scores_gemma":[0.9982179,0.0001247022,0.00023574384,0.00040179823,0.00027831268,0.00074158196],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014024223,0.00022446648,0.0008552459,0.0001939036,0.000031242686,0.0000050322155,0.00013095832,0.00011676283,0.0016070848],"category_scores_gemma":[0.00038333033,0.00009582564,0.00029639047,0.00016380836,0.00012438427,0.00012268021,0.000017158307,0.00038670652,0.000025440606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00983145,0.00014313823,0.003724187,0.0002630449,0.0007390775,0.0019066051,0.0010797444,0.0000010647638,0.11122038,0.0000055716528,0.21254629,0.6585394],"study_design_scores_gemma":[0.08304005,0.002859828,0.006233758,0.0020093522,0.0006014724,0.0077314437,0.00015552742,0.0000023373236,0.006818495,0.0000064759424,0.890394,0.00014728567],"about_ca_topic_score_codex":0.000047783065,"about_ca_topic_score_gemma":0.000020651789,"teacher_disagreement_score":0.6778477,"about_ca_system_score_codex":0.00011897716,"about_ca_system_score_gemma":0.00046123608,"threshold_uncertainty_score":0.9993056},"labels":[],"label_agreement":null},{"id":"W2277231138","doi":"10.1016/j.cjca.2015.12.016","title":"Incomplete and Misleading Table Used for Reappraisal of Statin Therapy","year":2015,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Number needed to treat; Table (database); Statin; Relative risk; Confidence interval; Internal medicine; Data mining","score_opus":0.05236574300487349,"score_gpt":0.297065936544748,"score_spread":0.24470019353987452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2277231138","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.087583385,0.08300151,0.02173358,0.7756081,0.008242876,0.0054676654,0.0025908938,0.000033212353,0.015738767],"genre_scores_gemma":[0.417579,0.0041423514,0.015990334,0.4435279,0.11419774,0.00014225554,0.0010957684,0.00067452877,0.00265013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982469,0.00024207476,0.0005767708,0.00019287784,0.00027243135,0.00046893064],"domain_scores_gemma":[0.9978005,0.00016819424,0.00042802148,0.0003295524,0.0007559156,0.00051778497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015293541,0.0002105321,0.0017048065,0.00042557387,0.000055758253,0.000013578492,0.00014380916,0.00056682754,0.0000103067605],"category_scores_gemma":[0.00032919002,0.00017143354,0.00046686246,0.00009766138,0.00019374935,0.00003964485,0.0000077197565,0.0009146115,7.365683e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109609886,7.926357e-7,0.00090016384,0.00031562152,0.0013159711,0.00061626144,0.00016172192,0.00002547223,0.00014421884,0.000019544757,0.9851463,0.011244365],"study_design_scores_gemma":[0.002579246,0.0012584735,0.0006304815,0.00016903224,0.00028206894,0.002493568,0.0000729047,0.000003995633,0.000047972313,0.00018038345,0.99214447,0.00013741758],"about_ca_topic_score_codex":0.0028190159,"about_ca_topic_score_gemma":0.00043433765,"teacher_disagreement_score":0.33208022,"about_ca_system_score_codex":0.0001269209,"about_ca_system_score_gemma":0.0050402745,"threshold_uncertainty_score":0.8941231},"labels":[],"label_agreement":null},{"id":"W2279238885","doi":"","title":"Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Gynecology; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ldl cholesterol; Observational study; Statin; Cholesterol; Internal medicine","score_opus":0.03589821376487027,"score_gpt":0.23921944413231322,"score_spread":0.20332123036744296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279238885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98766214,0.00010343537,7.681789e-7,0.0068997773,0.0000697428,0.0037083372,0.000029299534,0.000012744251,0.0015137466],"genre_scores_gemma":[0.9908652,0.000011739591,0.000049233524,0.0067491625,0.0003120699,0.0017230264,0.0000579062,0.000025022986,0.00020664922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821186,0.00012091359,0.00021844724,0.00023762234,0.0005204142,0.00069076003],"domain_scores_gemma":[0.9986426,0.000020177304,0.000034012766,0.0004201968,0.00013564045,0.00074734126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094710215,0.00013622011,0.00021525589,0.00017073604,0.00018647224,0.000042768268,0.00012506114,0.00006866698,0.00003346808],"category_scores_gemma":[0.000059488793,0.00008413176,0.00004827566,0.00030867997,0.00003652427,0.00009341923,0.000008281475,0.00030247032,0.000011501643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047084388,0.00012526153,0.79762995,0.0000040890036,0.000062027975,0.00001120388,0.00042130408,0.00005878729,4.4274785e-8,0.000017997618,0.00027349722,0.20134877],"study_design_scores_gemma":[0.0029561117,0.00011171147,0.90276325,0.0000064691744,0.000017076276,0.0000029379407,0.00011868483,0.000020353113,0.0000015208275,0.0000024011522,0.09391076,0.000088709625],"about_ca_topic_score_codex":0.9630938,"about_ca_topic_score_gemma":0.9989141,"teacher_disagreement_score":0.20126006,"about_ca_system_score_codex":0.0011283696,"about_ca_system_score_gemma":0.001379053,"threshold_uncertainty_score":0.34307936},"labels":[],"label_agreement":null},{"id":"W2279556601","doi":"10.1161/hyp.60.suppl_1.a60","title":"Abstract 60: Reduced Macrophage-dependent Inflammation Improves Endothelial Function and Vascular Remodeling, Oxidative Stress and Inflammation in a Model Of Endothelin-1 Induced Vascular Injury","year":2012,"lang":"en","type":"article","venue":"Hypertension","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Myograph; Inflammation; Internal medicine; Endocrinology; Endothelin 1; Endothelial dysfunction; Oxidative stress; Macrophage colony-stimulating factor; Medicine; Endothelium; Macrophage; Chemistry; Receptor; Biochemistry","score_opus":0.022190292218601894,"score_gpt":0.2448067093047616,"score_spread":0.2226164170861597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279556601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995722,0.0015256566,0.001256743,0.000080035265,0.00014209886,0.0011349864,0.000016298422,0.0000466527,0.00007552313],"genre_scores_gemma":[0.99700433,0.0013566538,0.0010577271,0.000056194836,0.00037333905,0.000049818515,0.00004239594,0.00004441397,0.0000151544355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997888,0.00013048576,0.0006203732,0.00038888177,0.00062365114,0.00034857346],"domain_scores_gemma":[0.9988161,0.000032114574,0.00023473974,0.000462579,0.00025137173,0.00020312663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012160743,0.00026455167,0.000577479,0.00029831432,0.00009451215,0.00002391485,0.000047943988,0.00028247832,0.0000062486138],"category_scores_gemma":[0.00019380286,0.00022626646,0.00015036028,0.00013409634,0.000051292496,0.0005199595,0.000072864605,0.00034093345,0.0000040425407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003223424,0.00010252828,0.0007705639,0.00042894811,0.00011884517,0.0000032028377,0.0006141961,0.00030317093,0.93282247,0.00006042642,0.0000014252741,0.064451896],"study_design_scores_gemma":[0.00603908,0.00041385187,0.10918844,0.000674204,0.00051398255,0.000044004326,0.0006769127,0.052869778,0.8287738,0.00034465603,0.00005195169,0.00040932235],"about_ca_topic_score_codex":0.00063226867,"about_ca_topic_score_gemma":0.00002568948,"teacher_disagreement_score":0.108417876,"about_ca_system_score_codex":0.000092121714,"about_ca_system_score_gemma":0.00010989774,"threshold_uncertainty_score":0.9226879},"labels":[],"label_agreement":null},{"id":"W2280249676","doi":"","title":"Hypercholestérolémie familiale Révision du diagnostic, du dépistage et du traitement","year":2016,"lang":"fr","type":"article","venue":"PubMed Central","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Political science; Humanities; Gynecology; Medicine; Philosophy","score_opus":0.013788954858982842,"score_gpt":0.22982247169705566,"score_spread":0.21603351683807281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280249676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7988103,0.03701921,0.008970659,0.11744246,0.022703387,0.005017785,0.00071261096,0.00027070165,0.009052859],"genre_scores_gemma":[0.921109,0.049380105,0.00026880758,0.0034392923,0.018123802,0.0005130781,0.0000692555,0.00011581376,0.006980808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927375,0.0006772306,0.00078675145,0.0008590459,0.0012310811,0.0037084334],"domain_scores_gemma":[0.9958264,0.000579158,0.00016422143,0.0009597807,0.00018317327,0.0022872295],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0038749436,0.0005412229,0.0008434783,0.00012209672,0.0002235172,0.00009082594,0.0003169645,0.00035464586,0.0015399717],"category_scores_gemma":[0.0036517484,0.0003936748,0.00064027624,0.00029485635,0.00030272588,0.00039970377,0.00017055821,0.00042974728,0.0007899069],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025208102,0.0013266437,0.14371598,0.00061873655,0.00052738993,0.0012583227,0.0010837506,0.000024263845,0.0003620516,0.006956729,0.055597007,0.78827703],"study_design_scores_gemma":[0.0048401924,0.00018149256,0.49095508,0.0005135582,0.00031720364,0.00015532877,0.000118288226,0.000039583247,0.00056532247,0.00005918372,0.50194246,0.00031229362],"about_ca_topic_score_codex":0.0012105074,"about_ca_topic_score_gemma":0.00021577763,"teacher_disagreement_score":0.78796476,"about_ca_system_score_codex":0.0018674384,"about_ca_system_score_gemma":0.00083451776,"threshold_uncertainty_score":0.9999881},"labels":[],"label_agreement":null},{"id":"W2280562444","doi":"10.71781/915","title":"Hypertension artérielle dans la population adulte du Burkina Faso : prévalence, détection, traitement et contrôle","year":2014,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut pour la Recherche en Santé Publique; Université de Montréal; Bill and Melinda Gates Foundation","keywords":"Medicine; Political science; Gynecology","score_opus":0.01729257494884936,"score_gpt":0.2893259317965061,"score_spread":0.2720333568476568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280562444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9423785,0.001786659,0.0023900128,0.0007929186,0.0027784791,0.0041915774,0.00007001207,0.000011353532,0.045600485],"genre_scores_gemma":[0.9763975,0.0012292145,0.0019048149,0.00026112236,0.0013905052,0.00024161243,0.0037223757,0.00010051102,0.014752316],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957001,0.0009014959,0.0009408406,0.0009756324,0.0009216452,0.00056024245],"domain_scores_gemma":[0.99769765,0.00013145684,0.0005145597,0.000836265,0.0004611697,0.00035891167],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030195797,0.0005445408,0.0011490298,0.00018144447,0.00049290986,0.00023165879,0.00032974753,0.00065520493,0.0017655542],"category_scores_gemma":[0.00032201144,0.00050277694,0.00044764607,0.0003229057,0.0000706947,0.0003126299,0.00008951782,0.00059598684,0.0005589844],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001035475,0.00095991703,0.005113421,0.0011306957,0.0008731592,0.00024552536,0.009854745,0.0005266002,0.0077489237,0.00085459,0.0018316524,0.96982527],"study_design_scores_gemma":[0.010214688,0.0014880564,0.3653652,0.0069684517,0.002638806,0.0006220337,0.013223616,0.008325507,0.011649082,0.00012946081,0.57804644,0.0013286519],"about_ca_topic_score_codex":0.013360808,"about_ca_topic_score_gemma":0.0068380153,"teacher_disagreement_score":0.9684966,"about_ca_system_score_codex":0.00031170758,"about_ca_system_score_gemma":0.00051431474,"threshold_uncertainty_score":0.9997424},"labels":[],"label_agreement":null},{"id":"W2280925219","doi":"10.1016/j.cjca.2016.02.063","title":"Optimizing the Prevention of Cardiovascular Events","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia; Canadian Heart Research Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Scopus; Guideline; Myocardial infarction; Medical prescription; Clinical trial; Dosing; Statin; Disease; Internal medicine; MEDLINE; Pathology; Pharmacology","score_opus":0.019984392592360803,"score_gpt":0.24707856928543906,"score_spread":0.22709417669307824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2280925219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7800176,0.051541407,0.14832275,0.0062327497,0.0024570758,0.0010065772,0.000026482034,0.000011613239,0.010383741],"genre_scores_gemma":[0.99750894,0.0007561221,0.0003617028,0.00006528905,0.001172152,0.0000038140493,7.489344e-7,0.000013644696,0.00011760457],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99867636,0.00029690863,0.0003889158,0.00010350391,0.00027042744,0.00026387867],"domain_scores_gemma":[0.9986497,0.000039919323,0.0001650838,0.00046343353,0.00033946853,0.00034239673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001765941,0.00009041732,0.0006651592,0.00016550622,0.00006328779,0.0000029374567,0.00015138608,0.00010424048,0.000020329107],"category_scores_gemma":[0.00024013709,0.000046135116,0.0013142395,0.00011659469,0.0001257722,0.000055349923,0.000010195334,0.0001566098,0.000005126781],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034249472,0.000013287681,0.038832325,0.00027354408,0.0221584,0.0008965223,0.00062387297,0.005246854,0.0032462028,0.0013301909,0.008118374,0.91891795],"study_design_scores_gemma":[0.0044198595,0.0010689519,0.07618114,0.0006569409,0.0021634344,0.006008993,0.0002721226,0.000003741069,0.0020176186,0.0009823452,0.9060384,0.00018646759],"about_ca_topic_score_codex":0.000560923,"about_ca_topic_score_gemma":0.00012102292,"teacher_disagreement_score":0.91873145,"about_ca_system_score_codex":0.00015093839,"about_ca_system_score_gemma":0.0014800433,"threshold_uncertainty_score":0.26255333},"labels":[],"label_agreement":null},{"id":"W2282648998","doi":"10.1373/clinchem.2015.247866","title":"Nonfasting Sample for the Determination of Routine Lipid Profile: Is It an Idea Whose Time Has Come?","year":2016,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Cardiovascular Society","funders":"Medical Research Council; Merck; Amgen","keywords":"Postprandial; Medicine; Meal; Internal medicine; Cholesterol; Lipid profile; Endocrinology; Epidemiology; Diabetes mellitus","score_opus":0.08620244986099876,"score_gpt":0.3805809023132874,"score_spread":0.29437845245228866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2282648998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644356,0.00021619276,0.017676003,0.015010308,0.00020294945,0.0011566643,0.00021474037,0.00006566953,0.001021925],"genre_scores_gemma":[0.98974353,0.0000521243,0.0042046974,0.0007446404,0.0026252018,0.00007358832,0.000052414696,0.000028147619,0.0024756526],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99858636,0.000038733328,0.00061677274,0.00028833357,0.0002619602,0.00020786315],"domain_scores_gemma":[0.99756104,0.0011432089,0.00021575183,0.0006805627,0.00024053559,0.00015890918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017076667,0.00011374913,0.00040277964,0.000007903179,0.00008979205,0.000011855505,0.00014828515,0.00017918309,0.00034097373],"category_scores_gemma":[0.003342819,0.0000629377,0.00034487576,0.00006536028,0.00018111992,0.000046329806,0.000051718867,0.00015351769,0.0000164133],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075661193,0.00069384754,0.03706417,0.0015898712,0.00029530146,0.00000640886,0.00019219788,2.541303e-7,0.058567382,0.000013747085,0.008378457,0.89244175],"study_design_scores_gemma":[0.020297114,0.0020144952,0.04172358,0.002175577,0.001411691,0.00013676021,0.00039999947,0.008796787,0.73045325,0.0003483352,0.19142328,0.0008191374],"about_ca_topic_score_codex":0.000019802354,"about_ca_topic_score_gemma":0.0000012014341,"teacher_disagreement_score":0.8916226,"about_ca_system_score_codex":0.0000321673,"about_ca_system_score_gemma":0.00019033307,"threshold_uncertainty_score":0.4001908},"labels":[],"label_agreement":null},{"id":"W2283142146","doi":"10.1016/j.ecl.2015.09.007","title":"Statins and Cognitive Side Effects","year":2016,"lang":"en","type":"review","venue":"Endocrinology and Metabolism Clinics of North America","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Waterloo; Research Institute for Aging","funders":"","keywords":"Medicine; Cognition; Statin; Adverse effect; Disease; Primary prevention; Atherosclerotic cardiovascular disease; Clinical trial; Intensive care medicine; Bioinformatics; Internal medicine; Psychiatry","score_opus":0.024220100267904533,"score_gpt":0.346152519145049,"score_spread":0.32193241887714447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283142146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017778302,0.9955646,0.00020052395,0.00005313878,0.00035217684,0.0013204155,0.00021729642,0.00003537283,0.00047865842],"genre_scores_gemma":[0.00045226305,0.99767387,0.00061716227,0.00039155444,0.00040177326,0.00014452072,0.00009576385,0.000051520412,0.00017157113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974,0.00044669738,0.00081730535,0.0006149763,0.00022010208,0.0005009522],"domain_scores_gemma":[0.9972185,0.0012687203,0.0006145974,0.00046328155,0.0001370941,0.00029779467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020381325,0.00043986304,0.0040176273,0.00023351288,0.0000793587,0.00000535329,0.000091261325,0.00021461013,0.000012534139],"category_scores_gemma":[0.000866369,0.00028853785,0.0005987946,0.00018835002,0.0006931881,0.00004468664,0.00016381759,0.0006233871,0.000027708711],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043515378,0.00006472702,0.00020658413,0.009621455,0.0014452203,0.00013511015,0.000036603797,3.966249e-9,5.731563e-8,0.00011067591,0.00002344549,0.9883126],"study_design_scores_gemma":[0.0016818491,0.00037751175,0.007354763,0.003914104,0.0059929388,0.00040759463,0.000016045004,1.6333397e-7,0.0000013692796,0.000042078114,0.9799579,0.00025372257],"about_ca_topic_score_codex":0.000047032157,"about_ca_topic_score_gemma":0.0000073021993,"teacher_disagreement_score":0.98805887,"about_ca_system_score_codex":0.000008956342,"about_ca_system_score_gemma":0.0004252846,"threshold_uncertainty_score":0.99995667},"labels":[],"label_agreement":null},{"id":"W2287351208","doi":"10.1126/scitranslmed.aad2195","title":"Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans","year":2016,"lang":"en","type":"article","venue":"Science Translational Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health; School of Medicine, New York University; York University; Ionis Pharmaceuticals","keywords":"Apolipoprotein B; Biology; Medicine; Chemistry; Computational biology; Internal medicine; Cholesterol","score_opus":0.02580118694746536,"score_gpt":0.2971360423362005,"score_spread":0.27133485538873514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287351208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98220146,0.000492443,0.004203186,0.009497064,0.000107102045,0.000882973,0.000004376206,0.000030365449,0.0025810408],"genre_scores_gemma":[0.9979656,0.000049982173,0.001448502,0.00021025444,0.00022383821,0.00005511433,0.0000021590772,0.0000114785935,0.00003307533],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974176,0.00007160735,0.0004739285,0.00033599217,0.0013570115,0.0003438437],"domain_scores_gemma":[0.9988671,0.0003980333,0.00009340359,0.0003005657,0.0001598145,0.00018110308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019313638,0.00013222308,0.00047221992,0.00044461142,0.00009548536,0.0000031655252,0.00014190786,0.00003889254,0.00019351977],"category_scores_gemma":[0.0010774421,0.00007790132,0.000090670306,0.0008676523,0.0010360702,0.00015320175,0.0000136506005,0.000096736556,0.000008965058],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008589807,0.00012331393,0.031695608,0.0008872309,0.000030020223,0.00003366093,0.00087593665,0.0000059537188,0.7994312,0.0054538804,0.000017488162,0.16135983],"study_design_scores_gemma":[0.004495206,0.00041225008,0.86227775,0.0054301,0.00009765986,0.00003697984,0.00011517763,0.0002459577,0.12395854,0.0025207682,0.00022678629,0.00018283041],"about_ca_topic_score_codex":0.0005392418,"about_ca_topic_score_gemma":0.00007604607,"teacher_disagreement_score":0.83058214,"about_ca_system_score_codex":0.00008787249,"about_ca_system_score_gemma":0.00035292807,"threshold_uncertainty_score":0.38174438},"labels":[],"label_agreement":null},{"id":"W2287953281","doi":"10.1016/j.ahj.2016.01.019","title":"Impact of PCSK9 inhibition on coronary atheroma progression: Rationale and design of Global Assessment of Plaque Regression with a PCSK9 Antibody as Measured by Intravascular Ultrasound (GLAGOV)","year":2016,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Montreal Heart Institute","funders":"Amgen","keywords":"Evolocumab; Medicine; PCSK9; Intravascular ultrasound; Atheroma; Cardiology; Internal medicine; Placebo; Statin; Alirocumab; Coronary atherosclerosis; Rosuvastatin; Clinical trial; Coronary artery disease; Urology; Cholesterol; Lipoprotein; Pathology; LDL receptor","score_opus":0.01653942157832703,"score_gpt":0.3417451698708911,"score_spread":0.32520574829256405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2287953281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871786,0.0006925441,0.010956032,0.00035280673,0.000024052719,0.00069736084,0.000047800626,0.000009446039,0.00004132488],"genre_scores_gemma":[0.99393606,0.0005445582,0.0053287684,0.000052535324,0.00008491138,0.000012500112,0.000014161646,0.000019664007,0.0000068485256],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974593,0.00045581625,0.00048317737,0.00022903098,0.0011420674,0.000230599],"domain_scores_gemma":[0.998432,0.00012572671,0.00053231814,0.00029739,0.00035169418,0.00026090353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009795874,0.00019606957,0.0007387167,0.00007208181,0.000081579856,0.0000097034435,0.00005029075,0.00006643462,0.000068170295],"category_scores_gemma":[0.000103756225,0.00010201105,0.00024810233,0.00024936587,0.00041751537,0.00012192677,0.00001549868,0.00018148484,6.380143e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028622602,0.0007554492,0.39827323,0.000099241544,0.00079444237,0.00006496823,0.00011364937,0.000050231956,0.5634941,0.000035206947,0.00057420233,0.03288306],"study_design_scores_gemma":[0.005281465,0.022691432,0.92482483,0.0034109042,0.00023939247,0.0066517848,0.00026191582,0.000054114967,0.036166653,0.000083206774,0.00013374828,0.00020057922],"about_ca_topic_score_codex":0.00022004679,"about_ca_topic_score_gemma":0.000002555883,"teacher_disagreement_score":0.5273274,"about_ca_system_score_codex":0.00022906804,"about_ca_system_score_gemma":0.0009879273,"threshold_uncertainty_score":0.41598898},"labels":[],"label_agreement":null},{"id":"W2289502462","doi":"10.1016/s0828-282x(07)70778-x","title":"","year":2007,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.021142050231330207,"score_gpt":0.2532320822510028,"score_spread":0.2320900320196726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289502462","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008982403,0.015252599,0.0057294643,0.9593816,0.005024509,0.0008940012,0.0000830759,0.000016679034,0.0046357154],"genre_scores_gemma":[0.051406845,0.0004848798,0.00053769915,0.81128055,0.1357161,0.000008229852,0.00013112354,0.00015207287,0.0002825191],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99336493,0.0007610418,0.0019558796,0.0005451809,0.0011569418,0.0022159975],"domain_scores_gemma":[0.9921791,0.00020097,0.0010516442,0.001431781,0.002157645,0.0029788928],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0044687144,0.0007190072,0.004791614,0.0028681026,0.00023896276,0.00005292539,0.00064907153,0.0040268125,0.000021711905],"category_scores_gemma":[0.00085708563,0.00060540036,0.0041593863,0.00048749207,0.00065775507,0.00011941982,0.000024411192,0.010550019,0.00001063207],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010867507,7.82344e-7,0.006383374,0.00038263458,0.003365613,0.14566772,0.00007469202,0.00008248365,0.000009949126,0.000006215605,0.8348242,0.009093659],"study_design_scores_gemma":[0.002361691,0.0013823501,0.014848281,0.00044534102,0.0018633828,0.12660305,0.00007527227,3.0231325e-7,0.00002553506,0.000087596534,0.85190964,0.00039758344],"about_ca_topic_score_codex":0.010588747,"about_ca_topic_score_gemma":0.0032845717,"teacher_disagreement_score":0.14810102,"about_ca_system_score_codex":0.0017376716,"about_ca_system_score_gemma":0.021852432,"threshold_uncertainty_score":0.99963975},"labels":[],"label_agreement":null},{"id":"W2290120395","doi":"10.1146/annurev-pharmtox-010716-104944","title":"PCSK9: Regulation and Target for Drug Development for Dyslipidemia","year":2016,"lang":"en","type":"review","venue":"The Annual Review of Pharmacology and Toxicology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"PCSK9; Kexin; Proprotein convertase; LDL receptor; Subtilisin; Proprotein Convertases; Drug development; Drug; Dyslipidemia; Pharmacology; Drug discovery; Receptor; Biology; Bioinformatics; Cholesterol; Medicine; Lipoprotein; Endocrinology; Internal medicine; Biochemistry; Disease; Enzyme","score_opus":0.03188942251251271,"score_gpt":0.3901929907340813,"score_spread":0.3583035682215686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290120395","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018201195,0.98817486,0.00047568185,0.003163089,0.00044152146,0.007464991,0.00014448134,0.000014953038,0.000102244914],"genre_scores_gemma":[0.000010534844,0.991966,0.0014992777,0.0026475133,0.000754282,0.0022136602,0.00011261253,0.000035370675,0.0007607378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977486,0.00047987574,0.0009056501,0.00040215492,0.000115665076,0.0003480248],"domain_scores_gemma":[0.9978843,0.0009565551,0.0005615511,0.0002349232,0.00024682042,0.00011587444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003470813,0.0003167936,0.002667536,0.00008987818,0.00016847043,0.0000025936301,0.00013912868,0.00030385185,0.000102691774],"category_scores_gemma":[0.0002737316,0.00016680337,0.0004739296,0.00009147446,0.0002482034,0.000040975952,0.000102455364,0.00022397433,0.0000054067877],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068116,0.0000322573,6.033794e-7,0.1798036,0.0006607765,0.0000010577282,0.00004509592,8.3368565e-9,0.0000073814936,0.000590742,0.020595113,0.79819524],"study_design_scores_gemma":[0.0011783034,0.00035522308,0.000010808405,0.022286657,0.0033855943,0.00012811171,0.000007911775,9.719071e-7,0.000058197955,0.00022021992,0.9722076,0.00016036953],"about_ca_topic_score_codex":9.911314e-7,"about_ca_topic_score_gemma":0.0000010855056,"teacher_disagreement_score":0.95161253,"about_ca_system_score_codex":0.00006821061,"about_ca_system_score_gemma":0.00066924805,"threshold_uncertainty_score":0.68020433},"labels":[],"label_agreement":null},{"id":"W2290366635","doi":"10.2174/1570161112666140819110429","title":"Editorial: Statin Potency, LDL Receptors and New Onset Diabetes","year":2014,"lang":"en","type":"editorial","venue":"Current Vascular Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Endocrinology; Diabetes mellitus; Internal medicine; Pathogenesis; Nod; Insulin","score_opus":0.014609172010073009,"score_gpt":0.316900633622641,"score_spread":0.302291461612568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290366635","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021992382,0.03694794,0.00020521796,0.00033834862,0.9582603,0.0016439469,0.00013361897,0.00020224797,0.00006913776],"genre_scores_gemma":[0.00009305981,0.024332434,0.00024691518,0.00020002278,0.9724214,0.00021839114,0.0018477214,0.00018293182,0.0004571432],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939084,0.00085028884,0.00084359635,0.001312213,0.0019904198,0.0010950668],"domain_scores_gemma":[0.99648434,0.0005033837,0.00039827084,0.0008843276,0.00058422866,0.0011454292],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0022417658,0.0008384755,0.002088095,0.00035123547,0.00020573258,0.00006525445,0.00036192307,0.0015282992,0.00051373255],"category_scores_gemma":[0.0010004012,0.00075740373,0.0009359288,0.0002839945,0.00023617495,0.00009698695,0.000283963,0.00292559,0.00017921795],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009793517,0.00017005594,0.00011685896,0.0016848437,0.0013593138,0.000007444868,0.00007704336,0.0000018180791,0.00010603315,0.0000031528034,0.9278556,0.06851987],"study_design_scores_gemma":[0.0065996763,0.000586501,0.000084376465,0.00038179406,0.0032003166,0.0000062883837,0.000009310035,0.000028539123,0.00021583117,0.000080699116,0.98814577,0.0006609212],"about_ca_topic_score_codex":0.00028000207,"about_ca_topic_score_gemma":0.0000112623065,"teacher_disagreement_score":0.06785895,"about_ca_system_score_codex":0.00033284022,"about_ca_system_score_gemma":0.002398821,"threshold_uncertainty_score":0.9997679},"labels":[],"label_agreement":null},{"id":"W2290767516","doi":"10.1096/fasebj.24.1_supplement.lb570","title":"Aging‐Related Decrease in Bax is Associated with Reduced Susceptibility to ACE Inhibitor‐Induced Remodeling in the Aorta of Spontaneously Hypertensive Rats","year":2010,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Enalapril; Internal medicine; Endocrinology; Muscle hypertrophy; Medicine; Lumen (anatomy); Aorta; Apoptosis; Hyperplasia; ACE inhibitor; Blood pressure; Vascular smooth muscle; Angiotensin II; Angiotensin-converting enzyme; Renin–angiotensin system; Chemistry; Smooth muscle","score_opus":0.018372951902065778,"score_gpt":0.2633028333803033,"score_spread":0.24492988147823752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290767516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940687,0.00012334046,0.000008817385,0.0045266654,0.00017795993,0.00088047486,0.000004841778,0.000013998384,0.00019524679],"genre_scores_gemma":[0.99810547,0.000030826584,0.0001817436,0.0013887966,0.0002091614,0.000008011886,0.0000054933457,0.000027827233,0.00004265593],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99735236,0.0005401507,0.0006202377,0.0002695348,0.00079029566,0.00042739353],"domain_scores_gemma":[0.99812925,0.0001788652,0.00024045422,0.0007382346,0.0004291945,0.00028400193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048500057,0.000203204,0.0005752561,0.00017347235,0.00015776673,0.000032993903,0.00026640896,0.00015988662,0.000060590533],"category_scores_gemma":[0.0014404597,0.00010738226,0.00020089118,0.0006730684,0.00007385959,0.000087574284,0.000039617196,0.0017666721,0.0000051112243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011303539,0.00040618115,0.010025582,0.000028380233,0.00025655463,0.0024394349,0.010856913,0.00020898758,0.96850634,0.000019882464,0.00013887639,0.0059825107],"study_design_scores_gemma":[0.022894569,0.003639475,0.44149005,0.004462817,0.0014461307,0.050991878,0.019649575,0.005675866,0.44735166,0.00087923673,0.00022387206,0.0012948521],"about_ca_topic_score_codex":0.0015587084,"about_ca_topic_score_gemma":0.0025836858,"teacher_disagreement_score":0.5211547,"about_ca_system_score_codex":0.00017678394,"about_ca_system_score_gemma":0.00076171744,"threshold_uncertainty_score":0.767541},"labels":[],"label_agreement":null},{"id":"W2291663719","doi":"10.1161/atvbaha.115.306683","title":"Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals","year":2016,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Subclinical infection; Confidence interval; Odds ratio; Internal medicine; Cardiology; Body mass index; Risk factor; Logistic regression; Calcification; Relative risk; Aortic valve; Gastroenterology","score_opus":0.049557684038811986,"score_gpt":0.30016876439803697,"score_spread":0.25061108035922497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291663719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953456,0.0003248207,0.00033610256,0.002881516,0.00005542207,0.0008945141,0.00008278571,0.0000566892,0.000022557257],"genre_scores_gemma":[0.9961568,0.0027028641,0.00015467474,0.00067560014,0.00010355928,0.00012375506,0.000026963105,0.000045102475,0.000010646574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973596,0.00041785452,0.0005249139,0.00081255863,0.0002934285,0.00059168175],"domain_scores_gemma":[0.9984692,0.00012330877,0.00018347816,0.00063864404,0.00009812022,0.00048727708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010869417,0.00033889245,0.0010361156,0.00014898727,0.000124571,0.000039402883,0.00009553475,0.00029090032,0.000067858855],"category_scores_gemma":[0.00027321823,0.00020580532,0.0003218787,0.00024164803,0.0005777237,0.00011538897,0.000118064294,0.00021212029,0.000013315678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016484382,0.00023624662,0.9929819,0.000076822354,0.0006737801,9.041877e-7,0.00017225296,2.9904922e-7,0.0030057488,0.000074834745,0.000023130171,0.002737586],"study_design_scores_gemma":[0.0045966255,0.00067268417,0.99242944,0.0009497129,0.00043401108,0.0000011507792,0.000083559346,0.000023989327,0.000037242542,0.00012195389,0.00033234246,0.0003172653],"about_ca_topic_score_codex":0.00011121138,"about_ca_topic_score_gemma":0.00018077211,"teacher_disagreement_score":0.004580141,"about_ca_system_score_codex":0.00007258738,"about_ca_system_score_gemma":0.00009757668,"threshold_uncertainty_score":0.8392498},"labels":[],"label_agreement":null},{"id":"W2292681792","doi":"10.1002/clc.22518","title":"Comparison of <scp>PCSK9</scp> Inhibitor Evolocumab vs Ezetimibe in Statin‐Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti‐<scp>PCSK9</scp> Antibody in Statin‐Intolerant Subjects 3 (<scp>GAUSS</scp>‐3) Trial","year":2016,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Kowa Company; Medicines Company; Cleveland Clinic; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Evolocumab; PCSK9; Statin; Ezetimibe; Kexin; Pharmacology; Alirocumab; Proprotein convertase; Internal medicine; Cholesterol; Apolipoprotein B; LDL receptor; Lipoprotein","score_opus":0.0503216242098047,"score_gpt":0.37047540976445686,"score_spread":0.3201537855546522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292681792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98668045,0.0014412039,0.0034767035,0.00018240939,0.0023608715,0.0052476134,0.0002232991,0.00007779821,0.00030964537],"genre_scores_gemma":[0.9957835,0.0005270765,0.0012393997,0.0006025996,0.0011718522,0.0003431372,0.00012103756,0.00013680529,0.00007460337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9831587,0.006564392,0.0050276066,0.0017495666,0.0017224107,0.0017772912],"domain_scores_gemma":[0.9883193,0.0063751363,0.0015971753,0.0022882174,0.0007755466,0.0006446482],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009235246,0.0009183698,0.005143292,0.0005228809,0.00014918883,0.00003460217,0.0008048013,0.0011762015,0.0000135441105],"category_scores_gemma":[0.011231745,0.00059954106,0.001569464,0.0008633446,0.0011905893,0.00028489318,0.00053113233,0.0018017519,0.000030671337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004352957,0.0032985662,0.9698566,0.0005457001,0.0008336629,0.00018432467,0.0024270313,0.0004147604,0.00450959,0.00006346793,0.0014155179,0.012097805],"study_design_scores_gemma":[0.069022365,0.011782666,0.9042972,0.0011401788,0.00052594335,0.000031805623,0.0023091312,0.00059734704,0.005520778,0.00016762436,0.004428321,0.00017665392],"about_ca_topic_score_codex":0.0005589814,"about_ca_topic_score_gemma":0.00018930138,"teacher_disagreement_score":0.06555943,"about_ca_system_score_codex":0.0003842749,"about_ca_system_score_gemma":0.0011537779,"threshold_uncertainty_score":0.9996456},"labels":[],"label_agreement":null},{"id":"W2292862520","doi":"10.1136/bmjopen-2015-007954","title":"Single and mixed dyslipidaemia in Canadian primary care settings: findings from the Canadian primary care sentinel surveillance network database","year":2015,"lang":"en","type":"article","venue":"BMJ Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Calgary; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Statin; Population; Internal medicine; Primary care; Epidemiology; Environmental health; Family medicine","score_opus":0.03847375957990903,"score_gpt":0.2944000715946939,"score_spread":0.2559263120147849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292862520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95141274,0.007588272,0.00000190356,0.004578056,0.00048141825,0.0071195327,0.0006858655,0.000026845315,0.02810539],"genre_scores_gemma":[0.98339975,0.000031230535,0.0008937474,0.00943576,0.0010482735,0.0002800133,0.0046914825,0.000057973826,0.00016179134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759114,0.00027198877,0.0003426398,0.0005063563,0.0004761856,0.00081167114],"domain_scores_gemma":[0.9973966,0.000065887456,0.00008071031,0.0010478153,0.00020306124,0.0012059148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020745993,0.00022840097,0.00056896365,0.00008884953,0.00033312518,0.00021107681,0.0003937503,0.00016016938,0.000018655435],"category_scores_gemma":[0.00022559495,0.0001854028,0.00007290218,0.0003453658,0.00006609004,0.00017211011,0.00031305084,0.00037556374,0.000016995822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012358205,0.000013097571,0.9437175,0.00051099126,0.00008678774,0.00046338662,0.0040458855,0.000020725909,0.000024160423,0.000012804374,0.039259735,0.011721387],"study_design_scores_gemma":[0.002383383,0.0000541498,0.84347504,0.0009881548,0.000050961335,0.00006171453,0.0035435653,0.00002015806,0.000026380254,0.000008203251,0.14909087,0.00029740602],"about_ca_topic_score_codex":0.98558754,"about_ca_topic_score_gemma":0.99808204,"teacher_disagreement_score":0.10983114,"about_ca_system_score_codex":0.0025077765,"about_ca_system_score_gemma":0.00909383,"threshold_uncertainty_score":0.9965237},"labels":[],"label_agreement":null},{"id":"W2294328256","doi":"10.1161/circ.132.suppl_3.11575","title":"Abstract 11575: Comparative Effectiveness of Generic Atorvastatin and Lipitor® in Patients Hospitalized With an Acute Coronary Syndrome","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Atorvastatin; Acute coronary syndrome; Internal medicine; Cardiology; Myocardial infarction","score_opus":0.024157991083536962,"score_gpt":0.27727341094793023,"score_spread":0.2531154198643933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294328256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99864143,0.000110434026,0.00021128275,0.0000042727697,0.000059602273,0.0008967379,0.000008586194,0.000013976637,0.000053681768],"genre_scores_gemma":[0.9993946,0.000005034572,0.00036421802,0.000009391128,0.000018505187,0.000030576535,0.00016372184,0.000013145074,8.003598e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905956,0.0001284034,0.00018153817,0.00019889371,0.00031933148,0.000112246365],"domain_scores_gemma":[0.9993998,0.000015789517,0.000092465336,0.00019547186,0.00016950585,0.0001269878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037810532,0.00010317126,0.00037882914,0.000074636766,0.000020169828,0.0000064326982,0.000023975368,0.000054623106,0.000002854255],"category_scores_gemma":[0.0000115789435,0.0000847403,0.000033738277,0.00015922415,0.000044075674,0.00016974687,0.000009822124,0.00007119646,0.0000017723448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078563305,0.00020524726,0.9958275,0.00019086008,0.00012297119,0.000028170278,0.00054545223,0.00025545707,0.00037258322,0.0000147758965,0.0000015085441,0.0016498569],"study_design_scores_gemma":[0.005414704,0.001094913,0.99249285,0.00017156413,0.00007495287,0.000040062223,0.000071323324,0.00033268155,0.0001657143,0.00004450395,0.000003168939,0.0000935448],"about_ca_topic_score_codex":0.00019146895,"about_ca_topic_score_gemma":0.000004758586,"teacher_disagreement_score":0.004629071,"about_ca_system_score_codex":0.00011335123,"about_ca_system_score_gemma":0.00011475567,"threshold_uncertainty_score":0.3455609},"labels":[],"label_agreement":null},{"id":"W2295777772","doi":"10.2174/1874467209666160112125446","title":"Mevalonate Cascade and Neurodevelopmental and Neurodegenerative Diseases: Future Targets for Therapeutic Application","year":2016,"lang":"en","type":"review","venue":"Current Molecular Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Mevalonate pathway; Neuroprotection; Neurodegeneration; Neuroscience; GTPase; Small GTPase; Biology; Signal transduction; Medicine; Bioinformatics; Pharmacology; Cell biology; Disease; Internal medicine; Enzyme; Biochemistry","score_opus":0.025483601801087656,"score_gpt":0.37160138383458396,"score_spread":0.3461177820334963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295777772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016316044,0.9876236,0.0053175655,0.00042126482,0.0011303631,0.005073797,0.00021383414,0.000046222533,0.000010220729],"genre_scores_gemma":[0.0002438117,0.9953222,0.00013650754,0.00058861455,0.0011285589,0.002079304,0.00038793037,0.00009117213,0.00002186117],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977993,0.00033203827,0.00041059067,0.0008516799,0.00021788348,0.00038850264],"domain_scores_gemma":[0.9990445,0.00005669591,0.00021143092,0.00026825137,0.00009120668,0.0003279313],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020141661,0.0004822081,0.0013533473,0.00015114353,0.00013369332,0.000017191762,0.0001077421,0.00020794298,0.000015904267],"category_scores_gemma":[0.000011092325,0.000337455,0.0004151119,0.00012043767,0.00012926431,0.00004034245,0.00011239599,0.00035531,0.0000060804596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004019598,0.000076626224,0.000003161963,0.011745211,0.00056053355,0.000029275021,0.000022279328,7.419471e-8,0.00035571022,0.00018710904,0.0005442402,0.9864356],"study_design_scores_gemma":[0.0017385334,0.00013660235,0.000040939674,0.0006638941,0.003680603,0.00031320288,0.0000029996302,0.000039692983,0.00014670045,0.000042038384,0.992877,0.00031777684],"about_ca_topic_score_codex":9.572109e-7,"about_ca_topic_score_gemma":1.9986857e-7,"teacher_disagreement_score":0.99233276,"about_ca_system_score_codex":0.00010228833,"about_ca_system_score_gemma":0.00039530903,"threshold_uncertainty_score":0.99990773},"labels":[],"label_agreement":null},{"id":"W2298316823","doi":"10.1371/journal.pone.0150990","title":"Statin Safety in Chinese: A Population-Based Study of Older Adults","year":2016,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hamilton Health Sciences; Population Health Research Institute; University of Ottawa; Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Western University","funders":"Astellas Pharma; Ontario Ministry of Health and Long-Term Care; Heart and Stroke Foundation of Canada; Institute for Clinical Evaluative Sciences; Schulich School of Medicine and Dentistry; Academic Medical Organization of Southwestern Ontario; Canadian Institutes of Health Research; Lawson Health Research Institute; Pfizer","keywords":"Medicine; Statin; Discontinuation; Hazard ratio; Internal medicine; Adverse effect; Retrospective cohort study; Population; Cohort study; Propensity score matching; Chinese people; Rhabdomyolysis; Chinese population; Diabetes mellitus; Confidence interval; China; Environmental health; Endocrinology","score_opus":0.016696601528194976,"score_gpt":0.25498731078815545,"score_spread":0.2382907092599605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2298316823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979311,0.00009897328,0.00007845922,0.00041008228,0.000012533433,0.0013283753,0.000011605706,0.000023066108,0.000105809624],"genre_scores_gemma":[0.9990009,0.000011113878,0.00068289245,0.00007406304,0.00007149311,0.000061002393,0.000012964022,0.000015538537,0.00007004184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987797,0.00008019575,0.00030807214,0.00017810034,0.00051718496,0.00013671392],"domain_scores_gemma":[0.9993319,0.000053121217,0.000066504654,0.00038890893,0.00009128863,0.00006825524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003103159,0.00008365431,0.00038581717,0.00009554097,0.00001807866,0.000001596383,0.00003926681,0.00003780835,0.00013075706],"category_scores_gemma":[0.00018785063,0.000050296356,0.000056441953,0.00020030324,0.0000070610736,0.000030741863,0.000012320608,0.00006683197,0.000009026188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048733279,0.005427529,0.9836239,0.00035931534,0.0001516439,0.000011297757,0.00051344966,0.0000018410524,0.00061862066,0.0000065509767,0.0000025627774,0.00879596],"study_design_scores_gemma":[0.009608256,0.00048609418,0.9881364,0.0010262884,0.00007055169,4.0173717e-7,0.000115857656,0.00006293043,0.00041462213,0.000015069841,0.0000019613133,0.00006153151],"about_ca_topic_score_codex":0.0016534552,"about_ca_topic_score_gemma":0.0006864793,"teacher_disagreement_score":0.0091209235,"about_ca_system_score_codex":0.00006840886,"about_ca_system_score_gemma":0.00006343963,"threshold_uncertainty_score":0.24995407},"labels":[],"label_agreement":null},{"id":"W2300317223","doi":"10.1007/s11901-016-0287-9","title":"Statins: the Panacea of Cirrhosis?","year":2016,"lang":"en","type":"article","venue":"Current Hepatology Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Panacea (medicine); Cirrhosis; Medicine; Intensive care medicine; Internal medicine; Alternative medicine; Pathology","score_opus":0.02560905017151881,"score_gpt":0.30292956958871337,"score_spread":0.27732051941719454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300317223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852433,0.008288512,0.0010665364,0.0028659827,0.0010617126,0.00052413,0.0000049771365,0.000042950167,0.00090187776],"genre_scores_gemma":[0.99835366,0.0011192415,0.00006808827,0.00012843197,0.00014631404,0.000046487068,0.000005648478,0.000012445542,0.000119664255],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864566,0.00009557728,0.00047699164,0.00025261208,0.00029272647,0.0002364383],"domain_scores_gemma":[0.998577,0.000056530615,0.0002655756,0.00085557037,0.00014651653,0.00009881217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006394959,0.000106276544,0.00040520364,0.000048585356,0.00005131662,0.000002131391,0.00005337164,0.00006822773,0.00012004262],"category_scores_gemma":[0.0002697704,0.00004864855,0.00023075934,0.00011079724,0.00017919882,0.000031017684,0.00004349371,0.00011841271,0.000014810928],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031211268,0.00013094376,0.65877193,0.00017831966,0.00016969714,0.00031611172,0.000110133326,5.8859786e-8,0.00064032536,0.00063542725,0.005102743,0.3339131],"study_design_scores_gemma":[0.0017419623,0.00036549283,0.30552724,0.0005706531,0.0005399135,0.008590487,0.000097619086,0.00001313626,0.009973543,0.0023703666,0.66993695,0.0002726445],"about_ca_topic_score_codex":0.00006478775,"about_ca_topic_score_gemma":0.000012339546,"teacher_disagreement_score":0.6648342,"about_ca_system_score_codex":0.0000395628,"about_ca_system_score_gemma":0.00028148163,"threshold_uncertainty_score":0.19838303},"labels":[],"label_agreement":null},{"id":"W2300419386","doi":"10.1093/eurheartj/ehw046","title":"Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents","year":2016,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; AstraZeneca","keywords":"Medicine; Statin; Medical prescription; Ldl cholesterol; Cholesterol; Reduction (mathematics); Internal medicine; Pharmacology; Cardiology","score_opus":0.09460294380599962,"score_gpt":0.35730595441286583,"score_spread":0.2627030106068662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2300419386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9122657,0.00061807275,0.07433384,0.011345042,0.0006399346,0.0007726619,0.0000074504937,0.000011255443,0.0000060135703],"genre_scores_gemma":[0.9941866,0.001031775,0.003080464,0.00026164038,0.0013252748,0.00001829632,0.0000029025546,0.000027002232,0.00006609406],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990473,0.000092166796,0.00037824537,0.00015224137,0.00015136848,0.00017869622],"domain_scores_gemma":[0.99936837,0.000023855857,0.00010905435,0.00019128188,0.00023149418,0.000075927645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001745529,0.00008534231,0.00020128342,0.00007124436,0.00021303055,0.000026922136,0.000050298913,0.000019181032,0.0000046856726],"category_scores_gemma":[0.00015224387,0.000049279017,0.00021368744,0.000048098653,0.000021082364,0.00011243543,0.000022161208,0.00009412316,5.5296107e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007542632,0.00009686703,0.01363031,0.00010438963,0.00032949218,0.0000046007485,0.0010208469,0.000194222,0.37950787,0.000019242772,0.0052304543,0.59910744],"study_design_scores_gemma":[0.004563576,0.00038618405,0.9717988,0.0004722715,0.00010846178,0.0005070938,0.00033301653,0.00024916246,0.0025274758,0.00006207816,0.018896589,0.00009531056],"about_ca_topic_score_codex":0.00003551001,"about_ca_topic_score_gemma":0.0000028263737,"teacher_disagreement_score":0.95816845,"about_ca_system_score_codex":0.000048503392,"about_ca_system_score_gemma":0.000037003443,"threshold_uncertainty_score":0.200954},"labels":[],"label_agreement":null},{"id":"W2301182905","doi":"10.1016/j.jcjd.2015.12.006","title":"Statin Use and the Risk for Incident Diabetes Mellitus in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Population-Based Retrospective Cohort Study in Taiwan","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Percutaneous coronary intervention; Statin; Internal medicine; Acute coronary syndrome; Hazard ratio; Diabetes mellitus; Retrospective cohort study; Conventional PCI; Cohort; Proportional hazards model; Cohort study; Population; Coronary artery disease; Myocardial infarction; Confidence interval; Endocrinology","score_opus":0.0050455012486789,"score_gpt":0.21075428561663354,"score_spread":0.20570878436795464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2301182905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963159,0.0008772523,0.0000118543485,0.00030407828,0.00009209179,0.002206642,0.00018788388,0.000003464093,8.41837e-7],"genre_scores_gemma":[0.9995082,0.000012401557,0.0001417703,0.00013938059,0.000026680735,0.000116576535,0.000016927579,0.000028282613,0.000009782314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982061,0.00031252808,0.00052982994,0.00022215933,0.00036670413,0.00036271987],"domain_scores_gemma":[0.9986844,0.00017181861,0.00026827605,0.00025361538,0.00029024598,0.0003316254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011867234,0.00017610993,0.0006434286,0.00031331868,0.000082762905,0.00004464747,0.00008719151,0.000058121157,0.000035838577],"category_scores_gemma":[0.00031751682,0.000097595745,0.00016087109,0.00016182405,0.00012349714,0.00020946158,0.000011615828,0.0002239674,5.428094e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044698713,0.00012031947,0.9952858,0.0000363914,0.00054560293,0.00034329516,0.00031894204,0.000009214065,6.6187687e-7,0.000002629421,0.0000064206706,0.0028837386],"study_design_scores_gemma":[0.011095367,0.0030210963,0.9843381,0.00061502913,0.00043305877,0.000036946803,0.00017649482,0.00003182901,0.0000016970073,0.0001166927,0.0000053813246,0.00012830715],"about_ca_topic_score_codex":0.0037073572,"about_ca_topic_score_gemma":0.0439177,"teacher_disagreement_score":0.040210344,"about_ca_system_score_codex":0.00080746657,"about_ca_system_score_gemma":0.00041006814,"threshold_uncertainty_score":0.9735283},"labels":[],"label_agreement":null},{"id":"W2301196075","doi":"10.1093/cvr/cvw053","title":"Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms","year":2016,"lang":"en","type":"article","venue":"Cardiovascular Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"LDL receptor; PCSK9; Internal medicine; Endocrinology; Apolipoprotein E; Kexin; Apolipoprotein B; Lipoprotein; Cholesterol; Lipogenesis; Chemistry; Biology; Medicine; Lipid metabolism","score_opus":0.06225339044670478,"score_gpt":0.3110566996130619,"score_spread":0.24880330916635715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2301196075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97751516,0.0119057875,0.0077011003,0.0004663939,0.000061905535,0.0019691873,0.0000073363785,0.00012043201,0.00025270678],"genre_scores_gemma":[0.9947206,0.0018065053,0.0022016917,0.00006689846,0.0002239042,0.00042901063,0.000013740974,0.00009798778,0.00043966644],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9950014,0.00067794754,0.0004118352,0.00091290113,0.0021008428,0.000895106],"domain_scores_gemma":[0.9974423,0.00011707222,0.00004221084,0.0012704077,0.00047112047,0.0006569132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006555838,0.0003115799,0.00091660244,0.00035692647,0.00059401005,0.00007621968,0.00016880818,0.00024973843,0.00006530828],"category_scores_gemma":[0.00038384064,0.00020925651,0.00051015924,0.00048029644,0.00034333518,0.00011833601,0.00035280033,0.0003213961,0.00009291452],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008385364,0.0002225672,0.007763067,0.0013902818,0.0057375305,0.00018599982,0.0007643327,5.741194e-7,0.22129759,0.00031163625,0.00011376577,0.7621288],"study_design_scores_gemma":[0.01832964,0.0021987727,0.5337051,0.002779453,0.0015799567,0.001278224,0.00063847663,0.00012049143,0.3557312,0.001948648,0.07981102,0.001879032],"about_ca_topic_score_codex":0.0003216272,"about_ca_topic_score_gemma":0.00002367673,"teacher_disagreement_score":0.76024973,"about_ca_system_score_codex":0.00025015278,"about_ca_system_score_gemma":0.00026504663,"threshold_uncertainty_score":0.8533233},"labels":[],"label_agreement":null},{"id":"W2302335519","doi":"10.18433/j3j02p","title":"The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin/Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy","year":2016,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Evolocumab; Proprotein convertase; Alirocumab; Medicine; Kexin; Statin; Clinical trial; Hyperlipidemia; Pharmacology; Internal medicine; Lipoprotein; LDL receptor; Cholesterol; Endocrinology","score_opus":0.08932132076456119,"score_gpt":0.43859508615465465,"score_spread":0.34927376539009347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302335519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010149049,0.98308986,0.00018983832,0.0028136051,0.00065740396,0.0027793543,0.000029495151,0.000014283788,0.00027709387],"genre_scores_gemma":[0.006553956,0.9909259,0.00039324228,0.00060463906,0.0012284251,0.00004521294,0.0000019789782,0.000040178595,0.00020647875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99481875,0.00086519535,0.0015542274,0.00055055966,0.0015543847,0.00065685896],"domain_scores_gemma":[0.9967276,0.00030239136,0.0009826096,0.00036293204,0.00027485858,0.0013496317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051350384,0.00053253217,0.0016947621,0.00031086188,0.00031153217,0.000103698876,0.00083193043,0.00008777444,0.0002208103],"category_scores_gemma":[0.0001676567,0.00023219912,0.00077586237,0.00060063996,0.0005429769,0.0003455825,0.00019378719,0.00073716725,0.000019024854],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038395706,0.00015224036,0.000028783832,0.0012360176,0.0007421394,0.000048163558,0.00041606597,0.0000017527857,0.0003878469,0.00016687198,0.0004944524,0.9959417],"study_design_scores_gemma":[0.0024055084,0.00090938667,0.000009683177,0.0037466767,0.0005540782,0.00030584834,0.00045091903,0.000073966075,0.0089513445,0.00024748524,0.98207754,0.0002675771],"about_ca_topic_score_codex":0.00018610083,"about_ca_topic_score_gemma":0.000004926285,"teacher_disagreement_score":0.99567413,"about_ca_system_score_codex":0.00016454891,"about_ca_system_score_gemma":0.0011974886,"threshold_uncertainty_score":0.9468806},"labels":[],"label_agreement":null},{"id":"W2302509766","doi":"10.1016/j.jacc.2016.01.041","title":"Improving the Monitoring and Care of Patients With Familial Hypercholesterolemia ∗","year":2016,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Intensive care medicine; Internal medicine; Cholesterol","score_opus":0.0077556437494531215,"score_gpt":0.228649044338676,"score_spread":0.22089340058922288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302509766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624918,0.0015366244,0.00007064562,0.03437805,0.00069297705,0.00051699905,0.00019449566,0.0000029473742,0.00011542703],"genre_scores_gemma":[0.98491466,0.00037738823,0.00027999384,0.007710764,0.0066088205,0.0000067879046,0.000002022769,0.000044752487,0.000054836106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780947,0.0004581424,0.0005704127,0.00017454416,0.0007243818,0.00026306478],"domain_scores_gemma":[0.9968576,0.00016146044,0.0015066662,0.0006705948,0.0007440901,0.000059586222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004600539,0.00021754697,0.0016272395,0.0001222425,0.00006829822,0.0000031951936,0.00033545142,0.0001764931,6.798817e-7],"category_scores_gemma":[0.00011517352,0.00008953059,0.0006314499,0.00015153203,0.0007346154,0.0000344934,0.00013165775,0.0010686528,1.4558243e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043361015,0.0000341782,0.7987936,0.0022408373,0.007903554,0.0009573127,0.0005158104,0.000045302633,0.0027840326,0.0000048416787,0.06886854,0.11351588],"study_design_scores_gemma":[0.0066576027,0.005996058,0.7075756,0.0019409724,0.003724864,0.0027645573,0.0020358243,7.783253e-7,0.0011392351,0.000015774198,0.26778004,0.00036868814],"about_ca_topic_score_codex":0.000054367,"about_ca_topic_score_gemma":8.7329346e-7,"teacher_disagreement_score":0.19891149,"about_ca_system_score_codex":0.00013953794,"about_ca_system_score_gemma":0.00046796407,"threshold_uncertainty_score":0.46428242},"labels":[],"label_agreement":null},{"id":"W2304627241","doi":"10.1007/s11883-016-0573-6","title":"Pharmacogenetics of Lipid-Lowering Agents: Precision or Indecision Medicine?","year":2016,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Pharmacogenetics; Medicine; Dyslipidemia; Precision medicine; Pharmacodynamics; Pharmacology; Bioinformatics; Intensive care medicine; Pharmacokinetics; Internal medicine; Gene; Genetics; Disease; Biology; Genotype","score_opus":0.1701930689103387,"score_gpt":0.4313428213922513,"score_spread":0.2611497524819126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304627241","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000714273,0.9891105,0.0009499818,0.000020865533,0.0058254083,0.0029667658,0.00002974581,0.0000926784,0.00028975747],"genre_scores_gemma":[0.00035823803,0.9960404,0.00013258662,0.000022909468,0.0024270099,0.000241783,0.000097027936,0.0001977437,0.00048230463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99301314,0.0002268234,0.0030535294,0.0011495486,0.0019758327,0.0005811133],"domain_scores_gemma":[0.99454045,0.00020963624,0.002163801,0.0021791735,0.0003853693,0.0005215896],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019887171,0.000839258,0.0042636227,0.00045771583,0.00010697464,0.00002044844,0.00029707316,0.0005091848,0.0012107679],"category_scores_gemma":[0.00083838945,0.0004472588,0.001817503,0.00067773915,0.00017772256,0.00008785332,0.00030449466,0.0005925436,0.000053030675],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032721222,0.0002174633,0.00012394291,0.018168546,0.00038749204,0.000060185717,0.00006500866,1.657053e-7,0.000031302825,9.5129946e-7,0.0040589003,0.9768533],"study_design_scores_gemma":[0.0007858524,0.00028919536,0.00022117152,0.15851857,0.0017673207,0.00051255914,0.0000043142572,0.0000010072679,0.00006617036,0.000008025839,0.8374625,0.0003633207],"about_ca_topic_score_codex":0.000010982114,"about_ca_topic_score_gemma":6.733355e-7,"teacher_disagreement_score":0.97649,"about_ca_system_score_codex":0.00036224636,"about_ca_system_score_gemma":0.00086530513,"threshold_uncertainty_score":0.99979794},"labels":[],"label_agreement":null},{"id":"W2308406514","doi":"10.1177/1076029616638504","title":"Effects of LEP G2548A and LEPR Q223R Polymorphisms on Serum Lipids and Response to Simvastatin Treatment in Chinese Patients With Primary Hyperlipidemia","year":2016,"lang":"en","type":"article","venue":"Clinical and Applied Thrombosis/Hemostasis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"Anhui Medical University; Anhui University; National Natural Science Foundation of China","keywords":"Simvastatin; Internal medicine; Hyperlipidemia; Genotype; Endocrinology; Genotyping; Medicine; Biology; Genetics; Gene; Diabetes mellitus","score_opus":0.01576196664491735,"score_gpt":0.2945162698227078,"score_spread":0.27875430317779043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308406514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960706,0.00027165594,0.000032043048,0.0016921763,0.00005838104,0.0016625226,0.00004920033,0.000027202146,0.00013618394],"genre_scores_gemma":[0.9967369,0.00061738375,0.00096753193,0.0013683005,0.00010167039,0.00011188626,0.000007894153,0.00003847814,0.0000499962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780107,0.00021477827,0.0006078493,0.0006886698,0.00034142638,0.0003462097],"domain_scores_gemma":[0.99765813,0.0012656185,0.0001282293,0.00043453122,0.000044916786,0.00046859382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008353171,0.00033435845,0.0012228509,0.00011682545,0.00007513516,0.000012443331,0.000054383545,0.00018316958,0.000010333368],"category_scores_gemma":[0.0002714079,0.00017608763,0.0001151101,0.0002212295,0.0002977316,0.000047341935,0.00009747166,0.0001585351,0.000005512504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064454265,0.0008897963,0.5146379,0.00027689178,0.00024708043,0.00000885386,0.00028047359,4.963313e-7,0.0039841575,0.00004692833,0.000048111568,0.4731339],"study_design_scores_gemma":[0.014939464,0.0046285978,0.9755096,0.0004702118,0.00018598586,0.0000030635226,0.00004079815,0.000001506114,0.0034707778,0.0000749602,0.00045319053,0.0002218486],"about_ca_topic_score_codex":0.000064689615,"about_ca_topic_score_gemma":0.000017010132,"teacher_disagreement_score":0.47291204,"about_ca_system_score_codex":0.00009406794,"about_ca_system_score_gemma":0.0001259543,"threshold_uncertainty_score":0.71806455},"labels":[],"label_agreement":null},{"id":"W2312025249","doi":"10.2174/1570161113666150827125040","title":"Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel","year":2015,"lang":"en","type":"article","venue":"Current Vascular Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Aegerion Pharmaceuticals","keywords":"Medicine; Disease; Microsomal triglyceride transfer protein; Middle East; Ezetimibe; Family medicine; Familial hypercholesterolemia; Pediatrics; Internal medicine; Statin; Geography; Lipoprotein; Cholesterol","score_opus":0.05856717137721748,"score_gpt":0.2937184370902438,"score_spread":0.23515126571302633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312025249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936711,0.003717165,0.00083573,0.00018931642,0.00041931585,0.0010165384,0.00011084805,0.000024064604,0.000015932375],"genre_scores_gemma":[0.9963303,0.0023218992,0.0002190923,0.00007747216,0.00015359728,0.00013796019,0.0007428483,0.000011319738,0.000005499299],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998978,0.00012581458,0.00031120787,0.00019872484,0.00023694264,0.00014927806],"domain_scores_gemma":[0.9991943,0.000016565344,0.00013238794,0.0002060267,0.00024288181,0.00020780164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001854917,0.00013986201,0.00031983716,0.00011274853,0.00005922821,0.000014599265,0.000035941634,0.00006839479,0.000012305975],"category_scores_gemma":[0.000017413848,0.00010986385,0.00006963901,0.00009700676,0.0000840023,0.00024613898,0.0000286927,0.00009846133,0.000007786256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007553131,0.0015414173,0.07591755,0.000306125,0.0009761309,0.0000044526732,0.0063260486,0.000017181452,0.0005693618,0.00001803954,0.0005794378,0.91298896],"study_design_scores_gemma":[0.04595448,0.0024062742,0.8046241,0.0001678977,0.002992564,0.00004884157,0.001592336,0.0009574566,0.0011856981,0.00005017472,0.13960047,0.0004197024],"about_ca_topic_score_codex":0.000115228955,"about_ca_topic_score_gemma":0.000009947393,"teacher_disagreement_score":0.9125692,"about_ca_system_score_codex":0.00011182721,"about_ca_system_score_gemma":0.00012284382,"threshold_uncertainty_score":0.4480118},"labels":[],"label_agreement":null},{"id":"W2312689866","doi":"10.1097/hco.0b013e32834b9fb1","title":"Lipid-lowering therapy and coronary artery bypass graft surgery","year":2011,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Perioperative; Statin; Coronary artery disease; Internal medicine; Cardiology; Atrial fibrillation; Regimen; Artery; Coronary artery bypass surgery; Surgery","score_opus":0.19090206951007435,"score_gpt":0.3808960392285766,"score_spread":0.18999396971850227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312689866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016143288,0.9847491,0.00007412067,0.000023170545,0.013212995,0.0014931855,0.00003150191,0.00006328314,0.00019125741],"genre_scores_gemma":[0.00014741773,0.9945424,0.000017238483,0.000024281435,0.004283878,0.00048544985,0.00040927102,0.00007775813,0.000012307894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969484,0.00058913475,0.0009055056,0.0007852594,0.00021513684,0.00055652583],"domain_scores_gemma":[0.99838614,0.00024183858,0.0002357918,0.00085119874,0.000058108373,0.00022689544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012330109,0.0005359152,0.00414409,0.00047171974,0.000057069705,0.000012056418,0.0001338095,0.00057849946,0.00002998465],"category_scores_gemma":[0.0000675423,0.0004165953,0.0014286806,0.00025457455,0.00014946627,0.000052084448,0.00012814622,0.0009347906,0.00003696655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033245527,0.00004165148,0.0017987045,0.016811574,0.00054769136,0.000036772155,0.000026490303,8.600603e-8,4.4550866e-8,0.00003931025,0.0021758496,0.97848856],"study_design_scores_gemma":[0.0005928553,0.0001187271,0.0041883867,0.012696185,0.0002201752,0.0030062958,0.0000074283453,4.5179533e-7,7.3892345e-8,0.000018888226,0.9788001,0.0003504167],"about_ca_topic_score_codex":0.000018762837,"about_ca_topic_score_gemma":5.789873e-7,"teacher_disagreement_score":0.97813815,"about_ca_system_score_codex":0.00014452722,"about_ca_system_score_gemma":0.0005636371,"threshold_uncertainty_score":0.9998286},"labels":[],"label_agreement":null},{"id":"W2312974175","doi":"10.1016/j.cjca.2013.07.534","title":"Describing the Use of Ezetimibe (Ezetrol®) in Saskatchewan: An Observational Study","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Saskatoon Medical Imaging","funders":"","keywords":"Ezetimibe; Medicine; Observational study; Statin; Clinical trial; Intensive care medicine; Internal medicine","score_opus":0.23195749899348003,"score_gpt":0.2912023361307668,"score_spread":0.05924483713728676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312974175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969866,0.00039881797,0.00042133196,0.0013423766,0.00023323865,0.00048402077,0.000005113262,0.0000019269773,0.000126569],"genre_scores_gemma":[0.99810874,0.000014556114,0.00054350606,0.00065069844,0.0006203281,0.000011975396,0.000003503327,0.000012908666,0.000033752465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984498,0.00041568527,0.00050595205,0.00011298605,0.00023280687,0.00028274287],"domain_scores_gemma":[0.99845624,0.0000831824,0.00015154875,0.00036171393,0.0004491569,0.000498143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011449032,0.000097132586,0.0005764653,0.00023204339,0.000058220856,0.000019333454,0.00014891304,0.000088481225,0.000044630004],"category_scores_gemma":[0.0003708473,0.00006529102,0.0002273849,0.00019670812,0.000108037704,0.00018735441,0.000009706977,0.00035498643,0.0000027534547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051733878,0.000018146915,0.9622695,0.000015608302,0.00043431594,0.00025617942,0.0020739192,0.0038710996,0.00024376497,0.000053456355,0.0024630656,0.028249236],"study_design_scores_gemma":[0.0012058131,0.00074217614,0.9836043,0.000048093883,0.000107865664,0.0005774568,0.004428667,0.00006709173,0.00001909228,0.000068542206,0.009063929,0.000066962726],"about_ca_topic_score_codex":0.043227848,"about_ca_topic_score_gemma":0.03320233,"teacher_disagreement_score":0.028182272,"about_ca_system_score_codex":0.00016420141,"about_ca_system_score_gemma":0.0026463084,"threshold_uncertainty_score":0.9844392},"labels":[],"label_agreement":null},{"id":"W2312994075","doi":"10.1016/j.cjca.2013.07.462","title":"Incidence of Cardiovascular Events With Varenicline for Smoking Cessation Post-Acute Coronary Syndrome","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Varenicline; Medicine; Bupropion; Smoking cessation; Myocardial infarction; Incidence (geometry); Acute coronary syndrome; Population; Randomized controlled trial; Internal medicine; Emergency medicine; Environmental health","score_opus":0.01297297384693604,"score_gpt":0.23684106708841965,"score_spread":0.2238680932414836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312994075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775265,0.0039722156,0.01658038,0.0005867455,0.0003597318,0.00073972315,0.000037482583,0.000004909839,0.00019231818],"genre_scores_gemma":[0.9978887,0.00018139266,0.0012464025,0.00018261044,0.00038199156,0.000030895113,0.000025787851,0.000026969521,0.000035291734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984773,0.00014125931,0.000502203,0.00017478691,0.00034399444,0.0003604575],"domain_scores_gemma":[0.99748456,0.00004719038,0.0002540437,0.00041113983,0.0012698596,0.00053320715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096241396,0.00014769574,0.0010513595,0.0002832393,0.000077135745,0.0000075586113,0.00015493226,0.00015386134,0.000027957309],"category_scores_gemma":[0.00014770858,0.000114247145,0.0007828991,0.00016132499,0.00010870714,0.00015977529,0.000010688235,0.00023650475,0.000002723749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011309927,0.0000310943,0.78442454,0.001263629,0.0549328,0.005353878,0.0007255547,0.020185323,0.0015456716,0.00028933838,0.0037145326,0.12640266],"study_design_scores_gemma":[0.0038047389,0.0030731093,0.94627154,0.0003443193,0.0025369378,0.026193194,0.00021574141,0.000036019912,0.0001851938,0.00020033983,0.016940344,0.00019852364],"about_ca_topic_score_codex":0.004687332,"about_ca_topic_score_gemma":0.00027570844,"teacher_disagreement_score":0.16184701,"about_ca_system_score_codex":0.00021084507,"about_ca_system_score_gemma":0.0019511787,"threshold_uncertainty_score":0.7085875},"labels":[],"label_agreement":null},{"id":"W2313648546","doi":"10.1021/pr500659r","title":"Metabolomics Reveals the Sex-Specific Effects of the SORT1 Low-Density Lipoprotein Cholesterol Locus in Healthy Young Adults","year":2014,"lang":"en","type":"article","venue":"Journal of Proteome Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Natural Sciences and Engineering Research Council of Canada; Alberta Innovates - Health Solutions; Alberta Cancer Foundation","keywords":"Metabolomics; Locus (genetics); Cholesterol; Biology; Lipoprotein; Genetics; Ldl cholesterol; Computational biology; Bioinformatics; Gene; Endocrinology","score_opus":0.02204877149586458,"score_gpt":0.3092351954371788,"score_spread":0.2871864239413142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313648546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864877,0.0037191743,0.00034642578,0.0048999162,0.00028046448,0.0041230507,0.0000018316614,0.000006857989,0.00013460367],"genre_scores_gemma":[0.9966198,0.001385931,0.00041805155,0.00019100301,0.0010852303,0.000097714335,4.9913797e-7,0.00003883505,0.00016288889],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9923125,0.00280152,0.0010659216,0.00030835305,0.0027874196,0.00072428636],"domain_scores_gemma":[0.9965092,0.0003628967,0.00051974866,0.0012702383,0.0010334249,0.00030451457],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.019260522,0.00020691333,0.0009659548,0.00038262404,0.00025372382,0.00004929227,0.00065475906,0.00020703503,0.000010883725],"category_scores_gemma":[0.001675124,0.000106438856,0.0005182162,0.0009867598,0.00031706417,0.00013076056,0.00022732688,0.0025957697,0.000012061907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017362682,0.0031460838,0.058078628,0.018837951,0.0013217066,0.00059673964,0.0092912745,0.00010117649,0.2805385,0.0010322859,0.0022126937,0.6074803],"study_design_scores_gemma":[0.016627405,0.0060258782,0.7585063,0.0065236073,0.000128232,0.001547029,0.00091219833,0.0001889517,0.20017043,0.001863563,0.007154427,0.000351991],"about_ca_topic_score_codex":0.001075738,"about_ca_topic_score_gemma":0.00018517561,"teacher_disagreement_score":0.70042765,"about_ca_system_score_codex":0.0003140065,"about_ca_system_score_gemma":0.0005837908,"threshold_uncertainty_score":0.99970526},"labels":[],"label_agreement":null},{"id":"W2313680023","doi":"10.1097/hco.0b013e3283499ef1","title":"Combination therapy for dyslipidemia","year":2011,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Ezetimibe; Simvastatin; Niacin; Dyslipidemia; Statin; Atorvastatin; Internal medicine; Pharmacology; Combination therapy; Metabolic syndrome; Clinical trial; Disease; Obesity","score_opus":0.2231853920608796,"score_gpt":0.44676047866210067,"score_spread":0.22357508660122108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313680023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000022134427,0.98124725,0.0011213686,0.000030279141,0.012718578,0.0043718438,0.000048971277,0.000046841727,0.0004126512],"genre_scores_gemma":[0.000006706404,0.9925695,0.00008978549,0.000019138133,0.0038269071,0.0021193249,0.0012759337,0.0000620777,0.000030592455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99759424,0.00048259395,0.00077901053,0.00058310706,0.00015649946,0.00040455413],"domain_scores_gemma":[0.99864125,0.0001525217,0.0002616825,0.0007009865,0.00012547207,0.000118106414],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013329149,0.0003724321,0.0031809616,0.00034197894,0.000044928303,0.0000059642034,0.00016330244,0.00060778426,0.000017937906],"category_scores_gemma":[0.0001415611,0.00028238667,0.0017005769,0.00023327765,0.000065503045,0.000029631472,0.000045736553,0.00061969156,0.000039734998],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029225133,0.00005762966,0.00007871557,0.024566783,0.00025447848,7.0299996e-7,0.000015413223,1.377911e-7,1.2807227e-8,0.0021571305,0.0049130563,0.96792674],"study_design_scores_gemma":[0.0017969051,0.00034033702,0.00024687444,0.008531741,0.0002207438,0.00010896955,0.0000033417955,0.000002125559,7.1316954e-8,0.00026561288,0.9882483,0.00023497891],"about_ca_topic_score_codex":0.000008681172,"about_ca_topic_score_gemma":2.2722523e-7,"teacher_disagreement_score":0.98333526,"about_ca_system_score_codex":0.00025246272,"about_ca_system_score_gemma":0.00057362893,"threshold_uncertainty_score":0.9999628},"labels":[],"label_agreement":null},{"id":"W2313998826","doi":"10.1056/nejmoa1600176","title":"Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":844,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Institut universitaire de cardiologie et de pneumologie de Québec; Population Health Research Institute; Université Laval; University of Toronto; Hamilton Health Sciences; McMaster University","funders":"Canadian Institutes of Health Research; AstraZeneca","keywords":"Medicine; Rosuvastatin; Hazard ratio; Internal medicine; Myocardial infarction; Placebo; Population; Confidence interval; Cardiology; Physical therapy; Pathology","score_opus":0.014564853394874375,"score_gpt":0.2557855890663765,"score_spread":0.24122073567150212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313998826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97906005,0.009129118,0.0060503706,0.004463018,0.00074215134,0.00028279063,0.0000038238304,0.000016747106,0.00025191827],"genre_scores_gemma":[0.98846465,0.004105158,0.00012857601,0.00029309225,0.0067211515,0.000003682766,0.000001314161,0.000031348376,0.00025103855],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976609,0.00017556945,0.0006132064,0.00021893662,0.0010103302,0.00032109502],"domain_scores_gemma":[0.99815184,0.00008272527,0.00021876232,0.00052172574,0.00013595646,0.00088896445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023162132,0.0001992375,0.0009341848,0.00032372237,0.000034603676,0.000007052149,0.00013842057,0.00006758674,0.00009561738],"category_scores_gemma":[0.000953535,0.000101012636,0.00047901284,0.00017294621,0.00011626432,0.00013766998,0.0000285404,0.00044226402,0.000008164498],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001147873,0.00006611345,0.25857005,0.00011320233,0.0008430723,0.0009910772,0.00072936394,0.00003039721,0.0007319491,0.0000041768976,0.0006757688,0.736097],"study_design_scores_gemma":[0.1621092,0.0020219835,0.7114541,0.0058344156,0.0019970732,0.002824993,0.00030236196,0.00002646568,0.00036071544,0.00012972885,0.11267672,0.00026222624],"about_ca_topic_score_codex":0.00035507028,"about_ca_topic_score_gemma":0.000048835685,"teacher_disagreement_score":0.7358347,"about_ca_system_score_codex":0.00014547848,"about_ca_system_score_gemma":0.00034505752,"threshold_uncertainty_score":0.41191757},"labels":[],"label_agreement":null},{"id":"W2314522863","doi":"10.1186/s40842-016-0024-x","title":"Lipoprotein (a), an independent cardiovascular risk marker","year":2016,"lang":"en","type":"review","venue":"Clinical Diabetes and Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Lipoprotein(a); Apolipoprotein B; Medicine; Lipoprotein; Risk factor; Epidemiology; PCSK9; Internal medicine; Endocrinology; Cardiology; Cholesterol; LDL receptor","score_opus":0.06123781838405713,"score_gpt":0.37054810325307463,"score_spread":0.3093102848690175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314522863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025646407,0.9932613,0.000047041667,0.000071581955,0.00092491554,0.002019079,0.00013252221,0.00014407925,0.00083486806],"genre_scores_gemma":[0.00027519857,0.99527735,0.00029101616,0.00023520106,0.0028957876,0.00042875935,0.000108679014,0.00014274949,0.00034525024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99289906,0.0020245356,0.0017060753,0.0016177684,0.00053769624,0.0012148534],"domain_scores_gemma":[0.99555725,0.0004812258,0.0004445257,0.002510747,0.00012853711,0.0008776899],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025776357,0.00074264273,0.006393109,0.00023350473,0.00016839855,0.00004003439,0.00032083216,0.001191916,0.00022685781],"category_scores_gemma":[0.0008462875,0.00046296732,0.0045081386,0.00017595504,0.00049338007,0.0000868946,0.00039848484,0.0017574659,0.0002575374],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019006413,0.00014872817,0.0014452543,0.0061683212,0.0052600373,0.00020270317,0.0000034644484,2.9465193e-8,4.1279065e-8,0.000111909976,0.0001594731,0.986481],"study_design_scores_gemma":[0.0017978053,0.0009867428,0.005364291,0.0045798197,0.0063469424,0.0002871782,0.0000068189156,0.0000021641752,5.6339894e-7,0.00018185303,0.9799309,0.00051496894],"about_ca_topic_score_codex":0.000112931215,"about_ca_topic_score_gemma":0.000008239817,"teacher_disagreement_score":0.9859661,"about_ca_system_score_codex":0.000090872636,"about_ca_system_score_gemma":0.0004044079,"threshold_uncertainty_score":0.9997822},"labels":[],"label_agreement":null},{"id":"W2315549209","doi":"10.33549/physiolres.930511","title":"Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease","year":2004,"lang":"en","type":"article","venue":"Physiological Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Ministerstvo Zdravotnictví Ceské Republiky","keywords":"Internal medicine; Medicine; Endocrinology; Apolipoprotein B; Coronary artery disease; Waist; Body mass index; Cholesterol; Immunoradiometric assay; Blood pressure; Lipoprotein(a); Lipoprotein; Radioimmunoassay","score_opus":0.09788537827045729,"score_gpt":0.3303303699241581,"score_spread":0.2324449916537008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315549209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977447,0.00016183675,0.000012511654,0.00029753064,0.000010016,0.001615417,0.000019242674,0.0000142990275,0.00012446985],"genre_scores_gemma":[0.99931926,0.000052103467,0.0002867007,0.00005242494,0.000045235425,0.00020343647,0.000019014606,0.000012356289,0.000009443319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972504,0.00029671195,0.0002950805,0.00043283036,0.0011788143,0.0005461829],"domain_scores_gemma":[0.9990019,0.000079199504,0.000037375587,0.00040461688,0.00019612582,0.00028076797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072917447,0.00014208615,0.0004695158,0.00029452142,0.000044191038,0.000008532792,0.0001649126,0.00010839357,0.00004179858],"category_scores_gemma":[0.0002920163,0.000084537074,0.00014274423,0.0008052802,0.00033625594,0.00006434246,0.0001127447,0.0005762329,0.0000074869936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047413167,0.0032029222,0.9759583,0.00040841842,0.00010049054,0.00028052597,0.00013428045,0.000045266042,0.002453446,0.0006562874,0.000007698591,0.012011076],"study_design_scores_gemma":[0.0040362324,0.0020313726,0.9898369,0.0002677799,0.000008054792,0.0000013165487,0.000045082877,0.000022743847,0.00014506733,0.0035017899,0.000004045362,0.00009966939],"about_ca_topic_score_codex":0.00028684313,"about_ca_topic_score_gemma":0.00005139368,"teacher_disagreement_score":0.013878574,"about_ca_system_score_codex":0.00009930385,"about_ca_system_score_gemma":0.0003345832,"threshold_uncertainty_score":0.34473217},"labels":[],"label_agreement":null},{"id":"W2316584874","doi":"10.1016/j.cjca.2012.07.713","title":"792 Acute Coronary Syndrome in Patients With Normal or Non-Obstructive Coronary Artery Disease: Patient Characteristics and Long-Term Outcomes","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Acute coronary syndrome; Coronary artery disease; Cardiology; Internal medicine; Term (time); Myocardial infarction","score_opus":0.00910624188146116,"score_gpt":0.22318384725301313,"score_spread":0.21407760537155196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316584874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783593,0.0006311432,0.00009367512,0.0001465357,0.00065772777,0.00045357377,0.00013343431,0.0000031879072,0.00004477217],"genre_scores_gemma":[0.99914014,0.0000802925,0.00007836603,0.00033346374,0.00024609736,0.000010688264,0.000057597386,0.000026835112,0.000026497586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851066,0.00011453987,0.00042323544,0.00015550725,0.00024927786,0.00054676045],"domain_scores_gemma":[0.9979052,0.000031821797,0.0001889186,0.00025887953,0.00018057393,0.001434627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021946516,0.00020368658,0.00087067485,0.0002610235,0.000072483155,0.000011450238,0.00007909054,0.000114225346,0.000022761598],"category_scores_gemma":[0.00004429584,0.00013915356,0.00016687723,0.0000924736,0.00017255085,0.00022219904,0.000021712352,0.0003498968,0.0000034094003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097151654,0.000016776514,0.97799975,0.000058023164,0.0009038569,0.007317149,0.00015576565,0.0000040158952,8.415227e-7,0.000003553934,0.00006015403,0.012508587],"study_design_scores_gemma":[0.0027768535,0.001352869,0.984857,0.00013679398,0.00045194698,0.009834819,0.000044474225,5.2106594e-7,6.9830105e-7,0.0000024132212,0.00038360475,0.00015800344],"about_ca_topic_score_codex":0.00008992036,"about_ca_topic_score_gemma":0.0001827266,"teacher_disagreement_score":0.012350583,"about_ca_system_score_codex":0.0002788953,"about_ca_system_score_gemma":0.00097407977,"threshold_uncertainty_score":0.5674518},"labels":[],"label_agreement":null},{"id":"W2317068719","doi":"10.1093/eurheartj/eht309.p3912","title":"Lipoprotein(a) levels, genotype and incident aortic stenosis: a prospective Mendelian randomization study and replication in a case-control cohort","year":2013,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Mendelian randomization; Lipoprotein(a); Internal medicine; Prospective cohort study; Genotype; Stenosis; Allele; Cohort; Aortic valve stenosis; Cohort study; Cardiology; Lipoprotein; Gastroenterology; Genetic variants; Genetics; Cholesterol; Gene","score_opus":0.021967219685410252,"score_gpt":0.27978318073864483,"score_spread":0.25781596105323457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317068719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926121,0.0011081973,0.0008067825,0.000845351,0.000051079718,0.0043108324,0.0000016322646,0.000027606153,0.00023639658],"genre_scores_gemma":[0.9984438,0.0001586234,0.0005128513,0.00032858006,0.00033184027,0.00011317783,0.0000010273602,0.000036966005,0.000073166106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997745,0.00080382224,0.00047717037,0.00037740468,0.0003587017,0.00023793841],"domain_scores_gemma":[0.99895656,0.000029039637,0.00014109386,0.0003883821,0.00021422256,0.00027071367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036022633,0.00015390021,0.0004261385,0.0001752478,0.00021387641,0.00013026476,0.000037296933,0.000034376866,0.000042730073],"category_scores_gemma":[0.00031726348,0.00012009669,0.00006927531,0.00017161354,0.000033859666,0.00020594036,0.00003890324,0.00038351704,0.000018908886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003378478,0.00021343699,0.9478857,0.00004537582,0.00025683045,0.0008671694,0.0016583594,0.00000863239,0.0008325066,0.0000040315813,0.000092269634,0.047797833],"study_design_scores_gemma":[0.01202373,0.0007296542,0.97721046,0.000092260954,0.00018859284,0.008264988,0.00073028,0.0004978222,0.000035752495,0.000028811983,0.000082277365,0.00011538502],"about_ca_topic_score_codex":0.00061525306,"about_ca_topic_score_gemma":0.00004719602,"teacher_disagreement_score":0.047682445,"about_ca_system_score_codex":0.00012528813,"about_ca_system_score_gemma":0.000076265074,"threshold_uncertainty_score":0.48974007},"labels":[],"label_agreement":null},{"id":"W2317448863","doi":"10.1016/j.cjca.2012.07.425","title":"462 Simvastatin in the Setting of INOS Deletion Improves Survival in Mice With Ventricular Hypertrophy Secondary to Calcineurin Overexpression","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services","funders":"","keywords":"Simvastatin; Medicine; Calcineurin; Internal medicine; Ventricle; Cardiology; Left ventricular hypertrophy; Muscle hypertrophy; Ventricular hypertrophy; Placebo; Heart disease; Endocrinology; Pathology; Transplantation; Blood pressure","score_opus":0.010014649855005438,"score_gpt":0.2343022773518716,"score_spread":0.22428762749686615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317448863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99642444,0.0013438419,0.00046900767,0.00079151965,0.00016792653,0.00031889247,0.000008186247,0.0000011914954,0.00047500018],"genre_scores_gemma":[0.998598,0.000018904799,0.0002941716,0.00038312838,0.00067824294,0.0000069840544,0.0000046227406,0.000012187726,0.0000037860332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984511,0.0004587063,0.00039410355,0.000101008976,0.00021958891,0.00037545722],"domain_scores_gemma":[0.9991388,0.000082729144,0.00014248592,0.00018203534,0.00012210297,0.00033186647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015817388,0.00010447116,0.00053803396,0.00033598483,0.000032415814,0.000005231271,0.00010541236,0.00008801796,0.000005564532],"category_scores_gemma":[0.00020499155,0.00006595888,0.00014468275,0.00028816971,0.000038403046,0.00007402408,0.0000099040335,0.00042595746,0.0000010373641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078666804,0.00004105254,0.91623825,0.0004157469,0.00034374467,0.0020444535,0.0043421495,0.004663395,0.024819598,0.0001086289,0.0014295895,0.044766698],"study_design_scores_gemma":[0.001801617,0.00064076873,0.9831659,0.00028284115,0.000067403,0.0022271124,0.0014903648,0.000009741517,0.0011275006,0.000011574669,0.009078692,0.00009645029],"about_ca_topic_score_codex":0.0056958804,"about_ca_topic_score_gemma":0.0023873858,"teacher_disagreement_score":0.06692766,"about_ca_system_score_codex":0.0001520171,"about_ca_system_score_gemma":0.00075467647,"threshold_uncertainty_score":0.8610505},"labels":[],"label_agreement":null},{"id":"W2317455908","doi":"10.1097/mol.0000000000000129","title":"Guidelines in the USA, a viewpoint contrary to those guidelines in Europe, Canada, Britain and the International Atherosclerosis Society","year":2014,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Regeneron Pharmaceuticals; Sanofi; AstraZeneca","keywords":"Medicine; Atherosclerotic cardiovascular disease; Disease; Health care; Task force; Position paper; Risk factor; Population; Family medicine; Gerontology; Intensive care medicine; Internal medicine; Environmental health; Pathology; Political science","score_opus":0.1959673842090508,"score_gpt":0.4374670161820882,"score_spread":0.24149963197303742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317455908","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046355115,0.9621651,0.00013088087,0.020623649,0.014387766,0.0024884485,0.000049064303,0.000008036069,0.00010070647],"genre_scores_gemma":[0.000006758844,0.9818537,0.00027433186,0.005896877,0.011030045,0.000715537,0.00010834359,0.000035996727,0.000078396595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951103,0.0014548128,0.0018425436,0.0006121485,0.00055316975,0.00042707787],"domain_scores_gemma":[0.9979727,0.00057368097,0.00031470985,0.0006792018,0.00035321846,0.000106433814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006496388,0.00040507797,0.0020250552,0.00017409876,0.000056431476,0.000034459226,0.0005890179,0.00022560403,0.000026436732],"category_scores_gemma":[0.0022391293,0.00022113683,0.0004136721,0.00065152586,0.0001514587,0.000035852834,0.00027528452,0.00093031616,0.000010209481],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032186756,0.000044224616,0.0006125744,0.003922064,0.000072897274,4.688545e-7,0.00016909013,0.0000065946642,9.1307555e-8,0.0010148446,0.18146488,0.8126601],"study_design_scores_gemma":[0.0020245067,0.000047653124,0.0017083627,0.015658058,0.00007485162,0.00009825195,0.00005558615,0.00012922798,1.7506665e-8,0.000031112268,0.97997296,0.00019942096],"about_ca_topic_score_codex":0.12006754,"about_ca_topic_score_gemma":0.10080252,"teacher_disagreement_score":0.81246066,"about_ca_system_score_codex":0.0002648165,"about_ca_system_score_gemma":0.0015615624,"threshold_uncertainty_score":0.9156055},"labels":[],"label_agreement":null},{"id":"W2318313616","doi":"10.1139/cjpp-2014-0169","title":"Protective effect of co-administration of rosuvastatin and probucol on atherosclerosis in rats","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"AstraZeneca","keywords":"Probucol; Rosuvastatin; Superoxide dismutase; Endocrinology; Internal medicine; Chemistry; Pharmacology; Oxidative stress; Monocyte; Adiponectin; Medicine; Cholesterol","score_opus":0.01178700384941733,"score_gpt":0.2895407524352349,"score_spread":0.2777537485858176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318313616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894756,0.0001737165,0.000020133384,0.00023277319,0.000087298,0.0004647432,0.0000074916593,8.0328545e-7,0.000065480126],"genre_scores_gemma":[0.999624,0.00004239618,0.000033811648,0.00017483352,0.000099693054,0.000014583378,0.0000017075732,0.0000055427836,0.0000034431234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99904615,0.0004204659,0.00025093276,0.000094970026,0.00005381729,0.00013369677],"domain_scores_gemma":[0.99938196,0.0001212232,0.00019153784,0.00005560846,0.00007087603,0.00017877802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070448697,0.00007800054,0.000454569,0.00015346854,0.000031042175,0.0000012015092,0.00003118096,0.00009070319,0.000048960956],"category_scores_gemma":[0.000056911595,0.000059647216,0.00005665123,0.00006517646,0.00019732138,0.00002460357,0.0000031527197,0.00022024836,2.9711597e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013379132,0.000040287327,0.007921586,0.0005787527,0.00013266075,0.000013878739,0.00036048485,0.000021393093,0.9823038,0.00007559281,0.0000790671,0.007134592],"study_design_scores_gemma":[0.0034240738,0.010011295,0.19668509,0.000120820834,0.000102663595,0.000092321854,0.000026472888,0.000049220034,0.7890381,0.00021749592,0.00017899524,0.000053409673],"about_ca_topic_score_codex":0.000489348,"about_ca_topic_score_gemma":0.00049753656,"teacher_disagreement_score":0.19326565,"about_ca_system_score_codex":0.000029016093,"about_ca_system_score_gemma":0.00035409085,"threshold_uncertainty_score":0.24323429},"labels":[],"label_agreement":null},{"id":"W2318466466","doi":"10.1016/s0735-1097(16)31934-9","title":"ESTIMATED PREVALENCE OF POSSIBLE AND PROBABLE FAMILIAL HYPERCHOLESTEROLEMIA IN 35,451 STATIN-TREATED PATIENTS IN EUROPE, CANADA, THE MIDDLE EAST, AND SOUTH AFRICA","year":2016,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Demography; Internal medicine; Cholesterol","score_opus":0.02282707742105366,"score_gpt":0.229298175053706,"score_spread":0.20647109763265234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318466466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981283,0.0007017211,0.000013295007,0.00041502895,0.00005578047,0.00039355576,0.00012683794,0.0000014657355,0.00016403831],"genre_scores_gemma":[0.9991928,0.00040643767,0.00018793701,0.00006821451,0.00003697851,0.000004626321,3.0638938e-7,0.00001091906,0.00009181631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830735,0.00050033827,0.00051879114,0.00013692003,0.00032040686,0.00021620694],"domain_scores_gemma":[0.99873483,0.00010888583,0.00049833313,0.00026852498,0.00030704399,0.00008235299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064815296,0.000114555034,0.0007592574,0.000100500976,0.000030673713,0.0000020184698,0.00015647575,0.000033293847,9.951643e-7],"category_scores_gemma":[0.00037818632,0.000053784974,0.00007690614,0.00045042328,0.000397806,0.00004071605,0.00008256711,0.00017975133,7.795154e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008540628,0.000032773634,0.99368554,0.00014468058,0.00013717337,0.00007024391,0.0002994014,0.000099345045,0.0013657972,0.0000057166358,0.00023783228,0.0030674392],"study_design_scores_gemma":[0.002812423,0.0009809618,0.9941524,0.0005324698,0.000118675955,0.00027295496,0.0005171355,0.000023538634,0.0002411833,0.000015583055,0.000272162,0.000060486273],"about_ca_topic_score_codex":0.007385865,"about_ca_topic_score_gemma":0.0037894147,"teacher_disagreement_score":0.0035964502,"about_ca_system_score_codex":0.000097978875,"about_ca_system_score_gemma":0.00072426884,"threshold_uncertainty_score":0.99922407},"labels":[],"label_agreement":null},{"id":"W2318655087","doi":"10.1016/j.atherosclerosis.2014.05.538","title":"Simvastatin and ezetimibe have opposing regulation on intestinal cholesterol absorption and trans intestinal cholesterol excretion (tice) during metabolic syndrome","year":2014,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ezetimibe; Simvastatin; Internal medicine; Cholesterol; Metabolic syndrome; Endocrinology; Excretion; Medicine; Insulin resistance; HMG-CoA reductase; Chemistry; Diabetes mellitus; Reductase; Biochemistry","score_opus":0.017963897972699656,"score_gpt":0.24077952807147013,"score_spread":0.22281563009877048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318655087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861617,0.00013260196,0.012023814,0.00065962144,0.00006594316,0.00069302745,0.000005116134,0.000117247255,0.00014092326],"genre_scores_gemma":[0.99682146,0.00019928526,0.0021417895,0.00039250895,0.00018605537,0.00006296584,0.000025161922,0.00006619461,0.00010458626],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979325,0.00021514684,0.00044634525,0.0005775528,0.00045877186,0.00036967726],"domain_scores_gemma":[0.9989607,0.000079986334,0.0001709402,0.00041753118,0.00009706779,0.0002738254],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007766024,0.00031658224,0.00055602356,0.00017406685,0.0002447347,0.0001173734,0.00006479596,0.0001370986,0.0000242313],"category_scores_gemma":[0.00013326,0.0002871625,0.00013289032,0.00014318411,0.00013714404,0.00024388405,0.000038302594,0.00033231208,0.000011078584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072459964,0.0004944343,0.12719026,0.0015761005,0.00033114004,0.000014052607,0.0039473507,0.0003431343,0.5686309,0.0004231087,0.000017034425,0.29630792],"study_design_scores_gemma":[0.0031412146,0.0008419516,0.9775682,0.0013976315,0.0002864927,0.00064423727,0.00013297149,0.003629378,0.011901645,0.0000655088,0.00013343697,0.00025732003],"about_ca_topic_score_codex":0.00021765409,"about_ca_topic_score_gemma":0.000026509626,"teacher_disagreement_score":0.850378,"about_ca_system_score_codex":0.000074211275,"about_ca_system_score_gemma":0.000021600146,"threshold_uncertainty_score":0.99995804},"labels":[],"label_agreement":null},{"id":"W2319524406","doi":"10.1016/j.cjca.2013.07.652","title":"Apoe P.Leu167Del Mutation in Familial Hypercholesterolemia","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Canadian Institute of Mining, Metallurgy and Petroleum","funders":"","keywords":"Kexin; PCSK9; Proprotein convertase; Familial hypercholesterolemia; Medicine; LDL receptor; Apolipoprotein B; Subtilisin; Mutation; Genetics; Apolipoprotein E; Phenotype; Gene; Lipoprotein; Internal medicine; Endocrinology; Cholesterol; Biochemistry; Biology; Enzyme","score_opus":0.014581037947044122,"score_gpt":0.2394276764185427,"score_spread":0.22484663847149858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319524406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894839,0.0011450016,0.0010119155,0.0017568753,0.0005014314,0.0002602258,0.0000031087704,0.0000033804345,0.005834148],"genre_scores_gemma":[0.99747694,0.00006632924,0.00027687257,0.00077328767,0.001313007,0.000008505261,0.000004659875,0.000013369753,0.000067028515],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99891,0.00014574299,0.00037207664,0.00010758062,0.00014634864,0.0003182188],"domain_scores_gemma":[0.9988829,0.000020305864,0.000078218705,0.00019592194,0.00024122762,0.0005814529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005428911,0.00009171284,0.0005016764,0.00035546772,0.000033515145,0.000013117803,0.0000850909,0.00015345916,0.000036358902],"category_scores_gemma":[0.00014848515,0.00007737397,0.00023681986,0.00013045505,0.000073896044,0.00010086685,0.0000048367515,0.0003723597,0.000045887962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016221039,0.000011419067,0.41510636,0.00017288716,0.00073244685,0.004475505,0.0011510385,0.0038976872,0.00266664,0.00032765887,0.02138484,0.5499113],"study_design_scores_gemma":[0.0025851713,0.000470909,0.93125045,0.00008051278,0.000079949925,0.005915526,0.0004148962,0.000040731145,0.00006900181,0.0004073695,0.058573306,0.00011217592],"about_ca_topic_score_codex":0.009584238,"about_ca_topic_score_gemma":0.0025924556,"teacher_disagreement_score":0.54979914,"about_ca_system_score_codex":0.00027863344,"about_ca_system_score_gemma":0.0014552732,"threshold_uncertainty_score":0.997011},"labels":[],"label_agreement":null},{"id":"W2319539094","doi":"10.1097/01.sa.0000407015.40323.bb","title":"Consequences of Succinylcholine Administration to Patients Using Statins","year":2011,"lang":"en","type":"article","venue":"Survey of Anesthesiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Administration (probate law); Anesthesia; Law","score_opus":0.09883523960565883,"score_gpt":0.32228528326395833,"score_spread":0.2234500436582995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319539094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992749,0.00006484242,0.00010879608,0.00001947736,0.000046610985,0.0003122068,0.000025314195,0.0000069392345,0.00014088325],"genre_scores_gemma":[0.9964336,0.000020347938,0.0033469289,0.0001158542,0.000014574011,0.0000032239707,0.000050607097,0.000007777875,0.0000070748897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989001,0.0003179336,0.00035077828,0.00014653882,0.00014900419,0.00013564847],"domain_scores_gemma":[0.9990775,0.00005764281,0.00014815899,0.0002454326,0.00038572188,0.000085520136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009148348,0.000075868,0.0004037654,0.000079916776,0.000018630397,6.845279e-7,0.000056065575,0.00007518934,0.000054583026],"category_scores_gemma":[0.00037493848,0.00006112842,0.000061447696,0.00014573282,0.00013027815,0.000021763404,0.0000113370625,0.000049732676,0.0000032748503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006610138,0.00017857828,0.99175364,0.00007835341,0.000039168528,0.000008946535,0.00022294004,0.0000016740487,0.0031630055,0.000046389276,0.000009250633,0.0038370397],"study_design_scores_gemma":[0.00045352543,0.0021261477,0.9632946,0.000032143304,0.000026012274,0.000025314648,0.000029743062,0.000002802586,0.03389736,0.000028547705,0.00003354463,0.000050234754],"about_ca_topic_score_codex":0.012111946,"about_ca_topic_score_gemma":0.0005051243,"teacher_disagreement_score":0.030734355,"about_ca_system_score_codex":0.000013332423,"about_ca_system_score_gemma":0.0002872348,"threshold_uncertainty_score":0.9944665},"labels":[],"label_agreement":null},{"id":"W2320364919","doi":"10.1097/00041433-200112000-00003","title":"The use of fibrates and of statins in preventing atherosclerosis in diabetes","year":2001,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"","keywords":"Diabetes mellitus; Medicine; Disease; Abnormality; Intensive care medicine; Complication; Atherosclerotic cardiovascular disease; Bioinformatics; Internal medicine; Endocrinology; Biology; Psychiatry","score_opus":0.23684380803648183,"score_gpt":0.40523323792569843,"score_spread":0.1683894298892166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320364919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0074348194,0.98805225,0.0000061410688,0.000033851295,0.0032184953,0.0012176909,0.000027949076,0.000004182843,0.0000046498194],"genre_scores_gemma":[0.0001226463,0.9987799,0.000114022325,0.0000034649547,0.0007334463,0.00015978765,0.00005751492,0.000021765078,0.00000745952],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99736583,0.00074447336,0.0011301435,0.0002897024,0.000161027,0.0003088156],"domain_scores_gemma":[0.9983705,0.0007409312,0.00044152167,0.00036767597,0.00003611538,0.00004320652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011461724,0.00020628203,0.0017232571,0.00031462088,0.000017565742,0.0000066820367,0.00010251266,0.00020508877,0.000007350537],"category_scores_gemma":[0.0004714683,0.00013994203,0.00023469131,0.0005265329,0.00014766557,0.000048621354,0.000104107654,0.000449021,6.8594403e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008424345,0.00013006818,0.04319807,0.03503182,0.00004423264,3.4612146e-8,0.000119471675,0.000002799906,0.0000011380376,0.000091595764,0.0001886431,0.9211837],"study_design_scores_gemma":[0.00081404386,0.0001665934,0.020994993,0.054006487,0.0000658141,0.0000047638955,0.00003561837,0.000033033182,0.0000010903611,0.000039627375,0.9237154,0.00012255102],"about_ca_topic_score_codex":0.00015159993,"about_ca_topic_score_gemma":0.00005314114,"teacher_disagreement_score":0.92352676,"about_ca_system_score_codex":0.00006203465,"about_ca_system_score_gemma":0.00020358716,"threshold_uncertainty_score":0.5706671},"labels":[],"label_agreement":null},{"id":"W2322632101","doi":"10.1161/atvb.34.suppl_1.427","title":"Abstract 427: Plasma PCSK9 Levels Are Positively Correlated With LDL-Cholesterol Concentrations in Familial Hypercholesterolemia","year":2014,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Université Laval","funders":"","keywords":"PCSK9; LDL receptor; Familial hypercholesterolemia; Kexin; Internal medicine; Endocrinology; Apolipoprotein B; Body mass index; Cholesterol; Medicine; Lipoprotein","score_opus":0.033051211941059915,"score_gpt":0.2723502181817048,"score_spread":0.23929900624064487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322632101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720526,0.00006673564,0.00074743276,0.0007587129,0.00013205851,0.0007521782,0.000041635838,0.00006711767,0.00022890014],"genre_scores_gemma":[0.99734384,0.000540541,0.0003557045,0.0014027039,0.00014521918,0.000092074195,0.000071644856,0.00004458824,0.000003691876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977571,0.0002597138,0.00049260963,0.00069427653,0.0002444741,0.00055187],"domain_scores_gemma":[0.9988275,0.00006838186,0.0001542711,0.00056507165,0.000117138756,0.00026763495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056444947,0.00035785834,0.000900862,0.000140937,0.0001885859,0.000057589175,0.000113116694,0.00034646926,0.000036807276],"category_scores_gemma":[0.00004182071,0.00027889427,0.00021958917,0.0002151393,0.0002823773,0.00014862225,0.000056739267,0.00040470206,0.000027529708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036775953,0.00030318182,0.8904659,0.000106762134,0.0004847663,0.0000010334969,0.0005132035,0.000018026816,0.10177535,0.00016129967,0.00001938246,0.006114283],"study_design_scores_gemma":[0.006112698,0.00088035304,0.9899453,0.00047472416,0.00020688487,0.000011285405,0.00023673398,0.00020430813,0.0005111501,0.000011729596,0.0010993556,0.00030550038],"about_ca_topic_score_codex":0.0004761158,"about_ca_topic_score_gemma":0.0005254062,"teacher_disagreement_score":0.10126419,"about_ca_system_score_codex":0.00009000852,"about_ca_system_score_gemma":0.00008185778,"threshold_uncertainty_score":0.9999663},"labels":[],"label_agreement":null},{"id":"W2323701220","doi":"10.1136/bcr-2014-205987","title":"A generalised sensation of coldness following introduction of rosuvastatin therapy","year":2014,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Université de Montréal","keywords":"Medicine; Rosuvastatin; Sensation; Physical therapy; Intensive care medicine; Internal medicine","score_opus":0.021233505939407857,"score_gpt":0.30394388474501327,"score_spread":0.2827103788056054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323701220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543685,0.00017751154,0.0027916527,0.00026608148,0.00032868987,0.0007789566,8.4050663e-7,0.000021268637,0.00019813358],"genre_scores_gemma":[0.9972893,0.000018733732,0.0017668131,0.000048502454,0.000723518,0.000032485103,0.00002802859,0.000015582784,0.00007704798],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99867076,0.000110549794,0.0005413012,0.00019156013,0.00038040808,0.000105401385],"domain_scores_gemma":[0.9988268,0.000015003318,0.0003616615,0.00054825185,0.00018724386,0.00006106188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017253022,0.00008004288,0.00037989093,0.00007240884,0.000031800744,0.0000035035416,0.000008074694,0.000055356817,0.000022548584],"category_scores_gemma":[0.00024126036,0.00006647006,0.00024533595,0.00015353052,0.000020944884,0.00004133019,0.000007661026,0.000052017782,4.691685e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006015017,0.0006144308,0.0172711,0.0016167234,0.0011883079,0.0917083,0.0020820277,0.0006854872,0.39802694,0.00035672955,0.002212719,0.48363572],"study_design_scores_gemma":[0.005282715,0.0010867058,0.022072759,0.00029020078,0.00052883214,0.48384327,0.0007129145,0.0015329539,0.4668058,0.00022569337,0.017226439,0.00039171518],"about_ca_topic_score_codex":0.0008080878,"about_ca_topic_score_gemma":0.000014944905,"teacher_disagreement_score":0.483244,"about_ca_system_score_codex":0.000030884043,"about_ca_system_score_gemma":0.00012380423,"threshold_uncertainty_score":0.271057},"labels":[],"label_agreement":null},{"id":"W2323812817","doi":"10.1097/md.0000000000001268","title":"Association Between SLCO1B1 Gene T521C Polymorphism and Statin-Related Myopathy Risk","year":2015,"lang":"en","type":"review","venue":"Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; SLCO1B1; Odds ratio; Internal medicine; Statin; Myopathy; Rhabdomyolysis; Confidence interval; Creatine kinase; Meta-analysis; Gastroenterology; Single-nucleotide polymorphism; Genotype; Genetics; Gene; Biology","score_opus":0.04468869158393709,"score_gpt":0.3325648529417422,"score_spread":0.28787616135780514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323812817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003320585,0.994326,0.000059390295,0.0011530438,0.00057848805,0.0019258901,0.0001749264,0.0001285528,0.0013216381],"genre_scores_gemma":[0.000032058033,0.99040455,0.00018069864,0.0002756943,0.0034434365,0.00008478258,0.001292216,0.00012413027,0.004162443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99537164,0.0006683349,0.0012583166,0.0006768625,0.001472643,0.00055221556],"domain_scores_gemma":[0.9968137,0.00024749932,0.0010816407,0.00085907546,0.00028513378,0.0007129619],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004834953,0.0005930208,0.004467897,0.00038299392,0.00012738003,0.000013890853,0.00014080443,0.0007924639,0.00023465249],"category_scores_gemma":[0.0011293606,0.00039712878,0.00047525996,0.0006206159,0.00011058042,0.000061722596,0.00008768979,0.0012827677,0.00013761439],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000070823685,0.000024312827,0.00062494085,0.005968188,0.0020854343,0.000107705586,0.0002076461,2.1461284e-8,2.973576e-7,0.00000819455,0.015575352,0.97539085],"study_design_scores_gemma":[0.0027184042,0.0005854102,0.0012419199,0.0089659225,0.01726201,0.00025690979,0.000030826253,0.0000019544582,7.3097374e-7,0.000065829794,0.9685522,0.0003178997],"about_ca_topic_score_codex":0.001073886,"about_ca_topic_score_gemma":0.0000073498345,"teacher_disagreement_score":0.9750729,"about_ca_system_score_codex":0.00079774443,"about_ca_system_score_gemma":0.00068528,"threshold_uncertainty_score":0.99984807},"labels":[],"label_agreement":null},{"id":"W2324672875","doi":"10.1097/00005344-200308000-00015","title":"Effect of Atorvastatin on ApoE and ApoC-I Synthesis and Secretion by THP-1 Macrophages","year":2003,"lang":"en","type":"article","venue":"Journal of Cardiovascular Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Cerivastatin; Atorvastatin; Apolipoprotein B; Apolipoprotein E; THP1 cell line; Secretion; Endocrinology; Cholesterol; Chemistry; Internal medicine; Messenger RNA; HMG-CoA reductase; Biochemistry; Biology; Reductase; Cell culture; Medicine; Enzyme; Pravastatin; Gene","score_opus":0.005705099575751648,"score_gpt":0.269035733734124,"score_spread":0.2633306341583723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324672875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93669415,0.0611328,0.00077304954,0.00014246699,0.0003377234,0.00046752248,0.0000079789825,0.000008286998,0.00043605553],"genre_scores_gemma":[0.98759943,0.01161742,0.00027232486,0.00017709238,0.00026306653,0.000017731149,0.0000012566029,0.000030174806,0.00002147534],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969328,0.0014837085,0.000469591,0.00022797938,0.00063705497,0.00024884733],"domain_scores_gemma":[0.9987466,0.0003352657,0.000244589,0.00023729383,0.00017426837,0.00026199897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004451215,0.00021382175,0.0012934026,0.00018425976,0.000065080065,0.000010419567,0.00005909665,0.00014124364,0.00006057291],"category_scores_gemma":[0.0003175401,0.00015739139,0.0008936932,0.00014160754,0.00014073837,0.000073574345,0.00002095701,0.0003642164,0.0000019450658],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005328299,0.00053620257,0.004455129,0.005161197,0.04213587,0.0019147065,0.0004394355,0.00055269076,0.2096972,0.00018291765,0.008531236,0.7210651],"study_design_scores_gemma":[0.013333338,0.0054955315,0.0028330714,0.00030042682,0.01086156,0.00663601,0.00008437872,0.000069009606,0.8704082,0.00003616767,0.08964852,0.00029377954],"about_ca_topic_score_codex":0.00001785698,"about_ca_topic_score_gemma":1.3523533e-7,"teacher_disagreement_score":0.7207713,"about_ca_system_score_codex":0.000064421096,"about_ca_system_score_gemma":0.00009676892,"threshold_uncertainty_score":0.6418235},"labels":[],"label_agreement":null},{"id":"W2325006626","doi":"10.1097/00041433-200308000-00004","title":"Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside","year":2003,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Lipoprotein(a); Fibrinolysis; Plasmin; Fibrin; Medicine; Coagulation; Plasminogen activator; Apolipoprotein B; Plasminogen activator inhibitor-1; Thrombosis; Tissue factor; Lipoprotein; Tissue plasminogen activator; Internal medicine; Pharmacology; Immunology; Chemistry; Biochemistry; Cholesterol; Enzyme","score_opus":0.24553030841211854,"score_gpt":0.4816453022430859,"score_spread":0.23611499383096735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325006626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017383232,0.9585351,0.000079690515,0.00008546855,0.027334226,0.013503751,0.00008876457,0.0000382352,0.00016096556],"genre_scores_gemma":[0.000054353037,0.985714,0.0005571496,0.0000245626,0.008561145,0.004396477,0.0005926633,0.00008835125,0.000011286132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927065,0.0023003141,0.0015733688,0.0010332799,0.001799642,0.00058691745],"domain_scores_gemma":[0.99699634,0.00012220614,0.0006536296,0.0013280854,0.00058810256,0.00031165194],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029548681,0.0006035861,0.0035695382,0.00069820625,0.00004475356,0.00001592166,0.0002925983,0.0006872225,0.00050573604],"category_scores_gemma":[0.0009410057,0.0004999157,0.00084789464,0.0008094678,0.00013398447,0.000063639134,0.00013477873,0.00090432604,0.0001870879],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002003604,0.00037383533,0.00010527229,0.023721326,0.0003394201,2.0711694e-7,0.00014619285,0.0000018350745,4.1974275e-7,0.00011120838,0.0011803269,0.9739999],"study_design_scores_gemma":[0.0015079731,0.0006466718,0.00064319925,0.034485746,0.0013550451,0.00006751547,0.0000190479,0.0000115278335,0.0000023416328,0.00031014776,0.960563,0.00038780074],"about_ca_topic_score_codex":0.00022385834,"about_ca_topic_score_gemma":0.000018653243,"teacher_disagreement_score":0.9736121,"about_ca_system_score_codex":0.0007073479,"about_ca_system_score_gemma":0.0032317128,"threshold_uncertainty_score":0.99974525},"labels":[],"label_agreement":null},{"id":"W2325083664","doi":"10.1097/hco.0b013e3283605fa2","title":"New therapies to reduce low-density lipoprotein cholesterol","year":2013,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Regeneron Pharmaceuticals; AstraZeneca; Pfizer; Amgen","keywords":"Medicine; Ezetimibe; PCSK9; Familial hypercholesterolemia; Alirocumab; Proprotein convertase; Evolocumab; Statin; Kexin; Internal medicine; Cholesterylester transfer protein; Cholesterol; Lipoprotein; Endocrinology; Pharmacology; LDL receptor","score_opus":0.10748657835904592,"score_gpt":0.40144836306505566,"score_spread":0.29396178470600975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325083664","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009067378,0.9822896,0.0010069739,0.00027614212,0.010180347,0.0058112023,0.000021131813,0.00009493592,0.0002289833],"genre_scores_gemma":[0.0000378024,0.9882353,0.00037700782,0.000067517234,0.009604528,0.0011470376,0.00026067102,0.00010072673,0.00016941546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99580646,0.000799764,0.0010633774,0.0010974887,0.0004875766,0.0007453531],"domain_scores_gemma":[0.9973195,0.000073197465,0.00026389514,0.0016313092,0.00013905554,0.0005730165],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090626307,0.00071033294,0.004597511,0.0005312139,0.000064478074,0.000037185262,0.00036810222,0.00073943497,0.000077165445],"category_scores_gemma":[0.00015619407,0.00054692576,0.0015972734,0.00055334694,0.00007050138,0.000063960724,0.00025667856,0.0013338872,0.0008572763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001807803,0.00003181748,0.000037951395,0.01920206,0.00033172086,0.0000066063526,0.000074884876,0.0000011221764,6.1342854e-7,0.000041489642,0.013414764,0.9668389],"study_design_scores_gemma":[0.00086577574,0.0002113857,0.0012604727,0.024413418,0.00025433503,0.0005194525,0.00001574857,4.1037617e-7,0.000001787973,0.000037687532,0.9719762,0.00044331665],"about_ca_topic_score_codex":0.00056430756,"about_ca_topic_score_gemma":0.000005810499,"teacher_disagreement_score":0.96639556,"about_ca_system_score_codex":0.00043130317,"about_ca_system_score_gemma":0.0011213687,"threshold_uncertainty_score":0.99992067},"labels":[],"label_agreement":null},{"id":"W2325583450","doi":"10.1093/eurheartj/ehw135","title":"Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia","year":2016,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cohort; Family history; Familial hypercholesterolemia; Logistic regression; Internal medicine; Genetic testing; Receiver operating characteristic; Medical history; Outpatient clinic; Cohort study; Pediatrics; Cholesterol","score_opus":0.06951148189240225,"score_gpt":0.3011787563276998,"score_spread":0.23166727443529755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325583450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60362184,0.000096779026,0.39524528,0.00006502061,0.00007501904,0.0008542005,0.000033158445,0.0000057973175,0.0000028706058],"genre_scores_gemma":[0.8940908,0.000030716663,0.10532935,0.000033276065,0.00041797172,0.000044550547,0.0000042982974,0.00002809724,0.000020953277],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984718,0.00014744686,0.00064693886,0.00018382886,0.00035593528,0.0001940738],"domain_scores_gemma":[0.99849504,0.0003278955,0.00035559776,0.0001289391,0.0006126466,0.00007986038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002412472,0.00011489575,0.00027995234,0.00011446712,0.00019401185,0.000019556577,0.00005650635,0.000051624505,6.362457e-7],"category_scores_gemma":[0.0007029792,0.00007453138,0.00013642115,0.000081696846,0.000059467886,0.00015701102,0.000024407767,0.00010941829,1.032271e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009656274,0.00011730195,0.08931258,0.0008652303,0.0002290483,0.0000013999113,0.0024280867,0.0024415338,0.6249567,0.0000072434577,0.000084524916,0.2785907],"study_design_scores_gemma":[0.0084411595,0.0021255666,0.78237945,0.0018352357,0.00054461166,0.0012826527,0.00021548236,0.056381054,0.14624447,0.00012813258,0.00026241993,0.00015978534],"about_ca_topic_score_codex":0.0000069451776,"about_ca_topic_score_gemma":0.0000017809605,"teacher_disagreement_score":0.69306684,"about_ca_system_score_codex":0.00006788876,"about_ca_system_score_gemma":0.00027021402,"threshold_uncertainty_score":0.30393013},"labels":[],"label_agreement":null},{"id":"W2325591307","doi":"10.1016/j.clpt.2005.12.259","title":"PIII-51In utero exposure to HMG-CoA reductase inhibitors; effects on fetal and neonatal outcome","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pregnancy; HMG-CoA reductase; Abortion; Fetus; In utero; Hyperlipidemia; Obstetrics; Therapeutic abortion; Clinical pharmacology; Gestational age; Reductase; Endocrinology; Pharmacology; Biology","score_opus":0.04301270185536927,"score_gpt":0.39303096523366216,"score_spread":0.3500182633782929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325591307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97653085,0.0025810245,0.00015366098,0.0161621,0.002879136,0.0013532286,0.000017028102,0.00011955917,0.00020340976],"genre_scores_gemma":[0.9028897,0.00030488317,0.0007014627,0.090614274,0.0048744446,0.0000680435,0.000026610545,0.00005541855,0.0004651542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715996,0.00046013205,0.0008214616,0.0006281447,0.00040523967,0.0005250391],"domain_scores_gemma":[0.99841213,0.00043864344,0.00012465639,0.00047389854,0.00010320958,0.00044744438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011214522,0.00031882068,0.00083047186,0.00010806482,0.00013889294,0.000020175812,0.00014030689,0.00040454202,0.00006428063],"category_scores_gemma":[0.000038758375,0.00025814126,0.00040978836,0.00018497203,0.00023673843,0.000047369143,0.000107946275,0.00094263296,0.00012120902],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065379385,0.0032960598,0.123851195,0.00075285113,0.0032381488,0.0031417303,0.00035199226,0.000050932358,0.047609027,0.00011853016,0.06761182,0.7434398],"study_design_scores_gemma":[0.032718323,0.015382918,0.24997714,0.00020388204,0.004482771,0.0007184442,0.00008693997,0.00018840714,0.08848756,0.00027835803,0.6063387,0.0011365819],"about_ca_topic_score_codex":0.000033108183,"about_ca_topic_score_gemma":0.0000060703137,"teacher_disagreement_score":0.7423032,"about_ca_system_score_codex":0.00007943129,"about_ca_system_score_gemma":0.00012351779,"threshold_uncertainty_score":0.99998707},"labels":[],"label_agreement":null},{"id":"W2325701870","doi":"10.1016/j.cjca.2013.07.565","title":"Safety, Tolerability, and Efficacy of Long-Term Administration of Amg 145: Preliminary Results From the Osler Study","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; PCSK9; Monoclonal antibody; Pharmacology; Monoclonal; Internal medicine; Adverse effect; Antibody; Immunology; Cholesterol; LDL receptor; Lipoprotein","score_opus":0.02102044564571868,"score_gpt":0.2685599751141032,"score_spread":0.2475395294683845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325701870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497384,0.0014446378,0.00011034085,0.0018822926,0.00022612505,0.00072279235,0.000048772163,0.0000016989032,0.0005894914],"genre_scores_gemma":[0.9990537,0.00010268903,0.000055478584,0.00007683336,0.0006655459,0.0000041090284,0.000013922859,0.000009396994,0.000018335373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830663,0.00038663394,0.0007600222,0.00015084112,0.00021168543,0.00018417109],"domain_scores_gemma":[0.9982178,0.00025539644,0.0003142857,0.0004701667,0.0003910331,0.00035128093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011478635,0.0001052236,0.000730912,0.00008684193,0.000056762517,0.000008678003,0.00013605536,0.000107393804,0.00002508878],"category_scores_gemma":[0.0005053456,0.00006945796,0.0002348245,0.00008514925,0.0002254478,0.00005539085,0.000020023188,0.00025420773,0.0000015666369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036909834,0.00008100946,0.8811196,0.00010624366,0.0020233965,0.00047321396,0.002659566,0.0001779972,0.00033341497,0.000026686239,0.002373175,0.10693468],"study_design_scores_gemma":[0.003129341,0.003535096,0.9910745,0.00009352339,0.0003351873,0.0005938803,0.00044517906,0.0000027599385,0.00011086947,0.000037612852,0.0005882796,0.000053779586],"about_ca_topic_score_codex":0.008016935,"about_ca_topic_score_gemma":0.00300027,"teacher_disagreement_score":0.10995486,"about_ca_system_score_codex":0.00006446565,"about_ca_system_score_gemma":0.0011567757,"threshold_uncertainty_score":0.99858874},"labels":[],"label_agreement":null},{"id":"W2325992311","doi":"10.3111/13696998.2012.726674","title":"Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain","year":2012,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Casa","funders":"European Commission","keywords":"Rosuvastatin; Medicine; Atorvastatin; Statin; Rosuvastatin Calcium; Cost effectiveness; Internal medicine; Risk analysis (engineering)","score_opus":0.040634616720675476,"score_gpt":0.3254239922523687,"score_spread":0.2847893755316932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325992311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911016,0.0012432939,0.00636789,0.0006959099,0.0002780228,0.00021337572,0.00000756034,0.0000028443083,0.00008948348],"genre_scores_gemma":[0.9962117,0.0012456458,0.001626332,0.00043445622,0.00044737753,0.000006943402,0.0000066710854,0.000015123236,0.0000057536104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978874,0.00029289856,0.0009304598,0.00010489543,0.0005066522,0.00027774353],"domain_scores_gemma":[0.9983919,0.0002716306,0.0004691055,0.00021877901,0.00009839432,0.00055018347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008553614,0.000110836154,0.0011379959,0.00047760768,0.0000150232545,0.000006296112,0.00013018724,0.00014456263,0.0002756673],"category_scores_gemma":[0.0006494744,0.00008868261,0.0005531392,0.00044060964,0.00006640101,0.0001143723,0.000035323643,0.00038125995,0.0000035880364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010116242,0.0010786011,0.6005901,0.0004944448,0.0049879146,0.00014713041,0.0010448248,0.0034137256,0.00013563677,0.00091398205,0.0001788063,0.3860032],"study_design_scores_gemma":[0.005194176,0.00046805205,0.9736828,0.0002770647,0.0015344948,0.00030396794,0.00050679233,0.008772899,0.0006441241,0.000049036935,0.008407252,0.00015930423],"about_ca_topic_score_codex":0.00017508036,"about_ca_topic_score_gemma":0.00006185329,"teacher_disagreement_score":0.38584387,"about_ca_system_score_codex":0.00028236405,"about_ca_system_score_gemma":0.0006074591,"threshold_uncertainty_score":0.36163718},"labels":[],"label_agreement":null},{"id":"W2328179025","doi":"10.1016/j.cjca.2014.07.591","title":"PPAR-γ AGONIST PIOGLITAZONE DECREASES ATHEROSCLEROTIC PLAQUE VULNERABILITY - AN IN VIVO STUDY BY 18F-FDG-PET/CT IN A RABBIT MODEL","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Pioglitazone; Agonist; In vivo; Internal medicine; Urology; Endocrinology; Nuclear medicine; Diabetes mellitus; Receptor; Type 2 diabetes","score_opus":0.020307117859892032,"score_gpt":0.2657642740034147,"score_spread":0.24545715614352265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328179025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995609,0.00070903526,0.0011191368,0.0004893878,0.00023503137,0.0007066189,0.00003162115,0.0000083506875,0.0010918098],"genre_scores_gemma":[0.99873036,0.000059277096,0.00018431006,0.00038974546,0.0005211044,0.000033228724,0.000008498657,0.000037168225,0.00003629921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965287,0.0012675842,0.00083964254,0.00038044824,0.00030743473,0.00067621854],"domain_scores_gemma":[0.99756104,0.000095858944,0.00017054669,0.0006934943,0.0001861991,0.0012928827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037553338,0.00025382653,0.0014261842,0.00044406322,0.000104494895,0.00002788151,0.0002563596,0.00005521552,0.000029566543],"category_scores_gemma":[0.00063173275,0.00022358407,0.00034252644,0.0002746059,0.00019235474,0.00013475608,0.000016955379,0.0007412079,0.0000036919346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064438756,0.0003205413,0.9428209,0.0001690998,0.0006686511,0.0076671536,0.00094843685,0.033945378,0.0021552423,0.00027070497,0.003489762,0.0068997345],"study_design_scores_gemma":[0.04682284,0.015462701,0.81409645,0.0010027828,0.001377679,0.038021546,0.007056319,0.011455729,0.002093227,0.0042142845,0.05619788,0.0021985893],"about_ca_topic_score_codex":0.036258202,"about_ca_topic_score_gemma":0.07730367,"teacher_disagreement_score":0.12872449,"about_ca_system_score_codex":0.00074053835,"about_ca_system_score_gemma":0.0023381903,"threshold_uncertainty_score":0.9701594},"labels":[],"label_agreement":null},{"id":"W2328696542","doi":"10.1097/01.cot.0000275519.10397.5d","title":"Androgen Deprivation May Raise Risk of Cardiovascular Death, Adding Toremifene May Improve Lipid &amp; Bone Profiles","year":2007,"lang":"en","type":"article","venue":"Oncology Times","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Toremifene; Medicine; Androgen deprivation therapy; Endocrinology; Internal medicine; Prostate cancer; Cancer; Breast cancer","score_opus":0.01833116909895852,"score_gpt":0.29012421058721466,"score_spread":0.2717930414882561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328696542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9527129,0.013671009,0.0062681683,0.00034520403,0.0005377782,0.0016927657,0.00004732609,0.00014566153,0.024579214],"genre_scores_gemma":[0.9732646,0.0019633127,0.020707764,0.00017734611,0.0014718468,0.000089068366,0.00012430888,0.00006374274,0.0021380365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975238,0.0002390279,0.0006341177,0.00049326965,0.0005875306,0.0005222767],"domain_scores_gemma":[0.9980517,0.00015296506,0.0002892442,0.0009744941,0.00028297876,0.00024862372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037921818,0.0002518079,0.0010836277,0.00021314938,0.00013809912,0.000008200001,0.000120109056,0.00042448376,0.00019432936],"category_scores_gemma":[0.00047895915,0.00021301283,0.0008408157,0.00027416952,0.00012875455,0.00008966394,0.00009257378,0.00036663224,0.000067979105],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011303882,0.0006567728,0.106339395,0.0007089513,0.006780598,0.00032068172,0.0007761847,0.00013772563,0.016210077,0.0007064206,0.0040265047,0.8622063],"study_design_scores_gemma":[0.0054728882,0.0010655225,0.05455224,0.00016938189,0.0027265814,0.0006111071,0.00025213233,0.000056772482,0.07685421,0.00013045021,0.8576959,0.0004128664],"about_ca_topic_score_codex":0.0006850457,"about_ca_topic_score_gemma":0.00004371886,"teacher_disagreement_score":0.86179346,"about_ca_system_score_codex":0.00031089984,"about_ca_system_score_gemma":0.0004028752,"threshold_uncertainty_score":0.8686411},"labels":[],"label_agreement":null},{"id":"W2330194691","doi":"10.1097/mol.0000000000000095","title":"Comparison of cardiovascular disease risk calculators","year":2014,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Medicine; Calculator; Coronary artery disease; Disease; Coronary artery calcium; Atherosclerotic cardiovascular disease; Duration (music); Risk assessment; Psychological intervention; Internal medicine; Computer science","score_opus":0.14518040732320486,"score_gpt":0.4450355221355243,"score_spread":0.2998551148123194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330194691","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018757342,0.95735633,0.0010231516,0.000012034524,0.03949803,0.0019292445,0.000071643095,0.00004297959,0.00004782692],"genre_scores_gemma":[0.00007869598,0.9826238,0.000076823584,0.0000041119793,0.016309585,0.00027982905,0.00054506754,0.000075290736,0.0000067862234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99460953,0.0016365205,0.0016618071,0.00086261966,0.00071773666,0.00051178667],"domain_scores_gemma":[0.9965628,0.00018445568,0.0006742603,0.002042685,0.00011772435,0.00041809923],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001884933,0.0005458869,0.006590543,0.0005653534,0.000052797433,0.000006838736,0.0002733041,0.00050465536,0.000043987166],"category_scores_gemma":[0.0005849934,0.00043596356,0.0040903008,0.00053379446,0.00019455668,0.00002974985,0.00015866035,0.0012430485,0.00007694925],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023621827,0.0002634004,0.0019985556,0.10450721,0.0012408518,2.4893376e-7,0.000029679251,0.00006456764,3.0972767e-9,0.00024512532,0.0033271036,0.88829964],"study_design_scores_gemma":[0.0009309123,0.00014893203,0.00055604416,0.022849372,0.003771321,0.000024300132,0.0000074828995,0.00008192046,4.2210512e-8,0.000023138457,0.9712857,0.00032085914],"about_ca_topic_score_codex":0.00011875908,"about_ca_topic_score_gemma":9.300977e-7,"teacher_disagreement_score":0.96795857,"about_ca_system_score_codex":0.0002070433,"about_ca_system_score_gemma":0.00077501044,"threshold_uncertainty_score":0.9998092},"labels":[],"label_agreement":null},{"id":"W2330595851","doi":"10.1016/j.cjca.2012.07.751","title":"N005 Who Will be the Next Canadian Heart Failure Champion?","year":2012,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Champion; Heart failure; Internal medicine; Cardiology; Intensive care medicine; Law","score_opus":0.022443990685344896,"score_gpt":0.24708654669980964,"score_spread":0.22464255601446476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330595851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6573612,0.03847558,0.0006767269,0.26463076,0.0056393486,0.0012579699,0.00011244761,0.000022239565,0.03182372],"genre_scores_gemma":[0.9841419,0.00014263204,0.0001345404,0.007850475,0.0074609285,0.0000065017325,0.00000756455,0.000028625818,0.00022685554],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980234,0.00028447472,0.00035634384,0.00012585525,0.00024980956,0.00096012134],"domain_scores_gemma":[0.9960149,0.000043924076,0.000100365476,0.0005032847,0.00028621676,0.0030513136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016176192,0.00016757903,0.00070922164,0.00033632494,0.00028282322,0.000029307832,0.00020008755,0.00023519207,0.00014145543],"category_scores_gemma":[0.00024005801,0.00011302987,0.00056199497,0.00021556248,0.00019378493,0.00019848117,0.000009660713,0.00067431916,0.000031040247],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047038793,0.0000046320174,0.21236357,0.000067070156,0.0015176922,0.0005410307,0.0015028986,0.00018471392,0.00014642994,0.0026605686,0.76587844,0.015085918],"study_design_scores_gemma":[0.00046774512,0.00013998896,0.10265558,0.00003886534,0.00015094355,0.007401101,0.0005809975,0.0000016073997,0.000023776629,0.00003771538,0.8884001,0.00010157887],"about_ca_topic_score_codex":0.15796874,"about_ca_topic_score_gemma":0.314516,"teacher_disagreement_score":0.32678068,"about_ca_system_score_codex":0.0005262686,"about_ca_system_score_gemma":0.0053798775,"threshold_uncertainty_score":0.9543672},"labels":[],"label_agreement":null},{"id":"W2330813682","doi":"10.1139/o2012-031","title":"My road to Damascus: how I converted to the prohormone theory and the proprotein convertases","year":2012,"lang":"en","type":"article","venue":"Biochemistry and Cell Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Proprotein Convertases; Prohormone; PCSK9; Prohormone convertase; Biology; Receptor; Hormone; Glycoprotein; Cell biology; Biochemistry; LDL receptor; Cholesterol; Lipoprotein","score_opus":0.008031714740829851,"score_gpt":0.2295851050064478,"score_spread":0.22155339026561793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330813682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96824235,0.016703302,0.00020013163,0.011876676,0.00007955251,0.0016802928,0.000021324042,0.00002803657,0.0011683442],"genre_scores_gemma":[0.9933579,0.00027029833,0.000076004115,0.003618203,0.00045047843,0.00027552494,0.00002538775,0.000011458452,0.0019147667],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893194,0.00020895059,0.00013434155,0.00027452793,0.00010532834,0.00034493642],"domain_scores_gemma":[0.9990859,0.00006580204,0.000042997526,0.00048157526,0.000051292966,0.00027242897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012824461,0.0001674547,0.00031420583,0.000015970669,0.00016063901,0.000019348008,0.00010543356,0.00015218364,0.000036197307],"category_scores_gemma":[0.00020313075,0.00007708266,0.00007738492,0.00009857918,0.0003063309,0.000019399029,0.000121567966,0.00016998491,0.000016091686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048262477,0.0002998253,0.0038093058,0.0009626136,0.0006919902,0.000012396005,0.0030744954,1.7368781e-7,0.81179917,0.0036052114,0.00581026,0.16510831],"study_design_scores_gemma":[0.0036047476,0.00041584522,0.0042508193,0.00003708233,0.00039792844,0.00018837742,0.0021820306,0.000010007963,0.8377025,0.00011899564,0.1508014,0.0002902405],"about_ca_topic_score_codex":0.0000980685,"about_ca_topic_score_gemma":0.0000016498786,"teacher_disagreement_score":0.16481808,"about_ca_system_score_codex":0.000015831645,"about_ca_system_score_gemma":0.00005730762,"threshold_uncertainty_score":0.31433395},"labels":[],"label_agreement":null},{"id":"W2331811566","doi":"10.1177/171516350413700902","title":"OTC Statins: Opportunity or Threat?","year":2004,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Business; Medicine","score_opus":0.06267482880377179,"score_gpt":0.3026733542081692,"score_spread":0.23999852540439742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331811566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864058,0.0024547349,0.00045203682,0.0010958641,0.0024689974,0.0010942197,0.000572489,0.000077380784,0.0053784773],"genre_scores_gemma":[0.97685033,0.008715262,0.00078711915,0.010253307,0.0018780567,0.000026951331,0.00005847355,0.00008911442,0.0013414047],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99648625,0.00013698621,0.0006996108,0.0004468351,0.00088050653,0.0013498211],"domain_scores_gemma":[0.9913918,0.00003749262,0.00021981989,0.0004932385,0.0006933389,0.007164332],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009892847,0.00043069388,0.00066372025,0.00037367173,0.0010024979,0.00014082303,0.0003854806,0.00009366981,0.0022392038],"category_scores_gemma":[0.0003558278,0.0003714269,0.00033693813,0.000713733,0.00018778816,0.00032854176,0.00003485644,0.0010587125,0.00002746168],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00058504555,0.0001750149,0.0011838044,0.00079119,0.0010416739,0.6176462,0.0013358839,0.00086159934,0.0010676183,0.00018082409,0.024062995,0.3510681],"study_design_scores_gemma":[0.0062502013,0.0001859886,0.000115056166,0.00007795662,0.00037999568,0.85464096,0.000035550434,0.00013390592,0.0021720084,0.00014882609,0.13533357,0.00052598683],"about_ca_topic_score_codex":0.15903984,"about_ca_topic_score_gemma":0.28160393,"teacher_disagreement_score":0.35054213,"about_ca_system_score_codex":0.0057137855,"about_ca_system_score_gemma":0.034015283,"threshold_uncertainty_score":0.99987376},"labels":[],"label_agreement":null},{"id":"W2332018270","doi":"10.1021/pr2000072","title":"Quantitative Proteomic Analysis of PCSK9 Gain of Function in Human Hepatic HuH7 Cells","year":2011,"lang":"en","type":"article","venue":"Journal of Proteome Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Université de Montréal; Montreal Clinical Research Institute; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Stable isotope labeling by amino acids in cell culture; Kexin; PCSK9; Proprotein convertase; LDL receptor; Biology; Cell biology; Lipoprotein; Molecular biology; Proteomics; Biochemistry; Cholesterol; Gene","score_opus":0.14022918458616684,"score_gpt":0.40612355948306655,"score_spread":0.2658943748968997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332018270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955145,0.0005003867,0.0017741822,0.00007027871,0.000034307606,0.0014352227,0.000004377287,0.000002939684,0.00066378474],"genre_scores_gemma":[0.99521124,0.00012428516,0.0044164932,0.0000062571867,0.000068782974,0.00004239995,0.000002064241,0.000017495271,0.00011095384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958794,0.00086765434,0.0010959934,0.00017897063,0.0016373503,0.00034060774],"domain_scores_gemma":[0.9973194,0.00008182897,0.0005634627,0.0004229949,0.001441346,0.0001709956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010201449,0.000113636816,0.0010109661,0.0026828325,0.000053091044,0.0000070523724,0.00018932896,0.00011789539,0.00025606217],"category_scores_gemma":[0.00041405152,0.00008547162,0.000561226,0.002425547,0.00018675634,0.00013321656,0.000053772957,0.00080330676,0.0000049234955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002506509,0.0009790715,0.03308824,0.0014013818,0.0027418262,0.00011691872,0.0024594753,0.00007721055,0.9539849,0.00041297305,0.00003702165,0.0021944665],"study_design_scores_gemma":[0.0032742117,0.011165603,0.34276688,0.0011079886,0.0011092625,0.000030041465,0.0017415677,0.0007887631,0.63647854,0.0013681356,0.000028062523,0.00014090388],"about_ca_topic_score_codex":0.0018300653,"about_ca_topic_score_gemma":0.00009199614,"teacher_disagreement_score":0.31750634,"about_ca_system_score_codex":0.00020553487,"about_ca_system_score_gemma":0.0005250888,"threshold_uncertainty_score":0.35356387},"labels":[],"label_agreement":null},{"id":"W2333109535","doi":"10.1097/mol.0000000000000295","title":"New developments in proprotein convertase subtilisin–kexin 9's biology and clinical implications","year":2016,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; LDL receptor; Kexin; Downregulation and upregulation; Proprotein convertase; Cholesterol; Liver X receptor; Endocrinology; Internal medicine; Biology; Medicine; Lipoprotein; Biochemistry; Nuclear receptor","score_opus":0.19249341560630764,"score_gpt":0.4959342225826489,"score_spread":0.30344080697634124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333109535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020203614,0.977388,0.000439355,0.0006539764,0.01800192,0.0033374373,0.000051644376,0.000035337605,0.00007207365],"genre_scores_gemma":[0.000011542645,0.98968613,0.0006224489,0.00004715026,0.008491648,0.0005452865,0.00048624174,0.000047005975,0.00006257405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99539524,0.0010144025,0.0018218354,0.001027096,0.00014884346,0.0005925702],"domain_scores_gemma":[0.9980454,0.00031288454,0.00040784644,0.0007907163,0.00007204315,0.00037114648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015734846,0.00045607061,0.0027953892,0.0005984705,0.00004102893,0.000010090965,0.0002352559,0.0008924121,0.00007128548],"category_scores_gemma":[0.000576828,0.00032180248,0.0004305909,0.00036849562,0.00021303543,0.000052171745,0.00022951803,0.0010201854,0.00013574424],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029418963,0.00014389487,0.009078262,0.007880006,0.00009431933,3.4585494e-7,0.000016665863,3.5038077e-9,1.4096274e-7,0.0020226305,0.0035622555,0.9771721],"study_design_scores_gemma":[0.0022968883,0.00019357952,0.0091083655,0.016648266,0.00008989218,0.00015161812,0.00000263265,3.7073062e-7,9.3393446e-8,0.00044350725,0.9707708,0.00029398876],"about_ca_topic_score_codex":0.00013160953,"about_ca_topic_score_gemma":0.000031159074,"teacher_disagreement_score":0.97687805,"about_ca_system_score_codex":0.00026983907,"about_ca_system_score_gemma":0.0025265457,"threshold_uncertainty_score":0.9999234},"labels":[],"label_agreement":null},{"id":"W2333635271","doi":"10.3821/1913-701x-144.suppl1.s3.fr","title":"Le fardeau de l'ostéoporose au Canada","year":2011,"lang":"fr","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.0328636381203663,"score_gpt":0.24737042592910036,"score_spread":0.21450678780873406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333635271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75420594,0.09373073,0.0006197318,0.0026222416,0.051299103,0.0022077183,0.0035303307,0.000084103915,0.09170007],"genre_scores_gemma":[0.952031,0.0200346,0.00040747644,0.010109643,0.009968538,0.00003337596,0.000053234264,0.00019764625,0.007164444],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9917701,0.00067071203,0.0012498063,0.00078580226,0.0012636458,0.0042599645],"domain_scores_gemma":[0.98506373,0.00009071971,0.00044623006,0.0008153897,0.0010054029,0.012578519],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00236085,0.00085638894,0.0011298937,0.00041142618,0.0020303533,0.00015175907,0.0009973123,0.00024905513,0.0039973618],"category_scores_gemma":[0.00042341833,0.0010075921,0.0005630534,0.0009223631,0.00052294385,0.0004598018,0.00008679881,0.0021907538,0.00004063375],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00023412444,0.00016597443,0.0053760633,0.0016317565,0.0017436701,0.5636397,0.0036613257,0.00036682532,0.00036755233,0.0010873477,0.12288506,0.2988406],"study_design_scores_gemma":[0.002699158,0.000077623525,0.00029419834,0.00014260533,0.0006283089,0.5120321,0.00009338509,0.00053223455,0.0022520404,0.000051353276,0.4804568,0.00074021774],"about_ca_topic_score_codex":0.9989935,"about_ca_topic_score_gemma":0.9993046,"teacher_disagreement_score":0.35757172,"about_ca_system_score_codex":0.031939413,"about_ca_system_score_gemma":0.3090455,"threshold_uncertainty_score":0.9992689},"labels":[],"label_agreement":null},{"id":"W2334188735","doi":"10.1136/eb-2013-101445","title":"Statin potency associated with incident diabetes in a real-world evaluation","year":2013,"lang":"en","type":"letter","venue":"Evidence-Based Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Statin; Incidence (geometry); Population; Internal medicine; Endocrinology; Environmental health","score_opus":0.06517951688456486,"score_gpt":0.32406589536220615,"score_spread":0.2588863784776413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334188735","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14614779,0.008890172,0.00007827705,0.8354248,0.0005555323,0.0068712696,0.000018923327,0.00018856938,0.0018247146],"genre_scores_gemma":[0.21646717,0.0018405853,0.0005256631,0.75848126,0.01085748,0.0029918395,0.0030459794,0.00029056723,0.005499432],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99011946,0.0014506851,0.0012643142,0.001065434,0.0050504827,0.0010496549],"domain_scores_gemma":[0.99470115,0.001290748,0.00082233164,0.0014847186,0.0013697088,0.0003313273],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0072528007,0.00074072205,0.002101471,0.001270236,0.00010097184,0.000035582198,0.00029509445,0.00071419636,0.0017919402],"category_scores_gemma":[0.0054719504,0.00049754936,0.00028325588,0.0015756728,0.00031379395,0.00026208741,0.000043857766,0.0027951316,0.00007722506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021704123,0.0001863695,0.06354558,0.0027341477,0.0006389611,0.0015586076,0.00029966905,0.00008444385,0.00013372599,0.000005012751,0.8958543,0.034742128],"study_design_scores_gemma":[0.023627644,0.00743445,0.6702106,0.16202946,0.0064320504,0.000039274364,0.00022207186,0.007983102,0.00036373394,0.0003475867,0.119465165,0.0018448394],"about_ca_topic_score_codex":0.016941914,"about_ca_topic_score_gemma":0.0025202134,"teacher_disagreement_score":0.7763892,"about_ca_system_score_codex":0.0024110763,"about_ca_system_score_gemma":0.003225856,"threshold_uncertainty_score":0.99974763},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2334198083","doi":"10.1177/1715163515578692","title":"Statins and their effect on cognition","year":2015,"lang":"en","type":"review","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Confusion; Humanities; Cognition; Psychology; Medicine; Philosophy; Psychiatry; Psychoanalysis","score_opus":0.06725948213265404,"score_gpt":0.3345384187772854,"score_spread":0.26727893664463137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334198083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002116912,0.99111384,0.000010718162,0.00002683526,0.0016146561,0.0018679067,0.0012781543,0.000030207844,0.0019407463],"genre_scores_gemma":[0.009003357,0.98628193,0.00002494676,0.0012929076,0.0024619682,0.00008677053,0.0003280041,0.00016209652,0.0003580091],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960673,0.00068016176,0.00083258335,0.00061736075,0.00069481484,0.0011078147],"domain_scores_gemma":[0.99319565,0.00017344167,0.00042440623,0.00044443898,0.00055563205,0.005206411],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019118161,0.00086261315,0.0024371797,0.0006659447,0.00061270496,0.00017443637,0.0002979164,0.00020916744,0.0002186092],"category_scores_gemma":[0.00025426393,0.00065325084,0.0006894323,0.0005909535,0.000164416,0.00013632473,0.000037876445,0.0018591709,0.000027032693],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00005107566,0.000018297846,0.0000028213767,0.01087424,0.00079758436,0.040600453,0.00011834479,0.0000019594734,0.0000018689984,0.0000036386177,0.009285443,0.9382443],"study_design_scores_gemma":[0.0013157087,0.00021896606,1.9986838e-7,0.0013154801,0.0014101758,0.4092719,0.0000022170764,0.00002241108,0.000013537436,0.000006637968,0.586061,0.0003617406],"about_ca_topic_score_codex":0.011867761,"about_ca_topic_score_gemma":0.02043429,"teacher_disagreement_score":0.93788254,"about_ca_system_score_codex":0.0047196858,"about_ca_system_score_gemma":0.016415354,"threshold_uncertainty_score":0.9995919},"labels":[],"label_agreement":null},{"id":"W2334318078","doi":"10.1136/eb-2012-100787","title":"Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events","year":2012,"lang":"en","type":"letter","venue":"Evidence-Based Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University","funders":"","keywords":"Internal medicine; Gastroenterology; Apolipoprotein B; Medicine; Web of science; Cholesterol; Endocrinology; Meta-analysis","score_opus":0.044907330294925954,"score_gpt":0.28133199026946504,"score_spread":0.2364246599745391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334318078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9317085,0.025958665,0.00048158815,0.034166753,0.0005270866,0.006501536,0.00026428612,0.00018160508,0.00020998075],"genre_scores_gemma":[0.9344122,0.002149271,0.00019428637,0.05583671,0.0030153848,0.00037491394,0.0035458656,0.00029900734,0.00017238487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9911315,0.0011820975,0.0013637701,0.0012055831,0.0039508045,0.0011662644],"domain_scores_gemma":[0.99407184,0.00071853254,0.0011649893,0.002142503,0.0011351593,0.00076698087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035671834,0.0011184157,0.0036016272,0.0007502169,0.00017723227,0.000020338104,0.00033910762,0.0012800471,0.00016188833],"category_scores_gemma":[0.0016516345,0.0007726165,0.00089166505,0.0008644959,0.00085554837,0.0003219707,0.000089425375,0.0020465555,0.000010079579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011572858,0.00044459625,0.8082988,0.00712745,0.016930496,0.0007226945,0.0002672509,0.00002136827,0.00005396059,1.697728e-7,0.13956647,0.02540942],"study_design_scores_gemma":[0.019536803,0.003432327,0.88386035,0.04084259,0.014632065,0.0000388644,0.00008310639,0.00008766723,0.00042366047,0.0000022648708,0.0362176,0.0008427027],"about_ca_topic_score_codex":0.020938955,"about_ca_topic_score_gemma":0.00006650648,"teacher_disagreement_score":0.10334886,"about_ca_system_score_codex":0.00057557266,"about_ca_system_score_gemma":0.0007649253,"threshold_uncertainty_score":0.9994725},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2334598944","doi":"10.15420/ecr.2007.0.1.16","title":"European Physicians’ Perspectives on Cholesterol Management and Inhibition of Cholesterol Absorption and Production","year":2007,"lang":"en","type":"article","venue":"European Cardiology Review","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Universiteit van Amsterdam","keywords":"Coronary heart disease; Medicine; Clinical trial; Cholesterol lowering; Cholesterol; Intensive care medicine; Disease management; Ldl cholesterol; Production (economics); Disease; Environmental health; Internal medicine","score_opus":0.01670079675108503,"score_gpt":0.26452341732641454,"score_spread":0.2478226205753295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334598944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8756659,0.080141686,0.0006752675,0.0010242097,0.00014498542,0.0016070608,0.0000032586686,0.00006564611,0.040671956],"genre_scores_gemma":[0.88267505,0.11544335,0.00014043205,0.0009732511,0.0005629144,0.0000064960086,0.000015221055,0.000032710737,0.00015054482],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982332,0.00064629846,0.00033560605,0.00043426832,0.00017575514,0.00017487143],"domain_scores_gemma":[0.99926853,0.000008970678,0.00013998999,0.0004325162,0.000078004865,0.00007195942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002838977,0.00015991511,0.00050373655,0.00007408785,0.000057401016,0.000006290424,0.000033569384,0.000024338375,0.0000021890864],"category_scores_gemma":[0.00004038166,0.00013234952,0.00014632815,0.00012197634,0.00013577423,0.000056962774,0.000054014814,0.00017717217,0.000029401883],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106225474,0.00010103168,0.0034570177,0.0084961625,0.00041693746,0.00020046557,0.0006456288,0.0000030277251,0.0030691733,0.00030203265,0.0008218021,0.9823805],"study_design_scores_gemma":[0.0010912339,0.00051551906,0.9607025,0.0054705944,0.00053727545,0.0005615667,0.00037856205,3.831564e-7,0.00030174686,0.0000072963985,0.030274164,0.00015919963],"about_ca_topic_score_codex":0.0000020216896,"about_ca_topic_score_gemma":4.3608532e-7,"teacher_disagreement_score":0.9822213,"about_ca_system_score_codex":0.000032511904,"about_ca_system_score_gemma":0.0000040520254,"threshold_uncertainty_score":0.5397057},"labels":[],"label_agreement":null},{"id":"W2334642185","doi":"10.1002/jcsm.12109","title":"Discussion around statin discontinuation in older adults and patients with wasting diseases","year":2016,"lang":"en","type":"article","venue":"Journal of Cachexia Sarcopenia and Muscle","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Simvastatin; Medicine; Discontinuation; Statin; Evolocumab; Internal medicine; PCSK9; Adverse effect; Clinical trial; Stroke (engine); Myocardial infarction; Gastroenterology; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.004836061483035888,"score_gpt":0.2239385066092514,"score_spread":0.21910244512621552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334642185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971867,0.0010367094,0.00030904805,0.001081901,0.00003899479,0.0003066238,0.000006447433,0.0000036595036,0.000029878043],"genre_scores_gemma":[0.9990504,0.00024115379,0.0004510185,0.000060326096,0.00011463567,0.0000044185035,0.0000030991725,0.000012804014,0.00006216068],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904233,0.000059796137,0.00028859905,0.00013190914,0.0003311364,0.00014622352],"domain_scores_gemma":[0.9993856,0.00003688945,0.00017930915,0.00010124248,0.00011615624,0.00018079276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027572384,0.000096301206,0.0002873942,0.000086553046,0.000045715904,0.00002262377,0.000027788761,0.00003184978,0.0000126334635],"category_scores_gemma":[0.00010493255,0.000039729857,0.000048530434,0.00007209322,0.000041963296,0.00029987923,0.00002401575,0.00009223066,4.840936e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005161526,0.00015788937,0.51166165,0.00009380494,0.000028011706,0.000022827424,0.00045675758,3.9557264e-7,0.00027076653,0.0000041868216,0.000028685698,0.4867589],"study_design_scores_gemma":[0.009289552,0.00048976426,0.986848,0.0021857906,0.00008743957,0.000027942275,0.000497903,0.000012950799,0.00007260773,0.00002503011,0.00038565142,0.00007737918],"about_ca_topic_score_codex":0.000027551521,"about_ca_topic_score_gemma":0.00002981557,"teacher_disagreement_score":0.4866815,"about_ca_system_score_codex":0.000042741874,"about_ca_system_score_gemma":0.0000759342,"threshold_uncertainty_score":0.16201366},"labels":[],"label_agreement":null},{"id":"W2335160143","doi":"10.1016/j.cjca.2014.07.576","title":"DECREASED PCSK9 FUNCTION INCREASES ENDOTOXIN CLEARANCE AND DECREASES THE ASSOCIATED INFLAMMATORY RESPONSE","year":2014,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"PCSK9; LDL receptor; Endocrinology; Internal medicine; Medicine; Hepatocyte; Lipopolysaccharide; Kexin; Receptor; Proprotein convertase; Cytokine; Lipoprotein; Cholesterol; Biology; In vitro; Biochemistry","score_opus":0.008823175931681701,"score_gpt":0.21393196854671792,"score_spread":0.20510879261503623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335160143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935104,0.003326123,0.00090904743,0.0010039345,0.00023598773,0.00021283317,0.000006150776,0.000009850296,0.0007856566],"genre_scores_gemma":[0.99756706,0.00012101814,0.000033874116,0.0011806352,0.0010243832,0.000007245206,0.0000041414382,0.000018280105,0.00004339159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976664,0.0013566085,0.00033509792,0.00013505775,0.00019045275,0.00031637462],"domain_scores_gemma":[0.99797994,0.00040174712,0.00018478023,0.00029910746,0.00029038146,0.00084404746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032610022,0.00012854897,0.00053410936,0.00020058909,0.00019938067,0.000022666174,0.000096373515,0.00014738017,0.000016307135],"category_scores_gemma":[0.0043257563,0.00008906144,0.0002767948,0.00012594553,0.00023656739,0.00006139758,0.000009379387,0.00032564017,0.0000053971994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014400487,0.000030604104,0.7985062,0.0001821619,0.0043096486,0.002390294,0.00040185812,0.0006500998,0.0064125517,0.001254985,0.022193773,0.14926736],"study_design_scores_gemma":[0.0018953463,0.0006911609,0.8049649,0.00010060336,0.00028241004,0.003224194,0.000116154784,0.000020307703,0.00014666766,0.00018554568,0.18828063,0.00009205388],"about_ca_topic_score_codex":0.0026620326,"about_ca_topic_score_gemma":0.0021014225,"teacher_disagreement_score":0.16608685,"about_ca_system_score_codex":0.00016068912,"about_ca_system_score_gemma":0.0017723526,"threshold_uncertainty_score":0.51786464},"labels":[],"label_agreement":null},{"id":"W2335964334","doi":"","title":"Lipid-lowering update 2001. Aggressive new goals.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital","funders":"","keywords":"Medicine; Coronary artery disease; Clinical trial; Intensive care medicine; Randomized controlled trial; MEDLINE; Diabetes mellitus; Lipid profile; Internal medicine; Cholesterol; Bioinformatics; Endocrinology","score_opus":0.024560478533171243,"score_gpt":0.24852181492267783,"score_spread":0.22396133638950658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335964334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91579896,0.011734872,0.0017253361,0.012748705,0.0015236106,0.0032322407,0.000006779936,0.0004185579,0.052810945],"genre_scores_gemma":[0.9708608,0.0034359694,0.00053505396,0.0034791885,0.0043348977,0.00073822343,0.000025865842,0.00006242089,0.016527588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842066,0.000027096808,0.00021875663,0.00028567412,0.00039076267,0.0006570451],"domain_scores_gemma":[0.9986645,0.000011085277,0.00009647572,0.0005446673,0.000056538367,0.000626732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045321317,0.00014646038,0.00034092768,0.0000835411,0.00006741401,0.000027526326,0.00009686674,0.000090629794,0.00022801114],"category_scores_gemma":[0.00019698705,0.00012182239,0.00022073662,0.0002539549,0.00002546606,0.00009264372,0.000051052128,0.0001927019,0.0001515128],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010761654,0.000052588,0.004465593,0.00004691869,0.0001638697,0.00039488773,0.00004160159,0.000008053957,0.000029079418,0.00003470844,0.030408755,0.96424633],"study_design_scores_gemma":[0.0021650621,0.00003671886,0.25957912,0.000059282473,0.00012931241,0.00043462796,0.000023237135,0.000016302203,0.0011727028,0.000080083104,0.7361148,0.00018871741],"about_ca_topic_score_codex":0.0003479043,"about_ca_topic_score_gemma":0.000032452408,"teacher_disagreement_score":0.9640576,"about_ca_system_score_codex":0.0001080955,"about_ca_system_score_gemma":0.00011295115,"threshold_uncertainty_score":0.4967773},"labels":[],"label_agreement":null},{"id":"W2336752160","doi":"","title":"Cost effectiveness of HMG-CoA reductase inhibition in Canada.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pravastatin; Medicine; Fluvastatin; Atorvastatin; Lovastatin; Simvastatin; Statin; Coronary artery disease; HMG-CoA reductase; Cost effectiveness; Internal medicine; Pharmacology; Cholesterol; Reductase; Risk analysis (engineering)","score_opus":0.026805578531667113,"score_gpt":0.24371851903268024,"score_spread":0.21691294050101312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336752160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956329,0.00043909173,0.000036993042,0.00032247818,0.000118186916,0.0016707083,0.000008716462,0.000009143971,0.0017617962],"genre_scores_gemma":[0.9986985,0.000083936975,0.000011694117,0.000114801376,0.000085105545,0.00092654483,0.000025545729,0.000009544285,0.00004436731],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99905795,0.0001167395,0.00016889689,0.00014031674,0.0002708936,0.0002452056],"domain_scores_gemma":[0.9995242,0.000030241952,0.00003609616,0.00022483029,0.000052582174,0.00013207234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083107565,0.0000663325,0.00025903736,0.000067455054,0.000014377449,0.000002224421,0.000018887891,0.000034439054,0.000010309034],"category_scores_gemma":[0.00011108351,0.000058930895,0.00005536846,0.00027132046,0.000018001369,0.000035040608,0.000011882481,0.000098865545,0.0000010401809],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018386132,0.0004436693,0.1506109,0.0018491684,0.0002170826,0.0016830706,0.00010727597,0.000253406,0.0019469216,0.00025664593,0.0011066241,0.83968663],"study_design_scores_gemma":[0.0021294341,0.000015407015,0.9754381,0.00009249303,0.000028419876,0.00010565252,0.000059356647,0.000011308674,0.019147936,0.00003193543,0.0028770054,0.000062927145],"about_ca_topic_score_codex":0.6827097,"about_ca_topic_score_gemma":0.4221826,"teacher_disagreement_score":0.8396237,"about_ca_system_score_codex":0.00061525684,"about_ca_system_score_gemma":0.0005112893,"threshold_uncertainty_score":0.5883611},"labels":[],"label_agreement":null},{"id":"W2336786040","doi":"","title":"HDL-Mediated Cellular Cholesterol Efflux Assay Method.","year":2015,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Efflux; Cholesterol; Reverse cholesterol transport; Context (archaeology); Centrifugation; Chemistry; High-density lipoprotein; Apolipoprotein B; Polyethylene glycol; Lipoprotein; Chromatography; Biology; Biochemistry","score_opus":0.042751956703053214,"score_gpt":0.26860326729908335,"score_spread":0.22585131059603014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336786040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8058987,0.007560787,0.05946364,0.011331537,0.0032645126,0.011556768,0.000045355224,0.0012148153,0.09966383],"genre_scores_gemma":[0.9883046,0.000039168164,0.002542107,0.002268566,0.0012693948,0.001698148,0.00007445997,0.00006069078,0.0037428227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776745,0.0003188652,0.00028083383,0.00033885025,0.00073407806,0.0005599462],"domain_scores_gemma":[0.9981346,0.000057292087,0.00006923361,0.0006959922,0.00016399861,0.0008788718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041111945,0.00017395512,0.0004628299,0.00010856916,0.000042449665,0.000028472954,0.00011405688,0.00015918392,0.000024679699],"category_scores_gemma":[0.0007337444,0.00013845357,0.00022606707,0.0002791076,0.000034542532,0.00008163531,0.0000543312,0.0002834088,0.0001862645],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010678702,0.00020995412,0.010323613,0.00018810475,0.00040972128,0.000091388305,0.00023984697,0.000016673303,0.00027185844,0.00006878587,0.009871365,0.9782019],"study_design_scores_gemma":[0.008449666,0.00015805857,0.4298932,0.000036462097,0.00042320119,0.00016930535,0.00014054576,0.00038026425,0.01307416,0.00016038785,0.54670614,0.0004086195],"about_ca_topic_score_codex":0.00023842347,"about_ca_topic_score_gemma":0.000009482697,"teacher_disagreement_score":0.9777933,"about_ca_system_score_codex":0.00017673116,"about_ca_system_score_gemma":0.00014427448,"threshold_uncertainty_score":0.56459725},"labels":[],"label_agreement":null},{"id":"W2337146508","doi":"10.1136/bmj.i2030","title":"Ignoring adverse experiences of people taking statins","year":2016,"lang":"en","type":"letter","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital","funders":"","keywords":"Adverse effect; Computer science; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medicine; Data science; Pharmacology; Statin; Internal medicine","score_opus":0.02780268839825791,"score_gpt":0.3092387109141042,"score_spread":0.2814360225158463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337146508","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22757077,0.0020284625,0.0015304955,0.7276567,0.0030591206,0.0035129758,0.000075089134,0.00018659701,0.03437979],"genre_scores_gemma":[0.36837402,0.0005442238,0.005485313,0.5425263,0.06630963,0.0014345564,0.0002185313,0.00026135455,0.014846082],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981831,0.00007055403,0.00038891484,0.00028661123,0.000740455,0.00033041096],"domain_scores_gemma":[0.9987692,0.00004990864,0.00035596744,0.00066254317,0.00009988071,0.0000624793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043231234,0.00017552041,0.00061381696,0.000103866296,0.00004523805,0.000004894672,0.00011270271,0.00027721855,0.0005289459],"category_scores_gemma":[0.00014593072,0.00012023349,0.00035046236,0.00010256914,0.000050128743,0.00004584633,0.00004939587,0.0004084616,0.00003770213],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035399462,0.000017072223,0.0007545879,0.0019301095,0.00032905905,0.00065082463,0.010729507,4.2823174e-7,0.00012418359,0.000017759492,0.9531459,0.032265127],"study_design_scores_gemma":[0.000749877,0.00014113628,0.0011506495,0.0012235357,0.00013481583,0.00012768914,0.0041812966,0.0000031738136,0.0006650981,0.0000109903995,0.9913985,0.00021320283],"about_ca_topic_score_codex":0.00027355636,"about_ca_topic_score_gemma":0.000011032439,"teacher_disagreement_score":0.1851304,"about_ca_system_score_codex":0.00006652297,"about_ca_system_score_gemma":0.00029504873,"threshold_uncertainty_score":0.57915866},"labels":[],"label_agreement":null},{"id":"W2337182746","doi":"10.1056/jc200804020000001","title":"Patterns of Ezetimibe Use in the U.S. and Canada","year":2008,"lang":"en","type":"article","venue":"Journal watch","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Simvastatin; Medicine; Coronary heart disease; Statin; Pharmacology; Internal medicine","score_opus":0.02236869500323216,"score_gpt":0.23737260155814435,"score_spread":0.2150039065549122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337182746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99115556,0.00031932368,0.000018989982,0.008274767,0.00005530064,0.000090816575,0.0000023229693,9.824327e-7,0.00008193121],"genre_scores_gemma":[0.9958711,0.002734734,0.000071041446,0.0009753813,0.00015146822,0.0000012126397,7.034633e-7,0.000004372558,0.00018998455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992861,0.000054839296,0.00015791583,0.000048143298,0.00034524224,0.00010777008],"domain_scores_gemma":[0.99968517,0.000024731975,0.00004083617,0.0001361852,0.000043649005,0.000069429734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034771455,0.00004280841,0.00015522982,0.00001731113,0.000054523887,0.0000057223106,0.00003887683,0.000021894544,0.000016754784],"category_scores_gemma":[0.00003696903,0.000023391323,0.000049214454,0.000043181608,0.0000102013,0.00003514764,0.0000083242985,0.00022665504,2.1471794e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029187093,0.00003802732,0.98781306,0.00004922308,0.000041089756,0.0012064868,0.0007512237,0.0000043288146,0.00007062985,0.0000066635384,0.007730937,0.0022591753],"study_design_scores_gemma":[0.0007606723,0.00007078306,0.9693846,0.000062425315,0.000021026895,0.006606059,0.0003041365,0.0000053838608,0.00017686166,0.000009236698,0.0225664,0.000032418506],"about_ca_topic_score_codex":0.52462584,"about_ca_topic_score_gemma":0.31503582,"teacher_disagreement_score":0.20958999,"about_ca_system_score_codex":0.000057460587,"about_ca_system_score_gemma":0.00029628607,"threshold_uncertainty_score":0.697463},"labels":[],"label_agreement":null},{"id":"W2338134757","doi":"10.1161/jaha.115.003012","title":"Lipoprotein(a) Interactions With Low‐Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS)","year":2016,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Odds ratio; Interquartile range; Internal medicine; Acute coronary syndrome; Risk factor; Lipoprotein(a); Prospective cohort study; Population; Lipoprotein; Cholesterol; Myocardial infarction","score_opus":0.006850344562015846,"score_gpt":0.23873808391541806,"score_spread":0.2318877393534022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338134757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684685,0.00025553547,0.00017735927,0.0017958779,0.00016885229,0.0007024843,0.000019677927,0.000016867993,0.000016475755],"genre_scores_gemma":[0.99865,0.00022532327,0.0003396129,0.0003642788,0.00019567745,0.000014967075,5.208734e-7,0.000034616987,0.00017497239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744153,0.00062803493,0.00043923722,0.000223214,0.0009792693,0.00028873628],"domain_scores_gemma":[0.99823356,0.00011972128,0.0007640015,0.00049375446,0.0002312534,0.00015771328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015995365,0.00019886455,0.0010243828,0.00015631077,0.00012702779,0.000031503794,0.00011052185,0.000087431355,0.000008625326],"category_scores_gemma":[0.00032810424,0.00010083136,0.000636374,0.0003601377,0.00009201896,0.00025277535,0.000051678435,0.0006349863,0.0000045009433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036745495,0.00011948985,0.9794465,0.000034552162,0.002709763,0.000052844098,0.0002884547,0.000026163594,0.0025404752,0.0000011016898,0.00011930736,0.014293909],"study_design_scores_gemma":[0.001729524,0.0006620996,0.99024117,0.0006349675,0.000721911,0.0017423991,0.00017221169,0.0000053729814,0.0026111412,0.000025119698,0.0013238417,0.00013023659],"about_ca_topic_score_codex":0.0030317912,"about_ca_topic_score_gemma":0.000360096,"teacher_disagreement_score":0.014163673,"about_ca_system_score_codex":0.00079007196,"about_ca_system_score_gemma":0.00015775318,"threshold_uncertainty_score":0.45831817},"labels":[],"label_agreement":null},{"id":"W2339218474","doi":"10.1016/j.jval.2015.09.797","title":"Management of Statin Intolerance (Si) in Patients at High Risk for Cardiovascular (Cv) Events: Results of a Canadian Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Amgen (Canada); Université de Montréal","funders":"","keywords":"Medicine; Statin; Internal medicine; Rhabdomyolysis; Medical prescription; Incidence (geometry); Population; Cohort; Retrospective cohort study; Pharmacology","score_opus":0.03743217193023744,"score_gpt":0.27884559185169244,"score_spread":0.24141341992145499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339218474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914159,0.0021463502,0.00007310487,0.00023679172,0.00021494654,0.005554732,0.00023373446,0.000008282942,0.00011612338],"genre_scores_gemma":[0.99598527,0.00066784996,0.0029293103,0.00006508485,0.000040920644,0.0001797082,0.00006333232,0.00002698092,0.000041540487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660516,0.0005760265,0.0010861731,0.00040546668,0.00085065915,0.00047654632],"domain_scores_gemma":[0.998189,0.000038626175,0.00028755065,0.00086612743,0.00022130653,0.00039739307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056203804,0.0001590001,0.00092654943,0.00060087285,0.00004115237,0.0000019907568,0.00012247924,0.00006726592,0.000001636322],"category_scores_gemma":[0.00019191779,0.00014897616,0.00025646668,0.0008235157,0.000022924625,0.000040437422,0.0000485831,0.00016313254,0.0000021140422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003650686,0.0023098572,0.8605161,0.0053157927,0.0016610288,0.00007691076,0.009611947,0.028012961,3.668023e-7,0.00023694914,0.00058064895,0.088026755],"study_design_scores_gemma":[0.032430146,0.0031244871,0.9563166,0.0010613714,0.000144219,0.0000014659389,0.0017105424,0.0004751563,0.000016641465,0.000181255,0.004387402,0.00015072379],"about_ca_topic_score_codex":0.88378936,"about_ca_topic_score_gemma":0.11915702,"teacher_disagreement_score":0.76463234,"about_ca_system_score_codex":0.0012741494,"about_ca_system_score_gemma":0.00066120405,"threshold_uncertainty_score":0.8969161},"labels":[],"label_agreement":null},{"id":"W2340149964","doi":"10.1056/jc201006090000004","title":"Treating Disease, Not Risk Factors","year":2010,"lang":"en","type":"article","venue":"Journal watch","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hyperlipidemia; Disease; Atherosclerotic cardiovascular disease; Internal medicine; Surrogate endpoint; Intima-media thickness; Cardiology; Carotid arteries; Diabetes mellitus; Endocrinology","score_opus":0.013044256900239873,"score_gpt":0.27217808871272214,"score_spread":0.2591338318124823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340149964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942199,0.00008888519,0.00015403885,0.004198115,0.00053673895,0.00014554917,0.0000073164515,0.000029019388,0.00062043767],"genre_scores_gemma":[0.9935358,0.0006681369,0.0009502607,0.0002247061,0.0019641567,0.0000029831372,0.000003508946,0.000021673663,0.0026287672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988933,0.000048228245,0.00022480093,0.000123257,0.00046881958,0.00024156315],"domain_scores_gemma":[0.9988772,0.000038035214,0.00010833972,0.00029805515,0.00009188462,0.00058647594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056338985,0.000107022446,0.00024505166,0.000038654507,0.00027244497,0.000045376637,0.000064412554,0.00006492663,0.00047535656],"category_scores_gemma":[0.00043146394,0.00005915936,0.00032172297,0.00009631133,0.000021408836,0.000078474215,0.000016938488,0.0009076169,0.00003009243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007394108,0.00027664582,0.8296854,0.00013005956,0.00048614843,0.0009746768,0.0009276834,0.000013208898,0.004169278,0.000050501178,0.0076189116,0.15492807],"study_design_scores_gemma":[0.0020270098,0.00026032244,0.8945935,0.000091562164,0.00044919786,0.0010096654,0.00025858858,0.00013304516,0.0023077682,0.00020747936,0.09848232,0.00017955653],"about_ca_topic_score_codex":0.0001984211,"about_ca_topic_score_gemma":0.000042137057,"teacher_disagreement_score":0.15474851,"about_ca_system_score_codex":0.00005290413,"about_ca_system_score_gemma":0.00021826173,"threshold_uncertainty_score":0.52048206},"labels":[],"label_agreement":null},{"id":"W2340159586","doi":"10.22374/cjgim.v8i1.100","title":"Statins and Diabetes: Evaluating the Truth?","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of General Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Diabetes mellitus; Intensive care medicine; Incidence (geometry); Endocrinology","score_opus":0.03237649385345079,"score_gpt":0.30750249576759364,"score_spread":0.2751260019141428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340159586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750563,0.006632245,0.00013759194,0.015076687,0.0009499007,0.00022363743,0.0000021807348,0.000003086225,0.0019184077],"genre_scores_gemma":[0.9918136,0.00012190456,0.0007177903,0.0036425053,0.0026792001,0.0000070020737,0.0000016505791,0.00001782781,0.0009985248],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99858123,0.00011241149,0.00047423888,0.00010906185,0.00041111023,0.0003119589],"domain_scores_gemma":[0.9980655,0.00011198136,0.00019164316,0.00020657202,0.00042441755,0.0009999397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011768931,0.00012413987,0.00038944356,0.00017891503,0.00010937211,0.000032974123,0.00013678771,0.000045627574,0.00077411684],"category_scores_gemma":[0.0009989165,0.00006464835,0.000111574715,0.00011080297,0.00022092064,0.000088609864,0.000011123228,0.000400489,0.000009929459],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011196045,0.000030326808,0.097475514,0.00030314503,0.0014530019,0.0006303464,0.0038468987,0.000044460034,0.016925054,0.0009836883,0.085674435,0.7925212],"study_design_scores_gemma":[0.012029342,0.01762804,0.8635164,0.0047129453,0.0014545429,0.009582166,0.004720512,0.008227288,0.0022018128,0.0036657404,0.071678296,0.0005829216],"about_ca_topic_score_codex":0.02787026,"about_ca_topic_score_gemma":0.0016856702,"teacher_disagreement_score":0.79193825,"about_ca_system_score_codex":0.00012221531,"about_ca_system_score_gemma":0.0006367261,"threshold_uncertainty_score":0.97860324},"labels":[],"label_agreement":null},{"id":"W2340281023","doi":"10.1161/res.111.suppl_1.a346","title":"Abstract 346: Lipophilic Statins Attenuate Human Atrial Fibroblast Viability In Vitro","year":2012,"lang":"en","type":"article","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Viability assay; Pravastatin; Atorvastatin; Statin; Simvastatin; Autophagy; Apoptosis; HMG-CoA reductase; Pharmacology; Pitavastatin; Programmed cell death; ATG5; Chemistry; Medicine; Reductase; Biology; Cholesterol; Internal medicine; Biochemistry; Enzyme","score_opus":0.1079045671850428,"score_gpt":0.4085667987150118,"score_spread":0.30066223152996896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340281023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539334,0.0003424289,0.000072850664,0.00069277204,0.000094496776,0.0013776332,0.000012066833,0.000050296978,0.0019641232],"genre_scores_gemma":[0.9981057,0.000014894342,0.00012277487,0.000039501563,0.0014447289,0.00005114414,0.00010936859,0.000029113693,0.00008277466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967181,0.00041379774,0.00044458837,0.00033814512,0.0013121587,0.0007732167],"domain_scores_gemma":[0.9984354,0.00015379323,0.000056650177,0.00070271717,0.00028719372,0.00036425953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006026588,0.0001281004,0.00033097566,0.00033591478,0.00022575758,0.000039156792,0.00009905255,0.0001559798,0.0003520994],"category_scores_gemma":[0.0005255274,0.00011915072,0.00025136647,0.0006286744,0.00012314419,0.0002322316,0.00006467562,0.00070606754,0.00022917542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012420298,0.0012549267,0.60799927,0.0022131891,0.00027504272,0.000069453825,0.0027142933,0.0010889439,0.30737075,0.0008894622,0.00064141804,0.07424121],"study_design_scores_gemma":[0.001833243,0.00006703562,0.9942443,0.00007474425,0.000012710795,0.000012307373,0.00013677275,0.00033426104,0.0019166885,0.00039456613,0.0008595317,0.00011385807],"about_ca_topic_score_codex":0.0018209617,"about_ca_topic_score_gemma":0.000072511175,"teacher_disagreement_score":0.386245,"about_ca_system_score_codex":0.0004648156,"about_ca_system_score_gemma":0.00023494345,"threshold_uncertainty_score":0.48588255},"labels":[],"label_agreement":null},{"id":"W2340569729","doi":"10.1016/j.cjca.2015.07.547","title":"LIPOPROTEIN(A) AND RECURRENT CARDIOVASCULAR EVENTS","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Interquartile range; Internal medicine; Single-nucleotide polymorphism; Acute coronary syndrome; Lipoprotein(a); Prospective cohort study; Population; Gastroenterology; Proportional hazards model; Rosuvastatin; Lipoprotein; Genotype; Cholesterol; Cardiology; Myocardial infarction","score_opus":0.0332453964459788,"score_gpt":0.2555497468917147,"score_spread":0.22230435044573593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340569729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8231067,0.1413142,0.007748063,0.003354532,0.0036225442,0.0009940404,0.000023131097,0.000021313384,0.019815467],"genre_scores_gemma":[0.9960843,0.0005247922,0.00053398235,0.00018767346,0.0025752601,0.0000061225282,0.000003688624,0.00002129016,0.00006293578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847645,0.00024220653,0.00035627265,0.00017563469,0.00037234748,0.00037706803],"domain_scores_gemma":[0.99707246,0.000012592739,0.0000977595,0.00040602,0.00049442955,0.0019167193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019403702,0.00014272257,0.000909487,0.000275772,0.000062348314,0.000011591971,0.0001031309,0.00016172031,0.0000057277425],"category_scores_gemma":[0.0004034645,0.00011725976,0.0006563186,0.00014194696,0.00011064902,0.00006883496,0.000016186965,0.00036856518,0.000011355505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004597504,0.0000113625165,0.08202749,0.00028258743,0.008293253,0.004710736,0.0007931004,0.0010837332,0.000051984982,0.0007061428,0.030394549,0.8711853],"study_design_scores_gemma":[0.002833795,0.0010187031,0.05585557,0.000112803544,0.0006236992,0.013529837,0.00023257149,0.00000694318,0.000046369933,0.000561367,0.92502,0.00015833977],"about_ca_topic_score_codex":0.0022065851,"about_ca_topic_score_gemma":0.00036662287,"teacher_disagreement_score":0.8946254,"about_ca_system_score_codex":0.00025808733,"about_ca_system_score_gemma":0.0026198006,"threshold_uncertainty_score":0.47817144},"labels":[],"label_agreement":null},{"id":"W2342166197","doi":"10.1001/jamacardio.2016.0096","title":"Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus","year":2016,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Rosuvastatin; Internal medicine; Rosuvastatin Calcium; Insulin resistance; Type 2 Diabetes Mellitus; Placebo; Type 2 diabetes; Diabetes mellitus; Endocrinology; Lipoprotein; Triglyceride; Insulin; Cholesterol; Gastroenterology","score_opus":0.006488361829854857,"score_gpt":0.22266970199186115,"score_spread":0.2161813401620063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342166197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870481,0.007815083,0.00039776543,0.0024963052,0.00011242117,0.0004671229,0.000025190675,0.000034017317,0.0016039929],"genre_scores_gemma":[0.9944824,0.0029463442,0.0010494603,0.00020310619,0.0003847908,0.000040870767,0.000011648014,0.000020250252,0.00086111674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986257,0.00022471877,0.00027226916,0.00026472,0.00033371575,0.00027890544],"domain_scores_gemma":[0.9988806,0.00013682952,0.00018461198,0.00036744372,0.00032469787,0.00010580607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010009091,0.00012469164,0.00064803846,0.00007825062,0.000038263795,0.0000070012284,0.000047243815,0.00019064867,0.000016068081],"category_scores_gemma":[0.0005530982,0.000074043775,0.000103115104,0.00016546887,0.00008896671,0.00006395352,0.000036772148,0.00012725056,0.000010307703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015787784,0.0000647664,0.6743469,0.0006804988,0.0022743512,0.00011439749,0.00025377888,0.000004814626,0.017341789,0.00097317924,0.0056406762,0.29672605],"study_design_scores_gemma":[0.005182836,0.0010725172,0.87474716,0.00035644547,0.00033439786,0.000048929574,0.000067361056,0.0000022610604,0.008254932,0.00039576314,0.109342135,0.00019527177],"about_ca_topic_score_codex":0.00006950459,"about_ca_topic_score_gemma":0.000071704686,"teacher_disagreement_score":0.29653075,"about_ca_system_score_codex":0.00014610103,"about_ca_system_score_gemma":0.00014645998,"threshold_uncertainty_score":0.30194175},"labels":[],"label_agreement":null},{"id":"W2343463190","doi":"10.1161/atvb.34.suppl_1.433","title":"Abstract 433: Examination of Factors Affecting the Association of PCSK9 With Low-Density Lipoprotein Particles in Human Plasma","year":2014,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Golder Associates (Canada); University of Ottawa","funders":"","keywords":"PCSK9; LDL receptor; Chemistry; Lipoprotein; Low-density lipoprotein; Intermediate-density lipoprotein; Endocrinology; Kexin; Cholesterol; Internal medicine; Very low-density lipoprotein; Biochemistry; Biology; Medicine","score_opus":0.020826463641378624,"score_gpt":0.25739182702345725,"score_spread":0.23656536338207862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343463190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991601,0.000020024427,0.000109071225,0.00012380282,0.00003223373,0.00046773723,0.0000032460725,0.0000145254835,0.00006927675],"genre_scores_gemma":[0.9996436,0.0001246069,0.0001050633,0.00003370734,0.00004709446,0.000016614238,0.000014624872,0.000013896066,7.984622e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858314,0.0003539289,0.00036117213,0.00025080447,0.00022639739,0.00022453946],"domain_scores_gemma":[0.9990823,0.00013615238,0.00029054383,0.0003353838,0.000103278195,0.000052308143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019998576,0.0001443178,0.00056613516,0.00007987433,0.00010388342,0.000010859144,0.00006199879,0.00015406996,0.000009757837],"category_scores_gemma":[0.0001325291,0.00009094148,0.00015805072,0.00016792591,0.00012008326,0.00005824046,0.00003475146,0.00014699785,7.209901e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000059721033,0.0001613012,0.6435984,0.00019595036,0.00026547906,2.5805706e-8,0.0011450675,0.000005038477,0.34936625,0.00019033576,0.0000014954936,0.005064742],"study_design_scores_gemma":[0.0013478276,0.0005169474,0.95478034,0.00021476866,0.000121441604,2.6704953e-7,0.0004640261,0.00006431005,0.042359214,0.000019251107,0.000021063943,0.0000905427],"about_ca_topic_score_codex":0.0013242639,"about_ca_topic_score_gemma":0.00084038824,"teacher_disagreement_score":0.311182,"about_ca_system_score_codex":0.000050811377,"about_ca_system_score_gemma":0.000019513283,"threshold_uncertainty_score":0.3708486},"labels":[],"label_agreement":null},{"id":"W2346021950","doi":"10.1016/j.cjca.2016.04.013","title":"Monoclonal Antibodies for the Treatment of Hypercholesterolemia: Targeting PCSK9","year":2016,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; McGill University Health Centre","funders":"","keywords":"Medicine; PCSK9; Magic bullet; LDL receptor; Monoclonal antibody; Kexin; Endocytosis; Familial hypercholesterolemia; Proprotein convertase; Pharmacology; Antibody; Monoclonal; Immunology; Lipoprotein; Receptor; Cholesterol; Bioinformatics; Internal medicine; Biology","score_opus":0.05795196350972396,"score_gpt":0.3307497004621002,"score_spread":0.27279773695237625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346021950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007707805,0.996385,0.00094519794,0.0003347811,0.0009031977,0.00091089983,0.00018789002,0.0000022205218,0.00025375854],"genre_scores_gemma":[0.00034801767,0.99314666,0.00028419943,0.000043303924,0.0058782254,0.000044758868,0.000016750611,0.000042011863,0.0001960622],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981509,0.0002385265,0.00086662086,0.0001747332,0.00015623002,0.0004130236],"domain_scores_gemma":[0.9978617,0.00043985786,0.00053484377,0.0004017626,0.00033564458,0.0004262362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087360776,0.00027887168,0.0032696626,0.00027282117,0.0001117045,0.000009191593,0.00019954574,0.0003424886,0.000014572079],"category_scores_gemma":[0.0002285645,0.00011704799,0.0026284964,0.0000876348,0.00020461848,0.00002490245,0.0000064923206,0.0002380752,0.0000037027648],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046550027,0.0000025998079,0.00009128661,0.0022220036,0.0030535087,0.0001698282,0.000048331345,0.0000039540882,6.5845467e-7,0.000021623677,0.0021061527,0.9922335],"study_design_scores_gemma":[0.0008940093,0.0012387289,0.000081281476,0.0037105642,0.0032626432,0.0035141583,0.000047427548,2.2613888e-7,0.0000024508595,0.000012233361,0.9871326,0.00010368384],"about_ca_topic_score_codex":0.00033439128,"about_ca_topic_score_gemma":0.00023600689,"teacher_disagreement_score":0.9921298,"about_ca_system_score_codex":0.0004729881,"about_ca_system_score_gemma":0.0059158914,"threshold_uncertainty_score":0.9997196},"labels":[],"label_agreement":null},{"id":"W2346332843","doi":"10.1161/circulationaha.116.021407","title":"Recent Update to the US Cholesterol Treatment Guidelines","year":2016,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Guideline; Medicine; Statin; Risk assessment; National Cholesterol Education Program; Canadian Cardiovascular Society; Absolute risk reduction; Evidence-based medicine; Intensive care medicine; Family medicine; Internal medicine; Alternative medicine; Confidence interval; Pathology; Metabolic syndrome","score_opus":0.10862208060284367,"score_gpt":0.38582151862975217,"score_spread":0.2771994380269085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346332843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005102653,0.9925069,0.0006659377,0.002858981,0.00044855796,0.0030792675,0.000025512956,0.000048926246,0.00031489492],"genre_scores_gemma":[0.000034843993,0.9958372,0.000091950445,0.00084464555,0.002282766,0.00042248098,0.00021858382,0.000050677703,0.0002168581],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833363,0.00014825593,0.00056117424,0.00037280776,0.00036574923,0.0002183802],"domain_scores_gemma":[0.9983919,0.000016825312,0.00016959343,0.0010678343,0.0002021624,0.00015167138],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00048552878,0.0002752586,0.0009931913,0.000097161064,0.00008953727,0.000026379552,0.000092492955,0.00017292747,0.00009331548],"category_scores_gemma":[0.00008593022,0.00012454244,0.00062795135,0.0002130412,0.000011729571,0.000029581744,0.000026516716,0.00009200758,0.00096792093],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000031380055,0.00001676748,0.00001788099,0.00094885,0.00023358745,0.000004166038,0.000011715085,0.0000042136244,2.134769e-7,0.000016520267,0.0008818392,0.9978611],"study_design_scores_gemma":[0.00035852997,0.00004325355,0.00063088606,0.0060649537,0.0010078853,0.00012571119,0.0000012911486,0.0000048938964,7.191699e-7,0.0000058366413,0.9916248,0.0001312709],"about_ca_topic_score_codex":0.00004148079,"about_ca_topic_score_gemma":0.000013773967,"teacher_disagreement_score":0.99772984,"about_ca_system_score_codex":0.00059182954,"about_ca_system_score_gemma":0.0003522428,"threshold_uncertainty_score":0.9998099},"labels":[],"label_agreement":null},{"id":"W2346421763","doi":"10.1016/j.jcrc.2016.04.031","title":"The association between prior statin use and long-term outcomes after critical care admission","year":2016,"lang":"en","type":"article","venue":"Journal of Critical Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Sepsis; Intensive care unit; Emergency medicine; Medical prescription; Statin; Multivariate analysis; Referral; Univariate analysis; Odds ratio; Internal medicine; Intensive care medicine","score_opus":0.02943371084815855,"score_gpt":0.3565454277026065,"score_spread":0.32711171685444795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346421763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759351,0.0060370434,0.00058215903,0.016896214,0.00026552274,0.00018438113,0.000045243105,0.000010627248,0.00004369492],"genre_scores_gemma":[0.9982819,0.00009881654,0.00043035514,0.00039373458,0.00069006055,0.000005723388,0.000001880563,0.00001907217,0.00007843662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797034,0.00021587306,0.00044318667,0.00014019028,0.0009160148,0.00031438764],"domain_scores_gemma":[0.9964059,0.0013856377,0.000075846,0.00021818446,0.0014337047,0.000480733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055541313,0.00012744484,0.0004137854,0.00005072969,0.00015693504,0.00009807141,0.00006639571,0.00014735395,0.000038427002],"category_scores_gemma":[0.007851227,0.00005952157,0.0002863367,0.00004616722,0.00010843498,0.0002481369,0.000043998785,0.00032135888,0.000004632723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015332787,0.000023270315,0.9422974,0.00063427014,0.00006247992,0.00021735796,0.0004761578,7.581838e-9,0.000053438085,0.00013709176,0.000052040243,0.055893153],"study_design_scores_gemma":[0.0013305111,0.00046016285,0.9945112,0.00037446324,0.0006318225,0.00008371584,0.0008643544,1.2606054e-7,0.00031881468,0.000098410936,0.0012369778,0.00008946452],"about_ca_topic_score_codex":0.0000057827538,"about_ca_topic_score_gemma":0.000011032953,"teacher_disagreement_score":0.05580369,"about_ca_system_score_codex":0.00033175445,"about_ca_system_score_gemma":0.00022058246,"threshold_uncertainty_score":0.939922},"labels":[],"label_agreement":null},{"id":"W2346519745","doi":"10.1016/j.ijcard.2016.05.003","title":"A contemporary cross-sectional study on dyslipidemia management, cardiovascular risk status, and patients' quality of life in Greece: The CHALLENGE study","year":2016,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca","keywords":"Medicine; Dyslipidemia; Guideline; Quality of life (healthcare); Cross-sectional study; Odds ratio; Internal medicine; Confidence interval; Physical therapy; Canadian Cardiovascular Society; Disease; Pathology; Myocardial infarction","score_opus":0.05195537176097008,"score_gpt":0.3534630252868982,"score_spread":0.3015076535259281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346519745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948929,0.0017386317,0.0003447699,0.00026992158,0.0008540001,0.0009397979,0.000039020684,0.000005832398,0.00091515994],"genre_scores_gemma":[0.9982282,0.0008363171,0.000016757833,0.000085028594,0.00077083707,0.00002928722,0.0000026850703,0.000014622457,0.000016251355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954351,0.0014658944,0.0012289465,0.00029302173,0.0013873485,0.00018968811],"domain_scores_gemma":[0.997748,0.00032385808,0.00059312274,0.00045412386,0.00075440685,0.0001264902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063701645,0.00016237418,0.0009444617,0.00029230028,0.000046602596,0.000013887928,0.00025243394,0.00008786897,0.00000939517],"category_scores_gemma":[0.00083904125,0.000088287205,0.0006219736,0.00009234966,0.00014158405,0.00011045709,0.00013351216,0.00037221445,0.000002467805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019551348,0.0005268031,0.97711974,0.000020934462,0.008638542,0.00012062609,0.0002568075,0.00008128906,0.0000034325078,0.00009451226,0.00007969126,0.011102477],"study_design_scores_gemma":[0.015022509,0.001904029,0.9801875,0.000050636794,0.00014376667,0.000029816478,0.0010550193,8.6591666e-7,0.0000021635792,0.00015699823,0.0013658397,0.000080906895],"about_ca_topic_score_codex":0.00035304896,"about_ca_topic_score_gemma":0.000022256458,"teacher_disagreement_score":0.013067374,"about_ca_system_score_codex":0.00018572387,"about_ca_system_score_gemma":0.00015188944,"threshold_uncertainty_score":0.36002478},"labels":[],"label_agreement":null},{"id":"W2346760803","doi":"10.1007/s12265-016-9694-0","title":"Translating Trial Results in Clinical Practice: the Risk GP Model","year":2016,"lang":"en","type":"article","venue":"Journal of Cardiovascular Translational Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Comisión Nacional de Investigación Científica y Tecnológica; Canadian Institutes of Health Research","keywords":"Inference; Generalization; Clinical trial; Population; Translation (biology); Medicine; Clinical Practice; Computer science; Artificial intelligence; Epistemology; Family medicine; Pathology","score_opus":0.15548314973562927,"score_gpt":0.4591848055638933,"score_spread":0.303701655828264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346760803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55262786,0.0809117,0.2259093,0.110627495,0.0013232456,0.006525144,0.00012489752,0.00004682422,0.021903547],"genre_scores_gemma":[0.98015046,0.009247796,0.0076900017,0.00009036343,0.0026533322,0.00002654706,0.0000029019263,0.000038145172,0.00010044087],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98712134,0.0039757416,0.002042315,0.00037590708,0.0059413468,0.0005433168],"domain_scores_gemma":[0.9933113,0.003168309,0.00032190426,0.00090193324,0.0019762204,0.00032034286],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08632044,0.0001769923,0.00094316754,0.00041128203,0.00022648933,0.000046014433,0.00032843061,0.0002565824,0.000015888836],"category_scores_gemma":[0.011009123,0.00008916878,0.003430539,0.0006986161,0.00029032133,0.00042188962,0.000025275487,0.002051483,0.000014999445],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08918126,0.0005516756,0.0006934199,0.00006630451,0.005494146,0.00047682447,0.00068291253,0.011941384,0.00008278909,0.00067323266,0.00046089536,0.88969517],"study_design_scores_gemma":[0.49342766,0.0047401153,0.047226198,0.0015703877,0.003710552,0.0026749142,0.0008409387,0.009816603,0.00021133083,0.008276575,0.42690453,0.00060019776],"about_ca_topic_score_codex":0.00008508034,"about_ca_topic_score_gemma":0.000018256815,"teacher_disagreement_score":0.88909495,"about_ca_system_score_codex":0.00016490096,"about_ca_system_score_gemma":0.002514469,"threshold_uncertainty_score":0.99732155},"labels":[],"label_agreement":null},{"id":"W2347189412","doi":"","title":"Study on the impact of the publication of the enhance trial results in a health area of spain","year":2015,"lang":"en","type":"article","venue":"European journal of clinical pharmacy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Medicine; Clinical trial; Demography; Internal medicine; Cholesterol","score_opus":0.2854574942268047,"score_gpt":0.5003098354271182,"score_spread":0.21485234120031343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2347189412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837439,0.00024777968,0.000019850655,0.012058123,0.00040137628,0.0011677133,0.000008980383,0.0000021499357,0.0023500999],"genre_scores_gemma":[0.9985633,0.00013561577,0.000019889827,0.0005456381,0.0006555016,0.0000012958627,4.630956e-7,0.000013970857,0.00006433617],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9879577,0.007982757,0.0028365336,0.00013487657,0.0009389676,0.00014913215],"domain_scores_gemma":[0.9951042,0.0005937069,0.0028343007,0.0007540715,0.00052564277,0.00018810363],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04306279,0.00010237034,0.00069347036,0.000060658713,0.000031087617,0.000006484399,0.0005018055,0.000015190109,0.000011980111],"category_scores_gemma":[0.011975788,0.00003934966,0.00084608456,0.00039601827,0.0001315083,0.000052691314,0.000085976775,0.0008106533,0.000002074934],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33466613,0.02498256,0.1774041,0.00030745758,0.0030577083,0.00011795057,0.014024052,0.0010024806,0.00089865556,0.00012876317,0.062186264,0.3812239],"study_design_scores_gemma":[0.116933964,0.012669786,0.86109316,0.00085506315,0.00015441833,0.000039698796,0.000726523,0.00007942295,0.0008939256,0.000041279207,0.006433893,0.00007888143],"about_ca_topic_score_codex":0.00015695939,"about_ca_topic_score_gemma":0.000004665851,"teacher_disagreement_score":0.68368906,"about_ca_system_score_codex":0.000059446214,"about_ca_system_score_gemma":0.0012587155,"threshold_uncertainty_score":0.9963468},"labels":[],"label_agreement":null},{"id":"W2347194428","doi":"10.1136/jim-52-suppl1-370","title":"370 LOVASTATIN-INDUCED CARDIAC CELL DEATH IS MEDIATED THROUGH INHIBITION OF PROTEIN SYNTHESIS.","year":2004,"lang":"en","type":"article","venue":"Journal of Investigative Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lovastatin; Chemistry; Cell biology; Pharmacology; Medicine; Biochemistry; Biology; Cholesterol","score_opus":0.050508276415361784,"score_gpt":0.28370037818818805,"score_spread":0.23319210177282626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2347194428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772187,0.0026400203,0.0007598496,0.016318643,0.00021820002,0.00085956993,0.000018600422,0.00001862032,0.0019478367],"genre_scores_gemma":[0.98824924,0.00039660817,0.008741774,0.0015385235,0.0009432482,0.000022694736,0.000010545098,0.000043433378,0.000053951408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962375,0.00028225424,0.0013035132,0.00025176277,0.0015972252,0.0003277395],"domain_scores_gemma":[0.9966744,0.00013439049,0.0012042631,0.00039545397,0.0011162392,0.0004752164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018946466,0.00030368834,0.0015127133,0.00027917812,0.000071806884,0.0000063888087,0.00011544925,0.00016510449,0.0001144127],"category_scores_gemma":[0.0020588224,0.00020150439,0.00045033297,0.0006025416,0.00058012665,0.00024291234,0.000030067402,0.00073486665,0.00001304758],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027740415,0.0003027985,0.0009026194,0.0010163368,0.0007494638,0.00034203733,0.007165913,0.00001107946,0.9853568,0.0009452255,0.0011192838,0.0018110547],"study_design_scores_gemma":[0.0052435463,0.0029319178,0.007990621,0.004887512,0.00067493995,0.00017192341,0.0019786353,0.0000031795314,0.969153,0.0058160406,0.0009691928,0.00017947862],"about_ca_topic_score_codex":0.0006588941,"about_ca_topic_score_gemma":0.0000042411793,"teacher_disagreement_score":0.01620377,"about_ca_system_score_codex":0.00029522993,"about_ca_system_score_gemma":0.0012281807,"threshold_uncertainty_score":0.82171106},"labels":[],"label_agreement":null},{"id":"W2349500629","doi":"10.1161/circ.132.suppl_3.17499","title":"Abstract 17499: ETC-1002 Incrementally Lowers Low Density Lipoprotein-cholesterol in Patients With Hypercholesterolemia Receiving Stable Statin Therapy","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"","keywords":"Medicine; Simvastatin; Placebo; Atorvastatin; Statin; Rosuvastatin; Internal medicine; Clinical endpoint; Apolipoprotein B; Pravastatin; Adverse effect; Cholesterol; Lipoprotein; Endocrinology; Pharmacology; Gastroenterology; Clinical trial","score_opus":0.020802627148715735,"score_gpt":0.24429053244207044,"score_spread":0.22348790529335472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2349500629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967177,0.000112511916,0.0005583984,0.00011864777,0.0001070229,0.0017680405,0.000006052517,0.00006792026,0.00054370787],"genre_scores_gemma":[0.998561,0.000018421992,0.0005697399,0.0004627867,0.000121262594,0.000050491602,0.00015043454,0.000052069776,0.000013786556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976607,0.00012680427,0.00041940412,0.00043746937,0.0009724637,0.0003831694],"domain_scores_gemma":[0.99866307,0.000019586232,0.00016905565,0.00057138165,0.00030625166,0.0002706398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010927201,0.0002373457,0.0004026014,0.00016201864,0.00007809185,0.00006108866,0.000084745654,0.00014834917,0.000036924568],"category_scores_gemma":[0.00007864699,0.00020297909,0.000086116816,0.00028046998,0.00004223887,0.0004050647,0.000026444419,0.00033423406,0.000035935645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063741894,0.0003364866,0.9261542,0.00010806354,0.00007342678,0.000015258482,0.00081596634,0.0006484368,0.0012111056,0.00000264523,0.00003520545,0.0699618],"study_design_scores_gemma":[0.008792329,0.00026479672,0.98889744,0.00033625768,0.000026247828,0.000007867284,0.00018745847,0.00013954357,0.0009721138,0.000030178177,0.0001337411,0.000212048],"about_ca_topic_score_codex":0.002845866,"about_ca_topic_score_gemma":0.00048574642,"teacher_disagreement_score":0.06974975,"about_ca_system_score_codex":0.00066210306,"about_ca_system_score_gemma":0.00027538138,"threshold_uncertainty_score":0.8277247},"labels":[],"label_agreement":null},{"id":"W2357785654","doi":"10.1002/clc.22533","title":"Association Between Very Low Levels of High‐Density Lipoprotein Cholesterol and Long‐term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the <scp>TRILOGY ACS</scp> Trial","year":2016,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Medtronic Foundation; National Institutes of Health; British Heart Foundation; Abiomed; Regado Biosciences; Duke Clinical Research Institute; Medicines Company; Abbott Laboratories; Regeneron Pharmaceuticals; Amgen; Ariad Pharmaceuticals; Janssen Pharmaceuticals; Gilead Sciences; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Pfizer; Daiichi Sankyo Europe; Sanofi","keywords":"Medicine; Hazard ratio; Internal medicine; Acute coronary syndrome; Interquartile range; Myocardial infarction; Cardiology; Stroke (engine); Ezetimibe; Clopidogrel; Aspirin; Revascularization; Proportional hazards model; Confidence interval; Cholesterol","score_opus":0.031926401764888604,"score_gpt":0.29522473032757307,"score_spread":0.2632983285626845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2357785654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959158,0.00019098552,0.0009192572,0.0002458674,0.00035788666,0.0020006956,0.00032490163,0.000032838117,0.000011774464],"genre_scores_gemma":[0.99866706,0.00021633143,0.00006811969,0.00020000861,0.00046429253,0.000045191704,0.00021072301,0.000033248474,0.00009499728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99596214,0.0014516067,0.0011207211,0.00057334034,0.0005907942,0.00030137776],"domain_scores_gemma":[0.99575907,0.0018879845,0.0007676557,0.00093403546,0.00047161005,0.00017964127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001189526,0.00027505954,0.0024169364,0.00006840334,0.00007828073,0.0000075337766,0.00017678532,0.0006736775,0.000006395051],"category_scores_gemma":[0.0015190728,0.00014153456,0.0005204068,0.00015752164,0.00040723925,0.00010218406,0.00014214966,0.0003433559,0.000006545115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016808168,0.000118326745,0.98147005,0.000040928462,0.0067286543,0.000045174056,0.000033637512,4.3373035e-7,0.000042584572,0.000005753433,0.000022176553,0.009811494],"study_design_scores_gemma":[0.047514033,0.0028787141,0.94623935,0.00013815878,0.0027823285,0.000023423238,0.0000051918914,2.5912894e-7,0.00020739283,0.00010677747,0.000030904153,0.00007345098],"about_ca_topic_score_codex":0.00024656276,"about_ca_topic_score_gemma":0.000047612255,"teacher_disagreement_score":0.045833215,"about_ca_system_score_codex":0.00010220409,"about_ca_system_score_gemma":0.00017920644,"threshold_uncertainty_score":0.5771612},"labels":[],"label_agreement":null},{"id":"W2373508336","doi":"","title":"Effects and Safety Assessment of Nine Lipid-Lowing Agents","year":2005,"lang":"en","type":"article","venue":"Zhongguo xunzheng yixue zazhi","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pravastatin; Gemfibrozil; Fluvastatin; Medicine; Fenofibrate; Lovastatin; Simvastatin; Rosuvastatin; Bezafibrate; Atorvastatin; Cerivastatin; Statin; Internal medicine; Pharmacology; Adverse effect; Cholesterol","score_opus":0.010371982797420435,"score_gpt":0.28998603240453197,"score_spread":0.27961404960711156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2373508336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837893,0.0023392453,0.0023080634,0.0010191874,0.00029838659,0.0010584089,0.000009088023,0.00009646531,0.00908184],"genre_scores_gemma":[0.9890585,0.00055191206,0.007912747,0.00058178493,0.0009327207,0.000032434546,0.00002084117,0.0000453366,0.00086374185],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99805707,0.00012340049,0.00044154722,0.0003797088,0.0006091537,0.0003891049],"domain_scores_gemma":[0.99890906,0.000084391475,0.00011471513,0.00052016106,0.00008916324,0.00028252538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008783394,0.00022934577,0.0006709474,0.0001338048,0.0001255908,0.00001745026,0.00009443306,0.00013260843,0.000118559146],"category_scores_gemma":[0.00010213751,0.00019654144,0.0002643235,0.00021971682,0.00006296987,0.00012828004,0.000096407246,0.0003135763,0.000018691462],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047952635,0.001404854,0.12139026,0.006466197,0.0023536768,0.00031241906,0.0017767405,0.00044905525,0.031360343,0.0025638205,0.0043984,0.8270447],"study_design_scores_gemma":[0.007421653,0.0005622736,0.89312536,0.00083866104,0.00058849953,0.00016949078,0.0001240487,0.002666603,0.00954663,0.000023042756,0.08455129,0.00038245236],"about_ca_topic_score_codex":0.00013159303,"about_ca_topic_score_gemma":0.000013259236,"teacher_disagreement_score":0.82666224,"about_ca_system_score_codex":0.00014211088,"about_ca_system_score_gemma":0.00015260099,"threshold_uncertainty_score":0.8014727},"labels":[],"label_agreement":null},{"id":"W2387534195","doi":"","title":"The association of the lipoprotein lipase S447X and cholesteryl ester transfer protein TaqIB polymorphism with coronary heart disease","year":2004,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CAE (Canada)","funders":"","keywords":"Lipoprotein lipase; Genotype; Internal medicine; Cholesterylester transfer protein; Allele; Endocrinology; Coronary heart disease; Medicine; Polymorphism (computer science); Restriction fragment length polymorphism; Lipoprotein; Chemistry; Cholesterol; Biology; Genetics; Gene","score_opus":0.00617344005395897,"score_gpt":0.20748947780729282,"score_spread":0.20131603775333384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2387534195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671605,0.001277554,0.00039774788,0.027923137,0.00005150321,0.0027881223,0.000011000184,0.000038108905,0.00035227984],"genre_scores_gemma":[0.99550676,0.00005199922,0.00020324656,0.0014205818,0.00015671592,0.00021916318,0.0000036109893,0.000030228568,0.0024077187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982477,0.0001229095,0.00028660384,0.000265506,0.00077162683,0.00030566187],"domain_scores_gemma":[0.9989023,0.000025248368,0.000063359636,0.00067314546,0.00011084888,0.00022507228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064226566,0.00017943418,0.00030345796,0.000031761345,0.00024171913,0.00003625221,0.000096718795,0.00008883253,0.000015954442],"category_scores_gemma":[0.00005789807,0.00008340686,0.00019534514,0.0001788132,0.00014143226,0.00010344881,0.000035938683,0.00025403235,0.0000046237255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025110373,0.0064005647,0.56684726,0.006403082,0.0058756634,0.0008241194,0.0062486078,0.0006093559,0.102855176,0.029596385,0.0019074432,0.247322],"study_design_scores_gemma":[0.008183246,0.0007644485,0.97000664,0.0008376143,0.0004086057,0.00020090879,0.00016677502,0.000017702296,0.0137623595,0.00041982438,0.0049653165,0.00026652793],"about_ca_topic_score_codex":0.00074786146,"about_ca_topic_score_gemma":0.0003210273,"teacher_disagreement_score":0.40315944,"about_ca_system_score_codex":0.0001385947,"about_ca_system_score_gemma":0.00041231408,"threshold_uncertainty_score":0.34012333},"labels":[],"label_agreement":null},{"id":"W2395063215","doi":"","title":"Reduction of myocardial ischemia with simvastatin in addition to conventional treatment in patients with chronic coronary artery disease.","year":2004,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Simvastatin; Medicine; Coronary artery disease; Internal medicine; Cardiology; Dyslipidemia; Cholesterol; Placebo; Ischemia; Disease; Coronary atherosclerosis; Angina; Risk factor; Artery; Randomized controlled trial; Myocardial infarction; Pathology","score_opus":0.007884101124775908,"score_gpt":0.20258979812619712,"score_spread":0.1947056970014212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395063215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969195,0.00011154358,0.00006412982,0.0002833099,0.00004796119,0.0024302956,0.000047691643,0.000011733607,0.00008383878],"genre_scores_gemma":[0.99708366,0.000015216102,0.00015848942,0.000043528267,0.00011988692,0.0021767172,0.00036053435,0.000013959068,0.000028031762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989937,0.000029917612,0.00018734024,0.00021488684,0.00035619971,0.00021796528],"domain_scores_gemma":[0.9995469,0.000005090883,0.000050324732,0.00018136475,0.000052204396,0.00016415387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011627803,0.00010456978,0.0002351968,0.00012559335,0.000015096968,0.000003485471,0.000019332052,0.000030377465,0.000016199105],"category_scores_gemma":[0.0000100713105,0.00007745651,0.00006389062,0.00021359272,0.000034356337,0.00007366468,0.000006434453,0.00006327385,0.0000024002381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01316457,0.0029488106,0.595946,0.0003493751,0.00053530955,0.00017957934,0.00033032362,0.005006197,0.000055625125,0.0000681338,0.00013935778,0.3812767],"study_design_scores_gemma":[0.011185028,0.0006736657,0.98719174,0.00014539526,0.00006928924,0.000008960377,0.00003924259,0.0000024334163,0.0003872646,0.00001921203,0.00019665333,0.000081097205],"about_ca_topic_score_codex":0.00026064957,"about_ca_topic_score_gemma":0.00011625662,"teacher_disagreement_score":0.39124572,"about_ca_system_score_codex":0.0009129254,"about_ca_system_score_gemma":0.0003067827,"threshold_uncertainty_score":0.31585848},"labels":[],"label_agreement":null},{"id":"W2396635029","doi":"10.1016/j.jacl.2016.03.038","title":"Environmental and Biological Markers of Survival in Septuagenarians and Octogenarians Carrying FH-Causing LDLR Gene Mutations*","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; LDL receptor; Gene; Gene mutation; Internal medicine; Genetics; Mutation; Cholesterol; Biology","score_opus":0.07337287944068112,"score_gpt":0.35197181323120424,"score_spread":0.27859893379052314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396635029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946256,0.0011977084,0.0011505687,0.0020716717,0.0006996759,0.00015794829,0.000010562047,0.000003403312,0.00008282011],"genre_scores_gemma":[0.9934186,0.0028482699,0.0022801736,0.0002921117,0.0011263533,0.0000013276529,0.0000013997619,0.000010512575,0.000021273261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744767,0.0006708535,0.0012588211,0.0002034219,0.00021097671,0.00020825074],"domain_scores_gemma":[0.9981871,0.00096380117,0.0004328882,0.00015587662,0.00004044207,0.00021984655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036851345,0.00011182346,0.000950251,0.00011888396,0.000033841065,0.0000039506963,0.000047864978,0.00025450104,0.00007843337],"category_scores_gemma":[0.0010867115,0.00006648758,0.0002503547,0.00005508298,0.00045587152,0.00006112538,0.00005810897,0.00030739952,0.000001387553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016513775,0.00025791678,0.8519433,0.000047998892,0.00040831562,0.000190113,0.0001875708,0.0000036350318,0.032063555,0.00007594782,0.00004674038,0.113123536],"study_design_scores_gemma":[0.006569211,0.0021724943,0.98578477,0.00012835463,0.00017615623,0.0018923669,0.00042799898,0.000017096821,0.00032671224,0.00025960704,0.00214203,0.000103209444],"about_ca_topic_score_codex":0.000021759095,"about_ca_topic_score_gemma":0.000011021547,"teacher_disagreement_score":0.13384147,"about_ca_system_score_codex":0.000035644924,"about_ca_system_score_gemma":0.00013100842,"threshold_uncertainty_score":0.27112848},"labels":[],"label_agreement":null},{"id":"W2396697388","doi":"","title":"The evaluation of physician patterns of practice in cardiac patients at two British Columbia tertiary referral hospitals.","year":2001,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Heart failure; Myocardial infarction; Referral; Acute coronary syndrome; Internal medicine; Unstable angina; Angina; Tertiary referral hospital; Tertiary care; Cardiology; Retrospective cohort study; Emergency medicine; Intensive care medicine","score_opus":0.016424322930849826,"score_gpt":0.26931673351607377,"score_spread":0.25289241058522394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396697388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930478,0.0015548356,0.0000014268071,0.00018952327,0.00021793385,0.0022859385,0.000021259371,0.000008178447,0.0026731587],"genre_scores_gemma":[0.99791896,0.0006152042,0.00000933985,0.00019975293,0.00013354552,0.0008701462,0.000039484374,0.0000149970065,0.000198574],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978978,0.00036515685,0.0003322043,0.00017323864,0.0009705622,0.0002610201],"domain_scores_gemma":[0.9988914,0.000061317274,0.00019054358,0.00038912133,0.00039602185,0.00007160374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002431305,0.000061202736,0.00028751578,0.000021997617,0.000053427597,0.000020761336,0.000066402725,0.000043834694,0.000008361401],"category_scores_gemma":[0.00049578503,0.00006586966,0.00016383553,0.00014224442,0.000034325174,0.000118269905,0.000044089767,0.00010340351,0.0000011899169],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028608352,0.00011232037,0.4735154,0.000027610975,0.00008316977,0.0000028491047,0.000087834764,0.0000024623514,0.0000035950138,6.1420434e-7,0.00022826555,0.5259073],"study_design_scores_gemma":[0.0023464751,0.000051600087,0.99373513,0.000061715924,0.0002472338,0.0000045417223,0.00016879875,0.000015942911,0.00009114967,0.000019284224,0.0031974355,0.00006070304],"about_ca_topic_score_codex":0.03311,"about_ca_topic_score_gemma":0.010681243,"teacher_disagreement_score":0.5258466,"about_ca_system_score_codex":0.00020902742,"about_ca_system_score_gemma":0.00006136173,"threshold_uncertainty_score":0.9733286},"labels":[],"label_agreement":null},{"id":"W2399984624","doi":"","title":"How to reach LDL targets quickly in patients with diabetes or metabolic syndrome.","year":2008,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Atorvastatin; Medicine; Metabolic syndrome; Statin; Diabetes mellitus; Internal medicine; Type 2 diabetes; Ldl cholesterol; Cholesterol; Gastroenterology; Endocrinology","score_opus":0.014486467064510252,"score_gpt":0.1969386358680707,"score_spread":0.18245216880356044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399984624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945537,0.0010198504,0.000019535251,0.0012707345,0.00011178815,0.0025873566,0.000007500528,0.000054857763,0.00037466272],"genre_scores_gemma":[0.99513793,0.000052021518,0.0004957016,0.0008640077,0.00012466329,0.0020180596,0.000023329212,0.000036762198,0.0012475245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981712,0.00006357342,0.00018413065,0.0003329939,0.00060181716,0.00064624747],"domain_scores_gemma":[0.9989311,0.000015023491,0.00004581918,0.0005017492,0.00009514075,0.0004111535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003791077,0.00016868205,0.00057005713,0.00018920867,0.000059732007,0.000016115655,0.00008983518,0.00007049907,0.000009982637],"category_scores_gemma":[0.00020734189,0.000107900945,0.00009517713,0.0005185095,0.000036200643,0.000118811055,0.000036879348,0.00016424338,0.000011719583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002872982,0.0003127255,0.88801306,0.000103834056,0.00021662493,0.00019039994,0.0001791508,0.0000024738,0.0000021383282,0.000011139956,0.0007035274,0.10997762],"study_design_scores_gemma":[0.0028190624,0.00022954788,0.97563225,0.000026131504,0.000059224967,0.000023002405,0.000017164963,0.0000012042374,0.00017470332,0.000002700642,0.020868681,0.00014635295],"about_ca_topic_score_codex":0.00011303663,"about_ca_topic_score_gemma":0.000047337835,"teacher_disagreement_score":0.10983126,"about_ca_system_score_codex":0.00008662691,"about_ca_system_score_gemma":0.00008747795,"threshold_uncertainty_score":0.4400073},"labels":[],"label_agreement":null},{"id":"W2401282172","doi":"","title":"Population health impact of statin treatment in Canada.","year":2016,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Ottawa Hospital; Bruyère; Public Health Agency of Canada; Institute for Clinical Evaluative Sciences; Statistics Canada","funders":"","keywords":"Medicine; Dyslipidemia; Statin; Guideline; Population; Framingham Risk Score; Risk assessment; Disease; Environmental health; Demography; Emergency medicine; Internal medicine","score_opus":0.020539969508415676,"score_gpt":0.2681463426557237,"score_spread":0.247606373147308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401282172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967948,0.0003616137,0.000018676054,0.0016453627,0.000032289612,0.0010055995,0.000023354427,0.000005812805,0.000112472524],"genre_scores_gemma":[0.9992632,0.00012653516,0.000035758567,0.00008553727,0.000042999356,0.00027926904,0.000011236075,0.0000070310484,0.00014843608],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992186,0.00005226633,0.00020039889,0.00009734686,0.00019047945,0.00024089987],"domain_scores_gemma":[0.99955255,0.000015691334,0.00006306716,0.00019002434,0.00001849972,0.0001601693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025988647,0.000058683774,0.00026850955,0.000048776856,0.000009497291,9.589477e-7,0.00001570345,0.000014620939,0.000014889302],"category_scores_gemma":[0.000033281573,0.000031064614,0.00007784167,0.00008887727,0.000004709851,0.000021859953,0.0000033995207,0.000019397059,4.9259677e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036647547,0.000032508775,0.407069,0.00002109368,0.000037865262,0.0000039990414,0.00002113394,0.000005441204,0.0000033952226,0.000010016133,0.00012312744,0.59263575],"study_design_scores_gemma":[0.0015521712,0.00008680384,0.99771273,0.00002135481,0.000007657945,0.000004312998,0.0000142799045,0.0000045502065,0.000085407824,0.000015658801,0.00046520345,0.000029854924],"about_ca_topic_score_codex":0.98784566,"about_ca_topic_score_gemma":0.93153054,"teacher_disagreement_score":0.5926059,"about_ca_system_score_codex":0.0035884338,"about_ca_system_score_gemma":0.0014342476,"threshold_uncertainty_score":0.93836296},"labels":[],"label_agreement":null},{"id":"W2401756357","doi":"","title":"Intensive surveillance and treatment of dyslipidemia in the postinfarct patient: evaluation of a nurse-oriented management approach.","year":2001,"lang":"en","type":"letter","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Dyslipidemia; Myocardial infarction; Coronary artery disease; Internal medicine; Cardiology; Angioplasty; Psychological intervention; Artery; Disease; Nursing","score_opus":0.03570227565189638,"score_gpt":0.25909969434294106,"score_spread":0.22339741869104468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401756357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7065904,0.015620323,0.00010051594,0.2070773,0.00074879196,0.04111508,0.00018348084,0.000046469428,0.028517613],"genre_scores_gemma":[0.91943634,0.0012836568,0.00024579803,0.06527242,0.0011949599,0.011168787,0.0010603656,0.00006746309,0.00027021513],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969726,0.0005991071,0.00052814564,0.00037368498,0.001186218,0.00034023725],"domain_scores_gemma":[0.99836487,0.00007687489,0.0003225798,0.0007057246,0.00048426597,0.000045705405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016845936,0.0002327384,0.0007686922,0.00022316976,0.000021405689,0.0000053024546,0.000077165525,0.00022036443,0.0000050682042],"category_scores_gemma":[0.00018204171,0.0001457425,0.000217864,0.00032054377,0.00009667698,0.000020941323,0.000019230696,0.00027813288,4.2028944e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025342123,0.00032282615,0.009597927,0.0010407986,0.0010912721,0.00011742428,0.0019814337,0.000020109848,4.836296e-7,0.000022861206,0.02693072,0.9586207],"study_design_scores_gemma":[0.007051204,0.000535889,0.7954386,0.00023071349,0.0015224736,0.00009932938,0.0022258824,0.00026372925,0.000019734249,0.000044230117,0.19231507,0.0002531765],"about_ca_topic_score_codex":0.00037381114,"about_ca_topic_score_gemma":0.000018023231,"teacher_disagreement_score":0.9583675,"about_ca_system_score_codex":0.0003092865,"about_ca_system_score_gemma":0.000058011232,"threshold_uncertainty_score":0.5943206},"labels":[],"label_agreement":null},{"id":"W2403248753","doi":"","title":"Novel insights on high-density lipoprotein in coronary heart disease.","year":2002,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Cardiology; Internal medicine; Coronary heart disease; High-density lipoprotein; Medicine; Disease; Cholesterol","score_opus":0.028673790226843743,"score_gpt":0.21437556669035712,"score_spread":0.18570177646351338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403248753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98821783,0.0015699202,0.000042523978,0.004965915,0.00025254377,0.0024817835,0.000007511446,0.00010017538,0.0023617994],"genre_scores_gemma":[0.9932725,0.00009195787,0.00014003376,0.0034407328,0.00048805607,0.0012729185,0.00001400667,0.000030750016,0.0012490578],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982285,0.000065278546,0.00024751868,0.00040451816,0.00058447744,0.00046969045],"domain_scores_gemma":[0.9987243,0.000023528946,0.000038428203,0.0006772124,0.00004389615,0.0004926405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031147816,0.00017591592,0.00039919763,0.00015066356,0.000067124485,0.000014962096,0.000075232085,0.000096818505,0.00006481522],"category_scores_gemma":[0.00013156064,0.00014724456,0.00016971811,0.00026516366,0.00004765083,0.000075607015,0.000042359665,0.00029937812,0.000116569514],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012632558,0.0030948685,0.01919388,0.0004322102,0.00020030655,0.0011873553,0.00025369512,0.000056382938,0.0002578228,0.0016469173,0.005837078,0.9665762],"study_design_scores_gemma":[0.0024741748,0.000082630766,0.98463047,0.000054984364,0.000039755618,0.000038963226,0.000009644477,0.000066837696,0.00039271623,0.00014430581,0.011907021,0.00015851384],"about_ca_topic_score_codex":0.0011167845,"about_ca_topic_score_gemma":0.00011381761,"teacher_disagreement_score":0.96641773,"about_ca_system_score_codex":0.0002007857,"about_ca_system_score_gemma":0.000033387907,"threshold_uncertainty_score":0.60044587},"labels":[],"label_agreement":null},{"id":"W2403287053","doi":"10.1016/j.jval.2016.03.128","title":"Identification and Management of Canadian Patients with Symptoms of Statin Intolerance: Results from a Real-World Clinical Practice Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Internal medicine","score_opus":0.04633829713438919,"score_gpt":0.3401803449154095,"score_spread":0.2938420477810203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403287053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959004,0.0002615996,0.00011511473,0.0017301776,0.00010796214,0.0011293112,0.00039843525,0.000006741079,0.00035027234],"genre_scores_gemma":[0.9930409,0.0038449448,0.0027322248,0.00016569936,0.000033511085,0.000015170797,0.00009016912,0.00001378651,0.00006356118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722636,0.00071438955,0.0010758148,0.00031816718,0.00044839672,0.00021685225],"domain_scores_gemma":[0.9979903,0.00044155502,0.0005214695,0.0005255898,0.00025567188,0.00026539984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00503499,0.00008791437,0.00042565216,0.00027786163,0.0000285069,0.0000041124763,0.000057466652,0.000047807043,0.0000035681178],"category_scores_gemma":[0.00044609493,0.000059903843,0.000034420475,0.00051925256,0.00006818897,0.000078889774,0.00001692168,0.000103328704,0.0000019146921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017735943,0.00028996676,0.82867646,0.0007020073,0.00019722972,0.000010926512,0.000498592,0.000016647198,0.0000024649996,0.00046088375,0.00020965273,0.16716157],"study_design_scores_gemma":[0.004980822,0.000494603,0.99122566,0.0014794194,0.000034535304,6.107606e-7,0.00007121583,0.000042540836,0.000014455862,0.000029829442,0.0015689515,0.000057365418],"about_ca_topic_score_codex":0.8698951,"about_ca_topic_score_gemma":0.24361993,"teacher_disagreement_score":0.6262752,"about_ca_system_score_codex":0.00020090614,"about_ca_system_score_gemma":0.000608661,"threshold_uncertainty_score":0.770182},"labels":[],"label_agreement":null},{"id":"W2403568346","doi":"10.1016/j.jval.2016.03.130","title":"Identifying and Managing Patients with Symptoms of Statin Intolerance: Results from a Survey of Clinicians in the United States","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Ezetimibe; Asymptomatic; Internal medicine; Physical therapy","score_opus":0.045341564051060046,"score_gpt":0.31031842399619003,"score_spread":0.26497685994513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403568346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734336,0.0005873472,0.0003069469,0.0007432934,0.000040590276,0.0007111622,0.0002482426,0.0000062248555,0.000012817308],"genre_scores_gemma":[0.9979937,0.0011265619,0.0004142123,0.00029868868,0.00001512609,0.000008967936,0.00012683883,0.000012861375,0.0000030115152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741215,0.000927697,0.00078519294,0.00022861826,0.0004205053,0.00022581709],"domain_scores_gemma":[0.9983848,0.00072456594,0.00031959752,0.00038304282,0.00012497387,0.000063049694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041052266,0.00009482606,0.00044880083,0.00020621407,0.000026192469,0.0000047436606,0.000078131954,0.000039425984,0.00000160765],"category_scores_gemma":[0.00031698565,0.000051151004,0.000028073098,0.00054392556,0.000075477954,0.000047105925,0.000022306844,0.00014448649,3.762604e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009759858,0.00016269561,0.9390509,0.00051475107,0.000043969736,0.0000056856516,0.0073371716,0.00019706965,0.0000035534092,0.000031078504,0.000014726323,0.05166237],"study_design_scores_gemma":[0.0062727733,0.0005898175,0.988639,0.0028150808,0.000010225195,7.821853e-7,0.0007912132,0.0005780787,0.00001577023,0.00018870283,0.00004406496,0.000054469492],"about_ca_topic_score_codex":0.2866449,"about_ca_topic_score_gemma":0.004387317,"teacher_disagreement_score":0.28225762,"about_ca_system_score_codex":0.000071558134,"about_ca_system_score_gemma":0.00018925568,"threshold_uncertainty_score":0.7181054},"labels":[],"label_agreement":null},{"id":"W2404402986","doi":"10.1016/j.jval.2016.03.615","title":"Model Observational Bridging Study on the Effectiveness of Ezetimibe on Cardiovascular Outcomes","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ezetimibe; Medicine; Cohort; Myocardial infarction; Cohort study; Population; Confidence interval; Internal medicine; Observational study; Prospective cohort study; Acute coronary syndrome; Statin; Cardiology","score_opus":0.117688988431826,"score_gpt":0.3257108274778754,"score_spread":0.20802183904604937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404402986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99115807,0.0003988834,0.0021224439,0.003315097,0.00012998798,0.0025562856,0.000012654364,0.00002889285,0.00027765974],"genre_scores_gemma":[0.99869204,0.000092551825,0.00013020857,0.0007731887,0.000088468354,0.0001585115,0.000002302556,0.000027924581,0.00003483798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623597,0.0015481224,0.0004464103,0.0003607604,0.0010941814,0.00031456884],"domain_scores_gemma":[0.9977664,0.0008988224,0.00009428825,0.0010439338,0.0000886115,0.00010795045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009397702,0.00016887467,0.0007894729,0.00013110909,0.00008937386,0.000004803822,0.00011931191,0.00005417314,0.000004835875],"category_scores_gemma":[0.0005879885,0.00008535886,0.00044233937,0.00023735671,0.000039985534,0.00003672252,0.000032785763,0.00020374569,0.0000105986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014650365,0.0024962376,0.77305514,0.002003186,0.0019358661,0.000056372628,0.0010584876,0.14954275,0.00029250383,0.027296154,0.000117273754,0.04068099],"study_design_scores_gemma":[0.0035965324,0.0010187086,0.9890958,0.001393999,0.000050736926,0.0000062258673,0.00009580218,0.0035855107,0.00032527474,0.00061399315,0.000108332424,0.00010908739],"about_ca_topic_score_codex":0.0023815406,"about_ca_topic_score_gemma":0.0000066602415,"teacher_disagreement_score":0.21604066,"about_ca_system_score_codex":0.00038224075,"about_ca_system_score_gemma":0.00047799572,"threshold_uncertainty_score":0.36001927},"labels":[],"label_agreement":null},{"id":"W2405171365","doi":"10.1016/s2213-8587(16)30041-9","title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel","year":2016,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Western University","funders":"British Heart Foundation","keywords":"Medicine; Familial hypercholesterolemia; Subclinical infection; Disease; Internal medicine; Cholesterol; Myocardial infarction; Risk stratification; Ldl cholesterol","score_opus":0.12123139253369282,"score_gpt":0.3749064451119221,"score_spread":0.2536750525782293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405171365","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029264566,0.9325047,0.00008618946,0.026955172,0.0011534394,0.0056382446,0.0037968946,0.00013349716,0.00046725644],"genre_scores_gemma":[0.0021662035,0.98263997,0.0008336543,0.008877452,0.0024736202,0.0022991286,0.00043368316,0.00009361417,0.00018266893],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99529904,0.001005243,0.0012249,0.0008934287,0.0003696384,0.001207747],"domain_scores_gemma":[0.9937622,0.0036149556,0.0005279166,0.0018344903,0.00013415574,0.00012627647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027215402,0.0005724888,0.0024271181,0.000039092807,0.00050287944,0.00010807504,0.0011386691,0.0003313883,0.000019754361],"category_scores_gemma":[0.00024186065,0.00025266572,0.0014416781,0.00011622429,0.0009970954,0.00004278132,0.000770358,0.0010807225,0.00003954917],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001697389,0.000052379393,0.005023073,0.0011468199,0.0048369584,0.0000022835632,0.00018889955,3.446598e-7,0.0000029950572,0.0022500267,0.009730905,0.9765956],"study_design_scores_gemma":[0.009026679,0.00010492951,0.02225571,0.0024755292,0.0036125875,0.000114973125,0.00021743437,0.000012333786,6.49814e-7,0.0009552224,0.96091264,0.00031131876],"about_ca_topic_score_codex":0.00009490832,"about_ca_topic_score_gemma":0.000026415219,"teacher_disagreement_score":0.97628427,"about_ca_system_score_codex":0.0002152701,"about_ca_system_score_gemma":0.0002325665,"threshold_uncertainty_score":0.99999255},"labels":[],"label_agreement":null},{"id":"W2405279726","doi":"10.14740/jocmr2596w","title":"Acute Myocardial Infarction in a 26-Year-Old Patient With Familial Hypercholesteremia","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Myocardial infarction; Chest pain; Thrombolysis; Percutaneous coronary intervention; Acute coronary syndrome; Artery; ST segment; Culprit; Diabetes mellitus; Right coronary artery; Coronary arteries; Coronary angiography","score_opus":0.11641754340070065,"score_gpt":0.46489475409253855,"score_spread":0.3484772106918379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405279726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740903,0.00040627478,0.00018657469,0.022363333,0.0005726241,0.0005429984,0.0000018775912,0.000011946694,0.0018240836],"genre_scores_gemma":[0.9903561,0.0033641795,0.00046331907,0.0006924201,0.0048492625,0.000012263992,7.2910063e-7,0.000035997527,0.00022574617],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9933835,0.0010497785,0.0016837692,0.00029827034,0.003062446,0.0005221968],"domain_scores_gemma":[0.9960685,0.0010808981,0.0003084337,0.0005226396,0.0012817212,0.0007378199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012820704,0.0001520613,0.0011831847,0.00053998316,0.000054907887,0.00000993793,0.00018278132,0.00024061395,0.00009765878],"category_scores_gemma":[0.0045812954,0.00006862215,0.0004318641,0.0005848612,0.00053213455,0.0001559019,0.000074699135,0.0018682571,0.00003743912],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015090564,0.00058682566,0.2181579,0.00012108157,0.0010971624,0.0030834991,0.00034412052,0.0000014456775,0.0021384712,0.000100194964,0.0059354412,0.7533433],"study_design_scores_gemma":[0.047663573,0.041222636,0.8357795,0.006793823,0.00049065123,0.005110417,0.0010604828,0.000011623615,0.0006361502,0.0005404506,0.060440615,0.00025009646],"about_ca_topic_score_codex":0.0001554967,"about_ca_topic_score_gemma":0.00002486088,"teacher_disagreement_score":0.7530932,"about_ca_system_score_codex":0.0002484058,"about_ca_system_score_gemma":0.001057747,"threshold_uncertainty_score":0.81167513},"labels":[],"label_agreement":null},{"id":"W2406198421","doi":"10.1016/j.jval.2016.03.074","title":"Characterization of Statin Effectiveness using Real-World Data in a Canadian Population","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Statin; Framingham Risk Score; Internal medicine; Cohort; Atorvastatin; Hyperlipidemia; Population; Diagnosis code; Cohort study; Physical therapy; Disease; Diabetes mellitus; Endocrinology","score_opus":0.07271361172813516,"score_gpt":0.34943334336236187,"score_spread":0.2767197316342267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406198421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768937,0.000059191418,0.0005035743,0.00063415844,0.00009108523,0.00090202695,0.00008195839,0.000008876746,0.000029767845],"genre_scores_gemma":[0.99881136,0.0002174893,0.00057970325,0.00008724369,0.00007048295,0.0000094373845,0.00020066567,0.000016373473,0.000007236559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830854,0.00050588505,0.00041575136,0.00024249291,0.0002166407,0.00031066127],"domain_scores_gemma":[0.9990332,0.000060481925,0.00014283275,0.00054203067,0.000035251916,0.00018619816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029564158,0.000075208336,0.00036975605,0.00045070038,0.000027484984,0.0000032148291,0.000066257824,0.000036094512,0.0000066166167],"category_scores_gemma":[0.0001473113,0.00005907992,0.000024603189,0.0005311722,0.00001656809,0.000118655225,0.000021035163,0.00007672425,0.0000013404135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008043396,0.00003999772,0.93446887,0.0008895843,0.000009722537,0.000010870161,0.00012029722,0.000072496936,0.0032687408,0.00045138603,7.5112115e-7,0.060586855],"study_design_scores_gemma":[0.00092913955,0.00007700188,0.9922439,0.0016811468,0.0000055717906,0.0000050070457,0.000008587571,0.0045216396,0.00023828461,0.000054582946,0.00018014669,0.00005497954],"about_ca_topic_score_codex":0.98638165,"about_ca_topic_score_gemma":0.7237686,"teacher_disagreement_score":0.2626131,"about_ca_system_score_codex":0.0012325798,"about_ca_system_score_gemma":0.0013580399,"threshold_uncertainty_score":0.32231534},"labels":[],"label_agreement":null},{"id":"W2406357772","doi":"10.1016/j.amjcard.2016.05.044","title":"Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study)","year":2016,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval","funders":"Pfizer","keywords":"Medicine; Internal medicine; Coronary artery disease; Atorvastatin; Diabetes mellitus; Rosuvastatin; Adiponectin; Cardiology; Gastroenterology; Endocrinology; Insulin; Insulin resistance","score_opus":0.006662362685011814,"score_gpt":0.228293301111632,"score_spread":0.2216309384266202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406357772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839015,0.008327742,0.0010134879,0.0011525145,0.00008360187,0.00096300367,0.000051620624,0.0000117160225,0.000006169203],"genre_scores_gemma":[0.99788755,0.0011437834,0.00018740715,0.000303279,0.00040412135,0.000029925299,0.000005744957,0.000034089633,0.000004079394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964994,0.0015928549,0.0005049345,0.00033486536,0.0006552624,0.00041269057],"domain_scores_gemma":[0.9975761,0.00043276604,0.00039031793,0.00079346885,0.0001732423,0.00063410884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014311824,0.0002553465,0.0010969435,0.00013251134,0.00013487357,0.00001741688,0.00020029639,0.000019419198,0.0000043858945],"category_scores_gemma":[0.0003987534,0.00010772741,0.00044399872,0.00031915336,0.00029731457,0.00008634882,0.00009564567,0.00022184449,0.0000021655842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002482728,0.0000427448,0.7498245,0.0000052572314,0.003993869,0.00037198386,0.00047565156,0.00034626367,0.000013454167,2.6168607e-7,0.000058649755,0.24238463],"study_design_scores_gemma":[0.0039614826,0.0016958689,0.9898009,0.00018070816,0.0022657525,0.000033427397,0.0013124797,0.000009218439,0.0000058927567,0.00004741093,0.0005377092,0.00014919901],"about_ca_topic_score_codex":0.0011381432,"about_ca_topic_score_gemma":0.00002699062,"teacher_disagreement_score":0.24223542,"about_ca_system_score_codex":0.00014527871,"about_ca_system_score_gemma":0.0002581534,"threshold_uncertainty_score":0.4392996},"labels":[],"label_agreement":null},{"id":"W2406521578","doi":"10.1016/j.jval.2016.03.127","title":"Identification and Management of Patients with Symptoms of Statin Intolerance: Results from A Survey of Brazilian Clinicians","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Regimen; Informed consent; Internal medicine; Family medicine; Physical therapy; Alternative medicine","score_opus":0.02553132790576081,"score_gpt":0.2964966045555379,"score_spread":0.2709652766497771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406521578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710226,0.00044921858,0.0005804317,0.00026544245,0.000055803514,0.000946349,0.00056631316,0.000005318275,0.000028881579],"genre_scores_gemma":[0.9978791,0.0010983247,0.0008642161,0.000035632434,0.000011202386,0.000010211056,0.00007050324,0.000011184159,0.000019611593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978905,0.00031864108,0.000985305,0.00024245334,0.0004183126,0.00014484243],"domain_scores_gemma":[0.9985576,0.00015105195,0.00054998393,0.00047106788,0.00019213205,0.000078144374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002218816,0.000079279045,0.00046595774,0.00009343127,0.000014265573,0.0000014423142,0.000055445642,0.00004247135,0.0000033426168],"category_scores_gemma":[0.000113370006,0.00005251609,0.000035650617,0.00023663203,0.00007789905,0.000039245493,0.000020187132,0.000054444827,6.605963e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018667052,0.00037924058,0.7772688,0.0021026134,0.0001473346,0.0000014916999,0.0008744228,0.000035423305,0.000043365766,0.00010669854,0.000027972203,0.21714589],"study_design_scores_gemma":[0.0059193983,0.00072965585,0.9904448,0.0023323991,0.00002214531,1.808934e-7,0.00007168395,0.00007403456,0.00026199766,0.000054604985,0.00004364865,0.000045458375],"about_ca_topic_score_codex":0.031704955,"about_ca_topic_score_gemma":0.00065146695,"teacher_disagreement_score":0.21710043,"about_ca_system_score_codex":0.00006203788,"about_ca_system_score_gemma":0.00015985742,"threshold_uncertainty_score":0.974743},"labels":[],"label_agreement":null},{"id":"W2406546185","doi":"","title":"Rapid increase in statins newly dispensed to Ontario seniors between 1994 and 2000.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital","funders":"","keywords":"Medicine; Poisson regression; Statin; Demography; Population; Gerontology; Internal medicine; Environmental health","score_opus":0.019593605986696575,"score_gpt":0.22811856776727202,"score_spread":0.20852496178057545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406546185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99150413,0.00039242575,0.0000845771,0.0005563064,0.000064203254,0.0019111799,0.000011155431,0.000027934106,0.005448107],"genre_scores_gemma":[0.9955764,0.000040334107,0.0011227641,0.00095908775,0.00012703873,0.0005278086,0.000020330168,0.00002255828,0.0016037002],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985302,0.00012572607,0.00025799184,0.00029947804,0.00030139877,0.0004851853],"domain_scores_gemma":[0.99891835,0.00004018455,0.000034437497,0.0003501374,0.000021375037,0.0006354867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001006997,0.0001407946,0.0004057077,0.00013625402,0.000044326327,0.00002070537,0.000041908548,0.00007154019,0.000064162734],"category_scores_gemma":[0.00020290607,0.00012163853,0.00008083531,0.00024260147,0.000025569612,0.00005718299,0.00002435964,0.0002116737,0.00000945259],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001521452,0.000098964934,0.47031963,0.00008403226,0.00012468414,0.0001369301,0.0014684239,0.000004427065,0.000011803345,0.000079811354,0.0008067175,0.5267124],"study_design_scores_gemma":[0.0024146885,0.00006180761,0.8778464,0.000017217588,0.00006451156,0.000021643067,0.00008986274,9.616314e-7,0.0001653931,0.000035415178,0.11915862,0.0001234771],"about_ca_topic_score_codex":0.07036531,"about_ca_topic_score_gemma":0.039711483,"teacher_disagreement_score":0.526589,"about_ca_system_score_codex":0.00034829386,"about_ca_system_score_gemma":0.00029087815,"threshold_uncertainty_score":0.9778113},"labels":[],"label_agreement":null},{"id":"W2407105331","doi":"10.1191/1358863x03vm518xx","title":"Vascular viewpoint","year":2003,"lang":"en","type":"review","venue":"Vascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":201,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Pravastatin; Rosuvastatin; Fluvastatin; Simvastatin; Atorvastatin; Statin; Lovastatin; Placebo; Internal medicine; Randomized controlled trial; Rosuvastatin Calcium; Population; Pharmacology; Cholesterol; Urology","score_opus":0.05335156589093921,"score_gpt":0.3408477808069434,"score_spread":0.2874962149160042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407105331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.4176366e-7,0.98216647,0.0010921117,0.0002615788,0.0011613128,0.004310265,0.000010144422,0.00023000452,0.010767259],"genre_scores_gemma":[3.0062202e-7,0.9914436,0.00086556515,0.0017107384,0.0029746352,0.0005008353,0.00047291064,0.00033784233,0.0016935682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923703,0.00091808103,0.0018166588,0.0014263531,0.0024275354,0.0010410493],"domain_scores_gemma":[0.99418473,0.00010630704,0.00048073503,0.0039056218,0.00029322418,0.0010293729],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0041379514,0.0012982014,0.008986417,0.0007552921,0.00018766042,0.000022131442,0.00041565948,0.0010369674,0.001752594],"category_scores_gemma":[0.00056449184,0.00083115866,0.0058459477,0.0014729183,0.00029768556,0.00006729055,0.00011992476,0.001628074,0.0010127663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037029881,0.000114033006,9.0148427e-7,0.056497507,0.0040272367,0.0003550723,0.00003860315,1.7204414e-7,3.5931902e-7,0.0005191772,0.0049116137,0.93353164],"study_design_scores_gemma":[0.0023416334,0.00040876307,0.0000083679015,0.0451676,0.019072028,0.0014462112,0.000028201868,0.000001695806,5.495282e-7,0.000041750765,0.9308118,0.00067139603],"about_ca_topic_score_codex":0.00016752198,"about_ca_topic_score_gemma":0.0000037352524,"teacher_disagreement_score":0.9328602,"about_ca_system_score_codex":0.0005175356,"about_ca_system_score_gemma":0.0012416751,"threshold_uncertainty_score":0.99997693},"labels":[],"label_agreement":null},{"id":"W2407813331","doi":"","title":"Effects of long term cholesterol lowering on coronary atherosclerosis in patient risk factor subgroups: the Simvastatin/enalapril Coronary Atherosclerosis Trial (SCAT).","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital","funders":"","keywords":"Medicine; Simvastatin; Internal medicine; Coronary atherosclerosis; Cardiology; Placebo; Diabetes mellitus; Risk factor; Enalapril; Cholesterol; Coronary artery disease; Endocrinology; Blood pressure; Angiotensin-converting enzyme; Pathology","score_opus":0.018364767362544235,"score_gpt":0.22442192384162024,"score_spread":0.20605715647907602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407813331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913665,0.00064175384,0.00008130362,0.000064477324,0.0006273897,0.006987723,0.000038471593,0.000060470215,0.00013188603],"genre_scores_gemma":[0.99552053,0.00077432464,0.000034173776,0.0003170926,0.00015998393,0.0030483345,0.000009210666,0.00008730444,0.00004902397],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99637413,0.0005901867,0.00074921583,0.0005830814,0.00091709907,0.00078625773],"domain_scores_gemma":[0.99796224,0.00039626803,0.00037060145,0.0009048035,0.00006982615,0.0002962882],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010531526,0.00040177334,0.00081176055,0.00014564599,0.00014781106,0.00003485828,0.00020686795,0.00019190481,0.000028645425],"category_scores_gemma":[0.00041337617,0.00027764906,0.00052285567,0.00034826653,0.0001386084,0.0001167304,0.00007202763,0.0005556995,0.000010581882],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006428007,0.0017912304,0.40208763,0.000562499,0.00048572707,0.000048022695,0.0018595629,0.00005851051,0.0010990443,0.000009628487,0.000026728154,0.5855434],"study_design_scores_gemma":[0.028213121,0.0011238623,0.9535846,0.00028519437,0.00018416725,0.00001647078,0.00011486849,0.000004548235,0.016140908,0.0000061276814,0.00008464292,0.00024148884],"about_ca_topic_score_codex":0.00021094912,"about_ca_topic_score_gemma":0.000049652128,"teacher_disagreement_score":0.58530194,"about_ca_system_score_codex":0.00032739041,"about_ca_system_score_gemma":0.00008610966,"threshold_uncertainty_score":0.9999676},"labels":[],"label_agreement":null},{"id":"W2407916448","doi":"","title":"Impact of routine in-hospital assessment of low-density lipoprotein levels and standardized orders on statin therapy in patients undergoing percutaneous coronary interventions.","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Statin; Internal medicine; Guideline; Cohort; Cardiology; Emergency medicine; Myocardial infarction","score_opus":0.017903201031347023,"score_gpt":0.29526608120059433,"score_spread":0.2773628801692473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407916448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967631,0.00025941426,0.00009760875,0.000168779,0.0000410912,0.0025014805,0.00004410779,0.000011955395,0.00011244402],"genre_scores_gemma":[0.99904174,0.00015750337,0.0005613218,0.00003340879,0.000025509538,0.0001274628,0.000018214372,0.000020440846,0.0000144310025],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99826324,0.00015193952,0.00055183924,0.00024653377,0.00048626075,0.00030017507],"domain_scores_gemma":[0.9992498,0.00005145315,0.00018312938,0.0002799159,0.00012510394,0.000110597095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088343426,0.00015854435,0.0005797026,0.00020211458,0.000022375429,0.000007716234,0.00005295385,0.00007243785,0.00002792935],"category_scores_gemma":[0.00015126966,0.0001290928,0.00026593075,0.00019103063,0.000058034493,0.000077956334,0.000035891047,0.0002038598,2.599119e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001147748,0.0017664763,0.48652783,0.0003110717,0.00025375505,0.000029288243,0.00037465603,0.00019998997,0.000040001505,0.00001687117,0.000008715701,0.5093236],"study_design_scores_gemma":[0.009250307,0.0023430318,0.98750246,0.00032230435,0.000021333262,0.000008943049,0.00010502461,0.00007464475,0.00023952727,0.000020486847,0.000004954841,0.000107009124],"about_ca_topic_score_codex":0.0009830092,"about_ca_topic_score_gemma":0.00042546933,"teacher_disagreement_score":0.5092166,"about_ca_system_score_codex":0.00053970306,"about_ca_system_score_gemma":0.00019239295,"threshold_uncertainty_score":0.5264252},"labels":[],"label_agreement":null},{"id":"W2408341429","doi":"10.1093/eurheartj/sux029","title":"ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic–therapeutic pathway in Italy","year":2017,"lang":"en","type":"article","venue":"European Heart Journal Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Medicine; Ezetimibe; Disease; Atherosclerotic cardiovascular disease; Cholesterol; Intensive care medicine; Ldl cholesterol; Internal medicine; Blood cholesterol; Medical therapy","score_opus":0.04531293223362465,"score_gpt":0.30170353872063754,"score_spread":0.2563906064870129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408341429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783366,0.009915308,0.00011627219,0.003319361,0.0014237801,0.0027268075,0.00018598925,0.0000998524,0.003876051],"genre_scores_gemma":[0.9891584,0.005513602,0.00068654574,0.0020226217,0.0019600058,0.00005346299,0.000049958104,0.00024173499,0.00031366336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99103993,0.0020629836,0.0017281327,0.0013360449,0.0022194532,0.0016134712],"domain_scores_gemma":[0.9946267,0.00022145819,0.00073942874,0.0028562422,0.00031716557,0.0012390306],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0069392384,0.0009375025,0.0018343399,0.00045720898,0.0015445785,0.00078364345,0.0005837757,0.0001817474,0.00038364498],"category_scores_gemma":[0.0008584624,0.0007944283,0.0013753225,0.00021744556,0.00035985475,0.00037963796,0.00048229808,0.0019321212,0.00038411017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013857286,0.0024292252,0.61438525,0.00092379405,0.007637554,0.01196977,0.0024459872,0.0005083195,0.00254618,0.0002064486,0.015243877,0.3403179],"study_design_scores_gemma":[0.016753469,0.0023916971,0.7385924,0.0015832765,0.0008454119,0.0017488864,0.00047796447,0.000045430694,0.0034169261,0.00016586954,0.23300543,0.0009732246],"about_ca_topic_score_codex":0.0011151587,"about_ca_topic_score_gemma":0.00011037476,"teacher_disagreement_score":0.33934468,"about_ca_system_score_codex":0.00046090307,"about_ca_system_score_gemma":0.0003077604,"threshold_uncertainty_score":0.99975526},"labels":[],"label_agreement":null},{"id":"W2409305992","doi":"10.1016/j.jval.2015.09.924","title":"Managing Patients With Statin-Associated Symptoms: Does Real-World Clinical Practice Align With Clinical Guidelines And Hta Recommendations In Europe?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Ezetimibe; Medicine; Statin; Family medicine; Concomitant; Clinical Practice; Internal medicine","score_opus":0.12308576949465633,"score_gpt":0.4295672057527932,"score_spread":0.3064814362581369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409305992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94393235,0.000563393,0.00024875219,0.050816387,0.00044437978,0.002187267,0.00003103633,0.00009317317,0.0016832614],"genre_scores_gemma":[0.85716826,0.018830184,0.09624787,0.02497949,0.0011088053,0.0001643903,0.0004982674,0.00023267206,0.00077004463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938734,0.0023939642,0.001925736,0.00060783373,0.0007045575,0.00049447815],"domain_scores_gemma":[0.99644077,0.0008103686,0.00064546854,0.0005546973,0.0009728013,0.0005758759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013003443,0.00021746206,0.00088118354,0.00024060228,0.00008501733,0.000032451757,0.000095783915,0.00009913642,0.000004980573],"category_scores_gemma":[0.0046173707,0.00013928647,0.000055243185,0.0010024881,0.000103940576,0.00022599437,0.00006844647,0.00067640364,0.000006181007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007528066,0.00082094775,0.93726826,0.000145903,0.00014021753,0.00006718736,0.00042724246,0.00015922695,1.7499188e-8,0.00020890436,0.002677478,0.057331804],"study_design_scores_gemma":[0.015189121,0.0035717224,0.9203168,0.0023714015,0.0001373702,0.000022703429,0.0011477896,0.0024494384,3.5576946e-7,0.00015427715,0.05434196,0.00029702365],"about_ca_topic_score_codex":0.027714849,"about_ca_topic_score_gemma":0.0055904705,"teacher_disagreement_score":0.095999114,"about_ca_system_score_codex":0.0003184646,"about_ca_system_score_gemma":0.0016822848,"threshold_uncertainty_score":0.9787597},"labels":[],"label_agreement":null},{"id":"W2410774145","doi":"10.1016/j.jacc.2016.03.520","title":"Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia","year":2016,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":939,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Human Genome Research Institute; National Heart, Lung, and Blood Institute; National Institute on Aging; Medical Research Council; National Institute for Health and Care Research; British Heart Foundation; Wellcome Trust","keywords":"Familial hypercholesterolemia; Medicine; Internal medicine; Missense mutation; Coronary artery disease; Cholesterol; PCSK9; Odds ratio; LDL receptor; Cohort; Apolipoprotein B; Endocrinology; Gastroenterology; Mutation; Lipoprotein; Genetics; Biology; Gene","score_opus":0.020756642262083055,"score_gpt":0.27279905263129295,"score_spread":0.2520424103692099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410774145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99831396,0.0002798473,0.0001535883,0.0005740561,0.00017738581,0.00034564713,0.00005865802,0.0000025705033,0.00009428823],"genre_scores_gemma":[0.9985337,0.0005925126,0.00039732104,0.00021239309,0.0002369087,0.000002640989,3.2036274e-7,0.000014730096,0.0000094573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977361,0.00053370267,0.0008921188,0.00019127694,0.00042828312,0.00021854985],"domain_scores_gemma":[0.99754184,0.00077597814,0.000721776,0.00047573965,0.00035017956,0.0001345087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013949652,0.00014637547,0.0014403578,0.00011229963,0.00002607265,0.0000014933937,0.00018819612,0.00009754097,0.0000022294987],"category_scores_gemma":[0.0011409305,0.00007157813,0.0003910847,0.00020719413,0.0007656714,0.0000664964,0.00009737754,0.0003319906,2.2231562e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016115613,0.00005542185,0.9703209,0.00005417787,0.00032852468,0.000057882928,0.000018716148,0.000016079823,0.0005830519,0.0000021864298,0.00008428898,0.026867233],"study_design_scores_gemma":[0.004443513,0.0023459021,0.9909145,0.0005451593,0.0002823848,0.0007408281,0.0001940526,0.0000031535521,0.00020863778,0.000017891096,0.000227822,0.000076113436],"about_ca_topic_score_codex":0.00006956977,"about_ca_topic_score_gemma":0.00002788642,"teacher_disagreement_score":0.02679112,"about_ca_system_score_codex":0.00009665761,"about_ca_system_score_gemma":0.00045521575,"threshold_uncertainty_score":0.29188713},"labels":[],"label_agreement":null},{"id":"W2410894294","doi":"10.1016/j.ahj.2016.05.010","title":"Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials","year":2016,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Pfizer","keywords":"PCSK9; Medicine; Spire (mollusc); Placebo; Internal medicine; Residual risk; Statin; Cholesterol; Disease; Clinical trial; Cardiology; Virology; Lipoprotein; LDL receptor; Pathology","score_opus":0.10341162650509182,"score_gpt":0.3969424842495555,"score_spread":0.2935308577444637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410894294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847732,0.010210148,0.0015176472,0.0006845976,0.0001258592,0.002670692,0.000011393209,0.0000053352014,0.0000011027233],"genre_scores_gemma":[0.9929676,0.004271664,0.0023611842,0.00010309939,0.00020219022,0.00006195681,8.446232e-7,0.000028297301,0.0000031564925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99421877,0.0024596523,0.0012842531,0.00047221483,0.0012997107,0.00026539556],"domain_scores_gemma":[0.99783254,0.0005022792,0.00063177006,0.00048918556,0.00035712792,0.00018708236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011833974,0.00028541856,0.0023123184,0.0001835886,0.00022109083,0.000011888915,0.00005874397,0.000074933014,0.0000015153342],"category_scores_gemma":[0.0016841638,0.00014272217,0.00065624143,0.0002571463,0.00066408154,0.00016963732,0.00013629656,0.00028192464,1.07627066e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037157768,0.00028834597,0.64938784,0.0005190623,0.010943432,0.0000059739746,0.0030513234,0.00066656835,0.0045883753,0.000012861486,0.0000070843453,0.32681337],"study_design_scores_gemma":[0.015583479,0.0034097796,0.97131765,0.0031796559,0.0020244892,0.00078306394,0.0018049619,0.000099628276,0.001360348,0.00010256527,0.000103557315,0.00023083456],"about_ca_topic_score_codex":0.0002936809,"about_ca_topic_score_gemma":0.0000089186115,"teacher_disagreement_score":0.32658252,"about_ca_system_score_codex":0.00008541373,"about_ca_system_score_gemma":0.00020001098,"threshold_uncertainty_score":0.5820041},"labels":[],"label_agreement":null},{"id":"W2410967529","doi":"10.1139/cjpp-2016-0062","title":"Synergistic in vitro antioxidant activity and observational clinical trial of F105, a phytochemical formulation including<i>Citrus bergamia</i>, in subjects with moderate cardiometabolic risk factors","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Medicine; Internal medicine; Antioxidant; Cholesterol; Lipid profile; Apolipoprotein B; Endocrinology; Pharmacology; Chemistry; Obesity; Biochemistry","score_opus":0.05565222527693647,"score_gpt":0.3361872206777008,"score_spread":0.2805349954007643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410967529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986699,0.00038016064,0.00009798537,0.00024862657,0.00024033437,0.00032255313,0.00002923887,0.0000016439328,0.000009550767],"genre_scores_gemma":[0.9989321,0.00054120424,0.00008915209,0.00009286427,0.00032231538,0.000007873232,0.0000028782365,0.000008815224,0.0000027529122],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985752,0.00041482344,0.00046457013,0.00018706293,0.00010367075,0.00025465593],"domain_scores_gemma":[0.99886477,0.00032845428,0.0003032557,0.00008360982,0.0001163932,0.00030353412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008302883,0.000123722,0.0007994932,0.00030318016,0.000048593793,0.0000025020618,0.00004777426,0.00017036311,0.0000177611],"category_scores_gemma":[0.00018815437,0.000080422134,0.00011036863,0.00017971589,0.00023130691,0.0001044202,0.000013731468,0.0003708354,1.2385459e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029615138,0.00012029931,0.095079124,0.00009870435,0.0003797889,0.00007558745,0.00013843155,0.00005673499,0.86756474,0.000042062602,0.00001401213,0.0068153986],"study_design_scores_gemma":[0.038667377,0.00092961104,0.8733094,0.00006216175,0.00020905158,0.0000614698,0.0000142876115,0.0002153635,0.085947976,0.00042469415,0.000057595193,0.000101049045],"about_ca_topic_score_codex":0.002481272,"about_ca_topic_score_gemma":0.0013629941,"teacher_disagreement_score":0.78161675,"about_ca_system_score_codex":0.00008658396,"about_ca_system_score_gemma":0.0009805798,"threshold_uncertainty_score":0.37509575},"labels":[],"label_agreement":null},{"id":"W2410968598","doi":"10.1358/dot.2004.40.7.850479","title":"Recent developments in lipid-lowering therapy - Highlights from theAtorvastatin Landmark Program: Global Investigators Meeting III","year":2004,"lang":"en","type":"article","venue":"Drugs of today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Medicine; Landmark; Guideline; Clinical trial; Clinical Practice; Modalities; Medical physics; Family medicine; Pharmacology; Pathology; Artificial intelligence; Computer science","score_opus":0.015449924834143256,"score_gpt":0.27475283255909616,"score_spread":0.2593029077249529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410968598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917538,0.0021196364,0.000018582181,0.0010812203,0.00027763893,0.0008894343,0.00001029427,0.000088114895,0.003761243],"genre_scores_gemma":[0.9877288,0.00200524,0.009465068,0.00041934138,0.0002095999,0.000080321144,0.00004805972,0.000025784193,0.000017823815],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981783,0.00006203908,0.0004896227,0.0003366098,0.00056553114,0.00036790644],"domain_scores_gemma":[0.9991878,0.000022459279,0.00012716977,0.0003537828,0.00008358842,0.00022519066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058994326,0.0002034978,0.00050097145,0.000070678834,0.000059045804,0.000017172086,0.00013033529,0.000109337474,0.000028240458],"category_scores_gemma":[0.000062965664,0.00015942716,0.00013306394,0.0003811787,0.00005397591,0.000073771385,0.000052093306,0.00015539651,0.000009287612],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048594704,0.0007085108,0.06079326,0.00014319502,0.00045980295,0.00008161079,0.0047698785,0.000059757378,0.0018083164,0.0004221084,0.000205142,0.9300625],"study_design_scores_gemma":[0.033772707,0.0008585689,0.43496582,0.0042416775,0.00013848288,0.00003458997,0.001838496,0.000023723624,0.20101288,0.0021485977,0.31989002,0.001074449],"about_ca_topic_score_codex":0.0043465425,"about_ca_topic_score_gemma":0.00019459896,"teacher_disagreement_score":0.92898804,"about_ca_system_score_codex":0.00032657804,"about_ca_system_score_gemma":0.00047944314,"threshold_uncertainty_score":0.6570701},"labels":[],"label_agreement":null},{"id":"W2411561458","doi":"10.7748/nop2003.10.15.7.31.c2277","title":"The treatment of cardiovascular disease in older people","year":2003,"lang":"en","type":"article","venue":"Nursing Older People","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Disease; Older people; Medicine; Gerontology; Elderly people; Intensive care medicine; Internal medicine","score_opus":0.012665277193615378,"score_gpt":0.26437327636840696,"score_spread":0.2517079991747916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411561458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94193935,0.052600697,0.00083819346,0.00086305564,0.0004836339,0.00143058,0.0000058790147,0.00004206281,0.0017965622],"genre_scores_gemma":[0.99587077,0.003176343,0.00017948479,0.00003797769,0.00014624115,0.000120584395,0.000013713157,0.00003821607,0.00041669264],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99805516,0.00019890827,0.00031901177,0.00035826897,0.00062155846,0.00044710308],"domain_scores_gemma":[0.99835193,0.00005597754,0.000053289266,0.0012090806,0.00008702411,0.00024271113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004852037,0.00020349532,0.0006179332,0.00008973416,0.00016687825,0.00002056481,0.00007356154,0.000076317636,0.000045251287],"category_scores_gemma":[0.000064293745,0.00013745403,0.00077800936,0.0004482521,0.00006758553,0.0000464041,0.000004845728,0.000104337225,0.000012405613],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006588187,0.009492906,0.31744924,0.0010470536,0.003792688,0.00025229988,0.043054454,0.0023599977,0.00016133013,0.0027878429,0.0018286688,0.6171147],"study_design_scores_gemma":[0.006454617,0.0004183313,0.9339604,0.0004996402,0.0012576635,0.000067132714,0.0014607327,0.00027036658,0.0011647376,0.0002328614,0.05394188,0.00027164575],"about_ca_topic_score_codex":0.0012331873,"about_ca_topic_score_gemma":0.00025335836,"teacher_disagreement_score":0.61684304,"about_ca_system_score_codex":0.0003324849,"about_ca_system_score_gemma":0.00032134593,"threshold_uncertainty_score":0.5605213},"labels":[],"label_agreement":null},{"id":"W2411837195","doi":"","title":"Application of the 1998 Canadian cholesterol guidelines to a military population: health benefits and cost effectiveness of improved cholesterol management.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Life expectancy; Interim; Statin; Population; Cost effectiveness; Coronary artery disease; Cholesterol; Environmental health; Internal medicine; Risk analysis (engineering)","score_opus":0.022183338968357308,"score_gpt":0.2643626610711492,"score_spread":0.2421793221027919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411837195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863176,0.002078421,0.00044476808,0.0016080043,0.00010648776,0.009201399,0.00003472156,0.00001310554,0.00019550433],"genre_scores_gemma":[0.99615556,0.000115792835,0.000299842,0.0014339146,0.0000410021,0.0018932341,0.00002089483,0.000015735568,0.000024038422],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987488,0.00015644198,0.00035404123,0.00024029771,0.00023156032,0.00026888738],"domain_scores_gemma":[0.99895304,0.000014354226,0.00008511613,0.0005408709,0.0001022192,0.0003043894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014766972,0.00010843454,0.00032335817,0.00011230588,0.000069858535,0.00000399697,0.000076423974,0.000050691422,4.972041e-7],"category_scores_gemma":[0.00006634045,0.000081718135,0.00008525432,0.00028424652,0.000024630031,0.000038621052,0.000023583423,0.00006581875,5.07691e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006406419,0.000050034207,0.14735155,0.0014314178,0.00012740078,3.459651e-7,0.000068296176,0.00017558734,0.000038713773,0.00032624617,0.000059595604,0.85030675],"study_design_scores_gemma":[0.0012581145,0.000041764863,0.99295324,0.0001367281,0.00005414299,0.000010043648,0.000032038108,0.000049031936,0.00036398048,0.000019560744,0.005021649,0.00005972041],"about_ca_topic_score_codex":0.1116963,"about_ca_topic_score_gemma":0.036890134,"teacher_disagreement_score":0.850247,"about_ca_system_score_codex":0.00016377926,"about_ca_system_score_gemma":0.00007139687,"threshold_uncertainty_score":0.9806841},"labels":[],"label_agreement":null},{"id":"W2412621275","doi":"","title":"Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada.","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Inro Consultants (Canada)","funders":"","keywords":"Atorvastatin; Medicine; Hazard ratio; Internal medicine; Quality-adjusted life year; Coronary heart disease; Cost effectiveness; Emergency medicine; Confidence interval","score_opus":0.035652471730290486,"score_gpt":0.2644718476231871,"score_spread":0.2288193758928966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412621275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887414,0.004400996,0.0014192866,0.000042881362,0.00015246603,0.005031474,0.00013159034,0.000007813803,0.000072105795],"genre_scores_gemma":[0.99849457,0.00025391468,0.00020537671,0.00002876512,0.000056676497,0.0008718798,0.000050902894,0.00002716408,0.00001073488],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99797505,0.00019447839,0.0005547979,0.0002950374,0.0006503848,0.00033025953],"domain_scores_gemma":[0.9976595,0.00015929705,0.00031172062,0.00058420555,0.0010958643,0.00018937883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001280162,0.00018705254,0.0010803944,0.00013648106,0.000018224537,0.000002229286,0.00009605291,0.00005178272,0.000008676437],"category_scores_gemma":[0.00039678803,0.00015866054,0.00048240778,0.0003202619,0.00007501224,0.00008092156,0.000018303508,0.000118408476,5.3751453e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034857728,0.00056696177,0.010885611,0.006539846,0.005172242,0.00004955753,0.00045601113,0.0030748695,0.0010230863,0.000055095086,0.00008836203,0.93723065],"study_design_scores_gemma":[0.022343582,0.001212155,0.92164254,0.00084383244,0.0007358614,0.000005124017,0.00071281166,0.0000979165,0.051034737,0.00004017869,0.0011025439,0.0002287432],"about_ca_topic_score_codex":0.060171846,"about_ca_topic_score_gemma":0.010317796,"teacher_disagreement_score":0.9370019,"about_ca_system_score_codex":0.00029509814,"about_ca_system_score_gemma":0.0015973601,"threshold_uncertainty_score":0.9460865},"labels":[],"label_agreement":null},{"id":"W2412922045","doi":"","title":"Cost-effectiveness of lipid-lowering treatment according to lipid level.","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Medicine; Simvastatin; Population; Cost effectiveness; Secondary prevention; Cholesterol; Primary prevention; Demography; Internal medicine; Environmental health; Disease","score_opus":0.08830833811782329,"score_gpt":0.30969913758975953,"score_spread":0.22139079947193624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412922045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883127,0.00032288744,0.0021271673,0.0005333418,0.0003477578,0.004523645,0.000012058857,0.00006955929,0.0037508784],"genre_scores_gemma":[0.9937825,0.00008389033,0.00051335356,0.00016160957,0.0011771583,0.0039070346,0.000006701434,0.000029023118,0.0003387358],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987045,0.00007095503,0.00023225624,0.00027306002,0.0002976712,0.00042155205],"domain_scores_gemma":[0.99905586,0.0000621734,0.000047206777,0.0004408501,0.0000773185,0.0003166076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009109036,0.00015234029,0.0004976805,0.00012244117,0.000048434318,0.000011417439,0.000067604175,0.00006476179,0.00001428051],"category_scores_gemma":[0.00012902195,0.00012232536,0.00025240605,0.00022820426,0.000016778997,0.00007045138,0.000041965417,0.0000759933,0.000020855128],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029212466,0.0001736759,0.006949116,0.00019260062,0.00022049555,0.000007861689,0.000105797015,0.00017235473,0.0007786518,0.000025546484,0.00003453922,0.99104726],"study_design_scores_gemma":[0.0039998526,0.0003039495,0.75406206,0.00016124401,0.00018202438,0.000044735123,0.00012723565,0.000025604637,0.14817145,0.0000029848889,0.09270695,0.00021193012],"about_ca_topic_score_codex":0.00022223529,"about_ca_topic_score_gemma":0.000023833516,"teacher_disagreement_score":0.9908353,"about_ca_system_score_codex":0.00054390874,"about_ca_system_score_gemma":0.00007424095,"threshold_uncertainty_score":0.49882835},"labels":[],"label_agreement":null},{"id":"W2413281585","doi":"","title":"A pharmacoeconomic evaluation of the myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) study in Canada.","year":2004,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atorvastatin; Myocardial infarction; Emergency medicine; Cost effectiveness; Angina; Population; Acute coronary syndrome; Indirect costs; Internal medicine; Cardiology","score_opus":0.021361441529479455,"score_gpt":0.2499716243573984,"score_spread":0.22861018282791895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413281585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950887,0.00025131914,0.000003839494,0.00043013925,0.0002612746,0.0035331568,0.0000020857872,0.0000060561383,0.00042340727],"genre_scores_gemma":[0.9981723,0.000011017484,0.0000053408908,0.000097663644,0.00018252988,0.001506936,0.0000017254832,0.0000121757475,0.000010306944],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99879515,0.00007563571,0.00020582681,0.0001827793,0.0005499036,0.00019072891],"domain_scores_gemma":[0.9993802,0.0000038639932,0.00015354522,0.00030019105,0.000092064176,0.0000701726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095516536,0.000085213294,0.00021889285,0.000043370223,0.000031591982,0.0000054948873,0.00005877045,0.000022455131,0.0000031114141],"category_scores_gemma":[0.00004181625,0.00005804505,0.000056323996,0.00015443939,0.000020041292,0.000063112304,0.000020288384,0.00015057281,3.6446147e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000891681,0.000554793,0.10872464,0.00019051005,0.001158943,0.000046512607,0.0018494603,0.031801235,0.0013696047,0.000002889435,0.00010559357,0.85330415],"study_design_scores_gemma":[0.008415393,0.000033690027,0.96738094,0.000062885214,0.00034080076,0.000044259887,0.0006880397,0.000036201956,0.022866528,0.000004199934,0.000054737353,0.00007230023],"about_ca_topic_score_codex":0.314555,"about_ca_topic_score_gemma":0.26068103,"teacher_disagreement_score":0.85865635,"about_ca_system_score_codex":0.001528626,"about_ca_system_score_gemma":0.0016793074,"threshold_uncertainty_score":0.75280964},"labels":[],"label_agreement":null},{"id":"W2413570669","doi":"","title":"Should you put all diabetic patients on statins?","year":2007,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Diabetes mellitus; Intensive care medicine; Statin; Internal medicine; Endocrinology","score_opus":0.0380839679612426,"score_gpt":0.26705612280346275,"score_spread":0.22897215484222014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413570669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97316813,0.00026571436,0.00014837048,0.00069585495,0.00038298767,0.0017136649,0.000008468094,0.00008023574,0.023536565],"genre_scores_gemma":[0.9946743,0.000034968958,0.00011909769,0.0033417193,0.00035455654,0.00034642103,0.000041144667,0.00002446051,0.0010633228],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982671,0.00003249862,0.00023190392,0.0002444462,0.0006398548,0.0005841923],"domain_scores_gemma":[0.999035,0.000031817308,0.000049447593,0.00042731687,0.00007405323,0.0003823577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009952378,0.00012322818,0.000248367,0.0000924654,0.00004124544,0.000012211768,0.00006222301,0.00008408522,0.000024554147],"category_scores_gemma":[0.00019558171,0.000096793214,0.00014819845,0.00013441974,0.00002519228,0.000036907426,0.00002335117,0.0001982858,0.000056527217],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012825354,0.000296736,0.038137455,0.00007996453,0.000121661666,0.00003612507,0.000079986276,0.0000016436486,0.0000047986464,0.00016752107,0.0015691521,0.9593767],"study_design_scores_gemma":[0.0017978242,0.00013779517,0.88910806,0.000013259805,0.000066682536,0.000002467254,0.000019503057,0.000003846623,0.001000057,0.000022190188,0.10773014,0.000098183875],"about_ca_topic_score_codex":0.00009305606,"about_ca_topic_score_gemma":0.000014714593,"teacher_disagreement_score":0.9592785,"about_ca_system_score_codex":0.0001413484,"about_ca_system_score_gemma":0.000024342016,"threshold_uncertainty_score":0.39471126},"labels":[],"label_agreement":null},{"id":"W2413688321","doi":"","title":"Analysis of low-density lipoprotein receptor gene mutations in a Chinese patient with clinically homozygous familial hypercholesterolemia.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Familial hypercholesterolemia; Genetics; Exon; Mutation; Point mutation; Gene; Apolipoprotein B; Proband; Genotype; Biology; Restriction fragment length polymorphism; Gene mutation; Molecular biology; LDL receptor; Lipoprotein; Cholesterol; Endocrinology","score_opus":0.011828230921323124,"score_gpt":0.2397504995881469,"score_spread":0.22792226866682377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413688321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679655,0.0001587838,0.00037279262,0.00012102687,0.00008155067,0.0019202807,0.000026491043,0.000031387477,0.00049113133],"genre_scores_gemma":[0.9967495,0.000060040984,0.0016720069,0.00024750328,0.00005278523,0.0010796869,0.00006008855,0.000024137313,0.000054252807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976673,0.00024903726,0.00070121535,0.00040746966,0.00058741675,0.0003875609],"domain_scores_gemma":[0.99858385,0.00005777917,0.00018163006,0.0006936053,0.00021049203,0.00027263517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011061059,0.00018555803,0.0008621112,0.00037436798,0.00004529979,0.00001135905,0.00007569152,0.0001319245,0.000019616451],"category_scores_gemma":[0.0005686536,0.00013632135,0.0003777632,0.0015665618,0.00009015329,0.00005964779,0.000024391291,0.00027479,0.0000044479634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015288279,0.0016990912,0.60174274,0.00028280637,0.0029353993,0.00027748608,0.0012772833,0.0010778563,0.00041637622,0.000019405066,0.000015499027,0.38872722],"study_design_scores_gemma":[0.0027073259,0.00029251567,0.99480385,0.000033511,0.0007998376,0.000044397744,0.0001411014,0.000075001524,0.0008133377,0.00001315612,0.00011561018,0.00016034121],"about_ca_topic_score_codex":0.0011761419,"about_ca_topic_score_gemma":0.00071904284,"teacher_disagreement_score":0.39306113,"about_ca_system_score_codex":0.000134174,"about_ca_system_score_gemma":0.0001716992,"threshold_uncertainty_score":0.5559023},"labels":[],"label_agreement":null},{"id":"W2413910352","doi":"","title":"Clinical use of ezetimibe.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Ezetimibe; Medicine; Atorvastatin; Statin; Simvastatin; Placebo; Drug; Pharmacology; Cholesterol; Dose; Internal medicine","score_opus":0.09305746558639731,"score_gpt":0.303949339537809,"score_spread":0.21089187395141168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413910352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842003,0.0007255535,0.00038723846,0.0003268228,0.0003612262,0.0011401637,0.0000027939002,0.000035916448,0.01281999],"genre_scores_gemma":[0.99582523,0.00023270682,0.0015680155,0.00062115514,0.00014700236,0.00019385987,0.0000020859804,0.000011682895,0.0013982529],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990488,0.000110061024,0.0002764873,0.00013739127,0.00022670274,0.0002005577],"domain_scores_gemma":[0.999245,0.000045930996,0.00004854261,0.00040663563,0.00006277475,0.00019114494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011222025,0.000054373566,0.00028589836,0.00003183177,0.0000140970915,0.0000043614627,0.00002610465,0.00007042866,0.000032970052],"category_scores_gemma":[0.0007975945,0.000042083633,0.00025105558,0.00010354696,0.000045473767,0.00003458591,0.000009287001,0.00011309602,0.000009316547],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008081822,0.0002808515,0.19453858,0.00012055534,0.00024655747,0.000031600553,0.00001734631,0.0000028622321,0.0000060138073,0.0015539576,0.0035919056,0.79952896],"study_design_scores_gemma":[0.00087543816,0.000034790064,0.75900733,0.0000072662947,0.00007039514,0.000021445689,0.0000058488286,0.000002772929,0.00043440596,0.000033682878,0.23946665,0.00003998787],"about_ca_topic_score_codex":0.00003737625,"about_ca_topic_score_gemma":0.0000022082334,"teacher_disagreement_score":0.79948896,"about_ca_system_score_codex":0.000016591177,"about_ca_system_score_gemma":0.000057250756,"threshold_uncertainty_score":0.17161207},"labels":[],"label_agreement":null},{"id":"W2414145618","doi":"","title":"Coronary Artery Disease - Eighth International Congress. From prevention to intervention.","year":2009,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Coronary artery disease; Clopidogrel; Percutaneous coronary intervention; Cardiology; Prasugrel; Internal medicine; Interventional cardiology; Myocardial infarction","score_opus":0.02041036681844336,"score_gpt":0.26184780742319297,"score_spread":0.24143744060474961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2414145618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812849,0.0012593768,0.0024418943,0.0077673495,0.00178323,0.0020827914,0.000055569097,0.00012019172,0.0032046598],"genre_scores_gemma":[0.9926282,0.000049907158,0.00027959945,0.001701671,0.00074964366,0.00060585566,0.00024375897,0.0000107897795,0.0037305583],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988529,0.000048085454,0.00023220001,0.0002612286,0.00039305518,0.00021253391],"domain_scores_gemma":[0.99913263,0.000008349714,0.00004900771,0.00032469784,0.00007154719,0.0004137789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026225892,0.000099704645,0.00018131781,0.00008745241,0.000035664427,0.000031298958,0.000094321294,0.00003922743,0.00022577713],"category_scores_gemma":[0.0000833428,0.00008837935,0.0002712794,0.00008156154,0.00001361477,0.00012062616,0.000030811683,0.00009350609,0.000059962465],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005863805,0.00043752237,0.010951724,0.00001969402,0.00025696034,0.00017456678,0.00002983948,0.0000049444534,0.000016501355,0.00017425751,0.006155546,0.98119205],"study_design_scores_gemma":[0.0016086244,0.00007988178,0.9642784,0.000072309595,0.00011028104,0.000016848337,0.000016524547,0.00003261117,0.00009095133,0.00097638834,0.032626715,0.00009046451],"about_ca_topic_score_codex":0.00003171981,"about_ca_topic_score_gemma":0.000007771391,"teacher_disagreement_score":0.9811016,"about_ca_system_score_codex":0.00011553587,"about_ca_system_score_gemma":0.000033434113,"threshold_uncertainty_score":0.36040053},"labels":[],"label_agreement":null},{"id":"W2415117000","doi":"10.1016/j.jlr.2026.101063","title":"PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role","year":2016,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Regeneron Pharmaceuticals; GlaxoSmithKline; AstraZeneca; Daiichi-Sankyo; Fondation Leducq; Pfizer; Amgen; Bristol-Myers Squibb; Eisai; Sanofi; Abbott Laboratories","keywords":"Evolocumab; PCSK9; Kexin; LDL receptor; Internal medicine; Endocrinology; Lipoprotein(a); Quartile; Lipoprotein; Monoclonal antibody; Medicine; Internalization; Low-density lipoprotein; Alirocumab; Receptor; Cholesterol; Chemistry; Antibody; Immunology; Confidence interval","score_opus":0.12690597811964371,"score_gpt":0.4673184434497075,"score_spread":0.3404124653300638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415117000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906139,0.0009633383,0.000069058595,0.007518221,0.00010015181,0.00046137464,0.0000060471866,0.0000036308197,0.00026428603],"genre_scores_gemma":[0.9948376,0.0031566815,0.00021566683,0.000025870151,0.0015363287,0.000010513638,0.0000039691977,0.000012142125,0.00020122097],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9913938,0.005313676,0.0013459594,0.00019237894,0.0015079807,0.0002461782],"domain_scores_gemma":[0.99590117,0.0016376983,0.0005226822,0.00041808677,0.0012483483,0.0002720338],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06642368,0.00008745579,0.0012444136,0.0009005341,0.000069427886,0.000021353411,0.000102024416,0.00014458512,0.00027506048],"category_scores_gemma":[0.0073410613,0.000035920166,0.00043165035,0.0012406928,0.00053524645,0.00017695833,0.000034928584,0.00064077135,0.0000046450864],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.110756926,0.0029015802,0.1863049,0.0003591651,0.015305404,0.00017652745,0.003129374,0.0001077123,0.06486525,0.00063874875,0.005835724,0.60961866],"study_design_scores_gemma":[0.11366378,0.022883398,0.7888185,0.0035786466,0.00535853,0.0010040422,0.012271258,0.001513494,0.016554954,0.0009500161,0.032882433,0.0005209511],"about_ca_topic_score_codex":0.00021996009,"about_ca_topic_score_gemma":0.000068162386,"teacher_disagreement_score":0.6090977,"about_ca_system_score_codex":0.00012173982,"about_ca_system_score_gemma":0.00061377557,"threshold_uncertainty_score":0.9613133},"labels":[],"label_agreement":null},{"id":"W2415698085","doi":"10.1371/journal.pone.0157230","title":"Trafficking Dynamics of PCSK9-Induced LDLR Degradation: Focus on Human PCSK9 Mutations and C-Terminal Domain","year":2016,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Institut de Cardiologie de Montréal; Fondation Institut de Cardiologie de Montréal; Institute of Nutrition, Metabolism and Diabetes; Heart and Stroke Foundation of Canada","keywords":"LDL receptor; PCSK9; Cell biology; Endocytosis; Endoplasmic reticulum; Endocytic cycle; Fluorescence recovery after photobleaching; Biology; Receptor; Biochemistry; Cholesterol; Lipoprotein","score_opus":0.05604166675105647,"score_gpt":0.2800887394752601,"score_spread":0.2240470727242036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415698085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957178,0.000082300015,0.0005860935,0.0019361459,0.000026183601,0.00046386666,0.000015517608,0.000042010608,0.001130084],"genre_scores_gemma":[0.9971777,0.000021446875,0.002272057,0.000057086883,0.00017403807,0.000031561074,0.000023325936,0.000021861952,0.00022090094],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99885654,0.00005573611,0.00025266316,0.00021562693,0.00044400996,0.00017541164],"domain_scores_gemma":[0.9993088,0.000051717092,0.00009162307,0.00033288728,0.000097811884,0.00011711059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002716318,0.00011137474,0.00033548905,0.0001079196,0.00010566401,0.0000090050835,0.000047367368,0.00007718243,0.000038638602],"category_scores_gemma":[0.000060152,0.00008078212,0.00008771843,0.00010818067,0.000057548204,0.00006038527,0.000017275048,0.000103699625,0.000008527454],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037734618,0.004368814,0.014603822,0.001517758,0.0019304794,0.00021784693,0.0014900918,0.0000011898971,0.4603896,0.031415034,0.000035670444,0.48365232],"study_design_scores_gemma":[0.034839556,0.011801037,0.3233223,0.01311717,0.004645266,0.00058670813,0.0025588304,0.0010972936,0.5854729,0.020451112,0.00030790622,0.001799976],"about_ca_topic_score_codex":0.000063027874,"about_ca_topic_score_gemma":0.00012540532,"teacher_disagreement_score":0.48185235,"about_ca_system_score_codex":0.00010376602,"about_ca_system_score_gemma":0.00006762046,"threshold_uncertainty_score":0.3294199},"labels":[],"label_agreement":null},{"id":"W2422521579","doi":"","title":"Dyslipidemias and the primary prevention of cardiovascular disease: analysis of the FAMUS primary care register.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Primary care; Medical prescription; Primary prevention; Disease; Family history; Internal medicine; Register (sociolinguistics); Pediatrics; Family medicine; Pharmacology","score_opus":0.013940814680593031,"score_gpt":0.21561933826361337,"score_spread":0.20167852358302035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422521579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89137137,0.0952338,0.00009017381,0.0006103,0.00008349242,0.0030274491,0.00003661608,0.000021157291,0.009525636],"genre_scores_gemma":[0.99482834,0.0030930615,0.00004234713,0.0002778072,0.00013292301,0.0005776749,0.00005121558,0.000015502781,0.0009811503],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978988,0.00040477238,0.00040423425,0.0002724582,0.0007993057,0.000220421],"domain_scores_gemma":[0.9981036,0.000047796064,0.00013695192,0.0014747878,0.000108348475,0.0001284892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015461282,0.00012767637,0.0008700297,0.00008303602,0.000076943885,0.000008033197,0.0001477717,0.00006667197,0.000015369696],"category_scores_gemma":[0.0000857895,0.00006839202,0.0018661516,0.0006448409,0.0002799665,0.000047497026,0.000063147294,0.00014092788,3.7034826e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000621015,0.00006503277,0.011677161,0.0014209534,0.012152575,0.000004960269,0.00036665806,0.0006489888,0.0000028755446,0.00007261312,0.00006906518,0.9728981],"study_design_scores_gemma":[0.0022492527,0.000013797755,0.9658917,0.00006725338,0.01681272,0.000005210491,0.000072725146,0.000034020595,0.00003817102,0.000030666895,0.014713662,0.000070781],"about_ca_topic_score_codex":0.00035647146,"about_ca_topic_score_gemma":0.000011566245,"teacher_disagreement_score":0.9728273,"about_ca_system_score_codex":0.00010446341,"about_ca_system_score_gemma":0.00012435434,"threshold_uncertainty_score":0.27889457},"labels":[],"label_agreement":null},{"id":"W2424761896","doi":"10.1016/j.jval.2015.09.923","title":"Real-World Identification Of European Patients With Statin-Associated Symptoms: Clinical Practice Compared With Clinical Guidelines","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Clinical Practice; Internal medicine; Clinical trial; Physical therapy; Family medicine","score_opus":0.14872329184930203,"score_gpt":0.4334190002766845,"score_spread":0.28469570842738245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2424761896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930908,0.00029201855,0.0004751653,0.0023773974,0.00033063252,0.001680296,0.000032180833,0.000079710284,0.0016418154],"genre_scores_gemma":[0.9860352,0.0005004439,0.01131576,0.0013724287,0.00035967448,0.000017415996,0.00020562978,0.00006359253,0.00012985269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99141395,0.003359831,0.0030852878,0.0005172818,0.0012395735,0.00038409536],"domain_scores_gemma":[0.9944042,0.00048432988,0.001668638,0.00083642517,0.0020557824,0.0005506414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019270193,0.0001952172,0.0010194655,0.00016493819,0.000058445094,0.00001739046,0.00014459084,0.000078841,0.0000034984812],"category_scores_gemma":[0.004572332,0.00013978922,0.0001300216,0.0007066668,0.00014783349,0.0001533265,0.000042797237,0.0004945903,0.000018919367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018641046,0.0019735196,0.9756337,0.0002598454,0.00029284117,0.000033051503,0.00043871324,0.00073828327,4.1100432e-7,0.00016818929,0.0024982998,0.01609908],"study_design_scores_gemma":[0.010572876,0.0032070337,0.9762445,0.0009357293,0.00015215563,0.000008977331,0.00039528048,0.0016419064,0.000002393727,0.000019594128,0.006663817,0.00015574064],"about_ca_topic_score_codex":0.011034552,"about_ca_topic_score_gemma":0.0005001638,"teacher_disagreement_score":0.015943341,"about_ca_system_score_codex":0.0003152337,"about_ca_system_score_gemma":0.0019635835,"threshold_uncertainty_score":0.99555105},"labels":[],"label_agreement":null},{"id":"W2426709627","doi":"10.4172/2368-0512.1000061","title":"Audit of cardiovascular risk assessment and lipid management by Canadian primary care physicians","year":2016,"lang":"en","type":"article","venue":"Current research. Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto; Canadian Respiratory Research Network; St. Michael's Hospital","funders":"","keywords":"Audit; Primary care; Risk assessment; Medicine; Environmental health; Medical emergency; Family medicine; Business; Accounting","score_opus":0.031008089666647518,"score_gpt":0.3385945786998071,"score_spread":0.30758648903315955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2426709627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6018784,0.31012756,0.0135522075,0.0026508875,0.002217754,0.007455739,0.0016497821,0.00015885381,0.060308825],"genre_scores_gemma":[0.93688816,0.06149588,0.00017920733,0.00004253813,0.000788264,0.00024291793,0.00019947567,0.00004113273,0.00012242599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958995,0.0010112071,0.00033489533,0.0007069915,0.0011019321,0.00094548566],"domain_scores_gemma":[0.9974785,0.00009261628,0.00006765529,0.0013167674,0.0005220074,0.0005224791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023679596,0.00022989814,0.0010432064,0.00038707702,0.0002309043,0.000014125203,0.00021245367,0.00015604631,0.000018704352],"category_scores_gemma":[0.00006472445,0.00016300385,0.0006929351,0.00030744728,0.00049878086,0.000066781846,0.00023029473,0.00054215296,0.000023624663],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047959325,0.000039623854,0.029902149,0.0012790749,0.0027183094,0.000103314196,0.00009760938,0.000007842731,0.00024052382,0.00032907692,0.010411663,0.95482284],"study_design_scores_gemma":[0.0025812176,0.00042369167,0.19174904,0.00047515528,0.0006015021,0.00005089738,0.00037653456,0.0000037320224,0.00014222284,0.00009349585,0.80328816,0.00021436425],"about_ca_topic_score_codex":0.008701099,"about_ca_topic_score_gemma":0.00050884543,"teacher_disagreement_score":0.9546085,"about_ca_system_score_codex":0.0011399975,"about_ca_system_score_gemma":0.0007858683,"threshold_uncertainty_score":0.99790007},"labels":[],"label_agreement":null},{"id":"W2433677697","doi":"","title":"Evaluation of Food Effects on the Oral Pharmacokinetics of Rosuvastatin","year":2016,"lang":"en","type":"article","venue":"Scholarship@Western (Western University)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Pharmacokinetics; Medicine; Pharmacology; Food science; Chemistry","score_opus":0.12662239655207486,"score_gpt":0.3506749169246153,"score_spread":0.22405252037254042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2433677697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976043,0.0001654256,0.00044466977,0.00045325528,0.00013431085,0.00092112133,0.00002514087,0.000028390275,0.00022339242],"genre_scores_gemma":[0.9993015,0.0000677036,0.000023816201,0.00017381378,0.000082034625,0.0000030395734,0.000003917469,0.000024436109,0.00031972007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970477,0.00083657715,0.00024307716,0.0002744245,0.0013569784,0.00024122439],"domain_scores_gemma":[0.99816793,0.00021564477,0.00022150158,0.0006454509,0.0006136489,0.00013579415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002261017,0.00017649765,0.00037649908,0.00022611572,0.000062710096,0.000011650481,0.00024611142,0.000099587545,0.000039496583],"category_scores_gemma":[0.0002501735,0.000111231006,0.00024108529,0.0003277451,0.00010683852,0.00020702188,0.000091642454,0.00020835767,0.00002519271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069548376,0.00037383375,0.79875183,0.0005468003,0.0010779523,0.000054449825,0.0003570853,0.00001916439,0.068648726,0.00040783756,0.0000032319144,0.12906362],"study_design_scores_gemma":[0.005020322,0.0011283114,0.68382996,0.00072518294,0.0009581833,0.000014338346,0.00006189436,7.418028e-7,0.3076268,0.00013682037,0.00037079863,0.00012666911],"about_ca_topic_score_codex":0.0000031492993,"about_ca_topic_score_gemma":0.00007325569,"teacher_disagreement_score":0.23897807,"about_ca_system_score_codex":0.0001795374,"about_ca_system_score_gemma":0.00024117394,"threshold_uncertainty_score":0.45358688},"labels":[],"label_agreement":null},{"id":"W2442275618","doi":"10.7748/ns.20.27.20.s27","title":"A quick fix?","year":2006,"lang":"en","type":"article","venue":"Nursing Standard","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"World Federation of Science Journalists","funders":"","keywords":"Computer science","score_opus":0.009739219158140317,"score_gpt":0.28457313402324924,"score_spread":0.27483391486510894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442275618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7547462,0.00536489,0.016105503,0.007516356,0.00070000347,0.0007827442,0.000033854223,0.0003582355,0.2143922],"genre_scores_gemma":[0.9938722,0.000018761693,0.0034084949,0.00027354743,0.0008680774,0.000007372408,0.000017262299,0.00002322499,0.00151106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896115,0.00002379966,0.00014670951,0.00017315282,0.00044977022,0.0002454458],"domain_scores_gemma":[0.9994807,0.000006698235,0.000026728416,0.00032035858,0.00008055876,0.00008493702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024891295,0.00008754786,0.00024153363,0.000050401883,0.00009314785,0.00001877904,0.000030658997,0.000063343774,0.00009381655],"category_scores_gemma":[0.000017869146,0.00007380594,0.00015606404,0.00012846792,0.000058799644,0.00003126807,0.000004052851,0.000122009944,0.00002819237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010013755,0.00037672807,0.0063451,0.00027172387,0.00012896695,0.00026017515,0.00047565336,0.000025273317,0.0030994758,0.012470102,0.1484996,0.82704586],"study_design_scores_gemma":[0.0070901117,0.0012540283,0.096352495,0.0015214742,0.0003849075,0.00076075224,0.00031752128,0.00009357553,0.016013393,0.007971382,0.8677961,0.00044425798],"about_ca_topic_score_codex":0.00015823123,"about_ca_topic_score_gemma":0.000009924591,"teacher_disagreement_score":0.82660156,"about_ca_system_score_codex":0.00024958988,"about_ca_system_score_gemma":0.00016555426,"threshold_uncertainty_score":0.30097187},"labels":[],"label_agreement":null},{"id":"W2462158264","doi":"10.14740/jmc.v7i7.2533","title":"Familial Hyperlipidemia Screening, Treatment and New Considerations","year":2016,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Hyperlipidemia; Disease; Pediatrics; Population; Genetic testing; Presentation (obstetrics); Internal medicine; Cholesterol; Endocrinology; Surgery; Diabetes mellitus; Environmental health","score_opus":0.07094265294787856,"score_gpt":0.33425632396222227,"score_spread":0.2633136710143437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462158264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9174844,0.0073267384,0.0050891284,0.069395326,0.00030292882,0.00016148237,0.00000477637,0.0000131606575,0.00022206698],"genre_scores_gemma":[0.9876229,0.0041873837,0.0026267671,0.001852249,0.0032598698,0.0000016838877,5.169646e-7,0.00001001776,0.0004386134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863976,0.00006956601,0.00035414787,0.00008816819,0.00071403274,0.00013431013],"domain_scores_gemma":[0.99852985,0.00035201432,0.00010161845,0.00012656323,0.000091328184,0.00079860823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063826336,0.00008334761,0.0003692881,0.00006178999,0.000052115684,0.000009798716,0.000028491526,0.000100344274,0.00064989086],"category_scores_gemma":[0.0024671268,0.000039054423,0.00018642144,0.00003434812,0.000080854705,0.000060956107,0.0000143881125,0.0001229545,0.000004711074],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024926197,0.00014669474,0.009888889,0.000031298845,0.00041198428,0.004418177,0.000119118864,3.195409e-7,0.00056737685,0.0005440162,0.04086789,0.942755],"study_design_scores_gemma":[0.03542799,0.010366993,0.076969065,0.002543122,0.0015027374,0.18952638,0.00055808324,0.00003974624,0.0037287278,0.0011886089,0.6778016,0.00034691318],"about_ca_topic_score_codex":0.00028965855,"about_ca_topic_score_gemma":0.000051636005,"teacher_disagreement_score":0.9424081,"about_ca_system_score_codex":0.00006064883,"about_ca_system_score_gemma":0.00095003843,"threshold_uncertainty_score":0.7115849},"labels":[],"label_agreement":null},{"id":"W2462627069","doi":"10.1161/circgenetics.116.001405","title":"Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation","year":2016,"lang":"en","type":"article","venue":"Circulation Cardiovascular Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Amarin Corporation; F. Hoffmann-La Roche; AstraZeneca","keywords":"Placebo; Medicine; Genotype; Internal medicine; Endocrinology; C-reactive protein; Cholesterol; Inflammation; Pharmacology; Gastroenterology; Pathology; Biology; Gene; Genetics","score_opus":0.010249104583389587,"score_gpt":0.22714129441049472,"score_spread":0.21689218982710512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462627069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622218,0.0053829667,0.030507868,0.00011778013,0.00023097967,0.0011731427,0.0000044125313,0.000051537587,0.00030952675],"genre_scores_gemma":[0.9977134,0.0012514826,0.00037796612,0.00006533381,0.00046501603,0.000041253217,0.000009768524,0.000042297295,0.000033496894],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979435,0.00017149598,0.00035676474,0.00039175162,0.0009101452,0.0002263248],"domain_scores_gemma":[0.99845594,0.00006430358,0.00009725115,0.001010888,0.00020564445,0.00016594942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006477397,0.00019471867,0.00053493393,0.00016551212,0.00006311236,0.000014207128,0.00006227302,0.00017608565,0.000008714205],"category_scores_gemma":[0.00014294196,0.00014499844,0.0005791191,0.0001521039,0.00007343666,0.000057087083,0.000035505203,0.00009519819,0.000025805039],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006189005,0.00007650016,0.040002413,0.0015697241,0.0025454157,0.000021029507,0.00021715419,0.001517452,0.090303734,0.0003191024,0.000012439933,0.86335313],"study_design_scores_gemma":[0.0050662793,0.00027512875,0.8569718,0.0003138942,0.00091627066,0.00011987036,0.00001114916,0.00014978556,0.13292834,0.00010988211,0.0029199761,0.00021763374],"about_ca_topic_score_codex":0.000014812611,"about_ca_topic_score_gemma":0.0000013780202,"teacher_disagreement_score":0.8631355,"about_ca_system_score_codex":0.000104296974,"about_ca_system_score_gemma":0.00007699853,"threshold_uncertainty_score":0.5912865},"labels":[],"label_agreement":null},{"id":"W2463343128","doi":"","title":"Clinical Research Regional Distribution and Metabolic Effect of PCSK9 insLEU and R46L Gene Mutations and apoE Genotype","year":2013,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PCSK9; Kexin; Genetics; Genotype; Apolipoprotein E; Biology; Population; Proprotein convertase; Apolipoprotein B; Mutation; Gene; Cholesterol; LDL receptor; Internal medicine; Medicine; Endocrinology; Lipoprotein; Disease","score_opus":0.05622311008518313,"score_gpt":0.390721850990755,"score_spread":0.33449874090557186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463343128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017394,0.0073085376,0.0005297321,0.0008807187,0.000026137097,0.00081057224,0.0000090269405,0.000013797276,0.00024753195],"genre_scores_gemma":[0.9956612,0.0028936588,0.0009062507,0.00009294391,0.00017432246,0.000049154798,0.00006448661,0.000008675553,0.00014930897],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99866045,0.00033802877,0.00025386174,0.00024034557,0.00032739743,0.00017990475],"domain_scores_gemma":[0.9990393,0.0002555789,0.000034418656,0.000228835,0.00021472438,0.0002271556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020713117,0.00008143179,0.0003644915,0.00006255575,0.00010456587,0.000018107308,0.000024313438,0.00010394694,0.00003032018],"category_scores_gemma":[0.00032206954,0.00005514013,0.00006558241,0.0001561615,0.00031074046,0.00006780041,0.000059887556,0.00021486472,0.000007992048],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039564748,0.00018762451,0.23673117,0.0007981379,0.0006464262,0.000015753196,0.00021028324,7.469108e-7,0.0050551747,0.0039693364,0.0026425705,0.74934715],"study_design_scores_gemma":[0.0025932936,0.00083950744,0.98543483,0.000035815046,0.00016056387,0.00012787788,0.00005614252,0.00031421115,0.0025447935,0.00038213987,0.007438079,0.00007271847],"about_ca_topic_score_codex":0.001153279,"about_ca_topic_score_gemma":0.000014950962,"teacher_disagreement_score":0.74927443,"about_ca_system_score_codex":0.0000114595805,"about_ca_system_score_gemma":0.00008713483,"threshold_uncertainty_score":0.22485493},"labels":[],"label_agreement":null},{"id":"W2465805460","doi":"10.1097/shk.0000000000000682","title":"Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis","year":2016,"lang":"en","type":"article","venue":"Shock","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Montreal Clinical Research Institute; Thrombosis and Atherosclerosis Research Institute; McMaster University Medical Centre; Canadian Institutes of Health Research","funders":"Canadian Institutes of Health Research","keywords":"Inflammation; Sepsis; PCSK9; Coagulation; Immunology; Differential (mechanical device); Medicine; Internal medicine; LDL receptor; Cholesterol","score_opus":0.014444631264518752,"score_gpt":0.25097929677079106,"score_spread":0.2365346655062723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465805460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97987247,0.00006432232,0.019568773,0.00013885781,0.000022868904,0.00024178228,0.000003918434,0.000010708492,0.000076279575],"genre_scores_gemma":[0.9992158,0.00012045163,0.0005156789,0.0000041967382,0.00005589045,0.0000075924645,0.000005569961,0.0000072119583,0.0000676484],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99935997,0.000027447139,0.00025284904,0.000107502645,0.00017753917,0.00007468771],"domain_scores_gemma":[0.99959666,0.000013322672,0.000078905345,0.00017842151,0.00009513681,0.000037563026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011230932,0.000060555754,0.00021778252,0.000104797626,0.000013709475,0.0000015133381,0.000014618218,0.000059839494,0.000034762303],"category_scores_gemma":[0.000049538878,0.00003913324,0.00005512641,0.000075558055,0.000027300097,0.00007040182,0.000023363733,0.00003273944,6.492321e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015308161,0.00005967622,0.13269514,0.00043443014,0.000033460365,5.061885e-7,0.00028196216,0.000757486,0.8231977,0.00019155462,0.000023829107,0.042171117],"study_design_scores_gemma":[0.0024590108,0.00010584593,0.38692114,0.0005068518,0.00004256783,0.0000038330268,0.00001173825,0.017669268,0.59072566,0.0014566976,0.00003045911,0.00006694468],"about_ca_topic_score_codex":0.00019122506,"about_ca_topic_score_gemma":0.00003822582,"teacher_disagreement_score":0.254226,"about_ca_system_score_codex":0.000023854103,"about_ca_system_score_gemma":0.00003344679,"threshold_uncertainty_score":0.15958072},"labels":[],"label_agreement":null},{"id":"W2466507786","doi":"","title":"The need for a different cholesterol lowering drug.","year":2003,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Drug; Cholesterol; Pharmacology; Traditional medicine; Internal medicine","score_opus":0.01791061249476652,"score_gpt":0.2293658735400791,"score_spread":0.21145526104531256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466507786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850607,0.0017174282,0.0015327386,0.0028882027,0.000583515,0.0039756973,0.0000023845073,0.0000650578,0.004174292],"genre_scores_gemma":[0.99240464,0.00009783546,0.000037858998,0.0005061423,0.00024188962,0.004478089,0.0000019809622,0.00001952011,0.0022120695],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991102,0.000030548013,0.00013941401,0.00014277187,0.0002002102,0.0003768228],"domain_scores_gemma":[0.9993629,0.000043061966,0.000029300876,0.0003716008,0.00003675083,0.00015640525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006204537,0.000086953136,0.000178705,0.000021478909,0.0001358815,0.000030325295,0.000052667532,0.000030754018,0.0000027186159],"category_scores_gemma":[0.0001592917,0.000049541104,0.00019858814,0.0000581676,0.000022173237,0.000021069955,0.000011403829,0.0000883956,0.0000028548207],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015115684,0.00011277877,0.0049342033,0.0002129616,0.00029597347,0.000004994777,0.0001439358,0.000002824883,0.00005785182,0.0011258362,0.0019265981,0.9910309],"study_design_scores_gemma":[0.0044197524,0.000049755618,0.51887757,0.000025750494,0.00015706272,0.000039431103,0.0001787052,0.00002362612,0.007948757,0.00026811028,0.46785584,0.00015562001],"about_ca_topic_score_codex":0.000015536718,"about_ca_topic_score_gemma":0.000018062867,"teacher_disagreement_score":0.99087524,"about_ca_system_score_codex":0.00005934082,"about_ca_system_score_gemma":0.000022140313,"threshold_uncertainty_score":0.20202276},"labels":[],"label_agreement":null},{"id":"W2466927139","doi":"10.1080/13543776.2016.1206080","title":"Proprotein convertase subtilisin / kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015)","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Fondation Leducq","keywords":"PCSK9; Alirocumab; Evolocumab; Kexin; Proprotein convertase; Dyslipidemia; Medicine; Pharmacology; Monoclonal antibody; Cholesterol; LDL receptor; Antibody; Internal medicine; Immunology; Lipoprotein; Disease","score_opus":0.08188793832644997,"score_gpt":0.36030734811684423,"score_spread":0.27841940979039426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466927139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003268545,0.98585415,0.00002030571,0.0027452493,0.0017437476,0.009362099,0.000102148064,0.00009113614,0.00004845729],"genre_scores_gemma":[0.0001224274,0.99210286,0.00003511239,0.003765591,0.0018234458,0.0011512572,0.0006651643,0.00018282153,0.00015132272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99286693,0.0024154591,0.0017286312,0.001081745,0.0012632075,0.00064401975],"domain_scores_gemma":[0.9957718,0.00010288499,0.0010936905,0.002301323,0.00029591442,0.0004343719],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027939011,0.0010435372,0.004231293,0.00022396963,0.00018409322,0.00003248457,0.000493785,0.00070151326,0.00051484065],"category_scores_gemma":[0.000035357556,0.00046853017,0.0013920453,0.00027337065,0.00038943245,0.00012959955,0.00010539697,0.0007916604,0.00011821613],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005709112,0.0002853962,0.000008512243,0.008240288,0.0010860243,0.000009889593,0.00013853189,8.606741e-9,0.000009612322,0.00014756642,0.0027981603,0.9867051],"study_design_scores_gemma":[0.0052301884,0.0007805369,0.000033385284,0.051469777,0.00024564555,0.000087908775,0.000044130033,0.0000028221186,0.00007980965,0.00004589388,0.9414789,0.0005010023],"about_ca_topic_score_codex":0.00014219143,"about_ca_topic_score_gemma":0.0000017940596,"teacher_disagreement_score":0.9862041,"about_ca_system_score_codex":0.00020271055,"about_ca_system_score_gemma":0.0005779772,"threshold_uncertainty_score":0.99977666},"labels":[],"label_agreement":null},{"id":"W2467648341","doi":"","title":"Façons d’identifier et de prendre en charge la dyslipidémie athérogène","year":2013,"lang":"fr","type":"article","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Humanities; Art","score_opus":0.010707813413016827,"score_gpt":0.2448302932442676,"score_spread":0.23412247983125078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467648341","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22370772,0.045239348,0.00017794834,0.016030133,0.0049025165,0.0026726406,0.0007498635,0.00013589153,0.70638394],"genre_scores_gemma":[0.7275649,0.0023124136,0.00041115878,0.18720885,0.011145729,0.00045732033,0.00034661047,0.00029514352,0.07025788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562216,0.0007330282,0.00043902916,0.00067733414,0.00053326186,0.0019951889],"domain_scores_gemma":[0.99572533,0.00011197581,0.00010794582,0.0012668257,0.00020774732,0.0025801852],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010855559,0.0004920284,0.0007555168,0.00028513474,0.0002787323,0.00022503505,0.00039193814,0.00051449554,0.00031832515],"category_scores_gemma":[0.000076505756,0.0005431903,0.0005778323,0.0005099384,0.00022764289,0.00042877652,0.00006848518,0.0009836989,0.0067778514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000110500005,0.00028027454,0.0007372948,0.0009134234,0.0011447177,0.00065167557,0.0021016456,0.000024297497,0.0056178523,0.028262634,0.45873252,0.5015226],"study_design_scores_gemma":[0.0010740712,0.00012579796,0.084685296,0.0008634828,0.00036640518,0.000031370957,0.0012644287,0.00028093258,0.0004378708,0.0006264824,0.90969795,0.0005459124],"about_ca_topic_score_codex":0.30666482,"about_ca_topic_score_gemma":0.032011267,"teacher_disagreement_score":0.63612604,"about_ca_system_score_codex":0.0017512438,"about_ca_system_score_gemma":0.0054160883,"threshold_uncertainty_score":0.999702},"labels":[],"label_agreement":null},{"id":"W2470129184","doi":"10.1016/j.cjca.2016.07.002","title":"The Sum of Its Parts: The Polygenic Basis of Coronary Artery Disease","year":2016,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University; University of Ottawa; Canadian Heart Research Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Coronary artery disease; Cardiology; Internal medicine; Basis (linear algebra); Geometry","score_opus":0.01626312776756616,"score_gpt":0.22908429071728156,"score_spread":0.2128211629497154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470129184","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010413973,0.083284564,0.00017766704,0.89905685,0.003205164,0.00082122465,0.00058711355,0.000004298395,0.0024491556],"genre_scores_gemma":[0.86290044,0.0064604916,0.00000881549,0.105619475,0.023701055,0.000022786227,0.000032465607,0.00007498966,0.0011795029],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724674,0.00071096263,0.00081207295,0.00017857534,0.00046637194,0.00058529485],"domain_scores_gemma":[0.99691755,0.00032989684,0.0006208587,0.00096539815,0.00058557536,0.00058071193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014053066,0.00023242662,0.001231736,0.00022295225,0.00013832781,0.0000087864655,0.0004800175,0.00040308837,0.000049239596],"category_scores_gemma":[0.00036929728,0.00011128486,0.0015341393,0.00010856917,0.00059356913,0.00003510429,0.000023809936,0.0011382567,0.0000075737444],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016814416,0.0000012736876,0.005110463,0.00027798547,0.0030829194,0.0030130928,0.00004524931,0.000012859451,0.000016449374,0.000048416867,0.96779484,0.020428304],"study_design_scores_gemma":[0.0006547699,0.00026673469,0.033231724,0.00036635058,0.0011004158,0.002814875,0.00005022885,4.892299e-7,0.000022962058,0.00010566084,0.96128005,0.000105765],"about_ca_topic_score_codex":0.0003400301,"about_ca_topic_score_gemma":0.00035531566,"teacher_disagreement_score":0.85248643,"about_ca_system_score_codex":0.00019525664,"about_ca_system_score_gemma":0.0062959953,"threshold_uncertainty_score":0.9993374},"labels":[],"label_agreement":null},{"id":"W2471384323","doi":"10.1016/j.jacl.2016.06.008","title":"Management strategies in patients with statin-associated muscle symptoms: What is the best strategy?","year":2016,"lang":"en","type":"editorial","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Tolerability; Statin; Dosing; Intensive care medicine; Management strategy; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Adverse effect","score_opus":0.02202002240606705,"score_gpt":0.3560976123873917,"score_spread":0.33407758998132464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471384323","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12951277,0.0019008686,0.00006108001,0.0022301048,0.8639456,0.0012311708,0.000078266276,0.000016308104,0.0010238234],"genre_scores_gemma":[0.038228482,0.016706938,0.0001801998,0.0008561517,0.94298327,0.0000256659,0.00008042351,0.00010019778,0.00083867315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933765,0.0011735559,0.002594193,0.00043244156,0.0018822193,0.0005410787],"domain_scores_gemma":[0.9933354,0.0021914567,0.0022733682,0.0006991112,0.0012271783,0.00027347083],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0056753904,0.00037849045,0.0021930258,0.00020521983,0.000070057686,0.00011527706,0.00044953995,0.0011782766,0.00011382307],"category_scores_gemma":[0.0011718277,0.00018231325,0.0007829521,0.00020691229,0.0003176217,0.00036049154,0.00010123452,0.0026533375,0.000028666833],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041015376,0.0021857733,0.014608873,0.00043517305,0.0047872015,0.00024641375,0.00016045714,0.000010986321,1.975953e-7,0.00009653383,0.6909113,0.28245553],"study_design_scores_gemma":[0.021045662,0.012505692,0.13455784,0.0039854017,0.0014628043,0.0000097787215,0.0012772545,0.0000014506147,3.4345248e-7,0.0005653375,0.82426965,0.00031875927],"about_ca_topic_score_codex":0.000051522195,"about_ca_topic_score_gemma":0.00007773824,"teacher_disagreement_score":0.28213677,"about_ca_system_score_codex":0.00020975905,"about_ca_system_score_gemma":0.0017339318,"threshold_uncertainty_score":0.99964756},"labels":[],"label_agreement":null},{"id":"W2472281584","doi":"10.2337/db16-0046","title":"Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol","year":2016,"lang":"en","type":"review","venue":"Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Dyslipidemia; Hypertriglyceridemia; Niacin; Medicine; Hyperlipidemia; Internal medicine; Type 2 diabetes; Diabetes mellitus; Cholesterol; Endocrinology; Triglyceride","score_opus":0.05997554743685255,"score_gpt":0.34069092197831286,"score_spread":0.2807153745414603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2472281584","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03779333,0.95903516,0.000018853834,0.00017428423,0.00043596982,0.0022718122,0.000019344716,0.000022283315,0.00022895359],"genre_scores_gemma":[0.013155685,0.9849422,0.000076681616,0.00028437335,0.0008792114,0.00036335344,0.000035922967,0.000061438746,0.00020111591],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972834,0.000649058,0.0008290144,0.00037280298,0.00041624147,0.0004494722],"domain_scores_gemma":[0.9986531,0.00017967317,0.0004598398,0.000571572,0.00005509465,0.00008067794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018382448,0.00032979806,0.0016749434,0.00007225736,0.00009620054,0.000019043397,0.00038529388,0.00027225024,0.00017393654],"category_scores_gemma":[0.00017211644,0.00014116077,0.0013966421,0.00026316586,0.00013176093,0.000062232066,0.00019919957,0.0006025762,0.000029928331],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004329199,0.00007133281,0.0007436105,0.005897244,0.0006079155,0.0000018295391,0.000041477208,5.332718e-7,0.00030003514,0.000010183726,0.0005916732,0.99172986],"study_design_scores_gemma":[0.0010967813,0.000103509155,0.0019391801,0.018096149,0.0018289288,0.000007612054,0.000027859825,0.000017522414,0.00042930103,0.00009003337,0.97609174,0.00027135754],"about_ca_topic_score_codex":0.000009564341,"about_ca_topic_score_gemma":0.0000024272958,"teacher_disagreement_score":0.9914585,"about_ca_system_score_codex":0.00016629312,"about_ca_system_score_gemma":0.00018876466,"threshold_uncertainty_score":0.57563686},"labels":[],"label_agreement":null},{"id":"W2473272179","doi":"10.1001/jamainternmed.2016.2751","title":"Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment","year":2016,"lang":"en","type":"article","venue":"JAMA Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Clalit Health Services","keywords":"Medicine; Internal medicine; Hazard ratio; Myocardial infarction; Statin; Cardiology; Propensity score matching; Proportional hazards model; Unstable angina; Population; Adverse effect; Cohort; Stroke (engine); Confidence interval","score_opus":0.011603211862202117,"score_gpt":0.25098481039449105,"score_spread":0.23938159853228894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473272179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933012,0.00023259461,0.00027447336,0.0044299555,0.00014299435,0.001363167,0.00010194556,0.000034292574,0.00011936478],"genre_scores_gemma":[0.9974059,0.00003959904,0.00019551085,0.0003724308,0.00064354826,0.00007637602,0.00005266528,0.000035742607,0.0011782155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976018,0.00018443607,0.00044267363,0.00043257614,0.0009167037,0.00042182332],"domain_scores_gemma":[0.9985796,0.00013484099,0.000279673,0.00037997015,0.00018913619,0.00043676316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077825494,0.000268334,0.00077364506,0.00013919972,0.000059648857,0.000006581635,0.00006388701,0.00010712941,0.00008270779],"category_scores_gemma":[0.0006491149,0.00015153002,0.00011023707,0.00014269873,0.000051742863,0.00019252278,0.000050647326,0.00021446787,0.000015622574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011976138,0.00015365423,0.9689124,0.00013527964,0.0004658728,0.000028218474,0.00021749256,2.631075e-7,0.00064710283,0.000001782922,0.00022273247,0.028017553],"study_design_scores_gemma":[0.015627578,0.0011680925,0.9769051,0.0028781486,0.00042297825,0.0000022585853,0.000061206454,0.0000023228033,0.0015399259,0.000021640713,0.0012064034,0.00016430952],"about_ca_topic_score_codex":0.005257297,"about_ca_topic_score_gemma":0.0001196906,"teacher_disagreement_score":0.027853243,"about_ca_system_score_codex":0.0011290374,"about_ca_system_score_gemma":0.00013200271,"threshold_uncertainty_score":0.7947495},"labels":[],"label_agreement":null},{"id":"W2473964618","doi":"10.1016/j.vph.2016.06.007","title":"Dietary high oleic canola oil supplemented with docosahexaenoic acid attenuates plasma proprotein convertase subtilisin kexin type 9 (PCSK9) levels in participants with cardiovascular disease risk: A randomized control trial","year":2016,"lang":"en","type":"article","venue":"Vascular Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Agriculture and Agri-Food Canada; Pennsylvania State University","keywords":"PCSK9; Canola; Cholesterol; Kexin; Apolipoprotein B; Internal medicine; Docosahexaenoic acid; Triglyceride; Chemistry; Endocrinology; Food science; Polyunsaturated fatty acid; Biology; LDL receptor; Medicine; Fatty acid; Biochemistry; Lipoprotein","score_opus":0.022407605940279136,"score_gpt":0.27079834390720003,"score_spread":0.2483907379669209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2473964618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817071,0.0064153364,0.0006554799,0.0014887548,0.0004974498,0.008734055,0.00030844298,0.00016941674,0.000023941826],"genre_scores_gemma":[0.9922023,0.0015142299,0.0002782177,0.0005146967,0.00065630546,0.004368107,0.00013500293,0.00015281039,0.00017835519],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9907935,0.0035110782,0.0011052884,0.0014269635,0.0015279897,0.0016351428],"domain_scores_gemma":[0.9963182,0.00033759393,0.0003576895,0.0015000191,0.00046046413,0.0010260046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004622329,0.00082260143,0.00324252,0.0004129989,0.00021548188,0.0000368107,0.00032233185,0.0002625966,0.0008146508],"category_scores_gemma":[0.0004898315,0.00046517735,0.0012261035,0.0006385653,0.00064617046,0.0002389398,0.00009332226,0.0006450954,0.00009153765],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92420167,0.0013302343,0.007025535,0.00057413435,0.024349125,0.0035726887,0.00024112046,0.0005607551,0.008256738,0.00001637686,0.00017486533,0.029696757],"study_design_scores_gemma":[0.9465953,0.0022593015,0.0060656522,0.00042742863,0.0133016,0.00009944967,0.00004946319,0.00080067577,0.023599936,0.000020655283,0.0060147033,0.0007658298],"about_ca_topic_score_codex":0.004333426,"about_ca_topic_score_gemma":0.0006623776,"teacher_disagreement_score":0.028930927,"about_ca_system_score_codex":0.00040528597,"about_ca_system_score_gemma":0.0016266634,"threshold_uncertainty_score":0.99978},"labels":[],"label_agreement":null},{"id":"W2475686707","doi":"","title":"The Canadian Activase for Stroke Effectiveness Study (CASES)","year":2000,"lang":"en","type":"article","venue":"Oxford University Research Archive (ORA) (University of Oxford)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stroke (engine); Emergency medicine","score_opus":0.031016217660971287,"score_gpt":0.2842774803642978,"score_spread":0.2532612627033265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2475686707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594449,0.00007371273,0.00091483525,0.0011638238,0.000053850796,0.00413278,0.00047575182,0.00004909625,0.03369129],"genre_scores_gemma":[0.9899686,0.0008821658,0.00077098154,0.000021641541,0.00007765686,0.0000023594541,0.00007432004,0.0000277614,0.008174523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962215,0.0009920654,0.0001358579,0.00058303896,0.0010321897,0.0010353777],"domain_scores_gemma":[0.99655235,0.0009162511,0.00006809479,0.0009812876,0.00056939747,0.00091264094],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.002600709,0.00022296784,0.0005204336,0.0006472788,0.00367386,0.000044453296,0.0008148521,0.00013373895,0.00025173204],"category_scores_gemma":[0.00016782066,0.00022084196,0.0005238964,0.0007696578,0.00079828565,0.00028051712,0.00023774951,0.0007625785,0.0000138210735],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057871386,0.0035157762,0.12117772,0.0014608699,0.006064215,0.00734812,0.0083457,0.00023400749,0.0010854471,0.012749461,0.00857637,0.7715709],"study_design_scores_gemma":[0.00827939,0.004047155,0.19390464,0.00012187708,0.00029482465,0.000064376494,0.023173839,0.0005163754,0.000080735976,0.00033716747,0.7688821,0.00029753364],"about_ca_topic_score_codex":0.14807849,"about_ca_topic_score_gemma":0.3682411,"teacher_disagreement_score":0.7712734,"about_ca_system_score_codex":0.00087444566,"about_ca_system_score_gemma":0.0020207553,"threshold_uncertainty_score":0.9976232},"labels":[],"label_agreement":null},{"id":"W2479121431","doi":"10.1097/01.hjh.0000491549.56503.e0","title":"[OP.7A.04] ANTIHYPERTENSIVE DRUGS AND THE RISK OF FEMUR FRACTURE IN HYPERTENSIVE PATIENTS IN SWEDISH PRIMARY HEALTH CARE. RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE (SPCCD)","year":2016,"lang":"en","type":"article","venue":"Journal of Hypertension","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Family Medicine","funders":"","keywords":"Medicine; Thiazide; Femur fracture; Osteoporosis; Internal medicine; Hip fracture; Femur; Population; Surgery; Blood pressure; Environmental health","score_opus":0.010007108300889231,"score_gpt":0.21547462065270098,"score_spread":0.20546751235181177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2479121431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89045876,0.099609554,0.000037507587,0.007409449,0.00056190544,0.0014410324,0.00038458302,0.000011597472,0.00008563242],"genre_scores_gemma":[0.94650376,0.042591836,0.00049634586,0.00942387,0.0007152866,0.000010326965,0.00019231455,0.000060222006,0.0000060667717],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9939506,0.0013172074,0.0016683178,0.00062201533,0.0018896975,0.00055216486],"domain_scores_gemma":[0.9941725,0.00096207653,0.0011042557,0.0014919387,0.001967059,0.0003021413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002832745,0.00043908827,0.0025333082,0.0002728568,0.00021542622,0.000027242715,0.00034383344,0.00020827241,0.0000033876831],"category_scores_gemma":[0.00168937,0.00019301742,0.0010168536,0.0004167956,0.00035786585,0.0003277235,0.00024217984,0.001131431,0.0000024473698],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047301766,0.0017979674,0.2783286,0.0027641102,0.00789899,0.005802669,0.04637137,0.00028109027,0.0031300064,0.000014982853,0.046881463,0.55942696],"study_design_scores_gemma":[0.05228667,0.00079546793,0.91700995,0.003931275,0.0014330059,0.00072669523,0.010279539,0.000019761585,0.00034669958,0.000037581984,0.012793037,0.0003402934],"about_ca_topic_score_codex":0.009015704,"about_ca_topic_score_gemma":0.00036952485,"teacher_disagreement_score":0.63868135,"about_ca_system_score_codex":0.00054362457,"about_ca_system_score_gemma":0.0009932054,"threshold_uncertainty_score":0.9975833},"labels":[],"label_agreement":null},{"id":"W2482219044","doi":"10.17925/use.2006.00.1.52","title":"Treating the Common Dyslipidemia in Patients with Type 2 Diabetes: Insights from FIELD on the Effects of Fenofibrate on CVD Risk","year":2006,"lang":"en","type":"article","venue":"US Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Fenofibrate; Medicine; Dyslipidemia; Type 2 diabetes; Internal medicine; Diabetes mellitus; Intensive care medicine; Endocrinology","score_opus":0.00446767229858048,"score_gpt":0.20795411919299106,"score_spread":0.2034864468944106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2482219044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577993,0.0004450887,0.000002572984,0.00037076758,0.00016998831,0.0006830266,0.000005034636,0.000019443074,0.0025241454],"genre_scores_gemma":[0.9984959,0.000044387525,0.000031856638,0.0011646844,0.00015784513,0.00003722644,0.000022917446,0.00001592667,0.000029249322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873656,0.00036058357,0.0002178177,0.00020756281,0.0002076755,0.00026979842],"domain_scores_gemma":[0.9981325,0.0010974315,0.00012401585,0.00058168906,0.000036570666,0.00002774482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007490583,0.00014106765,0.00037792238,0.00006249662,0.00008553198,0.0000048415995,0.00010442422,0.0000726163,0.000014645695],"category_scores_gemma":[0.00020542443,0.00006495098,0.00007372651,0.00015626193,0.00006337915,0.000015907926,0.000030626965,0.00037465975,0.000013135977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048000232,0.00023794542,0.979204,0.000062531515,0.00018708162,0.000029123587,0.00017131558,0.00005697289,0.00024401456,0.0011228957,0.00039424482,0.01780988],"study_design_scores_gemma":[0.0025896002,0.0032821859,0.97398806,0.00021997253,0.00009662445,7.438056e-7,0.00002585904,0.000035623296,0.018441098,0.00041875106,0.00082420534,0.000077267614],"about_ca_topic_score_codex":0.0037267725,"about_ca_topic_score_gemma":0.0005300273,"teacher_disagreement_score":0.018197084,"about_ca_system_score_codex":0.000043301243,"about_ca_system_score_gemma":0.000028847227,"threshold_uncertainty_score":0.563379},"labels":[],"label_agreement":null},{"id":"W2483759532","doi":"10.1177/1715163516662291","title":"A randomized trial of a community-based approach to dyslipidemia management","year":2016,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Dyslipidemia; Medicine; Pharmacist; Randomized controlled trial; Odds ratio; Internal medicine; Pharmacy; Psychological intervention; Physical therapy; Family medicine; Disease; Nursing","score_opus":0.05132925478622505,"score_gpt":0.29759414995203176,"score_spread":0.2462648951658067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2483759532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96718496,0.0004481535,0.010179692,0.0010548446,0.0021822453,0.005485867,0.00033982185,0.0000463235,0.0130780805],"genre_scores_gemma":[0.9894549,0.00072191574,0.0015753655,0.0065037073,0.00086280936,0.00017473818,0.000020790852,0.000059458198,0.0006262882],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99585754,0.0011488086,0.00097286963,0.0002744327,0.0008386231,0.0009077022],"domain_scores_gemma":[0.9951583,0.00022378014,0.00029540533,0.00066597096,0.00053389196,0.0031226366],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0048060613,0.0003516521,0.0012151712,0.000621834,0.0005367401,0.000042636144,0.0005141343,0.00007352211,0.00019993041],"category_scores_gemma":[0.00037456557,0.0002560049,0.0006382563,0.00065104774,0.00024402581,0.00011020904,0.000047935897,0.00064469373,0.000007657958],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56947315,0.0006243999,0.000087535795,0.0029733293,0.0031607216,0.019496003,0.001322265,0.0006400941,0.0016520857,0.0004620365,0.033331286,0.3667771],"study_design_scores_gemma":[0.87715673,0.00020487276,0.0000040845944,0.0001302726,0.00086945115,0.06333077,0.000015733236,0.00027815855,0.0021786725,0.00006148687,0.055350345,0.00041939973],"about_ca_topic_score_codex":0.023374824,"about_ca_topic_score_gemma":0.0072432617,"teacher_disagreement_score":0.36635768,"about_ca_system_score_codex":0.002451389,"about_ca_system_score_gemma":0.0042493655,"threshold_uncertainty_score":0.9999892},"labels":[],"label_agreement":null},{"id":"W2484224835","doi":"10.1136/ebm.14.2.48","title":"Rosuvastatin prevented major cardiovascular events in people with elevated C-reactive protein","year":2009,"lang":"en","type":"letter","venue":"Evidence-Based Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Nutrition, Metabolism and Diabetes","funders":"","keywords":"Rosuvastatin; C-reactive protein; Internal medicine; Rosuvastatin Calcium; Medicine; Cardiology; Inflammation","score_opus":0.0244332630287934,"score_gpt":0.2682027125472632,"score_spread":0.2437694495184698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2484224835","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.094441675,0.02873333,0.003284191,0.85540295,0.00041301365,0.016825251,0.000043488508,0.00040267842,0.00045343683],"genre_scores_gemma":[0.24108328,0.0012714727,0.004136843,0.7149478,0.0207943,0.0052160867,0.0036024791,0.0008562286,0.008091478],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98943526,0.0013271034,0.0013887387,0.0018028877,0.0046002194,0.0014457843],"domain_scores_gemma":[0.99493563,0.0003498973,0.000617349,0.0028555924,0.0007645418,0.00047701428],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0036848006,0.0012382363,0.0038508729,0.001112094,0.00013592857,0.000018184406,0.00047881695,0.001148384,0.00031671717],"category_scores_gemma":[0.0014566683,0.0008720165,0.0011034611,0.00206298,0.00024911025,0.00028686057,0.00005460966,0.0043113306,0.00006687696],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017782832,0.0025491817,0.032440215,0.041403554,0.01970033,0.056967296,0.002489704,0.0007099207,0.0062427735,0.000023811192,0.72603446,0.09365594],"study_design_scores_gemma":[0.04999249,0.016159505,0.12545304,0.19812545,0.010444547,0.001618676,0.00037472462,0.00034031784,0.0060103415,0.00016835185,0.587959,0.003353531],"about_ca_topic_score_codex":0.007159415,"about_ca_topic_score_gemma":0.00029333172,"teacher_disagreement_score":0.1567219,"about_ca_system_score_codex":0.0014117673,"about_ca_system_score_gemma":0.0028056593,"threshold_uncertainty_score":0.999452},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2485118186","doi":"10.1016/j.cjca.2016.07.510","title":"2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult","year":2016,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Population Health Research Institute; Robarts Clinical Trials; McMaster University; University of Toronto; St. Michael's Hospital; University of Ottawa; McGill University; McGill University Health Centre; St. Paul's Hospital; University of British Columbia; Centre hospitalier de l'Université Laval; Montreal Heart Institute; Institut universitaire de cardiologie et de pneumologie de Québec; Montreal General Hospital; Libin Cardiovascular Institute of Alberta; Université de Montréal; Native Mental Health Association of Canada; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Dyslipidemia; Framingham Risk Score; Disease; Statin; Diabetes mellitus; Risk assessment; Intensive care medicine; National Cholesterol Education Program; Clinical trial; Framingham Heart Study; Abdominal obesity; Pharmacotherapy; MEDLINE; Physical therapy; Internal medicine; Family medicine; Endocrinology; Metabolic syndrome","score_opus":0.07622463887351635,"score_gpt":0.34228278975426923,"score_spread":0.2660581508807529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2485118186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007672186,0.96801704,0.02197638,0.0023041482,0.0011437704,0.00583256,0.0005513959,0.0000025366253,0.0001645002],"genre_scores_gemma":[0.0009849325,0.9933816,0.00051834283,0.0002741322,0.0038600545,0.0007426757,0.000046390975,0.00007641804,0.00011541195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953477,0.00083998794,0.0018747754,0.00041402964,0.0007239277,0.00079959934],"domain_scores_gemma":[0.9939074,0.0006232111,0.0007380221,0.0022282803,0.0018734286,0.0006296829],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.011746511,0.00046631703,0.0038694665,0.00032748916,0.0002761653,0.00001951729,0.0010853248,0.0004272349,0.000006276696],"category_scores_gemma":[0.0007693542,0.00020562229,0.018016,0.00039280116,0.0003708144,0.000055592995,0.00003341023,0.00052131084,0.000001553958],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039845334,0.0000034009083,0.000021702272,0.010508873,0.051105436,0.000064037566,0.000064221254,0.0014940633,3.141617e-8,0.00043669654,0.024000054,0.91226166],"study_design_scores_gemma":[0.0014742461,0.00015058786,0.00021038896,0.009108673,0.03356097,0.00021666306,0.00032108912,0.000019678035,2.5535437e-7,0.0001538794,0.95458883,0.00019472666],"about_ca_topic_score_codex":0.032873157,"about_ca_topic_score_gemma":0.009929259,"teacher_disagreement_score":0.9305888,"about_ca_system_score_codex":0.0006853273,"about_ca_system_score_gemma":0.010033493,"threshold_uncertainty_score":0.9955787},"labels":[],"label_agreement":null},{"id":"W2486199294","doi":"10.1186/s12875-016-0471-6","title":"Statin prescription initiation and lifestyle behaviour: a primary care cohort study","year":2016,"lang":"en","type":"article","venue":"BMC Family Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Queen's University; United Kingdom Clinical Research Collaboration","keywords":"Medicine; Medical prescription; Statin; Primary care; Cohort; Physical activity; Recall; Physical therapy; Cohort study; Family medicine; Internal medicine; Nursing","score_opus":0.025517587429550882,"score_gpt":0.29455612966153605,"score_spread":0.26903854223198514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486199294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878692,0.0017343872,0.0019030122,0.0002075917,0.00015951328,0.0022000652,0.00001561115,0.00008392512,0.005826669],"genre_scores_gemma":[0.9945743,0.00047987723,0.0033129451,0.0008295553,0.00023982464,0.0002114854,0.00003743397,0.000028527069,0.00028607255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981641,0.00042335986,0.00026126514,0.0003527349,0.0006101716,0.00018833636],"domain_scores_gemma":[0.9987292,0.00020054985,0.00014441922,0.00046448893,0.00032074537,0.00014058521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011352511,0.00013135973,0.00026129652,0.00006741529,0.000103073515,0.000035061417,0.000040142168,0.000076186174,0.000010284493],"category_scores_gemma":[0.0006612585,0.0000931063,0.00006203408,0.00010050747,0.000028695056,0.00056340074,0.000049573977,0.00014460253,0.000033928303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048426804,0.0004563651,0.9715747,0.00024526805,0.00012890977,0.00006365262,0.001323806,3.9931368e-7,0.0015059756,0.000031167827,0.00036853395,0.023816925],"study_design_scores_gemma":[0.0030665193,0.00075231685,0.9826181,0.00010227571,0.0007161434,0.000094373834,0.0060584014,0.0000028990748,0.00006244998,0.000003396923,0.0064024627,0.000120638695],"about_ca_topic_score_codex":0.0007956297,"about_ca_topic_score_gemma":0.00005550082,"teacher_disagreement_score":0.023696285,"about_ca_system_score_codex":0.00020358326,"about_ca_system_score_gemma":0.0003117475,"threshold_uncertainty_score":0.37967646},"labels":[],"label_agreement":null},{"id":"W2486690983","doi":"10.1093/eurheartj/ehw292","title":"No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies","year":2016,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Amarin Corporation; Regeneron Pharmaceuticals; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Alirocumab; Medicine; PCSK9; Incidence (geometry); Diabetes mellitus; Internal medicine; Endocrinology; Total cholesterol; Cholesterol; LDL receptor","score_opus":0.02518181106636608,"score_gpt":0.3139039350772275,"score_spread":0.28872212401086145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486690983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959181,0.0024385503,0.00001891564,0.00087016256,0.00011236271,0.00024385871,0.000012170577,0.000008311557,0.00037754574],"genre_scores_gemma":[0.9987451,0.00024387256,0.00006905211,0.0002058805,0.0005629077,0.0000037045606,0.00000130902,0.000020179694,0.00014800916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969553,0.0015148394,0.00053004094,0.00018659497,0.0005883835,0.00022484842],"domain_scores_gemma":[0.9983537,0.00061784085,0.00023403886,0.00046489123,0.00020696255,0.00012252078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003871312,0.00015096551,0.00079980976,0.00023722008,0.00006798992,0.000010750584,0.00012447599,0.000026046346,0.00023394564],"category_scores_gemma":[0.0016385085,0.00006785376,0.0005308175,0.00039220392,0.000108349785,0.00006600096,0.00006281129,0.0002472702,0.00007154349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027628653,0.00084252696,0.55398285,0.00041496265,0.013237761,0.0004967398,0.0013713865,0.000029047764,0.3514933,0.000017928038,0.007653247,0.06769735],"study_design_scores_gemma":[0.019899711,0.010777009,0.7221648,0.0060362625,0.0046745446,0.000066182925,0.00027922916,0.00011543383,0.22718367,0.000045541787,0.00836608,0.00039150182],"about_ca_topic_score_codex":0.000037544818,"about_ca_topic_score_gemma":0.0000103202265,"teacher_disagreement_score":0.16818196,"about_ca_system_score_codex":0.00006633526,"about_ca_system_score_gemma":0.00005864475,"threshold_uncertainty_score":0.2766996},"labels":[],"label_agreement":null},{"id":"W2486736482","doi":"10.1136/bcr-2016-216048","title":"Ciprofloxacin and statin interaction: a cautionary tale of rhabdomyolysis","year":2016,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health","funders":"","keywords":"Medicine; Discontinuation; Simvastatin; Ciprofloxacin; Rhabdomyolysis; Statin; Urinary system; Atorvastatin; Medical history; Weakness; Internal medicine; Antibiotics; Surgery","score_opus":0.01901693068507085,"score_gpt":0.31446718782214644,"score_spread":0.2954502571370756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2486736482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954742,0.00061245303,0.00079407124,0.00088381907,0.00013143511,0.0005308685,0.000005770039,0.000025918085,0.0015414732],"genre_scores_gemma":[0.99783975,0.00009163213,0.00090272253,0.00006352373,0.00017117574,0.000058076166,0.0000054338193,0.0000113586075,0.00085632945],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9989299,0.000045945155,0.00041832612,0.00022058445,0.00026459838,0.00012064664],"domain_scores_gemma":[0.99906844,0.000037869922,0.00019868377,0.00044669697,0.00012258023,0.00012574288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006106617,0.00008308643,0.00028696956,0.00007530497,0.000042697175,0.0000036920849,0.00000656795,0.000050371596,0.00020092734],"category_scores_gemma":[0.00019686806,0.000052894702,0.00013251194,0.00009715038,0.000054336244,0.00007580759,0.000028789047,0.000054760443,0.0000048374723],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000208879,0.0001697914,0.013469252,0.0005868672,0.00044510467,0.6457773,0.000312592,8.6716665e-7,0.013102285,0.00013521776,0.0017671293,0.32402474],"study_design_scores_gemma":[0.00082388666,0.00019465748,0.009814102,0.00033858867,0.00021567063,0.95803505,0.00034170246,0.000013937723,0.010349858,0.00013308683,0.019621748,0.000117687305],"about_ca_topic_score_codex":0.00045088146,"about_ca_topic_score_gemma":0.000024573275,"teacher_disagreement_score":0.32390705,"about_ca_system_score_codex":0.00005158176,"about_ca_system_score_gemma":0.00016163457,"threshold_uncertainty_score":0.22000135},"labels":[],"label_agreement":null},{"id":"W2487586275","doi":"10.1371/journal.pone.0159550","title":"Combined Effects of Rosuvastatin and Exercise on Gene Expression of Key Molecules Involved in Cholesterol Metabolism in Ovariectomized Rats","year":2016,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada","keywords":"sed; Ovariectomized rat; Endocrinology; Internal medicine; LDL receptor; Rosuvastatin; Chemistry; PCSK9; Cholesterol; Medicine; Estrogen; Lipoprotein","score_opus":0.016248905598991628,"score_gpt":0.2243198783972653,"score_spread":0.2080709727982737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2487586275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695104,0.0014479532,0.0000934419,0.00012359358,0.00001968997,0.001316516,0.0000068260892,0.0000134661,0.000027456827],"genre_scores_gemma":[0.9952513,0.0010560706,0.0034349884,0.000060218314,0.00002341577,0.00012556152,0.0000057536786,0.000022816128,0.000019861434],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856365,0.000190858,0.0003910319,0.00024006717,0.0004291067,0.00018531633],"domain_scores_gemma":[0.99919194,0.00012287269,0.0001258596,0.0003927901,0.00006897249,0.00009758981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043175314,0.00013965592,0.00093401,0.0002195545,0.000010632067,0.000003136879,0.00005554148,0.00009176557,0.000006900758],"category_scores_gemma":[0.00025190532,0.00009289712,0.00007618549,0.00016630949,0.000054666736,0.000052825242,0.000044639513,0.00010822773,0.0000015864068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022532498,0.0016497298,0.008209027,0.0012235709,0.00007640428,0.000020996953,0.00039788257,6.009731e-7,0.9826084,0.000028179535,0.0000034782395,0.003528499],"study_design_scores_gemma":[0.017658385,0.0003146284,0.14919378,0.005277301,0.000117852105,3.572912e-7,0.000015385816,0.000020410385,0.8272146,0.00011282166,9.613686e-7,0.000073510164],"about_ca_topic_score_codex":0.00019889529,"about_ca_topic_score_gemma":0.00001947015,"teacher_disagreement_score":0.15539378,"about_ca_system_score_codex":0.000027312542,"about_ca_system_score_gemma":0.00005240233,"threshold_uncertainty_score":0.37882346},"labels":[],"label_agreement":null},{"id":"W2504019897","doi":"10.3389/fendo.2016.00095","title":"Statin Therapy Alters Lipid Storage in Diabetic Skeletal Muscle","year":2016,"lang":"en","type":"article","venue":"Frontiers in Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; McMaster University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Fluvastatin; Internal medicine; Endocrinology; Medicine; Skeletal muscle; Diabetes mellitus; Statin; Insulin resistance; CD36; Streptozotocin; Type 2 diabetes; Atorvastatin; Myopathy; Simvastatin","score_opus":0.01163251897486922,"score_gpt":0.24969453513901899,"score_spread":0.23806201616414976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2504019897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98680145,0.0034667936,0.0045611947,0.002425806,0.0012843289,0.0006326427,0.00001002057,0.000053527743,0.00076422346],"genre_scores_gemma":[0.9923428,0.0034213276,0.0028549547,0.00063423737,0.00024592874,0.00012484397,0.000007153992,0.000032941396,0.00033577147],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99813557,0.00021822646,0.00032446627,0.00038872476,0.00021128388,0.00072171265],"domain_scores_gemma":[0.9992733,0.000038064107,0.000054305558,0.0004949791,0.000025298159,0.000114055765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002519437,0.00017151653,0.0005444035,0.00035849374,0.000025709835,0.000004397404,0.00012707895,0.000097308075,0.00009878194],"category_scores_gemma":[0.000080783335,0.00012156662,0.00013870491,0.00021269178,0.00015744763,0.00007141187,0.000039151997,0.00025236304,0.000022864038],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012799441,0.0001841441,0.13945903,0.00004550304,0.00008796363,0.00047148866,0.00031594158,0.00000660926,0.0015964071,0.00014951115,0.0029798443,0.8545756],"study_design_scores_gemma":[0.013966052,0.00081467925,0.80517477,0.0001490855,0.000023052235,0.00009877195,0.0005228674,0.000073632415,0.0019781203,0.0006925517,0.17616902,0.0003374262],"about_ca_topic_score_codex":0.00023681908,"about_ca_topic_score_gemma":0.00005536338,"teacher_disagreement_score":0.85423815,"about_ca_system_score_codex":0.00027146295,"about_ca_system_score_gemma":0.00011744427,"threshold_uncertainty_score":0.4957343},"labels":[],"label_agreement":null},{"id":"W2505379829","doi":"10.1371/journal.pone.0158608","title":"Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis","year":2016,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Department of Health and Wellness; Nova Scotia Health Authority; Acadia University; Dalhousie University","funders":"Canadian Institutes of Health Research; Department of Health, Western Cape Government; Nova Scotia Department of Health and Wellness","keywords":"Rosuvastatin; Fluvastatin; Atorvastatin; Pravastatin; Medicine; Statin; Medical prescription; Simvastatin; Confidence interval; Nova scotia; Internal medicine; Pharmacology; Cholesterol; Geography","score_opus":0.03352129465851145,"score_gpt":0.2492485132150118,"score_spread":0.21572721855650034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505379829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533826,0.00012627273,0.00004641842,0.0038702583,0.0000076593205,0.00023584733,0.00003129606,0.00003185994,0.00031211693],"genre_scores_gemma":[0.9827268,0.00018632,0.0056956625,0.00033610748,0.000100921396,0.000066645116,0.00003608961,0.000023669576,0.010827765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871355,0.00008788274,0.0002598991,0.0002563776,0.00041024253,0.00027202442],"domain_scores_gemma":[0.9992594,0.000033442717,0.000032420783,0.00046631708,0.000046556397,0.00016187233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038225437,0.00010708985,0.0005461053,0.0007444545,0.000014997979,0.0000105331355,0.000049388207,0.00005926292,0.00056186545],"category_scores_gemma":[0.000107755666,0.00007360819,0.00013625571,0.0012694098,0.000019127361,0.0001290451,0.000030510535,0.00008750827,0.0001835434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088326033,0.002727674,0.86056405,0.00021256488,0.004182978,0.00036941384,0.0016930235,0.000027711338,0.044898156,0.00006492798,0.0022623779,0.08211386],"study_design_scores_gemma":[0.002265367,0.00038256755,0.9857446,0.0004138318,0.0008784583,0.0000037266802,0.00007128677,0.00007895738,0.008002807,0.000026206091,0.0019054194,0.00022677408],"about_ca_topic_score_codex":0.003560695,"about_ca_topic_score_gemma":0.005222699,"teacher_disagreement_score":0.12518054,"about_ca_system_score_codex":0.00012392647,"about_ca_system_score_gemma":0.000039418697,"threshold_uncertainty_score":0.6152033},"labels":[],"label_agreement":null},{"id":"W2507426012","doi":"10.1186/s40064-016-2912-z","title":"Association between SLCO1B1 −521T&gt;C and −388A&gt;G polymorphisms and risk of statin-induced adverse drug reactions: A meta-analysis","year":2016,"lang":"en","type":"review","venue":"SpringerPlus","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"SLCO1B1; Medicine; Drug; Meta-analysis; Statin; Genome-wide association study; Pharmacology; Pharmacogenomics; Adverse effect; Drug reaction; Bioinformatics; Internal medicine; Pharmacogenetics; Genotype; Single-nucleotide polymorphism; Gene; Biology; Genetics","score_opus":0.05492479557516053,"score_gpt":0.32339355699129035,"score_spread":0.26846876141612985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507426012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034562293,0.99356055,0.00012522095,0.00014421457,0.00010949549,0.0015708653,0.00048555527,0.000057914483,0.00048994174],"genre_scores_gemma":[0.0019193431,0.9942505,0.00065957475,0.000019340157,0.00039942627,0.00017120928,0.000080859354,0.00006482792,0.0024349613],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9958206,0.0007328372,0.0012863267,0.0007714739,0.0009648744,0.00042393134],"domain_scores_gemma":[0.995949,0.0005271086,0.0018323358,0.001114468,0.00023691956,0.00034021467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034431058,0.0005389232,0.0060584038,0.00070547865,0.00014666568,0.000026292426,0.00012825122,0.00044449852,0.00014361528],"category_scores_gemma":[0.00065792655,0.00035997818,0.0035693466,0.00075721246,0.000056847595,0.000114973955,0.00012979328,0.0005739937,0.000028488928],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014108765,0.000042745018,0.0015256173,0.0068453904,0.39606732,0.000017726023,0.0001242578,1.7663145e-7,0.0000055946,0.00004945253,0.00007837342,0.5952292],"study_design_scores_gemma":[0.000605743,0.000066706285,0.0034837646,0.0010248355,0.58452123,0.000015929887,0.000017684279,0.0000013299506,0.000012771531,0.000023706649,0.409929,0.00029729365],"about_ca_topic_score_codex":0.0024014344,"about_ca_topic_score_gemma":0.000149704,"teacher_disagreement_score":0.59493196,"about_ca_system_score_codex":0.0004428246,"about_ca_system_score_gemma":0.00040520035,"threshold_uncertainty_score":0.9998852},"labels":[],"label_agreement":null},{"id":"W2510117167","doi":"10.1186/s12944-016-0295-3","title":"Endothelial lipase genetic polymorphisms and the lipid-lowering response in patients with coronary artery disease on rosuvastatin","year":2016,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Jiangsu University","keywords":"Rosuvastatin; Internal medicine; Lipidology; Clinical chemistry; Triglyceride; Coronary artery disease; Endocrinology; Genotype; Cholesterol; Hepatic lipase; Lipid profile; Medicine; Clinical nutrition; Statin; Lipid metabolism; Lipoprotein lipase; Biology; Biochemistry; Gene; Adipose tissue","score_opus":0.0076716372802262565,"score_gpt":0.23326259898734364,"score_spread":0.22559096170711737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510117167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98753613,0.0024317894,0.00006340711,0.007980178,0.00014698107,0.0016794017,0.00012367175,0.000026204201,0.000012221928],"genre_scores_gemma":[0.9926913,0.00068758393,0.00008383982,0.00594264,0.0002666149,0.00020278922,0.000012279258,0.000032407737,0.0000805846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761766,0.0005790035,0.00042483662,0.0004574953,0.00042677316,0.00049423944],"domain_scores_gemma":[0.99720335,0.0003378596,0.00008843897,0.00054283027,0.000027610751,0.0017999323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087835675,0.00022424519,0.00040729324,0.0001684498,0.00014026479,0.000020104995,0.000060121434,0.00003404463,0.00001855274],"category_scores_gemma":[0.0007061953,0.0001194018,0.00007204009,0.00014401882,0.00023617859,0.0000743848,0.000049019178,0.00018476839,0.000004881042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16397645,0.0004290243,0.7751297,0.0005067838,0.000021858086,0.0002554156,0.00039054305,0.000008494027,0.000004523326,0.00011636262,0.000058851063,0.059102044],"study_design_scores_gemma":[0.023310242,0.0012279795,0.9733526,0.0010838688,0.000029204748,0.000009202511,0.000054794513,0.000052371513,0.000001620044,0.00015176846,0.0005712858,0.00015506205],"about_ca_topic_score_codex":0.00015138472,"about_ca_topic_score_gemma":0.000021670738,"teacher_disagreement_score":0.19822294,"about_ca_system_score_codex":0.0001188143,"about_ca_system_score_gemma":0.0008738054,"threshold_uncertainty_score":0.48690638},"labels":[],"label_agreement":null},{"id":"W2510502505","doi":"10.1016/j.jacl.2016.08.014","title":"Impact of a 1-year lifestyle modification program on plasma lipoprotein and PCSK9 concentrations in patients with coronary artery disease","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval","funders":"Canadian Institutes of Health Research; American Heart Association","keywords":"Medicine; PCSK9; Coronary artery disease; Internal medicine; Apolipoprotein B; Lipoprotein; Endocrinology; Cardiology; Cholesterol; LDL receptor","score_opus":0.037982505983665905,"score_gpt":0.3672439293652763,"score_spread":0.32926142338161035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510502505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979081,0.000055429442,0.00010063575,0.0009624416,0.00021076035,0.000698007,0.000014799265,0.000006609696,0.000043191143],"genre_scores_gemma":[0.99830484,0.00013393264,0.000718684,0.00009121279,0.00070438103,0.0000142915615,0.000005257708,0.000011762019,0.000015642818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805003,0.00032367188,0.00095768,0.000168691,0.0003221707,0.00017773676],"domain_scores_gemma":[0.99823993,0.00033062344,0.0005363301,0.00026139125,0.00027410284,0.00035764297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093940936,0.00010630166,0.0006315745,0.00010242514,0.000019031357,0.0000044372628,0.000059417045,0.00012305609,0.000028598404],"category_scores_gemma":[0.0010583509,0.000054803648,0.0002614026,0.000089783985,0.00020022264,0.00009255666,0.000014211827,0.00027122055,0.000003738273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009001301,0.001958559,0.8507808,0.000029298812,0.00019761542,0.000015447307,0.00001779393,0.000009237866,0.000028645698,0.000076425276,0.000086476364,0.13779844],"study_design_scores_gemma":[0.011227826,0.013731017,0.9741213,0.0003060749,0.000104902356,0.000035553632,0.0000076295955,0.000029560619,0.000012015659,0.00007205156,0.0002927524,0.000059357102],"about_ca_topic_score_codex":0.0000099064555,"about_ca_topic_score_gemma":0.0000061159803,"teacher_disagreement_score":0.13773909,"about_ca_system_score_codex":0.00005130825,"about_ca_system_score_gemma":0.0005016533,"threshold_uncertainty_score":0.22348279},"labels":[],"label_agreement":null},{"id":"W2510764118","doi":"10.1097/mcc.0000000000000351","title":"Role of lipoproteins and proprotein convertase subtilisin/kexin type 9 in endotoxin clearance in sepsis","year":2016,"lang":"en","type":"review","venue":"Current Opinion in Critical Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Proprotein convertase; Kexin; Sepsis; Lipoprotein; LDL receptor; Phospholipid transfer protein; Medicine; Cholesterol; Internal medicine; Endocrinology; Pharmacology; Immunology; Phospholipid; Biochemistry; Biology","score_opus":0.1176343074949018,"score_gpt":0.4404494117212529,"score_spread":0.3228151042263511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2510764118","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010092168,0.9941491,0.0000060557845,0.00010906419,0.0007853876,0.0036458503,0.0001668054,0.000020950052,0.00010755444],"genre_scores_gemma":[0.019322023,0.9793494,0.000089738925,0.000011596918,0.00040756655,0.0006200807,0.00012918127,0.000064691885,0.000005730317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963089,0.0005103836,0.0011980432,0.0008042356,0.000602037,0.00057637127],"domain_scores_gemma":[0.9984944,0.00017835177,0.00012760205,0.0007203828,0.00022200862,0.0002572589],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006748281,0.00046318147,0.0023992555,0.0005684465,0.000025491576,0.000017835848,0.00018124351,0.0004892984,0.00007469569],"category_scores_gemma":[0.0010519638,0.00035608854,0.00038577372,0.0006171712,0.00023709128,0.00009595409,0.00013938716,0.0010644483,0.000025111993],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108511034,0.00019190238,0.00058535865,0.12946324,0.000015662248,0.00001850605,0.00022907858,5.999609e-8,0.0000036317995,0.00056376326,0.000013940658,0.86880636],"study_design_scores_gemma":[0.0027394567,0.00050699693,0.0022995227,0.23171648,0.00012425853,0.00006550354,0.00041347378,0.000011515169,0.000070199145,0.0002624199,0.7611878,0.00060239446],"about_ca_topic_score_codex":0.00035072136,"about_ca_topic_score_gemma":0.00008505501,"teacher_disagreement_score":0.86820394,"about_ca_system_score_codex":0.0003934881,"about_ca_system_score_gemma":0.0007121771,"threshold_uncertainty_score":0.99988914},"labels":[],"label_agreement":null},{"id":"W2511267285","doi":"10.1016/s0140-6736(16)31532-x","title":"Why do people not take life-saving medications? The case of statins","year":2016,"lang":"en","type":"letter","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medicine; Intensive care medicine; Statin; Internal medicine","score_opus":0.03342804212233891,"score_gpt":0.29255159700347233,"score_spread":0.2591235548811334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511267285","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006872498,0.0021077648,0.0005087393,0.9870584,0.0003334682,0.0008308499,0.0003456794,0.00004671681,0.0018958889],"genre_scores_gemma":[0.048095908,0.0011354742,0.00021451856,0.9213515,0.028069375,0.00014924929,0.00009552541,0.000060138525,0.00082833477],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980547,0.00032766565,0.00036792722,0.00025942278,0.00058503135,0.00040525562],"domain_scores_gemma":[0.9967314,0.00041408764,0.00028150622,0.0023531977,0.00014295381,0.00007687349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015875136,0.00020103931,0.0008752626,0.000050953546,0.00018309103,0.000023004684,0.00041916544,0.00024422185,0.0003727264],"category_scores_gemma":[0.00035608397,0.000084781845,0.0002854467,0.00016263813,0.00016524538,0.000027082724,0.00008824268,0.001131477,0.00005244279],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029621422,0.000008267382,0.00007837648,0.00053231494,0.0003954274,0.00038779536,0.0009029642,3.6304846e-7,0.000017807812,0.00012530001,0.9845123,0.013009452],"study_design_scores_gemma":[0.0009615987,0.00005303486,0.0010213463,0.00037505757,0.00045592565,0.0012026664,0.00017600038,0.000009375028,0.000020843569,0.00014469739,0.9954673,0.000112166876],"about_ca_topic_score_codex":0.0021873,"about_ca_topic_score_gemma":0.0004133905,"teacher_disagreement_score":0.065706916,"about_ca_system_score_codex":0.00005118582,"about_ca_system_score_gemma":0.00032463245,"threshold_uncertainty_score":0.4915767},"labels":[],"label_agreement":null},{"id":"W2511420668","doi":"10.1016/j.atherosclerosis.2016.08.043","title":"A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I","year":2016,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Statin; Medicine; Randomized controlled trial; Internal medicine; Pharmacology; Cholesterol; Total cholesterol","score_opus":0.06538851783828546,"score_gpt":0.38116160003140365,"score_spread":0.31577308219311817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2511420668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98576957,0.00022001365,0.0030295698,0.002594605,0.00053103967,0.006798803,0.000044858105,0.00020476036,0.0008068065],"genre_scores_gemma":[0.9795393,0.0006489522,0.0022057558,0.007200485,0.0019173387,0.0023193774,0.000017703684,0.00017742925,0.00597371],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9954025,0.00077533425,0.0009625334,0.00081241137,0.0013348409,0.0007123617],"domain_scores_gemma":[0.9966577,0.0010993793,0.0003057704,0.0011893027,0.00021802256,0.0005298203],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003428536,0.00046259593,0.0017049724,0.00017121898,0.00024510457,0.00006646732,0.00022862431,0.00021860155,0.0018948667],"category_scores_gemma":[0.0020938055,0.0002602736,0.00086917455,0.00038330365,0.00009716282,0.00015612935,0.000055864853,0.00022994162,0.00040400046],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7422709,0.0008169106,0.000015067616,0.000037778664,0.0006109329,0.0000055580163,0.0007641462,0.000002087904,0.03711863,0.000059094997,0.001602794,0.21669611],"study_design_scores_gemma":[0.9687053,0.011521947,0.0001649216,0.0007984256,0.00042462727,0.000009810546,0.000111703586,0.000086635475,0.009465965,0.00009178552,0.008223168,0.00039569006],"about_ca_topic_score_codex":0.0013558768,"about_ca_topic_score_gemma":0.000055993143,"teacher_disagreement_score":0.22643442,"about_ca_system_score_codex":0.000294814,"about_ca_system_score_gemma":0.00048203455,"threshold_uncertainty_score":0.9999849},"labels":[],"label_agreement":null},{"id":"W2512596660","doi":"10.1016/j.ijcard.2016.08.273","title":"Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials","year":2016,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Alirocumab; Familial hypercholesterolemia; PCSK9; Internal medicine; Pooled analysis; Clinical trial; Atherosclerotic cardiovascular disease; Meta-analysis; Oncology; Cholesterol; LDL receptor; Lipoprotein; Disease","score_opus":0.08081113192650478,"score_gpt":0.4276831968868014,"score_spread":0.3468720649602966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512596660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799204,0.000828044,0.01737265,0.00029038166,0.00067232345,0.0007148718,0.00014102839,0.000011691225,0.000048617945],"genre_scores_gemma":[0.99441046,0.0011800436,0.0029943683,0.00004891494,0.001263136,0.000025476169,0.000037198657,0.000025607247,0.000014815849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99360746,0.0018555284,0.0027013235,0.0003394882,0.0012399649,0.0002562374],"domain_scores_gemma":[0.9957911,0.0006042048,0.0014698798,0.0006081435,0.0013352423,0.00019145389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058475444,0.0002328046,0.0039155157,0.0010043978,0.000023433755,0.00001003729,0.00033802475,0.000272927,0.000027449581],"category_scores_gemma":[0.0021126114,0.0001226539,0.0032543896,0.00047886328,0.0002609042,0.00012883006,0.000057455658,0.000405214,0.0000013783076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02306292,0.0009920989,0.49916074,0.000042147534,0.09220681,0.00076932955,0.00010599711,0.0032805966,0.00092205295,0.000044240798,0.000044618537,0.37936845],"study_design_scores_gemma":[0.061595667,0.0057239477,0.8990972,0.00045959902,0.026961187,0.0014613196,0.00007999253,0.00013096567,0.0005761506,0.00006688725,0.0036219242,0.00022516743],"about_ca_topic_score_codex":0.00036678108,"about_ca_topic_score_gemma":0.00007631528,"teacher_disagreement_score":0.39993644,"about_ca_system_score_codex":0.00017044213,"about_ca_system_score_gemma":0.00044506375,"threshold_uncertainty_score":0.5001681},"labels":[],"label_agreement":null},{"id":"W2514472325","doi":"10.1016/j.jacl.2016.08.015","title":"Model-observational bridging study on the effectiveness of ezetimibe on cardiovascular morbidity and mortality in France: A population-based study","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ezetimibe; Medicine; Cohort; Internal medicine; Statin; Population; Cohort study; Environmental health","score_opus":0.1660314909023489,"score_gpt":0.42052369063993805,"score_spread":0.2544921997375892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2514472325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99589044,0.000099729914,0.0016489131,0.00059473724,0.00057392835,0.0011578453,0.000005133501,0.0000050286394,0.000024234867],"genre_scores_gemma":[0.9985837,0.000025048754,0.000074103256,0.00031844393,0.0009562647,0.000024453311,8.6123833e-7,0.000013367489,0.0000038027679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99334186,0.0039756554,0.0013261187,0.00028763758,0.0009004014,0.0001683351],"domain_scores_gemma":[0.99486095,0.0036916689,0.0004502192,0.0005948623,0.0002893213,0.00011295666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023513515,0.00014641204,0.0014396652,0.000120283985,0.000048805778,0.000004729225,0.00012563719,0.00012914708,0.000008317316],"category_scores_gemma":[0.0042851744,0.00007454327,0.00067188434,0.00015650291,0.000081369595,0.000051335224,0.000032256823,0.0005236151,9.452635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015222683,0.0021856907,0.9871763,0.00005963043,0.00089523505,0.000025365995,0.000036811507,0.0044217748,0.000029570285,0.000097173994,0.000008450215,0.003541752],"study_design_scores_gemma":[0.008873454,0.004059118,0.9852061,0.00030031044,0.00033821925,0.000009857016,0.00004911521,0.0007078633,0.000025595145,0.00034071508,0.000018883275,0.000070768154],"about_ca_topic_score_codex":0.0002250669,"about_ca_topic_score_gemma":0.000028266504,"teacher_disagreement_score":0.01922834,"about_ca_system_score_codex":0.00006107602,"about_ca_system_score_gemma":0.00027379201,"threshold_uncertainty_score":0.81493616},"labels":[],"label_agreement":null},{"id":"W2516993883","doi":"10.1016/j.atherosclerosis.2016.08.017","title":"Statins probably do not cause cataracts","year":2016,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cataracts; Statin; Observational study; Myocardial infarction; Scopus; Nifedipine; Causality (physics); Internal medicine; MEDLINE; Ophthalmology","score_opus":0.043719465219080295,"score_gpt":0.27070495978893744,"score_spread":0.22698549456985714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516993883","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028056834,0.0008192102,0.00020909516,0.96188235,0.001062719,0.0027567814,0.00079279835,0.00039081072,0.0040293965],"genre_scores_gemma":[0.013641511,0.0022354606,0.000806152,0.95149195,0.014099711,0.0004269422,0.00047144765,0.00036477298,0.01646205],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99610627,0.0001669947,0.0005475738,0.0009098764,0.0012823489,0.0009869472],"domain_scores_gemma":[0.9971558,0.00008913571,0.0002802033,0.001983511,0.00022769993,0.00026367363],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00052458124,0.0005846617,0.0011055053,0.00015308752,0.0001606067,0.00008643394,0.00027924645,0.0010706772,0.00048077412],"category_scores_gemma":[0.00010037493,0.00040357452,0.000734827,0.00019330182,0.00013017905,0.00011574233,0.0001036821,0.0014120261,0.0012115517],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038986243,0.00005157984,0.000490813,0.00070402643,0.00073189597,0.00021955141,0.00018944984,1.05239025e-7,0.0017555755,0.000023944884,0.9743522,0.021441896],"study_design_scores_gemma":[0.0016016344,0.00030237905,0.005094538,0.0012312019,0.0005951958,0.00007499231,0.000012623144,5.4336857e-7,0.0014760817,0.000041032767,0.9890685,0.00050128467],"about_ca_topic_score_codex":0.0006634664,"about_ca_topic_score_gemma":0.000020972106,"teacher_disagreement_score":0.020940611,"about_ca_system_score_codex":0.00035629811,"about_ca_system_score_gemma":0.00049762375,"threshold_uncertainty_score":0.99984163},"labels":[],"label_agreement":null},{"id":"W2517292362","doi":"10.4212/cjhp.v69i4.1580","title":"New Antilipid Drugs: Do the Known Benefits Justify the Expense?","year":2016,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine","score_opus":0.018416423119334453,"score_gpt":0.2715597396737233,"score_spread":0.2531433165543889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517292362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6598258,0.026764017,0.000042429114,0.30766186,0.0024164098,0.0006784381,0.000017588432,0.000010765877,0.0025826925],"genre_scores_gemma":[0.99086523,0.0011629093,0.000035125715,0.0028186503,0.0041496675,0.000005082625,4.906336e-7,0.0000323444,0.00093052717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982189,0.00015243949,0.0003967591,0.00014040383,0.0005930558,0.0004984749],"domain_scores_gemma":[0.997833,0.00013196107,0.00022442335,0.00063845044,0.00027130806,0.00090085145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014437856,0.00018570291,0.0003059426,0.00008106751,0.0005662196,0.000103549915,0.0006375865,0.000040457242,0.0005934472],"category_scores_gemma":[0.00017954473,0.00006333925,0.00045397851,0.00021290264,0.00023482258,0.0001632242,0.000032592387,0.000511244,0.00009109066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013912935,0.000031776337,0.0023283828,0.000026568348,0.00070701,0.00023427824,0.004827942,0.00001261009,0.0001751451,0.0023642834,0.1967437,0.7924092],"study_design_scores_gemma":[0.003800623,0.00042685456,0.018275227,0.0003718459,0.0005773613,0.0011943578,0.001290499,0.000005933349,0.002000369,0.00047851025,0.9713697,0.00020871546],"about_ca_topic_score_codex":0.016239835,"about_ca_topic_score_gemma":0.0045180186,"teacher_disagreement_score":0.79220045,"about_ca_system_score_codex":0.00020887327,"about_ca_system_score_gemma":0.002855402,"threshold_uncertainty_score":0.9903111},"labels":[],"label_agreement":null},{"id":"W2517453984","doi":"10.1016/j.cjca.2016.08.016","title":"Contemporary Trends in the Management and Outcomes of Patients With Familial Hypercholesterolemia in Canada: A Prospective Observational Study","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; Sanofi (Canada); University of British Columbia; Providence Health Care Research Institute; Providence Health Care","funders":"Pfizer Canada; Amgen Canada; Sanofi; Pfizer; Amgen","keywords":"Medicine; Observational study; Familial hypercholesterolemia; Pediatrics; Intensive care medicine; Gerontology; Internal medicine; Cholesterol","score_opus":0.03190433298545645,"score_gpt":0.24763687072544407,"score_spread":0.21573253773998763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517453984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997704,0.00015335063,0.000015846668,0.00087924785,0.000068558984,0.0003713666,0.00002245507,3.7699309e-7,0.0007847759],"genre_scores_gemma":[0.999652,0.0000066076254,0.000022732866,0.0002264908,0.000055432414,0.000012259603,0.0000021926298,0.000005271473,0.000016980659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904114,0.0001627812,0.00030728077,0.00009829788,0.00023926991,0.00015123343],"domain_scores_gemma":[0.99949497,0.0000347817,0.000089467576,0.00014676605,0.000109469314,0.00012452212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050566206,0.000077680575,0.0004632876,0.000231393,0.000017491657,0.0000023763025,0.00007763521,0.000027455175,0.0000019277898],"category_scores_gemma":[0.000023465613,0.000037818172,0.000052051495,0.0001390898,0.000056794535,0.000044331697,0.000006899375,0.00012419159,5.5750313e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014320243,0.000008902844,0.990843,0.000009040506,0.00027569247,0.0003167937,0.00024076868,0.000009736487,4.0510884e-7,0.000022332672,0.00023395424,0.007896177],"study_design_scores_gemma":[0.0053418614,0.00047840172,0.9918168,0.000046222678,0.0000507505,0.000042715772,0.0010800097,1.6756327e-7,4.4828826e-7,0.0000151076965,0.0010871147,0.00004039033],"about_ca_topic_score_codex":0.40571406,"about_ca_topic_score_gemma":0.84460825,"teacher_disagreement_score":0.4388942,"about_ca_system_score_codex":0.0004487022,"about_ca_system_score_gemma":0.0018503062,"threshold_uncertainty_score":0.59824336},"labels":[],"label_agreement":null},{"id":"W2517814663","doi":"10.1111/dom.12749","title":"Ezetimibe increases intestinal expression of the <scp>LDL</scp> receptor gene in dyslipidaemic men with insulin resistance","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Ezetimibe; Endocrinology; PCSK9; Internal medicine; LDL receptor; Insulin resistance; Cholesterol; Familial hypercholesterolemia; HMG-CoA reductase; Liver X receptor; Chemistry; Medicine; Insulin; Biology; Reductase; Lipoprotein; Biochemistry; Transcription factor; Nuclear receptor; Gene","score_opus":0.005997450683939614,"score_gpt":0.19873182551777488,"score_spread":0.19273437483383526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517814663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881828,0.010337767,0.000052432446,0.00020867835,0.00005831827,0.0005046025,0.000028707449,0.000025796,0.00060093554],"genre_scores_gemma":[0.9957528,0.0014605543,0.0018166441,0.00018501279,0.00021517517,0.000049559065,0.0000057567177,0.000020690062,0.00049378054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998449,0.00022548913,0.00028708793,0.00031719086,0.00039430652,0.00032690878],"domain_scores_gemma":[0.9988856,0.00017556087,0.00014777711,0.00050989346,0.000121254685,0.00015994304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007204639,0.00018276501,0.00054803584,0.00009198644,0.00008872741,0.000010038854,0.00013825044,0.00009927893,0.000013063018],"category_scores_gemma":[0.0006364502,0.0000910396,0.00011008898,0.0002775759,0.00018755611,0.0001177965,0.00010748505,0.00017770726,0.0000035997698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102062986,0.00035895305,0.5863739,0.0004845002,0.000099755205,0.000006829962,0.00044046497,0.0000011830205,0.3988998,0.00025460724,0.0008828704,0.012095021],"study_design_scores_gemma":[0.002000575,0.000045072873,0.6753463,0.0010972654,0.000095040654,0.000004287457,0.000066388064,0.0000026299087,0.3141224,0.000116474934,0.0070539545,0.000049566846],"about_ca_topic_score_codex":0.00013084602,"about_ca_topic_score_gemma":0.000034879984,"teacher_disagreement_score":0.08897239,"about_ca_system_score_codex":0.000032925185,"about_ca_system_score_gemma":0.00012765217,"threshold_uncertainty_score":0.37124872},"labels":[],"label_agreement":null},{"id":"W2518726365","doi":"10.1161/jaha.116.003421","title":"Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study","year":2016,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Amgen; Daiichi-Sankyo; Regeneron Pharmaceuticals; Sanofi; Daiichi Sankyo Europe; Eli Lilly and Company","keywords":"Medicine; Alirocumab; Familial hypercholesterolemia; Statin; Ldl cholesterol; PCSK9; Atherosclerotic cardiovascular disease; Internal medicine; Cholesterol; LDL receptor; Total cholesterol; Lipoprotein; Disease","score_opus":0.010265429984223107,"score_gpt":0.2648552904499377,"score_spread":0.25458986046571463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518726365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435896,0.000051262115,0.000006522681,0.0048277825,0.000064939304,0.00066621933,0.0000061607375,0.000003383851,0.000014755483],"genre_scores_gemma":[0.9985484,0.0000930632,0.000038056547,0.0011314539,0.00011240379,0.0000045562065,3.2722062e-7,0.000014689621,0.00005703215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773186,0.0006202836,0.0004253168,0.0001132599,0.0009442742,0.00016502566],"domain_scores_gemma":[0.9983712,0.00039064788,0.00066885084,0.00028871722,0.00023029518,0.00005032859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018245401,0.000106410116,0.0005400228,0.0000706636,0.00010563488,0.000009549916,0.00009718402,0.00002946454,0.0000033459946],"category_scores_gemma":[0.00047193476,0.00004339681,0.00013125897,0.00023042732,0.000053057633,0.000085218264,0.000032110238,0.00026508508,7.567355e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026483596,0.0005386022,0.9522203,0.0000050149965,0.00028297325,6.8364625e-7,0.000789262,0.000009774986,0.0006345834,7.250534e-7,0.00011999534,0.042749733],"study_design_scores_gemma":[0.009470709,0.0049018143,0.98380244,0.0001840644,0.0000886664,0.0000041429626,0.0002487484,0.0000013240041,0.00016241927,0.0000035645508,0.0010795143,0.000052588264],"about_ca_topic_score_codex":0.00033109513,"about_ca_topic_score_gemma":0.000036022324,"teacher_disagreement_score":0.042697143,"about_ca_system_score_codex":0.0003853721,"about_ca_system_score_gemma":0.00012628331,"threshold_uncertainty_score":0.17696704},"labels":[],"label_agreement":null},{"id":"W2519634482","doi":"10.1016/s0140-6736(16)31357-5","title":"Interpretation of the evidence for the efficacy and safety of statin therapy","year":2016,"lang":"en","type":"review","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1844,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Medical Research Council; National Institute for Health and Care Research; British Heart Foundation; Cancer Research UK","keywords":"Interpretation (philosophy); Medicine; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive care medicine; Physical therapy; Internal medicine; Computer science","score_opus":0.10824552590847493,"score_gpt":0.39977731473023165,"score_spread":0.29153178882175673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519634482","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010372813,0.99419075,0.0010166587,0.001534404,0.000112792965,0.0028979843,0.000063094754,0.0000055603045,0.000075006705],"genre_scores_gemma":[0.001735928,0.99726766,0.000075787735,0.00018212621,0.00052452803,0.00011447671,0.000003101433,0.00001625742,0.000080134145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989041,0.00029548438,0.00033674395,0.00012435435,0.00022378717,0.0001155043],"domain_scores_gemma":[0.99695516,0.0016283831,0.000339793,0.0009871193,0.00007274848,0.0000167983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018136927,0.00011949367,0.0010890837,0.000013805668,0.0000575364,0.0000051712177,0.00029265435,0.000058510774,0.000011234272],"category_scores_gemma":[0.00047002482,0.000034040328,0.00038155616,0.0000907037,0.00013766275,0.000016638394,0.00004513795,0.00014767463,0.0000011097547],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002858813,0.0000071418776,0.0000063053308,0.006543428,0.0003151611,6.456859e-8,0.00027373256,2.3540683e-7,0.000002615666,0.00021405553,0.00031874666,0.99203265],"study_design_scores_gemma":[0.001200967,0.00014093428,0.0009588844,0.035118874,0.0006362505,0.000013244221,0.000018419383,0.000010393451,0.000012527585,0.00009322008,0.96174496,0.00005131946],"about_ca_topic_score_codex":0.00003317085,"about_ca_topic_score_gemma":0.000003431291,"teacher_disagreement_score":0.9919813,"about_ca_system_score_codex":0.000022473803,"about_ca_system_score_gemma":0.00018839333,"threshold_uncertainty_score":0.13881244},"labels":[],"label_agreement":null},{"id":"W2519884542","doi":"10.1016/j.amjcard.2016.08.071","title":"Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic Hypercholesterolemia","year":2016,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Merck","keywords":"Ezetimibe; Medicine; Statin; Internal medicine; Prediabetes; Atorvastatin; Triglyceride; Diabetes mellitus; Cholesterol; Type 2 diabetes; Endocrinology; Gastroenterology; Combination therapy","score_opus":0.009518011680239552,"score_gpt":0.26156939659434053,"score_spread":0.25205138491410095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2519884542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977263,0.00004178638,0.0010518535,0.0005898704,0.000073220894,0.00032797767,0.000019127647,0.0000044868693,0.00016533025],"genre_scores_gemma":[0.99877626,0.00001522749,0.00047826266,0.00050386856,0.0001921783,0.000006032387,4.129736e-7,0.000022457263,0.0000053112763],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99795896,0.00078216713,0.00040836312,0.0001448194,0.00039762535,0.0003080809],"domain_scores_gemma":[0.9985004,0.00044034628,0.0003830096,0.00034994906,0.00017965832,0.00014663524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017337804,0.00014309231,0.0010434705,0.00019676362,0.000029007537,0.0000031555871,0.00014836053,0.000028911849,0.000004462614],"category_scores_gemma":[0.00031485865,0.00006377948,0.0001976373,0.00025642224,0.00018294938,0.00003620799,0.000036771282,0.0002534167,0.0000048036836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027596997,0.000025576492,0.32736954,0.000035418165,0.00033323956,0.00004633833,0.00022503872,0.00044133954,0.0038850405,0.0000043299497,0.000013853531,0.6648606],"study_design_scores_gemma":[0.0035442817,0.020859638,0.97175574,0.00065374374,0.00014121711,0.00015009202,0.00010422759,0.000001170136,0.0025384196,0.0000052797227,0.00016503155,0.000081126214],"about_ca_topic_score_codex":0.0000133748645,"about_ca_topic_score_gemma":0.0000012172318,"teacher_disagreement_score":0.6647795,"about_ca_system_score_codex":0.00012697147,"about_ca_system_score_gemma":0.00011260014,"threshold_uncertainty_score":0.26008517},"labels":[],"label_agreement":null},{"id":"W2520021261","doi":"10.1016/j.ebiom.2016.09.014","title":"Genetic Association Studies Identify Unanticipated Gene Pathways Influencing Sepsis Outcome","year":2016,"lang":"en","type":"letter","venue":"EBioMedicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Genome-wide association study; Sepsis; PCSK9; Genetic association; Disease; Medicine; Bioinformatics; Clinical trial; Scopus; MEDLINE; Gene; Genetics; Biology; Genotype; Internal medicine; Single-nucleotide polymorphism; LDL receptor; Cholesterol","score_opus":0.06257988825765991,"score_gpt":0.3429675068790803,"score_spread":0.28038761862142036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520021261","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13122764,0.022890156,0.00051252864,0.8370339,0.0048497114,0.0022487342,0.00019544436,0.0004825691,0.00055927393],"genre_scores_gemma":[0.03987052,0.005118394,0.00079860876,0.89469624,0.046461582,0.00028253233,0.0006527496,0.00031765396,0.011801705],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99352133,0.0002907205,0.0014777585,0.00092909165,0.0024410847,0.0013400129],"domain_scores_gemma":[0.99633443,0.00033600169,0.0008341647,0.0013811333,0.00085354527,0.0002607258],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0020035082,0.0007030014,0.0023757787,0.0007115025,0.00022119617,0.000032019034,0.00025755636,0.0013154607,0.00021298842],"category_scores_gemma":[0.0014360435,0.00046447373,0.0007066133,0.0006242414,0.0001605915,0.000083175386,0.00018545869,0.0016042107,0.00047312802],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003248492,0.000035028737,0.019524561,0.002890291,0.0045331074,0.0038034674,0.0005410594,4.2311194e-7,0.0041164258,0.000002128221,0.95245856,0.012062466],"study_design_scores_gemma":[0.0050564026,0.00057334005,0.06675445,0.0029984347,0.0040293545,0.00033729675,0.00016303209,0.0000067556325,0.0010194476,0.00020683088,0.9180691,0.00078553427],"about_ca_topic_score_codex":0.0003087462,"about_ca_topic_score_gemma":0.000009533011,"teacher_disagreement_score":0.09135713,"about_ca_system_score_codex":0.0019732993,"about_ca_system_score_gemma":0.00037569166,"threshold_uncertainty_score":0.99998105},"labels":[],"label_agreement":null},{"id":"W2520883891","doi":"10.1016/j.atherosclerosis.2016.09.059","title":"Coronary atheroma progression rates in men and women following high-intensity statin therapy: A pooled analysis of REVERSAL, ASTEROID and SATURN","year":2016,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Rosuvastatin; Internal medicine; Atorvastatin; Gastroenterology; Atheroma; Cardiology; Intravascular ultrasound; Coronary artery disease; Post-hoc analysis; Apolipoprotein B; Urology; Cholesterol; Endocrinology","score_opus":0.014773702846985004,"score_gpt":0.2653945464075813,"score_spread":0.25062084356059633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520883891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997084,0.0017385435,0.00005012158,0.00046872525,0.000032523658,0.0005555229,0.000017380236,0.000028672262,0.000024471768],"genre_scores_gemma":[0.9967717,0.0022326293,0.0005841574,0.00020497489,0.000024074545,0.00006016977,0.000006714521,0.000028144923,0.00008743013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984649,0.00015122184,0.0003455591,0.00039078106,0.00033506367,0.00031246885],"domain_scores_gemma":[0.9991756,0.000084050895,0.00013403858,0.00038527633,0.000063016916,0.00015798993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085333374,0.0001908511,0.0008550043,0.0001942464,0.000058063106,0.00001598589,0.000057424975,0.00011074028,0.000037401413],"category_scores_gemma":[0.000052791947,0.00011693071,0.00017827956,0.00042160263,0.00009412448,0.00011462697,0.0000695066,0.00009673403,0.0000012128589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006570244,0.00014833291,0.65098274,0.00005559697,0.0023935393,0.000010693422,0.002719703,3.3637883e-7,0.22853898,0.0000070996775,0.000025167124,0.114460774],"study_design_scores_gemma":[0.004570307,0.00070241396,0.98540425,0.00042515015,0.00053036097,0.0000046556756,0.00070631696,0.00004508294,0.007347213,0.00004917585,0.00007446262,0.0001405843],"about_ca_topic_score_codex":0.0005298651,"about_ca_topic_score_gemma":0.000044367276,"teacher_disagreement_score":0.33442152,"about_ca_system_score_codex":0.00010369162,"about_ca_system_score_gemma":0.000041872303,"threshold_uncertainty_score":0.4768296},"labels":[],"label_agreement":null},{"id":"W2521062382","doi":"10.1016/j.cjca.2016.07.181","title":"THE EFFECTS OF ALIROCUMAB ON LDL CHOLESTEROL IN PATIENTS RECEIVING STATINS","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Alirocumab; Medicine; PCSK9; Kexin; Proprotein convertase; Ldl cholesterol; Subtilisin; Evolocumab; Internal medicine; Cholesterol; LDL receptor; Lipoprotein; Biochemistry","score_opus":0.005839044719246782,"score_gpt":0.2213538816933491,"score_spread":0.21551483697410231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521062382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961522,0.00052541273,0.00017170882,0.00097400893,0.0006921631,0.00024063665,0.0000050118397,0.0000013954157,0.0012374205],"genre_scores_gemma":[0.999108,0.0002255096,0.000017210557,0.00021572452,0.00036888753,0.000003824431,5.8822997e-7,0.000011891537,0.000048349157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881005,0.0002740941,0.00034865222,0.00008894615,0.00018994499,0.00028828075],"domain_scores_gemma":[0.99885213,0.00022648196,0.00016212858,0.0002629467,0.00017805982,0.0003182228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071170187,0.0000828801,0.0004522134,0.00017819915,0.000048753773,0.0000045392876,0.00010881058,0.00008108694,0.0000022652096],"category_scores_gemma":[0.0009732477,0.000043048512,0.00020618568,0.00008189718,0.00009805284,0.000034009983,0.0000061356673,0.00018638953,0.0000033458173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022254756,0.0000070620217,0.5197159,0.00010048727,0.00036378272,0.0001618807,0.0002212171,0.000022851726,0.000278082,0.00012351986,0.0026340517,0.4761486],"study_design_scores_gemma":[0.0035498426,0.0014578968,0.9608349,0.00048467692,0.000047466838,0.00008047477,0.000029004526,2.076263e-7,0.00039049328,0.00007394811,0.033000086,0.000050993065],"about_ca_topic_score_codex":0.00066288945,"about_ca_topic_score_gemma":0.0018282,"teacher_disagreement_score":0.4760976,"about_ca_system_score_codex":0.0002483971,"about_ca_system_score_gemma":0.0007049313,"threshold_uncertainty_score":0.17554675},"labels":[],"label_agreement":null},{"id":"W2521162055","doi":"10.1016/j.atherosclerosis.2016.07.156","title":"Identification and management of canadian patients with symptoms of statin intolerance: Results from a real-world clinical practice survey","year":2016,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Statin; Medicine; Clinical Practice; Identification (biology); Intensive care medicine; Family medicine; Internal medicine","score_opus":0.034647366020135156,"score_gpt":0.303520655533896,"score_spread":0.2688732895137609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521162055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975481,0.000051954703,0.00015291794,0.00041646557,0.00007037439,0.0006251771,0.00056268973,0.000009777187,0.00056253205],"genre_scores_gemma":[0.9957969,0.0020019459,0.0017979571,0.000093172486,0.000027854605,0.000020243457,0.00007800117,0.000019228473,0.00016470534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982306,0.00023231933,0.000640996,0.00031584295,0.00041750324,0.00016278456],"domain_scores_gemma":[0.9982249,0.00025887977,0.00037360133,0.0005982678,0.00035763305,0.00018671503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015988405,0.00010213658,0.00034844794,0.00012738818,0.00003524168,0.000007860595,0.000068425696,0.00005664366,0.0000107981905],"category_scores_gemma":[0.00022687974,0.00006595682,0.00006000063,0.00037137402,0.000104473125,0.000101476915,0.000022928,0.00006313207,0.0000046601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010322487,0.00024980557,0.8718553,0.000102656646,0.00059332745,0.0000014950883,0.00027823646,4.195248e-7,0.00022733797,0.00011579978,0.00029115748,0.12525222],"study_design_scores_gemma":[0.004712652,0.0003290079,0.9924656,0.0006579985,0.00019591147,1.5424831e-7,0.00005735338,0.0000030017059,0.00038187442,0.000007910568,0.0011132384,0.00007530508],"about_ca_topic_score_codex":0.34656945,"about_ca_topic_score_gemma":0.103468165,"teacher_disagreement_score":0.24310128,"about_ca_system_score_codex":0.00006765529,"about_ca_system_score_gemma":0.00010402342,"threshold_uncertainty_score":0.9128912},"labels":[],"label_agreement":null},{"id":"W2521206832","doi":"10.2217/pgs-2016-0091","title":"Rooted in Risk: Genetic Predisposition for Low-Density Lipoprotein Cholesterol Level Associates with Diminished Low-Density Lipoprotein Cholesterol Response to Statin Treatment","year":2016,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Medical Research Council; Johnson and Johnson; National Institutes of Health","keywords":"Cholesterol; Statin; Genetic predisposition; Low-density lipoprotein; Internal medicine; Lipoprotein; Medicine; Endocrinology; Disease","score_opus":0.020135368013175836,"score_gpt":0.2785513898299939,"score_spread":0.25841602181681805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521206832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97311175,0.0001611511,0.014958408,0.0018269256,0.00017887265,0.008737042,0.0008706135,0.00014483271,0.000010391634],"genre_scores_gemma":[0.99084157,0.00021605821,0.0054513644,0.0007461207,0.00058032415,0.0015623824,0.00008590859,0.00016422951,0.00035201857],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956324,0.0006633891,0.00086889195,0.0011354381,0.00067818846,0.001021654],"domain_scores_gemma":[0.9973132,0.00023168902,0.00041464283,0.0009827644,0.00036230832,0.0006954118],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017897502,0.0006600625,0.0011109865,0.00032096548,0.00027093646,0.000080564096,0.00023373886,0.00025889536,0.00002701876],"category_scores_gemma":[0.0002875461,0.00048436754,0.0003928273,0.00034636477,0.00009372902,0.00019319473,0.000106047824,0.00031169323,0.00006934069],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03657937,0.0021809414,0.027790682,0.00048793852,0.0012910975,0.00021499707,0.0025311878,0.0004859783,0.38400823,0.0000021798548,0.000129764,0.54429764],"study_design_scores_gemma":[0.022570565,0.0026461892,0.64645225,0.0005467607,0.0005647365,0.00007194475,0.00007971896,0.00043925364,0.32543436,0.000035687764,0.0005964279,0.00056210236],"about_ca_topic_score_codex":0.004563147,"about_ca_topic_score_gemma":0.0032174212,"teacher_disagreement_score":0.6186616,"about_ca_system_score_codex":0.0018241287,"about_ca_system_score_gemma":0.0005384224,"threshold_uncertainty_score":0.9997608},"labels":[],"label_agreement":null},{"id":"W2521322856","doi":"10.1016/j.atherosclerosis.2016.07.374","title":"Long-term treatment with evolocumab homozygous familial hypercholesterolemia patients: Results from the trial assessing long-term use of PCSK9 inhibition in subjects with genetic LDL disorders (Taussig)","year":2016,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Evolocumab; PCSK9; Familial hypercholesterolemia; Medicine; Placebo; Internal medicine; Randomized controlled trial; LDL receptor; Endocrinology; Cardiology; Gastroenterology; Apolipoprotein B; Lipoprotein; Cholesterol; Pathology","score_opus":0.028726704134069,"score_gpt":0.2514898786336894,"score_spread":0.22276317449962038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521322856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616617,0.0001640504,0.00056630047,0.00028366523,0.00012634408,0.0024809486,0.00014300381,0.000049088452,0.000020409781],"genre_scores_gemma":[0.9980933,0.0007374691,0.00032926086,0.00013340266,0.00023479293,0.00023067553,0.00012091633,0.00008260124,0.000037577156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706733,0.00034223124,0.0006414094,0.00068504893,0.0007852645,0.00047869122],"domain_scores_gemma":[0.99799263,0.00025878445,0.00032190574,0.0011360279,0.0001311011,0.00015952362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026587196,0.00040243735,0.00068972463,0.00010137756,0.00013573321,0.00008101163,0.00010742444,0.00018800767,0.00001251161],"category_scores_gemma":[0.000079012425,0.00019233143,0.00022423193,0.00029861994,0.00025682795,0.0003342188,0.00004686531,0.0001786533,0.000006971496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017858265,0.001174762,0.8574672,0.000041784264,0.00028305166,0.000033836714,0.00083719083,0.000012864065,0.002729402,6.1831736e-7,0.0000058268465,0.119555235],"study_design_scores_gemma":[0.101572394,0.004933905,0.88897604,0.0018547891,0.0003702456,0.000010798275,0.00005688543,0.0000043357986,0.0019677556,0.0000031954903,0.000012741821,0.00023689322],"about_ca_topic_score_codex":0.0037964568,"about_ca_topic_score_gemma":0.005384576,"teacher_disagreement_score":0.119318336,"about_ca_system_score_codex":0.0004574178,"about_ca_system_score_gemma":0.0002485379,"threshold_uncertainty_score":0.7843048},"labels":[],"label_agreement":null},{"id":"W2521347611","doi":"10.1016/j.atherosclerosis.2016.07.591","title":"Elevated levels of lecithin:cholesterol acyltransferase (LCAT) are associated with reduced atheroma burden – An ivus study","year":2016,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Lecithin—cholesterol acyltransferase; Cholesterol; Atheroma; Sterol O-acyltransferase; Intravascular ultrasound; Internal medicine; Lecithin; Reverse cholesterol transport; Medicine; High-density lipoprotein; Endocrinology; Lipoprotein; Chemistry; Biochemistry","score_opus":0.04248077964520317,"score_gpt":0.2715389046307101,"score_spread":0.22905812498550696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521347611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967732,0.00005694307,0.0002347258,0.00061650004,0.000079270736,0.0018033407,0.00012654572,0.00019948074,0.000109995475],"genre_scores_gemma":[0.9987393,0.000042855132,0.00012133796,0.00020698289,0.00016582916,0.00014265347,0.000012380917,0.00012864449,0.0004399921],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99674344,0.00042029942,0.0005950906,0.00069396954,0.000993975,0.0005531994],"domain_scores_gemma":[0.9974874,0.000083037754,0.0002754828,0.0013721741,0.0004175795,0.00036432652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010199009,0.00039702738,0.0009853994,0.00012747257,0.00014455692,0.000030742212,0.00027059406,0.00021872927,0.00020515767],"category_scores_gemma":[0.00015997415,0.00024146988,0.00027158862,0.00049424113,0.00014499758,0.00023794186,0.000036786776,0.00023031743,0.000024321398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047637714,0.002089703,0.122810215,0.00007885689,0.0015654787,0.000021572536,0.0035382335,0.000004116776,0.8547432,0.000012068545,0.000036339487,0.014623859],"study_design_scores_gemma":[0.01053156,0.003873576,0.89105564,0.0010250855,0.00047772785,0.000013905462,0.0010809065,0.000007286166,0.09154433,0.00001418364,0.000048765407,0.0003270064],"about_ca_topic_score_codex":0.0005413035,"about_ca_topic_score_gemma":0.00025944028,"teacher_disagreement_score":0.76824546,"about_ca_system_score_codex":0.00019115,"about_ca_system_score_gemma":0.00018888952,"threshold_uncertainty_score":0.98468566},"labels":[],"label_agreement":null},{"id":"W2522380048","doi":"10.21037/jtd.2016.08.83","title":"Reducing exposure to cardiovascular risk factors: the legacy of prevention","year":2016,"lang":"en","type":"letter","venue":"Journal of Thoracic Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Framingham Heart Study; Epidemiology; Framingham Risk Score; Risk factor; Atherosclerotic cardiovascular disease; Gerontology; Disease; Family medicine; Environmental health; Internal medicine","score_opus":0.022708779637502438,"score_gpt":0.3087327220044421,"score_spread":0.2860239423669396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2522380048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49064854,0.07519779,0.009467273,0.41622663,0.003625775,0.0037803324,0.00043835433,0.000055663557,0.00055964827],"genre_scores_gemma":[0.87483007,0.0046553644,0.0011554488,0.06456233,0.05117702,0.00006137437,0.00007064053,0.00029051676,0.0031972574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952274,0.00087837706,0.0010035026,0.00032230667,0.0021810858,0.0003873223],"domain_scores_gemma":[0.9960668,0.00009976519,0.0010577842,0.001638831,0.00066586444,0.0004709225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027302601,0.00034651358,0.0013385502,0.0003298373,0.000112849375,0.000055886358,0.00039544853,0.00030178612,0.00010106962],"category_scores_gemma":[0.00081823353,0.0001776813,0.0044689868,0.00024813914,0.000069798116,0.00023073853,0.00008239331,0.0014874145,0.000013615461],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015431831,0.00025840243,0.0022188625,0.0071424185,0.015951127,0.0032070538,0.0005692987,0.00039844785,0.0000887851,0.0000034724728,0.4760921,0.49252686],"study_design_scores_gemma":[0.0010843797,0.0010526514,0.018085612,0.009700158,0.01467722,0.00030848294,0.00020788514,0.0000020237953,0.00048829184,0.00021900376,0.95377487,0.00039940476],"about_ca_topic_score_codex":0.00007696751,"about_ca_topic_score_gemma":4.4137911e-7,"teacher_disagreement_score":0.49212745,"about_ca_system_score_codex":0.00020605503,"about_ca_system_score_gemma":0.0009779385,"threshold_uncertainty_score":0.72456336},"labels":[],"label_agreement":null},{"id":"W2523170917","doi":"10.1371/journal.pone.0162731","title":"Renoprotective Effects of Atorvastatin in Diabetic Mice: Downregulation of RhoA and Upregulation of Akt/GSK3","year":2016,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Canadian HIV Trials Network, Canadian Institutes of Health Research; British Heart Foundation; Agence Universitaire de la Francophonie; Fundação de Amparo à Pesquisa do Estado de São Paulo; Canadian Institutes of Health Research; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Atorvastatin; RHOA; Renal cortex; Endocrinology; Diabetic nephropathy; Internal medicine; Protein kinase B; Medicine; Kidney; Downregulation and upregulation; Diabetes mellitus; Kidney disease; Albuminuria; Statin; Chemistry; Phosphorylation; Signal transduction; Biochemistry","score_opus":0.012537061475912261,"score_gpt":0.2140333996155735,"score_spread":0.20149633813966122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523170917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977462,0.00059531856,0.00045524217,0.00009448811,0.0000081124235,0.0010171054,0.0000059619406,0.000007805811,0.00006971506],"genre_scores_gemma":[0.9977541,0.00008195848,0.0020506198,0.0000046364257,0.000031039068,0.000035721772,0.000003194535,0.000011427047,0.000027288632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989884,0.000099797384,0.00030740714,0.00014463362,0.00035590454,0.00010387931],"domain_scores_gemma":[0.99927145,0.000112652604,0.00018022464,0.00023666288,0.00015510939,0.000043897646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003506362,0.00007494515,0.0004685792,0.00012023342,0.000008932446,8.6373075e-7,0.000024402802,0.00007041092,0.000009637645],"category_scores_gemma":[0.00026778874,0.00005459706,0.00005378478,0.0001640691,0.00007382822,0.000054782235,0.000018192635,0.000046912428,7.1032036e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018916518,0.0004710708,0.027481101,0.0034186787,0.00020820442,0.0000011304248,0.00052000635,0.0000013623736,0.94043857,0.00021963088,6.208184e-7,0.027050463],"study_design_scores_gemma":[0.0016473256,0.00035663173,0.4695684,0.00186818,0.000113019145,4.7944485e-7,0.000018562929,0.000046073146,0.52589524,0.0004521517,4.2355512e-7,0.000033507233],"about_ca_topic_score_codex":0.00018541672,"about_ca_topic_score_gemma":0.000018084003,"teacher_disagreement_score":0.4420873,"about_ca_system_score_codex":0.000043369164,"about_ca_system_score_gemma":0.0000467854,"threshold_uncertainty_score":0.22264035},"labels":[],"label_agreement":null},{"id":"W2523254256","doi":"10.1016/j.atherosclerosis.2016.07.068","title":"A pilot study of MBX-8025 in the treatment of homozygous familial hypercholesterolemia (HoFH)","year":2016,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Internal medicine; Cholesterol","score_opus":0.05293155524711811,"score_gpt":0.2821940578967555,"score_spread":0.22926250264963738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523254256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782175,0.0002762955,0.000026094183,0.00020474188,0.000073764924,0.0013573394,0.000016548496,0.000015541475,0.00020791337],"genre_scores_gemma":[0.9986873,0.00076043466,0.00005541226,0.000099688805,0.00010424489,0.0001676103,0.0000012816536,0.000022650705,0.00010137698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843943,0.00021989812,0.0004045114,0.00024941508,0.00045990493,0.00022681363],"domain_scores_gemma":[0.998818,0.00009901793,0.00009760065,0.00086603477,0.000060126757,0.000059241756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004444663,0.00016132495,0.0005338891,0.00007833392,0.000036540107,0.0000047304698,0.00014241054,0.000038671038,0.000019740046],"category_scores_gemma":[0.00002881921,0.00007655658,0.0001788795,0.00021895501,0.000076690376,0.00003720501,0.000018763072,0.000061305844,0.000009577981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001471932,0.02768578,0.47458798,0.00015700463,0.00066997984,0.00003119873,0.01860879,0.000004053949,0.20587787,0.000056928973,0.000106176274,0.2707423],"study_design_scores_gemma":[0.010294669,0.02526381,0.9573755,0.00021027563,0.00020829139,0.00001242699,0.0018119941,0.0000015126225,0.004223363,0.000013791763,0.00049384777,0.00009051611],"about_ca_topic_score_codex":0.0046069296,"about_ca_topic_score_gemma":0.00079415285,"teacher_disagreement_score":0.48278752,"about_ca_system_score_codex":0.00010916965,"about_ca_system_score_gemma":0.000060900977,"threshold_uncertainty_score":0.696433},"labels":[],"label_agreement":null},{"id":"W2523564199","doi":"10.1161/atvbaha.114.304406","title":"PCSK9 R46L, Lower LDL, and Cardiovascular Disease Risk in Familial Hypercholesterolemia","year":2014,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; Internal medicine; Endocrinology; Familial hypercholesterolemia; Apolipoprotein B; Lipoprotein; Medicine; Population; Cholesterol; Kexin; Missense mutation; Odds ratio; LDL receptor; Biology; Genetics; Mutation","score_opus":0.0227223013071389,"score_gpt":0.25807301351679585,"score_spread":0.23535071220965695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523564199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955197,0.002141196,0.0008805002,0.0003781113,0.00022246526,0.00064733095,0.000024943198,0.000060663366,0.00012510894],"genre_scores_gemma":[0.97900033,0.019139616,0.00042384845,0.00092520844,0.00032422718,0.0001031821,0.00003261719,0.000048110174,0.0000028862976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971178,0.0005898075,0.00044331537,0.00097643666,0.000299875,0.000572731],"domain_scores_gemma":[0.9981234,0.00005397091,0.000069047914,0.001199593,0.00006396594,0.0004900117],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00157134,0.00037192053,0.0011210437,0.00016830498,0.00019579164,0.000049784998,0.000110437286,0.00027360834,0.000027350681],"category_scores_gemma":[0.00013923843,0.00030698336,0.00065410195,0.00018958184,0.00031719854,0.00011254605,0.00016172652,0.00035245667,0.000018759649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037129335,0.00026038496,0.94604725,0.00021921175,0.0014262353,0.0000012537863,0.00025053136,0.000015504982,0.0062832143,0.0002653895,0.000037395715,0.045156475],"study_design_scores_gemma":[0.00393483,0.000545667,0.9749913,0.00015874051,0.00078124175,0.0000034556738,0.00007231133,0.0003439572,0.000022202568,0.00011644283,0.018704044,0.00032580827],"about_ca_topic_score_codex":0.0009329362,"about_ca_topic_score_gemma":0.00007858343,"teacher_disagreement_score":0.044830665,"about_ca_system_score_codex":0.000043777447,"about_ca_system_score_gemma":0.00005094103,"threshold_uncertainty_score":0.99993825},"labels":[],"label_agreement":null},{"id":"W2524092621","doi":"10.1016/j.dib.2016.09.037","title":"Contemporary data on low-density lipoprotein cholesterol target value attainment and distance to target in a cohort of 57,885 statin-treated patients by country and region across the world","year":2016,"lang":"en","type":"article","venue":"Data in Brief","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Merck","keywords":"Statin; Cholesterol; Value (mathematics); Cohort; Internal medicine; Cohort study; Medicine; Psychology; Statistics; Mathematics","score_opus":0.019816704169265554,"score_gpt":0.2835704409941826,"score_spread":0.26375373682491704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524092621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870009,0.00075413723,0.00047821735,0.0014614527,0.0000445464,0.0023228333,0.007856972,0.000013787645,0.00006717742],"genre_scores_gemma":[0.9943164,0.0002181374,0.00022665526,0.0013126656,0.000045848898,0.00005630137,0.003693512,0.000025068937,0.00010543963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769825,0.00021144461,0.00046460464,0.00076061965,0.000552283,0.00031281434],"domain_scores_gemma":[0.9971056,0.00009043369,0.00015162746,0.0024435418,0.00005314998,0.00015566702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015638318,0.00020109583,0.0005076297,0.00005462999,0.00006451301,0.00002983695,0.00037842666,0.000069048096,0.0000041434487],"category_scores_gemma":[0.00027819592,0.00012579618,0.000017793982,0.00024168323,0.00017367641,0.0002983829,0.0006433162,0.00019031584,0.0000017822165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011344102,0.0004208797,0.9589422,0.00030196417,0.00009439832,0.00008560065,0.00030298767,9.694877e-7,0.00018245191,0.00002389142,0.023351518,0.015158729],"study_design_scores_gemma":[0.004876441,0.0002499109,0.9370834,0.0012253843,0.00002101538,0.000010012349,0.00009662496,0.00010588589,0.00079983566,0.00001954191,0.055334106,0.00017784485],"about_ca_topic_score_codex":0.009620397,"about_ca_topic_score_gemma":0.0019773613,"teacher_disagreement_score":0.03198259,"about_ca_system_score_codex":0.00010916146,"about_ca_system_score_gemma":0.00007510998,"threshold_uncertainty_score":0.99697465},"labels":[],"label_agreement":null},{"id":"W2524412350","doi":"10.1016/j.cjca.2016.07.180","title":"FREQUENCY OF STATIN DOWNTITRATION DURING OPEN LABEL EVOLOCUMAB TREATMENT IN THE OSLER-2 STUDIES","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Evolocumab; Medicine; PCSK9; Statin; Alirocumab; Dosing; Rescue therapy; Monoclonal; Monoclonal antibody; Internal medicine; Oncology; Intensive care medicine; Cholesterol; Antibody; Immunology; LDL receptor; Lipoprotein","score_opus":0.05900647730708385,"score_gpt":0.3272082102852621,"score_spread":0.26820173297817823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524412350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98874015,0.0051643783,0.00011886232,0.0035147867,0.00018989875,0.00040602504,0.000015782529,0.0000011214881,0.0018489738],"genre_scores_gemma":[0.9983217,0.0008839088,0.00023207314,0.00009283574,0.00037733628,0.000016692667,0.0000011159229,0.0000067705346,0.00006758137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988647,0.00030846766,0.00038171592,0.00009472706,0.00013760621,0.00021277265],"domain_scores_gemma":[0.99914235,0.000066841625,0.00015069969,0.00026393667,0.00022893836,0.00014726151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010155523,0.000085450265,0.00058226753,0.00016654612,0.0000550173,0.0000073619003,0.000160346,0.000058789487,0.000011543668],"category_scores_gemma":[0.00023940037,0.000041106417,0.00012985915,0.00010980877,0.00011072983,0.00008504538,0.000008194431,0.000093422896,0.0000024752085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006317907,0.00008411078,0.6791522,0.0004133635,0.0070840083,0.005269851,0.0107718455,0.00016486623,0.021251358,0.0059434124,0.0053241826,0.26390898],"study_design_scores_gemma":[0.016884057,0.0034311663,0.9462404,0.0006490103,0.0005419115,0.0037918387,0.0040713483,8.534193e-7,0.0025320395,0.0026351132,0.019008137,0.00021407382],"about_ca_topic_score_codex":0.0067416877,"about_ca_topic_score_gemma":0.016885845,"teacher_disagreement_score":0.26708823,"about_ca_system_score_codex":0.0004481048,"about_ca_system_score_gemma":0.0015372081,"threshold_uncertainty_score":0.9998725},"labels":[],"label_agreement":null},{"id":"W2525117557","doi":"10.1016/j.cjca.2016.07.353","title":"IMPACT OF BARIATRIC SURGERY ON PLASMA LDL CHOLESTEROL AND PCSK9 LEVELS IN PATIENTS WITH SEVERE OBESITY","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"PCSK9; Medicine; Kexin; Obesity; Proprotein convertase; Cholesterol; Disease; Internal medicine; Surgery; LDL receptor; Lipoprotein","score_opus":0.013565121136980558,"score_gpt":0.2234790306431864,"score_spread":0.20991390950620584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525117557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990056,0.00015277744,0.00007682667,0.00016283366,0.00013125168,0.00016829198,0.00004393978,0.0000013456621,0.0002570969],"genre_scores_gemma":[0.9996107,0.000035694655,0.000019254832,0.000053799282,0.00025446338,0.0000011326744,0.0000014942384,0.000012359526,0.000011056619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891615,0.00017316364,0.00032367403,0.0001238676,0.00017476552,0.00028839352],"domain_scores_gemma":[0.9987832,0.00009635918,0.00016455766,0.00020999285,0.00020753707,0.0005383598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059371424,0.00011636053,0.00077982486,0.00044860155,0.000025822927,0.000004043526,0.000053625787,0.000122281,0.000012012787],"category_scores_gemma":[0.00018236821,0.0000650019,0.00026090245,0.00013304052,0.000082486775,0.00006556888,0.0000056487856,0.00018039331,0.0000016625132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024655196,0.0000058920673,0.9663209,0.00002387357,0.00028768528,0.00010499098,0.000026296733,0.000051732248,0.000009401427,0.000006685125,0.00022792074,0.03268809],"study_design_scores_gemma":[0.0033117323,0.0011614508,0.9940384,0.00020659031,0.00007363451,0.00053724373,0.0000073734454,3.3117718e-7,0.00001759064,0.000019243209,0.0005529915,0.00007340004],"about_ca_topic_score_codex":0.0015752113,"about_ca_topic_score_gemma":0.0009798537,"teacher_disagreement_score":0.03261469,"about_ca_system_score_codex":0.00030579866,"about_ca_system_score_gemma":0.0017490528,"threshold_uncertainty_score":0.31027445},"labels":[],"label_agreement":null},{"id":"W2525626329","doi":"10.1016/j.cjca.2016.07.259","title":"ALIROCUMAB EFFICACY AND SAFETY IN PATIENTS WITH PRE-DIABETES VERSUS NORMOGLYCEMIA","year":2016,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Alirocumab; Diabetes mellitus; PCSK9; Internal medicine; Atherosclerotic cardiovascular disease; Endocrinology; Cholesterol; Lipoprotein","score_opus":0.006376748114443316,"score_gpt":0.21064572965725933,"score_spread":0.20426898154281603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525626329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968254,0.000754529,0.00012733371,0.00070970797,0.00026754115,0.00022494212,0.000011378795,0.0000026981713,0.0010764628],"genre_scores_gemma":[0.9992647,0.00008786003,0.00008687695,0.00010368961,0.00041472045,0.0000021904748,0.0000026013213,0.000014162883,0.000023191746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990162,0.000097322896,0.00026447052,0.000129986,0.00015232361,0.0003396621],"domain_scores_gemma":[0.9988914,0.000069705835,0.00008786408,0.00020588946,0.00016788382,0.00057721965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036671793,0.000105167135,0.0005252416,0.00021018281,0.000040921503,0.0000055796186,0.000065203014,0.00010731413,0.000012109408],"category_scores_gemma":[0.00019555225,0.00006150725,0.00009632209,0.000094070696,0.00013279336,0.00006475783,0.000007564595,0.00017204018,0.0000025876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002508956,0.0000035970018,0.8752818,0.00002526443,0.00040781722,0.00011536196,0.00006269668,0.000022147466,0.000017577227,0.000042729764,0.00047743577,0.12103461],"study_design_scores_gemma":[0.017320456,0.0017505459,0.9390406,0.00015211948,0.00010453042,0.00007426193,0.000012782459,2.4074762e-7,0.000015304671,0.000012016969,0.041437216,0.00007991555],"about_ca_topic_score_codex":0.00038525308,"about_ca_topic_score_gemma":0.0010455034,"teacher_disagreement_score":0.12095469,"about_ca_system_score_codex":0.00026279694,"about_ca_system_score_gemma":0.0009269149,"threshold_uncertainty_score":0.2508193},"labels":[],"label_agreement":null},{"id":"W2525828303","doi":"10.71781/32061","title":"Déterminants de la dysbêtalipoprotéinémie de type III : au-delà de l'apolipoprotéine E","year":2005,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Humanities; Physics; Philosophy","score_opus":0.02316608130072907,"score_gpt":0.3601132345961773,"score_spread":0.3369471532954482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525828303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8449671,0.0063335854,0.00031391918,0.00045157978,0.0012647208,0.004515834,0.00008901753,0.0000136067865,0.14205058],"genre_scores_gemma":[0.78159654,0.0036602,0.026971096,0.00065920537,0.009682403,0.00081971503,0.0014089233,0.00040302656,0.17479888],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935707,0.0009485974,0.0011212238,0.0011905346,0.0009373053,0.0022316603],"domain_scores_gemma":[0.99606687,0.00016506673,0.00054234185,0.0015759694,0.0003391784,0.00131059],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.005724363,0.0009291473,0.0017174191,0.00028529982,0.0005634606,0.00034775832,0.0011599829,0.0017052128,0.0072906218],"category_scores_gemma":[0.0006398231,0.0009332961,0.0006262974,0.000596708,0.00025332213,0.00034194766,0.00027377758,0.0015825514,0.001756021],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001448584,0.0008633942,0.0064065726,0.0011294327,0.0010384432,0.0014987697,0.014651203,0.00009236921,0.006681255,0.00021526005,0.0013890826,0.96458566],"study_design_scores_gemma":[0.011108025,0.0014966392,0.10284423,0.007553533,0.0039855773,0.0037494386,0.013190247,0.0017583931,0.08879718,0.00023913612,0.7630614,0.002216216],"about_ca_topic_score_codex":0.029903937,"about_ca_topic_score_gemma":0.0071883653,"teacher_disagreement_score":0.96236944,"about_ca_system_score_codex":0.0027539546,"about_ca_system_score_gemma":0.012237196,"threshold_uncertainty_score":0.99959075},"labels":[],"label_agreement":null},{"id":"W2526246517","doi":"10.1016/j.amjcard.2016.09.010","title":"Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program)","year":2016,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"European Atherosclerosis Society","keywords":"Alirocumab; Phase (matter); Medicine; Lipoprotein; Internal medicine; Chemistry; Cholesterol; Organic chemistry","score_opus":0.00972689901057275,"score_gpt":0.3152337451241557,"score_spread":0.3055068461135829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526246517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950558,0.00097103196,0.000462892,0.0023295083,0.00022526864,0.0006001015,0.000014415981,0.000013945236,0.00032701634],"genre_scores_gemma":[0.9969851,0.00050389266,0.000102753576,0.00051623734,0.0018199047,0.000024106557,0.0000012064492,0.000025051082,0.00002177249],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99728286,0.0013266517,0.00042372747,0.0001555741,0.00053231744,0.00027885276],"domain_scores_gemma":[0.99766284,0.0007236837,0.0005913362,0.00077392376,0.00012229735,0.00012592941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023558217,0.00016279772,0.0011312688,0.00006255116,0.000049016056,0.00000629612,0.0003074858,0.00004951823,0.000022771215],"category_scores_gemma":[0.00035166295,0.00005954405,0.0008163507,0.00019339415,0.00068762444,0.00003208772,0.00004544643,0.0003260906,0.000013070768],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004605709,0.000044645436,0.0017860334,0.000011696492,0.0012558281,0.00012762191,0.00008825302,0.0000071074464,0.006015719,0.00003382616,0.0009722294,0.98505133],"study_design_scores_gemma":[0.038701374,0.16856937,0.4950124,0.0013698036,0.0044137905,0.0063459375,0.00055019825,0.000014654456,0.03162123,0.00067182415,0.25211024,0.0006191882],"about_ca_topic_score_codex":0.00021000722,"about_ca_topic_score_gemma":0.0000015214454,"teacher_disagreement_score":0.98443216,"about_ca_system_score_codex":0.000064888714,"about_ca_system_score_gemma":0.00013877256,"threshold_uncertainty_score":0.2533581},"labels":[],"label_agreement":null},{"id":"W2527494156","doi":"10.14740/jocmr2739w","title":"LDLR C1725T Gene Polymorphism Frequency in Type 2 Diabetes Mellitus Patients With Dyslipidemia","year":2016,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Medicine; Internal medicine; Genotype; Type 2 Diabetes Mellitus; Lipid profile; LDL receptor; PCSK9; Gastroenterology; Diabetes mellitus; Gene polymorphism; Lipoprotein; Endocrinology; Cholesterol; Gene; Obesity; Genetics; Biology","score_opus":0.10957709877380856,"score_gpt":0.44861815800445215,"score_spread":0.3390410592306436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527494156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96750855,0.010498913,0.00008090889,0.019640662,0.00068674784,0.000496903,0.000002379924,0.000008725054,0.0010762226],"genre_scores_gemma":[0.986525,0.0073300335,0.00092881365,0.0006099589,0.00430651,0.0000066534194,0.0000028510317,0.000038183127,0.00025200876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927394,0.0011557313,0.0020480838,0.0003303854,0.0030046748,0.000721745],"domain_scores_gemma":[0.993527,0.0021784392,0.00045091775,0.0006607037,0.0022226388,0.0009603201],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0188293,0.00018056387,0.001474944,0.0005746412,0.00006053269,0.0000074813715,0.00030269483,0.0002592038,0.00057304],"category_scores_gemma":[0.0146045685,0.00007989819,0.0002713313,0.0008427981,0.00063361437,0.00014930122,0.000067689594,0.0016372247,0.000048306607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001198923,0.00041570968,0.7158813,0.000098102646,0.0002530078,0.00025925954,0.00004018695,2.3034426e-7,0.00041859088,0.00005454654,0.0022162502,0.27916393],"study_design_scores_gemma":[0.016514286,0.012451083,0.953426,0.00360253,0.00012026625,0.0000428033,0.00004540851,0.000004374251,0.00029494418,0.0009226453,0.012449614,0.00012606416],"about_ca_topic_score_codex":0.00010415796,"about_ca_topic_score_gemma":0.000016169904,"teacher_disagreement_score":0.27903786,"about_ca_system_score_codex":0.0002193135,"about_ca_system_score_gemma":0.0012198538,"threshold_uncertainty_score":0.99369586},"labels":[],"label_agreement":null},{"id":"W2528173920","doi":"10.1016/j.cjca.2015.07.729","title":"TARGETED NEXT-GENERATION SEQUENCING TO DIAGNOSE ABNORMALITIES OF HDL CHOLESTEROL","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Sanger sequencing; Medicine; Genetics; Mendelian inheritance; Bioinformatics; Exon; DNA sequencing; Gene; Internal medicine; Biology","score_opus":0.09572273463424762,"score_gpt":0.27406637789820365,"score_spread":0.17834364326395602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528173920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991329,0.0024984335,0.0020967415,0.0012226399,0.0008682065,0.00022242991,0.000014920154,0.0000041738963,0.0017434523],"genre_scores_gemma":[0.99586076,0.000056890283,0.00049347244,0.0008294198,0.002674012,0.0000054529223,0.000009187467,0.0000144591995,0.000056329955],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875325,0.00019963025,0.00043340743,0.000102705584,0.00022567803,0.00028534717],"domain_scores_gemma":[0.9977855,0.000018788358,0.00013595032,0.0002472743,0.00064712676,0.0011653453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011986551,0.000100312835,0.00061061094,0.00031828354,0.00003982632,0.0000137599,0.00009589243,0.00011439688,0.00001185302],"category_scores_gemma":[0.00049716595,0.000086076616,0.00024275691,0.00014454604,0.00006565533,0.0001115782,0.000008192317,0.0001972327,0.0000057824263],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083067344,0.000027428656,0.33517414,0.0007926354,0.005403596,0.006519209,0.021443121,0.08820204,0.0758528,0.0018689383,0.23919447,0.22469096],"study_design_scores_gemma":[0.009626708,0.0070370566,0.16058247,0.00068212405,0.0011432725,0.019127263,0.009057641,0.0002883275,0.03268629,0.00036824017,0.758587,0.0008136303],"about_ca_topic_score_codex":0.009453071,"about_ca_topic_score_gemma":0.004465757,"teacher_disagreement_score":0.5193925,"about_ca_system_score_codex":0.00041017897,"about_ca_system_score_gemma":0.0035422212,"threshold_uncertainty_score":0.9971431},"labels":[],"label_agreement":null},{"id":"W2529233490","doi":"10.1016/j.jacl.2016.09.015","title":"Predicting proprotein convertase subtilisin kexin type-9 loss of function mutations using plasma PCSK9 concentration","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; Kexin; Proprotein convertase; Genotyping; Subtilisin; Mutation; Medicine; LDL receptor; Genetics; Internal medicine; Biology; Lipoprotein; Gene; Genotype; Cholesterol; Biochemistry; Enzyme","score_opus":0.08100244998293878,"score_gpt":0.3805912096539901,"score_spread":0.29958875967105136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2529233490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880583,0.00022451847,0.006940584,0.0011740878,0.0031360367,0.00035883498,0.0000070168408,0.0000115775165,0.000089001885],"genre_scores_gemma":[0.9935113,0.00012752059,0.0019526961,0.00020889286,0.004115076,0.0000020559576,0.0000040486275,0.00001570976,0.00006266725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968608,0.0005403888,0.0017892058,0.00017729866,0.00042084875,0.00021147427],"domain_scores_gemma":[0.9968553,0.00058651704,0.001217066,0.0002432871,0.000877405,0.00022039206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003087781,0.0001124426,0.0008106496,0.00008601957,0.000051183182,0.000005419656,0.00007507123,0.00027015444,0.00014712992],"category_scores_gemma":[0.0042482335,0.000069442984,0.00040587533,0.00013560266,0.00026039185,0.00016023262,0.000021099022,0.0003718806,0.000010412034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009920904,0.0008268172,0.8137141,0.0003489192,0.0011902552,0.00008818036,0.0002074731,0.00010506364,0.04351189,0.0007171413,0.00046335903,0.12890589],"study_design_scores_gemma":[0.061349478,0.03164302,0.7949664,0.0039119087,0.004553784,0.0065622022,0.0008351884,0.006319863,0.05204034,0.0030910864,0.033964254,0.00076248567],"about_ca_topic_score_codex":0.000037650123,"about_ca_topic_score_gemma":0.00001110176,"teacher_disagreement_score":0.12814341,"about_ca_system_score_codex":0.00006375764,"about_ca_system_score_gemma":0.0008772019,"threshold_uncertainty_score":0.5085839},"labels":[],"label_agreement":null},{"id":"W2530029804","doi":"10.1002/pds.4112","title":"The effect of statins on influenza‐like illness morbidity and mortality","year":2016,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Statin; Incidence (geometry); Internal medicine; Cumulative incidence; Logistic regression; Cohort study; Propensity score matching; Pneumonia; Cohort; Emergency medicine","score_opus":0.024566386595867996,"score_gpt":0.3598016629895395,"score_spread":0.33523527639367146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530029804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186486,0.0032523319,0.00036014887,0.0031358763,0.00026392244,0.00054739224,0.000042267126,0.000028566034,0.0005046626],"genre_scores_gemma":[0.99190557,0.0061246166,0.000030672094,0.0016418889,0.00016701214,0.00003880752,0.0000035378891,0.000010508247,0.00007738226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997174,0.0016745211,0.00041445947,0.0002973288,0.00015161799,0.00028803432],"domain_scores_gemma":[0.9954631,0.003809074,0.00014341032,0.00035590352,0.000042633674,0.0001859037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007517568,0.00016720564,0.0006166275,0.000028683884,0.00024370942,0.0000021685528,0.000062068946,0.00008160613,0.000022547561],"category_scores_gemma":[0.0011554639,0.00007342017,0.00013182027,0.000058106816,0.00044538,0.000045539455,0.000063798594,0.00021462816,0.000005072436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025809696,0.00003494095,0.70812875,0.00036294476,0.0005132937,0.000013585094,0.00013924258,0.000004586106,0.0012671243,0.0014109213,0.0019554307,0.28358823],"study_design_scores_gemma":[0.0055853017,0.00048615286,0.9246666,0.0001212332,0.00034297875,0.000050965275,0.000031115138,0.00007848949,0.008260897,0.00048707714,0.059726354,0.00016285203],"about_ca_topic_score_codex":0.00040345316,"about_ca_topic_score_gemma":0.00002850166,"teacher_disagreement_score":0.2834254,"about_ca_system_score_codex":0.000026823162,"about_ca_system_score_gemma":0.000040147188,"threshold_uncertainty_score":0.29939875},"labels":[],"label_agreement":null},{"id":"W2530469753","doi":"10.1016/j.jacl.2016.10.004","title":"The Montreal-FH-SCORE: A new score to predict cardiovascular events in familial hypercholesterolemia","year":2016,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Cardiology; Cholesterol","score_opus":0.0650971866844904,"score_gpt":0.35441761803362604,"score_spread":0.28932043134913565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530469753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975722,0.0029587296,0.0022185289,0.013399849,0.0047821556,0.0006322978,0.0000042062193,0.000014812465,0.00026739042],"genre_scores_gemma":[0.9728268,0.004932557,0.00062945345,0.0024099962,0.018452827,0.000014169402,9.3203056e-7,0.00004056698,0.00069271825],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9949507,0.001093178,0.002123466,0.00035982003,0.0009317065,0.0005411176],"domain_scores_gemma":[0.9965278,0.0009959074,0.00039823042,0.0009574864,0.00027923496,0.0008413317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0085102515,0.00021342149,0.0016501198,0.00015445396,0.00006511432,0.000008814078,0.00040895276,0.0003736811,0.000021627877],"category_scores_gemma":[0.005536109,0.00010254875,0.0018752102,0.00022837886,0.00014073722,0.00010102142,0.00012743351,0.00085360894,0.000054996795],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030131713,0.00018166633,0.28671864,0.000026224376,0.0010235683,0.00012052175,0.00006342849,0.000026742806,0.000117751064,0.000029392597,0.0064765736,0.7022023],"study_design_scores_gemma":[0.010068232,0.0024888392,0.8314338,0.00046343755,0.00032985132,0.0007999271,0.0000285886,0.000003391636,0.000024200122,0.0005377836,0.15371297,0.0001090192],"about_ca_topic_score_codex":0.00032469284,"about_ca_topic_score_gemma":0.00032023445,"teacher_disagreement_score":0.7020933,"about_ca_system_score_codex":0.00013477144,"about_ca_system_score_gemma":0.0010694854,"threshold_uncertainty_score":0.662764},"labels":[],"label_agreement":null},{"id":"W2530605526","doi":"10.1016/s1878-6480(16)30271-3","title":"0220: Effectiveness of ezetimibe on blood lipids in real life clinical practice","year":2016,"lang":"en","type":"article","venue":"Archives of Cardiovascular Diseases Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ezetimibe; Medicine; Simvastatin; Statin; Cohort; Prospective cohort study; Internal medicine; Cohort study; Pediatrics","score_opus":0.017599916108744694,"score_gpt":0.3246954165862109,"score_spread":0.30709550047746625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530605526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825822,0.007750578,0.002242495,0.00021458256,0.00031520944,0.0022576028,0.00045897273,0.000047404625,0.0041309637],"genre_scores_gemma":[0.98626566,0.011726272,0.0013069592,0.00008566329,0.0003233015,0.0001340205,0.000088690904,0.00005189396,0.000017542172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99376637,0.0026393952,0.0010167097,0.00067678397,0.0014360914,0.00046465904],"domain_scores_gemma":[0.9955088,0.0018767711,0.0002311242,0.0017449285,0.00015740562,0.0004810086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028218206,0.00029282473,0.0016225075,0.0002842957,0.00004748826,0.000006271968,0.00024821187,0.000095316165,0.000054417582],"category_scores_gemma":[0.0022399202,0.00020825828,0.0029114368,0.00024551913,0.00029338704,0.0001435176,0.00016964652,0.00022142891,0.00000942326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014553413,0.007602212,0.6486026,0.0043306225,0.043207992,0.0005366987,0.00019766083,0.0002055135,0.0015147935,0.0017720835,0.00014559184,0.27733085],"study_design_scores_gemma":[0.024758106,0.002689587,0.9486881,0.0021149477,0.0068271607,0.000038636037,0.00011305698,0.000010873742,0.0040924987,0.00028603623,0.010061279,0.0003197006],"about_ca_topic_score_codex":0.0004881211,"about_ca_topic_score_gemma":0.000004058315,"teacher_disagreement_score":0.30008554,"about_ca_system_score_codex":0.00003867166,"about_ca_system_score_gemma":0.00048201077,"threshold_uncertainty_score":0.84925264},"labels":[],"label_agreement":null},{"id":"W2531661960","doi":"10.1016/j.cjca.2016.10.002","title":"Effective Management of Cardiovascular Risk Factors—Are We Doing Enough?","year":2016,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Scopus; Dyslipidemia; Diabetes mellitus; Asymptomatic; Smoking cessation; Internal medicine; Disease; MEDLINE; Pathology; Endocrinology","score_opus":0.013160274664358393,"score_gpt":0.22819145009786573,"score_spread":0.21503117543350733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531661960","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028899949,0.39087927,0.060363438,0.4318935,0.020849265,0.00955305,0.0026769533,0.000098813005,0.054785762],"genre_scores_gemma":[0.77483803,0.06726275,0.0019552847,0.045382872,0.107970744,0.00015050193,0.00019456737,0.0006731162,0.0015721499],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99578494,0.0010701655,0.00090349384,0.00047097902,0.00083006936,0.00094038056],"domain_scores_gemma":[0.99624443,0.00015692458,0.0009192901,0.0012847148,0.0006900496,0.00070458086],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018046973,0.0005120221,0.0035081804,0.00085441343,0.00013795296,0.000016710172,0.00040713826,0.0011565092,0.000039374358],"category_scores_gemma":[0.000100126854,0.00036235366,0.0045588547,0.00022368829,0.0002885242,0.000068186375,0.00004350045,0.002339992,0.000015369431],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103366394,0.0000035058406,0.0067839664,0.0034414874,0.08121778,0.030743226,0.00024146444,0.0009049151,0.000005391857,0.000029986997,0.7148122,0.16171269],"study_design_scores_gemma":[0.0017993349,0.00045155964,0.0075678425,0.0019574605,0.0066955085,0.0018192056,0.00015615793,3.0122087e-7,0.0000569991,0.00006563788,0.9791198,0.0003102183],"about_ca_topic_score_codex":0.0035138482,"about_ca_topic_score_gemma":0.00010130457,"teacher_disagreement_score":0.74593806,"about_ca_system_score_codex":0.00092273066,"about_ca_system_score_gemma":0.0013959924,"threshold_uncertainty_score":0.9999617},"labels":[],"label_agreement":null},{"id":"W2534038591","doi":"10.1016/j.cjca.2016.10.019","title":"An Evidence-Based Guide to Cholesterol-Lowering Guidelines","year":2016,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ezetimibe; Alirocumab; Statin; Relative risk; Familial hypercholesterolemia; Evolocumab; Clinical trial; Risk assessment; Proprotein convertase; Intensive care medicine; Internal medicine; Cholesterol; Lipoprotein; Confidence interval; LDL receptor","score_opus":0.10737798393880202,"score_gpt":0.3970790391145249,"score_spread":0.28970105517572287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2534038591","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031913252,0.9851399,0.010297425,0.0015369296,0.0016270592,0.0007194714,0.000044094868,0.000011767173,0.00059146254],"genre_scores_gemma":[0.00023632271,0.9848532,0.0010807336,0.001592795,0.011941095,0.00003115801,0.000010607253,0.00009282196,0.00016126133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963984,0.00049498567,0.0016178481,0.00039976372,0.00039096677,0.0006980378],"domain_scores_gemma":[0.99427855,0.00012109823,0.00050712156,0.0011465102,0.0011790575,0.0027676732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030066904,0.00043479257,0.0039512427,0.0010602372,0.00009504678,0.000042688258,0.0005537533,0.00053013547,0.000046715242],"category_scores_gemma":[0.0016567099,0.000283269,0.0020716442,0.0002806358,0.00009938691,0.00013559859,0.000018363009,0.000583212,0.000081165934],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015110867,9.09641e-7,0.00006724042,0.002030727,0.0005362422,0.00078650145,0.000006247057,0.00005506387,0.000002497068,0.0000048782936,0.01970791,0.9767867],"study_design_scores_gemma":[0.00043134348,0.00069161336,0.00012243663,0.046608422,0.0011916675,0.004781947,0.0000066417438,3.3588887e-7,0.0000024917883,0.0000030977483,0.94590926,0.0002507434],"about_ca_topic_score_codex":0.0012013802,"about_ca_topic_score_gemma":0.00068948895,"teacher_disagreement_score":0.9765359,"about_ca_system_score_codex":0.00093935576,"about_ca_system_score_gemma":0.016360644,"threshold_uncertainty_score":0.999962},"labels":[],"label_agreement":null},{"id":"W2537999615","doi":"10.1161/atvbaha.116.308027","title":"Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically","year":2016,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Familial hypercholesterolemia; Medicine; Internal medicine; Cardiology; Biology; Cholesterol","score_opus":0.05977201777553646,"score_gpt":0.33129963044128696,"score_spread":0.2715276126657505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2537999615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974081,0.0003286742,0.00040660394,0.0010468219,0.00024767066,0.00038947834,0.000024279125,0.000051169336,0.000097218246],"genre_scores_gemma":[0.9877269,0.01092578,0.0006420159,0.00042467192,0.00018014213,0.000045173852,0.000012665881,0.000034619054,0.0000079818265],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99798095,0.00022750316,0.00063323264,0.0005362691,0.00020135299,0.00042066388],"domain_scores_gemma":[0.99848074,0.00014364556,0.00015158126,0.00084207894,0.00012226497,0.00025969578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006839515,0.0002488729,0.000882162,0.00010246816,0.00008756799,0.0000106600755,0.00013087185,0.00029599768,0.00009407402],"category_scores_gemma":[0.00015285124,0.00015566341,0.000604741,0.00013923309,0.00033194124,0.000070716414,0.000116502306,0.00012292151,0.000028914581],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010733752,0.00020190874,0.3556486,0.000087838154,0.0015719337,1.6633959e-7,0.00011971298,8.69084e-8,0.6228721,0.0003285914,0.000053334817,0.019008346],"study_design_scores_gemma":[0.006156595,0.0020082619,0.9867026,0.00016594592,0.00046215352,0.0000022010895,0.00006209984,0.0000042079387,0.0014021737,0.000034845456,0.0027985608,0.0002003517],"about_ca_topic_score_codex":0.00016159877,"about_ca_topic_score_gemma":0.00004008448,"teacher_disagreement_score":0.631054,"about_ca_system_score_codex":0.000047148456,"about_ca_system_score_gemma":0.00009842586,"threshold_uncertainty_score":0.63477695},"labels":[],"label_agreement":null},{"id":"W2538126758","doi":"10.1007/s11883-016-0622-1","title":"Emerging Therapeutic Options for Lowering of Lipoprotein(a): Implications for Prevention of Cardiovascular Disease","year":2016,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lipoprotein(a); PCSK9; Angiology; Disease; Clinical trial; Internal medicine; Stroke (engine); Coronary artery disease; Atorvastatin; Lipoprotein; Intensive care medicine; Apolipoprotein B; Risk factor; Cardiology; Cholesterol","score_opus":0.11078533242488896,"score_gpt":0.3867588594295181,"score_spread":0.2759735270046291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538126758","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013915822,0.90520805,0.083701484,0.000031423417,0.0006320625,0.0098869465,0.0003387051,0.000051857478,0.000010327971],"genre_scores_gemma":[0.0021776576,0.9883139,0.00066009344,0.0000023232278,0.00056633045,0.0076544643,0.00040313927,0.00015047235,0.00007162952],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964408,0.00008330319,0.0017789024,0.0008002973,0.0004897153,0.0004069322],"domain_scores_gemma":[0.99545425,0.000092104914,0.0014151689,0.0022521522,0.0005400668,0.00024624943],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013097522,0.00046350824,0.0027408262,0.00024922597,0.00014334137,0.000014199578,0.00015780992,0.00021242915,0.000015431127],"category_scores_gemma":[0.00024472535,0.0003474898,0.007420681,0.00030775636,0.000094653195,0.00008269792,0.00006711486,0.00015580532,0.0000010019837],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015992626,0.00033005525,0.000020765901,0.04988822,0.0026930505,4.0519765e-7,0.000016697737,0.0000054786315,0.00005859774,0.00013768587,0.000039095317,0.946794],"study_design_scores_gemma":[0.00065208983,0.00017167648,0.00043642306,0.043515656,0.012167908,0.000028046748,0.0000037334496,0.0000031444697,0.00010711229,0.0004815224,0.94210935,0.00032332694],"about_ca_topic_score_codex":0.000013855453,"about_ca_topic_score_gemma":5.078599e-7,"teacher_disagreement_score":0.9464706,"about_ca_system_score_codex":0.00019224621,"about_ca_system_score_gemma":0.00070316024,"threshold_uncertainty_score":0.9998977},"labels":[],"label_agreement":null},{"id":"W2538372843","doi":"10.1016/j.atherosclerosis.2016.10.028","title":"Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations","year":2016,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; Indian Council of Medical Research","keywords":"Familial hypercholesterolemia; LDL receptor; Apolipoprotein B; Sanger sequencing; Mutation; Multiplex ligation-dependent probe amplification; Genetics; Compound heterozygosity; PCSK9; Biology; Exon; Gene mutation; Population; Gene; Medicine; Lipoprotein; Cholesterol; Endocrinology","score_opus":0.022466826913244777,"score_gpt":0.24450203107574256,"score_spread":0.22203520416249778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2538372843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645424,0.00004428111,0.0015860333,0.00076505775,0.00004406843,0.0005939758,0.00004477845,0.000026547483,0.0004410105],"genre_scores_gemma":[0.99795085,0.00007846797,0.0014733827,0.00016435552,0.000064042215,0.00011887634,0.000008637749,0.000035127327,0.00010624085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866253,0.000051290976,0.00036218137,0.00028001113,0.0003397494,0.0003042175],"domain_scores_gemma":[0.99928546,0.00006720296,0.000083423256,0.00041283833,0.000051122654,0.00009998169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030849437,0.00014683744,0.00038712446,0.0002426616,0.00003475506,0.000007702455,0.000086533226,0.0001028772,0.000029489049],"category_scores_gemma":[0.000058092905,0.000099061755,0.000112632704,0.0005057856,0.00011603946,0.000111013476,0.000022769873,0.00015541144,0.000018135934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019556636,0.0008034727,0.8669596,0.0001245588,0.00012924893,0.000044966022,0.0020863926,0.00006666186,0.108570464,0.0003940118,0.000011347192,0.020613734],"study_design_scores_gemma":[0.005904775,0.00033919554,0.98785347,0.00053981884,0.0000503975,0.00005037069,0.00028246568,0.000016797536,0.004673167,0.00010027304,0.00006512278,0.00012412966],"about_ca_topic_score_codex":0.0012036934,"about_ca_topic_score_gemma":0.0013654387,"teacher_disagreement_score":0.12089391,"about_ca_system_score_codex":0.00017284352,"about_ca_system_score_gemma":0.0001963717,"threshold_uncertainty_score":0.4039621},"labels":[],"label_agreement":null},{"id":"W2540214683","doi":"10.1016/j.jval.2016.09.1827","title":"Identification and Management of Patients with Statin Intolerance in Saudi Arabia and the United Arab Emirates: Comparison of Results from a Clinician Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Ezetimibe; Discontinuation; Concomitant; Fibrate; Family medicine; Internal medicine","score_opus":0.05091397687387444,"score_gpt":0.32305111330848535,"score_spread":0.2721371364346109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540214683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640733,0.0010043592,0.00029473996,0.00086201867,0.000033956414,0.0012483435,0.00013442,0.0000044208464,0.000010409504],"genre_scores_gemma":[0.99720865,0.002225482,0.00036800271,0.0000823757,0.000009616135,0.000019775865,0.00006925628,0.00000825279,0.000008578887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759,0.00078964117,0.00093259173,0.00024184967,0.000299302,0.00014658364],"domain_scores_gemma":[0.998609,0.00040042627,0.0004590941,0.00036833898,0.000103822786,0.0000592902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036738357,0.0000852816,0.0004940679,0.00012011729,0.000025620793,0.0000043141217,0.000051087107,0.000038887705,8.645454e-7],"category_scores_gemma":[0.00017100206,0.000047402737,0.00002022217,0.00036685762,0.00013408704,0.00003490923,0.000023030263,0.000101386904,3.5385648e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031783415,0.00021293186,0.96098524,0.00077404105,0.0000549528,9.807738e-7,0.0022425645,0.000106092826,0.000004532203,0.00014689006,0.00001733308,0.03227611],"study_design_scores_gemma":[0.012964057,0.0002629357,0.9830553,0.0021430708,0.000015115944,1.6109455e-7,0.0003121751,0.0009897781,0.00004336269,0.0001129212,0.000054676857,0.000046470428],"about_ca_topic_score_codex":0.052575413,"about_ca_topic_score_gemma":0.0026780982,"teacher_disagreement_score":0.049897313,"about_ca_system_score_codex":0.000061220344,"about_ca_system_score_gemma":0.000076585355,"threshold_uncertainty_score":0.95373356},"labels":[],"label_agreement":null},{"id":"W2540353830","doi":"10.1016/j.jval.2016.08.366","title":"Identification of Statin Intolerance: Results From A Survey of Clinicians in Taiwan","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Internal medicine; Creatine kinase; Physical therapy","score_opus":0.06280279987977974,"score_gpt":0.34439576369363706,"score_spread":0.28159296381385734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540353830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994565,0.0009944235,0.0007051152,0.0023750633,0.00015074789,0.0006815381,0.00047520286,0.000009238432,0.000043686756],"genre_scores_gemma":[0.9983813,0.00085305865,0.00049561256,0.000110741945,0.000051926618,0.000013531189,0.00005013974,0.000013168978,0.00003050932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653345,0.00087681186,0.001692631,0.0002861282,0.00038927371,0.00022173063],"domain_scores_gemma":[0.9983333,0.00030514802,0.0005253693,0.0005986357,0.00014758854,0.00008996683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076468363,0.000083032646,0.0005947995,0.00017798351,0.000012664496,0.0000018125656,0.000082172875,0.00008268469,0.000007671098],"category_scores_gemma":[0.001643717,0.0000618225,0.00007054634,0.00043690123,0.00005464382,0.000044029977,0.00001626496,0.00013336467,0.000005359589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028287745,0.0008508119,0.64252174,0.0014515164,0.000074433854,0.000015083318,0.0069797807,0.00043834062,0.004990796,0.00028273853,0.00029023056,0.33927575],"study_design_scores_gemma":[0.004393515,0.00027468646,0.99130183,0.0013956211,0.0000050359104,0.0000010321145,0.00018543495,0.00053849065,0.001406194,0.0003157283,0.00012597308,0.000056480563],"about_ca_topic_score_codex":0.19249828,"about_ca_topic_score_gemma":0.0072184736,"teacher_disagreement_score":0.34878007,"about_ca_system_score_codex":0.00018246911,"about_ca_system_score_gemma":0.00083294214,"threshold_uncertainty_score":0.8128789},"labels":[],"label_agreement":null},{"id":"W2541096280","doi":"10.1016/j.jval.2016.09.1826","title":"Identification of Statin Intolerance: Results from a Survey of Clinicians in Six European Countries","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Discontinuation; European commission; myalgia; Family medicine; Internal medicine; Physical therapy; European union","score_opus":0.0547740678631304,"score_gpt":0.3296423393531061,"score_spread":0.2748682714899757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541096280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951842,0.0012605565,0.00050989015,0.0015627004,0.00015484977,0.00059568544,0.0006077337,0.00001163591,0.000112754686],"genre_scores_gemma":[0.997101,0.0022889606,0.00027066574,0.00016119606,0.00006524577,0.000006095601,0.000053178606,0.000017437353,0.00003623599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99582666,0.0015611239,0.0017082721,0.00028296444,0.00040263863,0.00021836163],"domain_scores_gemma":[0.99808204,0.00053425384,0.000555655,0.0005689351,0.00017805214,0.00008104175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010692611,0.00008845932,0.00054804684,0.00015351927,0.000016845022,0.0000030634403,0.00009175133,0.000051758903,0.0000075935122],"category_scores_gemma":[0.0016574754,0.00006584955,0.00006077637,0.00033462018,0.00007579758,0.00005017489,0.000020038557,0.00012498687,0.000012441898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00361422,0.0007202155,0.8096603,0.0020715608,0.00009595293,0.000034785622,0.009176149,0.00054255937,0.0023964741,0.00044455784,0.0005467506,0.17069647],"study_design_scores_gemma":[0.0038658406,0.00024488737,0.9923467,0.0015442915,0.000005657719,0.0000011507706,0.00012588149,0.00023851077,0.00093068485,0.00009818144,0.00053943467,0.000058752503],"about_ca_topic_score_codex":0.14164582,"about_ca_topic_score_gemma":0.005157916,"teacher_disagreement_score":0.18268642,"about_ca_system_score_codex":0.00015104661,"about_ca_system_score_gemma":0.000629887,"threshold_uncertainty_score":0.86407006},"labels":[],"label_agreement":null},{"id":"W2541518521","doi":"10.1016/j.jval.2016.08.364","title":"Identification of Statin Intolerance: Results From A Survey of South Korean Clinicians","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Discontinuation; Internal medicine; Creatine kinase; Elevated transaminases; myalgia; Shoulders; Physical therapy; Surgery","score_opus":0.06689159316587932,"score_gpt":0.33439207756323075,"score_spread":0.2675004843973514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541518521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941683,0.0007627697,0.0019124288,0.0011678057,0.00017844875,0.0006570608,0.0010820518,0.000016051206,0.000055090353],"genre_scores_gemma":[0.9983101,0.0006821677,0.000649464,0.00011650633,0.00008735236,0.000009841501,0.00007715861,0.000016965578,0.000050449413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665415,0.00076700887,0.0015879007,0.00030907168,0.00045424342,0.00022764894],"domain_scores_gemma":[0.99782985,0.00039988384,0.0006962482,0.00073440967,0.00021594978,0.00012368344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065921675,0.00009511782,0.00060903706,0.00012900002,0.000022005133,0.0000023617724,0.00009026047,0.00008307456,0.000009269759],"category_scores_gemma":[0.0016254428,0.0000673685,0.00010266722,0.00032868923,0.00007008332,0.000038532133,0.000018314038,0.00011968984,0.000009308434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046128654,0.0009539786,0.53761154,0.002304067,0.0002585438,0.000014174021,0.0167752,0.000385032,0.0058591994,0.00050387275,0.00064341864,0.4300781],"study_design_scores_gemma":[0.004266573,0.0003653281,0.9898378,0.0012274694,0.00001408055,0.0000013492319,0.00023969103,0.00046642157,0.0031172687,0.00027231674,0.00011897028,0.000072680195],"about_ca_topic_score_codex":0.12395297,"about_ca_topic_score_gemma":0.0012353376,"teacher_disagreement_score":0.45222628,"about_ca_system_score_codex":0.00012004969,"about_ca_system_score_gemma":0.00078035623,"threshold_uncertainty_score":0.8818807},"labels":[],"label_agreement":null},{"id":"W2542411759","doi":"10.1016/j.jval.2016.08.365","title":"Management of Patients with Statin Intolerance in Japan, South Korea and Taiwan: Comparison of Results From A Clinician Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Statin; Medicine; Ezetimibe; Concomitant; Internal medicine","score_opus":0.04506475591994711,"score_gpt":0.3120484062235498,"score_spread":0.26698365030360266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542411759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973826,0.00063243875,0.00014914546,0.0003273942,0.00005386168,0.0010324938,0.00036115915,0.0000070441315,0.000053874446],"genre_scores_gemma":[0.9974713,0.0002453246,0.0020911596,0.00006971363,0.00001891396,0.000013222712,0.00006387751,0.0000151168615,0.000011414702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997442,0.00045162727,0.0010678179,0.00032951092,0.00045130795,0.00025773168],"domain_scores_gemma":[0.998742,0.00015565654,0.00043371477,0.0004527262,0.000092275455,0.0001236268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022383376,0.00012005317,0.00076207577,0.00012862174,0.000017041368,0.0000022369284,0.00006524611,0.000057056117,0.0000031806699],"category_scores_gemma":[0.000112048016,0.00007883622,0.000037507492,0.00028072693,0.00007462387,0.00003445198,0.000035580106,0.00013101527,0.0000010840347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019551006,0.00031575767,0.92080325,0.0006101084,0.000048098544,0.000003282274,0.0027663289,0.00006128692,0.0000012284991,0.0000371263,0.000012291184,0.07338615],"study_design_scores_gemma":[0.010716299,0.0009204064,0.98450446,0.0028378747,0.000012317529,1.5885189e-7,0.0006083743,0.00017888198,0.000031458658,0.000044131037,0.00007074472,0.00007490364],"about_ca_topic_score_codex":0.04454147,"about_ca_topic_score_gemma":0.0025262686,"teacher_disagreement_score":0.07331125,"about_ca_system_score_codex":0.00010909267,"about_ca_system_score_gemma":0.00018108706,"threshold_uncertainty_score":0.961821},"labels":[],"label_agreement":null},{"id":"W2542745445","doi":"10.1093/eurheartj/ehw089","title":"CardioPulse ArticlesThe PCSK9 storyWhat have we learned so far from the biology of PCSK9?Nabil G. Seidah PhDThe biology of PCSK9 inhibition: some unanswered questionsProfessor Ulrich Laufs MDThe annual Northwestern Cardiovascular Young Investigators' Forum in ChicagoNorthwestern Cardiovascular Young Investigators' Forum, 2015 Winners","year":2016,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Fondation Leducq","keywords":"PCSK9; Medicine; Internal medicine; LDL receptor; Cholesterol","score_opus":0.027582070331626747,"score_gpt":0.2748017909749495,"score_spread":0.24721972064332276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542745445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92921793,0.057997275,0.00096129347,0.008490516,0.0012147458,0.0015487208,0.00036015207,0.00011238644,0.00009699353],"genre_scores_gemma":[0.99147373,0.004787302,0.00050132244,0.00094650086,0.0018037023,0.00007114542,0.00009383731,0.0002264533,0.000095979696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9869812,0.006627165,0.002181201,0.0012842647,0.0014013358,0.0015248333],"domain_scores_gemma":[0.9942152,0.0002956521,0.0007808038,0.0028962493,0.00082756096,0.0009845664],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007969464,0.00091021374,0.0027243656,0.00058450893,0.0006184133,0.0000929659,0.00074205105,0.0004924064,0.00005583597],"category_scores_gemma":[0.00080666575,0.000584748,0.003157242,0.00077850616,0.001874808,0.0007234219,0.0004529812,0.0016867747,0.00005313507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041451337,0.000309964,0.92638904,0.00016594828,0.0060068914,0.00050551904,0.0053045913,0.00048490212,0.011814915,0.00023662296,0.0010211759,0.04734594],"study_design_scores_gemma":[0.023407515,0.0029326903,0.491258,0.004369762,0.004182248,0.006616474,0.014736026,0.00010780708,0.01960376,0.002656935,0.42776436,0.0023644324],"about_ca_topic_score_codex":0.0050674463,"about_ca_topic_score_gemma":0.0013423957,"teacher_disagreement_score":0.435131,"about_ca_system_score_codex":0.000445215,"about_ca_system_score_gemma":0.0012493122,"threshold_uncertainty_score":0.9996604},"labels":[],"label_agreement":null},{"id":"W2545374216","doi":"10.5539/gjhs.v9n5p253","title":"Comparing the Effects of Atorvastatin on LDL Reduction through Systematic Review Method and Meta-Analysis","year":2016,"lang":"en","type":"article","venue":"Global Journal of Health Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Meta-analysis; Medicine; Sample size determination; Meta-regression; Scopus; Random effects model; Internal medicine; MEDLINE; Mathematics; Statistics; Chemistry; Biochemistry","score_opus":0.06677438075589669,"score_gpt":0.3991799165920847,"score_spread":0.332405535836188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545374216","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15435125,0.68486685,0.12040467,0.034819942,0.0006336416,0.0045942473,0.000009189129,0.000019992927,0.00030019926],"genre_scores_gemma":[0.98434097,0.008771354,0.00537654,0.0014538094,0.00003603062,0.000009121829,8.115308e-8,0.000003050986,0.0000090671465],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968366,0.0005836291,0.00093654555,0.000175131,0.0012428219,0.00022528936],"domain_scores_gemma":[0.99776715,0.00013981081,0.0011428546,0.00042164192,0.00035854636,0.00016998143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011286128,0.00010228727,0.0019660294,0.00007749936,0.0001592321,0.000013288792,0.0001860535,0.000017371483,0.000004624626],"category_scores_gemma":[0.0007195485,0.000039124687,0.0006355888,0.0010903479,0.00017718122,0.00015067133,0.0000311701,0.00010115358,0.0000012477645],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024317342,0.0004686809,0.003976156,0.8646281,0.09320763,0.000075010415,0.0009022034,0.000111293746,0.0014014647,0.010459568,0.001275109,0.023251643],"study_design_scores_gemma":[0.0041798763,0.005824227,0.073296085,0.11825078,0.7771227,0.0126941595,0.00074244087,0.0001330123,0.0043570325,0.0026178742,0.00027094886,0.0005108725],"about_ca_topic_score_codex":0.0001499035,"about_ca_topic_score_gemma":0.0000024192339,"teacher_disagreement_score":0.8299897,"about_ca_system_score_codex":0.0002117005,"about_ca_system_score_gemma":0.0004843454,"threshold_uncertainty_score":0.39115694},"labels":[],"label_agreement":null},{"id":"W2545779875","doi":"10.1007/s40291-016-0238-8","title":"Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin","year":2016,"lang":"en","type":"article","venue":"Molecular Diagnosis & Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal; Programs for Assessment of Technology in Health Research Institute; Centre Hospitalier de l’Université de Montréal","funders":"Pfizer Canada; Génome Québec; Genome Canada; Pfizer","keywords":"Pharmacogenomics; Statin; Medicine; Myopathy; Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Test (biology); Rhabdomyolysis; Atorvastatin; Intensive care medicine; Cardiology; Physical therapy; Pharmacology; Biology","score_opus":0.028888418772774167,"score_gpt":0.299047655194667,"score_spread":0.2701592364218928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545779875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98990995,0.0035700363,0.0017587825,0.00017455412,0.00016472803,0.0040676533,0.00030093308,0.000027710084,0.000025631707],"genre_scores_gemma":[0.9922602,0.0032528087,0.001512928,0.00030160544,0.00013161766,0.0023734472,0.00007674769,0.000089552195,0.0000010956971],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702173,0.00054734293,0.00070390076,0.0005476893,0.0007619972,0.0004173534],"domain_scores_gemma":[0.9980154,0.00035325208,0.0003305423,0.0007092468,0.00045065602,0.0001408773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031562124,0.00028006596,0.00079593656,0.00022383,0.00006722242,0.000016309903,0.00013652239,0.000118802345,0.000057050063],"category_scores_gemma":[0.0006659152,0.00022311826,0.00068464025,0.00017110982,0.00003639726,0.000107758584,0.00003059016,0.00012642046,0.000009366305],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002293592,0.00058132684,0.16904885,0.000081120255,0.0011385861,0.000008215418,0.00046905162,0.00039723408,0.017099796,0.000022697006,0.000034121043,0.81088966],"study_design_scores_gemma":[0.06604735,0.0030719182,0.45584515,0.00053923205,0.0016349204,0.000005643844,0.00017297191,0.0011898918,0.46789947,0.00089314306,0.001995845,0.0007044625],"about_ca_topic_score_codex":0.0010997624,"about_ca_topic_score_gemma":0.00006033318,"teacher_disagreement_score":0.8101852,"about_ca_system_score_codex":0.0005557084,"about_ca_system_score_gemma":0.00046118765,"threshold_uncertainty_score":0.9098499},"labels":[],"label_agreement":null},{"id":"W2545830314","doi":"10.1016/j.jval.2016.09.1828","title":"Management of Patients with Statin Intolerance: Results from a Survey of Clinicians in Six European Countries","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Ezetimibe; Statin; Medicine; Czech; Family medicine; Fenofibrate; Internal medicine","score_opus":0.03287162819912684,"score_gpt":0.28906069460862405,"score_spread":0.25618906640949723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545830314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967968,0.00048570294,0.00020184705,0.0005099317,0.00007863532,0.0009417137,0.00062434736,0.000009710251,0.00035129985],"genre_scores_gemma":[0.997022,0.0013392519,0.0013181003,0.00016082826,0.000024383988,0.0000077188815,0.00007935532,0.000021577614,0.000026822603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695456,0.0009027002,0.0010721121,0.0002893971,0.00051982957,0.0002613869],"domain_scores_gemma":[0.99862343,0.00023520972,0.00037833885,0.00052017445,0.00015045113,0.000092377944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004205832,0.000111792964,0.0005698141,0.00012017422,0.00001580627,0.0000021762692,0.000088254346,0.000034526656,0.0000085261545],"category_scores_gemma":[0.00015948193,0.00007195394,0.000042617885,0.00031117984,0.00006952364,0.000039371298,0.00003278149,0.000109411376,0.0000054180637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031541418,0.0004071859,0.92752784,0.0010005155,0.00008058009,0.000031819374,0.0012272266,0.00014427373,0.00000128715,0.00008498055,0.00007415629,0.066266],"study_design_scores_gemma":[0.010100549,0.0007278333,0.98455805,0.003625864,0.000010109194,2.2225959e-7,0.00011256151,0.0000306775,0.000022346921,0.000023231949,0.00071924226,0.00006928785],"about_ca_topic_score_codex":0.06991105,"about_ca_topic_score_gemma":0.0026193932,"teacher_disagreement_score":0.067291655,"about_ca_system_score_codex":0.00015203618,"about_ca_system_score_gemma":0.00027683808,"threshold_uncertainty_score":0.9362825},"labels":[],"label_agreement":null},{"id":"W2545952291","doi":"10.1056/nejme1611081","title":"What Should Be the Screening Strategy for Familial Hypercholesterolemia?","year":2016,"lang":"en","type":"letter","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Pediatrics; Genetic disorder; Disease; Atherosclerotic cardiovascular disease; Ldl cholesterol; Internal medicine; Cholesterol","score_opus":0.0969979922152701,"score_gpt":0.33503888833975304,"score_spread":0.23804089612448293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545952291","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014791514,0.013640342,0.006593069,0.97372097,0.0033862137,0.00083206524,0.000017105354,0.00001666252,0.00031443377],"genre_scores_gemma":[0.002659722,0.0071053877,0.0004049872,0.73316973,0.2520357,0.000013252719,0.00006396907,0.000100150566,0.004447083],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960147,0.00027304588,0.0010405201,0.0003043609,0.0017913752,0.00057596475],"domain_scores_gemma":[0.99711794,0.000626312,0.0006576263,0.000682367,0.0005487626,0.00036699593],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003619778,0.0004248574,0.0015180089,0.00025239802,0.0001292106,0.0000585489,0.00039464078,0.0006421919,0.00013914505],"category_scores_gemma":[0.00040246284,0.0001821456,0.0006801465,0.00011871136,0.00020708537,0.00022522733,0.00003596663,0.0029135714,0.0000027324932],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004902445,0.000006048368,0.000018499448,0.00019991017,0.00045792366,0.00053277425,0.00019974611,0.0000027350995,0.000104463616,0.000005410326,0.5800521,0.4179302],"study_design_scores_gemma":[0.04437066,0.0026581013,0.0001433651,0.004337926,0.0014295861,0.005650193,0.00032413888,0.0000064391334,0.00004766202,0.00026954574,0.9405882,0.00017422065],"about_ca_topic_score_codex":0.0001482256,"about_ca_topic_score_gemma":0.000021299773,"teacher_disagreement_score":0.41775596,"about_ca_system_score_codex":0.00010925224,"about_ca_system_score_gemma":0.000723369,"threshold_uncertainty_score":0.9993867},"labels":[],"label_agreement":null},{"id":"W2547035332","doi":"10.1177/2047487316677115","title":"Seeking ‘meta guidelines’ for lipids","year":2016,"lang":"en","type":"letter","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Alberta","funders":"","keywords":"Medicine; MEDLINE; Intensive care medicine","score_opus":0.10078210483378083,"score_gpt":0.3391200301624858,"score_spread":0.23833792532870499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547035332","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016365096,0.03155346,0.2667425,0.67840385,0.006163669,0.0016486,0.000204526,0.00004776365,0.015071986],"genre_scores_gemma":[0.0017856249,0.0040570754,0.013116676,0.7017866,0.26271066,0.000043873824,0.00013847068,0.00043167893,0.01592939],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99422324,0.002670532,0.0015016844,0.00044579935,0.0005680979,0.0005906455],"domain_scores_gemma":[0.9950418,0.00023826209,0.0012371182,0.0007545316,0.0025554232,0.00017288768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007418026,0.00044906675,0.0027411706,0.00033625535,0.000082485865,0.000019013749,0.00040724187,0.00032606302,0.00010843996],"category_scores_gemma":[0.0013640865,0.0002730038,0.0052350718,0.00009000925,0.00013200424,0.00006848714,0.00012639465,0.0016013911,0.000052666324],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012329077,0.00000594594,0.000025771167,0.00033612005,0.014494671,0.004653519,0.000018889674,0.0000023709115,0.00023052169,0.000005653838,0.93598455,0.04411868],"study_design_scores_gemma":[0.0024385748,0.001190159,0.00028033965,0.0006950413,0.00891098,0.0067994427,0.000011797341,8.834109e-7,0.000038247534,0.00011370889,0.97926855,0.00025229485],"about_ca_topic_score_codex":0.0000010624739,"about_ca_topic_score_gemma":8.289047e-8,"teacher_disagreement_score":0.25654697,"about_ca_system_score_codex":0.00013425628,"about_ca_system_score_gemma":0.00039797803,"threshold_uncertainty_score":0.9999722},"labels":[],"label_agreement":null},{"id":"W2549608287","doi":"10.1053/j.ajkd.2016.08.037","title":"Renal Tubular Toxicity Associated With Rosuvastatin Therapy","year":2016,"lang":"en","type":"article","venue":"American Journal of Kidney Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Rosuvastatin; Toxicity; Urology; Internal medicine","score_opus":0.008402830153414313,"score_gpt":0.24589357046361482,"score_spread":0.2374907403102005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549608287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99086964,0.00081743085,0.0016858651,0.006154224,0.000054987293,0.00018000511,0.00007698655,0.000026721587,0.00013416051],"genre_scores_gemma":[0.994134,0.0006284837,0.00050260406,0.0042179124,0.00035331797,0.0000055605083,0.0000059913314,0.000029640445,0.00012246608],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982987,0.00019556587,0.00033979028,0.0001507321,0.00074269687,0.0002725112],"domain_scores_gemma":[0.99741936,0.00009139394,0.00045991622,0.00027385657,0.00035138646,0.001404065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034658625,0.00015386827,0.0005995568,0.00010237253,0.00005924675,0.00001496033,0.0001045354,0.000022407765,0.00016215666],"category_scores_gemma":[0.001322983,0.0000752049,0.00035216936,0.00027075037,0.0002739507,0.0001185575,0.000011841288,0.00012098792,0.0000048242264],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00555688,0.0015840592,0.24972706,0.00004077071,0.0037799873,0.0013979812,0.00024109252,0.0000052514442,0.020299032,0.000042559193,0.021466793,0.69585854],"study_design_scores_gemma":[0.02106011,0.020152045,0.89366823,0.0032066305,0.0012905147,0.001364406,0.00056259055,0.0000080232285,0.01565812,0.0002286168,0.042161185,0.0006395393],"about_ca_topic_score_codex":0.00003683154,"about_ca_topic_score_gemma":0.0000011893083,"teacher_disagreement_score":0.695219,"about_ca_system_score_codex":0.000120178316,"about_ca_system_score_gemma":0.0014728603,"threshold_uncertainty_score":0.30667672},"labels":[],"label_agreement":null},{"id":"W2550105191","doi":"10.1016/j.cjca.2016.09.011","title":"Familial Hypercholesterolemia: Awareness, Appraisal, and Action","year":2016,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Action (physics); Familial hypercholesterolemia; Internal medicine; Cholesterol","score_opus":0.0343110395950527,"score_gpt":0.29041147723145855,"score_spread":0.25610043763640583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550105191","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045086354,0.009756375,0.0030315036,0.92651427,0.00939869,0.00055788556,0.00018615188,0.0000206928,0.005448083],"genre_scores_gemma":[0.2404249,0.005231378,0.0002685624,0.513843,0.23851502,0.000027443475,0.00014979951,0.0002277699,0.0013121171],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812365,0.0002991309,0.0004646295,0.00026885213,0.00029162999,0.00055209297],"domain_scores_gemma":[0.9982793,0.000090030066,0.00024546485,0.00042069276,0.0003382996,0.0006262395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006465273,0.00026148855,0.0013132907,0.0004700233,0.00010457084,0.000024440671,0.00014485227,0.0012903239,0.000017405915],"category_scores_gemma":[0.00020158903,0.00018868835,0.0005527256,0.000068463494,0.00026455653,0.000078218836,0.000014286388,0.00196735,0.0000143807365],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038210077,3.474474e-7,0.0056790938,0.00022974589,0.0006809949,0.0037377295,0.000023406557,0.0000020450839,0.00006937954,0.0000042648576,0.9321392,0.05739559],"study_design_scores_gemma":[0.0011276905,0.00030030072,0.010134577,0.00026159512,0.00048418582,0.01697738,0.000025011557,2.967167e-7,0.000013562894,0.000046322555,0.9704655,0.00016359356],"about_ca_topic_score_codex":0.0018241212,"about_ca_topic_score_gemma":0.00056209386,"teacher_disagreement_score":0.41267127,"about_ca_system_score_codex":0.00033111218,"about_ca_system_score_gemma":0.0043628956,"threshold_uncertainty_score":0.99521595},"labels":[],"label_agreement":null},{"id":"W2550259650","doi":"10.1503/cmaj.160303","title":"Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation","year":2016,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Sunnybrook Hospital; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; Dabigatran; Lovastatin; Stroke (engine); Simvastatin; Internal medicine; Odds ratio; Statin; Atrial fibrillation; Population; Warfarin; Cholesterol","score_opus":0.015106149288154796,"score_gpt":0.25373885665177587,"score_spread":0.23863270736362108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550259650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877878,0.00008080225,0.00046904336,0.010469446,0.00034029162,0.0005404532,0.00023846571,0.000012242717,0.00006144269],"genre_scores_gemma":[0.9935387,0.000117626885,0.00071766146,0.0008431575,0.003918112,0.0000061560886,0.000057811736,0.000026378988,0.0007744045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972133,0.00018699623,0.0005762346,0.00019815209,0.0013129204,0.0005124125],"domain_scores_gemma":[0.9974263,0.00057078747,0.00046915901,0.000097954355,0.00043204942,0.0010037487],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0028090372,0.00012669536,0.00038462627,0.00020066592,0.00016993261,0.00007825254,0.00005749313,0.00043438296,0.0003036867],"category_scores_gemma":[0.010771614,0.00009016019,0.0001881895,0.00014824147,0.000013513024,0.00027842014,0.0000095235455,0.00037623968,0.000007818488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008021258,0.000004500627,0.8200937,0.000026313797,0.00019026671,0.000022384495,0.00007083306,3.6397586e-7,0.0000217392,0.0000031289153,0.0029550309,0.17653154],"study_design_scores_gemma":[0.011384734,0.00023338167,0.9294335,0.00021416647,0.00020564305,0.00003417842,0.000055261968,0.000073254705,0.00006371152,0.000019898054,0.058128126,0.00015413173],"about_ca_topic_score_codex":0.002148398,"about_ca_topic_score_gemma":0.01119919,"teacher_disagreement_score":0.1763774,"about_ca_system_score_codex":0.0028224897,"about_ca_system_score_gemma":0.0018040796,"threshold_uncertainty_score":0.9975611},"labels":[],"label_agreement":null},{"id":"W2551124976","doi":"10.2147/ndt.s115505","title":"Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease","year":2016,"lang":"en","type":"article","venue":"Neuropsychiatric Disease and Treatment","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute on Aging; National Institutes of Health; Elan Pharma International; H. Lundbeck A/S; Alzheimer's Society; Canadian Institutes of Health Research; Lundbeck Canada; Alzheimer Society; F. Hoffmann-La Roche; Heart and Stroke Foundation of Canada","keywords":"Medicine; Coronary artery disease; Statin; Internal medicine; Cardiology; Low-density lipoprotein; Disease; Cognition; Lipoprotein; Cholesterol; Psychiatry","score_opus":0.011517109398767322,"score_gpt":0.2114893617748962,"score_spread":0.19997225237612887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551124976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964839,0.0006339209,0.000029735063,0.00073238154,0.0000603014,0.001659122,0.00034197452,0.000040832834,0.000017780616],"genre_scores_gemma":[0.99850225,0.00060465623,0.00008960189,0.00039800498,0.000086425,0.000105370076,0.000063074825,0.00003095464,0.00011965846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986122,0.00010412619,0.00019698049,0.0004944908,0.00032614847,0.00026604423],"domain_scores_gemma":[0.99879485,0.0000308929,0.000058607457,0.00035681602,0.000061800485,0.0006970386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000051457413,0.00024227885,0.00027862223,0.00011558965,0.00009154674,0.000029387531,0.000020610367,0.000030934192,0.000018601648],"category_scores_gemma":[0.00002158225,0.00014014,0.000076911274,0.00012668133,0.000059173246,0.00017921491,0.00002441789,0.00005579699,0.000008556451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034819548,0.0012561537,0.85667586,0.00011380222,0.0001337776,0.0005685911,0.000021500013,3.0880815e-7,0.000004646485,0.000021160642,0.000018825296,0.1377034],"study_design_scores_gemma":[0.012900956,0.0012758076,0.9846252,0.00019395114,0.0006062338,0.000012062113,0.000008767847,0.0000063782504,0.000006654501,0.00010020009,0.00009753813,0.00016625124],"about_ca_topic_score_codex":0.00010421961,"about_ca_topic_score_gemma":0.000059819595,"teacher_disagreement_score":0.13753715,"about_ca_system_score_codex":0.00006634377,"about_ca_system_score_gemma":0.00017371227,"threshold_uncertainty_score":0.5714743},"labels":[],"label_agreement":null},{"id":"W2551904109","doi":"10.1074/jbc.m116.746883","title":"An Unbiased Mass Spectrometry Approach Identifies Glypican-3 as an Interactor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR) in Hepatocellular Carcinoma Cells","year":2016,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal; Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Fondation Leducq; Pfizer","keywords":"Kexin; Proprotein convertase; LDL receptor; PCSK9; Immunoprecipitation; Cell biology; Chemistry; Glypican 3; Biology; Biochemistry; Lipoprotein; Cholesterol; Cancer research; Hepatocellular carcinoma","score_opus":0.019250572374378164,"score_gpt":0.24937648375869942,"score_spread":0.23012591138432126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551904109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811214,0.00076969614,0.00030372862,0.00013122999,0.000089170964,0.0005050344,0.0000222164,0.000017013572,0.000049757233],"genre_scores_gemma":[0.9968504,0.00018737404,0.0023567877,0.000059949605,0.0004160777,0.000008848356,0.000024023993,0.000022564254,0.00007398958],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975558,0.00025355586,0.00085974,0.00045724591,0.00050830375,0.00036534926],"domain_scores_gemma":[0.9979799,0.00006400822,0.0005116302,0.00055523834,0.00038073945,0.00050849403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013002983,0.00028806657,0.0009845337,0.00011310885,0.000040951873,0.00002919842,0.0002594961,0.0004006404,0.00022061549],"category_scores_gemma":[0.000494746,0.00017011765,0.00026347084,0.00023795763,0.0002918777,0.00018109047,0.000056995665,0.00054108386,0.0000048089755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021383914,0.0011323963,0.035248466,0.00046678502,0.000088086614,0.00028358208,0.000074863136,1.7812748e-7,0.957757,0.000003629889,0.00001510385,0.0027914934],"study_design_scores_gemma":[0.003999958,0.0017539796,0.02119095,0.00034171194,0.000056101566,0.00036659167,0.00038347795,0.000057956575,0.97145206,0.00012351492,0.00005921123,0.00021450232],"about_ca_topic_score_codex":0.00025495613,"about_ca_topic_score_gemma":0.000003952136,"teacher_disagreement_score":0.014057514,"about_ca_system_score_codex":0.00018545095,"about_ca_system_score_gemma":0.0002850428,"threshold_uncertainty_score":0.6937197},"labels":[],"label_agreement":null},{"id":"W2552418914","doi":"","title":"Miscellaneous. Levelek a szerkesztőhöz. Folyóirat-referátumok. Könyvismertetések","year":2013,"lang":"hu","type":"article","venue":"Repository of the Academy's Library (Library of the Hungarian Academy of Sciences)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Heart failure; Gynecology; Cardiology","score_opus":0.02085898920217924,"score_gpt":0.23544655178529048,"score_spread":0.21458756258311124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552418914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80312777,0.038315997,0.000007801992,0.094403885,0.002403597,0.005675348,0.0001854289,0.00024908304,0.055631068],"genre_scores_gemma":[0.94079995,0.0019703542,0.0016211054,0.0044373153,0.0015402867,0.00005590975,0.000005064558,0.00019244531,0.04937756],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98769397,0.0021518103,0.0033457743,0.0015910822,0.0036492916,0.0015680532],"domain_scores_gemma":[0.99358976,0.00060477684,0.0033528802,0.0015833864,0.000060915216,0.00080829486],"candidate_categories":["metaepi_narrow","sts","open_science","research_integrity","insufficient_payload"],"consensus_categories":["sts","research_integrity"],"category_scores_codex":[0.0017588472,0.0010715249,0.002373368,0.00050095766,0.0013060827,0.00021011343,0.007903076,0.001451919,0.001041078],"category_scores_gemma":[0.00019182643,0.00066312676,0.0025343266,0.0024692002,0.0060697654,0.0027522016,0.0029571806,0.0031641545,0.00007844974],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001491986,0.002429171,0.09777106,0.014975456,0.005680312,0.00004467132,0.0053100046,0.001155241,0.33770132,0.03541021,0.46892753,0.029103015],"study_design_scores_gemma":[0.0027079808,0.00076846976,0.27582672,0.006042598,0.0013690474,0.00076911505,0.00088083406,0.001509004,0.64105123,0.008686827,0.059222642,0.0011655155],"about_ca_topic_score_codex":0.00032263476,"about_ca_topic_score_gemma":2.344633e-7,"teacher_disagreement_score":0.4097049,"about_ca_system_score_codex":0.000065115666,"about_ca_system_score_gemma":0.0016089194,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W2552644316","doi":"10.1016/j.cjca.2016.11.003","title":"Genetics for the Identification of Lipid Targets Beyond PCSK9","year":2016,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Mendelian randomization; Proprotein convertase; Ezetimibe; Cholesterylester transfer protein; Medicine; Microsomal triglyceride transfer protein; Computational biology; Apolipoprotein B; Gene; Genetics; Kexin; Bioinformatics; Biology; Statin; Genetic variants; Cholesterol; Lipoprotein; LDL receptor; Very low-density lipoprotein; Internal medicine","score_opus":0.03657680499800731,"score_gpt":0.3121862338724661,"score_spread":0.2756094288744588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552644316","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000490393,0.9871199,0.008975374,0.000390218,0.0019204324,0.0009323318,0.00019170485,0.0000015949231,0.00046351645],"genre_scores_gemma":[0.0006684389,0.99230194,0.00011294669,0.000063185274,0.0065646805,0.000035484598,0.000020932814,0.000039969997,0.00019242836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979279,0.00023772092,0.0011621672,0.00015923374,0.000192786,0.00032020343],"domain_scores_gemma":[0.9972352,0.00021498818,0.0009418999,0.00059068826,0.0006095089,0.00040771102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020406425,0.00019244025,0.0021532164,0.00030484682,0.00008557733,0.000009602904,0.00030407836,0.00034783848,0.00001535024],"category_scores_gemma":[0.00045088283,0.0001036683,0.001972376,0.00011948608,0.00018342929,0.000020444462,0.000010497979,0.00031301627,0.000007809353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008103694,7.967779e-7,0.000015340715,0.0029227436,0.0016068077,0.000023076338,0.000016361,0.0000061772726,0.0000030000433,0.00012446544,0.007876274,0.98739684],"study_design_scores_gemma":[0.0003661327,0.00018721345,0.00010044063,0.001662045,0.0024330884,0.0016248112,0.000012821343,5.880393e-7,0.000008000979,0.00008872376,0.9934249,0.00009121969],"about_ca_topic_score_codex":0.000078421326,"about_ca_topic_score_gemma":0.000097414704,"teacher_disagreement_score":0.98730564,"about_ca_system_score_codex":0.0002383267,"about_ca_system_score_gemma":0.0055788723,"threshold_uncertainty_score":0.989668},"labels":[],"label_agreement":null},{"id":"W2553653853","doi":"10.1016/j.artres.2016.08.036","title":"PO-33 STATIN THERAPY IN RHEUMATOID ARTHRITIS MAY IMPROVE ARTERIAL STIFFNESS IN WOMEN BUT NOT IN MEN: A PRELIMINARY ANALYSIS","year":2016,"lang":"en","type":"article","venue":"Artery Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Rheumatoid arthritis; Arterial stiffness; Internal medicine; Statin; Physical therapy; Cardiology; Blood pressure","score_opus":0.032329146531950056,"score_gpt":0.32855198665778423,"score_spread":0.29622284012583416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553653853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949794,0.00055584713,0.000038363796,0.0025275226,0.000068797366,0.0014146727,0.00005095881,0.000022741602,0.00034171232],"genre_scores_gemma":[0.99322647,0.005007054,0.000048288694,0.00014190648,0.00013718319,0.0010130957,0.000015412992,0.00003531206,0.00037527253],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9954256,0.0009510484,0.00066117896,0.0006643428,0.0011368388,0.0011610088],"domain_scores_gemma":[0.99836785,0.00029558584,0.000055749504,0.00086051604,0.00014933008,0.0002709741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049881428,0.00020395701,0.000816222,0.0014574671,0.000060478487,0.000050601797,0.00020730887,0.00016207638,0.000373775],"category_scores_gemma":[0.0002039006,0.00014773285,0.00016400288,0.001606628,0.00015796795,0.0002102204,0.00011225617,0.00051931123,0.0000741848],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0091483435,0.00073816784,0.028984806,0.00009160717,0.00033762748,0.0010714154,0.004281541,0.0000028906386,0.041799687,0.000023015038,0.00015905779,0.91336185],"study_design_scores_gemma":[0.01822151,0.0015859731,0.9690782,0.000544,0.000007116857,0.000038541606,0.0027847732,0.00015882532,0.0060496395,0.0002748515,0.0009917221,0.0002648651],"about_ca_topic_score_codex":0.0033984473,"about_ca_topic_score_gemma":0.0014061008,"teacher_disagreement_score":0.9400934,"about_ca_system_score_codex":0.00057875883,"about_ca_system_score_gemma":0.00047582437,"threshold_uncertainty_score":0.6024371},"labels":[],"label_agreement":null},{"id":"W2554189810","doi":"10.1161/atvbaha.116.308271","title":"Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis—Brief Report","year":2016,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Stenosis; Cardiology; Myocardial infarction; Medicine; Internal medicine; Incidence (geometry); Population; Environmental health","score_opus":0.02986341461884849,"score_gpt":0.3069845455737767,"score_spread":0.2771211309549282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554189810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761444,0.000063611915,0.00092173216,0.0008368044,0.00010103156,0.00042453685,0.0000061862916,0.000012777391,0.000018885796],"genre_scores_gemma":[0.99883586,0.00073730387,0.00015472365,0.00011200312,0.00011128384,0.000029909686,0.0000051611314,0.000013157728,5.770599e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987715,0.00017112136,0.00041227968,0.00026652197,0.00019400127,0.00018461433],"domain_scores_gemma":[0.99892646,0.0001328811,0.0002457316,0.0005487067,0.000087296336,0.0000589429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011532691,0.00014264241,0.00045836729,0.0000518534,0.00014044021,0.00001105722,0.00006106264,0.000095291754,0.000014935572],"category_scores_gemma":[0.0002469306,0.00006248129,0.00030148323,0.000114249604,0.00023135189,0.000063086496,0.00006848059,0.000085294785,6.69044e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009894544,0.000033072814,0.8803248,0.000043806052,0.0005234531,7.752144e-8,0.00015284629,0.000007891651,0.11097247,0.00014861778,0.000008005696,0.0077750892],"study_design_scores_gemma":[0.0005096769,0.00063784345,0.9974627,0.00029405372,0.00019369357,0.000007063187,0.000029357381,0.0001511014,0.00052869535,0.00009790714,0.000013266736,0.000074647374],"about_ca_topic_score_codex":0.0012514042,"about_ca_topic_score_gemma":0.000010630324,"teacher_disagreement_score":0.117137924,"about_ca_system_score_codex":0.000039571707,"about_ca_system_score_gemma":0.000035348894,"threshold_uncertainty_score":0.2547913},"labels":[],"label_agreement":null},{"id":"W2554832534","doi":"10.1001/jama.2016.16951","title":"Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients","year":2016,"lang":"en","type":"article","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Evolocumab; Alirocumab; Statin; Internal medicine; Placebo; PCSK9; Tolerability; Cardiology; Coronary atherosclerosis; Coronary artery disease; Atheroma; Intravascular ultrasound; Urology; Gastroenterology; Cholesterol; Adverse effect; Lipoprotein; Pathology; LDL receptor","score_opus":0.005424593299470449,"score_gpt":0.2760107170902736,"score_spread":0.27058612379080316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554832534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985759,0.00019080327,0.000004305682,0.00013639579,0.00003377823,0.00079384784,0.000026572434,0.00001084598,0.00022751848],"genre_scores_gemma":[0.99975973,0.000034337016,0.000026798072,0.000026008083,0.000030451003,0.000035123972,0.000019747598,0.000010601012,0.000057175428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900234,0.00016342117,0.00019335744,0.0001312199,0.00039287168,0.00011676556],"domain_scores_gemma":[0.9993527,0.000077699064,0.000079636055,0.00031627534,0.00007587461,0.00009779594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032984826,0.00007647553,0.00027008753,0.00006691757,0.000008563458,9.338308e-7,0.000033212633,0.000045190765,0.00003360203],"category_scores_gemma":[0.00031212598,0.000038636863,0.000095365605,0.00009001613,0.000034216355,0.000033213222,0.000018440478,0.00005068556,0.000007472515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033031225,0.00021793012,0.51771086,0.00035249174,0.000020768086,0.000023475544,0.00002008128,3.3768717e-7,0.00038501638,0.0000062047743,0.00007231097,0.47788736],"study_design_scores_gemma":[0.010043075,0.0041829194,0.9624722,0.0015693005,0.000044165423,7.0154374e-7,0.0000022386398,0.000010952323,0.021487543,0.000009281277,0.00013680136,0.000040831805],"about_ca_topic_score_codex":0.00008435566,"about_ca_topic_score_gemma":0.0000016643094,"teacher_disagreement_score":0.47784653,"about_ca_system_score_codex":0.00005787272,"about_ca_system_score_gemma":0.000052502877,"threshold_uncertainty_score":0.15755655},"labels":[],"label_agreement":null},{"id":"W2556558984","doi":"10.1097/jcn.0000000000000382","title":"Influence of Baseline Psychological Health on Muscle Pain During Atorvastatin Treatment","year":2016,"lang":"en","type":"article","venue":"The Journal of Cardiovascular Nursing","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Brief Pain Inventory; Beck Depression Inventory; Placebo; Depression (economics); Medicine; Physical therapy; Atorvastatin; Internal medicine; McGill Pain Questionnaire; Statin; Chronic pain; Psychiatry; Anxiety; Alternative medicine; Visual analogue scale","score_opus":0.02166430491560064,"score_gpt":0.304959783864797,"score_spread":0.2832954789491964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2556558984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97346777,0.0119960485,0.011580772,0.0023141762,0.000118691416,0.00040689824,0.000004268692,0.000015964528,0.00009541893],"genre_scores_gemma":[0.9939368,0.0045864377,0.0006648054,0.00024797488,0.00051276665,0.0000030455606,5.0691636e-7,0.000026215515,0.000021481243],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99599034,0.0016676988,0.0007249335,0.00018206648,0.0010878298,0.00034714973],"domain_scores_gemma":[0.99803305,0.00021317918,0.00035991834,0.00087846996,0.00026408763,0.00025132747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008457408,0.00019656267,0.0009820559,0.00014274466,0.00012968632,0.000006204566,0.00014875321,0.00006877023,0.000010406407],"category_scores_gemma":[0.0003878975,0.00009010053,0.001459983,0.00021514061,0.00015403036,0.000077341225,0.000011153757,0.00020597696,0.000004723411],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009807507,0.0004849684,0.0002972532,0.00012237679,0.0020042385,0.000116395146,0.00080752734,0.0057900734,0.008936846,0.000023078039,0.00014739335,0.9802891],"study_design_scores_gemma":[0.03966569,0.027067246,0.79523796,0.022223884,0.005391369,0.011654892,0.0026371977,0.00013040483,0.06676303,0.0005921301,0.027707962,0.0009282627],"about_ca_topic_score_codex":0.000050571525,"about_ca_topic_score_gemma":6.4382493e-7,"teacher_disagreement_score":0.9793608,"about_ca_system_score_codex":0.00050069694,"about_ca_system_score_gemma":0.00019058504,"threshold_uncertainty_score":0.36741933},"labels":[],"label_agreement":null},{"id":"W2557044136","doi":"10.1007/s40273-017-0492-6","title":"Evolocumab for Treating Primary Hypercholesterolaemia and Mixed Dyslipidaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal","year":2017,"lang":"en","type":"review","venue":"PharmacoEconomics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Health Technology Assessment Programme; National Institute for Health and Care Research","keywords":"Evolocumab; Ezetimibe; Medicine; Statin; Nice; Physical therapy; Placebo; Clinical trial; Cost effectiveness; Internal medicine; Alternative medicine; Cholesterol; Lipoprotein; Pathology","score_opus":0.11077338720664542,"score_gpt":0.4395810754571972,"score_spread":0.3288076882505518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557044136","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009353174,0.9934748,0.00010074562,0.0003606304,0.00035105832,0.004230981,0.00009638488,0.00006891723,0.0003811865],"genre_scores_gemma":[0.00023057057,0.9947652,0.002900775,0.0002783964,0.00079266663,0.000777791,0.00009892047,0.00012006921,0.000035562673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971288,0.00021580952,0.0010890512,0.00096455135,0.00016625982,0.00043555454],"domain_scores_gemma":[0.99651784,0.00044581635,0.00120923,0.0013359565,0.00024585525,0.00024531787],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019491127,0.0005477416,0.004185362,0.00027597215,0.00017367382,0.0000432095,0.0004461271,0.0004563162,0.000009867138],"category_scores_gemma":[0.00090144057,0.00048553423,0.0008630765,0.00011900927,0.0002349233,0.00038238303,0.00021133511,0.000718395,0.000005412355],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059145623,0.000103802995,0.000013948933,0.13211575,0.00059424393,0.0000072000034,0.000036260004,8.26709e-8,0.000046882098,0.00009109006,0.00014851804,0.8667831],"study_design_scores_gemma":[0.0018972723,0.0007700662,0.000016942975,0.0924432,0.008823151,0.00095883035,0.00008723844,0.000025099689,0.000050186438,0.00003660423,0.89436096,0.0005304652],"about_ca_topic_score_codex":0.000084687184,"about_ca_topic_score_gemma":0.000012969922,"teacher_disagreement_score":0.8942124,"about_ca_system_score_codex":0.0008370374,"about_ca_system_score_gemma":0.00079298625,"threshold_uncertainty_score":0.9997596},"labels":[],"label_agreement":null},{"id":"W2557055491","doi":"10.1016/j.ijcard.2016.11.046","title":"Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment","year":2016,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Université de Montréal; Montreal Clinical Research Institute","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Ezetimibe; Statin; Internal medicine; Adverse effect; Clinical endpoint; Familial hypercholesterolemia; Apolipoprotein B; Gastroenterology; Clinical trial; Cholesterol","score_opus":0.0295306507424814,"score_gpt":0.2921693733172047,"score_spread":0.2626387225747233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557055491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977963,0.00017105023,0.0005702168,0.000547655,0.00025428482,0.00030977803,0.00010449828,0.0000031824925,0.00024301281],"genre_scores_gemma":[0.998218,0.00041646423,0.00073337724,0.00014229912,0.00042895545,0.000007972134,0.000018442934,0.000016278766,0.000018208231],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986078,0.00010560911,0.0004715435,0.00018543677,0.00048966106,0.00013994086],"domain_scores_gemma":[0.99881905,0.00008422579,0.0002995773,0.00026122792,0.00045849037,0.000077437006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002860253,0.000121014564,0.00061465066,0.0001398318,0.00000923376,0.000010077897,0.00028547953,0.000084714746,0.000005262199],"category_scores_gemma":[0.000043484542,0.00006163185,0.00010744807,0.000048470247,0.000083110834,0.00012683374,0.00004509769,0.00011630639,0.0000022917761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04256763,0.0004185748,0.58535284,0.0000028487161,0.0031700504,0.00061875687,0.00019192041,0.00008721136,0.0011561752,0.000015218151,0.00006286492,0.36635593],"study_design_scores_gemma":[0.072550826,0.0081615,0.91522706,0.0002679156,0.00007177746,0.00026969268,0.000019876139,0.0000013261641,0.00035037778,0.000070440285,0.0029297967,0.00007943768],"about_ca_topic_score_codex":0.0004340016,"about_ca_topic_score_gemma":0.00011245805,"teacher_disagreement_score":0.36627647,"about_ca_system_score_codex":0.00031698935,"about_ca_system_score_gemma":0.00026933942,"threshold_uncertainty_score":0.2513274},"labels":[],"label_agreement":null},{"id":"W2557429430","doi":"10.1016/j.jacc.2016.09.929","title":"Bringing Structure to the Art of Lipid-Lowering Therapy","year":2016,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine","score_opus":0.010708938241267322,"score_gpt":0.25614197538572947,"score_spread":0.24543303714446216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557429430","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17849375,0.0024642434,0.0011468692,0.812192,0.0028554124,0.0010244666,0.0002988186,0.000009379031,0.0015150242],"genre_scores_gemma":[0.68496615,0.0023198493,0.00073439785,0.26815775,0.042098098,0.000012260226,0.000003349035,0.00013225674,0.0015758898],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971872,0.000509692,0.00083971844,0.00021023677,0.0008600836,0.00039309997],"domain_scores_gemma":[0.9964312,0.00022506261,0.0016301033,0.0011358779,0.0004886357,0.00008914817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010967223,0.0002760399,0.0023455378,0.00024809162,0.00006953011,0.0000040562204,0.00072632136,0.00021644733,0.000025944553],"category_scores_gemma":[0.00022125819,0.00012174993,0.0017966921,0.00040180847,0.00040119546,0.000026396001,0.00014874306,0.0013583323,0.0000021029211],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057677575,0.0000058295127,0.0012061367,0.0001452002,0.0031814582,0.0003973671,0.00005213167,0.00017044725,0.005241827,0.0000063637367,0.97505593,0.01396051],"study_design_scores_gemma":[0.00080799265,0.00096374354,0.0047473754,0.00047609708,0.00032535332,0.0049432362,0.00007325641,8.7821024e-7,0.0019189126,0.000036296926,0.98558044,0.00012641301],"about_ca_topic_score_codex":0.000019365529,"about_ca_topic_score_gemma":0.0000019408494,"teacher_disagreement_score":0.5440343,"about_ca_system_score_codex":0.0001429879,"about_ca_system_score_gemma":0.00058832485,"threshold_uncertainty_score":0.5901354},"labels":[],"label_agreement":null},{"id":"W2558300628","doi":"10.1182/blood.v118.21.2236.2236","title":"Apolipoprotein(a)-Dependent Inhibition of Pericellular Plasminogen Activation Is Mediated by Specific Cellular Receptors","year":2011,"lang":"en","type":"article","venue":"Blood","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Plasmin; Apolipoprotein B; Umbilical vein; Kringle domain; Population; Fibrinolysis; Biology; Chemistry; Molecular biology; Cancer research; Cell biology; Biochemistry; Medicine; Internal medicine; Cholesterol; In vitro","score_opus":0.019861483008038236,"score_gpt":0.20892028825807965,"score_spread":0.18905880525004143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558300628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99261934,0.0015808013,0.000967385,0.000097230004,0.00012996982,0.0009594349,0.00003294009,0.00007435284,0.0035385333],"genre_scores_gemma":[0.9975326,0.00042403108,0.00092044583,0.00013419603,0.000268836,0.00006232825,0.00022130384,0.00004863079,0.00038764506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980495,0.00008408719,0.00045172535,0.00038170852,0.00072972145,0.00030323284],"domain_scores_gemma":[0.9988319,0.000012997713,0.00020717244,0.0005909316,0.00015771578,0.000199274],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041660338,0.0002093778,0.00042599475,0.00013963472,0.00006955477,0.000008179786,0.00008171564,0.00021334253,0.001159077],"category_scores_gemma":[0.00003696006,0.00019069405,0.00023583169,0.00028453546,0.000065298074,0.00010856292,0.000036799072,0.00021461277,0.0000992428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017082284,0.0012692454,0.0019339253,0.00027040078,0.0003594503,0.00003596156,0.001412811,1.4285095e-7,0.9887471,0.000070265785,0.0016659182,0.0040639075],"study_design_scores_gemma":[0.003203436,0.0004098578,0.001166952,0.00011647279,0.0001968246,0.000024199611,0.00029132448,0.000004271141,0.9855178,0.000050182007,0.008837442,0.00018121718],"about_ca_topic_score_codex":0.0006898036,"about_ca_topic_score_gemma":0.0000021492915,"teacher_disagreement_score":0.0071715233,"about_ca_system_score_codex":0.00006220642,"about_ca_system_score_gemma":0.00008781643,"threshold_uncertainty_score":0.999754},"labels":[],"label_agreement":null},{"id":"W2558872400","doi":"10.18295/squmj.2016.16.04.002","title":"Statin-Associated Muscle Adverse Events: Update for clinicians","year":2016,"lang":"en","type":"review","venue":"Sultan Qaboos University medical journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Statin; Adverse effect; Guideline; Intensive care medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Bioinformatics; Internal medicine; Pathology","score_opus":0.03152784060655844,"score_gpt":0.3312133021534692,"score_spread":0.2996854615469108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558872400","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008659916,0.9880013,0.005279616,0.0015088519,0.0013656731,0.0019280835,0.00076173845,0.000104911036,0.00096324086],"genre_scores_gemma":[0.000019650151,0.99456584,0.00046266272,0.00042073164,0.0016728893,0.0000037744287,0.00021825888,0.00007558166,0.002560633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953305,0.00071293477,0.00095567264,0.00050937774,0.0016894977,0.0008019825],"domain_scores_gemma":[0.99590015,0.00044606527,0.0008685742,0.0005051027,0.0006004571,0.0016796218],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030051174,0.00046231603,0.002499287,0.00046468215,0.0004392304,0.000010382086,0.00056074164,0.0009428278,0.0011285181],"category_scores_gemma":[0.0023732695,0.00032656567,0.0025862635,0.00054085406,0.00015947176,0.00015341544,0.00013281198,0.0016370759,0.0001753009],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012059274,0.00023488062,0.000006009971,0.002750247,0.001642436,0.0014841885,0.00004275517,4.439446e-8,5.8967377e-8,0.00008644341,0.0067246463,0.9869077],"study_design_scores_gemma":[0.0057406453,0.00039300986,0.000030484238,0.028262218,0.0029038351,0.00055265165,0.0001991098,0.0000042122274,8.79229e-8,0.000047217065,0.96153456,0.00033197858],"about_ca_topic_score_codex":0.000024555804,"about_ca_topic_score_gemma":0.000028652159,"teacher_disagreement_score":0.9865757,"about_ca_system_score_codex":0.0012375328,"about_ca_system_score_gemma":0.0057156133,"threshold_uncertainty_score":0.9999211},"labels":[],"label_agreement":null},{"id":"W2558991743","doi":"10.1038/ncomms13457","title":"Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis","year":2016,"lang":"en","type":"article","venue":"Nature Communications","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":481,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"Amgen; Amgen Canada; McMaster University; Canadian Institutes of Health Research; Esperion Therapeutics; Heart and Stroke Foundation of Canada","keywords":"ATP citrate lyase; Prodrug; AMPK; Statin; Downregulation and upregulation; LDL receptor; Chemistry; Pharmacology; Endocrinology; Lipoprotein; Internal medicine; Cholesterol; Kinase; Biochemistry; Enzyme; Medicine; Protein kinase A; Citrate synthase","score_opus":0.022865203475323302,"score_gpt":0.26980391542208393,"score_spread":0.24693871194676062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558991743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86889803,0.10973305,0.0003952407,0.018961562,0.00007326427,0.00074682006,0.00016946754,0.00017449756,0.00084808323],"genre_scores_gemma":[0.9406983,0.055575322,0.0020862517,0.0010900451,0.00010280626,0.00010027372,0.00017000253,0.00003076727,0.0001461783],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884826,0.00016154101,0.0002324352,0.00027302452,0.00026335573,0.00022140805],"domain_scores_gemma":[0.99752736,0.0001635768,0.00008694278,0.0018146735,0.00018984747,0.00021757999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032556933,0.00016668458,0.00026311557,0.00007631298,0.00033844457,0.00003564309,0.00020555679,0.0002771795,0.000051968753],"category_scores_gemma":[0.00014103232,0.000115898416,0.00014551307,0.00022260884,0.0002400286,0.00014965957,0.00016126313,0.0004453773,0.000052267245],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020111284,0.0012211478,0.033188503,0.00018392941,0.0005338935,0.0000144196965,0.00089226465,1.133502e-7,0.64285004,0.009100433,0.056521554,0.2552926],"study_design_scores_gemma":[0.004773072,0.00038588466,0.21728596,0.0010514597,0.0003833928,0.00020068635,0.00028014058,0.000028706316,0.07277944,0.0003312474,0.70192397,0.00057606626],"about_ca_topic_score_codex":0.000087184526,"about_ca_topic_score_gemma":0.00009387364,"teacher_disagreement_score":0.6454024,"about_ca_system_score_codex":0.000091820104,"about_ca_system_score_gemma":0.000065678054,"threshold_uncertainty_score":0.47262},"labels":[],"label_agreement":null},{"id":"W2559592043","doi":"10.1016/s2213-8587(16)30396-5","title":"PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":391,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Sanofi; University College London Hospitals NHS Foundation Trust; Economic and Social Research Council; Lundbeckfonden; National Cancer Institute; British Heart Foundation; University College London; AstraZeneca; Amgen; National Institute for Health and Care Research; Medical Research Council; Foundation for the National Institutes of Health","keywords":"Medicine; Mendelian randomization; Type 2 diabetes; PCSK9; Mendelian inheritance; Diabetes mellitus; MEDLINE; Internal medicine; Bioinformatics; Genetic variants; Genetics; Endocrinology; Cholesterol; Genotype; Gene","score_opus":0.02064260349654017,"score_gpt":0.2663447683854673,"score_spread":0.2457021648889271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559592043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942585,0.002764021,0.000037524132,0.0015523047,0.00017936411,0.0009434042,0.000019261053,0.000046443245,0.00019913363],"genre_scores_gemma":[0.99663264,0.0023627703,0.00020442069,0.00027510972,0.0003634145,0.00008112961,0.0000025499617,0.000020170735,0.00005777917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980809,0.00048018765,0.0002927953,0.0002705521,0.00020365753,0.00067189644],"domain_scores_gemma":[0.9987062,0.000244566,0.00013574197,0.00074452464,0.00009293449,0.00007602146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008803418,0.00014850985,0.00073802954,0.00007544214,0.00007447719,0.0000064622986,0.00013459868,0.0000521542,0.00005936473],"category_scores_gemma":[0.00033682564,0.0000751191,0.00008848004,0.00013801754,0.00015561313,0.00003251949,0.0000830903,0.00014182809,0.000015804306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002661131,0.00011595454,0.87196374,0.00007301824,0.0010666085,0.000008544344,0.0002617174,0.0000014637894,0.007042896,0.00012024016,0.00014155704,0.118938126],"study_design_scores_gemma":[0.014152714,0.001177457,0.9764975,0.00005765571,0.000769416,0.000013356479,0.00011949537,0.000054533066,0.0037441496,0.00075908314,0.0025379306,0.000116741794],"about_ca_topic_score_codex":0.0000848142,"about_ca_topic_score_gemma":0.000023319904,"teacher_disagreement_score":0.11882138,"about_ca_system_score_codex":0.000026282964,"about_ca_system_score_gemma":0.000050238457,"threshold_uncertainty_score":0.30632678},"labels":[],"label_agreement":null},{"id":"W2559918890","doi":"10.1007/8904_2016_29","title":"Atypical Presentation and Treatment Response in a Child with Familial Hypercholesterolemia Having a Novel LDLR Mutation","year":2016,"lang":"en","type":"article","venue":"JIMD Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Familial hypercholesterolemia; Proband; PCSK9; Genetics; Penetrance; Medicine; LDL receptor; Allele; Apolipoprotein B; Genetic heterogeneity; Phenotype; Mutation; Biology; Internal medicine; Gene; Cholesterol; Lipoprotein","score_opus":0.014908362906647222,"score_gpt":0.2703907827571157,"score_spread":0.2554824198504685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559918890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650574,0.00010292446,0.0009665303,0.0014763357,0.000047188667,0.0007109091,0.0000018659722,0.000028969016,0.0001595651],"genre_scores_gemma":[0.99867946,0.000036058627,0.0007148017,0.00007821969,0.0001263853,0.00009246344,0.000007715876,0.000016011976,0.00024887573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893075,0.00006657425,0.00026120423,0.0003049005,0.00027815741,0.00015840631],"domain_scores_gemma":[0.9994351,0.000035933565,0.00008058804,0.00029802643,0.000042510645,0.00010778923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004489369,0.00010701358,0.00022621395,0.00009080033,0.000043396063,0.000012075552,0.000010520169,0.00006986675,0.000005317958],"category_scores_gemma":[0.000119778204,0.000059128306,0.000053991644,0.00008679999,0.000040436717,0.00009262648,0.0000115998,0.000063461055,0.0000014973874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020641947,0.00090111117,0.54373455,0.00013935355,0.00028015935,0.017200068,0.0028432363,0.00003084527,0.060571667,0.000026015614,0.000031877593,0.3535992],"study_design_scores_gemma":[0.0038511201,0.00089446624,0.9796315,0.00031975916,0.00007349286,0.012336984,0.00011892363,0.000027319824,0.0017776722,0.00001020625,0.0008747646,0.00008379058],"about_ca_topic_score_codex":0.00034967216,"about_ca_topic_score_gemma":0.00014269442,"teacher_disagreement_score":0.43589696,"about_ca_system_score_codex":0.00019996136,"about_ca_system_score_gemma":0.00014011687,"threshold_uncertainty_score":0.24111824},"labels":[],"label_agreement":null},{"id":"W2559937725","doi":"10.1016/j.atherosclerosissup.2016.10.001","title":"Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration","year":2016,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Pooling; Medicine; Disease; Computer science; Internal medicine; Artificial intelligence","score_opus":0.04636939765045045,"score_gpt":0.3229991045431135,"score_spread":0.27662970689266303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559937725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99478585,0.0014671151,0.00048201616,0.0005625526,0.00008824705,0.0022257057,0.0003752583,0.000007792594,0.0000054887864],"genre_scores_gemma":[0.9956764,0.0024525232,0.001397571,0.00019519108,0.000031087628,0.00020115683,0.000010195208,0.000014767953,0.000021083257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984706,0.0001429223,0.00040316983,0.00037520615,0.0003975381,0.00021053698],"domain_scores_gemma":[0.99922895,0.00007440778,0.00011655991,0.00029852593,0.00013889333,0.00014268707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004217647,0.00019324645,0.0004256173,0.000063665226,0.00011559128,0.00003406656,0.000066604036,0.000054744025,0.0000011280395],"category_scores_gemma":[0.00013909591,0.00012272064,0.000043563385,0.00014904347,0.00017278115,0.00018068531,0.00022718533,0.000054117594,1.16897e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029849744,0.000044421427,0.97293824,0.00065970025,0.0001710104,0.0000015902351,0.0019110044,0.000004492475,0.015629424,0.00008573688,0.000027051574,0.008228817],"study_design_scores_gemma":[0.0051189316,0.00026343108,0.98466134,0.00082493253,0.00021586097,0.0000022759211,0.0065242997,0.000008828391,0.002065811,0.000080794285,0.000108492284,0.00012497953],"about_ca_topic_score_codex":0.00014453735,"about_ca_topic_score_gemma":0.00018634713,"teacher_disagreement_score":0.0135636125,"about_ca_system_score_codex":0.00018756893,"about_ca_system_score_gemma":0.00007789615,"threshold_uncertainty_score":0.50044024},"labels":[],"label_agreement":null},{"id":"W2560403714","doi":"10.1016/s2213-8587(16)30398-9","title":"PCSK9 inhibition and diabetes: turning to Mendel for clues","year":2016,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Diabetes mellitus; MEDLINE; Bioinformatics; Endocrinology","score_opus":0.030734306734960692,"score_gpt":0.2845203620672843,"score_spread":0.2537860553323236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560403714","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1698939,0.004116478,0.00009776287,0.82180256,0.0005984594,0.0020863134,0.0002767156,0.00019753692,0.00093029765],"genre_scores_gemma":[0.038092896,0.00078916945,0.0008330263,0.92857933,0.028500617,0.0015892386,0.0003755532,0.0001483116,0.0010918536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99611175,0.00023371294,0.0003919901,0.000675971,0.0003246958,0.0022618598],"domain_scores_gemma":[0.9980349,0.00047404823,0.00016449449,0.0010650825,0.00013608995,0.00012536373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075392757,0.0004301938,0.0014836735,0.00019620969,0.00019390933,0.000039592796,0.00022368382,0.0004341575,0.000042073043],"category_scores_gemma":[0.00024582774,0.00025901844,0.00031783088,0.00010737322,0.00019627913,0.000053983294,0.00020591919,0.0010896259,0.000052366075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064372834,0.000014713229,0.0031340749,0.0014784618,0.00094837457,0.00007443791,0.00013245238,6.024572e-7,0.0032761437,0.0002690252,0.91244,0.07816732],"study_design_scores_gemma":[0.0020919223,0.0005612052,0.001737209,0.0005547167,0.00045631023,0.000044344863,0.000017674096,0.000011769961,0.0047976472,0.001930414,0.9874652,0.00033160218],"about_ca_topic_score_codex":0.000016585913,"about_ca_topic_score_gemma":0.000004956407,"teacher_disagreement_score":0.13180101,"about_ca_system_score_codex":0.00011648825,"about_ca_system_score_gemma":0.00008475798,"threshold_uncertainty_score":0.99998623},"labels":[],"label_agreement":null},{"id":"W2560591761","doi":"10.1111/bcp.13208","title":"Statin potency and the risk of hospitalization for community‐acquired pneumonia","year":2016,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Potency; Medicine; Hazard ratio; Internal medicine; Statin; Confidence interval; Cohort; Population; Retrospective cohort study; Logistic regression; Cohort study; Pharmacology; Biology; Environmental health","score_opus":0.03404338852254535,"score_gpt":0.38238011969939656,"score_spread":0.3483367311768512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560591761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847539,0.0033689511,0.0066845925,0.0038258508,0.0007144158,0.00053592585,0.000035471465,0.0000049043083,0.00007599285],"genre_scores_gemma":[0.9757811,0.021464033,0.00083824573,0.0010213872,0.0008037722,0.000009487847,0.0000015410067,0.000012413531,0.000068052315],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99673456,0.0016911532,0.0011474311,0.000080537786,0.00020574262,0.0001406011],"domain_scores_gemma":[0.99635935,0.0019875036,0.0008533654,0.000121051016,0.0005328341,0.00014589043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007892003,0.0000659203,0.00071994006,0.000032939282,0.00011774884,0.000006870592,0.00011978808,0.000097451615,0.00004493984],"category_scores_gemma":[0.0030874363,0.000038932605,0.0004341171,0.000056279856,0.000470897,0.000068539106,0.000038182392,0.00030894086,6.2540283e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003975427,0.0005715961,0.019307913,0.00018619701,0.0012892621,0.00008036034,0.00014436062,0.000004458301,0.001436971,0.00012541386,0.006763347,0.9661147],"study_design_scores_gemma":[0.094530396,0.0058744727,0.86238515,0.0007631441,0.0030822896,0.003350795,0.00027814702,0.00020238027,0.0011459067,0.007085017,0.021123096,0.00017918188],"about_ca_topic_score_codex":0.00017255214,"about_ca_topic_score_gemma":0.00001636387,"teacher_disagreement_score":0.9659355,"about_ca_system_score_codex":0.0000142095005,"about_ca_system_score_gemma":0.0001761345,"threshold_uncertainty_score":0.36961725},"labels":[],"label_agreement":null},{"id":"W2560615061","doi":"10.1177/2047487316682186","title":"Genetic invalidation of Lp-PLA<sub>2</sub> as a therapeutic target: Large-scale study of five functional Lp-PLA<sub>2</sub>-lowering alleles","year":2016,"lang":"en","type":"review","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Université de Genève; Helmholtz Zentrum München; National Institute for Health and Care Research; Bundesministerium für Bildung und Forschung; Institut National de la Santé et de la Recherche Médicale; NIHR Cambridge Biomedical Research Centre; European Commission; Regione Lombardia; Sydäntutkimussäätiö; British Heart Foundation; Münchner Zentrum für Gesundheitswissenschaften; Wellcome Trust; Foundation for Cardiovascular Research","keywords":"Medicine; Allele; Lipoprotein-associated phospholipase A2; Internal medicine; Genotyping; Randomized controlled trial; Gastroenterology; Genotype; Genetics; Gene; Lipoprotein; Biology; Cholesterol","score_opus":0.0279716611488948,"score_gpt":0.28613948380048937,"score_spread":0.25816782265159455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560615061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22329652,0.7622225,0.010482705,0.00002158931,0.0010955669,0.0020869498,0.00011513505,0.00002125942,0.0006577704],"genre_scores_gemma":[0.20894852,0.7885319,0.00014041891,0.000048893704,0.0020095615,0.000037183545,0.000055832825,0.00017575813,0.000051950577],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98856163,0.006272873,0.0027371726,0.0007272696,0.0010840538,0.00061701174],"domain_scores_gemma":[0.99421805,0.00031353757,0.003039245,0.0009145141,0.0011878993,0.00032674533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0053978963,0.00073681254,0.004755676,0.00070115156,0.00013216818,0.000017678474,0.00048557683,0.00027733407,0.00007886445],"category_scores_gemma":[0.00036001843,0.0005332075,0.0029884437,0.00038232247,0.00021536098,0.00013729541,0.00027563437,0.001089398,0.00009164723],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007838921,0.00094888086,0.00052144384,0.006642945,0.02001873,0.0017837896,0.0010383864,0.0001902928,0.009193393,0.00001772457,0.0005774597,0.95828307],"study_design_scores_gemma":[0.03673433,0.03269668,0.107039586,0.06355034,0.04664384,0.027219038,0.0041373153,0.000016272576,0.010176846,0.00046258915,0.66749734,0.003825834],"about_ca_topic_score_codex":0.000004396946,"about_ca_topic_score_gemma":0.000003985966,"teacher_disagreement_score":0.9544572,"about_ca_system_score_codex":0.00026179588,"about_ca_system_score_gemma":0.00091755384,"threshold_uncertainty_score":0.99971193},"labels":[],"label_agreement":null},{"id":"W2560696033","doi":"10.1126/scitranslmed.aal2805","title":"LDL cholesterol hitches a ride","year":2016,"lang":"en","type":"letter","venue":"Science Translational Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Cholesterol; Ldl cholesterol; Medicine; Internal medicine","score_opus":0.03226530644020167,"score_gpt":0.30485716071846586,"score_spread":0.2725918542782642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560696033","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011472509,0.0013190688,0.0016969286,0.98208386,0.00096342905,0.0008935444,0.000038768652,0.00009919237,0.011757967],"genre_scores_gemma":[0.037282083,0.0002451369,0.0008880229,0.9220469,0.03437053,0.00010171091,0.00020329391,0.00007523474,0.004787063],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99400175,0.00006165594,0.00055516564,0.0008653236,0.003752802,0.0007632891],"domain_scores_gemma":[0.99809486,0.0001315409,0.00014913821,0.0008916083,0.00041248856,0.00032034214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019539294,0.00036851177,0.0008060432,0.0006028912,0.00024872515,0.000022195612,0.00040867654,0.00031531465,0.0007765029],"category_scores_gemma":[0.00019468463,0.00021845127,0.00027248167,0.0007098657,0.0019681975,0.00022032893,0.000023553985,0.0011444392,0.00016783597],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010592251,0.000043441094,0.0015096002,0.0012174665,0.0002820945,0.0006431763,0.00074103964,0.000001798217,0.005927527,0.00044293984,0.8092962,0.17978883],"study_design_scores_gemma":[0.0024555218,0.00024676727,0.013052327,0.0016592734,0.00025563873,0.0005023362,0.00001626017,0.000018736866,0.00030892805,0.0011110967,0.98009735,0.00027575836],"about_ca_topic_score_codex":0.00013731564,"about_ca_topic_score_gemma":0.0000070597052,"teacher_disagreement_score":0.17951307,"about_ca_system_score_codex":0.00016351113,"about_ca_system_score_gemma":0.0016249851,"threshold_uncertainty_score":0.8908184},"labels":[],"label_agreement":null},{"id":"W2560899778","doi":"10.1161/atvbaha.116.307995","title":"Carriers of the PCSK9 R46L Variant Are Characterized by an Antiatherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy—Brief Report","year":2016,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"PCSK9; Nuclear magnetic resonance spectroscopy; Nuclear magnetic resonance; Spectroscopy; Lipoprotein; Magnetic resonance imaging; Medicine; Internal medicine; Cholesterol; LDL receptor; Physics; Radiology","score_opus":0.015161493794558278,"score_gpt":0.2528897315760129,"score_spread":0.23772823778145463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560899778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946358,0.00167931,0.00049048295,0.0011482737,0.00017606208,0.001474033,0.00026477163,0.00006736345,0.00006389928],"genre_scores_gemma":[0.9935063,0.0047647255,0.0006131285,0.0006032379,0.00016119533,0.00018201019,0.00005587414,0.00007804605,0.000035453624],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99706715,0.00046530116,0.000653666,0.00086826715,0.00036919047,0.00057644374],"domain_scores_gemma":[0.9976531,0.000026496293,0.00039338344,0.0015249548,0.00013543564,0.00026660896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083485496,0.00036732934,0.0010464349,0.00005392105,0.0002473783,0.000035089277,0.00026953977,0.00032000078,0.00031197033],"category_scores_gemma":[0.00007247666,0.00021616402,0.0004957484,0.00023267337,0.00047330523,0.00013967126,0.00013578043,0.00019576332,0.000008437484],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024962515,0.00025509374,0.037980974,0.00009012468,0.00027139453,0.000001146718,0.00008226535,6.0778365e-9,0.95528686,0.0000545002,0.00038937078,0.0055632745],"study_design_scores_gemma":[0.0030936506,0.0012254305,0.8990895,0.0003472559,0.00032983077,0.000032595213,0.000106385385,0.000010417503,0.03967772,0.000024385474,0.055720277,0.0003425611],"about_ca_topic_score_codex":0.0005272514,"about_ca_topic_score_gemma":0.000027887287,"teacher_disagreement_score":0.9156092,"about_ca_system_score_codex":0.00006613151,"about_ca_system_score_gemma":0.00012696687,"threshold_uncertainty_score":0.8814913},"labels":[],"label_agreement":null},{"id":"W2561229809","doi":"10.1159/000453626","title":"Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study","year":2016,"lang":"en","type":"article","venue":"American Journal of Nephrology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Fenofibrate; Internal medicine; Kidney disease; Diabetes mellitus; Type 2 diabetes; Statin; Endocrinology; Gastroenterology","score_opus":0.006002272876602302,"score_gpt":0.2283423814160365,"score_spread":0.2223401085394342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561229809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952565,0.0013186397,0.00054497476,0.00037061906,0.00008557539,0.002408098,0.000003323049,0.00001122445,0.0000010841421],"genre_scores_gemma":[0.9987377,0.00023889815,0.00027117456,0.00049731956,0.00013821984,0.00007000435,5.8077404e-7,0.00004411807,0.000001987756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569064,0.0017535982,0.0005920253,0.00036582188,0.0010983389,0.00049955514],"domain_scores_gemma":[0.99774706,0.00042494852,0.00050177856,0.000787993,0.00037584026,0.00016235185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002291364,0.00032496318,0.0023736288,0.00039449302,0.000073074276,0.000011739598,0.00018551356,0.00006930813,0.0000040864165],"category_scores_gemma":[0.00024572303,0.0001360939,0.00050075573,0.00061703596,0.000296186,0.00010938413,0.000032783824,0.00041769102,0.0000016358297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00825373,0.0006739684,0.779945,0.0000422783,0.0098257745,0.00007912237,0.00058636797,0.0003968377,0.00022429778,6.673425e-7,0.0000026449,0.1999693],"study_design_scores_gemma":[0.018319475,0.03373852,0.9442513,0.00034716708,0.001573379,0.000017065144,0.0002646139,0.0000029079124,0.0011337601,0.000012420659,0.00016788204,0.00017149789],"about_ca_topic_score_codex":0.002196545,"about_ca_topic_score_gemma":0.00040206307,"teacher_disagreement_score":0.19979781,"about_ca_system_score_codex":0.00020551865,"about_ca_system_score_gemma":0.00018161477,"threshold_uncertainty_score":0.5549748},"labels":[],"label_agreement":null},{"id":"W2562184463","doi":"10.1016/j.ymgmr.2016.11.006","title":"Comparing expression and activity of PCSK9 in SPRET/EiJ and C57BL/6J mouse strains shows lack of correlation with plasma cholesterol","year":2016,"lang":"en","type":"article","venue":"Molecular Genetics and Metabolism Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; LDL receptor; Kexin; Biology; Molecular biology; Proprotein convertase; Subtilisin; Promoter; Luciferase; Gene expression; Gene; Cholesterol; Lipoprotein; Genetics; Biochemistry; Transfection; Enzyme","score_opus":0.02091841995211696,"score_gpt":0.2564320682929093,"score_spread":0.23551364834079236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562184463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99220866,0.0024300509,0.004729076,0.00003380154,0.000032259915,0.0004626067,0.000005087717,0.000006367893,0.00009208084],"genre_scores_gemma":[0.99795103,0.00067452405,0.001278797,0.000018524204,0.00001917714,0.000010035355,0.0000029889948,0.000018483313,0.000026428652],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99890333,0.00005988332,0.0003102028,0.0002894614,0.00029077582,0.00014633746],"domain_scores_gemma":[0.99923563,0.0000099528515,0.00021768783,0.0003408296,0.00006772733,0.00012817413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034487003,0.00013494227,0.00048776314,0.00008900107,0.000022047367,0.000008384349,0.00001842306,0.000088542416,0.0000018402741],"category_scores_gemma":[0.000030313287,0.000090373156,0.00004415138,0.000062931824,0.0001036078,0.000045950128,0.000054646574,0.00008425235,3.258189e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092575465,0.00006414183,0.11740453,0.00021644295,0.00006548377,0.00010181933,0.000248524,0.00009050698,0.84914875,0.00003201752,0.0000013928442,0.03253384],"study_design_scores_gemma":[0.001938842,0.000110395275,0.5345091,0.00023840333,0.0001322593,0.00026106683,0.000030104304,0.00037018614,0.4620687,0.00003972579,0.0002018815,0.000099308534],"about_ca_topic_score_codex":0.00012207829,"about_ca_topic_score_gemma":0.00004267072,"teacher_disagreement_score":0.4171046,"about_ca_system_score_codex":0.000009495854,"about_ca_system_score_gemma":0.000059894897,"threshold_uncertainty_score":0.36853102},"labels":[],"label_agreement":null},{"id":"W2562621570","doi":"10.1093/eurheartj/ehw474","title":"Cardiovascular medicine at the Québec Heart and Lung Institute","year":2016,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval","funders":"","keywords":"Medicine; Excellence; Pavilion; Observational study; Gerontology; Family medicine; Library science; Internal medicine; History","score_opus":0.028949620393542087,"score_gpt":0.2731067014938866,"score_spread":0.2441570811003445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562621570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74544597,0.1130311,0.0014347878,0.122395195,0.001193119,0.00068356586,0.000003862652,0.000096956064,0.01571546],"genre_scores_gemma":[0.982773,0.0031022879,0.00021979558,0.0043366905,0.004777401,0.0000039833753,0.0000013367513,0.000063873646,0.004721615],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997728,0.0005602681,0.0003306119,0.00027377403,0.0007453848,0.00036197645],"domain_scores_gemma":[0.9985787,0.000056433073,0.000059836242,0.00073284784,0.00011445487,0.0004576972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003773601,0.00018208842,0.0004857344,0.000078168385,0.0005643929,0.000029154557,0.00010272325,0.00003476315,0.00034077858],"category_scores_gemma":[0.00027701718,0.00007952731,0.00049276056,0.000115090865,0.0003695213,0.00013337766,0.00012281929,0.0003566745,0.00021369796],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004374602,0.00010392226,0.14622833,0.00030104347,0.004167768,0.0024909256,0.0014392725,0.000020343556,0.024461199,0.00022851881,0.5297614,0.29035985],"study_design_scores_gemma":[0.0018464774,0.00017469421,0.22006246,0.00031575916,0.00024423687,0.017837051,0.00003160626,0.0000024562764,0.00016280977,0.000005707345,0.759225,0.00009170232],"about_ca_topic_score_codex":0.0007279182,"about_ca_topic_score_gemma":0.00012704341,"teacher_disagreement_score":0.29026815,"about_ca_system_score_codex":0.0001957414,"about_ca_system_score_gemma":0.00022796514,"threshold_uncertainty_score":0.4340911},"labels":[],"label_agreement":null},{"id":"W2562899840","doi":"10.1001/jamacardio.2016.4828","title":"Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes","year":2016,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University Medical Centre; University of Toronto; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Fenofibrate; Type 2 diabetes; Internal medicine; Diabetes mellitus; Statin; Hypertriglyceridemia; Population; Physical therapy; Triglyceride; Cholesterol; Endocrinology; Environmental health","score_opus":0.006659510377898717,"score_gpt":0.2122173814354689,"score_spread":0.20555787105757017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562899840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966007,0.0017122468,0.00019268661,0.00012267109,0.00007982267,0.0008789408,0.000048146718,0.000036850077,0.0003279427],"genre_scores_gemma":[0.9974886,0.0018460839,0.0001696248,0.00007055423,0.00018196699,0.00005348778,0.00006834459,0.000040502408,0.00008081272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780035,0.00059356843,0.00029606887,0.00037547623,0.00052021805,0.00041431503],"domain_scores_gemma":[0.99839616,0.00011840436,0.00021916801,0.0006554164,0.00051408965,0.000096781456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093049667,0.00020611729,0.001069438,0.0001346412,0.000036810437,0.000007751432,0.000074846685,0.00022306542,0.000020510644],"category_scores_gemma":[0.00014870304,0.00010784759,0.000283928,0.0003364397,0.000080292506,0.000101110505,0.000021854,0.00017734563,0.000010795039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008490131,0.000056938017,0.93511736,0.00005242872,0.0041098036,0.000039887516,0.00004798998,0.000033341767,0.000222658,0.000002504527,0.000060693455,0.05940735],"study_design_scores_gemma":[0.011456738,0.0018734605,0.9833415,0.00015735236,0.00041346453,0.000007447643,0.000009904431,0.0000012739293,0.0016043342,0.00000827199,0.0009722398,0.00015402345],"about_ca_topic_score_codex":0.00020913429,"about_ca_topic_score_gemma":0.00004232884,"teacher_disagreement_score":0.059253324,"about_ca_system_score_codex":0.00022274886,"about_ca_system_score_gemma":0.00014325777,"threshold_uncertainty_score":0.4397897},"labels":[],"label_agreement":null},{"id":"W2563179832","doi":"10.1016/j.cjca.2016.12.007","title":"Optimal Low-Density Lipoprotein Cholesterol for Cardiovascular Prevention: How Low Should We Go?","year":2016,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Mendelian randomization; Medicine; Dyslipidemia; Randomized controlled trial; Cholesterol; Clinical trial; Disease; Atherosclerotic cardiovascular disease; Epidemiology; HMG-CoA reductase; Statin; Intensive care medicine; Internal medicine; Reductase; Genetic variants","score_opus":0.057050215700584744,"score_gpt":0.30729617949397,"score_spread":0.25024596379338526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563179832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052028823,0.96390766,0.029013433,0.0010933025,0.0021216143,0.0032434182,0.00019390462,0.000016859382,0.00035777545],"genre_scores_gemma":[0.00071541034,0.9814422,0.00092933094,0.00012096807,0.01513837,0.00022873555,0.000061802544,0.00018405472,0.001179129],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99510825,0.0009812996,0.0012958578,0.0007303714,0.00070369325,0.0011805148],"domain_scores_gemma":[0.99451005,0.00011943761,0.0008390159,0.001631523,0.00094690826,0.0019530634],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0034106958,0.00080148695,0.0076705907,0.00083771907,0.00023128957,0.00008208981,0.0005809059,0.0014420846,0.000036478203],"category_scores_gemma":[0.0005131518,0.00056919514,0.014993918,0.00029147192,0.00030125407,0.00015899108,0.00005079308,0.001328881,0.00005802084],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004457294,0.000005300578,0.000005154874,0.012496683,0.0112752905,0.00087612227,0.000018629167,0.000031005096,6.282215e-7,0.000029190654,0.007804434,0.967413],"study_design_scores_gemma":[0.0022106008,0.0007505962,0.000045064553,0.02121791,0.00789854,0.013291911,0.000021771779,6.452366e-7,0.0000065412733,0.00004639215,0.9540221,0.00048791172],"about_ca_topic_score_codex":0.0003295959,"about_ca_topic_score_gemma":0.00038256697,"teacher_disagreement_score":0.9669251,"about_ca_system_score_codex":0.0011516007,"about_ca_system_score_gemma":0.010183282,"threshold_uncertainty_score":0.99985427},"labels":[],"label_agreement":null},{"id":"W2563256359","doi":"10.1097/mol.0000000000000387","title":"Does lifestyle contribute to disease severity in patients with inherited lipid disorders?","year":2016,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Obesity; Hyperlipidemia; Disease; Internal medicine; Diabetes mellitus; Abdominal obesity; Insulin resistance; Type 2 diabetes; Risk factor; Glycemic; Familial hypercholesterolemia; Metabolic syndrome; Endocrinology; Cholesterol","score_opus":0.03116828003699621,"score_gpt":0.3447911970284836,"score_spread":0.31362291699148737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563256359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031768074,0.9598321,0.00013046687,0.00066109584,0.033302598,0.0052568815,0.0004198529,0.00006189099,0.000017438748],"genre_scores_gemma":[0.00008241031,0.98813057,0.000041431373,0.000084299696,0.009547281,0.00096534524,0.0010393476,0.000076048884,0.00003324522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99605495,0.0007913369,0.0009787023,0.0009462653,0.00048127663,0.00074748386],"domain_scores_gemma":[0.99784607,0.00016061301,0.00028958017,0.0009917826,0.00012977622,0.00058219733],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006446568,0.0005804435,0.0026470788,0.0005963358,0.000047594076,0.000015450556,0.00024976343,0.00036279572,0.00008392471],"category_scores_gemma":[0.0005272916,0.00030099228,0.00045209273,0.00069050776,0.00011033207,0.000087523775,0.00020108362,0.000753689,0.00011221286],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037570237,0.0007054661,0.057332374,0.024190875,0.00010465143,5.382856e-7,0.000037413683,3.1799965e-7,3.3849623e-9,0.000053711145,0.003151243,0.9140477],"study_design_scores_gemma":[0.0034267511,0.00029898435,0.08547977,0.03900804,0.00012285577,0.0000025364627,0.0000032750795,6.4291766e-7,4.5524224e-9,0.00002294097,0.8712434,0.00039074584],"about_ca_topic_score_codex":0.000051937204,"about_ca_topic_score_gemma":0.000046567868,"teacher_disagreement_score":0.91365695,"about_ca_system_score_codex":0.00042593718,"about_ca_system_score_gemma":0.0007858828,"threshold_uncertainty_score":0.9999442},"labels":[],"label_agreement":null},{"id":"W2564082722","doi":"10.1016/j.jacc.2016.10.033","title":"Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels","year":2016,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":250,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Center for Advancing Translational Sciences; National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Medical Research Council; British Heart Foundation","keywords":"Medicine; Odds ratio; Internal medicine; Confidence interval; Biobank; Lipoprotein(a); Biomarker; Genetic testing; Disease; Genome-wide association study; Genotype; Bioinformatics; Oncology; Genetics; Gene; Lipoprotein; Biology; Single-nucleotide polymorphism","score_opus":0.01673910319473721,"score_gpt":0.2661478712037986,"score_spread":0.24940876800906142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564082722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99064815,0.00016283515,0.005917714,0.002156623,0.00025336823,0.00034199716,0.00007201486,0.0000044954563,0.00044281004],"genre_scores_gemma":[0.9979933,0.00016479945,0.0007124393,0.00017419981,0.0007317378,0.0000040418076,6.559877e-7,0.000019896692,0.00019896339],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980579,0.0003681668,0.00076048926,0.00013035965,0.00047909617,0.00020400439],"domain_scores_gemma":[0.9975203,0.0000576758,0.0011875877,0.00056016963,0.000563918,0.00011032323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008065641,0.00012691275,0.0012357712,0.00013492988,0.000044295408,0.0000013618187,0.00025658068,0.0000681897,0.000025072006],"category_scores_gemma":[0.00023513846,0.00006590015,0.00073322834,0.0002822891,0.0005341381,0.000040797087,0.000069872585,0.00015158464,0.0000014833595],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005714861,0.00004451719,0.008361303,0.00006539719,0.00077712274,0.000048563554,0.00001712186,0.0000065205318,0.9632721,0.00040836068,0.0001544758,0.02627303],"study_design_scores_gemma":[0.0026795636,0.0027368753,0.8957289,0.00032010258,0.0004645624,0.0015326653,0.000059613638,0.0000024418798,0.08924017,0.00042653593,0.006685535,0.00012302869],"about_ca_topic_score_codex":0.000012584727,"about_ca_topic_score_gemma":0.0000014560961,"teacher_disagreement_score":0.8873676,"about_ca_system_score_codex":0.00007820367,"about_ca_system_score_gemma":0.00035522724,"threshold_uncertainty_score":0.26873302},"labels":[],"label_agreement":null},{"id":"W2564354343","doi":"10.1007/s00134-016-4649-0","title":"Statin therapy for acute respiratory distress syndrome: an individual patient data meta-analysis of randomised clinical trials","year":2016,"lang":"en","type":"review","venue":"Intensive Care Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Medical Research Council; Public Health Agency; National Institute for Health and Care Research","keywords":"Medicine; Internal medicine; ARDS; Statin; Relative risk; Randomized controlled trial; Meta-analysis; Adverse effect; Placebo; Incidence (geometry); Clinical trial; Physical therapy; Confidence interval; Lung","score_opus":0.5103094176231476,"score_gpt":0.5453748768034872,"score_spread":0.03506545918033954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564354343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001395688,0.9575766,0.0007826892,0.00043002403,0.00079237507,0.011206689,0.029014606,0.000039055034,0.000018431087],"genre_scores_gemma":[0.00013667905,0.97067404,0.00021366091,0.003323258,0.00093824737,0.0012880097,0.023250809,0.00012982805,0.000045477165],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9844318,0.0057425667,0.006004424,0.0016021816,0.0017147415,0.00050427776],"domain_scores_gemma":[0.9777924,0.0060859714,0.0037986385,0.005011499,0.0066576656,0.00065384817],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.016660715,0.000911419,0.029978648,0.0009040749,0.00008152978,0.000016732656,0.0009428521,0.00068048533,0.00048949453],"category_scores_gemma":[0.02573556,0.00041644322,0.011368941,0.0008009981,0.0005657301,0.00009279247,0.00025102767,0.0006733696,0.000004868085],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012836405,0.00005418426,0.000002273167,0.002595944,0.42074022,0.00015520996,0.0002591326,4.498987e-8,5.0397426e-7,0.0000033439828,0.00485245,0.57005304],"study_design_scores_gemma":[0.013489387,0.0029118909,0.000013146406,0.0024454265,0.52875584,0.000046870082,0.0008837482,0.000001033353,0.0000017757228,0.0000024143376,0.4512226,0.00022588609],"about_ca_topic_score_codex":0.000121004385,"about_ca_topic_score_gemma":0.00002243026,"teacher_disagreement_score":0.56982714,"about_ca_system_score_codex":0.00011643605,"about_ca_system_score_gemma":0.0012441952,"threshold_uncertainty_score":0.99982876},"labels":[],"label_agreement":null},{"id":"W2566580306","doi":"10.1074/jbc.m116.769430","title":"The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation","year":2016,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Université de Sherbrooke; McGill University","funders":"Canadian Institutes of Health Research; Canada Excellence Research Chairs, Government of Canada; Fondation Leducq; University of Pennsylvania; Pfizer","keywords":"LDL receptor; PCSK9; Familial hypercholesterolemia; Kexin; Proprotein convertase; Internalization; Endosome; Low-density lipoprotein; Lipoprotein; Chemistry; Cholesterol; Endocrinology; Internal medicine; Receptor; Biology; Cell biology; Biochemistry; Medicine","score_opus":0.01751993100563607,"score_gpt":0.2510005427700183,"score_spread":0.23348061176438226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566580306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939607,0.0016847231,0.00024478813,0.0033011676,0.00016225886,0.00035645577,0.0000075387334,0.00002317851,0.00025921004],"genre_scores_gemma":[0.997272,0.00053531956,0.00046306787,0.00016046835,0.0008901868,0.000010029901,0.0000061086835,0.000013046513,0.00064973795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982493,0.00012525485,0.0005901414,0.00021554949,0.00051628065,0.00030350656],"domain_scores_gemma":[0.9982227,0.00012595166,0.00040362458,0.00038075278,0.0005828917,0.00028404556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014401026,0.00017563555,0.0004397752,0.000018546492,0.00014723885,0.00002690095,0.00018185457,0.00025540046,0.0002578924],"category_scores_gemma":[0.0017828249,0.00007167134,0.0003484919,0.00012360721,0.000222718,0.000054337896,0.000044932363,0.00036754098,0.000033091506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00268692,0.00013535668,0.0005799158,0.00012398094,0.00016076691,0.00024880594,0.000017886916,1.9308371e-7,0.92009634,0.000019925863,0.0007310942,0.07519884],"study_design_scores_gemma":[0.0019651137,0.0008242555,0.008303173,0.00037984984,0.000058960053,0.00068844215,0.0000951734,0.000003267214,0.9725431,0.0003788227,0.014609505,0.00015029538],"about_ca_topic_score_codex":0.000030732932,"about_ca_topic_score_gemma":0.0000028947434,"teacher_disagreement_score":0.07504854,"about_ca_system_score_codex":0.00019067268,"about_ca_system_score_gemma":0.00031557385,"threshold_uncertainty_score":0.29226726},"labels":[],"label_agreement":null},{"id":"W2567483554","doi":"10.1016/j.cjca.2016.09.010","title":"New Drugs for Atherosclerosis","year":2016,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Atherosclerotic cardiovascular disease; Disease; Statin; Drug; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.047035609745798686,"score_gpt":0.3109658759014746,"score_spread":0.26393026615567594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567483554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013536383,0.9860895,0.00872025,0.00037967745,0.0015710882,0.0007769399,0.000101685284,0.0000048756924,0.0023546137],"genre_scores_gemma":[0.000022816554,0.98595786,0.0007052575,0.00014331138,0.011944476,0.000022900504,0.000014501879,0.00007644197,0.0011124081],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99810475,0.00018951479,0.0007742646,0.00022071476,0.0001772947,0.00053348055],"domain_scores_gemma":[0.99704283,0.00012258875,0.00044757902,0.00048100765,0.00028293204,0.001623082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010068635,0.00029081144,0.0036742934,0.0004502855,0.00007371166,0.000015677786,0.0002479856,0.0005534037,0.000053006766],"category_scores_gemma":[0.0002435145,0.00018187505,0.0035698737,0.00013005195,0.000073321346,0.000033184475,0.000009387557,0.00041030245,0.000040344403],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007613997,3.1402962e-7,0.000008645552,0.0021825908,0.0012982512,0.000037100355,0.000015288842,2.4441567e-7,1.352461e-7,0.00011039326,0.048076488,0.94826293],"study_design_scores_gemma":[0.00091768836,0.00032586209,0.000022967712,0.00923075,0.0022669437,0.0023831155,0.000008342836,1.6668656e-8,3.632021e-7,0.00008749105,0.984592,0.00016443597],"about_ca_topic_score_codex":0.00049070007,"about_ca_topic_score_gemma":0.00012305853,"teacher_disagreement_score":0.9480985,"about_ca_system_score_codex":0.00058635365,"about_ca_system_score_gemma":0.01666304,"threshold_uncertainty_score":0.98891157},"labels":[],"label_agreement":null},{"id":"W2568022129","doi":"10.1097/mol.0000000000000392","title":"Lipoprotein(a): new insights from modern genomics","year":2017,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Fonds de Recherche du Québec - Santé; Servier; Ionis Pharmaceuticals; Amgen","keywords":"Genomics; Computational biology; Lipoprotein(a); Biology; Medicine; Lipoprotein; Genetics; Genome; Internal medicine; Cholesterol; Gene","score_opus":0.23113283036420812,"score_gpt":0.4280410590773191,"score_spread":0.19690822871311098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568022129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000044511803,0.920814,0.0007518633,0.00010526165,0.07518476,0.0026235094,0.000058774334,0.00007217415,0.0003852129],"genre_scores_gemma":[0.0000017213065,0.91468066,0.0004308816,0.000030243304,0.082981795,0.0002872996,0.0012985296,0.00011478836,0.00017409697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960388,0.0004651609,0.0012893315,0.0011594988,0.00043824644,0.00060897245],"domain_scores_gemma":[0.9960811,0.00011611997,0.00076021993,0.0024907654,0.00007384108,0.0004779439],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003826087,0.00072810374,0.0043292698,0.00050286384,0.00013457057,0.00005305276,0.00063443126,0.0010767872,0.00010735048],"category_scores_gemma":[0.00026842125,0.0005945968,0.0013359839,0.00018102195,0.00014368017,0.00010110156,0.00034656544,0.0016950603,0.0004222878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027594064,0.00011631795,0.000006606491,0.015089143,0.00025287987,0.0000012387632,0.00011702465,6.5992646e-7,2.1086554e-7,0.0002819238,0.010453555,0.97365284],"study_design_scores_gemma":[0.0014164009,0.00013331245,0.0000821826,0.025595937,0.0004447353,0.00010010142,0.000004457502,0.000021793536,1.3949557e-7,0.0013942613,0.97032917,0.0004774886],"about_ca_topic_score_codex":0.00091775943,"about_ca_topic_score_gemma":0.00004694719,"teacher_disagreement_score":0.97317535,"about_ca_system_score_codex":0.0005106758,"about_ca_system_score_gemma":0.0029298456,"threshold_uncertainty_score":0.99965054},"labels":[],"label_agreement":null},{"id":"W2568212737","doi":"10.1182/blood.v108.11.1466.1466","title":"Atorvastatin Reduced Platelet Accumulation in Arteriolar Thrombi and Increases Platelet S-Nitrosylated N-Ethylmaleimide-Sensitive Factor.","year":2006,"lang":"en","type":"article","venue":"Blood","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Platelet; Atorvastatin; Thrombus; Cremaster muscle; Chemistry; Internal medicine; Endocrinology; Platelet activation; Medicine; Microcirculation; Andrology","score_opus":0.01806562119665327,"score_gpt":0.2651225651505548,"score_spread":0.24705694395390154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568212737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998054,0.00060382363,0.000026411053,0.000108070235,0.00003746175,0.0007508317,0.000046254183,0.00009518444,0.0002779479],"genre_scores_gemma":[0.9987297,0.000085365486,0.0005779089,0.00014197767,0.00022878095,0.000022022477,0.00014240573,0.0000382134,0.000033604687],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983769,0.00014455267,0.00040172925,0.0003907048,0.00033052784,0.00035557977],"domain_scores_gemma":[0.9993391,0.00006757023,0.00010541453,0.0002617157,0.00008918066,0.0001370268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029450687,0.00022666338,0.0005295744,0.00015694543,0.000085226675,0.000034061373,0.00003717903,0.00017619028,0.00003595664],"category_scores_gemma":[0.00009100489,0.00020760266,0.000108527616,0.00024184457,0.00005676725,0.000104222025,0.000032856307,0.00025794737,0.000015113261],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008728434,0.0022431056,0.20025855,0.00052641815,0.0007574504,0.002723934,0.0014298287,0.000092215065,0.7652038,0.00019386958,0.00018498715,0.025513021],"study_design_scores_gemma":[0.0068641016,0.00024843364,0.871331,0.00016311338,0.000093947536,0.00043396582,0.00013202109,0.00013903873,0.12004974,0.000093952236,0.00022261465,0.00022807054],"about_ca_topic_score_codex":0.004527542,"about_ca_topic_score_gemma":0.00024067343,"teacher_disagreement_score":0.6710725,"about_ca_system_score_codex":0.00005444346,"about_ca_system_score_gemma":0.00011176256,"threshold_uncertainty_score":0.8465791},"labels":[],"label_agreement":null},{"id":"W2573199929","doi":"10.1111/jep.12663","title":"Addition of Ezetimibe to statins for patients at high cardiovascular risk: Systematic review of patient‐important outcomes","year":2017,"lang":"en","type":"review","venue":"Journal of Evaluation in Clinical Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Ezetimibe; Medicine; Internal medicine; Statin; Randomized controlled trial; Stroke (engine); MEDLINE; Intensive care medicine","score_opus":0.15461296160620983,"score_gpt":0.5168104393104377,"score_spread":0.36219747770422783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573199929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031408793,0.98566914,0.00016373926,0.00018746378,0.0010400008,0.012259558,0.00028454,0.000003074121,0.000078430014],"genre_scores_gemma":[0.0001946559,0.9930999,0.0055248807,0.00028632145,0.00024964643,0.00040552762,0.00017323747,0.000050579798,0.000015237177],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.978532,0.006060606,0.010847744,0.00038712999,0.0039471984,0.00022528632],"domain_scores_gemma":[0.9600025,0.007421894,0.024039563,0.0016542624,0.0066123665,0.00026945423],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06150991,0.00035817534,0.009300243,0.00034116584,0.000074235824,0.000015083644,0.0002750282,0.00036715073,0.00007517824],"category_scores_gemma":[0.31045648,0.00023627772,0.005873544,0.00026545292,0.000055732304,0.0002992195,0.00009133317,0.0008144725,0.000009814194],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019173742,0.0007761771,0.00023211891,0.68392086,0.0052574505,0.000015347763,0.000034829507,0.000009080917,4.1452526e-9,0.000006307365,0.0008651033,0.30869097],"study_design_scores_gemma":[0.003069503,0.0026695374,0.0011646819,0.63554895,0.07664187,0.00009992215,0.000035355657,0.000008923507,2.3730286e-7,0.000032159143,0.2805325,0.00019635972],"about_ca_topic_score_codex":0.00006454071,"about_ca_topic_score_gemma":0.0000055752553,"teacher_disagreement_score":0.3084946,"about_ca_system_score_codex":0.00061191455,"about_ca_system_score_gemma":0.0017628287,"threshold_uncertainty_score":0.966373},"labels":[],"label_agreement":null},{"id":"W2575071999","doi":"10.1097/med.0000000000000317","title":"Plaque burden, microstructures and compositions underachieving very low LDL-C levels","year":2017,"lang":"en","type":"review","venue":"Current Opinion in Endocrinology Diabetes and Obesity","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Cleveland Clinic; AstraZeneca","keywords":"Medicine; Atherosclerotic cardiovascular disease; Internal medicine; Intravascular ultrasound; Statin; Ldl cholesterol; Cardiology; Cholesterol; Disease","score_opus":0.10226002981728709,"score_gpt":0.3934268058899447,"score_spread":0.2911667760726576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2575071999","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013664839,0.9826721,0.0000125949355,0.0001387252,0.002171063,0.0011037213,0.00016467847,0.000039858303,0.00003243656],"genre_scores_gemma":[0.004985308,0.9936315,0.000076465876,0.000024033909,0.0008312086,0.00009203695,0.00031143983,0.000034295834,0.000013755067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772835,0.00025841707,0.00054969755,0.0006812188,0.00017202261,0.00061028294],"domain_scores_gemma":[0.99866855,0.0001303518,0.0002799913,0.0006641677,0.000050639195,0.00020630166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022127127,0.00047052267,0.0021652135,0.00029158502,0.00039614754,0.00007855153,0.00016806745,0.00031934824,0.000014362934],"category_scores_gemma":[0.00007129056,0.0003907998,0.00037069368,0.00008199143,0.00041630445,0.000090783455,0.0003151904,0.0010515563,0.0000068879654],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000048810407,0.00008218745,0.009259427,0.050804973,0.0002451444,0.0000120542445,0.00004112329,3.1308505e-7,0.0000016810335,0.00049824145,0.00026218515,0.9387878],"study_design_scores_gemma":[0.0011314579,0.000116378214,0.050935235,0.03035245,0.00048493771,0.0003582738,0.000015274996,0.0000088963625,0.000004273772,0.00022238021,0.91592944,0.00044099247],"about_ca_topic_score_codex":0.000060970047,"about_ca_topic_score_gemma":0.000007725954,"teacher_disagreement_score":0.9383468,"about_ca_system_score_codex":0.00010868236,"about_ca_system_score_gemma":0.00022770657,"threshold_uncertainty_score":0.9998544},"labels":[],"label_agreement":null},{"id":"W2578080489","doi":"10.1016/j.cjca.2017.01.008","title":"Barriers to the Implementation of Lipoprotein Apheresis in Canada","year":2017,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Plasmapheresis; Apheresis; Taxpayer; Familial hypercholesterolemia; Intensive care medicine; Family medicine; Pediatrics; Internal medicine; Immunology; Law; Cholesterol","score_opus":0.04149417988823402,"score_gpt":0.33623311598829564,"score_spread":0.29473893610006163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578080489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003801804,0.9959913,0.000031704625,0.0007419226,0.00078209955,0.0010689251,0.00012925922,6.5235946e-7,0.0008739803],"genre_scores_gemma":[0.025395494,0.97271156,0.00004159257,0.0002176794,0.0015067894,0.00004347868,0.000012154267,0.000034734687,0.000036509937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770665,0.0004674228,0.0009440655,0.00016586045,0.0002991995,0.0004168153],"domain_scores_gemma":[0.99717903,0.000047208905,0.00066211703,0.0007100746,0.00022277715,0.0011787757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015195285,0.00021088899,0.0026364222,0.00039188316,0.00010096355,0.000011740815,0.00044089078,0.00017255897,0.00007620271],"category_scores_gemma":[0.00047573377,0.00013696573,0.00082060276,0.00018936429,0.00006301848,0.000027560494,0.00001937831,0.0005510803,0.0000025413174],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000064818237,1.4469278e-7,0.0008856391,0.0013620508,0.00063470454,0.00041231958,0.000047054138,0.000019958858,5.6172166e-8,0.000012014784,0.0073040137,0.98931557],"study_design_scores_gemma":[0.00034040544,0.00012154577,0.0028682456,0.002350273,0.0007255897,0.0010216902,0.00043871487,6.169414e-8,0.0000011442518,0.0000046976534,0.9920218,0.0001058438],"about_ca_topic_score_codex":0.97914463,"about_ca_topic_score_gemma":0.9963491,"teacher_disagreement_score":0.9892097,"about_ca_system_score_codex":0.0017791977,"about_ca_system_score_gemma":0.09349179,"threshold_uncertainty_score":0.91164726},"labels":[],"label_agreement":null},{"id":"W2578698803","doi":"10.1016/j.atherosclerosis.2013.11.031","title":"An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia","year":2013,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Dyslipidemia; Atherosclerotic cardiovascular disease; Medicine; Position paper; Position (finance); Intensive care medicine; Disease; Internal medicine; Pathology; Business; Finance","score_opus":0.08038545538779479,"score_gpt":0.3748541085018321,"score_spread":0.2944686531140373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2578698803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011541875,0.98223174,0.006066068,0.001848327,0.0011364099,0.006812395,0.001116311,0.00012681227,0.00054651103],"genre_scores_gemma":[0.00013784593,0.9789224,0.015885113,0.00068502256,0.00064697105,0.0025753013,0.00083777227,0.00009640381,0.0002131284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727017,0.00015094143,0.0009661608,0.00063021545,0.0005835946,0.00039889148],"domain_scores_gemma":[0.9974943,0.00011553224,0.0005699659,0.0014023343,0.00024552722,0.00017238467],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009607777,0.00047540516,0.0013862641,0.000040526174,0.0002809083,0.0000832792,0.00058577285,0.00040631968,0.00039600843],"category_scores_gemma":[0.000012954522,0.0003134716,0.0025457488,0.00035741867,0.00010696693,0.00023606178,0.00011726335,0.00028626752,0.000043608874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008473859,0.0002344658,0.00004660287,0.0060768044,0.0037213461,9.822904e-8,0.000057304882,0.0000012528711,0.000012475771,0.0013526476,0.004254526,0.984234],"study_design_scores_gemma":[0.0009783157,0.00022426968,0.0017451139,0.009628357,0.005461565,0.000008100769,0.00019410157,0.00006987347,0.000005830846,0.00006398278,0.9813168,0.00030371337],"about_ca_topic_score_codex":0.00016134222,"about_ca_topic_score_gemma":0.000005395231,"teacher_disagreement_score":0.9839303,"about_ca_system_score_codex":0.0005853203,"about_ca_system_score_gemma":0.00014870374,"threshold_uncertainty_score":0.99993175},"labels":[],"label_agreement":null},{"id":"W2580648861","doi":"10.1161/atvb.33.suppl_1.a441","title":"Abstract 441: Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) is Elevated in Acute Coronary Syndromes and Resides Predominantly in LDL","year":2013,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Lipoprotein-associated phospholipase A2; Internal medicine; Medicine; Coronary artery disease; Acute coronary syndrome; Lipoprotein; Inflammation; Endocrinology; Gastroenterology; Phospholipase A2; Myocardial infarction; Cholesterol; Cardiology; Chemistry; Biochemistry","score_opus":0.025030932787684222,"score_gpt":0.27398525030302995,"score_spread":0.24895431751534572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580648861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953975,0.0014088826,0.000007785815,0.0012478718,0.00009513748,0.0016791871,0.00004263228,0.000058695052,0.000062299434],"genre_scores_gemma":[0.9823583,0.015906438,0.00025635114,0.00093096413,0.000039103426,0.00035869572,0.00008482429,0.000051947238,0.000013378022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711496,0.00023841961,0.000744583,0.000864139,0.00025790365,0.0007800057],"domain_scores_gemma":[0.99872583,0.00007452006,0.0001698638,0.00063963304,0.00010269637,0.000287484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008885053,0.00043429455,0.001294742,0.0002758306,0.00014429055,0.00006587029,0.00013396377,0.0005178802,0.00026302485],"category_scores_gemma":[0.00008520157,0.00036442518,0.0002622057,0.000388316,0.00028155866,0.00024084696,0.00014777984,0.00042100105,0.00003717335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053719694,0.0007165423,0.82704127,0.00027816652,0.0015998048,0.0000127860785,0.001109906,8.311852e-7,0.15846708,0.00006852235,0.00033594898,0.010315398],"study_design_scores_gemma":[0.0047987574,0.00072018744,0.9911702,0.00055209483,0.00022203624,0.000016463506,0.00022052035,0.00010960708,0.0014036313,0.00016512413,0.00023966968,0.00038166824],"about_ca_topic_score_codex":0.010569318,"about_ca_topic_score_gemma":0.0008553283,"teacher_disagreement_score":0.16412894,"about_ca_system_score_codex":0.00012484509,"about_ca_system_score_gemma":0.000094370036,"threshold_uncertainty_score":0.9998808},"labels":[],"label_agreement":null},{"id":"W2582534581","doi":"10.1161/atvbaha.116.307122","title":"CETP","year":2017,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Cholesterylester transfer protein; Medicine; Internal medicine; Genotype; Placebo; Gastroenterology; C-reactive protein; Endocrinology; Cholesterol; Inflammation; Lipoprotein; Pathology; Biology; Gene; Genetics","score_opus":0.05597991426558635,"score_gpt":0.32744327394769074,"score_spread":0.2714633596821044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2582534581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945245,0.00019663911,0.000323415,0.002338999,0.00023112675,0.00033591018,0.0000076825445,0.000052458414,0.0019892964],"genre_scores_gemma":[0.99249715,0.005430148,0.00077371317,0.00090689043,0.00029823135,0.00004117797,0.000014952848,0.000023198485,0.0000145650465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882925,0.00006497465,0.00021017749,0.00042093583,0.00013384942,0.00034079075],"domain_scores_gemma":[0.9983329,0.000011128915,0.00009966761,0.0012886781,0.000059935042,0.00020765641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004360011,0.0001797496,0.0005508173,0.000049246388,0.0006353443,0.00009078946,0.00014996155,0.0001742923,0.00010133928],"category_scores_gemma":[0.000061871666,0.00013906798,0.0003297042,0.00003041813,0.00029386734,0.00009928139,0.00015470371,0.00013730068,0.000047464848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005831106,0.0001806401,0.88345385,0.00013453783,0.0009888014,3.7968147e-7,0.00018032141,8.5650626e-8,0.09042127,0.003519676,0.0004195508,0.020695047],"study_design_scores_gemma":[0.001355932,0.0003058428,0.97194415,0.00006553667,0.00017680913,0.0000027381673,0.000033655073,0.000020717142,0.00024999204,0.000108749875,0.025580779,0.00015510905],"about_ca_topic_score_codex":0.00035363596,"about_ca_topic_score_gemma":0.000034520195,"teacher_disagreement_score":0.09017128,"about_ca_system_score_codex":0.000020961095,"about_ca_system_score_gemma":0.000036647776,"threshold_uncertainty_score":0.5671028},"labels":[],"label_agreement":null},{"id":"W2583632013","doi":"10.1016/j.jacl.2017.01.012","title":"The 9p21.3 locus and cardiovascular risk in familial hypercholesterolemia","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University; Université de Montréal; Population Health Research Institute; Hamilton Health Sciences; McGill University; Hamilton General Hospital; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; SNP; Familial hypercholesterolemia; Odds ratio; Dyslipidemia; Single-nucleotide polymorphism; Internal medicine; Allele; Confidence interval; Population; Locus (genetics); Genetics; Disease; Genotype; Cholesterol; Biology; Gene","score_opus":0.06037540104790643,"score_gpt":0.3881230423041327,"score_spread":0.32774764125622624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583632013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834814,0.008515049,0.00016767494,0.0033209876,0.0034047822,0.0002084908,0.0000017621918,0.0000043252558,0.00089549494],"genre_scores_gemma":[0.96905816,0.021983743,0.00040493484,0.00045410206,0.008003823,0.0000029752591,2.3220328e-7,0.000014882143,0.000077173565],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99686575,0.0009044038,0.0012834362,0.00021600565,0.00044450694,0.00028590165],"domain_scores_gemma":[0.99712026,0.00066446076,0.0006646611,0.0010796404,0.00019549421,0.00027548667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013383014,0.00012395257,0.0012390997,0.00005920164,0.00027341474,0.000047079175,0.00030063558,0.00029284786,0.00000544061],"category_scores_gemma":[0.0076250015,0.00007030581,0.0010762359,0.000034430443,0.0005197494,0.00009717908,0.00012673424,0.0014220037,0.000007973465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009080955,0.00008409959,0.40322462,0.000026260295,0.0007834248,0.00013858879,0.000039197374,0.000010101943,0.000011579169,0.000065646964,0.0005218232,0.59418654],"study_design_scores_gemma":[0.0060194726,0.0009256932,0.8198652,0.000074515665,0.00037239902,0.0008674891,0.000072922405,0.000020610434,0.000008276753,0.00047732654,0.17123047,0.00006561098],"about_ca_topic_score_codex":0.00020673193,"about_ca_topic_score_gemma":0.0001140235,"teacher_disagreement_score":0.5941209,"about_ca_system_score_codex":0.00002392699,"about_ca_system_score_gemma":0.00027772287,"threshold_uncertainty_score":0.91283894},"labels":[],"label_agreement":null},{"id":"W2585485826","doi":"10.1016/j.cjca.2015.07.730","title":"LIPOPROTEIN(A) INTERACTIONS WITH LOW-DENSITY LIPOPROTEIN CHOLESTEROL AND OTHER CARDIOVASCULAR RISK FACTORS: A CASE-ONLY STUDY OF PREMATURE ACS","year":2015,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lipoprotein(a); Dyslipidemia; Internal medicine; Epidemiology; Population; Lipoprotein; Logistic regression; Risk factor; Prospective cohort study; Cohort study; Percentile; Cholesterol; Endocrinology; Disease; Environmental health","score_opus":0.021831522101412246,"score_gpt":0.2505932521439647,"score_spread":0.22876173004255246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585485826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944186,0.0024718733,0.0008556516,0.000093686795,0.0003218413,0.0012785749,0.000044468354,0.000012060378,0.0005031991],"genre_scores_gemma":[0.998476,0.000033194505,0.0002194217,0.000064760105,0.001104114,0.000017282115,0.0000026693485,0.000050991755,0.000031554486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973703,0.00072342576,0.0006028358,0.0003395952,0.0005300482,0.0004337847],"domain_scores_gemma":[0.99647796,0.000043250326,0.00041161187,0.00086998974,0.000869804,0.0013273734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001642277,0.00030662707,0.0016322256,0.0004406005,0.00015091278,0.00003466942,0.00014812748,0.00023399081,0.000005461333],"category_scores_gemma":[0.0003587064,0.00022026131,0.0005382137,0.00027383867,0.00021730832,0.00015518256,0.000030639996,0.00094806025,0.000002025196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016633071,0.00018918424,0.8353047,0.0006127599,0.02887319,0.023813663,0.014818701,0.0052508577,0.00015666253,0.000030176276,0.0011969068,0.0880899],"study_design_scores_gemma":[0.021201422,0.014562179,0.5427038,0.0010659497,0.008791517,0.29998925,0.035459142,0.00002121504,0.0011797238,0.00010536883,0.073940426,0.0009800168],"about_ca_topic_score_codex":0.11277409,"about_ca_topic_score_gemma":0.0683491,"teacher_disagreement_score":0.2926009,"about_ca_system_score_codex":0.00025610585,"about_ca_system_score_gemma":0.0018273414,"threshold_uncertainty_score":0.9486511},"labels":[],"label_agreement":null},{"id":"W2585937149","doi":"10.1016/j.ihj.2017.01.015","title":"Comparison of different cardiovascular risk score calculators for cardiovascular risk prediction and guideline recommended statin uses","year":2017,"lang":"en","type":"article","venue":"Indian Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Framingham Risk Score; Guideline; Risk assessment; Internal medicine; Statin; Myocardial infarction; Nice; Disease; Cardiology; Physical therapy","score_opus":0.056867713661315815,"score_gpt":0.3455865629594455,"score_spread":0.2887188492981297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585937149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680107,0.016815979,0.0123063475,0.00037756047,0.00074972416,0.0013911563,0.00028775944,0.00003417781,0.00002655037],"genre_scores_gemma":[0.98797834,0.0041037174,0.006201267,0.00005828454,0.0014954911,0.000046692425,0.000039442413,0.000063287254,0.0000134812235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962115,0.0004843812,0.0011625855,0.00046478488,0.0011457556,0.00053093577],"domain_scores_gemma":[0.9965212,0.000085000225,0.000680907,0.0015911949,0.00051320245,0.0006085413],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0042778673,0.00033288982,0.0017948626,0.00023660605,0.0013328803,0.000146703,0.00018765069,0.00024311474,0.000026450713],"category_scores_gemma":[0.0010531009,0.00026317284,0.0030732013,0.000075968914,0.00015008014,0.00020696329,0.000085952066,0.0008604187,0.0000024879669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002068468,0.00016748972,0.8687599,0.00034327648,0.008913088,0.000044188913,0.0006204836,0.00042741763,0.0000460837,0.000008136271,0.0026767752,0.11778636],"study_design_scores_gemma":[0.009082472,0.0013691183,0.9036313,0.0005955677,0.005754855,0.0012462282,0.0007405167,0.0010265,0.0025038735,0.0003259788,0.07334034,0.00038323627],"about_ca_topic_score_codex":0.0013520925,"about_ca_topic_score_gemma":0.00007298154,"teacher_disagreement_score":0.11740313,"about_ca_system_score_codex":0.0001716789,"about_ca_system_score_gemma":0.00024853373,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W2586590344","doi":"10.1111/jth.13759","title":"Characterization of the I4399M variant of apolipoprotein(a): implications for altered prothrombotic properties of lipoprotein(a)","year":2017,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Robarts Clinical Trials; University of Windsor; Western University","funders":"British Heart Foundation; Ionis Pharmaceuticals; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; AstraZeneca; Heart and Stroke Foundation of Canada; Merck; Natural Sciences and Engineering Research Council of Canada; Amgen","keywords":"Fibrinolysis; Lipoprotein(a); Apolipoprotein B; Fibrin; Coagulation; Population; Lipoprotein; Tissue factor; Thrombus; Medicine; Internal medicine; Chemistry; Endocrinology; Immunology; Cholesterol","score_opus":0.09402238790473064,"score_gpt":0.3256648509730882,"score_spread":0.2316424630683576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586590344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894902,0.00055773306,0.0012963597,0.006244934,0.00016720836,0.002094942,0.0000889764,0.0000034049538,0.000056225916],"genre_scores_gemma":[0.9968439,0.0008910512,0.0018740386,0.000057902114,0.00023183895,0.000055657383,0.0000029680184,0.00002341929,0.000019270876],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982823,0.000070746464,0.0009301502,0.00015120955,0.00039261568,0.00017294432],"domain_scores_gemma":[0.9959969,0.000017808745,0.0021322244,0.0008757898,0.00087957334,0.00009773387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008830294,0.00014985225,0.00093727466,0.00010384147,0.0002552557,0.000027898115,0.00029666827,0.000103945604,0.000010534505],"category_scores_gemma":[0.00033414247,0.00008978633,0.00050804735,0.000099278295,0.0003106711,0.00020581314,0.00009410847,0.00014115607,1.2269844e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000374963,0.0004591336,0.0061070807,0.0027183504,0.0010952473,3.4881927e-7,0.00067073014,0.000002389123,0.9389896,0.0010682845,0.00005350822,0.048460357],"study_design_scores_gemma":[0.0018622624,0.00067197584,0.4880832,0.0014192769,0.0007261391,0.000059112874,0.00009688824,0.000025130737,0.5063062,0.00033891766,0.00032751512,0.00008339543],"about_ca_topic_score_codex":0.00033393496,"about_ca_topic_score_gemma":0.000016855687,"teacher_disagreement_score":0.48197615,"about_ca_system_score_codex":0.000035763733,"about_ca_system_score_gemma":0.00029527443,"threshold_uncertainty_score":0.36613804},"labels":[],"label_agreement":null},{"id":"W2586996257","doi":"10.1016/j.cjca.2017.02.001","title":"Aortic Calcification Progression in Heterozygote Familial Hypercholesterolemia","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Internal medicine; Calcification; Ezetimibe; Agatston score; Gastroenterology; Familial hypercholesterolemia; Cardiology; Cholesterol; Endocrinology","score_opus":0.029845937572662483,"score_gpt":0.31524206317661846,"score_spread":0.285396125603956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586996257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928431,0.00078545546,0.0006279006,0.0019065755,0.0006794917,0.00021756234,0.0000036147435,0.0000028965646,0.0029334049],"genre_scores_gemma":[0.99812955,0.000109118875,0.00022034888,0.00015957125,0.0013286668,0.0000034528734,0.0000031001232,0.00001278733,0.00003342567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989153,0.00012444428,0.00035793503,0.00013230462,0.00016535699,0.0003046376],"domain_scores_gemma":[0.9985542,0.000009811224,0.00020209249,0.00054036116,0.00016251765,0.00053096184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008347576,0.00009301886,0.00049999665,0.0002227173,0.00015086004,0.000030501033,0.00018947633,0.00016325404,0.0000046015934],"category_scores_gemma":[0.00029329056,0.00007518117,0.00023234432,0.00003925283,0.00015226108,0.00010408013,0.000011440191,0.0003760607,0.000008499294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014712536,0.000004556819,0.6803093,0.00006213852,0.00014561364,0.0011964303,0.0001830834,0.00012521351,0.0013594027,0.000046774898,0.0007805233,0.31563985],"study_design_scores_gemma":[0.0014454132,0.00027103376,0.94939476,0.0001703622,0.000061846666,0.0013988127,0.000047840305,0.00001672055,0.00021247545,0.0000765483,0.046832796,0.000071406386],"about_ca_topic_score_codex":0.002363566,"about_ca_topic_score_gemma":0.0017632586,"teacher_disagreement_score":0.31556845,"about_ca_system_score_codex":0.00024449467,"about_ca_system_score_gemma":0.0011849484,"threshold_uncertainty_score":0.35730207},"labels":[],"label_agreement":null},{"id":"W2587012494","doi":"10.1093/aje/163.suppl_11.s3-a","title":"Non-High-Density-Lipoprotein (NHDL) and its Risk Predictive Value in Coronary Heart Disease (CHD)","year":2006,"lang":"en","type":"article","venue":"American Journal of Epidemiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Medicine; Predictive value; Internal medicine; Coronary heart disease; Cardiology; Value (mathematics); Mathematics; Statistics","score_opus":0.011726697227125799,"score_gpt":0.27985451843125,"score_spread":0.26812782120412415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587012494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985363,0.0065815826,0.0023236035,0.004987849,0.00016032095,0.00047369502,0.00001752137,0.0000127355715,0.00007970434],"genre_scores_gemma":[0.99197614,0.0013144179,0.0034952383,0.0022669411,0.0008641369,0.000015238184,0.000008639819,0.000026968182,0.00003227268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99643123,0.0014357399,0.001017158,0.00034625523,0.00026949673,0.0005001],"domain_scores_gemma":[0.99755734,0.0006321205,0.00076427264,0.00033692186,0.0001881056,0.0005212518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043544825,0.00021996586,0.0015876245,0.000247429,0.00007713588,0.0000035021035,0.00009816164,0.000092074915,0.000018405155],"category_scores_gemma":[0.0018584211,0.0001700555,0.00030811178,0.00026610077,0.00038948146,0.00009739227,0.000056202996,0.0007660845,0.000007980709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033096592,0.00030591036,0.95576483,0.00008851271,0.0003051698,0.00092011417,0.00008931388,0.0018658928,0.00024300392,0.00073622534,0.0012044451,0.03516694],"study_design_scores_gemma":[0.0019581784,0.002714211,0.9870501,0.00019215887,0.0002497741,0.0013045097,0.00012072729,0.00091086695,0.00005726155,0.0044976934,0.00080270146,0.00014180916],"about_ca_topic_score_codex":0.013258046,"about_ca_topic_score_gemma":0.000080508944,"teacher_disagreement_score":0.03502513,"about_ca_system_score_codex":0.00015877902,"about_ca_system_score_gemma":0.0003298831,"threshold_uncertainty_score":0.9933128},"labels":[],"label_agreement":null},{"id":"W2587092521","doi":"10.3945/jn.116.235069","title":"Nutritional and Lipid Modulation of PCSK9: Effects on Cardiometabolic Risk Factors","year":2017,"lang":"en","type":"review","venue":"Journal of Nutrition","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Alberta","funders":"","keywords":"PCSK9; Endocrinology; Internal medicine; Kexin; LDL receptor; Sterol regulatory element-binding protein; Apolipoprotein B; Cholesterol; Biology; Lipoprotein; Lipid metabolism; Lipogenesis; Chemistry; Sterol; Medicine","score_opus":0.05263529060941791,"score_gpt":0.345119574881125,"score_spread":0.2924842842717071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587092521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01221568,0.9858846,0.000096196396,0.00003937581,0.00053414825,0.0010644686,0.00008724809,0.000006501543,0.00007179756],"genre_scores_gemma":[0.008841646,0.9869121,0.00035029982,0.000008259172,0.0036972063,0.000022597973,0.00012196932,0.000034531433,0.000011389802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976579,0.0003396672,0.00084790454,0.00019050033,0.0008060832,0.00015792692],"domain_scores_gemma":[0.99707717,0.00018437445,0.001811107,0.00038728327,0.0003477276,0.0001923506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094033976,0.00027397813,0.0028157004,0.0007454247,0.00011048163,0.000028788307,0.000097256234,0.00034319784,0.0000061904702],"category_scores_gemma":[0.00038655306,0.00019533727,0.001672113,0.00015731453,0.000050695762,0.00013915381,0.000019344858,0.0006405181,0.000002733194],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007593914,0.00034427777,0.00008977966,0.04151715,0.0009578345,0.000033098644,0.000012844471,7.684365e-7,0.0000105456975,0.000023177334,0.00016895177,0.95676565],"study_design_scores_gemma":[0.0030984506,0.0011814411,0.008538049,0.053943668,0.0045550847,0.00084091636,0.000008745515,0.000003949828,0.000045787558,0.0001493668,0.9274602,0.00017435863],"about_ca_topic_score_codex":0.00002156547,"about_ca_topic_score_gemma":3.8870417e-7,"teacher_disagreement_score":0.95659125,"about_ca_system_score_codex":0.00014965319,"about_ca_system_score_gemma":0.00021787423,"threshold_uncertainty_score":0.79656225},"labels":[],"label_agreement":null},{"id":"W2588053926","doi":"10.1016/j.pharmthera.2017.02.029","title":"Myotoxicity of statins: Mechanism of action","year":2017,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Pharmacology; Statin; Chemistry; Internal medicine; Myocyte; Endocrinology; Atorvastatin; Medicine","score_opus":0.3143587471228095,"score_gpt":0.4997394761489723,"score_spread":0.18538072902616282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588053926","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021365377,0.9963268,0.00032332478,0.000066088105,0.00084125996,0.0017196875,0.00007787464,0.000026536702,0.00040479557],"genre_scores_gemma":[0.0007775462,0.9977823,0.00027095128,0.0003944568,0.00040253383,0.00009960627,0.000040263072,0.000056921803,0.00017544918],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804723,0.0003523612,0.0007169478,0.0002785926,0.00034464512,0.0002601991],"domain_scores_gemma":[0.9978552,0.00008252469,0.0011015991,0.00066568726,0.00020081447,0.00009421692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007503545,0.000299497,0.0025458883,0.0001715551,0.00007333732,0.0000037424468,0.0002493035,0.00042616713,0.00015490987],"category_scores_gemma":[0.000007732273,0.000232727,0.0009693609,0.00010620225,0.0001637519,0.000036387213,0.000065952765,0.0005639882,0.00001203728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054660868,0.00022075982,0.0000013910151,0.026730232,0.0044185813,0.000013107429,0.0000548544,1.16258306e-7,0.0007066523,0.00011811586,0.00006351093,0.967618],"study_design_scores_gemma":[0.0011911796,0.00037327321,0.0000051840093,0.0020342176,0.016795937,0.00008395206,0.0000136209,0.000009367448,0.0056378082,0.00008879741,0.97361296,0.00015371596],"about_ca_topic_score_codex":0.000043851527,"about_ca_topic_score_gemma":0.000002501331,"teacher_disagreement_score":0.9735494,"about_ca_system_score_codex":0.00011372885,"about_ca_system_score_gemma":0.00085380767,"threshold_uncertainty_score":0.94903314},"labels":[],"label_agreement":null},{"id":"W2588365713","doi":"10.1097/mol.0000000000000386","title":"Complexity of mechanisms among human proprotein convertase subtilisin–kexin type 9 variants","year":2017,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"PCSK9; Kexin; Proprotein convertase; Mendelian randomization; Subtilisin; Biology; Cholesterol; Loss function; Disease; LDL receptor; Internal medicine; Bioinformatics; Genetics; Endocrinology; Medicine; Lipoprotein; Gene; Phenotype; Biochemistry; Genetic variants; Genotype","score_opus":0.38454868061535946,"score_gpt":0.46999518250216443,"score_spread":0.08544650188680497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588365713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038984515,0.9618766,0.00020894021,0.00003862232,0.033445593,0.0040116957,0.000101209,0.0000466422,0.0002317626],"genre_scores_gemma":[0.00014793794,0.9910398,0.00030198065,0.000009016601,0.0068416535,0.00028496835,0.0012110423,0.000080015394,0.00008355056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99570745,0.0008895503,0.0014600424,0.00084630534,0.00051222555,0.0005844347],"domain_scores_gemma":[0.99634016,0.000059197948,0.0011687157,0.0019376116,0.00023957119,0.00025475354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017354238,0.00057783717,0.0042361696,0.00049598614,0.000146455,0.00002042413,0.00052840624,0.0007605343,0.0002702141],"category_scores_gemma":[0.00042727232,0.00047071584,0.0008715445,0.0002450371,0.0006579437,0.00008420095,0.00027752432,0.0012104948,0.00007399546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008457303,0.00066070835,0.00022170914,0.1370471,0.00041881934,0.0000033718682,0.000084002604,1.7878413e-7,0.00000438897,0.015051673,0.0037335649,0.84268993],"study_design_scores_gemma":[0.0015453566,0.00057266984,0.0013384504,0.0352423,0.00041348298,0.00012029696,0.000009750208,0.000008488785,0.0000030555263,0.0012445844,0.9590993,0.0004022614],"about_ca_topic_score_codex":0.00055323023,"about_ca_topic_score_gemma":0.00003941258,"teacher_disagreement_score":0.9553657,"about_ca_system_score_codex":0.00020084856,"about_ca_system_score_gemma":0.0010203471,"threshold_uncertainty_score":0.99977446},"labels":[],"label_agreement":null},{"id":"W2588486746","doi":"10.1093/aje/163.suppl_11.s6-c","title":"10 Year Cad Risk Reduction After Treatment with Ezetimibe 10 Mg/Day Co-Administered with Statins in Patients with Primary Hypercholesterolemia Who Have Not Responded to Statin Monotherapy. S Bissonnette, R Habib, S Boukas","year":2006,"lang":"en","type":"article","venue":"American Journal of Epidemiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ezetimibe; Medicine; Statin; Internal medicine; Gastroenterology","score_opus":0.01286867750345303,"score_gpt":0.28310809822782523,"score_spread":0.2702394207243722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588486746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546385,0.00019837588,0.0012271566,0.0018355966,0.000026107955,0.0008650446,0.00009636764,0.000014977932,0.0002725457],"genre_scores_gemma":[0.963313,0.0001657642,0.032371167,0.001992796,0.00030510628,0.00006620805,0.000073797746,0.000095799616,0.0016163682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955736,0.0017723201,0.001050148,0.0005112164,0.00046560657,0.0006271189],"domain_scores_gemma":[0.997203,0.00035025988,0.001144041,0.0005854904,0.00033169246,0.00038552907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017770316,0.00038818296,0.0017254079,0.00043437557,0.00006816726,0.000013412178,0.0001063634,0.00009712851,0.00012051943],"category_scores_gemma":[0.00015714094,0.000231068,0.00016865933,0.00036025568,0.0003980322,0.000121441415,0.00001398756,0.00045087482,0.00001437102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.095337324,0.00071691227,0.8180064,0.000039869694,0.0008139407,0.00024406213,0.0010190278,0.0009813751,0.000099095356,0.0000049108057,0.0010220784,0.081715025],"study_design_scores_gemma":[0.010914685,0.053674784,0.9161206,0.0002985236,0.00030515474,0.00027472829,0.0003811577,0.000019256408,0.00014245154,0.000009637637,0.017587986,0.0002710688],"about_ca_topic_score_codex":0.0024033657,"about_ca_topic_score_gemma":0.00037464383,"teacher_disagreement_score":0.098114185,"about_ca_system_score_codex":0.00049270905,"about_ca_system_score_gemma":0.0005238188,"threshold_uncertainty_score":0.94226795},"labels":[],"label_agreement":null},{"id":"W2588614813","doi":"10.1016/s2213-8587(17)30044-x","title":"Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":218,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"Amgen","keywords":"Medicine; Evolocumab; Interim analysis; Ezetimibe; Internal medicine; Adverse effect; PCSK9; LDL apheresis; Familial hypercholesterolemia; Cholesterol; Clinical trial; Lipoprotein","score_opus":0.05832711720972705,"score_gpt":0.34472170470917196,"score_spread":0.2863945874994449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588614813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950431,0.00013754018,0.000006603011,0.0007006558,0.000064517924,0.0038585518,0.000093088434,0.000025966694,0.00006996208],"genre_scores_gemma":[0.9982739,0.000051953557,0.0001608985,0.00049802626,0.000089320005,0.0006789353,0.000067105335,0.000042850508,0.0001369932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972109,0.00050908554,0.00035245495,0.000590511,0.0005277208,0.0008092927],"domain_scores_gemma":[0.99668115,0.000053807555,0.00030834757,0.0026399577,0.00018825877,0.00012847813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004261148,0.00035822796,0.0015497865,0.00015479988,0.00029272313,0.000092865244,0.0010672493,0.000055793007,0.000042115975],"category_scores_gemma":[0.000021859394,0.00014264084,0.00009903229,0.00036479588,0.00039214478,0.00016478832,0.0002628511,0.00029324918,0.0000017853666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0093296645,0.0029129093,0.96368146,0.000027055596,0.004792547,0.00006139293,0.0008782236,0.00001205655,0.000050924442,0.000010236503,0.000011115566,0.018232416],"study_design_scores_gemma":[0.03468366,0.012936521,0.94961,0.00012309662,0.001674844,0.000016329112,0.00036368327,0.000019797573,0.0003100595,0.0000028139075,0.00006799546,0.00019118375],"about_ca_topic_score_codex":0.0019550214,"about_ca_topic_score_gemma":0.021181872,"teacher_disagreement_score":0.025353996,"about_ca_system_score_codex":0.00015328829,"about_ca_system_score_gemma":0.00022986264,"threshold_uncertainty_score":0.996679},"labels":[],"label_agreement":null},{"id":"W2588974371","doi":"10.1111/dom.12909","title":"Lipid‐lowering efficacy and safety of alirocumab in patients with or without diabetes: <scp>A</scp> sub‐analysis of <scp>ODYSSEY COMBO II</scp>","year":2017,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Ezetimibe; PCSK9; Medicine; Statin; Internal medicine; Adverse effect; Diabetes mellitus; Gastroenterology; Urology; Pharmacology; Endocrinology; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.008596369459351293,"score_gpt":0.23169539415642734,"score_spread":0.22309902469707604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588974371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956185,0.0028899387,0.000022220289,0.000023142218,0.00011712982,0.00094960956,0.000091559385,0.000027986673,0.000259896],"genre_scores_gemma":[0.9982558,0.0010269226,0.00027137966,0.00010954231,0.00010590899,0.000027898192,0.000062353465,0.000039707757,0.000100475394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735194,0.00013099486,0.0006396552,0.0005747459,0.00068374287,0.00061894604],"domain_scores_gemma":[0.9974131,0.00028328152,0.00053838803,0.0011398873,0.0002754202,0.00034994446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00110876,0.0003787147,0.0022823552,0.00046205294,0.00034972024,0.00005193205,0.00024171968,0.00021642359,0.0000036341667],"category_scores_gemma":[0.0010844793,0.00027928088,0.000286526,0.0004972453,0.00036413627,0.00028479347,0.00027687734,0.00030965626,9.023591e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005296304,0.0006236415,0.98809224,0.0006943669,0.0026220328,0.0000025481406,0.0011063798,0.00001199096,0.0006536381,0.00005032474,0.000017028136,0.0060728267],"study_design_scores_gemma":[0.008122731,0.00038981345,0.97321314,0.0004374701,0.004194916,4.3213905e-7,0.00013171005,0.00015383011,0.0115105705,0.000013864089,0.0017436494,0.00008789388],"about_ca_topic_score_codex":0.00030478457,"about_ca_topic_score_gemma":0.00014823893,"teacher_disagreement_score":0.01487914,"about_ca_system_score_codex":0.000028169192,"about_ca_system_score_gemma":0.000100174155,"threshold_uncertainty_score":0.99996597},"labels":[],"label_agreement":null},{"id":"W2589214591","doi":"10.1016/j.cjca.2017.02.005","title":"Statin Prescriptions for High-Risk Patients Are Increased by Laboratory-Initiated Framingham Risk Scores: A Quality-Improvement Initiative","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Alberta; Red Deer Regional Hospital; Alberta Health Services; Chinook Regional Hospital; Foothills Medical Centre; Calgary Laboratory Services; Alberta Health; University of Calgary","funders":"","keywords":"Medicine; Statin; Medical prescription; Framingham Risk Score; Pharmacist; Physical therapy; Risk assessment; Family medicine; Emergency medicine; Internal medicine; Disease; Pharmacy; Nursing","score_opus":0.027643661293156686,"score_gpt":0.2867126953240417,"score_spread":0.259069034030885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589214591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98443675,0.0008940042,0.005166847,0.00047264725,0.00079607917,0.0009816879,0.006996039,0.000009663881,0.00024628994],"genre_scores_gemma":[0.99734116,0.00027068894,0.0005216361,0.00060769886,0.0009834352,0.00006565025,0.00015472913,0.00003589529,0.000019089592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976005,0.00063914066,0.00069735927,0.00025509836,0.00030404818,0.0005038627],"domain_scores_gemma":[0.99506986,0.00015210004,0.001449072,0.0006672112,0.0016627148,0.0009990134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017480169,0.00021107306,0.0009744964,0.00022186099,0.0007689379,0.00007201733,0.00025215364,0.00022074945,0.000015019331],"category_scores_gemma":[0.005202433,0.00018373638,0.0003802788,0.00007658077,0.0002609325,0.00017524924,0.000020429225,0.0005703637,0.0000044475264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047251253,0.00004356193,0.94021547,0.00016031736,0.002559256,0.00011475314,0.00044461226,0.000041435844,0.00011222111,0.00012515672,0.036841046,0.018869638],"study_design_scores_gemma":[0.009893809,0.0021643434,0.93561846,0.00017732433,0.00079557806,0.00001653614,0.00059569534,0.000008184339,0.00038959074,0.0005306801,0.049576625,0.00023318418],"about_ca_topic_score_codex":0.02960815,"about_ca_topic_score_gemma":0.0076444224,"teacher_disagreement_score":0.021963727,"about_ca_system_score_codex":0.00039363457,"about_ca_system_score_gemma":0.0023349288,"threshold_uncertainty_score":0.9768538},"labels":[],"label_agreement":null},{"id":"W2589881841","doi":"","title":"Decreased PCSK9 expression in human hepatocellular carcinoma","year":2015,"lang":"en","type":"article","venue":"PMC","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; McGill University Health Centre","funders":"","keywords":"PCSK9; Hepatocellular carcinoma; Internalization; Carcinoma; Cancer research; Receptor; Internal medicine; Cholesterol; Medicine; Oncology; Biology; LDL receptor; Lipoprotein","score_opus":0.04049092575480219,"score_gpt":0.2802490280070087,"score_spread":0.2397581022522065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589881841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924404,0.0019738418,0.0001872071,0.00014766211,0.0000712288,0.00037949497,9.544041e-7,0.000040074152,0.0047591515],"genre_scores_gemma":[0.99861115,0.000009164802,0.000586782,0.00015170168,0.00025845107,0.000036427147,0.000019589008,0.000018164237,0.0003085431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990006,0.00007099405,0.00016968531,0.0001928066,0.00035597093,0.00020991892],"domain_scores_gemma":[0.9991609,0.0000059491435,0.000027824839,0.00043751407,0.00005663915,0.0003112159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004925591,0.00009151691,0.00024563546,0.00007708495,0.00003210568,0.000007569228,0.00005586401,0.000075009935,0.000053620377],"category_scores_gemma":[0.00006672869,0.00007449959,0.00009820779,0.00012322317,0.000018974959,0.00003877707,0.000030955336,0.00013579166,0.00004685751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101189245,0.0001857267,0.96196944,0.00012777462,0.000016553338,0.0005119024,0.00057568745,0.0000021142796,0.0308484,0.000083449544,0.0010346674,0.0045431005],"study_design_scores_gemma":[0.01243914,0.00060674705,0.6438204,0.0005068997,0.000101463076,0.00019074373,0.0007763699,0.0005390715,0.2903692,0.0007037745,0.049547832,0.00039831756],"about_ca_topic_score_codex":0.000979166,"about_ca_topic_score_gemma":0.000014422504,"teacher_disagreement_score":0.318149,"about_ca_system_score_codex":0.000102547405,"about_ca_system_score_gemma":0.00015392726,"threshold_uncertainty_score":0.30380052},"labels":[],"label_agreement":null},{"id":"W2592609486","doi":"","title":"Foreword Optimizing the Prevention of Cardiovascular Events","year":2016,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acute coronary syndrome; Guideline; Intensive care medicine; Clinical trial; Disease; Cardiovascular event; Adverse effect; Secondary prevention; Coronary heart disease; Internal medicine; Myocardial infarction; Pathology","score_opus":0.02139472347798511,"score_gpt":0.2657039787393282,"score_spread":0.24430925526134312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592609486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6588233,0.007058376,0.31933528,0.0028123222,0.00027885634,0.0017952544,0.0000058826586,0.00008820662,0.009802521],"genre_scores_gemma":[0.99402833,0.00057220174,0.0025077949,0.000077819386,0.00017177631,0.000032294865,0.0000012645332,0.00001301005,0.0025954845],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899554,0.000073286734,0.00018945355,0.00014221524,0.0004470026,0.00015250577],"domain_scores_gemma":[0.99910873,0.00001882983,0.00004059807,0.00069347245,0.000081740065,0.000056611414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008907418,0.00007175839,0.00027023,0.00003109215,0.000041028514,0.0000014470259,0.00006769234,0.00004666755,0.00011153357],"category_scores_gemma":[0.000050631385,0.000029754532,0.000784502,0.000098231416,0.000030311288,0.00004954961,0.00003323284,0.000048238067,0.000018446635],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100847305,0.000109159264,0.001847615,0.00020217104,0.0029870903,0.00000797801,0.00008562637,0.00003661987,0.0020246578,0.0020251647,0.00056324323,0.99000984],"study_design_scores_gemma":[0.032414615,0.0031498824,0.19702634,0.004470635,0.008151359,0.0009992613,0.0012462958,0.0005626071,0.22960863,0.007625632,0.5135708,0.0011739492],"about_ca_topic_score_codex":0.00010316562,"about_ca_topic_score_gemma":0.0000032727137,"teacher_disagreement_score":0.9888359,"about_ca_system_score_codex":0.000034602795,"about_ca_system_score_gemma":0.00006707839,"threshold_uncertainty_score":0.12212144},"labels":[],"label_agreement":null},{"id":"W2592870701","doi":"10.1161/atvb.33.suppl_1.a5","title":"Abstract 5: A Novel APOE p.Leu166del Mutation in Autosomal Dominant Familial Hypercholesterolemia","year":2013,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre; Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; Apolipoprotein B; Kexin; Exome sequencing; LDL receptor; Familial hypercholesterolemia; Apolipoprotein E; Genetics; Exon; Proband; Internal medicine; Compound heterozygosity; Mutation; Lipoprotein; Biology; Molecular biology; Endocrinology; Medicine; Cholesterol; Gene","score_opus":0.032719978114701,"score_gpt":0.2820007814394529,"score_spread":0.2492808033247519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592870701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970141,0.00013672591,0.00053256296,0.0010008734,0.00016343857,0.0009452884,0.00001221879,0.0000442542,0.00015055703],"genre_scores_gemma":[0.9962425,0.0011664747,0.0010743515,0.0009933494,0.0001827434,0.00024488123,0.000057302757,0.000034615212,0.0000037475083],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998103,0.00006816021,0.00051628094,0.0005885046,0.00020735963,0.00051667227],"domain_scores_gemma":[0.99906576,0.000035104593,0.00009273115,0.0005022777,0.00008712443,0.0002170009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049889163,0.00028365824,0.00073443045,0.00016774972,0.00011468096,0.000050072984,0.00009779923,0.00030883963,0.00010991705],"category_scores_gemma":[0.00004018414,0.00022690797,0.00030294756,0.00017677838,0.000163718,0.0001852111,0.00007736221,0.00027260155,0.00007705525],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010759253,0.00042823475,0.12971765,0.0001585929,0.00028004142,6.186788e-7,0.0005520909,0.000003586872,0.8555666,0.00019132564,0.00006483424,0.0130256675],"study_design_scores_gemma":[0.0041256673,0.00038631452,0.9929798,0.00016494672,0.000094227726,0.000008912062,0.00024428093,0.00034631498,0.0006177,0.000050920506,0.0007410446,0.00023984473],"about_ca_topic_score_codex":0.0026088068,"about_ca_topic_score_gemma":0.00015959049,"teacher_disagreement_score":0.8632622,"about_ca_system_score_codex":0.00008196089,"about_ca_system_score_gemma":0.000072102375,"threshold_uncertainty_score":0.9253039},"labels":[],"label_agreement":null},{"id":"W2593300661","doi":"10.1016/j.cjca.2017.02.013","title":"Management Strategies for Statin-Associated Muscle Symptoms: How Useful Is Same-Statin Rechallenge?","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"Eli Lilly Canada; Novo Nordisk; Merck; Sanofi; Boehringer Ingelheim; AstraZeneca; Amgen","keywords":"Medicine; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Internal medicine; Cardiology; Physical therapy; Intensive care medicine","score_opus":0.038321553254928475,"score_gpt":0.28572445141540337,"score_spread":0.2474028981604749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593300661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89383173,0.0057881265,0.02057609,0.040919155,0.0032848776,0.002264912,0.0004877486,0.00003793417,0.03280946],"genre_scores_gemma":[0.9960059,0.00054735306,0.0010834857,0.0006195653,0.0010398992,0.00002531241,0.00001467467,0.000035247493,0.0006285466],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846464,0.00014542876,0.00035604445,0.00022129704,0.00024698663,0.0005656152],"domain_scores_gemma":[0.99769497,0.000051747193,0.00043718726,0.00064173195,0.0005050244,0.0006693606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012945656,0.00018073755,0.00083194464,0.00022422307,0.0003908198,0.00012803948,0.0002976585,0.00019300792,0.000022431728],"category_scores_gemma":[0.00031148564,0.00015791219,0.00055842055,0.000049338916,0.00016679718,0.00017236597,0.000019288538,0.00030929956,0.0000042693346],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005416646,0.000039830753,0.036412366,0.0013332375,0.016478669,0.006361801,0.0048788665,0.00052478403,0.00018227124,0.008744102,0.21346253,0.7110399],"study_design_scores_gemma":[0.0057496233,0.0015498516,0.28212458,0.00035093314,0.0009124046,0.00045920626,0.006236323,0.000029749957,0.00004751229,0.004005765,0.6982088,0.00032520466],"about_ca_topic_score_codex":0.0012563043,"about_ca_topic_score_gemma":0.004064247,"teacher_disagreement_score":0.71071464,"about_ca_system_score_codex":0.0003519137,"about_ca_system_score_gemma":0.0017062601,"threshold_uncertainty_score":0.6439472},"labels":[],"label_agreement":null},{"id":"W2593929189","doi":"10.1503/cmaj.732623","title":"Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation","year":2017,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dabigatran; Lovastatin; Medicine; Atrial fibrillation; Statin; Stroke (engine); Simvastatin; Cardiology; Internal medicine; Warfarin; Cholesterol","score_opus":0.02014478086991165,"score_gpt":0.26538209306892235,"score_spread":0.2452373121990107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593929189","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54623467,0.00031458237,0.00011400181,0.4478952,0.0017544386,0.0018528912,0.0016047608,0.000025783003,0.00020368243],"genre_scores_gemma":[0.24864829,0.0011775369,0.0038662243,0.45584127,0.26046544,0.00009834224,0.009345416,0.0005639121,0.01999358],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947715,0.00034830766,0.0009478482,0.00038875363,0.0026489478,0.00089466345],"domain_scores_gemma":[0.9956259,0.00069208245,0.0016725668,0.00026686737,0.0007513377,0.0009912344],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0036912702,0.00030418046,0.00097012275,0.00040083134,0.00045139878,0.00036792946,0.00017388268,0.0024117355,0.00029564055],"category_scores_gemma":[0.015171713,0.00027241782,0.00047039773,0.00011201328,0.00002586264,0.00032063757,0.000021591906,0.0031702144,0.000009721239],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058923688,0.0000037354412,0.52269465,0.00019916329,0.0006659223,0.0003859203,0.000081658705,5.3038644e-7,7.048331e-7,2.7815543e-7,0.42233554,0.053573005],"study_design_scores_gemma":[0.0072406125,0.00019480509,0.24569061,0.0004203509,0.0006611631,0.00008523002,0.00002123332,0.000078951445,0.0000039071842,0.000009255155,0.7453139,0.0002799844],"about_ca_topic_score_codex":0.007408529,"about_ca_topic_score_gemma":0.012583976,"teacher_disagreement_score":0.32297838,"about_ca_system_score_codex":0.0048754625,"about_ca_system_score_gemma":0.0047207903,"threshold_uncertainty_score":0.9999728},"labels":[],"label_agreement":null},{"id":"W2594048999","doi":"10.1016/j.cjca.2017.03.004","title":"The Evolution of Targeted Interventions in the Age of Precision Medicine","year":2017,"lang":"en","type":"editorial","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Psychological intervention; Population; Preventive healthcare; Disease; Precision medicine; Odds; Gerontology; Population health; Family medicine; Environmental health; Public health; Internal medicine; Pathology; Nursing","score_opus":0.02194852842625667,"score_gpt":0.30454180997037134,"score_spread":0.28259328154411467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594048999","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003899387,0.1034654,0.0025088773,0.0032162692,0.8752652,0.0012033464,0.00020466853,0.000002961641,0.010233935],"genre_scores_gemma":[0.5109112,0.0026520393,0.00003131649,0.000016269327,0.48603913,0.000010473365,0.00007484903,0.000022284012,0.0002423998],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970537,0.00079183583,0.0010809926,0.00013280839,0.00065982045,0.0002808547],"domain_scores_gemma":[0.9963946,0.0005620577,0.0010396201,0.0008582881,0.0009604908,0.0001849843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006550257,0.00015373135,0.0013440067,0.00044696598,0.00014709246,0.0000090304675,0.0006534302,0.0005220901,0.000008754224],"category_scores_gemma":[0.0074204793,0.00007960655,0.0010312231,0.0001446015,0.00065463415,0.000035565885,0.000020071679,0.0011748858,7.682134e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014897107,0.000004001153,0.00066188205,0.00030578751,0.000667525,0.00028867213,0.00028643734,0.000040075764,0.000035562512,0.0001264969,0.988409,0.009025634],"study_design_scores_gemma":[0.0013921236,0.0010440262,0.023353625,0.0019595437,0.0005909295,0.000239242,0.0004458803,9.2882135e-7,0.0000037518341,0.0005156115,0.97039455,0.000059814105],"about_ca_topic_score_codex":0.016357934,"about_ca_topic_score_gemma":0.024934359,"teacher_disagreement_score":0.50701183,"about_ca_system_score_codex":0.00045753972,"about_ca_system_score_gemma":0.00507273,"threshold_uncertainty_score":0.99285805},"labels":[],"label_agreement":null},{"id":"W2594218367","doi":"10.1161/atvb.33.suppl_1.a336","title":"Abstract 336: Overrepresentation of Familial Hypercholesterolemia-causing Mutations in Patients with Familial Combined Hyperlipidemia","year":2013,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"PCSK9; Missense mutation; Familial hypercholesterolemia; Genetics; Apolipoprotein B; Candidate gene; LDL receptor; Biology; Sanger sequencing; Population; Mutation; Gene; Lipoprotein; Endocrinology; Medicine; Cholesterol","score_opus":0.024780195953766924,"score_gpt":0.27281894317534744,"score_spread":0.2480387472215805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594218367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983992,0.000026980742,0.00015029212,0.00018840628,0.000105044426,0.0010105361,0.000015972984,0.000024140794,0.000079420104],"genre_scores_gemma":[0.9984475,0.00025342143,0.0006735436,0.00028701714,0.00006671173,0.00008857653,0.00015602859,0.000026234376,9.686246e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835724,0.00012985697,0.00049942,0.00042016004,0.00024282893,0.00035052665],"domain_scores_gemma":[0.9990831,0.00004986797,0.00013756727,0.00042698148,0.0001696938,0.00013278273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003050114,0.00021506821,0.0006678636,0.00015159363,0.000093862676,0.000021783564,0.000057991987,0.00018781329,0.000053476677],"category_scores_gemma":[0.000042334348,0.00016709667,0.00017421761,0.00019722556,0.00020651042,0.00019316729,0.00005283819,0.00018764802,0.000009180694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022354987,0.0002971012,0.9566711,0.00008569879,0.00021360801,6.1142046e-8,0.00025739893,0.000008298553,0.039682172,0.00002929227,0.000012578971,0.002720311],"study_design_scores_gemma":[0.0054591508,0.000677666,0.9928332,0.00016229314,0.00013496021,3.884041e-7,0.00021861082,0.00007795194,0.00020365734,0.00003479083,0.000032830736,0.00016450645],"about_ca_topic_score_codex":0.0022401812,"about_ca_topic_score_gemma":0.00009991929,"teacher_disagreement_score":0.039478518,"about_ca_system_score_codex":0.00005489016,"about_ca_system_score_gemma":0.000054327964,"threshold_uncertainty_score":0.6814004},"labels":[],"label_agreement":null},{"id":"W2594441236","doi":"10.1161/circulationaha.116.025233","title":"Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension Studies","year":2017,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Amgen","keywords":"Medicine; Evolocumab; Open label; Extension (predicate logic); Double blind; Clinical trial; Internal medicine; Placebo; Alternative medicine; Pathology","score_opus":0.2327999701645792,"score_gpt":0.44715072984402127,"score_spread":0.21435075967944206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594441236","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06997619,0.9272491,0.00002408625,0.000010797698,0.00012869545,0.0024058125,0.00006693474,0.000007983546,0.00013040828],"genre_scores_gemma":[0.065058604,0.9330608,0.00006518892,0.000017935892,0.000089504836,0.0000671686,0.0015917743,0.00002757552,0.000021450907],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977031,0.00017977557,0.0008747206,0.0005589526,0.00052099465,0.00016249047],"domain_scores_gemma":[0.9976457,0.000071110015,0.0007314824,0.0011976046,0.00027336838,0.00008078792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089272595,0.00026952586,0.0033900484,0.0005224329,0.00010415275,0.00003546135,0.00014607051,0.00030671607,0.000023644405],"category_scores_gemma":[0.00019054774,0.00020877305,0.00037756943,0.0005078865,0.000055749853,0.00016522479,0.00018083918,0.00021734898,0.0000034225916],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038332585,0.00019102138,0.008195439,0.0040057846,0.006558547,0.0000075589196,0.000119478114,0.000008615714,6.160224e-7,0.000017767585,0.000011662892,0.98050016],"study_design_scores_gemma":[0.040349748,0.00013515622,0.75622237,0.025494302,0.065017864,0.000004926877,0.000037024627,0.00055601104,7.542978e-7,0.000087696826,0.11151006,0.0005840917],"about_ca_topic_score_codex":0.0014371901,"about_ca_topic_score_gemma":0.0001810793,"teacher_disagreement_score":0.9799161,"about_ca_system_score_codex":0.00031064078,"about_ca_system_score_gemma":0.00021426071,"threshold_uncertainty_score":0.8513518},"labels":[],"label_agreement":null},{"id":"W2595169180","doi":"10.1056/nejmoa1615758","title":"Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":977,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; Montreal Clinical Research Institute; St. Michael's Hospital","funders":"","keywords":"Medicine; PCSK9; Placebo; Cholesterol; Regimen; Internal medicine; Randomization; Endocrinology; Clinical endpoint; Lipoprotein; Gastroenterology; Randomized controlled trial; LDL receptor","score_opus":0.011246424614510829,"score_gpt":0.24054263465877146,"score_spread":0.22929621004426062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595169180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467367,0.0020008285,0.00018346524,0.0017546966,0.0004622571,0.0004037947,0.000003310486,0.0000095100595,0.0005084667],"genre_scores_gemma":[0.994824,0.0010840102,0.00024352608,0.00027613627,0.003381607,0.0000022109866,0.0000104292285,0.000032924178,0.00014516345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717057,0.00019799208,0.0006334457,0.00022584712,0.0014574853,0.0003146733],"domain_scores_gemma":[0.9974696,0.000040131054,0.0006209437,0.0010129645,0.00035668793,0.00049966015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025446115,0.0002222098,0.0011919654,0.0002261404,0.00019074183,0.00001913595,0.00024025954,0.00011023095,0.000062623694],"category_scores_gemma":[0.0006226811,0.00012625732,0.000266456,0.000114893504,0.0001394958,0.00016535542,0.000056934183,0.0006568282,0.00000583379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024885158,0.00010618497,0.67954695,0.00008088974,0.0010693821,0.0005511051,0.00044638803,0.00006290388,0.000045000776,0.0000047575313,0.00048815273,0.31510976],"study_design_scores_gemma":[0.15204312,0.0034973042,0.81650555,0.0009264523,0.0008072547,0.0005568171,0.000030091254,0.0000061346814,0.00016535283,0.000042826778,0.025306642,0.00011245902],"about_ca_topic_score_codex":0.0032983553,"about_ca_topic_score_gemma":0.00033433584,"teacher_disagreement_score":0.3149973,"about_ca_system_score_codex":0.00018482763,"about_ca_system_score_gemma":0.00018770112,"threshold_uncertainty_score":0.5148624},"labels":[],"label_agreement":null},{"id":"W2595673865","doi":"10.1016/s0735-1097(17)35137-9","title":"UNDERTREATMENT OF FEMALE PATIENTS IN LIPID-LOWERING FOR SECONDARY PREVENTION IN EUROPE, CANADA, SOUTH-AFRICA, MIDDLE EAST AND CHINA: RESULTS OF THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS)","year":2017,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; China; Statin; Internal medicine; Secondary prevention; Physical therapy; Traditional medicine; Disease","score_opus":0.026920161358277017,"score_gpt":0.26975574452397577,"score_spread":0.24283558316569875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595673865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761176,0.00012802676,0.000019724554,0.0005023087,0.0003994771,0.0006418997,0.00014581287,5.1955055e-7,0.00055044104],"genre_scores_gemma":[0.9995872,0.000038335216,0.00010918768,0.000018149152,0.00012791771,0.000007973174,0.0000010676416,0.000008809486,0.00010138959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842805,0.00028142027,0.00070629234,0.00012497719,0.00033148937,0.00012778283],"domain_scores_gemma":[0.9976795,0.00006417642,0.0014753765,0.0004298806,0.00030933626,0.00004177225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094892207,0.000094032024,0.00081628264,0.0000925973,0.000056397384,0.0000024444369,0.0002824396,0.000027067897,7.43642e-7],"category_scores_gemma":[0.0007678716,0.0000560347,0.00023486088,0.00014692592,0.00016406806,0.000043334338,0.0001471172,0.00017287,1.7120596e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024083194,0.00026253675,0.9900377,0.00009606022,0.0009915517,0.000025558129,0.0009407834,0.00053249736,0.00020755762,0.000012248833,0.00027946138,0.004205745],"study_design_scores_gemma":[0.0058929594,0.0011796592,0.9897437,0.00022049875,0.00015311848,0.000033123724,0.0019861984,0.000021593672,0.00017733891,0.000016337332,0.00053337746,0.000042085743],"about_ca_topic_score_codex":0.008137007,"about_ca_topic_score_gemma":0.017166028,"teacher_disagreement_score":0.00902902,"about_ca_system_score_codex":0.00016382987,"about_ca_system_score_gemma":0.00061413547,"threshold_uncertainty_score":0.9984679},"labels":[],"label_agreement":null},{"id":"W2595800522","doi":"10.1016/s0140-6736(17)30713-4","title":"Safety and efficacy of statins","year":2017,"lang":"en","type":"letter","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; York University","funders":"","keywords":"Medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pharmacology; Internal medicine; Statin","score_opus":0.033436606898661576,"score_gpt":0.30044506524184333,"score_spread":0.26700845834318176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595800522","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0079804305,0.0028380402,0.000048382095,0.97458893,0.00019305198,0.0006438785,0.0001560642,0.000027581176,0.013523656],"genre_scores_gemma":[0.018950457,0.006293261,0.0007388743,0.9192175,0.045924008,0.000023172448,0.00035542966,0.00009287072,0.008404416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912155,0.00007527208,0.00015727189,0.00015061065,0.00029596107,0.00019934031],"domain_scores_gemma":[0.99822825,0.000069443435,0.00014840688,0.001486841,0.000038367572,0.000028711067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005253901,0.000113207134,0.0008166318,0.000019890333,0.00008236734,0.0000128799675,0.00018405238,0.0001782656,0.000035020657],"category_scores_gemma":[0.0001133826,0.000062489096,0.00013244929,0.000019094965,0.00012643248,0.000011485265,0.000054873133,0.0007894842,0.000010705324],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016132747,0.000008033448,0.00018146171,0.0009391953,0.0003087311,0.000119038166,0.00018714428,1.7242593e-7,0.000009209779,0.000039528066,0.97165334,0.02639282],"study_design_scores_gemma":[0.0019478685,0.00007196219,0.024168668,0.00026406426,0.00020616129,0.000083556246,0.0000043601553,0.0000022995973,0.000017878694,0.00005413937,0.9731152,0.00006385603],"about_ca_topic_score_codex":0.00024391766,"about_ca_topic_score_gemma":0.000004347736,"teacher_disagreement_score":0.055371404,"about_ca_system_score_codex":0.000016134041,"about_ca_system_score_gemma":0.00008968748,"threshold_uncertainty_score":0.34299597},"labels":[],"label_agreement":null},{"id":"W2595873267","doi":"10.1161/atvb.32.suppl_1.a67","title":"Abstract 67: Phase I Safety, Pharmacokinetic, and Pharmacodynamic Results for ALN-PCS, a Novel RNAi Therapeutic for the Treatment of Hypercholesterolemia","year":2012,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kimberly-Clark (Canada)","funders":"","keywords":"PCSK9; Kexin; LDL receptor; Pharmacology; Pharmacodynamics; Pharmacokinetics; Proprotein convertase; Tolerability; Medicine; Internal medicine; Cholesterol; Endocrinology; Lipoprotein; Adverse effect","score_opus":0.0812440706305932,"score_gpt":0.37330878017289565,"score_spread":0.29206470954230246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595873267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98456293,0.0048172656,0.0056361905,0.0014805351,0.0002903654,0.002682331,0.0004755371,0.000026009164,0.000028851775],"genre_scores_gemma":[0.9648331,0.03266004,0.00082993804,0.0006438486,0.0004380665,0.0004315829,0.000121473786,0.000037575395,0.0000044007347],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984448,0.000061582585,0.0004933894,0.00038992567,0.00012145852,0.0004888482],"domain_scores_gemma":[0.9988571,0.00026714764,0.00015453792,0.00043574878,0.00008925507,0.00019623226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007821509,0.00028921926,0.0007049134,0.00006522783,0.00022463083,0.000017252547,0.00008293001,0.00014219046,0.000011761076],"category_scores_gemma":[0.000019218836,0.00017860743,0.00046511024,0.00006994743,0.00021607423,0.000072506686,0.00002739142,0.00007916234,0.0000010965174],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049932906,0.0021249845,0.0061536836,0.00033304922,0.0033733335,2.8336679e-8,0.0012715266,0.0000020236598,0.77888155,0.0002096244,0.00006744964,0.20708345],"study_design_scores_gemma":[0.037118495,0.0035297256,0.856466,0.00009593538,0.0025951786,0.0000061917744,0.00023836197,0.00092572835,0.005584615,0.000015991951,0.09313859,0.0002852072],"about_ca_topic_score_codex":0.00012050581,"about_ca_topic_score_gemma":0.000012082551,"teacher_disagreement_score":0.8503123,"about_ca_system_score_codex":0.000054579526,"about_ca_system_score_gemma":0.000036665817,"threshold_uncertainty_score":0.72833997},"labels":[],"label_agreement":null},{"id":"W2596293229","doi":"10.1016/s0140-6736(17)30720-1","title":"Remediating “Lessons from the controversy over statins”","year":2017,"lang":"en","type":"letter","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; York University","funders":"","keywords":"Scopus; Statin; Medicine; Disease; Clinical endpoint; Randomized controlled trial; Internal medicine; Atherosclerotic cardiovascular disease; MEDLINE; Family medicine; Political science; Law","score_opus":0.05005979461711363,"score_gpt":0.32380004349392155,"score_spread":0.2737402488768079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596293229","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041843345,0.0027588743,0.00004963129,0.9839267,0.0008939213,0.0008109917,0.00067411584,0.00006701286,0.006634414],"genre_scores_gemma":[0.007956504,0.0008206062,0.00019697461,0.88519967,0.1030001,0.00007327746,0.00053411006,0.0000686501,0.0021501293],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978022,0.00027928257,0.00024225957,0.0003339963,0.0008272869,0.0005149908],"domain_scores_gemma":[0.99566,0.0005438683,0.00033592456,0.0033410278,0.00006785088,0.000051336698],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010666671,0.0002539785,0.0010188064,0.000015279003,0.00041695763,0.00012407417,0.00072859746,0.0003418419,0.00016797168],"category_scores_gemma":[0.0006421299,0.00011859913,0.00037636756,0.000037461115,0.0001524068,0.00003788725,0.00012714505,0.0024912036,0.00011389335],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046694364,0.0000045625225,0.00052663917,0.000087732005,0.0004956723,0.00021594591,0.00038046515,3.008471e-7,0.000014954465,0.000038352806,0.9924014,0.0057872827],"study_design_scores_gemma":[0.002089585,0.000033166274,0.015393617,0.00032347362,0.0004574805,0.000024406725,0.000041873387,0.000024768753,0.000012068239,0.00043053896,0.98102397,0.00014507059],"about_ca_topic_score_codex":0.0038685566,"about_ca_topic_score_gemma":0.0001289375,"teacher_disagreement_score":0.10210617,"about_ca_system_score_codex":0.00008261647,"about_ca_system_score_gemma":0.00024283445,"threshold_uncertainty_score":0.9998101},"labels":[],"label_agreement":null},{"id":"W2596303303","doi":"10.1161/atvb.32.suppl_1.a18","title":"Abstract 18: Apo(a) Isoform Size Is Associated with Myocardial Infarction in a Study of an Admixed Population from the Central Valley of Costa Rica","year":2012,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Gene isoform; Apolipoprotein B; Lipoprotein(a); Population; Western blot; Lipoprotein; Single-nucleotide polymorphism; Allele; Biology; Internal medicine; Genetics; Genotype; Molecular biology; Gene; Demography; Medicine; Endocrinology; Cholesterol","score_opus":0.0372742015853317,"score_gpt":0.2904654970880436,"score_spread":0.2531912955027119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596303303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860567,0.0001230064,0.000014186357,0.00013711577,0.00010287958,0.00093261164,0.00004445411,0.000016374861,0.000023729473],"genre_scores_gemma":[0.99886066,0.0005542119,0.00008036264,0.00021003149,0.00011973964,0.000043659675,0.00011046752,0.000020705145,1.8236712e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982799,0.00031813193,0.00046660184,0.00029128056,0.00028362346,0.00036042332],"domain_scores_gemma":[0.99893534,0.000109669396,0.00023846327,0.00049997657,0.000084444946,0.0001320765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008096027,0.00018852248,0.00074935384,0.000057843434,0.000090506874,0.000010672624,0.00008200168,0.00017847234,0.00006635755],"category_scores_gemma":[0.000090560156,0.0001226487,0.00022697728,0.000225469,0.00009015609,0.00014500522,0.000043164855,0.0001651598,7.1974495e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047571182,0.0011548138,0.9830904,0.000019578947,0.0012524001,4.4587487e-8,0.002745613,0.0000021234894,0.010161096,0.000009704807,0.000011882076,0.001504764],"study_design_scores_gemma":[0.0038586543,0.0014631856,0.9923216,0.00010895455,0.0004952118,4.4354374e-7,0.0014419729,0.000023843173,0.0000985172,0.000013492911,0.000046020872,0.00012809674],"about_ca_topic_score_codex":0.011975019,"about_ca_topic_score_gemma":0.0012209055,"teacher_disagreement_score":0.010754114,"about_ca_system_score_codex":0.000066883105,"about_ca_system_score_gemma":0.00003861578,"threshold_uncertainty_score":0.99460435},"labels":[],"label_agreement":null},{"id":"W2596457116","doi":"10.1016/j.jacc.2017.03.585","title":"Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014","year":2017,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Medicine; Statin; Rosuvastatin; Atorvastatin; Medical prescription; Myocardial infarction; Intensity (physics); Internal medicine; Emergency medicine; Pharmacology","score_opus":0.020397894769506073,"score_gpt":0.28407903755515046,"score_spread":0.26368114278564436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596457116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992841,0.00024598764,0.00022121612,0.0055766744,0.0007005839,0.00021437285,0.00007257434,0.0000023163566,0.0001252713],"genre_scores_gemma":[0.99681574,0.00063925725,0.0009964964,0.0007848094,0.0006082793,0.00000664614,6.493221e-7,0.000015628628,0.00013246958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982452,0.00036922542,0.0006116086,0.00014579966,0.0004111553,0.00021704743],"domain_scores_gemma":[0.997298,0.00006493888,0.000992007,0.00094327336,0.0005750987,0.00012669203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010210647,0.00013501858,0.0015904726,0.0003139402,0.0000593866,0.000005387605,0.00026731694,0.00006209256,0.00002237554],"category_scores_gemma":[0.0002669596,0.0000848935,0.00082088885,0.00016889237,0.0004241515,0.000087751825,0.000104308565,0.0002926945,0.0000020234304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013832664,0.00010345483,0.8878884,0.000028199458,0.0022779745,0.00033307783,0.00015902246,0.0006957489,0.0037373651,0.000051742074,0.0476835,0.043208856],"study_design_scores_gemma":[0.0017027259,0.00152214,0.975626,0.00004849003,0.00013168028,0.00072411343,0.000089658206,0.0000029074758,0.00070449105,0.000057194542,0.019317182,0.00007341283],"about_ca_topic_score_codex":0.00161709,"about_ca_topic_score_gemma":0.000064526095,"teacher_disagreement_score":0.08773761,"about_ca_system_score_codex":0.00008882995,"about_ca_system_score_gemma":0.00022598733,"threshold_uncertainty_score":0.34618565},"labels":[],"label_agreement":null},{"id":"W2596676407","doi":"10.1056/nejmoa1614062","title":"Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":364,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Internal medicine; PCSK9; Placebo; Hazard ratio; Cholesterol; Apolipoprotein B; Evolocumab; Gastroenterology; Hyperlipidemia; Endocrinology; Confidence interval; Lipoprotein; Apolipoprotein A1; LDL receptor; Diabetes mellitus","score_opus":0.015504243846511579,"score_gpt":0.2962377380739194,"score_spread":0.28073349422740784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596676407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730161,0.0006393489,0.008423376,0.014988225,0.00053259166,0.00028796998,7.9160986e-7,0.000010480037,0.002101124],"genre_scores_gemma":[0.99050486,0.0010507274,0.0012162601,0.00011072463,0.0069808816,8.533546e-7,0.0000048942343,0.000010801014,0.000119993856],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987088,0.00008830263,0.00038324992,0.00011831124,0.0005518172,0.00014953887],"domain_scores_gemma":[0.99850225,0.000033705463,0.00046813293,0.00041287928,0.00027446897,0.00030857723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002417742,0.000117351825,0.0005043107,0.00009620904,0.00019935287,0.000026179234,0.000081208535,0.000059913193,0.00003987465],"category_scores_gemma":[0.00048227204,0.000064841544,0.00006672353,0.000047875023,0.00015555408,0.00034760937,0.00001743251,0.0003064366,0.0000010339431],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027002364,0.00011010838,0.023744918,0.0004285916,0.0004261071,0.00020625722,0.0018492892,0.000008043742,0.007701602,0.0003305829,0.0018194199,0.9606748],"study_design_scores_gemma":[0.1805876,0.008730877,0.6370901,0.0027535483,0.0019588494,0.0531912,0.00087487866,0.00027912567,0.0025733183,0.0012445132,0.11039499,0.00032100297],"about_ca_topic_score_codex":0.00025056762,"about_ca_topic_score_gemma":0.000011020722,"teacher_disagreement_score":0.96035385,"about_ca_system_score_codex":0.000050257506,"about_ca_system_score_gemma":0.00019891362,"threshold_uncertainty_score":0.26441616},"labels":[],"label_agreement":null},{"id":"W2596679318","doi":"10.71781/31015","title":"Contrôle pharmacologique de l'apoptose cardiovasculaire dans l'hypertension : implication de la voie de l'angiotensine et de la correction de la dysfonction endothéliale","year":2003,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Medical Research Council Canada; Heart and Stroke Foundation of Canada","keywords":"Medicine","score_opus":0.0038962533173491987,"score_gpt":0.21555932955912827,"score_spread":0.21166307624177907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596679318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8957221,0.030803908,0.04449074,0.00035512555,0.001997758,0.0013911879,0.000058968773,0.0003007737,0.024879476],"genre_scores_gemma":[0.9720145,0.013046627,0.0030424113,0.00063865166,0.0012709873,0.00020884624,0.0005931345,0.00012264043,0.009062196],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99149376,0.0049825725,0.00061210373,0.0009355957,0.0008486451,0.0011272999],"domain_scores_gemma":[0.9965559,0.000785241,0.00049690844,0.0007027811,0.00057450956,0.0008846257],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0045798314,0.0007262222,0.0009832561,0.00041317067,0.0040551224,0.00012398396,0.00029519212,0.0019550303,0.000032197982],"category_scores_gemma":[0.0008170234,0.0008467234,0.001264158,0.0005306838,0.00058640976,0.00036316022,0.00008523199,0.0017188084,0.000020771506],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.003198636,0.0013750992,0.040471688,0.0009110306,0.0037664939,0.009670832,0.02148931,0.036919117,0.8302677,0.0075355032,0.0051103425,0.03928423],"study_design_scores_gemma":[0.010814745,0.000514734,0.4475246,0.0015669079,0.0076863007,0.0591332,0.026156051,0.016025204,0.2918146,0.00042308826,0.13688266,0.0014579105],"about_ca_topic_score_codex":0.1267672,"about_ca_topic_score_gemma":0.0028112915,"teacher_disagreement_score":0.5384531,"about_ca_system_score_codex":0.029687094,"about_ca_system_score_gemma":0.014054902,"threshold_uncertainty_score":0.99939835},"labels":[],"label_agreement":null},{"id":"W2597166480","doi":"10.1016/s0735-1097(17)33542-8","title":"USE OF HIGH-INTENSITY STATIN THERAPY POST-ACUTE CORONARY SYNDROME IN THE ONGOING ODYSSEY OUTCOMES TRIAL OF ALIROCUMAB, A PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 MONOCLONAL ANTIBODY, VERSUS PLACEBO: INTERIM BASELINE DATA","year":2017,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Alirocumab; Medicine; PCSK9; Acute coronary syndrome; Kexin; Evolocumab; Statin; Internal medicine; Proprotein convertase; Placebo; Cardiology; Interim analysis; Clinical trial; Cholesterol; Lipoprotein; LDL receptor; Pathology; Myocardial infarction","score_opus":0.07592762772387579,"score_gpt":0.355455073305225,"score_spread":0.27952744558134923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597166480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929433,0.00025415045,0.000120189456,0.003639138,0.00089076767,0.0014025535,0.0007313342,0.0000038799863,0.000014699514],"genre_scores_gemma":[0.997406,0.0006959712,0.001323606,0.00030294163,0.00017776478,0.0000069200732,0.000034375113,0.000025763764,0.000026675549],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99620706,0.001252993,0.0011816756,0.00027297213,0.0007967415,0.00028855272],"domain_scores_gemma":[0.99378276,0.0006010863,0.0024457453,0.0022775726,0.00079682015,0.00009600059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034428402,0.00025054437,0.0024779188,0.00018080197,0.00010434717,0.000011861733,0.0011928363,0.00009353885,0.0000098292185],"category_scores_gemma":[0.0022296866,0.00013797494,0.0006489311,0.00020429805,0.0009970844,0.00020256947,0.00037780468,0.0005287165,5.489483e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8376236,0.0008320629,0.11234497,0.0002490729,0.010211597,0.0043456103,0.00034337566,0.00017606646,0.022318413,0.000111682515,0.002204067,0.009239489],"study_design_scores_gemma":[0.0769295,0.020917218,0.887859,0.0004158706,0.0011998938,0.0067402693,0.0013304611,0.00023404574,0.0028706596,0.000044236156,0.0011890281,0.000269829],"about_ca_topic_score_codex":0.0028683809,"about_ca_topic_score_gemma":0.0001119095,"teacher_disagreement_score":0.775514,"about_ca_system_score_codex":0.000080114696,"about_ca_system_score_gemma":0.0009172948,"threshold_uncertainty_score":0.5626455},"labels":[],"label_agreement":null},{"id":"W2598478600","doi":"10.5206/wurjhns.2016-17.10","title":"Western Faculty Profile: Dr. Bryan Heit","year":2016,"lang":"en","type":"article","venue":"Western Undergraduate Research Journal Health and Natural Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Psychology; Library science; Computer science","score_opus":0.10212205529177698,"score_gpt":0.43952584047837223,"score_spread":0.33740378518659525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598478600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72132236,0.023359304,0.0001569279,0.25357985,0.00041310786,0.000785329,0.000010679518,0.00004659413,0.00032583735],"genre_scores_gemma":[0.9785968,0.014371471,0.00026551847,0.0012694057,0.0009521168,0.000014540396,0.00000443765,0.000017696453,0.0045079817],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9940312,0.0007261254,0.0005098449,0.00047201256,0.0025712505,0.0016895941],"domain_scores_gemma":[0.99684477,0.00018749996,0.00017240748,0.0002604616,0.0003671567,0.0021676894],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.007861322,0.00021265083,0.00048601744,0.00038525343,0.0016664524,0.00024501845,0.00029467608,0.00009500157,0.000017236449],"category_scores_gemma":[0.00027963516,0.00010374947,0.00016233319,0.00074293336,0.0007883431,0.0006183527,0.00015659111,0.0010001338,0.00006816027],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002983774,0.00013806591,0.21617953,0.00045235013,0.000092534894,0.00011488798,0.00035918562,1.3375781e-7,0.0004937747,0.00060652144,0.003321066,0.77794355],"study_design_scores_gemma":[0.009240835,0.00985398,0.68361306,0.004653947,0.000056034354,0.018580407,0.0018553145,0.00006628762,0.001075975,0.006977699,0.2630781,0.0009483757],"about_ca_topic_score_codex":0.00036171198,"about_ca_topic_score_gemma":0.00022210377,"teacher_disagreement_score":0.7769952,"about_ca_system_score_codex":0.00034275162,"about_ca_system_score_gemma":0.0018596939,"threshold_uncertainty_score":0.99963325},"labels":[],"label_agreement":null},{"id":"W2598498016","doi":"10.1002/clc.22692","title":"Rationale and design of <scp>REDUCE‐IT</scp>: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial","year":2017,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":182,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Amarin Pharma; Amarin Corporation","keywords":"Medicine; Internal medicine; Myocardial infarction; Clinical endpoint; Residual risk; Triglyceride; Placebo; Ezetimibe; Statin; Hazard ratio; Randomized controlled trial; Cardiology; Cholesterol; Confidence interval","score_opus":0.11972873510140643,"score_gpt":0.3869967778816125,"score_spread":0.2672680427802061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598498016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727869,0.0030624913,0.02007393,0.00024720794,0.0010115261,0.0022667034,0.000011192878,0.000015595968,0.00052447605],"genre_scores_gemma":[0.9952542,0.0018967243,0.0012397527,0.000026721209,0.0012723266,0.000105795785,0.000027084598,0.000020845104,0.00015650713],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970205,0.00097029854,0.00087611884,0.0004639255,0.0004524671,0.00021673365],"domain_scores_gemma":[0.99753416,0.0002573938,0.0005157414,0.0011967076,0.00034002427,0.00015596906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050432887,0.00016142271,0.0014800319,0.00007116573,0.00011969204,0.000008109809,0.00014435743,0.0003077644,0.000006430932],"category_scores_gemma":[0.0021220308,0.00012475623,0.0012586538,0.000052965202,0.00048624366,0.00008425807,0.000086954235,0.0002954735,0.000004073055],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10840469,0.0050416864,0.1596645,0.0050480887,0.086116254,0.0005712738,0.0011541956,0.008002441,0.0050688055,0.0015947466,0.010926713,0.6084066],"study_design_scores_gemma":[0.2008415,0.024100611,0.7263446,0.0009246195,0.00828637,0.0015597566,0.0008693994,0.000252096,0.004273068,0.0012069691,0.031018766,0.0003222364],"about_ca_topic_score_codex":0.00011151741,"about_ca_topic_score_gemma":0.0000017383338,"teacher_disagreement_score":0.6080844,"about_ca_system_score_codex":0.00003218399,"about_ca_system_score_gemma":0.00022751198,"threshold_uncertainty_score":0.50874114},"labels":[],"label_agreement":null},{"id":"W2601739689","doi":"10.1016/j.diabet.2017.01.004","title":"Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial","year":2017,"lang":"en","type":"article","venue":"Diabetes & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Internal medicine; Type 2 diabetes; Placebo; PCSK9; Insulin; Statin; Diabetes mellitus; Endocrinology; Randomized controlled trial; Gastroenterology; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.014026602494856917,"score_gpt":0.23028986626442696,"score_spread":0.21626326376957006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601739689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97875786,0.018736059,0.000011277713,0.000044516277,0.00016236116,0.0022114364,0.000048711994,0.000009214992,0.000018581579],"genre_scores_gemma":[0.99540967,0.0037108539,0.00060546206,0.000034175475,0.00012988574,0.000032784665,0.000027290049,0.00002704407,0.000022806922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981921,0.0003494121,0.00039437448,0.000340589,0.0004734193,0.00025011384],"domain_scores_gemma":[0.99831945,0.00015831963,0.00028848663,0.0008296915,0.00029288887,0.0001111632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001008832,0.00021504868,0.0010116551,0.00008883779,0.00018214488,0.000029628898,0.0001219133,0.00012739876,0.000011169273],"category_scores_gemma":[0.0010460534,0.00012457797,0.00010810197,0.00020631753,0.00027295196,0.0001208936,0.0001077828,0.0001847781,7.2329425e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03105838,0.00076444,0.80530757,0.0007321406,0.004827814,0.000006195014,0.00091481896,0.0001723863,0.0012294296,0.00013266243,0.000051194314,0.154803],"study_design_scores_gemma":[0.05347247,0.0005869045,0.9411069,0.00018443487,0.001121707,6.337566e-7,0.000015946038,0.00009182636,0.0023100318,0.000051147777,0.00091579754,0.00014220303],"about_ca_topic_score_codex":0.00029810998,"about_ca_topic_score_gemma":0.000012568787,"teacher_disagreement_score":0.15466079,"about_ca_system_score_codex":0.000014935075,"about_ca_system_score_gemma":0.00012855923,"threshold_uncertainty_score":0.5080142},"labels":[],"label_agreement":null},{"id":"W2604231946","doi":"10.1016/j.jacl.2017.03.019","title":"Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Institut universitaire de cardiologie et de pneumologie de Québec; McMaster University; Université de Montréal; Université Laval; Population Health Research Institute; Hamilton Health Sciences; McGill University; Hamilton General Hospital; Montreal Clinical Research Institute","funders":"Fondation Leducq; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Internal medicine; Disease; Framingham Risk Score; Polygenic risk score; Cholesterol; Genetics; Single-nucleotide polymorphism; Gene","score_opus":0.043091295056510166,"score_gpt":0.3318935463281696,"score_spread":0.2888022512716594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604231946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956026,0.0019749017,0.00015545658,0.00020397315,0.001494282,0.00045665444,0.00002981758,0.000005042985,0.00007726135],"genre_scores_gemma":[0.99390143,0.002723032,0.00050504744,0.00012496962,0.0026873949,0.0000042000897,0.0000023264097,0.000022127064,0.000029447778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99613595,0.0007092171,0.0015724951,0.00031131,0.0009707914,0.00030025298],"domain_scores_gemma":[0.9959853,0.00019153534,0.001339772,0.0014687935,0.0004949886,0.0005195557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043470454,0.00017331674,0.0015558857,0.00012497361,0.000078281446,0.000011208619,0.00040862005,0.00023409046,0.000015363004],"category_scores_gemma":[0.0046202573,0.00011494217,0.0012471239,0.00006288363,0.00044508252,0.00017978525,0.00010783225,0.0009857131,0.0000039100355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054086642,0.0005513785,0.9536222,0.00034338076,0.0011710738,0.000056870267,0.00002812596,0.00012427455,0.0000018752664,0.0000046240752,0.0000543183,0.038633164],"study_design_scores_gemma":[0.0134427985,0.0030297246,0.97927624,0.00061396725,0.0018196495,0.000029404106,0.000006234594,0.000026521171,0.0000054656334,0.00004590063,0.0016088609,0.00009523248],"about_ca_topic_score_codex":0.00013881526,"about_ca_topic_score_gemma":0.000010279775,"teacher_disagreement_score":0.03853793,"about_ca_system_score_codex":0.00004258418,"about_ca_system_score_gemma":0.0007285095,"threshold_uncertainty_score":0.5531213},"labels":[],"label_agreement":null},{"id":"W2604674371","doi":"10.1038/srep45788","title":"Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials","year":2017,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Rosuvastatin; Atorvastatin; Statin; PCSK9; Medicine; Simvastatin; Ezetimibe; Internal medicine; Placebo; Pharmacology; Urology; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.17029186249967368,"score_gpt":0.4937388170007613,"score_spread":0.3234469545010876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604674371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959864,0.0003288787,0.00031086404,0.0001416047,0.0019456731,0.0008137704,0.0000095162295,0.000012537236,0.00045074816],"genre_scores_gemma":[0.99811065,0.00003051836,0.0010908631,0.000027220329,0.00014160594,0.000006419522,0.000051637675,0.000011865204,0.0005291931],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9962037,0.0002907316,0.0018216023,0.0006700339,0.0007893447,0.00022454522],"domain_scores_gemma":[0.9950434,0.00021760806,0.001480578,0.0023476414,0.00058667146,0.0003241109],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.023196138,0.00012675948,0.00159317,0.00036828278,0.00023942109,0.00013823973,0.00012483641,0.000090829555,0.00009890462],"category_scores_gemma":[0.010011349,0.00009562383,0.00058814103,0.0007596235,0.00027642996,0.0001053825,0.00012342731,0.000112087284,0.000003137612],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002973544,0.0019432948,0.13961473,0.00060910435,0.012772962,0.0009825889,0.00097310386,0.00006132539,0.10426449,0.00013112232,0.003783001,0.73189074],"study_design_scores_gemma":[0.016233023,0.0019179413,0.8961296,0.00068434555,0.026530603,0.00023972278,0.001446802,0.00076946977,0.033027172,0.00046708612,0.021963127,0.0005911163],"about_ca_topic_score_codex":0.00043538222,"about_ca_topic_score_gemma":0.000037707003,"teacher_disagreement_score":0.75651485,"about_ca_system_score_codex":0.000025265985,"about_ca_system_score_gemma":0.00040519433,"threshold_uncertainty_score":0.99832773},"labels":[],"label_agreement":null},{"id":"W2604860179","doi":"10.1161/circulationaha.117.028271","title":"Primary Prevention With Statin Therapy in the Elderly","year":2017,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Primary prevention; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Atherosclerotic cardiovascular disease; Intensive care medicine; Internal medicine; Physical therapy; Disease","score_opus":0.10922173133229053,"score_gpt":0.3773510448028908,"score_spread":0.26812931347060026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604860179","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007893973,0.9934972,0.0004270555,0.00005063634,0.000052669664,0.0031291172,0.0000026986736,0.000018194065,0.002033022],"genre_scores_gemma":[0.0019126673,0.996796,0.000119484765,0.000050732808,0.00031192933,0.00029926814,0.00040082113,0.000032219585,0.00007686931],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985551,0.00029507975,0.00031291615,0.00025000903,0.00043996444,0.00014691152],"domain_scores_gemma":[0.9987247,0.000029927129,0.00030272538,0.0008625675,0.000048274513,0.000031780524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010097557,0.00018093952,0.0008289424,0.00010011893,0.00009563146,0.000046498106,0.00011643977,0.00016491339,0.000013684378],"category_scores_gemma":[0.000022673126,0.00009633773,0.00034278329,0.00013558491,0.000026470567,0.00007854333,0.00000687728,0.00030676095,0.000014831885],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010299329,0.000047331447,0.0001382889,0.005171794,0.00010134642,0.000017623843,0.000078907644,7.6136223e-7,1.1669437e-7,0.00003704006,0.000017518461,0.994379],"study_design_scores_gemma":[0.0008696701,0.00028338996,0.027310422,0.009333046,0.00041959755,0.00019347362,0.000014791821,0.0000023000994,6.999966e-8,0.00007429955,0.96136266,0.00013627946],"about_ca_topic_score_codex":0.00006605817,"about_ca_topic_score_gemma":0.000017107533,"teacher_disagreement_score":0.99424267,"about_ca_system_score_codex":0.00014343298,"about_ca_system_score_gemma":0.00058092386,"threshold_uncertainty_score":0.3928539},"labels":[],"label_agreement":null},{"id":"W2604950485","doi":"10.1016/j.jacl.2017.01.008","title":"Mortality in the Familial Atherosclerosis Treatment Study-Observational Study","year":2017,"lang":"en","type":"letter","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"PCSK9; Medicine; Kexin; Proprotein convertase; Scopus; Internal medicine; Disease; Observational study; Coronary heart disease; Atherosclerotic cardiovascular disease; Cholesterol; Bioinformatics; MEDLINE; Lipoprotein; LDL receptor","score_opus":0.4816958245449386,"score_gpt":0.5051845335111509,"score_spread":0.0234887089662123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604950485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8055951,0.00018016803,0.0000069778357,0.18697748,0.005188102,0.0018335856,0.000014669111,0.0000057085367,0.00019819771],"genre_scores_gemma":[0.6019512,0.00073147286,0.00014104886,0.26135316,0.13502258,0.00011819088,0.000033538698,0.00005937714,0.0005894632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9904633,0.004104573,0.003077955,0.0004620453,0.0015032666,0.0003888553],"domain_scores_gemma":[0.99435717,0.0014893949,0.0020520734,0.0016032829,0.00037186974,0.00012622541],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.012829697,0.00035633615,0.00300813,0.00014755841,0.0001420461,0.00004434387,0.0006927902,0.0008873153,0.00006633996],"category_scores_gemma":[0.0021825577,0.00018768957,0.0017254791,0.00009739167,0.00020991676,0.00007399405,0.000077333905,0.0039089685,0.000017056178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038636167,0.0053796885,0.8500532,0.000047883444,0.0022728932,0.001256655,0.0004761477,0.0000016532383,4.5082695e-7,0.0000016104611,0.13479714,0.005326298],"study_design_scores_gemma":[0.0073450957,0.012726145,0.7171794,0.000059913735,0.0013987849,0.00018494375,0.00033612116,0.0000015197761,1.0622956e-7,0.000050609524,0.26061425,0.0001030982],"about_ca_topic_score_codex":0.0008327978,"about_ca_topic_score_gemma":0.0004095747,"teacher_disagreement_score":0.20364395,"about_ca_system_score_codex":0.00016344343,"about_ca_system_score_gemma":0.0012047644,"threshold_uncertainty_score":0.99838907},"labels":[],"label_agreement":null},{"id":"W2606121006","doi":"10.1001/jama.2017.3416","title":"Comparison of Recommended Eligibility for Primary Prevention Statin Therapy Based on the US Preventive Services Task Force Recommendations vs the ACC/AHA Guidelines","year":2017,"lang":"en","type":"article","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Interquartile range; Statin; Guideline; National Health and Nutrition Examination Survey; Internal medicine; Primary prevention; Population; Physical therapy; Disease; Environmental health; Pathology","score_opus":0.08035870829488126,"score_gpt":0.42351781809819405,"score_spread":0.34315910980331277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606121006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84698194,0.00059972727,0.007701061,0.13550311,0.00037657804,0.006243659,0.0002047502,0.000049405873,0.0023397766],"genre_scores_gemma":[0.98776686,0.00028012812,0.0046080407,0.005502667,0.00039419395,0.00055844156,0.00026541055,0.000026410778,0.0005978732],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982055,0.00035820712,0.0005777026,0.00028229208,0.00037206348,0.00020427041],"domain_scores_gemma":[0.9968859,0.00038574476,0.0006282403,0.0015157334,0.0005302228,0.00005417087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030098197,0.00016038258,0.00043227873,0.000034643323,0.0006328783,0.00007977338,0.00036430245,0.000091296046,0.000083904655],"category_scores_gemma":[0.00045936363,0.000085987114,0.00038962584,0.00006790937,0.000058694528,0.00013814721,0.00005707278,0.00020867083,0.000003086946],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003092799,0.0011558379,0.020268617,0.00082529354,0.0006457574,5.6695467e-7,0.0011752741,0.00010511439,0.0011288184,0.00046237907,0.03184924,0.9392903],"study_design_scores_gemma":[0.014656162,0.0033262686,0.6745109,0.0015995869,0.00053036655,0.000004614968,0.0018661027,0.024384756,0.02740013,0.0049730847,0.24634068,0.00040736588],"about_ca_topic_score_codex":0.000409277,"about_ca_topic_score_gemma":0.00020717966,"teacher_disagreement_score":0.93888295,"about_ca_system_score_codex":0.000075715165,"about_ca_system_score_gemma":0.00018958838,"threshold_uncertainty_score":0.4867652},"labels":[],"label_agreement":null},{"id":"W2606155718","doi":"10.1042/cs20160872","title":"Statins, PCSK9 inhibitors and cholesterol homeostasis: a view from within the hepatocyte","year":2017,"lang":"en","type":"editorial","venue":"Clinical Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Hepatocyte; Cholesterol; PCSK9; LDL receptor; Chemistry; Internal medicine; Endocrinology; Lipoprotein; Biology; Medicine; Biochemistry; In vitro","score_opus":0.04150080165348681,"score_gpt":0.37975656746232744,"score_spread":0.33825576580884065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606155718","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10634246,0.010706872,0.000038688562,0.0018561397,0.8785078,0.001753702,0.00023334226,0.0000779181,0.00048309524],"genre_scores_gemma":[0.057031225,0.007640154,0.0005504109,0.0010658349,0.9332037,0.0001017668,0.00007337715,0.000053496915,0.00028006427],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99453557,0.00030288767,0.000999391,0.0012073746,0.0024870543,0.00046773822],"domain_scores_gemma":[0.9950189,0.0009619491,0.00071924366,0.0022334529,0.00038552997,0.00068095356],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.010473092,0.00032897177,0.0011489666,0.00006203182,0.000788626,0.00040659687,0.0009507951,0.000628161,0.000011875449],"category_scores_gemma":[0.0118446145,0.00018542734,0.00036886783,0.00022609952,0.002944788,0.00021908396,0.00054049364,0.0019900221,0.000060709564],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001914421,0.00017332112,0.0028501477,0.00035049484,0.00023399397,0.000099709876,0.0003186421,3.198326e-7,0.000016861364,0.000025904212,0.54415137,0.45158777],"study_design_scores_gemma":[0.0017460315,0.00051409367,0.014453876,0.0014161963,0.00035222148,0.000008659506,0.00007001897,0.000049242328,0.00004335798,0.00017564296,0.98090154,0.00026911258],"about_ca_topic_score_codex":0.002242367,"about_ca_topic_score_gemma":0.0002599039,"teacher_disagreement_score":0.45131865,"about_ca_system_score_codex":0.000110877474,"about_ca_system_score_gemma":0.0035159495,"threshold_uncertainty_score":0.9997686},"labels":[],"label_agreement":null},{"id":"W2606505978","doi":"10.18433/j36c8n","title":"Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials","year":2017,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute for Medical Research Development","keywords":"Evolocumab; PCSK9; Alirocumab; Familial hypercholesterolemia; Kexin; Meta-analysis; Internal medicine; Medicine; Placebo; LDL receptor; Endocrinology; Lipoprotein; Pharmacology; Cholesterol; Gastroenterology; Pathology","score_opus":0.2878359085137892,"score_gpt":0.5086206952179305,"score_spread":0.2207847867041413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606505978","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042624637,0.9847325,0.0000135141645,0.0013252323,0.0012776348,0.007910964,0.00008754934,0.000010061826,0.00038005988],"genre_scores_gemma":[0.021988092,0.97531784,0.00013487272,0.0005238514,0.0013228637,0.0005169564,0.000009647441,0.000032321703,0.00015357323],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97444993,0.01267171,0.0077822427,0.000647574,0.003753396,0.00069514307],"domain_scores_gemma":[0.9834973,0.005662532,0.008471557,0.0007415928,0.0010339788,0.0005930153],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.08361731,0.0007982537,0.0374232,0.001673977,0.00031080018,0.00026508424,0.0013714825,0.00023085336,0.00095858256],"category_scores_gemma":[0.013509376,0.00025351468,0.031640373,0.001769343,0.0015113921,0.0004292949,0.00021184895,0.0017919041,0.000014464066],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03709822,0.0007449328,0.00009316147,0.0028256527,0.25487024,0.0000867509,0.00016884899,0.000014910507,0.000021167967,0.000026448752,0.00011401219,0.7039357],"study_design_scores_gemma":[0.11795558,0.00020201488,0.000006469121,0.00089365314,0.52482307,0.00003816029,0.000032286014,0.00020975473,0.0000613935,0.000016751914,0.355558,0.00020284811],"about_ca_topic_score_codex":0.00023611869,"about_ca_topic_score_gemma":0.000012585341,"teacher_disagreement_score":0.7037328,"about_ca_system_score_codex":0.00021460596,"about_ca_system_score_gemma":0.002715125,"threshold_uncertainty_score":0.9999917},"labels":[],"label_agreement":null},{"id":"W2606523900","doi":"10.15586/jcbmr.2017.18","title":"Recent flaws in Evidence Based Medicine: statin effects in primary prevention and consequences of suspending the treatment.","year":2017,"lang":"en","type":"article","venue":"Journal of Controversies in Biomedical Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Discontinuation; Statin; Medicine; Rosuvastatin; Medical prescription; Intensive care medicine; Disease; Primary prevention; Internal medicine; Pharmacology","score_opus":0.10044384772260126,"score_gpt":0.4432458102614384,"score_spread":0.3428019625388371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606523900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9500189,0.017818084,0.000059434093,0.030886853,0.00017400367,0.00075772277,0.0000011734065,0.0000010086721,0.00028285477],"genre_scores_gemma":[0.96426576,0.03521641,0.00020223795,0.00010834546,0.00015360946,0.0000134379325,8.69033e-7,0.00000500644,0.000034292752],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99648714,0.0009677772,0.0006021077,0.00014642623,0.0014877289,0.00030880875],"domain_scores_gemma":[0.99336684,0.0056430832,0.00029210147,0.00030751782,0.00022366134,0.00016678772],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012069513,0.000089349276,0.0006096932,0.0005481985,0.00008828512,0.000023425948,0.0002360084,0.000089899906,0.000040616116],"category_scores_gemma":[0.020059941,0.000049113554,0.00008526229,0.00028559938,0.0014623611,0.00015584873,0.000051691077,0.00054843945,3.8374594e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006600143,0.0008468303,0.17443751,0.0013683839,0.00020835771,0.0021672084,0.001523441,0.0000040578198,0.022779219,0.00043093512,0.00070519955,0.7889287],"study_design_scores_gemma":[0.03288466,0.011919305,0.91771644,0.016827548,0.000093689254,0.00012832633,0.0019857648,0.00033145657,0.003075115,0.0017273449,0.013198017,0.00011233116],"about_ca_topic_score_codex":0.0010964937,"about_ca_topic_score_gemma":0.00024967638,"teacher_disagreement_score":0.7888164,"about_ca_system_score_codex":0.00064241356,"about_ca_system_score_gemma":0.001150116,"threshold_uncertainty_score":0.9881945},"labels":[],"label_agreement":null},{"id":"W2606746339","doi":"10.71781/4935","title":"Impact de la non-adhésion aux statines sur la survenue d'événements coronariens en prévention primaire dans un contexte réel d'utilisation","year":2005,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Political science","score_opus":0.005052521728678812,"score_gpt":0.2237454380004124,"score_spread":0.2186929162717336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606746339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9678578,0.018251544,0.0025005625,0.00013278813,0.0011639033,0.001305363,0.00026119617,0.000104108694,0.008422752],"genre_scores_gemma":[0.97591156,0.003241315,0.00058235275,0.000049371218,0.00077929406,0.00007404818,0.002656831,0.00008413868,0.016621076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99489295,0.0013811989,0.00075496995,0.0008197523,0.0013460107,0.00080512563],"domain_scores_gemma":[0.9970751,0.00035694367,0.00067699736,0.0006358394,0.0006039782,0.00065113837],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0018486918,0.00069667515,0.0008241748,0.00031815647,0.004749907,0.00010015384,0.00032485623,0.0009859107,0.000116739655],"category_scores_gemma":[0.00033714186,0.0007612255,0.0009332743,0.00038292023,0.00040955367,0.00059651333,0.00012055996,0.0008799146,0.000046103876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.006527579,0.0032130037,0.51993865,0.0032076626,0.005126255,0.008092412,0.18823801,0.015430529,0.06866526,0.007390251,0.00095493847,0.17321546],"study_design_scores_gemma":[0.0050878343,0.00043161045,0.94673187,0.0017012821,0.0013706195,0.0017903635,0.022105537,0.0043261154,0.0053915065,0.00010132348,0.010331237,0.00063070614],"about_ca_topic_score_codex":0.10872726,"about_ca_topic_score_gemma":0.0123140365,"teacher_disagreement_score":0.42679322,"about_ca_system_score_codex":0.013223695,"about_ca_system_score_gemma":0.0072256224,"threshold_uncertainty_score":0.9994839},"labels":[],"label_agreement":null},{"id":"W2607384457","doi":"10.1161/atvb.33.suppl_1.a113","title":"Abstract 113: Streptococcal Serum Opacity Factor Activity Diverts Human High Density Lipoprotein (HDL)-Cholesteryl Esters (CE) to the LDL-Receptor Pathway in Human Huh7 Hepatocytes","year":2013,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fields Institute for Research in Mathematical Sciences","funders":"","keywords":"Internal medicine; Endocrinology; Cholesterylester transfer protein; Reverse cholesterol transport; Cholesterol; Chemistry; LDL receptor; Lipoprotein; High-density lipoprotein; Apolipoprotein B; Medicine","score_opus":0.03485223609448026,"score_gpt":0.27935094759348633,"score_spread":0.24449871149900607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607384457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946313,0.00004890608,0.00011576063,0.0014852476,0.00021024175,0.0032820865,0.00008189792,0.000102522514,0.000042064283],"genre_scores_gemma":[0.99776864,0.00019456232,0.00014876216,0.0009327681,0.00032862969,0.00049721956,0.000060013903,0.000061293824,0.000008131893],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965088,0.000460384,0.0006288399,0.0010876117,0.00040854057,0.00090581836],"domain_scores_gemma":[0.997801,0.00006176778,0.00019600334,0.0012953016,0.00014377269,0.00050216855],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007886286,0.0005807238,0.0012384432,0.00017790445,0.0006473388,0.000170865,0.0003133498,0.0004377088,0.00054326793],"category_scores_gemma":[0.000052978427,0.0004124904,0.00054856454,0.0002549064,0.00030116856,0.00029472608,0.000377302,0.00060047116,0.000120632685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012919306,0.00049677567,0.40425572,0.00015451995,0.00048472348,7.48648e-7,0.000837182,0.000002028796,0.56875134,0.00008603838,0.00011605218,0.02480195],"study_design_scores_gemma":[0.001829915,0.0007375567,0.98118585,0.00022875101,0.00007127684,0.0000018423818,0.00020904532,0.000009166719,0.014389039,0.000044119322,0.0008302902,0.0004631534],"about_ca_topic_score_codex":0.028700769,"about_ca_topic_score_gemma":0.0040708003,"teacher_disagreement_score":0.5769301,"about_ca_system_score_codex":0.00019554138,"about_ca_system_score_gemma":0.00007830977,"threshold_uncertainty_score":0.9998327},"labels":[],"label_agreement":null},{"id":"W2608167701","doi":"10.1093/cid/cix359","title":"Risk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES","year":2017,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute on Drug Abuse; VA Pittsburgh Healthcare System; National Institutes of Health; Valeant Pharmaceuticals International; Gilead Sciences; U.S. Department of Veterans Affairs","keywords":"Medicine; Internal medicine; Hepatitis C virus; Hepatitis C; Myocardial infarction; Cohort; Incidence (geometry); Population; Gastroenterology; Risk factor; Cohort study; Cholesterol; Lipid profile; Immunology; Virus","score_opus":0.02261961678010566,"score_gpt":0.32441661689115225,"score_spread":0.3017970001110466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608167701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878698,0.00035315435,0.00018723775,0.00017589997,0.00061653904,0.00092437945,0.0051404876,0.00009721995,0.004635258],"genre_scores_gemma":[0.98735267,0.010434849,0.00007078626,0.00020715118,0.0015347061,0.00005654166,0.00019072238,0.000036935508,0.00011566331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697405,0.00071561884,0.0008638653,0.00071069016,0.00043108474,0.00030470468],"domain_scores_gemma":[0.9959997,0.0012732473,0.0008341845,0.0011071058,0.00022727111,0.00055850955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006887573,0.00028566032,0.001097111,0.00008029046,0.0005990964,0.000079315236,0.00013414065,0.00025789047,0.000040369585],"category_scores_gemma":[0.004171892,0.00024219122,0.00077017164,0.000071526636,0.0010145504,0.0002608225,0.0003035451,0.00045402866,0.00002341255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001231039,0.0004011328,0.92473555,0.00003411817,0.0042268094,0.000056839846,0.0004995833,0.0000058524265,0.00003998213,0.000015469119,0.0005802136,0.068173446],"study_design_scores_gemma":[0.0065971385,0.0011999857,0.9860282,0.00020204151,0.003557154,0.0000075480775,0.000032618056,0.00019309155,0.00032729073,0.0010996751,0.0005138046,0.00024145935],"about_ca_topic_score_codex":0.042720195,"about_ca_topic_score_gemma":0.0022581036,"teacher_disagreement_score":0.06793199,"about_ca_system_score_codex":0.00012071001,"about_ca_system_score_gemma":0.00020304607,"threshold_uncertainty_score":0.98762715},"labels":[],"label_agreement":null},{"id":"W2609836833","doi":"10.1016/j.atherosclerosis.2017.04.023","title":"New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway","year":2017,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"PCSK9; Inflammation; TLR4; NF-κB; Medicine; Cancer research; LDL receptor; Internal medicine; Cholesterol; Lipoprotein","score_opus":0.02914457683193608,"score_gpt":0.25604694140892714,"score_spread":0.22690236457699106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609836833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99514186,0.0004936977,0.000324736,0.0014781128,0.00014498763,0.0011505983,0.0000038703456,0.000045286855,0.00121685],"genre_scores_gemma":[0.99817854,0.00028130595,0.0006830959,0.000068933085,0.00037850166,0.00007372989,0.000006746031,0.000043594417,0.00028552944],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982245,0.00012060778,0.0004681765,0.00031148738,0.0005420482,0.00033319596],"domain_scores_gemma":[0.997923,0.00003425049,0.00036281036,0.00144277,0.000105984414,0.00013117629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010882595,0.00019744747,0.00043425898,0.0000800047,0.00030293988,0.00008447825,0.0003287593,0.00016091914,0.00007748592],"category_scores_gemma":[0.00027731693,0.0001407127,0.00026045556,0.00015169257,0.00009939065,0.000278236,0.00011302033,0.00026401234,0.00003798356],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006831642,0.00018513708,0.18584347,0.00022481667,0.00013289419,0.0000020265347,0.0033066205,0.000030100957,0.49905097,0.0022006242,0.000053535063,0.3089015],"study_design_scores_gemma":[0.0019820777,0.0002617141,0.8557386,0.00074363133,0.00007395105,0.000005874583,0.0003453664,0.00039236972,0.13817374,0.001017391,0.0010994909,0.00016580336],"about_ca_topic_score_codex":0.00308064,"about_ca_topic_score_gemma":0.0005291089,"teacher_disagreement_score":0.6698951,"about_ca_system_score_codex":0.00012130022,"about_ca_system_score_gemma":0.00020960669,"threshold_uncertainty_score":0.57380974},"labels":[],"label_agreement":null},{"id":"W2610212762","doi":"10.1161/circulationaha.116.026646","title":"Letter by Ahmed et al Regarding Article, “Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial”","year":2017,"lang":"en","type":"letter","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Randomized controlled trial; Aspirin; Primary prevention; Diabetes mellitus; Family medicine; Gerontology; Internal medicine; Endocrinology; Disease","score_opus":0.011974882393429222,"score_gpt":0.24666963230301459,"score_spread":0.23469474990958536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610212762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667316,0.0025400014,0.0008422111,0.0061081867,0.00061587116,0.022963205,0.000040688556,0.000026296275,0.00013192644],"genre_scores_gemma":[0.97308373,0.00018483374,0.00037839473,0.018777749,0.00086779566,0.0022354363,0.004018646,0.00015853907,0.00029489523],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99536943,0.0010407583,0.0013046049,0.0005462614,0.0013705522,0.00036837728],"domain_scores_gemma":[0.9967029,0.0002454268,0.0012302237,0.0011016156,0.00065871724,0.00006109673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041764593,0.00036007885,0.0041772225,0.00028097213,0.00005742338,0.000017429753,0.00013722226,0.00046538567,0.00001582427],"category_scores_gemma":[0.0009787338,0.00027714917,0.002546861,0.00014858674,0.00008135525,0.00018290598,0.000030077332,0.00042599833,0.0000024414137],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9322383,0.0005276725,0.007560209,0.0036498955,0.015468455,0.000007649384,0.0001244439,0.00015776299,0.00028117857,0.0000041084204,0.034523334,0.005457038],"study_design_scores_gemma":[0.9691254,0.00046971525,0.00857367,0.0019103636,0.0042034592,5.882111e-7,0.0000023452938,0.00010234894,0.0001852301,0.000065234926,0.015083683,0.0002779804],"about_ca_topic_score_codex":0.000057995083,"about_ca_topic_score_gemma":0.0000017135695,"teacher_disagreement_score":0.036887128,"about_ca_system_score_codex":0.00019315149,"about_ca_system_score_gemma":0.00027512497,"threshold_uncertainty_score":0.99996805},"labels":[],"label_agreement":null},{"id":"W2610389201","doi":"10.1016/s2213-8587(17)30150-x","title":"PCSK9 inhibitors: smooth sailing or a little turbulence ahead?","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Medicine; Scopus; Web of science; Internal medicine; MEDLINE; Meta-analysis","score_opus":0.04458113329424931,"score_gpt":0.313264644494611,"score_spread":0.2686835112003617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610389201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741386,0.0037141028,0.000021084275,0.015841331,0.0006919744,0.0005776674,0.000016067357,0.00016351261,0.0048356233],"genre_scores_gemma":[0.991188,0.000895253,0.0005265754,0.0028475518,0.0035087764,0.0001141508,0.00000920919,0.000035632,0.0008748597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974972,0.0001398838,0.0002762953,0.00039090248,0.00028659814,0.0014090913],"domain_scores_gemma":[0.9972239,0.00012247694,0.00016540725,0.0022732264,0.0000789761,0.00013602241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075232226,0.00021703134,0.0007865012,0.000054808945,0.0005248227,0.00007447924,0.00057736895,0.0001011034,0.00013775768],"category_scores_gemma":[0.0005789065,0.00012590481,0.00021466755,0.00007395255,0.00038371602,0.00010299866,0.00027676325,0.0005179714,0.00014790893],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007209186,0.00029781566,0.21619901,0.0010261455,0.001166644,0.00071102055,0.00078331085,0.000013515921,0.0091939345,0.004053282,0.014171284,0.7516631],"study_design_scores_gemma":[0.006600157,0.0010041612,0.28707367,0.0006288139,0.0004583548,0.0003540118,0.00021532648,0.00026405742,0.03928078,0.0022739645,0.6612858,0.0005608964],"about_ca_topic_score_codex":0.00028909405,"about_ca_topic_score_gemma":0.00006540016,"teacher_disagreement_score":0.7511022,"about_ca_system_score_codex":0.000063059386,"about_ca_system_score_gemma":0.00014293233,"threshold_uncertainty_score":0.51342493},"labels":[],"label_agreement":null},{"id":"W2611527891","doi":"10.1007/s10557-017-6727-0","title":"Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries","year":2017,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"Amgen","keywords":"Medicine; Identification (biology); Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Clinical Practice; Extension (predicate logic); Intensive care medicine; Family medicine; Physical therapy; Internal medicine","score_opus":0.035596643869430726,"score_gpt":0.3588116334777675,"score_spread":0.3232149896083368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611527891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9778204,0.019962091,0.00027697557,0.00035295135,0.00016993795,0.0011539357,0.000020848327,0.000009942485,0.00023292244],"genre_scores_gemma":[0.9334615,0.06593202,0.00026505673,0.00017519933,0.00005619439,0.00002763673,0.0000135157725,0.000022710377,0.0000462052],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975362,0.0005303728,0.0007278951,0.00040968478,0.00060897955,0.00018689857],"domain_scores_gemma":[0.9977725,0.00012704886,0.00036523587,0.0012376518,0.00037661672,0.00012095278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010761798,0.00014688662,0.00092439016,0.000085611646,0.00010064919,0.000039013088,0.00010362528,0.00012807384,0.0000032272949],"category_scores_gemma":[0.000402104,0.00012195126,0.0004224197,0.00009339199,0.00017635248,0.000120962686,0.00007150724,0.00013501749,0.0000015595986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011861611,0.00036349893,0.15537596,0.00039639956,0.006709349,0.000050705716,0.0013667519,0.000009107225,0.00007037117,0.00019978287,0.00004949871,0.83422244],"study_design_scores_gemma":[0.0051357816,0.00029684303,0.98569655,0.0003472761,0.00036506067,0.000009498649,0.000541161,0.000028323357,0.00016416099,0.000044172928,0.007251822,0.000119360324],"about_ca_topic_score_codex":0.0011718371,"about_ca_topic_score_gemma":0.00005434869,"teacher_disagreement_score":0.83410305,"about_ca_system_score_codex":0.000024962323,"about_ca_system_score_gemma":0.00006244853,"threshold_uncertainty_score":0.49730283},"labels":[],"label_agreement":null},{"id":"W2611655616","doi":"10.1186/s13054-017-1695-0","title":"Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial","year":2017,"lang":"en","type":"article","venue":"Critical Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Medical Research Council; Public Health Agency; Efficacy and Mechanism Evaluation Programme; National Institute for Health and Care Research; Health Research Board; Intensive Care Foundation","keywords":"Medicine; Simvastatin; Acute respiratory distress; Intensive care medicine; Randomized controlled trial; Respiratory distress; Term (time); Emergency medicine; Physical therapy; Internal medicine; Anesthesia; Lung","score_opus":0.031534386901461264,"score_gpt":0.355539406315725,"score_spread":0.32400501941426374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611655616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98435587,0.0005062789,0.0011842372,0.00014212723,0.00031751604,0.012768968,0.00061678403,0.000030079324,0.000078154124],"genre_scores_gemma":[0.996483,0.000004804773,0.00013550493,0.00016012548,0.0001559115,0.002830897,0.00018178366,0.000034589524,0.000013332962],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998414,0.00019212923,0.00027590117,0.0004058352,0.00040533397,0.00030679858],"domain_scores_gemma":[0.99756813,0.00093611225,0.000079175916,0.0006702725,0.00043966787,0.0003066201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003105628,0.00022076958,0.0011815827,0.000032248718,0.0003764504,0.00012253106,0.00010690462,0.000121292665,0.000016728101],"category_scores_gemma":[0.0021144964,0.0001416445,0.00034145964,0.00001853492,0.0002531241,0.00010925881,0.000049642877,0.00015343279,0.0000016624815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7601942,0.00035430363,0.21899076,0.0010932768,0.0010919533,0.00046164013,0.000118903496,1.2573621e-7,0.0000148293875,0.00007927785,0.000012512393,0.01758822],"study_design_scores_gemma":[0.5458884,0.001354772,0.45127168,0.00017875055,0.001067201,0.0000039552465,0.00003471882,0.0000026245161,0.000035548564,0.000020002257,0.000024893334,0.00011739432],"about_ca_topic_score_codex":0.000046333975,"about_ca_topic_score_gemma":0.000021887727,"teacher_disagreement_score":0.23228092,"about_ca_system_score_codex":0.00007293205,"about_ca_system_score_gemma":0.00012209809,"threshold_uncertainty_score":0.57760954},"labels":[],"label_agreement":null},{"id":"W2611809244","doi":"","title":"Risk-treatment paradox in use of statins [3] (multiple letters)","year":2004,"lang":"en","type":"article","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive care medicine; Internal medicine; Statin","score_opus":0.024216822150541856,"score_gpt":0.26438834328436384,"score_spread":0.24017152113382198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611809244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99683,0.00023904588,0.00069185963,0.0016160907,0.000043206543,0.00045989963,0.000027095184,0.000018202792,0.00007463796],"genre_scores_gemma":[0.9944133,0.0003542117,0.0045547322,0.00044706953,0.00012412986,0.000028437826,0.000016592363,0.000012521,0.000048994774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922955,0.000045497876,0.0001990169,0.00014714432,0.00021162376,0.00016715632],"domain_scores_gemma":[0.9994345,0.00003789519,0.000065945664,0.00035404105,0.000029644,0.00007797888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015830997,0.000085054526,0.0002703277,0.00006471887,0.000020080952,0.000007739385,0.00002570204,0.00004692194,0.0000144860105],"category_scores_gemma":[0.00014314872,0.00006350256,0.00013751356,0.00011609547,0.00002359673,0.00006505025,0.00001072935,0.000097798926,0.000018317873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069055345,0.0014783698,0.6424856,0.0002469637,0.00046386666,0.0006092068,0.003141285,0.0030729133,0.007221019,0.0002897842,0.0005137967,0.33978665],"study_design_scores_gemma":[0.013756007,0.0005488453,0.95148647,0.00014633776,0.000094279945,0.00003389894,0.00012533949,0.00010193275,0.0152073,0.000059470676,0.018331558,0.0001085673],"about_ca_topic_score_codex":0.012551703,"about_ca_topic_score_gemma":0.0008424543,"teacher_disagreement_score":0.33967808,"about_ca_system_score_codex":0.00018798787,"about_ca_system_score_gemma":0.00008961699,"threshold_uncertainty_score":0.9940238},"labels":[],"label_agreement":null},{"id":"W2613274125","doi":"10.1161/jaha.116.005045","title":"American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)","year":2017,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Internal medicine; National Cholesterol Education Program; Atherosclerotic cardiovascular disease; Canadian Cardiovascular Society; Cholesterol; Physical therapy; Cardiology; Disease; Myocardial infarction; Metabolic syndrome; Obesity","score_opus":0.07176294624735438,"score_gpt":0.36514599790903396,"score_spread":0.29338305166167955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613274125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97210455,0.00014088437,0.00069249084,0.019675618,0.0002812001,0.0063379453,0.0007522075,0.00001159174,0.0000035096273],"genre_scores_gemma":[0.99657184,0.00023491842,0.0011839321,0.0010546058,0.000544149,0.00033081262,0.000008089328,0.00005042204,0.00002123896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99349576,0.003071846,0.0015725931,0.00030894054,0.0011288199,0.0004220394],"domain_scores_gemma":[0.9867722,0.0034421347,0.005392797,0.0022759957,0.0019682185,0.00014868562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008488648,0.0003039733,0.0028037927,0.00012443829,0.0012250944,0.000031361713,0.0006426006,0.00007012394,8.1556175e-7],"category_scores_gemma":[0.0062787365,0.00018119575,0.0020857044,0.00044893468,0.00019614001,0.000074275835,0.00007732843,0.00045896496,5.010172e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005730362,0.0012014117,0.97765595,0.000023078856,0.004355121,1.2684261e-7,0.0018702558,0.0034841106,0.0007065926,0.0000015289977,0.0025953637,0.0075334497],"study_design_scores_gemma":[0.004362652,0.016378215,0.9662076,0.0001159029,0.002548249,0.0000032507726,0.0068108477,0.0005161939,0.0002622636,0.000011840634,0.002655523,0.00012745702],"about_ca_topic_score_codex":0.03675783,"about_ca_topic_score_gemma":0.002927223,"teacher_disagreement_score":0.03383061,"about_ca_system_score_codex":0.002226753,"about_ca_system_score_gemma":0.00062717183,"threshold_uncertainty_score":0.96965647},"labels":[],"label_agreement":null},{"id":"W2613582920","doi":"10.1093/ndt/gfx067a","title":"Opponent’s comments","year":2017,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.023193343354912136,"score_gpt":0.29029214381400464,"score_spread":0.2670988004590925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613582920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985947,0.00010985189,0.0030121764,0.0049508717,0.00018713714,0.00033947255,0.000013675872,0.000055966055,0.005383817],"genre_scores_gemma":[0.9951418,0.00097330706,0.0005064296,0.0027125683,0.00026857917,0.000042541305,0.00019030063,0.0000125024,0.0001519755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991038,0.00006820141,0.0001836224,0.00021580949,0.00023069214,0.0001978727],"domain_scores_gemma":[0.9990724,0.000017424272,0.00009759949,0.00065803813,0.0000500674,0.000104471335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031481954,0.00010046603,0.00030016757,0.00007551914,0.00037100865,0.000029962664,0.00011076916,0.00012373956,0.000112564936],"category_scores_gemma":[0.000018896471,0.000088496476,0.0002111153,0.000032631946,0.000083879466,0.000117989424,0.000009070812,0.00012398057,0.00008654391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046725664,0.0010701837,0.5413995,0.0011312922,0.0049934685,0.0014800262,0.003053045,0.00006408001,0.06193556,0.0031277626,0.0040533175,0.37301922],"study_design_scores_gemma":[0.0043133516,0.00016089813,0.97719955,0.000027197464,0.0013114441,0.00016841567,0.000015706935,0.00012521823,0.0030946862,0.00015017932,0.013319106,0.00011421399],"about_ca_topic_score_codex":0.00041885988,"about_ca_topic_score_gemma":0.00014202947,"teacher_disagreement_score":0.4358001,"about_ca_system_score_codex":0.000027113398,"about_ca_system_score_gemma":0.000043734228,"threshold_uncertainty_score":0.36087814},"labels":[],"label_agreement":null},{"id":"W2613610978","doi":"10.1161/atvb.33.suppl_1.a452","title":"Abstract 452: Detailed Characterization of the Role of the Epidermal Growth Factor Precursor Homology Domain A of the Low-density Lipoprotein Receptor in Proprotein Convertase Subtilisin/kexin-type 9 Binding","year":2013,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Proprotein convertase; Kexin; LDL receptor; PCSK9; Epidermal growth factor; Subtilisin; Endosome; Biochemistry; Endocytosis; Biology; Receptor; Binding domain; Heparin-binding EGF-like growth factor; Cell biology; Chemistry; Binding site; Molecular biology; Lipoprotein; Cholesterol; Enzyme","score_opus":0.01403542593630469,"score_gpt":0.22881438994920186,"score_spread":0.21477896401289717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613610978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958472,0.0001102465,0.000014921471,0.00080702495,0.000245143,0.0028919498,0.000059068454,0.000011014639,0.000013427471],"genre_scores_gemma":[0.9991641,0.00037280467,0.00009172532,0.00014671888,0.000056619483,0.00011742146,0.000019997267,0.000027210714,0.0000034194964],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997387,0.0007395122,0.00077809946,0.00041319852,0.00030824475,0.00037393734],"domain_scores_gemma":[0.9980389,0.00005553354,0.00059369224,0.00096580916,0.00026425737,0.000081823855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007098863,0.00027062232,0.00091921625,0.00008831941,0.00015011906,0.000012165573,0.00033302975,0.00033085592,0.00012613442],"category_scores_gemma":[0.00020997686,0.00014084755,0.0005336288,0.00040286395,0.0006211576,0.00010260923,0.00024492783,0.00032368366,0.0000051744305],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001627225,0.0001543097,0.3323941,0.00019480585,0.00017125775,1.7403345e-8,0.00043604214,1.2265943e-7,0.6656342,0.00008283126,0.0000021002825,0.000913929],"study_design_scores_gemma":[0.0009025644,0.0001699232,0.71829724,0.00035003547,0.00007302968,0.0000013116063,0.000117070944,0.000012209728,0.2798444,0.00009100592,0.000040975887,0.00010020663],"about_ca_topic_score_codex":0.0024620795,"about_ca_topic_score_gemma":0.00029366382,"teacher_disagreement_score":0.38590318,"about_ca_system_score_codex":0.000054764932,"about_ca_system_score_gemma":0.0001595854,"threshold_uncertainty_score":0.57435966},"labels":[],"label_agreement":null},{"id":"W2613900028","doi":"10.1016/j.jacl.2017.04.018","title":"Predicting Cardiovascular Events in Familial Hypercholesterolemia: Validation of the Montreal-FH-SCORE","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine; Traditional medicine","score_opus":0.0830498208820497,"score_gpt":0.3756182711196162,"score_spread":0.2925684502375665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613900028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99319077,0.00061555364,0.00012388745,0.0013662105,0.003909029,0.0003161008,0.0000029718633,0.0000037291868,0.00047175738],"genre_scores_gemma":[0.9935662,0.00064995664,0.00021485558,0.00021734911,0.0052898955,0.0000032563205,0.0000010049489,0.0000147768405,0.00004269458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630034,0.00087649736,0.0017150866,0.00019676381,0.00068893883,0.00022235328],"domain_scores_gemma":[0.9968879,0.0002561493,0.001278516,0.0011205181,0.0003067007,0.0001501922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007734897,0.00012094602,0.0013409333,0.00007906689,0.000100742254,0.000006822091,0.0004157819,0.0003400794,0.000007261207],"category_scores_gemma":[0.006027121,0.00007439228,0.001724128,0.00006509956,0.00018741636,0.00013037137,0.00014324239,0.0010228485,0.0000022368902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046103675,0.00018909547,0.945713,0.00007912369,0.00056544744,0.00001935802,0.00007298433,0.00015266446,0.000104732346,0.00000812345,0.00006488256,0.052569587],"study_design_scores_gemma":[0.0057977107,0.0006189516,0.9902046,0.0003730074,0.00047442946,0.00034197,0.000048080106,0.000039124665,0.00024143644,0.00022207656,0.0015851292,0.000053524214],"about_ca_topic_score_codex":0.0004996135,"about_ca_topic_score_gemma":0.00009708445,"teacher_disagreement_score":0.05251606,"about_ca_system_score_codex":0.00004886828,"about_ca_system_score_gemma":0.0003840766,"threshold_uncertainty_score":0.72154623},"labels":[],"label_agreement":null},{"id":"W2614740079","doi":"10.2174/138161282310170512174010","title":"Editorial: The Different Facets of Diabetes, Dyslipidemia and Hypertension in Cardio-metabolic Diseases: Current Perspective and Future Developments","year":2017,"lang":"en","type":"editorial","venue":"Current Pharmaceutical Design","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"University of Saskatchewan","keywords":"Dyslipidemia; Diabetes mellitus; Perspective (graphical); Medicine; Intensive care medicine; Current (fluid); Endocrinology; Engineering; Computer science","score_opus":0.040304247547667926,"score_gpt":0.3527020605956632,"score_spread":0.3123978130479953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614740079","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026778488,0.23754019,0.00007311796,0.00028720315,0.75696236,0.0022147659,0.0001956961,0.000031519427,0.000017299399],"genre_scores_gemma":[0.013661662,0.10994661,0.00003537233,0.000024112482,0.87584955,0.00025515797,0.00014612271,0.000072430565,0.000008989676],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99479645,0.0008414421,0.00071394246,0.0010084551,0.0019183597,0.0007213211],"domain_scores_gemma":[0.99689275,0.0006345249,0.00033651092,0.00084520545,0.00061479775,0.00067618344],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014939331,0.00072005525,0.0020084337,0.00020731015,0.00026186267,0.000091008405,0.00033389044,0.0006208894,0.000007938585],"category_scores_gemma":[0.0014764407,0.0004521463,0.00037582187,0.00015285533,0.00041744916,0.000120123026,0.00035779344,0.002562302,0.0000036747165],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003502477,0.0003826999,0.0022991416,0.0019043288,0.00053716166,0.000007509925,0.0002263135,5.294076e-7,0.000054063294,0.000055987388,0.73762923,0.2565528],"study_design_scores_gemma":[0.004755126,0.00014086427,0.022604333,0.0013259111,0.0018866899,0.000002975444,0.00006817388,0.000111461435,0.00008423887,0.00012425876,0.9684479,0.0004480279],"about_ca_topic_score_codex":0.000019752048,"about_ca_topic_score_gemma":0.0000020079108,"teacher_disagreement_score":0.25610474,"about_ca_system_score_codex":0.00031217237,"about_ca_system_score_gemma":0.0009931008,"threshold_uncertainty_score":0.99979305},"labels":[],"label_agreement":null},{"id":"W2615162929","doi":"10.1080/14737159.2017.1332997","title":"Recent advances in genetic testing for familial hypercholesterolemia","year":2017,"lang":"en","type":"review","venue":"Expert Review of Molecular Diagnostics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Genetic testing; Familial hypercholesterolemia; Medicine; Molecular diagnostics; Reimbursement; Disease; Personalized medicine; Bioinformatics; Computational biology; Health care; Biology; Pathology; Internal medicine","score_opus":0.07459120197801379,"score_gpt":0.4121356060858567,"score_spread":0.3375444041078429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615162929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002230015,0.99211663,0.0006388582,0.00010221796,0.00042028315,0.006236823,0.000058135476,0.000021278522,0.00040355712],"genre_scores_gemma":[3.2874934e-7,0.98210835,0.014530594,0.00081968465,0.0005772362,0.0016335583,0.00019316502,0.00012659644,0.00001046292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963942,0.00028718487,0.0015600029,0.0006636326,0.0006196639,0.00047528255],"domain_scores_gemma":[0.9962935,0.00049979583,0.0008264313,0.0017678781,0.0003986071,0.00021377343],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010051489,0.00057354645,0.004457375,0.00015982523,0.00006569438,0.000018172526,0.000446544,0.00033456692,0.00001042603],"category_scores_gemma":[0.011120691,0.0004508591,0.0013494625,0.00026293707,0.000095102456,0.00005154957,0.0001318494,0.00044324636,0.000010827266],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032203902,0.00007775082,0.00000971483,0.23378749,0.00008310556,0.00013631907,0.0000059597287,2.9089065e-7,0.0000011185289,0.0000065819036,0.00029428286,0.7655942],"study_design_scores_gemma":[0.00039282418,0.00020764675,0.000014153182,0.33823764,0.00090788363,0.00013694742,0.0000017486068,0.0000012887817,0.000006384995,0.0000089204095,0.65984124,0.00024332244],"about_ca_topic_score_codex":0.000019489737,"about_ca_topic_score_gemma":0.000004817554,"teacher_disagreement_score":0.7653508,"about_ca_system_score_codex":0.00020685195,"about_ca_system_score_gemma":0.0010113092,"threshold_uncertainty_score":0.9997943},"labels":[],"label_agreement":null},{"id":"W2616560686","doi":"10.1093/eurheartj/ehx275","title":"Reduction of LDL-C-related residual cardiovascular risk with ezetimibe: are mechanistic considerations warranted in practice?","year":2017,"lang":"en","type":"letter","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ezetimibe; Residual risk; Ldl cholesterol; Cardiology; Atherosclerotic cardiovascular disease; Residual; Internal medicine; Reduction (mathematics); Intensive care medicine; Cholesterol; Disease","score_opus":0.03400894309288017,"score_gpt":0.2813531796295056,"score_spread":0.24734423653662546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616560686","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051536772,0.033386525,0.0020334555,0.87267727,0.0046236683,0.0058518187,0.00029357983,0.00031518404,0.029281706],"genre_scores_gemma":[0.8289949,0.011898947,0.027578404,0.0841439,0.041618753,0.00005712439,0.00051877927,0.0013326412,0.0038564953],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.992854,0.0035088407,0.00095164793,0.0005719334,0.0015893144,0.00052427035],"domain_scores_gemma":[0.9959186,0.00013061005,0.0012635502,0.0016260617,0.0008501014,0.00021108642],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0048277364,0.00042675185,0.0014638095,0.00048992195,0.0005793572,0.00015310604,0.00016320359,0.00037547966,0.00011866042],"category_scores_gemma":[0.0019641137,0.00034021094,0.00088983227,0.00018636038,0.00019940539,0.00024757348,0.000056592486,0.0059970845,0.00006276271],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007287767,0.00032525082,0.0013643877,0.0010980206,0.013219371,0.10093175,0.0010919943,0.00089430204,0.0003018358,0.000029067087,0.87672716,0.0032880716],"study_design_scores_gemma":[0.008307824,0.0013102533,0.027428681,0.0052771578,0.006747824,0.20591739,0.0005412295,0.00003606367,0.00025816902,0.00014479474,0.7432294,0.0008012166],"about_ca_topic_score_codex":0.00028960966,"about_ca_topic_score_gemma":0.000011309388,"teacher_disagreement_score":0.7885334,"about_ca_system_score_codex":0.00017745877,"about_ca_system_score_gemma":0.00078725995,"threshold_uncertainty_score":0.999905},"labels":[],"label_agreement":null},{"id":"W2616652498","doi":"10.1038/s41598-017-02080-w","title":"Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet","year":2017,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Fundamental Research Funds for the Central Universities; Central South University; National Natural Science Foundation of China","keywords":"Atorvastatin; Metformin; Medicine; Cholesterol; Pharmacology; Internal medicine; Combination therapy; Efflux; Endocrinology; Diabetes mellitus; Biology; Biochemistry","score_opus":0.037182324611854015,"score_gpt":0.2744154712528609,"score_spread":0.23723314664100692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616652498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977947,0.0001455215,0.000031409647,0.0002492915,0.0009755547,0.00071811106,0.000005869101,0.000020107003,0.00005945164],"genre_scores_gemma":[0.9980853,0.000043944397,0.0009402449,0.000036483398,0.00003112541,0.000035845074,0.000022292525,0.000018845767,0.000785908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979817,0.000053929758,0.00055977073,0.0005502813,0.0005766534,0.00027761186],"domain_scores_gemma":[0.9974958,0.000028007125,0.00046625698,0.0016729262,0.00016608842,0.00017097137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021888379,0.00014177561,0.000513269,0.00014207744,0.00028581882,0.00025477575,0.00008288757,0.00007505271,0.000013676215],"category_scores_gemma":[0.0005453852,0.00011307715,0.00012854283,0.00014225644,0.00034453778,0.00031572938,0.00011984063,0.00011895174,0.000003151059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028917246,0.00032769208,0.9220429,0.0003623485,0.00014199049,0.00044146352,0.0009279702,0.000004389594,0.05383682,0.00006696715,0.0014665633,0.020091742],"study_design_scores_gemma":[0.0016764337,0.00031408024,0.95848006,0.00036588157,0.00007990305,0.00011609692,0.00007312225,0.000065390566,0.035253715,0.00046899373,0.0029573366,0.00014895979],"about_ca_topic_score_codex":0.0017878807,"about_ca_topic_score_gemma":0.0002380622,"teacher_disagreement_score":0.036437202,"about_ca_system_score_codex":0.000037922357,"about_ca_system_score_gemma":0.00012463734,"threshold_uncertainty_score":0.46111524},"labels":[],"label_agreement":null},{"id":"W2617989231","doi":"10.2146/ajhp160714","title":"Coenzyme Q10 supplementation in the management of statin-associated myalgia","year":2017,"lang":"en","type":"review","venue":"American Journal of Health-System Pharmacy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"myalgia; Medicine; Ezetimibe; Myopathy; Statin; Niacin; Adverse effect; Internal medicine; Muscle cramp; Muscle weakness; Simvastatin; Weakness; Stroke (engine); Physical therapy; Surgery","score_opus":0.10165914423901497,"score_gpt":0.4498341171468159,"score_spread":0.348174972907801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617989231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025030065,0.99377626,0.00017991748,0.002225619,0.00042441452,0.0027492093,0.00009959732,0.00001066101,0.0002840485],"genre_scores_gemma":[0.012189521,0.9864147,0.000604203,0.00023471937,0.00029512655,0.00009291053,0.00008053197,0.000057365127,0.000030945506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99256,0.0021049255,0.0031499083,0.0002643055,0.0014117081,0.00050911494],"domain_scores_gemma":[0.99045706,0.00014430248,0.00817578,0.0007189517,0.00027274218,0.00023117854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008878899,0.00037413277,0.004184124,0.00040903324,0.00016990356,0.00003506952,0.0005781335,0.000045796445,0.000028590684],"category_scores_gemma":[0.00003236271,0.0002351308,0.0010680091,0.0005285696,0.00011434876,0.000097561075,0.000050008668,0.0008006921,0.0000081851695],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007234075,0.0001696659,0.000068814334,0.056362793,0.0015299597,0.00031883738,0.00042389455,5.666281e-7,7.539842e-8,0.0000484199,0.0024143185,0.9385903],"study_design_scores_gemma":[0.0034786533,0.00097045273,0.00036526704,0.053993087,0.0021150908,0.0012103393,0.0029486604,0.0000049244595,8.577317e-7,0.000001767016,0.93473923,0.0001716452],"about_ca_topic_score_codex":0.0024655536,"about_ca_topic_score_gemma":0.00001878185,"teacher_disagreement_score":0.9384187,"about_ca_system_score_codex":0.0010607041,"about_ca_system_score_gemma":0.0018104787,"threshold_uncertainty_score":0.9588356},"labels":[],"label_agreement":null},{"id":"W2618303337","doi":"10.1097/hco.0000000000000424","title":"The emerging role of proprotein convertase subtilisin/kexin type-9 inhibition in secondary prevention","year":2017,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Western University; McMaster University; LMC Diabetes & Endocrinology (Canada); Cambridge Cardiac Care Centre; University of Toronto","funders":"","keywords":"Kexin; Proprotein convertase; Subtilisin; Medicine; Proprotein Convertases; PCSK9; Cancer research; Internal medicine; Biochemistry; Cholesterol; Enzyme; LDL receptor; Lipoprotein","score_opus":0.12482110287274549,"score_gpt":0.43111603814008237,"score_spread":0.30629493526733687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618303337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002602852,0.99226516,0.000022774842,0.000041733758,0.003663759,0.0032037706,0.00003605917,0.00001642106,0.00049002527],"genre_scores_gemma":[0.0012653176,0.99635273,0.000013292439,0.000002454991,0.0010569617,0.0005405852,0.0006959741,0.000038995917,0.000033686836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966113,0.000996598,0.0011484544,0.000523005,0.000317349,0.00040327242],"domain_scores_gemma":[0.9979851,0.0000863519,0.00063816976,0.0010714455,0.00013574441,0.00008319192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023425121,0.0003370577,0.002382583,0.00034664496,0.00010455972,0.00001625929,0.00017213845,0.0004509586,0.00001569033],"category_scores_gemma":[0.0003219777,0.0002371482,0.0008852744,0.0002278587,0.0001822993,0.00007266372,0.00013847482,0.001105728,0.000020886762],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052356212,0.00004753782,0.00016832448,0.020280853,0.00012836244,0.0000092450855,0.00004099094,0.0000010881316,0.0000011811201,0.00017464682,0.00023095829,0.97886443],"study_design_scores_gemma":[0.0010256276,0.00018619493,0.00077319477,0.025673896,0.00017057922,0.00019695582,0.000052679716,0.0000071854615,0.000006007159,0.00028242788,0.97143185,0.00019337068],"about_ca_topic_score_codex":0.000103728766,"about_ca_topic_score_gemma":0.000022942142,"teacher_disagreement_score":0.9786711,"about_ca_system_score_codex":0.00026287517,"about_ca_system_score_gemma":0.0013120607,"threshold_uncertainty_score":0.9670623},"labels":[],"label_agreement":null},{"id":"W2618542302","doi":"10.1016/s2213-8587(17)30096-7","title":"Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université Laval; Université de Montréal; Western University; University of Ottawa","funders":"National Institute of General Medical Sciences; British Heart Foundation; National Institute of Nursing Research; National Heart, Lung, and Blood Institute; National Institute for Health and Care Research","keywords":"Medicine; Internal medicine; Hazard ratio; Diabetes mellitus; Single-nucleotide polymorphism; Proportional hazards model; Population; Cardiology; Lipoprotein; Blood pressure; Lipoprotein(a); Coronary artery disease; Cholesterol; Endocrinology; Genotype; Genetics; Confidence interval; Biology","score_opus":0.011135084700190754,"score_gpt":0.25313532937448807,"score_spread":0.24200024467429732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618542302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931251,0.0020284327,0.000028740546,0.0024203483,0.00003348246,0.0022400757,0.00007524969,0.000014171708,0.00003443631],"genre_scores_gemma":[0.9991511,0.00018744415,0.00019544586,0.00016084345,0.00008647586,0.00017798481,0.000018898052,0.000013393979,0.0000084150515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799055,0.0007248623,0.0002859684,0.00025986062,0.00031156765,0.0004271777],"domain_scores_gemma":[0.99841124,0.00018541809,0.00028699203,0.00094707846,0.00009517608,0.000074085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070600415,0.0001318451,0.0005780152,0.00003510356,0.00028824143,0.000039178925,0.00014650915,0.000046069654,0.000005192089],"category_scores_gemma":[0.000532723,0.00007779934,0.00004916758,0.00006852469,0.0003092184,0.000065369815,0.00010796684,0.00026827527,7.180927e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014174939,0.00010094657,0.9968803,0.00003486563,0.0004901334,0.000009679382,0.0001336286,0.000014364787,0.00000911111,0.00013709565,0.000012420038,0.002035732],"study_design_scores_gemma":[0.00814386,0.0002928014,0.9895805,0.000032286593,0.0009606485,0.000001378866,0.000037127633,0.000057969723,0.000018977678,0.0007564311,0.00003925279,0.000078775614],"about_ca_topic_score_codex":0.0009305955,"about_ca_topic_score_gemma":0.00015009803,"teacher_disagreement_score":0.008002111,"about_ca_system_score_codex":0.000045116907,"about_ca_system_score_gemma":0.000077013676,"threshold_uncertainty_score":0.3172565},"labels":[],"label_agreement":null},{"id":"W2618685600","doi":"10.1186/s12933-017-0552-4","title":"Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular risk","year":2017,"lang":"en","type":"article","venue":"Cardiovascular Diabetology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Ezetimibe; Fenofibrate; PCSK9; Internal medicine; Dyslipidemia; Statin; Type 2 diabetes; Endocrinology; Diabetes mellitus; Gastroenterology; Cholesterol; Lipoprotein; Apolipoprotein A1","score_opus":0.016522273997367557,"score_gpt":0.2391748565043356,"score_spread":0.22265258250696804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618685600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569787,0.03899346,0.00049946754,0.00013565141,0.000381311,0.0029095504,0.000019230909,0.000022484684,0.00006017216],"genre_scores_gemma":[0.9932826,0.0048135817,0.0014131659,0.0000354246,0.0002468879,0.00011859268,0.000015543013,0.00006153737,0.0000126292025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995932,0.0011655089,0.0007477571,0.0008227083,0.00079690025,0.0005351712],"domain_scores_gemma":[0.9962164,0.00045265822,0.00044849256,0.0024387555,0.00023054796,0.00021313905],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0052272524,0.00040596628,0.002667308,0.00018667801,0.00042572335,0.00003526208,0.00027595542,0.00039509355,0.000006821583],"category_scores_gemma":[0.0013991031,0.00029267216,0.0007293106,0.00023530015,0.0009174028,0.00015406405,0.00047446918,0.00043860322,9.0472605e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064361123,0.00024576497,0.80302,0.0025010137,0.03661532,0.00005384713,0.0010599972,0.004809981,0.002085329,0.00018844311,0.0000963702,0.14288785],"study_design_scores_gemma":[0.05502873,0.0006326235,0.9264777,0.00053641037,0.0046688784,0.000094873365,0.000077643104,0.000106893414,0.009248486,0.00011694809,0.0026120024,0.00039881663],"about_ca_topic_score_codex":0.0002693685,"about_ca_topic_score_gemma":0.000035909503,"teacher_disagreement_score":0.14248903,"about_ca_system_score_codex":0.00010452923,"about_ca_system_score_gemma":0.00022358865,"threshold_uncertainty_score":0.99995255},"labels":[],"label_agreement":null},{"id":"W2619015076","doi":"10.1001/jamainternmed.2017.1442","title":"Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults","year":2017,"lang":"en","type":"article","venue":"JAMA Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":186,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; York University; AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Primary prevention; Primary care; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Secondary prevention; Internal medicine; Atherosclerotic cardiovascular disease; Physical therapy; Gerontology; Family medicine; Disease","score_opus":0.008927863325884109,"score_gpt":0.29279293023862324,"score_spread":0.2838650669127391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619015076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851233,0.0039237314,0.00022167352,0.00039782468,0.00062065513,0.0017451383,0.000013830488,0.000036733883,0.00791713],"genre_scores_gemma":[0.9966791,0.0004977104,0.000070302944,0.00012619997,0.0016352367,0.0001376886,0.00007836066,0.000041674208,0.00073369313],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99739766,0.00026756732,0.0004719812,0.00044872682,0.0011190937,0.0002949848],"domain_scores_gemma":[0.99763006,0.000096087766,0.00030757237,0.0015088612,0.00020680105,0.00025063968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010285402,0.00030960445,0.0012712186,0.0001388082,0.00013065973,0.000019947456,0.00020546478,0.00015391073,0.000098676996],"category_scores_gemma":[0.00049738464,0.00019023562,0.0008912322,0.000049236543,0.00020855645,0.00011574143,0.00006149982,0.00028471428,0.000015520232],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037371381,0.0002101382,0.059013452,0.0024293836,0.002232491,0.00047319723,0.002016399,0.000007598744,0.00011557722,0.00001091082,0.0003921775,0.9293615],"study_design_scores_gemma":[0.035143618,0.031778518,0.8941711,0.012292551,0.001835747,0.00013576659,0.00039881407,0.000040237283,0.019562155,0.000005075422,0.0044327136,0.00020369998],"about_ca_topic_score_codex":0.0055580554,"about_ca_topic_score_gemma":0.00005891892,"teacher_disagreement_score":0.92915785,"about_ca_system_score_codex":0.00038868596,"about_ca_system_score_gemma":0.00008686698,"threshold_uncertainty_score":0.84021544},"labels":[],"label_agreement":null},{"id":"W2619736297","doi":"10.14740/jocmr3066w","title":"Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Dementia; Statin; Internal medicine; Hyperlipidemia; Diabetes mellitus; Coronary artery disease; Vascular dementia; Disease; Physical therapy; Endocrinology","score_opus":0.12160351551899792,"score_gpt":0.510437895655832,"score_spread":0.388834380136834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619736297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805676,0.00033319043,0.000003177947,0.015374704,0.0008444803,0.00075728376,0.000007166429,0.000002841319,0.0021095874],"genre_scores_gemma":[0.99506754,0.0013469631,0.00006361751,0.00023157406,0.0030169534,0.000006361047,0.000006294502,0.000018984561,0.00024173291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917967,0.001294738,0.002215156,0.00025282262,0.0039992323,0.00044138063],"domain_scores_gemma":[0.9923782,0.0024683853,0.0016388542,0.0005654255,0.0023912445,0.0005579088],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03505957,0.00013865247,0.0013631016,0.000538115,0.00013589066,0.000014189835,0.00026734843,0.0002674605,0.000103079445],"category_scores_gemma":[0.06731497,0.00009021276,0.00046074513,0.00025437385,0.00039522827,0.00013616722,0.00010490232,0.002299119,0.000013995602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00548616,0.0026150888,0.8728842,0.00021286176,0.00057296414,0.00023867589,0.00035959482,0.0000014086543,0.00007947439,0.000015652035,0.010405685,0.10712824],"study_design_scores_gemma":[0.021086106,0.018735984,0.95203406,0.0047467565,0.0001657068,0.000012182652,0.00039471476,0.00001625236,0.0010984517,0.0002427913,0.0013941659,0.00007280234],"about_ca_topic_score_codex":0.00042382497,"about_ca_topic_score_gemma":0.00001930733,"teacher_disagreement_score":0.10705544,"about_ca_system_score_codex":0.0003786063,"about_ca_system_score_gemma":0.00077171146,"threshold_uncertainty_score":0.9988656},"labels":[],"label_agreement":null},{"id":"W2620773502","doi":"10.4172/2368-0512.1000071","title":"Alternate day versus daily atorvastatin in low-density lipoprotein cholesterol reduction: A meta-analysis","year":2016,"lang":"en","type":"article","venue":"Current research. Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Meta-analysis; Low-density lipoprotein; Cholesterol; Chemistry; Internal medicine; Medicine","score_opus":0.1899111690295813,"score_gpt":0.4151407437484317,"score_spread":0.22522957471885038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620773502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97582465,0.011776383,0.0035411408,0.0041365395,0.0012393852,0.00216299,0.00007164519,0.0001069163,0.0011403518],"genre_scores_gemma":[0.9960802,0.0015668386,0.00009957784,0.000028487977,0.00123087,0.00052848074,0.000044864537,0.00003626282,0.00038441917],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9929613,0.0028291869,0.0006508564,0.0010944447,0.0013682808,0.0010959225],"domain_scores_gemma":[0.9968105,0.00026520842,0.0001212195,0.0017517805,0.0005764925,0.00047482402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074162846,0.0003174804,0.002129646,0.0009894363,0.00015480575,0.000033554265,0.00032318413,0.00021314752,0.00023949979],"category_scores_gemma":[0.00073639705,0.00020055605,0.0021930435,0.0013745105,0.0004664906,0.0001473239,0.0002929725,0.0009427366,0.00028154426],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004771774,0.00069828314,0.018240191,0.0009268416,0.27108863,0.001599332,0.0009433561,0.00023096673,0.0070102164,0.0014497713,0.005090084,0.68795055],"study_design_scores_gemma":[0.051148966,0.005203626,0.5636358,0.00064378354,0.18320034,0.0017558617,0.0011422011,0.00026659115,0.019513454,0.0026986091,0.16789131,0.002899417],"about_ca_topic_score_codex":0.0013869569,"about_ca_topic_score_gemma":0.00028961312,"teacher_disagreement_score":0.68505114,"about_ca_system_score_codex":0.0004916637,"about_ca_system_score_gemma":0.00038321127,"threshold_uncertainty_score":0.81784385},"labels":[],"label_agreement":null},{"id":"W2621174987","doi":"10.1016/j.atherosclerosis.2017.06.006","title":"Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management","year":2017,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McMaster University; Canadian Respiratory Research Network; McGill University; University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Medicine; Atherosclerotic cardiovascular disease; Asymptomatic; Angina; Disease; Internal medicine; Ezetimibe; Statin; Cardiology; Intensive care medicine; Myocardial infarction","score_opus":0.031993469732115816,"score_gpt":0.2675750908067578,"score_spread":0.23558162107464198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621174987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992815,0.0013843011,0.0019755256,0.0005665239,0.00033493957,0.0025845564,0.000025429958,0.000053188007,0.0002605198],"genre_scores_gemma":[0.9966881,0.0014771372,0.00037727505,0.00016665406,0.00038550817,0.0006588608,0.0000054171205,0.00005033043,0.00019066244],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981023,0.000094872055,0.00033515957,0.0004329983,0.0006761761,0.000358512],"domain_scores_gemma":[0.99676293,0.000043866927,0.00036851713,0.0024278217,0.00020122543,0.00019566074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007824054,0.00023567514,0.0005465283,0.00005912248,0.0008551503,0.000088025976,0.0004047953,0.000090733214,0.000011716678],"category_scores_gemma":[0.00024870483,0.0001566226,0.0012814343,0.00009290434,0.00029834392,0.00014055443,0.00011845185,0.00013419036,0.000012628486],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022423412,0.0010672631,0.091007665,0.004824493,0.020059863,0.000043607288,0.0034455117,0.0010816293,0.09668534,0.0010956395,0.00029302348,0.7781536],"study_design_scores_gemma":[0.002789041,0.00024862564,0.98636514,0.00057209015,0.0020071622,0.000006043066,0.00041217482,0.00029012887,0.0035973834,0.0001248499,0.0033910242,0.00019635902],"about_ca_topic_score_codex":0.00047311143,"about_ca_topic_score_gemma":0.000009474655,"teacher_disagreement_score":0.89535743,"about_ca_system_score_codex":0.000074201074,"about_ca_system_score_gemma":0.000055267374,"threshold_uncertainty_score":0.6577211},"labels":[],"label_agreement":null},{"id":"W2624210375","doi":"10.1016/j.cct.2017.06.006","title":"Intensive versus moderate atorvastatin therapy and one-year graft patency after CABG: Rationale and design of the ACTIVE (Aggressive Cholesterol Therapy to Inhibit Vein Graft Events) randomized controlled trial (NCT01528709)","year":2017,"lang":"en","type":"article","venue":"Contemporary Clinical Trials","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"American Heart Association","keywords":"Medicine; Atorvastatin; Randomized controlled trial; Cholesterol; Surgery; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.302002769090148,"score_gpt":0.42836495215524767,"score_spread":0.12636218306509966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624210375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9537394,0.0045523657,0.0009065707,0.006163221,0.001273828,0.033166457,0.0000839522,0.000023441533,0.00009077352],"genre_scores_gemma":[0.989592,0.0047031804,0.00038585506,0.0017655265,0.00090134726,0.0023858973,0.000012815216,0.000046084784,0.00020728272],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98688227,0.00887041,0.0025932684,0.0006768476,0.0006981491,0.00027903588],"domain_scores_gemma":[0.9876356,0.007352244,0.0026713843,0.001084735,0.00088939717,0.0003666421],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01866989,0.0004005402,0.0050454107,0.0000961742,0.00027855285,0.00010845373,0.0002308002,0.00031216745,0.000040395127],"category_scores_gemma":[0.034010354,0.00022092155,0.0014683707,0.000075017684,0.00056303083,0.00025420287,0.00013367104,0.0004571176,0.0000047886256],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.980779,0.00032796402,0.00055898965,0.000023968429,0.003017968,0.00001484423,0.000680639,0.0000017715607,0.0002578774,0.000046362704,0.00019867362,0.014091955],"study_design_scores_gemma":[0.98718494,0.0028467276,0.0059691025,0.00042874357,0.00040621808,0.0000033791077,0.00018604725,0.00007623453,0.001200107,0.0012782704,0.00019131141,0.00022894329],"about_ca_topic_score_codex":0.00016135351,"about_ca_topic_score_gemma":0.00000896762,"teacher_disagreement_score":0.03585262,"about_ca_system_score_codex":0.000030944328,"about_ca_system_score_gemma":0.0009673364,"threshold_uncertainty_score":0.9741266},"labels":[],"label_agreement":null},{"id":"W2624801309","doi":"10.1016/j.jacl.2017.06.005","title":"A case of hypocholesterolemia and steatosis in a carrier of a PCSK9 loss-of-function mutation and polymorphisms predisposing to nonalcoholic fatty liver disease","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Steatosis; Hypocholesterolemia; Nonalcoholic fatty liver disease; Fatty liver; Internal medicine; Loss function; Disease; Mutation; Gastroenterology; Genetics; Gene; Cholesterol; Phenotype; Biology","score_opus":0.06644746104700279,"score_gpt":0.3797804533995022,"score_spread":0.31333299235249945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624801309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970962,0.0008724653,0.0007113145,0.00060826546,0.00040837217,0.00026823874,0.000017765979,0.0000013313725,0.000016062744],"genre_scores_gemma":[0.99813944,0.00023429186,0.0007318363,0.00020197597,0.00067304634,0.000003021187,9.568257e-7,0.000009356627,0.000006100159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798256,0.00027346206,0.0012246792,0.00016473916,0.00022755263,0.00012698499],"domain_scores_gemma":[0.9977657,0.00028298903,0.0010370013,0.0003180065,0.00026052416,0.00033577494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020014357,0.00009547612,0.0009217702,0.0001729757,0.000038851784,0.000006961853,0.000064631946,0.00015182878,0.000007313713],"category_scores_gemma":[0.0020354157,0.000074448726,0.0002458664,0.000057813377,0.00028921742,0.00011951503,0.000065522785,0.0002765694,1.8936905e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006326913,0.000321161,0.90060943,0.0004905125,0.00029570455,0.0007723836,0.000513217,0.000021423184,0.0011435099,0.00006328684,0.000017259563,0.08942519],"study_design_scores_gemma":[0.0046767523,0.002120298,0.9883372,0.0005054631,0.0005515485,0.0030552396,0.00007192094,0.00014887203,0.00025558355,0.00014776258,0.00007324376,0.00005608695],"about_ca_topic_score_codex":0.00032679332,"about_ca_topic_score_gemma":0.00008374585,"teacher_disagreement_score":0.08936911,"about_ca_system_score_codex":0.000017419761,"about_ca_system_score_gemma":0.00021502623,"threshold_uncertainty_score":0.3035931},"labels":[],"label_agreement":null},{"id":"W2625162529","doi":"10.18051/univmed.2014.v33.73-74","title":"Statins and risk of diabetes mellitus","year":2014,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Diabetes mellitus; Medicine; Internal medicine; Endocrinology","score_opus":0.1129121087430257,"score_gpt":0.4891818044988526,"score_spread":0.3762696957558269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625162529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455625,0.05010733,0.00046921082,0.00010649242,0.00018734255,0.00054993684,0.000042741183,0.000019042562,0.002955409],"genre_scores_gemma":[0.9472359,0.051453866,0.00070351,0.00019927826,0.000238829,0.000021601181,0.000008051816,0.00004060598,0.00009836951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973552,0.00042549233,0.0007480906,0.00033428762,0.00079458347,0.00034232135],"domain_scores_gemma":[0.9976347,0.00028239063,0.00070886064,0.0006618074,0.00032798888,0.00038422615],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031359706,0.00022823336,0.001160451,0.00039104206,0.00014185178,0.00019214564,0.0005859205,0.00009951332,0.0015152948],"category_scores_gemma":[0.00069402915,0.00017880464,0.0002815642,0.00044660745,0.00016192353,0.0005622136,0.0003510781,0.00036668632,0.000005332591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092730486,0.00016557571,0.80204636,0.000516733,0.0006966396,0.0000061662695,0.0001360453,0.000016584421,0.012813165,0.00008421175,0.0029082885,0.18051751],"study_design_scores_gemma":[0.0013093135,0.000058391488,0.9497273,0.00055158546,0.00047110795,0.000009336434,0.000055215303,0.0001237127,0.029867336,0.0023573197,0.015265548,0.00020382529],"about_ca_topic_score_codex":0.0017647243,"about_ca_topic_score_gemma":0.000044093867,"teacher_disagreement_score":0.18031369,"about_ca_system_score_codex":0.000039911036,"about_ca_system_score_gemma":0.000132073,"threshold_uncertainty_score":0.99939746},"labels":[],"label_agreement":null},{"id":"W2625453599","doi":"10.1161/circulationaha.117.027252","title":"Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus","year":2017,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Diabetes mellitus; Disease; Type 2 Diabetes Mellitus; Secondary prevention; Internal medicine; Risk factor; Intensive care medicine; Endocrinology","score_opus":0.012633787875241923,"score_gpt":0.23750963690029983,"score_spread":0.22487584902505792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625453599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956678,0.0030189867,0.00018903233,0.000021223257,0.00008431295,0.00062910176,0.0000033356334,0.000010865265,0.00037531942],"genre_scores_gemma":[0.9996301,0.0000621041,0.00010297081,0.000009931372,0.000066927605,0.000013109388,0.00009315724,0.000013136431,0.000008557971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912393,0.000043527078,0.00015843027,0.00017864283,0.0003778411,0.00011761738],"domain_scores_gemma":[0.99883115,0.00000376762,0.00009642808,0.00084150577,0.00014885071,0.00007831864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003001053,0.000073770345,0.00025797298,0.00006083138,0.00006811837,0.000012513026,0.000048127436,0.00004397485,0.000020385933],"category_scores_gemma":[0.000071950504,0.00006227196,0.00017438053,0.00006407842,0.000037011818,0.00015448354,0.000015776624,0.00007303996,0.000004308073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094092866,0.00009724463,0.9078828,0.0002614578,0.00031896148,0.000002928394,0.00002717871,0.0005019317,0.000015164005,0.000026673895,0.000002613037,0.09076895],"study_design_scores_gemma":[0.00222542,0.00008134284,0.9961775,0.00019483476,0.00032761716,1.8579398e-7,0.0000033321842,0.00024182892,0.00009364334,0.00012552422,0.00046156824,0.00006721409],"about_ca_topic_score_codex":0.000095218886,"about_ca_topic_score_gemma":0.0000037734299,"teacher_disagreement_score":0.09070174,"about_ca_system_score_codex":0.000052694253,"about_ca_system_score_gemma":0.00012201355,"threshold_uncertainty_score":0.2539377},"labels":[],"label_agreement":null},{"id":"W2626097771","doi":"10.1161/circoutcomes.4.suppl_2.ap235","title":"Abstract P235: Implications of the Selection of Target Markers for LDL Lowering","year":2011,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Apolipoprotein B; Framingham Risk Score; Medicine; Relative risk; Incidence (geometry); Internal medicine; Epidemiology; Demography; Cardiology; Cholesterol; Confidence interval; Mathematics; Disease","score_opus":0.07067054494220859,"score_gpt":0.31421440477726675,"score_spread":0.24354385983505816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626097771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9590584,0.001560186,0.036526456,0.00024285678,0.00016373202,0.0013256841,0.00003114984,0.00003181113,0.0010597467],"genre_scores_gemma":[0.99822277,0.00006866279,0.0014744506,0.000085729414,0.00005441252,0.000051267576,0.000012919661,0.000015981812,0.000013809342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986561,0.00009227012,0.00051062624,0.00023071608,0.00035984014,0.00015043473],"domain_scores_gemma":[0.9987562,0.00006488892,0.00019413159,0.0006430429,0.0002747008,0.00006705633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018154805,0.00011974447,0.00059970596,0.00006686054,0.0001187833,0.000005115664,0.00006905252,0.00010753615,0.000024770055],"category_scores_gemma":[0.00024230963,0.000089270805,0.0015028503,0.00020093283,0.000087802786,0.00007931677,0.000024665786,0.00009199924,4.818135e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008595826,0.0000986637,0.9601097,0.0014570514,0.0030113775,2.6235244e-7,0.00036992435,0.0002129017,0.0017348237,0.0023985994,0.000015689136,0.030505009],"study_design_scores_gemma":[0.0009824451,0.000023514396,0.9926658,0.000046242654,0.00046010542,0.000013248266,0.00010546305,0.000031920594,0.0041945376,0.0006969752,0.00068739086,0.00009235584],"about_ca_topic_score_codex":0.00040179736,"about_ca_topic_score_gemma":0.00000966409,"teacher_disagreement_score":0.03916439,"about_ca_system_score_codex":0.000044820194,"about_ca_system_score_gemma":0.000095373805,"threshold_uncertainty_score":0.36403576},"labels":[],"label_agreement":null},{"id":"W2626195555","doi":"10.1186/s12944-017-0502-x","title":"The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels","year":2017,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Fonds de Recherche du Québec - Santé; Institut sur la Nutrition et les Aliments Fonctionnels; Centre Hospitalier Universitaire de Québec; Canadian Institutes of Health Research; Université Laval","keywords":"PCSK9; Apolipoprotein B; Internal medicine; Lipidology; Endocrinology; Familial hypercholesterolemia; Clinical chemistry; Cholesterol; LDL receptor; Medicine; Chemistry; Lipoprotein","score_opus":0.03463973875698822,"score_gpt":0.3171289630611146,"score_spread":0.2824892243041264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626195555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952484,0.0015770909,0.000069910464,0.0017524419,0.00013923706,0.0010010122,0.00007567809,0.000004409284,0.00013187027],"genre_scores_gemma":[0.99859047,0.0006568719,0.00013296018,0.00039464093,0.0001248253,0.00005261713,0.000011068852,0.000009213506,0.00002731118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824446,0.00015528657,0.00074760366,0.0001990156,0.00039305814,0.00026055126],"domain_scores_gemma":[0.99844784,0.00007591242,0.00039266577,0.0006088551,0.000092135764,0.00038260157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011730007,0.00010646227,0.0004254342,0.00008852077,0.00017888808,0.0000126122395,0.00011916769,0.00007236282,0.0000059111053],"category_scores_gemma":[0.00086328376,0.000083135696,0.00009279008,0.00008469495,0.00017288278,0.00010113918,0.00004949487,0.00021657457,3.9560462e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018317003,0.0002765862,0.8771419,0.0025510862,0.000040229446,0.0000061745172,0.0030745994,0.000025257455,0.0005626626,0.002361199,0.000027834836,0.112100765],"study_design_scores_gemma":[0.004860545,0.00043861812,0.98986995,0.00091218215,0.000026794327,0.000002473811,0.0013192532,0.0006840299,0.00077434216,0.00051612523,0.0005149653,0.000080691236],"about_ca_topic_score_codex":0.003608657,"about_ca_topic_score_gemma":0.0006354558,"teacher_disagreement_score":0.112728074,"about_ca_system_score_codex":0.000072200084,"about_ca_system_score_gemma":0.0013292021,"threshold_uncertainty_score":0.5455234},"labels":[],"label_agreement":null},{"id":"W2626486323","doi":"10.1016/j.atherosclerosis.2017.06.026","title":"Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN","year":2017,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Genentech; Cleveland Clinic; Roche; Sigma-Tau Pharmaceuticals; Novartis; Deutsche Forschungsgemeinschaft; Merck; GlaxoSmithKline; Anthera; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Rosuvastatin; Medicine; Atheroma; Atorvastatin; Internal medicine; Intravascular ultrasound; Cardiology; Lipoprotein(a); Coronary artery disease; Mace; Statin; Lipoprotein; Cholesterol; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.025778466889975725,"score_gpt":0.28544261838673973,"score_spread":0.25966415149676403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626486323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937694,0.0037439668,0.000033881966,0.0006298714,0.0002896436,0.0012872622,0.000026088404,0.0001448649,0.000075002965],"genre_scores_gemma":[0.9944221,0.0033393379,0.00096271106,0.00027957058,0.0005548428,0.00011697069,0.00004705702,0.00008826232,0.00018916637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978646,0.000105667255,0.0003376479,0.00069729175,0.0005719241,0.00042289207],"domain_scores_gemma":[0.99765146,0.000032216572,0.00029908805,0.0015458238,0.00015013065,0.0003212729],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021763076,0.00037341134,0.00074100593,0.00005755094,0.00096920773,0.0002126107,0.00024464095,0.00024422898,0.00008574815],"category_scores_gemma":[0.00006506463,0.0002755208,0.00022428439,0.00006031333,0.0002664036,0.00029428178,0.00023197848,0.00036513965,0.00003395899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001002099,0.00031462382,0.6188025,0.0001518949,0.00052462955,0.0001117129,0.0009181644,1.7982035e-7,0.19947393,0.000028810675,0.000036592704,0.1786349],"study_design_scores_gemma":[0.004221771,0.00046557913,0.90813875,0.0007585468,0.000092044436,0.000035964877,0.00004644206,0.00001262,0.085701644,0.00014042963,0.00010692599,0.00027928132],"about_ca_topic_score_codex":0.0030644627,"about_ca_topic_score_gemma":0.00020320133,"teacher_disagreement_score":0.2893363,"about_ca_system_score_codex":0.00008698427,"about_ca_system_score_gemma":0.000066821405,"threshold_uncertainty_score":0.9999697},"labels":[],"label_agreement":null},{"id":"W2626971118","doi":"10.1007/s40264-017-0552-z","title":"Lipophilic Statins and the Risk of Intracranial Hemorrhage Following Ischemic Stroke: A Population-Based Study","year":2017,"lang":"en","type":"article","venue":"Drug Safety","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Hospital; Health Sciences Centre; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pravastatin; Odds ratio; Statin; Rosuvastatin; Atorvastatin; Stroke (engine); Internal medicine; Intracerebral hemorrhage; Population; Confidence interval; Subarachnoid hemorrhage; Cholesterol","score_opus":0.007320156132173619,"score_gpt":0.2591175840512058,"score_spread":0.25179742791903215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626971118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996362,0.0003389033,0.00034733486,0.00094069337,0.00014678302,0.0012527735,0.000049020437,0.000023165227,0.0005393727],"genre_scores_gemma":[0.9986644,0.0000338773,0.00082470325,0.00008660406,0.00021995086,0.000027998261,0.000015767191,0.000019263245,0.00010745549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859536,0.00020460412,0.00034155548,0.00023023128,0.0004498878,0.00017838644],"domain_scores_gemma":[0.9984559,0.00014028582,0.00025216243,0.0010116451,0.000051209314,0.0000888333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001955305,0.00013449276,0.0004945261,0.00003658738,0.0005173835,0.000030645817,0.00013980483,0.00004354572,0.000016900805],"category_scores_gemma":[0.0005630074,0.00008559749,0.00029596264,0.000046623638,0.000068560315,0.00007142272,0.000060640825,0.00025113526,0.0000023884932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016786823,0.00034489937,0.88139415,0.00024465207,0.0007605544,0.0001085227,0.0020877821,0.000055309683,0.00019645973,0.0000509697,0.000028227396,0.113049805],"study_design_scores_gemma":[0.014471858,0.000110406734,0.9799185,0.0000559375,0.00078478054,0.000011482569,0.0009219515,0.0032727644,0.00015579026,0.000036225032,0.00015059656,0.0001097066],"about_ca_topic_score_codex":0.007886212,"about_ca_topic_score_gemma":0.00048709844,"teacher_disagreement_score":0.1129401,"about_ca_system_score_codex":0.000039847848,"about_ca_system_score_gemma":0.000102988386,"threshold_uncertainty_score":0.99872035},"labels":[],"label_agreement":null},{"id":"W2679732736","doi":"10.1161/res.109.suppl_1.ap351","title":"Abstract P351: Statins Prevent Expansive Remodeling in Arterialized Vein Grafts","year":2011,"lang":"en","type":"article","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Atorvastatin; Medicine; Expansive; Urology; Placebo; Artery; Jugular vein; Statin; Intimal hyperplasia; Vein; Cardiology; Surgery; Internal medicine; Pathology","score_opus":0.21869215217216625,"score_gpt":0.40590681089561037,"score_spread":0.18721465872344412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2679732736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915326,0.000310718,0.0007488504,0.00021478353,0.00008212554,0.0012329833,0.0000034916354,0.000035237354,0.005839202],"genre_scores_gemma":[0.9987876,0.00009340399,0.0006138966,0.000054379652,0.00018237873,0.00010553275,0.000038226648,0.000025421039,0.00009917547],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99760455,0.00027463268,0.00038491073,0.00033612933,0.00097052305,0.00042922658],"domain_scores_gemma":[0.99878514,0.00004541894,0.00004953344,0.0005395315,0.00039634877,0.00018405834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028151553,0.00010009303,0.00026906826,0.00034045606,0.00010150176,0.00002609775,0.000083754305,0.00011154059,0.00047719516],"category_scores_gemma":[0.0003163273,0.00009353452,0.000115225266,0.0004179906,0.000056766683,0.00012837419,0.000035997036,0.00040234535,0.00008854354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037049071,0.0044374745,0.1335045,0.0039610607,0.00078529003,0.0017136694,0.04952468,0.0031642094,0.20716286,0.00510901,0.0013870301,0.5855453],"study_design_scores_gemma":[0.0025282388,0.0001317826,0.9877961,0.0002830926,0.000015080018,0.000025822892,0.0009058206,0.0030244791,0.0022404296,0.0023964616,0.000509244,0.000143419],"about_ca_topic_score_codex":0.0025137041,"about_ca_topic_score_gemma":0.00013566887,"teacher_disagreement_score":0.8542916,"about_ca_system_score_codex":0.00021951195,"about_ca_system_score_gemma":0.00037157114,"threshold_uncertainty_score":0.52249527},"labels":[],"label_agreement":null},{"id":"W269739206","doi":"","title":"Lipoprotein-complexed C-reactive protein and the biphasic transmittance waveform in critically ill patients.","year":2002,"lang":"en","type":"review","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Very low-density lipoprotein; Lipoprotein; Apolipoprotein B; Internal medicine; Coagulation; C-reactive protein; High-density lipoprotein; Precipitation; Thrombus; Cholesterol; Endocrinology; Biochemistry; Chemistry; Biology; Medicine; Inflammation; Physics","score_opus":0.03235406863298151,"score_gpt":0.26057492183516817,"score_spread":0.22822085320218666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W269739206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036050647,0.9671673,0.000030313246,0.0009027592,0.0001195269,0.026578113,0.000046938436,0.00006137329,0.0047331667],"genre_scores_gemma":[0.0015716937,0.96243095,0.00016741318,0.0008156653,0.00041116186,0.03379639,0.00005713378,0.000119291035,0.000630317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959177,0.00046709893,0.001042679,0.0007850523,0.0008366425,0.00095085974],"domain_scores_gemma":[0.9978304,0.0001389312,0.000246126,0.00096156314,0.00045419968,0.00036880202],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015763114,0.0006290196,0.0031337256,0.00026230802,0.00012053556,0.000057571626,0.00026367846,0.0004198804,0.000026465297],"category_scores_gemma":[0.00107791,0.00035813812,0.0009990634,0.00062185747,0.0003886931,0.00011761134,0.00006925227,0.0011683895,0.000019625475],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010896693,0.00014490637,0.00000677928,0.012175088,0.00028992762,0.000043185777,0.00009108875,1.2633822e-8,2.2884617e-8,0.00047803417,0.000029945044,0.98663205],"study_design_scores_gemma":[0.007026064,0.000097716525,0.003413832,0.0055874987,0.0011874185,0.00010791046,0.000026490381,0.000005807287,0.0000028832717,0.0001964421,0.9818501,0.0004978756],"about_ca_topic_score_codex":0.00042013865,"about_ca_topic_score_gemma":0.00006370185,"teacher_disagreement_score":0.9861342,"about_ca_system_score_codex":0.00040513225,"about_ca_system_score_gemma":0.00016034457,"threshold_uncertainty_score":0.99988705},"labels":[],"label_agreement":null},{"id":"W27039945","doi":"10.1056/nejmoa1600177","title":"مقایسه تشخیص بروسلوزیس در انسان به روش PCR با استفاده از ژنهای srRNA16،12/L7L و روش های سرولوژیک","year":2012,"lang":"fa","type":"article","venue":"مجله دانشگاه علوم پزشکی اراک","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Computer science","score_opus":0.02823923222141689,"score_gpt":0.2766207389732506,"score_spread":0.24838150675183374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W27039945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6598308,0.1644427,0.0025082214,0.012268261,0.023351729,0.009531988,0.0006850345,0.0017382748,0.12564299],"genre_scores_gemma":[0.9288091,0.008867569,0.0014776171,0.0062934156,0.02367733,0.00053579075,0.00043803113,0.00074508047,0.02915607],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9821091,0.0015535617,0.003030325,0.0026355323,0.0045339013,0.0061375555],"domain_scores_gemma":[0.98778564,0.00047807881,0.0011458014,0.0054468806,0.00080811925,0.004335501],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.006991788,0.002478562,0.0042025484,0.0007022511,0.0013803621,0.00040152215,0.0015651586,0.0021733232,0.007334707],"category_scores_gemma":[0.0010605514,0.0022758623,0.0031645666,0.0019844065,0.0007511886,0.001366265,0.0010405895,0.0036330537,0.0147357825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026769442,0.009521048,0.10372721,0.011030546,0.011772343,0.002395384,0.020808754,0.00012908848,0.00779975,0.012037793,0.23306096,0.5850402],"study_design_scores_gemma":[0.011065318,0.0017524441,0.09949816,0.0021217098,0.003688032,0.0014659368,0.003574198,0.0003673574,0.0055200146,0.0005110967,0.8670363,0.003399452],"about_ca_topic_score_codex":0.005636753,"about_ca_topic_score_gemma":0.0006792881,"teacher_disagreement_score":0.6339753,"about_ca_system_score_codex":0.0015627926,"about_ca_system_score_gemma":0.0013160601,"threshold_uncertainty_score":0.9999197},"labels":[],"label_agreement":null},{"id":"W2728263861","doi":"10.14740/cr548w","title":"Heterozygous Familial Hypercholesterolemia With APOE Haplotype: A Prospective Harbinger of a Catastrophic Cardiovascular Event","year":2017,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Coronary artery disease; Familial hypercholesterolemia; Cardiac catheterization; Family history; Cholesterol","score_opus":0.06585675580580136,"score_gpt":0.3646117594980881,"score_spread":0.29875500369228675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2728263861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889521,0.004273966,0.0009010393,0.0003816698,0.00018066126,0.0018861544,0.000032434295,0.000045216773,0.0033467498],"genre_scores_gemma":[0.997446,0.00039421674,0.0003880153,0.000038497194,0.0010035402,0.00037832794,0.000019217066,0.00006455571,0.0002676302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958499,0.0006601156,0.00034839168,0.00080872746,0.0014451235,0.000887759],"domain_scores_gemma":[0.9950346,0.000057253645,0.00010300693,0.0034458742,0.0010270623,0.00033220273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003606961,0.00026158887,0.0016087493,0.00024577146,0.00059004495,0.000046056626,0.0004964492,0.00029510257,0.00001016216],"category_scores_gemma":[0.00050028873,0.000192278,0.0008661867,0.00017866804,0.0013898241,0.0001155341,0.00036505982,0.0011698757,0.00005454647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073295757,0.00044935758,0.85799944,0.001973568,0.020339256,0.007181288,0.0011671197,0.0006426769,0.017646737,0.0003536613,0.0015742165,0.08334312],"study_design_scores_gemma":[0.0072777937,0.0032993476,0.9691172,0.0004146749,0.0007208201,0.0030540656,0.00030288997,0.000053489246,0.0039258595,0.00011011665,0.0113852415,0.00033848328],"about_ca_topic_score_codex":0.0010391658,"about_ca_topic_score_gemma":0.000028652812,"teacher_disagreement_score":0.111117795,"about_ca_system_score_codex":0.00026320358,"about_ca_system_score_gemma":0.00067608996,"threshold_uncertainty_score":0.784087},"labels":[],"label_agreement":null},{"id":"W2729453526","doi":"10.14740/jocmr3046e","title":"Detection of Apolipoprotein E Gene Polymorphism and Blood Lipid Level in Hemodialysis Patients","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Internal medicine; Medicine; Hemodialysis; Apolipoprotein B; Apolipoprotein E; Endocrinology; Lipid profile; Triglyceride; Genotype; Dyslipidemia; Lipoprotein; Blood lipids; Gene polymorphism; Cholesterol; Disease; Gene; Biology; Biochemistry","score_opus":0.2171236880045352,"score_gpt":0.4799177940345313,"score_spread":0.2627941060299961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2729453526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921311,0.0019371896,0.00012394381,0.0044980035,0.0003499431,0.00044769817,0.0000027767353,0.000002431564,0.00050692266],"genre_scores_gemma":[0.9916351,0.0045727794,0.00049138075,0.000081682316,0.0031162833,0.000005901906,0.0000011106671,0.00001789792,0.000077849814],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9947479,0.0006801682,0.0018650007,0.00024305012,0.0021096654,0.0003542636],"domain_scores_gemma":[0.9960265,0.000545438,0.000894669,0.00076566916,0.0012227295,0.0005449722],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018572483,0.00012387683,0.0013695089,0.0005949972,0.00015370148,0.000015291356,0.0002793441,0.00023648031,0.000033164808],"category_scores_gemma":[0.01582578,0.00008191733,0.00033121178,0.0002404393,0.0007087094,0.000132059,0.00014117677,0.0014508405,0.0000022660747],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015558198,0.00079545355,0.27284476,0.00028924158,0.00039475062,0.00016478306,0.00013001537,3.721112e-7,0.0068833693,0.000012227637,0.000095348376,0.7168339],"study_design_scores_gemma":[0.016803445,0.0058732233,0.96122134,0.000981303,0.0002580412,0.00015394218,0.00008981328,0.000039410712,0.013236568,0.00027294643,0.0009953154,0.00007464095],"about_ca_topic_score_codex":0.001950323,"about_ca_topic_score_gemma":0.000102226855,"teacher_disagreement_score":0.7167592,"about_ca_system_score_codex":0.000053559295,"about_ca_system_score_gemma":0.0004168479,"threshold_uncertainty_score":0.99246436},"labels":[],"label_agreement":null},{"id":"W2730104500","doi":"10.71781/31208","title":"Implication des protéines kinases C dans l'activation et la fonction plaquettaire","year":2005,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Molecular biology; Chemistry; Biology","score_opus":0.006224678864909915,"score_gpt":0.21219494472281036,"score_spread":0.20597026585790046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2730104500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.914589,0.018348519,0.0025617413,0.0006090124,0.00085988076,0.0018549734,0.000055714045,0.00022823141,0.06089293],"genre_scores_gemma":[0.96690667,0.002859049,0.0011152533,0.00014895396,0.0012991413,0.00028464638,0.0019904694,0.00007891236,0.025316887],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99646264,0.00046580465,0.0006000418,0.00083427154,0.0010464471,0.00059077475],"domain_scores_gemma":[0.997584,0.00013027819,0.00054859644,0.00065401447,0.0006318031,0.00045135012],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.000623554,0.000598392,0.0006201429,0.0003909153,0.0062354673,0.00008425601,0.00024250647,0.0008201038,0.000051119776],"category_scores_gemma":[0.00017706557,0.0006594826,0.0006153172,0.0005087246,0.00036235797,0.00083457347,0.00008274229,0.00070765114,0.00007397122],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049732635,0.0022457675,0.09028657,0.004930644,0.0030147373,0.0020374977,0.08863207,0.0085770255,0.32582834,0.119851515,0.0007209372,0.34890163],"study_design_scores_gemma":[0.0032413758,0.0004520032,0.7445138,0.0028205304,0.00153021,0.003339757,0.055161998,0.0011540751,0.12170392,0.0004236032,0.064711176,0.0009475233],"about_ca_topic_score_codex":0.07656927,"about_ca_topic_score_gemma":0.015981628,"teacher_disagreement_score":0.65422726,"about_ca_system_score_codex":0.0115639595,"about_ca_system_score_gemma":0.0037059821,"threshold_uncertainty_score":0.9995856},"labels":[],"label_agreement":null},{"id":"W2731199601","doi":"10.1210/jc.2017-00684","title":"The Effect of PCSK9 Loss-of-Function Variants on the Postprandial Lipid and ApoB-Lipoprotein Response","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; University of Alberta; University of Ottawa; Ottawa Hospital","funders":"","keywords":"PCSK9; Postprandial; Apolipoprotein B; Internal medicine; Endocrinology; LDL receptor; Kexin; Lipoprotein; Proprotein convertase; Cholesterol; Chemistry; Medicine; Insulin","score_opus":0.03540371316497981,"score_gpt":0.36483228530379175,"score_spread":0.32942857213881194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731199601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9705958,0.0055354508,0.000065146625,0.021100959,0.0017388063,0.00066595356,0.000004320604,0.0000055856885,0.00028800868],"genre_scores_gemma":[0.99165994,0.0054777926,0.00003486569,0.0005055677,0.0021964125,0.000008515285,2.6095498e-7,0.000018764857,0.0000978849],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9929346,0.0045037633,0.00138899,0.00017011965,0.0006583315,0.0003442029],"domain_scores_gemma":[0.9905255,0.0058571543,0.0017326557,0.001427155,0.00030948143,0.00014805721],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018400144,0.00019655583,0.0013051089,0.0000755173,0.0005654877,0.000024183802,0.0006116212,0.00016810573,0.000024427101],"category_scores_gemma":[0.015539987,0.00007431042,0.00073048845,0.00007122233,0.0014073335,0.00008236521,0.0001578336,0.0013031515,0.000007081698],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33918372,0.00036435723,0.011690042,0.00013887743,0.00448745,0.00019232083,0.0003229937,0.000011747756,0.005148433,0.008392751,0.0007498632,0.62931746],"study_design_scores_gemma":[0.010973824,0.0100864,0.9277929,0.00017691757,0.001981893,0.0011471246,0.00006604715,0.00001305503,0.006423147,0.0011229194,0.040123478,0.00009228674],"about_ca_topic_score_codex":0.00016174196,"about_ca_topic_score_gemma":0.000010250393,"teacher_disagreement_score":0.9161029,"about_ca_system_score_codex":0.000009951721,"about_ca_system_score_gemma":0.0002714827,"threshold_uncertainty_score":0.99275255},"labels":[],"label_agreement":null},{"id":"W2731831602","doi":"10.1161/01.str.32.suppl_1.362","title":"Clinical Characteristics of Coronary Heart Disease as Predictors of Ischemic Stroke: A Long-term Prospective Follow-up in the BIP Study.","year":2000,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bezafibrate; Internal medicine; Stroke (engine); Myocardial infarction; Cardiology; Angina; Canadian Cardiovascular Society; Coronary heart disease; Unstable angina; Vascular disease; Risk factor; Ischemic stroke; Physical therapy; Ischemia","score_opus":0.016243823448010817,"score_gpt":0.3069117216501141,"score_spread":0.29066789820210326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731831602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99578696,0.00048862485,0.0000039301735,0.00016359508,0.00018277888,0.0020951086,0.00018025904,0.0000192405,0.0010795017],"genre_scores_gemma":[0.9979609,0.00018593828,0.000023941777,0.0001741401,0.0003629826,0.00009174931,0.00003365265,0.000021808974,0.0011448391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977556,0.00024169711,0.0007000657,0.00032256296,0.00072319014,0.00025687905],"domain_scores_gemma":[0.9987187,0.000082246894,0.00013275178,0.00078293757,0.00010171053,0.00018168923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009564288,0.00016838913,0.00070182164,0.000066197426,0.000037341888,0.000006444269,0.00016386589,0.00008707714,0.00018515409],"category_scores_gemma":[0.0001750326,0.000116707895,0.00041111448,0.00015982955,0.00016627477,0.000050497805,0.000038663282,0.0003835507,0.000013939223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020335275,0.0013166952,0.98585945,0.00016373562,0.00028199592,0.00012752473,0.0005690172,2.6790664e-7,0.00015729967,0.00000492518,0.00018585399,0.009299691],"study_design_scores_gemma":[0.004353433,0.001882992,0.9921568,0.0001485193,0.00039133383,0.000026372492,0.0003546158,0.0000039407114,0.00011153015,0.0000036548558,0.00047943648,0.000087358894],"about_ca_topic_score_codex":0.00014801246,"about_ca_topic_score_gemma":0.000023099983,"teacher_disagreement_score":0.009212332,"about_ca_system_score_codex":0.000046929057,"about_ca_system_score_gemma":0.00036409395,"threshold_uncertainty_score":0.47592098},"labels":[],"label_agreement":null},{"id":"W2732184791","doi":"10.4212/cjhp.v70i3.1664","title":"Should Patients Continue to Receive Statins Once They Reach 80 Years of Age?","year":2017,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia; Native Mental Health Association of Canada","funders":"","keywords":"Medicine; Family medicine; Demography; Sociology","score_opus":0.0347378404197968,"score_gpt":0.3197811434372865,"score_spread":0.2850433030174897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732184791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073017,0.00035503044,0.000008239605,0.0052383686,0.00070947903,0.0004685602,0.000049436887,0.0000027161434,0.002437993],"genre_scores_gemma":[0.9983561,0.00008104681,0.00020519992,0.00070980884,0.0004203317,0.0000031427721,0.00000311664,0.000022251425,0.00019897606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99873143,0.0000710545,0.00034814546,0.00010490845,0.0004523883,0.00029206392],"domain_scores_gemma":[0.9979312,0.00002514357,0.00038453945,0.0004993998,0.00041761657,0.0007421408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000804901,0.0001059657,0.0003564588,0.00009822984,0.00024656544,0.000066523186,0.0004377528,0.00003069483,0.000050726314],"category_scores_gemma":[0.00055043696,0.000076713775,0.00022433557,0.00005220927,0.00011840347,0.00014403168,0.000028204295,0.00038238545,0.000014039643],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065056636,0.00035331066,0.2581431,0.00017481235,0.0015785748,0.0026286393,0.023874832,0.000060437465,0.0008293473,0.0003284048,0.03836569,0.67301226],"study_design_scores_gemma":[0.004468938,0.0014013905,0.88844824,0.00040443297,0.0002956116,0.000070925926,0.00038320493,0.000005475373,0.001676692,0.0002811909,0.10236726,0.0001966646],"about_ca_topic_score_codex":0.069188304,"about_ca_topic_score_gemma":0.022390475,"teacher_disagreement_score":0.6728156,"about_ca_system_score_codex":0.00018478028,"about_ca_system_score_gemma":0.0010324429,"threshold_uncertainty_score":0.99544835},"labels":[],"label_agreement":null},{"id":"W2732792053","doi":"10.1016/j.ijcard.2017.06.105","title":"Risk factors associated with atherogenic dyslipidemia in the presence of optimal statin therapy","year":2017,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Dyslipidemia; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ldl cholesterol; Atherosclerotic cardiovascular disease; Internal medicine; Intensive care medicine; Cholesterol; Disease","score_opus":0.03721382481593154,"score_gpt":0.3297387410199592,"score_spread":0.29252491620402765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2732792053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968597,0.000493773,0.0010446862,0.00068728457,0.00030303307,0.00015361664,0.00001872514,0.0000021953408,0.0004369493],"genre_scores_gemma":[0.9987595,0.00056008704,0.00014400532,0.0000740779,0.0004332589,0.0000035164567,0.000004063199,0.000008252691,0.000013212379],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984027,0.0003796988,0.00037457517,0.000092367816,0.00062028924,0.00013033251],"domain_scores_gemma":[0.99809813,0.00027198406,0.0007795871,0.0002966492,0.0005107789,0.000042876087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019689852,0.00008808677,0.0004535495,0.000088770874,0.00004931195,0.000017181628,0.00049498363,0.0000772946,0.000009985079],"category_scores_gemma":[0.001155273,0.00004583798,0.00030607163,0.000034205576,0.00015028393,0.000091210655,0.000028381553,0.00036744194,4.9416457e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077347795,0.000060838145,0.98277384,0.000004089997,0.0028739064,0.0002319094,0.00084893,0.0018690553,0.00044574842,0.00011080803,0.00019303337,0.009814392],"study_design_scores_gemma":[0.0028294416,0.0006472956,0.99363035,0.00008399235,0.000081644655,0.00026478537,0.00034013955,0.00005294726,0.00061911275,0.00011635648,0.0012856151,0.000048318532],"about_ca_topic_score_codex":0.0001293757,"about_ca_topic_score_gemma":0.00001854685,"teacher_disagreement_score":0.01085654,"about_ca_system_score_codex":0.00006939144,"about_ca_system_score_gemma":0.00019944763,"threshold_uncertainty_score":0.18692185},"labels":[],"label_agreement":null},{"id":"W2734434515","doi":"10.1161/circulationaha.117.028208","title":"Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia","year":2017,"lang":"en","type":"letter","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Robarts Research Institute; University of Cape Town; Cedars-Sinai Medical Center; University of Pennsylvania","keywords":"Medicine; Microsomal triglyceride transfer protein; Familial hypercholesterolemia; Triglyceride; Internal medicine; Cholesterylester transfer protein; Endocrinology; Cholesterol; Lipoprotein; Very low-density lipoprotein","score_opus":0.010589634190535494,"score_gpt":0.22473028377321488,"score_spread":0.2141406495826794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734434515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98759186,0.00020904306,0.00007164015,0.007438728,0.0001734659,0.004385513,0.00005825036,0.000018277347,0.000053233503],"genre_scores_gemma":[0.99318534,0.000013094912,0.000029483692,0.005143956,0.0011279664,0.00007186734,0.00030148728,0.00007126489,0.00005552055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774235,0.00018703591,0.00053472235,0.00050324004,0.0007083965,0.0003242605],"domain_scores_gemma":[0.99853516,0.00002479996,0.00019097103,0.0010375354,0.000143993,0.000067541914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027616337,0.00032808317,0.00076056767,0.00013085753,0.00013888847,0.00003658988,0.00016109998,0.0006294702,0.0000059088857],"category_scores_gemma":[0.0000565115,0.00022292185,0.00023305247,0.000103466205,0.00020593246,0.00011450103,0.000039537033,0.00096659723,0.0000019652175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025982559,0.0002654887,0.9514111,0.0030199655,0.00034488327,0.00022327929,0.00041339398,0.000017517728,0.0029051094,0.0000017549742,0.00060242636,0.038196784],"study_design_scores_gemma":[0.011716102,0.00017904383,0.98357314,0.0020192796,0.00025871635,0.00005680512,0.0000022637298,0.0000030508415,0.0005292829,0.0000032392584,0.0014302887,0.00022880164],"about_ca_topic_score_codex":0.00014642134,"about_ca_topic_score_gemma":0.00004940555,"teacher_disagreement_score":0.037967984,"about_ca_system_score_codex":0.00021515673,"about_ca_system_score_gemma":0.00025647625,"threshold_uncertainty_score":0.9090489},"labels":[],"label_agreement":null},{"id":"W2735575702","doi":"10.1002/jca.21569","title":"Impact of lipoprotein apheresis with dextran‐sulfate adsorption on the expression of genes involved in cardiovascular health in the blood of patients with homozygous familial hypercholesterolemia","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Apheresis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; Université Laval","keywords":"Medicine; Familial hypercholesterolemia; Lipoprotein; Apheresis; Internal medicine; Whole blood; Lipoprotein(a); Blood lipids; Cholesterol; Endocrinology; Immunology; Platelet","score_opus":0.04318635970141457,"score_gpt":0.3352089156645957,"score_spread":0.29202255596318116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735575702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965123,0.0017465515,0.00007316456,0.00039272202,0.00005493645,0.0011423081,0.000024091702,0.0000027372514,0.000051182564],"genre_scores_gemma":[0.99745923,0.0015269892,0.00067801005,0.00008635529,0.00019710428,0.000015552712,0.0000029907046,0.000030222254,0.0000035170187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944933,0.0013750659,0.0020136791,0.00027349882,0.0015377232,0.00030670268],"domain_scores_gemma":[0.99517566,0.00039872667,0.0022620743,0.0014805386,0.00050881825,0.00017417534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062279175,0.00025533102,0.001980538,0.00015638392,0.00008462527,0.00001879618,0.0005504865,0.00018301298,0.000016623244],"category_scores_gemma":[0.0007226561,0.00010916933,0.0013850966,0.00025442056,0.00032905818,0.00015421801,0.00004991576,0.0007993596,4.0859578e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012210065,0.0033165885,0.8980056,0.0004701171,0.0015667402,0.00007354597,0.00038513442,0.0005092349,0.0007297545,0.000006489895,0.000041440115,0.082685284],"study_design_scores_gemma":[0.011899407,0.00841068,0.97402155,0.0026230244,0.00044784215,0.000025821273,0.00028655914,0.000008675437,0.00209352,0.00003832217,0.000038387276,0.00010617707],"about_ca_topic_score_codex":0.0033612305,"about_ca_topic_score_gemma":0.0009152117,"teacher_disagreement_score":0.082579106,"about_ca_system_score_codex":0.00005789475,"about_ca_system_score_gemma":0.00063830405,"threshold_uncertainty_score":0.50811976},"labels":[],"label_agreement":null},{"id":"W2735680270","doi":"10.1021/acs.biochem.6b01174","title":"Relationship between Amphipathic β Structures in the β<sub>1</sub> Domain of Apolipoprotein B and the Properties of the Secreted Lipoprotein Particles in McA-RH7777 Cells","year":2017,"lang":"en","type":"article","venue":"Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; University of Ottawa","keywords":"Apolipoprotein B; Microsomal triglyceride transfer protein; Chemistry; Amphiphile; Secretion; Lipoprotein; Biochemistry; Very low-density lipoprotein; Phospholipid; Cholesterol; Copolymer","score_opus":0.027077637218320082,"score_gpt":0.24695681135901906,"score_spread":0.219879174140699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2735680270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940419,0.0021987846,0.0000054381667,0.0023346548,0.000026810108,0.0012568772,0.000014093261,0.000007422097,0.000113971866],"genre_scores_gemma":[0.99951905,0.000041640782,0.00006308107,0.00006378312,0.00017010518,0.00011153697,0.0000030805331,0.000015455442,0.000012283106],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998181,0.00034139908,0.00048134744,0.00024111694,0.0005111881,0.00024399141],"domain_scores_gemma":[0.9980264,0.000104582316,0.0003381769,0.0014164316,0.00006148496,0.000052929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020793574,0.00017052461,0.0004259777,0.000035199133,0.00022440587,0.000034928507,0.00042917643,0.00019745601,0.0000015295655],"category_scores_gemma":[0.00090627803,0.00008078685,0.0001737573,0.00016268728,0.000923803,0.000045285564,0.00014221173,0.00046306456,4.965805e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045339865,0.00006104731,0.14708804,0.0015336782,0.00007473187,0.0000067758942,0.0027852324,0.000003882886,0.842036,0.0006873891,0.000018783732,0.0052510626],"study_design_scores_gemma":[0.0015275881,0.000023658187,0.3551889,0.0003242671,0.000046657504,0.000009869484,0.0005532086,0.00001084646,0.6405078,0.0017325291,0.000010130931,0.00006451157],"about_ca_topic_score_codex":0.0015988491,"about_ca_topic_score_gemma":0.00016763396,"teacher_disagreement_score":0.20810089,"about_ca_system_score_codex":0.000038375532,"about_ca_system_score_gemma":0.00018851843,"threshold_uncertainty_score":0.3403791},"labels":[],"label_agreement":null},{"id":"W2736782919","doi":"10.3390/jcm6080075","title":"Statins, Muscle Disease and Mitochondria","year":2017,"lang":"en","type":"review","venue":"Journal of Clinical Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mitochondrion; Disease; Statin; Pharmacology; Internal medicine; Biochemistry","score_opus":0.2660537970352437,"score_gpt":0.5355849338444598,"score_spread":0.26953113680921614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736782919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004448168,0.9936178,0.00006821955,0.0021796902,0.0023855574,0.0007579823,0.000012568854,0.00000873965,0.00092498],"genre_scores_gemma":[0.00002470983,0.9828502,0.00062977127,0.00053329935,0.015232009,0.00000821984,0.000015073809,0.00005247493,0.00065422116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994283,0.00050595694,0.003526165,0.0003315779,0.0010901095,0.0002631428],"domain_scores_gemma":[0.992692,0.0008436033,0.003297585,0.0010318692,0.00038178527,0.0017531554],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005586797,0.00035199831,0.006791398,0.00021084258,0.00009136855,0.000020195288,0.0002801628,0.0003595234,0.00012422256],"category_scores_gemma":[0.013501947,0.00018521895,0.0019006844,0.000089030946,0.0004326004,0.000082577135,0.00007795321,0.0017904128,0.000015040078],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117894655,0.00010732164,0.00007431922,0.017499454,0.000873996,0.0013508354,0.000011733618,7.611869e-9,3.285829e-8,0.000019658124,0.007807731,0.97213703],"study_design_scores_gemma":[0.003098692,0.0014065948,0.0033608144,0.07110937,0.0097881425,0.0007845895,0.000011895871,9.709538e-7,8.185809e-9,0.00009146816,0.9102118,0.00013564501],"about_ca_topic_score_codex":0.000016073405,"about_ca_topic_score_gemma":0.0000016378891,"teacher_disagreement_score":0.9720014,"about_ca_system_score_codex":0.000047196703,"about_ca_system_score_gemma":0.0019530935,"threshold_uncertainty_score":0.9948077},"labels":[],"label_agreement":null},{"id":"W2738197143","doi":"10.1161/circulationaha.116.025158","title":"Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia","year":2017,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"AstraZeneca","keywords":"Medicine; Intima-media thickness; Rosuvastatin; Internal medicine; Cardiology; Confidence interval; Common carotid artery; Carotid arteries; Familial hypercholesterolemia; Arteriosclerosis; Cholesterol","score_opus":0.010722788546985296,"score_gpt":0.2660674616789938,"score_spread":0.25534467313200854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738197143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998209,0.0000358031,0.00025839393,0.000052901454,0.000092995986,0.0010000502,0.0000069487983,0.000021837595,0.00032207943],"genre_scores_gemma":[0.99952435,0.000008227829,0.000091595255,0.000049761118,0.00020183827,0.00004055391,0.000055765584,0.00002461524,0.0000033095714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879164,0.00013586262,0.00021502322,0.00025829772,0.0004204775,0.00017873314],"domain_scores_gemma":[0.99893916,0.000037134203,0.00014244992,0.0007483374,0.00005777169,0.00007513955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006642574,0.00014196367,0.0003963206,0.00010220607,0.00009080196,0.000023095161,0.000093352726,0.000106514264,0.000004666361],"category_scores_gemma":[0.00016593057,0.00010616914,0.00010312204,0.00006348787,0.00008052728,0.00010264893,0.000021998203,0.00022227016,0.000009149322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027746096,0.000043314452,0.9518333,0.00015513426,0.00004613231,0.0000076627,0.000247531,0.00034861782,0.0023903928,0.000012060071,0.0000022382692,0.044636134],"study_design_scores_gemma":[0.0041698916,0.00046654564,0.9902833,0.00030110136,0.00008243982,0.000088597946,0.000010160967,0.00013972589,0.004353135,0.000008729306,0.000003068865,0.00009327252],"about_ca_topic_score_codex":0.00067745097,"about_ca_topic_score_gemma":0.000063361025,"teacher_disagreement_score":0.04454286,"about_ca_system_score_codex":0.00008731661,"about_ca_system_score_gemma":0.0000628178,"threshold_uncertainty_score":0.4329452},"labels":[],"label_agreement":null},{"id":"W2738941847","doi":"10.1161/jaha.117.005549","title":"Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol","year":2017,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto; University Health Network","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; AstraZeneca","keywords":"Medicine; Internal medicine; Very low-density lipoprotein; Cholesterol; Lipoprotein; Endocrinology; Rosuvastatin; Statin; Hazard ratio; Residual risk; Population; Lipoprotein particle; Triglyceride; Confidence interval","score_opus":0.00827780238559539,"score_gpt":0.24856869965018843,"score_spread":0.24029089726459305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738941847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776065,0.00073666376,0.000048911705,0.0004977107,0.000098343924,0.00081695913,0.000024694844,0.000009053385,0.000007033243],"genre_scores_gemma":[0.99830747,0.00049662904,0.00041892275,0.00011164041,0.0005595944,0.000014310902,8.1535774e-7,0.000034337732,0.00005626647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965614,0.00067409023,0.0005842219,0.0002510572,0.0016129311,0.00031629033],"domain_scores_gemma":[0.99554425,0.00006551812,0.0024118582,0.0012268907,0.00045423818,0.00029725465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004041077,0.0002079163,0.0012969848,0.00009734451,0.00042829846,0.000086133194,0.0002596536,0.00008438103,0.0000023134648],"category_scores_gemma":[0.0015140342,0.0001345655,0.0009147087,0.00014740716,0.00029957565,0.0002734234,0.00012463747,0.0005069476,0.0000021732676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029514506,0.000100320765,0.9718699,0.00010402578,0.0021615122,0.000025618005,0.00017692782,0.00007077647,0.00017443439,3.272016e-7,0.00005046807,0.02497054],"study_design_scores_gemma":[0.0020024236,0.00055706355,0.9888721,0.0006500252,0.0020495185,0.00009366379,0.0000835623,0.000049501665,0.005310929,0.000033911267,0.00015913404,0.00013812979],"about_ca_topic_score_codex":0.005727066,"about_ca_topic_score_gemma":0.00025472287,"teacher_disagreement_score":0.02483241,"about_ca_system_score_codex":0.00025252797,"about_ca_system_score_gemma":0.00033557304,"threshold_uncertainty_score":0.8657649},"labels":[],"label_agreement":null},{"id":"W2739969222","doi":"10.1371/journal.pone.0180869","title":"Roles of the low density lipoprotein receptor and related receptors in inhibition of lipoprotein(a) internalization by proprotein convertase subtilisin/kexin type 9","year":2017,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Western University; University of Windsor","funders":"Ionis Pharmaceuticals; Regeneron Pharmaceuticals; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Internalization; PCSK9; Kexin; Proprotein convertase; LDL receptor; Lipoprotein; Receptor; Endocrinology; Internal medicine; Biology; Lipoprotein(a); Low-density lipoprotein; Familial hypercholesterolemia; Cell biology; Cholesterol; Biochemistry; Medicine","score_opus":0.01675227756962213,"score_gpt":0.22567262464808985,"score_spread":0.2089203470784677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739969222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953918,0.0009851654,0.000032753833,0.0008207929,0.000087994726,0.0024096582,0.000020783127,0.000025143057,0.00022591212],"genre_scores_gemma":[0.9983933,0.0004223776,0.0005531298,0.000047364545,0.00006886305,0.000059419228,0.000045502988,0.000034555615,0.00037547582],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99790454,0.00020881988,0.00059586845,0.0003483766,0.0007185417,0.00022383289],"domain_scores_gemma":[0.9979286,0.000016749274,0.00057879253,0.0009833903,0.0003812184,0.0001112355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008911528,0.00019382576,0.00064422993,0.00010529098,0.00013506303,0.000024586023,0.00016300734,0.00024194695,0.00010238658],"category_scores_gemma":[0.001026302,0.00014939728,0.00012498241,0.00018742301,0.00030418244,0.00017891792,0.00014254465,0.00035025654,0.000007693948],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013746247,0.0021297666,0.05815037,0.002930971,0.00054346427,0.000012587117,0.0010429324,0.0000010704541,0.9058513,0.00021647238,0.00016452793,0.02758192],"study_design_scores_gemma":[0.0022417763,0.00042722462,0.028044092,0.003967033,0.00015416741,0.0000072807384,0.00007800637,0.000110640925,0.9644634,0.00031404645,0.000045723853,0.00014660979],"about_ca_topic_score_codex":0.004091085,"about_ca_topic_score_gemma":0.00061249366,"teacher_disagreement_score":0.05861211,"about_ca_system_score_codex":0.000097565244,"about_ca_system_score_gemma":0.0001403303,"threshold_uncertainty_score":0.61845237},"labels":[],"label_agreement":null},{"id":"W2740003000","doi":"10.1016/j.gheart.2017.03.002","title":"World Heart Federation Cholesterol Roadmap","year":2017,"lang":"en","type":"review","venue":"Global Heart","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Hamilton Health Sciences; McGill University Health Centre","funders":"World Heart Federation","keywords":"Medicine; Psychological intervention; Disease; Statin; Population; Intensive care medicine; Cholesterol; Environmental health; Nursing; Internal medicine","score_opus":0.11118869558523026,"score_gpt":0.42632417924993815,"score_spread":0.3151354836647079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740003000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012862137,0.98100144,0.000020577067,0.00068529503,0.00093136344,0.0021624602,0.00006235099,0.000114405746,0.015009256],"genre_scores_gemma":[0.000071270006,0.9910495,0.00036952127,0.0011710074,0.0026516675,0.00016963008,0.00022793005,0.000051088056,0.004238364],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973327,0.00020737568,0.00061753107,0.00062834437,0.00069442973,0.0005196052],"domain_scores_gemma":[0.9975619,0.000013591518,0.00019541942,0.0017118916,0.00010267682,0.00041455252],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00072031573,0.0004566798,0.0026916966,0.000095408745,0.00036202144,0.00020373282,0.00016724199,0.0003786961,0.00009739268],"category_scores_gemma":[0.000071441806,0.00035771108,0.0016211163,0.0002038827,0.000060881895,0.00010610271,0.00009204625,0.00050912035,0.0015962155],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008565762,0.00005360852,0.00008624769,0.0095608765,0.00018548965,0.00002787961,0.0000025743955,5.6482843e-8,3.7944147e-8,0.00006686898,0.02941962,0.96058816],"study_design_scores_gemma":[0.00046453884,0.00011177273,0.001011993,0.01229047,0.00077874196,0.0013301676,0.0000017179237,0.0000010210108,4.0029218e-7,0.000014876566,0.98373055,0.00026373786],"about_ca_topic_score_codex":0.0005112519,"about_ca_topic_score_gemma":0.00029603505,"teacher_disagreement_score":0.96032447,"about_ca_system_score_codex":0.000510492,"about_ca_system_score_gemma":0.0010226766,"threshold_uncertainty_score":0.99988747},"labels":[],"label_agreement":null},{"id":"W2740992979","doi":"10.1097/01.hjh.0000523555.59908.14","title":"[PP.14.12] LABORATORY PREDICTORS OF THE RISK OF ADVERSE OUTCOMES IN UNSTABLE ANGINA AND ARTERIAL HYPERTENSION","year":2017,"lang":"en","type":"article","venue":"Journal of Hypertension","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Unstable angina; Internal medicine; Cardiology; Myocardial infarction; Adverse effect; Blood pressure; Angina; Canadian Cardiovascular Society; Von Willebrand factor; Platelet","score_opus":0.016097340769025765,"score_gpt":0.2297970245031656,"score_spread":0.21369968373413983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740992979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969279,0.0012523476,0.0000062900695,0.00061934354,0.0008759877,0.00023753339,0.000013367772,0.0000031501097,0.00006403867],"genre_scores_gemma":[0.99760073,0.0017711773,0.00025082284,0.00012373707,0.00021120043,7.674041e-7,5.640496e-7,0.000014474033,0.000026520142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847084,0.00013453202,0.00054473773,0.000121228244,0.00057059963,0.00015803706],"domain_scores_gemma":[0.99795943,0.000045047644,0.000805218,0.0006145713,0.0004675439,0.000108206856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001102229,0.00012539061,0.00079379336,0.0001064851,0.000121624464,0.0000060229945,0.00013385096,0.000116501236,0.000005909493],"category_scores_gemma":[0.0008084473,0.00006736749,0.00029339647,0.0000712947,0.00014251421,0.0001795534,0.00007888419,0.00029170993,4.8666203e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008468232,0.00036782757,0.90674525,0.00019070585,0.0003500328,0.00025093966,0.0001804138,0.000026631342,0.087119445,0.000008438563,0.00088816724,0.0030252936],"study_design_scores_gemma":[0.0050404924,0.00041611274,0.9857572,0.0005503613,0.00044372916,0.00035241572,0.00020570819,0.00011317868,0.005575306,0.000022512695,0.0014575864,0.00006541894],"about_ca_topic_score_codex":0.00034398126,"about_ca_topic_score_gemma":0.000038606264,"teacher_disagreement_score":0.08154414,"about_ca_system_score_codex":0.00003559117,"about_ca_system_score_gemma":0.00021543904,"threshold_uncertainty_score":0.27471665},"labels":[],"label_agreement":null},{"id":"W2741564293","doi":"10.1016/j.jacl.2017.07.008","title":"Cardiovascular disease in familial hypercholesterolemia: Validation and refinement of the Montreal-FH-SCORE","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Sanofi; Pfizer; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Disease; Internal medicine; Cholesterol","score_opus":0.08225324443632,"score_gpt":0.37062234136677635,"score_spread":0.28836909693045637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741564293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924121,0.0017731143,0.0000721479,0.0036828816,0.001592608,0.0002531855,0.0000040014797,0.0000019818751,0.00020799281],"genre_scores_gemma":[0.9945511,0.0022968159,0.00019959861,0.00031549603,0.0025811105,0.000003334502,0.0000010097665,0.000009427159,0.00004206435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974983,0.0005276217,0.0011568166,0.00017809708,0.00048403835,0.00015513481],"domain_scores_gemma":[0.9977908,0.0001436154,0.000680818,0.0009777793,0.00019329207,0.00021366615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004468266,0.000099527395,0.0009850381,0.000058182166,0.00007360281,0.000011255613,0.00021774821,0.0001652898,0.0000069868274],"category_scores_gemma":[0.0030857695,0.000058888276,0.000936028,0.000037701066,0.00025773144,0.000077543635,0.00012561324,0.0005569968,9.0831355e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011575258,0.00026119885,0.84426415,0.00014816133,0.0006238283,0.000046925416,0.000066750086,0.00011313685,0.00008246865,0.000045267,0.00020760843,0.15298298],"study_design_scores_gemma":[0.0050811567,0.0004694488,0.9853188,0.00022731078,0.0006014559,0.000093289105,0.000020584568,0.000029477442,0.00004885458,0.00024109516,0.007820833,0.000047725065],"about_ca_topic_score_codex":0.00038233786,"about_ca_topic_score_gemma":0.00004939618,"teacher_disagreement_score":0.15293525,"about_ca_system_score_codex":0.000028346376,"about_ca_system_score_gemma":0.00029656166,"threshold_uncertainty_score":0.36941773},"labels":[],"label_agreement":null},{"id":"W2741746182","doi":"10.1016/j.hlc.2017.06.604","title":"Use of High-Intensity Statin Therapy Post-Acute Coronary Syndrome in the Ongoing ODYSSEY OUTCOMES Trial of Alirocumab, A Proprotein Convertase Subtilisin/Kexin type 9 Monoclonal Antibody, Versus Placebo: Interim Baseline Data","year":2017,"lang":"en","type":"article","venue":"Heart Lung and Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta","funders":"","keywords":"Alirocumab; PCSK9; Medicine; Evolocumab; Internal medicine; Acute coronary syndrome; Rosuvastatin; Statin; Interquartile range; Atorvastatin; Placebo; Gastroenterology; Apolipoprotein B; Myocardial infarction; Cholesterol; Lipoprotein; LDL receptor; Apolipoprotein A1; Pathology","score_opus":0.09928528665819061,"score_gpt":0.3648585546714165,"score_spread":0.2655732680132259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741746182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617684,0.00024368065,0.00014937676,0.0011624178,0.000268579,0.0018583186,0.00012165987,0.000013880739,0.000005239688],"genre_scores_gemma":[0.9984624,0.00015674975,0.0004686409,0.00016883382,0.00005441914,0.000016294754,0.00064151717,0.000017306274,0.000013876086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833006,0.00024935798,0.00044839052,0.00032508688,0.00046761206,0.00017946791],"domain_scores_gemma":[0.9980605,0.00014154532,0.00024044192,0.0012750392,0.00021743227,0.00006504394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014397282,0.00015873699,0.00060384197,0.00008185302,0.0001362362,0.000043346332,0.0001496645,0.00009697942,0.000019048724],"category_scores_gemma":[0.0004482467,0.00011252584,0.00010213799,0.00006953693,0.00011973721,0.00030540058,0.00008481623,0.00018707268,0.0000012934745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29275325,0.001515911,0.63773084,0.0010667244,0.0019126058,0.000488516,0.0019896775,0.00007319879,0.03543535,0.00024376252,0.00032618118,0.026463997],"study_design_scores_gemma":[0.030624364,0.0012159056,0.96222734,0.0002002898,0.00016648548,0.00018729013,0.00012635232,0.0045476523,0.00047374456,0.000014469196,0.000097732685,0.00011836153],"about_ca_topic_score_codex":0.008578186,"about_ca_topic_score_gemma":0.00021912114,"teacher_disagreement_score":0.32449654,"about_ca_system_score_codex":0.000033830194,"about_ca_system_score_gemma":0.00018429945,"threshold_uncertainty_score":0.99802375},"labels":[],"label_agreement":null},{"id":"W2741915075","doi":"10.1089/met.2017.0027","title":"Association Between Plasma Proprotein Convertase Subtilisin/Kexin Type 9 and the Presence of Metabolic Syndrome in a Predominantly Rural-Based Sub-Saharan African Population","year":2017,"lang":"en","type":"article","venue":"Metabolic Syndrome and Related Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Sysmex Corporation; International Business Machines Corporation","keywords":"PCSK9; Medicine; Kexin; Metabolic syndrome; Internal medicine; Waist; Endocrinology; Body mass index; Dyslipidemia; Proprotein convertase; Population; Diabetes mellitus; Cholesterol; Lipoprotein; LDL receptor; Environmental health","score_opus":0.0075302172872540735,"score_gpt":0.23335009059072923,"score_spread":0.22581987330347514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741915075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97548234,0.01972532,0.000011110658,0.0020562876,0.00015017793,0.0023202703,0.0000255635,0.000029260123,0.00019969305],"genre_scores_gemma":[0.99318147,0.0062091737,0.00004986207,0.000024586518,0.000020933661,0.00010706546,0.00005544697,0.000032819782,0.00031863418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754333,0.00042327878,0.0006448769,0.0003892874,0.00059083046,0.00040841286],"domain_scores_gemma":[0.9982783,0.00013818701,0.0005514706,0.0007544564,0.000119287186,0.00015826071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018892123,0.00027756748,0.0012268436,0.00024894768,0.00032288325,0.000062848005,0.00018637185,0.00030944817,0.000019669118],"category_scores_gemma":[0.00096032926,0.00018893498,0.00019205264,0.00040007534,0.0003404706,0.00024245454,0.00006987303,0.00041176312,0.000006174677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014020201,0.00031986044,0.932694,0.0006998161,0.002431798,0.000095946656,0.0012370936,0.00006585976,0.00035888737,0.0011203861,0.000031785738,0.059542507],"study_design_scores_gemma":[0.010856722,0.00018540693,0.9841572,0.00027814927,0.0011502793,0.00013173027,0.000121873985,0.0011315348,0.00039848854,0.0006026158,0.0007673845,0.0002185811],"about_ca_topic_score_codex":0.009127803,"about_ca_topic_score_gemma":0.0003003776,"teacher_disagreement_score":0.059323926,"about_ca_system_score_codex":0.000029352766,"about_ca_system_score_gemma":0.0001365703,"threshold_uncertainty_score":0.9974705},"labels":[],"label_agreement":null},{"id":"W2742601683","doi":"10.1111/jgs.15013","title":"The Variation of Statin Use Among Nursing Home Residents and Physicians: A Cross‐Sectional Analysis","year":2017,"lang":"en","type":"article","venue":"Journal of the American Geriatrics Society","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; St. Michael's Hospital; University of Toronto; Sunnybrook Health Science Centre; University of Waterloo; Health Sciences Centre; Mount Sinai Hospital; Regional Municipality of Waterloo; University of Calgary; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Heart and Stroke Foundation of Canada","keywords":"Medicine; Odds ratio; Cross-sectional study; Statin; Confidence interval; Logistic regression; Intraclass correlation; Nursing homes; Polypharmacy; Family medicine; Nursing; Internal medicine","score_opus":0.014793331548865297,"score_gpt":0.3097036187778963,"score_spread":0.294910287229031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742601683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617916,0.00040639358,0.0023247742,0.0007010388,0.00023441901,0.0001270431,0.000008997534,0.0000028521752,0.00001532507],"genre_scores_gemma":[0.9957,0.0015811387,0.002087661,0.00009916754,0.00043915884,0.0000013497121,6.379419e-7,0.000010221226,0.00008066747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843717,0.0001362397,0.0004269297,0.000110097506,0.00073489326,0.00015469207],"domain_scores_gemma":[0.9964932,0.00013155112,0.0023455939,0.00052702636,0.00043466844,0.0000679518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015087273,0.000086492706,0.00041105764,0.00004552452,0.00073120015,0.00019787227,0.00022089019,0.00003565138,0.0000014111799],"category_scores_gemma":[0.00036305335,0.000049863047,0.0009906503,0.00039383068,0.00055171957,0.00022080822,0.000053824806,0.00026881133,1.15110225e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013354252,0.000058957292,0.98889565,0.000022134549,0.0018964513,0.0000017368374,0.0011275501,0.00021183408,0.00051804155,0.000020641879,0.00025825054,0.0068552154],"study_design_scores_gemma":[0.00059172965,0.000108446075,0.99681103,0.000038785856,0.001124209,0.000020652853,0.00040794697,0.0005443934,0.000051041858,0.00020398968,0.000047769943,0.000049982827],"about_ca_topic_score_codex":0.0013776523,"about_ca_topic_score_gemma":0.000014942612,"teacher_disagreement_score":0.007915407,"about_ca_system_score_codex":0.00016172644,"about_ca_system_score_gemma":0.0001766504,"threshold_uncertainty_score":0.5623874},"labels":[],"label_agreement":null},{"id":"W2743093337","doi":"10.1016/j.bbrc.2017.08.026","title":"Atorvastatin and lovastatin, but not pravastatin, increased cellular complex formation between PCSK9 and the LDL receptor in human hepatocyte-like C3A cells","year":2017,"lang":"en","type":"article","venue":"Biochemical and Biophysical Research Communications","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Graduate Women – New South Wales; Institute of Infection and Immunity; North Carolina State University; University of South Florida; Grant Foundation","keywords":"PCSK9; LDL receptor; Atorvastatin; Pravastatin; Proprotein convertase; Lovastatin; Kexin; Hepatocyte; Statin; Chemistry; Familial hypercholesterolemia; Pharmacology; Endocrinology; Internal medicine; Cholesterol; Lipoprotein; Biology; Biochemistry; Medicine; In vitro","score_opus":0.12178393794899131,"score_gpt":0.3829654673672274,"score_spread":0.26118152941823614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743093337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98994714,0.00050339854,0.00010823565,0.007881523,0.000007635607,0.0011779849,0.00010948944,0.000019771951,0.0002448002],"genre_scores_gemma":[0.99565494,0.0012963524,0.0022953744,0.00015973892,0.0001242114,0.00015172042,0.00022503319,0.000018284392,0.00007436687],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975578,0.0006873957,0.00040174133,0.00033565928,0.0006226254,0.00039474058],"domain_scores_gemma":[0.9969628,0.0006686433,0.00013131661,0.0016198334,0.0002655694,0.00035188027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021693131,0.00017497916,0.00046690291,0.000093151706,0.0012221548,0.00021189678,0.0004741778,0.00011792496,0.0000093828785],"category_scores_gemma":[0.0005838066,0.000112020396,0.00009265488,0.00016450461,0.0025445505,0.0001476854,0.0008581363,0.0007862507,0.000009923935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002595208,0.00020993457,0.001590922,0.00030948725,0.00006946134,0.0000032992684,0.0005286864,1.6584597e-8,0.9770981,0.0023295784,0.0006536035,0.016947366],"study_design_scores_gemma":[0.014904648,0.00078714226,0.19165424,0.00073241064,0.00023310892,0.000021730391,0.0018698074,0.004706004,0.75853825,0.0030712727,0.022792272,0.0006890952],"about_ca_topic_score_codex":0.0037071006,"about_ca_topic_score_gemma":0.000061997016,"teacher_disagreement_score":0.21855986,"about_ca_system_score_codex":0.000061957624,"about_ca_system_score_gemma":0.00009760071,"threshold_uncertainty_score":0.93999505},"labels":[],"label_agreement":null},{"id":"W2743957775","doi":"10.1111/dme.13450","title":"Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase <scp>III ODYSSEY</scp> clinical trials","year":2017,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Prediabetes; Alirocumab; Medicine; PCSK9; Internal medicine; Type 2 diabetes; Population; Diabetes mellitus; Placebo; Endocrinology; Statin; Evolocumab; Cholesterol; Gastroenterology; Lipoprotein; LDL receptor","score_opus":0.038173220120295476,"score_gpt":0.36832083198925814,"score_spread":0.3301476118689627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743957775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930164,0.0030340962,0.00040460518,0.000869458,0.00007791152,0.0018997543,0.000062837855,0.000024992736,0.00060989324],"genre_scores_gemma":[0.9967538,0.0014226771,0.0005124155,0.00022059464,0.00036110036,0.000074230906,0.00021586333,0.00004329276,0.00039603384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947167,0.0008312446,0.002127215,0.0006936958,0.0011264642,0.00050465745],"domain_scores_gemma":[0.992665,0.003002114,0.0014497313,0.0018965373,0.00041565695,0.00057094963],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012443643,0.00039014575,0.004822687,0.0005152873,0.00013371346,0.000012254869,0.00026075772,0.00023940679,0.0001747921],"category_scores_gemma":[0.011812567,0.00022844353,0.00038402985,0.0007779915,0.00082468585,0.00008576879,0.00011763554,0.0003637397,0.0000021145945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01737913,0.002584337,0.8629517,0.002377401,0.017884266,0.00019861007,0.0033843298,0.00007249867,0.004025413,0.00006118709,0.0013634025,0.08771775],"study_design_scores_gemma":[0.106694415,0.008591332,0.8465046,0.002656919,0.026915852,0.000021883014,0.0005499571,0.0027193637,0.0039355247,0.000008635926,0.0012222566,0.0001792557],"about_ca_topic_score_codex":0.00072921824,"about_ca_topic_score_gemma":0.0005188981,"teacher_disagreement_score":0.08931529,"about_ca_system_score_codex":0.00006871949,"about_ca_system_score_gemma":0.00037499508,"threshold_uncertainty_score":0.99651134},"labels":[],"label_agreement":null},{"id":"W2744264776","doi":"10.1016/j.atherosclerosis.2017.06.208","title":"Genetic studies in definite/probable FH in Argentina","year":2017,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Familial hypercholesterolemia; Genetic diagnosis; Medicine; Pediatrics; Internal medicine; Genetics; Biology; Cholesterol","score_opus":0.12077315460751412,"score_gpt":0.34407847475978154,"score_spread":0.22330532015226742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744264776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993008,0.003453944,0.000011696765,0.000480642,0.00019172943,0.00048529194,0.0000016404401,0.00002430744,0.0023427552],"genre_scores_gemma":[0.9934854,0.004312222,0.0012709496,0.0002792353,0.00013286038,0.00012542332,0.0000013952096,0.000027626855,0.00036487437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869436,0.00005143687,0.00029231654,0.0003197085,0.00026201623,0.0003801788],"domain_scores_gemma":[0.99879783,0.000019703606,0.00009325898,0.0009586025,0.00004434912,0.00008626791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005722949,0.00014776079,0.0004686666,0.00009240388,0.00015560894,0.00003488662,0.00015993537,0.00008860853,0.000027809918],"category_scores_gemma":[0.0002183454,0.00012547556,0.00015213528,0.00011759404,0.000109798944,0.00006979838,0.00010577269,0.00017637738,0.000081796934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028375907,0.00017370623,0.98490196,0.00017355151,0.000081996266,0.000038860377,0.0005715784,0.000011848511,0.001800212,0.0001726036,0.00018446018,0.011860857],"study_design_scores_gemma":[0.0021096817,0.00010121235,0.993952,0.00048012397,0.00003808528,0.000010268241,0.00021202074,0.000026255118,0.0007889811,0.00030614698,0.001846432,0.00012878643],"about_ca_topic_score_codex":0.0012057738,"about_ca_topic_score_gemma":0.0012822442,"teacher_disagreement_score":0.011732071,"about_ca_system_score_codex":0.00012860961,"about_ca_system_score_gemma":0.000061513056,"threshold_uncertainty_score":0.5116745},"labels":[],"label_agreement":null},{"id":"W2745246284","doi":"10.1161/jaha.117.005639","title":"Alirocumab Treatment and Achievement of Non‐High‐Density Lipoprotein Cholesterol and Apolipoprotein B Goals in Patients With Hypercholesterolemia: Pooled Results From 10 Phase 3 ODYSSEY Trials","year":2017,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Alirocumab; Medicine; Apolipoprotein B; Internal medicine; Ezetimibe; Statin; PCSK9; Evolocumab; Placebo; Endocrinology; Cholesterol; Lipoprotein; Gastroenterology; Apolipoprotein A1; LDL receptor; Pathology","score_opus":0.017743281897618465,"score_gpt":0.3017636663371935,"score_spread":0.284020384439575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745246284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99493325,0.00007353209,0.000013831163,0.0036093849,0.00007304167,0.0011933094,0.000090328074,0.000003771099,0.000009550227],"genre_scores_gemma":[0.9986654,0.00012315906,0.00060895825,0.00023834026,0.0002603034,0.000013995102,0.000008517541,0.000018654224,0.000062674386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971514,0.00066574,0.0009716657,0.00023452648,0.0007478862,0.00022882773],"domain_scores_gemma":[0.99607193,0.00016259162,0.0027038248,0.0006075298,0.00029408923,0.00016003914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031930932,0.00020061793,0.0016370347,0.00011052107,0.00017244647,0.0000682916,0.00011804323,0.00008735641,0.000002446575],"category_scores_gemma":[0.0013176744,0.0001190954,0.00025095444,0.00009074823,0.00010544743,0.00019422255,0.000066865316,0.0002588616,8.224636e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009436609,0.0011395162,0.8172315,0.000038460854,0.0012028416,0.0000070396522,0.00063538016,0.0000068348036,0.008910154,6.246923e-7,0.000082408405,0.16130865],"study_design_scores_gemma":[0.030188747,0.003948379,0.9549627,0.00036338952,0.00058640033,0.0000074080467,0.000089779904,0.0000096045205,0.009575584,0.000022408269,0.0001480864,0.00009756965],"about_ca_topic_score_codex":0.018830067,"about_ca_topic_score_gemma":0.0007032234,"teacher_disagreement_score":0.16121107,"about_ca_system_score_codex":0.0005483711,"about_ca_system_score_gemma":0.00015526247,"threshold_uncertainty_score":0.9877036},"labels":[],"label_agreement":null},{"id":"W2745340993","doi":"10.1210/jc.2017-00699","title":"Acute and Chronic Impact of Bariatric Surgery on Plasma LDL Cholesterol and PCSK9 Levels in Patients With Severe Obesity","year":2017,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Université Laval; GlaxoSmithKline; Université de Sherbrooke; Pfizer","keywords":"PCSK9; Internal medicine; Medicine; Endocrinology; Kexin; Obesity; Biliopancreatic Diversion; Diabetes mellitus; Cholesterol; Weight loss; Lipoprotein; LDL receptor; Gastric bypass","score_opus":0.038358584291712405,"score_gpt":0.35138280703927754,"score_spread":0.31302422274756514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745340993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971113,0.0015464408,0.00000922831,0.00072057237,0.0002560062,0.00029645575,0.000011352412,0.000003428041,0.00004517278],"genre_scores_gemma":[0.9950836,0.004193744,0.000061269755,0.000157231,0.00047081622,0.0000014159124,7.37525e-7,0.0000148904755,0.000016341697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976411,0.00050485716,0.0009746564,0.00017589558,0.0003763006,0.0003271847],"domain_scores_gemma":[0.99738526,0.0005222904,0.0010703655,0.0006215139,0.00018829669,0.00021228865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001957512,0.00018082919,0.0015441641,0.000158036,0.00011557414,0.000014791059,0.00019920626,0.00013540561,0.000012057299],"category_scores_gemma":[0.0006642445,0.000091562375,0.00036862402,0.000063552725,0.00037716923,0.00015537204,0.000103498016,0.0009097236,0.0000014834172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003141911,0.00033599962,0.8885116,0.000048162663,0.001269559,0.00007840028,0.000055780176,0.000011536018,0.000023074681,0.00004637137,0.000034912664,0.10644268],"study_design_scores_gemma":[0.011404907,0.0015526864,0.9849159,0.00012974233,0.00084474974,0.0006326438,0.000007450682,0.000008618568,0.00011945424,0.000090600246,0.00021303307,0.000080196],"about_ca_topic_score_codex":0.00012715772,"about_ca_topic_score_gemma":0.000027401386,"teacher_disagreement_score":0.106362484,"about_ca_system_score_codex":0.00003331654,"about_ca_system_score_gemma":0.00042740584,"threshold_uncertainty_score":0.39523467},"labels":[],"label_agreement":null},{"id":"W2745511617","doi":"10.1016/j.jacc.2017.07.752","title":"Optimizing Cholesterol Treatment in Patients With Muscle Complaints","year":2017,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Women's College Hospital; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Statin; Guideline; Internal medicine; Exercise intolerance; Cholesterol; Intensive care medicine; Physical therapy; Cardiology; Heart failure; Pathology","score_opus":0.0399709220963126,"score_gpt":0.3232771815282076,"score_spread":0.283306259431895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745511617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026014144,0.97063047,0.00003859056,0.00014629072,0.00045337615,0.0019200414,0.00014803302,0.0000040497857,0.0006450257],"genre_scores_gemma":[0.025807783,0.9729657,0.0005688346,0.000048863054,0.0004744904,0.000022459757,0.0000052220084,0.000046569636,0.000060073522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99755436,0.0006536105,0.0008749846,0.00020019317,0.00044794971,0.00026888782],"domain_scores_gemma":[0.9958952,0.00008490427,0.002665354,0.0009982454,0.00023212488,0.0001241902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006153814,0.0003050413,0.005577098,0.00026377777,0.00007292234,0.0000051955476,0.00040213222,0.000109048524,0.000001834925],"category_scores_gemma":[0.00008534138,0.00014733696,0.0017556081,0.00021466872,0.00037483868,0.00003770279,0.00008161879,0.0004561088,0.0000012581809],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003860048,0.00014302353,0.00764864,0.0017160691,0.003327354,0.00038505494,0.000023938559,0.00006576106,1.5551164e-7,0.0000033548788,0.00017003698,0.9861306],"study_design_scores_gemma":[0.003699678,0.003546782,0.063723646,0.007400342,0.0031910609,0.0016615111,0.00004620237,6.3925677e-7,4.6876468e-7,0.0000018465807,0.9165684,0.000159413],"about_ca_topic_score_codex":0.000053110965,"about_ca_topic_score_gemma":0.00001074102,"teacher_disagreement_score":0.9859712,"about_ca_system_score_codex":0.0005209575,"about_ca_system_score_gemma":0.000985143,"threshold_uncertainty_score":0.6008227},"labels":[],"label_agreement":null},{"id":"W2745653865","doi":"10.1016/j.jacc.2017.06.058","title":"Efficacy of Rosuvastatin in Children With Homozygous Familial Hypercholesterolemia and Association With Underlying Genetic Mutations","year":2017,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Rosuvastatin; Familial hypercholesterolemia; Association (psychology); Internal medicine; Oncology; Genetics; Pediatrics; Cholesterol","score_opus":0.013080166962188179,"score_gpt":0.27319729509492635,"score_spread":0.2601171281327382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745653865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984505,0.00017043775,0.00035002214,0.0005572138,0.000037436595,0.00031707875,0.000021736647,0.0000016269568,0.000093923045],"genre_scores_gemma":[0.9977679,0.00013441144,0.0019098865,0.000048851896,0.0001086831,0.000003242983,5.9497654e-7,0.000012057299,0.000014352227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885327,0.00021997404,0.00034253814,0.00010045805,0.00034195566,0.00014182796],"domain_scores_gemma":[0.998147,0.000085734675,0.0011574187,0.0003446095,0.00020790298,0.00005732869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005198868,0.00008976178,0.00078670157,0.00010088518,0.000085975706,0.000005531363,0.00014275455,0.000039816656,3.7290096e-7],"category_scores_gemma":[0.00020209845,0.000052820174,0.00015201708,0.00012540542,0.00036458147,0.00004451822,0.0000342742,0.00023812165,7.7670144e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064733974,0.000027722843,0.99047196,0.000019021854,0.0007682695,0.000059590788,0.000086138396,0.0010225157,0.0008272988,0.0000062249014,0.000018905417,0.006044992],"study_design_scores_gemma":[0.0040230267,0.0014725619,0.98999834,0.00012046485,0.00040503536,0.0033649986,0.00034464654,0.000012204441,0.00016022529,0.000020014852,0.00002766342,0.000050827584],"about_ca_topic_score_codex":0.00021859912,"about_ca_topic_score_gemma":0.000052942036,"teacher_disagreement_score":0.0059941644,"about_ca_system_score_codex":0.00010051973,"about_ca_system_score_gemma":0.00033503433,"threshold_uncertainty_score":0.21539442},"labels":[],"label_agreement":null},{"id":"W2745889990","doi":"10.1016/j.amjmed.2017.02.037","title":"When and Why Statins Fail to Save Lives","year":2017,"lang":"en","type":"letter","venue":"The American Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Rosuvastatin; Statin; Diabetes mellitus; Placebo; Disease; Scopus; Internal medicine; MEDLINE; Alternative medicine; Endocrinology; Pathology","score_opus":0.022232711883307263,"score_gpt":0.29520001522678824,"score_spread":0.27296730334348096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2745889990","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022877216,0.0044856817,0.0005636283,0.9703893,0.0004010422,0.00040959904,0.00000999238,0.000010107788,0.00085342064],"genre_scores_gemma":[0.020362303,0.0028655634,0.0013433368,0.9488663,0.024881816,0.000007919852,0.000009977455,0.00007511246,0.0015876547],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970943,0.00032044237,0.00062925613,0.00023447676,0.0013411436,0.00038040665],"domain_scores_gemma":[0.99662507,0.00023016603,0.001380148,0.0010256015,0.00037026862,0.0003687345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019707486,0.0003086399,0.0018264799,0.0002719809,0.00015770624,0.000028820145,0.0004548398,0.000085467065,0.000110094545],"category_scores_gemma":[0.0006895812,0.00015260698,0.00027022167,0.00010644962,0.001178008,0.000052361127,0.00008601333,0.0021151907,0.000010822036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024348334,0.000008492238,0.000081627455,0.00014445114,0.00066665735,0.002055704,0.0028527668,2.8108744e-7,0.000058585018,0.0000027388646,0.8693559,0.124529265],"study_design_scores_gemma":[0.0016265885,0.0059138304,0.002215977,0.0019439241,0.0011037521,0.007524153,0.0018103961,0.0000015349519,0.00001359306,0.00020891281,0.97747827,0.00015907481],"about_ca_topic_score_codex":0.0011321893,"about_ca_topic_score_gemma":0.000010565229,"teacher_disagreement_score":0.124370195,"about_ca_system_score_codex":0.000087396795,"about_ca_system_score_gemma":0.00032486863,"threshold_uncertainty_score":0.91895694},"labels":[],"label_agreement":null},{"id":"W2747401552","doi":"10.1016/j.jacbts.2017.03.015","title":"Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell Calcification","year":2017,"lang":"en","type":"article","venue":"JACC Basic to Translational Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec; Heart and Stroke Foundation of Canada; Amgen","keywords":"Calcification; Aortic valve; Alkaline phosphatase; Matrix gla protein; Lipoprotein; Chemistry; Cell biology; Signal transduction; Apoptosis; Phosphorylation; Internal medicine; Phosphatase; Lipoprotein(a); Endocrinology; Medicine; Cholesterol; Biology; Biochemistry; Ectopic calcification; Enzyme","score_opus":0.036620504395491936,"score_gpt":0.33337333540305186,"score_spread":0.29675283100755995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747401552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97190243,0.000066345136,0.005562228,0.004456007,0.00027189797,0.0007975008,0.000008903547,0.00004411112,0.016890606],"genre_scores_gemma":[0.9962738,0.000004223745,0.002552267,0.00034439974,0.00052180816,0.000057153906,0.0000093720955,0.000011791474,0.00022516488],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978189,0.000023299806,0.00025693447,0.0004784272,0.0010937215,0.000328735],"domain_scores_gemma":[0.9985474,0.000013882091,0.00010341418,0.000795047,0.00020363565,0.00033663225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010251116,0.00012821563,0.00020070114,0.00015483389,0.0011615141,0.00017513134,0.00043186385,0.00006401316,0.00013953172],"category_scores_gemma":[0.000106221596,0.00011162428,0.00018692357,0.0002328144,0.00036008173,0.00044900776,0.000043748147,0.0001759017,0.0001020288],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001638716,0.00045112774,0.01624568,0.00022696794,0.00007708817,0.000018850702,0.0024952416,0.00009406167,0.5610199,0.011353463,0.0002602258,0.40759352],"study_design_scores_gemma":[0.0008764901,0.0002078082,0.94925004,0.00009468522,0.000056004577,0.000016447919,0.000053720312,0.0002380878,0.04583416,0.00072272663,0.002459106,0.00019068943],"about_ca_topic_score_codex":0.0010719656,"about_ca_topic_score_gemma":0.000093866875,"teacher_disagreement_score":0.9330044,"about_ca_system_score_codex":0.00009345021,"about_ca_system_score_gemma":0.00046160075,"threshold_uncertainty_score":0.8933545},"labels":[],"label_agreement":null},{"id":"W2748532164","doi":"10.1001/jama.2017.11750","title":"Genetic Studies Help Clarify the Complexities of Lipid Biology and Treatment","year":2017,"lang":"en","type":"letter","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Family medicine; Otorhinolaryngology; MEDLINE; Psychiatry; Law","score_opus":0.0716715615511731,"score_gpt":0.3341064360396814,"score_spread":0.2624348744885083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2748532164","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047859054,0.056175657,0.000009131575,0.892077,0.00051388564,0.0010031137,0.00009320476,0.000021308106,0.0022476406],"genre_scores_gemma":[0.113473356,0.057038594,0.0012898834,0.70102406,0.11382889,0.000543232,0.00031691388,0.0001457308,0.012339362],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998982,0.00014647804,0.00022555159,0.00024582894,0.00018010034,0.00022003091],"domain_scores_gemma":[0.99867314,0.000098833625,0.00017415424,0.0009026815,0.00011956267,0.000031640935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020324408,0.0002080177,0.00086587906,0.000051998242,0.00015388802,0.000017578304,0.000100403886,0.0006405565,0.0000206342],"category_scores_gemma":[0.00007282114,0.00010599653,0.0002520171,0.000018643324,0.0004963442,0.000011659412,0.00007624581,0.00070540956,0.0000067088695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005260387,0.000031283333,0.0024125597,0.0012219452,0.003434823,0.00024321793,0.00081748876,1.2623973e-7,0.000028891798,0.00013264299,0.85856676,0.13305764],"study_design_scores_gemma":[0.0012466329,0.0006565791,0.025465228,0.00019597095,0.0004991897,0.00020020298,0.00015059751,0.0000017637404,0.000060062674,0.00036254377,0.9710645,0.000096700816],"about_ca_topic_score_codex":0.0008066097,"about_ca_topic_score_gemma":0.000034742206,"teacher_disagreement_score":0.19105297,"about_ca_system_score_codex":0.00006476256,"about_ca_system_score_gemma":0.00011217655,"threshold_uncertainty_score":0.49405584},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2750131287","doi":"10.1161/circulationaha.117.029435","title":"The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia","year":2017,"lang":"en","type":"letter","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Familial hypercholesterolemia; Lipoprotein; Genotype; LDL receptor; Internal medicine; Low-density lipoprotein; Apheresis; Cholesterol; Endocrinology; Genetics; Gene; Platelet; Biology","score_opus":0.007979396848447137,"score_gpt":0.2114472151900231,"score_spread":0.20346781834157596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750131287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799597,0.00029655176,0.0001822299,0.008710643,0.0007110247,0.009889479,0.00012807957,0.000063654596,0.00005863004],"genre_scores_gemma":[0.98683256,0.00007270979,0.000109269604,0.008828401,0.0025936645,0.0008167955,0.00029551922,0.00019444183,0.0002566541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925144,0.00094509625,0.0014738666,0.0014434191,0.002553295,0.0010699704],"domain_scores_gemma":[0.9931518,0.000094257644,0.0016591477,0.0039074253,0.000964981,0.00022240389],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0013872248,0.0009557829,0.0015111209,0.00017776291,0.00082999334,0.00032363486,0.00075574295,0.0016012384,0.00003311056],"category_scores_gemma":[0.00034631544,0.00062025856,0.0007587645,0.00039940377,0.00088697404,0.0003994706,0.00023425168,0.0026605744,0.00003563127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007342226,0.0012664039,0.5620435,0.008945434,0.0018882514,0.001166594,0.004945798,0.00008959476,0.008351238,0.0000060142033,0.008973328,0.39498165],"study_design_scores_gemma":[0.003906755,0.0002854432,0.9806846,0.0037882864,0.0004798925,0.00004087465,0.000043910935,0.00013826077,0.007232613,0.00005552738,0.002620685,0.00072314497],"about_ca_topic_score_codex":0.016595727,"about_ca_topic_score_gemma":0.0046033086,"teacher_disagreement_score":0.41864112,"about_ca_system_score_codex":0.00093978015,"about_ca_system_score_gemma":0.0007776946,"threshold_uncertainty_score":0.9996949},"labels":[],"label_agreement":null},{"id":"W2750626511","doi":"10.1016/j.plipres.2017.09.001","title":"The renaissance of lipoprotein(a): Brave new world for preventive cardiology?","year":2017,"lang":"en","type":"review","venue":"Progress in Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Lipoprotein(a); Medicine; Epidemiology; Atherosclerotic cardiovascular disease; Disease; The Renaissance; Risk factor; Lipoprotein; Bioinformatics; Intensive care medicine; Internal medicine; Biology; Cholesterol","score_opus":0.2744051298932346,"score_gpt":0.5184521516529561,"score_spread":0.24404702175972148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750626511","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000032202026,0.9820703,0.00004279486,0.00047219088,0.0005463881,0.013399378,0.00004038945,0.000024513067,0.0034008115],"genre_scores_gemma":[0.00008981144,0.9782815,0.0009024284,0.000004776096,0.004581738,0.0054611606,0.000054248285,0.00011436158,0.010509971],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99379104,0.0014587109,0.0011226607,0.00089478784,0.0014693687,0.0012634161],"domain_scores_gemma":[0.9943731,0.00097445905,0.0005878552,0.0029858185,0.00075719634,0.00032155897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012183171,0.00043483975,0.0034026585,0.00063845405,0.0005534183,0.00011221378,0.0012912038,0.0005151986,0.000012387219],"category_scores_gemma":[0.002285999,0.00025983027,0.0016646124,0.0007890588,0.0013688126,0.0000752374,0.00054140395,0.0021041161,0.000021487105],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018696075,0.000057847392,0.000115958836,0.0295477,0.000744804,0.000033374294,0.00003674344,6.6748264e-8,4.5209234e-8,0.0007249123,0.0049818456,0.96356976],"study_design_scores_gemma":[0.0009848911,0.00058012985,0.00015625282,0.031954017,0.00032622923,0.00006168022,0.000018358913,0.0000025037114,0.000010450909,0.00041644985,0.96527994,0.00020911722],"about_ca_topic_score_codex":0.00023118392,"about_ca_topic_score_gemma":0.00022803668,"teacher_disagreement_score":0.9633606,"about_ca_system_score_codex":0.00033177403,"about_ca_system_score_gemma":0.0035133597,"threshold_uncertainty_score":0.9999854},"labels":[],"label_agreement":null},{"id":"W2750646243","doi":"10.1136/bmjopen-2017-016461","title":"Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis","year":2017,"lang":"en","type":"review","venue":"BMJ Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":344,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; McGill University; University of Toronto; Royal Victoria Hospital; Sunnybrook Health Science Centre; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Institute of Circulatory and Respiratory Health; University of Toronto; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; McGill University","keywords":"Medicine; Meta-analysis; Epidemiology; Systematic review; MEDLINE; Public health; Family medicine; Pediatrics; Pathology","score_opus":0.331814335823395,"score_gpt":0.492848381677878,"score_spread":0.161034045854483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750646243","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.692932e-7,0.9478179,0.000053685264,0.00017978702,0.000032364245,0.0514872,0.00010093809,0.000009256158,0.0003180947],"genre_scores_gemma":[0.00000872651,0.985863,0.0008803133,0.00044739843,0.00007639563,0.010764343,0.000019956842,0.00003902865,0.001900839],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953192,0.0014224163,0.0017174942,0.00055868377,0.0007502863,0.00023193729],"domain_scores_gemma":[0.99303234,0.00017360057,0.0020167695,0.0044821315,0.00016334864,0.00013180447],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009205938,0.0004344056,0.015352343,0.00010029347,0.00017997705,0.00014794047,0.0012351355,0.00018653146,0.000055317076],"category_scores_gemma":[0.0013271298,0.00019537042,0.00446727,0.0002663162,0.00010412271,0.00011789428,0.0007646745,0.0004164708,0.000017015223],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002012641,0.000013535481,7.5531483e-7,0.87295884,0.11373096,0.000019219355,0.000021386193,2.2679878e-7,4.83062e-9,0.0000023198706,0.00003839917,0.013212316],"study_design_scores_gemma":[0.00010823249,0.00004700998,0.0000061702967,0.22533248,0.7667083,0.00060145615,0.0000028249544,0.0000089784135,2.3814119e-8,0.0000017545345,0.0070408657,0.00014190096],"about_ca_topic_score_codex":0.00032949512,"about_ca_topic_score_gemma":0.000017150822,"teacher_disagreement_score":0.65297735,"about_ca_system_score_codex":0.000050518796,"about_ca_system_score_gemma":0.00044196594,"threshold_uncertainty_score":0.9992658},"labels":[],"label_agreement":null},{"id":"W2752200415","doi":"10.1194/jlr.m079822","title":"Polygenic determinants in extremes of high-density lipoprotein cholesterol","year":2017,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Western University","funders":"Canadian Institutes of Health Research; Genome Canada","keywords":"High-density lipoprotein; Cholesterol; Ldl cholesterol; Biology; Internal medicine; Medicine","score_opus":0.09072979962759084,"score_gpt":0.40645317411765935,"score_spread":0.3157233744900685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752200415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628395,0.0007805345,0.000024377745,0.0018884094,0.0002688033,0.00041444437,0.0000019027874,0.0000029489784,0.00033465645],"genre_scores_gemma":[0.99708325,0.0007072438,0.00037262874,0.000028313405,0.001361834,0.000005443156,2.2036157e-7,0.0000205423,0.0004205053],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965575,0.00035157788,0.0007039076,0.00018160662,0.0017551788,0.0004502679],"domain_scores_gemma":[0.9973682,0.00006587399,0.00044963995,0.0010233662,0.00080575026,0.00028713423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068436856,0.00011528147,0.00074645964,0.00051605,0.0001956923,0.00005492587,0.00047592228,0.00014521724,0.000045806726],"category_scores_gemma":[0.0012866422,0.00008404129,0.0003179567,0.00016481937,0.0002425735,0.00022829192,0.00019332152,0.0010226726,0.000012867507],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018253485,0.0007257612,0.21164846,0.00088947226,0.00026122728,0.0012662126,0.0005125362,0.0000022791685,0.038190614,0.000041075702,0.00063379837,0.74400324],"study_design_scores_gemma":[0.003382384,0.001005511,0.93757695,0.00094425626,0.000028203433,0.0006129828,0.00012088416,0.00002382201,0.0552021,0.00019344878,0.00083688006,0.000072564544],"about_ca_topic_score_codex":0.0046120672,"about_ca_topic_score_gemma":0.000723475,"teacher_disagreement_score":0.74393064,"about_ca_system_score_codex":0.00014635228,"about_ca_system_score_gemma":0.0006156709,"threshold_uncertainty_score":0.6972097},"labels":[],"label_agreement":null},{"id":"W2752312135","doi":"10.1161/circresaha.117.311849","title":"Reducing the Global Burden of Cardiovascular Disease, Part 2","year":2017,"lang":"en","type":"review","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":422,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Atrial fibrillation; Intensive care medicine; Disease; Diabetes mellitus; Stroke (engine); Heart failure; Coronary artery disease; Blood pressure; Antithrombotic; Disease management; Psychological intervention; Physical therapy; Cardiology; Internal medicine","score_opus":0.306172059925977,"score_gpt":0.472053910350155,"score_spread":0.16588185042417797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752312135","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047962658,0.9908225,0.000067481684,0.00019543804,0.0002521103,0.003268144,0.000060337752,0.000026884862,0.0052591264],"genre_scores_gemma":[0.0022356,0.9944879,0.000015657666,0.0000047014832,0.0023569444,0.00031842466,0.00017970172,0.000048992504,0.00035212436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939256,0.0012631493,0.0006692015,0.00064201705,0.0029683355,0.0005317077],"domain_scores_gemma":[0.99405706,0.00012641473,0.00024051484,0.0044779642,0.0007383782,0.0003596616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071830787,0.00026704237,0.0019406856,0.00018387842,0.0005445371,0.000101762416,0.00055395334,0.00028826957,0.000075371616],"category_scores_gemma":[0.001352333,0.00017027282,0.003024149,0.000617877,0.00036972822,0.00007107291,0.00023176047,0.0008185069,0.000104845436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009483836,0.000023411816,0.00003435261,0.021148996,0.002555092,0.000058637885,0.000022908354,0.000263796,2.0516536e-8,0.00024561357,0.00044841765,0.97518927],"study_design_scores_gemma":[0.00026492067,0.0000237976,0.0006140414,0.013000504,0.0027384649,0.000076583514,0.000020888303,0.00010982635,7.632188e-8,0.00010560745,0.98290676,0.00013850888],"about_ca_topic_score_codex":0.0019747622,"about_ca_topic_score_gemma":0.000002487803,"teacher_disagreement_score":0.98245835,"about_ca_system_score_codex":0.0005193503,"about_ca_system_score_gemma":0.002830619,"threshold_uncertainty_score":0.6943524},"labels":[],"label_agreement":null},{"id":"W2752557859","doi":"10.1194/jlr.d079301","title":"Use of next-generation sequencing to detect LDLR gene copy number variation in familial hypercholesterolemia","year":2017,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Genome Canada; Heart and Stroke Foundation of Canada; Valeant Pharmaceuticals International; Merck; Sanofi; Amgen; Pfizer; Eli Lilly and Company","keywords":"Familial hypercholesterolemia; Copy-number variation; PCSK9; LDL receptor; Genetics; Biology; Variation (astronomy); Gene; Computational biology; Genome; Cholesterol; Lipoprotein; Endocrinology","score_opus":0.29025667136322747,"score_gpt":0.41364339890861823,"score_spread":0.12338672754539076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752557859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678224,0.00008854562,0.0012011616,0.0010727647,0.00031766575,0.0003842262,0.000002532522,0.0000026995688,0.00014817472],"genre_scores_gemma":[0.98919165,0.00036738027,0.0076769055,0.000109284694,0.0025174392,0.00000727591,0.0000014024993,0.000018030927,0.00011063947],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99719846,0.00039738463,0.0005811866,0.00016050518,0.0013639014,0.00029854485],"domain_scores_gemma":[0.9979251,0.00006368034,0.00023074071,0.0005689325,0.001005759,0.00020580634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005784632,0.00008723686,0.00040101868,0.00033442889,0.00017506974,0.00012943856,0.00020036445,0.00012616979,0.00003086254],"category_scores_gemma":[0.0017789584,0.0000695809,0.00016201651,0.00019129056,0.00005190449,0.00046801585,0.000081406084,0.00067387783,0.000014939083],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055621995,0.000058928712,0.029313488,0.00011366471,0.00008332365,0.000114919865,0.00063908513,0.00033788537,0.91453236,0.000011195937,0.00053688703,0.053702056],"study_design_scores_gemma":[0.0045898706,0.0018811916,0.76322603,0.00089801895,0.00007659141,0.00077803637,0.00022445133,0.0020059033,0.2204242,0.000071606155,0.0056321523,0.00019192121],"about_ca_topic_score_codex":0.0015267126,"about_ca_topic_score_gemma":0.00017650664,"teacher_disagreement_score":0.7339126,"about_ca_system_score_codex":0.00050883094,"about_ca_system_score_gemma":0.00070677156,"threshold_uncertainty_score":0.29277012},"labels":[],"label_agreement":null},{"id":"W2752669381","doi":"10.1016/j.ahj.2017.09.001","title":"Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants","year":2017,"lang":"en","type":"letter","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute; Université de Montréal","funders":"University of Oxford; Bayer","keywords":"Acarbose; Medicine; Postprandial; Diabetes mellitus; Internal medicine; Coronary heart disease; Type 2 diabetes; Insulin; Cardiology; Endocrinology","score_opus":0.09586218853558469,"score_gpt":0.3518454306288781,"score_spread":0.2559832420932934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752669381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85194,0.004886633,0.00006691047,0.14005293,0.0011766638,0.0017511054,0.000034362794,0.000023719047,0.00006768886],"genre_scores_gemma":[0.91250134,0.0029127824,0.00049552636,0.06006995,0.023497846,0.0001415269,0.00013368085,0.00008891049,0.00015846363],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941874,0.0015628401,0.0008672466,0.00055254286,0.002066141,0.00076381955],"domain_scores_gemma":[0.99754244,0.00011796744,0.0005763196,0.0010501964,0.00034683538,0.00036623082],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0068209176,0.00040999523,0.0024030309,0.0003141841,0.00025892287,0.00020595443,0.00017706584,0.00035469144,0.00007800697],"category_scores_gemma":[0.0013340674,0.00032342784,0.00092032255,0.00013857018,0.00035256328,0.00012958827,0.0000677809,0.0029469028,0.0000127778885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007634287,0.00036625605,0.21761043,0.0007335889,0.0053696223,0.008053188,0.0006668991,0.0000024180267,0.00003725291,5.9996745e-7,0.24894895,0.5105765],"study_design_scores_gemma":[0.032070667,0.002304768,0.27005345,0.0012267077,0.0036848115,0.003646178,0.00016077518,0.0008646585,0.000010056298,0.000030466086,0.6851805,0.00076700066],"about_ca_topic_score_codex":0.0014908294,"about_ca_topic_score_gemma":0.00002055622,"teacher_disagreement_score":0.5098095,"about_ca_system_score_codex":0.0002575732,"about_ca_system_score_gemma":0.0012503193,"threshold_uncertainty_score":0.9999218},"labels":[],"label_agreement":null},{"id":"W2753261797","doi":"10.1016/j.atherosclerosis.2017.08.024","title":"Is atherosclerosis imaging the most sensitive way to assess patients' risk and the best way to conduct future drug trials? A pros-and-cons debate","year":2017,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Clinical trial; Medicine; Risk stratification; Asymptomatic; cons; Intensive care medicine; Surrogate endpoint; Pathology; Internal medicine; Computer science","score_opus":0.12225576935166012,"score_gpt":0.363263224251772,"score_spread":0.24100745490011188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753261797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030872362,0.94015867,0.00012183777,0.006411934,0.0013099033,0.01886556,0.0017485142,0.00012808199,0.0003831469],"genre_scores_gemma":[0.011270637,0.98046166,0.00048153376,0.0030558049,0.0017185693,0.0020294995,0.00007369121,0.00029523612,0.0006133756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919063,0.0027915759,0.0015593506,0.0016019868,0.0011245785,0.0010162166],"domain_scores_gemma":[0.9931576,0.0011969269,0.0013481027,0.00302235,0.00053201424,0.0007429874],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0078461105,0.0013006475,0.0055473223,0.00021007807,0.0016579692,0.0007795502,0.000702467,0.00043723104,0.000027580974],"category_scores_gemma":[0.0017685464,0.0006349983,0.0019282212,0.00055961695,0.00061123574,0.00020401651,0.0007279001,0.001410425,0.00013189064],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011146006,0.00012429555,0.00091311126,0.0018188687,0.0014604747,0.000003074161,0.003732863,1.3839384e-7,0.000015604004,0.00006354912,0.0015989022,0.99015766],"study_design_scores_gemma":[0.0062163686,0.00032851438,0.007525822,0.017205391,0.012662092,0.000071281414,0.0018920687,0.000009438198,0.00008296217,0.00003003814,0.9527809,0.0011951409],"about_ca_topic_score_codex":0.002983853,"about_ca_topic_score_gemma":0.0001617128,"teacher_disagreement_score":0.98896253,"about_ca_system_score_codex":0.000258836,"about_ca_system_score_gemma":0.00028249025,"threshold_uncertainty_score":0.9999745},"labels":[],"label_agreement":null},{"id":"W2753504277","doi":"10.1080/14656566.2017.1369957","title":"Time for new low density lipoprotein cholesterol (LDL-C) targets?","year":2017,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Kexin; Proprotein convertase; PCSK9; Subtilisin; Medicine; Cholesterol; Ldl cholesterol; Lipoprotein; Low-density lipoprotein; Internal medicine; Endocrinology; Pharmacology; LDL receptor; Biochemistry; Enzyme; Biology","score_opus":0.03531593968877128,"score_gpt":0.36188147889046013,"score_spread":0.32656553920168885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753504277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.703007,0.049772304,0.039775554,0.14612895,0.017269436,0.030206153,0.00017614964,0.0019119601,0.011752529],"genre_scores_gemma":[0.78808814,0.034799132,0.016206993,0.086743094,0.04781342,0.0018840649,0.00030643606,0.00073819485,0.02342055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813104,0.00006342942,0.0002982104,0.00054074667,0.00050710933,0.0004594468],"domain_scores_gemma":[0.9979654,0.00002562755,0.00019023847,0.0012414397,0.00011011908,0.0004671935],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004616088,0.00031050286,0.0005453879,0.00008046624,0.0005365236,0.0001000977,0.0003025748,0.00015177761,0.0005541615],"category_scores_gemma":[0.00005328416,0.00025751084,0.00048538618,0.000042596574,0.000081392114,0.00018661152,0.000034015848,0.0002319991,0.00024224527],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019003233,0.00037653005,0.00006192926,0.000079573474,0.0003745234,0.0000114315635,0.0005091617,0.0000040464306,0.08034684,0.00007870126,0.082335494,0.83392143],"study_design_scores_gemma":[0.010919652,0.00064767915,0.0030860084,0.00019929103,0.000009493691,0.00003031926,0.000012964614,0.0005130426,0.29569164,0.0000837024,0.68851787,0.00028830813],"about_ca_topic_score_codex":0.0007141039,"about_ca_topic_score_gemma":0.000004891578,"teacher_disagreement_score":0.8336331,"about_ca_system_score_codex":0.00010807941,"about_ca_system_score_gemma":0.00020545564,"threshold_uncertainty_score":0.9999877},"labels":[],"label_agreement":null},{"id":"W2754294894","doi":"10.1093/nutrit/nux047","title":"Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel","year":2017,"lang":"en","type":"review","venue":"Nutrition Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":287,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Esperion Therapeutics; Servier; Mylan; Sanofi; Kowa Company; Amarin Corporation; Abbott Vascular; Regeneron Pharmaceuticals; Novo Nordisk; Valeant Pharmaceuticals International; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Nutraceutical; Dyslipidemia; Medicine; Statin; Intensive care medicine; Lipid profile; Bioinformatics; Internal medicine; Cholesterol; Disease; Pathology; Biology","score_opus":0.27133946092349814,"score_gpt":0.5210971150898861,"score_spread":0.24975765416638795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754294894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000865721,0.9882024,0.00012937919,0.0023118777,0.0019521455,0.00497209,0.000087451735,0.000064029795,0.0022719814],"genre_scores_gemma":[0.0000040500004,0.97497886,0.0052627297,0.0029792457,0.01296505,0.001580442,0.0020374814,0.00008827125,0.00010385883],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932732,0.0015518583,0.0029509508,0.0010589026,0.0007667924,0.000398325],"domain_scores_gemma":[0.99578434,0.00025219348,0.0012569195,0.0020287584,0.00024137547,0.00043642145],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004762208,0.00056465354,0.0043999325,0.00022862683,0.00012926644,0.00016865591,0.00048027173,0.000971231,0.0005425811],"category_scores_gemma":[0.0025536534,0.00044709968,0.0022238106,0.00016565034,0.000085626736,0.00085385627,0.00010369604,0.0014630766,0.0004931324],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006196744,0.0014115141,0.0000075173953,0.01041007,0.00022922053,0.00014127002,0.000023923341,8.0308e-9,0.000001678227,0.000049540537,0.002830002,0.9848333],"study_design_scores_gemma":[0.0014588315,0.00020001455,0.0001466845,0.07994501,0.0010390573,0.00035955,0.000016872198,0.0000029861646,8.2378364e-7,0.00002073898,0.9164365,0.000372941],"about_ca_topic_score_codex":0.00017968433,"about_ca_topic_score_gemma":0.000021689275,"teacher_disagreement_score":0.98446035,"about_ca_system_score_codex":0.00042061572,"about_ca_system_score_gemma":0.00033569193,"threshold_uncertainty_score":0.99979806},"labels":[],"label_agreement":null},{"id":"W2754562397","doi":"10.1016/s2213-8587(17)30313-3","title":"Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":596,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"National Institute for Health and Care Research; Amgen","keywords":"Medicine; Evolocumab; PCSK9; Internal medicine; Diabetes mellitus; Type 2 diabetes; Clinical endpoint; Myocardial infarction; Stroke (engine); Cardiology; Endocrinology; Clinical trial; Cholesterol; Lipoprotein","score_opus":0.007369601405536356,"score_gpt":0.23838794260371504,"score_spread":0.23101834119817868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754562397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867901,0.0064415857,0.0000015437739,0.0003826096,0.00010410178,0.00613515,0.00007696363,0.0000075761986,0.00006034244],"genre_scores_gemma":[0.9987324,0.00087888533,0.000019356447,0.000046575995,0.00011312716,0.00017085961,0.0000042191405,0.000022681423,0.000011915483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952999,0.002329172,0.0007350509,0.00041545197,0.00065090484,0.0005695506],"domain_scores_gemma":[0.99410635,0.0023511548,0.00094573153,0.002397271,0.00012273189,0.00007673099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036212448,0.00033346566,0.0038056846,0.00014344661,0.00023537513,0.000020345742,0.00038913524,0.00013087358,0.0000032784062],"category_scores_gemma":[0.0032222413,0.00012910014,0.0007185828,0.00025250603,0.002091504,0.000050425984,0.00031505522,0.0004327233,5.4040196e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17866972,0.000064714564,0.80035913,0.00019172968,0.011772489,2.7499843e-7,0.00035626013,0.000041119027,0.00006154458,0.000031934287,0.0000080884865,0.008442989],"study_design_scores_gemma":[0.39841646,0.001150967,0.5894805,0.0001755014,0.008054108,5.8408585e-7,0.000019506637,0.00022923526,0.0023194398,0.00004555184,0.000028258226,0.000079847865],"about_ca_topic_score_codex":0.0003504481,"about_ca_topic_score_gemma":0.0000678331,"teacher_disagreement_score":0.21974674,"about_ca_system_score_codex":0.000025460098,"about_ca_system_score_gemma":0.00007711291,"threshold_uncertainty_score":0.7706233},"labels":[],"label_agreement":null},{"id":"W2755740638","doi":"10.1161/circoutcomes.117.003764","title":"Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines","year":2017,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Medicine; Socioeconomic status; Odds ratio; Odds; Demography; Internal medicine; National Cholesterol Education Program; Health equity; Diabetes mellitus; Statin; Observational study; Gerontology; Logistic regression; Population; Public health; Environmental health; Obesity; Metabolic syndrome; Endocrinology","score_opus":0.06518477672248021,"score_gpt":0.35743363313971793,"score_spread":0.29224885641723775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755740638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797678,0.0010552456,0.0004722974,0.017710356,0.00006298983,0.0007915086,0.00009003301,0.000024042592,0.00002571917],"genre_scores_gemma":[0.9979304,0.0010380857,0.00013181685,0.0006871329,0.00009667255,0.000052294774,0.000017793971,0.000017023296,0.000028794055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717623,0.0009996267,0.0005426309,0.0004559482,0.00054472015,0.00028087298],"domain_scores_gemma":[0.9977037,0.00039535557,0.00056177564,0.00094613334,0.0002942062,0.000098872944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005526423,0.00022138555,0.0018160294,0.00007800312,0.0003305198,0.00004731294,0.000108544635,0.00011013826,0.0000021448222],"category_scores_gemma":[0.0007777775,0.00015063894,0.0004583688,0.00010076073,0.0006186125,0.00012176291,0.000065698594,0.00021676882,8.914272e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032934302,0.000018107416,0.9920883,0.00006931799,0.0019155241,0.0000016245804,0.00016963462,0.00021476533,0.000023089056,0.00007258005,0.00003455335,0.005359536],"study_design_scores_gemma":[0.0018475464,0.000084569365,0.9950731,0.000052498446,0.00042487457,0.000011081428,0.0016411113,0.00015160922,0.000018581213,0.00013407742,0.00038724925,0.00017373096],"about_ca_topic_score_codex":0.0061637647,"about_ca_topic_score_gemma":0.0032158254,"teacher_disagreement_score":0.018162578,"about_ca_system_score_codex":0.0002153016,"about_ca_system_score_gemma":0.00011107999,"threshold_uncertainty_score":0.931781},"labels":[],"label_agreement":null},{"id":"W2756207122","doi":"10.1136/annrheumdis-2017-eular.1436","title":"SAT0115 Effect of biological disease modifying anti-rheumatic drugs (BDMARDS) on cardio vascular disease (CVD) risk in ra patients:three years results from a canadian cohort","year":2017,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Internal medicine; Cohort; Incidence (geometry); Prospective cohort study; Framingham Risk Score; Population; Disease; Cohort study","score_opus":0.025549563768472863,"score_gpt":0.2803023893263353,"score_spread":0.25475282555786244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756207122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139655,0.0027040208,0.0000060466864,0.0004698799,0.00024051669,0.0023794821,0.0026386606,0.000026087606,0.00013874265],"genre_scores_gemma":[0.99706197,0.0023092856,0.00001745471,0.00014699236,0.000059059214,0.00012154412,0.00023318201,0.00004133272,0.0000092038745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960022,0.0007634317,0.00089024485,0.0005876115,0.0011894874,0.00056700007],"domain_scores_gemma":[0.99429154,0.00041755574,0.000690007,0.0032356633,0.00017649216,0.0011887623],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015406936,0.00038041925,0.0014073092,0.00021076026,0.00029538228,0.000054181623,0.0006701272,0.000109098415,0.000029005136],"category_scores_gemma":[0.00901093,0.00024930062,0.0013757268,0.00017245908,0.00034958447,0.00013477437,0.00020029355,0.0002532899,0.00002136835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016018726,0.00043019745,0.94072974,0.0008907558,0.0011868934,0.000046716716,0.00018838324,0.00040048608,0.0000011316008,0.000021856256,0.00035205486,0.054149907],"study_design_scores_gemma":[0.0046681818,0.00022529911,0.9882069,0.0042017736,0.0009829028,2.931131e-7,0.000032143555,0.0007611294,0.000038022954,0.00058430905,0.000054500753,0.00024454054],"about_ca_topic_score_codex":0.15495665,"about_ca_topic_score_gemma":0.0019892443,"teacher_disagreement_score":0.15296741,"about_ca_system_score_codex":0.00011414289,"about_ca_system_score_gemma":0.0006034697,"threshold_uncertainty_score":0.99999595},"labels":[],"label_agreement":null},{"id":"W2756966385","doi":"10.1016/j.cjca.2017.07.204","title":"OBSERVED VERSUS PREDICTED MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND LOW-RISK GRACE SCORES","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services","funders":"","keywords":"Medicine; Ezetimibe; Internal medicine; Randomized controlled trial; Statin; Type 2 diabetes; Metformin; Diabetes mellitus; Ldl cholesterol; Cholesterol; Gastroenterology; Insulin; Endocrinology","score_opus":0.026501993698761956,"score_gpt":0.2542722636533304,"score_spread":0.22777026995456842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756966385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979358,0.00068875466,0.000031526437,0.00017872834,0.00050280424,0.00028319797,0.00008323836,0.0000033925596,0.00029256172],"genre_scores_gemma":[0.9993306,0.00028406156,0.00007619279,0.000040868123,0.00022192048,0.0000037454854,0.000015831836,0.00001497837,0.000011819112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998868,0.00014971779,0.00028117205,0.00016691396,0.00021237905,0.0003218454],"domain_scores_gemma":[0.9983168,0.000026417887,0.00026451648,0.00050690776,0.00023312581,0.000652224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050124933,0.00013063686,0.00069345045,0.00014725866,0.00018216974,0.000026232497,0.00015558231,0.00013117712,0.0000057588295],"category_scores_gemma":[0.0002771359,0.00009816215,0.00014675308,0.00004958349,0.00029326044,0.0001366984,0.000019803201,0.0003773876,7.81255e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069276657,0.0000037706027,0.99252605,0.000029085648,0.0012277002,0.0016859099,0.000044304987,0.000039174152,0.0000015594554,0.000008671321,0.00016686291,0.0035741557],"study_design_scores_gemma":[0.0074351635,0.0012781243,0.9892935,0.00012993568,0.0005172557,0.0005369828,0.000032638996,0.0000054564894,0.0000041206504,0.000025608217,0.0006496594,0.00009152392],"about_ca_topic_score_codex":0.006929669,"about_ca_topic_score_gemma":0.010885059,"teacher_disagreement_score":0.006742397,"about_ca_system_score_codex":0.00015201277,"about_ca_system_score_gemma":0.0012593364,"threshold_uncertainty_score":0.99968326},"labels":[],"label_agreement":null},{"id":"W2757588171","doi":"10.1016/j.cjca.2017.07.224","title":"ON-TREATMENT LDL-C LEVELS WHEN ALIROCUMAB DOSE IS DECREASED FROM 150 TO 75 MG EVERY 2 WEEKS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM ODYSSEY","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Alirocumab; Cohort; Placebo; Internal medicine; Statin; Population; Gastroenterology; Familial hypercholesterolemia; Cholesterol; Apolipoprotein B","score_opus":0.024230048980385496,"score_gpt":0.25216022559999896,"score_spread":0.22793017661961346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757588171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427676,0.00023987133,0.00014272518,0.0017997101,0.0006933305,0.0006010547,0.0013519151,0.000006094963,0.00088850706],"genre_scores_gemma":[0.9958031,0.000031287844,0.0004529817,0.0020453657,0.0014413302,0.000013906241,0.00009994704,0.00004413542,0.00006792885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752355,0.00026573145,0.0006606682,0.00048442776,0.00044540936,0.0006202018],"domain_scores_gemma":[0.99634326,0.0001054544,0.00032197093,0.0013363932,0.00029195266,0.0016009923],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040551563,0.00034147716,0.001338153,0.00033046652,0.00021346213,0.000069308786,0.0003655943,0.0003177727,0.000028433235],"category_scores_gemma":[0.00040723942,0.0002496059,0.00039631425,0.00005497326,0.00012708074,0.00013437067,0.000029786133,0.0004783607,0.000034045876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017509392,0.00013811898,0.7985238,0.000030902564,0.004719577,0.008838823,0.0045728087,0.0008477118,0.00025597648,0.000008272592,0.013729046,0.15082556],"study_design_scores_gemma":[0.020482972,0.0029443367,0.9571127,0.000354825,0.00031181658,0.00009808956,0.00010177135,0.0000031167847,0.00010037557,0.0001372494,0.018116554,0.00023616191],"about_ca_topic_score_codex":0.113825694,"about_ca_topic_score_gemma":0.032949608,"teacher_disagreement_score":0.15858893,"about_ca_system_score_codex":0.0011824428,"about_ca_system_score_gemma":0.0018422467,"threshold_uncertainty_score":0.9999956},"labels":[],"label_agreement":null},{"id":"W2757850790","doi":"10.1016/j.cjca.2017.07.267","title":"GUIDELINES ORIENTED APPROACH TO LIPID (GOAL) MEDICAL PRACTICE ACTIVITY (MPA) TO ACHIEVE LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) TARGETS","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Dyslipidemia; Blood pressure; Coronary artery disease; Internal medicine; Diabetes mellitus; Statin; Disease; Cardiology; Familial hypercholesterolemia; Physical therapy; Cholesterol; Endocrinology","score_opus":0.029104116528667092,"score_gpt":0.3137386764599857,"score_spread":0.28463455993131864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757850790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76155907,0.00065546005,0.120385624,0.09704892,0.0037725158,0.0020386176,0.000044889708,0.000032056618,0.0144628445],"genre_scores_gemma":[0.9774103,0.00008926914,0.0061625997,0.007264826,0.008813754,0.000032474578,0.0000062144118,0.000048677397,0.00017185055],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963702,0.00055266015,0.00073314056,0.00048505032,0.0010063732,0.0008525856],"domain_scores_gemma":[0.99166286,0.000072402225,0.0004754273,0.00142516,0.0018760232,0.0044881077],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047131963,0.00031974821,0.0014500327,0.00039080568,0.0005315246,0.000088009736,0.0006590397,0.00045885675,0.000017209544],"category_scores_gemma":[0.014782355,0.00026678192,0.0005912278,0.00018134936,0.00020714119,0.00029028385,0.0001245716,0.0010824025,0.00004897272],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037700816,0.00012728195,0.011672358,0.00037323672,0.003630178,0.0055129128,0.0012097713,0.0014446082,0.001609692,0.00032924797,0.09472563,0.875595],"study_design_scores_gemma":[0.0031687967,0.0017469155,0.16992286,0.00037974125,0.00046504822,0.012926308,0.00028501902,0.00007681022,0.00092566054,0.000022667986,0.8096515,0.00042869037],"about_ca_topic_score_codex":0.020011656,"about_ca_topic_score_gemma":0.007602125,"teacher_disagreement_score":0.8751663,"about_ca_system_score_codex":0.0004904035,"about_ca_system_score_gemma":0.0046358895,"threshold_uncertainty_score":0.9999784},"labels":[],"label_agreement":null},{"id":"W2757868675","doi":"10.1016/j.cjca.2017.07.234","title":"THE EFFECT OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 ANTIBODIES ON MORTALITY AND CARDIOVASCULAR OUTCOMES: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"PCSK9; Medicine; Alirocumab; Ezetimibe; Evolocumab; Internal medicine; Placebo; Randomized controlled trial; Kexin; Statin; Rosuvastatin; Proprotein convertase; Meta-analysis; Cholesterol; Lipoprotein; LDL receptor; Pathology","score_opus":0.08542043077575537,"score_gpt":0.3541520218720001,"score_spread":0.2687315910962448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757868675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.923883,0.06978718,0.00026384642,0.00086595217,0.0005208382,0.003636586,0.00008782693,0.0000032195655,0.0009515415],"genre_scores_gemma":[0.99832916,0.0012474617,0.000026423757,0.000046215075,0.00022287412,0.00005502272,0.0000046318764,0.000015251004,0.00005293285],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9904456,0.006327028,0.0020221937,0.00023499914,0.0006483432,0.00032180062],"domain_scores_gemma":[0.9923357,0.002917241,0.001954365,0.0015450409,0.0008223766,0.0004253192],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.04906157,0.00029943627,0.023983205,0.0005040508,0.00026199658,0.000043025408,0.00028410272,0.00019596823,0.00002158178],"category_scores_gemma":[0.034082495,0.00012522002,0.02147372,0.00012698396,0.0010091178,0.00005243915,0.000021247011,0.0003139218,6.0439555e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032756392,0.000003285301,0.035704464,0.00012814278,0.9290778,0.00018973456,0.000061487866,0.00037567533,0.000050208513,0.0001540323,0.00009482847,0.0014039241],"study_design_scores_gemma":[0.13842462,0.0010169247,0.060098946,0.000039263214,0.7978725,0.000104083985,0.00005708927,0.000036885423,0.000956545,0.000071889124,0.0011873274,0.0001339349],"about_ca_topic_score_codex":0.011096671,"about_ca_topic_score_gemma":0.0017731374,"teacher_disagreement_score":0.13120534,"about_ca_system_score_codex":0.000051268486,"about_ca_system_score_gemma":0.0009260332,"threshold_uncertainty_score":0.9954885},"labels":[],"label_agreement":null},{"id":"W2757930501","doi":"10.1097/mol.0000000000000458","title":"Implications of GLAGOV study","year":2017,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"InfraRedx; Anthera; Amgen","keywords":"Evolocumab; PCSK9; Medicine; Kexin; Internal medicine; Statin; Proprotein convertase; Alirocumab; Coronary artery disease; Placebo; Cardiology; Coronary atherosclerosis; Cholesterol; Atherosclerotic cardiovascular disease; Lipoprotein; Endocrinology; Disease; LDL receptor; Pathology","score_opus":0.3791009625679572,"score_gpt":0.5247919051650544,"score_spread":0.14569094259709714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757930501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004472079,0.96743506,0.000032159674,0.00007276734,0.028801747,0.0030847574,0.000040455267,0.00002026713,0.0005082998],"genre_scores_gemma":[0.000023708382,0.9873105,0.000032895583,0.000003998375,0.011678875,0.00065924315,0.00022709992,0.00003303982,0.000030637726],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976234,0.00041598402,0.0009769045,0.0004855676,0.00021875964,0.00027940611],"domain_scores_gemma":[0.99728703,0.000095107185,0.00061597204,0.001787305,0.00010122652,0.00011333809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009132123,0.00027876516,0.0027983228,0.00037591392,0.00006160128,0.0000072335033,0.00033803398,0.0002836647,0.00006478835],"category_scores_gemma":[0.00026669324,0.0002179114,0.0007041081,0.00020249898,0.00010981277,0.00002995048,0.00016245237,0.00062177295,0.000047552137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006377353,0.0005822337,0.0008174388,0.030285934,0.00015782115,7.8181095e-8,0.000054337488,4.643212e-8,1.2735407e-8,0.0005095614,0.0039268173,0.96365935],"study_design_scores_gemma":[0.00080087973,0.00031558154,0.0033582193,0.011358686,0.00040370738,0.00007981988,0.000020018933,2.2365346e-7,8.5871035e-9,0.000058352063,0.98346174,0.00014274062],"about_ca_topic_score_codex":0.00005391393,"about_ca_topic_score_gemma":0.0000065938593,"teacher_disagreement_score":0.9795349,"about_ca_system_score_codex":0.00012329906,"about_ca_system_score_gemma":0.0008179771,"threshold_uncertainty_score":0.88861686},"labels":[],"label_agreement":null},{"id":"W2758118321","doi":"10.1016/j.cjca.2017.07.203","title":"3-MONTH RESULTS FOR GOAL-RCT: A RANDOMIZED TRIAL COMPARING COLESEVELAM VS. EZETIMIBE IN TYPE 2 DIABETES","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Ezetimibe; Medicine; Randomized controlled trial; Type 2 diabetes; Internal medicine; Statin; Metformin; Diabetes mellitus; Ldl cholesterol; Gastroenterology; Cholesterol; Insulin; Endocrinology","score_opus":0.028168193588504455,"score_gpt":0.28537463884403014,"score_spread":0.25720644525552566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758118321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744365,0.002970751,0.00041404332,0.0042903656,0.0032167872,0.0023493757,0.00003259662,0.0000063589523,0.012283224],"genre_scores_gemma":[0.9961091,0.00018361758,0.00035763308,0.00021465168,0.0029284696,0.000037774804,0.00001306987,0.000020284004,0.00013539923],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980276,0.00032553225,0.000771325,0.00018975721,0.00017623865,0.00050949457],"domain_scores_gemma":[0.9977665,0.00022617591,0.00045420893,0.00055245764,0.00039051674,0.0006101448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047736624,0.0001522494,0.0021013005,0.00029255537,0.00020730628,0.000049647086,0.00026577438,0.00020426218,0.0000038461126],"category_scores_gemma":[0.0050981957,0.00012135749,0.00075128383,0.0000640375,0.00026469067,0.00007795727,0.000017613642,0.00037582958,0.0000032208018],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9507816,0.000011834458,0.016376395,0.00014056916,0.0015668622,0.0005136432,0.00032254454,0.0006445118,0.000032893422,0.00033783555,0.016844204,0.012427093],"study_design_scores_gemma":[0.8762248,0.0012209744,0.033638407,0.00023847877,0.00039173683,0.00017847389,0.000051018393,0.0001774421,0.000040797626,0.0003144241,0.087369174,0.00015428051],"about_ca_topic_score_codex":0.0023985056,"about_ca_topic_score_gemma":0.0062637897,"teacher_disagreement_score":0.07455682,"about_ca_system_score_codex":0.00024535423,"about_ca_system_score_gemma":0.002319249,"threshold_uncertainty_score":0.6103385},"labels":[],"label_agreement":null},{"id":"W2758540757","doi":"10.1056/nejme1711407","title":"CETP Inhibitors — A New Inning?","year":2017,"lang":"en","type":"letter","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cholesterylester transfer protein; Medicine; Atherosclerotic cardiovascular disease; Statin; Cholesterol; Disease; Internal medicine; Pharmacology; Lipoprotein","score_opus":0.02579849452383872,"score_gpt":0.2893579380068674,"score_spread":0.2635594434830287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2758540757","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027552827,0.019236136,0.00041368126,0.9642903,0.0050661666,0.00040931645,0.0000031941474,0.00002689302,0.0077990103],"genre_scores_gemma":[0.005089211,0.0026255045,0.0009499492,0.44420198,0.521385,0.0000019903462,0.00005978995,0.00013254608,0.025554037],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99560934,0.00016990317,0.00117234,0.00031737334,0.0022081663,0.0005228966],"domain_scores_gemma":[0.99605113,0.0001349943,0.0014616372,0.001045373,0.0004334709,0.0008734039],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021741735,0.00046982267,0.002294442,0.00054779043,0.0001242533,0.000036960446,0.00042742823,0.0007722451,0.0005198908],"category_scores_gemma":[0.0013618383,0.00028751526,0.00065584027,0.0001422677,0.00017143879,0.00011970536,0.000055559678,0.004756193,0.00002939249],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022192964,0.000012372076,0.00018949766,0.00029305887,0.00055385963,0.010175267,0.0003413471,5.5959083e-7,0.00004700068,0.0000026617615,0.7787512,0.20941126],"study_design_scores_gemma":[0.047982045,0.0021706098,0.00053347665,0.0051049,0.0014107813,0.019479753,0.000026410495,0.0000012029374,0.000061286686,0.00031924216,0.92268986,0.00022045673],"about_ca_topic_score_codex":0.0014540039,"about_ca_topic_score_gemma":0.000017708337,"teacher_disagreement_score":0.5200884,"about_ca_system_score_codex":0.0001807974,"about_ca_system_score_gemma":0.0025791274,"threshold_uncertainty_score":0.9999577},"labels":[],"label_agreement":null},{"id":"W2760495556","doi":"10.1007/s40801-017-0116-7","title":"The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin","year":2017,"lang":"en","type":"article","venue":"Drugs - Real World Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; Dalhousie University; Acadia University","funders":"Canadian Institutes of Health Research; Dalhousie University; Nova Scotia Health Research Foundation; Canadian Diabetes Association","keywords":"Simvastatin; Medicine; Environmental health; Pharmacology; Business","score_opus":0.011538709658854849,"score_gpt":0.3129625105223872,"score_spread":0.3014238008635324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760495556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594568,0.00050658267,0.0000025348206,0.036580216,0.00018544932,0.0008399922,0.00006134666,0.000013015298,0.0023540515],"genre_scores_gemma":[0.99622744,0.00052001217,0.0000624152,0.00050502387,0.000046533587,0.000011132188,0.000012332154,0.000020899855,0.0025942146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982501,0.00012763422,0.00053381384,0.0002019912,0.0005275402,0.00035889854],"domain_scores_gemma":[0.99780715,0.0002185139,0.00045823964,0.0011481427,0.00010994253,0.0002579891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015634876,0.00017143389,0.00071315054,0.00005064507,0.0005891477,0.00002402943,0.00024775323,0.000031345033,0.00001791598],"category_scores_gemma":[0.00023841838,0.0000804287,0.00023589269,0.00015350715,0.00012646263,0.000039627506,0.00012059627,0.00024665004,0.0000015378001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044421334,0.000056165325,0.7828912,0.000227455,0.001127288,0.000021290438,0.0033410667,0.00011314148,0.000017383658,0.0017483002,0.012290517,0.19772197],"study_design_scores_gemma":[0.001336525,0.00014883559,0.9885563,0.00010253007,0.000051525705,0.000007304706,0.00026246553,0.000036240795,0.00004506544,0.000077903875,0.009298549,0.000076703735],"about_ca_topic_score_codex":0.95688605,"about_ca_topic_score_gemma":0.69983137,"teacher_disagreement_score":0.25705466,"about_ca_system_score_codex":0.00027044961,"about_ca_system_score_gemma":0.0012355164,"threshold_uncertainty_score":0.4531307},"labels":[],"label_agreement":null},{"id":"W2760576860","doi":"10.1007/s11883-017-0679-5","title":"Pharmacogenetics of Lipid-Lowering Agents: an Update Review on Genotype-Dependent Effects of HDL-Targetingand Statin Therapies","year":2017,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Cholesterylester transfer protein; Medicine; Pharmacogenetics; Statin; Pharmacogenomics; Pharmacology; Bioinformatics; Internal medicine; Randomized controlled trial; Cholesterol; Genotype; Oncology; Lipoprotein; Genetics; Biology; Gene","score_opus":0.10789757508697706,"score_gpt":0.40828830729614934,"score_spread":0.3003907322091723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760576860","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005219431,0.98820066,0.00004686661,0.000011709623,0.0020233893,0.0043258527,0.000061870865,0.000053966574,0.00005624109],"genre_scores_gemma":[0.0018251017,0.9965816,0.00014478026,0.000058037764,0.0005919512,0.00031707995,0.00024372204,0.00018943111,0.000048286453],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99455017,0.00044526902,0.0022565967,0.0009363356,0.0013150523,0.0004965496],"domain_scores_gemma":[0.992786,0.00007832213,0.0038192926,0.0026493224,0.00032605304,0.00034102844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002085653,0.00079743017,0.004552627,0.00019274901,0.00014475963,0.000033544766,0.00036344936,0.00025633615,0.000114325165],"category_scores_gemma":[0.0004065795,0.00059244584,0.0017513313,0.00018961598,0.00013197094,0.00008219502,0.00016285943,0.0006267066,0.000013310312],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001100796,0.0004577959,0.00010389988,0.21714187,0.0007363946,0.00003996789,0.00010263556,7.010233e-7,0.00009600428,0.0000011401313,0.0002862955,0.7810223],"study_design_scores_gemma":[0.000523684,0.00039014462,0.00041423948,0.22347683,0.0037694073,0.0000759651,0.0000037119528,9.486236e-7,0.00084708043,0.0000025765519,0.77007484,0.00042057649],"about_ca_topic_score_codex":0.00003888357,"about_ca_topic_score_gemma":0.0000017288444,"teacher_disagreement_score":0.78060174,"about_ca_system_score_codex":0.00015007035,"about_ca_system_score_gemma":0.0005431578,"threshold_uncertainty_score":0.9996527},"labels":[],"label_agreement":null},{"id":"W2760813376","doi":"10.1093/eurheartj/ehx493.p6213","title":"P6213Differences in recommendations and associated level of evidence for statins in primary prevention of CVD according to the ACC/AHA 2013, CCS 2016, ESC 2016, and USPSTF 2016 clinical practice guidelines","year":2017,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Primary prevention; Clinical Practice; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive care medicine; MEDLINE; Family medicine; Statin; Internal medicine; Disease","score_opus":0.5966057041769449,"score_gpt":0.5350767121880868,"score_spread":0.061528991988858084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760813376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92366844,0.004055202,0.0024962437,0.06807215,0.00037363532,0.001043073,0.00003937909,0.0000058797305,0.00024601893],"genre_scores_gemma":[0.9219191,0.035887815,0.038916234,0.0013908682,0.000815958,0.00001542576,0.000010188262,0.00003873884,0.0010056564],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99703085,0.0011824745,0.0010610183,0.00021173783,0.0003093214,0.00020461249],"domain_scores_gemma":[0.997254,0.0009536454,0.0007528191,0.0003402137,0.00056456134,0.00013475426],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015988544,0.00011189402,0.00046327023,0.000116801,0.0002287552,0.000072554394,0.00015833507,0.000048499227,0.000009427247],"category_scores_gemma":[0.015067342,0.00006982073,0.00012366203,0.000077635435,0.000073353054,0.00048739614,0.00014333549,0.00036994144,0.000002733139],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011182725,0.000505354,0.23993438,0.00027725534,0.00028948876,0.000027023276,0.0010457708,0.000013395073,0.0010465011,0.000012658881,0.10915705,0.6465728],"study_design_scores_gemma":[0.0021929748,0.00069110823,0.97715986,0.0039169253,0.00010528314,0.00013764991,0.00065460714,0.00009479534,0.00004050577,0.00006311247,0.014855039,0.00008813382],"about_ca_topic_score_codex":0.00035583804,"about_ca_topic_score_gemma":0.0002208774,"teacher_disagreement_score":0.7372255,"about_ca_system_score_codex":0.00004671348,"about_ca_system_score_gemma":0.0004292782,"threshold_uncertainty_score":0.99322915},"labels":[],"label_agreement":null},{"id":"W2762347028","doi":"10.1093/eurheartj/ehx501.p624","title":"P624Trends in the prescribing of drugs to prevent cardiovascular disease (CVD) in England between 1998-2015","year":2017,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Disease; Intensive care medicine; Polypill; Emergency medicine; Internal medicine","score_opus":0.050048093389620595,"score_gpt":0.31179807376750757,"score_spread":0.261749980377887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762347028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99005485,0.0037077805,0.00008456427,0.0028539302,0.00015202418,0.00051102653,0.000008744058,0.0000079270185,0.002619183],"genre_scores_gemma":[0.9976955,0.00019881716,0.00018885372,0.00022388471,0.0015515789,0.000006197434,0.0000037441116,0.000031991425,0.00009943932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970291,0.0010569781,0.0004469461,0.00024034941,0.00087200763,0.0003546046],"domain_scores_gemma":[0.99812716,0.000037619146,0.00011135453,0.0012954767,0.00004813913,0.00038025566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072910427,0.00015052344,0.0005121477,0.00018001247,0.00021043462,0.00009216249,0.0003594104,0.0000275108,0.000010536325],"category_scores_gemma":[0.00032616963,0.00010149232,0.00056114607,0.00011930257,0.00004706885,0.00012477602,0.00013342907,0.0005822803,0.000027762766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041111017,0.0005689571,0.7533991,0.0004297377,0.0010403987,0.0036081648,0.011867769,0.0006881147,0.0002885516,0.000023764176,0.0030098204,0.22466455],"study_design_scores_gemma":[0.0017609169,0.00014472097,0.83737963,0.0005336053,0.00015175571,0.00016786842,0.00011990091,0.00001201448,0.00007282275,0.000014283218,0.15954731,0.00009514172],"about_ca_topic_score_codex":0.00022582586,"about_ca_topic_score_gemma":0.00001695453,"teacher_disagreement_score":0.22456941,"about_ca_system_score_codex":0.00007114864,"about_ca_system_score_gemma":0.00014332637,"threshold_uncertainty_score":0.41387364},"labels":[],"label_agreement":null},{"id":"W2762606656","doi":"10.1016/j.cjca.2017.09.016","title":"Do Oxidized Lipoproteins Cause Atherosclerotic Cardiovascular Diseases?","year":2017,"lang":"en","type":"editorial","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Ezetimibe; Internal medicine; Apolipoprotein B; Statin; Cholesterol; Disease; Coronary artery disease; Clinical trial; Scopus; Cardiology; MEDLINE","score_opus":0.019375716530958736,"score_gpt":0.2657674563070016,"score_spread":0.24639173977604287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762606656","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025181214,0.08578886,0.0009711773,0.00039892984,0.90401495,0.0015957438,0.00078218133,0.000035310593,0.0038947233],"genre_scores_gemma":[0.081331104,0.005460724,0.00015136521,0.00007299321,0.91191566,0.000053760315,0.00017138869,0.00021846812,0.00062454824],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942288,0.0007683771,0.0011799426,0.0007460496,0.0018109711,0.0012659074],"domain_scores_gemma":[0.9902173,0.00018258739,0.0009834922,0.0033899683,0.0020049817,0.0032216252],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0028257314,0.00075103965,0.005135536,0.0008359406,0.000500449,0.00020146708,0.0010289741,0.0021696112,0.000059626716],"category_scores_gemma":[0.0053441026,0.0006433019,0.006169107,0.00017054092,0.00058326346,0.00016574352,0.000070926086,0.0029095365,0.000073491174],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020358585,0.000007406556,0.0005782741,0.00054240297,0.014586287,0.0076722493,0.000058835467,0.0001747933,0.000014586832,0.000015084475,0.962711,0.013435513],"study_design_scores_gemma":[0.0043818927,0.0007262659,0.002489111,0.0009179245,0.0076112906,0.0016639188,0.00003319151,7.9977195e-7,0.000010558817,0.000105500105,0.9815311,0.000528486],"about_ca_topic_score_codex":0.006745384,"about_ca_topic_score_gemma":0.0013644424,"teacher_disagreement_score":0.08032814,"about_ca_system_score_codex":0.0012691997,"about_ca_system_score_gemma":0.023748042,"threshold_uncertainty_score":0.9998688},"labels":[],"label_agreement":null},{"id":"W2763504758","doi":"10.24870/cjb.2017-a16","title":"Drug targets and lipid biomarkers of hyperlipidemia associated diseases","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Biotechnology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Hyperlipidemia; Drug; Medicine; Pharmacology; Diabetes mellitus; Endocrinology","score_opus":0.00956674414089043,"score_gpt":0.23877011516543956,"score_spread":0.22920337102454913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763504758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97530735,0.008440228,0.00005349655,0.01536359,0.0004033436,0.00014594958,0.000036350622,0.000009778864,0.00023991958],"genre_scores_gemma":[0.99866223,0.0006765153,0.00026542522,0.00017294296,0.00015253553,9.5055464e-7,0.0000034006143,0.000012838163,0.00005314294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991121,0.000039511047,0.00032008244,0.00011908522,0.00013768586,0.00027149578],"domain_scores_gemma":[0.9983968,0.000022658025,0.00041965002,0.0004602449,0.00014514998,0.00055546255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048923277,0.000098644625,0.0005155124,0.0003554264,0.00019405635,0.00001624295,0.00021098612,0.0002621396,0.000027380456],"category_scores_gemma":[0.0017998541,0.00008207212,0.00018094064,0.00007818041,0.00049787527,0.00006654076,0.000023749497,0.0002975912,0.0000014714268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022145065,0.00011935485,0.54568714,0.0004934124,0.0033046638,0.0020512238,0.00029279105,0.0000026555729,0.016005088,0.0017075972,0.013124674,0.41698992],"study_design_scores_gemma":[0.004085069,0.0008124982,0.87290347,0.0006938215,0.00073197973,0.0011992822,0.00038001814,0.000047628415,0.018472899,0.00074080727,0.099659145,0.00027336943],"about_ca_topic_score_codex":0.00822614,"about_ca_topic_score_gemma":0.007972989,"teacher_disagreement_score":0.41671655,"about_ca_system_score_codex":0.00012764543,"about_ca_system_score_gemma":0.0010924913,"threshold_uncertainty_score":0.99837816},"labels":[],"label_agreement":null},{"id":"W2763903839","doi":"10.1016/j.jacl.2017.10.001","title":"Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk","year":2017,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"Fonds de Recherche du Québec - Santé; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Pfizer; European Commission; Ionis Pharmaceuticals; Agence Nationale de la Recherche","keywords":"Medicine; Kexin; Subtilisin; Atorvastatin; Type 2 Diabetes Mellitus; Proprotein convertase; Cholesterylester transfer protein; Internal medicine; PCSK9; Endocrinology; Diabetes mellitus; Cholesterol; Lipoprotein; Pharmacology; LDL receptor; Biochemistry; Enzyme","score_opus":0.030036964991493567,"score_gpt":0.32477968899625503,"score_spread":0.2947427240047615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763903839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959219,0.0011481455,0.00006195694,0.0002956863,0.0005345736,0.0019877714,0.00001643768,0.000008358046,0.000025164485],"genre_scores_gemma":[0.9980504,0.00026863467,0.00042056278,0.0001093122,0.0010579041,0.00003157896,0.0000044738067,0.000043565724,0.000013551137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943825,0.0020307936,0.0019094712,0.00048929214,0.00078587537,0.00040204014],"domain_scores_gemma":[0.9969244,0.00046261406,0.00095155975,0.00082754035,0.0005033407,0.0003305344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009644244,0.00031733455,0.0023196114,0.0001912515,0.00017564342,0.00003722721,0.00014241929,0.00045302208,0.000015489555],"category_scores_gemma":[0.0056691864,0.00022597722,0.0006160235,0.00010945887,0.00045207603,0.00020625128,0.00010859319,0.0010395701,0.0000032802884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032926758,0.0003298809,0.71656275,0.0011217444,0.00088030833,0.000042386528,0.00011405895,0.0000173696,0.0011676992,0.00001988323,0.000010294422,0.27644095],"study_design_scores_gemma":[0.0167986,0.012649907,0.95400643,0.0013199989,0.0004967299,0.000049148133,0.000007127185,0.000019531442,0.014011423,0.00012810671,0.00032199203,0.00019098305],"about_ca_topic_score_codex":0.00019906598,"about_ca_topic_score_gemma":0.000032709468,"teacher_disagreement_score":0.27624995,"about_ca_system_score_codex":0.00006634415,"about_ca_system_score_gemma":0.00014175965,"threshold_uncertainty_score":0.9215084},"labels":[],"label_agreement":null},{"id":"W2763968521","doi":"10.1093/eurheartj/ehx493.5938","title":"5938Efficacy of evinacumab in homozygous familial hypercholesterolemia patients with null or non-null LDL-receptor mutations and on various background therapies","year":2017,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Null (SQL); LDL receptor; Null allele; Internal medicine; Genetics; Cholesterol; Lipoprotein; Gene; Phenotype","score_opus":0.03345119727006848,"score_gpt":0.297875065821222,"score_spread":0.2644238685511535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763968521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973395,0.00019265355,0.00007041221,0.00046913914,0.00017910884,0.00046452173,0.00001298889,0.000011629343,0.0012600551],"genre_scores_gemma":[0.99764514,0.00019163195,0.0011354948,0.0003124485,0.00040349385,0.0000035532364,0.000009364581,0.000052371466,0.00024649277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983594,0.00026949946,0.00035777033,0.00023936135,0.0004939144,0.0002800803],"domain_scores_gemma":[0.9988021,0.0000479551,0.00020665614,0.0005458505,0.00016962283,0.00022776052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078181917,0.00018813892,0.00043517954,0.00014067614,0.0003883088,0.00012946608,0.00014912864,0.00004454294,0.000049123137],"category_scores_gemma":[0.00010685751,0.0001218517,0.00011525467,0.000069137655,0.00015623175,0.0001810354,0.000050583505,0.0005198292,0.000047553363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063248104,0.0021967369,0.80015945,0.00039018542,0.00070384925,0.0014662516,0.007087367,0.00007296757,0.001386676,0.00002764469,0.0019569106,0.17822713],"study_design_scores_gemma":[0.007600923,0.002354716,0.9811255,0.0005813994,0.00005615208,0.00058552355,0.00024620825,0.000010776185,0.000046497393,0.0000037624163,0.007252318,0.00013622972],"about_ca_topic_score_codex":0.00008788993,"about_ca_topic_score_gemma":0.00004242592,"teacher_disagreement_score":0.18096602,"about_ca_system_score_codex":0.000078227815,"about_ca_system_score_gemma":0.00017582979,"threshold_uncertainty_score":0.4968968},"labels":[],"label_agreement":null},{"id":"W2764002994","doi":"10.1093/eurheartj/ehx493.p5375","title":"P5375A default in acetyl-CoA carboxylase phosphorylation increases thrombus growth in vitro and in vivo, and in a collagen-dependent manner","year":2017,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; In vivo; Phosphorylation; In vitro; Acetyl-CoA carboxylase; Thrombus; Pyruvate carboxylase; Biochemistry; Pharmacology; Internal medicine; Enzyme; Genetics","score_opus":0.02252832192947312,"score_gpt":0.2778868850780578,"score_spread":0.2553585631485847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764002994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99421203,0.0030301753,0.00000537364,0.00080860604,0.00009021199,0.00044769762,0.0000049239493,0.0000084950125,0.0013925114],"genre_scores_gemma":[0.9973703,0.0017679204,0.0002325749,0.00028463034,0.00022600302,0.0000051274938,0.0000020238592,0.00003586807,0.00007555705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796915,0.00054133544,0.00045505434,0.00030449012,0.00036030717,0.00036967976],"domain_scores_gemma":[0.999234,0.00003826795,0.00012553252,0.0003067823,0.000047731348,0.00024765727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027977524,0.00017807729,0.00047789994,0.00033718132,0.00014571665,0.00012639521,0.0000925075,0.00006616321,0.000022567277],"category_scores_gemma":[0.00035878387,0.0001577978,0.000068151094,0.00013646715,0.00007375605,0.00024601805,0.000117665484,0.0005145107,0.000006203678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017480986,0.0003559835,0.9610892,0.00017942792,0.000041959054,0.0075405976,0.0013474042,0.000051448696,0.02234505,0.000008543057,0.00028096008,0.0050113564],"study_design_scores_gemma":[0.0066099185,0.00016515906,0.98637736,0.0005013167,0.000019075691,0.0017003515,0.00030264293,0.00023842324,0.0033695789,0.000032768992,0.0005229586,0.00016044025],"about_ca_topic_score_codex":0.0035189332,"about_ca_topic_score_gemma":0.0022694753,"teacher_disagreement_score":0.025288193,"about_ca_system_score_codex":0.00018683693,"about_ca_system_score_gemma":0.00013523447,"threshold_uncertainty_score":0.6434807},"labels":[],"label_agreement":null},{"id":"W2764166115","doi":"10.1161/circulationaha.117.029008","title":"Letter by Vos et al Regarding Article, “Primary Prevention With Statin Therapy in the Elderly: New Meta-Analyses From the Contemporary JUPITER and HOPE-3 Randomized Trials”","year":2017,"lang":"en","type":"letter","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Rosuvastatin; Randomized controlled trial; Statin; Gerontology; Primary prevention; Family medicine; Internal medicine","score_opus":0.17890944263912406,"score_gpt":0.37067769565498254,"score_spread":0.19176825301585848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2764166115","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06533122,0.021790706,0.010141711,0.896291,0.00012975259,0.0057627573,0.000053582247,0.000030928433,0.00046833907],"genre_scores_gemma":[0.20728384,0.00066065474,0.0004164929,0.7867128,0.0021347292,0.00044704627,0.0019399158,0.000067788904,0.00033669677],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99228245,0.005240333,0.0008416273,0.00050106796,0.00091879355,0.00021573566],"domain_scores_gemma":[0.9964813,0.0014710592,0.0008495093,0.0010686315,0.00008470852,0.00004478763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0078128595,0.00034750695,0.002279734,0.00008455981,0.00016360884,0.00029023679,0.00016652093,0.00027092276,0.00006471233],"category_scores_gemma":[0.00044758513,0.00014845045,0.0010992443,0.00009389854,0.00011316107,0.00026658285,0.000020300306,0.0010085896,0.0000035446478],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005321817,0.00003077621,0.00039725416,0.000043845193,0.008240471,0.00007048819,0.0006864455,0.0000074507902,0.00042047814,0.0000028459667,0.9658207,0.018957429],"study_design_scores_gemma":[0.13457602,0.00018830033,0.01082005,0.00032924183,0.01291755,0.00005415154,0.00005748848,0.000092608854,0.00012764752,0.0009276099,0.83950454,0.0004047732],"about_ca_topic_score_codex":0.0036837966,"about_ca_topic_score_gemma":0.000041037605,"teacher_disagreement_score":0.14195262,"about_ca_system_score_codex":0.000052367024,"about_ca_system_score_gemma":0.0002716694,"threshold_uncertainty_score":0.60536337},"labels":[],"label_agreement":null},{"id":"W2765156675","doi":"","title":"Abstract 261: Liver-specific Pcsk9 Knockout And Transgenic Mice","year":2007,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Medicine; PCSK9; Genetically modified mouse; Knockout mouse; Transgene; LDL receptor; Internal medicine; Cholesterol; Receptor; Lipoprotein; Gene; Genetics","score_opus":0.026703519790055592,"score_gpt":0.26183060099934735,"score_spread":0.23512708120929177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765156675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98375523,0.0057703108,0.006251763,0.00013213596,0.00014988738,0.00040919622,0.0000015898739,0.00005545534,0.003474455],"genre_scores_gemma":[0.9985354,0.0003376678,0.0003293752,0.00012563134,0.0005918425,0.000003826183,0.000025335159,0.000016839542,0.000034106106],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991218,0.000014045881,0.00020389695,0.00021134461,0.00025940116,0.00018955297],"domain_scores_gemma":[0.9995177,0.000023224207,0.000040736006,0.00022613723,0.000056968976,0.00013522628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057906786,0.00009068402,0.00017001532,0.00007590418,0.00007773606,0.0000140372285,0.000024114343,0.00010295125,0.000086482985],"category_scores_gemma":[0.000012294925,0.000086264954,0.00011708946,0.00012237343,0.000027548132,0.00007680193,0.000004814011,0.00012893237,0.000048154267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016499367,0.0001195297,0.029248357,0.00047396857,0.00014045647,0.00006794475,0.0010185252,0.000029002736,0.08412387,0.00084481755,0.00016930036,0.8835992],"study_design_scores_gemma":[0.0008968963,0.000024104422,0.97882634,0.00004865031,0.00005240422,0.00010149581,0.000073344156,0.00007960581,0.0024277575,0.0000581063,0.017318202,0.00009309985],"about_ca_topic_score_codex":0.00008355525,"about_ca_topic_score_gemma":0.000019823576,"teacher_disagreement_score":0.949578,"about_ca_system_score_codex":0.00007179528,"about_ca_system_score_gemma":0.00003539965,"threshold_uncertainty_score":0.3517783},"labels":[],"label_agreement":null},{"id":"W2765332076","doi":"10.1001/jamacardio.2017.3833","title":"Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome","year":2017,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; University of Toronto; Université de Montréal; St. Michael's Hospital","funders":"","keywords":"Medicine; Unstable angina; Acute coronary syndrome; Internal medicine; Myocardial infarction; Cardiology; Angina","score_opus":0.010071493130660145,"score_gpt":0.26383508784377907,"score_spread":0.25376359471311893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765332076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543935,0.000864615,0.00029298782,0.00039285084,0.0003833552,0.00067682203,0.000058695412,0.000020031415,0.0018713196],"genre_scores_gemma":[0.9981153,0.00061853864,0.0006643365,0.000029151897,0.00017898067,0.00005372232,0.000035454897,0.0000234122,0.00028107406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832153,0.00021531328,0.0003623814,0.00028945395,0.0005196344,0.000291671],"domain_scores_gemma":[0.99787945,0.00005120799,0.0007279247,0.0010443754,0.00019884661,0.00009818067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001354302,0.00015695907,0.0010955682,0.00006961224,0.00012731973,0.000005867508,0.00018437766,0.00028276315,0.000009577133],"category_scores_gemma":[0.00044692523,0.00012233785,0.0006346138,0.00006282668,0.00006472062,0.00010879121,0.00009838204,0.00034741487,0.000007043021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006292508,0.00005831391,0.9552874,0.00023154663,0.008718202,0.00035550713,0.000081285136,0.0000107259275,0.0021754599,0.000015554642,0.0005775874,0.031859197],"study_design_scores_gemma":[0.003847345,0.0011652381,0.987976,0.00028786092,0.0019969451,0.0006708083,0.000037654678,0.000011806676,0.0020053065,0.000049745682,0.0018280272,0.00012325357],"about_ca_topic_score_codex":0.0004521306,"about_ca_topic_score_gemma":0.000016240238,"teacher_disagreement_score":0.03268864,"about_ca_system_score_codex":0.00015525342,"about_ca_system_score_gemma":0.00017301562,"threshold_uncertainty_score":0.49887925},"labels":[],"label_agreement":null},{"id":"W2765436739","doi":"10.1016/j.jcjd.2017.08.160","title":"Real-World Tolerability and Efficacy of Evolocumab among Patients with a History of Statin-Associated Muscle Symptoms (SAMS)","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Evolocumab; Medicine; Tolerability; Statin; Discontinuation; myalgia; Kexin; PCSK9; Proprotein convertase; Internal medicine; Subtilisin; Cholesterol; Adverse effect; Lipoprotein; LDL receptor; Biochemistry","score_opus":0.009058869371354679,"score_gpt":0.21859945905657602,"score_spread":0.20954058968522135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765436739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977972,0.000719546,7.364989e-7,0.0000815214,0.00014325333,0.00024989524,0.00003298295,0.000002546948,0.0009723418],"genre_scores_gemma":[0.99969894,0.000010784955,0.000077629855,0.00003187581,0.00005065229,0.0000018252252,0.0000052469845,0.000014627318,0.000108396336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987369,0.00008018511,0.00044916404,0.00012251912,0.00035305155,0.00025817694],"domain_scores_gemma":[0.99749094,0.00006154925,0.00080026657,0.00047457553,0.0005893471,0.00058329536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069546944,0.000113110545,0.0006543243,0.00018879805,0.00008367827,0.000012157345,0.0001346697,0.00005944097,0.000042911965],"category_scores_gemma":[0.00067717663,0.00008823558,0.00014843036,0.000061699175,0.0004006392,0.00013536689,0.0000116539195,0.00019285429,1.9982792e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018629435,0.00007594906,0.9833433,0.00015440506,0.00029519174,0.000006107842,0.0003820826,0.0000024529938,0.000029720984,0.00000988869,0.00029220732,0.015390091],"study_design_scores_gemma":[0.003300008,0.0008124007,0.99446183,0.00054335856,0.00023309507,4.118512e-7,0.00003089736,0.000013812123,0.0000775825,0.000017160712,0.000430154,0.00007931264],"about_ca_topic_score_codex":0.020821942,"about_ca_topic_score_gemma":0.032802943,"teacher_disagreement_score":0.015310778,"about_ca_system_score_codex":0.00061597413,"about_ca_system_score_gemma":0.0018899731,"threshold_uncertainty_score":0.98569846},"labels":[],"label_agreement":null},{"id":"W276549403","doi":"10.5114/aoms.2011.26602","title":"Editorials Statins: the high risks of discontinuation and large benefits of continuation","year":2011,"lang":"en","type":"article","venue":"Archives of Medical Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; Canadian Institutes of Health Research; Universidad del Atlántico; International Atherosclerosis Society; Sunovion; Brigham and Women's Hospital; Bristol-Myers Squibb; Florida Atlantic University; GlaxoSmithKline; Stryker; Amgen","keywords":"Medicine; Discontinuation; Statin; Stroke (engine); Randomized controlled trial; Myocardial infarction; Atherosclerotic cardiovascular disease; Internal medicine; Cholesterol; Relative risk; Revascularization; Cardiology; Disease; Confidence interval","score_opus":0.055463868471322814,"score_gpt":0.3343388590109614,"score_spread":0.2788749905396386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W276549403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945121,0.00038194613,0.0030380047,0.00067501684,0.0003634713,0.00028999837,0.000014218994,0.0000040883915,0.0007211468],"genre_scores_gemma":[0.9977535,0.00038800266,0.0014812099,0.000033833698,0.0003251518,0.0000062824747,0.0000025760905,0.0000026630303,0.000006802914],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979276,0.0000798523,0.00032272423,0.00014046686,0.0013865157,0.00014282452],"domain_scores_gemma":[0.99913543,0.00021011513,0.00020309526,0.00023782508,0.000090258654,0.00012328666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003150574,0.00005005604,0.00023971408,0.000059621092,0.000052897292,0.000002624413,0.00019331061,0.00003223923,0.000036881353],"category_scores_gemma":[0.0019343547,0.000028151437,0.000052318977,0.00017381631,0.0010113842,0.00007167217,0.000091832255,0.00008679748,2.47764e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018094819,0.00041470845,0.025881736,0.0002467223,0.000069547576,0.0000014934001,0.01156394,0.0000012960363,0.011172187,0.081687026,0.00007815944,0.86870223],"study_design_scores_gemma":[0.0013831988,0.00048519662,0.9508534,0.00034927635,0.00006263825,0.0000041589437,0.00063645036,0.00034952394,0.043311514,0.0021619792,0.00035662932,0.000046043035],"about_ca_topic_score_codex":0.0011245057,"about_ca_topic_score_gemma":0.000051427745,"teacher_disagreement_score":0.92497164,"about_ca_system_score_codex":0.0000035042085,"about_ca_system_score_gemma":0.00023471113,"threshold_uncertainty_score":0.37264872},"labels":[],"label_agreement":null},{"id":"W2765610051","doi":"10.1373/clinchem.2017.279422","title":"Imputation of Baseline LDL Cholesterol Concentration in Patients with Familial Hypercholesterolemia on Statins or Ezetimibe","year":2017,"lang":"en","type":"article","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care Research Institute; St. Paul's Hospital; Montreal Clinical Research Institute; University of British Columbia; Providence Health Care; McGill University Health Centre; McGill University; Western University; Université de Montréal; Royal Victoria Regional Health Centre; Université Laval; Royal Victoria Hospital","funders":"Sanofi; Pfizer; Amgen","keywords":"Ezetimibe; Familial hypercholesterolemia; Medicine; PCSK9; Internal medicine; Apolipoprotein B; Ldl cholesterol; Cholesterol; Statin; Percentile; Gastroenterology; LDL receptor; Endocrinology; Lipoprotein","score_opus":0.03288752003790477,"score_gpt":0.3489960089922518,"score_spread":0.316108488954347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765610051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998486,0.000007741327,0.00012281186,0.00029631273,0.000073592426,0.00042781667,0.000032611923,0.000014650193,0.00053850486],"genre_scores_gemma":[0.9986419,0.000030993127,0.00034262467,0.00040612603,0.00028003054,0.000015474665,0.00014635992,0.000018583627,0.0001179186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983897,0.000064197775,0.0006214653,0.0003289755,0.00041330355,0.00018234833],"domain_scores_gemma":[0.9985248,0.000094353374,0.0003125473,0.00073131593,0.00017372567,0.00016326139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069593434,0.00013666405,0.00044587613,0.0000112122825,0.000058446192,0.000019431087,0.000118606826,0.00018394855,0.000031805906],"category_scores_gemma":[0.0009049413,0.00009607878,0.00011467797,0.00003885323,0.00015555922,0.000078999394,0.000029680523,0.00035612696,0.000005199177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032584057,0.0008409236,0.932294,0.00035572352,0.000059095997,0.000016562404,0.00004632541,0.000022270884,0.0003146784,0.0000015086509,0.000078940524,0.062711544],"study_design_scores_gemma":[0.012672791,0.0009050389,0.9794589,0.00043149843,0.00006596512,0.0000026055245,0.000028629409,0.00028354579,0.0058212355,0.0000045290335,0.00021560726,0.00010962524],"about_ca_topic_score_codex":0.00004085775,"about_ca_topic_score_gemma":0.000012896827,"teacher_disagreement_score":0.06260192,"about_ca_system_score_codex":0.00006026553,"about_ca_system_score_gemma":0.00024362198,"threshold_uncertainty_score":0.3917979},"labels":[],"label_agreement":null},{"id":"W2765660745","doi":"10.1111/1755-5922.12308","title":"Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high‐dose statin","year":2017,"lang":"en","type":"article","venue":"Cardiovascular Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer","keywords":"Medicine; Tolerability; PCSK9; Placebo; Internal medicine; Clinical endpoint; Gastroenterology; Statin; Adverse effect; Kexin; Endocrinology; Urology; Pharmacology; Randomized controlled trial; Lipoprotein; Cholesterol; LDL receptor","score_opus":0.031177089789447825,"score_gpt":0.2941826839491778,"score_spread":0.26300559415972996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765660745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904866,0.00527353,0.00021980763,0.00007117149,0.00017673086,0.003593143,0.000024213521,0.000038354752,0.00011645204],"genre_scores_gemma":[0.99734163,0.0011825177,0.0008447443,0.00010356032,0.00018323709,0.00012932206,0.000061500636,0.00011128487,0.000042189004],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967531,0.0004422878,0.000653043,0.0006562138,0.00094334834,0.0005519928],"domain_scores_gemma":[0.99665,0.000090410336,0.0003971957,0.0023635123,0.00030949485,0.00018943305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008628375,0.0005123971,0.0019499523,0.00023829332,0.00017557,0.000047603346,0.0003112799,0.00026138427,0.0000073701744],"category_scores_gemma":[0.00006569727,0.00038932325,0.00087752077,0.0001512854,0.00031426974,0.00009423955,0.00006403069,0.00038753334,0.000005215786],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026329385,0.0051357974,0.033281215,0.008158408,0.033183604,0.0032532664,0.008461036,0.0003859147,0.3920395,0.0003100926,0.0000041724006,0.4894576],"study_design_scores_gemma":[0.06636836,0.026189782,0.26139656,0.0037902691,0.006081739,0.00046216836,0.000501683,0.0003494881,0.63138264,0.00009923186,0.0023463136,0.0010317677],"about_ca_topic_score_codex":0.0017446968,"about_ca_topic_score_gemma":0.00013603263,"teacher_disagreement_score":0.48842582,"about_ca_system_score_codex":0.00034846604,"about_ca_system_score_gemma":0.0007084937,"threshold_uncertainty_score":0.9998559},"labels":[],"label_agreement":null},{"id":"W2766118755","doi":"10.1016/j.jcjd.2017.08.098","title":"GOAL-RCT: A Randomized Trial Comparing Colesevelam vs. Ezetimibe in Type 2 Diabetes","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Ezetimibe; Medicine; Type 2 diabetes; Randomized controlled trial; Statin; Ldl cholesterol; Internal medicine; Diabetes mellitus; Cholesterol; Endocrinology","score_opus":0.019274878196317152,"score_gpt":0.2604285701428116,"score_spread":0.24115369194649447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766118755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893556,0.0045058844,0.0000026381217,0.0019260595,0.0012054129,0.0008402165,0.000004494246,0.000005833381,0.0021538348],"genre_scores_gemma":[0.99815124,0.00007595935,0.0002081258,0.00044658247,0.00094475335,0.000017584292,0.0000042482748,0.000028665143,0.00012283998],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99798113,0.00020569445,0.00069657183,0.00016817416,0.00034794956,0.0006004788],"domain_scores_gemma":[0.99762756,0.00013030598,0.00046016616,0.0005504724,0.00029076968,0.00094072626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029572041,0.00018523997,0.0015774486,0.00038775263,0.0002510254,0.00016360269,0.00033409192,0.00013621914,0.00010519999],"category_scores_gemma":[0.0025783742,0.00014915057,0.0005090037,0.00012428577,0.0002573139,0.00018821633,0.000023767972,0.0004862256,0.000014962083],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06522618,0.00017005957,0.8973487,0.0005097242,0.0018308121,0.00037042506,0.00090826896,0.00006297773,0.0002061091,0.00036534242,0.004567936,0.028433472],"study_design_scores_gemma":[0.7804802,0.00073976483,0.21007466,0.001135608,0.0004102273,0.000012048708,0.00007089076,0.00037874232,0.00043287972,0.00040529206,0.005594033,0.00026565528],"about_ca_topic_score_codex":0.0019963156,"about_ca_topic_score_gemma":0.007887774,"teacher_disagreement_score":0.715254,"about_ca_system_score_codex":0.00024008066,"about_ca_system_score_gemma":0.002078004,"threshold_uncertainty_score":0.6082184},"labels":[],"label_agreement":null},{"id":"W2766247145","doi":"10.1373/clinchem.2017.280172","title":"Partitioning the Genetic Architecture of Plasma Lipoprotein(a) and Kringle IV Type 2 Repeats: Implications for Therapeutic Lowering","year":2017,"lang":"en","type":"letter","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Heart and Stroke Foundation; University of Toronto","funders":"Peter Munk Cardiac Centre, University Health Network; National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Plasma lipoprotein; Lipoprotein(a); Lipoprotein; Plasma concentration; Genetics; Chemistry; Pharmacology; Biology; Biochemistry; Cholesterol","score_opus":0.06156990422041187,"score_gpt":0.35541766163456134,"score_spread":0.2938477574141495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766247145","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3116834,0.0089602005,0.0013095172,0.67032427,0.0005881247,0.0032454834,0.0002063895,0.0001264192,0.0035561908],"genre_scores_gemma":[0.81753063,0.003200297,0.0043504117,0.12917358,0.035896983,0.0011997003,0.0008829735,0.0003378245,0.007427567],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984275,0.000036723544,0.0005774547,0.000481533,0.00020007667,0.0002767298],"domain_scores_gemma":[0.9973957,0.00032601177,0.00038351363,0.0016245232,0.00017301207,0.000097244636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000540761,0.00021342008,0.0006363843,0.0000134393595,0.00021764515,0.000036233097,0.0002556011,0.00070081797,0.000024331854],"category_scores_gemma":[0.0006232644,0.0001499466,0.00046977366,0.000042126012,0.00033256895,0.00001258655,0.00008857323,0.001351551,0.0000016124408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007363174,0.00037176843,0.015011823,0.020984778,0.0043457146,0.00017380333,0.00015792523,0.00002396047,0.0063508814,0.000023283592,0.2286738,0.72314596],"study_design_scores_gemma":[0.0012638683,0.00030247043,0.01051503,0.000933425,0.0010331037,0.0004040141,0.000010227205,0.00003577542,0.0059394897,0.0010648898,0.9781815,0.00031620733],"about_ca_topic_score_codex":0.000014684132,"about_ca_topic_score_gemma":0.0000015924543,"teacher_disagreement_score":0.7495077,"about_ca_system_score_codex":0.000027190934,"about_ca_system_score_gemma":0.00024103596,"threshold_uncertainty_score":0.6114645},"labels":[],"label_agreement":null},{"id":"W2767465682","doi":"10.1161/atvbaha.117.310052","title":"Evaluation of the Pleiotropic Effects of Statins","year":2017,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Hazard ratio; Pleiotropy; Confidence interval; Mendelian randomization; Internal medicine; Medicine; Statin; Randomized controlled trial; Diabetes mellitus; Atorvastatin; Cardiology; Endocrinology; Biology; Genetics; Genetic variants; Phenotype; Genotype","score_opus":0.053776177002277346,"score_gpt":0.33454152160212824,"score_spread":0.2807653445998509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767465682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814504,0.00032531537,0.00011687804,0.00034232193,0.00020380176,0.0006796596,0.0000064989595,0.000005770104,0.00017474],"genre_scores_gemma":[0.99806285,0.0015564396,0.00018436574,0.000084951476,0.000057425103,0.000039229923,0.0000033867007,0.000010134671,0.0000012247075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987261,0.00030868882,0.0002422321,0.00020585109,0.00036568556,0.00015141716],"domain_scores_gemma":[0.9983929,0.000029208079,0.00024236346,0.001039926,0.0002434257,0.000052183594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010882823,0.000107029395,0.0004622621,0.000031897638,0.00020093405,0.000010397229,0.00013907393,0.000099333236,0.000020265983],"category_scores_gemma":[0.0003144332,0.00006616467,0.00029372188,0.000041934818,0.0003148825,0.00004144526,0.00010970454,0.0000759022,0.0000010904405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032459238,0.0001959458,0.56011575,0.0004951197,0.0012007657,1.7223524e-8,0.0003883042,0.0000012223544,0.41103587,0.0009294103,0.000030642965,0.025603717],"study_design_scores_gemma":[0.0019897653,0.00033591298,0.9867102,0.00021171861,0.0009766214,3.3134057e-7,0.000029962213,0.00010801757,0.009224695,0.00015348992,0.00019860681,0.00006069045],"about_ca_topic_score_codex":0.00044529146,"about_ca_topic_score_gemma":0.000060488474,"teacher_disagreement_score":0.42659444,"about_ca_system_score_codex":0.000023550334,"about_ca_system_score_gemma":0.00009690231,"threshold_uncertainty_score":0.2698117},"labels":[],"label_agreement":null},{"id":"W2767858411","doi":"","title":"Abstract 19570: Efficacy and Barriers to Evolocumab Therapy in Real-World, High Risk Secondary Prevention Patients Not at LDL Targets","year":2017,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; LMC Diabetes & Endocrinology (Canada); Cambridge Cardiac Care Centre","funders":"","keywords":"Medicine; Evolocumab; Secondary prevention; Atherosclerotic cardiovascular disease; Intensive care medicine; Internal medicine; Disease; Cholesterol; Apolipoprotein B","score_opus":0.017390826073986662,"score_gpt":0.28908405008505655,"score_spread":0.2716932240110699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767858411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970713,0.00016763287,0.00004611302,0.00021818433,0.0002149648,0.0013089555,0.000013590492,0.00002929486,0.0009299118],"genre_scores_gemma":[0.99905413,0.0002847358,0.000117186326,0.0001296997,0.00017209414,0.000041422827,0.000102811,0.000023616472,0.00007429887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987545,0.00007160054,0.00027885925,0.0003411051,0.00034515734,0.00020877234],"domain_scores_gemma":[0.99881256,0.000018673278,0.00019551073,0.00064729934,0.00008136527,0.00024460125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005792424,0.00013409823,0.00027667903,0.00013850618,0.0003588786,0.00004114629,0.00006478635,0.00009849847,0.00014199493],"category_scores_gemma":[0.00024024399,0.00012517942,0.000093851435,0.00007152072,0.000033654807,0.00023177052,0.000037156366,0.0001706113,0.000024167957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035661427,0.00006928962,0.74510443,0.000057570316,0.0000646293,0.000004979909,0.00034117544,0.00006887001,0.00071784685,0.000031249197,0.00006407787,0.2531193],"study_design_scores_gemma":[0.005458501,0.00013770508,0.99235964,0.000095859505,0.000034123088,0.0000018139754,0.000011334181,0.000061858715,0.00058985146,0.00016907572,0.00095476746,0.00012546979],"about_ca_topic_score_codex":0.0029718722,"about_ca_topic_score_gemma":0.0007076052,"teacher_disagreement_score":0.25299382,"about_ca_system_score_codex":0.00025854213,"about_ca_system_score_gemma":0.00011135821,"threshold_uncertainty_score":0.5104669},"labels":[],"label_agreement":null},{"id":"W2767963750","doi":"10.1080/03007995.2017.1401529","title":"Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review","year":2017,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mace; Stroke (engine); Internal medicine; Myocardial infarction; Incidence (geometry); Observational study; Adverse effect; Mortality rate; Percutaneous coronary intervention","score_opus":0.136619001560884,"score_gpt":0.42454012431765503,"score_spread":0.28792112275677106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767963750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002630465,0.983539,0.000016094069,0.000168218,0.00053343293,0.015472709,0.00013912919,0.000047993002,0.000057121495],"genre_scores_gemma":[0.00005553806,0.99399465,0.000010746789,0.000025447694,0.0014453924,0.0024132824,0.0018361983,0.00013337337,0.00008534155],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.983327,0.003369867,0.0013358056,0.0016932341,0.009050941,0.0012231575],"domain_scores_gemma":[0.98999804,0.00034901858,0.00029062337,0.0047469563,0.0010716178,0.0035437504],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006743578,0.00088998163,0.0071790717,0.00079912075,0.00038074335,0.0002031663,0.0007574703,0.00035911493,0.000033105833],"category_scores_gemma":[0.0034067251,0.0005426997,0.0032786145,0.0012284052,0.0005659826,0.00017193059,0.0005389364,0.0030822314,0.000053023825],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067555535,0.00016605938,0.000096920114,0.56176966,0.002257054,0.00035303447,0.000013102229,2.889631e-7,2.1339219e-10,0.000024723331,0.00028019553,0.4349714],"study_design_scores_gemma":[0.0013538742,0.00012806432,0.0014499692,0.5098684,0.0026271432,0.000016210375,0.0000024947828,0.000008759255,1.1462108e-9,0.000006078461,0.4842695,0.00026956006],"about_ca_topic_score_codex":0.00016878,"about_ca_topic_score_gemma":0.0000046183145,"teacher_disagreement_score":0.4839893,"about_ca_system_score_codex":0.0005651341,"about_ca_system_score_gemma":0.0030397435,"threshold_uncertainty_score":0.99970245},"labels":[],"label_agreement":null},{"id":"W2768478526","doi":"10.1093/eurheartj/ehx659","title":"Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: a contemporary population-based study","year":2017,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novo Nordisk Fonden; Novo Nordisk; Gentofte Hospital","keywords":"Medicine; Primary prevention; Internal medicine; Canadian Cardiovascular Society; Population; Family medicine; Statin; Cardiology; Intensive care medicine; Physical therapy; Environmental health; Myocardial infarction; Disease; Angina","score_opus":0.1577087097186416,"score_gpt":0.37749161996763153,"score_spread":0.21978291024898994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768478526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768859,0.00026575368,0.01720317,0.0013604678,0.00015653453,0.0036201547,0.0000653367,0.000046161054,0.00039651964],"genre_scores_gemma":[0.95554835,0.00008300994,0.041115623,0.0018835705,0.0009847514,0.000048372676,0.00007701701,0.00016665964,0.000092625305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963521,0.0011588782,0.0010590578,0.00048222404,0.0005149154,0.00043284622],"domain_scores_gemma":[0.99772817,0.00012456391,0.0006729989,0.00078646484,0.00047626233,0.00021155931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010813754,0.00031321356,0.0009137151,0.00012134213,0.00069836865,0.00016966273,0.0003337238,0.00004625815,0.0000030998024],"category_scores_gemma":[0.0002774716,0.00024098695,0.00094092084,0.00015034579,0.000048135546,0.00022521116,0.0000993109,0.00036592147,0.0000039229126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008345236,0.00026666856,0.9644215,0.00020053759,0.00075563695,0.000011471913,0.0010839662,0.000748245,0.008103413,0.0000012708025,0.0058806185,0.01769214],"study_design_scores_gemma":[0.015990222,0.0029148487,0.9675158,0.000725927,0.00013093531,0.00003833707,0.0017633893,0.00008286267,0.0003535401,0.0000035551463,0.010206178,0.0002743535],"about_ca_topic_score_codex":0.00007864766,"about_ca_topic_score_gemma":0.0000029596638,"teacher_disagreement_score":0.023912452,"about_ca_system_score_codex":0.00015878615,"about_ca_system_score_gemma":0.0003718852,"threshold_uncertainty_score":0.98271626},"labels":[],"label_agreement":null},{"id":"W2768690917","doi":"10.1002/jcla.22358","title":"Circulating <scp>PCSK</scp>9 is lowered acutely following surgery","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Laboratory Analysis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Physicians' Services Incorporated Foundation; Heart and Stroke Foundation of Canada","keywords":"Kexin; Internal medicine; PCSK9; Endocrinology; Lipoprotein; Cholesterol; Medicine; Low-density lipoprotein; High-density lipoprotein; LDL receptor","score_opus":0.07428739802906376,"score_gpt":0.4052228460605116,"score_spread":0.33093544803144787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768690917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938964,0.0022174583,0.00095687836,0.00087297824,0.0010154146,0.00011257146,0.00001602568,0.000018598788,0.0008936542],"genre_scores_gemma":[0.9936837,0.00064646074,0.001306511,0.0017294694,0.0023883975,0.0000019811093,0.000005176014,0.00003182144,0.00020648054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947272,0.0004791862,0.0026546132,0.00036922246,0.0013728392,0.00039693105],"domain_scores_gemma":[0.9924489,0.001221649,0.0029471552,0.0014951705,0.0011266214,0.00076046446],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012619429,0.00023691315,0.0028522937,0.00042842457,0.00044433083,0.00018414568,0.0003665515,0.00033636723,0.00009511229],"category_scores_gemma":[0.016087001,0.00018317917,0.006718826,0.0008229548,0.00012008236,0.00048197462,0.00007986605,0.0009579352,0.000024750314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007722761,0.0003066733,0.9492813,0.00008662814,0.024545996,0.0032803004,0.00009113163,0.000032081913,0.0001997689,0.000017664255,0.0054095737,0.016671663],"study_design_scores_gemma":[0.0022074021,0.0002548953,0.92826474,0.00032029583,0.019480994,0.00008368067,0.00024990292,0.00037041903,0.0005149946,0.00007593557,0.048031937,0.00014480187],"about_ca_topic_score_codex":0.000041608273,"about_ca_topic_score_gemma":0.000011031569,"teacher_disagreement_score":0.04262236,"about_ca_system_score_codex":0.00006674053,"about_ca_system_score_gemma":0.0011750554,"threshold_uncertainty_score":0.9922009},"labels":[],"label_agreement":null},{"id":"W2769501767","doi":"10.1161/atvbaha.117.305140","title":"Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering","year":2017,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Rosuvastatin; Internal medicine; Endocrinology; Apolipoprotein B; Medicine; LDL receptor; Apolipoprotein E; Aortic sinus; Lipoprotein; Coronary atherosclerosis; Scavenger receptor; Foam cell; Cholesterol; Coronary artery disease; Chemistry; Artery","score_opus":0.04153178691625103,"score_gpt":0.2986182775689827,"score_spread":0.25708649065273165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769501767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99744326,0.0003809854,0.000026701382,0.00054606906,0.00035735365,0.0010604078,0.000032673026,0.000042176627,0.00011034866],"genre_scores_gemma":[0.9924637,0.006482481,0.00045461403,0.00019567693,0.00016366884,0.00011639295,0.000035692603,0.000069421236,0.000018354684],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99715495,0.00018762483,0.0007837082,0.0008871977,0.00032325095,0.00066325103],"domain_scores_gemma":[0.9980241,0.000047331472,0.00040559308,0.0010995669,0.0001313867,0.00029201934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00089371606,0.0004531332,0.0012786536,0.00020139765,0.00035899327,0.00011306406,0.00027365217,0.00042044176,0.0000624179],"category_scores_gemma":[0.00006919547,0.0004011738,0.00029673026,0.00013869301,0.00065365626,0.00028767833,0.00031422125,0.00038837187,0.000015415124],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014317881,0.0003686564,0.27180865,0.0003342564,0.00073827215,0.0000010979152,0.0011913063,0.0000019529396,0.7096525,0.000049438964,0.000027262926,0.015683454],"study_design_scores_gemma":[0.0059295003,0.0010460909,0.9714201,0.00070205296,0.00022996063,0.000014984079,0.00034963887,0.000068900226,0.01938099,0.000018074814,0.0004560312,0.0003836537],"about_ca_topic_score_codex":0.001246375,"about_ca_topic_score_gemma":0.0003926168,"teacher_disagreement_score":0.6996115,"about_ca_system_score_codex":0.00008576465,"about_ca_system_score_gemma":0.00010095098,"threshold_uncertainty_score":0.999844},"labels":[],"label_agreement":null},{"id":"W2769855657","doi":"10.1161/circulationaha.117.029785","title":"PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment","year":2017,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Heart and Stroke Foundation; University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institute of Neurological Disorders and Stroke; Agency for Healthcare Research and Quality","keywords":"Neurocognitive; Medicine; PCSK9; California Verbal Learning Test; Verbal fluency test; Verbal memory; Verbal learning; Odds ratio; Internal medicine; Neuropsychology; Psychiatry; Cognition; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.017629299027597457,"score_gpt":0.26555386476047876,"score_spread":0.2479245657328813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769855657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525446,0.00011731757,0.001503355,0.00065186527,0.00013903104,0.0009807029,0.0000034236,0.00004540076,0.0013044274],"genre_scores_gemma":[0.99897945,0.000037841273,0.00013945802,0.00035834208,0.0003758671,0.000032026455,0.000016973183,0.000018110128,0.000041953266],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990171,0.000049900467,0.0001614315,0.00030240588,0.00028647916,0.00018267847],"domain_scores_gemma":[0.99895793,0.000007643844,0.00012125971,0.0006447797,0.0001133231,0.00015508731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003761416,0.00011792413,0.00023410229,0.00004546704,0.0003874687,0.000094086965,0.00005152296,0.00008855521,0.000019445912],"category_scores_gemma":[0.00012394848,0.00010867877,0.000096052165,0.000030719475,0.00006419958,0.00020180366,0.000057426314,0.00014181934,0.000031390617],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020439232,0.00025717137,0.20728827,0.0005445309,0.00023591839,0.00015996298,0.0005066605,0.00000847514,0.012732392,0.0003689989,0.000043127107,0.7776501],"study_design_scores_gemma":[0.0017789772,0.00008009904,0.9950594,0.00013808541,0.00009559652,0.00015457837,0.00002680919,0.0004896149,0.001592741,0.00028023444,0.00020118785,0.00010268774],"about_ca_topic_score_codex":0.00079338654,"about_ca_topic_score_gemma":0.000033396434,"teacher_disagreement_score":0.7877711,"about_ca_system_score_codex":0.000054399647,"about_ca_system_score_gemma":0.000057582343,"threshold_uncertainty_score":0.44317916},"labels":[],"label_agreement":null},{"id":"W2770109786","doi":"10.1194/jlr.m078360","title":"PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction","year":2017,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; McGill University; Johns Hopkins University","keywords":"Apolipoprotein B; PCSK9; Secretion; Endothelial dysfunction; Apolipoprotein C2; Medicine; Internal medicine; Endocrinology; Lipoprotein; LDL receptor; Cholesterol; Very low-density lipoprotein","score_opus":0.08187787674707826,"score_gpt":0.3748063028230781,"score_spread":0.29292842607599984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770109786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989751,0.0016828465,0.00021830769,0.0044329194,0.0005181287,0.00041521582,0.000003868667,0.000009019544,0.00296873],"genre_scores_gemma":[0.99200654,0.0025272958,0.0005500954,0.000046892357,0.0040107383,0.000010992911,8.642692e-7,0.00002227706,0.0008243274],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997114,0.00026559448,0.00042365317,0.00020455875,0.001589165,0.00040303546],"domain_scores_gemma":[0.9978161,0.000053747364,0.00029957693,0.00057573384,0.00090544013,0.00034940924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063086883,0.00011326128,0.00038198006,0.00028222677,0.00086553954,0.00020345238,0.0002501232,0.00012736213,0.00009243556],"category_scores_gemma":[0.0013119129,0.00007982639,0.0002113651,0.000119865064,0.00034595773,0.0002802285,0.00011144484,0.0008269493,0.000019283241],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00200362,0.00071503856,0.03762687,0.0008241918,0.00041219508,0.00013867949,0.001379627,0.000005510246,0.5487645,0.0012578592,0.005798358,0.40107352],"study_design_scores_gemma":[0.012088538,0.007351908,0.69322914,0.0020247088,0.00022545524,0.003395486,0.001958406,0.00013028561,0.14132737,0.0015445445,0.1362858,0.0004383541],"about_ca_topic_score_codex":0.000314374,"about_ca_topic_score_gemma":0.0000107833575,"teacher_disagreement_score":0.6556023,"about_ca_system_score_codex":0.0001322587,"about_ca_system_score_gemma":0.00049265276,"threshold_uncertainty_score":0.6657118},"labels":[],"label_agreement":null},{"id":"W2770192733","doi":"10.1016/j.atherosclerosis.2017.11.014","title":"Reply to: “PCSK9 antagonists and inflammation”","year":2017,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"PCSK9; Inflammation; Alirocumab; Medicine; Canakinumab; Internal medicine; Cholesterol; Endocrinology; LDL receptor; Apolipoprotein B; Lipoprotein; Disease","score_opus":0.026628111229256617,"score_gpt":0.27159176862411066,"score_spread":0.24496365739485404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770192733","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035204776,0.0005038874,0.00006705156,0.9596318,0.000488955,0.0013377136,0.000060490747,0.00013456038,0.0025707812],"genre_scores_gemma":[0.01064986,0.0006295936,0.001650105,0.9643282,0.011379813,0.00023949827,0.0002490803,0.00017261159,0.01070119],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785936,0.00006844896,0.00034358216,0.0006446422,0.00064124825,0.00044274036],"domain_scores_gemma":[0.9975079,0.00003205052,0.00020328644,0.0019144543,0.00013161161,0.00021066972],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004527757,0.00034484486,0.00076999073,0.000114300026,0.0003149737,0.0001744229,0.00020450263,0.0005667565,0.00007257319],"category_scores_gemma":[0.00016077973,0.00029599268,0.00031284997,0.00007191718,0.00009793103,0.000083720275,0.0001314025,0.00091381854,0.00022661457],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017259481,0.000010333398,0.0010630615,0.00051880354,0.0002402143,0.00009788244,0.00018187346,1.0972405e-7,0.00076348544,0.000008842388,0.9693481,0.027750086],"study_design_scores_gemma":[0.00068571296,0.00018368456,0.023280516,0.00060989324,0.00023777116,0.00009935672,0.000007303189,0.0000021758788,0.00095586025,0.000030521627,0.9736159,0.00029129544],"about_ca_topic_score_codex":0.0009842387,"about_ca_topic_score_gemma":0.000008585552,"teacher_disagreement_score":0.02745879,"about_ca_system_score_codex":0.00010971001,"about_ca_system_score_gemma":0.00015898289,"threshold_uncertainty_score":0.9999492},"labels":[],"label_agreement":null},{"id":"W2770394202","doi":"10.1038/nsmb.3471","title":"Insights into a PCSK9 structural groove: a harbinger of new drugs to reduce LDL-cholesterol","year":2017,"lang":"en","type":"article","venue":"Nature Structural & Molecular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; LDL receptor; Endosome; Proprotein convertase; Cholesterol; Chemistry; Kexin; Monoclonal antibody; Biochemistry; Receptor; Pharmacology; Cell biology; Antibody; Biology; Lipoprotein; Genetics","score_opus":0.008060991369240844,"score_gpt":0.3352241035150996,"score_spread":0.3271631121458588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770394202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889785,0.003939983,0.00032403917,0.004200816,0.0010745,0.0009928102,0.000011755967,0.000052080686,0.00042552577],"genre_scores_gemma":[0.99127585,0.000020000172,0.0047206692,0.0028926823,0.0007828141,0.000018166013,0.00006628449,0.000049667913,0.00017385787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976514,0.000131296,0.0004711143,0.0007728875,0.0004545666,0.0005187211],"domain_scores_gemma":[0.99710995,0.000013278122,0.00031085915,0.0017778486,0.00028539784,0.0005026517],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015019883,0.00041888352,0.0009201525,0.00020487193,0.00029095882,0.0000551415,0.0006092142,0.00084882573,0.00004546014],"category_scores_gemma":[0.00041718854,0.00030484857,0.0004782585,0.00017634108,0.00023148104,0.00011454325,0.00032587562,0.0010461824,0.000011104625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006332208,0.000012429292,0.0018131573,0.00022288019,0.0006566846,0.000120271805,0.0015002459,0.000006883513,0.8505504,0.008870023,0.00048576153,0.135128],"study_design_scores_gemma":[0.0073567657,0.0015152141,0.33223227,0.0003646628,0.0004899727,0.0005612701,0.00016371149,0.000078859106,0.6119376,0.023455765,0.020868817,0.0009751024],"about_ca_topic_score_codex":0.0016513057,"about_ca_topic_score_gemma":0.00008511952,"teacher_disagreement_score":0.33041912,"about_ca_system_score_codex":0.000114330156,"about_ca_system_score_gemma":0.0003081186,"threshold_uncertainty_score":0.99994034},"labels":[],"label_agreement":null},{"id":"W2772041452","doi":"10.3389/fphys.2017.01031","title":"The Associations between Apolipoprotein E Gene Epsilon2/Epsilon3/Epsilon4 Polymorphisms and the Risk of Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus","year":2017,"lang":"en","type":"article","venue":"Frontiers in Physiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Natural Science Foundation of China","keywords":"Internal medicine; Apolipoprotein E; Odds ratio; Coronary artery disease; Type 2 Diabetes Mellitus; Medicine; Diabetes mellitus; Allele; Confidence interval; Gastroenterology; Meta-analysis; Disease; Endocrinology; Genetics; Gene; Biology","score_opus":0.007368928033102815,"score_gpt":0.22082601249683945,"score_spread":0.21345708446373662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772041452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920838,0.0055579836,0.000029070061,0.00069775485,0.00031400513,0.0011661724,0.00010245875,0.000009451769,0.00003929382],"genre_scores_gemma":[0.9977863,0.0012801584,0.00047793493,0.000101048805,0.00013770281,0.00007883419,0.00008556878,0.000022112516,0.000030342284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982405,0.00041954918,0.00036123444,0.00030510014,0.0002811621,0.00039249213],"domain_scores_gemma":[0.9982412,0.00013845778,0.00037153505,0.001038525,0.00009233149,0.000117964184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007482522,0.00018084154,0.00070535747,0.00008021989,0.00039393062,0.000019126808,0.00026190092,0.00010804591,0.0000027840144],"category_scores_gemma":[0.00038568964,0.00009881023,0.000125418,0.000113267866,0.00082636194,0.00008351191,0.00011386699,0.00033597898,0.0000016846891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011130826,0.00009084599,0.98489386,0.000025722526,0.00041699785,0.0000031807506,0.000121655175,0.000012967513,0.000021396452,0.000057012927,0.00015042094,0.013092879],"study_design_scores_gemma":[0.0051817526,0.00027169278,0.99032396,0.00005381007,0.00023450376,2.5408696e-7,0.000031845364,0.000102447746,0.000068974616,0.0034980767,0.00012206217,0.000110646506],"about_ca_topic_score_codex":0.00081843697,"about_ca_topic_score_gemma":0.00007006447,"teacher_disagreement_score":0.0129822325,"about_ca_system_score_codex":0.00008480478,"about_ca_system_score_gemma":0.00013276438,"threshold_uncertainty_score":0.40293643},"labels":[],"label_agreement":null},{"id":"W2772281339","doi":"10.1161/jaha.117.007402","title":"Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very‐Low‐Density Lipoproteins","year":2017,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto; University Health Network","funders":"National Heart, Lung, and Blood Institute","keywords":"Very low-density lipoprotein; Internal medicine; Medicine; Endocrinology; Cholesterol; Lipoprotein; Statin; Triglyceride; Residual risk; Lipoprotein particle","score_opus":0.014188762936823853,"score_gpt":0.27195894392013803,"score_spread":0.25777018098331417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772281339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618584,0.00011680297,0.00006899402,0.0027254624,0.0003124809,0.0005488755,0.000003751728,0.0000038603907,0.000033931876],"genre_scores_gemma":[0.99857956,0.00020966532,0.0006413283,0.00008736241,0.00039424762,0.0000073923934,4.4428288e-7,0.000014182272,0.000065808556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974139,0.00069493125,0.0005729046,0.00013927952,0.0009774838,0.00020152723],"domain_scores_gemma":[0.997796,0.00006126919,0.0010627989,0.00071207574,0.00028135531,0.00008650573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004837478,0.00009618866,0.0008141066,0.00019570207,0.00016820623,0.000012140004,0.00015633028,0.000069482994,0.0000022347313],"category_scores_gemma":[0.0036276192,0.00007503263,0.0007070979,0.00033914752,0.000041872958,0.00016197356,0.000055912667,0.00049262523,0.0000042588076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014838342,0.00012396612,0.9918064,0.000019607443,0.00038059714,0.0000032065545,0.00039132673,0.0014779536,0.0020601028,0.0000026154441,0.00011793636,0.0034679207],"study_design_scores_gemma":[0.0011333735,0.00024852162,0.99609697,0.0003402883,0.00023255915,0.000027705662,0.00014720253,0.000031383115,0.0013695869,0.000102311526,0.00020736152,0.000062714644],"about_ca_topic_score_codex":0.0069224085,"about_ca_topic_score_gemma":0.0004217946,"teacher_disagreement_score":0.006500614,"about_ca_system_score_codex":0.0010173942,"about_ca_system_score_gemma":0.0002455064,"threshold_uncertainty_score":0.9996906},"labels":[],"label_agreement":null},{"id":"W2773691289","doi":"10.1002/cpt.973","title":"Food Effect on Rosuvastatin Disposition and Low‐Density Lipoprotein Cholesterol","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Rosuvastatin; Medicine; Rosuvastatin Calcium; Internal medicine; Endocrinology; Cholesterol; Low-density lipoprotein; Pharmacology","score_opus":0.05393566413035072,"score_gpt":0.4060748040629718,"score_spread":0.3521391399326211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773691289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884972,0.0003458069,0.00016391613,0.008243213,0.0010925692,0.0013267855,0.00001103253,0.00006855354,0.0002509069],"genre_scores_gemma":[0.96371895,0.0005635302,0.00011276745,0.03401087,0.0014113395,0.0000630093,0.000010611042,0.00003651755,0.000072433235],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99793696,0.0005178834,0.00043154054,0.0004913082,0.00027412138,0.00034819354],"domain_scores_gemma":[0.99835235,0.00026459986,0.0002359154,0.00076333963,0.000084891195,0.00029892306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014911749,0.0002373182,0.0006756321,0.00004215483,0.0004529532,0.00005313724,0.00017123442,0.00029923063,0.00003831744],"category_scores_gemma":[0.0000568707,0.00018496804,0.0003205416,0.000033441396,0.00048280024,0.000074090734,0.00010851352,0.00080546417,0.00005760732],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005940624,0.0014015951,0.045913357,0.00042875516,0.0028414703,0.00017784741,0.00014301088,0.000002737664,0.017064499,0.000040254068,0.0009171698,0.9251287],"study_design_scores_gemma":[0.014269669,0.016483959,0.9249394,0.00016529267,0.0019945402,0.00009466977,0.000010433005,0.00034457864,0.034746394,0.0001488789,0.006509453,0.00029275732],"about_ca_topic_score_codex":0.00003215174,"about_ca_topic_score_gemma":0.000013382049,"teacher_disagreement_score":0.9248359,"about_ca_system_score_codex":0.000045721947,"about_ca_system_score_gemma":0.00007465116,"threshold_uncertainty_score":0.7542778},"labels":[],"label_agreement":null},{"id":"W2774613779","doi":"10.1016/j.cjca.2017.12.007","title":"The Atherogenic Dyslipidemia Complex and Novel Approaches to Cardiovascular Disease Prevention in Diabetes","year":2017,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University; Diabetes Canada; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Dyslipidemia; Diabetes mellitus; Atherosclerotic cardiovascular disease; Disease; Type 2 diabetes; Internal medicine; Intensive care medicine; Endocrinology","score_opus":0.27667431411629295,"score_gpt":0.3386691046954471,"score_spread":0.061994790579154135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774613779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028604158,0.9966079,0.00046156446,0.0004215559,0.0004549849,0.001304065,0.000043208573,0.0000032306095,0.0004174472],"genre_scores_gemma":[0.0069238213,0.9901553,0.000127524,0.000056457717,0.0024826226,0.000094233765,0.000026546,0.000058968137,0.00007454889],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972193,0.00066078914,0.00084669737,0.00035856184,0.0003008253,0.00061380357],"domain_scores_gemma":[0.99672616,0.00011467249,0.00037999693,0.0012106668,0.00011415818,0.0014543716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004005045,0.00034193252,0.0034893078,0.0004067046,0.00027636983,0.000067106885,0.00040819906,0.00031661216,0.000002549468],"category_scores_gemma":[0.0007338049,0.00022241005,0.002866163,0.00014914802,0.00025059824,0.00005193533,0.00005061015,0.00072912115,0.0000055148944],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001180793,0.0000021246497,0.000587011,0.002189567,0.0039464813,0.00014055651,0.000016984233,0.00007366193,7.5677654e-8,0.00012442001,0.0004028945,0.9925044],"study_design_scores_gemma":[0.0005829335,0.00012460053,0.005878536,0.00349373,0.003628611,0.00060341955,0.000018431205,0.0000041693975,4.0319637e-8,0.000066205495,0.9854083,0.00019103462],"about_ca_topic_score_codex":0.00031908837,"about_ca_topic_score_gemma":0.0007247683,"teacher_disagreement_score":0.9923134,"about_ca_system_score_codex":0.0004460501,"about_ca_system_score_gemma":0.0045978674,"threshold_uncertainty_score":0.90696186},"labels":[],"label_agreement":null},{"id":"W2774670971","doi":"","title":"Abstract 15861: Adherence to the 2012 Canadian Lipid Screening Guidelines in Primary Prevention Patients: The CANHEART Study","year":2016,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Ottawa; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Cohort; Hyperlipidemia; Ambulatory; Population; Statin; Family history; Lipid profile; Internal medicine; Cohort study; Gerontology; Demography; Cholesterol; Diabetes mellitus; Endocrinology; Environmental health","score_opus":0.050383969350963176,"score_gpt":0.3116478766064761,"score_spread":0.2612639072555129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774670971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156755,0.00021673532,0.0012735826,0.0037748062,0.00021082864,0.00228579,0.0000066859384,0.000016749555,0.00064724864],"genre_scores_gemma":[0.9982465,0.000012482641,0.000089464884,0.00093713636,0.0004408309,0.00010571144,0.000013830243,0.000012832671,0.00014119939],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99876875,0.00010466758,0.00032103187,0.00019970228,0.00038749276,0.00021835181],"domain_scores_gemma":[0.99910754,0.000028249595,0.000063538704,0.00045543534,0.00021904967,0.00012619063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012426205,0.00008941168,0.00014322487,0.00008680013,0.00013709789,0.000018780936,0.000084466556,0.000046193803,0.0000724135],"category_scores_gemma":[0.00022404258,0.00004438137,0.00007658096,0.000219253,0.0000132449695,0.00017190329,0.000018275785,0.00009431146,0.000057356676],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022227176,0.000050634026,0.43561056,0.000015187232,0.000031027594,0.0000025063941,0.00031141724,0.00011573511,0.0001205315,0.000009816525,0.0008805543,0.5628298],"study_design_scores_gemma":[0.00081096607,0.00009499643,0.9881033,0.00017549675,0.00002981489,0.0000033248082,0.0001376933,0.000025629372,0.000006473224,0.000015115053,0.0105336355,0.00006358473],"about_ca_topic_score_codex":0.08399433,"about_ca_topic_score_gemma":0.16421661,"teacher_disagreement_score":0.5627662,"about_ca_system_score_codex":0.00027177396,"about_ca_system_score_gemma":0.00030109417,"threshold_uncertainty_score":0.92210543},"labels":[],"label_agreement":null},{"id":"W2776087670","doi":"10.3389/fphys.2017.01088","title":"Statin Therapy Negatively Impacts Skeletal Muscle Regeneration and Cutaneous Wound Repair in Type 1 Diabetic Mice","year":2017,"lang":"en","type":"article","venue":"Frontiers in Physiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Regeneration (biology); Medicine; Skeletal muscle; Type 2 diabetes; Statin; Internal medicine; Endocrinology; Diabetes mellitus; Bioinformatics; Surgery; Biology; Cell biology","score_opus":0.014055721254074834,"score_gpt":0.26846598170566877,"score_spread":0.25441026045159393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776087670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503064,0.0033965297,0.000058837817,0.00039256277,0.00046443756,0.00048036457,0.0000057813395,0.000020803749,0.00015001926],"genre_scores_gemma":[0.993859,0.0024127283,0.003029359,0.00034295183,0.0001964061,0.000022619322,0.00001986612,0.00001724432,0.00009980815],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99899197,0.0001466348,0.00018968435,0.0002966159,0.00010554665,0.0002695718],"domain_scores_gemma":[0.9993296,0.000019191633,0.00009582959,0.00043606453,0.000043646476,0.00007567085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020272915,0.00012255396,0.0004001825,0.0000875941,0.000101443744,0.000012150358,0.000072878225,0.00012031601,0.000009281179],"category_scores_gemma":[0.00016873433,0.000104353705,0.00006546243,0.000069953436,0.00015188126,0.000090093214,0.000031033684,0.00020832822,0.000002902609],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002136338,0.0006187764,0.105337985,0.0005680689,0.0005612407,0.0004928609,0.0043279477,0.00012775356,0.30003613,0.00019783147,0.010704076,0.574891],"study_design_scores_gemma":[0.002394713,0.00072119205,0.98824394,0.00006397492,0.000017129043,0.000030419256,0.00018622368,0.0011455168,0.0014900415,0.0018657758,0.0036924786,0.0001486206],"about_ca_topic_score_codex":0.00077958324,"about_ca_topic_score_gemma":0.00017601516,"teacher_disagreement_score":0.88290596,"about_ca_system_score_codex":0.00009226987,"about_ca_system_score_gemma":0.000112923735,"threshold_uncertainty_score":0.42554206},"labels":[],"label_agreement":null},{"id":"W2776790897","doi":"10.1038/nrendo.2017.169","title":"Nutraceuticals in endocrine disorders","year":2017,"lang":"en","type":"review","venue":"Nature Reviews Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Nutraceutical; Endocrine system; Osteoporosis; Obesity; Diabetes mellitus; Metabolic syndrome; Clinical Practice; Type 2 Diabetes Mellitus; Type 2 diabetes; Intensive care medicine; Bioinformatics; Endocrinology; Family medicine; Pathology; Hormone","score_opus":0.10436472156407606,"score_gpt":0.4595671785042592,"score_spread":0.35520245694018315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2776790897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.708079e-7,0.97895664,0.000006647514,0.0007016668,0.00090975873,0.0062084324,0.000027396663,0.000075786375,0.013113009],"genre_scores_gemma":[0.000008217997,0.9953435,0.000452304,0.00049512956,0.0010127932,0.0012186307,0.00020322179,0.00011977405,0.0011464193],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946149,0.00085392833,0.0016792633,0.0011601979,0.00042018274,0.0012715477],"domain_scores_gemma":[0.99566656,0.00015447018,0.000733734,0.0030768842,0.00006078047,0.00030759146],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00092575594,0.0009150175,0.009018532,0.000623282,0.000119715194,0.000030682793,0.0006966961,0.0011848446,0.00016297362],"category_scores_gemma":[0.0014666797,0.00062417705,0.0029929946,0.0003893302,0.00020946327,0.00007290418,0.00025946085,0.0055651623,0.00047694665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008632672,0.00012697844,0.00001973191,0.054751717,0.00024506458,0.000703883,0.0000035622909,7.3984214e-9,3.2161537e-8,0.0015046217,0.0012421462,0.9413936],"study_design_scores_gemma":[0.0008815753,0.00012257011,0.00005963688,0.025579536,0.0016860398,0.0040190937,0.000001743233,1.9108887e-7,3.1459408e-7,0.00010726415,0.96709317,0.00044885723],"about_ca_topic_score_codex":0.000081491016,"about_ca_topic_score_gemma":0.00013783427,"teacher_disagreement_score":0.965851,"about_ca_system_score_codex":0.0003449448,"about_ca_system_score_gemma":0.00061788986,"threshold_uncertainty_score":0.999621},"labels":[],"label_agreement":null},{"id":"W2780654395","doi":"10.1093/fampra/cmx124","title":"Number of patients needed to prescribe statins in primary cardiovascular prevention: mirage and reality","year":2017,"lang":"en","type":"article","venue":"Family Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University; Institut National d'Excellence en Santé et en Services Sociaux","funders":"Abbott Vascular; Fonds de recherche du Québec; MSD France","keywords":"Medicine; Number needed to treat; Confidence interval; Relative risk; Randomized controlled trial; Internal medicine; Demography; Emergency medicine","score_opus":0.0389336478048037,"score_gpt":0.33630854428148504,"score_spread":0.29737489647668136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2780654395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611204,0.00068135787,0.00044598797,0.00083332224,0.00014507932,0.0013412186,0.000028024228,0.000017506462,0.035387095],"genre_scores_gemma":[0.9902222,0.0005362084,0.0072121634,0.0013708146,0.00012621161,0.000071880575,0.000037338115,0.000026592572,0.00039655573],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980497,0.0003102025,0.00036378784,0.00034511578,0.0007055176,0.00022569693],"domain_scores_gemma":[0.99787724,0.00007257523,0.00021818148,0.0013771008,0.00028039116,0.0001744955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019124976,0.00013483533,0.0005348411,0.000048755875,0.000121274614,0.000041082738,0.00011955211,0.00009266566,0.000010530043],"category_scores_gemma":[0.00153324,0.00012598702,0.00021946605,0.00009304431,0.000052814397,0.00048681552,0.00016140247,0.00022219091,0.00001436898],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007260751,0.0043223905,0.36670795,0.0061507034,0.005669402,0.000846111,0.006210115,0.00008028264,0.0012845184,0.0006876872,0.016440839,0.58433926],"study_design_scores_gemma":[0.0032344898,0.00020967239,0.8991508,0.00017162818,0.0003709129,0.000029552868,0.00045597058,0.0000067339433,0.00013317866,0.000037545284,0.09607598,0.00012356263],"about_ca_topic_score_codex":0.008841247,"about_ca_topic_score_gemma":0.000036644004,"teacher_disagreement_score":0.5842157,"about_ca_system_score_codex":0.0001229839,"about_ca_system_score_gemma":0.00021366574,"threshold_uncertainty_score":0.997759},"labels":[],"label_agreement":null},{"id":"W2781509466","doi":"10.1016/j.jacc.2017.10.080","title":"Primary Prevention With Statins in the Elderly","year":2018,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Life expectancy; Excellence; Context (archaeology); Atherosclerotic cardiovascular disease; Statin; Primary prevention; Population; Primary care; Gerontology; Canadian Cardiovascular Society; Intensive care medicine; Disease; Family medicine; Internal medicine; Environmental health; Myocardial infarction","score_opus":0.026446735530894938,"score_gpt":0.32295135207361214,"score_spread":0.2965046165427172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781509466","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005158022,0.99098325,0.00024099396,0.00044708452,0.00025014384,0.0012907663,0.000048012076,0.0000028547026,0.0015788834],"genre_scores_gemma":[0.0020145762,0.9956713,0.00078657473,0.00017922363,0.0011462462,0.00002602206,0.0000039096135,0.000031354106,0.0001407986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99608016,0.0019360777,0.00095234514,0.00016505775,0.00063590746,0.0002304756],"domain_scores_gemma":[0.9965141,0.0002176888,0.002184648,0.00076372165,0.00025955797,0.0000602916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024876934,0.00022903006,0.003597113,0.00021181502,0.000047159432,0.0000038091184,0.0004853352,0.00010351551,0.0000030243436],"category_scores_gemma":[0.00013443643,0.00009300762,0.0017826561,0.00074708275,0.00051136856,0.000031515214,0.000056609242,0.00074132014,0.0000014547176],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053364143,0.00009873322,0.00033274255,0.0066955737,0.0036522234,0.0007348326,0.00006219899,0.000008390492,0.0000014103396,0.00006388305,0.0076084463,0.9802079],"study_design_scores_gemma":[0.0007787753,0.005909504,0.0020236576,0.006221211,0.0029198094,0.017908147,0.00025857004,1.3985581e-7,5.5273784e-7,0.0000469245,0.96382993,0.0001027791],"about_ca_topic_score_codex":0.000019231831,"about_ca_topic_score_gemma":0.000011208317,"teacher_disagreement_score":0.98010516,"about_ca_system_score_codex":0.0002028988,"about_ca_system_score_gemma":0.002217102,"threshold_uncertainty_score":0.3933044},"labels":[],"label_agreement":null},{"id":"W2781693957","doi":"10.1161/circgen.117.001849","title":"Polygenic Contribution in Individuals With Early-Onset Coronary Artery Disease","year":2018,"lang":"en","type":"article","venue":"Circulation Genomic and Precision Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"Medical Research Council; Canadian Institutes of Health Research; McMaster University","keywords":"Medicine; Dyslipidemia; Coronary artery disease; Familial hypercholesterolemia; Internal medicine; Cohort; Heritability; Odds ratio; Polygenic risk score; Disease; Cardiology; Cholesterol; Genetics; Genotype; Single-nucleotide polymorphism; Biology; Gene","score_opus":0.014609457364761488,"score_gpt":0.262965160357236,"score_spread":0.2483557029924745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781693957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910611,0.0032613277,0.0031943305,0.001160991,0.00013746899,0.0009458477,0.000013393005,0.000032648608,0.00019292692],"genre_scores_gemma":[0.9980176,0.00026245872,0.00015926344,0.0007456543,0.0005595013,0.000028602351,0.0001390433,0.000018492698,0.000069362424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984888,0.00012010388,0.00037144063,0.00035556636,0.00043158946,0.00023251085],"domain_scores_gemma":[0.9989787,0.00006937243,0.00009426507,0.00038799742,0.00013684128,0.00033284814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009272116,0.00015378672,0.00037824048,0.00021524956,0.00011400778,0.000010974365,0.000047615045,0.00008921158,0.00019377843],"category_scores_gemma":[0.000129378,0.00010968085,0.000049085662,0.00023775054,0.00021444258,0.00008657075,0.0000271941,0.00014908455,0.00003302887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005916769,0.000039948092,0.96355075,0.000035011282,0.000072045215,0.000042365096,0.00049695384,0.0000054223974,0.00078060076,0.000073927025,0.00017625098,0.03413508],"study_design_scores_gemma":[0.005119925,0.00061077013,0.99063706,0.00033648335,0.00015569422,0.00026202298,0.00007864084,0.0003786231,0.000017632421,0.0006525938,0.0016301044,0.0001204378],"about_ca_topic_score_codex":0.00006524132,"about_ca_topic_score_gemma":0.00001261278,"teacher_disagreement_score":0.034014642,"about_ca_system_score_codex":0.00010043626,"about_ca_system_score_gemma":0.00015206629,"threshold_uncertainty_score":0.44726554},"labels":[],"label_agreement":null},{"id":"W2781992965","doi":"10.1136/bcr-2017-222155","title":"Management of homozygous familial hypercholesterolaemia in two brothers","year":2018,"lang":"en","type":"article","venue":"BMJ Case Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Apheresis Group","funders":"Amryt Pharma","keywords":"Medicine; Pediatrics; Internal medicine","score_opus":0.02209320899072709,"score_gpt":0.3346334189983834,"score_spread":0.3125402100076563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2781992965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98388654,0.000203729,0.0001577297,0.0000766306,0.00023302362,0.0011971387,0.000001058211,0.00002846826,0.014215672],"genre_scores_gemma":[0.9976404,0.00003665308,0.0013207388,0.00014840768,0.00033364788,0.00006775686,0.0000036696179,0.000022095497,0.00042664455],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99856377,0.000046582056,0.000506127,0.00027972923,0.00037923525,0.00022456248],"domain_scores_gemma":[0.9988685,0.0000057270972,0.00012662527,0.00080463244,0.00008029754,0.000114168965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009651784,0.0001094799,0.0003389311,0.00009871798,0.000030986608,0.0000057009593,0.000020951078,0.00004816654,0.00005169656],"category_scores_gemma":[0.000022233931,0.00009406607,0.00015051142,0.00018881769,0.0000758388,0.000037566526,0.000042559182,0.00010208507,0.000013484216],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009817807,0.00011528593,0.007239397,0.0003533161,0.00013573488,0.8837042,0.00021785617,0.0000037049954,0.0002606812,0.000026241152,0.00013222385,0.10771317],"study_design_scores_gemma":[0.0023286825,0.00028037038,0.03808281,0.0005646406,0.00017893141,0.94808316,0.00053458364,0.000037500726,0.0018890285,0.00007827853,0.0077684796,0.00017356129],"about_ca_topic_score_codex":0.0023545616,"about_ca_topic_score_gemma":0.00027896,"teacher_disagreement_score":0.10753961,"about_ca_system_score_codex":0.00009226687,"about_ca_system_score_gemma":0.00009810043,"threshold_uncertainty_score":0.38359028},"labels":[],"label_agreement":null},{"id":"W2782019090","doi":"10.1016/j.acvdsp.2017.11.166","title":"Open-label ODYSSEY APPRISE study: Interim data from the first 843 participants","year":2018,"lang":"en","type":"article","venue":"Archives of Cardiovascular Diseases Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Tolerability; Adverse effect; Internal medicine; Statin; Interim analysis; Physical therapy; Randomized controlled trial","score_opus":0.10992053755614087,"score_gpt":0.367188182977925,"score_spread":0.25726764542178415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782019090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9621551,0.018948514,0.0034515066,0.00085689494,0.0006037736,0.007248108,0.0046074484,0.000100625,0.0020280369],"genre_scores_gemma":[0.9946748,0.00091059675,0.0011302481,0.00046609688,0.0009604553,0.00028249214,0.0014546268,0.00007199919,0.00004870033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955533,0.00052766374,0.00071431015,0.0010935962,0.0014161044,0.0006950379],"domain_scores_gemma":[0.9920919,0.00018258033,0.00016466857,0.0069933184,0.000117241805,0.0004503218],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001025393,0.000371529,0.0012116485,0.000084521445,0.00039565723,0.00012197499,0.0025264274,0.000044972752,0.00036306318],"category_scores_gemma":[0.0003341605,0.00026098368,0.0007192379,0.00026993328,0.00045517157,0.0003129651,0.004007056,0.00019902908,0.00007889429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004761196,0.012760505,0.529097,0.0006763916,0.09278436,0.00047259298,0.005637412,0.000026948464,0.00016110069,0.00009468292,0.03341229,0.32011554],"study_design_scores_gemma":[0.025388757,0.0019453835,0.55589944,0.0005459613,0.013646201,0.00002145992,0.0027295046,0.00089464965,0.0005045377,0.00037258785,0.39745602,0.0005954695],"about_ca_topic_score_codex":0.0045977747,"about_ca_topic_score_gemma":0.0005180371,"teacher_disagreement_score":0.36404374,"about_ca_system_score_codex":0.000033378696,"about_ca_system_score_gemma":0.00031533925,"threshold_uncertainty_score":0.99998426},"labels":[],"label_agreement":null},{"id":"W2782380257","doi":"10.7326/m17-0681","title":"Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population","year":2018,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Herlev Hospital; Aarhus Universitet","keywords":"Medicine; Nice; Guideline; Atherosclerotic cardiovascular disease; Canadian Cardiovascular Society; Statin; Population; Observational study; Primary care; Excellence; Internal medicine; Family medicine; Primary prevention; Physical therapy; Disease; Myocardial infarction; Environmental health; Pathology","score_opus":0.2337893298384343,"score_gpt":0.4699389520176179,"score_spread":0.23614962217918356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782380257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925597,0.0018571285,0.0020716682,0.0021943538,0.00015902525,0.00085607596,0.00001448813,0.0000068001573,0.0002808116],"genre_scores_gemma":[0.99374825,0.000072629395,0.0037833343,0.0013887613,0.00051965605,0.00002974397,0.00010178562,0.000013785196,0.00034206605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801016,0.000088008324,0.0011998826,0.00018021931,0.00037071636,0.00015099811],"domain_scores_gemma":[0.9984664,0.00007246287,0.00038047662,0.00021605434,0.00079899054,0.00006563186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012696829,0.000111021174,0.0007558389,0.00028917284,0.000010058372,0.0000019923912,0.00006838408,0.00006934689,0.000023464545],"category_scores_gemma":[0.0009947594,0.00008435469,0.0001295937,0.00016664548,0.00008334439,0.000110039866,0.000023553868,0.00010312711,5.776852e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00597534,0.00063480035,0.8989484,0.0014878624,0.00026929172,0.000020772652,0.0017854202,0.000031583644,0.010064656,0.00025011122,0.021867532,0.058664266],"study_design_scores_gemma":[0.007499253,0.0047672456,0.9629737,0.005576722,0.000050971194,0.000013461886,0.00049088127,0.002801035,0.013527503,0.0006063453,0.0015829813,0.000109893066],"about_ca_topic_score_codex":0.015695045,"about_ca_topic_score_gemma":0.00094539666,"teacher_disagreement_score":0.06402534,"about_ca_system_score_codex":0.000034538924,"about_ca_system_score_gemma":0.00009338215,"threshold_uncertainty_score":0.9908595},"labels":[],"label_agreement":null},{"id":"W2782406355","doi":"10.1161/atvbaha.117.310368","title":"Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy","year":2018,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; Disease; Lipoprotein(a); Cardiology; Lipoprotein; Atherosclerotic cardiovascular disease; Cholesterol; Vascular disease; Arteriosclerosis","score_opus":0.0502117188071651,"score_gpt":0.29466071442040953,"score_spread":0.24444899561324443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782406355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521625,0.00060805015,0.00044348417,0.0004260154,0.00020462296,0.0028622935,0.000048125046,0.00009592375,0.00009524481],"genre_scores_gemma":[0.9915659,0.0059860544,0.00064362184,0.0007882183,0.0004110365,0.0004523254,0.00003579049,0.000113789465,0.000003274285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958853,0.00056398613,0.00071146525,0.0012623804,0.0007532528,0.00082361413],"domain_scores_gemma":[0.99691683,0.00006278814,0.00023228538,0.0017819541,0.0005397835,0.00046638594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011900975,0.00063696003,0.0017242548,0.00032804205,0.00023644757,0.000039761304,0.00023696893,0.00029774074,0.00006609564],"category_scores_gemma":[0.00013039901,0.00044625887,0.00086482154,0.0006056807,0.0009839053,0.00013626498,0.00013560473,0.0003706562,0.000017216582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041574962,0.0012093559,0.8485161,0.0005360195,0.0045286776,0.0000015384727,0.0016540855,0.000022859256,0.12535255,0.00026133732,0.00004213766,0.017459603],"study_design_scores_gemma":[0.006418714,0.006847238,0.9748045,0.0018440192,0.000439062,0.0000041416106,0.00023272952,0.00007670071,0.007938175,0.00002519635,0.0009042098,0.00046528585],"about_ca_topic_score_codex":0.0006323007,"about_ca_topic_score_gemma":0.000084005784,"teacher_disagreement_score":0.12628843,"about_ca_system_score_codex":0.00011933287,"about_ca_system_score_gemma":0.00019403992,"threshold_uncertainty_score":0.9997989},"labels":[],"label_agreement":null},{"id":"W2782889826","doi":"10.1016/j.jacc.2017.11.014","title":"NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis","year":2018,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":495,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Western University","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute","keywords":"Medicine; Epidemiology; Disease; Intensive care medicine; Lipoprotein(a); Internal medicine; Stenosis; Lung disease; Cardiology; Lipoprotein; Lung; Cholesterol","score_opus":0.032966050160332376,"score_gpt":0.3070414471181463,"score_spread":0.2740753969578139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782889826","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010945564,0.9846612,0.0005588893,0.00050122116,0.0007501075,0.0020356008,0.0004209427,0.000010075859,0.00011639113],"genre_scores_gemma":[0.017278919,0.97892857,0.0017898772,0.00008242687,0.00172749,0.000071607996,0.000011454538,0.00007646657,0.00003319734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940219,0.0024316767,0.0018223171,0.0004395948,0.0008801374,0.00040438064],"domain_scores_gemma":[0.99378955,0.00041697043,0.003027115,0.001646079,0.0005998893,0.00052039523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033958945,0.00044149594,0.0066158613,0.0005550473,0.0001367617,0.0000074263926,0.000530875,0.0001814201,0.000006463498],"category_scores_gemma":[0.0017361842,0.00027828675,0.0052678324,0.0013939665,0.0006719978,0.00004429804,0.00030073847,0.0008012779,0.0000026994],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000539768,0.000083314924,0.0007356538,0.004958557,0.03397011,0.00016771119,0.0000371785,0.00005716901,0.0000067551446,0.000016183498,0.003043906,0.9563837],"study_design_scores_gemma":[0.0009070948,0.0014013494,0.0032605059,0.011048541,0.031145664,0.0010837859,0.00015311994,0.000003927103,0.0000052111627,0.000033949,0.950679,0.0002778758],"about_ca_topic_score_codex":0.00016790724,"about_ca_topic_score_gemma":0.000002715289,"teacher_disagreement_score":0.9561058,"about_ca_system_score_codex":0.00025713575,"about_ca_system_score_gemma":0.0010773477,"threshold_uncertainty_score":0.9999669},"labels":[],"label_agreement":null},{"id":"W2783064818","doi":"10.1111/bph.14140","title":"Prophylactic benefits of systemically delivered simvastatin treatment in a house dust mite challenged murine model of allergic asthma","year":2018,"lang":"en","type":"article","venue":"British Journal of Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Winnipeg; Canadian Respiratory Research Network; University of Manitoba; Children's Hospital Research Institute of Manitoba; Research Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Reseau canadien de recherche respiratoire; Research Manitoba; Canada Research Chairs; Institute of Circulatory and Respiratory Health; GlaxoSmithKline","keywords":"Simvastatin; House dust mite; Asthma; Medicine; Allergic asthma; Immunology; Allergy; Pharmacology; Allergen","score_opus":0.02599635003975338,"score_gpt":0.2874008196411599,"score_spread":0.2614044696014065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783064818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98772943,0.010822786,0.00018001036,0.00028993364,0.00018108255,0.0006689671,0.000023081662,0.000009901792,0.00009482917],"genre_scores_gemma":[0.99329793,0.004473854,0.0015610914,0.00010787028,0.0004579781,0.000018897259,0.0000017612823,0.00003548092,0.00004515425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784654,0.0002615433,0.0010025214,0.00018950045,0.00040718375,0.0002927052],"domain_scores_gemma":[0.99837357,0.00004794827,0.0006119694,0.00012187613,0.000661247,0.00018341928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006991671,0.00015322927,0.0009696863,0.00026394034,0.000031481795,0.000004765134,0.00012590205,0.00011932429,0.00008275037],"category_scores_gemma":[0.00005751989,0.0001454367,0.0003022132,0.00020465259,0.00013406792,0.000076725984,0.00003546407,0.0002681938,0.0000023499601],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012778713,0.009529256,0.001102813,0.0059742015,0.0042116963,0.006504025,0.0038159813,0.011886532,0.52156,0.00007656404,0.00083799113,0.42172223],"study_design_scores_gemma":[0.19648033,0.063353315,0.08044349,0.01045239,0.005004367,0.068234906,0.0019117086,0.044099793,0.52679634,0.00019191594,0.0015298533,0.0015016111],"about_ca_topic_score_codex":0.00043458203,"about_ca_topic_score_gemma":0.00020791455,"teacher_disagreement_score":0.4202206,"about_ca_system_score_codex":0.00020627635,"about_ca_system_score_gemma":0.0004994417,"threshold_uncertainty_score":0.59307367},"labels":[],"label_agreement":null},{"id":"W2784169762","doi":"10.1016/j.atherosclerosis.2018.01.005","title":"High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Université Laval","keywords":"LDL apheresis; Quartile; Apheresis; Familial hypercholesterolemia; Lipoprotein(a); Internal medicine; Medicine; Triglyceride; Endocrinology; Lipoprotein; Cholesterol; Chemistry; Confidence interval; Platelet","score_opus":0.009469921316140288,"score_gpt":0.21921688059263147,"score_spread":0.20974695927649117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784169762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707156,0.0000938478,0.00023951643,0.0005663503,0.000115780495,0.0016888898,0.00011368316,0.000047390782,0.00006295412],"genre_scores_gemma":[0.9987141,0.00010026418,0.0002937258,0.00039269004,0.00019973608,0.00010408762,0.00006133414,0.00005450603,0.000079576734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786735,0.00019736719,0.00048904284,0.0004012667,0.00061533845,0.00042961433],"domain_scores_gemma":[0.99864864,0.000051508945,0.00017885782,0.00076213514,0.00021993156,0.00013891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039979428,0.00025128096,0.00049346196,0.00006185488,0.00014729553,0.000029055476,0.00017959537,0.00014554252,0.000070093905],"category_scores_gemma":[0.000051831685,0.00016403444,0.00017500723,0.0004536795,0.00031342116,0.00012486258,0.000033796325,0.0002524201,0.00002861608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003900353,0.001821772,0.80796087,0.0001868348,0.000580391,0.0000036868892,0.0018907143,0.000048764494,0.0914373,0.00009051405,0.00080594764,0.091272846],"study_design_scores_gemma":[0.010253628,0.0012307488,0.96230936,0.0002784092,0.00017598801,0.0000026255248,0.0000942596,0.000023747294,0.025044689,0.000010231897,0.00039657118,0.00017975425],"about_ca_topic_score_codex":0.0033930663,"about_ca_topic_score_gemma":0.0006210547,"teacher_disagreement_score":0.15434848,"about_ca_system_score_codex":0.000120322875,"about_ca_system_score_gemma":0.00010359365,"threshold_uncertainty_score":0.668913},"labels":[],"label_agreement":null},{"id":"W2784174436","doi":"10.1186/s12944-017-0649-5","title":"Ezetimibe prescriptions in older Canadian adults after an acute myocardial infarction: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Robarts Clinical Trials; Institute for Clinical Evaluative Sciences; Western University; St Joseph's Health Care; Lawson Health Research Institute","funders":"Western University; Ontario Ministry of Health and Long-Term Care; Schulich School of Medicine and Dentistry; Academic Medical Organization of Southwestern Ontario; Canadian Institutes of Health Research; Genome Canada; Lawson Health Research Institute; Institute for Clinical Evaluative Sciences; Heart and Stroke Foundation of Canada","keywords":"Ezetimibe; Medicine; Myocardial infarction; Medical prescription; Population; Internal medicine; Heart failure; Coronary artery disease; Cohort; Emergency medicine; Intensive care medicine; Statin","score_opus":0.008432451340534915,"score_gpt":0.2808741779507453,"score_spread":0.2724417266102104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784174436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328333,0.00054760714,0.000014961235,0.0023771785,0.00039309284,0.0031867845,0.000072192866,0.000034286735,0.00009057601],"genre_scores_gemma":[0.9892742,0.00006538342,0.00011914849,0.00864327,0.0009219831,0.00073026854,0.00019137019,0.000021301948,0.00003304614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979774,0.0003152253,0.00042237376,0.00045977044,0.0003369221,0.0004883107],"domain_scores_gemma":[0.9966275,0.000014241226,0.000044465516,0.0005507016,0.000081575214,0.0026814817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006588206,0.00016189953,0.00035922648,0.00036358027,0.00019265935,0.000027608221,0.000046887017,0.00007549582,0.00010363165],"category_scores_gemma":[0.00013868287,0.00015351338,0.00007627783,0.0003461956,0.00004707926,0.00012812382,0.000014660522,0.00022558503,0.00000770834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010794039,0.00037464846,0.99410534,0.00019917735,0.000030388435,0.000051592142,0.0009033143,0.000010237672,6.7260984e-8,0.000012745621,0.00016684379,0.0030662213],"study_design_scores_gemma":[0.003579406,0.0008054168,0.99265796,0.00019736814,0.000061552695,0.0000042479433,0.00032990158,0.0011197925,5.5884005e-8,0.000031391566,0.0010763108,0.00013661305],"about_ca_topic_score_codex":0.41975173,"about_ca_topic_score_gemma":0.33298957,"teacher_disagreement_score":0.08676216,"about_ca_system_score_codex":0.00035242495,"about_ca_system_score_gemma":0.0022920775,"threshold_uncertainty_score":0.67918164},"labels":[],"label_agreement":null},{"id":"W2784310755","doi":"10.1016/j.ahj.2017.12.018","title":"Rationale and design of the Statins Evaluation in Coronary procedUres and REvascularization: The SECURE-PCI Trial","year":2018,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministério da Saúde; CHEO Research Institute","keywords":"Medicine; Conventional PCI; Revascularization; Cardiology; Internal medicine; Myocardial infarction","score_opus":0.03854139485516305,"score_gpt":0.32220672930428657,"score_spread":0.2836653344491235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2784310755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073446,0.0015667182,0.0016709524,0.004155574,0.00009218389,0.0017318948,0.0000015605854,0.0000031317263,0.000043552598],"genre_scores_gemma":[0.99661016,0.0004359211,0.0015760723,0.00084673706,0.0004682189,0.000035137633,0.0000012707625,0.000007431158,0.000019041],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99847335,0.00055910985,0.00023350526,0.000102956146,0.0005285057,0.000102576],"domain_scores_gemma":[0.9993513,0.000081697406,0.00012479904,0.00015737166,0.00022947718,0.00005533069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002207051,0.00006175351,0.00019289146,0.000040186795,0.0001878992,0.00001855451,0.00003722037,0.000020443913,0.000032463322],"category_scores_gemma":[0.0004958755,0.00003312375,0.000057223824,0.00021634191,0.00033328982,0.000056592584,0.000018686402,0.00016249948,5.444357e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036483463,0.0010273692,0.39842704,0.0005612777,0.0016182554,0.000032596658,0.028954314,0.0011699407,0.013240093,0.0013335699,0.014870226,0.50228184],"study_design_scores_gemma":[0.022681737,0.0031597272,0.95860887,0.00026513688,0.00032244503,0.002909445,0.0021870697,0.0048329085,0.00048189887,0.0009443848,0.0034726637,0.00013370047],"about_ca_topic_score_codex":0.00009075675,"about_ca_topic_score_gemma":0.000041732677,"teacher_disagreement_score":0.56018186,"about_ca_system_score_codex":0.00003633241,"about_ca_system_score_gemma":0.0007460885,"threshold_uncertainty_score":0.14451878},"labels":[],"label_agreement":null},{"id":"W2785614344","doi":"10.1136/annrheumdis-2017-212902","title":"Response to: ‘Statins in systemic lupus erythematosus’ by Abud-Mendoza","year":2018,"lang":"en","type":"letter","venue":"Annals of the Rheumatic Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Rijksinstituut voor Volksgezondheid en Milieu","keywords":"Medicine; Statin; Disease; Clinical Practice; Systemic therapy; Internal medicine; Lupus erythematosus; Systemic lupus erythematosus; Clinical trial; Medical record; Physical therapy; Intensive care medicine; Immunology","score_opus":0.025391641986925916,"score_gpt":0.2986443463231878,"score_spread":0.2732527043362619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785614344","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5018741,0.00957059,0.00003183711,0.4835399,0.0007654026,0.0029325266,0.0008833776,0.00006862083,0.00033364896],"genre_scores_gemma":[0.29014927,0.0018517794,0.0001624412,0.6919119,0.0011654907,0.0007489261,0.00032681818,0.0002851725,0.013398234],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99573207,0.00089968817,0.00096383947,0.00047426808,0.0013161291,0.0006140188],"domain_scores_gemma":[0.9965734,0.000448167,0.00046649444,0.0020216107,0.0002441624,0.0002461777],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012442413,0.00042361385,0.0014280522,0.0002627088,0.00008024641,0.000034651424,0.0005419813,0.0002999881,0.00013380755],"category_scores_gemma":[0.0015440651,0.0002769182,0.0008584437,0.00041098782,0.00015413716,0.000056609315,0.0001349914,0.0005049602,0.00012608561],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006501529,0.00014540907,0.0005345281,0.0053508035,0.00047820038,0.00009310292,0.00043742647,0.0000026728146,0.00003352207,0.0000050396134,0.9897561,0.002513016],"study_design_scores_gemma":[0.006296356,0.0016042099,0.011306845,0.07330723,0.0015931905,0.0022579348,0.001269816,0.000074085016,0.0010297665,0.0009648163,0.8987931,0.0015026346],"about_ca_topic_score_codex":0.00031458764,"about_ca_topic_score_gemma":0.000005118506,"teacher_disagreement_score":0.21172482,"about_ca_system_score_codex":0.000098259035,"about_ca_system_score_gemma":0.00057022827,"threshold_uncertainty_score":0.9999683},"labels":[],"label_agreement":null},{"id":"W2787480145","doi":"10.1016/j.jacl.2018.01.013","title":"Alirocumab in high-risk patients: Observations from the open-label expanded use program","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Familial hypercholesterolemia; PCSK9; Statin; Internal medicine; Evolocumab; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.2118351454886508,"score_gpt":0.4463498752314411,"score_spread":0.2345147297427903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787480145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99056196,0.00014341634,0.00018753321,0.004769229,0.0034372855,0.0007922109,0.000015842721,0.000011751364,0.00008074777],"genre_scores_gemma":[0.9630654,0.0007551867,0.019075105,0.006405721,0.0105396975,0.000026423535,0.000022707258,0.000023180353,0.00008657808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961137,0.0011726143,0.0018120173,0.00023239695,0.00040291148,0.00026636553],"domain_scores_gemma":[0.9959587,0.0015637077,0.00094197976,0.0005979225,0.0007150362,0.0002226713],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0037850789,0.0001285192,0.0009873935,0.000055117944,0.00010376802,0.0000504041,0.0004255807,0.00026790306,0.000084963816],"category_scores_gemma":[0.008763457,0.00007290799,0.0002621547,0.00023901791,0.00027099365,0.000256094,0.00017104807,0.000967891,0.000021506512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013071358,0.0020881142,0.80317515,0.0000049717714,0.00030656983,0.0000087037015,0.00009594621,4.888931e-7,0.0000047914295,0.00017727687,0.009088792,0.18374208],"study_design_scores_gemma":[0.015498704,0.0051894137,0.8762681,0.000099458055,0.00022644481,0.000019763856,0.00004564339,0.000027613114,0.0000055430605,0.001095947,0.10145483,0.000068575],"about_ca_topic_score_codex":0.0017314173,"about_ca_topic_score_gemma":0.0008461331,"teacher_disagreement_score":0.1836735,"about_ca_system_score_codex":0.000046772722,"about_ca_system_score_gemma":0.00042930007,"threshold_uncertainty_score":0.99958616},"labels":[],"label_agreement":null},{"id":"W2787959738","doi":"10.1111/dom.13257","title":"Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Ezetimibe; Medicine; Internal medicine; Dyslipidemia; PCSK9; Population; Type 2 diabetes; Fenofibrate; Gastroenterology; Endocrinology; Clinical endpoint; Statin; Randomized controlled trial; Cholesterol; Diabetes mellitus; Apolipoprotein B; Lipoprotein; Apolipoprotein A1; LDL receptor","score_opus":0.009826980854002007,"score_gpt":0.25888975585096974,"score_spread":0.24906277499696772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2787959738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863199,0.008571633,0.000008773968,0.00053891237,0.00068867457,0.0034831925,0.000027649947,0.000061917446,0.00029932882],"genre_scores_gemma":[0.99341536,0.00083910115,0.00037125847,0.0030005139,0.0018916117,0.00032534986,0.000036901987,0.000054118354,0.000065776614],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99680656,0.0006851265,0.0005204732,0.00063869584,0.0006428524,0.0007063199],"domain_scores_gemma":[0.99815136,0.0004942564,0.0001596958,0.0006019551,0.00023071842,0.00036199085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029125814,0.00042670072,0.0017001985,0.00024081097,0.00032822482,0.00011816424,0.00016641572,0.00023595415,0.000050689625],"category_scores_gemma":[0.00085675047,0.00025560026,0.00019283826,0.00048253403,0.0003328059,0.00014754137,0.00011134798,0.00048939727,0.000016166625],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36379403,0.0009181004,0.16742168,0.0009978625,0.0036730603,0.000024124372,0.028327482,0.000019911957,0.0037689311,0.0012253547,0.0019033274,0.42792612],"study_design_scores_gemma":[0.6529739,0.0037090199,0.290916,0.00057890796,0.00078805146,0.0000041064127,0.001143068,0.000031255993,0.02114249,0.000245184,0.027772695,0.00069534866],"about_ca_topic_score_codex":0.00019153341,"about_ca_topic_score_gemma":0.00009492653,"teacher_disagreement_score":0.42723078,"about_ca_system_score_codex":0.00004270567,"about_ca_system_score_gemma":0.00018981747,"threshold_uncertainty_score":0.9999896},"labels":[],"label_agreement":null},{"id":"W2788051791","doi":"10.1161/circgen.118.002052","title":"Therapeutic Lowering of Lipoprotein(a)","year":2018,"lang":"en","type":"letter","venue":"Circulation Genomic and Precision Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lipoprotein(a); Lipoprotein; Cardiology; Internal medicine; Cholesterol","score_opus":0.03242386664890135,"score_gpt":0.2826255515996069,"score_spread":0.25020168495070555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788051791","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28347656,0.08488419,0.039679896,0.56545186,0.003900749,0.0071874773,0.00005434253,0.00026800725,0.015096887],"genre_scores_gemma":[0.67257863,0.00353654,0.00076579093,0.29409307,0.025917755,0.00007219075,0.0005468962,0.00019803131,0.0022911245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974964,0.00009134517,0.0007452357,0.000542396,0.00083935267,0.0002852681],"domain_scores_gemma":[0.99820524,0.00012030232,0.00035949552,0.00090420264,0.00027675033,0.00013397732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010644936,0.00031890505,0.0010712993,0.0003255044,0.00009457054,0.000009681828,0.00012062178,0.00068696984,0.00087017205],"category_scores_gemma":[0.0001278871,0.00023898896,0.00022392166,0.00019400554,0.00029155193,0.00004063223,0.000059309743,0.00075611286,0.000031390697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032566104,0.000046845147,0.0020611351,0.0036884923,0.0010199412,0.00017109633,0.001056805,0.000009477782,0.016103568,0.000039047616,0.28268763,0.69279027],"study_design_scores_gemma":[0.002716457,0.00076505676,0.06805029,0.0020879377,0.0008742489,0.00047217423,0.00005127808,0.00021686424,0.00040339062,0.0012939908,0.9227156,0.00035271313],"about_ca_topic_score_codex":0.00014424491,"about_ca_topic_score_gemma":0.0000013003211,"teacher_disagreement_score":0.6924376,"about_ca_system_score_codex":0.000100052224,"about_ca_system_score_gemma":0.00016221627,"threshold_uncertainty_score":0.97456867},"labels":[],"label_agreement":null},{"id":"W2789244140","doi":"10.1177/0891988718764330","title":"Loss-of-Function PCSK9 Mutations Are Not Associated With Alzheimer Disease","year":2018,"lang":"en","type":"article","venue":"Journal of Geriatric Psychiatry and Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Douglas Mental Health University Institute; Université de Montréal; Montreal Clinical Research Institute","funders":"National Institute on Aging; Canadian Institutes of Health Research; Institut de Recherche Clinique De Montréal","keywords":"PCSK9; Medicine; Disease; Apolipoprotein E; Alzheimer's disease; Genotype; Mutation; Risk factor; Internal medicine; Dementia; Population; Neurocognitive; Genetics; LDL receptor; Cholesterol; Biology; Lipoprotein; Psychiatry; Gene; Cognition","score_opus":0.015520443331896325,"score_gpt":0.2599969107842839,"score_spread":0.24447646745238755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789244140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900801,0.0025563107,0.00036996687,0.0054752887,0.0012005884,0.00016439841,0.000007906118,0.000009697923,0.00013572552],"genre_scores_gemma":[0.99653906,0.00017805645,0.00018773436,0.0016358377,0.0014226121,0.000002356702,0.0000031155323,0.000014334336,0.000016875298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891716,0.00013628347,0.00037969323,0.0001437175,0.0002634037,0.00015971526],"domain_scores_gemma":[0.9986896,0.000045300323,0.00055705104,0.0001755967,0.0003162157,0.00021625598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036735312,0.00010686951,0.00038010534,0.00018176479,0.00009456264,0.0000062634886,0.000048145816,0.00009501096,0.000035706715],"category_scores_gemma":[0.00009617303,0.00007542455,0.00016562779,0.00027557788,0.00014372243,0.000076619595,0.000012173461,0.00026475836,0.0000024110916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018006988,0.0011394926,0.9696809,0.00017016628,0.0020211593,0.00032414516,0.00012126347,0.000028796214,0.00021344438,0.0006244472,0.0015671154,0.006102067],"study_design_scores_gemma":[0.0031361103,0.005251819,0.9868225,0.000049522183,0.0018090967,0.00080894335,0.000030377592,0.000027410142,0.00003491444,0.0004949614,0.0014576869,0.00007669449],"about_ca_topic_score_codex":0.0000058911987,"about_ca_topic_score_gemma":0.000008309753,"teacher_disagreement_score":0.017141549,"about_ca_system_score_codex":0.0000065210843,"about_ca_system_score_gemma":0.0003105642,"threshold_uncertainty_score":0.3075724},"labels":[],"label_agreement":null},{"id":"W2789510102","doi":"10.1161/circulationaha.117.031676","title":"Response by Kusters et al to Letter Regarding Article, “Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia: The CHARON Study (Hypercholesterolemia in Children and Adolescents Taking Rosuvastatin Open Label)”","year":2018,"lang":"en","type":"letter","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hospital for Sick Children; University of British Columbia; McMaster University; St. Paul's Hospital; University of Toronto","funders":"Hospital for Sick Children; Université de Montréal; University of Toronto; McMaster University; AstraZeneca","keywords":"Rosuvastatin; Familial hypercholesterolemia; Medicine; Intima-media thickness; Pediatrics; Internal medicine; Carotid arteries; Cholesterol","score_opus":0.0170299474680626,"score_gpt":0.28902710322635256,"score_spread":0.27199715575829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789510102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9545384,0.000045376197,0.00009111985,0.03637179,0.0001190542,0.008694012,0.00009833828,0.000034531076,0.000007358],"genre_scores_gemma":[0.8374437,0.0000069269868,0.000082971455,0.1613448,0.0003126211,0.00035165425,0.00031410117,0.0001375095,0.0000057146467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99292266,0.0030234763,0.00088763563,0.001220555,0.0012586472,0.00068702776],"domain_scores_gemma":[0.9979329,0.0002237342,0.00043434976,0.0011464509,0.000117124764,0.00014542112],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0044687428,0.0006591064,0.0012736013,0.00051675894,0.00012964135,0.000199961,0.00044871282,0.0004413952,0.0000035809583],"category_scores_gemma":[0.00030691203,0.00048226395,0.00011205818,0.0005348718,0.00015885654,0.00028676674,0.00029007197,0.0022380315,0.000008777634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003351907,0.0002336469,0.97480226,0.00013119518,0.00021737911,0.000054117747,0.0032046144,0.0001691716,0.003009788,9.9308835e-8,0.009646263,0.005179533],"study_design_scores_gemma":[0.0139834415,0.0016704383,0.98037946,0.0023931006,0.00021245168,0.00022340291,0.000110455745,0.000052774365,0.00031330538,9.2614374e-7,0.00022274333,0.00043750164],"about_ca_topic_score_codex":0.002001839,"about_ca_topic_score_gemma":0.00026351874,"teacher_disagreement_score":0.124973,"about_ca_system_score_codex":0.0004510917,"about_ca_system_score_gemma":0.00013445808,"threshold_uncertainty_score":0.9997629},"labels":[],"label_agreement":null},{"id":"W2789648792","doi":"10.1097/hco.0000000000000518","title":"An update on trials of novel lipid-lowering drugs","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"AstraZeneca","keywords":"Medicine; Evolocumab; Canakinumab; PCSK9; Kexin; Cholesterylester transfer protein; Proprotein convertase; Population; Cholesterol; Internal medicine; Pharmacology; Coronary artery disease; Clinical trial; Statin; Lipoprotein; Disease; LDL receptor","score_opus":0.23101075881889993,"score_gpt":0.4738872178933312,"score_spread":0.24287645907443128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789648792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042223364,0.9794307,0.00072347204,0.000025017445,0.017061755,0.0021281664,0.0002235789,0.000040977353,0.00032411536],"genre_scores_gemma":[0.00008390633,0.9867053,0.000112360416,0.000017743756,0.011765892,0.00028544574,0.0009554868,0.00006874875,0.000005106781],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99499035,0.001231544,0.0020661985,0.0008145401,0.0004326466,0.00046472595],"domain_scores_gemma":[0.9970831,0.0002733762,0.00080305943,0.0014892898,0.0001402624,0.00021089977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006277833,0.0005001365,0.0074406466,0.0005929352,0.000037982903,0.000009109365,0.00029828819,0.0006272609,0.00003389423],"category_scores_gemma":[0.0005654986,0.0003668406,0.0024824727,0.00037386524,0.00014381613,0.000040382016,0.00009853877,0.00078719924,0.000053621156],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067218425,0.0001558852,0.000014141307,0.031939685,0.00047599015,0.0000019823967,0.000032903095,0.000005167268,5.478681e-7,0.00023443764,0.001792979,0.96527904],"study_design_scores_gemma":[0.00167322,0.00052488205,0.000034048164,0.03003398,0.00056102267,0.00012111712,0.000011568896,0.000004751497,0.0000018299609,0.000008711288,0.9667542,0.0002706905],"about_ca_topic_score_codex":0.000017756098,"about_ca_topic_score_gemma":3.306075e-7,"teacher_disagreement_score":0.9650084,"about_ca_system_score_codex":0.00022931135,"about_ca_system_score_gemma":0.00072411646,"threshold_uncertainty_score":0.99987835},"labels":[],"label_agreement":null},{"id":"W2790059086","doi":"10.1111/dom.13235","title":"Effect of proprotein convertase subtilisin/kexin type 9 ( <scp>PCSK9</scp> ) monoclonal antibodies on new‐onset diabetes mellitus and glucose metabolism: <scp>A</scp> systematic review and meta‐analysis","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Capital Health","keywords":"Medicine; PCSK9; Internal medicine; Alirocumab; Type 2 diabetes; Meta-analysis; Diabetes mellitus; Kexin; Publication bias; Subgroup analysis; Confidence interval; Gastroenterology; Endocrinology; Cholesterol; LDL receptor; Lipoprotein","score_opus":0.020657028541026294,"score_gpt":0.28550547619983746,"score_spread":0.26484844765881116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790059086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10331809,0.88671994,0.000004854288,0.00003167934,0.00018587761,0.008945693,0.0006602062,0.000091246715,0.000042431515],"genre_scores_gemma":[0.00142159,0.995455,0.0003249898,0.0005149513,0.00031931518,0.00069648336,0.0005146947,0.00015119539,0.0006017833],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9903169,0.0033576384,0.0021028987,0.0017461161,0.0012603938,0.0012160174],"domain_scores_gemma":[0.99233115,0.0024697213,0.0015433816,0.0020317049,0.00050518935,0.0011188643],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.006637522,0.0018490567,0.022297392,0.0010303416,0.00032532774,0.00017983826,0.00042790704,0.0008385643,0.000024626423],"category_scores_gemma":[0.0043374086,0.0011799245,0.0037145973,0.0015582896,0.0006383666,0.0002745703,0.0003645833,0.0009560577,0.000039022118],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007851705,0.00018655274,0.00027113903,0.8586878,0.13049291,0.000018876548,0.00015107107,1.11783656e-7,0.000008787837,0.000094017894,0.00042521933,0.009655631],"study_design_scores_gemma":[0.0011791803,0.0006019315,0.0008763876,0.0380501,0.8593683,0.000038267535,0.000022295353,0.000012368164,0.0020116377,0.00005530388,0.09743987,0.00034433804],"about_ca_topic_score_codex":0.00021486876,"about_ca_topic_score_gemma":0.000015004636,"teacher_disagreement_score":0.8206377,"about_ca_system_score_codex":0.000044736815,"about_ca_system_score_gemma":0.00039738204,"threshold_uncertainty_score":0.9994254},"labels":[],"label_agreement":null},{"id":"W2790294015","doi":"10.1016/j.atherosclerosis.2018.03.025","title":"Pathological significance of lipoprotein(a) in aortic valve stenosis","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Lipoprotein(a); Lipoprotein; Stenosis; Aortic valve stenosis; Aortic valve; Internal medicine; PCSK9; Calcification; Medicine; Population; Cardiology; Pathological; Endocrinology; Cholesterol; Chemistry; LDL receptor","score_opus":0.03260134715224822,"score_gpt":0.27720196644949857,"score_spread":0.24460061929725035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790294015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963695,0.00025485462,0.00043989625,0.00029255424,0.00010024439,0.00081850844,0.00000755832,0.00005280926,0.0016641126],"genre_scores_gemma":[0.9967777,0.00020067804,0.002068395,0.00043822383,0.0002522231,0.00013613234,0.0000030808146,0.00002968667,0.00009387825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982585,0.00011659313,0.00043177628,0.0003791627,0.00044898887,0.0003650209],"domain_scores_gemma":[0.9989041,0.000034399913,0.000113663766,0.00066773494,0.0001423225,0.00013777736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069098093,0.00016600883,0.0005481122,0.00009162919,0.000052613574,0.000008890034,0.0001262917,0.00016201053,0.00020698221],"category_scores_gemma":[0.00014087136,0.00013156826,0.00036576565,0.00045621776,0.00025252817,0.000053682965,0.000053160427,0.00018749328,0.00007247814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003909782,0.0014882152,0.49349138,0.0005298233,0.00033387015,0.000017667811,0.0020734095,0.0000045390702,0.29548204,0.0007457978,0.00029796807,0.20514432],"study_design_scores_gemma":[0.0013129046,0.0011200327,0.94954884,0.00025637986,0.00008313968,0.000006527656,0.00014678574,0.000044813183,0.046725348,0.00017771551,0.00042930985,0.00014820839],"about_ca_topic_score_codex":0.00087325694,"about_ca_topic_score_gemma":0.000042612184,"teacher_disagreement_score":0.45605746,"about_ca_system_score_codex":0.00008024093,"about_ca_system_score_gemma":0.000085735934,"threshold_uncertainty_score":0.53651977},"labels":[],"label_agreement":null},{"id":"W2790310724","doi":"10.1016/j.jacc.2017.12.025","title":"A Comparative Analysis of Current Lipid Treatment Guidelines","year":2018,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Task force; Atherosclerotic cardiovascular disease; Statin; Canadian Cardiovascular Society; Intensive care medicine; Veterans Affairs; Family medicine; Secondary prevention; Disease; Physical therapy; Internal medicine; Myocardial infarction; Pathology","score_opus":0.1234086778179531,"score_gpt":0.43229957300406224,"score_spread":0.3088908951861091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790310724","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018879143,0.9956787,0.00020028239,0.00020013262,0.00068435003,0.0007171718,0.00039334665,0.0000029751632,0.00023507979],"genre_scores_gemma":[0.0019480741,0.99533427,0.0005356655,0.00004597764,0.0020360595,0.000017011187,0.000009880067,0.000018497463,0.00005455397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955967,0.0012153666,0.0021314912,0.0002333756,0.0005909234,0.00023211418],"domain_scores_gemma":[0.99234056,0.00023376229,0.0048808632,0.0009822529,0.0014171741,0.00014538156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001202934,0.00035903917,0.012407592,0.0007623898,0.00004223632,0.0000019236402,0.00039564908,0.00010744555,0.000008115646],"category_scores_gemma":[0.0002354098,0.00017422973,0.009401389,0.0019294638,0.00067922386,0.000017948356,0.00009473481,0.00032025343,0.000001477886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005839304,0.00025247573,0.0006873927,0.0046621687,0.15990834,0.00012696961,0.00009047295,0.00019228923,0.00000581029,0.000051101757,0.027941009,0.80549806],"study_design_scores_gemma":[0.0005230029,0.002196385,0.00041921844,0.0029674147,0.0651453,0.0011524494,0.000108516026,0.0000081305325,0.000008301574,0.000004083301,0.92735296,0.00011421332],"about_ca_topic_score_codex":0.00003779835,"about_ca_topic_score_gemma":0.00000961985,"teacher_disagreement_score":0.899412,"about_ca_system_score_codex":0.0003580351,"about_ca_system_score_gemma":0.0016457599,"threshold_uncertainty_score":0.9481553},"labels":[],"label_agreement":null},{"id":"W2790445336","doi":"10.1002/pds.4393","title":"Importance of the lipid‐related pathways in the association between statins, mortality, and cardiovascular disease risk: The Multi‐Ethnic Study of Atherosclerosis","year":2018,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; The Quebec Population Health Research Network","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Heart, Lung, and Blood Institute","keywords":"Medicine; Ethnic group; Disease; Pharmacoepidemiology; Atherosclerotic cardiovascular disease; Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Bioinformatics; Cholesterol; Pharmacology","score_opus":0.07412529716109159,"score_gpt":0.3485537903122317,"score_spread":0.27442849315114015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790445336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911998,0.005764089,0.000079779,0.001062239,0.00012907227,0.0015993167,0.00010474024,0.000012249526,0.00004874016],"genre_scores_gemma":[0.99404526,0.005177864,0.000030842097,0.0004535663,0.00020154536,0.00005886006,0.000009383675,0.000012649101,0.000010035685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927825,0.0054124165,0.0007830065,0.0003564599,0.00039532332,0.00027029135],"domain_scores_gemma":[0.9970541,0.0014746023,0.00047936873,0.00079130754,0.00010856599,0.0000920283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019220255,0.00017182088,0.000760664,0.00003295881,0.00025966743,0.0000030354724,0.00019340456,0.00008807558,0.00000767269],"category_scores_gemma":[0.0014924586,0.0000834182,0.0003245411,0.000307382,0.00032609742,0.000047634996,0.00012708466,0.0005234496,7.5694146e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008151434,0.00017561471,0.9876862,0.000074394535,0.001882047,0.0000012080735,0.004340641,0.000046939487,0.000032024505,0.000040989806,0.000068766196,0.005569632],"study_design_scores_gemma":[0.002935919,0.000101116755,0.9922996,0.00004566785,0.0023684674,0.0000021073597,0.0012122944,0.00044135738,0.0000498742,0.0001538287,0.00031060513,0.000079146324],"about_ca_topic_score_codex":0.003193264,"about_ca_topic_score_gemma":0.00051485153,"teacher_disagreement_score":0.017727798,"about_ca_system_score_codex":0.00004361596,"about_ca_system_score_gemma":0.00007861081,"threshold_uncertainty_score":0.66613954},"labels":[],"label_agreement":null},{"id":"W2790540315","doi":"10.1002/mnfr.201700729","title":"Mice Fed a High‐Cholesterol Diet Supplemented with Quercetin‐3‐Glucoside Show Attenuated Hyperlipidemia and Hyperinsulinemia Associated with Differential Regulation of PCSK9 and LDLR in their Liver and Pancreas","year":2018,"lang":"en","type":"article","venue":"Molecular Nutrition & Food Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Computer Research Institute of Montréal; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Endocrinology; Internal medicine; LDL receptor; PCSK9; Hyperinsulinemia; Hyperlipidemia; Cholesterol; Apolipoprotein B; Kexin; Biology; Insulin; Chemistry; Lipoprotein; Diabetes mellitus; Medicine; Insulin resistance","score_opus":0.026815627870446914,"score_gpt":0.2787951810707351,"score_spread":0.2519795532002882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790540315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957304,0.0012087901,0.0003291112,0.00092398445,0.000010423284,0.0016789844,0.00006254843,0.000028078402,0.000027690612],"genre_scores_gemma":[0.99838233,0.00045145318,0.00054941594,0.00007926063,0.000088145665,0.0001380459,0.00024996023,0.000043941985,0.000017427812],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973246,0.0006681271,0.0003196631,0.00051378954,0.00073844235,0.00043541015],"domain_scores_gemma":[0.9986216,0.00010155113,0.00009064934,0.00032763492,0.00064138573,0.00021720941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010124036,0.0002179652,0.00053317606,0.00031338658,0.000149441,0.000049257214,0.00006231307,0.0001850792,0.000015665024],"category_scores_gemma":[0.0001571494,0.000163145,0.000044820463,0.0005179986,0.00044882664,0.000090631846,0.00009269264,0.00041142205,5.988758e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018852899,0.0015572688,0.068420045,0.0019458261,0.0012926213,0.00017052794,0.001404129,0.000002093699,0.89699996,0.0002868927,0.000181892,0.008885828],"study_design_scores_gemma":[0.021596257,0.012816748,0.82406765,0.0019053705,0.00020201787,0.00019269677,0.00064895273,0.0009521915,0.13692796,0.000108503715,0.00027751923,0.00030412187],"about_ca_topic_score_codex":0.0010839847,"about_ca_topic_score_gemma":0.0011692158,"teacher_disagreement_score":0.760072,"about_ca_system_score_codex":0.000093631505,"about_ca_system_score_gemma":0.00009223362,"threshold_uncertainty_score":0.665286},"labels":[],"label_agreement":null},{"id":"W27914534","doi":"10.1007/s005920300007","title":"The relationship between lipoprotein(a) and the complications of diabetes mellitus","year":2003,"lang":"en","type":"review","venue":"Acta Diabetologica","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Diabetes mellitus; Medicine; Lipoprotein(a); Internal medicine; Endocrinology; Lipoprotein; Population; Disease; Type 2 Diabetes Mellitus; Cholesterol","score_opus":0.08166572093292274,"score_gpt":0.33236554968230053,"score_spread":0.2506998287493778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W27914534","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062028674,0.99202627,0.000012478002,0.0015570455,0.00006639081,0.003249045,0.000041655167,0.000036354093,0.0023905023],"genre_scores_gemma":[0.024591746,0.97384685,0.00017358345,0.00012279477,0.00015938078,0.00083069433,0.00009603794,0.000035081568,0.00014384804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690944,0.0010749252,0.00083654263,0.0003903963,0.00039150132,0.00039720422],"domain_scores_gemma":[0.99264383,0.0050122202,0.00057070714,0.0015239759,0.00011029957,0.00013899326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023138525,0.00034032456,0.0022453242,0.000074307885,0.00057163724,0.000043361546,0.00035136708,0.00039010166,0.000009572701],"category_scores_gemma":[0.0017129196,0.00014554974,0.0008410503,0.0004418315,0.0008765457,0.00003104298,0.000113064474,0.0007680235,0.000018008492],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000040048453,0.000030314744,0.0038204894,0.0053669442,0.00070633536,6.6577735e-7,0.000024305842,1.4113144e-8,6.940835e-8,0.014471801,0.00034287278,0.9752322],"study_design_scores_gemma":[0.00054496917,0.00007542027,0.022531804,0.002080126,0.0024709608,0.000013237639,0.000015331394,4.8290195e-7,9.481643e-7,0.00241234,0.96969515,0.0001592405],"about_ca_topic_score_codex":0.000023871966,"about_ca_topic_score_gemma":0.0000027413707,"teacher_disagreement_score":0.9750729,"about_ca_system_score_codex":0.000051564177,"about_ca_system_score_gemma":0.00022717546,"threshold_uncertainty_score":0.5935346},"labels":[],"label_agreement":null},{"id":"W2791456541","doi":"10.1016/s0735-1097(18)32296-4","title":"PCSK9 INHIBITION: REAL WORLD APPLICATION AND CHALLENGES TO ACHIEVE UNMET CHOLESTEROL TARGETS IN CANADIAN ATHEROSCLEROTIC HEART DISEASE, THE PRACTICAL STUDY","year":2018,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cambridge Cardiac Care Centre","funders":"","keywords":"Medicine; PCSK9; Ldl cholesterol; Cholesterol; Atherosclerotic cardiovascular disease; Cardiology; Internal medicine; Reduction (mathematics); Cholesterol lowering; Disease; Heart disease; LDL receptor; Lipoprotein","score_opus":0.025593737669745965,"score_gpt":0.30639174888534015,"score_spread":0.28079801121559417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791456541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92161995,0.00045974486,0.000071279595,0.07611794,0.00013002944,0.0011091699,0.000018148075,0.0000031755358,0.00047058333],"genre_scores_gemma":[0.99696565,0.0003227194,0.00018196185,0.00166376,0.0007956756,0.00003555894,3.7459714e-7,0.000014230164,0.000020085567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811804,0.0007284481,0.0003859377,0.00017565663,0.00033477345,0.00025712673],"domain_scores_gemma":[0.99859405,0.00010492872,0.00026158564,0.00048529427,0.00020795238,0.00034621177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016957839,0.00011360543,0.0006772766,0.00019581986,0.00009944087,0.0000050296735,0.00011907257,0.000029369405,0.0000019469662],"category_scores_gemma":[0.00020300003,0.00006605049,0.0001699671,0.0004293568,0.00036633544,0.00004321298,0.000063254985,0.00028551283,0.0000021212434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068986295,0.00066066073,0.95862985,0.00019648648,0.0017516204,0.0005737307,0.0020096616,0.0002897329,0.0013540951,0.0019888538,0.006520291,0.019126363],"study_design_scores_gemma":[0.0008737314,0.0021296171,0.97408473,0.00005870398,0.00017885973,0.00052474847,0.001362174,0.000012690962,0.000025795935,0.00014110479,0.020542793,0.000065016204],"about_ca_topic_score_codex":0.00800092,"about_ca_topic_score_gemma":0.0438228,"teacher_disagreement_score":0.0753457,"about_ca_system_score_codex":0.00018936538,"about_ca_system_score_gemma":0.0006074349,"threshold_uncertainty_score":0.9986049},"labels":[],"label_agreement":null},{"id":"W2791615591","doi":"10.1161/circulationaha.118.034032","title":"Inflammatory and Cholesterol Risk in the FOURIER Trial","year":2018,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":273,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Institute for Health and Care Research","keywords":"Evolocumab; Medicine; Internal medicine; PCSK9; Interquartile range; Alirocumab; Cardiology; Stroke (engine); Population; Unstable angina; Clinical endpoint; Myocardial infarction; Rosuvastatin; C-reactive protein; Statin; Placebo; Gastroenterology; Cholesterol; Apolipoprotein B; Lipoprotein; Clinical trial; Inflammation; Apolipoprotein A1; Pathology","score_opus":0.017874433718790814,"score_gpt":0.269323969693993,"score_spread":0.2514495359752022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791615591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975813,0.0001334519,0.0003940554,0.00024006556,0.00009913999,0.00066834054,4.291022e-7,0.000011175862,0.0008720642],"genre_scores_gemma":[0.9985608,0.000020859976,0.000048091195,0.00027813463,0.0010517412,0.000024913881,0.0000034040881,0.0000053160115,0.0000067433084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994126,0.00010150351,0.00011535638,0.00009962658,0.00019218106,0.00007874348],"domain_scores_gemma":[0.99964416,0.000014463698,0.000035563433,0.0002486666,0.000028988523,0.000028128426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087683066,0.00004201796,0.0000878731,0.000037482423,0.00005936536,0.00001321288,0.000020621133,0.00004916452,0.0000104187575],"category_scores_gemma":[0.00007942845,0.000028167844,0.000039657203,0.00007427644,0.00003833223,0.000048013393,0.000006032885,0.00009161821,0.0000130721155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022138995,0.0000772771,0.69856197,0.00008502299,0.00006588045,0.000011762222,0.0038180028,0.000008571876,0.0002696606,0.00051733863,0.00015656868,0.29421404],"study_design_scores_gemma":[0.012353438,0.000080519225,0.9830894,0.000019655874,0.00003694275,0.000021447278,0.00006378988,0.0004980591,0.000024347137,0.00023175578,0.0035485837,0.000032081756],"about_ca_topic_score_codex":0.000073387746,"about_ca_topic_score_gemma":0.000036336787,"teacher_disagreement_score":0.29418194,"about_ca_system_score_codex":0.000020630489,"about_ca_system_score_gemma":0.000030855983,"threshold_uncertainty_score":0.11486513},"labels":[],"label_agreement":null},{"id":"W2791673698","doi":"10.1097/jcn.0000000000000394","title":"Statins and Cardiovascular Health","year":2017,"lang":"en","type":"article","venue":"The Journal of Cardiovascular Nursing","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cardiovascular health; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MEDLINE; Statin; Internal medicine; Disease","score_opus":0.0287374116932646,"score_gpt":0.30908048831996254,"score_spread":0.28034307662669794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791673698","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35307974,0.58638746,0.04517241,0.008020248,0.001470639,0.0012673826,0.000006682924,0.00004350361,0.0045519536],"genre_scores_gemma":[0.9731741,0.022921596,0.0021012546,0.00027208784,0.0014265436,0.0000025549732,0.0000010994604,0.000054298358,0.00004644251],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963617,0.00059543696,0.00061290344,0.0002281201,0.0017379813,0.0004638655],"domain_scores_gemma":[0.99611354,0.0000439211,0.0004604142,0.0025770962,0.0003877696,0.00041724814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009873531,0.00024279981,0.0015318531,0.00013424279,0.0011251215,0.00013435792,0.00037471383,0.000093070616,0.0000067358856],"category_scores_gemma":[0.00032443844,0.00015566939,0.002883533,0.00009499399,0.00042402744,0.00028541396,0.00007064653,0.0006152594,0.000003981969],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022246891,0.00007697687,0.00040792566,0.0002450716,0.014147263,0.00021622625,0.001508391,0.0006348602,0.00005820343,0.00012220454,0.000932242,0.98142815],"study_design_scores_gemma":[0.023953956,0.0034895104,0.26620042,0.007465055,0.031732075,0.08054871,0.007656787,0.0005383999,0.0026158763,0.0020817968,0.572456,0.0012613683],"about_ca_topic_score_codex":0.00037213622,"about_ca_topic_score_gemma":0.000002469619,"teacher_disagreement_score":0.9801668,"about_ca_system_score_codex":0.00019012361,"about_ca_system_score_gemma":0.00049251446,"threshold_uncertainty_score":0.86536384},"labels":[],"label_agreement":null},{"id":"W2792215908","doi":"10.1016/s0735-1097(18)30589-8","title":"INDEPENDENT PREDICTORS OF LIPID-LOWERING THERAPY INTENSIFICATION AMONG PATIENTS HOSPITALIZED FOR AN ACUTE CORONARY SYNDROME: INSIGHTS FROM THE AMI-OPTIMA STUDY","year":2018,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Cardiology; Intensive care medicine; Myocardial infarction","score_opus":0.013964634684552814,"score_gpt":0.268317361689413,"score_spread":0.25435272700486017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792215908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962709,0.00018982185,0.0004997693,0.0002011582,0.001042478,0.001660986,0.00009488945,0.0000071477557,0.000032834047],"genre_scores_gemma":[0.9986878,0.00023044234,0.00023771475,0.00015849626,0.000611099,0.000029597999,0.000006447917,0.000028251156,0.000010133931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768966,0.00051912444,0.0007862083,0.00020931104,0.000607081,0.00018859732],"domain_scores_gemma":[0.99649197,0.00013874526,0.001360272,0.0007775291,0.0011256434,0.00010586151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000737401,0.000175501,0.0012432112,0.0001067365,0.000117789314,0.0000046513987,0.0004510683,0.00007075458,0.0000027603717],"category_scores_gemma":[0.00018850788,0.00009213858,0.0006371493,0.00029253715,0.0006648962,0.00009954633,0.00009082338,0.00024267836,2.7438017e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038903216,0.0003545407,0.9847973,0.000011851691,0.005422058,0.000036376114,0.0008422275,0.000046676516,0.0020274452,0.0000056994654,0.00059462304,0.001970869],"study_design_scores_gemma":[0.004086823,0.017438255,0.9739283,0.000067677196,0.00066930533,0.00021379639,0.0023897807,0.000030753803,0.0007121262,0.00003982489,0.0003394276,0.00008394304],"about_ca_topic_score_codex":0.00015204659,"about_ca_topic_score_gemma":0.000012431532,"teacher_disagreement_score":0.017083714,"about_ca_system_score_codex":0.00010471178,"about_ca_system_score_gemma":0.00022460597,"threshold_uncertainty_score":0.37573022},"labels":[],"label_agreement":null},{"id":"W2792326468","doi":"10.1016/j.ebiom.2018.01.037","title":"LDL Receptor Gene-Ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia with Dominant Inheritance and Diet-Induced Coronary Atherosclerosis","year":2018,"lang":"en","type":"letter","venue":"EBioMedicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Familial hypercholesterolemia; Rodent; Gene; Hamster; LDL receptor; Genetics; Rodent model; Inheritance (genetic algorithm); Biology; Medicine; Cholesterol; Internal medicine; Lipoprotein","score_opus":0.029569891132475653,"score_gpt":0.24692007059438115,"score_spread":0.2173501794619055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792326468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92285264,0.0017736487,0.00054588297,0.0720394,0.00052715966,0.0018779557,0.00019754388,0.00007791202,0.000107834305],"genre_scores_gemma":[0.68214595,0.0050596576,0.0081081055,0.28662232,0.012761912,0.00042925816,0.0016236657,0.0005901469,0.0026589502],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958185,0.00014288531,0.00086338626,0.0010353662,0.0014160688,0.00072378013],"domain_scores_gemma":[0.9974688,0.000043393724,0.0004216419,0.0013750612,0.00037506525,0.00031603468],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006436975,0.00071679114,0.0019297196,0.00029305628,0.00011268729,0.000018777075,0.00024887256,0.0010084601,0.00004590941],"category_scores_gemma":[0.00003835157,0.0004950927,0.00025725274,0.00034690142,0.00064251584,0.000095565054,0.00013391995,0.0013163316,0.000015689597],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00720985,0.0005272526,0.005108928,0.0075783716,0.0024100735,0.00084164547,0.003430185,0.000007361959,0.62037134,0.0000017048003,0.33342543,0.019087836],"study_design_scores_gemma":[0.1242349,0.10007151,0.10370902,0.06486007,0.015712824,0.0051112142,0.0021323806,0.0059227017,0.1096074,0.00011084874,0.4602518,0.008275328],"about_ca_topic_score_codex":0.0006306795,"about_ca_topic_score_gemma":0.000033315093,"teacher_disagreement_score":0.51076394,"about_ca_system_score_codex":0.0002810166,"about_ca_system_score_gemma":0.00042334554,"threshold_uncertainty_score":0.9997501},"labels":[],"label_agreement":null},{"id":"W2793323219","doi":"10.1097/mol.0000000000000487","title":"Familial hypercholesterolemia: experience from the French-Canadian population","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Familial hypercholesterolemia; Disease; Medicine; Population; Family aggregation; Cholesterol; Internal medicine; Environmental health","score_opus":0.145677955331017,"score_gpt":0.4064243736772268,"score_spread":0.2607464183462098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793323219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002284647,0.9278133,0.000031421478,0.00016833583,0.07015605,0.0013797411,0.0001070626,0.000027876946,0.000087747154],"genre_scores_gemma":[0.000090586596,0.94480956,0.00006080403,0.0001345647,0.052836925,0.0003647731,0.0016460374,0.000040961648,0.000015818216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969519,0.0006761505,0.00081428915,0.00069838087,0.00033134437,0.00052797265],"domain_scores_gemma":[0.9981822,0.00015699673,0.00021752364,0.001095702,0.00006589615,0.00028172715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005964431,0.0003870352,0.0015282407,0.00025511286,0.00013087653,0.00002505562,0.00037191383,0.0006195975,0.0001443871],"category_scores_gemma":[0.00025780956,0.00025660664,0.0005415046,0.00036799483,0.00017605205,0.0000619731,0.000101666206,0.0010266383,0.00023741652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000046257564,0.000031570715,0.0014360057,0.002607451,0.000047884412,2.5381834e-7,0.00026927193,1.0962628e-7,1.593514e-8,0.000039931354,0.018260248,0.9773026],"study_design_scores_gemma":[0.00040180533,0.000076049175,0.015122072,0.011165617,0.00014286608,0.000063206724,0.000031568543,0.0000040006853,1.1796211e-8,0.00004751918,0.9727356,0.00020972244],"about_ca_topic_score_codex":0.087044805,"about_ca_topic_score_gemma":0.0118156485,"teacher_disagreement_score":0.9770929,"about_ca_system_score_codex":0.00049735385,"about_ca_system_score_gemma":0.0008598104,"threshold_uncertainty_score":0.9999886},"labels":[],"label_agreement":null},{"id":"W2793718010","doi":"10.1007/s11606-018-4349-2","title":"Application and Impact of Run-In Studies for the Evaluation of Statin Efficacy and Safety","year":2018,"lang":"en","type":"review","venue":"Journal of General Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; Royal College of Physicians and Surgeons of Canada; Engelberg Foundation; Laura and John Arnold Foundation","keywords":"Medicine; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Occupational safety and health; MEDLINE; Internal medicine; Pathology","score_opus":0.13694004359369835,"score_gpt":0.4921547376404499,"score_spread":0.35521469404675154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793718010","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012760962,0.98417115,0.001144555,0.00021704422,0.00018414456,0.0014813015,0.0000120768955,9.375104e-7,0.000027802591],"genre_scores_gemma":[0.009617413,0.9883956,0.00037520487,0.00002268505,0.0015001268,0.000025843472,0.0000064971487,0.000016961618,0.000039678725],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974369,0.00023791798,0.001383281,0.00013575678,0.0006938157,0.00011234948],"domain_scores_gemma":[0.9966769,0.00043645877,0.0014999062,0.00021775113,0.0010826202,0.000086338274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056859762,0.00018488368,0.0020351473,0.00023978812,0.000023548764,0.0000026738005,0.00009646708,0.000086113265,0.000009946297],"category_scores_gemma":[0.0010987447,0.00008150044,0.0003740851,0.00014041751,0.0002137427,0.000032605432,0.0000320071,0.00025078745,9.938331e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042100056,0.000040111117,0.00008877138,0.006627903,0.0019610927,0.0000020956777,0.00032133487,0.0000066464354,0.000047369624,0.000015921014,0.00063405465,0.9898337],"study_design_scores_gemma":[0.04924672,0.0365308,0.06712856,0.2891934,0.06224953,0.0059617907,0.0014329815,0.004509502,0.00013672812,0.0009896159,0.48193875,0.00068162574],"about_ca_topic_score_codex":0.0003291432,"about_ca_topic_score_gemma":0.000019149336,"teacher_disagreement_score":0.9891521,"about_ca_system_score_codex":0.00021329937,"about_ca_system_score_gemma":0.00037700674,"threshold_uncertainty_score":0.33234915},"labels":[],"label_agreement":null},{"id":"W2793767710","doi":"10.1016/j.cjca.2018.02.027","title":"Can We Eliminate Low-Density Lipoprotein Cholesterol-Related Cardiovascular Events Through More Aggressive Primary Prevention Therapy?","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of British Columbia","funders":"Janssen Pharmaceuticals; Heart and Stroke Foundation of Canada; Amgen; Boehringer Ingelheim; Canadian Institutes of Health Research; Genome Canada; Novartis; Bayer; AstraZeneca; Novo Nordisk; Sanofi; Merck","keywords":"Medicine; Mendelian randomization; Observational study; Internal medicine; Cholesterol; Randomized controlled trial; Familial hypercholesterolemia; Clinical trial; Primary prevention; Lipoprotein; Randomization; Ldl cholesterol; Cardiology; Endocrinology; Disease","score_opus":0.01724848452761805,"score_gpt":0.25464684840893426,"score_spread":0.23739836388131622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793767710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96943134,0.020651469,0.0018240408,0.0035778333,0.0015794943,0.0010180535,0.000022940414,0.000023737131,0.0018711115],"genre_scores_gemma":[0.9921671,0.0031166992,0.00030181566,0.00082195306,0.0032711392,0.000019700763,0.000028565948,0.00006369806,0.00020933939],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99675745,0.00066277746,0.0007787371,0.00041934426,0.00062924414,0.0007524754],"domain_scores_gemma":[0.9966467,0.00002171972,0.00055820507,0.00092957506,0.00096501224,0.00087875966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001514396,0.00034360544,0.0015707081,0.00033513497,0.0002768524,0.000023145885,0.00028990692,0.00045880105,0.000038147442],"category_scores_gemma":[0.000192565,0.00028789198,0.0018139951,0.00033905648,0.0004363386,0.00017318428,0.000034113174,0.0007571619,0.000027039332],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008461611,0.000048283742,0.011157878,0.00044099469,0.017537165,0.0067103906,0.003586335,0.00041904807,0.0011376855,0.00009275059,0.004372011,0.9536513],"study_design_scores_gemma":[0.017425997,0.005688827,0.6557807,0.002999557,0.002973138,0.040166847,0.0009293666,0.00001682388,0.006762372,0.0048356187,0.2612682,0.0011525737],"about_ca_topic_score_codex":0.0063725314,"about_ca_topic_score_gemma":0.0014149259,"teacher_disagreement_score":0.95249873,"about_ca_system_score_codex":0.00061654695,"about_ca_system_score_gemma":0.0028820413,"threshold_uncertainty_score":0.9999573},"labels":[],"label_agreement":null},{"id":"W2795156725","doi":"10.1016/j.jpsychores.2018.03.170","title":"Anxiety, depression, and health-related quality of life in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Journal of Psychosomatic Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Royal Victoria Hospital; Sunnybrook Health Science Centre; McGill University Health Centre; Royal Victoria Regional Health Centre; Ontario Tech University; McGill University; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research; Institute for Clinical Evaluative Sciences","keywords":"Meta-analysis; Anxiety; Medicine; Cochrane Library; Depression (economics); Psychosocial; Strictly standardized mean difference; Quality of life (healthcare); MEDLINE; Psychiatry; Clinical psychology; Internal medicine","score_opus":0.309300441074354,"score_gpt":0.5030901298154878,"score_spread":0.19378968874113384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795156725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011177729,0.9929925,0.0000278907,0.00095270784,0.0000445697,0.004798237,0.000020261838,0.0000050616813,0.000040995415],"genre_scores_gemma":[0.0011490682,0.99781096,0.00040808172,0.0002600267,0.00008288581,0.0001733121,0.000006377014,0.00004559744,0.00006366144],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9812525,0.008117014,0.0070405737,0.00052699173,0.0025600253,0.00050288474],"domain_scores_gemma":[0.9928627,0.0006006817,0.0034492041,0.0014296677,0.0009219552,0.00073580333],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.041452523,0.000441699,0.020088207,0.0015477862,0.00009376905,0.000049446495,0.00040625746,0.00041787073,0.000059552014],"category_scores_gemma":[0.00200364,0.0002453602,0.003593083,0.0022405074,0.00023911725,0.00011463488,0.00015453447,0.0017920046,0.00000591605],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025310643,0.00016590559,0.0001656903,0.918196,0.074458495,0.00002307674,0.0001691613,7.683112e-8,1.6354852e-7,0.000002675367,0.00032321474,0.0064702197],"study_design_scores_gemma":[0.0018601803,0.0008759008,0.0016199063,0.4515458,0.53861195,0.0023724306,0.00016485662,0.000006237911,1.2164719e-7,0.000106285304,0.002516313,0.00032000366],"about_ca_topic_score_codex":0.00058010203,"about_ca_topic_score_gemma":0.00007845378,"teacher_disagreement_score":0.4666502,"about_ca_system_score_codex":0.00022052131,"about_ca_system_score_gemma":0.0010390766,"threshold_uncertainty_score":0.9999999},"labels":[],"label_agreement":null},{"id":"W2795179779","doi":"10.1093/eurheartj/ehx501.p629","title":"P629Undertreatment of female patients in lipid-lowering for secondary prevention in Europe, Canada, South Africa, Middle East and China: results of the Dyslipidemia International Study (DYSIS)","year":2017,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Middle East; China; Secondary prevention; Traditional medicine; Environmental health; Internal medicine; Obesity","score_opus":0.05725083079294911,"score_gpt":0.28276898688898405,"score_spread":0.22551815609603493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795179779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598026,0.000118668046,0.0000124338385,0.0002768642,0.00034747735,0.00063269783,0.000033257158,0.0000018101656,0.002596529],"genre_scores_gemma":[0.9992692,0.000017701219,0.00014186655,0.000021608495,0.0001960829,0.000003953193,0.000003963717,0.000017547069,0.00032810666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985272,0.0002569613,0.000519581,0.00016981234,0.00036748854,0.00015894364],"domain_scores_gemma":[0.99903655,0.000017764542,0.00036007195,0.000350941,0.0001521859,0.00008248334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014386103,0.00009860603,0.00029062797,0.00007891135,0.0001407797,0.000025267998,0.00015198377,0.000016132719,0.0000061741525],"category_scores_gemma":[0.00050370436,0.00006944556,0.00009625001,0.00006910568,0.000031669657,0.00009224319,0.00011944894,0.00023698778,3.5043792e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056389446,0.00057672843,0.9825792,0.000097944845,0.00016448648,0.00003833457,0.0052302694,0.000046930756,0.0000782725,0.0000029281564,0.00028871017,0.010332351],"study_design_scores_gemma":[0.0071908967,0.00048384708,0.98923117,0.0004586549,0.000037278474,0.000020577509,0.0007475476,0.000028633127,0.00007660136,0.0000028042355,0.0016685926,0.000053418746],"about_ca_topic_score_codex":0.005478284,"about_ca_topic_score_gemma":0.02070607,"teacher_disagreement_score":0.015227786,"about_ca_system_score_codex":0.00010891733,"about_ca_system_score_gemma":0.00027819764,"threshold_uncertainty_score":0.9971635},"labels":[],"label_agreement":null},{"id":"W2795629913","doi":"10.1016/j.jacl.2018.03.087","title":"Severe xanthomatosis in heterozygous familial hypercholesterolemia","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Pediatrics; Internal medicine; Cholesterol","score_opus":0.07083815891387707,"score_gpt":0.40579267028163213,"score_spread":0.33495451136775506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795629913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907905,0.00028153407,0.00024075616,0.0023920485,0.0046002157,0.00016375846,0.0000017603885,0.000010919828,0.0015184918],"genre_scores_gemma":[0.9760076,0.00045474543,0.0024739862,0.00424212,0.016701285,0.0000020635357,9.2102357e-7,0.00001940706,0.000097919314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966104,0.0006221347,0.0018328752,0.00021635048,0.0003964001,0.00032185807],"domain_scores_gemma":[0.9981662,0.00034588517,0.0004572236,0.0003827032,0.0003180081,0.00032995056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004097749,0.00013415742,0.0012830591,0.00017027653,0.00003454524,0.000008275811,0.00017179988,0.00038897345,0.000113796894],"category_scores_gemma":[0.0017166638,0.000096473945,0.0006705266,0.00016291323,0.0002741372,0.00008476244,0.000060088627,0.0009420613,0.000074536576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048234025,0.0009833144,0.6895371,0.00013560864,0.00047627752,0.00043722472,0.00028252078,0.000004943537,0.0008423428,0.00008544132,0.009053278,0.29333854],"study_design_scores_gemma":[0.010514093,0.0069812927,0.8635635,0.0003006904,0.0002000769,0.007652681,0.00012072998,0.000044540673,0.00020073737,0.0003471413,0.1099059,0.00016865262],"about_ca_topic_score_codex":0.000037685662,"about_ca_topic_score_gemma":0.000059579997,"teacher_disagreement_score":0.2931699,"about_ca_system_score_codex":0.000051058156,"about_ca_system_score_gemma":0.00039373504,"threshold_uncertainty_score":0.409284},"labels":[],"label_agreement":null},{"id":"W2795654674","doi":"10.9778/cmajo.20180011","title":"Evaluation of the cost-effectiveness of evolocumab in the FOURIER study: a Canadian analysis","year":2018,"lang":"en","type":"article","venue":"CMAJ Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre; Montreal General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Evolocumab; PCSK9; Medicine; Life expectancy; Kexin; Confidence interval; Proprotein convertase; Statin; Internal medicine; Cholesterol; Population; Lipoprotein; Environmental health","score_opus":0.07758973747722663,"score_gpt":0.3915359523453644,"score_spread":0.3139462148681378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795654674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98711956,0.00012437296,0.000034387012,0.0002343867,0.000048133315,0.00569944,0.000006160817,9.936632e-7,0.006732543],"genre_scores_gemma":[0.9995173,0.0000018492115,0.000016518434,0.00009856449,0.00004251858,0.00029344409,0.0000038409817,0.0000048355723,0.000021117923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970787,0.001595243,0.00017058685,0.0001349877,0.00090529444,0.000115181945],"domain_scores_gemma":[0.9983311,0.000048528895,0.00006650602,0.0010092653,0.00050055893,0.000044017375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016548239,0.000054971017,0.00030790377,0.00011228516,0.00006459492,0.000011134083,0.00030578888,0.000033913748,0.00011041175],"category_scores_gemma":[0.00044155936,0.000028528379,0.00013124193,0.0009995312,0.00006249261,0.000038020324,0.000059451082,0.000076776596,0.0000028154213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021383185,0.00040044944,0.8094837,0.00008681108,0.002866287,0.0000054368693,0.006588292,0.00013006535,0.00009123492,0.0001856455,0.00014939114,0.17979883],"study_design_scores_gemma":[0.0018080176,0.00022144722,0.99262536,0.00005510975,0.0022554349,0.0000023010446,0.0014883626,0.0006014531,0.00039446139,0.0000829448,0.00043324128,0.000031892407],"about_ca_topic_score_codex":0.6302603,"about_ca_topic_score_gemma":0.6972004,"teacher_disagreement_score":0.1831416,"about_ca_system_score_codex":0.00020554168,"about_ca_system_score_gemma":0.001138314,"threshold_uncertainty_score":0.5735322},"labels":[],"label_agreement":null},{"id":"W2795927670","doi":"10.1177/1715163518768534","title":"Prevention and management of statin adverse effects: A practical approach for pharmacists","year":2018,"lang":"en","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Royal Inland Hospital; University of Alberta; Native Mental Health Association of Canada; University of British Columbia; Interior Health","funders":"University of Alberta","keywords":"Statin; Medicine; Adverse effect; Intensive care medicine; Myopathy; Physical therapy; Clinical trial; Clinical Practice; Internal medicine","score_opus":0.037085082200840676,"score_gpt":0.3290586089827545,"score_spread":0.29197352678191385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795927670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643965,0.0025650214,0.02308857,0.00017272208,0.0016491943,0.0046005035,0.00033659805,0.000039227216,0.0031516918],"genre_scores_gemma":[0.97316843,0.004751235,0.019392503,0.000928114,0.0010021015,0.00011699894,0.00005005404,0.000057774145,0.0005327645],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99750555,0.0001711573,0.000583558,0.00042104564,0.0005424348,0.00077623775],"domain_scores_gemma":[0.9968761,0.000063527914,0.0002724759,0.00027315092,0.00063341117,0.0018813163],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001193119,0.00029704723,0.00052728225,0.000260476,0.0004707635,0.00004169202,0.00016110372,0.0000625307,0.00012900383],"category_scores_gemma":[0.00010683042,0.00029033396,0.00024572312,0.00038528207,0.0002497223,0.00022859806,0.000036636924,0.00036278067,0.0000019529787],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025862646,0.00054493657,0.0012399319,0.01843115,0.0042408607,0.04802674,0.0017342761,0.00007300849,0.003428327,0.00048470212,0.031919055,0.8872908],"study_design_scores_gemma":[0.027591506,0.0011926536,0.00036706068,0.00042080187,0.0039195926,0.8463326,0.00011582503,0.0144360205,0.019664094,0.00018080889,0.0846702,0.0011088025],"about_ca_topic_score_codex":0.002852759,"about_ca_topic_score_gemma":0.0022301218,"teacher_disagreement_score":0.88618195,"about_ca_system_score_codex":0.0010687112,"about_ca_system_score_gemma":0.0025234236,"threshold_uncertainty_score":0.9999549},"labels":[],"label_agreement":null},{"id":"W2796014911","doi":"10.1016/j.jacl.2018.03.088","title":"Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal; Pfizer","keywords":"Medicine; PCSK9; Placebo; Internal medicine; Familial hypercholesterolemia; Adverse effect; Randomized controlled trial; Evolocumab; Alirocumab; Myocardial infarction; Stroke (engine); Cardiology; Placebo-controlled study; Cholesterol; Lipoprotein; Double blind; LDL receptor; Pathology","score_opus":0.05984281726075641,"score_gpt":0.3525676212761616,"score_spread":0.2927248040154052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796014911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99223393,0.00059129327,0.0016868234,0.0012847387,0.002438829,0.0015473427,0.00003762504,0.000010925713,0.00016846966],"genre_scores_gemma":[0.98248476,0.00040320243,0.0014667553,0.0003988376,0.015144409,0.000017087243,0.000039253046,0.00002844065,0.000017281858],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98818684,0.0057809935,0.0041952888,0.000365569,0.0012088962,0.00026239228],"domain_scores_gemma":[0.99211276,0.0022764395,0.0030808402,0.00080549944,0.0014890531,0.00023539035],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028511036,0.00023334609,0.0042703124,0.00010243213,0.00009798133,0.000013834359,0.0001500398,0.000399281,0.000017629285],"category_scores_gemma":[0.010139158,0.0001068526,0.0025040868,0.00019497599,0.0011180037,0.00014885773,0.00004383197,0.0009331065,0.00000537986],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8512392,0.0010722073,0.030262496,0.00009079102,0.012211116,0.00003823024,0.0006664814,0.00015392197,0.00011005491,0.000017807759,0.0025070086,0.10163069],"study_design_scores_gemma":[0.58730745,0.011554773,0.3806906,0.001614219,0.007482493,0.00026016764,0.0003489428,0.000026570568,0.00053986756,0.00020526265,0.009751681,0.0002179798],"about_ca_topic_score_codex":0.0003288663,"about_ca_topic_score_gemma":0.000035933524,"teacher_disagreement_score":0.3504281,"about_ca_system_score_codex":0.000067834204,"about_ca_system_score_gemma":0.00052027975,"threshold_uncertainty_score":0.99819887},"labels":[],"label_agreement":null},{"id":"W2796183245","doi":"10.1016/j.jacl.2018.03.092","title":"Posttranslational modification of proprotein convertase subtilisin/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomics","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital du Sacré-Cœur de Montréal; Université de Montréal; Montreal Clinical Research Institute","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; Fondation Leducq","keywords":"Kexin; Proprotein convertase; Subtilisin; Medicine; PCSK9; Proteomics; Bioinformatics; Computational biology; Internal medicine; Biochemistry; LDL receptor; Cholesterol; Lipoprotein; Enzyme; Gene; Biology","score_opus":0.05505515265896005,"score_gpt":0.39439821204186704,"score_spread":0.339343059382907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796183245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992585,0.00039978424,0.00073291495,0.00392752,0.00085214595,0.0013931061,0.00005250696,0.000010018935,0.000047017795],"genre_scores_gemma":[0.99442464,0.00010279812,0.0032099334,0.00051337987,0.001309055,0.000017333226,0.000044095657,0.000028147593,0.00035059912],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9950726,0.0014472796,0.0022146548,0.0003364523,0.00063593936,0.00029306542],"domain_scores_gemma":[0.9968394,0.0002891363,0.0008566234,0.0005044871,0.0011468683,0.00036347384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004336965,0.00020266777,0.0015041244,0.00034505062,0.000043668642,0.000008563124,0.00017840587,0.0003722126,0.00017279656],"category_scores_gemma":[0.0037202316,0.00015342307,0.00048441166,0.0005026813,0.00023229096,0.00007546063,0.000031331532,0.0004460001,0.000028923056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24310775,0.004025106,0.23704073,0.00030915887,0.003032316,0.00010040118,0.0012256927,0.000015884476,0.44413978,0.00011245107,0.0049386364,0.061952084],"study_design_scores_gemma":[0.011494421,0.009462521,0.951516,0.00021866831,0.00045202085,0.0002103823,0.00002721089,0.00012696664,0.019858945,0.00030767216,0.0061447895,0.00018044493],"about_ca_topic_score_codex":0.00017396091,"about_ca_topic_score_gemma":0.000017958628,"teacher_disagreement_score":0.7144752,"about_ca_system_score_codex":0.00008956211,"about_ca_system_score_gemma":0.0010500316,"threshold_uncertainty_score":0.6256411},"labels":[],"label_agreement":null},{"id":"W2796633818","doi":"10.1038/s41598-018-20281-9","title":"New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia","year":2018,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"National Heart, Lung, and Blood Institute; Conseil National de la Recherche Scientifique; Canadian Institutes of Health Research; National Institutes of Health; Centre National de la Recherche Scientifique; Saint Joseph University; Fondation Leducq; Broad Institute; Agence Nationale de la Recherche; Institut National de la Santé et de la Recherche Médicale; Harvard University; Massachusetts General Hospital","keywords":"PCSK9; Exome sequencing; Genetics; Compound heterozygosity; Mutation; Apolipoprotein B; Proband; Biology; Exome; Familial hypercholesterolemia; Gene; Exon; LDL receptor; In silico; Cholesterol; Lipoprotein; Endocrinology","score_opus":0.02235625200457944,"score_gpt":0.28219930529252807,"score_spread":0.25984305328794866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796633818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929698,0.0004942066,0.0016167889,0.0007979805,0.0021484927,0.0006218656,7.0668204e-7,0.0002646303,0.0010855218],"genre_scores_gemma":[0.98881346,0.0000063913117,0.00900695,0.00003977875,0.00022905198,0.00002953301,0.00002400545,0.000018967454,0.0018318535],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976287,0.00004320956,0.00059096405,0.00071060297,0.0006039482,0.00042259574],"domain_scores_gemma":[0.99827516,0.000013543355,0.00016612206,0.0011940172,0.00021830219,0.00013282729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016416467,0.00014242964,0.0003356337,0.00040633042,0.0002708905,0.00010419098,0.00009123045,0.00013741746,0.000037313624],"category_scores_gemma":[0.0005303456,0.000117736636,0.00013320438,0.0011451246,0.00026942554,0.00014866418,0.00007736429,0.0002355117,0.000031831813],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005530024,0.000102033744,0.03325102,0.00022501266,0.000093919305,0.0055328463,0.0038830948,0.000054774653,0.80748093,0.0001805961,0.004809407,0.14433105],"study_design_scores_gemma":[0.002314584,0.0004129737,0.045613565,0.0019835955,0.00021984467,0.01211149,0.0075429333,0.0007563818,0.87209964,0.010063363,0.04616011,0.00072153955],"about_ca_topic_score_codex":0.00072981254,"about_ca_topic_score_gemma":0.00027962885,"teacher_disagreement_score":0.14360951,"about_ca_system_score_codex":0.0003178895,"about_ca_system_score_gemma":0.001059898,"threshold_uncertainty_score":0.48011607},"labels":[],"label_agreement":null},{"id":"W2796659858","doi":"10.1038/s41598-018-24248-8","title":"Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Scientific Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":200,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health","funders":"","keywords":"Dementia; Relative risk; Meta-analysis; Medicine; Internal medicine; Vascular dementia; Cognitive impairment; Subgroup analysis; Alzheimer's disease; Disease; Confidence interval","score_opus":0.08113804236682326,"score_gpt":0.3419763289866397,"score_spread":0.26083828661981645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2796659858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022869393,0.9918057,0.000042857428,0.000019750749,0.000088055654,0.007648619,0.00014100567,0.0000060364137,0.00001930468],"genre_scores_gemma":[0.00047372034,0.9984436,0.000215415,0.00003545986,0.000010822148,0.00032856117,0.00008215902,0.000017980468,0.00039226824],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9949831,0.0011759935,0.002065791,0.00076694286,0.0008202025,0.00018802028],"domain_scores_gemma":[0.9943205,0.00035408433,0.0032037674,0.0014471216,0.00052469195,0.00014980555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012994639,0.00031387937,0.0082072485,0.00029506694,0.00015866043,0.000083462044,0.000057002537,0.00009074956,0.000050634553],"category_scores_gemma":[0.0012683821,0.0001422413,0.002408421,0.00091986766,0.00095828995,0.00006863222,0.000134063,0.00015481957,6.941154e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004491891,0.000030849882,0.000025487276,0.77679145,0.22157414,0.000026561076,0.00014793221,1.4783077e-8,2.4609745e-8,0.0000053485237,0.0001836793,0.0012100266],"study_design_scores_gemma":[0.00019020661,0.000052515006,0.000023543724,0.048419625,0.94324774,0.00047602077,0.000043703025,0.000002701206,0.0000014744261,0.00003502358,0.0073978035,0.00010967078],"about_ca_topic_score_codex":0.00028365396,"about_ca_topic_score_gemma":0.00003683648,"teacher_disagreement_score":0.7283718,"about_ca_system_score_codex":0.000014560483,"about_ca_system_score_gemma":0.00023085154,"threshold_uncertainty_score":0.5800432},"labels":[],"label_agreement":null},{"id":"W2797764507","doi":"10.1007/s40291-018-0323-2","title":"A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention","year":2018,"lang":"en","type":"article","venue":"Molecular Diagnosis & Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Université Laval; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Statin; Medicine; Rhabdomyolysis; Myopathy; Pharmacogenomics; Dyslipidemia; Internal medicine; Physical therapy; Intensive care medicine; Pharmacology; Disease","score_opus":0.047191261548934965,"score_gpt":0.34435620710186415,"score_spread":0.29716494555292916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797764507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95717376,0.00045032887,0.03762584,0.00020201481,0.00007506429,0.0043391176,0.00008519818,0.000014785047,0.000033877383],"genre_scores_gemma":[0.9939352,0.00016122132,0.0035146954,0.0007894188,0.00009055354,0.0013815495,0.000054253214,0.00007123711,0.0000018677005],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976466,0.00036953183,0.00071786117,0.0004712974,0.00040994963,0.0003848117],"domain_scores_gemma":[0.99871767,0.00025915893,0.00017020096,0.00057104416,0.00016372693,0.00011817872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016404121,0.00024371283,0.0006137313,0.0001985027,0.000072975294,0.000025707803,0.00015594704,0.0000994989,0.000013584095],"category_scores_gemma":[0.00023601778,0.00020630275,0.000542107,0.00022394705,0.00004278437,0.0000938722,0.00005096753,0.0001976076,0.0000033328176],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015769268,0.0016653836,0.03777299,0.0003169821,0.0012309502,0.000018883165,0.005799767,0.4283775,0.014843836,0.0002028881,0.000022106204,0.5081718],"study_design_scores_gemma":[0.02940341,0.0062962463,0.24558075,0.000767353,0.0005283531,0.0000043582463,0.00041354477,0.5903099,0.12287585,0.0021723083,0.000798264,0.0008496403],"about_ca_topic_score_codex":0.00025853197,"about_ca_topic_score_gemma":0.000052126066,"teacher_disagreement_score":0.50732213,"about_ca_system_score_codex":0.00041321042,"about_ca_system_score_gemma":0.00041753575,"threshold_uncertainty_score":0.8412782},"labels":[],"label_agreement":null},{"id":"W2800345973","doi":"10.1016/j.atherosclerosis.2018.04.035","title":"Strokes, cholesterol and statins: When mortality is an endpoint","year":2018,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Stroke (engine); Cohort; Prospective cohort study; Internal medicine; Population; Statin; Cohort study; Cholesterol; Incidence (geometry)","score_opus":0.0625651502100891,"score_gpt":0.2919469474511207,"score_spread":0.2293817972410316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800345973","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83302134,0.0008399055,0.00025391649,0.16157468,0.00045571534,0.0018539435,0.0009600826,0.0002533686,0.0007870457],"genre_scores_gemma":[0.040533055,0.0012594338,0.0022920107,0.94356805,0.008383496,0.000235984,0.001048238,0.00028763508,0.0023920727],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996551,0.0002274004,0.00052757334,0.0010183064,0.0010197926,0.0006559347],"domain_scores_gemma":[0.9973349,0.00002512524,0.00023512145,0.0019272356,0.00016963594,0.00030795974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065437815,0.00054264534,0.0010422672,0.00010699195,0.00016570068,0.00013547295,0.00021702655,0.00089558214,0.0005667009],"category_scores_gemma":[0.000029379313,0.00045714003,0.00039903613,0.000088600966,0.00024314296,0.00016885543,0.000115760355,0.0012546767,0.00007837808],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046403675,0.0001925716,0.019692939,0.0016187981,0.0015140864,0.00006771435,0.0023932324,5.856189e-8,0.0007501037,0.000008664302,0.95270425,0.021011172],"study_design_scores_gemma":[0.0017840184,0.00091190066,0.22506823,0.0005077638,0.00092379964,0.000043823307,0.00010511034,0.000018773442,0.00085944374,0.00017595997,0.76901674,0.00058443804],"about_ca_topic_score_codex":0.0024030283,"about_ca_topic_score_gemma":0.00007444924,"teacher_disagreement_score":0.7924883,"about_ca_system_score_codex":0.00014200622,"about_ca_system_score_gemma":0.00016379195,"threshold_uncertainty_score":0.99978805},"labels":[],"label_agreement":null},{"id":"W2800492785","doi":"10.1002/cpt.1110","title":"Therapeutic Agents Targeting Cardiometabolic Risk for Preventing and Treating Atherosclerotic Cardiovascular Diseases","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacology & Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Ezetimibe; PCSK9; Statin; Atherosclerotic cardiovascular disease; Pharmacology; Canakinumab; Type 2 diabetes; Diabetes mellitus; Internal medicine; Lipoprotein; Endocrinology; Disease; Cholesterol; LDL receptor","score_opus":0.14605455818238083,"score_gpt":0.45191468108929117,"score_spread":0.30586012290691034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800492785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018631588,0.9879979,0.0010019112,0.00008094397,0.0022858991,0.0063668927,0.00018448789,0.00018121563,0.00003761109],"genre_scores_gemma":[0.00041783412,0.9858176,0.0010619573,0.0029725682,0.008198509,0.0009169887,0.00016017881,0.0003153808,0.00013895056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99193406,0.0028273168,0.0020942958,0.0015152093,0.0005737715,0.0010553482],"domain_scores_gemma":[0.9955112,0.0014772337,0.0010219696,0.0011179186,0.00030980827,0.00056187715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004632243,0.00095721503,0.0064390614,0.00023871059,0.00058051787,0.00006576192,0.00038171132,0.00096643454,0.000047098805],"category_scores_gemma":[0.00020122954,0.0007344486,0.007420618,0.00045756059,0.00061093713,0.000075059164,0.00024053095,0.0013343774,0.00003637755],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082489576,0.00032451557,0.0007302111,0.0110556865,0.04041446,0.000024076442,0.000055057022,0.0000022638176,0.0000013616464,0.0000014243984,0.0006492077,0.94665927],"study_design_scores_gemma":[0.0032630577,0.00058029994,0.0005475413,0.0018276793,0.13904725,0.00008102523,0.000028252587,0.00020133349,0.0000025532825,0.000032178894,0.8538434,0.00054545497],"about_ca_topic_score_codex":0.000015373065,"about_ca_topic_score_gemma":5.2733606e-7,"teacher_disagreement_score":0.94611377,"about_ca_system_score_codex":0.00016586758,"about_ca_system_score_gemma":0.0006649821,"threshold_uncertainty_score":0.99951065},"labels":[],"label_agreement":null},{"id":"W2800574556","doi":"10.1002/cpdd.458","title":"A Study of the Potential Interaction Between Bazedoxifene and Atorvastatin in Healthy Postmenopausal Women","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"Pfizer","keywords":"Atorvastatin; Cmax; Medicine; Pharmacokinetics; Pharmacology; Dosing; Urology; Internal medicine","score_opus":0.04281427300583475,"score_gpt":0.40654031695031073,"score_spread":0.363726043944476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800574556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960034,0.00007074066,0.0000063422262,0.0013137448,0.0011133092,0.0014174477,0.0000013181349,0.000011025278,0.00006267653],"genre_scores_gemma":[0.99741095,0.000058556823,0.0002735297,0.001591291,0.0004814247,0.00013213888,0.000002507037,0.00001278997,0.000036789483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972154,0.00075080513,0.0010846389,0.00035561158,0.00026889524,0.0003246858],"domain_scores_gemma":[0.99919116,0.00017738281,0.0001877563,0.00019352845,0.00008146232,0.00016869546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030527336,0.00013084845,0.00058623706,0.0001281924,0.00006817079,0.0000037375191,0.00011272269,0.0000919402,0.000064641055],"category_scores_gemma":[0.000101238176,0.00009509754,0.000044714645,0.00026483464,0.00017546152,0.00003935882,0.00020431174,0.0005233591,0.0000091383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030817224,0.003425097,0.9099318,0.00013505915,0.0005110009,0.00010510824,0.0140921185,0.000005129938,0.00041838118,0.0000023750688,0.0006439187,0.06764833],"study_design_scores_gemma":[0.009666651,0.0017472034,0.9837924,0.000049137936,0.000054116023,0.000015418782,0.0021840616,0.00001584792,0.000550419,0.000019497977,0.0018177918,0.000087422566],"about_ca_topic_score_codex":0.00017025699,"about_ca_topic_score_gemma":0.0002449214,"teacher_disagreement_score":0.073860675,"about_ca_system_score_codex":0.00027290513,"about_ca_system_score_gemma":0.00053218706,"threshold_uncertainty_score":0.3877965},"labels":[],"label_agreement":null},{"id":"W2801110209","doi":"10.1016/j.jacc.2018.02.032","title":"Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United States","year":2018,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"Medical Research Council","keywords":"Medicine; Rosuvastatin; Statin; Myocardial infarction; Medical prescription; Atorvastatin; Population; Guideline; Internal medicine; Confidence interval; Physical therapy","score_opus":0.020178235765006346,"score_gpt":0.270003491402109,"score_spread":0.24982525563710264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801110209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958886,0.000088818495,0.00023700237,0.0029046575,0.00052117475,0.0002851041,0.000018121536,0.0000033595763,0.000053160886],"genre_scores_gemma":[0.9975937,0.000270528,0.00025909173,0.0012775091,0.00056651724,0.000004302546,0.000002266258,0.000009495049,0.000016583594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974309,0.0011993186,0.0005469691,0.000121904704,0.00046412862,0.00023676034],"domain_scores_gemma":[0.99853754,0.00031218462,0.0004616337,0.00036253748,0.0002717484,0.000054349377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019669656,0.00012133722,0.001153222,0.0002999723,0.000062405146,0.0000067148108,0.00022025431,0.000050927425,0.0000016783176],"category_scores_gemma":[0.0004975348,0.00006375889,0.00058098166,0.0009032465,0.0004317457,0.00006372016,0.000056392502,0.00042977976,5.571505e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015606389,0.000056671874,0.9914241,0.000020843538,0.0011210843,0.00037614806,0.00078880525,0.00039796767,0.00060692703,0.00006298838,0.0019595742,0.0016242733],"study_design_scores_gemma":[0.0015144222,0.0014406302,0.9882504,0.0000882585,0.00020978376,0.0009140838,0.004396217,0.00009310428,0.00013485561,0.00023091906,0.002656804,0.00007052817],"about_ca_topic_score_codex":0.0023957375,"about_ca_topic_score_gemma":0.00013243298,"teacher_disagreement_score":0.0036074116,"about_ca_system_score_codex":0.000121353725,"about_ca_system_score_gemma":0.00021790095,"threshold_uncertainty_score":0.36216542},"labels":[],"label_agreement":null},{"id":"W2801470862","doi":"10.1016/j.cjca.2018.05.006","title":"Getting Real With PCSK9 Inhibitors in Familial Hypercholesterolemia","year":2018,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Robarts Clinical Trials; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Fondation Leducq; Heart and Stroke Foundation of Canada; Genome Canada","keywords":"Medicine; Scopus; Familial hypercholesterolemia; Population; Disease; Internal medicine; MEDLINE; Pediatrics; Cholesterol","score_opus":0.014263504810085714,"score_gpt":0.23351305148387938,"score_spread":0.21924954667379368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801470862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56819516,0.0039108815,0.00027160053,0.38907832,0.0049287574,0.0012095271,0.000092851595,0.000024813471,0.03228805],"genre_scores_gemma":[0.560521,0.00040235854,0.0006327865,0.2969759,0.14059785,0.000021666565,0.00012259692,0.00021570614,0.0005101058],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997176,0.00041718152,0.0007562336,0.0003396608,0.00045704833,0.00085386774],"domain_scores_gemma":[0.9979844,0.000052366442,0.00033923122,0.0005445416,0.00044581507,0.0006336326],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012013122,0.00033840002,0.0016890904,0.00091731484,0.000077960685,0.000026250022,0.00024638828,0.0012186537,0.000014197254],"category_scores_gemma":[0.00013543354,0.00026202563,0.00056292955,0.00022253068,0.00034607234,0.00006798902,0.000016361719,0.0034189392,0.000015310225],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016411189,0.0000017373145,0.050802484,0.00031488086,0.0009345577,0.036693987,0.0002835455,0.00007202334,0.00004812104,0.0000028187642,0.8905107,0.020171052],"study_design_scores_gemma":[0.0018877893,0.0010797844,0.03206527,0.0007722171,0.00033666068,0.012675784,0.00009162869,7.9418504e-7,0.000015238919,0.000020269796,0.9508024,0.0002521844],"about_ca_topic_score_codex":0.010106524,"about_ca_topic_score_gemma":0.007620754,"teacher_disagreement_score":0.13566908,"about_ca_system_score_codex":0.00087867025,"about_ca_system_score_gemma":0.0064074425,"threshold_uncertainty_score":0.9999832},"labels":[],"label_agreement":null},{"id":"W2801534920","doi":"10.1093/eurheartj/ehy182","title":"Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract","year":2018,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":381,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Western University","funders":"Esperion Therapeutics; Servier; Mylan; Medicines Company; Regeneron Pharmaceuticals; Sanofi; Kowa Company; Danone; Genentech; Valeant Pharmaceuticals International; Quest Diagnostics; Amgen; Pfizer; Abbott Diagnostics; European Atherosclerosis Society; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Stroke (engine); Adverse effect; Renal function; Statin; Homeostasis; Internal medicine; Diabetes mellitus; Cardiology; Endocrinology","score_opus":0.0546630015167935,"score_gpt":0.32853535567060027,"score_spread":0.2738723541538068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801534920","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04721365,0.950747,0.00014339421,0.00013504799,0.00023869477,0.001375711,0.000023203664,0.000015592968,0.0001076731],"genre_scores_gemma":[0.019452577,0.97864497,0.000112127265,0.00034801022,0.0012279481,0.000012880596,0.000016300104,0.00007204317,0.00011314629],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955884,0.002528426,0.0005865355,0.00037842928,0.0006307498,0.00028744707],"domain_scores_gemma":[0.9980894,0.0005431761,0.00046098378,0.00040178013,0.00022174133,0.00028291834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029905078,0.00036864894,0.0012026189,0.00019840768,0.0003287225,0.000061916144,0.00009348557,0.0000821666,0.00007861836],"category_scores_gemma":[0.0005094222,0.00020719269,0.000506467,0.00016737971,0.00021202562,0.00012793971,0.00005805348,0.0009529222,0.00007621843],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032378623,0.000063776206,0.00015787549,0.005353795,0.00042393123,0.0001783029,0.00020994384,5.297986e-8,0.000011688034,7.977441e-7,0.0011563543,0.99211967],"study_design_scores_gemma":[0.0035507062,0.010678252,0.101449534,0.10661576,0.0047393977,0.009966608,0.00019658674,0.0000076288766,0.000037338617,0.000009213933,0.76224136,0.00050757977],"about_ca_topic_score_codex":0.000042025287,"about_ca_topic_score_gemma":0.0000039727897,"teacher_disagreement_score":0.99161214,"about_ca_system_score_codex":0.00007608986,"about_ca_system_score_gemma":0.00030234244,"threshold_uncertainty_score":0.8449072},"labels":[],"label_agreement":null},{"id":"W2801700336","doi":"10.1016/j.jacl.2018.04.012","title":"PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Amgen Canada; Fondation Leducq","keywords":"Medicine; Odds ratio; Coronary artery disease; Internal medicine; Familial hypercholesterolemia; Genotype; Confidence interval; Cohort; Logistic regression; Allele; Single-nucleotide polymorphism; Gastroenterology; Polymorphism (computer science); Endocrinology; Genetics; Cholesterol; Gene; Biology","score_opus":0.03517950720577244,"score_gpt":0.3370644296585654,"score_spread":0.30188492245279297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801700336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565995,0.00016438916,0.00015438777,0.0008317684,0.0026445813,0.00031489466,0.0000064375226,0.000009504926,0.00021409753],"genre_scores_gemma":[0.986632,0.00011053643,0.0007215797,0.0029079034,0.009547144,0.0000026839693,0.00000809475,0.000022044544,0.000048051254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720967,0.0004369536,0.0012671114,0.00023583844,0.0005415266,0.00030889572],"domain_scores_gemma":[0.9979719,0.00019760511,0.0004102381,0.0003893154,0.00044561943,0.0005853448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017761935,0.00014598924,0.00091054064,0.0001267831,0.00003488295,0.000006453389,0.00014220229,0.0002064018,0.000078567486],"category_scores_gemma":[0.0008594199,0.00009518476,0.00031109355,0.00012064115,0.00030989258,0.000118547156,0.00004544298,0.00075834565,0.000035172026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015345648,0.00084999047,0.9440842,0.000037589285,0.00020751046,0.0001483838,0.00004345572,0.0000032629925,0.000008694377,0.0000070028104,0.00090430025,0.038359936],"study_design_scores_gemma":[0.0127463145,0.008959628,0.9676008,0.00016653918,0.0002240826,0.00012906568,0.000009927606,0.00001898109,0.0000033774365,0.00006927541,0.009985754,0.00008623098],"about_ca_topic_score_codex":0.000008547977,"about_ca_topic_score_gemma":0.000016517251,"teacher_disagreement_score":0.038273707,"about_ca_system_score_codex":0.000054615404,"about_ca_system_score_gemma":0.00068195665,"threshold_uncertainty_score":0.3881522},"labels":[],"label_agreement":null},{"id":"W2802027070","doi":"10.1161/atvbaha.118.310907","title":"Response by Labos et al to Letter Regarding Article, “Evaluation of the Pleiotropic Effects of Statins: A Reanalysis of the Randomized Trial Evidence Using Egger Regression”","year":2018,"lang":"en","type":"letter","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"George (robot); Randomized controlled trial; Library science; Medicine; History; Internal medicine; Art history; Computer science","score_opus":0.05960388975673651,"score_gpt":0.3543585192907837,"score_spread":0.2947546295340472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802027070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8530658,0.0005677719,0.00034358323,0.1422786,0.0004059293,0.0032964628,0.00003226806,0.000006977678,0.0000026208193],"genre_scores_gemma":[0.8161774,0.0012287647,0.000527345,0.18141304,0.00032939317,0.00025109004,0.000017621996,0.000048545684,0.000006755102],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9873141,0.009573003,0.0010546084,0.0005881586,0.0011361392,0.0003339977],"domain_scores_gemma":[0.99575174,0.0010306342,0.0009552653,0.0016188977,0.0005798803,0.0000635638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008132968,0.00034680564,0.0021687981,0.00016342639,0.00014522336,0.000018687513,0.0002875885,0.00043276328,0.000032901567],"category_scores_gemma":[0.0035349205,0.00017555438,0.0014859692,0.00046252797,0.00061704044,0.00006221537,0.000254216,0.0004571218,8.3618346e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02126187,0.00017620558,0.0037824914,0.0007356912,0.0055102333,2.1492977e-7,0.0012000194,0.000008108497,0.8505897,0.0000070489737,0.11620438,0.0005240296],"study_design_scores_gemma":[0.58369344,0.0029948377,0.2566255,0.019305179,0.024548,0.0000050413228,0.00012449402,0.00082240056,0.06553648,0.000088312176,0.04531696,0.00093934266],"about_ca_topic_score_codex":0.00059522374,"about_ca_topic_score_gemma":0.00001577368,"teacher_disagreement_score":0.78505325,"about_ca_system_score_codex":0.00009746503,"about_ca_system_score_gemma":0.00027426073,"threshold_uncertainty_score":0.71589},"labels":[],"label_agreement":null},{"id":"W2802267574","doi":"10.1097/mol.0000000000000519","title":"Predicting cardiovascular disease in familial hypercholesterolemia","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Disease; Residual risk; Risk stratification; Atherosclerotic cardiovascular disease; Internal medicine; Bioinformatics; Cholesterol; Biology","score_opus":0.1272635995713204,"score_gpt":0.3909030174916906,"score_spread":0.26363941792037016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802267574","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019865888,0.9423547,0.00005412052,0.000031716725,0.05468857,0.0024740908,0.000054424214,0.00006717947,0.00007656252],"genre_scores_gemma":[0.00003483137,0.9505556,0.00004927154,0.000021699567,0.047986932,0.00069658767,0.0005482017,0.000092498805,0.000014348331],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99469113,0.0012566836,0.0013757682,0.0012238577,0.00065877783,0.0007937978],"domain_scores_gemma":[0.9974574,0.00011707683,0.00022154953,0.0017084009,0.000085731976,0.0004098294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002102203,0.0006155372,0.0036709327,0.00079251546,0.000055447326,0.000018037417,0.0003205401,0.00062704366,0.000029007311],"category_scores_gemma":[0.0004998704,0.0005261237,0.002157765,0.00067839853,0.00018975009,0.000080344755,0.00025587488,0.0015741272,0.00014184807],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005343027,0.0002003994,0.0048241005,0.06394837,0.000375762,0.000004021838,0.00006849819,0.000008908185,1.269418e-8,0.000028944289,0.0012162762,0.9292713],"study_design_scores_gemma":[0.0016548055,0.00014139547,0.0025500413,0.046082076,0.00075972656,0.00011827287,0.00001090618,0.000033703735,8.501396e-9,0.000018484408,0.9482748,0.00035580463],"about_ca_topic_score_codex":0.00017941825,"about_ca_topic_score_gemma":0.000008774028,"teacher_disagreement_score":0.9470585,"about_ca_system_score_codex":0.00055918604,"about_ca_system_score_gemma":0.0012301496,"threshold_uncertainty_score":0.999719},"labels":[],"label_agreement":null},{"id":"W2802886454","doi":"10.1161/jaha.117.007535","title":"Projected Real‐World Effectiveness of Using Aggressive Low‐Density Lipoprotein Cholesterol Targets Among Elderly Statin Users Following Acute Coronary Syndromes in Canada","year":2018,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Women's College Hospital; Western University; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University Health Network; University of Toronto; Health Sciences Centre","funders":"Canadian Institutes of Health Research; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Acute coronary syndrome; Myocardial infarction; Statin; Internal medicine; Cholesterol; Adverse effect; Population; Cohort; Cardiology; Proportional hazards model","score_opus":0.009349874463666086,"score_gpt":0.27314701387282503,"score_spread":0.26379713940915894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802886454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985667,0.000060204522,0.000044125034,0.0001894157,0.00037254533,0.0007415777,0.00000886364,0.000006098451,0.000010486626],"genre_scores_gemma":[0.9991213,0.000026951602,0.0005178919,0.00013443758,0.00014813629,0.000006606718,0.0000019456936,0.000023382136,0.000019315452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967546,0.0011422203,0.00059077324,0.00016166837,0.0010394362,0.0003113109],"domain_scores_gemma":[0.99724364,0.00020852838,0.0017076063,0.00025888297,0.00047154535,0.000109824025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020886736,0.00015265186,0.0010487138,0.00017922928,0.000111883026,0.000013900254,0.00011644984,0.00004524339,0.0000027428991],"category_scores_gemma":[0.00053113775,0.00011439844,0.00038025048,0.0007531044,0.00007195435,0.0001749273,0.000042604264,0.00039679636,3.5346196e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003902616,0.000056675955,0.9855528,0.00008427011,0.00081444404,0.000107747706,0.00025247288,0.0000700631,0.00999677,1.9832096e-7,0.00006506264,0.0026092408],"study_design_scores_gemma":[0.0013746658,0.000535687,0.9836899,0.0013915215,0.00031258605,0.00010460764,0.00029908167,0.00019236829,0.011982552,0.00000876377,0.000008654453,0.000099609555],"about_ca_topic_score_codex":0.78923076,"about_ca_topic_score_gemma":0.42677423,"teacher_disagreement_score":0.36245653,"about_ca_system_score_codex":0.0035976209,"about_ca_system_score_gemma":0.002161925,"threshold_uncertainty_score":0.9407654},"labels":[],"label_agreement":null},{"id":"W2803057033","doi":"10.1016/j.cjca.2018.04.014","title":"Attainment of Recommended Lipid Targets in Patients With Familial Hypercholesterolemia: Real-World Experience With PCSK9 Inhibitors","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; Sanofi; Amgen","keywords":"PCSK9; Medicine; Familial hypercholesterolemia; Dyslipidemia; Alirocumab; Evolocumab; Internal medicine; Kexin; Cohort; Cholesterol; LDL receptor; Apolipoprotein B; Gastroenterology; Endocrinology; Lipoprotein; Disease","score_opus":0.011295037622560103,"score_gpt":0.2401736963647581,"score_spread":0.228878658742198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803057033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590695,0.000100044235,0.00019058833,0.0004177339,0.0004144663,0.00033137813,0.000010237801,0.0000030307262,0.0026256002],"genre_scores_gemma":[0.99801946,0.00002855717,0.0004453522,0.00030300982,0.0011423101,0.000008477894,0.0000062351774,0.000021738566,0.00002488564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983749,0.0001805125,0.00050571345,0.0001960947,0.00032103396,0.00042174605],"domain_scores_gemma":[0.998377,0.000020180612,0.00022453403,0.00034001202,0.00045178577,0.0005864428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000537259,0.0001613814,0.0007974479,0.00041648428,0.00005736621,0.0000061034084,0.00012716783,0.00010939762,0.000015634192],"category_scores_gemma":[0.000051007344,0.00011227,0.0001379071,0.00027772895,0.000302697,0.0000832627,0.000012693596,0.00034798795,0.0000017549569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080311013,0.000012896282,0.9869229,0.00003339995,0.00021463916,0.00015313772,0.00086440955,0.00005535265,0.00005653403,0.00001324487,0.00080299005,0.010067374],"study_design_scores_gemma":[0.0049260175,0.003931722,0.9548862,0.00029694653,0.00009297309,0.00018323252,0.00052040705,0.0000012139086,0.00066429016,0.0000072812145,0.034349844,0.0001398737],"about_ca_topic_score_codex":0.004312829,"about_ca_topic_score_gemma":0.016591515,"teacher_disagreement_score":0.033546854,"about_ca_system_score_codex":0.00045259437,"about_ca_system_score_gemma":0.0013339154,"threshold_uncertainty_score":0.9258455},"labels":[],"label_agreement":null},{"id":"W2803189008","doi":"10.1101/329052","title":"Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in <i>PCSK9</i>","year":2018,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"Medical Research Council; Blood Cancer UK; Rosetrees Trust; National Institute for Health and Care Research; British Heart Foundation; Wellcome Trust","keywords":"PCSK9; Internal medicine; Medicine; Mendelian randomization; Odds ratio; Single-nucleotide polymorphism; Placebo; Diabetes mellitus; Type 2 diabetes; Oncology; Cholesterol; Endocrinology; Genotype; Genetics; Biology; Lipoprotein; Genetic variants; LDL receptor; Pathology; Gene","score_opus":0.01091289417711295,"score_gpt":0.2275203220580137,"score_spread":0.21660742788090076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803189008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941398,0.0012672178,0.0023949961,0.00017864122,0.00064106757,0.0010706134,0.00015590247,0.000121354366,0.000030438985],"genre_scores_gemma":[0.99581456,0.0004738186,0.0024086384,0.0004767142,0.0005664671,0.00014331007,0.0000015236348,0.000109011526,0.0000059426407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960462,0.00021659397,0.0010744181,0.0010237613,0.0009902831,0.0006487833],"domain_scores_gemma":[0.99603486,0.00009217113,0.0008346532,0.002019025,0.00071502,0.0003042535],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019690325,0.00048638452,0.0017291805,0.0010446077,0.00006566382,0.0000749479,0.00032921435,0.000730803,0.0000650317],"category_scores_gemma":[0.0006828057,0.0005269922,0.0006669917,0.0018129334,0.000061069586,0.00008807588,0.000321988,0.0007625955,0.00002921669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008142772,0.00038044195,0.93847215,0.0013097088,0.00585191,0.000101829435,0.000038848266,0.000502246,0.053133983,0.000008551991,0.00009638233,0.000022509766],"study_design_scores_gemma":[0.0011447555,0.00008554814,0.9726766,0.0006554457,0.0032268015,1.2752531e-8,0.0000023021148,0.00062320015,0.02027204,8.072335e-7,0.00089449796,0.00041799774],"about_ca_topic_score_codex":0.00064500177,"about_ca_topic_score_gemma":0.000046471843,"teacher_disagreement_score":0.03420443,"about_ca_system_score_codex":0.0011043311,"about_ca_system_score_gemma":0.00075985637,"threshold_uncertainty_score":0.9997182},"labels":[],"label_agreement":null},{"id":"W2803252171","doi":"10.2146/ajhp170707","title":"Proprotein convertase subtilisin/kexin type 9 inhibitors for reduction of cardiovascular events","year":2018,"lang":"en","type":"review","venue":"American Journal of Health-System Pharmacy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Evolocumab; Alirocumab; PCSK9; Kexin; Medicine; Proprotein convertase; Pharmacology; Placebo; Adverse effect; Familial hypercholesterolemia; Internal medicine; Cholesterol; LDL receptor; Lipoprotein","score_opus":0.06068419422584077,"score_gpt":0.37847556637290564,"score_spread":0.3177913721470649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803252171","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008233676,0.9896101,0.0006359694,0.00041582406,0.0025684405,0.00580615,0.00008035662,0.00003488896,0.000024902209],"genre_scores_gemma":[0.007607039,0.9864251,0.0014496467,0.000059438662,0.004012327,0.00016205318,0.00005480577,0.00017966265,0.000049949875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914354,0.0018801317,0.0038557798,0.0005725663,0.0015650952,0.0006909965],"domain_scores_gemma":[0.99079216,0.00008523987,0.0056821564,0.0010553986,0.0016920944,0.0006929677],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0077812322,0.00063376775,0.007843776,0.00069461553,0.00017504589,0.000015387923,0.00035932608,0.00014855416,0.000015493002],"category_scores_gemma":[0.00020521338,0.00046915992,0.0047780355,0.0009291279,0.00025009344,0.00014322643,0.000052047086,0.0007774475,0.000018147943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046734573,0.00015088038,0.000007206629,0.09273108,0.005114992,0.000039648694,0.00012865034,0.0000018636384,0.0000035283988,0.0000044812036,0.0013572951,0.899993],"study_design_scores_gemma":[0.0027447247,0.0032474552,0.0000032033477,0.042012405,0.0054455088,0.0055227233,0.00032558138,0.0000064137616,0.000120891644,0.0000017870535,0.9402629,0.00030641805],"about_ca_topic_score_codex":0.0014271914,"about_ca_topic_score_gemma":0.0000011683192,"teacher_disagreement_score":0.9389056,"about_ca_system_score_codex":0.001264325,"about_ca_system_score_gemma":0.0067740125,"threshold_uncertainty_score":0.999776},"labels":[],"label_agreement":null},{"id":"W2803715345","doi":"10.1111/dom.13384","title":"Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials","year":2018,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Ezetimibe; PCSK9; Medicine; Internal medicine; Placebo; Diabetes mellitus; Statin; Endocrinology; Lipoprotein; Cholesterol; LDL receptor; Apolipoprotein A1; Pathology","score_opus":0.03600435787991747,"score_gpt":0.29793487863960166,"score_spread":0.2619305207596842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803715345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4123946,0.5841912,0.000005313482,0.000016207516,0.000052523537,0.0031508915,0.00016306783,0.000015177621,0.000011032612],"genre_scores_gemma":[0.04636231,0.9524457,0.00012049333,0.00008122728,0.00046915075,0.0002998308,0.00014497437,0.000066797635,0.000009539498],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942105,0.0022795848,0.0011397887,0.00087808823,0.00088144286,0.00061059877],"domain_scores_gemma":[0.9969535,0.00066548213,0.0004967727,0.0013012663,0.000105730316,0.00047723248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008700439,0.0007052852,0.006367962,0.00030606156,0.00020309056,0.00009719095,0.00022157347,0.00035110692,0.000009193177],"category_scores_gemma":[0.00075383397,0.00039398336,0.001074062,0.00048317993,0.000672182,0.00015327438,0.00015147308,0.0005149733,0.0000016379254],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010017803,0.0006286564,0.010090772,0.034222122,0.008222922,0.00002383799,0.00071637117,7.0513835e-7,0.0000014353379,0.0001226738,0.000020100197,0.94585025],"study_design_scores_gemma":[0.01572987,0.00045577227,0.2160682,0.021315642,0.053697985,0.000012530116,0.000076034856,0.000008852788,0.000024634148,0.000106443,0.691646,0.0008580709],"about_ca_topic_score_codex":0.00009621533,"about_ca_topic_score_gemma":0.0000056783338,"teacher_disagreement_score":0.9449922,"about_ca_system_score_codex":0.000024409164,"about_ca_system_score_gemma":0.0002331674,"threshold_uncertainty_score":0.9998512},"labels":[],"label_agreement":null},{"id":"W2803884424","doi":"10.1161/atvb.36.suppl_1.390","title":"Abstract 390: Human Aortic Valve Interstitial Cells Exhibit Decreased Cholesterol Efflux Associated with Hypo- α1-nascent HDL Particles","year":2016,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cholesterol; Internal medicine; Efflux; ABCA1; Aortic valve; Aortic valve stenosis; Lipoprotein; Fast protein liquid chromatography; Medicine; Population; Endocrinology; Stenosis; High-density lipoprotein; Cardiology; Chemistry; Biochemistry; High-performance liquid chromatography; Gene; Chromatography; Transporter","score_opus":0.032488845206371846,"score_gpt":0.2771337141180611,"score_spread":0.24464486891168924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803884424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976301,0.000073609466,0.00053095433,0.0006045703,0.00015056861,0.0007640495,0.000036645397,0.00012613028,0.00008332938],"genre_scores_gemma":[0.9977291,0.0008815323,0.00013361985,0.0007982352,0.00022332714,0.00011264369,0.00005112609,0.00006394044,0.0000064775313],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99731696,0.00024716053,0.00056552445,0.0007797305,0.00034278963,0.0007478323],"domain_scores_gemma":[0.99831873,0.0000931082,0.00020931414,0.0007682752,0.00014022074,0.0004703685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069300475,0.00042395177,0.0009588699,0.00011548319,0.00027424475,0.00006226935,0.00014753098,0.00028689243,0.00024251209],"category_scores_gemma":[0.00007053506,0.0002611351,0.0006001899,0.00015358174,0.00042304548,0.00013599067,0.00009514717,0.00019648635,0.00005492397],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023440258,0.0006536945,0.20937197,0.00010124835,0.0022311653,8.5813326e-7,0.00024188058,4.4888552e-7,0.7803953,0.000073323674,0.00014476918,0.0067618457],"study_design_scores_gemma":[0.0057273037,0.0013876262,0.97749174,0.0008275201,0.0006898866,0.0000036049933,0.00008210101,0.000010523395,0.012815087,0.000032192376,0.00056160684,0.00037079406],"about_ca_topic_score_codex":0.00043230498,"about_ca_topic_score_gemma":0.00024268815,"teacher_disagreement_score":0.76811975,"about_ca_system_score_codex":0.00014910084,"about_ca_system_score_gemma":0.00008286668,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W2804048509","doi":"10.1016/j.cjca.2018.05.015","title":"Simplified Canadian Definition for Familial Hypercholesterolemia","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Alberta; University of Toronto; Western University; McMaster University; St. Paul's Hospital; Montreal Heart Institute; Montreal Clinical Research Institute; University of British Columbia; Institute for Clinical Evaluative Sciences; McGill University Health Centre; McGill University; Dalhousie University; Royal Victoria Hospital; Saint John Regional Hospital; Université Laval; Royal Victoria Regional Health Centre; Hospital for Sick Children; Université de Montréal; Providence Health Care Research Institute","funders":"Kowa Company; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Valeant Pharmaceuticals International; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Cholesterol","score_opus":0.03978232582672294,"score_gpt":0.26949255412039735,"score_spread":0.2297102282936744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804048509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9327072,0.0010904176,0.011443382,0.0055619893,0.003384417,0.0008453929,0.00020409553,0.000012848592,0.044750255],"genre_scores_gemma":[0.98979187,0.000032390977,0.00082978734,0.0023546128,0.0068859393,0.000008921942,0.000022986756,0.000023499417,0.00004997229],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987729,0.0000860866,0.0003369727,0.00014451578,0.00012298896,0.00053650246],"domain_scores_gemma":[0.9973648,0.000030975647,0.000084283376,0.00026518726,0.000660149,0.0015945899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076134887,0.00011756403,0.00053156057,0.00040731396,0.00018771282,0.00001540365,0.00011541748,0.00022292518,0.000024681915],"category_scores_gemma":[0.00029436516,0.00010487321,0.00039582406,0.000111580775,0.00018177813,0.000051837942,0.000003614024,0.00023983158,0.000025383082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018647109,0.000015104312,0.1749487,0.00051488454,0.0047194483,0.0030664785,0.0019856542,0.00025733217,0.005039134,0.012579631,0.36116293,0.433846],"study_design_scores_gemma":[0.0021679306,0.0013066606,0.09918828,0.00006071182,0.00027006914,0.003751254,0.00015695956,0.000007781689,0.00018916752,0.0010272318,0.8917326,0.00014140636],"about_ca_topic_score_codex":0.07996605,"about_ca_topic_score_gemma":0.3387388,"teacher_disagreement_score":0.5305696,"about_ca_system_score_codex":0.00047826176,"about_ca_system_score_gemma":0.0064104046,"threshold_uncertainty_score":0.99922234},"labels":[],"label_agreement":null},{"id":"W2804217240","doi":"10.1016/j.jacl.2018.05.010","title":"PCSK9 inhibitors in familial hypercholesterolemia: What is the evidence?","year":2018,"lang":"en","type":"editorial","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Western University; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Familial hypercholesterolemia; PCSK9; Internal medicine; LDL receptor; Cholesterol; Lipoprotein","score_opus":0.0790981821848273,"score_gpt":0.4256803845327321,"score_spread":0.3465822023479048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804217240","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045699216,0.016992457,0.00001619911,0.013213599,0.92345035,0.000504931,0.0000083150835,0.000009695221,0.00010522996],"genre_scores_gemma":[0.0039154897,0.05287296,0.00020179518,0.004396788,0.93817556,0.000010431248,0.0000073974124,0.00005799145,0.00036156797],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99013203,0.0023179958,0.0043074545,0.000576175,0.0020908907,0.00057543576],"domain_scores_gemma":[0.98688066,0.007944525,0.0021074899,0.0011931502,0.0014105338,0.00046366546],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.02140558,0.0004087656,0.0032216583,0.00028841462,0.000079388694,0.000085793625,0.00073491834,0.0033606607,0.00012587808],"category_scores_gemma":[0.023632923,0.00023420835,0.0022733724,0.00028131367,0.0007107835,0.00038656648,0.00023158749,0.007748995,0.0001062663],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020084244,0.00021471991,0.0022519012,0.00020044076,0.0004169227,0.0001269442,0.00019386367,5.940251e-7,0.0000068408262,0.0000015304613,0.9069262,0.08765161],"study_design_scores_gemma":[0.004218322,0.004761999,0.0045195543,0.004510401,0.0006934356,0.00032703351,0.00021836364,0.0000026166229,0.000011859909,0.00016631746,0.98038065,0.00018946604],"about_ca_topic_score_codex":0.00010829773,"about_ca_topic_score_gemma":0.000096144424,"teacher_disagreement_score":0.08746215,"about_ca_system_score_codex":0.00021344105,"about_ca_system_score_gemma":0.0036507398,"threshold_uncertainty_score":0.9979332},"labels":[],"label_agreement":null},{"id":"W2804373208","doi":"10.1016/j.jacl.2018.05.007","title":"Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Amgen Canada; REGENXBIO; Sanofi; Amgen","keywords":"Evolocumab; Medicine; Tolerability; Familial hypercholesterolemia; Alirocumab; Randomized controlled trial; PCSK9; Clinical endpoint; Placebo; Internal medicine; Kexin; Adverse effect; Lipoprotein; Cholesterol; Pathology; LDL receptor","score_opus":0.046588446418501024,"score_gpt":0.3418543693989348,"score_spread":0.2952659229804338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804373208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977912,0.00016185181,0.0002761919,0.0003748946,0.00048974843,0.0008884383,0.0000035804105,0.0000016728111,0.000012451187],"genre_scores_gemma":[0.99791807,0.00015765718,0.0006845015,0.00016383032,0.0010596705,0.0000022673119,4.7523653e-7,0.000008269739,0.0000052313053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965002,0.0011702457,0.0015363735,0.00019091375,0.00046672128,0.00013553949],"domain_scores_gemma":[0.99750173,0.00088815024,0.00068617874,0.00034242857,0.00046920453,0.000112303176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004358679,0.000105409825,0.0010257658,0.00008303978,0.000036142974,0.0000032432663,0.00010979282,0.0001513502,0.0000064967307],"category_scores_gemma":[0.0019189619,0.00005804752,0.00013594923,0.00014282977,0.00039026185,0.00005598669,0.00008080833,0.00046377524,2.9601972e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007358933,0.0014408471,0.9813297,0.00006253247,0.00010989972,0.0000024875058,0.0002592005,0.000024861678,0.000011895961,0.0000025820514,0.000035302754,0.0093618035],"study_design_scores_gemma":[0.014364598,0.012744434,0.9722784,0.00005145725,0.0002442798,0.000046090834,0.000061495026,0.000020656345,0.000012553359,0.000034715624,0.00009615785,0.000045131124],"about_ca_topic_score_codex":0.000030046014,"about_ca_topic_score_gemma":0.000059348968,"teacher_disagreement_score":0.011303588,"about_ca_system_score_codex":0.000022892602,"about_ca_system_score_gemma":0.00030702841,"threshold_uncertainty_score":0.23671092},"labels":[],"label_agreement":null},{"id":"W2804944249","doi":"10.5539/gjhs.v10n7p11","title":"Hypercholesterolemia Prevalence, Awareness, Treatment and Control among Adults in Malaysia: The 2015 National Health and Morbidity Survey, Malaysia","year":2018,"lang":"en","type":"article","venue":"Global Journal of Health Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Logistic regression; Marital status; Descriptive statistics; Disease; Obesity; Environmental health; Diabetes mellitus; Public health; Stratified sampling; Demography; Gerontology; Internal medicine; Population","score_opus":0.027801705047353173,"score_gpt":0.34061061760797356,"score_spread":0.3128089125606204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804944249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852327,0.0075605065,0.00011287217,0.0061439443,0.00022127552,0.0006440022,0.000040606967,0.0000055040564,0.000038566457],"genre_scores_gemma":[0.99477774,0.0032719567,0.00017627298,0.0015147516,0.00024080483,0.000006938815,0.0000016823722,0.0000048082093,0.0000050632866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971432,0.00036033543,0.00067894394,0.00031048965,0.0010115966,0.00049540587],"domain_scores_gemma":[0.99804586,0.000048668906,0.00045049272,0.00023372385,0.0006119784,0.000609248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008631947,0.00015170526,0.00053986005,0.0000965177,0.0003708958,0.000054991735,0.0001866839,0.00004846429,0.00000382947],"category_scores_gemma":[0.00021195387,0.00009109743,0.00006325277,0.00054450333,0.0008454329,0.00028331802,0.000048901613,0.00019766929,0.0000016444678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002355807,0.00009145484,0.9847589,0.00014130387,0.000017849958,0.000008237727,0.00017221972,0.000024720677,0.0000042758634,0.00003228101,0.0001874811,0.0143256895],"study_design_scores_gemma":[0.002904003,0.0018770541,0.9919724,0.00045393998,0.000010675053,0.0013450587,0.00015898031,0.0009813432,0.000005015173,0.00005863438,0.00016996516,0.00006295614],"about_ca_topic_score_codex":0.00588009,"about_ca_topic_score_gemma":0.00089990406,"teacher_disagreement_score":0.014262733,"about_ca_system_score_codex":0.00088244514,"about_ca_system_score_gemma":0.0054374966,"threshold_uncertainty_score":0.9645886},"labels":[],"label_agreement":null},{"id":"W2805147040","doi":"10.1016/j.atherosclerosissup.2018.04.486","title":"Athroprotective and Atheroregressive Potential of an [aza-Y4]-GHRP-6 Analogue, a Selective CD36 Ligand, in Apolipoprotein E-deficient Mice","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"CD36; Apolipoprotein B; Chemistry; Ligand (biochemistry); Internal medicine; Endocrinology; Medicine; Biochemistry; Receptor; Cholesterol","score_opus":0.013458254886138157,"score_gpt":0.2755384914989833,"score_spread":0.26208023661284513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805147040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957954,0.00033490444,0.0006595521,0.00020086428,0.00012601896,0.002500269,0.00017396058,0.000046816167,0.00016218261],"genre_scores_gemma":[0.99651635,0.00019022655,0.0022702022,0.0002408248,0.00031684941,0.00027632507,0.000068700545,0.000075779826,0.000044759858],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966512,0.00026023848,0.00066884514,0.00085155637,0.0008382306,0.0007299777],"domain_scores_gemma":[0.9982532,0.00002135222,0.0003063534,0.0007153564,0.00040647556,0.0002972491],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00086492643,0.00040024647,0.0008277207,0.00029876432,0.00021919697,0.00003595604,0.000196208,0.0002289678,0.00012026111],"category_scores_gemma":[0.00007807362,0.00034905536,0.0002296954,0.0006513709,0.0004084112,0.00020942745,0.00016445026,0.00034321885,0.000019994848],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021070717,0.0027727273,0.052654106,0.00045409627,0.0011288124,0.00005315722,0.01127846,0.000016082635,0.888963,0.0003031972,0.00016030441,0.040109023],"study_design_scores_gemma":[0.010672116,0.0057817465,0.54974127,0.0006477895,0.00031528642,0.00008583259,0.0027707478,0.00049421523,0.42804873,0.00037482948,0.0005106585,0.0005568126],"about_ca_topic_score_codex":0.008655028,"about_ca_topic_score_gemma":0.001406299,"teacher_disagreement_score":0.49708715,"about_ca_system_score_codex":0.00024302659,"about_ca_system_score_gemma":0.00019015168,"threshold_uncertainty_score":0.99989617},"labels":[],"label_agreement":null},{"id":"W2805801404","doi":"10.1016/j.vhri.2017.12.003","title":"Analysis of Cost of Illness, Treatment, Complications, and Interventions of Hypercolesterolemia in Mexico in 2016","year":2018,"lang":"en","type":"article","venue":"Value in Health Regional Issues","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Psychological intervention; Intensive care medicine; Medicine; Psychiatry","score_opus":0.08538799350656755,"score_gpt":0.3985330967458122,"score_spread":0.31314510323924466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805801404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98171467,0.01412699,0.00009052241,0.0031691378,0.000020432359,0.0007453648,0.000030216042,0.0000041440535,0.00009852881],"genre_scores_gemma":[0.99271965,0.0063578486,0.0006302485,0.00012582302,0.000022669714,0.00006129674,0.000044040433,0.0000071857507,0.000031261407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838346,0.00021818641,0.0008446908,0.00019679581,0.00020506917,0.00015178285],"domain_scores_gemma":[0.9991521,0.00008115483,0.00024903947,0.00033462653,0.000111571324,0.0000714679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077196053,0.00008874167,0.00076854613,0.0007524314,0.000018927014,0.0000014863513,0.00005605721,0.00006156833,0.000010259466],"category_scores_gemma":[0.000044757202,0.000075355034,0.00018044753,0.0008627953,0.00018430971,0.000039170096,0.00001988002,0.00006598295,7.4837567e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012914487,0.0009801422,0.96877056,0.001212416,0.00032740604,0.000002857805,0.0028522199,0.00023327806,0.00011673333,0.0017526355,0.00006346333,0.023559144],"study_design_scores_gemma":[0.0015479602,0.00056872354,0.99090886,0.0020895377,0.00011118134,0.0000056943845,0.00070022536,0.0011510167,0.00027883996,0.00017524522,0.0024079646,0.00005477126],"about_ca_topic_score_codex":0.042891514,"about_ca_topic_score_gemma":0.00737425,"teacher_disagreement_score":0.035517264,"about_ca_system_score_codex":0.0001645983,"about_ca_system_score_gemma":0.00022046953,"threshold_uncertainty_score":0.96348196},"labels":[],"label_agreement":null},{"id":"W2806064078","doi":"10.1016/j.numecd.2018.05.010","title":"Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus","year":2018,"lang":"en","type":"article","venue":"Nutrition Metabolism and Cardiovascular Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Chinese Academy of Medical Sciences; Capital Health","keywords":"Coronary artery disease; Medicine; Internal medicine; Type 2 Diabetes Mellitus; Cardiology; Diabetes mellitus; Type 2 diabetes; Disease; Lipoprotein(a); Lipoprotein; Cholesterol; Endocrinology","score_opus":0.008394280959083482,"score_gpt":0.20705050452160048,"score_spread":0.198656223562517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806064078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9257389,0.07225451,0.00003421114,0.00010476253,0.000042622247,0.0015220841,0.00025941557,0.000034435237,0.000009111333],"genre_scores_gemma":[0.997545,0.001791399,0.000061044164,0.00013250092,0.00016487215,0.0001447875,0.0001232388,0.000029109,0.000008033775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776065,0.0003707843,0.00022775166,0.00045107142,0.00087963935,0.00031012733],"domain_scores_gemma":[0.9983455,0.000046321245,0.00010335902,0.0006627839,0.0005460989,0.00029596518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042581168,0.00024304874,0.0007803331,0.00010217722,0.00014991651,0.000032349217,0.00007904387,0.00007729158,0.000014283749],"category_scores_gemma":[0.00016523687,0.00015219614,0.00023302001,0.00047240156,0.00047265043,0.00019378586,0.00004972263,0.00014718958,8.9211136e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024120624,0.0012624338,0.96658075,0.0010320194,0.0033566894,0.00007527195,0.00013388901,0.00000985031,0.000038448885,0.000033192766,0.00012038256,0.024945013],"study_design_scores_gemma":[0.00630044,0.00031485237,0.9891812,0.0006692729,0.0019882284,0.0000048814277,0.00010911088,0.000029615047,0.00019752665,0.00006884315,0.0009307895,0.00020522664],"about_ca_topic_score_codex":0.00006303222,"about_ca_topic_score_gemma":0.00002017607,"teacher_disagreement_score":0.07180616,"about_ca_system_score_codex":0.000020901041,"about_ca_system_score_gemma":0.000110869194,"threshold_uncertainty_score":0.62063783},"labels":[],"label_agreement":null},{"id":"W2806155844","doi":"10.1016/j.atherosclerosissup.2018.04.214","title":"Higher Adipose Tissue Surface-expression of LDLR and CD36 and Risk Factors for T2D in Normocholesterolemic Subjects with Low Plasma PCSK9","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Montreal Heart Institute; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Adipose tissue; CD36; Internal medicine; Medicine; Endocrinology; LDL receptor; Receptor; Cholesterol","score_opus":0.015688672987302903,"score_gpt":0.2601664141448458,"score_spread":0.24447774115754292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806155844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788666,0.00020062363,0.00012321223,0.00005971887,0.000080909624,0.0013909173,0.00020560477,0.000021322036,0.000031042495],"genre_scores_gemma":[0.996763,0.0004257274,0.0024084856,0.00005831673,0.0000702745,0.00005604222,0.00006515252,0.00005353604,0.00009946115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837166,0.00007562576,0.00035437307,0.00044676373,0.00035489348,0.0003966742],"domain_scores_gemma":[0.9990709,0.000061386396,0.00016819574,0.00041407143,0.000094132214,0.00019131265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003571048,0.00025209648,0.00051667966,0.00008189798,0.000113276765,0.000022192093,0.000077461424,0.00012877578,0.000087847424],"category_scores_gemma":[0.000023917075,0.0001841294,0.00006195544,0.00014218877,0.00014630423,0.00012900445,0.00007245742,0.00013367948,0.000002676677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004846969,0.00018585999,0.87314385,0.00029916217,0.00013991064,0.0000011765945,0.0012520078,0.0000027330505,0.121263705,0.0000049106075,0.00017837429,0.0030436136],"study_design_scores_gemma":[0.007854764,0.0018413245,0.686344,0.0005159698,0.00016395503,0.0000038231206,0.00020448885,0.000033660348,0.30132958,0.000010222953,0.0015220883,0.00017610798],"about_ca_topic_score_codex":0.0015071095,"about_ca_topic_score_gemma":0.00055497483,"teacher_disagreement_score":0.18679982,"about_ca_system_score_codex":0.000053241198,"about_ca_system_score_gemma":0.000044249507,"threshold_uncertainty_score":0.7508579},"labels":[],"label_agreement":null},{"id":"W2806278460","doi":"10.1016/j.atherosclerosissup.2018.04.073","title":"Phase 3 Evaluation of Bempedoic Acid Added to Ezetimibe in Patients with Elevated LDL-cholesterol Receiving No Greater Than Low Dose Statins: CLEAR Tranquility","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of British Columbia","funders":"","keywords":"Mainstream; Medicine; Thematic analysis; Acupuncture; Ezetimibe; Harm; Inclusion (mineral); Depression (economics); Dilemma; Focus group; Qualitative research; Health care; Psychiatry; Alternative medicine; Nursing; Family medicine; Psychology; Social psychology; Statin","score_opus":0.03183731646926371,"score_gpt":0.30950804443793234,"score_spread":0.27767072796866865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806278460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995612,0.000009080712,0.00012367345,0.00009402525,0.00012066959,0.003648234,0.0002934926,0.000037069076,0.00006171092],"genre_scores_gemma":[0.9975674,0.000012547729,0.0012073,0.00037983808,0.000108472224,0.00027446382,0.00036634217,0.00006821967,0.000015406204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959595,0.00040529366,0.00072724174,0.0006351297,0.0016558378,0.00061696855],"domain_scores_gemma":[0.99767935,0.000015551801,0.00020636371,0.0009225063,0.00091927225,0.00025693548],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019308372,0.00031500074,0.0005945503,0.00018992827,0.000106711166,0.000029130786,0.00016451078,0.00011349228,0.001032204],"category_scores_gemma":[0.00012455994,0.0002557917,0.00013997384,0.00048282923,0.00009242565,0.00021312833,0.000068082176,0.00017317293,0.000082639795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054255403,0.0040037786,0.9074998,0.0002942219,0.0004236454,0.0000011293818,0.004987918,0.000010936448,0.03134012,9.568172e-7,0.0002952632,0.045716714],"study_design_scores_gemma":[0.037810743,0.0072763525,0.91981876,0.0006932672,0.0002687157,5.186762e-7,0.00014497119,0.00020951705,0.033414703,0.0000037374316,0.000118082324,0.0002406091],"about_ca_topic_score_codex":0.0006192361,"about_ca_topic_score_gemma":0.00046506696,"teacher_disagreement_score":0.045476105,"about_ca_system_score_codex":0.00029718055,"about_ca_system_score_gemma":0.00015015854,"threshold_uncertainty_score":0.99998945},"labels":[],"label_agreement":null},{"id":"W2806731689","doi":"10.1016/j.atherosclerosissup.2018.04.072","title":"Lp(a) and Cardiovascular Outcomes: an Analysis from the ODYSSEY OUTCOMES Trial","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.04091624803525698,"score_gpt":0.31035475012877556,"score_spread":0.2694385020935186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806731689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515736,0.00041649496,0.0009166684,0.0010689915,0.00037755692,0.0016087292,0.0002459936,0.00008516678,0.00012303873],"genre_scores_gemma":[0.9949662,0.00027958924,0.0010704444,0.002292898,0.0007775953,0.00018251284,0.0002502672,0.00005544463,0.0001250327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646163,0.00034424558,0.0005558996,0.00077807903,0.0013216494,0.0005384911],"domain_scores_gemma":[0.9968262,0.00010131455,0.00011235121,0.002484992,0.00015011727,0.00032507585],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001531928,0.00036554097,0.0012860958,0.000113566115,0.0004420765,0.00012267353,0.0002965054,0.00014635567,0.00091352704],"category_scores_gemma":[0.00012596766,0.00022079481,0.0014913566,0.0004909318,0.00019584072,0.0001665127,0.00016346463,0.00019921301,0.000061688705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064769917,0.00025227066,0.97327334,0.000010001987,0.01677114,0.000003114686,0.00080174615,0.0000019078316,0.00015380404,0.00003326952,0.00056920445,0.0074825254],"study_design_scores_gemma":[0.03138044,0.0006944911,0.94399947,0.000019132958,0.007075924,0.0000017335105,0.0007167238,0.000077668396,0.00028172022,0.000043532473,0.015455177,0.00025398206],"about_ca_topic_score_codex":0.011096336,"about_ca_topic_score_gemma":0.0014105215,"teacher_disagreement_score":0.03073274,"about_ca_system_score_codex":0.00007569989,"about_ca_system_score_gemma":0.00007306946,"threshold_uncertainty_score":0.99999976},"labels":[],"label_agreement":null},{"id":"W2806801282","doi":"10.1016/j.atherosclerosissup.2018.04.267","title":"Macrophage Receptor with Collagenous Structure (MARCO) Potentiates Experimental Atherosclerosis","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Titration; Chemistry; Endothermic process; Exothermic reaction; Intermolecular force; Aqueous solution; Molecule; Adsorption; Crystallography; Physical chemistry; Organic chemistry","score_opus":0.013313746803960821,"score_gpt":0.2546002000063721,"score_spread":0.2412864532024113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806801282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957121,0.0004143006,0.00026033758,0.00030331183,0.0004169312,0.0017866121,0.00044273963,0.00019278406,0.00047088705],"genre_scores_gemma":[0.9885303,0.00017099569,0.007884851,0.0012423041,0.0008117469,0.0001741539,0.0002867795,0.0001816643,0.0007172417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99626714,0.00013753779,0.0005276814,0.00088469894,0.0011813354,0.0010016138],"domain_scores_gemma":[0.9978506,0.000017352639,0.00019446074,0.0011804103,0.00026885173,0.0004883455],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031605596,0.00054994354,0.0007157189,0.00012528211,0.0006314067,0.00012389678,0.00030432732,0.00021890007,0.007843219],"category_scores_gemma":[0.000017607352,0.00042377628,0.0003144976,0.00050874136,0.0003316749,0.00020007371,0.00017134755,0.00026067515,0.0003160759],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005882202,0.0008482097,0.06951094,0.00011801246,0.0009553559,0.00001077475,0.0019482357,0.0000016896619,0.9148431,0.00005117576,0.0068672234,0.00425708],"study_design_scores_gemma":[0.010055509,0.0051766434,0.105692856,0.00034102183,0.00035663188,0.000079538426,0.0014031945,0.000029759089,0.8446983,0.00001656175,0.031382475,0.00076750404],"about_ca_topic_score_codex":0.0007167284,"about_ca_topic_score_gemma":0.00013016278,"teacher_disagreement_score":0.07014478,"about_ca_system_score_codex":0.0003403469,"about_ca_system_score_gemma":0.00016668093,"threshold_uncertainty_score":0.9998214},"labels":[],"label_agreement":null},{"id":"W2806923326","doi":"10.1186/s12944-018-0752-2","title":"Six-year time-trend analysis of dyslipidemia among adults in Newfoundland and Labrador: findings from the laboratory information system between 2009 and 2014","year":2018,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"Newfoundland and Labrador Centre for Applied Health Research","keywords":"Dyslipidemia; Lipidology; Clinical chemistry; Lipid profile; Medicine; Internal medicine; Confounding; Cholesterol; Clinical nutrition; Demography; Disease","score_opus":0.005550669798616134,"score_gpt":0.2414512771337512,"score_spread":0.23590060733513507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806923326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507505,0.0032350374,0.000018994633,0.0005926121,0.000052945255,0.00053081935,0.0004298373,0.000017005348,0.000047679252],"genre_scores_gemma":[0.9983424,0.00030168187,0.00007993939,0.0007454483,0.00031887073,0.000017705004,0.00017997925,0.000007382305,0.0000065721365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849176,0.00024184122,0.0005455755,0.00022656696,0.00024892364,0.00024533313],"domain_scores_gemma":[0.9986311,0.00016254337,0.00015059565,0.0003210417,0.000055502827,0.000679182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011513198,0.0001314132,0.0005616002,0.00026804543,0.000106182306,0.000026495341,0.000046710407,0.000089617206,0.000012628201],"category_scores_gemma":[0.00029085434,0.000095980904,0.00005359958,0.0005439972,0.00014561653,0.0001964267,0.000041858486,0.00017364901,0.000003223082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034954995,0.000014674053,0.99168795,0.0008813667,0.000094377385,0.0000013880482,0.0017163499,0.0000017151933,5.651654e-7,0.000046669156,0.00046894993,0.004736431],"study_design_scores_gemma":[0.0020146682,0.00014934909,0.9935309,0.0005620387,0.00024670936,2.3780929e-7,0.0009968528,0.0015600949,5.919726e-7,0.000012650015,0.0008427958,0.00008308811],"about_ca_topic_score_codex":0.01198506,"about_ca_topic_score_gemma":0.0030154397,"teacher_disagreement_score":0.00896962,"about_ca_system_score_codex":0.000093593226,"about_ca_system_score_gemma":0.00026447463,"threshold_uncertainty_score":0.9945942},"labels":[],"label_agreement":null},{"id":"W2806985499","doi":"10.1016/j.atherosclerosissup.2018.04.182","title":"Circulating Soluble Low Density Lipoprotein Receptor Levels in Heterozygous Familial Hypercholesterolemia Subjects Before and After Statin Therapy","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Transponder (aeronautics); Calibration; Waveform; Radar; Range (aeronautics); Altimeter; Power (physics); Computer science; Remote sensing; Engineering; Telecommunications; Geology; Mathematics; Statistics; Physics; Meteorology","score_opus":0.024776542104981626,"score_gpt":0.27311280651045816,"score_spread":0.24833626440547654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806985499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719745,0.00013517015,0.00019200498,0.00024320316,0.00027447985,0.0017751794,0.00007870351,0.00006832184,0.0000354744],"genre_scores_gemma":[0.99493605,0.00013524733,0.0025825503,0.0013117184,0.00050943915,0.00029310014,0.000053103184,0.00009031423,0.000088496534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969691,0.00020241435,0.0005930936,0.00073801965,0.0006933311,0.00080401334],"domain_scores_gemma":[0.99870837,0.000022050705,0.00012980352,0.00070989144,0.0001499443,0.00027991447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00085214793,0.0003816211,0.0006267624,0.00013851727,0.00021054732,0.00007964211,0.0001333345,0.00020530465,0.0003922981],"category_scores_gemma":[0.00005038735,0.00033888972,0.00017971678,0.0002643527,0.00016766855,0.00022079067,0.00014525562,0.0003281696,0.00005725413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005204649,0.00038755775,0.76459605,0.00021147156,0.00020321575,0.000033830485,0.0050329166,8.4463426e-7,0.09826904,0.0000050306644,0.00016372484,0.13057584],"study_design_scores_gemma":[0.0069837784,0.0011710176,0.9571828,0.00044707648,0.00003400523,0.000033070228,0.00030855343,0.00007875955,0.03264756,0.000053186577,0.0007450023,0.0003151941],"about_ca_topic_score_codex":0.003484194,"about_ca_topic_score_gemma":0.0038391727,"teacher_disagreement_score":0.19258672,"about_ca_system_score_codex":0.00023445472,"about_ca_system_score_gemma":0.00011344683,"threshold_uncertainty_score":0.9999063},"labels":[],"label_agreement":null},{"id":"W2807007384","doi":"10.1016/j.atherosclerosissup.2018.04.167","title":"Canadian Definition for Familial Hypercholesterolemia","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Western University; Montreal Heart Institute; University of British Columbia; Montreal Clinical Research Institute; St. Paul's Hospital; McGill University Health Centre; McGill University; Dalhousie University; Royal Victoria Hospital; Université Laval; Royal Victoria Regional Health Centre; Université de Montréal","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Internal medicine; Cholesterol","score_opus":0.04652338534090319,"score_gpt":0.28923983240506146,"score_spread":0.24271644706415826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807007384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931657,0.000039391194,0.0010623244,0.001371181,0.0004022236,0.0013888063,0.0003945505,0.000054716376,0.0021211212],"genre_scores_gemma":[0.98938614,0.000054675133,0.0051683756,0.0036449216,0.00087506446,0.00026168665,0.0003478024,0.000046722365,0.00021463081],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99858916,0.000030391708,0.00024351313,0.00031344415,0.00029217097,0.00053132453],"domain_scores_gemma":[0.9989534,0.000012103335,0.0000390265,0.00044449707,0.00017198757,0.00037896377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035483312,0.00015302603,0.00024474287,0.00009716516,0.00027115535,0.000030271836,0.000092150294,0.00010745858,0.00044003592],"category_scores_gemma":[0.000034990848,0.00014115733,0.00019865767,0.000120699544,0.0000515728,0.00007320775,0.000021840478,0.00008434354,0.00019729443],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084382,0.0008144848,0.56348723,0.0006272938,0.0014283216,0.000012602277,0.0027715825,9.756395e-7,0.12068216,0.0032444124,0.12750584,0.17858131],"study_design_scores_gemma":[0.011219288,0.00259595,0.43984342,0.00025369888,0.00040986654,0.00003502124,0.00038954357,0.00008874047,0.02347268,0.0007031963,0.5204649,0.0005236902],"about_ca_topic_score_codex":0.054620955,"about_ca_topic_score_gemma":0.061590783,"teacher_disagreement_score":0.39295906,"about_ca_system_score_codex":0.0003402106,"about_ca_system_score_gemma":0.00028717212,"threshold_uncertainty_score":0.9555327},"labels":[],"label_agreement":null},{"id":"W2807173487","doi":"10.1016/j.atherosclerosissup.2018.04.154","title":"Surviving Familial Hypercholesterolemia without Coronary Artery Disease: A Unique Phenomenon Associated with Newly Identified Biological and Genetic Markers","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Chicoutimi; Université de Montréal","funders":"","keywords":"Familial hypercholesterolemia; Coronary artery disease; Disease; Medicine; Cardiology; Internal medicine; Genetics; Biology; Cholesterol","score_opus":0.028883524507130262,"score_gpt":0.259328666257439,"score_spread":0.23044514175030872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807173487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971712,0.00015398834,0.00078443077,0.0002087423,0.00013181804,0.0012402545,0.00012515883,0.000078801495,0.000105594496],"genre_scores_gemma":[0.9970691,0.0003063252,0.0010477351,0.00074492785,0.00023349366,0.00013211294,0.00021872645,0.000064802574,0.00018276775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745065,0.0003134452,0.00039883042,0.00066018366,0.00057318603,0.0006037168],"domain_scores_gemma":[0.99865973,0.000045256773,0.00012665673,0.00057478406,0.00013695216,0.00045659477],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005526366,0.00033049026,0.00051462784,0.000079895486,0.00026704883,0.0000708031,0.0001359076,0.00013342338,0.0002935429],"category_scores_gemma":[0.000061173625,0.0002532716,0.00012456412,0.00019528493,0.00030191208,0.00011632244,0.00013116049,0.00019897404,0.000023413559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006339819,0.0002421954,0.980332,0.000040394098,0.0004113047,0.000032216416,0.00023094048,8.038462e-7,0.011985539,0.000003330712,0.00018443559,0.0059028566],"study_design_scores_gemma":[0.005053492,0.0013615713,0.9916272,0.00034862585,0.00026390338,0.00003392188,0.00018127795,0.00010242878,0.00022773253,0.000029658457,0.00049076293,0.00027939526],"about_ca_topic_score_codex":0.00018953053,"about_ca_topic_score_gemma":0.0002556644,"teacher_disagreement_score":0.011757807,"about_ca_system_score_codex":0.00017735126,"about_ca_system_score_gemma":0.00013535476,"threshold_uncertainty_score":0.99999195},"labels":[],"label_agreement":null},{"id":"W2807278498","doi":"10.1016/j.atherosclerosissup.2018.04.096","title":"Effects of Lipoprotein(a) on Plasma Clot Formation and Lysis in vitro","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Plasma lipoprotein; In vitro; Lysis; Chemistry; Clot formation; Plasma; Biophysics; Lipoprotein; Internal medicine; Medicine; Biochemistry; Coagulation; Biology; Cholesterol; Physics","score_opus":0.012555139282790138,"score_gpt":0.2541200867339481,"score_spread":0.24156494745115795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807278498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802357,0.00008045026,0.00018189599,0.00019528401,0.00007787458,0.0011603688,0.000019727697,0.000021622212,0.00023922321],"genre_scores_gemma":[0.9979862,0.00021525832,0.0011368226,0.00029392398,0.00013230507,0.00014068383,0.00003297783,0.000024652074,0.00003718478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985979,0.00007953938,0.00033996845,0.00025067647,0.0004482411,0.00028367873],"domain_scores_gemma":[0.9993566,0.000037118,0.00010367941,0.00033537237,0.000063491076,0.000103741244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037746815,0.00015401714,0.0003824084,0.0001521815,0.00006683241,0.000011783959,0.00006295411,0.00008247148,0.00005385803],"category_scores_gemma":[0.00005660263,0.00013092977,0.00011216212,0.00022548072,0.00006619604,0.0001034433,0.00004875314,0.00010225106,0.000024881278],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010005764,0.00075527735,0.0129642915,0.0011170374,0.000258355,0.00000529446,0.0015738944,8.535423e-7,0.7857629,0.00012380959,0.0004541096,0.19598362],"study_design_scores_gemma":[0.0052714576,0.00114178,0.1466651,0.0003158818,0.00008953278,0.0000041837343,0.00007755643,0.00018556346,0.8444769,0.000032862758,0.0016266207,0.00011261079],"about_ca_topic_score_codex":0.00064629613,"about_ca_topic_score_gemma":0.000074285694,"teacher_disagreement_score":0.19587101,"about_ca_system_score_codex":0.00008667424,"about_ca_system_score_gemma":0.00002459499,"threshold_uncertainty_score":0.5339161},"labels":[],"label_agreement":null},{"id":"W2807358884","doi":"10.2217/fmeb2013.13.21","title":"PCSK9 inhibition: drug development for low-density lipoprotein lowering","year":2013,"lang":"en","type":"other","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Women's College Hospital","funders":"","keywords":"PCSK9; Drug; Drug development; Low-density lipoprotein; Lipoprotein; Pharmacology; LDL receptor; Internal medicine; Medicine; Cholesterol","score_opus":0.011992614792905806,"score_gpt":0.23929147352604327,"score_spread":0.22729885873313746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807358884","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005759955,0.002546585,0.024006214,0.00083861966,0.0009573176,0.009742145,0.000019305575,0.0009734351,0.95515645],"genre_scores_gemma":[0.0025233198,0.000108996486,0.022051213,0.0008431658,0.0023304776,0.00081006816,0.00018115823,0.00055932754,0.97059226],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981041,0.000020653832,0.00036655084,0.00053892913,0.0005362338,0.00043352705],"domain_scores_gemma":[0.99874467,0.0000105052795,0.00013833719,0.0007165773,0.00011399667,0.00027589806],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004117766,0.00037294262,0.0007971502,0.00019488005,0.00008996026,0.000031912085,0.00007280828,0.00035038,0.004349692],"category_scores_gemma":[0.000030793846,0.00030106844,0.00037256686,0.00010361993,0.000037884547,0.000032269414,0.00007872735,0.00025396506,0.00084217306],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046567508,0.00015584537,0.00002048681,0.0041499375,0.0006204529,0.000053274052,0.000103698534,2.524422e-7,0.00013734767,0.00027025092,0.8431539,0.15128799],"study_design_scores_gemma":[0.0016758274,0.00005725931,0.0002551669,0.0016946347,0.00010206098,0.000051417803,0.000036768382,0.000007864963,0.014793071,0.000024051458,0.98089194,0.00040995964],"about_ca_topic_score_codex":0.0024393294,"about_ca_topic_score_gemma":0.000700923,"teacher_disagreement_score":0.15087803,"about_ca_system_score_codex":0.00018250787,"about_ca_system_score_gemma":0.00038894053,"threshold_uncertainty_score":0.99994415},"labels":[],"label_agreement":null},{"id":"W2807460385","doi":"10.1016/j.atherosclerosissup.2018.04.087","title":"Apolipoprotein A-IV is an Endogenous Protective Factor for Atherothrombosis","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Canadian Blood Services; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Endogeny; Apolipoprotein B; Risk factor; Protective factor; Internal medicine; Medicine; Cholesterol","score_opus":0.10519826097228535,"score_gpt":0.3254171857401846,"score_spread":0.22021892476789923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807460385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808504,0.0000947724,0.0063997447,0.0006272106,0.00029903481,0.0092558395,0.0017832156,0.00022241923,0.000467339],"genre_scores_gemma":[0.98627394,0.00006321771,0.007547553,0.0019377742,0.0013507222,0.002266571,0.000138124,0.00016293589,0.00025913643],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99675757,0.00011970666,0.00052004226,0.00088416866,0.0007815978,0.0009369044],"domain_scores_gemma":[0.99761313,0.000024068713,0.00017961819,0.0013130672,0.00042696908,0.0004431374],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005436683,0.00042850059,0.00069418055,0.00012568437,0.00053684076,0.000074360396,0.00027991645,0.00022086514,0.0027664527],"category_scores_gemma":[0.000065118795,0.00037063585,0.0005091379,0.00027504936,0.00017067895,0.0002350363,0.00008954629,0.00019339482,0.00020565542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097044767,0.0024567707,0.02072517,0.0006318099,0.0024896835,0.0000048906772,0.014536664,3.9696437e-7,0.7872109,0.0003123779,0.0043859873,0.16627494],"study_design_scores_gemma":[0.012559817,0.010424937,0.0846336,0.00029448498,0.0005309365,0.000045212502,0.000936168,0.00017236604,0.7882935,0.0006370248,0.10047113,0.001000858],"about_ca_topic_score_codex":0.0020877104,"about_ca_topic_score_gemma":0.00021314864,"teacher_disagreement_score":0.16527408,"about_ca_system_score_codex":0.00029366824,"about_ca_system_score_gemma":0.00019102523,"threshold_uncertainty_score":0.99987453},"labels":[],"label_agreement":null},{"id":"W2807462403","doi":"10.1016/j.atherosclerosissup.2018.04.166","title":"Characterization of the Effects of Familial Hypercholesterolemia Mutations in LDLR on PCSK9 Binding","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"PCSK9; Familial hypercholesterolemia; Apolipoprotein B; LDL receptor; Mutation; Genetics; Loss function; Internal medicine; Endocrinology; Medicine; Biology; Cholesterol; Lipoprotein; Phenotype; Gene","score_opus":0.015964112458591573,"score_gpt":0.2648889416945129,"score_spread":0.2489248292359213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807462403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843967,0.0000058875858,0.00006175921,0.00013074429,0.0002854174,0.0009273291,0.00006058704,0.000009035442,0.00007958517],"genre_scores_gemma":[0.9993408,0.00003471575,0.000093676914,0.00023113009,0.0001058892,0.00005864111,0.000060525406,0.00002081411,0.000053818843],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99876153,0.00010731508,0.00034671903,0.00018200692,0.0004121859,0.00019022232],"domain_scores_gemma":[0.99928206,0.00003174747,0.00014159705,0.00042455655,0.00007561613,0.000044426983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002567619,0.000109902176,0.00026869433,0.00009778034,0.00006305891,0.0000052165533,0.0001075723,0.00006543079,0.000045678644],"category_scores_gemma":[0.00007486947,0.0000795781,0.00013585796,0.0003097913,0.00008779567,0.000054580076,0.00004656954,0.00010025646,0.000010880089],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003601019,0.00018245936,0.17130664,0.00015764691,0.000044460692,2.4975583e-7,0.00070807926,3.6394988e-7,0.82363904,0.000025996751,0.000014021767,0.0038850454],"study_design_scores_gemma":[0.0016253457,0.00036878194,0.57251,0.00045201238,0.00004348295,6.422221e-7,0.000044939105,0.000009667906,0.4246787,0.0000053061867,0.00022117053,0.000039930746],"about_ca_topic_score_codex":0.0002247881,"about_ca_topic_score_gemma":0.000053305346,"teacher_disagreement_score":0.40120336,"about_ca_system_score_codex":0.00007597488,"about_ca_system_score_gemma":0.00005479802,"threshold_uncertainty_score":0.32451007},"labels":[],"label_agreement":null},{"id":"W2807516139","doi":"10.1093/cvr/cvy119","title":"Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence","year":2018,"lang":"en","type":"review","venue":"Cardiovascular Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Statin; Pharmacogenetics; Medicine; Discontinuation; myalgia; Myopathy; Bioinformatics; Genome-wide association study; Disease; Pharmacogenomics; Internal medicine; Pharmacology; Genetics; Genotype; Single-nucleotide polymorphism; Biology; Gene","score_opus":0.11053252089166156,"score_gpt":0.36687479726642486,"score_spread":0.2563422763747633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807516139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031356946,0.9653809,0.0003069172,0.000002898527,0.000024768471,0.002647301,0.00020528777,0.000006784036,0.00006820916],"genre_scores_gemma":[0.012598621,0.98624676,0.00073918724,0.0000021850162,0.00007212094,0.00012955476,0.00015719763,0.000042812186,0.0000115385365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942617,0.0023729154,0.0008137191,0.0004329303,0.0017962736,0.00032248892],"domain_scores_gemma":[0.9971142,0.00036873014,0.0002585605,0.0011170283,0.0010409952,0.00010053354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076621743,0.0002144971,0.0019038431,0.00039309092,0.00006127809,0.000023424973,0.00018336417,0.0003118463,0.000007073683],"category_scores_gemma":[0.0011092562,0.00015140664,0.0007355946,0.0009759132,0.0004603611,0.00006795161,0.00014808784,0.00051958236,5.002119e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032234908,0.00015625622,0.0006223789,0.025669767,0.003089448,0.00001265064,0.0009475072,0.00021610306,0.000015469122,0.000024055262,0.000044503766,0.9691696],"study_design_scores_gemma":[0.019278789,0.013573847,0.10379716,0.13885279,0.027008278,0.00068512664,0.0075635333,0.011779804,0.0006475566,0.00028868995,0.6746902,0.0018342637],"about_ca_topic_score_codex":0.000900704,"about_ca_topic_score_gemma":0.000019665522,"teacher_disagreement_score":0.96733534,"about_ca_system_score_codex":0.00009622317,"about_ca_system_score_gemma":0.0005548865,"threshold_uncertainty_score":0.61741835},"labels":[],"label_agreement":null},{"id":"W2807539078","doi":"10.1016/j.amjcard.2018.05.016","title":"Willingness to be Reinitiated on a Statin (from the REasons for Geographic and Racial Differences in Stroke Study)","year":2018,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; U.S. Department of Health and Human Services; Agency for Healthcare Research and Quality; National Institutes of Health; Amgen; Icahn School of Medicine at Mount Sinai","keywords":"Discontinuation; Medicine; Statin; Confidence interval; Internal medicine; Physical therapy","score_opus":0.033333567801716195,"score_gpt":0.3095427031952278,"score_spread":0.2762091353935116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807539078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258554,0.00029289201,0.0011473848,0.005130054,0.00014972567,0.0005985583,0.000028745833,0.000004792693,0.00006231053],"genre_scores_gemma":[0.9964708,0.00018222535,0.00019610289,0.0018665275,0.001239196,0.000027777687,0.0000012853471,0.000011185142,0.0000048801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983706,0.0007070487,0.00030054725,0.00014888274,0.00025273667,0.00022020323],"domain_scores_gemma":[0.9986613,0.00052086427,0.00022919198,0.00029510385,0.00019365526,0.00009990666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016907471,0.00011063176,0.000761714,0.00008614018,0.0001203069,0.000012057799,0.00016190084,0.000025014848,0.0000023969765],"category_scores_gemma":[0.00037228572,0.00005290318,0.00018416047,0.00022853061,0.000442853,0.000017624361,0.000032160486,0.0002609039,5.9202927e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01146815,0.0001308289,0.7883818,0.000011374469,0.0024804014,0.00014985033,0.009826067,0.000039178543,0.00055327546,0.000118907374,0.00039703646,0.1864431],"study_design_scores_gemma":[0.0016770735,0.011898931,0.9760429,0.00005017028,0.00028266397,0.00015210161,0.007418003,0.00001152624,0.000026108211,0.0001498754,0.0022219673,0.000068627836],"about_ca_topic_score_codex":0.0004902422,"about_ca_topic_score_gemma":0.00013272192,"teacher_disagreement_score":0.18766113,"about_ca_system_score_codex":0.000021203074,"about_ca_system_score_gemma":0.000107143205,"threshold_uncertainty_score":0.2157329},"labels":[],"label_agreement":null},{"id":"W2807539308","doi":"10.1016/j.atherosclerosissup.2018.04.076","title":"Clinical Outcomes in Patients with Definite/Probable Familial Hypercholesterolemia (FH) or Severe Hypercholesterolemia: the CANHEART FH Study","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Virtualization; Cloud computing; Computer science; Moment (physics); Resource (disambiguation); Familial hypercholesterolemia; Supercomputer; Distributed computing; Operating system; Medicine; Computer network; Internal medicine; Cholesterol","score_opus":0.042219365040764616,"score_gpt":0.317141112606638,"score_spread":0.2749217475658734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807539308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945665,0.000017240049,0.000017420281,0.000483929,0.00039512708,0.0040946277,0.0001240162,0.00007399832,0.00022711669],"genre_scores_gemma":[0.9942717,0.000048235575,0.00069827476,0.0035949622,0.0003536357,0.00037683683,0.00009031679,0.00011392405,0.00045209122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99484235,0.0006017097,0.0011616027,0.0009629592,0.0014520639,0.0009793377],"domain_scores_gemma":[0.9972675,0.00014426006,0.00020200555,0.0017405893,0.0002972024,0.00034845664],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001912144,0.00052795367,0.001123945,0.00012991461,0.0003876831,0.00009851261,0.00045858553,0.00023644809,0.000284735],"category_scores_gemma":[0.00014479931,0.00029160824,0.00030608682,0.00049662584,0.00028226216,0.00023453558,0.00029251166,0.00077641266,0.00019974248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010520569,0.0026340215,0.9877542,0.000033987963,0.0004426128,0.00000839534,0.00085788005,0.0000013995867,0.00001911388,0.0000025016507,0.0013865903,0.0058072256],"study_design_scores_gemma":[0.022225458,0.006137033,0.96314603,0.00017822253,0.00032175798,0.000008263115,0.0010512035,0.000004490625,0.000023433415,0.0000049373025,0.006566612,0.00033255847],"about_ca_topic_score_codex":0.002587593,"about_ca_topic_score_gemma":0.008831439,"teacher_disagreement_score":0.024608186,"about_ca_system_score_codex":0.00027520693,"about_ca_system_score_gemma":0.00030539572,"threshold_uncertainty_score":0.9999536},"labels":[],"label_agreement":null},{"id":"W2807573121","doi":"10.1016/j.atherosclerosissup.2018.04.078","title":"Novel Anti-proteoglycan Antibody Inhibits Arterial Lipoprotein Retention and Prevents Cardiac Hypertrophy in a Rat Model of Insulin Resistance","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Insulin resistance; Lipoprotein; Internal medicine; Lipoprotein(a); Disease; Cardiology; Intensive care medicine; Endocrinology; Insulin; Cholesterol","score_opus":0.027234272559695048,"score_gpt":0.27070059437562327,"score_spread":0.24346632181592823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807573121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504656,0.0002673184,0.0016064999,0.00017963407,0.00023401079,0.0022658634,0.00025031943,0.00003098224,0.00011880706],"genre_scores_gemma":[0.98976403,0.0005261812,0.008788579,0.00011179694,0.00029094252,0.00017425005,0.00013311794,0.000059117407,0.00015195622],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973277,0.00012134013,0.00072906836,0.0006228763,0.0007033583,0.00049566553],"domain_scores_gemma":[0.99872106,0.000009728373,0.00023231217,0.0006964155,0.00016580049,0.00017469819],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007631503,0.00029485679,0.00077992986,0.00017735524,0.00012118016,0.000029886925,0.00012609409,0.00017093316,0.000044513432],"category_scores_gemma":[0.00005637195,0.0002756118,0.00022195165,0.00036010082,0.0001762974,0.00019464048,0.00013427205,0.00018597751,0.000006765614],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004465426,0.0003774432,0.013363241,0.00029241567,0.00011163861,0.0000010792689,0.00040715246,0.000003352779,0.982085,0.00005397582,0.000100743855,0.0027574503],"study_design_scores_gemma":[0.019882688,0.0014569723,0.22558384,0.002345104,0.00033047126,0.000008180357,0.00021869404,0.0012878168,0.7461752,0.00024642845,0.0017561879,0.00070837996],"about_ca_topic_score_codex":0.00095515745,"about_ca_topic_score_gemma":0.00019726947,"teacher_disagreement_score":0.23590973,"about_ca_system_score_codex":0.00011225844,"about_ca_system_score_gemma":0.00013638307,"threshold_uncertainty_score":0.9999696},"labels":[],"label_agreement":null},{"id":"W2807624081","doi":"10.1016/j.atherosclerosissup.2018.04.099","title":"Identification of Regions in PCSK9 Important for Its Secretion","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"PCSK9; Identification (biology); Secretion; Medicine; Biology; Internal medicine; LDL receptor; Cholesterol; Lipoprotein","score_opus":0.03773833087350714,"score_gpt":0.31504399134996003,"score_spread":0.2773056604764529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807624081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371576,0.00012463746,0.003654127,0.0005388983,0.0001682925,0.0015891476,0.00012037094,0.000021211003,0.00006756319],"genre_scores_gemma":[0.9983334,0.00018234123,0.00058622606,0.00014275947,0.00017752804,0.00024392689,0.00014645046,0.000023840767,0.00016352287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985873,0.00003514881,0.00059018034,0.000248655,0.00030294515,0.00023578331],"domain_scores_gemma":[0.99910897,0.000013767992,0.00019056734,0.00041407874,0.00020238223,0.000070259295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007902552,0.00009968311,0.00025460543,0.00009916037,0.000065415064,0.00000848879,0.000074475676,0.000069920956,0.00013260459],"category_scores_gemma":[0.00007806041,0.00009165662,0.00015740709,0.00021862338,0.00004284931,0.00007660355,0.00002270344,0.000052309373,0.000013915015],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022456514,0.0005440288,0.13034971,0.00039933578,0.00019192875,7.726976e-7,0.0010793722,9.909056e-7,0.8579186,0.0021774496,0.0022983886,0.004814836],"study_design_scores_gemma":[0.006622506,0.0011638141,0.43432826,0.00036001767,0.000205975,0.000006725196,0.00044814218,0.00094455155,0.53749,0.0005678321,0.017630395,0.00023175024],"about_ca_topic_score_codex":0.00013819677,"about_ca_topic_score_gemma":0.00014361553,"teacher_disagreement_score":0.32042858,"about_ca_system_score_codex":0.00008279716,"about_ca_system_score_gemma":0.00006732323,"threshold_uncertainty_score":0.37376484},"labels":[],"label_agreement":null},{"id":"W2807674644","doi":"10.1016/j.atherosclerosissup.2018.04.180","title":"Functional Analysis of Novel PCSK9 Mutants from Sapiens (R96L, R105W and P174S) and Denisovan (H449L)","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Homo sapiens; PCSK9; Mutant; Evolutionary biology; Biology; Genetics; Sociology; LDL receptor; Gene; Anthropology; Cholesterol","score_opus":0.039778035669807026,"score_gpt":0.2808686343490165,"score_spread":0.24109059867920946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807674644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959229,0.00035124784,0.0021743018,0.0002179467,0.0001402113,0.00038926935,0.0006752421,0.000027118502,0.00010173745],"genre_scores_gemma":[0.9950198,0.00033720094,0.0035200731,0.00047106427,0.00024154832,0.000027124479,0.0002535883,0.000030369642,0.00009926687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980782,0.000042182437,0.000430295,0.000510242,0.00060683984,0.00033221967],"domain_scores_gemma":[0.99887824,0.00004333377,0.0001462215,0.000526841,0.0001678951,0.00023744979],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00035186388,0.00021562193,0.0006367765,0.00021126072,0.00017025984,0.000028328343,0.00007213524,0.00011204447,0.0012036512],"category_scores_gemma":[0.000041147574,0.00018694904,0.00022119284,0.00050065847,0.00020977894,0.00010006589,0.000119453,0.00010565144,0.000011029789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019765696,0.0005053732,0.81672376,0.000061178005,0.0067270575,0.0000021977323,0.000988688,0.0000024369133,0.15690012,0.00011150105,0.0008093439,0.016970662],"study_design_scores_gemma":[0.004375507,0.00039453368,0.9761668,0.00007738404,0.0027317228,0.00000702892,0.00032165324,0.00054234645,0.012027606,0.000025069217,0.003163128,0.00016726054],"about_ca_topic_score_codex":0.0025375937,"about_ca_topic_score_gemma":0.00068660075,"teacher_disagreement_score":0.15944299,"about_ca_system_score_codex":0.0000551851,"about_ca_system_score_gemma":0.00005722979,"threshold_uncertainty_score":0.99970937},"labels":[],"label_agreement":null},{"id":"W2808119216","doi":"10.1007/s10900-018-0527-8","title":"South Asian Cardiovascular Disease &amp; Cancer Risk: Genetics &amp; Pathophysiology","year":2018,"lang":"en","type":"review","venue":"Journal of Community Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health","funders":"National Institute on Minority Health and Health Disparities; National Institute of Nursing Research; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Disease; Medicine; Population; Coronary artery disease; Ethnic group; Bioinformatics; Gerontology; Environmental health; Internal medicine; Biology","score_opus":0.09519800451951858,"score_gpt":0.3865251681860999,"score_spread":0.2913271636665813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808119216","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018298634,0.99394876,0.00091759535,0.00037711443,0.0010500287,0.0014379768,0.00031002105,0.000032458567,0.00009616033],"genre_scores_gemma":[0.00016565541,0.9925668,0.0018027426,0.00081930374,0.004158197,0.00004454101,0.00017467939,0.00015719728,0.000110831614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98619366,0.009080274,0.0022242947,0.00030049306,0.0013879554,0.00081333355],"domain_scores_gemma":[0.990079,0.00017368303,0.0028182708,0.0042470815,0.00084290927,0.0018390947],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008635469,0.0007021862,0.0065132887,0.0005088413,0.0008103187,0.000040852647,0.00083442085,0.0005010109,0.00008507831],"category_scores_gemma":[0.00065903994,0.0005115391,0.006350449,0.00055191637,0.00026244632,0.0000653803,0.0002915626,0.0055087274,0.000088965804],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094608215,0.00028818753,0.00008403517,0.036160834,0.005199683,0.000035186094,0.00093534077,0.0000136270555,3.4503753e-8,0.0000026561245,0.0041547096,0.9530311],"study_design_scores_gemma":[0.0010141843,0.00058010116,0.0012023613,0.017093051,0.008058544,0.00046511416,0.00011035292,6.211862e-7,3.647474e-8,0.00011993644,0.97102,0.0003357011],"about_ca_topic_score_codex":0.0033400133,"about_ca_topic_score_gemma":0.00061821897,"teacher_disagreement_score":0.9668653,"about_ca_system_score_codex":0.0011577928,"about_ca_system_score_gemma":0.0104390355,"threshold_uncertainty_score":0.9997336},"labels":[],"label_agreement":null},{"id":"W2808173897","doi":"10.1161/jaha.118.008920","title":"Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi‐Ethnic Study of Atherosclerosis)","year":2018,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Statin; Internal medicine; Coronary artery calcium; Confidence interval; Guideline; Coronary artery disease; Atherosclerotic cardiovascular disease; Cardiology; Atherosclerosis Risk in Communities; Task force; Canadian Cardiovascular Society; Physical therapy; Myocardial infarction; Disease; Angina","score_opus":0.04189594808528404,"score_gpt":0.35411724159919833,"score_spread":0.3122212935139143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808173897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481696,0.0007713756,0.00093382853,0.0017356677,0.00022853886,0.0014546884,0.000045244946,0.000011677045,0.0000020123182],"genre_scores_gemma":[0.9967346,0.0005693267,0.0009095322,0.0012983272,0.0003389892,0.000025558838,0.000006391913,0.000030851876,0.00008643038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954332,0.0015505225,0.0010114854,0.0002587113,0.0014205477,0.00032551907],"domain_scores_gemma":[0.9962382,0.0002504,0.0011306003,0.00061457383,0.0016059878,0.00016025802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006056962,0.00020680767,0.0010199047,0.00014787522,0.00022367656,0.000027570411,0.00024030019,0.000048748705,0.0000037269217],"category_scores_gemma":[0.0005483593,0.000121264406,0.0005802737,0.00075648894,0.00007560223,0.00015470445,0.0001590454,0.0002961047,0.0000034793318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005437967,0.0006059071,0.9627348,0.00012344874,0.0049207476,0.0000044493495,0.011961492,0.0011851895,0.004633118,6.158377e-7,0.0011038507,0.012182553],"study_design_scores_gemma":[0.002283047,0.0023084902,0.96693325,0.0004309316,0.0010248373,0.000044837587,0.024607519,0.00064912153,0.00064934336,0.00003313507,0.0008982651,0.0001372258],"about_ca_topic_score_codex":0.0045284415,"about_ca_topic_score_gemma":0.00043798418,"teacher_disagreement_score":0.012646026,"about_ca_system_score_codex":0.0005480327,"about_ca_system_score_gemma":0.00022495173,"threshold_uncertainty_score":0.68456787},"labels":[],"label_agreement":null},{"id":"W2808641584","doi":"10.1016/j.atherosclerosis.2018.06.002","title":"Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":423,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of British Columbia","funders":"Esperion Therapeutics","keywords":"Ezetimibe; Familial hypercholesterolemia; Statin; Medicine; Placebo; Randomized controlled trial; Internal medicine; Cholesterol","score_opus":0.010127252236469184,"score_gpt":0.2491877645965813,"score_spread":0.2390605123601121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808641584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896828,0.00009106442,0.0003222788,0.00019676857,0.00005583801,0.00943326,0.0000163415,0.000034029283,0.0001676005],"genre_scores_gemma":[0.99749976,0.000051765892,0.0012159294,0.00051736063,0.000077736775,0.0005405253,0.000008240892,0.00005099689,0.00003765783],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972067,0.00049470813,0.00075522484,0.0005051698,0.00065340253,0.00038477738],"domain_scores_gemma":[0.9984731,0.00020678743,0.00017736838,0.0006413029,0.0002505498,0.000250866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017078256,0.00029892704,0.0018289037,0.00017940621,0.000091490176,0.000023038128,0.00011111198,0.000099178935,0.000046740515],"category_scores_gemma":[0.0003124161,0.0001955645,0.00018205009,0.00034340643,0.00018688728,0.00007128316,0.0000767571,0.00021154463,0.000013251176],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82868326,0.0025437525,0.1340685,0.00012192213,0.0010641811,0.000004757821,0.012303042,0.000013784223,0.0019436249,0.000008195956,0.000035543657,0.019209424],"study_design_scores_gemma":[0.5717874,0.0030266228,0.42333037,0.0003618746,0.000375868,0.0000015797254,0.0004113156,0.000033099,0.00048723698,0.0000021703356,0.000030161673,0.00015230264],"about_ca_topic_score_codex":0.00054504257,"about_ca_topic_score_gemma":0.0002908828,"teacher_disagreement_score":0.28926188,"about_ca_system_score_codex":0.00008031768,"about_ca_system_score_gemma":0.00009101913,"threshold_uncertainty_score":0.79748887},"labels":[],"label_agreement":null},{"id":"W2809333384","doi":"10.1210/jc.2018-00777","title":"Associations Between Soluble LDLR and Lipoproteins in a White Cohort and the Effect of PCSK9 Loss-of-Function","year":2018,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute; Ottawa Hospital; University of Ottawa","funders":"Heart and Stroke Foundation of Canada","keywords":"PCSK9; LDL receptor; Internal medicine; Endocrinology; Ectodomain; Population; Cholesterol; Lipoprotein; Dyslipidemia; Biology; Medicine; Receptor; Disease","score_opus":0.026581419503438182,"score_gpt":0.3487415929515462,"score_spread":0.32216017344810804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809333384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888799,0.0060385624,0.0002453819,0.0035276809,0.00044153124,0.0006287967,0.000005036226,0.000004942316,0.00022815443],"genre_scores_gemma":[0.9947968,0.0032962356,0.00014683562,0.00023906978,0.0014510044,0.0000062130493,0.0000012532005,0.000011619749,0.000050941933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99595416,0.0018021036,0.001457909,0.00013557028,0.0004017329,0.00024853507],"domain_scores_gemma":[0.99668324,0.0015851837,0.0009921144,0.00037008533,0.00026414354,0.000105222585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010117023,0.00013048534,0.0017031098,0.00012215348,0.00008994912,0.0000055690684,0.0001497552,0.00015075832,0.000016387672],"category_scores_gemma":[0.002358289,0.000062973166,0.0003610233,0.0001974887,0.001153114,0.00007195437,0.00009398687,0.0008143249,0.0000016454973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029922947,0.000076858916,0.9366961,0.000054338525,0.0016516907,0.000009342232,0.00030996875,0.00000241987,0.00010673802,0.00079120527,0.000098601995,0.05721042],"study_design_scores_gemma":[0.0106530525,0.0016752846,0.98043513,0.00006936209,0.0023778155,0.00018720789,0.000035562407,0.000013732042,0.0007416606,0.0010154075,0.002746306,0.000049459184],"about_ca_topic_score_codex":0.0004069384,"about_ca_topic_score_gemma":0.000053058207,"teacher_disagreement_score":0.057160962,"about_ca_system_score_codex":0.0000118531,"about_ca_system_score_gemma":0.00013059076,"threshold_uncertainty_score":0.42486966},"labels":[],"label_agreement":null},{"id":"W2809736698","doi":"10.1038/s41569-018-0052-6","title":"The complex molecular genetics of familial hypercholesterolaemia","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":297,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Disease; Familial hypercholesterolemia; Family history; Genetic testing; Bioinformatics; Clinical phenotype; Phenotype; Population; Genetic counseling; Intensive care medicine; Genetics; Internal medicine; Cholesterol; Gene; Biology","score_opus":0.06306956413718486,"score_gpt":0.3844453032655319,"score_spread":0.32137573912834705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809736698","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009891156,0.99232846,0.0001267838,0.00007172626,0.0009703432,0.003914582,0.000050590006,0.000026084444,0.0025015166],"genre_scores_gemma":[0.000018876075,0.99541044,0.0008570198,0.00047534227,0.0025875987,0.00026257132,0.00022332503,0.000091773916,0.00007304013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946459,0.0020759448,0.0015150767,0.000696225,0.0005082812,0.00055858877],"domain_scores_gemma":[0.9960129,0.00017810588,0.00068137725,0.0026122422,0.00031649283,0.00019888223],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0028985227,0.00063171866,0.007147292,0.00012331591,0.00012360387,0.000013523717,0.0006084293,0.0020330967,0.000009388945],"category_scores_gemma":[0.00056662783,0.00033073092,0.0046511153,0.00042629993,0.00044361388,0.0000133323065,0.00022033349,0.0021852944,0.00010806743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010587888,0.000008772414,0.000005278092,0.019633781,0.0010045423,0.0000542269,0.000004085526,6.9453115e-8,0.000004778292,0.00016798887,0.006765542,0.97234035],"study_design_scores_gemma":[0.00029029275,0.00021857597,0.000062510284,0.0065737055,0.004382884,0.0018878687,0.0000023963162,4.529694e-7,0.0000015517263,0.0000317206,0.98630464,0.00024339551],"about_ca_topic_score_codex":0.000005720422,"about_ca_topic_score_gemma":0.000002817385,"teacher_disagreement_score":0.9795391,"about_ca_system_score_codex":0.00016064558,"about_ca_system_score_gemma":0.00073573604,"threshold_uncertainty_score":0.99991447},"labels":[],"label_agreement":null},{"id":"W2809860024","doi":"10.1002/clc.23018","title":"Rationale and design of a randomized study to assess the efficacy and safety of evolocumab in patients with diabetes and dyslipidemia: The BERSON clinical trial","year":2018,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"Amgen","keywords":"Evolocumab; Medicine; Dyslipidemia; PCSK9; Internal medicine; Atorvastatin; Placebo; Hyperlipidemia; Statin; Diabetes mellitus; Type 2 diabetes; Gastroenterology; Familial hypercholesterolemia; Alirocumab; Endocrinology; Cholesterol; Lipoprotein; Pathology","score_opus":0.0840738462412197,"score_gpt":0.38794600968339416,"score_spread":0.30387216344217444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809860024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99075526,0.00042780404,0.0007145852,0.00058315956,0.00021461061,0.0072620767,0.0000048866686,0.000004678806,0.00003291862],"genre_scores_gemma":[0.9984627,0.00012733831,0.00036992322,0.00034988316,0.0005599485,0.00011289837,0.0000031169866,0.000009430336,0.000004800242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924581,0.0055183703,0.0012280059,0.0003580513,0.00026829916,0.00016916686],"domain_scores_gemma":[0.9876133,0.011298353,0.0002577156,0.00048997416,0.00023203985,0.00010860883],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021799067,0.00012433257,0.002031389,0.000039661736,0.00006772153,0.0000053012122,0.000083795596,0.00015670607,0.0000027869698],"category_scores_gemma":[0.011071438,0.000056074903,0.00019054218,0.00011828429,0.0014035511,0.000021921986,0.00011403232,0.0003390534,4.2858278e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32179016,0.00028558593,0.6700002,0.000019987498,0.0007722614,0.000001209911,0.00024217863,0.0000052976957,7.49972e-7,0.0000344816,0.00007127263,0.0067766514],"study_design_scores_gemma":[0.33385655,0.008392559,0.6569086,0.00003058821,0.00048296008,0.0000013292073,0.00014121196,0.00004200139,8.723679e-7,0.00003754003,0.000063162945,0.000042652904],"about_ca_topic_score_codex":0.00001768944,"about_ca_topic_score_gemma":0.000011281269,"teacher_disagreement_score":0.013091608,"about_ca_system_score_codex":0.000009755679,"about_ca_system_score_gemma":0.00013200662,"threshold_uncertainty_score":0.9972587},"labels":[],"label_agreement":null},{"id":"W2809946846","doi":"10.1038/s41401-018-0013-y","title":"Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites","year":2018,"lang":"en","type":"article","venue":"Acta Pharmacologica Sinica","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Natural Science Foundation of China","keywords":"SLCO1B1; Rosuvastatin; Single-nucleotide polymorphism; Internal medicine; Atorvastatin; Pharmacogenetics; Medicine; Rosuvastatin Calcium; Pharmacology; Endocrinology; Statin; Chemistry; Biology; Genetics; Gene; Genotype","score_opus":0.020151181674351242,"score_gpt":0.2921524325191914,"score_spread":0.2720012508448401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809946846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953272,0.0016690574,0.00001208994,0.0008377928,0.0002782133,0.0015983671,0.00007770044,0.00005474091,0.00014489041],"genre_scores_gemma":[0.99606663,0.0011381023,0.0012817695,0.00109663,0.000238928,0.00007521663,0.00001163513,0.00003742314,0.000053670796],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99751735,0.00042739077,0.0006086295,0.0005740632,0.00045969198,0.00041288437],"domain_scores_gemma":[0.9978701,0.0006385891,0.00037252385,0.00034129462,0.00036433688,0.00041314357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086739816,0.0003140047,0.0010575578,0.00015921202,0.00012171376,0.000014117959,0.0001390432,0.00019945607,0.000093537856],"category_scores_gemma":[0.0009406012,0.00023585936,0.00013585677,0.00040589154,0.00013161238,0.00008276484,0.00015260279,0.00028958908,0.000009853679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013064867,0.0005316579,0.0009998676,0.0005008104,0.00061339006,0.00008553475,0.00050161016,0.0000015963753,0.9794532,0.00008842918,0.00035345132,0.015563969],"study_design_scores_gemma":[0.0061819726,0.004845242,0.24700633,0.00023269758,0.00067724276,0.00004534132,0.000065706925,0.000088827466,0.73991615,0.00002861544,0.0007060137,0.00020588616],"about_ca_topic_score_codex":0.000055989243,"about_ca_topic_score_gemma":0.0000028470345,"teacher_disagreement_score":0.24600646,"about_ca_system_score_codex":0.000027286458,"about_ca_system_score_gemma":0.00013940096,"threshold_uncertainty_score":0.96180654},"labels":[],"label_agreement":null},{"id":"W2810654503","doi":"10.7326/l18-0181","title":"Comparison of Five Major Guidelines for Statin Use in Primary Prevention","year":2018,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Statin; Guideline; Primary prevention; Population; Clinical trial; Internal medicine; Family medicine; Disease; Pathology","score_opus":0.1909205835904571,"score_gpt":0.4548596806493003,"score_spread":0.2639390970588432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810654503","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18038446,0.011505087,0.0062295836,0.79494363,0.0014401918,0.004007137,0.00029721146,0.000036442776,0.0011562571],"genre_scores_gemma":[0.020368146,0.0015570342,0.012519178,0.92987645,0.020118399,0.00023470214,0.0018458656,0.00017723384,0.013302983],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962605,0.00013445961,0.0019293304,0.0003753403,0.00096633454,0.00033403345],"domain_scores_gemma":[0.99561644,0.00026523307,0.0010387842,0.0005972005,0.0023953472,0.0000870201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015276177,0.00029806164,0.0019951547,0.00045545105,0.000015497648,0.000004193324,0.00021546334,0.00041004896,0.00012202417],"category_scores_gemma":[0.002025712,0.00021602077,0.000498669,0.00015864863,0.00021896821,0.0000744253,0.00005876257,0.0006678122,0.0000032298249],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008810581,0.00012711431,0.0024905205,0.004385282,0.0005924397,0.000055384076,0.00029150455,0.0000012992665,0.00032968313,0.0000051347442,0.9780047,0.012835891],"study_design_scores_gemma":[0.007451763,0.010085229,0.014497502,0.03386593,0.00081038364,0.00008454714,0.00031220773,0.00022032835,0.009045015,0.0005100841,0.92275023,0.00036676967],"about_ca_topic_score_codex":0.0033674615,"about_ca_topic_score_gemma":0.00011143327,"teacher_disagreement_score":0.16001631,"about_ca_system_score_codex":0.000052583684,"about_ca_system_score_gemma":0.00022755966,"threshold_uncertainty_score":0.8809071},"labels":[],"label_agreement":null},{"id":"W2810704879","doi":"10.1194/jlr.m086264","title":"Plasma PCSK9 correlates with apoB-48-containing triglyceride-rich lipoprotein production in men with insulin resistance","year":2018,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"PCSK9; Endocrinology; Internal medicine; Apolipoprotein B; Kexin; Triglyceride; Insulin resistance; Chylomicron; Insulin; Chemistry; Lipoprotein; Cholesterol; LDL receptor; Very low-density lipoprotein; Biology; Medicine","score_opus":0.0345051936367944,"score_gpt":0.322463807312683,"score_spread":0.2879586136758886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810704879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985088,0.0013085946,0.000102883205,0.0041953716,0.00020665188,0.0011389669,0.0000011396687,0.000018612809,0.007939805],"genre_scores_gemma":[0.9898423,0.00040248,0.0032072691,0.00003687756,0.003655551,0.000046707137,0.0000018307338,0.00005350026,0.0027534668],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9953279,0.00052469946,0.00072076026,0.0003834967,0.002359862,0.00068331667],"domain_scores_gemma":[0.9966451,0.00011141639,0.00033124222,0.0005546043,0.0020280387,0.00032959826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008046801,0.00020291729,0.00069437566,0.00081682985,0.0002539375,0.00006641107,0.00023152897,0.00014926828,0.000074829884],"category_scores_gemma":[0.00093504024,0.00012570094,0.00010719209,0.0016398305,0.00036783048,0.0003194081,0.00005500334,0.0017522143,0.000034075238],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33990118,0.004033784,0.21807408,0.00407855,0.004225466,0.007751335,0.025657905,0.0006534352,0.030919526,0.0006532276,0.037941847,0.32610968],"study_design_scores_gemma":[0.08915169,0.07822063,0.29054376,0.027030881,0.00068910106,0.018193612,0.032082867,0.0013426279,0.250444,0.0007486205,0.20943256,0.00211965],"about_ca_topic_score_codex":0.00023247802,"about_ca_topic_score_gemma":0.0006759725,"teacher_disagreement_score":0.32399002,"about_ca_system_score_codex":0.00049582636,"about_ca_system_score_gemma":0.0014918019,"threshold_uncertainty_score":0.7612596},"labels":[],"label_agreement":null},{"id":"W2810788589","doi":"10.1016/j.jval.2018.04.370","title":"A Discrete Event Simulation Model For A Pharmacogenomics Test For Statin-Induced Myopathy In Patients Initiating A Statin In Secondary Cardiovascular Prevention","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Université Laval; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Statin; Pharmacogenomics; Dyslipidemia; Myopathy; Rhabdomyolysis; Internal medicine; Physical therapy; Cardiology; Pharmacology","score_opus":0.06368450406815251,"score_gpt":0.35470105840453175,"score_spread":0.29101655433637924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810788589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9239319,0.0005318151,0.067066744,0.00014994333,0.00014923647,0.007928541,0.00019481187,0.000025583226,0.000021409465],"genre_scores_gemma":[0.9845842,0.00007871167,0.013485328,0.00040726166,0.00023322314,0.000874823,0.00025796724,0.00006687663,0.000011610791],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99683,0.0003573869,0.0011809024,0.0005470611,0.00043405915,0.0006506307],"domain_scores_gemma":[0.9986818,0.0002613144,0.00028549673,0.00038805994,0.00020809205,0.00017524582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043225326,0.0002278375,0.0007554501,0.00036129256,0.00011218084,0.000016026377,0.00007931667,0.000116191804,0.0000034936957],"category_scores_gemma":[0.00067107927,0.00023703478,0.0003557488,0.00036751624,0.000021043732,0.00016900642,0.000035405614,0.00028712902,0.0000015048316],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016063041,0.0011440315,0.023990182,0.0052233925,0.00019586412,0.000007706903,0.011182159,0.5400775,0.00018147346,0.000058704827,0.000019340754,0.41631332],"study_design_scores_gemma":[0.015318567,0.0018501752,0.034656458,0.0008276588,0.000052738138,0.0000015233504,0.00023688919,0.945633,0.00013386006,0.00091617444,0.00016009665,0.00021288515],"about_ca_topic_score_codex":0.0022721216,"about_ca_topic_score_gemma":0.00037743823,"teacher_disagreement_score":0.41610044,"about_ca_system_score_codex":0.0010522509,"about_ca_system_score_gemma":0.0013774454,"threshold_uncertainty_score":0.96659976},"labels":[],"label_agreement":null},{"id":"W2811129839","doi":"10.1016/j.thromres.2018.07.002","title":"Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen on the surface of vascular endothelial and smooth muscle cells","year":2018,"lang":"en","type":"article","venue":"Thrombosis Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"Canadian Institutes of Health Research","keywords":"Plasmin; Kringle domain; Umbilical vein; Chemistry; Biochemistry; Apolipoprotein B; Lipoprotein(a); Vascular smooth muscle; Lipoprotein; Molecular biology; Biology; Enzyme; In vitro; Endocrinology; Smooth muscle; Cholesterol","score_opus":0.06641897530875623,"score_gpt":0.3382350406732068,"score_spread":0.2718160653644506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811129839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232197,0.0003811008,0.000028106084,0.0022604482,0.000093298164,0.0024374228,0.000054299,0.00001781885,0.0024055613],"genre_scores_gemma":[0.9982735,0.0006261888,0.000221127,0.0003000265,0.00030812767,0.000046097262,0.0000037227237,0.000041365296,0.00017987828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956294,0.0007501307,0.00039667168,0.00045782476,0.0021497577,0.0006162261],"domain_scores_gemma":[0.9969525,0.000545891,0.000097827426,0.0014449328,0.0006979729,0.0002609247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051165447,0.00020700104,0.00056962477,0.00017352002,0.00039094893,0.000026631898,0.00041277247,0.00015062657,0.0003273614],"category_scores_gemma":[0.00040326768,0.00011612815,0.00025359384,0.00073878426,0.0009768315,0.000049910104,0.00036595514,0.00045674903,0.00016166524],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003761941,0.00026687898,0.0009035393,0.00048862596,0.00040529863,0.000003548801,0.0027841905,0.000011997576,0.9842162,0.0006145397,0.0032807433,0.006648227],"study_design_scores_gemma":[0.001195769,0.0018429788,0.029176105,0.00027108518,0.00009104874,0.0000030624024,0.0010661712,0.000093748145,0.9482557,0.0000677669,0.017814288,0.00012227712],"about_ca_topic_score_codex":0.0038689317,"about_ca_topic_score_gemma":0.00006968797,"teacher_disagreement_score":0.035960518,"about_ca_system_score_codex":0.000097929886,"about_ca_system_score_gemma":0.00028432303,"threshold_uncertainty_score":0.5848693},"labels":[],"label_agreement":null},{"id":"W2811414353","doi":"10.2196/resprot.9248","title":"Therapeutic Management of Dyslipidemia Patients at Very High Cardiovascular Risk (CARDIO TRACK): Protocol for the Observational Registry Study","year":2018,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Medicine; Observational study; Statin; Internal medicine; Risk factor; Atherosclerotic cardiovascular disease; Physical therapy; Disease; Pitavastatin","score_opus":0.29205545570005587,"score_gpt":0.5120932364981284,"score_spread":0.22003778079807257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811414353","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014725986,0.000016586495,0.0004048469,0.00016262825,0.000023336239,0.98391944,0.000045628934,0.000053310232,0.0006482054],"genre_scores_gemma":[0.027995741,0.0000017804554,0.0005881044,0.00005756145,0.00090778066,0.96951723,0.000019847637,0.00007212843,0.00083984603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99281085,0.0012426482,0.00075865735,0.0007722353,0.0036134734,0.00080216455],"domain_scores_gemma":[0.9946153,0.00029566724,0.00024386546,0.002846635,0.0017838902,0.00021461306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00948477,0.00029452096,0.0007719362,0.0001398373,0.0008187083,0.000060455994,0.0006104771,0.00017493367,0.0001153719],"category_scores_gemma":[0.000204254,0.0001869736,0.00093216385,0.0006804109,0.00044511564,0.00012463392,0.00039912024,0.0006214934,0.000043574564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025489526,0.010847016,0.44633844,0.017578166,0.020191388,0.00007524128,0.0011838096,0.00009495912,0.00013015687,0.001283135,0.04578272,0.43100545],"study_design_scores_gemma":[0.014665255,0.0051350566,0.51699096,0.0009837407,0.00014629115,0.0000028290958,0.00022903737,0.000046323225,0.0005710099,0.00022259585,0.46084192,0.00016500057],"about_ca_topic_score_codex":0.00015068325,"about_ca_topic_score_gemma":0.000014201338,"teacher_disagreement_score":0.43084043,"about_ca_system_score_codex":0.00045662705,"about_ca_system_score_gemma":0.00034845807,"threshold_uncertainty_score":0.7624562},"labels":[],"label_agreement":null},{"id":"W2835370860","doi":"10.1016/j.cjca.2018.06.019","title":"The Cardiovascular Burden of Undiagnosed Familial Hypercholesterolemia: Need to Modify Guidelines to Encourage Earlier Diagnosis and Therapy","year":2018,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Internal medicine; Life expectancy; Disease; Coronary artery disease; Statin; Pediatrics; Cholesterol; Population","score_opus":0.042017341440390585,"score_gpt":0.28215078657171144,"score_spread":0.24013344513132084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2835370860","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24415553,0.058305334,0.0013555143,0.68789446,0.003934702,0.0026531245,0.00026945508,0.000015126991,0.0014167619],"genre_scores_gemma":[0.34433308,0.032450266,0.0018792511,0.46888536,0.15079227,0.00039354974,0.000069408925,0.00041264028,0.0007841852],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960343,0.00066340546,0.0011321856,0.00046566894,0.00083189376,0.0008725491],"domain_scores_gemma":[0.9951735,0.00026374587,0.0002863635,0.0012929038,0.0018071787,0.0011763105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002672286,0.00046619572,0.002405772,0.0006998287,0.0002271295,0.000059670783,0.000587505,0.0009262231,0.000020114227],"category_scores_gemma":[0.00094168715,0.00031866707,0.0017158691,0.00032083772,0.00037369187,0.00005190826,0.000061962244,0.0015452033,0.000011755718],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010033915,0.0000014148358,0.0023918443,0.00008924544,0.004364986,0.001326503,0.00032120672,0.00053853844,0.00003339929,0.0000025425306,0.8882058,0.10262417],"study_design_scores_gemma":[0.0014280031,0.0011201969,0.004712419,0.0003506505,0.0007950694,0.0013203598,0.00024765468,0.0000021869942,0.00007534569,0.00004247647,0.9896267,0.00027894886],"about_ca_topic_score_codex":0.017975496,"about_ca_topic_score_gemma":0.000619276,"teacher_disagreement_score":0.21900909,"about_ca_system_score_codex":0.00025376264,"about_ca_system_score_gemma":0.0023897053,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W2848978533","doi":"10.1016/j.jacc.2018.04.054","title":"The Evolving Future of PCSK9 Inhibitors","year":2018,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":264,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"PCSK9; Medicine; Ezetimibe; Proprotein convertase; Kexin; Clinical trial; Coronary artery disease; Internal medicine; Monoclonal antibody; Disease; Acute coronary syndrome; Cholesterol; LDL receptor; Pharmacology; Lipoprotein; Antibody; Immunology; Myocardial infarction","score_opus":0.01722825365685192,"score_gpt":0.30324153793483,"score_spread":0.28601328427797806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2848978533","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006788635,0.99466765,0.000027653716,0.0006951104,0.0023338916,0.00065152615,0.000062038125,0.0000036421368,0.0008796116],"genre_scores_gemma":[0.0023764647,0.98877555,0.00025891306,0.00007061436,0.008303482,0.00000867269,0.0000010734416,0.000045111952,0.00016014614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99581903,0.0013330943,0.0015889842,0.0001861729,0.0007563859,0.0003163502],"domain_scores_gemma":[0.9932743,0.0003858629,0.004240985,0.0011392018,0.0008265899,0.00013307265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027620876,0.00030513937,0.0051699206,0.00020234117,0.00013318955,0.000004279071,0.0007143325,0.00020965318,0.000004756031],"category_scores_gemma":[0.00052586145,0.00013264864,0.0049215998,0.00077752984,0.0011230205,0.00002895844,0.00019301505,0.0008877866,0.0000019968813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002747731,0.000033502114,0.00022330464,0.006305407,0.008090408,0.00019551588,0.00003201949,0.000003907326,0.0000098886785,0.00015368195,0.06458915,0.92008847],"study_design_scores_gemma":[0.00035395497,0.0010190324,0.00026377998,0.0046693087,0.003217381,0.0070836795,0.00033526958,4.3587983e-7,0.000010699834,0.00003386962,0.9829066,0.000106022926],"about_ca_topic_score_codex":0.000015373038,"about_ca_topic_score_gemma":0.0000029508362,"teacher_disagreement_score":0.91998243,"about_ca_system_score_codex":0.00020568806,"about_ca_system_score_gemma":0.0020186517,"threshold_uncertainty_score":0.54092544},"labels":[],"label_agreement":null},{"id":"W2883063400","doi":"10.1016/j.ihj.2018.03.011","title":"Adaptation of 2016 European Society of Cardiology/European Atherosclerosis Society guideline for lipid management to Indian patients – A consensus document","year":2018,"lang":"en","type":"review","venue":"Indian Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"American Heart Association","keywords":"Dyslipidemia; Medicine; Guideline; Canadian Cardiovascular Society; Consensus conference; Family medicine; Cardiology; Internal medicine; Pathology","score_opus":0.065465522955158,"score_gpt":0.33398895585880434,"score_spread":0.26852343290364633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883063400","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039586914,0.97449833,0.00584952,0.0009112788,0.0020210352,0.010754277,0.00089365535,0.00006558025,0.0010476365],"genre_scores_gemma":[0.00056539685,0.9572557,0.037655592,0.0007484751,0.003152457,0.000055501336,0.00021179618,0.00016864955,0.00018643995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951827,0.0008674444,0.0021636009,0.00048860774,0.0007416697,0.00055600604],"domain_scores_gemma":[0.9968241,0.00006538989,0.0011349272,0.00073685526,0.0007478224,0.000490923],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0053777276,0.0004523731,0.0021822054,0.00020753383,0.0002256676,0.000032622334,0.0002743554,0.00021149249,0.000025815136],"category_scores_gemma":[0.00008110907,0.00034944518,0.00386312,0.0002977502,0.00013886334,0.000039718547,0.00016031407,0.00048885756,0.000057859972],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041615902,0.000101763966,0.00020142642,0.013999725,0.0031953577,0.000016923965,0.001318602,0.00001071055,0.000002445118,0.0000020643338,0.17472592,0.80638343],"study_design_scores_gemma":[0.0020949962,0.0011661947,0.00093199423,0.014457469,0.0014452204,0.00024477523,0.00040114322,0.000002012918,0.0000033900126,0.0000036507333,0.9789763,0.00027282612],"about_ca_topic_score_codex":0.00003134037,"about_ca_topic_score_gemma":0.000002041128,"teacher_disagreement_score":0.8061106,"about_ca_system_score_codex":0.00037709382,"about_ca_system_score_gemma":0.00054892455,"threshold_uncertainty_score":0.99989575},"labels":[],"label_agreement":null},{"id":"W2883976099","doi":"10.1161/jaha.118.008918","title":"Effects of Lipid‐Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE‐3 Trial","year":2018,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; McMaster University; Université Laval; Population Health Research Institute; Hamilton General Hospital","funders":"Servier; AstraZeneca; Amgen","keywords":"Medicine; Primary prevention; Internal medicine; Pharmacology; Physical therapy; Traditional medicine; Disease","score_opus":0.009468116897137446,"score_gpt":0.29069643645831,"score_spread":0.28122831956117256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883976099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979373,0.00010551606,0.000014963092,0.0011829856,0.00016418607,0.00058059744,0.0000039269003,0.0000015512428,0.000008952974],"genre_scores_gemma":[0.9987027,0.00014334229,0.00019223032,0.0006135047,0.00032015025,0.000006619589,0.0000012107375,0.0000059014146,0.0000143234465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983419,0.0005445109,0.0004578533,0.00009023912,0.00045180303,0.00011368734],"domain_scores_gemma":[0.99872375,0.00013449225,0.0007046148,0.00016609229,0.00021477141,0.000056311106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012338207,0.00006559632,0.00074415805,0.00024148241,0.000039076695,0.000005183498,0.000053950367,0.000034833374,0.0000019641316],"category_scores_gemma":[0.0005629733,0.000039838713,0.00032036132,0.000955613,0.000039299306,0.000079248195,0.000024265912,0.000119674994,1.7015638e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054186904,0.0005906621,0.9718159,0.00007270781,0.0010920184,0.0000025187985,0.000995727,0.000052768253,0.0076399175,0.0000010568584,0.000112529844,0.012205528],"study_design_scores_gemma":[0.0059214314,0.0026434478,0.9886664,0.00023477923,0.00070445985,0.0000068911663,0.00012014346,0.000042108582,0.0015644899,0.0000054439847,0.000058846774,0.000031562482],"about_ca_topic_score_codex":0.0006177421,"about_ca_topic_score_gemma":0.00022809916,"teacher_disagreement_score":0.016850522,"about_ca_system_score_codex":0.00044982767,"about_ca_system_score_gemma":0.00018869793,"threshold_uncertainty_score":0.16245756},"labels":[],"label_agreement":null},{"id":"W2884122380","doi":"10.1016/j.atherosclerosis.2018.07.038","title":"PCSK9 inhibition for patients with and without prior coronary revascularization: Potential additional benefit of a novel therapeutic agent","year":2018,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Canadian VIGOUR Centre","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Percutaneous coronary intervention; Coronary artery disease; Guideline; Canadian Cardiovascular Society; Revascularization; Conventional PCI; Angina; Statin; Myocardial infarction; Pathology","score_opus":0.020758422079682058,"score_gpt":0.23192569970502927,"score_spread":0.2111672776253472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884122380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.871887,0.0012458201,0.030683434,0.05984491,0.00090658956,0.016718248,0.018261923,0.00023659249,0.0002154611],"genre_scores_gemma":[0.47407216,0.0005752295,0.030921033,0.42874455,0.0113211265,0.003198635,0.048766375,0.00077365106,0.0016272615],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.997786,0.000038863927,0.00040839406,0.0005561126,0.0008970212,0.00031362838],"domain_scores_gemma":[0.9984001,0.000034274824,0.0003322754,0.0005327095,0.00061177666,0.000088898174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018701695,0.00034570205,0.00068322197,0.00010774439,0.00016569067,0.000027477468,0.00007031986,0.00050725776,0.00035774094],"category_scores_gemma":[0.000021690801,0.00027054982,0.0003614053,0.00012696664,0.00019229362,0.000085970954,0.000043158867,0.00033276595,0.0000043449977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006731024,0.007466418,0.09569097,0.020069128,0.02164107,0.000033899818,0.0014970226,0.0000449396,0.005358202,0.000334115,0.7430963,0.09803694],"study_design_scores_gemma":[0.025970334,0.0058540795,0.65980875,0.004910645,0.00428359,0.00010380926,0.000027418822,0.00023305319,0.0003990111,0.0001439435,0.29721916,0.0010461907],"about_ca_topic_score_codex":0.000034572095,"about_ca_topic_score_gemma":0.000004121898,"teacher_disagreement_score":0.5641178,"about_ca_system_score_codex":0.000104476254,"about_ca_system_score_gemma":0.0001532892,"threshold_uncertainty_score":0.99997467},"labels":[],"label_agreement":null},{"id":"W2884685238","doi":"","title":"Abstract 16232: Lipoprotein(a) is Not Associated With the Risk of Ischemic Cardiovascular Events Following Acute Coronary Syndrome","year":2016,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; St. Michael's Hospital","funders":"","keywords":"Medicine; Acute coronary syndrome; Cardiology; Internal medicine; Lipoprotein(a); Lipoprotein; Myocardial infarction; Cholesterol","score_opus":0.013625927486052866,"score_gpt":0.23321369891135427,"score_spread":0.2195877714253014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884685238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489945,0.0010608974,0.0020088952,0.00046212517,0.00010250176,0.0011184292,0.00004621271,0.00005540821,0.00024605854],"genre_scores_gemma":[0.9993742,0.00012623868,0.00007033347,0.00011287836,0.0000775032,0.00006564659,0.000039230257,0.000046474066,0.00008750974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771976,0.00012841432,0.00033321918,0.00036773348,0.0011519179,0.00029897582],"domain_scores_gemma":[0.9984389,0.000073135576,0.00025827636,0.0009563449,0.00016592344,0.000107424734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013051606,0.00020469593,0.00058149896,0.00007144815,0.00015540994,0.0000083097,0.00011801113,0.00017261144,0.00004921872],"category_scores_gemma":[0.00013634142,0.00011198073,0.0010228272,0.00026819305,0.000055366625,0.00017017344,0.000030451067,0.00020026274,0.000027251777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047407605,0.00030639675,0.7634577,0.00032199256,0.039848737,0.0005017531,0.0007027463,0.00025822932,0.05331577,0.000019979107,0.00044295535,0.14034967],"study_design_scores_gemma":[0.0028047902,0.000094894014,0.9891823,0.0005302634,0.0023046983,0.0001684529,0.00003150311,0.000038946622,0.004205833,0.000026603495,0.00044665154,0.00016509418],"about_ca_topic_score_codex":0.00027006335,"about_ca_topic_score_gemma":0.000007113523,"teacher_disagreement_score":0.22572458,"about_ca_system_score_codex":0.00020631346,"about_ca_system_score_gemma":0.00014833164,"threshold_uncertainty_score":0.45664415},"labels":[],"label_agreement":null},{"id":"W2884696809","doi":"10.4212/cjhp.v51i5.1976","title":"Suspected pravastatin-induced rhabdomyolysis in a patient experiencing a myocardial infarction","year":2018,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pravastatin; Rhabdomyolysis; Myocardial infarction; Medicine; Internal medicine; Cardiology; Cholesterol","score_opus":0.016003686319854916,"score_gpt":0.2778605630275121,"score_spread":0.26185687670765717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884696809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936362,0.00049481844,0.000026846154,0.0036373907,0.00095704803,0.00043162378,0.0000028239044,0.0000068413674,0.000806414],"genre_scores_gemma":[0.997817,0.000026402955,0.000109183224,0.00074966945,0.001253651,0.0000110456385,0.0000015154844,0.000020556578,0.000010989795],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984644,0.00014313002,0.00044545764,0.00012919477,0.000438923,0.0003788907],"domain_scores_gemma":[0.998521,0.000020540827,0.00020628252,0.00023761987,0.00045363134,0.0005609555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006867463,0.00013159991,0.00031704162,0.00029761577,0.00022561828,0.000050677256,0.00012877148,0.00003621386,0.00016349988],"category_scores_gemma":[0.00023030261,0.00009260723,0.00024511197,0.00046856413,0.000112367445,0.00017138827,0.0000138661735,0.00043590966,0.000014242184],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017019735,0.0005046683,0.11522494,0.00013121865,0.0030262878,0.006343802,0.19070251,0.00006519838,0.022293989,0.00026923962,0.008971645,0.6507645],"study_design_scores_gemma":[0.030830234,0.018750533,0.6739131,0.0012820801,0.0017241946,0.0073911324,0.030495012,0.00076798425,0.102912314,0.000779103,0.12943317,0.0017211231],"about_ca_topic_score_codex":0.05137341,"about_ca_topic_score_gemma":0.022352412,"teacher_disagreement_score":0.6490434,"about_ca_system_score_codex":0.0005624752,"about_ca_system_score_gemma":0.0022869504,"threshold_uncertainty_score":0.9954871},"labels":[],"label_agreement":null},{"id":"W2884766884","doi":"10.4149/gpb_2017047","title":"Exercise training increased gene expression of LDL-R and PCSK9 inintestine: link to transintestinal cholesterol excretion","year":2018,"lang":"en","type":"article","venue":"General Physiology and Biophysics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Montfort Hospital; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Internal medicine; Endocrinology; Ovariectomized rat; PCSK9; Cholesterol; Excretion; LDL receptor; Kexin; Receptor; Chemistry; Medicine; Lipoprotein; Estrogen","score_opus":0.020100491416571383,"score_gpt":0.2606142090044742,"score_spread":0.2405137175879028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884766884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807656,0.00020568937,0.00093766104,0.00026568226,0.00007841528,0.00033727117,0.000011394754,0.00003045227,0.000056871108],"genre_scores_gemma":[0.9898691,0.00010286355,0.008160584,0.00054736773,0.0012133382,0.000020718557,0.000046767855,0.000016828672,0.000022387288],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990056,0.00006700078,0.00022389335,0.00034507058,0.00013095228,0.00022745201],"domain_scores_gemma":[0.9993234,0.000018181205,0.000069673406,0.00025541594,0.00014196403,0.00019132084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017976327,0.00017038158,0.0004432647,0.000058286292,0.00010457406,0.000006366732,0.000048209808,0.00011374974,0.000009773515],"category_scores_gemma":[0.000027718317,0.00013330174,0.0000818983,0.00014161428,0.00026014252,0.00005178368,0.000048431317,0.00014123545,0.0000038624476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037701277,0.000042501502,0.0002469289,0.00012279609,0.000020271229,0.0000031445943,0.00038748773,0.0000028014033,0.91412574,0.00003070463,0.000023168359,0.08461743],"study_design_scores_gemma":[0.001650853,0.0017599162,0.14278635,0.00046511568,0.00012997961,0.000098369936,0.000058012138,0.00032750404,0.85185957,0.00047497576,0.00020013485,0.00018919687],"about_ca_topic_score_codex":0.00011122979,"about_ca_topic_score_gemma":0.0000023865928,"teacher_disagreement_score":0.14253941,"about_ca_system_score_codex":0.000008444964,"about_ca_system_score_gemma":0.00005784489,"threshold_uncertainty_score":0.54358876},"labels":[],"label_agreement":null},{"id":"W2884800433","doi":"10.1001/jamacardio.2018.2112","title":"Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial","year":2018,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amarin Corporation; Sanofi; Esperion Therapeutics; Amgen","keywords":"Medicine; Acute coronary syndrome; Atheroma; Internal medicine; Tolerability; Cardiology; Placebo; Statin; Gastroenterology; Urology; Myocardial infarction; Adverse effect; Pathology","score_opus":0.009977385861871276,"score_gpt":0.25319301575314745,"score_spread":0.24321562989127618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884800433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934474,0.00019064432,0.000018051905,0.00019336169,0.0003643292,0.005637237,0.00004955225,0.000024125762,0.00007528256],"genre_scores_gemma":[0.99884754,0.000046876165,0.0000849574,0.00024210266,0.00023037624,0.00029872675,0.00019547575,0.000042993222,0.000010942096],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99483716,0.002535775,0.00074063137,0.00060995144,0.00074734254,0.0005291208],"domain_scores_gemma":[0.9977796,0.00027453597,0.00030589136,0.0012576049,0.00018368082,0.00019868281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028883268,0.0003659004,0.001733894,0.00032157934,0.00008064635,0.0000074399923,0.00028376616,0.00025974953,0.000016170992],"category_scores_gemma":[0.00031012236,0.00022723954,0.0002740472,0.0003964015,0.0003849055,0.00009689287,0.000109507586,0.0005452976,0.0000075022695],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55761427,0.0011864802,0.37818944,0.0004267393,0.0006123314,0.0019565253,0.0003255726,0.000025085175,0.00038990713,0.00008262809,0.000034772158,0.059156254],"study_design_scores_gemma":[0.06913553,0.1259817,0.80281645,0.00047799267,0.00033550823,0.00020009032,0.000033151155,0.000019081015,0.00072426186,0.00006902681,0.000021480404,0.00018573873],"about_ca_topic_score_codex":0.005358757,"about_ca_topic_score_gemma":0.00023752643,"teacher_disagreement_score":0.48847875,"about_ca_system_score_codex":0.00016717476,"about_ca_system_score_gemma":0.00023501042,"threshold_uncertainty_score":0.92665595},"labels":[],"label_agreement":null},{"id":"W2885199433","doi":"10.1007/s12291-018-0763-9","title":"Genotyping and Frequency of PCSK9 Variations Among Hypercholesterolemic and Diabetic Subjects","year":2018,"lang":"en","type":"article","venue":"Indian Journal of Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ottawa Hospital Research Institute","keywords":"PCSK9; Single-nucleotide polymorphism; SNP; SNP genotyping; Genotyping; Population; Glycated hemoglobin; Medicine; Genetics; Biology; Diabetes mellitus; Genotype; Type 2 diabetes; Internal medicine; Cholesterol; Endocrinology; Gene; LDL receptor; Lipoprotein","score_opus":0.023388636604904634,"score_gpt":0.3243027721020038,"score_spread":0.30091413549709917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885199433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732167,0.0017475716,0.0001089976,0.0003345199,0.00012577344,0.000086025895,0.0000050449294,0.0000039969013,0.00026642118],"genre_scores_gemma":[0.9967485,0.0002775162,0.0016985789,0.00019353407,0.001053001,8.754328e-7,0.0000016371486,0.000010539375,0.000015832851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985456,0.00007256245,0.000845207,0.00015309759,0.00023401796,0.00014950031],"domain_scores_gemma":[0.998584,0.00013215038,0.00042060975,0.00023706639,0.00026485496,0.00036137103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014514333,0.000092326845,0.0005021493,0.00005417555,0.000047432542,0.000013140608,0.00007278279,0.00020145257,0.000021689742],"category_scores_gemma":[0.0010474165,0.00007486206,0.00017573794,0.0000917433,0.00040355787,0.00005642917,0.000029817307,0.00040715683,0.0000012161163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011256616,0.00014744115,0.8941454,0.00054417015,0.00044627258,0.00014263375,0.0004387175,9.3844115e-8,0.044187322,0.000012360257,0.000046173915,0.059776805],"study_design_scores_gemma":[0.0028110957,0.0007692595,0.9404927,0.0009235532,0.0003208761,0.0010551553,0.00015947224,0.000008394343,0.05284558,0.00040253182,0.000087714034,0.00012365467],"about_ca_topic_score_codex":0.000019816815,"about_ca_topic_score_gemma":0.0000030865472,"teacher_disagreement_score":0.05965315,"about_ca_system_score_codex":0.000016815542,"about_ca_system_score_gemma":0.00031449707,"threshold_uncertainty_score":0.3052786},"labels":[],"label_agreement":null},{"id":"W2885514890","doi":"10.1161/circoutcomes.109.848473","title":"Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein","year":2009,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Sanofi; Kowa Company; Genentech; BG Medicine; Anthera; Pfizer; National Heart, Lung, and Blood Institute; National Cancer Institute; Brigham and Women's Hospital; Fondation Leducq; Bristol-Myers Squibb; Donald W. Reynolds Foundation","keywords":"Rosuvastatin; Medicine; Number needed to treat; Statin; Body mass index; Internal medicine; Rosuvastatin Calcium; Placebo; Population; Cholesterol; Myocardial infarction; C-reactive protein; Absolute risk reduction; Surrogate endpoint; Relative risk; Physical therapy; Endocrinology; Confidence interval; Environmental health; Pathology; Inflammation","score_opus":0.01292361712032582,"score_gpt":0.25478022133725947,"score_spread":0.24185660421693364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885514890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98578656,0.00052632537,0.007017837,0.00080213015,0.000021572345,0.00564357,0.00003111053,0.00012464,0.00004624682],"genre_scores_gemma":[0.9976024,0.00007236548,0.0010631138,0.00063506933,0.00011176379,0.0003545974,0.000034655786,0.00006703988,0.000058974125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99506104,0.00084150134,0.00058858766,0.0013704154,0.0014357495,0.00070270506],"domain_scores_gemma":[0.9971538,0.00008235128,0.00015848358,0.0012562939,0.0003464104,0.0010026388],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032666938,0.00068200333,0.0022015027,0.0001985193,0.0004419775,0.00015359737,0.00006537163,0.00025434556,0.000004204388],"category_scores_gemma":[0.00020840592,0.0005295409,0.00044191102,0.00043615137,0.00013173911,0.00040636532,0.00010888719,0.0003482649,0.0000037183886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047309725,0.0010944698,0.754254,0.004576996,0.02346575,0.0007509567,0.0145589085,0.0040856656,0.0043833503,0.00027119927,0.00001287224,0.18781486],"study_design_scores_gemma":[0.0062951767,0.0005157188,0.98577154,0.00056579337,0.0011179912,0.00038612488,0.00095540186,0.00006679043,0.0034438295,0.000096911805,0.000083204395,0.0007015385],"about_ca_topic_score_codex":0.009741386,"about_ca_topic_score_gemma":0.00027442627,"teacher_disagreement_score":0.23151752,"about_ca_system_score_codex":0.00031722363,"about_ca_system_score_gemma":0.000101311234,"threshold_uncertainty_score":0.9997156},"labels":[],"label_agreement":null},{"id":"W2885580564","doi":"","title":"Persistent lipid abnormalities in patients treated with statins: Portuguese results of the Dyslipidemia International Study (DYSIS).","year":2011,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Medicine; Simvastatin; Internal medicine; Statin; Population; Triglyceride; Risk factor; Cholesterol; Disease; Environmental health","score_opus":0.029296482804982267,"score_gpt":0.2224905612088397,"score_spread":0.19319407840385744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885580564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895524,0.000053709184,9.5033914e-7,0.00010036059,0.00015240567,0.0021296411,0.00003557622,0.000018043005,0.007956959],"genre_scores_gemma":[0.99851334,0.000015064921,0.000038654336,0.00010062991,0.00008048563,0.00058796915,0.000027653348,0.000014319225,0.0006218852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828464,0.000144882,0.00044977423,0.0002248766,0.0006430892,0.00025276162],"domain_scores_gemma":[0.99899673,0.000017256458,0.00018177953,0.00047613567,0.00022738625,0.00010072842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088566483,0.00012103957,0.00030332958,0.00010485114,0.000027930228,0.000005206562,0.00014519098,0.00004178225,0.000015755018],"category_scores_gemma":[0.00020938025,0.00006912718,0.00015571318,0.00020977035,0.000059465958,0.000091285205,0.000057265977,0.00014620909,0.0000012280706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016008854,0.0010783671,0.9620035,0.000038456074,0.00046841655,0.000010750126,0.0036420038,0.000004901439,3.0794774e-7,0.0000112427015,0.000100745536,0.031040395],"study_design_scores_gemma":[0.0067403214,0.00043192864,0.98945314,0.00004081195,0.0001363064,0.0000028194302,0.0027935025,0.0000065979743,0.0000971308,0.0000018131886,0.00022297888,0.00007267248],"about_ca_topic_score_codex":0.0027716393,"about_ca_topic_score_gemma":0.00030299183,"teacher_disagreement_score":0.030967724,"about_ca_system_score_codex":0.00013567865,"about_ca_system_score_gemma":0.000060870716,"threshold_uncertainty_score":0.4189908},"labels":[],"label_agreement":null},{"id":"W2885868731","doi":"10.1161/circ.132.suppl_3.18914","title":"Abstract 18914: Comparison of Statin Eligibility Using the Pooled Cohort Equations, ATP-III Framingham and Reynolds Risk Scores Among Adults Who Experienced ASCVD Events: The Atherosclerosis Risk in Communities Study","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"","keywords":"Medicine; Framingham Risk Score; Internal medicine; Statin; Cohort; Stroke (engine); Framingham Heart Study; Diabetes mellitus; Demography; Relative risk; Cardiology; Confidence interval; Disease; Endocrinology","score_opus":0.05803427284022741,"score_gpt":0.3459399303889757,"score_spread":0.2879056575487483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885868731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408054,0.00074566493,0.0025562241,0.000028359795,0.00005741106,0.0024690817,0.000016446727,0.000024930863,0.000021308371],"genre_scores_gemma":[0.9996016,0.0000948297,0.000090816015,0.000018942192,0.000050585608,0.00010255996,0.000021711443,0.000017690232,0.0000012863637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741346,0.00081623957,0.00066451804,0.00022697156,0.0006923827,0.00018644528],"domain_scores_gemma":[0.9980371,0.0002877963,0.0004832089,0.0008430502,0.0002731547,0.00007569281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00358124,0.00015726204,0.00045498228,0.000078900375,0.00035655242,0.000037636633,0.00012793747,0.0000895048,0.000007399887],"category_scores_gemma":[0.00056627113,0.00010335273,0.00009560794,0.00028320568,0.00020787807,0.00017964451,0.000062143525,0.00037113111,6.4291515e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010335277,0.00023520633,0.9192927,0.00003582833,0.00010920372,2.2048704e-7,0.071751855,0.004175228,0.00005026737,0.000006352709,0.0000026612145,0.004237151],"study_design_scores_gemma":[0.0019769117,0.00011333132,0.8659278,0.00022605088,0.00020591018,7.491876e-7,0.08757365,0.043722738,0.00009498709,0.00006746758,0.000002371044,0.00008799605],"about_ca_topic_score_codex":0.05436922,"about_ca_topic_score_gemma":0.003677822,"teacher_disagreement_score":0.053364836,"about_ca_system_score_codex":0.00017217317,"about_ca_system_score_gemma":0.00011296516,"threshold_uncertainty_score":0.95192784},"labels":[],"label_agreement":null},{"id":"W2885935805","doi":"10.1161/circgen.118.002165","title":"Genetic Regulation of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Plasma Levels","year":2018,"lang":"en","type":"letter","venue":"Circulation Genomic and Precision Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Clinical Research Institute","funders":"","keywords":"Kexin; PCSK9; Subtilisin; Proprotein convertase; Proprotein Convertases; LDL receptor; Chemistry; Endocrinology; Cholesterol; Biology; Biochemistry; Lipoprotein; Enzyme","score_opus":0.03828867792389773,"score_gpt":0.27305914237835716,"score_spread":0.23477046445445943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885935805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8986701,0.011464154,0.0058961217,0.07602827,0.0019604354,0.004364179,0.000092373775,0.000112393966,0.0014120042],"genre_scores_gemma":[0.91993743,0.0008329922,0.0026715493,0.058765154,0.0134925945,0.000051403695,0.0012599733,0.00018373503,0.0028051673],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962968,0.00027510815,0.0011517371,0.0007855512,0.0011285116,0.00036224167],"domain_scores_gemma":[0.9971855,0.00016776819,0.000600183,0.0011488086,0.0006867676,0.00021094215],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011519698,0.00044048298,0.0012689083,0.00045355395,0.00013151894,0.000015897092,0.0001526965,0.0009922266,0.0016902613],"category_scores_gemma":[0.00038208088,0.00035123725,0.00021037238,0.0002919632,0.00038951405,0.000064947286,0.00006872699,0.00074624666,0.00008310497],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013338528,0.00009800922,0.008073955,0.005170764,0.0011161215,0.0002661408,0.0018260032,0.00009314768,0.0604894,0.00005657163,0.5515988,0.36987725],"study_design_scores_gemma":[0.0056119943,0.0012505271,0.4608332,0.0021310102,0.0011620063,0.0006518467,0.000064052605,0.003113453,0.0012600551,0.0012322711,0.5221109,0.0005787177],"about_ca_topic_score_codex":0.00023060532,"about_ca_topic_score_gemma":0.000004893331,"teacher_disagreement_score":0.45275924,"about_ca_system_score_codex":0.00017242118,"about_ca_system_score_gemma":0.00036615037,"threshold_uncertainty_score":0.99989396},"labels":[],"label_agreement":null},{"id":"W2886129529","doi":"10.1007/s10557-018-6816-8","title":"Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus","year":2018,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"Amgen","keywords":"Medicine; Statin; Rosuvastatin; Diabetes mellitus; Myocardial infarction; Atorvastatin; Internal medicine; Intensity (physics); Pharmacy; Cardiology; Endocrinology","score_opus":0.006761172454070548,"score_gpt":0.22533713733122956,"score_spread":0.21857596487715902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886129529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883855,0.0086323805,0.0004817135,0.0001859064,0.00025018048,0.0014678254,0.000006822152,0.00004769246,0.000088940695],"genre_scores_gemma":[0.993578,0.004121912,0.00072131323,0.0010097723,0.0004010461,0.00007542235,0.00003745171,0.000044369823,0.000010723577],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99813384,0.00014327327,0.0002271613,0.0005143449,0.00063193135,0.00034944678],"domain_scores_gemma":[0.9989662,0.000010979631,0.000042803713,0.0005416059,0.00023157023,0.00020680806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008717583,0.00025732745,0.00080387335,0.00014767538,0.0001646644,0.00006189064,0.00004622783,0.00011052514,0.0000051270745],"category_scores_gemma":[0.0000129076325,0.00018783551,0.00042888668,0.00027462543,0.00008980692,0.00016204925,0.000025484784,0.00016472403,0.000004111028],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016342435,0.00011397803,0.37206203,0.000031070067,0.008712837,0.000008233433,0.0018177845,0.0000097875945,0.00043960198,0.000028419481,0.000033695324,0.6151083],"study_design_scores_gemma":[0.012726691,0.0017741892,0.971912,0.00010935106,0.0003609953,0.000008495383,0.000114805465,0.000028531062,0.0020097154,0.00006932017,0.010569163,0.0003167031],"about_ca_topic_score_codex":0.00041510814,"about_ca_topic_score_gemma":0.000010149635,"teacher_disagreement_score":0.61479163,"about_ca_system_score_codex":0.000058576177,"about_ca_system_score_gemma":0.0000596389,"threshold_uncertainty_score":0.76597095},"labels":[],"label_agreement":null},{"id":"W2886262235","doi":"10.1161/circ.136.suppl_1.23087","title":"Abstract 23087: Applying the FOURIER Trial amongst Real-world Cardiovascular Disease Patients: The Cardiovascular Health in Ambulatory Care Research Team (CANHEART) PCSK9 Study","year":2017,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Unstable angina; Hazard ratio; Population; Cohort; PCSK9; Internal medicine; Stroke (engine); Ambulatory; Emergency medicine; Cardiology; Confidence interval; Myocardial infarction; Cholesterol; Environmental health","score_opus":0.07382185628680699,"score_gpt":0.3548073001308774,"score_spread":0.2809854438440704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886262235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651859,0.01058588,0.00006150154,0.00064230274,0.00072652183,0.020771425,0.000025319208,0.00007766731,0.0019235065],"genre_scores_gemma":[0.99498856,0.00039087646,0.000021841524,0.00015701693,0.0018567547,0.0023723636,0.00008915872,0.000091456044,0.00003198566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921544,0.0014763285,0.0008275536,0.0009984839,0.0036496185,0.00089361623],"domain_scores_gemma":[0.99194115,0.00012738783,0.00026457675,0.0065742107,0.00065641676,0.00043625134],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.012425618,0.0003670096,0.0010581174,0.00027915297,0.0028753746,0.00031127175,0.00057457027,0.00013854005,0.000016025955],"category_scores_gemma":[0.00066905183,0.00024371281,0.001997466,0.0005444927,0.00033404,0.00032688255,0.0002357886,0.0011913349,0.000032354772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024451886,0.00078973226,0.64294565,0.0006707377,0.0036542022,0.000086813976,0.0045361198,0.004929079,0.0000025191448,0.00009661849,0.0004902512,0.3393531],"study_design_scores_gemma":[0.020801669,0.00016179646,0.94259155,0.0002117765,0.00056048925,0.0000028127758,0.002499904,0.00033327218,0.000002004452,0.000050836123,0.03254798,0.00023588471],"about_ca_topic_score_codex":0.025893914,"about_ca_topic_score_gemma":0.0017210628,"teacher_disagreement_score":0.33911723,"about_ca_system_score_codex":0.001210021,"about_ca_system_score_gemma":0.001066228,"threshold_uncertainty_score":0.99842274},"labels":[],"label_agreement":null},{"id":"W2886308947","doi":"10.1139/cjpp-2018-0102","title":"Efficiency of atorvastatin and simvastatin in improving cardiac function during the different degrees of hyperhomocysteinemia","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Simvastatin; Atorvastatin; Hyperhomocysteinemia; Internal medicine; Cardiology; Medicine; Homocysteine; Cardiac function curve; Heart failure","score_opus":0.00808977648829876,"score_gpt":0.24231380542325684,"score_spread":0.23422402893495808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886308947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665093,0.0026646503,0.000019542893,0.0001205844,0.00034901281,0.00015956358,0.000008155598,9.538941e-7,0.00002660112],"genre_scores_gemma":[0.9994457,0.000135068,0.000035924848,0.00007429443,0.00029114855,0.0000027477665,8.099951e-7,0.0000057032544,0.000008600927],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99915653,0.00018941799,0.00030912174,0.00009642058,0.00006405664,0.00018443489],"domain_scores_gemma":[0.9993581,0.00007732371,0.00019402873,0.000075737495,0.00013152057,0.0001632923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037930137,0.00008041981,0.00040187515,0.00014788787,0.00007416624,0.0000015599741,0.000047805523,0.000063687345,0.0000849541],"category_scores_gemma":[0.000034180095,0.000052388536,0.00007246401,0.000090905305,0.0003818985,0.00002727254,0.000013831862,0.00020826864,2.012386e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031089925,0.000020072865,0.03451471,0.00041872112,0.00015577416,0.00001450459,0.00075538695,0.000019118528,0.95907086,0.000040793595,0.000030524505,0.0046486366],"study_design_scores_gemma":[0.0020246082,0.0013396702,0.8811736,0.00006781784,0.00020762712,0.00011291376,0.00043040334,0.00014448939,0.11423251,0.000052833348,0.00015137593,0.00006213633],"about_ca_topic_score_codex":0.0018519581,"about_ca_topic_score_gemma":0.0011710963,"teacher_disagreement_score":0.8466589,"about_ca_system_score_codex":0.000034715646,"about_ca_system_score_gemma":0.0003328996,"threshold_uncertainty_score":0.2799619},"labels":[],"label_agreement":null},{"id":"W2886541216","doi":"10.4212/cjhp.v52i4.1818","title":"Le PharmD de niveau d'entrée — Est-il nécessaire?","year":2018,"lang":"fr","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.014349937558214666,"score_gpt":0.2773157550698726,"score_spread":0.26296581751165793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886541216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6724455,0.1145554,0.00032753378,0.1820008,0.0150407795,0.000729645,0.00009346991,0.000017316403,0.014789597],"genre_scores_gemma":[0.9742426,0.0018449754,0.00018909627,0.0037484253,0.017473856,0.000004701644,0.000003077518,0.00007276974,0.0024204983],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996754,0.0003832145,0.00066324265,0.0002267254,0.0006461935,0.0013266358],"domain_scores_gemma":[0.99544483,0.00005938544,0.00039993814,0.00050290773,0.0007808983,0.002812037],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026783026,0.00031041965,0.0005766939,0.00020226916,0.0010063078,0.00021034387,0.00068581465,0.00010989309,0.0014220942],"category_scores_gemma":[0.00027158202,0.00024759554,0.0006449549,0.00040513393,0.0012629488,0.000413959,0.00003851466,0.0011112967,0.00035299305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005954285,0.0007731193,0.021091044,0.0007688611,0.0055341837,0.013847813,0.02256995,0.00013325765,0.00079475093,0.018564433,0.36877906,0.5465481],"study_design_scores_gemma":[0.0054703597,0.0014129357,0.006405675,0.00066794915,0.0011421726,0.00322601,0.0013518198,0.000247348,0.005220982,0.001789688,0.9726879,0.00037715398],"about_ca_topic_score_codex":0.23815677,"about_ca_topic_score_gemma":0.058683187,"teacher_disagreement_score":0.60390884,"about_ca_system_score_codex":0.0011302098,"about_ca_system_score_gemma":0.027318886,"threshold_uncertainty_score":0.9999976},"labels":[],"label_agreement":null},{"id":"W2886615031","doi":"10.1016/j.cjca.2018.07.477","title":"Cholesterol Lowering Guidelines: From Whence We Came and Where We Are Now","year":2018,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Clinical trial; Cholesterol; Bile acid; Intensive care medicine; Randomized controlled trial; Cholestyramine; Internal medicine; Pathology","score_opus":0.07009219043951172,"score_gpt":0.32626453403848515,"score_spread":0.25617234359897345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886615031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011204546,0.9939243,0.00075063517,0.0026692837,0.0015917752,0.00043655728,0.00014397001,0.000007677155,0.0003637151],"genre_scores_gemma":[0.00014615749,0.98885375,0.00031473453,0.00032931476,0.010047238,0.000012119203,0.000015919535,0.000073132614,0.00020763531],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99731773,0.0002620705,0.0011764517,0.00040969608,0.00027988333,0.0005541736],"domain_scores_gemma":[0.99639845,0.00006918806,0.00073964935,0.000719536,0.00062348443,0.0014496989],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090165867,0.00043898678,0.004007909,0.00042936218,0.00010306782,0.00004694265,0.00031719502,0.00067988713,0.000042751442],"category_scores_gemma":[0.00028809824,0.00033039114,0.0012707402,0.00016402702,0.00024137297,0.00007643888,0.000038540147,0.0009736382,0.000043514476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010117172,0.000001178387,0.0005700423,0.0072832145,0.0018689105,0.0013887738,0.000094283176,0.0000039607344,3.1810558e-7,0.0000022066097,0.035037175,0.9537398],"study_design_scores_gemma":[0.0004975609,0.00020180111,0.00018752998,0.03973602,0.0019111565,0.0085927,0.00007941698,8.177897e-7,3.0332174e-7,0.000018963949,0.9485321,0.00024159907],"about_ca_topic_score_codex":0.0019946978,"about_ca_topic_score_gemma":0.006691564,"teacher_disagreement_score":0.95349824,"about_ca_system_score_codex":0.00041319625,"about_ca_system_score_gemma":0.004416363,"threshold_uncertainty_score":0.9999148},"labels":[],"label_agreement":null},{"id":"W2887397898","doi":"10.1016/j.cjca.2018.08.027","title":"A Novel Cause of Familial Hypercholesterolemia: PCSK9 Gene Duplication","year":2018,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Clinical Research Institute","funders":"","keywords":"Familial hypercholesterolemia; Medicine; PCSK9; LDL receptor; Apolipoprotein B; Internal medicine; Cholesterol; Endocrinology; Lipoprotein; Genetics; Biology","score_opus":0.03132778756032079,"score_gpt":0.2576589286245864,"score_spread":0.2263311410642656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887397898","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27610928,0.011869373,0.024965404,0.66454005,0.009787153,0.0023903318,0.0012205378,0.00003356957,0.009084284],"genre_scores_gemma":[0.41375315,0.000953574,0.0029608386,0.42855942,0.15193959,0.000041516403,0.00050978345,0.0002727019,0.0010094309],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772716,0.00019342291,0.00083993276,0.00028549132,0.00041605355,0.0005379331],"domain_scores_gemma":[0.9969602,0.000044827848,0.0005466003,0.000823562,0.0010588437,0.00056596874],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00087350886,0.00027524898,0.0016412453,0.0006236619,0.00006433722,0.000011604128,0.00030542925,0.0013212617,0.000020809444],"category_scores_gemma":[0.00022501824,0.00023783953,0.000927213,0.00016456707,0.00035463469,0.000047565056,0.000018532959,0.0018468772,0.000017593607],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008950263,0.000004139096,0.0027303982,0.0004125865,0.0025723698,0.0024877016,0.00013226955,0.00003854237,0.0033105086,0.000008293174,0.9810922,0.00712145],"study_design_scores_gemma":[0.0014438058,0.000638249,0.015563057,0.00021364448,0.0010740571,0.015798386,0.000019558367,0.0000015193876,0.00032057482,0.000023642904,0.9647261,0.00017741499],"about_ca_topic_score_codex":0.0035754598,"about_ca_topic_score_gemma":0.00061085034,"teacher_disagreement_score":0.23598066,"about_ca_system_score_codex":0.00047014793,"about_ca_system_score_gemma":0.005115179,"threshold_uncertainty_score":0.9999752},"labels":[],"label_agreement":null},{"id":"W2887473262","doi":"10.1002/clc.23049","title":"Consistent LDL‐C response with evolocumab among patient subgroups in PROFICIO: A pooled analysis of 3146 patients from phase 3 studies","year":2018,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"European Society of Cardiology; Amgen","keywords":"Evolocumab; Medicine; PCSK9; Placebo; Internal medicine; Regimen; Alirocumab; Dosing; Adverse effect; Diabetes mellitus; Demography; Hypertriglyceridemia; Gastroenterology; Lipoprotein; Endocrinology; Cholesterol; Triglyceride","score_opus":0.05005643842866261,"score_gpt":0.38973453282256126,"score_spread":0.3396780943938987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887473262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996765,0.0013047878,0.00012573707,0.00018664532,0.00032301876,0.0010582997,0.00009489725,0.000028728362,0.00011287119],"genre_scores_gemma":[0.99861956,0.00015017096,0.00027420302,0.00045224882,0.00024893603,0.00009987447,0.00011764067,0.000021445485,0.000015917421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951638,0.0019261033,0.0013619784,0.0006975812,0.00046401305,0.000386527],"domain_scores_gemma":[0.9965035,0.00096478243,0.00037791856,0.001090369,0.0008439092,0.00021952591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025309774,0.0002362889,0.0026537043,0.00033158797,0.000055453223,0.000004048589,0.00011155262,0.00029138062,0.00003204471],"category_scores_gemma":[0.002813514,0.0001613592,0.00091237336,0.0007671687,0.0012007039,0.000036818543,0.00012279673,0.000360275,0.0000109184675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021381395,0.0006705983,0.95323443,0.000034272267,0.014073242,0.00019318583,0.0005271631,0.000018162766,0.000035324923,0.0000072624366,0.00018739617,0.009637571],"study_design_scores_gemma":[0.010625635,0.0112719275,0.969759,0.00010777432,0.0063854647,0.0000060203897,0.0007926781,0.0001397083,0.00008013342,0.000020674841,0.00064521853,0.00016577508],"about_ca_topic_score_codex":0.00035919063,"about_ca_topic_score_gemma":0.0003681031,"teacher_disagreement_score":0.016524563,"about_ca_system_score_codex":0.00014734876,"about_ca_system_score_gemma":0.00024309792,"threshold_uncertainty_score":0.65800375},"labels":[],"label_agreement":null},{"id":"W2887565581","doi":"10.1016/j.cjca.2018.07.479","title":"Whole-Gene Duplication of PCSK9 as a Novel Genetic Mechanism for Severe Familial Hypercholesterolemia","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Ottawa; Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Gene duplication; PCSK9; Mechanism (biology); Familial hypercholesterolemia; Genetics; Internal medicine; Gene; Cholesterol; LDL receptor; Lipoprotein","score_opus":0.021019116739690397,"score_gpt":0.2590617801104124,"score_spread":0.23804266337072202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887565581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93038064,0.0004985058,0.065389976,0.0012786846,0.0007190268,0.0005010103,0.00008963142,0.0000044371545,0.0011380801],"genre_scores_gemma":[0.99137723,0.000039901148,0.004278874,0.0008217696,0.0033434392,0.000013763751,0.00001219136,0.000024591498,0.00008821028],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988283,0.00006140076,0.00044754767,0.00016604816,0.00017694144,0.00031974277],"domain_scores_gemma":[0.9978758,0.000024640318,0.00019647629,0.0003610479,0.0009918606,0.00055014173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000541233,0.00012025515,0.000625698,0.00022385205,0.00007736947,0.000006816275,0.0001475608,0.0002060581,0.000010661253],"category_scores_gemma":[0.00022795695,0.00010620305,0.00040742176,0.00010723593,0.0001484219,0.00003732169,0.0000091919455,0.00017454776,0.000010306688],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019149411,0.00004790037,0.020571262,0.00079373503,0.004807514,0.00041184106,0.0018208757,0.00072237983,0.6974256,0.0075621763,0.008513974,0.25540778],"study_design_scores_gemma":[0.01864513,0.012174338,0.3598071,0.0004840017,0.0024303803,0.040804334,0.00080078753,0.00020266726,0.045336284,0.007421956,0.5111373,0.00075574877],"about_ca_topic_score_codex":0.0013452726,"about_ca_topic_score_gemma":0.0010498376,"teacher_disagreement_score":0.65208936,"about_ca_system_score_codex":0.00017265812,"about_ca_system_score_gemma":0.0021976933,"threshold_uncertainty_score":0.43308347},"labels":[],"label_agreement":null},{"id":"W2888281906","doi":"10.1016/j.atherosclerosis.2018.06.218","title":"DNA copy number variation screening in familial hypercholesterolemia-related genes","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Copy-number variation; Familial hypercholesterolemia; Genetics; Gene; DNA sequencing; Biology; Computational biology; Apolipoprotein B; PCSK9; Bioinformatics; LDL receptor; Genome; Lipoprotein; Cholesterol; Endocrinology","score_opus":0.024321981994514505,"score_gpt":0.27309283772652576,"score_spread":0.24877085573201124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888281906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956264,0.0001260048,0.0013296753,0.00037029633,0.00026534175,0.00041930948,0.000005586045,0.00009843021,0.0017589511],"genre_scores_gemma":[0.99600214,0.00020124445,0.0021122957,0.00080223347,0.0005195962,0.000041596275,0.000017184193,0.000047015026,0.0002566746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984269,0.000111314985,0.00035639293,0.00036206975,0.00039120432,0.00035210903],"domain_scores_gemma":[0.99918765,0.000020389847,0.00007018442,0.0004834687,0.00010489189,0.00013343617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062590366,0.00017232036,0.00035150358,0.00007217326,0.00011243433,0.000026628359,0.000089797075,0.00021180787,0.00026004505],"category_scores_gemma":[0.000042931097,0.00015451982,0.00017225307,0.0003670736,0.00008331963,0.00012098752,0.00004458975,0.00020874293,0.00033168914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021244245,0.0002817465,0.750548,0.0000715653,0.00024693622,0.000008559005,0.0028015983,0.000013017586,0.10937297,0.00018463015,0.00020325149,0.13605525],"study_design_scores_gemma":[0.003353975,0.00022407212,0.98503375,0.00021901604,0.00008506051,0.000024701922,0.00011097193,0.00028471995,0.008091503,0.00005820022,0.0023369265,0.00017707632],"about_ca_topic_score_codex":0.0012672793,"about_ca_topic_score_gemma":0.00008275044,"teacher_disagreement_score":0.23448575,"about_ca_system_score_codex":0.00008406122,"about_ca_system_score_gemma":0.000064285196,"threshold_uncertainty_score":0.6301135},"labels":[],"label_agreement":null},{"id":"W2888332678","doi":"10.1016/j.atherosclerosis.2018.06.216","title":"A mendelian randomization study comparing the effect of low-density lipoproteins and triglyceride-rich very low-density lipoproteins on the risk of coronary heart disease","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Mendelian randomization; Very low-density lipoprotein; Triglyceride; Internal medicine; Coronary heart disease; Medicine; Cardiology; Lipoprotein; Low-density lipoprotein; Endocrinology; Cholesterol; Chemistry; Biochemistry; Gene; Genotype","score_opus":0.013988746651668792,"score_gpt":0.2422553773395535,"score_spread":0.2282666306878847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888332678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927568,0.00027772732,0.00022303994,0.0004716952,0.00016740922,0.0059670187,0.000026534379,0.000059527636,0.00005028999],"genre_scores_gemma":[0.9988991,0.00017660811,0.00004299221,0.00024027792,0.00031120976,0.00023753326,0.000007704115,0.00005451112,0.000030061636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960418,0.0014425539,0.0006220713,0.0005440227,0.0009776808,0.00037188613],"domain_scores_gemma":[0.9971395,0.00046584994,0.00038102508,0.001535369,0.00025073328,0.00022751045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035752964,0.00037526395,0.0011449287,0.000097572505,0.000580718,0.000036171772,0.00022045933,0.00011346211,0.000033706598],"category_scores_gemma":[0.00070157874,0.00020460766,0.00043377464,0.00046024297,0.00048103026,0.000087585315,0.00018902705,0.00040063285,0.000016515232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019297501,0.0012882254,0.95431423,0.0006432861,0.0013331822,0.0000078572075,0.002478984,0.00007230021,0.014788287,0.00004035182,0.00019757118,0.005538194],"study_design_scores_gemma":[0.012678004,0.004132526,0.93283904,0.00057333056,0.0010532015,0.000007606226,0.00030521656,0.0006815445,0.04747529,0.00003372715,0.000023278637,0.00019725607],"about_ca_topic_score_codex":0.0037390068,"about_ca_topic_score_gemma":0.00029548982,"teacher_disagreement_score":0.032687,"about_ca_system_score_codex":0.00008769077,"about_ca_system_score_gemma":0.000094389565,"threshold_uncertainty_score":0.8343658},"labels":[],"label_agreement":null},{"id":"W2888733154","doi":"10.1002/acr.23735","title":"Statin Use and Knee Osteoarthritis Outcomes: A Longitudinal Cohort Study","year":2018,"lang":"en","type":"article","venue":"Arthritis Care & Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; Medical Research Council; National Institute for Health and Care Research; Mylan; GlaxoSmithKline; French Dairy Interbranch Organization; Radius Health; Les Laboratories Pierre Fabre; Novartis Pharmaceuticals Corporation; Pfizer; National Institutes of Health; U.S. Department of Health and Human Services; Foundation for the National Institutes of Health","keywords":"Osteoarthritis; Medicine; Cohort; Statin; Physical therapy; Cohort study; Longitudinal study; Internal medicine; Physical medicine and rehabilitation; Alternative medicine; Pathology","score_opus":0.06037823546269663,"score_gpt":0.37674393285761965,"score_spread":0.31636569739492304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888733154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880216,0.0062188487,0.00001794425,0.00023988595,0.00014957934,0.003480615,0.000046401532,0.00008272647,0.0017423788],"genre_scores_gemma":[0.9973477,0.0006744624,0.00035725167,0.0001515336,0.00046512723,0.0004272913,0.000029160337,0.00005361214,0.0004938253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955817,0.00051763334,0.00037725715,0.00077504246,0.0019149897,0.00083340256],"domain_scores_gemma":[0.99668217,0.00017129577,0.00003503382,0.0010749145,0.0015260634,0.00051052653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021073772,0.00021792963,0.00063303055,0.0002913743,0.00056810415,0.00021825268,0.00011017908,0.00011120261,0.00023495665],"category_scores_gemma":[0.0005964753,0.00019289604,0.00015459284,0.0004940459,0.0005172126,0.00024746216,0.00025943478,0.0006003655,0.00018702741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097803786,0.00012978949,0.72996914,0.00005758762,0.00013315023,0.0007568284,0.0024549875,2.3949163e-8,0.00003318949,0.00006777622,0.00038075607,0.26591897],"study_design_scores_gemma":[0.005931552,0.0073785293,0.96819806,0.00023515408,0.000045121025,0.00029068897,0.0091209,0.00000210239,0.00012162163,0.000034557146,0.008453279,0.00018842534],"about_ca_topic_score_codex":0.005214545,"about_ca_topic_score_gemma":0.00791604,"teacher_disagreement_score":0.26573056,"about_ca_system_score_codex":0.000145948,"about_ca_system_score_gemma":0.00031463476,"threshold_uncertainty_score":0.7882867},"labels":[],"label_agreement":null},{"id":"W2888893923","doi":"10.1016/j.atherosclerosis.2018.08.036","title":"Long-term safety and efficacy of alirocumab in patients with heterozygous familial hypercholesterolemia: An open-label extension of the ODYSSEY program","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Aegerion Pharmaceuticals; Seventh Framework Programme; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Orion Corporation; Amarin Corporation; Regeneron Pharmaceuticals; Sanofi; European Commission; Pfizer; Amgen","keywords":"Familial hypercholesterolemia; Alirocumab; Extension (predicate logic); Term (time); Medicine; Open label; Internal medicine; Adverse effect; Cholesterol; Computer science; Lipoprotein; Physics","score_opus":0.028398018311212237,"score_gpt":0.293402990230041,"score_spread":0.26500497191882877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888893923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974768,0.00008467131,0.000022705166,0.000058381396,0.00006711203,0.002208103,0.000014512127,0.00001997169,0.00004772127],"genre_scores_gemma":[0.99896353,0.00007686221,0.0006193741,0.00018479896,0.000055677567,0.000032799908,0.000013916998,0.000038428225,0.000014590794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837065,0.00014418276,0.0003977885,0.00037901808,0.00045520565,0.0002531731],"domain_scores_gemma":[0.99855983,0.000018574023,0.0001649295,0.0009368363,0.00020379905,0.0001160106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038115555,0.00018015056,0.0005307918,0.000047999478,0.00009023046,0.00002008569,0.00024052463,0.00012326184,0.0000061158426],"category_scores_gemma":[0.000036287478,0.000108697466,0.00005687958,0.00024887355,0.00031089375,0.00013970373,0.00020193953,0.0001671115,0.0000012115039],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021217428,0.0029763456,0.8066198,0.00014456913,0.00009046081,9.552336e-7,0.0006479723,9.545395e-7,0.007516126,0.000006386038,0.000004674413,0.17986996],"study_design_scores_gemma":[0.015561685,0.0055914624,0.9755014,0.00070544373,0.0001100072,0.000004955847,0.00002793875,0.000014812388,0.002344048,0.0000022219247,0.000026850455,0.00010917594],"about_ca_topic_score_codex":0.0005955208,"about_ca_topic_score_gemma":0.00026316426,"teacher_disagreement_score":0.17976078,"about_ca_system_score_codex":0.000052563864,"about_ca_system_score_gemma":0.000067599954,"threshold_uncertainty_score":0.44325542},"labels":[],"label_agreement":null},{"id":"W2889173752","doi":"10.1016/j.jacl.2018.08.011","title":"Alirocumab dosing patterns during 40 months of open-label treatment in patients with heterozygous familial hypercholesterolemia","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek; European Commission; Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Dosing; Placebo; Familial hypercholesterolemia; Internal medicine; Open label study; Adverse effect; Clinical trial; Open label; Cholesterol; Lipoprotein; Alternative medicine","score_opus":0.0677263020277176,"score_gpt":0.39127738179474775,"score_spread":0.3235510797670301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889173752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976971,0.00009044649,0.00007995901,0.00030218335,0.0011721451,0.00052390184,0.000007639788,0.0000048504567,0.0001217831],"genre_scores_gemma":[0.99524766,0.0001744648,0.0012628451,0.00042503022,0.0028190503,0.0000057428742,0.0000035535527,0.000025985471,0.00003567955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968013,0.000459444,0.0017371624,0.00026387142,0.0004237358,0.0003144588],"domain_scores_gemma":[0.9980207,0.00016018908,0.00077905203,0.0004342353,0.00035294853,0.0002528669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012778464,0.00018074381,0.0015067182,0.0001518599,0.000045141718,0.000014571749,0.00023448233,0.00022254573,0.00002793502],"category_scores_gemma":[0.00028917522,0.00011502351,0.00024118983,0.00011191437,0.00017713547,0.00015338678,0.00010647563,0.00043735225,0.000004623663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0132574625,0.0025233005,0.910961,0.0000732136,0.0004189317,0.000063823514,0.00019911474,0.0000035511246,0.0001505328,0.0000025883353,0.000030793566,0.0723157],"study_design_scores_gemma":[0.04148666,0.018994555,0.93744415,0.00042326294,0.00020669444,0.00016230476,0.0000489677,0.000008403959,0.00029591765,0.000013584338,0.00081844017,0.00009707697],"about_ca_topic_score_codex":0.00033230704,"about_ca_topic_score_gemma":0.00022376163,"teacher_disagreement_score":0.07221862,"about_ca_system_score_codex":0.0001413478,"about_ca_system_score_gemma":0.00030014417,"threshold_uncertainty_score":0.46905228},"labels":[],"label_agreement":null},{"id":"W2889297232","doi":"10.1161/circ.130.suppl_2.16680","title":"Abstract 16680: Lipoprotein(a) and Progression Rate of Aortic Valve Stenosis - A Pooled-Analysis of Two Prospective Studies","year":2014,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; McMaster University; Ottawa Heart Institute","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Lipoprotein(a); Stenosis; Hemodynamics; Aortic valve stenosis; Cohort; Aortic valve; Prospective cohort study; Lipoprotein; Cholesterol","score_opus":0.023476045330325428,"score_gpt":0.3262432866902733,"score_spread":0.30276724135994787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889297232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952946,0.0021943697,0.0011966546,0.00008558757,0.000035449368,0.0009170576,0.0000037524985,0.000023769566,0.00024878324],"genre_scores_gemma":[0.99927765,0.00009931668,0.00042426816,0.000026226011,0.000077197474,0.00005916108,0.0000174239,0.000013363707,0.00000541147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871564,0.00010047648,0.00042685724,0.00027026443,0.00035053582,0.00013623807],"domain_scores_gemma":[0.9987618,0.000058864916,0.00032896906,0.0003754211,0.00040437767,0.00007058582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010126632,0.00012239082,0.0007130818,0.00024256494,0.00005676256,0.0000069044777,0.000031472915,0.000063456675,0.000013143618],"category_scores_gemma":[0.00026601582,0.000095390475,0.000368865,0.00053094607,0.00009118871,0.000081668666,0.000026154567,0.00008725446,0.0000012402319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016965279,0.00027529817,0.7308052,0.0018056914,0.014471272,0.0000021666272,0.0020655743,0.0008285018,0.03044274,0.000917001,0.00000535608,0.2182115],"study_design_scores_gemma":[0.001090044,0.00013373219,0.98029304,0.00027738302,0.0062228423,0.0000019299991,0.00016101435,0.0036966084,0.007239485,0.0007938544,0.000005383408,0.000084695814],"about_ca_topic_score_codex":0.0002531698,"about_ca_topic_score_gemma":0.000019132453,"teacher_disagreement_score":0.24948779,"about_ca_system_score_codex":0.0000625278,"about_ca_system_score_gemma":0.00004167439,"threshold_uncertainty_score":0.38899106},"labels":[],"label_agreement":null},{"id":"W2889315495","doi":"10.1093/eurheartj/ehy563.p4591","title":"P4591Outcomes of stable coronary artery disease worldwide. Insights from the CLARIFY registry","year":2018,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Montreal Heart Institute","funders":"","keywords":"Medicine; Coronary artery disease; Cardiology; Internal medicine; Intensive care medicine","score_opus":0.03323952567635975,"score_gpt":0.2764234062394478,"score_spread":0.24318388056308804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889315495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97940874,0.0065427125,0.00030688854,0.0054150093,0.0006777742,0.00026505123,0.000017444458,0.00003526992,0.0073311185],"genre_scores_gemma":[0.98916894,0.000241396,0.0006352057,0.0045412574,0.0041458816,0.0000012316684,0.000010918833,0.000042417156,0.0012127283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979323,0.0005920575,0.00040714498,0.00020750178,0.00059545005,0.00026553075],"domain_scores_gemma":[0.9983137,0.000079315825,0.00015654298,0.0008358742,0.00017636847,0.00043818232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008459724,0.00015210501,0.00034475003,0.000054153556,0.0003211621,0.00005135079,0.00019355107,0.000046659698,0.00037782534],"category_scores_gemma":[0.00016759339,0.00009064698,0.00035680397,0.00014530281,0.00020401082,0.00011352507,0.00008446907,0.0008632104,0.00018760405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016423792,0.00047559192,0.7320617,0.0001437744,0.0012174342,0.0045524873,0.0018186009,0.000008335212,0.0042302106,0.00028360554,0.23182009,0.021745825],"study_design_scores_gemma":[0.00092962314,0.00016883417,0.77475667,0.0002477356,0.00012717705,0.0006796361,0.00013042316,0.0000114157,0.00018241158,0.00012136858,0.22256169,0.00008303347],"about_ca_topic_score_codex":0.000046438094,"about_ca_topic_score_gemma":0.000011001973,"teacher_disagreement_score":0.042694986,"about_ca_system_score_codex":0.000044693483,"about_ca_system_score_gemma":0.0002812024,"threshold_uncertainty_score":0.41369227},"labels":[],"label_agreement":null},{"id":"W2889778517","doi":"10.1016/j.jacl.2018.08.012","title":"Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal","year":2018,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Lipoprotein(a); Confounding; Population; Secondary prevention; Risk factor; Internal medicine; Disease; Critical appraisal; Coronary heart disease; Lipoprotein; Cholesterol; Pathology; Alternative medicine; Environmental health","score_opus":0.1484425562686993,"score_gpt":0.5066070700772614,"score_spread":0.35816451380856207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889778517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007803367,0.99057007,0.00084655994,0.00030470063,0.0064113284,0.0007707716,0.0000125754605,0.000009752559,0.0002939077],"genre_scores_gemma":[0.00019410039,0.9776325,0.0055439016,0.00011427571,0.016338205,0.000015489451,0.000008708492,0.000060093225,0.000092726295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99181056,0.0022011248,0.0045968653,0.00041629662,0.00062683946,0.0003483123],"domain_scores_gemma":[0.99268323,0.003107748,0.0025028288,0.00062497216,0.00059060025,0.0004906307],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008391396,0.00035897695,0.0068571065,0.0002660674,0.00004373493,0.000008363087,0.00024464878,0.0012112592,0.00029776935],"category_scores_gemma":[0.013315905,0.00024355717,0.0033561017,0.00018902095,0.00067085755,0.000100062774,0.00014084557,0.0020091846,0.000025181424],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024342311,0.0005724718,0.000051012797,0.024145186,0.0016341414,0.000033070522,0.000018144083,1.545359e-8,3.9841183e-7,0.00024118561,0.001174438,0.9718865],"study_design_scores_gemma":[0.0022332112,0.008098221,0.00066847797,0.021843966,0.005362764,0.005253331,0.000018208384,0.0000012855287,7.4382797e-7,0.00071955414,0.9556105,0.00018974043],"about_ca_topic_score_codex":0.000008720595,"about_ca_topic_score_gemma":0.0000034985082,"teacher_disagreement_score":0.9716968,"about_ca_system_score_codex":0.000043626264,"about_ca_system_score_gemma":0.0022012203,"threshold_uncertainty_score":0.99499536},"labels":[],"label_agreement":null},{"id":"W2889941290","doi":"10.1161/circ.134.suppl_1.13838","title":"Abstract 13838: Smooth Muscle Cells Are the Origin of the Majority of Foam Cells in Atherosclerotic Lesions of Apolipoprotein E-deficient Mice","year":2016,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Smooth muscle; Apolipoprotein B; Apolipoprotein E; Pathology; Anatomy; Internal medicine; Cholesterol; Disease","score_opus":0.026563715185280237,"score_gpt":0.2526799127496175,"score_spread":0.22611619756433726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889941290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972906,0.00024216763,0.0005162872,0.00034643046,0.00016668826,0.0011700403,0.000032322194,0.000009094672,0.00022637416],"genre_scores_gemma":[0.99971926,0.00004564884,0.00007113394,0.00003428817,0.00007074789,0.000020276788,0.0000016490675,0.000016626198,0.000020358699],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99847203,0.00012715523,0.0004990642,0.00019453507,0.0005229007,0.00018430174],"domain_scores_gemma":[0.9985416,0.00008972136,0.0004034231,0.00076544477,0.00015266059,0.00004717541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008476416,0.000113526665,0.00033758476,0.000071737784,0.000051085237,0.0000031057614,0.00014905006,0.00010224071,0.00003698751],"category_scores_gemma":[0.00008810223,0.000058269678,0.00027291352,0.00031884696,0.00013258564,0.00004591018,0.000036581136,0.0001286395,0.0000061554524],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029495428,0.00026049573,0.030061213,0.00046552726,0.000031664797,8.4281277e-7,0.00038563955,0.0004877769,0.9512924,0.00030582436,0.000019136978,0.016660003],"study_design_scores_gemma":[0.0008460956,0.00002642842,0.83668756,0.00059051404,0.000053809727,8.581304e-7,0.00021964266,0.00007740667,0.16106904,0.00017438794,0.0001967417,0.000057498695],"about_ca_topic_score_codex":0.0015060974,"about_ca_topic_score_gemma":0.00010737724,"teacher_disagreement_score":0.8066264,"about_ca_system_score_codex":0.00011048898,"about_ca_system_score_gemma":0.00014866087,"threshold_uncertainty_score":0.23761685},"labels":[],"label_agreement":null},{"id":"W2890357553","doi":"10.1161/jaha.118.009545","title":"Variants at the <i>APOE/C1/C2/C4</i> Locus Modulate Cholesterol Efflux Capacity Independently of High‐Density Lipoprotein Cholesterol","year":2018,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Robarts Clinical Trials; Western University; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Institut de Cardiologie de Montréal; McGill University","keywords":"Medicine; Cholesterol; Apolipoprotein E; Efflux; High-density lipoprotein; Internal medicine; Locus (genetics); Lipoprotein; Endocrinology; Genetics; Gene; Disease; Biology","score_opus":0.011137917258986841,"score_gpt":0.24689748550766208,"score_spread":0.23575956824867525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890357553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105763,0.000048378042,0.00018736295,0.0073157214,0.0006719158,0.00061012123,0.000015640242,0.000013794127,0.00007943893],"genre_scores_gemma":[0.9944851,0.000051594467,0.00020443878,0.0033171172,0.0014652015,0.0000063912844,0.000001403168,0.00003105219,0.0004376996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959079,0.0008895436,0.000790985,0.0002234719,0.0017962061,0.00039186922],"domain_scores_gemma":[0.99620587,0.00012134532,0.0018217813,0.00079414283,0.00087637163,0.00018047029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038054176,0.00021079276,0.0010297059,0.00009646893,0.00032007194,0.000040320487,0.0002931034,0.00012809418,0.00002925064],"category_scores_gemma":[0.00059652934,0.00012483634,0.0007099603,0.00047509646,0.00025418322,0.00017634928,0.0001386635,0.00068824855,0.0000345993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090994197,0.00061421987,0.8826876,0.00014652936,0.0025411749,0.000007989785,0.0019307291,0.00016846358,0.07271267,0.000015146141,0.010686983,0.027578501],"study_design_scores_gemma":[0.0018148393,0.00076580764,0.951814,0.00015773218,0.00038677096,0.0003142522,0.000068583584,0.00004946914,0.042532105,0.00009627339,0.0018872566,0.0001129347],"about_ca_topic_score_codex":0.008680899,"about_ca_topic_score_gemma":0.0008502866,"teacher_disagreement_score":0.06912632,"about_ca_system_score_codex":0.001041929,"about_ca_system_score_gemma":0.00024544666,"threshold_uncertainty_score":0.9979204},"labels":[],"label_agreement":null},{"id":"W2890723626","doi":"10.1111/dme.13817","title":"Alirocumab safety in people with and without diabetes mellitus: pooled data from 14 <scp>ODYSSEY</scp> trials","year":2018,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Diabetes mellitus; Hazard ratio; Internal medicine; Adverse effect; PCSK9; Endocrinology; Cholesterol; Confidence interval","score_opus":0.032681332778477595,"score_gpt":0.29880283860356954,"score_spread":0.266121505825092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890723626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764488,0.015786877,0.0006273215,0.0027893302,0.00035165608,0.0016408142,0.00008554378,0.0000895362,0.0021801575],"genre_scores_gemma":[0.9906354,0.0021025918,0.001191625,0.002262053,0.0025540756,0.00007295766,0.00080094027,0.000076408694,0.00030392662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956476,0.0005519673,0.0010390318,0.0009822557,0.0010566884,0.0007224657],"domain_scores_gemma":[0.99588335,0.00090929563,0.0002898315,0.0021529568,0.0002080288,0.0005565267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0056210156,0.0004177327,0.0024155567,0.0002407115,0.00013106021,0.000027218188,0.00034032972,0.00020843427,0.0003260689],"category_scores_gemma":[0.0044030673,0.00026285893,0.000086878346,0.0005701041,0.0005376373,0.00015492528,0.00020061489,0.00039044477,0.000050550923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007404097,0.00053841056,0.84471035,0.0012818326,0.0029470092,0.000098435456,0.0064559095,0.000001181827,0.0047150785,0.00021776541,0.013925518,0.12436808],"study_design_scores_gemma":[0.035811663,0.0030383754,0.8783184,0.004049082,0.0035359457,0.000047490066,0.0020652618,0.001338386,0.0036692366,0.0007278892,0.0670478,0.00035047438],"about_ca_topic_score_codex":0.0020547288,"about_ca_topic_score_gemma":0.0009025551,"teacher_disagreement_score":0.1240176,"about_ca_system_score_codex":0.00008149286,"about_ca_system_score_gemma":0.0002693932,"threshold_uncertainty_score":0.99998236},"labels":[],"label_agreement":null},{"id":"W2890737184","doi":"10.1016/j.jacl.2018.09.006","title":"The spectrum of type III hyperlipoproteinemia","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Royal Victoria Hospital; McGill University Health Centre","funders":"Google; American Heart Association; Aetna Foundation","keywords":"Chylomicron; Hypertriglyceridemia; Internal medicine; Apolipoprotein B; Medicine; Triglyceride; Hyperlipidemia; Cholesterol; Lipoprotein; Very low-density lipoprotein; Endocrinology; Percentile; Diabetes mellitus","score_opus":0.05967622492712722,"score_gpt":0.39825411751260054,"score_spread":0.33857789258547333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890737184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726982,0.001977851,0.00042065143,0.011075511,0.00854442,0.0002530063,7.338756e-7,0.00000893368,0.005020711],"genre_scores_gemma":[0.97085124,0.0010560825,0.0013848112,0.0010014556,0.02482249,9.410849e-7,4.1011924e-7,0.000014832231,0.00086774764],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972235,0.0003526033,0.0016319754,0.00012721904,0.0004199536,0.000244745],"domain_scores_gemma":[0.997205,0.0005809562,0.0008416311,0.0004866203,0.00067007204,0.00021571797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057616653,0.00009605466,0.0009407842,0.00005823535,0.00007983235,0.000005498329,0.00021547421,0.00021746944,0.00023653074],"category_scores_gemma":[0.0032874364,0.00005084912,0.0006317997,0.00018308379,0.00057224405,0.000033862896,0.00005394368,0.0006589374,0.000055070825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023395462,0.0012422783,0.086612105,0.00020183329,0.003474967,0.00013590627,0.00027428052,0.000004740137,0.0031701042,0.00782486,0.116160296,0.75750315],"study_design_scores_gemma":[0.0062069716,0.01614822,0.12146647,0.00015001438,0.00042879264,0.0017801223,0.000114265116,0.00004391337,0.0020189008,0.00262321,0.8489026,0.00011655816],"about_ca_topic_score_codex":0.000038611106,"about_ca_topic_score_gemma":0.00002746265,"teacher_disagreement_score":0.7573866,"about_ca_system_score_codex":0.000021304828,"about_ca_system_score_gemma":0.00066148443,"threshold_uncertainty_score":0.3935606},"labels":[],"label_agreement":null},{"id":"W2890833213","doi":"10.1016/j.jacl.2018.09.008","title":"Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre; Université de Montréal; Montreal Clinical Research Institute","funders":"Merck; Sanofi; AstraZeneca; Fondation Leducq; Pfizer; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Diabetes mellitus; Disease; Atherosclerotic cardiovascular disease; Internal medicine; Pediatrics; Endocrinology; Cholesterol","score_opus":0.025770732921513825,"score_gpt":0.30672280103424915,"score_spread":0.2809520681127353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890833213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987312,0.0002325218,0.00008100046,0.000098018565,0.0004339979,0.00033732902,0.000032244192,0.000008096313,0.000045581262],"genre_scores_gemma":[0.996345,0.00011045075,0.00062011456,0.0006614846,0.0022123484,0.0000036478411,0.000012454469,0.00002953668,0.000005003875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956024,0.0015217767,0.0013292403,0.0003022534,0.0009152451,0.0003290582],"domain_scores_gemma":[0.99654967,0.00032094328,0.0008343004,0.00069179584,0.0010278579,0.0005754457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004934834,0.00018638199,0.0017958716,0.00016634635,0.00004092373,0.0000065509203,0.00017098692,0.0002463893,0.000027919488],"category_scores_gemma":[0.0027291318,0.000113451926,0.00071879115,0.0002519253,0.00045709428,0.00013165806,0.00003492731,0.0007561177,0.0000029339735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073525864,0.0010548312,0.97819364,0.00003933241,0.0030435189,0.000026706113,0.000064434025,0.00003253438,0.0000029663909,0.0000014672876,0.00006352719,0.010124458],"study_design_scores_gemma":[0.017693628,0.014070479,0.9645398,0.00033980026,0.0021831717,0.000006607506,0.000020650334,0.00007845462,0.000026007854,0.000031641397,0.00089105585,0.00011870323],"about_ca_topic_score_codex":0.00016976181,"about_ca_topic_score_gemma":0.000031855005,"teacher_disagreement_score":0.013653837,"about_ca_system_score_codex":0.00005674847,"about_ca_system_score_gemma":0.00059417787,"threshold_uncertainty_score":0.4626435},"labels":[],"label_agreement":null},{"id":"W2891396588","doi":"10.1055/a-0677-2944","title":"The Association between Genetic Polymorphisms and Simvastatin-Induced Myopathy: A Narrative Synthesis of Evidence","year":2018,"lang":"en","type":"article","venue":"Drug Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Beijing Municipal Administration of Hospitals; National Natural Science Foundation of China","keywords":"SLCO1B1; Myopathy; Simvastatin; Genetics; Genetic association; SNP; Allele; Population; Medicine; Genotype; Pharmacogenetics; Bioinformatics; Internal medicine; Biology; Single-nucleotide polymorphism; Gene","score_opus":0.1258101092280829,"score_gpt":0.4001344501623763,"score_spread":0.2743243409342934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891396588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926013,0.0013786606,0.00002136174,0.0047377297,0.000047530433,0.00062796345,0.000004882601,0.000011486592,0.0005690887],"genre_scores_gemma":[0.99792546,0.0004973756,0.0001717579,0.000029160536,0.00063491636,0.00007039653,8.759545e-7,0.000014356873,0.0006556835],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9969916,0.0008271674,0.00023750187,0.00022883929,0.0013423694,0.00037253837],"domain_scores_gemma":[0.9963489,0.0021653848,0.00008924577,0.00042621233,0.0008279974,0.00014221281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006617429,0.00007777537,0.0002595423,0.0001012285,0.00043753505,0.00003703602,0.00012474865,0.00006517147,0.000019422601],"category_scores_gemma":[0.0048760567,0.00004578896,0.000074779346,0.00040511685,0.00021066143,0.000055011875,0.00009266321,0.00028373708,0.000023778657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002878073,0.00007906269,0.2223799,0.00033287963,0.0007431903,0.000024157755,0.0191739,2.3834112e-7,0.018039914,0.00017702841,0.002423423,0.7363385],"study_design_scores_gemma":[0.0005637993,0.00072889205,0.88963115,0.0005912302,0.0001229484,0.000009916342,0.0048990385,0.00010352852,0.10044599,0.0003906092,0.0023928434,0.00012007225],"about_ca_topic_score_codex":0.0011438852,"about_ca_topic_score_gemma":0.00009888254,"teacher_disagreement_score":0.73621845,"about_ca_system_score_codex":0.00017079287,"about_ca_system_score_gemma":0.0003747549,"threshold_uncertainty_score":0.5837447},"labels":[],"label_agreement":null},{"id":"W2892110856","doi":"10.1161/circ.134.suppl_1.12117","title":"Abstract 12117: Global Real-World Data on the Use of Lomitapide in Treating Homozygous Familial Hypercholesterolemia: The Lomitapide Observational Worldwide Evaluation Registry (LOWER), Two-Year Data","year":2016,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Observational study; Real world data; Intensive care medicine; Internal medicine; Cholesterol","score_opus":0.25111385910420664,"score_gpt":0.37025873561888595,"score_spread":0.11914487651467931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892110856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991336,0.000115738345,0.00052044564,0.0047779437,0.00020453555,0.0013676157,0.0004047159,0.00003450367,0.0012384935],"genre_scores_gemma":[0.99700946,0.00009336257,0.00056687265,0.00045615667,0.00065281586,0.00004144444,0.0011206073,0.0000267219,0.00003256679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99659413,0.00045658264,0.00074895576,0.00066306524,0.0012414559,0.00029580548],"domain_scores_gemma":[0.9944747,0.0008191775,0.00041551652,0.0039696875,0.0002419007,0.00007901239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004391124,0.00020953857,0.00037793428,0.00008790584,0.00014282405,0.0000549242,0.00060429523,0.0000901377,0.000039973598],"category_scores_gemma":[0.0027897658,0.00011774657,0.000114399736,0.00051871856,0.00015790843,0.00061603996,0.00021862694,0.0002677296,0.000025100688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006186677,0.00024590796,0.7420334,0.000100399324,0.00023874703,0.000026655036,0.00009769404,0.0022672743,0.002106613,0.0024033166,0.0026718422,0.24718945],"study_design_scores_gemma":[0.0021395362,0.000030218667,0.9877997,0.0005211019,0.00018841171,0.000019226973,0.00009739244,0.007292025,0.000036847865,0.00033485962,0.0014128276,0.00012784143],"about_ca_topic_score_codex":0.004504366,"about_ca_topic_score_gemma":0.008200683,"teacher_disagreement_score":0.24706161,"about_ca_system_score_codex":0.0005526102,"about_ca_system_score_gemma":0.0004962262,"threshold_uncertainty_score":0.68092835},"labels":[],"label_agreement":null},{"id":"W2892297170","doi":"10.1007/s40291-018-0356-6","title":"Value of a Hypothetical Pharmacogenomic Test for the Diagnosis of Statin-Induced Myopathy in Patients at High Cardiovascular Risk","year":2018,"lang":"en","type":"article","venue":"Molecular Diagnosis & Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Test (biology); Pharmacogenomics; Medicine; Myopathy; Internal medicine; Statin; Physical therapy; Rhabdomyolysis; Intensive care medicine; Pharmacology","score_opus":0.01752684110000915,"score_gpt":0.2681719099362016,"score_spread":0.2506450688361925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892297170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98563206,0.009425724,0.00054766866,0.00035308796,0.00020362758,0.0036140326,0.00017874593,0.000021663887,0.000023395904],"genre_scores_gemma":[0.98765707,0.00878137,0.0007851135,0.0006154616,0.00018636593,0.0018523891,0.000024947123,0.000094040806,0.0000032153164],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705166,0.00038168044,0.0006892474,0.00053024874,0.00086665596,0.00048051402],"domain_scores_gemma":[0.9973034,0.0006481223,0.00025903244,0.001230034,0.00040290033,0.00015649547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013754682,0.00032029347,0.000988656,0.00016256669,0.00012925643,0.000010675115,0.00028820543,0.0001523297,0.00008090089],"category_scores_gemma":[0.00047971497,0.00023160466,0.0012604082,0.000410497,0.00022727625,0.00003877252,0.00008247172,0.00020324602,0.000009474497],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012059509,0.0028330758,0.6566281,0.00021997477,0.00379223,0.000022882867,0.0010468754,0.00012735574,0.0124059245,0.00010543853,0.00032237798,0.32128987],"study_design_scores_gemma":[0.011836301,0.0031585349,0.4683956,0.00014387864,0.0009229352,0.0000037075163,0.000042235926,0.00010706236,0.5087572,0.00013744563,0.0062453747,0.00024975603],"about_ca_topic_score_codex":0.0015685124,"about_ca_topic_score_gemma":0.000022385359,"teacher_disagreement_score":0.49635127,"about_ca_system_score_codex":0.00017534412,"about_ca_system_score_gemma":0.00013331838,"threshold_uncertainty_score":0.9444564},"labels":[],"label_agreement":null},{"id":"W2892535663","doi":"10.1016/j.cjca.2018.07.433","title":"NURSING ROLE AND SUPPORT IN ASSIMILATING PCSK9 INHIBITORS INTO LIPID THERAPY","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Research Manitoba","funders":"","keywords":"Medicine; Psychological intervention; Regimen; PCSK9; Family medicine; Guideline; Medical prescription; Apprehension; Nursing; Intensive care medicine; Internal medicine; Cholesterol","score_opus":0.014308721023959787,"score_gpt":0.2700434658630489,"score_spread":0.2557347448390891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892535663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98135823,0.0032675052,0.0003122478,0.0017598257,0.0007898007,0.00016604518,0.0000016218136,0.0000042258416,0.012340501],"genre_scores_gemma":[0.99423134,0.00016010014,0.00043389728,0.00045996718,0.004674448,0.000001642153,0.000001515359,0.00001601359,0.00002105356],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99892825,0.0001362018,0.00034763096,0.0001296657,0.00013123374,0.00032704097],"domain_scores_gemma":[0.9989749,0.000021210006,0.000101649544,0.0001633106,0.00018075865,0.0005581451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000981844,0.0001009656,0.0005170665,0.00034141823,0.00009022664,0.000013447261,0.000059511018,0.00014297369,0.000022036102],"category_scores_gemma":[0.0001268391,0.00008454324,0.00015857526,0.0001454592,0.00024086233,0.00006567618,0.0000048693296,0.00031107117,0.0000031440893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116383104,0.0000037550647,0.2501021,0.000021964355,0.00020428459,0.00042379583,0.0027207653,0.000020631716,0.0015193314,0.00007280572,0.0021816874,0.7426125],"study_design_scores_gemma":[0.0041660587,0.0027837234,0.5534873,0.00050995394,0.00011191548,0.007493645,0.0018355006,0.000043744443,0.0021374815,0.0010791563,0.42607793,0.00027358884],"about_ca_topic_score_codex":0.0014573596,"about_ca_topic_score_gemma":0.0016945978,"teacher_disagreement_score":0.7423389,"about_ca_system_score_codex":0.00023655743,"about_ca_system_score_gemma":0.0015659872,"threshold_uncertainty_score":0.3447573},"labels":[],"label_agreement":null},{"id":"W2893252855","doi":"10.1016/j.cjca.2018.07.374","title":"THE HIGH PREVALENCE OF FAMILIAL HYPERCHOLESTEROLEMIA IN A POPULATION OF ASCVD PATIENTS WITH LDL-C ABOVE TARGET: AN ANALYSIS FROM THE REACT REGISTRY","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Population; Internal medicine; Statin; Diabetes mellitus; Patient registry; Pediatrics; Disease; Cholesterol; Endocrinology","score_opus":0.00789677741905874,"score_gpt":0.22983596878634172,"score_spread":0.22193919136728296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893252855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983321,0.00058572245,0.00025903777,0.00026702584,0.00016577449,0.00019154407,0.00009496994,0.000001036988,0.00010282403],"genre_scores_gemma":[0.9989878,0.000072752744,0.00014265612,0.00009662147,0.0006556369,0.0000022071915,0.000025738316,0.000009352125,0.0000072700223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851406,0.00036379544,0.00048007426,0.00013704595,0.00029522655,0.00020977604],"domain_scores_gemma":[0.99827564,0.00007715332,0.00037957582,0.00057744916,0.0004779361,0.00021223602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010043951,0.000095483614,0.0005888745,0.00015107043,0.000070533555,0.000006761303,0.00021981826,0.00011104458,0.00000809923],"category_scores_gemma":[0.00023200033,0.00005152182,0.0002363251,0.00028706697,0.0002840371,0.00006587721,0.0000083159075,0.00025629072,3.6993515e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029000096,0.0000043231084,0.99433535,0.000016726139,0.0007005931,0.000014286816,0.0002649706,0.0002933689,0.000041494186,0.000020951627,0.000063261,0.0039546965],"study_design_scores_gemma":[0.0010170093,0.0006526722,0.9960256,0.000081699814,0.0007110513,0.00002521039,0.00015460895,0.000017257345,0.000038851864,0.00008914124,0.0011394396,0.000047442194],"about_ca_topic_score_codex":0.051633853,"about_ca_topic_score_gemma":0.033077266,"teacher_disagreement_score":0.01855659,"about_ca_system_score_codex":0.0001469296,"about_ca_system_score_gemma":0.00068211055,"threshold_uncertainty_score":0.98456657},"labels":[],"label_agreement":null},{"id":"W2893392508","doi":"10.1016/j.cjca.2018.07.214","title":"RISK FACTORS, BIOMARKERS AND FRAMINGHAM RISK ESTIMATE FAIL TO IDENTIFY PRESENCE OF SUBCLINICAL ATHEROSCLEROSIS IN YOUNG INDIVIDUAL WITH FAMILY HISTORY OF PREMATURE CORONARY ARTERY DISEASE PILOT DATA OF EARLY ATHEROSCLEROSIS CLINIC","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Family history; Subclinical infection; Framingham Risk Score; Coronary artery disease; Internal medicine; Risk factor; Myocardial infarction; Cardiology; Coronary atherosclerosis; Framingham Heart Study; Disease","score_opus":0.06237033068937474,"score_gpt":0.30574030246126,"score_spread":0.24336997177188524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893392508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940832,0.003213624,0.00052637776,0.000053822463,0.0005102654,0.0004883704,0.0010752722,0.000004269314,0.000044767105],"genre_scores_gemma":[0.9981548,0.0007330968,0.00076161016,0.000039294726,0.00023472073,0.000004853698,0.00002527698,0.00003500137,0.000011332835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695325,0.00067248865,0.0010941501,0.00040611287,0.00047468915,0.00039929734],"domain_scores_gemma":[0.9964011,0.0002837448,0.0009132199,0.0010193024,0.00042415442,0.0009585039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002594548,0.00023196648,0.0013450485,0.000412627,0.00005142995,0.000009619323,0.0004881194,0.0002168488,0.000013314665],"category_scores_gemma":[0.0012232742,0.00018541732,0.00025634168,0.00023191998,0.0010817435,0.00018088259,0.000101273494,0.00055066205,0.0000010889298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011778745,0.000025915559,0.99322,0.00013716855,0.0011424496,0.000034918252,0.0011742222,0.00002625258,0.00068603014,0.0000013476186,0.0011604303,0.001213437],"study_design_scores_gemma":[0.0020707771,0.0038056774,0.9913873,0.00068296585,0.001014532,0.00006749738,0.00042596663,0.000016568369,0.00003140506,0.00001813323,0.00033168,0.00014746939],"about_ca_topic_score_codex":0.015560974,"about_ca_topic_score_gemma":0.00490035,"teacher_disagreement_score":0.010660625,"about_ca_system_score_codex":0.00019123021,"about_ca_system_score_gemma":0.0024195928,"threshold_uncertainty_score":0.9909945},"labels":[],"label_agreement":null},{"id":"W2893605108","doi":"10.1016/j.cjca.2018.07.213","title":"REAL-WORLD EFFECTIVENESS OF COLESEVELAM IN THE TREATMENT OF HYPERCHOLESTEROLEMIA IN A CANADIAN ROUTINE-CARE SETTING: RESULTS FROM THE CV-CARE REGISTRY","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Contraindication; Internal medicine; Adverse effect; Familial hypercholesterolemia; Gastroenterology; Hyperlipidemia; Randomized controlled trial; Cholesterol; Endocrinology; Diabetes mellitus","score_opus":0.017136889966216762,"score_gpt":0.27773367241278873,"score_spread":0.260596782446572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893605108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892139,0.0022196458,0.000008422168,0.0011132035,0.00027442953,0.0006466255,0.00031998495,0.0000014728307,0.006202361],"genre_scores_gemma":[0.9985555,0.00019629474,0.00004379595,0.00015185525,0.0009545008,0.000014908615,0.00005521606,0.00001701334,0.000010905767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971784,0.0012605827,0.0006572604,0.00021064658,0.0002261987,0.00046695585],"domain_scores_gemma":[0.9977966,0.0003653433,0.00025370004,0.000717969,0.000452201,0.00041419838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018245268,0.00017095434,0.00087585405,0.00036001654,0.00008079395,0.000009599155,0.00030577832,0.0001845835,0.0000032446758],"category_scores_gemma":[0.0003335263,0.00010384847,0.00034359112,0.00038165663,0.00031067894,0.000030111913,0.000007663055,0.00035102895,0.0000011746596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009193305,0.000010966286,0.959095,0.00014875748,0.00043869222,0.00097049226,0.022240011,0.00040201156,0.0001639752,0.00007949333,0.00045283636,0.015078442],"study_design_scores_gemma":[0.0039845454,0.0010248818,0.9609434,0.00066450343,0.00016865095,0.00022684809,0.008390027,0.000003187794,0.0003017591,0.000033027816,0.024176585,0.000082596765],"about_ca_topic_score_codex":0.8310568,"about_ca_topic_score_gemma":0.9559974,"teacher_disagreement_score":0.12494063,"about_ca_system_score_codex":0.00153873,"about_ca_system_score_gemma":0.006066327,"threshold_uncertainty_score":0.99956834},"labels":[],"label_agreement":null},{"id":"W2893705378","doi":"10.1016/j.atherosclerosis.2018.08.020","title":"Familial hypercholesterolaemia patient support groups and advocacy: A multinational perspective","year":2018,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Canadian Arthritis Patient Alliance","funders":"","keywords":"Multinational corporation; Perspective (graphical); Coronary heart disease; Familial hypercholesterolemia; Medicine; Family medicine; Identification (biology); Pediatrics; Political science; Cholesterol; Internal medicine; Law","score_opus":0.04257268055201442,"score_gpt":0.3185731110269311,"score_spread":0.2760004304749167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893705378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006139287,0.98991776,0.00003410044,0.0000894596,0.0003251536,0.0021867119,0.000119454795,0.000095429416,0.0010926684],"genre_scores_gemma":[0.0018454936,0.99518144,0.0006642455,0.0004281727,0.000979192,0.00040234512,0.00014451906,0.0001299568,0.00022464794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971999,0.00020462909,0.0006038524,0.00085786247,0.0006977557,0.00043603432],"domain_scores_gemma":[0.99832183,0.00006822093,0.00025341066,0.00073028455,0.00029976555,0.00032646421],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048045203,0.00053109106,0.0018083912,0.0001708676,0.00017516596,0.00005204897,0.00013735476,0.00046920075,0.00010689973],"category_scores_gemma":[0.00013988439,0.00040579494,0.0009518641,0.0002477951,0.00020765916,0.000087688524,0.00016978831,0.00051934476,0.0001793271],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025755342,0.00021891783,0.000109976485,0.004994756,0.00066669437,0.000011953678,0.0014600665,1.6742332e-8,0.000004473531,0.00013482844,0.00086802343,0.99150455],"study_design_scores_gemma":[0.0012462701,0.0009933198,0.0026501936,0.0070828074,0.0018602284,0.00029629812,0.00045356594,0.0000028520762,0.0000036742852,0.00003012744,0.9849127,0.00046796203],"about_ca_topic_score_codex":0.00027461225,"about_ca_topic_score_gemma":0.000012320067,"teacher_disagreement_score":0.9910366,"about_ca_system_score_codex":0.0005594574,"about_ca_system_score_gemma":0.0007013837,"threshold_uncertainty_score":0.99983937},"labels":[],"label_agreement":null},{"id":"W2893967374","doi":"10.1016/j.atherosclerosis.2018.05.040","title":"Familial hypercholesterolemia in Canada: Initial results from the FH Canada national registry","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Montreal Clinical Research Institute; Western University; Royal Victoria Hospital; Université Laval; Université de Montréal; Royal Victoria Regional Health Centre; St. Paul's Hospital; McGill University; McGill University Health Centre; Providence Health Care Research Institute; Providence Health Care","funders":"Canadian Institutes of Health Research","keywords":"Patient registry; Familial hypercholesterolemia; Medicine; Scope (computer science); Imputation (statistics); National database; Baseline (sea); Family medicine; Pediatrics; Political science; Cholesterol; Missing data; Database; Internal medicine","score_opus":0.03138147100852198,"score_gpt":0.25147062382870833,"score_spread":0.22008915282018635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893967374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914262,0.00008632784,0.000008627071,0.0046621226,0.00048659174,0.00027790197,0.0005477111,0.000013108038,0.0024913799],"genre_scores_gemma":[0.9896998,0.00003692527,0.00008857982,0.008334839,0.0015875979,0.000025810583,0.00009447253,0.000022278575,0.000109691035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978924,0.00010604394,0.0003646006,0.00033369972,0.0009838684,0.00031940104],"domain_scores_gemma":[0.99892247,0.00013318752,0.000079911035,0.00055674644,0.00016495855,0.00014270544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004330901,0.00014949661,0.00026230275,0.000017144026,0.00014025763,0.000018014454,0.00019490442,0.000079053345,0.000048710397],"category_scores_gemma":[0.00030748823,0.00010895516,0.00007078553,0.0001865888,0.00008076072,0.000041546755,0.000051726558,0.00029396563,0.000009718421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001873301,0.00024217748,0.62119657,0.00007501923,0.0007232887,0.00015330593,0.0026538302,0.00006632101,0.008823255,0.0001782773,0.3098993,0.05411533],"study_design_scores_gemma":[0.002411168,0.000049148963,0.9646691,0.00012742642,0.000029379025,0.000009085204,0.00040641008,0.00007206126,0.0009926597,0.000022167069,0.031085577,0.0001258165],"about_ca_topic_score_codex":0.9998161,"about_ca_topic_score_gemma":0.99991024,"teacher_disagreement_score":0.3434725,"about_ca_system_score_codex":0.0016636176,"about_ca_system_score_gemma":0.010022525,"threshold_uncertainty_score":0.99558973},"labels":[],"label_agreement":null},{"id":"W2893980284","doi":"10.1016/j.atherosclerosis.2018.08.051","title":"Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":238,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Universitaire Ziekenhuizen Leuven, KU Leuven; Det Sundhedsvidenskabelige Fakultet, Københavns Universitet; lékařská fakulta Univerzity Karlovy; University of Ioannina; National Health Laboratory Service; Masarykova Univerzita; Faculty of Health and Medical Sciences, University of Western Australia; University Of Al-Qadisiyah; Karl-Franzens-Universität Graz; Golestan University of Medical Sciences; Universität zu Köln; Institut National de la Recherche Agronomique; Institut National de la Santé et de la Recherche Médicale; National Taiwan University; Tallinna Tehnikaülikool; Uniwersytet Łódzki; Gentofte Hospital; Technische Universität München; National Yang-Ming University; Medical University Sofia; Universitetet i Oslo; Rigshospitalet; Aristotle University of Thessaloniki; University of Cape Town; Mount Sylvia Diatomite; Chinese University of Hong Kong; Ahvaz Jundishapur University of Medical Sciences; Univerza v Ljubljani; Amgen; University of Cyprus; National Taiwan University Hospital; Universitair Ziekenhuis Gent; Universität Wien; Universidade de São Paulo; Ege Üniversitesi; Linköpings Universitet; Medizinische Universität Graz; Technische Universität Dresden; Deutsches Zentrum für Herz-Kreislaufforschung; Cyprus University of Technology; Hamad Medical Corporation; Central European Institute of Technology; Universität Heidelberg; Sanofi; Universidad de Concepción; Imperial College London; University of the Philippines; Universität Basel; Duke-NUS Medical School; Universidad de Buenos Aires; Sveučilište u Zagrebu; McGill University Health Centre; Medizinische Universität Wien; National and Kapodistrian University of Athens; Medisinske fakultet, Universitetet i Oslo; Clínica Las Condes; Univerzita Karlova v Praze; McGill University; Mashhad University of Medical Sciences; Debreceni Egyetem; Helsingin Yliopisto; Amgen Foundation; Ministry of Health of the Russian Federation; Sultan Qaboos University; Pfizer","keywords":"Medicine; Current (fluid); Pediatrics; Internal medicine; Engineering","score_opus":0.054275155462927334,"score_gpt":0.3448545443870914,"score_spread":0.2905793889241641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893980284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97177714,0.025284741,0.000007840453,0.00038794242,0.00085647433,0.0013547136,0.00018726547,0.000022015887,0.000121854406],"genre_scores_gemma":[0.9821009,0.016609082,0.000053905806,0.0006395539,0.00041651507,0.00010287816,0.000013385265,0.000039252314,0.000024507708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970346,0.00039606195,0.00072265975,0.000382844,0.000983125,0.00048069342],"domain_scores_gemma":[0.99761975,0.000098052646,0.0002870987,0.0010983599,0.00079397985,0.0001027748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072037225,0.00028931105,0.0007733589,0.00008176799,0.00020015013,0.000028885202,0.00028694712,0.00014152974,0.000014314786],"category_scores_gemma":[0.00025358872,0.00016725688,0.0003186227,0.00069156993,0.00076133857,0.0001698128,0.00019690685,0.00037325552,0.000007657438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010882632,0.00046949906,0.7972041,0.0032860502,0.0007073578,0.0000021302014,0.057833336,0.0000317099,0.02288988,0.00046899548,0.0012945938,0.114724085],"study_design_scores_gemma":[0.0030058513,0.0005460491,0.9617458,0.0014562341,0.00031234228,0.0000024494402,0.005026044,0.000021908772,0.006562488,0.000040706916,0.021107344,0.00017279416],"about_ca_topic_score_codex":0.0013914976,"about_ca_topic_score_gemma":0.0026785827,"teacher_disagreement_score":0.16454169,"about_ca_system_score_codex":0.00043122584,"about_ca_system_score_gemma":0.0006097128,"threshold_uncertainty_score":0.68205374},"labels":[],"label_agreement":null},{"id":"W2894170432","doi":"10.1007/s12170-018-0592-7","title":"Lipoprotein(a)—It Is Risky, but What Do We Do About It?","year":2018,"lang":"en","type":"article","venue":"Current Cardiovascular Risk Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Lipoprotein(a); Internal medicine; Niacin; Lipoprotein; Kexin; Blood pressure; PCSK9; Body mass index; Endocrinology; Cardiology; Cholesterol; LDL receptor","score_opus":0.022132091556474644,"score_gpt":0.2917770606607264,"score_spread":0.26964496910425173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894170432","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17071502,0.80257756,0.005981559,0.0016737903,0.009684346,0.004487281,0.000049187456,0.00048776407,0.004343488],"genre_scores_gemma":[0.55125976,0.4357442,0.0010115317,0.0006339089,0.009865973,0.00053323363,0.000082436476,0.00026347852,0.0006054714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9899494,0.0005906228,0.0017323891,0.00232047,0.00396949,0.001437594],"domain_scores_gemma":[0.98995245,0.00004266005,0.0007293371,0.00693032,0.0012385334,0.0011067296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005964691,0.0009554483,0.0024344116,0.00040807264,0.0007031884,0.00052113255,0.00035264896,0.0005363362,0.00077904377],"category_scores_gemma":[0.00060482475,0.0008184298,0.0064346255,0.0009386375,0.0005004568,0.00071583886,0.00038524403,0.0013430283,0.0007172062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009840167,0.00026039276,0.0042327447,0.00069843617,0.0052785054,0.0018960516,0.0009773324,0.00001605835,0.00002211203,0.000017816805,0.024633097,0.96186906],"study_design_scores_gemma":[0.0021098666,0.0003502374,0.005139749,0.003456953,0.0040068934,0.005581753,0.00084053655,0.000035184483,0.0027230463,0.00051975774,0.9743091,0.00092696346],"about_ca_topic_score_codex":0.0011694246,"about_ca_topic_score_gemma":0.000029130068,"teacher_disagreement_score":0.9609421,"about_ca_system_score_codex":0.00040562323,"about_ca_system_score_gemma":0.00075854675,"threshold_uncertainty_score":0.99942666},"labels":[],"label_agreement":null},{"id":"W2894523108","doi":"10.1002/jcp.27254","title":"PCSK9: A novel inflammation modulator in atherosclerosis?","year":2018,"lang":"en","type":"review","venue":"Journal of Cellular Physiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"National Natural Science Foundation of China; Education Department of Hunan Province","keywords":"PCSK9; Kexin; Inflammation; Proprotein convertase; LDL receptor; Evolocumab; Alirocumab; Cholesterol; Lipoprotein; Medicine; Internal medicine","score_opus":0.05047576482647637,"score_gpt":0.31438359088200224,"score_spread":0.2639078260555259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894523108","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010695877,0.9874572,0.00050191936,0.00003479206,0.0005775013,0.00064304034,0.0000045565967,0.000008065709,0.00007701669],"genre_scores_gemma":[0.001607863,0.9935211,0.0005840207,0.000044693315,0.0040647388,0.00001785784,0.000029080424,0.00006140312,0.00006924749],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973923,0.00026680896,0.0013774381,0.0002573875,0.00039675544,0.00030928955],"domain_scores_gemma":[0.997766,0.00004721112,0.0012511929,0.0005279934,0.0002441408,0.00016346143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011503622,0.000320559,0.002970299,0.0004136729,0.000032124797,0.000010822791,0.00021041757,0.0005285127,0.000056011962],"category_scores_gemma":[0.00011637491,0.00022115085,0.0015243063,0.0003083511,0.00008077113,0.000079655656,0.000057157904,0.0007943876,0.00005719878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014661295,0.0005023081,0.000009254249,0.03161731,0.0017697371,0.00010636664,0.00021581503,0.000010352067,0.032127813,0.00017069891,0.0003276503,0.9329961],"study_design_scores_gemma":[0.0015070508,0.0006042144,0.00034963398,0.013367215,0.0009490522,0.00049929734,0.000009008801,0.000017733677,0.00026524582,0.00007454048,0.9821474,0.00020963632],"about_ca_topic_score_codex":0.000014745758,"about_ca_topic_score_gemma":0.0000020844047,"teacher_disagreement_score":0.98181975,"about_ca_system_score_codex":0.0002607071,"about_ca_system_score_gemma":0.0007497375,"threshold_uncertainty_score":0.90182704},"labels":[],"label_agreement":null},{"id":"W2894645224","doi":"10.1016/s0140-6736(18)31652-0","title":"Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials","year":2018,"lang":"en","type":"review","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":550,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Heart and Stroke Foundation of Canada","keywords":"Statin; Meta-analysis; Medicine; Baseline (sea); Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Outcome (game theory); Cardiology; Biology","score_opus":0.5749837391627718,"score_gpt":0.45216349290211044,"score_spread":0.12282024626066135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894645224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011909721,0.9041059,0.0020491648,0.00013546042,0.00010847514,0.006805398,0.08663685,0.000021433445,0.000018227676],"genre_scores_gemma":[0.00028449233,0.9857964,0.003720447,0.00009134419,0.0010675208,0.0012163186,0.0076800482,0.00006955544,0.0000738759],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9927909,0.0025068244,0.0023897816,0.0007529528,0.0012151102,0.0003444667],"domain_scores_gemma":[0.99271905,0.0010539001,0.001608351,0.004232568,0.00026732517,0.00011878027],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.01608506,0.0005367536,0.016255977,0.00036356386,0.00008367428,0.000015636328,0.00045545714,0.0002387039,0.00009024137],"category_scores_gemma":[0.0018208853,0.0002615031,0.00776719,0.00059797656,0.00010243012,0.000052042964,0.0001532073,0.00021069261,0.0000025898073],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112311114,0.00014159252,0.000008482875,0.0066305897,0.48322338,0.0000018532498,0.00012611643,0.000014488125,9.4565294e-8,0.00001525933,0.00036917365,0.5093567],"study_design_scores_gemma":[0.0016519112,0.0008571434,0.00008261007,0.00043870287,0.5377414,0.0000059860295,0.000024272184,0.00003632684,0.0000073758565,0.000014761777,0.45903134,0.00010815965],"about_ca_topic_score_codex":0.000517162,"about_ca_topic_score_gemma":0.000027656952,"teacher_disagreement_score":0.5092485,"about_ca_system_score_codex":0.00008936855,"about_ca_system_score_gemma":0.0003106926,"threshold_uncertainty_score":0.9999837},"labels":[],"label_agreement":null},{"id":"W2894660847","doi":"10.1161/jaha.118.009778","title":"Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life","year":2018,"lang":"en","type":"review","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"National Heart, Lung, and Blood Institute; National Health and Medical Research Council; American Heart Association; Medical Research Council; National Institute on Aging; National Institutes of Health","keywords":"Medicine; Atherosclerotic cardiovascular disease; Apolipoprotein B; Disease; Internal medicine; Cardiology; Ldl cholesterol; Cholesterol","score_opus":0.02305697983348728,"score_gpt":0.29089391610027876,"score_spread":0.2678369362667915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2894660847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027417116,0.96863335,0.000066655775,0.0013956378,0.00033123692,0.002089766,0.000027565215,0.000011854062,0.000026820422],"genre_scores_gemma":[0.026871443,0.968794,0.00021256809,0.0002681492,0.0034676616,0.000093841154,0.000004783586,0.00011190003,0.00017566868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939372,0.0015337779,0.0016154547,0.00031307904,0.0021296432,0.00047087463],"domain_scores_gemma":[0.9948181,0.00025343188,0.002945736,0.0013137462,0.0003693105,0.00029969309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064411853,0.00037472922,0.0037397158,0.00020925474,0.00016414722,0.000043701097,0.00052701373,0.00017434763,0.00001214245],"category_scores_gemma":[0.0030320717,0.00021150461,0.004645972,0.0010605115,0.00019300276,0.00009561438,0.00013709099,0.0012169011,0.000012205761],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021078317,0.0004530187,0.0052720886,0.012601512,0.016308056,0.000030355399,0.0011363418,0.00031292986,0.000091450675,0.0000055463174,0.00813756,0.95544034],"study_design_scores_gemma":[0.00091145886,0.0003897222,0.0046333307,0.018030463,0.0061038607,0.000102903185,0.00016481902,0.00004619221,0.000026906191,0.00001746995,0.96923953,0.00033335717],"about_ca_topic_score_codex":0.0026989796,"about_ca_topic_score_gemma":0.0000061088,"teacher_disagreement_score":0.96110195,"about_ca_system_score_codex":0.0013549717,"about_ca_system_score_gemma":0.0014706225,"threshold_uncertainty_score":0.8624908},"labels":[],"label_agreement":null},{"id":"W2895206452","doi":"10.1097/md.0000000000012225","title":"ST segment elevation myocardial infarction (STEMI) patients are more likely to achieve lipid-lowering treatment goals","year":2018,"lang":"en","type":"article","venue":"Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Dyslipidemia; Cardiology; Myocardial infarction; Unstable angina; Acute coronary syndrome; Statin; Revascularization; Discontinuation; Percutaneous coronary intervention; Canadian Cardiovascular Society; Angina","score_opus":0.01817475217871233,"score_gpt":0.28716883176746527,"score_spread":0.26899407958875293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895206452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98330843,0.00022702142,0.0025032551,0.009477071,0.0015210657,0.0019214636,0.000020001398,0.0001177407,0.0009039218],"genre_scores_gemma":[0.989121,0.00017577775,0.00025802836,0.0029335062,0.00662977,0.0001748895,0.00017516971,0.000043280124,0.0004885771],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99778044,0.00004921501,0.00044767687,0.0004425507,0.00089489296,0.00038522345],"domain_scores_gemma":[0.99845004,0.000021909627,0.00013921138,0.00062765426,0.00036420906,0.0003969982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005031064,0.00026571282,0.0006173164,0.00020914419,0.00016371607,0.000010179113,0.00006942621,0.00011411579,0.00015776309],"category_scores_gemma":[0.00017447559,0.00018755281,0.0001572743,0.0003702169,0.000077590295,0.000070535985,0.000043961554,0.00012888829,0.000105749416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021427434,0.00087500317,0.25061288,0.000416301,0.0012883829,0.000047339323,0.0069616735,0.000036987803,0.0068870727,0.000041833446,0.023423383,0.7072664],"study_design_scores_gemma":[0.009054387,0.0125225205,0.7861446,0.001016387,0.00053033244,0.000033030912,0.00075927953,0.000060773214,0.0032816746,0.000016811915,0.1862714,0.00030877587],"about_ca_topic_score_codex":0.0006480174,"about_ca_topic_score_gemma":0.000053634845,"teacher_disagreement_score":0.70695764,"about_ca_system_score_codex":0.00069230347,"about_ca_system_score_gemma":0.00009076317,"threshold_uncertainty_score":0.7648182},"labels":[],"label_agreement":null},{"id":"W2895329389","doi":"10.1177/1849454418804099","title":"Effect of statins on oxidative DNA damage in diabetic polyneuropathy","year":2018,"lang":"en","type":"article","venue":"Journal of Circulating Biomarkers","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Oxidative damage; Medicine; Oxidative phosphorylation; Oxidative stress; Polyneuropathy; Pharmacology; Diabetes mellitus; Chemistry; Internal medicine; Endocrinology; Biochemistry","score_opus":0.010035006146698531,"score_gpt":0.2889960711975483,"score_spread":0.2789610650508497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895329389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750507,0.00014197893,0.00011096212,0.00013122213,0.00021512041,0.00030065555,0.00000309318,0.0000070820192,0.0015847911],"genre_scores_gemma":[0.9992346,0.0000117603495,0.0003445524,0.00011512903,0.00025969496,0.0000017562165,0.000001492934,0.00002345429,0.000007540656],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978382,0.00052568986,0.0006342378,0.00014628677,0.0006235119,0.00023205834],"domain_scores_gemma":[0.9986078,0.00026987994,0.0005107607,0.00027766605,0.00018671743,0.00014713855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028262818,0.00014376685,0.0005895556,0.00035178612,0.00004313868,0.00000981045,0.0000893335,0.00006660807,0.00003289109],"category_scores_gemma":[0.0010267515,0.00010463311,0.00031007838,0.00040560844,0.00012763203,0.000072226256,0.000019804489,0.00024659306,0.000004498357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035316225,0.00041418953,0.25022537,0.0012856598,0.0011748774,0.001051216,0.0019635144,0.000042252163,0.5681252,0.00004158714,0.00026548252,0.17187907],"study_design_scores_gemma":[0.006398848,0.011404175,0.7888906,0.0018663675,0.00027671925,0.00033602832,0.0002522934,0.00049882906,0.18974075,0.00003307132,0.00013611917,0.00016617644],"about_ca_topic_score_codex":0.000049338694,"about_ca_topic_score_gemma":0.000004408503,"teacher_disagreement_score":0.53866524,"about_ca_system_score_codex":0.000120146615,"about_ca_system_score_gemma":0.00015201893,"threshold_uncertainty_score":0.42668143},"labels":[],"label_agreement":null},{"id":"W2895727459","doi":"10.1016/s0140-6736(18)31922-6","title":"Lipoprotein(a): lodestar for future clinical trials","year":2018,"lang":"en","type":"letter","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lipoprotein(a); Scopus; Lipoprotein; Internal medicine; Mendelian randomization; Myocardial infarction; Population; Apolipoprotein B; Context (archaeology); Disease; Cardiology; MEDLINE; Cholesterol; Genetics; Biology; Genetic variants","score_opus":0.1798439097245367,"score_gpt":0.42792444654377426,"score_spread":0.24808053681923756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895727459","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007441973,0.0046122666,0.0007826203,0.9828241,0.0037132844,0.0050880597,0.00036409497,0.00014904584,0.001722321],"genre_scores_gemma":[0.00007429314,0.0012483569,0.0018914012,0.5694017,0.42370927,0.00035855512,0.00040778812,0.00008402852,0.0028246278],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952955,0.0015246428,0.0011416883,0.00059453555,0.00072824454,0.00071535324],"domain_scores_gemma":[0.9954895,0.0007265814,0.00053236866,0.0028780065,0.00024990484,0.00012365244],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.018074064,0.00038280393,0.0036121968,0.00005513181,0.00017402515,0.00005975144,0.0005512995,0.0014688635,0.00024497818],"category_scores_gemma":[0.0018375278,0.00019966463,0.0020252492,0.00011792356,0.00020569132,0.000027453072,0.00007667067,0.0026211771,0.0002149236],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059783494,0.000021591795,0.000022061673,0.00093943905,0.00085658085,0.00007140993,0.000053611035,3.511766e-8,0.0000020626871,0.000041479387,0.9435128,0.053881083],"study_design_scores_gemma":[0.00440882,0.00061608973,0.00041380132,0.0003178822,0.0011465626,0.00010690957,0.000019832878,0.000009286865,0.000027216847,0.0008144997,0.99188125,0.00023784384],"about_ca_topic_score_codex":0.00009002815,"about_ca_topic_score_gemma":0.000013895048,"teacher_disagreement_score":0.419996,"about_ca_system_score_codex":0.000065493885,"about_ca_system_score_gemma":0.00040921726,"threshold_uncertainty_score":0.99982744},"labels":[],"label_agreement":null},{"id":"W2896665449","doi":"10.1016/j.jcjo.2018.07.011","title":"Elevated lipoprotein(a) levels as the cause of cryptogenic stroke in a young Ashkenazi Jewish female","year":2018,"lang":"en","type":"letter","venue":"Canadian Journal of Ophthalmology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Judaism; Stroke (engine); Medicine; Lipoprotein(a); Internal medicine; Endocrinology; Lipoprotein; Pediatrics; History; Cholesterol; Engineering","score_opus":0.04045163994320901,"score_gpt":0.290933970363894,"score_spread":0.250482330420685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896665449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9003561,0.006046337,0.000011040146,0.083060056,0.0016395582,0.0011310668,0.00018791501,0.000004765744,0.007563147],"genre_scores_gemma":[0.9699969,0.000038477014,0.00021046042,0.020349266,0.005444505,0.000029181252,0.000040327457,0.000114292125,0.003776589],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99588495,0.0006371399,0.0013040944,0.00038946088,0.00075018144,0.0010341718],"domain_scores_gemma":[0.99634343,0.00011435141,0.00094307103,0.0010934168,0.00089183764,0.0006139054],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018473137,0.0004329301,0.0016478522,0.0010182319,0.00012421032,0.000034189266,0.000691232,0.0013131703,0.0022108206],"category_scores_gemma":[0.0007309229,0.0003220632,0.0008291113,0.00049248594,0.0005386924,0.00008287055,0.000041971143,0.003326529,0.000049482995],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045002747,0.000121075966,0.067061946,0.0015211977,0.0059189918,0.7192709,0.0017344292,0.0000132429395,0.0006796145,0.000077132434,0.20077226,0.002379187],"study_design_scores_gemma":[0.003359379,0.0030637104,0.079072505,0.0011788524,0.0009199509,0.8300701,0.00020307502,0.0000037309933,0.001110965,0.00053905294,0.07995263,0.00052607065],"about_ca_topic_score_codex":0.04223919,"about_ca_topic_score_gemma":0.003851484,"teacher_disagreement_score":0.12081963,"about_ca_system_score_codex":0.0006562805,"about_ca_system_score_gemma":0.008528323,"threshold_uncertainty_score":0.9999833},"labels":[],"label_agreement":null},{"id":"W2896697579","doi":"10.2217/pgs-2018-0106","title":"<i>RYR1</i> and <i>CACNA1S</i> genetic variants identified with statin-associated muscle symptoms","year":2018,"lang":"en","type":"article","venue":"Pharmacogenomics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of Washington; University at Buffalo; National Heart, Lung, and Blood Institute; Australian Government; Dartmouth College; School of Medicine, Johns Hopkins University; Cedars-Sinai Medical Center; McMaster University; Johns Hopkins University; National Institutes of Health; John R. Oishei Foundation","keywords":"RYR1; Statin; Exome sequencing; Gene; Biology; Genetics; Medicine; Bioinformatics; Internal medicine; Mutation","score_opus":0.011775578103133441,"score_gpt":0.2587749441166387,"score_spread":0.24699936601350525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896697579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492764,0.0009837373,0.0012071849,0.00020438875,0.00026725495,0.0007094166,0.00005068895,0.00009765022,0.0015520195],"genre_scores_gemma":[0.99458057,0.0005919988,0.001437096,0.002335226,0.0005947529,0.00003304429,0.000031903477,0.000068354835,0.00032704242],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984059,0.00008046441,0.00029029336,0.00042376653,0.00035541522,0.00044418324],"domain_scores_gemma":[0.99893796,0.000026285323,0.00011832564,0.0003795577,0.00019730501,0.00034054433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004343069,0.00021758089,0.0003810155,0.000070199174,0.00019780133,0.000051365663,0.000096908254,0.00007447838,0.000118693955],"category_scores_gemma":[0.000025909874,0.00018392893,0.000090237554,0.00022395093,0.00015364971,0.00007985313,0.000066411696,0.00018590227,0.00007086524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002370355,0.001474695,0.057090238,0.0009256812,0.005936807,0.0010465026,0.004670689,0.000067165616,0.5196791,0.00019279007,0.008803463,0.39774248],"study_design_scores_gemma":[0.04832731,0.003927926,0.69308984,0.00055074197,0.005457409,0.0019657465,0.0005421623,0.0072621475,0.10410911,0.0004753861,0.13201627,0.0022759235],"about_ca_topic_score_codex":0.0002209976,"about_ca_topic_score_gemma":0.000043681393,"teacher_disagreement_score":0.6359996,"about_ca_system_score_codex":0.00010220287,"about_ca_system_score_gemma":0.00020511201,"threshold_uncertainty_score":0.7500404},"labels":[],"label_agreement":null},{"id":"W2897285419","doi":"10.1161/circ.132.suppl_3.19911","title":"Abstract 19911: Markers of Survival in Septuagenarians and Octogenarians With Heterozygous or Homozygous Familial Hypercholesterolemia","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Chicoutimi; Université de Montréal","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Internal medicine; Cholesterol; Survival analysis; Gastroenterology; Endocrinology","score_opus":0.03697544513771016,"score_gpt":0.2672604835307503,"score_spread":0.23028503839304015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897285419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681,0.0002575174,0.0006942281,0.00013438996,0.000103539554,0.0006296102,0.000009975484,0.000031351476,0.0013293703],"genre_scores_gemma":[0.9992703,0.000029082816,0.0003609099,0.00009651615,0.00012988193,0.000017653027,0.000038108694,0.000028019052,0.000029480234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986778,0.000077898694,0.00031548244,0.00027213598,0.00043902628,0.00021764208],"domain_scores_gemma":[0.9992527,0.000026472464,0.00008649322,0.0003426694,0.00010339046,0.00018832363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063718617,0.00014604886,0.00040414638,0.00012949585,0.000030235118,0.000014518062,0.00004436122,0.0001283395,0.0000130880635],"category_scores_gemma":[0.00006278478,0.00011050883,0.00006902286,0.00021470038,0.00007352794,0.000112444024,0.00001677928,0.00016091276,0.000003891832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005539916,0.00045184916,0.8850159,0.0009897728,0.0004156172,0.0012220017,0.0049411715,0.002645612,0.010231456,0.000052306936,0.00008869924,0.08840569],"study_design_scores_gemma":[0.005090782,0.00038231054,0.9915462,0.00017702277,0.00009767545,0.0005516343,0.0010325976,0.0004544082,0.00015439847,0.000024465939,0.0003353852,0.00015312311],"about_ca_topic_score_codex":0.0012454784,"about_ca_topic_score_gemma":0.00062365155,"teacher_disagreement_score":0.106530294,"about_ca_system_score_codex":0.00012813693,"about_ca_system_score_gemma":0.00025789978,"threshold_uncertainty_score":0.45064193},"labels":[],"label_agreement":null},{"id":"W2897800944","doi":"10.1002/humu.23634","title":"ClinVar database of global familial hypercholesterolemia‐associated DNA variants","year":2018,"lang":"en","type":"article","venue":"Human Mutation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"National Human Genome Research Institute; Fundação para a Ciência e a Tecnologia; National Institutes of Health; Esperion Therapeutics; University College London Hospitals NHS Foundation Trust; Sanofi; Kowa Company; Association for Molecular Pathology; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Ministerstvo Zdravotnictví Ceské Republiky; British Heart Foundation; Alexion Pharmaceuticals; Pfizer; National Institute of Diabetes and Digestive and Kidney Diseases; Amgen","keywords":"Biology; Personalized medicine; Resource (disambiguation); Mendelian inheritance; Whole genome sequencing; Disease; Bioinformatics; Database; Genetics; Genome; Medicine; Internal medicine; Computer science; Gene","score_opus":0.03314537112461285,"score_gpt":0.3245010502300823,"score_spread":0.29135567910546945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897800944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956524,0.00005300398,0.0009857867,0.000066095825,0.00016126168,0.00033018744,0.000066250344,0.00004656774,0.0026384974],"genre_scores_gemma":[0.9983651,0.0000074658465,0.0004153818,0.00031804503,0.0005028588,0.000008211065,0.00030457592,0.000012194932,0.0000661906],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99885124,0.000099778554,0.00029010177,0.00020554282,0.0003823796,0.0001709796],"domain_scores_gemma":[0.9992077,0.000008899025,0.000109869914,0.00034499937,0.00023553595,0.000093009556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005403175,0.00009197034,0.00024016191,0.00003311206,0.00009568097,0.000008770576,0.000055511828,0.000089704175,0.0000768477],"category_scores_gemma":[0.00012521834,0.00008559383,0.00010261083,0.00016932211,0.000086447624,0.00009080765,0.000024913701,0.00008310781,0.00005841543],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023760207,0.0045050574,0.32187322,0.0026534875,0.0031476466,0.00078619417,0.006134889,0.000024531668,0.41899353,0.015885863,0.010170748,0.2134488],"study_design_scores_gemma":[0.004048244,0.00079169375,0.98923314,0.00022790553,0.00026546695,0.000055721477,0.00019700827,0.00018631144,0.004091453,0.00050832646,0.00027013177,0.00012457663],"about_ca_topic_score_codex":0.0006351023,"about_ca_topic_score_gemma":0.00025534054,"teacher_disagreement_score":0.66735995,"about_ca_system_score_codex":0.00013335439,"about_ca_system_score_gemma":0.000121729536,"threshold_uncertainty_score":0.3490415},"labels":[],"label_agreement":null},{"id":"W2897893124","doi":"10.1161/str.49.suppl_1.104","title":"Abstract 104: First Stroke Reduced 44 Percent by Well Tolerated Medications. Stroke Outcomes From the Heart Outcomes Prevention Evaluation 3 Study","year":2018,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Rosuvastatin; Stroke (engine); Candesartan; Hydrochlorothiazide; Placebo; Internal medicine; Discontinuation; Blood pressure; Confidence interval; Cardiology; Angiotensin II","score_opus":0.035217343625252584,"score_gpt":0.33481388400620443,"score_spread":0.29959654038095185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897893124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98120725,0.00069446466,0.00010144048,0.010271695,0.00095303723,0.0038552156,0.0003178679,0.00017173207,0.0024272893],"genre_scores_gemma":[0.9935118,0.000078643134,0.00026177205,0.00084649376,0.0006391513,0.000360211,0.00040724623,0.000049730723,0.003844979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995456,0.00039714502,0.0008004678,0.000684729,0.002166619,0.00049504434],"domain_scores_gemma":[0.9973355,0.00016884437,0.00025617683,0.0014870889,0.0004777525,0.00027466385],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023399922,0.0003690815,0.000740916,0.00010265357,0.0005623411,0.00009382773,0.00028620788,0.00018525949,0.0021001387],"category_scores_gemma":[0.0003477171,0.0002450047,0.0004975142,0.00018373373,0.00017548686,0.00017243937,0.00008216951,0.00045744312,0.00035192276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004293864,0.0033048575,0.8821465,0.0000830258,0.0045139417,0.0000106253665,0.0033392895,0.000017767818,0.011777096,0.000029653702,0.05683932,0.03750854],"study_design_scores_gemma":[0.005067378,0.00068881793,0.9688571,0.00007532009,0.0010565316,0.000005387329,0.0028331012,0.00025744174,0.0017777474,0.000016806416,0.019131135,0.00023322081],"about_ca_topic_score_codex":0.002940319,"about_ca_topic_score_gemma":0.001112761,"teacher_disagreement_score":0.08671062,"about_ca_system_score_codex":0.00032814397,"about_ca_system_score_gemma":0.00043069947,"threshold_uncertainty_score":0.99910015},"labels":[],"label_agreement":null},{"id":"W2899561579","doi":"10.1016/j.jval.2018.07.249","title":"Burden of Ischemic Heart Disease And Stroke And Impact of Lipid Control And Modifiable Risk Factors In China","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Stroke (engine); Environmental health; Disease; Population; Obesity; Risk factor; Diabetes mellitus; Disease burden; Public health; Demography; Gerontology; Internal medicine","score_opus":0.01394295970635822,"score_gpt":0.28171289580616343,"score_spread":0.2677699360998052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899561579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926712,0.0059545934,0.000025324434,0.00033624878,0.000029228935,0.0008007985,0.000114005226,0.0000067003975,0.000061909515],"genre_scores_gemma":[0.99826187,0.0013869321,0.00014961221,0.0000358745,0.00012508604,0.0000074573422,0.0000037221344,0.0000130489425,0.00001637265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873686,0.00018917656,0.00038063573,0.0002275539,0.00019955878,0.00026623675],"domain_scores_gemma":[0.9991725,0.000066679226,0.00012754425,0.00025772292,0.00003461122,0.00034096328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009991771,0.0001214554,0.00061764446,0.00015638853,0.00003591088,0.0000047209023,0.000026550262,0.000060005197,0.0000090502035],"category_scores_gemma":[0.00017273774,0.00009279252,0.00006748904,0.00012839008,0.00013733307,0.000053461088,0.000024727598,0.00017592005,2.4986616e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055083627,0.00008844845,0.9929183,0.0012900577,0.00006881998,0.0000025377765,0.0015107157,0.0005562296,0.0012596371,0.000016228558,0.00011675464,0.0016214335],"study_design_scores_gemma":[0.0041651,0.0012960798,0.976763,0.00045319519,0.00004049743,0.000011488598,0.00016209402,0.016624426,0.00019572872,0.000060101287,0.00014690748,0.00008138649],"about_ca_topic_score_codex":0.15162691,"about_ca_topic_score_gemma":0.000034555203,"teacher_disagreement_score":0.15159236,"about_ca_system_score_codex":0.00007654527,"about_ca_system_score_gemma":0.00037304198,"threshold_uncertainty_score":0.8540225},"labels":[],"label_agreement":null},{"id":"W2899639588","doi":"10.1093/geroni/igy023.371","title":"EFFECT OF LONG-TERM POLYPHARMACY AND THE DRUG BURDEN INDEX (DBI) ON CARDIAC FUNCTION AND FIBROSIS IN AGED MICE","year":2018,"lang":"en","type":"article","venue":"Innovation in Aging","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Polypharmacy; Simvastatin; Metoprolol; Pharmacology; Cardiac function curve; Anesthesia; Internal medicine; Heart failure","score_opus":0.008737213183691752,"score_gpt":0.28605450745958355,"score_spread":0.2773172942758918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899639588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768454,0.00048577125,0.000118066055,0.000672317,0.00015654457,0.00062084896,9.717548e-7,0.0000121230705,0.00024881453],"genre_scores_gemma":[0.9992705,0.00006222722,0.000011399408,0.00027620592,0.00029823094,0.00003209712,0.0000075866933,0.00000972472,0.000031999858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904543,0.00020822202,0.0002744206,0.00015912046,0.00019882862,0.00011396366],"domain_scores_gemma":[0.9995553,0.00011581692,0.000087306384,0.00016011829,0.00006412245,0.000017335582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022654193,0.00008490283,0.00025460322,0.00029149873,0.000049031347,0.000014539744,0.000025935638,0.00003633269,0.000005988296],"category_scores_gemma":[0.00010140083,0.00005912673,0.000030715244,0.0006928864,0.000094869654,0.000069397196,0.000026409247,0.00018630801,0.0000010429458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014659747,0.000015843196,0.82274294,0.0005319432,0.00007525371,0.0000037462432,0.0017458695,0.0000053000244,0.014956475,0.00023575516,0.000039224415,0.15818168],"study_design_scores_gemma":[0.006181551,0.0001610421,0.9757866,0.00045894514,0.00004434245,0.000006713271,0.00009195748,0.00018696245,0.01690269,0.00004380177,0.00007172506,0.000063618565],"about_ca_topic_score_codex":0.0009722989,"about_ca_topic_score_gemma":0.000022289489,"teacher_disagreement_score":0.15811807,"about_ca_system_score_codex":0.00004385827,"about_ca_system_score_gemma":0.000023852373,"threshold_uncertainty_score":0.2411118},"labels":[],"label_agreement":null},{"id":"W2899889410","doi":"10.1161/jaha.118.010007","title":"Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study","year":2018,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University Health Network; University of Toronto; Western University; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; PCSK9; Hazard ratio; Internal medicine; Confidence interval; Cholesterol; LDL receptor; Lipoprotein","score_opus":0.02596122284766515,"score_gpt":0.3922805527349378,"score_spread":0.3663193298872726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899889410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942848,0.0001293508,0.00001195889,0.004552904,0.0004472981,0.00051353755,0.0000057384664,0.000006270334,0.00004810406],"genre_scores_gemma":[0.9972721,0.00006440702,0.00016435959,0.00091196946,0.0014899764,0.000002688098,2.9832555e-7,0.000012332918,0.00008188035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969115,0.0009800158,0.00083460665,0.0001344451,0.0009426061,0.00019680127],"domain_scores_gemma":[0.99738854,0.0003479946,0.0009733824,0.00045875623,0.0006929475,0.00013838807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006924256,0.00011642747,0.00092750834,0.00005889269,0.0001476874,0.000023531193,0.000114191615,0.000054618013,0.000012252765],"category_scores_gemma":[0.0017402682,0.00005597739,0.0009345782,0.00034056258,0.00020133964,0.000080059785,0.00007083954,0.00044064736,0.0000044840212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018606786,0.00029457934,0.9899393,0.000006810063,0.00070420746,0.0000013821626,0.00030712865,0.000002006647,0.00013697142,0.0000011401662,0.00450958,0.003910827],"study_design_scores_gemma":[0.001291774,0.003703632,0.99204737,0.000035871268,0.00036083546,0.00007595396,0.00048050543,0.000014264153,0.00005734545,0.000029169203,0.0018504588,0.00005282584],"about_ca_topic_score_codex":0.0017806095,"about_ca_topic_score_gemma":0.00014832504,"teacher_disagreement_score":0.0051839883,"about_ca_system_score_codex":0.00043108774,"about_ca_system_score_gemma":0.0004953833,"threshold_uncertainty_score":0.26917607},"labels":[],"label_agreement":null},{"id":"W2899953763","doi":"10.1016/j.ijcard.2018.10.090","title":"The spectrum of the dyslipidemia in Colombia: The PURE study","year":2018,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Servier; Canadian Institutes of Health Research; AstraZeneca Canada; Boehringer Ingelheim; Heart and Stroke Foundation of Canada; Sanofi; Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS); Population Health Research Institute","keywords":"Dyslipidemia; Medicine; Environmental health; Lipid profile; Rural area; Demography; Disease; Cholesterol; Internal medicine; Pathology","score_opus":0.013029198260921278,"score_gpt":0.3088441053581825,"score_spread":0.2958149070972612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899953763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97378224,0.00075086945,0.00012220228,0.019551829,0.0029011776,0.00034355998,0.000002338645,0.0000021386645,0.0025436492],"genre_scores_gemma":[0.9959217,0.0001354032,0.000011794278,0.0004588387,0.0033619825,0.0000057164143,2.4387953e-7,0.0000065899158,0.000097781594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981822,0.00047518016,0.00049784174,0.00008350796,0.0006193572,0.0001419561],"domain_scores_gemma":[0.9986395,0.00020572532,0.0003015722,0.00032830547,0.0004913428,0.00003353612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027493334,0.000072004535,0.00034164247,0.000059842718,0.00008279078,0.000010827041,0.0005537094,0.000059953225,0.00001201274],"category_scores_gemma":[0.00053935935,0.00002899314,0.00036340786,0.000122031954,0.00030225966,0.00002882694,0.00010782285,0.00043246447,0.0000037186476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017978654,0.00018732922,0.93795,0.000012641771,0.0052059535,0.00033081448,0.0014936429,0.00026731633,0.0008519501,0.002662551,0.019286986,0.029952921],"study_design_scores_gemma":[0.0018945569,0.0008076126,0.9288312,0.000048468828,0.00012341497,0.0016154484,0.0011179141,0.000017736007,0.00037504418,0.0009674725,0.06416369,0.00003739848],"about_ca_topic_score_codex":0.00005187098,"about_ca_topic_score_gemma":0.00017716497,"teacher_disagreement_score":0.044876706,"about_ca_system_score_codex":0.00011497212,"about_ca_system_score_gemma":0.00026284732,"threshold_uncertainty_score":0.1878867},"labels":[],"label_agreement":null},{"id":"W2899996011","doi":"10.1503/cmaj.180804","title":"Nonfasting lipid testing: the new standard for cardiovascular risk assessment","year":2018,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Coronary heart disease; Risk assessment; Risk factor; Internal medicine; Cardiology; Computer science","score_opus":0.017781955270975345,"score_gpt":0.27504712319438124,"score_spread":0.25726516792340587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899996011","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16915467,0.008938626,0.39340907,0.35265014,0.014927759,0.0062589087,0.00034397183,0.0003033687,0.054013476],"genre_scores_gemma":[0.79574245,0.00075905974,0.041504506,0.03283393,0.12705113,0.00007544386,0.000032499847,0.00015822175,0.0018427776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99587977,0.00028207235,0.00045801798,0.00021609533,0.0025044729,0.0006595767],"domain_scores_gemma":[0.99551517,0.00029195557,0.0002415617,0.00032578874,0.0014611195,0.0021643883],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010036104,0.00014334425,0.00043762007,0.0001011657,0.00093783403,0.0001358561,0.00018931298,0.00027642242,0.0005951623],"category_scores_gemma":[0.010564038,0.000098065444,0.000738584,0.0003184983,0.000057464273,0.00007345567,0.000018006882,0.0010841019,0.000038681777],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027543207,0.000015052833,0.03371906,0.000028792258,0.0023218733,0.000102801634,0.00024446446,0.0000140649945,0.000005561008,0.00015049784,0.20034881,0.76302147],"study_design_scores_gemma":[0.0023904003,0.00039453388,0.029728852,0.00013102822,0.0005270918,0.00062424527,0.00023410367,0.00074200454,0.00001492321,0.00023876192,0.96485054,0.00012352435],"about_ca_topic_score_codex":0.007370972,"about_ca_topic_score_gemma":0.0076917373,"teacher_disagreement_score":0.76450175,"about_ca_system_score_codex":0.0016556695,"about_ca_system_score_gemma":0.014303256,"threshold_uncertainty_score":0.999239},"labels":[],"label_agreement":null},{"id":"W2899997727","doi":"10.1056/nejmoa1801174","title":"Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3519,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Acute coronary syndrome; Medicine; Cardiology; Internal medicine; Myocardial infarction; Cholesterol","score_opus":0.012001850561217093,"score_gpt":0.2628868912093092,"score_spread":0.2508850406480921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899997727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97001266,0.021425884,0.0009864776,0.005804081,0.0008063911,0.00024448585,0.0000019612776,0.000017131488,0.0007009333],"genre_scores_gemma":[0.9905595,0.0021638703,0.0009439444,0.0016814932,0.004079397,0.000002614998,0.0000022736383,0.000028199574,0.000538703],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.997828,0.00010963252,0.0005303988,0.00019858051,0.0010639617,0.00026943246],"domain_scores_gemma":[0.99846715,0.000050396742,0.00013798331,0.00047551343,0.00027476833,0.00059417414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016891004,0.00020532768,0.0012054705,0.00019752495,0.00006107593,0.00000900575,0.00009285985,0.00009674341,0.00028573826],"category_scores_gemma":[0.00016347997,0.00011914127,0.0003900861,0.00014656007,0.00023063771,0.000110683555,0.000039205024,0.00034681102,0.000011394767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026165184,0.000091481226,0.17583217,0.00020590497,0.01010212,0.01612328,0.0016132314,0.0000011409317,0.00024072215,0.000055401466,0.005608339,0.7875097],"study_design_scores_gemma":[0.05411614,0.0041266168,0.7444447,0.0005380053,0.002989803,0.09036745,0.00013485314,0.000004278438,0.000059548525,0.00024544325,0.102826156,0.00014699168],"about_ca_topic_score_codex":0.00014712778,"about_ca_topic_score_gemma":0.000013736063,"teacher_disagreement_score":0.7873627,"about_ca_system_score_codex":0.00004443462,"about_ca_system_score_gemma":0.0001932043,"threshold_uncertainty_score":0.485844},"labels":[],"label_agreement":null},{"id":"W2900031678","doi":"10.1016/j.atherosclerosis.2018.11.001","title":"ApoB in clinical care: Pro and Con","year":2018,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Apolipoprotein B; Blood pressure; Medicine; Arterial wall; Intensive care medicine; Cardiology; Internal medicine; Risk analysis (engineering); Cholesterol","score_opus":0.12704680782010155,"score_gpt":0.40213760014962724,"score_spread":0.2750907923295257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900031678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013878214,0.9953067,0.000005661914,0.00003619107,0.00029870504,0.0020903074,0.000019496023,0.000045951954,0.00080919574],"genre_scores_gemma":[0.0002962231,0.9977045,0.00028554056,0.0002110261,0.00095294445,0.00023690106,0.000047774116,0.00008844431,0.00017666901],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974168,0.000337876,0.00090850744,0.00067747594,0.0003162141,0.00034314962],"domain_scores_gemma":[0.99851924,0.00008521527,0.00021184285,0.0008799673,0.00007318167,0.00023055263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001262124,0.00035055596,0.0025451875,0.000105064246,0.000051795956,0.000026900989,0.000118819014,0.0006413574,0.00003454145],"category_scores_gemma":[0.00014572669,0.000252193,0.00090123515,0.00025772004,0.000174651,0.000032139716,0.0001019752,0.0005893028,0.00012004627],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000069030702,0.000059540445,0.00083474943,0.015450862,0.0001710951,0.0000057287625,0.00008869972,1.6046312e-9,1.2390622e-7,0.000016738506,0.00034254888,0.983023],"study_design_scores_gemma":[0.0009920705,0.00038446047,0.0033925402,0.019622555,0.0009614437,0.000035000663,0.00003197507,4.264862e-7,7.1045224e-7,0.0000040772256,0.9743429,0.00023185622],"about_ca_topic_score_codex":0.00019159712,"about_ca_topic_score_gemma":0.000042043146,"teacher_disagreement_score":0.9827911,"about_ca_system_score_codex":0.00014382288,"about_ca_system_score_gemma":0.0004191705,"threshold_uncertainty_score":0.999993},"labels":[],"label_agreement":null},{"id":"W2900103074","doi":"10.1016/j.jacc.2018.10.039","title":"Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events","year":2018,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital","funders":"","keywords":"Medicine; Alirocumab; Cardiology; Internal medicine; Intensive care medicine; Total cholesterol","score_opus":0.010733420473716533,"score_gpt":0.2618442107093339,"score_spread":0.25111079023561733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900103074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408555,0.0029147647,0.00031643073,0.00089635066,0.0006600176,0.00027016734,0.000043789238,0.0000058424866,0.0008070831],"genre_scores_gemma":[0.99625474,0.00045968793,0.00083799276,0.00015005369,0.0021745574,0.0000030631875,7.5701854e-7,0.000020504307,0.000098668],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979895,0.00038115532,0.00051715324,0.00019168698,0.00065468904,0.00026586038],"domain_scores_gemma":[0.99827003,0.00004782559,0.00050056726,0.00059412397,0.00041878526,0.00016863938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011413777,0.0001620262,0.001471206,0.00013049672,0.000102879116,0.0000031068037,0.00021417397,0.00006693488,0.000005729084],"category_scores_gemma":[0.00022062514,0.00010097027,0.0014049255,0.00032427665,0.0008790912,0.000067481305,0.00015013742,0.00027829089,0.0000021334608],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022186156,0.0007671629,0.23308879,0.0013259184,0.11847516,0.0059041954,0.0016184811,0.0009016644,0.11646411,0.0013516179,0.05157931,0.44633743],"study_design_scores_gemma":[0.008293514,0.009081515,0.7635062,0.00042851327,0.00417146,0.11506746,0.0023646615,0.00003923162,0.020146534,0.0003149648,0.076096654,0.0004893301],"about_ca_topic_score_codex":0.000054420165,"about_ca_topic_score_gemma":0.0000016668893,"teacher_disagreement_score":0.5304174,"about_ca_system_score_codex":0.00007520056,"about_ca_system_score_gemma":0.00035579156,"threshold_uncertainty_score":0.4117448},"labels":[],"label_agreement":null},{"id":"W2900168942","doi":"10.1016/j.jacl.2018.10.012","title":"Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Institute for Clinical Evaluative Sciences; McGill University; University of Toronto; Royal Victoria Hospital; Sunnybrook Health Science Centre; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Heart and Stroke Foundation of Canada","keywords":"Medicine; Meta-analysis; Odds ratio; Internal medicine; Confidence interval; Diabetes mellitus; Family history; Body mass index; Cochrane Library; Disease; Relative risk; Endocrinology","score_opus":0.2202542433955947,"score_gpt":0.447504653023783,"score_spread":0.2272504096281883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900168942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010103572,0.9934099,0.0005930342,0.00014076987,0.0007629303,0.004795624,0.00018234119,0.000009125376,0.000005291173],"genre_scores_gemma":[0.000085163636,0.9958561,0.00054824166,0.00065374124,0.0024373855,0.00025810194,0.000036390713,0.00006708055,0.00005776202],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9842573,0.0065494184,0.0071594887,0.00076184055,0.00082064496,0.00045134153],"domain_scores_gemma":[0.9901412,0.003006275,0.0037171775,0.0017502564,0.00054902775,0.00083602476],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.020902192,0.0006620956,0.039836988,0.0006164976,0.000060160422,0.000023488983,0.00039165467,0.00084830105,0.000028637633],"category_scores_gemma":[0.01458358,0.00035357606,0.05539301,0.0005583674,0.00022865157,0.00007646868,0.00011346577,0.0017385806,0.000007495733],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006077621,0.00013019162,0.00008882703,0.53386617,0.46143416,0.000053995256,0.000008232839,0.0000022685065,5.9799926e-10,0.000002068822,0.00012868004,0.0042246613],"study_design_scores_gemma":[0.0008927041,0.00070121535,0.00008262445,0.022705317,0.8153309,0.00031163052,0.000004911745,0.0000029130856,3.4171512e-9,0.000020457432,0.15973593,0.00021137515],"about_ca_topic_score_codex":0.000054468146,"about_ca_topic_score_gemma":0.00001536579,"teacher_disagreement_score":0.51116085,"about_ca_system_score_codex":0.00010813763,"about_ca_system_score_gemma":0.0007712618,"threshold_uncertainty_score":0.99989164},"labels":[],"label_agreement":null},{"id":"W2900354984","doi":"10.1016/j.jcmg.2018.04.015","title":"Effects of Statins on Coronary Atherosclerotic Plaques","year":2018,"lang":"en","type":"article","venue":"JACC. Cardiovascular imaging","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":509,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Atheroma; Cardiology; Internal medicine; Coronary artery disease; Statin; Coronary atherosclerosis; Stenosis; Artery","score_opus":0.009173624886574454,"score_gpt":0.2461965272010494,"score_spread":0.23702290231447495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900354984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686297,0.012761544,0.0087553775,0.0001851971,0.00063552643,0.0018312692,0.000009641834,0.00022283003,0.0069688717],"genre_scores_gemma":[0.995803,0.00041327986,0.001947817,0.0006092499,0.0009744949,0.000050437968,0.0000124214475,0.00008758207,0.00010172381],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971342,0.000258573,0.00038697384,0.0005496565,0.0011681663,0.0005023957],"domain_scores_gemma":[0.99797976,0.00009138775,0.00009675303,0.001327201,0.0002813264,0.00022357533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010441255,0.00030028555,0.0009872415,0.0001872781,0.0001340037,0.000025014662,0.00015495898,0.000083848405,0.000044654505],"category_scores_gemma":[0.00021580071,0.00025771186,0.0016520354,0.00030239538,0.00022576391,0.00012179915,0.00008482206,0.00027325854,0.00012427029],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007280895,0.0008201504,0.029319257,0.004166839,0.012205085,0.0014543805,0.0018628684,0.00011143555,0.023147102,0.00072098797,0.002544969,0.92291886],"study_design_scores_gemma":[0.01172487,0.001618671,0.7227327,0.00225758,0.003609631,0.00096627156,0.00040706655,0.0007286268,0.20483881,0.0002454113,0.049976822,0.00089352514],"about_ca_topic_score_codex":0.00029891304,"about_ca_topic_score_gemma":0.0000027185133,"teacher_disagreement_score":0.9220253,"about_ca_system_score_codex":0.0001459073,"about_ca_system_score_gemma":0.00015805059,"threshold_uncertainty_score":0.9999875},"labels":[],"label_agreement":null},{"id":"W2901655499","doi":"10.1007/s10557-018-6840-8","title":"Medical Expenditures Among Medicare Beneficiaries with Statin-Associated Adverse Effects Following Myocardial Infarction","year":2018,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Amgen","keywords":"Medicine; Statin; Ezetimibe; Discontinuation; Adverse effect; Myocardial infarction; Internal medicine; Emergency medicine","score_opus":0.005418490729975448,"score_gpt":0.23245149411686675,"score_spread":0.2270330033868913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901655499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700238,0.02578143,0.0010258812,0.00021596908,0.0006589756,0.0010894451,0.00000597819,0.00018299348,0.0010155182],"genre_scores_gemma":[0.9930811,0.0041659004,0.00014971587,0.00076646137,0.0015200432,0.0001385571,0.00007245544,0.000075993135,0.000029805506],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9958796,0.00036904123,0.00032234428,0.00062209216,0.00225931,0.0005476013],"domain_scores_gemma":[0.99831784,0.00009125409,0.00008837841,0.00078002806,0.0001929959,0.0005295248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001925287,0.00037542052,0.001110944,0.00013992474,0.0004422324,0.000047632657,0.00012126579,0.0003577348,0.000059191156],"category_scores_gemma":[0.00018684706,0.0002656417,0.0013373013,0.00026029558,0.0003419267,0.0001681598,0.000055636334,0.00041507062,0.000008404604],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088259234,0.00025640609,0.056722883,0.00027042266,0.042042736,0.001058923,0.006006268,0.000025699926,0.00014716924,0.00020963121,0.00052653346,0.8918507],"study_design_scores_gemma":[0.044783536,0.0040815086,0.79110074,0.0021186194,0.0046349796,0.000592016,0.004661646,0.00039119323,0.0043696435,0.00027562046,0.14130609,0.0016844175],"about_ca_topic_score_codex":0.0009310069,"about_ca_topic_score_gemma":0.000081463295,"teacher_disagreement_score":0.89016634,"about_ca_system_score_codex":0.000092720904,"about_ca_system_score_gemma":0.00030454734,"threshold_uncertainty_score":0.99997956},"labels":[],"label_agreement":null},{"id":"W2901728784","doi":"10.1161/circulationaha.118.035658","title":"Whole-Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized With Early-Onset Myocardial Infarction","year":2019,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":332,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Stephen's University","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; Harvard Catalyst; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Human Genome Research Institute; Massachusetts General Hospital; National Institute of General Medical Sciences; American Heart Association","keywords":"Medicine; Myocardial infarction; Whole genome sequencing; Genome; Genome-wide association study; Genetics; Internal medicine; Cardiology; Gene; Single-nucleotide polymorphism; Genotype; Biology","score_opus":0.008316160120197182,"score_gpt":0.22163362758440106,"score_spread":0.21331746746420388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901728784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733716,0.000059411177,0.00036834134,0.00023613105,0.000104333856,0.0017557334,0.000052838095,0.000035139466,0.000050930084],"genre_scores_gemma":[0.99909014,0.000010543297,0.000064883934,0.0002358674,0.00009475091,0.000061972445,0.00040932035,0.00001956197,0.000012983374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989196,0.00006307926,0.00022502744,0.00027743398,0.0002874586,0.00022739318],"domain_scores_gemma":[0.99935675,0.000006899651,0.00006541281,0.00029186756,0.0001367448,0.0001423459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002641739,0.00011905173,0.00029194326,0.00016068983,0.000058323472,0.000025695846,0.00002610296,0.00009091567,0.000014362705],"category_scores_gemma":[0.000036528647,0.00010975789,0.00007930506,0.00028225596,0.000015123842,0.00016517422,0.00001832331,0.00012215522,0.000049885268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001994035,0.00002604309,0.9859633,0.000030806317,0.000084472325,0.0000018398639,0.00033713516,0.00007310798,0.012049783,0.000012736947,0.0000012160932,0.0012201867],"study_design_scores_gemma":[0.0036719732,0.00026683716,0.9953607,0.000065827546,0.00006911386,0.000015436595,0.000021679298,0.00010971307,0.00005764736,0.000016778235,0.0002135701,0.0001307728],"about_ca_topic_score_codex":0.00038049763,"about_ca_topic_score_gemma":0.0000063298753,"teacher_disagreement_score":0.011992136,"about_ca_system_score_codex":0.00041564458,"about_ca_system_score_gemma":0.00012252953,"threshold_uncertainty_score":0.4475797},"labels":[],"label_agreement":null},{"id":"W2901788545","doi":"10.1016/j.ebiom.2018.11.032","title":"Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors","year":2018,"lang":"en","type":"article","venue":"EBioMedicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Sepsis; Genotype; Medicine; Immunology; Internal medicine; Biology; Genetics; LDL receptor; Gene; Cholesterol","score_opus":0.03321001563005368,"score_gpt":0.3439475795187978,"score_spread":0.31073756388874413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901788545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977679,0.00050976704,0.0002873469,0.00008584011,0.00032851833,0.00035718217,0.0000075073667,0.000015879386,0.00064002234],"genre_scores_gemma":[0.9989286,0.00050397124,0.00005876539,0.00003063976,0.00041313443,0.0000055563746,0.000027759934,0.000011782007,0.000019797724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888986,0.00006452866,0.00032612003,0.00020130954,0.00036038182,0.00015777207],"domain_scores_gemma":[0.9992718,0.000020765223,0.00011442335,0.00032846924,0.00015455626,0.00010995642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007961661,0.000114682385,0.00042040626,0.00022360627,0.000022625896,0.0000016290966,0.00002322743,0.00009015105,0.00013649788],"category_scores_gemma":[0.000066339846,0.000081233135,0.00012071165,0.000498928,0.00018470765,0.000035062167,0.000017508979,0.00013166985,0.0000071524696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007996665,0.00026325652,0.9408782,0.00040559526,0.00029859005,0.000007158786,0.0002464164,0.0000017597006,0.0019337597,0.000054804663,0.00011068701,0.055000108],"study_design_scores_gemma":[0.0019433951,0.005750273,0.9901202,0.0004044389,0.00013765652,0.000011499458,0.000024496036,0.000055414293,0.0008985195,0.00006710753,0.00052584324,0.00006121116],"about_ca_topic_score_codex":0.01334713,"about_ca_topic_score_gemma":0.0003547827,"teacher_disagreement_score":0.054938897,"about_ca_system_score_codex":0.000107815926,"about_ca_system_score_gemma":0.000096036165,"threshold_uncertainty_score":0.9932231},"labels":[],"label_agreement":null},{"id":"W2902007237","doi":"10.1002/jcsm.12344","title":"Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions","year":2018,"lang":"en","type":"review","venue":"Journal of Cachexia Sarcopenia and Muscle","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Statin; Medicine; Open label; Physical therapy; Internal medicine; Physical medicine and rehabilitation; Clinical trial","score_opus":0.1395506762243864,"score_gpt":0.4372346251102469,"score_spread":0.29768394888586047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902007237","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045242164,0.94977486,0.000009725453,0.00016655246,0.00010370407,0.004647027,0.000019515634,0.00000506739,0.000031369047],"genre_scores_gemma":[0.025800576,0.9735582,0.00016845042,0.00017824718,0.000082413135,0.0001228815,0.000020439316,0.00004456819,0.0000242624],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9937835,0.00206693,0.0029383262,0.00031039177,0.00063871435,0.000262162],"domain_scores_gemma":[0.9933254,0.0010711626,0.0040584244,0.00059138116,0.0008216337,0.00013198022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010457474,0.00038737518,0.0066315955,0.00026457524,0.00012482374,0.000050769955,0.0002801032,0.00014269246,0.0000121759185],"category_scores_gemma":[0.0022119826,0.0002079493,0.00042867372,0.00058400724,0.00023118727,0.00015269329,0.00018174334,0.00059845066,5.8463814e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008645664,0.00025090823,0.00011134945,0.9403638,0.0062039318,0.000047579706,0.0008014633,9.2229726e-7,0.000045856483,0.000019554736,0.00037215362,0.051696014],"study_design_scores_gemma":[0.00579108,0.0013021895,0.0021684435,0.97693205,0.009863616,0.0004072351,0.0007202373,0.000015180687,0.000026249882,0.00006877904,0.0024463919,0.00025854292],"about_ca_topic_score_codex":0.0001633449,"about_ca_topic_score_gemma":0.000069036905,"teacher_disagreement_score":0.05143747,"about_ca_system_score_codex":0.0001736069,"about_ca_system_score_gemma":0.000743822,"threshold_uncertainty_score":0.8479926},"labels":[],"label_agreement":null},{"id":"W2902555080","doi":"10.1097/mol.0000000000000565","title":"Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"ATP citrate lyase; LDL receptor; Endocrinology; Internal medicine; Lipogenesis; Chemistry; Apolipoprotein B; Lipoprotein; Cholesterol; Lipid metabolism; Biochemistry; Medicine; Enzyme","score_opus":0.09978454856380961,"score_gpt":0.3882565664402808,"score_spread":0.28847201787647114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902555080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006748332,0.94604033,0.000042075146,0.00009654959,0.050342243,0.0032208217,0.000026409289,0.00007454907,0.000089527384],"genre_scores_gemma":[0.000009747106,0.9526396,0.00015815323,0.00007923037,0.045732044,0.0010530078,0.00018925298,0.00010378698,0.000035218985],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959259,0.0010049924,0.0008877067,0.0010814046,0.00043921327,0.0006607966],"domain_scores_gemma":[0.9979192,0.0002299946,0.00035474714,0.0011134618,0.000069422495,0.0003131928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011475245,0.0007065379,0.0035566331,0.0006180589,0.00009558892,0.000026470821,0.00022260995,0.00080119603,0.00004987279],"category_scores_gemma":[0.00037613,0.00053343165,0.0008181648,0.00048285545,0.00020415681,0.00005187646,0.00019709431,0.0012242787,0.0002646271],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002792463,0.0001379885,0.000016401389,0.058129903,0.0001773292,2.4379918e-7,0.000056529916,1.494826e-8,7.782997e-7,0.00038271872,0.005788045,0.9352821],"study_design_scores_gemma":[0.0014670205,0.00061287754,0.00048069406,0.04380817,0.00050899404,0.00010489005,0.00000400387,0.0000010000294,0.0000039690485,0.000063979765,0.9525567,0.00038769268],"about_ca_topic_score_codex":0.000044117707,"about_ca_topic_score_gemma":0.0000028858149,"teacher_disagreement_score":0.94676864,"about_ca_system_score_codex":0.00016581481,"about_ca_system_score_gemma":0.000362694,"threshold_uncertainty_score":0.99971175},"labels":[],"label_agreement":null},{"id":"W2902584466","doi":"10.1161/atvbaha.118.311581","title":"Recent Highlights of <i>ATVB</i>","year":2018,"lang":"en","type":"review","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute","keywords":"Political science","score_opus":0.08637952785913156,"score_gpt":0.3477195493186741,"score_spread":0.26134002145954255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902584466","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013847786,0.9962779,0.00004197935,0.00014118316,0.0004214947,0.0012721913,0.00006615738,0.000051614352,0.00034268104],"genre_scores_gemma":[0.00021765241,0.9980811,0.00046189755,0.00021582514,0.00056278054,0.00014031162,0.0002330827,0.00007970222,0.000007682021],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970149,0.00041273207,0.0009862828,0.00084241346,0.00025958972,0.00048407546],"domain_scores_gemma":[0.9977996,0.000055164946,0.00041564452,0.0012760526,0.00018960741,0.0002639429],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007727627,0.0005616734,0.0040165945,0.00021613907,0.00012498103,0.000019292873,0.0001937927,0.000757026,0.00016267858],"category_scores_gemma":[0.000042704094,0.00038137348,0.0016090864,0.00034989827,0.00040303188,0.000039734838,0.00018757662,0.0002760584,0.000062306266],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000033189772,0.00035103076,0.00030624727,0.020199707,0.0052852347,2.8063252e-7,0.000099675555,4.995845e-9,0.00019276417,0.0007663632,0.0013380268,0.97145736],"study_design_scores_gemma":[0.00064956787,0.0007655274,0.0077797114,0.0073754992,0.0035275775,0.0000075445205,0.000008695559,5.295709e-7,0.000008635892,0.000014361634,0.9795191,0.00034325029],"about_ca_topic_score_codex":0.000066217646,"about_ca_topic_score_gemma":0.0000121836065,"teacher_disagreement_score":0.97818106,"about_ca_system_score_codex":0.0000713766,"about_ca_system_score_gemma":0.000245054,"threshold_uncertainty_score":0.9998638},"labels":[],"label_agreement":null},{"id":"W2902745272","doi":"10.1016/j.jacl.2018.11.007","title":"Individualized low-density lipoprotein cholesterol reduction with alirocumab titration strategy in heterozygous familial hypercholesterolemia: Results from an open-label extension of the ODYSSEY LONG TERM trial","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Regeneron Pharmaceuticals; Sanofi; Mylan; Pfizer; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Alirocumab; Open label; Open label study; Ldl cholesterol; Internal medicine; Low-density lipoprotein; Lipoprotein; Endocrinology; Cholesterol; Clinical trial; Adverse effect","score_opus":0.11641847434220684,"score_gpt":0.41734076573286005,"score_spread":0.3009222913906532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902745272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942498,0.000060884897,0.00021516926,0.00109134,0.0027596126,0.001497474,0.000018139763,0.000010871639,0.00009670536],"genre_scores_gemma":[0.9886389,0.000092368864,0.0010009019,0.00081431586,0.009350399,0.00001050347,0.000027746664,0.000030443667,0.000034429624],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9933215,0.0021994128,0.0028273326,0.0005281255,0.0008121431,0.00031153657],"domain_scores_gemma":[0.99594057,0.00021580409,0.0018936809,0.0010115227,0.00067429926,0.00026414063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006147411,0.00024311642,0.0015535646,0.00014620817,0.00010585178,0.00005102043,0.00048798518,0.0006120434,0.0000117958125],"category_scores_gemma":[0.0012169109,0.00014799737,0.000249755,0.00024795806,0.00047196663,0.00042823167,0.00015296285,0.0013216687,0.000004185208],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60294944,0.0072006444,0.014591353,0.00012022265,0.00079332653,0.00012940005,0.00096091174,0.00004851383,0.03241663,0.00001598876,0.00048386853,0.34028968],"study_design_scores_gemma":[0.203414,0.026536047,0.7630431,0.00082934974,0.00040813882,0.00074649707,0.00014113783,0.00005297259,0.0043330425,0.00018132702,0.00013261546,0.00018175738],"about_ca_topic_score_codex":0.0013994942,"about_ca_topic_score_gemma":0.0017973135,"teacher_disagreement_score":0.74845177,"about_ca_system_score_codex":0.00008564501,"about_ca_system_score_gemma":0.0007775887,"threshold_uncertainty_score":0.60351574},"labels":[],"label_agreement":null},{"id":"W2902955133","doi":"10.1016/j.cjca.2018.09.005","title":"Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Manitoba; Queen Elizabeth II Health Sciences Centre; Thrombosis and Atherosclerosis Research Institute; Western University; Hospital for Sick Children; Population Health Research Institute; Dalhousie University; Hamilton Health Sciences; Centre Hospitalier Universitaire Sainte-Justine; St. Boniface Hospital; Université de Montréal; Université Laval; McMaster University; McGill University Health Centre; Royal Victoria Hospital; Institute for Clinical Evaluative Sciences; McGill University; University of Toronto; Health Sciences Centre; Saint John Regional Hospital; University of British Columbia; Montreal Clinical Research Institute; St. Michael's Hospital; Sunnybrook Health Science Centre; University of Alberta; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Ezetimibe; Familial hypercholesterolemia; Position statement; Position paper; Dyslipidemia; PCSK9; Disease; Intensive care medicine; Evolocumab; Statin; Family medicine; Pediatrics; Internal medicine; Cholesterol; Pathology; Lipoprotein; LDL receptor","score_opus":0.01569689835101843,"score_gpt":0.2454391160848332,"score_spread":0.22974221773381479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902955133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95181227,0.0049546813,0.005571545,0.013664422,0.0047101043,0.0009631598,0.00023317787,0.000024983688,0.018065665],"genre_scores_gemma":[0.9877377,0.00041414122,0.0004320598,0.004700454,0.0065517183,0.0000073291194,0.000036866848,0.00003918835,0.00008052956],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976546,0.00026924227,0.0005393521,0.0002935307,0.00044318734,0.00080007914],"domain_scores_gemma":[0.99652416,0.000014244273,0.0001208901,0.0006562681,0.000622224,0.0020622087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017531016,0.00023042774,0.00091480266,0.00037208677,0.00030243848,0.000032993514,0.00019405407,0.00031455726,0.000053118423],"category_scores_gemma":[0.000065637076,0.00020089178,0.0014301222,0.00019983007,0.00025648632,0.0000954383,0.0000115265275,0.0005821387,0.00012140111],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006897037,0.000025891859,0.033695903,0.0002875002,0.021159139,0.0066805324,0.0017839087,0.0029205307,0.0010795901,0.00084346585,0.7442697,0.18656413],"study_design_scores_gemma":[0.002009107,0.0014046123,0.0330582,0.00010845205,0.00065125054,0.0030913607,0.00023858403,0.000013597827,0.00029498606,0.00009517704,0.9588254,0.00020927198],"about_ca_topic_score_codex":0.12021787,"about_ca_topic_score_gemma":0.11441391,"teacher_disagreement_score":0.2145557,"about_ca_system_score_codex":0.002369314,"about_ca_system_score_gemma":0.00696024,"threshold_uncertainty_score":0.9986694},"labels":[],"label_agreement":null},{"id":"W2903347258","doi":"10.2337/dc18-1491","title":"Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Esperion Therapeutics; Ionis Pharmaceuticals; Mylan; Novo Nordisk; Medicines Company; Sanofi; Kowa Company; Regeneron Pharmaceuticals; Eli Lilly and Company; AstraZeneca; CSL Behring; Amgen; Pfizer","keywords":"PCSK9; Medicine; Diabetes mellitus; Dyslipidemia; Internal medicine; Placebo; Adverse effect; Cholesterol; Endocrinology; Type 2 diabetes; Apolipoprotein B; Randomized controlled trial; Lipoprotein; Gastroenterology; LDL receptor; Pathology","score_opus":0.02028013790582422,"score_gpt":0.32055816959254707,"score_spread":0.30027803168672285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903347258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98905325,0.0056337067,0.00001035907,0.00031055286,0.0009089328,0.002411426,0.00005369273,0.00004262751,0.0015754252],"genre_scores_gemma":[0.9969428,0.00028385624,0.000161257,0.00064217625,0.0017625939,0.00011569499,0.000036277263,0.00003076195,0.000024593603],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99716836,0.0008243666,0.00067527284,0.00038499958,0.00050353876,0.0004434339],"domain_scores_gemma":[0.99731296,0.0010969305,0.00021438308,0.00069398154,0.00045422063,0.0002274966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002972065,0.00020500534,0.0013034617,0.0000823619,0.00015542361,0.000027056147,0.000120510886,0.0001713316,0.000056936395],"category_scores_gemma":[0.0024463355,0.00012046976,0.0006909915,0.00022240348,0.0010405922,0.00006321254,0.000107361004,0.0003118173,0.000021852275],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16782089,0.00032149075,0.53753775,0.00075191056,0.0032064584,0.0000072056855,0.008820092,6.791343e-7,0.00029068833,0.0003933029,0.0012153015,0.27963427],"study_design_scores_gemma":[0.88096297,0.0044979234,0.08735508,0.00039666455,0.0015574531,9.466861e-7,0.005307061,0.0001354191,0.003486913,0.00050675264,0.015448776,0.00034401225],"about_ca_topic_score_codex":0.0000564659,"about_ca_topic_score_gemma":0.00002404581,"teacher_disagreement_score":0.7131421,"about_ca_system_score_codex":0.00005534105,"about_ca_system_score_gemma":0.00022569545,"threshold_uncertainty_score":0.49126142},"labels":[],"label_agreement":null},{"id":"W2903390893","doi":"10.3899/jrheum.180732","title":"Statins and Mortality in Connective Tissue Diseases: Should We Resume the Cardio-rheumatology Spirit in Our Clinics?","year":2018,"lang":"en","type":"letter","venue":"The Journal of Rheumatology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Cholesterol; Rheumatology; Statin; Inflammation; Lipoprotein; Endocrinology; Cardiology","score_opus":0.03658655777590562,"score_gpt":0.3470114004217841,"score_spread":0.31042484264587844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903390893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5748347,0.013937607,0.00008012332,0.40925515,0.0009117263,0.000845028,0.000051265783,0.000011081733,0.00007334667],"genre_scores_gemma":[0.8845535,0.047953293,0.00010523006,0.06646859,0.00061364076,0.000047334743,0.000033335982,0.000110199675,0.0001148623],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930544,0.0032167234,0.0018888452,0.0003965026,0.00074268354,0.00070086704],"domain_scores_gemma":[0.99603087,0.0011192966,0.0012569587,0.0011030575,0.00032977114,0.00016002008],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0049795057,0.00044511017,0.002874457,0.00040253592,0.00012559768,0.000024431773,0.0005492374,0.0009765968,0.00003204764],"category_scores_gemma":[0.0012280663,0.00024461106,0.00042443638,0.00030052374,0.000562616,0.00008688288,0.0001902543,0.004193438,0.000017670525],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011758292,0.00015458273,0.66801876,0.0016319628,0.002318768,0.0023822652,0.0033868824,0.000013317343,0.0000024189258,0.00017424351,0.3160432,0.004697796],"study_design_scores_gemma":[0.013437764,0.0027896478,0.25523004,0.005228124,0.0030387389,0.0997059,0.007864246,0.00010616657,0.00001812373,0.0074517988,0.60414356,0.0009859012],"about_ca_topic_score_codex":0.004425127,"about_ca_topic_score_gemma":0.0018129701,"teacher_disagreement_score":0.4127887,"about_ca_system_score_codex":0.0002046601,"about_ca_system_score_gemma":0.000948422,"threshold_uncertainty_score":0.9981039},"labels":[],"label_agreement":null},{"id":"W2903518851","doi":"10.1161/circ.132.suppl_3.18396","title":"Abstract 18396: Low Rate of LDL-Goal-Attainment in 57,855 High-Risk-Patients in Europe, Canada, South-Africa, Middle East and China - Results of DYSIS","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Guideline; Statin; Context (archaeology); Internal medicine; Population; Physical therapy; Environmental health; Disease; Pathology","score_opus":0.020882665724188804,"score_gpt":0.21233928833989466,"score_spread":0.19145662261570584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903518851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985337,0.00026056453,0.000035174555,0.00007010614,0.000080468606,0.0005117603,0.000073124844,0.0000055039513,0.00042957676],"genre_scores_gemma":[0.9997024,0.00002307244,0.00007257524,0.000016800377,0.000041354942,0.000008477155,0.00010657586,0.000014619916,0.000014123507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985025,0.00012490201,0.0005355303,0.00023184794,0.0004281198,0.00017709221],"domain_scores_gemma":[0.99906397,0.000015973012,0.00028456489,0.00031687843,0.00019069502,0.00012793712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007849455,0.000111156754,0.00036035152,0.00014039305,0.000019294146,0.0000045840184,0.00004380993,0.00006119756,0.000004209534],"category_scores_gemma":[0.00030944904,0.000103445585,0.000039314276,0.00041049236,0.000034147884,0.00006415462,0.000023414825,0.00012899257,0.0000017049931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004598528,0.00028559664,0.97890335,0.0004040064,0.00007056492,0.00002473506,0.0054911524,0.0048982627,0.00034145307,0.000038004044,0.000091969254,0.008991026],"study_design_scores_gemma":[0.005047112,0.00007310726,0.9930873,0.00021202047,0.00003955338,0.0000010046225,0.00031324098,0.00077022536,0.00024695188,0.00003637784,0.0000879873,0.00008511549],"about_ca_topic_score_codex":0.35412008,"about_ca_topic_score_gemma":0.053529203,"teacher_disagreement_score":0.30059087,"about_ca_system_score_codex":0.00022605421,"about_ca_system_score_gemma":0.0003095116,"threshold_uncertainty_score":0.9637414},"labels":[],"label_agreement":null},{"id":"W2903940403","doi":"10.1111/jth.14351","title":"Fifty years new","year":2018,"lang":"en","type":"editorial","venue":"Journal of Thrombosis and Haemostasis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Editorial board; Thrombosis; Public relations; Library science; Political science; Surgery; Computer science","score_opus":0.0381182653517076,"score_gpt":0.3378973303367004,"score_spread":0.2997790649849928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903940403","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023109537,0.017419804,0.00015025001,0.0025316672,0.95520985,0.00045860023,0.00010902528,0.000025183814,0.0009860963],"genre_scores_gemma":[0.0009094598,0.031042935,0.0029291005,0.0002552029,0.9640936,0.0000015314837,0.000028235107,0.00006814724,0.00067178544],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972617,0.000070029666,0.00069309666,0.00025363403,0.001439852,0.00028166614],"domain_scores_gemma":[0.997693,0.00010699852,0.0006339075,0.00045460445,0.00058482355,0.0005266414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010916822,0.00026414913,0.001405388,0.00021427782,0.000078161574,0.000078370256,0.00016532103,0.0006718387,0.000323483],"category_scores_gemma":[0.00047823534,0.00020166069,0.0007563323,0.00015381626,0.00009545521,0.00010958885,0.00007993393,0.0009475886,0.000023563534],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001469821,0.000057328114,0.00006420513,0.00022259828,0.0012490024,0.00005637817,0.00016719573,9.0703466e-8,0.000012109655,0.0000030135816,0.9440228,0.053998347],"study_design_scores_gemma":[0.0025003776,0.0011216069,0.002870985,0.00092816487,0.0017482882,0.00011897486,0.00006221425,7.0764105e-7,0.00009344045,0.00008927094,0.9902818,0.00018416988],"about_ca_topic_score_codex":0.00030584465,"about_ca_topic_score_gemma":0.000017669077,"teacher_disagreement_score":0.053814176,"about_ca_system_score_codex":0.00014842946,"about_ca_system_score_gemma":0.0014313326,"threshold_uncertainty_score":0.8223484},"labels":[],"label_agreement":null},{"id":"W2904059000","doi":"10.1093/eurheartj/ehy653","title":"Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies","year":2018,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Heart, Lung, and Blood Institute; NIHR Cambridge Biomedical Research Centre; Medical Research Council; Merck Sharp and Dohme; Versus Arthritis; Servier; FONDATION ALZHEIMER; Syddansk Universitet; Novo Nordisk; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Rijksuniversiteit Groningen; World Health Organization; Wellcome Trust; Cancer Research UK; National Institute of Environmental Health Sciences; Daiichi-Sankyo; NHS Blood and Transplant; National Institute for Health and Care Research; Medicines Company; National Institutes of Health; Österreichische Forschungsförderungsgesellschaft; Regeneron Pharmaceuticals; Yale University; British Heart Foundation; Brigham and Women's Hospital; European Commission; H2020 European Research Council; Kowa Company; Sanofi; Singulex; Amgen; Pfizer; Erasmus Universiteit Rotterdam; AstraZeneca; Eli Lilly and Company; American Heart Association; Aetna Foundation","keywords":"Medicine; Meta-analysis; Equalization (audio); Algorithm; Prospective cohort study; Internal medicine","score_opus":0.4053938118198431,"score_gpt":0.41666700764539466,"score_spread":0.011273195825551585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904059000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082936705,0.9947967,0.0023208056,0.000017550783,0.00023789368,0.00229919,0.00012765123,0.000022771852,0.00009449785],"genre_scores_gemma":[0.001980475,0.9945804,0.0020460526,0.000037464957,0.0009490626,0.0001424431,0.000034512992,0.00011258095,0.000117007],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98552305,0.0085620945,0.0029073264,0.0005393768,0.0021043234,0.0003638505],"domain_scores_gemma":[0.9945935,0.00023673913,0.002238968,0.0014622451,0.0012071546,0.0002613649],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.01699085,0.0005381476,0.012316777,0.0009231376,0.0001655666,0.00006385088,0.00022510254,0.00014232774,0.00012412475],"category_scores_gemma":[0.0011794127,0.00032190685,0.016297536,0.0016242332,0.0001626006,0.00014391747,0.00015237174,0.00063340086,0.000029629033],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016627522,0.00008338188,0.00007032223,0.10897286,0.88432956,0.00016121294,0.0011255173,0.000042187305,7.387576e-8,0.0000071304007,0.00017858649,0.005012539],"study_design_scores_gemma":[0.0003678093,0.0003967222,0.0004700957,0.016715841,0.9414951,0.00068507745,0.00021463008,0.000022215188,0.000003945717,0.000008027073,0.03936188,0.00025865994],"about_ca_topic_score_codex":0.0000135790115,"about_ca_topic_score_gemma":0.0000030032656,"teacher_disagreement_score":0.09225702,"about_ca_system_score_codex":0.000120999546,"about_ca_system_score_gemma":0.0003726942,"threshold_uncertainty_score":0.9999233},"labels":[],"label_agreement":null},{"id":"W2904161276","doi":"10.1016/j.cjca.2018.04.002","title":"Cardiovascular Efficacy and Safety of PCSK9 Inhibitors: Systematic Review and Meta-analysis Including the ODYSSEY OUTCOMES Trial","year":2018,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mace; Medicine; PCSK9; Meta-analysis; Confidence interval; Relative risk; Kexin; Randomized controlled trial; Adverse effect; Internal medicine; Cholesterol; LDL receptor","score_opus":0.10561068391618697,"score_gpt":0.3451888236536692,"score_spread":0.23957813973748224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904161276","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014208118,0.994491,0.00015676819,0.000410552,0.0002897481,0.0043647047,0.00007841423,0.0000037997938,0.00019082887],"genre_scores_gemma":[0.00079661014,0.99768454,0.000055231427,0.00023139689,0.0010385441,0.000085863714,0.000014166226,0.000045921784,0.000047754536],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9925135,0.0032520227,0.002775188,0.00041319663,0.0006133829,0.00043274692],"domain_scores_gemma":[0.9948676,0.0006573338,0.0016193095,0.001523907,0.0005758398,0.00075597485],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.011539949,0.0005501746,0.025853824,0.0007971286,0.00019069201,0.00003142187,0.00035469476,0.00044245753,0.000018007213],"category_scores_gemma":[0.0026286964,0.00027062255,0.016063381,0.000740505,0.00042969317,0.0000542929,0.00007373119,0.00075907854,0.00000241206],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053889005,0.0000020914692,0.000007369618,0.32750762,0.66663027,0.00011891739,0.00003876633,0.0000033948884,5.2352997e-9,0.000019769754,0.00040076522,0.005217185],"study_design_scores_gemma":[0.0019400314,0.0001959643,0.000011844465,0.012921441,0.6323855,0.0018934224,0.000018023286,6.5930145e-8,3.6343238e-8,0.0000034812863,0.3504922,0.00013801495],"about_ca_topic_score_codex":0.0007601759,"about_ca_topic_score_gemma":0.00022995638,"teacher_disagreement_score":0.35009146,"about_ca_system_score_codex":0.00024610042,"about_ca_system_score_gemma":0.0023786814,"threshold_uncertainty_score":0.9999746},"labels":[],"label_agreement":null},{"id":"W2904293596","doi":"10.1002/mus.26397","title":"Clinical features related to statin‐associated muscle symptoms","year":2018,"lang":"en","type":"article","venue":"Muscle & Nerve","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute on Minority Health and Health Disparities; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Physical medicine and rehabilitation; Internal medicine; Cardiology; Physical therapy","score_opus":0.019603270492118813,"score_gpt":0.32620458658952567,"score_spread":0.3066013160974069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904293596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98587173,0.00038125794,0.00007238532,0.0018821799,0.00081236305,0.00081325736,0.000023507742,0.0002735508,0.009869756],"genre_scores_gemma":[0.9915812,0.00003636091,0.00072371203,0.0030010717,0.0008985014,0.00003907948,0.00006330918,0.000062756684,0.0035940197],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973532,0.000290726,0.00060675957,0.0005556494,0.0006202062,0.0005734626],"domain_scores_gemma":[0.99801767,0.00008322831,0.00012643407,0.0008768493,0.00033986865,0.0005559243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017018188,0.00021911011,0.0006109333,0.00010174487,0.0001868011,0.000035649944,0.0001596679,0.0003076927,0.00039674336],"category_scores_gemma":[0.0007312496,0.00018178453,0.00047414898,0.0005590469,0.000107048545,0.00006892135,0.00010499662,0.00047683824,0.00056719524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002803451,0.000883273,0.025064124,0.000110335095,0.0010107578,0.00032929695,0.0021387932,0.000006185623,0.0022953614,0.0007505383,0.059525497,0.90760547],"study_design_scores_gemma":[0.0026624592,0.001604084,0.9100804,0.00016679004,0.0001654693,0.00002464177,0.00014388934,0.00006062593,0.0002620112,0.00014153404,0.08445554,0.00023256154],"about_ca_topic_score_codex":0.0007544843,"about_ca_topic_score_gemma":0.00019986297,"teacher_disagreement_score":0.90737295,"about_ca_system_score_codex":0.0001386651,"about_ca_system_score_gemma":0.00019187463,"threshold_uncertainty_score":0.7412958},"labels":[],"label_agreement":null},{"id":"W2904431953","doi":"10.1016/j.amjcard.2018.12.013","title":"Evaluating the Potential Association Between Lipoprotein(a) and Atherosclerosis (from the Mediators of Atherosclerosis Among South Asians Living in America Cohort)","year":2018,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Novartis; American Medical Association; Cliff Lede Family Charitable Foundation; AstraZeneca; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Boehringer Ingelheim; National Center for Research Resources; American Heart Association","keywords":"Cohort; Association (psychology); Medicine; Lipoprotein(a); Gerontology; Cohort study; Environmental health; Demography; Lipoprotein; Internal medicine; Psychology; Cholesterol; Sociology","score_opus":0.02026421897615796,"score_gpt":0.2861891046950366,"score_spread":0.2659248857188786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904431953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541074,0.00044352046,0.0014568331,0.001896554,0.00019371787,0.00050573866,0.000016945285,0.000009214357,0.000066758],"genre_scores_gemma":[0.99586797,0.0006394146,0.00032992772,0.0003884988,0.0027139934,0.000019894343,0.0000015657624,0.00003149487,0.000007252374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955103,0.0022859385,0.0007517984,0.00022393925,0.00084877794,0.0003792861],"domain_scores_gemma":[0.9962523,0.0010708752,0.0016549757,0.0005742163,0.0003400043,0.000107633634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006254101,0.00019403816,0.0011792638,0.00007876013,0.00023892322,0.000025730862,0.0003646764,0.00009169924,0.000011073748],"category_scores_gemma":[0.0012806773,0.000095594674,0.00046773296,0.00046053817,0.0012658279,0.00006284105,0.00012494656,0.0006446823,0.0000026358337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115413306,0.0000101098185,0.9356275,0.0000056699446,0.0013434822,0.0000014498207,0.0039776056,0.00008620019,0.002153662,0.000001918805,0.00004115354,0.056635797],"study_design_scores_gemma":[0.0006126048,0.0017152568,0.9910979,0.00016826535,0.0010748862,0.000031882526,0.0047965837,0.00010247459,0.000177574,0.00005483357,0.000075339936,0.00009234895],"about_ca_topic_score_codex":0.0021442992,"about_ca_topic_score_gemma":0.00003747072,"teacher_disagreement_score":0.05654345,"about_ca_system_score_codex":0.0001616648,"about_ca_system_score_gemma":0.00019378863,"threshold_uncertainty_score":0.46639955},"labels":[],"label_agreement":null},{"id":"W2904792752","doi":"10.1016/j.jacl.2018.11.003","title":"JCL roundtable—Lipoprotein(a): The emerging risk factor","year":2018,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lipoprotein(a); Lipoprotein; Apolipoprotein B; Risk factor; Internal medicine; Apolipoprotein E; Cardiology; Cholesterol; Endocrinology; Bioinformatics; Biology; Disease","score_opus":0.09065624832823797,"score_gpt":0.42415623949223985,"score_spread":0.33349999116400186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904792752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95767933,0.0018497253,0.009441982,0.01475682,0.013778661,0.00046073334,0.0000076873985,0.00002736092,0.001997696],"genre_scores_gemma":[0.93905467,0.0013973751,0.002631581,0.0033226965,0.052273218,0.000004033911,7.313544e-7,0.000030646563,0.0012850804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99579674,0.0010674376,0.0018559139,0.00023441984,0.00063607923,0.00040942096],"domain_scores_gemma":[0.9962047,0.00079583516,0.0012555398,0.0006871633,0.0006925242,0.00036426165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007502902,0.00016938218,0.0011655493,0.000098895245,0.00021115264,0.000034927387,0.00030269392,0.00030848122,0.0005448565],"category_scores_gemma":[0.005894936,0.00009025268,0.0011159146,0.00021605972,0.00035651732,0.00018054205,0.00008595403,0.001532074,0.00010924715],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023630112,0.0005011074,0.0718784,0.0000779691,0.0019720849,0.000119290984,0.00034157265,0.0000054739717,0.00020677046,0.00069810025,0.018245624,0.9035906],"study_design_scores_gemma":[0.0040883594,0.0050050816,0.24564262,0.000109198154,0.00054441683,0.0023116297,0.00015314878,0.00006384993,0.00024372926,0.0012856853,0.74040544,0.00014683722],"about_ca_topic_score_codex":0.00019714375,"about_ca_topic_score_gemma":0.000073486364,"teacher_disagreement_score":0.90344375,"about_ca_system_score_codex":0.00006390821,"about_ca_system_score_gemma":0.00049244886,"threshold_uncertainty_score":0.7057215},"labels":[],"label_agreement":null},{"id":"W2904886200","doi":"10.1161/circ.128.suppl_22.a18613","title":"Abstract 18613: Utilization of High-Potency Statin Therapy Following Hospitalization for CHD Among Medicare Beneficiaries","year":2013,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Statin; Potency; Physical therapy; Family medicine; Emergency medicine; Gerontology; Intensive care medicine; Internal medicine","score_opus":0.023403604554701588,"score_gpt":0.27289318141049973,"score_spread":0.24948957685579815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904886200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94444954,0.0009139329,0.05218141,0.00017602819,0.00021861798,0.0018448834,0.000008254895,0.00005905664,0.00014824081],"genre_scores_gemma":[0.99794525,0.0001340848,0.0008386309,0.000060835362,0.00018381201,0.00016222999,0.0006321855,0.000031581818,0.000011409627],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998725,0.000028220935,0.00039793554,0.00021927936,0.00045659477,0.00017297216],"domain_scores_gemma":[0.9990324,0.00003690411,0.000199444,0.0002849412,0.0003706812,0.000075646785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003399177,0.000121752535,0.00029669175,0.00010304921,0.00010700385,0.000023886847,0.00004435859,0.00013821924,0.00009822751],"category_scores_gemma":[0.00018665788,0.00010837724,0.00020833594,0.00020754314,0.000025955143,0.00028655172,0.000006741261,0.00005991432,0.000004031198],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006054859,0.00020673861,0.41263527,0.0007447448,0.00039689848,0.0000024015108,0.0016694261,0.0018197787,0.0081474595,0.0033883983,0.00013983836,0.5707885],"study_design_scores_gemma":[0.0014314812,0.000083490064,0.9900503,0.0001489717,0.000073008705,0.0000010448991,0.00027237556,0.0039411844,0.0020794047,0.0017009256,0.00011080812,0.0001069786],"about_ca_topic_score_codex":0.0013886257,"about_ca_topic_score_gemma":0.000038206003,"teacher_disagreement_score":0.57741505,"about_ca_system_score_codex":0.0000674898,"about_ca_system_score_gemma":0.00009889181,"threshold_uncertainty_score":0.44194955},"labels":[],"label_agreement":null},{"id":"W2905446252","doi":"10.1373/clinchem.2018.298026","title":"Type III Hyperlipoproteinemia: The Forgotten, Disregarded, Neglected, Overlooked, Ignored but Highly Atherogenic, and Highly Treatable Dyslipoproteinemia","year":2018,"lang":"en","type":"letter","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Hyperlipidemia; Apolipoprotein B; Type (biology); Internal medicine; Nothing; Cholesterol; Pediatrics; Endocrinology; Philosophy; Biology; Epistemology; Diabetes mellitus","score_opus":0.02465683294084478,"score_gpt":0.2856837531200564,"score_spread":0.2610269201792116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905446252","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6350935,0.018207561,0.00003754694,0.33273575,0.0014563184,0.0046925945,0.0002850213,0.0006597428,0.0068319696],"genre_scores_gemma":[0.07366291,0.0077530392,0.002029264,0.5358135,0.13857429,0.0015755391,0.004768585,0.0014027235,0.23442014],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99243224,0.00030376104,0.002039652,0.0021524755,0.0015788873,0.0014929678],"domain_scores_gemma":[0.99313986,0.0005089289,0.0008025837,0.0040863054,0.0007660276,0.00069629046],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.001233747,0.0012764765,0.002740271,0.00006902057,0.00049855973,0.00017796215,0.00090187264,0.00426076,0.0007217345],"category_scores_gemma":[0.0013196368,0.0008663724,0.0015983547,0.00049532135,0.0013125916,0.00010775775,0.00054536393,0.006234498,0.0002753639],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087741384,0.0001967146,0.0011710052,0.0017364422,0.0018134073,0.0010290209,0.000028916596,1.5099114e-7,0.00223131,0.0000027257172,0.9773124,0.013600526],"study_design_scores_gemma":[0.0063264095,0.00076688424,0.00042275243,0.00077670196,0.0023060704,0.0011725422,0.0000701214,0.00003625444,0.009814381,0.00012406825,0.9771522,0.0010315807],"about_ca_topic_score_codex":0.0011585297,"about_ca_topic_score_gemma":0.00003679817,"teacher_disagreement_score":0.5614306,"about_ca_system_score_codex":0.00032617015,"about_ca_system_score_gemma":0.0012716254,"threshold_uncertainty_score":0.9999987},"labels":[],"label_agreement":null},{"id":"W2906145006","doi":"10.1016/j.jcjd.2018.12.004","title":"Erratum to “Cardiovascular Protection in People With Diabetes”","year":2018,"lang":"en","type":"erratum","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Myocardial infarction; Stroke (engine); Disease; Angiotensin Receptor Blockers; Type 2 diabetes; Internal medicine; Intensive care medicine; Cardiology; Angiotensin-converting enzyme; Endocrinology; Blood pressure","score_opus":0.010039528022380397,"score_gpt":0.20899002284995952,"score_spread":0.19895049482757912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906145006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8822807,0.058254257,0.00013162981,0.005173282,0.029731212,0.004823889,0.000115518946,0.0000515559,0.019437928],"genre_scores_gemma":[0.9325661,0.00028718467,0.0013740967,0.0040848134,0.02883381,0.0004272714,0.00021104387,0.0006796922,0.031536005],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996363,0.0002105604,0.00075754785,0.00048144645,0.0010503134,0.0011371493],"domain_scores_gemma":[0.99571586,0.000015288051,0.00032343387,0.0010039927,0.0009267499,0.0020146763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001841452,0.00049228204,0.0020161264,0.0016939113,0.00014772048,0.00011045345,0.00033804282,0.0006443904,0.00012349049],"category_scores_gemma":[0.00041597252,0.0003965411,0.001038283,0.0011802727,0.00011716964,0.00015965835,0.00002348578,0.0019439714,0.000048029167],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035940873,0.00007527184,0.064680524,0.0021681488,0.004722654,0.0004248209,0.00071161095,0.00007982537,0.000039800325,0.000004925072,0.89621586,0.030840619],"study_design_scores_gemma":[0.0016481181,0.0025972337,0.14907785,0.00516951,0.0009828357,0.00007338944,0.0001153703,0.000025878377,0.00013358674,0.000048332666,0.83957493,0.00055294775],"about_ca_topic_score_codex":0.0037170514,"about_ca_topic_score_gemma":0.05855825,"teacher_disagreement_score":0.084397316,"about_ca_system_score_codex":0.001127752,"about_ca_system_score_gemma":0.00874052,"threshold_uncertainty_score":0.99984866},"labels":[],"label_agreement":null},{"id":"W2907325214","doi":"10.1016/j.pathol.2018.12.001","title":"Lipids and cardiovascular disease","year":2018,"lang":"en","type":"editorial","venue":"Pathology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Disease; Medicine; Internal medicine","score_opus":0.01012114504740614,"score_gpt":0.26017632000281854,"score_spread":0.2500551749554124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907325214","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033794707,0.056129754,0.0003103813,0.00017674602,0.9369292,0.0008047827,0.00016444549,0.00012562114,0.0019795531],"genre_scores_gemma":[0.0013339936,0.007356077,0.00036716045,0.0001616919,0.9890569,0.00011813499,0.00040250903,0.000089411646,0.0011141236],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729955,0.00024578266,0.0002802506,0.00085963774,0.00088821165,0.00042658657],"domain_scores_gemma":[0.99738836,0.00007688085,0.00006266434,0.0017154607,0.00028259557,0.00047403915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012691941,0.00032198243,0.0011894485,0.00013257968,0.000098513934,0.000018824416,0.000108032466,0.0009258721,0.00007984708],"category_scores_gemma":[0.001150187,0.00027192183,0.00081675116,0.00009530477,0.0002789675,0.000025999228,0.00015376211,0.0006946157,0.00013660062],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014351847,0.000041557796,0.00014554145,0.00086902594,0.0010377624,0.0018453618,0.0000509473,2.5660617e-7,0.000005280659,0.000015048243,0.97579426,0.020051418],"study_design_scores_gemma":[0.0013491375,0.0003068058,0.0011575908,0.0001416599,0.002123059,0.0001922375,0.000009765363,0.0000043430223,0.0000064337282,0.000092374,0.994376,0.00024056184],"about_ca_topic_score_codex":0.00008977769,"about_ca_topic_score_gemma":0.0000037021323,"teacher_disagreement_score":0.052127652,"about_ca_system_score_codex":0.000059735754,"about_ca_system_score_gemma":0.0006269979,"threshold_uncertainty_score":0.9999733},"labels":[],"label_agreement":null},{"id":"W2908533470","doi":"10.1016/j.jmb.2019.01.015","title":"The Elusive Inhibitory Function of the Acidic N-Terminal Segment of the Prodomain of PCSK9: The Plot Thickens","year":2019,"lang":"en","type":"letter","venue":"Journal of Molecular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Fondation Leducq","keywords":"Terminal (telecommunication); Function (biology); Inhibitory postsynaptic potential; PCSK9; Chemistry; Plot (graphics); Biochemistry; Biology; Stereochemistry; Mathematics; Cell biology; Endocrinology; Statistics; Computer science; Cholesterol; LDL receptor","score_opus":0.008606306984399686,"score_gpt":0.24718596163298515,"score_spread":0.23857965464858547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908533470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59919626,0.015803402,0.00085033994,0.37715337,0.0039376263,0.0026328492,0.00004399564,0.000005232691,0.00037693686],"genre_scores_gemma":[0.89432734,0.0008828704,0.000095338684,0.09963266,0.004440908,0.00002930546,0.000013609156,0.000079041034,0.000498901],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99575853,0.0016709368,0.0010636232,0.00020682126,0.0009898357,0.00031022434],"domain_scores_gemma":[0.9954659,0.00022142066,0.0023444407,0.0012928466,0.0006402323,0.000035155597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025249228,0.0002633091,0.0009121887,0.00009650745,0.0001345858,0.0000066015327,0.000717701,0.0006002491,0.000011791039],"category_scores_gemma":[0.00035287213,0.00009471913,0.0015422511,0.00020607362,0.00094148365,0.00001781083,0.0002478638,0.0022565897,0.0000017225532],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024553856,0.00043721288,0.0037951497,0.0032800296,0.011075703,0.00036969475,0.00152516,0.00010318932,0.73022974,0.0009294658,0.22023356,0.02556571],"study_design_scores_gemma":[0.0050534974,0.0059915795,0.015379305,0.003107175,0.005129523,0.0046971804,0.0009403397,0.00001079841,0.25161436,0.0017403226,0.70592046,0.00041548544],"about_ca_topic_score_codex":0.000058861377,"about_ca_topic_score_gemma":0.000007509144,"teacher_disagreement_score":0.48568687,"about_ca_system_score_codex":0.00011825841,"about_ca_system_score_gemma":0.0010691218,"threshold_uncertainty_score":0.9803885},"labels":[],"label_agreement":null},{"id":"W2908800019","doi":"10.1097/mol.0000000000000573","title":"Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment","year":2019,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Internal medicine; Statin; Asymptomatic; Residual risk; Atherosclerotic cardiovascular disease; Cardiology; Coronary artery disease; Cholesterol; Disease","score_opus":0.164244205787295,"score_gpt":0.39535925005903894,"score_spread":0.23111504427174392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908800019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022032227,0.959688,0.00006268198,0.000013163411,0.014098224,0.0039141723,0.0001445561,0.000032783624,0.000014200507],"genre_scores_gemma":[0.0021215628,0.99310017,0.000111043475,0.000011165315,0.0028301938,0.0005631349,0.0011762701,0.00007903424,0.00000740556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99441534,0.0018909209,0.0015053785,0.001202335,0.0004494526,0.0005365656],"domain_scores_gemma":[0.99776965,0.00045563714,0.00039842023,0.0011182401,0.00006510356,0.00019292181],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011185028,0.00060937187,0.00338349,0.00039492638,0.000060631828,0.000024984567,0.00015251653,0.00067600067,0.00001102821],"category_scores_gemma":[0.00021426678,0.0004990205,0.001103934,0.00027863804,0.00012589837,0.00008491027,0.00010835412,0.0009769824,0.000046620517],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005122986,0.0006102191,0.0748551,0.013537607,0.00039560042,3.1781485e-7,0.0001401759,0.000013083139,5.4231368e-8,0.000012677406,0.00008474627,0.9102992],"study_design_scores_gemma":[0.009090798,0.0021906649,0.16626592,0.017604524,0.0013171259,0.000057951253,0.00006998395,0.000032181928,7.402228e-8,0.000022015742,0.8027718,0.0005769323],"about_ca_topic_score_codex":0.00025624505,"about_ca_topic_score_gemma":0.00006433529,"teacher_disagreement_score":0.90972227,"about_ca_system_score_codex":0.0007228982,"about_ca_system_score_gemma":0.00067708915,"threshold_uncertainty_score":0.99974614},"labels":[],"label_agreement":null},{"id":"W2908928093","doi":"10.1503/cmaj.180853","title":"One-year survival and admission to hospital for cardiovascular events among older residents of long-term care facilities who were prescribed intensive- and moderate-dose statins","year":2019,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; Term (time); Long-term care; Emergency medicine; Intensive care; Intensive care medicine; Pediatrics; Nursing","score_opus":0.009292284835048984,"score_gpt":0.243009642816993,"score_spread":0.233717357981944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908928093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942905,0.0017680619,0.00032903245,0.0018964291,0.00039535054,0.0010787075,0.00014172094,0.000007690393,0.00009251409],"genre_scores_gemma":[0.99798423,0.00044973692,0.00013406696,0.0003811842,0.00042059468,0.000017990238,0.00003708477,0.000025054134,0.00055007223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972243,0.00017672055,0.00040632367,0.00026517373,0.0015165668,0.0004109575],"domain_scores_gemma":[0.99660414,0.000052244603,0.00012989952,0.0002049986,0.0012233324,0.0017854068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012026244,0.00014768225,0.0006575197,0.00015481444,0.00014960016,0.0000473053,0.00008243035,0.00027787714,0.0001492115],"category_scores_gemma":[0.001389114,0.00013695445,0.00030858666,0.00007817347,0.000031980224,0.00013282496,0.00003494916,0.0004151915,0.0000039104652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001340956,0.000028880107,0.9549942,0.0007938077,0.0015625546,0.000079988036,0.004748764,0.0000094917605,0.000009249739,0.000029822904,0.0014462936,0.03616285],"study_design_scores_gemma":[0.004156729,0.00038136152,0.9872042,0.0009140654,0.00019714619,0.00003244187,0.0058265156,0.000053338124,0.000044087286,0.000025577176,0.0010101188,0.00015443213],"about_ca_topic_score_codex":0.007260362,"about_ca_topic_score_gemma":0.0063993894,"teacher_disagreement_score":0.036008418,"about_ca_system_score_codex":0.00048136152,"about_ca_system_score_gemma":0.0014069106,"threshold_uncertainty_score":0.99935037},"labels":[],"label_agreement":null},{"id":"W2909216997","doi":"10.1161/circgen.118.002335","title":"Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition","year":2019,"lang":"en","type":"letter","venue":"Circulation Genomic and Precision Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut de Readaptation Gingras Lindsay de Montreal","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Canadian Institutes of Health Research","keywords":"PCSK9; Kexin; Proprotein convertase; Subtilisin; Medicine; Internal medicine; Endocrinology; Cholesterol; LDL receptor; Chemistry; Lipoprotein; Biochemistry; Enzyme","score_opus":0.015519762816602627,"score_gpt":0.24164482723211417,"score_spread":0.22612506441551153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909216997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978342,0.011451245,0.0022793135,0.0041030217,0.00049691426,0.0032303568,0.000059131733,0.000026388787,0.000011650739],"genre_scores_gemma":[0.9915354,0.0015808205,0.00018540972,0.0041468004,0.0010625805,0.000036745765,0.001348503,0.00006540291,0.000038305327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99580956,0.0009935331,0.0010680674,0.00080494897,0.0010441958,0.0002796782],"domain_scores_gemma":[0.9975239,0.0001932666,0.0006531063,0.0009793671,0.0004314954,0.00021887913],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002240334,0.00038803864,0.0014094284,0.00064987637,0.00007417299,0.000013720552,0.00007485804,0.00068743015,0.00005305149],"category_scores_gemma":[0.000558235,0.00033282864,0.00022847814,0.00038152232,0.00023329002,0.00017572955,0.00005498791,0.000766927,0.000005301368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007549204,0.00060729834,0.35431737,0.075446606,0.0062398803,0.001717989,0.012740546,0.010641548,0.2520244,0.00012942386,0.007734903,0.2708508],"study_design_scores_gemma":[0.0075116497,0.0007756149,0.97244394,0.003074945,0.0026902538,0.00004826817,0.000053561675,0.010068228,0.00092663046,0.00079463044,0.0012587873,0.00035349716],"about_ca_topic_score_codex":0.0019202124,"about_ca_topic_score_gemma":0.0000065327,"teacher_disagreement_score":0.6181266,"about_ca_system_score_codex":0.00012983171,"about_ca_system_score_gemma":0.00033440767,"threshold_uncertainty_score":0.9999124},"labels":[],"label_agreement":null},{"id":"W2909540503","doi":"10.1016/j.atherosclerosis.2019.01.001","title":"HDL cholesterol and ASCVD risk stratification: A debate","year":2019,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; McGill University Health Centre","funders":"","keywords":"Mendelian randomization; Atherosclerotic cardiovascular disease; Cholesterol; Medicine; Internal medicine; Risk stratification; Confusion; Disease; Cardiovascular health; Cardiology; Epidemiology; Endocrinology; Biology; Psychology","score_opus":0.07580189798339075,"score_gpt":0.3277881105151249,"score_spread":0.25198621253173414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909540503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007465942,0.99577856,0.00007393466,0.000051400326,0.00018822883,0.0022664915,0.000075917545,0.00008264155,0.0007362418],"genre_scores_gemma":[0.00039587409,0.99738264,0.0002934901,0.00013727686,0.00038713703,0.00029485984,0.00009761386,0.000117258285,0.00089385326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977132,0.00024490955,0.0005861742,0.0006960373,0.0004210785,0.00033857996],"domain_scores_gemma":[0.9978808,0.00006405617,0.000376919,0.0013711192,0.00006836558,0.0002387102],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063189364,0.00045382394,0.0020723925,0.00010425896,0.00012108211,0.000085095984,0.00014838179,0.00044932627,0.00006959981],"category_scores_gemma":[0.00004800035,0.00033204927,0.00085071364,0.00024947003,0.00006932813,0.00007149065,0.00006662407,0.0005804923,0.00040161263],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029484286,0.00004429964,0.000098291566,0.012403165,0.00046339235,0.00000126241,0.00004337101,5.3338763e-8,0.0000020270252,0.00003287364,0.00012704951,0.98678124],"study_design_scores_gemma":[0.0007162981,0.00019332803,0.002876644,0.011001997,0.0041035605,0.000100745456,0.000016388054,0.0000040593836,0.000003745927,0.000012046491,0.9806407,0.00033047257],"about_ca_topic_score_codex":0.00026576562,"about_ca_topic_score_gemma":0.000014516983,"teacher_disagreement_score":0.9864508,"about_ca_system_score_codex":0.000110834226,"about_ca_system_score_gemma":0.0002857208,"threshold_uncertainty_score":0.99991316},"labels":[],"label_agreement":null},{"id":"W2909584936","doi":"10.1093/ehjqcco/qcz001","title":"The cost implication of primary prevention in the HOPE 3 trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal - Quality of Care and Clinical Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Candesartan; Medicine; Rosuvastatin; Clinical trial; Developing country; Health care; Indirect costs; Gross domestic product; Intensive care medicine; Blood pressure; Internal medicine; Business; Angiotensin II; Economic growth; Economics","score_opus":0.1304118500572023,"score_gpt":0.45814806321083507,"score_spread":0.32773621315363277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909584936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908161,0.0017194392,0.000024481706,0.0030773429,0.00023648948,0.00089609815,0.0000026580826,0.000003607472,0.0032237659],"genre_scores_gemma":[0.9965847,0.0018733509,0.00010883403,0.0009819879,0.00030141513,0.0000022023537,0.0000048559536,0.000008491131,0.00013417157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99559987,0.0024270795,0.0012297529,0.0001250159,0.00049675687,0.000121524004],"domain_scores_gemma":[0.9978059,0.0011523851,0.00037645022,0.00043308488,0.00016061374,0.00007159351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012293838,0.000075262884,0.0005514328,0.000026134358,0.00007653192,0.000021867238,0.00012489497,0.000042202548,0.000009729493],"category_scores_gemma":[0.0008666776,0.000036751466,0.0007623365,0.00007547002,0.00009245202,0.000050901876,0.0000384477,0.00041332655,0.000007685195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064659133,0.00029991794,0.7224039,0.00031588966,0.0002246075,0.000004512744,0.0006762466,6.34898e-7,0.00005370734,0.00040000383,0.00041074606,0.26874393],"study_design_scores_gemma":[0.012193454,0.001487831,0.9648779,0.000098003045,0.00006839183,0.000026259595,0.0009292929,3.0745682e-7,0.0000074047243,0.000075200755,0.020195147,0.000040795272],"about_ca_topic_score_codex":0.00003994596,"about_ca_topic_score_gemma":0.000017917278,"teacher_disagreement_score":0.26870313,"about_ca_system_score_codex":0.000021312491,"about_ca_system_score_gemma":0.00013341871,"threshold_uncertainty_score":0.42608234},"labels":[],"label_agreement":null},{"id":"W2909842054","doi":"10.1161/jaha.118.010376","title":"Adherence to Statin Therapy Among US Adults Between 2007 and 2014","year":2019,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; Canadian Heart Research Centre; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; University of Alabama at Birmingham; National Center for Research Resources; Amgen","keywords":"Medicine; Statin; Diabetes mellitus; Internal medicine; Myocardial infarction; Retrospective cohort study; Coronary artery disease; Physical therapy; Endocrinology","score_opus":0.009801933825812972,"score_gpt":0.28001734957225194,"score_spread":0.270215415746439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909842054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969921,0.00023091711,0.000036359572,0.0020992206,0.00018911886,0.00036496724,0.000004015636,0.0000052417045,0.00007802007],"genre_scores_gemma":[0.99673295,0.00025149502,0.0005833474,0.0016004298,0.0005077101,0.0000022854852,5.0314594e-7,0.000010689481,0.00031056427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986515,0.00022709393,0.0002778911,0.00009064295,0.00058912975,0.00016373594],"domain_scores_gemma":[0.9988796,0.00011817349,0.00045710374,0.00018164085,0.00022907362,0.00013436786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015039786,0.00007223963,0.00048321675,0.00005422514,0.000044945682,0.000017972678,0.000063560685,0.000031370328,0.000027282056],"category_scores_gemma":[0.0002383386,0.000045763067,0.00020512415,0.00017692472,0.000019665109,0.00007423977,0.000019697383,0.00022797316,0.000027299384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010674378,0.000016296108,0.97459984,0.000009068531,0.00012895613,7.1623344e-7,0.00021419345,0.0000054929747,0.00042624742,5.0940207e-7,0.0051145745,0.019377384],"study_design_scores_gemma":[0.0008603717,0.0012862115,0.9901234,0.00010220451,0.000043340166,0.000012361415,0.00015731074,0.00001022961,0.00034301466,0.000011231523,0.006999653,0.00005068616],"about_ca_topic_score_codex":0.0010161516,"about_ca_topic_score_gemma":0.000016539283,"teacher_disagreement_score":0.019326698,"about_ca_system_score_codex":0.0002291282,"about_ca_system_score_gemma":0.00011168465,"threshold_uncertainty_score":0.18661636},"labels":[],"label_agreement":null},{"id":"W2910267328","doi":"10.1503/cmaj.181671","title":"All, some or none? Statin prescribing for frail older adults","year":2019,"lang":"en","type":"letter","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Hydroxymethylglutaryl-CoA Reductase Inhibitors; Randomized controlled trial; Statin; Medicine; Key (lock); Alternative medicine; MEDLINE; Gerontology; Physical therapy; Computer science; Internal medicine; Computer security; Political science; Pathology","score_opus":0.01437124102639102,"score_gpt":0.2545970355872428,"score_spread":0.24022579456085177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910267328","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022277564,0.0010830141,0.000279238,0.9906432,0.0032428827,0.0016456185,0.0003687745,0.000033399567,0.00047610662],"genre_scores_gemma":[0.0004499616,0.0004920223,0.00045709213,0.93958724,0.048720393,0.000088952766,0.0005847066,0.000117534604,0.009502076],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.993629,0.0002776621,0.00086849276,0.00043718962,0.003493335,0.0012943608],"domain_scores_gemma":[0.99609923,0.0004079357,0.0005512449,0.00038349698,0.0008573287,0.0017007514],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0029296838,0.00034835536,0.0010054648,0.00034727232,0.0002507105,0.00013978823,0.00030653484,0.0026198293,0.0038922995],"category_scores_gemma":[0.0036885713,0.00027198004,0.0006943839,0.00014840598,0.000028428269,0.00015693644,0.00002165667,0.005339094,0.00022539697],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049519895,0.000016721327,0.0004099417,0.00050866423,0.0008516534,0.0019879842,0.00023257348,3.4871564e-7,2.914847e-7,0.0000045281968,0.9608518,0.035085976],"study_design_scores_gemma":[0.0046619275,0.00020634319,0.0013784125,0.0014145277,0.00031681938,0.00090317545,0.00013791707,0.000105153085,0.0000023596888,0.000023783607,0.990542,0.00030758287],"about_ca_topic_score_codex":0.0060093487,"about_ca_topic_score_gemma":0.006276197,"teacher_disagreement_score":0.05105595,"about_ca_system_score_codex":0.0029539773,"about_ca_system_score_gemma":0.016009206,"threshold_uncertainty_score":0.99997324},"labels":[],"label_agreement":null},{"id":"W2911014938","doi":"10.1093/cvr/cvz003","title":"Novel strategies to target proprotein convertase subtilisin kexin 9: beyond monoclonal antibodies","year":2019,"lang":"en","type":"review","venue":"Cardiovascular Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Fondazione Cariplo; Horizon 2020 Framework Programme; Canada Research Chairs; Ministero della Salute; Fondation Leducq","keywords":"Proprotein convertase; Kexin; Subtilisin; PCSK9; Monoclonal antibody; Antibody; Monoclonal; Medicine; Proprotein Convertases; Chemistry; Internal medicine; Biochemistry; Immunology; LDL receptor; Enzyme; Lipoprotein; Cholesterol","score_opus":0.18182451954596648,"score_gpt":0.429994741737313,"score_spread":0.24817022219134652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911014938","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009842197,0.9744183,0.0020871896,0.00013247725,0.0005198854,0.015386833,0.00033965803,0.00016935429,0.0068478775],"genre_scores_gemma":[0.00007669182,0.9869959,0.0042872457,0.00008472101,0.002034671,0.0020081091,0.00083729485,0.00041501052,0.0032604067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.985728,0.0018252772,0.0013743767,0.0025160734,0.0062489137,0.0023073498],"domain_scores_gemma":[0.9908752,0.00024058094,0.00017083243,0.0057981135,0.001667919,0.0012473434],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0123353945,0.001255188,0.007897787,0.0016764776,0.00046527662,0.0004622642,0.0010942186,0.0011922067,0.00023157352],"category_scores_gemma":[0.0008329111,0.0009776107,0.009230239,0.0019999475,0.00048094432,0.00028128098,0.00093903806,0.0034855928,0.002426877],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001190563,0.00026529818,0.0000065663744,0.09202841,0.013678011,0.0017647594,0.0001658438,0.000038723007,0.000027606855,0.00062444224,0.00263227,0.888649],"study_design_scores_gemma":[0.001505412,0.00049511745,0.00004131357,0.011549459,0.002997612,0.0022521089,0.0002835683,0.00001318934,0.000086252956,0.00005728867,0.97978616,0.0009325424],"about_ca_topic_score_codex":0.0013513705,"about_ca_topic_score_gemma":0.000017501363,"teacher_disagreement_score":0.97715384,"about_ca_system_score_codex":0.0010146943,"about_ca_system_score_gemma":0.00764244,"threshold_uncertainty_score":0.99926746},"labels":[],"label_agreement":null},{"id":"W2911088522","doi":"10.1194/jlr.m089193","title":"Identification of amino acid residues in the ligand binding repeats of LDL receptor important for PCSK9 binding","year":2019,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; National Natural Science Foundation of China","keywords":"PCSK9; LDL receptor; Kexin; Proprotein convertase; Familial hypercholesterolemia; Subtilisin; Receptor; Biochemistry; Chemistry; Biology; Cholesterol; Lipoprotein; Enzyme","score_opus":0.06286131137615258,"score_gpt":0.38303914945912104,"score_spread":0.32017783808296846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911088522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596506,0.0013087931,0.000036154448,0.0013222744,0.00026714057,0.00091941055,0.000010354797,0.0000020976759,0.00016871425],"genre_scores_gemma":[0.99739915,0.0011348036,0.00034554067,0.000012857925,0.00064355426,0.000012845223,0.0000047697554,0.0000169882,0.0004294647],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996398,0.00035634523,0.0011857809,0.00015715334,0.0016014148,0.00030135977],"domain_scores_gemma":[0.9975732,0.0003239992,0.0006458754,0.00048537765,0.0008836232,0.00008793886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020760229,0.00008197494,0.0005018417,0.00070512394,0.00007021076,0.00002484067,0.00027364134,0.000100804995,0.000025094972],"category_scores_gemma":[0.00141332,0.000050328956,0.00030416567,0.0006447256,0.00007754152,0.00013552328,0.000040223902,0.00054462627,0.000006028627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068871333,0.00015881256,0.053370822,0.0009352351,0.0001375796,0.000012368558,0.0013256304,0.0000024531498,0.93782544,0.00010308389,0.0011289554,0.00431093],"study_design_scores_gemma":[0.0026238095,0.0018762171,0.05218252,0.0014072536,0.000060033104,0.00015434356,0.0051173484,0.000036916812,0.93249375,0.00010290549,0.0038669677,0.00007795402],"about_ca_topic_score_codex":0.000045510296,"about_ca_topic_score_gemma":0.000008378222,"teacher_disagreement_score":0.01934691,"about_ca_system_score_codex":0.00012772212,"about_ca_system_score_gemma":0.00044069713,"threshold_uncertainty_score":0.7195123},"labels":[],"label_agreement":null},{"id":"W2911142797","doi":"10.1097/mol.0000000000000581","title":"Progress in finding pathogenic DNA copy number variations in dyslipidemia","year":2019,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Copy-number variation; Genetics; Biology; Hypertriglyceridemia; Gene duplication; Familial hypercholesterolemia; Gene; DNA sequencing; Computational biology; Genome; Triglyceride; Cholesterol","score_opus":0.15500567878848293,"score_gpt":0.45014983522047347,"score_spread":0.29514415643199055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911142797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008957525,0.9380502,0.000056864992,0.00012048785,0.058068484,0.0033874756,0.000042246193,0.000035686444,0.00014899521],"genre_scores_gemma":[0.000097025426,0.987081,0.00020369799,0.000025665788,0.010344037,0.0012547123,0.00087359303,0.000075825345,0.000044444285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948678,0.0013234846,0.0017133408,0.00092520565,0.0003775887,0.00079254986],"domain_scores_gemma":[0.99806994,0.0003306325,0.00047093903,0.00091610814,0.0000595429,0.00015284354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022696666,0.000517594,0.003389161,0.0009253796,0.00003620134,0.000016309014,0.00028003304,0.00092454517,0.00015977734],"category_scores_gemma":[0.00033225058,0.00045767188,0.0006945704,0.0012759232,0.00008495961,0.000085353684,0.0001765205,0.0018800497,0.00039978922],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023459901,0.0003597239,0.04367708,0.05269678,0.00008445937,0.0000019430656,0.00016517995,0.0000017667492,4.1657493e-8,0.0016553318,0.00317345,0.89816076],"study_design_scores_gemma":[0.0018332892,0.00007889827,0.006330743,0.036597215,0.00015413726,0.00012704829,0.000015057406,0.000026651487,2.7922471e-8,0.000063239335,0.9544123,0.00036143698],"about_ca_topic_score_codex":0.000037784932,"about_ca_topic_score_gemma":0.000026230813,"teacher_disagreement_score":0.9512388,"about_ca_system_score_codex":0.0008636677,"about_ca_system_score_gemma":0.0014386403,"threshold_uncertainty_score":0.9997875},"labels":[],"label_agreement":null},{"id":"W2911252395","doi":"10.1016/j.tips.2019.01.004","title":"New Frontiers in Lp(a)-Targeted Therapies","year":2019,"lang":"en","type":"review","venue":"Trends in Pharmacological Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Lipoprotein(a); Mendelian randomization; Medicine; PCSK9; Context (archaeology); Lipoprotein; Epidemiology; Disease; Risk factor; Internal medicine; Bioinformatics; Cholesterol; Biology; LDL receptor; Genetics; Gene; Genetic variants; Genotype","score_opus":0.13682227299983438,"score_gpt":0.43398050934327925,"score_spread":0.29715823634344485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911252395","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018307469,0.9913693,0.00002141661,0.00033571073,0.0010586905,0.00078125676,0.0000058512082,0.000048681624,0.006195983],"genre_scores_gemma":[0.00026303306,0.99529976,0.0021735607,0.00030308275,0.0003676188,0.00008751188,0.000018594132,0.000014990841,0.001471848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968641,0.00040671715,0.00062447024,0.0007939068,0.0006595182,0.00065130345],"domain_scores_gemma":[0.9992555,0.00008974095,0.00016435972,0.00024018824,0.000014145842,0.00023609298],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016850635,0.00036815193,0.0022882733,0.00081267074,0.0000621201,0.00003532894,0.00048468847,0.0003406264,0.0016421581],"category_scores_gemma":[0.000041969906,0.00020770478,0.0006742299,0.0027899023,0.00022416598,0.00009201821,0.00009607826,0.00075734715,0.000050323164],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016523049,0.000082978004,0.0004025016,0.0008704103,0.00009696728,0.000082584804,0.000039469767,0.0000028082918,8.228072e-7,0.000028850305,0.0047079423,0.99366814],"study_design_scores_gemma":[0.001058754,0.00032323934,0.0012613597,0.00161818,0.00041215756,0.000034080753,0.000041096446,0.000029357941,0.000001959035,0.00008755078,0.9948518,0.0002804136],"about_ca_topic_score_codex":0.00020769815,"about_ca_topic_score_gemma":0.000018172055,"teacher_disagreement_score":0.9933877,"about_ca_system_score_codex":0.00027965626,"about_ca_system_score_gemma":0.00067067094,"threshold_uncertainty_score":0.9992705},"labels":[],"label_agreement":null},{"id":"W2911506813","doi":"10.1016/j.cjca.2019.01.009","title":"To Risk Stratify or Not for Statin Therapy","year":2019,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Framingham Risk Score; Statin; Waist; Framingham Heart Study; Cholesterol; Incidence (geometry); Disease; Cardiology; Obesity","score_opus":0.041563171905874954,"score_gpt":0.2927110262676075,"score_spread":0.25114785436173254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911506813","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016881526,0.0048808055,0.016924186,0.944335,0.0070127407,0.004665331,0.0021822571,0.000017047802,0.0031011058],"genre_scores_gemma":[0.020904223,0.0010792803,0.0028491158,0.9145654,0.05670889,0.000071738345,0.00016908007,0.00016775653,0.0034845443],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977048,0.00033928713,0.000629991,0.0002911042,0.0003295985,0.0007052236],"domain_scores_gemma":[0.9974767,0.00024623697,0.00038120142,0.00061511167,0.00063654874,0.0006441774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012474109,0.00029266134,0.0017597005,0.00051225553,0.00009037979,0.000030369314,0.00026514824,0.0008656008,0.000081305865],"category_scores_gemma":[0.00051797985,0.00020360794,0.0010966059,0.00012246463,0.00006833014,0.000032308573,0.0000066276025,0.0018783938,0.000032371347],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044316016,5.590713e-7,0.00056678633,0.00014545876,0.0014296324,0.001427222,0.0000801434,0.00008664431,0.000013400226,0.0000047229473,0.9553438,0.040458467],"study_design_scores_gemma":[0.0020787388,0.002726096,0.0037157836,0.0001249765,0.00036474472,0.0018828566,0.000043888092,0.0000015770684,0.0000343053,0.000037428377,0.9887791,0.00021047857],"about_ca_topic_score_codex":0.0028123439,"about_ca_topic_score_gemma":0.0015707535,"teacher_disagreement_score":0.04969615,"about_ca_system_score_codex":0.00036650043,"about_ca_system_score_gemma":0.00943103,"threshold_uncertainty_score":0.9961846},"labels":[],"label_agreement":null},{"id":"W2911802438","doi":"10.1177/2047487319829746","title":"Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk","year":2019,"lang":"en","type":"review","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"University of Toronto","keywords":"Medicine; Familial hypercholesterolemia; Odds ratio; Internal medicine; Confidence interval; Genetic testing; Population; Myocardial infarction; Family history; Atherosclerotic cardiovascular disease; Cholesterol; Disease","score_opus":0.07512971623777298,"score_gpt":0.3409763791041744,"score_spread":0.2658466628664014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911802438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0089121545,0.9860791,0.0010612963,0.000005936122,0.0006411016,0.0025849512,0.00020891753,0.000013844827,0.000492695],"genre_scores_gemma":[0.0040127174,0.9905318,0.0012163998,0.000027548716,0.0038894473,0.00007878422,0.000025863474,0.00016447587,0.00005296808],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99264324,0.0047478266,0.0011749032,0.00062795595,0.00032977478,0.0004763244],"domain_scores_gemma":[0.99680054,0.0006852845,0.0009252522,0.00088279956,0.00037048993,0.0003356025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036279932,0.00068199955,0.005706946,0.00033078634,0.00010402079,0.000028181792,0.00021275286,0.00021278308,0.000004472524],"category_scores_gemma":[0.00075330806,0.00041528084,0.007823143,0.0001514495,0.00010196507,0.000041347575,0.00008699797,0.0008189452,0.00002966962],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109399334,0.000056050503,0.0016611036,0.0033925609,0.016127452,0.0008736762,0.000031384912,0.000111320645,6.6848554e-7,5.4310203e-7,0.00022478061,0.97741103],"study_design_scores_gemma":[0.0041151736,0.012918614,0.021932065,0.0097779725,0.033263214,0.008953623,0.000023038221,0.000001573734,0.0000010453086,0.000006123621,0.90863436,0.00037316442],"about_ca_topic_score_codex":0.000015669326,"about_ca_topic_score_gemma":2.2101031e-7,"teacher_disagreement_score":0.9770379,"about_ca_system_score_codex":0.00039584085,"about_ca_system_score_gemma":0.0005843346,"threshold_uncertainty_score":0.9998299},"labels":[],"label_agreement":null},{"id":"W2911974495","doi":"10.1161/circulationaha.118.034311","title":"Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups","year":2019,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":391,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Hamilton Health Sciences; Université de Sherbrooke; McMaster University; Population Health Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Lipoprotein(a); Medicine; Internal medicine; Ethnic group; Gene isoform; Apolipoprotein B; Odds ratio; Lipoprotein; Myocardial infarction; Diabetes mellitus; Demography; Endocrinology; Cholesterol; Biology; Genetics; Gene","score_opus":0.016077093915051605,"score_gpt":0.24961574347749102,"score_spread":0.23353864956243942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911974495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434876,0.0010566787,0.0018421393,0.00015835522,0.00017735778,0.0012976654,0.0000030088916,0.000024640103,0.0010913954],"genre_scores_gemma":[0.99936426,0.00013667504,0.00006566345,0.000072591996,0.00027830855,0.000029839437,0.000010542008,0.000013171835,0.000028962768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895847,0.00018433662,0.00021982177,0.00017289193,0.00034934966,0.00011514587],"domain_scores_gemma":[0.9992607,0.00004835689,0.00014386524,0.00040500477,0.00009257771,0.00004948719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012382057,0.00008294798,0.00028356392,0.00005724297,0.000059956226,0.000008650846,0.000030464935,0.00010328885,0.000033918917],"category_scores_gemma":[0.000119666525,0.00005615493,0.00019956085,0.00017104283,0.00009993744,0.00009762554,0.000020724687,0.00018226643,0.000014318061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025172785,0.000028507637,0.8768685,0.00024746536,0.00044273332,8.6812696e-7,0.0010386917,0.00047046074,0.002602244,0.0022464383,0.0000098781675,0.11579252],"study_design_scores_gemma":[0.0029690003,0.000043575972,0.992967,0.00005253317,0.00022203856,0.000017557459,0.00009619794,0.0023176041,0.00023623953,0.00089897716,0.00011955741,0.0000597191],"about_ca_topic_score_codex":0.0009882203,"about_ca_topic_score_gemma":0.000018301369,"teacher_disagreement_score":0.11609854,"about_ca_system_score_codex":0.000038603026,"about_ca_system_score_gemma":0.000040355393,"threshold_uncertainty_score":0.22899316},"labels":[],"label_agreement":null},{"id":"W2912265873","doi":"10.1161/circ.133.suppl_1.p308","title":"Abstract P308: Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease","year":2016,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Statin; Randomized controlled trial; Confidence interval; Relative risk; National Health and Nutrition Examination Survey; Number needed to treat; Primary prevention; Absolute risk reduction; Physical therapy; Risk assessment; Internal medicine; Disease; Environmental health; Population","score_opus":0.038435516559459496,"score_gpt":0.3157795176760695,"score_spread":0.27734400111661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912265873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734955,0.0010774366,0.023009924,0.00015054674,0.000048882313,0.0020000902,0.000057379388,0.000020034115,0.00014020248],"genre_scores_gemma":[0.99801916,0.00007979781,0.0013524952,0.000060171118,0.000103219594,0.00022537647,0.0001339937,0.000017456636,0.000008346111],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99827194,0.00013258489,0.00047826822,0.00029478196,0.0006275601,0.00019483475],"domain_scores_gemma":[0.998801,0.00016004378,0.00016067163,0.00067172264,0.00013252301,0.000074041614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025440117,0.00011528423,0.00036619842,0.000087149936,0.00005444997,0.000011133854,0.00007372919,0.00006379283,0.00001429217],"category_scores_gemma":[0.00034566174,0.00007303456,0.00049517595,0.00014554428,0.00003635114,0.00013726366,0.000013818481,0.00006563757,0.0000018747418],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003622531,0.00023995801,0.1291589,0.0013544157,0.0004453356,0.000009821019,0.00076441176,0.0006990368,0.0024782838,0.00027129243,0.000018118071,0.8641982],"study_design_scores_gemma":[0.0033676377,0.00005848968,0.992044,0.00032366914,0.00033341994,0.000003925226,0.00007979257,0.00014005226,0.0002975395,0.0024706991,0.00078730844,0.000093471695],"about_ca_topic_score_codex":0.000097751275,"about_ca_topic_score_gemma":0.000010123402,"teacher_disagreement_score":0.8641047,"about_ca_system_score_codex":0.00013483754,"about_ca_system_score_gemma":0.00019896033,"threshold_uncertainty_score":0.2978263},"labels":[],"label_agreement":null},{"id":"W2912885478","doi":"10.1007/s10557-019-06864-2","title":"Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria","year":2019,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; U.S. Department of Health and Human Services; National Institutes of Health; Amgen","keywords":"Medicine; Hazard ratio; Internal medicine; Stroke (engine); Myocardial infarction; PCSK9; Clinical trial; Cardiology; Cholesterol; Confidence interval; Lipoprotein","score_opus":0.017528691469809926,"score_gpt":0.28040837125761675,"score_spread":0.2628796797878068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912885478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9115574,0.08204942,0.00021862244,0.0005535717,0.00010461473,0.005275778,0.00004558194,0.00006483029,0.00013017806],"genre_scores_gemma":[0.9621703,0.036389668,0.00012093385,0.00017473925,0.00037433387,0.00053572236,0.00004736565,0.00014829343,0.000038648857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99190855,0.0023915067,0.0005879857,0.0014379018,0.0027687054,0.00090532884],"domain_scores_gemma":[0.99597806,0.00021796333,0.0001536012,0.0025991201,0.00048185664,0.0005693963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008692519,0.00070342625,0.0025167428,0.00040690394,0.00070696353,0.00024186121,0.00016381749,0.00022371135,0.000015634265],"category_scores_gemma":[0.00015439789,0.00041560695,0.0014884948,0.0009960545,0.0008522679,0.0003433983,0.00035509886,0.00081391,0.000002437356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04384703,0.00078565796,0.53767306,0.0015455916,0.075058185,0.001723701,0.025622522,0.0010502235,0.00023226849,0.00014811473,0.000054899054,0.31225875],"study_design_scores_gemma":[0.092950515,0.0029029187,0.8649942,0.0011783807,0.0050987583,0.00032125466,0.0074815215,0.0011217461,0.00047771426,0.0003019676,0.021711813,0.0014591706],"about_ca_topic_score_codex":0.0031412358,"about_ca_topic_score_gemma":0.00004192052,"teacher_disagreement_score":0.32732117,"about_ca_system_score_codex":0.0001263654,"about_ca_system_score_gemma":0.0002948688,"threshold_uncertainty_score":0.9998296},"labels":[],"label_agreement":null},{"id":"W2913047438","doi":"10.1161/circoutcomes.11.suppl_1.127","title":"Abstract 127: Risk Factors for Cardiovascular Disease in Heterozygous Familial Hypercholesterolemia: A Systematic Review and Meta-analysis","year":2018,"lang":"en","type":"review","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Tech University; Institute for Clinical Evaluative Sciences; McGill University; University of Toronto","funders":"","keywords":"Medicine; Meta-analysis; Odds ratio; Confidence interval; Internal medicine; Cochrane Library; Body mass index; Population; Publication bias; Disease; Demography; Environmental health","score_opus":0.16676723134635266,"score_gpt":0.38150168754179226,"score_spread":0.2147344561954396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913047438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075281545,0.9826672,0.0021283056,0.000058291098,0.00010938349,0.0133324,0.0008509176,0.00009155798,0.000009121052],"genre_scores_gemma":[0.0058742305,0.99042004,0.00014837815,0.00031188416,0.00016042446,0.0021817365,0.00073876115,0.00013506194,0.00002949147],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.989408,0.003043425,0.0030628648,0.0019901332,0.0018160804,0.000679503],"domain_scores_gemma":[0.9932221,0.0007381991,0.00087705447,0.004121804,0.00036043453,0.0006804084],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.012100821,0.0013101876,0.026612392,0.0007482339,0.00030246095,0.00014432316,0.00026390495,0.0007205445,0.000017622795],"category_scores_gemma":[0.002162022,0.000893089,0.057273343,0.0009494781,0.00020368535,0.00022681884,0.00013821882,0.0007276956,0.0000093563185],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006251771,0.000041348005,0.0006314617,0.53052604,0.46530712,0.000023338827,0.000049715232,0.000060220533,3.757825e-9,0.000009761646,0.0000024587184,0.00334228],"study_design_scores_gemma":[0.0009908032,0.00002690537,0.019041654,0.011725872,0.95148915,0.000048019443,0.00003746362,0.0000141520195,3.507294e-8,0.00003074332,0.01576308,0.00083213643],"about_ca_topic_score_codex":0.0012936208,"about_ca_topic_score_gemma":0.00003729373,"teacher_disagreement_score":0.5188002,"about_ca_system_score_codex":0.0003204869,"about_ca_system_score_gemma":0.00028941347,"threshold_uncertainty_score":0.99996495},"labels":[],"label_agreement":null},{"id":"W2913301281","doi":"10.1016/j.pop.2018.10.004","title":"Prescription of Aspirin and Statins in Primary Prevention","year":2019,"lang":"en","type":"review","venue":"Primary Care Clinics in Office Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"U.S. Food and Drug Administration; Canadian Institutes of Health Research; Regeneron Pharmaceuticals; Novartis; AstraZeneca; British Heart Foundation; Amgen","keywords":"Medicine; Aspirin; Intensive care medicine; Primary prevention; Diabetes mellitus; Disease; Medical prescription; Polypill; Drug; Pharmacotherapy; Primary care; Adjunctive treatment; Internal medicine; Pharmacology; Family medicine; Endocrinology","score_opus":0.07282344938150247,"score_gpt":0.4089439610195899,"score_spread":0.3361205116380874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913301281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000777071,0.9800665,0.000059352456,0.000050880393,0.00046626633,0.0039217263,0.000050808234,0.00002580925,0.014581601],"genre_scores_gemma":[0.000064850705,0.99273825,0.005078381,0.0003830418,0.00018712891,0.00014655685,0.0010462627,0.0000838015,0.00027174555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99492586,0.0013021785,0.0019091016,0.000785092,0.00074315234,0.00033462458],"domain_scores_gemma":[0.9957096,0.0014394646,0.0013707308,0.0010382629,0.00032892037,0.00011302622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039868294,0.0004052998,0.0028566308,0.00044706548,0.00002592185,0.000025793857,0.00018108687,0.00065103685,0.000011170684],"category_scores_gemma":[0.0015609036,0.00038207887,0.0005678905,0.0005281117,0.00006407011,0.0004368985,0.00023566287,0.001667619,0.00002547036],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028582494,0.00039955328,0.00018441147,0.17039941,0.00017879934,0.000056576086,0.0002078669,0.0000021496262,6.608271e-7,0.00003685859,0.000028784247,0.8282191],"study_design_scores_gemma":[0.0021125514,0.0006893055,0.0035034902,0.031567533,0.0025184094,0.00018001784,0.00031939623,0.0000031134266,4.1044493e-7,0.000012809373,0.9587708,0.0003221299],"about_ca_topic_score_codex":0.00021326414,"about_ca_topic_score_gemma":0.00005155081,"teacher_disagreement_score":0.958742,"about_ca_system_score_codex":0.0010885212,"about_ca_system_score_gemma":0.0033936538,"threshold_uncertainty_score":0.9998631},"labels":[],"label_agreement":null},{"id":"W2913551716","doi":"10.1016/j.jacc.2018.11.025","title":"The Cat Has 9 Lives, Until it Dies","year":2019,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine","score_opus":0.01929138545151175,"score_gpt":0.2605220346733285,"score_spread":0.24123064922181678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913551716","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017286204,0.0073633594,0.000074087104,0.9672786,0.0031911307,0.000774294,0.00014046069,0.000008076326,0.0038837618],"genre_scores_gemma":[0.17229198,0.019839317,0.0006879752,0.7430677,0.0412248,0.000034885346,0.000015088587,0.00021810709,0.022620143],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99622196,0.00108523,0.00095059135,0.00023501104,0.0010206071,0.00048660944],"domain_scores_gemma":[0.99498975,0.00069772184,0.0021415867,0.0014407544,0.00065432553,0.000075865566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001552544,0.00032519814,0.0027631032,0.00016912397,0.00021771484,0.00001489154,0.0008455195,0.00026164923,0.000008685673],"category_scores_gemma":[0.0005220535,0.00015421078,0.0026828996,0.00034068647,0.0015646311,0.000032342774,0.00021312371,0.001971565,0.000011515641],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003169324,0.000007407356,0.0009552189,0.00016489411,0.0033365958,0.0009841085,0.00003281721,0.000032104366,0.00006282187,0.0000097255115,0.9927464,0.0013509617],"study_design_scores_gemma":[0.00074155646,0.0011182332,0.0039008406,0.0002638818,0.0012533227,0.010271416,0.0004722793,0.0000030296683,0.0000488113,0.00006999459,0.9817113,0.00014532935],"about_ca_topic_score_codex":0.00009499426,"about_ca_topic_score_gemma":0.0000098983255,"teacher_disagreement_score":0.22421092,"about_ca_system_score_codex":0.00024770273,"about_ca_system_score_gemma":0.0017999917,"threshold_uncertainty_score":0.8565578},"labels":[],"label_agreement":null},{"id":"W2913667911","doi":"10.1038/s41569-018-0153-2","title":"Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lipoprotein(a); Risk factor; Atherosclerotic cardiovascular disease; Lipoprotein; Apolipoprotein B; Internal medicine; Pathogenesis; Disease; Cardiology; Calcification; Epidemiology; Pathology; Endocrinology; Cholesterol","score_opus":0.05392921588676615,"score_gpt":0.36294369164407314,"score_spread":0.309014475757307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913667911","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029777557,0.9745569,0.0009407332,0.00007280081,0.0014577205,0.021094132,0.00015343314,0.00012332387,0.0015979345],"genre_scores_gemma":[0.000013317513,0.98780113,0.0012920706,0.0007394928,0.0038720146,0.0044844826,0.00064524583,0.00028349945,0.000868746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920216,0.0026696946,0.0014760717,0.0020856455,0.0007182576,0.0010287239],"domain_scores_gemma":[0.9939282,0.00047256032,0.00053299515,0.0040165996,0.0002750018,0.0007746676],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"category_scores_codex":[0.008026664,0.0013486906,0.014977494,0.00037164302,0.0002077487,0.00004717002,0.0004380287,0.002752923,0.000035397486],"category_scores_gemma":[0.0026957055,0.00091733213,0.014077703,0.0005591604,0.00021659587,0.00008062715,0.0002775994,0.0028055457,0.00018168037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014996725,0.000017374947,0.0000016946698,0.13432035,0.0070824213,0.00015544661,0.0000084637095,5.8381835e-7,3.3766892e-7,0.0025290446,0.0010097801,0.8547245],"study_design_scores_gemma":[0.0016948144,0.00023390599,0.0000066944363,0.021313006,0.03828015,0.002167644,0.000008623724,0.000001131072,6.229353e-7,0.00042385006,0.9350783,0.0007912034],"about_ca_topic_score_codex":0.000022425198,"about_ca_topic_score_gemma":5.8162607e-7,"teacher_disagreement_score":0.93406856,"about_ca_system_score_codex":0.0002808824,"about_ca_system_score_gemma":0.001776322,"threshold_uncertainty_score":0.9999264},"labels":[],"label_agreement":null},{"id":"W2914020771","doi":"10.1016/j.mayocp.2018.11.002","title":"Effective Lowering of Cholesterol With Portfolio Diet in a Highly Trained Young Man","year":2019,"lang":"en","type":"letter","venue":"Mayo Clinic Proceedings","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Health","funders":"","keywords":"Medicine; Statin; myalgia; Rhabdomyolysis; Internal medicine; Myopathy; Cholesterol; Scopus; Adverse effect; Physical therapy; MEDLINE","score_opus":0.011864487700377225,"score_gpt":0.2617085874608449,"score_spread":0.24984409976046767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914020771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9085533,0.00047497888,0.000032345517,0.064868696,0.00059676805,0.006403802,0.000037109152,0.00016216666,0.018870806],"genre_scores_gemma":[0.8271727,0.0002316435,0.00024241992,0.16077736,0.004426944,0.00064309296,0.00013947263,0.00030049012,0.0060659107],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963341,0.000023826336,0.0009512396,0.00094692875,0.0010231235,0.00072080246],"domain_scores_gemma":[0.99836224,0.00008044478,0.0006083035,0.0005395681,0.0002972985,0.00011216774],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013028987,0.00056653115,0.002046253,0.00048696485,0.000034615063,0.00003526939,0.0002679483,0.0010015548,0.000074733485],"category_scores_gemma":[0.00015547384,0.00044462032,0.0005537401,0.0004791419,0.00013071872,0.0001470205,0.00009797805,0.002646563,0.000046713558],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009803276,0.0009990725,0.21000902,0.06175192,0.0051129763,0.003632442,0.0052938736,0.0000018121333,0.001261874,0.00001942683,0.678686,0.02342831],"study_design_scores_gemma":[0.032918476,0.019848146,0.39644578,0.02415481,0.0029715418,0.0017633729,0.0007629216,0.00004695576,0.0023826957,0.00011045973,0.51607895,0.0025158843],"about_ca_topic_score_codex":0.00039641117,"about_ca_topic_score_gemma":0.000014632393,"teacher_disagreement_score":0.18643676,"about_ca_system_score_codex":0.00025922142,"about_ca_system_score_gemma":0.00027817444,"threshold_uncertainty_score":0.99980056},"labels":[],"label_agreement":null},{"id":"W2914063169","doi":"10.1161/circresaha.118.313171","title":"Lipid-Lowering Agents","year":2019,"lang":"en","type":"article","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Chemistry; Pharmacology; Medicine","score_opus":0.10347995074690985,"score_gpt":0.40437231684543196,"score_spread":0.3008923660985221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914063169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636682,0.0001866276,0.00024399578,0.0005354997,0.00016445726,0.00077345193,5.9404243e-7,0.000040700917,0.034386467],"genre_scores_gemma":[0.9971915,0.00003544201,0.000054325516,0.0001205309,0.0003617218,0.000023340383,0.000014177218,0.000017315399,0.0021816834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982634,0.00008221634,0.00013256454,0.00022481533,0.0009997506,0.00029725558],"domain_scores_gemma":[0.99903923,0.000030557192,0.000014938965,0.00052436226,0.00024306712,0.00014785535],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015097097,0.000053688735,0.00014667318,0.00017304446,0.00008912514,0.000029017965,0.000059784415,0.00006965979,0.0011173461],"category_scores_gemma":[0.00011111106,0.000048514812,0.000106864296,0.00037268896,0.000024550276,0.00007065514,0.000043705393,0.0002749623,0.0016956206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014633815,0.00022435335,0.8243178,0.0010841497,0.00024210381,0.00007630731,0.0006041282,0.0010573925,0.025234204,0.0016063645,0.0035434316,0.14186344],"study_design_scores_gemma":[0.0010776387,0.00008764213,0.9635713,0.00009443754,0.0000088306015,0.000031084845,0.00010188837,0.0030894727,0.00075019844,0.000100263744,0.031012591,0.000074650736],"about_ca_topic_score_codex":0.00014923773,"about_ca_topic_score_gemma":0.0000028932097,"teacher_disagreement_score":0.14178878,"about_ca_system_score_codex":0.00013398148,"about_ca_system_score_gemma":0.00014844674,"threshold_uncertainty_score":0.9997958},"labels":[],"label_agreement":null},{"id":"W2914116140","doi":"10.1097/mol.0000000000000586","title":"Recently reported familial hypercholesterolemia-related mutations from cases in the Middle East and North Africa region","year":2019,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Middle East; North east; Disease; Heterozygote advantage; Pediatrics; Genotype; Internal medicine; Genetics; Geography; Cholesterol; Biology; Gene; Socioeconomics","score_opus":0.41040401807561966,"score_gpt":0.38334728392650386,"score_spread":0.027056734149115802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914116140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0050036903,0.97400105,0.000008464822,0.00018635196,0.018281233,0.0023331644,0.00007771381,0.0000303901,0.00007791884],"genre_scores_gemma":[0.0007103159,0.991764,0.00002074521,0.00003238709,0.0039739823,0.00032036102,0.0031150407,0.000041527215,0.000021638318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99602413,0.0012472348,0.0012490938,0.0007504835,0.00032722717,0.00040183516],"domain_scores_gemma":[0.9980388,0.00039385134,0.00045420785,0.000932311,0.000069600865,0.00011121997],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006696841,0.00039444995,0.0018523332,0.00033778182,0.000062543135,0.000020640116,0.00019421362,0.0004948648,0.000012887412],"category_scores_gemma":[0.00041759858,0.00027121016,0.00039206952,0.00067444413,0.00014481679,0.00006316479,0.000091908005,0.001321897,0.00003829339],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005004136,0.00031483808,0.002039064,0.012193413,0.00018941263,0.00001983165,0.0029201503,0.0000024547776,7.371458e-8,0.000042793527,0.003222317,0.97900563],"study_design_scores_gemma":[0.0013703274,0.00018315301,0.0041653556,0.014315372,0.0004950691,0.0015072166,0.0003924784,0.000010453479,3.4016787e-9,0.000030593255,0.9772987,0.00023129622],"about_ca_topic_score_codex":0.00037004068,"about_ca_topic_score_gemma":0.00010735955,"teacher_disagreement_score":0.9787743,"about_ca_system_score_codex":0.00018141461,"about_ca_system_score_gemma":0.00043842616,"threshold_uncertainty_score":0.999974},"labels":[],"label_agreement":null},{"id":"W2914333345","doi":"10.1016/j.clinbiochem.2019.02.008","title":"SLC22A3 is associated with lipoprotein (a) concentration and cardiovascular disease in familial hypercholesterolemia","year":2019,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Institut de Recherche Clinique De Montréal; Fondation Leducq","keywords":"Familial hypercholesterolemia; Medicine; Atherosclerotic cardiovascular disease; Disease; Internal medicine; Lipoprotein(a); Ldl cholesterol; Lipoprotein; Cardiology; Endocrinology; Cholesterol","score_opus":0.018705701754897597,"score_gpt":0.28380358138231854,"score_spread":0.26509787962742093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914333345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995181,0.0029345213,0.000017162158,0.00038639386,0.00007741845,0.0007425832,0.000021515605,0.000039124247,0.00060028],"genre_scores_gemma":[0.9979372,0.00042679757,0.00007839046,0.00082095177,0.00027545297,0.000033127137,0.000078530196,0.000024231196,0.00032531287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979802,0.00010564687,0.00044263256,0.00066241797,0.0005197328,0.00028936513],"domain_scores_gemma":[0.99851257,0.000058372414,0.00006986627,0.000863752,0.000094753785,0.00040070576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010418667,0.00018518086,0.0006448512,0.000013774174,0.000031160977,0.0000217,0.00007356519,0.00028168102,0.000038897822],"category_scores_gemma":[0.00039259324,0.00015028672,0.00036351997,0.0001495878,0.00014552457,0.000050861672,0.000045424295,0.00045638,0.000020484746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082804426,0.00036892845,0.9558589,0.00045948132,0.0008932071,0.00022731262,0.00005237941,0.000012358591,0.0028500103,0.0000049552536,0.00012539358,0.038319048],"study_design_scores_gemma":[0.012733388,0.00049532077,0.97278637,0.0010679861,0.000588704,0.000036229692,0.000102937935,0.00040921028,0.009436243,0.00002614584,0.0019074762,0.00040997588],"about_ca_topic_score_codex":0.00010202667,"about_ca_topic_score_gemma":0.0000029440957,"teacher_disagreement_score":0.037909072,"about_ca_system_score_codex":0.00007739187,"about_ca_system_score_gemma":0.0003250872,"threshold_uncertainty_score":0.6128515},"labels":[],"label_agreement":null},{"id":"W2914417608","doi":"10.3899/jrheum.180574","title":"Effect of Timing and Duration of Statin Exposure on Risk of Hip or Knee Revision Arthroplasty: A Population-based Cohort Study","year":2019,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Versus Arthritis; National Institute for Health and Care Research","keywords":"Medicine; Arthroplasty; Propensity score matching; Proportional hazards model; Statin; Population; Cohort study; Cohort; Internal medicine; Retrospective cohort study; Surgery","score_opus":0.008393869548733064,"score_gpt":0.27381812053696847,"score_spread":0.2654242509882354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914417608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982065,0.00045483126,0.00026391997,0.00005758194,0.000094960385,0.00091011974,0.000002840635,0.0000023559437,0.000006876576],"genre_scores_gemma":[0.99945194,0.00035396442,0.00016114302,0.000007930367,0.0000063314988,0.0000017335043,0.0000020394712,0.0000092701885,0.0000056467607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977387,0.0009811698,0.00073531904,0.0000743845,0.0003881017,0.00008231664],"domain_scores_gemma":[0.99760157,0.0007963509,0.0011232691,0.0002653549,0.00017558079,0.00003785613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036749376,0.0000889075,0.00083954306,0.00012673902,0.00002912966,0.0000015130571,0.000040918167,0.00005681471,0.000035181176],"category_scores_gemma":[0.0006266638,0.00004546235,0.00011030324,0.00010197661,0.000035564204,0.00003106404,0.000011842491,0.00017878052,8.8242416e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003967367,0.000105771884,0.9780913,0.0007083227,0.00032032173,0.000002633133,0.00045560655,0.00032638686,0.00025780333,0.000007400362,0.000011147252,0.015745934],"study_design_scores_gemma":[0.0071467482,0.021438776,0.96605915,0.0012113204,0.0007169239,0.0004965013,0.0005489315,0.000575303,0.0017346024,0.0000102331005,0.000008590616,0.000052931828],"about_ca_topic_score_codex":0.0005748589,"about_ca_topic_score_gemma":0.00003243645,"teacher_disagreement_score":0.021333005,"about_ca_system_score_codex":0.000020435946,"about_ca_system_score_gemma":0.00009585558,"threshold_uncertainty_score":0.18539008},"labels":[],"label_agreement":null},{"id":"W2914502026","doi":"10.1016/j.amjcard.2019.01.034","title":"Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)","year":2019,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Centers for Medicare and Medicaid Services; Johnson and Johnson; Alberta Innovates - Health Solutions; Takeda Pharmaceuticals U.S.A.; Agency for Healthcare Research and Quality; Yale University; Alberta Innovates; Canadian Cardiovascular Society; Medtronic; Roche; European Society of Cardiology; Merck; Bayer","keywords":"Ezetimibe; Medicine; Acute coronary syndrome; Internal medicine; Cardiology; Phenotype; Intensive care medicine; Myocardial infarction; Statin","score_opus":0.005457217677203533,"score_gpt":0.22161411625467375,"score_spread":0.21615689857747022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914502026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99247473,0.006024801,0.00008677001,0.0002428452,0.00034195266,0.00064714864,0.00004197334,0.0000066293123,0.00013317032],"genre_scores_gemma":[0.99487734,0.0040922468,0.00027736742,0.0004250213,0.00024977897,0.00002533858,0.0000078813155,0.000028212833,0.000016844098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997754,0.00072467484,0.0004907581,0.00027407124,0.000431588,0.000324935],"domain_scores_gemma":[0.9985285,0.00010374113,0.00035810116,0.0007099187,0.00013613432,0.00016359809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006136939,0.00022768455,0.0016081256,0.0001156851,0.000039867147,0.000008982666,0.00010565433,0.0000620895,0.00001544489],"category_scores_gemma":[0.000031448362,0.00013157773,0.0008362378,0.00014463495,0.00022583225,0.000059317994,0.000068578884,0.0003557519,0.000015428643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002645095,0.00006263202,0.6287745,0.000011609306,0.0062340526,0.00043781145,0.0005273867,0.00022382755,0.000032648688,0.00000118891,0.00004604442,0.36100316],"study_design_scores_gemma":[0.0037608638,0.008402827,0.97681004,0.000052596042,0.0016345987,0.0006446944,0.00046934464,0.0000101867745,0.000036974172,0.000039760358,0.00799571,0.00014239647],"about_ca_topic_score_codex":0.0007367686,"about_ca_topic_score_gemma":0.0000052372725,"teacher_disagreement_score":0.36086076,"about_ca_system_score_codex":0.00022330368,"about_ca_system_score_gemma":0.00016117601,"threshold_uncertainty_score":0.53655845},"labels":[],"label_agreement":null},{"id":"W2914732195","doi":"10.1161/atvbaha.118.312267","title":"Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid Atherosclerosis","year":2019,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; Lipoprotein(a); Risk factor; Relative risk; Prospective cohort study; Atherosclerosis Risk in Communities; Framingham Risk Score; Gastroenterology; Lipoprotein; Confidence interval; Cholesterol; Disease","score_opus":0.02528546475743046,"score_gpt":0.25678472689688125,"score_spread":0.2314992621394508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914732195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978815,0.00017487362,0.00014212064,0.00024121937,0.00014575693,0.0012096408,0.000046845864,0.000048437792,0.00010961927],"genre_scores_gemma":[0.9950378,0.0040477524,0.00042958895,0.0002446615,0.000046504018,0.00011104731,0.00003896458,0.000038206603,0.000005452182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746317,0.0005033722,0.00060122524,0.0006326485,0.0003012106,0.0004983618],"domain_scores_gemma":[0.99858123,0.000098155775,0.00027831632,0.00076512765,0.000112965245,0.00016417944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010982731,0.00032196223,0.0014049093,0.0002139463,0.00008702225,0.000020219288,0.00014357574,0.000355334,0.00015549336],"category_scores_gemma":[0.00010702613,0.00025462318,0.000541424,0.00039006813,0.00021069002,0.00006792191,0.00007897689,0.00030118786,0.000020725956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008355907,0.00032137564,0.9359348,0.00013727865,0.00047475233,2.2483162e-8,0.00019129556,0.0000030805274,0.062205747,0.00007319146,0.0000062844615,0.0006438198],"study_design_scores_gemma":[0.0041619022,0.0012024892,0.9916108,0.0004481182,0.00025888564,2.5390446e-7,0.00012911577,0.0002678839,0.0015125347,0.00003106006,0.00011983472,0.00025707786],"about_ca_topic_score_codex":0.003042887,"about_ca_topic_score_gemma":0.00036687253,"teacher_disagreement_score":0.06069321,"about_ca_system_score_codex":0.00007667795,"about_ca_system_score_gemma":0.00009780838,"threshold_uncertainty_score":0.9999906},"labels":[],"label_agreement":null},{"id":"W2914847373","doi":"10.1007/s12170-019-0597-x","title":"Worldwide Dyslipidemia Guidelines","year":2019,"lang":"en","type":"article","venue":"Current Cardiovascular Risk Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Guideline; Canadian Cardiovascular Society; Atherosclerotic cardiovascular disease; Intensive care medicine; Excellence; Disease; Family medicine; Statin; MEDLINE; Internal medicine; Pathology","score_opus":0.028243447470289305,"score_gpt":0.30701187134377045,"score_spread":0.27876842387348116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914847373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7526782,0.22415283,0.0050919177,0.00025781567,0.0073747113,0.0030234957,0.000012039833,0.0004771282,0.006931828],"genre_scores_gemma":[0.9771117,0.0122197345,0.00388438,0.00032580187,0.0045558093,0.00022079193,0.0001764256,0.00019289675,0.001312465],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99453795,0.0002727851,0.0012526662,0.0011818635,0.0020446116,0.0007101087],"domain_scores_gemma":[0.9944059,0.000034850564,0.0003712989,0.0039809775,0.0007020161,0.00050495786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0049131755,0.00045445372,0.0016562085,0.00023615712,0.00014376582,0.000048056212,0.00013635894,0.00019727538,0.00023689201],"category_scores_gemma":[0.000949243,0.0003724436,0.004600263,0.00055108435,0.000062266714,0.00015721876,0.00014962093,0.00076374254,0.0004853946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043148193,0.000105900304,0.2420621,0.000607119,0.0035803977,0.0008760812,0.000044319673,0.0006395253,0.000048762875,0.000044586955,0.010148466,0.7417996],"study_design_scores_gemma":[0.0013651508,0.000078331635,0.06642209,0.00044165264,0.0019463623,0.002328246,0.000036153087,0.00017019988,0.00041239135,0.00016954508,0.9261801,0.0004497363],"about_ca_topic_score_codex":0.00027154404,"about_ca_topic_score_gemma":0.00000490371,"teacher_disagreement_score":0.91603166,"about_ca_system_score_codex":0.00022070108,"about_ca_system_score_gemma":0.00044907694,"threshold_uncertainty_score":0.99987274},"labels":[],"label_agreement":null},{"id":"W2915303682","doi":"","title":"Family Medicine Forum Research Proceedings 2014/Compte rendu sur la recherche au Forum en médecine familiale 2014","year":2015,"lang":"fr","type":"article","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Psychological intervention; Context (archaeology); Disease; Framingham Risk Score; Coronary artery disease; Family medicine; Randomized controlled trial; MEDLINE; Framingham Heart Study; Intensive care medicine; Internal medicine; Pathology; Nursing","score_opus":0.1996137420560056,"score_gpt":0.3680677708863858,"score_spread":0.16845402883038021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915303682","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063771546,0.1662277,0.00021971518,0.10627357,0.0077520004,0.004552508,0.00053707114,0.00023754097,0.65042835],"genre_scores_gemma":[0.5492343,0.030357802,0.0031824687,0.21654697,0.06579513,0.0012331422,0.0011881423,0.0017007795,0.1307613],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9866043,0.0022935823,0.0012873221,0.001781835,0.0029604642,0.0050724987],"domain_scores_gemma":[0.98761106,0.0012093574,0.00029745421,0.0019399954,0.0024923522,0.006449806],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.019150663,0.0010917421,0.002143506,0.0013200445,0.0007317094,0.00017138499,0.001257492,0.0017960363,0.000043899618],"category_scores_gemma":[0.0023553735,0.0010633938,0.0006439978,0.002325721,0.001455084,0.00077381457,0.00031008633,0.0045889793,0.00271468],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00015737966,0.00019760091,0.002212748,0.0005479344,0.0004568039,0.00032185984,0.0012480114,0.000007389092,0.0019106013,0.006822969,0.8004277,0.18568902],"study_design_scores_gemma":[0.006000125,0.0017315324,0.018735342,0.0027472847,0.00042214498,0.000047417565,0.028783463,0.0004092421,0.00018625555,0.0060691116,0.9339192,0.0009488759],"about_ca_topic_score_codex":0.6214561,"about_ca_topic_score_gemma":0.09289395,"teacher_disagreement_score":0.5285621,"about_ca_system_score_codex":0.011911118,"about_ca_system_score_gemma":0.020150278,"threshold_uncertainty_score":0.99949986},"labels":[],"label_agreement":null},{"id":"W2915650922","doi":"10.1159/000497447","title":"Role of Lipoprotein Apheresis in Cardiovascular Disease Risk Reduction","year":2019,"lang":"en","type":"review","venue":"Blood Purification","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster Children's Hospital; McMaster University","funders":"","keywords":"Medicine; Alirocumab; Disease; Adverse effect; PCSK9; Familial hypercholesterolemia; Lipoprotein(a); Intensive care medicine; Internal medicine; Lipoprotein; Randomized controlled trial; Cholesterol; LDL receptor","score_opus":0.02646796452776751,"score_gpt":0.27781581747237966,"score_spread":0.25134785294461215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915650922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008415561,0.9933655,0.000037872047,0.000013053127,0.00013337469,0.0050303475,0.000075652744,0.0000486593,0.0004539412],"genre_scores_gemma":[0.0022066114,0.9953039,0.00039584702,0.0000024709238,0.00058223493,0.0008149973,0.00041538823,0.000090203444,0.00018830999],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964681,0.0006276787,0.0009652831,0.0007997402,0.0008468929,0.0002922924],"domain_scores_gemma":[0.99637026,0.000024361594,0.0005662741,0.0026861327,0.0001526737,0.00020030035],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015241681,0.00037858117,0.002514176,0.00042374892,0.00004424133,0.000015094277,0.00018602057,0.00042143016,0.000031725052],"category_scores_gemma":[0.00020525236,0.00032634262,0.002484942,0.00076477,0.000045611243,0.00008047064,0.000035072746,0.000534401,0.000095570846],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003058576,0.0002998479,0.000036221572,0.029622365,0.0019353296,0.000006951244,0.000032999746,0.000013808492,0.000009239862,0.00006442026,0.000013366817,0.96793485],"study_design_scores_gemma":[0.0011586654,0.00010920617,0.0017602873,0.012355813,0.025817282,0.00008643279,0.00005248056,0.000012971203,0.00009959454,0.00007450454,0.958089,0.00038375406],"about_ca_topic_score_codex":0.0014849534,"about_ca_topic_score_gemma":0.0000052703463,"teacher_disagreement_score":0.9675511,"about_ca_system_score_codex":0.00014492722,"about_ca_system_score_gemma":0.00082472246,"threshold_uncertainty_score":0.9999189},"labels":[],"label_agreement":null},{"id":"W2915984970","doi":"10.1101/560458","title":"Genetic inhibition of <i>PCSK9</i> , atherogenic lipoprotein concentrations, and calcific aortic valve stenosis","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Medical Research Council","keywords":"PCSK9; Medicine; Internal medicine; Aortic valve; Lipoprotein; Apolipoprotein B; Aortic valve stenosis; Population; Lipoprotein(a); Cholesterol; Dyslipidemia; Endocrinology; Cardiology; LDL receptor; Disease","score_opus":0.012446901086857717,"score_gpt":0.22351430371668335,"score_spread":0.21106740262982562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915984970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807029,0.013502975,0.0019550065,0.00014065608,0.00043080354,0.002946687,0.0001644043,0.00014794088,0.000008672649],"genre_scores_gemma":[0.993141,0.002224242,0.0035109909,0.00022032899,0.00045957885,0.00030426195,0.0000012877956,0.0001335011,0.0000047955377],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967679,0.00020345759,0.0008504877,0.0009770686,0.0006930673,0.00050802843],"domain_scores_gemma":[0.99675226,0.00003417738,0.00051732874,0.0017433508,0.0005854424,0.00036741453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007114317,0.0005056763,0.001094979,0.000209634,0.00010327907,0.00007415695,0.00014977255,0.0006150305,0.000039521197],"category_scores_gemma":[0.00011841965,0.0005089831,0.00054110447,0.00036342206,0.00017522086,0.000079319994,0.00023156326,0.0006763924,0.000038387647],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014469904,0.0004981525,0.06905461,0.0075476468,0.0018542156,0.00006778704,0.00005782188,0.00014820705,0.9199907,0.0003561132,0.00014429224,0.00013570504],"study_design_scores_gemma":[0.0025089518,0.00036356633,0.5500308,0.0023234827,0.0015671849,3.2860837e-7,0.000013532299,0.0005672263,0.44072014,0.000005075793,0.001077055,0.00082263345],"about_ca_topic_score_codex":0.00034458088,"about_ca_topic_score_gemma":0.0000027854949,"teacher_disagreement_score":0.48097622,"about_ca_system_score_codex":0.00026560976,"about_ca_system_score_gemma":0.0011205834,"threshold_uncertainty_score":0.9997362},"labels":[],"label_agreement":null},{"id":"W2916419981","doi":"10.1016/j.cjca.2019.02.013","title":"Prevalence and Treatment of Familial Hypercholesterolemia in France","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Université de Toulouse; Fondation de France; Fédération Française de Cardiologie; Institut National de la Santé et de la Recherche Médicale; Parke-Davis; Agence Nationale de la Recherche; Mutuelle Générale de l'Education Nationale; Pfizer","keywords":"Medicine; Humanities; Library science; Family medicine","score_opus":0.011463786958827936,"score_gpt":0.23687043854037268,"score_spread":0.22540665158154474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916419981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140894,0.006738684,0.00003106558,0.0002266136,0.00022983675,0.00019259863,0.0000073965252,7.517037e-7,0.0011641304],"genre_scores_gemma":[0.99821687,0.0011826722,0.000077792974,0.00007718169,0.00032540184,0.0000018457292,5.656932e-7,0.0000060937246,0.0001115509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932975,0.00008011264,0.0002426086,0.00009165907,0.00008538466,0.0001705099],"domain_scores_gemma":[0.99940336,0.000019264931,0.00006690555,0.00017470113,0.00007653787,0.00025921935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026454002,0.00006804918,0.0005292298,0.00015527483,0.000009948365,0.0000021064325,0.000042733653,0.000084271625,0.0000084804515],"category_scores_gemma":[0.000028166116,0.000052814943,0.00014135068,0.00005751628,0.00006998609,0.000029816962,0.0000026992209,0.00010431171,0.000002520115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037154263,0.00000224025,0.9731913,0.00008297497,0.00009128282,0.00014527966,0.00017740627,0.000100339676,0.0004424199,0.000016714608,0.000030672556,0.025682222],"study_design_scores_gemma":[0.002052821,0.0011055889,0.96692824,0.00011429355,0.00005875512,0.0010496355,0.000055699973,0.00000419864,0.00012061513,0.000016388496,0.028452696,0.00004108382],"about_ca_topic_score_codex":0.0018165974,"about_ca_topic_score_gemma":0.00047357852,"teacher_disagreement_score":0.028422024,"about_ca_system_score_codex":0.00012200094,"about_ca_system_score_gemma":0.00076399965,"threshold_uncertainty_score":0.2746164},"labels":[],"label_agreement":null},{"id":"W2916465613","doi":"10.1111/hdi.12730","title":"Statin use among Veterans with dialysis‐dependent chronic kidney disease","year":2019,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"American Society of Nephrology","keywords":"Medicine; Veterans Affairs; Dialysis; Statin; Kidney disease; Population; Internal medicine; Intensive care medicine; Pharmacy; Emergency medicine; Physical therapy; Family medicine","score_opus":0.010552216815167869,"score_gpt":0.24791856959582484,"score_spread":0.23736635278065696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2916465613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161977,0.00010024941,0.0041060583,0.0009296541,0.00036871238,0.00060739584,0.00010978765,0.0000686534,0.0020897503],"genre_scores_gemma":[0.99190116,0.00009229396,0.0006591881,0.0009033546,0.0006680854,0.00008883657,0.0006149824,0.00003865394,0.00503346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975743,0.00008219801,0.00032183476,0.0004906717,0.0012461653,0.00028478145],"domain_scores_gemma":[0.9983636,0.00004434899,0.00012043801,0.0007108897,0.00024866866,0.0005120403],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031562315,0.00020630234,0.00041233236,0.00022419599,0.000056905625,0.000099488854,0.00016775233,0.000060907696,0.002211837],"category_scores_gemma":[0.00011982027,0.00016062311,0.0004184183,0.00020010643,0.0000557533,0.00029835405,0.00005654538,0.00020857574,0.00027155108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013759306,0.00046106026,0.9678606,0.00023445414,0.0038219562,0.00034661585,0.00038906094,0.0021613152,0.001676601,0.00057321583,0.0012136295,0.019885568],"study_design_scores_gemma":[0.011709724,0.00042189998,0.9164038,0.00046107225,0.0017343957,0.000064901185,0.0001052039,0.017385144,0.0017947879,0.00006005657,0.04920489,0.00065414025],"about_ca_topic_score_codex":0.000618804,"about_ca_topic_score_gemma":0.00010784242,"teacher_disagreement_score":0.051456805,"about_ca_system_score_codex":0.00041634566,"about_ca_system_score_gemma":0.00050415215,"threshold_uncertainty_score":0.99870026},"labels":[],"label_agreement":null},{"id":"W2917374946","doi":"10.1097/mol.0000000000000499","title":"The journey towards understanding lipoprotein(a) and cardiovascular disease risk: are we there yet?","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Sanofi; Pfizer","keywords":"Lipoprotein(a); Medicine; Disease; Atherosclerotic cardiovascular disease; Clinical significance; Risk factor; Lipoprotein; Plasma lipoprotein; Intensive care medicine; Internal medicine; Cholesterol","score_opus":0.24113213736083425,"score_gpt":0.3991725633705843,"score_spread":0.15804042600975007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917374946","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005231979,0.95752996,0.00073006394,0.0005357615,0.0379887,0.0029252674,0.000086651475,0.000065718064,0.00013265735],"genre_scores_gemma":[0.000035380748,0.9733239,0.000037865168,0.000013396847,0.025848603,0.00051674986,0.0000796662,0.00010871074,0.000035766847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942387,0.001958235,0.0010411484,0.0011153608,0.000824799,0.0008217872],"domain_scores_gemma":[0.99640065,0.00033031902,0.00057749444,0.0020222268,0.000119183715,0.0005501409],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003644579,0.0007085119,0.0029633748,0.0003415728,0.00049394043,0.00009463326,0.00038315146,0.0005362087,0.000041556214],"category_scores_gemma":[0.0010077182,0.00044038717,0.0021391707,0.00055888586,0.0005391731,0.000076711825,0.00033781974,0.0013795667,0.000043909953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005867679,0.00006891046,0.00013410283,0.032257926,0.0014531522,0.000002882726,0.000090836926,0.0000012506173,2.0283488e-9,0.0006631042,0.012394282,0.9528749],"study_design_scores_gemma":[0.00085750525,0.00014456538,0.00031096992,0.04382774,0.0017697953,0.0001976218,0.00025919665,0.000016655555,1.43607215e-8,0.0008018059,0.95140797,0.00040615274],"about_ca_topic_score_codex":0.00010987824,"about_ca_topic_score_gemma":0.000015923151,"teacher_disagreement_score":0.9524687,"about_ca_system_score_codex":0.0005451465,"about_ca_system_score_gemma":0.0010574338,"threshold_uncertainty_score":0.9998048},"labels":[],"label_agreement":null},{"id":"W2918318471","doi":"10.1111/dom.13680","title":"Randomised study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Primary results of the BERSON clinical trial","year":2019,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"Amgen","keywords":"Evolocumab; Medicine; Placebo; Atorvastatin; Internal medicine; Statin; Type 2 diabetes; PCSK9; Gastroenterology; Diabetes mellitus; Cholesterol; Endocrinology; Lipoprotein; Apolipoprotein A1","score_opus":0.014141394061538503,"score_gpt":0.2587694760928445,"score_spread":0.244628082031306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918318471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534976,0.00085969234,1.0854e-7,0.000023133322,0.00030152017,0.00327491,0.00001895746,0.000006302431,0.00016560922],"genre_scores_gemma":[0.99953234,0.00010692092,0.000055633685,0.00012847631,0.000095290285,0.000017253227,0.000016502561,0.000013494846,0.00003408224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783635,0.0004926924,0.00058937486,0.00032628977,0.0005395096,0.00021576679],"domain_scores_gemma":[0.9986567,0.00029516715,0.00027235228,0.00054934766,0.00013564606,0.000090806585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020120814,0.00015846995,0.0010825066,0.00007935153,0.000040671745,0.000009162388,0.00007858574,0.00010599137,0.000004786876],"category_scores_gemma":[0.00028574336,0.00009259692,0.00011000439,0.00021692744,0.00010670507,0.00007077434,0.00006741452,0.0002662933,8.39287e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043536533,0.0017063082,0.9441722,0.00027163883,0.0003050132,3.6522363e-7,0.00048195975,0.0000019107881,0.00005546767,0.000010626789,0.000022328804,0.009435643],"study_design_scores_gemma":[0.2564027,0.0026337325,0.7400653,0.00013112307,0.00026603145,3.6853e-8,0.00012128213,0.0000073726187,0.00018179146,0.0000065987947,0.0001113318,0.00007270471],"about_ca_topic_score_codex":0.000074436604,"about_ca_topic_score_gemma":0.000013808404,"teacher_disagreement_score":0.21286617,"about_ca_system_score_codex":0.000015892583,"about_ca_system_score_gemma":0.00009288112,"threshold_uncertainty_score":0.37759927},"labels":[],"label_agreement":null},{"id":"W2918462316","doi":"10.1161/circoutcomes.11.suppl_1.279","title":"Abstract 279: Eligibility and Cost Estimates for Anti-inflammatory Therapy for Atherosclerotic Disease: Implications of the CANTOS Trial for the US Adult Population","year":2018,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Canakinumab; Statin; National Health and Nutrition Examination Survey; Population; Internal medicine; Physical therapy; Disease; Environmental health","score_opus":0.06413761134301631,"score_gpt":0.3670030212752082,"score_spread":0.30286540993219185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918462316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95547223,0.003652103,0.02682336,0.0017184187,0.00028362963,0.011773413,0.00023639608,0.000034957797,0.0000054963502],"genre_scores_gemma":[0.99719006,0.00026418746,0.00033507377,0.00038700097,0.00043736523,0.0012616641,0.00009106188,0.000028151082,0.0000054275256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828124,0.00012326382,0.0005889139,0.00040845256,0.00036860228,0.0002295004],"domain_scores_gemma":[0.9974037,0.0006354724,0.00023145135,0.0010512578,0.0005640328,0.000114115835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026344575,0.00019317203,0.00067228265,0.000032351818,0.000626737,0.000044227334,0.000098701414,0.00011601767,0.0000024237743],"category_scores_gemma":[0.0012545515,0.00011681834,0.0014146555,0.0001010361,0.00022545774,0.00009535901,0.000022853712,0.000070474336,1.9952584e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031192373,0.00012949997,0.92053795,0.0015412277,0.00284778,8.232701e-8,0.0002591163,0.0003794912,0.00035862322,0.004473977,0.000037476737,0.06631555],"study_design_scores_gemma":[0.018808113,0.000067477304,0.97595114,0.000050101753,0.00090250943,0.0000025654203,0.00004739476,0.0008543997,0.00019313704,0.0017985671,0.0011855956,0.00013899832],"about_ca_topic_score_codex":0.0004239989,"about_ca_topic_score_gemma":0.00006636725,"teacher_disagreement_score":0.06617655,"about_ca_system_score_codex":0.000062491425,"about_ca_system_score_gemma":0.0001431243,"threshold_uncertainty_score":0.48204178},"labels":[],"label_agreement":null},{"id":"W2918499521","doi":"10.1177/0003319719833520","title":"Noncoronary Artery Disease in Familial Hypercholesterolemia: Underdiagnosis of Peripheral Arterial Disease?","year":2019,"lang":"en","type":"letter","venue":"Angiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Arterial disease; Familial hypercholesterolemia; Disease; Peripheral; Cardiology; Internal medicine; Vascular disease; Radiology; Cholesterol","score_opus":0.016790001837485215,"score_gpt":0.2559955266955581,"score_spread":0.23920552485807287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918499521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7488727,0.0035904737,0.000038614566,0.24323821,0.0019995174,0.0015363444,0.00036276403,0.000047062877,0.00031428327],"genre_scores_gemma":[0.57979697,0.0006073622,0.000051483978,0.40756252,0.00927096,0.00021895845,0.001914536,0.00009393381,0.00048330033],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99727476,0.00039785242,0.0005848182,0.0007114064,0.00040971636,0.0006214505],"domain_scores_gemma":[0.998314,0.00012179823,0.00015008498,0.0011365713,0.0000694949,0.0002080235],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002193636,0.0004030722,0.0013457582,0.00024406317,0.000028642933,0.0000083223795,0.00020247397,0.0008682787,0.00017737578],"category_scores_gemma":[0.00006631791,0.00035737312,0.00091349985,0.0001174007,0.00020656771,0.0000601688,0.000108437715,0.0011681669,0.000074732176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034365854,0.0005641674,0.31314504,0.0040065865,0.0010461217,0.012996171,0.00022509188,0.000047158373,0.00027061158,0.000020419777,0.6546064,0.009635637],"study_design_scores_gemma":[0.0038073556,0.0005683061,0.72555566,0.000545915,0.00066001073,0.00008897121,0.000021713286,0.000030215762,0.0000039001143,0.00015628872,0.26815107,0.0004105907],"about_ca_topic_score_codex":0.00034167463,"about_ca_topic_score_gemma":0.00002627307,"teacher_disagreement_score":0.41241062,"about_ca_system_score_codex":0.00021811122,"about_ca_system_score_gemma":0.00077867234,"threshold_uncertainty_score":0.9998878},"labels":[],"label_agreement":null},{"id":"W2919072615","doi":"10.1016/s0735-1097(19)32323-x","title":"RISKS OF INCIDENT CARDIOVASCULAR DISEASE ASSOCIATED WITH CONCOMITANT ELEVATIONS IN LIPOPROTEIN(A) AND LOW-DENSITY LIPOPROTEIN CHOLESTEROL: THE FRAMINGHAM HEART STUDY","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Framingham Risk Score; Concomitant; Internal medicine; Framingham Heart Study; Cardiology; Cholesterol; Atherosclerotic cardiovascular disease; Disease; Coronary heart disease","score_opus":0.018488506255331296,"score_gpt":0.27266704618370424,"score_spread":0.25417853992837297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919072615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495244,0.0013464311,0.000104472114,0.0010650342,0.00014264735,0.0023016012,0.000035005265,0.000005835883,0.000046561003],"genre_scores_gemma":[0.9993114,0.00014964677,0.000080708305,0.00019891387,0.00017592337,0.00003063045,9.319503e-7,0.000027179774,0.000024678375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99602944,0.0014929057,0.0008443539,0.00026420248,0.0010817843,0.00028729218],"domain_scores_gemma":[0.99684423,0.00023138536,0.0010363018,0.0011386302,0.0005883356,0.000161107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036613243,0.00022081974,0.0020947251,0.00018812371,0.00008715934,0.00000716754,0.00029019,0.00007236043,0.000002240751],"category_scores_gemma":[0.0007332629,0.00012090944,0.00088291144,0.00068542524,0.00056139124,0.000068833826,0.00015765752,0.00065116154,5.9054605e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016418443,0.00029223014,0.9866416,0.000114934846,0.004892871,0.00024904037,0.0002665305,0.0028200934,0.00081046496,0.00002044068,0.000060601997,0.002189333],"study_design_scores_gemma":[0.0040099137,0.0024310572,0.98867875,0.00037269222,0.0011668744,0.0005405562,0.001971136,0.00006400741,0.00033140637,0.000041707284,0.00027368078,0.000118197844],"about_ca_topic_score_codex":0.0015105241,"about_ca_topic_score_gemma":0.00017612692,"teacher_disagreement_score":0.004358975,"about_ca_system_score_codex":0.0001874578,"about_ca_system_score_gemma":0.00060083176,"threshold_uncertainty_score":0.4930544},"labels":[],"label_agreement":null},{"id":"W2919922987","doi":"10.1016/s0735-1097(19)32379-4","title":"LONG-TERM RESIDUAL RISK AND PREDICTORS OF CARDIOVASCULAR DISEASE IN INDIVIDUALS TAKING STATINS FOR PRIMARY PREVENTION: INSIGHTS FROM THE CARTAGENE STUDY","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Heart Institute","funders":"","keywords":"Medicine; Primary prevention; Residual risk; Statin; Term (time); Disease; Residual; Internal medicine; Psychological intervention; Physical therapy; Intensive care medicine; Cardiology; Psychiatry","score_opus":0.013800791830491278,"score_gpt":0.26844790767114174,"score_spread":0.2546471158406505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2919922987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877639,0.009172586,0.00027343034,0.00015431833,0.0003047211,0.0019999917,0.00029690177,0.000003066268,0.00003107921],"genre_scores_gemma":[0.9979399,0.0011104284,0.0002583347,0.0000553849,0.0005653901,0.000026415093,0.0000056878644,0.000021609158,0.000016846905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661505,0.0014263446,0.00079747266,0.00023260654,0.00073636806,0.00019216379],"domain_scores_gemma":[0.997103,0.00041266493,0.0012947442,0.0008277045,0.0002525633,0.000109322995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018480167,0.00016520369,0.0016369375,0.00013430924,0.00006840158,0.000004628484,0.0002788885,0.0000492805,0.0000024198112],"category_scores_gemma":[0.00037676573,0.00009337685,0.0010001311,0.00030940273,0.0002850062,0.00006225001,0.00014186474,0.00031031086,1.4698108e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070513546,0.000102421276,0.98785305,0.000106981155,0.0064217923,0.000054637876,0.00038550733,0.001635639,0.000121285375,0.000006740549,0.00006597821,0.0025408564],"study_design_scores_gemma":[0.0040147887,0.0018817149,0.9885251,0.00020194976,0.0031633058,0.00006783525,0.0012796147,0.0000050959047,0.00007090168,0.00008280181,0.0006250139,0.00008188222],"about_ca_topic_score_codex":0.00023514025,"about_ca_topic_score_gemma":0.000029703864,"teacher_disagreement_score":0.010175997,"about_ca_system_score_codex":0.00008525912,"about_ca_system_score_gemma":0.00058564794,"threshold_uncertainty_score":0.38077977},"labels":[],"label_agreement":null},{"id":"W2920258545","doi":"10.1016/s0735-1097(19)30639-4","title":"PATIENTS WITH ACUTE CORONARY SYNDROME, ELEVATED ATHEROGENIC LIPOPROTEINS, AND PRIOR CORONARY ARTERY BYPASS GRAFTING DERIVE LARGE ABSOLUTE BENEFIT FROM ALIROCUMAB: INSIGHTS FROM THE ODYSSEY OUTCOMES TRIAL","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Medicine; Alirocumab; Cardiology; Internal medicine; Bypass grafting; Acute coronary syndrome; Artery; Coronary atherosclerosis; Lipoprotein; Coronary artery disease; Cholesterol; Myocardial infarction","score_opus":0.006534532970196622,"score_gpt":0.22377359765167912,"score_spread":0.2172390646814825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920258545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945968,0.0015497999,0.00006658384,0.0007497989,0.00058563513,0.0018944624,0.0005200883,0.000014369348,0.000022494187],"genre_scores_gemma":[0.9978531,0.00035442674,0.00051769963,0.00080250605,0.00030771372,0.000023527355,0.000028559252,0.000055129804,0.000057358797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968639,0.00057141704,0.00091088313,0.00036571277,0.000881807,0.00040625746],"domain_scores_gemma":[0.9966563,0.00035820235,0.0014819351,0.0009562774,0.00036431555,0.0001829705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048496062,0.00035064027,0.002150403,0.00010000473,0.0001891733,0.000012391843,0.0004454782,0.000138009,0.000016959977],"category_scores_gemma":[0.00009822854,0.00017724125,0.00080020796,0.00031293483,0.0003437227,0.00013062196,0.000233038,0.0005998745,0.000004778987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047469743,0.0003151815,0.91762507,0.0000349173,0.026685204,0.001563004,0.00037762988,0.000054298038,0.0017429963,0.00004225916,0.0003075842,0.0037821284],"study_design_scores_gemma":[0.035816982,0.004128679,0.95438164,0.00016699868,0.0018028676,0.001793868,0.00050604856,0.000015521073,0.000091868795,0.00013557886,0.00095798407,0.00020193556],"about_ca_topic_score_codex":0.00027800808,"about_ca_topic_score_gemma":0.00006280641,"teacher_disagreement_score":0.036756612,"about_ca_system_score_codex":0.00014268537,"about_ca_system_score_gemma":0.00036385955,"threshold_uncertainty_score":0.72276884},"labels":[],"label_agreement":null},{"id":"W2920999775","doi":"10.1139/cjpp-2018-0570","title":"Tβ4–Ac-SDKP pathway: Any relevance for the cardiovascular system?","year":2019,"lang":"en","type":"review","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Pharmacology","score_opus":0.04517229613776491,"score_gpt":0.3182107293819274,"score_spread":0.2730384332441625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920999775","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001574967,0.9934231,0.000099707366,0.00021069818,0.0039421553,0.0019437306,0.00011884065,0.0000069541547,0.00009733598],"genre_scores_gemma":[0.002894888,0.9922432,0.00006020178,0.0005820288,0.0038525024,0.00011956296,0.000024989464,0.000058455942,0.00016417484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975925,0.00056907267,0.0007291865,0.00035639055,0.00015746665,0.0005953939],"domain_scores_gemma":[0.997548,0.0004963485,0.0005118462,0.00050156243,0.00031181538,0.000630465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015892659,0.00036867507,0.0032975157,0.00024960388,0.00027609916,0.000010558269,0.000313339,0.00053736585,0.00011085481],"category_scores_gemma":[0.00007708767,0.00022366225,0.0023753063,0.00017015342,0.0002659912,0.000044251596,0.000024940555,0.0010513731,0.000019603885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010024091,0.000019754756,0.000004833769,0.10154784,0.0153494645,0.00049647887,0.00008483837,0.00002976857,0.0001435685,0.0004106978,0.00858813,0.8732244],"study_design_scores_gemma":[0.0012449751,0.00042564134,0.000026103931,0.0023052816,0.010445135,0.004230803,0.000031793978,0.000012448098,0.00003873494,0.000024437717,0.98102254,0.00019211066],"about_ca_topic_score_codex":0.0005353204,"about_ca_topic_score_gemma":0.00009954032,"teacher_disagreement_score":0.9724344,"about_ca_system_score_codex":0.00030030642,"about_ca_system_score_gemma":0.005559846,"threshold_uncertainty_score":0.9862928},"labels":[],"label_agreement":null},{"id":"W2921172883","doi":"10.1161/circresaha.118.313245","title":"Cholesterol-Lowering Agents","year":2019,"lang":"en","type":"review","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada","keywords":"Dyslipidemia; Medicine; Disease; Diabetes mellitus; Statin; Familial hypercholesterolemia; Risk factor; Intensive care medicine; Kidney disease; Atherosclerotic cardiovascular disease; Internal medicine; Cholesterol; Endocrinology","score_opus":0.39563386624350755,"score_gpt":0.5122505764156858,"score_spread":0.11661671017217828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921172883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019137419,0.9887866,0.00008159506,0.00004395821,0.0002614844,0.0030884119,0.000006735418,0.000050450686,0.007489406],"genre_scores_gemma":[0.0009501164,0.99578476,0.00001717493,0.00003666617,0.00076969905,0.0001966359,0.00021112872,0.00008946311,0.0019443312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964078,0.00038145186,0.00047845775,0.0005595936,0.0016445181,0.00052819785],"domain_scores_gemma":[0.9979618,0.00008776048,0.00009582607,0.0013024409,0.0003030231,0.00024915842],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025403139,0.00022705665,0.0013703378,0.0005824624,0.00013880167,0.000083500185,0.00018774654,0.0004062203,0.0003021392],"category_scores_gemma":[0.00018688328,0.00018512312,0.000813598,0.0007575865,0.000052406565,0.00007417903,0.00012980633,0.0011519074,0.0023997133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000022537652,0.000032746906,0.00009316475,0.042343695,0.00021559431,0.000019951789,0.000019241486,0.0000039812285,3.6118422e-7,0.000021662392,0.00049763784,0.95674974],"study_design_scores_gemma":[0.00035645394,0.000044405468,0.0021573205,0.012390712,0.00029199995,0.0001295347,0.0000072592966,0.00003839052,3.4568754e-7,0.00000532776,0.9844336,0.0001446496],"about_ca_topic_score_codex":0.00009312021,"about_ca_topic_score_gemma":0.0000021606452,"teacher_disagreement_score":0.98393595,"about_ca_system_score_codex":0.00049984606,"about_ca_system_score_gemma":0.00093346386,"threshold_uncertainty_score":0.998377},"labels":[],"label_agreement":null},{"id":"W2921299509","doi":"10.1016/j.jacl.2019.02.006","title":"Atypical familial dysbetalipoproteinemia associated with high polygenic cholesterol and triglyceride scores treated with ezetimibe and evolocumab","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Ezetimibe; Medicine; Evolocumab; Dyslipidemia; Internal medicine; Hyperlipidemia; Triglyceride; Familial hypercholesterolemia; Population; Endocrinology; Apolipoprotein E; Cholesterol; Gastroenterology; Diabetes mellitus; Apolipoprotein B; Disease","score_opus":0.020330219128774755,"score_gpt":0.3021754602368027,"score_spread":0.28184524110802794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921299509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674207,0.00061405613,0.000067901216,0.001377191,0.0004288753,0.0006359495,0.0000066448233,0.000023883335,0.000103437014],"genre_scores_gemma":[0.9956798,0.0004215262,0.0009015361,0.00089195336,0.0017322367,0.0000057994903,0.00000808499,0.00004051621,0.00031855179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968046,0.00055964006,0.0012448126,0.0004039478,0.00059303857,0.00039396706],"domain_scores_gemma":[0.997421,0.00053819316,0.00077375525,0.00040273805,0.00034806642,0.0005162496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018604993,0.00027510247,0.0019078426,0.00014584616,0.00005931852,0.000025241234,0.00011272813,0.00046453596,0.00007163829],"category_scores_gemma":[0.0008438274,0.00015829562,0.0002703432,0.0001886074,0.00045166258,0.00012975356,0.000056535187,0.0010752553,0.0000072199937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024740934,0.0004063246,0.94936347,0.0001172278,0.001808317,0.00016213184,0.00003712512,0.000008555758,0.00044830132,0.00009161334,0.00020955499,0.022606464],"study_design_scores_gemma":[0.024176562,0.016924648,0.9537035,0.0004306828,0.00083262305,0.0024418656,0.000039332626,0.000042803567,0.00018298133,0.000051680025,0.0009859181,0.00018736097],"about_ca_topic_score_codex":0.00014641463,"about_ca_topic_score_gemma":0.00009984435,"teacher_disagreement_score":0.022419102,"about_ca_system_score_codex":0.00004530602,"about_ca_system_score_gemma":0.00044517723,"threshold_uncertainty_score":0.6455108},"labels":[],"label_agreement":null},{"id":"W2921707010","doi":"10.1016/j.cjco.2019.02.005","title":"Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia","year":2019,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Evolocumab; Familial hypercholesterolemia; Kexin; Medicine; PCSK9; Proprotein convertase; Internal medicine; Endocrinology; Gastroenterology; Lipoprotein; Cholesterol; LDL receptor","score_opus":0.01686912459503036,"score_gpt":0.29845611021026947,"score_spread":0.2815869856152391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921707010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878909,0.0009727849,0.0000074533546,0.00033868724,0.00010102876,0.0016320992,0.000002815556,0.00001234444,0.009041873],"genre_scores_gemma":[0.99773693,0.000081810416,0.00031231213,0.00040629986,0.00007088932,0.000030374005,0.000011222335,0.000023330438,0.0013268245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988227,0.000072423245,0.00029775192,0.00027070398,0.00030090762,0.00023550887],"domain_scores_gemma":[0.99873924,0.000023917255,0.000057710797,0.0010311503,0.000040795665,0.00010717403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006804659,0.0001075402,0.0006122285,0.0000875591,0.000015470367,0.000016217944,0.00029968025,0.000095232455,0.00029403903],"category_scores_gemma":[0.000050852133,0.00008993096,0.00017032496,0.00021653724,0.000023353636,0.000100699515,0.00019824042,0.00019018857,0.0003174438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071826307,0.001515415,0.6122869,0.0012811843,0.0010372066,0.00019326998,0.0022238598,0.00011462734,0.0434437,0.0009968671,0.0016876243,0.32803667],"study_design_scores_gemma":[0.013271982,0.0005928512,0.97018576,0.0003195227,0.00008356684,0.00009468842,0.00013430016,0.000065072556,0.004869224,0.000050531035,0.010169588,0.00016292045],"about_ca_topic_score_codex":0.001181948,"about_ca_topic_score_gemma":0.000041679086,"teacher_disagreement_score":0.3578988,"about_ca_system_score_codex":0.000093406095,"about_ca_system_score_gemma":0.00024922646,"threshold_uncertainty_score":0.40802035},"labels":[],"label_agreement":null},{"id":"W2921898859","doi":"10.1177/0003319719835433","title":"Risk of Ischemic Stroke and Peripheral Arterial Disease in Heterozygous Familial Hypercholesterolemia: A Meta-Analysis","year":2019,"lang":"en","type":"review","venue":"Angiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McGill University Health Centre; Health Sciences Centre; McGill University; Institute for Clinical Evaluative Sciences; Royal Victoria Hospital; University of Toronto","funders":"Institute for Clinical Evaluative Sciences","keywords":"Medicine; Odds ratio; Internal medicine; Meta-analysis; Familial hypercholesterolemia; Stroke (engine); Confidence interval; Cardiology; Cochrane Library; Cholesterol","score_opus":0.060897608192011676,"score_gpt":0.32992664063993876,"score_spread":0.2690290324479271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921898859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037868783,0.9603476,0.00003807775,0.000022649243,0.000116544834,0.0010202877,0.00047661288,0.000011492533,0.0000979343],"genre_scores_gemma":[0.012824246,0.9858391,0.000103111444,0.00010051759,0.0002804701,0.00017410322,0.0003143094,0.000036651258,0.00032743457],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974018,0.000687779,0.0007582643,0.00061440794,0.00020704241,0.00033072208],"domain_scores_gemma":[0.9984657,0.000087263536,0.000321917,0.0008961366,0.00004401384,0.00018498037],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005429453,0.00038217203,0.0065478524,0.00034743908,0.000020186251,0.000007028057,0.0001225233,0.00046042353,0.00014073997],"category_scores_gemma":[0.00007083112,0.00025712172,0.005327331,0.00023317376,0.00011741398,0.000028857068,0.00009234591,0.00048814845,0.000014070795],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053303136,0.00029146086,0.0045985226,0.02549317,0.49542657,0.0003589358,0.00019705875,0.000020412339,0.000018440125,0.000008840275,0.0003855355,0.47266802],"study_design_scores_gemma":[0.0009658379,0.00022182074,0.0017382072,0.00018134694,0.61864436,0.000074923875,0.000009981893,0.000012541774,3.8353397e-7,0.0000017962969,0.37792996,0.00021882386],"about_ca_topic_score_codex":0.0006713854,"about_ca_topic_score_gemma":0.000076284334,"teacher_disagreement_score":0.47244918,"about_ca_system_score_codex":0.000064589585,"about_ca_system_score_gemma":0.0002634711,"threshold_uncertainty_score":0.9999881},"labels":[],"label_agreement":null},{"id":"W2922259155","doi":"10.1139/cjpp-2018-0542","title":"Evolocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, promotes angiogenesis in vitro","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Isfahan University of Medical Sciences","keywords":"Kexin; Angiogenesis; Proprotein convertase; Evolocumab; Umbilical vein; Human umbilical vein endothelial cell; Endothelial stem cell; Pharmacology; Chemistry; Endocrinology; Internal medicine; Biology; In vitro; Cancer research; Biochemistry; Medicine; Apolipoprotein B; Lipoprotein; LDL receptor; Cholesterol","score_opus":0.010457597586476491,"score_gpt":0.255816715745696,"score_spread":0.24535911815921949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922259155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920262,0.0054039294,0.0000013661571,0.0010877161,0.00080008287,0.0005808797,0.000009767933,0.000004255971,0.00008578897],"genre_scores_gemma":[0.9979279,0.00012990294,0.00010993518,0.0012493986,0.0004411417,0.000009032236,0.000009888859,0.000016230799,0.00010656652],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987356,0.00023151228,0.00033715527,0.00020419536,0.0000973144,0.00039420053],"domain_scores_gemma":[0.9989726,0.000040532883,0.00013347206,0.0001505869,0.00019762335,0.0005052036],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005129522,0.00014615583,0.00058300304,0.00033485674,0.000054398944,0.0000052105897,0.00009015508,0.00019633546,0.001052726],"category_scores_gemma":[0.00004273986,0.00012004546,0.000137192,0.0001905485,0.00015885895,0.00007561477,0.00001396886,0.00039872897,0.000027831855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001092458,0.000054470733,0.008810911,0.00029301556,0.00021788152,0.00044588366,0.0002511316,0.000005567561,0.9849154,0.000019697049,0.0006809114,0.0032127188],"study_design_scores_gemma":[0.0064710435,0.0019901113,0.050734557,0.00010396411,0.00023833313,0.00133019,0.000118274605,0.00010726471,0.92630327,0.00033519338,0.012029145,0.00023862954],"about_ca_topic_score_codex":0.002540416,"about_ca_topic_score_gemma":0.0006622013,"teacher_disagreement_score":0.05861206,"about_ca_system_score_codex":0.000116143085,"about_ca_system_score_gemma":0.0017690771,"threshold_uncertainty_score":0.99986047},"labels":[],"label_agreement":null},{"id":"W2922644891","doi":"10.1016/j.cjca.2019.03.003","title":"The 2018 ACC/AHA Lipid Guidelines: A Little More or Less Canadian?","year":2019,"lang":"en","type":"editorial","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; University of Alberta; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Dyslipidemia; Guideline; Scopus; Library science; Family medicine; MEDLINE; Internal medicine; Pathology; Law; Political science","score_opus":0.03422912224753948,"score_gpt":0.3079501482474033,"score_spread":0.2737210259998638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922644891","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039222097,0.023642154,0.00013620874,0.011144462,0.9553157,0.0009156489,0.00051443867,0.000011095427,0.007928048],"genre_scores_gemma":[0.0021229142,0.005090339,0.00010755543,0.001181567,0.9803579,0.000023953755,0.00014754623,0.00012992416,0.010838326],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954924,0.00040448384,0.0012844178,0.0004295264,0.0009245329,0.0014646443],"domain_scores_gemma":[0.9912143,0.0005864332,0.0005750142,0.0013986453,0.0033072424,0.0029183715],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0034157757,0.00049330515,0.0022111991,0.0006923535,0.00045268366,0.00012102303,0.00090643397,0.0017610197,0.0000640663],"category_scores_gemma":[0.007502051,0.00030203428,0.0013563704,0.00031936538,0.00035425177,0.00008703356,0.00004019923,0.002457352,0.000088864464],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014916672,8.784887e-7,0.0002088051,0.00014593359,0.0014305803,0.0020001167,0.00006991211,0.00007225446,7.8264486e-7,0.00002906653,0.98474246,0.011150045],"study_design_scores_gemma":[0.0014648832,0.00054288533,0.00040972704,0.00040751122,0.00072939123,0.002122082,0.00062257185,0.0000031365191,0.0000015166386,0.000021165106,0.9933724,0.00030272832],"about_ca_topic_score_codex":0.4255612,"about_ca_topic_score_gemma":0.6194181,"teacher_disagreement_score":0.19385691,"about_ca_system_score_codex":0.0022052475,"about_ca_system_score_gemma":0.09516984,"threshold_uncertainty_score":0.9999432},"labels":[],"label_agreement":null},{"id":"W2922770581","doi":"10.1016/j.cjca.2019.03.002","title":"Statin Use in Primary Prevention: A Simple Trial-Based Approach Compared With Guideline-Recommended Risk Algorithms for Selection of Eligible Patients","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Canadian Institutes of Health Research; Merck Sharp and Dohme; Novo Nordisk; National Institute for Health and Care Research; Novartis; Schering-Plough; Sanofi; Merck; GlaxoSmithKline; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Bayer; Pfizer","keywords":"Medicine; Guideline; Statin; Selection (genetic algorithm); Primary prevention; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Simple (philosophy); Algorithm; Secondary prevention; Intensive care medicine; Machine learning; Internal medicine; Pathology","score_opus":0.031186707696556484,"score_gpt":0.2827005051054868,"score_spread":0.2515137974089303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922770581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92837477,0.00013493164,0.068771526,0.00009964276,0.00023708557,0.0019825762,0.00008974073,0.000004020169,0.00030568492],"genre_scores_gemma":[0.9783158,0.0000149400785,0.020887632,0.00016224671,0.00032387688,0.000037171616,0.00020478324,0.00002240412,0.000031150805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982273,0.00032826478,0.00076308235,0.0001730138,0.00021171499,0.0002966546],"domain_scores_gemma":[0.9982447,0.00007841807,0.00046394006,0.00021939198,0.0007084042,0.00028515764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013780553,0.00012614703,0.0009398061,0.00037386382,0.000039831044,0.000009295477,0.00007700502,0.00011598239,0.000011395587],"category_scores_gemma":[0.000162414,0.00010087502,0.0003363221,0.00023031898,0.000031806932,0.00007930638,0.000004143179,0.00024227319,5.574428e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022652956,0.00012755035,0.891046,0.00047494558,0.001417158,0.000022572589,0.00014861292,0.046899676,0.000051309984,0.000019544408,0.011691122,0.025448551],"study_design_scores_gemma":[0.33618194,0.022859685,0.48795918,0.0004007762,0.0012788894,0.00032977707,0.00045617012,0.005082161,0.00039108619,0.00021729688,0.14426768,0.0005753734],"about_ca_topic_score_codex":0.0035696784,"about_ca_topic_score_gemma":0.0019169055,"teacher_disagreement_score":0.4030868,"about_ca_system_score_codex":0.00036164766,"about_ca_system_score_gemma":0.0030033072,"threshold_uncertainty_score":0.53963095},"labels":[],"label_agreement":null},{"id":"W2923409000","doi":"10.1042/bsr20182096","title":"Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels","year":2019,"lang":"en","type":"article","venue":"Bioscience Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Jiangsu University","keywords":"Medicine; Internal medicine; Quartile; Myocardial infarction; Lipoprotein(a); Confounding; Logistic regression; Coronary artery disease; Lipoprotein; Incidence (geometry); Cholesterol; Gastroenterology; Cardiology; Confidence interval","score_opus":0.008698023524498336,"score_gpt":0.21933583733027556,"score_spread":0.21063781380577723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923409000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487805,0.000025821604,0.00015693832,0.000649127,0.00028528934,0.0036926644,0.000019887197,0.000103581064,0.00018865088],"genre_scores_gemma":[0.99860686,0.00000374241,0.0001035549,0.00063611363,0.000120289864,0.00011541008,0.000032033655,0.00004228357,0.00033969578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99547327,0.00018920192,0.0005599778,0.0008917408,0.002114666,0.00077117543],"domain_scores_gemma":[0.997263,0.000022504308,0.0006711154,0.0012473569,0.0005412298,0.0002548022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001971776,0.00036941396,0.00070055615,0.00019981185,0.000255599,0.000098520926,0.00017948092,0.00022766396,0.00003200922],"category_scores_gemma":[0.00020392546,0.00021874401,0.00020462302,0.0013006259,0.0002403164,0.0004698393,0.000105758285,0.00055616314,0.000018787898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048773165,0.00045019478,0.981085,0.00008525625,0.00041887857,0.0004788422,0.00029641812,0.00006550066,0.0058065676,0.0000037669686,0.00004303394,0.010778786],"study_design_scores_gemma":[0.00272604,0.00091303076,0.9884191,0.00054047606,0.00013502539,0.00024630423,0.000074876465,0.00003493118,0.0063893115,0.0000051342713,0.00019256718,0.00032316515],"about_ca_topic_score_codex":0.0016043772,"about_ca_topic_score_gemma":0.0006377102,"teacher_disagreement_score":0.0104556205,"about_ca_system_score_codex":0.00040520978,"about_ca_system_score_gemma":0.0006185882,"threshold_uncertainty_score":0.89201224},"labels":[],"label_agreement":null},{"id":"W2923799102","doi":"10.1016/j.ihj.2019.03.004","title":"Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction","year":2019,"lang":"en","type":"review","venue":"Indian Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Lipoprotein(a); Internal medicine; Myocardial infarction; Coronary artery disease; Lipoprotein; Cardiology; Risk factor; Population; Biomarker; Fibrinolysis; Cholesterol; Genetics","score_opus":0.054279360802173604,"score_gpt":0.3352967579732662,"score_spread":0.2810173971710926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923799102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005161696,0.98838365,0.00032386158,0.00009600132,0.00088117545,0.0046223393,0.0004857582,0.000035755886,0.000009737271],"genre_scores_gemma":[0.00082623074,0.9919711,0.0010533797,0.00016956517,0.0053895717,0.00021994713,0.000116735384,0.00016200656,0.00009147372],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962111,0.00046272832,0.0007952065,0.00080639566,0.0010383745,0.00068620325],"domain_scores_gemma":[0.9967755,0.00005187562,0.00026713332,0.0009951129,0.00020341283,0.0017069483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001149616,0.00062272715,0.002936905,0.00047636314,0.00039036194,0.00028678786,0.00013288738,0.00060557685,0.00003579385],"category_scores_gemma":[0.00009927669,0.000497089,0.002920368,0.00016530266,0.0000999145,0.00025612398,0.00009186226,0.001286809,0.000019757264],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009681033,0.000041424322,0.0002924387,0.009813181,0.00949998,0.00042823656,0.00010785291,0.000001281323,0.0000011656916,0.0000038104527,0.00013351876,0.9795803],"study_design_scores_gemma":[0.0020716898,0.00077088206,0.009033265,0.0035671918,0.015017936,0.020778265,0.000022485505,0.0000063335387,6.9741156e-7,0.00003968563,0.94815123,0.0005403275],"about_ca_topic_score_codex":0.00015715431,"about_ca_topic_score_gemma":0.0000068675586,"teacher_disagreement_score":0.97903997,"about_ca_system_score_codex":0.000248124,"about_ca_system_score_gemma":0.0017075293,"threshold_uncertainty_score":0.99974805},"labels":[],"label_agreement":null},{"id":"W2928534885","doi":"10.1161/jaha.118.011662","title":"Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance","year":2019,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":433,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; University of British Columbia","funders":"Ionis Pharmaceuticals; Abbott Vascular; Regeneron Pharmaceuticals; Novo Nordisk; Valeant Pharmaceuticals International; Sanofi; Servier; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Esperion Therapeutics; GlaxoSmithKline","keywords":"Medicine; Internal medicine; Endocrinology; Placebo; Statin; Cholesterol; Apolipoprotein B; Adverse effect; Lipoprotein; Gastroenterology","score_opus":0.003975081270474817,"score_gpt":0.2322927632510741,"score_spread":0.22831768198059926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2928534885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987265,0.00012547802,0.000008265029,0.00082344963,0.000036076744,0.00026009866,0.0000022926154,0.0000013354893,0.000016543077],"genre_scores_gemma":[0.9990137,0.00007716722,0.0005090144,0.0003407829,0.00003539042,6.449164e-7,4.5912756e-7,0.000006488445,0.000016330943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903786,0.0001509535,0.00025945003,0.00006559212,0.00039336312,0.000092766735],"domain_scores_gemma":[0.99923307,0.00006425694,0.00040863323,0.00011284861,0.0001359651,0.000045228135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007231519,0.000054565386,0.000435199,0.000050171893,0.000019138979,0.000005898047,0.000028723836,0.000021274202,0.0000016446367],"category_scores_gemma":[0.0001338085,0.000033200595,0.000055384073,0.00015414965,0.000031578253,0.0000681333,0.00001567923,0.00019074058,4.3721982e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006514669,0.00005234278,0.9881962,0.000028354856,0.00006654388,2.8321986e-7,0.00030297457,0.000011199038,0.0006157006,9.002022e-7,0.000019395546,0.010054644],"study_design_scores_gemma":[0.003850693,0.0008476445,0.9945011,0.00019746559,0.00004809858,0.000008575518,0.00009128723,0.000009932494,0.00016850168,0.000004555701,0.0002395227,0.000032590615],"about_ca_topic_score_codex":0.00008436553,"about_ca_topic_score_gemma":0.000009873599,"teacher_disagreement_score":0.0100220535,"about_ca_system_score_codex":0.00015080295,"about_ca_system_score_gemma":0.000070531016,"threshold_uncertainty_score":0.1353881},"labels":[],"label_agreement":null},{"id":"W2930347059","doi":"10.1161/hcq.12.suppl_1.146","title":"Abstract 146: Evolving Clinical Benefits and Social Value of Lipid Lowering Therapies","year":2019,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MacEwan University","funders":"","keywords":"Ezetimibe; Medicine; Hazard ratio; Internal medicine; Disease; Statin; Clinical trial; Confidence interval","score_opus":0.06660098397471204,"score_gpt":0.3460761899994953,"score_spread":0.27947520602478326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930347059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982491,0.015169187,0.00051593815,0.00044369666,0.00029178985,0.0005961021,0.000008957433,0.000049213275,0.00043412313],"genre_scores_gemma":[0.9981237,0.00093194953,0.00023101318,0.0003061103,0.0003433492,0.000007807827,0.000016719254,0.000026028325,0.000013330437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975975,0.0002411765,0.0007522169,0.00044190823,0.00073588674,0.0002313101],"domain_scores_gemma":[0.99879056,0.00017708456,0.00017337556,0.0005707207,0.00017348134,0.0001147517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00412059,0.00020087707,0.0013020951,0.00008845027,0.00013434426,0.000035540834,0.00005612171,0.00023131835,0.000037387683],"category_scores_gemma":[0.00017993724,0.00017346209,0.0014701113,0.00010980144,0.000117850446,0.00017048961,0.000058856025,0.00023981014,0.0000069605644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003845371,0.000051192317,0.87716055,0.0010470365,0.002747339,0.0000030310832,0.00056541554,0.000119515025,0.00016409492,0.0017157434,0.0000038415687,0.11638381],"study_design_scores_gemma":[0.0023210153,0.000037124693,0.9952609,0.0001010513,0.00034226058,0.000022349019,0.00034046968,0.0000735653,0.00006597312,0.00008924387,0.0011547655,0.00019127317],"about_ca_topic_score_codex":0.0002030249,"about_ca_topic_score_gemma":0.0000029074909,"teacher_disagreement_score":0.11810039,"about_ca_system_score_codex":0.000037456022,"about_ca_system_score_gemma":0.000074512565,"threshold_uncertainty_score":0.7073579},"labels":[],"label_agreement":null},{"id":"W2931042525","doi":"10.1016/s1957-2557(19)30042-2","title":"Au-delà du risque cardiovasculaire : le rôle des lipoprotéines contenant l’apoB athérogènes dans l’étiologie du diabète de type 2","year":2019,"lang":"fr","type":"article","venue":"Médecine des Maladies Métaboliques","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Apolipoprotein B; Internal medicine; Cholesterol","score_opus":0.015864295389757192,"score_gpt":0.2535248730516939,"score_spread":0.2376605776619367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2931042525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7555656,0.22459386,0.0016028268,0.0022624491,0.0030943495,0.0020512748,0.00011697299,0.00044066852,0.010271982],"genre_scores_gemma":[0.867021,0.11012551,0.0017677216,0.0003189847,0.007632448,0.0003017432,0.00010195219,0.0002635924,0.01246702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99243855,0.0012546093,0.0012436371,0.0013746354,0.0008961357,0.0027924322],"domain_scores_gemma":[0.99500686,0.00031279196,0.0003435562,0.0020985221,0.0012730486,0.00096524786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037665893,0.0011960424,0.0027884045,0.0003311076,0.0009117148,0.00016302797,0.0007014151,0.0007835559,0.0003739639],"category_scores_gemma":[0.0014481402,0.0010098389,0.0017269017,0.00090109947,0.0018526434,0.0008519913,0.0004971449,0.00086407195,0.0003897187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074736023,0.0009255294,0.8379817,0.0055964272,0.0036559163,0.00079247967,0.0045905416,0.00082007487,0.0055149384,0.014003783,0.0017865659,0.12358466],"study_design_scores_gemma":[0.0082358075,0.0025148997,0.6903462,0.005365757,0.0020894525,0.002104744,0.011220206,0.0011876246,0.017571852,0.0043411353,0.25320038,0.0018219645],"about_ca_topic_score_codex":0.02551357,"about_ca_topic_score_gemma":0.003304926,"teacher_disagreement_score":0.2514138,"about_ca_system_score_codex":0.0016373195,"about_ca_system_score_gemma":0.0018591845,"threshold_uncertainty_score":0.9992352},"labels":[],"label_agreement":null},{"id":"W2932576832","doi":"10.1186/s12882-019-1280-7","title":"Statin use and the risk of acute kidney injury in older adults","year":2019,"lang":"en","type":"article","venue":"BMC Nephrology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Nephrology; Internal medicine; Acute kidney injury; Statin; Kidney disease; Emergency medicine; Intensive care medicine","score_opus":0.006647716604443553,"score_gpt":0.2431301978592487,"score_spread":0.23648248125480514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2932576832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997851,0.00022189681,0.00010676269,0.0005322559,0.000076069904,0.0010489433,0.000042487056,0.000009463909,0.00011108549],"genre_scores_gemma":[0.9951969,0.00062560133,0.00092199654,0.0029945157,0.00006052968,0.000036489095,0.000013286961,0.000011672759,0.00013901891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989675,0.00032076015,0.00021836907,0.0001827412,0.00013272601,0.00017790416],"domain_scores_gemma":[0.99925673,0.00010286386,0.00008595447,0.00043070765,0.00004537523,0.00007835799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068540825,0.00008273802,0.00039758408,0.00006663099,0.000016373162,0.0000037874347,0.0000483271,0.000094690135,0.00007378678],"category_scores_gemma":[0.0001599327,0.0000494443,0.000102046455,0.000106098465,0.00011927728,0.00004071673,0.00004755581,0.00019460711,0.0000163022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009228408,0.00012676872,0.97360635,0.00036794943,0.0005767708,0.00001767736,0.001617253,0.0000025133972,0.00055704673,0.0012341464,0.0023572932,0.010307838],"study_design_scores_gemma":[0.012523692,0.0003297054,0.9807265,0.00005105685,0.00022511455,0.00004793975,0.00006904763,0.00033767233,0.00020082094,0.00012760251,0.0053025153,0.000058363632],"about_ca_topic_score_codex":0.0018711439,"about_ca_topic_score_gemma":0.000068983616,"teacher_disagreement_score":0.010249474,"about_ca_system_score_codex":0.000011839338,"about_ca_system_score_gemma":0.00012959992,"threshold_uncertainty_score":0.28286225},"labels":[],"label_agreement":null},{"id":"W2935776145","doi":"","title":"The Canadian activase for stroke effectiveness study","year":2000,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stroke (engine)","score_opus":0.013814138132152614,"score_gpt":0.28388732949974477,"score_spread":0.27007319136759217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2935776145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856408,0.000351732,0.000042016898,0.00049955805,0.0001753553,0.0029998112,0.000076566255,0.00003277293,0.010181351],"genre_scores_gemma":[0.99370587,0.000027958433,0.00005037828,0.00014889774,0.0003848541,0.0003880971,0.000008477355,0.000022592234,0.0052628564],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988422,0.00012178908,0.000125708,0.00021710715,0.0002966535,0.00039655663],"domain_scores_gemma":[0.9989785,0.00010053695,0.000018047313,0.00053156307,0.000076365424,0.00029497588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009390049,0.00011416023,0.0002377872,0.000044597586,0.00058967894,0.000041097774,0.000092136834,0.00005838212,0.00009073567],"category_scores_gemma":[0.00006303782,0.00007371682,0.00021980255,0.0000748622,0.00003747902,0.00003298947,0.0000073018873,0.0001664441,0.000036341193],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001404017,0.00033833724,0.03184022,0.00014822008,0.0012208906,0.00010134511,0.00041790833,0.000021843012,0.0004594276,0.0003034879,0.00089911185,0.9628452],"study_design_scores_gemma":[0.007706182,0.0021999262,0.5322047,0.000051086285,0.0003813291,0.00005369699,0.00093748077,0.00006251968,0.0025824432,0.00006207628,0.4535251,0.00023348392],"about_ca_topic_score_codex":0.09267227,"about_ca_topic_score_gemma":0.18719049,"teacher_disagreement_score":0.96261173,"about_ca_system_score_codex":0.00023277782,"about_ca_system_score_gemma":0.00053354335,"threshold_uncertainty_score":0.9133697},"labels":[],"label_agreement":null},{"id":"W2935850363","doi":"10.2337/db18-0999","title":"Statins Promote Interleukin-1β–Dependent Adipocyte Insulin Resistance Through Lower Prenylation, Not Cholesterol","year":2019,"lang":"en","type":"article","venue":"Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University; Population Health Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Insulin resistance; Internal medicine; Adipose tissue; Atorvastatin; Endocrinology; Inflammasome; Statin; Lipogenesis; Adipocyte; Insulin; Insulin receptor; Biology; Medicine; Inflammation","score_opus":0.010801086900487774,"score_gpt":0.2474916561446704,"score_spread":0.2366905692441826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2935850363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99149287,0.0014589524,0.0001338546,0.00079459266,0.0004189133,0.0013542231,0.000033171356,0.00011527799,0.0041981703],"genre_scores_gemma":[0.9923581,0.00009627687,0.0012006953,0.0015941212,0.00029040664,0.00009288313,0.000059265,0.0000522572,0.004256002],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979504,0.00008773224,0.0004059601,0.000482806,0.0006251092,0.00044798982],"domain_scores_gemma":[0.9986118,0.000037261507,0.00013781253,0.00089104293,0.00017939133,0.00014270861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046864388,0.00022717057,0.00048900116,0.00006329884,0.00006814996,0.000050221603,0.00014288584,0.0001233818,0.0002792521],"category_scores_gemma":[0.000090999994,0.00019092219,0.00020665632,0.00017728971,0.000046290177,0.00024235323,0.000062013954,0.00029743268,0.00044415996],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035091562,0.0042626495,0.3879258,0.0152732115,0.0064681186,0.00034351263,0.024351042,0.00027830835,0.24897838,0.0047213673,0.010296142,0.2935923],"study_design_scores_gemma":[0.011397301,0.0017438527,0.33389252,0.0022119018,0.00043993385,0.000016606973,0.00025544723,0.0003650378,0.43924075,0.0008750837,0.2085374,0.0010241832],"about_ca_topic_score_codex":0.000050205774,"about_ca_topic_score_gemma":0.000036383673,"teacher_disagreement_score":0.29256812,"about_ca_system_score_codex":0.0001385084,"about_ca_system_score_gemma":0.00013426311,"threshold_uncertainty_score":0.7785581},"labels":[],"label_agreement":null},{"id":"W2936127254","doi":"10.1016/j.jacl.2019.04.005","title":"PCSK9 inhibition in patients with and without prior myocardial infarction or ischemic stroke: A pooled analysis of nine randomized-controlled studies of alirocumab","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi Pasteur; Manitoba Beekeepers' Association; Regeneron Pharmaceuticals","keywords":"Medicine; Alirocumab; Internal medicine; Myocardial infarction; Cardiology; PCSK9; Stroke (engine); Randomized controlled trial; Ischemic stroke; Ischemia; Cholesterol","score_opus":0.023303845832343253,"score_gpt":0.35291366836183347,"score_spread":0.3296098225294902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936127254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969803,0.0008657194,0.00009290682,0.00034256553,0.0004753265,0.0011242501,0.0000049403297,0.0000030487906,0.00011095376],"genre_scores_gemma":[0.9977452,0.00076888874,0.0006335359,0.00024461423,0.0005141024,0.000011763711,0.0000049594873,0.000010791078,0.00006612599],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952448,0.0010328429,0.0028168936,0.00019305578,0.00055382145,0.00015857947],"domain_scores_gemma":[0.99525505,0.0012727402,0.0022739714,0.00023464317,0.0008566304,0.00010693466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006884667,0.00015158414,0.006236043,0.0005390712,0.000014329134,0.0000030942851,0.00004002858,0.00020369976,0.00004884818],"category_scores_gemma":[0.0047429353,0.00007982096,0.0011813993,0.00034374572,0.00025221152,0.000096251846,0.00003012131,0.0004326132,5.8745553e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44311926,0.00037600685,0.5324131,0.00012649056,0.020453956,0.000002201714,0.00012592823,0.0000807233,0.00018883256,0.0000068885615,0.000036331436,0.0030702483],"study_design_scores_gemma":[0.5215142,0.0042784023,0.45891365,0.00029501758,0.014383297,0.000026754573,0.00015563946,0.00015070589,0.0000847609,0.000011021057,0.000110787834,0.000075810705],"about_ca_topic_score_codex":0.000036087047,"about_ca_topic_score_gemma":0.000031663378,"teacher_disagreement_score":0.078394905,"about_ca_system_score_codex":0.000036659352,"about_ca_system_score_gemma":0.0002703316,"threshold_uncertainty_score":0.5678079},"labels":[],"label_agreement":null},{"id":"W2936465592","doi":"10.1016/j.rec.2018.11.018","title":"Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 Inhibitors","year":2019,"lang":"es","type":"letter","venue":"Revista Española de Cardiología (English Edition)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Réseau Provincial de Recherche en Adaptation-Réadaptation","keywords":"PCSK9; Coronary heart disease; Medicine; Internal medicine; Cardiology; Cholesterol; LDL receptor","score_opus":0.008821512612675006,"score_gpt":0.23688037029872314,"score_spread":0.22805885768604814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2936465592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89806217,0.018921517,0.001184401,0.009022828,0.008046306,0.02127548,0.042236466,0.000519562,0.0007312982],"genre_scores_gemma":[0.88948274,0.0012305351,0.00080187066,0.021619374,0.02824865,0.0013953075,0.055985916,0.00054780015,0.0006878309],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99307644,0.0008505571,0.0013879238,0.0015352225,0.0015781673,0.0015716917],"domain_scores_gemma":[0.99355286,0.00065338466,0.0008124035,0.0021339008,0.002161922,0.0006855465],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015128145,0.0011828564,0.003489074,0.00040244783,0.00033466777,0.00017826633,0.000427181,0.001074464,0.00022566886],"category_scores_gemma":[0.0011523471,0.0009953519,0.0016812228,0.00037948383,0.00049631984,0.00032826237,0.00017210326,0.0015642147,0.00005965894],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019377449,0.00024823053,0.48494297,0.013742134,0.0017063,0.00016990521,0.000090984984,0.000142518,0.000022317312,0.00006461643,0.496445,0.00048727554],"study_design_scores_gemma":[0.0049692267,0.0011612638,0.39659628,0.004936956,0.0034211383,0.000025917037,0.00009784338,0.000052119158,0.000050316645,0.0000121439825,0.5877737,0.0009030782],"about_ca_topic_score_codex":0.00014021312,"about_ca_topic_score_gemma":0.0000016406954,"teacher_disagreement_score":0.0913287,"about_ca_system_score_codex":0.0010909181,"about_ca_system_score_gemma":0.001943591,"threshold_uncertainty_score":0.9992497},"labels":[],"label_agreement":null},{"id":"W2937077063","doi":"10.1016/j.cjco.2019.03.004","title":"Lipoprotein(a), Oxidized Phospholipids, and Aortic Valve Microcalcification Assessed by 18F-Sodium Fluoride Positron Emission Tomography and Computed Tomography","year":2019,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec; McGill University Health Centre; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; University of California, San Diego; National Institutes of Health; British Heart Foundation; Ionis Pharmaceuticals; Sanofi; Amgen; Pfizer; Heart and Stroke Foundation of Canada","keywords":"Positron emission tomography; Positron Emission Tomography-Computed Tomography; Microcalcification; Sodium fluoride; Tomography; Computed tomography; Nuclear medicine; Medicine; Radiology; Fluoride; Internal medicine; Chemistry; Mammography; Inorganic chemistry; Breast cancer","score_opus":0.008018082417062995,"score_gpt":0.2594890524656671,"score_spread":0.25147097004860414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937077063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851692,0.008292543,0.00051313185,0.0007205263,0.00021794335,0.003828882,0.000020858957,0.00010041384,0.0011365568],"genre_scores_gemma":[0.99455214,0.00056416244,0.0032740345,0.00068965135,0.0001431214,0.00012800646,0.00021225141,0.000054375458,0.00038224575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977675,0.00014592758,0.00044142062,0.0007649919,0.0004513405,0.00042879384],"domain_scores_gemma":[0.99832606,0.00004728097,0.00017738908,0.0008538703,0.00015783226,0.0004375674],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008300065,0.00031742567,0.000857347,0.00017602411,0.00019644409,0.0002236374,0.00025423552,0.00018207473,0.000056976474],"category_scores_gemma":[0.000031727006,0.0002702414,0.0002743241,0.00053191365,0.000093268376,0.00028259202,0.00025429003,0.00030554974,0.00001991325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014692601,0.0005957854,0.053479567,0.0011338143,0.0010564872,0.000017584884,0.00039131168,6.583911e-7,0.85822797,0.00016670888,0.008058376,0.07540249],"study_design_scores_gemma":[0.020779204,0.0017906949,0.4540467,0.0012952081,0.0009851385,0.00034319097,0.00043416422,0.00068740867,0.4550007,0.00038901213,0.06300419,0.001244395],"about_ca_topic_score_codex":0.0014705439,"about_ca_topic_score_gemma":0.0000058386354,"teacher_disagreement_score":0.40322727,"about_ca_system_score_codex":0.00005118051,"about_ca_system_score_gemma":0.00011572892,"threshold_uncertainty_score":0.99997497},"labels":[],"label_agreement":null},{"id":"W2938132638","doi":"10.1097/mol.0000000000000484","title":"The ever-expanding saga of the proprotein convertases and their roles in body homeostasis: emphasis on novel proprotein convertase subtilisin kexin number 9 functions and regulation","year":2018,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Proprotein convertase; Kexin; LDL receptor; Proprotein Convertases; Downregulation and upregulation; microRNA; Biology; Endocrinology; Lipoprotein; Cholesterol; Gene; Genetics","score_opus":0.08369572057341579,"score_gpt":0.36321984035364235,"score_spread":0.27952411978022657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938132638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003860118,0.9833747,0.00010649526,0.00038791494,0.005887999,0.00613568,0.000192396,0.00002574402,0.000028913628],"genre_scores_gemma":[0.006482797,0.9894409,0.00002500877,0.000026597167,0.002504979,0.0011870748,0.00019006635,0.00006170458,0.00008084951],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962901,0.00096078374,0.0011455705,0.0007536418,0.00038045642,0.00046948835],"domain_scores_gemma":[0.99781716,0.0003814499,0.00060995633,0.0009433369,0.00012574336,0.00012235617],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017034003,0.0005369013,0.0017422069,0.00029689085,0.00024400132,0.00003642467,0.00021402402,0.00045323608,0.000030821906],"category_scores_gemma":[0.00052631914,0.000283921,0.00037451566,0.000539053,0.0006753266,0.00008774194,0.00020686266,0.0008099548,0.000008551427],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002664758,0.00037483964,0.0015332457,0.016277181,0.00023721806,1.9653524e-7,0.00031154044,5.892657e-7,0.000011558397,0.0005257082,0.0009870622,0.97947437],"study_design_scores_gemma":[0.0025603482,0.000436419,0.004422733,0.025859559,0.0003461793,0.0001949574,0.00031623404,0.000048812435,0.000069932496,0.00013725089,0.9652307,0.00037688733],"about_ca_topic_score_codex":0.00021118196,"about_ca_topic_score_gemma":0.00010828283,"teacher_disagreement_score":0.9790975,"about_ca_system_score_codex":0.0001972252,"about_ca_system_score_gemma":0.00060595205,"threshold_uncertainty_score":0.9999613},"labels":[],"label_agreement":null},{"id":"W2938505737","doi":"10.1161/circ.132.suppl_3.10426","title":"Abstract 10426: One Year Impact of the 2013 Cholesterol Guidelines on Patterns of Lipid Lowering Treatment","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Guideline; Internal medicine; Diabetes mellitus; Discontinuation; Atherosclerotic cardiovascular disease; Coronary artery disease; Canadian Cardiovascular Society; Disease; Physical therapy; Cardiology; Myocardial infarction; Angina; Endocrinology","score_opus":0.08503895086567576,"score_gpt":0.33632547212158115,"score_spread":0.2512865212559054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2938505737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985224,0.00011644071,0.00018763119,0.000280713,0.00010964578,0.00041235608,0.000010381232,0.0000107206415,0.00034968756],"genre_scores_gemma":[0.9994936,0.000049573162,0.00003819076,0.000030675994,0.00033184327,0.0000072745197,0.000014535119,0.000012465721,0.000021821937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919504,0.000018678236,0.00026319956,0.00010755532,0.0003242483,0.000091269794],"domain_scores_gemma":[0.9991866,0.0000067468163,0.0001307962,0.00042591317,0.00018020828,0.00006977349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023489422,0.000080480386,0.00022125724,0.00004163755,0.000015007918,0.000003893865,0.0000370916,0.000051394556,0.000030223608],"category_scores_gemma":[0.000041335457,0.00004941907,0.00025519566,0.00006342519,0.000011228016,0.000037327234,0.00000922968,0.000045973036,0.000009703671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015180581,0.00042662417,0.90943426,0.00021868554,0.0004419337,0.0000015531851,0.0005966295,0.010738478,0.014810429,0.000019694908,0.00023185035,0.06292808],"study_design_scores_gemma":[0.0013296867,0.00022122139,0.9927234,0.00023723296,0.000062093946,0.0000040256577,0.00003330271,0.00018275526,0.00496103,0.000011296285,0.00019313906,0.000040799336],"about_ca_topic_score_codex":0.0018761201,"about_ca_topic_score_gemma":0.000021584769,"teacher_disagreement_score":0.083289176,"about_ca_system_score_codex":0.00018124263,"about_ca_system_score_gemma":0.00011621085,"threshold_uncertainty_score":0.2836145},"labels":[],"label_agreement":null},{"id":"W2939813637","doi":"10.14740/cr857","title":"Atherosclerotic Coronary Artery Disease in Patients With Cardiometabolic Syndrome","year":2019,"lang":"en","type":"review","venue":"Cardiology Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Fukuoka University","keywords":"Medicine; Cardiology; Internal medicine; Coronary artery disease; Disease","score_opus":0.10467843294429767,"score_gpt":0.37789362479058997,"score_spread":0.2732151918462923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939813637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02525276,0.96636987,0.0000059600825,0.00002513611,0.00030949299,0.007221896,0.00011668373,0.000043971042,0.00065425626],"genre_scores_gemma":[0.021105424,0.97597665,0.000018691853,0.00003410095,0.00041885852,0.001073388,0.00063331623,0.00017503068,0.000564515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99273926,0.0025324363,0.0006559777,0.0012125596,0.0015194138,0.0013403395],"domain_scores_gemma":[0.996025,0.00030514805,0.00010642801,0.002533358,0.00038964115,0.00064039225],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0028219558,0.000560676,0.0063546444,0.0012873526,0.000111502406,0.000026874928,0.00041690667,0.00063688814,0.000039146064],"category_scores_gemma":[0.0002775271,0.0003814413,0.0013867758,0.0014204101,0.00044222863,0.00007086697,0.0003133821,0.0023268647,0.0007806469],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000406619,0.00021115979,0.1382695,0.04137197,0.0039555356,0.005687077,0.000021527501,0.000010355153,3.2122493e-8,0.000031759195,0.00036012975,0.8096743],"study_design_scores_gemma":[0.0022376592,0.00079282804,0.41651532,0.008752762,0.0016141711,0.00079837086,0.000009664281,7.5746595e-7,5.462945e-9,0.000007037527,0.5689006,0.00037087253],"about_ca_topic_score_codex":0.00003690509,"about_ca_topic_score_gemma":0.000001355071,"teacher_disagreement_score":0.80930346,"about_ca_system_score_codex":0.0006397785,"about_ca_system_score_gemma":0.0024489006,"threshold_uncertainty_score":0.9999974},"labels":[],"label_agreement":null},{"id":"W2941018557","doi":"10.1016/j.jacl.2019.04.006","title":"LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal; Montreal Clinical Research Institute","funders":"Amgen Canada; Institut de Recherche Clinique De Montréal; Fondation Leducq","keywords":"Medicine; Familial hypercholesterolemia; Lipoprotein(a); Internal medicine; Odds ratio; Risk factor; Apolipoprotein B; Confidence interval; Population; Genotype; Cohort; Genotyping; Disease; Gastroenterology; Endocrinology; Cholesterol; Genetics; Gene; Biology","score_opus":0.03779753070997961,"score_gpt":0.33029809264641413,"score_spread":0.29250056193643453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941018557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992383,0.0032982598,0.00006969958,0.0014777717,0.0018922214,0.0004777147,0.0000072498538,0.000012318463,0.00038174473],"genre_scores_gemma":[0.99220335,0.00074478734,0.00041587473,0.002857616,0.0034414937,0.0000038676817,0.000006934586,0.00003384128,0.0002922189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962645,0.00081356213,0.0013393344,0.00033928358,0.00087796204,0.0003653507],"domain_scores_gemma":[0.9975798,0.00033033144,0.00045509427,0.0007408268,0.0004008783,0.00049306126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047474336,0.00019380833,0.0019402185,0.00014597306,0.000023569557,0.000010891283,0.00018744287,0.00043908297,0.000101155725],"category_scores_gemma":[0.001627016,0.0001275577,0.0014374076,0.00023523967,0.00010688238,0.00010212396,0.000049470094,0.0015032804,0.000046849127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067747897,0.00076514215,0.96109974,0.00021584566,0.0039466424,0.00069590413,0.0001561104,0.00046472115,0.00007098046,0.000030551688,0.0011412384,0.024638355],"study_design_scores_gemma":[0.011742105,0.0024219584,0.94656974,0.0004944502,0.0010163811,0.00033958425,0.000036631427,0.00007623486,0.000010684179,0.00010500132,0.037031405,0.00015583717],"about_ca_topic_score_codex":0.00003517813,"about_ca_topic_score_gemma":0.000013773054,"teacher_disagreement_score":0.035890166,"about_ca_system_score_codex":0.000095021795,"about_ca_system_score_gemma":0.0008621559,"threshold_uncertainty_score":0.6531089},"labels":[],"label_agreement":null},{"id":"W2942138886","doi":"10.1016/j.cjca.2019.03.017","title":"Low Rates of Identification and Treatment of Familial Hypercholesterolemia in France and Elsewhere: A Call for Universal Screening","year":2019,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Identification (biology); Internal medicine; Cholesterol","score_opus":0.019658906538725436,"score_gpt":0.25340265305171755,"score_spread":0.23374374651299212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942138886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9540067,0.010186217,0.0026541252,0.031239238,0.0004972324,0.0010594012,0.00025949097,0.0000015872206,0.000096021],"genre_scores_gemma":[0.9888428,0.0018390147,0.00046267954,0.005668818,0.0027430293,0.000010860326,0.00007417792,0.00003763714,0.0003209853],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99891376,0.00013754494,0.00045080736,0.00016852209,0.000113837625,0.00021549895],"domain_scores_gemma":[0.9990611,0.000087557935,0.0002938576,0.00020385308,0.00022290272,0.00013069213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036814096,0.00014012892,0.0011068012,0.0003520555,0.000019691679,0.00000536992,0.0000617099,0.00040731338,9.725989e-7],"category_scores_gemma":[0.00005619032,0.00012055877,0.00024621608,0.00005941994,0.00015533305,0.000037788675,0.0000045352986,0.0003174351,1.3408582e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011719005,0.000025143234,0.5071923,0.0060837064,0.0059928643,0.0027660346,0.0026064948,0.00092045823,0.0065062805,0.000026842798,0.09466701,0.37204096],"study_design_scores_gemma":[0.009304767,0.0027350872,0.3448321,0.0011124404,0.0009400718,0.0015265523,0.00027585475,0.000057224235,0.00056602247,0.000029077893,0.63837636,0.00024449307],"about_ca_topic_score_codex":0.0035206254,"about_ca_topic_score_gemma":0.000889223,"teacher_disagreement_score":0.54370934,"about_ca_system_score_codex":0.0001582401,"about_ca_system_score_gemma":0.0009753136,"threshold_uncertainty_score":0.5322156},"labels":[],"label_agreement":null},{"id":"W2942547854","doi":"10.1016/j.jacc.2019.01.070","title":"Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":318,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Western University; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"National Heart, Lung, and Blood Institute; University of California, San Diego; ZonMw; Amsterdam University Medical Centers; British Heart Foundation; Wellcome Trust","keywords":"Medicine; Interquartile range; Internal medicine; Calcification; Apolipoprotein B; Cardiology; Stenosis; Lipoprotein; Hazard ratio; Positron emission tomography; Confidence interval; Nuclear medicine; Cholesterol","score_opus":0.006221155355566742,"score_gpt":0.23236102730607056,"score_spread":0.2261398719505038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942547854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977731,0.0002615157,0.00007203807,0.00063451583,0.00014473661,0.0009212021,0.000012015423,0.0000033330548,0.00017754744],"genre_scores_gemma":[0.998701,0.00012970294,0.00084875233,0.0001391308,0.00011715601,0.0000087722165,8.6238424e-7,0.000017501547,0.000037116446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843884,0.0002663533,0.00048506452,0.00015739299,0.00045562824,0.00019672884],"domain_scores_gemma":[0.9983774,0.000041822637,0.0007062546,0.00044908168,0.00033194412,0.00009350914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007233733,0.00012544735,0.0011006068,0.00013783225,0.00002709407,0.0000027265194,0.00013397167,0.000052589414,0.0000038109479],"category_scores_gemma":[0.00010651634,0.00007181295,0.00035378573,0.0004171967,0.00021779847,0.000052414518,0.000045937835,0.0002719021,0.0000010969134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026715992,0.00009659111,0.9850157,0.00011953266,0.00081658503,0.000017246415,0.00006876936,0.00007860249,0.0018833056,0.00003424892,0.00009823194,0.009099589],"study_design_scores_gemma":[0.004423419,0.0026661996,0.9902958,0.00016281301,0.00026288154,0.00015713731,0.00018438125,0.000014257047,0.0009818417,0.000033435863,0.0007371498,0.000080634716],"about_ca_topic_score_codex":0.00007614838,"about_ca_topic_score_gemma":0.0000021636604,"teacher_disagreement_score":0.009018954,"about_ca_system_score_codex":0.00011330086,"about_ca_system_score_gemma":0.00024144823,"threshold_uncertainty_score":0.2928447},"labels":[],"label_agreement":null},{"id":"W2942748655","doi":"10.1016/j.ihj.2019.04.007","title":"Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians","year":2019,"lang":"en","type":"review","venue":"Indian Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Coronary artery disease; Diabetes mellitus; Risk factor; Internal medicine; Lipoprotein(a); Myocardial infarction; Cardiology; Disease; Lipoprotein; Cholesterol; Endocrinology","score_opus":0.06490221456769679,"score_gpt":0.34142521810029436,"score_spread":0.27652300353259757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942748655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014182308,0.97551244,0.00021386387,0.00009625085,0.0013642124,0.007474794,0.0010832265,0.00004441084,0.000028490409],"genre_scores_gemma":[0.008678462,0.98567873,0.0015144914,0.0001895012,0.0029028596,0.00041050752,0.00019409944,0.00025299343,0.00017836734],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99417925,0.0013950593,0.0015960549,0.0008290531,0.00087897445,0.001121602],"domain_scores_gemma":[0.99612296,0.0002238235,0.00068922335,0.0011459265,0.0001553198,0.0016627703],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019247392,0.0007589225,0.0032835149,0.0009227258,0.00033315108,0.00017766429,0.0003209288,0.0006655845,0.00033203184],"category_scores_gemma":[0.00034401962,0.0005936134,0.002413721,0.00036472414,0.00008058657,0.00021246084,0.000056682395,0.0023405394,0.00018981857],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002385277,0.00024136601,0.0045862254,0.0144158285,0.00066781865,0.0020825672,0.00031879265,0.0000023923426,6.5409233e-7,8.828215e-7,0.0000939119,0.977351],"study_design_scores_gemma":[0.0082559595,0.0024696481,0.1774514,0.049748883,0.0056185015,0.05310072,0.0002303474,0.000036364552,0.0000012886809,0.00029420145,0.7009018,0.0018908839],"about_ca_topic_score_codex":0.00024721446,"about_ca_topic_score_gemma":0.00027243965,"teacher_disagreement_score":0.9754602,"about_ca_system_score_codex":0.00073055236,"about_ca_system_score_gemma":0.004558743,"threshold_uncertainty_score":0.9999611},"labels":[],"label_agreement":null},{"id":"W2943816618","doi":"10.1161/atvb.36.suppl_1.546","title":"Abstract 546: Characterization of the I4399M Variant of Apolipoprotein(a): Implications for Altered Prothrombotic Properties of Lipoprotein(a)","year":2016,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Lipoprotein(a); Apolipoprotein B; Chemistry; Lipoprotein; Protease; Biochemistry; Molecular biology; Population; Fibrinogen; Glycoprotein; Fibrin; Biology; Medicine; Immunology; Enzyme; Cholesterol","score_opus":0.052940730812995475,"score_gpt":0.27707762457596474,"score_spread":0.22413689376296927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2943816618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912255,0.0001197842,0.0032279603,0.002040234,0.00011284976,0.003081143,0.00015622194,0.000017817412,0.000018489163],"genre_scores_gemma":[0.99755913,0.0011355832,0.0005423516,0.0000859647,0.000117793286,0.0005060826,0.000018074612,0.000031308675,0.0000036990127],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99830496,0.00011899507,0.0007473993,0.00037345698,0.00017257278,0.0002826183],"domain_scores_gemma":[0.99812156,0.000031573494,0.00050396443,0.0009313611,0.00032811018,0.00008344046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005806134,0.00021065178,0.0008551497,0.00009093138,0.00010936487,0.0000065613967,0.00017981819,0.00018905263,0.000021622294],"category_scores_gemma":[0.00011669283,0.00011219695,0.0005034599,0.00018122513,0.0004703369,0.00008647694,0.00009065593,0.000068996254,8.2013395e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019924637,0.00022851597,0.017341588,0.0008148559,0.0004704147,2.868027e-9,0.00014876972,1.256768e-7,0.9718323,0.001548077,0.0000034012498,0.007592049],"study_design_scores_gemma":[0.0013884279,0.0004608448,0.8029411,0.0007802201,0.00023105268,0.0000011508175,0.000021377107,0.0000054742422,0.19367065,0.00016490537,0.00022523447,0.00010959454],"about_ca_topic_score_codex":0.00029563776,"about_ca_topic_score_gemma":0.000021915244,"teacher_disagreement_score":0.78559947,"about_ca_system_score_codex":0.000029044293,"about_ca_system_score_gemma":0.00013129783,"threshold_uncertainty_score":0.45752588},"labels":[],"label_agreement":null},{"id":"W2945006463","doi":"10.1016/j.jacl.2019.04.010","title":"Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":504,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Statement (logic); Biomarker; Association (psychology); Clinical Practice; Lipoprotein(a); Internal medicine; Family medicine; Lipoprotein; Cholesterol; Biochemistry; Law; Epistemology","score_opus":0.1747784884710103,"score_gpt":0.44304946973812026,"score_spread":0.26827098126710996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945006463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618402,0.0004035909,0.00010161883,0.030503554,0.005968699,0.00082423276,0.000037820435,0.0000078397225,0.00031241888],"genre_scores_gemma":[0.9735431,0.00065484527,0.00863535,0.007046335,0.008753206,0.00001249568,0.000041627336,0.000036406676,0.0012766031],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9895459,0.0033943532,0.0044897804,0.00037269082,0.0018711676,0.00032613386],"domain_scores_gemma":[0.9822771,0.011408267,0.0036274397,0.0004963664,0.00195546,0.0002353959],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.043684006,0.00015952198,0.0014821491,0.00018451348,0.000069644455,0.000076029784,0.00026461118,0.00046660792,0.00040397907],"category_scores_gemma":[0.046616293,0.00010244723,0.0010064935,0.0003947642,0.00030663228,0.00037284562,0.00012283337,0.0013404263,0.00017685762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008447002,0.004411738,0.7547355,0.000091808026,0.0032731676,0.0000425813,0.0003229617,0.000059581664,0.0011025139,0.00021219115,0.14516766,0.08213327],"study_design_scores_gemma":[0.0048819897,0.0012717646,0.5271879,0.00018716528,0.00023549018,0.000052347656,0.000051041094,0.0003922988,0.000022956174,0.00018716784,0.46545082,0.000079034304],"about_ca_topic_score_codex":0.00020048593,"about_ca_topic_score_gemma":0.00005284622,"teacher_disagreement_score":0.32028317,"about_ca_system_score_codex":0.00023129712,"about_ca_system_score_gemma":0.0019816326,"threshold_uncertainty_score":0.9847286},"labels":[],"label_agreement":null},{"id":"W2945048855","doi":"10.1016/j.jacl.2019.05.006","title":"Low LDL cholesterol—Friend or foe?","year":2019,"lang":"en","type":"letter","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Apolipoprotein B; Ldl cholesterol; Cholesterol; Internal medicine; Endocrinology","score_opus":0.10073003751435704,"score_gpt":0.41376267884036505,"score_spread":0.313032641326008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945048855","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020303031,0.0011444007,0.0005000025,0.9355343,0.0391663,0.00085298374,0.000024562163,0.000030509149,0.0024438954],"genre_scores_gemma":[0.0016117997,0.0016999415,0.0010523363,0.7727543,0.21319556,0.000005671233,0.000033314176,0.000100967336,0.009546109],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926769,0.0012688508,0.0036698645,0.0005181885,0.0011904654,0.00067572953],"domain_scores_gemma":[0.993389,0.0019011138,0.0024781507,0.0012129646,0.00066706643,0.00035166705],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.005484125,0.00042492914,0.0045168535,0.00030198708,0.00004421834,0.000028908898,0.00050239405,0.0031592834,0.0008408063],"category_scores_gemma":[0.0040529696,0.00025881513,0.0029533175,0.00016226312,0.00027227268,0.00010122205,0.00012669642,0.009308199,0.0004122857],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013245872,0.00021393063,0.0017038325,0.0008353417,0.0013095604,0.0015400071,0.000021793201,0.00000118947,0.0000049437745,0.000003906167,0.9602768,0.0327641],"study_design_scores_gemma":[0.0062152413,0.0058718002,0.006110249,0.00077608915,0.0009982256,0.0077387,0.000013097945,0.0000037310826,0.000012146421,0.000063207466,0.9719618,0.00023568758],"about_ca_topic_score_codex":0.000013267822,"about_ca_topic_score_gemma":0.000005939817,"teacher_disagreement_score":0.17402926,"about_ca_system_score_codex":0.00009259933,"about_ca_system_score_gemma":0.0021475852,"threshold_uncertainty_score":0.9999864},"labels":[],"label_agreement":null},{"id":"W2946093159","doi":"10.1101/615898","title":"Long-Term Exposure to Elevated Lipoprotein(a) Levels, Parental Lifespan and Risk of Mortality","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Medical Research Council; Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Ionis Pharmaceuticals; Amgen; Pfizer; Cancer Research UK","keywords":"Medicine; Lipoprotein(a); Confidence interval; Odds ratio; Demography; Biobank; EPIC; Longevity; Lipoprotein; Internal medicine; Gerontology; Genetics; Biology; Cholesterol","score_opus":0.021101412562381048,"score_gpt":0.2546873503863628,"score_spread":0.23358593782398177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946093159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897584,0.0038417384,0.0009463461,0.00009645208,0.00076320895,0.0035743988,0.0007872809,0.00022561927,0.000006611199],"genre_scores_gemma":[0.99595296,0.0011340347,0.0015901197,0.00014928405,0.00074874714,0.00024712484,0.0000021460685,0.00016557146,0.000010001671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995721,0.0003044839,0.0009150623,0.0013457909,0.0010411966,0.00067247654],"domain_scores_gemma":[0.99497086,0.000035110057,0.00061985437,0.002921727,0.0006876713,0.0007647907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015863801,0.0007075893,0.0016218016,0.00031706996,0.000116767056,0.00008466674,0.00034817887,0.0007827933,0.000053854383],"category_scores_gemma":[0.00037867564,0.0006828549,0.000461082,0.00047304906,0.0001300276,0.000094334304,0.00065819424,0.0011547788,0.000042048938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016092631,0.00027457884,0.88263315,0.0037278847,0.0018457092,0.000110528745,0.000025047511,0.000029848654,0.11105975,0.000031739546,0.000048046175,0.00005280022],"study_design_scores_gemma":[0.001430461,0.00038005118,0.89081943,0.0013490644,0.0009618919,1.6754092e-7,0.0000038743906,0.000027448834,0.104217835,4.75555e-7,0.00023023874,0.000579086],"about_ca_topic_score_codex":0.0011440979,"about_ca_topic_score_gemma":0.000032120235,"teacher_disagreement_score":0.008186261,"about_ca_system_score_codex":0.0002635141,"about_ca_system_score_gemma":0.0010350052,"threshold_uncertainty_score":0.99956226},"labels":[],"label_agreement":null},{"id":"W2946105917","doi":"10.1093/eurheartj/ehz299","title":"Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"American Regent; Genentech; Esperion Therapeutics; Idorsia Pharmaceuticals; Duke Clinical Research Institute; Astellas Pharma; Eisai; Bayer HealthCare; Medicines Company; Regado Biosciences; Verily Life Sciences; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; St. Jude Medical; Flatiron Health; Green Lane Research and Educational Fund; Regeneron Pharmaceuticals; Abbott Vascular; Boston VA Research Institute; Boston Scientific Corporation; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; CSL Behring; Belvoir Media Group; Novo Nordisk; MyoKardia; Janssen Pharmaceuticals; Ablynx; Daiichi Sankyo Europe; Servier; Gilead Sciences; GlaxoSmithKline; Amgen; Pfizer; Sanofi; American Heart Association","keywords":"Medicine; Alirocumab; Myocardial infarction; Cardiology; Internal medicine; PCSK9; Intensive care medicine; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.01707089362362753,"score_gpt":0.26831057169922434,"score_spread":0.25123967807559683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946105917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916058,0.0011130425,0.000020709189,0.0007750729,0.0015069714,0.0005805728,0.000002399066,0.000011781618,0.0043836343],"genre_scores_gemma":[0.99654776,0.00014522206,0.00009361615,0.0009279362,0.0020796661,0.0000014142639,0.0000023921748,0.000025946749,0.00017606677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980276,0.00069666875,0.00036106055,0.00013406415,0.0006435417,0.00013702612],"domain_scores_gemma":[0.9989725,0.0002399734,0.00016761861,0.00041384887,0.0000971797,0.00010887789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006984467,0.000118552576,0.00050206063,0.000063707004,0.000073918774,0.000015931579,0.00010527016,0.00003765454,0.00008637957],"category_scores_gemma":[0.00021119845,0.00006531196,0.00051330595,0.00009954134,0.00004003601,0.000049950835,0.000036531128,0.0003955229,0.00013717354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13556954,0.0043716314,0.5235396,0.0018397756,0.020244954,0.0012276202,0.012447458,0.0005826964,0.09719404,0.0031528757,0.06651891,0.13331088],"study_design_scores_gemma":[0.028821511,0.0021645532,0.9143604,0.00031077187,0.00023061718,0.0001038237,0.00006103925,0.0000040445248,0.0028775223,0.00004646277,0.05092786,0.00009137941],"about_ca_topic_score_codex":0.00005939828,"about_ca_topic_score_gemma":0.0000010788126,"teacher_disagreement_score":0.3908208,"about_ca_system_score_codex":0.000027396562,"about_ca_system_score_gemma":0.000109706256,"threshold_uncertainty_score":0.2663344},"labels":[],"label_agreement":null},{"id":"W2946343948","doi":"10.1161/circgen.118.002376","title":"Rare Protein-Truncating Variants in <i>APOB</i> , Lower Low-Density Lipoprotein Cholesterol, and Protection Against Coronary Heart Disease","year":2019,"lang":"en","type":"article","venue":"Circulation Genomic and Precision Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Perelman School of Medicine, University of Pennsylvania; Samsung; Technische Universität München; Università degli Studi di Parma; Regeneron Pharmaceuticals; Universität zu Lübeck; British Heart Foundation; Sungkyunkwan University; University of Oxford; University of Leicester; University of Pennsylvania; National Human Genome Research Institute; Wellcome Trust; University of Ottawa; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares; National Institute for Health and Care Research; Massachusetts General Hospital","keywords":"Apolipoprotein B; Internal medicine; Medicine; Triglyceride; Endocrinology; Cholesterol; Odds ratio; Lipoprotein; Genetics; Biology","score_opus":0.014031901563374466,"score_gpt":0.23825015027559707,"score_spread":0.2242182487122226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946343948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99049926,0.001969144,0.0009231629,0.00161588,0.00023965312,0.004444102,0.0000050684757,0.000054073236,0.00024967888],"genre_scores_gemma":[0.9976464,0.00015449087,0.0002658683,0.0011822416,0.0003681347,0.00011290214,0.00004999049,0.000038727623,0.00018122615],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977302,0.00020332003,0.0005669756,0.0006782034,0.0005291932,0.00029210912],"domain_scores_gemma":[0.9987177,0.000042012583,0.00015845805,0.00057873235,0.00012164194,0.00038140576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013148877,0.00025944144,0.0005978682,0.00021583666,0.00014443538,0.000026831784,0.000057536912,0.0001688886,0.00008911919],"category_scores_gemma":[0.00021776847,0.00021616947,0.00007613606,0.00023679581,0.0000954843,0.00019191249,0.000079989295,0.000371161,0.00003177966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028599442,0.00025756113,0.19832654,0.0020704942,0.000091386304,0.00012839766,0.0010827506,0.00029187454,0.35505995,0.00008618004,0.000079255966,0.43966568],"study_design_scores_gemma":[0.0051320572,0.00033001,0.9879329,0.0018224881,0.000054740598,0.00013911983,0.00011836852,0.00301972,0.00020015113,0.00041058415,0.00062075077,0.00021909148],"about_ca_topic_score_codex":0.00031214714,"about_ca_topic_score_gemma":0.000017963943,"teacher_disagreement_score":0.7896064,"about_ca_system_score_codex":0.00014832376,"about_ca_system_score_gemma":0.00014388583,"threshold_uncertainty_score":0.88151354},"labels":[],"label_agreement":null},{"id":"W2946627926","doi":"10.1016/j.jacl.2019.04.011","title":"The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada; Amgen","keywords":"Medicine; Statin; Adverse effect; Diabetes mellitus; Disease; Stroke (engine); Physical therapy; Internal medicine; Intensive care medicine; Emergency medicine","score_opus":0.08136892810638283,"score_gpt":0.4271468875689741,"score_spread":0.34577795946259127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946627926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605405,0.0006854855,0.00012972634,0.00009279518,0.0023408236,0.0006004315,0.000004038316,0.0000036398785,0.000088996705],"genre_scores_gemma":[0.9965958,0.0017296636,0.00095416425,0.00017696281,0.0004314321,0.000011534714,0.000002985695,0.00001400387,0.000083463136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99388903,0.0012890901,0.0037498337,0.00020793293,0.0006071448,0.00025694826],"domain_scores_gemma":[0.9891605,0.0039958195,0.005440214,0.00054377393,0.00068120885,0.00017848956],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005302651,0.00014378344,0.0014055718,0.000052757205,0.000044198692,0.0000034670495,0.00016620028,0.00012893204,0.000029780495],"category_scores_gemma":[0.012219995,0.000076630546,0.0006357555,0.00013756269,0.00025746465,0.00006902405,0.0000368709,0.0002939434,0.0000027307292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027338446,0.0007181338,0.8542999,0.00007785658,0.00028877973,0.0000194093,0.0022386403,0.000011200921,0.0005363148,0.000012391021,0.000053973745,0.13900958],"study_design_scores_gemma":[0.006282767,0.008862099,0.9763857,0.00014688648,0.000046941674,0.000030386675,0.0008849204,0.000018499295,0.0042280676,0.000022049737,0.0030247087,0.00006697024],"about_ca_topic_score_codex":0.00024653762,"about_ca_topic_score_gemma":0.000022241722,"teacher_disagreement_score":0.1389426,"about_ca_system_score_codex":0.00004490554,"about_ca_system_score_gemma":0.00046685978,"threshold_uncertainty_score":0.9961005},"labels":[],"label_agreement":null},{"id":"W2947137661","doi":"10.1155/2019/7059806","title":"The Evolving View of Coronary Artery Calcium: A Personalized Shared Decision-Making Tool in Primary Prevention","year":2019,"lang":"en","type":"review","venue":"Cardiology Research and Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Medicine; Coronary artery calcium; Secondary prevention; Intensive care medicine; Canadian Cardiovascular Society; Asymptomatic; Coronary artery disease; Primary prevention; Risk assessment; Disease; Physical therapy; Internal medicine; Angina; Family medicine; Pathology; Myocardial infarction","score_opus":0.17969199579393125,"score_gpt":0.47992831554112264,"score_spread":0.3002363197471914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947137661","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002325119,0.99192387,0.0002471648,0.00014890153,0.00018290192,0.0034266128,0.000021474494,0.000010777809,0.0038057617],"genre_scores_gemma":[0.0005565205,0.99754405,0.0006028813,0.00006832164,0.00034620272,0.0003767008,0.000074520496,0.000041865333,0.0003889193],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99159473,0.005468487,0.00081472594,0.0006126589,0.0009041761,0.0006052087],"domain_scores_gemma":[0.9836144,0.014368769,0.0003079765,0.0010097726,0.0006011034,0.000097990065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017408185,0.00026805024,0.0025794576,0.00028417713,0.00022503315,0.000055243025,0.00025058878,0.0004914702,0.00003989149],"category_scores_gemma":[0.007676729,0.0001705506,0.0007225269,0.0004974135,0.00037166892,0.00023316403,0.0003311813,0.0017755382,0.00004842341],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087049126,0.000043368767,0.00007451833,0.016067524,0.0010532778,0.0005147704,0.000083747516,1.5744136e-7,0.0000013650243,0.00007960806,0.00074524415,0.98046595],"study_design_scores_gemma":[0.00091344304,0.0006203655,0.0013808759,0.022008184,0.0009100519,0.008533725,0.0002876275,0.00000417646,3.608304e-8,0.0001944925,0.96499115,0.00015589973],"about_ca_topic_score_codex":0.000020154823,"about_ca_topic_score_gemma":0.00000330887,"teacher_disagreement_score":0.98031,"about_ca_system_score_codex":0.00034922807,"about_ca_system_score_gemma":0.0024024048,"threshold_uncertainty_score":0.9190316},"labels":[],"label_agreement":null},{"id":"W2947177174","doi":"10.1016/j.dsx.2019.05.034","title":"Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?","year":2019,"lang":"en","type":"review","venue":"Diabetes & Metabolic Syndrome Clinical Research & Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"MSD K.K.; Daiichi Sankyo Company; Shionogi; National Institute of Biomedical Innovation; Astellas Pharma; Mochida Pharmaceutical Company; Teijin Pharma; Novo Nordisk; Daiichi-Sankyo; Boehringer Ingelheim Japan; XBiotech; Kowa Pharmaceutical Europe; Takeda Pharmaceuticals U.S.A.; Takeda Pharmaceuticals North America; IFM Therapeutics; Novartis Pharma; Otsuka Pharmaceutical; Bayer Yakuhin; Novartis; AstraZeneca; Amgen; Pfizer; Astellas Pharma US; Kaken Pharmaceutical; Sanofi; Merck","keywords":"Residual; Key (lock); Residual risk; Diabetes mellitus; Alpha (finance); Risk analysis (engineering); Medicine; Computer science; Internal medicine; Endocrinology; Computer security; Surgery; Algorithm","score_opus":0.20152712806336925,"score_gpt":0.46939234071277436,"score_spread":0.2678652126494051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947177174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005849866,0.97126824,0.0000017842599,0.0008539438,0.0010940355,0.020322803,0.000147679,0.000071706774,0.00038992046],"genre_scores_gemma":[0.00020947566,0.9892813,0.00010532197,0.0011586475,0.0028916362,0.0047270823,0.00025569875,0.00032189264,0.0010489679],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9456764,0.037361067,0.0063151033,0.0026784549,0.004488731,0.0034802428],"domain_scores_gemma":[0.97346085,0.013263169,0.0017487833,0.009661812,0.0006644976,0.0012009143],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow","research_integrity"],"category_scores_codex":[0.11783627,0.0015575374,0.016248286,0.00072460575,0.0006304577,0.00032019787,0.0035523644,0.0014709362,0.0005616616],"category_scores_gemma":[0.035702594,0.00072043063,0.009599023,0.0043942025,0.0022315546,0.0002740556,0.0015666252,0.0117558185,0.0024497828],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009266834,0.00035052173,0.0025823675,0.015588612,0.0024006066,0.000059037753,0.0000711818,4.1167849e-7,1.4052515e-7,0.0001598196,0.006653018,0.972125],"study_design_scores_gemma":[0.0013813142,0.00061581313,0.010871353,0.026457086,0.0063164453,0.000038636845,0.00003305443,0.000011425674,8.19339e-7,0.00013187346,0.9534516,0.00069061934],"about_ca_topic_score_codex":0.00025468974,"about_ca_topic_score_gemma":0.000028845494,"teacher_disagreement_score":0.9714344,"about_ca_system_score_codex":0.0002899762,"about_ca_system_score_gemma":0.0026792039,"threshold_uncertainty_score":0.99982536},"labels":[],"label_agreement":null},{"id":"W2947974592","doi":"10.1177/1074248419852955","title":"Effects of Extended-Release Niacin on Quartile Lp-PLA <sub>2</sub> Levels and Clinical Outcomes in Statin-treated Patients with Established Cardiovascular Disease and Low Baseline Levels of HDL-Cholesterol: Post Hoc Analysis of the AIM HIGH Trial","year":2019,"lang":"en","type":"article","venue":"Journal of Cardiovascular Pharmacology and Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; Niacin; Ezetimibe; Placebo; Quartile; Simvastatin; Statin; Randomized controlled trial; Myocardial infarction; Stroke (engine); Diabetes mellitus; Gastroenterology; Cardiology; Endocrinology; Confidence interval","score_opus":0.011233192995989025,"score_gpt":0.2773706685073362,"score_spread":0.2661374755113472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947974592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870126,0.010421896,0.00022317696,0.000085918284,0.0003137756,0.001789168,0.00014570836,0.0000056161152,0.0000021312974],"genre_scores_gemma":[0.9964953,0.002987369,0.00005868116,0.00029756126,0.000100053454,0.000012549804,0.000009012762,0.00003656377,0.0000029024477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947275,0.0020453807,0.0012913196,0.000426727,0.00119985,0.0003092198],"domain_scores_gemma":[0.996905,0.00068589085,0.000700975,0.00069218886,0.00071773503,0.00029817809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035134782,0.00035845087,0.0029547664,0.00047581422,0.00005612572,0.000013438058,0.00014942879,0.00022137474,0.0000068725117],"category_scores_gemma":[0.00016867158,0.00022320997,0.0023045435,0.0005656567,0.0003550976,0.00014402418,0.00007054876,0.00058573356,2.2417132e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08084776,0.0042536086,0.443795,0.0021634803,0.27501112,0.00030702908,0.00049716874,0.008357913,0.005448629,0.000016389427,0.000006882316,0.17929505],"study_design_scores_gemma":[0.0811877,0.0036046952,0.8555995,0.0002641207,0.049754072,0.000020218187,0.00005472916,0.00035807438,0.008897476,0.000009895499,0.00006090065,0.00018856784],"about_ca_topic_score_codex":0.00009301599,"about_ca_topic_score_gemma":0.0000110144565,"teacher_disagreement_score":0.41180456,"about_ca_system_score_codex":0.00004928272,"about_ca_system_score_gemma":0.00029266914,"threshold_uncertainty_score":0.9102238},"labels":[],"label_agreement":null},{"id":"W2948744549","doi":"10.2337/db19-1482-p","title":"1482-P: Low-Density Lipoprotein Cholesterol (LDL-C) Management in Patients with Atherosclerotic Cardiovascular Diseases (ASCVD) and Preexisting Diabetes in Alberta, Canada","year":2019,"lang":"en","type":"article","venue":"Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Internal medicine; Guideline; Myocardial infarction; Atherosclerotic cardiovascular disease; Statin; Heart failure; Cholesterol; Retrospective cohort study; Disease; Cardiology; Endocrinology; Pathology","score_opus":0.003449222650121847,"score_gpt":0.17184865007804678,"score_spread":0.16839942742792494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948744549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957297,0.0010286918,0.000001413132,0.0000873602,0.00009300476,0.0027687445,0.00001383186,0.000026242844,0.0002510367],"genre_scores_gemma":[0.99907273,0.000029822831,0.00008367632,0.00035036317,0.000059372866,0.00019962761,0.00005468294,0.000056256842,0.000093477734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972976,0.00014191489,0.00036205584,0.00066634413,0.00082585344,0.00070624467],"domain_scores_gemma":[0.998671,0.000059224723,0.00008152501,0.0008720509,0.000071320115,0.00024489607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038291476,0.00033179976,0.00091580994,0.00015432299,0.0000590485,0.00004001747,0.00012070863,0.000085353175,0.000014609095],"category_scores_gemma":[0.00006047527,0.00027720188,0.00016651938,0.00031716385,0.000055623164,0.00014232454,0.000120505894,0.0002474919,0.000008870705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037207967,0.00017405614,0.9694774,0.0012870845,0.0005255002,0.000015876054,0.00006489588,0.00010951868,0.000016007141,0.0000074554,0.000009028303,0.028275961],"study_design_scores_gemma":[0.0051715868,0.00021770051,0.99194825,0.0011543813,0.00022665317,4.0495382e-7,0.00006207602,0.0002509448,0.0004125242,0.000014863022,0.00022606798,0.0003145509],"about_ca_topic_score_codex":0.28484377,"about_ca_topic_score_gemma":0.14334792,"teacher_disagreement_score":0.14149585,"about_ca_system_score_codex":0.00028831282,"about_ca_system_score_gemma":0.00013381738,"threshold_uncertainty_score":0.999968},"labels":[],"label_agreement":null},{"id":"W2948745207","doi":"10.1186/s12944-019-1080-x","title":"Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol","year":2019,"lang":"en","type":"review","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Natural Science Foundation of China; International Atherosclerosis Society; National Institutes of Health; Canadian Cardiovascular Society","keywords":"Lipidology; Mace; Very low-density lipoprotein; Clinical nutrition; Chylomicron; Lipoprotein; Cholesterol; Medicine; Internal medicine; Clinical chemistry; National Cholesterol Education Program; Intermediate-density lipoprotein; Endocrinology; Metabolic syndrome","score_opus":0.09374726209304186,"score_gpt":0.3819687549687018,"score_spread":0.28822149287565996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948745207","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005461219,0.9779801,0.0008500824,0.001165474,0.0006743803,0.018541208,0.000098606004,0.000056001565,0.00008806214],"genre_scores_gemma":[0.0029917152,0.98653644,0.0005512415,0.004032398,0.002130779,0.0030066841,0.00011910462,0.00010091946,0.0005306919],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957014,0.0003151564,0.0009883197,0.0011930398,0.0006113906,0.0011907339],"domain_scores_gemma":[0.9954978,0.00018359946,0.00028729023,0.0013387538,0.0000653374,0.0026271914],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002025038,0.0006114195,0.0024711702,0.000709088,0.00022932675,0.00006584741,0.00020250601,0.00022804599,0.000011050379],"category_scores_gemma":[0.0003574981,0.0005012913,0.0006242994,0.0005560293,0.00002957494,0.00008409742,0.00018539382,0.000547822,0.00007022107],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043379303,0.00011351622,0.000026052956,0.20498113,0.00007713234,0.000030801413,0.000056715264,0.000004732783,1.1119915e-8,0.00028303036,0.00028897403,0.7937041],"study_design_scores_gemma":[0.0040386254,0.0042709396,0.002284065,0.2895555,0.0013582658,0.000031503,0.00016675386,0.00006667451,7.301393e-7,0.000247603,0.6969406,0.0010387773],"about_ca_topic_score_codex":0.00088816904,"about_ca_topic_score_gemma":0.00005475989,"teacher_disagreement_score":0.7926653,"about_ca_system_score_codex":0.00049465284,"about_ca_system_score_gemma":0.0016587223,"threshold_uncertainty_score":0.9997439},"labels":[],"label_agreement":null},{"id":"W2948893274","doi":"10.1210/jc.2018-02703","title":"Efficacy and Safety of Alirocumab 300 mg Every 4 Weeks in Individuals With Type 2 Diabetes on Maximally Tolerated Statin","year":2019,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Placebo; Statin; Internal medicine; Context (archaeology); Adverse effect; PCSK9; Gastroenterology; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.024867096659997756,"score_gpt":0.3276345931020253,"score_spread":0.30276749644202755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948893274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915904,0.0047977353,0.000009882622,0.0023810233,0.0003224135,0.00049173227,0.0000054008956,0.000007786124,0.00039366996],"genre_scores_gemma":[0.99127984,0.0061057005,0.00064665277,0.0015576936,0.0003083284,0.000001917968,0.0000028690197,0.000022396975,0.000074586475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964991,0.0009777955,0.0014425549,0.00019114332,0.0005183486,0.00037102305],"domain_scores_gemma":[0.99731743,0.0010614789,0.0007322771,0.0004565969,0.00027473934,0.00015748068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030668639,0.00018373391,0.001608647,0.00018542039,0.000032948195,0.000006527163,0.00020557627,0.00013880122,0.000088231776],"category_scores_gemma":[0.0007366284,0.00009825428,0.00019249445,0.0002624985,0.0002489656,0.000074266056,0.00006653144,0.0011143663,0.000013379789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045074128,0.0029857936,0.5968226,0.000485308,0.007307351,0.0003612093,0.0016439434,0.00067059335,0.0034457846,0.0032361364,0.0008339525,0.33713317],"study_design_scores_gemma":[0.017871121,0.0034756828,0.96212906,0.00029192245,0.0005914776,0.00025330717,0.00013458547,0.000015354977,0.000865183,0.00015712055,0.014107617,0.00010757701],"about_ca_topic_score_codex":0.000051709216,"about_ca_topic_score_gemma":0.000007941899,"teacher_disagreement_score":0.36530644,"about_ca_system_score_codex":0.000015296126,"about_ca_system_score_gemma":0.00037098533,"threshold_uncertainty_score":0.48414293},"labels":[],"label_agreement":null},{"id":"W2949057895","doi":"10.1161/circ.132.suppl_3.14231","title":"Abstract 14231: Effectiveness and Safety of Statin Therapy in Children: A Multi-Center, Real-World Clinical Practice Experience","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Atorvastatin; Statin; Internal medicine; Clinical Practice; Clinical trial; Myositis; Clinical endpoint; Anthropometry; Physical therapy","score_opus":0.061822283967406674,"score_gpt":0.393600107689867,"score_spread":0.3317778237224603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949057895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672705,0.00060236227,0.0011581386,0.00005800945,0.0000826661,0.000982126,0.0000035426997,0.000017133856,0.00036896052],"genre_scores_gemma":[0.99805164,0.00059750007,0.0011170682,0.00007980404,0.000089753084,0.000026657424,0.000023957802,0.00001186138,0.0000017629335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986648,0.00028625634,0.00040663613,0.00023352905,0.0002906636,0.00011811932],"domain_scores_gemma":[0.99917215,0.0001379378,0.00015629051,0.00026167207,0.00015755635,0.0001144117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002096449,0.00008627894,0.00030512293,0.00007192849,0.000022658262,0.0000072628686,0.000030326739,0.000067665744,0.0000039753536],"category_scores_gemma":[0.00046569007,0.00007476646,0.00007221937,0.00017652904,0.00005485433,0.0001654422,0.000013101959,0.00015050844,0.000002023744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006639878,0.00050739263,0.8971688,0.000045580255,0.0000542301,0.0000062037366,0.00069942937,0.000043048836,0.00021339525,0.00004585996,0.0000023995945,0.10054965],"study_design_scores_gemma":[0.009523027,0.000111478235,0.9893024,0.00012455025,0.000016340284,0.00002969552,0.0001894728,0.00026614612,0.00014599977,0.000015311458,0.00020853941,0.000067038156],"about_ca_topic_score_codex":0.0015165424,"about_ca_topic_score_gemma":0.000042852917,"teacher_disagreement_score":0.10048261,"about_ca_system_score_codex":0.00008542897,"about_ca_system_score_gemma":0.00012983703,"threshold_uncertainty_score":0.30488878},"labels":[],"label_agreement":null},{"id":"W2950154198","doi":"10.7326/acpj201906180-065","title":"Pooled RCTs: Lowering LDL-C levels using statins reduces major vascular events in all age groups","year":2019,"lang":"en","type":"letter","venue":"Annals of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Randomized controlled trial; Meta-analysis; Statin; Clinical trial; Internal medicine; Cholesterol; Pharmacology","score_opus":0.095591713358727,"score_gpt":0.36475450268693593,"score_spread":0.2691627893282089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950154198","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76506054,0.010607321,0.0007589562,0.21792437,0.0021678922,0.0020240946,0.000078740086,0.000058412472,0.0013196758],"genre_scores_gemma":[0.41532987,0.0017730494,0.00048576487,0.5702411,0.009857471,0.000046194775,0.0003134285,0.00024939823,0.0017037527],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942364,0.00030004568,0.001637247,0.00082222297,0.002071872,0.00093218515],"domain_scores_gemma":[0.9972516,0.00018056108,0.0007512962,0.0011657395,0.00042901197,0.000221816],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0022396897,0.0006848572,0.0026090338,0.0008710967,0.00003366341,0.00001087119,0.0005128993,0.0007078488,0.00036532222],"category_scores_gemma":[0.0007029346,0.0005280631,0.0008260126,0.00033968218,0.00017578724,0.00014964773,0.00018141772,0.0023629314,0.000032265983],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020229053,0.0010086318,0.006817076,0.02757074,0.024026955,0.0332862,0.006182457,0.000109891385,0.04392012,0.00003138512,0.8156765,0.039347123],"study_design_scores_gemma":[0.024950303,0.007228759,0.038981076,0.1255995,0.0046802657,0.0021103574,0.001097987,0.0003902973,0.026409749,0.0008904366,0.76490647,0.0027548275],"about_ca_topic_score_codex":0.0067971195,"about_ca_topic_score_gemma":0.00005188322,"teacher_disagreement_score":0.3523167,"about_ca_system_score_codex":0.00019656199,"about_ca_system_score_gemma":0.0002813598,"threshold_uncertainty_score":0.99993867},"labels":[],"label_agreement":null},{"id":"W2951284864","doi":"","title":"Statin-prescribing trends for primary and secondary prevention of cardiovascular disease.","year":2017,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Manitoba Health; Seven Oaks General Hospital","funders":"","keywords":"Medicine; Statin; Secondary prevention; Disease; Primary prevention; Medical record; Population; Primary care; Retrospective cohort study; Internal medicine; Pediatrics; Family medicine; Environmental health","score_opus":0.03466672458149777,"score_gpt":0.2626410703722853,"score_spread":0.2279743457907875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951284864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95086163,0.028713293,0.0048056045,0.0008203932,0.0003797825,0.0037508046,0.00013880694,0.00006105195,0.01046861],"genre_scores_gemma":[0.9957066,0.00045092258,0.0008596679,0.00005617609,0.00028292582,0.0013662619,0.000057570887,0.000023125624,0.001196755],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99896824,0.00003795939,0.00019299812,0.00025010106,0.00031126058,0.00023945005],"domain_scores_gemma":[0.99868286,0.000013768259,0.00010479026,0.00090777694,0.000071415554,0.00021941864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094488694,0.000096106894,0.00040260205,0.00006681596,0.00016092589,0.000029406881,0.000077469216,0.000043274078,0.000006296721],"category_scores_gemma":[0.00016226128,0.000084225256,0.0005188318,0.000028655422,0.00006724752,0.000141483,0.000062067804,0.00007507529,2.2734916e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017008533,0.000041448762,0.0018594911,0.0009106074,0.000925288,0.000007684473,0.000024015248,0.000004025551,0.000012718049,0.00008722102,0.00016113884,0.99579626],"study_design_scores_gemma":[0.0027984735,0.000054997454,0.95986193,0.000055878987,0.0009718065,0.000007726836,0.000015800248,0.000038651666,0.00029611294,0.00018952946,0.035618138,0.00009096863],"about_ca_topic_score_codex":0.00009904906,"about_ca_topic_score_gemma":0.000003066378,"teacher_disagreement_score":0.9957053,"about_ca_system_score_codex":0.0000376454,"about_ca_system_score_gemma":0.00008409467,"threshold_uncertainty_score":0.34346062},"labels":[],"label_agreement":null},{"id":"W2952046919","doi":"10.1016/j.jacl.2019.05.010","title":"Did the ACC/AHA/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA cholesterol guidelines get apoB right?","year":2019,"lang":"en","type":"letter","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Guideline; Apolipoprotein B; Cover (algebra); Family medicine; Cholesterol; Internal medicine; Pathology","score_opus":0.13927878760279444,"score_gpt":0.43701122338987664,"score_spread":0.2977324357870822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952046919","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013961303,0.0067412173,0.0007335786,0.93393284,0.0395235,0.0017177544,0.0000745429,0.000063810054,0.0032514734],"genre_scores_gemma":[0.0028607808,0.004081362,0.0015808956,0.73483425,0.24622403,0.00002807146,0.00010772773,0.00021105591,0.010071843],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9809065,0.0041745673,0.009282572,0.0012135961,0.0029794564,0.0014433154],"domain_scores_gemma":[0.9829555,0.0043795886,0.005944858,0.0034432001,0.0026536374,0.0006232132],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.018651418,0.0011034665,0.007029924,0.000503575,0.00025254246,0.00013405812,0.0020300548,0.004376114,0.0012220953],"category_scores_gemma":[0.009818113,0.0006061577,0.00634993,0.00037988406,0.00084421795,0.00030995827,0.0004634943,0.014162267,0.0007586174],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007323276,0.0002486339,0.0033081053,0.00046703272,0.0027159872,0.000796462,0.000061226776,0.000013367321,0.0000144129945,0.000038583636,0.96649796,0.025105929],"study_design_scores_gemma":[0.0068863314,0.0029870435,0.009921497,0.0008345651,0.0022435763,0.0064687473,0.000033370896,0.00003760469,0.000017792176,0.0005598853,0.96945107,0.0005585228],"about_ca_topic_score_codex":0.00011298597,"about_ca_topic_score_gemma":0.000030878145,"teacher_disagreement_score":0.20670052,"about_ca_system_score_codex":0.00023430862,"about_ca_system_score_gemma":0.0031427469,"threshold_uncertainty_score":0.99969095},"labels":[],"label_agreement":null},{"id":"W2952347736","doi":"10.1016/j.cjco.2019.05.006","title":"Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm","year":2019,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of British Columbia; Canadian Respiratory Research Network; Hamilton General Hospital; University of Toronto; Western University; Saint John Regional Hospital; Dalhousie University; St. Paul's Hospital; McMaster University; Population Health Research Institute; Université de Montréal; McGill University Health Centre","funders":"Ionis Pharmaceuticals; Sanofi; Novartis; HLS Therapeutics; Pfizer; Amgen","keywords":"Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Medicine; Disease; Internal medicine; Algorithm; Cardiology; Computer science; Cholesterol","score_opus":0.02613065797896163,"score_gpt":0.25067067406714494,"score_spread":0.2245400160881833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952347736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99543816,0.0003438456,0.00027836033,0.0000134043685,0.00037212964,0.0031816717,0.00022576014,0.000022773502,0.00012391212],"genre_scores_gemma":[0.99792594,0.0002233666,0.0012452698,0.00006540408,0.00011374484,0.00004418015,0.00022855337,0.000046525765,0.00010703056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977263,0.00031475784,0.00042778908,0.0004943078,0.0007402156,0.00029661445],"domain_scores_gemma":[0.9982935,0.000011749436,0.00012121772,0.0011953155,0.00015125016,0.00022695141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095849275,0.00018312564,0.00079391233,0.00010036305,0.00006252613,0.000024624389,0.00020581229,0.00011850258,0.00006769645],"category_scores_gemma":[0.000066470224,0.00016234649,0.0003452902,0.00027765508,0.000036865516,0.00019822315,0.00028463322,0.0002117052,0.000046684265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008961605,0.00046421954,0.92497325,0.00029816007,0.0009859025,0.000022864906,0.00022507517,0.0014100727,0.00082727394,0.000002598254,0.000038625178,0.06985578],"study_design_scores_gemma":[0.011667906,0.00031118852,0.98222446,0.0004552425,0.00066731306,0.0000053528865,0.00003901501,0.0026499408,0.000568284,0.000014591738,0.0012476554,0.00014903492],"about_ca_topic_score_codex":0.0042922106,"about_ca_topic_score_gemma":0.000008092613,"teacher_disagreement_score":0.069706745,"about_ca_system_score_codex":0.00041894199,"about_ca_system_score_gemma":0.00017213733,"threshold_uncertainty_score":0.66202974},"labels":[],"label_agreement":null},{"id":"W2952907069","doi":"10.1016/j.cjca.2019.06.009","title":"The Lifelong Burden of Homozygous Familial Hypercholesterolemia","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université Laval; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"Aegerion Pharmaceuticals; Instituto Danone; Flax Council of Canada; Canola Council of Canada; Dow AgroSciences; Merck; Sanofi; Agriculture and Agri-Food Canada; Canadian Institutes of Health Research; Novartis; Pfizer; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Pediatrics; Coronary artery disease; Disease; Internal medicine; Cholesterol; Cardiology","score_opus":0.010057378447657991,"score_gpt":0.2302785331142697,"score_spread":0.2202211546666117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952907069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984628,0.0043890155,0.00016671549,0.0017371656,0.0012182661,0.00023277049,0.000007894698,0.0000026104904,0.0076175444],"genre_scores_gemma":[0.99672484,0.00032686206,0.00006199554,0.00022526208,0.00239132,0.0000017021939,0.000001595723,0.000014972167,0.00025146495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879116,0.00016580448,0.00040094333,0.00009900458,0.00021880193,0.0003243131],"domain_scores_gemma":[0.9985743,0.00006601636,0.0001514428,0.00041310376,0.00032341774,0.00047172757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010108313,0.00009468343,0.0006203662,0.0001364284,0.00007294106,0.000010168579,0.00019254569,0.0001356375,0.000011498175],"category_scores_gemma":[0.00016231804,0.00006120463,0.00045718346,0.00010057608,0.00015651656,0.00003543374,0.000011181157,0.0003775449,0.000019688718],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011880439,0.000009740104,0.36334485,0.00054585125,0.0059765596,0.0040507927,0.0026182258,0.007329979,0.008143731,0.0017837329,0.037951607,0.5670569],"study_design_scores_gemma":[0.0024800948,0.0010778626,0.16328585,0.00014909077,0.00028064448,0.009794282,0.0009476707,0.00001667854,0.00021182728,0.00014189679,0.8214835,0.00013058171],"about_ca_topic_score_codex":0.002927067,"about_ca_topic_score_gemma":0.00064553024,"teacher_disagreement_score":0.7835319,"about_ca_system_score_codex":0.0001300932,"about_ca_system_score_gemma":0.0021335206,"threshold_uncertainty_score":0.4424869},"labels":[],"label_agreement":null},{"id":"W2953455436","doi":"10.1016/j.jad.2019.07.002","title":"Do statins have an effect on depressive symptoms? A systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Journal of Affective Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Ontario Mental Health Foundation; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; National Institute of Mental Health; Ontario Brain Institute; Grand Challenges Canada; AstraZeneca; Bristol-Myers Squibb","keywords":"Meta-analysis; Depression (economics); Medicine; Placebo; Subgroup analysis; Internal medicine; Major depressive disorder; Statin; Population; Strictly standardized mean difference; MEDLINE; Clinical trial; Publication bias; Randomized controlled trial; Psychiatry; Physical therapy; Alternative medicine","score_opus":0.0369254196681465,"score_gpt":0.3723608877105004,"score_spread":0.3354354680423539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953455436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038976657,0.99093294,0.00019050475,0.000052378004,0.00006115632,0.008455008,0.000058564692,0.000010713812,0.00019973355],"genre_scores_gemma":[0.0003664176,0.9986674,0.000027845,0.00032263037,0.00007009211,0.00034502533,0.000029939825,0.00008283972,0.00008777774],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9929589,0.00366203,0.0014095533,0.0005507696,0.0010953028,0.00032343235],"domain_scores_gemma":[0.9945499,0.0009765939,0.002626001,0.0011156534,0.00037473865,0.0003571702],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0035626374,0.0007554631,0.018860841,0.0008224797,0.0000784833,0.00006303585,0.0002384594,0.00026756193,0.000073275194],"category_scores_gemma":[0.0010506298,0.00038647628,0.010478933,0.00071937457,0.000059989423,0.00015248777,0.000045194403,0.0010131544,0.000013745558],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016431106,0.00009540399,0.000009369765,0.6050779,0.3445278,0.000038273814,0.00004412071,0.0000031801983,1.5207158e-8,0.0000069987877,0.000029558109,0.050150927],"study_design_scores_gemma":[0.0007194875,0.0034386122,0.000022933807,0.08978541,0.9015799,0.00037820835,0.000039273244,0.0000022717206,2.4804902e-7,0.000007830083,0.003734273,0.0002915341],"about_ca_topic_score_codex":0.000059335096,"about_ca_topic_score_gemma":0.00003661406,"teacher_disagreement_score":0.5570521,"about_ca_system_score_codex":0.00025184872,"about_ca_system_score_gemma":0.00035729242,"threshold_uncertainty_score":0.99985874},"labels":[],"label_agreement":null},{"id":"W2954325082","doi":"10.1016/j.cjco.2019.06.001","title":"Genetic Determinants of Myocardial Infarction Risk in Familial Hypercholesterolemia","year":2019,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Mach-Gaensslen Foundation of Canada; Heart and Stroke Foundation of Canada","keywords":"Medicine; Myocardial infarction; Internal medicine; Familial hypercholesterolemia; Cholesterol; Genotyping; Single-nucleotide polymorphism; Diabetes mellitus; Gastroenterology; Endocrinology; Cardiology; Genotype; Genetics; Gene; Biology","score_opus":0.014356500747709383,"score_gpt":0.28691499955713146,"score_spread":0.27255849880942207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954325082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538606,0.00018377729,0.000011866628,0.000027084692,0.0002413427,0.001220187,0.0000074923337,0.0000069576854,0.0029152264],"genre_scores_gemma":[0.99881375,0.00021511519,0.00041689957,0.000168341,0.00015337385,0.000032586246,0.0000038285916,0.00001580541,0.00018028928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989945,0.00010464349,0.00027007144,0.00021683746,0.00024146795,0.00017246896],"domain_scores_gemma":[0.9992671,0.000012357695,0.00007211979,0.00053280825,0.00004242233,0.00007319454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053604576,0.00008666473,0.0004850614,0.00007091525,0.00001902622,0.00001372304,0.00014887734,0.00009162778,0.000054078417],"category_scores_gemma":[0.0000421562,0.00007450184,0.000113283,0.0001250147,0.00002260406,0.00008652391,0.00012788016,0.00016385305,0.0001019197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020472436,0.000042506337,0.8267812,0.00007237085,0.000036348785,0.0000130711405,0.00015196213,0.000023635062,0.0011369601,0.0000021194558,0.000027209755,0.1715079],"study_design_scores_gemma":[0.003572738,0.00031667613,0.9922848,0.000114290764,0.00005372497,0.000047778634,0.00007940381,0.00013224372,0.0006975511,0.000029585472,0.0025957264,0.00007550389],"about_ca_topic_score_codex":0.0049251965,"about_ca_topic_score_gemma":0.00021083443,"teacher_disagreement_score":0.17143239,"about_ca_system_score_codex":0.000060051323,"about_ca_system_score_gemma":0.00014956613,"threshold_uncertainty_score":0.74454564},"labels":[],"label_agreement":null},{"id":"W2954453953","doi":"10.1016/s2213-8587(19)30158-5","title":"Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":328,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Gilead UK and Ireland Corporate Contributions; Seventh Framework Programme; Daiichi Sankyo Europe; St. Jude Medical; Esperion Therapeutics; Idorsia Pharmaceuticals; Biotronik; Ferring Pharmaceuticals; NIHR Imperial Biomedical Research Centre; Eisai; Daiichi-Sankyo; Hartstichting; Actavis; Bayer HealthCare; Ironwood Pharmaceuticals, Incorporated; Medicines Company; Arrien Pharmaceuticals; Tenax Therapeutics; Janssen Pharmaceuticals; Novo Nordisk; MyoKardia; Assistance publique-Hôpitaux de Paris; Luitpold Pharmaceuticals; Regado Biosciences; Merck Sharp and Dohme; Novartis; Belvoir Media Group; Portola Pharmaceuticals; Boston Scientific Corporation; Bristol-Myers Squibb; Cleveland Clinic; Boehringer Ingelheim; American College of Cardiology Foundation; Sanofi; National Lipid Association; GlaxoSmithKline; Mayo Clinic; Merck; Servier; Abbott Laboratories; Bayer; National Institute for Health and Care Research; CSL Behring; Pfizer; Icahn School of Medicine at Mount Sinai; Eli Lilly and Company; Amarin Corporation; Genentech; AstraZeneca; Roche; Flatiron Health; Duke Clinical Research Institute; Astellas Pharma US; Amgen; Regeneron Pharmaceuticals; American Heart Association","keywords":"Medicine; Alirocumab; Acute coronary syndrome; Diabetes mellitus; Internal medicine; Metabolic syndrome; Randomized controlled trial; MEDLINE; Cardiology; Myocardial infarction; Cholesterol; Endocrinology; Total cholesterol","score_opus":0.00810748051552855,"score_gpt":0.24004475415659474,"score_spread":0.2319372736410662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954453953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98764545,0.0024635426,0.0000015958735,0.00026167405,0.00021506312,0.009310899,0.000035236553,0.000024980627,0.000041568936],"genre_scores_gemma":[0.99771786,0.00023133605,0.000029838937,0.0006325618,0.00003463035,0.0012116983,0.000011003931,0.000035535446,0.000095533906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963573,0.0009822876,0.00066497014,0.0004527463,0.0007215094,0.00082114496],"domain_scores_gemma":[0.99689656,0.0010190441,0.00032234777,0.0015857327,0.000102110236,0.00007417314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008391159,0.00037298727,0.0056405454,0.00031247962,0.00004144771,0.00000958146,0.0003105108,0.00011025255,0.000028476323],"category_scores_gemma":[0.00026545723,0.00015490342,0.0013542407,0.0005227339,0.00023161012,0.000053821077,0.00013293365,0.0003214982,0.000002227599],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1426944,0.00026943206,0.8144883,0.00020038396,0.041374553,0.00001737138,0.00011941592,0.000032708427,0.000036890342,0.00002895999,0.0000022352087,0.00073535077],"study_design_scores_gemma":[0.37989113,0.0008624042,0.60758626,0.00006867736,0.011097269,0.0000016265794,0.000009875292,0.000025444833,0.0003061689,0.000007753603,0.00003491371,0.00010845186],"about_ca_topic_score_codex":0.000064712585,"about_ca_topic_score_gemma":0.000023754927,"teacher_disagreement_score":0.23719674,"about_ca_system_score_codex":0.000035956964,"about_ca_system_score_gemma":0.00007302244,"threshold_uncertainty_score":0.6316778},"labels":[],"label_agreement":null},{"id":"W2955000120","doi":"10.1016/j.cjca.2019.06.017","title":"Estimating the Prevalence of Familial Hypercholesterolemia in Acute Coronary Syndrome: A Systematic Review and Meta-analysis","year":2019,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Michael Smith Health Research BC","keywords":"Medicine; Meta-analysis; Familial hypercholesterolemia; Acute coronary syndrome; Internal medicine; Cardiology; Cholesterol; Myocardial infarction","score_opus":0.0656823820228553,"score_gpt":0.3287424728283456,"score_spread":0.2630600908054903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955000120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013621572,0.9968612,0.00010991284,0.00016400726,0.0001240015,0.0024049038,0.00015140462,0.000001514178,0.00004684118],"genre_scores_gemma":[0.0036239943,0.9956209,0.00015857059,0.00027940888,0.00007378004,0.00008155599,0.000009962584,0.000027784501,0.00012403903],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.995362,0.0017826144,0.0019211158,0.00027943263,0.00032371093,0.00033114708],"domain_scores_gemma":[0.9969621,0.00023922882,0.0012468192,0.00095094694,0.00023887542,0.00036205517],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.004111495,0.00034268416,0.014948359,0.0006172839,0.00004073704,0.000011174301,0.00040298887,0.00028434343,0.00002083591],"category_scores_gemma":[0.00041887086,0.00018048516,0.004960298,0.00058615464,0.0001648101,0.000050060095,0.00003442064,0.0008506832,0.000003909029],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002046525,9.895011e-7,0.000119014236,0.8187608,0.17780411,0.0006662096,0.000023563867,0.000037104124,1.516091e-8,0.000002926783,0.00004552022,0.0025376657],"study_design_scores_gemma":[0.00015991823,0.00016803319,0.0006915363,0.058048166,0.9042665,0.03097011,0.000009215777,0.0000031307618,6.2560583e-9,0.0000028235147,0.005559156,0.0001214273],"about_ca_topic_score_codex":0.00043556135,"about_ca_topic_score_gemma":0.00017686587,"teacher_disagreement_score":0.7607127,"about_ca_system_score_codex":0.00023819228,"about_ca_system_score_gemma":0.0026937446,"threshold_uncertainty_score":0.99967575},"labels":[],"label_agreement":null},{"id":"W2955142473","doi":"10.1371/journal.pone.0218115","title":"Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing","year":2019,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"National Institute on Aging; Engineering and Physical Sciences Research Council; Medical Research Council; National Heart, Lung, and Blood Institute; Vetenskapsrådet; Science for Life Laboratory; National Institutes of Health; Uppsala Universitet; Karolinska Institutet; Economic and Social Research Council; European Commission; Knut och Alice Wallenbergs Stiftelse; King's College London; National Institute for Health and Care Research; University of Liverpool; National Human Genome Research Institute; Wellcome Trust","keywords":"Exome sequencing; Statin; Rhabdomyolysis; Exome; Pharmacogenomics; Myopathy; Medicine; Genome-wide association study; Minor allele frequency; Meta-analysis; Bioinformatics; Genetics; Internal medicine; Allele; Allele frequency; Biology; Single-nucleotide polymorphism; Genotype; Mutation; Gene; Pharmacology","score_opus":0.2803531453639258,"score_gpt":0.3454904571956757,"score_spread":0.06513731183174992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955142473","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035084682,0.9900088,0.000058269263,0.000021711674,0.000051856478,0.0021784478,0.0037973528,0.000030261508,0.00034488086],"genre_scores_gemma":[0.00079442555,0.99285716,0.0027208573,0.00006317565,0.0001135887,0.00009231967,0.0027717296,0.000110707915,0.00047605415],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953818,0.0005175039,0.0019180756,0.0006598959,0.0011944027,0.0003283568],"domain_scores_gemma":[0.99596024,0.00022176123,0.0015798976,0.0016338021,0.00040472692,0.00019958473],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001221547,0.0005014851,0.012863884,0.0006668991,0.00003075297,0.000010399711,0.00029701585,0.00039066735,0.0012293508],"category_scores_gemma":[0.00014912481,0.00037741972,0.0061476426,0.0013435166,0.00005032541,0.00006230265,0.00010834197,0.0005968629,0.000084779975],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021494872,0.0005019797,0.000012577926,0.0402442,0.91497487,0.00005455796,0.00020820895,0.000012170186,0.00066276535,0.0000159997,0.0000103860775,0.043280765],"study_design_scores_gemma":[0.0006945738,0.00011024347,0.000024911815,0.0035297032,0.9850005,0.00000572701,0.000032497923,0.00016787034,0.00024699644,0.000012709068,0.0098848855,0.00028937965],"about_ca_topic_score_codex":0.0008082283,"about_ca_topic_score_gemma":0.000007753194,"teacher_disagreement_score":0.07002561,"about_ca_system_score_codex":0.00026253055,"about_ca_system_score_gemma":0.0011555954,"threshold_uncertainty_score":0.9998678},"labels":[],"label_agreement":null},{"id":"W2955231153","doi":"10.1161/atvbaha.118.311894","title":"Group IIA Secretory Phospholipase A <sub>2</sub> , Vascular Inflammation, and Incident Cardiovascular Disease","year":2019,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Heart and Stroke Foundation; University of Toronto","funders":"British Heart Foundation; National Heart, Lung, and Blood Institute; Medical Research Council; National Institute for Health and Care Research","keywords":"Rosuvastatin; Internal medicine; Medicine; Placebo; Inflammation; Risk factor; Population; Gastroenterology; Hazard ratio; Endocrinology; Confidence interval; Pathology","score_opus":0.01565959778495203,"score_gpt":0.23499520000952126,"score_spread":0.21933560222456921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955231153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990116,0.0065368786,0.00078631414,0.00032785122,0.00030978868,0.0017150814,0.000027823433,0.00013384686,0.000046401274],"genre_scores_gemma":[0.9658048,0.032421835,0.0002679918,0.0006264063,0.00037702566,0.00024092534,0.0001756621,0.00008283144,0.0000025020954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636024,0.00042312482,0.0006375903,0.0012398522,0.000620336,0.00071887975],"domain_scores_gemma":[0.99713755,0.000046785146,0.00015153812,0.0017225742,0.00017960482,0.00076194643],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015342223,0.000549517,0.001420963,0.00021496542,0.0003009719,0.00009255323,0.00015402531,0.000348559,0.000069352915],"category_scores_gemma":[0.0000803302,0.00047762535,0.0012594212,0.00029084925,0.00030086798,0.00025109353,0.00029232737,0.00033939927,0.0000856123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058309848,0.0003254485,0.49803683,0.0013674309,0.009215461,0.0000048506386,0.0007651342,0.000025457533,0.46419957,0.0017077413,0.00011830326,0.024175456],"study_design_scores_gemma":[0.0038717382,0.00047677045,0.97517496,0.00025512493,0.0017389623,0.000007918785,0.00013931996,0.00025391634,0.0016393331,0.0001272495,0.015750745,0.0005639628],"about_ca_topic_score_codex":0.0003361576,"about_ca_topic_score_gemma":0.00002539109,"teacher_disagreement_score":0.47713813,"about_ca_system_score_codex":0.00011454472,"about_ca_system_score_gemma":0.00012336063,"threshold_uncertainty_score":0.99976754},"labels":[],"label_agreement":null},{"id":"W2955786349","doi":"10.1016/j.jacl.2019.06.006","title":"Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ironwood Pharmaceuticals, Incorporated; Manitoba Beekeepers' Association; Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Alirocumab; Pooled analysis; Randomized controlled trial; Internal medicine; Meta-analysis; Total cholesterol","score_opus":0.05460852246808687,"score_gpt":0.3953743566006576,"score_spread":0.3407658341325708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955786349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070764,0.006048049,0.0001675688,0.00073770405,0.0015609408,0.0006827324,0.00000428238,0.0000085966985,0.00008247297],"genre_scores_gemma":[0.9918131,0.0043470385,0.0012373213,0.00047796583,0.002016584,0.000009083573,0.000008812717,0.000017200855,0.00007286222],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994987,0.0019442502,0.002018082,0.0003215138,0.00044574158,0.00028337407],"domain_scores_gemma":[0.9912121,0.006802989,0.0009356147,0.0004293376,0.00026833414,0.00035161563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057836873,0.00023089169,0.0063528945,0.0003209263,0.00003943033,0.000010100822,0.000085483916,0.00021819919,0.00008644842],"category_scores_gemma":[0.004960757,0.00012382424,0.0021288274,0.00028697148,0.0001382637,0.000059000635,0.00008583401,0.00033325554,0.0000064846763],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27006868,0.0005461482,0.48436037,0.0002839228,0.090353146,0.00033433505,0.0005544942,0.00008787364,0.0017360176,0.000052327465,0.0002091686,0.15141353],"study_design_scores_gemma":[0.60036814,0.029524967,0.28347763,0.00072158943,0.076742515,0.00034742008,0.0012809031,0.00029060894,0.00063050166,0.00029969637,0.0059140082,0.00040198924],"about_ca_topic_score_codex":0.00039088217,"about_ca_topic_score_gemma":0.000031506865,"teacher_disagreement_score":0.3302995,"about_ca_system_score_codex":0.000074536285,"about_ca_system_score_gemma":0.00009146562,"threshold_uncertainty_score":0.5938848},"labels":[],"label_agreement":null},{"id":"W2957357699","doi":"10.71781/29862","title":"Economic evaluations of a pharmacogenomics test for Statin-induced myopathy in secondary cardiovascular prevention","year":2018,"lang":"en","type":"dissertation","venue":"Open MIND","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Génome Québec; Genome Canada; Université Laval","keywords":"Pharmacogenomics; Myopathy; Statin; Medicine; Test (biology); Internal medicine; Pharmacology; Biology","score_opus":0.04905993765225082,"score_gpt":0.38432393247631985,"score_spread":0.33526399482406904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957357699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788525,0.0017552559,0.00008334398,0.00002096475,0.0005332139,0.0067995708,0.00044417568,0.000001913751,0.011509023],"genre_scores_gemma":[0.94662887,0.0008370487,0.025365638,0.00004870576,0.0015002515,0.0023001712,0.014075415,0.00024129493,0.009002624],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979569,0.00011153555,0.00078419363,0.00058013684,0.00030708103,0.00026017288],"domain_scores_gemma":[0.9984727,0.00005961104,0.00037265883,0.00071117043,0.00027431932,0.00010952192],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0023502938,0.00025690492,0.0010644386,0.00023654185,0.00007482364,0.0000420931,0.0002442684,0.00026446715,0.0011015569],"category_scores_gemma":[0.00014561195,0.00027129395,0.0008170848,0.000120797595,0.000020137708,0.00013911416,0.00004073872,0.00024693133,0.00008632077],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048566013,0.0002523134,0.00010752936,0.0007490942,0.0013952991,0.000007945508,0.0014312194,0.00002029859,0.005383544,0.0000031055395,0.00020580993,0.98995817],"study_design_scores_gemma":[0.059929408,0.0075844685,0.05952171,0.0060269483,0.019181382,0.00017829389,0.011385276,0.0024995678,0.51983047,0.0008838334,0.31029746,0.002681221],"about_ca_topic_score_codex":0.00048594517,"about_ca_topic_score_gemma":0.0016843905,"teacher_disagreement_score":0.987277,"about_ca_system_score_codex":0.000346161,"about_ca_system_score_gemma":0.0033390974,"threshold_uncertainty_score":0.99997395},"labels":[],"label_agreement":null},{"id":"W2959497138","doi":"10.1016/j.cjca.2019.05.011","title":"Improving Statin Noncompliance: If You Build It, Will They Come?","year":2019,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Women's College Hospital; University of Toronto; Institute for Clinical Evaluative Sciences; Western University","funders":"","keywords":"Medicine; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.016549771835370146,"score_gpt":0.2516462996799806,"score_spread":0.23509652784461044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959497138","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005875373,0.011249727,0.007330505,0.9360333,0.011599401,0.0017923568,0.00062461523,0.00003096676,0.025463754],"genre_scores_gemma":[0.12227219,0.00080521,0.0014790003,0.7879213,0.08180616,0.000025874684,0.00031924175,0.0003042476,0.0050667557],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99645376,0.00046529606,0.0009600859,0.0004305437,0.00059070153,0.0010996339],"domain_scores_gemma":[0.9966147,0.00013972029,0.00071602844,0.0010395355,0.0007223173,0.0007677034],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014119695,0.0004580004,0.0024915314,0.0006517161,0.00013543558,0.000048322923,0.00049629336,0.0012424814,0.000093724935],"category_scores_gemma":[0.0003478496,0.00037877847,0.0014138632,0.00014353955,0.00019216443,0.00010955841,0.000032479737,0.004249477,0.00007855119],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038797316,0.0000010993951,0.0036508292,0.0005516088,0.0012500081,0.0077737314,0.00010569009,0.00018131864,0.000022515784,0.000010870661,0.97561544,0.010798091],"study_design_scores_gemma":[0.0015597332,0.0006165329,0.0022790998,0.0004538117,0.00064169604,0.011116628,0.00009488941,0.000009559857,0.000005390695,0.00007491762,0.98281294,0.00033482473],"about_ca_topic_score_codex":0.009447086,"about_ca_topic_score_gemma":0.0010753933,"teacher_disagreement_score":0.14811198,"about_ca_system_score_codex":0.0009407039,"about_ca_system_score_gemma":0.008429888,"threshold_uncertainty_score":0.9998664},"labels":[],"label_agreement":null},{"id":"W2959775262","doi":"10.1016/j.jcjd.2019.07.003","title":"Dyslipidemia Management in Adults With Diabetes","year":2019,"lang":"en","type":"review","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Dyslipidemia; Diabetes mellitus; Diabetes management; Type 2 diabetes; Endocrinology","score_opus":0.019690029769655892,"score_gpt":0.26350931956632767,"score_spread":0.24381928979667178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959775262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00481919,0.9915646,7.413444e-7,0.00011375239,0.00041891614,0.0012673554,0.000026275737,0.000005309806,0.0017838625],"genre_scores_gemma":[0.001372227,0.99677444,0.00035872543,0.0003242986,0.00070363923,0.00004815411,0.000039636732,0.00010592093,0.00027297385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973781,0.00016252516,0.00094085076,0.00029945924,0.00043258365,0.00078645925],"domain_scores_gemma":[0.9975906,0.000070674694,0.0005396627,0.0006021671,0.00015675332,0.0010401118],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010095515,0.00041143582,0.0029758373,0.0011823834,0.000042867377,0.000040136005,0.0002999899,0.00028103858,0.00009131008],"category_scores_gemma":[0.00007561811,0.00027757778,0.00084025675,0.0005595047,0.00007051339,0.00009500235,0.000017492692,0.0009001524,0.00005163089],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002516887,0.000016242046,0.0073573287,0.051405866,0.0013214645,0.00022875294,0.000036082907,0.0000016103784,1.2913603e-8,0.000030905336,0.0010348886,0.9385643],"study_design_scores_gemma":[0.0012613068,0.00042575411,0.0026939465,0.11498792,0.0022382713,0.000022123717,0.000047371712,0.0000018838238,4.053975e-7,0.000011240729,0.8780191,0.00029065626],"about_ca_topic_score_codex":0.00017059765,"about_ca_topic_score_gemma":0.0019900408,"teacher_disagreement_score":0.93827367,"about_ca_system_score_codex":0.0007144952,"about_ca_system_score_gemma":0.0034054543,"threshold_uncertainty_score":0.99996763},"labels":[],"label_agreement":null},{"id":"W2960453033","doi":"10.1016/j.cjca.2019.04.008","title":"Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Amgen (Canada); University of Calgary","funders":"Government of Alberta; Calgary Laboratory Services; Amgen","keywords":"Medicine; Guideline; Internal medicine; Atherosclerotic cardiovascular disease; Statin; Disease; Cholesterol; Cohort; Retrospective cohort study; Clinical trial; Lipid profile; Physical therapy; Pathology","score_opus":0.012041574861713013,"score_gpt":0.23254578404343584,"score_spread":0.22050420918172284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960453033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967569,0.0008604559,0.00003814338,0.00025538946,0.00023528372,0.0014469551,0.000004588656,0.0000023783516,0.00039987144],"genre_scores_gemma":[0.99886984,0.0005454884,0.00005569083,0.00016293305,0.00025418328,0.000027211347,0.0000070614424,0.000026174304,0.00005141864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803513,0.00039765707,0.00054607866,0.00034606786,0.0002463638,0.0004286999],"domain_scores_gemma":[0.9982217,0.000045046007,0.00010921321,0.00061390415,0.00010029939,0.00090984686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078057265,0.0002059899,0.0011992223,0.0003264028,0.000029567276,0.000014949154,0.00009450882,0.00013209727,0.0000053602603],"category_scores_gemma":[0.00006950156,0.00015393588,0.0004855109,0.00015847925,0.0001084337,0.00006934582,0.000017217655,0.00030340333,0.000010807056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003932693,0.000033569322,0.94264734,0.00008852538,0.0011771099,0.0012227241,0.000100159334,0.0009964085,4.3693652e-7,0.00001281941,0.00001168068,0.05331593],"study_design_scores_gemma":[0.01333232,0.0013143164,0.97897184,0.0002857662,0.00040990286,0.00009988581,0.000057491186,0.00001735395,0.000002033675,0.0000126558825,0.0053577456,0.00013870328],"about_ca_topic_score_codex":0.029631197,"about_ca_topic_score_gemma":0.016562058,"teacher_disagreement_score":0.053177226,"about_ca_system_score_codex":0.00044416834,"about_ca_system_score_gemma":0.00063211104,"threshold_uncertainty_score":0.9768306},"labels":[],"label_agreement":null},{"id":"W2962747389","doi":"10.5114/pg.2019.86746","title":"Inherited thrombophilia in a patient with colorectal carcinoma","year":2019,"lang":"en","type":"article","venue":"Gastroenterology Review","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Thrombophilia; Colorectal cancer; Gastroenterology; Cancer; Thrombosis","score_opus":0.007944968894801431,"score_gpt":0.23422971711413418,"score_spread":0.22628474821933275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962747389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765875,0.01983283,0.000008257593,0.0012027855,0.00007500434,0.0018117749,0.0000029140963,0.000022301054,0.0004566577],"genre_scores_gemma":[0.9883107,0.004723866,0.00024552245,0.006499626,0.000031933516,0.00012789996,0.000024079573,0.000018444383,0.00001791795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986931,0.00016317039,0.00030201938,0.00029773117,0.0001990451,0.00034491756],"domain_scores_gemma":[0.9993417,0.000006090625,0.000077860284,0.00041437274,0.00005488075,0.00010508079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026849916,0.00014932654,0.0007790114,0.000058501297,0.000013319504,0.0000026056796,0.000060070102,0.00005366347,0.00020954922],"category_scores_gemma":[0.0000137991,0.000103214166,0.00014756138,0.00016675108,0.000043341344,0.000032897173,0.000038286293,0.00023741147,0.00009576705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005092513,0.00014558394,0.9898893,0.0027391731,0.00009494723,0.00036874387,0.000056174405,8.79468e-7,0.00014675967,0.000010645898,0.00031716176,0.0057213297],"study_design_scores_gemma":[0.0033197482,0.0060223266,0.9758195,0.0036270882,0.0001615605,0.003946548,0.000027163573,0.000014246531,0.0000216403,0.0000032282808,0.0069457106,0.000091210786],"about_ca_topic_score_codex":0.000070527254,"about_ca_topic_score_gemma":0.000080540965,"teacher_disagreement_score":0.015108965,"about_ca_system_score_codex":0.00006918766,"about_ca_system_score_gemma":0.000062361694,"threshold_uncertainty_score":0.42089516},"labels":[],"label_agreement":null},{"id":"W2963429759","doi":"10.1016/j.jacc.2019.03.013","title":"Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":237,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"","keywords":"Medicine; Acute coronary syndrome; Alirocumab; Cardiology; Internal medicine; Intensive care medicine; Myocardial infarction","score_opus":0.004433949634475362,"score_gpt":0.2205717679473544,"score_spread":0.21613781831287904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963429759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970783,0.0009983714,0.000018167906,0.0011271583,0.00015460553,0.00051275763,0.00003245843,0.0000023311618,0.00007586544],"genre_scores_gemma":[0.9985507,0.0007977152,0.00019091071,0.0003448726,0.000050832667,0.0000031287877,0.0000015593616,0.000015693911,0.00004459354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986128,0.00025629517,0.00034850073,0.00013796704,0.00045688247,0.00018754479],"domain_scores_gemma":[0.998791,0.000030750456,0.0003934422,0.00043606764,0.00018874262,0.00016004241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039629592,0.00011728738,0.0010357678,0.00012104912,0.000022398266,0.0000016630273,0.00012941264,0.000031277097,0.0000071668496],"category_scores_gemma":[0.000043034375,0.00006605557,0.00030680172,0.00028392408,0.00021540863,0.000047248777,0.00006782629,0.00022678725,0.0000010163967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033783,0.000057966925,0.9917771,0.000050236107,0.0014635946,0.000664352,0.000010770861,0.00007689808,0.000040218605,0.000017832312,0.00016728207,0.002295413],"study_design_scores_gemma":[0.0041426327,0.0024644327,0.98802006,0.00012779864,0.00054761965,0.0024989967,0.000083752886,0.0000031946506,0.000011082974,0.00002714312,0.0020011067,0.000072149305],"about_ca_topic_score_codex":0.000015192136,"about_ca_topic_score_gemma":0.0000010607079,"teacher_disagreement_score":0.0037570458,"about_ca_system_score_codex":0.00010390427,"about_ca_system_score_gemma":0.00032305846,"threshold_uncertainty_score":0.26936677},"labels":[],"label_agreement":null},{"id":"W2963459076","doi":"10.1016/j.jacc.2019.05.043","title":"Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Genome British Columbia; Canada Foundation for Innovation","keywords":"Medicine; Familial hypercholesterolemia; Confidence interval; Hazard ratio; Internal medicine; Unstable angina; Myocardial infarction; Cardiology; Cholesterol","score_opus":0.006016704244508267,"score_gpt":0.22328966114500198,"score_spread":0.21727295690049372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963459076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826545,0.0004480832,0.000018947067,0.0001521611,0.0003355673,0.0006137733,0.00008850073,0.000002440814,0.00007508642],"genre_scores_gemma":[0.9993477,0.00017688198,0.00020240856,0.00006646501,0.00015714874,0.000003302646,0.0000011579348,0.000020937598,0.00002399664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981238,0.000469402,0.00051438325,0.0001493173,0.00053051865,0.000212581],"domain_scores_gemma":[0.9980075,0.0000877572,0.00088038907,0.00063296396,0.0002567182,0.00013470517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049648236,0.00014428998,0.0011956767,0.0001359154,0.000020184509,0.0000012860851,0.00023921365,0.000058029633,0.0000037861112],"category_scores_gemma":[0.00015632735,0.00008267469,0.0006753619,0.0003576405,0.00023994855,0.000043564934,0.00006103004,0.00040552003,0.0000013303347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013614828,0.000077981334,0.9825125,0.00007458112,0.0009337791,0.000019012557,0.000032652137,0.0015814742,0.00039171823,0.0000055307205,0.00005386326,0.00070211885],"study_design_scores_gemma":[0.007989985,0.0030200167,0.9876084,0.00017005336,0.00067149615,0.00004172437,0.0001485698,0.000014851258,0.000087891945,0.000012632296,0.000161233,0.00007316755],"about_ca_topic_score_codex":0.000049292285,"about_ca_topic_score_gemma":0.000006301459,"teacher_disagreement_score":0.005624843,"about_ca_system_score_codex":0.00012779969,"about_ca_system_score_gemma":0.00044011528,"threshold_uncertainty_score":0.3371376},"labels":[],"label_agreement":null},{"id":"W2964516039","doi":"10.1016/j.atherosclerosis.2019.06.167","title":"Reduction Of Plasma Lipoprotein(A) With Antisense Oligonucleotides In Human Subjects Does Not Affect Fibrinolysis","year":2019,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lipoprotein(a); Fibrinolysis; Lipoprotein; Apolipoprotein B; Internal medicine; Medicine; Endocrinology; Biology; Pharmacology; Cholesterol","score_opus":0.013372900432997764,"score_gpt":0.24185256012557244,"score_spread":0.22847965969257467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964516039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974799,0.00006942281,0.000013267606,0.00016812705,0.0001099231,0.0012657716,0.000009280284,0.000072955554,0.00081131345],"genre_scores_gemma":[0.99821955,0.00016056788,0.00088569144,0.000046523695,0.00013571847,0.000054825345,0.000009742604,0.000061819985,0.00042556407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812126,0.000111737245,0.0003688915,0.00047815772,0.00054683,0.00037313055],"domain_scores_gemma":[0.9987825,0.0000282191,0.0001708238,0.0008128493,0.00009019794,0.00011541603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047889663,0.00023852644,0.000733718,0.00021461124,0.00006611618,0.000019982488,0.00009648334,0.00013938414,0.00009454227],"category_scores_gemma":[0.000019679866,0.00016425691,0.0002740512,0.00047150368,0.000099904784,0.0001654334,0.000042034677,0.00021318553,0.000032338263],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035164464,0.00020603006,0.075797245,0.0005342214,0.0002237398,0.000008110939,0.00046848968,0.000040882012,0.90969723,0.00012844677,0.00001179069,0.012532178],"study_design_scores_gemma":[0.0024644192,0.00082081597,0.36701044,0.0006663145,0.000109268934,0.000032690565,0.00023752333,0.000029167848,0.6283956,0.0000100169045,0.000053682892,0.00017005691],"about_ca_topic_score_codex":0.0034663053,"about_ca_topic_score_gemma":0.0002460616,"teacher_disagreement_score":0.29121318,"about_ca_system_score_codex":0.00009782684,"about_ca_system_score_gemma":0.00006786212,"threshold_uncertainty_score":0.66982025},"labels":[],"label_agreement":null},{"id":"W2965219717","doi":"10.1016/j.cjca.2019.07.629","title":"Finding the Familial Hypercholesterolemia Needle in Acute Coronary Syndrome: The Haystack Is Smaller Than You Think","year":2019,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Population; Acute coronary syndrome; Internal medicine; Statin; Disease; Atherosclerotic cardiovascular disease; Pediatrics; Cholesterol; Myocardial infarction","score_opus":0.02482507150326643,"score_gpt":0.24421193031953,"score_spread":0.21938685881626357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965219717","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32959145,0.006134529,0.0000723494,0.6550473,0.004385872,0.0012501867,0.00015732668,0.000008699777,0.0033523294],"genre_scores_gemma":[0.5874511,0.00072714326,0.000028707856,0.40123466,0.008135592,0.000017575436,0.000070820686,0.000098016404,0.0022363735],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99642324,0.0008142611,0.0008046091,0.0003732437,0.00059243443,0.0009922143],"domain_scores_gemma":[0.99762326,0.00019392617,0.00037842654,0.0012315231,0.00023660713,0.00033626152],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019346958,0.0004306468,0.0017094833,0.00048238027,0.00021514122,0.00006130962,0.00087201415,0.0012413135,0.000056423552],"category_scores_gemma":[0.00010980477,0.00024361708,0.0012725947,0.00025217113,0.00034769185,0.00008454304,0.00006092823,0.005825117,0.00007118023],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087557004,0.0000016729978,0.027652415,0.00012309384,0.0029047022,0.025086202,0.0010416843,0.00014056903,0.000009446674,0.0000068513855,0.9398967,0.0030491152],"study_design_scores_gemma":[0.0012316665,0.00040035698,0.13611232,0.0003117313,0.00077089487,0.052388914,0.00041543646,0.000004826119,0.0000017206315,0.000040360163,0.8081071,0.00021469308],"about_ca_topic_score_codex":0.005209808,"about_ca_topic_score_gemma":0.0015054821,"teacher_disagreement_score":0.25785968,"about_ca_system_score_codex":0.0007944902,"about_ca_system_score_gemma":0.005609375,"threshold_uncertainty_score":0.9964685},"labels":[],"label_agreement":null},{"id":"W2965327853","doi":"10.1177/2047487319864671","title":"Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy","year":2019,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":360,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"National Institutes of Health; Esperion Therapeutics; Ionis Pharmaceuticals; Mylan; National Institute for Health and Care Research; Medicines Company; Amarin Corporation; Sanofi; Kowa Company; Regeneron Pharmaceuticals; American Heart Association; Pfizer; Amgen; Abbott Diagnostics; European Atherosclerosis Society; Eli Lilly and Company","keywords":"Ezetimibe; Medicine; Internal medicine; Placebo; Statin; Clinical endpoint; Fixed-dose combination; Familial hypercholesterolemia; Combination therapy; Cholesterol; Gastroenterology; Endocrinology; Clinical trial; Pathology","score_opus":0.006406354205373587,"score_gpt":0.20842791978387187,"score_spread":0.2020215655784983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965327853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972023,0.0005842671,0.00067927,0.00008421139,0.00007745457,0.0008317967,0.000016500124,0.000011671449,0.0005125462],"genre_scores_gemma":[0.9983543,0.0005572979,0.0006863649,0.00014968768,0.00008149035,0.00000427072,0.000047222515,0.00004848019,0.00007085441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966164,0.0020389366,0.00046808287,0.00028129682,0.00033832053,0.00025694654],"domain_scores_gemma":[0.998644,0.000039708262,0.00043341314,0.00027537512,0.00046486245,0.0001426477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013398961,0.00022466923,0.00082807767,0.00021779709,0.00004440437,0.000019470683,0.00009808387,0.000053223805,0.00002015091],"category_scores_gemma":[0.000042281026,0.0001432998,0.00012557706,0.00020383707,0.000093959,0.00013985613,0.000032457963,0.0005143808,0.000011205359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008560147,0.00019823188,0.9364104,0.00005722337,0.0011720854,0.0006906377,0.0005323829,0.0003757186,0.000628838,0.000007102547,0.0000522733,0.051314935],"study_design_scores_gemma":[0.029934062,0.010141041,0.95828074,0.0002874263,0.00018136301,0.00027900972,0.00011617835,0.000013312041,0.0002334077,0.000006441367,0.00037946692,0.00014756247],"about_ca_topic_score_codex":0.000030168441,"about_ca_topic_score_gemma":0.0000042773713,"teacher_disagreement_score":0.051167373,"about_ca_system_score_codex":0.00011303323,"about_ca_system_score_gemma":0.00012148485,"threshold_uncertainty_score":0.5843596},"labels":[],"label_agreement":null},{"id":"W2966051937","doi":"10.1016/j.atherosclerosis.2019.06.020","title":"Efficacy and Safety of Bempedoic Acid + Ezetimibe Fixed-Dose Combination in Patients at High CVD Risk and with Elevated LDL-C Receiving Maximally Tolerated Statin Therapy","year":2019,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Ezetimibe; Medicine; Statin; Pharmacology; Ldl cholesterol; Combination therapy; Fixed-dose combination; Internal medicine; Cholesterol; Gastroenterology; Chemistry","score_opus":0.007735542667518523,"score_gpt":0.20853281863478557,"score_spread":0.20079727596726704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966051937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978283,0.0002586678,0.000028345567,0.00011971584,0.000042607433,0.0015969235,0.00003233725,0.000034302047,0.00005882399],"genre_scores_gemma":[0.9965283,0.0025387704,0.0005554757,0.00014411157,0.0000116588,0.00002899952,0.00008742279,0.00004555773,0.000059652997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983454,0.00019700649,0.00038705967,0.00039476136,0.00040737804,0.0002684083],"domain_scores_gemma":[0.9990395,0.00007546866,0.00022093665,0.00038802263,0.00016324571,0.00011286884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050399004,0.00021699448,0.00054166577,0.000109205626,0.0000862854,0.00001913108,0.00005535594,0.00012221269,0.00006376309],"category_scores_gemma":[0.00005126566,0.00016730525,0.0000503985,0.0003419922,0.00007351741,0.00010708782,0.000048421116,0.00019532682,0.0000064607466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029683681,0.00046164263,0.9334188,0.00012863912,0.00017042419,9.240563e-7,0.001101332,0.000021051843,0.019031065,0.000015129841,0.000013887816,0.04266871],"study_design_scores_gemma":[0.024306286,0.0023645542,0.9638987,0.00040636506,0.00005844437,0.0000018897732,0.00006137183,0.00012258474,0.008517389,0.000008787824,0.00008216004,0.00017145315],"about_ca_topic_score_codex":0.0011732245,"about_ca_topic_score_gemma":0.000098509816,"teacher_disagreement_score":0.04249726,"about_ca_system_score_codex":0.000108365835,"about_ca_system_score_gemma":0.000051869552,"threshold_uncertainty_score":0.68225104},"labels":[],"label_agreement":null},{"id":"W2966321577","doi":"10.1136/jmedgenet-2019-106102","title":"Hypolipidaemia among patients with PMM2-CDG is associated with low circulating PCSK9 levels: a case report followed by observational and experimental studies","year":2019,"lang":"en","type":"article","venue":"Journal of Medical Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Hospital for Sick Children; Hamilton Health Sciences; University of Toronto; McMaster University; Population Health Research Institute","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Fondation Leducq","keywords":"PCSK9; LDL receptor; Kexin; Internal medicine; Proband; Glycosylation; Endocrinology; Proprotein convertase; Medicine; Biology; Cholesterol; Lipoprotein; Mutation; Genetics; Gene","score_opus":0.03575523309084041,"score_gpt":0.3079722673685239,"score_spread":0.2722170342776835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966321577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957406,0.0031110288,0.00011050784,0.00044357157,0.00017661776,0.00036484556,0.000008564588,0.000007999119,0.00003628884],"genre_scores_gemma":[0.99794716,0.00006722357,0.00094435766,0.0006634568,0.00024913703,0.0000050456397,0.000012277192,0.000028844492,0.00008248641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629456,0.00008378227,0.00065911165,0.00021050597,0.0025035916,0.00024844363],"domain_scores_gemma":[0.9981393,0.000099084034,0.00056286954,0.00020781349,0.0005607633,0.00043011812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011400956,0.00017856051,0.0006448705,0.000058792866,0.00008875307,0.000021355925,0.00007093356,0.00015738313,0.00006602502],"category_scores_gemma":[0.0005170078,0.00011347283,0.000119191,0.00015404573,0.00013491292,0.000080798556,0.000051588315,0.00040455163,6.7798277e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017362436,0.00038893006,0.97562337,0.00015346183,0.0019364118,0.016375711,0.001322252,0.000022238875,0.0002816444,0.0000017930216,0.0014025929,0.002317963],"study_design_scores_gemma":[0.025897712,0.004366052,0.90478516,0.0035954865,0.0009864216,0.050755493,0.0047957785,0.0010514243,0.0024122368,0.0000118672015,0.00081888883,0.000523457],"about_ca_topic_score_codex":0.000030634772,"about_ca_topic_score_gemma":0.000009718015,"teacher_disagreement_score":0.0708382,"about_ca_system_score_codex":0.00017595637,"about_ca_system_score_gemma":0.00046497936,"threshold_uncertainty_score":0.46272877},"labels":[],"label_agreement":null},{"id":"W2966792429","doi":"10.1111/febs.15036","title":"Functional analysis of natural <scp>PCSK</scp>9 mutants in modern and archaic humans","year":2019,"lang":"en","type":"article","venue":"FEBS Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Fondation Leducq","keywords":"Biology; Genetics; DNA methylation; Mutation; Gene; Gene expression","score_opus":0.013979034853421715,"score_gpt":0.2536267164671701,"score_spread":0.2396476816137484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966792429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946012,0.0037225597,0.00054897857,0.00009679088,0.00021071918,0.0001545739,0.0000059040995,0.000006559967,0.00065273384],"genre_scores_gemma":[0.99839294,0.00029526663,0.00018676594,0.00014361177,0.00022713149,0.0000020611128,0.000011580283,0.00001111306,0.0007295109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986162,0.00007066489,0.00032262885,0.00016952193,0.0005649274,0.00025602785],"domain_scores_gemma":[0.99935305,0.00004534813,0.00011902967,0.0002109946,0.00011681253,0.00015474977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075565977,0.000102345024,0.00049668475,0.0005276695,0.000050507562,0.0000170585,0.000053432075,0.0000673007,0.00010407488],"category_scores_gemma":[0.00007705494,0.000078897865,0.00031279091,0.000437525,0.000035516616,0.000090018846,0.000028168515,0.0004792621,0.0000075372445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001738422,0.00020925299,0.9476007,0.00020497106,0.004083767,0.00019943774,0.0018428717,0.0014626336,0.008866489,0.0001797584,0.00036376354,0.034812473],"study_design_scores_gemma":[0.0019584433,0.00014770856,0.9898529,0.00008626802,0.0005550119,0.0004160059,0.0004108375,0.0056533003,0.00019248835,0.00026066252,0.0004274961,0.000038883936],"about_ca_topic_score_codex":0.00006811712,"about_ca_topic_score_gemma":0.00007777931,"teacher_disagreement_score":0.042252153,"about_ca_system_score_codex":0.0000783023,"about_ca_system_score_gemma":0.00014181728,"threshold_uncertainty_score":0.32173616},"labels":[],"label_agreement":null},{"id":"W2968129698","doi":"10.1503/cmaj.190107","title":"Proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors","year":2019,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Kexin; Proprotein convertase; Subtilisin; PCSK9; Medicine; Computer science; Bioinformatics; Endocrinology; LDL receptor; Biology; Biochemistry; Cholesterol; Enzyme; Lipoprotein","score_opus":0.005860739606589788,"score_gpt":0.2256319742155583,"score_spread":0.21977123460896852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968129698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9596892,0.00085337926,0.000018254617,0.028888466,0.0022162949,0.00069041224,0.000011436429,0.000034431858,0.007598127],"genre_scores_gemma":[0.9787588,0.00012824414,0.00011543316,0.013745447,0.003281962,0.000007914944,0.000025418656,0.000033693697,0.0039031007],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964087,0.00018115363,0.00045144104,0.00020865456,0.0021613538,0.0005886844],"domain_scores_gemma":[0.99642015,0.0000407837,0.00016798332,0.00024468423,0.0006226409,0.0025037813],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0027091787,0.00014338036,0.0003904947,0.00019328976,0.00015771632,0.0000624596,0.00012683103,0.00047345785,0.009085116],"category_scores_gemma":[0.001476301,0.00011898732,0.00023057009,0.00028814803,0.000027449894,0.00010881695,0.000013738697,0.0012311451,0.0016479153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016996887,0.00016700574,0.47587457,0.0002542707,0.0009841821,0.003231011,0.00064885546,0.000004481197,0.00044918034,0.0005309599,0.24879165,0.26889387],"study_design_scores_gemma":[0.0028934553,0.00031961215,0.04208274,0.00025796331,0.000069614885,0.0013535143,0.00029771007,0.00013157396,0.00042581695,0.00006617488,0.95189184,0.00020996864],"about_ca_topic_score_codex":0.0065555116,"about_ca_topic_score_gemma":0.0067561255,"teacher_disagreement_score":0.7031002,"about_ca_system_score_codex":0.0014122747,"about_ca_system_score_gemma":0.0077060373,"threshold_uncertainty_score":0.9991294},"labels":[],"label_agreement":null},{"id":"W2969533384","doi":"10.1101/743195","title":"A transient amphipathic helix in PCSK9’s prodomain facilitates low-density lipoprotein binding","year":2019,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Pfizer","keywords":"Proprotein convertase; Kexin; LDL receptor; PCSK9; Familial hypercholesterolemia; Chemistry; Biophysics; Allosteric regulation; Alanine; Helix (gastropod); Biochemistry; Plasma protein binding; Endosome; Lipoprotein; Receptor; Cholesterol; Amino acid; Biology","score_opus":0.014530569944435932,"score_gpt":0.2260223886211694,"score_spread":0.21149181867673347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969533384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863859,0.0036675239,0.0013960629,0.0007698946,0.0011526993,0.005940545,0.00022366141,0.00044868328,0.0000150526985],"genre_scores_gemma":[0.9944659,0.000522166,0.0030010564,0.00032099077,0.0006596852,0.0007781549,0.0000022458587,0.0002275897,0.00002220627],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9935583,0.0005224548,0.0011966749,0.002048246,0.0013828684,0.0012914941],"domain_scores_gemma":[0.9952975,0.00006595709,0.00041262334,0.0030411426,0.00055545976,0.00062730355],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003724546,0.0010022988,0.0020248303,0.0008160485,0.00016333368,0.00015473898,0.00048248968,0.0012118503,0.000053410164],"category_scores_gemma":[0.00050875475,0.0010015501,0.0007874735,0.00095623103,0.00016931583,0.00016164807,0.00042043434,0.0024602413,0.0003406359],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007194138,0.0012767601,0.025064284,0.018909872,0.0010857321,0.0013677913,0.00028089495,0.00022971639,0.9505522,0.00025681843,0.00012260361,0.00013391061],"study_design_scores_gemma":[0.007790908,0.0006814909,0.5414846,0.013376657,0.00073582545,0.0000010064516,0.000067394685,0.0007777917,0.42256096,0.0000075518738,0.009465733,0.0030501087],"about_ca_topic_score_codex":0.0010618664,"about_ca_topic_score_gemma":0.000051606785,"teacher_disagreement_score":0.52799124,"about_ca_system_score_codex":0.0011941314,"about_ca_system_score_gemma":0.002100814,"threshold_uncertainty_score":0.9998411},"labels":[],"label_agreement":null},{"id":"W2969612059","doi":"10.11591/ijphs.v8i3.20060","title":"Detection of lipoprotein(a)- cholesterol expression in Bangladeshi adults with dyslipidemia","year":2019,"lang":"en","type":"article","venue":"International Journal of Public Health Science (IJPHS)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Dyslipidemia; Medicine; Internal medicine; Population; Hypertriglyceridemia; Body mass index; Endocrinology; Hyperlipidemia; Lipoprotein; Apolipoprotein B; Cholesterol; Triglyceride; Obesity; Diabetes mellitus; Environmental health","score_opus":0.02186325393419039,"score_gpt":0.3086990431482686,"score_spread":0.28683578921407826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969612059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899186,0.00028815636,0.0025326565,0.0054757344,0.00085488125,0.00057041756,0.0000027439369,0.000010509241,0.0003462974],"genre_scores_gemma":[0.99678415,0.00010876255,0.0018744871,0.00075259653,0.0004187731,0.000009805563,0.0000019965728,0.000013149735,0.000036262445],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99557674,0.000109961315,0.0009463584,0.00029020157,0.0026398364,0.00043689852],"domain_scores_gemma":[0.99679786,0.000035863224,0.0008936135,0.00033010787,0.0014494043,0.0004931267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006647879,0.00013515925,0.0004796914,0.0010472642,0.000057964735,0.000060380342,0.0005426732,0.000078331635,0.0000612879],"category_scores_gemma":[0.0003701916,0.0000947348,0.00014096514,0.00081366464,0.0001715965,0.001027332,0.00007408072,0.0004935158,0.000009373324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010881567,0.00070188794,0.1827384,0.00054468994,0.00011538786,0.00007129788,0.002576163,0.00019464821,0.06225567,0.00021826023,0.0000615477,0.7494339],"study_design_scores_gemma":[0.008179764,0.002813236,0.9466524,0.0032003473,0.000010294066,0.001297264,0.0015974618,0.00081143464,0.029552877,0.000055827237,0.005640378,0.00018868866],"about_ca_topic_score_codex":0.0005496913,"about_ca_topic_score_gemma":0.00014745438,"teacher_disagreement_score":0.76391405,"about_ca_system_score_codex":0.00074157305,"about_ca_system_score_gemma":0.0028088216,"threshold_uncertainty_score":0.49827293},"labels":[],"label_agreement":null},{"id":"W2969747169","doi":"10.1371/journal.pone.0220254","title":"Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer’s disease: A genetic and proteomic multi-cohort study","year":2019,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University; Douglas Mental Health University Institute","funders":"Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; McGill University","keywords":"PCSK9; Kexin; Internal medicine; Apolipoprotein B; Endocrinology; Proprotein convertase; LDL receptor; Alzheimer's disease; Apolipoprotein E; Medicine; Cholesterol; Lipoprotein; Biology; Disease","score_opus":0.04278302162070848,"score_gpt":0.2640516438290552,"score_spread":0.22126862220834673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969747169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97952163,0.0049504144,0.0000044203116,0.00020325757,0.000043206397,0.015132263,0.000008915646,0.00006312619,0.00007276449],"genre_scores_gemma":[0.9961491,0.00014641382,0.0022987102,0.00015615816,0.00010810331,0.0007510272,0.000021533968,0.000054828517,0.00031412079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977721,0.00016741481,0.00035781012,0.00060577,0.00072571245,0.00037118403],"domain_scores_gemma":[0.9985729,0.000013502487,0.0000713358,0.0008727758,0.00013391844,0.00033559784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005710382,0.00023145911,0.0007008761,0.0001395763,0.00004453684,0.000024717425,0.00009331529,0.00008809668,0.00015158993],"category_scores_gemma":[0.00012466744,0.00019760111,0.0000773134,0.00021922194,0.000049319806,0.00007174732,0.000079106394,0.00029918773,0.00021967331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006113471,0.0058468273,0.98449004,0.00054603955,0.00081190007,0.00023788547,0.00023981441,0.0000011697135,0.005746564,0.000004319426,0.000005285803,0.0014588091],"study_design_scores_gemma":[0.005424642,0.0010127048,0.9875214,0.0004009072,0.0009437172,0.000011760211,0.00010588909,0.00077269855,0.003538346,0.0000117624395,0.000024192548,0.00023197482],"about_ca_topic_score_codex":0.0010653634,"about_ca_topic_score_gemma":0.00010849235,"teacher_disagreement_score":0.016627474,"about_ca_system_score_codex":0.00006239936,"about_ca_system_score_gemma":0.0002925474,"threshold_uncertainty_score":0.80579394},"labels":[],"label_agreement":null},{"id":"W2970027184","doi":"10.1891/9780826194985.0010c","title":"Atherosclerosis and Hyperlipidaemia, Canadian Guideline","year":2019,"lang":"en","type":"book-chapter","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Medicine; Internal medicine; Cardiology; Pathology","score_opus":0.018562912636166294,"score_gpt":0.23051064372131685,"score_spread":0.21194773108515055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970027184","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000487369,0.0024137485,0.00004206703,0.0017095418,0.00023747339,0.0008114907,0.00004185854,0.000048951613,0.9942075],"genre_scores_gemma":[0.0039660814,0.002265916,0.0012078871,0.006537576,0.0009532045,0.000005714128,0.00012737182,0.00011302411,0.9848232],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863154,0.0000065456015,0.0003336655,0.0003986067,0.0003370181,0.00029262784],"domain_scores_gemma":[0.9984921,0.000009723296,0.000058107547,0.0007279842,0.00013467763,0.000577382],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003164101,0.0002747086,0.0006662465,0.00016231478,0.00006051989,0.000019251396,0.000058246565,0.0004611195,0.0025203072],"category_scores_gemma":[0.00001427859,0.00022148389,0.00026863418,0.000016057025,0.00004248701,0.0000236167,0.000035298854,0.00034508915,0.0004851338],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006058136,0.000033100983,0.0031298562,0.0016958265,0.0025325688,0.00013877332,0.00017424456,0.0000023458495,0.00028240285,0.18595083,0.26064584,0.5453536],"study_design_scores_gemma":[0.0006238448,0.00011432914,0.0009027591,0.00026773696,0.0002488634,0.000114358314,0.000010044871,0.00001591257,0.000013852033,0.00016054469,0.997287,0.00024076641],"about_ca_topic_score_codex":0.09691323,"about_ca_topic_score_gemma":0.05716657,"teacher_disagreement_score":0.7366411,"about_ca_system_score_codex":0.00022005712,"about_ca_system_score_gemma":0.0010565438,"threshold_uncertainty_score":0.9983915},"labels":[],"label_agreement":null},{"id":"W2970115505","doi":"10.1001/jamacardio.2019.2851","title":"Cost-effectiveness of Low-density Lipoprotein Cholesterol Level–Guided Statin Treatment in Patients With Borderline Cardiovascular Risk","year":2019,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Statin; Internal medicine; Cohort; National Health and Nutrition Examination Survey; Cohort study; Emergency medicine; Physical therapy; Environmental health; Population","score_opus":0.022559415191593782,"score_gpt":0.2686393805182192,"score_spread":0.2460799653266254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970115505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899932,0.00063442026,0.0017797753,0.000033172906,0.00019654096,0.0068215206,0.00014511448,0.000042227297,0.00035400773],"genre_scores_gemma":[0.99832124,0.00018863598,0.00051260076,0.000059023292,0.00017637489,0.00041956393,0.00022551189,0.00005898611,0.000038046168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959106,0.0015820231,0.0005420174,0.0007530248,0.0006637699,0.00054858235],"domain_scores_gemma":[0.99747187,0.00014170098,0.00020076089,0.0015364633,0.00046923134,0.00017997375],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020756715,0.00038774172,0.0023101598,0.00022064587,0.000047452202,0.000010928764,0.00012217178,0.00033235524,0.000016204442],"category_scores_gemma":[0.00017102816,0.0002840945,0.00082886877,0.00034182012,0.00011814773,0.000100757024,0.00006861687,0.00039975488,0.000034373756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00249427,0.00037225508,0.8627048,0.0006974671,0.0032175507,0.00009928007,0.0001551031,0.0033586877,0.000108752916,0.000013837419,0.000011061999,0.12676695],"study_design_scores_gemma":[0.027628373,0.0027384935,0.96425605,0.0003040024,0.000505809,0.000059073343,0.00006833022,0.000039170733,0.0025471298,0.00001678003,0.0015780585,0.0002587215],"about_ca_topic_score_codex":0.008992494,"about_ca_topic_score_gemma":0.00020356779,"teacher_disagreement_score":0.12650822,"about_ca_system_score_codex":0.0005101358,"about_ca_system_score_gemma":0.00032157396,"threshold_uncertainty_score":0.99996114},"labels":[],"label_agreement":null},{"id":"W2970157666","doi":"10.1016/j.jacc.2019.07.016","title":"How the Cow Ate the CABG","year":2019,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Cardiology","score_opus":0.015334983932412593,"score_gpt":0.24759228846135917,"score_spread":0.23225730452894658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970157666","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021664185,0.003985382,0.00014694851,0.9690718,0.0023850545,0.0009780207,0.00013975271,0.000006055158,0.0016228078],"genre_scores_gemma":[0.31684145,0.0028823977,0.00014859116,0.6396585,0.029695278,0.000025692541,0.000006819224,0.00011625096,0.010624995],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99569356,0.0017906112,0.00066102715,0.00022662536,0.001165854,0.00046228952],"domain_scores_gemma":[0.99458116,0.000617184,0.0022395323,0.0018976937,0.0006041918,0.000060223778],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0020530012,0.00032725354,0.0025220823,0.00012722319,0.00016227907,0.000016986427,0.0011885839,0.00029066057,0.000006796769],"category_scores_gemma":[0.00043262547,0.00012274635,0.0029578828,0.00044721624,0.0012692136,0.000034770033,0.00021122704,0.00331508,0.0000059860927],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022335933,0.000006010703,0.0010084898,0.000120325196,0.0031839467,0.00075003074,0.000026361226,0.00005515322,0.00008610347,0.000021449405,0.99278516,0.0017336247],"study_design_scores_gemma":[0.00085817697,0.0008389433,0.0074105086,0.00014724908,0.0016073525,0.014904772,0.00037630042,0.0000044331823,0.000049532802,0.00007328721,0.97360164,0.0001278304],"about_ca_topic_score_codex":0.00007236634,"about_ca_topic_score_gemma":0.0000048452516,"teacher_disagreement_score":0.32941326,"about_ca_system_score_codex":0.0001847737,"about_ca_system_score_gemma":0.0011320091,"threshold_uncertainty_score":0.99898434},"labels":[],"label_agreement":null},{"id":"W2970435958","doi":"10.1001/jamacardio.2019.3066","title":"Effectiveness of Interventions Aimed at Increasing Statin-Prescribing Rates in Primary Cardiovascular Disease Prevention","year":2019,"lang":"en","type":"review","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Ottawa Hospital; University of Ottawa; Libin Cardiovascular Institute of Alberta; Western University; St. Michael's Hospital; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Statin; Cochrane Library; Psychological intervention; MEDLINE; Randomized controlled trial; Clinical trial; Meta-analysis; Odds ratio; Publication bias; Funnel plot; Deprescribing; Internal medicine; Number needed to treat; Physical therapy; Polypharmacy; Emergency medicine; Relative risk; Confidence interval; Nursing","score_opus":0.06361427847778003,"score_gpt":0.3570659769402737,"score_spread":0.29345169846249364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970435958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011399998,0.98080134,0.001033574,0.0000065680006,0.000514187,0.005348848,0.00013582625,0.000046445737,0.0007131992],"genre_scores_gemma":[0.010546941,0.9861148,0.000219509,0.000011004177,0.0003609434,0.0007674267,0.0017651474,0.00011523369,0.00009901782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98868686,0.007876746,0.0013408003,0.0009632932,0.00059430546,0.0005379868],"domain_scores_gemma":[0.99653006,0.0007503678,0.0004688599,0.0018131942,0.00020452231,0.00023300001],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007573187,0.0005504203,0.006925181,0.00058704737,0.00006604328,0.00001716894,0.00023407814,0.0006144538,0.000018183819],"category_scores_gemma":[0.0009808505,0.00046801585,0.00890581,0.0005019216,0.00013461502,0.000120362245,0.00040126208,0.0007649473,0.000038774106],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005000136,0.00009359536,0.0015733719,0.29495895,0.0077372757,0.0003419986,0.000014264886,0.00010663801,0.000009591396,0.000034996083,0.000025120089,0.6946042],"study_design_scores_gemma":[0.007933805,0.0007195834,0.079074524,0.27050737,0.037566647,0.0017981711,0.000039205974,0.000018503019,0.000018472532,0.00010890082,0.6011301,0.0010847215],"about_ca_topic_score_codex":0.00038986639,"about_ca_topic_score_gemma":0.0000042635943,"teacher_disagreement_score":0.6935195,"about_ca_system_score_codex":0.0012634541,"about_ca_system_score_gemma":0.0011257621,"threshold_uncertainty_score":0.99977714},"labels":[],"label_agreement":null},{"id":"W297071309","doi":"10.1016/j.jacc.2015.02.025","title":"Using Age- and Sex-Specific Risk Thresholds to Guide Statin Therapy","year":2015,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Statin; Offspring; Framingham Risk Score; Internal medicine; Disease; Physical therapy; Pregnancy","score_opus":0.05001385835881012,"score_gpt":0.32331834874128473,"score_spread":0.2733044903824746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W297071309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120915,0.0034139208,0.0028071513,0.0010651434,0.00030368206,0.0003231306,0.00003164582,0.000004374036,0.00084178156],"genre_scores_gemma":[0.98600197,0.002148557,0.010253125,0.0006211856,0.0008353418,0.0000022010631,2.4530922e-7,0.000020870706,0.00011650002],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99818724,0.0005185673,0.00049500004,0.00013751561,0.00045240918,0.00020924535],"domain_scores_gemma":[0.9983479,0.000072953924,0.00055098435,0.00045980976,0.00031693155,0.00025146923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018641426,0.00012554452,0.0010906383,0.00013220997,0.000058113736,0.0000048467923,0.00017146753,0.000042911182,0.0000021691517],"category_scores_gemma":[0.00017725232,0.00007462052,0.00038522147,0.00033212107,0.00030007213,0.000032481814,0.000074816635,0.00026468685,6.2428666e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0086497,0.00021173905,0.5578585,0.00010479035,0.0070485966,0.0045049773,0.0022503068,0.012712233,0.034208965,0.000500616,0.13085905,0.2410905],"study_design_scores_gemma":[0.007088128,0.006645931,0.20354839,0.00015145869,0.00048036905,0.017174121,0.0061071757,0.00008018715,0.0024840995,0.00084092445,0.7550886,0.00031058912],"about_ca_topic_score_codex":0.00014053744,"about_ca_topic_score_gemma":0.000004525506,"teacher_disagreement_score":0.6242296,"about_ca_system_score_codex":0.00013347158,"about_ca_system_score_gemma":0.00043658045,"threshold_uncertainty_score":0.30429363},"labels":[],"label_agreement":null},{"id":"W2970851438","doi":"10.1016/j.jacc.2019.07.015","title":"Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery","year":2019,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Alirocumab; Bypass surgery; Cardiology; Internal medicine; Coronary artery bypass surgery; Cholesterol; Artery; Lipoprotein","score_opus":0.00614112704955248,"score_gpt":0.22856996210506295,"score_spread":0.22242883505551048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970851438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930378,0.0045668194,0.00009329722,0.00039998768,0.0010287018,0.0004805338,0.00002436329,0.0000047148806,0.0003637503],"genre_scores_gemma":[0.9980116,0.0008058159,0.00012979766,0.0003739932,0.00048798232,0.000011499738,6.982801e-7,0.000031525382,0.0001470894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690586,0.0008984359,0.00073179614,0.0001980686,0.0009772005,0.00028865758],"domain_scores_gemma":[0.9973294,0.00043228833,0.0008543781,0.000912731,0.0003390256,0.00013215984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014729669,0.00019911079,0.0027106644,0.00022729581,0.000026644055,0.0000010817347,0.0002434458,0.000091781054,0.000009440592],"category_scores_gemma":[0.00026820303,0.00012454318,0.0038070322,0.0003913801,0.00024042785,0.00004315275,0.00008973996,0.0003570347,0.0000062205495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016444944,0.00046349608,0.8856135,0.0025852253,0.035637118,0.0037038063,0.00008886485,0.002359034,0.010742353,0.000095740805,0.008273345,0.033992544],"study_design_scores_gemma":[0.0027527746,0.0022555843,0.9662194,0.0005848484,0.0016205099,0.0041903807,0.00010813644,0.000003404647,0.0053290506,0.00004602615,0.016733345,0.00015649358],"about_ca_topic_score_codex":0.000037548787,"about_ca_topic_score_gemma":5.523759e-7,"teacher_disagreement_score":0.08060592,"about_ca_system_score_codex":0.0001361862,"about_ca_system_score_gemma":0.00046681706,"threshold_uncertainty_score":0.5078723},"labels":[],"label_agreement":null},{"id":"W2971212205","doi":"10.1891/9780826194985.0012j","title":"Proteinuria, Canadian Guideline","year":2019,"lang":"en","type":"book-chapter","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Proteinuria; Medicine; Internal medicine; Pathology","score_opus":0.016223689408550183,"score_gpt":0.24555578192061417,"score_spread":0.229332092512064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971212205","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009754751,0.0022731447,0.00009756948,0.0029422892,0.000332385,0.002461477,0.00003914016,0.000074509255,0.99176973],"genre_scores_gemma":[0.0003715095,0.00022318223,0.0015978303,0.0055399225,0.0015379827,0.000016894974,0.00027911545,0.000120706194,0.9903129],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822384,0.000007792934,0.00043900427,0.00042147408,0.00054219493,0.00036569717],"domain_scores_gemma":[0.9978242,0.0000045855063,0.000080798796,0.0011940687,0.00025977145,0.0006365755],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00040116976,0.00031026686,0.0007354384,0.00022853319,0.000047147052,0.000015142246,0.00010002397,0.0005593551,0.013499532],"category_scores_gemma":[0.000020227684,0.00024620813,0.00051056326,0.000020673277,0.000029246059,0.000022117067,0.000028472892,0.00047770783,0.0040066424],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006528522,0.000020412037,0.000038467937,0.00092102314,0.0014289062,0.0009144638,0.000035268513,0.0000017583158,0.000022172482,0.25747716,0.47901192,0.26006314],"study_design_scores_gemma":[0.0006221098,0.00015785049,0.00003524319,0.000274327,0.00019882403,0.00017687037,0.000004039395,0.000009305591,0.000022013264,0.00080151646,0.99743515,0.00026273803],"about_ca_topic_score_codex":0.17005104,"about_ca_topic_score_gemma":0.12012089,"teacher_disagreement_score":0.51842326,"about_ca_system_score_codex":0.0004151181,"about_ca_system_score_gemma":0.0039171767,"threshold_uncertainty_score":0.99999905},"labels":[],"label_agreement":null},{"id":"W2971575888","doi":"10.1161/circulationaha.119.042551","title":"Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes","year":2019,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Université de Paris; Assistance publique-Hôpitaux de Paris; Imperial College London; Institut National de la Santé et de la Recherche Médicale; State University of New York; Sanofi","keywords":"Medicine; Alirocumab; Cardiology; Internal medicine; Acute coronary syndrome; Categorization; Association (psychology); Intensive care medicine; Cholesterol; Myocardial infarction; Lipoprotein","score_opus":0.03665739200627338,"score_gpt":0.32162081485239385,"score_spread":0.2849634228461205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971575888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9686282,0.00018383576,0.027833661,0.0005970305,0.00017155807,0.002485759,0.00004322146,0.000032910324,0.000023805653],"genre_scores_gemma":[0.9929595,0.00013159211,0.0062383753,0.0001367159,0.00014942855,0.000051022253,0.00012856667,0.00002665944,0.0001781267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998744,0.00009465577,0.00037166543,0.0003124002,0.0002952932,0.00018200405],"domain_scores_gemma":[0.99916506,0.00003695575,0.00027035535,0.00023051475,0.0001992263,0.00009791154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003965375,0.00014081455,0.00056960096,0.00015581764,0.00008541699,0.0000080693235,0.000025136684,0.0000607695,0.0000013646911],"category_scores_gemma":[0.00007286157,0.00013492437,0.00021041774,0.00031063275,0.000008565833,0.000117106916,0.000015777488,0.000039609557,0.000003891339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012787283,0.000023295846,0.95519,0.000085274216,0.0014068303,0.0000033723334,0.00017154889,0.011686545,0.0039352407,0.000084128675,0.00011050305,0.027175402],"study_design_scores_gemma":[0.0020740977,0.00047781144,0.98323154,0.000069988404,0.0011893228,0.00003102765,0.00021642038,0.011289114,0.00021155819,0.00004458198,0.0010398593,0.00012465043],"about_ca_topic_score_codex":0.0005433146,"about_ca_topic_score_gemma":0.000011674696,"teacher_disagreement_score":0.02804158,"about_ca_system_score_codex":0.0006637717,"about_ca_system_score_gemma":0.0000782371,"threshold_uncertainty_score":0.55020565},"labels":[],"label_agreement":null},{"id":"W2971968715","doi":"10.1161/atvbaha.119.313247","title":"Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor)","year":2019,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Université de Montréal; Montreal Clinical Research Institute","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Proprotein convertase; PCSK9; Kexin; Subtilisin; LDL receptor; Chemistry; Phosphorylation; Sequence (biology); Similarity (geometry); Biochemistry; Lipoprotein; Enzyme; Computer science; Cholesterol","score_opus":0.02988601374111497,"score_gpt":0.27418454282175714,"score_spread":0.24429852908064217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971968715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331355,0.00074078183,0.00041767256,0.0016215366,0.00017756439,0.0034574403,0.00015184908,0.00006454108,0.000055036457],"genre_scores_gemma":[0.9962846,0.0010672346,0.0008039467,0.0013138076,0.000086435306,0.0002414546,0.00013914859,0.000047038884,0.000016318701],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99646,0.00059328025,0.0006750024,0.0010826611,0.0005635727,0.000625447],"domain_scores_gemma":[0.9974967,0.00009196558,0.00027194552,0.0014107389,0.00039018426,0.0003384543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016934493,0.0004900366,0.0012160868,0.00008074503,0.00026563887,0.000048235637,0.00026570848,0.00037056548,0.00024124299],"category_scores_gemma":[0.0001071182,0.00032125093,0.00038465514,0.00039606696,0.00041162333,0.00018320813,0.00015517008,0.00040382863,0.00005899357],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012910564,0.00027977244,0.04831674,0.00044423508,0.0003914296,2.4624947e-7,0.00048143638,0.000004732567,0.9462061,0.0000741766,0.00017948964,0.003492545],"study_design_scores_gemma":[0.0020127296,0.0019694811,0.7249881,0.00038458852,0.00024656783,0.000002423573,0.00036968943,0.00013604575,0.26641554,0.000029315026,0.0029991192,0.0004463802],"about_ca_topic_score_codex":0.0041824016,"about_ca_topic_score_gemma":0.0004953342,"teacher_disagreement_score":0.67979056,"about_ca_system_score_codex":0.00012020752,"about_ca_system_score_gemma":0.00017618386,"threshold_uncertainty_score":0.99992394},"labels":[],"label_agreement":null},{"id":"W2972496016","doi":"10.1210/jendso/bvz015","title":"Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort","year":2019,"lang":"en","type":"article","venue":"Journal of the Endocrine Society","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; Familial hypercholesterolemia; LDL receptor; Apolipoprotein B; Cohort; Internal medicine; Medicine; Kexin; Mutation; Genetics; Endocrinology; Gastroenterology; Lipoprotein; Biology; Gene; Cholesterol","score_opus":0.005231431991410382,"score_gpt":0.23778395230861055,"score_spread":0.23255252031720017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972496016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99839324,0.000060129372,0.00008009912,0.00088749884,0.00017634645,0.0003264182,0.0000038559656,0.0000031901277,0.0000692341],"genre_scores_gemma":[0.9984308,0.00028619272,0.0002587921,0.00078588247,0.00016717557,0.0000022283732,0.0000031459358,0.00001320036,0.00005259592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987995,0.000077947,0.00039491602,0.00008763524,0.0004912201,0.00014875627],"domain_scores_gemma":[0.99914294,0.00000988716,0.00034370009,0.0002996426,0.00014313143,0.00006069059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003424927,0.00008410805,0.00043436766,0.00003289659,0.000014834305,0.000004503315,0.00012545582,0.000018880692,0.000006742092],"category_scores_gemma":[0.000032032924,0.000053642027,0.0006076132,0.00033081623,0.000050000835,0.00005984302,0.00004481732,0.00033950288,0.0000015684336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007142518,0.00007986578,0.8957187,0.000093895,0.00019906381,0.000014313131,0.00024551945,0.00005221001,0.09960575,0.0000043852933,0.000032318134,0.0038825367],"study_design_scores_gemma":[0.0014634205,0.00020510214,0.9870605,0.00007789477,0.00009809028,0.00021190062,0.00013951154,0.0000796156,0.009425915,0.000002064734,0.0011893418,0.00004665032],"about_ca_topic_score_codex":0.00008706559,"about_ca_topic_score_gemma":0.000008751946,"teacher_disagreement_score":0.09134177,"about_ca_system_score_codex":0.00010524972,"about_ca_system_score_gemma":0.00015304943,"threshold_uncertainty_score":0.21874583},"labels":[],"label_agreement":null},{"id":"W2972725783","doi":"10.1152/ajpcell.00308.2019","title":"Statin administration activates system xC <sup>−</sup> in skeletal muscle: a potential mechanism explaining statin-induced muscle pain","year":2019,"lang":"en","type":"article","venue":"American Journal of Physiology-Cell Physiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Natural Sciences and Engineering Research Council of Canada; Government of Canada","keywords":"Statin; Mechanism (biology); Skeletal muscle; Medicine; Internal medicine; Physical therapy; Pharmacology; Physical medicine and rehabilitation; Physics","score_opus":0.007707473911042868,"score_gpt":0.23965432598169115,"score_spread":0.23194685207064827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972725783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979874,0.000116650874,0.0005173516,0.00026574256,0.00029699787,0.0006509395,0.000014380078,0.00004333747,0.00010719836],"genre_scores_gemma":[0.9964949,0.000077546836,0.0020132342,0.00052741525,0.00070428016,0.000035487974,0.000057807705,0.00006709942,0.000022240538],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99531025,0.0017227596,0.0011154651,0.0006059888,0.00047898325,0.0007665775],"domain_scores_gemma":[0.99726844,0.00032061987,0.0012354242,0.00059091195,0.00028647453,0.00029813754],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016147872,0.0004213983,0.001704859,0.0003455682,0.00010372742,0.000016353759,0.00028514105,0.00019393412,0.00012816017],"category_scores_gemma":[0.000111394285,0.0003525212,0.0005392222,0.00044573547,0.00019111681,0.00020791231,0.00008185685,0.0009618175,0.00004540814],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064605294,0.00037952935,0.00004757801,0.00033266042,0.00022667901,0.0000857951,0.00083753583,0.001342499,0.96246,0.00012154935,0.00005192764,0.03346819],"study_design_scores_gemma":[0.04552273,0.123146944,0.34770513,0.0031712144,0.0013538498,0.0023365028,0.18168102,0.056264672,0.22856155,0.0031388903,0.0030973963,0.0040201065],"about_ca_topic_score_codex":0.00030832572,"about_ca_topic_score_gemma":0.000004891814,"teacher_disagreement_score":0.73389846,"about_ca_system_score_codex":0.0002527217,"about_ca_system_score_gemma":0.00066163647,"threshold_uncertainty_score":0.99989265},"labels":[],"label_agreement":null},{"id":"W2972726674","doi":"10.1016/j.diabet.2019.101120","title":"Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trials","year":2019,"lang":"en","type":"article","venue":"Diabetes & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals","keywords":"Body mass index; Medicine; Alirocumab; Phase (matter); Internal medicine; Pooled analysis; Meta-analysis; Chemistry; Cholesterol","score_opus":0.010540184560849762,"score_gpt":0.28599802143268743,"score_spread":0.27545783687183767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972726674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667625,0.029649869,0.00036838144,0.0004261236,0.00028865717,0.0014221703,0.00038889074,0.00008766852,0.0006057718],"genre_scores_gemma":[0.994778,0.0008358168,0.00036344986,0.0008604648,0.0007074921,0.00006825882,0.0008613991,0.000052086583,0.001473048],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963273,0.00063752354,0.0008991144,0.00074915285,0.00078806694,0.00059888104],"domain_scores_gemma":[0.99757373,0.00034656707,0.00030470412,0.0011582943,0.00014402658,0.0004726452],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025551114,0.0003858471,0.0028934497,0.0003190755,0.00009962263,0.00008353831,0.0001634105,0.0002586191,0.0024222103],"category_scores_gemma":[0.00055112294,0.00029904966,0.0009451635,0.0007735053,0.000058569698,0.00014939594,0.000068863475,0.00030609543,0.00020628872],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042610588,0.0022135242,0.09735397,0.00049159164,0.08142293,0.000052696676,0.00079509924,0.000026746724,0.37590173,0.00044595756,0.00864876,0.42838594],"study_design_scores_gemma":[0.07255472,0.0004610739,0.46265715,0.0001478352,0.04838114,0.0000022598251,0.0001731031,0.0019209279,0.03167236,0.00033942453,0.38065386,0.0010361634],"about_ca_topic_score_codex":0.00042462334,"about_ca_topic_score_gemma":0.0000037757147,"teacher_disagreement_score":0.42734978,"about_ca_system_score_codex":0.0000447308,"about_ca_system_score_gemma":0.00009827725,"threshold_uncertainty_score":0.9999462},"labels":[],"label_agreement":null},{"id":"W2973012742","doi":"10.1194/jlr.p119000173","title":"PCSK9 loss-of-function variants and Lp(a) phenotypes among black US adults","year":2019,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke","keywords":"PCSK9; Phenotype; Genetics; Biology; Loss function; LDL receptor; Gene; Cholesterol; Lipoprotein; Endocrinology","score_opus":0.029462583181783648,"score_gpt":0.3272640930216447,"score_spread":0.2978015098398611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973012742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939224,0.0011195857,0.00009023135,0.000533397,0.00033268068,0.00039722244,0.0000016465038,0.0000044025173,0.0035984463],"genre_scores_gemma":[0.99646056,0.0009000604,0.0002016987,0.00004236788,0.0014908239,0.0000016270918,0.0000010585137,0.000018220444,0.0008835628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974296,0.00025368907,0.00042511107,0.00015898689,0.0014293866,0.00030320603],"domain_scores_gemma":[0.9981201,0.000108955326,0.00017644631,0.00032509165,0.0010021821,0.00026721004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003823362,0.00008849815,0.00044176116,0.00032687336,0.00005720096,0.000024290151,0.000106211926,0.00011792557,0.00023766671],"category_scores_gemma":[0.0003490817,0.00006188814,0.00018159095,0.00031936233,0.0001653199,0.00016711556,0.00006409677,0.0007298248,0.000046649853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077206986,0.0005980261,0.8901162,0.0029568772,0.001207913,0.00026958127,0.0012992515,0.000063300875,0.012688041,0.00043418704,0.004526551,0.078119345],"study_design_scores_gemma":[0.004461578,0.003173118,0.9786107,0.0010253992,0.0000786354,0.00031104567,0.00054383214,0.0003267489,0.0016469187,0.00016551894,0.009569297,0.00008720372],"about_ca_topic_score_codex":0.00018017275,"about_ca_topic_score_gemma":0.00000970306,"teacher_disagreement_score":0.08849447,"about_ca_system_score_codex":0.00007205934,"about_ca_system_score_gemma":0.00034376213,"threshold_uncertainty_score":0.31707662},"labels":[],"label_agreement":null},{"id":"W2973215412","doi":"10.5830/cvja-2019-039","title":"Long-term safety and efficacy of alirocumab in South African patients with heterozygous familial hypercholesterolaemia: the ODYSSEY Open-Label Extension study","year":2019,"lang":"en","type":"article","venue":"Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexus Clinical Research (Canada)","funders":"","keywords":"Alirocumab; Discontinuation; Medicine; PCSK9; Placebo; Internal medicine; Ldl cholesterol; Familial hypercholesterolemia; Open label; Gastroenterology; Clinical trial; Lipoprotein; Cholesterol; LDL receptor","score_opus":0.021152942291311996,"score_gpt":0.23965805675492127,"score_spread":0.21850511446360926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973215412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9398667,0.053483557,0.0023370504,0.0000523011,0.0004576298,0.003516075,0.00005628362,0.000018709816,0.00021164407],"genre_scores_gemma":[0.9977502,0.00057917024,0.000730121,0.00004498086,0.00061280496,0.000017032276,0.000005510578,0.00021964514,0.000040514416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9862243,0.0025124424,0.003385478,0.0009972234,0.005763499,0.0011170486],"domain_scores_gemma":[0.99056923,0.0002608797,0.0023343554,0.0031642236,0.002805093,0.0008662279],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.013762803,0.0010238652,0.0059066736,0.0010552745,0.0003001276,0.0002342273,0.0016654446,0.00043115226,0.000022336333],"category_scores_gemma":[0.0006821324,0.000631406,0.005081349,0.001556649,0.0004461584,0.0006088743,0.00061862933,0.0024757776,0.000019768844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030963005,0.007776261,0.6540905,0.0013412988,0.10491267,0.0061167907,0.10719707,0.010225197,0.00032302478,0.0000066995576,0.000038780545,0.077008694],"study_design_scores_gemma":[0.13478862,0.011104064,0.7802126,0.0030300391,0.022240521,0.005308865,0.039145824,0.000031477117,0.00007109971,0.000022130194,0.0026767175,0.0013680361],"about_ca_topic_score_codex":0.000042826123,"about_ca_topic_score_gemma":0.000002692946,"teacher_disagreement_score":0.1261221,"about_ca_system_score_codex":0.00045822866,"about_ca_system_score_gemma":0.0007798359,"threshold_uncertainty_score":0.99982554},"labels":[],"label_agreement":null},{"id":"W2973253443","doi":"10.1161/circulationaha.118.038840","title":"Effect of Alirocumab on Mortality After Acute Coronary Syndromes","year":2019,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; St. Michael's Hospital","funders":"Duke Clinical Research Institute; Assistance publique-Hôpitaux de Paris","keywords":"Alirocumab; Medicine; Acute coronary syndrome; Internal medicine; PCSK9; Hazard ratio; Statin; Placebo; Cardiology; Cholesterol; Lipoprotein; Myocardial infarction; Confidence interval; LDL receptor; Pathology","score_opus":0.011148510898026646,"score_gpt":0.284092779338033,"score_spread":0.27294426844000635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973253443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99763966,0.00021996451,0.000064947264,0.00003366135,0.00015539382,0.000785651,0.000004878517,0.000027913318,0.0010679568],"genre_scores_gemma":[0.9996813,0.00001312238,0.000014509248,0.000091712966,0.000057294958,0.000028138411,0.000043198685,0.000013527847,0.000057179044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991319,0.00008193491,0.0001545059,0.00017238778,0.00035273,0.00010651639],"domain_scores_gemma":[0.9993882,0.000023306713,0.000051168,0.00045114732,0.000035195913,0.000050966944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037135577,0.00008599782,0.00029232306,0.00004768283,0.000014250786,0.0000033006413,0.000024564644,0.00007355834,0.00016245655],"category_scores_gemma":[0.000014466206,0.000066932625,0.00019558016,0.00008126905,0.000015005349,0.00005036638,0.000009995476,0.000075003314,0.000109788605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037187125,0.000041778734,0.97711784,0.00058485364,0.00034760448,0.000039176346,0.000048124024,0.000053751737,0.002475409,0.00006866687,0.000013061483,0.018837871],"study_design_scores_gemma":[0.0012887989,0.000527763,0.99418145,0.00011828451,0.00026691493,0.00006995357,0.0000028940817,0.00020999703,0.0031579065,0.000024936173,0.00008885563,0.00006221808],"about_ca_topic_score_codex":0.00004299795,"about_ca_topic_score_gemma":7.2427576e-7,"teacher_disagreement_score":0.018775653,"about_ca_system_score_codex":0.000062470914,"about_ca_system_score_gemma":0.00003075477,"threshold_uncertainty_score":0.27294335},"labels":[],"label_agreement":null},{"id":"W2973566820","doi":"10.1177/2324709619877050","title":"Severe Combined Dyslipidemia With a Complex Genetic Basis","year":2019,"lang":"en","type":"article","venue":"Journal of Investigative Medicine High Impact Case Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Medicine; Internal medicine; Ezetimibe; Dyslipidemia; Apolipoprotein E; Endocrinology; Missense mutation; Compound heterozygosity; Familial hypercholesterolemia; Fenofibrate; Gastroenterology; Allele; Cholesterol; Genetics; Disease; Biology; Mutation","score_opus":0.032120758218540296,"score_gpt":0.2948007091738768,"score_spread":0.26267995095533647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973566820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197006,0.0009099467,0.00022646735,0.0047180955,0.00038649575,0.00092329737,0.000005597776,0.000028395129,0.00083163154],"genre_scores_gemma":[0.99193573,0.000052514843,0.0049450067,0.0017258071,0.0010442293,0.0000067183005,0.000015366595,0.00006106724,0.00021358351],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99605167,0.0002785233,0.0015186092,0.00034380035,0.0013402632,0.0004671337],"domain_scores_gemma":[0.9946031,0.00014663252,0.0018269465,0.00082389027,0.0012077615,0.001391649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002031488,0.0004145191,0.0018485856,0.0003997383,0.00009619615,0.000017171771,0.00006543624,0.00013764338,0.00090997264],"category_scores_gemma":[0.0010507348,0.00022495487,0.00041518928,0.0006292443,0.00058697845,0.00019050628,0.00003453167,0.0007609324,0.000009505055],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015901595,0.00034350855,0.33556318,0.0011057206,0.0044607148,0.60757613,0.0019167016,0.0006399031,0.017308472,0.00009959166,0.02299686,0.006399065],"study_design_scores_gemma":[0.005241315,0.008661875,0.32405144,0.0015110339,0.00090898067,0.65593493,0.00055607053,0.000059742564,0.0011260351,0.00044247674,0.0012731637,0.00023294863],"about_ca_topic_score_codex":0.0010426211,"about_ca_topic_score_gemma":0.000019949945,"teacher_disagreement_score":0.048358794,"about_ca_system_score_codex":0.00046244133,"about_ca_system_score_gemma":0.0015834433,"threshold_uncertainty_score":0.99635625},"labels":[],"label_agreement":null},{"id":"W2974509005","doi":"10.1186/s12872-019-1187-z","title":"Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9","year":2019,"lang":"en","type":"article","venue":"BMC Cardiovascular Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"National Institute of Mental Health; National Heart, Lung, and Blood Institute; Netherlands Heart Institute; Det Sundhedsvidenskabelige Fakultet, Københavns Universitet; Medical Research Council; Economic and Social Research Council; Berlin Institute of Health; Hjartavernd; Faculty of Health and Medical Sciences, University of Western Australia; Rheinische Friedrich-Wilhelms-Universität Bonn; Centre hospitalier régional universitaire de Lille; Freie Universität Berlin; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft; Universität Potsdam; Northwest Regional Development Agency; Engineering and Physical Sciences Research Council; Humboldt-Universität zu Berlin; Institut National de la Santé et de la Recherche Médicale; Blood Cancer UK; Erasmus Medisch Centrum; University of Oxford; Wellcome Trust; Cancer Research UK; Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease; British Heart Foundation; Versus Arthritis; Agence Nationale de la Recherche; Novo Nordisk; Bundesministerium für Bildung und Forschung; National Institute on Aging; National Institute for Health and Care Research; National Institutes of Health; Rosetrees Trust; Université de Lille; Alan Turing Institute; South Australian Health and Medical Research Institute; Novo Nordisk Foundation Center for Basic Metabolic Research; Universität zu Lübeck; John D. and Catherine T. MacArthur Foundation; National Institute for Social Care and Health Research","keywords":"PCSK9; Medicine; Internal medicine; Angiology; Odds ratio; Single-nucleotide polymorphism; Mendelian randomization; Diabetes mellitus; Type 2 diabetes; Myocardial infarction; Placebo; Cholesterol; Endocrinology; Genotype; Lipoprotein; Genetics; Pathology; LDL receptor; Genetic variants; Biology","score_opus":0.007738540087034135,"score_gpt":0.22270260855119745,"score_spread":0.2149640684641633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974509005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790385,0.006521531,0.010775156,0.00006357281,0.00022461335,0.0011852378,0.000012534468,0.000043758046,0.002135102],"genre_scores_gemma":[0.9981064,0.0007838118,0.0006206904,0.00013596745,0.00007225719,0.000059175243,0.00004869257,0.000047094625,0.00012590323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968505,0.00024740444,0.0005957561,0.0005891586,0.0012363838,0.00048081434],"domain_scores_gemma":[0.9980152,0.00010460494,0.0001698447,0.0014568964,0.00012029298,0.00013316463],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017861422,0.0002471265,0.0015189624,0.00066770834,0.000034782788,0.000021498707,0.00015061085,0.00020655489,0.0000953702],"category_scores_gemma":[0.0002828184,0.0002498649,0.0031437634,0.0016628944,0.000024644085,0.00010375634,0.000067623674,0.00023759172,0.000048004742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004925176,0.00011790783,0.9307326,0.00034112958,0.012500143,0.0000068089553,0.00019895566,0.03903009,0.00007135193,0.0000050595913,0.000010228701,0.016936447],"study_design_scores_gemma":[0.0034879693,0.00007652691,0.9855852,0.00008131379,0.005329328,0.0000036314402,0.00021298853,0.0018563756,0.00006179247,0.000020964557,0.0030487473,0.00023513839],"about_ca_topic_score_codex":0.0018533262,"about_ca_topic_score_gemma":0.0008595771,"teacher_disagreement_score":0.054852597,"about_ca_system_score_codex":0.00036480196,"about_ca_system_score_gemma":0.00017072535,"threshold_uncertainty_score":0.99999535},"labels":[],"label_agreement":null},{"id":"W2974753935","doi":"","title":"The responsibilities of the World Medical Association President","year":2009,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Rosuvastatin; Medicine; Family medicine; Clinical trial; Management; Library science; Political science; Internal medicine","score_opus":0.008512690055071786,"score_gpt":0.2755439537995366,"score_spread":0.26703126374446484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974753935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7476549,0.0019969435,0.000047279336,0.14170025,0.0003339406,0.000840798,0.0000012266204,0.00004798334,0.10737664],"genre_scores_gemma":[0.9277187,0.00011760934,0.000048622634,0.0022626873,0.00023764314,0.000005674786,3.0547994e-7,0.0000030883666,0.06960569],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982769,0.00016486757,0.00019945345,0.000073872245,0.0011596524,0.00012525693],"domain_scores_gemma":[0.9991704,0.00019817772,0.000055824596,0.000420776,0.00010293555,0.0000518349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002433473,0.000041369563,0.00012658176,0.000016506394,0.00009267946,0.000007962733,0.000089497466,0.00005267091,0.00017438449],"category_scores_gemma":[0.0012632711,0.000016945776,0.00017086894,0.00013669103,0.00003199126,0.000016173228,0.000020880603,0.00015922597,0.0000065999493],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011567519,0.0005531392,0.096595645,0.00021027478,0.00096492417,0.000026550599,0.0016569685,0.000010717301,0.0012818039,0.14330773,0.29651612,0.45771936],"study_design_scores_gemma":[0.0006880842,0.000118792006,0.8616209,0.000084829946,0.00006112014,0.000013346356,0.00023738646,0.000047533267,0.005826292,0.0014962356,0.1297649,0.000040582167],"about_ca_topic_score_codex":0.00016168065,"about_ca_topic_score_gemma":0.0006091037,"teacher_disagreement_score":0.76502526,"about_ca_system_score_codex":0.00009051238,"about_ca_system_score_gemma":0.00029205016,"threshold_uncertainty_score":0.19093879},"labels":[],"label_agreement":null},{"id":"W2976144989","doi":"10.1001/jamacardio.2019.3502","title":"Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels","year":2019,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cholesterol; Ldl cholesterol; Internal medicine; Pharmacology; Endocrinology","score_opus":0.013196840826671321,"score_gpt":0.28482073735957314,"score_spread":0.2716238965329018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976144989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438787,0.00024715395,0.00007771214,0.00015894313,0.00034704787,0.001528673,0.00003090404,0.000033305438,0.0031884238],"genre_scores_gemma":[0.99876827,0.000044944187,0.000062903906,0.00032173013,0.00050435483,0.00003526725,0.000014156336,0.000028891005,0.00021946499],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99778,0.000671612,0.00043735528,0.0003756669,0.0004273584,0.0003079609],"domain_scores_gemma":[0.9982086,0.0002695229,0.00018225059,0.001070952,0.00015195759,0.00011672377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017732433,0.00021650332,0.0016640302,0.00014470487,0.000026554273,0.000004154021,0.0001383894,0.00035083052,0.00007539281],"category_scores_gemma":[0.0004346018,0.00014059465,0.00060413545,0.00018337063,0.00012366526,0.000047202197,0.000090095855,0.00034918095,0.000074674324],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015416553,0.00021353751,0.08397545,0.007985012,0.0025010894,0.00034518476,0.000448839,0.00019138934,0.11008491,0.00026341912,0.000553858,0.77802074],"study_design_scores_gemma":[0.011576972,0.015107023,0.615167,0.0007244554,0.00035586033,0.0005160973,0.00005973105,0.000018100398,0.3534065,0.000027123377,0.0028110885,0.0002300139],"about_ca_topic_score_codex":0.0005595427,"about_ca_topic_score_gemma":0.000011453466,"teacher_disagreement_score":0.7777907,"about_ca_system_score_codex":0.00005937923,"about_ca_system_score_gemma":0.00012970234,"threshold_uncertainty_score":0.5733283},"labels":[],"label_agreement":null},{"id":"W2976451193","doi":"10.1016/j.amjcard.2019.09.011","title":"Meta-analysis of Randomized Controlled Trials Assessing the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies on Mortality and Cardiovascular Outcomes","year":2019,"lang":"en","type":"review","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Heart Institute; Montreal Neurological Institute and Hospital; Université de Montréal; McGill University Health Centre","funders":"Servier; Sanofi; AstraZeneca; Amgen","keywords":"PCSK9; Medicine; Ezetimibe; Internal medicine; Myocardial infarction; Stroke (engine); Randomized controlled trial; Alirocumab; Coronary artery disease; Odds ratio; Kexin; Placebo; Statin; Confidence interval; Cardiology; Cholesterol; Lipoprotein; LDL receptor; Apolipoprotein A1; Pathology","score_opus":0.233076861852075,"score_gpt":0.4647364984891067,"score_spread":0.2316596366370317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976451193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0367944,0.95741594,0.00030051876,0.00009511909,0.00017227503,0.005015034,0.00008866901,0.0000052441746,0.000112794885],"genre_scores_gemma":[0.19619255,0.8033052,0.000054154534,0.000045061737,0.0002609831,0.00007149699,0.00001387314,0.000038281596,0.000018398021],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96345323,0.0298588,0.004680666,0.00037235703,0.001291756,0.00034318794],"domain_scores_gemma":[0.976962,0.009888467,0.0098730475,0.0020711587,0.00106439,0.00014096807],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.06808015,0.0007076511,0.10102345,0.00077926123,0.00007540336,0.000031440566,0.00044415073,0.0001962366,0.000029883133],"category_scores_gemma":[0.008383034,0.00022003535,0.09649529,0.0008433168,0.001597096,0.00005190474,0.00008339585,0.0008702813,0.0000011085305],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012056135,0.000029716834,0.00035294838,0.0010962819,0.93869567,0.000041870353,0.00005858592,0.00054490764,0.0000030067094,0.000015482026,0.000017173475,0.047088217],"study_design_scores_gemma":[0.030230923,0.00093796756,0.0018835963,0.0004480513,0.96432394,0.00040768832,0.00014442025,0.000017868684,0.0000039572606,0.00002107055,0.0013969194,0.00018357331],"about_ca_topic_score_codex":0.0010520206,"about_ca_topic_score_gemma":0.000001374821,"teacher_disagreement_score":0.15939815,"about_ca_system_score_codex":0.00009229171,"about_ca_system_score_gemma":0.0014301917,"threshold_uncertainty_score":0.9999698},"labels":[],"label_agreement":null},{"id":"W2976451944","doi":"10.1016/j.amjcard.2019.09.010","title":"Usefulness of Gemcabene in Homozygous Familial Hypercholesterolemia (from COBALT-1)","year":2019,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Familial hypercholesterolemia; Ezetimibe; PCSK9; Medicine; Tolerability; LDL receptor; Internal medicine; Apolipoprotein B; Gastroenterology; Endocrinology; Lipoprotein; Cholesterol; Adverse effect","score_opus":0.014378750663865476,"score_gpt":0.25741051175748425,"score_spread":0.24303176109361876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976451944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970233,0.0009022872,0.00038395918,0.0005212064,0.00035628627,0.00021908159,0.0000096327,0.0000049366663,0.0005793465],"genre_scores_gemma":[0.99804175,0.0004389113,0.00022301121,0.00054278807,0.0007127271,0.0000032423054,0.0000021701105,0.000018278886,0.000017141143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812526,0.0005444999,0.0005637447,0.00014529756,0.00036774142,0.000253469],"domain_scores_gemma":[0.9985362,0.00015782111,0.00045932957,0.0005687149,0.00017835108,0.00009955387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012130957,0.00012883006,0.0014502639,0.00013504794,0.000017285904,0.0000036376794,0.00025133748,0.000057646135,0.000012366695],"category_scores_gemma":[0.00007330843,0.00007954108,0.00041722835,0.0002610705,0.0003072426,0.00004148518,0.000053432264,0.00047358277,0.000012574964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006168485,0.00012532283,0.6075386,0.00012059348,0.0024343615,0.0010905006,0.0013758925,0.003560722,0.034482695,0.00012231471,0.00038330976,0.34259725],"study_design_scores_gemma":[0.0033403768,0.0025471603,0.983712,0.0001474205,0.00029000783,0.003946176,0.0016001608,0.00001999592,0.00093735795,0.00018720675,0.0031507711,0.00012137856],"about_ca_topic_score_codex":0.0005302954,"about_ca_topic_score_gemma":0.000008422614,"teacher_disagreement_score":0.37617344,"about_ca_system_score_codex":0.000084630476,"about_ca_system_score_gemma":0.00025767414,"threshold_uncertainty_score":0.32435912},"labels":[],"label_agreement":null},{"id":"W2976623184","doi":"10.1194/jlr.p094763","title":"Potent reduction of plasma lipoprotein (a) with an antisense oligonucleotide in human subjects does not affect ex vivo fibrinolysis","year":2019,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Fibrinolysis; Lipoprotein(a); Fibrinogen; Ex vivo; In vivo; Internal medicine; Apolipoprotein B; Lipoprotein; Medicine; Plasminogen activator; Endocrinology; Plasminogen activator inhibitor-1; Placebo; Tissue plasminogen activator; Pharmacology; Cholesterol; Biology; Pathology","score_opus":0.03356010881467813,"score_gpt":0.34060133322805386,"score_spread":0.3070412244133757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976623184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99706095,0.00015030107,0.000010376083,0.000718488,0.00019093105,0.0009669969,0.0000034960092,0.000010207083,0.00088824064],"genre_scores_gemma":[0.99697244,0.00031169923,0.0008214485,0.000013513176,0.0011758682,0.000006835116,0.0000020278635,0.000042498566,0.00065367215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9954125,0.00075151195,0.0006922869,0.00031206993,0.002293747,0.0005378665],"domain_scores_gemma":[0.9977439,0.00007309904,0.00032335706,0.00069634715,0.0008256959,0.00033757155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054435795,0.00017422723,0.00085063674,0.0010853851,0.00009307094,0.0000398686,0.00020631331,0.00014157535,0.00011554235],"category_scores_gemma":[0.00016221378,0.000107791224,0.00031419884,0.00075603067,0.00015272414,0.00028616263,0.00006785168,0.0010517377,0.000011259411],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044967392,0.00064454984,0.014831074,0.0010269175,0.00038796995,0.00052109984,0.0006499999,0.00022629842,0.95824754,0.00006504504,0.00010911374,0.018793635],"study_design_scores_gemma":[0.005223795,0.0086061945,0.09842315,0.0015287921,0.00007913659,0.0016847786,0.0015046871,0.00012587203,0.88217574,0.000028175318,0.00045298517,0.00016669677],"about_ca_topic_score_codex":0.0013444556,"about_ca_topic_score_gemma":0.00014883201,"teacher_disagreement_score":0.08359208,"about_ca_system_score_codex":0.00025160966,"about_ca_system_score_gemma":0.00047568302,"threshold_uncertainty_score":0.45693353},"labels":[],"label_agreement":null},{"id":"W2977707585","doi":"10.1097/mol.0000000000000641","title":"Proprotein convertase subtilisin/kexin type 9 inhibitors and lipoprotein(a)-mediated risk of atherosclerotic cardiovascular disease: more than meets the eye?","year":2019,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Evolocumab; Kexin; PCSK9; Proprotein convertase; Alirocumab; Medicine; Lipoprotein(a); Lipoprotein; Internal medicine; Apolipoprotein B; LDL receptor; Atherosclerotic cardiovascular disease; Endocrinology; Disease; Pharmacology; Cholesterol","score_opus":0.08092281503551076,"score_gpt":0.35476954591784865,"score_spread":0.2738467308823379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977707585","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010423671,0.9704135,0.000023614768,0.00016896866,0.018508418,0.00952651,0.0002444331,0.00006038315,0.000011822945],"genre_scores_gemma":[0.00064504263,0.9907402,0.000037191163,0.000016828842,0.006813698,0.00082276977,0.00074089767,0.00014193797,0.000041444222],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99331015,0.002152191,0.0015074491,0.0012480442,0.0010456438,0.0007365222],"domain_scores_gemma":[0.9956613,0.00029148962,0.0008130762,0.0025614027,0.00026280497,0.00040990423],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026960284,0.0008646975,0.004268312,0.00046891923,0.000117602096,0.00002616649,0.00042583433,0.0006971454,0.000043769036],"category_scores_gemma":[0.0012280777,0.000553285,0.0019542505,0.0008118409,0.00061336986,0.000084135296,0.00033534085,0.0016581554,0.000078094614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023820948,0.000354439,0.0026482432,0.11420233,0.0024768207,0.0000026647992,0.0002100466,0.000013537045,0.0000013242962,0.000104572406,0.0011183206,0.8786295],"study_design_scores_gemma":[0.001897497,0.0003526492,0.0038566524,0.025966968,0.0029754932,0.000046747882,0.000041779967,0.00005206267,0.0000016397095,0.000020856607,0.964294,0.00049361173],"about_ca_topic_score_codex":0.0006392435,"about_ca_topic_score_gemma":0.000008495808,"teacher_disagreement_score":0.9631757,"about_ca_system_score_codex":0.00020660493,"about_ca_system_score_gemma":0.0013110413,"threshold_uncertainty_score":0.99969184},"labels":[],"label_agreement":null},{"id":"W2978430228","doi":"10.1016/s2213-8587(19)30264-5","title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Western University","funders":"Janssen Pharmaceuticals; Silence Therapeutics; Akebia Therapeutics; Eli Lilly and Company; Lundbeckfonden; Novartis; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Ionis Pharmaceuticals; Institut de Cardiologie de Montréal; AstraZeneca; REGENXBIO; Regeneron Pharmaceuticals; Amgen; Boehringer Ingelheim; Unilever; European Commission; Meso Scale Diagnostics; European Atherosclerosis Society; Sanofi; MedImmune; HLS Therapeutics; GlaxoSmithKline; Merck; Pfizer","keywords":"Medicine; Task force; Intensive care medicine; Family medicine","score_opus":0.06134634696561439,"score_gpt":0.31501951223427677,"score_spread":0.25367316526866235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978430228","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006390234,0.97963655,0.00012006349,0.0018416902,0.0009495853,0.005957597,0.0007548551,0.00026128392,0.0040881196],"genre_scores_gemma":[0.0008445404,0.9821216,0.0024659366,0.009403866,0.0024296287,0.0005700789,0.0005125931,0.00024631713,0.0014054483],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945269,0.0008167743,0.000895708,0.0011046659,0.0005130679,0.0021428596],"domain_scores_gemma":[0.9962524,0.00023101196,0.00031869812,0.0027654949,0.00010379336,0.00032856647],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010944156,0.0007454351,0.0035667357,0.00012946632,0.00019018409,0.000059230853,0.0008874668,0.00017671664,0.00015129926],"category_scores_gemma":[0.00006271594,0.0005037569,0.0011122186,0.0004684649,0.000095413976,0.000021094065,0.000923146,0.0007978243,0.00234987],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004634291,0.00005884326,0.00012546878,0.010191952,0.0040671327,0.00004774966,0.00034853446,0.000007688916,0.00007189013,0.0002528311,0.030663788,0.9541178],"study_design_scores_gemma":[0.0013169546,0.0003010279,0.000862503,0.0045343395,0.0034388932,0.000008831562,0.00008330772,0.000002668312,0.000024610832,0.000033215496,0.9888954,0.0004982446],"about_ca_topic_score_codex":0.00011431423,"about_ca_topic_score_gemma":0.0000144123815,"teacher_disagreement_score":0.9582316,"about_ca_system_score_codex":0.00039561494,"about_ca_system_score_gemma":0.00015837145,"threshold_uncertainty_score":0.9997414},"labels":[],"label_agreement":null},{"id":"W2978627093","doi":"10.14740/jocmr3901","title":"Ezetimibe Monotherapy Reduces Serum Levels of Platelet-Activating Factor Acetylhydrolase in Patients With Dyslipidemia","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Medicine; Internal medicine; Dyslipidemia; Statin; Endocrinology; Metabolic syndrome; Cholesterol; Lipoprotein; Gastroenterology; Disease; Obesity","score_opus":0.1616128593038372,"score_gpt":0.4865369100093622,"score_spread":0.324924050705525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978627093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365777,0.00055547716,0.00003168153,0.004019563,0.00030268572,0.0008328633,0.0000067710416,0.0000052055066,0.00058799086],"genre_scores_gemma":[0.99727905,0.0004186631,0.00074193755,0.00023654198,0.0011422872,0.0000031272148,0.00000124402,0.000035662753,0.00014150073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931461,0.000961018,0.0022264277,0.00029051723,0.0028838285,0.0004920717],"domain_scores_gemma":[0.9948838,0.0019249455,0.0008328666,0.00050291,0.0013580982,0.0004974161],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.013407531,0.00017436169,0.0017981165,0.0005079157,0.000038925693,0.0000071832155,0.00026080603,0.00024583258,0.0005857584],"category_scores_gemma":[0.0047102314,0.00009819526,0.0002884021,0.00066191197,0.00029223994,0.00017703378,0.000052765743,0.002417449,0.000008632186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061943703,0.0006080675,0.6288546,0.00036001398,0.0004515658,0.00006825481,0.00040598496,0.000024024093,0.0012585116,0.000008383854,0.00022769121,0.36153856],"study_design_scores_gemma":[0.021321664,0.012486543,0.95719916,0.0027778842,0.000017188504,0.000021357268,0.00037179296,0.0000744851,0.003392382,0.000043664626,0.002196391,0.00009749421],"about_ca_topic_score_codex":0.00006402911,"about_ca_topic_score_gemma":0.000003874856,"teacher_disagreement_score":0.36144105,"about_ca_system_score_codex":0.00012883024,"about_ca_system_score_gemma":0.00093925995,"threshold_uncertainty_score":0.999884},"labels":[],"label_agreement":null},{"id":"W2978976683","doi":"10.3821/1913-701x-144.suppl1.s21.fr","title":"Observance du traitement contre l'ostéoporose","year":2011,"lang":"fr","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.05679687935740134,"score_gpt":0.26095989299608474,"score_spread":0.2041630136386834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978976683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7297247,0.19485806,0.0005975806,0.0021857687,0.048686747,0.0031137594,0.0030305653,0.000101263635,0.01770157],"genre_scores_gemma":[0.9012903,0.07024099,0.0005780128,0.010157989,0.009944338,0.000050167622,0.0000570881,0.00017693687,0.0075041736],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9927053,0.00058902265,0.0014631508,0.0008495116,0.0012207528,0.003172293],"domain_scores_gemma":[0.9876717,0.00008416479,0.0005367985,0.00077281956,0.0012792319,0.009655328],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0022881012,0.00090648275,0.0012435789,0.0004180516,0.0014376126,0.00020309846,0.000904585,0.00023456122,0.010165415],"category_scores_gemma":[0.00026554675,0.000982315,0.0007658291,0.0009080367,0.00055649946,0.0007008878,0.00007475589,0.0018203692,0.00013622687],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0003125299,0.00024628473,0.0034620739,0.001457561,0.0016171434,0.40388703,0.005042161,0.00016591411,0.0004637173,0.0003962574,0.07322943,0.5097199],"study_design_scores_gemma":[0.0049928743,0.00017013779,0.00029843606,0.00023413962,0.0009883763,0.49973577,0.000089119174,0.0011226378,0.0016465759,0.00006678799,0.48985478,0.00080034864],"about_ca_topic_score_codex":0.39768466,"about_ca_topic_score_gemma":0.42672816,"teacher_disagreement_score":0.50891954,"about_ca_system_score_codex":0.009645697,"about_ca_system_score_gemma":0.019128894,"threshold_uncertainty_score":0.9998624},"labels":[],"label_agreement":null},{"id":"W2979426392","doi":"10.1161/jaha.119.013170","title":"Mortality Benefit of Alirocumab: A Bayesian Perspective","year":2019,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Hazard ratio; Alirocumab; Medicine; Internal medicine; Bayesian probability; Proportional hazards model; Statistics; Confidence interval; Cardiology; Mathematics; Cholesterol; Apolipoprotein B","score_opus":0.009203086808896145,"score_gpt":0.2893732464148939,"score_spread":0.2801701596059978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979426392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950542,0.00019375123,0.00004527889,0.0035619114,0.00020398083,0.00021627861,0.000003545295,0.000004274802,0.00071680825],"genre_scores_gemma":[0.9983375,0.000058035366,0.00032922826,0.0006585615,0.00029502175,9.771326e-7,2.3832717e-7,0.000009593451,0.0003108543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998485,0.00015150539,0.0003388346,0.000077963356,0.0008135148,0.00013316055],"domain_scores_gemma":[0.9982305,0.000058560137,0.0008239651,0.0002693268,0.00055027317,0.00006733375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001321879,0.0000661968,0.000621492,0.00005867929,0.00003321602,0.0000066780167,0.00007517934,0.000033325236,0.000028250122],"category_scores_gemma":[0.0003336039,0.00004323337,0.0006623987,0.0002801216,0.00002738194,0.00006730198,0.00001986342,0.0002271018,0.0000056569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082457664,0.00007984116,0.994374,0.000023007113,0.0005813516,0.0000012902044,0.00036047466,0.000032313874,0.002852549,0.000121521385,0.0006095251,0.00088166475],"study_design_scores_gemma":[0.00062801025,0.00044768985,0.9949813,0.00007149082,0.00023610664,0.000049701943,0.0008971994,0.000042548487,0.0012675,0.000325933,0.0010090026,0.000043557895],"about_ca_topic_score_codex":0.0012887472,"about_ca_topic_score_gemma":0.000025187035,"teacher_disagreement_score":0.0032833193,"about_ca_system_score_codex":0.00077440555,"about_ca_system_score_gemma":0.00021557024,"threshold_uncertainty_score":0.20250435},"labels":[],"label_agreement":null},{"id":"W2979874565","doi":"10.1016/j.jacl.2019.10.003","title":"Effect of evolocumab on lipoprotein apheresis requirement and lipid levels: Results of the randomized, controlled, open-label DE LAVAL study","year":2019,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novartis Pharma; Miltenyi Biotec; Amgen","keywords":"Evolocumab; Medicine; Apheresis; Clinical endpoint; Randomized controlled trial; Internal medicine; Alirocumab; Gastroenterology; Urology; Lipoprotein; Cholesterol; Endocrinology","score_opus":0.06162361087302733,"score_gpt":0.4142984293133187,"score_spread":0.35267481844029136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979874565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987657,0.00087915093,0.000040065457,0.0021133905,0.0021330887,0.005860621,0.000007135385,0.0000041985995,0.0013053162],"genre_scores_gemma":[0.9964859,0.0004365751,0.00037554032,0.00042785186,0.0018135528,0.00003920849,5.430443e-7,0.000021819424,0.0003989993],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.984926,0.009546118,0.0039375774,0.00032080663,0.0009732992,0.00029620566],"domain_scores_gemma":[0.9874996,0.008059011,0.0029092466,0.0009078772,0.00040328765,0.00022099128],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.059462894,0.00023599647,0.0059270356,0.000118335236,0.000046864254,0.000013529173,0.00046595332,0.00029171852,0.000050220035],"category_scores_gemma":[0.022418559,0.000111738795,0.0012119026,0.00015296992,0.0003378136,0.000068325295,0.00024604128,0.00086421863,0.0000044285407],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9292494,0.0023526757,0.011420837,0.00033127272,0.0034891015,0.00001365283,0.00020419159,0.000017033251,0.00083910656,0.00013335227,0.0007501382,0.051199254],"study_design_scores_gemma":[0.930958,0.043946046,0.018798199,0.0007791218,0.0021141178,0.00014828779,0.00015320862,0.00008709769,0.001604321,0.00013732171,0.0011609605,0.00011334536],"about_ca_topic_score_codex":0.000352192,"about_ca_topic_score_gemma":0.000038717644,"teacher_disagreement_score":0.05108591,"about_ca_system_score_codex":0.00004936443,"about_ca_system_score_gemma":0.0006245208,"threshold_uncertainty_score":0.985816},"labels":[],"label_agreement":null},{"id":"W2980067870","doi":"10.1182/blood.v104.11.3821.3821","title":"Atorvastatin Inhibits Leukocyte Firm Adhesion to Arterial Thrombi as Observed in the Mouse Cremaster Muscle.","year":2004,"lang":"en","type":"article","venue":"Blood","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Atorvastatin; Cremaster muscle; CD18; Thrombus; Internal medicine; Lovastatin; Medicine; Endocrinology; Pharmacology; In vivo; Immunology; Biology; Cholesterol; Integrin; Microcirculation; Receptor","score_opus":0.03082825072001421,"score_gpt":0.2605507162328461,"score_spread":0.22972246551283187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980067870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960716,0.00025206077,0.000030406554,0.0018039733,0.00010637981,0.0011245434,0.000004860993,0.000048078866,0.0005581077],"genre_scores_gemma":[0.99536103,0.000032253316,0.0007519433,0.0031464645,0.00046467155,0.00008764655,0.000017365068,0.000031262472,0.00010735092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99836737,0.00011310039,0.00030706445,0.00031483034,0.00054946216,0.00034818563],"domain_scores_gemma":[0.9990898,0.000020217141,0.000047546466,0.0006253415,0.00005206375,0.0001650396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060055975,0.00017060214,0.0003374454,0.00006902198,0.00007651205,0.0000361665,0.00012622774,0.000099640776,0.00006020882],"category_scores_gemma":[0.000108169,0.00011646705,0.00017726366,0.00025489295,0.000023569515,0.000056280773,0.00005091251,0.00021018284,0.00021393855],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019264426,0.009363089,0.008631718,0.0013712316,0.0007428816,0.0027371896,0.037910122,0.00015782344,0.8959712,0.0014737298,0.0020172708,0.03769735],"study_design_scores_gemma":[0.045178127,0.0036234527,0.42054498,0.0009442453,0.00048492855,0.00057517155,0.002569972,0.0000057611906,0.50624436,0.0006072913,0.018499315,0.00072238495],"about_ca_topic_score_codex":0.0009953422,"about_ca_topic_score_gemma":0.00037052916,"teacher_disagreement_score":0.41191328,"about_ca_system_score_codex":0.00006354558,"about_ca_system_score_gemma":0.0002086247,"threshold_uncertainty_score":0.47493884},"labels":[],"label_agreement":null},{"id":"W2980285492","doi":"10.1016/j.cjca.2019.07.397","title":"EVIDENCE OF OVERCOMING TREATMENT INERTIA IN PATIENTS WITH CARDIOVASCULAR DISEASE OR FH","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Blood pressure; Statin; Diabetes mellitus; Familial hypercholesterolemia; Physical therapy; Disease; Cholesterol; Endocrinology","score_opus":0.021519859416990625,"score_gpt":0.23734576279033534,"score_spread":0.21582590337334473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980285492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988601,0.010078616,0.00013603433,0.0001447898,0.00023209052,0.000505407,0.000009529565,0.0000019296406,0.000290586],"genre_scores_gemma":[0.999111,0.00035317065,0.00012760697,0.00007045168,0.00027499892,0.0000055187425,0.0000034490902,0.000017982788,0.00003585173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859804,0.00018776796,0.00039052783,0.00017597554,0.00033489626,0.00031279],"domain_scores_gemma":[0.9983112,0.000046253976,0.00012759533,0.00056966796,0.0002829202,0.0006623485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057018857,0.00014236134,0.0010592687,0.00030760682,0.000022090708,0.0000053608433,0.00009862453,0.00007898277,0.000036155965],"category_scores_gemma":[0.00017970301,0.00008933624,0.00058408856,0.00019607533,0.00007043543,0.000096014606,0.000007755882,0.00016571683,0.000004292077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013059939,0.000009023176,0.97508574,0.00013545298,0.0014857734,0.0005965381,0.0000883357,0.003939455,0.000010302006,0.0000104067985,0.000057252357,0.017275747],"study_design_scores_gemma":[0.004930066,0.0023031025,0.97693056,0.0007981851,0.0006650076,0.00016533425,0.000056987436,0.000007715899,0.000029063292,0.0000072509206,0.014000358,0.00010638022],"about_ca_topic_score_codex":0.004492709,"about_ca_topic_score_gemma":0.0011892273,"teacher_disagreement_score":0.017169368,"about_ca_system_score_codex":0.00049946905,"about_ca_system_score_gemma":0.0031921929,"threshold_uncertainty_score":0.6791662},"labels":[],"label_agreement":null},{"id":"W2980761229","doi":"10.1016/j.mayocp.2019.08.021","title":"Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies","year":2019,"lang":"en","type":"article","venue":"Mayo Clinic Proceedings","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Baxter Healthcare Corporation","keywords":"Medicine; Placebo; Renal function; PCSK9; Internal medicine; Pharmacokinetics; Gastroenterology; Pharmacodynamics; Urology; Endocrinology; Cholesterol; Lipoprotein; Pathology; LDL receptor","score_opus":0.01898809790312502,"score_gpt":0.31827164087111814,"score_spread":0.29928354296799314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980761229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579066,0.0019258001,0.000002380588,0.0007612991,0.00010106194,0.0012388915,0.000007785485,0.000008618331,0.00016351967],"genre_scores_gemma":[0.9972386,0.002258233,0.000044785535,0.00026166963,0.000085383166,0.00001331477,0.000001563004,0.000011637458,0.000084813175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984922,0.000055342483,0.00053795846,0.00027038995,0.00049555505,0.00014860032],"domain_scores_gemma":[0.99862564,0.0003877817,0.00036579676,0.00027169148,0.00027721515,0.000071898095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018419386,0.00014453728,0.0008154916,0.000113623995,0.000060919618,0.0000051993297,0.00012206819,0.00006757507,0.000018490877],"category_scores_gemma":[0.00039888188,0.0000727146,0.0002433124,0.00046326534,0.00023160981,0.000035885576,0.00015060614,0.00019270484,6.6948667e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010272862,0.003248112,0.749093,0.018637583,0.033999883,0.000007826087,0.027019808,0.000065842854,0.06968385,0.0032738051,0.0014512987,0.08324613],"study_design_scores_gemma":[0.006654048,0.0038683496,0.94665104,0.001098265,0.006258064,0.0000071992004,0.0017414506,0.0005244017,0.031942002,0.00009587402,0.001011105,0.00014821287],"about_ca_topic_score_codex":0.00005550121,"about_ca_topic_score_gemma":0.0000027539588,"teacher_disagreement_score":0.19755802,"about_ca_system_score_codex":0.000029611023,"about_ca_system_score_gemma":0.000051596402,"threshold_uncertainty_score":0.29652154},"labels":[],"label_agreement":null},{"id":"W2980930510","doi":"10.1016/j.cjca.2019.10.014","title":"Failure of Statins to Improve Outcomes in Dialysis Patients: Does Peritonitis Modify the Impact of Lipids on Cardiovascular Events?","year":2019,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Atorvastatin; Rosuvastatin; Hemodialysis; Internal medicine; Dialysis; Peritoneal dialysis; Randomized controlled trial; Diabetes mellitus; Kidney disease; Placebo; Statin; Endocrinology; Alternative medicine; Pathology","score_opus":0.009006066968148591,"score_gpt":0.2458621313090833,"score_spread":0.2368560643409347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980930510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9225988,0.00161573,0.00023792192,0.06737686,0.0025652042,0.0023681242,0.0025817903,0.0000049901896,0.00065060525],"genre_scores_gemma":[0.98287034,0.0001651779,0.000071083385,0.0124252215,0.0041418388,0.00003244329,0.000094210845,0.00008222447,0.000117442665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99584,0.0009325472,0.0012383396,0.000378169,0.00088440324,0.0007265345],"domain_scores_gemma":[0.99633545,0.00022798762,0.0006434116,0.0014354662,0.0009503384,0.0004073519],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013902404,0.00045584512,0.0039647683,0.0011709456,0.000051440224,0.000012795806,0.0005002025,0.0007969394,0.00003189672],"category_scores_gemma":[0.00077236496,0.00025092057,0.0053227884,0.00034495612,0.00016487803,0.00005978913,0.00003727722,0.001999811,0.0000060030184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039786732,0.000044484634,0.6636743,0.0012971767,0.04424299,0.0014556927,0.0015726882,0.015401253,0.000076947814,0.000009651396,0.24143115,0.030395804],"study_design_scores_gemma":[0.00541815,0.005238559,0.556231,0.00084115466,0.003192025,0.0002807219,0.0003602737,0.0000053362046,0.00010174823,0.00006510332,0.42768204,0.00058386166],"about_ca_topic_score_codex":0.033140138,"about_ca_topic_score_gemma":0.002176747,"teacher_disagreement_score":0.18625091,"about_ca_system_score_codex":0.0009823213,"about_ca_system_score_gemma":0.0035465308,"threshold_uncertainty_score":0.9999943},"labels":[],"label_agreement":null},{"id":"W2981367457","doi":"10.1093/eurheartj/ehz746.0298","title":"P5329Montreal score and coronary artery calcification in the prediction of cardiovascular event in patients with familial hypercholesterolemia","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Interquartile range; Internal medicine; Cardiology; Coronary Calcium Score; Framingham Risk Score; Population; Familial hypercholesterolemia; Incidence (geometry); Coronary artery disease; Disease; Cholesterol; Coronary artery calcium","score_opus":0.01823102620566117,"score_gpt":0.22604325492174704,"score_spread":0.20781222871608587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981367457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998036,0.0006846786,0.000053691852,0.00013616965,0.00008946064,0.0006237278,0.000005194342,0.0000051074435,0.00036596286],"genre_scores_gemma":[0.99944067,0.0001663832,0.000058474714,0.00012071295,0.00016877199,0.0000030851268,0.000013725435,0.000017249396,0.000010947863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823976,0.0005651252,0.00030290984,0.00016787586,0.0005617255,0.00016263528],"domain_scores_gemma":[0.99944174,0.000014771481,0.000059531045,0.00034437323,0.00006587318,0.000073703304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013939078,0.000096614895,0.0002787935,0.00011217224,0.00003785202,0.000014754805,0.000058419824,0.000030198738,0.0000051869943],"category_scores_gemma":[0.000015003397,0.000060229053,0.00013243592,0.0001198982,0.00003353821,0.000103254024,0.00001760407,0.00039105528,0.0000064912706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003034512,0.00013331289,0.9814616,0.00005040386,0.00009021551,0.00008439463,0.0005723984,0.0001810128,0.00006932224,0.0000015138713,0.00004387566,0.017008515],"study_design_scores_gemma":[0.0044514197,0.0007483795,0.99199486,0.00028963955,0.00006384965,0.0008642101,0.0002253161,0.00004663046,0.000007795039,0.0000020085167,0.0012572051,0.00004866971],"about_ca_topic_score_codex":0.00004890706,"about_ca_topic_score_gemma":0.0000064549663,"teacher_disagreement_score":0.016959846,"about_ca_system_score_codex":0.00006374987,"about_ca_system_score_gemma":0.000057276106,"threshold_uncertainty_score":0.24560694},"labels":[],"label_agreement":null},{"id":"W2981369828","doi":"10.1093/eurheartj/ehz746.0798","title":"P6193Dalcetrapib reduces incident diabetes in patients with recent acute coronary syndrome","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; St. Michael's Hospital","funders":"","keywords":"Medicine; Diabetes mellitus; Internal medicine; Acute coronary syndrome; Type 2 diabetes; Cholesterylester transfer protein; Cohort; Placebo; Myocardial infarction; Cholesterol; Endocrinology; Lipoprotein","score_opus":0.01320511274205624,"score_gpt":0.24278296829484786,"score_spread":0.22957785555279162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981369828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961996,0.0006815445,0.000002002723,0.0007234393,0.0003875202,0.0005553001,0.0000035741125,0.000027353317,0.0014196617],"genre_scores_gemma":[0.9979,0.00033258242,0.00039229408,0.0008441114,0.00017502272,0.0000024215994,0.000014817987,0.00005639996,0.00028235855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785584,0.00035479694,0.00035239916,0.0002556248,0.0007478792,0.00043343502],"domain_scores_gemma":[0.9990556,0.000015141628,0.00011162553,0.0003605105,0.00013528643,0.00032183217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011721116,0.00017484037,0.0004267297,0.00017254091,0.00008716002,0.000048635888,0.000110775756,0.000034512774,0.00036617345],"category_scores_gemma":[0.00002606749,0.00012321532,0.00014842112,0.0002332457,0.00003366686,0.00017401889,0.000057548932,0.0006201407,0.0003486139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000195801,0.00019664581,0.9893558,0.000032149106,0.00020520351,0.00071300566,0.000084828374,0.000009010535,0.00020844258,0.0000013419052,0.00080927135,0.008188479],"study_design_scores_gemma":[0.0037001579,0.0020382882,0.98256433,0.0004347683,0.00006393995,0.0015780465,0.00004006654,0.000004066771,0.00012684787,0.0000027516376,0.009295978,0.0001507414],"about_ca_topic_score_codex":0.0000046075247,"about_ca_topic_score_gemma":0.0000010191525,"teacher_disagreement_score":0.008486707,"about_ca_system_score_codex":0.00016107658,"about_ca_system_score_gemma":0.00014514364,"threshold_uncertainty_score":0.5024575},"labels":[],"label_agreement":null},{"id":"W2981502437","doi":"10.1093/eurheartj/ehz746.0015","title":"4945Inclisiran-mediated reductions in Lp(a) in the ORION-1 trial","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; PCSK9; LDL receptor; Internal medicine; Statin; Gastroenterology; Endocrinology; Cholesterol; Lipoprotein","score_opus":0.04125482580301087,"score_gpt":0.3095414082840534,"score_spread":0.26828658248104253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981502437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788965,0.00065351464,0.000010599349,0.0058030463,0.00096010376,0.0007461799,0.0000014100406,0.000016535525,0.012912122],"genre_scores_gemma":[0.99532384,0.0003359501,0.00015051157,0.0011936481,0.0024658893,0.0000043444734,0.000005580548,0.000027661059,0.0004925996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974864,0.0011507296,0.00040334006,0.00016818184,0.0005004183,0.00029094075],"domain_scores_gemma":[0.99929464,0.000076050026,0.00006617838,0.00039174658,0.000046428017,0.00012493481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048882635,0.00010011614,0.0002849618,0.00026532137,0.00010553676,0.000071687275,0.000121148725,0.00003750433,0.00027612536],"category_scores_gemma":[0.00027824327,0.00006661312,0.00022172093,0.0004432592,0.000030135381,0.00009216852,0.000024347115,0.0009847056,0.0006157711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07113012,0.008033453,0.45837793,0.0007639907,0.0011565709,0.017717514,0.031336084,0.001065037,0.017398275,0.0015717397,0.22825007,0.1631992],"study_design_scores_gemma":[0.046206407,0.001046594,0.51187533,0.0002503377,0.000033202286,0.004554818,0.0009578143,0.000038839124,0.000018851511,0.00003459054,0.43483472,0.00014848475],"about_ca_topic_score_codex":0.0001150463,"about_ca_topic_score_gemma":0.000033157467,"teacher_disagreement_score":0.20658465,"about_ca_system_score_codex":0.000105559535,"about_ca_system_score_gemma":0.00022620274,"threshold_uncertainty_score":0.7914697},"labels":[],"label_agreement":null},{"id":"W2981566717","doi":"10.1093/eurheartj/ehz745.0097","title":"4078Lipoprotein(a) and clinical outcomes in patients after revascularization of peripheral arteries","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Cardiology; Revascularization; Myocardial infarction; Clinical endpoint; Proportional hazards model; Stroke (engine); Unstable angina; Coronary artery disease; Canadian Cardiovascular Society; Angina; Confidence interval; Surgery; Randomized controlled trial","score_opus":0.017458482409555706,"score_gpt":0.2889970682053448,"score_spread":0.2715385857957891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981566717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812955,0.00028897103,0.00005716124,0.00023391837,0.00025860866,0.00042574227,0.0000017023731,0.000008490421,0.0005958767],"genre_scores_gemma":[0.9980836,0.00012297976,0.0009251995,0.00040044,0.0002118632,0.0000015289532,0.000003100654,0.000025677971,0.00022563699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983019,0.00045363262,0.0005153886,0.00017183929,0.00038196097,0.0001752685],"domain_scores_gemma":[0.9993531,0.000014952396,0.00010411944,0.0002767721,0.00010279656,0.00014822853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001520922,0.000105863815,0.00045085637,0.00008661392,0.000031084797,0.000025185414,0.000040695242,0.000042649215,0.0001434227],"category_scores_gemma":[0.000116054434,0.0000794629,0.00027505244,0.00007773414,0.0000487392,0.00011922333,0.000042808,0.00034341431,0.00002967223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019328238,0.00012779597,0.9896942,0.00006431507,0.00007051918,0.000029324274,0.00012120583,0.0000010947562,0.000025702815,0.0000044987014,0.00003814741,0.009629908],"study_design_scores_gemma":[0.003295713,0.0007793253,0.9916356,0.00018249363,0.000029351091,0.000076419965,0.000033785265,0.000008355987,0.000013531434,0.000007701648,0.0038607877,0.00007690789],"about_ca_topic_score_codex":0.000010829884,"about_ca_topic_score_gemma":0.0000025985644,"teacher_disagreement_score":0.009553,"about_ca_system_score_codex":0.000028892742,"about_ca_system_score_gemma":0.00004930363,"threshold_uncertainty_score":0.3240403},"labels":[],"label_agreement":null},{"id":"W2981623448","doi":"10.1093/eurheartj/ehz746.0329","title":"P5364Safety profile of bempedoic acid: pooled analysis of 4 phase 3 clinical trials","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Placebo; Internal medicine; Adverse effect; Discontinuation; Hazard ratio; Gastroenterology; Confidence interval; Endocrinology; Pathology","score_opus":0.12160926921130794,"score_gpt":0.43944896609593,"score_spread":0.31783969688462205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981623448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99175704,0.001441148,0.0006616169,0.00041481998,0.00040298008,0.00055486656,0.000034428573,0.000015629754,0.0047174576],"genre_scores_gemma":[0.99634963,0.00035823387,0.0015410112,0.00031168066,0.0009056718,0.000001003383,0.00002187744,0.00003129546,0.00047957912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932256,0.003569134,0.0019968296,0.00023941524,0.0007170421,0.0002519923],"domain_scores_gemma":[0.99761283,0.0002317952,0.00080597715,0.0006816168,0.00030820037,0.00035955617],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.025095457,0.00014420379,0.0020175902,0.00037670677,0.000051557286,0.000013929243,0.00013228483,0.000065476765,0.0019952694],"category_scores_gemma":[0.0013244635,0.000101562546,0.0024571533,0.0006229962,0.0000667637,0.00006961308,0.000051215517,0.0005614706,0.00013330625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074017597,0.004783311,0.43937352,0.00092233246,0.050598457,0.0005848493,0.0009876341,0.00013660669,0.14103043,0.000162273,0.016139686,0.33787915],"study_design_scores_gemma":[0.022671105,0.0050817416,0.89391404,0.0004620185,0.015791941,0.000605384,0.00029752386,0.0007315187,0.009005432,0.00000968277,0.05114167,0.00028792012],"about_ca_topic_score_codex":0.000010494185,"about_ca_topic_score_gemma":7.9855903e-7,"teacher_disagreement_score":0.45454055,"about_ca_system_score_codex":0.000027932876,"about_ca_system_score_gemma":0.00029261803,"threshold_uncertainty_score":0.99891704},"labels":[],"label_agreement":null},{"id":"W2981687740","doi":"10.1093/eurheartj/ehz746.0291","title":"P5322Oxidized phospholipids on apolipoprotein B-100 among black US adults with and without PCSK9 loss-of-function variants","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Apolipoprotein B; PCSK9; Medicine; Internal medicine; Lipoprotein(a); Population; Lipoprotein; Endocrinology; Cholesterol; LDL receptor","score_opus":0.015181192356925435,"score_gpt":0.2506777927602947,"score_spread":0.23549660040336928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981687740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890334,0.0003574725,0.00024736722,0.00024460693,0.00029971835,0.00086818746,0.0000037158645,0.00004374362,0.00890178],"genre_scores_gemma":[0.9962664,0.00016850574,0.00079705194,0.0006022265,0.0009985549,0.0000033070683,0.0000047890435,0.00008937613,0.0010697406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975577,0.00041521963,0.00044058668,0.0003791473,0.00079438876,0.00041298318],"domain_scores_gemma":[0.99850845,0.000020653251,0.00024295335,0.00058041274,0.00019593771,0.0004516064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015655162,0.00026514978,0.0006184279,0.00016997097,0.00013677764,0.000059790913,0.000091982976,0.00007183203,0.00025111812],"category_scores_gemma":[0.00006341378,0.0001857423,0.00021616391,0.00021056064,0.00014782364,0.00017448288,0.000045424043,0.000731139,0.00022311574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011698653,0.00047515307,0.9603714,0.0007484574,0.00087343156,0.00039582537,0.0010637956,0.00012556654,0.005598211,0.00014338999,0.0015110768,0.016995039],"study_design_scores_gemma":[0.010643517,0.0041779676,0.9682471,0.001768607,0.00017467728,0.0022471503,0.00015762635,0.0001363039,0.0019910522,0.0000128836555,0.0101890415,0.00025405214],"about_ca_topic_score_codex":0.00014116633,"about_ca_topic_score_gemma":0.0000066810867,"teacher_disagreement_score":0.016740985,"about_ca_system_score_codex":0.00006347352,"about_ca_system_score_gemma":0.00014697057,"threshold_uncertainty_score":0.75743514},"labels":[],"label_agreement":null},{"id":"W2981690585","doi":"10.1093/eurheartj/ehz745.0975","title":"P4590Temporal trends of the characteristics, management, and clinical outcomes of patients with acute coronary syndrome and multi-vessel disease - the ACSIS registry","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mace; Myocardial infarction; Acute coronary syndrome; Internal medicine; Percutaneous coronary intervention; Cardiology; Unstable angina; Coronary artery disease; Revascularization; Guideline; Stroke (engine); Canadian Cardiovascular Society; Angina","score_opus":0.02460487509467716,"score_gpt":0.2916556244780728,"score_spread":0.2670507493833956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981690585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99840254,0.00021904634,0.0000151947925,0.0006976529,0.00016488749,0.00028889466,0.000042234064,0.000005029861,0.00016451126],"genre_scores_gemma":[0.9977489,0.00032536956,0.00032395325,0.0003296213,0.000047114667,7.415308e-7,0.0000071067634,0.000022497503,0.0011946803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861264,0.0003285765,0.00038588175,0.00015945558,0.0003693022,0.00014412413],"domain_scores_gemma":[0.99895066,0.000029952434,0.00027294495,0.0004882448,0.000069491245,0.00018872094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008243743,0.000115032446,0.0003788303,0.00004226965,0.00009368859,0.00001892186,0.00011281877,0.000019346124,0.000023367116],"category_scores_gemma":[0.00003243954,0.000053574644,0.00019775832,0.00007600892,0.00018669537,0.000060481667,0.00013317651,0.00029281472,0.0000024255555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002653954,0.00015207245,0.9925651,0.0000996275,0.0006240645,0.00014976256,0.000039072806,1.3875174e-7,0.0000016262776,0.00000679722,0.00027718462,0.0058191437],"study_design_scores_gemma":[0.002739695,0.0003369911,0.9938099,0.00017383618,0.0004847366,0.00035482022,0.000043705557,0.000010354333,6.046597e-7,0.0000015300049,0.0019834628,0.000060399252],"about_ca_topic_score_codex":0.0000055019727,"about_ca_topic_score_gemma":4.6806866e-7,"teacher_disagreement_score":0.0057587447,"about_ca_system_score_codex":0.000009689507,"about_ca_system_score_gemma":0.000038520855,"threshold_uncertainty_score":0.21847105},"labels":[],"label_agreement":null},{"id":"W2981691995","doi":"10.1093/eurheartj/ehz747.0421","title":"P822Statin treatment in symptomatic patients with non-obstructive coronary artery disease reduces the risk of all-cause mortality","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Internal medicine; Coronary artery disease; Statin; Acute coronary syndrome; Cardiology; Medical prescription; Mortality rate; Stenosis; Angina; Cause of death; Disease; Myocardial infarction","score_opus":0.02116777691020185,"score_gpt":0.274117707224037,"score_spread":0.25294993031383517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981691995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981457,0.00024204592,0.000013484966,0.00015015554,0.0001279289,0.00091047847,0.000023971304,0.000008936165,0.00037730942],"genre_scores_gemma":[0.99917144,0.00018543417,0.00025559484,0.00012155194,0.00014079663,0.000006343629,0.000011741059,0.000030629486,0.00007644348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801636,0.0006917547,0.0003600585,0.00018797047,0.00051179744,0.000232064],"domain_scores_gemma":[0.99894714,0.00005107428,0.00020979291,0.0004574811,0.000090579895,0.00024395573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075989595,0.00015837631,0.0003459646,0.00006924124,0.00007746731,0.00002264339,0.00007606858,0.000014953053,0.00006205941],"category_scores_gemma":[0.000039320934,0.000082643375,0.00019393307,0.00010572426,0.00006635949,0.00010887418,0.000025238032,0.00027194733,0.000041499556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038388584,0.0003465088,0.9931616,0.000049987564,0.0010619323,0.00026774936,0.0008042782,0.000096152384,0.00004432038,0.0000024155042,0.000079478814,0.003701687],"study_design_scores_gemma":[0.0034943887,0.0010047274,0.99378645,0.00028307794,0.0005380807,0.0001849467,0.00029506683,0.000055967466,0.000056334025,0.000015772732,0.0001971826,0.000088001616],"about_ca_topic_score_codex":0.000052548785,"about_ca_topic_score_gemma":0.0000067809046,"teacher_disagreement_score":0.0036136855,"about_ca_system_score_codex":0.00011927344,"about_ca_system_score_gemma":0.00018145739,"threshold_uncertainty_score":0.3370099},"labels":[],"label_agreement":null},{"id":"W2981803122","doi":"10.1093/eurheartj/ehz745.0119","title":"4115Effect of alirocumab on recurrent cardiovascular events after acute coronary syndrome, according to the intensity of background statin treatment","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rosuvastatin; Mace; Atorvastatin; Statin; Alirocumab; Internal medicine; Acute coronary syndrome; Hazard ratio; Cardiology; Rosuvastatin Calcium; Clinical endpoint; Randomized controlled trial; Myocardial infarction; Cholesterol; Percutaneous coronary intervention; Lipoprotein; Confidence interval","score_opus":0.032628000135712674,"score_gpt":0.29311554346442753,"score_spread":0.2604875433287149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981803122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574566,0.0017359856,0.00012885297,0.0003302041,0.0006380165,0.0010216526,0.000019483263,0.00001158794,0.00036855525],"genre_scores_gemma":[0.9984389,0.00039738556,0.00041218082,0.00029001324,0.00022198411,0.000008441027,0.000005639292,0.000047834103,0.00017762899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972778,0.00080425624,0.00046643757,0.0002740199,0.0008658525,0.00031162758],"domain_scores_gemma":[0.9985258,0.000051378014,0.00014295182,0.0008582039,0.00017788258,0.00024378508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021720442,0.00021874395,0.0008515005,0.00013001432,0.000085974214,0.000015289008,0.00013431598,0.000031541695,0.00008063633],"category_scores_gemma":[0.000036240184,0.00013142159,0.0011400705,0.00017654784,0.000027644728,0.00006343047,0.00009399476,0.000344766,0.00021023874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011975896,0.002138083,0.6754633,0.0010735245,0.02358391,0.007184833,0.003124457,0.0010110849,0.003063562,0.00002649829,0.003410288,0.26794454],"study_design_scores_gemma":[0.0026879238,0.007355481,0.965356,0.0009556326,0.0006704945,0.008169645,0.0003500258,0.000012123146,0.00072183943,0.0000030580209,0.013569811,0.00014794772],"about_ca_topic_score_codex":0.000047179845,"about_ca_topic_score_gemma":0.000001545633,"teacher_disagreement_score":0.2898927,"about_ca_system_score_codex":0.00023973323,"about_ca_system_score_gemma":0.00010543488,"threshold_uncertainty_score":0.5359217},"labels":[],"label_agreement":null},{"id":"W2981840750","doi":"10.1093/eurheartj/ehz745.0879","title":"P4485The number of lipoprotein(a) kringle IV-type 2 repeats is associated with the osteogenic profile of aortic valvular interstitial cells induced by plasma from patients with calcific aortic stenosis","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Heart Institute; Université Laval","funders":"","keywords":"Osteocalcin; Medicine; Calcification; Aortic valve; Aortic valve stenosis; Internal medicine; Matrix gla protein; Lipoprotein(a); Lipoprotein; Population; Stenosis; Pathology; Endocrinology; Cardiology; Biology; Alkaline phosphatase; Biochemistry; Cholesterol; Ectopic calcification","score_opus":0.015700039773936064,"score_gpt":0.24467210813580276,"score_spread":0.2289720683618667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981840750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972155,0.000092751565,0.0000226341,0.00016923134,0.0002510865,0.0010766886,0.00006881098,0.00002435601,0.001078931],"genre_scores_gemma":[0.99881667,0.00001942013,0.00024351962,0.00021485474,0.00018651379,0.0000050945855,0.000043404198,0.00010078992,0.00036975308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967552,0.0006492486,0.0006149516,0.0003594932,0.001200986,0.00042015756],"domain_scores_gemma":[0.99780834,0.00007056727,0.00058102555,0.00074707094,0.0005442113,0.00024878865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095655286,0.0002766563,0.0007101086,0.00007560176,0.0001410773,0.000041726806,0.000222797,0.000082049955,0.00075716863],"category_scores_gemma":[0.00008010629,0.00016238539,0.0002955937,0.00035663645,0.000101137775,0.000121228106,0.00008043503,0.00070440135,0.000117164054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006978558,0.0028068295,0.72217876,0.00058723433,0.008426778,0.00025758153,0.0065709343,0.00005382197,0.21334842,0.000003916919,0.011897969,0.026889207],"study_design_scores_gemma":[0.012834225,0.009719974,0.83741814,0.0029703774,0.0015645308,0.00014708526,0.0008412203,0.00020503378,0.1315424,0.0000047953954,0.0020718102,0.00068043504],"about_ca_topic_score_codex":0.00021508589,"about_ca_topic_score_gemma":0.000005091944,"teacher_disagreement_score":0.11523936,"about_ca_system_score_codex":0.00011783062,"about_ca_system_score_gemma":0.00023185354,"threshold_uncertainty_score":0.82904655},"labels":[],"label_agreement":null},{"id":"W2981877182","doi":"10.1093/eurheartj/ehz745.0118","title":"4114Efficacy of alirocumab treatment after acute coronary syndrome according to new ACC/AHA guidelines for lipid-lowering therapy","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Mace; Internal medicine; Acute coronary syndrome; Alirocumab; Myocardial infarction; Unstable angina; Cardiology; Dyslipidemia; Coronary artery disease; Percutaneous coronary intervention; Disease; Cholesterol; Lipoprotein","score_opus":0.0787160659564468,"score_gpt":0.35651638924393103,"score_spread":0.2778003232874842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981877182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907622,0.0022809391,0.0017488417,0.0029790623,0.0007161056,0.0011980677,0.000008951857,0.00004016117,0.00026567798],"genre_scores_gemma":[0.980448,0.00106594,0.011493314,0.0024093057,0.0018871628,0.000014112085,0.0000061435435,0.000112862705,0.0025631348],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981537,0.00011108298,0.0005951726,0.00029945522,0.00042703009,0.00041359803],"domain_scores_gemma":[0.99855536,0.000037172384,0.00012884151,0.00053848315,0.00025697798,0.00048318558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090694503,0.00024494328,0.0006643424,0.00016077279,0.000097124816,0.000051194926,0.00013579763,0.000041281673,0.00024210886],"category_scores_gemma":[0.0000620922,0.00017529467,0.00067028496,0.00013672574,0.000010614194,0.00013081371,0.00005885664,0.00018062234,0.00015823537],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008028945,0.0007115748,0.10315134,0.00028883654,0.004301571,0.0023028194,0.002165639,0.00035823704,0.051286086,0.000014019021,0.023223944,0.804167],"study_design_scores_gemma":[0.014438696,0.010362562,0.4341477,0.0012215764,0.00037777837,0.017064339,0.00032992,0.00003795153,0.004504869,0.000011406976,0.51701635,0.00048683034],"about_ca_topic_score_codex":0.000031911524,"about_ca_topic_score_gemma":0.0000010263234,"teacher_disagreement_score":0.8036802,"about_ca_system_score_codex":0.00013874733,"about_ca_system_score_gemma":0.00025460715,"threshold_uncertainty_score":0.7148309},"labels":[],"label_agreement":null},{"id":"W2981891128","doi":"10.1093/eurheartj/ehz747.0258","title":"P651Prevalence of hypertriglyceridemia in statin treated high risk patients who might benefit from treatment with icosapent ethyl for secondary prevention in clinical practice - Results of DYSIS","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Hypertriglyceridemia; Statin; Diabetes mellitus; Triglyceride; Gastroenterology; Cholesterol; Disease; Endocrinology","score_opus":0.027795981203676295,"score_gpt":0.3260590616303497,"score_spread":0.2982630804266734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981891128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99712694,0.00068730646,0.00006004631,0.00020301733,0.00011129111,0.0012152109,0.00019121339,0.0000058503247,0.00039912117],"genre_scores_gemma":[0.9893159,0.0019475579,0.008190662,0.00008711246,0.00014968881,0.000008617886,0.0000856831,0.00003588961,0.00017883616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962952,0.0013197712,0.0013378061,0.00033994377,0.00047302712,0.00023425413],"domain_scores_gemma":[0.9978519,0.00048112872,0.00082669134,0.00042396467,0.0002599442,0.00015634805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032902895,0.00017120007,0.0007950149,0.00015292317,0.000035055207,0.000011134854,0.00007833075,0.0000660693,0.00006235791],"category_scores_gemma":[0.00048525684,0.00011939839,0.00029552038,0.00019329168,0.00003730805,0.00017625316,0.00002482665,0.00045340028,0.000010289529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012822178,0.001725345,0.8197718,0.00013644146,0.00044908476,0.00007582036,0.0006048214,0.00013471366,0.00013852664,0.0000030969802,0.00015571888,0.16398244],"study_design_scores_gemma":[0.028458564,0.009988913,0.95348024,0.0010933185,0.00030253187,0.000036299014,0.000116032315,0.0000879122,0.00075629447,0.000017047676,0.0055562602,0.00010660651],"about_ca_topic_score_codex":0.0013056671,"about_ca_topic_score_gemma":0.0001328717,"teacher_disagreement_score":0.16387583,"about_ca_system_score_codex":0.0001790677,"about_ca_system_score_gemma":0.00022577419,"threshold_uncertainty_score":0.48689252},"labels":[],"label_agreement":null},{"id":"W2982089964","doi":"10.1093/eurheartj/ehz746.0014","title":"4944The contribution of familial hypercholesterolemia (FH) to premature coronary artery disease decreased by 2-fold between 1998 and 2018 in a founder population with high prevalence of FH","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Coronary artery disease; Ezetimibe; Population; Internal medicine; PCSK9; Disease; LDL receptor; Statin; Cholesterol; Lipoprotein; Environmental health","score_opus":0.013028763791770395,"score_gpt":0.2506277705779503,"score_spread":0.23759900678617993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982089964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779075,0.0007097292,0.00024118707,0.00036929615,0.00006386256,0.0007350007,0.00005310457,0.000009035418,0.000028020586],"genre_scores_gemma":[0.99902713,0.000082916325,0.00028025877,0.00026313387,0.00021971748,0.000002379146,0.00004145142,0.000025045629,0.000057953668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983115,0.00042052,0.000374894,0.0002067258,0.00046972357,0.00021664421],"domain_scores_gemma":[0.99909765,0.000036628127,0.00013745924,0.00028762058,0.000087806606,0.00035282667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010395754,0.00013144097,0.0003905394,0.00009699732,0.00004287695,0.000015080695,0.00006138476,0.00004232129,0.000014389684],"category_scores_gemma":[0.000059228838,0.000097277625,0.0000887012,0.00010825452,0.0000357297,0.00013637917,0.000031511667,0.00028902767,0.000008380648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011597206,0.00008535215,0.99156994,0.00036186745,0.00006945597,0.00004464241,0.00010561174,0.000018548877,0.004914649,0.000005013964,0.0003338846,0.0013313218],"study_design_scores_gemma":[0.0032109662,0.0008279205,0.9934511,0.0012553601,0.00014389,0.00028070054,0.00002568432,0.000017026847,0.0001507415,0.000014569661,0.00052899687,0.00009299578],"about_ca_topic_score_codex":0.00006229925,"about_ca_topic_score_gemma":0.0000061733745,"teacher_disagreement_score":0.0047639073,"about_ca_system_score_codex":0.00007930305,"about_ca_system_score_gemma":0.000095305986,"threshold_uncertainty_score":0.39668664},"labels":[],"label_agreement":null},{"id":"W2982176408","doi":"10.1093/eurheartj/ehz746.0051","title":"5192Management and outcomes of patients with unstable angina with undetectable, normal, or intermediate hsTnT levels - A RAPID CPU substudy","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Unstable angina; Cardiology; Percutaneous coronary intervention; Myocardial infarction; Conventional PCI; TIMI; Troponin; Odds ratio; Canadian Cardiovascular Society; Acute coronary syndrome; Angina","score_opus":0.019816676831614404,"score_gpt":0.24678493658928458,"score_spread":0.22696825975767018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982176408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959035,0.0003182413,0.00022297808,0.00016006842,0.00014937697,0.00077308976,0.00000852894,0.000021075053,0.0024431746],"genre_scores_gemma":[0.9974425,0.00012006251,0.0008776399,0.00039660934,0.00011002337,0.00000277601,0.000003821522,0.000053081465,0.0009934941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823207,0.00020859172,0.0003227434,0.00022804984,0.0006493379,0.0003592119],"domain_scores_gemma":[0.9989976,0.000025780337,0.00016872615,0.00038879242,0.00016815837,0.0002509246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010150089,0.00019818638,0.0005354672,0.0001629905,0.000106049156,0.000050624763,0.0000883159,0.000020007643,0.0003067092],"category_scores_gemma":[0.000022008557,0.00010691799,0.00009979536,0.00019368085,0.000058926824,0.00018696423,0.000078241945,0.00031109987,0.00003175132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010848384,0.00023259713,0.9895263,0.00024305674,0.0006354036,0.00020770908,0.00034536188,0.000022336091,0.000037195692,0.0000047726835,0.00041614857,0.0072443318],"study_design_scores_gemma":[0.0068843584,0.00397093,0.9757187,0.00031349514,0.00016951573,0.00025336785,0.00035256636,0.000008473979,0.00008462803,7.009701e-7,0.012094376,0.00014889125],"about_ca_topic_score_codex":0.00002105531,"about_ca_topic_score_gemma":0.000010653651,"teacher_disagreement_score":0.013807552,"about_ca_system_score_codex":0.000053676944,"about_ca_system_score_gemma":0.00013586579,"threshold_uncertainty_score":0.43599892},"labels":[],"label_agreement":null},{"id":"W2982360444","doi":"10.15586/jptcp.v26i2.627","title":"REVERSIBLE NEUROTROPHIC KERATOPATHY ASSOCIATED WITH ROSUVASTATIN THERAPY: A CASE REPORT","year":2019,"lang":"en","type":"article","venue":"Journal of Population Therapeutics and Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Discontinuation; Medicine; Visual acuity; Ophthalmology; Adverse effect; Surgery; Internal medicine","score_opus":0.05284404767537367,"score_gpt":0.38256074984693195,"score_spread":0.3297167021715583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982360444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957547,0.00091302197,0.000107609696,0.002016746,0.00073427416,0.0004090736,0.0000020836035,0.000010933189,0.00005153494],"genre_scores_gemma":[0.99383146,0.0010846348,0.0002681482,0.004148811,0.0004913347,0.0000019144109,0.0000071203544,0.000021070791,0.00014553902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816585,0.00036117082,0.00083750946,0.00017562864,0.00029385329,0.0001659776],"domain_scores_gemma":[0.9984329,0.00016879721,0.00072631077,0.00015585635,0.00034378679,0.00017235678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017528551,0.00011873305,0.0005697693,0.00008289751,0.000063295694,0.000014947266,0.000040994917,0.00013123236,0.00010607021],"category_scores_gemma":[0.000052817526,0.00007958752,0.00023596543,0.00014728295,0.00005006014,0.00007788793,0.000013868603,0.0005216363,0.0000023158186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005112128,0.0015757019,0.8619252,0.00009084895,0.004096364,0.057558298,0.00021071508,0.00016763354,0.0033514265,0.000075242264,0.00047104782,0.06536543],"study_design_scores_gemma":[0.02858354,0.01280438,0.7898887,0.00015854996,0.002058451,0.14589296,0.00017512978,0.00221488,0.00027245603,0.00033235454,0.017276194,0.00034239722],"about_ca_topic_score_codex":0.000035570785,"about_ca_topic_score_gemma":0.0000061947535,"teacher_disagreement_score":0.088334665,"about_ca_system_score_codex":0.000042559186,"about_ca_system_score_gemma":0.00015271189,"threshold_uncertainty_score":0.32454845},"labels":[],"label_agreement":null},{"id":"W2982515366","doi":"10.1093/eurheartj/ehz771","title":"A tip of the CAP1 to cholesterol metabolism","year":2019,"lang":"en","type":"letter","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Metabolism; Cholesterol; Internal medicine","score_opus":0.03366916543480287,"score_gpt":0.27561078336272093,"score_spread":0.24194161792791807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982515366","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037027728,0.0024144785,0.00009859843,0.9412746,0.0034965205,0.0012619128,0.00003056346,0.000029004581,0.014366589],"genre_scores_gemma":[0.011956487,0.000113746515,0.00038438954,0.94876754,0.026402563,0.0000031277618,0.000007814161,0.00016053027,0.012203812],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99669164,0.0009893009,0.0004904708,0.00026935912,0.0011360609,0.00042318154],"domain_scores_gemma":[0.99818385,0.000027361835,0.00023572451,0.0011793156,0.00019603177,0.00017772995],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016653202,0.0002580083,0.00078699435,0.00016610781,0.000115178955,0.000055587912,0.0003538381,0.00015491257,0.00016485642],"category_scores_gemma":[0.00012212979,0.0001515923,0.0010329712,0.00018176044,0.00004282283,0.00004117308,0.00015488981,0.0032937024,0.0006371285],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016651857,0.0000150587075,0.000519559,0.00019841248,0.0002250271,0.00027651215,0.00015292878,0.0000035553428,0.0002790498,0.000001016492,0.99587363,0.0024385927],"study_design_scores_gemma":[0.0007469672,0.00012369653,0.087291025,0.0006580807,0.000245081,0.0050799837,0.000009007534,5.730508e-7,0.00014921978,0.0000019298482,0.90556604,0.00012841848],"about_ca_topic_score_codex":0.000027934744,"about_ca_topic_score_gemma":7.701354e-7,"teacher_disagreement_score":0.09030762,"about_ca_system_score_codex":0.00006379184,"about_ca_system_score_gemma":0.00031622063,"threshold_uncertainty_score":0.99900573},"labels":[],"label_agreement":null},{"id":"W2982655420","doi":"10.1016/j.cjca.2019.10.027","title":"Efficacy and Safety of High-intensity Statins in Patients With Acute Myocardial Infarction: An Asian Perspective","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Sanofi","keywords":"Medicine; Perspective (graphical); Myocardial infarction; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.005172084750973367,"score_gpt":0.22015884896104043,"score_spread":0.21498676421006707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982655420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99681056,0.00013067278,0.00016423763,0.00064356445,0.00033513427,0.00039668722,0.000034210763,0.0000021878586,0.0014827338],"genre_scores_gemma":[0.99919105,0.0000407579,0.00022267632,0.00015807211,0.00035292096,0.0000010420052,0.000011684397,0.000013159213,0.00000863571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894834,0.00015575167,0.00029424322,0.00016218003,0.00019504158,0.000244419],"domain_scores_gemma":[0.99845827,0.000016817014,0.00014320259,0.0002473853,0.0006499825,0.00048434304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004047094,0.00011056702,0.00084426015,0.0002774016,0.000036433048,0.0000056536437,0.000059262562,0.00010762341,0.000012159411],"category_scores_gemma":[0.00006330169,0.000086098116,0.0001250587,0.00014341007,0.00013708127,0.000092987386,0.000008348221,0.0003370988,0.0000014498225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038894422,0.000014087204,0.9825253,0.000026171836,0.0018689558,0.0002442015,0.0011263221,0.0003891943,0.000021389264,0.00054114976,0.00014454263,0.009209236],"study_design_scores_gemma":[0.0070483615,0.0029240518,0.98615617,0.00005683998,0.00021899078,0.000614619,0.00070108304,0.0000014375612,0.0000087502685,0.000060149217,0.0021283738,0.00008117509],"about_ca_topic_score_codex":0.0064539905,"about_ca_topic_score_gemma":0.0021125195,"teacher_disagreement_score":0.009128061,"about_ca_system_score_codex":0.0003164566,"about_ca_system_score_gemma":0.0012776961,"threshold_uncertainty_score":0.9756546},"labels":[],"label_agreement":null},{"id":"W2984293502","doi":"10.1161/circulationaha.119.043826","title":"Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES","year":2019,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":130,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; St. Michael's Hospital","funders":"","keywords":"Alirocumab; Medicine; Stroke (engine); Internal medicine; PCSK9; Placebo; Cardiology; Statin; Cholesterol; Lipoprotein; LDL receptor; Pathology","score_opus":0.008394156119040007,"score_gpt":0.2779612155375801,"score_spread":0.2695670594185401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984293502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99575555,0.0000828469,0.000050407503,0.00008265478,0.00011243189,0.0006614614,0.000001292735,0.0000149951,0.003238372],"genre_scores_gemma":[0.9997518,0.0000045525617,0.000015658745,0.00007134737,0.000038298167,0.000010113517,0.000013779158,0.000009268756,0.000085181244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992859,0.000071527014,0.00015297577,0.00012448395,0.0002716325,0.00009349202],"domain_scores_gemma":[0.99955714,0.000046267774,0.000042794643,0.0003019609,0.000021188145,0.000030651783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046473177,0.00006479129,0.00028627954,0.00009567812,0.000007980635,0.000002379612,0.000021562217,0.00005922197,0.000044794353],"category_scores_gemma":[0.000060386697,0.000049112747,0.00013548814,0.000087223736,0.0000062724525,0.000031743166,0.0000055718983,0.000072850584,0.000061004415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098002674,0.000030718624,0.9673591,0.00027963176,0.000035548313,0.0000027559283,0.00004840481,0.0003415409,0.0039987653,0.00021955374,0.0000042931742,0.02758167],"study_design_scores_gemma":[0.002410682,0.00029092014,0.9916025,0.00008884472,0.000030159557,0.0000037695252,0.000008468289,0.0004953704,0.0048946603,0.000015154977,0.00011623174,0.000043276625],"about_ca_topic_score_codex":0.00011630021,"about_ca_topic_score_gemma":0.000004112355,"teacher_disagreement_score":0.027538393,"about_ca_system_score_codex":0.000068901856,"about_ca_system_score_gemma":0.000024832674,"threshold_uncertainty_score":0.20027597},"labels":[],"label_agreement":null},{"id":"W2985301387","doi":"10.1161/circoutcomes.119.006002","title":"Baseline Predictors of Low-Density Lipoprotein Cholesterol and Systolic Blood Pressure Goal Attainment After 1 Year in the ISCHEMIA Trial","year":2019,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute","keywords":"Medicine; Blood pressure; Baseline (sea); Cardiology; Internal medicine; Ischemia; Cholesterol","score_opus":0.015094515401087381,"score_gpt":0.266267057422247,"score_spread":0.25117254202115963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985301387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901991,0.0062223305,0.00022645632,0.00030147217,0.00013606995,0.0027768293,0.000020177451,0.000024604928,0.00009297819],"genre_scores_gemma":[0.999015,0.00015980365,0.000058552112,0.00031687136,0.00025420668,0.00011329857,0.000026503816,0.000019879053,0.000035920206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678147,0.0008215303,0.000628391,0.00046998987,0.0010579675,0.00024068014],"domain_scores_gemma":[0.99847615,0.00010861385,0.00013055222,0.0010723105,0.00009892351,0.00011343332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004992762,0.00022680857,0.0010491726,0.00009634968,0.000054357253,0.000032168733,0.00008300532,0.00021154132,0.000018205219],"category_scores_gemma":[0.0002207565,0.00016153551,0.0007870287,0.00017095798,0.00009285761,0.0001151586,0.00006332508,0.0002793653,0.000004140911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002433445,0.00032659268,0.97798336,0.0039676074,0.0050795926,0.000028084383,0.0015061836,0.00020623319,0.0003488882,0.00023941245,0.0000083435425,0.007872278],"study_design_scores_gemma":[0.025350815,0.000107850276,0.97124344,0.00016336895,0.0014978996,0.000050187504,0.0003105333,0.00007403427,0.00033546856,0.0000245653,0.00066989136,0.00017194008],"about_ca_topic_score_codex":0.0007499838,"about_ca_topic_score_gemma":0.0000237638,"teacher_disagreement_score":0.02291737,"about_ca_system_score_codex":0.000025714318,"about_ca_system_score_gemma":0.000071321614,"threshold_uncertainty_score":0.6587227},"labels":[],"label_agreement":null},{"id":"W2985333121","doi":"10.1093/eurheartj/ehz809","title":"Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis","year":2019,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Esperion Therapeutics; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Servier; Belvoir Media Group; Medicines Company; Regado Biosciences; Novo Nordisk; Daiichi-Sankyo; AstraZeneca; Amarin Corporation; Luitpold Pharmaceuticals; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Duke Clinical Research Institute; Eisai; Boston VA Research Institute; Boston Scientific Corporation; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; CSL Behring; Amgen; Pfizer; Bayer HealthCare; Sanofi; American Heart Association","keywords":"Medicine; Alirocumab; Internal medicine; Acute coronary syndrome; Cardiology; Intensive care medicine; Myocardial infarction; Cholesterol; Total cholesterol","score_opus":0.02351587982491802,"score_gpt":0.32180503988979725,"score_spread":0.2982891600648792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985333121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958008,0.00051868206,0.00014376093,0.0003210985,0.00087359187,0.0014328506,0.000013836845,0.000061644714,0.00083376927],"genre_scores_gemma":[0.9971943,0.00006894892,0.00046626313,0.00091987004,0.00051156903,0.000017587361,0.000015698522,0.00010355149,0.0007022135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942872,0.0021066554,0.0007637478,0.0005634176,0.0017066351,0.00057233445],"domain_scores_gemma":[0.99718696,0.0001566254,0.0001700588,0.0016799583,0.00012788374,0.0006784854],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0057609146,0.0004322135,0.0025339832,0.0007271677,0.00014504972,0.00010164979,0.00027407112,0.000086217726,0.00023524834],"category_scores_gemma":[0.00021004799,0.0002900362,0.004250893,0.0005983984,0.000037516857,0.00021745052,0.0001299745,0.00066545204,0.00040599046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015856152,0.00022824563,0.93466556,0.00015718222,0.024995105,0.0042905407,0.0002526463,0.00044171934,0.0002102163,0.0000038437993,0.00020382878,0.01869498],"study_design_scores_gemma":[0.026207086,0.0076353336,0.9533305,0.00015829038,0.0068258843,0.0010353061,0.00007208166,0.000010153383,0.00020087592,0.0000013619099,0.0041992087,0.00032391556],"about_ca_topic_score_codex":0.000042868323,"about_ca_topic_score_gemma":0.0000024680571,"teacher_disagreement_score":0.018664964,"about_ca_system_score_codex":0.00014321275,"about_ca_system_score_gemma":0.000093500224,"threshold_uncertainty_score":0.9999552},"labels":[],"label_agreement":null},{"id":"W2985476501","doi":"10.1161/circulationaha.119.044440","title":"REDUCE-IT USA","year":2019,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Amarin Pharma; Amarin Corporation; Esperion Therapeutics; Regeneron Pharmaceuticals; National Heart, Lung, and Blood Institute; Gilead Sciences; Amgen","keywords":"Medicine; Hazard ratio; Myocardial infarction; Internal medicine; Placebo; Unstable angina; Stroke (engine); Diabetes mellitus; Clinical endpoint; Cardiology; Randomized controlled trial; Confidence interval; Endocrinology","score_opus":0.026445702754180508,"score_gpt":0.28855187222375306,"score_spread":0.26210616946957255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985476501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745195,0.00015585993,0.00036008822,0.00062981073,0.00020197411,0.00038426658,4.057171e-7,0.00004019722,0.023707895],"genre_scores_gemma":[0.99835384,0.000012311878,0.0001598807,0.0004550944,0.00027973394,0.0000067924298,0.000014898373,0.000009051258,0.0007084036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944085,0.000016576678,0.000099273086,0.00012998894,0.00021552232,0.00009778416],"domain_scores_gemma":[0.99956125,0.000004660439,0.000024326398,0.000307703,0.00004681866,0.00005521907],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001876784,0.000045098608,0.000118290285,0.000035408535,0.000023175506,0.000006716649,0.000018246532,0.00005047072,0.0005443096],"category_scores_gemma":[0.000017937518,0.00004022,0.0000945664,0.00009248944,0.0000065577633,0.00004972813,0.0000059938257,0.00006186566,0.0010301525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000584211,0.00008558555,0.84307414,0.0003502438,0.00014099405,0.000014798423,0.00031275698,0.00038595998,0.02363982,0.0018206064,0.0019600966,0.12815657],"study_design_scores_gemma":[0.000729022,0.00002615969,0.97581375,0.00004363982,0.000034211564,0.00005194337,0.000022551409,0.0009962633,0.000536356,0.000117687756,0.021571089,0.000057355173],"about_ca_topic_score_codex":0.00005375745,"about_ca_topic_score_gemma":0.0000018707331,"teacher_disagreement_score":0.13273957,"about_ca_system_score_codex":0.000055041248,"about_ca_system_score_gemma":0.000059956234,"threshold_uncertainty_score":0.99974763},"labels":[],"label_agreement":null},{"id":"W2986081689","doi":"10.1016/j.bbalip.2019.158555","title":"Surf4 regulates expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) but is not required for PCSK9 secretion in cultured human hepatocytes","year":2019,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"PCSK9; Endocrinology; Internal medicine; LDL receptor; Kexin; Very low-density lipoprotein; Apolipoprotein B; Apolipoprotein E; Lipoprotein; Cholesterol; Triglyceride; Biology; Chemistry; Medicine; Disease","score_opus":0.014156200920110855,"score_gpt":0.2661669797312339,"score_spread":0.25201077881112305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986081689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962324,0.0008572905,0.000045514353,0.00042969408,0.00012317006,0.0020251696,0.00011701,0.000030423556,0.000139351],"genre_scores_gemma":[0.9976844,0.00019234775,0.0009556355,0.0002776234,0.00009812243,0.000063107014,0.00054350885,0.000043141805,0.00014209353],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978047,0.00024675697,0.00063525455,0.0006715799,0.00026058545,0.00038112214],"domain_scores_gemma":[0.9984853,0.000046229437,0.00036036098,0.0007274242,0.00024214768,0.00013852984],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048913254,0.00034207664,0.0009827125,0.00017025277,0.00005939641,0.000011560399,0.00017452889,0.00046243623,0.000029326053],"category_scores_gemma":[0.000051577943,0.0002727188,0.00038527203,0.00021210207,0.00029567746,0.00007201897,0.00010238252,0.00021989229,0.000004345955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013995023,0.00029679813,0.0003608506,0.0010538488,0.00011266234,0.0000028339766,0.00037991404,5.893483e-7,0.9957725,0.00015675672,0.000057051664,0.00040669463],"study_design_scores_gemma":[0.0035531814,0.0021173912,0.0021297014,0.00034187248,0.00014122986,0.000005818532,0.00014525441,0.00010461744,0.9906084,0.00021227711,0.00035997713,0.00028029454],"about_ca_topic_score_codex":0.00035172259,"about_ca_topic_score_gemma":0.000004315156,"teacher_disagreement_score":0.005164113,"about_ca_system_score_codex":0.000034228062,"about_ca_system_score_gemma":0.00015562327,"threshold_uncertainty_score":0.9999725},"labels":[],"label_agreement":null},{"id":"W2987229306","doi":"10.1016/j.ahj.2019.11.005","title":"Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS","year":2019,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"Novo Nordisk; Sanofi; Merck; GlaxoSmithKline; Janssen Pharmaceuticals; Genentech; AstraZeneca; Bayer; Amgen; Boehringer Ingelheim","keywords":"Medicine; Ezetimibe; Mace; Internal medicine; Sitagliptin; Myocardial infarction; Type 2 diabetes; Diabetes mellitus; Stroke (engine); Placebo; Cholesterol; Gastroenterology; Endocrinology; Percutaneous coronary intervention; Pathology","score_opus":0.005489832942289588,"score_gpt":0.21404685684135366,"score_spread":0.20855702389906408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987229306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960668,0.0026790234,0.0000063687976,0.00021109633,0.00008570396,0.0009096898,0.000008359168,0.00001832877,0.00001460042],"genre_scores_gemma":[0.9985883,0.00046347026,0.00035398803,0.0003873454,0.00012342808,0.000016762682,0.000014039947,0.000031558993,0.000021105723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839103,0.00016911386,0.000248271,0.0003801502,0.0005036754,0.00030774582],"domain_scores_gemma":[0.99875176,0.000036902515,0.000083178486,0.00053380744,0.000112362744,0.00048201482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018008493,0.0002359421,0.0009774863,0.00013864908,0.00008916924,0.00007049278,0.000041929758,0.00004143658,0.00001675743],"category_scores_gemma":[0.00004131879,0.00015178892,0.00019590049,0.00019690984,0.000118953714,0.00017632268,0.000036893274,0.0002565251,0.000009445752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023721044,0.00019607268,0.9361543,0.000031390464,0.0007841694,0.000030157282,0.00013960476,0.000008462102,0.000058936355,3.683041e-7,0.000007264318,0.062352043],"study_design_scores_gemma":[0.00443429,0.0016311874,0.9918319,0.00018192455,0.0002923395,0.000017405177,0.00010356661,0.000022431777,0.00016143947,0.000010718616,0.0011369037,0.00017590678],"about_ca_topic_score_codex":0.002310183,"about_ca_topic_score_gemma":0.00007889396,"teacher_disagreement_score":0.06217614,"about_ca_system_score_codex":0.00013712795,"about_ca_system_score_gemma":0.00014214026,"threshold_uncertainty_score":0.61897725},"labels":[],"label_agreement":null},{"id":"W2987323146","doi":"10.1186/s12881-019-0901-0","title":"Cascade screening for familial hypercholesterolemia-identification of the C308Y mutation in multiple family members and relatives for the first time in mainland China","year":2019,"lang":"en","type":"article","venue":"BMC Medical Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Proband; Familial hypercholesterolemia; Genetics; Exon; Medicine; Mutation; Population; Internal medicine; Family history; Biology; Cholesterol; Gene","score_opus":0.023295012549415278,"score_gpt":0.27331322902861066,"score_spread":0.25001821647919537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987323146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98521334,0.0010517072,0.010819331,0.00063742494,0.00010660241,0.0021242863,0.000018622384,0.0000047071726,0.000024003057],"genre_scores_gemma":[0.9970803,0.00020362312,0.0021186348,0.00016040592,0.00010668198,0.00015250043,0.000017134915,0.000015283855,0.00014540362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987998,0.00008622647,0.0003701791,0.00019236439,0.000392271,0.00015917275],"domain_scores_gemma":[0.9989895,0.0005533109,0.00008943502,0.00026972094,0.00003880749,0.000059176153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014419717,0.000084748375,0.00022438983,0.00004546629,0.00005696875,0.000007407072,0.000100968726,0.0001394449,0.0000044761023],"category_scores_gemma":[0.0008428839,0.00005125783,0.000098600314,0.00011614081,0.000094923846,0.000022443885,0.000036137186,0.00015883587,9.1662463e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013535818,0.00024239648,0.8437514,0.0027313742,0.00018827495,0.000004268674,0.0067035365,0.006682001,0.011127448,0.00011895725,0.00028023805,0.12681654],"study_design_scores_gemma":[0.004032435,0.00009296608,0.8565338,0.00021738179,0.000049349946,0.000010056907,0.00037323133,0.13724737,0.000564655,0.00004522395,0.000781118,0.0000523972],"about_ca_topic_score_codex":0.00017743435,"about_ca_topic_score_gemma":0.0004746403,"teacher_disagreement_score":0.13056538,"about_ca_system_score_codex":0.000031464613,"about_ca_system_score_gemma":0.00014024875,"threshold_uncertainty_score":0.20902336},"labels":[],"label_agreement":null},{"id":"W2987471862","doi":"10.1186/s12933-019-0951-9","title":"Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies","year":2019,"lang":"en","type":"article","venue":"Cardiovascular Diabetology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; Servier; Sanofi; Kowa Company; Novo Nordisk; National Institute for Health and Care Research; Medicines Company; University of California, San Diego; Regeneron Pharmaceuticals; Esperion Therapeutics; GlaxoSmithKline; NIHR Imperial Biomedical Research Centre; Amgen; Pfizer; Les Laboratories Pierre Fabre; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Dyslipidemia; Alirocumab; Medicine; Internal medicine; PCSK9; Endocrinology; Type 2 diabetes; Diabetes mellitus; Apolipoprotein B; Insulin; Cholesterol; Lipoprotein; Apolipoprotein A1; LDL receptor","score_opus":0.017724159584149655,"score_gpt":0.2509312485716827,"score_spread":0.23320708898753303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987471862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6372572,0.36107576,0.000022833641,0.00013965966,0.0001498424,0.0012786286,0.000015287302,0.00002670648,0.00003408229],"genre_scores_gemma":[0.9592832,0.039955072,0.00015223054,0.00025432586,0.000102551916,0.0001395251,0.000027142829,0.00006387748,0.000022081478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954933,0.0010680743,0.00062728376,0.0010512534,0.0010684332,0.000691645],"domain_scores_gemma":[0.9964167,0.00021662157,0.00016527789,0.0026133829,0.00031879367,0.00026921264],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002849052,0.00048691808,0.003674258,0.00047056732,0.000116475865,0.000024601482,0.00023709159,0.00027217084,0.00001713531],"category_scores_gemma":[0.00029421196,0.0003129515,0.00211284,0.0018066894,0.00058748905,0.00010991919,0.00022250912,0.0004272061,0.0000050336985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086200555,0.00008496329,0.8389326,0.000639153,0.11404891,0.000022289158,0.00049784686,0.0026886545,0.0001180533,0.00007639498,0.000011414314,0.042793564],"study_design_scores_gemma":[0.0047711655,0.0003025904,0.96939296,0.00028723708,0.017953714,0.000018884826,0.00035171915,0.0002793166,0.00035754545,0.00008736562,0.005807676,0.0003898506],"about_ca_topic_score_codex":0.00014923111,"about_ca_topic_score_gemma":0.000023422412,"teacher_disagreement_score":0.32202598,"about_ca_system_score_codex":0.00010895469,"about_ca_system_score_gemma":0.00020825319,"threshold_uncertainty_score":0.9999322},"labels":[],"label_agreement":null},{"id":"W2987674105","doi":"10.1016/s0140-6736(05)72112-7","title":"Lowering of LDL cholesterol","year":2000,"lang":"en","type":"letter","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Scopus; Medicine; Clinical trial; Assertion; Disease; Coronary artery disease; MEDLINE; Psychology; Political science; Internal medicine; Law; Computer science","score_opus":0.028578213753667703,"score_gpt":0.2719118343378922,"score_spread":0.24333362058422447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987674105","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02675021,0.003006104,0.000044224667,0.9455212,0.00032450323,0.00070413126,0.000052384745,0.00007475779,0.023522528],"genre_scores_gemma":[0.015364482,0.0013847991,0.0000875599,0.9456992,0.033915486,0.000034438897,0.00009221691,0.000061499944,0.0033602768],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988906,0.000043946933,0.00019875016,0.0001694295,0.00041331502,0.00028395836],"domain_scores_gemma":[0.99846303,0.000019620664,0.00007765914,0.0013850025,0.000026826727,0.000027877677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000328395,0.00014450554,0.000839688,0.00003636389,0.000029500381,0.000009644543,0.00022649503,0.0002526297,0.0002762724],"category_scores_gemma":[0.000011965847,0.00008522225,0.00027147302,0.00007210877,0.000055862638,0.000013657257,0.000029155379,0.0011174263,0.00007766176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052508774,0.000009289814,0.00009382831,0.0010214808,0.00024374924,0.00011800411,0.000109096305,0.0000017578841,0.00005858223,0.0000014501426,0.9726212,0.025669077],"study_design_scores_gemma":[0.00085441594,0.00006122509,0.0022697535,0.0004200697,0.00016182999,0.00013421301,0.0000028361621,0.0000014935297,0.0003138089,0.00003049359,0.99566895,0.00008092312],"about_ca_topic_score_codex":0.00015056955,"about_ca_topic_score_gemma":0.0000024111396,"teacher_disagreement_score":0.033590984,"about_ca_system_score_codex":0.000027500095,"about_ca_system_score_gemma":0.00006569913,"threshold_uncertainty_score":0.48547235},"labels":[],"label_agreement":null},{"id":"W2987850771","doi":"10.1001/jama.2019.16585","title":"Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease","year":2019,"lang":"en","type":"article","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":478,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Medicines Company; Amarin Corporation; Kowa Company; Ionis Pharmaceuticals; Esperion Therapeutics; Regeneron Pharmaceuticals; Novo Nordisk; Sanofi; AstraZeneca; Pfizer; Amgen","keywords":"Medicine; Placebo; Internal medicine; Randomization; Gastroenterology; Cholesterol; Clinical endpoint; Randomized controlled trial; Lipoprotein; Familial hypercholesterolemia; Lipid profile; Endocrinology; Pathology","score_opus":0.00470603381070763,"score_gpt":0.22313421543129902,"score_spread":0.21842818162059138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987850771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897387,0.00013850929,0.00016025944,0.00015877999,0.00023296748,0.009186498,0.00027877692,0.000052760115,0.00005272909],"genre_scores_gemma":[0.99810386,0.000027955135,0.000276613,0.00041560517,0.00020563228,0.00052424904,0.0002509636,0.00007164929,0.00012345899],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967174,0.0005346787,0.00049360434,0.00070217875,0.0010433239,0.00050884456],"domain_scores_gemma":[0.9975792,0.00011177718,0.00015665428,0.0014278229,0.00027299873,0.0004515027],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016991033,0.00034766467,0.0011975861,0.00022148745,0.00007385344,0.000023554898,0.00014906921,0.0001837605,0.00004105494],"category_scores_gemma":[0.0006872562,0.00028419943,0.00091146503,0.0003159717,0.000028728184,0.000090620495,0.000107213215,0.0003073523,0.00014162892],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13749228,0.0013656878,0.28164595,0.0072496384,0.0034607907,0.00012943198,0.0008193397,0.002941653,0.00179869,0.000020191557,0.00070495176,0.5623714],"study_design_scores_gemma":[0.045651518,0.008558954,0.89293176,0.0008695614,0.0007054712,0.0000025480088,0.000013451074,0.00024242152,0.04954463,0.000007537274,0.001128609,0.00034354324],"about_ca_topic_score_codex":0.002432423,"about_ca_topic_score_gemma":0.00010958044,"teacher_disagreement_score":0.6112858,"about_ca_system_score_codex":0.00035331104,"about_ca_system_score_gemma":0.00013010419,"threshold_uncertainty_score":0.999961},"labels":[],"label_agreement":null},{"id":"W2988030222","doi":"10.1016/j.puhe.2019.09.002","title":"Prevalence of hypercholesterolemia in Nigeria: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"Public Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Bundesministerium für Gesundheit; World Health Organization","keywords":"Medicine; Meta-analysis; Confidence interval; Population; Prevalence; Demography; Environmental health; Urbanization; Public health; Internal medicine","score_opus":0.17550744068091145,"score_gpt":0.39565472460840734,"score_spread":0.22014728392749588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988030222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000016966371,0.9875381,0.00004244883,0.0018273426,0.000023376082,0.010330697,0.00012582744,0.000020402227,0.000090125475],"genre_scores_gemma":[0.000031398264,0.9956949,0.00013783833,0.0023361843,0.000025201496,0.001116957,0.000069271315,0.00004507002,0.00054318144],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99283624,0.0024571307,0.0026727638,0.0007135763,0.0007701743,0.0005500989],"domain_scores_gemma":[0.99577516,0.00017151705,0.0013289033,0.0020787898,0.00016650319,0.0004791401],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.010989032,0.00046457956,0.0216821,0.00076314533,0.000030040685,0.00002399185,0.00026394153,0.00025765016,0.00012776353],"category_scores_gemma":[0.00059027725,0.0002830965,0.003787043,0.0017767317,0.000045644836,0.000090026384,0.00010112846,0.000587549,0.000023913284],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[3.7474723e-7,0.00005232572,0.000013880328,0.9268863,0.058572564,0.0000035318394,0.000051531395,1.8094688e-8,9.023673e-10,0.000018606328,0.000029906707,0.014370949],"study_design_scores_gemma":[0.00016540736,0.00010572292,0.000041556294,0.14845783,0.77989036,0.0001630156,0.0000128495385,7.7605915e-7,3.227228e-9,8.945192e-7,0.07097567,0.00018595447],"about_ca_topic_score_codex":0.00022722756,"about_ca_topic_score_gemma":0.000040956304,"teacher_disagreement_score":0.7784285,"about_ca_system_score_codex":0.0003399142,"about_ca_system_score_gemma":0.0026051402,"threshold_uncertainty_score":0.9999621},"labels":[],"label_agreement":null},{"id":"W2988829342","doi":"10.1161/circoutcomes.119.005858","title":"Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial","year":2019,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; Emergency medicine; Alirocumab; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.028402674291723405,"score_gpt":0.30599478147576487,"score_spread":0.2775921071840415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988829342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901861,0.005945871,0.00022445404,0.0009790822,0.0002830895,0.0020827444,0.00002697409,0.000029123388,0.00024253783],"genre_scores_gemma":[0.99881065,0.0005453659,0.000105983905,0.00025975914,0.0001134427,0.00006008159,0.00005510101,0.000020353546,0.00002927514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997197,0.0005772276,0.0006528423,0.00048068233,0.0008538519,0.00023841792],"domain_scores_gemma":[0.99854505,0.00028191108,0.00016284651,0.00076147064,0.00012941733,0.00011932615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025912425,0.000254184,0.0012246275,0.00014070375,0.00012610505,0.000063595355,0.00007739783,0.00016673394,0.000009281765],"category_scores_gemma":[0.00057949097,0.00017819031,0.0007232205,0.00018988943,0.00018079708,0.00019685394,0.00007422298,0.00017273561,0.0000021200158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030136676,0.00023747391,0.98065,0.00046844935,0.0019917362,0.000011251079,0.0032773411,0.000050433897,0.000029351086,0.0031304748,0.000007562737,0.009844558],"study_design_scores_gemma":[0.016699174,0.00021554495,0.9792073,0.00006465059,0.0005820417,0.000030058902,0.0023998332,0.000040183942,0.000022297212,0.00029802145,0.00021547779,0.00022543609],"about_ca_topic_score_codex":0.0012732351,"about_ca_topic_score_gemma":0.000031858748,"teacher_disagreement_score":0.016397808,"about_ca_system_score_codex":0.000038847676,"about_ca_system_score_gemma":0.00008273242,"threshold_uncertainty_score":0.726639},"labels":[],"label_agreement":null},{"id":"W2988851086","doi":"10.1161/atvbaha.119.313381","title":"Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease","year":2019,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; Canadian Institutes of Health Research","keywords":"Hazard ratio; Mendelian randomization; Medicine; Proportional hazards model; Internal medicine; Triglyceride; Cholesterol; Sepsis; Logistic regression; High-density lipoprotein; Demography; Biology; Confidence interval; Genotype; Genetics; Genetic variants","score_opus":0.023359755969261566,"score_gpt":0.2785162631379023,"score_spread":0.25515650716864074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988851086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99506724,0.00016197268,0.0032083145,0.00008087415,0.000088648056,0.001242245,0.00012454689,0.000018917981,0.0000072144408],"genre_scores_gemma":[0.99578905,0.0027569998,0.0011733434,0.00010930252,0.000060191665,0.00006968418,0.000017543825,0.000022134971,0.0000017403294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856275,0.00016873446,0.00041378613,0.00044427897,0.00014753225,0.00026289877],"domain_scores_gemma":[0.9987597,0.00009129209,0.00019245282,0.0005737845,0.00017306415,0.00020971509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005009031,0.0002074331,0.00088437967,0.00008528631,0.000066816676,0.000011510197,0.00006451962,0.00017037119,0.000023421379],"category_scores_gemma":[0.00013676117,0.00016697751,0.0002679461,0.00008434199,0.0002400761,0.000049251412,0.00010169474,0.00010718954,0.0000018669111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044767185,0.00017008708,0.80202836,0.00072027266,0.00082191586,5.892765e-8,0.00012803405,0.0000025073516,0.16978505,0.00036198535,0.0000016147668,0.025935348],"study_design_scores_gemma":[0.0032752778,0.001602578,0.9898852,0.000165431,0.00063809945,0.0000010812038,0.000017518974,0.00016556396,0.0037330564,0.00030033922,0.000055538727,0.00016033057],"about_ca_topic_score_codex":0.0016347219,"about_ca_topic_score_gemma":0.00017709707,"teacher_disagreement_score":0.18785682,"about_ca_system_score_codex":0.000015325715,"about_ca_system_score_gemma":0.000070204274,"threshold_uncertainty_score":0.6809145},"labels":[],"label_agreement":null},{"id":"W2991103112","doi":"10.1093/cvr/cvz294","title":"Cardiovascular research highlights from the UK Biobank: opportunities and challenges","year":2019,"lang":"en","type":"article","venue":"Cardiovascular Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Circle Cardiovascular Imaging; European Commission; National Institute for Health and Care Research; British Heart Foundation; National Institute on Handicapped Research","keywords":"Biobank; Medicine; Bioinformatics; Biology","score_opus":0.2666932054347876,"score_gpt":0.36008462423749227,"score_spread":0.09339141880270468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991103112","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35155722,0.6197635,0.000045425964,0.0073606796,0.00041146085,0.0033035558,0.000032242333,0.00011395115,0.017412005],"genre_scores_gemma":[0.68033534,0.3156949,0.0001616847,0.00012954645,0.0020351065,0.00035966747,0.00005922149,0.00012503847,0.001099491],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98280877,0.0047642095,0.00054592785,0.0017531714,0.00829232,0.0018355926],"domain_scores_gemma":[0.98939115,0.0009438444,0.000041332543,0.006917009,0.0019298871,0.00077679026],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.033859517,0.0004680436,0.0017665853,0.0006027638,0.0010300141,0.00028340143,0.0008347173,0.0005028056,0.0002691017],"category_scores_gemma":[0.00072896224,0.00031643664,0.003022473,0.0010676782,0.0011722984,0.00020213585,0.0010053642,0.0022689041,0.00070202444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085361546,0.00040773698,0.0051639685,0.0035800824,0.06425026,0.004216468,0.006214446,0.00009483859,0.00085434475,0.0317374,0.01425427,0.86837256],"study_design_scores_gemma":[0.0027960008,0.00041127513,0.02588938,0.0004481488,0.0006318895,0.00039855525,0.008562884,0.00003550402,0.0008240272,0.00054979755,0.95905626,0.00039626102],"about_ca_topic_score_codex":0.005436009,"about_ca_topic_score_gemma":0.00005480304,"teacher_disagreement_score":0.944802,"about_ca_system_score_codex":0.0003603911,"about_ca_system_score_gemma":0.0008517195,"threshold_uncertainty_score":0.9999288},"labels":[],"label_agreement":null},{"id":"W2992949531","doi":"10.1016/j.jcmg.2019.09.024","title":"Long-Term Administration of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Reduces Arterial FDG Uptake","year":2019,"lang":"en","type":"letter","venue":"JACC. Cardiovascular imaging","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Servier; Amgen; Boehringer Ingelheim; Novo Nordisk; European Regional Development Fund; Angelini Pharma; European Commission; Meso Scale Diagnostics; Sanofi; Bausch Health; Novartis; Pfizer; Bayer; AstraZeneca; Eli Lilly and Company","keywords":"Kexin; Proprotein convertase; Subtilisin; PCSK9; Pharmacology; Medicine; Internal medicine; Endocrinology; Chemistry; Cholesterol; Biochemistry; LDL receptor; Lipoprotein; Enzyme","score_opus":0.017329730259127384,"score_gpt":0.25933295534712053,"score_spread":0.24200322508799316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992949531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.796425,0.071493305,0.0011996818,0.0946935,0.014531414,0.017283717,0.00040075238,0.00072850456,0.0032441488],"genre_scores_gemma":[0.89667714,0.0014009107,0.0012562636,0.05150395,0.040209353,0.00043949875,0.005806071,0.0008001482,0.0019066576],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924239,0.00057460804,0.0014643598,0.0015735758,0.002924166,0.0010394084],"domain_scores_gemma":[0.9948748,0.000053105152,0.00060820807,0.0033558914,0.00087821926,0.00022977518],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020175872,0.0009925396,0.003029783,0.0005324454,0.0001524484,0.0001819444,0.00042808324,0.001027495,0.00019063387],"category_scores_gemma":[0.00028111364,0.0009161993,0.0043318016,0.0004833905,0.00027142727,0.00034463714,0.00017049507,0.0021612814,0.00016398256],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028952635,0.0006462803,0.006247408,0.027497014,0.030638816,0.02585697,0.00079537544,0.000045655048,0.01813042,0.000011337408,0.5652485,0.32198697],"study_design_scores_gemma":[0.0103866495,0.0008673726,0.019907257,0.005078305,0.01035663,0.0056816996,0.00016009402,0.00009189467,0.08440784,0.00002249119,0.86051536,0.0025244376],"about_ca_topic_score_codex":0.0003907808,"about_ca_topic_score_gemma":0.0000068875966,"teacher_disagreement_score":0.31946254,"about_ca_system_score_codex":0.00038210533,"about_ca_system_score_gemma":0.0018587128,"threshold_uncertainty_score":0.99932885},"labels":[],"label_agreement":null},{"id":"W2993257843","doi":"10.69645/ybdm6125","title":"Expanding frontiers of cerebrovascular disease","year":2019,"lang":"en","type":"article","venue":"˜The œbiomedical & life sciences collection.","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Disease; Medicine; Intensive care medicine; Internal medicine","score_opus":0.012785792564566268,"score_gpt":0.26522873811518916,"score_spread":0.2524429455506229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993257843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9556536,0.0080890795,0.016386047,0.0067098965,0.0042316252,0.0021931347,0.000012844005,0.00013824723,0.0065854914],"genre_scores_gemma":[0.9952949,0.00021727667,0.00088828057,0.0008439226,0.00042606427,0.00003797311,0.0000062004374,0.000011855357,0.0022734865],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99723446,0.00012541917,0.00034447762,0.00038463212,0.0015542933,0.0003567317],"domain_scores_gemma":[0.998714,0.000056938174,0.00010068455,0.0004889399,0.00009244808,0.0005469772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016530311,0.0001293097,0.00038188873,0.00024027633,0.00040073466,0.000023303706,0.00025873,0.00007685154,0.0003070462],"category_scores_gemma":[0.00019476669,0.00007832689,0.00037993948,0.0019200781,0.0007482908,0.000095899966,0.000073463256,0.00019718173,0.00005395587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011674975,0.001784944,0.5510128,0.0016061516,0.0022433384,0.00005878231,0.0021653941,0.0004347526,0.003626283,0.0017274773,0.39767775,0.036494814],"study_design_scores_gemma":[0.011218083,0.003421014,0.38560674,0.00065476925,0.001148596,0.00024301361,0.0067404797,0.025443062,0.00096609705,0.0018213566,0.56175107,0.0009857238],"about_ca_topic_score_codex":0.0002672338,"about_ca_topic_score_gemma":0.0000075852745,"teacher_disagreement_score":0.16540606,"about_ca_system_score_codex":0.00009791196,"about_ca_system_score_gemma":0.0011962983,"threshold_uncertainty_score":0.33619407},"labels":[],"label_agreement":null},{"id":"W2993495213","doi":"10.1016/j.jacc.2019.06.083","title":"Exposure to Low Lipoprotein(a) Levels","year":2019,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Fonds de Recherche du Québec - Santé; Novartis; Canadian Institutes of Health Research; Ionis Pharmaceuticals; Merck; Pfizer","keywords":"Medicine; Lipoprotein(a); Internal medicine; Environmental health; Lipoprotein; Cholesterol","score_opus":0.016176246284112416,"score_gpt":0.2633553994572463,"score_spread":0.24717915317313388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993495213","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15258683,0.0020974798,0.00091002794,0.8352433,0.0037859008,0.0023138903,0.0005286389,0.000017070151,0.0025168594],"genre_scores_gemma":[0.38598186,0.0003118465,0.0019914026,0.5790582,0.027417524,0.000029998102,0.000007167495,0.00015961284,0.0050424123],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958188,0.0008689205,0.001113695,0.00033591257,0.0013265752,0.0005361247],"domain_scores_gemma":[0.9952379,0.00020543045,0.0018808821,0.0016592667,0.0008594077,0.00015711594],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001347394,0.00039225622,0.003820485,0.00040716628,0.000059685077,0.000006356043,0.0008001799,0.0004611677,0.000023632621],"category_scores_gemma":[0.0005157718,0.00024160059,0.0027868175,0.0006323414,0.00036473467,0.000038389244,0.000215968,0.0024961184,0.000024183671],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047797165,0.000017045475,0.0008477458,0.0004717553,0.0025892658,0.0022341022,0.000021628055,0.00022382694,0.00093077275,0.000006601441,0.9872306,0.0049486975],"study_design_scores_gemma":[0.0013444438,0.0040269126,0.015504891,0.00068701094,0.0009366801,0.011884414,0.00009699125,0.0000010276401,0.00059709273,0.000046944442,0.96461433,0.00025924444],"about_ca_topic_score_codex":0.00005073929,"about_ca_topic_score_gemma":0.0000019010868,"teacher_disagreement_score":0.2561851,"about_ca_system_score_codex":0.00028841142,"about_ca_system_score_gemma":0.0015446224,"threshold_uncertainty_score":0.99980515},"labels":[],"label_agreement":null},{"id":"W2995036789","doi":"","title":"Prevalence of clinical familial hypercholesterolaemia among patients with high cholesterol levels.","year":2019,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lockheed Martin (Canada)","funders":"","keywords":"Medicine; Ldl cholesterol; Cholesterol; Internal medicine; MEDLINE; Hydroxymethylglutaryl-CoA Reductase Inhibitors","score_opus":0.026448882758780917,"score_gpt":0.2590582893746356,"score_spread":0.2326094066158547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995036789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956297,0.00006825241,0.000017334245,0.000063679225,0.00037645447,0.002688257,0.000029913566,0.00003716834,0.0010891834],"genre_scores_gemma":[0.997787,0.000029201972,0.00014892551,0.00033007254,0.00024429438,0.00029033187,0.000011038088,0.000030652867,0.0011284682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779916,0.00012647487,0.00054786814,0.0004097348,0.00073867594,0.00037811577],"domain_scores_gemma":[0.99848884,0.000039843282,0.00018624934,0.0007963438,0.00019871307,0.00029001455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008812865,0.00015896924,0.0006007637,0.000057792306,0.000022104714,0.000010619425,0.00014410036,0.00015603383,0.00004073883],"category_scores_gemma":[0.00011980229,0.00011177979,0.00021033673,0.000114001254,0.00011915398,0.00012694826,0.000058090263,0.00031876648,0.00002547133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002873274,0.00020463567,0.8944816,0.00051593233,0.0001222095,0.0000026267971,0.000030124003,0.0000032115265,0.0000025806326,0.0000035291532,0.00003752761,0.10430871],"study_design_scores_gemma":[0.00652799,0.00032967413,0.9922071,0.00011025575,0.00016325824,0.0000032464516,0.000009794688,0.000004501907,0.00013564108,0.0000029354317,0.0003894918,0.00011607686],"about_ca_topic_score_codex":0.00012166791,"about_ca_topic_score_gemma":0.0000082047745,"teacher_disagreement_score":0.10419264,"about_ca_system_score_codex":0.000043677595,"about_ca_system_score_gemma":0.00007913539,"threshold_uncertainty_score":0.45582476},"labels":[],"label_agreement":null},{"id":"W2995065776","doi":"10.1016/s2213-8587(19)30389-4","title":"LDL cholesterol: lower, faster, younger?","year":2019,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ezetimibe; Cholesterol; PCSK9; Internal medicine; Type 2 diabetes; Diabetes mellitus; Randomized controlled trial; Clinical trial; Relative risk; Ldl cholesterol; Meta-analysis; Statin; Drug class; Endocrinology; Drug; Pharmacology; Confidence interval; Lipoprotein; LDL receptor","score_opus":0.029746175073489114,"score_gpt":0.27137853520218747,"score_spread":0.24163236012869835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995065776","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.090078704,0.008141295,0.000012413774,0.8876674,0.003999648,0.0018126534,0.00014501881,0.00034179477,0.0078010582],"genre_scores_gemma":[0.014689702,0.0017378632,0.00008171524,0.94528276,0.029504262,0.0002758683,0.00047992982,0.00018664532,0.0077612633],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944332,0.00044992144,0.0005304268,0.0008620967,0.0006993425,0.003025016],"domain_scores_gemma":[0.9958247,0.00022995849,0.0002670013,0.003461892,0.00012709704,0.00008933596],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005867136,0.00064692984,0.0023329644,0.00018714966,0.00012352981,0.00005884089,0.0008482887,0.0008071958,0.00025862432],"category_scores_gemma":[0.000083219486,0.00042323637,0.00075398176,0.00018440615,0.00030145395,0.000081457845,0.00033411372,0.0041435305,0.0013568107],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054567765,0.000043548764,0.004103983,0.0010413751,0.0012631203,0.0006026356,0.000046384466,0.0000010901175,0.0001594849,0.000050090497,0.9743108,0.018322913],"study_design_scores_gemma":[0.0025290877,0.0004876913,0.008125466,0.0002572837,0.0006633609,0.00041770615,0.000010078446,0.000009083995,0.00030116033,0.00012072885,0.9866781,0.00040021335],"about_ca_topic_score_codex":0.00012703607,"about_ca_topic_score_gemma":0.000007842225,"teacher_disagreement_score":0.075389005,"about_ca_system_score_codex":0.0001485927,"about_ca_system_score_gemma":0.00019799646,"threshold_uncertainty_score":0.99982196},"labels":[],"label_agreement":null},{"id":"W2995212685","doi":"10.1016/j.atherosclerosis.2019.12.006","title":"Effects of intensive lipid-lowering therapy on mortality after coronary bypass surgery: A meta-analysis of 7 randomised trials","year":2019,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Meta-analysis; Internal medicine; Clinical trial; Acute coronary syndrome; Cardiology; Relative risk; Cholesterol; Randomized controlled trial; Bypass surgery; Lipid profile; Surgery; Confidence interval; Myocardial infarction; Artery","score_opus":0.27457285714439333,"score_gpt":0.392975374505421,"score_spread":0.11840251736102769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995212685","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023371493,0.9703618,0.000047220372,0.000024133555,0.00038637713,0.0054602497,0.00028869676,0.00003334908,0.00002664882],"genre_scores_gemma":[0.019875698,0.977307,0.000027979,0.00044852303,0.0001840172,0.0017807345,0.00014190709,0.0001327994,0.000101321195],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922418,0.0025309923,0.0028025375,0.0008517192,0.0011527755,0.0004201608],"domain_scores_gemma":[0.9899169,0.004868226,0.0023387389,0.0020721839,0.0006095122,0.00019439141],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.006634991,0.00084045745,0.029082302,0.00072399987,0.000033102253,0.000016469516,0.00023213675,0.00056853186,0.00039635657],"category_scores_gemma":[0.0017862197,0.00049913704,0.03823749,0.0012242061,0.000114203416,0.0000493955,0.0000728468,0.00041921766,0.000017601738],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018357969,0.00036740923,0.00013126375,0.026521808,0.7628228,0.000012177825,0.00013625188,0.0000023363116,0.00011228011,0.0000021515953,0.00011822912,0.20793751],"study_design_scores_gemma":[0.007284617,0.00042405474,0.004932407,0.005269712,0.94959414,0.000003516252,0.0000116579595,0.0000015118851,0.0007958314,0.0000010145507,0.031231642,0.00044988628],"about_ca_topic_score_codex":0.00050512364,"about_ca_topic_score_gemma":0.000008463231,"teacher_disagreement_score":0.20748763,"about_ca_system_score_codex":0.00012808877,"about_ca_system_score_gemma":0.00042276454,"threshold_uncertainty_score":0.999746},"labels":[],"label_agreement":null},{"id":"W2995340392","doi":"10.1016/j.ahj.2019.11.008","title":"Corrigendum to “Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design” [212 (2019) 36–44]","year":2019,"lang":"en","type":"erratum","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Impact","funders":"","keywords":"Medicine; Randomized controlled trial; Adverse effect; Heart failure; Intensive care medicine; Cardiology; Internal medicine","score_opus":0.013146670229650883,"score_gpt":0.27041975344967356,"score_spread":0.2572730832200227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995340392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.934317,0.0023945104,0.0014790732,0.00410102,0.012027466,0.045384135,0.000087327295,0.000044237557,0.00016523169],"genre_scores_gemma":[0.67584735,0.006154904,0.12556273,0.06085368,0.035154335,0.009824822,0.0015559989,0.0022898638,0.08275631],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99324185,0.0015481708,0.0017765991,0.00066860934,0.002064183,0.0007006129],"domain_scores_gemma":[0.9963348,0.00020659126,0.00089838536,0.00083292444,0.00083831087,0.00088902056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039141946,0.0006167625,0.0061393445,0.00089790695,0.00013411288,0.00003524609,0.00019298942,0.00027316622,0.00013531251],"category_scores_gemma":[0.0011809483,0.00043196205,0.0011737072,0.0007096641,0.000103716506,0.00014902219,0.00008466812,0.0014050761,0.00003623558],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7604084,0.00044039552,0.004295004,0.000112984046,0.0014653591,0.000012722523,0.0002102086,0.00014968008,0.000031757787,0.0000012099006,0.2323562,0.00051610003],"study_design_scores_gemma":[0.82563496,0.006641989,0.028756935,0.0012785408,0.0010333849,0.000102618425,0.00015457737,0.000024300964,0.000013010571,0.000005923129,0.13589704,0.00045672257],"about_ca_topic_score_codex":0.00071705965,"about_ca_topic_score_gemma":0.000043484055,"teacher_disagreement_score":0.25846964,"about_ca_system_score_codex":0.00032205693,"about_ca_system_score_gemma":0.0022981279,"threshold_uncertainty_score":0.9998132},"labels":[],"label_agreement":null},{"id":"W2995442437","doi":"10.1016/j.amjcard.2019.12.006","title":"Meta-analysis of the Relation of Body Mass Index to Cardiovascular Outcomes in Patients Receiving Intensive Low-Density Lipoprotein Cholesterol Lowering Therapy","year":2019,"lang":"en","type":"review","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of General Medical Sciences","keywords":"Medicine; Internal medicine; Hazard ratio; Ezetimibe; Body mass index; Meta-analysis; Myocardial infarction; Confidence interval; Randomized controlled trial; Placebo; Cholesterol; Cardiology","score_opus":0.05825537480877158,"score_gpt":0.31957341543968865,"score_spread":0.26131804063091707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995442437","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27379,0.72174835,0.001372876,0.00016874334,0.0003806728,0.0024653554,0.00002706402,0.0000055309747,0.00004141271],"genre_scores_gemma":[0.5617531,0.43776643,0.00005414357,0.00019611578,0.0001363259,0.000029924904,0.0000053520293,0.00004614023,0.000012458773],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9931347,0.0028633433,0.0020246576,0.00038842062,0.0012375931,0.00035132092],"domain_scores_gemma":[0.99307656,0.00034919303,0.0030950704,0.0021609967,0.0012027248,0.00011545219],"candidate_categories":["metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.004697183,0.00046956923,0.015365113,0.00089352694,0.000043624168,0.0000086579585,0.0006525714,0.0002042339,0.0000050104277],"category_scores_gemma":[0.0005906297,0.00022357938,0.01717036,0.001794915,0.00028527624,0.00005716929,0.00017279795,0.0011162257,0.000002182148],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002877272,0.00003575958,0.018883552,0.0008416001,0.50335604,0.000016186572,0.00021856235,0.0032932751,0.000009110068,0.0000011828448,0.0000052013947,0.47305182],"study_design_scores_gemma":[0.0011580052,0.0011507872,0.63123703,0.0012512781,0.35534164,0.00013748728,0.00019615718,0.0000050327567,0.00002155264,0.000007354189,0.009217085,0.00027657108],"about_ca_topic_score_codex":0.00057893683,"about_ca_topic_score_gemma":0.000010110849,"teacher_disagreement_score":0.6123535,"about_ca_system_score_codex":0.00026073848,"about_ca_system_score_gemma":0.00036749238,"threshold_uncertainty_score":0.9992528},"labels":[],"label_agreement":null},{"id":"W2997794494","doi":"10.1016/j.cjco.2019.12.002","title":"GOAL Canada: Physician Education and Support Can Improve Patient Management","year":2019,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; St. Paul's Hospital; University of British Columbia; Canadian Heart Research Centre; Montreal Heart Institute; Université de Montréal; St. Michael's Hospital; University of Toronto","funders":"Janssen Pharmaceuticals; Duke Clinical Research Institute; Johnson and Johnson; Bristol-Myers Squibb Canada; Esperion Therapeutics; Ferring Pharmaceuticals; Novo Nordisk; University of Toronto; Luitpold Pharmaceuticals; Daiichi-Sankyo; Medicines Company; Regeneron Pharmaceuticals; Sunovion; Heart and Stroke Foundation of Canada; Tenax Therapeutics; New York University; Actelion Pharmaceuticals; York University; Pfizer; Novartis; Kowa Company; Sanofi; Merck; HLS Therapeutics; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Servier; Bayer; CSL Behring; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Medical education; Nursing; Family medicine; Intensive care medicine","score_opus":0.005092703167109514,"score_gpt":0.2408151809565494,"score_spread":0.2357224777894399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997794494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8391531,0.00019477723,0.0000033601618,0.001428592,0.00056352856,0.0025541938,0.000013002822,0.000008279563,0.15608114],"genre_scores_gemma":[0.98617166,0.00003003277,0.00019155223,0.0047374335,0.00012888113,0.00008895295,0.000050592273,0.000012337504,0.008588582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993236,0.000014791119,0.000105592764,0.00019622456,0.00021332572,0.00014645791],"domain_scores_gemma":[0.9994304,0.0000031114685,0.000035544523,0.00037137695,0.000039060054,0.00012047597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112779206,0.00007165605,0.00020216251,0.000017198417,0.00003774822,0.000025960677,0.00007368808,0.00001944609,0.00006625518],"category_scores_gemma":[0.0000035386404,0.00006022017,0.000028302193,0.00004981156,0.00000742727,0.000045591885,0.00011779348,0.000060210812,0.00001784183],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003064022,0.000104102604,0.0026721347,0.00025998667,0.00015076829,0.000023800603,0.00021819175,5.518085e-7,0.00014381773,0.0008348636,0.013934719,0.98162645],"study_design_scores_gemma":[0.0020760437,0.000523426,0.15711084,0.00014660208,0.00015754017,0.00003922477,0.0024732477,0.000012572611,0.001481421,0.00009281352,0.835652,0.00023429451],"about_ca_topic_score_codex":0.35087022,"about_ca_topic_score_gemma":0.058739606,"teacher_disagreement_score":0.98139215,"about_ca_system_score_codex":0.00019001127,"about_ca_system_score_gemma":0.0009741801,"threshold_uncertainty_score":0.95843595},"labels":[],"label_agreement":null},{"id":"W2998820157","doi":"10.1016/j.ahj.2020.01.007","title":"Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapib","year":2020,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Cholesterylester transfer protein; Genotype; Placebo; Myocardial infarction; Pharmacogenetics; Internal medicine; Adverse effect; Stroke (engine); Pharmacology; Cardiology; Bioinformatics; Cholesterol; Pathology; Gene; Lipoprotein; Genetics","score_opus":0.05047115337448941,"score_gpt":0.3120107916301127,"score_spread":0.26153963825562326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998820157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865689,0.002773806,0.008655373,0.00026597502,0.0001447329,0.0015553553,0.0000026961259,0.000016148146,0.0000170114],"genre_scores_gemma":[0.9884261,0.0005455486,0.009808619,0.00010883776,0.0010467246,0.000023178336,0.0000017618114,0.000036113663,0.0000031068682],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969902,0.00070983457,0.00061285414,0.0002676938,0.0011472645,0.00027213522],"domain_scores_gemma":[0.9987302,0.000024076606,0.0003156326,0.00030602977,0.00027547506,0.0003485819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015896718,0.0001682126,0.0010675474,0.0001125024,0.00009125501,0.000007453065,0.00009613948,0.000027324375,0.000028609831],"category_scores_gemma":[0.00009788103,0.00012895688,0.00061971607,0.00062293495,0.00011564139,0.00006213368,0.000024539402,0.00034458184,0.0000021479052],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19248469,0.006939763,0.064000875,0.0010464826,0.05623995,0.0014311699,0.015009334,0.06401748,0.34003544,0.0000023443085,0.0028102857,0.2559822],"study_design_scores_gemma":[0.35748416,0.18546161,0.055679113,0.00088421087,0.022343032,0.015446699,0.04005416,0.0014039016,0.30831245,0.000022597505,0.011058311,0.0018497298],"about_ca_topic_score_codex":0.00021493944,"about_ca_topic_score_gemma":1.8393024e-7,"teacher_disagreement_score":0.25413245,"about_ca_system_score_codex":0.000048729104,"about_ca_system_score_gemma":0.00050338183,"threshold_uncertainty_score":0.5258709},"labels":[],"label_agreement":null},{"id":"W2998927333","doi":"10.1016/j.acvdsp.2019.09.327","title":"Hypercholesterolemia in France, from recommendations to management in real life: The French gap","year":2020,"lang":"en","type":"article","venue":"Archives of Cardiovascular Diseases Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Gerontology","score_opus":0.02160740674465105,"score_gpt":0.2763860198824213,"score_spread":0.2547786131377702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998927333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96571946,0.009819706,0.00481298,0.01033189,0.00018011869,0.0041651167,0.0009374101,0.000057677382,0.003975639],"genre_scores_gemma":[0.9907784,0.0034592277,0.002522527,0.0020644376,0.00023272226,0.00038766777,0.00049621187,0.00003486833,0.000023927103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738604,0.00034449014,0.0005673385,0.000541354,0.000767562,0.00039319662],"domain_scores_gemma":[0.99838036,0.0000706912,0.00005518133,0.0010384982,0.000023833492,0.000431417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027102802,0.00021967817,0.00073099526,0.00019431832,0.000056494988,0.000018276347,0.00032688334,0.00003562941,0.000111808935],"category_scores_gemma":[0.000068155976,0.00018001386,0.0008805452,0.0004890354,0.00006065008,0.00009578703,0.00026646638,0.00021292309,0.00001975958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048536924,0.0007878299,0.53085566,0.0008257061,0.008951681,0.00034243055,0.0036078417,0.0031756293,0.00017771772,0.00028316546,0.0035107494,0.4469962],"study_design_scores_gemma":[0.005336707,0.00013284296,0.89639133,0.00026865405,0.0007983219,0.0000014264303,0.0006845871,0.00021317926,0.00008051834,0.00018980946,0.09570741,0.00019520777],"about_ca_topic_score_codex":0.0027142838,"about_ca_topic_score_gemma":0.00009702424,"teacher_disagreement_score":0.446801,"about_ca_system_score_codex":0.000040208695,"about_ca_system_score_gemma":0.00010093156,"threshold_uncertainty_score":0.7340752},"labels":[],"label_agreement":null},{"id":"W2998974244","doi":"10.1111/jgs.16342","title":"Benefits and Harms of Statins in People with Dementia: A Systematic Review and Meta‐Analysis","year":2020,"lang":"en","type":"review","venue":"Journal of the American Geriatrics Society","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; South London and Maudsley NHS Foundation Trust; King’s College London","keywords":"Medicine; Dementia; Randomized controlled trial; Meta-analysis; Confidence interval; Odds ratio; Observational study; Adverse effect; Systematic review; Vascular dementia; Statin; MEDLINE; Cohort study; Internal medicine; Physical therapy; Disease","score_opus":0.027561921271752048,"score_gpt":0.30107283134581786,"score_spread":0.2735109100740658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998974244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001300325,0.9975344,0.0001364295,0.0006623675,0.000012917379,0.0014758384,0.000042587482,0.0000025919098,0.0000028240554],"genre_scores_gemma":[0.00014089864,0.99661005,0.0025643993,0.00056962715,0.000043510114,0.000034866727,0.0000023760736,0.000027706268,0.000006570534],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9971384,0.00048583042,0.0013237369,0.00020864392,0.0006745943,0.00016884085],"domain_scores_gemma":[0.9950745,0.00015223853,0.003966247,0.00042783323,0.00021372754,0.00016542364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018721642,0.00028678187,0.010274563,0.000121195844,0.000042449137,0.000018741446,0.00019163419,0.000056821707,0.000005626652],"category_scores_gemma":[0.00013503949,0.00013218452,0.004057838,0.0027368627,0.000097742195,0.000041851206,0.00010763572,0.00051710225,1.5394868e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005940195,0.00003754463,0.0000976848,0.763641,0.2287465,0.0000067190044,0.00023705725,0.0000036773235,3.9441293e-8,0.000002750066,0.00007756122,0.00714353],"study_design_scores_gemma":[0.00026775638,0.00025075293,0.00020452784,0.025362927,0.96988785,0.00042454046,0.00021749848,0.0000044220865,8.809432e-8,0.0000010587161,0.0032515982,0.00012694851],"about_ca_topic_score_codex":0.00016002211,"about_ca_topic_score_gemma":0.000017135117,"teacher_disagreement_score":0.7411414,"about_ca_system_score_codex":0.000098500655,"about_ca_system_score_gemma":0.00055878627,"threshold_uncertainty_score":0.7023486},"labels":[],"label_agreement":null},{"id":"W2999113451","doi":"10.1016/j.clinbiochem.2020.01.003","title":"Circulating PCSK9 is associated with liver biomarkers and hepatic steatosis","year":2020,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Heart Institute; Université de Montréal; Montreal Clinical Research Institute","funders":"Københavns Universitet; Fondation Leducq; University of Cambridge; Novo Nordisk Canada; Institut de Recherche Clinique De Montréal; National Institute for Health and Care Research; FURTHERMORE grants in publishing; Ionis Pharmaceuticals; Amgen; Boehringer Ingelheim; Regeneron Pharmaceuticals; Novartis; Center for Global Health; Danish International Development Agency; Pfizer; Rådet for Udviklingsforskning; NIHR Bristol Biomedical Research Centre; Eli Lilly and Company; Valeant Pharmaceuticals International; NIHR Cambridge Biomedical Research Centre; Amgen Canada; Sanofi; Merck","keywords":"Steatosis; Internal medicine; Medicine; PCSK9; Endocrinology; Fatty liver; Metabolic syndrome; Bilirubin; Albumin; Cirrhosis; Alkaline phosphatase; Gastroenterology; Cholesterol; Biology; Disease; Obesity; Lipoprotein; LDL receptor; Biochemistry","score_opus":0.044058638421360256,"score_gpt":0.3047175588715545,"score_spread":0.26065892045019423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999113451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953646,0.0011996547,0.000059672773,0.002082526,0.000022332946,0.00021928032,0.000012546544,0.00006705444,0.0009723165],"genre_scores_gemma":[0.9948218,0.00015545102,0.0004206808,0.004212227,0.00026706682,0.000007931165,0.000030329398,0.000021309805,0.00006320708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986323,0.00005553095,0.00036896757,0.00044518188,0.00029466694,0.00020332722],"domain_scores_gemma":[0.9988983,0.00013696223,0.00011310943,0.00030606118,0.00008316287,0.00046234945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046221205,0.00014054307,0.0004550843,0.000008907846,0.0000613874,0.000017133374,0.000055765424,0.0002189869,0.00007948072],"category_scores_gemma":[0.0011288022,0.000109916924,0.0002110918,0.00017479055,0.00015388471,0.00002118282,0.00005347562,0.00028915232,0.000011610944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000735448,0.0005698587,0.83406615,0.0024594564,0.005311483,0.0012918962,0.00050084444,6.111292e-7,0.02310365,0.000005669799,0.004930952,0.127024],"study_design_scores_gemma":[0.03361203,0.0047725965,0.69632244,0.004578476,0.006240799,0.0009870927,0.0017543662,0.012022889,0.22917582,0.000051377887,0.007978675,0.0025034389],"about_ca_topic_score_codex":0.000021394098,"about_ca_topic_score_gemma":6.0750233e-7,"teacher_disagreement_score":0.20607217,"about_ca_system_score_codex":0.000033255285,"about_ca_system_score_gemma":0.00014689019,"threshold_uncertainty_score":0.4482282},"labels":[],"label_agreement":null},{"id":"W3000196126","doi":"10.1074/jbc.ra119.010221","title":"A transient amphipathic helix in the prodomain of PCSK9 facilitates binding to low-density lipoprotein particles","year":2020,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research; Government of Canada; Heart and Stroke Foundation of Canada; Fondo Nacional de Desarrollo Científico y Tecnológico; Pfizer","keywords":"Proprotein convertase; Kexin; PCSK9; LDL receptor; Familial hypercholesterolemia; Endosome; Chemistry; Biochemistry; Biophysics; Low-density lipoprotein; Proprotein Convertases; Lipoprotein; Receptor; Cholesterol; Biology","score_opus":0.043121471398061134,"score_gpt":0.26795094968052713,"score_spread":0.224829478282466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000196126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070734,0.0006418538,0.00022990315,0.008023644,0.000015573414,0.0003188847,0.000007211433,0.0000073513143,0.00004826759],"genre_scores_gemma":[0.9982872,0.000067477114,0.0006648123,0.0007231132,0.0002382737,0.000008830175,0.0000018206201,0.0000047013114,0.0000037788561],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985115,0.00013717709,0.00055804825,0.00016448417,0.0004147965,0.00021399642],"domain_scores_gemma":[0.99926037,0.000071997034,0.00015654205,0.00017270062,0.000110487716,0.00022793308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001576427,0.00011664838,0.0004983783,0.000021102816,0.000030190926,0.000008947263,0.00016787965,0.00012156486,0.00003248267],"category_scores_gemma":[0.0009552325,0.00006139329,0.0003116497,0.00027757822,0.00007851184,0.000023806188,0.00002950134,0.00042761283,0.0000042234396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006844322,0.00021087624,0.0033281837,0.00045272024,0.000058467216,0.00019697646,0.0015412068,0.000017482444,0.98486876,0.0000036445956,0.000042270996,0.0085949525],"study_design_scores_gemma":[0.0016462535,0.0014084266,0.039068714,0.00044084335,0.000056924157,0.00037824936,0.0028785868,0.000023153794,0.9523865,0.00009727961,0.0014818326,0.00013323152],"about_ca_topic_score_codex":0.000018656747,"about_ca_topic_score_gemma":0.0000012893662,"teacher_disagreement_score":0.035740532,"about_ca_system_score_codex":0.00004195289,"about_ca_system_score_gemma":0.00009094474,"threshold_uncertainty_score":0.2503546},"labels":[],"label_agreement":null},{"id":"W3000263047","doi":"10.1016/j.jacl.2020.01.001","title":"Efficacy and safety of alirocumab in statin-intolerant patients over 3 years: open-label treatment period of the ODYSSEY ALTERNATIVE trial","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Statin; Online transaction processing; Internal medicine; Ezetimibe; Atorvastatin; Cholesterol; Lipoprotein; Database","score_opus":0.1230577307056659,"score_gpt":0.42616008427213575,"score_spread":0.30310235356646986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000263047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546283,0.00023393758,0.000030357936,0.0022644103,0.00097531016,0.0009171767,0.00001679717,0.0000012576289,0.000097944125],"genre_scores_gemma":[0.9966101,0.00064362254,0.00059828983,0.00080229033,0.0013146137,0.000003608727,0.0000019549918,0.000011115334,0.0000144182795],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9967045,0.000773041,0.0018273934,0.0001744027,0.000379277,0.00014134595],"domain_scores_gemma":[0.99784523,0.0004938877,0.0010826172,0.0002227899,0.00017784319,0.00017760534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014135792,0.00011063493,0.0014014725,0.00004288853,0.000017384144,0.0000055923488,0.00019794678,0.00012401756,0.000046654397],"category_scores_gemma":[0.0020622737,0.000063410065,0.00028553695,0.000114983,0.00016667307,0.000054687185,0.0001282554,0.000371223,8.938145e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.489867,0.011236481,0.16563226,0.0002448045,0.0026857003,0.000082463936,0.0059089144,0.00005034959,0.00032032258,0.0003305654,0.0009933892,0.32264775],"study_design_scores_gemma":[0.37055522,0.027728148,0.5913806,0.00025246522,0.00032253502,0.00002875744,0.00013416412,0.000087075154,0.00012586119,0.00007866331,0.009226039,0.00008048188],"about_ca_topic_score_codex":0.00014500745,"about_ca_topic_score_gemma":0.000021604706,"teacher_disagreement_score":0.42574835,"about_ca_system_score_codex":0.000046387624,"about_ca_system_score_gemma":0.00043525198,"threshold_uncertainty_score":0.25857875},"labels":[],"label_agreement":null},{"id":"W3000311404","doi":"10.1080/14779072.2020.1715797","title":"Lower LDL is better – can this be achieved with CETP inhibition therapy?","year":2020,"lang":"en","type":"editorial","venue":"Expert Review of Cardiovascular Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Internal medicine; Ldl cholesterol; Cardiology; Cholesterol","score_opus":0.016622463829744118,"score_gpt":0.2823948127846916,"score_spread":0.26577234895494745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000311404","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002489545,0.8795803,0.00026073956,0.0079281265,0.10582683,0.004594872,0.0002062217,0.00015703005,0.0011968869],"genre_scores_gemma":[0.00008170372,0.65900385,0.0006577674,0.018591711,0.3196797,0.0005627936,0.0009735278,0.00028112394,0.00016784096],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9897669,0.0009546223,0.0013037808,0.0015714573,0.0056471974,0.0007560504],"domain_scores_gemma":[0.9935483,0.00010670408,0.00056344096,0.0040197656,0.0012676995,0.0004941066],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0023732996,0.0012817971,0.0057214294,0.00018565709,0.00016370375,0.00005748323,0.0004719313,0.0011008666,0.0008231385],"category_scores_gemma":[0.00018863872,0.00086637493,0.00832753,0.00073590246,0.000237594,0.00014315048,0.00009177271,0.0016808388,0.000039628634],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059804646,0.00017870264,0.0000035169312,0.006493365,0.016908016,0.0002751619,0.00044486328,3.6783655e-7,0.00012845082,0.0000015986393,0.80365217,0.17131574],"study_design_scores_gemma":[0.0064598415,0.0016276607,0.000015438016,0.016303983,0.0013569624,0.00008896852,0.000022763488,6.2417536e-7,0.002754022,0.0000043576774,0.9704819,0.00088348455],"about_ca_topic_score_codex":0.0008390848,"about_ca_topic_score_gemma":0.0000044232024,"teacher_disagreement_score":0.2205765,"about_ca_system_score_codex":0.0002973744,"about_ca_system_score_gemma":0.001428531,"threshold_uncertainty_score":0.9999934},"labels":[],"label_agreement":null},{"id":"W3000712048","doi":"10.1016/j.jacc.2019.10.057","title":"Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":572,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; St. Michael's Hospital; University of Alberta","funders":"American Regent; Esperion Therapeutics; Duke Clinical Research Institute; Astellas Pharma; Eisai; University of Toronto; Daiichi-Sankyo; Bayer HealthCare; European Commission; AstraZeneca; Amarin Corporation; Eli Lilly and Company; University of Alabama; Regeneron Pharmaceuticals; Boston VA Research Institute; Medicines Company; University of Alabama at Birmingham; Bristol-Myers Squibb; Cleveland Clinic; Novo Nordisk; MyoKardia; University of Pennsylvania; Belvoir Media Group; Servier; Gilead Sciences; York University; Pfizer; Heart and Stroke Foundation of Canada; HLS Therapeutics; GlaxoSmithKline; CSL Behring; Amgen; St. Jude Medical; Kowa Company; Sanofi; American Heart Association","keywords":"Medicine; Alirocumab; Acute coronary syndrome; Cardiology; Internal medicine; Lipoprotein(a); Lipoprotein; Cholesterol; Myocardial infarction","score_opus":0.006028763705398898,"score_gpt":0.23731776683749062,"score_spread":0.23128900313209172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000712048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922509,0.005320226,0.00022979631,0.0010199026,0.00019308535,0.000688286,0.00013055782,0.000007028565,0.0001601984],"genre_scores_gemma":[0.9971139,0.0018084607,0.00029458405,0.00037699958,0.00034567327,0.000014818497,6.615209e-7,0.00003159659,0.000013295996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967722,0.0013393307,0.0006317988,0.00024215454,0.00076958805,0.00024491447],"domain_scores_gemma":[0.9979322,0.00018377295,0.0007578757,0.00069425226,0.00019749878,0.0002344008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016074172,0.000231445,0.0027044853,0.00011787612,0.000051240124,0.0000023897544,0.00023758695,0.0000915313,0.00000672969],"category_scores_gemma":[0.00035410735,0.00013676613,0.0022480467,0.00038610635,0.0005392444,0.000042207885,0.00013445095,0.0005303876,0.000001683385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09516831,0.000263074,0.5066939,0.0036573608,0.12950087,0.03060609,0.0005398625,0.0035318588,0.008586813,0.00011306077,0.006500841,0.21483798],"study_design_scores_gemma":[0.0106447,0.05707038,0.84989166,0.00055753306,0.013241587,0.046484057,0.00030389678,0.000052867137,0.010046418,0.00006221042,0.011252834,0.00039183657],"about_ca_topic_score_codex":0.000049036815,"about_ca_topic_score_gemma":5.331278e-7,"teacher_disagreement_score":0.3431978,"about_ca_system_score_codex":0.000054507665,"about_ca_system_score_gemma":0.00018612653,"threshold_uncertainty_score":0.55771613},"labels":[],"label_agreement":null},{"id":"W3001274601","doi":"10.1016/j.cjco.2020.01.003","title":"Familial Hypercholesterolemia and the Founder Effect Among Franco-Americans: A Brief History and Call to Action","year":2020,"lang":"en","type":"review","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Founder effect; Familial hypercholesterolemia; Population; Demography; Genetic epidemiology; Ethnic group; Medicine; Gerontology; Epidemiology; Disease; Genetics; Cholesterol; Allele; Internal medicine; Environmental health; Biology; Sociology; Anthropology","score_opus":0.05065367117266934,"score_gpt":0.34187438544699045,"score_spread":0.2912207142743211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001274601","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064899115,0.98984295,0.00012824316,0.0002921059,0.00032712487,0.0062326174,0.000008464257,0.000026987116,0.0024925028],"genre_scores_gemma":[0.00034290255,0.99513704,0.00010865656,0.0021005846,0.00073287537,0.00078360934,0.000024168436,0.00006743485,0.00070271746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979905,0.00057569705,0.00033343481,0.000568514,0.00030934883,0.00022249197],"domain_scores_gemma":[0.99875206,0.00013927856,0.00012916984,0.00062492,0.00003154621,0.00032304335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010245121,0.00033180162,0.0026486248,0.000057095378,0.000096542564,0.000077579505,0.00023262306,0.00020621481,0.000019360261],"category_scores_gemma":[0.00015941577,0.000194754,0.00034482914,0.00013948284,0.00022334339,0.00008810314,0.00033075167,0.00060929137,0.000027131386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014409589,0.000007887663,0.000023985576,0.006733831,0.00034850556,0.000042691434,0.00025474362,2.7858366e-8,6.619966e-7,0.000009507356,0.002773189,0.98966086],"study_design_scores_gemma":[0.002345734,0.00031003053,0.0008921921,0.003934676,0.0016674462,0.00026124978,0.00002906311,0.0000030783044,1.6994697e-7,0.000002672578,0.99036264,0.00019101494],"about_ca_topic_score_codex":0.0046417643,"about_ca_topic_score_gemma":0.00013917609,"teacher_disagreement_score":0.9894699,"about_ca_system_score_codex":0.0004233183,"about_ca_system_score_gemma":0.00042625665,"threshold_uncertainty_score":0.79418373},"labels":[],"label_agreement":null},{"id":"W3001574311","doi":"10.1007/978-3-030-33304-1_18","title":"Statins and Neuromuscular Disease","year":2020,"lang":"en","type":"book-chapter","venue":"Contemporary cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Atorvastatin; Reductase; HMG-CoA reductase; Statin; Disease; Medicine; Bioinformatics; Biology; Pharmacology; Internal medicine; Enzyme; Biochemistry","score_opus":0.0392168541268484,"score_gpt":0.2482029084271574,"score_spread":0.20898605430030898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001574311","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008287711,0.0785452,0.0004472653,0.0049685305,0.0005734603,0.001995014,0.0004029244,0.00023109846,0.91200775],"genre_scores_gemma":[0.7781537,0.008465956,0.00023365392,0.013082957,0.005348468,0.000121368335,0.0018115764,0.00041607607,0.19236624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813783,0.000103748054,0.00040761693,0.0007856378,0.00033172482,0.0002334361],"domain_scores_gemma":[0.99808586,0.00004342948,0.00013477581,0.0008608362,0.00009900708,0.00077608036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023794746,0.00042076572,0.0015777707,0.00010421063,0.00006843603,0.0000132234145,0.000092329065,0.00034853758,0.000054025048],"category_scores_gemma":[0.00009123415,0.0003746614,0.00077447144,0.000023270979,0.00023930665,0.00004151605,0.00015403339,0.0006555037,0.00009488434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057539283,0.00009853959,0.015309026,0.012437468,0.020845713,0.17041928,0.00045319946,0.000014641024,0.00035444292,0.29893652,0.33008403,0.14529322],"study_design_scores_gemma":[0.0012963947,0.00043263112,0.0054010786,0.00015135946,0.0005907671,0.00040105853,0.000009128324,0.000009292914,0.0000018246176,0.0022277154,0.9891444,0.00033438642],"about_ca_topic_score_codex":0.00001562988,"about_ca_topic_score_gemma":4.9944543e-7,"teacher_disagreement_score":0.7773249,"about_ca_system_score_codex":0.00004475464,"about_ca_system_score_gemma":0.0007831206,"threshold_uncertainty_score":0.99987054},"labels":[],"label_agreement":null},{"id":"W3001830091","doi":"10.1016/j.jcjd.2020.01.007","title":"Lipoprotein(a) and Apolipoproteins as Predictors for Diabetic Retinopathy and Its Severity in Adults With Type 2 Diabetes: A Case-Cohort Study","year":2020,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cutoff; Apolipoprotein B; Internal medicine; Receiver operating characteristic; Apolipoprotein A1; Diabetes mellitus; Gastroenterology; Type 2 diabetes; Diabetic retinopathy; Univariate analysis; Retinopathy; Lipoprotein(a); Cohort; Logistic regression; Area under the curve; Lipoprotein; Multivariate analysis; Endocrinology; Cholesterol","score_opus":0.009832511497848228,"score_gpt":0.21890597827692898,"score_spread":0.20907346677908076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001830091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98913854,0.0062841238,0.0000019842078,0.0010950691,0.000102578066,0.0032727048,0.000041094052,0.0000132932755,0.0000505932],"genre_scores_gemma":[0.99854773,0.00004369151,0.0001756538,0.00066158973,0.0003953912,0.000105042214,0.000005890076,0.00005389448,0.000011089589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979908,0.00013461869,0.0005117347,0.00038897427,0.00035737513,0.0006165355],"domain_scores_gemma":[0.9973376,0.00006599774,0.00020404215,0.00024023281,0.00037835102,0.0017738014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009472332,0.000277177,0.0008878393,0.0002739821,0.0001490038,0.000060100156,0.00010531517,0.00013444986,0.000023244893],"category_scores_gemma":[0.0009002834,0.00022465004,0.000103668455,0.00040847278,0.00010370264,0.00017921052,0.000023368606,0.00045264725,0.0000015453813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096121585,0.00006229808,0.98836017,0.0008837616,0.0003912551,0.00083914667,0.0024840194,0.0000030872104,0.00006217386,0.000007044789,0.000049738344,0.006761177],"study_design_scores_gemma":[0.006915265,0.012944568,0.97373486,0.0012665807,0.0006487734,0.00033403284,0.0020063326,0.00043801646,0.00077187765,0.000049325416,0.0005148741,0.00037550365],"about_ca_topic_score_codex":0.0019383858,"about_ca_topic_score_gemma":0.009700331,"teacher_disagreement_score":0.014625326,"about_ca_system_score_codex":0.00012996295,"about_ca_system_score_gemma":0.0010925896,"threshold_uncertainty_score":0.91609627},"labels":[],"label_agreement":null},{"id":"W3002870176","doi":"10.1111/jgs.16330","title":"Primary Prevention Statins in Older Adults: Personalized Care for a Heterogeneous Population","year":2020,"lang":"en","type":"article","venue":"Journal of the American Geriatrics Society","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"National Institute on Aging","keywords":"Medicine; Interim; Primary care; Primary prevention; Randomized controlled trial; Clinical trial; Gerontology; Population; MEDLINE; Statin; Family medicine; Coronary artery calcium; Coronary artery disease; Internal medicine","score_opus":0.010900030742569476,"score_gpt":0.27318165041403547,"score_spread":0.262281619671466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002870176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900257,0.0028683848,0.0040848427,0.0021013531,0.00011095848,0.0007771568,0.000015167988,0.000008391227,0.000008033197],"genre_scores_gemma":[0.9824756,0.0008720641,0.013388721,0.0025587527,0.00063957187,0.00001388268,0.000013953357,0.000023407873,0.000014091003],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998745,0.000102735416,0.00041440275,0.000129251,0.00044729622,0.00016126176],"domain_scores_gemma":[0.99881244,0.000029806863,0.00067724363,0.00014527344,0.00022380457,0.000111440764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003433498,0.000098887365,0.00046834876,0.00002620824,0.000069894166,0.0000129339,0.00010109901,0.000039234877,0.0000048992797],"category_scores_gemma":[0.000103912316,0.000068294874,0.0011319687,0.00040147436,0.000036835776,0.000054526594,0.000029334278,0.00021901813,2.8429727e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009865239,0.0012031799,0.21934396,0.008901688,0.0024074854,0.000074200725,0.11507266,0.0026942308,0.0037251704,0.000036699446,0.00769924,0.6289762],"study_design_scores_gemma":[0.026279163,0.0049183224,0.9166758,0.00078299805,0.0015710342,0.00045545714,0.03268637,0.0023325833,0.00046151143,0.00012314005,0.013167315,0.0005463207],"about_ca_topic_score_codex":0.00011068702,"about_ca_topic_score_gemma":0.000005328912,"teacher_disagreement_score":0.69733185,"about_ca_system_score_codex":0.000358578,"about_ca_system_score_gemma":0.0002755102,"threshold_uncertainty_score":0.2784984},"labels":[],"label_agreement":null},{"id":"W3003588057","doi":"10.12927/hcq.2020.26091","title":"Making Informed CHOICES: The Launch of a “Big Data” Pragmatic Trial to Improve Cholesterol Management and Prevent Heart Disease in Ontario","year":2020,"lang":"en","type":"article","venue":"Healthcare Quarterly","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Institute of Circulatory and Respiratory Health; Canadian Institutes of Health Research; Sanofi; Ontario Ministry of Health and Long-Term Care; AstraZeneca; Heart and Stroke Foundation of Canada; Amgen","keywords":"Randomized controlled trial; Medicine; Disease management; Cluster (spacecraft); Cluster randomised controlled trial; High cholesterol; Statin; Cholesterol; Medical emergency; Disease; Family medicine; Gerontology; Surgery; Internal medicine; Computer science","score_opus":0.06523883583321553,"score_gpt":0.3260464537041457,"score_spread":0.26080761787093015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003588057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529988,0.0007560971,0.00023925182,0.036899567,0.00031056014,0.0085484395,0.00005396707,0.000034825214,0.0001585044],"genre_scores_gemma":[0.9899566,0.000018616473,0.0004451189,0.008705423,0.00038082738,0.0003543092,0.00004819761,0.000019631072,0.000071243085],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978488,0.00017270091,0.000643625,0.00043276945,0.00055498624,0.0003471063],"domain_scores_gemma":[0.9983038,0.00004250091,0.00012897782,0.0010316067,0.000049475428,0.00044368935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007306379,0.00017277063,0.0005018968,0.00007781723,0.00006876515,0.000034834433,0.00019753382,0.000055203996,0.000008992663],"category_scores_gemma":[0.00005352512,0.0001231649,0.000089470734,0.00020598118,0.000030194795,0.000112576956,0.00009218372,0.00031120027,0.000007742708],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031381823,0.0007820477,0.034896445,0.027610345,0.00047754278,0.00016352913,0.056731306,0.000009748541,0.000038088176,0.0004790489,0.0012003996,0.8462297],"study_design_scores_gemma":[0.05639343,0.012709885,0.7809598,0.00325122,0.0004230753,0.00002909747,0.0055440073,0.00038547034,0.000009281545,0.00019973725,0.1396154,0.00047960636],"about_ca_topic_score_codex":0.028818643,"about_ca_topic_score_gemma":0.08386816,"teacher_disagreement_score":0.8457501,"about_ca_system_score_codex":0.0001746744,"about_ca_system_score_gemma":0.00082955736,"threshold_uncertainty_score":0.97764856},"labels":[],"label_agreement":null},{"id":"W3003694221","doi":"10.14740/cr992","title":"Is Lipoprotein (a) a Risk Factor for Coronary Artery Ectasia?","year":2020,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Coronary artery ectasia; Medicine; Internal medicine; Cardiology; Coronary artery disease; Risk factor; Lipoprotein(a); Ectasia; Odds ratio; Prospective cohort study; Lipoprotein; Population; Coronary angiography; Cholesterol; Myocardial infarction","score_opus":0.13448976566215284,"score_gpt":0.3885077239959844,"score_spread":0.25401795833383156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003694221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96385497,0.0064844894,0.0048744464,0.014680409,0.00023771301,0.005007707,0.00062410306,0.00016942961,0.004066741],"genre_scores_gemma":[0.99356115,0.0006824711,0.00068003684,0.0015429689,0.0025516134,0.0005423715,0.000035649806,0.00005370034,0.00035003672],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968908,0.00064192497,0.0002840791,0.00068493135,0.0006593562,0.00083890394],"domain_scores_gemma":[0.99791443,0.00024126779,0.00004213872,0.0007578997,0.00047303145,0.0005712047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017006254,0.0001839721,0.000914043,0.0001321401,0.00028848072,0.0000197753,0.00020837171,0.00031723588,0.00020635425],"category_scores_gemma":[0.001098848,0.00015205373,0.00066919375,0.0003522486,0.00027097034,0.000049557886,0.00014588163,0.0010174258,0.0002933596],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056772646,0.00013923105,0.10456175,0.001896488,0.005349119,0.0021907464,0.0031113164,0.000016609454,0.014891927,0.00034013996,0.09417146,0.76765394],"study_design_scores_gemma":[0.009259074,0.008297319,0.48493084,0.000115735515,0.0003877221,0.0017405053,0.0011452052,0.0007987473,0.008741323,0.00091851724,0.48305935,0.00060564943],"about_ca_topic_score_codex":0.000051234332,"about_ca_topic_score_gemma":0.0000025819127,"teacher_disagreement_score":0.7670483,"about_ca_system_score_codex":0.00010884781,"about_ca_system_score_gemma":0.00047282162,"threshold_uncertainty_score":0.6200571},"labels":[],"label_agreement":null},{"id":"W3003956143","doi":"10.1155/2020/3491764","title":"Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule","year":2020,"lang":"en","type":"review","venue":"Journal of Lipids","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"University of Jeddah; Saudi Arabian Cultural Bureau","keywords":"Medicine; Lipoprotein; Pathogenicity; Function (biology); Lipoprotein(a); Metabolism; Lipid metabolism; Bioinformatics; Cholesterol; Internal medicine; Computational biology; Biology; Genetics; Microbiology","score_opus":0.022277108548132484,"score_gpt":0.29309462730483815,"score_spread":0.2708175187567057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003956143","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021136952,0.98972154,0.0019962564,0.0038634043,0.0015076492,0.0024282457,0.00001496725,0.00003573068,0.00022082147],"genre_scores_gemma":[0.0013653892,0.98449284,0.00095271604,0.0011027299,0.0117847435,0.000047537564,0.000019990648,0.00012478868,0.00010928374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946153,0.0010275255,0.0017232387,0.00048381436,0.0017224496,0.00042765372],"domain_scores_gemma":[0.99557465,0.00029546587,0.0018264044,0.0011239045,0.00044198096,0.0007375726],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002449715,0.0006537464,0.0029658019,0.00032309873,0.0005680823,0.0001671846,0.000630223,0.00047439034,0.0000999798],"category_scores_gemma":[0.0011941325,0.0003093327,0.0018764524,0.0012994929,0.0001987276,0.00017327665,0.00031162106,0.0027202065,0.000012563251],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041887502,0.000040097308,0.000004032075,0.0035343524,0.0025674377,0.000057346875,0.0011569333,8.5880794e-7,0.000025037465,0.000286417,0.0010533677,0.9912322],"study_design_scores_gemma":[0.0008754089,0.00037253601,0.0002052676,0.0042893025,0.009187242,0.0029926738,0.00014712631,0.000005006072,0.000036294652,0.000350161,0.98126125,0.00027773198],"about_ca_topic_score_codex":0.00039574967,"about_ca_topic_score_gemma":0.00006597818,"teacher_disagreement_score":0.9909545,"about_ca_system_score_codex":0.00019225557,"about_ca_system_score_gemma":0.002950317,"threshold_uncertainty_score":0.99993587},"labels":[],"label_agreement":null},{"id":"W3004745180","doi":"10.1161/circ.138.suppl_1.17150","title":"Abstract 17150: LDL-C Response to Portfolio Foods Containing High Levels of Phytosterols, Whole Food Fiber, and Alpha-Linoleic Acid in Statin Reluctant Patients: Impact of CYP7A1-rs3808607 and APOE Isoforms","year":2018,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Population; Statin; Simvastatin; Internal medicine; Cholesterol; Ingestion; Endocrinology; Food science; Environmental health; Biology","score_opus":0.021528653412447904,"score_gpt":0.2900692565294677,"score_spread":0.26854060311701977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004745180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980388,0.0004324649,0.00026985558,0.00007010179,0.0000516918,0.00091193296,0.00011669365,0.000015487842,0.00009294909],"genre_scores_gemma":[0.9992896,0.000016225264,0.0004636697,0.0000575006,0.00007445088,0.000016842498,0.000048080925,0.000026926555,0.0000067513033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983748,0.00008225699,0.0006042256,0.00029971192,0.00037386746,0.00026512457],"domain_scores_gemma":[0.9988839,0.00004923153,0.00027201197,0.00036406185,0.00026709054,0.0001637055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009704948,0.00017374569,0.0005169663,0.00027793765,0.000052980555,0.000013115881,0.000043593598,0.0001240255,0.00003608267],"category_scores_gemma":[0.0002590067,0.00014671517,0.000103696664,0.0002749098,0.00007488106,0.00018973544,0.00003901813,0.00012225064,0.0000034724678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006762777,0.00036025062,0.63408154,0.0006847916,0.0004474125,0.000014408635,0.0046378765,0.000113639144,0.12152033,0.00006427466,0.00003602921,0.23127669],"study_design_scores_gemma":[0.004269807,0.0031876455,0.98579437,0.0003753277,0.00005023805,0.000015245206,0.0002046289,0.00008528208,0.0056715882,0.00015706391,0.00005443493,0.00013437618],"about_ca_topic_score_codex":0.00034376996,"about_ca_topic_score_gemma":0.000035603578,"teacher_disagreement_score":0.35171285,"about_ca_system_score_codex":0.00014109009,"about_ca_system_score_gemma":0.0001663349,"threshold_uncertainty_score":0.5982871},"labels":[],"label_agreement":null},{"id":"W3004796391","doi":"10.1186/s12944-020-1199-9","title":"The enigma of soluble LDLR: could inflammation be the key?","year":2020,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Montreal Clinical Research Institute; Ottawa Hospital","funders":"Fondation Mérieux; Fondation Jean-Louis Lévesque","keywords":"Ectodomain; LDL receptor; Inflammation; ADAM10; Lipidology; Receptor; Metalloproteinase; Clinical chemistry; Chemistry; Biology; Cell biology; Lipoprotein; Cholesterol; Disintegrin; Biochemistry; Immunology; Enzyme","score_opus":0.02561576687820565,"score_gpt":0.28548256946182254,"score_spread":0.2598668025836169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004796391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5538647,0.029853564,0.00031306144,0.41245785,0.00037607132,0.0022463258,0.000023317545,0.000051411946,0.0008137083],"genre_scores_gemma":[0.980884,0.003421119,0.00007142225,0.014755551,0.00070760306,0.00006190123,0.000016190257,0.00001014585,0.000072038165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987792,0.0001799285,0.00034449008,0.00014810129,0.00031665587,0.00023164276],"domain_scores_gemma":[0.9986627,0.000101546364,0.00008786663,0.00031560753,0.00004222359,0.000790041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008198826,0.00007973806,0.00021013124,0.000018841367,0.000223777,0.000014545279,0.000067811234,0.00003363754,0.000010444254],"category_scores_gemma":[0.0007581426,0.000044027456,0.00008542634,0.00015872336,0.00008441255,0.000039248833,0.00003671633,0.00020171123,0.0000024595593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009579104,0.0004289249,0.22031257,0.022163391,0.00028218018,0.000066033725,0.02944282,0.00024878953,0.00020638402,0.051467523,0.049937967,0.61586434],"study_design_scores_gemma":[0.0050188233,0.00095572043,0.098861314,0.00040163848,0.00010006115,0.000008987063,0.0034712967,0.0058596022,0.0000969661,0.0016595564,0.883354,0.00021205068],"about_ca_topic_score_codex":0.00029728105,"about_ca_topic_score_gemma":0.00003864339,"teacher_disagreement_score":0.83341604,"about_ca_system_score_codex":0.000027355429,"about_ca_system_score_gemma":0.0008215347,"threshold_uncertainty_score":0.17953876},"labels":[],"label_agreement":null},{"id":"W3005065383","doi":"10.1186/s12933-020-0991-1","title":"Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol","year":2020,"lang":"en","type":"article","venue":"Cardiovascular Diabetology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Agence Nationale de la Recherche; Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; PCSK9; Internal medicine; Medicine; Dyslipidemia; Fenofibrate; Endocrinology; Apolipoprotein B; Ezetimibe; Lipoprotein; Post-hoc analysis; Cholesterol; Type 2 diabetes; Diabetes mellitus; Apolipoprotein A1; LDL receptor","score_opus":0.006356251757083605,"score_gpt":0.2137622230081693,"score_spread":0.2074059712510857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005065383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883168,0.008484484,0.00020501355,0.0005922753,0.00020059494,0.0019649763,0.00002821387,0.00012350496,0.00008415633],"genre_scores_gemma":[0.9974961,0.000426829,0.00032460596,0.0009457718,0.00048386207,0.00012389716,0.00009714236,0.00009218555,0.000009564808],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961406,0.0008860213,0.0004642654,0.0009311524,0.00093731604,0.0006406687],"domain_scores_gemma":[0.9976503,0.00014286596,0.00016243481,0.0013414051,0.00019209659,0.00051084894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014809802,0.0004966341,0.0027895952,0.00015880307,0.00010473421,0.000023873845,0.0001859333,0.00038705484,0.000029810111],"category_scores_gemma":[0.00037422,0.000369578,0.0007759972,0.0005092962,0.0003160775,0.00008409946,0.00013378139,0.000553626,0.000037973048],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036465111,0.00032876353,0.072341934,0.008192015,0.028480059,0.0007521058,0.00043309925,0.00038230603,0.004851759,0.00029069997,0.000541996,0.8797588],"study_design_scores_gemma":[0.037866298,0.026850216,0.45127502,0.0010361136,0.00944561,0.00042659533,0.000047177055,0.00009192741,0.45903093,0.000082702296,0.012497919,0.0013495033],"about_ca_topic_score_codex":0.00054351444,"about_ca_topic_score_gemma":0.000007821034,"teacher_disagreement_score":0.87840927,"about_ca_system_score_codex":0.00007063774,"about_ca_system_score_gemma":0.00014527419,"threshold_uncertainty_score":0.9998756},"labels":[],"label_agreement":null},{"id":"W3005689325","doi":"10.1001/jamacardio.2019.5954","title":"Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease","year":2020,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; PCSK9; Cohort; Biobank; Myocardial infarction; Population; Rotterdam Study; Cohort study; Cardiology; LDL receptor; Cholesterol; Lipoprotein; Bioinformatics","score_opus":0.013692201098834681,"score_gpt":0.21652010902562388,"score_spread":0.2028279079267892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005689325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99015415,0.0050807614,0.0023690925,0.001143468,0.00007772076,0.00074912555,0.00009347814,0.00004520787,0.00028702372],"genre_scores_gemma":[0.9970894,0.0014156961,0.00036219458,0.0004182885,0.0005661048,0.000044702712,0.000029758246,0.00004246303,0.00003141788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974899,0.00061103,0.0004449981,0.00042877244,0.00069078227,0.0003344653],"domain_scores_gemma":[0.99813443,0.00007345663,0.00026804468,0.00089392683,0.00028479056,0.00034533167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010152931,0.00020372603,0.0014100395,0.00006861022,0.00004114907,0.0000056398258,0.00013533578,0.0002311143,0.000014979412],"category_scores_gemma":[0.0005123019,0.00016081777,0.0014290023,0.000292508,0.000094380324,0.00006176765,0.00006120978,0.00036918474,0.000015210594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022227531,0.00006851563,0.95483506,0.00076320424,0.01763877,0.000100482,0.00038915154,0.004803474,0.0028065366,0.000031719337,0.00036194402,0.015978394],"study_design_scores_gemma":[0.0059678014,0.0010957003,0.97713184,0.0000904571,0.0064768805,0.000060752078,0.000112016314,0.00023005078,0.0012001635,0.000021272104,0.0074176756,0.00019536642],"about_ca_topic_score_codex":0.00025719168,"about_ca_topic_score_gemma":0.0000035175233,"teacher_disagreement_score":0.02229681,"about_ca_system_score_codex":0.00012977804,"about_ca_system_score_gemma":0.00027837924,"threshold_uncertainty_score":0.6557958},"labels":[],"label_agreement":null},{"id":"W3005859947","doi":"10.1136/heartjnl-2019-315840","title":"ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis","year":2020,"lang":"en","type":"article","venue":"Heart","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Boniface Hospital; University of Ottawa; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; British Heart Foundation","keywords":"Medicine; Stenosis; Conjunction (astronomy); Cardiology; Internal medicine","score_opus":0.026813882547141205,"score_gpt":0.27859622708893644,"score_spread":0.25178234454179527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005859947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919883,0.000826824,0.00023723539,0.004844096,0.00006130687,0.0011358145,0.0000062997833,0.0000745094,0.00082560495],"genre_scores_gemma":[0.99750036,0.00010173247,0.0010572857,0.0010005528,0.00020678535,0.00005754445,0.000023414617,0.000023566643,0.000028763854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998586,0.00009653379,0.0003052623,0.00026231736,0.000522711,0.00022717917],"domain_scores_gemma":[0.9993474,0.000015950209,0.00007060291,0.00027909953,0.00009083754,0.00019611881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002976974,0.00012536676,0.00049174676,0.000065674314,0.00004148822,0.0000075700136,0.000038419967,0.00007442247,0.000114878116],"category_scores_gemma":[0.00005030405,0.00009000893,0.0001226327,0.00032312475,0.00007636325,0.000062462284,0.000024952078,0.00019156058,0.00001956557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040004672,0.0009185828,0.80084616,0.004660999,0.000521626,0.00016197174,0.0022606133,0.000067934954,0.028277943,0.00014276245,0.011202667,0.1469383],"study_design_scores_gemma":[0.008017437,0.0074281995,0.9293715,0.0014562149,0.00028079617,0.000121397,0.0007810277,0.0020754973,0.021017235,0.000021022848,0.02913076,0.00029891057],"about_ca_topic_score_codex":0.00015676099,"about_ca_topic_score_gemma":0.000008960752,"teacher_disagreement_score":0.14663938,"about_ca_system_score_codex":0.00004064899,"about_ca_system_score_gemma":0.00015012956,"threshold_uncertainty_score":0.36704576},"labels":[],"label_agreement":null},{"id":"W3006116566","doi":"10.1093/eurheartj/ehz962","title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1527,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Steno Diabetes Center Aarhus; National Heart, Lung, and Blood Institute; Novo Nordisk Fonden; European Atherosclerosis Society","keywords":"Medicine; Consensus conference; Atherosclerotic cardiovascular disease; Disease; Statement (logic); Pathophysiology; Bioinformatics; Pathology; Internal medicine; Law","score_opus":0.08577055249063832,"score_gpt":0.25824735931297393,"score_spread":0.17247680682233563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006116566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748722,0.016551036,0.0007493157,0.006068828,0.00019009456,0.0012516006,0.00006536415,0.00014644089,0.00010512817],"genre_scores_gemma":[0.9802447,0.005385691,0.0015325057,0.010256508,0.0023819853,0.000010195174,0.000013271774,0.00015179045,0.000023370161],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9924738,0.0042192675,0.0007687576,0.0008258727,0.0010795519,0.0006327539],"domain_scores_gemma":[0.9970132,0.00015909593,0.00023859671,0.0011341743,0.0002307195,0.0012242221],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020398311,0.0005086431,0.00087005086,0.000026250884,0.0009789912,0.00024155619,0.00026815684,0.00006996495,0.000058898702],"category_scores_gemma":[0.00022493367,0.0003222494,0.001382465,0.00022149275,0.0004972665,0.000033665758,0.00029357852,0.0010935757,0.00015605844],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003633374,0.0030140914,0.09791432,0.0017625884,0.04293406,0.018274637,0.036661476,0.003783114,0.46834147,0.000081504,0.039969042,0.2836303],"study_design_scores_gemma":[0.004070863,0.0006970595,0.95429426,0.0003954224,0.0014764712,0.0004700086,0.0009012705,0.000492592,0.00042424988,0.00005280532,0.03622006,0.0005049418],"about_ca_topic_score_codex":0.00010362333,"about_ca_topic_score_gemma":0.0000023058824,"teacher_disagreement_score":0.8563799,"about_ca_system_score_codex":0.000099126504,"about_ca_system_score_gemma":0.00020657899,"threshold_uncertainty_score":0.99992293},"labels":[],"label_agreement":null},{"id":"W3006247054","doi":"10.1093/ehjcvp/pvaa010","title":"Low adherence to statin treatment during the 1st year after an acute myocardial infarction is associated with increased 2nd-year mortality risk—an inverse probability of treatment weighted study on 54 872 patients","year":2020,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Vetenskapsrådet","keywords":"Medicine; Myocardial infarction; Statin; Internal medicine; Cardiology; Emergency medicine","score_opus":0.042396250297567196,"score_gpt":0.3070202954930183,"score_spread":0.2646240451954511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006247054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515384,0.00014752617,0.000054430515,0.00009370627,0.00014055111,0.0040249024,0.00023711662,0.00008290631,0.000065008106],"genre_scores_gemma":[0.9972437,0.0006297632,0.0002082429,0.00084049127,0.0007747362,0.00012523825,0.000039480536,0.0001255458,0.0000128234715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915254,0.0049938615,0.0007006475,0.0007745999,0.001515816,0.0004896577],"domain_scores_gemma":[0.9971539,0.000032406064,0.00027312172,0.0011639292,0.00044638055,0.00093027955],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020563803,0.00052528025,0.0011477044,0.000117014926,0.00036351243,0.00009210905,0.00019465642,0.00005962735,0.0001633738],"category_scores_gemma":[0.00004617378,0.00032531403,0.0014363312,0.00048424368,0.00008448397,0.00023412188,0.00003551706,0.00049488747,0.000038439586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01187562,0.0071206726,0.8834505,0.000062685554,0.05240923,0.0006356747,0.020797776,0.0012952634,0.0029086613,3.174311e-7,0.000113095964,0.019330466],"study_design_scores_gemma":[0.023603527,0.028708043,0.93718886,0.00008966642,0.003537733,0.00004205251,0.0004854999,0.00008099389,0.0041926694,0.0000015520366,0.0017183486,0.00035106926],"about_ca_topic_score_codex":0.001059358,"about_ca_topic_score_gemma":0.000050811366,"teacher_disagreement_score":0.053738315,"about_ca_system_score_codex":0.0008129468,"about_ca_system_score_gemma":0.00028547697,"threshold_uncertainty_score":0.9999199},"labels":[],"label_agreement":null},{"id":"W3007309254","doi":"10.1177/2047487320905185","title":"Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab","year":2020,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of California, San Diego; Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Alirocumab; Internal medicine; Cholesterol; Endocrinology; Ezetimibe; Triglyceride; High-density lipoprotein; Lipoprotein; Placebo; Statin; Apolipoprotein A1","score_opus":0.03147206141299505,"score_gpt":0.3002676256073128,"score_spread":0.2687955641943177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007309254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699912,0.0010262681,0.023060722,0.0040504094,0.0001118101,0.0011871769,0.00001363414,0.000007169247,0.0005515886],"genre_scores_gemma":[0.99619085,0.0003860928,0.00061973784,0.0014148232,0.0013329666,0.000010144395,0.0000083339255,0.000022555036,0.000014477423],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9937773,0.004544863,0.0008176505,0.00024680368,0.00037327083,0.00024015424],"domain_scores_gemma":[0.998736,0.00012825085,0.00048189753,0.00025663446,0.00017570207,0.0002215203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059756953,0.00018611735,0.0011502227,0.00006544673,0.000081421655,0.000029833178,0.00015434099,0.000039545823,0.000014617532],"category_scores_gemma":[0.0005031972,0.00010718633,0.00035644748,0.00015424158,0.00014930041,0.00009119493,0.00004749548,0.0005252373,0.000006722308],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047485795,0.0019586168,0.03277032,0.0011636968,0.015791092,0.05432786,0.030326527,0.0012240155,0.07681291,0.00049959257,0.009935918,0.72770363],"study_design_scores_gemma":[0.07402011,0.019256731,0.8617728,0.0006587102,0.0024087396,0.008667006,0.0039037052,0.000044517517,0.0055800336,0.00006627258,0.023159428,0.00046197147],"about_ca_topic_score_codex":0.00002730867,"about_ca_topic_score_gemma":0.0000057332186,"teacher_disagreement_score":0.82900244,"about_ca_system_score_codex":0.00005030087,"about_ca_system_score_gemma":0.00015978556,"threshold_uncertainty_score":0.43709317},"labels":[],"label_agreement":null},{"id":"W3007572154","doi":"10.1111/ijcp.13492","title":"Baseline plasma lipid levels in patients with acute coronary syndrome: Association with 20‐year mortality. The ABC‐5a* Study on Heart Disease","year":2020,"lang":"en","type":"article","venue":"International Journal of Clinical Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"Università degli Studi di Padova","keywords":"Medicine; Internal medicine; Hazard ratio; Acute coronary syndrome; Coronary artery disease; Cardiology; Proportional hazards model; Prospective cohort study; Cause of death; Sudden cardiac death; Myocardial infarction; Disease; Confidence interval","score_opus":0.05555582734833504,"score_gpt":0.3985291098702318,"score_spread":0.3429732825218968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007572154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9439942,0.000022204924,0.00018096964,0.05454998,0.00044754622,0.0006050792,0.000038799757,0.000008672195,0.00015249664],"genre_scores_gemma":[0.9876653,0.000031405758,0.0005828517,0.01076467,0.0008659215,0.0000075168673,0.00001487102,0.000021163538,0.00004629884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99490213,0.0008732018,0.0010606109,0.00023874201,0.002772814,0.00015252356],"domain_scores_gemma":[0.995527,0.0015647954,0.0010370837,0.00023916872,0.0012941255,0.00033782446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004186059,0.0001425812,0.00053140224,0.00006260237,0.000045317032,0.00004904071,0.00022828128,0.000066941655,0.00005513623],"category_scores_gemma":[0.0068616914,0.00008068841,0.00020495053,0.00016524752,0.000038569473,0.0004450459,0.000047732065,0.0011147711,0.000030013929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018405661,0.0029633138,0.9707181,0.000008786297,0.002861038,0.0022769205,0.00013232099,0.00017840015,5.929311e-7,0.000013101362,0.00096151343,0.0014802417],"study_design_scores_gemma":[0.011238279,0.0061958255,0.97519326,0.00015175377,0.0009027293,0.00019317748,0.00029377636,0.00010085616,0.0000016027842,0.000007192625,0.005631634,0.00008990025],"about_ca_topic_score_codex":0.00003107284,"about_ca_topic_score_gemma":0.000009379136,"teacher_disagreement_score":0.04378531,"about_ca_system_score_codex":0.00016759639,"about_ca_system_score_gemma":0.0006151194,"threshold_uncertainty_score":0.8214581},"labels":[],"label_agreement":null},{"id":"W3007854907","doi":"10.14740/jem.v10i1.628","title":"Statin Intolerance in Familial Hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"Journal of Endocrinology and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Statin; Internal medicine; Cholesterol","score_opus":0.022588791824616157,"score_gpt":0.27948193538865096,"score_spread":0.2568931435640348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007854907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97717345,0.016005743,0.00024793565,0.0059206034,0.00022019453,0.000107530126,0.0000017658293,0.000005812545,0.00031694604],"genre_scores_gemma":[0.9905858,0.0033825338,0.0015352786,0.00379771,0.0006657374,0.0000022513184,5.440284e-7,0.000007929763,0.000022217537],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990522,0.00009711764,0.00036961221,0.00011312258,0.0001652419,0.00020266234],"domain_scores_gemma":[0.99952203,0.00002092318,0.00010667939,0.000092033355,0.00007646777,0.0001818921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020842336,0.000087774446,0.00052888005,0.00009349409,0.000020639669,0.0000050800336,0.000056939596,0.000056535773,0.000016097129],"category_scores_gemma":[0.00014477411,0.00006620227,0.00011063461,0.000102729624,0.000057150763,0.00008212901,0.000025790287,0.0005062397,0.0000036148729],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027848387,0.00029249772,0.077198796,0.00042626052,0.0005805421,0.0039629103,0.004926247,0.000054453983,0.036965255,0.0033326382,0.0009997523,0.8684758],"study_design_scores_gemma":[0.009701157,0.0005090267,0.7989095,0.00007482163,0.00018743682,0.002960748,0.00044566032,0.000030854837,0.0026659833,0.00025792327,0.18414341,0.00011348766],"about_ca_topic_score_codex":0.000026970136,"about_ca_topic_score_gemma":0.0000046865566,"teacher_disagreement_score":0.8683623,"about_ca_system_score_codex":0.000011349591,"about_ca_system_score_gemma":0.000106176245,"threshold_uncertainty_score":0.26996505},"labels":[],"label_agreement":null},{"id":"W3007953981","doi":"10.1002/047167849x.bio119","title":"Lipids and Diabetes","year":2020,"lang":"en","type":"other","venue":"Bailey's Industrial Oil and Fat Products","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Dyslipidemia; Diabetes mellitus; Medicine; Lipid profile; Diabetes management; Lipid metabolism; Lipoprotein; Internal medicine; Type 2 diabetes; Endocrinology; Cholesterol","score_opus":0.03097237852552643,"score_gpt":0.23545374767585778,"score_spread":0.20448136915033135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007953981","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019054,0.10691691,0.0000027350352,0.02791347,0.006220531,0.002077464,0.00031654027,0.000912287,0.83658606],"genre_scores_gemma":[0.0068345354,0.016033025,0.00068193,0.0017316554,0.062411632,0.000119422184,0.0002778894,0.00078826246,0.91112167],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981455,0.00008538442,0.00026021487,0.00075903337,0.0003938082,0.00035606392],"domain_scores_gemma":[0.9989365,0.000016516762,0.00012689416,0.00051643467,0.00003915321,0.00036454704],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028930703,0.0003655645,0.0009288324,0.00013778028,0.000064102125,0.000049137136,0.00007313132,0.00067000714,0.0002695353],"category_scores_gemma":[0.0003620804,0.00028783525,0.00010229065,0.0002418065,0.00014653766,0.000034548117,0.00011803418,0.0006516443,0.000037951533],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054924792,0.000034773526,0.0006432096,0.00093187706,0.0003203238,0.000034176683,0.00003882503,1.1293617e-8,0.0001524308,0.000056316145,0.5326014,0.46513173],"study_design_scores_gemma":[0.0024266003,0.000318319,0.00022404261,0.00077494193,0.0003912241,0.000026553782,0.000028392209,9.884849e-7,0.00049661443,0.000008250302,0.99500316,0.0003008955],"about_ca_topic_score_codex":0.00021675415,"about_ca_topic_score_gemma":0.000007705811,"teacher_disagreement_score":0.46483085,"about_ca_system_score_codex":0.000023116962,"about_ca_system_score_gemma":0.00022290477,"threshold_uncertainty_score":0.9999574},"labels":[],"label_agreement":null},{"id":"W3009158578","doi":"10.1111/ene.14196","title":"Statin treatment and accrual of covert cerebral ischaemia on neuroimaging: a systematic review and meta‐analysis of randomized trials","year":2020,"lang":"en","type":"review","venue":"European Journal of Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Randomized controlled trial; Internal medicine; Rosuvastatin; Statin; Confidence interval; Stroke (engine); Asymptomatic; Relative risk; Magnetic resonance imaging; Odds ratio; Cardiology; Radiology","score_opus":0.1408502642923544,"score_gpt":0.3811185306133633,"score_spread":0.24026826632100892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009158578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009856694,0.9949444,0.00006663603,0.001154137,0.00006379737,0.003483414,0.00008000349,0.000005554179,0.00010348125],"genre_scores_gemma":[0.0004268127,0.99782664,0.00011018458,0.0014192165,0.00009704364,0.00002328508,0.000011526774,0.00005970604,0.00002555995],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96950245,0.025003819,0.004521374,0.00036672922,0.00042237167,0.00018326602],"domain_scores_gemma":[0.9905996,0.0024936148,0.0059042713,0.0005356697,0.00020156389,0.00026530016],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.011115485,0.0004897268,0.036838964,0.00059734716,0.00002411839,0.000012771376,0.00017560733,0.00006480903,0.00004614073],"category_scores_gemma":[0.0041779648,0.00025041687,0.007783368,0.0004274696,0.00015630912,0.00003466925,0.00007374617,0.00052886136,0.0000020861614],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041964403,0.00012875356,8.551743e-7,0.58368605,0.39313316,0.0013202493,0.00012192487,0.0000018720709,0.0000011568641,0.000034028104,0.00008476469,0.017290749],"study_design_scores_gemma":[0.018944168,0.0031324995,0.0000057436628,0.014575232,0.9361216,0.0024321636,0.0000042018123,0.0000055890882,7.15498e-7,0.0000017378151,0.024659952,0.000116388364],"about_ca_topic_score_codex":0.000008189424,"about_ca_topic_score_gemma":4.2818556e-7,"teacher_disagreement_score":0.5691108,"about_ca_system_score_codex":0.000018613722,"about_ca_system_score_gemma":0.00025245847,"threshold_uncertainty_score":0.9999948},"labels":[],"label_agreement":null},{"id":"W3011005820","doi":"10.1056/nejmoa1913805","title":"Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":801,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Familial hypercholesterolemia; Medicine; PCSK9; Placebo; Internal medicine; Cholesterol; Endocrinology; Confidence interval; Gastroenterology; Lipoprotein; LDL receptor","score_opus":0.04857532042122918,"score_gpt":0.3031275938948083,"score_spread":0.2545522734735791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011005820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9318613,0.015805468,0.005931583,0.0449654,0.0005905366,0.0006926338,0.0000069743323,0.000008958753,0.00013714626],"genre_scores_gemma":[0.9813934,0.003377,0.00052328006,0.0020868874,0.012536693,0.0000036585407,0.000004482442,0.000016679773,0.000057943158],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987038,0.00005803779,0.0005190388,0.000098115044,0.0004755952,0.0001454082],"domain_scores_gemma":[0.9988872,0.00019121151,0.0002138032,0.00020029659,0.00017460091,0.00033290737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055830076,0.00012272656,0.00067470205,0.000050313425,0.000042262647,0.0000032738967,0.00009781653,0.000049949424,0.00002315018],"category_scores_gemma":[0.00021636148,0.000055392764,0.00029116432,0.0000985507,0.00007402605,0.000029452554,0.0000069434477,0.00014705014,0.0000010573111],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036416322,0.00011526914,0.0017485924,0.00014262635,0.0006011697,0.00010529492,0.0049425187,0.00004413624,0.0053989463,0.00002045381,0.0025813237,0.98065805],"study_design_scores_gemma":[0.16034755,0.042210344,0.010654567,0.00037224506,0.0017166071,0.0015645174,0.00079042255,0.00021222988,0.002648832,0.00009450253,0.7792891,0.00009905001],"about_ca_topic_score_codex":0.00015715368,"about_ca_topic_score_gemma":0.000013721525,"teacher_disagreement_score":0.980559,"about_ca_system_score_codex":0.000046499543,"about_ca_system_score_gemma":0.00018220612,"threshold_uncertainty_score":0.22588514},"labels":[],"label_agreement":null},{"id":"W3011515401","doi":"10.1161/circresaha.119.316206","title":"Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation","year":2020,"lang":"en","type":"article","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"ZonMw; European Commission; Velux Stiftung; Heart and Stroke Foundation of Canada","keywords":"Inflammation; Glycolysis; Leukocyte extravasation; Downregulation and upregulation; Extravasation; Proinflammatory cytokine; Endothelium; Cell biology; Endothelial stem cell; Biology; Cancer research; Internal medicine; Immunology; Endocrinology; Medicine; Biochemistry; Metabolism; In vitro","score_opus":0.08343496136436657,"score_gpt":0.3402703880132921,"score_spread":0.25683542664892556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011515401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98726034,0.003130569,0.00573312,0.0011545578,0.000013981387,0.002094517,0.0000034325362,0.000101739155,0.00050775765],"genre_scores_gemma":[0.9981287,0.0003242159,0.00060820975,0.00010049401,0.00048691875,0.00021602327,0.000072862735,0.000030632236,0.00003195961],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99700904,0.0005424027,0.00036632008,0.00047320867,0.0012618402,0.0003471739],"domain_scores_gemma":[0.9985459,0.00013594776,0.000071853254,0.00042329414,0.0004763082,0.00034672825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002298477,0.0001454896,0.00030711808,0.00016773406,0.00032326192,0.000095078525,0.00007895944,0.00014226351,0.00015808635],"category_scores_gemma":[0.0011355754,0.00013618181,0.00017857208,0.0006597718,0.00010768096,0.00023071766,0.000067114335,0.00038316794,0.00009521366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041098444,0.00011685001,0.041350193,0.0018304097,0.0007442721,0.000048993075,0.00552983,0.002210426,0.1690312,0.0016751238,0.00010973348,0.77694196],"study_design_scores_gemma":[0.007549293,0.0009274491,0.8052806,0.00043279375,0.00034762343,0.000110903835,0.0050841505,0.14502832,0.02199212,0.0015813012,0.010946318,0.0007191129],"about_ca_topic_score_codex":0.0010282168,"about_ca_topic_score_gemma":0.000035021367,"teacher_disagreement_score":0.7762229,"about_ca_system_score_codex":0.00014518539,"about_ca_system_score_gemma":0.00024357325,"threshold_uncertainty_score":0.5553333},"labels":[],"label_agreement":null},{"id":"W3011544274","doi":"10.1159/000505365","title":"Cholesteryl Ester Transfer Protein Inhibitors and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","year":2020,"lang":"en","type":"review","venue":"Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Cholesterylester transfer protein; Medicine; Mace; Internal medicine; Randomized controlled trial; Meta-analysis; Cholesterol; Lipoprotein; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.09251149918782109,"score_gpt":0.3526399605945118,"score_spread":0.2601284614066907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011544274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006171262,0.94113225,0.00083342305,0.00029383597,0.00007110148,0.05736249,0.0001751795,0.000041347328,0.00008420027],"genre_scores_gemma":[0.00018948346,0.981688,0.00006358879,0.000538121,0.0001517358,0.017047368,0.00010464207,0.00009024665,0.00012679631],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.966851,0.02358819,0.007096687,0.0011704171,0.00088214694,0.0004115542],"domain_scores_gemma":[0.9931507,0.002727827,0.0013710808,0.0020442482,0.00032155565,0.00038454984],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.038269397,0.0012122971,0.2577299,0.00077696657,0.000054058673,0.000034087883,0.00019625349,0.0007878202,0.000039503517],"category_scores_gemma":[0.00960959,0.00056028605,0.10972402,0.00080765755,0.0003513105,0.000048944272,0.000097734715,0.00064037094,0.0000052553414],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004297784,0.0000072614234,3.3611914e-7,0.4551482,0.5427293,0.00006542251,0.00001923108,3.4071255e-7,7.858834e-8,0.000023552091,0.0000061522815,0.0015703285],"study_design_scores_gemma":[0.054991424,0.00008440361,4.613511e-7,0.02990461,0.8951948,0.00041587095,0.000016743013,0.0000012415942,2.3903905e-7,0.000003212517,0.01902691,0.00036006718],"about_ca_topic_score_codex":0.00003760781,"about_ca_topic_score_gemma":0.0000012634388,"teacher_disagreement_score":0.4252436,"about_ca_system_score_codex":0.000058332058,"about_ca_system_score_gemma":0.00034419374,"threshold_uncertainty_score":0.9996849},"labels":[],"label_agreement":null},{"id":"W3011624369","doi":"10.1016/s0735-1097(20)32461-x","title":"CARDIOVASCULAR RISK OF MONOGENIC VERSUS POLYGENIC CAUSES OF HYPERCHOLESTEROLEMIA","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Familial hypercholesterolemia; Medicine; PCSK9; Atherosclerotic cardiovascular disease; Apolipoprotein B; Polygenic risk score; LDL receptor; Internal medicine; Disease; Cholesterol; Ldl cholesterol; Lipoprotein; Genetics; Gene; Endocrinology; Biology","score_opus":0.022251107082092835,"score_gpt":0.2622164073981055,"score_spread":0.23996530031601265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011624369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888815,0.0087980395,0.00048656584,0.00078611035,0.0003559165,0.00031459026,0.00012837395,0.0000050476397,0.00024382702],"genre_scores_gemma":[0.9951555,0.00327096,0.0007429963,0.0001530338,0.0006392934,0.000002793367,6.498636e-7,0.000027246842,0.0000075360895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969526,0.0008522637,0.0009835252,0.00018738088,0.00078060664,0.00024360839],"domain_scores_gemma":[0.99681026,0.00017234277,0.0014392494,0.00084525166,0.00053133233,0.00020157508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001154651,0.00018466967,0.0026096283,0.0001348769,0.00003795414,0.0000012361724,0.0004074132,0.000088562585,0.0000052788682],"category_scores_gemma":[0.000717324,0.00012220322,0.0036699018,0.00062560546,0.0006011644,0.00004129211,0.00013224367,0.00045202885,0.0000010607657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043892898,0.00043471076,0.565793,0.0022226092,0.15833709,0.0013781589,0.0012821429,0.034852754,0.13003643,0.00025543864,0.007392697,0.054122094],"study_design_scores_gemma":[0.026163287,0.019775627,0.8000137,0.00048177768,0.026102629,0.0059412313,0.0052316594,0.00011499062,0.07335262,0.00010868368,0.042106982,0.00060676737],"about_ca_topic_score_codex":0.00015624349,"about_ca_topic_score_gemma":0.000003630372,"teacher_disagreement_score":0.23422077,"about_ca_system_score_codex":0.00007925886,"about_ca_system_score_gemma":0.00063716684,"threshold_uncertainty_score":0.49833024},"labels":[],"label_agreement":null},{"id":"W3011699788","doi":"10.1016/s0735-1097(20)30671-9","title":"LIPID-LOWERING THERAPY PATTERNS AND LOW-DENSITY LIPOPROTEIN-CHOLESTEROL MANAGEMENT AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION IN ALBERTA, CANADA","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myocardial infarction; Internal medicine; Cholesterol; Ldl cholesterol; Cardiology","score_opus":0.004840545613012321,"score_gpt":0.2031382494012239,"score_spread":0.1982977037882116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011699788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639916,0.000054041127,0.00017336904,0.0024137779,0.00021336322,0.00063582574,0.00002061414,0.0000027087744,0.00008711176],"genre_scores_gemma":[0.99793935,0.0004105234,0.00007228138,0.0011958043,0.00034353902,0.000008793028,0.0000011669553,0.00001878681,0.000009751624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847686,0.00020942863,0.00042064633,0.00018035299,0.00049670285,0.000215991],"domain_scores_gemma":[0.9988825,0.000032711872,0.00048592305,0.00027848338,0.00015650921,0.00016389717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025952925,0.00015911399,0.0009509373,0.00007966846,0.000046949375,0.0000046136092,0.00014087274,0.00003937223,0.0000015618234],"category_scores_gemma":[0.000029857223,0.000100936355,0.00027411015,0.00026763103,0.00015047385,0.000060644892,0.000084200394,0.00031517865,1.212436e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021729919,0.00002954547,0.9805494,0.00008016883,0.0025519978,0.00030177046,0.00009312775,0.0003311371,0.00009547798,0.0000026030837,0.00025208286,0.013539701],"study_design_scores_gemma":[0.0033640917,0.0011655774,0.99294996,0.00012242989,0.00025159298,0.00025514312,0.00021154984,0.000011396724,0.0002501822,0.0000024003944,0.0013207716,0.00009488427],"about_ca_topic_score_codex":0.092203476,"about_ca_topic_score_gemma":0.033489857,"teacher_disagreement_score":0.058713615,"about_ca_system_score_codex":0.00015301415,"about_ca_system_score_gemma":0.00026457172,"threshold_uncertainty_score":0.9841464},"labels":[],"label_agreement":null},{"id":"W3011714396","doi":"10.1016/j.atherosclerosis.2020.03.018","title":"The year 2019 in Atherosclerosis","year":2020,"lang":"en","type":"editorial","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"British Heart Foundation","keywords":"Quality (philosophy); Medicine; Psychology; Philosophy","score_opus":0.01308042731315507,"score_gpt":0.2539439079714357,"score_spread":0.24086348065828062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011714396","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070414427,0.0042593246,0.000025729227,0.005069097,0.96775717,0.0037271776,0.01044895,0.00038714617,0.0012839688],"genre_scores_gemma":[0.0040669437,0.024160586,0.0002495974,0.0008169779,0.96152997,0.0005491007,0.00623016,0.0003872282,0.002009465],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954634,0.0002491805,0.00075819134,0.0008842837,0.0018281041,0.00081686286],"domain_scores_gemma":[0.9970494,0.0004706797,0.00026435396,0.0016545812,0.0002069009,0.00035411268],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012154179,0.0005752135,0.0011804975,0.000097548,0.00027342016,0.00016054163,0.0005688505,0.001152686,0.00009451892],"category_scores_gemma":[0.000922375,0.00040109144,0.00089000736,0.00058807945,0.0001787889,0.0000661073,0.00021954821,0.0019329734,0.0011451315],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011349177,0.00011687426,0.00064929284,0.0001443122,0.00022053331,0.0000045465285,0.00011298724,7.6928154e-7,0.00021764137,0.000018634963,0.9962932,0.0021077085],"study_design_scores_gemma":[0.0022793864,0.0004353213,0.009710727,0.00053095963,0.00023397541,0.000001272312,0.000076089505,0.0000047437934,0.00009473329,0.000026415913,0.9862243,0.00038208967],"about_ca_topic_score_codex":0.0013133098,"about_ca_topic_score_gemma":0.00025174377,"teacher_disagreement_score":0.019901263,"about_ca_system_score_codex":0.00041199668,"about_ca_system_score_gemma":0.00066915,"threshold_uncertainty_score":0.9998441},"labels":[],"label_agreement":null},{"id":"W3012051999","doi":"10.1161/atvb.34.suppl_1.437","title":"Abstract 437: Lipoprotein(a) Internalization in HepG2 Cells is Regulated by Proprotein Convertase Subtilisin Kexin Type 9 Through the Low-Density Lipoprotein Receptor","year":2014,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University of Windsor","funders":"","keywords":"Internalization; PCSK9; Kexin; Proprotein convertase; LDL receptor; Lipoprotein; Apolipoprotein B; Lipoprotein(a); Endocytosis; Subtilisin; Familial hypercholesterolemia; Receptor; Lysine; Low-density lipoprotein; Chemistry; Endocrinology; Biochemistry; Internal medicine; Cholesterol; Biology; Medicine; Amino acid; Enzyme","score_opus":0.019112209212160336,"score_gpt":0.26273625048118054,"score_spread":0.2436240412690202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012051999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99297583,0.0005191131,0.001216995,0.002358208,0.00033392408,0.0023264512,0.00003555382,0.00009793612,0.00013597947],"genre_scores_gemma":[0.99276775,0.0032533344,0.00054050924,0.0026964264,0.0002720078,0.00017731653,0.0001840203,0.00007661221,0.000032026586],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9964324,0.00058152794,0.000825084,0.0010131395,0.00044364974,0.00070415094],"domain_scores_gemma":[0.9979278,0.000059015834,0.0002890898,0.0012778029,0.00022006746,0.00022626169],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001495707,0.00051771675,0.0010885763,0.000113770686,0.00028577796,0.00009739494,0.0002788294,0.000537979,0.00035987303],"category_scores_gemma":[0.00012669375,0.00036949752,0.00039151215,0.00039622388,0.00040877276,0.00019480189,0.00016045768,0.000529381,0.000106817024],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011744541,0.0005918336,0.011518041,0.0004917382,0.00065841404,6.898934e-7,0.001444076,0.0000025522145,0.96788657,0.0003615329,0.0026386133,0.014288499],"study_design_scores_gemma":[0.0049355947,0.0015207469,0.76323575,0.0010397406,0.00026775073,0.0000057723887,0.0002775626,0.0004454251,0.19040354,0.00039729237,0.036625806,0.00084503833],"about_ca_topic_score_codex":0.010753868,"about_ca_topic_score_gemma":0.0005263027,"teacher_disagreement_score":0.77748305,"about_ca_system_score_codex":0.0001250607,"about_ca_system_score_gemma":0.00008967633,"threshold_uncertainty_score":0.9998757},"labels":[],"label_agreement":null},{"id":"W3012265841","doi":"10.1056/nejmoa1912387","title":"Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol","year":2020,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1564,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Esperion Therapeutics; HLS Therapeutics; Imperial College London; Daiichi Sankyo Europe; Silence Therapeutics; Sanofi; Kowa Company; Novo Nordisk; National Institute for Health and Care Research; Medicines Company; REGENXBIO; Regeneron Pharmaceuticals; Eli Lilly and Company; AstraZeneca; CSL Behring; Gilead Sciences; NIHR Imperial Biomedical Research Centre; Singulex; Amgen; Pfizer","keywords":"Ldl cholesterol; Phase (matter); Cholesterol; Internal medicine; Medicine; Chemistry","score_opus":0.039539835172066995,"score_gpt":0.3263639915282541,"score_spread":0.28682415635618713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012265841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080765,0.0010422752,0.00052963675,0.0067680166,0.00016264632,0.000496067,0.000005563918,0.0000066134426,0.00018154905],"genre_scores_gemma":[0.99495465,0.00015006331,0.00033208512,0.001488616,0.0030268559,0.0000010377901,0.000016075242,0.000018946777,0.000011644602],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970373,0.00032397747,0.0013416561,0.00013341696,0.0009827734,0.00018089719],"domain_scores_gemma":[0.9981165,0.0001231464,0.0007351313,0.00019482689,0.00032397904,0.00050641433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003224557,0.00015392911,0.0015738428,0.00020297516,0.00001592064,0.0000036541746,0.000101113685,0.00005508451,0.00013804804],"category_scores_gemma":[0.0014638915,0.00008261725,0.00015291426,0.000363426,0.000058125017,0.000082064646,0.00001385508,0.0004293593,0.0000011426445],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03340445,0.0008648034,0.17818835,0.0004759468,0.0009838458,0.0004467127,0.0040861783,0.00006231002,0.0049128565,0.000024184632,0.0018086958,0.77474165],"study_design_scores_gemma":[0.826597,0.027067874,0.124093086,0.0022459922,0.00092209387,0.00020661503,0.00025170587,0.000040105202,0.0020538506,0.00004500622,0.016331093,0.00014563119],"about_ca_topic_score_codex":0.00020863682,"about_ca_topic_score_gemma":0.000019076353,"teacher_disagreement_score":0.7931925,"about_ca_system_score_codex":0.0000390351,"about_ca_system_score_gemma":0.00028737815,"threshold_uncertainty_score":0.33690336},"labels":[],"label_agreement":null},{"id":"W3012322231","doi":"10.1016/s0735-1097(20)30799-3","title":"LIPID TESTING, LIPID MODIFYING THERAPY AND PCSK9 INHIBITOR ELIGIBILITY IN 22,603 PATIENTS WITH INCIDENT ACUTE CORONARY SYNDROME","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Medicine; Acute coronary syndrome; PCSK9; Internal medicine; Cardiology; Cholesterol; Lipoprotein; LDL receptor; Myocardial infarction","score_opus":0.02060665934029573,"score_gpt":0.26468673745360005,"score_spread":0.24408007811330432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012322231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966912,0.00057256536,0.000060436894,0.0017792364,0.00016786605,0.00059987634,0.000034695866,0.0000076141796,0.00008650474],"genre_scores_gemma":[0.99713767,0.0003921424,0.0010711692,0.0009992511,0.0003635867,0.00000732568,0.0000010195223,0.000022858598,0.0000049748637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979039,0.00043264293,0.0006399165,0.00023550868,0.0005346036,0.00025341677],"domain_scores_gemma":[0.9981732,0.00013340109,0.0007698139,0.00036039768,0.0003516084,0.00021160708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070874917,0.00018580181,0.0014382943,0.0001054309,0.00005783612,0.000004459146,0.00019625385,0.000060505114,0.000003332558],"category_scores_gemma":[0.00031722613,0.00010980271,0.00031410196,0.0005283239,0.00038518343,0.00007550801,0.00012091563,0.00046976158,4.735554e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028488485,0.000079218036,0.98664457,0.00007280185,0.0008105483,0.0005058733,0.000097867545,0.00019825394,0.00090042927,0.000004119852,0.00039793906,0.0074395193],"study_design_scores_gemma":[0.00408603,0.0062165856,0.9843669,0.00015137914,0.00019736725,0.003308349,0.00020643852,0.000036726502,0.00018417388,0.000016669701,0.0011174899,0.00011189964],"about_ca_topic_score_codex":0.000056359724,"about_ca_topic_score_gemma":0.000002632224,"teacher_disagreement_score":0.00732762,"about_ca_system_score_codex":0.00013032465,"about_ca_system_score_gemma":0.00041930468,"threshold_uncertainty_score":0.4477625},"labels":[],"label_agreement":null},{"id":"W3012488719","doi":"10.1093/eurheartj/ehaa078","title":"Triglyceride reduction in secondary atherosclerotic cardiovascular disease prevention: core concepts in contemporary therapeutic targeting","year":2020,"lang":"en","type":"letter","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ted Rogers Centre for Heart Research; University Health Network","funders":"","keywords":"Medicine; Atherosclerotic cardiovascular disease; Secondary prevention; Disease; Internal medicine; Cardiology; Reduction (mathematics); Core (optical fiber); Intensive care medicine","score_opus":0.10686820656331253,"score_gpt":0.3197909326109447,"score_spread":0.21292272604763218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012488719","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10935431,0.2728182,0.00051437656,0.5969278,0.0050815004,0.006833665,0.000068207744,0.00032194346,0.008079956],"genre_scores_gemma":[0.73131293,0.002854834,0.00039016534,0.23481575,0.028669346,0.000050077662,0.00039528077,0.00043463122,0.0010769776],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937273,0.0026817617,0.001096083,0.00072489964,0.0011663511,0.000603566],"domain_scores_gemma":[0.9983978,0.00003743898,0.00029629545,0.0007337502,0.00011201755,0.00042264318],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027980083,0.00047739543,0.0013538288,0.000341268,0.00017128055,0.0001034851,0.00021425699,0.0002101866,0.00023847667],"category_scores_gemma":[0.00013894512,0.0004358015,0.0017543173,0.0004007014,0.000116723,0.0002091452,0.00007826676,0.005846332,0.00010792156],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001119948,0.0002794256,0.010571899,0.002772759,0.0029073192,0.08043278,0.0013229339,0.000223125,0.0003832503,0.0000034975048,0.8559461,0.044036943],"study_design_scores_gemma":[0.0052233487,0.0003936192,0.046904467,0.0024557868,0.00036127047,0.0027761543,0.00019555567,0.000037304235,0.000014945066,0.000072876246,0.94109344,0.0004712449],"about_ca_topic_score_codex":0.00003809537,"about_ca_topic_score_gemma":5.3596995e-7,"teacher_disagreement_score":0.6219586,"about_ca_system_score_codex":0.00039226047,"about_ca_system_score_gemma":0.0013470371,"threshold_uncertainty_score":0.9998094},"labels":[],"label_agreement":null},{"id":"W3012527193","doi":"10.1093/eurheartj/ehaa099","title":"Targeting cardiovascular inflammation: next steps in clinical translation","year":2020,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":428,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ted Rogers Centre for Heart Research; University Health Network; St. Michael's Hospital; University of New Brunswick","funders":"Canadian Institutes of Health Research; Peter Munk Cardiac Centre, University Health Network; Commission for Environmental Cooperation","keywords":"Medicine; Inflammation; Translation (biology); Intensive care medicine; Cardiology; Internal medicine","score_opus":0.17192554154289033,"score_gpt":0.38375514759790497,"score_spread":0.21182960605501464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012527193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037866794,0.99489737,0.0006875329,0.0003651638,0.00069841684,0.0011748011,0.0000034284647,0.000055451546,0.002079948],"genre_scores_gemma":[0.000066704735,0.98469555,0.0021811305,0.00015135997,0.012658689,0.000008378375,0.000054414686,0.00014892656,0.000034860215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99136066,0.004539295,0.002201576,0.0005089625,0.00096934685,0.00042015346],"domain_scores_gemma":[0.9982419,0.00011128543,0.00039339933,0.0005983708,0.00011110385,0.00054391165],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010435924,0.00040903376,0.0032274388,0.0002594397,0.00015062105,0.00013822448,0.00019102574,0.00022360074,0.0000909724],"category_scores_gemma":[0.00043212922,0.00032411722,0.0046993624,0.00048797362,0.0000435219,0.00018879311,0.00005782529,0.003012471,0.00051568024],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015446858,0.000022895834,0.000057853216,0.0047215084,0.00086033973,0.0021234602,0.000072698924,0.000012970809,3.119368e-7,0.0000023424495,0.00076967076,0.9913405],"study_design_scores_gemma":[0.0011873398,0.00016874592,0.0004091746,0.010219549,0.0014681919,0.0047709793,0.000027429263,0.000030045698,1.2346418e-7,0.0000014482133,0.9814516,0.00026542894],"about_ca_topic_score_codex":0.0000048736965,"about_ca_topic_score_gemma":5.52241e-7,"teacher_disagreement_score":0.9910751,"about_ca_system_score_codex":0.0001792975,"about_ca_system_score_gemma":0.00082243414,"threshold_uncertainty_score":0.9999211},"labels":[],"label_agreement":null},{"id":"W3013032147","doi":"10.1016/j.cjca.2020.03.020","title":"Pediatric Dyslipidemia—Beyond Familial Hypercholesterolemia","year":2020,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Familial hypercholesterolemia; Dyslipidemia; Pediatrics; Internal medicine; Cholesterol; Obesity","score_opus":0.03764464038851117,"score_gpt":0.29916928163479267,"score_spread":0.2615246412462815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013032147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004762115,0.99185866,0.0002472283,0.00034081916,0.0024268732,0.0005952558,0.00009159564,0.000010691785,0.0043812785],"genre_scores_gemma":[0.0003024634,0.9702266,0.00017300707,0.0005955463,0.02848418,0.00001405733,0.00004320479,0.00009563975,0.00006531869],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964559,0.000689661,0.0013973617,0.00038352664,0.00037690264,0.0006966305],"domain_scores_gemma":[0.9958279,0.00011145676,0.0006313023,0.0006030587,0.00031447713,0.0025117898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012440226,0.00048512255,0.005835799,0.00079491106,0.00009654344,0.000026432515,0.00042139174,0.00096425385,0.000027377484],"category_scores_gemma":[0.0005901062,0.00037361323,0.0033436595,0.00047940537,0.00012749941,0.00005878664,0.000031914296,0.0022183207,0.00012320654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012278996,0.0000011262986,0.0003384976,0.005904872,0.0011419064,0.0034720113,0.000027021813,0.000005208726,1.0292594e-7,0.000025999921,0.026537543,0.9625334],"study_design_scores_gemma":[0.0006492454,0.00038924627,0.0002497254,0.0012981956,0.0059275366,0.013383791,0.00001723115,1.958036e-7,5.9327846e-8,0.000020651745,0.97780895,0.0002551579],"about_ca_topic_score_codex":0.000279581,"about_ca_topic_score_gemma":0.0001464282,"teacher_disagreement_score":0.96227825,"about_ca_system_score_codex":0.0007985068,"about_ca_system_score_gemma":0.018345773,"threshold_uncertainty_score":0.99987155},"labels":[],"label_agreement":null},{"id":"W3013717847","doi":"10.1016/j.cjca.2020.03.022","title":"Outcome and Cost of Optimal Control of Dyslipidemia in Adults With High Risk for Cardiovascular Disease","year":2020,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"Alberta Innovates","keywords":"Medicine; Dyslipidemia; Disease; Outcome (game theory); Atherosclerotic cardiovascular disease; Intensive care medicine; Internal medicine","score_opus":0.013450543591248608,"score_gpt":0.22940087323059244,"score_spread":0.21595032963934382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013717847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9428397,0.012318025,0.04181893,0.0013517216,0.00015122678,0.0011079775,0.00034689647,0.0000027236931,0.00006278571],"genre_scores_gemma":[0.9980628,0.0001963952,0.00085744885,0.00021738898,0.0006228958,0.000015258975,0.000006501503,0.000019561983,0.0000017393962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849474,0.00021455709,0.00061073824,0.00018056184,0.0002134026,0.000286018],"domain_scores_gemma":[0.9979666,0.00008709239,0.00025003275,0.00027237792,0.00036351397,0.0010604152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010485151,0.00013465692,0.0015749662,0.00017368176,0.000028006876,0.0000029031485,0.00009296436,0.00010760876,0.0000034099783],"category_scores_gemma":[0.0007202561,0.00010287635,0.0007860731,0.0001304336,0.00018931892,0.000042061896,0.000006739485,0.0002819346,2.17708e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003966311,0.0000050975527,0.9325929,0.0009061046,0.0044592703,0.00058064406,0.0002552945,0.042581018,0.000018386845,0.00019394474,0.00025627168,0.014184703],"study_design_scores_gemma":[0.033787273,0.0035675673,0.925068,0.0005248121,0.0047368687,0.0004416955,0.00056333875,0.0007161337,0.000057030742,0.000054662025,0.030202076,0.00028049943],"about_ca_topic_score_codex":0.002621937,"about_ca_topic_score_gemma":0.00046113972,"teacher_disagreement_score":0.0552231,"about_ca_system_score_codex":0.00007895154,"about_ca_system_score_gemma":0.001288678,"threshold_uncertainty_score":0.41951758},"labels":[],"label_agreement":null},{"id":"W3013740472","doi":"10.1002/mds.28038","title":"Progressive Supranuclear Palsy and Statin Use","year":2020,"lang":"en","type":"article","venue":"Movement Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"National Institute on Aging","keywords":"Pravastatin; Progressive supranuclear palsy; Medicine; Internal medicine; Rating scale; Atorvastatin; Rosuvastatin; Clinical Dementia Rating; Epworth Sleepiness Scale; Physical therapy; Psychology; Dementia; Disease; Cholesterol","score_opus":0.01831822645127646,"score_gpt":0.24966494849261273,"score_spread":0.23134672204133627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013740472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732113,0.0015880957,0.00045352537,0.022854047,0.000033883753,0.0010622352,0.0000129602795,0.00007882637,0.00070516416],"genre_scores_gemma":[0.96611106,0.00068786147,0.0016133032,0.031240534,0.0000988792,0.000058086553,0.000026704727,0.00003395815,0.00012961942],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991212,0.000033204775,0.0001399187,0.00022792011,0.0002835411,0.00019424586],"domain_scores_gemma":[0.99955255,0.00001094449,0.00003494357,0.0001699621,0.000026237261,0.00020537233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000097980315,0.00010405843,0.00020001989,0.0000205134,0.00005855004,0.000029391076,0.000030469002,0.000032437096,0.00015471538],"category_scores_gemma":[0.000059264756,0.00008592998,0.000080883096,0.00009458382,0.000043751785,0.00007283762,0.00004020175,0.0000996618,0.000017678818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014203772,0.0009203395,0.30824393,0.0024918027,0.001604298,0.0003657479,0.010362856,0.00004408872,0.0023974834,0.0056741256,0.047459118,0.6190158],"study_design_scores_gemma":[0.021399735,0.0054351687,0.6197086,0.00036115816,0.00067522924,0.000006528993,0.01002842,0.003461748,0.0020760153,0.006318835,0.32935357,0.0011749894],"about_ca_topic_score_codex":0.00021253299,"about_ca_topic_score_gemma":0.000014932153,"teacher_disagreement_score":0.6178408,"about_ca_system_score_codex":0.000018274754,"about_ca_system_score_gemma":0.000034121105,"threshold_uncertainty_score":0.3504123},"labels":[],"label_agreement":null},{"id":"W3013898768","doi":"10.1161/circulationaha.120.046524","title":"Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; St. Michael's Hospital","funders":"Sanofi","keywords":"Medicine; Internal medicine; Acute coronary syndrome; Cardiology; Alirocumab; Coronary artery disease; Placebo; Quartile; Statin; PCSK9; Lipoprotein; Cholesterol; Myocardial infarction; Confidence interval; Apolipoprotein A1; Pathology","score_opus":0.014706678247680826,"score_gpt":0.2446837572486098,"score_spread":0.22997707900092898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013898768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628294,0.0014751855,0.0006051175,0.0009648957,0.000073609466,0.000499758,0.000012847196,0.000047344663,0.000038294707],"genre_scores_gemma":[0.9979108,0.000072576106,0.00006719062,0.001623787,0.00018130054,0.000039505965,0.00007571793,0.000020295498,0.000008815484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923384,0.00003388222,0.0001281713,0.00022459541,0.00023617662,0.00014334948],"domain_scores_gemma":[0.9994451,0.0000025252195,0.000026586311,0.0001944609,0.000026920146,0.00030440648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058869246,0.00009554574,0.0002242162,0.000021592277,0.00005292779,0.000010717204,0.000021719012,0.000046012075,0.000083137806],"category_scores_gemma":[0.000010804135,0.00008937702,0.00010493209,0.00007800097,0.000021387454,0.00010139958,0.000019886464,0.00008521578,0.000030836458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041233152,0.0001790655,0.97693735,0.0005438006,0.000523129,0.0017540134,0.0011539336,0.00005340952,0.0013637544,0.000040772804,0.000055456534,0.016983002],"study_design_scores_gemma":[0.0007989299,0.000116017196,0.9968698,0.000048458678,0.00031506922,0.0004090452,0.000017245604,0.0010389835,0.0000037783077,0.00010686857,0.00018482322,0.000091001726],"about_ca_topic_score_codex":0.0000075758794,"about_ca_topic_score_gemma":4.3448628e-7,"teacher_disagreement_score":0.019932449,"about_ca_system_score_codex":0.00004885279,"about_ca_system_score_gemma":0.00006738756,"threshold_uncertainty_score":0.3644689},"labels":[],"label_agreement":null},{"id":"W3014102931","doi":"10.2196/16400","title":"Low-Density Lipoprotein Cholesterol Target Attainment in Patients With Established Cardiovascular Disease: Analysis of Routine Care Data","year":2020,"lang":"en","type":"article","venue":"JMIR Medical Informatics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Universitair Medisch Centrum Utrecht; Universiteit Utrecht","keywords":"Medicine; Referral; Logistic regression; Medical record; Odds ratio; Internal medicine; Cluster (spacecraft); Health care; Emergency medicine; Family medicine","score_opus":0.012712620861875152,"score_gpt":0.2511106308209741,"score_spread":0.23839800995909896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014102931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99214655,0.00044993815,0.004531976,0.00053216954,0.00003272215,0.0019446491,0.00019629463,0.00005361187,0.00011208619],"genre_scores_gemma":[0.99374795,0.000056547902,0.0014604316,0.0016026242,0.00012646956,0.000060825914,0.0029184218,0.000024004554,0.0000027406306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946558,0.000110577,0.0010034924,0.00033428095,0.0034980748,0.0003978166],"domain_scores_gemma":[0.9963559,0.000020614161,0.00021799072,0.0020719417,0.0002869609,0.0010465874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083332683,0.00026683754,0.0013357173,0.00022209772,0.00004642335,0.00002610374,0.0004680001,0.00017146961,0.000107983295],"category_scores_gemma":[0.0003237945,0.00019410034,0.00044123732,0.0013939462,0.00012624823,0.00033004026,0.00039668163,0.00048685822,0.000008504382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020210335,0.001457429,0.79440784,0.010956981,0.016954368,0.0002282983,0.015527821,0.002641221,0.0000011400126,0.000018737066,0.00080072496,0.15498438],"study_design_scores_gemma":[0.009389812,0.0005094615,0.94969773,0.0006127153,0.0036607007,0.0000021625087,0.0021449253,0.028753707,0.00006138051,9.684137e-7,0.0048280153,0.00033844533],"about_ca_topic_score_codex":0.00033665323,"about_ca_topic_score_gemma":0.000045728,"teacher_disagreement_score":0.15528984,"about_ca_system_score_codex":0.0001351642,"about_ca_system_score_gemma":0.0004978289,"threshold_uncertainty_score":0.7915182},"labels":[],"label_agreement":null},{"id":"W3014335532","doi":"10.1007/s00421-020-04360-2","title":"The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations","year":2020,"lang":"en","type":"review","venue":"European Journal of Applied Physiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre; Health Sciences Centre","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Sports medicine; Human physiology; Physical activity; Medicine; Exercise physiology; Physical therapy; Physical exercise; Physical medicine and rehabilitation; Internal medicine","score_opus":0.12147455402467111,"score_gpt":0.379027585444653,"score_spread":0.25755303141998187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014335532","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06415748,0.9338996,0.00003869064,0.00022440845,0.000114473936,0.0011890641,0.00007562721,0.0000060617344,0.00029462954],"genre_scores_gemma":[0.07038568,0.92915505,0.00015994464,0.00003121058,0.00022455087,0.0000046707924,0.0000031212146,0.00003280389,0.000002942749],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778295,0.0011303341,0.0004897287,0.00020616189,0.0002420386,0.00014877951],"domain_scores_gemma":[0.9978112,0.00029565196,0.0011679177,0.00047602633,0.00009521891,0.00015400375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011041583,0.00024222198,0.0017686528,0.000054280295,0.00010591667,0.000010003073,0.00022543046,0.00004580767,0.0000058847927],"category_scores_gemma":[0.00007854678,0.000108384935,0.00066100335,0.0001793336,0.00019133805,0.000040965882,0.00012343779,0.0007153498,0.0000014236231],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033957,0.00012878225,1.223554e-7,0.002699431,0.00049181783,0.000004140999,0.00025159863,0.0000020485568,0.00085407053,0.00085555104,0.00009084854,0.994282],"study_design_scores_gemma":[0.008959226,0.030195136,0.043234933,0.15654069,0.023692781,0.001848819,0.0012744927,0.00020722773,0.002358861,0.00987915,0.7197973,0.0020113655],"about_ca_topic_score_codex":0.000015207936,"about_ca_topic_score_gemma":5.7667097e-7,"teacher_disagreement_score":0.99227065,"about_ca_system_score_codex":0.000042743468,"about_ca_system_score_gemma":0.00029417136,"threshold_uncertainty_score":0.44198093},"labels":[],"label_agreement":null},{"id":"W3014693317","doi":"10.1016/j.cjca.2020.03.041","title":"The Rationale, Indications, Safety, and Use of Statins in the Pediatric Population","year":2020,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; University of Alberta Hospital; University of Alberta","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.04345045399424939,"score_gpt":0.30093398008125066,"score_spread":0.25748352608700126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014693317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018968637,0.99736804,0.00020320341,0.0012161256,0.00016570766,0.00067419553,0.000067673696,8.3901614e-7,0.00011453569],"genre_scores_gemma":[0.0045856535,0.99400157,0.000075501855,0.00011241435,0.0011366287,0.000010869014,0.000053624546,0.000012793886,0.000010920357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791485,0.0008122846,0.0007964798,0.00010257042,0.00021352043,0.00016031296],"domain_scores_gemma":[0.9984065,0.00045598435,0.0005445874,0.00024373691,0.00013525785,0.00021389393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014081305,0.00012031603,0.0011574321,0.00029236512,0.00010867447,0.000019671266,0.00014576719,0.00015596503,0.0000021128722],"category_scores_gemma":[0.0008158531,0.00006443584,0.0003950898,0.00034224585,0.00007955447,0.00004181739,0.000008820178,0.0005326465,0.0000010603385],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016219143,0.000001329754,0.008503127,0.0014816028,0.00037447122,0.00012416863,0.00016790592,0.000026028343,9.53273e-9,0.001380029,0.0019903467,0.98593473],"study_design_scores_gemma":[0.00020916607,0.00009170003,0.034355093,0.00031521963,0.0008328905,0.0016242572,0.000061203005,7.887265e-7,3.5237588e-9,0.00005600181,0.9624049,0.00004876507],"about_ca_topic_score_codex":0.0011515764,"about_ca_topic_score_gemma":0.001397424,"teacher_disagreement_score":0.985886,"about_ca_system_score_codex":0.00015251413,"about_ca_system_score_gemma":0.0036277066,"threshold_uncertainty_score":0.64353955},"labels":[],"label_agreement":null},{"id":"W3015522882","doi":"10.1016/j.pcad.2020.04.004","title":"What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?","year":2020,"lang":"en","type":"review","venue":"Progress in Cardiovascular Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Sanofi","keywords":"Medicine; Niacin; PCSK9; Lipoprotein(a); Kexin; Internal medicine; Apolipoprotein B; Lipoprotein; Familial hypercholesterolemia; Ezetimibe; Endocrinology; Adverse effect; Clinical trial; Gastroenterology; Cholesterol; LDL receptor","score_opus":0.015758877682839508,"score_gpt":0.2924538116458625,"score_spread":0.27669493396302297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015522882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004744387,0.99254686,0.0000040966534,0.00013770522,0.00033546437,0.0062113977,0.00020223063,0.000062011364,0.000025786969],"genre_scores_gemma":[0.0047584213,0.98839414,0.00005443588,0.000029339268,0.0009087723,0.0055074473,0.00007890156,0.00023086529,0.00003767793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932841,0.0012648127,0.0012936142,0.0013129105,0.0020436947,0.00080087525],"domain_scores_gemma":[0.99630356,0.00010276857,0.00034643593,0.0027343251,0.00013980012,0.00037312068],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012312902,0.0008775919,0.005546727,0.00042954733,0.00005381169,0.00024215435,0.0007010459,0.0004972891,0.000039634622],"category_scores_gemma":[0.00015853473,0.00060904777,0.00860288,0.0015014922,0.00030201656,0.00042365838,0.00046234697,0.00079547724,0.000052447158],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115244715,0.00028179455,0.0015422227,0.026659057,0.005653233,0.0009897739,0.00017801157,0.000005659547,3.3401577e-8,0.000023787848,0.000008179778,0.964543],"study_design_scores_gemma":[0.0010016651,0.00009205699,0.0028825118,0.06808073,0.008619019,0.00012486542,0.00025193626,0.0000055821884,0.000008665746,0.00004573871,0.91834044,0.0005467959],"about_ca_topic_score_codex":0.00008903019,"about_ca_topic_score_gemma":0.000022533837,"teacher_disagreement_score":0.96399623,"about_ca_system_score_codex":0.00033332687,"about_ca_system_score_gemma":0.0010419064,"threshold_uncertainty_score":0.9996361},"labels":[],"label_agreement":null},{"id":"W3016102083","doi":"10.1016/j.cjco.2020.04.002","title":"Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome","year":2020,"lang":"en","type":"review","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Trillium Health Centre; Université de Montréal; University of Alberta; Canadian VIGOUR Centre; University of Toronto; Hamilton Health Sciences; Montreal Heart Institute; Canadian Heart Research Centre; St. Michael's Hospital","funders":"Duke Clinical Research Institute; American Regent; Bristol-Myers Squibb Canada; Esperion Therapeutics; GlaxoSmithKline; HLS Therapeutics; Bayer; Servier; University of Toronto; Novo Nordisk; Daiichi-Sankyo; Bayer Canada; Regeneron Pharmaceuticals; HDL Therapeutics; Valeant Pharmaceuticals International; AstraZeneca Canada; Actelion Pharmaceuticals; York University; Pfizer; Heart and Stroke Foundation of Canada; Novartis; Sanofi; Merck; Boehringer Ingelheim; Amgen; CSL Behring; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Acute coronary syndrome; Medicine; Ezetimibe; Residual risk; Eicosapentaenoic acid; Type 2 diabetes; Proprotein convertase; Clinical trial; Statin; Secondary prevention; Internal medicine; Ticagrelor; Pioglitazone; Pharmacology; Diabetes mellitus; Cholesterol; Endocrinology; Lipoprotein; Myocardial infarction; Fatty acid; Polyunsaturated fatty acid; Biochemistry","score_opus":0.0648228337220232,"score_gpt":0.37458829269366956,"score_spread":0.30976545897164637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016102083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012280764,0.9894301,0.0002552141,0.0008081472,0.0002863717,0.007946735,0.00013051493,0.000069038084,0.0009510573],"genre_scores_gemma":[0.00035282187,0.99212116,0.0015023396,0.0017603552,0.00025973975,0.002056948,0.0004947713,0.0001101878,0.0013416912],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971738,0.0003746844,0.0006919865,0.00083123136,0.00054694206,0.0003813914],"domain_scores_gemma":[0.99793726,0.000038741684,0.00021135052,0.0012461477,0.000088129505,0.00047835356],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008025286,0.00049118366,0.0032265435,0.00014198886,0.000079153135,0.00028129225,0.0006598697,0.00030324582,0.0017365282],"category_scores_gemma":[0.000039715367,0.0003789203,0.0010607532,0.0004398257,0.00003739329,0.00051021576,0.00053818023,0.00064353104,0.0015507222],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017727053,0.000045741042,0.0000029347873,0.022471353,0.0012068998,0.0038960695,0.000019236539,2.796577e-7,2.6289564e-7,0.000029185709,0.0022551515,0.9698956],"study_design_scores_gemma":[0.0005991766,0.0008492074,0.00042287356,0.05375333,0.0036352053,0.0015609548,0.00002026288,9.2166226e-7,0.0000010319062,0.000038112707,0.9387447,0.00037419124],"about_ca_topic_score_codex":0.00007791838,"about_ca_topic_score_gemma":0.000013894937,"teacher_disagreement_score":0.9695214,"about_ca_system_score_codex":0.0002808449,"about_ca_system_score_gemma":0.005818619,"threshold_uncertainty_score":0.99986625},"labels":[],"label_agreement":null},{"id":"W3017012034","doi":"10.1002/edm2.126","title":"Use of non‐LDL‐C lipid‐lowering medications in patients with type 2 diabetes","year":2020,"lang":"en","type":"article","venue":"Endocrinology Diabetes & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"AstraZeneca","keywords":"Fibrate; Medicine; Type 2 diabetes; Niacin; Triglyceride; Internal medicine; Insulin resistance; Guideline; Statin; Disease; Diabetes mellitus; Fish oil; Endocrinology; Cholesterol; Fish <Actinopterygii>; Biology; Pathology","score_opus":0.014669846526162687,"score_gpt":0.23689541863180277,"score_spread":0.2222255721056401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017012034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550706,0.002157952,0.000024428551,0.00114842,0.0002711262,0.0006511965,0.000018062561,0.000056990382,0.00016474874],"genre_scores_gemma":[0.99639773,0.00025545544,0.0013060924,0.0015525159,0.0002888786,0.00006561184,0.000065361986,0.000038565307,0.000029755256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980826,0.000088766465,0.00043074955,0.0003940605,0.0003842995,0.0006195754],"domain_scores_gemma":[0.99878705,0.00007784179,0.00013617873,0.0005433603,0.00020731162,0.0002482383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012500968,0.00021972871,0.0008727118,0.00019260819,0.000045633773,0.000009118583,0.00015160617,0.000100147285,0.000107437474],"category_scores_gemma":[0.00032911176,0.00017553635,0.00013548255,0.00059556303,0.00016476966,0.00015246209,0.00009988212,0.000373684,0.000039226947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007298531,0.00022168018,0.9721116,0.00018045967,0.0005152568,0.000008080974,0.00028412038,0.000024586348,0.0026138471,0.00011802768,0.00026670317,0.023582684],"study_design_scores_gemma":[0.002654423,0.00037486717,0.967799,0.00008001673,0.00032491435,6.6788465e-7,0.00002405313,0.000078984755,0.011056712,0.000009319146,0.017432474,0.00016456813],"about_ca_topic_score_codex":0.0000410758,"about_ca_topic_score_gemma":0.000005369566,"teacher_disagreement_score":0.023418115,"about_ca_system_score_codex":0.000024561388,"about_ca_system_score_gemma":0.000115203286,"threshold_uncertainty_score":0.7158165},"labels":[],"label_agreement":null},{"id":"W3017798522","doi":"10.1161/jaha.119.014347","title":"Use of Low‐Density Lipoprotein–Lowering Therapies Before and After PCSK9 Inhibitor Initiation","year":2020,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novelis (Canada)","funders":"","keywords":"Medicine; Kexin; Internal medicine; Ezetimibe; Evolocumab; Oncology; Statin; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.015049239319060074,"score_gpt":0.2485357705399344,"score_spread":0.23348653122087432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017798522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907337,0.00017043544,0.000112724745,0.008637659,0.000107575484,0.00022124659,0.0000041082526,0.000007311233,0.0000052698783],"genre_scores_gemma":[0.99629104,0.000090980335,0.0006504263,0.002275575,0.0006622163,0.0000026368477,4.7649823e-7,0.0000123182845,0.000014344396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871945,0.00016084468,0.00035446012,0.00008286622,0.0005650044,0.00011734934],"domain_scores_gemma":[0.998799,0.00005492735,0.00061165605,0.00012840383,0.0003103851,0.0000956043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063087663,0.00008085807,0.0004950729,0.000045421148,0.00005067861,0.000022279626,0.00003613614,0.000041587442,0.0000054489137],"category_scores_gemma":[0.000681379,0.00005462107,0.00030009917,0.00022464074,0.000043984706,0.00018257124,0.000034018445,0.00024139794,0.0000013088327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048366515,0.000056203335,0.96027344,0.00011768387,0.00036607202,0.0000074391332,0.002114845,0.000011546376,0.017099125,0.000002565493,0.0003261591,0.019141264],"study_design_scores_gemma":[0.00045687638,0.00057501986,0.98725796,0.00014894141,0.00012769605,0.000035293164,0.00014119576,0.000050210238,0.010023395,0.000022428538,0.0011116359,0.00004932418],"about_ca_topic_score_codex":0.00016304025,"about_ca_topic_score_gemma":0.00003053431,"teacher_disagreement_score":0.02698455,"about_ca_system_score_codex":0.00016216745,"about_ca_system_score_gemma":0.00009981923,"threshold_uncertainty_score":0.22273825},"labels":[],"label_agreement":null},{"id":"W3019259851","doi":"10.1503/cmaj.190848","title":"Calibration and discrimination of the Framingham Risk Score and the Pooled Cohort Equations","year":2020,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Health Sciences Centre; Women's College Hospital; University Health Network; University of Toronto; Sunnybrook Health Science Centre; McGill University Health Centre; McGill University; University of Calgary","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Framingham Risk Score; Cohort; Medicine; Population; Cohort study; Demography; Internal medicine; Risk assessment; Framingham Heart Study; Disease; Environmental health","score_opus":0.009152442066678378,"score_gpt":0.2217348377365952,"score_spread":0.21258239566991682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019259851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7292053,0.0017084592,0.0048896098,0.26284,0.00023632532,0.0006303529,0.000025815312,0.000008387744,0.00045571133],"genre_scores_gemma":[0.9911686,0.00055173895,0.00003832979,0.007571072,0.0006173197,0.000006248109,0.000005016202,0.0000060585094,0.000035605706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982835,0.00032042322,0.0002676379,0.00008602347,0.0009119848,0.00013042463],"domain_scores_gemma":[0.9988124,0.00014932644,0.00020523308,0.0000827243,0.00018320033,0.0005671164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002033081,0.000056701785,0.00018350715,0.000032016913,0.0003230413,0.000039610655,0.000059152237,0.0001289161,0.00009742147],"category_scores_gemma":[0.0056037745,0.000031192183,0.000086151704,0.00015728269,0.0000957388,0.00006434759,0.0000148058725,0.000538127,8.7255063e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060952643,0.00002133989,0.8757378,0.0001028784,0.0006824986,0.00002213515,0.0048588547,0.000016425303,0.000022045038,0.00594591,0.0066856076,0.10584355],"study_design_scores_gemma":[0.0037986382,0.0000721916,0.9655992,0.00014918493,0.00058658706,0.00013457087,0.0010823245,0.021322181,0.000033602722,0.00065822277,0.006484238,0.000079062156],"about_ca_topic_score_codex":0.0038605246,"about_ca_topic_score_gemma":0.0068271705,"teacher_disagreement_score":0.26196328,"about_ca_system_score_codex":0.00013402049,"about_ca_system_score_gemma":0.001094832,"threshold_uncertainty_score":0.6708646},"labels":[],"label_agreement":null},{"id":"W3020299137","doi":"10.1002/pds.5023","title":"The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented","year":2020,"lang":"en","type":"article","venue":"Pharmacoepidemiology and Drug Safety","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Medical Research Council Canada; University of Manchester; National Institute for Health and Care Excellence","keywords":"Discontinuation; Medicine; Statin; Cohort; Pharmacoepidemiology; Disease; Cohort study; Lower risk; Risk assessment; Demography; Internal medicine; Emergency medicine; Pediatrics; Confidence interval; Pharmacology","score_opus":0.036015433064180355,"score_gpt":0.35822335074144523,"score_spread":0.32220791767726487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020299137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98118293,0.0013958375,0.0004555,0.015699966,0.00001777699,0.0009434647,0.000062640655,0.00000901259,0.00023286634],"genre_scores_gemma":[0.99659115,0.0016574019,0.0001318929,0.0014518651,0.0000792946,0.00003528972,0.000012624679,0.000012425058,0.000028079501],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9967284,0.0021945185,0.00045309676,0.00024116905,0.00016387751,0.00021890458],"domain_scores_gemma":[0.9965066,0.0028615645,0.00019036268,0.00023884392,0.00007000155,0.00013264971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006083867,0.00015340652,0.0005241042,0.000016885198,0.0002237458,0.0000048721627,0.00006951604,0.00003826086,0.000046521087],"category_scores_gemma":[0.002120127,0.00006731133,0.00021149362,0.00011194692,0.00016679315,0.000037598948,0.00007468372,0.00027383422,0.000005453322],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038007267,0.0009874662,0.31910503,0.0015069069,0.031296823,0.00006635465,0.03934331,0.027952302,0.011234085,0.010630296,0.028757583,0.4911126],"study_design_scores_gemma":[0.010859444,0.0029515873,0.90480435,0.0010219456,0.0022466928,0.00009655597,0.0030985023,0.05246868,0.010539038,0.0025334267,0.008700592,0.0006792107],"about_ca_topic_score_codex":0.00040673523,"about_ca_topic_score_gemma":0.0000025672143,"teacher_disagreement_score":0.5856993,"about_ca_system_score_codex":0.000016517111,"about_ca_system_score_gemma":0.000053879186,"threshold_uncertainty_score":0.27448764},"labels":[],"label_agreement":null},{"id":"W3021163647","doi":"10.1016/j.jacc.2020.03.029","title":"Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of Alberta; Canadian VIGOUR Centre","funders":"","keywords":"Alirocumab; Medicine; Acute coronary syndrome; Statin; Internal medicine; Placebo; PCSK9; Cost effectiveness; Population; Cholesterol; Apolipoprotein B; Lipoprotein; Apolipoprotein A1; LDL receptor; Myocardial infarction","score_opus":0.01720382325859107,"score_gpt":0.2724335701792895,"score_spread":0.25522974692069844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021163647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978768,0.0002487165,0.00028367055,0.0006490927,0.000101664264,0.00065190136,0.00005806312,0.000002495215,0.00012758159],"genre_scores_gemma":[0.99923694,0.00011153374,0.0003303077,0.00021793784,0.00007582448,0.000006440913,0.0000014863919,0.000015128857,0.000004372027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823576,0.0006096659,0.0004404716,0.00011765681,0.00043612957,0.00016029894],"domain_scores_gemma":[0.99854946,0.0001166643,0.0006395599,0.00027352798,0.0003148848,0.00010591999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055454386,0.00011500403,0.0015143952,0.00009188308,0.000018571527,7.7808727e-7,0.00019029142,0.000040018833,0.0000028170493],"category_scores_gemma":[0.00011687816,0.00006606349,0.00043619928,0.00046702445,0.00031916756,0.000040327523,0.000063988366,0.00025381937,3.661781e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013162958,0.00010235971,0.9781957,0.00024093922,0.0029107663,0.00068782177,0.0000567987,0.00073441665,0.00070539943,0.00003639476,0.0002779754,0.0028884425],"study_design_scores_gemma":[0.005030664,0.005723739,0.985734,0.00019944906,0.00046273705,0.0013564748,0.00018550841,0.000005809388,0.00063271605,0.000018115956,0.00058682804,0.00006399385],"about_ca_topic_score_codex":0.000022149632,"about_ca_topic_score_gemma":0.0000010231267,"teacher_disagreement_score":0.008132295,"about_ca_system_score_codex":0.00009655888,"about_ca_system_score_gemma":0.00039240226,"threshold_uncertainty_score":0.2693991},"labels":[],"label_agreement":null},{"id":"W3021363219","doi":"10.1002/14651858.cd010254.pub2","title":"Rosuvastatin for lowering lipids","year":2014,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rosuvastatin; Medicine; Rosuvastatin Calcium; Placebo; Statin; Randomized controlled trial; Cholesterol; Adverse effect; Internal medicine; Meta-analysis; Cochrane Library; Clinical trial; Pharmacology","score_opus":0.1102313727445546,"score_gpt":0.3997257017052628,"score_spread":0.28949432896070815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021363219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.5213259e-7,0.95168567,0.018561289,0.000008344793,0.00049800455,0.028425084,0.00046446815,0.000038465318,0.00031854937],"genre_scores_gemma":[4.112338e-7,0.98460406,0.0056425557,0.000055810367,0.00090017694,0.0063999076,0.0019043526,0.00013852275,0.0003541902],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9921598,0.0009542266,0.004942908,0.0006973935,0.00080047606,0.00044523794],"domain_scores_gemma":[0.9918428,0.0008511493,0.0028377585,0.0038720113,0.00029541418,0.00030086192],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.011602533,0.00076428277,0.01800187,0.00026266713,0.00007060079,0.000028991273,0.00044088988,0.00025683834,0.00007424454],"category_scores_gemma":[0.0052741314,0.00046089521,0.00430297,0.00039309464,0.000060010363,0.0000737326,0.00011202451,0.00032429455,0.0002671002],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000049947284,0.000045173118,4.061134e-8,0.8043303,0.0003822957,0.0000069305534,0.000018031235,2.53916e-8,0.0000012199409,0.000081443846,0.0016261878,0.1935034],"study_design_scores_gemma":[0.00032699242,0.0000912505,2.0687441e-8,0.5196818,0.006134584,0.00024582606,0.0000075678236,0.000005732181,0.0000017808908,0.0000010176971,0.47331074,0.0001926692],"about_ca_topic_score_codex":0.000021215712,"about_ca_topic_score_gemma":0.0000027255833,"teacher_disagreement_score":0.47168455,"about_ca_system_score_codex":0.00012974288,"about_ca_system_score_gemma":0.00041771244,"threshold_uncertainty_score":0.9997843},"labels":[],"label_agreement":null},{"id":"W3021372031","doi":"10.1016/j.cjca.2020.04.025","title":"Bayesian Clinical Trials: The Art of Moving Forward While Looking Back","year":2020,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill Genome Centre; McGill University Health Centre","funders":"","keywords":"Medicine; Coronary artery disease; Dyslipidemia; Test (biology); Stress testing (software); Family history; Disease; Stress test; Medical history; Diabetes mellitus; Internal medicine; Cardiology","score_opus":0.08620145312491839,"score_gpt":0.33679371935001295,"score_spread":0.25059226622509456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021372031","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025060895,0.009879475,0.011975764,0.9505264,0.0050535076,0.0010582542,0.00012820435,0.000008276619,0.02111949],"genre_scores_gemma":[0.092354104,0.0015671046,0.00086686434,0.76113623,0.14281672,0.000014994234,0.000122451,0.0001791414,0.0009424078],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925931,0.0034915332,0.0024627424,0.00031828936,0.000520096,0.00061421766],"domain_scores_gemma":[0.9954282,0.00095815206,0.0014637427,0.00077868445,0.0005113407,0.0008598539],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.009532693,0.00031334185,0.0041912072,0.00032855477,0.00010485985,0.000028216333,0.00048210478,0.001070232,0.00018382198],"category_scores_gemma":[0.0039770314,0.00020308325,0.0038780654,0.00020202849,0.00039760373,0.00004505981,0.000031024578,0.004408659,0.000058875325],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006612088,8.898788e-7,0.001850554,0.00024908796,0.002707844,0.003071595,0.000055885648,0.00004582395,0.0000033783983,0.000008395193,0.97731733,0.014623094],"study_design_scores_gemma":[0.0012722574,0.000582953,0.00080132583,0.0004106618,0.0017114577,0.0031348353,0.00008142284,0.000014134688,0.0000068809686,0.00013023155,0.9916933,0.00016049291],"about_ca_topic_score_codex":0.00060443894,"about_ca_topic_score_gemma":0.0003327651,"teacher_disagreement_score":0.18939021,"about_ca_system_score_codex":0.00022940048,"about_ca_system_score_gemma":0.0070564863,"threshold_uncertainty_score":0.9985726},"labels":[],"label_agreement":null},{"id":"W3021844096","doi":"","title":"Low-density lipoprotein apheresis: an evidence-based analysis.","year":2007,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Apheresis; Medicine; Internal medicine; Platelet","score_opus":0.03880362794060258,"score_gpt":0.27001189106204593,"score_spread":0.23120826312144335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021844096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98232514,0.001862957,0.011268024,0.000879184,0.00013725465,0.0021259994,0.0000026411994,0.0002048813,0.001193934],"genre_scores_gemma":[0.99549025,0.000051225405,0.0010162249,0.0017927636,0.0007505245,0.00050521735,0.000020752293,0.000028199638,0.00034485036],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972644,0.00014828773,0.00040956293,0.0005195315,0.00091443874,0.00074380776],"domain_scores_gemma":[0.9976123,0.000065759676,0.00011081077,0.0012287063,0.00021643174,0.00076598406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004577272,0.00020214987,0.0006205386,0.0003510431,0.00011930224,0.00004036062,0.00015123482,0.0001693304,0.000082953455],"category_scores_gemma":[0.00042075108,0.00016787417,0.0006384852,0.0012917315,0.00006916286,0.00019595133,0.000030625775,0.00026327962,0.000027468739],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007217356,0.00037364895,0.030474573,0.00024032056,0.0011961332,0.00026722334,0.000052090945,0.000059442616,0.0001958898,0.00005962581,0.00016330158,0.966196],"study_design_scores_gemma":[0.001010696,0.00009249774,0.9768237,0.00005357739,0.0013365875,0.000010948391,0.00005797724,0.00013035601,0.019038241,0.00002536691,0.0012267309,0.0001933474],"about_ca_topic_score_codex":0.0022298389,"about_ca_topic_score_gemma":0.0013586052,"teacher_disagreement_score":0.96600264,"about_ca_system_score_codex":0.00019814193,"about_ca_system_score_gemma":0.00013991792,"threshold_uncertainty_score":0.68457097},"labels":[],"label_agreement":null},{"id":"W3022401702","doi":"10.1097/01.ogx.0000344393.60303.0a","title":"Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein","year":2009,"lang":"en","type":"article","venue":"Obstetrical & Gynecological Survey","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3658,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Rosuvastatin; Medicine; Placebo; Hazard ratio; C-reactive protein; Rosuvastatin Calcium; Internal medicine; Confidence interval; Unstable angina; Myocardial infarction; Statin; Cardiology; Randomization; Cholesterol; Liter; Randomized controlled trial; Gastroenterology; Endocrinology; Inflammation; Pathology","score_opus":0.017304648486986984,"score_gpt":0.265517344455447,"score_spread":0.24821269596846002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022401702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545026,0.00034299606,0.00021836348,0.0004117472,0.000022992313,0.0029464052,0.000010066247,0.000062838444,0.00053431327],"genre_scores_gemma":[0.99761134,0.000027005495,0.0010959209,0.00062299334,0.00003026324,0.00032242818,0.000025779851,0.000018765215,0.00024552486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662507,0.00081270386,0.0004249152,0.00066502026,0.00072584325,0.00074643083],"domain_scores_gemma":[0.9981644,0.00049506716,0.00007820269,0.00039511514,0.00015721089,0.00070997485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017355463,0.0002797887,0.0008341649,0.00017944389,0.00007211135,0.000018163864,0.0001206964,0.00021142296,0.00010921172],"category_scores_gemma":[0.004031269,0.00018234583,0.00008772462,0.0013941069,0.00004091924,0.00007138209,0.000069925234,0.00044742963,0.00003098409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007182753,0.012368798,0.52178776,0.00025776547,0.0009699666,0.0014093078,0.0019057338,0.00013893937,0.009774854,0.00024961628,0.00025544933,0.44369906],"study_design_scores_gemma":[0.002859046,0.0050336733,0.9903533,0.000060745922,0.000022368702,0.000012858268,0.00013187496,0.000033778655,0.00038518064,0.0001673178,0.00069050887,0.00024937483],"about_ca_topic_score_codex":0.0004213509,"about_ca_topic_score_gemma":0.000057579724,"teacher_disagreement_score":0.46856552,"about_ca_system_score_codex":0.00062263734,"about_ca_system_score_gemma":0.00013377517,"threshold_uncertainty_score":0.7435847},"labels":[],"label_agreement":null},{"id":"W3022660031","doi":"10.1016/j.phrs.2020.104891","title":"Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic","year":2020,"lang":"en","type":"article","venue":"Pharmacological Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Amryt Pharma; Novo Nordisk; Sanofi; Valeant Pharmaceuticals International; Servier; Amgen; Pfizer; Bayer","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Medicine; Medical prescription; Intensive care medicine; Familial hypercholesterolemia; Disease; Medical emergency; Pharmacology; Infectious disease (medical specialty); Internal medicine; Cholesterol","score_opus":0.19086966900737312,"score_gpt":0.43068897287606217,"score_spread":0.23981930386868905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022660031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94454134,0.000042049796,0.00006133436,0.05186903,0.000027562679,0.0018543251,0.000020696252,0.000032389853,0.0015512978],"genre_scores_gemma":[0.9859378,0.00070413563,0.00006214214,0.012746538,0.00014919888,0.00027093934,0.000012022805,0.000011231174,0.00010603877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739754,0.0006248865,0.00020706112,0.00028664272,0.0011341457,0.0003497371],"domain_scores_gemma":[0.99875045,0.00036418348,0.0000390534,0.00027076705,0.00023038842,0.00034516345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012801655,0.00009955671,0.00018473208,0.000035099918,0.00037499325,0.00001730795,0.00028295748,0.000046629855,0.00043486105],"category_scores_gemma":[0.0003105673,0.00004298861,0.00009455655,0.0004307639,0.00022401703,0.000026726773,0.00020713136,0.0008366103,0.000035041456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038475804,0.005158116,0.6008001,0.0052995533,0.0061759916,0.00068190205,0.00527934,0.00055232074,0.015910452,0.0073465747,0.060386244,0.25393364],"study_design_scores_gemma":[0.023269746,0.004405933,0.80325353,0.00025328033,0.00047311053,0.000026467456,0.0024872078,0.00036579446,0.003061434,0.00018495736,0.1618924,0.0003261553],"about_ca_topic_score_codex":0.00006764821,"about_ca_topic_score_gemma":0.0000034519674,"teacher_disagreement_score":0.25360748,"about_ca_system_score_codex":0.00018830468,"about_ca_system_score_gemma":0.00010214799,"threshold_uncertainty_score":0.47614238},"labels":[],"label_agreement":null},{"id":"W3022979041","doi":"10.1016/j.jneb.2019.05.591","title":"The Impact of Nutrition and Statins on Cardiovascular Diseases","year":2019,"lang":"en","type":"article","venue":"Journal of Nutrition Education and Behavior","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Medical education; Gerontology; Engineering ethics; Engineering; Internal medicine","score_opus":0.012444650524518137,"score_gpt":0.31664777620072465,"score_spread":0.3042031256762065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022979041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832564,0.015407668,0.0000103176335,0.00041274598,0.00023540633,0.0006170742,0.000016468215,0.0000033922163,0.000040503033],"genre_scores_gemma":[0.9913709,0.007861411,0.0002227854,0.000039826653,0.00039077288,0.000049193404,0.000012615236,0.000008163093,0.000044312368],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991521,0.00007355451,0.0002735121,0.00008552069,0.0003296843,0.00008559314],"domain_scores_gemma":[0.9991272,0.000040196966,0.00016752342,0.00018200146,0.0003372687,0.0001458074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003029513,0.00007737488,0.00028938733,0.000115315575,0.000065969434,0.000024740499,0.000028755217,0.000042277083,0.000022856259],"category_scores_gemma":[0.00003952414,0.0000473726,0.00039311295,0.00009234306,0.0000404672,0.000098033204,0.0000054829684,0.00012424782,0.0000013689819],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085212983,0.04181365,0.15053748,0.0022354412,0.0012142952,0.000025803572,0.000586937,0.000008226286,0.0068230466,0.00035875835,0.0062703947,0.78927386],"study_design_scores_gemma":[0.0032569284,0.0017061447,0.9821866,0.00058495655,0.0006983746,0.00057873636,0.0016400628,0.000004620853,0.0004922821,0.00011370799,0.008669446,0.0000681469],"about_ca_topic_score_codex":0.000044021588,"about_ca_topic_score_gemma":5.5201696e-7,"teacher_disagreement_score":0.8316491,"about_ca_system_score_codex":0.0000726986,"about_ca_system_score_gemma":0.00021690576,"threshold_uncertainty_score":0.19317986},"labels":[],"label_agreement":null},{"id":"W3023514887","doi":"10.1155/2020/7026530","title":"Comparing the Effect of Combining Exercise with Rosuvastatin versus Atorvastatin on Lipid Profile and Functional Capacity: A Retrospective Cohort Study","year":2020,"lang":"en","type":"article","venue":"BioMed Research International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton; Université de Sherbrooke; Regional Municipality of Durham; University of New Brunswick; Université de Montréal; Vitalité Health Network; University of Manitoba","funders":"Fondation de la recherche en santé du Nouveau-Brunswick","keywords":"Rosuvastatin; Atorvastatin; Medicine; Statin; Confounding; Internal medicine; Cohort; Cholesterol; Retrospective cohort study; Cohort study; Rosuvastatin Calcium; Physical therapy","score_opus":0.08039177686063344,"score_gpt":0.3448333413304952,"score_spread":0.2644415644698618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023514887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99482703,0.00003629685,0.000095387055,0.0011187706,0.00024765002,0.0021670198,0.000027619853,0.000025277808,0.0014549204],"genre_scores_gemma":[0.9989851,0.00001201761,0.00015302337,0.000026197766,0.00038396055,0.0003195547,0.000041819192,0.000018814326,0.000059479775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667656,0.00034742046,0.00021429124,0.00035728223,0.0021707374,0.00023371622],"domain_scores_gemma":[0.9987736,0.0003328746,0.00007463428,0.00022198725,0.00041647337,0.00018043199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023906806,0.00012611634,0.00036911495,0.00016199544,0.00017341819,0.0000440262,0.00011676996,0.000034248795,0.00009145352],"category_scores_gemma":[0.0005603452,0.00007506722,0.000069950576,0.00040806795,0.00026942085,0.00005492851,0.00011507368,0.00049279636,0.000013807579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014415979,0.00026378565,0.976368,0.00016480921,0.0011794354,0.000039645118,0.0014117574,0.000017125407,0.0010980791,0.00029400288,0.0014265073,0.003320876],"study_design_scores_gemma":[0.009882904,0.009350456,0.9736809,0.00019269584,0.00008041696,0.0000140304555,0.0010627008,0.0019795962,0.003250933,0.0000059830068,0.0004110088,0.000088367604],"about_ca_topic_score_codex":0.0003382796,"about_ca_topic_score_gemma":0.000017650576,"teacher_disagreement_score":0.00908667,"about_ca_system_score_codex":0.00018555847,"about_ca_system_score_gemma":0.00012274452,"threshold_uncertainty_score":0.30611524},"labels":[],"label_agreement":null},{"id":"W3024335606","doi":"10.22374/cjgim.v15i1.343","title":"Rhabdomyolysis as a Side Effect of the Drug Interaction between Atorvastatin and Sacubitril/Valsartan","year":2020,"lang":"en","type":"article","venue":"Canadian Journal of General Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Sacubitril, Valsartan; Medicine; Rhabdomyolysis; Atorvastatin; Sacubitril; Statin; Internal medicine; Valsartan; Pharmacology","score_opus":0.014056876022520535,"score_gpt":0.2764005756522314,"score_spread":0.2623436996297109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024335606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771651,0.0030742632,0.00020177494,0.017967265,0.00047132585,0.00023883497,0.000007441617,0.000003304902,0.0008707015],"genre_scores_gemma":[0.9950065,0.000087438355,0.000115733485,0.0020721648,0.0024536778,0.0000018461196,0.0000023241462,0.000020238302,0.00024006568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982747,0.00025176618,0.0006426106,0.0001455536,0.00046754588,0.00021784953],"domain_scores_gemma":[0.9979518,0.000117603246,0.00039628736,0.00018866788,0.00021654346,0.0011291128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085354847,0.00016578716,0.0009442996,0.0001797197,0.000067067806,0.000012960241,0.00017209616,0.000055116892,0.00014479275],"category_scores_gemma":[0.00092463294,0.00009311969,0.00030079015,0.0002459386,0.0001824168,0.0000782821,0.000021878452,0.0005252222,0.0000033138012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016830752,0.000023485742,0.66693604,0.0012720338,0.0032056542,0.0016905331,0.007963176,0.00006306937,0.038781654,0.00013679265,0.03362638,0.24461809],"study_design_scores_gemma":[0.028381914,0.024725687,0.46514854,0.0133025255,0.009478062,0.013615983,0.0038290168,0.0010628509,0.2853286,0.00046236254,0.15370151,0.00096292264],"about_ca_topic_score_codex":0.028581169,"about_ca_topic_score_gemma":0.0019170025,"teacher_disagreement_score":0.24654695,"about_ca_system_score_codex":0.0001411805,"about_ca_system_score_gemma":0.00054358586,"threshold_uncertainty_score":0.9778876},"labels":[],"label_agreement":null},{"id":"W3025439780","doi":"10.1111/hdi.12839","title":"Alirocumab in a high cardiovascular risk patient on hemodialysis with liver abnormalities","year":2020,"lang":"en","type":"article","venue":"Hemodialysis International","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Alirocumab; Ezetimibe; Hemodialysis; Hyperlipidemia; Statin; Internal medicine; Gastroenterology; Cholesterol; Endocrinology; Lipoprotein; Diabetes mellitus","score_opus":0.012397506187731026,"score_gpt":0.21548514087757606,"score_spread":0.20308763468984503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025439780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896489,0.00077292114,0.0026633607,0.001714845,0.00015578915,0.0005492057,0.000072716335,0.00008239555,0.0043398836],"genre_scores_gemma":[0.99448174,0.00059934123,0.0016295944,0.0021637678,0.00074201956,0.00012701265,0.00014997066,0.00003944564,0.00006713467],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99673533,0.00021474979,0.00045807328,0.00061007624,0.0016691819,0.00031255785],"domain_scores_gemma":[0.9987235,0.000054826352,0.00013768957,0.00060107216,0.00023063301,0.00025228842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004613127,0.0002705652,0.00078782934,0.00028381383,0.00007900945,0.000048298916,0.00017991956,0.000110957924,0.00043476123],"category_scores_gemma":[0.000188639,0.00021614524,0.00091803237,0.00046369428,0.00006321195,0.00013494029,0.000074832504,0.00037290718,0.00012573149],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008239842,0.0018189711,0.19686164,0.0005285295,0.032418817,0.004006812,0.011974837,0.062180612,0.00013135423,0.003266552,0.002848661,0.6757234],"study_design_scores_gemma":[0.05026407,0.005164468,0.609626,0.00096115,0.0101688225,0.0005045705,0.0037595134,0.04058241,0.018011134,0.00049818074,0.2572541,0.0032056],"about_ca_topic_score_codex":0.0024166876,"about_ca_topic_score_gemma":0.00008558681,"teacher_disagreement_score":0.6725178,"about_ca_system_score_codex":0.00030114275,"about_ca_system_score_gemma":0.00013711402,"threshold_uncertainty_score":0.8814147},"labels":[],"label_agreement":null},{"id":"W3025648277","doi":"10.1111/dom.14084","title":"Goal achievement of <scp>HbA1c</scp> and <scp>LDL‐</scp> cholesterol in a randomized trial comparing colesevelam with ezetimibe: <scp>GOAL‐RCT</scp>","year":2020,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); Mount Sinai Hospital","funders":"","keywords":"Ezetimibe; Medicine; Internal medicine; Gastroenterology; Randomized controlled trial; Type 2 diabetes; Discontinuation; Cholesterol; Statin; Endocrinology; Diabetes mellitus","score_opus":0.01245808594523028,"score_gpt":0.2262069639989136,"score_spread":0.2137488780536833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025648277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98038286,0.013056685,0.0002771758,0.00025829163,0.00025376957,0.0047298907,0.000047400918,0.00010553999,0.0008884015],"genre_scores_gemma":[0.9936613,0.0022784579,0.0010363181,0.0015319452,0.00075281947,0.00033088116,0.00007882422,0.00008148138,0.00024800518],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948347,0.0008234198,0.0011802354,0.0009909709,0.001111177,0.0010594748],"domain_scores_gemma":[0.99678254,0.0009674961,0.0005059047,0.00063639716,0.00021867437,0.0008889576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029293806,0.0006860478,0.0039248513,0.00032337641,0.00023395859,0.00013120232,0.00027392438,0.00035746468,0.0000037810266],"category_scores_gemma":[0.001882714,0.0005481431,0.00054967275,0.00063431385,0.0004973978,0.00030246892,0.00030796445,0.00087722734,0.000009212106],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04228784,0.007717908,0.8234743,0.014149667,0.012870747,0.0003445316,0.042845365,0.0003954764,0.020174649,0.0038146826,0.0040575056,0.027867354],"study_design_scores_gemma":[0.59383565,0.00076347933,0.37590915,0.00056821073,0.0019932925,0.000016555972,0.0011782378,0.0009500875,0.010682846,0.00011944273,0.01386107,0.00012200784],"about_ca_topic_score_codex":0.00034067553,"about_ca_topic_score_gemma":0.00007853064,"teacher_disagreement_score":0.55154777,"about_ca_system_score_codex":0.00004256382,"about_ca_system_score_gemma":0.00025897534,"threshold_uncertainty_score":0.999697},"labels":[],"label_agreement":null},{"id":"W3025904056","doi":"10.5546/aap.2019.eng.41","title":"Parental hypercholesterolemia and family medical history as predictors of hypercholesterolemia in their children","year":2019,"lang":"en","type":"article","venue":"Archivos Argentinos de Pediatria","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Odds ratio; Family history; Confidence interval; Predictive value; Internal medicine; Familial hypercholesterolemia; Cholesterol; Medical history; Likelihood ratios in diagnostic testing","score_opus":0.00872223471935047,"score_gpt":0.2277185719315539,"score_spread":0.21899633721220343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025904056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99254197,0.0040123146,0.000013827314,0.00016829536,0.00037625546,0.001038849,0.000031090396,0.000051704086,0.0017656919],"genre_scores_gemma":[0.9963619,0.0017329843,0.00018139489,0.00078180915,0.00063951424,0.000035189685,0.00007781428,0.00005208738,0.00013727866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99717385,0.00025337702,0.00066567695,0.0005390251,0.000801291,0.00056680443],"domain_scores_gemma":[0.998527,0.00009760568,0.00014189536,0.00064273115,0.000039742747,0.00055103615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010912368,0.0002831474,0.00073404104,0.00027685342,0.000030159266,0.000009179569,0.0002355337,0.00023570152,0.0002050057],"category_scores_gemma":[0.00015260713,0.00024204142,0.00026463205,0.00013264116,0.00014861916,0.00009864616,0.00019773307,0.0006784181,0.000058056117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023703057,0.00019627341,0.9868233,0.00023338682,0.00013257889,0.00003113366,0.0010249133,0.000002402906,0.003735996,0.000049658796,0.0003391808,0.007194118],"study_design_scores_gemma":[0.004593906,0.0003951205,0.9904773,0.00017695117,0.00012780694,0.0003620471,0.00017233647,0.000082630184,0.00025443465,0.00006130621,0.0030951358,0.00020100574],"about_ca_topic_score_codex":0.00073933194,"about_ca_topic_score_gemma":0.000039579372,"teacher_disagreement_score":0.006993112,"about_ca_system_score_codex":0.00019047869,"about_ca_system_score_gemma":0.0007745472,"threshold_uncertainty_score":0.98701626},"labels":[],"label_agreement":null},{"id":"W3025995639","doi":"10.1016/j.tcm.2020.04.001","title":"Editorial Commentary: What Determines the Risk of Cardiovascular Disease in Familial Hypercholesterolemia?","year":2020,"lang":"en","type":"review","venue":"Trends in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Familial hypercholesterolemia; Disease; Medicine; Atherosclerotic cardiovascular disease; Cardiology; Internal medicine; Intensive care medicine; Cholesterol","score_opus":0.036733727018452705,"score_gpt":0.3156682101060133,"score_spread":0.27893448308756064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025995639","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012488633,0.973866,0.00004296891,0.0007509607,0.022231836,0.0026707062,0.00012454703,0.00006954646,0.00011853888],"genre_scores_gemma":[0.0005046899,0.9130315,0.000048522852,0.00026936288,0.084728226,0.00061365525,0.0005689106,0.0002172353,0.0000179001],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9870978,0.003398416,0.0025157575,0.0017339672,0.0042715506,0.0009825106],"domain_scores_gemma":[0.99277735,0.000393057,0.00049366115,0.0054125357,0.00019984064,0.0007235545],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0075088004,0.0013842802,0.011918004,0.0012813841,0.00011997024,0.000045385463,0.0009743023,0.0008029323,0.000042319753],"category_scores_gemma":[0.0007464814,0.00085763715,0.013060469,0.0028649368,0.00067263586,0.0002654829,0.0004108549,0.0029271008,0.000015854359],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019357931,0.00013942481,0.0002354198,0.010375876,0.017203527,0.0010336218,0.0003471506,0.00023792728,8.74515e-8,0.0000020063992,0.0048930184,0.96533835],"study_design_scores_gemma":[0.006908779,0.00035450325,0.0006814399,0.025510117,0.044640683,0.0001456299,0.00024406094,0.000035141722,4.1791392e-7,0.00001139743,0.9208706,0.0005972056],"about_ca_topic_score_codex":0.0054421346,"about_ca_topic_score_gemma":0.00010463262,"teacher_disagreement_score":0.9647412,"about_ca_system_score_codex":0.00074691814,"about_ca_system_score_gemma":0.00059710885,"threshold_uncertainty_score":0.99989074},"labels":[],"label_agreement":null},{"id":"W3027509627","doi":"10.1152/ajpendo.00125.2020","title":"Statins activate the NLRP3 inflammasome and impair insulin signaling via p38 and mTOR","year":2020,"lang":"en","type":"article","venue":"American Journal of Physiology-Endocrinology and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Canadian Institutes of Health Research; Government of Canada","keywords":"Insulin resistance; Inflammasome; Internal medicine; Adipose tissue; Endocrinology; GLUT4; Protein kinase B; Statin; Insulin; PI3K/AKT/mTOR pathway; Atorvastatin; Insulin receptor; Biology; Chemistry; Medicine; Inflammation; Signal transduction; Cell biology","score_opus":0.010552496819007214,"score_gpt":0.2447252634829004,"score_spread":0.2341727666638932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027509627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806598,0.011209809,0.0001852772,0.007587276,0.000115882314,0.00020004621,0.0000058600353,0.000016904125,0.000019160745],"genre_scores_gemma":[0.9856253,0.008683378,0.0009866974,0.0038528724,0.00081977755,0.000006765416,0.0000014616444,0.000017938288,0.000005782257],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984431,0.00037264256,0.00040770957,0.00025758194,0.00015404877,0.00036487042],"domain_scores_gemma":[0.9988236,0.00016457516,0.00039545484,0.00017410867,0.00011955873,0.000322721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029410006,0.00020293058,0.0009397552,0.000087678716,0.00017161034,0.000011894481,0.00009657767,0.000053760563,0.000016513855],"category_scores_gemma":[0.00015382953,0.0001232937,0.00013971562,0.00016984339,0.00089400774,0.00011580943,0.000105880215,0.0007223909,0.0000017350013],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015229214,0.00007192386,0.0027221448,0.00012822112,0.0013634418,0.00013908732,0.0028546762,0.00001269683,0.585764,0.0007676271,0.00009148894,0.40456182],"study_design_scores_gemma":[0.005750126,0.002889663,0.935617,0.000054640066,0.0009063464,0.00417591,0.003680786,0.00008683236,0.013355949,0.0011620753,0.032015007,0.00030561147],"about_ca_topic_score_codex":0.00008350401,"about_ca_topic_score_gemma":0.0000013714725,"teacher_disagreement_score":0.9328949,"about_ca_system_score_codex":0.000009103371,"about_ca_system_score_gemma":0.00010925473,"threshold_uncertainty_score":0.50277716},"labels":[],"label_agreement":null},{"id":"W3027606422","doi":"10.1056/nejmc2004861","title":"Lipoprotein(a) Reduction in Persons with Cardiovascular Disease","year":2020,"lang":"en","type":"letter","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Lipoprotein(a); Disease; Reduction (mathematics); Atherosclerotic cardiovascular disease; Lipoprotein; Cardiology; Internal medicine; Cholesterol","score_opus":0.020591402521326387,"score_gpt":0.24215180656865068,"score_spread":0.2215604040473243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027606422","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047084526,0.036808632,0.0008790211,0.9549606,0.00094522734,0.00096052047,0.00000639311,0.000030088468,0.0007010652],"genre_scores_gemma":[0.10516623,0.0101892445,0.0025396524,0.4881313,0.38998574,0.000049327144,0.00029612347,0.00040320327,0.003239141],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99514705,0.0003593509,0.00083920744,0.00044641967,0.0027680802,0.0004398718],"domain_scores_gemma":[0.99756855,0.000048716942,0.0004423983,0.0008070176,0.00029768178,0.00083565136],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0014013705,0.0004494818,0.002127644,0.0005333857,0.000055776934,0.000015807398,0.0002027378,0.00031050766,0.00011201062],"category_scores_gemma":[0.00040302039,0.00027487281,0.0008268412,0.0004977121,0.00017096834,0.00010311146,0.000024552859,0.003969529,0.000005788153],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002590457,0.000053134332,0.0002521978,0.0015163029,0.003575548,0.06418196,0.0009386001,0.00010784369,0.000042665364,0.0000045878865,0.70085204,0.22588466],"study_design_scores_gemma":[0.043932516,0.0024052646,0.00076980947,0.004015998,0.003960221,0.013603571,0.00014102961,0.000013261161,0.000017690165,0.000094318064,0.9307888,0.00025749663],"about_ca_topic_score_codex":0.0009341587,"about_ca_topic_score_gemma":0.000011277147,"teacher_disagreement_score":0.46682927,"about_ca_system_score_codex":0.0002612525,"about_ca_system_score_gemma":0.0015532046,"threshold_uncertainty_score":0.9999703},"labels":[],"label_agreement":null},{"id":"W3027623583","doi":"10.3390/life10050073","title":"Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolemia: A Propensity Score Analysis","year":2020,"lang":"en","type":"article","venue":"Life","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"British Heart Foundation; Heart and Stroke Foundation of British Columbia and Yukon","keywords":"Rosuvastatin; Familial hypercholesterolemia; Medicine; Internal medicine; Polygenic risk score; Apolipoprotein B; Propensity score matching; Gastroenterology; Cholesterol; Endocrinology; Genetics; Biology; Gene; Genotype","score_opus":0.08746032301922682,"score_gpt":0.2989107516019167,"score_spread":0.2114504285826899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027623583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907256,0.00050910236,0.00028414154,0.007362224,0.00010628042,0.00073117524,0.000011605557,0.000055355827,0.00021453734],"genre_scores_gemma":[0.99162537,0.000022369244,0.0003955647,0.0074037025,0.0003045694,0.00005864525,0.000020489017,0.000026474147,0.00014281394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824697,0.0001925467,0.0003212998,0.0004672569,0.00044209673,0.00032982303],"domain_scores_gemma":[0.9986629,0.000035276415,0.00004700946,0.0005366296,0.00008754927,0.0006306279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038908565,0.0001649949,0.00067359564,0.000197883,0.000044783184,0.000022294387,0.00011979313,0.00010130687,0.00010728846],"category_scores_gemma":[0.00029288247,0.00014319774,0.00033971661,0.0016324642,0.000022054895,0.0000564132,0.00010117724,0.00027910914,0.0001322901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03739788,0.00045207716,0.89703435,0.0006971796,0.0058005974,0.0013969152,0.00483231,0.002302524,0.019405572,0.00014270534,0.0016971478,0.028840728],"study_design_scores_gemma":[0.004192614,0.0005607665,0.9884776,0.000043893346,0.0008135194,0.0000052798464,0.00013696696,0.0001179397,0.0009362091,0.0000024255355,0.0045220405,0.0001907372],"about_ca_topic_score_codex":0.00047994702,"about_ca_topic_score_gemma":0.00020099153,"teacher_disagreement_score":0.09144325,"about_ca_system_score_codex":0.00011835787,"about_ca_system_score_gemma":0.00032921243,"threshold_uncertainty_score":0.5839434},"labels":[],"label_agreement":null},{"id":"W3028277312","doi":"10.1016/j.jacc.2020.03.065","title":"Ascertainment Bias in the Association Between Elevated Lipoprotein(a) and Familial Hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Association (psychology); Lipoprotein(a); Cardiology; Lipoprotein; Cholesterol","score_opus":0.02870089066686809,"score_gpt":0.2749938475911257,"score_spread":0.24629295692425762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028277312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779488,0.00031673608,0.000092406255,0.020892026,0.00007993882,0.00041401864,0.000025141953,0.000003118839,0.00022782199],"genre_scores_gemma":[0.9965476,0.00028689858,0.00016034234,0.002058767,0.00091765856,0.0000053510853,8.95668e-7,0.000010289775,0.000012225299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975698,0.0009990146,0.00052649557,0.00011918985,0.0005957367,0.00018977224],"domain_scores_gemma":[0.99860936,0.00022124326,0.0006810603,0.0002412648,0.00015361584,0.00009345327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020495148,0.00010913787,0.00097140495,0.00006635032,0.000044728382,0.000004564375,0.00021254086,0.000069651054,0.000001054166],"category_scores_gemma":[0.000713109,0.000058904036,0.0003832355,0.00042118228,0.00013908192,0.00003181556,0.000059618622,0.0004985922,6.9246113e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009166235,0.000033207838,0.97427493,0.000092637376,0.0014529245,0.00019421136,0.0005088141,0.00015837474,0.0053500063,0.00004751131,0.0022935474,0.014677188],"study_design_scores_gemma":[0.0019910655,0.0015787807,0.97980106,0.000057373967,0.0004364909,0.00045842418,0.0012987634,0.000018004766,0.0005849082,0.00005565088,0.013651631,0.00006782675],"about_ca_topic_score_codex":0.00008574518,"about_ca_topic_score_gemma":0.00000638294,"teacher_disagreement_score":0.01883326,"about_ca_system_score_codex":0.00016023795,"about_ca_system_score_gemma":0.0002092251,"threshold_uncertainty_score":0.2402037},"labels":[],"label_agreement":null},{"id":"W3028800184","doi":"10.1161/circulationaha.119.044795","title":"Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease","year":2020,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":555,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Daiichi Sankyo Europe; Imperial College London; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Sanofi; Mylan; Pfizer; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Population; Disease; MEDLINE; Meta-analysis; Ethnic group; Demography; Internal medicine; Pediatrics; Gerontology; Environmental health; Cholesterol","score_opus":0.02409479612430166,"score_gpt":0.2589432795362966,"score_spread":0.23484848341199493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028800184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23817308,0.7588794,0.00021461939,0.0000076151605,0.00006061503,0.0025975865,0.000035689056,0.000022589733,0.000008803999],"genre_scores_gemma":[0.35465652,0.6446376,0.00004612997,0.000017047689,0.0002632161,0.000095948715,0.0002303539,0.000047826303,0.0000053807776],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99786705,0.00028796558,0.00044049203,0.00045850276,0.00078261795,0.00016339206],"domain_scores_gemma":[0.9986391,0.000021566122,0.00024341796,0.00080260955,0.000113076276,0.0001802392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031736848,0.0002787254,0.0011086867,0.00006421007,0.000087568704,0.000020041703,0.000087304514,0.00014808017,0.000003820542],"category_scores_gemma":[0.00006719994,0.00016937799,0.00069508445,0.00021144829,0.000088285546,0.00009537552,0.00004081712,0.0002469384,0.0000024975645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022593187,0.000029029197,0.24323662,0.026656339,0.0007175138,0.000004092586,0.00004836187,0.000111887195,1.4834491e-7,0.000012086843,0.0000012968165,0.72916],"study_design_scores_gemma":[0.000684191,0.000047685175,0.97273874,0.0057324935,0.0074306945,0.00000794081,0.0000025266872,0.00018248771,6.731241e-8,0.000005302427,0.0130021125,0.0001657823],"about_ca_topic_score_codex":0.00013730522,"about_ca_topic_score_gemma":0.0000011724248,"teacher_disagreement_score":0.7295021,"about_ca_system_score_codex":0.0001241905,"about_ca_system_score_gemma":0.00014810139,"threshold_uncertainty_score":0.6907034},"labels":[],"label_agreement":null},{"id":"W3029608756","doi":"10.1161/circulationaha.120.046961","title":"What Is Familial Hypercholesterolemia, and Why Does It Matter?","year":2020,"lang":"en","type":"letter","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Human Genome Research Institute; Canadian Institutes of Health Research","keywords":"Medicine; Familial hypercholesterolemia; Cardiology; Internal medicine; Cholesterol","score_opus":0.020644163938494595,"score_gpt":0.25494840024594845,"score_spread":0.23430423630745384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3029608756","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037879836,0.0017865414,0.00036481983,0.9576389,0.00096033234,0.0008635135,0.000024316123,0.00006490717,0.00041681255],"genre_scores_gemma":[0.03563639,0.00083671487,0.000092370996,0.95477104,0.0075798575,0.000039586062,0.0005550444,0.000071302326,0.00041770923],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981776,0.000091537615,0.00031024154,0.00056755083,0.00059733354,0.00025574464],"domain_scores_gemma":[0.9991199,0.00002083973,0.00010200379,0.00055628223,0.00008263291,0.00011838518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013271837,0.00026306332,0.00054888794,0.00009767644,0.000082011524,0.00015231458,0.00006697717,0.0005741006,0.00022086495],"category_scores_gemma":[0.000013304184,0.00020795105,0.0002557446,0.00009572685,0.000053422096,0.00024908717,0.000043246164,0.0009374254,0.00016735509],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002187336,0.000010624177,0.008979361,0.0019647786,0.00022913779,0.00028211824,0.00089299836,0.0000014012599,0.00030273903,0.0000010348969,0.9647579,0.022556039],"study_design_scores_gemma":[0.00086760195,0.000034523477,0.035357155,0.00062703434,0.00041799666,0.000186782,0.00013390968,0.00010830156,0.0000546105,0.00017787408,0.9617599,0.00027430142],"about_ca_topic_score_codex":0.00014188128,"about_ca_topic_score_gemma":0.000005247917,"teacher_disagreement_score":0.026377795,"about_ca_system_score_codex":0.00010786228,"about_ca_system_score_gemma":0.00007535196,"threshold_uncertainty_score":0.84799975},"labels":[],"label_agreement":null},{"id":"W3031008396","doi":"10.7759/cureus.8330","title":"Features of Rhabdomyolysis Secondary to Immobility and Statin-Induced Myopathy in a 70-Year-Old Female","year":2020,"lang":"en","type":"article","venue":"Cureus","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Hospital Edmonton; University of Alberta Hospital","funders":"","keywords":"Rhabdomyolysis; Medicine; Myopathy; Adverse effect; Statin; Creatine kinase; Internal medicine","score_opus":0.02007976655666907,"score_gpt":0.27288371017154517,"score_spread":0.2528039436148761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031008396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392265,0.0018162275,0.000053632266,0.0019945086,0.000047977854,0.0006432065,0.000022151995,0.000023640383,0.0014760214],"genre_scores_gemma":[0.99676764,0.00008308901,0.0011689407,0.001749321,0.00013492598,0.000031257787,0.000007464018,0.0000158838,0.00004146581],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988926,0.00007237504,0.0002562845,0.00031977938,0.00025719308,0.00020174737],"domain_scores_gemma":[0.999186,0.0000355203,0.000047233723,0.00038342757,0.000065865,0.0002819611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039470787,0.00011905987,0.00047963575,0.000046355803,0.000024526073,0.000008485751,0.00006706826,0.00008083888,0.00010190415],"category_scores_gemma":[0.00033000368,0.00010216463,0.00012482311,0.0002850498,0.000022046475,0.00004725577,0.00007351642,0.00023364785,0.0000071659165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032411667,0.00091411907,0.21427171,0.0052988776,0.00090673595,0.0004488687,0.030543784,0.000010840678,0.17160691,0.00091146457,0.0038222068,0.5680233],"study_design_scores_gemma":[0.0031963685,0.0017758051,0.9280202,0.0001550893,0.00013007941,0.00002989926,0.0027039312,0.000016544536,0.060831923,0.00008371326,0.0028292208,0.00022727659],"about_ca_topic_score_codex":0.0012342171,"about_ca_topic_score_gemma":0.00019660249,"teacher_disagreement_score":0.71374846,"about_ca_system_score_codex":0.000047236215,"about_ca_system_score_gemma":0.00014744503,"threshold_uncertainty_score":0.41661528},"labels":[],"label_agreement":null},{"id":"W3031879468","doi":"10.1016/j.atherosclerosis.2020.05.013","title":"Molecular mechanism linking a novel PCSK9 copy number variant to severe hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Mechanism (biology); Familial hypercholesterolemia; Computational biology; Chemistry; Biology; LDL receptor; Cholesterol; Biochemistry; Lipoprotein; Physics","score_opus":0.032536847212538675,"score_gpt":0.26053525870464067,"score_spread":0.22799841149210198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031879468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9319568,0.000061667495,0.058045544,0.007125176,0.00014955821,0.0009594801,0.000029817129,0.00021103873,0.0014608924],"genre_scores_gemma":[0.952389,0.000038690927,0.014947325,0.031936858,0.0004044448,0.00009479678,0.000016652828,0.000102854596,0.00006938115],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978063,0.00006180858,0.00034418242,0.0006234545,0.00067071256,0.0004935604],"domain_scores_gemma":[0.9984395,0.000018818517,0.0000651864,0.0006664364,0.000115391085,0.00069469254],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035533396,0.00028758188,0.00056298595,0.0000372823,0.000117791205,0.00006251188,0.00020096355,0.0002029716,0.00017568331],"category_scores_gemma":[0.0000764222,0.00026172493,0.0003677338,0.00040978554,0.00002273618,0.00007912824,0.00015635298,0.00036122097,0.00061964296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021226739,0.00027189395,0.0048565473,0.0003626222,0.0005332341,0.00010978062,0.0029605592,0.0001152198,0.97228014,0.004031569,0.00046475334,0.013801417],"study_design_scores_gemma":[0.03140214,0.004330792,0.07203788,0.0041246074,0.0027746463,0.0015278907,0.0017578965,0.0029209952,0.7422182,0.0012133678,0.13162115,0.004070405],"about_ca_topic_score_codex":0.00018665253,"about_ca_topic_score_gemma":0.000004470585,"teacher_disagreement_score":0.23006192,"about_ca_system_score_codex":0.000110713816,"about_ca_system_score_gemma":0.00012452363,"threshold_uncertainty_score":0.9999835},"labels":[],"label_agreement":null},{"id":"W3032951899","doi":"10.1093/ndt/gfaa139.so086","title":"SO086SNF472 CONSISTENTLY SLOWS PROGRESSION OF CORONARY CALCIFICATION IN PATIENTS ON HEMODIALYSIS: SUBGROUP ANALYSIS OF THE CALIPSO STUDY","year":2020,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Medicine; Placebo; Hemodialysis; Internal medicine; Population; Dialysis; Diabetes mellitus; Randomization; Coronary artery disease; Clinical endpoint; Coronary Calcium Score; Randomized controlled trial; Urology; Coronary artery calcium; Endocrinology","score_opus":0.01763062384398623,"score_gpt":0.27019391597575015,"score_spread":0.25256329213176393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032951899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974921,0.00006710787,0.00030606045,0.000509643,0.0000437425,0.0014456403,0.000054582855,0.000017442848,0.00006371962],"genre_scores_gemma":[0.9987256,0.00008506437,0.000064796084,0.00058048556,0.000032394804,0.00008685927,0.0004094937,0.000012955386,0.0000023363446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973209,0.00061435986,0.00079044845,0.00039771938,0.000700212,0.00017639842],"domain_scores_gemma":[0.998801,0.00008765343,0.0003561276,0.00048284445,0.00018972058,0.000082635626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005205418,0.00016538451,0.0008942297,0.00037051298,0.000057229277,0.000003643706,0.00012921722,0.00015015093,0.00002781595],"category_scores_gemma":[0.000052592914,0.00011841908,0.00056062284,0.0018285597,0.000104306106,0.00005263487,0.000012886964,0.00019008869,0.0000024103467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030684406,0.0014181157,0.9778903,0.00017307901,0.0027245383,0.000009235582,0.0038801671,0.0026579788,0.0020717415,0.000023755016,0.000008371783,0.00607424],"study_design_scores_gemma":[0.0046940977,0.0011658755,0.97888005,0.000035060497,0.01075925,7.506852e-7,0.00026896835,0.0022372813,0.0018580662,0.000003786144,0.00001220101,0.00008462586],"about_ca_topic_score_codex":0.00032537375,"about_ca_topic_score_gemma":0.0004683805,"teacher_disagreement_score":0.008034712,"about_ca_system_score_codex":0.000054073702,"about_ca_system_score_gemma":0.00008612778,"threshold_uncertainty_score":0.48289898},"labels":[],"label_agreement":null},{"id":"W3033499384","doi":"10.1038/s41586-020-2338-1","title":"Repositioning of the global epicentre of non-optimal cholesterol","year":2020,"lang":"en","type":"article","venue":"Nature","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":291,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Simon Fraser University; Hospital for Sick Children; Kingston Health Sciences Centre; Statistics Canada; McGill University; Université de Montréal; Public Health Agency of Canada; Dalhousie University","funders":"Fogarty International Center; Economic and Social Research Council; Novo Nordisk Fonden; Medical Research Council; Public Health Agency; National Institute for Health and Care Research; Lundbeckfonden; British Heart Foundation; Wellcome Trust","keywords":"Epicenter; Geology","score_opus":0.005890163650192219,"score_gpt":0.2560514856794711,"score_spread":0.2501613220292789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033499384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98825526,0.0013563066,0.0001827451,0.0069871903,0.00011056325,0.00029181037,0.00001706447,0.000011196534,0.0027878734],"genre_scores_gemma":[0.9966766,0.000011922843,0.000600314,0.0024636742,0.0002133061,0.000001572514,0.0000042730135,0.0000046176683,0.00002368768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993429,0.000023129132,0.00013776676,0.00010502305,0.00030914135,0.00008200643],"domain_scores_gemma":[0.9995308,0.0000039181355,0.00007566861,0.00024310658,0.00008561536,0.000060876268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008194064,0.000052572665,0.00018675177,0.000005559587,0.000023798191,0.000002497586,0.0000705731,0.00028480968,0.000013705054],"category_scores_gemma":[0.00006319163,0.000033124077,0.00019364156,0.00018507989,0.000025582187,0.000019104133,0.000035336787,0.00057636085,0.0000014170007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019781857,0.00074860326,0.7625877,0.007887079,0.0025026586,0.00022146548,0.0060254056,0.00097521354,0.07229526,0.0035846275,0.020249747,0.120944016],"study_design_scores_gemma":[0.002625163,0.00030797883,0.9185768,0.0005192247,0.00029949826,0.0001493826,0.00026704435,0.0004382055,0.067582145,0.000020711073,0.00911821,0.00009563349],"about_ca_topic_score_codex":0.000032349282,"about_ca_topic_score_gemma":0.0000021287397,"teacher_disagreement_score":0.15598907,"about_ca_system_score_codex":0.000024170306,"about_ca_system_score_gemma":0.0000792155,"threshold_uncertainty_score":0.2504033},"labels":[],"label_agreement":null},{"id":"W3034053585","doi":"10.1016/j.cjco.2020.06.002","title":"Effectiveness and Safety of Statin Therapy in Children: A Real-World Clinical Practice Experience","year":2020,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Interquartile range; Statin; Internal medicine; Triglyceride; Anthropometry; Cholesterol; Creatine kinase","score_opus":0.04119929463090741,"score_gpt":0.4063661503495544,"score_spread":0.36516685571864704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034053585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918636,0.000602835,0.00012602321,0.001139928,0.00002840124,0.0020524096,0.0000048613133,0.000009599555,0.004172319],"genre_scores_gemma":[0.9944833,0.0023014417,0.0017597195,0.0012705717,0.00008758857,0.00006233926,0.0000052758724,0.0000120450695,0.000017748001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998615,0.00046100144,0.00032914575,0.00027709885,0.00020086714,0.00011684309],"domain_scores_gemma":[0.9992092,0.00021970342,0.000093519244,0.00027915725,0.00005917352,0.00013923363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017327433,0.000079058555,0.0005339527,0.000021645661,0.000027394712,0.000015750962,0.00012232542,0.00004120961,0.000032944143],"category_scores_gemma":[0.0005158211,0.0000615371,0.00006136675,0.00023718545,0.00006589019,0.0001477601,0.000120041674,0.00018332574,0.0000032621142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006475438,0.00031504958,0.65593743,0.00015217833,0.00024654059,0.000059907834,0.0027414712,0.0000031168627,0.00033217558,0.0006802398,0.00008948262,0.33296695],"study_design_scores_gemma":[0.0057474533,0.000755844,0.98660773,0.00012330693,0.000022110651,0.000022679891,0.00034318914,0.000018151428,0.000810082,0.000012653809,0.0054679727,0.00006880569],"about_ca_topic_score_codex":0.0026739328,"about_ca_topic_score_gemma":0.00002682608,"teacher_disagreement_score":0.33289817,"about_ca_system_score_codex":0.000020794341,"about_ca_system_score_gemma":0.00016497898,"threshold_uncertainty_score":0.40422046},"labels":[],"label_agreement":null},{"id":"W3034075048","doi":"10.1016/j.cjca.2020.05.035","title":"Pediatric Lipid Screening and Treatment in Canada: Practices, Attitudes, and Barriers","year":2020,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; SickKids Foundation; University of Toronto; University of British Columbia; Hospital for Sick Children; Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Medicine; Dieticians; Dyslipidemia; Overweight; Family medicine; Pediatrics; Primary care; Obesity; Internal medicine","score_opus":0.025716173247845506,"score_gpt":0.25130258441413644,"score_spread":0.22558641116629094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034075048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97638905,0.015387455,0.000119050135,0.0072819153,0.00016066156,0.0001962106,0.000012797936,0.0000017771297,0.0004510597],"genre_scores_gemma":[0.9952666,0.0019733463,0.00024337652,0.0009008974,0.0015972328,0.0000022970319,0.0000017374728,0.000009771786,0.000004716477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991247,0.00012691237,0.00024535626,0.00013705058,0.000114985916,0.0002510031],"domain_scores_gemma":[0.9980646,0.000046865338,0.00016070876,0.00009161271,0.00006443783,0.0015717788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003146223,0.000097594886,0.00053133955,0.000121375684,0.000052747033,0.000011948817,0.00003975457,0.00006234105,0.00000839012],"category_scores_gemma":[0.0004406356,0.00008092157,0.000073137686,0.000117042684,0.00003827447,0.000053493863,0.0000071642676,0.00023411348,2.7154903e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053210613,4.216876e-7,0.9751347,0.00005177034,0.00020944804,0.002137038,0.00016175419,0.00013883137,0.0000058377527,0.000012064125,0.0011905902,0.020904385],"study_design_scores_gemma":[0.0021106594,0.00057336706,0.7813817,0.000024034505,0.00025992884,0.003164578,0.0005588194,0.000028993441,0.000004556644,0.0000021188184,0.21179575,0.00009545611],"about_ca_topic_score_codex":0.83323985,"about_ca_topic_score_gemma":0.8968693,"teacher_disagreement_score":0.21060516,"about_ca_system_score_codex":0.00043704093,"about_ca_system_score_gemma":0.011692227,"threshold_uncertainty_score":0.99391055},"labels":[],"label_agreement":null},{"id":"W3034162438","doi":"10.1097/mol.0000000000000686","title":"Evidence for improved survival with treatment of homozygous familial hypercholesterolemia","year":2020,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Familial hypercholesterolemia; PCSK9; LDL receptor; Medicine; Apolipoprotein B; Internal medicine; Genetic enhancement; Cholesterol; Endocrinology; Genetics; Lipoprotein; Gene; Biology","score_opus":0.3063777822530571,"score_gpt":0.45230519188938517,"score_spread":0.14592740963632805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034162438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020116984,0.9738062,0.000681431,0.00015699439,0.020414239,0.004743944,0.00013366847,0.00003215303,0.00001123076],"genre_scores_gemma":[0.000008027472,0.98146236,0.00044510543,0.000011327672,0.01632769,0.0012766746,0.00038846952,0.000066441855,0.000013925449],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972615,0.00039425355,0.00093919685,0.00074854493,0.00023414603,0.00042233051],"domain_scores_gemma":[0.9981695,0.00040384976,0.0003892913,0.0007156679,0.00012335656,0.00019833626],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039540548,0.0004986319,0.003818177,0.0002201693,0.000032578686,0.00000757267,0.00018023771,0.00036382812,0.000009173273],"category_scores_gemma":[0.00019655253,0.0003332665,0.000939163,0.00031703856,0.00013150767,0.000043164287,0.000052848536,0.0003563866,0.000008862523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040163635,0.00026267275,0.0000602382,0.04761227,0.00028014943,6.219017e-7,0.000080119535,3.692677e-7,9.2076914e-7,0.000041648702,0.0003274133,0.95093197],"study_design_scores_gemma":[0.0031053126,0.004505775,0.00008440783,0.026770707,0.00085623824,0.00020306517,0.00001737577,0.000012613265,4.7354575e-7,0.0000056740614,0.9641963,0.00024202513],"about_ca_topic_score_codex":0.00007227045,"about_ca_topic_score_gemma":0.000012594303,"teacher_disagreement_score":0.9638689,"about_ca_system_score_codex":0.00040390738,"about_ca_system_score_gemma":0.0014996566,"threshold_uncertainty_score":0.99991196},"labels":[],"label_agreement":null},{"id":"W3034733399","doi":"10.1016/j.avsg.2020.06.003","title":"Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease","year":2020,"lang":"en","type":"article","venue":"Annals of Vascular Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Humber River Regional Hospital; University Health Network","funders":"","keywords":"Medicine; Dyslipidemia; Coronary artery disease; Internal medicine; Diabetes mellitus; Population; Disease; Statin; Atherosclerotic cardiovascular disease; Lipid profile; Vascular disease; Cardiology; Cholesterol; Endocrinology","score_opus":0.10611404622682574,"score_gpt":0.35599141901334713,"score_spread":0.2498773727865214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034733399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97689813,0.01047233,0.008479939,0.00037977757,0.00018432223,0.0033348096,0.00014333031,0.000067453584,0.000039881466],"genre_scores_gemma":[0.99324656,0.0033493682,0.0011874344,0.0013453306,0.00032568641,0.0002842367,0.00015339753,0.00010504265,0.0000029239216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951248,0.0003708615,0.0011579437,0.00084250333,0.0019172559,0.0005866481],"domain_scores_gemma":[0.9951824,0.00025853733,0.0003565185,0.00178178,0.0016089807,0.0008118183],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024787115,0.0004162404,0.0022769463,0.00016133279,0.00010591565,0.00002107454,0.00024368476,0.00014430363,0.000029896213],"category_scores_gemma":[0.00082500436,0.00034368498,0.0047075567,0.00063742045,0.00010159277,0.00015550783,0.00007957062,0.0002085907,0.000004690327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004921755,0.0019005496,0.6839464,0.0126314815,0.019359829,0.000026246451,0.0017542958,0.00228529,0.0004118526,0.00008765784,0.00050178845,0.27217287],"study_design_scores_gemma":[0.005382558,0.0030227879,0.9654496,0.0013479618,0.0010440361,4.6314508e-7,0.00039388132,0.000048671125,0.002644731,0.0000127033,0.019964702,0.00068791234],"about_ca_topic_score_codex":0.00029743928,"about_ca_topic_score_gemma":0.0000047574686,"teacher_disagreement_score":0.28150323,"about_ca_system_score_codex":0.00003596526,"about_ca_system_score_gemma":0.000660297,"threshold_uncertainty_score":0.99990153},"labels":[],"label_agreement":null},{"id":"W3035298991","doi":"10.2337/db20-1093-p","title":"1093-P: Association between First-Line Monotherapy with Metformin and the Risk of Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus","year":2020,"lang":"en","type":"article","venue":"Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Metformin; Medicine; Internal medicine; Atrial fibrillation; Type 2 Diabetes Mellitus; Diabetes mellitus; Type 2 diabetes; Retrospective cohort study; Incidence (geometry); Heart failure; Insulin; Cardiology; Endocrinology","score_opus":0.007758647120343383,"score_gpt":0.21028518537803234,"score_spread":0.20252653825768896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035298991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948918,0.003608792,0.000020828515,0.00054557464,0.00002073253,0.0008499175,0.000024341643,0.00001623877,0.00002172518],"genre_scores_gemma":[0.9984038,0.00085545337,0.0002431277,0.000096345546,0.00031038577,0.000006522108,0.00006185918,0.000018299868,0.0000042457277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893034,0.000120646546,0.00023198454,0.00016743495,0.0003705992,0.00017900349],"domain_scores_gemma":[0.99916685,0.0002571837,0.00021675228,0.00016193856,0.00013073848,0.000066548986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059657055,0.00011500347,0.0004901553,0.0000405384,0.00004747633,0.000012103679,0.000035872887,0.00007046344,0.0000069219773],"category_scores_gemma":[0.00026069803,0.000062171726,0.00008823917,0.0002948344,0.00004537208,0.000072936826,0.000013124352,0.00012069649,0.0000014752226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005256232,0.000008388384,0.965872,0.00008612814,0.0006294677,1.1857602e-7,0.0003420612,0.00015892937,0.0000037848552,0.000006812432,0.000006962796,0.032359745],"study_design_scores_gemma":[0.0117788585,0.0013755945,0.9833578,0.00008865887,0.0005245889,2.3713774e-8,0.000021311376,0.0007515558,0.0011435595,0.00007150696,0.00078983064,0.000096707714],"about_ca_topic_score_codex":0.00009691778,"about_ca_topic_score_gemma":0.000014854598,"teacher_disagreement_score":0.032263037,"about_ca_system_score_codex":0.000045097742,"about_ca_system_score_gemma":0.000039751558,"threshold_uncertainty_score":0.25352895},"labels":[],"label_agreement":null},{"id":"W3035352568","doi":"10.1016/s0140-6736(19)33156-3","title":"Questioning statin therapy for older patients","year":2020,"lang":"en","type":"letter","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Statin; Scopus; Clinical trial; Population; Family medicine; MEDLINE; Alternative medicine; Harm; Physical therapy; Gerontology; Psychology; Internal medicine; Pathology; Environmental health","score_opus":0.03536706218854535,"score_gpt":0.29514395463771226,"score_spread":0.2597768924491669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035352568","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023990152,0.00164881,0.00066596933,0.9919294,0.00042322077,0.0020994141,0.0001523797,0.00009535546,0.0005864467],"genre_scores_gemma":[0.0020898967,0.00040156386,0.000810338,0.97398996,0.020414898,0.00027720927,0.001093394,0.00006581355,0.00085694593],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988862,0.00009772767,0.00016902098,0.00023042991,0.00032147835,0.00029513906],"domain_scores_gemma":[0.9991076,0.00006303297,0.00009372344,0.0006058788,0.00009869356,0.000031078223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024122995,0.00016157635,0.00061783066,0.000019899775,0.00009941601,0.000027993034,0.00015759029,0.00016063284,0.000057078436],"category_scores_gemma":[0.00007709242,0.00009375212,0.00023072414,0.00006219661,0.000027594688,0.000016330723,0.000019871148,0.0008036611,0.000036181864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008469001,0.000011255373,0.00038025665,0.00041258908,0.0001950537,0.0000124465205,0.00023505524,3.2303257e-7,0.0000020178022,0.000008413784,0.9679239,0.030734021],"study_design_scores_gemma":[0.0034458078,0.00019624454,0.0053831106,0.00020422427,0.00008726817,0.000004345301,0.0000067832307,0.000010016058,0.0000324331,0.00016709224,0.99035335,0.00010932188],"about_ca_topic_score_codex":0.00006236233,"about_ca_topic_score_gemma":6.9348465e-7,"teacher_disagreement_score":0.030624699,"about_ca_system_score_codex":0.00004282633,"about_ca_system_score_gemma":0.000099750105,"threshold_uncertainty_score":0.38231006},"labels":[],"label_agreement":null},{"id":"W3035497061","doi":"10.1016/j.jacl.2020.06.007","title":"A cautionary tale: Is this APOB whole-gene duplication actually pathogenic?","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Gene duplication; Apolipoprotein B; Medicine; Sanger sequencing; Familial hypercholesterolemia; Gene; LDL receptor; Genetics; Ldl cholesterol; Bioinformatics; Cholesterol; Lipoprotein; Internal medicine; Biology; Mutation","score_opus":0.08394923489520024,"score_gpt":0.3789151098864681,"score_spread":0.29496587499126786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035497061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8115187,0.0040762913,0.0061668665,0.17261861,0.0033796323,0.00059922296,0.000044004588,0.000050116712,0.0015465008],"genre_scores_gemma":[0.9100452,0.002433471,0.007236928,0.054204434,0.025539326,0.000008460978,0.000029280785,0.000038195853,0.00046466585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967171,0.00045974654,0.0017434958,0.0002877365,0.0005436492,0.00024826528],"domain_scores_gemma":[0.99732107,0.00037458134,0.0007971472,0.00038519703,0.00048123644,0.0006407842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027006587,0.00014857373,0.0011014062,0.00006899409,0.00005904982,0.000009263309,0.00019675738,0.0004215457,0.0005976834],"category_scores_gemma":[0.002939484,0.00011151786,0.0010750766,0.0002083217,0.00013448347,0.00009330728,0.000070041424,0.0010638392,0.00022453546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009827889,0.0023967822,0.055123143,0.000607098,0.0038666918,0.0007607781,0.0023444332,0.0000352455,0.04063269,0.00071805296,0.41551507,0.46817213],"study_design_scores_gemma":[0.006013574,0.0057238885,0.11750057,0.00007286591,0.0007276168,0.0026982536,0.00010579925,0.00022006006,0.0006019403,0.0003035286,0.8658364,0.0001955354],"about_ca_topic_score_codex":0.0000048907978,"about_ca_topic_score_gemma":0.0000010381181,"teacher_disagreement_score":0.4679766,"about_ca_system_score_codex":0.00004090192,"about_ca_system_score_gemma":0.0008398478,"threshold_uncertainty_score":0.65442145},"labels":[],"label_agreement":null},{"id":"W3035597748","doi":"10.71781/29840","title":"Interaction entre les apoB-lipoprotéines et le tissu adipeux blanc dans la régulation du risque cardiométabolique chez l’humain","year":2019,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; AstraZeneca","keywords":"Apolipoprotein B; Biology; Chemistry; Biochemistry; Cholesterol","score_opus":0.01679965418147058,"score_gpt":0.3123600307418382,"score_spread":0.29556037656036765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035597748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80544174,0.0045392397,0.0013236323,0.0009870634,0.0030738472,0.0061074835,0.00022982237,0.000016939042,0.17828026],"genre_scores_gemma":[0.96880776,0.0014826026,0.0011060324,0.00006993574,0.002297724,0.00040724492,0.007089099,0.00017508747,0.018564519],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952268,0.0011519259,0.0009801143,0.0011662252,0.00081873604,0.000656175],"domain_scores_gemma":[0.99728477,0.00016859898,0.0006677877,0.0011010298,0.00046784538,0.00030998883],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0026355803,0.000757886,0.0015510004,0.00029374618,0.0003783857,0.00043124863,0.0005296754,0.0010954133,0.002389813],"category_scores_gemma":[0.00027191566,0.0007553619,0.0007175035,0.00038382973,0.0001061743,0.000722111,0.00016990506,0.0010846385,0.0011056801],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013223299,0.0008149178,0.010479848,0.0022150078,0.0024206298,0.00032053652,0.030847454,0.0022337954,0.014235042,0.0027414004,0.0006696836,0.93169934],"study_design_scores_gemma":[0.007942326,0.00050791644,0.123394184,0.0055736895,0.0022258607,0.000647494,0.040395163,0.0029835857,0.06118469,0.0000807917,0.7535624,0.0015018969],"about_ca_topic_score_codex":0.029024182,"about_ca_topic_score_gemma":0.010428326,"teacher_disagreement_score":0.9301975,"about_ca_system_score_codex":0.00066252233,"about_ca_system_score_gemma":0.0019392327,"threshold_uncertainty_score":0.99967206},"labels":[],"label_agreement":null},{"id":"W3035707988","doi":"10.2337/db20-185-or","title":"185-OR: Efficacy and Safety of Bempedoic Acid in Patients with Diabetes, Prediabetes, and Normoglycemia: Analysis of Pooled Patient-Level Data from Four Phase 3 Clinical Trials","year":2020,"lang":"en","type":"article","venue":"Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Glycemic; Prediabetes; Diabetes mellitus; Internal medicine; Placebo; Statin; Clinical endpoint; Clinical trial; Endocrinology; Gastroenterology; Type 2 diabetes; Alternative medicine","score_opus":0.10062709541975302,"score_gpt":0.3465717311613925,"score_spread":0.2459446357416395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035707988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99114877,0.002968867,0.00004492714,0.00018233433,0.000049274673,0.0013958059,0.004179233,0.000021231319,0.000009549038],"genre_scores_gemma":[0.99506164,0.00029495126,0.0016546822,0.00037138007,0.00011681851,0.00002153615,0.0024454969,0.00003201421,0.000001507241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958099,0.0006733733,0.0017378302,0.00076687406,0.00063571933,0.00037628054],"domain_scores_gemma":[0.99645895,0.0012273189,0.0006628449,0.0010498227,0.00017908949,0.00042200065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021270136,0.00029000695,0.002870362,0.00022749284,0.00003943381,0.000017312897,0.00021448884,0.00021177561,0.000058967824],"category_scores_gemma":[0.0040035755,0.00020098798,0.00024427898,0.0008755855,0.00020969595,0.00017011883,0.00028841692,0.00031512635,9.700027e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026204523,0.0007118604,0.8424238,0.00029324397,0.0050247246,0.0000038973294,0.00018579687,0.0000036265853,0.00064994796,9.4814925e-7,0.00008275102,0.14799897],"study_design_scores_gemma":[0.033873223,0.004014167,0.94794077,0.00032712892,0.008542203,5.5940262e-8,0.00005319336,0.00207547,0.002621248,0.000005070371,0.00030647253,0.00024097296],"about_ca_topic_score_codex":0.00007667638,"about_ca_topic_score_gemma":0.00003216828,"teacher_disagreement_score":0.14775799,"about_ca_system_score_codex":0.000021955368,"about_ca_system_score_gemma":0.00018058797,"threshold_uncertainty_score":0.81960523},"labels":[],"label_agreement":null},{"id":"W3036336535","doi":"10.1007/s11886-020-01323-z","title":"Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?","year":2020,"lang":"en","type":"review","venue":"Current Cardiology Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Apolipoprotein B; Medicine; Cholesterol; Hypertriglyceridemia; Internal medicine; Residual risk; Metabolic syndrome; Endocrinology; Ldl cholesterol; Lipoprotein; Diabetes mellitus; Obesity; Triglyceride","score_opus":0.08487732393879004,"score_gpt":0.3694447352950445,"score_spread":0.28456741135625446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036336535","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021792749,0.9717765,0.008921422,0.00010552453,0.0025590102,0.0161547,0.00009898131,0.0000723942,0.000093581904],"genre_scores_gemma":[0.002385825,0.9869326,0.00015991565,0.000056774,0.0029211093,0.0065868013,0.0005597875,0.0001740789,0.00022316027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99477714,0.0005045572,0.0016834788,0.0014576673,0.00093446544,0.0006426878],"domain_scores_gemma":[0.9947208,0.00013806738,0.00073933083,0.0032662994,0.000509957,0.00062550436],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024202713,0.00075981434,0.0059466944,0.00017647863,0.00014821805,0.000025229738,0.00031513796,0.00045539203,0.000024954845],"category_scores_gemma":[0.0011217743,0.00044478872,0.007273445,0.0006371199,0.00010538303,0.000051152692,0.00025730766,0.0007250256,0.000035736535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014237377,0.000081366925,0.00011828389,0.036690786,0.010721902,0.0002490212,0.00005480554,0.00009342182,5.158652e-7,0.000004002022,0.0015685128,0.950275],"study_design_scores_gemma":[0.00066450983,0.0006292663,0.0006192944,0.010548336,0.022558859,0.0021335068,0.000012533086,0.000008610432,0.0000025117538,0.000034468285,0.9623976,0.00039050874],"about_ca_topic_score_codex":0.000030178722,"about_ca_topic_score_gemma":0.000002105243,"teacher_disagreement_score":0.9608291,"about_ca_system_score_codex":0.00022213353,"about_ca_system_score_gemma":0.0026498812,"threshold_uncertainty_score":0.9998004},"labels":[],"label_agreement":null},{"id":"W3038973605","doi":"10.1016/j.jacbts.2020.05.004","title":"Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis","year":2020,"lang":"en","type":"article","venue":"JACC Basic to Translational Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Ottawa; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Horizon 2020; European Research Council; Fonds de Recherche du Québec - Santé; National Institutes of Health; Akebia Therapeutics; Conseil Régional des Pays de la Loire; Skånes universitetssjukhus; Agence Nationale de la Recherche; Fondazione Gigi e Pupa Ferrari; Medical Research Council; Medical Research Council Canada; Servier; Knut och Alice Wallenbergs Stiftelse; Pfizer; Fritz Thyssen Stiftung; Deutsche Forschungsgemeinschaft; Fédération Française de Cardiologie; Canadian Institutes of Health Research; Daimler und Benz Stiftung; Stiftelsen för Strategisk Forskning; National Heart, Lung, and Blood Institute; Crafoordska Stiftelsen; Cancer Research UK; Hjärt-Lungfonden; Ionis Pharmaceuticals; Merck; Edwards Lifesciences; Boehringer Ingelheim; Medtronic; Assistance Publique - Hôpitaux de Paris; Stiftelsen för Strategisk Forskning; National Institute for Health and Care Research; Novartis; Vetenskapsrådet; Ministero della Salute","keywords":"PCSK9; Odds ratio; Stenosis; Internal medicine; Cardiology; Medicine; Confidence interval; Aortic valve; Aortic valve stenosis; In vitro; Chemistry; Cholesterol; Lipoprotein; LDL receptor; Biochemistry","score_opus":0.02108164748262714,"score_gpt":0.26313224071171193,"score_spread":0.2420505932290848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038973605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289584,0.00043167945,0.001894851,0.004251791,0.000015922049,0.00036382474,0.0000089003715,0.000007640012,0.00012957593],"genre_scores_gemma":[0.99504477,0.000025918192,0.0042312,0.00063241104,0.000046774217,0.00001106297,0.0000019087531,0.000004154008,0.0000017842556],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989592,0.000019176103,0.00018392404,0.00025662067,0.0004438059,0.00013731315],"domain_scores_gemma":[0.999611,0.000021520462,0.000022788232,0.00008470756,0.00005375338,0.0002061847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003170059,0.000060342434,0.00015930193,0.000093914685,0.000049694707,0.000011796646,0.000031515327,0.000025631307,0.0000126956875],"category_scores_gemma":[0.000042633856,0.000052962503,0.000043327298,0.0005590688,0.00014459407,0.00009139198,0.0000133963085,0.0000643159,0.0000019428915],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027984814,0.000075626915,0.06854893,0.0003251191,0.000021396463,0.000009650899,0.0029618812,0.00020649775,0.7026431,0.00025981906,0.000009466561,0.22465868],"study_design_scores_gemma":[0.0006892223,0.00010108615,0.97700816,0.000044876477,0.000024441122,0.00001004614,0.000060159724,0.0017617984,0.020013055,0.00013743689,0.000088698034,0.00006101661],"about_ca_topic_score_codex":0.00009360083,"about_ca_topic_score_gemma":0.000007882741,"teacher_disagreement_score":0.90845925,"about_ca_system_score_codex":0.000017771152,"about_ca_system_score_gemma":0.00015519252,"threshold_uncertainty_score":0.21597482},"labels":[],"label_agreement":null},{"id":"W3039823791","doi":"10.1016/j.jacc.2020.05.027","title":"Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Regeneron Pharmaceuticals","keywords":"Medicine; Familial hypercholesterolemia; Alirocumab; Ldl cholesterol; Internal medicine; Cholesterol; Total cholesterol","score_opus":0.008782707180646472,"score_gpt":0.23903771060880627,"score_spread":0.2302550034281598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039823791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560726,0.0007166926,0.00016332924,0.0028060395,0.000058921054,0.00033829504,0.000028189228,0.0000026425928,0.00027863574],"genre_scores_gemma":[0.99788994,0.0006820634,0.00061314326,0.00049826986,0.00029498152,0.0000018263366,4.351191e-7,0.0000136914805,0.00000563299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985219,0.00029973814,0.0005470673,0.00013182515,0.00033966737,0.0001597683],"domain_scores_gemma":[0.9988155,0.000084822816,0.0005305768,0.00026481773,0.00017263133,0.00013168225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042524067,0.00011513927,0.0013252839,0.000082102706,0.000021805581,0.0000010230532,0.00015714613,0.000047508405,0.0000012558694],"category_scores_gemma":[0.00017608951,0.00006690658,0.0002797017,0.0003595314,0.0004366245,0.000029199522,0.00006358343,0.00032912398,1.9698608e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20720896,0.00046580305,0.6229658,0.002222659,0.006496793,0.0058409534,0.0035345764,0.005570859,0.022030896,0.00027523082,0.0028157264,0.12057173],"study_design_scores_gemma":[0.017435655,0.008749881,0.9559038,0.0006633181,0.00049271516,0.009336622,0.0020658816,0.00004005948,0.0007656097,0.00001605855,0.004391876,0.0001385065],"about_ca_topic_score_codex":0.00006126521,"about_ca_topic_score_gemma":0.000009144685,"teacher_disagreement_score":0.33293802,"about_ca_system_score_codex":0.000047507965,"about_ca_system_score_gemma":0.00030092738,"threshold_uncertainty_score":0.2728371},"labels":[],"label_agreement":null},{"id":"W3039860945","doi":"10.1016/j.cjco.2020.07.002","title":"Barriers and Facilitators to Using Statins: A Qualitative Study With Patients and Family Physicians","year":2020,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Diabetes Canada","keywords":"Medicine; Statin; Focus group; Family medicine; Guideline; Psychological intervention; Qualitative research; Primary care; Disease; Nursing; Internal medicine","score_opus":0.036862146988861366,"score_gpt":0.34716625528878864,"score_spread":0.3103041082999273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039860945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622613,0.00009376817,0.0003356623,0.0003938897,0.000014190122,0.0026134443,0.000050369872,0.000012259193,0.00026027043],"genre_scores_gemma":[0.99526346,0.000005152246,0.0017234384,0.002888425,0.00002602588,0.00005083488,0.0000047928233,0.000017057537,0.000020798096],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99895644,0.00016138221,0.00013644325,0.00031625404,0.0002749398,0.00015455938],"domain_scores_gemma":[0.9993429,0.000018862977,0.000035335466,0.00015986901,0.000084906904,0.00035810692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029315305,0.00011487143,0.00040555894,0.000024401155,0.00010898588,0.0000520517,0.00006314633,0.000018163555,0.000005622412],"category_scores_gemma":[0.000102096485,0.00008679617,0.000021476713,0.00017888544,0.000044017605,0.00012613043,0.00013232883,0.00008244921,0.0000031604643],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019720595,0.00021595118,0.12614976,0.00032670156,0.0010193231,0.000085825675,0.79199076,0.00001819763,0.0004370822,0.000051439354,0.0006619611,0.07707094],"study_design_scores_gemma":[0.0100871315,0.009602623,0.15890029,0.00020027097,0.00028832626,0.0000040098826,0.8174262,0.00014853654,0.00010128619,0.000023968953,0.0028635198,0.00035383017],"about_ca_topic_score_codex":0.0013087121,"about_ca_topic_score_gemma":0.000039214767,"teacher_disagreement_score":0.0767171,"about_ca_system_score_codex":0.00003181336,"about_ca_system_score_gemma":0.00010463178,"threshold_uncertainty_score":0.3539445},"labels":[],"label_agreement":null},{"id":"W3040745624","doi":"10.2459/jcm.0000000000000970","title":"Lipid-lowering nutraceuticals update on scientific evidence","year":2020,"lang":"en","type":"review","venue":"Journal of Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Nutraceutical; Dyslipidemia; Cholesterol; Internal medicine; Diabetes mellitus; Lipid profile; Drug; Coronary artery disease; Disease; Pharmacology; Endocrinology; Pathology","score_opus":0.10877071816879351,"score_gpt":0.3793175882076042,"score_spread":0.27054687003881067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040745624","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011936464,0.990691,0.0017334572,0.0017334413,0.0035743192,0.0015644691,0.0000070357582,0.000049800325,0.00063455553],"genre_scores_gemma":[0.0001257535,0.98575014,0.00040269023,0.0004725199,0.012914252,0.000022214555,0.000017792392,0.00016465638,0.00012995677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98960525,0.0007981527,0.0026875134,0.0009143265,0.0052882642,0.00070649234],"domain_scores_gemma":[0.9937193,0.00036741234,0.0011843233,0.002402761,0.0009462348,0.0013799873],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011126102,0.00088914734,0.0104992455,0.0010252647,0.00018125749,0.00009326514,0.00073721947,0.0005572132,0.00017579492],"category_scores_gemma":[0.0037433603,0.00054874836,0.011330482,0.0016080661,0.0004578065,0.00022041469,0.00014787284,0.002728485,0.00025922718],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009870922,0.000072402356,6.6815323e-7,0.02629668,0.012342497,0.0041369526,0.000057955596,0.000012798258,0.0000026243015,0.00004292297,0.0039181923,0.9530176],"study_design_scores_gemma":[0.0014640242,0.0011978196,0.00000596224,0.13412903,0.029292865,0.009186819,0.000027873586,0.0000029265832,0.0000128195325,0.000012473486,0.82432836,0.00033899618],"about_ca_topic_score_codex":0.00000937108,"about_ca_topic_score_gemma":2.7243283e-7,"teacher_disagreement_score":0.9526786,"about_ca_system_score_codex":0.00066100934,"about_ca_system_score_gemma":0.0022050145,"threshold_uncertainty_score":0.9996964},"labels":[],"label_agreement":null},{"id":"W3041525889","doi":"10.1194/jlr.ra120000830","title":"Generation and characterization of LPA-KIV9, a murine monoclonal antibody binding a single site on apolipoprotein (a)","year":2020,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute","keywords":"Polyclonal antibodies; Monoclonal antibody; Lipoprotein(a); Antibody; Monoclonal; Molecular biology; Lipoprotein; Apolipoprotein B; Binding site; Biology; Chemistry; Immunology; Biochemistry; Cholesterol","score_opus":0.13961573661989224,"score_gpt":0.38237915985494764,"score_spread":0.2427634232350554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041525889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927523,0.00021003945,0.0005832018,0.005799102,0.00009059298,0.00040513772,0.000009515155,0.000006018485,0.0001440883],"genre_scores_gemma":[0.9948206,0.00051024527,0.0006751276,0.00016680427,0.0036823838,0.0000036532065,0.000028057542,0.000020938645,0.000092209586],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976028,0.00026107123,0.00047546532,0.0001669166,0.0012582444,0.00023550382],"domain_scores_gemma":[0.99867946,0.000037170692,0.00022465157,0.0001603959,0.00059587037,0.00030244142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019165088,0.000096142336,0.0004030448,0.00035981013,0.0000988902,0.000038596223,0.00007291586,0.000083120445,0.000049395385],"category_scores_gemma":[0.00036965313,0.00007430175,0.00014261011,0.00044695562,0.00006289713,0.00015163685,0.000052278458,0.00054024195,0.000007857627],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005443615,0.0001608026,0.0030963803,0.0002929115,0.00009135676,0.00005964455,0.0003608936,0.000006224398,0.9805019,0.000049359158,0.00010432734,0.01473182],"study_design_scores_gemma":[0.005284426,0.010658491,0.07658513,0.0010171033,0.00009744077,0.00060897775,0.00022242568,0.0037381207,0.88785076,0.000012725663,0.013719852,0.0002045214],"about_ca_topic_score_codex":0.000027672722,"about_ca_topic_score_gemma":0.0000013703233,"teacher_disagreement_score":0.092651136,"about_ca_system_score_codex":0.0000840362,"about_ca_system_score_gemma":0.0002356581,"threshold_uncertainty_score":0.30299377},"labels":[],"label_agreement":null},{"id":"W3041760231","doi":"10.1007/s11886-020-01331-z","title":"New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines","year":2020,"lang":"en","type":"review","venue":"Current Cardiology Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Guideline; Atherosclerotic cardiovascular disease; Statin; Disease; Intensive care medicine; Canadian Cardiovascular Society; Disease management; Cardiovascular health; Alternative medicine; Internal medicine; Pathology; Myocardial infarction","score_opus":0.15570544551255425,"score_gpt":0.4294587493458108,"score_spread":0.2737533038332566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3041760231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045868674,0.9780349,0.00045127448,0.012387992,0.0017922925,0.007017474,0.00007308051,0.000035095763,0.00016201312],"genre_scores_gemma":[0.000019735604,0.9958365,0.0006642527,0.0005614728,0.0016531189,0.00073570403,0.00029067002,0.00006408731,0.0001744773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99396014,0.0011155575,0.002480914,0.0012537403,0.0007402994,0.0004493555],"domain_scores_gemma":[0.99565744,0.00018075274,0.0007308408,0.0025251012,0.00039925365,0.0005065797],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004902973,0.00065947743,0.003790431,0.00016532453,0.00013532143,0.000027888656,0.00026035227,0.00023576383,0.000028228631],"category_scores_gemma":[0.0012353734,0.00036325285,0.0016672639,0.0005576526,0.00014720931,0.00003893429,0.0005196876,0.0006807029,0.0000090457725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020357405,0.000021518821,0.00005494377,0.0050030164,0.003239511,0.00026191698,0.000028972197,0.00003055507,4.5793605e-8,0.00011087825,0.13167748,0.8595508],"study_design_scores_gemma":[0.0003665375,0.000086369124,0.0002962379,0.02209393,0.006912629,0.0006893192,0.000044672746,0.000004091242,4.0099226e-7,0.000101788275,0.9691018,0.00030226688],"about_ca_topic_score_codex":0.00009497194,"about_ca_topic_score_gemma":0.000003124223,"teacher_disagreement_score":0.8592485,"about_ca_system_score_codex":0.00020253123,"about_ca_system_score_gemma":0.0007738777,"threshold_uncertainty_score":0.9998819},"labels":[],"label_agreement":null},{"id":"W3042819427","doi":"10.1002/14651858.cd008226.pub3","title":"Atorvastatin for lowering lipids","year":2015,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"","keywords":"Atorvastatin; Medicine; Adverse effect; Placebo; Statin; Meta-analysis; Cholesterol; Internal medicine; Randomized controlled trial; Clinical trial; Pharmacology; Alternative medicine","score_opus":0.1691335617696014,"score_gpt":0.4186889209554867,"score_spread":0.2495553591858853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042819427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.9342171e-7,0.96360326,0.0039960723,0.0000068532286,0.0005384532,0.030697443,0.0007496342,0.000038183454,0.0003699316],"genre_scores_gemma":[1.7094447e-7,0.9854961,0.00514667,0.00003411723,0.00078018964,0.0060067303,0.0020480026,0.0001313029,0.00035673732],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99258727,0.00085308705,0.004483494,0.0006485932,0.0010041122,0.0004234389],"domain_scores_gemma":[0.99250335,0.00046603289,0.0024965478,0.003599703,0.0005188278,0.00041552127],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.013529868,0.00073665974,0.016601766,0.00025219616,0.000052573592,0.000025544356,0.00042426193,0.0002520892,0.000057841287],"category_scores_gemma":[0.0044776215,0.00044392154,0.0033662878,0.00046340635,0.000057273734,0.000095386975,0.00012574138,0.00031253672,0.00027938097],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000064723117,0.000053280677,4.4680156e-8,0.8106328,0.0004175598,0.0000141411565,0.000031903593,1.5905373e-8,5.8715335e-7,0.00005040203,0.00390392,0.18488882],"study_design_scores_gemma":[0.0003612384,0.000087791756,1.0856547e-8,0.5061089,0.0061583803,0.000289625,0.000018293524,0.0000026052403,9.222734e-7,0.0000013288552,0.48678827,0.00018263425],"about_ca_topic_score_codex":0.000022702774,"about_ca_topic_score_gemma":0.0000022003908,"teacher_disagreement_score":0.48288438,"about_ca_system_score_codex":0.00022723713,"about_ca_system_score_gemma":0.00096286257,"threshold_uncertainty_score":0.9998013},"labels":[],"label_agreement":null},{"id":"W3042841923","doi":"10.1007/s11695-020-04450-2","title":"Acute and Chronic Impact of Biliopancreatic Diversion with Duodenal Switch Surgery on Plasma Lipoprotein(a) Levels in Patients with Severe Obesity","year":2020,"lang":"en","type":"article","venue":"Obesity Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Institute of Circulatory and Respiratory Health; Canadian Institutes of Health Research","keywords":"Medicine; Duodenal switch; Biliopancreatic Diversion; Weight loss; Obesity; Lipoprotein(a); Internal medicine; Lipoprotein; Severe obesity; Surgery; Gastroenterology; Cholesterol; Morbid obesity","score_opus":0.014830909707027329,"score_gpt":0.222103644708763,"score_spread":0.20727273500173568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042841923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984198,0.00017862937,0.000040469688,0.00019127723,0.00003730227,0.0009653268,0.00006619769,0.000046161407,0.000054805445],"genre_scores_gemma":[0.99943095,0.00012337559,0.00007788652,0.00011790725,0.00010953162,0.000015337004,0.00006266652,0.000039504623,0.000022857435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748474,0.00016237803,0.00040455683,0.00055320753,0.0009128334,0.00048230006],"domain_scores_gemma":[0.9984483,0.0002578606,0.00022560506,0.00048600713,0.00016431196,0.00041788945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005632755,0.00034742203,0.0013498054,0.00025879237,0.00010619486,0.000019378196,0.0000706171,0.00014946063,0.0000666628],"category_scores_gemma":[0.00012446847,0.00023462312,0.00035473614,0.00065482047,0.00009995893,0.00020706994,0.00007359724,0.00035685627,0.000012291674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031630886,0.00046536583,0.9879441,0.00076389336,0.00053935987,0.0002470599,0.00013214927,0.000051474115,0.0001130897,0.0000022135116,0.00019232741,0.0063858298],"study_design_scores_gemma":[0.0026924415,0.0015336368,0.9919191,0.0010985766,0.00024562047,0.00005606914,0.000025459773,0.00010628086,0.0020135127,0.0000033974604,0.00001944031,0.00028644904],"about_ca_topic_score_codex":0.0009632969,"about_ca_topic_score_gemma":0.00009259802,"teacher_disagreement_score":0.0060993806,"about_ca_system_score_codex":0.00033510287,"about_ca_system_score_gemma":0.0008727411,"threshold_uncertainty_score":0.9567653},"labels":[],"label_agreement":null},{"id":"W3042975627","doi":"10.1016/j.ajpc.2020.100036","title":"Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation","year":2020,"lang":"en","type":"article","venue":"American Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Medicine; Coronary artery disease; Internal medicine; Cardiology; Primary prevention; Disease","score_opus":0.025826946336553382,"score_gpt":0.2994596689722125,"score_spread":0.27363272263565913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042975627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.939355,0.0032347285,0.055718828,0.00039826008,0.00013869224,0.0010690432,0.00005209983,0.000008189044,0.000025120957],"genre_scores_gemma":[0.99544007,0.0023739685,0.0014127947,0.00026683047,0.0004070147,0.00002365001,0.000048555205,0.000021056214,0.0000060785133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983049,0.00036762372,0.00068490766,0.00021118663,0.00027894782,0.00015243482],"domain_scores_gemma":[0.9982031,0.00010570057,0.0008611663,0.00019041992,0.0004636307,0.0001760111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007639838,0.00014231387,0.0009435711,0.00008534072,0.000031713975,0.0000033131507,0.00008377133,0.000055514003,0.000007046856],"category_scores_gemma":[0.00027271165,0.000117841606,0.0004918825,0.00017071296,0.00023548675,0.0001153009,0.0000387495,0.00014857188,1.0494636e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008260383,0.0004886461,0.86606675,0.0019493965,0.004667403,0.00002463928,0.0015370406,0.00038335554,0.02406987,0.000063644846,0.0002766111,0.092212245],"study_design_scores_gemma":[0.0026308077,0.006014748,0.9873201,0.00031088103,0.00049423525,0.00007130599,0.00038315143,0.000024998775,0.0017505764,0.00025926722,0.00064404897,0.00009584172],"about_ca_topic_score_codex":0.0000015075243,"about_ca_topic_score_gemma":1.7128693e-7,"teacher_disagreement_score":0.12125337,"about_ca_system_score_codex":0.000047703288,"about_ca_system_score_gemma":0.00028384844,"threshold_uncertainty_score":0.48054412},"labels":[],"label_agreement":null},{"id":"W3043448525","doi":"10.1161/atvbaha.120.314194","title":"Circulating Rather Than Intestinal PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Regulates Postprandial Lipemia in Mice","year":2020,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Fondation Leducq; Agence Nationale de la Recherche; Pfizer","keywords":"PCSK9; Kexin; Alirocumab; LDL receptor; Proprotein convertase; Endocrinology; Internal medicine; Familial hypercholesterolemia; Medicine; Chemistry; Lipoprotein; Cholesterol","score_opus":0.045474355190650996,"score_gpt":0.28171770427239357,"score_spread":0.23624334908174258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043448525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957353,0.0005823618,0.00018089844,0.0021397637,0.00014917008,0.001029465,0.000010888974,0.00008220987,0.00008995759],"genre_scores_gemma":[0.99618375,0.0007335976,0.00095555704,0.0015750983,0.00035124618,0.00006807978,0.00007901837,0.000051929477,0.0000016981317],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976223,0.00032916598,0.000544296,0.0007557252,0.00021906784,0.00052942865],"domain_scores_gemma":[0.99893874,0.00006739598,0.00012682109,0.0004190322,0.00011545807,0.00033253874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064772106,0.00034644225,0.00092698215,0.00010721928,0.00013463265,0.000047249,0.00013229725,0.00028545634,0.0001431554],"category_scores_gemma":[0.00027342702,0.0002907256,0.00031223582,0.00035767752,0.00020395461,0.00010179182,0.00012126761,0.00037176313,0.000039438804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014964251,0.00016703593,0.3690093,0.000282897,0.00039205473,0.000005116456,0.0013667791,0.000003292735,0.62351716,0.00015211599,0.00003757317,0.004917068],"study_design_scores_gemma":[0.0034977405,0.0017533136,0.9875483,0.00030974235,0.00018780513,0.000015857688,0.00025051934,0.00077697134,0.0040780655,0.00003942515,0.0011875809,0.00035470343],"about_ca_topic_score_codex":0.0011210177,"about_ca_topic_score_gemma":0.00013125621,"teacher_disagreement_score":0.61943907,"about_ca_system_score_codex":0.00005728882,"about_ca_system_score_gemma":0.00010980353,"threshold_uncertainty_score":0.99995446},"labels":[],"label_agreement":null},{"id":"W3043635100","doi":"10.1371/journal.pmed.1003121","title":"Efficacy and safety of bempedoic acid for the treatment of hypercholesterolemia: A systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"PLoS Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mylan; Sanofi; Valeant Pharmaceuticals International; Esperion Therapeutics; Regeneron Pharmaceuticals; Servier; Amgen","keywords":"Odds ratio; Internal medicine; Medicine; Confidence interval; Meta-analysis; Gastroenterology; Randomized controlled trial; Cholesterol; Apolipoprotein B; Lipoprotein; Endocrinology","score_opus":0.13694758970140333,"score_gpt":0.36998338486493065,"score_spread":0.23303579516352732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043635100","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003331766,0.98317116,0.00010569814,0.0021946237,0.000014218913,0.014354793,0.0001249006,0.00001146815,0.000019810428],"genre_scores_gemma":[0.000056506462,0.99767417,0.00012307352,0.00034170388,0.00012566379,0.0014519343,0.00009525126,0.00004053811,0.000091142865],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996694,0.00039242857,0.0017322516,0.0004428163,0.00055975304,0.00017872742],"domain_scores_gemma":[0.99667925,0.0009303194,0.00087856007,0.0011404351,0.00016330117,0.0002081138],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0011710578,0.0004704852,0.018623656,0.00016811513,0.000049023205,0.0000032877301,0.00012926731,0.00015183269,0.000044005137],"category_scores_gemma":[0.0006427133,0.00018346262,0.0027039035,0.00060111313,0.00018324272,0.000014684487,0.000032039825,0.00017006008,0.0000010020908],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020367916,0.00008320401,3.1780297e-7,0.69870585,0.27223337,0.0000050500494,0.00014060979,1.9064144e-8,4.2818323e-7,0.000007180687,0.000016139693,0.028787438],"study_design_scores_gemma":[0.0012404077,0.0012366286,0.000003020459,0.080385216,0.83876854,0.000081667626,0.000030237823,0.0000028492882,0.0000016028532,9.3698674e-7,0.078156695,0.00009220017],"about_ca_topic_score_codex":0.000040322204,"about_ca_topic_score_gemma":0.000005716254,"teacher_disagreement_score":0.61832064,"about_ca_system_score_codex":0.00006380147,"about_ca_system_score_gemma":0.00013830124,"threshold_uncertainty_score":0.99594593},"labels":[],"label_agreement":null},{"id":"W3043909035","doi":"10.1016/j.jacl.2020.07.010","title":"Failure of cosegregation between a rare STAP1 missense variant and hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Familial hypercholesterolemia; Missense mutation; PCSK9; Kexin; Proprotein convertase; Medicine; Locus (genetics); Genetics; Apolipoprotein B; Gene; LDL receptor; Lipoprotein; Internal medicine; Endocrinology; Cholesterol; Mutation; Biology","score_opus":0.10036274044262207,"score_gpt":0.381254003830548,"score_spread":0.28089126338792597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043909035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97136325,0.0005940857,0.0017494791,0.025669646,0.00035076382,0.0001764128,0.000008596275,0.00000667258,0.00008110454],"genre_scores_gemma":[0.98593223,0.00031498165,0.005056009,0.0028550406,0.005811767,6.223625e-7,0.0000039817905,0.000012950645,0.000012416082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974365,0.0004935448,0.0014453992,0.00016152364,0.00031745093,0.00014557074],"domain_scores_gemma":[0.9978372,0.0005293082,0.0006820411,0.00018363647,0.00031503857,0.00045279687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021851554,0.000100605874,0.0012242194,0.000054762295,0.000021768114,0.0000058982705,0.00008035902,0.0002704572,0.00003554715],"category_scores_gemma":[0.0025726727,0.00007152963,0.00038891297,0.00010379183,0.0001298512,0.00006275787,0.000041601896,0.00071005715,0.0000038508397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00679142,0.00056855055,0.50712794,0.0016583675,0.002939029,0.0011890803,0.0015891026,0.000019141056,0.004678208,0.00046223652,0.017534638,0.4554423],"study_design_scores_gemma":[0.01782266,0.013241173,0.80248463,0.0004950422,0.0017573424,0.0054634414,0.0006233083,0.00012040105,0.00070647587,0.00057142717,0.15647258,0.00024153794],"about_ca_topic_score_codex":0.000008652775,"about_ca_topic_score_gemma":0.000002572968,"teacher_disagreement_score":0.45520076,"about_ca_system_score_codex":0.000011481932,"about_ca_system_score_gemma":0.00029856546,"threshold_uncertainty_score":0.30848846},"labels":[],"label_agreement":null},{"id":"W3043920439","doi":"10.1007/978-981-15-6082-8_9","title":"Proprotein Convertase Subtilisin/Kexin-Type 9 and Lipid Metabolism","year":2020,"lang":"en","type":"review","venue":"Advances in experimental medicine and biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"PCSK9; Kexin; Proprotein convertase; LDL receptor; Internal medicine; Cholesterol; Endocrinology; Familial hypercholesterolemia; Chemistry; Sterol regulatory element-binding protein; Receptor; Lipoprotein; Medicine; Biology; Sterol","score_opus":0.05653689911772496,"score_gpt":0.4022152514274625,"score_spread":0.34567835230973754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043920439","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035561607,0.99617237,0.000009022841,0.0003758807,0.000618749,0.001869597,0.000011923778,0.000035795903,0.00055103033],"genre_scores_gemma":[0.0011080982,0.9958939,0.00031166078,0.00080825394,0.0013490003,0.00018884055,0.00025881923,0.000042175896,0.00003927305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99778503,0.0002355765,0.00067473267,0.0007693243,0.00016635355,0.0003689657],"domain_scores_gemma":[0.9990192,0.00008367498,0.00019320796,0.0003460023,0.000044931094,0.00031299205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031824908,0.00049728673,0.003083215,0.00019561235,0.000058043945,0.0000059242025,0.00010369483,0.00034568476,0.00007853135],"category_scores_gemma":[0.00019585925,0.00030277783,0.00014678914,0.00033071576,0.000620953,0.00008888993,0.00014058308,0.00052795693,0.00000961816],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011562107,0.000059547474,0.000038892893,0.005770796,0.00013025603,0.00012425134,0.00022193622,3.6571204e-9,0.0001899253,0.000515213,0.00004464441,0.9927889],"study_design_scores_gemma":[0.0018089059,0.0015904553,0.000009260959,0.0046084113,0.00041261426,0.00068296737,0.00035304148,0.0000016951686,0.00018139991,0.000051052284,0.99002945,0.00027072808],"about_ca_topic_score_codex":0.00017132616,"about_ca_topic_score_gemma":0.00001019752,"teacher_disagreement_score":0.9925182,"about_ca_system_score_codex":0.00006543468,"about_ca_system_score_gemma":0.00018917123,"threshold_uncertainty_score":0.9999424},"labels":[],"label_agreement":null},{"id":"W3044130787","doi":"10.1016/j.jacl.2020.07.008","title":"The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Institut de Recherche Clinique De Montréal; Merck; Sanofi; Amgen; Fondation Leducq; AstraZeneca","keywords":"Medicine; Myocardial infarction; Familial hypercholesterolemia; Internal medicine; Genotype; Hazard ratio; Population; SNP; Genotyping; Confidence interval; Gastroenterology; Single-nucleotide polymorphism; Genetics; Cholesterol; Gene","score_opus":0.037728263471364924,"score_gpt":0.3222774633278502,"score_spread":0.28454919985648525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044130787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98872036,0.000226956,0.00017262904,0.008079437,0.0022511384,0.0003067448,0.0000021532167,0.000008248885,0.00023230615],"genre_scores_gemma":[0.98436767,0.0004011817,0.00033855953,0.0053274995,0.009532999,0.000002740608,0.0000031813877,0.000016032514,0.000010113085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729323,0.00055917236,0.0011941482,0.000171131,0.00054481067,0.00023750366],"domain_scores_gemma":[0.9983796,0.0003373096,0.00041291863,0.00022592585,0.00031775123,0.00032647906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002180389,0.00011079152,0.00075476343,0.000045680565,0.000053854008,0.000011144311,0.0001394664,0.00021864049,0.000010482898],"category_scores_gemma":[0.0020118637,0.000059894064,0.0004236478,0.0001532792,0.00015311992,0.00007651075,0.000044350374,0.0011132037,0.00001379107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0102981785,0.00018698753,0.90365624,0.000027757986,0.00041392812,0.000017454708,0.00011267672,0.000045890345,0.000013176503,0.000022983913,0.0017528104,0.08345191],"study_design_scores_gemma":[0.008933235,0.0059211077,0.91859204,0.000042447657,0.0001645136,0.000043671895,0.000033993078,0.000024613324,0.0000026185262,0.000027865635,0.066160284,0.00005363926],"about_ca_topic_score_codex":0.000013221927,"about_ca_topic_score_gemma":0.000012843788,"teacher_disagreement_score":0.083398275,"about_ca_system_score_codex":0.00003974305,"about_ca_system_score_gemma":0.0004260704,"threshold_uncertainty_score":0.4836378},"labels":[],"label_agreement":null},{"id":"W3044442609","doi":"10.1161/circulationaha.120.045851","title":"The Expected 30-Year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Primary prevention; Disease; Secondary prevention; Internal medicine; Cardiology; Intensive care medicine; Environmental health","score_opus":0.023415156120936125,"score_gpt":0.24051660917116266,"score_spread":0.21710145305022654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044442609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837744,0.010539473,0.004505192,0.000119754666,0.00012998217,0.0006588266,0.0000136661465,0.000036408903,0.00022228323],"genre_scores_gemma":[0.999092,0.00043423363,0.000070344184,0.000018026409,0.00024892495,0.000022810982,0.0000878502,0.000021042362,0.0000047921253],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99863315,0.00007449485,0.0003127855,0.00021237042,0.00062948227,0.00013773509],"domain_scores_gemma":[0.99906236,0.000025417386,0.00012046483,0.00047708317,0.00016893513,0.0001457155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029774322,0.00009731922,0.0002992683,0.00002632277,0.00006762156,0.000008480587,0.00006625148,0.000059341903,0.000013744461],"category_scores_gemma":[0.00011484401,0.000081912425,0.00051914796,0.00021836997,0.000035966896,0.00007684849,0.000027148193,0.00008896917,0.000005036415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020294124,0.00079629314,0.06685609,0.004441437,0.021025758,0.000029480156,0.0037684957,0.03973363,0.041481208,0.0013365964,0.00071778824,0.7995191],"study_design_scores_gemma":[0.0090357615,0.0009813883,0.97677135,0.00028704837,0.0027334094,0.000003279024,0.0002056414,0.0014639532,0.0044380007,0.000043886947,0.0037363817,0.0002998961],"about_ca_topic_score_codex":0.000076196244,"about_ca_topic_score_gemma":5.443674e-7,"teacher_disagreement_score":0.90991527,"about_ca_system_score_codex":0.00006144264,"about_ca_system_score_gemma":0.00011376068,"threshold_uncertainty_score":0.33402917},"labels":[],"label_agreement":null},{"id":"W3045139528","doi":"10.1210/jendso/bvaa057","title":"Statin Use is Associated With Insulin Resistance in Participants of the Canadian Multicentre Osteoporosis Study","year":2020,"lang":"en","type":"article","venue":"Journal of the Endocrine Society","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Kingston Health Sciences Centre; Queen's University","funders":"Canadian Institutes of Health Research; Pfizer Canada; Novartis Pharmaceuticals Canada; Canadian Frailty Network; Arthritis Society; Amgen Canada; Sanofi; Eli Lilly and Company; Roche; Eli Lilly Canada; Servier; Amgen; Pfizer; Dairy Farmers of Canada; Servier Canada","keywords":"Statin; Medicine; Insulin resistance; Internal medicine; Osteoporosis; Diabetes mellitus; Cholesterol; Endocrinology; Insulin","score_opus":0.03700327814117162,"score_gpt":0.2750392789770501,"score_spread":0.2380360008358785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045139528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842303,0.0003358769,0.0000016053162,0.014654065,0.00007931575,0.0006292445,0.0000289057,0.0000032993403,0.000037408536],"genre_scores_gemma":[0.9967189,0.0000643131,0.00030448136,0.0026451664,0.00007820702,0.000003954484,5.3015333e-7,0.000015985497,0.00016846569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804616,0.00026561858,0.0004912793,0.00011673588,0.00077352714,0.00030665423],"domain_scores_gemma":[0.9986387,0.00006818181,0.00044071482,0.00031632278,0.00029434892,0.00024172907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000629784,0.00011358425,0.00043687478,0.000017832512,0.00012303205,0.00001786083,0.00020850114,0.00003234523,0.000020115003],"category_scores_gemma":[0.00079004606,0.0000569312,0.00040619785,0.0005266723,0.000061189225,0.00007542513,0.00005066951,0.000546475,4.8579614e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032631293,0.00046220983,0.945144,0.00010993874,0.0012280763,0.00012547213,0.04496874,0.00017109099,0.00019219148,0.0000045832394,0.0069292015,0.00033818238],"study_design_scores_gemma":[0.0065427716,0.00030723898,0.9791254,0.000361935,0.00044833065,0.000015503427,0.009656295,0.0001115983,0.0010790945,0.000007456771,0.0022646124,0.00007977786],"about_ca_topic_score_codex":0.019428296,"about_ca_topic_score_gemma":0.19386245,"teacher_disagreement_score":0.17443416,"about_ca_system_score_codex":0.0003569612,"about_ca_system_score_gemma":0.0009472142,"threshold_uncertainty_score":0.98710144},"labels":[],"label_agreement":null},{"id":"W3045157703","doi":"10.1093/eurheartj/ehaa574","title":"Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"Medical Research Council; British Heart Foundation; Nuffield Department of Population Health, University of Oxford","keywords":"Medicine; Myopathy; Simvastatin; Internal medicine; Hazard ratio; myalgia; Risk factor; Statin; Cardiology; Physical therapy; Confidence interval","score_opus":0.029565011286446532,"score_gpt":0.2710990857664498,"score_spread":0.24153407448000327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045157703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526626,0.0008769673,0.0019091944,0.0011555555,0.00014619711,0.00041162074,0.000021457226,0.000023344382,0.0001894073],"genre_scores_gemma":[0.9978366,0.00036817655,0.0008782787,0.00048434234,0.00033305006,0.0000015822021,0.0000034093837,0.0000384208,0.00005617763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987279,0.00022258985,0.00033336823,0.00019316023,0.00031810626,0.00020488285],"domain_scores_gemma":[0.99903023,0.000097563774,0.00012535432,0.00015675752,0.00010043201,0.00048965175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056513096,0.0001257056,0.00035433852,0.000051882387,0.00011417974,0.000022956461,0.000058656628,0.000026169839,0.0000413271],"category_scores_gemma":[0.0006176597,0.00008982555,0.00019852906,0.000092406386,0.000022361577,0.000040462757,0.000048315007,0.0003344764,0.000014296615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001524028,0.00056760886,0.66436666,0.0012869419,0.0016373007,0.0003926048,0.023479545,0.0013461362,0.043294087,0.00017587263,0.011229386,0.25069985],"study_design_scores_gemma":[0.0020237444,0.0018078905,0.967443,0.00019006272,0.00015802555,0.00013502305,0.0003586083,0.00019568455,0.001835569,0.000023436296,0.025692021,0.00013692965],"about_ca_topic_score_codex":0.00000965033,"about_ca_topic_score_gemma":0.0000010881407,"teacher_disagreement_score":0.30307636,"about_ca_system_score_codex":0.00002608397,"about_ca_system_score_gemma":0.000043392298,"threshold_uncertainty_score":0.36629796},"labels":[],"label_agreement":null},{"id":"W3045773125","doi":"10.1016/j.atherosclerosis.2020.07.007","title":"Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study","year":2020,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"Heart Care Foundation of India","keywords":"Medicine; Internal medicine; Coronary artery disease; Familial hypercholesterolemia; Myocardial infarction; Cardiology; Acute coronary syndrome; Revascularization; Disease; Cholesterol","score_opus":0.021538635267783674,"score_gpt":0.23282838443288534,"score_spread":0.21128974916510165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045773125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702555,0.00016234729,0.000009549429,0.0008274672,0.000042131258,0.001801256,0.000048326667,0.000023901794,0.000059462465],"genre_scores_gemma":[0.99815446,0.000042391373,0.000025001587,0.0015403873,0.000074273376,0.000088748275,0.000008698571,0.000031770538,0.000034245044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840415,0.00015851534,0.0002855764,0.0003311277,0.0005998111,0.00022085177],"domain_scores_gemma":[0.9990682,0.000025530642,0.00007037544,0.0005623967,0.00007651903,0.00019695362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021900769,0.00016392686,0.00030928873,0.000026724232,0.000050652492,0.000012822862,0.00016407108,0.000041356227,0.000032811495],"category_scores_gemma":[0.000038481758,0.00009823551,0.00011967554,0.00019948205,0.00008484952,0.00010168543,0.00007177992,0.00019625216,0.000013675183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050697353,0.0005935801,0.99321437,0.00022395187,0.00009076024,0.000009144533,0.0019593087,0.000004107769,0.000254426,0.0000011365778,0.000030787098,0.003111427],"study_design_scores_gemma":[0.003657428,0.0013742966,0.9939455,0.00020176085,0.00019614941,0.0000014496661,0.0004178649,0.000010888794,0.000051196766,0.0000015938278,0.00003997983,0.00010193314],"about_ca_topic_score_codex":0.00010261594,"about_ca_topic_score_gemma":0.00001735751,"teacher_disagreement_score":0.0031504547,"about_ca_system_score_codex":0.00004192571,"about_ca_system_score_gemma":0.000074184005,"threshold_uncertainty_score":0.4005928},"labels":[],"label_agreement":null},{"id":"W3045874060","doi":"10.1016/j.curtheres.2020.100595","title":"Efficacy and Tolerability of a Fixed-Dose Combination of Rosuvastatin and Ezetimibe Compared with a Fixed-Dose Combination of Simvastatin and Ezetimibe in Brazilian Patients with Primary Hypercholesterolemia or Mixed Dyslipidemia: A Multicenter, Randomized Trial","year":2020,"lang":"en","type":"article","venue":"Current Therapeutic Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ipsen; EMS Ingénierie; Abbott Laboratories","keywords":"Ezetimibe; Rosuvastatin; Simvastatin; Tolerability; Medicine; Dyslipidemia; Fixed-dose combination; Statin; Urology; Randomized controlled trial; Internal medicine; Combination therapy; Pharmacology; Gastroenterology; Adverse effect","score_opus":0.07105391249144995,"score_gpt":0.3614800364595567,"score_spread":0.29042612396810674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045874060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99006724,0.0013557462,0.0002878103,0.0005106643,0.000041637457,0.00766647,0.000041861076,0.00001400107,0.000014579231],"genre_scores_gemma":[0.9986663,0.00039915682,0.00052056287,0.000050809173,0.00002085707,0.0001969213,0.00010983778,0.000031203766,0.0000043496693],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946492,0.0020862494,0.0010768727,0.0005582277,0.0012641207,0.00036537801],"domain_scores_gemma":[0.9966897,0.0015073768,0.00039878328,0.00039710646,0.0007403469,0.00026672817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032663255,0.00027289306,0.0016740683,0.00027877354,0.00007420781,0.000028866347,0.00012535612,0.00010932848,0.000010891163],"category_scores_gemma":[0.00079119764,0.0001813075,0.0000948222,0.0005934191,0.0009317783,0.00014849825,0.0001223953,0.0005972487,2.5088912e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78483903,0.0036412277,0.07572568,0.00441157,0.00031769308,0.00000384436,0.004691126,0.000016579517,0.0011860796,0.000030160762,0.00001406888,0.12512295],"study_design_scores_gemma":[0.64003134,0.0051173335,0.34919596,0.0010272088,0.00018277222,0.0000025754928,0.00043296683,0.0033229631,0.00048656273,0.000034370107,0.000024218143,0.00014171591],"about_ca_topic_score_codex":0.0001385,"about_ca_topic_score_gemma":0.00003958891,"teacher_disagreement_score":0.27347028,"about_ca_system_score_codex":0.000090104375,"about_ca_system_score_gemma":0.00035841283,"threshold_uncertainty_score":0.73935056},"labels":[],"label_agreement":null},{"id":"W3046033709","doi":"10.1177/2047487320941987","title":"Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial","year":2020,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Genentech; Esperion Therapeutics; Sirtex Medical; Servier; Eisai; Medicines Company; Amarin Corporation; Regeneron Pharmaceuticals; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; European Society of Cardiology; American Regent; Sanofi; Amgen; Pfizer","keywords":"Alirocumab; Medicine; Statin; Internal medicine; Hazard ratio; PCSK9; Acute coronary syndrome; Adverse effect; Placebo; Myocardial infarction; Cardiology; Cholesterol; Confidence interval; Lipoprotein; LDL receptor","score_opus":0.02869394666617581,"score_gpt":0.2715843761862793,"score_spread":0.24289042952010348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046033709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894409,0.007451671,0.0010144587,0.0009780109,0.00020447235,0.00063745334,0.00017310881,0.0000072282787,0.00009267147],"genre_scores_gemma":[0.9965653,0.0024617014,0.00020575839,0.00032258205,0.00033488576,0.000006313402,0.000033307933,0.00002227701,0.000047892652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99622226,0.0025244707,0.000621068,0.00022713182,0.00027076592,0.00013431293],"domain_scores_gemma":[0.99865955,0.00015270154,0.00052043295,0.00024560496,0.00025705277,0.00016463413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007634363,0.00017172011,0.00092571904,0.000037222635,0.000059960486,0.000007909244,0.000115009,0.000043428307,0.000013968017],"category_scores_gemma":[0.00028564953,0.0000982324,0.00042180132,0.000066260676,0.00009807666,0.00006813486,0.00007256116,0.00030007877,0.000007962063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31998324,0.0016657347,0.3642952,0.0003366104,0.08594306,0.029400425,0.030871836,0.0001585736,0.026654575,0.00015673327,0.019772029,0.120761976],"study_design_scores_gemma":[0.023506815,0.0060954397,0.9641715,0.00006459963,0.0020203777,0.00059952855,0.00042391694,0.000008504938,0.0005645397,0.00005572785,0.0023832803,0.00010576344],"about_ca_topic_score_codex":0.00002783905,"about_ca_topic_score_gemma":0.0000014035095,"teacher_disagreement_score":0.5998763,"about_ca_system_score_codex":0.000047472124,"about_ca_system_score_gemma":0.00008358601,"threshold_uncertainty_score":0.40058008},"labels":[],"label_agreement":null},{"id":"W3047515600","doi":"10.1016/j.atherosclerosis.2020.07.028","title":"Lomitapide for treatment of homozygous familial hypercholesterolemia: The Québec experience","year":2020,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute; Université du Québec à Chicoutimi; McGill University; Université de Montréal; Université Laval; McGill University Health Centre","funders":"Dow AgroSciences; Instituto Danone; Dairy Australia; Medicines Company; Flax Council of Canada; Canola Council of Canada; Amarin Corporation; Ionis Pharmaceuticals; Dairy Farmers of Canada; Regeneron Pharmaceuticals; Novartis; Chiesi Farmaceutici; AstraZeneca; Amgen; Pfizer; Fondation Leducq; Danone Institute North America; Sanofi; Merck","keywords":"Familial hypercholesterolemia; Medicine; Internal medicine; Cholesterol","score_opus":0.066552303807905,"score_gpt":0.2857416877740859,"score_spread":0.21918938396618087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047515600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913298,0.0010299144,0.0009873855,0.005286015,0.00006959535,0.0010842464,0.000025922813,0.000042371565,0.00014478086],"genre_scores_gemma":[0.9961575,0.00050254026,0.00058733864,0.0018921526,0.0003746874,0.0003509324,0.000004883123,0.000030197469,0.00009972266],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99898946,0.00004022422,0.0002544231,0.00026090702,0.00023421142,0.00022078317],"domain_scores_gemma":[0.99918854,0.00006857793,0.000065826614,0.00046324247,0.000064703585,0.00014909277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010425508,0.00014775078,0.00042074017,0.000013141868,0.000105113635,0.000010480022,0.00011127508,0.00006953644,0.000021731175],"category_scores_gemma":[0.00006733514,0.000087758395,0.00041481247,0.00011206609,0.000109843146,0.000035340694,0.00002109882,0.000046036377,0.000013613605],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001824435,0.0014108409,0.07878634,0.00065781426,0.0012451326,0.000016463262,0.071655735,0.000064716514,0.31670585,0.0003085517,0.0021264965,0.5251976],"study_design_scores_gemma":[0.025153352,0.016757645,0.36172336,0.00032119633,0.0016590391,0.00010162052,0.011135107,0.0010074383,0.25904375,0.00004938664,0.32220367,0.000844447],"about_ca_topic_score_codex":0.0053738244,"about_ca_topic_score_gemma":0.00030380642,"teacher_disagreement_score":0.5243532,"about_ca_system_score_codex":0.000101579244,"about_ca_system_score_gemma":0.0001660841,"threshold_uncertainty_score":0.8123651},"labels":[],"label_agreement":null},{"id":"W3048315625","doi":"10.14740/cr1079","title":"Low-Density Lipoprotein Cholesterol Targets in Patients With Coronary Heart Disease in Extremadura (Spain): LYNX Registry","year":2020,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Medicine; Dyslipidemia; Internal medicine; Cardiology; Logistic regression; Diabetes mellitus; Coronary heart disease; Atrial fibrillation; Disease; Cholesterol; Ldl cholesterol; Endocrinology","score_opus":0.03354446299525589,"score_gpt":0.3026028796323328,"score_spread":0.2690584166370769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048315625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99030334,0.001156615,0.000078747486,0.0054716687,0.000054930813,0.0025428315,0.000019891719,0.000047861537,0.00032410992],"genre_scores_gemma":[0.9976043,0.000068665235,0.00009285609,0.001334538,0.000416807,0.00024993683,0.00010754944,0.000047481368,0.00007784749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99557966,0.0011826345,0.0003836532,0.00086783845,0.0010424072,0.0009438292],"domain_scores_gemma":[0.99777,0.00007821425,0.000043503995,0.0010035903,0.0003340463,0.00077065674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001914984,0.00024191815,0.0010387443,0.0002480349,0.00010855704,0.000018774894,0.0002229057,0.0002474254,0.000027540984],"category_scores_gemma":[0.0007409503,0.00019979388,0.00019007227,0.0007144869,0.00040267094,0.00009998605,0.00023559468,0.0014816953,0.00008191692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043348595,0.00018319271,0.98532856,0.00045168592,0.000083835235,0.002161102,0.0001640277,0.000060584043,0.00014901767,0.000008659202,0.0007547795,0.0063196723],"study_design_scores_gemma":[0.0053374767,0.00094531267,0.9915146,0.00024496732,0.000021257252,0.000037619524,0.00010953273,0.000056014505,0.000103719714,0.000028460125,0.0014179827,0.00018302971],"about_ca_topic_score_codex":0.0005441071,"about_ca_topic_score_gemma":0.00005796277,"teacher_disagreement_score":0.0073009753,"about_ca_system_score_codex":0.00029511805,"about_ca_system_score_gemma":0.00061385916,"threshold_uncertainty_score":0.8147358},"labels":[],"label_agreement":null},{"id":"W3049374360","doi":"10.1161/circgen.120.002919","title":"Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"Circulation Genomic and Precision Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St. Paul's Hospital; Montreal Clinical Research Institute; McGill University; University of British Columbia","funders":"Medical Research Council","keywords":"Medicine; Internal medicine; Familial hypercholesterolemia; Hazard ratio; Cohort; Atherosclerotic cardiovascular disease; Myocardial infarction; Biobank; PCSK9; Framingham Risk Score; Proportional hazards model; Cardiology; Cholesterol; Endocrinology; Lipoprotein; Disease; LDL receptor; Confidence interval; Bioinformatics; Biology","score_opus":0.023822526533876533,"score_gpt":0.2545294637450882,"score_spread":0.2307069372112117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049374360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96797544,0.00770011,0.020242006,0.0018215524,0.0001354625,0.0020172135,0.000020224401,0.00005132506,0.00003664701],"genre_scores_gemma":[0.9958183,0.00094734534,0.0003124824,0.0020199493,0.00077887287,0.00004412895,0.00003504946,0.000034031633,0.00000983066],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99727607,0.00032115667,0.0006581214,0.0007890988,0.00061416416,0.00034141706],"domain_scores_gemma":[0.9984387,0.000066378,0.00010755705,0.00056233705,0.00014583753,0.00067915366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001781292,0.0002840528,0.00095047127,0.0002052486,0.00014735156,0.00002431711,0.00008659394,0.00022872529,0.00003232447],"category_scores_gemma":[0.0005984288,0.00024453524,0.00020405154,0.00035507808,0.00009519735,0.00010680162,0.00010765523,0.00041928838,0.000029251281],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010895131,0.00005407829,0.15589938,0.0003104487,0.0004962059,0.000060108723,0.0034462947,0.0008441577,0.074888475,0.0000330761,0.0000822688,0.762796],"study_design_scores_gemma":[0.006867743,0.0003775709,0.98708516,0.00026296332,0.00033803424,0.00012005704,0.0001959349,0.0021351161,0.00052462774,0.0001109462,0.0017590936,0.00022275193],"about_ca_topic_score_codex":0.000894466,"about_ca_topic_score_gemma":0.00003784268,"teacher_disagreement_score":0.8311858,"about_ca_system_score_codex":0.00013900003,"about_ca_system_score_gemma":0.000090956746,"threshold_uncertainty_score":0.99718577},"labels":[],"label_agreement":null},{"id":"W3080356411","doi":"10.1093/eurheartj/ehaa498","title":"Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian VIGOUR Centre; St. Michael's Hospital; University of Alberta","funders":"","keywords":"Medicine; Alirocumab; Acute coronary syndrome; PCSK9; Renal function; Internal medicine; Hazard ratio; Unstable angina; Cardiology; Myocardial infarction; Placebo; Confidence interval; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.03436603245559996,"score_gpt":0.3104830270275693,"score_spread":0.27611699457196937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080356411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942576,0.00025714166,0.0010037833,0.00094695087,0.00046040508,0.0029609038,0.000017736122,0.00002340893,0.000072047456],"genre_scores_gemma":[0.99780697,0.00015913197,0.00022540364,0.0011207671,0.0005577307,0.000022833066,0.00004117631,0.0000504204,0.000015566353],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.988357,0.008201616,0.0011582529,0.00048158283,0.0014865767,0.00031498243],"domain_scores_gemma":[0.9977011,0.0006834975,0.0003213826,0.00069968053,0.0001468039,0.00044751068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009930152,0.00029080667,0.0023562296,0.00018728645,0.00013708194,0.00002687683,0.00020108052,0.00006666161,0.00009309619],"category_scores_gemma":[0.0013315032,0.00015503298,0.0026780937,0.00070106104,0.000048250386,0.000093074676,0.00009943452,0.0008268494,0.000043214146],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6282416,0.00018873467,0.34058973,0.00001534701,0.017924417,0.00032697147,0.00010688419,0.00040709222,0.0000035871617,3.5982524e-7,0.00021435345,0.011980895],"study_design_scores_gemma":[0.3574934,0.0057888976,0.6282742,0.00014162011,0.0071234903,0.000029245242,0.0000260305,0.000019712477,0.000008383274,6.040242e-7,0.0009864413,0.00010800531],"about_ca_topic_score_codex":0.00004823866,"about_ca_topic_score_gemma":0.0000027940896,"teacher_disagreement_score":0.28768444,"about_ca_system_score_codex":0.00010475076,"about_ca_system_score_gemma":0.0001061347,"threshold_uncertainty_score":0.6322061},"labels":[],"label_agreement":null},{"id":"W3081393036","doi":"10.2459/jcm.0000000000001108","title":"Updated clinical evidence and place in therapy of bempedoic acid for hypercholesterolemia: ANMCO position paper","year":2020,"lang":"en","type":"review","venue":"Journal of Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Medicine; Atherosclerotic cardiovascular disease; Familial hypercholesterolemia; Position (finance); Cardiovascular health; Position paper; Ldl cholesterol; Disease; Mechanism (biology); Cholesterol; Intensive care medicine; Internal medicine; Pathology","score_opus":0.11365750479861858,"score_gpt":0.407075333941597,"score_spread":0.2934178291429784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081393036","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012018656,0.9939275,0.00070828217,0.0012974436,0.00049632497,0.0023111387,0.000012164999,0.000011535631,0.000033767767],"genre_scores_gemma":[0.0015114889,0.99379826,0.00075903087,0.00056086376,0.0031873635,0.00004478431,0.00003930333,0.00009076082,0.0000081422995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932125,0.001264494,0.003073289,0.00053967844,0.001564358,0.00034565481],"domain_scores_gemma":[0.9962977,0.00046141454,0.0011845208,0.0009091801,0.0006603852,0.00048677291],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010290316,0.0005293041,0.008759064,0.0004823126,0.000040175237,0.000012560147,0.00028445545,0.0006750194,0.000016773145],"category_scores_gemma":[0.0014568319,0.00033588396,0.0050043873,0.00058639597,0.00025685833,0.00021472714,0.00006173259,0.0015505643,0.0000016870425],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005773874,0.00010217974,0.000039826602,0.012128431,0.00810436,0.0005259288,0.00011644747,0.000004655827,0.000015679643,0.0000043107693,0.00048957905,0.9778912],"study_design_scores_gemma":[0.00822477,0.0035181385,0.0005446092,0.05282201,0.010906613,0.0052309944,0.00008328062,0.0000058659466,0.000008532579,0.000010723986,0.9184103,0.0002341833],"about_ca_topic_score_codex":0.00003401706,"about_ca_topic_score_gemma":0.0000021004987,"teacher_disagreement_score":0.977657,"about_ca_system_score_codex":0.0002095788,"about_ca_system_score_gemma":0.0011747049,"threshold_uncertainty_score":0.99990934},"labels":[],"label_agreement":null},{"id":"W3081608012","doi":"10.1161/circulationaha.119.045407","title":"Phenomics, Not Genomics, for Cardiovascular Risk Assessment","year":2020,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Phenomics; Medicine; Genomics; Risk assessment; Internal medicine; Genome; Genetics; Gene","score_opus":0.06341869937732583,"score_gpt":0.33416366249412144,"score_spread":0.27074496311679563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081608012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012815811,0.9364779,0.056537353,0.00006117645,0.00051502266,0.005771697,0.0002153548,0.00010150682,0.00030717097],"genre_scores_gemma":[0.00035212038,0.98869056,0.0055848113,0.00010435771,0.0031159483,0.00058094336,0.0013804872,0.00017318416,0.000017612347],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722046,0.00024549005,0.0008238303,0.00082937087,0.00053321675,0.0003476264],"domain_scores_gemma":[0.9978031,0.000069995025,0.00043064592,0.0012509472,0.00018129918,0.0002640162],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013020049,0.000453776,0.0032332395,0.00014574015,0.00017195805,0.000055186934,0.00014348792,0.00044257723,0.00001785801],"category_scores_gemma":[0.00017155473,0.000413554,0.0066169314,0.0002100779,0.00003158406,0.000060954917,0.000054323576,0.0005292157,0.000074337724],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009039591,0.000025914806,0.000023908531,0.018844953,0.005007253,0.000012098783,0.000023354412,0.00006204754,5.760059e-7,0.00026608852,0.00011235805,0.9756124],"study_design_scores_gemma":[0.00097272475,0.000050871935,0.00034244804,0.0015998285,0.016506454,0.00007612814,0.000009081637,0.0004895259,7.8309523e-7,0.000086999455,0.9794999,0.0003652925],"about_ca_topic_score_codex":0.0000712756,"about_ca_topic_score_gemma":0.0000013269287,"teacher_disagreement_score":0.9793875,"about_ca_system_score_codex":0.0012618646,"about_ca_system_score_gemma":0.0013610527,"threshold_uncertainty_score":0.9998316},"labels":[],"label_agreement":null},{"id":"W3081628262","doi":"10.3390/jcm9092843","title":"Fatty Acid Binding Protein 4—A Circulating Protein Associated with Peripheral Arterial Disease in Diabetic Patients","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Western University; McMaster University; University of Toronto; St. Michael's Hospital","funders":"Blair Foundation","keywords":"Medicine; Peripheral; Arterial disease; Internal medicine; Diabetes mellitus; Fatty acid-binding protein; Disease; Vascular disease; Endocrinology; Biochemistry; Gene","score_opus":0.04874331480195594,"score_gpt":0.33475525811225343,"score_spread":0.2860119433102975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081628262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895992,0.00019456602,0.00028466902,0.008094747,0.0002759573,0.001379539,0.0000047851795,0.000021422089,0.00014510576],"genre_scores_gemma":[0.9956497,0.000014749461,0.00059016526,0.0010651873,0.0025854418,0.000023602688,0.000016497932,0.000035068733,0.000019572184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952322,0.0005285194,0.0021201621,0.0003129759,0.0014199733,0.00038615245],"domain_scores_gemma":[0.996969,0.00011914359,0.0010898348,0.00024584663,0.00042587979,0.0011503136],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0026389556,0.00023710073,0.0015664359,0.000114196984,0.000059183603,0.00001556392,0.00014745284,0.0001361286,0.00012748234],"category_scores_gemma":[0.012110694,0.00014771975,0.0003650391,0.00045130483,0.00017614209,0.00014681717,0.000037294787,0.0011276671,0.0000040457967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070621944,0.0013241394,0.9465992,0.00072046893,0.00067371444,0.0025296707,0.00051795266,0.00002401247,0.0100888815,0.000023488848,0.00011370127,0.030322589],"study_design_scores_gemma":[0.036945477,0.009377059,0.943714,0.007771962,0.00047112192,0.000023510389,0.00016028892,0.00048334978,0.00042628116,0.00004649415,0.00034000116,0.00024041222],"about_ca_topic_score_codex":0.000014303845,"about_ca_topic_score_gemma":0.0000044204653,"teacher_disagreement_score":0.030082177,"about_ca_system_score_codex":0.00014271223,"about_ca_system_score_gemma":0.0005474618,"threshold_uncertainty_score":0.9962107},"labels":[],"label_agreement":null},{"id":"W3082030579","doi":"10.20996/1819-6446-2020-08-21","title":"Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues","year":2020,"lang":"en","type":"article","venue":"Rational Pharmacotherapy in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; PCSK9; Dyslipidemia; Intensive care medicine; Proprotein convertase; Alirocumab; Canadian Cardiovascular Society; Internal medicine; Cholesterol; Lipoprotein; Disease; LDL receptor; Health care; Angina","score_opus":0.03189662194605036,"score_gpt":0.31094136386834104,"score_spread":0.2790447419222907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082030579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782594,0.014713371,0.00046184435,0.004534049,0.00006922738,0.0017719038,0.000023718187,0.000013068493,0.00015344672],"genre_scores_gemma":[0.9925469,0.0040153423,0.00055843446,0.0022976215,0.0003527174,0.00016230646,0.00004517805,0.00001657233,0.000004922241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984417,0.00024636215,0.0003573582,0.00027981648,0.0005122581,0.00016253826],"domain_scores_gemma":[0.99952966,0.000023236513,0.00005185054,0.00022562197,0.000105597064,0.000064031075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005224452,0.00013835102,0.00049709505,0.00005904934,0.00002840192,0.0000060652856,0.00008182205,0.000040591563,0.000016133366],"category_scores_gemma":[0.000009605606,0.00008833374,0.00018558667,0.00022769073,0.00007482897,0.00004566129,0.000020895532,0.00011841818,0.0000012451287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020571651,0.00040732574,0.9077372,0.0011414924,0.0058983816,0.0002644336,0.0017676521,0.015828094,0.00058763206,0.00089414394,0.0023093985,0.06110707],"study_design_scores_gemma":[0.011595334,0.0005618428,0.9489257,0.00016167112,0.00045852788,0.0000124484,0.00055178325,0.00028421945,0.00019429535,0.000085572545,0.036977492,0.00019112496],"about_ca_topic_score_codex":0.000043758864,"about_ca_topic_score_gemma":0.0000015966336,"teacher_disagreement_score":0.060915947,"about_ca_system_score_codex":0.000038004328,"about_ca_system_score_gemma":0.000043408872,"threshold_uncertainty_score":0.36021456},"labels":[],"label_agreement":null},{"id":"W3082598532","doi":"10.20956/mff.v24i2.10384","title":"PENGGUNAAN STATIN DAN ANTIPLATELET SEBAGAI PENCEGAHAN SEKUNDER KOMPLIKASI KARDIOVASKULER PADA PASIEN DIABETES MELITUS TIPE 2","year":2020,"lang":"id","type":"article","venue":"Majalah Farmasi dan Farmakologi","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aspirin; Gynecology; Internal medicine","score_opus":0.02872732429364055,"score_gpt":0.2561188049112857,"score_spread":0.22739148061764514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082598532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93574333,0.020649312,0.001237539,0.016486436,0.00291682,0.005255813,0.00044049555,0.001236501,0.016033737],"genre_scores_gemma":[0.96898305,0.0035968467,0.0013912414,0.01863105,0.0037725775,0.00030899254,0.00097584876,0.00044651233,0.0018938591],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98486143,0.002389521,0.0025454306,0.003202492,0.0030045565,0.003996591],"domain_scores_gemma":[0.99215513,0.00050008134,0.0009383352,0.002875166,0.0006786452,0.002852656],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0032851112,0.0021301752,0.0039985115,0.0003922912,0.0010451296,0.00045268078,0.0016187712,0.0012671937,0.0008652292],"category_scores_gemma":[0.001044215,0.0019408984,0.0021767956,0.0017987856,0.00097004045,0.00066875486,0.0012331834,0.0035888897,0.0012231942],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035043112,0.0044630305,0.35310835,0.014252219,0.022095105,0.014391223,0.021605218,0.0016116715,0.043380376,0.0024113846,0.10917469,0.41000244],"study_design_scores_gemma":[0.023154233,0.005069388,0.11262481,0.0012597373,0.0053055016,0.0007072346,0.014887442,0.0064525874,0.030955048,0.00015267618,0.7940622,0.0053691515],"about_ca_topic_score_codex":0.00034492818,"about_ca_topic_score_gemma":0.00004413447,"teacher_disagreement_score":0.6848875,"about_ca_system_score_codex":0.00060802663,"about_ca_system_score_gemma":0.0010872477,"threshold_uncertainty_score":0.99955446},"labels":[],"label_agreement":null},{"id":"W3082704660","doi":"10.1016/j.jacl.2020.08.009","title":"Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"Abbott Vascular; National Institutes of Health; Novo Nordisk; Medicines Company; Valeant Pharmaceuticals International; Novartis; Eli Lilly and Company; AstraZeneca; Pfizer; NIHR Imperial Biomedical Research Centre; Amgen; Boehringer Ingelheim; Kowa Company; Meso Scale Diagnostics; Sanofi; Esperion Therapeutics; Merck; American Heart Association; American Diabetes Association","keywords":"Medicine; Placebo; Internal medicine; Discontinuation; Gastroenterology; Adverse effect; myalgia; Uric acid","score_opus":0.5493554365692096,"score_gpt":0.565551082466481,"score_spread":0.016195645897271405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082704660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7956081,0.007878117,0.08384033,0.097095035,0.013012077,0.0011751389,0.0007491429,0.00008214349,0.0005598929],"genre_scores_gemma":[0.8734023,0.0056956364,0.011264005,0.024407096,0.084796295,0.0000027504648,0.00033677262,0.00004411893,0.00005103638],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97875017,0.009201116,0.009914201,0.00077006954,0.0009512916,0.00041316176],"domain_scores_gemma":[0.98333496,0.0082567185,0.0040904144,0.0019054036,0.00057633035,0.0018361496],"candidate_categories":["metaresearch","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.055004135,0.00027844604,0.0072491663,0.00017602429,0.0000704341,0.000028166292,0.0009199714,0.000760845,0.0016568572],"category_scores_gemma":[0.092626825,0.00018796089,0.004826203,0.0006157378,0.00025117962,0.00019270962,0.00035693328,0.0024372048,0.00014420619],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05728999,0.003952405,0.122590676,0.00012835575,0.07745731,0.0012421518,0.0001361952,0.000030220403,0.0005259318,0.00008605979,0.10940362,0.6271571],"study_design_scores_gemma":[0.068905376,0.012346512,0.14717151,0.00014362457,0.05722229,0.00032660182,0.0001948351,0.0043608095,0.000068912916,0.00045365785,0.70838016,0.0004257229],"about_ca_topic_score_codex":0.00003714594,"about_ca_topic_score_gemma":0.000026226018,"teacher_disagreement_score":0.6267314,"about_ca_system_score_codex":0.000027947463,"about_ca_system_score_gemma":0.0013808752,"threshold_uncertainty_score":0.9998642},"labels":[],"label_agreement":null},{"id":"W3082704731","doi":"10.1002/jcp.30025","title":"Physiology and role of PCSK9 in vascular disease: Potential impact of localized PCSK9 in vascular wall","year":2020,"lang":"en","type":"review","venue":"Journal of Cellular Physiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Canadian Institutes of Health Research; National Natural Science Foundation of China","keywords":"PCSK9; Proprotein convertase; LDL receptor; Kexin; Medicine; Pathogenesis; Coronary artery disease; Vascular disease; Internal medicine; Bioinformatics; Cholesterol; Lipoprotein; Endocrinology; Biology","score_opus":0.012780310938862135,"score_gpt":0.2885186346306465,"score_spread":0.27573832369178436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082704731","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09240533,0.90630466,0.00009962618,0.000026113039,0.00014004542,0.0009796044,0.000026541387,0.000005833669,0.000012264295],"genre_scores_gemma":[0.14771233,0.8514382,0.00012822995,0.00003153883,0.0005042674,0.000018438563,0.00008760606,0.000075968645,0.0000034047464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942502,0.0015658971,0.0023923914,0.000567701,0.0006607476,0.0005630671],"domain_scores_gemma":[0.99660605,0.000103734244,0.0017166629,0.0008228548,0.00027662358,0.00047408137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012334113,0.000633179,0.0075955056,0.000753294,0.000024305049,0.0000059790987,0.00039606285,0.0006381256,0.000111155474],"category_scores_gemma":[0.00020098357,0.00045115672,0.0046251626,0.00062586763,0.0002766442,0.00008823801,0.00018883297,0.0013124347,0.0000051688135],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003816152,0.003085232,0.00038949607,0.11233001,0.017291777,0.0029383001,0.0005048617,0.0015144517,0.13418646,0.00015648978,0.00008329261,0.72370344],"study_design_scores_gemma":[0.034320783,0.010494285,0.05759277,0.04852478,0.023484187,0.0012982786,0.00025243263,0.0020662183,0.0010929737,0.0038951717,0.814357,0.0026211687],"about_ca_topic_score_codex":0.00032099578,"about_ca_topic_score_gemma":0.000003967457,"teacher_disagreement_score":0.81427366,"about_ca_system_score_codex":0.00025819303,"about_ca_system_score_gemma":0.0017577878,"threshold_uncertainty_score":0.999794},"labels":[],"label_agreement":null},{"id":"W3082719615","doi":"10.1056/nejmoa2019910","title":"Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; Centre hospitalier universitaire de Québec","funders":"Amgen","keywords":"Evolocumab; Familial hypercholesterolemia; PCSK9; Kexin; Proprotein convertase; Medicine; Alirocumab; Monoclonal antibody; Monoclonal; Heterozygote advantage; Internal medicine; Endocrinology; Cholesterol; Lipoprotein; LDL receptor; Antibody; Genetics; Biology; Immunology; Allele; Gene","score_opus":0.02411238369754403,"score_gpt":0.2695301940061424,"score_spread":0.24541781030859838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082719615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658524,0.0061222627,0.00061780267,0.025947426,0.00046381867,0.00020524133,7.8899126e-7,0.000014248427,0.000776032],"genre_scores_gemma":[0.9743342,0.0021626714,0.0004225276,0.0040656123,0.01894072,9.92821e-7,0.0000024391675,0.00002078944,0.000050045284],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978758,0.00012841167,0.00070733886,0.0001643976,0.0008764497,0.00024759746],"domain_scores_gemma":[0.9987106,0.0000615988,0.00019439617,0.00020603444,0.00013325835,0.00069415994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011192713,0.0001568885,0.0007794205,0.00020837736,0.000021952546,0.000005744071,0.00013030699,0.00009276974,0.000085252876],"category_scores_gemma":[0.00062058325,0.000101724225,0.00016201497,0.00034090402,0.00004033482,0.00008263233,0.000023221754,0.00072477886,0.000011098625],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048629716,0.00017539304,0.17541327,0.0006255659,0.00021869277,0.0059442846,0.005763908,0.00013761112,0.0031829518,0.000031319956,0.015249001,0.78839505],"study_design_scores_gemma":[0.3414672,0.016406726,0.46533772,0.0009749499,0.0012611839,0.013284092,0.00075320737,0.0002539402,0.00039962266,0.00028299328,0.15915108,0.00042729278],"about_ca_topic_score_codex":0.00015943391,"about_ca_topic_score_gemma":0.000021866186,"teacher_disagreement_score":0.78796774,"about_ca_system_score_codex":0.00007489113,"about_ca_system_score_gemma":0.00036558133,"threshold_uncertainty_score":0.41481933},"labels":[],"label_agreement":null},{"id":"W3082766308","doi":"10.1016/j.cjco.2020.08.009","title":"Landscape of Lipid Management Following an Acute Coronary Syndrome Event: Survey of Canadian Specialists","year":2020,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Montreal Heart Institute; University of Alberta; Université de Montréal; McMaster University; Canadian Respiratory Research Network","funders":"","keywords":"Medicine; Acute coronary syndrome; Guideline; Cholesterol; Familial hypercholesterolemia; Internal medicine; Ldl cholesterol; Statin; Population; Clinical trial; Myocardial infarction; Environmental health","score_opus":0.03808640381193011,"score_gpt":0.2959104914594657,"score_spread":0.25782408764753556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082766308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98274016,0.00027180676,0.000022652948,0.0006913294,0.00018161553,0.0012100167,0.00011379948,0.000009969039,0.014758666],"genre_scores_gemma":[0.99833435,0.00011859515,0.000377165,0.00055379217,0.000074144715,0.000014637613,0.00023266504,0.000021400965,0.0002732388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884033,0.00011324307,0.00028350952,0.0002336932,0.0003196031,0.0002096109],"domain_scores_gemma":[0.9989717,0.000008532017,0.00006955588,0.00046409268,0.000057912617,0.00042821563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077806547,0.000100700665,0.0006009779,0.000121670586,0.000042375053,0.000015225728,0.0003128562,0.000051297644,0.00029555577],"category_scores_gemma":[0.000025781772,0.00009233621,0.00014503712,0.00048168475,0.0000163122,0.000103462466,0.00014538271,0.00008006945,0.00001826311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019885441,0.0006814209,0.8526494,0.0027620874,0.011712683,0.013513449,0.003596711,0.0000711378,0.0007326781,0.0015583035,0.024886664,0.08584694],"study_design_scores_gemma":[0.0018411822,0.0005471077,0.98873925,0.00013473617,0.00022733756,0.00006878697,0.00014678926,0.000035868423,0.00012553607,0.000006601628,0.008020828,0.000105983716],"about_ca_topic_score_codex":0.15563281,"about_ca_topic_score_gemma":0.040441923,"teacher_disagreement_score":0.13608986,"about_ca_system_score_codex":0.000045553643,"about_ca_system_score_gemma":0.00029657732,"threshold_uncertainty_score":0.97706753},"labels":[],"label_agreement":null},{"id":"W3083258151","doi":"10.1161/jaha.119.014711","title":"Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low‐Density Lipoprotein Cholesterol—The Framingham Heart Study","year":2020,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Saskatchewan; McGill University Health Centre; University of Toronto","funders":"National Heart, Lung, and Blood Institute; School of Medicine, Boston University","keywords":"Medicine; Internal medicine; Lipoprotein(a); Lipoprotein; Hazard ratio; Framingham Risk Score; Cholesterol; Risk factor; High-density lipoprotein; Framingham Heart Study; Endocrinology; Disease; Cardiology; Confidence interval","score_opus":0.02645278912454591,"score_gpt":0.2810247984969638,"score_spread":0.2545720093724179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083258151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98907137,0.0005480238,0.00009884063,0.008611574,0.00006796101,0.0015746136,0.000009475219,0.000012453635,0.00000571097],"genre_scores_gemma":[0.9980431,0.000069314585,0.00010150626,0.0014320165,0.0002871357,0.00002764064,0.0000013028989,0.000026096186,0.00001183775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957184,0.0012811255,0.00074047846,0.00023209679,0.0017599275,0.00026793618],"domain_scores_gemma":[0.99753886,0.00020735283,0.00095013203,0.0004948336,0.00056220684,0.00024659978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004056283,0.00018623826,0.001244497,0.00009420394,0.00017032641,0.000040064246,0.00015453593,0.00005920304,0.0000024509575],"category_scores_gemma":[0.0029269848,0.00011333227,0.00063438487,0.0008308748,0.00012449286,0.0001316181,0.00008603186,0.000738866,0.0000011806628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003665049,0.00035397048,0.9928274,0.00004385416,0.0015385026,0.00002355542,0.001273832,0.00051671406,0.00049754244,0.000001276402,0.00011610602,0.0024407017],"study_design_scores_gemma":[0.0025432133,0.0012469672,0.9927401,0.00026381286,0.00095641793,0.000030160301,0.0011786547,0.00029772232,0.00037956296,0.000014468582,0.00023749124,0.00011144354],"about_ca_topic_score_codex":0.0039245863,"about_ca_topic_score_gemma":0.00035368695,"teacher_disagreement_score":0.008971802,"about_ca_system_score_codex":0.00058956246,"about_ca_system_score_gemma":0.00042005323,"threshold_uncertainty_score":0.5932827},"labels":[],"label_agreement":null},{"id":"W3083451975","doi":"10.1007/s12325-020-01483-y","title":"Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease","year":2020,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Medicine; Internal medicine; Coronary artery disease; Lipoprotein(a); Population; Platelet; P2Y12; Gastroenterology; Univariate analysis; Endocrinology; Lipoprotein; Cardiology; Cholesterol; Multivariate analysis; Platelet aggregation","score_opus":0.014335108524475558,"score_gpt":0.2750602372448577,"score_spread":0.2607251287203821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083451975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915599,0.0044206795,0.00084102945,0.0018603186,0.000022732702,0.0011935043,0.000012601917,0.000016439819,0.000072794704],"genre_scores_gemma":[0.9947115,0.0025681928,0.0017888662,0.00074967736,0.000054617223,0.000090778536,0.00001891497,0.0000125483175,0.0000049057085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914175,0.00007260313,0.00019419215,0.00022674317,0.00023478108,0.0001299498],"domain_scores_gemma":[0.99956024,0.000026330557,0.000062834086,0.00018003315,0.000025881509,0.00014469866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017856952,0.00009645869,0.0002890646,0.000054272703,0.000020535423,0.0000048351803,0.000034146484,0.00003535517,0.000009523381],"category_scores_gemma":[0.000036931076,0.000076546,0.00002482209,0.00024317908,0.000050615745,0.00023919159,0.000010144334,0.00013536448,9.5003895e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019058689,0.00013700161,0.79370785,0.00008795492,0.000044616823,0.000038080456,0.0011713923,0.0005156487,0.0011486186,0.00036216847,0.0000034372692,0.20087738],"study_design_scores_gemma":[0.00398483,0.0006756067,0.98975885,0.00018408251,0.0000109631865,0.00001262288,0.00010404432,0.00007525792,0.0019978504,0.00041232945,0.002684707,0.000098842866],"about_ca_topic_score_codex":0.00011170431,"about_ca_topic_score_gemma":0.00010199973,"teacher_disagreement_score":0.20077854,"about_ca_system_score_codex":0.000030879608,"about_ca_system_score_gemma":0.00008841064,"threshold_uncertainty_score":0.31214553},"labels":[],"label_agreement":null},{"id":"W3083461542","doi":"10.24875/acme.m20000106","title":"Phenotype of definite familial hypercholesterolemia with negative genetic study in Argentina","year":2020,"lang":"es","type":"article","venue":"Archivos de cardiolog�a de M�xico (English ed Internet)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Secretaría de Ciencia y Técnica, Universidad de Buenos Aires; Robarts Research Institute; Universidad de Buenos Aires; Sanofi; Amgen","keywords":"Familial hypercholesterolemia; Single-nucleotide polymorphism; PCSK9; Genetics; Apolipoprotein B; SNP; Gene duplication; Gene; Genetic diagnosis; Context (archaeology); Disease; LDL receptor; Biology; Medicine; Bioinformatics; Internal medicine; Genotype; Lipoprotein; Cholesterol","score_opus":0.01569147391524568,"score_gpt":0.24647945408220226,"score_spread":0.2307879801669566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083461542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98795927,0.002621009,0.001774117,0.00016510961,0.00033933792,0.002681603,0.00009401536,0.00011341883,0.004252138],"genre_scores_gemma":[0.99342424,0.00093498675,0.0017918847,0.0011942826,0.0021685727,0.00023776297,0.000046456546,0.00015632696,0.000045505905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932639,0.0021083744,0.0012282885,0.0012516164,0.0008228971,0.0013249391],"domain_scores_gemma":[0.9969775,0.00037099712,0.00036315262,0.0011437202,0.00036613346,0.0007785122],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013105345,0.0007568789,0.0021887897,0.00030189977,0.000068403715,0.0000782833,0.000719759,0.00034604,0.000043448494],"category_scores_gemma":[0.0014177801,0.00066580065,0.0007270589,0.0006195079,0.0004519571,0.00011998419,0.00046259884,0.0017220643,0.000054418855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036185423,0.0006451141,0.92786205,0.0009228586,0.0028096999,0.001804914,0.046489324,0.0014797604,0.0012117473,0.00011853243,0.00041411835,0.012623333],"study_design_scores_gemma":[0.010758532,0.007675336,0.9632452,0.0010630962,0.0014170508,0.00017094915,0.010310346,0.0010269461,0.0015470921,0.000108489825,0.0019483343,0.0007286021],"about_ca_topic_score_codex":0.0014136513,"about_ca_topic_score_gemma":0.00011955259,"teacher_disagreement_score":0.03617898,"about_ca_system_score_codex":0.00039650148,"about_ca_system_score_gemma":0.00087499263,"threshold_uncertainty_score":0.9995793},"labels":[],"label_agreement":null},{"id":"W3083630580","doi":"10.1016/j.diabres.2020.108416","title":"Real-world effectiveness of treatments for type 2 diabetes, hypercholesterolemia, and hypertension in Canadian routine care – Results from the CardioVascular and metabolic treatment in Canada: Assessment of REal-life therapeutic value (CV-CARE) registry, 12-months results","year":2020,"lang":"en","type":"article","venue":"Diabetes Research and Clinical Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); University of Toronto; Canada Research Chairs; University of New Brunswick; LMC Diabetes & Endocrinology (Canada)","funders":"Bausch Health","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Chlorthalidone; Internal medicine; Population; Metformin; Blood pressure; Endocrinology","score_opus":0.10308767880120356,"score_gpt":0.4060361879303143,"score_spread":0.30294850912911075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083630580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96620786,0.027757704,7.5594266e-7,0.0023024918,0.00005815963,0.0025802688,0.0005623795,0.0000053073995,0.00052506325],"genre_scores_gemma":[0.9721636,0.026795218,0.00019021689,0.000281159,0.00012353183,0.00011773347,0.0002925547,0.000029834582,0.0000061496908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99423486,0.0027210477,0.00088735134,0.0007816962,0.00075357227,0.00062145974],"domain_scores_gemma":[0.9903047,0.0074397945,0.0001813516,0.0007992566,0.00054838654,0.00072648993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00527168,0.0002431416,0.0013303448,0.00011644273,0.00012339426,0.000028636146,0.00013097432,0.0001591811,6.9652464e-7],"category_scores_gemma":[0.005736496,0.00016685504,0.00017939915,0.0004312777,0.00021508722,0.00010484177,0.00009317674,0.00052750856,1.9126851e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004953684,0.0002775355,0.91414595,0.00066928857,0.0027974015,0.00009048106,0.00073769165,0.000045404755,0.00023102725,0.00005149682,0.000031638763,0.07596841],"study_design_scores_gemma":[0.013322993,0.0025709427,0.9748114,0.00041391124,0.0009283529,0.0000011493939,0.0020518664,0.0007075219,0.00030100674,0.000014283298,0.004743902,0.00013267268],"about_ca_topic_score_codex":0.9865932,"about_ca_topic_score_gemma":0.916511,"teacher_disagreement_score":0.075835735,"about_ca_system_score_codex":0.0007026929,"about_ca_system_score_gemma":0.0043921713,"threshold_uncertainty_score":0.77915233},"labels":[],"label_agreement":null},{"id":"W3084528625","doi":"10.1016/j.cjco.2020.09.007","title":"Montreal-FH-SCORE Predicts Coronary Artery Calcium Score in Patients With Familial Hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Montreal Clinical Research Institute; Université de Montréal","funders":"Amgen Canada; Institut de Recherche Clinique De Montréal; Fondation Leducq; Sanofi","keywords":"Medicine; Odds ratio; Internal medicine; Familial hypercholesterolemia; Confidence interval; Univariate analysis; Population; Coronary artery disease; Coronary Calcium Score; Framingham Risk Score; Cardiology; Risk factor; Disease; Multivariate analysis; Cholesterol; Coronary artery calcium","score_opus":0.02954253144135661,"score_gpt":0.25771284674698997,"score_spread":0.22817031530563336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084528625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99254036,0.00014209482,0.000060149283,0.0009031915,0.0001020301,0.0025497999,0.000050319803,0.00004675959,0.0036052987],"genre_scores_gemma":[0.9950382,0.000020274218,0.00019346307,0.0039112,0.00031028595,0.00010456566,0.00021626527,0.000047965106,0.00015778527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820155,0.000083484614,0.00030805802,0.00049528753,0.0005434097,0.0003682342],"domain_scores_gemma":[0.99883896,0.000012006139,0.000061282306,0.00057582796,0.00008917567,0.00042275403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020230713,0.00021730916,0.000654369,0.00004876831,0.0000605859,0.00004756091,0.0002955126,0.00012168779,0.000054579756],"category_scores_gemma":[0.000039438342,0.00016375721,0.00009152096,0.00022403913,0.000058162223,0.00024021603,0.00023799465,0.0003520901,0.00005975585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025963332,0.00026731417,0.95000976,0.00018425408,0.00014923769,0.0005277325,0.00086062297,0.00002014537,0.00006467776,0.000005356491,0.0023633435,0.042951237],"study_design_scores_gemma":[0.011393917,0.0013996102,0.98407257,0.0003214576,0.000091254755,0.00003471096,0.00013192226,0.0000685209,0.00006670277,0.000007963547,0.0022360089,0.00017535182],"about_ca_topic_score_codex":0.0012594409,"about_ca_topic_score_gemma":0.0002636459,"teacher_disagreement_score":0.042775888,"about_ca_system_score_codex":0.00011137809,"about_ca_system_score_gemma":0.0002902774,"threshold_uncertainty_score":0.66778255},"labels":[],"label_agreement":null},{"id":"W3084579319","doi":"10.1097/ccm.0000000000004519","title":"Lipoprotein Biology in Sepsis*","year":2020,"lang":"en","type":"letter","venue":"Critical Care Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Sepsis; Columbia university; Intensive care medicine; Gerontology; Internal medicine; Library science; Media studies","score_opus":0.03364326717052769,"score_gpt":0.33434446911474774,"score_spread":0.30070120194422006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3084579319","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022740738,0.02413901,0.0003307419,0.9599202,0.0010591081,0.0012112855,0.000051380648,0.00015573546,0.0129050845],"genre_scores_gemma":[0.05924418,0.00025603833,0.0004630496,0.9104809,0.027728878,0.0002050704,0.0012439154,0.00012524685,0.0002527201],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960569,0.00034672167,0.00077706773,0.0010056598,0.0009155534,0.0008980734],"domain_scores_gemma":[0.9978119,0.00028371395,0.000059445407,0.001029989,0.0003672662,0.0004476508],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00033652934,0.00053690176,0.0020552375,0.00035166345,0.000067176545,0.000011156988,0.0002492611,0.0013119577,0.00096741616],"category_scores_gemma":[0.0028682158,0.00040411268,0.00042279545,0.00049920456,0.00075745804,0.0000315487,0.000116949275,0.0045887074,0.00018394997],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000838835,0.000031760086,0.00041053985,0.009691993,0.00011641389,0.016896404,0.000550355,4.8182937e-8,0.00010611311,0.0005329387,0.9323918,0.039187744],"study_design_scores_gemma":[0.0022235573,0.0016746795,0.00031529643,0.001822458,0.0005348524,0.00028884993,0.00060801907,0.0000074662007,0.00007710137,0.0011041141,0.9909652,0.00037840707],"about_ca_topic_score_codex":0.0011480541,"about_ca_topic_score_gemma":0.000030102425,"teacher_disagreement_score":0.05901677,"about_ca_system_score_codex":0.00031746298,"about_ca_system_score_gemma":0.00044394212,"threshold_uncertainty_score":0.99998456},"labels":[],"label_agreement":null},{"id":"W3085335913","doi":"10.1097/hco.0000000000000800","title":"Generalizability of Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial in patients with a history of coronary artery bypass graft surgery","year":2020,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Institut universitaire de cardiologie et de pneumologie de Québec; North York General Hospital; University of Toronto","funders":"","keywords":"Medicine; Generalizability theory; Artery; Population; Cohort; Internal medicine; Randomized controlled trial; Bypass grafting; Cardiology; Surgery; Environmental health","score_opus":0.08453285407993578,"score_gpt":0.33075441478043205,"score_spread":0.24622156070049628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085335913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02069899,0.9693055,0.0002259632,0.000006943367,0.005235767,0.0044130273,0.0000856117,0.00001301016,0.000015191296],"genre_scores_gemma":[0.026783288,0.9707622,0.000042261203,0.0000013133249,0.00056317303,0.00051021064,0.0012824379,0.000052301275,0.0000027957685],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99344,0.0024191348,0.0021400377,0.0007927319,0.00088578206,0.00032235205],"domain_scores_gemma":[0.9972479,0.00009768569,0.0011511346,0.0010705413,0.00031320445,0.00011955535],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021285661,0.0004677133,0.006474273,0.000609837,0.00001045698,0.0000011178279,0.00015888196,0.00040499392,0.000010228893],"category_scores_gemma":[0.00012160866,0.000356851,0.0030534174,0.00049748836,0.00024436912,0.00006625857,0.000086022286,0.0006419684,9.681941e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012698343,0.0013768753,0.02665064,0.104180366,0.0056734607,0.000015652093,0.00010443837,0.000110205896,2.1107661e-7,0.000008787147,0.00043175824,0.8487493],"study_design_scores_gemma":[0.05838648,0.0053284545,0.056041684,0.053155154,0.005325108,0.00026633654,0.00004278714,0.0000067392475,0.0000018464468,0.000012676619,0.8206806,0.0007520915],"about_ca_topic_score_codex":0.00018718769,"about_ca_topic_score_gemma":0.0000024277551,"teacher_disagreement_score":0.8479972,"about_ca_system_score_codex":0.0012019209,"about_ca_system_score_gemma":0.0015740421,"threshold_uncertainty_score":0.99988836},"labels":[],"label_agreement":null},{"id":"W3085832865","doi":"10.1001/jamacardio.2020.4120","title":"Genetic Confirmation of Monogenic Familial Hypercholesterolemia Advises a More Intensive Lipid-Lowering Approach—Reply","year":2020,"lang":"en","type":"letter","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; Psychiatry","score_opus":0.023075149532948543,"score_gpt":0.2538735782602622,"score_spread":0.23079842872731365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085832865","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38611263,0.010152152,0.013271002,0.5750736,0.003189007,0.0060186973,0.0005487272,0.0004418352,0.0051923343],"genre_scores_gemma":[0.22523218,0.0011684371,0.0013340503,0.7484507,0.022113295,0.00030576412,0.0011118755,0.00016838388,0.00011531691],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965636,0.00042034284,0.000891729,0.00089102995,0.00064071675,0.0005925764],"domain_scores_gemma":[0.99743176,0.000094453615,0.00037339382,0.0012315841,0.0006853496,0.00018346291],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002863698,0.0005310866,0.0025041117,0.00025002292,0.00006244426,0.000021229216,0.00029167222,0.0012688471,0.000013978682],"category_scores_gemma":[0.00045918292,0.00047616503,0.0013771425,0.00021084715,0.00030245067,0.00006048435,0.00019597182,0.0023867225,0.000039114562],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067286775,0.000031976568,0.0021181656,0.005589467,0.0048731454,0.0036954547,0.0012910147,0.00034817262,0.0038296806,0.0000035430955,0.9397066,0.037839893],"study_design_scores_gemma":[0.0042087603,0.0009149687,0.023291951,0.00042986858,0.002340808,0.0054927543,0.0006685915,0.0003706657,0.0005877817,0.000022335431,0.9609755,0.00069600006],"about_ca_topic_score_codex":0.00031707573,"about_ca_topic_score_gemma":8.186195e-7,"teacher_disagreement_score":0.17337707,"about_ca_system_score_codex":0.00018675599,"about_ca_system_score_gemma":0.00044312546,"threshold_uncertainty_score":0.9999148},"labels":[],"label_agreement":null},{"id":"W3086296235","doi":"10.1016/j.jacc.2020.07.033","title":"Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto; University Health Network; Health Sciences Centre; Ted Rogers Centre for Heart Research; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Conventional PCI; Hazard ratio; Percutaneous coronary intervention; Internal medicine; Myocardial infarction; Confidence interval; Cardiology; Stroke (engine)","score_opus":0.008994503884139896,"score_gpt":0.2329655244760686,"score_spread":0.22397102059192872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3086296235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946568,0.0020996707,0.0007455756,0.001635949,0.00023999512,0.0005207852,0.000031951422,0.000008190887,0.00006108154],"genre_scores_gemma":[0.99756384,0.00055667805,0.00040566406,0.0007953093,0.0006216016,0.0000065036793,8.126398e-7,0.000023756902,0.000025825471],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977717,0.0006231991,0.0005874952,0.00022126129,0.0005800526,0.00021630141],"domain_scores_gemma":[0.99846846,0.00003221703,0.0005013895,0.00048211723,0.00027989814,0.00023592541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007771227,0.00017936072,0.0014739244,0.00007861513,0.00005185049,0.0000023262858,0.00018446681,0.00007680477,0.0000077723],"category_scores_gemma":[0.00019631343,0.00012246855,0.0019926822,0.00023927209,0.00032223787,0.00006378399,0.00016767051,0.00041769503,0.0000026474845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041726865,0.0006540089,0.38058293,0.0038863095,0.046138827,0.03358609,0.0013032791,0.003223064,0.030023707,0.000049223443,0.002801834,0.45602387],"study_design_scores_gemma":[0.004086297,0.004082457,0.9186505,0.0004299149,0.0022264407,0.060767006,0.0010654433,0.00005105771,0.0016612208,0.000056909645,0.0066984957,0.00022426785],"about_ca_topic_score_codex":0.000078186065,"about_ca_topic_score_gemma":0.0000053599992,"teacher_disagreement_score":0.5380676,"about_ca_system_score_codex":0.00009486557,"about_ca_system_score_gemma":0.00014976761,"threshold_uncertainty_score":0.49941224},"labels":[],"label_agreement":null},{"id":"W3087016701","doi":"10.1016/j.jacc.2020.07.059","title":"Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":386,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Heart, Lung, and Blood Institute; University of Maryland","keywords":"Medicine; Ldl cholesterol; Cardiovascular event; Atherosclerotic cardiovascular disease; Event (particle physics); Cholesterol; Disease; Internal medicine; Cardiology","score_opus":0.008838613306444225,"score_gpt":0.2392384658018606,"score_spread":0.23039985249541636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087016701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848067,0.010939801,0.0005705725,0.00291219,0.00013061127,0.00038517494,0.0001668071,0.0000051569095,0.000082981474],"genre_scores_gemma":[0.9965431,0.0021234944,0.00020758866,0.00040098734,0.00068062166,0.0000036019867,8.151337e-7,0.000021057715,0.00001872188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977028,0.0007234164,0.0006135649,0.00018355905,0.00058614084,0.00019051637],"domain_scores_gemma":[0.9978143,0.00007093142,0.0007894884,0.0006421029,0.00032598042,0.0003572102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011052679,0.00016060218,0.0018119671,0.00006144748,0.00004663953,0.0000019583692,0.00021517278,0.00004926885,0.00000549268],"category_scores_gemma":[0.0003357173,0.00009955889,0.0018888992,0.00028985128,0.0005818348,0.000038410097,0.000105110914,0.00033626027,0.0000010931556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01257007,0.00046564554,0.7436592,0.0017652466,0.0668275,0.0024407927,0.0009763434,0.032912366,0.010191196,0.00007721752,0.019150503,0.10896395],"study_design_scores_gemma":[0.0062882816,0.0047443453,0.9377721,0.0002910535,0.008358541,0.0032075145,0.0013636841,0.00036115968,0.001181352,0.0000674203,0.03611075,0.00025378919],"about_ca_topic_score_codex":0.00002041158,"about_ca_topic_score_gemma":3.3365762e-7,"teacher_disagreement_score":0.19411293,"about_ca_system_score_codex":0.000030803345,"about_ca_system_score_gemma":0.00042327226,"threshold_uncertainty_score":0.40598938},"labels":[],"label_agreement":null},{"id":"W3088201852","doi":"10.1155/2020/9340480","title":"Association of the rs562556 PCSK9 Gene Polymorphism with Reduced Mortality in Severe Malaria among Malian Children","year":2020,"lang":"en","type":"article","venue":"Canadian Journal of Infectious Diseases and Medical Microbiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Manitoba; Montreal Clinical Research Institute","funders":"Institut Mérieux; Fondation Jean-Louis Lévesque","keywords":"Malaria; Allele; Single-nucleotide polymorphism; SNP; Biology; Immunology; Cohort; Minor allele frequency; PCSK9; Immune system; Internal medicine; Genetics; Allele frequency; Medicine; Genotype; Gene; Cholesterol; LDL receptor","score_opus":0.004690062913716735,"score_gpt":0.20177537119197986,"score_spread":0.19708530827826312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088201852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912225,0.001643576,0.000011105245,0.006597288,0.00015337847,0.00024215665,0.00007068861,0.000003487634,0.00005583689],"genre_scores_gemma":[0.9974815,0.00013443796,0.000008518553,0.0020408204,0.00029752194,0.0000022823497,0.000011430412,0.000009535676,0.000013903481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989569,0.00017486107,0.00035209453,0.00013136293,0.00014485454,0.00023989852],"domain_scores_gemma":[0.9985135,0.000021894906,0.00025159007,0.0001220524,0.00011591086,0.00097504957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033381738,0.00010159778,0.000435925,0.00007886561,0.00005875027,0.000007300018,0.00008770874,0.00017511644,0.00014416262],"category_scores_gemma":[0.0004963547,0.00006385643,0.00017096598,0.0001866364,0.0001796762,0.00003216611,0.000015610112,0.00036249476,5.775128e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042253127,0.000028784709,0.99689347,0.000045265304,0.00039968963,0.00012257924,0.00011078321,0.0000043447894,0.0006245036,0.000015182883,0.00037436123,0.0013387738],"study_design_scores_gemma":[0.0022435847,0.00033412653,0.9948071,0.0001811734,0.00031839355,0.001458963,0.000037160462,0.0000031800078,0.00017227451,0.000017091981,0.00035812258,0.0000687913],"about_ca_topic_score_codex":0.016549662,"about_ca_topic_score_gemma":0.019479686,"teacher_disagreement_score":0.0062590665,"about_ca_system_score_codex":0.00018203372,"about_ca_system_score_gemma":0.0020973713,"threshold_uncertainty_score":0.99841225},"labels":[],"label_agreement":null},{"id":"W3088357126","doi":"10.47093/2218-7332.2020.11.1.38-48","title":"Adherence to statin therapy in patients with high and very high cardiovascular risk in real clinical practice","year":2020,"lang":"en","type":"article","venue":"Sechenov Medical Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Statin; Depression (economics); Hospital Anxiety and Depression Scale; Anxiety; Physical therapy; Montreal Cognitive Assessment; Disease; Cognitive impairment; Psychiatry","score_opus":0.02805649985419059,"score_gpt":0.3191097553593906,"score_spread":0.29105325550520006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088357126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924207,0.00137026,0.0011245677,0.0040153926,0.00020782143,0.00070482696,0.000007487673,0.000021132873,0.00012785975],"genre_scores_gemma":[0.9789619,0.008438496,0.0064669605,0.005134166,0.0009366818,0.000015928332,0.000009122337,0.000033417615,0.0000033197655],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9949664,0.001005514,0.00084511004,0.00045680132,0.0022919734,0.00043423483],"domain_scores_gemma":[0.99761355,0.0002656575,0.00017809038,0.00034309784,0.000242181,0.0013574403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005385232,0.0002076458,0.00091714563,0.000109128196,0.000065636676,0.000035030575,0.00016313102,0.00024403897,0.00010852935],"category_scores_gemma":[0.0036017706,0.00014226718,0.00020696763,0.00047657944,0.00009990561,0.00016397133,0.00007315731,0.0021964405,0.000012855326],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003948657,0.0004991861,0.35426605,0.000056878434,0.00072210334,0.0017023592,0.0009197721,0.000026493983,0.0000017921366,0.000027444354,0.00028272282,0.63754654],"study_design_scores_gemma":[0.01932107,0.0061687124,0.967436,0.00034564896,0.00016447456,0.00015773665,0.0003970315,0.000032887907,0.00000971942,0.00006557266,0.0057058707,0.0001952798],"about_ca_topic_score_codex":0.002393071,"about_ca_topic_score_gemma":0.00007794093,"teacher_disagreement_score":0.6373513,"about_ca_system_score_codex":0.00012203733,"about_ca_system_score_gemma":0.0009032228,"threshold_uncertainty_score":0.9542563},"labels":[],"label_agreement":null},{"id":"W3088438455","doi":"10.1016/j.jpeds.2020.09.042","title":"Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry","year":2020,"lang":"en","type":"article","venue":"The Journal of Pediatrics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; National Institutes of Health; Amgen; Portola Pharmaceuticals; Patient-Centered Outcomes Research Institute; Regeneron Pharmaceuticals; Novartis; Genzyme; Fondation Leducq; Pfizer; Sanofi; Merck; Heart Foundation","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Lipid profile; Pediatrics; Ldl cholesterol; Cholesterol","score_opus":0.05859568879773318,"score_gpt":0.29334144146405305,"score_spread":0.23474575266631986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088438455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736964,0.002169265,0.018705199,0.0047740093,0.000054319167,0.00046538867,0.00012734882,0.000006561031,0.0000015168315],"genre_scores_gemma":[0.99106485,0.0024672204,0.00041592825,0.0028542948,0.0030978925,0.0000034660172,0.000074780175,0.000019968578,0.0000015896239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863666,0.00026790184,0.00030911848,0.00013391914,0.00048330327,0.00016912038],"domain_scores_gemma":[0.998622,0.0004074262,0.00023015251,0.0005368368,0.000106643616,0.00009691265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016362855,0.000118781536,0.0002506553,0.000044833178,0.00019892125,0.000045954854,0.0004990483,0.00006109074,7.104587e-7],"category_scores_gemma":[0.0002757077,0.00004957606,0.00006214632,0.00034692013,0.00006347153,0.00009450555,0.000085354186,0.0006421548,3.1581826e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012591454,0.00033226635,0.8370125,0.00083955645,0.0012353689,0.0003743252,0.03667674,0.010439646,0.00057466835,0.0000048944416,0.011650452,0.08826808],"study_design_scores_gemma":[0.011341403,0.0020885286,0.95294714,0.00017142104,0.0037218463,0.003226753,0.014988609,0.0051190117,0.00013782125,0.000057949,0.0058947965,0.00030470063],"about_ca_topic_score_codex":0.002154919,"about_ca_topic_score_gemma":0.0003025351,"teacher_disagreement_score":0.11593461,"about_ca_system_score_codex":0.000022194312,"about_ca_system_score_gemma":0.0001449594,"threshold_uncertainty_score":0.32576075},"labels":[],"label_agreement":null},{"id":"W3089741209","doi":"10.24095/hpcdp.32.2.01f","title":"Expériences de prise en charge du poids chez des adultes canadiens faisant de l’embonpoint ou obèses : résultats d’un sondage national","year":2012,"lang":"fr","type":"article","venue":"Maladies chroniques et blessures au Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta; McMaster University; Dalhousie University","funders":"","keywords":"Humanities; Political science; Philosophy","score_opus":0.012215671523383757,"score_gpt":0.25944131762822903,"score_spread":0.24722564610484526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089741209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8834018,0.09156433,0.00044033866,0.0059022023,0.0020389126,0.00096732663,0.0006793967,0.0001255726,0.01488013],"genre_scores_gemma":[0.976295,0.009154583,0.001985863,0.002681261,0.005270002,0.0002539833,0.0001046324,0.00011659255,0.0041380757],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932852,0.00094010646,0.0007337136,0.0006284416,0.0013866317,0.003025955],"domain_scores_gemma":[0.9964954,0.00045908504,0.0002670105,0.000529742,0.00052758836,0.0017211294],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0038996513,0.0007152251,0.000970861,0.00018196726,0.00080055936,0.00012471153,0.0004241912,0.00036362486,0.0019581392],"category_scores_gemma":[0.0010809136,0.0006799883,0.0003410844,0.000362085,0.0006327346,0.00053254195,0.00018600977,0.00070143625,0.00001528004],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00030511318,0.0009796573,0.63476354,0.010221275,0.003850353,0.002044984,0.1404665,0.0012629405,0.00096209423,0.047136348,0.11437803,0.043629173],"study_design_scores_gemma":[0.0022820497,0.00062525884,0.3623454,0.0032301436,0.00087580737,0.002679959,0.014960668,0.0012582969,0.020654563,0.00038077417,0.5891373,0.0015697347],"about_ca_topic_score_codex":0.9651837,"about_ca_topic_score_gemma":0.9816077,"teacher_disagreement_score":0.4747593,"about_ca_system_score_codex":0.009331545,"about_ca_system_score_gemma":0.022104478,"threshold_uncertainty_score":0.9995651},"labels":[],"label_agreement":null},{"id":"W3090086510","doi":"","title":"Primary hyperlipidemia with associated ischemic strokes in a West Highland white terrier dog.","year":2020,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Greo","funders":"","keywords":"Hyperlipidemia; Medicine; Hypertriglyceridemia; Magnetic resonance imaging; Internal medicine; Triglyceride; Radiology; Endocrinology; Cholesterol; Diabetes mellitus","score_opus":0.015276719092414744,"score_gpt":0.20557292487847312,"score_spread":0.19029620578605838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090086510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97918653,0.0006767357,0.000036815334,0.0071220365,0.000055507237,0.0012479783,0.000014756644,0.00010389803,0.011555746],"genre_scores_gemma":[0.99416775,0.000048474965,0.00019058477,0.0038781792,0.00034945167,0.00069567095,0.00006018112,0.00003501433,0.0005747118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984468,0.00006856317,0.00025594723,0.00033343717,0.00042183907,0.00047340294],"domain_scores_gemma":[0.999213,0.000021147138,0.000074095144,0.0002706396,0.00004848788,0.0003726747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000473045,0.00016329577,0.000515683,0.00005786864,0.000032555887,0.000019211293,0.00008124791,0.000121876124,0.000029341387],"category_scores_gemma":[0.00016971928,0.00011984633,0.000113187445,0.00033746293,0.000038713002,0.000087451815,0.000037339847,0.0003560367,0.000011604101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033518948,0.00013070859,0.94548106,0.00030930567,0.00034513007,0.00018729077,0.00045239125,0.000015705065,0.0002810205,0.0000063686352,0.0033409877,0.049114823],"study_design_scores_gemma":[0.0037319392,0.00008113314,0.97870183,0.000052667376,0.0001079544,0.000016868396,0.000063350795,0.000033804423,0.00023420747,0.0000015418448,0.01682654,0.00014813607],"about_ca_topic_score_codex":0.00016309756,"about_ca_topic_score_gemma":0.00006716834,"teacher_disagreement_score":0.048966687,"about_ca_system_score_codex":0.00018784241,"about_ca_system_score_gemma":0.00013994379,"threshold_uncertainty_score":0.48871914},"labels":[],"label_agreement":null},{"id":"W3091387850","doi":"10.1016/j.cjco.2020.09.018","title":"Liver Injury Associated With Ezetimibe Monotherapy","year":2020,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; Western University","funders":"Schulich School of Medicine and Dentistry; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Ezetimibe; Medicine; Statin; myalgia; Internal medicine; Gastroenterology; Liver injury; Prednisone; Pharmacology; Endocrinology","score_opus":0.02826458059629796,"score_gpt":0.2865611188524888,"score_spread":0.25829653825619087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091387850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9399396,0.001186946,0.00073236757,0.012506447,0.00007853025,0.0029810364,0.000024025368,0.0001665969,0.042384427],"genre_scores_gemma":[0.9817382,0.00019967745,0.00084091,0.015405356,0.00025181464,0.000043835276,0.000028980849,0.000039393868,0.0014517937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991861,0.000055217937,0.00011349577,0.0002209603,0.0002546997,0.0001695197],"domain_scores_gemma":[0.99937993,0.000009943498,0.00004330007,0.00029416764,0.00006566326,0.00020702154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021430473,0.000097496995,0.00037486473,0.000014878499,0.000057216064,0.000043693297,0.00016311648,0.00006118305,0.0004544825],"category_scores_gemma":[0.000050653816,0.00006920915,0.00007804689,0.00018788793,0.000025215024,0.00008779791,0.00007003724,0.00014951325,0.000113699454],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010522174,0.0013232264,0.062240902,0.0005425309,0.0066488534,0.0023120597,0.009361734,0.00003925111,0.0057201814,0.0020056705,0.18452668,0.7147567],"study_design_scores_gemma":[0.022352234,0.006497913,0.25051552,0.0006673707,0.0006256113,0.000099914985,0.00050822285,0.0011429668,0.013782318,0.00009633408,0.70277977,0.00093186327],"about_ca_topic_score_codex":0.00026529582,"about_ca_topic_score_gemma":0.000017668237,"teacher_disagreement_score":0.71382487,"about_ca_system_score_codex":0.000035407775,"about_ca_system_score_gemma":0.00018035193,"threshold_uncertainty_score":0.49762648},"labels":[],"label_agreement":null},{"id":"W3092148658","doi":"10.15586/jptcp.v27i3.676","title":"Statin Initiation: Guideline Concordance and Characteristics of New Users in Quebec, Canada","year":2020,"lang":"en","type":"article","venue":"Journal of Population Therapeutics and Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; Canadians Living with HIV; Université du Québec à Chicoutimi; Montreal Heart Institute; Centre Hospitalier de l’Université de Montréal; Université Laval; Université de Montréal","funders":"Pfizer","keywords":"Concordance; Medicine; Dyslipidemia; Statin; Guideline; Physical therapy; Internal medicine; Disease; Pathology","score_opus":0.06502052101527463,"score_gpt":0.39544814949061147,"score_spread":0.33042762847533685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092148658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758651,0.001091535,0.0004974208,0.02205904,0.0003348101,0.00013573344,0.0000053739786,0.0000017129689,0.000009269878],"genre_scores_gemma":[0.9809004,0.0022923055,0.0007065257,0.015340214,0.000730281,3.3722495e-7,0.000007987625,0.0000068086156,0.000015125513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984027,0.0001299646,0.001123107,0.000085879394,0.00017597164,0.00008236925],"domain_scores_gemma":[0.9989471,0.00011447388,0.0005289777,0.000043790416,0.00016763796,0.00019805908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005085717,0.00006678713,0.00046743985,0.000029933257,0.000014561947,0.0000045000725,0.000032331744,0.000062188505,0.00004103623],"category_scores_gemma":[0.000097223325,0.00005526368,0.000060542017,0.00007782191,0.00003411149,0.000045581557,0.000013099849,0.00025326174,8.6865555e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016975603,0.0001334668,0.71371865,0.00014851039,0.00050834287,0.000100986676,0.000319502,0.00004198665,0.0010455857,0.00011745714,0.0037128069,0.27845517],"study_design_scores_gemma":[0.005287178,0.00061862794,0.9537813,0.000040698415,0.00032063958,0.00002718961,0.00014702074,0.0018518926,0.00008758822,0.00006120183,0.037705597,0.00007104137],"about_ca_topic_score_codex":0.076751284,"about_ca_topic_score_gemma":0.060623944,"teacher_disagreement_score":0.27838412,"about_ca_system_score_codex":0.00005408483,"about_ca_system_score_gemma":0.0005820579,"threshold_uncertainty_score":0.9565172},"labels":[],"label_agreement":null},{"id":"W3092288248","doi":"10.1093/eurheartj/ehaa649","title":"Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital","funders":"NIHR Imperial Biomedical Research Centre; American Regent; Genentech; Esperion Therapeutics; Sirtex Medical; HLS Therapeutics; Idorsia Pharmaceuticals; Novo Nordisk; Duke Clinical Research Institute; Astellas Pharma; Eisai; Daiichi-Sankyo; European Commission; Medicines Company; Regado Biosciences; Tenax Therapeutics; AstraZeneca; Amarin Corporation; Ionis Pharmaceuticals; Luitpold Pharmaceuticals; F. Hoffmann-La Roche; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Boston VA Research Institute; Boston Scientific Corporation; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; National Institute for Health and Care Research; CSL Behring; Belvoir Media Group; Servier; Gilead Sciences; European Society of Cardiology; Amgen; Pfizer; St. Jude Medical; Kowa Company; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; American Heart Association","keywords":"Medicine; Alirocumab; Ldl cholesterol; Cholesterol; Lipoprotein; Atherosclerotic cardiovascular disease; Lipoprotein(a); Internal medicine; Cardiology; Disease; Apolipoprotein A1","score_opus":0.029907537619010348,"score_gpt":0.2707455877341741,"score_spread":0.24083805011516377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092288248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99065745,0.0031828843,0.0008895497,0.0024019661,0.00063680933,0.0017678287,0.000015561369,0.00005372752,0.00039423615],"genre_scores_gemma":[0.9965012,0.0002860735,0.00018494448,0.0002663783,0.0024862357,0.000013788429,0.0000063519606,0.00010940995,0.00014560737],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9944893,0.0007937646,0.0012426088,0.0005305809,0.0023741778,0.0005695567],"domain_scores_gemma":[0.9974801,0.000042649404,0.0005133392,0.0010591802,0.00029204544,0.0006127114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036951026,0.00042361594,0.0014879274,0.0001164904,0.00026673774,0.00006935714,0.00046404573,0.00012184233,0.0000862526],"category_scores_gemma":[0.0004997391,0.00029962815,0.0020780547,0.0003034988,0.0001376199,0.00020227736,0.00032295138,0.0012053691,0.00003911633],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059071027,0.0036779812,0.0085029015,0.0056749326,0.03789365,0.003476676,0.018920133,0.00870188,0.3858048,0.000020792506,0.009064574,0.45919067],"study_design_scores_gemma":[0.15853865,0.011846353,0.2642215,0.0039115045,0.0035312073,0.007232434,0.0027173168,0.0002407943,0.5096404,0.000032913435,0.035996865,0.0020900494],"about_ca_topic_score_codex":0.00057845697,"about_ca_topic_score_gemma":0.0000017453322,"teacher_disagreement_score":0.4571006,"about_ca_system_score_codex":0.000099393634,"about_ca_system_score_gemma":0.00024020587,"threshold_uncertainty_score":0.9999456},"labels":[],"label_agreement":null},{"id":"W3092643226","doi":"10.1016/j.ajpc.2020.100091","title":"C-reactive protein levels and plaque regression with evolocumab: Insights from GLAGOV","year":2020,"lang":"en","type":"article","venue":"American Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Amgen","keywords":"Evolocumab; Medicine; Internal medicine; C-reactive protein; PCSK9; Coronary artery disease; Gastroenterology; Statin; Cardiology; Atorvastatin; Alirocumab; Atheroma; Placebo; Diabetes mellitus; Inflammation; Lipoprotein; Cholesterol; Endocrinology; Pathology; Apolipoprotein A1; LDL receptor","score_opus":0.013683967184121204,"score_gpt":0.25878614895184776,"score_spread":0.24510218176772655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092643226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816903,0.0021390712,0.013357076,0.0019536067,0.000057480127,0.00047315954,0.000014937051,0.000013305863,0.00030105657],"genre_scores_gemma":[0.9950774,0.000061769046,0.0034136712,0.0005928731,0.00079004595,0.000014006436,0.0000052188425,0.000025896152,0.00001913637],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99811035,0.0006219064,0.00037547166,0.00030707644,0.0003733169,0.00021190365],"domain_scores_gemma":[0.9984263,0.00008697168,0.00055492995,0.00023086288,0.00032514578,0.00037575964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000252665,0.00020702173,0.0012714555,0.000084448984,0.000058860434,0.0000090214335,0.0001008234,0.00007787594,0.000014364777],"category_scores_gemma":[0.0001843291,0.00012771995,0.00028582886,0.00021163748,0.0004103925,0.00012364835,0.00005810029,0.0005400358,0.0000028191216],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039333396,0.000490424,0.18106163,0.0005327818,0.029733246,0.017315432,0.020401033,0.00016366647,0.28758267,0.0009632564,0.0021236262,0.42029884],"study_design_scores_gemma":[0.019658089,0.044115487,0.83035266,0.002983431,0.0032258786,0.008674806,0.018291581,0.00012209798,0.047245987,0.0017278814,0.022429522,0.0011725631],"about_ca_topic_score_codex":0.00012689915,"about_ca_topic_score_gemma":0.000003914928,"teacher_disagreement_score":0.64929104,"about_ca_system_score_codex":0.000083176725,"about_ca_system_score_gemma":0.00033521527,"threshold_uncertainty_score":0.5208269},"labels":[],"label_agreement":null},{"id":"W3092984943","doi":"10.1016/j.ahj.2020.10.052","title":"Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction","year":2020,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital","funders":"CSL Behring","keywords":"Medicine; Placebo; Myocardial infarction; Internal medicine; Coronary artery disease; Randomized controlled trial; Multicenter trial; Stroke (engine); Cardiology; Cholesterol; Surgery; Pathology; Multicenter study","score_opus":0.02853460989701299,"score_gpt":0.31098988585393555,"score_spread":0.28245527595692255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092984943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865692,0.001410853,0.0010817557,0.0040581757,0.00005564257,0.0068073063,0.000003933866,0.000006673977,0.000006433937],"genre_scores_gemma":[0.99599206,0.0009593771,0.0017714782,0.00077344704,0.00015667432,0.00031973596,0.0000027496349,0.000019492942,0.000004990894],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970345,0.0009576059,0.0009598004,0.00029196483,0.0004890131,0.00026710494],"domain_scores_gemma":[0.9987663,0.0003276005,0.00031097437,0.00020214362,0.000087368615,0.00030560815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003157769,0.00020243968,0.0014895729,0.00022495697,0.00012716884,0.00002014012,0.00006762346,0.000036459154,0.000010566161],"category_scores_gemma":[0.00030897692,0.00013848535,0.00022537306,0.00039119244,0.00024630185,0.00012372398,0.00009384452,0.000435305,5.477828e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.965652,0.0008414945,0.00663322,0.000058219437,0.0012548214,0.00006617042,0.014548062,0.0017434427,0.005596514,0.0000020632742,0.00006016922,0.0035438496],"study_design_scores_gemma":[0.97272605,0.005126862,0.014271207,0.00037448283,0.0007779698,0.0005474878,0.0028701548,0.0025491142,0.00036032507,0.0000049968035,0.00019781408,0.00019353004],"about_ca_topic_score_codex":0.00083784864,"about_ca_topic_score_gemma":0.00002828023,"teacher_disagreement_score":0.011677908,"about_ca_system_score_codex":0.0000711911,"about_ca_system_score_gemma":0.00023732096,"threshold_uncertainty_score":0.5647269},"labels":[],"label_agreement":null},{"id":"W3093531331","doi":"10.1016/j.ahj.2020.10.055","title":"Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease","year":2020,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Center for Advancing Translational Sciences; Duke Clinical Research Institute; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Hazard ratio; Internal medicine; Dialysis; Stroke (engine); Myocardial infarction; Statin; Kidney disease; Proportional hazards model; Cardiology; Confidence interval","score_opus":0.016684779349426502,"score_gpt":0.24897998409243746,"score_spread":0.23229520474301096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093531331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306214,0.00054284435,0.00014790862,0.0055360286,0.000029713068,0.000637814,0.00000873753,0.000022953218,0.000011839644],"genre_scores_gemma":[0.99122936,0.0003135591,0.00078042963,0.0074636084,0.00013660314,0.000022831511,0.0000030089861,0.000043320055,0.0000073109527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977128,0.00029377767,0.0003393409,0.0003882258,0.00089563965,0.00037019548],"domain_scores_gemma":[0.998262,0.00005669608,0.00009476236,0.00034944655,0.00007836754,0.0011587333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047204763,0.00023533514,0.0010191879,0.00012034724,0.000153328,0.00006143205,0.00005083207,0.000027688113,0.000016775135],"category_scores_gemma":[0.0002493874,0.00016634005,0.00030835712,0.0003079353,0.00020487097,0.00009580061,0.000044548666,0.00041711563,0.000008135587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003563673,0.00015205798,0.99024254,0.000059481117,0.00038204665,0.000062111976,0.00056720106,0.00012049841,0.0000208009,0.000002701276,0.000050521812,0.007983686],"study_design_scores_gemma":[0.0031145061,0.0022185205,0.9925735,0.00011937971,0.00032791877,0.00005890332,0.00033796142,0.00007077913,0.00000906698,0.000007619902,0.0009828967,0.00017892843],"about_ca_topic_score_codex":0.0005268647,"about_ca_topic_score_gemma":0.00001588786,"teacher_disagreement_score":0.0078047574,"about_ca_system_score_codex":0.00011284061,"about_ca_system_score_gemma":0.00017258263,"threshold_uncertainty_score":0.67831504},"labels":[],"label_agreement":null},{"id":"W3093716487","doi":"10.34171/mjiri.34.154","title":"Economic burden of osteoporosis in the world: A systematic review.","year":2020,"lang":"en","type":"review","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Iran University of Medical Sciences","keywords":"Medical journal; Medicine; Osteoporosis; Alternative medicine; Systematic review; Traditional medicine; MEDLINE; Family medicine; Pathology; Law","score_opus":0.03606071850685645,"score_gpt":0.30008248809199284,"score_spread":0.2640217695851364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093716487","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.258772e-7,0.97725046,4.350058e-7,0.00069817837,0.0001004492,0.019160591,0.000021921203,0.000015239779,0.0027518026],"genre_scores_gemma":[0.000023694547,0.98062193,0.0000122980255,0.00044873284,0.00038585797,0.018050563,0.000038314272,0.000039189923,0.00037938647],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970291,0.000653325,0.0013486916,0.0003117761,0.00036673385,0.0002903249],"domain_scores_gemma":[0.997997,0.00015406338,0.0005859478,0.0011151253,0.000022385102,0.00012546398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002924499,0.0002782545,0.005198381,0.000188097,0.000016056289,0.000012911741,0.0003513978,0.00010488729,0.000020812839],"category_scores_gemma":[0.00032224527,0.00015028563,0.0014707682,0.00051745534,0.000027681914,0.000023527586,0.000054400516,0.0003809669,0.00006734583],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000010399327,0.0000072455164,2.754757e-7,0.6443328,0.00023874879,0.00001871927,0.00003008721,3.7146666e-8,3.1265807e-10,0.000021386744,0.0004923223,0.35485733],"study_design_scores_gemma":[0.0001579224,0.000011135914,0.0000106876705,0.35733306,0.005672779,0.000100472986,0.00002580838,3.9411583e-7,4.0569883e-8,0.0000019063572,0.63659173,0.000094053525],"about_ca_topic_score_codex":0.00014248077,"about_ca_topic_score_gemma":0.000039070394,"teacher_disagreement_score":0.6360994,"about_ca_system_score_codex":0.00028793103,"about_ca_system_score_gemma":0.0002999349,"threshold_uncertainty_score":0.612847},"labels":[],"label_agreement":null},{"id":"W3094458672","doi":"10.1016/j.jacl.2020.09.011","title":"Importance of the triglyceride level in identifying patients with a Type III Hyperlipoproteinemia phenotype using the ApoB algorithm","year":2020,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Institutes of Health; Strålsäkerhetsmyndigheten; American Heart Association; Novo Nordisk; Sanofi; Quest Diagnostics; Aetna Foundation","keywords":"Medicine; Triglyceride; Apolipoprotein B; Cutoff; Internal medicine; Gastroenterology; Type 2 diabetes; Algorithm; Gold standard (test); Lipoprotein; Cholesterol; Predictive value; Endocrinology; Very low-density lipoprotein; Diabetes mellitus; Mathematics","score_opus":0.134640533330754,"score_gpt":0.3755043372432961,"score_spread":0.24086380391254214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094458672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928918,0.00053652877,0.0022063027,0.0025246276,0.0012933933,0.00048169395,0.000003716207,0.0000040349028,0.000057897392],"genre_scores_gemma":[0.9869307,0.00008334611,0.0073616495,0.002643658,0.0029332358,0.000001838445,0.0000011841475,0.000022139175,0.000022209812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969206,0.0004443266,0.0016101517,0.00019065443,0.00060598995,0.00022827002],"domain_scores_gemma":[0.9975233,0.00026183843,0.0011880938,0.00037996686,0.00048371314,0.00016308374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002252383,0.00013451999,0.0010212275,0.000046102763,0.000056622906,0.000007102769,0.00028250352,0.00014916077,0.000046678517],"category_scores_gemma":[0.0020092572,0.000063278836,0.00042320424,0.00045930373,0.00017737031,0.00007322134,0.00009002153,0.0010307833,0.0000021272047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066863494,0.0005418341,0.87288254,0.00020163062,0.00080222223,0.000056839894,0.0005497304,0.0001906149,0.000652128,0.000055968503,0.00084698544,0.116533145],"study_design_scores_gemma":[0.012806667,0.0027045861,0.9768443,0.00039824273,0.000513778,0.00018035216,0.00022548648,0.0008281674,0.00024499476,0.00013288716,0.0049703363,0.00015017092],"about_ca_topic_score_codex":0.00010146097,"about_ca_topic_score_gemma":0.000042239142,"teacher_disagreement_score":0.11638297,"about_ca_system_score_codex":0.00004618009,"about_ca_system_score_gemma":0.0007559945,"threshold_uncertainty_score":0.44782978},"labels":[],"label_agreement":null},{"id":"W3095251893","doi":"10.14740/jocmr4367","title":"Associations Between High Levels of High-Density Lipoprotein Cholesterol and the Presence and Severity of Coronary Artery Disease in Patients Who Have Undergone Coronary Computed Tomography Angiography","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Coronary artery disease; Internal medicine; Cardiology; High-density lipoprotein; Triglyceride; Cholesterol; Stenosis; Angiography; Coronary atherosclerosis; Coronary angiography; Myocardial infarction","score_opus":0.09517425722227796,"score_gpt":0.38592460077067237,"score_spread":0.2907503435483944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095251893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823772,0.0019044935,0.00019664217,0.0142831765,0.00006946068,0.0010628363,0.000085343825,0.0000037428927,0.000017119717],"genre_scores_gemma":[0.9980517,0.00081202143,0.0002029946,0.00034430227,0.000550442,0.0000045485554,0.000014057113,0.000014077362,0.000005872658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936204,0.002014555,0.0018151213,0.00028769215,0.0019760495,0.0002861578],"domain_scores_gemma":[0.99428827,0.0027591777,0.0007234261,0.0003582755,0.0011265178,0.0007443407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00823068,0.00015244946,0.0017028967,0.00034529617,0.000087546454,0.0000087777335,0.00021621516,0.00015861736,0.000014627466],"category_scores_gemma":[0.003721989,0.000095143616,0.00041911547,0.0007237541,0.001576286,0.000127626,0.00021474727,0.0013220395,3.2887752e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003452909,0.00034326492,0.96132535,0.0003133107,0.00072689034,0.000057848407,0.00029482055,0.0000031630416,0.00000546483,0.000033340297,0.00026280936,0.03318083],"study_design_scores_gemma":[0.015414096,0.0031297184,0.9788387,0.0009640675,0.0003187789,0.000009839254,0.00011810339,0.00011039812,0.000026710946,0.0009886165,0.000012707063,0.00006828953],"about_ca_topic_score_codex":0.001398721,"about_ca_topic_score_gemma":0.000043024775,"teacher_disagreement_score":0.033112537,"about_ca_system_score_codex":0.000027909757,"about_ca_system_score_gemma":0.00029489293,"threshold_uncertainty_score":0.5807892},"labels":[],"label_agreement":null},{"id":"W3096392259","doi":"10.18433/jpps31197","title":"Cardiovascular and safety events of PCSK9 inhibitors in statin-treated patients with cardiovascular risk: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Meta-analysis; Internal medicine; Number needed to treat; Myocardial infarction; Stroke (engine); Relative risk; Adverse effect; Evolocumab; Randomized controlled trial; PCSK9; Confidence interval; Cholesterol; Lipoprotein","score_opus":0.079732129747503,"score_gpt":0.38236445563139365,"score_spread":0.30263232588389066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096392259","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00052418915,0.9945505,0.000079781064,0.00013167944,0.000044560766,0.0045204894,0.00011466507,0.000009525754,0.00002458251],"genre_scores_gemma":[0.0050772764,0.99419934,0.00035815826,0.00016491761,0.00007075799,0.00007771529,0.000009901353,0.000037637885,0.000004300765],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9895335,0.0030279334,0.0029363406,0.0007592408,0.0032494082,0.00049356336],"domain_scores_gemma":[0.99606115,0.00032153376,0.0017278277,0.0005614187,0.0005201824,0.00080788985],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.010185316,0.0007039058,0.01645875,0.00072351506,0.0001373148,0.000041593885,0.00039003376,0.000114241266,0.000063075706],"category_scores_gemma":[0.00056145043,0.0003695065,0.009200276,0.0033289047,0.00038739186,0.00028614866,0.00016228254,0.0011032986,0.000001929739],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006821653,0.0001672486,0.0012327132,0.4787149,0.4118188,0.00018547961,0.000051942523,0.00002744487,8.2226556e-8,0.0000016190774,0.0000071449476,0.10772441],"study_design_scores_gemma":[0.0022714064,0.0002554889,0.000100937774,0.022651106,0.8504286,0.00028473325,0.000020491132,0.00002955949,0.000004559265,0.0000013910329,0.12364797,0.000303754],"about_ca_topic_score_codex":0.00018757755,"about_ca_topic_score_gemma":0.0000032554096,"teacher_disagreement_score":0.4560638,"about_ca_system_score_codex":0.00018135636,"about_ca_system_score_gemma":0.000614183,"threshold_uncertainty_score":0.99987566},"labels":[],"label_agreement":null},{"id":"W3096556476","doi":"10.14740/cr1145","title":"Lipoprotein(a) and Familial Hypercholesterolemia: A Short Review Including the Laboratory Viewpoint","year":2020,"lang":"en","type":"review","venue":"Cardiology Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Lipoprotein(a); Medicine; Internal medicine; Atherosclerotic cardiovascular disease; Cardiology; Lipoprotein; Value (mathematics); Disease; Ldl cholesterol; Cholesterol; Statistics; Mathematics","score_opus":0.23235366675689625,"score_gpt":0.4677173841118364,"score_spread":0.23536371735494013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096556476","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000017369804,0.9875683,0.00001950345,0.0031767404,0.00021217483,0.0070054363,0.00006688262,0.00007182506,0.0018617625],"genre_scores_gemma":[0.000031717896,0.99233353,0.00006709315,0.001782028,0.0033111714,0.0021361986,0.000090077345,0.00012532479,0.00012283797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99022317,0.005332143,0.0009549759,0.001208271,0.0012937246,0.0009877108],"domain_scores_gemma":[0.9962752,0.00050868944,0.00010967966,0.0019598685,0.00056319,0.00058338826],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011516047,0.0005864581,0.0062838295,0.0002524058,0.0004955912,0.000046637124,0.0005866461,0.0008858628,0.000017966113],"category_scores_gemma":[0.001984986,0.00034178924,0.0013787266,0.0012723488,0.00087304844,0.000053212625,0.0011558562,0.0053827777,0.0001984222],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015640855,0.000008655887,0.000016769785,0.08640927,0.0009249065,0.0007570075,0.000026301519,1.7847405e-8,0.0000017391308,0.00003832258,0.008151909,0.90364945],"study_design_scores_gemma":[0.00022671069,0.0002916581,0.000054671353,0.041432135,0.001892445,0.0028174398,0.00003885766,8.606178e-7,7.329359e-7,0.000012862043,0.9529784,0.00025326092],"about_ca_topic_score_codex":0.0000422738,"about_ca_topic_score_gemma":0.0000034400223,"teacher_disagreement_score":0.9448265,"about_ca_system_score_codex":0.00042379985,"about_ca_system_score_gemma":0.0022652533,"threshold_uncertainty_score":0.99990344},"labels":[],"label_agreement":null},{"id":"W3096677053","doi":"10.1161/atvbaha.120.314965","title":"Genome-Wide Association Study Highlights <i>APOH</i> as a Novel Locus for Lipoprotein(a) Levels—Brief Report","year":2020,"lang":"en","type":"review","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Medical Research Council","keywords":"Biobank; Locus (genetics); Lipoprotein(a); Genetics; Genome-wide association study; Genetic association; Biology; Genotype; Single-nucleotide polymorphism; Lipoprotein; Gene; Endocrinology; Cholesterol","score_opus":0.07748255796370386,"score_gpt":0.3427158402659386,"score_spread":0.26523328230223475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096677053","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010678476,0.9658622,0.0021989339,0.0020061836,0.00093760475,0.0173415,0.00042114686,0.00030798386,0.00024597291],"genre_scores_gemma":[0.00467566,0.9888729,0.0007297624,0.00095312163,0.0012796338,0.0024378968,0.0007829968,0.00021051562,0.00005753458],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99433756,0.00049455324,0.0016985256,0.0019278601,0.00063025946,0.000911263],"domain_scores_gemma":[0.99623126,0.00029185263,0.0011049412,0.0015101464,0.00033651426,0.00052529114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021621352,0.0010209599,0.0057095657,0.00024018406,0.0004194408,0.00012690725,0.00031086706,0.0011085034,0.000053725536],"category_scores_gemma":[0.0006943774,0.0007947646,0.0025758909,0.0004896606,0.00010471036,0.00010222943,0.00028611804,0.0006130878,0.00006042147],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102940394,0.009411652,0.024589146,0.07597288,0.113720655,0.00007666976,0.0028259607,6.859837e-7,0.0037785298,0.0012183015,0.002661525,0.76564103],"study_design_scores_gemma":[0.0028029855,0.0021456026,0.07493479,0.0018021299,0.007650194,0.000025707652,0.00006082888,0.000001098416,0.0000041235808,0.000018247469,0.90981406,0.0007402578],"about_ca_topic_score_codex":0.00045056088,"about_ca_topic_score_gemma":0.00007077446,"teacher_disagreement_score":0.90715253,"about_ca_system_score_codex":0.000527647,"about_ca_system_score_gemma":0.00066013203,"threshold_uncertainty_score":0.9994503},"labels":[],"label_agreement":null},{"id":"W3096992450","doi":"10.1016/j.jacc.2020.09.536","title":"Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization","year":2020,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Heart and Stroke Foundation; University of Toronto","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; U.S. Department of Veterans Affairs","keywords":"Medicine; Internal medicine; Cardiology; Percutaneous coronary intervention; Conventional PCI; Hazard ratio; Myocardial infarction; Clinical endpoint; Diabetes mellitus; Stroke (engine); Revascularization; Coronary artery disease; Type 2 Diabetes Mellitus; Cumulative incidence; Confidence interval; Randomized controlled trial; Cohort; Endocrinology","score_opus":0.007759085432761975,"score_gpt":0.22060989145316018,"score_spread":0.21285080602039821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096992450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774015,0.00063892506,0.00035157287,0.00063530396,0.00007056348,0.0004999456,0.000016739052,0.0000047459644,0.000042033585],"genre_scores_gemma":[0.9988627,0.00023996871,0.0002404844,0.00053378544,0.00009209319,0.0000044278977,0.0000011670579,0.000023361872,0.000002012834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771434,0.0003874061,0.0006723311,0.00018835417,0.00082099065,0.00021657896],"domain_scores_gemma":[0.9981496,0.00012604882,0.0007125355,0.00054379256,0.000354611,0.0001134304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006704663,0.00017067553,0.0018252403,0.0001432691,0.000032435935,0.0000022341042,0.00022309291,0.00005588034,7.110943e-7],"category_scores_gemma":[0.00044813112,0.00010573536,0.00092348683,0.0005090627,0.0002489965,0.0000782609,0.00007183954,0.0003172754,4.1026712e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007238572,0.000051930616,0.90547144,0.00019164427,0.0024524601,0.000051833744,0.00004731537,0.08908055,0.0002694344,0.00000884108,0.000011883999,0.0016388192],"study_design_scores_gemma":[0.0035902786,0.0029341565,0.9912319,0.00038344148,0.0005404238,0.00004576151,0.00010271456,0.000018081313,0.0008516829,0.000010066508,0.00019739966,0.00009409374],"about_ca_topic_score_codex":0.000015675801,"about_ca_topic_score_gemma":0.0000020164127,"teacher_disagreement_score":0.08906247,"about_ca_system_score_codex":0.0001109781,"about_ca_system_score_gemma":0.00026126803,"threshold_uncertainty_score":0.43117628},"labels":[],"label_agreement":null},{"id":"W3097148212","doi":"10.14740/cr1157","title":"A Strict Target for Low-Density Lipoprotein Cholesterol May not Be Necessary for Secondary Prevention of Cardiovascular Disease in All Elderly Patients With Dyslipidemia","year":2020,"lang":"en","type":"review","venue":"Cardiology Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Fukuoka University","keywords":"Medicine; Dyslipidemia; Cardiology; Internal medicine; Disease; Atherosclerotic cardiovascular disease; Cholesterol; Secondary prevention","score_opus":0.11428722341110788,"score_gpt":0.39347745775186344,"score_spread":0.27919023434075557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097148212","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005992182,0.963799,0.0020713194,0.00035495567,0.00022641511,0.025996186,0.0014389799,0.000048387188,0.000072585535],"genre_scores_gemma":[0.013724505,0.96602637,0.0013310893,0.00012410969,0.0018362475,0.011033434,0.005454752,0.0003081108,0.00016138342],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909001,0.0032321785,0.0013302645,0.001684024,0.0015956851,0.0012577584],"domain_scores_gemma":[0.99494874,0.00073524856,0.0003566185,0.0020903428,0.0011603575,0.00070867955],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008419013,0.00070123817,0.007162972,0.00072417106,0.00016484791,0.000028864733,0.00053996616,0.0009763615,0.000010173053],"category_scores_gemma":[0.0018110474,0.00054882717,0.004383314,0.00080214976,0.0003487585,0.00012879935,0.0002952541,0.0019947214,0.0000071974296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022610803,0.00018904108,0.00053754786,0.08312029,0.009106877,0.00015810497,0.000036045607,0.000043845015,7.304065e-7,0.00001743715,0.0010443382,0.90348464],"study_design_scores_gemma":[0.0074110366,0.0037781263,0.0045885425,0.007664874,0.004730145,0.00003118557,0.000028921371,0.000026652171,0.000012067247,0.00005355279,0.9711663,0.00050855544],"about_ca_topic_score_codex":0.0002725518,"about_ca_topic_score_gemma":0.000017720715,"teacher_disagreement_score":0.970122,"about_ca_system_score_codex":0.0005669372,"about_ca_system_score_gemma":0.003533524,"threshold_uncertainty_score":0.9996963},"labels":[],"label_agreement":null},{"id":"W3098026321","doi":"10.1161/circ.142.suppl_3.14485","title":"Abstract 14485: Landscape of Lipid Management Following an Acute Coronary Syndrome: Survey of Canadian Specialists","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Montreal Heart Institute; Robarts Clinical Trials; Canadian Respiratory Research Network; University of Alberta","funders":"","keywords":"Medicine; Acute coronary syndrome; Ezetimibe; Statin; Internal medicine; Myocardial infarction","score_opus":0.036882785999290076,"score_gpt":0.26735653350660676,"score_spread":0.2304737475073167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098026321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653536,0.0001652877,0.00009688894,0.00017894889,0.00013945883,0.00045064505,0.00003875971,0.000016053373,0.0023785767],"genre_scores_gemma":[0.9991092,0.000044209286,0.00015478887,0.00013162824,0.00009086594,0.0000044228773,0.00044209446,0.000016340176,0.0000064263877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990052,0.000049983297,0.00027890285,0.00018316068,0.0003357964,0.00014694885],"domain_scores_gemma":[0.99931014,0.000009015084,0.000086274114,0.0002709385,0.00007692465,0.00024670234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004355173,0.00008307845,0.00030809137,0.00017364153,0.00003490628,0.0000058503106,0.000059585487,0.00006538412,0.000111443216],"category_scores_gemma":[0.000025963938,0.00008462819,0.00013990901,0.0004473858,0.000012421095,0.00008360258,0.000011382327,0.00006833631,0.000008046662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009328443,0.000063163585,0.9806705,0.00055771135,0.00078095053,0.00041206687,0.00039938293,0.00024350345,0.0012644132,0.00012260117,0.00023590268,0.015156532],"study_design_scores_gemma":[0.0007413357,0.00008415295,0.99822354,0.00006668454,0.00015081931,0.00002637285,0.00005645098,0.0002493938,0.000087808025,0.0000059771623,0.00023564725,0.00007180748],"about_ca_topic_score_codex":0.034191903,"about_ca_topic_score_gemma":0.007661347,"teacher_disagreement_score":0.026530556,"about_ca_system_score_codex":0.000057283036,"about_ca_system_score_gemma":0.00015371168,"threshold_uncertainty_score":0.9722395},"labels":[],"label_agreement":null},{"id":"W3098286361","doi":"10.1111/jth.15161","title":"Professor Marian A. Packham, CM, PhD, DSc, FRSC (1927–2020)","year":2020,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; University of Toronto; SickKids Foundation; York University; Hospital for Sick Children; McMaster University","funders":"","keywords":"Library science; Medicine; Gerontology","score_opus":0.07518975193630184,"score_gpt":0.3211128712874709,"score_spread":0.24592311935116906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098286361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8590208,0.006925424,0.00048024787,0.13070229,0.0004899975,0.00062116224,0.000033046697,0.000035673227,0.0016913571],"genre_scores_gemma":[0.9796766,0.00845168,0.0035375645,0.0064677484,0.0017144332,0.000005655575,0.0000061439946,0.000044381777,0.00009581599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800766,0.000115659524,0.0006426992,0.00023881359,0.0006869611,0.00030820858],"domain_scores_gemma":[0.9984043,0.00003674562,0.00035675993,0.00027942532,0.0002731216,0.0006496033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071431906,0.00021153856,0.0009614376,0.00007852315,0.0001528588,0.00006012771,0.000129152,0.00014364095,0.0003830277],"category_scores_gemma":[0.00016973146,0.00015263194,0.00051780575,0.00027873387,0.00007145345,0.0001889777,0.00008179841,0.00050922023,0.0000257588],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002619068,0.0012077737,0.04881225,0.0034471978,0.008861604,0.0013740287,0.008155804,0.00001085744,0.010731117,0.0010007187,0.35141343,0.5623661],"study_design_scores_gemma":[0.021740865,0.0070498837,0.31196555,0.0019848077,0.0056896745,0.0028065941,0.0072573,0.00025283836,0.015550188,0.00088052603,0.6236461,0.0011756618],"about_ca_topic_score_codex":0.000049233913,"about_ca_topic_score_gemma":0.0000072423168,"teacher_disagreement_score":0.5611905,"about_ca_system_score_codex":0.00006429162,"about_ca_system_score_gemma":0.000234068,"threshold_uncertainty_score":0.622415},"labels":[],"label_agreement":null},{"id":"W3098658954","doi":"10.1161/circ.142.suppl_3.14997","title":"Abstract 14997: Icosapent Ethyl Reduces Ischemic Events in Patients With Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; St. Michael's Hospital","funders":"","keywords":"Medicine; Clinical endpoint; Hazard ratio; Myocardial infarction; Cardiology; Internal medicine; Placebo; Stroke (engine); Coronary artery disease; Angina; Unstable angina; Statin; Confidence interval; Randomized controlled trial","score_opus":0.023099903065361364,"score_gpt":0.2575237561899427,"score_spread":0.23442385312458136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3098658954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962576,0.00019532967,0.000059407554,0.0015699833,0.00011108605,0.0012182852,0.000004910853,0.000056384895,0.0005270121],"genre_scores_gemma":[0.9986319,0.00001596413,0.00014483623,0.0006149166,0.00025484263,0.000043912343,0.00024653442,0.000036322275,0.000010750113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982187,0.00005034598,0.00039737494,0.00042238837,0.00063616387,0.00027498233],"domain_scores_gemma":[0.9992034,0.000016137665,0.00015125291,0.00030567887,0.00011167631,0.00021184646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002535317,0.0001827211,0.00033729954,0.00007390862,0.000069409034,0.000011477602,0.0000733489,0.00012198474,0.00006257743],"category_scores_gemma":[0.000074272706,0.00016018348,0.000119751676,0.00025400624,0.000024935001,0.00017897617,0.000024470322,0.00029458178,0.00004399184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059874204,0.00035272533,0.94915336,0.00027109898,0.00019972057,0.000044786342,0.001102285,0.0002611052,0.006797175,0.0000033343017,0.00026437052,0.040951263],"study_design_scores_gemma":[0.004178233,0.00014327836,0.99330246,0.00023702628,0.00008361291,0.00001553043,0.00012320874,0.00018467673,0.0011867732,0.0000074710865,0.00036306787,0.00017465213],"about_ca_topic_score_codex":0.000050950875,"about_ca_topic_score_gemma":0.0000051519523,"teacher_disagreement_score":0.04414908,"about_ca_system_score_codex":0.00019027713,"about_ca_system_score_gemma":0.00019735248,"threshold_uncertainty_score":0.65320927},"labels":[],"label_agreement":null},{"id":"W3099972977","doi":"10.1161/circ.142.suppl_3.14248","title":"Abstract 14248: Efficacy and Safety of Bempedoic Acid in Patients Who Cannot Tolerate Statins: Pooled Analysis of 4 Phase 3 Clinical Trials","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Michael's Hospital","funders":"","keywords":"Medicine; myalgia; Placebo; Discontinuation; Adverse effect; Internal medicine; Statin; Clinical endpoint; Gastroenterology; Clinical trial; Phases of clinical research; Dyslipidemia; Disease; Pathology","score_opus":0.08448918701929443,"score_gpt":0.3949313866847083,"score_spread":0.31044219966541386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099972977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99765503,0.00030429117,0.00078678806,0.00022884604,0.00003697308,0.000854364,0.00007244134,0.0000088142015,0.000052429776],"genre_scores_gemma":[0.99927384,0.00009100825,0.00008819754,0.0001696028,0.00008021733,0.0000055444175,0.00028136442,0.00000948636,7.717556e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974918,0.00034288823,0.0014453226,0.00024930906,0.00035757085,0.000113153044],"domain_scores_gemma":[0.99876976,0.000166947,0.00050406565,0.0002373473,0.00017655888,0.00014532714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023664115,0.00009869822,0.0012227696,0.00016602164,0.000020087315,0.0000055140363,0.000033451026,0.00010235042,0.000053070104],"category_scores_gemma":[0.0016908804,0.000086097556,0.00032706241,0.0006277467,0.000037764516,0.00006272605,0.0000137528405,0.00013304707,0.0000010342013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031621663,0.00085369765,0.67227775,0.00044198506,0.002998928,0.000006374995,0.0016447785,0.00153271,0.003931518,0.000024572644,0.00001784169,0.31310767],"study_design_scores_gemma":[0.0133932475,0.0002904916,0.9783141,0.00008087033,0.0019225624,1.544098e-7,0.000045513094,0.0053463466,0.00048149572,0.0000038093308,0.000054617663,0.000066762885],"about_ca_topic_score_codex":0.00021536966,"about_ca_topic_score_gemma":0.000018064997,"teacher_disagreement_score":0.3130409,"about_ca_system_score_codex":0.000034514283,"about_ca_system_score_gemma":0.00012274098,"threshold_uncertainty_score":0.35109565},"labels":[],"label_agreement":null},{"id":"W3100021729","doi":"10.1161/circ.142.suppl_3.15091","title":"Abstract 15091: Significant Reductions in Both Adjudicated and Investigator-Reported Ischemic Events in REDUCE-IT","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Clinical endpoint; Myocardial infarction; Unstable angina; Hazard ratio; Internal medicine; Stroke (engine); Placebo; Cardiology; Clinical trial; Emergency medicine; Confidence interval","score_opus":0.05711154981990633,"score_gpt":0.2923241303412831,"score_spread":0.23521258052137675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100021729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921356,0.00036223332,0.000056264576,0.006159611,0.00005269231,0.00066384405,0.0000020556745,0.00004493271,0.0005228055],"genre_scores_gemma":[0.99897367,0.000076558805,0.00012575868,0.00052858517,0.00014992933,0.000037865073,0.00008232831,0.00001799111,0.000007299811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987692,0.00004591605,0.0004250363,0.00033245815,0.00025396462,0.00017342975],"domain_scores_gemma":[0.9993523,0.000010881722,0.000105528066,0.00022196848,0.000039587252,0.00026978247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036809818,0.00010645878,0.00026085504,0.00011906112,0.0000332127,0.000006014781,0.000030919837,0.00011257249,0.000036205172],"category_scores_gemma":[0.00040156316,0.00011011208,0.00005923729,0.00049746135,0.00003957162,0.000104113635,0.000013201099,0.00025272684,0.000010040761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009895088,0.00016858132,0.6002084,0.00037083536,0.000115480434,0.00010542991,0.0014454802,0.00047382968,0.38750166,0.000042862895,0.0010183146,0.008450204],"study_design_scores_gemma":[0.0013709677,0.000021190352,0.9938022,0.00017383105,0.000045076817,0.000042692674,0.0002072056,0.0011418306,0.002426349,0.00008910784,0.0005716904,0.0001078392],"about_ca_topic_score_codex":0.0005964204,"about_ca_topic_score_gemma":0.000016384425,"teacher_disagreement_score":0.39359385,"about_ca_system_score_codex":0.00012088208,"about_ca_system_score_gemma":0.0003052731,"threshold_uncertainty_score":0.44902402},"labels":[],"label_agreement":null},{"id":"W3101862857","doi":"10.1161/circ.142.suppl_3.14328","title":"Abstract 14328: Relation of Lipoprotein(a) Levels to Incident Diabetes and Modification by Alirocumab Treatment: An Analysis of the Odyssey Outcomes Trial","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Alirocumab; Quartile; Internal medicine; Diabetes mellitus; Placebo; Statin; Cohort; Lipoprotein(a); PCSK9; Gastroenterology; Lipoprotein; Endocrinology; Cholesterol; Confidence interval; Apolipoprotein A1; LDL receptor; Pathology","score_opus":0.05109198154971324,"score_gpt":0.3062234127339216,"score_spread":0.2551314311842084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101862857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996206,0.00016502429,0.0012508719,0.0008584854,0.000034177385,0.0013944223,0.00003417091,0.000017446255,0.000039396182],"genre_scores_gemma":[0.99952227,0.000010490559,0.00010558695,0.000107852,0.00006711117,0.000046504636,0.00012353226,0.000011234575,0.0000054207803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873626,0.00008272186,0.00042498118,0.00023775268,0.00042179157,0.00009650113],"domain_scores_gemma":[0.9990817,0.000030016032,0.00025817723,0.00041034175,0.00010770597,0.00011208121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030541577,0.000106817366,0.00044422178,0.000108242464,0.00005661124,0.000010965383,0.0000491229,0.00008500888,0.000017767346],"category_scores_gemma":[0.0001761953,0.0000760416,0.0002483254,0.0004942698,0.000024295485,0.00011654384,0.000012893764,0.000050926028,0.000001151658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011505904,0.0003666842,0.76170415,0.00021726184,0.0020572525,4.9277867e-7,0.0038437524,0.0059296074,0.14399369,0.00026770463,0.00000871166,0.08046009],"study_design_scores_gemma":[0.0047703492,0.00022433168,0.97925484,0.000019740011,0.001212858,1.8768857e-7,0.00008246773,0.0058822744,0.008426383,0.000032626278,0.000028702236,0.00006525278],"about_ca_topic_score_codex":0.0005482599,"about_ca_topic_score_gemma":0.000029340183,"teacher_disagreement_score":0.21755065,"about_ca_system_score_codex":0.000097567485,"about_ca_system_score_gemma":0.000052570576,"threshold_uncertainty_score":0.31008863},"labels":[],"label_agreement":null},{"id":"W3106060008","doi":"10.1093/eurheartj/ehaa842","title":"The cardiovascular benefit of Lp(a) reduction: not there yet","year":2020,"lang":"en","type":"letter","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Imperial Biomedical Research Centre; American Regent; Genentech; Esperion Therapeutics; Sirtex Medical; HLS Therapeutics; Idorsia Pharmaceuticals; Novo Nordisk; Duke Clinical Research Institute; Astellas Pharma; Eisai; Daiichi-Sankyo; European Commission; Medicines Company; Regado Biosciences; Tenax Therapeutics; AstraZeneca; Amarin Corporation; Ionis Pharmaceuticals; Luitpold Pharmaceuticals; F. Hoffmann-La Roche; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Boston VA Research Institute; Boston Scientific Corporation; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; National Institute for Health and Care Research; CSL Behring; Belvoir Media Group; Servier; Gilead Sciences; European Society of Cardiology; Amgen; Pfizer; St. Jude Medical; Kowa Company; Sanofi; American Heart Association","keywords":"Medicine; Reduction (mathematics); Cardiology; Internal medicine; Intensive care medicine","score_opus":0.04410665789276214,"score_gpt":0.26326415102941914,"score_spread":0.219157493136657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106060008","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027262538,0.03968876,0.00008556221,0.94092524,0.0028332667,0.000720475,0.000027206781,0.00007440559,0.012918808],"genre_scores_gemma":[0.031427156,0.020359455,0.0012651074,0.7930608,0.14201857,0.000016583524,0.00009683247,0.00067517784,0.011080327],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99550253,0.001027654,0.0007042229,0.00040752295,0.0018468682,0.0005112037],"domain_scores_gemma":[0.9976596,0.000058063535,0.00029956945,0.0013677351,0.00034346,0.0002715607],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0024078977,0.0003535632,0.0010714916,0.00009624803,0.00052258826,0.00011596907,0.00035824333,0.0001634544,0.00013994989],"category_scores_gemma":[0.00014707902,0.00022541212,0.0028929887,0.00022020598,0.00016646314,0.000058304333,0.0001160466,0.0043185474,0.00022494326],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006479693,0.000011981965,0.000040006064,0.00030180273,0.0024704027,0.0036524062,0.00009736115,0.000013129116,0.00007253359,0.0000067752135,0.97363186,0.019636957],"study_design_scores_gemma":[0.00077332166,0.0003226222,0.002471658,0.00046575043,0.00076350686,0.017924562,0.00006888102,0.0000024718447,0.00016919231,0.000026986538,0.97680825,0.00020278482],"about_ca_topic_score_codex":0.000022076902,"about_ca_topic_score_gemma":3.1166974e-7,"teacher_disagreement_score":0.14786448,"about_ca_system_score_codex":0.000108776214,"about_ca_system_score_gemma":0.00033498622,"threshold_uncertainty_score":0.9979785},"labels":[],"label_agreement":null},{"id":"W3106996279","doi":"10.1093/ehjci/ehaa946.3341","title":"REDUCE-IT: outcomes by baseline statin type","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Statin; Rosuvastatin; Simvastatin; Pravastatin; Atorvastatin; Internal medicine; Clinical endpoint; Placebo; Myocardial infarction; Hazard ratio; Cardiology; Pharmacology; Randomized controlled trial; Cholesterol; Confidence interval","score_opus":0.07195410710364705,"score_gpt":0.33483190547271985,"score_spread":0.26287779836907277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106996279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65655357,0.005840357,0.0029680606,0.30825725,0.0011556579,0.0006640282,0.000037721,0.00022508838,0.02429828],"genre_scores_gemma":[0.92351943,0.00061066676,0.005433561,0.064489044,0.0029583129,9.285816e-7,0.000022068378,0.00010276301,0.0028632204],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982362,0.00047462367,0.0003412901,0.0001898421,0.00048444892,0.00027358995],"domain_scores_gemma":[0.9988768,0.000027166525,0.00007290424,0.00023229662,0.00012735403,0.0006634968],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001458914,0.0001348653,0.00034006455,0.00003559648,0.00013660509,0.000048557526,0.00008660338,0.0000232892,0.00086010195],"category_scores_gemma":[0.0004939632,0.00009974086,0.00023665997,0.00016323994,0.000025100653,0.000065333756,0.000038410824,0.0005706173,0.0008165232],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014644735,0.000074825824,0.01058503,0.00004943615,0.00016270766,0.00063863106,0.000381763,0.000008881302,0.003798059,0.000005905682,0.9570203,0.027128013],"study_design_scores_gemma":[0.0015556247,0.0005811424,0.032362126,0.000060080365,0.00006260719,0.0010455927,0.00015159052,0.000072984076,0.0005241086,0.0000022100112,0.96346074,0.00012121036],"about_ca_topic_score_codex":0.0000074657446,"about_ca_topic_score_gemma":2.911541e-7,"teacher_disagreement_score":0.2669659,"about_ca_system_score_codex":0.000031787622,"about_ca_system_score_gemma":0.00015149053,"threshold_uncertainty_score":0.99996144},"labels":[],"label_agreement":null},{"id":"W3107302989","doi":"10.1016/j.cjco.2020.11.019","title":"A Comparative Analysis of the Lipoprotein(a) and Low-Density Lipoprotein Proteomic Profiles Combining Mass Spectrometry and Mendelian Randomization","year":2020,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Western University; Institut Universitaire de Cardiologie et de Pneumologie de Québec; Université Laval","funders":"Fonds de Recherche du Québec - Santé; Horizon 2020; Canadian Institutes of Health Research; Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Agence Nationale de la Recherche; Heart and Stroke Foundation of Canada","keywords":"Mendelian randomization; Lipoprotein; Proteome; Apolipoprotein B; Lipoprotein(a); Chemistry; Cholesterol; Blood proteins; PCSK9; Low-density lipoprotein; Internal medicine; LDL receptor; Biochemistry; Medicine; Genetic variants; Gene","score_opus":0.02236285793320804,"score_gpt":0.28216588618349625,"score_spread":0.2598030282502882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107302989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880275,0.00049895287,0.0020515036,0.0022207794,0.000026953638,0.005895999,0.000021633585,0.000025260508,0.0012314257],"genre_scores_gemma":[0.9953913,0.0000728089,0.0037882493,0.00038760662,0.00008296549,0.00016891651,0.000024441424,0.000015519763,0.00006820481],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982483,0.00028944062,0.00039472367,0.0004420983,0.00041890403,0.00020655259],"domain_scores_gemma":[0.9989153,0.000027959128,0.0002475021,0.00047137443,0.00013469631,0.0002031732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008690324,0.0001936699,0.0013419283,0.00013373574,0.00018428423,0.00008715816,0.00020460355,0.0000913085,0.000051977215],"category_scores_gemma":[0.00017561391,0.0001319044,0.00020316466,0.0011578404,0.00015027942,0.00014296618,0.000314103,0.00025508823,0.000002526581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020042403,0.00087762973,0.085270636,0.005030011,0.03189357,0.0001753798,0.025842715,0.0005627818,0.77992636,0.0044274246,0.00077075046,0.045180358],"study_design_scores_gemma":[0.04111237,0.001676182,0.42525887,0.0010027087,0.008278422,0.00010195197,0.003629282,0.037792902,0.4791765,0.00069624756,0.0003870065,0.000887563],"about_ca_topic_score_codex":0.0012498018,"about_ca_topic_score_gemma":0.00007404215,"teacher_disagreement_score":0.33998823,"about_ca_system_score_codex":0.0000432447,"about_ca_system_score_gemma":0.00014652168,"threshold_uncertainty_score":0.53789055},"labels":[],"label_agreement":null},{"id":"W3107325099","doi":"10.1093/ehjci/ehaa946.3011","title":"REDUCE-IT: total ischemic events reduced across the full range of baseline LDL cholesterol and other key subgroups","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Myocardial infarction; Internal medicine; Clinical endpoint; Hazard ratio; Stroke (engine); Unstable angina; Cardiology; Proportional hazards model; Confounding; Coronary artery disease; Confidence interval; Randomized controlled trial","score_opus":0.04768747262396953,"score_gpt":0.3104202766567503,"score_spread":0.26273280403278076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107325099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851408,0.001663797,0.00012369959,0.011556864,0.000165552,0.0003213905,0.000017467428,0.000021534996,0.0009889216],"genre_scores_gemma":[0.9919405,0.00018329118,0.00028853564,0.004986757,0.0023212803,0.0000019944805,0.0000019316856,0.000059076137,0.000216645],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979457,0.0005637593,0.00044713725,0.00023470505,0.00048728086,0.00032136252],"domain_scores_gemma":[0.9989745,0.000028780492,0.00015059626,0.0003401548,0.00009847953,0.00040748573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002438635,0.00016756776,0.00037972775,0.000026978827,0.00018367777,0.000038553182,0.00012418238,0.00003949309,0.00012445028],"category_scores_gemma":[0.00018901394,0.00010901544,0.00027913714,0.00014179022,0.00008239222,0.00008009937,0.00009251461,0.0006300217,0.00005710185],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050822007,0.0009674589,0.09931087,0.0014330962,0.0020248778,0.0011743762,0.033912495,0.00008316928,0.6455751,0.000016553799,0.111191966,0.09922783],"study_design_scores_gemma":[0.012854788,0.0019408362,0.597353,0.0010388921,0.0003753263,0.024208432,0.0021186043,0.00033999776,0.012503142,0.0000047251947,0.34676674,0.000495563],"about_ca_topic_score_codex":0.000015835496,"about_ca_topic_score_gemma":0.0000011416964,"teacher_disagreement_score":0.63307196,"about_ca_system_score_codex":0.00002288797,"about_ca_system_score_gemma":0.00007410323,"threshold_uncertainty_score":0.44455206},"labels":[],"label_agreement":null},{"id":"W3107432659","doi":"10.1016/j.jacc.2020.10.029","title":"Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk","year":2020,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Atherosclerotic cardiovascular disease; Disease; Cardiology; Cholesterol; Ldl cholesterol; Internal medicine","score_opus":0.015170190628611777,"score_gpt":0.23581396498358206,"score_spread":0.2206437743549703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107432659","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3372923,0.024829505,0.00092429615,0.63202333,0.0017460432,0.002054559,0.0008260918,0.0000290416,0.00027483352],"genre_scores_gemma":[0.7263474,0.017090302,0.0006858903,0.23882101,0.016612843,0.000027100255,0.00001005394,0.00018738794,0.00021804047],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99545705,0.0015989032,0.0009102219,0.00041165587,0.0012210613,0.00040108952],"domain_scores_gemma":[0.9960005,0.00014929661,0.0016582749,0.001485405,0.00037801245,0.00032846504],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010979269,0.00039083805,0.003670172,0.00018311688,0.00010744985,0.000008644457,0.00045563316,0.00021799559,0.0000030891927],"category_scores_gemma":[0.00060692127,0.00023881321,0.0041861883,0.00037743978,0.0009149609,0.000040463055,0.00021031691,0.0024797586,0.000002531713],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020910103,0.000056153927,0.038033023,0.0021688724,0.04807095,0.018909438,0.000083824765,0.0008112955,0.00025722216,0.000011006672,0.86872333,0.02078388],"study_design_scores_gemma":[0.0021909745,0.0013016397,0.08286996,0.0005137716,0.011029037,0.0071756435,0.00008614798,0.000021191801,0.00003107527,0.00013347807,0.89436823,0.0002788607],"about_ca_topic_score_codex":0.00006549632,"about_ca_topic_score_gemma":5.690259e-7,"teacher_disagreement_score":0.3932023,"about_ca_system_score_codex":0.00015017691,"about_ca_system_score_gemma":0.00079352834,"threshold_uncertainty_score":0.99982154},"labels":[],"label_agreement":null},{"id":"W3108102955","doi":"10.1093/ehjci/ehaa946.2845","title":"Recommendations and associated levels of evidence for statin use in primary prevention of cardiovascular disease: a comparison at population level of the ESC, ACC/AHA, USPSTF, and CCS Guidelines","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Statin; Population; Internal medicine; Canadian Cardiovascular Society; Physical therapy; Myocardial infarction; Environmental health; Pathology","score_opus":0.5844628396651926,"score_gpt":0.4277949832847932,"score_spread":0.15666785638039943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108102955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678374,0.0055219377,0.004475403,0.002413528,0.000050084025,0.0006406057,0.00010538639,0.0000044150315,0.0000049141127],"genre_scores_gemma":[0.9941148,0.0009133339,0.0046893586,0.0001253078,0.00007728558,0.0000027236279,0.000016813061,0.000017288683,0.00004307455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979187,0.0007192868,0.0007060297,0.00014767714,0.0004009187,0.00010736525],"domain_scores_gemma":[0.99891627,0.00011816844,0.00034456243,0.00020008745,0.00030279538,0.00011808819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002276273,0.000087319866,0.0004560133,0.000054735036,0.00008087254,0.000012390649,0.000051270483,0.000024100162,0.0000067736764],"category_scores_gemma":[0.001446065,0.000061344435,0.00029225848,0.00015587611,0.0000367933,0.00015534155,0.00006297359,0.00014421064,1.456043e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066153123,0.00019621916,0.89325356,0.0013005922,0.00095269346,0.0000074104873,0.001118866,0.0015090278,0.0038846307,0.000012007239,0.0025893203,0.09451412],"study_design_scores_gemma":[0.0016459678,0.00018809331,0.9938196,0.0014612775,0.00035655047,0.00002753981,0.00006265245,0.0009936215,0.0003242222,0.000013901534,0.0010505024,0.00005608165],"about_ca_topic_score_codex":0.00010382428,"about_ca_topic_score_gemma":0.000022989512,"teacher_disagreement_score":0.100566,"about_ca_system_score_codex":0.00006122661,"about_ca_system_score_gemma":0.00010988845,"threshold_uncertainty_score":0.25015536},"labels":[],"label_agreement":null},{"id":"W3108111074","doi":"10.1093/ehjci/ehaa946.3012","title":"Baseline triglycerides and non-HDL-C and apoB goal attainment in the ORION-10 and ORION-11 trials","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Quartile; Medicine; Apolipoprotein B; Placebo; Internal medicine; Triglyceride; Logistic regression; Endocrinology; Gastroenterology; Cholesterol; Confidence interval; Pathology","score_opus":0.06320543090272131,"score_gpt":0.31873902209854926,"score_spread":0.25553359119582797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108111074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669044,0.0064863833,0.00036570593,0.025006507,0.000118904325,0.00060716725,0.0000064672863,0.000014493092,0.0004899775],"genre_scores_gemma":[0.9884659,0.0031601007,0.00078318786,0.0048248055,0.0026458562,0.000003605394,0.000003910326,0.000030192672,0.00008242783],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971252,0.0014339522,0.00052721106,0.00025206435,0.00041634482,0.00024524113],"domain_scores_gemma":[0.99904567,0.00020732597,0.00011181745,0.00018314553,0.00004753343,0.00040449054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009167866,0.00016395832,0.0005656498,0.00006855676,0.00020599033,0.00012833273,0.0000601377,0.000034422457,0.00009783245],"category_scores_gemma":[0.00076834793,0.000097630065,0.00012880754,0.0001374572,0.000070502814,0.00008760047,0.00006748837,0.00044394046,0.00001374138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058459877,0.0006228979,0.19762032,0.0014463288,0.0009476552,0.007811145,0.017137375,0.000039715313,0.010564755,0.00018710394,0.13190056,0.6258761],"study_design_scores_gemma":[0.011079073,0.0017611455,0.41232154,0.0003458117,0.000257642,0.006395147,0.0015783748,0.00044489175,0.00020364023,0.000026005182,0.565324,0.0002627149],"about_ca_topic_score_codex":0.00003290628,"about_ca_topic_score_gemma":0.00000641706,"teacher_disagreement_score":0.62561345,"about_ca_system_score_codex":0.000024982242,"about_ca_system_score_gemma":0.000090706715,"threshold_uncertainty_score":0.39812383},"labels":[],"label_agreement":null},{"id":"W3108123134","doi":"10.1093/ehjci/ehaa946.1410","title":"Low-density lipoprotein cholesterol goal attainment and treatment patterns in a cohort of &amp;gt;143,000 patients with atherosclerotic cardiovascular disease in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University; Toronto Rehabilitation Institute; St. Michael's Hospital; Amgen (Canada)","funders":"","keywords":"Medicine; Statin; Atherosclerotic cardiovascular disease; Internal medicine; Cohort; Retrospective cohort study; Observational study; Cholesterol; Cohort study; Disease; Ldl cholesterol; Cardiology","score_opus":0.018254156222701927,"score_gpt":0.20810403684124215,"score_spread":0.18984988061854022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108123134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774593,0.00028890203,0.000072333365,0.0003570643,0.000052404033,0.0014054417,0.000018494573,0.000008428907,0.000051011404],"genre_scores_gemma":[0.999048,0.000096860735,0.00011176732,0.0004864989,0.00015175635,0.00001577537,0.00001770785,0.000046055335,0.000025592213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973655,0.00047711376,0.00046371738,0.00038904874,0.00093481573,0.00036983172],"domain_scores_gemma":[0.9986286,0.000010596172,0.00010007242,0.0004503498,0.000075933196,0.0007344165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063637807,0.00025429516,0.0007219697,0.0000745166,0.00006928652,0.000028791312,0.00007367334,0.000028010196,0.00006279109],"category_scores_gemma":[0.000031498188,0.0001929013,0.00023205405,0.00012096166,0.000038537033,0.00007116034,0.000055026783,0.000434537,0.000003411363],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004395032,0.00026771953,0.9896088,0.00010219731,0.00037716096,0.0007224919,0.00064988574,0.00040584648,0.000022797965,1.5896472e-7,0.000026219537,0.007377167],"study_design_scores_gemma":[0.00652266,0.0007071464,0.9884444,0.00061034574,0.00019863254,0.00007220683,0.00004085029,0.000017286595,0.000051122868,2.5788646e-7,0.0031677776,0.00016730641],"about_ca_topic_score_codex":0.6978372,"about_ca_topic_score_gemma":0.6908905,"teacher_disagreement_score":0.007209861,"about_ca_system_score_codex":0.0008993195,"about_ca_system_score_gemma":0.0006741247,"threshold_uncertainty_score":0.78662866},"labels":[],"label_agreement":null},{"id":"W3108497567","doi":"10.1093/ehjci/ehaa946.1736","title":"Low-density lipoprotein cholesterol &amp;lt;50 mg/dL is an appropriate target after acute coronary syndrome: propensity score-matched analysis of the ODYSSEY OUTCOMES trial","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Alirocumab; Medicine; Mace; Placebo; PCSK9; Acute coronary syndrome; Internal medicine; Propensity score matching; Lipoprotein; Clinical trial; Simvastatin; Cholesterol; Cardiology; Percutaneous coronary intervention; LDL receptor; Myocardial infarction; Pathology","score_opus":0.055904603408369676,"score_gpt":0.28214767860188206,"score_spread":0.2262430751935124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3108497567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923063,0.00022011051,0.0007021317,0.0043119094,0.00042827032,0.0018243274,0.000056472407,0.00007156997,0.000078916244],"genre_scores_gemma":[0.99078935,0.000052443156,0.0013611607,0.0067078746,0.00070090336,0.000013617703,0.00002614957,0.000094954405,0.0002535248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942948,0.0017873335,0.0010719125,0.00066289114,0.0015972563,0.0005858119],"domain_scores_gemma":[0.9967804,0.00002397379,0.0005107524,0.0014590784,0.0003441938,0.0008816342],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002686175,0.00044810603,0.0017903391,0.00021164415,0.000352891,0.00014314111,0.00046676947,0.00012524404,0.00042523537],"category_scores_gemma":[0.00019784798,0.00028272028,0.0018513713,0.00088509533,0.00017428862,0.0003028836,0.00035112898,0.00126586,0.000131004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038337942,0.001812266,0.90320885,0.00060202274,0.022945486,0.0034778297,0.0064695124,0.00018274697,0.013570841,0.000005221777,0.0023428993,0.007044403],"study_design_scores_gemma":[0.012515125,0.0010880361,0.97873104,0.00015735289,0.0034140858,0.0013046364,0.00004745142,0.00009653717,0.0008325026,0.0000069380008,0.0015098092,0.00029650898],"about_ca_topic_score_codex":0.00015919477,"about_ca_topic_score_gemma":0.000047194342,"teacher_disagreement_score":0.075522184,"about_ca_system_score_codex":0.000102524835,"about_ca_system_score_gemma":0.0003055851,"threshold_uncertainty_score":0.9999625},"labels":[],"label_agreement":null},{"id":"W3109359857","doi":"10.1093/ehjci/ehaa946.3191","title":"Differences in lipid treatment patterns in women versus men in a large cohort of patients with atherosclerotic cardiovascular disease in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; McMaster University; St. Michael's Hospital; Amgen (Canada)","funders":"","keywords":"Medicine; Cohort; Internal medicine; Guideline; Statin; Atherosclerotic cardiovascular disease; Cohort study; Disease; Cardiology; Pathology","score_opus":0.02488313001377092,"score_gpt":0.21568811573022217,"score_spread":0.19080498571645124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109359857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985545,0.00027527634,0.0000049526616,0.00021698713,0.00007133061,0.00069076475,0.000015820902,0.000003952754,0.00016636956],"genre_scores_gemma":[0.9995109,0.00014763205,0.000018027333,0.00016386871,0.00008986561,0.000019969431,0.000009801026,0.000027203809,0.000012760646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976345,0.0005363496,0.00044091605,0.00027586476,0.0006728706,0.0004395573],"domain_scores_gemma":[0.99918455,0.000019203884,0.00006542942,0.00027466784,0.000033085085,0.00042307808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007357309,0.00018007305,0.0007017895,0.00013025418,0.000025601192,0.00001356907,0.000085453925,0.000020978476,0.00009367876],"category_scores_gemma":[0.000044485696,0.00013393715,0.00014521407,0.00022897744,0.000015386237,0.00006124104,0.00003541707,0.0004194334,0.0000019266238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012685844,0.00032447546,0.9938651,0.000051204046,0.00022623154,0.0011138851,0.0020165602,0.0002109518,0.0000011654437,2.817729e-7,0.00001338835,0.0009082207],"study_design_scores_gemma":[0.01422033,0.00081506703,0.98263216,0.0003702639,0.000049830112,0.000004897176,0.00032747825,0.000045681994,0.0000024988378,2.3648725e-7,0.0014116374,0.000119910714],"about_ca_topic_score_codex":0.64350194,"about_ca_topic_score_gemma":0.77586293,"teacher_disagreement_score":0.132361,"about_ca_system_score_codex":0.0017252992,"about_ca_system_score_gemma":0.0010830726,"threshold_uncertainty_score":0.5461799},"labels":[],"label_agreement":null},{"id":"W3109581922","doi":"10.1093/ehjci/ehaa946.3510","title":"A longitudinal evaluation of cardiovascular risk factors, treatment patterns, and outcomes in patients with documented cardiovascular disease treated with lipid lowering therapy in the United Kingdom","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amgen","keywords":"Medicine; Dyslipidemia; Revascularization; Internal medicine; Myocardial infarction; Cohort; Angina; Canadian Cardiovascular Society; Stroke (engine); Disease; Cardiology; Emergency medicine","score_opus":0.060710799754082646,"score_gpt":0.2850670838556815,"score_spread":0.22435628410159889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109581922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609464,0.0020607458,0.00017103838,0.0001587254,0.000024474026,0.0014424359,0.000016872875,0.00001574387,0.00001530151],"genre_scores_gemma":[0.9985829,0.001060571,0.000041082876,0.00007934009,0.00012795208,0.0000163659,0.00004371793,0.000047274756,8.153346e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954726,0.0018633548,0.00037703203,0.0003595593,0.0016404595,0.00028700283],"domain_scores_gemma":[0.9987774,0.000034842844,0.00012469849,0.00057014276,0.00021963513,0.00027329143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023172332,0.00028924848,0.0007670124,0.00021282198,0.00011514118,0.000056923785,0.000090258516,0.000026866024,0.000013531162],"category_scores_gemma":[0.00008175834,0.0001459418,0.00052562327,0.00044510598,0.000047999194,0.00012356532,0.000021701806,0.0003506291,0.0000010602683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088599545,0.000290387,0.9772217,0.00003763311,0.0035870378,0.00023512696,0.00076600077,0.0059847576,0.0000010493917,2.5512358e-7,0.0000024773462,0.010987543],"study_design_scores_gemma":[0.01726863,0.0020468233,0.9768976,0.00027462264,0.0016855029,0.000041118732,0.00018406642,0.00019304219,0.00002538358,2.8570025e-7,0.0012281743,0.00015474352],"about_ca_topic_score_codex":0.0019436534,"about_ca_topic_score_gemma":0.000016090065,"teacher_disagreement_score":0.016382635,"about_ca_system_score_codex":0.00016713708,"about_ca_system_score_gemma":0.000120320394,"threshold_uncertainty_score":0.59513336},"labels":[],"label_agreement":null},{"id":"W3109742192","doi":"10.1093/ehjci/ehaa946.3009","title":"Pooled safety and efficacy of inclisiran in patients with statin intolerance (ORION-10 and ORION-11)","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Medicines Company","keywords":"Medicine; Tolerability; Statin; Placebo; myalgia; Internal medicine; Gastroenterology; Adverse effect","score_opus":0.015367089566859444,"score_gpt":0.25017458341521875,"score_spread":0.2348074938483593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109742192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697757,0.00070519064,0.00016492074,0.0014320193,0.0000367082,0.0002905461,0.000005399951,0.000010438109,0.00037721766],"genre_scores_gemma":[0.99772835,0.00017151996,0.0011095944,0.0006931181,0.00024150759,3.4333928e-7,0.0000051215666,0.00002664401,0.00002382454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998621,0.00029486246,0.00036091413,0.00018534173,0.00036275375,0.00017514857],"domain_scores_gemma":[0.9992913,0.000034479875,0.000109233835,0.00014083978,0.00010234018,0.00032180405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074316777,0.00011669453,0.00037789138,0.00006336767,0.0000826775,0.000022455697,0.00004212484,0.000021189382,0.000047389018],"category_scores_gemma":[0.00014679374,0.00008461524,0.00005313683,0.00016318214,0.00005638924,0.00008405021,0.000046370875,0.00033291557,0.0000056876543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032793344,0.00018959038,0.90917814,0.00024474788,0.00012129491,0.00017127239,0.0024109024,0.000038812817,0.00017508719,0.000019791285,0.0004216529,0.08374937],"study_design_scores_gemma":[0.00947721,0.0013090358,0.973265,0.00031492327,0.000041029343,0.00009479552,0.00007159792,0.000041564108,0.000032288437,0.0000016347954,0.01526386,0.00008705882],"about_ca_topic_score_codex":0.000019740473,"about_ca_topic_score_gemma":0.0000049562573,"teacher_disagreement_score":0.08366231,"about_ca_system_score_codex":0.00002359772,"about_ca_system_score_gemma":0.00007588325,"threshold_uncertainty_score":0.34505096},"labels":[],"label_agreement":null},{"id":"W3110233470","doi":"10.1136/bmjopen-2020-038469","title":"Strategies for enhancing the initiation of cholesterol lowering medication among patients at high cardiovascular disease risk: a qualitative descriptive exploration of patient and general practitioners’ perspectives on a facilitated relay intervention in Alberta, Canada","year":2020,"lang":"en","type":"article","venue":"BMJ Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; University of Calgary","funders":"Diabetes Canada","keywords":"Medicine; Medical prescription; Psychological intervention; Focus group; Thematic analysis; Intervention (counseling); Qualitative research; Nursing; Family medicine; Statin; Descriptive statistics; Health care","score_opus":0.05071079448808248,"score_gpt":0.33133768184320295,"score_spread":0.2806268873551205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110233470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875707,0.00013048669,0.004882391,0.0005838237,0.00004408042,0.006664416,0.00008547615,0.0000036589825,0.000034952856],"genre_scores_gemma":[0.9981711,0.000041641393,0.00015487237,0.0000479187,0.000027030435,0.0013379001,0.00020249872,0.000011110796,0.0000059542012],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9981636,0.00051819737,0.000467487,0.00026815437,0.00048149252,0.00010111253],"domain_scores_gemma":[0.9988954,0.00011228943,0.00038675987,0.00024284961,0.00027853667,0.00008414765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009885334,0.00010711546,0.00032517355,0.000046847985,0.00007631844,0.000018837725,0.000059466136,0.00003497813,0.0000043025234],"category_scores_gemma":[0.00096855353,0.00008319178,0.00012693148,0.00012840427,0.000052244668,0.0005264647,0.000060155122,0.00009515993,2.1951504e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009034148,0.0006662535,0.018078497,0.002380888,0.0024923275,0.000009504138,0.9373628,0.016693065,0.00046710906,0.0011932532,0.00015375968,0.0114683965],"study_design_scores_gemma":[0.00951814,0.0024000949,0.44711205,0.0016567121,0.00064836984,0.0000012188452,0.53012866,0.0031715983,0.004657263,0.00029187725,0.00012161716,0.00029239192],"about_ca_topic_score_codex":0.4446055,"about_ca_topic_score_gemma":0.23395598,"teacher_disagreement_score":0.42903355,"about_ca_system_score_codex":0.00030502398,"about_ca_system_score_gemma":0.00034574803,"threshold_uncertainty_score":0.7800223},"labels":[],"label_agreement":null},{"id":"W3110249077","doi":"10.1093/ehjci/ehaa946.2997","title":"Inter-individual variability in LDL-C reductions with inclisiran – data from ORION-10 and ORION-11","year":2020,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Medicines Company","keywords":"Medicine; Interquartile range; Placebo; Confidence interval; Ezetimibe; Internal medicine; Statin; Odds ratio","score_opus":0.0937724598505559,"score_gpt":0.30901217701864503,"score_spread":0.21523971716808912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110249077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812117,0.0006057088,0.0026983013,0.013140026,0.00027572585,0.00036078005,0.00010306498,0.000053934655,0.0015507502],"genre_scores_gemma":[0.9905206,0.00012260165,0.0051426985,0.0012589488,0.0027437527,0.0000012461649,0.000104251194,0.00004267012,0.00006326286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975308,0.00091903197,0.0003904547,0.00045630577,0.00044932053,0.00025408974],"domain_scores_gemma":[0.9985304,0.000069349444,0.00008601764,0.0007094851,0.00008188043,0.0005228876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030247453,0.00015895955,0.0003798845,0.000073753006,0.00018306487,0.00010633526,0.00022135662,0.000039550312,0.00048365182],"category_scores_gemma":[0.0005137661,0.00011906162,0.00007418181,0.00025008488,0.00008580074,0.00026682,0.0003026137,0.0007808156,0.00006402917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019590147,0.0009312366,0.7250586,0.0003387498,0.001343697,0.0036833626,0.007983064,0.00005342161,0.0014338983,0.00010057506,0.09726044,0.15985394],"study_design_scores_gemma":[0.003645101,0.00081063155,0.6382036,0.00033742381,0.0002444275,0.0026563085,0.0006171629,0.00030540678,0.000049686645,0.00004118177,0.3528556,0.00023345325],"about_ca_topic_score_codex":0.00017205352,"about_ca_topic_score_gemma":0.000054306933,"teacher_disagreement_score":0.25559515,"about_ca_system_score_codex":0.000049617753,"about_ca_system_score_gemma":0.00024507244,"threshold_uncertainty_score":0.52956486},"labels":[],"label_agreement":null},{"id":"W3110921254","doi":"10.1016/j.cjco.2020.12.006","title":"Patient Perspectives Regarding Genetic Testing for Familial Hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Genome British Columbia; Michael Smith Health Research BC; Providence Health Care","keywords":"Familial hypercholesterolemia; Genetic testing; Medicine; Predictive testing; Genetic counseling; Test (biology); Genetic disorder; Disease; Family medicine; Internal medicine; Cholesterol; Genetics; Biology","score_opus":0.05033604131039164,"score_gpt":0.30302984357661567,"score_spread":0.252693802266224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110921254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842656,0.0009475024,0.0016551862,0.002469447,0.00009181906,0.0025421632,0.00001208258,0.000057291425,0.007958895],"genre_scores_gemma":[0.97384256,0.000016071755,0.022997454,0.0021777682,0.00070110516,0.00015154264,0.000006690691,0.000031942134,0.00007487673],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900967,0.000038576087,0.00018647817,0.00034511695,0.00020245233,0.00021771189],"domain_scores_gemma":[0.9992834,0.000033227723,0.000045393514,0.00028687716,0.00014159783,0.0002095232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019279523,0.0001070789,0.00036401505,0.000019433624,0.00011933921,0.00006290183,0.00013910903,0.000048791866,0.000016567876],"category_scores_gemma":[0.0005049654,0.00009015679,0.00013013494,0.00012410474,0.000023402736,0.00007559435,0.00016581162,0.00012561402,0.000019812189],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011548524,0.00019827709,0.020224087,0.00084762403,0.0005251579,0.00018675931,0.01588283,0.0001310985,0.025789455,0.00030501455,0.005496555,0.9292583],"study_design_scores_gemma":[0.04745022,0.020478923,0.4005349,0.0022930799,0.0019367621,0.0011580241,0.06328592,0.011782112,0.02192928,0.0007605931,0.42590737,0.002482811],"about_ca_topic_score_codex":0.00013391404,"about_ca_topic_score_gemma":0.0000027723077,"teacher_disagreement_score":0.92677546,"about_ca_system_score_codex":0.0000738863,"about_ca_system_score_gemma":0.00015477715,"threshold_uncertainty_score":0.36764875},"labels":[],"label_agreement":null},{"id":"W3110934408","doi":"10.1007/s00395-020-00838-4","title":"Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering","year":2020,"lang":"en","type":"article","venue":"Basic Research in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Deutsche Forschungsgemeinschaft","keywords":"Macrophage; Cholesterol; Internal medicine; Regression; Regression analysis; Cardiology; Medicine; Chemistry; Biochemistry; In vitro; Statistics; Mathematics","score_opus":0.06824234508807828,"score_gpt":0.37817403903421676,"score_spread":0.3099316939461385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110934408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883836,0.00031861154,0.0003661397,0.008972117,0.000051376697,0.0015100561,0.000007462035,0.000015360638,0.00037528545],"genre_scores_gemma":[0.9987935,0.00016555557,0.000175806,0.0003075487,0.00027140116,0.00023501604,0.000014387375,0.000018991614,0.000017800077],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967063,0.0015173679,0.00040838207,0.0004072164,0.0005345686,0.00042614326],"domain_scores_gemma":[0.9990177,0.00019801066,0.000036699763,0.00036471363,0.00016621935,0.00021666953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00557105,0.000109835964,0.00056472234,0.00046697803,0.000036996225,0.000009454679,0.00008293662,0.0001843413,0.000011286735],"category_scores_gemma":[0.0012417508,0.000092025555,0.000108088316,0.0007136596,0.00009048882,0.00007037488,0.00013034248,0.00061608216,0.000026766073],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028481452,0.00015754218,0.092164434,0.0014652548,0.0000737609,0.0033959514,0.0039020684,0.0011251692,0.8016082,0.00007833396,0.00092782005,0.066620015],"study_design_scores_gemma":[0.0106879845,0.004439275,0.7280344,0.001919236,0.000017747687,0.0003071185,0.0011106723,0.0005667626,0.24722025,0.0002017048,0.005219483,0.0002754142],"about_ca_topic_score_codex":0.00013015559,"about_ca_topic_score_gemma":0.000024920206,"teacher_disagreement_score":0.6358699,"about_ca_system_score_codex":0.00023330895,"about_ca_system_score_gemma":0.0002836906,"threshold_uncertainty_score":0.37526932},"labels":[],"label_agreement":null},{"id":"W3111059202","doi":"10.1097/med.0000000000000594","title":"Best practice for treating dyslipidaemia in patients with diabetes based on current international guidelines","year":2020,"lang":"en","type":"review","venue":"Current Opinion in Endocrinology Diabetes and Obesity","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Medicine; Diabetes mellitus; Statin; Internal medicine; Context (archaeology); Type 2 diabetes; Intensive care medicine; Endocrinology","score_opus":0.06059136713678184,"score_gpt":0.38439720935089283,"score_spread":0.323805842214111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111059202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004816896,0.98874754,0.000054717755,0.0004140342,0.0029549883,0.0027630434,0.00017735145,0.000035608242,0.000035807567],"genre_scores_gemma":[0.0007675564,0.9953048,0.00057960884,0.00008362807,0.0010749254,0.00077339105,0.0013604579,0.00005326335,0.0000023510192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970462,0.00025202488,0.00089525006,0.0008148809,0.00039453682,0.00059711],"domain_scores_gemma":[0.99832,0.00042751303,0.00042732203,0.00036925075,0.0002899149,0.00016600014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003499563,0.00050584757,0.0018427463,0.00042261506,0.000076877055,0.000031510215,0.00017827828,0.00017264018,0.000007810539],"category_scores_gemma":[0.0010583503,0.00038123524,0.00033098992,0.00028795932,0.00008963392,0.00010865134,0.0001149692,0.0008292052,0.000006510884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004984028,0.0008834812,0.16876972,0.017608507,0.00010034539,0.0000013385687,0.000012786702,0.0000050918993,1.2854393e-8,0.0000764312,0.00017918083,0.81231326],"study_design_scores_gemma":[0.0041290578,0.0010373086,0.0086739585,0.037892606,0.00042973075,0.0000014472305,0.000015572507,0.00049779913,9.1296016e-7,0.000012372227,0.946936,0.00037323823],"about_ca_topic_score_codex":0.000009547816,"about_ca_topic_score_gemma":0.0000029282335,"teacher_disagreement_score":0.94675684,"about_ca_system_score_codex":0.00029294763,"about_ca_system_score_gemma":0.0003100108,"threshold_uncertainty_score":0.999864},"labels":[],"label_agreement":null},{"id":"W3111839769","doi":"10.1007/978-3-030-56514-5_19","title":"Lipoprotein (a): Principles from Bench to Bedside","year":2020,"lang":"en","type":"book-chapter","venue":"Contemporary cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lipoprotein(a); Epidemiology; Lipoprotein; Disease; Medicine; Internal medicine; Vascular disease; Population; Genetic epidemiology; Pathophysiology; Cardiology; Bioinformatics; Endocrinology; Biology; Cholesterol","score_opus":0.06324916360515467,"score_gpt":0.26292448871486757,"score_spread":0.1996753251097129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111839769","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007885372,0.023155453,0.0010310715,0.0060977885,0.0009662943,0.0033895392,0.0005875222,0.00031572615,0.96366805],"genre_scores_gemma":[0.50030905,0.0014523388,0.0029286654,0.021849044,0.020286553,0.00056879345,0.0043748347,0.00066528475,0.44756544],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964052,0.00012639593,0.0009325766,0.0014043227,0.00066912634,0.00046238975],"domain_scores_gemma":[0.9966335,0.00008975526,0.00026961087,0.001876383,0.00022483022,0.0009058906],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004783442,0.0007466979,0.0030604287,0.0002321053,0.00010053664,0.00002414893,0.0003481863,0.0011075675,0.0003854393],"category_scores_gemma":[0.00019181207,0.000684642,0.001473142,0.00006991245,0.00016508633,0.000057802325,0.00041963602,0.0011679978,0.0011283484],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004983815,0.0001117293,0.00451599,0.001978342,0.027924681,0.04422083,0.0009201666,0.000073284864,0.002287897,0.14875041,0.5351236,0.2291093],"study_design_scores_gemma":[0.0012669426,0.0008207134,0.0018120261,0.0003852454,0.00041152147,0.00025008796,0.00002318656,0.0000039550673,0.00018236869,0.0024793353,0.9917555,0.00060914096],"about_ca_topic_score_codex":0.0007080983,"about_ca_topic_score_gemma":0.000030077961,"teacher_disagreement_score":0.5161027,"about_ca_system_score_codex":0.000226476,"about_ca_system_score_gemma":0.0016769222,"threshold_uncertainty_score":0.9996494},"labels":[],"label_agreement":null},{"id":"W3112381082","doi":"10.1016/j.abb.2020.108717","title":"PCSK9: Associated with cardiac diseases and their risk factors?","year":2020,"lang":"en","type":"review","venue":"Archives of Biochemistry and Biophysics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Canadian Institutes of Health Research; National Natural Science Foundation of China","keywords":"PCSK9; Internal medicine; Medicine; Contractility; Heart failure; Cardiology; Atrial fibrillation; Myocardial infarction; Diabetes mellitus; Cholesterol; Endocrinology; LDL receptor; Lipoprotein","score_opus":0.012287127523930966,"score_gpt":0.24074175884991886,"score_spread":0.2284546313259879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112381082","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030721745,0.966989,0.000011555136,0.000011429999,0.000018483292,0.00040441917,0.0016265566,0.000026205355,0.00019062676],"genre_scores_gemma":[0.029871885,0.9690588,0.00003975864,0.0000072559124,0.00024993546,0.000015369462,0.00068645185,0.000031833555,0.00003868911],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989602,0.000078624274,0.00023497788,0.00039556,0.00015510748,0.00017552696],"domain_scores_gemma":[0.9989221,0.00018097604,0.00027443143,0.00034364927,0.000020431502,0.0002584203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044233446,0.00036735213,0.0017695915,0.000023715393,0.00007334306,0.000014603729,0.000071883565,0.00012864896,0.0000011022688],"category_scores_gemma":[0.00006508963,0.0002129364,0.0006073948,0.00013351472,0.00030862994,0.000017301221,0.000092581446,0.0003152786,2.6887193e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003368627,0.00008749864,0.0005195176,0.020993259,0.002469807,0.000009785618,0.00012258753,1.4706655e-8,0.00019252037,0.0000070168358,0.000009863975,0.97555447],"study_design_scores_gemma":[0.0034121852,0.0022893783,0.01178892,0.08182981,0.03543753,0.00010566282,0.0010232456,0.000031980027,0.024479866,0.00048427525,0.83627105,0.0028461216],"about_ca_topic_score_codex":0.0000254521,"about_ca_topic_score_gemma":1.4498659e-7,"teacher_disagreement_score":0.97270834,"about_ca_system_score_codex":0.000011628801,"about_ca_system_score_gemma":0.00023786152,"threshold_uncertainty_score":0.86832947},"labels":[],"label_agreement":null},{"id":"W3112952992","doi":"10.14740/cr1180","title":"Association Between the Level of Low-Density Lipoprotein Cholesterol and Coronary Atherosclerosis in Patients Who Have Undergone Coronary Computed Tomography Angiography","year":2020,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Fukuoka University","keywords":"Medicine; Cardiology; Internal medicine; Coronary angiography; Coronary atherosclerosis; Computed tomography; Computed tomography angiography; Radiology; Angiography; Coronary artery disease; Myocardial infarction","score_opus":0.095687636625611,"score_gpt":0.3130151751030072,"score_spread":0.2173275384773962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112952992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509263,0.0010277878,0.0002036241,0.0017123569,0.0000371413,0.001633819,0.00009787739,0.000018845281,0.00017592344],"genre_scores_gemma":[0.99894935,0.00023756054,0.000056284083,0.00032080285,0.00023301406,0.00006125096,0.000085606465,0.0000265307,0.000029619283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963738,0.0013729722,0.0003965441,0.00047739394,0.0008537352,0.0005256047],"domain_scores_gemma":[0.99843574,0.00030609092,0.000112521084,0.00047809372,0.00043615964,0.00023137193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022990417,0.00017617266,0.00093673734,0.00026938962,0.00017297163,0.000014492827,0.00019342687,0.00032818463,0.000006656477],"category_scores_gemma":[0.00020364871,0.00013806314,0.0004521758,0.0008337645,0.0004029026,0.00006331156,0.00027236412,0.00084199687,0.0000074177037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026446255,0.000053699932,0.98879886,0.00017437538,0.0010765652,0.000009077326,0.00030154438,0.0000069527014,0.00015482832,0.00000502251,0.0007299274,0.0084246965],"study_design_scores_gemma":[0.0028371192,0.0009185827,0.99525225,0.000120692,0.0001178389,0.0000059842782,0.00017514524,0.000038538463,0.00030097028,0.000042912445,0.00008238463,0.00010759645],"about_ca_topic_score_codex":0.00067063427,"about_ca_topic_score_gemma":0.00004554709,"teacher_disagreement_score":0.0083171,"about_ca_system_score_codex":0.00012266412,"about_ca_system_score_gemma":0.000099126526,"threshold_uncertainty_score":0.56300515},"labels":[],"label_agreement":null},{"id":"W3114128957","doi":"10.3390/jcm10010064","title":"Identifying Markers of Cardiovascular Event-Free Survival in Familial Hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Chicoutimi; Université de Montréal","funders":"","keywords":"Medicine; Adiponectin; Internal medicine; Familial hypercholesterolemia; Logistic regression; Cohort; Odds ratio; Cholesterol; Endocrinology; Obesity; Insulin resistance","score_opus":0.10434085489912859,"score_gpt":0.39140447826820457,"score_spread":0.287063623369076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114128957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690528,0.012067065,0.0033695665,0.012062754,0.0017378125,0.00040509694,0.0000037353007,0.00001145586,0.0012896928],"genre_scores_gemma":[0.98792607,0.004632617,0.0010470839,0.0015849656,0.0047583845,0.0000018774407,0.0000022295749,0.000028601336,0.000018164059],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9937072,0.00067345257,0.0030845855,0.0002732756,0.0019869625,0.0002745471],"domain_scores_gemma":[0.9971391,0.00039540484,0.00068881,0.00069424685,0.00041123206,0.0006712],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0105333775,0.00018765627,0.002671885,0.00017151474,0.00002071405,0.000004539523,0.00036751703,0.00021782279,0.00007278816],"category_scores_gemma":[0.009381649,0.00013031652,0.0016742204,0.00042787543,0.00022551781,0.00011156648,0.000106332845,0.0012411103,0.000004473245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014187596,0.00088582875,0.36874577,0.003381429,0.008551465,0.0046780147,0.0014899183,0.00045288412,0.0019989228,0.000095781215,0.005453003,0.59007937],"study_design_scores_gemma":[0.048565138,0.009497554,0.90039176,0.0036626067,0.0027714942,0.00051663554,0.0021050256,0.00022963944,0.00022369389,0.00028086308,0.031498052,0.00025755368],"about_ca_topic_score_codex":0.00015864428,"about_ca_topic_score_gemma":0.000009666959,"teacher_disagreement_score":0.5898218,"about_ca_system_score_codex":0.0000546035,"about_ca_system_score_gemma":0.00041685885,"threshold_uncertainty_score":0.99896276},"labels":[],"label_agreement":null},{"id":"W3114329052","doi":"10.1016/j.atherosclerosis.2020.10.045","title":"Atherogenic lipoprotein(A) increases vascular glycolysis, thereby facilitating inflammation and leukocyte extravasation","year":2020,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Inflammation; Extravasation; Leukocyte extravasation; Endothelium; Medicine; Glycolysis; Immunology; Internal medicine; Metabolism","score_opus":0.0264948877441051,"score_gpt":0.2385063256790663,"score_spread":0.2120114379349612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114329052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909091,0.002684015,0.0037436916,0.000801541,0.000024931185,0.0014361481,0.000009843097,0.00019973701,0.0001909837],"genre_scores_gemma":[0.99501437,0.0012007658,0.0024509558,0.00056956743,0.00041251606,0.00022576633,0.000036355446,0.00005481226,0.00003488501],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980105,0.00018025957,0.00041756476,0.0005164483,0.0005561755,0.00031903895],"domain_scores_gemma":[0.9988786,0.000058484147,0.00013861131,0.00046445715,0.00011618034,0.00034365966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005797508,0.00026151605,0.0004927053,0.000053753218,0.0002040659,0.00006618018,0.00009051708,0.00015548679,0.00012483643],"category_scores_gemma":[0.00028662969,0.00023096096,0.0003361507,0.0003181218,0.00007787575,0.0002035367,0.00006588757,0.00021223005,0.000076400866],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002740874,0.00013785253,0.020512026,0.00087757566,0.0011359797,0.0000086389455,0.005711215,0.00010774695,0.4676919,0.00045109633,0.00008921724,0.5030027],"study_design_scores_gemma":[0.017880555,0.0033418015,0.644101,0.001220016,0.0027196468,0.000104340375,0.0068250643,0.015372621,0.2763459,0.0005555257,0.029402446,0.002131066],"about_ca_topic_score_codex":0.00096796494,"about_ca_topic_score_gemma":0.00003376639,"teacher_disagreement_score":0.623589,"about_ca_system_score_codex":0.00008296498,"about_ca_system_score_gemma":0.00009215785,"threshold_uncertainty_score":0.9418314},"labels":[],"label_agreement":null},{"id":"W3115723705","doi":"10.15173/mumj.v17i1.2306","title":"Statin-induced rhabdomyolysis: a cautionary tale for high-dose rosuvastatin","year":2020,"lang":"en","type":"article","venue":"McMaster University Medical Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; McMaster University","funders":"","keywords":"Rhabdomyolysis; Rosuvastatin; Medicine; Statin; Adverse effect; Acute kidney injury; Percutaneous coronary intervention; Internal medicine; Atorvastatin; Intensive care medicine","score_opus":0.025319571517483517,"score_gpt":0.24863776085592096,"score_spread":0.22331818933843745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115723705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80603117,0.00030549656,0.123382,0.06675988,0.00045533673,0.0009413245,0.00007223202,0.00011539779,0.0019371742],"genre_scores_gemma":[0.98324454,0.00011994646,0.007751123,0.0060023186,0.0015349714,0.0000020091177,0.000038244656,0.000028341588,0.0012785356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99785936,0.00015485736,0.00028051008,0.0002628496,0.0010851866,0.0003572352],"domain_scores_gemma":[0.99813044,0.00007278001,0.00012021498,0.0001456483,0.00020134327,0.0013295871],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006199264,0.00015066612,0.00042839444,0.000091399386,0.00028414527,0.000024057368,0.00018908638,0.0001422388,0.0023925274],"category_scores_gemma":[0.00032385328,0.00013176435,0.0003549105,0.00024262801,0.000074103154,0.00015442708,0.000085790794,0.00060982356,0.00003748917],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065825256,0.0008037647,0.0022194965,0.00086509204,0.0023843949,0.009817224,0.0046936115,0.000029909346,0.004207492,0.0014977349,0.045242686,0.9216561],"study_design_scores_gemma":[0.090092465,0.009229037,0.05525269,0.0012631224,0.0034084977,0.007923636,0.02247716,0.009492586,0.002754328,0.0005945219,0.7959682,0.0015438027],"about_ca_topic_score_codex":0.000058684138,"about_ca_topic_score_gemma":0.0000074781756,"teacher_disagreement_score":0.92011225,"about_ca_system_score_codex":0.0001501832,"about_ca_system_score_gemma":0.00080214196,"threshold_uncertainty_score":0.9985194},"labels":[],"label_agreement":null},{"id":"W3115888582","doi":"10.1161/circulationaha.120.050276","title":"Reduction in Revascularization With Icosapent Ethyl","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; Percutaneous coronary intervention; Hazard ratio; Coronary artery disease; Cardiology; Placebo; Myocardial infarction; Confidence interval; Pathology","score_opus":0.022872497139574084,"score_gpt":0.24748400396734468,"score_spread":0.2246115068277706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115888582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97147244,0.00028832175,0.023658821,0.0029152208,0.000046612826,0.0007294603,3.5461184e-7,0.000060624792,0.0008281634],"genre_scores_gemma":[0.9986464,0.000038013033,0.0005713569,0.00035927803,0.00027389947,0.000022837963,0.00006770863,0.000014539333,0.0000060036655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919814,0.000046519755,0.00015389551,0.0002062631,0.0002943481,0.00010081742],"domain_scores_gemma":[0.99963063,0.000002590362,0.000041528587,0.00017533202,0.000064374704,0.00008556251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018959478,0.00006722532,0.00015505534,0.000052291332,0.000030619514,0.000009893219,0.000018119876,0.00005995294,0.000030589952],"category_scores_gemma":[0.000040306015,0.000058128408,0.000061339415,0.00037333622,0.000012101894,0.00009549831,0.0000056315484,0.000114273214,0.000022167338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011815885,0.00035718354,0.6582062,0.001536046,0.00034452655,0.00013112064,0.0046509393,0.025166959,0.066804975,0.002741798,0.00019487887,0.23868376],"study_design_scores_gemma":[0.0020757136,0.00014116798,0.9872979,0.00011204259,0.00008328214,0.00008647993,0.00013634672,0.0069193295,0.001626877,0.000072139264,0.0013378479,0.000110893794],"about_ca_topic_score_codex":0.00005639644,"about_ca_topic_score_gemma":0.0000041770195,"teacher_disagreement_score":0.32909167,"about_ca_system_score_codex":0.000094258234,"about_ca_system_score_gemma":0.0000777106,"threshold_uncertainty_score":0.23704077},"labels":[],"label_agreement":null},{"id":"W3117003265","doi":"10.3760/cma.j.cn112148-20200331-00270","title":"[Association between lipoprotein (a) level and chronic cardio-renal syndrome in elderly patients].","year":2020,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northern College","funders":"","keywords":"Medicine; Ejection fraction; Renal function; Internal medicine; Logistic regression; Heart failure; Cardiology; Kidney disease","score_opus":0.02753605231406452,"score_gpt":0.22320518515476487,"score_spread":0.19566913284070034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117003265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919916,0.0010893086,0.00008605007,0.004132049,0.000062845975,0.0020810675,0.00003736234,0.000051408908,0.00046835735],"genre_scores_gemma":[0.99799013,0.0000843046,0.00006537483,0.00029539058,0.00054821343,0.0007472621,0.00004776922,0.000024317731,0.0001972601],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998278,0.000095027055,0.00028845275,0.00032222964,0.00056071026,0.0004555806],"domain_scores_gemma":[0.9992906,0.000024373669,0.00008730702,0.0001972196,0.000062511375,0.00033798564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062411226,0.0001396978,0.00048611301,0.00007358213,0.000045860612,0.000023982213,0.00005896846,0.00014742037,0.00000906207],"category_scores_gemma":[0.00024461548,0.00013018228,0.00013907514,0.00026903267,0.000017935623,0.00009856556,0.00004724896,0.0002961698,0.00001362925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034988563,0.00003235703,0.35922712,0.00024905597,0.0003192964,0.00003767626,0.00011044241,0.0000036891915,0.00001133546,0.000008772797,0.0002709907,0.6396943],"study_design_scores_gemma":[0.0032054381,0.00025542043,0.9887593,0.00003072886,0.00015499472,0.000006564097,0.000010730701,0.00000919613,0.0002703145,0.000016654723,0.00715006,0.00013060884],"about_ca_topic_score_codex":0.00039846616,"about_ca_topic_score_gemma":0.00006415423,"teacher_disagreement_score":0.6395637,"about_ca_system_score_codex":0.000482368,"about_ca_system_score_gemma":0.00008976565,"threshold_uncertainty_score":0.5308679},"labels":[],"label_agreement":null},{"id":"W3117832897","doi":"10.1016/j.atherosclerosis.2020.10.143","title":"Palmar striated xanthomas expression beyond type III dysbetalipoproteinemia","year":2020,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Xanthoma; Dyslipidemia; Internal medicine; Lipoprotein lipase; Endocrinology; Cholesterol; Apolipoprotein B; Chemistry; Medicine; Biology; Disease; Adipose tissue","score_opus":0.034109812670562345,"score_gpt":0.25620087787139817,"score_spread":0.22209106520083582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117832897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908794,0.0011156652,0.0007589767,0.0027178205,0.00023566063,0.0011299782,0.000018410235,0.00034078505,0.0028033033],"genre_scores_gemma":[0.99406296,0.00039401467,0.0017245302,0.0027186435,0.0005653171,0.000052018437,0.00006633113,0.00007785859,0.00033830735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979221,0.0000962221,0.00039232805,0.00052636064,0.0006401871,0.00042275884],"domain_scores_gemma":[0.99850255,0.000021483324,0.00011694106,0.00065931503,0.0001857622,0.00051392766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030136318,0.00027280938,0.0005988303,0.000044744334,0.00016168179,0.000034232275,0.00015711453,0.00022012537,0.00063536054],"category_scores_gemma":[0.00017802096,0.00021866562,0.0002826163,0.00068150455,0.000059882463,0.00010255285,0.00010338385,0.00032573717,0.00025647492],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006058036,0.00018735765,0.006308507,0.00026297563,0.0002857942,0.000027146154,0.0008962292,0.000012565982,0.957903,0.00014963392,0.0080665555,0.02529439],"study_design_scores_gemma":[0.018780608,0.0037085775,0.13822936,0.000982031,0.0009003616,0.000053790725,0.00086369895,0.00086386985,0.6992339,0.00013349965,0.134867,0.0013833431],"about_ca_topic_score_codex":0.00022262699,"about_ca_topic_score_gemma":0.00000400045,"teacher_disagreement_score":0.25866917,"about_ca_system_score_codex":0.00006475443,"about_ca_system_score_gemma":0.00015600972,"threshold_uncertainty_score":0.8916925},"labels":[],"label_agreement":null},{"id":"W3117939710","doi":"10.1016/j.pcad.2020.12.008","title":"How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors","year":2020,"lang":"en","type":"review","venue":"Progress in Cardiovascular Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Sanofi","keywords":"Medicine; PCSK9; Adverse effect; Clinical trial; Secondary prevention; Intensive care medicine; Disease; Ldl cholesterol; Cholesterol; Drug; Epidemiology; Pharmacology; Internal medicine; LDL receptor; Lipoprotein","score_opus":0.0597450074608118,"score_gpt":0.3738832317379662,"score_spread":0.31413822427715443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3117939710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003666617,0.98763657,0.0000125354645,0.00081212935,0.00025561065,0.0073645865,0.00015543145,0.00004138632,0.000055148364],"genre_scores_gemma":[0.028083747,0.9695057,0.00011273437,0.00013272895,0.00076361944,0.0009615987,0.0003216842,0.00011055015,0.000007594804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912526,0.0032577836,0.0019580617,0.0013249399,0.0016046464,0.00060197484],"domain_scores_gemma":[0.99683386,0.00034547682,0.0004082718,0.001956072,0.00009659413,0.0003597015],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0040663416,0.00074030797,0.006097878,0.00036189207,0.000060834216,0.00010380926,0.00049453997,0.0006489055,0.000010086858],"category_scores_gemma":[0.00060486136,0.0005219602,0.005290329,0.0011911879,0.00045477037,0.00017431256,0.0003152767,0.002326392,0.0000020875368],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001596577,0.0008234939,0.010763065,0.028084343,0.0029447286,0.00078468013,0.00012731344,9.787886e-7,5.8576384e-9,0.0000089491905,0.00005567311,0.9562471],"study_design_scores_gemma":[0.008566238,0.00043732187,0.093327485,0.030543946,0.0077073686,0.00025423226,0.0002466489,0.0000053430854,7.0534776e-7,0.00002588393,0.8582973,0.00058750936],"about_ca_topic_score_codex":0.00005843388,"about_ca_topic_score_gemma":0.000049368387,"teacher_disagreement_score":0.9556596,"about_ca_system_score_codex":0.00019538196,"about_ca_system_score_gemma":0.0012267815,"threshold_uncertainty_score":0.99997526},"labels":[],"label_agreement":null},{"id":"W3118732329","doi":"10.1097/mol.0000000000000737","title":"Polygenic scores for dyslipidemia: the emerging genomic model of plasma lipoprotein trait inheritance","year":2020,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Dyslipidemia; Familial hypercholesterolemia; Multifactorial Inheritance; Polygene; Medicine; Polygenic risk score; Trait; Coronary artery disease; Quantitative trait locus; Bioinformatics; Disease; Genetics; Internal medicine; Cholesterol; Single-nucleotide polymorphism; Biology; Genotype; Gene","score_opus":0.15565688141315226,"score_gpt":0.3964331639091785,"score_spread":0.24077628249602623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118732329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029318906,0.9732446,0.0034502565,0.0006130491,0.017216926,0.0051479596,0.00021994038,0.000044545963,0.00003339326],"genre_scores_gemma":[0.0000308815,0.97997546,0.0011104171,0.000050321116,0.016947504,0.0015012608,0.0002431722,0.000113216345,0.000027758182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959333,0.0004715357,0.0017590637,0.00083406625,0.00036414998,0.00063788623],"domain_scores_gemma":[0.9976793,0.00031094695,0.00078571483,0.0009357247,0.00010241744,0.00018590449],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012548247,0.00058080605,0.0036757856,0.00029866194,0.00009379631,0.000010765153,0.0005343423,0.00057084876,0.000018292729],"category_scores_gemma":[0.00048609692,0.00040979794,0.0016263633,0.0004900682,0.00020432266,0.000049415852,0.00018894098,0.0012973741,0.0000140114535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114987626,0.000078123,0.0000072877,0.061027944,0.00027646704,1.0995499e-7,0.0001666303,0.00006374705,0.0000053447106,0.0017085946,0.0034060755,0.9331447],"study_design_scores_gemma":[0.0013502853,0.00026548942,0.000020062591,0.013522184,0.0005053356,0.0000562734,0.000028429458,0.0024136833,9.5249874e-7,0.00023145489,0.98128605,0.00031981556],"about_ca_topic_score_codex":0.000033554657,"about_ca_topic_score_gemma":0.000011636851,"teacher_disagreement_score":0.97787994,"about_ca_system_score_codex":0.00026728417,"about_ca_system_score_gemma":0.0015117862,"threshold_uncertainty_score":0.9998354},"labels":[],"label_agreement":null},{"id":"W3120916025","doi":"10.1093/eurjpc/zwaa047","title":"EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study","year":2020,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":767,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Netherlands Heart Institute; NIHR Imperial Biomedical Research Centre; Abbott Vascular; Esperion Therapeutics; Novo Nordisk; Teva Pharmaceutical Industries; Department of Health and Social Care; British Heart Foundation; Amryt Pharma; Allergan; AstraZeneca; Amarin Corporation; Regeneron Pharmaceuticals; Mylan; Ionis Pharmaceuticals; Valeant Pharmaceuticals International; Boston Scientific Corporation; Abbott Laboratories; National Institute for Health and Care Research; Medicines Company; Daiichi Sankyo Europe; Servier; Gilead Sciences; Celgene; Bristol-Myers Squibb; Eli Lilly and Company; Amgen; Pfizer; European Commission; Kowa Company; Sanofi","keywords":"Medicine; Section (typography); Library science; Humanities","score_opus":0.0644997782625557,"score_gpt":0.3144904581917192,"score_spread":0.24999067992916352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120916025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878137,0.007081039,0.00020485742,0.00048061577,0.0007992927,0.00249515,0.000031653857,0.00003120008,0.0010624988],"genre_scores_gemma":[0.9939528,0.0014490247,0.00013315967,0.0026039805,0.0016684585,0.000024327412,0.00000869208,0.00010198562,0.00005757024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9897723,0.0064826943,0.0016522715,0.0006939398,0.0008870398,0.0005117503],"domain_scores_gemma":[0.99687517,0.00031345218,0.00088552426,0.0007731906,0.0007779993,0.00037469095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004727144,0.00046803706,0.0017431185,0.00020526121,0.00028767687,0.000079774996,0.00048209354,0.00008989904,0.000022524335],"category_scores_gemma":[0.0005167404,0.00032746937,0.0007240841,0.000576154,0.0003419496,0.0003526591,0.0005130124,0.0013970251,0.000006792814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005202579,0.0012522568,0.9290592,0.00022898053,0.0035111464,0.0045100795,0.032741696,0.00088909315,0.0076068584,0.000004383247,0.003280435,0.011713275],"study_design_scores_gemma":[0.018123461,0.01179112,0.89649916,0.00014884361,0.0005235155,0.0013599677,0.010276338,0.000008928991,0.00037579302,0.0000029177447,0.06055109,0.0003388888],"about_ca_topic_score_codex":0.00013970162,"about_ca_topic_score_gemma":0.000042319356,"teacher_disagreement_score":0.057270654,"about_ca_system_score_codex":0.00016500872,"about_ca_system_score_gemma":0.00025485797,"threshold_uncertainty_score":0.99991775},"labels":[],"label_agreement":null},{"id":"W3120916426","doi":"10.1161/circulationaha.120.049447","title":"Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; St. Michael's Hospital","funders":"","keywords":"Alirocumab; Medicine; Acute coronary syndrome; Mace; Internal medicine; Myocardial infarction; Unstable angina; Placebo; Cardiology; Statin; Propensity score matching; Hazard ratio; PCSK9; Cholesterol; Lipoprotein; Percutaneous coronary intervention","score_opus":0.044903283560726655,"score_gpt":0.31794391435367403,"score_spread":0.2730406307929474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120916426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920212,0.00026978136,0.0064293426,0.00026290034,0.000121407946,0.0008211753,0.00002438933,0.000019466841,0.000030320456],"genre_scores_gemma":[0.99806345,0.00006627885,0.0014205218,0.00025077403,0.00008879192,0.000014358106,0.000046893107,0.000022534363,0.000026415371],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827313,0.00015894462,0.0006385255,0.00036153398,0.0003964495,0.00017140758],"domain_scores_gemma":[0.998821,0.000050468887,0.00014846161,0.0005742011,0.0002302204,0.00017564102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069344416,0.00013307322,0.00065174745,0.00006922185,0.00004456361,0.0000081748885,0.000046438156,0.00016095163,0.000021858637],"category_scores_gemma":[0.00017024302,0.00012948435,0.00022662082,0.0002143066,0.000055105753,0.00009032155,0.00009598616,0.0001769425,0.0000063882158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017042529,0.00040361544,0.7718942,0.00094316417,0.00079965463,0.00027987148,0.00037540944,0.000053263244,0.030673437,0.000034171753,0.000007112278,0.19283181],"study_design_scores_gemma":[0.003051129,0.00017684714,0.9920211,0.00053248013,0.00027199008,0.0004833071,0.000060215138,0.00007473342,0.0031715673,0.000022256067,0.00002500613,0.00010940549],"about_ca_topic_score_codex":0.00014511574,"about_ca_topic_score_gemma":0.000024744551,"teacher_disagreement_score":0.22012682,"about_ca_system_score_codex":0.000056005563,"about_ca_system_score_gemma":0.00014540208,"threshold_uncertainty_score":0.5280219},"labels":[],"label_agreement":null},{"id":"W3123472463","doi":"10.1093/eurjpc/zwaa156","title":"Current perceptions and practices in lipid management: results of a European Society of Cardiology/European Atherosclerosis Society Survey","year":2021,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Canadian Cardiovascular Society; Family medicine; Internal medicine; Physical therapy; Myocardial infarction","score_opus":0.05880710992864541,"score_gpt":0.3213034384587521,"score_spread":0.2624963285301067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123472463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673202,0.007905014,0.005156405,0.00028860912,0.0004898934,0.00040750147,0.0001380369,0.000013721201,0.018280614],"genre_scores_gemma":[0.9612986,0.035087954,0.0024920993,0.000077133016,0.00083182956,0.0000013571959,0.000047557885,0.00005210993,0.000111403926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.985716,0.011906829,0.0012850853,0.00043044347,0.00035219803,0.0003094718],"domain_scores_gemma":[0.99694014,0.00019435912,0.001424508,0.0005570159,0.00072421675,0.0001597936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014859337,0.00023370703,0.0011540613,0.00010631174,0.00007227892,0.000012949051,0.00022817486,0.000048134516,0.000008278092],"category_scores_gemma":[0.00059354614,0.00020113948,0.0013383849,0.00033221403,0.00033172965,0.00011216827,0.0003586504,0.00064595626,0.000007232007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017994457,0.0008912705,0.66449124,0.0028651492,0.013396047,0.0020453457,0.01011886,0.00069843646,0.0347232,0.00007889076,0.027883604,0.24100855],"study_design_scores_gemma":[0.0045255404,0.00054110825,0.97100496,0.00068934064,0.00057164684,0.0005982313,0.0018035806,0.000005595367,0.00010011792,0.0000056991234,0.020010568,0.00014358126],"about_ca_topic_score_codex":0.000011343182,"about_ca_topic_score_gemma":0.0000034342972,"teacher_disagreement_score":0.3065138,"about_ca_system_score_codex":0.00006537911,"about_ca_system_score_gemma":0.00011885033,"threshold_uncertainty_score":0.820223},"labels":[],"label_agreement":null},{"id":"W3124429314","doi":"10.36660/abc.20190516","title":"Percepção Inadequada do Risco Cardiovascular e Baixo Conhecimento sobre Hipercolesterolemia Familiar em Indivíduos com Hipercolesterolemia Grave","year":2021,"lang":"pt","type":"article","venue":"Arquivos Brasileiros de Cardiologia","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Air (Canada)","funders":"","keywords":"Medicine; Atherosclerotic cardiovascular disease; Familial hypercholesterolemia; Disease; Internal medicine; Cholesterol","score_opus":0.025063633499497716,"score_gpt":0.26875683712576576,"score_spread":0.24369320362626803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124429314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90715086,0.07472049,0.0050544287,0.00051229703,0.0033359788,0.0046710772,0.00093367085,0.00058329414,0.0030379277],"genre_scores_gemma":[0.97258437,0.013635418,0.00049451325,0.0041060364,0.0038835357,0.0009347052,0.0010058066,0.0005505136,0.002805089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97906566,0.0054781875,0.0028930819,0.0043204897,0.0037568735,0.004485726],"domain_scores_gemma":[0.9867911,0.0005132343,0.0007037786,0.007814194,0.0015862423,0.0025914465],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.006195938,0.002710529,0.006833021,0.0006330202,0.0011891876,0.0008685759,0.001685591,0.0033543326,0.0006189137],"category_scores_gemma":[0.0012337165,0.002710583,0.0075545954,0.0017666143,0.000891974,0.00066278013,0.0016352215,0.0044321246,0.0011832032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011448944,0.0013067198,0.7708816,0.005583824,0.03770898,0.017046547,0.015485665,0.0028481504,0.020236881,0.00033053232,0.029675901,0.097750336],"study_design_scores_gemma":[0.015890906,0.0021589037,0.86153334,0.0030743023,0.011840511,0.0066953185,0.045506813,0.0005620511,0.007608028,0.00015565714,0.04091236,0.004061787],"about_ca_topic_score_codex":0.0013028225,"about_ca_topic_score_gemma":0.00023733242,"teacher_disagreement_score":0.09368855,"about_ca_system_score_codex":0.0033125198,"about_ca_system_score_gemma":0.003738021,"threshold_uncertainty_score":0.9995945},"labels":[],"label_agreement":null},{"id":"W3124550532","doi":"10.1093/eurjpc/zwaa044","title":"DNA sequencing in familial hypercholesterolaemia: the next generation","year":2020,"lang":"en","type":"letter","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Schulich School of Medicine and Dentistry; Canadian Institutes of Health Research","keywords":"Medicine; DNA sequencing; DNA; Computational biology; Genetics","score_opus":0.08553774666892071,"score_gpt":0.2726695350637873,"score_spread":0.1871317883948666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124550532","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2827224,0.017431619,0.0067806602,0.67505085,0.00544086,0.0020042916,0.000041740066,0.00004418511,0.010483373],"genre_scores_gemma":[0.4047337,0.0022399647,0.00048521982,0.5255195,0.0663798,0.0000094365105,0.00010273703,0.00014357369,0.00038605873],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99205637,0.0057941307,0.0009384691,0.00034068074,0.0005135759,0.00035677606],"domain_scores_gemma":[0.9984953,0.000085380074,0.00054385024,0.0004691142,0.00030082694,0.000105528874],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0028984763,0.00029483516,0.0012649933,0.00019017773,0.00007543623,0.00003634084,0.00034422494,0.00021780933,0.000015388197],"category_scores_gemma":[0.00040043605,0.00019344548,0.0010618769,0.00016985105,0.00013634116,0.0001041909,0.000115901836,0.004214072,0.00004748696],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020880121,0.000014363075,0.0005312069,0.00037233633,0.0022470616,0.08457492,0.0010836076,0.00020077125,0.0148072485,0.0000049256555,0.8549809,0.04097387],"study_design_scores_gemma":[0.002919366,0.0013833451,0.009402996,0.0006062819,0.0010630308,0.01308465,0.00027843745,0.000035132558,0.00017426074,0.000035267705,0.97070825,0.00030899394],"about_ca_topic_score_codex":0.000009083177,"about_ca_topic_score_gemma":0.0000015000143,"teacher_disagreement_score":0.14953136,"about_ca_system_score_codex":0.00044030914,"about_ca_system_score_gemma":0.00059976714,"threshold_uncertainty_score":0.99808323},"labels":[],"label_agreement":null},{"id":"W3125331816","doi":"10.20517/2574-1209.2020.71","title":"The local effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) on the inflammatory atheroma: beyond LDL cholesterol lowering","year":2021,"lang":"en","type":"article","venue":"Vessel Plus","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"PCSK9; Kexin; Proprotein convertase; LDL receptor; Atheroma; Cholesterol; Proprotein Convertases; Subtilisin; Evolocumab; Lipoprotein; Internal medicine; Medicine; Endocrinology; Cancer research; Biology; Biochemistry; Enzyme","score_opus":0.008392995686062306,"score_gpt":0.2294386110200728,"score_spread":0.2210456153340105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125331816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99155676,0.004056406,0.00030189523,0.0014544377,0.00045140693,0.0012994374,0.0000031714378,0.00004549827,0.0008309811],"genre_scores_gemma":[0.9979765,0.00020456436,0.000024310999,0.0007328339,0.00026857262,0.000094981166,0.000008505143,0.000043046653,0.0006467194],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998206,0.00020847193,0.00031806642,0.00030350013,0.0006217212,0.00034221367],"domain_scores_gemma":[0.9981931,0.00023687471,0.000109801076,0.0011147022,0.0002079325,0.00013758884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073728664,0.00020525117,0.00039891948,0.000035248297,0.00020659843,0.00003650112,0.0001754241,0.00012820245,0.000030954834],"category_scores_gemma":[0.00034766045,0.00011349963,0.00021553764,0.00023506396,0.00021080155,0.00004846876,0.00008910155,0.00041363336,0.00006861987],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006832884,0.0022943355,0.0064647663,0.018873682,0.0054627378,0.006884686,0.01041674,0.00059710135,0.35174778,0.018509056,0.010245847,0.56167036],"study_design_scores_gemma":[0.0056488295,0.0011555778,0.02614065,0.0013970265,0.00031483665,0.00024052584,0.0008686875,0.0005006833,0.9201982,0.0002936105,0.042881902,0.0003594433],"about_ca_topic_score_codex":0.000110651985,"about_ca_topic_score_gemma":0.000046041274,"teacher_disagreement_score":0.56845045,"about_ca_system_score_codex":0.000114926625,"about_ca_system_score_gemma":0.00053854735,"threshold_uncertainty_score":0.46283805},"labels":[],"label_agreement":null},{"id":"W3125503134","doi":"10.3390/nu13010235","title":"Impact of Diet on Plasma Lipids in Individuals with Heterozygous Familial Hypercholesterolemia: A Systematic Review of Randomized Controlled Nutritional Studies","year":2021,"lang":"en","type":"review","venue":"Nutrients","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Psychological intervention; Randomized controlled trial; Meta-analysis; Guar gum; Internal medicine; Psychiatry","score_opus":0.036501105894712414,"score_gpt":0.3597253315859418,"score_spread":0.3232242256912294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125503134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004916163,0.9714345,0.000002699877,0.000018071789,0.00013084557,0.023165403,0.0002569731,0.000013441938,0.00006195638],"genre_scores_gemma":[0.0011317814,0.9931952,0.000084433275,0.00008724671,0.00015534903,0.0049521453,0.00029666434,0.00006176504,0.000035465524],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9899959,0.0036573212,0.003718037,0.00054036465,0.0017238007,0.00036458543],"domain_scores_gemma":[0.99454355,0.001628372,0.002013154,0.0009722551,0.00068220287,0.0001604731],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.005453603,0.00069961423,0.03259296,0.0005348418,0.000035910773,0.000010870978,0.00020727956,0.00034875885,0.0000144699225],"category_scores_gemma":[0.003877775,0.00035820692,0.0059889085,0.000684682,0.00017810994,0.000043551187,0.000076117045,0.0007128847,0.0000052821215],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015794208,0.0009813051,0.0000498319,0.96479243,0.016013239,0.00006199688,0.00008039761,4.2914598e-7,6.580405e-8,0.000012005215,0.00007553725,0.0021385592],"study_design_scores_gemma":[0.22694789,0.0012453245,0.000010564387,0.7538237,0.016943553,0.00016227699,0.0000322388,6.467115e-7,4.9972516e-7,0.0000027557924,0.00064747554,0.00018307085],"about_ca_topic_score_codex":0.000028745955,"about_ca_topic_score_gemma":0.0000016993639,"teacher_disagreement_score":0.21115367,"about_ca_system_score_codex":0.00046461646,"about_ca_system_score_gemma":0.0009102932,"threshold_uncertainty_score":0.999887},"labels":[],"label_agreement":null},{"id":"W3125520517","doi":"10.1093/eurjpc/zwaa097","title":"Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study","year":2020,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Internal medicine; Adverse effect; Statin; Familial hypercholesterolemia; Evolocumab; Tolerability; Cholesterol; Lipoprotein","score_opus":0.02503213564825833,"score_gpt":0.28396441648558224,"score_spread":0.2589322808373239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125520517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904988,0.0025358698,0.0015861589,0.0015482798,0.00010053845,0.000659437,0.000003619977,0.0000068190675,0.003060522],"genre_scores_gemma":[0.9978701,0.0010227204,0.00014097126,0.0003106913,0.0006114633,0.0000011689884,0.000001329706,0.000022248047,0.000019301822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951343,0.0034501667,0.0007762122,0.00019371053,0.00026972636,0.00017591145],"domain_scores_gemma":[0.9988239,0.00014498369,0.00039846767,0.00026195304,0.00017233388,0.00019839377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004342472,0.00013001988,0.00084975007,0.000072787014,0.000042920856,0.0000056552367,0.00016308144,0.000026722024,0.000008878708],"category_scores_gemma":[0.0009966476,0.00008204607,0.0003460719,0.00017577113,0.00011007385,0.0000371153,0.00013117176,0.0004567197,0.000003507214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02341682,0.0017682826,0.5414275,0.001163508,0.016419685,0.019814646,0.06820696,0.002393187,0.0061726,0.0004585468,0.004942743,0.3138155],"study_design_scores_gemma":[0.0080567645,0.0025180879,0.97989327,0.00011503262,0.00044328236,0.00053224416,0.0033416133,0.000014799297,0.00003120115,0.0000058064234,0.0049678534,0.00008004429],"about_ca_topic_score_codex":0.000009787561,"about_ca_topic_score_gemma":9.785402e-7,"teacher_disagreement_score":0.43846574,"about_ca_system_score_codex":0.000025672274,"about_ca_system_score_gemma":0.00013784479,"threshold_uncertainty_score":0.33457416},"labels":[],"label_agreement":null},{"id":"W3126290524","doi":"10.3389/fgene.2021.625959","title":"Mutational Spectrum of LDLR and PCSK9 Genes Identified in Iranian Patients With Premature Coronary Artery Disease and Familial Hypercholesterolemia","year":2021,"lang":"en","type":"article","venue":"Frontiers in Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; National Science Foundation","keywords":"PCSK9; Familial hypercholesterolemia; LDL receptor; Genetics; Apolipoprotein B; Biology; Exon; Gene; Mutation; Single-nucleotide polymorphism; Intron; Cholesterol; Lipoprotein; Endocrinology; Genotype","score_opus":0.0055548800383509326,"score_gpt":0.20600066645173093,"score_spread":0.20044578641337998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126290524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893069,0.009573462,0.00032729606,0.00013206014,0.00017316488,0.00041744116,0.00004292967,0.000004744702,0.00002199327],"genre_scores_gemma":[0.99329525,0.00073224737,0.005615688,0.00013277214,0.00006293069,0.00001178492,0.00009309022,0.000016567523,0.000039642386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899775,0.000067234665,0.00021821258,0.00025873235,0.00030041795,0.00015767135],"domain_scores_gemma":[0.99954754,0.000008054766,0.000040993502,0.00022156554,0.00005332693,0.00012853797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010392645,0.00011177809,0.00028409073,0.000093630355,0.000021905002,0.000011504219,0.000032248725,0.000078840945,0.0000037448826],"category_scores_gemma":[0.000017454568,0.00010075496,0.000035269033,0.00012332079,0.00008632273,0.00003891039,0.000036155256,0.00014070832,1.8316678e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039590837,0.00012388016,0.9830564,0.00033360842,0.00007192286,0.00021290318,0.00034757517,0.00005632575,0.00013867373,0.000002965699,0.000051309325,0.015208493],"study_design_scores_gemma":[0.0034649111,0.000113386166,0.99487406,0.00018557442,0.000094844065,0.000035893667,0.0003165356,0.00027278773,0.00024175509,0.00019551872,0.000108624794,0.00009611354],"about_ca_topic_score_codex":0.000010178218,"about_ca_topic_score_gemma":0.000078765115,"teacher_disagreement_score":0.01511238,"about_ca_system_score_codex":0.000039552207,"about_ca_system_score_gemma":0.00015313426,"threshold_uncertainty_score":0.4108668},"labels":[],"label_agreement":null},{"id":"W3126500637","doi":"10.1136/postgradmedj-2020-139172","title":"Statin use and clinical outcomes in patients with COVID-19: An updated systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Postgraduate Medical Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Meta-analysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MEDLINE; Statin; 2019-20 coronavirus outbreak; Intensive care medicine; Systematic review; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Betacoronavirus; Coronavirus Infections; Bioinformatics; Internal medicine; Pathology; Disease","score_opus":0.15476511678951604,"score_gpt":0.43868550210855894,"score_spread":0.2839203853190429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3126500637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023465819,0.993788,0.00016564016,0.002429379,0.000046439716,0.0031941296,0.00011977694,0.000019428397,0.000002514871],"genre_scores_gemma":[0.000046139492,0.98999614,0.00059945683,0.00842032,0.000054668304,0.0000831525,0.00067530794,0.00006050384,0.000064345804],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98733175,0.0055542476,0.0034547818,0.0007673604,0.0024165933,0.00047524672],"domain_scores_gemma":[0.9926694,0.00075801637,0.0012975442,0.00096820993,0.000448432,0.0038583982],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.009472651,0.00066699035,0.018581832,0.00049558654,0.0001279971,0.00017088259,0.00023885338,0.00040946982,0.0006653261],"category_scores_gemma":[0.01010847,0.0003204422,0.003262892,0.000990072,0.00020756363,0.0001817169,0.00013064477,0.0020856124,0.0000039553315],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028420805,0.000655918,0.0075345985,0.5799623,0.38470733,0.0023055633,0.000035945308,6.98467e-8,1.4275953e-10,0.0000098691835,0.00026204195,0.024497911],"study_design_scores_gemma":[0.0018716272,0.0004477159,0.0023155794,0.03685987,0.94305444,0.0018158467,0.000017061258,0.000004011582,1.0850635e-9,0.000003073575,0.013256717,0.0003540354],"about_ca_topic_score_codex":0.00021323717,"about_ca_topic_score_gemma":0.00014188775,"teacher_disagreement_score":0.5583471,"about_ca_system_score_codex":0.00018393977,"about_ca_system_score_gemma":0.002583084,"threshold_uncertainty_score":0.9999248},"labels":[],"label_agreement":null},{"id":"W3128038504","doi":"10.1097/med.0000000000000624","title":"Expert position statements: comparison of recommendations for the care of adults and youth with elevated lipoprotein(a)","year":2021,"lang":"en","type":"review","venue":"Current Opinion in Endocrinology Diabetes and Obesity","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Position (finance); Medicine; MEDLINE; Environmental health; Psychology; Business; Political science","score_opus":0.08075546117481078,"score_gpt":0.4120473618773235,"score_spread":0.3312919007025127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128038504","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007263531,0.98923165,0.00013494819,0.00009828044,0.0004659772,0.0024092004,0.00038394055,0.0000097031725,0.0000027632998],"genre_scores_gemma":[0.011828223,0.98547703,0.0002502782,0.000006884806,0.00009591332,0.0003476108,0.0019751831,0.000017968323,9.265742e-7],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99842274,0.00018929657,0.000623699,0.00034774962,0.00015558918,0.00026090248],"domain_scores_gemma":[0.9988755,0.000115677154,0.00037468816,0.0003409401,0.00023376515,0.000059402893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015313615,0.00023489901,0.0015272765,0.00013399447,0.000089071626,0.000007723853,0.00007256015,0.00011360834,0.0000052993078],"category_scores_gemma":[0.00004173815,0.00015141579,0.00019740516,0.00017837893,0.00015783276,0.000043777087,0.000083716586,0.00028920587,1.1864866e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002954959,0.00022466644,0.005015809,0.03226877,0.00035796067,1.6918415e-7,0.0010364971,2.7914174e-7,3.2402477e-7,0.00018101376,0.000050491122,0.96083444],"study_design_scores_gemma":[0.008738545,0.0031886694,0.009710448,0.16869844,0.0035337312,0.00003331797,0.012756663,0.00007940704,0.000284631,0.000030492218,0.79218394,0.00076170085],"about_ca_topic_score_codex":0.00016409854,"about_ca_topic_score_gemma":0.00001971857,"teacher_disagreement_score":0.96007276,"about_ca_system_score_codex":0.000055699686,"about_ca_system_score_gemma":0.00014172008,"threshold_uncertainty_score":0.61745566},"labels":[],"label_agreement":null},{"id":"W3128314035","doi":"10.14814/phy2.14721","title":"Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface‐expression of LDLR and CD36 and NLRP3 inflammasome","year":2021,"lang":"en","type":"article","venue":"Physiological Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Heart Institute; Université de Montréal; Montreal Clinical Research Institute","funders":"Institute of Nutrition, Metabolism and Diabetes; Canadian Institutes of Health Research","keywords":"Inflammasome; PCSK9; CD36; Downregulation and upregulation; Adipose tissue; LDL receptor; Medicine; Expression (computer science); Pathology; Inflammation; Internal medicine; Biology; Receptor; Cholesterol; Computer science; Lipoprotein; Genetics; Gene","score_opus":0.01339243444201884,"score_gpt":0.24646792334736786,"score_spread":0.23307548890534902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128314035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979408,0.0012627603,0.000003968848,0.00011374435,0.00004253158,0.00041419116,0.000004548544,0.000035325946,0.0001821551],"genre_scores_gemma":[0.99916834,0.00023701001,0.00019545465,0.00014576572,0.00002908088,0.000011964159,0.000049619888,0.000017878876,0.00014490442],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99821824,0.00012833903,0.0004600873,0.0005325367,0.00037040675,0.000290406],"domain_scores_gemma":[0.9989257,0.000060456216,0.00022731684,0.0004308684,0.00016233251,0.00019333337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036147542,0.00020004319,0.0007368247,0.000039015493,0.000043840348,0.000013006762,0.000028475135,0.0002308586,0.000048963993],"category_scores_gemma":[0.00032055477,0.000133778,0.000074792784,0.0002542209,0.00012202519,0.00007644919,0.00010613083,0.00026267796,8.873488e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037963325,0.00032006015,0.059423037,0.00021160686,0.00012782589,0.0043029124,0.00022478528,0.00005860997,0.9318504,0.0000040041587,0.000052005977,0.0030451338],"study_design_scores_gemma":[0.0014958843,0.00061074155,0.7626473,0.0007117821,0.00007582128,0.0006792327,0.000031443604,0.000050880855,0.23325695,0.00015452641,0.00012845329,0.00015700479],"about_ca_topic_score_codex":0.00008131578,"about_ca_topic_score_gemma":0.000023377399,"teacher_disagreement_score":0.70322424,"about_ca_system_score_codex":0.00004226057,"about_ca_system_score_gemma":0.00011137673,"threshold_uncertainty_score":0.54553086},"labels":[],"label_agreement":null},{"id":"W3128325240","doi":"10.1016/j.jacl.2021.01.010","title":"Characteristics and trends of PCSK9 inhibitor prescription fills in the United States","year":2021,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Alirocumab; Evolocumab; Medicine; Medical prescription; Quarter (Canadian coin); Demography; PCSK9; Family medicine; Pharmacology; Internal medicine; Cholesterol; Total cholesterol; Geography; Lipoprotein","score_opus":0.06425957143169246,"score_gpt":0.3801233647856103,"score_spread":0.31586379335391784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128325240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99231803,0.00059894845,0.00009654738,0.005714258,0.0011006872,0.00005493257,0.000007157357,0.000001819665,0.0001076102],"genre_scores_gemma":[0.99027497,0.0035401748,0.0005711908,0.0022138008,0.0032642474,0.0000011712166,0.000025283749,0.0000068267723,0.00010232083],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975427,0.00079981826,0.0012001256,0.000094947696,0.00024478708,0.000117614574],"domain_scores_gemma":[0.9983359,0.0006108926,0.0004665356,0.00019369212,0.0003012374,0.000091771115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003243849,0.000065464854,0.00069643266,0.00013895144,0.000015314885,0.000006383606,0.000058171867,0.00014874211,0.00005316869],"category_scores_gemma":[0.002159362,0.00003899953,0.00023919219,0.0002453261,0.000112477624,0.000034992958,0.000026313986,0.000533141,7.855341e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033922563,0.0023939938,0.47659793,0.0006299115,0.00082374766,0.0006277421,0.0017686693,0.000018976232,0.0019474751,0.00075687596,0.01437368,0.49666876],"study_design_scores_gemma":[0.0027464053,0.0014777086,0.887863,0.0001513562,0.00017838404,0.00086319336,0.00030238152,0.00008214467,0.00015336132,0.00017359608,0.105965205,0.000043283773],"about_ca_topic_score_codex":0.000025244719,"about_ca_topic_score_gemma":0.000011937553,"teacher_disagreement_score":0.49662545,"about_ca_system_score_codex":0.000010102628,"about_ca_system_score_gemma":0.00013675545,"threshold_uncertainty_score":0.2585114},"labels":[],"label_agreement":null},{"id":"W3131041843","doi":"10.1016/j.ajpc.2021.100153","title":"Erratum to “C-Reactive Protein Levels and Plaque Regression with Evolocumab: Insights From GLAGOV” [American Journal of Preventive Cardiology 3C (2020) 100091]","year":2021,"lang":"en","type":"erratum","venue":"American Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Evolocumab; Internal medicine; Medicine; Cardiology; Apolipoprotein B","score_opus":0.008289428006067644,"score_gpt":0.2674407299944875,"score_spread":0.25915130198841985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131041843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9346418,0.031140199,0.0173424,0.001904361,0.0086541055,0.0027373747,0.0003844777,0.000033711414,0.003161612],"genre_scores_gemma":[0.9717598,0.0030062036,0.0074667325,0.00059291034,0.0118750455,0.00011134023,0.00017126228,0.0002671491,0.0047495742],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98822534,0.005554997,0.0022892097,0.001242009,0.0016953675,0.0009931022],"domain_scores_gemma":[0.9874072,0.0004370915,0.005957364,0.001246374,0.003788626,0.0011633344],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019789026,0.001188832,0.008939411,0.0009847934,0.00020592769,0.000058409947,0.0007056609,0.0007271741,0.00004115013],"category_scores_gemma":[0.0011296503,0.0008318641,0.0022454436,0.0011636137,0.0018537967,0.00030006882,0.00042005145,0.004893999,0.00000467469],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040511906,0.0011957904,0.014487778,0.0014347848,0.13844152,0.07676691,0.013974632,0.00038361002,0.020506486,0.00013205143,0.34900236,0.34316218],"study_design_scores_gemma":[0.019360686,0.11259684,0.28753328,0.032125413,0.022321109,0.10230015,0.047637954,0.000018619718,0.004261172,0.0019009231,0.3655226,0.0044212257],"about_ca_topic_score_codex":0.0005972523,"about_ca_topic_score_gemma":0.000079703146,"teacher_disagreement_score":0.33874094,"about_ca_system_score_codex":0.0010183136,"about_ca_system_score_gemma":0.005429389,"threshold_uncertainty_score":0.9994132},"labels":[],"label_agreement":null},{"id":"W3131406717","doi":"10.14740/cr1224","title":"Effect of Ezetimibe Added to High-Intensity Statin Therapy on Low-Density Lipoprotein Cholesterol Levels: A Meta-Analysis","year":2021,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Medicine; Internal medicine; Cardiology; Meta-analysis; Statin; Intensity (physics); Cholesterol","score_opus":0.15365415425868995,"score_gpt":0.4177849224783058,"score_spread":0.26413076821961584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131406717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920807,0.0019429104,0.00081537315,0.0024258178,0.00010761798,0.0019964448,0.000089493784,0.000044984554,0.00049668725],"genre_scores_gemma":[0.9970383,0.00015629582,0.00034520664,0.00093863293,0.00034659257,0.00038152086,0.000073776435,0.000040342602,0.00067929865],"study_design_codex":"meta_analysis","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9905626,0.005550132,0.00051469076,0.0010169978,0.0015407492,0.0008147873],"domain_scores_gemma":[0.99447244,0.0007452374,0.00008370624,0.0023277039,0.0019098425,0.0004610529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010539278,0.000322062,0.0043873005,0.0006070717,0.00018465954,0.000025298661,0.00025176996,0.000329885,0.00030755767],"category_scores_gemma":[0.0017925774,0.00022330903,0.00292522,0.0018729876,0.00027592768,0.000034631383,0.00024986482,0.0010692038,0.00012963956],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014884998,0.0006844099,0.009458706,0.0013973226,0.7233903,0.005055748,0.0014086514,0.0013102596,0.0886512,0.00021518685,0.006552716,0.14699054],"study_design_scores_gemma":[0.0049975975,0.008651738,0.2832277,0.000056675777,0.04117514,0.00031418333,0.000186619,0.000044257613,0.6591328,0.00008550088,0.0017191072,0.00040872747],"about_ca_topic_score_codex":0.001742805,"about_ca_topic_score_gemma":0.000092703274,"teacher_disagreement_score":0.6822151,"about_ca_system_score_codex":0.00016133193,"about_ca_system_score_gemma":0.00037054528,"threshold_uncertainty_score":0.91062784},"labels":[],"label_agreement":null},{"id":"W3131639069","doi":"10.36660/abc.20200128","title":"Associação entre Terapia com Estatinas e Menor Incidência de Hiperglicemia em Pacientes Internados com Síndromes Coronarianas Agudas","year":2021,"lang":"pt","type":"article","venue":"Arquivos Brasileiros de Cardiologia","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Petro-Canada","funders":"","keywords":"Medicine; Gynecology","score_opus":0.019674868758888697,"score_gpt":0.27943474113497224,"score_spread":0.25975987237608356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131639069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96306163,0.022580786,0.005537508,0.0012306285,0.0026234102,0.0018431633,0.00082160364,0.00042046147,0.0018807818],"genre_scores_gemma":[0.98207575,0.0022605886,0.0008598745,0.004574462,0.0017118556,0.0002770996,0.00082282163,0.00023975929,0.0071778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9891534,0.0027594678,0.0015857207,0.0019547378,0.0015994332,0.002947252],"domain_scores_gemma":[0.99344206,0.0008562097,0.00072004786,0.00255957,0.00089554914,0.0015265498],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0031908613,0.0013466191,0.0032001564,0.0003016993,0.00071662973,0.00038194968,0.00094317377,0.0014028336,0.0009806864],"category_scores_gemma":[0.002342382,0.0013232877,0.002215484,0.0009984097,0.0004922447,0.00029305182,0.00083000073,0.002248493,0.00041721092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003986101,0.0005374357,0.9192821,0.000948363,0.0056818416,0.009636221,0.009706637,0.00013666334,0.008635959,0.00035234482,0.020491796,0.024192026],"study_design_scores_gemma":[0.0072045955,0.0011396355,0.94144773,0.0014896179,0.0025951643,0.005819999,0.021006167,0.0013541309,0.0061794873,0.00017725966,0.009931101,0.0016551215],"about_ca_topic_score_codex":0.0011696889,"about_ca_topic_score_gemma":0.0004274645,"teacher_disagreement_score":0.022536905,"about_ca_system_score_codex":0.0033124946,"about_ca_system_score_gemma":0.0032678526,"threshold_uncertainty_score":0.9999325},"labels":[],"label_agreement":null},{"id":"W3133098859","doi":"10.1161/jaha.120.017948","title":"Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease","year":2021,"lang":"en","type":"review","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Ezetimibe; Internal medicine; Relative risk; Clinical endpoint; Adverse effect; Gastroenterology; Statin; Randomized controlled trial; Confidence interval","score_opus":0.033788647315840234,"score_gpt":0.3162555379141852,"score_spread":0.28246689059834496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133098859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029786313,0.9691097,0.000014751789,0.0003709559,0.00012167715,0.0005673722,0.000022938246,0.0000029257571,0.0000033324745],"genre_scores_gemma":[0.006303614,0.9926797,0.00010309595,0.0006188927,0.00019856583,0.000014129763,0.000016594198,0.000033703916,0.000031664284],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996562,0.00088298845,0.0008909707,0.00017618314,0.0012911926,0.00019665445],"domain_scores_gemma":[0.99533224,0.0001783803,0.0023084744,0.0005199161,0.0015282054,0.00013275535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015409146,0.00022271716,0.0062478655,0.0004683338,0.00003410373,0.000015249594,0.00013217906,0.00006772208,0.000017889473],"category_scores_gemma":[0.0006863636,0.00011633513,0.0077262935,0.0021123027,0.000037425794,0.00005956365,0.000037408678,0.0005096095,5.65868e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019239848,0.0004108503,0.14966352,0.0012128508,0.6904258,0.000022155687,0.00014987584,0.000087632754,4.9370533e-7,9.339587e-7,0.00020760426,0.15762587],"study_design_scores_gemma":[0.0010476934,0.00054767967,0.27441436,0.002956985,0.6219204,0.0000102429485,0.00008650877,0.000003663035,0.000002200349,0.0000010050812,0.09880346,0.00020579463],"about_ca_topic_score_codex":0.00020728177,"about_ca_topic_score_gemma":0.000011794182,"teacher_disagreement_score":0.15742007,"about_ca_system_score_codex":0.0006767476,"about_ca_system_score_gemma":0.000782771,"threshold_uncertainty_score":0.7792174},"labels":[],"label_agreement":null},{"id":"W3133227659","doi":"10.1161/jaha.120.017470","title":"Lipoprotein(a) and Coronary Artery Disease Risk Without a Family History of Heart Disease","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Fondation Leducq; National Heart, Lung, and Blood Institute; Massachusetts General Hospital","keywords":"Medicine; Coronary artery disease; Population; Family history; Gerontology; Internal medicine","score_opus":0.012776855528373493,"score_gpt":0.2421787505386924,"score_spread":0.2294018950103189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133227659","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6430076,0.018277986,0.00003006663,0.33659717,0.0011663125,0.00075580436,0.000104385515,0.000016123753,0.000044589855],"genre_scores_gemma":[0.37921146,0.0031437788,0.0009651521,0.601379,0.010072515,0.000040704428,0.00004646275,0.00014753403,0.004993423],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99560547,0.0012560807,0.00075158104,0.00027907954,0.0017876452,0.0003201528],"domain_scores_gemma":[0.99617964,0.00018738379,0.0020239728,0.00069692376,0.00057099655,0.00034109133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014977122,0.0002672672,0.0016172642,0.00016829024,0.000082746534,0.000019984991,0.00013254791,0.00016239783,0.000016227643],"category_scores_gemma":[0.0011303265,0.0001967817,0.0013524933,0.00019777859,0.00017989561,0.00010236741,0.00007613134,0.0018250529,0.00000297574],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039540115,0.00009406247,0.35309422,0.00031751045,0.00077018613,0.00024745855,0.00008738562,0.0000040207783,0.00018516809,2.3735628e-7,0.64308894,0.001715405],"study_design_scores_gemma":[0.000666119,0.0002470687,0.66217804,0.00055468926,0.0016625685,0.00014976217,0.00003959251,0.000017494918,0.0000041919657,0.00003482636,0.33431074,0.0001349131],"about_ca_topic_score_codex":0.0004554385,"about_ca_topic_score_gemma":0.000004795136,"teacher_disagreement_score":0.30908382,"about_ca_system_score_codex":0.0021114564,"about_ca_system_score_gemma":0.002704887,"threshold_uncertainty_score":0.80245245},"labels":[],"label_agreement":null},{"id":"W3133793751","doi":"10.1093/cvr/cvab078","title":"Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trials","year":2021,"lang":"en","type":"review","venue":"Cardiovascular Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"National Institute on Aging; AstraZeneca","keywords":"Rosuvastatin; Medicine; Interquartile range; Internal medicine; Hazard ratio; Rosuvastatin Calcium; Randomized controlled trial; Cohort; Confidence interval","score_opus":0.15527450579132804,"score_gpt":0.4530651361559653,"score_spread":0.29779063036463727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133793751","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016909098,0.96784025,0.0028761232,0.00009562756,0.00019385612,0.02854938,0.00012807245,0.000009597583,0.00013801511],"genre_scores_gemma":[0.0009648549,0.992638,0.00017486866,0.0000142498575,0.00042653288,0.005184621,0.00014125026,0.00007778432,0.00037784467],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96860874,0.02425019,0.0028859633,0.00072646263,0.0029910828,0.0005375921],"domain_scores_gemma":[0.98328793,0.010452692,0.0010753535,0.0031484652,0.001890263,0.00014529767],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.119047895,0.0004622357,0.036565688,0.00085458154,0.00027692472,0.00007904126,0.00046664928,0.00043490378,0.000054986365],"category_scores_gemma":[0.022062672,0.00019521828,0.060963992,0.0027770095,0.00068571087,0.00003601638,0.0003144651,0.0008396533,0.0000010591624],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003803992,0.00012235752,4.365175e-7,0.014164431,0.35970545,0.000007970319,0.00014299608,0.000024616249,0.0000025028633,0.00020770424,0.000089501635,0.621728],"study_design_scores_gemma":[0.13386393,0.00017300763,0.00003196306,0.010106657,0.58941936,0.00006460303,0.00021359632,0.00016898822,0.000024992174,0.00007244435,0.26564667,0.00021377971],"about_ca_topic_score_codex":0.00030766657,"about_ca_topic_score_gemma":0.000012105652,"teacher_disagreement_score":0.62151426,"about_ca_system_score_codex":0.00012970986,"about_ca_system_score_gemma":0.0020350881,"threshold_uncertainty_score":0.9861749},"labels":[],"label_agreement":null},{"id":"W3133802300","doi":"10.1002/cpdd.926","title":"Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Medicine; Telmisartan; Rosuvastatin; Ezetimibe; Pharmacokinetic interaction; Pharmacology; Pharmacokinetics; Internal medicine; Drug interaction; Statin; Blood pressure","score_opus":0.03683423971864972,"score_gpt":0.3937161031873667,"score_spread":0.356881863468717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133802300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923032,0.0010175508,0.00008735811,0.0025011487,0.0018138314,0.00053964416,0.0000013096718,0.000048496215,0.0016874557],"genre_scores_gemma":[0.9858953,0.0016114003,0.0042605754,0.0061810804,0.0005705511,0.0001243363,0.00003305637,0.000026929029,0.001296798],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99752504,0.00040296532,0.0009240429,0.00053869386,0.00024988677,0.0003593706],"domain_scores_gemma":[0.9989463,0.00026899166,0.00011760485,0.00018579641,0.00014029253,0.0003409886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014146913,0.00018467085,0.0005744532,0.00010176848,0.00007687169,0.0000141446535,0.00006653728,0.00012385043,0.0006704403],"category_scores_gemma":[0.00017599853,0.00017287103,0.00013097154,0.00023675188,0.000165243,0.000073356525,0.00014255785,0.0007229206,0.000055592354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006983206,0.0020844198,0.41282704,0.0005564319,0.0011141619,0.0032709055,0.0021239037,0.000051135346,0.005129379,0.00001440256,0.038839456,0.53329045],"study_design_scores_gemma":[0.007990864,0.00008554256,0.81289834,0.0001650301,0.00021911158,0.00026320404,0.00031737878,0.0005684847,0.02318748,0.000027567754,0.15399402,0.00028294895],"about_ca_topic_score_codex":0.000028098613,"about_ca_topic_score_gemma":0.00005755574,"teacher_disagreement_score":0.5330075,"about_ca_system_score_codex":0.00014017295,"about_ca_system_score_gemma":0.00054655893,"threshold_uncertainty_score":0.73408514},"labels":[],"label_agreement":null},{"id":"W3134344235","doi":"10.2459/jcm.0000000000001175","title":"Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paper","year":2021,"lang":"en","type":"article","venue":"Journal of Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Medicine; Cholesterol; Internal medicine; Lipoprotein; Atherosclerotic cardiovascular disease; Triglyceride; Residual risk; Disease; Biomarker; Ldl cholesterol; Cardiology; Endocrinology; Biochemistry","score_opus":0.018433871661290593,"score_gpt":0.31527960949690137,"score_spread":0.2968457378356108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134344235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.953383,0.022787804,0.005197348,0.011957285,0.0035948625,0.0016936617,0.000005412399,0.000056104927,0.0013244705],"genre_scores_gemma":[0.97562766,0.006676616,0.0035931175,0.0041501494,0.009657238,0.000035114852,0.00004493254,0.00012155808,0.000093600356],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9890857,0.0017013584,0.0029991034,0.0009850787,0.0043713036,0.0008574877],"domain_scores_gemma":[0.99236584,0.00028757134,0.0010626905,0.0024481511,0.0027846165,0.0010511165],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0142991105,0.0006680515,0.0038280417,0.00050195045,0.00018840509,0.00007504609,0.0003640496,0.00075010373,0.00010422321],"category_scores_gemma":[0.004399982,0.0005431357,0.0033379223,0.0010656405,0.00034502914,0.0008752843,0.00020730906,0.0029472362,0.00005582667],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008574746,0.0021734375,0.0014687077,0.0014383736,0.01688932,0.031675573,0.00089313014,0.00037451476,0.0056256093,0.00005067775,0.0016828107,0.9291531],"study_design_scores_gemma":[0.0756923,0.0057767336,0.80907047,0.0058035054,0.009955522,0.025023304,0.0017266491,0.00007480002,0.012869538,0.00013313451,0.05294044,0.0009336058],"about_ca_topic_score_codex":0.004376091,"about_ca_topic_score_gemma":0.00037415093,"teacher_disagreement_score":0.9282195,"about_ca_system_score_codex":0.0006315413,"about_ca_system_score_gemma":0.0012096767,"threshold_uncertainty_score":0.99970204},"labels":[],"label_agreement":null},{"id":"W3134963806","doi":"10.1016/j.jacc.2020.12.058","title":"Pooled Patient-Level Analysis of Inclisiran Trials in Patients With Familial Hypercholesterolemia or Atherosclerosis","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis","keywords":"Medicine; Familial hypercholesterolemia; PCSK9; Placebo; Internal medicine; Statin; Endocrinology; Atherosclerotic cardiovascular disease; Cholesterol; Lipoprotein; Dosing; Randomization; Gastroenterology; Clinical trial; Disease; LDL receptor; Pathology","score_opus":0.03411595838465424,"score_gpt":0.28733216075984563,"score_spread":0.2532162023751914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134963806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841714,0.00016479417,0.00019824771,0.00034307555,0.00016400653,0.00034473272,0.00029678707,0.0000019988245,0.00006921299],"genre_scores_gemma":[0.99830467,0.00016120952,0.0010031998,0.00035920262,0.00012294172,0.0000047614153,0.0000056239905,0.000017284634,0.000021107715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954901,0.0018823177,0.0014908799,0.00018435945,0.0007335551,0.00021878692],"domain_scores_gemma":[0.99630535,0.00035880718,0.0018000656,0.0006049552,0.0008235195,0.00010731568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020216836,0.0001629271,0.003819684,0.00041332326,0.000032641667,0.0000028084999,0.00020096023,0.00007819451,0.00001182095],"category_scores_gemma":[0.0013015948,0.00008579201,0.0015735232,0.0019431957,0.00027771873,0.00004490897,0.0000899668,0.0002913204,1.8318886e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071633235,0.00024838303,0.9654224,0.00005559368,0.011482191,0.000094258845,0.00014870081,0.0013171745,0.003090811,0.0000067836895,0.00016232466,0.010808039],"study_design_scores_gemma":[0.0057421583,0.0028685092,0.98335046,0.00017021612,0.005250118,0.000097365984,0.00078999175,0.0000097456,0.0012625236,0.0000057988455,0.00036845388,0.00008468309],"about_ca_topic_score_codex":0.00009453924,"about_ca_topic_score_gemma":0.00007376935,"teacher_disagreement_score":0.017928021,"about_ca_system_score_codex":0.0001394746,"about_ca_system_score_gemma":0.00070232485,"threshold_uncertainty_score":0.34984964},"labels":[],"label_agreement":null},{"id":"W3135352584","doi":"10.2217/fca-2021-0027","title":"Lessons Learned From Large Cardiovascular Outcome Trials Targeting Inflammation in Cardiovascular Disease (CANTOS, CIRT, Colcot and LoDoCo2)","year":2021,"lang":"en","type":"editorial","venue":"Future Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Université de Montréal","keywords":"Medicine; Inflammation; Myocardial infarction; Biomarker; Internal medicine; Coronary artery disease; Cardiology; Disease; Stroke (engine); Clinical trial; Randomized controlled trial","score_opus":0.04384754218682656,"score_gpt":0.3232547045682242,"score_spread":0.2794071623813976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135352584","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009199351,0.45504302,0.0018499056,0.0018448788,0.524742,0.003879973,0.0028752638,0.00023591693,0.00032968243],"genre_scores_gemma":[0.016679114,0.059232313,0.00042509811,0.00014238001,0.9086134,0.00074746227,0.013708035,0.0002871989,0.0001650331],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.983864,0.0065619643,0.0024369291,0.002839313,0.002828535,0.0014692367],"domain_scores_gemma":[0.99268436,0.0011337554,0.00058694894,0.0038257595,0.0008793696,0.00088980456],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.016397778,0.0012856298,0.01127688,0.0005538998,0.0003141432,0.00014312589,0.00041737917,0.0035062502,0.00008188244],"category_scores_gemma":[0.012066438,0.0011665995,0.008594584,0.00063694693,0.00018490564,0.00017789424,0.0005137455,0.0034850084,0.000032067695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025089367,0.00019218541,0.013671024,0.0066016717,0.09749567,0.021700628,0.0007937638,0.002572296,0.0002611843,0.00027248898,0.73875177,0.115178406],"study_design_scores_gemma":[0.009042914,0.000103022896,0.0072829123,0.0005371125,0.011624499,0.000059072907,0.0005315273,0.00003541629,0.000027490674,0.00012046037,0.9696219,0.0010137021],"about_ca_topic_score_codex":0.0018464186,"about_ca_topic_score_gemma":0.00014652073,"teacher_disagreement_score":0.3958107,"about_ca_system_score_codex":0.00075406703,"about_ca_system_score_gemma":0.0021555643,"threshold_uncertainty_score":0.99998957},"labels":[],"label_agreement":null},{"id":"W3135824461","doi":"10.15280/jlm.2021.11.1.43","title":"Use of Lifestyle Modifications for Management of a Patient with Severely High Total Cholesterol (&gt; 14 mmol/L) and Triglycerides (&gt; 40 mmol/L)","year":2021,"lang":"en","type":"article","venue":"Journal of Lifestyle Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton General Hospital; Health Canada; St. Michael's Hospital","funders":"","keywords":"Mole; Total cholesterol; Cholesterol; Internal medicine; Endocrinology; Chemistry; Medicine","score_opus":0.022685431224740062,"score_gpt":0.26152792522092744,"score_spread":0.23884249399618737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135824461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881332,0.003444575,0.0030472912,0.0040294365,0.0002613622,0.0008869842,0.000037108388,0.000011660444,0.00014837689],"genre_scores_gemma":[0.98530895,0.0020149928,0.011191606,0.00041849408,0.00049603236,0.00003589337,0.000024750916,0.000045057706,0.00046420938],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99684304,0.00013902667,0.0013077032,0.00028821605,0.0011280876,0.00029394357],"domain_scores_gemma":[0.99664104,0.00021437995,0.00096489576,0.0006013524,0.0011911385,0.00038720583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009369588,0.00025575687,0.0012181445,0.00026551288,0.00007645642,0.000014331758,0.000101862504,0.00010705588,0.000032320193],"category_scores_gemma":[0.0003239238,0.00017290654,0.0002725834,0.00040221747,0.00021328493,0.00018620193,0.000056367146,0.0002630941,6.667774e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05808757,0.018686092,0.086123444,0.053570263,0.045847923,0.012760819,0.021128584,0.0057912976,0.09548431,0.019618222,0.033672266,0.5492292],"study_design_scores_gemma":[0.06636763,0.032064315,0.722618,0.022229865,0.012389462,0.026298882,0.006483443,0.0009437672,0.03813781,0.00045,0.07086761,0.0011492029],"about_ca_topic_score_codex":0.000107918095,"about_ca_topic_score_gemma":0.000013723473,"teacher_disagreement_score":0.6364946,"about_ca_system_score_codex":0.00008555316,"about_ca_system_score_gemma":0.0003266281,"threshold_uncertainty_score":0.70509243},"labels":[],"label_agreement":null},{"id":"W3136377995","doi":"10.1186/s12876-021-01704-w","title":"A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis","year":2021,"lang":"en","type":"review","venue":"BMC Gastroenterology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"University of Alberta","keywords":"Medicine; Hepatology; Pharmacokinetics; Cirrhosis; Internal medicine; Intensive care medicine; Pharmacology; Gastroenterology","score_opus":0.03378946312903422,"score_gpt":0.3269895865542905,"score_spread":0.29320012342525625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136377995","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018280714,0.9928507,0.00015083021,0.00006655969,0.00013852098,0.0064507844,0.00010540018,0.000019298517,0.00003509616],"genre_scores_gemma":[0.000058097525,0.9975791,0.0005792699,0.0005300764,0.000066917986,0.00091358536,0.00016963246,0.00006741448,0.0000359197],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9941841,0.0021641157,0.0019167286,0.0006765835,0.0005941094,0.00046441104],"domain_scores_gemma":[0.9975695,0.00018314848,0.00057872984,0.0013684466,0.00012914461,0.00017101898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020597803,0.00054200005,0.011229005,0.00030762673,0.000023867597,0.000006810576,0.00017032979,0.00021367395,0.00003314778],"category_scores_gemma":[0.0005666762,0.00037732648,0.0028089,0.00024127122,0.000089050845,0.000019701403,0.00013535906,0.0005154746,0.0000073521046],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003205309,0.00013362391,0.0011846796,0.9721382,0.003982644,0.00011021217,0.000014487326,8.8180695e-7,5.4132833e-8,0.0000131674915,0.000054372336,0.022335604],"study_design_scores_gemma":[0.0022061388,0.0006427214,0.00093117467,0.9343493,0.023469085,0.00095667684,0.000026247366,0.0000026501027,5.33719e-7,7.7082444e-7,0.037218235,0.00019645948],"about_ca_topic_score_codex":0.00005436538,"about_ca_topic_score_gemma":0.0000242948,"teacher_disagreement_score":0.037788913,"about_ca_system_score_codex":0.0001512668,"about_ca_system_score_gemma":0.00027631887,"threshold_uncertainty_score":0.99986786},"labels":[],"label_agreement":null},{"id":"W3136667809","doi":"10.2337/dc20-2842","title":"Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment","year":2021,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Type 2 diabetes; Internal medicine; Diabetes mellitus; Hazard ratio; Lipoprotein; PCSK9; Placebo; Lipoprotein(a); Endocrinology; Type 1 diabetes; Cholesterol; Confidence interval; LDL receptor; Apolipoprotein A1","score_opus":0.019564105372577637,"score_gpt":0.2711637698460497,"score_spread":0.25159966447347204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136667809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98647064,0.01201748,0.000033114797,0.0004085179,0.00009348241,0.00061292236,0.00005771343,0.000029480827,0.0002766535],"genre_scores_gemma":[0.9982012,0.00020203786,0.0006741758,0.00021447823,0.00009260198,0.00008850486,0.00033540773,0.000022208975,0.00016937817],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989398,0.00006177024,0.00022250025,0.00028687733,0.00029055806,0.00019850946],"domain_scores_gemma":[0.99899757,0.00002221828,0.000063493244,0.00043865762,0.00032646797,0.00015156707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011346199,0.00013067815,0.00034991896,0.000058076574,0.000055652174,0.000015339889,0.000031736483,0.0000920753,0.000028103146],"category_scores_gemma":[0.000109974346,0.00011511817,0.000101646634,0.00022794111,0.000021183167,0.00005420927,0.000031702562,0.000059602324,0.000021053338],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003296533,0.00017461913,0.3361423,0.00090529403,0.000410356,0.00000769662,0.0031654257,0.000031678213,0.2083001,0.0001182175,0.00048866565,0.45022267],"study_design_scores_gemma":[0.0011681103,0.0007794757,0.5179733,0.00021480405,0.00023708529,0.0000018694632,0.00082816527,0.0000751625,0.46986303,0.000048828562,0.008646225,0.00016394568],"about_ca_topic_score_codex":0.0000615334,"about_ca_topic_score_gemma":0.000014072562,"teacher_disagreement_score":0.45005873,"about_ca_system_score_codex":0.00017524172,"about_ca_system_score_gemma":0.00011290262,"threshold_uncertainty_score":0.46943825},"labels":[],"label_agreement":null},{"id":"W3136868778","doi":"10.1161/str.52.suppl_1.57","title":"Abstract 57: Reduction in Ischemic Stroke With Icosapent Ethyl - Insights From REDUCE-IT","year":2021,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada); Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Stroke (engine); Myocardial infarction; Internal medicine; Hazard ratio; Placebo; Clinical endpoint; Cardiology; Relative risk; Unstable angina; Randomized controlled trial; Confidence interval","score_opus":0.017308597730277014,"score_gpt":0.26615266921013336,"score_spread":0.24884407147985635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136868778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715693,0.0030900617,0.00004484891,0.0014003125,0.00031126468,0.00038085668,0.000034338223,0.000048992268,0.02312005],"genre_scores_gemma":[0.9948766,0.0004728688,0.0015431893,0.00023971038,0.0008188705,0.000044937595,0.00017002683,0.000034160254,0.0017996246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981983,0.000056508412,0.00033389858,0.0005022953,0.0005997038,0.0003093381],"domain_scores_gemma":[0.99888414,0.000019388202,0.000084201485,0.0007002489,0.000114879724,0.0001971539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016324408,0.00019645739,0.00044781272,0.000100276935,0.000060604536,0.00002911605,0.00007240293,0.00016084457,0.000330182],"category_scores_gemma":[0.000034544206,0.00016113593,0.00018791888,0.0002117806,0.00004937409,0.00011996423,0.000036177116,0.00055965065,0.00006334697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006661851,0.0006118048,0.003845181,0.00022758768,0.0007116535,0.0013140485,0.0013914271,0.00004914148,0.91816646,0.0000699198,0.003307335,0.069639236],"study_design_scores_gemma":[0.006695509,0.00034253226,0.16755004,0.00079396984,0.00028654927,0.00038526126,0.004071922,0.000022657807,0.7302724,0.00005893047,0.089083254,0.00043696325],"about_ca_topic_score_codex":0.0012368858,"about_ca_topic_score_gemma":0.00031727308,"teacher_disagreement_score":0.18789408,"about_ca_system_score_codex":0.00019345009,"about_ca_system_score_gemma":0.00058574724,"threshold_uncertainty_score":0.6570933},"labels":[],"label_agreement":null},{"id":"W3141408688","doi":"10.1016/j.cjca.2021.03.018","title":"A Snapshot of Lipid-Reporting Practices in Canadian Clinical Laboratories: An Urgent Need for Harmonisation","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Brampton Civic Hospital; Hospital for Sick Children; Royal Columbian Hospital; University of Calgary; Calgary Laboratory Services; SickKids Foundation; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Dyslipidemia; Population; Family medicine; Medical education; Environmental health; Pathology; Disease","score_opus":0.11676876162684423,"score_gpt":0.39616951683583723,"score_spread":0.279400755208993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141408688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99011016,0.0019135132,0.0002372462,0.00462357,0.0014049389,0.00032735674,0.000041226656,0.0000019802194,0.0013399889],"genre_scores_gemma":[0.99535793,0.00013975392,0.0010628618,0.0008289613,0.0025165514,0.000008539047,0.000055621156,0.00001620045,0.00001356681],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972755,0.00041445412,0.0015191247,0.00018871346,0.00016538361,0.0004368268],"domain_scores_gemma":[0.9940231,0.00013013653,0.002017386,0.00031460007,0.0013079622,0.0022068569],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0055126664,0.00010290804,0.0009575848,0.00032601674,0.0000688754,0.000017294367,0.00008684732,0.00022843276,0.000060598308],"category_scores_gemma":[0.024372084,0.000097308024,0.0003862198,0.0003064126,0.00008133703,0.00012223207,0.000004870277,0.00036386872,4.41197e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017335144,0.000013921932,0.9731254,0.0001812235,0.0007534382,0.0021575699,0.0005884515,0.000310725,0.0005266072,0.00030928483,0.0043706847,0.017489357],"study_design_scores_gemma":[0.0024504506,0.00092667755,0.3975924,0.00015787469,0.00036021366,0.002413036,0.0028208492,0.000053000123,0.00072909694,0.00013701877,0.59219676,0.00016264454],"about_ca_topic_score_codex":0.21573143,"about_ca_topic_score_gemma":0.6955925,"teacher_disagreement_score":0.5878261,"about_ca_system_score_codex":0.0004047743,"about_ca_system_score_gemma":0.042950187,"threshold_uncertainty_score":0.98384607},"labels":[],"label_agreement":null},{"id":"W3141555379","doi":"10.35693/2500-1388-2021-6-1-54-60","title":"New groups of hypolipidemic drugs based on inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9). Part 1","year":2021,"lang":"en","type":"article","venue":"Science and Innovations in Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PCSK9; Kexin; Proprotein convertase; LDL receptor; Subtilisin; Pharmacology; Cholesterol; Mechanism of action; Receptor; Chemistry; Lipoprotein; Enzyme; Biochemistry; Medicine; In vitro","score_opus":0.026424820199839574,"score_gpt":0.30249152829761455,"score_spread":0.276066708097775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141555379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98822165,0.0004648757,0.0005864862,0.0077598416,0.0002263979,0.0004918547,0.0000050021886,0.000011996138,0.0022318899],"genre_scores_gemma":[0.996219,0.000089791436,0.0013812706,0.001957581,0.0001821009,0.000010413572,0.000037956557,0.0000068226236,0.00011507293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980278,0.0000463496,0.0005377737,0.0002873428,0.00090805034,0.00019269544],"domain_scores_gemma":[0.99820447,0.000047354213,0.00014230386,0.00044035516,0.0010617858,0.000103746126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025813088,0.000098016935,0.00038765825,0.0005250546,0.00006440986,0.0000042348593,0.00006345387,0.00005981965,0.00013124227],"category_scores_gemma":[0.0020300045,0.00007475054,0.000028355347,0.0037977574,0.0005944905,0.0001162302,0.00002714223,0.0001889423,0.00000187359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005549911,0.0006782317,0.028148422,0.0015970704,0.00005243754,0.00006591031,0.0023749117,0.000052581832,0.701048,0.0465865,0.009324119,0.20951684],"study_design_scores_gemma":[0.0126085915,0.003390733,0.111619234,0.006362796,0.00014858365,0.000081536724,0.0038264974,0.002721391,0.8411381,0.0039195176,0.013791,0.0003920143],"about_ca_topic_score_codex":0.00046047877,"about_ca_topic_score_gemma":0.000022502705,"teacher_disagreement_score":0.20912482,"about_ca_system_score_codex":0.00007829849,"about_ca_system_score_gemma":0.0018430694,"threshold_uncertainty_score":0.3269526},"labels":[],"label_agreement":null},{"id":"W3142398284","doi":"10.1161/circresaha.118.313238","title":"Cholesterol-Lowering Agents","year":2019,"lang":"en","type":"review","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"PCSK9; Medicine; Ezetimibe; Evolocumab; Internal medicine; Clinical trial; Myocardial infarction; Coronary artery disease; Disease; Proprotein convertase; Cardiology; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.39563386624350755,"score_gpt":0.5122505764156858,"score_spread":0.11661671017217828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3142398284","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019137419,0.9887866,0.00008159506,0.00004395821,0.0002614844,0.0030884119,0.000006735418,0.000050450686,0.007489406],"genre_scores_gemma":[0.0009501164,0.99578476,0.00001717493,0.00003666617,0.00076969905,0.0001966359,0.00021112872,0.00008946311,0.0019443312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964078,0.00038145186,0.00047845775,0.0005595936,0.0016445181,0.00052819785],"domain_scores_gemma":[0.9979618,0.00008776048,0.00009582607,0.0013024409,0.0003030231,0.00024915842],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025403139,0.00022705665,0.0013703378,0.0005824624,0.00013880167,0.000083500185,0.00018774654,0.0004062203,0.0003021392],"category_scores_gemma":[0.00018688328,0.00018512312,0.000813598,0.0007575865,0.000052406565,0.00007417903,0.00012980633,0.0011519074,0.0023997133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000022537652,0.000032746906,0.00009316475,0.042343695,0.00021559431,0.000019951789,0.000019241486,0.0000039812285,3.6118422e-7,0.000021662392,0.00049763784,0.95674974],"study_design_scores_gemma":[0.00035645394,0.000044405468,0.0021573205,0.012390712,0.00029199995,0.0001295347,0.0000072592966,0.00003839052,3.4568754e-7,0.00000532776,0.9844336,0.0001446496],"about_ca_topic_score_codex":0.00009312021,"about_ca_topic_score_gemma":0.0000021606452,"teacher_disagreement_score":0.98393595,"about_ca_system_score_codex":0.00049984606,"about_ca_system_score_gemma":0.00093346386,"threshold_uncertainty_score":0.998377},"labels":[],"label_agreement":null},{"id":"W3143382887","doi":"10.14740/jmc2533w","title":"Familial Hyperlipidemia Screening, Treatment and New Considerations","year":2016,"lang":"en","type":"article","venue":"Journal of Medical Cases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Hyperlipidemia; Disease; Pediatrics; Population; Genetic testing; Presentation (obstetrics); Internal medicine; Cholesterol; Surgery; Endocrinology; Environmental health; Diabetes mellitus","score_opus":0.07094265294787856,"score_gpt":0.33425632396222227,"score_spread":0.2633136710143437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143382887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9174844,0.0073267384,0.0050891284,0.069395326,0.00030292882,0.00016148237,0.00000477637,0.0000131606575,0.00022206698],"genre_scores_gemma":[0.9876229,0.0041873837,0.0026267671,0.001852249,0.0032598698,0.0000016838877,5.169646e-7,0.00001001776,0.0004386134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863976,0.00006956601,0.00035414787,0.00008816819,0.00071403274,0.00013431013],"domain_scores_gemma":[0.99852985,0.00035201432,0.00010161845,0.00012656323,0.000091328184,0.00079860823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063826336,0.00008334761,0.0003692881,0.00006178999,0.000052115684,0.000009798716,0.000028491526,0.000100344274,0.00064989086],"category_scores_gemma":[0.0024671268,0.000039054423,0.00018642144,0.00003434812,0.000080854705,0.000060956107,0.0000143881125,0.0001229545,0.000004711074],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024926197,0.00014669474,0.009888889,0.000031298845,0.00041198428,0.004418177,0.000119118864,3.195409e-7,0.00056737685,0.0005440162,0.04086789,0.942755],"study_design_scores_gemma":[0.03542799,0.010366993,0.076969065,0.002543122,0.0015027374,0.18952638,0.00055808324,0.00003974624,0.0037287278,0.0011886089,0.6778016,0.00034691318],"about_ca_topic_score_codex":0.00028965855,"about_ca_topic_score_gemma":0.000051636005,"teacher_disagreement_score":0.9424081,"about_ca_system_score_codex":0.00006064883,"about_ca_system_score_gemma":0.00095003843,"threshold_uncertainty_score":0.7115849},"labels":[],"label_agreement":null},{"id":"W3149882015","doi":"10.1016/s0140-6736(14)60214-2","title":"Refining the American guidelines for prevention of cardiovascular disease","year":2014,"lang":"en","type":"letter","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Calculator; Scopus; Guideline; Medicine; Family medicine; Disease; MEDLINE; Internal medicine; Computer science; Pathology","score_opus":0.11242549411852147,"score_gpt":0.3547765257113116,"score_spread":0.2423510315927901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3149882015","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019084902,0.016600417,0.0063474565,0.9731522,0.000266597,0.0012250809,0.00008128348,0.00005427595,0.00036419052],"genre_scores_gemma":[0.004922473,0.0023272003,0.0024570592,0.92591983,0.06143446,0.0006013183,0.00045286873,0.00011615436,0.0017686086],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795955,0.00032374897,0.0003790198,0.0002873504,0.0007230228,0.0003273065],"domain_scores_gemma":[0.9965407,0.000114641705,0.0003081089,0.0026435568,0.000346584,0.00004637977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023040406,0.00020052603,0.0013554798,0.000036224108,0.00010816837,0.000015742655,0.00035756058,0.000096527845,0.000006233887],"category_scores_gemma":[0.0005399873,0.00009615807,0.0016262948,0.00012743489,0.00016011554,0.000013642785,0.000050473558,0.00056484714,0.0000065301692],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014815704,0.0000065564714,0.000056906014,0.0010233148,0.002128146,0.000012438568,0.000023036595,0.000090778565,0.000003389143,0.000022354336,0.93035626,0.06612865],"study_design_scores_gemma":[0.0008570454,0.00012962344,0.00096108636,0.0004070658,0.0027516761,0.000022956985,0.000012237193,0.00013411879,0.000011568332,0.00021056908,0.99439025,0.00011178134],"about_ca_topic_score_codex":0.00049051375,"about_ca_topic_score_gemma":0.0000036394415,"teacher_disagreement_score":0.06601687,"about_ca_system_score_codex":0.000033166903,"about_ca_system_score_gemma":0.00013445994,"threshold_uncertainty_score":0.39212123},"labels":[],"label_agreement":null},{"id":"W3151155682","doi":"","title":"Lipids in Health and Disease","year":2015,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Toronto","funders":"","keywords":"Fenofibrate; Ezetimibe; Atorvastatin; Combination therapy; Medicine; Dyslipidemia; Internal medicine; Statin; Pharmacology; Randomized controlled trial; Gastroenterology; Cholesterol; Endocrinology; Disease","score_opus":0.030600217432972417,"score_gpt":0.2984670445753904,"score_spread":0.267866827142418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3151155682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92477036,0.018044045,0.0007630172,0.039956983,0.00016825866,0.0009128513,0.0000019044362,0.000087776134,0.015294788],"genre_scores_gemma":[0.99119836,0.00027384583,0.00075502996,0.0063596424,0.00017457164,0.000010081769,0.0000047649874,0.000006558544,0.0012171188],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994801,0.000044268207,0.0000994563,0.00010125416,0.0001543076,0.00012060816],"domain_scores_gemma":[0.9987247,0.0000040968653,0.0000096147005,0.00016999661,0.000017851722,0.0010737501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056145474,0.00003914237,0.00014102337,0.00003664485,0.000013185895,0.0000040850136,0.00001125782,0.000014533567,0.000013597327],"category_scores_gemma":[0.00015190619,0.00002830291,0.000026415459,0.00006991023,0.000012945036,0.00002292405,0.000014000356,0.000068399895,0.000011737097],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075360166,0.00043471507,0.58055955,0.0016663044,0.00006820409,0.0002219132,0.0020669452,0.000008032421,0.00000880458,0.012034348,0.03949748,0.3626801],"study_design_scores_gemma":[0.01159892,0.0012183106,0.4279882,0.00039488787,0.000030669144,0.00013025213,0.0022766765,0.0009681062,0.000020327327,0.0028424317,0.5522666,0.00026460542],"about_ca_topic_score_codex":0.0007788117,"about_ca_topic_score_gemma":0.000035313784,"teacher_disagreement_score":0.5127691,"about_ca_system_score_codex":0.000047947608,"about_ca_system_score_gemma":0.00060276827,"threshold_uncertainty_score":0.11773355},"labels":[],"label_agreement":null},{"id":"W3151350362","doi":"10.1101/2021.03.17.21252755","title":"The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for <i>LDLR</i> variant classification","year":2021,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institutes of Health; University College London; British Heart Foundation; American Diabetes Association; Canadian Institutes of Health Research; National Institute for Health and Care Research; Stanford Diabetes Research Center; Heart and Stroke Foundation of Canada; National Human Genome Research Institute; Michael Smith Health Research BC; Ministerstvo Zdravotnictví Ceské Republiky","keywords":"Familial hypercholesterolemia; Medical genetics; Genomics; Computational biology; Population; Consistency (knowledge bases); Resource (disambiguation); Medicine; Computer science; Bioinformatics; Genetics; Genome; Biology; Artificial intelligence; Gene; Internal medicine; Cholesterol","score_opus":0.24023260429846605,"score_gpt":0.4020269505342883,"score_spread":0.16179434623582223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3151350362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7903111,0.02478756,0.09436892,0.07201549,0.007553678,0.009156557,0.00027357144,0.0004259764,0.0011071416],"genre_scores_gemma":[0.8653168,0.026444811,0.043586418,0.022054683,0.032552943,0.0035246839,0.0036671413,0.00051303045,0.0023394746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99364793,0.0009867459,0.0023794377,0.0013937064,0.0009782187,0.0006139461],"domain_scores_gemma":[0.9937901,0.0006411285,0.0006901,0.0027487157,0.0017419443,0.00038801608],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0077070617,0.0005258378,0.001253923,0.0000879066,0.0004962583,0.00022989907,0.00047199774,0.0009471712,0.000012989611],"category_scores_gemma":[0.004309833,0.00037236777,0.0012371737,0.00017187085,0.00022343684,0.000049995073,0.00038028444,0.0013039433,0.000017585193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0097800335,0.00331681,0.008538575,0.006543541,0.011367293,0.0030411624,0.005982064,0.0022662375,0.07249313,0.0032239405,0.071426526,0.80202067],"study_design_scores_gemma":[0.0053680926,0.000503197,0.058843557,0.0010636128,0.0014131573,0.0008779648,0.0017876057,0.017107323,0.00039268978,0.00038536606,0.9112779,0.0009795655],"about_ca_topic_score_codex":0.0002633,"about_ca_topic_score_gemma":0.000097252196,"teacher_disagreement_score":0.8398513,"about_ca_system_score_codex":0.0002162847,"about_ca_system_score_gemma":0.0015940409,"threshold_uncertainty_score":0.9998728},"labels":[],"label_agreement":null},{"id":"W3152340772","doi":"10.1161/circoutcomes.120.006646","title":"Lipid Testing, Lipid-Modifying Therapy, and PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Eligibility in 27 979 Patients With Incident Acute Coronary Syndrome","year":2021,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta Hospital; St. Michael's Hospital","funders":"","keywords":"Medicine; PCSK9; Acute coronary syndrome; Evolocumab; Internal medicine; Statin; Population; Unstable angina; Cohort; Lipoprotein; Gastroenterology; Cholesterol; Myocardial infarction; LDL receptor","score_opus":0.05209750510048519,"score_gpt":0.3079381120838482,"score_spread":0.255840606983363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152340772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892441,0.007893115,0.00030985687,0.0003416316,0.00028649723,0.0017614487,0.00003102364,0.00008866013,0.000043680004],"genre_scores_gemma":[0.997658,0.00047756903,0.000782232,0.00063265115,0.0001129693,0.0000563538,0.00020089936,0.000050995855,0.000028340753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956887,0.000790231,0.0008149508,0.0010055645,0.0012479101,0.00045264966],"domain_scores_gemma":[0.9974683,0.0001661967,0.00018392262,0.0012280479,0.00063068233,0.00032288235],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024929198,0.00041909475,0.0014990916,0.00015873228,0.00021753278,0.000094270465,0.000080258316,0.00026559556,0.000028987279],"category_scores_gemma":[0.0006810802,0.00034634108,0.0005524444,0.00053405797,0.0001743038,0.00030350863,0.00012530509,0.0004211658,0.000007130759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002554434,0.00023406948,0.966406,0.0005699137,0.0016775813,0.00027227623,0.00032885096,0.00007543421,0.00015625537,0.000044224467,0.0000048734937,0.029975079],"study_design_scores_gemma":[0.00759371,0.00022318515,0.9894611,0.00023457671,0.00044288993,0.00038350018,0.00017740256,0.00008079229,0.00031746927,0.00006809419,0.0005930425,0.0004241853],"about_ca_topic_score_codex":0.0012361695,"about_ca_topic_score_gemma":0.00009247924,"teacher_disagreement_score":0.029550895,"about_ca_system_score_codex":0.0002273384,"about_ca_system_score_gemma":0.00037311765,"threshold_uncertainty_score":0.99989885},"labels":[],"label_agreement":null},{"id":"W3153020707","doi":"10.1101/2021.04.11.439364","title":"Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR that is shed by Furin","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"LDL receptor; Asialoglycoprotein receptor; PCSK9; Endocytosis; Biology; Receptor; Molecular biology; Kexin; Chemistry; Biochemistry; Cholesterol; Lipoprotein; Hepatocyte; In vitro","score_opus":0.018572057464611134,"score_gpt":0.22567343004687374,"score_spread":0.2071013725822626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153020707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745992,0.01630964,0.0025745255,0.0010454312,0.0010662621,0.003122897,0.0010041078,0.00025150026,0.000026437245],"genre_scores_gemma":[0.9879078,0.0021239547,0.0068431776,0.0014186341,0.0008926859,0.00046097612,0.0000047275616,0.00026771007,0.00008029481],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9941149,0.00018364475,0.0010535849,0.0018916626,0.0018452725,0.00091097504],"domain_scores_gemma":[0.99407333,0.000036287984,0.00077420525,0.0033264167,0.0010628782,0.0007268943],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013808985,0.000953607,0.002055339,0.00033436046,0.00015408073,0.0001796108,0.00057920214,0.0013955703,0.0006825722],"category_scores_gemma":[0.00020956581,0.0009633628,0.0012737289,0.00062035,0.00015369433,0.00016572974,0.0007858859,0.0015917047,0.00008731629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020438906,0.0008624041,0.0035510052,0.004019881,0.0023007041,0.00017142775,0.00012931923,0.000001609142,0.98525786,0.000042914344,0.0033909478,0.00006756224],"study_design_scores_gemma":[0.0027014324,0.00020929666,0.028716424,0.0021128245,0.00088683446,5.225498e-7,0.000022301212,0.000059951635,0.94574136,3.6535582e-7,0.018647326,0.00090137485],"about_ca_topic_score_codex":0.0015475424,"about_ca_topic_score_gemma":0.000010174781,"teacher_disagreement_score":0.03951649,"about_ca_system_score_codex":0.00057931565,"about_ca_system_score_gemma":0.0021758357,"threshold_uncertainty_score":0.9999008},"labels":[],"label_agreement":null},{"id":"W3153448733","doi":"10.30629/0023-2149-2020-98-11-12-739-744","title":"New groups of hypolipidemic medications based on inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9). Part 1","year":2021,"lang":"en","type":"article","venue":"Clinical Medicine (Russian Journal)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PCSK9; Proprotein convertase; Kexin; Alirocumab; Medicine; Evolocumab; LDL receptor; Subtilisin; Pharmacology; Cholesterol; Internal medicine; Lipoprotein; Endocrinology; Biochemistry; Enzyme; Chemistry","score_opus":0.053554059995931415,"score_gpt":0.359840569204412,"score_spread":0.30628650920848055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153448733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6980983,0.016726077,0.023416148,0.23692116,0.0069851587,0.0032262914,0.00006194993,0.00015490303,0.014409981],"genre_scores_gemma":[0.98310333,0.0019291319,0.003974994,0.005393059,0.0048600044,0.0000124287735,0.00010932012,0.000054166412,0.00056355225],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99473363,0.000746853,0.0024308204,0.00043325042,0.0012876416,0.0003678078],"domain_scores_gemma":[0.9956326,0.000562471,0.00096182426,0.0010697795,0.00061140745,0.0011619228],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004418459,0.0002557419,0.0014888926,0.00025151015,0.00009525067,0.000006634949,0.00016065425,0.00032313875,0.0019564098],"category_scores_gemma":[0.006902317,0.00017878384,0.00059077033,0.0006916369,0.00045275173,0.00007306412,0.000035816156,0.0012556373,0.000031477808],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069513833,0.005888294,0.079782195,0.00467665,0.0031665752,0.0031309165,0.0014952864,0.00007570759,0.013931878,0.012132457,0.18586463,0.682904],"study_design_scores_gemma":[0.11083418,0.043953355,0.363265,0.062653646,0.009502962,0.00543896,0.0036467505,0.0028268078,0.09727852,0.018627128,0.27990746,0.002065209],"about_ca_topic_score_codex":0.00008625125,"about_ca_topic_score_gemma":0.000016354688,"teacher_disagreement_score":0.6808388,"about_ca_system_score_codex":0.00009372153,"about_ca_system_score_gemma":0.0028692917,"threshold_uncertainty_score":0.99895597},"labels":[],"label_agreement":null},{"id":"W3153935355","doi":"10.1161/circ.142.suppl_3.13130","title":"Abstract 13130: Efficacy and Safety of Bempedoic Acid by Sex: Pooled Analyses From Phase 3 Trials","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Michael's Hospital","funders":"","keywords":"Medicine; Placebo; Internal medicine; Adverse effect; Statin; Clinical endpoint; Familial hypercholesterolemia; Tolerability; Endocrinology; Gastroenterology; Cholesterol; Clinical trial","score_opus":0.08762452908464992,"score_gpt":0.37095317259004656,"score_spread":0.28332864350539666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153935355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887957,0.0033250975,0.006289273,0.00056912337,0.000038037964,0.00064475584,0.00010327041,0.000037097303,0.00019766718],"genre_scores_gemma":[0.9985127,0.00014586186,0.00019303497,0.0002636364,0.00036887187,0.000005971009,0.00049246394,0.000014124924,0.0000033337012],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986967,0.00012083283,0.00052313745,0.00024325402,0.00030921525,0.00010686943],"domain_scores_gemma":[0.9992332,0.00010412266,0.00020128723,0.0002340455,0.000058923495,0.00016846224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005954148,0.000107760745,0.000655544,0.000037801845,0.000046051926,0.0000125780425,0.000031993182,0.000093977964,0.00019052069],"category_scores_gemma":[0.0005186111,0.0000908534,0.00020077014,0.00014861903,0.000028177223,0.00006743117,0.0000114237855,0.00010079609,0.000007424682],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007128568,0.00017582183,0.0042595994,0.00018863441,0.00076825445,0.000010739671,0.0005512474,0.000078867844,0.8205261,0.000008641406,0.0003041405,0.17241506],"study_design_scores_gemma":[0.029375387,0.00033782847,0.7599918,0.00017331305,0.0023093666,0.000008768001,0.00022091031,0.0021695322,0.20150541,0.00009493744,0.0035400507,0.00027268022],"about_ca_topic_score_codex":0.00022429909,"about_ca_topic_score_gemma":0.0000012257085,"teacher_disagreement_score":0.75573224,"about_ca_system_score_codex":0.000026134083,"about_ca_system_score_gemma":0.000068737645,"threshold_uncertainty_score":0.37048942},"labels":[],"label_agreement":null},{"id":"W3154073621","doi":"10.31579/2641-0419/154","title":"Is Treatment Inertia Unique to Publicly Funded Healthcare? Insights from the Guidelines Oriented Approach to Lipid lowering (GOAL) Canada Program","year":2021,"lang":"en","type":"article","venue":"Clinical Cardiology and Cardiovascular Interventions","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Heart Research Centre","funders":"HLS Therapeutics; Servier; University of Toronto; Duke Clinical Research Institute; Novo Nordisk; Daiichi-Sankyo; Regeneron Pharmaceuticals; York University; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Sunovion; Pfizer; Heart and Stroke Foundation of Canada; American Regent; Sanofi; Esperion Therapeutics; GlaxoSmithKline; Amgen","keywords":"Ezetimibe; Guideline; Medicine; Internal medicine; Statin; Physical therapy","score_opus":0.1305337855450241,"score_gpt":0.3959519768915952,"score_spread":0.26541819134657113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154073621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84222245,0.0693019,0.047997445,0.029631793,0.003032807,0.005263805,0.00029208433,0.0002772327,0.001980477],"genre_scores_gemma":[0.977023,0.0028284842,0.0054794988,0.009845861,0.0027266769,0.0012956073,0.00040818975,0.00006208657,0.00033061492],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99483967,0.0013174005,0.0013662232,0.0013008079,0.0006065701,0.0005693083],"domain_scores_gemma":[0.9953372,0.00027084007,0.00009614042,0.0023052478,0.0010783377,0.00091224816],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016944051,0.00040204296,0.0018710205,0.00008291124,0.0003764019,0.00006748627,0.00024010234,0.00035920198,0.000023952149],"category_scores_gemma":[0.001850189,0.0002794488,0.0044342503,0.00067355664,0.00014063486,0.000059352446,0.00035262387,0.0005544406,0.00001466457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005628824,0.0015640673,0.18862441,0.0007056979,0.057041947,0.0010870808,0.0007216158,0.0006988212,0.00003742282,0.0017041927,0.04593665,0.7013152],"study_design_scores_gemma":[0.0023051486,0.0009886214,0.23625204,0.00036532021,0.0021151947,0.000516332,0.0009793756,0.00003615284,0.000102218546,0.00007016827,0.75590307,0.00036636053],"about_ca_topic_score_codex":0.16408983,"about_ca_topic_score_gemma":0.11577618,"teacher_disagreement_score":0.7099664,"about_ca_system_score_codex":0.0002748913,"about_ca_system_score_gemma":0.0010791045,"threshold_uncertainty_score":0.9999658},"labels":[],"label_agreement":null},{"id":"W3155678673","doi":"10.1016/j.ijcard.2021.04.025","title":"Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the risk for neurocognitive adverse events: A systematic review, meta-analysis and meta-regression","year":2021,"lang":"en","type":"review","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Proprotein convertase; Kexin; Subtilisin; PCSK9; Meta-analysis; Adverse effect; Meta-regression; Internal medicine; Oncology; Pharmacology; Cholesterol; LDL receptor; Enzyme; Lipoprotein; Biochemistry","score_opus":0.0665605902386,"score_gpt":0.3734462757248529,"score_spread":0.3068856854862529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155678673","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019385303,0.9928453,0.0014225653,0.0007569579,0.00036139594,0.0043528345,0.00021723451,0.000005176325,0.000019179857],"genre_scores_gemma":[0.0005484167,0.99723685,0.00025392568,0.0005638744,0.0005258851,0.0006085191,0.00010231468,0.0000343264,0.00012586829],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99303955,0.0036164979,0.0018681171,0.00041021497,0.00087422214,0.00019140683],"domain_scores_gemma":[0.9935313,0.0011090281,0.0025212746,0.0004510203,0.0022234125,0.00016396964],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0057090484,0.00047584204,0.013032857,0.00042309266,0.00007487563,0.000020142761,0.00025873905,0.00023592028,0.000040494426],"category_scores_gemma":[0.0043669567,0.00019588541,0.011942442,0.00029075655,0.00017185291,0.00008640457,0.00013445974,0.000685447,0.0000023390417],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021388808,0.000020913129,0.000006887367,0.117837794,0.8725837,0.000356325,0.000028413764,0.000002892501,1.5484453e-7,0.000040348434,0.00016606117,0.008742609],"study_design_scores_gemma":[0.0013149324,0.00016941447,0.0000049630744,0.018692477,0.91117185,0.00488471,0.000038383365,0.0000050258714,0.0000023153507,0.000044407894,0.06352579,0.00014573033],"about_ca_topic_score_codex":0.000035342764,"about_ca_topic_score_gemma":0.0000047385734,"teacher_disagreement_score":0.09914532,"about_ca_system_score_codex":0.00009063997,"about_ca_system_score_gemma":0.00045078818,"threshold_uncertainty_score":0.9979527},"labels":[],"label_agreement":null},{"id":"W3155766971","doi":"10.1016/j.atherosclerosis.2021.04.004","title":"Healthy ageing to guide targeted versus universal treatment: A different approach to prevention","year":2021,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Guideline; Scopus; Internal medicine; Disease; Statin; Cardiology; MEDLINE; Pathology","score_opus":0.05934330794931715,"score_gpt":0.2891861566784617,"score_spread":0.22984284872914457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155766971","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34818062,0.0028917252,0.012411132,0.6047186,0.003826202,0.013083012,0.00038004108,0.00079793006,0.013710681],"genre_scores_gemma":[0.055253554,0.0025058514,0.01870482,0.8549461,0.017274605,0.0026563143,0.005836202,0.00088400795,0.041938554],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996211,0.0003371617,0.0005259959,0.0011572848,0.0009092316,0.0008593474],"domain_scores_gemma":[0.9976566,0.00005208212,0.00014541282,0.0014628153,0.00015443192,0.00052866165],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023994323,0.0006286966,0.0013027586,0.0002684322,0.00020517025,0.000077501005,0.00020916044,0.0007144958,0.00012143247],"category_scores_gemma":[0.00006595073,0.0005356137,0.0010121603,0.00048495748,0.000025659685,0.00005119859,0.00013375096,0.00075635203,0.00011292194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001360609,0.0016425442,0.00040830928,0.0017106184,0.0047896286,0.0004620726,0.002899293,0.000060353083,0.0029652028,0.000048532103,0.9107806,0.072872244],"study_design_scores_gemma":[0.0058554886,0.0037754353,0.006386171,0.0007830644,0.0011290106,0.000019410383,0.00029827908,0.000023318593,0.0006432654,0.000003402378,0.98045796,0.00062519964],"about_ca_topic_score_codex":0.0023345305,"about_ca_topic_score_gemma":0.00010218195,"teacher_disagreement_score":0.2929271,"about_ca_system_score_codex":0.0023857919,"about_ca_system_score_gemma":0.00046231056,"threshold_uncertainty_score":0.99970955},"labels":[],"label_agreement":null},{"id":"W3156740020","doi":"10.1097/mol.0000000000000754","title":"Update on apolipoprotein B","year":2021,"lang":"en","type":"article","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Apolipoprotein E; Triglycerides blood; Apolipoprotein A1","score_opus":0.06517855259956185,"score_gpt":0.3639708801944913,"score_spread":0.29879232759492946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156740020","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31754312,0.11194851,0.00474336,0.05445963,0.48872924,0.004782937,0.00008691154,0.0006303371,0.017075947],"genre_scores_gemma":[0.72117215,0.04880824,0.004266366,0.008071388,0.21319656,0.0011291303,0.0017906625,0.0002600233,0.0013054562],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983909,0.00022965684,0.00032345735,0.0004156262,0.00027526217,0.00036509137],"domain_scores_gemma":[0.9990641,0.000034005217,0.000053767777,0.0006133199,0.000085317624,0.00014952075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040361838,0.00014880199,0.00042424622,0.00015185673,0.000041927913,0.000008717658,0.00007097297,0.00013158796,0.00035256022],"category_scores_gemma":[0.0002057748,0.00013471935,0.00018555488,0.000311888,0.0000538986,0.000034292956,0.00006561714,0.0004524087,0.00034006903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053936196,0.0017977346,0.015966387,0.0022432588,0.00017317584,0.000010188969,0.0002985311,0.00005620319,0.00077118253,0.07022745,0.15455477,0.75336176],"study_design_scores_gemma":[0.0022688303,0.0002171259,0.020679101,0.00050520117,0.000013045875,0.00017417622,0.00004002737,0.000042824882,0.0004531501,0.0007983963,0.97466105,0.00014703805],"about_ca_topic_score_codex":0.000027864322,"about_ca_topic_score_gemma":0.000005859937,"teacher_disagreement_score":0.8201063,"about_ca_system_score_codex":0.00009704795,"about_ca_system_score_gemma":0.00027982492,"threshold_uncertainty_score":0.5493695},"labels":[],"label_agreement":null},{"id":"W3157513278","doi":"10.1093/eurheartj/ehab225","title":"Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Institut universitaire de cardiologie et de pneumologie de Québec; Population Health Research Institute; Université Laval; University of Toronto; Hamilton Health Sciences; McMaster University","funders":"BERLIN-CHEMIE; Canadian Institutes of Health Research; Esperion Therapeutics; Menarini Group; Sanofi; Kowa Company; Novo Nordisk; Medicines Company; Hamilton Health Sciences; Servier; Pfizer; Amgen; AstraZeneca; Eli Lilly and Company; Population Health Research Institute","keywords":"Mace; Medicine; Rosuvastatin; Myocardial infarction; Blood pressure; Internal medicine; Placebo; Randomized controlled trial; Cardiology; Adverse effect; Confidence interval; Heart failure; Percutaneous coronary intervention","score_opus":0.08713227006309189,"score_gpt":0.36006901942646535,"score_spread":0.2729367493633735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157513278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460906,0.0030320126,0.00015858015,0.0001418741,0.00041539414,0.0014738792,0.000017311699,0.000013144617,0.00013873243],"genre_scores_gemma":[0.9980628,0.00014848253,0.0008596252,0.00006104598,0.00022412415,0.000014716098,0.00000689369,0.00005011637,0.0005721797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940581,0.0019737699,0.0012780232,0.00037691754,0.0019667568,0.00034646151],"domain_scores_gemma":[0.99763244,0.00005055095,0.00035466295,0.001026977,0.0006435236,0.00029182542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009549957,0.00018777899,0.0010732412,0.00017483938,0.000065711785,0.000017723853,0.00013820131,0.00004495746,0.00006946706],"category_scores_gemma":[0.0012896591,0.00015826666,0.0010098608,0.00036161247,0.000025335477,0.00013680093,0.00013917201,0.00027662847,0.000007867256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009142867,0.028381474,0.60435116,0.0042705443,0.06990067,0.0014783343,0.021580115,0.016793948,0.05976467,0.0000063220505,0.00385792,0.180472],"study_design_scores_gemma":[0.012451262,0.0026354373,0.96029794,0.0012649299,0.00478478,0.00038728805,0.0005442644,0.000018578925,0.013276185,0.0000042300358,0.004184566,0.00015053382],"about_ca_topic_score_codex":0.000071324794,"about_ca_topic_score_gemma":0.00002664457,"teacher_disagreement_score":0.3559468,"about_ca_system_score_codex":0.000037775568,"about_ca_system_score_gemma":0.00046966385,"threshold_uncertainty_score":0.64539266},"labels":[],"label_agreement":null},{"id":"W3157600424","doi":"10.1210/jendso/bvab048.1046","title":"The Use of Genetic Testing Panels for Dyslipidemia: A Quality Improvement Project at the McGill University Health Centre","year":2021,"lang":"en","type":"article","venue":"Journal of the Endocrine Society","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Genetic testing; Dyslipidemia; Medicine; Specialty; Family medicine; Test (biology); Internal medicine; Biology; Obesity","score_opus":0.09446574034944528,"score_gpt":0.3246109292588507,"score_spread":0.23014518890940544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157600424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91546816,0.0026686364,0.00065997633,0.078482285,0.0005927919,0.0017892725,0.00029894104,0.000013107069,0.000026812808],"genre_scores_gemma":[0.8463967,0.0164217,0.07516978,0.027709182,0.004695002,0.000027957618,0.000020473826,0.00018551367,0.029373713],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979927,0.00042450742,0.0005749937,0.00014213765,0.0005461911,0.00031949574],"domain_scores_gemma":[0.9972612,0.00065634784,0.00080158625,0.0005518577,0.0006361762,0.000092785995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017640393,0.00011452869,0.00040961598,0.0000089459,0.00069393666,0.000008446753,0.00019052705,0.000032328953,0.0000043276664],"category_scores_gemma":[0.0009697112,0.000052886095,0.0011926432,0.00025481958,0.00008304538,0.000045261942,0.00021846246,0.00037952443,2.0329813e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001521525,0.0012903103,0.043403972,0.005338754,0.00897605,0.00013016233,0.005832088,0.0016880871,0.03342413,0.0005807461,0.34761134,0.55020285],"study_design_scores_gemma":[0.005024319,0.0006410606,0.051097363,0.0004100561,0.00068616006,0.00070228294,0.007413344,0.0004682706,0.0085427845,0.00010342642,0.9247572,0.00015373593],"about_ca_topic_score_codex":0.0007316854,"about_ca_topic_score_gemma":0.00013111431,"teacher_disagreement_score":0.5771459,"about_ca_system_score_codex":0.0006437309,"about_ca_system_score_gemma":0.00087665825,"threshold_uncertainty_score":0.533727},"labels":[],"label_agreement":null},{"id":"W3157748245","doi":"10.1016/s0735-1097(21)02831-x","title":"GENETIC IDENTIFICATION OF HOMOZOGOUS FAMILIAL HYPERCHOLESTEROLEMIA AMONG PATIENTS WITH CLINICALLY DIAGNOSED HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Internal medicine; Identification (biology); Heterozygote advantage; Pediatrics; Genetics; Cholesterol; Allele; Gene","score_opus":0.009234588794512777,"score_gpt":0.2530521209649456,"score_spread":0.24381753217043284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157748245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997448,0.00027279614,0.00072476285,0.0002621967,0.00057194097,0.00049880607,0.00012762805,0.0000070865676,0.000086729924],"genre_scores_gemma":[0.99745774,0.00043916292,0.0010654026,0.0003684959,0.0005688776,0.000011584715,0.000005804284,0.000039759474,0.000043140008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958068,0.0009493402,0.0016764251,0.0003141949,0.0009330206,0.00032019572],"domain_scores_gemma":[0.99534976,0.0002050577,0.0018479682,0.0010208541,0.0013749439,0.00020141076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009182122,0.0002364166,0.0018482221,0.00015529929,0.0000733573,0.0000074996065,0.00039721502,0.00014210187,0.0000030276763],"category_scores_gemma":[0.00053951045,0.0001566094,0.0010062056,0.0005054258,0.0009008369,0.00007746606,0.00013226413,0.0005611793,0.0000013309907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023325845,0.00025518218,0.97092533,0.0001253811,0.0012200136,0.00056508963,0.00009486562,0.00086407404,0.010405261,0.0000026126363,0.00028763557,0.012921995],"study_design_scores_gemma":[0.0045349393,0.0028617468,0.98797715,0.00018784976,0.0008326018,0.0011692889,0.00039044573,0.0000142828985,0.0014747395,0.000018776815,0.00040479182,0.00013340297],"about_ca_topic_score_codex":0.0000542416,"about_ca_topic_score_gemma":0.000016973814,"teacher_disagreement_score":0.017051827,"about_ca_system_score_codex":0.00014179037,"about_ca_system_score_gemma":0.00074380677,"threshold_uncertainty_score":0.6386346},"labels":[],"label_agreement":null},{"id":"W3157811151","doi":"10.1016/j.jacl.2021.04.001","title":"Clinical reasoning and prevention of cardiovascular disease","year":2021,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Servier; Novartis","keywords":"Medicine; Observational study; Clinical trial; Disease; Randomized controlled trial; Metric (unit); Intensive care medicine; Event (particle physics); Primary prevention; Pathology","score_opus":0.08588843561969628,"score_gpt":0.4219238485394571,"score_spread":0.3360354129197608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157811151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616475,0.028673824,0.004759734,0.0013929727,0.0029335837,0.00016929135,0.0000024138099,0.0000070240058,0.00041367274],"genre_scores_gemma":[0.95035744,0.023479845,0.014820517,0.00064042147,0.010433706,0.0000021121352,0.000005093852,0.000022069791,0.00023880352],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952902,0.0015442597,0.0022231468,0.000255697,0.0005114451,0.00017524457],"domain_scores_gemma":[0.99699295,0.00056905166,0.0006846598,0.0005531499,0.0006530753,0.0005471202],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009882484,0.000102979444,0.00177093,0.000060798913,0.000029517478,0.000005856723,0.000073697716,0.00024354634,0.000059448073],"category_scores_gemma":[0.009527305,0.00007913131,0.0026858787,0.00012432948,0.00021601234,0.000065253436,0.00007686739,0.0007049271,0.0000029810337],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019052936,0.0008713259,0.30964673,0.0004296771,0.0065638325,0.0006332412,0.000026990323,0.000044855064,0.000029144763,0.0006268973,0.0013120332,0.67791],"study_design_scores_gemma":[0.0076347436,0.0022223594,0.81022745,0.0006087302,0.0039887433,0.0016419808,0.000077828445,0.00007972462,0.000051122577,0.0012282315,0.17212446,0.00011461962],"about_ca_topic_score_codex":0.0000071460845,"about_ca_topic_score_gemma":0.000001372319,"teacher_disagreement_score":0.67779535,"about_ca_system_score_codex":0.000012891181,"about_ca_system_score_gemma":0.0010343231,"threshold_uncertainty_score":0.9988159},"labels":[],"label_agreement":null},{"id":"W3158223130","doi":"10.15420/ecr.2020.42","title":"Management of Dyslipidaemia in Real-world Clinical Practice: Rationale and Design of the VIPFARMA ISCP Project","year":2021,"lang":"en","type":"review","venue":"European Cardiology Review","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Pharmacotherapy; Family medicine; Medical prescription; Clinical Practice; Internal medicine; Nursing","score_opus":0.16051801254864836,"score_gpt":0.44463393479437935,"score_spread":0.284115922245731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158223130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.905841e-7,0.97302777,0.00012001362,0.00017635681,0.00025398337,0.005992395,0.00001476835,0.000010167694,0.020403532],"genre_scores_gemma":[0.0000028312343,0.9962267,0.0023178584,0.00037813254,0.00038444373,0.0001351355,0.00005590392,0.00005476103,0.0004441839],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98383635,0.012919938,0.002092161,0.00056676957,0.00036333085,0.00022142056],"domain_scores_gemma":[0.9967658,0.00062234496,0.0010270282,0.0013288454,0.00019005033,0.00006596534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012828193,0.00031793563,0.004842207,0.000105423234,0.00003337566,0.00000441604,0.0002482547,0.000121627134,0.000012749183],"category_scores_gemma":[0.0009541083,0.00019157266,0.0015295452,0.00073540234,0.00018063954,0.000032572414,0.00035287667,0.00072814577,0.000011413265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009660597,0.00003924889,0.000058856156,0.15187404,0.001558737,0.00047645695,0.000007635784,9.517283e-7,3.73595e-8,0.00022654417,0.0033788434,0.84236896],"study_design_scores_gemma":[0.00036770213,0.000071282164,0.0006128204,0.14514732,0.0060755857,0.0005758629,0.000013305744,3.839712e-7,5.231862e-8,7.6010537e-7,0.84701806,0.000116864074],"about_ca_topic_score_codex":0.000012373581,"about_ca_topic_score_gemma":9.611537e-7,"teacher_disagreement_score":0.8436392,"about_ca_system_score_codex":0.00007498261,"about_ca_system_score_gemma":0.0006763678,"threshold_uncertainty_score":0.78121066},"labels":[],"label_agreement":null},{"id":"W3158518803","doi":"10.1016/j.atherosclerosis.2021.04.013","title":"The year 2020 in Atherosclerosis","year":2021,"lang":"en","type":"editorial","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"British Heart Foundation","keywords":"Medicine; Cardiology","score_opus":0.010778027051256618,"score_gpt":0.25662972423666314,"score_spread":0.24585169718540653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158518803","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022881728,0.010534416,0.000028879498,0.0022511762,0.9583514,0.0020271202,0.00024507695,0.0002262561,0.0034539828],"genre_scores_gemma":[0.008352445,0.05463002,0.00036834835,0.00038733054,0.9278676,0.00056414376,0.0004043153,0.00036157883,0.007064212],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949014,0.000339354,0.0008106354,0.0009988002,0.0020306997,0.00091906486],"domain_scores_gemma":[0.9963656,0.00058155356,0.00025420845,0.0021302614,0.00037008792,0.000298309],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0017409835,0.0005886917,0.0012808758,0.00008660641,0.00033053095,0.00022386001,0.00048277434,0.001343781,0.0001840866],"category_scores_gemma":[0.0011474715,0.00042483248,0.0010291239,0.000732336,0.00018381832,0.00007303075,0.00025046506,0.0019657137,0.00024773652],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007156945,0.00015998645,0.0014839236,0.00021857135,0.00033392195,0.000016121216,0.00016605317,0.0000012176266,0.00043943006,0.000033424272,0.9910683,0.0060075005],"study_design_scores_gemma":[0.0023880778,0.00021027411,0.012501677,0.0012100992,0.00026555714,0.0000034513125,0.0002423303,0.0000063529974,0.00025139266,0.000028589071,0.9824651,0.0004270898],"about_ca_topic_score_codex":0.0010974476,"about_ca_topic_score_gemma":0.00066181965,"teacher_disagreement_score":0.044095602,"about_ca_system_score_codex":0.00054872176,"about_ca_system_score_gemma":0.001130791,"threshold_uncertainty_score":0.9999527},"labels":[],"label_agreement":null},{"id":"W3160263194","doi":"10.1161/strokeaha.120.030790","title":"Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial","year":2021,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Institut universitaire de cardiologie et de pneumologie de Québec; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Stroke (engine); Internal medicine; Rosuvastatin; Hazard ratio; Placebo; Blood pressure; Cardiology; Confidence interval","score_opus":0.01967458312015321,"score_gpt":0.284653441711645,"score_spread":0.26497885859149184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160263194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904591,0.005954545,0.000463466,0.0007467389,0.00015365233,0.0010176752,0.00024694978,0.000010120261,0.00094777544],"genre_scores_gemma":[0.9884244,0.0015797805,0.0029371814,0.0010989198,0.00036591405,0.00009437511,0.0001235471,0.000020748692,0.005355108],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99898213,0.00011494834,0.00025097572,0.00022188565,0.00028657768,0.00014347698],"domain_scores_gemma":[0.9991405,0.00005826844,0.000097947996,0.00043820142,0.00020791909,0.000057188077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003470004,0.00009347145,0.0005457053,0.00007208837,0.00007742858,0.000013337091,0.000047074354,0.000056917474,0.000083392944],"category_scores_gemma":[0.00007192538,0.00006042172,0.00068962155,0.00025270483,0.00005802377,0.000035967285,0.000034050834,0.00010871179,2.1938818e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023058457,0.0010075377,0.026190897,0.00097011914,0.027460864,0.000046468518,0.0011065049,0.000011459038,0.07332189,0.0005957491,0.0015314425,0.8446986],"study_design_scores_gemma":[0.118034385,0.002603988,0.7834082,0.00014152964,0.007242725,0.00006099508,0.001765337,0.00015358103,0.0367492,0.00017808781,0.04936455,0.000297388],"about_ca_topic_score_codex":0.00003355797,"about_ca_topic_score_gemma":0.00002821144,"teacher_disagreement_score":0.84440124,"about_ca_system_score_codex":0.000017776327,"about_ca_system_score_gemma":0.00045081213,"threshold_uncertainty_score":0.24639262},"labels":[],"label_agreement":null},{"id":"W3160827164","doi":"10.1161/circ.143.suppl_1.p027","title":"Abstract P027: Individualized Protein Based Cardiovascular Risk Stratification: Impact On Patient And Physician Decision Making In Patients With Real World Cardiovascular Disease","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mace; Internal medicine; Cohort; Coronary artery disease; Risk assessment; Framingham Risk Score; Population; Statin; Canadian Cardiovascular Society; Retrospective cohort study; Aspirin; Disease; Physical therapy; Surgery; Conventional PCI; Myocardial infarction; Angina","score_opus":0.012896541498259096,"score_gpt":0.256215419027485,"score_spread":0.24331887752922593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160827164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935543,0.0016095603,0.0017135629,0.00002931313,0.000057322213,0.0023019337,0.000055136214,0.000056076275,0.00062282314],"genre_scores_gemma":[0.99800986,0.000040806794,0.0011060274,0.00007757684,0.00013604063,0.00015810621,0.0004135473,0.000056282097,0.0000017337836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962928,0.0003314977,0.00047947207,0.000811096,0.0017351446,0.0003499502],"domain_scores_gemma":[0.9977047,0.000055472956,0.00017995517,0.0014734928,0.00032396027,0.00026240663],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007973258,0.00032996858,0.000734977,0.00028714124,0.00017986378,0.00008750495,0.000058790865,0.00010554385,0.00002691972],"category_scores_gemma":[0.00013286064,0.00026870734,0.000842636,0.000760058,0.000045967354,0.00019536681,0.00002503655,0.00033030065,0.000008766006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010627912,0.000503523,0.5120036,0.00024314356,0.0015203598,0.00013913427,0.0001311518,0.03831661,0.000025988002,0.000044402434,0.000004998491,0.4460043],"study_design_scores_gemma":[0.0052979724,0.00012583775,0.9907648,0.0010002131,0.0007290883,0.0000018929941,0.00002896462,0.001257839,0.00011438009,0.000121437704,0.00026308146,0.00029447893],"about_ca_topic_score_codex":0.00031089623,"about_ca_topic_score_gemma":0.00003219637,"teacher_disagreement_score":0.47876123,"about_ca_system_score_codex":0.00042519066,"about_ca_system_score_gemma":0.00042751132,"threshold_uncertainty_score":0.9999765},"labels":[],"label_agreement":null},{"id":"W3161040503","doi":"10.1161/circ.142.suppl_3.15281","title":"Abstract 15281: Triglyceride Levels and Cardiovascular Outcomes After Acute Coronary Syndrome: Insights From the Odyssey Outcomes Trial","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Mace; Internal medicine; Myocardial infarction; Acute coronary syndrome; Cardiology; Placebo; Coronary artery disease; Dyslipidemia; Percutaneous coronary intervention; Disease","score_opus":0.03463394646498135,"score_gpt":0.26453282157979574,"score_spread":0.22989887511481438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161040503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891934,0.0044609415,0.0006560793,0.0031805048,0.0003857383,0.0018635663,0.000054638273,0.000104188155,0.00010094926],"genre_scores_gemma":[0.9967166,0.00009567061,0.0001327683,0.0023829502,0.00040532634,0.000114729526,0.00009227297,0.000045356188,0.000014330016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977004,0.00013773513,0.00048455235,0.00053738075,0.00089142635,0.000248526],"domain_scores_gemma":[0.9985927,0.0001284744,0.00010143542,0.00084334577,0.00007833969,0.0002557459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032869718,0.00028423674,0.00093408866,0.000046783516,0.00016077068,0.00006256076,0.00010984876,0.00018861481,0.00012559893],"category_scores_gemma":[0.00016862144,0.00018314275,0.00089835544,0.0001813899,0.000072148985,0.00021680316,0.0000629918,0.0003082957,0.000058219528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00608383,0.00014279755,0.9482284,0.00019540028,0.01125147,0.0014434017,0.0019797587,0.00014241271,0.0005264049,0.00009812029,0.00018760539,0.029720375],"study_design_scores_gemma":[0.02062504,0.00008711593,0.9755068,0.00004310901,0.001291903,0.00008672415,0.00010391508,0.00009869333,0.000034338686,0.00013519418,0.0017768465,0.0002103412],"about_ca_topic_score_codex":0.00031495976,"about_ca_topic_score_gemma":0.0000107531105,"teacher_disagreement_score":0.029510034,"about_ca_system_score_codex":0.000069212045,"about_ca_system_score_gemma":0.00013031544,"threshold_uncertainty_score":0.74683446},"labels":[],"label_agreement":null},{"id":"W3161167603","doi":"","title":"A novel mutation in a young patient underwent coronary arterty bypass grafting with familial hypercholesterolemia","year":2014,"lang":"en","type":"article","venue":"Experimental & clinical cardiology/Experimental and clinical cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Bypass grafting; Mutation; Internal medicine; Cardiology; Grafting; Surgery; Artery; Cholesterol; Genetics; Gene","score_opus":0.036319133199975984,"score_gpt":0.3530879885098273,"score_spread":0.3167688553098513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161167603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899111,0.0020375745,0.0015237274,0.00032121607,0.0014828142,0.0015788963,0.000024543984,0.00013158875,0.0029885853],"genre_scores_gemma":[0.99369544,0.00020957795,0.001158864,0.0025660035,0.0017539893,0.00035255865,0.00015013841,0.00008500865,0.000028440829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923503,0.0019081618,0.0023088641,0.0018290519,0.00061008945,0.0009935576],"domain_scores_gemma":[0.9971736,0.0006457158,0.000365387,0.0009322615,0.00011439362,0.00076860876],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027726216,0.00069390476,0.0029347138,0.00014278342,0.00023551192,0.000036913054,0.00023345799,0.000950701,0.000022528877],"category_scores_gemma":[0.0002907034,0.0005361157,0.0012616739,0.00021106708,0.0014590075,0.00016754025,0.00042393632,0.0014347122,0.000037940295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034213923,0.0010334619,0.97695,0.000033036333,0.0011249583,0.00065639603,0.00035468716,0.000047597547,0.0065788077,0.00016865614,0.000116252566,0.009514794],"study_design_scores_gemma":[0.01713772,0.014910127,0.95499307,0.00012660796,0.00030305528,0.0058788788,0.0037755638,0.00037814604,0.00041305073,0.000036488713,0.001372403,0.0006748949],"about_ca_topic_score_codex":0.00031911957,"about_ca_topic_score_gemma":0.000041695268,"teacher_disagreement_score":0.021956895,"about_ca_system_score_codex":0.0003226341,"about_ca_system_score_gemma":0.00018555648,"threshold_uncertainty_score":0.999709},"labels":[],"label_agreement":null},{"id":"W3161603870","doi":"10.1016/j.bbalip.2021.158968","title":"Substantial PCSK9 inactivation in β-cells does not modify glucose homeostasis or insulin secretion in mice","year":2021,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Pfizer Canada; Canada Excellence Research Chairs, Government of Canada","keywords":"PCSK9; Internal medicine; Endocrinology; Kexin; Glucose homeostasis; LDL receptor; Insulin; Biology; Proprotein convertase; Cholesterol; Chemistry; Insulin resistance; Lipoprotein; Medicine","score_opus":0.01181756640440704,"score_gpt":0.25339730985650727,"score_spread":0.24157974345210023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161603870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963081,0.0013032149,0.00017207733,0.0012051068,0.00019274518,0.00052257715,0.000074723765,0.000024794688,0.000196659],"genre_scores_gemma":[0.99378574,0.004383122,0.0007103893,0.00060036924,0.0001452029,0.000031983007,0.0002878405,0.000032893047,0.000022488282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976876,0.00044451046,0.00058051513,0.0006563738,0.00024575507,0.00038524577],"domain_scores_gemma":[0.99901724,0.00007425214,0.00019597913,0.00045455134,0.0001264078,0.00013159163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044009945,0.000299238,0.00077168684,0.0002727441,0.000044373115,0.00001804797,0.000116737385,0.00040869732,0.000027678818],"category_scores_gemma":[0.00007493416,0.00023121714,0.0002395754,0.0006362763,0.00019378026,0.00008255267,0.000108288135,0.00040509328,0.0000034115594],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010955657,0.0005821553,0.00005253067,0.0003534313,0.00009335073,0.000059647675,0.00034537842,0.0000028549412,0.99197334,0.0001168812,0.000008169987,0.005316707],"study_design_scores_gemma":[0.0033120262,0.00054837734,0.0053570843,0.00014336483,0.000101760794,0.000016287888,0.00041854358,0.00012256707,0.9893709,0.00010078675,0.00024184414,0.00026649775],"about_ca_topic_score_codex":0.00048285542,"about_ca_topic_score_gemma":0.0000731137,"teacher_disagreement_score":0.0053045535,"about_ca_system_score_codex":0.00007923504,"about_ca_system_score_gemma":0.0003383523,"threshold_uncertainty_score":0.9428761},"labels":[],"label_agreement":null},{"id":"W3162547924","doi":"10.1161/circ.142.suppl_3.14407","title":"Abstract 14407: The Longer-term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia","year":2020,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Placebo; PCSK9; Internal medicine; Pediatrics; LDL receptor; Gastroenterology; Lipoprotein; Cholesterol","score_opus":0.014314383053221576,"score_gpt":0.2342606338725273,"score_spread":0.21994625081930572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162547924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984555,0.00020709183,0.00011982986,0.00022081002,0.000023495295,0.0007964969,0.000004706443,0.000013589216,0.00015845534],"genre_scores_gemma":[0.99960196,0.00002366054,0.000033761346,0.00018613685,0.00009214679,0.000006763901,0.000041938703,0.000012653181,9.536499e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917215,0.000036403046,0.00021515493,0.00017341318,0.00029385963,0.00010904593],"domain_scores_gemma":[0.9995569,0.00002224793,0.00006696749,0.00022203247,0.00006108988,0.000070782175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016617724,0.00008509964,0.00021885552,0.000028492354,0.000037711285,0.000007779761,0.00003768199,0.000055865217,0.0000068849886],"category_scores_gemma":[0.00004444574,0.000055694465,0.00004595438,0.00013064843,0.000043747867,0.00006181115,0.000015382635,0.00014348316,0.0000036048252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008121866,0.00010262068,0.8973995,0.00025709465,0.000053881548,0.000010947397,0.0015797777,0.00017706465,0.000393546,0.000013492631,0.000005361639,0.09919455],"study_design_scores_gemma":[0.004517803,0.00014534825,0.9948665,0.000120509605,0.00005473999,0.0000063233515,0.00005838572,0.000088137516,0.00003318886,0.0000031338845,0.000048900507,0.000057055244],"about_ca_topic_score_codex":0.000028923978,"about_ca_topic_score_gemma":0.0000061307933,"teacher_disagreement_score":0.09913749,"about_ca_system_score_codex":0.000045407134,"about_ca_system_score_gemma":0.000050427338,"threshold_uncertainty_score":0.22711544},"labels":[],"label_agreement":null},{"id":"W3165267576","doi":"10.1161/jaha.120.019286","title":"Sex Differences in the Presentation, Treatment, and Outcome of Patients With Familial Hypercholesterolemia","year":2021,"lang":"en","type":"letter","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; McGill University Health Centre; University of Ottawa; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Presentation (obstetrics); Library science; Medicine; Thais; Gerontology; Family medicine; History; Sociology; Demography; Surgery","score_opus":0.021216804912060322,"score_gpt":0.27809148902711317,"score_spread":0.2568746841150529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165267576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8961776,0.00010450084,0.0000032018745,0.103262946,0.000096360964,0.0003172924,0.000020665591,0.0000012479372,0.000016174783],"genre_scores_gemma":[0.9337558,0.0001756763,0.00008814345,0.06460582,0.0010405806,0.000008745474,0.000015942307,0.000015238966,0.0002940679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768424,0.0007737791,0.00043972806,0.00010414177,0.0008591944,0.00013894477],"domain_scores_gemma":[0.9983703,0.00023702074,0.0009012639,0.00022658642,0.00023971249,0.000025107764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005981218,0.0001245212,0.00088459015,0.00007713327,0.00004479315,0.0000230864,0.000087468135,0.00009017209,0.0000021530861],"category_scores_gemma":[0.0001800423,0.000056354067,0.00028163425,0.00020551009,0.000056753983,0.000049206043,0.000015180938,0.00060346874,2.101324e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046117853,0.00007014797,0.9865219,0.000040783212,0.00030747853,0.000007791354,0.00049527123,8.2898396e-7,0.000008705328,7.887136e-8,0.0113399485,0.001160973],"study_design_scores_gemma":[0.0012044258,0.00065741903,0.9881709,0.00010416857,0.00040184672,0.000027460137,0.00033522284,0.0000014589741,0.000014367658,0.0000046095843,0.009027844,0.000050251107],"about_ca_topic_score_codex":0.000729778,"about_ca_topic_score_gemma":0.00005774125,"teacher_disagreement_score":0.038657133,"about_ca_system_score_codex":0.0003544388,"about_ca_system_score_gemma":0.00016627976,"threshold_uncertainty_score":0.2621805},"labels":[],"label_agreement":null},{"id":"W3165297872","doi":"10.17816/rcf19137-46","title":"Hypolipidemic drugs inhibiting the proprotein convertase of subtilisin/kexin type 9 (PCSK9): monoclonal antibodies, antisense oligonucleotides, small interfering ribonucleic acids","year":2021,"lang":"en","type":"article","venue":"Reviews on Clinical Pharmacology and Drug Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PCSK9; Proprotein convertase; Kexin; Alirocumab; LDL receptor; Evolocumab; Pharmacology; Chemistry; Subtilisin; Monoclonal antibody; Cholesterol; Lipoprotein; Biochemistry; Antibody; Biology; Enzyme; Immunology","score_opus":0.09023443268592535,"score_gpt":0.39690194238444304,"score_spread":0.3066675096985177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165297872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89650697,0.097122744,0.000015911148,0.003685028,0.0007936223,0.0015613552,0.000011665873,0.00004190905,0.00026078417],"genre_scores_gemma":[0.7497785,0.23604867,0.0006134194,0.012238922,0.0010125804,0.00004494577,0.00002107038,0.000041801173,0.00020007831],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952218,0.0019679007,0.0015037798,0.0006268148,0.00024097518,0.00043876132],"domain_scores_gemma":[0.9976927,0.0007638357,0.00045913534,0.00056784786,0.00023842798,0.000278057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005508885,0.00033734873,0.001549743,0.00006769142,0.00019020688,0.000018021925,0.0001727015,0.00020590055,0.00021898597],"category_scores_gemma":[0.0005910299,0.00021605047,0.00063354784,0.00027366058,0.00047538936,0.000057025623,0.00012843107,0.0010533982,0.000045801058],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004108109,0.0013831919,0.023189783,0.0017369627,0.0014043016,0.0003448781,0.0008246439,0.0000051117595,0.07092999,0.00036506596,0.007587564,0.8881204],"study_design_scores_gemma":[0.01777871,0.0027261074,0.026892796,0.0031107527,0.0011375645,0.0006161404,0.00042868505,0.00047778932,0.22148752,0.000416419,0.72398996,0.00093754206],"about_ca_topic_score_codex":0.00008472237,"about_ca_topic_score_gemma":0.000012761267,"teacher_disagreement_score":0.88718283,"about_ca_system_score_codex":0.00003916383,"about_ca_system_score_gemma":0.00032811688,"threshold_uncertainty_score":0.88102823},"labels":[],"label_agreement":null},{"id":"W3167236341","doi":"10.1007/s12265-021-10144-6","title":"A Less than Provocative Approach for the Primary Prevention of CAD","year":2021,"lang":"en","type":"review","venue":"Journal of Cardiovascular Translational Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Canada Foundation for Innovation","keywords":"Medicine; Coronary artery disease; Primary prevention; Risk stratification; Internal medicine; CAD; Statin; PCSK9; Cholesterol; Risk assessment; Clinical trial; Blood cholesterol; Lipoprotein; Cardiology; Bioinformatics; Intensive care medicine; Disease; Biology; LDL receptor; Biochemistry","score_opus":0.2412102712413681,"score_gpt":0.44418474492325727,"score_spread":0.20297447368188917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167236341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010659827,0.89460737,0.10020831,0.00011289494,0.00012180148,0.004157888,0.00005360313,0.0000039999563,0.0007234588],"genre_scores_gemma":[0.00017298343,0.99021846,0.00701874,0.000006184574,0.0016599788,0.000397041,0.00021754214,0.00007847651,0.0002306142],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99048257,0.0020602418,0.0014724702,0.00040326695,0.0051530967,0.00042833234],"domain_scores_gemma":[0.9933373,0.0010254589,0.000522161,0.0009850378,0.003932774,0.00019727564],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.020104276,0.00031779084,0.0037852712,0.00056748244,0.00021216155,0.00004589099,0.00045317403,0.00039793804,0.000009034799],"category_scores_gemma":[0.00056723494,0.00018953207,0.013264841,0.0010628086,0.0002496001,0.00012693519,0.000051919673,0.0016801793,8.327442e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013214027,0.0002396549,0.0000024128149,0.036886934,0.024711741,0.00003135071,0.000121034376,0.00021763345,0.0000010127173,0.0003205101,0.00012498171,0.9372106],"study_design_scores_gemma":[0.0019815604,0.00044002107,0.00012342373,0.012401872,0.012536426,0.0015678545,0.00033153957,0.000034888388,0.000011878666,0.000108489345,0.9702853,0.00017677242],"about_ca_topic_score_codex":0.000033675566,"about_ca_topic_score_gemma":0.0000014815661,"teacher_disagreement_score":0.9701603,"about_ca_system_score_codex":0.00028524725,"about_ca_system_score_gemma":0.00861955,"threshold_uncertainty_score":0.99700063},"labels":[],"label_agreement":null},{"id":"W3168150447","doi":"10.3390/medicina57060616","title":"Cognition, Statins, and Cholesterol in Elderly Ischemic Stroke Patients: A Neurologist’s Perspective","year":2021,"lang":"en","type":"article","venue":"Medicina","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perspective (graphical); Ischemic stroke; Stroke (engine); Medicine; Cognition; Cholesterol; Internal medicine; Cardiology; Psychiatry; Ischemia; Computer science; Engineering; Artificial intelligence","score_opus":0.010320811751414312,"score_gpt":0.25752886573702954,"score_spread":0.24720805398561524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168150447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98679334,0.00226082,0.00012227027,0.0037726108,0.0001032498,0.00040879904,0.000017177796,0.00002870054,0.0064930366],"genre_scores_gemma":[0.9958036,0.00049460644,0.00015353184,0.003058523,0.00014667021,0.000024829917,0.000050365623,0.000015518353,0.000252369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878234,0.00009244322,0.00020918736,0.00032593773,0.00036448924,0.00022562912],"domain_scores_gemma":[0.99925697,0.000034035416,0.000044493874,0.00024871904,0.00026848714,0.00014732577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002471149,0.00011731974,0.00031824198,0.000074783355,0.000039687147,0.000010196089,0.000029784725,0.00007558865,0.00005738785],"category_scores_gemma":[0.0004674532,0.000099352146,0.00005850455,0.00015868196,0.000085651875,0.00005524906,0.000030879182,0.0003156045,0.000007994538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009768648,0.0022200323,0.5823789,0.001471308,0.0006638459,0.0028172089,0.015561969,0.0000029911523,0.0058102678,0.00041791995,0.0107643865,0.37691426],"study_design_scores_gemma":[0.013880728,0.0018977849,0.9587733,0.00035946263,0.00025313697,0.00032849147,0.00778636,0.000041557196,0.0019848049,0.00016032059,0.0143243,0.00020974857],"about_ca_topic_score_codex":0.0003692159,"about_ca_topic_score_gemma":0.00016109686,"teacher_disagreement_score":0.3767045,"about_ca_system_score_codex":0.00007275108,"about_ca_system_score_gemma":0.00016491381,"threshold_uncertainty_score":0.4051463},"labels":[],"label_agreement":null},{"id":"W3168490200","doi":"10.1096/fasebj.24.1_supplement.593.5","title":"Impaired Arteriolar Dilation in a Mouse Model of Familial Hypercholesterolemia: Impact of Chronic Exercise and Anti‐Cholesterol Therapy","year":2010,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Society for Exercise Physiology","funders":"","keywords":"Dilator; Medicine; Inflammation; Simvastatin; Internal medicine; Endothelial dysfunction; Oxidative stress; Endocrinology; Probucol; Dyslipidemia; Antioxidant; Cholesterol; Obesity; Chemistry; Biochemistry","score_opus":0.01802680795968049,"score_gpt":0.27007943601430046,"score_spread":0.25205262805462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168490200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983756,0.00070806453,0.00031067195,0.00008839561,0.000054360462,0.00042694306,0.000018091727,0.000006718271,0.000011189212],"genre_scores_gemma":[0.9974598,0.0021599142,0.00012800258,0.00003379409,0.00017700413,0.000005675045,0.0000028415832,0.000019346917,0.00001361146],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99886525,0.000085713495,0.0004016487,0.00011856398,0.00031604533,0.0002127894],"domain_scores_gemma":[0.9991993,0.000014890037,0.00018345474,0.00037807596,0.000093450944,0.0001308416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010484041,0.00013556768,0.00044695524,0.00012918112,0.000059415022,0.000017602484,0.00010480589,0.000111932655,0.000011633684],"category_scores_gemma":[0.00001860142,0.00007834454,0.00026137757,0.000092050286,0.00010805908,0.00014019312,0.000022994842,0.00063097326,6.44017e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003803438,0.00012861412,0.028528638,0.000047185953,0.00007420474,0.000004008894,0.0008563712,0.000771323,0.92912775,0.0000017025313,0.0000038349335,0.040076043],"study_design_scores_gemma":[0.011128459,0.001308209,0.6682574,0.00044778734,0.00014024197,0.00070771715,0.0001841596,0.027682021,0.28983608,0.00012398082,0.000005032498,0.00017888508],"about_ca_topic_score_codex":0.00023311931,"about_ca_topic_score_gemma":0.000039438823,"teacher_disagreement_score":0.6397288,"about_ca_system_score_codex":0.00006621151,"about_ca_system_score_gemma":0.00033047175,"threshold_uncertainty_score":0.31947976},"labels":[],"label_agreement":null},{"id":"W3169931362","doi":"10.3389/fmed.2021.656694","title":"Association of Preadmission Statin Use and Mortality in Critically Ill Patients: A Meta-Analysis of Cohort Studies","year":2021,"lang":"en","type":"article","venue":"Frontiers in Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Meta-analysis; Observational study; Internal medicine; Cohort study; Mechanical ventilation; Subgroup analysis; Confidence interval; MEDLINE; Statin","score_opus":0.05112177066587788,"score_gpt":0.34290818394585904,"score_spread":0.29178641327998117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169931362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98351556,0.013123072,0.0009303922,0.0017579946,0.00012085808,0.00043306628,0.000035032223,0.0000048420184,0.00007921061],"genre_scores_gemma":[0.9853511,0.004690921,0.008375625,0.0010905225,0.00003215254,0.000041038344,0.00013654838,0.000011957099,0.00027017223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977047,0.00034402538,0.0007474336,0.0002564992,0.0007910576,0.00015629473],"domain_scores_gemma":[0.9974657,0.00016498652,0.00019395548,0.0003290593,0.0017559316,0.00009033346],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002094677,0.00011074715,0.0022360443,0.00032202946,0.000012697138,0.000002003554,0.000030663763,0.000082590894,0.000048315334],"category_scores_gemma":[0.0118283685,0.00007839042,0.00026247095,0.0008558132,0.000096625125,0.00006792054,0.00003138533,0.0001439979,4.447792e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047984606,0.00018116288,0.91408724,0.0003430025,0.0822714,0.000020954112,0.0008347544,0.000011510589,0.0000453039,0.000013412903,0.0014514466,0.0006918606],"study_design_scores_gemma":[0.0015340983,0.00014817066,0.87787896,0.00009616637,0.11772806,4.4406144e-7,0.0018892561,0.00022108102,0.00018904493,0.0001051517,0.0001568075,0.000052782558],"about_ca_topic_score_codex":0.0008252068,"about_ca_topic_score_gemma":0.0003328391,"teacher_disagreement_score":0.036208272,"about_ca_system_score_codex":0.00016380477,"about_ca_system_score_gemma":0.00008673368,"threshold_uncertainty_score":0.9964954},"labels":[],"label_agreement":null},{"id":"W3170415721","doi":"10.1097/hco.0000000000000889","title":"Optimal medical therapy after coronary artery bypass grafting: a primer for surgeons","year":2021,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Manitoba","funders":"","keywords":"Medicine; Antithrombotic; Mace; Coronary artery disease; Bypass grafting; Internal medicine; Cardiology; Medical therapy; Artery; Diabetes mellitus; Statin; Surgery; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.11384789398805731,"score_gpt":0.4124701925396091,"score_spread":0.29862229855155176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170415721","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008407191,0.9842544,0.0010515152,0.00018830989,0.011066685,0.0031158417,0.00013135573,0.000052909534,0.000054873966],"genre_scores_gemma":[0.0000795753,0.98870105,0.00016310242,0.00007828319,0.004679094,0.0039573372,0.0022139193,0.00010156004,0.000026110481],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954072,0.0009879268,0.0011850838,0.0010200918,0.00062804145,0.00077163486],"domain_scores_gemma":[0.9978231,0.0004200746,0.00021978267,0.0009875109,0.00017295023,0.00037658957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018615497,0.0005967036,0.004723065,0.00031388248,0.00005986423,0.000015557196,0.00022956247,0.0010330501,0.00015438693],"category_scores_gemma":[0.000305357,0.00045930504,0.0031340015,0.0003260002,0.0001643426,0.000034336674,0.00016402452,0.0012497443,0.000027197148],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009683302,0.00013354183,0.00075902924,0.012752535,0.0013898804,0.00016730293,0.000025890726,9.747088e-7,2.1303945e-8,0.000052597406,0.0057258382,0.97889555],"study_design_scores_gemma":[0.0020489898,0.00023155316,0.000751585,0.015501072,0.00042627857,0.0035229882,0.000013101061,0.0000069062316,7.502771e-8,0.0000052053047,0.9771028,0.00038943128],"about_ca_topic_score_codex":0.000010060411,"about_ca_topic_score_gemma":0.0000010108984,"teacher_disagreement_score":0.97850615,"about_ca_system_score_codex":0.00023950136,"about_ca_system_score_gemma":0.0025958319,"threshold_uncertainty_score":0.99978584},"labels":[],"label_agreement":null},{"id":"W3170428065","doi":"10.1155/2021/9913969","title":"Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry","year":2021,"lang":"en","type":"article","venue":"Journal of Lipids","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute for Medical Research Development","keywords":"Medicine; Familial hypercholesterolemia; Pediatrics; Internal medicine; Cholesterol","score_opus":0.030734842755765473,"score_gpt":0.2705910353737385,"score_spread":0.23985619261797306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170428065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98905706,0.0018050006,0.00011142118,0.007072468,0.0008110075,0.00010578698,0.000007822382,0.000006485165,0.0010229683],"genre_scores_gemma":[0.99107015,0.00069579785,0.001042663,0.0022986569,0.004437139,0.000002057262,0.0000049342434,0.000021987795,0.0004266187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982534,0.00018034338,0.0005166857,0.00015490233,0.0006705701,0.00022407236],"domain_scores_gemma":[0.99898237,0.000097418306,0.00014068426,0.00047431557,0.00014696203,0.00015825566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001140906,0.00011933406,0.00047737098,0.000056464407,0.00005799732,0.000039268423,0.00017027564,0.00013932983,0.000102734724],"category_scores_gemma":[0.00040681672,0.000077442186,0.00040570064,0.00021515494,0.000045523433,0.00009690217,0.00005097471,0.0008760141,0.000018788221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014776852,0.00052400323,0.8305562,0.00029762814,0.0010386354,0.004770451,0.0039009815,0.000041207895,0.038654994,0.00016576893,0.059587326,0.058985107],"study_design_scores_gemma":[0.005592597,0.00028616888,0.8638632,0.0008450476,0.0002267346,0.0019215995,0.0019650846,0.000014949796,0.002304908,0.00016980116,0.12267439,0.00013550636],"about_ca_topic_score_codex":0.00019304348,"about_ca_topic_score_gemma":0.00007039427,"teacher_disagreement_score":0.06308706,"about_ca_system_score_codex":0.00013969865,"about_ca_system_score_gemma":0.0003756236,"threshold_uncertainty_score":0.38058943},"labels":[],"label_agreement":null},{"id":"W3171018091","doi":"10.1016/j.jacl.2021.05.006","title":"ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia","year":2021,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Institut de Recherche Clinique De Montréal; Fondation Leducq; AstraZeneca; Amgen","keywords":"Mace; Medicine; Internal medicine; Myocardial infarction; Genotype; Coronary artery disease; Cohort; Unstable angina; Genome-wide association study; Genotyping; Population; Hazard ratio; Single-nucleotide polymorphism; Genetics; Confidence interval; Gene; Percutaneous coronary intervention; Biology","score_opus":0.03504758172690741,"score_gpt":0.3235173776024441,"score_spread":0.28846979587553667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171018091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99459964,0.0014518893,0.00032698936,0.000518962,0.002527147,0.00027504674,0.000004258728,0.000008328201,0.00028775053],"genre_scores_gemma":[0.99161977,0.0006023432,0.0017995208,0.0013691882,0.00449882,0.000003370726,0.000013141592,0.000029091503,0.00006473786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99588346,0.0009515901,0.0015458411,0.00032190155,0.00094824645,0.00034895414],"domain_scores_gemma":[0.9976538,0.00019620855,0.00036431514,0.00062928686,0.00078142097,0.00037499925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003369515,0.00017166063,0.0017008028,0.00012485133,0.00003079275,0.0000051587067,0.00014395652,0.0003607563,0.0000430681],"category_scores_gemma":[0.0015822663,0.00012044629,0.0010753996,0.00025276555,0.000094636875,0.00010364561,0.00007117892,0.0011368807,0.000016031338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022798742,0.0008150581,0.9308673,0.000081093116,0.0013074398,0.00024743436,0.0000396418,0.00006516266,0.000009677868,0.000008514783,0.00026004287,0.064018756],"study_design_scores_gemma":[0.016115349,0.002560647,0.9533098,0.00020695798,0.00051379285,0.00042628337,0.000026749785,0.0000048070733,0.000018475954,0.00005057853,0.026662745,0.00010382144],"about_ca_topic_score_codex":0.000020631733,"about_ca_topic_score_gemma":0.000020614307,"teacher_disagreement_score":0.06391493,"about_ca_system_score_codex":0.000079536934,"about_ca_system_score_gemma":0.0009800987,"threshold_uncertainty_score":0.49392444},"labels":[],"label_agreement":null},{"id":"W3172189498","doi":"10.1096/fasebj.2021.35.s1.03146","title":"Surf4 Knockdown Protects Against Cardiovascular Disease","year":2021,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; National Natural Science Foundation of China","keywords":"LDL receptor; PCSK9; Endocrinology; Very low-density lipoprotein; Internal medicine; Apolipoprotein B; Kexin; Secretion; Chemistry; Lipoprotein; Cholesterol; Triglyceride; Biology; Medicine","score_opus":0.01882192517348348,"score_gpt":0.2401969737385184,"score_spread":0.22137504856503493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172189498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94370675,0.04544064,0.002090098,0.0036806345,0.00054817024,0.00070868357,0.000010957143,0.00006201772,0.003752062],"genre_scores_gemma":[0.99239266,0.00268264,0.0003469465,0.0013238075,0.0020952832,0.000027468532,0.00001436207,0.000039469982,0.0010773609],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748605,0.00042338757,0.00029183624,0.0002510735,0.001122775,0.00042486933],"domain_scores_gemma":[0.9977737,0.000023925622,0.00007163663,0.0011807085,0.0003252395,0.0006247899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017613802,0.00017762714,0.00044807713,0.000054600474,0.00045850207,0.00009276413,0.00015086771,0.000062704414,0.00017187325],"category_scores_gemma":[0.0002975511,0.00010878914,0.001422968,0.00029213965,0.00006989054,0.00008145418,0.00007440086,0.00073301257,0.000090031135],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012184652,0.0010316414,0.007595311,0.0012989668,0.019919302,0.05345183,0.0012668448,0.004943442,0.0642008,0.0006092708,0.0093774935,0.83508664],"study_design_scores_gemma":[0.01794814,0.00060965715,0.10287576,0.0021840085,0.006200203,0.039952543,0.0020033203,0.0013284027,0.1950859,0.0017011702,0.6285964,0.0015144452],"about_ca_topic_score_codex":0.000028565584,"about_ca_topic_score_gemma":0.0000025291572,"teacher_disagreement_score":0.8335722,"about_ca_system_score_codex":0.00012895673,"about_ca_system_score_gemma":0.0010928223,"threshold_uncertainty_score":0.44362926},"labels":[],"label_agreement":null},{"id":"W3172790696","doi":"10.1016/j.atherosclerosis.2021.06.006","title":"Paternal inheritance predicts earlier cardiovascular event onset in patients with familial hypercholesterolemia","year":2021,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"Institut de Recherche Clinique De Montréal; Fondation Leducq; AstraZeneca; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Myocardial infarction; Hazard ratio; Cardiology; Proportional hazards model; Offspring; Pregnancy; Cholesterol; Genetics; Biology; Confidence interval","score_opus":0.01204821125253905,"score_gpt":0.21418865148756447,"score_spread":0.20214044023502542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172790696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976092,0.0009332079,0.00024423344,0.00014909077,0.0001693946,0.000631056,0.000042030857,0.00005220541,0.00016955388],"genre_scores_gemma":[0.9978314,0.00028840746,0.00070526527,0.0006374065,0.00016816096,0.000100129735,0.00006105862,0.00006567619,0.00014248784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973332,0.00018584605,0.00035845512,0.00058059423,0.0010622232,0.00047968142],"domain_scores_gemma":[0.9984651,0.000013340038,0.000055464283,0.0010246295,0.00020816334,0.0002333048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004238103,0.00025727254,0.00065492396,0.000061660794,0.00007455698,0.000034818597,0.00010839435,0.00015948802,0.000050044495],"category_scores_gemma":[0.000043812273,0.00021008076,0.00043802883,0.0003418875,0.000063830885,0.0001225209,0.00007249678,0.00035469612,0.00003823718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021056023,0.00046615547,0.9797689,0.00011254991,0.00050146616,0.000051859508,0.00027800008,0.00008017024,0.00033652663,0.000003843136,0.00006116902,0.018128827],"study_design_scores_gemma":[0.0072372714,0.0004255869,0.987262,0.0005631669,0.00019464709,0.000021296857,0.000070402755,0.000015909338,0.0010344038,0.0000064718142,0.0029529054,0.00021593695],"about_ca_topic_score_codex":0.0004174186,"about_ca_topic_score_gemma":0.00009404296,"teacher_disagreement_score":0.017912889,"about_ca_system_score_codex":0.00022627896,"about_ca_system_score_gemma":0.00022086264,"threshold_uncertainty_score":0.85668445},"labels":[],"label_agreement":null},{"id":"W3173111500","doi":"10.1016/j.jcjd.2021.06.002","title":"Impact of the 2016 Canadian Lipid Guidelines on Daily Practice at a Community Hospital","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Horizon Health Network; Moncton Hospital","funders":"","keywords":"Medicine; Dyslipidemia; Guideline; Triglyceride; Diabetes mellitus; Internal medicine; Apolipoprotein B; Myocardial infarction; Disease; Cholesterol; Physical therapy; Endocrinology; Pathology","score_opus":0.023120538905095214,"score_gpt":0.2909170837278212,"score_spread":0.267796544822726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173111500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97914034,0.004266207,5.0826395e-7,0.012384667,0.0004615605,0.00017085641,0.00007850193,0.0000021026342,0.003495266],"genre_scores_gemma":[0.9954762,0.00006578491,0.00015328322,0.0032638086,0.0005473385,0.0000018508283,0.000007662752,0.000022242893,0.00046182744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827844,0.0003683833,0.00044902108,0.00008970604,0.00034224623,0.0004722333],"domain_scores_gemma":[0.99573416,0.00012919166,0.0002887795,0.00069221994,0.0016980713,0.0014575776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013085499,0.00014081573,0.00042958744,0.00018528383,0.0003416525,0.000033084452,0.00024130815,0.000098318014,0.00020358154],"category_scores_gemma":[0.0045990865,0.00009018922,0.00061656773,0.0003069545,0.00009957272,0.0001249556,0.000025069516,0.00061501894,0.000010280987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003467474,0.00023419189,0.6498811,0.00025138695,0.002978395,0.0005822915,0.0021851636,0.00012611841,0.0012480534,0.0001852856,0.31481677,0.027476555],"study_design_scores_gemma":[0.0012397876,0.0012350207,0.8291463,0.00082899194,0.000368706,0.0002178949,0.0010667345,0.0000072949747,0.0014208733,0.000047526177,0.16426012,0.00016074652],"about_ca_topic_score_codex":0.43033743,"about_ca_topic_score_gemma":0.4763185,"teacher_disagreement_score":0.1792652,"about_ca_system_score_codex":0.0010583106,"about_ca_system_score_gemma":0.015998319,"threshold_uncertainty_score":0.98958004},"labels":[],"label_agreement":null},{"id":"W3174025339","doi":"10.1016/j.clinbiochem.2021.06.004","title":"Laboratory reporting of framingham risk score increases statin prescriptions in at-risk patients","year":2021,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Libin Cardiovascular Institute of Alberta; Alberta Health; University of Calgary","funders":"Alberta Health Services","keywords":"Medical prescription; Medicine; Statin; Dyslipidemia; Framingham Risk Score; Internal medicine; Medical record; Psychological intervention; Relative risk; Physical therapy; Confidence interval; Pharmacology; Disease","score_opus":0.029993207153986727,"score_gpt":0.33684226453386135,"score_spread":0.3068490573798746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174025339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672115,0.0022717507,0.00001997847,0.000040335948,0.000104889186,0.00019954905,0.00025067216,0.000026342186,0.00036530825],"genre_scores_gemma":[0.99692374,0.00085935614,0.0013600407,0.00014246812,0.000239651,0.00001865254,0.00022649675,0.000018097446,0.00021147424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967751,0.00022297712,0.0019566186,0.00045868955,0.00037272152,0.00021388677],"domain_scores_gemma":[0.99689543,0.0002225475,0.0013396911,0.00084298145,0.0004649263,0.00023439217],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001981007,0.00012618542,0.00061784236,0.000023699891,0.000063323365,0.0000067350643,0.00006449693,0.00025090302,0.00009516623],"category_scores_gemma":[0.032780267,0.00011683434,0.00033643452,0.0002706207,0.00013470507,0.000025058816,0.00013321926,0.0005633664,0.0000067444744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008371925,0.0007901133,0.9886548,0.00042168392,0.000102834674,0.00009353234,0.00002732047,0.0000015995868,0.0020700775,8.7732894e-7,0.00058996613,0.0071635037],"study_design_scores_gemma":[0.0020088672,0.00011458266,0.9227031,0.0004835506,0.00017099731,0.00000950489,0.000149704,0.0000186631,0.07331558,0.000023605879,0.0008854991,0.00011636333],"about_ca_topic_score_codex":0.00034157507,"about_ca_topic_score_gemma":0.000033885215,"teacher_disagreement_score":0.07124551,"about_ca_system_score_codex":0.00008630676,"about_ca_system_score_gemma":0.000666232,"threshold_uncertainty_score":0.975367},"labels":[],"label_agreement":null},{"id":"W3174110496","doi":"10.1161/atvb.36.suppl_1.262","title":"Abstract 262: Lipoprotein(a) Stimulates Pro-Inflammatory Phenotypes in Vascular Cells: Demonstration of a Role for the Lysine-Binding Properties of Apolipoprotein(a)","year":2016,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of Windsor","funders":"","keywords":"Apolipoprotein B; Lipoprotein(a); Lipoprotein; Cell adhesion molecule; Phenotype; Monocyte; Umbilical vein; Inflammation; U937 cell; Cell adhesion; Biology; Cell; In vitro; Molecular biology; Cell biology; Chemistry; Immunology; Biochemistry; Cholesterol; Gene","score_opus":0.035096569555166,"score_gpt":0.26425399885582823,"score_spread":0.22915742930066224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174110496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99384934,0.001687846,0.001399126,0.00046576138,0.000085066495,0.0024318846,0.000025917154,0.000029396771,0.000025693354],"genre_scores_gemma":[0.9955299,0.003154109,0.00065428234,0.00004402949,0.00013687434,0.0004301349,0.000008607778,0.00003964866,0.000002427239],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978827,0.00016463162,0.000769735,0.0004728704,0.00028395155,0.0004260899],"domain_scores_gemma":[0.99858826,0.00012034889,0.0003035628,0.00068329414,0.00020798502,0.000096572025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015645727,0.0002915947,0.0008994928,0.00017186426,0.00014085861,0.00001722337,0.00016865128,0.00025724174,0.000027797587],"category_scores_gemma":[0.0001129171,0.0001610773,0.00052456476,0.00018497938,0.00041219857,0.00013836773,0.000074532574,0.00012502656,0.0000031364398],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042275817,0.00016911136,0.023942705,0.00063353835,0.0006967997,4.8190888e-8,0.0003486967,0.0000063219854,0.9563764,0.00032763818,0.000004831638,0.017451642],"study_design_scores_gemma":[0.003235072,0.00053781713,0.7350933,0.0012092239,0.00040994142,7.3837856e-7,0.00038883407,0.00035494653,0.25793284,0.0001445041,0.0004285651,0.0002641974],"about_ca_topic_score_codex":0.0007192528,"about_ca_topic_score_gemma":0.00015838796,"teacher_disagreement_score":0.7111506,"about_ca_system_score_codex":0.000051724488,"about_ca_system_score_gemma":0.00012683311,"threshold_uncertainty_score":0.6568542},"labels":[],"label_agreement":null},{"id":"W3175216425","doi":"10.1096/fasebj.20.4.a90-b","title":"Replacement of helix 1′ enhances the lipid binding activity of apoE3 N‐terminal domain","year":2006,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa","funders":"National Institutes of Health; Tobacco-Related Disease Research Program","keywords":"Helix (gastropod); LDL receptor; Apolipoprotein B; Chemistry; Conformational change; Receptor; Biophysics; Helix bundle; Turn (biochemistry); Biochemistry; Lipoprotein; Protein structure; Cholesterol; Biology","score_opus":0.01400579260306884,"score_gpt":0.2663069385274355,"score_spread":0.25230114592436664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3175216425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950165,0.00060672266,0.0016036336,0.001055656,0.00019847372,0.0002644107,0.0000058030414,0.000005472617,0.0012433229],"genre_scores_gemma":[0.9981565,0.00018537004,0.00038251182,0.00006767553,0.0009680662,0.0000051432057,0.0000011500159,0.000009350483,0.00022421806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851185,0.00021114573,0.00033453418,0.0000953197,0.0006364303,0.00021069794],"domain_scores_gemma":[0.9990427,0.00006292464,0.00034784898,0.00040174497,0.00008608708,0.000058676946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027234901,0.00009805961,0.00030448285,0.000056933037,0.00020620249,0.000014346671,0.00015219087,0.000038152095,0.00009407519],"category_scores_gemma":[0.000028254437,0.000046385598,0.00029781408,0.00014274652,0.00013492585,0.000051601306,0.00003752388,0.00032134305,0.0000041245444],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076267606,0.00019774993,0.0018226589,0.0001514249,0.0002753983,0.00003366156,0.00045423137,0.000031377276,0.9732718,0.00022754332,0.00074298534,0.022028532],"study_design_scores_gemma":[0.0015497771,0.0006284582,0.012047514,0.00025653208,0.00022037853,0.0015426688,0.00073545193,0.000036154106,0.98052573,0.00043177733,0.0019465416,0.0000790434],"about_ca_topic_score_codex":0.00024660723,"about_ca_topic_score_gemma":0.000019678613,"teacher_disagreement_score":0.021949489,"about_ca_system_score_codex":0.00006370902,"about_ca_system_score_gemma":0.00016625265,"threshold_uncertainty_score":0.18915498},"labels":[],"label_agreement":null},{"id":"W3176043084","doi":"10.3389/fmed.2021.694668","title":"Saudi Familial Hypercholesterolemia Patients With Rare LDLR Stop Gain Variant Showed Variable Clinical Phenotype and Resistance to Multiple Drug Regimen","year":2021,"lang":"en","type":"article","venue":"Frontiers in Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"King Abdulaziz University","keywords":"Familial hypercholesterolemia; LDL receptor; Genetics; Mutation; Medicine; Phenotype; Internal medicine; Bioinformatics; Biology; Cholesterol; Gene; Lipoprotein","score_opus":0.012250756630153148,"score_gpt":0.25985786188141546,"score_spread":0.2476071052512623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176043084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94367886,0.007511136,0.03305734,0.007833708,0.0021855333,0.0021532401,0.00004520179,0.00008875158,0.003446221],"genre_scores_gemma":[0.77043027,0.0011361671,0.20798449,0.011889106,0.0019236723,0.00013955338,0.00035347126,0.00013657624,0.0060067126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968959,0.00037004484,0.0006642221,0.0007753244,0.00080437,0.0004901074],"domain_scores_gemma":[0.9980721,0.00010897049,0.00010891012,0.00089573214,0.0002999928,0.00051431364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017372196,0.0002732039,0.001203745,0.00014602269,0.000100408244,0.000014269558,0.00013421454,0.00017191944,0.00003751402],"category_scores_gemma":[0.0011824992,0.00020491447,0.00007369288,0.0005647442,0.00018303683,0.000084967745,0.00009342766,0.00057290256,0.0000039341085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005251708,0.00054686016,0.83523273,0.00070743245,0.00051147235,0.0009569047,0.002441592,0.000024743034,0.000127278,0.00011728212,0.12306169,0.03102028],"study_design_scores_gemma":[0.034573354,0.0011587661,0.80861634,0.0031386781,0.0005713095,0.000045903045,0.0031022131,0.00027380514,0.00006516729,0.0003447959,0.14755978,0.00054988713],"about_ca_topic_score_codex":0.00024676367,"about_ca_topic_score_gemma":0.00020780314,"teacher_disagreement_score":0.17492715,"about_ca_system_score_codex":0.00019922273,"about_ca_system_score_gemma":0.00035989744,"threshold_uncertainty_score":0.83561695},"labels":[],"label_agreement":null},{"id":"W3177246177","doi":"10.1016/j.mayocpiqo.2021.03.009","title":"Risk Factors for Premature Myocardial Infarction: A Systematic Review and Meta-analysis of 77 Studies","year":2021,"lang":"en","type":"review","venue":"Mayo Clinic Proceedings Innovations Quality & Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Minority Health and Health Disparities; National Heart, Lung, and Blood Institute; Brigham and Women's Hospital","keywords":"Medicine; Odds ratio; Dyslipidemia; Myocardial infarction; Body mass index; Internal medicine; Risk factor; Meta-analysis; Diabetes mellitus; Family history; Disease; Endocrinology","score_opus":0.29422895987591885,"score_gpt":0.4988185688343068,"score_spread":0.20458960895838796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177246177","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000066921166,0.98800325,0.000056894518,0.0011280889,0.00014959111,0.009470787,0.0009793737,0.00007796863,0.000067115565],"genre_scores_gemma":[0.00005460478,0.9928553,0.0010296125,0.0011192125,0.000097338045,0.0032460773,0.0005221915,0.000065739616,0.0010099028],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99158645,0.00042807095,0.0056541646,0.0009633828,0.0010126535,0.00035527957],"domain_scores_gemma":[0.9880055,0.0021966489,0.00490936,0.001101918,0.0036566516,0.00012987667],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.011263759,0.00082515326,0.029406125,0.0009345994,0.0002490147,0.00006160576,0.0002536088,0.0005535633,0.00006783149],"category_scores_gemma":[0.025196102,0.0004956511,0.011757002,0.004878784,0.00017341514,0.00014936949,0.00019749932,0.0008106586,0.0000026635037],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001926396,0.000056826768,0.00021127763,0.57667977,0.42093858,2.7925316e-7,0.00017428576,2.174976e-8,9.436754e-9,0.0008987428,0.00038485928,0.0006534384],"study_design_scores_gemma":[0.0002819521,0.00008308589,0.00033460165,0.031176131,0.9277159,0.0000148091185,0.0008554616,3.5102423e-7,1.8461321e-7,0.000064919506,0.039088685,0.00038389995],"about_ca_topic_score_codex":0.00005816648,"about_ca_topic_score_gemma":0.0000071647673,"teacher_disagreement_score":0.5455036,"about_ca_system_score_codex":0.00020432057,"about_ca_system_score_gemma":0.00052823086,"threshold_uncertainty_score":0.99974954},"labels":[],"label_agreement":null},{"id":"W3178266213","doi":"10.1007/s11883-021-00951-2","title":"Lipoprotein (a): When to Measure and How to Treat?","year":2021,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Mendelian randomization; Lipoprotein(a); Medicine; Angiology; Lipoprotein; Internal medicine; Population; Epidemiology; Risk factor; Familial hypercholesterolemia; Disease; Cardiology; Cholesterol; Gene; Genetics","score_opus":0.09855623850612781,"score_gpt":0.34065686755893454,"score_spread":0.24210062905280672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178266213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003840228,0.991256,0.00036472047,0.00061151164,0.001073564,0.00589762,0.0000400321,0.00014452895,0.00022800367],"genre_scores_gemma":[0.00010658966,0.9936703,0.0010364448,0.00015684693,0.0015031175,0.00172586,0.00016908492,0.00021952743,0.0014122318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949935,0.00029987382,0.00094335555,0.0017279069,0.0013048832,0.0007304628],"domain_scores_gemma":[0.9954287,0.000036075424,0.0004603121,0.0023864827,0.000339735,0.0013487067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001331872,0.0009107592,0.004166665,0.000332906,0.00016769288,0.00022922385,0.00015725041,0.00046176979,0.00009715002],"category_scores_gemma":[0.0006433197,0.0007067584,0.0015931621,0.0006904514,0.000045310724,0.00007741959,0.0003287964,0.00070509326,0.000055240787],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004658501,0.00012997529,0.000039423358,0.014396625,0.00025272043,0.00016349314,0.00018794363,6.452139e-8,0.000013983345,0.000006133734,0.0093996655,0.97540534],"study_design_scores_gemma":[0.0002568632,0.00020387152,0.00013938331,0.057657383,0.00199895,0.0010963355,0.000019292134,1.0038336e-7,0.00003077432,0.0000039618894,0.9379802,0.00061289396],"about_ca_topic_score_codex":0.000096256575,"about_ca_topic_score_gemma":0.000015195711,"teacher_disagreement_score":0.9747924,"about_ca_system_score_codex":0.00042343995,"about_ca_system_score_gemma":0.0008720728,"threshold_uncertainty_score":0.99953836},"labels":[],"label_agreement":null},{"id":"W3179196498","doi":"10.4212/cjhp.v74i3.3149","title":"Evaluation of Statin Use and Prescribing in Patients with Chronic Kidney Disease Not Receiving Treatment with Kidney Transplant or Dialysis","year":2021,"lang":"en","type":"article","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health; Vancouver Hospital and Health Sciences Centre; University of British Columbia Hospital; Vancouver General Hospital","funders":"","keywords":"Medicine; Kidney disease; Statin; Dialysis; Odds ratio; Internal medicine; Logistic regression; Medical record; Confidence interval; Retrospective cohort study; Disease; Physical therapy","score_opus":0.030426850522398196,"score_gpt":0.27162072704162704,"score_spread":0.24119387651922886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3179196498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961861,0.00084128376,0.000017156059,0.0021041045,0.000070947244,0.00063346454,0.0001333476,0.0000017366192,0.000011871044],"genre_scores_gemma":[0.99907386,0.00035730944,0.00012103945,0.0002682225,0.00008908958,0.000013052726,0.000030436324,0.000018499757,0.000028516002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839056,0.00025281773,0.00029416324,0.00013490286,0.00070727366,0.00022030751],"domain_scores_gemma":[0.9979457,0.000036410147,0.00016485078,0.00019692455,0.00056707184,0.001089031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007369611,0.00012967958,0.00032010383,0.00011789136,0.00009040704,0.000041676296,0.00005292653,0.000014716803,0.0001251369],"category_scores_gemma":[0.00030730624,0.00006397434,0.00008011326,0.00022033865,0.00006285998,0.00021736264,0.000004053156,0.00014595043,2.289815e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046456563,0.0003567623,0.91645515,0.00029482195,0.0018879722,0.0014065028,0.0049797446,0.0005194329,0.00007904859,0.000003532898,0.00014504285,0.06922631],"study_design_scores_gemma":[0.034047276,0.004412393,0.948512,0.002448915,0.0059860963,0.00011487565,0.00021176737,0.0009625966,0.0017546922,0.0000078639505,0.0013070715,0.00023446039],"about_ca_topic_score_codex":0.017157938,"about_ca_topic_score_gemma":0.0448465,"teacher_disagreement_score":0.06899185,"about_ca_system_score_codex":0.0007366061,"about_ca_system_score_gemma":0.015265863,"threshold_uncertainty_score":0.9903167},"labels":[],"label_agreement":null},{"id":"W3180027933","doi":"10.14740/cr1254","title":"Small Dense Low-Density Lipoprotein for Risk Prediction of Acute Coronary Syndrome","year":2021,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Acute coronary syndrome; Cardiology; Coronary artery disease; Risk factor; Coronary angiography; Artery; Low-density lipoprotein; Cholesterol; Myocardial infarction","score_opus":0.06901479634846966,"score_gpt":0.3346035787102325,"score_spread":0.26558878236176287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180027933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905616,0.0027239877,0.0035356982,0.00038081812,0.00028261723,0.0016943697,0.0002853639,0.000048833375,0.00048672702],"genre_scores_gemma":[0.99496347,0.0016606952,0.0013425193,0.00005685545,0.0004430854,0.00031466936,0.00022142193,0.000036248337,0.00096101034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968253,0.0010238398,0.00037609437,0.0005696962,0.00057658635,0.0006285092],"domain_scores_gemma":[0.99679387,0.00025454676,0.000068221016,0.0010937679,0.0015357219,0.00025388016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00414417,0.0001481113,0.0010004728,0.00017928408,0.00026188832,0.000008934167,0.00012886999,0.00037638788,0.00003040649],"category_scores_gemma":[0.00091587193,0.00013344311,0.0006242621,0.00039737872,0.00034377247,0.000035796555,0.00018984471,0.0007771619,0.000028565673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008418993,0.0008874304,0.63520074,0.0058501773,0.025427354,0.027127428,0.0007462623,0.00011913972,0.1311391,0.0012069653,0.014217917,0.14965852],"study_design_scores_gemma":[0.0035176384,0.0020932925,0.9550954,0.0001859965,0.0007503673,0.012047639,0.00022505946,0.00013856753,0.022174925,0.00086265325,0.0027638723,0.00014460662],"about_ca_topic_score_codex":0.00021576078,"about_ca_topic_score_gemma":0.000018070912,"teacher_disagreement_score":0.31989467,"about_ca_system_score_codex":0.00016041883,"about_ca_system_score_gemma":0.00082801795,"threshold_uncertainty_score":0.5441652},"labels":[],"label_agreement":null},{"id":"W3180324452","doi":"10.7454/jpdi.v8i2.456","title":"Hubungan Kadar Proprotein Convertase Kexin/Type 9 (PCSK9) dengan Aterosklerosis pada Penyandang Diabetes Melitus Tipe 2: Sebuah Telaah Sistematis","year":2021,"lang":"id","type":"article","venue":"Jurnal Penyakit Dalam Indonesia","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gynecology; Medicine; Humanities; Art","score_opus":0.016502003412664012,"score_gpt":0.24858631096700712,"score_spread":0.23208430755434312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180324452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9562531,0.0324719,0.00010926169,0.0022493722,0.003070086,0.0039707236,0.00018085097,0.00027423396,0.0014204718],"genre_scores_gemma":[0.98243433,0.0021042703,0.0005284528,0.001419275,0.0036240832,0.00034820603,0.00068655575,0.0004213452,0.008433474],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9862085,0.0021399325,0.0028423518,0.0023288839,0.0037048592,0.00277549],"domain_scores_gemma":[0.9912004,0.00035432697,0.0012480041,0.0033773214,0.001892381,0.0019275555],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0034313484,0.0017620121,0.0037167512,0.0004567226,0.0013783596,0.0008752245,0.00092996843,0.0012190295,0.0011214516],"category_scores_gemma":[0.00096291234,0.0016027051,0.0018630195,0.0016638145,0.0004948927,0.0008101599,0.0006436445,0.0027858126,0.0012251069],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002174343,0.0048597874,0.5158197,0.029763212,0.013688932,0.016098848,0.006174208,0.000037432394,0.33443233,0.00088546926,0.009861594,0.0662041],"study_design_scores_gemma":[0.01626654,0.0029357076,0.35053924,0.010935242,0.006155673,0.002272645,0.0030394222,0.00040073332,0.5593256,0.00015010766,0.044286508,0.0036925897],"about_ca_topic_score_codex":0.0006512634,"about_ca_topic_score_gemma":0.00044140872,"teacher_disagreement_score":0.22489327,"about_ca_system_score_codex":0.0009820622,"about_ca_system_score_gemma":0.003439874,"threshold_uncertainty_score":0.99992174},"labels":[],"label_agreement":null},{"id":"W3182438669","doi":"10.1161/jaha.120.020126","title":"Treatment Inertia in Patients With Familial Hypercholesterolemia","year":2021,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary; Université de Montréal; Canadian Heart Research Centre; Montreal Heart Institute; St. Michael's Hospital; University of British Columbia; University of Toronto","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Ezetimibe; Internal medicine; Statin; Gastroenterology; Clinical endpoint; Cholesterol; Randomized controlled trial","score_opus":0.007439284242738624,"score_gpt":0.24647798363243334,"score_spread":0.23903869938969471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182438669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967578,0.00006913349,0.0000059362947,0.0028742226,0.0001097455,0.00012589639,0.0000024988715,0.0000024982985,0.000052287156],"genre_scores_gemma":[0.9983095,0.000047202415,0.00038272797,0.00092333416,0.00020849617,0.000002013756,0.0000015019009,0.000008432142,0.000116799376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988401,0.00021431009,0.00023470807,0.00006953574,0.00051462295,0.00012670222],"domain_scores_gemma":[0.99923164,0.000032110052,0.00025064798,0.00016375032,0.00026440245,0.00005744202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002966641,0.00006388252,0.00041709465,0.000042316806,0.000030982665,0.000010097719,0.000030537365,0.000023876306,0.0000043811065],"category_scores_gemma":[0.00016087799,0.000035477617,0.00021801093,0.00026917367,0.000014330921,0.00005186737,0.000010763729,0.00015901403,0.0000021109493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018243601,0.00020380592,0.990769,0.0000040484906,0.00014190936,0.0000089101695,0.000110022906,0.000020179492,0.0003728582,4.90677e-7,0.0001811476,0.008005137],"study_design_scores_gemma":[0.0027100584,0.00083014334,0.99330354,0.000051544725,0.000114153634,0.000037603495,0.00009052976,0.0000053496765,0.0004716196,0.0000039097354,0.0023465808,0.00003496637],"about_ca_topic_score_codex":0.00026025937,"about_ca_topic_score_gemma":0.0000926011,"teacher_disagreement_score":0.00797017,"about_ca_system_score_codex":0.0010990454,"about_ca_system_score_gemma":0.0003140501,"threshold_uncertainty_score":0.28739655},"labels":[],"label_agreement":null},{"id":"W3185437709","doi":"10.1093/jalm/jfab064","title":"Pushing the New NIH LDL-Cholesterol Equation to Its Limits","year":2021,"lang":"en","type":"letter","venue":"The Journal of Applied Laboratory Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Ldl cholesterol; Cholesterol; Computer science; Medicine; Internal medicine","score_opus":0.03825787050635793,"score_gpt":0.27824840522452293,"score_spread":0.239990534718165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185437709","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007956966,0.011768488,0.0015426129,0.9740343,0.0015142935,0.0014054857,0.000009877638,0.000029597037,0.0017383642],"genre_scores_gemma":[0.016472692,0.0018707574,0.00023175609,0.9288673,0.051497065,0.000021036472,0.000041526157,0.00013182916,0.00086608145],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949572,0.00044440772,0.001190178,0.00029603695,0.0026102273,0.00050194905],"domain_scores_gemma":[0.9958759,0.00041725067,0.0009925988,0.0012561383,0.0010518292,0.0004062816],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005400802,0.00045914872,0.0013814844,0.0002711528,0.0002217267,0.00004638335,0.0006353753,0.0005031966,0.00021664434],"category_scores_gemma":[0.0005974408,0.00021936602,0.00026308125,0.0009457091,0.00011585531,0.00008435579,0.00008248878,0.0043104147,0.000059276397],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027420995,0.000021680675,0.0000031814568,0.00033193233,0.0007192388,0.0003751048,0.0023380944,0.00006547734,0.005984723,0.00004511494,0.97992545,0.009915769],"study_design_scores_gemma":[0.0024322502,0.00056934246,0.00030306494,0.0017598671,0.002097851,0.0005695222,0.0009572893,0.00000553196,0.002825397,0.000072277995,0.9881968,0.0002108324],"about_ca_topic_score_codex":0.000047336234,"about_ca_topic_score_gemma":0.000014338756,"teacher_disagreement_score":0.04998277,"about_ca_system_score_codex":0.00027117538,"about_ca_system_score_gemma":0.0017638209,"threshold_uncertainty_score":0.9979867},"labels":[],"label_agreement":null},{"id":"W3185614567","doi":"10.1093/cvr/cvab247","title":"The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitors","year":2021,"lang":"en","type":"article","venue":"Cardiovascular Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Agence Nationale de la Recherche","keywords":"PCSK9; Apolipoprotein B; Lipoprotein; Lipoprotein(a); Reduction (mathematics); Internal medicine; LDL receptor; Endocrinology; Chemistry; Medicine; Cholesterol; Mathematics","score_opus":0.04925802966700194,"score_gpt":0.33643571341929707,"score_spread":0.28717768375229513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185614567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97817504,0.017461674,0.000023513881,0.0010742671,0.00027896804,0.0024216187,0.000014036226,0.000015758756,0.0005351443],"genre_scores_gemma":[0.99761075,0.0011207322,0.00009916114,0.00003122103,0.00038184077,0.0002958084,0.000007337582,0.00005915093,0.00039402462],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9910387,0.0024762165,0.0008282405,0.00073106,0.00413921,0.0007865799],"domain_scores_gemma":[0.9946212,0.00012607372,0.00015050278,0.0036296565,0.0012236076,0.00024895617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010853325,0.00024893254,0.0009447762,0.00017909083,0.0003564875,0.000049693943,0.00053564593,0.00034594224,0.00002926091],"category_scores_gemma":[0.0015773576,0.00015983441,0.0016015149,0.001905062,0.0004782736,0.00013388693,0.00043360287,0.0013639134,0.000005861989],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003996485,0.00063689623,0.0015480355,0.0010268505,0.0019780663,0.00015445772,0.0016443603,0.000030155546,0.45908698,0.00019515818,0.0005178098,0.5327816],"study_design_scores_gemma":[0.0023011018,0.0003607746,0.023837956,0.00050492166,0.00016135263,0.00030545675,0.0028203167,0.000032952845,0.9576463,0.00026315442,0.011575205,0.00019050352],"about_ca_topic_score_codex":0.0069070556,"about_ca_topic_score_gemma":0.00024975894,"teacher_disagreement_score":0.53259104,"about_ca_system_score_codex":0.0003483163,"about_ca_system_score_gemma":0.0013183472,"threshold_uncertainty_score":0.99970603},"labels":[],"label_agreement":null},{"id":"W3185626009","doi":"10.1016/j.jlr.2021.100096","title":"PCSK9 is not secreted from mature differentiated intestinal cells","year":2021,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Fondazione Cariplo; Fondation Leducq; Agence Nationale de la Recherche","keywords":"PCSK9; Secretion; Kexin; Biology; Ex vivo; LDL receptor; Proprotein convertase; Internal medicine; Intestinal mucosa; Endocrinology; Cell biology; In vivo; Cholesterol; Lipoprotein; Medicine","score_opus":0.07202484813705237,"score_gpt":0.36522627348196957,"score_spread":0.2932014253449172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185626009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861757,0.0023423226,0.00033970902,0.009464427,0.0005993838,0.00019084371,0.00002236393,0.0000127954945,0.0008524548],"genre_scores_gemma":[0.9900372,0.0007570105,0.002254675,0.0008202869,0.0033661115,0.000003156436,0.00002053315,0.00003600459,0.0027050425],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960174,0.0005462306,0.0005298657,0.00023443597,0.0022253518,0.0004467212],"domain_scores_gemma":[0.996467,0.00014463816,0.00014896308,0.0005162891,0.0022323374,0.0004908063],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001856812,0.00013339968,0.0005723617,0.0002531752,0.00012256642,0.00008342697,0.00020158189,0.00018031472,0.0017168452],"category_scores_gemma":[0.00052947784,0.0000951555,0.0004581089,0.00060947274,0.0000669134,0.00008064081,0.00013656724,0.0020885598,0.000085427564],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001999869,0.000701743,0.0069406605,0.0005125847,0.0011790552,0.005332476,0.00094788306,0.000004596002,0.87351644,0.00003798823,0.060182948,0.04864378],"study_design_scores_gemma":[0.0062990347,0.0012477394,0.09303503,0.0018611093,0.00025449952,0.0034521145,0.0014247355,0.0003491129,0.77806216,0.00026364205,0.11350547,0.00024534698],"about_ca_topic_score_codex":0.000116433504,"about_ca_topic_score_gemma":0.000007315701,"teacher_disagreement_score":0.09545425,"about_ca_system_score_codex":0.0001518112,"about_ca_system_score_gemma":0.0010576083,"threshold_uncertainty_score":0.9991957},"labels":[],"label_agreement":null},{"id":"W3185845820","doi":"10.1016/j.jacc.2021.04.102","title":"Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; National Institute for Health and Care Research; Sanofi","keywords":"Alirocumab; Medicine; Interquartile range; PCSK9; Hazard ratio; Internal medicine; Statin; Mace; Ezetimibe; Evolocumab; Acute coronary syndrome; Placebo; Atorvastatin; Gastroenterology; Lipoprotein; Confidence interval; Cholesterol; Myocardial infarction; Percutaneous coronary intervention; LDL receptor; Apolipoprotein A1","score_opus":0.0051132412676029425,"score_gpt":0.21864444074739245,"score_spread":0.21353119947978952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185845820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745196,0.0005616148,0.00009704292,0.0009787764,0.00008034774,0.0004924323,0.000026389876,0.0000014603118,0.00030996845],"genre_scores_gemma":[0.99887794,0.00012521759,0.00055536634,0.00023539129,0.00014551531,0.0000071823683,0.0000013288673,0.000012613799,0.00003942956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843615,0.00023240643,0.0006331975,0.00012897575,0.0004122882,0.00015699958],"domain_scores_gemma":[0.9979897,0.00006775797,0.00090313895,0.00031888584,0.0006400015,0.000080489204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000628337,0.000117538344,0.0016494554,0.00014215491,0.000024999244,0.0000023056048,0.00006386767,0.000051726343,0.0000028253228],"category_scores_gemma":[0.00016129005,0.00007043903,0.00039051913,0.00033082845,0.00027212678,0.000045266665,0.00005354483,0.00023741652,1.2855551e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025323335,0.0004624054,0.9409717,0.00040445104,0.0032102284,0.00071941724,0.00014710607,0.0010431086,0.00792077,0.00027745552,0.00016721834,0.019352835],"study_design_scores_gemma":[0.01896258,0.00293866,0.9727552,0.0003494408,0.0004043091,0.0012881358,0.0002731625,0.000008602235,0.0025333432,0.000093423645,0.00031993294,0.00007318673],"about_ca_topic_score_codex":0.000043870543,"about_ca_topic_score_gemma":0.000029493076,"teacher_disagreement_score":0.03178355,"about_ca_system_score_codex":0.000066331944,"about_ca_system_score_gemma":0.0002863756,"threshold_uncertainty_score":0.28724203},"labels":[],"label_agreement":null},{"id":"W3185992264","doi":"10.1161/circgen.120.003271","title":"Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic <i>LPA</i> Gene Expression Levels With Cardiovascular Outcomes: Mendelian Randomization and Observational Analyses","year":2021,"lang":"en","type":"article","venue":"Circulation Genomic and Precision Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Common Fund; National Human Genome Research Institute; National Institute on Drug Abuse; Cancer Research UK; NIH Office of the Director; National Heart, Lung, and Blood Institute; National Institute of Mental Health; Medical Research Council; National Institute of Neurological Disorders and Stroke; National Institute for Health and Care Research; Canadian Institutes of Health Research; National Institutes of Health; National Cancer Institute; British Heart Foundation","keywords":"Mendelian randomization; Observational study; Biology; Gene; Genetics; Lipoprotein(a); Lipoprotein; Mendelian inheritance; Internal medicine; Endocrinology; Medicine; Genetic variants; Cholesterol; Genotype","score_opus":0.09128549761471672,"score_gpt":0.3128661464496531,"score_spread":0.2215806488349364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185992264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85712016,0.016920477,0.1242175,0.00044550435,0.00007098214,0.0010179284,0.00004237548,0.000036284902,0.00012878075],"genre_scores_gemma":[0.9826301,0.0023227534,0.014067736,0.00023846104,0.0002299453,0.000045578523,0.00039067454,0.00003889262,0.00003585863],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99671096,0.00038263772,0.0009093471,0.0006593669,0.0011002275,0.00023745066],"domain_scores_gemma":[0.9978595,0.00034337136,0.00030330196,0.0006093396,0.0006090346,0.00027545952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015904172,0.00028579155,0.0012357581,0.00020866402,0.00027623086,0.000033419637,0.00005158834,0.00019201815,0.000068354915],"category_scores_gemma":[0.0005656179,0.00021476914,0.00017690867,0.00042300587,0.00017828986,0.00013441077,0.00007039869,0.00018896922,5.5953e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003832825,0.0001388116,0.36757854,0.0007060138,0.0024267074,0.00005923022,0.0021934959,0.0057392824,0.4885799,0.00022378554,0.000059717222,0.13191122],"study_design_scores_gemma":[0.010898605,0.00016001033,0.9734036,0.0004836173,0.0009688378,0.00024804214,0.00033043858,0.0070483717,0.005482366,0.00038791998,0.00035004484,0.0002381663],"about_ca_topic_score_codex":0.00010132336,"about_ca_topic_score_gemma":0.000008024159,"teacher_disagreement_score":0.60582507,"about_ca_system_score_codex":0.00009064154,"about_ca_system_score_gemma":0.0001966447,"threshold_uncertainty_score":0.8758031},"labels":[],"label_agreement":null},{"id":"W3186469567","doi":"10.3390/jcdd8070082","title":"The Effect of Mipomersen in the Management of Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis of Clinical Trials","year":2021,"lang":"en","type":"review","venue":"Journal of Cardiovascular Development and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; York University; McMaster University; Impact","funders":"","keywords":"Medicine; Internal medicine; Placebo; Meta-analysis; Familial hypercholesterolemia; Adverse effect; Randomized controlled trial; Gastroenterology; Apolipoprotein B; Clinical trial; Relative risk; Confidence interval; Cholesterol; Pathology","score_opus":0.10194463521848877,"score_gpt":0.393735335469667,"score_spread":0.2917907002511782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186469567","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015908682,0.9938802,0.000036797628,0.000034694327,0.000037559996,0.0043757213,0.000028440118,9.833212e-7,0.000014728284],"genre_scores_gemma":[0.0011127925,0.99841356,0.0001759278,0.000038957714,0.00002762961,0.00017241143,0.000030698484,0.000018319826,0.000009673132],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98566544,0.007323293,0.0045972946,0.00028426066,0.0019623095,0.00016739352],"domain_scores_gemma":[0.99487686,0.00087722973,0.002607388,0.0009980376,0.00038942514,0.0002510387],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.039672844,0.00037522573,0.019906584,0.00028229525,0.000044795102,0.000018831694,0.00023831998,0.00011580001,0.0000033952647],"category_scores_gemma":[0.0010687124,0.00013757069,0.013826505,0.00075827865,0.000115122864,0.0000426626,0.000091866474,0.0003460786,1.2314703e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010926139,0.00006797746,0.00016055038,0.4585635,0.47424224,0.000090743146,0.000024680523,0.0000015504093,8.0810714e-10,0.0000031900408,0.000007396598,0.06672891],"study_design_scores_gemma":[0.0019549625,0.00017176809,0.0023954187,0.05940079,0.92235696,0.000026212188,0.000060043454,2.8139408e-7,1.2399947e-7,5.672591e-7,0.013520452,0.000112392074],"about_ca_topic_score_codex":0.000004184541,"about_ca_topic_score_gemma":9.3522317e-7,"teacher_disagreement_score":0.44811475,"about_ca_system_score_codex":0.00003799221,"about_ca_system_score_gemma":0.00055304193,"threshold_uncertainty_score":0.99604976},"labels":[],"label_agreement":null},{"id":"W3186850405","doi":"10.1093/eurheartj/ehab462","title":"The promise and challenges of RNA-targeted therapeutics in preventive cardiology","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Interventional cardiology; Cardiology; Internal medicine; Intensive care medicine","score_opus":0.05775457459971208,"score_gpt":0.2983228615199443,"score_spread":0.24056828692023222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186850405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8247068,0.16077669,0.00003503578,0.007740072,0.00018835082,0.00022585351,0.0000012803356,0.0000075483176,0.006318374],"genre_scores_gemma":[0.94474703,0.05419192,0.00028949455,0.0001963503,0.00039749424,0.0000014927509,5.9676023e-7,0.000017260107,0.00015835672],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998252,0.0010450586,0.00022890833,0.00011684943,0.00018066408,0.00017653524],"domain_scores_gemma":[0.99946386,0.000052471172,0.000060938848,0.00021996078,0.00011745979,0.000085325184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018387695,0.0000714371,0.00027121877,0.000033913348,0.000092088514,0.0000131662655,0.000042794418,0.000025825599,0.000007049766],"category_scores_gemma":[0.00009011756,0.000045046425,0.00014065251,0.00007043107,0.000063971216,0.00002470337,0.00004117861,0.0003413123,0.000003228438],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007576098,0.00037414866,0.08278561,0.0006906671,0.0025269112,0.0057172365,0.0059956824,0.000030388179,0.029954573,0.0013232917,0.0011715875,0.8686723],"study_design_scores_gemma":[0.0016270046,0.00032384077,0.86638606,0.000195342,0.00007703794,0.005011189,0.0010191783,0.000010303248,0.0017629818,0.000129485,0.123388164,0.00006943421],"about_ca_topic_score_codex":0.0000020564219,"about_ca_topic_score_gemma":0.000005406767,"teacher_disagreement_score":0.8686029,"about_ca_system_score_codex":0.000020151316,"about_ca_system_score_gemma":0.00014212794,"threshold_uncertainty_score":0.18369399},"labels":[],"label_agreement":null},{"id":"W3188907904","doi":"10.1136/bmjopen-2021-052341","title":"Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review","year":2021,"lang":"en","type":"review","venue":"BMJ Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Bern","keywords":"Medicine; Tolerability; Statin; MEDLINE; Meta-analysis; Protocol (science); Randomized controlled trial; Clinical trial; Physical therapy; Alternative medicine; Adverse effect; Internal medicine; Pathology","score_opus":0.09752676160716123,"score_gpt":0.4279301683730892,"score_spread":0.330403406765928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188907904","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000024910898,0.4019891,0.00006760665,0.0000056407107,0.000017396627,0.59730804,0.0002158721,0.0000066178736,0.00038719754],"genre_scores_gemma":[0.0000016341128,0.09450937,0.0024164175,0.00007819307,0.000009408133,0.90195614,0.00053186214,0.000062120336,0.0004348659],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.994314,0.0011273053,0.002723801,0.0004663042,0.001132598,0.00023598889],"domain_scores_gemma":[0.99309623,0.00018518393,0.0038693384,0.0018290317,0.0009146497,0.00010557994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045547276,0.00037237475,0.0075331866,0.00008631436,0.000018884313,0.000006193341,0.0003992437,0.0001235431,0.00008797716],"category_scores_gemma":[0.0005348543,0.00024122337,0.0010600946,0.00035037933,0.00006474193,0.000041839117,0.00015760944,0.0001412035,9.923813e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111913854,0.00092782814,0.000023772665,0.9217951,0.001998697,0.0000058958876,0.00004018108,2.7519252e-7,9.3766666e-9,0.000018707118,0.00069099496,0.07438662],"study_design_scores_gemma":[0.0041992827,0.0010087907,0.000102443664,0.895332,0.0071238847,0.000001028779,0.000024714966,0.0000045401903,3.6904615e-7,0.0000011501268,0.09199974,0.0002020636],"about_ca_topic_score_codex":0.00019264288,"about_ca_topic_score_gemma":0.0000127169415,"teacher_disagreement_score":0.30747974,"about_ca_system_score_codex":0.00095679617,"about_ca_system_score_gemma":0.0035244587,"threshold_uncertainty_score":0.98368037},"labels":[],"label_agreement":null},{"id":"W3189016707","doi":"","title":"Comparative Effectiveness of Lipid-Modifying Agents [Internet]","year":2009,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Tolerability; Medicine; Statin; Intensive care medicine; Adverse effect; Key (lock); Pharmacology; Agency (philosophy); Internal medicine; Computer science","score_opus":0.04242093134808449,"score_gpt":0.3404933158280887,"score_spread":0.2980723844800042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3189016707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9457186,0.00028866704,0.005731914,0.000084159605,0.00008101656,0.0005492634,8.3721153e-7,0.00003825307,0.047507327],"genre_scores_gemma":[0.9987284,0.000016923845,0.0005332534,0.00021720091,0.00009883466,0.000006775142,0.000005859571,0.000004773664,0.00038795712],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992038,0.00010325092,0.00015507996,0.00015414128,0.00024559945,0.00013814219],"domain_scores_gemma":[0.9995205,0.000030467725,0.000036736787,0.00024158847,0.00008241406,0.00008831439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044402567,0.00008612254,0.00044997878,0.000050139744,0.000017049239,0.000004256565,0.000044483302,0.0000435894,0.0001244965],"category_scores_gemma":[0.000017546925,0.000063114974,0.000186082,0.000108985376,0.00002194222,0.000035996214,0.000012336195,0.00008665259,0.000027149244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012625506,0.008892108,0.12344818,0.012230405,0.008012427,0.00059272174,0.011496312,0.00070905825,0.30772248,0.06805918,0.01855025,0.42766136],"study_design_scores_gemma":[0.0036294234,0.0012744716,0.7776218,0.00060766103,0.00011926508,0.00006251905,0.00015039516,0.00070229586,0.21179882,0.00018858661,0.0036917415,0.00015298893],"about_ca_topic_score_codex":0.00021298957,"about_ca_topic_score_gemma":0.000002228569,"teacher_disagreement_score":0.6541737,"about_ca_system_score_codex":0.00004549534,"about_ca_system_score_gemma":0.000045719404,"threshold_uncertainty_score":0.25737542},"labels":[],"label_agreement":null},{"id":"W3190075243","doi":"10.1161/circulationaha.121.055698","title":"Response by Brunham et al to Letter Regarding Article, “Inhibition of Cholesteryl Ester Transfer Protein Preserves High-Density Lipoprotein Cholesterol and Improves Survival in Sepsis”","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cholesterylester transfer protein; Cholesterol; Lipoprotein; Ldl cholesterol; Cholesteryl ester; Lipoprotein(a)","score_opus":0.014302460248238173,"score_gpt":0.25562906293315635,"score_spread":0.24132660268491818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190075243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9741452,0.00015199535,0.003992859,0.02008556,0.0000623462,0.001485873,0.000012437368,0.00003698449,0.000026784332],"genre_scores_gemma":[0.9944397,0.000008702746,0.00040042106,0.0048433067,0.000056713874,0.00010669856,0.00004945196,0.000035493,0.000059479815],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976392,0.0005930693,0.00046740528,0.0005050842,0.00052026944,0.00027496982],"domain_scores_gemma":[0.9990797,0.00004121955,0.000057074634,0.0004946617,0.00017242314,0.000154894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015629784,0.00018518206,0.00044265098,0.00014019394,0.000053601536,0.000058026766,0.000036294314,0.00013647601,0.000011064658],"category_scores_gemma":[0.00019949242,0.00018435379,0.00012994194,0.00030513402,0.00004255412,0.00033576347,0.00004619925,0.00024341178,0.0000038903686],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086699094,0.00014085721,0.013539086,0.00020120782,0.00004972379,0.00003355559,0.0005003447,0.000049823873,0.9736378,0.00003709029,0.00012350387,0.010820008],"study_design_scores_gemma":[0.002428811,0.00010419434,0.6504358,0.00039625957,0.000029477764,0.000026115496,0.00005811283,0.0000898009,0.3455817,0.000047337355,0.00066696916,0.0001353704],"about_ca_topic_score_codex":0.0009001343,"about_ca_topic_score_gemma":0.00039610988,"teacher_disagreement_score":0.6368967,"about_ca_system_score_codex":0.00009608056,"about_ca_system_score_gemma":0.000096367636,"threshold_uncertainty_score":0.75177294},"labels":[],"label_agreement":null},{"id":"W3194232190","doi":"10.1016/j.cjca.2021.08.012","title":"Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Coronary artery disease; Apolipoprotein B; Familial hypercholesterolemia; Hyperlipidemia; Lipoprotein(a); Lipoprotein; Population; Cholesterol; Endocrinology; Gastroenterology; Diabetes mellitus","score_opus":0.007831160765984243,"score_gpt":0.2055471033939085,"score_spread":0.19771594262792425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194232190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604356,0.001766183,0.000089004454,0.0009146653,0.0004295911,0.0004709838,0.00005208395,0.0000067187125,0.00022720789],"genre_scores_gemma":[0.99781597,0.00010615285,0.00017300594,0.0009467247,0.0007882747,0.000010455767,0.000068664944,0.000032218697,0.000058564667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980555,0.00035001416,0.0004908485,0.00029725564,0.0003243208,0.0004820248],"domain_scores_gemma":[0.9976499,0.0000386398,0.00012706881,0.00040741023,0.00048375747,0.0012932091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046053334,0.00021962912,0.0009627552,0.00024972914,0.000079064615,0.000019945144,0.00010004102,0.00024094735,0.0000107196],"category_scores_gemma":[0.00027015942,0.00017879902,0.00022262023,0.0002135067,0.0001792125,0.00011424247,0.000021125186,0.0007318575,0.000002511638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017919721,0.00002292015,0.98044467,0.00013865811,0.00045210135,0.004905404,0.00010782098,0.00018436692,0.00015676742,0.000019457686,0.00062505127,0.011150783],"study_design_scores_gemma":[0.007913046,0.00086822425,0.98291445,0.0002809759,0.00025261103,0.0013380396,0.00010949869,0.0000084379935,0.000027503962,0.000060018687,0.006057598,0.00016958163],"about_ca_topic_score_codex":0.00052958826,"about_ca_topic_score_gemma":0.001823352,"teacher_disagreement_score":0.010981201,"about_ca_system_score_codex":0.00025128128,"about_ca_system_score_gemma":0.0029610845,"threshold_uncertainty_score":0.72912127},"labels":[],"label_agreement":null},{"id":"W3194362009","doi":"10.1161/atvbaha.121.316106","title":"Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia","year":2021,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia; Western University; McGill University Health Centre; Université de Montréal; Montreal Clinical Research Institute","funders":"Institut de Recherche Clinique De Montréal; Agence Nationale de la Recherche","keywords":"Familial hypercholesterolemia; Medicine; Internal medicine; Hazard ratio; Cohort; Framingham Risk Score; Atherosclerotic cardiovascular disease; Proportional hazards model; Cohort study; Family history; Cholesterol; Disease; Confidence interval","score_opus":0.05279197033570439,"score_gpt":0.2852622450753541,"score_spread":0.2324702747396497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194362009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844794,0.012167476,0.0010767381,0.00022369153,0.00053557707,0.0012427401,0.000056949128,0.00012394652,0.00009348278],"genre_scores_gemma":[0.95015574,0.047001112,0.0009744247,0.00069106685,0.00077824283,0.00014243933,0.00013998128,0.00010932212,0.00000766271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935258,0.0012780402,0.0010820426,0.0020781737,0.00089876924,0.0011371656],"domain_scores_gemma":[0.9964475,0.00007759679,0.00016044948,0.0023383945,0.0002091221,0.00076693174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002551688,0.00078809133,0.0027027575,0.00025438517,0.00037332054,0.00010241936,0.0002437837,0.00077039766,0.000026783098],"category_scores_gemma":[0.00027439411,0.0007310561,0.0021620747,0.00057527324,0.00033630384,0.00028540927,0.0005082042,0.0009839012,0.00001240911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000208156,0.00021128391,0.9543083,0.00032426737,0.005888147,0.000011324434,0.00061577326,0.000051467436,0.0105909975,0.000035891862,0.000018419372,0.02792337],"study_design_scores_gemma":[0.00801072,0.00045036385,0.98236316,0.0005670432,0.0028709085,0.00006986625,0.00046439248,0.00012925499,0.00027877232,0.000099898854,0.004057551,0.0006380591],"about_ca_topic_score_codex":0.00657552,"about_ca_topic_score_gemma":0.0008499123,"teacher_disagreement_score":0.034833636,"about_ca_system_score_codex":0.0001726479,"about_ca_system_score_gemma":0.00039721062,"threshold_uncertainty_score":0.99951404},"labels":[],"label_agreement":null},{"id":"W3194497957","doi":"10.1055/s-0041-1731273","title":"Current Status of Primary, Secondary, and Tertiary Prevention of Coronary Artery Disease","year":2021,"lang":"en","type":"review","venue":"International Journal of Angiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Coronary artery disease; Dyslipidemia; Hyperhomocysteinemia; Diabetes mellitus; Risk factor; Internal medicine; Intensive care medicine; CAD; Disease; Endocrinology","score_opus":0.03298758857405231,"score_gpt":0.3558907227032067,"score_spread":0.3229031341291544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194497957","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047524315,0.99351484,0.00021333853,0.000073963696,0.0009925743,0.0002606169,0.0001093753,0.0000021004628,0.00008079053],"genre_scores_gemma":[0.0026392543,0.99614185,0.000260155,0.000044578814,0.0005776878,0.0000058278124,0.00028750522,0.000016102804,0.000027048894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795246,0.00025600157,0.0010671574,0.00015659466,0.00042407683,0.00014371969],"domain_scores_gemma":[0.99793917,0.00008706599,0.0010622953,0.00018079256,0.0005417025,0.00018899728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040835782,0.00015924676,0.0015340861,0.000315796,0.000008943508,0.000004603578,0.00013710951,0.00011309133,0.00010394427],"category_scores_gemma":[0.00011278207,0.00011953501,0.0011794312,0.000057100755,0.00009950171,0.000063228894,0.00009889822,0.0003521068,8.288837e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012545071,0.00022814117,0.0011042927,0.0062230793,0.002242071,0.0003887169,0.00002284166,2.3797118e-7,0.0000049807923,0.00007262094,0.00030017438,0.9892874],"study_design_scores_gemma":[0.0014618465,0.00054067024,0.049293816,0.023112625,0.002390272,0.0057250033,0.0000153756,9.549692e-7,0.000004211453,0.00016762296,0.9171664,0.00012120059],"about_ca_topic_score_codex":0.0000079490155,"about_ca_topic_score_gemma":0.000001040346,"teacher_disagreement_score":0.9891662,"about_ca_system_score_codex":0.00014722528,"about_ca_system_score_gemma":0.0022712443,"threshold_uncertainty_score":0.48744962},"labels":[],"label_agreement":null},{"id":"W3195313977","doi":"10.1016/j.ijcard.2021.08.031","title":"Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registry","year":2021,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Myocardial infarction; Diabetes mellitus; Percutaneous coronary intervention; Hypertriglyceridemia; Canadian Cardiovascular Society; Unstable angina; Angina; Coronary artery disease; Hazard ratio; Stroke (engine); Cardiology; Confidence interval; Cholesterol; Triglyceride","score_opus":0.035107729298031826,"score_gpt":0.3242651906339413,"score_spread":0.28915746133590947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195313977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935959,0.0010886132,0.0021389285,0.0012662461,0.0007485998,0.0010058288,0.00013729992,0.0000025388106,0.000016070024],"genre_scores_gemma":[0.9985055,0.000602604,0.00040120812,0.00011573127,0.00026293183,0.00002787033,0.000049415095,0.0000150511,0.000019721243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99712104,0.0007640309,0.0009538649,0.00022037864,0.00079530943,0.00014539735],"domain_scores_gemma":[0.9955012,0.00013035745,0.0012694699,0.0005206216,0.002513338,0.000064976564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026309849,0.00013129768,0.0015118145,0.00011778128,0.00005868998,0.000008022595,0.00023291598,0.00013431747,0.0000033935257],"category_scores_gemma":[0.00086349534,0.00007282557,0.0023157138,0.0002268792,0.00021315202,0.000060923932,0.00004180365,0.0001574971,5.771e-9],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019751623,0.00082964636,0.81791794,0.00017016342,0.12353077,0.000004455885,0.00080596644,0.008732786,0.00684341,0.00011467588,0.00047664766,0.020821918],"study_design_scores_gemma":[0.03007508,0.0014078028,0.9554307,0.00014422776,0.0041412036,0.000052693482,0.00031041045,0.000091033646,0.007390347,0.00010379566,0.000765583,0.00008715874],"about_ca_topic_score_codex":0.00039333064,"about_ca_topic_score_gemma":0.00004908061,"teacher_disagreement_score":0.13751273,"about_ca_system_score_codex":0.00015327024,"about_ca_system_score_gemma":0.00060889457,"threshold_uncertainty_score":0.29697406},"labels":[],"label_agreement":null},{"id":"W3195604829","doi":"10.1016/j.atherosclerosis.2021.08.018","title":"Fasting lipids are not a good way to assess the effects of diet on cardiovascular risk","year":2021,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Griffin; Cholesterol; Internal medicine; Medicine; Endocrinology; Ldl cholesterol; Saturated fat; Disease","score_opus":0.03580997333976588,"score_gpt":0.24913050639046228,"score_spread":0.2133205330506964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195604829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6747469,0.014184787,0.0033290733,0.28621325,0.0066032694,0.01135368,0.0006991501,0.00049953116,0.002370386],"genre_scores_gemma":[0.5359284,0.0037430855,0.00080832286,0.44216654,0.014219388,0.0012811061,0.00017301277,0.00054055685,0.0011395356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942137,0.0010884209,0.0006219259,0.0010679085,0.0022127947,0.00079523964],"domain_scores_gemma":[0.99484336,0.00076903385,0.00040678043,0.0034399098,0.00033379789,0.00020708914],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0015989124,0.000679647,0.0022403228,0.00015158574,0.00028183858,0.00007812559,0.00045143513,0.0008974309,0.000031271557],"category_scores_gemma":[0.0012766273,0.0004611857,0.0033260807,0.0006030802,0.00009424279,0.000038595183,0.0002475139,0.002599658,0.00006311252],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062800146,0.0011920313,0.018932799,0.03268122,0.04901357,0.0014658998,0.0032040963,0.00038476178,0.010790854,0.00005096693,0.6322697,0.2493861],"study_design_scores_gemma":[0.0036723868,0.0029324729,0.1840671,0.0135569675,0.008346453,0.000048371316,0.0002416025,0.000021394766,0.0229643,0.0000086934715,0.7629661,0.0011741553],"about_ca_topic_score_codex":0.0010325356,"about_ca_topic_score_gemma":0.000015057369,"teacher_disagreement_score":0.24821195,"about_ca_system_score_codex":0.00023821385,"about_ca_system_score_gemma":0.00015807056,"threshold_uncertainty_score":0.999784},"labels":[],"label_agreement":null},{"id":"W3198517583","doi":"10.1161/circgen.121.003312","title":"Utility of Genetically Predicted Lp(a) (Lipoprotein [a]) and ApoB Levels for Cardiovascular Risk Assessment","year":2021,"lang":"en","type":"article","venue":"Circulation Genomic and Precision Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Medical Research Council; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Apolipoprotein B; Lipoprotein(a); Biobank; Internal medicine; Context (archaeology); Prospective cohort study; Lipoprotein; Endocrinology; Cardiology; Cholesterol; Bioinformatics; Biology","score_opus":0.03564621130665246,"score_gpt":0.3004701312611815,"score_spread":0.26482391995452903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198517583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7077385,0.0258651,0.26355824,0.0005286857,0.00016341178,0.0015204381,0.00007102593,0.000027119397,0.0005274632],"genre_scores_gemma":[0.98201543,0.002803215,0.014378459,0.00015231762,0.00040776617,0.000050370905,0.000108091364,0.000026457965,0.000057891233],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975834,0.00027268444,0.00067330134,0.00058463664,0.00065837184,0.00022759626],"domain_scores_gemma":[0.99802166,0.00020340072,0.00016394998,0.0007637293,0.00055929064,0.00028796933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023341945,0.00019873747,0.0008999153,0.00010628727,0.00015167521,0.000012633266,0.000052572257,0.00018307808,0.00016890251],"category_scores_gemma":[0.0007685592,0.0001617881,0.00034104823,0.00019136765,0.00018870538,0.00004896422,0.00006978753,0.00019560973,6.7924015e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002475364,0.0000972347,0.046965167,0.0011219262,0.0015366815,0.000017056425,0.00044173174,0.00014491202,0.017157365,0.00049022335,0.0002218477,0.9315583],"study_design_scores_gemma":[0.0054255445,0.00030239415,0.9693637,0.00028942974,0.0012725422,0.00014148682,0.00017836744,0.010176407,0.00088076695,0.0021794848,0.009640417,0.00014949897],"about_ca_topic_score_codex":0.00011942507,"about_ca_topic_score_gemma":0.000006797218,"teacher_disagreement_score":0.9314088,"about_ca_system_score_codex":0.00004157501,"about_ca_system_score_gemma":0.00030215963,"threshold_uncertainty_score":0.6597528},"labels":[],"label_agreement":null},{"id":"W3198540846","doi":"10.1016/j.jbc.2021.101177","title":"Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furin","year":2021,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Canada Excellence Research Chairs, Government of Canada; Fondation Leducq; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"LDL receptor; Asialoglycoprotein receptor; PCSK9; Biology; Furin; Kexin; Molecular biology; Receptor; Proprotein convertase; Chemistry; Biochemistry; Cholesterol; Lipoprotein; Hepatocyte","score_opus":0.025496283157765073,"score_gpt":0.2543332051582681,"score_spread":0.22883692200050304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198540846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991221,0.006545594,0.00029537056,0.00096787605,0.0000778968,0.00012683807,0.00004029529,0.000009408432,0.00071570015],"genre_scores_gemma":[0.994853,0.0011439206,0.002147435,0.00046163672,0.0006807779,0.0000038144321,0.000018471219,0.000012725774,0.00067818747],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982913,0.00004201839,0.00065769744,0.00023652278,0.0005319088,0.00024054149],"domain_scores_gemma":[0.9985601,0.000035436773,0.0003943828,0.00030478253,0.00041866006,0.0002866733],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006129223,0.00016542326,0.00071533315,0.000018979446,0.00003545036,0.000012286583,0.00014087667,0.00036816712,0.00094330555],"category_scores_gemma":[0.00037907108,0.00011157694,0.00073305937,0.0001412312,0.00007523486,0.000033426528,0.00007628415,0.0005544839,0.000008443413],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003766401,0.00050440076,0.0009741589,0.00025133157,0.00032358718,0.00018546755,0.00004291818,2.880956e-7,0.9883488,0.000003326967,0.0020774852,0.0069116047],"study_design_scores_gemma":[0.0022561038,0.00040841225,0.0031832566,0.00022827377,0.000097631615,0.0017556967,0.00015174829,0.0000029319415,0.96829057,0.00002167187,0.023485864,0.00011781741],"about_ca_topic_score_codex":0.00001840218,"about_ca_topic_score_gemma":3.7786424e-7,"teacher_disagreement_score":0.021408377,"about_ca_system_score_codex":0.00009622689,"about_ca_system_score_gemma":0.00029822366,"threshold_uncertainty_score":0.99996996},"labels":[],"label_agreement":null},{"id":"W3198898259","doi":"10.1016/s0140-6736(21)01122-3","title":"Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)","year":2021,"lang":"en","type":"article","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":305,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIHR Imperial Biomedical Research Centre; Imperial College London; Canadian Institutes of Health Research; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Merck; Sanofi; Pfizer; Amgen","keywords":"Perspective (graphical); Cross-sectional study; Medicine; Pediatrics; Computer science; Pathology; Artificial intelligence","score_opus":0.06327643285215734,"score_gpt":0.3704606552888694,"score_spread":0.30718422243671206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198898259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98777574,0.004715625,0.000050120416,0.0043964293,0.0007831452,0.001039123,0.00046508427,0.000055342854,0.00071941194],"genre_scores_gemma":[0.9931543,0.0003821533,0.00015953236,0.0018442336,0.004200037,0.000091428905,0.000047503083,0.000020133259,0.00010066921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711007,0.0006309611,0.0004598957,0.0004941842,0.00097553234,0.0003293676],"domain_scores_gemma":[0.99718785,0.00018713826,0.00013563466,0.0012230296,0.0011856006,0.00008074056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012784873,0.00023073716,0.0008296,0.000020493379,0.00034039485,0.00010403174,0.00030719078,0.0001325871,0.000018988596],"category_scores_gemma":[0.0007108412,0.00013361996,0.0002491265,0.0005399806,0.0003130827,0.00013180925,0.00020144056,0.0004439058,0.000016748581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013552775,0.00039108316,0.9840718,0.000054266297,0.0015441136,0.00006410445,0.008530384,0.000082121645,0.0010094331,0.00051003514,0.001306153,0.0010812294],"study_design_scores_gemma":[0.005332242,0.0003194249,0.96289384,0.000056021145,0.000312474,0.000082858336,0.028739013,0.000023056784,0.00016340963,0.000738361,0.0012214103,0.000117894655],"about_ca_topic_score_codex":0.0028652244,"about_ca_topic_score_gemma":0.0029871096,"teacher_disagreement_score":0.021177966,"about_ca_system_score_codex":0.00056119537,"about_ca_system_score_gemma":0.0005659476,"threshold_uncertainty_score":0.54488635},"labels":[],"label_agreement":null},{"id":"W3199383294","doi":"10.1161/circ.132.suppl_3.12450","title":"Abstract 12450: Long-Term Efficacy and Safety of Lomitapide for the Treatment of Homozygous Familial Hypercholesterolemia: Results of the Phase 3 Extension Trial","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Robarts Clinical Trials","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Adverse effect; Internal medicine; Apheresis; Surgery; Gastroenterology; Cholesterol","score_opus":0.06797770056201222,"score_gpt":0.3335645383019249,"score_spread":0.26558683773991265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199383294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952779,0.0011737747,0.00044167347,0.00017617355,0.0002171426,0.0026139682,0.0000490759,0.000006136178,0.000044173325],"genre_scores_gemma":[0.9993432,0.000224534,0.000051107516,0.000014512991,0.00028398755,0.000023075,0.00004086753,0.000010613947,0.000008063749],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99890304,0.00006384066,0.00047333498,0.00016135165,0.00030144886,0.000096968135],"domain_scores_gemma":[0.9988009,0.00016692976,0.0002498807,0.00052570837,0.00019862634,0.00005795951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006793239,0.000093029,0.00035010424,0.000032759413,0.0000480421,0.0000033281033,0.00004480046,0.00008621185,9.745736e-7],"category_scores_gemma":[0.00024397587,0.000049920574,0.00021957417,0.00007562155,0.00008935239,0.00003347704,0.000010255035,0.00005056919,2.6569202e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12625752,0.0023226833,0.0067809857,0.00043660591,0.00047255942,0.0000069968487,0.0025949997,0.0005839704,0.03270531,0.000032089833,0.000046725592,0.82775956],"study_design_scores_gemma":[0.15581463,0.0015650657,0.8357919,0.00015943094,0.00048176426,0.000023999593,0.00008473171,0.00025981918,0.005548257,0.000022584487,0.00019716617,0.000050639057],"about_ca_topic_score_codex":0.00017490625,"about_ca_topic_score_gemma":0.00001679407,"teacher_disagreement_score":0.8290109,"about_ca_system_score_codex":0.000075399475,"about_ca_system_score_gemma":0.00013078509,"threshold_uncertainty_score":0.20357019},"labels":[],"label_agreement":null},{"id":"W3199437220","doi":"10.1161/circoutcomes.120.007183","title":"Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of Cardiology/Multisociety, US Preventive Services Task Force, Department of Veterans Affairs/Department of Defense, Canadian Cardiovascular Society, and European Society of Cardiology/European Atherosclerosis Society Clinical Practice Guidelines","year":2021,"lang":"en","type":"article","venue":"Circulation Cardiovascular Quality and Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Veterans Affairs; Population; Guideline; Internal medicine; Canadian Cardiovascular Society; Cardiology; Family medicine; Myocardial infarction; Pathology; Environmental health","score_opus":0.26237822966845875,"score_gpt":0.4110885372400911,"score_spread":0.14871030757163234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199437220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709987,0.012241229,0.009631354,0.00037053868,0.000095775365,0.0021846057,0.004455256,0.000010828761,0.000011726649],"genre_scores_gemma":[0.97915894,0.008172596,0.011987744,0.00011700587,0.000050173403,0.000045904155,0.0004126807,0.00004355841,0.000011417016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9895903,0.0053671338,0.0027010632,0.0007044174,0.0012999072,0.00033716188],"domain_scores_gemma":[0.9928441,0.0013253373,0.0021756333,0.0011474489,0.0023322909,0.00017518055],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013764304,0.0003474333,0.0038427657,0.000080020654,0.00015921387,0.000009011165,0.00015070173,0.00017874897,7.292954e-7],"category_scores_gemma":[0.0018221318,0.000306168,0.0073844213,0.00063790695,0.00058178924,0.00022301024,0.00020331706,0.00022182995,4.4885176e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012108799,0.00016271253,0.9458653,0.0025678882,0.034300502,0.000001094744,0.0010198253,0.008546729,0.00066255615,0.000013478821,0.00011926559,0.006619577],"study_design_scores_gemma":[0.0034361552,0.0002057955,0.98280424,0.0008231099,0.007840853,0.000008611046,0.0028059415,0.0004476199,0.0004145084,0.000015712405,0.0009640856,0.00023335418],"about_ca_topic_score_codex":0.012179191,"about_ca_topic_score_gemma":0.001093006,"teacher_disagreement_score":0.036938973,"about_ca_system_score_codex":0.00044762512,"about_ca_system_score_gemma":0.00047358865,"threshold_uncertainty_score":0.999939},"labels":[],"label_agreement":null},{"id":"W3200079007","doi":"10.5114/amsad.2021.109257","title":"Similarity and differences in small dense low-density lipoprotein assessment: two methods compared","year":2021,"lang":"en","type":"article","venue":"Archives of Medical Science - Atherosclerotic Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ministry of Education, Culture, Sports, Science and Technology","keywords":"Similarity (geometry); Lipoprotein; Geography; Medicine; Artificial intelligence; Computer science; Internal medicine; Cholesterol","score_opus":0.04337741232783329,"score_gpt":0.3621832884464103,"score_spread":0.318805876118577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200079007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870099,0.0012542858,0.009083285,0.0015656592,0.000104099185,0.0004959616,0.000011241282,0.00003345498,0.00044212624],"genre_scores_gemma":[0.97630817,0.000629435,0.022503031,0.00041097015,0.0000821597,0.000029787065,0.0000064456826,0.000011215427,0.000018790583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99631053,0.0005872943,0.00045944288,0.0006567509,0.0014735865,0.0005124043],"domain_scores_gemma":[0.9976512,0.0005366888,0.00010714527,0.00059669133,0.000082240214,0.0010260298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019458232,0.0001967517,0.00074859755,0.00014798294,0.00020102785,0.00005753186,0.00037317091,0.00006255339,0.00014528206],"category_scores_gemma":[0.0023217697,0.00015145185,0.00019154669,0.0005780906,0.0020725853,0.00009988716,0.00045614873,0.00035921313,0.0000012545128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014050699,0.0017652734,0.50360984,0.0011027026,0.00010976678,0.00031818548,0.000919698,0.0000055771166,0.014204276,0.0032484413,0.0000046866485,0.47457105],"study_design_scores_gemma":[0.0021544895,0.000121740624,0.98172486,0.001173548,0.00008884943,0.00004330768,0.00043666913,0.007487023,0.0027751897,0.0038240217,0.000014007698,0.00015626855],"about_ca_topic_score_codex":0.0011348766,"about_ca_topic_score_gemma":0.00031962915,"teacher_disagreement_score":0.47811505,"about_ca_system_score_codex":0.000040932264,"about_ca_system_score_gemma":0.0016693916,"threshold_uncertainty_score":0.7636527},"labels":[],"label_agreement":null},{"id":"W3201121031","doi":"10.21203/rs.3.rs-930142/v1","title":"Study of effect modifiers of genetically predicted CETP reduction","year":2021,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal","keywords":"Reduction (mathematics); Mathematics","score_opus":0.061610654976631256,"score_gpt":0.4079221706872991,"score_spread":0.3463115157106678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201121031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907978,0.0023819855,0.00010644142,0.00010934332,0.00021148172,0.0053996486,0.00003568381,0.00003353762,0.0009240819],"genre_scores_gemma":[0.99790114,0.00073581963,0.00026915022,0.0000022927409,0.00039877655,0.00037968092,0.00015680268,0.000044405017,0.00011193777],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9933204,0.001895611,0.0006014682,0.0006553191,0.003087155,0.00044006182],"domain_scores_gemma":[0.9957609,0.00011374497,0.00013261706,0.0018417718,0.0018683336,0.00028261068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003952622,0.00020952013,0.001100068,0.00046600838,0.00007016218,0.000021808033,0.00022159099,0.00039822274,0.00008487206],"category_scores_gemma":[0.00092292635,0.00017540564,0.00047633777,0.0006383296,0.00018979066,0.000022651566,0.0006376362,0.0016144967,0.0000020457223],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012376894,0.02793001,0.124140106,0.23224398,0.023363173,0.00295593,0.03898395,0.008504693,0.09941147,0.00021676646,0.0038341593,0.42603886],"study_design_scores_gemma":[0.016828697,0.040959004,0.77922827,0.014511613,0.0020195825,0.00026123654,0.03357901,0.0015658274,0.10974508,0.0001804313,0.00035600757,0.0007652267],"about_ca_topic_score_codex":0.0019397862,"about_ca_topic_score_gemma":0.00002338323,"teacher_disagreement_score":0.6550882,"about_ca_system_score_codex":0.00022001995,"about_ca_system_score_gemma":0.0013144809,"threshold_uncertainty_score":0.71528345},"labels":[],"label_agreement":null},{"id":"W3201570690","doi":"10.1038/s41598-021-97643-3","title":"Machine learning risk prediction model for acute coronary syndrome and death from use of non-steroidal anti-inflammatory drugs in administrative data","year":2021,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Department of Health, Government of Western Australia","keywords":"Acute coronary syndrome; Medicine; Gradient boosting; Receiver operating characteristic; Machine learning; Boosting (machine learning); Population; Cohort; Support vector machine; Artificial intelligence; Emergency medicine; Internal medicine; Computer science; Myocardial infarction; Random forest","score_opus":0.0411760771981501,"score_gpt":0.2991261595307595,"score_spread":0.2579500823326094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201570690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930929,0.0007305336,0.004183763,0.000033712284,0.0006290944,0.00086606696,0.0004231158,0.000022928472,0.000017919861],"genre_scores_gemma":[0.9919139,0.0001958256,0.004867534,0.000009720646,0.00003167281,0.00003134155,0.0022000282,0.00001870298,0.00073125644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780446,0.00007894799,0.0005799469,0.0008387792,0.000490923,0.00020695727],"domain_scores_gemma":[0.9981423,0.0000451261,0.0003059262,0.0012001438,0.00017017193,0.00013632614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016032136,0.00013132766,0.0004333612,0.00009979308,0.00015618105,0.0000673353,0.00006060455,0.000087603104,0.000010465118],"category_scores_gemma":[0.0002061814,0.00011826285,0.000097889184,0.00016604712,0.000088929424,0.0003412593,0.00016730127,0.0002182282,5.02319e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018833294,0.00021215381,0.9728798,0.00027003462,0.00063907995,0.004030251,0.0015973783,0.0011604513,0.013066404,0.000005858318,0.00028539432,0.0056648497],"study_design_scores_gemma":[0.001510873,0.00017487505,0.5948024,0.0003477008,0.0006307568,0.0026062457,0.00027012097,0.39423743,0.003990334,0.00033038805,0.0009233482,0.00017556877],"about_ca_topic_score_codex":0.0002512587,"about_ca_topic_score_gemma":0.000092593975,"teacher_disagreement_score":0.393077,"about_ca_system_score_codex":0.000045442797,"about_ca_system_score_gemma":0.00061536866,"threshold_uncertainty_score":0.4822619},"labels":[],"label_agreement":null},{"id":"W3201695038","doi":"10.1016/j.jlr.2021.100130","title":"The PCSK9 discovery, an inactive protease with varied functions in hypercholesterolemia, viral infections, and cancer","year":2021,"lang":"en","type":"review","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Proprotein convertase; LDL receptor; Kexin; Endosome; Familial hypercholesterolemia; Apolipoprotein B; Biology; Cancer research; Endoplasmic reticulum; Cholesterol; Cell biology; Chemistry; Receptor; Endocrinology; Biochemistry; Lipoprotein","score_opus":0.09201523223334673,"score_gpt":0.43429544647577956,"score_spread":0.3422802142424328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201695038","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00705093,0.9902669,0.00005707106,0.0005828521,0.0002218114,0.0015843067,0.00001624483,0.000003909276,0.00021592811],"genre_scores_gemma":[0.00080692186,0.9958708,0.00004899967,0.000025273946,0.0021065944,0.00034147472,0.000009725611,0.000045544475,0.0007446463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99534756,0.0019697477,0.0006670935,0.00030159304,0.0012789153,0.00043508312],"domain_scores_gemma":[0.9977026,0.0003205906,0.00028763138,0.0005372056,0.0008114382,0.00034051845],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005175747,0.00023007637,0.001383524,0.0005298766,0.00038561923,0.00025791806,0.00016778888,0.0002216819,0.000018041314],"category_scores_gemma":[0.0004536741,0.000115451956,0.00036639912,0.0008653519,0.0002471608,0.00036488587,0.000109727,0.003600525,0.000002388786],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023306419,0.00032484106,0.00056842726,0.003058041,0.0008414454,0.0002491205,0.00011213692,0.0000026634157,0.0000032712892,0.000037278533,0.00023779778,0.9943319],"study_design_scores_gemma":[0.0011254174,0.0016865695,0.00069007016,0.016406244,0.0005061031,0.002368196,0.0005845089,0.0000023609628,0.0000028171069,0.0000093858625,0.97649384,0.00012449815],"about_ca_topic_score_codex":0.0008823853,"about_ca_topic_score_gemma":0.0004724192,"teacher_disagreement_score":0.99420744,"about_ca_system_score_codex":0.0008364369,"about_ca_system_score_gemma":0.005956189,"threshold_uncertainty_score":0.9996791},"labels":[],"label_agreement":null},{"id":"W3202122649","doi":"10.1002/clc.23732","title":"Prevalence of atherosclerotic cardiovascular disease and subsequent major adverse cardiovascular events in <scp>Alberta, Canada</scp>: A real‐world evidence study","year":2021,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; Amgen (Canada); University of Calgary","funders":"Government of Alberta; Alberta Precision Laboratories; Amgen","keywords":"Mace; Medicine; Myocardial infarction; Atherosclerotic cardiovascular disease; Cohort; Confidence interval; Atherosclerosis Risk in Communities; Internal medicine; Cohort study; Incidence (geometry); Emergency medicine; Disease; Percutaneous coronary intervention","score_opus":0.054351489132531704,"score_gpt":0.3222348824293665,"score_spread":0.2678833932968348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202122649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9440897,0.052310213,0.000062894826,0.00014545296,0.00069000473,0.002378887,0.000033476455,0.00002599008,0.00026338483],"genre_scores_gemma":[0.981829,0.016404593,0.00009037834,0.00019055072,0.00055113755,0.00026074742,0.00001633988,0.00005758994,0.0005996711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.991246,0.003567575,0.0015239968,0.0015488801,0.0013540633,0.000759476],"domain_scores_gemma":[0.9938491,0.0015426318,0.0001982011,0.0031223763,0.00044598427,0.0008417126],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0058162925,0.00043401922,0.0031073252,0.00014120492,0.000091213486,0.0000060371676,0.00029380058,0.00024287082,0.000015936204],"category_scores_gemma":[0.006680148,0.00039704467,0.0027668208,0.00062900834,0.0003031219,0.00010179702,0.00036834655,0.0007336499,0.000008567683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012296853,0.00027952608,0.98537165,0.0012955052,0.007637077,0.002076995,0.000108444205,0.0005914937,0.00001617514,0.000025680773,0.000092583534,0.0023818885],"study_design_scores_gemma":[0.0035021885,0.00042109028,0.9856951,0.0006145234,0.005842528,0.000097344295,0.0004828169,0.0000358071,0.000026236989,0.00003091418,0.0030763554,0.0001750995],"about_ca_topic_score_codex":0.23447332,"about_ca_topic_score_gemma":0.07714587,"teacher_disagreement_score":0.15732744,"about_ca_system_score_codex":0.00036408825,"about_ca_system_score_gemma":0.0029813799,"threshold_uncertainty_score":0.9998481},"labels":[],"label_agreement":null},{"id":"W3203721135","doi":"10.1016/j.jacc.2021.08.009","title":"Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT","year":2021,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Clinical endpoint; Myocardial infarction; Concordance; Unstable angina; Internal medicine; Stroke (engine); Placebo; Cardiology; Randomized controlled trial; Surrogate endpoint; Revascularization","score_opus":0.03573280280697685,"score_gpt":0.3194443340398711,"score_spread":0.2837115312328943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203721135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98872656,0.001512517,0.000014139503,0.008654783,0.00017883896,0.00020161453,0.00000948056,0.0000021579067,0.0006998857],"genre_scores_gemma":[0.99823064,0.00062907557,0.00051491277,0.00035901283,0.00016466243,0.0000059424337,0.0000014300538,0.000007789898,0.00008652832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982191,0.0005480805,0.0006707656,0.00014766307,0.00025101195,0.00016340622],"domain_scores_gemma":[0.99862087,0.000064587955,0.0005921887,0.00031350023,0.00027116065,0.00013769389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007647424,0.000097953736,0.001205401,0.00017872371,0.000026946629,9.180358e-7,0.00009107622,0.000052890166,0.0000039257716],"category_scores_gemma":[0.0006380366,0.00007091243,0.00026338882,0.00090971007,0.00039842966,0.00003714312,0.00005980817,0.00042549483,3.296737e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018248913,0.00036304476,0.7082917,0.00018473876,0.0041032755,0.0032123076,0.0008764375,0.0012538045,0.24164309,0.00013008754,0.036250733,0.0018658817],"study_design_scores_gemma":[0.0036158378,0.00051515206,0.93576,0.0004677984,0.00039011522,0.02399187,0.0047596763,0.000034057393,0.02013976,0.00029311367,0.009898214,0.0001343702],"about_ca_topic_score_codex":0.00008899947,"about_ca_topic_score_gemma":0.000028565619,"teacher_disagreement_score":0.22746833,"about_ca_system_score_codex":0.0001285097,"about_ca_system_score_gemma":0.0013379627,"threshold_uncertainty_score":0.28917247},"labels":[],"label_agreement":null},{"id":"W3203892369","doi":"10.1007/s10557-021-07268-x","title":"The Projected Impact of Population-Wide Achievement of LDL Cholesterol &lt;70 mg/dL on the Number of Recurrent Events Among US Adults with ASCVD","year":2021,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"","keywords":"Medicine; Ezetimibe; Atherosclerotic cardiovascular disease; Population; Cumulative incidence; Internal medicine; PCSK9; Incidence (geometry); Evolocumab; Statin; Familial hypercholesterolemia; Cholesterol; Endocrinology; Lipoprotein; Cohort; Disease; LDL receptor; Environmental health","score_opus":0.009495244920186595,"score_gpt":0.25865906467720745,"score_spread":0.24916381975702084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203892369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856982,0.012234614,0.000052062882,0.00017472087,0.00008597458,0.0014863912,0.000023368284,0.000012223491,0.00023243192],"genre_scores_gemma":[0.9907026,0.008877056,0.000046710513,0.00006530558,0.00009922722,0.00009092864,0.0000470933,0.00003657945,0.000034495177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729484,0.0004740598,0.00049079076,0.00035099583,0.0011168481,0.00027245248],"domain_scores_gemma":[0.9977054,0.00010628363,0.00025153332,0.0013633516,0.00046802062,0.000105386476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013443362,0.0002554979,0.00085713755,0.0000478834,0.00013592913,0.000014894647,0.00013176982,0.00009188461,0.00001616394],"category_scores_gemma":[0.00007055279,0.00012288327,0.0014961447,0.00036540593,0.00013745087,0.00005170573,0.000041303214,0.00022352037,7.8625334e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028343464,0.00083001313,0.6304155,0.000647127,0.025389304,0.000022383905,0.002537228,0.00030538134,0.00040382292,0.00023808792,0.00008439643,0.3362924],"study_design_scores_gemma":[0.005757963,0.0006399713,0.98611563,0.00083001767,0.00044615034,0.000043913904,0.00042992597,0.00004889614,0.003878612,0.00004483514,0.0016107279,0.00015336156],"about_ca_topic_score_codex":0.0014670591,"about_ca_topic_score_gemma":0.000032012213,"teacher_disagreement_score":0.3557001,"about_ca_system_score_codex":0.000064211075,"about_ca_system_score_gemma":0.00018534163,"threshold_uncertainty_score":0.5011034},"labels":[],"label_agreement":null},{"id":"W3203942868","doi":"10.1007/s41669-021-00300-8","title":"Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia","year":2021,"lang":"en","type":"article","venue":"PharmacoEconomics - Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Evolocumab; Medicine; Ezetimibe; Familial hypercholesterolemia; Dyslipidemia; Statin; Internal medicine; Quality-adjusted life year; Alirocumab; Cost effectiveness; Cholesterol; Disease; Lipoprotein","score_opus":0.11329147644652462,"score_gpt":0.427569372084309,"score_spread":0.3142778956377844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203942868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920399,0.0023478442,0.0006024463,0.0007835559,0.00011940453,0.0035162594,0.00016033564,0.0000021613964,0.00042806147],"genre_scores_gemma":[0.9976152,0.0011199365,0.00024218742,0.0002712325,0.00007338559,0.0005813323,0.000054601845,0.0000123552,0.000029724159],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987509,0.00026533552,0.0004937162,0.00022199562,0.00011660698,0.00015141434],"domain_scores_gemma":[0.9980753,0.00081319915,0.00025487124,0.00068051176,0.00013720753,0.000038877053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021550972,0.00011378728,0.000951387,0.000091641436,0.00004046492,0.000012070602,0.00027050043,0.000041513606,0.000089453366],"category_scores_gemma":[0.00006937576,0.0000682609,0.0005393949,0.00038140384,0.000057953723,0.00005501674,0.000054045024,0.00006713874,7.1902144e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008283414,0.005899205,0.22270125,0.0025219268,0.06654343,0.000037655245,0.008066596,0.044575926,0.020575857,0.0058388007,0.0011256174,0.6138303],"study_design_scores_gemma":[0.030223817,0.0013845336,0.52512014,0.000232654,0.023639979,0.00001856814,0.0020709392,0.035243202,0.28164625,0.00041273772,0.099634506,0.00037269387],"about_ca_topic_score_codex":0.0026215587,"about_ca_topic_score_gemma":0.00042951686,"teacher_disagreement_score":0.6134576,"about_ca_system_score_codex":0.00018345076,"about_ca_system_score_gemma":0.00031422125,"threshold_uncertainty_score":0.396303},"labels":[],"label_agreement":null},{"id":"W3204230360","doi":"10.2196/29379","title":"Statin Use and COVID-19 Infectivity and Severity in South Korea: Two Population-Based Nationwide Cohort Studies","year":2021,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Institute for Information and Communications Technology Promotion; Iran Telecommunication Research Center; Ministry of Science and ICT, South Korea; National Health Insurance Service","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Cohort; Population; Cohort study; Pandemic; Infectivity; Environmental health; Epidemiology; Virology; Outbreak; Internal medicine; Disease; Infectious disease (medical specialty); Virus","score_opus":0.05368629618633777,"score_gpt":0.3557728579457016,"score_spread":0.3020865617593639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204230360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823178,0.00502312,0.0005099156,0.011025951,0.000051129868,0.00093424617,0.00005711404,0.000053156236,0.00002753637],"genre_scores_gemma":[0.9902741,0.0014978955,0.00040550347,0.007448517,0.00006457793,0.00011617343,0.0001497868,0.000013015677,0.000030431043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977745,0.0006886522,0.0003677936,0.0004640501,0.0003289546,0.00037603875],"domain_scores_gemma":[0.99812794,0.00043990696,0.00011647768,0.00027640295,0.0002318705,0.0008074289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027964634,0.00015897673,0.0006302924,0.00013265836,0.0002418676,0.00007950237,0.000019472705,0.000069834015,0.000005307516],"category_scores_gemma":[0.0036130385,0.00014262708,0.00004018696,0.00038924464,0.00008463605,0.00017067714,0.000047143807,0.00021825558,3.430899e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037919697,0.000060808383,0.98652214,0.0010551153,0.00005495945,0.000024030582,0.00097366597,0.0000059858503,8.2753564e-7,0.0001345591,0.00009073526,0.0110392785],"study_design_scores_gemma":[0.0024861784,0.00008276921,0.9908897,0.000028195604,0.0000023717464,0.000046304518,0.00043056777,0.00062642776,5.1286895e-7,0.000073152434,0.0052072513,0.00012652767],"about_ca_topic_score_codex":0.0043098046,"about_ca_topic_score_gemma":0.010211942,"teacher_disagreement_score":0.010912751,"about_ca_system_score_codex":0.00023392477,"about_ca_system_score_gemma":0.001975183,"threshold_uncertainty_score":0.65151644},"labels":[],"label_agreement":null},{"id":"W3205096741","doi":"10.1016/j.cjca.2021.07.178","title":"SUBOPTIMAL CONTROL OF CHOLESTEROL LEVELS AMONG INDIVIDUALS WITH FAMILIAL HYPERCHOLESTEROLEMIA AND SEVERE HYPERCHOLESTEROLEMIA IN ONTARIO, CANADA","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Interquartile range; Cohort; Population; Internal medicine; Ambulatory; Cholesterol; Lipid profile; Pediatrics; Environmental health","score_opus":0.012473134670063786,"score_gpt":0.20761351003806242,"score_spread":0.19514037536799864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205096741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966197,0.00086618395,0.00026708486,0.00063962326,0.00022342005,0.00027945667,0.00008367052,0.0000022721463,0.001018601],"genre_scores_gemma":[0.9984052,0.000027710317,0.00027469618,0.0008678443,0.00029858935,0.0000067578753,0.000011631302,0.000028415305,0.00007914853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977133,0.00032976092,0.0007086387,0.00028789413,0.0004103081,0.0005500499],"domain_scores_gemma":[0.9979311,0.000067449546,0.00023191945,0.00038504213,0.00045787432,0.000926621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080882484,0.0002417141,0.0013990371,0.00026974772,0.0000589779,0.000022816012,0.0001471909,0.00025050313,0.00002641807],"category_scores_gemma":[0.0001141288,0.00020561095,0.00019230165,0.00017350496,0.00024683875,0.00013376196,0.000019932595,0.00093391206,3.672515e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012123474,0.000004413486,0.99216795,0.00006680912,0.00051592395,0.0021146222,0.00033513719,0.0011662166,0.00028855444,0.000009180468,0.00019496265,0.0030149745],"study_design_scores_gemma":[0.006598884,0.0004224598,0.970942,0.00031547336,0.00029113577,0.009547033,0.0004665595,0.000004472875,0.00017222334,0.000009365592,0.011058873,0.00017149019],"about_ca_topic_score_codex":0.886391,"about_ca_topic_score_gemma":0.994721,"teacher_disagreement_score":0.10832998,"about_ca_system_score_codex":0.0008213682,"about_ca_system_score_gemma":0.018012663,"threshold_uncertainty_score":0.9875543},"labels":[],"label_agreement":null},{"id":"W3205253670","doi":"10.1016/j.cjca.2021.07.169","title":"COVID-19 PANDEMIC INDUCED DISRUPTIONS IN TROPONIN AND LOW-DENSITY LIPOPROTEIN CHOLESTEROL LABORATORY TEST VOLUMES ACROSS ALBERTA","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Coronavirus Infections; Test (biology); Internal medicine; Cardiology; Outbreak","score_opus":0.02258335588911922,"score_gpt":0.2932478879188445,"score_spread":0.2706645320297253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205253670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931372,0.002436623,0.00023993202,0.003395836,0.00029566075,0.00024246106,0.000055336914,0.0000060136817,0.00019094365],"genre_scores_gemma":[0.99661773,0.00031692462,0.000062665815,0.0019704686,0.00087977306,0.000010420336,0.000012215272,0.000021960721,0.00010782152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981778,0.00039236015,0.0004766086,0.00026438292,0.00017964354,0.0005092028],"domain_scores_gemma":[0.9971297,0.00014059356,0.00014161714,0.00038937473,0.000331647,0.0018670749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011474726,0.00016693046,0.00085481827,0.00019881113,0.00016630934,0.000034846897,0.000099265824,0.00029040576,0.000022639728],"category_scores_gemma":[0.0032951415,0.00015641189,0.00023215624,0.00032532105,0.00020671546,0.0000949282,0.000027316777,0.00071194675,0.000005780792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060166407,0.000012884636,0.970811,0.00019240075,0.00029560423,0.0035440535,0.0011550065,0.00008101952,0.0047602076,0.000031134008,0.00076901616,0.018287513],"study_design_scores_gemma":[0.0034509723,0.0003136294,0.92516124,0.00014174318,0.00012109821,0.010763181,0.0011501164,0.000010863417,0.0003361623,0.00006520885,0.058292776,0.00019300646],"about_ca_topic_score_codex":0.03634397,"about_ca_topic_score_gemma":0.28361338,"teacher_disagreement_score":0.2472694,"about_ca_system_score_codex":0.0006824501,"about_ca_system_score_gemma":0.008116278,"threshold_uncertainty_score":0.9975068},"labels":[],"label_agreement":null},{"id":"W3205478177","doi":"10.4103/jrms.jrms_970_19","title":"Apolipoprotein B gene mutation related to familial hypercholesterolemia in an Iranian population","year":2021,"lang":"en","type":"article","venue":"Journal of Research in Medical Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Apolipoprotein B; Medicine; Familial hypercholesterolemia; Exon; Mutation; Complementary DNA; Internal medicine; Gene; genomic DNA; Population; Primer (cosmetics); Genetics; Endocrinology; Molecular biology; Cholesterol; Biology; Chemistry","score_opus":0.09788253547347636,"score_gpt":0.45594210102417354,"score_spread":0.3580595655506972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205478177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98340887,0.00049144187,0.00007122764,0.015380496,0.00016047995,0.0002716993,5.506511e-7,0.0000044919298,0.00021075176],"genre_scores_gemma":[0.9962593,0.00020413595,0.0028251593,0.00033963646,0.0003347257,0.0000069599946,0.00000318876,0.000006062668,0.000020854332],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9934892,0.0009939485,0.00064290315,0.00024715654,0.004191967,0.0004348224],"domain_scores_gemma":[0.99865717,0.00010331069,0.00006770319,0.00017750375,0.0003068956,0.0006874204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018471766,0.000070066664,0.00031993646,0.0007319508,0.000102103084,0.000052049825,0.00024379315,0.0001539634,0.00009436713],"category_scores_gemma":[0.0025763558,0.00005093296,0.00008134214,0.0022902407,0.00018743268,0.0002722633,0.000059297767,0.0010132304,0.00000757819],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003444699,0.00063164695,0.28529477,0.00017253947,0.000025775535,0.011348014,0.0016946087,0.0005210644,0.014314642,0.0003178609,0.00006945634,0.6852651],"study_design_scores_gemma":[0.002916139,0.0020147867,0.98197067,0.0013193983,0.000007951615,0.002321359,0.0017971522,0.0016498945,0.0027279821,0.0027233846,0.00044852818,0.00010272843],"about_ca_topic_score_codex":0.0014705006,"about_ca_topic_score_gemma":0.0013197664,"teacher_disagreement_score":0.6966759,"about_ca_system_score_codex":0.00030743456,"about_ca_system_score_gemma":0.0014652216,"threshold_uncertainty_score":0.64019823},"labels":[],"label_agreement":null},{"id":"W3205769256","doi":"10.1210/endrev/bnab035","title":"The Multifaceted Biology of PCSK9","year":2021,"lang":"en","type":"review","venue":"Endocrine Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; LDL receptor; Proprotein convertase; Cell biology; Biology; Receptor; Downregulation and upregulation; Cancer research; Cholesterol; Biochemistry; Lipoprotein","score_opus":0.09529019139979464,"score_gpt":0.421521547957104,"score_spread":0.3262313565573094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205769256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.876179e-7,0.9942609,0.00003873138,0.00011703467,0.00038798325,0.0032681327,0.00001969478,0.00002343784,0.0018837202],"genre_scores_gemma":[3.2339648e-7,0.996094,0.00063967385,0.000058288337,0.0006328739,0.00051950343,0.0002198472,0.000053553278,0.0017819487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962903,0.0010980499,0.0015396765,0.0004349498,0.0002306125,0.0004063833],"domain_scores_gemma":[0.9970105,0.0002082458,0.00065311545,0.0018511715,0.0001323838,0.00014457652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013344309,0.00041425964,0.0055847173,0.000081889004,0.00008560513,0.000010794424,0.00026095507,0.0001394094,0.00015848874],"category_scores_gemma":[0.0010642192,0.00019882974,0.0032503544,0.0005098175,0.0001016047,0.000013813642,0.00015737412,0.00058112846,0.00017935093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014760891,0.000029712179,8.385484e-7,0.03666193,0.00040350226,0.000027196718,0.000004520699,4.145479e-9,5.718232e-7,0.00029128653,0.0015187513,0.9610602],"study_design_scores_gemma":[0.000262023,0.000074228024,7.688598e-7,0.024417855,0.0019080812,0.0006453342,0.0000061897595,2.6746318e-7,0.00000638202,0.000003711456,0.9725228,0.00015238216],"about_ca_topic_score_codex":0.00007726306,"about_ca_topic_score_gemma":0.000006741101,"teacher_disagreement_score":0.971004,"about_ca_system_score_codex":0.00008100682,"about_ca_system_score_gemma":0.00053102017,"threshold_uncertainty_score":0.8108041},"labels":[],"label_agreement":null},{"id":"W3205958687","doi":"10.1016/j.cjca.2021.07.174","title":"SMARTPHONE APPLICATION TO RISK STRATIFY PATIENTS WITH CORONARY ARTERY DISEASE AND FACILITATE PERSONALIZED GUIDELINE-DIRECTED MEDICAL THERAPY","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Coronary artery disease; Intensive care medicine; Disease; Residual risk; Smoking cessation; Comorbidity; Risk assessment; Physical therapy; Internal medicine; Pathology","score_opus":0.011781038681985727,"score_gpt":0.24014788956660357,"score_spread":0.22836685088461783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205958687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98486364,0.00438631,0.0068624625,0.0030787948,0.00015348628,0.0003721401,0.000103542574,0.000008959188,0.0001706824],"genre_scores_gemma":[0.9963685,0.0006175712,0.0007710432,0.0015369409,0.00054392224,0.000015638061,0.00008941414,0.000016337844,0.000040577244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848855,0.0002942743,0.00037537882,0.00020912533,0.00037496266,0.00025772577],"domain_scores_gemma":[0.9969174,0.00003853109,0.00009943057,0.00026390326,0.00072652975,0.001954164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058938144,0.00012751753,0.00053108647,0.000116561816,0.00008940294,0.000011747096,0.00006406319,0.000099498626,0.00006612826],"category_scores_gemma":[0.00033982217,0.00009454823,0.00016696096,0.00014918689,0.0001259043,0.000038620667,0.000007583945,0.00027582853,0.0000042130005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001551305,0.000021347625,0.7116835,0.000046436355,0.001674689,0.0025301473,0.00051651965,0.00013084807,0.00007928027,0.000022020002,0.0071004983,0.2746434],"study_design_scores_gemma":[0.0039098356,0.00049250654,0.85113776,0.00005080909,0.00017619866,0.0009555875,0.00010411134,0.00003317071,0.000008228949,0.000036401754,0.1429902,0.00010519223],"about_ca_topic_score_codex":0.000650743,"about_ca_topic_score_gemma":0.0015047442,"teacher_disagreement_score":0.27453822,"about_ca_system_score_codex":0.00010544917,"about_ca_system_score_gemma":0.0034901255,"threshold_uncertainty_score":0.6191333},"labels":[],"label_agreement":null},{"id":"W3205985798","doi":"10.1161/circ.132.suppl_3.18667","title":"Abstract 18667: Lipoprotein(a) Catabolism and Apolipoprotein(a) Secretion is Regulated by Sortilin","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Internalization; LDL receptor; Apolipoprotein B; PCSK9; Catabolism; Endocytosis; Kexin; Lipoprotein; Receptor; Proprotein convertase; Secretion; Internal medicine; Endocrinology; Cell biology; Biology; Biochemistry; Medicine; Cholesterol; Metabolism","score_opus":0.023485877363787894,"score_gpt":0.2670939761907389,"score_spread":0.24360809882695098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205985798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888333,0.0046055596,0.0015923018,0.0013547029,0.00018207794,0.0014125232,0.00002254858,0.00017676175,0.0018202025],"genre_scores_gemma":[0.99785775,0.000117451375,0.0003597982,0.00050050707,0.0005494145,0.00007067974,0.00031879562,0.000049268434,0.00017635839],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979242,0.000060011917,0.0004164907,0.0004886981,0.00076611555,0.00034448164],"domain_scores_gemma":[0.9984372,0.000009487871,0.00016424064,0.0006335588,0.00028060522,0.00047488871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007916802,0.00022996264,0.00040625603,0.00012570516,0.00012340024,0.00005339071,0.000059469374,0.00028902665,0.00007608271],"category_scores_gemma":[0.0001274378,0.00022185307,0.00013712926,0.0002723657,0.00007815509,0.00024973473,0.00003199778,0.00025675178,0.00006686069],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008738934,0.0005546036,0.04700885,0.0014544366,0.0006396161,0.00008912563,0.004048202,0.00014817552,0.14801268,0.0014215795,0.017746724,0.77800214],"study_design_scores_gemma":[0.0053941114,0.00015721841,0.9354664,0.00026154815,0.00025809763,0.00028264645,0.00028023933,0.0037294566,0.018196901,0.0024267854,0.03298004,0.0005665762],"about_ca_topic_score_codex":0.0021638097,"about_ca_topic_score_gemma":0.000015525116,"teacher_disagreement_score":0.88845754,"about_ca_system_score_codex":0.00017157062,"about_ca_system_score_gemma":0.00020585,"threshold_uncertainty_score":0.90469056},"labels":[],"label_agreement":null},{"id":"W3206740620","doi":"10.1016/j.clinbiochem.2021.10.003","title":"Validating the NIH LDL-C equation in a specialized lipid cohort: Does it add up?","year":2021,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Structural equation modeling; Chemistry; Ldl cholesterol; Cohort; Hypertriglyceridemia; Internal medicine; Medicine; Cholesterol; Triglyceride; Mathematics; Statistics","score_opus":0.058006392303869135,"score_gpt":0.3719475895326534,"score_spread":0.3139411972287843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206740620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985238,0.00068840757,0.00014684054,0.006025459,0.0006878914,0.0003755753,0.000010609524,0.000037903334,0.006789276],"genre_scores_gemma":[0.9883727,0.0006147111,0.00060066715,0.0027743857,0.004220147,0.00004948919,0.00015520162,0.000021472086,0.0031912413],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783456,0.00021195824,0.00078366906,0.00047995817,0.00043375755,0.00025611767],"domain_scores_gemma":[0.99828595,0.00036245762,0.00014273966,0.00088897935,0.00015574484,0.00016413673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002441229,0.00013594251,0.0004821662,0.000013546264,0.00007510981,0.00003447963,0.000119217264,0.0002652499,0.0006809702],"category_scores_gemma":[0.0048086517,0.00008502576,0.00041973748,0.00024744304,0.000115467774,0.000024741776,0.000101299396,0.0005463007,0.000046700905],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011641535,0.0021992642,0.4863275,0.002365195,0.0017377513,0.00090598897,0.00086649676,0.000010304409,0.09403749,0.00040936412,0.041134253,0.36884224],"study_design_scores_gemma":[0.014009567,0.00023778886,0.11579035,0.0016888949,0.00085686275,0.00024700936,0.0031999191,0.0005363253,0.715623,0.0008077675,0.14617337,0.0008291062],"about_ca_topic_score_codex":0.00004952981,"about_ca_topic_score_gemma":0.000029949759,"teacher_disagreement_score":0.62158555,"about_ca_system_score_codex":0.000083594314,"about_ca_system_score_gemma":0.0005285788,"threshold_uncertainty_score":0.74561465},"labels":[],"label_agreement":null},{"id":"W3207185617","doi":"10.1016/j.cjco.2021.10.003","title":"Increasing Prevalence and Incidence of Atherosclerotic Cardiovascular Disease in Adult Patients in Ontario, Canada From 2002 to 2018","year":2021,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; McMaster University; St. Michael's Hospital; Amgen (Canada)","funders":"Canadian Institutes of Health Research; Amgen Canada; Novo Nordisk; Government of Ontario; Institute for Clinical Evaluative Sciences; Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Novartis; Merck; GlaxoSmithKline; Bayer","keywords":"Medicine; Incidence (geometry); Atherosclerotic cardiovascular disease; Demographics; Observational study; Epidemiology; Internal medicine; Disease; Demography","score_opus":0.013290367323276058,"score_gpt":0.23076826318113394,"score_spread":0.21747789585785787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207185617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966138,0.0017671713,0.000009919422,0.00009529236,0.00007442175,0.0010990133,0.000031953707,0.0000025872932,0.00030582887],"genre_scores_gemma":[0.9984763,0.0002134203,0.00062228274,0.00040183013,0.000023159451,0.000052351385,0.000019119227,0.000013237204,0.00017829199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840444,0.00018676117,0.00028995913,0.0003937048,0.0005153333,0.00020977207],"domain_scores_gemma":[0.99879235,0.000032898293,0.000039259932,0.00071553374,0.0001430369,0.00027689323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045467608,0.000113242066,0.0005476564,0.00003930877,0.000026981294,0.000021701051,0.0001548712,0.00003919955,0.00013454276],"category_scores_gemma":[0.00048889825,0.000110059365,0.000075632626,0.00020537153,0.000021442444,0.00011413537,0.00028710967,0.00014815008,0.0000028895893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014772936,0.00008315878,0.99389726,0.00017191029,0.00009568774,0.00021739012,0.0003574068,0.00008460481,0.000044618435,0.0000029967957,0.00007898834,0.00481822],"study_design_scores_gemma":[0.0019866077,0.00003972322,0.9951903,0.0014138022,0.00010157262,0.0000046968075,0.000061049635,0.000035043096,0.00016227129,0.000011061546,0.0008826185,0.00011123963],"about_ca_topic_score_codex":0.9979789,"about_ca_topic_score_gemma":0.9909866,"teacher_disagreement_score":0.0069923257,"about_ca_system_score_codex":0.0005265852,"about_ca_system_score_gemma":0.0020074013,"threshold_uncertainty_score":0.44880906},"labels":[],"label_agreement":null},{"id":"W3207452427","doi":"10.1016/j.cjca.2021.07.056","title":"HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Ezetimibe; Disease; Pediatrics; Compound heterozygosity; Genetic testing; Internal medicine; Statin; Cholesterol; Mutation; Genetics","score_opus":0.01235489255459267,"score_gpt":0.21904574584018513,"score_spread":0.20669085328559245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207452427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863287,0.004063116,0.00016919305,0.0017639588,0.0010321959,0.00008204628,0.000014726198,0.000001420222,0.0065446077],"genre_scores_gemma":[0.99710315,0.00017279526,0.00011817226,0.0013208259,0.0011945039,0.0000016994386,0.000005337589,0.000012573894,0.000070934366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987814,0.00017194565,0.00035925338,0.00012371957,0.0001914307,0.00037224655],"domain_scores_gemma":[0.9986553,0.000024332196,0.000059309456,0.00026056255,0.0002652637,0.0007352117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037534817,0.000092206006,0.0006398996,0.00014986226,0.000034270088,0.0000071058043,0.00008543623,0.00009438946,0.00002576129],"category_scores_gemma":[0.00019135543,0.00008469048,0.00021661389,0.00017652653,0.000041403015,0.000030945008,0.000007894017,0.00044636114,0.0000031641878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000118252414,0.0000049150813,0.66680145,0.00013327737,0.0007390148,0.17302597,0.00023809902,0.0027777427,0.00068253756,0.00013652335,0.023492167,0.13185002],"study_design_scores_gemma":[0.0019248833,0.00012439654,0.5741634,0.000095348936,0.00009781107,0.045297746,0.00060859637,0.0000054948655,0.00017178612,0.000052856787,0.37733987,0.00011784047],"about_ca_topic_score_codex":0.8981328,"about_ca_topic_score_gemma":0.9911115,"teacher_disagreement_score":0.35384768,"about_ca_system_score_codex":0.0013260174,"about_ca_system_score_gemma":0.04152157,"threshold_uncertainty_score":0.9639121},"labels":[],"label_agreement":null},{"id":"W3207549389","doi":"10.1093/eurheartj/ehab724.1254","title":"12-month post-trial follow-up of participants in the Australian arm of the second low-dose colchicine trial","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Placebo; Randomized controlled trial; Internal medicine; Myocardial infarction; Clinical trial; Physical therapy; Stroke (engine); Cohort; Smoking cessation; Surgery","score_opus":0.07324009751438443,"score_gpt":0.321881726260687,"score_spread":0.24864162874630258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207549389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907323,0.00037524907,0.0000020883706,0.0035745923,0.001402421,0.00097300846,0.00001651675,0.000005250098,0.0029185521],"genre_scores_gemma":[0.9951132,0.000046731035,0.000053874068,0.0010150336,0.0018703694,0.000004616041,0.0000041362655,0.000028310338,0.0018637358],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957704,0.00198378,0.0008357886,0.0001908548,0.0008264563,0.00039271713],"domain_scores_gemma":[0.9985303,0.00009399093,0.00027000814,0.00070351205,0.00021435211,0.00018781889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004296627,0.00015348129,0.00058695924,0.00007159586,0.00013050897,0.000032412612,0.0002240129,0.000050495128,0.00053825596],"category_scores_gemma":[0.0006651213,0.000084890606,0.00067004765,0.00025758016,0.00009671086,0.000060073413,0.00007154785,0.00077947794,0.000012991981],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7339446,0.010330699,0.04095739,0.0018505291,0.0030288536,0.007571136,0.025363738,0.00013250644,0.092355646,0.00038396113,0.059536032,0.024544919],"study_design_scores_gemma":[0.5035996,0.0068734903,0.40182325,0.0010269996,0.0004846979,0.0017705386,0.0024858941,0.000011815701,0.012403732,0.000043823773,0.069235496,0.00024069757],"about_ca_topic_score_codex":0.00005488299,"about_ca_topic_score_gemma":0.00028542016,"teacher_disagreement_score":0.36086586,"about_ca_system_score_codex":0.00004087922,"about_ca_system_score_gemma":0.00056983775,"threshold_uncertainty_score":0.58935255},"labels":[],"label_agreement":null},{"id":"W3208237440","doi":"10.1097/mol.0000000000000796","title":"Familial combined hyperlipidemia is a polygenic trait","year":2021,"lang":"en","type":"article","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Etiology; Multifactorial Inheritance; Polygenic risk score; Epigenetics; Genomics; Hyperlipidemia; Trait; Cohort","score_opus":0.06609036665825542,"score_gpt":0.35345271874514694,"score_spread":0.28736235208689154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208237440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7084608,0.049143255,0.0012777264,0.018050108,0.2185093,0.0017611602,0.00008987842,0.00025061078,0.0024571253],"genre_scores_gemma":[0.8663013,0.017342586,0.0015592766,0.0061129527,0.1057349,0.00048247058,0.0010575836,0.00016909062,0.001239854],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997905,0.00028981068,0.00051337696,0.0005119617,0.00031021182,0.00046964778],"domain_scores_gemma":[0.99892503,0.00007460104,0.000072394905,0.0006065647,0.00011141458,0.00020998971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004272055,0.0002026538,0.00069484726,0.00014821555,0.000055423927,0.000009190894,0.00010369758,0.00022022026,0.000529796],"category_scores_gemma":[0.0002357838,0.00018515342,0.00037518222,0.00037288782,0.00008592405,0.000049927174,0.000086491826,0.0005376799,0.000088407476],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012358729,0.0026404946,0.15291132,0.003924815,0.00057898735,0.000010256516,0.0021220262,0.000017869303,0.0041675717,0.0124509055,0.4290125,0.39092737],"study_design_scores_gemma":[0.0065864637,0.0004142822,0.16575645,0.0003761994,0.000059668964,0.0003361252,0.00019237174,0.00017234827,0.00027637326,0.00059883256,0.8249644,0.00026646547],"about_ca_topic_score_codex":0.000055876997,"about_ca_topic_score_gemma":0.000011037078,"teacher_disagreement_score":0.3959519,"about_ca_system_score_codex":0.00011941175,"about_ca_system_score_gemma":0.0004621487,"threshold_uncertainty_score":0.75503373},"labels":[],"label_agreement":null},{"id":"W3208705919","doi":"10.1161/circulationaha.121.055560","title":"Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"Amarin Corporation; Brigham and Women's Hospital","keywords":"Renal function; Disease; Kidney disease; Kidney; Creatinine","score_opus":0.01865975771296765,"score_gpt":0.24456437442692272,"score_spread":0.22590461671395506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208705919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962884,0.0019043554,0.00035100814,0.0003196505,0.00012943675,0.00089122896,0.000041593485,0.000012454112,0.00006183183],"genre_scores_gemma":[0.99913526,0.00006861093,0.000048815953,0.00026970272,0.000119551216,0.000056222194,0.00026637496,0.000022065618,0.000013429732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998033,0.0001724799,0.00038029568,0.00030440357,0.0008912526,0.00021857934],"domain_scores_gemma":[0.9983015,0.000028929131,0.00013386388,0.0008506807,0.00049458735,0.00019041279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007607785,0.00012926821,0.00044404404,0.000059417922,0.00006295324,0.000013765475,0.000056386965,0.000077471894,0.00004263603],"category_scores_gemma":[0.0004996623,0.000084004314,0.00032444735,0.0005866571,0.000056034565,0.00013558326,0.000031232048,0.00013718738,0.0000015029887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000991225,0.00037069203,0.9474312,0.0007667572,0.00083467306,0.0000070105716,0.0005445352,0.008094,0.00018768845,0.000024065033,0.00007305333,0.04067512],"study_design_scores_gemma":[0.004624227,0.00011066907,0.9923042,0.0005804411,0.00057803036,0.0000016492157,0.00012798105,0.00020448162,0.0006572315,0.00001394369,0.00070286664,0.000094281175],"about_ca_topic_score_codex":0.000115380426,"about_ca_topic_score_gemma":0.00002186106,"teacher_disagreement_score":0.044873018,"about_ca_system_score_codex":0.00009633331,"about_ca_system_score_gemma":0.00047171683,"threshold_uncertainty_score":0.34255964},"labels":[],"label_agreement":null},{"id":"W3208891341","doi":"10.3389/fcvm.2021.764038","title":"Regulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications","year":2021,"lang":"en","type":"review","venue":"Frontiers in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"PCSK9; Proprotein convertase; Kexin; LDL receptor; Cancer research; Cytotoxic T cell; Cholesterol; Lipoprotein; Immunology; Medicine; Biology; Endocrinology; Biochemistry","score_opus":0.030764463828110367,"score_gpt":0.2897559068684099,"score_spread":0.25899144304029953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208891341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007413937,0.93297803,0.064355515,0.00012394288,0.00060742896,0.0016151314,0.000009235893,0.000029081173,0.00027419423],"genre_scores_gemma":[0.00036073214,0.993693,0.004827672,0.0000739138,0.0004724393,0.00021928705,0.00019260742,0.000072009905,0.00008833311],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968643,0.0004892382,0.00084616186,0.00076949195,0.00075242255,0.00027839578],"domain_scores_gemma":[0.9978875,0.00005599168,0.0002401037,0.0014366476,0.00017120416,0.0002085735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001858105,0.00042434726,0.004452321,0.00050666224,0.000083118975,0.000009314964,0.00009159341,0.00049280043,0.000025156285],"category_scores_gemma":[0.00011701094,0.00031527967,0.0011175178,0.0006770523,0.00022108699,0.000048104117,0.000089677524,0.00047023283,6.102613e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014250582,0.000025633208,0.00006713353,0.012788652,0.002581719,0.000017624841,0.00006670399,0.0000018264158,0.000019253323,0.00035790994,0.00038115983,0.9836781],"study_design_scores_gemma":[0.0019579015,0.00021984399,0.00270668,0.024031151,0.011196365,0.00075491436,0.00025690015,0.0000142120825,0.000012526154,0.0008152221,0.9577477,0.00028657567],"about_ca_topic_score_codex":0.00004613437,"about_ca_topic_score_gemma":0.000001132394,"teacher_disagreement_score":0.9833916,"about_ca_system_score_codex":0.00014627003,"about_ca_system_score_gemma":0.00027700816,"threshold_uncertainty_score":0.9999299},"labels":[],"label_agreement":null},{"id":"W3209323499","doi":"10.1161/jaha.121.022330","title":"Statins and SARS‐CoV‐2 Infection: Results of a Population‐Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces","year":2021,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; University of Toronto; Institute for Clinical Evaluative Sciences; University of Alberta; Canadian VIGOUR Centre; St. Michael's Hospital","funders":"Government of Alberta; Cancer Care Ontario; Alberta Health Services","keywords":"Statin; Emergency department; Observational study; Prospective cohort study; Odds ratio; Cohort study; Propensity score matching; Intensive care unit","score_opus":0.008130106013683793,"score_gpt":0.2719398029269943,"score_spread":0.2638096969133105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209323499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977899,0.00007503702,0.000007668666,0.0012969836,0.0001222582,0.0005883597,0.00005132104,0.0000036299468,0.00006479847],"genre_scores_gemma":[0.9991545,0.000034476594,0.0004110139,0.00019231843,0.00016242624,0.0000057170046,0.000008494648,0.000008555346,0.000022487244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808514,0.00043610018,0.00054018083,0.00012676463,0.00069498556,0.000116806536],"domain_scores_gemma":[0.99768656,0.00012541964,0.0010566418,0.0002134708,0.0008376431,0.00008025223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010583864,0.0000767449,0.00062142307,0.00010418007,0.00008041545,0.000011421384,0.0000360621,0.000030145367,0.0000031203977],"category_scores_gemma":[0.0012460372,0.000056542212,0.00018307312,0.00042638625,0.000025727688,0.00007303856,0.000013970259,0.00019071701,2.4121854e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025599243,0.00020621197,0.99647695,0.000021333763,0.0004422574,0.000004559906,0.00077520945,0.00004269752,0.00040759167,9.750675e-7,0.00024481054,0.0011214095],"study_design_scores_gemma":[0.0022171498,0.00087910495,0.99378276,0.00014022154,0.0003030794,0.000012585987,0.0007988292,0.000073132665,0.0015493775,0.000023143513,0.00017334186,0.000047286223],"about_ca_topic_score_codex":0.5244831,"about_ca_topic_score_gemma":0.24637437,"teacher_disagreement_score":0.2781087,"about_ca_system_score_codex":0.00078110717,"about_ca_system_score_gemma":0.00093221024,"threshold_uncertainty_score":0.7673773},"labels":[],"label_agreement":null},{"id":"W3209557925","doi":"10.1161/circulationaha.121.056290","title":"Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Montreal Heart Institute","funders":"","keywords":"Artery; Coronary artery disease; Coronary artery bypass surgery; Ischemia; Bypass operation","score_opus":0.01897994184396932,"score_gpt":0.2440573043683025,"score_spread":0.2250773625243332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209557925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953444,0.0022915958,0.0000456112,0.00016028719,0.00019376345,0.0006542332,0.0000022983509,0.000019490975,0.0012883143],"genre_scores_gemma":[0.9991378,0.00005080331,0.0001540206,0.00013566483,0.000082314866,0.000038488866,0.00020282994,0.000020323841,0.00017772256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985383,0.00010189315,0.0003648093,0.00030580003,0.00050862436,0.00018056465],"domain_scores_gemma":[0.99913096,0.000014160014,0.00015826973,0.00039868866,0.00021358284,0.00008433057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002602286,0.0001242848,0.0003340971,0.00008700766,0.000021273996,0.0000021845842,0.000043318618,0.000094718314,0.0000662368],"category_scores_gemma":[0.000065259206,0.000115917275,0.000116440606,0.00017426634,0.00003112287,0.00009614539,0.000021686299,0.00016623289,0.0000061579367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031006377,0.0007348765,0.9564355,0.00043917628,0.00029801758,0.00005530171,0.0014488065,0.00010110987,0.012004463,0.000008418726,0.0005403316,0.027623931],"study_design_scores_gemma":[0.0032884653,0.000100085876,0.9933446,0.0003958472,0.00013859519,0.0000488369,0.000086178356,0.000073162155,0.0015020946,0.000009972876,0.00089343026,0.00011873658],"about_ca_topic_score_codex":0.000066080844,"about_ca_topic_score_gemma":0.000012174564,"teacher_disagreement_score":0.036909092,"about_ca_system_score_codex":0.00067894225,"about_ca_system_score_gemma":0.0005965618,"threshold_uncertainty_score":0.47269693},"labels":[],"label_agreement":null},{"id":"W3210257301","doi":"10.3390/ijms222111756","title":"Off-Target Effect of Lovastatin Disrupts Dietary Lipid Uptake and Dissemination through Pro-Drug Inhibition of the Mesenteric Lymphatic Smooth Muscle Cell Contractile Apparatus","year":2021,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Cumming School of Medicine, University of Calgary; Crohn's and Colitis Canada; University of Calgary","keywords":"Lovastatin; Simvastatin; Pharmacology; Pravastatin; Lymphatic system; In vivo; Atorvastatin; Chemistry; Biology; Endocrinology; Cholesterol; Immunology","score_opus":0.009203605260153753,"score_gpt":0.2901173437891147,"score_spread":0.28091373852896095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210257301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992218,0.0040104236,0.0014847976,0.0010548142,0.00042916773,0.0002500261,0.000010683695,0.0000024777205,0.00053960516],"genre_scores_gemma":[0.99784654,0.0003926291,0.0015105412,0.00011140566,0.00009513892,0.0000046066975,0.0000046445493,0.0000065403124,0.000027959806],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778885,0.00023115936,0.00048398727,0.00015310901,0.0012286569,0.000114264345],"domain_scores_gemma":[0.99861777,0.00015661037,0.00055211096,0.0001339268,0.00048500544,0.000054600994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001043174,0.000101611506,0.0003176826,0.00008362931,0.000050517956,0.000031813222,0.00015395464,0.00003137948,0.00001982714],"category_scores_gemma":[0.0004090796,0.000063071246,0.0002737855,0.0002456545,0.00019553759,0.00023008263,0.00006152761,0.000102697006,3.5743497e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003338334,0.00062301324,0.011386293,0.0005787079,0.00042083897,0.00040740147,0.0020037063,0.00038818456,0.88857245,0.00026694813,0.0002453735,0.09477322],"study_design_scores_gemma":[0.0019074879,0.00065264315,0.08829905,0.0012178421,0.00020320057,0.00055172516,0.000826184,0.00082893524,0.90436083,0.00039615488,0.0006480579,0.000107874315],"about_ca_topic_score_codex":0.000035202604,"about_ca_topic_score_gemma":0.0000035773314,"teacher_disagreement_score":0.09466535,"about_ca_system_score_codex":0.000043339733,"about_ca_system_score_gemma":0.00025131783,"threshold_uncertainty_score":0.25719708},"labels":[],"label_agreement":null},{"id":"W3210301436","doi":"10.1016/j.hfc.2021.07.008","title":"New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia","year":2021,"lang":"en","type":"review","venue":"Heart Failure Clinics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Sanofi Genzyme; Swedish Orphan Biovitrum; Shire; Sanofi; Pfizer; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Intensive care medicine; Genetic disorder; Disease; Bioinformatics; Therapeutic approach; Atherosclerotic cardiovascular disease; Genetic enhancement; Internal medicine; Cholesterol; Gene; Genetics","score_opus":0.049205593978969474,"score_gpt":0.3591121878491755,"score_spread":0.309906593870206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210301436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001680899,0.99619466,0.00011566657,0.00061436184,0.0007153615,0.0020725352,0.000033753717,0.000018852934,0.000066708206],"genre_scores_gemma":[0.000005880637,0.98844695,0.009140606,0.00033722108,0.0013455059,0.00011596064,0.00018962917,0.00006126239,0.00035698953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99685675,0.00059766765,0.0011168767,0.00051543297,0.0005496745,0.00036361456],"domain_scores_gemma":[0.9978307,0.0001784392,0.00020235503,0.0015194232,0.0000724841,0.0001966071],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077035936,0.0004183548,0.0038590503,0.00015768211,0.00004395812,0.000022080545,0.00017945151,0.00061612646,0.000027741173],"category_scores_gemma":[0.00008703273,0.0002488213,0.0024171118,0.00050291454,0.000055002816,0.000025529203,0.00002704724,0.00063269964,0.000028455841],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012296112,0.00028653085,0.00018177835,0.0043571014,0.00036392832,0.00020640848,0.00020417581,2.7731426e-7,3.2666815e-8,0.0000073333485,0.019430352,0.9749498],"study_design_scores_gemma":[0.0013145738,0.00075931253,0.00007474502,0.0065385695,0.0019349222,0.0006280762,0.00023116243,0.0000010119986,3.2847126e-7,0.000006907102,0.98833734,0.000173066],"about_ca_topic_score_codex":0.00022834727,"about_ca_topic_score_gemma":0.00009718707,"teacher_disagreement_score":0.97477674,"about_ca_system_score_codex":0.00023035858,"about_ca_system_score_gemma":0.0022659115,"threshold_uncertainty_score":0.9999964},"labels":[],"label_agreement":null},{"id":"W3211313464","doi":"10.5114/aoms/143476","title":"Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISE","year":2021,"lang":"en","type":"article","venue":"Archives of Medical Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Sanofi","keywords":"Medicine; Alirocumab; Statin; Internal medicine; Pharmacology; Total cholesterol; Cholesterol","score_opus":0.024173283698204283,"score_gpt":0.31913309013413854,"score_spread":0.2949598064359343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211313464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963367,0.0005283936,0.0000749443,0.002183646,0.0000366897,0.00040089386,0.00003519145,0.000003882983,0.00039964748],"genre_scores_gemma":[0.99745136,0.0022027516,0.00024098177,0.000063023195,0.000021145024,0.0000061373744,0.000007661361,0.0000027465032,0.000004183797],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979204,0.00027418157,0.00039040783,0.0003234903,0.0009240654,0.00016748265],"domain_scores_gemma":[0.9969791,0.0022272544,0.00013506562,0.0003492551,0.0000393359,0.0002699462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016201446,0.000094838135,0.00046630553,0.00004630729,0.000046727477,0.000004267133,0.00013196308,0.000032127296,0.000008587147],"category_scores_gemma":[0.0055625774,0.000050822764,0.0000596343,0.00020320478,0.0012909065,0.00001943338,0.00015316537,0.0001517799,1.9534043e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00391894,0.00056380004,0.02303339,0.00041894396,0.00012533148,0.00009771266,0.010680832,0.0000074999857,0.012559623,0.0012574957,0.000021051716,0.9473154],"study_design_scores_gemma":[0.01189287,0.0032625757,0.9343838,0.0021949895,0.00008224707,0.000025016207,0.0009414633,0.0031997543,0.04370775,0.00011190522,0.00010736197,0.00009025707],"about_ca_topic_score_codex":0.0022155335,"about_ca_topic_score_gemma":0.000071600974,"teacher_disagreement_score":0.9472251,"about_ca_system_score_codex":0.000017772316,"about_ca_system_score_gemma":0.0005367997,"threshold_uncertainty_score":0.66593266},"labels":[],"label_agreement":null},{"id":"W3211327692","doi":"","title":"Étude THEMIS : le ticagrélor en association avec l’acide acétylsalicylique est-il efficace et sécuritaire pour prévenir les événements cardiovasculaires ischémiques chez les patients diabétiques ayant une maladie coronarienne stable?","year":2021,"lang":"fr","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"","keywords":"Medicine; Gynecology","score_opus":0.010170841390737506,"score_gpt":0.24692392111013595,"score_spread":0.23675307971939843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211327692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91285306,0.04365503,0.003211591,0.027770882,0.0010418181,0.0023756644,0.00045203805,0.00043887203,0.008201015],"genre_scores_gemma":[0.94685054,0.028314356,0.0033332533,0.0011694498,0.0015903303,0.00036482827,0.00085470185,0.00025535055,0.017267201],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98999345,0.0029220628,0.0014658306,0.0015247288,0.0021613764,0.0019325744],"domain_scores_gemma":[0.9945804,0.000666348,0.00057494995,0.0016244886,0.00171042,0.0008433867],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0046016416,0.0010535733,0.0021116124,0.0001750813,0.0006453369,0.00030223082,0.00045062733,0.001163513,0.0008139537],"category_scores_gemma":[0.0024681361,0.0009980471,0.0016723814,0.00074931467,0.00023401694,0.00062157604,0.0005188449,0.0013349475,0.00012645593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081089325,0.011975255,0.3109023,0.011455932,0.02902091,0.0018224339,0.029148132,0.0007780089,0.0075412905,0.03319292,0.02133249,0.5420194],"study_design_scores_gemma":[0.016321963,0.0012292864,0.5929447,0.0061754207,0.0047168205,0.00022131522,0.012802508,0.0008667703,0.13826941,0.0013936664,0.22242384,0.002634358],"about_ca_topic_score_codex":0.029221151,"about_ca_topic_score_gemma":0.012855441,"teacher_disagreement_score":0.5393851,"about_ca_system_score_codex":0.0022265797,"about_ca_system_score_gemma":0.0027100262,"threshold_uncertainty_score":0.999247},"labels":[],"label_agreement":null},{"id":"W3211755826","doi":"10.1001/jamacardio.2021.5080","title":"Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related Risk","year":2021,"lang":"en","type":"letter","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Otorhinolaryngology; Neurology; Family medicine; Internal medicine; Psychiatry","score_opus":0.008057700285888614,"score_gpt":0.2164680591418293,"score_spread":0.20841035885594067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211755826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81882423,0.009543324,0.0010103384,0.14377993,0.0022212178,0.02059293,0.000780328,0.000644921,0.0026027805],"genre_scores_gemma":[0.81803787,0.0032897396,0.0011749709,0.1486167,0.019733692,0.0033670096,0.0020420763,0.0010355547,0.0027023808],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.976063,0.00639434,0.0041783745,0.004891303,0.0048379363,0.003635031],"domain_scores_gemma":[0.9831048,0.0005725691,0.003461399,0.009242274,0.0024341191,0.0011847933],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.007836669,0.0034960383,0.010008755,0.0011793345,0.0012768784,0.00046012946,0.0020074393,0.009593541,0.00020419342],"category_scores_gemma":[0.0021303894,0.0028209796,0.0041842377,0.0017609645,0.0027425834,0.0005688439,0.0021776934,0.017331922,0.00033461556],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005300441,0.0008632654,0.002014092,0.016420133,0.022277063,0.013737497,0.0021658798,0.00009880914,0.017502049,0.0001415255,0.07901006,0.8404692],"study_design_scores_gemma":[0.043294933,0.008923856,0.50358343,0.014274328,0.016113145,0.034499098,0.0008895599,0.00012827998,0.111118376,0.003795265,0.253832,0.009547724],"about_ca_topic_score_codex":0.14251672,"about_ca_topic_score_gemma":0.0020787704,"teacher_disagreement_score":0.8309215,"about_ca_system_score_codex":0.001198097,"about_ca_system_score_gemma":0.0027108677,"threshold_uncertainty_score":0.9999714},"labels":[],"label_agreement":null},{"id":"W3213036992","doi":"10.3389/fcvm.2021.789931","title":"Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol","year":2021,"lang":"en","type":"review","venue":"Frontiers in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Ezetimibe; Medicine; Statin; Drug; PCSK9; Cholesterol; Clinical trial; Pharmacology; Adverse effect; Residual risk; Atherosclerotic cardiovascular disease; Internal medicine; Disease; Lipoprotein; LDL receptor","score_opus":0.029932586249705736,"score_gpt":0.32001437539856464,"score_spread":0.2900817891488589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213036992","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003520486,0.91312647,0.07471858,0.00016159643,0.0030233825,0.00851054,0.00006108027,0.00010913739,0.00025399227],"genre_scores_gemma":[0.000053375425,0.98094344,0.009810357,0.000115256196,0.0038163885,0.0032789276,0.0011425894,0.00030909522,0.0005305866],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932536,0.00049645506,0.001774449,0.0018180979,0.0014895201,0.0011679076],"domain_scores_gemma":[0.99533564,0.000094192,0.00037789656,0.0032574867,0.00033400292,0.00060079654],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0032096698,0.0012827867,0.011143444,0.001027328,0.0002453398,0.00004226454,0.00033246487,0.0008216538,0.00003475126],"category_scores_gemma":[0.00041088185,0.0010107645,0.008147824,0.0012363169,0.00021576592,0.000109657354,0.00013335768,0.0009670424,0.00001328301],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029156301,0.00018742587,0.000022346236,0.027996931,0.010903104,0.0007275965,0.00024877558,0.000042289408,7.47959e-7,0.000004741577,0.0015733163,0.9582636],"study_design_scores_gemma":[0.0062849084,0.00053231494,0.00011420722,0.054374184,0.015502955,0.00072320394,0.00043019728,0.00007765225,0.00002251375,0.000010574924,0.9211736,0.00075372634],"about_ca_topic_score_codex":0.0013026356,"about_ca_topic_score_gemma":0.000056838377,"teacher_disagreement_score":0.9575098,"about_ca_system_score_codex":0.0020803856,"about_ca_system_score_gemma":0.0011971452,"threshold_uncertainty_score":0.9999924},"labels":[],"label_agreement":null},{"id":"W3213146953","doi":"10.1016/j.cjca.2021.10.013","title":"Influence of the LDL-Receptor Genotype on Statin Response in Heterozygous Familial Hypercholesterolemia: Insights From the Canadian FH Registry","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; St. Paul's Hospital; Montreal Clinical Research Institute; University of British Columbia; Providence Health Care; McGill University Health Centre; McGill University; Providence Health Care Research Institute; Université de Montréal; Université Laval; Royal Victoria Regional Health Centre; Royal Victoria Hospital","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Statin; Internal medicine; Genotype; LDL receptor; Confidence interval; Endocrinology; Gastroenterology; Ldl cholesterol; Cholesterol; Lipoprotein; Genetics; Biology","score_opus":0.01327718318179891,"score_gpt":0.23445715500307382,"score_spread":0.2211799718212749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213146953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087423,0.0023906021,0.0000094271145,0.005482902,0.00047989297,0.00020506897,0.00011879828,0.000001652865,0.0004374078],"genre_scores_gemma":[0.9964625,0.00010607731,0.000054049222,0.0026723063,0.0006273854,0.000004451016,0.00000836057,0.000018438524,0.000046400553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749726,0.0011284687,0.0004936444,0.0001953055,0.0003085816,0.0003767578],"domain_scores_gemma":[0.99785554,0.00018112997,0.00017719547,0.00075139996,0.00039655156,0.0006381796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008086378,0.0001478913,0.0005965992,0.00013834484,0.00016069473,0.0000178191,0.0003266324,0.0002535115,0.000011767064],"category_scores_gemma":[0.00092252606,0.00009307278,0.00031243204,0.00028603498,0.00026654423,0.000040108644,0.0000196006,0.00093566114,0.0000075942776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0089529045,0.000054982178,0.70019966,0.00030443683,0.004470445,0.027829407,0.015322919,0.12227544,0.059638556,0.00083764334,0.022019705,0.03809389],"study_design_scores_gemma":[0.0012242058,0.00029320683,0.90638083,0.00031009002,0.0000859016,0.0008233409,0.00051670085,0.0000025479003,0.00093287474,0.000082582614,0.08925447,0.000093245966],"about_ca_topic_score_codex":0.3363907,"about_ca_topic_score_gemma":0.7084467,"teacher_disagreement_score":0.37205598,"about_ca_system_score_codex":0.00080044597,"about_ca_system_score_gemma":0.013448817,"threshold_uncertainty_score":0.992144},"labels":[],"label_agreement":null},{"id":"W3213838648","doi":"10.2139/ssrn.3951147","title":"An Adverse Lipoprotein Phenotype- Hypertriglyceridemic HyperapoB- and the Long-Term Risk of Type 2 Diabetes Mellitus","year":2021,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Type 2 Diabetes Mellitus; Adverse effect; Internal medicine; Diabetes mellitus; Term (time); Endocrinology","score_opus":0.006394304880421211,"score_gpt":0.23809699723395505,"score_spread":0.23170269235353386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213838648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87782526,0.12057715,0.00040383215,0.0005769491,0.00014525195,0.00032046108,0.0000029141236,0.000018124467,0.00013006838],"genre_scores_gemma":[0.9011158,0.097716115,0.00016778756,0.00019035146,0.0005809876,0.000007829578,0.000009511525,0.000032297197,0.0001793429],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971945,0.00047569603,0.00040145303,0.00026772634,0.00045755442,0.0012030625],"domain_scores_gemma":[0.99864763,0.000069424226,0.00020951118,0.0005854199,0.00030234567,0.00018567735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032656672,0.00018796636,0.00058186357,0.00007157201,0.00022063656,0.000022311875,0.00014320998,0.00011608475,0.000056621855],"category_scores_gemma":[0.0002597197,0.000118356096,0.0003106942,0.00028617735,0.0001853187,0.000118533855,0.00003792793,0.0016936682,0.000008178592],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028534543,0.00047781676,0.10962633,0.0003146723,0.004824064,0.00011397824,0.00066821935,0.000042390013,0.011849038,0.018686652,0.000021420787,0.850522],"study_design_scores_gemma":[0.08513223,0.012513205,0.63005537,0.0015166358,0.012687903,0.019941693,0.008116791,0.001975418,0.04569719,0.17511263,0.0049004415,0.0023504854],"about_ca_topic_score_codex":0.0002537806,"about_ca_topic_score_gemma":0.00034485824,"teacher_disagreement_score":0.8481715,"about_ca_system_score_codex":0.00023211597,"about_ca_system_score_gemma":0.0025055585,"threshold_uncertainty_score":0.7358239},"labels":[],"label_agreement":null},{"id":"W3214050765","doi":"10.2196/32568","title":"Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation","year":2021,"lang":"en","type":"article","venue":"JMIR Human Factors","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Cascade; Web application; Computational biology; Computer science; Genetics; Medicine; Bioinformatics; Biology; Internal medicine; World Wide Web; Engineering; Cholesterol","score_opus":0.07431780365639472,"score_gpt":0.3326292215664487,"score_spread":0.25831141791005396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214050765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762625,0.00019903363,0.00011433647,0.00006467304,0.000070194925,0.0015313489,0.00006119309,0.00004274341,0.00029025407],"genre_scores_gemma":[0.9936274,0.0000015389649,0.0049909777,0.00051817327,0.00014446366,0.000307295,0.00026866054,0.000032088414,0.00010938459],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99810743,0.00008295555,0.00045311672,0.00039788504,0.00069048296,0.0002680979],"domain_scores_gemma":[0.9986087,0.0000792001,0.000085007065,0.00036826418,0.0006409732,0.00021783123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007720311,0.00018503272,0.00041247005,0.00011729265,0.00015491125,0.00002753625,0.000056141023,0.00012858059,0.000028418879],"category_scores_gemma":[0.00055752485,0.00016819563,0.0001314659,0.00021438472,0.00002327396,0.000055953697,0.000052544437,0.00014800149,0.0000037617522],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002910458,0.0005769055,0.14505674,0.0024018358,0.00036081322,0.00008351842,0.0028661275,0.0000815489,0.5116769,0.000047206937,0.0008514552,0.33570585],"study_design_scores_gemma":[0.004268485,0.0002860537,0.9417118,0.00032861548,0.00017301049,0.000014912209,0.00045984105,0.0001899867,0.04165571,0.000013986998,0.010700606,0.00019701224],"about_ca_topic_score_codex":0.000099292214,"about_ca_topic_score_gemma":0.00012797254,"teacher_disagreement_score":0.79665506,"about_ca_system_score_codex":0.00022004887,"about_ca_system_score_gemma":0.0013693438,"threshold_uncertainty_score":0.6858819},"labels":[],"label_agreement":null},{"id":"W3214653312","doi":"10.1371/journal.pgen.1009891","title":"Deficiency of ASGR1 in pigs recapitulates reduced risk factor for cardiovascular disease in humans","year":2021,"lang":"en","type":"article","venue":"PLoS Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Sichuan Agricultural University; National Natural Science Foundation of China","keywords":"LDL receptor; Biology; Internal medicine; Cholesterol; Endocrinology; Disease; Lipoprotein; Asialoglycoprotein receptor; Lipid metabolism; Familial hypercholesterolemia; Transcriptome; Medicine; Gene; Genetics; Gene expression; Hepatocyte","score_opus":0.0331298104564378,"score_gpt":0.26682650874526626,"score_spread":0.23369669828882844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214653312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95797485,0.040506072,0.000203783,0.000075291115,0.00008396391,0.00092762435,0.00012667934,0.000015307683,0.00008640774],"genre_scores_gemma":[0.99428153,0.0036333003,0.0017289199,0.00003448601,0.00014113149,0.00008124958,0.00003256395,0.00003465515,0.000032152042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982205,0.00014035286,0.00042863766,0.00039808606,0.00049219176,0.0003202483],"domain_scores_gemma":[0.99862456,0.000043786687,0.00006582135,0.00091240695,0.00018955028,0.00016389854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036819273,0.00015016297,0.0005915666,0.00012752438,0.000035610123,0.000008492448,0.000085730906,0.000098353274,0.000035683475],"category_scores_gemma":[0.00041857478,0.00014416518,0.0006672566,0.0003244655,0.00003853419,0.000021871725,0.00004376782,0.00017132668,0.0000030441158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006688017,0.003968039,0.81601727,0.007835338,0.0032216918,0.0007126046,0.005498841,0.013107516,0.053984344,0.0003131189,0.000063508734,0.09460892],"study_design_scores_gemma":[0.007608837,0.00047962315,0.86603326,0.00080570293,0.001972922,0.000011271177,0.000517856,0.0047335736,0.114066266,0.0011422952,0.002051988,0.0005764145],"about_ca_topic_score_codex":0.000111658395,"about_ca_topic_score_gemma":0.000084976135,"teacher_disagreement_score":0.0940325,"about_ca_system_score_codex":0.00008840665,"about_ca_system_score_gemma":0.00041879693,"threshold_uncertainty_score":0.5878886},"labels":[],"label_agreement":null},{"id":"W3215230673","doi":"10.1161/circ.144.suppl_1.10361","title":"Abstract 10361: Cardiovascular Risk Factor Control and Treatment Across the Spectrum of Patients with Atherosclerotic Cardiovascular Disease: The Precision Medicine Initiative - All of Us Study","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atherosclerotic cardiovascular disease; Risk factor; Guideline; Disease; Epidemiology; Precision medicine; Internal medicine; Canadian Cardiovascular Society; Cohort; Gerontology; Family medicine; Myocardial infarction; Pathology; Angina","score_opus":0.02551166120080699,"score_gpt":0.26253620388120685,"score_spread":0.23702454268039985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215230673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834588,0.011666212,0.0011318971,0.00013293706,0.0000818455,0.0033019227,0.0001793922,0.000015369433,0.000031603002],"genre_scores_gemma":[0.99891084,0.0007181769,0.000011834349,0.000036769845,0.00015678188,0.00008598189,0.000046546367,0.00003081799,0.000002220021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969513,0.0005605238,0.00046960168,0.00043092642,0.001350114,0.00023756563],"domain_scores_gemma":[0.99756676,0.00017804088,0.00025309375,0.0014737436,0.00039801007,0.00013032745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001115363,0.00024220647,0.00091091683,0.000038509836,0.0001905182,0.000015879383,0.00008266407,0.00006406903,0.000026292933],"category_scores_gemma":[0.00023313006,0.000117151445,0.00069935323,0.00025275777,0.00020444219,0.0000824055,0.000033012602,0.00016148503,0.0000011103951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004611779,0.00055828696,0.90410626,0.00013610271,0.014555937,0.000028090395,0.0041806824,0.0046148114,0.000055794924,0.000007590092,0.0000013064183,0.071293965],"study_design_scores_gemma":[0.009387461,0.0005220462,0.9837034,0.00013797331,0.0045402907,0.0000055559913,0.00092935894,0.00017395323,0.00010611177,0.00003200385,0.00035198184,0.00010991415],"about_ca_topic_score_codex":0.0011301504,"about_ca_topic_score_gemma":0.00007801309,"teacher_disagreement_score":0.07959709,"about_ca_system_score_codex":0.0001353021,"about_ca_system_score_gemma":0.00014203055,"threshold_uncertainty_score":0.47772974},"labels":[],"label_agreement":null},{"id":"W3215734728","doi":"10.1161/circ.144.suppl_1.13767","title":"Abstract 13767: Reaching the LDL-Cholesterol Target Recommended by the Guidelines: Be Ambitious to Get the Maximum Benefit","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ldl cholesterol; Cholesterol; Atherosclerotic cardiovascular disease; Internal medicine; Disease","score_opus":0.044885347149511284,"score_gpt":0.3044313254809057,"score_spread":0.25954597833139437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215734728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7512029,0.0025978494,0.007527866,0.23377156,0.0005211345,0.0015927068,0.000042122963,0.00009734741,0.0026465405],"genre_scores_gemma":[0.9645972,0.00007028976,0.00032475436,0.033712804,0.00078061974,0.000100209225,0.00023697973,0.000034994722,0.0001421489],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981962,0.00015510623,0.0004448444,0.00032361565,0.000596858,0.00028337675],"domain_scores_gemma":[0.99825245,0.000094625655,0.00012221592,0.0011352065,0.0002911504,0.0001043691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016909094,0.00016730092,0.0002360296,0.000027839207,0.00051037536,0.000113302136,0.0001709038,0.00009778129,0.0000998654],"category_scores_gemma":[0.0003290491,0.000087641674,0.0002463034,0.00024866784,0.000028162325,0.00008668878,0.000060452614,0.0003821036,0.000033888115],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013988902,0.00032874983,0.0112236,0.00031262654,0.0009330742,0.00007798726,0.0071823783,0.008287112,0.029222896,0.0013088781,0.13617028,0.80481255],"study_design_scores_gemma":[0.0018160098,0.000061800245,0.4472883,0.00021590538,0.00034178843,0.0005338768,0.0024638253,0.0020139883,0.0022713868,0.0034384688,0.5392051,0.00034954373],"about_ca_topic_score_codex":0.0009631761,"about_ca_topic_score_gemma":0.00020152028,"teacher_disagreement_score":0.80446297,"about_ca_system_score_codex":0.00014210201,"about_ca_system_score_gemma":0.00011314232,"threshold_uncertainty_score":0.39254463},"labels":[],"label_agreement":null},{"id":"W3215953108","doi":"10.5603/cj.a2021.0147","title":"Management of dyslipidemia in Poland: Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. The Fourth Declaration of Sopot","year":2021,"lang":"en","type":"article","venue":"Cardiology Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bausch Health; Mylan; Novo Nordisk; Valeant Pharmaceuticals International; Sanofi; Teva Pharmaceutical Industries; AstraZeneca; Servier; Pfizer; Amgen","keywords":"Dyslipidemia; Reduction (mathematics); Weight loss; Position statement; Olive oil","score_opus":0.02512475035676561,"score_gpt":0.30817256299128315,"score_spread":0.28304781263451756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215953108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89078635,0.0800375,0.01905555,0.0053155045,0.0016196771,0.0014064477,0.0000328742,0.000020448055,0.0017256731],"genre_scores_gemma":[0.98620355,0.01153016,0.00046621065,0.00066729955,0.00096396264,0.00006658503,0.00004974008,0.000026314927,0.00002618083],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965971,0.0012638282,0.00070322293,0.00028776447,0.000790705,0.00035737996],"domain_scores_gemma":[0.9987637,0.00008102719,0.00025240687,0.0006134108,0.00019939349,0.00009009737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045131277,0.00020252091,0.00086013187,0.00006595437,0.00023514176,0.000019012665,0.000173256,0.00013181657,0.000014084181],"category_scores_gemma":[0.000016163838,0.00012223207,0.0017989777,0.0002584317,0.00013966311,0.00006111797,0.0001244002,0.00065234996,0.0000010556388],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032057967,0.0008643619,0.029223768,0.0009940165,0.07900327,0.0018413987,0.015466804,0.012317505,0.0954508,0.0011512896,0.06853112,0.69194984],"study_design_scores_gemma":[0.05682869,0.004510289,0.4351834,0.006816919,0.012194281,0.008748825,0.10778844,0.0019763461,0.080948144,0.0029274896,0.27982455,0.0022526009],"about_ca_topic_score_codex":0.000030842708,"about_ca_topic_score_gemma":0.0000022519555,"teacher_disagreement_score":0.68969727,"about_ca_system_score_codex":0.0003991433,"about_ca_system_score_gemma":0.00014984168,"threshold_uncertainty_score":0.49844792},"labels":[],"label_agreement":null},{"id":"W3216042908","doi":"10.1161/circ.144.suppl_1.11692","title":"Abstract 11692: High-Sensitivity Cardiac Troponin and the Efficacy of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Ejection fraction; Heart failure; Internal medicine; Cardiology","score_opus":0.008682702494560872,"score_gpt":0.23980069237410082,"score_spread":0.23111798987953994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216042908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986365,0.000097710814,0.000083169245,0.00030830948,0.000088111934,0.0007537033,0.000008112759,0.000006097503,0.00001831313],"genre_scores_gemma":[0.9997138,0.000010947715,0.000062708146,0.00001986173,0.00010704092,0.0000079965885,0.00006892288,0.0000075547296,0.0000011751871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986894,0.0004026307,0.0002521858,0.00021270709,0.00036184557,0.000081209066],"domain_scores_gemma":[0.9991492,0.00009693614,0.00015385925,0.00038668956,0.00017507687,0.00003826217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007560863,0.00008175316,0.0004669462,0.00009397742,0.000072651965,0.000012203863,0.000014650171,0.00007547502,0.0000059236327],"category_scores_gemma":[0.00015976859,0.000050017425,0.00016161484,0.000582496,0.00008758367,0.00009943653,0.000012482553,0.0001395461,8.950081e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006510046,0.00028223978,0.98130554,0.000072097784,0.0008134969,0.0000012303141,0.00029348623,0.0014383445,0.005484005,0.00011315868,0.000004077609,0.0036822506],"study_design_scores_gemma":[0.017533788,0.00007417152,0.9793344,0.00004562329,0.0010624632,0.0000019784627,0.00021569146,0.0005935894,0.0010647926,0.000009653052,0.000015180345,0.00004864538],"about_ca_topic_score_codex":0.001070302,"about_ca_topic_score_gemma":0.00020969701,"teacher_disagreement_score":0.011023742,"about_ca_system_score_codex":0.000057778245,"about_ca_system_score_gemma":0.000090769296,"threshold_uncertainty_score":0.20396514},"labels":[],"label_agreement":null},{"id":"W3217115154","doi":"10.1161/circ.144.suppl_1.12756","title":"Abstract 12756: Long-Term Efficacy and Safety of Evinacumab in Adult and Adolescent Patients With Homozygous Familial Hypercholesterolemia","year":2021,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Pediatrics; Term (time); Internal medicine; Intensive care medicine; Cholesterol","score_opus":0.010420327783659833,"score_gpt":0.24175484406170122,"score_spread":0.23133451627804139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217115154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985219,0.0006167078,0.00012545606,0.000062408115,0.00003452185,0.0005446173,0.00000637163,0.000010406656,0.000077582714],"genre_scores_gemma":[0.99943817,0.00021998693,0.00007115271,0.00009035351,0.000053853193,0.0000057040706,0.00010407139,0.000013659584,0.0000030513365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990749,0.000038371123,0.00024293002,0.00023851656,0.0002772473,0.00012804427],"domain_scores_gemma":[0.99942905,0.000014312445,0.00006413472,0.00023799312,0.00017087768,0.0000836591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012521012,0.00010001225,0.0002681657,0.000054230295,0.000032370554,0.000010104281,0.00001730275,0.0000782204,0.0000049223777],"category_scores_gemma":[0.000046914774,0.00008564487,0.00003807034,0.00010939934,0.00004040459,0.0000719656,0.000018985944,0.00013197518,0.0000010973016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030214112,0.00020458366,0.8984164,0.0005997996,0.000032445347,0.000042663793,0.00015233965,0.000022897444,0.00056651287,0.0000067811393,0.0000014218151,0.09965203],"study_design_scores_gemma":[0.0068866443,0.00007449276,0.99177295,0.00083211676,0.000068493486,0.00005458785,0.000028535243,0.000029856163,0.00015770626,0.000003213275,0.000009776919,0.0000816372],"about_ca_topic_score_codex":0.000037085607,"about_ca_topic_score_gemma":0.000047669142,"teacher_disagreement_score":0.09957039,"about_ca_system_score_codex":0.00007582102,"about_ca_system_score_gemma":0.00008068979,"threshold_uncertainty_score":0.34924963},"labels":[],"label_agreement":null},{"id":"W3217690404","doi":"10.1161/atvbaha.121.316902","title":"PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Triggers Vascular Smooth Muscle Cell Senescence and Apoptosis: Implication of Its Direct Role in Degenerative Vascular Disease","year":2021,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Vascular smooth muscle; Senescence; Vascular disease; PCSK9; Degenerative disease; Blood vessel; Degenerative Disorder; Cell; Smooth muscle; Disease","score_opus":0.021562183263725675,"score_gpt":0.2647050624158852,"score_spread":0.24314287915215954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217690404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98496974,0.01294877,0.00022054838,0.0004090816,0.00010759372,0.0011885007,0.000052810596,0.000042179872,0.000060788305],"genre_scores_gemma":[0.9653388,0.033228144,0.00057209464,0.00036187196,0.000084444815,0.0001895576,0.00016921038,0.000050338145,0.0000054977127],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967776,0.00062750134,0.000648183,0.0010655522,0.00034512513,0.0005360693],"domain_scores_gemma":[0.9980037,0.00004713773,0.00018207931,0.0009981465,0.00035088928,0.00041802396],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087237393,0.00041519597,0.0011847523,0.0001796403,0.00017014006,0.000042294876,0.00012576797,0.00028660652,0.000067545174],"category_scores_gemma":[0.00014356709,0.00036912528,0.00047732357,0.00051245245,0.00023847101,0.00015481669,0.00015219014,0.00023820161,0.000008347994],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003478571,0.0006018854,0.062202707,0.0007502477,0.0005228054,0.0000013709271,0.0005987807,0.000009335647,0.92935026,0.00016448436,0.000020662023,0.005742676],"study_design_scores_gemma":[0.003217097,0.00039622572,0.91422105,0.00034328894,0.00059890794,8.060576e-7,0.00041538553,0.00035745226,0.07717917,0.000037187634,0.0028297862,0.00040363293],"about_ca_topic_score_codex":0.0005468294,"about_ca_topic_score_gemma":0.00008719109,"teacher_disagreement_score":0.85217106,"about_ca_system_score_codex":0.00007953598,"about_ca_system_score_gemma":0.00027838827,"threshold_uncertainty_score":0.9998761},"labels":[],"label_agreement":null},{"id":"W33272946","doi":"10.1136/bmjgh-2020-003897","title":"心敬と慈円和歌 : その受容と変奏 (中世文学小特集 文学生成のあらたな場 : 軍記・説話・伝承)","year":2013,"lang":"ja","type":"article","venue":"文学・語学","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Computer science","score_opus":0.012789503337678452,"score_gpt":0.24557008508419256,"score_spread":0.23278058174651411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W33272946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7604026,0.061819006,0.0009846757,0.019691797,0.0066453577,0.006628095,0.00009544093,0.00063472433,0.14309825],"genre_scores_gemma":[0.9478399,0.003191085,0.00078956276,0.0040345886,0.0065710577,0.0002955546,0.0000798263,0.00018846968,0.037009954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99437803,0.0003597914,0.0009884811,0.0010881638,0.0015451988,0.0016403572],"domain_scores_gemma":[0.99542695,0.00010581198,0.0002610153,0.0025581925,0.00045551857,0.0011924928],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0013612055,0.00070694624,0.0014045901,0.0002417169,0.00038229037,0.0001885771,0.0005021006,0.0006347131,0.010422625],"category_scores_gemma":[0.00032014586,0.0006085718,0.0010273854,0.0006533348,0.00023904683,0.00035684239,0.00027577122,0.0011024859,0.021930773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021764122,0.0013124993,0.0061431783,0.0031625808,0.0026584312,0.0007605548,0.0043842895,0.000020032647,0.0054292744,0.0020155944,0.24085131,0.7330446],"study_design_scores_gemma":[0.0070249937,0.0013165952,0.08669155,0.0012773288,0.0011769308,0.0004154908,0.0026199447,0.0007284449,0.0029833838,0.00066936214,0.89374906,0.0013468999],"about_ca_topic_score_codex":0.0067701335,"about_ca_topic_score_gemma":0.00010887841,"teacher_disagreement_score":0.73169774,"about_ca_system_score_codex":0.000371412,"about_ca_system_score_gemma":0.0006535821,"threshold_uncertainty_score":0.9998439},"labels":[],"label_agreement":null},{"id":"W335220206","doi":"","title":"Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries.","year":2010,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Medicine; Pharmacoepidemiology; Statin; Observational study; Demographics; Rosuvastatin Calcium; Drug; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Primary care; Health care; Internal medicine; Intensive care medicine; Pharmacology; Family medicine; Demography","score_opus":0.026525703422143155,"score_gpt":0.2510389557857897,"score_spread":0.22451325236364655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W335220206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855167,0.00010792571,0.00036017215,0.00020459107,0.000060004502,0.00058113324,0.000058719248,0.0000059334675,0.000069840506],"genre_scores_gemma":[0.9991199,0.00023751863,0.00023664904,0.00015783629,0.000055767803,0.000040778392,0.0000070360397,0.000012142233,0.00013237761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935955,0.000022895005,0.00021673691,0.0001048218,0.00016701638,0.00012898454],"domain_scores_gemma":[0.9995852,0.000024349833,0.00009813974,0.00014507462,0.00004574565,0.00010146354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042830833,0.00006168689,0.00023564532,0.00006079573,0.000009475115,0.0000061107285,0.000020381363,0.000038978207,0.0000147817955],"category_scores_gemma":[0.00010929069,0.000053239342,0.000022067863,0.000058319376,0.000036914458,0.000035606787,0.000014289816,0.000086732114,1.3390719e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056499448,0.000022517852,0.8321592,0.00037784732,0.000025648642,0.0000029849807,0.0008502423,2.268615e-7,0.00008878423,0.00010555168,0.000031995492,0.16627851],"study_design_scores_gemma":[0.0012347506,0.000018246817,0.9939661,0.00003232481,0.00003221148,0.000006783092,0.00009724549,0.00003027752,0.0010959127,0.000027615964,0.0034150546,0.000043481898],"about_ca_topic_score_codex":0.0015805945,"about_ca_topic_score_gemma":0.0007006497,"teacher_disagreement_score":0.16623503,"about_ca_system_score_codex":0.000008983002,"about_ca_system_score_gemma":0.000056414407,"threshold_uncertainty_score":0.23893964},"labels":[],"label_agreement":null},{"id":"W33526970","doi":"10.1097/01.smj.0000251470.39036.ea","title":"Lipid Lowering Inefficacy of High-dose Statin Therapy Due to Concurrent Use of Phenytoin","year":2006,"lang":"en","type":"article","venue":"Southern Medical Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Atorvastatin; Pharmacology; Bioavailability; Discontinuation; Pitavastatin; Lovastatin; Statin; Phenytoin; CYP3A4; HMG-CoA reductase; Adverse effect; Simvastatin; Reductase; Cholesterol; Cytochrome P450; Internal medicine; Metabolism; Enzyme; Epilepsy; Biochemistry","score_opus":0.02180651347724804,"score_gpt":0.2799442940483275,"score_spread":0.25813778057107944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W33526970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821678,0.0010767675,0.014580253,0.0013495029,0.00037742578,0.00033758863,0.000030811403,0.000018544182,0.00006131679],"genre_scores_gemma":[0.9963686,0.00025668246,0.00126681,0.00043413317,0.0015406408,0.0000055882547,0.000008604918,0.000034032186,0.000084915955],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9968984,0.00014969998,0.0008099789,0.00017767599,0.001638226,0.00032597827],"domain_scores_gemma":[0.99854416,0.00009314443,0.0002513777,0.000309348,0.0002539273,0.0005480228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001284362,0.00016320388,0.0006896622,0.00013045757,0.000052234387,0.000016038111,0.00015303041,0.000120259116,0.00078269665],"category_scores_gemma":[0.0004393711,0.000112369606,0.00032674597,0.00021423526,0.000115574934,0.000042321113,0.0000429541,0.00052726525,0.00002220596],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085243647,0.0010503208,0.004951126,0.00021067221,0.00041786107,0.0005101589,0.0016711653,0.00013462595,0.0060026445,0.00016598534,0.0016612579,0.98237175],"study_design_scores_gemma":[0.12287014,0.01506454,0.5289486,0.015187982,0.0013666153,0.012477412,0.00742785,0.0013636966,0.08355177,0.002495443,0.2063827,0.0028632528],"about_ca_topic_score_codex":0.0010875631,"about_ca_topic_score_gemma":0.00003877358,"teacher_disagreement_score":0.9795085,"about_ca_system_score_codex":0.000054225075,"about_ca_system_score_gemma":0.00048734318,"threshold_uncertainty_score":0.85699797},"labels":[],"label_agreement":null},{"id":"W4200060368","doi":"10.7860/jcdr/2021/51587.15507","title":"Prognostic Relevance of C-Reactive Protein in Short Term Adverse Outcome in Patients with Acute Ischaemic Stroke","year":2021,"lang":"en","type":"article","venue":"JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Stroke (engine); Internal medicine; Myocardial infarction; Unstable angina; C-reactive protein; Ischaemic stroke; Cardiology; Acute stroke; Angina; Prospective cohort study; Ischemia","score_opus":0.07700742373548136,"score_gpt":0.4365073211168283,"score_spread":0.3594998973813469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200060368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750686,0.00056302274,0.000021163154,0.000653473,0.0000661618,0.0009867889,0.000009641689,0.000001922973,0.00019098456],"genre_scores_gemma":[0.998195,0.00071880594,0.00076819904,0.00004687024,0.00014662356,0.000027594224,0.0000038092749,0.000014182434,0.00007892375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960109,0.0005644812,0.0014521894,0.0002627322,0.0013650495,0.00034463653],"domain_scores_gemma":[0.9949976,0.003159633,0.00016426588,0.0003002132,0.0010613423,0.00031694138],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0045584063,0.00011694523,0.000990839,0.00024955702,0.000026928503,0.000009950001,0.000107407526,0.00014262136,0.00001714816],"category_scores_gemma":[0.023379022,0.00007612628,0.00020258114,0.0004278348,0.00025950285,0.00014409903,0.00009626744,0.001542319,0.0000021017722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002102104,0.001319528,0.9730548,0.00022882434,0.00016793952,0.0024919948,0.00007202954,0.0000029655419,0.000076705735,0.000020206764,0.000012965596,0.020449897],"study_design_scores_gemma":[0.0069382084,0.0029627234,0.98729473,0.0018261661,0.000086798245,0.000079358026,0.00014337679,0.000010074075,0.00038247803,0.00010911886,0.00009481528,0.00007213314],"about_ca_topic_score_codex":0.00005718805,"about_ca_topic_score_gemma":0.00006363669,"teacher_disagreement_score":0.020377764,"about_ca_system_score_codex":0.000059386875,"about_ca_system_score_gemma":0.00094204705,"threshold_uncertainty_score":0.9848475},"labels":[],"label_agreement":null},{"id":"W4200070138","doi":"10.1093/eurjpc/zwab209","title":"Hyperglycaemic disorders associated with PCSK9 inhibitors: a real-world, pharmacovigilance study","year":2021,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University Medical Centre","funders":"","keywords":"Medicine; Evolocumab; Adverse Event Reporting System; Odds ratio; Internal medicine; Pharmacovigilance; Adverse effect; Cholesterol","score_opus":0.015676969637538167,"score_gpt":0.2813079490726644,"score_spread":0.2656309794351262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200070138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97876406,0.0027336576,0.0008363588,0.00030352813,0.0005214638,0.00045150486,0.000007594613,0.000028103921,0.01635375],"genre_scores_gemma":[0.9963662,0.0010788512,0.00020426726,0.00020030032,0.0011292425,0.000005086207,0.000012199319,0.000055332926,0.0009485453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99473315,0.0035495155,0.0006181574,0.0003104026,0.00046116035,0.00032758253],"domain_scores_gemma":[0.99826485,0.0000878144,0.00044905252,0.00035922218,0.0006235889,0.00021545222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002710442,0.00021357769,0.00097513734,0.00016160823,0.00008733048,0.000015879552,0.00014254967,0.00003052302,0.000040143477],"category_scores_gemma":[0.00033289587,0.00016001715,0.0005745246,0.00044971314,0.00010045977,0.0000913789,0.00008397842,0.0006160547,0.000015796235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016405858,0.0015043743,0.86155546,0.00013586823,0.014838347,0.042865224,0.0013068115,0.0003598545,0.009121861,0.000030103387,0.006307291,0.060334206],"study_design_scores_gemma":[0.01217675,0.0034912962,0.94670224,0.00056801864,0.0017495063,0.0025719628,0.0013427489,0.0000029924363,0.00087836303,0.0000203249,0.030204631,0.00029115888],"about_ca_topic_score_codex":0.000009338512,"about_ca_topic_score_gemma":0.000030906867,"teacher_disagreement_score":0.08514677,"about_ca_system_score_codex":0.00014536743,"about_ca_system_score_gemma":0.00037070885,"threshold_uncertainty_score":0.65253097},"labels":[],"label_agreement":null},{"id":"W4200115483","doi":"10.1093/eurheartj/ehab804","title":"Alirocumab after acute coronary syndrome in patients with a history of heart failure","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital","funders":"","keywords":"Alirocumab; Medicine; Mace; Internal medicine; Hazard ratio; Heart failure; PCSK9; Acute coronary syndrome; Cardiology; Placebo; Post-hoc analysis; Confidence interval; Percutaneous coronary intervention; Cholesterol; Lipoprotein; Myocardial infarction; LDL receptor","score_opus":0.0110283290151912,"score_gpt":0.22277996208215212,"score_spread":0.2117516330669609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200115483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519163,0.0024420184,0.000018810875,0.0009997509,0.00019686093,0.00018676963,0.000005081664,0.000013015962,0.00094606366],"genre_scores_gemma":[0.99508244,0.000046160774,0.0022425023,0.0012388043,0.0001268738,0.000002512703,0.0000100248435,0.000042514403,0.0012081617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998231,0.000374881,0.00033232715,0.00020463488,0.0005885073,0.0002686518],"domain_scores_gemma":[0.9991052,0.000009095401,0.0000765213,0.00037699228,0.00018957419,0.00024259205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000525139,0.00013691101,0.00042963037,0.00011578112,0.00003199933,0.000010763448,0.000053642503,0.000034828605,0.000450989],"category_scores_gemma":[0.000022522257,0.00010698122,0.00022031816,0.0001349705,0.000051408133,0.000112079746,0.000047616402,0.00050530804,0.000052374566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000675964,0.00040265147,0.9675165,0.00013292364,0.0003122282,0.009338168,0.00029753443,0.0000033208098,0.00019407026,0.0000033990111,0.01976271,0.0013605407],"study_design_scores_gemma":[0.003154096,0.0007505234,0.87992644,0.00036846855,0.00008973027,0.010766435,0.000029435421,7.7039095e-7,0.000021556674,0.0000013801834,0.10479292,0.00009823674],"about_ca_topic_score_codex":0.000008931641,"about_ca_topic_score_gemma":0.0000064778756,"teacher_disagreement_score":0.08759004,"about_ca_system_score_codex":0.00029269757,"about_ca_system_score_gemma":0.0004920977,"threshold_uncertainty_score":0.49380133},"labels":[],"label_agreement":null},{"id":"W4200157835","doi":"10.1093/eurjpc/zwab224","title":"Major adverse cardiovascular events in homozygous familial hypercholesterolaemia: a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Medicine; Mace; Myocardial infarction; Meta-analysis; Internal medicine; Confidence interval; Cardiology; Pediatrics; Conventional PCI","score_opus":0.059131370119763285,"score_gpt":0.3217615494251077,"score_spread":0.26263017930534444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200157835","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030344256,0.9953032,0.00072395604,0.000042812946,0.00017401206,0.003345574,0.0000620104,0.000010502215,0.00030757533],"genre_scores_gemma":[0.0002768042,0.9982299,0.00026676344,0.00027341532,0.0003436483,0.000114665934,0.000059758167,0.00010946175,0.0003255491],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97196496,0.022716999,0.0032300237,0.0007769961,0.0008360808,0.00047491712],"domain_scores_gemma":[0.99554163,0.00019277295,0.0016453862,0.0016298573,0.00062076654,0.00036956815],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.014804913,0.00078253244,0.030592533,0.00089602306,0.00006022408,0.000012761345,0.0004389097,0.00024398054,0.000042106516],"category_scores_gemma":[0.0010117827,0.0005098177,0.03195578,0.0011364805,0.00010385071,0.00010380959,0.00029524864,0.0016036542,0.000028418373],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006919976,0.000039282804,0.0000066686903,0.4163674,0.56517386,0.010962235,0.000027127326,0.000005679312,4.6721674e-8,0.0000016064067,0.00004693443,0.0073622214],"study_design_scores_gemma":[0.00081508694,0.0001972789,0.00014159299,0.062229827,0.8548612,0.02235573,0.000040147697,7.4543244e-8,3.855971e-8,0.0000013285756,0.05906055,0.00029717182],"about_ca_topic_score_codex":0.00001099837,"about_ca_topic_score_gemma":0.0000024930432,"teacher_disagreement_score":0.3541376,"about_ca_system_score_codex":0.00026297825,"about_ca_system_score_gemma":0.00048321765,"threshold_uncertainty_score":0.99973536},"labels":[],"label_agreement":null},{"id":"W4200158653","doi":"10.1016/j.atherosclerosis.2021.12.002","title":"Guidelines versus trial-evidence for statin use in primary prevention: The Copenhagen General Population Study","year":2021,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Center for Computational Sciences, University of Kentucky; European Society of Contraception and Reproductive Health; American Heart Association; Gentofte Hospital; Canadian Cardiovascular Society; State Key Laboratory of Environmental Adaptability for Industrial Products; National Institute for Health and Care Excellence; American Chemistry Council","keywords":"Primary prevention; Statin; Medicine; Primary (astronomy); Population; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Environmental health; Internal medicine; Disease","score_opus":0.324028289258925,"score_gpt":0.42427020470423843,"score_spread":0.10024191544531341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200158653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929668,0.0011179157,0.0007479844,0.0011024546,0.0004135513,0.0035755553,0.000009149694,0.000029332396,0.00003729398],"genre_scores_gemma":[0.9865113,0.00043799693,0.007266776,0.00082050497,0.00068782497,0.00092089345,0.00008941454,0.00004057209,0.0032247396],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981562,0.00031956838,0.0005241908,0.00035189337,0.00043357018,0.00021457738],"domain_scores_gemma":[0.99870026,0.00022912488,0.000111325426,0.0006473953,0.00025182433,0.000060080547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014775315,0.00013463624,0.0003612209,0.00003058289,0.00012770688,0.00007009831,0.00008746555,0.000062047155,0.00009086655],"category_scores_gemma":[0.0009873278,0.000096495685,0.00025150192,0.00028387515,0.00001527946,0.00018420682,0.00005516545,0.00010410095,0.0000127256135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1041853,0.0074302447,0.37314877,0.0011147243,0.0028741756,0.00008029096,0.004742023,0.0008581741,0.018791879,0.00063416595,0.03041997,0.4557203],"study_design_scores_gemma":[0.055246472,0.0016136909,0.9371082,0.00027865375,0.00036734247,0.000003292504,0.00047834768,0.00014450663,0.00046055584,0.000023648818,0.0041168504,0.00015839409],"about_ca_topic_score_codex":0.0012647832,"about_ca_topic_score_gemma":0.0008207283,"teacher_disagreement_score":0.5639595,"about_ca_system_score_codex":0.00016365015,"about_ca_system_score_gemma":0.00022698102,"threshold_uncertainty_score":0.39349797},"labels":[],"label_agreement":null},{"id":"W4200197638","doi":"10.3389/fneur.2021.736365.s001","title":"Table_1_Relationship Between Lipoprotein (a) [Lp(a)] and Cognition in Different Ischemic Stroke Subtypes.XLS","year":2021,"lang":"en","type":"paratext","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quartile; Medicine; Montreal Cognitive Assessment; Internal medicine; Cognition; Stroke (engine); Cognitive impairment; Subgroup analysis; Physical therapy; Confidence interval; Disease; Psychiatry","score_opus":0.042960828712836685,"score_gpt":0.28550944654991345,"score_spread":0.24254861783707676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200197638","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05094866,0.10517195,0.000023381379,0.00080768345,0.00052811735,0.0069456617,0.6388747,0.00015462037,0.19654524],"genre_scores_gemma":[0.18184061,0.00074755313,0.00006881954,0.0001969348,0.0028687608,0.0012170611,0.76274025,0.00012828821,0.050191734],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99757373,0.00015770464,0.0005047731,0.0006857424,0.00061579485,0.00046227462],"domain_scores_gemma":[0.9986018,0.00013427375,0.00020636762,0.00061710324,0.00015633162,0.00028411142],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00014590549,0.00044599906,0.0011348824,0.00026043333,0.00009595128,0.000080946884,0.00010528719,0.00089091953,0.113814615],"category_scores_gemma":[0.0005377844,0.0004014252,0.0003164162,0.00026422832,0.000013416434,0.00008230087,0.00014834729,0.0013467934,0.0038553572],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005280941,0.00010675432,0.0007403806,0.007366907,0.00055480853,0.00015107132,0.00008110187,0.0000027642382,0.00019623955,0.000001169711,0.96218866,0.028557325],"study_design_scores_gemma":[0.0029527212,0.00018399803,0.052190457,0.027108759,0.00045565597,0.00010781505,0.00008192859,0.000025337626,0.00548559,0.000009383864,0.9106734,0.00072496996],"about_ca_topic_score_codex":0.00014105029,"about_ca_topic_score_gemma":0.000056847344,"teacher_disagreement_score":0.1463535,"about_ca_system_score_codex":0.00020101249,"about_ca_system_score_gemma":0.0004776263,"threshold_uncertainty_score":0.9998438},"labels":[],"label_agreement":null},{"id":"W4200213654","doi":"10.1093/eurheartj/suab136.001","title":"459 Evaluation of LDL-C reductions by siRNA treatment with inclisiran in patients with diabetes mellitus, metabolic syndrome or neither","year":2021,"lang":"en","type":"article","venue":"European Heart Journal Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Ezetimibe; Metabolic syndrome; Internal medicine; Diabetes mellitus; Placebo; Demographics; Gastroenterology; Endocrinology; Randomized controlled trial; Type 2 diabetes; Cholesterol; Pathology","score_opus":0.03241728793800555,"score_gpt":0.2963728589007559,"score_spread":0.26395557096275035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200213654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953401,0.0029668065,0.000015661546,0.00039192755,0.0000945506,0.00082923064,0.00007181284,0.000009882374,0.00028000536],"genre_scores_gemma":[0.9977461,0.00029863455,0.0011370291,0.00015578691,0.00011961434,0.000020828451,0.00019353945,0.000057975165,0.0002704772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966226,0.00091939326,0.00052233157,0.00028337393,0.0012953707,0.0003568916],"domain_scores_gemma":[0.99866205,0.000016367821,0.00017374198,0.00041770004,0.0004937414,0.0002363871],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013992025,0.00020793073,0.0005346702,0.00014456331,0.00013141637,0.00003647662,0.00006275109,0.0000254861,0.0010533069],"category_scores_gemma":[0.0000415286,0.00012509803,0.00013376666,0.00041491853,0.00003983154,0.00016385793,0.000028978671,0.0002077941,0.0000151745835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054755283,0.002387115,0.9463823,0.0000725279,0.0018600427,0.00022197803,0.0006346679,0.00007876256,0.00058921624,0.0000030308067,0.0012812299,0.0459416],"study_design_scores_gemma":[0.017054692,0.0044860323,0.9318912,0.00040450454,0.0010225826,0.000361242,0.00027370776,0.000012619324,0.0024851032,0.000006322941,0.04180942,0.00019259572],"about_ca_topic_score_codex":0.00009221309,"about_ca_topic_score_gemma":0.000059602982,"teacher_disagreement_score":0.045749005,"about_ca_system_score_codex":0.00022339597,"about_ca_system_score_gemma":0.00040469217,"threshold_uncertainty_score":0.99985987},"labels":[],"label_agreement":null},{"id":"W4200272690","doi":"10.1016/j.jacl.2021.11.014","title":"Health-related quality of life in homozygous familial hypercholesterolemia: A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of British Columbia; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Institute of Genetics; McGill University","keywords":"Medicine; Meta-analysis; MEDLINE; Psychosocial; Quality of life (healthcare); Systematic review; Physical therapy; Internal medicine; Psychiatry","score_opus":0.3462716066557222,"score_gpt":0.5105386654572085,"score_spread":0.1642670588014863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200272690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008785031,0.9949947,0.000039998973,0.002306973,0.00047558596,0.0020199504,0.000039478608,0.0000054008215,0.000030088107],"genre_scores_gemma":[0.00012456394,0.9955314,0.00040415075,0.0031911323,0.00055759004,0.000048434602,0.000025567058,0.000034783377,0.000082412545],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9607799,0.018682504,0.018836105,0.00052056334,0.0008275367,0.00035340348],"domain_scores_gemma":[0.9828693,0.0035205027,0.011104302,0.0012154427,0.000625349,0.0006650704],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.041903544,0.00046808127,0.06879048,0.00056667655,0.000027415226,0.000009599078,0.0003087834,0.0010355449,0.000102830076],"category_scores_gemma":[0.018300904,0.00027265222,0.017847868,0.0011899531,0.00019947987,0.0000495357,0.00013023063,0.0028077615,0.0000050511303],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003365779,0.0003034306,0.00005645105,0.77520025,0.2103748,0.0000782849,0.000015897353,4.6339082e-7,5.29799e-9,0.00003062407,0.0001806139,0.013725487],"study_design_scores_gemma":[0.0013290349,0.0007612498,0.00022706448,0.08451904,0.88864684,0.0023391666,0.000020009784,4.7675448e-7,3.2033611e-9,0.000013197334,0.021958359,0.00018554632],"about_ca_topic_score_codex":0.00022947443,"about_ca_topic_score_gemma":0.000118881595,"teacher_disagreement_score":0.6906812,"about_ca_system_score_codex":0.000106648185,"about_ca_system_score_gemma":0.0030631672,"threshold_uncertainty_score":0.9999726},"labels":[],"label_agreement":null},{"id":"W4200296051","doi":"10.1016/j.cjco.2021.12.005","title":"Is Deprescription of Ezetimibe Safe in Familial Hypercholesterolemia Patients Taking Evolocumab?","year":2021,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Pfizer; HLS Therapeutics; Heart and Stroke Foundation of Canada; Schulich School of Medicine and Dentistry; Sanofi; Canadian Institutes of Health Research; Novartis","keywords":"Ezetimibe; Medicine; Familial hypercholesterolemia; Evolocumab; Internal medicine; Ldl cholesterol; Gastroenterology; Statin; Atherosclerotic cardiovascular disease; Endocrinology; Gynecology; Cholesterol; Lipoprotein; Disease","score_opus":0.03193504220894744,"score_gpt":0.30975620117780855,"score_spread":0.2778211589688611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200296051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877759,0.00045938225,0.00006274691,0.0002658108,0.00017347386,0.0006310737,0.000011849675,0.0000074193326,0.010612343],"genre_scores_gemma":[0.9971223,0.000113901064,0.0009849214,0.0011321994,0.00008810057,0.0000306915,0.000050910945,0.00001709386,0.00045991596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874735,0.00010378632,0.00031075737,0.00027855427,0.00037015651,0.00018939508],"domain_scores_gemma":[0.9990788,0.000010006267,0.00008387175,0.0005778492,0.00016613257,0.00008333743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003841207,0.000095694515,0.0004413416,0.000057030837,0.00003359538,0.000025182188,0.00014839252,0.00009663237,0.00021334343],"category_scores_gemma":[0.00014616585,0.000088821136,0.00011564917,0.00020343359,0.000023520597,0.00014671008,0.00021921606,0.00016862857,0.00002654409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043851841,0.0005365994,0.7144734,0.0003829984,0.00014440919,0.00012254351,0.0014513001,0.000016797228,0.005650948,0.00007430003,0.0011599845,0.27554816],"study_design_scores_gemma":[0.0050186072,0.00015813192,0.97993785,0.0003889135,0.00005579031,0.000021282907,0.00022631805,0.000054691016,0.007122572,0.000053994205,0.0068596113,0.000102246275],"about_ca_topic_score_codex":0.0015573374,"about_ca_topic_score_gemma":0.00014848214,"teacher_disagreement_score":0.2754459,"about_ca_system_score_codex":0.00011351598,"about_ca_system_score_gemma":0.00021041185,"threshold_uncertainty_score":0.36220208},"labels":[],"label_agreement":null},{"id":"W4200429699","doi":"10.1016/j.diabres.2021.109177","title":"Care gaps in achieving cholesterol targets in people with diabetes: A population-based study in a universal health care setting","year":2021,"lang":"en","type":"article","venue":"Diabetes Research and Clinical Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Libin Cardiovascular Institute of Alberta; Foothills Medical Centre; University of Calgary","funders":"Diabetes Canada; Canadian Diabetes Association","keywords":"Medicine; Diabetes mellitus; Statin; Internal medicine; Population; Myocardial infarction; Logistic regression; Observational study; Disease; Stroke (engine); Physical therapy; Endocrinology; Environmental health","score_opus":0.034473254275496815,"score_gpt":0.4191507160397969,"score_spread":0.3846774617643001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200429699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864775,0.006875115,0.0000030747385,0.004669855,0.000035674308,0.0017153142,0.000009560849,0.00001749536,0.00019639287],"genre_scores_gemma":[0.99767095,0.00019660547,0.0006601672,0.0011102273,0.00010807649,0.00010123603,0.00011322755,0.000030779265,0.0000087094495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99340725,0.0033172632,0.0007211007,0.00072618405,0.0009733395,0.0008548822],"domain_scores_gemma":[0.99578446,0.0026694934,0.0001295943,0.00053257967,0.0005027223,0.00038114845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006431028,0.00017215197,0.0007409845,0.00034000567,0.00015674027,0.00008159811,0.000104225626,0.00013782097,0.0000100565485],"category_scores_gemma":[0.006450695,0.00015233963,0.00008612284,0.0012097647,0.000056536515,0.00030504158,0.00013033698,0.0018514489,0.0000029889513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002874545,0.0011029769,0.96805847,0.0008145771,0.000063493615,0.00025986639,0.0030568994,0.000039320792,0.000003979615,0.000003116476,0.000006798518,0.026303038],"study_design_scores_gemma":[0.0066179447,0.0025113965,0.933457,0.0008535525,0.000028724675,0.0000013611296,0.055760607,0.00026279048,0.000009613411,0.0000028967868,0.00036461907,0.00012950209],"about_ca_topic_score_codex":0.0040392503,"about_ca_topic_score_gemma":0.03310011,"teacher_disagreement_score":0.05270371,"about_ca_system_score_codex":0.0005869049,"about_ca_system_score_gemma":0.00164732,"threshold_uncertainty_score":0.9845433},"labels":[],"label_agreement":null},{"id":"W4200452731","doi":"10.3389/fneur.2021.736365","title":"Relationship Between Lipoprotein (a) [Lp(a)] and Cognition in Different Ischemic Stroke Subtypes","year":2021,"lang":"en","type":"article","venue":"Frontiers in Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ischemic stroke; Cognition; Lipoprotein(a); Lipoprotein; Stroke (engine); Neuroscience; Medicine; Psychology; Cardiology; Internal medicine; Ischemia; Cholesterol; Engineering","score_opus":0.017888772525484393,"score_gpt":0.25033488955622757,"score_spread":0.23244611703074317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200452731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913292,0.002361475,0.00069682964,0.0037800514,0.00025446533,0.00039343923,0.0000082718925,0.000022335102,0.0011539283],"genre_scores_gemma":[0.99808294,0.00017166283,0.0006504102,0.0005414867,0.00022428704,0.00004853709,0.000063805375,0.00001534076,0.00020155273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998733,0.00023739607,0.00026063068,0.0003452871,0.00016409386,0.00025959936],"domain_scores_gemma":[0.999508,0.00007535318,0.00004416248,0.00025692975,0.000024870866,0.00009067994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023892334,0.00012314376,0.0004344608,0.00019817133,0.0000334643,0.000007680205,0.000037252958,0.00021539016,0.000010155609],"category_scores_gemma":[0.0002886456,0.00011723997,0.000071270195,0.00017687782,0.000066381144,0.000043687312,0.000042204014,0.00055209605,0.0000030466197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013823174,0.000046337347,0.98947567,0.00008806919,0.000025038818,0.00020288497,0.00006816533,0.000001392791,0.0002918401,0.00003227334,0.00076292263,0.008867169],"study_design_scores_gemma":[0.0021668873,0.00017616473,0.9905543,0.000031175197,0.00006220377,0.00009219739,0.000053958007,0.00006397383,0.0015199652,0.00074084994,0.004449299,0.00008905954],"about_ca_topic_score_codex":0.00007138296,"about_ca_topic_score_gemma":0.00010258893,"teacher_disagreement_score":0.008778109,"about_ca_system_score_codex":0.000033651097,"about_ca_system_score_gemma":0.00007069146,"threshold_uncertainty_score":0.47809073},"labels":[],"label_agreement":null},{"id":"W4200479449","doi":"10.1139/apnm-2021-0081","title":"The influence of menopause and cardiorespiratory fitness on lipoprotein particles in midlife women","year":2021,"lang":"en","type":"article","venue":"Applied Physiology Nutrition and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute on Aging","keywords":"Cardiorespiratory fitness; Lipoprotein; Menopause; Internal medicine; Endocrinology; Medicine; Postmenopausal women; Lipoprotein(a); Cholesterol","score_opus":0.009381285267644682,"score_gpt":0.24099014725000054,"score_spread":0.23160886198235586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200479449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904599,0.008507488,0.0000014985463,0.000429481,0.00003082193,0.00044881596,0.0000062285117,0.000011847869,0.000103888786],"genre_scores_gemma":[0.9929785,0.0053844047,0.00007935498,0.001018041,0.000121546895,0.000390925,0.000005374173,0.000009341933,0.000012513652],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990249,0.00012905733,0.00022795076,0.0002462144,0.00014950035,0.00022235779],"domain_scores_gemma":[0.99939656,0.00006761897,0.000056182405,0.00030420022,0.00006946838,0.000105975654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003926572,0.00010754297,0.0004325293,0.00004522409,0.00008862381,0.000007911659,0.000035564884,0.00008508107,0.000003982345],"category_scores_gemma":[0.00005131507,0.00007726101,0.000040511193,0.00016244208,0.00020228126,0.000026812131,0.000040496732,0.00015861553,0.0000018532331],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005764354,0.0003804598,0.0001932733,0.00051606784,0.00020260374,0.000020556925,0.0007196984,0.000026478543,0.8981674,0.024392636,0.00006989449,0.074734524],"study_design_scores_gemma":[0.00547779,0.000057546,0.8563774,0.00009020233,0.000057587513,0.000020452522,0.0008019878,0.0000053929666,0.072412774,0.0054709855,0.05910475,0.00012313166],"about_ca_topic_score_codex":0.000031891203,"about_ca_topic_score_gemma":0.0000070830456,"teacher_disagreement_score":0.8561841,"about_ca_system_score_codex":0.000014635275,"about_ca_system_score_gemma":0.00006559996,"threshold_uncertainty_score":0.31506124},"labels":[],"label_agreement":null},{"id":"W4200489650","doi":"10.1016/j.atherosclerosis.2021.11.032","title":"Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia","year":2021,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; Canadian Institutes of Health Research; University of British Columbia; British Heart Foundation; Michael Smith Health Research BC","keywords":"Dyslipidemia; Genetics; Hazard ratio; Medicine; Genetic architecture; Disease; Internal medicine; Phenotype; Confidence interval; Biology; Gene","score_opus":0.012644551245563256,"score_gpt":0.22009403883100306,"score_spread":0.2074494875854398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200489650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98727536,0.010512225,0.00087121606,0.00024441665,0.00014579843,0.00033925934,0.000034975368,0.000048634567,0.0005280883],"genre_scores_gemma":[0.9919521,0.0049023596,0.0023846251,0.00029290392,0.00024055332,0.000023142615,0.000014354928,0.00004104619,0.00014890835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982542,0.00023673246,0.00030966406,0.00041474708,0.00050384545,0.00028083666],"domain_scores_gemma":[0.998538,0.00005508962,0.00007159659,0.000999356,0.00013683626,0.00019909465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006253091,0.00018759957,0.00079484156,0.000051282237,0.00009752916,0.000011709523,0.00006653293,0.00016142488,0.000044705484],"category_scores_gemma":[0.00021255754,0.00015689587,0.0009160266,0.00027133946,0.000109723966,0.000030380172,0.00008158864,0.0002957337,0.000007759137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043422796,0.00056799897,0.45686752,0.0011913117,0.011090167,0.00005834923,0.0016320412,0.00015366718,0.15427029,0.0004876193,0.00060550054,0.37264132],"study_design_scores_gemma":[0.004937862,0.0004071367,0.95785964,0.00021634974,0.001954549,0.000118363394,0.00032866866,0.000055043947,0.026082508,0.00021969751,0.0075511714,0.00026903953],"about_ca_topic_score_codex":0.0007027105,"about_ca_topic_score_gemma":0.000027037044,"teacher_disagreement_score":0.5009921,"about_ca_system_score_codex":0.000029229366,"about_ca_system_score_gemma":0.00015173496,"threshold_uncertainty_score":0.63980275},"labels":[],"label_agreement":null},{"id":"W4200501757","doi":"10.18433/jpps32342","title":"Changes in Rosuvastatin Pharmacokinetics During Postnatal Ontogenesis in Rats","year":2021,"lang":"en","type":"article","venue":"Journal of Pharmacy & Pharmaceutical Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Univerzita Karlova v Praze","keywords":"Rosuvastatin; Pharmacokinetics; Medicine; Dosing; Rosuvastatin Calcium; Pharmacology; Urology","score_opus":0.06596762958032486,"score_gpt":0.39973840861869503,"score_spread":0.33377077903837016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200501757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97892714,0.013167591,0.000022199625,0.0066820527,0.00046593967,0.00024279219,0.000005713044,0.0000109633265,0.00047561916],"genre_scores_gemma":[0.9867013,0.010027619,0.0010805161,0.0014972513,0.0006153366,0.000006998123,0.0000012659056,0.00001583378,0.00005384329],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967943,0.00030719928,0.0007389285,0.00032554605,0.0012126032,0.00062146055],"domain_scores_gemma":[0.99886966,0.00010619411,0.00018322718,0.00013037883,0.00023229251,0.00047825507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00224775,0.00019938868,0.000566099,0.00041321685,0.00009548214,0.000056685378,0.00024053933,0.00004392263,0.0005301501],"category_scores_gemma":[0.00019924597,0.00016075537,0.00023518657,0.0013592906,0.00019003362,0.00028117,0.00010327011,0.0006565817,0.000007751291],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000759871,0.0007894225,0.15256839,0.00045356495,0.00011063878,0.011027132,0.00049272773,0.0003641283,0.70727116,0.000032817454,0.000089535635,0.1260406],"study_design_scores_gemma":[0.0093579795,0.00019507302,0.0915364,0.0003640421,0.00016872174,0.004418447,0.0004953068,0.0021045473,0.8725199,0.000018514067,0.018579232,0.00024181887],"about_ca_topic_score_codex":0.00008150019,"about_ca_topic_score_gemma":0.00013555193,"teacher_disagreement_score":0.16524874,"about_ca_system_score_codex":0.00021998797,"about_ca_system_score_gemma":0.0007509993,"threshold_uncertainty_score":0.6555414},"labels":[],"label_agreement":null},{"id":"W4205169005","doi":"10.1161/atvbaha.121.317335","title":"Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion","year":2022,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Apolipoprotein B; Secretion; Biosynthesis; Coupling (piping); Enzyme; Receptor; Intracellular","score_opus":0.05239830854585999,"score_gpt":0.3140502062612091,"score_spread":0.26165189771534914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205169005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850692,0.0003067384,0.012471931,0.00067395635,0.00008772047,0.0010824859,0.00027186144,0.00001972569,0.000016360766],"genre_scores_gemma":[0.9968672,0.0006466405,0.0015739247,0.00015617657,0.00004627324,0.00027508824,0.0004085947,0.00002311632,0.0000029894509],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985976,0.00018163376,0.0005134959,0.0003796098,0.00015128561,0.00017632394],"domain_scores_gemma":[0.99901086,0.000060581628,0.00030318488,0.0004019347,0.00014472129,0.000078715275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007728731,0.00015452113,0.00057198893,0.0001131455,0.00020319645,0.000008854367,0.00006390085,0.000105510735,0.000035228455],"category_scores_gemma":[0.000040294566,0.00014422969,0.00023776255,0.00015666275,0.00013048408,0.000082261286,0.00008514094,0.000096764044,2.467673e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028630257,0.000173848,0.10819769,0.00027980816,0.00041638012,4.0134935e-9,0.00058497937,0.000026716827,0.88344884,0.0014653732,0.00008569813,0.0052920664],"study_design_scores_gemma":[0.0017307865,0.0011146683,0.9896949,0.000069702255,0.00024504316,0.0000026953255,0.00018980302,0.0024327494,0.0030299448,0.00042534882,0.0009293483,0.00013500522],"about_ca_topic_score_codex":0.00017735275,"about_ca_topic_score_gemma":0.000011413447,"teacher_disagreement_score":0.8814972,"about_ca_system_score_codex":0.000057646488,"about_ca_system_score_gemma":0.000050187915,"threshold_uncertainty_score":0.5881516},"labels":[],"label_agreement":null},{"id":"W4205409282","doi":"10.1093/jn/nxab375","title":"Reduction in Serum LDL Cholesterol Using a Nutrient Compendium in Hyperlipidemic Adults Unable or Unwilling to Use Statin Therapy: A Double-Blind Randomized Crossover Clinical Trial","year":2021,"lang":"en","type":"article","venue":"Journal of Nutrition","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Cargill (Canada)","funders":"California Walnut Commission","keywords":"Cholesterol; Medicine; Crossover study; Population; Statin; Internal medicine; Randomized controlled trial; Endocrinology; Food science; Chemistry","score_opus":0.1521264178499795,"score_gpt":0.4084205187299723,"score_spread":0.2562941008799928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205409282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99245507,0.0009870294,0.0010484142,0.0013876392,0.0010746353,0.003028643,0.000005655997,0.000008296958,0.000004599461],"genre_scores_gemma":[0.98777646,0.004066773,0.0056415508,0.00043484618,0.0019378058,0.00006572659,0.000014912804,0.000029443429,0.00003245759],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99583334,0.00092748966,0.0020052001,0.00029788227,0.00062392565,0.00031215782],"domain_scores_gemma":[0.9981847,0.00025888966,0.0005704644,0.0002565531,0.0005009822,0.00022841418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004809649,0.00017371727,0.0014183397,0.00043067377,0.000057409212,0.00008821804,0.00006607002,0.00020753552,0.000033810076],"category_scores_gemma":[0.00067656743,0.00013282613,0.0005682363,0.0006545063,0.000041760617,0.00041154033,0.000023592582,0.00072182645,0.0000020139144],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9906809,0.0025484303,0.0006944256,0.00018646076,0.00014795412,0.00027947355,0.0004480861,0.00032592996,0.0015287793,0.000008563609,0.00005895835,0.003092073],"study_design_scores_gemma":[0.98697084,0.001398767,0.0018083197,0.0032420151,0.00012593987,0.0010145884,0.0006767055,0.00060147984,0.0025781605,0.00008965237,0.0013546231,0.00013890547],"about_ca_topic_score_codex":0.00036089765,"about_ca_topic_score_gemma":0.00008840208,"teacher_disagreement_score":0.004678603,"about_ca_system_score_codex":0.00042106956,"about_ca_system_score_gemma":0.00062517944,"threshold_uncertainty_score":0.5416493},"labels":[],"label_agreement":null},{"id":"W4205717887","doi":"10.1002/14651858.cd013673","title":"Pravastatin for lowering lipids","year":2020,"lang":"en","type":"article","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pravastatin; Medicine; Cholesterol; Adverse effect; Cholesterol lowering; Lipoprotein; Pharmacology; Internal medicine","score_opus":0.09466168112556032,"score_gpt":0.35383434240638734,"score_spread":0.259172661280827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205717887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057026865,0.69368917,0.26103362,0.001909314,0.00044426505,0.035249922,0.00045431827,0.00011776375,0.0013989328],"genre_scores_gemma":[0.3641325,0.38229692,0.2165455,0.011661081,0.006563064,0.01399145,0.003292557,0.00050516776,0.0010117628],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9974821,0.00019193698,0.0013868432,0.00029108694,0.0004451294,0.00020289271],"domain_scores_gemma":[0.9979263,0.00016161248,0.00048013972,0.0010025983,0.00018171917,0.00024764994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030127456,0.00018838594,0.002168688,0.000039788458,0.00003828564,0.000011428502,0.00014689624,0.000041260108,0.000075905016],"category_scores_gemma":[0.0042460957,0.0001259156,0.00056269614,0.00021037678,0.00002663274,0.0000803616,0.000045669523,0.00009655093,0.00009720245],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045202516,0.00004091689,0.000010427537,0.98992336,0.00011989377,0.0000102475215,0.0002951836,5.661755e-7,0.0051950207,0.00015203698,0.0029014235,0.0013057268],"study_design_scores_gemma":[0.0054890146,0.0012515838,0.000047722373,0.92799604,0.003280364,0.00027344454,0.0008722333,0.0015495246,0.011677683,0.000012077369,0.046972472,0.000577838],"about_ca_topic_score_codex":0.000014633408,"about_ca_topic_score_gemma":0.000001238652,"teacher_disagreement_score":0.3584298,"about_ca_system_score_codex":0.000022857937,"about_ca_system_score_gemma":0.000094019466,"threshold_uncertainty_score":0.5134689},"labels":[],"label_agreement":null},{"id":"W4205800360","doi":"10.1016/s0735-1097(01)97877-5","title":"ZD4522 is superior to atorvastatin in decreasing low density lipoprotein cholesterol and increasing high density lipoprotein cholesterol in patients with type IIa or IIb hypercholesterolemia Michael H. Davidson, Patrick T. S. Ma, Evan Stein, Howard G. Hutchinson, Rohini Chitra, Ali Raza, Antonio Gotto, Jr.. Chicago Center for Clinical Research, Chicago, IL, Heart Health Institute Research Clinic, Calgary, Canada","year":2001,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atorvastatin; Internal medicine; Ldl cholesterol; Cholesterol; Endocrinology; Familial hypercholesterolemia; Gerontology","score_opus":0.04312954300231552,"score_gpt":0.3607355847357065,"score_spread":0.31760604173339096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205800360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859754,0.0005235925,0.00009684236,0.007953745,0.00046798165,0.004724425,0.0002330347,0.000013458023,0.000011538435],"genre_scores_gemma":[0.99059045,0.000990843,0.0044632517,0.0030088625,0.00070950575,0.0000657616,0.000021365073,0.0001115627,0.000038385566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9858393,0.0065053008,0.0026390129,0.001106121,0.0022827613,0.0016274845],"domain_scores_gemma":[0.9935743,0.0007944277,0.0010507792,0.0014705074,0.001916819,0.001193122],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.015785966,0.00058578496,0.0036619666,0.0009135459,0.00049796025,0.00005798044,0.00075694296,0.00033788057,0.0000060356147],"category_scores_gemma":[0.002849935,0.00041616015,0.0004958268,0.0020518021,0.0012661043,0.0002756966,0.0005545708,0.003025311,0.0000026672324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03285166,0.0005689915,0.9161477,0.00036481855,0.0005513187,0.00038582983,0.00038676086,0.000032231866,0.00026978523,0.0000025236789,0.001582786,0.046855606],"study_design_scores_gemma":[0.01302591,0.008757607,0.9646766,0.0015682041,0.00011835446,0.0014540447,0.0005610162,0.000027400667,0.00027376358,0.000023838957,0.009152306,0.00036096535],"about_ca_topic_score_codex":0.39286083,"about_ca_topic_score_gemma":0.32842,"teacher_disagreement_score":0.06444083,"about_ca_system_score_codex":0.0016455052,"about_ca_system_score_gemma":0.0063127126,"threshold_uncertainty_score":0.999829},"labels":[],"label_agreement":null},{"id":"W4205902905","doi":"10.1001/jamacardio.2021.2051","title":"Error in Figure","year":2021,"lang":"en","type":"erratum","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Circle Cardiovascular Imaging","funders":"Alnylam Pharmaceuticals; Pfizer","keywords":"Medicine; Humanities; Philosophy","score_opus":0.019946115071802425,"score_gpt":0.28556619628297164,"score_spread":0.2656200812111692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205902905","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004327144,0.10763667,0.000093075476,0.0081401365,0.04714936,0.0015121802,0.00014767013,0.00014896248,0.8308448],"genre_scores_gemma":[0.027954437,0.027851496,0.0006258891,0.01158753,0.07541978,0.0006762906,0.012562941,0.0003773733,0.84294426],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972218,0.00049714255,0.00046884385,0.00074578135,0.000451982,0.000614426],"domain_scores_gemma":[0.99816066,0.000043614193,0.00010706253,0.0013156926,0.00017685341,0.00019611332],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00083821925,0.0003565317,0.0022830188,0.0002513888,0.000039810213,0.00001902383,0.00015894235,0.0026097777,0.00033830496],"category_scores_gemma":[0.00046976257,0.00031407984,0.00096340396,0.0003141658,0.00008254582,0.000032338834,0.00012802806,0.0032190876,0.00015507427],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054490698,0.000023083321,0.000907073,0.000717536,0.0006147825,0.0070791747,0.000046613946,0.000007631928,0.000012684014,0.00007343475,0.97322947,0.017234053],"study_design_scores_gemma":[0.0014761398,0.00015145047,0.032362994,0.00046898398,0.00026784968,0.0019686427,0.00011880618,0.000011190484,0.000005763987,0.000036496647,0.96287614,0.0002555618],"about_ca_topic_score_codex":0.0004188128,"about_ca_topic_score_gemma":0.00012229227,"teacher_disagreement_score":0.079785176,"about_ca_system_score_codex":0.0003044891,"about_ca_system_score_gemma":0.0015185167,"threshold_uncertainty_score":0.99993116},"labels":[],"label_agreement":null},{"id":"W4205960258","doi":"10.1016/j.cjca.2022.01.006","title":"The Power to Predict: Does LDLR Mutation Status Determine Statin Responsiveness?","year":2022,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Statin; Internal medicine; LDL receptor; Mutation; Cardiology; Genetics; Cholesterol; Lipoprotein; Gene","score_opus":0.01114160493302346,"score_gpt":0.24726434899054298,"score_spread":0.2361227440575195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205960258","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047223892,0.008290394,0.0012495953,0.92576194,0.010276235,0.0019604117,0.0010353436,0.000022535713,0.0041796593],"genre_scores_gemma":[0.22895588,0.0012429373,0.00058053975,0.7268188,0.036015324,0.00024137572,0.0005385018,0.00031313844,0.0052934852],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962164,0.0011259379,0.00075651327,0.00029836665,0.00068687793,0.0009158867],"domain_scores_gemma":[0.9968837,0.0003864368,0.00040552433,0.00073721615,0.00067806605,0.0009090615],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018985556,0.00028380242,0.0011198194,0.0006281174,0.00039015102,0.00005344652,0.0003345309,0.00042701716,0.00018853358],"category_scores_gemma":[0.0012735781,0.00017647592,0.0007159664,0.00025267163,0.0001774162,0.000048535174,0.000036558777,0.0023749697,0.000012308424],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039389505,8.6599385e-7,0.0010100517,0.00008176523,0.0009906472,0.019122174,0.00033293955,0.0002760652,0.000013087308,0.000010443929,0.9612208,0.01654728],"study_design_scores_gemma":[0.0007669855,0.0014872969,0.009450051,0.00008375706,0.00036166853,0.0057599833,0.00037701026,0.0000010860151,0.000011231158,0.00010446648,0.9814195,0.00017696434],"about_ca_topic_score_codex":0.0023118462,"about_ca_topic_score_gemma":0.0019777354,"teacher_disagreement_score":0.19894312,"about_ca_system_score_codex":0.0010536652,"about_ca_system_score_gemma":0.00870199,"threshold_uncertainty_score":0.99992657},"labels":[],"label_agreement":null},{"id":"W4206181927","doi":"10.1002/alz.053239","title":"Sex‐related differences in cognition with statin usage in a geriatric memory clinic cohort","year":2021,"lang":"en","type":"article","venue":"Alzheimer s & Dementia","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Addiction and Mental Health; York University; University of Toronto; McMaster University; St. Michael's Hospital","funders":"","keywords":"Rosuvastatin; Atorvastatin; Medicine; Cognition; Montreal Cognitive Assessment; Memory clinic; Geriatric Depression Scale; Population; Cohort; Dementia; Statin; Activities of daily living; Psychology; Physical therapy; Clinical psychology; Psychiatry; Internal medicine; Cognitive impairment; Depressive symptoms; Disease","score_opus":0.022705244727596104,"score_gpt":0.27094977641079626,"score_spread":0.24824453168320015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206181927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94509083,0.050113548,0.00006280512,0.00019854186,0.00011475079,0.00081655284,0.0000058674977,0.00003342426,0.0035636586],"genre_scores_gemma":[0.99773216,0.00080528297,0.000766688,0.00030568443,0.000057023837,0.00011702059,0.00012429302,0.00002336589,0.00006849217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810046,0.00026045233,0.0004857145,0.00040832546,0.00042314624,0.0003219247],"domain_scores_gemma":[0.9993411,0.00004798291,0.000096459196,0.00033331194,0.00007568058,0.00010548997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007893365,0.00016180635,0.00049019477,0.00015250755,0.000041481217,0.000020565443,0.000054135122,0.00010429259,0.0009049054],"category_scores_gemma":[0.000031192667,0.00013581854,0.000098916404,0.0006180117,0.000043151787,0.0000862246,0.000037674436,0.00029269338,0.00006344713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021119704,0.0007113667,0.87672323,0.00007706655,0.013878934,0.0014765228,0.00087037584,0.000004139673,0.00046434358,0.00002183259,0.00020825084,0.10535273],"study_design_scores_gemma":[0.0047360435,0.0002591526,0.98123074,0.00015687707,0.009104062,0.00009311379,0.00061392906,0.00008615063,0.0031708907,0.000090223504,0.00023475291,0.00022407768],"about_ca_topic_score_codex":0.00057347026,"about_ca_topic_score_gemma":0.0004939243,"teacher_disagreement_score":0.10512865,"about_ca_system_score_codex":0.000013406236,"about_ca_system_score_gemma":0.00031982435,"threshold_uncertainty_score":0.9908079},"labels":[],"label_agreement":null},{"id":"W4206212302","doi":"10.1002/14651858.cd010254","title":"Lipid lowering efficacy of rosuvastatin","year":2012,"lang":"en","type":"reference-entry","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rosuvastatin; Medicine; Cholesterol; Placebo; Rosuvastatin Calcium; Adverse effect; Internal medicine; Ldl cholesterol; Randomized controlled trial; Cholesterol lowering; Pathology","score_opus":0.07986496189021748,"score_gpt":0.351016279840656,"score_spread":0.2711513179504385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206212302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053932733,0.9693518,0.001619219,0.000022037713,0.0012528377,0.011317795,0.0009163647,0.000032964377,0.0149476435],"genre_scores_gemma":[0.0014828363,0.9871817,0.002527225,0.000045752393,0.0014900479,0.00057680556,0.0029225599,0.0001104195,0.003662622],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9922519,0.0008498756,0.0042412686,0.00053751294,0.0016215878,0.0004979066],"domain_scores_gemma":[0.99151844,0.0004733814,0.0031714789,0.0040524364,0.00040999212,0.0003742587],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0069154203,0.0006515168,0.008567109,0.00029083306,0.000043997607,0.000013502244,0.00044242028,0.00030629794,0.0004785999],"category_scores_gemma":[0.0037637404,0.00042480053,0.0017289743,0.00041015988,0.00010172851,0.000114799994,0.00019070513,0.0005635983,0.00025835965],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003766099,0.00027690784,0.000013782127,0.9659624,0.00054778875,0.000018118426,0.00013912846,1.3651984e-7,0.000053950214,0.000034644134,0.022386773,0.010528722],"study_design_scores_gemma":[0.0014146379,0.0001568104,0.00005203154,0.94691575,0.0045504244,0.00027194273,0.00006946063,0.0000046159735,0.0003262883,8.208475e-7,0.045896888,0.00034035192],"about_ca_topic_score_codex":0.00015099431,"about_ca_topic_score_gemma":0.0000056144,"teacher_disagreement_score":0.023510115,"about_ca_system_score_codex":0.00013502585,"about_ca_system_score_gemma":0.00047081325,"threshold_uncertainty_score":0.99982035},"labels":[],"label_agreement":null},{"id":"W4206334347","doi":"10.1016/s0735-1097(01)97599-0","title":"Niacin plus simvastatin protect against atherosclerosis progression and clinical events in CAD patients with low HDLc and diabetes mellitus or impaired fasting glucose Josiah S. Morse, B. Greg Brown, Xue-Qiao Zhao, Lloyd Fisher, Alan Chait, Alice Dowdy, Leny Serafini, Ellen Huss-Frechette, Debbie DeAngelis, Jiri Frohllich, John Albers. University of Washington, Seattle, WA, University of British Columbia, Vancouver, BC, Canada","year":2001,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Simvastatin; Niacin; Diabetes mellitus; Internal medicine; Endocrinology; Gastroenterology","score_opus":0.007396142182940041,"score_gpt":0.20867283696545205,"score_spread":0.201276694782512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206334347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973871,0.00069923716,0.00004378195,0.00021843189,0.00016367176,0.0010964356,0.00033235582,0.00000775672,0.00005121459],"genre_scores_gemma":[0.9945642,0.0038162249,0.0012713028,0.00009790051,0.000066601766,0.000001534832,0.000007058721,0.000030852323,0.0001443552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99666643,0.0010899145,0.00075279595,0.00038358592,0.0006660108,0.00044127746],"domain_scores_gemma":[0.9968494,0.00029724752,0.0015553101,0.00040929715,0.0005932494,0.00029550435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012051245,0.00023341845,0.0018945492,0.00010636967,0.00016274372,0.000006380539,0.00031813604,0.0001580476,0.000006038372],"category_scores_gemma":[0.0003064394,0.00021808846,0.00034065847,0.00060318527,0.0006725495,0.00014938966,0.00021613935,0.0005316244,5.8121625e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021341196,0.00019245596,0.9667224,0.00027489764,0.0010336802,0.00024603776,0.00014490403,0.00023631187,0.00012221248,8.7790646e-8,0.0033549361,0.025537957],"study_design_scores_gemma":[0.010366018,0.0025425625,0.9802808,0.0015722432,0.00051493413,0.0001268272,0.0021127083,0.0002309111,0.00007598989,0.0000033825363,0.0019307581,0.00024287775],"about_ca_topic_score_codex":0.327716,"about_ca_topic_score_gemma":0.6535262,"teacher_disagreement_score":0.32581022,"about_ca_system_score_codex":0.0003919829,"about_ca_system_score_gemma":0.0012835893,"threshold_uncertainty_score":0.88933897},"labels":[],"label_agreement":null},{"id":"W4206573384","doi":"10.1016/j.pcad.2022.01.002","title":"Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know","year":2022,"lang":"en","type":"review","venue":"Progress in Cardiovascular Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Comparability; Harmonization; Stakeholder; Mendelian randomization; Lipoprotein(a); MEDLINE; Intensive care medicine; Family medicine; Public relations; Lipoprotein","score_opus":0.05737758269368069,"score_gpt":0.38010524151245245,"score_spread":0.32272765881877175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206573384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037414537,0.9877068,0.0000389057,0.0024927922,0.00050582446,0.008449105,0.00016583015,0.0000621383,0.00020450527],"genre_scores_gemma":[0.0014922217,0.9950865,0.00040335112,0.00039690753,0.00038517016,0.002098098,0.00005741952,0.00006120214,0.000019118655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939357,0.0021734827,0.0011782342,0.0009859377,0.0012830897,0.0004435338],"domain_scores_gemma":[0.9961984,0.00070533337,0.00026909838,0.0023870813,0.00010973978,0.00033035516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004207442,0.000521756,0.0027813024,0.00016651179,0.00047579178,0.00022811728,0.0002994751,0.00022476826,0.00003605664],"category_scores_gemma":[0.00057035993,0.00030936374,0.0029918265,0.0007796286,0.0005557387,0.000117761614,0.00053683703,0.00067532563,0.0000034227937],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004850454,0.0001927234,0.0010703597,0.006806761,0.0074733044,0.00022790629,0.000058883314,0.000017014256,2.637124e-10,0.002741494,0.0005335707,0.9808295],"study_design_scores_gemma":[0.0010378682,0.00026204425,0.0053629535,0.016721318,0.014867156,0.00017235312,0.0011324721,0.000008056721,3.9819767e-8,0.0002582572,0.9598246,0.00035285274],"about_ca_topic_score_codex":0.000076451026,"about_ca_topic_score_gemma":0.00003208278,"teacher_disagreement_score":0.9804766,"about_ca_system_score_codex":0.00021520586,"about_ca_system_score_gemma":0.00051579357,"threshold_uncertainty_score":0.99993587},"labels":[],"label_agreement":null},{"id":"W4206654024","doi":"10.1016/j.cjca.2021.03.016","title":"2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults","year":2021,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":833,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; St. Paul's Hospital; Hamilton Health Sciences; Population Health Research Institute; St. Michael's Hospital; University of Toronto; Western University; McMaster University; Providence Health Care Research Institute; University of British Columbia; Montreal Heart Institute; University of Alberta; Providence Health Care; Centre hospitalier universitaire de Québec; Libin Cardiovascular Institute of Alberta; McGill University Health Centre; University of Ottawa; McGill University; University of Calgary; Université de Montréal; Université Laval","funders":"Association des pharmaciens du Canada; University of Toronto; Providence Health Care; McGill University; Alberta Health Services","keywords":"Medicine; Dyslipidemia; Disease; Atherosclerotic cardiovascular disease; Disease management; Intensive care medicine; Canadian Cardiovascular Society; Cardiovascular health; Gerontology; Family medicine; Internal medicine; Myocardial infarction","score_opus":0.037947393603712756,"score_gpt":0.29071401261904356,"score_spread":0.2527666190153308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206654024","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049605258,0.7478412,0.17398667,0.017082244,0.0035250282,0.0065885214,0.0006200923,0.0000063010575,0.00074471004],"genre_scores_gemma":[0.9804696,0.01269269,0.003436563,0.00037829977,0.0025839233,0.00021126667,0.00004868058,0.000047720467,0.00013130065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975152,0.00026047937,0.0009500925,0.00028835554,0.00045139182,0.000534479],"domain_scores_gemma":[0.9957604,0.00016981518,0.00021943857,0.0011645885,0.0020761963,0.0006095825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048924014,0.000195143,0.0012857768,0.0001592057,0.00017277837,0.0000109387265,0.00030473276,0.00016936839,0.000011839258],"category_scores_gemma":[0.0005920374,0.00013060549,0.00589735,0.00036030056,0.00017789986,0.00005027766,0.000023822038,0.0002567314,4.1972132e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006161925,0.000021374239,0.008426846,0.0042664595,0.10830505,0.00070516916,0.0005889036,0.3249157,0.000021089765,0.0014102363,0.028890343,0.52183264],"study_design_scores_gemma":[0.0052444865,0.0002232707,0.036926743,0.0010885736,0.010838379,0.0002086562,0.0024086582,0.001104439,0.00010524553,0.00035154365,0.9412948,0.00020519354],"about_ca_topic_score_codex":0.043718584,"about_ca_topic_score_gemma":0.037421357,"teacher_disagreement_score":0.9308643,"about_ca_system_score_codex":0.00036720876,"about_ca_system_score_gemma":0.005293482,"threshold_uncertainty_score":0.9801432},"labels":[],"label_agreement":null},{"id":"W4210368789","doi":"10.1016/j.ahjo.2022.100097","title":"The design and rationale of the Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia (ACCURATE) study","year":2022,"lang":"en","type":"article","venue":"American Heart Journal Plus Cardiology Research and Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Vancouver General Hospital; St. Paul's Hospital; University of British Columbia","funders":"Vancouver Coastal Health Research Institute; Genome British Columbia","keywords":"Medicine; Familial hypercholesterolemia; Acute coronary syndrome; Cohort; Guideline; Clinical endpoint; Randomized controlled trial; Internal medicine; Coronary care unit; Genetic testing; Disease; Intensive care medicine; Pediatrics; Cholesterol; Pathology; Myocardial infarction","score_opus":0.11186106808303954,"score_gpt":0.43966060399367357,"score_spread":0.32779953591063404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210368789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97708607,0.016033446,0.00020115725,0.0048967265,0.00007589373,0.0015593816,0.000012250947,0.0000032247133,0.00013187379],"genre_scores_gemma":[0.9914626,0.0071919165,0.0009075798,0.00015489999,0.000119981305,0.00013097026,0.000002372823,0.000011879213,0.000017840113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98930746,0.009183774,0.00028515147,0.00020956798,0.00071906566,0.00029497553],"domain_scores_gemma":[0.99428934,0.0044830325,0.00017103238,0.00036525147,0.0005162575,0.00017509058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007774985,0.000109124776,0.0005929255,0.00009436578,0.0012286061,0.000032552143,0.000077016484,0.000023328259,0.0000031348407],"category_scores_gemma":[0.0006057806,0.00006175369,0.00012398227,0.0002975985,0.0006704385,0.00008027856,0.000121730656,0.00065517274,1.00312775e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011173723,0.000565556,0.67692447,0.00016810109,0.0041899583,0.00033116143,0.009189009,0.0042055384,0.005853457,0.00007362461,0.0008374845,0.28648794],"study_design_scores_gemma":[0.005611227,0.032660976,0.6145416,0.000044465603,0.0007051434,0.005425268,0.2576559,0.00024279986,0.00022195405,0.000038354017,0.082694404,0.0001579542],"about_ca_topic_score_codex":0.0005923917,"about_ca_topic_score_gemma":0.0000112862635,"teacher_disagreement_score":0.28632998,"about_ca_system_score_codex":0.00022909933,"about_ca_system_score_gemma":0.0014206216,"threshold_uncertainty_score":0.9449569},"labels":[],"label_agreement":null},{"id":"W4210528054","doi":"10.2165/00128413-200715730-00068","title":"A pravastatin/aspirin combination therapy [PravASA; Paladin Labs] has been launched in Canada.","year":2007,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Launched; Medicine; Pravastatin; Aspirin; Pharmacy; Family medicine; Internal medicine; Engineering","score_opus":0.032241837680085705,"score_gpt":0.2847662141551547,"score_spread":0.252524376475069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210528054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887981,0.001411361,0.0003522297,0.005461346,0.0002831397,0.001095625,0.000014728113,0.000058658752,0.0025248327],"genre_scores_gemma":[0.9952214,0.00022461824,0.00034390608,0.003272739,0.00026851293,0.000045403714,0.00006864646,0.000042791624,0.00051202497],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99771273,0.00011682345,0.0004951256,0.00033653248,0.00078690686,0.000551871],"domain_scores_gemma":[0.99894994,0.000076110846,0.00011675453,0.00039958974,0.00016824785,0.00028933087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016049026,0.0002123484,0.00043908774,0.00018111944,0.00008484432,0.00002675423,0.00012508013,0.00009626847,0.00018960865],"category_scores_gemma":[0.00007220276,0.0001926167,0.00011098627,0.00049678236,0.000044616667,0.00009917759,0.000028965573,0.00041957773,0.000030840147],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013275425,0.0009921669,0.24291424,0.00047490702,0.000567572,0.0024452277,0.0026027425,0.00003145514,0.026985556,0.0004650679,0.021490805,0.69970274],"study_design_scores_gemma":[0.011824472,0.00036845196,0.7691893,0.00015358921,0.000048361235,0.00012011963,0.0007331468,0.00020617299,0.025176285,0.00009981083,0.19172484,0.00035545178],"about_ca_topic_score_codex":0.6435594,"about_ca_topic_score_gemma":0.61650527,"teacher_disagreement_score":0.69934726,"about_ca_system_score_codex":0.0007560376,"about_ca_system_score_gemma":0.0021925056,"threshold_uncertainty_score":0.7854681},"labels":[],"label_agreement":null},{"id":"W4210840666","doi":"10.1038/s41467-022-28240-9","title":"Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance","year":2022,"lang":"en","type":"article","venue":"Nature Communications","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University of Calgary; St. Joseph's Hospital; St. Joseph’s Healthcare Hamilton; McMaster University Medical Centre; Libin Cardiovascular Institute of Alberta; Thrombosis and Atherosclerosis Research Institute; Université de Montréal; Population Health Research Institute; McMaster University","funders":"Canadian Institutes of Health Research; Esperion Therapeutics; Novo Nordisk; Sanofi; Amgen Canada; Fondation Leducq; Amgen; McMaster University; Eli Lilly and Company; Heart and Stroke Foundation of Canada","keywords":"PCSK9; LDL receptor; Cholesterol; Caffeine; Chemistry; Cell biology; Biology; Biochemistry; Endocrinology; Lipoprotein","score_opus":0.016144402527191383,"score_gpt":0.32106608784836715,"score_spread":0.30492168532117575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210840666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650546,0.0087462645,0.00016534665,0.021405768,0.00033233044,0.0017822601,0.000056940757,0.00023586265,0.0022206507],"genre_scores_gemma":[0.9895616,0.0003163828,0.002568876,0.005973585,0.00014521033,0.00073200965,0.00022643688,0.000043638593,0.00043226994],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997912,0.0003825869,0.00034314254,0.00035671622,0.00068990415,0.00031568407],"domain_scores_gemma":[0.9954729,0.00012165068,0.00011806999,0.0038388213,0.00018946955,0.00025906868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066591345,0.00018357477,0.00038044766,0.0001615063,0.00075176515,0.00002119317,0.000874741,0.00018745933,0.00013062714],"category_scores_gemma":[0.00032818693,0.00017406323,0.00018015453,0.0007963176,0.000041653864,0.00006715944,0.0007500069,0.0020829379,0.00006115038],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001067188,0.0042912215,0.013404194,0.0004925999,0.0007921307,0.00008310697,0.007435807,0.0003447002,0.7451996,0.0008707918,0.05124225,0.17477639],"study_design_scores_gemma":[0.0024895263,0.0008815409,0.0935228,0.00041883904,0.00022168549,0.00018006796,0.0006593536,0.0011129152,0.042849284,0.00004308054,0.85699713,0.0006237817],"about_ca_topic_score_codex":0.00017124476,"about_ca_topic_score_gemma":0.00019190977,"teacher_disagreement_score":0.8057549,"about_ca_system_score_codex":0.00023963535,"about_ca_system_score_gemma":0.00018647383,"threshold_uncertainty_score":0.9049445},"labels":[],"label_agreement":null},{"id":"W4210875640","doi":"10.1161/circgen.121.003489","title":"Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk","year":2022,"lang":"en","type":"article","venue":"Circulation Genomic and Precision Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"Agence Nationale de la Recherche","keywords":"Penetrant (biochemical); Locus (genetics); Phenotype; Disease; Gene","score_opus":0.011885997921721845,"score_gpt":0.21331481287230444,"score_spread":0.2014288149505826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210875640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792912,0.003531731,0.015207266,0.00012517284,0.000086330074,0.0015457514,0.00006407537,0.000031505195,0.00011699587],"genre_scores_gemma":[0.9975887,0.0011391515,0.00032683634,0.00009563808,0.00012038982,0.000070444854,0.00056642306,0.000042340496,0.000050108454],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99698687,0.00032893367,0.00082198414,0.00043063582,0.0011917178,0.0002398591],"domain_scores_gemma":[0.9981894,0.000110108245,0.00049625477,0.00065612333,0.00036804812,0.00018007081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023268452,0.00021551929,0.0009800023,0.00028113765,0.00020147896,0.00000487271,0.00011158147,0.00010952167,0.0002571358],"category_scores_gemma":[0.00028342893,0.00016906012,0.00024222687,0.0005419511,0.00015263745,0.000053739826,0.000070785296,0.00028327838,0.0000010903611],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014949595,0.00026469727,0.1454031,0.00046671962,0.0026820777,0.000035019508,0.0023141548,0.0027457261,0.73952395,0.00008938169,0.000007991307,0.104972236],"study_design_scores_gemma":[0.0050216615,0.0012108622,0.9867199,0.0001716545,0.0010671708,0.000080504455,0.00013871361,0.0015475142,0.0018363475,0.0001442721,0.0018876193,0.00017378139],"about_ca_topic_score_codex":0.00016429226,"about_ca_topic_score_gemma":0.0000031881839,"teacher_disagreement_score":0.8413168,"about_ca_system_score_codex":0.00017438887,"about_ca_system_score_gemma":0.00021168054,"threshold_uncertainty_score":0.68940717},"labels":[],"label_agreement":null},{"id":"W4210972738","doi":"10.1016/b978-0-12-812535-9.00007-8","title":"Lipoprotein and Lipid Metabolism","year":2021,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lipid metabolism; Triglyceride; Lipoprotein; Internal medicine; Medicine; Cholesterol; Endocrinology; Low-density lipoprotein","score_opus":0.01427317429162677,"score_gpt":0.2394123476155325,"score_spread":0.22513917332390573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210972738","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019844998,0.05347236,0.000008357715,0.00032857023,0.00041255547,0.0013040076,0.000023775798,0.00008762617,0.9441643],"genre_scores_gemma":[0.00030360374,0.0031795364,0.0010766971,0.0013876782,0.0032322928,0.00008474298,0.00008957471,0.00016736296,0.9904785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99762315,0.00004451795,0.0004926586,0.00072741765,0.00073509174,0.0003771691],"domain_scores_gemma":[0.997965,0.000019057106,0.0001652846,0.0012241779,0.00020228438,0.00042420946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004939659,0.0005157652,0.0014442384,0.00015593306,0.00011649006,0.000051478382,0.00009997273,0.00056561653,0.0005045689],"category_scores_gemma":[0.000038042337,0.00044500764,0.0007023946,0.000017365603,0.00014207712,0.000027063166,0.00018028381,0.0008738248,0.0001067145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027062937,0.000008801092,0.0000012035958,0.0006037667,0.0006038424,0.00031984755,0.00007006127,1.6807752e-8,0.00008428499,0.007921466,0.000085084896,0.99027455],"study_design_scores_gemma":[0.000972633,0.000085580556,0.000117205906,0.0011155283,0.0009831953,0.00063304976,0.000009833231,9.3501274e-7,0.0002405551,0.0012928694,0.99414253,0.00040605705],"about_ca_topic_score_codex":0.0000073353017,"about_ca_topic_score_gemma":0.00002429947,"teacher_disagreement_score":0.9940575,"about_ca_system_score_codex":0.000072563365,"about_ca_system_score_gemma":0.00044586507,"threshold_uncertainty_score":0.99980015},"labels":[],"label_agreement":null},{"id":"W4211004768","doi":"10.1016/j.jcjd.2017.10.019","title":"Dyslipidemia","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Traditional medicine; Internal medicine; Obesity","score_opus":0.013084029935761174,"score_gpt":0.24223489086235217,"score_spread":0.22915086092659098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211004768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878112,0.0025141896,0.000018646158,0.0018879982,0.0005769037,0.0000732024,0.000003080812,0.000003944284,0.007110855],"genre_scores_gemma":[0.995039,0.0000043079476,0.0004519165,0.0018015079,0.0025072147,7.0326945e-7,8.354913e-7,0.000012124694,0.00018240236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924225,0.000029732913,0.00022016627,0.00006311361,0.0001604937,0.00028422594],"domain_scores_gemma":[0.9984493,0.000014092603,0.00007998416,0.00018507555,0.00032012348,0.00095140905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056316104,0.00006417271,0.0002572173,0.0001765373,0.00007737032,0.000016064463,0.000076393066,0.000057413446,0.0003800543],"category_scores_gemma":[0.00025954007,0.000049899598,0.00017886233,0.00013453422,0.000106414496,0.000058730664,0.000003147927,0.00016476268,0.000055349414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007674984,0.000020504733,0.80489844,0.00013539316,0.00060283946,0.000116081865,0.00046711578,0.0000012234385,0.0014992433,0.0005543175,0.06569849,0.12599868],"study_design_scores_gemma":[0.001275406,0.0011811414,0.5585383,0.0003593979,0.000210212,0.000087380125,0.000122046484,0.000018659379,0.005224805,0.0004794402,0.43235776,0.00014542931],"about_ca_topic_score_codex":0.00034885656,"about_ca_topic_score_gemma":0.0023245488,"teacher_disagreement_score":0.36665928,"about_ca_system_score_codex":0.000109209424,"about_ca_system_score_gemma":0.001616693,"threshold_uncertainty_score":0.41613278},"labels":[],"label_agreement":null},{"id":"W4211017770","doi":"10.1016/j.atherosclerosis.2022.02.005","title":"The Cholesterol Uptake Capacity: The search for scalable HDL function tests continues","year":2022,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Mendelian randomization; Cholesterylester transfer protein; Medicine; Niacin; Internal medicine; Cholesterol; Dyslipidemia; Epidemiology; Lipoprotein; High-density lipoprotein; Reverse cholesterol transport; ABCA1; Endocrinology; Disease; Bioinformatics; Genetics; Biology; Gene; Genetic variants","score_opus":0.05233833178693929,"score_gpt":0.2651944001334172,"score_spread":0.2128560683464779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211017770","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0735507,0.0037309881,0.0004781744,0.90900105,0.0030118816,0.007716986,0.00037386708,0.00028543646,0.001850938],"genre_scores_gemma":[0.03281414,0.0024798259,0.0001908389,0.9028016,0.015764615,0.006096381,0.0005874902,0.0004757066,0.0387894],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963462,0.0003790414,0.00046928946,0.0006451177,0.0012977336,0.0008626179],"domain_scores_gemma":[0.9971638,0.00045687307,0.00019175967,0.0018373667,0.00025028,0.000099943994],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0023691661,0.00040458297,0.0006599716,0.00006711877,0.0016029506,0.0002436935,0.00047180746,0.00047904608,0.0001831035],"category_scores_gemma":[0.000116730385,0.00022613947,0.00090329204,0.00029000698,0.00024636416,0.000068374924,0.00014913963,0.0022656326,0.00006169329],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109726214,0.00004802545,0.00058182876,0.0003307943,0.0007349564,0.0000030565177,0.00027024187,0.0000028578493,0.0004078049,0.0000385829,0.9403114,0.05716073],"study_design_scores_gemma":[0.0012113088,0.000655786,0.019158933,0.00014890765,0.00058995985,0.000027687678,0.00018025728,0.000026079135,0.00023187557,0.00005528769,0.9774902,0.00022375466],"about_ca_topic_score_codex":0.0010325398,"about_ca_topic_score_gemma":0.000072591814,"teacher_disagreement_score":0.05693698,"about_ca_system_score_codex":0.00027510268,"about_ca_system_score_gemma":0.00021865679,"threshold_uncertainty_score":0.99969685},"labels":[],"label_agreement":null},{"id":"W4211072399","doi":"10.1002/14651858.cd012501.pub2","title":"Cerivastatin for lowering lipids","year":2020,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cerivastatin; Rosuvastatin; Atorvastatin; Medicine; Statin; Fluvastatin; Placebo; Cholesterol; Pharmacology; Adverse effect; Internal medicine; Pravastatin; Clinical trial; Simvastatin","score_opus":0.12975152598870027,"score_gpt":0.39756986572426467,"score_spread":0.2678183397355644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211072399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.2588826e-8,0.9591971,0.008632477,0.000025648054,0.0003961507,0.030628446,0.0008181358,0.00004426475,0.00025767204],"genre_scores_gemma":[2.6557385e-7,0.9849711,0.0064659356,0.00007016988,0.00086208724,0.0055800923,0.0017729142,0.00013670984,0.00014073525],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9929333,0.0007248727,0.0044651045,0.000716464,0.000771771,0.00038854344],"domain_scores_gemma":[0.99356365,0.00058440736,0.0023735475,0.0028811353,0.0002248451,0.0003723859],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.005200761,0.0007467092,0.016958645,0.00018613455,0.00006032301,0.00002715293,0.0004429268,0.0002108429,0.0000920576],"category_scores_gemma":[0.004924129,0.00046291488,0.004113213,0.00051797053,0.00005178122,0.000080033686,0.00014373822,0.00035748075,0.00028146023],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000070220217,0.00003753596,2.5483182e-8,0.760625,0.00047864972,0.00002751085,0.000033453634,1.0740731e-8,0.0000020211303,0.000048737114,0.0015105294,0.2372295],"study_design_scores_gemma":[0.00028761948,0.000096404445,1.3988793e-8,0.5040418,0.0061945124,0.00027342062,0.000015036499,0.0000043231903,0.0000023071957,6.576665e-7,0.48890352,0.00018038334],"about_ca_topic_score_codex":0.000015486668,"about_ca_topic_score_gemma":0.000001287452,"teacher_disagreement_score":0.487393,"about_ca_system_score_codex":0.00014106836,"about_ca_system_score_gemma":0.00059803185,"threshold_uncertainty_score":0.99978226},"labels":[],"label_agreement":null},{"id":"W4211089118","doi":"10.1093/eurheartj/ehac014","title":"New therapeutic targets in the prevention of atherosclerotic cardiovascular disease","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atherosclerotic cardiovascular disease; Disease; ATHEROSCLEROTIC VASCULAR DISEASE; Intensive care medicine; Cardiology; Internal medicine","score_opus":0.04688011880637359,"score_gpt":0.2828347522910211,"score_spread":0.2359546334846475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211089118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8816162,0.09729353,0.009369053,0.0048630675,0.00082039286,0.001993714,0.0000072832013,0.000045638917,0.0039911754],"genre_scores_gemma":[0.9977969,0.00031490065,0.000310695,0.00069728185,0.00055759796,0.0000069639086,0.000003769245,0.00002982156,0.00028205733],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965481,0.0018709067,0.00028095138,0.0001481195,0.000942018,0.00020988901],"domain_scores_gemma":[0.999178,0.000017211709,0.00007076949,0.0005294103,0.000031857624,0.00017274791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043096473,0.000094835064,0.0002677117,0.00009137489,0.00020603009,0.000020023776,0.00016043568,0.000008985101,0.0003430812],"category_scores_gemma":[0.000037213405,0.00006567697,0.00078891707,0.00023943422,0.000019562362,0.00004816185,0.000054421824,0.0005329819,0.000014851016],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019107148,0.002624178,0.09784779,0.00071454095,0.0054151807,0.00548362,0.012440098,0.017224804,0.0043704757,0.0009789803,0.025723739,0.8252659],"study_design_scores_gemma":[0.0025718121,0.0006400971,0.7328952,0.000110056135,0.0003996118,0.0019093534,0.00059722073,0.00006096849,0.00003875663,0.0002701783,0.26038986,0.000116894116],"about_ca_topic_score_codex":0.00002652613,"about_ca_topic_score_gemma":6.320645e-7,"teacher_disagreement_score":0.825149,"about_ca_system_score_codex":0.0000688653,"about_ca_system_score_gemma":0.00026389165,"threshold_uncertainty_score":0.37564984},"labels":[],"label_agreement":null},{"id":"W4211152466","doi":"10.1161/cir.0000000000000624","title":"2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines","year":2019,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":905,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Center for Innovations in Quality, Effectiveness and Safety; University of California, San Francisco; University of North Carolina at Chapel Hill; Public Health Agency of Canada; U.S. Department of Veterans Affairs; Rush University; University of Pittsburgh; Office of Science; Johns Hopkins University; American Pharmacists Association; Northwestern University; Emory University; Temple University; American Diabetes Association; American Heart Association; University of Miami","keywords":"Medicine; Guideline; Clinical Practice; Task force; Internal medicine; Family medicine; Pathology; Political science; Public administration","score_opus":0.08429557355256359,"score_gpt":0.41025476593420307,"score_spread":0.3259591923816395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211152466","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019438531,0.9030269,0.0021972088,0.018194636,0.004505835,0.032843888,0.0020746829,0.00018645845,0.01753189],"genre_scores_gemma":[0.026176061,0.962903,0.0028096621,0.0032498767,0.0019960285,0.00037505644,0.00074782496,0.00021655201,0.0015258982],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9888891,0.002622642,0.0048576174,0.0009941108,0.0021919892,0.00044453068],"domain_scores_gemma":[0.9843141,0.0011989115,0.009030844,0.003084037,0.002244153,0.00012794968],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011848134,0.0006065026,0.0050238003,0.0002481087,0.00012809531,0.00001221736,0.00046372195,0.00038622456,0.0000057396896],"category_scores_gemma":[0.0045037754,0.000374956,0.0028673974,0.0013053888,0.00045922518,0.00010947792,0.00019467593,0.0008147108,0.000012840022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012299987,0.0020039834,0.02403536,0.02344056,0.048025496,0.0002786085,0.00025184776,0.0011968941,0.00005779725,0.0030384294,0.16506414,0.7313769],"study_design_scores_gemma":[0.0013681352,0.0010677282,0.017856628,0.0085101845,0.014678989,0.0003491049,0.00050792604,0.00006826401,0.000012831623,0.000034595014,0.9551853,0.00036031837],"about_ca_topic_score_codex":0.0006194672,"about_ca_topic_score_gemma":0.000010740161,"teacher_disagreement_score":0.79012114,"about_ca_system_score_codex":0.00058424275,"about_ca_system_score_gemma":0.0010664759,"threshold_uncertainty_score":0.99987024},"labels":[],"label_agreement":null},{"id":"W4211180010","doi":"10.1038/nrdp.2017.93","title":"Familial hypercholesterolaemia","year":2017,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":528,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Ezetimibe; LDL receptor; Familial hypercholesterolemia; PCSK9; Medicine; Apolipoprotein B; Disease; Cholesterol; Asymptomatic; Genetic disorder; Internal medicine; Lipoprotein; Bioinformatics; Endocrinology; Genetics; Biology","score_opus":0.10392781583487566,"score_gpt":0.4303521135777788,"score_spread":0.32642429774290316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211180010","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.96203e-7,0.98902893,0.0000066417692,0.0001199393,0.0010108779,0.0066238535,0.00010455836,0.00009475466,0.003009424],"genre_scores_gemma":[0.0000017895266,0.9933399,0.00039122286,0.00095165626,0.0024805223,0.00064544927,0.00066318945,0.00016213134,0.0013641242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99570656,0.0005740531,0.0011002303,0.0010985843,0.0008965661,0.0006240138],"domain_scores_gemma":[0.99379617,0.00003903738,0.00078908657,0.0039106384,0.00012231366,0.0013427833],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0014473645,0.0009371815,0.006020643,0.00023578464,0.0002461789,0.00009208658,0.00066755136,0.0013247295,0.00009603317],"category_scores_gemma":[0.0010720564,0.0006125986,0.005869416,0.00023495637,0.00013287281,0.00012487218,0.00018579072,0.0031696826,0.00087496237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022386277,0.00006764456,0.0000062046906,0.103488676,0.0004441089,0.00018305426,0.00000309723,3.6482577e-9,4.3645173e-8,0.000025395246,0.0049542673,0.8908051],"study_design_scores_gemma":[0.00044998628,0.00003397429,0.00011952175,0.062412106,0.011532436,0.00013477798,7.67332e-7,1.9206367e-7,6.462417e-8,0.000005674283,0.92482764,0.00048283805],"about_ca_topic_score_codex":0.000013861815,"about_ca_topic_score_gemma":0.0000013444014,"teacher_disagreement_score":0.9198734,"about_ca_system_score_codex":0.00042926808,"about_ca_system_score_gemma":0.0024549284,"threshold_uncertainty_score":0.99997175},"labels":[],"label_agreement":null},{"id":"W4211197780","doi":"10.1007/978-94-007-7741-5_20-1","title":"PCSK9 as a Biomarker of Cardiovascular Disease","year":2015,"lang":"en","type":"book-chapter","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Biomarker; Disease; Medicine; PCSK9; Internal medicine; Biology; Genetics; Cholesterol","score_opus":0.05023347106641014,"score_gpt":0.27622659498124075,"score_spread":0.22599312391483062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211197780","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012831124,0.09188774,0.0002707533,0.0001946661,0.00021666575,0.0011818113,0.000052717678,0.000085321444,0.905982],"genre_scores_gemma":[0.016863937,0.003441384,0.00037787732,0.0003381584,0.0008331303,0.000039545554,0.0002246307,0.00018955099,0.97769177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968754,0.000032699565,0.0004655085,0.0005445233,0.0018137731,0.00026807675],"domain_scores_gemma":[0.9962579,0.000012078811,0.00011581285,0.0022938587,0.0005013069,0.00081904186],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008960721,0.00039055748,0.0014437195,0.00020608162,0.000028977265,0.000008091975,0.00012604821,0.00035764897,0.002312859],"category_scores_gemma":[0.000084272564,0.00030120387,0.0028783197,0.000046433997,0.00013188942,0.000033969038,0.00010603031,0.0002826673,0.00049076614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017711953,0.00029909675,0.00006287212,0.0065835356,0.06529662,0.0046961675,0.000104149105,0.000027129721,0.000031217285,0.13326803,0.086670436,0.7011896],"study_design_scores_gemma":[0.0014917196,0.00016614243,0.00012897541,0.00052420184,0.0049026157,0.00013605208,0.000008667694,0.000017593216,0.000024006298,0.0036833335,0.9886119,0.00030484443],"about_ca_topic_score_codex":0.00056094315,"about_ca_topic_score_gemma":0.0000029559926,"teacher_disagreement_score":0.9019414,"about_ca_system_score_codex":0.00014320543,"about_ca_system_score_gemma":0.0011773946,"threshold_uncertainty_score":0.99994403},"labels":[],"label_agreement":null},{"id":"W4211223825","doi":"10.1002/14651858.cd012735.pub2","title":"Pitavastatin for lowering lipids","year":2020,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pitavastatin; Medicine; Internal medicine; Chemistry; Statin","score_opus":0.12411601172317849,"score_gpt":0.39592730185621566,"score_spread":0.2718112901330372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211223825","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.980013e-8,0.9584944,0.008597668,0.0000243595,0.0003973821,0.031397376,0.00078657956,0.000043857322,0.00025827088],"genre_scores_gemma":[2.4722956e-7,0.985514,0.006171407,0.00007308624,0.0008419082,0.0053781737,0.001732715,0.00013482285,0.00015362572],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9928147,0.00074100046,0.0045380048,0.0007222571,0.000792016,0.00039200162],"domain_scores_gemma":[0.99351907,0.00064634084,0.0023666285,0.0028503626,0.00024390282,0.00037368765],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00583288,0.00074953586,0.016976874,0.00019251266,0.000060566144,0.000027136773,0.0004367527,0.00021176582,0.00008378259],"category_scores_gemma":[0.005371496,0.00046313065,0.0041357568,0.0005067243,0.00005138683,0.00008224583,0.00012864266,0.00036575604,0.00033096792],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006605522,0.000040333525,2.3482103e-8,0.75950795,0.000497656,0.000027943255,0.000037860038,1.0217195e-8,0.0000015395176,0.00005663663,0.0017919975,0.23803146],"study_design_scores_gemma":[0.00029565726,0.000105026564,1.3192424e-8,0.5073237,0.0066620456,0.00026369604,0.000018169361,0.0000043307405,0.0000017629919,7.685169e-7,0.4851426,0.00018226673],"about_ca_topic_score_codex":0.000014827151,"about_ca_topic_score_gemma":0.0000014086763,"teacher_disagreement_score":0.4833506,"about_ca_system_score_codex":0.00014029306,"about_ca_system_score_gemma":0.0006171064,"threshold_uncertainty_score":0.999782},"labels":[],"label_agreement":null},{"id":"W4211230225","doi":"10.1007/978-94-011-4375-2_2","title":"Pathogenesis of Atherosclerosis","year":2000,"lang":"en","type":"book-chapter","venue":"Developments in cardiovascular medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Asymptomatic; Cardiology; Thrombosis; Myocardial infarction; Pathogenesis; Internal medicine; Coronary atherosclerosis; Sudden death; Angina; Unstable angina; Occlusion; Vascular disease; Coronary artery disease","score_opus":0.027319681612464716,"score_gpt":0.2442501703881854,"score_spread":0.2169304887757207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211230225","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031452666,0.09678578,0.00015793831,0.00017585965,0.0006744842,0.0023910296,0.000049145132,0.000103562146,0.8965169],"genre_scores_gemma":[0.24491629,0.30262762,0.0127833085,0.0034658515,0.0056706094,0.0007118758,0.0020833472,0.0019108396,0.42583027],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943256,0.00008881713,0.0014488909,0.0009781597,0.00261833,0.0005402257],"domain_scores_gemma":[0.99708754,0.000043970107,0.00025160532,0.00203432,0.00026025303,0.00032233793],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021247612,0.00074004586,0.003730669,0.0008069686,0.00005962326,0.00000515146,0.00028020568,0.00077600236,0.0011540116],"category_scores_gemma":[0.00008571015,0.00062403834,0.0019180096,0.00025405217,0.0003127619,0.00004579155,0.000105765794,0.0006623787,0.000109820256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024593022,0.00012312242,0.0022269767,0.0020788799,0.0131253395,0.00087968464,0.00067630317,0.000033317097,0.0002175935,0.0021310453,0.0009496303,0.97731215],"study_design_scores_gemma":[0.006359899,0.00030452487,0.08279206,0.007544542,0.0028070374,0.00038891885,0.000045734814,0.0000020365824,0.00021947589,0.0006482594,0.8981005,0.0007869937],"about_ca_topic_score_codex":0.00023295279,"about_ca_topic_score_gemma":0.000013257034,"teacher_disagreement_score":0.9765252,"about_ca_system_score_codex":0.0004381499,"about_ca_system_score_gemma":0.00065877574,"threshold_uncertainty_score":0.9997591},"labels":[],"label_agreement":null},{"id":"W4213030116","doi":"10.1016/j.jacc.2021.11.055","title":"Repeat Measures of Lipoprotein(a) Molar Concentration and Cardiovascular Risk","year":2022,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of General Medical Sciences; National Heart, Lung, and Blood Institute","keywords":"Medicine; Lipoprotein; Internal medicine; Molar; Lipoprotein(a); Coronary artery disease; Proportional hazards model; Cholesterol; Cardiology; Endocrinology; Dentistry","score_opus":0.01421255454442348,"score_gpt":0.23956901012379161,"score_spread":0.22535645557936812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213030116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98330164,0.013780239,0.0009934885,0.0005270034,0.00031421756,0.0005040003,0.00009218642,0.0000047283315,0.00048247713],"genre_scores_gemma":[0.9965584,0.0023144453,0.00060661783,0.00010502264,0.00036072035,0.000011768108,7.935841e-7,0.00001707641,0.000025122345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99655724,0.0014503553,0.000647323,0.00016827491,0.0009906845,0.00018615102],"domain_scores_gemma":[0.9976797,0.00007828702,0.0010554019,0.0006831662,0.00040217335,0.00010125531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030558684,0.00012837407,0.0015468583,0.00008542015,0.00014920339,0.0000019351833,0.00020862621,0.000039113173,0.0000069715024],"category_scores_gemma":[0.00043515663,0.00008834293,0.0014610994,0.00040146787,0.00044450286,0.000038330778,0.0001388488,0.0004710097,1.0650535e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012018357,0.00041155703,0.5217539,0.0008922751,0.051266782,0.0021129686,0.0010003153,0.0480066,0.048731275,0.0010589099,0.0093936175,0.30335346],"study_design_scores_gemma":[0.013084844,0.014278877,0.68074805,0.00027902456,0.010610986,0.041836947,0.008707563,0.00025286645,0.025697459,0.0010335784,0.20285428,0.0006155458],"about_ca_topic_score_codex":0.00021240421,"about_ca_topic_score_gemma":0.0000021003902,"teacher_disagreement_score":0.30273792,"about_ca_system_score_codex":0.00010034923,"about_ca_system_score_gemma":0.00042325564,"threshold_uncertainty_score":0.36025202},"labels":[],"label_agreement":null},{"id":"W4213092974","doi":"10.36106/ijar/3213824","title":"EVALUATION OF SERUM LIPID PROFILE IN PATIENTS OF CORONARY ARTERY DISEASE","year":2022,"lang":"en","type":"article","venue":"INDIAN JOURNAL OF APPLIED RESEARCH","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Musée de la Civilisation","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Cholesterol; Hyperlipidemia; Coronary artery disease; Coronary arteries; Artery; High-density lipoprotein; Lipoprotein; Incidence (geometry); Endocrinology; Diabetes mellitus","score_opus":0.05143294954590564,"score_gpt":0.34748056165792895,"score_spread":0.2960476121120233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213092974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971704,0.00034254385,0.0000015112469,0.00019989247,0.000084435516,0.0011000797,0.000039182196,0.0000013476565,0.0010605946],"genre_scores_gemma":[0.99965256,0.000028756423,0.000064921034,0.000023717308,0.0001327259,0.00005446626,0.00001186452,0.000013738811,0.000017219836],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9941166,0.00056587154,0.0005307563,0.000119103475,0.0044283783,0.00023925652],"domain_scores_gemma":[0.9982464,0.000047288067,0.00021822176,0.00028783994,0.0009816516,0.00021862336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01221741,0.00006307946,0.0003166409,0.00062297634,0.00007133459,0.0000038609437,0.0001560361,0.000033424712,0.0005802436],"category_scores_gemma":[0.00017285974,0.000054281154,0.00013518592,0.00053219916,0.00007940743,0.000043272852,0.00009211839,0.0006868387,0.0000032096593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008424846,0.003499914,0.26303893,0.001228118,0.00063530565,0.0005266632,0.0046930453,0.0012661552,0.0016996872,0.00012858649,0.0012852021,0.7135735],"study_design_scores_gemma":[0.007083114,0.00167185,0.98651254,0.00015826656,0.00009786148,0.000045240628,0.0018561971,0.00012382591,0.0016007588,0.00051977916,0.00027005517,0.000060530034],"about_ca_topic_score_codex":0.00001101378,"about_ca_topic_score_gemma":0.000002081425,"teacher_disagreement_score":0.72347355,"about_ca_system_score_codex":0.0003579219,"about_ca_system_score_gemma":0.0021735271,"threshold_uncertainty_score":0.6353261},"labels":[],"label_agreement":null},{"id":"W4213360317","doi":"10.1007/s12325-021-02031-y","title":"A Case Series Assessing the Effects of Lomitapide on Carotid Intima-Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting","year":2022,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université de Montréal","funders":"Amryt Pharma","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; PCSK9; Intima-media thickness; Cardiology; Triglyceride; Lipoprotein; LDL receptor; Cholesterol; Gastroenterology","score_opus":0.007816532930660992,"score_gpt":0.2772037853522879,"score_spread":0.2693872524216269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213360317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636745,0.0015393898,0.000011809036,0.0001405699,0.00026378527,0.001464653,0.00000834642,0.00001971029,0.00018429483],"genre_scores_gemma":[0.99665403,0.0017109853,0.00043635786,0.00061751134,0.00007779014,0.0004458036,0.000014874647,0.000036541624,0.0000061299274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977774,0.00060993864,0.00039817946,0.0003363184,0.0005455254,0.0003326476],"domain_scores_gemma":[0.9988493,0.00042421234,0.00014602538,0.00046323598,0.00007013769,0.0000471093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084435206,0.00019980488,0.0005086946,0.0002643361,0.00011249454,0.000013606879,0.00013591214,0.00004448832,0.0000037011555],"category_scores_gemma":[0.00013684652,0.00013477771,0.00007679569,0.00077195384,0.00010716783,0.00028712652,0.000054102828,0.00072281854,3.0738204e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014626205,0.00049802527,0.788211,0.00042476613,0.000032118558,0.002353054,0.007707503,0.00081703544,0.00026146098,0.00006308893,0.0000029403088,0.19816642],"study_design_scores_gemma":[0.020911576,0.0022504458,0.9653752,0.0017067391,0.000028891936,0.0010775207,0.005660197,0.00006150937,0.0017904055,0.00022397275,0.00051857316,0.00039500382],"about_ca_topic_score_codex":0.0017545564,"about_ca_topic_score_gemma":0.004205852,"teacher_disagreement_score":0.19777142,"about_ca_system_score_codex":0.00030543754,"about_ca_system_score_gemma":0.00013590058,"threshold_uncertainty_score":0.5496076},"labels":[],"label_agreement":null},{"id":"W4213370194","doi":"10.1093/eurjpc/zwac025","title":"Rationale and design of two trials assessing the efficacy, safety, and tolerability of inclisiran in adolescents with homozygous and heterozygous familial hypercholesterolaemia","year":2022,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Novartis Institutes for BioMedical Research; Novartis Pharma","keywords":"Medicine; Tolerability; Familial hypercholesterolemia; Clinical endpoint; Statin; Surrogate endpoint; Adverse effect; Placebo; Internal medicine; Pediatrics; Disease; Compound heterozygosity; Clinical trial; Cholesterol; Mutation; Pathology; Genetics","score_opus":0.04692933481646987,"score_gpt":0.3152609561642302,"score_spread":0.26833162134776034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213370194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865346,0.0041866982,0.008245089,0.00010571989,0.00008208329,0.0007785827,0.000011778652,0.0000020255372,0.00005341296],"genre_scores_gemma":[0.9988467,0.00038255178,0.00054032105,0.00006896654,0.00013807566,0.0000032901573,0.0000017242363,0.000014437378,0.0000039241313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98971003,0.008845216,0.0008455282,0.00018263915,0.00028717105,0.00012940272],"domain_scores_gemma":[0.998763,0.00027777723,0.00054424605,0.00018829251,0.00015359244,0.000073078845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01196195,0.00011761536,0.0010511413,0.000111052555,0.000095117335,0.000009987415,0.000088967376,0.000020186302,0.0000022138788],"category_scores_gemma":[0.00044065516,0.000075135504,0.00014828997,0.000102371996,0.0002767176,0.00006915537,0.00015347867,0.00039783338,4.5298798e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01726639,0.00071295834,0.61385036,0.001052296,0.002354426,0.002496898,0.0065540224,0.009618939,0.034084477,0.000044708406,0.00004271376,0.31192178],"study_design_scores_gemma":[0.010898145,0.002433769,0.9802323,0.00039886872,0.00033563547,0.0046277293,0.00066788285,0.000036643563,0.00012833644,0.000045775865,0.00011639601,0.00007852588],"about_ca_topic_score_codex":0.000013245407,"about_ca_topic_score_gemma":0.0000016972468,"teacher_disagreement_score":0.3663819,"about_ca_system_score_codex":0.00004353187,"about_ca_system_score_gemma":0.00013323118,"threshold_uncertainty_score":0.41457972},"labels":[],"label_agreement":null},{"id":"W4214548498","doi":"10.1161/circinterventions.121.011382","title":"Effect of Evolocumab in Patients With Prior Percutaneous Coronary Intervention","year":2022,"lang":"en","type":"article","venue":"Circulation Cardiovascular Interventions","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cosmetic and Laser Surgery","funders":"","keywords":"Evolocumab; Percutaneous coronary intervention; Myocardial infarction; Conventional PCI; Percutaneous; Coronary artery disease; Intervention (counseling)","score_opus":0.008711372941205596,"score_gpt":0.25498317239452806,"score_spread":0.24627179945332245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214548498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911115,0.0033699756,0.0027094213,0.000025070525,0.00022572622,0.0022082096,0.00003654597,0.000057228834,0.00025632343],"genre_scores_gemma":[0.9990287,0.000012053913,0.00014137718,0.0000144782325,0.00004107297,0.0002954368,0.00036057114,0.0000444298,0.00006187804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641573,0.0009132668,0.00064801687,0.00042971972,0.0013406703,0.0002526003],"domain_scores_gemma":[0.99849457,0.000040309133,0.0001715575,0.0010016384,0.00019967488,0.00009224553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002249466,0.00020396,0.0007858175,0.00042021959,0.00018143063,0.000012372056,0.00012674404,0.00006816711,0.0004152578],"category_scores_gemma":[0.00010840796,0.0001869608,0.003079713,0.00059883954,0.00006156785,0.00011987194,0.0001185025,0.00035396978,0.000008637658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022980103,0.0019522854,0.6648451,0.0033684026,0.005737501,0.00028027492,0.00033949647,0.024735132,0.000058099373,0.00011840712,0.000047307218,0.29621994],"study_design_scores_gemma":[0.010616413,0.003649694,0.98139185,0.0005429136,0.0015398227,0.00068627764,0.0001239647,0.00036668012,0.00007022992,0.000017256003,0.0007773393,0.00021753488],"about_ca_topic_score_codex":0.00019516834,"about_ca_topic_score_gemma":0.000012048862,"teacher_disagreement_score":0.31654674,"about_ca_system_score_codex":0.00054826954,"about_ca_system_score_gemma":0.00007131451,"threshold_uncertainty_score":0.76240396},"labels":[],"label_agreement":null},{"id":"W4214620255","doi":"10.3390/metabo12030215","title":"The Emerging Roles of Intracellular PCSK9 and Their Implications in Endoplasmic Reticulum Stress and Metabolic Diseases","year":2022,"lang":"en","type":"review","venue":"Metabolites","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"Canadian Institutes of Health Research; Amgen Canada; McMaster University; Heart and Stroke Foundation of Canada; Amgen","keywords":"PCSK9; Endoplasmic reticulum; LDL receptor; Kexin; Proprotein convertase; Intracellular; Unfolded protein response; Biology; Subtilisin; Disease; Cell biology; Bioinformatics; Cholesterol; Lipoprotein; Medicine; Endocrinology; Internal medicine; Biochemistry; Enzyme","score_opus":0.02023070392596464,"score_gpt":0.2858998140236823,"score_spread":0.26566911009771765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214620255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073852777,0.9906608,0.000008875269,0.00014220265,0.00007413264,0.0012992478,0.0003335431,0.00002167952,0.00007425981],"genre_scores_gemma":[0.0022287609,0.99672747,0.00005910367,0.000019876134,0.000161751,0.0005699167,0.0001314398,0.000047083147,0.000054621403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979048,0.00047847486,0.00066029944,0.0004185651,0.00021991604,0.0003179816],"domain_scores_gemma":[0.9983279,0.00040873565,0.0002744734,0.0007950425,0.000043891843,0.00014996328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074120524,0.00033604022,0.001970649,0.00023053153,0.00020547342,0.000038296974,0.00017246498,0.00009105935,0.00002939597],"category_scores_gemma":[0.0002811979,0.0001922053,0.00046196659,0.00046304573,0.00018167797,0.000046854373,0.00020358083,0.00040094415,6.958356e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005210724,0.00005511773,0.00073904713,0.0060373116,0.000455606,0.0000033924007,0.00015347541,3.038137e-7,0.000008378637,0.0033368098,0.0000048559514,0.9892005],"study_design_scores_gemma":[0.00029555097,0.000022180819,0.0024026358,0.0012284359,0.0020729296,0.000082177874,0.00041426485,0.0000073640276,0.00010906963,0.00019131022,0.99301016,0.00016393387],"about_ca_topic_score_codex":0.00012115069,"about_ca_topic_score_gemma":0.00004233288,"teacher_disagreement_score":0.9930053,"about_ca_system_score_codex":0.000019632234,"about_ca_system_score_gemma":0.00023657283,"threshold_uncertainty_score":0.78379047},"labels":[],"label_agreement":null},{"id":"W4220670177","doi":"10.1111/dom.14687","title":"Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance","year":2022,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Western University","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Pioglitazone; Medicine; Stroke (engine); Diabetes mellitus; Insulin resistance; Adverse effect; Internal medicine; Placebo; Hazard ratio; Heart failure; Insulin; Myocardial infarction; Type 2 diabetes; Cardiology; Endocrinology; Confidence interval","score_opus":0.017495620797651955,"score_gpt":0.26119936239177355,"score_spread":0.2437037415941216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220670177","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44067612,0.55770266,0.0000010841399,0.00000422584,0.000083299055,0.0011920457,0.00029330264,0.0000070774277,0.000040152274],"genre_scores_gemma":[0.046766788,0.952333,0.0002336472,0.000044357555,0.00008085084,0.00018438841,0.00013849273,0.000051088675,0.00016740747],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997292,0.00029187126,0.0008215576,0.0005002965,0.0007210138,0.00037329004],"domain_scores_gemma":[0.9985682,0.000117881726,0.00035032237,0.0007031589,0.00010193063,0.00015854572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006274081,0.00040099514,0.0033200893,0.00032655144,0.00004154021,0.0000065043932,0.00014593652,0.00020630473,0.00013905687],"category_scores_gemma":[0.00010064465,0.00026211873,0.00057926995,0.0005506707,0.00014813087,0.000072215305,0.0000814924,0.00049726,0.0000013682527],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029105681,0.0033468483,0.009799376,0.09749089,0.0021066011,0.00006362646,0.0005926835,0.0000013151976,0.0000018897547,0.000035063604,0.000052944226,0.8835982],"study_design_scores_gemma":[0.0050348043,0.00039648608,0.18859334,0.00827792,0.0027946576,0.0000014464418,0.000017466376,1.7228805e-7,0.000011988744,0.0000014840246,0.7945778,0.00029247496],"about_ca_topic_score_codex":0.0000403218,"about_ca_topic_score_gemma":0.000034345394,"teacher_disagreement_score":0.8833057,"about_ca_system_score_codex":0.00005502279,"about_ca_system_score_gemma":0.00032509083,"threshold_uncertainty_score":0.99998313},"labels":[],"label_agreement":null},{"id":"W4220731413","doi":"10.2139/ssrn.4039857","title":"Blockers of PCSK9 Ribosome Synthesis: Computational Predictions and in Vitro Confirmation","year":2022,"lang":"en","type":"article","venue":"SSRN Electronic Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; In vitro; Chemistry; Pharmacology; Medicine; Internal medicine; Biochemistry; LDL receptor; Cholesterol; Lipoprotein","score_opus":0.006669576837202041,"score_gpt":0.22988968408025093,"score_spread":0.2232201072430489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220731413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98976207,0.0046350164,0.0029702268,0.002105607,0.00007497504,0.00027073312,0.000015701133,0.000013789257,0.00015188298],"genre_scores_gemma":[0.9989237,0.0006012585,0.00021609104,0.00007318514,0.00008448162,0.000032154898,0.00001276784,0.000009710078,0.000046648463],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985458,0.00013620508,0.0002739257,0.00010256222,0.00041872714,0.0005227501],"domain_scores_gemma":[0.99965036,0.00003848553,0.00010793975,0.00008850525,0.00005468038,0.00006001533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016128807,0.000066517074,0.00021087404,0.00019420576,0.00016684033,0.000006067818,0.000045941535,0.000026167723,0.00003418658],"category_scores_gemma":[0.000045161472,0.00006409269,0.00009627504,0.00018778622,0.00003206541,0.000055133667,0.000022790857,0.00093094277,7.9429554e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012158952,0.0046177204,0.06831561,0.001294382,0.009923655,0.000259992,0.006772026,0.07237441,0.04502473,0.13167898,0.0010416057,0.6465379],"study_design_scores_gemma":[0.048167553,0.008931424,0.33179933,0.000793579,0.0032943198,0.090761036,0.07766857,0.10247792,0.014388065,0.29108724,0.028666003,0.001964977],"about_ca_topic_score_codex":0.000105319414,"about_ca_topic_score_gemma":0.00003028055,"teacher_disagreement_score":0.644573,"about_ca_system_score_codex":0.00062513293,"about_ca_system_score_gemma":0.001636606,"threshold_uncertainty_score":0.4044535},"labels":[],"label_agreement":null},{"id":"W4220735712","doi":"10.1016/j.cjco.2022.03.003","title":"Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study","year":2022,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cardiome (Canada); Université Laval; Centre hospitalier universitaire de Québec; Amgen (Canada); Cambridge Cardiac Care Centre; Island Health; University of British Columbia; McMaster University","funders":"Amgen Canada; Sanofi; Kowa Company; Amgen; Boehringer Ingelheim; Novo Nordisk; Bayer; AstraZeneca; Regeneron Pharmaceuticals; Novartis; HLS Therapeutics; Pfizer","keywords":"Evolocumab; Medicine; PCSK9; Internal medicine; Statin; Alirocumab; Adverse effect; Hyperlipidemia; Apolipoprotein B; Gastroenterology; Cholesterol; Lipoprotein; Endocrinology; Diabetes mellitus; Apolipoprotein A1","score_opus":0.01880120690716842,"score_gpt":0.2718837726999043,"score_spread":0.2530825657927359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220735712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99479574,0.00011475027,0.0000020409354,0.0006133055,0.000090805246,0.002689559,0.000028114211,0.000012305759,0.0016533732],"genre_scores_gemma":[0.9972106,0.000010273146,0.00013046023,0.0014532103,0.00007895221,0.00033513893,0.00024675895,0.000025929194,0.0005086699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776703,0.00051453867,0.00030529444,0.00045387482,0.00067550375,0.00028373784],"domain_scores_gemma":[0.99811095,0.00007942481,0.00007921411,0.0013784824,0.0000887875,0.00026314802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081191806,0.00015398215,0.000685942,0.00030906897,0.00041653842,0.00008587159,0.0004889866,0.000034755154,0.00037467064],"category_scores_gemma":[0.000071675255,0.000096832984,0.00011830193,0.0018711309,0.000029513036,0.0001664783,0.0003516418,0.00045046644,0.000012514022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024590717,0.00026687412,0.99218464,0.0000031251652,0.0012032844,0.000096747826,0.0026344915,0.00013516884,3.760268e-7,0.000032022483,0.0009371875,0.0022602032],"study_design_scores_gemma":[0.0037248118,0.00042986358,0.97308314,0.000014485223,0.000815642,5.096198e-7,0.0019833304,0.00005899368,0.0000012215917,0.00002649732,0.01973314,0.00012837708],"about_ca_topic_score_codex":0.9692779,"about_ca_topic_score_gemma":0.9694494,"teacher_disagreement_score":0.019101486,"about_ca_system_score_codex":0.0008578452,"about_ca_system_score_gemma":0.0007789684,"threshold_uncertainty_score":0.41023806},"labels":[],"label_agreement":null},{"id":"W4220749594","doi":"10.3390/metabo12030262","title":"Whole Exome/Genome Sequencing Joint Analysis of a Family with Oligogenic Familial Hypercholesterolemia","year":2022,"lang":"en","type":"article","venue":"Metabolites","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute; McGill University Health Centre","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Agence Nationale de la Recherche; Broad Institute","keywords":"Proband; Genetics; Exome sequencing; Phenotype; Gene; Biology; Exome; Genetic linkage; Mutation","score_opus":0.03195139166317637,"score_gpt":0.25463401271637326,"score_spread":0.2226826210531969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220749594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881508,0.009795925,0.00044812504,0.000120561774,0.00006723572,0.0004578776,0.0001558208,0.00005332377,0.000750355],"genre_scores_gemma":[0.9966828,0.00013685759,0.0016084011,0.0007405566,0.00014644358,0.00013326964,0.00015104757,0.000036086043,0.00036453095],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99756676,0.0002128683,0.00046782626,0.00041589345,0.00095877144,0.00037786164],"domain_scores_gemma":[0.99865556,0.000020251222,0.00014877241,0.0008527453,0.00014386233,0.00017878994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010364187,0.00020275459,0.0011136523,0.0006303688,0.0001626616,0.000014929801,0.00014459141,0.00004510228,0.00015495984],"category_scores_gemma":[0.00003366699,0.00016001814,0.0006681567,0.0019172567,0.00007118972,0.0000666118,0.00012994779,0.0003103436,0.00000792946],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032378215,0.00022207815,0.027228132,0.00024214716,0.00842867,0.00013479836,0.0022384217,0.0044094566,0.94904745,0.00024602714,0.000028496217,0.0074505475],"study_design_scores_gemma":[0.0028454978,0.0006872514,0.93341154,0.00003349613,0.011537184,0.0001539028,0.0042960504,0.0007448012,0.010389913,0.000036923153,0.03548071,0.00038272078],"about_ca_topic_score_codex":0.0009810247,"about_ca_topic_score_gemma":0.000027641416,"teacher_disagreement_score":0.9386575,"about_ca_system_score_codex":0.00020760951,"about_ca_system_score_gemma":0.00037985478,"threshold_uncertainty_score":0.652535},"labels":[],"label_agreement":null},{"id":"W4220782725","doi":"10.1139/bcb-2021-0540","title":"The biological relevance of PCSK9: when less is better…","year":2022,"lang":"en","type":"review","venue":"Biochemistry and Cell Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Fondation Jean-Louis Lévesque","keywords":"PCSK9; Kexin; Proprotein convertase; LDL receptor; Biology; Immunity; Cholesterol; Inflammation; Regulator; Immunology; Lipoprotein; Endocrinology; Internal medicine; Medicine; Genetics; Immune system; Gene","score_opus":0.04882303932400325,"score_gpt":0.30094770592313114,"score_spread":0.2521246665991279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220782725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016278604,0.99470437,0.000002877586,0.0001332402,0.00012898691,0.00038220198,0.00009696124,0.0000148814215,0.0029086526],"genre_scores_gemma":[0.0002464043,0.9975276,0.000057790454,0.00019075473,0.0003537731,0.000110969195,0.0002499519,0.000016437029,0.0012463471],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99858135,0.00012913196,0.00044405618,0.00046323572,0.000112298956,0.0002699256],"domain_scores_gemma":[0.99872994,0.00021476892,0.00026460458,0.00066789205,0.00002654907,0.00009625267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049396284,0.00026001735,0.0012222136,0.00001907614,0.00015130072,0.0000059348804,0.00022224608,0.00050663034,0.00022695053],"category_scores_gemma":[0.00007713714,0.00014319461,0.0005531048,0.00008947161,0.00032261663,0.0000043377545,0.00020073145,0.0004978909,0.0000040843597],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018618082,0.00003166858,0.000017327968,0.008864196,0.00016129583,0.000008910124,0.000010304904,9.626073e-10,0.00039950194,0.000019592875,0.00063456374,0.989834],"study_design_scores_gemma":[0.00020440898,0.0001645906,0.000002059682,0.00050389953,0.00029486234,0.00012341797,0.000041273932,1.0624426e-7,0.0022009255,0.000054986445,0.99626315,0.00014632303],"about_ca_topic_score_codex":0.000020554138,"about_ca_topic_score_gemma":2.5418987e-7,"teacher_disagreement_score":0.9956286,"about_ca_system_score_codex":0.000041456064,"about_ca_system_score_gemma":0.00023700466,"threshold_uncertainty_score":0.5839307},"labels":[],"label_agreement":null},{"id":"W4220783899","doi":"10.1016/j.taap.2022.115978","title":"Evaluation of the distribution and excretion of [14C]-inclisiran following single subcutaneous administration in cynomolgus monkeys","year":2022,"lang":"en","type":"article","venue":"Toxicology and Applied Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Kidney; Internal medicine; Endocrinology; Excretion; Distribution (mathematics); Asialoglycoprotein receptor; Chemistry; Receptor; Pharmacokinetics; Pharmacology; Biology; Hepatocyte; Biochemistry; Medicine; In vitro","score_opus":0.026265560956045816,"score_gpt":0.3091862271914337,"score_spread":0.28292066623538786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220783899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971638,0.0006455487,0.000055136774,0.0004467779,0.00022011992,0.001029946,0.00001698018,0.0000073488004,0.0004143833],"genre_scores_gemma":[0.99952644,0.000028666029,0.000022729482,0.00015445013,0.000044815344,0.00016388601,0.00004416267,0.0000059314143,0.000008905257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986749,0.00041926684,0.00027651925,0.00018560779,0.0003082288,0.00013545799],"domain_scores_gemma":[0.9996128,0.000063235304,0.00013473863,0.00010837882,0.000044471773,0.000036362464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014907983,0.00007793269,0.00027295883,0.000051119867,0.00012224309,0.000001535601,0.000042773474,0.000088957175,0.00009222191],"category_scores_gemma":[0.000030384648,0.000068431174,0.000060495433,0.0001678347,0.000110233406,0.000017302613,0.00007048866,0.00020605978,1.7069098e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002019338,0.000991515,0.006429931,0.00021128089,0.00032531336,0.000036102327,0.0009256243,0.0011484568,0.8989275,0.0017344741,0.000098499215,0.08715193],"study_design_scores_gemma":[0.027332895,0.00786028,0.2507343,0.000058474052,0.004826541,0.0015898651,0.0019224769,0.009368282,0.6891893,0.00425434,0.0023935987,0.00046961245],"about_ca_topic_score_codex":0.000027588723,"about_ca_topic_score_gemma":0.000025115782,"teacher_disagreement_score":0.24430437,"about_ca_system_score_codex":0.00014650832,"about_ca_system_score_gemma":0.00019942546,"threshold_uncertainty_score":0.27905422},"labels":[],"label_agreement":null},{"id":"W4220794223","doi":"10.1002/jcsm.12960","title":"Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from <i>the International Lipid Expert Panel</i> (ILEP)","year":2022,"lang":"en","type":"review","venue":"Journal of Cachexia Sarcopenia and Muscle","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIH Clinical Center; Respicardia; Chugai Pharmaceutical; Esperion Therapeutics; Sorbonne Université; Cliniques Universitaires Saint-Luc; University Of Al-Qadisiyah; Servier; Alexandria University; Medizinische Universität Wien; Valeant Pharmaceuticals International; Universität Wien; Institut National de la Santé et de la Recherche Médicale; Hebrew University of Jerusalem; Amryt Pharma; Institute of Genetics; AstraZeneca; Amarin Corporation; Mylan; Univerzita Karlova v Praze; Ionis Pharmaceuticals; lékařská fakulta Univerzity Karlovy; Università di Bologna; Teva Pharmaceutical Industries; Helsinn; Umeå Universitet; Danone; Kowa Company; Uniwersytet Łódzki; Western Sydney Local Health District; Sanofi; Deutsches Zentrum für Herz-Kreislaufforschung; Novo Nordisk; Amgen; Pfizer; Eli Lilly and Company; Abbott Laboratories","keywords":"Medicine; Statin; Nocebo Effect; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Position paper; Position (finance); Physical therapy; Intensive care medicine; Alternative medicine; Internal medicine; Pathology; Placebo","score_opus":0.0192665129188195,"score_gpt":0.2763080888961365,"score_spread":0.257041575977317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220794223","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08963494,0.90641344,0.000009594331,0.0006660043,0.00063893665,0.002192764,0.0002517037,0.0000069541566,0.00018566528],"genre_scores_gemma":[0.011918195,0.9863594,0.000093766634,0.0009211417,0.00023256363,0.0002493115,0.00013841968,0.000049870094,0.000037319613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965885,0.00078991614,0.0010064839,0.00030440983,0.0010716172,0.00023906585],"domain_scores_gemma":[0.99800193,0.0004360541,0.0009492468,0.0003697863,0.000111516296,0.00013147383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014392276,0.00032537372,0.0013868925,0.00010568345,0.0001334041,0.000057908303,0.00035264465,0.00015083395,0.00018187777],"category_scores_gemma":[0.00012516796,0.00018401025,0.0006362752,0.00026420646,0.000068896916,0.00014403045,0.0002962333,0.0006507281,0.0000011014297],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009294124,0.0002959353,0.002187464,0.0017586256,0.00119093,0.000033785087,0.00029879232,3.4925563e-7,0.000014271823,0.0000036513304,0.005644734,0.98847854],"study_design_scores_gemma":[0.0041694464,0.00053062243,0.045927517,0.0107312985,0.0017846777,0.000031277737,0.00021909398,0.000004519937,0.000007332342,0.0000046505406,0.93639576,0.00019381293],"about_ca_topic_score_codex":0.00061935966,"about_ca_topic_score_gemma":0.000061992476,"teacher_disagreement_score":0.9882847,"about_ca_system_score_codex":0.00039743318,"about_ca_system_score_gemma":0.00014567414,"threshold_uncertainty_score":0.75037205},"labels":[],"label_agreement":null},{"id":"W4220864502","doi":"10.1016/j.jacc.2022.01.010","title":"Key Questions About Familial Hypercholesterolemia","year":2022,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University Health Centre","funders":"Servier; Ionis Pharmaceuticals","keywords":"Familial hypercholesterolemia; Medicine; Atherosclerotic cardiovascular disease; Population; Internal medicine; Bioinformatics; Endocrinology; Disease; Cholesterol; Biology; Environmental health","score_opus":0.03281869016110258,"score_gpt":0.32726088770088896,"score_spread":0.2944421975397864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220864502","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011617163,0.99455637,0.00007595844,0.00033974857,0.0013566981,0.00073391316,0.00028705318,0.00000861866,0.0014799453],"genre_scores_gemma":[0.00086323754,0.9960377,0.0003810346,0.00027420945,0.0020771534,0.000035443463,0.0000063309258,0.000058217905,0.0002666421],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954179,0.0018960583,0.0013552713,0.00023690923,0.00077863684,0.0003152471],"domain_scores_gemma":[0.9960356,0.0002714522,0.002236897,0.0010334721,0.00023496633,0.00018763162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016974712,0.0003255688,0.0057123424,0.0003411434,0.00012974755,0.0000038865064,0.0006493705,0.00015870089,0.000026879667],"category_scores_gemma":[0.0004695339,0.00019308679,0.0047982,0.00076132454,0.0005239125,0.000031159867,0.00024870527,0.001550461,0.000003716957],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023086002,0.00006319188,0.00020660229,0.004202867,0.0048845587,0.0009264768,0.000024794117,0.00005145645,0.0000061939513,0.00013855277,0.009568957,0.9796955],"study_design_scores_gemma":[0.0005187836,0.00096132694,0.00071086804,0.0022702771,0.0045492244,0.025061065,0.00011762552,4.005193e-7,5.2762346e-7,0.000019892283,0.96565145,0.00013857911],"about_ca_topic_score_codex":0.0000406592,"about_ca_topic_score_gemma":0.000002278738,"teacher_disagreement_score":0.9795569,"about_ca_system_score_codex":0.0004926631,"about_ca_system_score_gemma":0.002737125,"threshold_uncertainty_score":0.7873851},"labels":[],"label_agreement":null},{"id":"W4220867780","doi":"10.1093/cdn/nzac042","title":"Let’s Be Clear about Expected Cardiovascular Risk: A Commentary on the Massive Rise in LDL Cholesterol Induced by Carbohydrate Restriction in the Proposed “Lean Mass Hyper-Responder” Phenotype","year":2022,"lang":"en","type":"letter","venue":"Current Developments in Nutrition","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Phenotype; Cholesterol; Internal medicine; Ldl cholesterol; Medicine; Biology; Endocrinology; Gene; Genetics","score_opus":0.03349864946092474,"score_gpt":0.26936964959381815,"score_spread":0.23587100013289342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220867780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80349624,0.0067791482,0.000036494712,0.17585619,0.0019317076,0.011361704,0.0002883412,0.00009209082,0.00015809965],"genre_scores_gemma":[0.7018019,0.024921788,0.00021674417,0.24574333,0.0038380031,0.011089866,0.011923264,0.00040719443,0.000057932968],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99147886,0.0032155174,0.0010813213,0.001070161,0.0023219537,0.0008321803],"domain_scores_gemma":[0.9979184,0.00019883312,0.00038769437,0.0012953029,0.00011157209,0.00008814494],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002581173,0.0006777262,0.0010689829,0.0010241208,0.0003524808,0.00009065848,0.00057975244,0.0005818531,0.00004520693],"category_scores_gemma":[0.00018603832,0.0005065202,0.00049157185,0.0016914664,0.000085330095,0.00014134614,0.00013492513,0.0060960962,0.000012887755],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029691479,0.0036945401,0.009158458,0.0030663463,0.0016737176,0.0016124094,0.0088682985,0.0001296259,0.00040070486,0.000016798967,0.91885847,0.049551476],"study_design_scores_gemma":[0.01142164,0.0005749194,0.032334957,0.0030035502,0.00037639297,0.000016492642,0.0020951482,0.00006355028,0.00022004439,0.00014775948,0.9488734,0.00087212725],"about_ca_topic_score_codex":0.0013996788,"about_ca_topic_score_gemma":0.00008296682,"teacher_disagreement_score":0.10169434,"about_ca_system_score_codex":0.0026431144,"about_ca_system_score_gemma":0.000366283,"threshold_uncertainty_score":0.99973863},"labels":[],"label_agreement":null},{"id":"W4220891817","doi":"10.1016/s0735-1097(22)02493-7","title":"THE ASSOCIATION OF HIGH-SENSITIVITY C-REACTIVE PROTEIN WITH RATES OF ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION","year":2022,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Atrial fibrillation; Internal medicine; Cardiology; Adverse effect; Association (psychology); C-reactive protein; Inflammation","score_opus":0.005377321925325017,"score_gpt":0.23331086536475681,"score_spread":0.22793354343943178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220891817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810696,0.000046511726,0.00003927931,0.0008637955,0.00011075284,0.0007095303,0.00007564913,0.0000012917462,0.000046212543],"genre_scores_gemma":[0.99964416,0.000011107745,0.00016788136,0.000018466028,0.00011495095,0.0000033632439,0.0000016254719,0.000009157785,0.000029298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743456,0.0011503788,0.00045969838,0.000084747604,0.00074098754,0.00012962823],"domain_scores_gemma":[0.99673826,0.00033685047,0.0021248683,0.0002457472,0.0005257315,0.000028524015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017030162,0.00008793485,0.0010272808,0.00009931185,0.000070434005,6.4082917e-7,0.000081408914,0.000026126285,0.0000010415147],"category_scores_gemma":[0.0004031171,0.0000433996,0.0003965838,0.00040719163,0.00018645597,0.000040300205,0.00005167159,0.00024101311,4.1165595e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008161782,0.00002928496,0.98272127,0.000017865375,0.0013463392,0.000014227257,0.000052697294,0.0066547673,0.0003268821,0.000048696307,0.000027322021,0.00059884705],"study_design_scores_gemma":[0.004187418,0.0034916904,0.99015445,0.000039891944,0.00028120863,0.000059055972,0.0006947327,0.000010873031,0.0007279516,0.00002983207,0.0002780419,0.00004486395],"about_ca_topic_score_codex":0.00028022102,"about_ca_topic_score_gemma":0.00004784178,"teacher_disagreement_score":0.007433151,"about_ca_system_score_codex":0.00030565,"about_ca_system_score_gemma":0.00044593582,"threshold_uncertainty_score":0.17697842},"labels":[],"label_agreement":null},{"id":"W4220903911","doi":"10.1016/j.jacl.2022.03.001","title":"Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trials","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital; University of Toronto; St. Michael's Hospital","funders":"Daiichi Sankyo Europe; NIHR Imperial Biomedical Research Centre; Sanofi-Aventis Deutschland; Ministero della Salute; National Institute for Health and Care Research; Novartis; Esperion Therapeutics; Amgen","keywords":"Ezetimibe; Medicine; Tolerability; Statin; Placebo; Internal medicine; Concomitant; Adverse effect; Cohort; Gastroenterology; Population; Familial hypercholesterolemia; Cholesterol","score_opus":0.18603691046425694,"score_gpt":0.5038343641630217,"score_spread":0.3177974536987648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220903911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422395,0.00043299535,0.00008917569,0.0017975231,0.0027375512,0.000623576,0.000021750424,0.000003628775,0.00006985275],"genre_scores_gemma":[0.9943681,0.0014109297,0.001096171,0.0011780354,0.0018995134,0.000006286361,0.00000822038,0.000016863798,0.000015932292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98273176,0.008586566,0.00747978,0.00028909039,0.000627064,0.00028575963],"domain_scores_gemma":[0.9896977,0.006998085,0.0024689918,0.000333021,0.00019356848,0.00030865904],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.060271185,0.00013616828,0.0032319995,0.00029683174,0.000042692453,0.000003977804,0.00016179601,0.00022929517,0.00018895982],"category_scores_gemma":[0.042774603,0.00010623701,0.00074612984,0.00027598094,0.0001755453,0.00006353286,0.00015739753,0.00197386,0.0000013527581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036597088,0.0047034244,0.55875325,0.00007908828,0.0002911973,0.000060508108,0.00021193062,0.000028400338,0.00007064104,0.000034566456,0.00052771624,0.3986422],"study_design_scores_gemma":[0.07838223,0.014373164,0.8946703,0.00014765952,0.00018930733,0.000071553506,0.00012944963,0.000042573593,0.000022967733,0.000081496924,0.011797915,0.000091356385],"about_ca_topic_score_codex":0.00003207155,"about_ca_topic_score_gemma":0.000022056203,"teacher_disagreement_score":0.39855084,"about_ca_system_score_codex":0.00007376418,"about_ca_system_score_gemma":0.00066620734,"threshold_uncertainty_score":0.96764857},"labels":[],"label_agreement":null},{"id":"W4220930519","doi":"10.1161/jaha.121.022937","title":"Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI","year":2022,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Université de Montréal; Montreal Heart Institute","funders":"Amarin Pharma; Idorsia Pharmaceuticals; Servier; Abiomed; Medicines Company; Amarin Corporation; Abbott Vascular; Regeneron Pharmaceuticals; Medicure; Boston Scientific Corporation; Daiichi Sankyo Europe; Kowa Company; Sanofi; George Washington University; University of Pennsylvania; Esperion Therapeutics; GlaxoSmithKline; Amgen; Pfizer; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Joslin Diabetes Center","keywords":"Conventional PCI; Percutaneous coronary intervention; Clinical endpoint; Revascularization; Myocardial infarction; Randomized controlled trial","score_opus":0.009231006140559132,"score_gpt":0.26083088908350577,"score_spread":0.25159988294294666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220930519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415624,0.0001551879,0.0000069450316,0.0046920064,0.00019349903,0.00074345135,0.0000120033355,0.000006739266,0.000033911183],"genre_scores_gemma":[0.99800366,0.000029787934,0.00057334005,0.0008659429,0.0001745372,0.000031920208,0.000012121862,0.000022921864,0.00028578867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975807,0.00045180574,0.00041885814,0.00018308738,0.0011743021,0.00019122181],"domain_scores_gemma":[0.9987282,0.00005803037,0.00061251613,0.0002816445,0.00019174149,0.00012788069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034921986,0.00013946767,0.00058992236,0.000110542685,0.00014705863,0.0000096517,0.00011434071,0.000024620715,0.000038393075],"category_scores_gemma":[0.00006532206,0.000084789644,0.00028881,0.0004078404,0.000017889108,0.000073391624,0.000055945955,0.0003490507,0.0000040513683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048293835,0.0014340905,0.9688104,0.000011297575,0.0008958044,0.000072255,0.0020145997,0.0002649972,0.0019580002,3.3914094e-7,0.0009775946,0.018731277],"study_design_scores_gemma":[0.0043122657,0.008495123,0.9785146,0.00019257946,0.00028480054,0.0003905231,0.0011526258,0.000011076937,0.0004747659,0.0000057457983,0.006053371,0.00011248795],"about_ca_topic_score_codex":0.00089059956,"about_ca_topic_score_gemma":0.00007286102,"teacher_disagreement_score":0.018618789,"about_ca_system_score_codex":0.003804211,"about_ca_system_score_gemma":0.00033648987,"threshold_uncertainty_score":0.99478793},"labels":[],"label_agreement":null},{"id":"W4220939039","doi":"10.22541/au.164864502.22517521/v1","title":"Lipoprotein (a) is an Upstream Mediator of Aortic Stenosis","year":2022,"lang":"en","type":"preprint","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Stenosis; Medicine; Calcification; Fibrosis; Cardiology; Internal medicine; Aortic valve; Aortic valve stenosis; Lipoprotein(a); Angiogenesis; Lipoprotein; Cholesterol","score_opus":0.029241817401271387,"score_gpt":0.2995860137149646,"score_spread":0.2703441963136932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220939039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98401004,0.0014081533,0.00024956142,0.0013429279,0.00055321207,0.0024069662,0.00015949729,0.00016716431,0.009702465],"genre_scores_gemma":[0.99003035,0.0009080156,0.003969544,0.00097579916,0.0008126703,0.0006209304,0.000281344,0.000103602055,0.0022977402],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965508,0.00018614692,0.000701454,0.00075281796,0.0014369426,0.00037184329],"domain_scores_gemma":[0.9966004,0.000020701655,0.00029246908,0.0024783206,0.00019593838,0.000412205],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009588034,0.00035164476,0.0012271835,0.00022652032,0.00007608711,0.000017826058,0.00033214156,0.00034906642,0.008964602],"category_scores_gemma":[0.000075590324,0.00029314723,0.00086044765,0.00021242419,0.00007001732,0.000042942844,0.00069262774,0.0009385406,0.000026149053],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088117697,0.0041745477,0.057263613,0.016977686,0.0069916737,0.00033424486,0.005992153,0.000102920756,0.0017024268,0.0010339682,0.009753363,0.8947922],"study_design_scores_gemma":[0.023883129,0.017324395,0.39124313,0.0046004844,0.01641531,0.00034349554,0.020061946,0.0047603976,0.35562938,0.0099815605,0.14841095,0.0073458506],"about_ca_topic_score_codex":0.006932196,"about_ca_topic_score_gemma":0.000036025132,"teacher_disagreement_score":0.88744634,"about_ca_system_score_codex":0.00020499754,"about_ca_system_score_gemma":0.000939292,"threshold_uncertainty_score":0.9999521},"labels":[],"label_agreement":null},{"id":"W4220975688","doi":"10.1007/s11883-022-01016-8","title":"Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms","year":2022,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Agence Nationale de la Recherche","keywords":"Apolipoprotein E; Lipoprotein; Lipoprotein(a); Apolipoprotein B; Population; Catabolism; Endocrinology; Gene; Cholesterol; Internal medicine; Biology; Genetics; Medicine; Metabolism; Disease","score_opus":0.045491751478806464,"score_gpt":0.30604763539085283,"score_spread":0.26055588391204637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220975688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024572816,0.9683109,0.0012770125,0.0000150540545,0.00058926636,0.0051194774,0.000012613898,0.00006230654,0.00004055483],"genre_scores_gemma":[0.07887425,0.9189328,0.00018195296,0.000015488387,0.00033792062,0.0011818027,0.0003427832,0.00010867868,0.000024308309],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954064,0.00035911475,0.001746907,0.0008713237,0.0012288685,0.00038739774],"domain_scores_gemma":[0.9964736,0.00007371786,0.0018296159,0.0013064519,0.00011454032,0.00020204092],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00095858023,0.00057008764,0.0019021609,0.00012164657,0.00044470726,0.00006108374,0.00015162512,0.00027183504,0.00008976379],"category_scores_gemma":[0.00025700757,0.00038299346,0.0007737966,0.0005214854,0.00014371634,0.00009393803,0.00018651315,0.0006904564,0.0000024891924],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004232588,0.000105728795,0.000047031157,0.011865138,0.0002148387,0.000009690001,0.0005658414,0.0000048106285,0.00031387515,0.000051031548,0.000036029458,0.9867818],"study_design_scores_gemma":[0.0005138011,0.00030262084,0.00076779496,0.011063346,0.0021503184,0.00043784804,0.00007697693,0.00046093055,0.00011908186,0.0004939617,0.9829801,0.0006332393],"about_ca_topic_score_codex":0.0005914837,"about_ca_topic_score_gemma":0.000009388419,"teacher_disagreement_score":0.98614854,"about_ca_system_score_codex":0.0004018939,"about_ca_system_score_gemma":0.00050144363,"threshold_uncertainty_score":0.9998622},"labels":[],"label_agreement":null},{"id":"W4220975828","doi":"10.1016/j.jacc.2022.01.014","title":"Lipoprotein(a) Cholesterol Masquerading as Low-Density Lipoprotein Cholesterol","year":2022,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Cholesterol; Lipoprotein; Ldl cholesterol; Low-density lipoprotein receptor-related protein 8; Internal medicine; Very low-density lipoprotein","score_opus":0.012038940942131354,"score_gpt":0.25476571750891985,"score_spread":0.2427267765667885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220975828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60158706,0.0017370598,0.0003126593,0.3869838,0.0033876977,0.0032331066,0.00032285065,0.000051713818,0.0023840421],"genre_scores_gemma":[0.6546299,0.0009539998,0.00070707704,0.31831762,0.022381488,0.00014787012,0.000030660543,0.00030211892,0.0025292656],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99157137,0.0024259912,0.001890582,0.0006826771,0.0025104543,0.00091891934],"domain_scores_gemma":[0.9923033,0.0002197975,0.004080245,0.0023547914,0.0007424614,0.00029938217],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0026751717,0.00075237366,0.005015557,0.00068773376,0.00031393557,0.000024252513,0.0013787322,0.000616939,0.0001026566],"category_scores_gemma":[0.0005542076,0.00054113707,0.003973797,0.0009368619,0.0009337313,0.000119825425,0.0006303105,0.006469741,0.000014549868],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004009964,0.00021586724,0.0029050042,0.0023919106,0.0126762185,0.020765465,0.00020173645,0.00044830173,0.003372071,0.00004117786,0.9107347,0.042237557],"study_design_scores_gemma":[0.003703092,0.0054218518,0.020530129,0.0009534351,0.0022409344,0.05630058,0.00036369913,0.0000079815645,0.0022587215,0.00021150256,0.90737265,0.0006354257],"about_ca_topic_score_codex":0.0011249302,"about_ca_topic_score_gemma":0.000022813318,"teacher_disagreement_score":0.06866618,"about_ca_system_score_codex":0.00087732146,"about_ca_system_score_gemma":0.0016590671,"threshold_uncertainty_score":0.999704},"labels":[],"label_agreement":null},{"id":"W4221031892","doi":"10.1016/j.cjca.2022.03.019","title":"Canadian Society of Clinical Chemists Harmonized Clinical Laboratory Lipid Reporting Recommendations on the Basis of the 2021 Canadian Cardiovascular Society Lipid Guidelines","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Royal Columbian Hospital; University of Toronto; Calgary Laboratory Services; St. Michael's Hospital; University of Calgary; University of Alberta; Brampton Civic Hospital","funders":"Center for Sepsis Control and Care","keywords":"Medicine; Guideline; Harmonization; Dyslipidemia; Canadian Cardiovascular Society; Standardization; Medical laboratory; Working group; Medical physics; Family medicine; Pathology; Disease; Internal medicine; Political science; Law","score_opus":0.11005304783047075,"score_gpt":0.36100546095069647,"score_spread":0.2509524131202257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221031892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75126487,0.011786629,0.00027692068,0.2132678,0.010882401,0.0022705642,0.0014451743,0.000015802341,0.008789835],"genre_scores_gemma":[0.98244953,0.0016825548,0.000903185,0.008554485,0.006048376,0.000034747995,0.00003631253,0.000055142948,0.00023563618],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923973,0.0018872509,0.003814258,0.00040655804,0.0007080921,0.00078651274],"domain_scores_gemma":[0.99219495,0.00040013087,0.0020637477,0.0015187386,0.0019840864,0.0018383422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026198182,0.00025736692,0.002066415,0.00017479458,0.0008540324,0.000018327155,0.0006608664,0.00038251217,0.00025288487],"category_scores_gemma":[0.006777966,0.00018151512,0.0066244844,0.00077433436,0.00048618988,0.000049487127,0.000076512784,0.0020285037,0.000002030219],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006989202,0.000020956035,0.19315568,0.00012736434,0.01094868,0.00025884295,0.00058600534,0.0015538012,0.00006307167,0.00019749848,0.7445933,0.04842487],"study_design_scores_gemma":[0.0013057037,0.00022480541,0.04130945,0.00011268447,0.00085832673,0.00051685824,0.0022771242,0.000060923616,0.00015620005,0.000018261582,0.95299053,0.0001691164],"about_ca_topic_score_codex":0.58636653,"about_ca_topic_score_gemma":0.38054496,"teacher_disagreement_score":0.23118469,"about_ca_system_score_codex":0.001255659,"about_ca_system_score_gemma":0.04559427,"threshold_uncertainty_score":0.95981634},"labels":[],"label_agreement":null},{"id":"W4221050577","doi":"10.1161/circulationaha.121.057631","title":"Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease","year":2022,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"British Heart Foundation","keywords":"Primary prevention; Disease; Atherosclerotic cardiovascular disease; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Secondary prevention; Risk assessment; Disease prevention","score_opus":0.02409368218673047,"score_gpt":0.2883768969871307,"score_spread":0.26428321480040023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221050577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8811546,0.003828972,0.111420125,0.00002507538,0.00007098912,0.0031082523,0.00027140445,0.000014164857,0.00010642312],"genre_scores_gemma":[0.9983581,0.00009499098,0.00017158836,0.000011822545,0.0000521735,0.0006915403,0.0005869265,0.000014774744,0.000018133302],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9983245,0.00041438435,0.00027212876,0.00021461294,0.0006652135,0.00010911941],"domain_scores_gemma":[0.9987297,0.000150465,0.00019911284,0.0006568573,0.00020912026,0.000054717915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022639262,0.00007830386,0.00045758544,0.00017241659,0.00016593425,0.0000038685776,0.00005891095,0.000025017956,0.00008272821],"category_scores_gemma":[0.00015312954,0.00006444003,0.0013799247,0.0007365443,0.000034039156,0.000042778986,0.000033811673,0.00008049628,3.8827721e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012636932,0.00041007873,0.17042434,0.0012825909,0.026900848,0.0000029014197,0.00038815115,0.63663685,0.0005795193,0.000684782,0.000026253638,0.16139999],"study_design_scores_gemma":[0.001650803,0.00010585062,0.9605026,0.000019020565,0.018624855,0.0000011131791,0.00012907431,0.016668344,0.0001042022,0.0002718888,0.0018596721,0.00006254107],"about_ca_topic_score_codex":0.00025237797,"about_ca_topic_score_gemma":0.0000032957612,"teacher_disagreement_score":0.7900783,"about_ca_system_score_codex":0.00017178644,"about_ca_system_score_gemma":0.0001969424,"threshold_uncertainty_score":0.26277882},"labels":[],"label_agreement":null},{"id":"W4223584485","doi":"10.1161/strokeaha.121.034924","title":"Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C (Low-Density Lipoprotein) and Inflammation Levels","year":2022,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Inflammation; Stroke (engine); Ischemic stroke; Ischemia; Risk factor; Stroke risk; Vascular disease","score_opus":0.010494944316826687,"score_gpt":0.25389543492616956,"score_spread":0.24340049060934288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223584485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995173,0.00071844226,0.00007045879,0.00040525178,0.00028736133,0.0022710161,0.00021520208,0.000078686135,0.00078060216],"genre_scores_gemma":[0.99760634,0.00007423507,0.00016509903,0.000100036115,0.00039561462,0.00032322304,0.000060060956,0.000039795777,0.0012356178],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996806,0.0005026216,0.000457285,0.00055923325,0.0012437591,0.00043106385],"domain_scores_gemma":[0.99841577,0.00013975055,0.00026240034,0.0008341393,0.00012594694,0.00022199757],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019401483,0.00030961572,0.0007618036,0.00019353193,0.0003914511,0.000019891075,0.00014837288,0.0001187638,0.00020145642],"category_scores_gemma":[0.0003190595,0.00027066594,0.00032115026,0.00022591214,0.000120864555,0.00009662731,0.0002982911,0.0005714668,0.000030167595],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038645386,0.0002204675,0.015553957,0.003316731,0.00055789883,0.00016854181,0.0007538293,0.00013147289,0.15460818,0.00024875664,0.000322238,0.8202534],"study_design_scores_gemma":[0.0058705956,0.007845532,0.0837159,0.00052330503,0.00030039813,0.0002128274,0.00015189275,0.00041878692,0.897336,0.00004755979,0.0031331403,0.00044403982],"about_ca_topic_score_codex":0.00076763897,"about_ca_topic_score_gemma":0.00006722281,"teacher_disagreement_score":0.8198094,"about_ca_system_score_codex":0.00027957384,"about_ca_system_score_gemma":0.00012554204,"threshold_uncertainty_score":0.99997455},"labels":[],"label_agreement":null},{"id":"W4224027734","doi":"10.1016/j.jacc.2022.02.018","title":"Elevated Lipoprotein(a) and Risk of Atrial Fibrillation","year":2022,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; Université Laval; Impact; Institut Universitaire de Cardiologie et de Pneumologie de Québec; Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Mendelian randomization; Medicine; Internal medicine; Lipoprotein(a); Atrial fibrillation; Atherosclerotic cardiovascular disease; Cardiology; Heart failure; Risk factor; Stroke (engine); Lipoprotein; Biobank; Cholesterol; Endocrinology; Disease; Bioinformatics; Genetic variants","score_opus":0.00965718268089757,"score_gpt":0.25167980038718374,"score_spread":0.24202261770628616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224027734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957137,0.0025450701,0.00016729505,0.000675829,0.00030410293,0.0003326325,0.000089719586,0.0000029859377,0.00016867608],"genre_scores_gemma":[0.9971543,0.0013907778,0.00052752736,0.000041711945,0.0008318318,0.0000015443075,8.1251466e-7,0.0000113021715,0.000040208826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979005,0.00084803294,0.00053252757,0.000097229684,0.00049346406,0.00012828592],"domain_scores_gemma":[0.99791235,0.00011815171,0.0013465198,0.00032274908,0.00023491001,0.000065343105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015889994,0.00008410447,0.0010184348,0.00013486895,0.00009597628,9.891867e-7,0.00012229256,0.000029057039,0.000010223587],"category_scores_gemma":[0.00037843935,0.000056176275,0.00083057914,0.0004223002,0.00026316903,0.00002221668,0.00012037586,0.00030733208,1.2008837e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018767662,0.0000603824,0.78526294,0.00032333704,0.013038222,0.00036873354,0.00028699715,0.03145378,0.024656398,0.00060806074,0.0050357003,0.12013779],"study_design_scores_gemma":[0.0094028795,0.012717019,0.8430197,0.00010739323,0.0036322982,0.016621506,0.0021624805,0.0004006345,0.0044261003,0.0009166042,0.106335424,0.0002579187],"about_ca_topic_score_codex":0.00016213857,"about_ca_topic_score_gemma":0.0000024206754,"teacher_disagreement_score":0.11987987,"about_ca_system_score_codex":0.00007534665,"about_ca_system_score_gemma":0.00034175438,"threshold_uncertainty_score":0.2290802},"labels":[],"label_agreement":null},{"id":"W4224246511","doi":"10.51731/cjht.2022.311","title":"Colchicine (Myinfla)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Antithrombotic; Medicine; Drug; Drug class; Colchicine; Intensive care medicine; Family medicine; Pharmacology; Internal medicine; Political science; Health care","score_opus":0.021402850192954282,"score_gpt":0.26422724025130406,"score_spread":0.24282439005834977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224246511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47882673,0.29045957,0.0004946404,0.22578217,0.0013316309,0.0011102197,0.000044574135,0.00022412198,0.0017263395],"genre_scores_gemma":[0.9967943,0.0003586624,0.0004732635,0.0021825053,0.000029905923,0.000015502377,0.0000031664838,0.000015950069,0.00012675037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984779,0.00009068279,0.0005087187,0.0001134228,0.0003699767,0.00043932424],"domain_scores_gemma":[0.9990315,0.000015599326,0.00029085117,0.0003705498,0.00013196007,0.00015958339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017015869,0.00009486339,0.0004923329,0.00066319376,0.0005388859,0.000010526871,0.00022758356,0.00005886482,0.00014577441],"category_scores_gemma":[0.00026819442,0.00008149257,0.00016948876,0.0004937299,0.00010219537,0.0000410038,0.000034706733,0.00083723245,0.000003903351],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050394312,0.00003576613,0.007735822,0.00021644802,0.00013806386,0.0012411586,0.00030438878,0.00006387664,0.00004204272,0.0022203333,0.018328473,0.9696232],"study_design_scores_gemma":[0.0011437869,0.001754249,0.014156382,0.00009540212,0.000029682156,0.005420501,0.0056357286,0.000007857398,0.00011164568,0.001392813,0.9701558,0.000096200165],"about_ca_topic_score_codex":0.0064636013,"about_ca_topic_score_gemma":0.0011283295,"teacher_disagreement_score":0.969527,"about_ca_system_score_codex":0.00089284,"about_ca_system_score_gemma":0.006765811,"threshold_uncertainty_score":0.9988649},"labels":[],"label_agreement":null},{"id":"W4224259495","doi":"10.1016/j.jlr.2022.100216","title":"Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a)","year":2022,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University of Windsor; Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; McMaster University","keywords":"Apolipoprotein B; Secretion; Internalization; Gene knockdown; Lipoprotein; Lipoprotein(a); PCSK9; Internal medicine; Chemistry; Endocrinology; Cell biology; Biology; Cholesterol; LDL receptor; Biochemistry; Cell; Gene; Medicine","score_opus":0.04381561452870661,"score_gpt":0.35391957599564977,"score_spread":0.3101039614669432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224259495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896107,0.004329032,0.00038929784,0.0017403426,0.0003375182,0.0026125186,0.000019679348,0.000017869372,0.00094305514],"genre_scores_gemma":[0.99447906,0.0012597,0.0020897146,0.00007181449,0.0016146711,0.00018034985,0.0000119102015,0.000059010043,0.00023378457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99170536,0.0014157046,0.0014223448,0.00043329046,0.004372116,0.00065121445],"domain_scores_gemma":[0.99649805,0.00029305235,0.0009775517,0.0007329494,0.0011769425,0.0003214711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009801838,0.0002854372,0.0012359582,0.0008254621,0.00037223563,0.00002870821,0.00035741698,0.00019911981,0.0002124089],"category_scores_gemma":[0.0013289974,0.00023014472,0.0005466289,0.0010830972,0.00035845986,0.00023807793,0.000270046,0.0018994272,0.000003704292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066976263,0.001524823,0.0010486117,0.0068380795,0.0008830653,0.00019709431,0.003013988,0.00007398201,0.7211674,0.0019531301,0.0005657463,0.25603646],"study_design_scores_gemma":[0.005616958,0.024313705,0.016058018,0.0022178735,0.00019505262,0.00083498517,0.0020099329,0.00023016558,0.9345192,0.0033979097,0.010301335,0.00030489967],"about_ca_topic_score_codex":0.0008873862,"about_ca_topic_score_gemma":0.000019747167,"teacher_disagreement_score":0.25573155,"about_ca_system_score_codex":0.00029776085,"about_ca_system_score_gemma":0.0008901566,"threshold_uncertainty_score":0.93850297},"labels":[],"label_agreement":null},{"id":"W4224279217","doi":"10.51731/cjht.2022.312","title":"Inclisiran (Leqvio)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Familial hypercholesterolemia; Drug; Drug class; Statin; Ldl cholesterol; Physical therapy; Internal medicine; Intensive care medicine; Cholesterol; Pharmacology; Political science; Health care","score_opus":0.023769985502235004,"score_gpt":0.2676920870916604,"score_spread":0.24392210158942543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224279217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5254008,0.32336602,0.00039047038,0.14674382,0.0013785367,0.00087974686,0.000044913726,0.00022173669,0.0015739426],"genre_scores_gemma":[0.9969882,0.0003372903,0.0005359489,0.001995397,0.00002859659,0.000012770231,0.0000029963157,0.000016252852,0.0000825552],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99844676,0.00010715893,0.0005036961,0.00012094091,0.00037537565,0.00044603823],"domain_scores_gemma":[0.9990373,0.000015712576,0.00027083524,0.00039871703,0.00011569403,0.00016174313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019477042,0.00009385037,0.00045926668,0.0006681902,0.00058834587,0.000012605617,0.00026068895,0.00006358396,0.00013073126],"category_scores_gemma":[0.00028062373,0.00008139858,0.00019254813,0.0004763302,0.00010281291,0.00004890567,0.000044048957,0.00084886194,0.000004105188],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001876476,0.00002092389,0.0040844246,0.00010448791,0.000072704315,0.000605228,0.00023626482,0.000018827737,0.000011253056,0.0010378227,0.006080561,0.98770875],"study_design_scores_gemma":[0.0008236674,0.0014237327,0.011031606,0.00007222468,0.000021889706,0.004024643,0.005760172,0.0000045142974,0.00008468986,0.0014112457,0.97525346,0.000088122055],"about_ca_topic_score_codex":0.008056006,"about_ca_topic_score_gemma":0.0010311713,"teacher_disagreement_score":0.9876206,"about_ca_system_score_codex":0.000896875,"about_ca_system_score_gemma":0.00639393,"threshold_uncertainty_score":0.9992389},"labels":[],"label_agreement":null},{"id":"W4224306655","doi":"10.1016/j.xjon.2022.04.009","title":"Commentary: Postcoronary artery bypass grafting treatment of dyslipidemia: Better hit those targets!","year":2022,"lang":"en","type":"editorial","venue":"JTCVS Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Dyslipidemia; Bypass grafting; Medicine; Artery; Cardiology; Internal medicine; Revascularization; Cohort","score_opus":0.0217090017400612,"score_gpt":0.315987521603245,"score_spread":0.2942785198631838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224306655","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007364599,0.013077229,0.000019211238,0.01953869,0.9400522,0.009203515,0.0025755174,0.00013976972,0.008029229],"genre_scores_gemma":[0.0011014601,0.0018548673,0.0018988587,0.0053013708,0.9713038,0.0015714479,0.012324154,0.00027960032,0.004364447],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99549925,0.00046547665,0.000943511,0.00087639794,0.0015885971,0.00062676135],"domain_scores_gemma":[0.9969417,0.00035012222,0.0005162177,0.0017321187,0.00016885315,0.00029100847],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013638143,0.0005898246,0.0022064727,0.00016850258,0.00027796093,0.000063120046,0.00066673296,0.0006181388,0.0014814979],"category_scores_gemma":[0.00013524783,0.00048732085,0.0008764313,0.0002060098,0.00007279667,0.00016713089,0.0008349202,0.0010046999,0.000034529032],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060493423,0.0006575152,0.0008357137,0.00036718647,0.0022867243,0.0004556236,0.00034972373,0.0000015095242,0.000037722653,0.0000038201383,0.9597333,0.034666203],"study_design_scores_gemma":[0.0058905696,0.0026277837,0.0007424462,0.00029554628,0.0012680949,0.000023451701,0.00024986052,0.0000057477655,0.000100349214,0.000040029627,0.9883522,0.0004039187],"about_ca_topic_score_codex":0.0062046456,"about_ca_topic_score_gemma":0.0001347798,"teacher_disagreement_score":0.034262285,"about_ca_system_score_codex":0.0013421432,"about_ca_system_score_gemma":0.0008591474,"threshold_uncertainty_score":0.9997578},"labels":[],"label_agreement":null},{"id":"W4224321135","doi":"10.1016/j.jacc.2022.02.035","title":"Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction","year":2022,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Medicine; Clinical endpoint; Myocardial infarction; Internal medicine; Cardiology; Placebo; Stroke (engine); Unstable angina; Angina; Sudden cardiac death; Ventricular fibrillation; Randomized controlled trial","score_opus":0.008567732698835451,"score_gpt":0.24433273716099105,"score_spread":0.2357650044621556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224321135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796706,0.00063509546,0.00024056212,0.00015900607,0.0001553175,0.000736684,0.000033084198,0.000002206351,0.00007097229],"genre_scores_gemma":[0.9993509,0.00017430293,0.00027446353,0.000051046438,0.00010427597,0.000019021003,0.000002481004,0.000014942159,0.000008559034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972681,0.00088929135,0.00051253475,0.00016145986,0.0010037846,0.00016482537],"domain_scores_gemma":[0.99837446,0.000031150114,0.0007911427,0.00045082584,0.0002824123,0.00007001905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015623802,0.00012358809,0.0013035513,0.00017294753,0.00006741635,0.0000010976672,0.00012832515,0.000030438483,0.000003140669],"category_scores_gemma":[0.000054729928,0.00007625138,0.0006407188,0.000491046,0.00022790805,0.000051381558,0.000106024345,0.00035324472,4.558512e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033199675,0.00014521721,0.97932434,0.00007795248,0.0048253676,0.000041718402,0.000053312244,0.0062155505,0.000050750725,0.000011117168,0.00003570527,0.005898971],"study_design_scores_gemma":[0.0051548034,0.0050247363,0.985924,0.000076745666,0.001182355,0.00056553807,0.00037925996,0.0000060717744,0.00006377044,0.000035905417,0.0015124028,0.00007443208],"about_ca_topic_score_codex":0.00014241158,"about_ca_topic_score_gemma":0.0000076238575,"teacher_disagreement_score":0.0065996093,"about_ca_system_score_codex":0.00018242888,"about_ca_system_score_gemma":0.00043713526,"threshold_uncertainty_score":0.3109441},"labels":[],"label_agreement":null},{"id":"W4226072456","doi":"10.1007/s11883-022-01018-6","title":"Monogenic Versus Polygenic Forms of Hypercholesterolemia and Cardiovascular Risk: Are There Any Differences?","year":2022,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Familial hypercholesterolemia; Medicine; Polygenic risk score; Internal medicine; Angiology; Genotype; Bioinformatics; Genetics; Cholesterol; Single-nucleotide polymorphism; Gene; Biology","score_opus":0.10726670388076172,"score_gpt":0.3233598195180826,"score_spread":0.21609311563732092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226072456","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.093235955,0.90267295,0.000021586444,0.0000035480246,0.0013494579,0.0023859374,0.00014445248,0.000086296364,0.00009980297],"genre_scores_gemma":[0.03560637,0.962923,0.000032159955,0.000005196677,0.00038298682,0.0006927199,0.00014345394,0.00018453578,0.000029615208],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9941083,0.0005268768,0.0017071948,0.0014036865,0.0015760418,0.0006778654],"domain_scores_gemma":[0.99452937,0.00013317558,0.0017868927,0.0030022727,0.0001037094,0.00044459352],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017349327,0.000908896,0.0050725886,0.00028033103,0.00027609637,0.00005179049,0.00027403343,0.00044548165,0.00021081048],"category_scores_gemma":[0.00030167817,0.0006702297,0.0051507624,0.00055375334,0.00017704796,0.00010041642,0.00042270494,0.0013935443,0.0000075223115],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032225867,0.00019703674,0.009816128,0.016832143,0.0040141884,0.00007148296,0.000091581285,6.349844e-7,0.0000010759645,0.0000027286233,0.00004912482,0.9688916],"study_design_scores_gemma":[0.001245136,0.00038954534,0.026150484,0.0142904855,0.014211222,0.0006193255,0.00013369425,0.0000018622333,0.000003572941,0.000012143939,0.9422281,0.000714473],"about_ca_topic_score_codex":0.00014783381,"about_ca_topic_score_gemma":0.000008986743,"teacher_disagreement_score":0.9681772,"about_ca_system_score_codex":0.00035768494,"about_ca_system_score_gemma":0.00059171626,"threshold_uncertainty_score":0.9995749},"labels":[],"label_agreement":null},{"id":"W4226464146","doi":"10.21037/apm-21-3464","title":"The association between statin and COVID-19 adverse outcomes: national COVID-19 cohort in South Korea","year":2022,"lang":"en","type":"article","venue":"Annals of Palliative Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Research Foundation of Korea; National Research Foundation","keywords":"Medicine; Statin; Odds ratio; Retrospective cohort study; Confidence interval; Internal medicine; Clinical endpoint; Cohort; Medical prescription; Population; Cohort study; Emergency medicine; Intensive care unit; Stroke (engine); Clinical trial","score_opus":0.11058903282096705,"score_gpt":0.4086975068696982,"score_spread":0.29810847404873114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226464146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7680505,0.00318996,0.0020858173,0.22004293,0.00023933203,0.0030455806,0.00073673,0.000070969385,0.0025381797],"genre_scores_gemma":[0.97412324,0.0007103978,0.00006377399,0.02361404,0.00022178066,0.00019008515,0.0002731454,0.000018498724,0.0007850466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960132,0.000596632,0.0006660931,0.00033414477,0.0020543814,0.00033552892],"domain_scores_gemma":[0.99682057,0.0015968786,0.00050944096,0.00026878188,0.000333235,0.0004710858],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008371164,0.0001826242,0.0007210969,0.00022409184,0.00037622757,0.0000048726743,0.00013378571,0.00006841357,0.00020386447],"category_scores_gemma":[0.011465978,0.00012294385,0.00014664674,0.0005158265,0.00020474425,0.00004457167,0.000098373195,0.00041969444,0.0000030904023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016447098,0.000055365635,0.9832454,0.0001700866,0.0006469079,0.000025040044,0.006489074,0.00010782792,0.0000070474002,0.0010984294,0.0072390554,0.0007513082],"study_design_scores_gemma":[0.004574326,0.0005269608,0.91745794,0.00003377256,0.00015012597,0.0000024095707,0.006718283,0.000074152464,0.000013951877,0.0017332768,0.06859978,0.000115039635],"about_ca_topic_score_codex":0.002053569,"about_ca_topic_score_gemma":0.00024113654,"teacher_disagreement_score":0.20607273,"about_ca_system_score_codex":0.000809051,"about_ca_system_score_gemma":0.0012546879,"threshold_uncertainty_score":0.99686086},"labels":[],"label_agreement":null},{"id":"W4229000569","doi":"10.1136/bmj-2021-069116","title":"PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis","year":2022,"lang":"en","type":"review","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Ezetimibe; Medicine; PCSK9; Relative risk; Internal medicine; Statin; Stroke (engine); Meta-analysis; Myocardial infarction; Cochrane Library; Confidence interval; Cholesterol; Lipoprotein","score_opus":0.11065214572930865,"score_gpt":0.36525468949884277,"score_spread":0.2546025437695341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229000569","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.786847e-7,0.97198206,0.0006736309,0.00016440859,0.000076471704,0.026905557,0.00010934802,0.00005174635,0.000035769895],"genre_scores_gemma":[0.000001920221,0.9769817,0.004244443,0.00023185842,0.0006401909,0.01692498,0.00017777177,0.00012393706,0.000673191],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9939838,0.002159249,0.0014748339,0.0009787724,0.0010090009,0.00039436744],"domain_scores_gemma":[0.9962746,0.00023662606,0.0011110004,0.0019641716,0.0001564033,0.00025721878],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0085796,0.0006985381,0.017445428,0.0002154711,0.00031208133,0.00005820555,0.00012556204,0.00018259697,0.000173001],"category_scores_gemma":[0.0002457457,0.00035085954,0.009106561,0.0013760076,0.00008090068,0.000053877746,0.000069251575,0.00049449364,0.0000017978972],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003445311,0.000017482567,0.0000012006149,0.52042925,0.4247278,0.000020156627,0.00003088764,0.000007589517,4.6248352e-10,0.0000029422272,0.0008228219,0.053905398],"study_design_scores_gemma":[0.00041268958,0.00028195372,3.647478e-7,0.022669561,0.5373115,0.00088979333,0.000039749,0.0000033477613,1.469145e-8,0.0000022543124,0.4381497,0.00023907567],"about_ca_topic_score_codex":0.0001899296,"about_ca_topic_score_gemma":0.000016197386,"teacher_disagreement_score":0.4977597,"about_ca_system_score_codex":0.000113220325,"about_ca_system_score_gemma":0.00052770984,"threshold_uncertainty_score":0.9998943},"labels":[],"label_agreement":null},{"id":"W4229023932","doi":"10.1136/heartjnl-2021-320556","title":"Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Heart","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Discontinuation; PCSK9; Internal medicine; Evolocumab; Meta-analysis; myalgia; Adverse effect; Relative risk; Confidence interval; Cholesterol; Lipoprotein","score_opus":0.08168436502770937,"score_gpt":0.3441983842360509,"score_spread":0.26251401920834155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229023932","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.9440024e-7,0.9856139,0.000010732634,0.00030095808,0.000028868346,0.013665764,0.00022104448,0.000034499564,0.00012376391],"genre_scores_gemma":[0.0000046725604,0.99513483,0.00017749332,0.00069080177,0.00005395168,0.002712016,0.00025911783,0.00006292231,0.0009041697],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9941651,0.0016696891,0.002139025,0.00066328223,0.001059133,0.00030372478],"domain_scores_gemma":[0.9967429,0.00016103376,0.00077418203,0.0019301302,0.00012724669,0.00026452806],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004388096,0.00052946864,0.01933201,0.0003771114,0.00009458003,0.000015223865,0.00013685932,0.0002043678,0.0021678365],"category_scores_gemma":[0.0004587039,0.00032211337,0.008547714,0.0012321594,0.00007581118,0.00004306261,0.00013903496,0.0005773548,0.000030681796],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004307824,0.000052783165,3.8052627e-7,0.8625991,0.1346159,0.00003098381,0.000014383149,2.5538546e-8,3.6841882e-8,0.000013997233,0.00030996065,0.0023581414],"study_design_scores_gemma":[0.000106476014,0.000074645235,3.2423378e-7,0.03767959,0.55746055,0.00026718943,0.000008261367,4.11546e-7,7.028826e-7,9.05152e-7,0.40425757,0.00014335617],"about_ca_topic_score_codex":0.0003398113,"about_ca_topic_score_gemma":0.000012392732,"teacher_disagreement_score":0.8249195,"about_ca_system_score_codex":0.00014907398,"about_ca_system_score_gemma":0.0006034842,"threshold_uncertainty_score":0.9999231},"labels":[],"label_agreement":null},{"id":"W4229027239","doi":"10.1136/bmj-2021-069066","title":"PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations","year":2022,"lang":"en","type":"article","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Ezetimibe; PCSK9; Medicine; Guideline; Adverse effect; Statin; Drug; Cholesterol; Risk assessment; Pharmacology; Intensive care medicine; Internal medicine; Lipoprotein; LDL receptor","score_opus":0.04105569519282302,"score_gpt":0.3715003759649737,"score_spread":0.33044468077215067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229027239","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3551477,0.0432321,0.18701348,0.37025744,0.0058430354,0.033073507,0.0006014706,0.00028802207,0.004543264],"genre_scores_gemma":[0.84139246,0.0047389125,0.14356036,0.0021353844,0.004484814,0.002690089,0.00029746944,0.000096396514,0.00060409616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797624,0.00048606796,0.00063564564,0.00025645134,0.00051412644,0.00013143734],"domain_scores_gemma":[0.99843645,0.00023332365,0.00031437213,0.0006462965,0.000297615,0.00007192838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075328113,0.00009225423,0.00034790408,0.00004176838,0.00032322077,0.0000069706516,0.00005786756,0.00004376425,0.000031050284],"category_scores_gemma":[0.0010640273,0.00006118779,0.00038167712,0.00019819054,0.00005623846,0.00007117765,0.000052332252,0.00029915918,6.4178425e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029553352,0.00089752174,0.0013393246,0.00023642484,0.009610576,0.000019266205,0.0007782284,0.0032782606,0.000053690874,0.00035779507,0.15967374,0.8207998],"study_design_scores_gemma":[0.0030698879,0.0010763645,0.0018167007,0.000037008253,0.0024401231,0.000588936,0.003758842,0.0005822361,0.00010088364,0.000058768896,0.9863752,0.00009503203],"about_ca_topic_score_codex":0.000637108,"about_ca_topic_score_gemma":0.000008954929,"teacher_disagreement_score":0.82670146,"about_ca_system_score_codex":0.00004652924,"about_ca_system_score_gemma":0.0002698093,"threshold_uncertainty_score":0.2610737},"labels":[],"label_agreement":null},{"id":"W4229043687","doi":"10.3389/fcvm.2022.915262","title":"Editorial: Highlights in Lipids in Cardiovascular Disease: 2021","year":2022,"lang":"en","type":"editorial","venue":"Frontiers in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Institut de Cardiologie de Montréal; Fondation Institut de Cardiologie de Montréal","keywords":"Disease; Medicine; Atherosclerotic cardiovascular disease; Intensive care medicine; Cardiology; Internal medicine","score_opus":0.007062050652208065,"score_gpt":0.23877004518302913,"score_spread":0.23170799453082108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229043687","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006898577,0.3855535,0.00039012442,0.0005380305,0.60937315,0.002920594,0.00011361275,0.00008602857,0.0009559338],"genre_scores_gemma":[0.0006054962,0.071303196,0.0004985943,0.0001068886,0.9217194,0.0019124999,0.002715695,0.00046980896,0.0006684666],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97426164,0.003477294,0.0027574026,0.0037548519,0.01347978,0.002269029],"domain_scores_gemma":[0.99006706,0.00041148797,0.0003504765,0.007440989,0.0005530561,0.0011769009],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.02084205,0.0018094801,0.010391995,0.0039015687,0.0002340115,0.000056710793,0.0012730123,0.002535532,0.00036735335],"category_scores_gemma":[0.0053937407,0.0017097992,0.0067915237,0.0041778754,0.000515789,0.0002961802,0.0006204334,0.008212096,0.000029487319],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010235289,0.00037059528,0.0026628133,0.0024308828,0.009473764,0.0073763826,0.00048850366,0.002465949,0.0000012901194,0.000011632496,0.952756,0.020938653],"study_design_scores_gemma":[0.020341942,0.00041886658,0.003870478,0.0035003745,0.004967633,0.000041005133,0.0007428961,0.00010988834,0.000002559311,0.00012254519,0.96446425,0.0014175624],"about_ca_topic_score_codex":0.010840203,"about_ca_topic_score_gemma":0.00023206101,"teacher_disagreement_score":0.31425032,"about_ca_system_score_codex":0.0057742046,"about_ca_system_score_gemma":0.003789868,"threshold_uncertainty_score":0.99946505},"labels":[],"label_agreement":null},{"id":"W4230352024","doi":"10.1002/(sici)1098-1004(200003)15:3<294::aid-humu14>3.3.co;2-5","title":"Microsomal triglyceride transfer protein (MTP) gene mutations in Canadian subjects with abetalipoproteinemia Communicated by: Mark H. Paalman Online Citation: Human Mutation, Mutation in Brief #297 (1999) Online http://journals.wiley.com/1059-7794/pdf/mutation/297.pdf","year":2000,"lang":"en","type":"article","venue":"Human Mutation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Microsomal triglyceride transfer protein; Missense mutation; Biology; Genetics; Mutation; Nonsense mutation; Frameshift mutation; Apolipoprotein B; Compound heterozygosity; Gene mutation; Mutant; Gene; Molecular biology; Endocrinology; Lipoprotein; Cholesterol; Very low-density lipoprotein","score_opus":0.01836720239801071,"score_gpt":0.27554043645812387,"score_spread":0.25717323406011317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230352024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885257,0.0012957365,0.00054233096,0.0024022697,0.00007814115,0.0057261186,0.00038684712,0.00019562122,0.00084724586],"genre_scores_gemma":[0.9662765,0.00013059594,0.0026101966,0.0008467125,0.000339528,0.00085330964,0.027152479,0.00021288062,0.0015777901],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.992556,0.0009934331,0.0024242403,0.0011913123,0.0014763952,0.0013586491],"domain_scores_gemma":[0.99657017,0.000109869,0.0004818944,0.0011061938,0.00086641824,0.0008654337],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016504122,0.0008915865,0.0012647207,0.0017811012,0.0010284396,0.0002798129,0.0004451836,0.0005783278,0.0021944898],"category_scores_gemma":[0.00016252673,0.0009380875,0.00035503466,0.0026807988,0.00036610648,0.0010321295,0.000025126612,0.001444756,0.00018888031],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009241575,0.018099068,0.055751473,0.0059646135,0.0045228363,0.024213916,0.06297969,0.046920404,0.37334144,0.0021200418,0.0022878253,0.39455712],"study_design_scores_gemma":[0.059553836,0.0049307602,0.85853755,0.0047482485,0.0013523472,0.004016777,0.008237513,0.009871381,0.037059158,0.0027655887,0.0052310536,0.0036957555],"about_ca_topic_score_codex":0.23278762,"about_ca_topic_score_gemma":0.55981725,"teacher_disagreement_score":0.8027861,"about_ca_system_score_codex":0.0022959781,"about_ca_system_score_gemma":0.0015954642,"threshold_uncertainty_score":0.999307},"labels":[],"label_agreement":null},{"id":"W4230737044","doi":"10.1016/s0140-6736(07)60516-9","title":"Statins for primary prevention of coronary artery disease","year":2007,"lang":"en","type":"letter","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Scopus; Coronary artery disease; Framingham Heart Study; Internal medicine; Disease; Framingham Risk Score; Cardiology; Gerontology; MEDLINE","score_opus":0.03680509639871698,"score_gpt":0.3020192648594149,"score_spread":0.2652141684606979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230737044","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03584298,0.008910655,0.006906708,0.93690485,0.0007616809,0.006016479,0.0012345288,0.00011835876,0.0033037784],"genre_scores_gemma":[0.0044973963,0.00073860714,0.0021206078,0.95768964,0.025480848,0.00025338095,0.0033227992,0.00008685913,0.0058098864],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987416,0.00008264096,0.00026165182,0.0001913055,0.00043316864,0.00028957962],"domain_scores_gemma":[0.9986963,0.0000804303,0.00015495105,0.00093710143,0.00007709239,0.000054093118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070247735,0.0001429872,0.00068824936,0.00004575295,0.00004169471,0.0000056950566,0.00014177676,0.00016583999,0.000036777397],"category_scores_gemma":[0.00003766286,0.00009142873,0.00040066233,0.00005463527,0.000061345774,0.000021377782,0.000027890912,0.0005173414,0.000007519395],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007087746,0.000045674937,0.00049368816,0.004659483,0.00037323855,0.00016252845,0.000052939948,6.5542406e-7,0.00001907143,0.000018439481,0.96553624,0.027929243],"study_design_scores_gemma":[0.0017889785,0.00021677393,0.06481629,0.00045716492,0.0005734599,0.000047126912,0.000007312923,0.000004604025,0.000014047715,0.0005675046,0.9314048,0.00010192393],"about_ca_topic_score_codex":0.000013144971,"about_ca_topic_score_gemma":0.0000019284244,"teacher_disagreement_score":0.064322606,"about_ca_system_score_codex":0.00006385946,"about_ca_system_score_gemma":0.0002696046,"threshold_uncertainty_score":0.37283555},"labels":[],"label_agreement":null},{"id":"W4230986977","doi":"10.1016/j.jval.2016.08.367","title":"Identification of Statin Intolerance: Results From a Survey of Clinicians in Japan","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Creatine kinase; Internal medicine; Physical therapy; Family medicine","score_opus":0.06476042054602767,"score_gpt":0.3441394531380865,"score_spread":0.2793790325920589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230986977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959882,0.0008871688,0.0004239947,0.001441047,0.00014518845,0.0006586876,0.0004064317,0.000008858863,0.000040455692],"genre_scores_gemma":[0.9980671,0.0012629188,0.00040298892,0.00010848392,0.000051593976,0.000013474202,0.00004791253,0.000012926481,0.000032622534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966208,0.0008176129,0.0016777158,0.0002837248,0.00038084955,0.00021931421],"domain_scores_gemma":[0.9981842,0.00047928165,0.000512326,0.0005967996,0.00013834416,0.00008906266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007486737,0.00008198447,0.0005926214,0.00017646902,0.000012298468,0.0000017375557,0.00008115989,0.000082723185,0.000007666075],"category_scores_gemma":[0.0016408514,0.00006103894,0.00007032032,0.0004273529,0.000052752443,0.000043005417,0.000015754316,0.0001315707,0.0000058584187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019383221,0.00063198525,0.6966311,0.0010695255,0.00005574225,0.0000062803792,0.004895474,0.00029801702,0.0037282784,0.0002028004,0.00018673521,0.29035577],"study_design_scores_gemma":[0.0039944686,0.00026885828,0.9918197,0.0013478677,0.000004838079,9.558283e-7,0.00015445285,0.0005239056,0.001507299,0.00023573238,0.000089415844,0.00005250909],"about_ca_topic_score_codex":0.2694232,"about_ca_topic_score_gemma":0.0074115754,"teacher_disagreement_score":0.29518864,"about_ca_system_score_codex":0.0001702434,"about_ca_system_score_gemma":0.00072850916,"threshold_uncertainty_score":0.7354418},"labels":[],"label_agreement":null},{"id":"W4232050253","doi":"10.2165/00128415-200711780-00010","title":"Rosiglitazone use restricted in Canada","year":2007,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosiglitazone; Medicine; Endocrinology; Diabetes mellitus","score_opus":0.02053965973396285,"score_gpt":0.2558476387428613,"score_spread":0.23530797900889847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232050253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326503,0.00022145828,0.0004627495,0.0008903938,0.00021692457,0.0003182456,0.0000054385255,0.00003875355,0.004580976],"genre_scores_gemma":[0.9971378,0.000106146486,0.00055387965,0.00027597026,0.00017208442,0.000009617578,0.000017736214,0.0000145316735,0.0017122444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998963,0.000024664952,0.00025873352,0.00015989796,0.0003169865,0.0002767311],"domain_scores_gemma":[0.99925995,0.00006486467,0.000037221747,0.00038849193,0.000068358066,0.000181086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027566875,0.000077974575,0.00018963747,0.000144715,0.000051302464,0.000007999034,0.000031331918,0.00005393088,0.000031880212],"category_scores_gemma":[0.00016220367,0.00007168144,0.00006754614,0.0005290674,0.000011392255,0.00008004909,0.000009936097,0.00025221857,0.000013955413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087770825,0.0010929939,0.68035114,0.00044587805,0.0005804642,0.004526246,0.0002962288,0.0001942687,0.038650963,0.002605061,0.032551832,0.23782721],"study_design_scores_gemma":[0.0006601575,0.000037224636,0.8306527,0.000046380537,0.000024671115,0.00016654699,0.00024086794,0.00002644917,0.000724087,0.0000069017924,0.1673446,0.000069417634],"about_ca_topic_score_codex":0.984064,"about_ca_topic_score_gemma":0.9553261,"teacher_disagreement_score":0.23775779,"about_ca_system_score_codex":0.001230427,"about_ca_system_score_gemma":0.0014229867,"threshold_uncertainty_score":0.32175237},"labels":[],"label_agreement":null},{"id":"W4232199021","doi":"10.1203/01.pdr.0000015127.99522.7f","title":"A Randomized Crossover Trial of Combination Pharmacologic Therapy in Children with Familial Hyperlipidemia","year":2002,"lang":"en","type":"article","venue":"Pediatric Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Regimen; Pravastatin; Adverse effect; Crossover study; Bile acid; Pill; Combination therapy; Internal medicine; Familial hypercholesterolemia; Hyperlipidemia; Randomized controlled trial; Gastroenterology; Pharmacology; Cholesterol; Endocrinology","score_opus":0.07697314941281047,"score_gpt":0.3789741773776821,"score_spread":0.3020010279648716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232199021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896599,0.002926998,0.000015904068,0.0003790662,0.000079002806,0.005183213,0.0000028771528,0.00001984384,0.0017331956],"genre_scores_gemma":[0.9839396,0.014103946,0.00008531722,0.00006142245,0.0010775808,0.00038530197,0.000007944776,0.000017905633,0.000321013],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99646646,0.0010200295,0.0004294605,0.00028736028,0.0013846748,0.00041200494],"domain_scores_gemma":[0.998793,0.00038340382,0.00008771686,0.00031813848,0.00029571023,0.00012201964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058031883,0.00011728605,0.000720899,0.0004490268,0.000074404554,0.000015437281,0.00012798907,0.00012542141,0.00024144913],"category_scores_gemma":[0.0006086028,0.00007498284,0.00021945553,0.0010525346,0.0001738711,0.0000691197,0.000034178316,0.00058321113,0.000023069977],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86717784,0.0018914103,0.10480258,0.00009737022,0.00026262668,0.000020350295,0.0003285618,0.0000097800985,0.000101018166,0.00010442141,0.001394432,0.023809612],"study_design_scores_gemma":[0.9538866,0.0018123784,0.043347824,0.000007905587,0.00007132735,0.000015060581,0.000017274673,0.00038320967,0.00016250787,0.00008480727,0.00012788946,0.00008316135],"about_ca_topic_score_codex":0.0007590386,"about_ca_topic_score_gemma":0.0000038542853,"teacher_disagreement_score":0.086708814,"about_ca_system_score_codex":0.000101985825,"about_ca_system_score_gemma":0.00019438381,"threshold_uncertainty_score":0.30577114},"labels":[],"label_agreement":null},{"id":"W4232409041","doi":"10.1016/j.cjca.2018.07.277","title":"GUIDELINES ORIENTED APPROACH TO LIPID LOWERING (GOAL) MEDICAL PRACTICE ACTIVITY (MPA) TO ACHIEVE LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) TARGETS","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Blood pressure; Statin; Diabetes mellitus; Familial hypercholesterolemia; Family history; Cardiology; Cholesterol; Disease; Physical therapy; Endocrinology","score_opus":0.022386526170778152,"score_gpt":0.2981405497219777,"score_spread":0.27575402355119955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232409041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7301591,0.00041996938,0.23114505,0.026871279,0.0028809556,0.0012812205,0.000019547831,0.000032745404,0.0071901376],"genre_scores_gemma":[0.9703908,0.000049665847,0.0071059996,0.008795876,0.013477862,0.000025335075,0.000005169065,0.000052345415,0.00009694059],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964124,0.00047706463,0.000772516,0.0004874239,0.0009526609,0.00089796266],"domain_scores_gemma":[0.99250144,0.00007545832,0.00026554495,0.0007817542,0.002288908,0.0040869038],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004200646,0.00031615488,0.0012871815,0.00050517067,0.00024780573,0.000038248447,0.0003734426,0.00041397626,0.000028692051],"category_scores_gemma":[0.0074797818,0.00026943674,0.00048691247,0.0005098891,0.00020650431,0.00019977031,0.00008996162,0.0009197032,0.00007092629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00562086,0.0001538717,0.005812394,0.00044175904,0.004146454,0.0041349884,0.0026913376,0.0015513677,0.0053965314,0.00019293513,0.093070924,0.8767866],"study_design_scores_gemma":[0.0029027371,0.0037454457,0.0470061,0.00048827767,0.00044535063,0.01677453,0.0004515741,0.00011427057,0.003708331,0.000015932155,0.92383593,0.0005115402],"about_ca_topic_score_codex":0.009764291,"about_ca_topic_score_gemma":0.00587173,"teacher_disagreement_score":0.87627506,"about_ca_system_score_codex":0.00057113287,"about_ca_system_score_gemma":0.003966861,"threshold_uncertainty_score":0.9999758},"labels":[],"label_agreement":null},{"id":"W4232533377","doi":"10.1055/s-0031-1276379","title":"C-Reactive Protein and Cardiovascular Diseases","year":2003,"lang":"en","type":"article","venue":"International Journal of Angiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Angiology; C-reactive protein; Internal medicine; Cardiology; Inflammation","score_opus":0.009723507469075887,"score_gpt":0.2646980286925443,"score_spread":0.25497452122346836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232533377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832426,0.011968585,0.0018643897,0.00076381315,0.0004257994,0.00016518914,0.0000046170094,0.000006523421,0.0015584902],"genre_scores_gemma":[0.9980188,0.00017186368,0.0009945885,0.00024805573,0.0004871031,0.0000044818526,0.0000021771982,0.000007984949,0.00006494545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991149,0.00011221491,0.0002176639,0.00010106028,0.00035088038,0.00010329218],"domain_scores_gemma":[0.9992359,0.000023673214,0.00009563008,0.00012169153,0.0004022991,0.00012078589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004029493,0.000071359565,0.00032271995,0.00012535093,0.00001924065,0.000008974172,0.000065637694,0.00005301484,0.000049912935],"category_scores_gemma":[0.0003316846,0.00005284123,0.00045271125,0.00003980574,0.000060574013,0.00006813554,0.000015249966,0.0001342332,0.0000039587576],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048621884,0.0022422774,0.37568218,0.00034281707,0.0785029,0.016902912,0.0015720312,0.0002587439,0.03692062,0.08133205,0.0046891696,0.39669213],"study_design_scores_gemma":[0.014250602,0.0029078384,0.35185808,0.00051241106,0.0019124374,0.050600357,0.00097599556,0.00002727997,0.017122254,0.010777024,0.54856646,0.0004892545],"about_ca_topic_score_codex":0.000020579684,"about_ca_topic_score_gemma":6.1856724e-7,"teacher_disagreement_score":0.5438773,"about_ca_system_score_codex":0.00004709233,"about_ca_system_score_gemma":0.00015768033,"threshold_uncertainty_score":0.21548028},"labels":[],"label_agreement":null},{"id":"W4233571514","doi":"10.2165/00128415-200510740-00004","title":"Health Canada has received 19 reports of amnesia suspected to be associated with statins,","year":2005,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Amnesia; Medicine; Psychology; Psychiatry","score_opus":0.02141692787412219,"score_gpt":0.2643564101203471,"score_spread":0.2429394822462249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233571514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91704065,0.00039769633,0.0003553403,0.07831069,0.00015217774,0.0011989073,0.00006012467,0.00012854968,0.0023558827],"genre_scores_gemma":[0.99315065,0.000069096524,0.0017220587,0.0022346133,0.00014875022,0.000038625178,0.00017550531,0.000033559707,0.002427114],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980413,0.00010117576,0.00053364935,0.00029746688,0.00068254693,0.000343882],"domain_scores_gemma":[0.99821514,0.00004959555,0.00032228857,0.0006155047,0.00032270345,0.00047479742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055324734,0.00014595348,0.00053115695,0.00012398181,0.00019648366,0.000011877636,0.00004145571,0.000060617487,0.00006209422],"category_scores_gemma":[0.0003872422,0.00012364231,0.000090268804,0.000603728,0.00003267433,0.000057150522,0.000011972913,0.00022388418,0.0000024464896],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071922207,0.0024550392,0.054793067,0.0009393911,0.003676807,0.0011764397,0.00312748,0.001897732,0.007228934,0.00035132084,0.8510699,0.072564624],"study_design_scores_gemma":[0.0012106854,0.00062442,0.38325116,0.00027830258,0.00013393397,0.00064111996,0.00071285537,0.00004288987,0.00088610593,0.000005437705,0.6120167,0.00019643853],"about_ca_topic_score_codex":0.7880849,"about_ca_topic_score_gemma":0.8867607,"teacher_disagreement_score":0.3284581,"about_ca_system_score_codex":0.001552793,"about_ca_system_score_gemma":0.006483178,"threshold_uncertainty_score":0.99914914},"labels":[],"label_agreement":null},{"id":"W4233907022","doi":"10.1016/s0828-282x(10)71102-8","title":"Canadian Society for Atherosclerosis, Thrombosis and Vascular Biology (CSATVB) CSATVB140 Oral: Pathophysiology and Remodeling in Cardiovascular Disease Sunday, October 24, 2010","year":2010,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pathophysiology; Thrombosis; Disease; Atherosclerotic cardiovascular disease; Internal medicine; Cardiology","score_opus":0.028775642710376546,"score_gpt":0.2593508746241642,"score_spread":0.23057523191378762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233907022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98014617,0.012749211,0.001570514,0.002799375,0.0016459263,0.00083243183,0.00014957805,0.000010492242,0.0000962982],"genre_scores_gemma":[0.9889307,0.0053533134,0.0030327372,0.0011473632,0.001377181,0.000038490554,0.00003916811,0.000065267115,0.000015769188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746966,0.00026525866,0.0005921617,0.0005423937,0.0001711142,0.0009593879],"domain_scores_gemma":[0.99636924,0.00008692877,0.00013134588,0.0007052273,0.00036040487,0.0023468696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023672532,0.00032759577,0.0016166593,0.00043936205,0.00026898462,0.000035389745,0.00018500218,0.00059711863,0.000013492872],"category_scores_gemma":[0.0003420983,0.00029038065,0.0014979597,0.00020199874,0.00047820245,0.000111450434,0.000032150165,0.0009228946,0.0000014494393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018436884,0.000026573613,0.8811111,0.0007319006,0.010802402,0.0001746869,0.0011722447,0.0021866295,0.015068666,0.0017651941,0.009030279,0.077746],"study_design_scores_gemma":[0.004331388,0.00043775016,0.64464873,0.00012179963,0.0016197831,0.0003425296,0.00023596881,0.00043556213,0.000024593372,0.00210827,0.3451947,0.0004988963],"about_ca_topic_score_codex":0.18394738,"about_ca_topic_score_gemma":0.18665475,"teacher_disagreement_score":0.3361644,"about_ca_system_score_codex":0.0003001069,"about_ca_system_score_gemma":0.0035985343,"threshold_uncertainty_score":0.9999548},"labels":[],"label_agreement":null},{"id":"W4234150897","doi":"10.7287/peerj.7856v0.1/reviews/2","title":"Peer Review #2 of \"The association between serum lipids and risk of premature mortality in Latin America: a systematic review of population-based prospective cohort studies (v0.1)\"","year":2019,"lang":"en","type":"review","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Imperial College London; International Seafood Sustainability Foundation; Wellcome Trust","keywords":"Medicine; Latin Americans; Association (psychology); Prospective cohort study; Demography; Internal medicine; Psychology; Political science; Sociology","score_opus":0.04027194503789803,"score_gpt":0.35686606956168004,"score_spread":0.316594124523782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234150897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021921138,0.97914284,0.000004372739,0.0002195767,0.00007295549,0.019811273,0.00030596196,0.000011664379,0.00021214834],"genre_scores_gemma":[0.00029603872,0.9980208,0.00011495619,0.00011954876,0.000068343885,0.0005092343,0.00018114966,0.00003279565,0.0006571034],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99242634,0.0019914894,0.0028834075,0.00041214813,0.0020961962,0.0001904133],"domain_scores_gemma":[0.991102,0.00057290203,0.004958888,0.0012729396,0.0020384155,0.000054898333],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00957422,0.0003912248,0.010834755,0.00011252302,0.00002828614,0.0000033918898,0.00015689428,0.00027785046,0.0000148042045],"category_scores_gemma":[0.01287043,0.00020924739,0.0014821995,0.0010109326,0.000051253683,0.00003922859,0.000080420454,0.0005192071,0.0000016184413],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000010336412,0.000031572406,0.25896883,0.7335549,0.004115412,1.964082e-7,0.000020919972,1.10418334e-7,5.070168e-9,0.0000078707935,0.0001450838,0.0031540543],"study_design_scores_gemma":[0.00023035739,0.000064103886,0.1723111,0.7817178,0.04314631,0.0000016561793,0.000016550825,0.000001184019,4.9879617e-7,0.000005543771,0.0023780982,0.00012680283],"about_ca_topic_score_codex":0.0008698909,"about_ca_topic_score_gemma":0.000053487744,"teacher_disagreement_score":0.08665773,"about_ca_system_score_codex":0.0005682724,"about_ca_system_score_gemma":0.00051385426,"threshold_uncertainty_score":0.9954446},"labels":[],"label_agreement":null},{"id":"W4234506504","doi":"10.1515/iupac.73.0345","title":"Hyperlipoproteinemia","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan College","funders":"","keywords":"Table (database); Commission; Product (mathematics); Food science; Chemistry; Biochemistry; Organic chemistry; Polymer science; Computer science; Political science; Mathematics; Data mining; Law","score_opus":0.013924249595217104,"score_gpt":0.38165614896828365,"score_spread":0.36773189937306655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234506504","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000235226,0.004628959,0.00013874452,0.0018625655,0.0007663281,0.0013209885,0.990719,0.00014079359,0.00018738647],"genre_scores_gemma":[0.000023584022,0.0035458428,0.00015452076,0.0011917207,0.0054383692,0.00007526703,0.9881258,0.00009336397,0.0013515055],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951422,0.00010605914,0.0006665642,0.00079324347,0.0025797803,0.00071210746],"domain_scores_gemma":[0.9959979,0.00003405033,0.00024383212,0.0024062542,0.00076465256,0.00055332924],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011194044,0.0006169369,0.0015212154,0.00028660413,0.00013217863,0.000037895923,0.00030044187,0.0007595511,0.0048096534],"category_scores_gemma":[0.0006512643,0.00041132246,0.00080335536,0.00026004756,0.00015675461,0.00006279816,0.00016715519,0.0009315042,0.000016008778],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033372917,0.00022239127,0.000006818691,0.00088655396,0.00044963742,0.00046797696,0.0000031424008,9.242262e-8,0.000022549875,0.000004906754,0.949424,0.048178166],"study_design_scores_gemma":[0.003101521,0.0006635519,0.00010013032,0.0014247532,0.0006485774,0.00045055704,0.000010436309,7.5017306e-7,0.00007348365,0.00004486261,0.99301064,0.0004707283],"about_ca_topic_score_codex":0.0006135665,"about_ca_topic_score_gemma":0.00029482387,"teacher_disagreement_score":0.047707435,"about_ca_system_score_codex":0.00080331473,"about_ca_system_score_gemma":0.0026931183,"threshold_uncertainty_score":0.9998339},"labels":[],"label_agreement":null},{"id":"W4234794799","doi":"10.4212/cjhp.v70i4.1691","title":"Should Patients Continue to Receive Statins Once They Reach 80 Years of Age? The “Con” Side: Correction","year":2017,"lang":"en","type":"erratum","venue":"The Canadian Journal of Hospital Pharmacy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.028253052995557814,"score_gpt":0.30762152189963426,"score_spread":0.27936846890407646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234794799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6885131,0.013191157,0.000034317116,0.030917661,0.17667967,0.0069109965,0.00096416834,0.000035150628,0.08275379],"genre_scores_gemma":[0.971531,0.0009719241,0.000039554245,0.0015163576,0.004545195,0.000017453774,0.000083619576,0.00009199659,0.021202935],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738187,0.00026453537,0.0006918331,0.00022521186,0.00095268583,0.00048384286],"domain_scores_gemma":[0.9961924,0.00008329299,0.001134959,0.0008444652,0.0009448452,0.0008000617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015573945,0.0002870391,0.00082607317,0.00022215919,0.00041786462,0.00012618533,0.000801654,0.00016023281,0.00006800981],"category_scores_gemma":[0.0011729106,0.00018139224,0.0005751238,0.00013482684,0.00022232236,0.00014078326,0.000046474932,0.002199693,0.000020811463],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013446384,0.000058550897,0.0014856581,0.00008190299,0.0007355611,0.0004411228,0.004509116,0.000015240259,0.000009320989,0.000009382458,0.876647,0.11587266],"study_design_scores_gemma":[0.0018852816,0.0011746744,0.06853738,0.0011946936,0.0007783328,0.00014405645,0.0005416574,0.000008352544,0.000101014506,0.00008575802,0.92529243,0.00025639267],"about_ca_topic_score_codex":0.13124296,"about_ca_topic_score_gemma":0.07543829,"teacher_disagreement_score":0.28301787,"about_ca_system_score_codex":0.00060253637,"about_ca_system_score_gemma":0.004455666,"threshold_uncertainty_score":0.95566934},"labels":[],"label_agreement":null},{"id":"W4236537247","doi":"10.2165/00128413-200313780-00008","title":"Statin therapy cost saving for prevention of CVD in Canada","year":2003,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Intensive care medicine; Family medicine","score_opus":0.03379908012347198,"score_gpt":0.31107448877685345,"score_spread":0.27727540865338146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236537247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945625,0.0014218376,0.001261184,0.00031104664,0.00016145076,0.0013708924,0.000017398941,0.000007142828,0.0008865275],"genre_scores_gemma":[0.9980907,0.0002141389,0.00094539666,0.00036793563,0.00005264428,0.00011119885,0.000013471813,0.000014488833,0.00019001895],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99915624,0.00007223721,0.00024379343,0.00012217299,0.0002243456,0.00018121292],"domain_scores_gemma":[0.9996044,0.00003570303,0.00006546158,0.00015624614,0.000069215035,0.00006896937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042736297,0.00007137804,0.00023324185,0.0000437184,0.000021224909,0.0000028272864,0.000033933848,0.000025008985,0.000091659706],"category_scores_gemma":[0.000061271,0.00006337949,0.00008525602,0.00012109294,0.000008822713,0.000033836797,0.000003727245,0.000081612074,0.0000010039712],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006710823,0.0004311844,0.06728333,0.0009397321,0.00034319347,0.000065268345,0.0006048677,0.00013475749,0.03290577,0.00088035857,0.007947645,0.8877928],"study_design_scores_gemma":[0.030238338,0.0010827561,0.3204204,0.00064121134,0.00014432003,0.000100512174,0.002258258,0.0005555141,0.27871913,0.0006453095,0.3646886,0.00050562405],"about_ca_topic_score_codex":0.36345375,"about_ca_topic_score_gemma":0.23098381,"teacher_disagreement_score":0.8872872,"about_ca_system_score_codex":0.00023772837,"about_ca_system_score_gemma":0.0012255345,"threshold_uncertainty_score":0.78304875},"labels":[],"label_agreement":null},{"id":"W4236788575","doi":"10.2165/00151234-200605110-00006","title":"Ezetimibe add-on to atorvastatin: evidence for adoption in Canada","year":2006,"lang":"en","type":"article","venue":"PharmacoEconomics & Outcomes News","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Ezetimibe; Quality of Life Research; Business; Public health; Medicine; Pharmacology; Statin; Internal medicine","score_opus":0.043245420535249504,"score_gpt":0.35861665981557744,"score_spread":0.31537123928032795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236788575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796742,0.00035176115,0.0005045249,0.016083281,0.0006567697,0.0018970496,0.00005486411,0.000029166176,0.00074838963],"genre_scores_gemma":[0.9547383,0.00014288802,0.0024800114,0.041213304,0.0005313449,0.00032256602,0.000034389406,0.000045671233,0.000491508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849653,0.00003781881,0.0004997107,0.0003801542,0.00017876927,0.00040698668],"domain_scores_gemma":[0.99908626,0.00018797192,0.00009625708,0.0003572484,0.000047148467,0.00022513517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037731446,0.00019898753,0.00051052734,0.00011532565,0.000049205548,0.000019767922,0.0001136052,0.00003750362,0.00010943309],"category_scores_gemma":[0.00006518225,0.0001881305,0.0002052655,0.000097168246,0.00000703048,0.00009969642,0.00002782335,0.00014805779,0.00004897036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017398852,0.00023692084,0.59811145,0.00059701834,0.0002614709,0.00008077617,0.00015878302,0.013759016,0.0011452832,0.00093850907,0.20184839,0.18112251],"study_design_scores_gemma":[0.009240512,0.00031606742,0.5623506,0.00024408063,0.00019805123,0.00002555738,0.00020298305,0.003064502,0.005029025,0.00015033915,0.41849735,0.00068096246],"about_ca_topic_score_codex":0.80401564,"about_ca_topic_score_gemma":0.7959099,"teacher_disagreement_score":0.21664897,"about_ca_system_score_codex":0.0016860733,"about_ca_system_score_gemma":0.0011559483,"threshold_uncertainty_score":0.76717395},"labels":[],"label_agreement":null},{"id":"W4237175380","doi":"10.1016/j.jvs.2011.04.002","title":"Reply","year":2011,"lang":"en","type":"article","venue":"Journal of Vascular Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University College London; York University; Cleveland Clinic","keywords":"Medicine; Scopus; Statin; Meta-regression; Meta-analysis; Guideline; Coronary heart disease; Internal medicine; Disease; Cholesterol; MEDLINE; Cardiology; Pathology","score_opus":0.039167531063342975,"score_gpt":0.2507837403701108,"score_spread":0.21161620930676783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237175380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98343164,0.009589302,0.001648687,0.00039317957,0.000888091,0.00014370633,4.9223434e-7,0.000022274615,0.0038826328],"genre_scores_gemma":[0.9921039,0.0020760014,0.0030054965,0.0016354433,0.0010265155,0.0000022670308,0.0000010186657,0.000029609426,0.000119797376],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99840385,0.00009790968,0.0005583105,0.00010311772,0.00063717045,0.00019963903],"domain_scores_gemma":[0.99868315,0.00004268981,0.0002583404,0.00044350937,0.00031929836,0.00025298496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028130035,0.000097782024,0.0006089928,0.00022633541,0.000035100344,0.0000071628306,0.000062793624,0.000060672177,0.00026346682],"category_scores_gemma":[0.00033168355,0.00007008932,0.0015644208,0.00018982921,0.000029762223,0.00011385386,0.000015822849,0.0002469851,0.000027698465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016139208,0.0022245068,0.40941373,0.0013496433,0.010376353,0.014584701,0.0021497377,0.0000052411865,0.0031305172,0.0005259378,0.09367377,0.46095195],"study_design_scores_gemma":[0.0019902333,0.0005271614,0.6038166,0.0007238371,0.0010809137,0.009756003,0.0002679232,0.000008511891,0.009114181,0.00036741394,0.37204015,0.00030702696],"about_ca_topic_score_codex":0.00008055068,"about_ca_topic_score_gemma":6.3664845e-7,"teacher_disagreement_score":0.46064493,"about_ca_system_score_codex":0.000045981542,"about_ca_system_score_gemma":0.00035893897,"threshold_uncertainty_score":0.2884777},"labels":[],"label_agreement":null},{"id":"W4237487324","doi":"10.3410/f.1164081.793483978","title":"Faculty Opinions recommendation of Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.","year":2013,"lang":"en","type":"dataset","venue":"Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Atorvastatin; Medicine; Secondary prevention; Internal medicine; Cardiology; Stroke (engine); Reduction (mathematics); Cholesterol; Ischemic stroke; Engineering; Ischemia","score_opus":0.02311259711583038,"score_gpt":0.31034532582735935,"score_spread":0.287232728711529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237487324","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01093527,0.0015738686,0.000017666194,0.009542774,0.0003652622,0.0067422283,0.9708118,0.000007402777,0.000003734527],"genre_scores_gemma":[0.00695628,0.00096767885,0.00012450785,0.00018772665,0.00008727906,0.0007783049,0.9907788,0.000026064343,0.00009333347],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920095,0.0023652636,0.002243718,0.00064427895,0.0024409392,0.00029627897],"domain_scores_gemma":[0.99007773,0.00008719331,0.004061519,0.0021637043,0.0034704164,0.00013942775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035608297,0.00045186494,0.0019748285,0.00055849925,0.00012986072,0.000026618934,0.0008962161,0.00049233634,0.00007789682],"category_scores_gemma":[0.0027430826,0.00022618772,0.0019265679,0.0036826052,0.00033728834,0.00027038186,0.00024068182,0.0011726527,0.0000013142908],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038351258,0.0017401314,0.0019130334,0.006169248,0.007216789,3.7227455e-8,0.0005543246,0.000011856946,0.0000063156826,0.000003912535,0.973608,0.008392846],"study_design_scores_gemma":[0.012597898,0.00060656806,0.3924269,0.02039121,0.0051348833,0.0000044889116,0.00016658941,0.000007371205,0.00014277366,0.0000042278666,0.5682624,0.0002546955],"about_ca_topic_score_codex":0.0010704902,"about_ca_topic_score_gemma":0.000037892365,"teacher_disagreement_score":0.4053456,"about_ca_system_score_codex":0.00021047059,"about_ca_system_score_gemma":0.0007127652,"threshold_uncertainty_score":0.92236674},"labels":[],"label_agreement":null},{"id":"W4237568352","doi":"10.32388/d29q7b","title":"Hypoalphalipoproteinemia","year":2020,"lang":"en","type":"article","venue":"Definitions","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Shaughnessy Hospital","funders":"","keywords":"Computer science; World Wide Web","score_opus":0.0828571062868596,"score_gpt":0.266970848946459,"score_spread":0.1841137426595994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237568352","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43411967,0.002934972,0.012986069,0.10043714,0.00025825071,0.0018968742,0.00013847018,0.0010528639,0.4461757],"genre_scores_gemma":[0.98738384,0.00011084906,0.0040866886,0.0076686596,0.0005471029,0.000062554514,0.000058588805,0.000016841306,0.00006485628],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99935216,0.000017557766,0.00012543112,0.00015243611,0.00020651837,0.00014592025],"domain_scores_gemma":[0.99944293,0.000009308502,0.000017824072,0.000221242,0.000049892988,0.00025880555],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000642094,0.00006983415,0.000166154,0.00002425819,0.00007713593,0.000009417465,0.000033004868,0.00004503124,0.00043441786],"category_scores_gemma":[0.00010490329,0.0000618744,0.00016915958,0.0002068212,0.000025833628,0.000031095733,0.000017488625,0.00014047067,0.0007878647],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006453236,0.0012290179,0.010702313,0.0021206369,0.0016518622,0.0020988493,0.0030404544,0.00003953928,0.03927341,0.55871844,0.15668711,0.22379301],"study_design_scores_gemma":[0.009858426,0.0018917035,0.10491055,0.00024771108,0.0009812821,0.0014607658,0.0007723902,0.0005590511,0.019072419,0.012170098,0.84714514,0.00093047257],"about_ca_topic_score_codex":0.000034703568,"about_ca_topic_score_gemma":0.0000017841433,"teacher_disagreement_score":0.690458,"about_ca_system_score_codex":0.00001582469,"about_ca_system_score_gemma":0.00008723247,"threshold_uncertainty_score":0.99999017},"labels":[],"label_agreement":null},{"id":"W4238264197","doi":"10.1016/j.jcjd.2013.02.024","title":"Dyslipidemia","year":2013,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Obesity","score_opus":0.010168310992302743,"score_gpt":0.21841310456630655,"score_spread":0.2082447935740038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238264197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882437,0.0036948405,0.000008563946,0.0034796968,0.00030733887,0.00013995949,0.0000017485104,0.0000037548432,0.00412037],"genre_scores_gemma":[0.9967979,0.000006609245,0.00042409502,0.001790486,0.00072096096,0.0000032245264,0.0000010912942,0.000012383367,0.00024324463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922377,0.000029413906,0.00023831577,0.0000582111,0.00015825342,0.00029201302],"domain_scores_gemma":[0.9983397,0.000018209876,0.00007980063,0.0001734649,0.00025695132,0.0011318442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035258653,0.000067597415,0.00027526886,0.00016792628,0.000050486073,0.000027216145,0.0000739404,0.000057716512,0.0008445513],"category_scores_gemma":[0.00020738381,0.000051034243,0.00020175171,0.00010713245,0.000042167678,0.000106054256,0.000002871964,0.00020214578,0.00010904448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000011728348,0.00001649342,0.7835115,0.00014580801,0.0004268606,0.00005500003,0.00018842302,0.0000061215014,0.0013641769,0.00025065104,0.08049746,0.13353632],"study_design_scores_gemma":[0.0008821969,0.00033134397,0.8993115,0.00023033995,0.00012003062,0.000050800187,0.00013469139,0.000024080502,0.0011657119,0.0006044286,0.09702871,0.000116167736],"about_ca_topic_score_codex":0.0014363314,"about_ca_topic_score_gemma":0.00081126735,"teacher_disagreement_score":0.13342015,"about_ca_system_score_codex":0.00010763988,"about_ca_system_score_gemma":0.0011911781,"threshold_uncertainty_score":0.92472446},"labels":[],"label_agreement":null},{"id":"W4238313864","doi":"10.1097/hco.0000000000000273","title":"Editorial introductions","year":2016,"lang":"en","type":"article","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gold medal; Section (typography); Library science; Art history; History","score_opus":0.03933644072220536,"score_gpt":0.3440801647201583,"score_spread":0.3047437239979529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238313864","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076589165,0.0069005094,0.0039329985,0.003486647,0.97667634,0.00051421404,0.000016718493,0.00007822616,0.00073543284],"genre_scores_gemma":[0.11544034,0.007309511,0.00007610812,0.000020252532,0.8769242,0.00013156325,0.00002918053,0.000016965918,0.000051886873],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988979,0.00013249442,0.00022273157,0.0002875819,0.00020766232,0.00025164784],"domain_scores_gemma":[0.99932426,0.00003960081,0.000031602853,0.00041489108,0.000092964336,0.000096678246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046241068,0.000094494426,0.00035917165,0.000119636185,0.000029839946,0.0000024331443,0.000054495682,0.00012009395,0.000037454156],"category_scores_gemma":[0.00022716224,0.000060199516,0.00020104117,0.00013721987,0.00007905828,0.000041718144,0.000038324877,0.00018922606,0.00011194765],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102422906,0.000046295456,0.020117825,0.00010980298,0.00006916262,5.9586796e-7,0.000022926348,0.000004369399,0.00041464416,0.001431868,0.7644949,0.21318518],"study_design_scores_gemma":[0.0017509533,0.000109417604,0.035837684,0.00011650462,0.000013708409,0.00009236813,0.0000101794185,8.4717817e-7,0.000017398592,0.00029669257,0.96167934,0.00007491392],"about_ca_topic_score_codex":0.000011781493,"about_ca_topic_score_gemma":5.1206445e-7,"teacher_disagreement_score":0.21311025,"about_ca_system_score_codex":0.00012873774,"about_ca_system_score_gemma":0.0001487829,"threshold_uncertainty_score":0.2454865},"labels":[],"label_agreement":null},{"id":"W4239199806","doi":"10.1002/14651858.cd012282","title":"Fluvastatin for lowering lipids","year":2016,"lang":"en","type":"article","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"","keywords":"Fluvastatin; Medicine; Cholesterol; Adverse effect; Cholesterol lowering; Lipoprotein; Pharmacology; Internal medicine; Simvastatin","score_opus":0.06768039613674054,"score_gpt":0.3488764358497081,"score_spread":0.2811960397129676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239199806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011539649,0.55142444,0.40246847,0.00083577016,0.00090992695,0.030512998,0.0006364352,0.00010855267,0.0015637346],"genre_scores_gemma":[0.37214017,0.49693912,0.10358247,0.0014763713,0.0036657033,0.015016353,0.0007727447,0.0003759408,0.0060311304],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99745286,0.00020281768,0.0013924168,0.00027863603,0.00043241226,0.0002408607],"domain_scores_gemma":[0.9972295,0.00035354047,0.0004673352,0.0015763714,0.00021247387,0.0001607816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004945726,0.00019032082,0.0019873441,0.00007772748,0.00004032061,0.000007326844,0.00014296066,0.00004453952,0.000115960924],"category_scores_gemma":[0.0036533456,0.00009383178,0.00058914674,0.00013829078,0.000040974355,0.00010126362,0.000039662547,0.00004807364,0.00013551897],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004204775,0.000060645572,0.000021924887,0.96812195,0.00012905076,0.0000073148626,0.00006982345,4.167793e-8,0.019979939,0.0003417284,0.0023146376,0.008910872],"study_design_scores_gemma":[0.0034590978,0.00035336925,0.000056683115,0.96664125,0.0011095088,0.00025826955,0.00011536586,0.000030447594,0.0123512745,0.000026168425,0.015329142,0.0002694458],"about_ca_topic_score_codex":0.000015954909,"about_ca_topic_score_gemma":0.0000029259609,"teacher_disagreement_score":0.36060053,"about_ca_system_score_codex":0.000048839618,"about_ca_system_score_gemma":0.00008448903,"threshold_uncertainty_score":0.43736598},"labels":[],"label_agreement":null},{"id":"W4240464449","doi":"10.1016/s0140-6736(09)61231-9","title":"Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial","year":2009,"lang":"en","type":"letter","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre","funders":"","keywords":"Rosuvastatin; C-reactive protein; Medicine; Apolipoprotein B; Cholesterol; Internal medicine; Ldl cholesterol; Placebo; Randomized controlled trial; Gastroenterology; Inflammation; Pathology; Alternative medicine","score_opus":0.02719776881527712,"score_gpt":0.2777426699662309,"score_spread":0.2505449011509538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240464449","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033015244,0.0018235387,0.000041839627,0.9544386,0.0002958849,0.0057168673,0.00004662109,0.00007967994,0.004541709],"genre_scores_gemma":[0.009093673,0.00024772657,0.0001564945,0.9335979,0.052077454,0.0006194873,0.00012189874,0.00007365346,0.004011714],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973791,0.0006047947,0.00034740227,0.00040752042,0.0007409636,0.0005202208],"domain_scores_gemma":[0.9978323,0.00012934707,0.00023342283,0.0016541727,0.00008907776,0.00006165825],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016658672,0.00034669583,0.0013932484,0.00004647994,0.00018022639,0.00012085305,0.00032528944,0.0003933066,0.000034377827],"category_scores_gemma":[0.00013915043,0.00015188055,0.0003843903,0.00010897969,0.0003135234,0.000051841205,0.00007556591,0.0026041425,0.000043726515],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019734608,0.00003286632,0.000009097743,0.00036033426,0.0006096212,0.00015931169,0.0007660507,1.9832207e-7,0.000022069737,0.000103352286,0.954014,0.02418849],"study_design_scores_gemma":[0.07489426,0.00038773843,0.0007054453,0.00030341247,0.0004565669,0.00021146843,0.00002520922,0.0000048621187,0.00004151299,0.0009912959,0.9217943,0.00018394498],"about_ca_topic_score_codex":0.0002781856,"about_ca_topic_score_gemma":0.000009411444,"teacher_disagreement_score":0.05515965,"about_ca_system_score_codex":0.00005733703,"about_ca_system_score_gemma":0.00013190733,"threshold_uncertainty_score":0.9996969},"labels":[],"label_agreement":null},{"id":"W4242258105","doi":"10.1016/j.atherosclerosissup.2018.04.074","title":"Apolipoprotein C-III Inhibition with Volanesorsen in Patients with Hypertriglyceridemia (COMPASS): a Randomized, Double-Blind, Placebo-controlled Trial","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Lipoprotein(a); Hypertriglyceridemia; Internal medicine; Mendelian randomization; Lipoprotein; Diabetes mellitus; Apolipoprotein B; Randomized controlled trial; Gemfibrozil; Cholesterol; Endocrinology; Triglyceride","score_opus":0.019625870823902686,"score_gpt":0.26178063141888624,"score_spread":0.24215476059498356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242258105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97238535,0.000034737695,0.00037453067,0.00033060467,0.0001957066,0.025938053,0.000030390762,0.00009849771,0.0006121468],"genre_scores_gemma":[0.99177766,0.000026191437,0.001014445,0.0004576481,0.0007160532,0.0053394674,0.000322761,0.000113277325,0.00023250723],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99532187,0.00039928945,0.0011090644,0.00081165374,0.00148656,0.00087155815],"domain_scores_gemma":[0.9978714,0.00008579981,0.00043621726,0.0009150084,0.0003623593,0.00032923746],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018260723,0.0005636713,0.0021791297,0.00032886918,0.00023366736,0.000079542115,0.00015504012,0.00022832402,0.0005735363],"category_scores_gemma":[0.0000580608,0.00035422662,0.00040980836,0.0005588935,0.00029713125,0.0002585263,0.00007247244,0.00039061572,0.00007614862],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9791162,0.001066213,0.017630732,0.00005269383,0.0008044697,0.000006242517,0.00032498522,0.0000037077361,0.000098739794,0.000046035242,0.0002549414,0.0005950577],"study_design_scores_gemma":[0.9862103,0.0045585143,0.005947421,0.00042051886,0.00065265596,0.0000069641205,0.00009214582,0.00007861604,0.0010688449,0.000016640906,0.00052399206,0.00042340136],"about_ca_topic_score_codex":0.0038753913,"about_ca_topic_score_gemma":0.0011407286,"teacher_disagreement_score":0.020598585,"about_ca_system_score_codex":0.00032361946,"about_ca_system_score_gemma":0.0002740943,"threshold_uncertainty_score":0.999891},"labels":[],"label_agreement":null},{"id":"W4242265478","doi":"10.5489/cuaj.722","title":"La mesure de l’APS demeure essentielle","year":2013,"lang":"fr","type":"article","venue":"Canadian Urological Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Physics","score_opus":0.008184049819751018,"score_gpt":0.22285921782083898,"score_spread":0.21467516800108796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242265478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55251116,0.06279253,0.00089139165,0.3387812,0.0049292473,0.00087268703,0.00007412434,0.00005714373,0.039090518],"genre_scores_gemma":[0.96870935,0.0027737601,0.00035647416,0.011145967,0.0055152746,0.00002087362,0.000014424391,0.000029714594,0.0114341555],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99575245,0.0015121463,0.0004667838,0.00024165117,0.00063343096,0.0013935071],"domain_scores_gemma":[0.9962453,0.00022755246,0.00026460842,0.00021180665,0.00046373712,0.0025869485],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.004131316,0.0002191961,0.0004621525,0.00015218156,0.00046452836,0.00025706372,0.0001883879,0.0010862676,0.010074763],"category_scores_gemma":[0.0017508041,0.00019145398,0.00047543965,0.00029783093,0.000069386246,0.0001906604,0.000021814376,0.0020437657,0.0011444173],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010915224,0.000096272604,0.51533586,0.000060533115,0.00076441886,0.00080818025,0.00036982787,0.000089687055,0.000047304366,0.0016322874,0.38004297,0.10074172],"study_design_scores_gemma":[0.0007012195,0.00013341596,0.45693567,0.000052299503,0.00020001174,0.0012794659,0.00022895016,0.0002377015,0.0000071433847,0.0019794488,0.5381066,0.00013803379],"about_ca_topic_score_codex":0.02057145,"about_ca_topic_score_gemma":0.0016696961,"teacher_disagreement_score":0.41619822,"about_ca_system_score_codex":0.0030286266,"about_ca_system_score_gemma":0.0025705658,"threshold_uncertainty_score":0.9996333},"labels":[],"label_agreement":null},{"id":"W4242376011","doi":"10.1177/0141076809701002","title":"The Case for Statins: Has it Really been Made?","year":2004,"lang":"en","type":"article","venue":"Journal of the Royal Society of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Athabasca University","funders":"","keywords":"Computer science; World Wide Web; Data science; Medicine","score_opus":0.02723718966258624,"score_gpt":0.2949565682510145,"score_spread":0.26771937858842826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242376011","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22322689,0.013741926,0.0181244,0.7413744,0.001235558,0.0015347896,0.00001950555,0.000015658288,0.0007269082],"genre_scores_gemma":[0.9796585,0.001527783,0.0071990914,0.0065946607,0.0034871912,0.000010561123,0.0000020535774,0.000035927926,0.0014842595],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807435,0.000068797824,0.00070907536,0.0000997829,0.0008010213,0.00024695505],"domain_scores_gemma":[0.9981585,0.00019219484,0.00060313975,0.00037927058,0.0004857289,0.00018115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035521423,0.00012928483,0.0005400593,0.000017524422,0.00037964055,0.000009976031,0.00022968375,0.000093665185,0.000020834304],"category_scores_gemma":[0.0005257645,0.000055124256,0.00095560885,0.0001261867,0.00044750454,0.000030738338,0.000040654366,0.00043757126,6.606952e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001823412,0.0005769442,0.0006050202,0.002258502,0.0057166,0.0006996686,0.01733758,0.0020221274,0.0023454933,0.001662709,0.83018625,0.13476571],"study_design_scores_gemma":[0.07884718,0.013782652,0.019273842,0.0076205162,0.0063595017,0.02623873,0.04875417,0.0020344863,0.004816942,0.01211808,0.7795956,0.00055828586],"about_ca_topic_score_codex":0.0007368148,"about_ca_topic_score_gemma":0.000047673897,"teacher_disagreement_score":0.7564316,"about_ca_system_score_codex":0.00017692124,"about_ca_system_score_gemma":0.00057319424,"threshold_uncertainty_score":0.29199263},"labels":[],"label_agreement":null},{"id":"W4243122267","doi":"10.1161/str.32.suppl_1.362","title":"Clinical Characteristics of Coronary Heart Disease as Predictors of Ischemic Stroke: A Long-term Prospective Follow-up in the BIP Study.","year":2001,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Myocardial infarction; Cardiology; Stroke (engine); Angina; Canadian Cardiovascular Society; Unstable angina; Heart failure; Bezafibrate; Proportional hazards model; Confidence interval","score_opus":0.02025611363192697,"score_gpt":0.3163317446846769,"score_spread":0.2960756310527499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243122267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99600816,0.00051406363,0.00001670641,0.00020826481,0.0002833923,0.0021228418,0.000120134224,0.000019592977,0.000706834],"genre_scores_gemma":[0.99837714,0.00021085361,0.000025383504,0.00016657356,0.00041937438,0.000092766866,0.00003157337,0.000022084047,0.0006542756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977262,0.00023237099,0.00070360815,0.00032166485,0.0007465117,0.00026962577],"domain_scores_gemma":[0.9986051,0.00009366483,0.00018174497,0.0007871464,0.00014282728,0.00018952138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010797213,0.00016970883,0.000709666,0.000084926694,0.000037412898,0.000006492949,0.00016603249,0.00008815474,0.00005182587],"category_scores_gemma":[0.00032284178,0.00011753963,0.00040854767,0.00019088184,0.00015971062,0.00005201776,0.000065592234,0.00038825924,0.0000073396027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019148875,0.0013849264,0.99185264,0.00015109725,0.00029391164,0.00023966165,0.0004777669,1.6018188e-7,0.00026560438,0.000008342266,0.00016993078,0.0032410664],"study_design_scores_gemma":[0.004538527,0.0019089885,0.99175143,0.00014748446,0.00039944728,0.00004906514,0.00059466355,0.0000040113223,0.00009442182,0.000004357615,0.00041969292,0.00008792536],"about_ca_topic_score_codex":0.00015015362,"about_ca_topic_score_gemma":0.000036440906,"teacher_disagreement_score":0.003153141,"about_ca_system_score_codex":0.00005388875,"about_ca_system_score_gemma":0.00036891794,"threshold_uncertainty_score":0.4793127},"labels":[],"label_agreement":null},{"id":"W4243279716","doi":"10.2165/00128415-200410300-00003","title":"Rosuvastatin: more reports of rhabdomyolysis in Canada","year":2004,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Rhabdomyolysis; Medicine; Pharmacology; Internal medicine","score_opus":0.008883950284352281,"score_gpt":0.24309650966905227,"score_spread":0.23421255938469998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243279716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939758,0.00029174006,0.00030327565,0.002400822,0.00013288393,0.00026333568,0.0000053517156,0.000015929383,0.002610827],"genre_scores_gemma":[0.9985819,0.00007035606,0.00085505773,0.00012935563,0.00006386321,0.0000225082,0.000011365016,0.000011940888,0.0002536613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989374,0.000015039409,0.00036997406,0.00016287266,0.00035430942,0.00016039208],"domain_scores_gemma":[0.99924326,0.000013074598,0.00010681752,0.000457391,0.00007636885,0.00010306352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020516264,0.000074567935,0.00028666193,0.000101254445,0.00003136329,0.000002532778,0.000023583045,0.000035212197,0.00003107122],"category_scores_gemma":[0.00008580206,0.000067722016,0.000116332994,0.00036656827,0.00001973527,0.00004269435,0.0000096695885,0.00014589129,0.0000020377036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046359122,0.0027530557,0.50479084,0.0034012836,0.0024817549,0.016905446,0.0028193204,0.01980899,0.04498564,0.0021193193,0.009253728,0.390217],"study_design_scores_gemma":[0.0019629418,0.00012794462,0.94240594,0.0004026239,0.0001918118,0.0025169854,0.0021481959,0.000028440389,0.015245023,0.0002370477,0.034521144,0.0002119246],"about_ca_topic_score_codex":0.97131056,"about_ca_topic_score_gemma":0.7434758,"teacher_disagreement_score":0.43761507,"about_ca_system_score_codex":0.0007447531,"about_ca_system_score_gemma":0.0028326323,"threshold_uncertainty_score":0.50249684},"labels":[],"label_agreement":null},{"id":"W4243617676","doi":"10.3821/1913-701x-141.sp2.s17","title":"Lipid-Lowering Agents","year":2008,"lang":"fr","type":"article","venue":"Canadian Pharmacists Journal / Revue des Pharmaciens du Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Traditional medicine; Pharmacology; Chemistry","score_opus":0.05216489513675647,"score_gpt":0.28178614122383283,"score_spread":0.22962124608707635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243617676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8541869,0.08657399,0.00035040334,0.0011711322,0.044807736,0.0012619508,0.000950489,0.000066821936,0.010630587],"genre_scores_gemma":[0.83911556,0.12230946,0.00019520668,0.0066798734,0.017522039,0.000022648343,0.000042746356,0.00017194902,0.013940493],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9928758,0.0003929106,0.0012285293,0.00077335606,0.001432158,0.0032972551],"domain_scores_gemma":[0.9873621,0.00008319335,0.00037242187,0.0007263832,0.0009280283,0.010527895],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015883446,0.00081745407,0.0011171388,0.0006125852,0.0025311168,0.00017888886,0.000786805,0.00023680621,0.0066016824],"category_scores_gemma":[0.0003664494,0.00093352713,0.00078157213,0.001163748,0.00058099825,0.0006072165,0.000086566644,0.0021997937,0.00022785978],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000107277374,0.00010415572,0.0025668838,0.0010574312,0.001109395,0.57433087,0.0015867753,0.00097378984,0.0004200871,0.000027740774,0.15258457,0.265131],"study_design_scores_gemma":[0.0025463812,0.00006983431,0.0001225759,0.00014821993,0.0004065164,0.55909383,0.000012123326,0.0011840698,0.0010087084,0.000006755465,0.43484828,0.0005527056],"about_ca_topic_score_codex":0.22916369,"about_ca_topic_score_gemma":0.13489302,"teacher_disagreement_score":0.2822637,"about_ca_system_score_codex":0.012163295,"about_ca_system_score_gemma":0.026685234,"threshold_uncertainty_score":0.9993115},"labels":[],"label_agreement":null},{"id":"W4244165730","doi":"10.1002/14651858.cd008226","title":"Lipid lowering efficacy of atorvastatin","year":2010,"lang":"en","type":"reference-entry","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"","keywords":"Atorvastatin; Ldl cholesterol; Medicine; Cholesterol; Adverse effect; Internal medicine; Cholesterol lowering; Endocrinology","score_opus":0.06409800398709992,"score_gpt":0.34656170518647667,"score_spread":0.28246370119937675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244165730","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018893563,0.96117264,0.0014446909,0.000038983504,0.0020066486,0.015412498,0.0012221694,0.000047198137,0.01676582],"genre_scores_gemma":[0.0008686988,0.98736,0.0037756125,0.000054581993,0.0013315735,0.00057858374,0.0026084334,0.0001173253,0.0033051714],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99245995,0.00065994886,0.0042054146,0.0006373167,0.001633575,0.00040382126],"domain_scores_gemma":[0.9908909,0.0004985283,0.003160374,0.004612478,0.0005064477,0.00033126865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006164366,0.00064611185,0.008466353,0.00029730255,0.000047609454,0.000016308511,0.0005175129,0.000426311,0.00047134262],"category_scores_gemma":[0.005466405,0.00042356466,0.0017429338,0.00039821948,0.00012683394,0.00008311334,0.0001867561,0.00095553603,0.00019778141],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003597718,0.00020912982,0.000007950692,0.97019005,0.0004582634,0.00003420212,0.00009415957,7.6819305e-8,0.00016372358,0.000036569094,0.019340767,0.009429132],"study_design_scores_gemma":[0.0014958511,0.00017572494,0.000031870193,0.9324655,0.0033696373,0.0002816946,0.00005143163,0.0000064765154,0.00057385064,0.0000014647892,0.061207984,0.00033853858],"about_ca_topic_score_codex":0.00017312795,"about_ca_topic_score_gemma":0.000017297461,"teacher_disagreement_score":0.04186722,"about_ca_system_score_codex":0.00009063903,"about_ca_system_score_gemma":0.0006837383,"threshold_uncertainty_score":0.9998216},"labels":[],"label_agreement":null},{"id":"W4244620111","doi":"10.1093/eurheartj/ehaa166","title":"Editor's Note: Relates to: ‘Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease : Consensus Statement of the European Atherosclerosis Society ’","year":2020,"lang":"en","type":"erratum","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Coronary heart disease; Statement (logic); Consensus conference; Population; Intensive care medicine; Canadian Cardiovascular Society; Family medicine; Internal medicine; Myocardial infarction; Angina; Law","score_opus":0.044823489945678044,"score_gpt":0.3284954161258344,"score_spread":0.28367192618015635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244620111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60875386,0.0073021892,0.0007261903,0.32109267,0.045768436,0.01335034,0.0012016944,0.00013279464,0.0016718353],"genre_scores_gemma":[0.74038434,0.003708939,0.0080106035,0.14812298,0.08618452,0.00014328354,0.00040105722,0.00078266475,0.012261612],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99435407,0.0025496627,0.0011144733,0.00057656947,0.000932964,0.0004722687],"domain_scores_gemma":[0.9979902,0.00016759003,0.00031916713,0.00076670223,0.00019520037,0.00056116114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0037565557,0.00040425648,0.0007519544,0.00006529964,0.00040926257,0.000105127016,0.0003209282,0.00012190452,0.0000102522545],"category_scores_gemma":[0.00036361744,0.00026216565,0.00081961125,0.00027359353,0.0000965142,0.000043524135,0.00022560828,0.0014000493,0.000013912517],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026440163,0.00018265811,0.013889413,0.00027895885,0.00017347094,0.000053507312,0.0016253522,0.00016298758,0.000111163354,0.0000016513893,0.98198646,0.0012699717],"study_design_scores_gemma":[0.001429214,0.0006354386,0.63308525,0.0013872551,0.00027107148,0.00010448176,0.00020370026,0.000076494005,0.0000055712826,0.0000129597265,0.36259404,0.00019455589],"about_ca_topic_score_codex":0.00009619166,"about_ca_topic_score_gemma":0.000032559044,"teacher_disagreement_score":0.61939245,"about_ca_system_score_codex":0.0002813569,"about_ca_system_score_gemma":0.00050258153,"threshold_uncertainty_score":0.9999831},"labels":[],"label_agreement":null},{"id":"W4244848009","doi":"10.1161/circulationaha.110.967208","title":"Response to Letters Regarding Article, “Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia: Results From the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and Meta-Analysis of Women from Primary Prevention Trials”","year":2010,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"McGill University Health Centre; University of Pennsylvania; National Heart, Lung, and Blood Institute; McGill University; Brigham and Women's Hospital; Sanofi; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Amgen","keywords":"Medicine; Dyslipidemia; Primary prevention; C-reactive protein; Sensitivity (control systems); Primary (astronomy); Internal medicine; Cardiology; Inflammation; Disease","score_opus":0.14392563764948108,"score_gpt":0.36099674425831896,"score_spread":0.21707110660883788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244848009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86493194,0.0001068778,0.121550165,0.000493149,0.00006269332,0.012423914,0.0004197565,0.000011353773,1.6795838e-7],"genre_scores_gemma":[0.9859655,0.0000074421077,0.009795756,0.00004996337,0.000091302776,0.003438013,0.00061089464,0.000030798285,0.000010359977],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9913394,0.0049447515,0.0019450289,0.00059937034,0.0008784676,0.00029298034],"domain_scores_gemma":[0.99140304,0.0052740583,0.0017133171,0.0010180076,0.0005175878,0.00007397779],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.034471072,0.00023358362,0.0016443833,0.00029732287,0.00013373882,0.00003341366,0.0001158241,0.00013648519,0.000010235615],"category_scores_gemma":[0.007835951,0.00013439443,0.00088133774,0.000942797,0.00008392618,0.0004456173,0.00004134959,0.00025799757,8.648414e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41251147,0.0011171122,0.0017935283,0.00041078738,0.05926161,0.000001424218,0.0151717095,0.047714002,0.33607987,0.000025573425,0.000004353478,0.12590857],"study_design_scores_gemma":[0.03886469,0.0019058114,0.88507676,0.00023952928,0.051435795,0.0000011178671,0.0021216546,0.014521057,0.0052400497,0.0003758153,0.00002647768,0.00019124497],"about_ca_topic_score_codex":0.0027743038,"about_ca_topic_score_gemma":0.0015745193,"teacher_disagreement_score":0.88328326,"about_ca_system_score_codex":0.0004714043,"about_ca_system_score_gemma":0.00031098773,"threshold_uncertainty_score":0.9942152},"labels":[],"label_agreement":null},{"id":"W4245034157","doi":"10.21203/rs.3.rs-123414/v1","title":"Association of “Hypertriglyceridemic Waist” with Increased 5-Year Risk of Subclinical Atherosclerosis in a Multi-Ethnic Population: A Prospective Cohort Study","year":2020,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Ethnic group; Medicine; Prospective cohort study; Subclinical infection; Waist; Cohort; Waist–hip ratio; Internal medicine; Population; Demography; Body mass index; Environmental health; Political science","score_opus":0.09777553739484648,"score_gpt":0.41560944055570875,"score_spread":0.31783390316086224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245034157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98894423,0.0004395981,0.00007893529,0.00020062065,0.000041577474,0.009997503,0.00016790634,0.000041657688,0.00008795373],"genre_scores_gemma":[0.9968887,0.0009838502,0.0007635889,0.000009135105,0.00017292298,0.00091463304,0.00015221641,0.00006514849,0.000049784732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99179655,0.002684605,0.0010436876,0.00089910184,0.0031093142,0.00046673085],"domain_scores_gemma":[0.995908,0.00058263086,0.00062280666,0.0011376076,0.0014864026,0.0002625587],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010327206,0.00027376565,0.0017520095,0.0003907627,0.00007101997,0.000016669836,0.00023273246,0.0005079191,0.000048696435],"category_scores_gemma":[0.0055117006,0.00021763623,0.00046201234,0.0011812383,0.00010968823,0.000046491245,0.0004012333,0.0027660325,0.000007761641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018447653,0.0016597431,0.9918618,0.0016738016,0.001411887,0.00002069936,0.0009786284,0.000059202583,0.00008833796,0.0000065931335,0.000022669505,0.0003718753],"study_design_scores_gemma":[0.007494929,0.0024431825,0.9860204,0.0015267372,0.00048129595,0.0000015350292,0.0011123338,0.00055305206,0.00012622174,0.00006805548,0.0000060876055,0.0001662035],"about_ca_topic_score_codex":0.04657899,"about_ca_topic_score_gemma":0.0038992674,"teacher_disagreement_score":0.042679723,"about_ca_system_score_codex":0.0013584117,"about_ca_system_score_gemma":0.0011351,"threshold_uncertainty_score":0.9995346},"labels":[],"label_agreement":null},{"id":"W4245451219","doi":"10.26419/pia.00094.001","title":"The Real Deal on Brain Health Supplements: GCBH Recommendations on Vitamins, Minerals, and Other Dietary Supplements","year":2019,"lang":"en","type":"report","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Food science; Medicine; Chemistry","score_opus":0.06056603534468163,"score_gpt":0.3747733820647457,"score_spread":0.31420734672006406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245451219","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015499614,0.010319252,0.00019054873,0.4499921,0.007745135,0.024201019,0.009495997,0.00051599654,0.48204035],"genre_scores_gemma":[0.026489459,0.24982321,0.003992461,0.1422633,0.011014979,0.0016839608,0.036594782,0.001023051,0.5271148],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951089,0.00043760816,0.0010313271,0.00076659926,0.0018226577,0.00083287887],"domain_scores_gemma":[0.9970368,0.00036712328,0.00043690845,0.0015562841,0.00019216671,0.0004106893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041814526,0.0005545293,0.0011153262,0.00022081753,0.0004805746,0.00007433993,0.00019078827,0.0002832922,0.00084261724],"category_scores_gemma":[0.00016385177,0.00034361938,0.00042296568,0.00015391495,0.00006437597,0.000047833706,0.0001257248,0.00077726116,0.00010311509],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012915643,0.00021613778,0.0018604565,0.0005039732,0.000813105,0.000011181409,0.00008486475,3.8386514e-7,0.0000051499087,0.00038625384,0.8704059,0.12558341],"study_design_scores_gemma":[0.0022540963,0.0021403886,0.0057596266,0.00064816495,0.00014632441,0.00007405765,0.00035519202,0.000005994656,0.000014997913,0.000024980583,0.9882755,0.0003006453],"about_ca_topic_score_codex":0.021062722,"about_ca_topic_score_gemma":0.005572252,"teacher_disagreement_score":0.3077288,"about_ca_system_score_codex":0.00090462633,"about_ca_system_score_gemma":0.0020717012,"threshold_uncertainty_score":0.9999016},"labels":[],"label_agreement":null},{"id":"W4245557636","doi":"10.1002/14651858.cd009753","title":"Fibrates for primary prevention of cardiovascular disease events","year":2012,"lang":"en","type":"reference-entry","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Placebo; Primary care; Harm; Disease; Primary prevention; Intensive care medicine; Protocol (science); Internal medicine; Pharmacology; Alternative medicine; Family medicine; Psychology; Pathology","score_opus":0.07942039628314511,"score_gpt":0.34018852564230034,"score_spread":0.2607681293591552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245557636","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020376741,0.9635243,0.007385581,0.000016729122,0.00071940816,0.023794431,0.0025351965,0.000019094268,0.0018015235],"genre_scores_gemma":[0.00035439886,0.97416246,0.0033029295,0.000028608589,0.000994775,0.0035601794,0.012645829,0.00010271254,0.0048480975],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9926038,0.0012414828,0.003304877,0.00062232703,0.0017914671,0.00043609343],"domain_scores_gemma":[0.9920989,0.00024833856,0.00225384,0.004394265,0.0005713695,0.00043326252],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007704271,0.00061692577,0.008118323,0.00024147039,0.00005632971,0.000009096499,0.0003776374,0.0002736628,0.00012550602],"category_scores_gemma":[0.0020741578,0.00041744168,0.005189941,0.0002774381,0.00006425022,0.00018251763,0.00014189501,0.0002717807,0.000061934465],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097104465,0.0003160638,0.00002263585,0.97454983,0.003934469,0.0000068438385,0.000028236227,9.3851645e-7,0.0000071869313,0.000039214807,0.009314238,0.011683252],"study_design_scores_gemma":[0.0017194886,0.00018824152,0.000112983376,0.88493466,0.03147115,0.0000593482,0.00002848859,0.000010020397,0.00006692521,0.00002437367,0.081013836,0.00037045218],"about_ca_topic_score_codex":0.000054102587,"about_ca_topic_score_gemma":8.866731e-7,"teacher_disagreement_score":0.08961513,"about_ca_system_score_codex":0.00015826356,"about_ca_system_score_gemma":0.00080465584,"threshold_uncertainty_score":0.99982774},"labels":[],"label_agreement":null},{"id":"W4245684639","doi":"10.1016/j.cjca.2017.06.010","title":"President's Page","year":2017,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Canadian Cardiovascular Society","funders":"","keywords":"Delegate; Medicine; Session (web analytics); Human immunodeficiency virus (HIV); Summit; Medical education; Public relations; Family medicine","score_opus":0.02314838038528477,"score_gpt":0.2702454415351988,"score_spread":0.24709706114991403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245684639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8175521,0.006766357,0.0023079729,0.009732133,0.0031242222,0.0003713996,0.00001620591,0.000008703242,0.16012092],"genre_scores_gemma":[0.9957278,0.00015540599,0.00015356728,0.00027357994,0.0032763002,0.0000014209818,0.0000010186403,0.000011438831,0.00039948337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992116,0.00006735772,0.00022195891,0.00008685974,0.00013954684,0.00027269326],"domain_scores_gemma":[0.9982226,0.000011142126,0.00017519588,0.00059940555,0.00021125635,0.0007804377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006829199,0.00007407855,0.0004849502,0.00012811173,0.0002365253,0.000038042945,0.0002127958,0.000107776774,0.000035467354],"category_scores_gemma":[0.00045296716,0.000059235397,0.00038968743,0.000019185607,0.00015364922,0.00008198024,0.000011522938,0.000259143,0.000018967507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021211781,0.0000046128516,0.66178495,0.00018549968,0.0026795112,0.015616831,0.00030548222,0.00017111264,0.00092693424,0.0021435835,0.145744,0.17022535],"study_design_scores_gemma":[0.0008711471,0.00020146371,0.53806394,0.000046299367,0.00014360975,0.004244679,0.00003717922,0.0000012950967,0.0001093282,0.0002471391,0.45597756,0.00005635404],"about_ca_topic_score_codex":0.0033103598,"about_ca_topic_score_gemma":0.001682713,"teacher_disagreement_score":0.31023356,"about_ca_system_score_codex":0.00010379883,"about_ca_system_score_gemma":0.0018467818,"threshold_uncertainty_score":0.5004296},"labels":[],"label_agreement":null},{"id":"W4248050824","doi":"10.21203/rs.3.rs-26729/v1","title":"Blood Lipid Levels in Patients with Osteopenia and Osteoporosis: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Research Square (Research Square)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteopenia; Meta-analysis; Medicine; Cochrane Library; Osteoporosis; Internal medicine; Confidence interval; Inclusion and exclusion criteria; Lipid profile; Publication bias; Cholesterol; Bone mineral; Pathology; Alternative medicine","score_opus":0.1606539769606792,"score_gpt":0.4308234503086947,"score_spread":0.27016947334801544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248050824","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000103523096,0.9624791,0.0000051890383,0.0010641862,0.000012651624,0.035542704,0.0005485679,0.00006319353,0.00018087517],"genre_scores_gemma":[0.0012633293,0.9888932,0.0001803627,0.00015793466,0.00013638614,0.008214215,0.0003856311,0.00023830702,0.00053063635],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9698245,0.013835458,0.0025034992,0.002625384,0.008833573,0.0023776148],"domain_scores_gemma":[0.98881555,0.0022139598,0.0004869999,0.0034230007,0.0030645414,0.0019959663],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.026811529,0.0012339565,0.019238204,0.0037124578,0.00055332686,0.0004662794,0.0009197394,0.000684964,0.00051499193],"category_scores_gemma":[0.0043673594,0.0007408273,0.0030446663,0.01145261,0.0006963923,0.00031997656,0.0012795214,0.0050890357,0.00015077635],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005638369,0.00040410456,0.00010904792,0.8886243,0.095086075,0.00035087205,0.00026610395,9.187235e-8,4.3781604e-8,0.00002976227,0.00020535373,0.014867847],"study_design_scores_gemma":[0.0026948538,0.0039075282,0.0005504429,0.24021365,0.6918104,0.00014656426,0.00042481264,0.0000041141084,6.80519e-7,0.000011749154,0.059302893,0.0009322657],"about_ca_topic_score_codex":0.0011010166,"about_ca_topic_score_gemma":0.0003600066,"teacher_disagreement_score":0.6484107,"about_ca_system_score_codex":0.00063791295,"about_ca_system_score_gemma":0.0026126641,"threshold_uncertainty_score":0.99950427},"labels":[],"label_agreement":null},{"id":"W4248123634","doi":"10.1101/2021.09.09.21263362","title":"Study of effect modifiers of genetically predicted CETP reduction","year":2021,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Fonds de Recherche du Québec - Santé; Pfizer; Institut de Cardiologie de Montréal; Institut de Valorisation des Données; Canadian Institutes of Health Research; Genome Canada; Université de Montréal","keywords":"Biobank; Body mass index; Cholesterol; Observational study; Medicine; Internal medicine; Bioinformatics; Endocrinology; Biology","score_opus":0.02114662843152322,"score_gpt":0.2873898180725094,"score_spread":0.2662431896409862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248123634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480087,0.0012401039,0.0003138368,0.000060307073,0.0006879599,0.002357828,0.000011598241,0.00004169703,0.0004857865],"genre_scores_gemma":[0.9986304,0.00025890232,0.00048234878,0.000008790188,0.0003300404,0.00013611466,0.000060313567,0.000037321028,0.000055784396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972311,0.00048171173,0.00064439,0.00051455427,0.00092791376,0.00020029771],"domain_scores_gemma":[0.99776447,0.000027725704,0.00025446946,0.0014252702,0.00037439517,0.00015369832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011025048,0.00022996854,0.0011922922,0.0001584991,0.000024369083,0.0000073246183,0.00014552461,0.0002966846,0.00004346715],"category_scores_gemma":[0.0002557329,0.00019166862,0.00046659092,0.00023495658,0.00008038796,0.0000143017705,0.00023815004,0.00056911336,9.0305195e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034663144,0.011829385,0.582835,0.042274788,0.021026181,0.0011425485,0.018414633,0.0061571477,0.16870666,0.000052486368,0.0004656583,0.14362918],"study_design_scores_gemma":[0.0061328397,0.0054110545,0.88512886,0.001698753,0.0035207917,0.00015960641,0.001977577,0.00041851154,0.09508697,0.00002945268,0.00008813028,0.00034743073],"about_ca_topic_score_codex":0.0004681692,"about_ca_topic_score_gemma":0.000009018565,"teacher_disagreement_score":0.30229387,"about_ca_system_score_codex":0.000061688435,"about_ca_system_score_gemma":0.00037274967,"threshold_uncertainty_score":0.78160197},"labels":[],"label_agreement":null},{"id":"W4248133440","doi":"10.1016/j.atherosclerosissup.2018.04.468","title":"LDL-C Therapeutic Target Attainment in Patients with Homozygous Familial Hypercholesterolemia treated with Lomitapide","year":2018,"lang":"en","type":"article","venue":"Atherosclerosis Supplements","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Internal medicine; Cholesterol","score_opus":0.012001038650542568,"score_gpt":0.23494598015216603,"score_spread":0.22294494150162347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248133440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969001,0.000053722197,0.00029395337,0.00019091534,0.00006420361,0.0020477138,0.00008481112,0.00007165962,0.00029291844],"genre_scores_gemma":[0.9960925,0.000037987964,0.0016848362,0.0012964843,0.00017502635,0.00023751361,0.00023965501,0.00010596763,0.00013001807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969684,0.00014220724,0.00044780227,0.0006573376,0.0010011073,0.0007831581],"domain_scores_gemma":[0.9985357,0.00001693531,0.000120930315,0.0008763957,0.00019314763,0.00025689398],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035258863,0.0004114023,0.0006271498,0.00014391002,0.0001635529,0.000041889944,0.00017416333,0.00012330728,0.000349823],"category_scores_gemma":[0.00000775831,0.00027656174,0.0001225257,0.00039439445,0.00018148951,0.00015353019,0.00006242459,0.00024324672,0.00008075005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011993465,0.00087962364,0.98956114,0.00004446941,0.00037164302,0.000011632822,0.0003969966,0.000004178825,0.00064780284,0.000006058323,0.00019090691,0.0066861897],"study_design_scores_gemma":[0.018450417,0.0052143075,0.9689581,0.00026401997,0.00019298808,0.000008244998,0.00018139517,0.000021308466,0.002826791,0.00000799194,0.0035438128,0.00033062173],"about_ca_topic_score_codex":0.00095383235,"about_ca_topic_score_gemma":0.00036240154,"teacher_disagreement_score":0.02060305,"about_ca_system_score_codex":0.00040585737,"about_ca_system_score_gemma":0.00012435137,"threshold_uncertainty_score":0.99996865},"labels":[],"label_agreement":null},{"id":"W4248481164","doi":"10.12968/bjca.2015.10.8.394","title":"Familial hyperlipidaemia","year":2015,"lang":"en","type":"article","venue":"British Journal of Cardiac Nursing","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Stroke Network","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Apolipoprotein B; Intensive care medicine; Internal medicine; Cholesterol","score_opus":0.02073514083892618,"score_gpt":0.2804740572148095,"score_spread":0.2597389163758833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248481164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9256819,0.04905471,0.0006691423,0.0004907362,0.0034800842,0.00021038797,0.000005129719,0.000024796682,0.02038314],"genre_scores_gemma":[0.9899928,0.0010603018,0.00322105,0.00019639856,0.0053375256,0.0000013481772,0.0000031291697,0.00003074592,0.00015668372],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982534,0.00013276433,0.00039659053,0.00011365864,0.0008510861,0.00025251426],"domain_scores_gemma":[0.99862283,0.000014748793,0.00014241846,0.00016867074,0.00054563634,0.0005056839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014201067,0.00009264294,0.00058872893,0.000083649174,0.000063965635,0.00005448987,0.00006735959,0.000089384914,0.000007715887],"category_scores_gemma":[0.00025200198,0.00009904715,0.0006230635,0.00014927541,0.000067420566,0.00016543975,0.000009586904,0.0003961605,0.000008558426],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014769497,0.00007790402,0.0013882056,0.00003197656,0.00018755371,0.00064628094,0.00024392159,0.000012602288,0.0006566943,0.000021413365,0.019881748,0.976704],"study_design_scores_gemma":[0.013780255,0.0025585962,0.28245616,0.011865489,0.00275044,0.1986536,0.0069017084,0.000072136434,0.0067096045,0.0013678292,0.4719968,0.0008873481],"about_ca_topic_score_codex":0.0000774809,"about_ca_topic_score_gemma":7.578979e-7,"teacher_disagreement_score":0.97581667,"about_ca_system_score_codex":0.0002920266,"about_ca_system_score_gemma":0.0005712836,"threshold_uncertainty_score":0.40390256},"labels":[],"label_agreement":null},{"id":"W4248816441","doi":"10.1016/j.cjca.2016.05.004","title":"Erratum","year":2016,"lang":"en","type":"erratum","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.015274715347623223,"score_gpt":0.2471262942155811,"score_spread":0.23185157886795787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248816441","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017844645,0.060246035,0.0014902952,0.0063748285,0.11471389,0.00042431545,0.00013997774,0.000014212691,0.816418],"genre_scores_gemma":[0.09229494,0.018006409,0.0003811401,0.004200572,0.26464173,0.000023886098,0.0002241689,0.00037301553,0.61985415],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978233,0.00022288578,0.0006479814,0.00024323423,0.0003788481,0.0006837388],"domain_scores_gemma":[0.99642336,0.000025740317,0.00038698173,0.00069088733,0.0007312086,0.0017418059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096761226,0.00029327287,0.0018992139,0.00070321624,0.00009287354,0.000019058602,0.0002824752,0.0011123429,0.00011483165],"category_scores_gemma":[0.00041086812,0.00020154584,0.0014650305,0.00013645935,0.00022995533,0.000048338214,0.000014880933,0.0017459462,0.00008442941],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027248168,6.0969404e-7,0.00040518306,0.00012065739,0.0011210559,0.0026811513,0.000017821578,0.0000017862342,0.000006468849,0.00008127168,0.97672886,0.0188079],"study_design_scores_gemma":[0.0008635057,0.00045138763,0.0038316955,0.0006248914,0.0005792895,0.011181978,0.000021673135,1.752359e-7,0.000003357283,0.00033274177,0.9819207,0.00018860691],"about_ca_topic_score_codex":0.00094218075,"about_ca_topic_score_gemma":0.0011977635,"teacher_disagreement_score":0.19656385,"about_ca_system_score_codex":0.0006252498,"about_ca_system_score_gemma":0.019407375,"threshold_uncertainty_score":0.9861517},"labels":[],"label_agreement":null},{"id":"W4249311964","doi":"10.15173/m.v1i38.2629","title":"Atherosclerosis","year":2021,"lang":"en","type":"article","venue":"The Meducator","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.023995094172570723,"score_gpt":0.27758707479700273,"score_spread":0.253591980624432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249311964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9756746,0.0025819999,0.000050542425,0.014223605,0.00039144888,0.00016286585,0.0000015121315,0.000034894514,0.0068785246],"genre_scores_gemma":[0.98985195,0.00024491956,0.00050310005,0.003668721,0.0007425821,0.000032227996,0.00000455659,0.000016063494,0.0049358536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993782,0.00005483789,0.00008379328,0.000119300996,0.00021591448,0.00014796121],"domain_scores_gemma":[0.99920297,0.00001843823,0.0000151556615,0.0006017011,0.00005705487,0.0001047023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028109233,0.000056338606,0.0001421059,0.000010387993,0.00007863136,0.000011094954,0.000051100335,0.000028137685,0.0005448594],"category_scores_gemma":[0.000083846266,0.000032578642,0.00015871604,0.0001463417,0.00003243717,0.000012683194,0.000025695794,0.00010889506,0.0002314148],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002135659,0.0025723944,0.070666745,0.0011289618,0.0027940094,0.00024399206,0.015616547,0.0000036882534,0.22237375,0.020783847,0.14504626,0.51855624],"study_design_scores_gemma":[0.001210167,0.000092994946,0.2938247,0.000121823716,0.00032223086,0.0005845394,0.0024744389,0.0000069814514,0.09667245,0.00035838323,0.6041605,0.00017077794],"about_ca_topic_score_codex":0.000053554788,"about_ca_topic_score_gemma":0.0000052366854,"teacher_disagreement_score":0.51838547,"about_ca_system_score_codex":0.000035317178,"about_ca_system_score_gemma":0.00036614315,"threshold_uncertainty_score":0.59658283},"labels":[],"label_agreement":null},{"id":"W4249409508","doi":"10.1002/14651858.cd012501","title":"Cerivastatin for lowering lipids","year":2017,"lang":"en","type":"article","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cerivastatin; Medicine; Cholesterol; Adverse effect; Pharmacology; Internal medicine; Pravastatin","score_opus":0.09477225538401562,"score_gpt":0.3781463237087702,"score_spread":0.2833740683247546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249409508","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.028615002,0.7567867,0.1456973,0.0011045625,0.002333917,0.05566724,0.0008103855,0.0001283325,0.008856566],"genre_scores_gemma":[0.61521107,0.27757207,0.08954839,0.00078884675,0.0033882337,0.009238292,0.0010226679,0.0002723533,0.002958056],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99771047,0.00012497311,0.0012393252,0.00027631072,0.00042002124,0.00022888953],"domain_scores_gemma":[0.9951154,0.00012751164,0.00096918276,0.0034279043,0.00020245137,0.00015756219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004831314,0.00019362896,0.0021864346,0.000054405737,0.00018403905,0.00004024262,0.00031675695,0.000047029887,0.000059872164],"category_scores_gemma":[0.005329271,0.00012747999,0.00062282535,0.000047115587,0.000063761465,0.00015080757,0.00008628768,0.00008389629,0.000068029796],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032947744,0.000056653796,0.00005030933,0.99231064,0.00012717799,0.0000113604965,0.00009146418,1.3280865e-7,0.0025416256,0.00025436998,0.0013502648,0.0031730256],"study_design_scores_gemma":[0.0038247511,0.00038846995,0.0005307561,0.9705426,0.0019122106,0.00032438678,0.0002178076,0.00026202336,0.006020006,0.000030506084,0.015556136,0.00039035256],"about_ca_topic_score_codex":0.00007373133,"about_ca_topic_score_gemma":0.0000075806124,"teacher_disagreement_score":0.5865961,"about_ca_system_score_codex":0.00003261406,"about_ca_system_score_gemma":0.000081744474,"threshold_uncertainty_score":0.638002},"labels":[],"label_agreement":null},{"id":"W4249912557","doi":"10.1002/14651858.cd012735","title":"Pitavastatin for lowering lipids","year":2017,"lang":"en","type":"article","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pitavastatin; Chemistry; Internal medicine; Cardiology; Medicine; Statin","score_opus":0.09039702314134236,"score_gpt":0.37647941882809033,"score_spread":0.286082395686748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249912557","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024264399,0.78678554,0.12730606,0.0009193925,0.0020534762,0.05008939,0.00068232755,0.00011148669,0.007787911],"genre_scores_gemma":[0.59678835,0.2969026,0.0882129,0.00084949145,0.003415452,0.009180002,0.0010304154,0.00027723223,0.0033435698],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976734,0.00012766352,0.0012587733,0.00027835363,0.00043097223,0.00023084736],"domain_scores_gemma":[0.9951266,0.00014122471,0.00096528593,0.0033890232,0.00021987192,0.0001580186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005429821,0.00019418079,0.0021860022,0.00005626343,0.00018476293,0.00004019802,0.00031200054,0.000047193495,0.00005432373],"category_scores_gemma":[0.005820846,0.00012741146,0.00062545924,0.00004600237,0.0000632411,0.00015506662,0.000076968754,0.00008578749,0.00008026066],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031150983,0.00006133704,0.00004670664,0.9925506,0.00013298722,0.000011602145,0.00010450985,1.2702527e-7,0.0019424162,0.00029818524,0.001617873,0.0032025133],"study_design_scores_gemma":[0.0038546158,0.00041529644,0.00049120886,0.9746308,0.0020161408,0.0003058052,0.00025909275,0.0002575273,0.004494141,0.00003505498,0.012854235,0.00038612325],"about_ca_topic_score_codex":0.000070546426,"about_ca_topic_score_gemma":0.0000083157865,"teacher_disagreement_score":0.57252395,"about_ca_system_score_codex":0.000032396485,"about_ca_system_score_gemma":0.00008429915,"threshold_uncertainty_score":0.6968517},"labels":[],"label_agreement":null},{"id":"W4250985170","doi":"10.1161/atvb.37.suppl_1.174","title":"Abstract 174: The Use of Next-Generation Sequencing to Detect Copy Number Variation in the Molecular Diagnosis of Familial Hypercholesterolemia","year":2017,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Multiplex ligation-dependent probe amplification; Copy-number variation; Familial hypercholesterolemia; PCSK9; Concordance; Genetics; Multiplex; Computational biology; Medicine; Bioinformatics; LDL receptor; Apolipoprotein B; Biology; Gene; Internal medicine; Cholesterol; Exon; Lipoprotein; Genome","score_opus":0.1558650864707548,"score_gpt":0.32631940240282903,"score_spread":0.17045431593207422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250985170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717903,0.00006627351,0.0008629244,0.0009725748,0.00010394978,0.00076189596,0.000016666507,0.0000067088245,0.000029965755],"genre_scores_gemma":[0.995949,0.0018290844,0.0009855068,0.0009540645,0.00011073637,0.00014208832,0.000013002044,0.000016148259,4.0293804e-7],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984939,0.00029309106,0.0004331453,0.00031462067,0.00023776607,0.0002274668],"domain_scores_gemma":[0.9984807,0.00008982393,0.00020791985,0.0010544027,0.000105774816,0.00006139727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011081975,0.00016739081,0.0004912094,0.00006095196,0.00025052976,0.00009150442,0.00021303097,0.00016102663,0.000017418504],"category_scores_gemma":[0.0002168958,0.00010174484,0.00025517953,0.000117267766,0.00016664906,0.00015681317,0.00008090529,0.00016078615,0.0000029379855],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000977743,0.00006861758,0.1958275,0.00007656624,0.00024634768,2.8187566e-7,0.0011989814,0.00003785244,0.7955119,0.00018944597,0.000046402558,0.0067863576],"study_design_scores_gemma":[0.00076853397,0.00023360141,0.98885757,0.00013482201,0.00017635824,0.0000016948063,0.0001147297,0.00011901291,0.008885991,0.000027762251,0.0005786327,0.00010130035],"about_ca_topic_score_codex":0.004755289,"about_ca_topic_score_gemma":0.0004774697,"teacher_disagreement_score":0.7930301,"about_ca_system_score_codex":0.00004335801,"about_ca_system_score_gemma":0.000054199085,"threshold_uncertainty_score":0.71886057},"labels":[],"label_agreement":null},{"id":"W4251144626","doi":"10.1001/jama.2013.284440","title":"Formulation of Treatment Recommendations for Statins","year":2014,"lang":"en","type":"letter","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Island Health","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; Psychiatry","score_opus":0.047450806344798764,"score_gpt":0.3212740222430025,"score_spread":0.27382321589820374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251144626","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000722824,0.00013383744,0.010668223,0.9838805,0.00023166291,0.0019411697,0.00027221005,0.00003273862,0.0021168103],"genre_scores_gemma":[0.00929711,0.00040403695,0.026360111,0.91934586,0.01774374,0.0009751378,0.0155539205,0.00013348556,0.01018659],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991769,0.000040825234,0.00027910856,0.00017276454,0.000170467,0.00015989109],"domain_scores_gemma":[0.9991061,0.000089053494,0.00016801259,0.00042533813,0.0001755387,0.000035927314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019528154,0.00012818234,0.00044002102,0.00008876643,0.000041299554,0.0000086495165,0.000033455904,0.00031859716,0.00006881454],"category_scores_gemma":[0.000057973848,0.000097599754,0.0003764576,0.000047947706,0.000008940158,0.000029227482,0.0000059222352,0.00019077661,0.000009097215],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002714009,0.000024067878,0.00002316934,0.0005400478,0.00023355236,0.0000025530446,0.00007842237,0.0000010064088,0.000010975949,0.000082170554,0.8154213,0.18355563],"study_design_scores_gemma":[0.0024655059,0.00091825065,0.00022004789,0.00014341192,0.00034576998,0.000014594994,0.000010308428,0.00014760884,0.00026223832,0.00018501896,0.9952077,0.0000795426],"about_ca_topic_score_codex":0.00029551116,"about_ca_topic_score_gemma":0.0000105705485,"teacher_disagreement_score":0.18347609,"about_ca_system_score_codex":0.00022773237,"about_ca_system_score_gemma":0.00018006461,"threshold_uncertainty_score":0.39800024},"labels":[],"label_agreement":null},{"id":"W4251201260","doi":"10.1016/s1701-2163(16)30111-6","title":"Statins","year":2003,"lang":"en","type":"review","venue":"Journal of Obstetrics and Gynaecology Canada","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; HMG-CoA reductase; Statin; Randomized controlled trial; Secondary prevention; Coronary artery disease; Risk stratification; Internal medicine; Reductase","score_opus":0.027158099395781465,"score_gpt":0.28608248868416947,"score_spread":0.258924389288388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251201260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005166212,0.9895314,0.000012961944,0.000033010954,0.008680547,0.00029910303,0.000021680387,0.0000016427294,0.0013679923],"genre_scores_gemma":[0.00006884037,0.9987261,0.00040848902,0.00030042895,0.00007890188,0.000003853849,0.0000067966344,0.000028101877,0.00037847238],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809355,0.00015660805,0.0008482648,0.00015190974,0.00048368023,0.0002659686],"domain_scores_gemma":[0.9974377,0.00087726006,0.0007618727,0.00023157289,0.0003004613,0.00039110176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053505076,0.0002239166,0.002241607,0.00030142535,0.00006198028,0.000012827892,0.00009435837,0.00027945347,0.00016875291],"category_scores_gemma":[0.002137539,0.00015364708,0.00043571298,0.0004015311,0.00003355838,0.000023688808,0.000022897484,0.0008007685,8.831481e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[3.0447907e-7,0.000022965794,0.000065939,0.004859614,0.00052646594,0.0042743618,0.0000040699565,1.4552003e-7,1.8795414e-9,0.000040959967,0.0026103086,0.98759484],"study_design_scores_gemma":[0.000758067,0.00028882085,0.0003850358,0.0003052842,0.001646262,0.0016286324,0.000022680397,2.4431392e-7,4.4192518e-8,0.000009788151,0.9948329,0.00012227979],"about_ca_topic_score_codex":0.005748668,"about_ca_topic_score_gemma":0.0043848194,"teacher_disagreement_score":0.99222255,"about_ca_system_score_codex":0.0015747938,"about_ca_system_score_gemma":0.014893836,"threshold_uncertainty_score":0.9906908},"labels":[],"label_agreement":null},{"id":"W4252937945","doi":"10.1002/clc.4960171602","title":"Introduction","year":2009,"lang":"en","type":"article","venue":"Clinical Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Panel discussion; Quarter (Canadian coin); Library science; Citation; Family medicine; Computer science; Philosophy","score_opus":0.04200429353368523,"score_gpt":0.3761302106458162,"score_spread":0.33412591711213097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252937945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89921874,0.0019289196,0.005010949,0.05329138,0.0028386281,0.0006089015,0.0000019031764,0.00023036907,0.03687023],"genre_scores_gemma":[0.9763409,0.0004133671,0.00062740344,0.0043874662,0.01769225,0.0000049947143,0.000017199927,0.0000064612586,0.000509986],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99886554,0.0001927854,0.00033593265,0.000294093,0.00011924774,0.00019239035],"domain_scores_gemma":[0.99916214,0.000038510254,0.000036920403,0.0005317683,0.0000769609,0.00015367861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012456595,0.0000725443,0.000564806,0.00002993966,0.00003350434,0.0000029098044,0.000041362622,0.00019700502,0.00006767192],"category_scores_gemma":[0.0005544075,0.000055686076,0.00051027077,0.00008562655,0.000077961275,0.000019050562,0.00001185501,0.00031129344,0.0002253817],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042131855,0.00012826468,0.044991694,0.000023528462,0.00034976736,0.0002573678,0.000011160547,0.000014874315,0.00026929518,0.0038422556,0.120178975,0.8295115],"study_design_scores_gemma":[0.0007983516,0.0009958161,0.5512449,0.0000032032985,0.00009381135,0.0005376891,0.000007174133,0.0000069273838,0.000021506154,0.0005724117,0.44566584,0.000052360174],"about_ca_topic_score_codex":0.000002745641,"about_ca_topic_score_gemma":1.9895475e-7,"teacher_disagreement_score":0.82945913,"about_ca_system_score_codex":0.000024088708,"about_ca_system_score_gemma":0.000068985035,"threshold_uncertainty_score":0.28969008},"labels":[],"label_agreement":null},{"id":"W4253126237","doi":"10.1136/bmj.e3228","title":"Familial hypercholesterolaemia","year":2012,"lang":"de","type":"article","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Computer science; Medicine; World Wide Web; Data science","score_opus":0.03049442609602216,"score_gpt":0.30853983651836253,"score_spread":0.2780454104223404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253126237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73246056,0.21160051,0.00040037525,0.006625437,0.015287027,0.0024953044,0.000040476767,0.00014382681,0.030946495],"genre_scores_gemma":[0.9433347,0.0019227986,0.0005691328,0.0033232134,0.04807787,0.00007118662,0.000038415714,0.000062422514,0.002600242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974661,0.00022683335,0.00043535457,0.00026098388,0.00073423755,0.00087648426],"domain_scores_gemma":[0.99809283,0.000031094758,0.000089160465,0.0010257772,0.0000757868,0.0006853773],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021226124,0.00023584826,0.00051594723,0.000070717644,0.0001125928,0.000024422514,0.00012125012,0.00028166806,0.0002892454],"category_scores_gemma":[0.00020537608,0.00020184214,0.0004036459,0.00016273688,0.000081094826,0.00015444591,0.000088551176,0.00045600923,0.006996202],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004777589,0.0009963637,0.2023409,0.0014859973,0.002544271,0.00021501808,0.003311033,0.000003594494,0.0010345647,0.0011499657,0.22534214,0.5610984],"study_design_scores_gemma":[0.0017563557,0.00015130655,0.20591062,0.00021017174,0.00078517135,0.000078348356,0.00019988365,0.000020068426,0.00039723385,0.000010180595,0.79024625,0.00023442366],"about_ca_topic_score_codex":0.00030147258,"about_ca_topic_score_gemma":0.0000036018985,"teacher_disagreement_score":0.5649041,"about_ca_system_score_codex":0.00016276081,"about_ca_system_score_gemma":0.0002541875,"threshold_uncertainty_score":0.993777},"labels":[],"label_agreement":null},{"id":"W4253743227","doi":"10.1093/med/9780199235292.003.1240","title":"Familial hypercholesterolaemia","year":2011,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Coronary heart disease; Population; Family history; Incidence (geometry); Disease; Pediatrics; Internal medicine; Environmental health","score_opus":0.045756552426718715,"score_gpt":0.2591164472408079,"score_spread":0.21335989481408918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253743227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7354997,0.00009766621,0.0007835308,0.00009422308,0.000095567055,0.00017332804,4.0731183e-7,0.00007487985,0.2631807],"genre_scores_gemma":[0.992104,0.000029450788,0.0037885276,0.0015509339,0.00020516652,0.000009514179,0.0000018574264,0.000009741913,0.002300816],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99950135,0.000013128984,0.000086752836,0.00011272426,0.00015433758,0.00013170917],"domain_scores_gemma":[0.99953765,0.000001842326,0.000008016865,0.0003020261,0.000031132116,0.00011936379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015166897,0.000052310184,0.00012971913,0.000025837184,0.000021962598,0.0000025656666,0.000031205458,0.000046068526,0.0005197829],"category_scores_gemma":[0.0000112442995,0.000036516896,0.00010824804,0.000050492607,0.000018301704,0.000032064472,0.000015041194,0.00008265932,0.00025765452],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006504507,0.00070644525,0.16260912,0.00033589083,0.00052007544,0.00048320994,0.0024901128,1.5814484e-7,0.0091649005,0.010068739,0.008290526,0.80468035],"study_design_scores_gemma":[0.0023212503,0.00046103876,0.93075746,0.000033522283,0.00011476674,0.00043721474,0.00026193715,0.000017472115,0.012972353,0.00026479436,0.052200958,0.00015724913],"about_ca_topic_score_codex":0.0004211201,"about_ca_topic_score_gemma":0.00001013009,"teacher_disagreement_score":0.8045231,"about_ca_system_score_codex":0.00001747963,"about_ca_system_score_gemma":0.00004534326,"threshold_uncertainty_score":0.56912583},"labels":[],"label_agreement":null},{"id":"W4253846085","doi":"10.1517/14656560802233827","title":"Effect of omega-3-acid ethyl esters on steady-state plasma pharmacokinetics of atorvastatin in healthy adults","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"American College of Clinical Pharmacy","keywords":"Medicine; Pharmacokinetics; Atorvastatin; Plasma levels; Pharmacology; Plasma concentration; Traditional medicine; Internal medicine","score_opus":0.024148094478118772,"score_gpt":0.35244344519124926,"score_spread":0.3282953507131305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253846085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99163043,0.004602157,0.000064752814,0.00069275044,0.0008868868,0.0016478511,0.000035124463,0.000054836608,0.00038519246],"genre_scores_gemma":[0.9588304,0.03767176,0.0002665427,0.0026481745,0.00031081494,0.00013728172,0.000027844395,0.00007897636,0.000028181737],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99695814,0.00053534476,0.0007457695,0.00045641593,0.0008764442,0.0004278867],"domain_scores_gemma":[0.9986949,0.00019380018,0.0002759493,0.0004741377,0.00008966463,0.00027156877],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000718738,0.00035574983,0.00090815505,0.00034705029,0.00005697183,0.000003437818,0.00015148243,0.00009927164,0.00010132405],"category_scores_gemma":[0.000028199578,0.00028712853,0.00032867663,0.00039143793,0.000119797376,0.000062341904,0.000015976551,0.00039380192,0.000015641448],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13323158,0.0021968454,0.002474826,0.001548724,0.0005552847,0.0001447621,0.01154914,0.00047274755,0.18075673,0.000040883402,0.0032751933,0.6637533],"study_design_scores_gemma":[0.043029465,0.018418608,0.0015420797,0.0008238189,0.000008402875,0.00005699486,0.00008907234,0.0009299515,0.8994522,0.0000020532057,0.035350613,0.00029670735],"about_ca_topic_score_codex":0.00024058773,"about_ca_topic_score_gemma":0.000001968064,"teacher_disagreement_score":0.7186955,"about_ca_system_score_codex":0.00013960533,"about_ca_system_score_gemma":0.0001755636,"threshold_uncertainty_score":0.9999581},"labels":[],"label_agreement":null},{"id":"W4253965972","doi":"10.1097/hco.0000000000000503","title":"Editorial introductions","year":2018,"lang":"en","type":"article","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gold medal; Section (typography); Library science; Art history; History","score_opus":0.04322496581519514,"score_gpt":0.3618959753126784,"score_spread":0.3186710094974833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253965972","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009553937,0.0048424946,0.0015619355,0.0009249593,0.9807302,0.0004629683,0.000007784959,0.00006820893,0.0018475465],"genre_scores_gemma":[0.0988105,0.0016428643,0.00011158703,0.000026632062,0.89925593,0.000067078894,0.00005291628,0.000012501253,0.000019996523],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99889374,0.00012551069,0.00022088677,0.00029289737,0.00021028401,0.0002566828],"domain_scores_gemma":[0.99926233,0.000017812257,0.00003128098,0.00042791927,0.00016685808,0.00009376843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004980031,0.0000955398,0.00035728386,0.0001290712,0.00005419125,0.0000041143085,0.000058336027,0.00012759866,0.000043992855],"category_scores_gemma":[0.0001687987,0.00008285559,0.00017496574,0.00021562497,0.00015184209,0.00003365673,0.000043581593,0.0003012733,0.00015885581],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106705564,0.000048368933,0.0107454695,0.00011233791,0.000065903325,3.7364188e-7,0.00007253211,0.0000056207086,0.00008731324,0.0009528433,0.93127275,0.056529798],"study_design_scores_gemma":[0.001096236,0.0002456233,0.030794442,0.00005492798,0.000016725608,0.000103598875,0.000025590087,0.00000979805,0.000015956264,0.00020884835,0.9673528,0.00007543102],"about_ca_topic_score_codex":0.000026096472,"about_ca_topic_score_gemma":0.000001351727,"teacher_disagreement_score":0.08925656,"about_ca_system_score_codex":0.000093621136,"about_ca_system_score_gemma":0.00016333416,"threshold_uncertainty_score":0.3378753},"labels":[],"label_agreement":null},{"id":"W4254178737","doi":"10.1161/circ.132.suppl_3.17252","title":"Abstract 17252: High Low-density Lipoprotein Cholesterol Levels are Common Among High-risk Patients One Year After Initiating Statin Therapy: Results of a Large Canadian Cohort Study","year":2015,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Amgen (Canada); Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Statin; Cohort; Risk factor; Diabetes mellitus; Cohort study; Retrospective cohort study; Incidence (geometry); Obesity; Endocrinology","score_opus":0.02540282441313398,"score_gpt":0.25744366055448764,"score_spread":0.23204083614135365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254178737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959399,0.000042031174,0.00005749355,0.000058106914,0.00014167426,0.0031758095,0.00042808437,0.00004309618,0.00011376657],"genre_scores_gemma":[0.9990663,0.000006537035,0.00009400836,0.00015211695,0.0002126376,0.000103735634,0.0003137682,0.000045293764,0.0000055881355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973578,0.00028390271,0.0006554711,0.0004098878,0.0009331813,0.00035978857],"domain_scores_gemma":[0.997804,0.000027347149,0.0004882418,0.0007310608,0.0005604209,0.00038895133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017983456,0.00020765795,0.0005775434,0.00018656281,0.00011790013,0.000032158918,0.00007823257,0.00016443456,0.000034484427],"category_scores_gemma":[0.00027912908,0.00020021481,0.000112944035,0.00023888264,0.00003479146,0.00019422449,0.00002944408,0.00032921782,0.000020460724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028213905,0.00052673684,0.98616254,0.00006326624,0.00025422193,0.000018334133,0.0015918452,0.000069380636,0.00002402462,0.0000021790138,0.000020589678,0.010984736],"study_design_scores_gemma":[0.008947928,0.00026225756,0.9893191,0.00023449451,0.0001362559,6.889855e-7,0.00044769715,0.000055692642,0.00036112597,0.000042130396,0.000012457366,0.00018019351],"about_ca_topic_score_codex":0.4580334,"about_ca_topic_score_gemma":0.16912147,"teacher_disagreement_score":0.28891197,"about_ca_system_score_codex":0.00038611685,"about_ca_system_score_gemma":0.00025768677,"threshold_uncertainty_score":0.8460399},"labels":[],"label_agreement":null},{"id":"W4254345843","doi":"10.1016/j.amjhyper.2005.10.004","title":"The road ahead with β-blockers: Expanding treatment options in cardiovascular diseaseCME information","year":2005,"lang":"en","type":"article","venue":"American Journal of Hypertension","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Cardiology; Intensive care medicine; Internal medicine","score_opus":0.013959736587734483,"score_gpt":0.24185742317762524,"score_spread":0.22789768658989076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254345843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887056,0.006137811,0.0005120445,0.0040433425,0.000063851534,0.00029279804,0.0000010838663,0.000010649453,0.0000678669],"genre_scores_gemma":[0.99392503,0.0035396507,0.0018650736,0.00032951107,0.00030279552,0.000011137554,0.0000036119798,0.000011368287,0.000011811574],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99862725,0.00010734676,0.0003864577,0.00008969446,0.0005694025,0.00021984645],"domain_scores_gemma":[0.9990356,0.000029973206,0.0001973421,0.0003357232,0.000217374,0.0001839909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005676368,0.00012422523,0.00051262707,0.000156955,0.00014154159,0.00002819854,0.000059622038,0.000022738255,0.0000030517622],"category_scores_gemma":[0.000046579262,0.00006218264,0.00041520703,0.00028788505,0.00009957949,0.00035245353,0.000010782421,0.00016106995,0.000007817405],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059667334,0.00011907213,0.001994044,0.0000093587105,0.00063639623,0.00014071462,0.00038871533,0.0010433063,0.00011875131,0.000012749878,0.000076141725,0.99486405],"study_design_scores_gemma":[0.025003312,0.015285784,0.51639,0.0016204045,0.0037961134,0.020639108,0.022231812,0.003040241,0.0015300243,0.00003150379,0.38967475,0.0007568949],"about_ca_topic_score_codex":0.00044104995,"about_ca_topic_score_gemma":0.000025191082,"teacher_disagreement_score":0.9941072,"about_ca_system_score_codex":0.0003060233,"about_ca_system_score_gemma":0.00022957785,"threshold_uncertainty_score":0.25357345},"labels":[],"label_agreement":null},{"id":"W4254441527","doi":"10.1515/iupac.79.0868","title":"Atherosclerosis","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glossary; Chemical nomenclature; Computer science; Toxicology; Library science; Chemistry; Philosophy; Biology; Linguistics; Organic chemistry","score_opus":0.01905542860520653,"score_gpt":0.3896748692477298,"score_spread":0.3706194406425233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254441527","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003159545,0.002133888,0.00013252064,0.0013139056,0.0006684337,0.0007502978,0.9944931,0.000099637946,0.00009221078],"genre_scores_gemma":[0.000029548939,0.006347738,0.000077453304,0.001164191,0.0032454666,0.000039522747,0.9882476,0.000073783485,0.00077471376],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962823,0.0000904661,0.00049580523,0.00060605304,0.0019808817,0.0005444928],"domain_scores_gemma":[0.9969894,0.000031213924,0.00018806283,0.0018635559,0.0005170068,0.0004107164],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009240247,0.00045866938,0.001185396,0.00018668607,0.000108416425,0.0000319112,0.0002249765,0.0005529657,0.0039036786],"category_scores_gemma":[0.00036223294,0.0003023172,0.000712783,0.00019231152,0.00012281585,0.000046122994,0.00012504007,0.00059647684,0.000011199128],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015799711,0.00021974924,0.000019514819,0.0005094723,0.000413749,0.00006927018,0.000004405397,5.2734865e-8,0.000018393177,0.0000029844628,0.9808725,0.017711906],"study_design_scores_gemma":[0.0024648386,0.000506662,0.0003688564,0.0013567515,0.00056220917,0.00009432461,0.000010050038,4.2278285e-7,0.000041799514,0.000021774302,0.99423546,0.0003368391],"about_ca_topic_score_codex":0.00035825066,"about_ca_topic_score_gemma":0.00021181817,"teacher_disagreement_score":0.017375067,"about_ca_system_score_codex":0.0006417482,"about_ca_system_score_gemma":0.0015670536,"threshold_uncertainty_score":0.9999429},"labels":[],"label_agreement":null},{"id":"W4254813370","doi":"10.1515/iupac.84.0206","title":"α-Fetoprotein (AFP)","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto","funders":"","keywords":"Glossary; Immunotoxicology; Medicine; Immunology; Immune system; Philosophy; Linguistics","score_opus":0.014225471976415204,"score_gpt":0.3913842401286317,"score_spread":0.3771587681522165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254813370","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001744503,0.004629374,0.0002333478,0.0020968267,0.00077267946,0.00145557,0.9902827,0.00013591452,0.00021909962],"genre_scores_gemma":[0.000025041809,0.0034662394,0.00015068085,0.0011713994,0.004956863,0.00007961458,0.98849684,0.00009215532,0.0015611768],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949989,0.0001352855,0.0006891111,0.00080597284,0.0026335593,0.0007372134],"domain_scores_gemma":[0.99599797,0.000035650133,0.0002656682,0.0024218576,0.00072540616,0.00055344304],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00136401,0.00061245036,0.0015346596,0.00029997795,0.00013676297,0.000041015064,0.00031258093,0.0007392332,0.0062896325],"category_scores_gemma":[0.0005513836,0.00041384264,0.00082446483,0.00021856277,0.0001616413,0.00006704302,0.00017934846,0.00092760683,0.000023893857],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003567432,0.00024443405,0.000006344624,0.0009018592,0.0004865282,0.000533773,0.000004376589,9.087129e-8,0.000017434662,0.000009190416,0.9557014,0.04173784],"study_design_scores_gemma":[0.0031410893,0.00067995006,0.000101406185,0.0014464655,0.0005676499,0.0003145752,0.0000129005775,7.9370596e-7,0.00008864113,0.00007633451,0.99309933,0.0004708425],"about_ca_topic_score_codex":0.00067538815,"about_ca_topic_score_gemma":0.00036852522,"teacher_disagreement_score":0.041267,"about_ca_system_score_codex":0.00083379657,"about_ca_system_score_gemma":0.0026540395,"threshold_uncertainty_score":0.9998313},"labels":[],"label_agreement":null},{"id":"W4255013428","doi":"10.1016/j.athoracsur.2005.07.092","title":"Invited commentary","year":2005,"lang":"en","type":"letter","venue":"The Annals of Thoracic Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Myocardial infarction; Statin; Cardiology; Troponin; Internal medicine; Troponin T; Troponin I; Revascularization; Ischemia; Surgery","score_opus":0.12454737896899452,"score_gpt":0.37776398625712326,"score_spread":0.2532166072881287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255013428","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017349627,0.01097149,0.000008856087,0.9703212,0.000407418,0.00052267144,0.000063217325,0.000061013867,0.00029450445],"genre_scores_gemma":[0.0019788048,0.003999356,0.000050233437,0.9813868,0.011450744,0.000039486884,0.0006725498,0.00007983612,0.00034219873],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99695235,0.0005648351,0.0006540928,0.00030549854,0.0009997094,0.0005235192],"domain_scores_gemma":[0.9969852,0.0006298321,0.0003778431,0.001682995,0.00022261722,0.00010154291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029998089,0.00032080754,0.0012845357,0.00029138988,0.00008977597,0.000015501977,0.00024139779,0.00050089794,0.00015776732],"category_scores_gemma":[0.00017047171,0.00020684201,0.0014666889,0.00032896694,0.00016439565,0.00005620221,0.00009958506,0.0015299867,0.00003612486],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012238002,0.000044925997,0.00017870338,0.0008435719,0.0006901678,0.0002582791,0.000035579542,5.661034e-7,0.000007945022,1.3037264e-7,0.8724388,0.12537894],"study_design_scores_gemma":[0.000050185397,0.0000377202,0.00047515554,0.0007897451,0.00031618765,0.00016662775,0.000019601597,0.000004718492,0.0023221702,0.000044625496,0.9955779,0.0001953759],"about_ca_topic_score_codex":0.00044148025,"about_ca_topic_score_gemma":0.0000040080113,"teacher_disagreement_score":0.12518355,"about_ca_system_score_codex":0.000030494466,"about_ca_system_score_gemma":0.00007970357,"threshold_uncertainty_score":0.84347725},"labels":[],"label_agreement":null},{"id":"W4255039318","doi":"10.1503/cmaj.050770","title":"Correction","year":2005,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Computer science; Information retrieval; World Wide Web; Data science","score_opus":0.005871952877404534,"score_gpt":0.23474123609084474,"score_spread":0.22886928321344022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255039318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40984914,0.0023429235,0.0014589349,0.40306064,0.009969002,0.0005200277,0.000009174013,0.00012039843,0.17266974],"genre_scores_gemma":[0.93524873,0.00039043106,0.00032988784,0.041136365,0.015029423,0.000005343674,0.000007377881,0.00001809641,0.007834367],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799526,0.00007300522,0.00023414737,0.00008390435,0.001298176,0.0003155117],"domain_scores_gemma":[0.99768674,0.00002722407,0.00007263403,0.00008910402,0.00027382598,0.0018504823],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017261946,0.00005970756,0.00016098509,0.00011655471,0.00018077149,0.00003235363,0.00005088793,0.0002511957,0.004955829],"category_scores_gemma":[0.0011992737,0.00005156903,0.00015064262,0.00014506473,0.000010228202,0.00007322762,0.0000035467488,0.0007962151,0.00048834755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000045339616,0.000016362637,0.014532473,0.0000033440167,0.00008801144,0.00015316995,0.00006453358,0.000003132305,0.0000035697128,0.0000417713,0.42160314,0.563486],"study_design_scores_gemma":[0.0007376581,0.00004133764,0.050186954,0.000043228974,0.00002802575,0.0025584514,0.00007720333,0.0005015997,0.000024493991,0.000010486096,0.9457373,0.000053250045],"about_ca_topic_score_codex":0.0023832219,"about_ca_topic_score_gemma":0.0212736,"teacher_disagreement_score":0.5634327,"about_ca_system_score_codex":0.0016800009,"about_ca_system_score_gemma":0.003588763,"threshold_uncertainty_score":0.9965856},"labels":[],"label_agreement":null},{"id":"W4255068639","doi":"10.1515/iupac.73.0409","title":"Low-Density Lipoprotein (LDL)","year":2016,"lang":"en","type":"dataset","venue":"IUPAC Standards Online","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan College","funders":"","keywords":"Table (database); Food science; Commission; Lipidology; Chemistry; Biochemistry; Product (mathematics); Human nutrition; Clinical chemistry; Organic chemistry; Polymer science; Computer science; Business; Mathematics; Database","score_opus":0.012073102606103926,"score_gpt":0.36637946663332477,"score_spread":0.3543063640272208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255068639","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013313356,0.0023986513,0.0003352408,0.0017213392,0.000986237,0.0016799509,0.9912653,0.00017071255,0.00011125572],"genre_scores_gemma":[0.00014338175,0.003114308,0.00013030216,0.0013346282,0.0057660122,0.00006133272,0.9883252,0.00010592974,0.0010189211],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940834,0.00018743535,0.00079700776,0.0010069354,0.0030609735,0.00086422265],"domain_scores_gemma":[0.99496835,0.000044801018,0.00033571754,0.0029242653,0.0010330557,0.0006937796],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017245867,0.0007445462,0.0018860359,0.00031497417,0.00019336611,0.000053319578,0.0003592048,0.00091373146,0.0030344478],"category_scores_gemma":[0.0008728002,0.00052329677,0.0009775428,0.00030417423,0.00021237698,0.00008418285,0.00026609778,0.0011905774,0.000024475727],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005546174,0.00041328566,0.0000052135006,0.0013464286,0.00055358256,0.00078507874,0.000007060212,1.1221846e-7,0.000030999166,0.0000052039304,0.9339144,0.062384006],"study_design_scores_gemma":[0.00339633,0.00070335186,0.00026416974,0.0023046935,0.0006567363,0.00035569578,0.000016024102,0.0000010997743,0.00047358315,0.00007232652,0.99117386,0.0005821232],"about_ca_topic_score_codex":0.0018147143,"about_ca_topic_score_gemma":0.0014245685,"teacher_disagreement_score":0.06180188,"about_ca_system_score_codex":0.001004616,"about_ca_system_score_gemma":0.002865483,"threshold_uncertainty_score":0.9997219},"labels":[],"label_agreement":null},{"id":"W4255261043","doi":"10.1161/atvb.37.suppl_1.14","title":"Abstract 14: Characterization of the Oxidized Phospholipid Modification of Apolipoprotein(a) Kringle KIV10: Insights Into the Site of OxPC Addition","year":2017,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; Western University; University of Windsor; Robarts Clinical Trials","funders":"","keywords":"Lysine; Covalent bond; Chemistry; Biochemistry; Apolipoprotein B; Kringle domain; Lipoprotein; Alanine; Amino acid; Gene; Cholesterol","score_opus":0.033173317011456364,"score_gpt":0.28189072136761084,"score_spread":0.24871740435615447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255261043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979355,0.00012463544,0.00022641086,0.0006099803,0.00016513473,0.00081155373,0.000041438867,0.000010657618,0.000074714575],"genre_scores_gemma":[0.9959962,0.0034734835,0.00013101392,0.00009670825,0.00011085187,0.00007030492,0.00010085117,0.000018239714,0.0000023631853],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99859816,0.0001454746,0.00053368305,0.0002908006,0.0002574876,0.00017439786],"domain_scores_gemma":[0.99753106,0.000026512242,0.0007714953,0.0013807387,0.00023175069,0.000058440688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054871687,0.00017232938,0.00061765424,0.00005899457,0.00034459666,0.000018870538,0.00021375295,0.00018500657,0.00004102763],"category_scores_gemma":[0.000100582656,0.000101145626,0.00039829244,0.000102605976,0.00053164695,0.00012285639,0.00012709216,0.00013203184,0.0000019218203],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015211204,0.00014096068,0.015691027,0.00021239561,0.0002748668,9.487214e-9,0.0009273804,7.212828e-7,0.9782434,0.00042321676,0.000005819185,0.004064979],"study_design_scores_gemma":[0.00084509316,0.00016754564,0.83188725,0.0002284069,0.00018658793,3.192794e-7,0.00005427248,0.00005669209,0.16575596,0.00007874753,0.0006581678,0.00008094833],"about_ca_topic_score_codex":0.0014857119,"about_ca_topic_score_gemma":0.00007963514,"teacher_disagreement_score":0.81619626,"about_ca_system_score_codex":0.000024201823,"about_ca_system_score_gemma":0.00005632976,"threshold_uncertainty_score":0.41245988},"labels":[],"label_agreement":null},{"id":"W4255330038","doi":"10.1016/b978-0-12-824048-9.00015-8","title":"Lipoprotein(a)","year":2021,"lang":"en","type":"book-chapter","venue":"Elsevier eBooks","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lipoprotein(a); Lipoprotein; Apolipoprotein B; Biology; Allele; Gene; Genetics; Internal medicine; Medicine; Endocrinology; Cholesterol","score_opus":0.017557675740451768,"score_gpt":0.25034019073237607,"score_spread":0.2327825149919243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255330038","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047472324,0.017181456,0.000007763403,0.00028127062,0.0004299903,0.0013815628,0.000019784235,0.00013075062,0.98051995],"genre_scores_gemma":[0.00027579433,0.0008135257,0.0008601846,0.0015590782,0.0025328638,0.000085775406,0.00010602425,0.00019748122,0.99356925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974103,0.000031344964,0.0005106308,0.0006926568,0.0009507013,0.00040437572],"domain_scores_gemma":[0.9974867,0.000015558966,0.00017158719,0.0016807497,0.0002609562,0.0003844333],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004097844,0.0004996128,0.0012615429,0.00014185852,0.0001071163,0.00003772116,0.0001367664,0.00063207635,0.001474347],"category_scores_gemma":[0.000032202162,0.0004448672,0.0012108745,0.000017241005,0.00010434623,0.000019002115,0.00014099876,0.00096990116,0.00053322455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024282284,0.000011607491,0.0000014459248,0.00061257527,0.0005873357,0.0008999483,0.00003537309,4.0404437e-8,0.000031262614,0.0064652544,0.0002896221,0.99104124],"study_design_scores_gemma":[0.00074290734,0.0001531729,0.00003819306,0.0016847393,0.00062832463,0.0006446498,0.000006560963,7.604201e-7,0.00024319626,0.0016430336,0.99380475,0.00040968283],"about_ca_topic_score_codex":0.0000035182304,"about_ca_topic_score_gemma":0.000021766744,"teacher_disagreement_score":0.99351513,"about_ca_system_score_codex":0.00018463997,"about_ca_system_score_gemma":0.0007556802,"threshold_uncertainty_score":0.9998003},"labels":[],"label_agreement":null},{"id":"W4255557507","doi":"10.1016/j.cjca.2020.07.071","title":"PEDIATRIC LIPID SCREENING AND TREATMENT IN CANADA: PRACTICES, ATTITUDES, AND BARRIERS","year":2020,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Dyslipidemia; Family medicine; Primary care; Disease; Pediatrics; Internal medicine","score_opus":0.025716173247845506,"score_gpt":0.25130258441413644,"score_spread":0.22558641116629094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255557507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97638905,0.015387455,0.000119050135,0.0072819153,0.00016066156,0.0001962106,0.000012797936,0.0000017771297,0.0004510597],"genre_scores_gemma":[0.9952666,0.0019733463,0.00024337652,0.0009008974,0.0015972328,0.0000022970319,0.0000017374728,0.000009771786,0.000004716477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991247,0.00012691237,0.00024535626,0.00013705058,0.000114985916,0.0002510031],"domain_scores_gemma":[0.9980646,0.000046865338,0.00016070876,0.00009161271,0.00006443783,0.0015717788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003146223,0.000097594886,0.00053133955,0.000121375684,0.000052747033,0.000011948817,0.00003975457,0.00006234105,0.00000839012],"category_scores_gemma":[0.0004406356,0.00008092157,0.000073137686,0.000117042684,0.00003827447,0.000053493863,0.0000071642676,0.00023411348,2.7154903e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053210613,4.216876e-7,0.9751347,0.00005177034,0.00020944804,0.002137038,0.00016175419,0.00013883137,0.0000058377527,0.000012064125,0.0011905902,0.020904385],"study_design_scores_gemma":[0.0021106594,0.00057336706,0.7813817,0.000024034505,0.00025992884,0.003164578,0.0005588194,0.000028993441,0.000004556644,0.0000021188184,0.21179575,0.00009545611],"about_ca_topic_score_codex":0.83323985,"about_ca_topic_score_gemma":0.8968693,"teacher_disagreement_score":0.21060516,"about_ca_system_score_codex":0.00043704093,"about_ca_system_score_gemma":0.011692227,"threshold_uncertainty_score":0.99391055},"labels":[],"label_agreement":null},{"id":"W4256565351","doi":"10.1503/cmaj.1041748","title":"Rebuttal","year":2005,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Heart and Stroke Foundation of Canada","keywords":"Rebuttal; Coronary artery disease; Population; Computer science; Medicine; Cardiology; Environmental health","score_opus":0.006248842704533605,"score_gpt":0.23804487965760496,"score_spread":0.23179603695307135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256565351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.515764,0.0020870469,0.0003532318,0.4017253,0.0013580439,0.00031813094,0.0000134615,0.000062229614,0.078318566],"genre_scores_gemma":[0.93306625,0.0003307625,0.0006791664,0.04969271,0.013110506,0.0000044864346,0.000007702142,0.00001894762,0.0030894836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99757975,0.00007532094,0.00027018733,0.00009518399,0.0015786351,0.0004009067],"domain_scores_gemma":[0.99704826,0.000021926904,0.00007312887,0.00011358261,0.00025978987,0.0024833055],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020363496,0.00006889863,0.00019296461,0.00011205781,0.00017489662,0.000034974444,0.00007363046,0.00027333866,0.0059579937],"category_scores_gemma":[0.0009579099,0.00005825566,0.00018567526,0.00013694364,0.000014077773,0.0000744585,0.0000055020187,0.0008253129,0.00058372214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000844268,0.000033466553,0.026462749,0.000010130997,0.00022482047,0.0007466423,0.00013653703,0.000002017422,0.0000085687725,0.00032165,0.2901676,0.6818774],"study_design_scores_gemma":[0.0009987152,0.000041642706,0.035926193,0.00003777996,0.000029334273,0.0026071062,0.000071948314,0.0000933616,0.000019357904,0.00002392902,0.96008813,0.000062472674],"about_ca_topic_score_codex":0.0017103091,"about_ca_topic_score_gemma":0.014177614,"teacher_disagreement_score":0.6818149,"about_ca_system_score_codex":0.0014376962,"about_ca_system_score_gemma":0.004269724,"threshold_uncertainty_score":0.9949507},"labels":[],"label_agreement":null},{"id":"W4280498324","doi":"10.1007/s11910-022-01197-4","title":"Lipid-Modifying Therapies and Stroke Prevention","year":2022,"lang":"en","type":"review","venue":"Current Neurology and Neuroscience Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Academic Medical Organization of Southwestern Ontario; Heart and Stroke Foundation of Canada","keywords":"Ezetimibe; Medicine; PCSK9; Stroke (engine); Internal medicine; Diabetes mellitus; Proprotein convertase; Statin; Neurology; Intracerebral hemorrhage; Cholesterol; Lipoprotein; Endocrinology; LDL receptor","score_opus":0.1128718790118551,"score_gpt":0.38474542000292544,"score_spread":0.27187354099107036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280498324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004584153,0.991579,0.000031081767,0.00010464133,0.00244094,0.001116902,0.0000057255065,0.000056677032,0.00008085641],"genre_scores_gemma":[0.0009735002,0.9982125,0.0000075328417,0.00022294147,0.00025123844,0.00017429612,0.000016048185,0.00002933115,0.00011257955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972382,0.0003897435,0.0005527126,0.0010360291,0.00042414558,0.00035915797],"domain_scores_gemma":[0.99871427,0.00007221415,0.0004240398,0.0005667581,0.00001788073,0.00020486084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009434513,0.0003134085,0.0011833768,0.00022625203,0.00038698246,0.000038707552,0.00007921701,0.00014697916,0.000028613289],"category_scores_gemma":[0.00020590941,0.00024287119,0.00035866085,0.00024634512,0.00027701227,0.00009017238,0.00024532463,0.00097264675,6.3229226e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007959844,0.00006585687,0.00030894284,0.00455992,0.000015507301,0.00057119026,0.000023100045,1.2698969e-7,0.0000049700116,0.000018406643,0.000039360297,0.99438465],"study_design_scores_gemma":[0.00013376793,0.0005292845,0.0007355198,0.00049420283,0.00044623757,0.019873103,0.000002818016,0.0000062406325,8.00895e-7,0.000030519765,0.97758967,0.00015784946],"about_ca_topic_score_codex":0.0000048719903,"about_ca_topic_score_gemma":5.9583994e-7,"teacher_disagreement_score":0.9942268,"about_ca_system_score_codex":0.000016349773,"about_ca_system_score_gemma":0.0003540091,"threshold_uncertainty_score":0.99039996},"labels":[],"label_agreement":null},{"id":"W4280501338","doi":"10.34067/kid.0007022021","title":"Inhibitory Antibodies against PCSK9 Reduce Surface CD36 and Mitigate Diet-Induced Renal Lipotoxicity","year":2022,"lang":"en","type":"article","venue":"Kidney360","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal; Montreal Clinical Research Institute; St. Joseph’s Healthcare Hamilton","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"CD36; Endocrinology; PCSK9; Internal medicine; Kidney; Lipotoxicity; Nephrology; LDL receptor; Inflammation; Chemistry; Receptor; Biology; Medicine; Lipoprotein; Cholesterol; Insulin resistance; Diabetes mellitus","score_opus":0.018707950151632985,"score_gpt":0.26000960771535386,"score_spread":0.24130165756372088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280501338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98905534,0.002143139,0.000008210027,0.0031594182,0.0004847563,0.0006998611,0.00010127,0.00014342197,0.004204594],"genre_scores_gemma":[0.99506766,0.0002818237,0.00041894504,0.0024345543,0.0005686348,0.000046110395,0.0000674475,0.000047699206,0.0010671213],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769354,0.00023123177,0.00033165605,0.00052261294,0.000758723,0.00046224386],"domain_scores_gemma":[0.99867827,0.00003089578,0.000101101396,0.00060048554,0.00008124037,0.00050800486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009588326,0.00023852957,0.0005176454,0.00008853397,0.00053751573,0.000024040244,0.00011232156,0.00009355839,0.00010067933],"category_scores_gemma":[0.00015158963,0.0002244612,0.0002349097,0.00026781985,0.00010629344,0.000095230826,0.00026511232,0.00062978786,0.000017351267],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008961108,0.0005013229,0.007759864,0.0007708316,0.0007157946,0.0008965114,0.001677577,0.000070642534,0.92912334,0.0003051052,0.03491125,0.02237167],"study_design_scores_gemma":[0.011309742,0.0031775974,0.08377156,0.0006707966,0.00061812886,0.0010800669,0.0035677317,0.00077238923,0.49427193,0.00044199923,0.39866892,0.0016491255],"about_ca_topic_score_codex":0.00027471143,"about_ca_topic_score_gemma":0.000008952498,"teacher_disagreement_score":0.43485138,"about_ca_system_score_codex":0.00017018091,"about_ca_system_score_gemma":0.00041556454,"threshold_uncertainty_score":0.91532624},"labels":[],"label_agreement":null},{"id":"W4280586201","doi":"10.1093/eurjpc/zwac056.061","title":"LDL goal as a risk factor target in the post-intervention outpatient cardiology population","year":2022,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lakeridge Health","funders":"","keywords":"Medicine; Internal medicine; Percutaneous coronary intervention; Coronary artery disease; Cardiology; Population; Conventional PCI; Concordance; Outpatient clinic; Myocardial infarction","score_opus":0.012910104984122917,"score_gpt":0.2672937953913225,"score_spread":0.25438369040719955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280586201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041295,0.0027355505,0.0027661775,0.0003828257,0.0010666715,0.00062230363,0.0000665653,0.000010154814,0.001936821],"genre_scores_gemma":[0.9981909,0.00017220456,0.00017532369,0.0003458904,0.0009315602,0.0000161847,0.00006006728,0.00002869289,0.000079182006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9854168,0.012767826,0.0007868158,0.00024283389,0.00049703097,0.00028864644],"domain_scores_gemma":[0.998593,0.00009146853,0.0006236866,0.00036331284,0.00023576738,0.0000927974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006581587,0.00016761538,0.0007472364,0.00025144935,0.00017181164,0.000010648917,0.00026650215,0.00004146071,0.00014015843],"category_scores_gemma":[0.00056232087,0.000118314085,0.0011971209,0.00019200734,0.000055210425,0.00007188419,0.0001518888,0.0010862382,0.000021119333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004330597,0.00061139144,0.776638,0.0001734752,0.004363685,0.014903392,0.008836066,0.008465324,0.0010396461,0.00032133423,0.0027474943,0.17756961],"study_design_scores_gemma":[0.0028378211,0.0050494545,0.9637476,0.00004081545,0.00026608873,0.0056147985,0.0027610282,0.0000111667205,0.000012027789,0.00018170607,0.019364614,0.00011285271],"about_ca_topic_score_codex":0.000119135475,"about_ca_topic_score_gemma":0.000003910647,"teacher_disagreement_score":0.18710963,"about_ca_system_score_codex":0.00023247945,"about_ca_system_score_gemma":0.000088464876,"threshold_uncertainty_score":0.48247084},"labels":[],"label_agreement":null},{"id":"W4281250602","doi":"10.1016/j.atherosclerosis.2022.04.009","title":"Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis","year":2022,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lipoprotein(a); Fibrinolysis; Apolipoprotein B; Fibrin; Tissue factor; Medicine; Antifibrinolytic; Thrombosis; Microvesicle; Tissue factor pathway inhibitor; Lipoprotein; Internal medicine; Coagulation; Endocrinology; Immunology; Chemistry; Biochemistry; Cholesterol; Surgery","score_opus":0.06956352934997967,"score_gpt":0.3355714054928409,"score_spread":0.26600787614286125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281250602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010493513,0.9927557,0.0000017864173,0.00005120486,0.00016293503,0.0015842201,0.00004830297,0.000035054407,0.004311413],"genre_scores_gemma":[0.0012373916,0.9975189,0.000047349284,0.00010676342,0.00019771646,0.0005960221,0.00005749959,0.00010025447,0.00013807835],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971031,0.0003988041,0.00085128,0.00047377052,0.0007647122,0.00040831184],"domain_scores_gemma":[0.99792564,0.00022118054,0.00041604158,0.0013130032,0.000030314382,0.000093834045],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011757298,0.0003701357,0.002599769,0.00027845812,0.00017683866,0.000036204972,0.0003699087,0.00023580488,0.0007301569],"category_scores_gemma":[0.00007785866,0.00025192922,0.0017163268,0.0010181924,0.00012094768,0.000043365184,0.00022780031,0.0006940959,0.00003302091],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003678534,0.00009654404,0.00029248718,0.0053133992,0.00078944914,0.0000016243747,0.00034126354,6.0548916e-7,0.000017941858,0.00035473984,0.00008819961,0.99270004],"study_design_scores_gemma":[0.0003835941,0.00013017099,0.0006901195,0.0060825157,0.0020558813,0.000022238492,0.00040463638,0.000002336195,0.00001379625,0.00003738351,0.98995537,0.00022194628],"about_ca_topic_score_codex":0.0024797274,"about_ca_topic_score_gemma":0.000089629764,"teacher_disagreement_score":0.99247813,"about_ca_system_score_codex":0.00040137063,"about_ca_system_score_gemma":0.00046264543,"threshold_uncertainty_score":0.9999933},"labels":[],"label_agreement":null},{"id":"W4281252302","doi":"10.1016/j.atherosclerosis.2022.04.017","title":"The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target","year":2022,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Regeneron Pharmaceuticals; Sanofi; Eli Lilly and Company; Amgen","keywords":"Lipoprotein(a); Lipoprotein; Ethnic group; Genetic epidemiology; Publication; Medicine; Curiosity; Epidemiology; Disease; Engineering ethics; Intensive care medicine; Psychology; Political science; Internal medicine; Engineering; Neuroscience; Cholesterol; Law","score_opus":0.081816754963065,"score_gpt":0.3152123330048583,"score_spread":0.23339557804179328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281252302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019986961,0.99248606,0.0005911667,0.00020576174,0.0006593965,0.0052294815,0.00018958705,0.0000834406,0.00035522986],"genre_scores_gemma":[0.0003259191,0.99581623,0.000462729,0.00032840052,0.00092199474,0.0015554813,0.000114444294,0.00022568341,0.0002490978],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939649,0.0011276725,0.0012346959,0.0009063994,0.002057593,0.0007087416],"domain_scores_gemma":[0.99484766,0.00033614456,0.0005226659,0.0037488518,0.00013519177,0.0004094649],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031866326,0.0007076202,0.004159601,0.00016080559,0.0006107003,0.00007755511,0.00084799266,0.00038572273,0.00049478066],"category_scores_gemma":[0.00023824254,0.00045548542,0.006340068,0.0009118505,0.00012443871,0.000056001507,0.00045735005,0.0011543863,0.000098037184],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025515508,0.00010424906,0.000040589526,0.0032087509,0.006928049,0.000013803624,0.00014122114,0.0000043864193,0.0000031856362,0.000028918856,0.00030406108,0.98919725],"study_design_scores_gemma":[0.00053274794,0.00028125552,0.0008362716,0.0049778363,0.005768295,0.0000455517,0.00006056132,0.0000017709713,0.000036141864,0.000047916004,0.9869797,0.0004319248],"about_ca_topic_score_codex":0.0025702051,"about_ca_topic_score_gemma":0.0000384825,"teacher_disagreement_score":0.98876536,"about_ca_system_score_codex":0.000476984,"about_ca_system_score_gemma":0.0007832993,"threshold_uncertainty_score":0.9997897},"labels":[],"label_agreement":null},{"id":"W4281256164","doi":"10.1016/j.atherosclerosis.2022.04.015","title":"Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective","year":2022,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Cardiology; Internal medicine; valvular heart disease; Epidemiology; Lipoprotein(a); Disease; Stroke (engine); Coronary artery disease; Lipoprotein; Cholesterol","score_opus":0.07192131058600731,"score_gpt":0.3215692077976607,"score_spread":0.24964789721165337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281256164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004181042,0.9952902,0.00012690882,0.000073229254,0.00015448351,0.0034318136,0.00011461298,0.00012900209,0.00026163436],"genre_scores_gemma":[0.00019260451,0.99624586,0.0008583527,0.00023279952,0.00055596896,0.0015984643,0.00005187384,0.00015727703,0.00010680376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953033,0.0011347381,0.00067318877,0.0015047643,0.00078768627,0.00059632043],"domain_scores_gemma":[0.9973601,0.00023209123,0.00020645013,0.001539944,0.00006571922,0.00059568987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012485574,0.00075551355,0.0046650562,0.00017641457,0.00036710425,0.00005433638,0.00019039024,0.00045535344,0.00025403965],"category_scores_gemma":[0.0005633339,0.0005564964,0.0031631212,0.0004074187,0.00028248582,0.00005075295,0.00044368554,0.0008893789,0.00001762298],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011807839,0.0000926321,0.00014250878,0.0085681025,0.0036670954,0.00006953228,0.000100293764,6.9607825e-7,3.1336748e-7,0.00018367362,0.000103271246,0.98706007],"study_design_scores_gemma":[0.00084891403,0.00049297675,0.0033573352,0.0031129029,0.011688216,0.0006197014,0.00022964786,0.0000065047398,1.5096577e-7,0.00018398071,0.978893,0.0005666948],"about_ca_topic_score_codex":0.0009366011,"about_ca_topic_score_gemma":0.0000030597962,"teacher_disagreement_score":0.98649335,"about_ca_system_score_codex":0.00035335793,"about_ca_system_score_gemma":0.00031121244,"threshold_uncertainty_score":0.9996886},"labels":[],"label_agreement":null},{"id":"W4281298326","doi":"10.1007/s12325-022-02130-4","title":"Cost-Effectiveness Analysis of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease in Canada","year":2022,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); Université de Montréal; Montreal Heart Institute","funders":"Amgen Canada; Amgen","keywords":"Evolocumab; Medicine; Ezetimibe; Statin; Dyslipidemia; Internal medicine; Context (archaeology); Cohort; Quality-adjusted life year; Cardiology; Physical therapy; Cost effectiveness; Disease; Cholesterol; Apolipoprotein B","score_opus":0.010983426101665434,"score_gpt":0.255251527536024,"score_spread":0.24426810143435854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281298326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834928,0.014621137,0.00009117433,0.00001974026,0.00006961096,0.0016313377,0.00004091372,0.000005380011,0.000027934635],"genre_scores_gemma":[0.9968105,0.0022358438,0.000038738253,0.00012133414,0.000009339404,0.0007119624,0.000050961575,0.000019453963,0.0000018847239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771637,0.00044349502,0.0002901503,0.00034419823,0.00094307825,0.0002626999],"domain_scores_gemma":[0.99902797,0.00006123997,0.000070513706,0.00067788543,0.00007929459,0.000083081126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006042748,0.00014320972,0.00077236345,0.00032755322,0.000032299766,0.0000021242747,0.0001127739,0.000017730048,0.000035462675],"category_scores_gemma":[0.000035396817,0.000118372634,0.00023516806,0.0018692741,0.000032149033,0.000091020804,0.000026812562,0.000211464,1.193341e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011151034,0.00022803186,0.74242115,0.00006591146,0.0006784997,0.00005488644,0.00012719064,0.19321132,0.0000020316115,0.000010980722,1.8812285e-7,0.062084686],"study_design_scores_gemma":[0.0075738127,0.00021609795,0.9896434,0.00008840271,0.00020170017,5.304609e-7,0.00022883133,0.0009557712,0.00003191615,0.00001962954,0.00091025315,0.00012965317],"about_ca_topic_score_codex":0.6183978,"about_ca_topic_score_gemma":0.5113878,"teacher_disagreement_score":0.24722223,"about_ca_system_score_codex":0.0013057038,"about_ca_system_score_gemma":0.00069150014,"threshold_uncertainty_score":0.49752808},"labels":[],"label_agreement":null},{"id":"W4281490019","doi":"10.1186/s12875-022-01735-6","title":"A cross-sectional study evaluating cardiovascular risk and statin prescribing in the Canadian Primary Care Sentinel Surveillance Network database","year":2022,"lang":"en","type":"article","venue":"BMC Primary Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Queen's University; World Wildlife Fund Canada; University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Socioeconomic status; Observational study; Concordance; Cross-sectional study; Disease; Logistic regression; Statin; Primary care; Risk assessment; Family medicine; Environmental health; Emergency medicine; Internal medicine; Population","score_opus":0.03584504882167454,"score_gpt":0.2930299485465341,"score_spread":0.25718489972485953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281490019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.955475,0.038815636,0.000058460024,0.000018614051,0.00027791393,0.0030026303,0.0005406521,0.000045131583,0.001765976],"genre_scores_gemma":[0.9949397,0.00009610353,0.0009365272,0.0005838834,0.00061759335,0.00061809394,0.0021278048,0.000051598596,0.000028737486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99401253,0.0021243934,0.0004969809,0.0007883779,0.0019401539,0.00063758093],"domain_scores_gemma":[0.9979246,0.00015430736,0.00012097743,0.0013001137,0.000279503,0.0002204746],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0062672747,0.00026968104,0.0005966585,0.00015117478,0.0015535428,0.00013628854,0.0002647445,0.000068395224,0.000034217996],"category_scores_gemma":[0.00017360912,0.00023327729,0.0003776219,0.00057301583,0.00006554946,0.00011409381,0.00036850377,0.0009366963,0.000002026778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015501572,0.00006187171,0.9782604,0.0008861696,0.00024276742,0.00022183373,0.0039885626,0.00713739,0.000004140731,0.0000034665684,0.00008533677,0.008953029],"study_design_scores_gemma":[0.0035797118,0.00030471935,0.9831916,0.000046848167,0.0002012791,0.00017460839,0.009148327,0.00016347677,7.1242704e-7,0.0000037177365,0.0029428825,0.00024213092],"about_ca_topic_score_codex":0.18846627,"about_ca_topic_score_gemma":0.16969006,"teacher_disagreement_score":0.03946467,"about_ca_system_score_codex":0.001970653,"about_ca_system_score_gemma":0.0029729342,"threshold_uncertainty_score":0.9997463},"labels":[],"label_agreement":null},{"id":"W4281569226","doi":"10.1371/journal.pone.0269002","title":"Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen","year":2022,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Guideline; Family medicine; Concordance; Risk assessment; Cross-sectional study; Statin; Canadian Cardiovascular Society; Physical therapy; Internal medicine; Pathology; Myocardial infarction","score_opus":0.03769493591879155,"score_gpt":0.29997161620791524,"score_spread":0.2622766802891237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281569226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868429,0.010395852,0.00012734992,0.00021020217,0.00002173305,0.0011853212,0.00010293325,0.000016683904,0.0010970585],"genre_scores_gemma":[0.99378157,0.0029415842,0.0027614976,0.00011247573,0.00008793298,0.00023217929,0.000037054306,0.00002443817,0.000021261902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789375,0.00059216726,0.0003146651,0.00022292159,0.0008269742,0.00014952627],"domain_scores_gemma":[0.99895936,0.00012176301,0.00019321842,0.00047378548,0.00020239527,0.00004945503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010488733,0.000108003864,0.0006381,0.00009372292,0.00007485749,0.0000051458333,0.00006544351,0.0000258448,0.00004601553],"category_scores_gemma":[0.00018103213,0.00010250816,0.00020140412,0.00030441556,0.00005470291,0.000093027746,0.00007365341,0.00021118531,5.9116775e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089704106,0.03850231,0.7866444,0.004614175,0.021931373,0.00007386644,0.0111883795,0.00073525985,0.005739386,0.00096422376,0.00008558595,0.128624],"study_design_scores_gemma":[0.0048149773,0.0018195941,0.98742115,0.00033787827,0.0017593554,0.0000060610946,0.0015113616,0.0004543519,0.0007462299,0.00012492636,0.000867022,0.00013709822],"about_ca_topic_score_codex":0.000289181,"about_ca_topic_score_gemma":0.000018147206,"teacher_disagreement_score":0.20077676,"about_ca_system_score_codex":0.00010930953,"about_ca_system_score_gemma":0.00020512717,"threshold_uncertainty_score":0.41801614},"labels":[],"label_agreement":null},{"id":"W4281759141","doi":"10.1016/j.ahj.2022.05.021","title":"Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronary heart disease","year":2022,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University","funders":"","keywords":"Medicine; Discontinuation; Statin; Internal medicine; Medical prescription; Myocardial infarction; Cardiology; Persistence (discontinuity); Observational study; Pharmacology","score_opus":0.016731741864463585,"score_gpt":0.25561690601162784,"score_spread":0.23888516414716426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281759141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972304,0.00044958876,0.0000106891375,0.0016742203,0.000105103594,0.00047196727,0.000009005472,0.0000132041705,0.000035810877],"genre_scores_gemma":[0.9973828,0.00009275319,0.0004975165,0.0017676365,0.00012527994,0.00004877406,0.0000072827497,0.000018885139,0.000059068312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847215,0.00011483861,0.00021532044,0.00025584255,0.00061464694,0.0003272042],"domain_scores_gemma":[0.99913365,0.00001733019,0.00007191463,0.0002348132,0.00006362519,0.00047869244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026795192,0.00014931215,0.0004425176,0.00011081104,0.00029183543,0.0000219896,0.000045482997,0.00000989603,0.00009475128],"category_scores_gemma":[0.000014789079,0.00011423419,0.00013538261,0.0002112924,0.0001392091,0.0000653357,0.00008500459,0.00032187338,0.000003052487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014671979,0.00041636286,0.9810986,0.000013843867,0.0000785124,0.00021486823,0.00027722705,0.000052739637,0.000019019884,7.5719703e-7,0.00019172912,0.01616913],"study_design_scores_gemma":[0.0022823394,0.00813856,0.9816263,0.000068501824,0.000080151316,0.00089907483,0.0014987139,0.000033546356,0.0000064468413,0.0000028785014,0.005237203,0.00012630175],"about_ca_topic_score_codex":0.00041298277,"about_ca_topic_score_gemma":0.000012381347,"teacher_disagreement_score":0.016042829,"about_ca_system_score_codex":0.00058470835,"about_ca_system_score_gemma":0.00030960055,"threshold_uncertainty_score":0.46583354},"labels":[],"label_agreement":null},{"id":"W4281812785","doi":"10.2337/db22-162-lb","title":"162-LB: Cardiovascular Outcomes in People with Type 2 Diabetes and Acute Coronary Syndrome—The ELIXA Biomarker Study","year":2022,"lang":"en","type":"article","venue":"Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Mace; Hazard ratio; Internal medicine; Acute coronary syndrome; Myocardial infarction; Type 2 diabetes; Proportional hazards model; Diabetes mellitus; Confidence interval; Conventional PCI; Endocrinology","score_opus":0.010210613569811355,"score_gpt":0.23409548867383828,"score_spread":0.22388487510402694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281812785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863093,0.0110251,0.000001071185,0.00046104606,0.00019108217,0.0018346705,0.000023017627,0.00006543981,0.00008926049],"genre_scores_gemma":[0.9983966,0.00012993717,0.000045662433,0.0005387944,0.000028871124,0.0005932237,0.000039889674,0.000055330624,0.00017168857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997413,0.0003822098,0.0002768847,0.00049062195,0.0009204407,0.0005168388],"domain_scores_gemma":[0.9986321,0.00010323966,0.000057173555,0.0010081838,0.000063892716,0.00013541321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001505091,0.00026203936,0.0009600945,0.00016597072,0.00030846283,0.00003256191,0.00017627077,0.00004661888,0.0001004104],"category_scores_gemma":[0.0000483134,0.00016878654,0.00027853853,0.0007075152,0.00008326136,0.00007998254,0.00027484918,0.00036179798,0.000009380516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046628033,0.00034033952,0.987063,0.000082224586,0.004411776,0.0003247994,0.0005269116,0.000026229007,0.0000878214,0.0000037486577,0.00009864753,0.006987911],"study_design_scores_gemma":[0.0026098327,0.0015490926,0.99063843,0.000027780496,0.0010435404,0.00011468778,0.0016271095,0.00009606391,0.000058168665,0.000013924101,0.0019943865,0.00022700285],"about_ca_topic_score_codex":0.00022388546,"about_ca_topic_score_gemma":0.00003907577,"teacher_disagreement_score":0.01208729,"about_ca_system_score_codex":0.00011599047,"about_ca_system_score_gemma":0.00012454508,"threshold_uncertainty_score":0.68829155},"labels":[],"label_agreement":null},{"id":"W4281848556","doi":"10.1016/j.jacl.2022.05.067","title":"Benefits of icosapent ethyl for enhancing residual cardiovascular risk reduction: A review of key findings from REDUCE-IT","year":2022,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"St. Jude Medical; Esperion Therapeutics; HLS Therapeutics; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Servier; Assistance publique-Hôpitaux de Paris; Pfizer; Moderna; Medicines Company; Regado Biosciences; Belvoir Media Group; MyoKardia; Novo Nordisk; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Duke Clinical Research Institute; Eisai; Brigham and Women's Hospital; Boston VA Research Institute; Boston Scientific Corporation; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; CSL Behring; Novartis; Amgen; Sanofi; American Heart Association","keywords":"Medicine; Residual risk; Hypertriglyceridemia; Myocardial infarction; Internal medicine; Cardiology; Revascularization; Clinical endpoint; Randomized controlled trial; Stroke (engine); Triglyceride; Cholesterol","score_opus":0.19410173038570255,"score_gpt":0.4499473697340759,"score_spread":0.25584563934837334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281848556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00067987596,0.98866916,0.00019228368,0.00065166806,0.0073449467,0.0021234653,0.00024067523,0.000009155202,0.00008875705],"genre_scores_gemma":[0.00001989084,0.9774085,0.005497266,0.00028259828,0.01642085,0.00009341673,0.00012179193,0.00009220772,0.00006344436],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.984036,0.0040493524,0.009117743,0.0007121955,0.0016357566,0.0004489277],"domain_scores_gemma":[0.9862213,0.003573193,0.007255232,0.0015660155,0.0009756461,0.00040859764],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.030663196,0.0005166136,0.014614142,0.0003758988,0.00010315598,0.000006606098,0.00060597947,0.0009444466,0.00058899616],"category_scores_gemma":[0.017726623,0.0003864102,0.015355658,0.0005110426,0.00023713015,0.00007455081,0.00023286122,0.003009069,0.000005800688],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042699985,0.00032496022,0.000013118328,0.09164771,0.01127117,0.000014574553,0.00005528171,0.000008031359,9.0035473e-7,0.00002669955,0.008365293,0.8878453],"study_design_scores_gemma":[0.002229529,0.0027804116,0.00010887168,0.10186794,0.029208364,0.0012609492,0.00005525996,1.7170063e-7,0.00001840744,0.00005133805,0.8621882,0.00023051056],"about_ca_topic_score_codex":0.00010593935,"about_ca_topic_score_gemma":0.0000060706366,"teacher_disagreement_score":0.8876147,"about_ca_system_score_codex":0.00020544956,"about_ca_system_score_gemma":0.0035053075,"threshold_uncertainty_score":0.9998588},"labels":[],"label_agreement":null},{"id":"W4281932311","doi":"10.1016/j.cjca.2022.05.021","title":"Alirocumab and Cardiovascular Outcomes in Patients With Previous Myocardial Infarction: Prespecified Subanalysis From ODYSSEY OUTCOMES","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; St. Michael's Hospital; University of Alberta; University of Toronto","funders":"European Metrology Programme for Innovation and Research; American Regent; Esperion Therapeutics; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Servier; Duke Clinical Research Institute; Eisai; Astellas Pharma; Uppsala Universitet; MyoKardia; Novo Nordisk; Daiichi-Sankyo; Medicines Company; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; Regeneron Pharmaceuticals; Pfizer; York University; Cleveland Clinic; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; University of Toronto; Heart and Stroke Foundation of Canada; European Commission; Sanofi; HLS Therapeutics; GlaxoSmithKline; Instituto de Salud Carlos III; Amgen","keywords":"Medicine; Mace; Myocardial infarction; Internal medicine; Hazard ratio; Alirocumab; Cardiology; Unstable angina; Acute coronary syndrome; Confidence interval; Percutaneous coronary intervention; Cholesterol","score_opus":0.009588145241084471,"score_gpt":0.21082006271836165,"score_spread":0.20123191747727717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281932311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922855,0.0047303513,0.0002303798,0.0007833905,0.0005345306,0.00052167283,0.00007962725,0.000007748499,0.0008267916],"genre_scores_gemma":[0.998728,0.00012936925,0.0001356497,0.00041164263,0.00044942595,0.00003258521,0.000037587317,0.000032969197,0.000042805383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997288,0.00060147926,0.00059725094,0.0003367735,0.00073508633,0.00044144556],"domain_scores_gemma":[0.9982113,0.000071186805,0.00018205763,0.0006679464,0.00024404729,0.00062341715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00105682,0.00023813744,0.0019669188,0.0006225677,0.00019630359,0.000025993288,0.00017989441,0.00011594385,0.000064315354],"category_scores_gemma":[0.00016103245,0.00018649189,0.0010383655,0.00032140742,0.00011846046,0.00009924761,0.00004745126,0.0006283519,0.0000016838294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002439115,0.000009567372,0.9767339,0.000012068302,0.007784205,0.00040060852,0.00019164907,0.0025198404,7.4061705e-7,0.000014896102,0.000431001,0.011657576],"study_design_scores_gemma":[0.005672975,0.0005718559,0.9237735,0.000014276511,0.0014069352,0.0002506671,0.00026766348,0.0000024395729,0.0000011771469,0.000045358734,0.06782148,0.00017166385],"about_ca_topic_score_codex":0.010255771,"about_ca_topic_score_gemma":0.0022447552,"teacher_disagreement_score":0.06739048,"about_ca_system_score_codex":0.0004694396,"about_ca_system_score_gemma":0.0010971318,"threshold_uncertainty_score":0.996335},"labels":[],"label_agreement":null},{"id":"W4282023851","doi":"10.5853/jos.2021.02152","title":"Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)","year":2022,"lang":"en","type":"article","venue":"Journal of Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Pfizer Canada; Canadian Institutes of Health Research; Chest Heart and Stroke Scotland; Vetenskapsrådet; AstraZeneca; Canadian Stroke Network; Stroke Association; Heart and Stroke Foundation of Canada","keywords":"Medicine; Association (psychology); Stroke (engine); Internal medicine; Psychology","score_opus":0.00974825289417705,"score_gpt":0.2576662166033759,"score_spread":0.24791796370919886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282023851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971462,0.00041033103,0.00019297916,0.00071852905,0.00027184314,0.0009574226,0.00016481522,0.000008916885,0.0001289468],"genre_scores_gemma":[0.99834955,0.000057391266,0.0005835426,0.00010481851,0.00051559886,0.00003685991,0.000003131851,0.000024240502,0.00032488038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710345,0.00036343117,0.00073436304,0.00020947718,0.0013473242,0.00024193084],"domain_scores_gemma":[0.9983146,0.000055694105,0.0007759358,0.00028158125,0.00038694363,0.00018523913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025189968,0.00016427312,0.0006837312,0.00045477177,0.00009925267,0.000031411415,0.0001539909,0.00006114775,0.00011993386],"category_scores_gemma":[0.00013615636,0.00013303485,0.00018442565,0.00016008205,0.00003295527,0.00028120514,0.00006243746,0.00072401675,3.8183376e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039989734,0.0017518005,0.9644246,0.000081811406,0.0017385203,0.0032824113,0.0018647619,0.00030249212,0.0031651251,0.000026951713,0.00004544306,0.0193171],"study_design_scores_gemma":[0.04282248,0.031597454,0.8773813,0.00022303093,0.001393827,0.015784603,0.0248746,0.0006225944,0.0017720794,0.000021774282,0.003107572,0.00039863624],"about_ca_topic_score_codex":0.0010750871,"about_ca_topic_score_gemma":0.00092106266,"teacher_disagreement_score":0.08704326,"about_ca_system_score_codex":0.0005021335,"about_ca_system_score_gemma":0.00023418889,"threshold_uncertainty_score":0.5425004},"labels":[],"label_agreement":null},{"id":"W4282829495","doi":"10.1097/mol.0000000000000823","title":"Understanding the ins and outs of lipoprotein (a) metabolism","year":2022,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"Canadian Institutes of Health Research","keywords":"Metabolism; Medicine; Endocrinology","score_opus":0.3837020292446779,"score_gpt":0.4250440476110824,"score_spread":0.0413420183664045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282829495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000030661488,0.9700101,0.00034297202,0.00016907862,0.027181374,0.0019691084,0.000034318713,0.000020008327,0.00026997464],"genre_scores_gemma":[0.000020841155,0.9921162,0.000039301915,0.000021523896,0.007179441,0.00042806406,0.00012901194,0.00004219083,0.000023401277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99702364,0.0009291597,0.0008326993,0.00046320734,0.00041243547,0.00033887697],"domain_scores_gemma":[0.9984836,0.00027853023,0.0004067496,0.0007068153,0.0000237406,0.0001005372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016361789,0.00032038215,0.002253368,0.00041282937,0.00010485228,0.000009146368,0.00021292423,0.00024407363,0.0002137659],"category_scores_gemma":[0.00024968694,0.00020945129,0.0005716407,0.0005323452,0.00021359866,0.000033265784,0.00030166542,0.0011792617,0.00000629164],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017949387,0.00008578732,0.000015054493,0.034772877,0.00019870095,2.3855551e-7,0.00023163891,5.409182e-7,6.3277035e-8,0.008748704,0.0024159686,0.9535125],"study_design_scores_gemma":[0.00066141185,0.00011535439,0.000073986645,0.0057640364,0.00039516692,0.0001526828,0.00016404368,0.0000036303845,4.2031527e-8,0.00036804468,0.99213886,0.0001627092],"about_ca_topic_score_codex":0.00006610018,"about_ca_topic_score_gemma":0.0000044279905,"teacher_disagreement_score":0.9897229,"about_ca_system_score_codex":0.0002409484,"about_ca_system_score_gemma":0.000534524,"threshold_uncertainty_score":0.8541176},"labels":[],"label_agreement":null},{"id":"W4282966850","doi":"10.1093/eurjpc/zwac107","title":"Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab","year":2022,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"American Regent; Regeneron Pharmaceuticals; National Institutes of Health; GlaxoSmithKline; HLS Therapeutics; Servier; Duke Clinical Research Institute; Astellas Pharma; Novo Nordisk; Daiichi-Sankyo; St. Jude Medical; Boston Scientific Corporation; Pfizer; York University; Cleveland Clinic; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; University of Toronto; Heart and Stroke Foundation of Canada; European Commission; Sanofi; Esperion Therapeutics; Amgen","keywords":"Alirocumab; Medicine; Ezetimibe; Acute coronary syndrome; Interquartile range; Statin; Internal medicine; Placebo; Cardiology; Cholesterol; Lipoprotein; Myocardial infarction","score_opus":0.011920852903500012,"score_gpt":0.253230899390221,"score_spread":0.24131004648672097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282966850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941468,0.0031829616,0.0014186001,0.00017945362,0.0001264065,0.00047383233,0.00009130764,0.000007153549,0.0003734853],"genre_scores_gemma":[0.99751204,0.0005907139,0.0012556268,0.00015772627,0.00011887737,0.00002056833,0.000025078229,0.00003844863,0.0002808964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630797,0.0023149108,0.00051557994,0.00024011548,0.00039211588,0.00022932314],"domain_scores_gemma":[0.9988996,0.000027500459,0.0003801153,0.00033061585,0.00015684932,0.00020533276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016103842,0.00018587957,0.00086586527,0.0001365158,0.000085315536,0.000005884307,0.00010787157,0.00001818353,0.00009721439],"category_scores_gemma":[0.000011983405,0.00012991761,0.0003284382,0.00009245659,0.00012548025,0.00007680729,0.00011882074,0.00025457988,0.0000020844666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032331374,0.002932589,0.33467063,0.0005896365,0.050423544,0.26067966,0.00999222,0.0013384174,0.0073226015,0.00020205737,0.00089200324,0.29862526],"study_design_scores_gemma":[0.007160844,0.0414862,0.8993113,0.00010704552,0.0017552517,0.041938268,0.001159765,0.0000028153556,0.00020197294,0.000028857923,0.0066824206,0.00016526949],"about_ca_topic_score_codex":0.000011504483,"about_ca_topic_score_gemma":0.0000013495513,"teacher_disagreement_score":0.56464064,"about_ca_system_score_codex":0.00015122359,"about_ca_system_score_gemma":0.00016733517,"threshold_uncertainty_score":0.5297887},"labels":[],"label_agreement":null},{"id":"W4283035029","doi":"10.1136/bmjmed-2022-000134","title":"Safety of ezetimibe in lipid-lowering treatment: systematic review and meta-analysis of randomised controlled trials and cohort studies","year":2022,"lang":"en","type":"article","venue":"BMJ Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"West China Hospital, Sichuan University; Sichuan University","keywords":"Ezetimibe; Meta-analysis; Medicine; Systematic review; Randomized controlled trial; Internal medicine; MEDLINE; Cholesterol; Biology","score_opus":0.10906229949736009,"score_gpt":0.39869970599019416,"score_spread":0.2896374064928341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283035029","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025234208,0.95031726,0.000045196874,0.0040626153,0.000048299666,0.019989032,0.00003552278,0.000010722801,0.00025712416],"genre_scores_gemma":[0.78203166,0.21066822,0.00009001214,0.0009998388,0.00007635034,0.0055221794,0.000037634574,0.00002231476,0.0005518261],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99432826,0.0018472119,0.0027415853,0.0002699657,0.00067142054,0.0001415662],"domain_scores_gemma":[0.99625045,0.0019199576,0.0010412016,0.0005430731,0.00015093737,0.000094403425],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.02413116,0.00021493321,0.020692108,0.00039466968,0.00005143173,0.0000013292475,0.00004743648,0.000030307576,0.00028506527],"category_scores_gemma":[0.0067212177,0.000105588944,0.0015002649,0.0006377499,0.00011016047,0.00001856285,0.000047223763,0.00008741428,9.059782e-8],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059317783,0.0001438131,0.0005307751,0.14617124,0.8455197,0.0000457405,0.0012124865,0.00003349184,0.000113790265,0.00003728337,0.0000738324,0.00018601646],"study_design_scores_gemma":[0.07733166,0.0006698968,0.00054120965,0.0027698644,0.9174625,0.000041713938,0.00096357777,0.00008454764,0.000023744238,0.0000046577197,0.000033036486,0.00007356019],"about_ca_topic_score_codex":0.00029050806,"about_ca_topic_score_gemma":0.00002908591,"teacher_disagreement_score":0.75679743,"about_ca_system_score_codex":0.00008815483,"about_ca_system_score_gemma":0.00007383503,"threshold_uncertainty_score":0.9938467},"labels":[],"label_agreement":null},{"id":"W4283311979","doi":"10.1016/j.cjca.2022.06.013","title":"PCSK9 Inhibition Following Myocardial Infarction: A Right Time to Act","year":2022,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Alirocumab; PCSK9; Evolocumab; Myocardial infarction; Mace; Internal medicine; Statin; Residual risk; Acute coronary syndrome; Randomized controlled trial; Adverse effect; Cardiology; Cholesterol; Lipoprotein; Percutaneous coronary intervention; LDL receptor","score_opus":0.010133924553547202,"score_gpt":0.22548658336767186,"score_spread":0.21535265881412466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283311979","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076555614,0.0031630374,0.00043775036,0.9071559,0.008769965,0.0013748225,0.00021350218,0.000036767455,0.0711927],"genre_scores_gemma":[0.056790058,0.000076048615,0.00026490437,0.8349815,0.10270436,0.00008736183,0.00060615694,0.00020655034,0.0042830794],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968317,0.00062341685,0.00070351304,0.0003589955,0.0007163561,0.00076602143],"domain_scores_gemma":[0.9977914,0.000062458115,0.00027622937,0.0005953706,0.0002856697,0.00098887],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013759964,0.0003380023,0.001789847,0.0011704497,0.00027295938,0.000040354662,0.00020881089,0.0007992398,0.0015679974],"category_scores_gemma":[0.00024275023,0.00031584388,0.00237829,0.00037631192,0.00007102396,0.00008581742,0.00003700529,0.003189329,0.0002334007],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005713236,8.788675e-7,0.00022643738,0.00005173998,0.0020798838,0.018352179,0.0000580931,0.00018967804,0.00002980367,0.0000024743063,0.97514856,0.0038031167],"study_design_scores_gemma":[0.0010069062,0.0009068592,0.0013422595,0.00013982358,0.0009740129,0.01367703,0.00001750681,7.404268e-7,0.000008646649,0.000043474225,0.9816138,0.0002689269],"about_ca_topic_score_codex":0.0013027168,"about_ca_topic_score_gemma":0.000114924725,"teacher_disagreement_score":0.093934394,"about_ca_system_score_codex":0.0015603104,"about_ca_system_score_gemma":0.0058873263,"threshold_uncertainty_score":0.99992937},"labels":[],"label_agreement":null},{"id":"W4283382810","doi":"10.1097/cd9.0000000000000053","title":"Rationale, Criteria, and Impact of Identifying Extreme Risk in Patients with Atherosclerotic Cardiovascular Disease","year":2022,"lang":"en","type":"article","venue":"Cardiology Discovery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Medicine; Dyslipidemia; Atherosclerotic cardiovascular disease; Risk stratification; Intensive care medicine; Disease; Risk assessment; Clinical Practice; Terminology; Internal medicine; Physical therapy; Computer science","score_opus":0.022805375018220646,"score_gpt":0.2545690219809509,"score_spread":0.23176364696273025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283382810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207675,0.00550108,0.0009863023,0.000015344553,0.00011304482,0.0010054479,0.00021404034,0.000013011493,0.00007499509],"genre_scores_gemma":[0.9991868,0.0002497154,0.000058354985,0.000037242047,0.00010246707,0.00015886227,0.00015045487,0.000026736789,0.000029323142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810797,0.00048122657,0.00026627723,0.00039573558,0.00049497734,0.00025381814],"domain_scores_gemma":[0.9990139,0.000036327503,0.00008824284,0.0006646708,0.000069774265,0.00012706517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075509987,0.00016450467,0.0007426723,0.00015222539,0.00012206761,0.000013582305,0.000070402966,0.000041711817,0.000027580027],"category_scores_gemma":[0.00009432813,0.00012913145,0.0006675514,0.00021272391,0.00012154461,0.0001694633,0.00012600295,0.0002455749,8.636715e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078201323,0.000083490864,0.98894054,0.0001135594,0.0017026681,0.00007415176,0.000100760335,0.006593771,0.00004379713,0.00002091134,0.000042237756,0.0015021052],"study_design_scores_gemma":[0.0038232657,0.00043218464,0.99457186,0.000044375505,0.00059856975,0.000030801886,0.00012385275,0.00006226034,0.0000043171576,0.00007150014,0.00010670272,0.00013028526],"about_ca_topic_score_codex":0.00034603605,"about_ca_topic_score_gemma":0.0000026083724,"teacher_disagreement_score":0.0071101096,"about_ca_system_score_codex":0.00019858689,"about_ca_system_score_gemma":0.00024775494,"threshold_uncertainty_score":0.5265828},"labels":[],"label_agreement":null},{"id":"W4283524809","doi":"10.1016/j.jval.2022.04.1033","title":"HSD32 Using Natural Language Processing (NLP) of Unstructured EMR Data to Describe Canadian Patients with Familial Hypercholesterolemia (FH) and Their Management","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); St. Michael's Hospital; University of Regina; University of British Columbia","funders":"","keywords":"Medicine; Ezetimibe; Statin; Medical record; Diabetes mellitus; Electronic medical record; Internal medicine; Familial hypercholesterolemia; Natural history; Pediatrics; Cholesterol; Family medicine","score_opus":0.03412514860987251,"score_gpt":0.27114720835118716,"score_spread":0.23702205974131466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283524809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955175,0.0022831592,0.000049241567,0.0004394429,0.00012517787,0.0013122814,0.00021796189,0.000013972131,0.000041290205],"genre_scores_gemma":[0.9944765,0.000020801317,0.00374273,0.0014378128,0.00005923094,0.000016305688,0.00020852964,0.000027819491,0.0000102678905],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983019,0.00018604784,0.00030887264,0.00039143735,0.00040765235,0.00040404522],"domain_scores_gemma":[0.99894685,0.000009038273,0.0000835525,0.00061484805,0.00003994701,0.00030575146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000765704,0.00014294594,0.0003628476,0.00026485568,0.00020492962,0.0000139766635,0.00017966049,0.000029600063,0.0000057980074],"category_scores_gemma":[0.000018634224,0.00011238418,0.000025992125,0.0004057595,0.000029478397,0.00007799784,0.00019738881,0.0003045038,1.8240048e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081241503,0.00023454182,0.16032007,0.004963182,0.00021810287,0.00017129527,0.021683512,0.0034755657,0.00020878007,0.00005079933,0.0002646274,0.8075971],"study_design_scores_gemma":[0.0081321895,0.001238743,0.94121873,0.0017116328,0.00011217326,0.00021743597,0.017992364,0.022055924,0.00006603492,0.000020158237,0.0067212717,0.0005133602],"about_ca_topic_score_codex":0.25874323,"about_ca_topic_score_gemma":0.019854402,"teacher_disagreement_score":0.8070837,"about_ca_system_score_codex":0.0006195591,"about_ca_system_score_gemma":0.0008010107,"threshold_uncertainty_score":0.9980307},"labels":[],"label_agreement":null},{"id":"W4283591226","doi":"10.14740/jocmr4740","title":"The Necessity of Collaboration With Doctors Involved in Annual Medical Checkups in the Identification of Familial Hypercholesterolemia in Japan","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Foundation for Development of Community","keywords":"Medicine; Identification (biology); Familial hypercholesterolemia; Family medicine; Internal medicine; Cholesterol","score_opus":0.10474900459914255,"score_gpt":0.4883092246423055,"score_spread":0.3835602200431629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283591226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97015035,0.0010104937,0.00001667473,0.027900886,0.00019373225,0.0006292418,0.0000039394004,0.0000012166873,0.0000934837],"genre_scores_gemma":[0.99773324,0.0014451647,0.000021371281,0.00022018107,0.0005192761,0.000028338445,0.000004308466,0.000008685425,0.000019466628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98619086,0.004932965,0.0031670798,0.00019705725,0.0052152304,0.0002968201],"domain_scores_gemma":[0.994644,0.0030011935,0.00073651393,0.00047724374,0.00096025586,0.00018082184],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0940704,0.00008872054,0.0008333983,0.00047416624,0.00009040564,0.0000076770175,0.0005485777,0.00012878161,0.000027611954],"category_scores_gemma":[0.014182004,0.000042876032,0.00012465147,0.0020697527,0.00075038,0.00010117768,0.00010213198,0.0029498613,3.4075853e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006677918,0.0013708636,0.92620647,0.000273873,0.00009719514,0.00025634278,0.006806329,0.00008214703,0.00088264147,0.00020146092,0.0010098933,0.05613487],"study_design_scores_gemma":[0.008317697,0.0041889837,0.94333106,0.0006146548,0.00003300331,0.00007739028,0.041282967,0.00029025614,0.00018117912,0.00020088974,0.0014402475,0.000041646814],"about_ca_topic_score_codex":0.0010337878,"about_ca_topic_score_gemma":0.0022659567,"teacher_disagreement_score":0.079888396,"about_ca_system_score_codex":0.00018154696,"about_ca_system_score_gemma":0.0022934142,"threshold_uncertainty_score":0.99935037},"labels":[],"label_agreement":null},{"id":"W4283739701","doi":"10.1161/circulationaha.121.057807","title":"Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab","year":2022,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; St. Michael's Hospital","funders":"Sanofi","keywords":"Medicine; Residual risk; Acute coronary syndrome; Cardiology; Internal medicine; Alirocumab; Apolipoprotein B; Atherosclerotic cardiovascular disease; Cholesterol; Disease; Myocardial infarction; Apolipoprotein A1","score_opus":0.0059349546890569704,"score_gpt":0.21736393198106774,"score_spread":0.21142897729201077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283739701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98410785,0.013419184,0.00075633056,0.00006210382,0.00014767883,0.0013557865,0.000032701253,0.000046734218,0.00007162797],"genre_scores_gemma":[0.9988064,0.00024728928,0.00028564112,0.000097095806,0.00008897225,0.00034561034,0.00006337613,0.000034617184,0.000031005246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980368,0.0003055087,0.0002695591,0.00034657543,0.0008278295,0.00021374851],"domain_scores_gemma":[0.99902976,0.00002823723,0.00010246363,0.0006682192,0.000058645004,0.000112654474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006924528,0.0001459022,0.0004984849,0.00013854523,0.00017997078,0.000007673883,0.0000519089,0.00007358974,0.00005574678],"category_scores_gemma":[0.00004431786,0.00014629985,0.0003739013,0.00023038429,0.000053458898,0.00007704201,0.000104914354,0.0002529824,0.0000041664484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015171146,0.0005551862,0.74949443,0.004301785,0.012939192,0.0041838214,0.0020321556,0.0017734546,0.005387109,0.00041675623,0.00027973938,0.21711923],"study_design_scores_gemma":[0.0024099199,0.00031619414,0.99163234,0.00006118119,0.0015199691,0.0016520798,0.000056484896,0.0001540528,0.00071064214,0.00022544569,0.0011116099,0.00015009705],"about_ca_topic_score_codex":0.00056409655,"about_ca_topic_score_gemma":0.0000028363172,"teacher_disagreement_score":0.24213786,"about_ca_system_score_codex":0.0001358471,"about_ca_system_score_gemma":0.00009080701,"threshold_uncertainty_score":0.5965935},"labels":[],"label_agreement":null},{"id":"W4283757146","doi":"10.1093/eurheartj/ehac339","title":"Aortic stenosis in homozygous familial hypercholesterolaemia: a paradigm shift over a century","year":2022,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Cardiology; Stenosis; Familial hypercholesterolemia; Statin; Supravalvular aortic stenosis; Disease; Coronary artery disease; Pediatrics; Cholesterol","score_opus":0.07056346351888988,"score_gpt":0.33381066777335344,"score_spread":0.2632472042544636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283757146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034342068,0.99216634,0.000009137545,0.00019658357,0.001098729,0.0012314653,0.000029021396,0.00005631048,0.0017782281],"genre_scores_gemma":[0.00079269137,0.99491423,0.00008225692,0.00090194325,0.0028501202,0.00004381112,0.000046399557,0.0002443117,0.00012422867],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932226,0.0028538934,0.0012969621,0.0006171109,0.0011783144,0.0008311065],"domain_scores_gemma":[0.99792373,0.00010036076,0.00035359422,0.0009392496,0.000018825398,0.0006642557],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0032335124,0.00058102154,0.0026409978,0.00059885276,0.00029511642,0.00014531525,0.00035570253,0.00017613813,0.00073146715],"category_scores_gemma":[0.00012454676,0.0004568626,0.0021369245,0.0005863877,0.00005822102,0.00012447614,0.00025297116,0.0044369213,0.000262113],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047542362,0.00026185092,0.00055467954,0.0055603995,0.00040835043,0.010493781,0.00027347525,0.0000011315793,1.7988123e-7,0.00000923069,0.0016068663,0.9807825],"study_design_scores_gemma":[0.001375901,0.00039409578,0.014620163,0.007496458,0.00095741573,0.015766172,0.000030884054,9.3441264e-7,1.8181101e-8,0.000006090713,0.9589867,0.00036517624],"about_ca_topic_score_codex":0.000051776045,"about_ca_topic_score_gemma":0.0000035734538,"teacher_disagreement_score":0.9804173,"about_ca_system_score_codex":0.0008245996,"about_ca_system_score_gemma":0.0010127637,"threshold_uncertainty_score":0.9997883},"labels":[],"label_agreement":null},{"id":"W4283802206","doi":"10.1111/cge.14185","title":"Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the <scp> <i>APOE</i> </scp> gene","year":2022,"lang":"en","type":"review","venue":"Clinical Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Clinical Research Institute","funders":"","keywords":"Apolipoprotein E; Phenotype; Genetics; Biology; Gene; Familial hypercholesterolemia; Neuroscience; Medicine; Cholesterol; Internal medicine; Endocrinology","score_opus":0.17784803835469304,"score_gpt":0.39621265349424123,"score_spread":0.2183646151395482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283802206","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014382342,0.9799849,0.00016547731,0.0001761623,0.00062328816,0.003988668,0.000107561595,0.000037794984,0.00053382595],"genre_scores_gemma":[0.0014246736,0.991141,0.0013143588,0.0008206771,0.0042163716,0.00045549063,0.00027541775,0.0001248235,0.00022714832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99166685,0.0032369772,0.00226026,0.00096740155,0.0012057142,0.00066281564],"domain_scores_gemma":[0.985229,0.01144584,0.00062843773,0.0023131385,0.00006282109,0.00032072514],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0070240977,0.0005666092,0.002394716,0.00014509336,0.0004383568,0.00015360587,0.0009232282,0.00081715477,0.000018546405],"category_scores_gemma":[0.007749601,0.00033159278,0.001149398,0.0009895213,0.0003395696,0.000040435978,0.00053326215,0.003542685,0.000028885801],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028651828,0.0000974324,0.029570876,0.0034560508,0.0002899589,0.00017337337,0.00016552655,0.0000034194193,7.8482955e-8,0.000049224756,0.00092796213,0.96526325],"study_design_scores_gemma":[0.0007828812,0.00030165256,0.14692552,0.0010290565,0.0027607724,0.00033432478,0.00009864483,0.000010254913,1.236455e-7,0.00026652185,0.84736335,0.00012686064],"about_ca_topic_score_codex":0.0001121468,"about_ca_topic_score_gemma":0.000025966801,"teacher_disagreement_score":0.96513635,"about_ca_system_score_codex":0.00011909019,"about_ca_system_score_gemma":0.0010651447,"threshold_uncertainty_score":0.99991363},"labels":[],"label_agreement":null},{"id":"W4283817584","doi":"10.1161/jaha.122.025813","title":"Intensity of and Adherence to Lipid‐Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease","year":2022,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Mace; Internal medicine; Hazard ratio; Myocardial infarction; Odds ratio; Cardiology; Stroke (engine); Confidence interval; Percutaneous coronary intervention","score_opus":0.008361251681253295,"score_gpt":0.24373374893150077,"score_spread":0.23537249725024748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283817584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983532,0.00019074096,0.000005587467,0.00079104584,0.00014845682,0.0004885232,0.000014364494,0.0000032485243,0.0000048653706],"genre_scores_gemma":[0.9991052,0.00004112213,0.000113849565,0.0006507264,0.000050199124,0.0000084726025,9.763363e-7,0.000011030403,0.000018426446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980289,0.00025495834,0.0003585162,0.00010528307,0.0011211404,0.00013123263],"domain_scores_gemma":[0.99888223,0.000052907733,0.0004065458,0.00026287953,0.00027818815,0.000117226205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011826783,0.00008516091,0.00080934644,0.00010726831,0.000057261386,0.0000026136843,0.00007277199,0.000014246737,0.0000067796464],"category_scores_gemma":[0.00031468828,0.000056944882,0.0004235079,0.00032117873,0.00004055602,0.00006210033,0.00006936137,0.00021894358,2.3687092e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015667808,0.00019020845,0.99550134,0.000019874633,0.0006059613,0.0000035966789,0.00029779485,0.00035651927,0.00013011058,3.0509733e-7,0.000093030845,0.0012344767],"study_design_scores_gemma":[0.0019776772,0.0024270425,0.9944455,0.000072029514,0.00017768415,0.0000119422975,0.00033887927,0.000004430114,0.00009334215,0.0000049203577,0.00039482504,0.00005175276],"about_ca_topic_score_codex":0.0006764028,"about_ca_topic_score_gemma":0.0000062005824,"teacher_disagreement_score":0.002236834,"about_ca_system_score_codex":0.0003455919,"about_ca_system_score_gemma":0.00021454314,"threshold_uncertainty_score":0.23221448},"labels":[],"label_agreement":null},{"id":"W4285286761","doi":"10.1007/978-981-19-1592-5_2","title":"HDL and Cholesterol Ester Transfer Protein (CETP)","year":2022,"lang":"en","type":"article","venue":"Advances in experimental medicine and biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cholesterylester transfer protein; Reverse cholesterol transport; Cholesterol; Chemistry; Internal medicine; Endocrinology; Biochemistry; Lipoprotein; Medicine","score_opus":0.02458762084508887,"score_gpt":0.3362056878870194,"score_spread":0.3116180670419305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285286761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92302763,0.073188685,0.000063087806,0.0016974856,0.00014957452,0.0006719629,0.0000034397765,0.000018057004,0.0011800765],"genre_scores_gemma":[0.99542016,0.0014555549,0.0001372894,0.0023789355,0.00018975475,0.0003153023,0.000019543419,0.000011813743,0.000071663446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990222,0.00010435064,0.00021953558,0.0003163533,0.00012081905,0.00021672715],"domain_scores_gemma":[0.9996958,0.000017548087,0.000020145733,0.0001579127,0.000008640441,0.00009994685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026218646,0.0001315514,0.0003712096,0.00009563831,0.000092864226,0.0000021897195,0.000044277633,0.000045741755,0.00014665043],"category_scores_gemma":[0.000011068463,0.00009378441,0.000033269498,0.000102935184,0.0002614614,0.00007172804,0.0000684119,0.00021687293,7.623859e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001457576,0.0006438402,0.046716183,0.0004141454,0.00012541744,0.00018231253,0.0061103734,0.0000027229921,0.43196985,0.0044095838,0.00008368813,0.5078843],"study_design_scores_gemma":[0.035573013,0.02789964,0.028305952,0.0005722925,0.00013917405,0.0033427153,0.027627809,0.00009532408,0.08799279,0.0015818602,0.78597105,0.0008983904],"about_ca_topic_score_codex":0.0001728701,"about_ca_topic_score_gemma":0.000018000244,"teacher_disagreement_score":0.78588736,"about_ca_system_score_codex":0.000042469994,"about_ca_system_score_gemma":0.000017747005,"threshold_uncertainty_score":0.38244173},"labels":[],"label_agreement":null},{"id":"W4285368380","doi":"10.1161/atvb.41.suppl_1.p110","title":"Abstract P110: Molecular Modeling Of Apolipoprotein(a): Insight Into The Orientation Of Key Functional Domains Mediating Lipoprotein(a) Assembly And Ligand Binding","year":2021,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Kringle domain; Protein Data Bank (RCSB PDB); Chemistry; Apolipoprotein B; Lipoprotein; Molecular dynamics; Molecular model; Crystallography; Stereochemistry; Biochemistry; Recombinant DNA; Cholesterol; Gene","score_opus":0.029718223947476963,"score_gpt":0.27861566320551107,"score_spread":0.2488974392580341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285368380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917593,0.0017013703,0.0051227226,0.00059520826,0.00013278732,0.0005290525,0.000011906869,0.00002011977,0.00012755874],"genre_scores_gemma":[0.99276435,0.004459949,0.0022542737,0.00020099046,0.0001413975,0.00006698694,0.0000803911,0.000030616586,0.0000010556456],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979704,0.00019008221,0.0006417782,0.0005079965,0.00039006997,0.00029969768],"domain_scores_gemma":[0.99871284,0.00007457876,0.00024668055,0.0005342875,0.00029033987,0.00014126868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093710836,0.0002453249,0.0007433361,0.00012698496,0.00024621742,0.000030863226,0.0000772798,0.00022855386,0.000018808689],"category_scores_gemma":[0.00016538934,0.00018191701,0.0003174526,0.00031314287,0.00023458432,0.000113379916,0.00014010671,0.00022449931,0.0000013539462],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012186766,0.0001147423,0.013368209,0.00038502275,0.00074874115,5.579931e-7,0.0019138593,0.00005254096,0.9770739,0.0014080504,0.000001872579,0.004920294],"study_design_scores_gemma":[0.0032473453,0.00054749596,0.82623553,0.00057378365,0.00067993783,0.000012917713,0.0018452877,0.0023475226,0.16348684,0.00043064565,0.000228372,0.00036432443],"about_ca_topic_score_codex":0.00095607113,"about_ca_topic_score_gemma":0.00008319502,"teacher_disagreement_score":0.81358707,"about_ca_system_score_codex":0.000036526013,"about_ca_system_score_gemma":0.00014365198,"threshold_uncertainty_score":0.7418361},"labels":[],"label_agreement":null},{"id":"W4285370853","doi":"10.1161/atvb.41.suppl_1.mp47","title":"Abstract MP47: Assessment Of Atherosclerosis In A Novel Transgenic Mouse Expressing Pathogenic Levels Of Human Lipoprotein(a)","year":2021,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Apolipoprotein B; Transgene; Genetically modified mouse; Lipoprotein; Endocrinology; Internal medicine; Very low-density lipoprotein; Cholesterol; Lipoprotein(a); LDL receptor; Gene isoform; Biology; Chemistry; Molecular biology; Gene; Medicine; Biochemistry","score_opus":0.07642078063005343,"score_gpt":0.34024616726320456,"score_spread":0.26382538663315114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285370853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973486,0.00037221398,0.0012454788,0.00013326018,0.000062556974,0.0005781323,0.00011099524,0.000024568562,0.00012417708],"genre_scores_gemma":[0.993868,0.0019377106,0.0038282182,0.00012688382,0.00006177164,0.00008047303,0.000045908335,0.00004755107,0.0000034984853],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99739635,0.00020881284,0.00095069647,0.0006534871,0.00034107448,0.0004495864],"domain_scores_gemma":[0.99846184,0.0000456425,0.00026805236,0.00087939994,0.00018273942,0.00016234849],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009734325,0.00031308824,0.0013775534,0.0001735831,0.00010719833,0.000019637067,0.00013364904,0.00031950284,0.00016009278],"category_scores_gemma":[0.000035547677,0.0002831952,0.00072231214,0.00033322617,0.0002476462,0.00009640355,0.00010189295,0.00027574576,9.12987e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034109278,0.00068623817,0.08058853,0.0004664876,0.00046628044,1.4832047e-7,0.00046105083,0.0000035283372,0.91521746,0.00026892466,0.0000010937898,0.0018368305],"study_design_scores_gemma":[0.0035540333,0.00042240776,0.8991207,0.0005956945,0.00021603315,0.0000014228576,0.0002725799,0.000029467561,0.09548653,0.000025154253,0.000052004463,0.00022396528],"about_ca_topic_score_codex":0.00059820083,"about_ca_topic_score_gemma":0.00021916794,"teacher_disagreement_score":0.81973094,"about_ca_system_score_codex":0.000082363,"about_ca_system_score_gemma":0.00027554188,"threshold_uncertainty_score":0.99996203},"labels":[],"label_agreement":null},{"id":"W4285744945","doi":"10.3389/fcvm.2022.895031","title":"High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells","year":2022,"lang":"en","type":"article","venue":"Frontiers in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Probucol; Atherosclerotic cardiovascular disease; Mechanism (biology); Foam cell; Medicine; Disease; Lipoprotein; Cardiology; Cholesterol; Internal medicine; Physics","score_opus":0.014605040170812449,"score_gpt":0.22650113619898773,"score_spread":0.21189609602817527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285744945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43340963,0.11361078,0.42664874,0.0035256739,0.0073276036,0.014021282,0.00008985743,0.00024838423,0.0011180431],"genre_scores_gemma":[0.9793817,0.00029534393,0.017868042,0.0011418146,0.00043171743,0.00065728335,0.00006164062,0.00009341268,0.00006908422],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99456096,0.00054471806,0.00095703,0.00081675686,0.002452629,0.0006679196],"domain_scores_gemma":[0.9975454,0.000042293323,0.00020171859,0.0018217155,0.00017987422,0.00020898902],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0053534633,0.00040599337,0.0023748411,0.00091961824,0.0001255694,0.0000054125976,0.00035035235,0.00020138078,0.00009226076],"category_scores_gemma":[0.00009632074,0.00036874693,0.0011308822,0.0014135437,0.00021450082,0.00005642709,0.0001518957,0.0009995855,0.000001947141],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008189046,0.007418198,0.038537044,0.009558874,0.024457933,0.006731902,0.007993685,0.07642968,0.06950305,0.0035287142,0.005915813,0.74173605],"study_design_scores_gemma":[0.22853667,0.014487444,0.17999977,0.005378568,0.013617097,0.0017727612,0.021354103,0.041455258,0.33073694,0.008690366,0.14880209,0.005168952],"about_ca_topic_score_codex":0.0059268414,"about_ca_topic_score_gemma":0.000070709415,"teacher_disagreement_score":0.7365671,"about_ca_system_score_codex":0.00082385924,"about_ca_system_score_gemma":0.0005584766,"threshold_uncertainty_score":0.99987644},"labels":[],"label_agreement":null},{"id":"W4285795804","doi":"10.1093/brain/awac259","title":"Does the magnitude of lipid lowering with statin therapy indicate higher intracranial bleeding risk?","year":2022,"lang":"en","type":"letter","venue":"Brain","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Statin; Internal medicine; Cardiology","score_opus":0.012637938663978865,"score_gpt":0.24488517559204553,"score_spread":0.23224723692806667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285795804","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21277007,0.0013758852,0.00019871592,0.7796607,0.0013441864,0.0024652826,0.00021674189,0.00013248232,0.0018359112],"genre_scores_gemma":[0.064897254,0.0028628833,0.0019712967,0.88734245,0.032005165,0.00075563224,0.00048899127,0.00047775998,0.00919857],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973009,0.00029745363,0.00039417093,0.0004328833,0.00113953,0.00043505715],"domain_scores_gemma":[0.9984718,0.00020689504,0.00039743626,0.0007838223,0.000073227144,0.00006681741],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012351722,0.00032182355,0.00070311775,0.0001433173,0.0001974034,0.00003346733,0.00029458877,0.00026163558,0.0019316138],"category_scores_gemma":[0.00006063329,0.00014490535,0.000310683,0.00027071673,0.00014051644,0.000040773906,0.00009217689,0.0024954113,0.000007995412],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015393953,0.00019866622,0.004257885,0.0018486951,0.004134584,0.0020541637,0.0023923921,0.000022060914,0.0007684725,0.000024893408,0.77361655,0.20914227],"study_design_scores_gemma":[0.0021367066,0.0007159045,0.009178538,0.0001984577,0.0002238397,0.00008287072,0.00010851827,0.0000041977823,0.00027743293,0.000038161983,0.9867912,0.00024416152],"about_ca_topic_score_codex":0.0009732314,"about_ca_topic_score_gemma":0.00001909296,"teacher_disagreement_score":0.21317469,"about_ca_system_score_codex":0.00009619793,"about_ca_system_score_gemma":0.00025939615,"threshold_uncertainty_score":0.99980587},"labels":[],"label_agreement":null},{"id":"W4286516530","doi":"10.1016/j.jacl.2022.07.005","title":"Cognitive function with evolocumab in pediatric heterozygous familial hypercholesterolemia","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Université Laval; Université du Québec à Chicoutimi; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Amgen","keywords":"Evolocumab; Medicine; Familial hypercholesterolemia; Placebo; Cognition; Cognitive test; Tolerability; Confidence interval; Internal medicine; Adverse effect; Lipoprotein; Psychiatry; Cholesterol","score_opus":0.049849199616764955,"score_gpt":0.3603224030052448,"score_spread":0.31047320338847983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286516530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99418414,0.00081644545,0.0004905849,0.000932021,0.0028799453,0.00027723642,0.000003871297,0.000009760954,0.00040602393],"genre_scores_gemma":[0.98945385,0.000373378,0.0002497672,0.0026192158,0.007186226,0.00001598615,0.0000049794526,0.000020119502,0.000076473865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964678,0.0010606167,0.0012926927,0.00023314128,0.0006786085,0.00026710404],"domain_scores_gemma":[0.9982717,0.0004994843,0.0005605831,0.00021688324,0.00023720264,0.0002141246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004254984,0.00012533799,0.0009708319,0.0002608316,0.00007035893,0.000005531915,0.00010856311,0.00014952423,0.00013181698],"category_scores_gemma":[0.0008153003,0.00009142709,0.00041973495,0.0002921972,0.00008579793,0.000074983844,0.00007474642,0.0018306057,0.0000100298885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025854785,0.0013685005,0.86648756,0.000100781755,0.00044364954,0.00071874016,0.0001662921,0.00017768187,0.000029041666,0.00002559825,0.0014390919,0.1031883],"study_design_scores_gemma":[0.015975362,0.019914528,0.94744885,0.00004206327,0.0007263699,0.0042466316,0.00040453658,0.000027168046,0.0000036952251,0.00010444506,0.010989553,0.000116780015],"about_ca_topic_score_codex":0.000027742948,"about_ca_topic_score_gemma":0.000026067539,"teacher_disagreement_score":0.10307152,"about_ca_system_score_codex":0.00008628656,"about_ca_system_score_gemma":0.0006760726,"threshold_uncertainty_score":0.79531723},"labels":[],"label_agreement":null},{"id":"W4288535711","doi":"10.1007/s11883-022-01057-z","title":"Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond","year":2022,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Angiology; Medicine; Computational biology; Internal medicine; Bioinformatics; LDL receptor; Biology; Cholesterol; Lipoprotein","score_opus":0.09002270990961742,"score_gpt":0.3655635555840245,"score_spread":0.27554084567440706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288535711","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013055469,0.9829507,0.00002059912,0.000012141994,0.00095965783,0.0026189336,0.00006211397,0.00006250662,0.0002578696],"genre_scores_gemma":[0.0040731463,0.9939728,0.00011113934,0.000018663086,0.00025037926,0.0011173853,0.000275729,0.00014381376,0.000036943642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952029,0.00040514016,0.0020172603,0.0011543409,0.0006129119,0.00060746184],"domain_scores_gemma":[0.9969239,0.00013679352,0.0013147932,0.0013073131,0.000056057077,0.00026111965],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017834667,0.0006883711,0.003990094,0.0005898084,0.00013685104,0.000028725113,0.00017557126,0.0004146371,0.00026341536],"category_scores_gemma":[0.00020503307,0.00056925614,0.0013211876,0.00076234055,0.00020134148,0.00007760166,0.0003834233,0.0009450351,0.000003569992],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005597797,0.00028949368,0.006726047,0.012094623,0.00023288472,0.000012404154,0.00026081892,2.0833909e-7,0.00005254738,0.000034390294,0.0000481849,0.9802428],"study_design_scores_gemma":[0.0005914473,0.00023492654,0.0016493772,0.013143017,0.0011004984,0.00029968942,0.00007280242,0.0000012274569,0.000031666077,0.000049361824,0.9823472,0.00047878653],"about_ca_topic_score_codex":0.00009189146,"about_ca_topic_score_gemma":0.000010214967,"teacher_disagreement_score":0.98229903,"about_ca_system_score_codex":0.0003722493,"about_ca_system_score_gemma":0.00049561076,"threshold_uncertainty_score":0.99967587},"labels":[],"label_agreement":null},{"id":"W4289714329","doi":"10.1016/j.cjco.2022.05.003","title":"Prevalence and Treatment of Familial Hypercholesterolemia and Severe Hypercholesterolemia in Older Adults in Ontario, Canada","year":2022,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; Health Sciences Centre; Institute for Clinical Evaluative Sciences; McGill University; University Health Network; University of Toronto; Royal Victoria Hospital; Sunnybrook Health Science Centre; McGill University Health Centre","funders":"Canadian Institutes of Health Research; University of Toronto; Pfizer; Ministry of Health -Singapore; Heart and Stroke Foundation of Canada; Institute for Clinical Evaluative Sciences; McGill University; Canada Research Chairs; AstraZeneca; Novartis; Amgen; Sanofi; Merck","keywords":"Familial hypercholesterolemia; Medicine; Ambulatory; Population; Internal medicine; Cholesterol; Statin; Pediatrics; Gerontology; Gastroenterology","score_opus":0.01345974176805215,"score_gpt":0.2452784750554356,"score_spread":0.23181873328738345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289714329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964555,0.001036892,2.113359e-7,0.00024649332,0.000054680295,0.0015464482,0.000029971452,0.000003061085,0.00062674715],"genre_scores_gemma":[0.9984101,0.0002304725,0.00007876931,0.0003415244,0.000018158256,0.00021273598,0.000016832675,0.000013054591,0.0006783303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878746,0.00011385126,0.00026465955,0.0003452906,0.00028067414,0.00020805188],"domain_scores_gemma":[0.9994592,0.00002071673,0.000042886586,0.0003398844,0.000019019297,0.00011828265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029509197,0.00013108144,0.00048162515,0.00006156534,0.000050775114,0.000013468825,0.00011493143,0.00004147535,0.000094754105],"category_scores_gemma":[0.000009485835,0.000116956,0.000029448442,0.00009592384,0.000029462735,0.0000800777,0.00022258694,0.00020263944,2.4590585e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006073781,0.00021127844,0.9497879,0.0001963001,0.000031959495,0.00021368581,0.0034670334,0.000015785788,0.00006959534,0.0000036603299,0.00006248899,0.045332912],"study_design_scores_gemma":[0.008525743,0.00050877844,0.98620164,0.00024197642,0.000033760232,0.00023639627,0.0009350971,0.000021567292,0.000053051506,0.0000043794535,0.0031317219,0.00010586868],"about_ca_topic_score_codex":0.9796974,"about_ca_topic_score_gemma":0.98348826,"teacher_disagreement_score":0.045227043,"about_ca_system_score_codex":0.0009619662,"about_ca_system_score_gemma":0.0010710467,"threshold_uncertainty_score":0.4769327},"labels":[],"label_agreement":null},{"id":"W4289860843","doi":"10.1017/s0007114522002355","title":"Are all fibres created equal with respect to lipid lowering? Comparing the effect of viscous dietary fibre to non-viscous fibre from cereal sources: a systematic review and meta-analysis of randomised controlled trials","year":2022,"lang":"en","type":"review","venue":"British Journal Of Nutrition","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Dietary fibre; Randomized controlled trial; Medicine; Cholesterol; Internal medicine; Meta-analysis; Gastroenterology; Animal science; Food science; Chemistry; Biology","score_opus":0.07632212361760257,"score_gpt":0.34259727977374477,"score_spread":0.26627515615614217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289860843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028608015,0.9780981,0.0002382612,0.0001719969,0.000051655137,0.01781599,0.00073380227,0.00001253394,0.000016873972],"genre_scores_gemma":[0.008687635,0.9888545,0.00015098233,0.00020967434,0.000314583,0.0014924594,0.00019862753,0.000073861826,0.000017667411],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9865617,0.006190984,0.0048886198,0.00047689688,0.0015642265,0.00031756467],"domain_scores_gemma":[0.987462,0.004493695,0.0065220734,0.0007440816,0.0004307106,0.0003474556],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.013033891,0.00061349914,0.03885325,0.0006800717,0.00013469833,0.000109899716,0.00038394897,0.00017643863,0.00017841923],"category_scores_gemma":[0.004252147,0.00034044246,0.010881813,0.0010969756,0.00006094878,0.00009029285,0.00010678918,0.0006629015,7.6547116e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009928539,0.00022691042,0.0000020564694,0.6170169,0.36633092,0.0006125916,0.000081311635,0.000068320594,0.0000065481513,8.730437e-8,0.0006144669,0.0051113423],"study_design_scores_gemma":[0.023983195,0.0026156195,0.000017722357,0.2599511,0.7095524,0.0018798909,0.00008430528,0.000008559416,0.000009721881,7.4475685e-7,0.00167092,0.0002258085],"about_ca_topic_score_codex":0.0007741353,"about_ca_topic_score_gemma":0.00009028507,"teacher_disagreement_score":0.3570658,"about_ca_system_score_codex":0.00017376237,"about_ca_system_score_gemma":0.00019432163,"threshold_uncertainty_score":0.99990475},"labels":[],"label_agreement":null},{"id":"W4289866215","doi":"10.1016/j.clinbiochem.2022.08.002","title":"Association between circulating PCSK9 and proteinuria in nephrotic syndrome: A cross-sectional study","year":2022,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; McGill University","funders":"Institut de Recherche Clinique De Montréal; Fondation Leducq; AstraZeneca; Amgen","keywords":"Proteinuria; Nephrotic syndrome; Medicine; Cross-sectional study; Internal medicine; Pathology; Kidney","score_opus":0.04218264246624167,"score_gpt":0.36915183919485717,"score_spread":0.3269691967286155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289866215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982632,0.00021028964,0.0000051920674,0.00020608243,0.00011319979,0.0009638973,0.000016391125,0.00003820732,0.00018356585],"genre_scores_gemma":[0.99872106,0.0000036360927,0.00007981506,0.00012734912,0.00043420962,0.00019190166,0.000046070618,0.000016458243,0.0003794832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977043,0.00021915382,0.0007238049,0.00048281765,0.000636134,0.00023375913],"domain_scores_gemma":[0.99908084,0.00018416886,0.00018672994,0.00033704456,0.000060221726,0.00015099916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039253435,0.00011268703,0.0004184346,0.000034497247,0.00017421429,0.00003080341,0.000076905926,0.00016533937,0.00013418589],"category_scores_gemma":[0.0010794043,0.000116439754,0.00018267382,0.00023127448,0.00004294354,0.000027800996,0.00016288449,0.0008309711,0.000005320699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043181088,0.000369849,0.99708307,0.00010946241,0.00022719025,0.00011988301,0.000027558872,0.0000038495564,0.00033067112,6.5489644e-7,0.000023200328,0.0016614199],"study_design_scores_gemma":[0.0029957043,0.00041479937,0.9956781,0.000023295834,0.00008484914,0.00013519106,0.00014247598,0.000029130331,0.00014921378,0.000036800233,0.00019900501,0.000111412715],"about_ca_topic_score_codex":0.00010295593,"about_ca_topic_score_gemma":0.0000021197138,"teacher_disagreement_score":0.0029525233,"about_ca_system_score_codex":0.0003974066,"about_ca_system_score_gemma":0.00022244597,"threshold_uncertainty_score":0.47482756},"labels":[],"label_agreement":null},{"id":"W4290775737","doi":"10.1016/j.cjca.2022.05.002","title":"The Detection, Evaluation, and Management of Dyslipidemia in Children and Adolescents: A Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Clinical Practice Update","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Public Health Ontario; McGill University; McMaster University; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; Western University; Stollery Children's Hospital; University of British Columbia; BC Children's Hospital; Hospital for Sick Children; Université de Montréal; University of Alberta","funders":"Janssen Pharmaceuticals","keywords":"Dyslipidemia; Medicine; Disease; Intensive care medicine; Statin; Pediatrics; Internal medicine","score_opus":0.01185293378671965,"score_gpt":0.27668566512617354,"score_spread":0.2648327313394539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290775737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8869047,0.09769391,0.0004363214,0.008276855,0.0023279018,0.0025656405,0.00013206262,0.000007981066,0.0016545927],"genre_scores_gemma":[0.9873495,0.010436918,0.00012188942,0.0007663792,0.0012349148,0.0000415809,0.000015602718,0.000022850994,0.0000103613975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99542195,0.0021539298,0.0008745938,0.00032166275,0.00057310704,0.00065474666],"domain_scores_gemma":[0.99718755,0.0001326652,0.00038861134,0.00042623343,0.00072564476,0.0011393147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017258951,0.00017004904,0.00092603854,0.000496027,0.0005588198,0.00002447066,0.00018591051,0.00024595542,0.0000060167827],"category_scores_gemma":[0.0010310316,0.00015432648,0.0006419851,0.0004949915,0.00013442653,0.00009183616,0.000039497907,0.0009582591,0.0000012839123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052890922,0.0000028368054,0.9298047,0.000050519022,0.0044116243,0.00019192288,0.00010514786,0.0017837198,4.417557e-7,0.00006662071,0.004519924,0.05900967],"study_design_scores_gemma":[0.0019820281,0.00019383262,0.78810173,0.00001907028,0.001924507,0.0016858601,0.0005709136,0.00003806077,3.0437448e-7,0.00006359266,0.20530766,0.00011245871],"about_ca_topic_score_codex":0.31734022,"about_ca_topic_score_gemma":0.41838238,"teacher_disagreement_score":0.20078774,"about_ca_system_score_codex":0.00248756,"about_ca_system_score_gemma":0.006013675,"threshold_uncertainty_score":0.99962133},"labels":[],"label_agreement":null},{"id":"W4291019013","doi":"10.1093/fampra/cmac090","title":"Factors associated with statin discontinuation near end of life in a Danish primary health care cohort","year":2022,"lang":"en","type":"article","venue":"Family Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Discontinuation; Statin; Danish; Retrospective cohort study; Comorbidity; Cohort; Cohort study; Internal medicine; Odds ratio; Logistic regression; Clinical endpoint; Randomized controlled trial","score_opus":0.027707566880682006,"score_gpt":0.2849296841413494,"score_spread":0.2572221172606674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291019013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99152297,0.002291605,0.000101619546,0.001151661,0.000090494315,0.0012888121,0.000114221,0.000036492787,0.0034021556],"genre_scores_gemma":[0.9948307,0.00007543803,0.0006149403,0.003535731,0.000035310833,0.00009938382,0.0007071789,0.000032196927,0.00006911253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997193,0.00078486383,0.00042005442,0.00027710258,0.0010657456,0.00025922732],"domain_scores_gemma":[0.9986024,0.00026046444,0.00047865702,0.00035152945,0.0001685089,0.00013847108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018028943,0.00013283372,0.0005491,0.000078801655,0.00017021444,0.00001751145,0.0000712086,0.000041136584,0.00003273757],"category_scores_gemma":[0.00093480793,0.00011290361,0.00008415227,0.0004253165,0.00004151512,0.00022294445,0.00006098781,0.00047429415,9.4676113e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021811763,0.0024505586,0.92748874,0.0008038732,0.0016506294,0.0001427035,0.03186191,0.0006901657,0.00036736586,0.00016566514,0.00501452,0.027182711],"study_design_scores_gemma":[0.00249045,0.0013057675,0.9524837,0.000065894514,0.0001554854,0.0000056371837,0.023349276,0.000032540655,0.000016550299,0.0000013441519,0.019975206,0.00011815364],"about_ca_topic_score_codex":0.0072176107,"about_ca_topic_score_gemma":0.0003805099,"teacher_disagreement_score":0.027064558,"about_ca_system_score_codex":0.00083539705,"about_ca_system_score_gemma":0.0024248417,"threshold_uncertainty_score":0.9993934},"labels":[],"label_agreement":null},{"id":"W4291513501","doi":"10.1080/14656566.2022.2112945","title":"Colesevelam – a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia","year":2022,"lang":"en","type":"article","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Bile acid; Adverse effect; Internal medicine; Cholesterol; Diabetes mellitus; Glycemic; Pharmacology; Endocrinology; Gastroenterology","score_opus":0.031668729767103776,"score_gpt":0.34460110448075304,"score_spread":0.31293237471364926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291513501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.962212,0.02457296,0.002131972,0.004747943,0.0015108411,0.0037068068,0.00012267826,0.00030610987,0.0006886635],"genre_scores_gemma":[0.9815913,0.0031120789,0.0024412074,0.009465863,0.0012148037,0.0017138135,0.00007831879,0.00010215733,0.00028048787],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983572,0.00012437915,0.0002787517,0.00046169478,0.0004278444,0.00035016402],"domain_scores_gemma":[0.9993143,0.00004939653,0.00008248872,0.00030726,0.00004652047,0.00019999786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005169778,0.0002226513,0.00036435117,0.00011419887,0.00044750105,0.000029941535,0.00009584194,0.000056363697,0.00018599867],"category_scores_gemma":[0.000013734926,0.0001946849,0.00021066943,0.00013661609,0.000035495596,0.00007259309,0.000037703576,0.00029023332,0.000002454679],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021828818,0.00025459705,0.00018586151,0.000114958006,0.00013980994,0.000016001719,0.0015564223,0.000033355285,0.53775316,0.0001160929,0.0024630337,0.45518383],"study_design_scores_gemma":[0.019842114,0.0035832322,0.00048217166,0.00010241035,0.000023717785,0.00054183276,0.0012365774,0.003960328,0.17423116,0.000039976865,0.795473,0.0004834817],"about_ca_topic_score_codex":0.00011893439,"about_ca_topic_score_gemma":8.390005e-7,"teacher_disagreement_score":0.79301,"about_ca_system_score_codex":0.00022854323,"about_ca_system_score_gemma":0.00017440738,"threshold_uncertainty_score":0.793902},"labels":[],"label_agreement":null},{"id":"W4292261879","doi":"10.1016/j.bbalip.2022.159217","title":"PCSK9 deficiency results in a specific shedding of excess LDLR in female mice only: Role of hepatic cholesterol","year":2022,"lang":"en","type":"article","venue":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Hôpital Maisonneuve-Rosemont; Western University; Robarts Clinical Trials; Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"LDL receptor; PCSK9; Endocrinology; Internal medicine; Cholesterol; Biology; Knockout mouse; HMG-CoA reductase; Receptor; Lipoprotein; Medicine; Biochemistry; Reductase","score_opus":0.009541061243274378,"score_gpt":0.2451036340159646,"score_spread":0.23556257277269022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292261879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955455,0.0023709887,0.000019666675,0.00024187147,0.00008448448,0.0006014303,0.00010108598,0.000011112925,0.0010238626],"genre_scores_gemma":[0.99884444,0.0005069282,0.00031335812,0.00011850095,0.000047260626,0.000035660378,0.000095913296,0.000025946458,0.000012012362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974927,0.00044134012,0.0008393716,0.00055547483,0.00031218823,0.00035893056],"domain_scores_gemma":[0.99881124,0.00006830281,0.0003774989,0.00059248577,0.000060614642,0.00008984068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008326492,0.0002421104,0.0009004575,0.0003817065,0.000046519992,0.0000049073024,0.00025715062,0.00014962994,0.000009867328],"category_scores_gemma":[0.000035616395,0.00022869233,0.00027348404,0.00063904107,0.00027128556,0.000039394134,0.00023860659,0.00036751747,7.359356e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005781612,0.0008115856,0.0012907882,0.0004194802,0.000050225663,0.00000912036,0.0011652253,0.000019974974,0.9933364,0.00015352167,0.0000053284716,0.002160195],"study_design_scores_gemma":[0.0033490397,0.0015691288,0.02743215,0.00016252177,0.00008001169,0.000018988527,0.0010777041,0.0001069683,0.9656344,0.00011844511,0.00023533948,0.00021528477],"about_ca_topic_score_codex":0.0006420829,"about_ca_topic_score_gemma":0.000018359677,"teacher_disagreement_score":0.027701976,"about_ca_system_score_codex":0.000051578783,"about_ca_system_score_gemma":0.0001954901,"threshold_uncertainty_score":0.9325803},"labels":[],"label_agreement":null},{"id":"W4292605929","doi":"","title":"Frequency of Testing for Dyslipidemia: An Evidence-Based Analysis.","year":2014,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Observational study; Medicine; Randomized controlled trial; Internal medicine; Generalizability theory; Environmental health; Disease; Psychology","score_opus":0.08253026430329773,"score_gpt":0.2934793628455742,"score_spread":0.21094909854227645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292605929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9489511,0.0012268188,0.04463094,0.0011703612,0.00014013422,0.0024380167,0.000009049771,0.000087912595,0.0013456317],"genre_scores_gemma":[0.9845131,0.000003561492,0.013066152,0.0006059434,0.00048935186,0.0012414812,0.000015695892,0.000015174522,0.000049517017],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99864167,0.00011661065,0.0003372007,0.00026410355,0.00031764578,0.00032278977],"domain_scores_gemma":[0.9983675,0.00035001713,0.0001395088,0.0006247453,0.0002809859,0.00023722675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031474775,0.000099245684,0.00052824203,0.00017192173,0.00004922378,0.000008617035,0.00009160506,0.00008431544,0.000008548727],"category_scores_gemma":[0.0041493457,0.00007945287,0.0003655109,0.00061102386,0.000037391248,0.000095862946,0.000009540155,0.00009528852,0.0000010668628],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005512617,0.0001058958,0.37328,0.00063799956,0.000608238,0.0000017092392,0.000021279264,0.00027571945,0.00063390547,0.00038459137,0.00008885319,0.6239067],"study_design_scores_gemma":[0.0010257664,0.00022188,0.98968875,0.000064404965,0.0017339068,0.0000016368223,0.000010200669,0.0045396183,0.0020350183,0.00024811117,0.00032740438,0.00010329682],"about_ca_topic_score_codex":0.00039910022,"about_ca_topic_score_gemma":0.000046884707,"teacher_disagreement_score":0.6238034,"about_ca_system_score_codex":0.00005727769,"about_ca_system_score_gemma":0.00010437135,"threshold_uncertainty_score":0.4967454},"labels":[],"label_agreement":null},{"id":"W4293462875","doi":"10.1093/eurheartj/ehac361","title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1297,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Western University; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Genentech; Regeneron Pharmaceuticals; Mylan; National Institutes of Health; Esperion Therapeutics; Gilead Sciences; Servier; Daiichi-Sankyo; Agence Nationale de la Recherche; Quest Diagnostics; Ionis Pharmaceuticals; AstraZeneca; Amarin Corporation; Boston Scientific Corporation; Silence Therapeutics; Kowa Company; European Atherosclerosis Society; Sanofi; Amgen; Pfizer; Eli Lilly and Company; World Heart Federation; Amryt Pharma; U.S. Department of Veterans Affairs","keywords":"Medicine; Lipoprotein(a); Internal medicine; Risk factor; Cardiology; Familial hypercholesterolemia; Lipoprotein; Cholesterol","score_opus":0.0438328079251105,"score_gpt":0.2639777590560184,"score_spread":0.2201449511309079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293462875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98851633,0.007132933,0.00016844337,0.0019383914,0.00024732895,0.0011209656,0.000023334505,0.00008180217,0.00077048485],"genre_scores_gemma":[0.9949286,0.0014097493,0.0010001977,0.0016342988,0.00058700977,0.000042402728,0.000007908167,0.00015427878,0.00023555584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99377716,0.0028939561,0.000728631,0.0005784364,0.0013511286,0.00067069364],"domain_scores_gemma":[0.9980715,0.00003119033,0.00016060726,0.00083948596,0.00008777494,0.0008094787],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0076574488,0.00031652595,0.0006388539,0.00014218567,0.0007901224,0.00012616783,0.0001753471,0.00002148564,0.00017828537],"category_scores_gemma":[0.000091033304,0.0002907091,0.0010841799,0.00034126072,0.00012349543,0.000075022144,0.00035941528,0.0011165611,0.000047586578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023102313,0.004850837,0.5780058,0.0025920898,0.015587,0.014083398,0.020102091,0.01401793,0.016155405,0.00012731022,0.02990275,0.30226514],"study_design_scores_gemma":[0.0053843167,0.0007372672,0.9260764,0.00035377877,0.00059169054,0.0010283156,0.0014114702,0.0003906299,0.000030757543,0.000017986817,0.06358295,0.0003944468],"about_ca_topic_score_codex":0.00009202021,"about_ca_topic_score_gemma":0.0000011610971,"teacher_disagreement_score":0.3480706,"about_ca_system_score_codex":0.00037204786,"about_ca_system_score_gemma":0.00023704988,"threshold_uncertainty_score":0.9999545},"labels":[],"label_agreement":null},{"id":"W4293579189","doi":"10.1016/j.atherosclerosis.2022.06.862","title":"Association of combined intensity and adherence to statin/ezetimibe therapy with major adverse cardiovascular outcomes in patients with coronary heart disease","year":2022,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Mace; Internal medicine; Myocardial infarction; Cardiology; Intensity (physics); Adverse effect; Regimen; Ezetimibe; Angina; Heart failure; Unstable angina; Observational study; Statin; Percutaneous coronary intervention","score_opus":0.012700791394646322,"score_gpt":0.2206547735282334,"score_spread":0.20795398213358707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293579189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748975,0.00014574976,0.000031218715,0.00054626924,0.000041480547,0.0016237969,0.000084316365,0.000026411297,0.000010996107],"genre_scores_gemma":[0.99794775,0.000040244235,0.0005088384,0.0010947916,0.00000863565,0.00023673548,0.000036458976,0.000032188203,0.00009437114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980283,0.00017218456,0.0002312627,0.00033801122,0.0009858955,0.00024435745],"domain_scores_gemma":[0.9989837,0.00003479644,0.00009989784,0.0005103034,0.00018188324,0.00018941415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005509208,0.00017036138,0.00065733254,0.000079383055,0.00010969446,0.0000066630714,0.00006645308,0.000031883574,0.000045964865],"category_scores_gemma":[0.000043476404,0.00012674223,0.00016684414,0.00029626815,0.000037096823,0.00006623228,0.000075978365,0.0001746023,0.0000018545151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002738425,0.0005047729,0.99380887,0.000044111177,0.00059828203,0.000004411886,0.0004523839,0.00011647972,0.000049783543,0.0000027815265,0.00007029468,0.0016093934],"study_design_scores_gemma":[0.009500133,0.0038736474,0.9856342,0.00007366935,0.00020042877,0.0000010271586,0.0002735756,0.00000832082,0.000058363825,0.000005423172,0.00022317124,0.00014803866],"about_ca_topic_score_codex":0.0011113246,"about_ca_topic_score_gemma":0.000045896417,"teacher_disagreement_score":0.008174679,"about_ca_system_score_codex":0.00023128165,"about_ca_system_score_gemma":0.00010996432,"threshold_uncertainty_score":0.5168398},"labels":[],"label_agreement":null},{"id":"W4293585127","doi":"10.1016/j.atherosclerosis.2022.06.416","title":"Postprandial apolipoprotein(a) metabolism in familial hypercholesterolaemia: Therapeutic effect of omega-3 fatty acid supplementation","year":2022,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Postprandial; Internal medicine; Apolipoprotein B; Endocrinology; Triglyceride; Lipoprotein; Lipid metabolism; Lipoprotein(a); Apolipoprotein C2; Metabolism; Fatty acid; Omega 3 fatty acid; Medicine; Biology; Very low-density lipoprotein; Cholesterol; Biochemistry; Docosahexaenoic acid; Polyunsaturated fatty acid; Insulin","score_opus":0.016461872621051823,"score_gpt":0.2690434829366772,"score_spread":0.25258161031562537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293585127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959059,0.0010991533,0.00014244547,0.00041890418,0.00029521913,0.0018152621,0.000094433955,0.000045679782,0.00018300273],"genre_scores_gemma":[0.99783754,0.00021235917,0.00022071398,0.00060531695,0.00019733365,0.0007541016,0.00009312587,0.000054806726,0.000024727087],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971691,0.00064065395,0.0004898435,0.00039545327,0.00088706677,0.00041788438],"domain_scores_gemma":[0.99907434,0.00005532614,0.00013839692,0.0005730431,0.000043167514,0.00011573467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014947694,0.00024516642,0.00074358477,0.00021422163,0.00016627394,0.00001553195,0.00017331813,0.0000967255,0.00023312483],"category_scores_gemma":[0.000035744957,0.00021228494,0.00040171223,0.00050298986,0.00006549517,0.000107486005,0.00012009559,0.00046071364,0.000009514071],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004889196,0.0006068786,0.16558248,0.0004334288,0.00047137323,0.000013857824,0.0023957656,0.00006781449,0.70834357,0.00019625961,0.00005204186,0.11694732],"study_design_scores_gemma":[0.018299794,0.00435198,0.8201497,0.00007125547,0.00043307449,0.00004108584,0.00043925075,0.000050938743,0.15405208,0.000056831108,0.0017675684,0.00028641292],"about_ca_topic_score_codex":0.0017985323,"about_ca_topic_score_gemma":0.00006412663,"teacher_disagreement_score":0.65456724,"about_ca_system_score_codex":0.00022519768,"about_ca_system_score_gemma":0.000102851125,"threshold_uncertainty_score":0.8656729},"labels":[],"label_agreement":null},{"id":"W4293585396","doi":"10.1016/j.atherosclerosis.2022.06.466","title":"Whole exome/genome sequencing joint analysis in a family with oligogenic familial hypercholesterolemia","year":2022,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Clinical Research Institute","funders":"","keywords":"Exome sequencing; Proband; Genetics; Biology; Gene; Exome; Genetic linkage; Phenotype; Mutation","score_opus":0.035297547840989374,"score_gpt":0.2376498878193885,"score_spread":0.20235233997839913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293585396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971803,0.00062848465,0.0004371339,0.00032618767,0.000061016133,0.00068515114,0.000058051646,0.00008909166,0.00053462083],"genre_scores_gemma":[0.9965061,0.00012160345,0.00072297343,0.0017219386,0.00011490619,0.0003776853,0.000074400254,0.000066188775,0.00029422253],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99716264,0.00023025229,0.00046792088,0.0006368524,0.0009297629,0.00057256425],"domain_scores_gemma":[0.99864495,0.000016900465,0.00011182559,0.0009434086,0.00006192694,0.00022098562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010100532,0.00026952237,0.0008389278,0.0004948748,0.00025639375,0.000033410044,0.00018328853,0.00008082788,0.00013900682],"category_scores_gemma":[0.000014971803,0.00023425215,0.0005398895,0.002121304,0.00006335909,0.000091097485,0.00016562869,0.00054881396,0.000030640665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040068105,0.00049118366,0.19746113,0.00016430207,0.002778433,0.00017807964,0.0048456993,0.010930922,0.7768819,0.000040204097,0.00006233162,0.0057651475],"study_design_scores_gemma":[0.0031151075,0.0007357658,0.9878484,0.00005680785,0.0010870687,0.000060111346,0.0030488584,0.0004899543,0.0007783357,0.000011920791,0.0024296634,0.00033799975],"about_ca_topic_score_codex":0.0030521825,"about_ca_topic_score_gemma":0.00033511297,"teacher_disagreement_score":0.7903873,"about_ca_system_score_codex":0.0010685686,"about_ca_system_score_gemma":0.00033952296,"threshold_uncertainty_score":0.9552525},"labels":[],"label_agreement":null},{"id":"W4293778394","doi":"10.3390/ijms23169417","title":"Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels","year":2022,"lang":"en","type":"review","venue":"International Journal of Molecular Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"NewAmsterdam Pharma","keywords":"Cholesterylester transfer protein; Apolipoprotein B; Internal medicine; Mendelian randomization; Lipoprotein; Endocrinology; Medicine; Cholesterol; Pharmacology; Chemistry; Biochemistry; Genetic variants; Genotype","score_opus":0.04520261637509573,"score_gpt":0.3268203595623641,"score_spread":0.2816177431872684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293778394","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032060686,0.96164864,0.0029524514,0.00026884547,0.0010943792,0.0015423974,0.0000866436,0.000022810993,0.00032314466],"genre_scores_gemma":[0.024284542,0.9731222,0.00082598213,0.00025942104,0.00094016624,0.00021177421,0.00006378093,0.000095864045,0.00019629598],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99247015,0.00046458654,0.0014288246,0.00062928937,0.0045690793,0.00043807027],"domain_scores_gemma":[0.99828637,0.00003247399,0.0005865681,0.0004549145,0.00034806805,0.00029162763],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003348102,0.0004992935,0.0018253285,0.00081379234,0.00018729155,0.00010967271,0.000929861,0.00022893735,0.00026278934],"category_scores_gemma":[0.00014500441,0.00039008475,0.0036512634,0.00056222355,0.00019422923,0.0004409682,0.00018296162,0.00095899275,0.000015307895],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005218466,0.00023526781,0.000002696612,0.0018673581,0.003942186,0.001795404,0.000100741614,0.000045207336,0.0011849221,0.000032146498,0.00006178185,0.9906801],"study_design_scores_gemma":[0.0017508178,0.0006036828,0.000012552235,0.013512204,0.0018104044,0.0060750637,0.00010417749,0.0000020230175,0.0062025804,0.000069737835,0.96933746,0.0005192652],"about_ca_topic_score_codex":0.000077700424,"about_ca_topic_score_gemma":0.0000013607659,"teacher_disagreement_score":0.9901608,"about_ca_system_score_codex":0.0005998295,"about_ca_system_score_gemma":0.0014155115,"threshold_uncertainty_score":0.9998551},"labels":[],"label_agreement":null},{"id":"W4294012734","doi":"10.3949/ccjm.89a.21103","title":"Primary and secondary prevention of atherosclerotic cardiovascular disease: A case-based approach","year":2022,"lang":"en","type":"review","venue":"Cleveland Clinic Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Medtronic (Canada)","funders":"AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Medicine; Atherosclerotic cardiovascular disease; Modalities; Intensive care medicine; Primary care; Disease; Expert opinion; Risk assessment; Primary prevention; Secondary prevention; Medical decision making; Internal medicine; Family medicine","score_opus":0.10861992514305169,"score_gpt":0.3496311032312771,"score_spread":0.24101117808822542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294012734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037540102,0.99511707,0.0018794802,0.00008940274,0.000462982,0.0014867951,0.00004088851,0.00001149633,0.0005365132],"genre_scores_gemma":[0.00039987388,0.99692255,0.000722245,0.00014356706,0.0013008782,0.000051819177,0.00013822808,0.00008545659,0.0002353995],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99430317,0.0010638703,0.0023645128,0.0004447516,0.0015288675,0.00029485102],"domain_scores_gemma":[0.99618614,0.00038740155,0.0016604159,0.0009871316,0.00020025973,0.0005786761],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007857619,0.0004488553,0.005499513,0.0004444009,0.000107018015,0.0000072865337,0.00020998539,0.00026908878,0.0005783989],"category_scores_gemma":[0.0005248554,0.00028934728,0.0031623882,0.00040337176,0.00032049874,0.00006023173,0.00008712914,0.0015758671,0.0000016413553],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019458527,0.0002747685,0.00001977819,0.063332886,0.004728508,0.0032947995,0.000055470337,0.0000026413236,1.0854719e-7,0.000005313822,0.00045430748,0.9276368],"study_design_scores_gemma":[0.008245753,0.0021823847,0.00030261345,0.026143987,0.0299977,0.032652643,0.00019066111,0.000008464606,1.0423392e-7,0.000036976184,0.89999443,0.00024428248],"about_ca_topic_score_codex":0.000022529137,"about_ca_topic_score_gemma":3.794587e-7,"teacher_disagreement_score":0.92739254,"about_ca_system_score_codex":0.00021509119,"about_ca_system_score_gemma":0.0031546615,"threshold_uncertainty_score":0.9999559},"labels":[],"label_agreement":null},{"id":"W4294129812","doi":"10.1093/eurjpc/zwac188","title":"Effect of the LDL receptor mutation type on incident major adverse cardiovascular events in familial hypercholesterolaemia","year":2022,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia; Western University; McGill University Health Centre; Université de Montréal; Montreal Clinical Research Institute","funders":"Fondation Leducq; Agence Nationale de la Recherche","keywords":"Medicine; Mace; Internal medicine; Hazard ratio; LDL receptor; Incidence (geometry); Prospective cohort study; Mutation; Cohort study; Gastroenterology; Null allele; Cholesterol; Allele; Genetics; Lipoprotein; Gene; Confidence interval; Myocardial infarction; Biology","score_opus":0.01039891779556206,"score_gpt":0.25382913027733794,"score_spread":0.24343021248177588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294129812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948121,0.0018809307,0.00015884929,0.00010181252,0.0014678469,0.00072375225,0.000010408009,0.000005552941,0.0008387615],"genre_scores_gemma":[0.9990695,0.0001283637,0.00004341065,0.00015271321,0.00046765574,0.000010756109,0.000008315314,0.00003242166,0.00008684915],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9870686,0.011142016,0.00061382947,0.00022221956,0.0007415808,0.0002117838],"domain_scores_gemma":[0.99874336,0.00009980494,0.0003738188,0.0005008686,0.00017960675,0.000102549726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009020842,0.00016366607,0.0008525054,0.00019973346,0.00009423618,0.0000016898713,0.00027156618,0.00003672551,0.00003592397],"category_scores_gemma":[0.00068391796,0.000111768044,0.0014110205,0.00031408542,0.00006634406,0.000047432393,0.000194293,0.0007691381,0.000013995852],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03896746,0.00094861846,0.3927964,0.0015632653,0.020156568,0.012228719,0.0050665117,0.080190115,0.03154097,0.00008822575,0.0026361383,0.413817],"study_design_scores_gemma":[0.012168185,0.013030729,0.9523985,0.00032155216,0.0012070144,0.003515758,0.0004451514,0.0000063846473,0.00215535,0.000022272436,0.014542988,0.00018614376],"about_ca_topic_score_codex":0.000018079945,"about_ca_topic_score_gemma":8.5748627e-7,"teacher_disagreement_score":0.5596021,"about_ca_system_score_codex":0.00035892334,"about_ca_system_score_gemma":0.00018847309,"threshold_uncertainty_score":0.45577684},"labels":[],"label_agreement":null},{"id":"W4294408851","doi":"10.1210/clinem/dgac503","title":"Dysbetalipoproteinemia Is Associated With Increased Risk of Coronary and Peripheral Vascular Disease","year":2022,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Peripheral; Cardiology; Medicine; Internal medicine; Vascular disease; Arterial disease; Disease","score_opus":0.021305941971761343,"score_gpt":0.3043369023964446,"score_spread":0.2830309604246833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294408851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97487444,0.022281677,0.000118167074,0.0018814539,0.00024572044,0.0004745904,0.00004755048,0.000014242074,0.000062174644],"genre_scores_gemma":[0.99069643,0.0066041388,0.0002915185,0.0017930965,0.0004828829,0.000016265103,0.000006557407,0.00003048823,0.000078639445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99449015,0.0026596272,0.0012841553,0.0002167477,0.000991555,0.00035779751],"domain_scores_gemma":[0.9969022,0.0004771934,0.0012475981,0.00063630723,0.0003369361,0.00039973707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00470442,0.00020503992,0.0015184968,0.000102198515,0.00024522725,0.0000054777106,0.00028293053,0.000075468044,0.000364078],"category_scores_gemma":[0.0013725203,0.00011840034,0.00076011935,0.00021422768,0.00054118305,0.000069480215,0.00019049438,0.0015780242,9.295968e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031110357,0.0036617438,0.7843194,0.00025132997,0.02686262,0.0033362329,0.0012681279,0.0005948364,0.0005500517,0.0010493749,0.0020752172,0.14492069],"study_design_scores_gemma":[0.011282775,0.001610353,0.96249044,0.00005067029,0.005649234,0.0013815997,0.00026342986,0.00010560666,0.00008580116,0.00042808254,0.016522566,0.00012947117],"about_ca_topic_score_codex":0.00033329098,"about_ca_topic_score_gemma":0.0000067791584,"teacher_disagreement_score":0.178171,"about_ca_system_score_codex":0.000037570633,"about_ca_system_score_gemma":0.00065020303,"threshold_uncertainty_score":0.6855818},"labels":[],"label_agreement":null},{"id":"W4294707281","doi":"10.1016/j.jacl.2022.08.007","title":"Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association","year":2022,"lang":"en","type":"erratum","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Statement (logic); Clinical Practice; Biomarker; Association (psychology); Family medicine; Medical physics; Internal medicine; Biochemistry; Epistemology","score_opus":0.19563533106437056,"score_gpt":0.4475313405418341,"score_spread":0.2518960094774635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294707281","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1625305,0.01645873,0.0003176748,0.26702616,0.53641653,0.0075557097,0.002199412,0.00008517239,0.0074101137],"genre_scores_gemma":[0.050990976,0.054768473,0.04294894,0.08705565,0.47651222,0.00055962184,0.007161114,0.0010106389,0.27899235],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9753319,0.009671635,0.009048966,0.0007739107,0.0046015014,0.0005720849],"domain_scores_gemma":[0.96769863,0.016824145,0.01096937,0.0009324744,0.0031733061,0.00040206368],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.07342317,0.00038227483,0.0034598066,0.00047623954,0.00022868752,0.0001490011,0.00065854174,0.0015156489,0.0014782037],"category_scores_gemma":[0.113942996,0.00026576538,0.0025476997,0.00074585725,0.00064703723,0.00035148012,0.00042950915,0.006899565,0.000062290914],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032345653,0.0023807036,0.011161756,0.00009352901,0.0032153975,0.000083157756,0.00012191229,0.000011928549,0.000015135287,0.000026387323,0.9559163,0.023739269],"study_design_scores_gemma":[0.0042461962,0.001956228,0.13595858,0.0004558915,0.0010212993,0.00012596711,0.000068286885,0.00020563147,0.000001321644,0.00018110017,0.8555969,0.00018262673],"about_ca_topic_score_codex":0.0004990179,"about_ca_topic_score_gemma":0.0001737852,"teacher_disagreement_score":0.27158225,"about_ca_system_score_codex":0.0008600166,"about_ca_system_score_gemma":0.009320428,"threshold_uncertainty_score":0.99997944},"labels":[],"label_agreement":null},{"id":"W4294832533","doi":"10.1016/j.atherosclerosis.2022.08.016","title":"Lipoprotein(a) variability over time in adult lipid clinic patients","year":2022,"lang":"en","type":"letter","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Dyslipidemia; Lipoprotein(a); Apolipoprotein B; Medicine; Myocardial infarction; Lipoprotein; Internal medicine; Cardiology; Atherosclerotic cardiovascular disease; Risk factor; Stroke (engine); Cholesterol; Disease","score_opus":0.015045707019719887,"score_gpt":0.24598029108001673,"score_spread":0.23093458406029685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294832533","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70391434,0.00025653152,0.000024540594,0.2692731,0.002825155,0.010228535,0.00092900044,0.000549312,0.011999501],"genre_scores_gemma":[0.030627709,0.00068768574,0.0005314285,0.9428673,0.008285791,0.0021416408,0.0026403093,0.00054225913,0.011675922],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938913,0.00089100323,0.0010944158,0.0013475922,0.0018356309,0.00094003894],"domain_scores_gemma":[0.99664706,0.00019575091,0.00038287241,0.00236444,0.00021721004,0.00019264147],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0017204565,0.0006517033,0.0016158735,0.00025205745,0.0001668715,0.00004591509,0.00042073324,0.0012700012,0.012539481],"category_scores_gemma":[0.000526098,0.0006087151,0.0011422364,0.0006029422,0.00011153825,0.00010459798,0.0003242609,0.0038977638,0.00081421534],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023103127,0.00094517966,0.059801064,0.0011253896,0.00048444982,0.00006316132,0.00022861004,0.0000010031275,0.00006670742,0.0000040970303,0.9227848,0.01426451],"study_design_scores_gemma":[0.0048410906,0.0011197821,0.25472206,0.0005273857,0.00038130805,0.0000067915025,0.0000080231675,0.000025644858,0.00004061379,0.00005932724,0.73752123,0.0007467473],"about_ca_topic_score_codex":0.002147423,"about_ca_topic_score_gemma":0.00002425174,"teacher_disagreement_score":0.6735942,"about_ca_system_score_codex":0.0009653196,"about_ca_system_score_gemma":0.00036914856,"threshold_uncertainty_score":0.99996376},"labels":[],"label_agreement":null},{"id":"W4294967762","doi":"10.1016/s2213-8587(22)00254-6","title":"PCSK9 inhibition in children with familial hypercholesterolaemia","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Canadian Institutes of Health Research; Academic Medical Organization of Southwestern Ontario; Heart and Stroke Foundation of Canada","keywords":"Medicine; MEDLINE; PCSK9; Pediatrics; Internal medicine; Cholesterol; LDL receptor","score_opus":0.01879361050873658,"score_gpt":0.24641889897606134,"score_spread":0.22762528846732477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294967762","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6922833,0.0013041465,0.0000016071864,0.3037271,0.00020412327,0.0011708121,0.000106145366,0.00011266026,0.0010901084],"genre_scores_gemma":[0.22283505,0.0005978367,0.00008360041,0.76344496,0.009996355,0.000900095,0.0016744877,0.00012830604,0.00033930692],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960581,0.00055573345,0.00035945323,0.000633564,0.00058195356,0.0018111735],"domain_scores_gemma":[0.99828637,0.00008142701,0.00014398873,0.0013899516,0.000042456093,0.000055820547],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00052468997,0.00040287545,0.0013408462,0.00023871147,0.00013484171,0.000023709717,0.0002815652,0.00034844506,0.00020368646],"category_scores_gemma":[0.00003623484,0.00026507568,0.00023540182,0.00028416567,0.00023443678,0.000049639242,0.00022765236,0.004565952,0.00004285747],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004033307,0.00015981068,0.4192874,0.00063114415,0.0020638185,0.0026951046,0.0002533339,0.000038025744,0.00026541905,0.000103572514,0.54977924,0.024319774],"study_design_scores_gemma":[0.0050273295,0.000903288,0.2529533,0.00015313477,0.0004672996,0.0016985069,0.000028274644,0.0000056751114,0.00030066964,0.00017179211,0.7378874,0.00040333386],"about_ca_topic_score_codex":0.00041517726,"about_ca_topic_score_gemma":0.000044614586,"teacher_disagreement_score":0.46944824,"about_ca_system_score_codex":0.00026985104,"about_ca_system_score_gemma":0.00018356382,"threshold_uncertainty_score":0.99998015},"labels":[],"label_agreement":null},{"id":"W4294967876","doi":"10.1016/s2213-8587(22)00221-2","title":"Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Centre hospitalier universitaire de Québec","funders":"HLS Therapeutics; Amgen; ZonMw; Sanofi; Kowa Company; Novo Nordisk; Medicines Company; F. Hoffmann-La Roche; Abbott Laboratories; Regeneron Pharmaceuticals; Novartis; Pfizer","keywords":"Medicine; Evolocumab; Placebo; Adverse effect; Randomized controlled trial; Clinical endpoint; Internal medicine; Population; Cholesterol; Lipoprotein; Pathology","score_opus":0.03278071262394313,"score_gpt":0.26891457946732217,"score_spread":0.23613386684337903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294967876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307317,0.001456954,0.000034408135,0.00093070796,0.00019273779,0.0038272564,0.00025557636,0.000112869515,0.00011634047],"genre_scores_gemma":[0.9953685,0.00009007955,0.0011347557,0.001722729,0.00029070076,0.00092703215,0.00027150067,0.000095936426,0.00009876626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962911,0.00042772476,0.000481131,0.0007068965,0.00062214053,0.0014710128],"domain_scores_gemma":[0.9974955,0.00022240699,0.00031848013,0.001487455,0.00032116188,0.00015504904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051880704,0.0003905922,0.0013572706,0.0001725368,0.00036117388,0.000031391595,0.0006211244,0.0000887846,0.000033675915],"category_scores_gemma":[0.00010307912,0.00024261519,0.00013603501,0.00043420363,0.00020996286,0.000122060126,0.00045714324,0.0005505197,0.000004798352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020723158,0.00810706,0.80984515,0.0008338824,0.0025554951,0.00023841496,0.00069884775,0.0003316063,0.0053203725,0.00010851827,0.0025521868,0.14868534],"study_design_scores_gemma":[0.20502758,0.072645575,0.6654584,0.0004293692,0.0045253765,0.0004585288,0.00089615793,0.0012661893,0.013325677,0.00015131976,0.034280177,0.0015356833],"about_ca_topic_score_codex":0.00038672038,"about_ca_topic_score_gemma":0.00007398384,"teacher_disagreement_score":0.18430443,"about_ca_system_score_codex":0.00023644093,"about_ca_system_score_gemma":0.00014595666,"threshold_uncertainty_score":0.98935604},"labels":[],"label_agreement":null},{"id":"W4295066229","doi":"10.3390/jcm11175250","title":"Statin Intolerance—We Know Everything, We Know Nothing","year":2022,"lang":"en","type":"editorial","venue":"Journal of Clinical Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mylan; Sanofi; Valeant Pharmaceuticals International; Esperion Therapeutics; Teva Pharmaceutical Industries; Amgen","keywords":"Medicine; Nothing; Need to know; Statin; Intensive care medicine; Internal medicine; Epistemology; Computer security","score_opus":0.042579389568996207,"score_gpt":0.4138441773749631,"score_spread":0.3712647878059669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295066229","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031467513,0.14276102,0.0006488287,0.035218008,0.8188054,0.00065936864,0.00004150763,0.000050336515,0.0015008859],"genre_scores_gemma":[0.00018310788,0.24684638,0.0015297508,0.0017781844,0.7460239,0.0000153827,0.00006984947,0.00013298485,0.0034204656],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98377675,0.0013035946,0.0064288517,0.00075521844,0.007013251,0.0007223466],"domain_scores_gemma":[0.9842407,0.006329334,0.004848611,0.0012960772,0.0019217016,0.0013635564],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.021620966,0.00069234177,0.0059254724,0.000583956,0.0002241716,0.00003530389,0.0007999716,0.0014759178,0.0027973247],"category_scores_gemma":[0.038681734,0.00047131054,0.0022716594,0.0005562897,0.00041223198,0.00020244616,0.00025799425,0.01297695,0.000035663958],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012760643,0.00028411043,0.00008427925,0.0012353901,0.0010429623,0.0014026553,0.000813767,0.0000071711565,0.0000052177757,0.0000074721643,0.6575496,0.33629128],"study_design_scores_gemma":[0.012827693,0.007962106,0.00019890082,0.016272752,0.0021240232,0.00044904006,0.00063159724,0.000042916956,0.000004364506,0.00020817053,0.95890874,0.00036967584],"about_ca_topic_score_codex":0.00021643486,"about_ca_topic_score_gemma":0.000015913456,"teacher_disagreement_score":0.33592162,"about_ca_system_score_codex":0.00051243947,"about_ca_system_score_gemma":0.0049880724,"threshold_uncertainty_score":0.99982035},"labels":[],"label_agreement":null},{"id":"W4295221059","doi":"10.1016/j.jacl.2022.09.001","title":"Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GLS Industries (Canada)","funders":"","keywords":"Medicine; Statin; Discontinuation; Tolerability; Intensive care medicine; Physical therapy; Psychological intervention; Internal medicine; Adverse effect; Psychiatry","score_opus":0.07177615053071422,"score_gpt":0.44054462916167497,"score_spread":0.36876847863096074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295221059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793526,0.0005581271,0.00025559653,0.0145067945,0.003340958,0.0004472093,0.00007409069,0.000009914968,0.0014547374],"genre_scores_gemma":[0.9886733,0.0016322185,0.001896182,0.0034992201,0.00408963,0.000016277363,0.000015401425,0.000015732048,0.00016203253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99342483,0.0026685866,0.0020382018,0.00025450613,0.001408379,0.0002054667],"domain_scores_gemma":[0.99289626,0.0037325015,0.002136191,0.00019720658,0.00087842986,0.00015943366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018532893,0.00011426706,0.0010307906,0.00006317518,0.00014566837,0.000010872119,0.00018192167,0.00016341063,0.00022086583],"category_scores_gemma":[0.0028990647,0.000079790305,0.0007356061,0.00019140985,0.0001249907,0.000052347896,0.00019831033,0.0013066997,0.000001972315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001294949,0.0031674893,0.892088,0.00005157775,0.009774865,0.000042794276,0.0004561431,0.00007692999,0.000028748573,0.006092211,0.02729726,0.059629012],"study_design_scores_gemma":[0.00617206,0.0026742325,0.9609832,0.000055333174,0.00067719514,0.000029479836,0.0013130164,0.00015293581,8.5247154e-7,0.001671066,0.026202137,0.00006849363],"about_ca_topic_score_codex":0.00009011912,"about_ca_topic_score_gemma":0.000015349771,"teacher_disagreement_score":0.068895176,"about_ca_system_score_codex":0.00055533164,"about_ca_system_score_gemma":0.0006770463,"threshold_uncertainty_score":0.64231676},"labels":[],"label_agreement":null},{"id":"W4295752126","doi":"10.46747/cfp.6809e256","title":"Approche de la stratification du risque de maladies cardiovasculaires athéroscléreuses","year":2022,"lang":"fr","type":"article","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risk stratification; Medicine; Internal medicine","score_opus":0.011923225431492556,"score_gpt":0.2279325898930178,"score_spread":0.21600936446152524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295752126","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3328047,0.2683404,0.0015813957,0.006324452,0.0032377318,0.0024131692,0.0010984988,0.00022027381,0.38397938],"genre_scores_gemma":[0.96124226,0.0030145005,0.0004336501,0.027747497,0.004423679,0.00060931017,0.00018961054,0.00014342387,0.0021960589],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956147,0.0013834735,0.00035923815,0.00060283835,0.0006430366,0.0013966954],"domain_scores_gemma":[0.99735636,0.00010624909,0.00010998677,0.0011112837,0.00012301921,0.0011931087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002152827,0.00038149708,0.0006561665,0.00026182388,0.0011032486,0.00012386736,0.00038947785,0.00022993625,0.00004020401],"category_scores_gemma":[0.00008648003,0.00046872193,0.00076589035,0.00066080265,0.00036691458,0.00014735438,0.000077268756,0.00092217495,0.000078344376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00010792855,0.0007223207,0.0040638545,0.0025913795,0.004920356,0.0029043597,0.008327314,0.019332873,0.0077015953,0.050616406,0.18426721,0.7144444],"study_design_scores_gemma":[0.0009789639,0.00019971997,0.053266704,0.00024950388,0.0008618673,0.00011804676,0.010731076,0.0015193229,0.00059355673,0.0014441448,0.92949176,0.0005453067],"about_ca_topic_score_codex":0.21083169,"about_ca_topic_score_gemma":0.009960218,"teacher_disagreement_score":0.7452246,"about_ca_system_score_codex":0.0055790315,"about_ca_system_score_gemma":0.007723993,"threshold_uncertainty_score":0.9997764},"labels":[],"label_agreement":null},{"id":"W4295761140","doi":"10.46747/cfp.6809654","title":"Approach to risk stratification of atherosclerotic cardiovascular disease","year":2022,"lang":"en","type":"article","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Statin; Dyslipidemia; Framingham Risk Score; Internal medicine; Cholesterol; Coronary artery disease; Disease; Risk assessment; Framingham Heart Study; Cardiology; Intensive care medicine","score_opus":0.02211798221897645,"score_gpt":0.21670882003031028,"score_spread":0.19459083781133382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295761140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9023441,0.00616366,0.0021488299,0.00036222112,0.00031765018,0.0034747466,0.00076176046,0.00007328199,0.08435375],"genre_scores_gemma":[0.9910965,0.00002699984,0.00033275675,0.0077785025,0.00021332972,0.00029122617,0.0001319853,0.000039395876,0.00008932594],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982564,0.00016666172,0.00020845863,0.00038050124,0.00064543984,0.00034253922],"domain_scores_gemma":[0.9977638,0.000006209103,0.00005523331,0.0011984628,0.00008530827,0.00089099084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048026687,0.0001393328,0.00038431288,0.00018429135,0.0002775794,0.000011441852,0.00015966658,0.000027078182,0.00000408517],"category_scores_gemma":[0.000016272461,0.00014900342,0.00052645674,0.0005638738,0.000036363606,0.00003699532,0.000029249528,0.00022214682,0.000019819669],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003627568,0.0014893556,0.0036706382,0.0012688393,0.006328605,0.00015175172,0.0022003865,0.086393945,0.006582303,0.012401686,0.017774189,0.8613756],"study_design_scores_gemma":[0.0024383315,0.00060193095,0.54409105,0.00009604641,0.002213306,0.000005914664,0.004877501,0.0026745007,0.00035890515,0.00061853003,0.4412062,0.00081778615],"about_ca_topic_score_codex":0.03728663,"about_ca_topic_score_gemma":0.00024895743,"teacher_disagreement_score":0.86055773,"about_ca_system_score_codex":0.0004389768,"about_ca_system_score_gemma":0.0010809868,"threshold_uncertainty_score":0.96912414},"labels":[],"label_agreement":null},{"id":"W4295798372","doi":"10.3389/fphys.2022.960272","title":"Pathogenic gain-of-function mutations in the prodomain and C-terminal domain of PCSK9 inhibit LDL binding","year":2022,"lang":"en","type":"article","venue":"Frontiers in Physiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"PCSK9; Kexin; LDL receptor; Proprotein convertase; Mutant; Alanine; Mutation; Point mutation; Familial hypercholesterolemia; Chemistry; Subtilisin; Biochemistry; Lipoprotein; Amino acid; Cholesterol; Gene; Enzyme","score_opus":0.010655895442088696,"score_gpt":0.2421538044100677,"score_spread":0.231497908967979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295798372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973182,0.00094044255,0.0006089064,0.00017049523,0.00023447958,0.00058184285,0.000013710636,0.000004639964,0.00012728834],"genre_scores_gemma":[0.9980236,0.000037915015,0.0015384032,0.00012364582,0.000055016815,0.00014947855,0.000045110235,0.0000084209305,0.00001835722],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987548,0.00043669232,0.0002741442,0.0001868845,0.00018182048,0.00016567616],"domain_scores_gemma":[0.99959105,0.00003580886,0.00010191107,0.00023220871,0.000017352739,0.000021682894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009328357,0.00007543409,0.0003340985,0.00022146804,0.00006788688,0.0000013700505,0.000068633,0.000045494675,0.000014468052],"category_scores_gemma":[0.00003701689,0.000059607126,0.000087487046,0.00037320663,0.000120702556,0.000026094434,0.000052337582,0.00024616648,3.0283348e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042809295,0.0018653672,0.19310884,0.0020274192,0.0006266452,0.0003603983,0.02643987,0.0013974013,0.62723476,0.0044442154,0.0034726046,0.13474154],"study_design_scores_gemma":[0.009221539,0.003463155,0.90719587,0.00019527934,0.00027524246,0.00047244644,0.03956394,0.0009447455,0.00285195,0.030764598,0.0047001354,0.0003511321],"about_ca_topic_score_codex":0.00007520138,"about_ca_topic_score_gemma":0.0000092423215,"teacher_disagreement_score":0.714087,"about_ca_system_score_codex":0.000069397276,"about_ca_system_score_gemma":0.00009407916,"threshold_uncertainty_score":0.24307081},"labels":[],"label_agreement":null},{"id":"W4297101324","doi":"10.1016/j.jacc.2022.07.026","title":"Population-Based Recalibration of the Framingham Risk Score and Pooled Cohort Equations","year":2022,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University Health Network; Health Sciences Centre; Libin Cardiovascular Institute of Alberta; McGill University Health Centre; Institute for Clinical Evaluative Sciences; McGill University; Ted Rogers Centre for Heart Research; University of Calgary; University of Toronto; North York General Hospital; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cohort; Framingham Risk Score; Population; Cohort study; Risk assessment; Demography; Relative risk; Absolute risk reduction; Confidence interval; Disease; Internal medicine; Environmental health","score_opus":0.010960686542108787,"score_gpt":0.2505033316630835,"score_spread":0.23954264512097467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297101324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940424,0.0004976059,0.0019954888,0.0025590719,0.00028743746,0.00041387978,0.00009250498,0.0000028543213,0.00010874186],"genre_scores_gemma":[0.9989576,0.00006146939,0.00040996802,0.00032994358,0.00018479853,0.000009944262,0.0000026106904,0.000010031626,0.0000336369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785703,0.0009710219,0.00047980895,0.000090790214,0.000501784,0.00009957057],"domain_scores_gemma":[0.9979856,0.0002134985,0.0011708859,0.00039412171,0.00018934216,0.000046554836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013190767,0.00007398101,0.0006740742,0.00009848044,0.00019492129,0.0000017717937,0.00015830767,0.000027104425,0.0000096979265],"category_scores_gemma":[0.00057393237,0.000043275068,0.0004921241,0.0004632023,0.00020363108,0.000025045958,0.00007765424,0.00032440093,5.5762747e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033249694,0.000029086545,0.9803793,0.00002817883,0.00063286984,0.000008624776,0.00003150798,0.01503813,0.0007280299,0.00026047448,0.00051132834,0.002020005],"study_design_scores_gemma":[0.0008889685,0.00065027,0.994471,0.00003486661,0.0007301238,0.0003647308,0.00032431193,0.0008896459,0.00029639367,0.00030275705,0.0010012018,0.000045732653],"about_ca_topic_score_codex":0.00022246996,"about_ca_topic_score_gemma":0.0000084964595,"teacher_disagreement_score":0.014148484,"about_ca_system_score_codex":0.00009776396,"about_ca_system_score_gemma":0.00045813108,"threshold_uncertainty_score":0.17647061},"labels":[],"label_agreement":null},{"id":"W4297177888","doi":"10.1016/j.atherosclerosis.2022.09.008","title":"Modulation of vascular endothelial inflammatory response by proprotein convertase subtilisin-kexin type 9","year":2022,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Proinflammatory cytokine; PCSK9; LDL receptor; Endothelial stem cell; Kexin; Endocytosis; Umbilical vein; Endocrinology; Internal medicine; Biology; Inflammation; Chemistry; Receptor; Medicine; Biochemistry; Lipoprotein; Cholesterol","score_opus":0.014286553599996012,"score_gpt":0.23368371168503563,"score_spread":0.21939715808503962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297177888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971752,0.0006797179,0.0001496119,0.0003376729,0.00017437158,0.0012275733,0.00010758372,0.000075258955,0.00007300919],"genre_scores_gemma":[0.99838924,0.0000913383,0.00023244014,0.000367189,0.000075349075,0.00020315786,0.0000686571,0.000058664402,0.0005139814],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975427,0.00051276234,0.00040794825,0.00034803755,0.0009066248,0.00028196612],"domain_scores_gemma":[0.99871016,0.00005533452,0.00016112457,0.0007931804,0.00013841555,0.00014181764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001625335,0.00018069759,0.00042361277,0.0001047843,0.00019727398,0.000010519446,0.00013663562,0.000086275424,0.0005761909],"category_scores_gemma":[0.00019813908,0.00017192429,0.0003120146,0.00029498144,0.00008168211,0.00007193725,0.00009905924,0.00026222088,0.000024144469],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024842322,0.00032948342,0.016361298,0.00014390338,0.0002475571,0.0000074140858,0.00068297016,0.00011104976,0.97282284,0.00006564037,0.0012733482,0.005470284],"study_design_scores_gemma":[0.012020605,0.0038771366,0.43061113,0.00019670126,0.00035907482,0.00005215606,0.0008253759,0.0013697159,0.40873697,0.00011801107,0.14109062,0.0007425005],"about_ca_topic_score_codex":0.0005100961,"about_ca_topic_score_gemma":0.000004392881,"teacher_disagreement_score":0.56408584,"about_ca_system_score_codex":0.00020315657,"about_ca_system_score_gemma":0.00028352172,"threshold_uncertainty_score":0.70108694},"labels":[],"label_agreement":null},{"id":"W4297221502","doi":"10.1161/strokeaha.122.039728","title":"Yield of Dual Therapy With Statin and Ezetimibe in the Treat Stroke to Target Trial","year":2022,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"AstraZeneca; Pfizer","keywords":"Medicine; Ezetimibe; Internal medicine; Stroke (engine); Statin; Cardiology; Myocardial infarction; Cholesterol; Post-hoc analysis","score_opus":0.022052038945497624,"score_gpt":0.26619793483396426,"score_spread":0.24414589588846664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297221502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463534,0.0005898008,0.00003686179,0.0012038536,0.00004315856,0.0012774145,0.00008283326,0.0000060094812,0.0021247247],"genre_scores_gemma":[0.99813604,0.00007540551,0.00039280724,0.00056283956,0.00010405663,0.00020461182,0.000008679035,0.0000107073065,0.00050485204],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99887896,0.00014901665,0.00017795111,0.0001644241,0.0004526881,0.00017696076],"domain_scores_gemma":[0.9995716,0.00006218579,0.00003476652,0.00026683317,0.000015186328,0.000049430393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076501665,0.00008387614,0.00028404113,0.00009712906,0.00004284843,0.0000060380353,0.000056913068,0.000021846898,0.00012454457],"category_scores_gemma":[0.000026781127,0.000050841463,0.000062075655,0.00016801542,0.000024670144,0.000018114308,0.000025651141,0.00021518616,4.573677e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36180896,0.0048533394,0.21060519,0.0005061534,0.0009892813,0.0026817678,0.05540959,0.0013725699,0.0123702735,0.0024457069,0.0050664023,0.34189078],"study_design_scores_gemma":[0.368015,0.069112465,0.38892022,0.00022020837,0.00022701509,0.00069108256,0.047854144,0.00020224256,0.012145181,0.00019651242,0.11158662,0.0008293346],"about_ca_topic_score_codex":0.0012015654,"about_ca_topic_score_gemma":0.00020615773,"teacher_disagreement_score":0.34106144,"about_ca_system_score_codex":0.000034370507,"about_ca_system_score_gemma":0.00012020155,"threshold_uncertainty_score":0.20732546},"labels":[],"label_agreement":null},{"id":"W4297225618","doi":"10.1161/strokeaha.122.040567","title":"Is It About the Destination or About the Journey?","year":2022,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Library science; Family medicine","score_opus":0.04587320706257288,"score_gpt":0.31812919192187283,"score_spread":0.27225598485929997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297225618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83611536,0.0063978895,0.001053653,0.10170172,0.0012290755,0.0023123124,0.00011885232,0.000110214976,0.05096091],"genre_scores_gemma":[0.9676897,0.00023596601,0.000105886305,0.009228065,0.00067927083,0.00015650321,0.0000090108,0.000017947707,0.021877665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986096,0.00016055626,0.00017240454,0.00015061506,0.0006900556,0.0002167738],"domain_scores_gemma":[0.99918586,0.000056986795,0.00006857302,0.0005555447,0.00006893607,0.000064095504],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011993443,0.000085826134,0.00015070988,0.000031803716,0.00067549717,0.000030161667,0.00017338443,0.00002593806,0.001789279],"category_scores_gemma":[0.00011739002,0.000040266288,0.00020216637,0.00018701937,0.0000489254,0.000029509989,0.00008605237,0.00041503113,0.000042846466],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008937404,0.0003952797,0.014619714,0.00034285715,0.001284858,0.0003640118,0.016771786,0.00022369248,0.0013279463,0.006200042,0.3608952,0.5966809],"study_design_scores_gemma":[0.0011295602,0.00030687213,0.054527946,0.000027710585,0.00017104129,0.0005497054,0.0030024957,0.00028917583,0.0003988804,0.00008850231,0.93942136,0.000086772576],"about_ca_topic_score_codex":0.00022905467,"about_ca_topic_score_gemma":0.000035191646,"teacher_disagreement_score":0.5965941,"about_ca_system_score_codex":0.000100077385,"about_ca_system_score_gemma":0.00025111338,"threshold_uncertainty_score":0.9991232},"labels":[],"label_agreement":null},{"id":"W4297262532","doi":"","title":"Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.","year":2022,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetic testing; Familial hypercholesterolemia; Medicine; Grading (engineering); Genetic counseling; Personalized medicine; Risk assessment; Intensive care medicine; Bioinformatics; Internal medicine; Genetics; Cholesterol; Biology; Computer science","score_opus":0.0438988879602183,"score_gpt":0.2921450902222693,"score_spread":0.24824620226205102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297262532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744735,0.0020032772,0.0027095464,0.012582047,0.0005323346,0.006044548,0.000049692353,0.00029327496,0.0013118081],"genre_scores_gemma":[0.97044617,0.000019606578,0.010919882,0.002673649,0.00038807638,0.015241493,0.000019513469,0.000036733152,0.00025486527],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998361,0.00007955772,0.00028285076,0.00032873126,0.00036786997,0.0005799988],"domain_scores_gemma":[0.99919385,0.00003667697,0.00008820296,0.00043462892,0.00006618624,0.0001804603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010942625,0.00011027443,0.00035055215,0.00016990457,0.00035621173,0.000010617307,0.00011942043,0.000056039684,0.00000840701],"category_scores_gemma":[0.00014280989,0.00010763483,0.00012860233,0.00040898894,0.0000339135,0.000021746479,0.0001249453,0.0003728624,0.0000012121741],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032595668,0.00010456123,0.032950897,0.00016290604,0.00006716486,0.000016833877,0.000023293038,0.000046355628,0.00008252253,0.0001308859,0.00073184463,0.96565014],"study_design_scores_gemma":[0.0031406458,0.00070649956,0.9128672,0.000010271604,0.000077161574,0.0004002872,0.00045651902,0.00027188408,0.00004361945,0.00026269996,0.0816155,0.00014770898],"about_ca_topic_score_codex":0.000116910385,"about_ca_topic_score_gemma":0.0000073801084,"teacher_disagreement_score":0.96550244,"about_ca_system_score_codex":0.00044597065,"about_ca_system_score_gemma":0.00038580422,"threshold_uncertainty_score":0.4389221},"labels":[],"label_agreement":null},{"id":"W4297535916","doi":"10.1016/j.jacl.2022.08.009","title":"Guidance for the diagnosis and treatment of hypolipidemia disorders","year":2022,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Western University","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.28991388833509557,"score_gpt":0.5016598527501303,"score_spread":0.21174596441503468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297535916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064877,0.99294287,0.00012035475,0.0017300936,0.0036718692,0.0013558439,0.000033289638,0.0000033959197,0.000077403325],"genre_scores_gemma":[0.000016180009,0.9894514,0.00079559226,0.00028838997,0.009049598,0.00025295097,0.000006233824,0.000034446603,0.0001052292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99535686,0.0009878107,0.002879483,0.00024058564,0.00030335787,0.00023188439],"domain_scores_gemma":[0.9849318,0.011883832,0.0023740137,0.00051552395,0.000100689176,0.00019412607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046972875,0.00024293052,0.004906147,0.00010723058,0.00008050428,0.000004288744,0.00020453069,0.00035446178,0.000107889144],"category_scores_gemma":[0.0044458676,0.00011915941,0.0039355285,0.0001300491,0.0002498865,0.000020050751,0.000058805694,0.00060135144,0.0000010195865],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018821057,0.000329262,0.0008310014,0.0032565075,0.0021245964,0.0000037749107,0.000016541773,6.6884456e-7,6.4267147e-9,0.000090762696,0.0036496427,0.98950905],"study_design_scores_gemma":[0.0020757325,0.006275132,0.0007274317,0.0012608303,0.0062358337,0.0003595454,0.000022930753,0.000002143017,7.0515824e-8,0.00011433892,0.98283947,0.000086526896],"about_ca_topic_score_codex":0.000036086287,"about_ca_topic_score_gemma":0.000016432143,"teacher_disagreement_score":0.9894225,"about_ca_system_score_codex":0.00009369396,"about_ca_system_score_gemma":0.0009720811,"threshold_uncertainty_score":0.532244},"labels":[],"label_agreement":null},{"id":"W4297575344","doi":"10.1016/j.ahj.2022.06.009","title":"Corrigendum to “Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease” [Am Heart J (2021) 231:36–44]","year":2022,"lang":"en","type":"erratum","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Atherosclerotic cardiovascular disease; Cardiology; Internal medicine; Dialysis; Disease; Intensive care medicine","score_opus":0.015810144899275708,"score_gpt":0.255902501000222,"score_spread":0.24009235610094629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297575344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839429,0.0037956678,0.00006841413,0.0042788927,0.0045328857,0.003011218,0.00016128254,0.00005575952,0.0001529564],"genre_scores_gemma":[0.96568334,0.003965622,0.0014961174,0.01713461,0.0024859966,0.0006116059,0.00023367818,0.0005362846,0.007852719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926007,0.0010476821,0.00096309365,0.0012367024,0.0030285686,0.0011232577],"domain_scores_gemma":[0.99578285,0.00009666209,0.0003420698,0.0014612114,0.00021675733,0.0021004714],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0016183496,0.00085695664,0.0034280007,0.0008262623,0.0006190654,0.00019442642,0.00021113706,0.00016395349,0.00025656502],"category_scores_gemma":[0.00043691456,0.0006834635,0.0011478041,0.00092615926,0.00034808344,0.00013172836,0.0002627122,0.0024902122,0.000027239892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009572153,0.00074308953,0.9049389,0.00031696176,0.0021120268,0.0003034588,0.0008830574,0.0001879134,0.000008219119,0.0000025606162,0.08052976,0.009016886],"study_design_scores_gemma":[0.0023154868,0.00390771,0.80866337,0.00061991933,0.0009728981,0.00025679907,0.00051888055,0.000019750369,0.0000013198387,0.0000072952425,0.18212216,0.0005944051],"about_ca_topic_score_codex":0.0036819137,"about_ca_topic_score_gemma":0.0001870983,"teacher_disagreement_score":0.1015924,"about_ca_system_score_codex":0.0009838439,"about_ca_system_score_gemma":0.0011939857,"threshold_uncertainty_score":0.99981105},"labels":[],"label_agreement":null},{"id":"W4297905305","doi":"10.1093/eurheartj/ehab724.2534","title":"Role of statins in patients with MINOCA. A systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Observational study; Meta-analysis; Mace; Statin; MEDLINE; Internal medicine; Myocardial infarction; Coronary artery disease; Physical therapy; Intensive care medicine","score_opus":0.06825667776382756,"score_gpt":0.33294242688758746,"score_spread":0.2646857491237599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297905305","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021306474,0.997814,0.0000095914575,0.000037556372,0.000008807523,0.0018116906,0.00003112152,0.00000438662,0.0002615314],"genre_scores_gemma":[0.000036010693,0.9988104,0.0005538122,0.00025188233,0.00003837093,0.000021728853,0.000042073334,0.00005398065,0.00019171869],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9944156,0.002979317,0.0013884209,0.00028894134,0.0007102161,0.00021749594],"domain_scores_gemma":[0.9979591,0.000060191243,0.00079268095,0.0006862879,0.00026311763,0.00023864987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031981133,0.0003172914,0.010334063,0.00035276444,0.000042796622,0.00003281154,0.00009919034,0.00004370389,0.00017196703],"category_scores_gemma":[0.00018860109,0.00016786486,0.0030160693,0.0008266918,0.000026835234,0.00004475105,0.00005269505,0.0006051823,0.000013220936],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000027728586,0.00009959582,0.00011250486,0.8534529,0.14047644,0.00016711757,0.00004094555,2.4221802e-7,5.39906e-9,0.0000020512718,0.00010060131,0.005544788],"study_design_scores_gemma":[0.00029102867,0.00017409172,0.0005174176,0.12740701,0.80283767,0.00078190974,0.000015095588,1.4333402e-7,2.0889054e-8,1.5902788e-7,0.06783868,0.00013678231],"about_ca_topic_score_codex":0.000007946206,"about_ca_topic_score_gemma":0.000003982977,"teacher_disagreement_score":0.7260459,"about_ca_system_score_codex":0.00005933343,"about_ca_system_score_gemma":0.0002757582,"threshold_uncertainty_score":0.7064159},"labels":[],"label_agreement":null},{"id":"W4297955634","doi":"","title":"British society for cardiovascular research: joint late spring meeting with the british cardiovascular society. Causes and consequences of myocardial infarction: new concepts.","year":2008,"lang":"en","type":"other","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myocardial infarction; Spring (device); Joint (building); Canadian Cardiovascular Society; Cardiology; Intensive care medicine; Internal medicine; Mechanical engineering","score_opus":0.05785721920176114,"score_gpt":0.26448323387463896,"score_spread":0.20662601467287783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297955634","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016789269,0.9229521,0.0019479202,0.0015037698,0.00078574545,0.018854817,0.00021531993,0.00049160863,0.036459427],"genre_scores_gemma":[0.10026242,0.6446949,0.014987659,0.0020586485,0.023568608,0.017399734,0.00023084595,0.0031901947,0.19360696],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947056,0.00034459887,0.00051594764,0.0010391463,0.0023019793,0.0010926973],"domain_scores_gemma":[0.99748707,0.00011774702,0.0002374293,0.0012323344,0.00049084064,0.00043456553],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00476206,0.00042501854,0.002073186,0.000079350495,0.0006524035,0.00027607518,0.0002321832,0.0005567075,0.000030405716],"category_scores_gemma":[0.0002339103,0.00038669578,0.006197233,0.00047744153,0.001847972,0.000088458524,0.00017958926,0.0008524011,0.0000012388087],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008020984,0.000063874926,0.00095888245,0.0037946783,0.09297245,0.00031130726,0.0007545445,0.000209418,0.000016696633,0.000025208037,0.55317837,0.34763438],"study_design_scores_gemma":[0.0040912223,0.000103964136,0.01174866,0.0012857764,0.0036362943,0.0014364948,0.000691314,0.0000068627032,0.000094652976,0.000020170102,0.97638637,0.0004982488],"about_ca_topic_score_codex":0.11399961,"about_ca_topic_score_gemma":0.0018027094,"teacher_disagreement_score":0.42320797,"about_ca_system_score_codex":0.00020369221,"about_ca_system_score_gemma":0.00088261964,"threshold_uncertainty_score":0.9998585},"labels":[],"label_agreement":null},{"id":"W4298092349","doi":"10.1016/j.jacl.2022.09.006","title":"A mechanism-based operational definition and classification of hypercholesterolemia","year":2022,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Daiichi Sankyo Europe; Instituto de Salud Carlos III; Gobierno de Aragón; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares; Ministerio de Economía y Competitividad; Sanofi; Amgen","keywords":"Medicine; Mechanism (biology); Guideline; Intensive care medicine; Statement (logic); Familial hypercholesterolemia; Internal medicine; Cholesterol; Epistemology; Pathology","score_opus":0.3154252477381304,"score_gpt":0.4585147656570687,"score_spread":0.1430895179189383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298092349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009560907,0.9945341,0.0011106437,0.00058918656,0.0019176059,0.0005484101,0.000029825129,0.0000064979577,0.0003076846],"genre_scores_gemma":[0.0005156709,0.9921266,0.0037327248,0.0006117959,0.0028622816,0.00002474294,0.00008113048,0.000027741631,0.000017305807],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99473137,0.0015497125,0.0028115252,0.00023766336,0.0005312671,0.00013848553],"domain_scores_gemma":[0.9959917,0.0012826633,0.0019589597,0.0003261665,0.00024337227,0.00019710175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005707744,0.00018372256,0.0031233577,0.00025629555,0.00004819543,0.0000074958925,0.00013251226,0.0005013837,0.00023841417],"category_scores_gemma":[0.0018587857,0.00013167808,0.0014041426,0.00015008647,0.00012349605,0.00004387265,0.000047113783,0.0013332162,0.000005227169],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021591739,0.0003042752,0.00008969673,0.005469654,0.00046148605,0.000017171225,0.000007480697,5.3679656e-7,0.0000037501068,0.002351765,0.00035535733,0.9907229],"study_design_scores_gemma":[0.0018010515,0.00222039,0.0008251986,0.002259655,0.0021987674,0.0015942993,0.000013486066,0.000015751371,6.918333e-7,0.00036238742,0.9886107,0.00009766475],"about_ca_topic_score_codex":0.000003070016,"about_ca_topic_score_gemma":0.00000121947,"teacher_disagreement_score":0.99062526,"about_ca_system_score_codex":0.000075524804,"about_ca_system_score_gemma":0.002139964,"threshold_uncertainty_score":0.5792235},"labels":[],"label_agreement":null},{"id":"W4298625043","doi":"10.1016/j.cjco.2022.09.007","title":"The Impact of Low-Density Lipoprotein Equation Changes on Cholesterol Treatment in Canada","year":2022,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Academic Medical Organization of Southwestern Ontario; Heart and Stroke Foundation of Canada","keywords":"Low-density lipoprotein; Ldl cholesterol; Structural equation modeling; Cholesterol; Internal medicine; Medicine; Mathematics; Statistics","score_opus":0.030942233087739895,"score_gpt":0.29812169955346174,"score_spread":0.2671794664657218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298625043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538726,0.00019307643,0.0000025021052,0.0014228515,0.00006927174,0.0019976725,0.00002049587,0.0000035393048,0.00090333656],"genre_scores_gemma":[0.99897367,0.000044376735,0.0000071031172,0.0002047378,0.00005955699,0.0003619816,0.000021921403,0.000010278223,0.00031637624],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990267,0.00015580791,0.00014076741,0.00015202766,0.0003539326,0.00017075798],"domain_scores_gemma":[0.99931526,0.000027411483,0.00007123416,0.00049200625,0.000027089325,0.00006700554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005640991,0.00008599318,0.0002945455,0.00003173183,0.00014064394,0.000014498609,0.00014733066,0.0000149780835,0.00006321865],"category_scores_gemma":[0.000026594915,0.00005210748,0.00007652884,0.00013897805,0.0000106417965,0.000018002569,0.00010854516,0.0001096138,0.0000020756297],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013568485,0.000435944,0.019137794,0.00007170851,0.00035636136,0.00013883805,0.0009823063,0.0012375562,0.00080049114,0.00009195134,0.00055532134,0.97483486],"study_design_scores_gemma":[0.0056668962,0.003608663,0.97450846,0.000094960036,0.000051204996,0.000048340065,0.0011893386,0.0006926136,0.0095848525,0.00006646481,0.004328676,0.00015954964],"about_ca_topic_score_codex":0.987089,"about_ca_topic_score_gemma":0.9384853,"teacher_disagreement_score":0.97467536,"about_ca_system_score_codex":0.002178794,"about_ca_system_score_gemma":0.0016508909,"threshold_uncertainty_score":0.56974703},"labels":[],"label_agreement":null},{"id":"W4299921504","doi":"","title":"Abstracts from the Chinese-Canada Symposium in Atherosclerosis and Cardiovascular Disease Conference, September 23-25, 2012, Beijing, China..","year":2012,"lang":"en","type":"other","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Beijing; China; Medicine; Disease; Library science; Gerontology; Political science; Geography; Internal medicine; Computer science; Archaeology","score_opus":0.012756348383823632,"score_gpt":0.19921253376760067,"score_spread":0.18645618538377703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4299921504","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10982412,0.16742484,0.000036882728,0.0024831626,0.0027430258,0.010158679,0.0011361332,0.00026663693,0.70592654],"genre_scores_gemma":[0.8071787,0.005859366,0.000043395765,0.0008012707,0.003862576,0.002645969,0.00038963908,0.0006172682,0.17860185],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99679923,0.00020923713,0.00040873676,0.0006927981,0.0010676256,0.0008223993],"domain_scores_gemma":[0.9972604,0.000051645,0.00017431733,0.0016613503,0.000038297803,0.0008139904],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087225996,0.0005509078,0.001157745,0.000107930966,0.00008350244,0.00006304051,0.00024065528,0.00032742557,0.00065372605],"category_scores_gemma":[0.00008090003,0.0003581918,0.00054928625,0.00021991233,0.00011480476,0.0000815762,0.00012684739,0.0006119148,0.00003185872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001255155,0.00038555835,0.31651336,0.0013698746,0.009529081,0.00017588785,0.00026677552,0.000036777285,0.000004479117,0.00005156293,0.5498516,0.12168953],"study_design_scores_gemma":[0.0008960558,0.0000034147029,0.5491461,0.0001643328,0.0006260747,0.0000049375917,0.000011292222,0.000003212307,0.0000010012878,0.000006082613,0.44891655,0.00022093474],"about_ca_topic_score_codex":0.3780057,"about_ca_topic_score_gemma":0.16325179,"teacher_disagreement_score":0.69735456,"about_ca_system_score_codex":0.0001632417,"about_ca_system_score_gemma":0.00043151344,"threshold_uncertainty_score":0.999887},"labels":[],"label_agreement":null},{"id":"W4301175044","doi":"10.17615/pc2a-ev84","title":"Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction","year":2020,"lang":"en","type":"article","venue":"UNC Libraries","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Fondation Leducq; Canadian Institutes of Health Research; Donovan Family Foundation; Cleveland Clinic; Foundation for Barnes-Jewish Hospital; National Human Genome Research Institute; Massachusetts General Hospital","keywords":"Exome sequencing; Myocardial infarction; Allele; Exome; Genetics; Biology; Medicine; Internal medicine; Computational biology; Mutation; Gene","score_opus":0.03380076316579308,"score_gpt":0.24006198103370321,"score_spread":0.20626121786791013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301175044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702189,0.0072246306,0.012588874,0.006024246,0.0004155309,0.0014934562,0.00007263873,0.0003834652,0.001578235],"genre_scores_gemma":[0.989564,0.0002868898,0.006526151,0.0017221572,0.0015363726,0.00007716459,0.00008095096,0.0000405089,0.0001657968],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99893945,0.00005506743,0.00022906941,0.0002979566,0.0002460134,0.0002324399],"domain_scores_gemma":[0.99939775,0.00006699456,0.000071092494,0.00020500865,0.0000647271,0.00019444038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002248062,0.00014954762,0.0003838449,0.00005573612,0.00023958973,0.00015817721,0.000052824173,0.000097349206,0.000032179898],"category_scores_gemma":[0.00032589896,0.00012850143,0.00018655969,0.000104567735,0.000098397286,0.00045898362,0.00007485925,0.00017346028,0.0000062553368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063427845,0.00017945637,0.22028114,0.015639566,0.00998561,0.00037318096,0.077811494,0.00058443967,0.04410699,0.32674167,0.042144373,0.2558093],"study_design_scores_gemma":[0.022047127,0.0031929445,0.20046403,0.0010650615,0.0032318083,0.00049523293,0.034660827,0.007159202,0.086090185,0.094842106,0.5444109,0.0023406118],"about_ca_topic_score_codex":0.00018882407,"about_ca_topic_score_gemma":0.000009961534,"teacher_disagreement_score":0.50226647,"about_ca_system_score_codex":0.000028824574,"about_ca_system_score_gemma":0.0002169964,"threshold_uncertainty_score":0.52401364},"labels":[],"label_agreement":null},{"id":"W4301400982","doi":"10.1016/j.jad.2022.09.148","title":"Association between statins and the risk of suicide attempt, depression, anxiety, and seizure: A population-based, self-controlled case series study","year":2022,"lang":"en","type":"article","venue":"Journal of Affective Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Anxiety; Medicine; Depression (economics); Medical prescription; Statin; Population; Psychiatry; Incidence (geometry); Internal medicine; Pharmacology","score_opus":0.00454419088590591,"score_gpt":0.2521234077838365,"score_spread":0.2475792168979306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301400982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530965,0.0019057891,0.00023865563,0.0007987111,0.000058212572,0.0016258112,0.00003144912,0.000007984772,0.000023755829],"genre_scores_gemma":[0.99933845,0.0003247808,0.00011290479,0.000062297426,0.00007823485,0.00005288321,0.0000040324153,0.000014609466,0.000011799234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722016,0.0014799673,0.00041603833,0.00013378858,0.0006218989,0.00012816371],"domain_scores_gemma":[0.9979846,0.00073956774,0.0008392859,0.00014781475,0.000212048,0.00007672275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038916739,0.00012031166,0.00068543525,0.00011917662,0.00039039628,0.000017237855,0.000041194005,0.000036620095,0.000009652411],"category_scores_gemma":[0.00079331576,0.00007469946,0.00023586015,0.00020921111,0.000031559022,0.00009846352,0.000043467844,0.00040108137,4.7094144e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001861247,0.00022714074,0.9841632,0.000051060386,0.002260875,0.000038896567,0.0021982365,0.0004037292,0.0000034435773,0.0000039865486,0.000050175826,0.008737958],"study_design_scores_gemma":[0.033208564,0.0013249695,0.95302594,0.000023761431,0.002569076,0.00046563914,0.008758941,0.00025813715,0.000010121994,0.0002147634,0.00006446631,0.00007564794],"about_ca_topic_score_codex":0.004035232,"about_ca_topic_score_gemma":0.0013752737,"teacher_disagreement_score":0.031347316,"about_ca_system_score_codex":0.00016134245,"about_ca_system_score_gemma":0.00013578107,"threshold_uncertainty_score":0.6100091},"labels":[],"label_agreement":null},{"id":"W4303833275","doi":"","title":"Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease","year":2016,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronary artery disease; Internal medicine; Medicine; Statin; Cardiology; Low-density lipoprotein; Disease; Lipoprotein; Cognition; Cholesterol; Psychiatry","score_opus":0.1272421516407212,"score_gpt":0.43623927341117696,"score_spread":0.3089971217704558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303833275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950985,0.0021071215,0.0003287212,0.00025490244,0.00011431354,0.0017616486,0.00022857456,0.000026108433,0.00008015356],"genre_scores_gemma":[0.9972683,0.0017546929,0.00015657488,0.0004533449,0.00010705398,0.00006281774,0.00003156822,0.000053471013,0.00011216368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971895,0.00031663742,0.00062105875,0.00049487804,0.0009788858,0.0003990425],"domain_scores_gemma":[0.99790496,0.00012714087,0.0003994516,0.0005438204,0.00044398863,0.00058065815],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009505312,0.00029856927,0.00078607263,0.00043599104,0.00013784647,0.00028063485,0.00032844415,0.0000921794,0.0011534905],"category_scores_gemma":[0.00028501972,0.00019783947,0.00012827579,0.00037778125,0.00014873606,0.0020919568,0.0003084232,0.00028759718,0.000008635012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023571372,0.00040277993,0.9003874,0.00025281232,0.00022628278,0.00024021343,0.00004861552,0.0000016085613,0.0018436279,0.000005753538,0.0005691378,0.09366462],"study_design_scores_gemma":[0.005220089,0.00007287718,0.9888492,0.002441458,0.00017043707,0.0000234394,0.000025198697,0.0000047445365,0.0020828096,0.0005873823,0.00023063178,0.00029170015],"about_ca_topic_score_codex":0.0007292896,"about_ca_topic_score_gemma":0.00017548802,"teacher_disagreement_score":0.09337291,"about_ca_system_score_codex":0.0001360585,"about_ca_system_score_gemma":0.0002909734,"threshold_uncertainty_score":0.9997596},"labels":[],"label_agreement":null},{"id":"W4304123548","doi":"10.1161/jaha.122.025858","title":"Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk","year":2022,"lang":"en","type":"review","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université Laval; Centre hospitalier universitaire de Québec; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Apolipoprotein B; Lipoprotein; Cholesterol; Internal medicine; Chylomicron; Low-density lipoprotein; Intermediate-density lipoprotein; High-density lipoprotein; Endocrinology; Apolipoprotein E; Very low-density lipoprotein; Medicine","score_opus":0.02062976614658821,"score_gpt":0.29169322723026764,"score_spread":0.2710634610836794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304123548","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6483762,0.3454139,0.00016318134,0.00027108702,0.00040443536,0.0051492527,0.00020059456,0.000015022339,0.0000063308717],"genre_scores_gemma":[0.24329802,0.7541827,0.00039503962,0.00035518518,0.0013315567,0.0002681874,0.000013908529,0.0000940817,0.00006132097],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99163014,0.0030234768,0.0018456433,0.0005599733,0.0023943312,0.00054646237],"domain_scores_gemma":[0.9923084,0.00086812343,0.004409445,0.0015435878,0.0006403936,0.00023005274],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0085702995,0.0006133126,0.006310598,0.00022923555,0.00044128575,0.000050248,0.00052341673,0.00035287585,0.00003519561],"category_scores_gemma":[0.002761582,0.00035823954,0.0064675678,0.0007644545,0.0003669599,0.00014862628,0.00039944635,0.0018653746,0.0000021384901],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065771467,0.00047483045,0.004393539,0.0066188974,0.010933489,0.00001229509,0.00019994656,0.000037633265,0.00019734273,0.000002824096,0.0003519117,0.9761196],"study_design_scores_gemma":[0.00440316,0.0038666246,0.6391932,0.00708347,0.022035606,0.00065677863,0.00034716426,0.000058936563,0.0013261151,0.00010400797,0.32014552,0.000779404],"about_ca_topic_score_codex":0.02837086,"about_ca_topic_score_gemma":0.00016996385,"teacher_disagreement_score":0.9753402,"about_ca_system_score_codex":0.00094350585,"about_ca_system_score_gemma":0.0008738674,"threshold_uncertainty_score":0.99988693},"labels":[],"label_agreement":null},{"id":"W4304193755","doi":"10.1038/s41467-022-33510-7","title":"Whole genome sequence analysis of blood lipid levels in &gt;66,000 individuals","year":2022,"lang":"en","type":"article","venue":"Nature Communications","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Université de Montréal; Université Laval; University of Ottawa; McGill University; University of Calgary","funders":"National Institute of Environmental Health Sciences; National Human Genome Research Institute; National Institute on Aging; National Cancer Institute; Science and Technology Facilities Council; Boston Scientific Corporation; Novo Nordisk Fonden; Yale University; Invitae; Bristol-Myers Squibb; AstraZeneca; National Institute of Mental Health; National Heart, Lung, and Blood Institute; Pfizer; National Institute of Diabetes and Digestive and Kidney Diseases; Amgen; Regeneron Pharmaceuticals; U.S. Department of Veterans Affairs; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Genetics; Biology; Gene; Mendelian inheritance; Whole genome sequencing; Dyslipidemia; Genome; Allele; Computational biology; Genome-wide association study; Single-nucleotide polymorphism; Genotype; Endocrinology","score_opus":0.041910277208598294,"score_gpt":0.32841900770220267,"score_spread":0.28650873049360437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304193755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9287217,0.05578818,0.00003734972,0.008006296,0.00011774218,0.0010563175,0.0021144971,0.00007027389,0.0040876083],"genre_scores_gemma":[0.99472743,0.0007149071,0.002429871,0.0008120612,0.000033659053,0.00016014125,0.00092939206,0.000014516953,0.00017803673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983111,0.00038798788,0.0003851165,0.0002043462,0.00052713935,0.0001842992],"domain_scores_gemma":[0.9965821,0.000111227935,0.0001467852,0.0029484928,0.0001321909,0.00007920195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012468048,0.00010206878,0.00049454125,0.0005988869,0.00022738957,0.000008669277,0.0007876207,0.00013518153,0.00020187211],"category_scores_gemma":[0.0001276386,0.00010209135,0.00030279616,0.002873733,0.000086130734,0.000049561615,0.0005394722,0.0012802948,0.0000031886022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013657281,0.009604104,0.62414175,0.0006276115,0.034971945,0.00009736666,0.021741988,0.0072163898,0.21798965,0.03976639,0.0026623115,0.041043933],"study_design_scores_gemma":[0.00112131,0.00012725858,0.7403055,0.000028100472,0.0030663342,0.00003469362,0.0005659555,0.00040324975,0.00022079596,0.0000830747,0.25387248,0.00017128346],"about_ca_topic_score_codex":0.00032218438,"about_ca_topic_score_gemma":0.0004990456,"teacher_disagreement_score":0.25121018,"about_ca_system_score_codex":0.000114984054,"about_ca_system_score_gemma":0.0002298537,"threshold_uncertainty_score":0.55623156},"labels":[],"label_agreement":null},{"id":"W4306252831","doi":"10.1093/eurheartj/ehac544.1233","title":"Longer-term safety of alirocumab with 24,610 patient-years of placebo-controlled observation: further insights from the ODYSSEY OUTCOMES trial","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta","funders":"","keywords":"Alirocumab; Medicine; PCSK9; Internal medicine; Post-hoc analysis; Unstable angina; Placebo; Myocardial infarction; Mace; Evolocumab; Acute coronary syndrome; Cholesterol; Lipoprotein; Percutaneous coronary intervention","score_opus":0.030317928768122636,"score_gpt":0.25511778498528276,"score_spread":0.22479985621716012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306252831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946706,0.001259519,0.00007708694,0.0013448482,0.0005890889,0.0012162165,0.000021659978,0.000016071153,0.00080488593],"genre_scores_gemma":[0.99751127,0.0000746822,0.00052551815,0.00091474864,0.0006879648,0.000015406476,0.000016270076,0.000048696063,0.00020543752],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99610883,0.0015166149,0.0007689862,0.00019668242,0.0012049207,0.0002039616],"domain_scores_gemma":[0.99841636,0.00021464386,0.0004874997,0.0005881297,0.0001531565,0.00014023068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013512031,0.0001626426,0.0008014082,0.00007844344,0.00026030236,0.000023762297,0.00019014713,0.000021698552,0.0004751898],"category_scores_gemma":[0.00014789715,0.0000961659,0.00052662165,0.00019550633,0.00006822604,0.00008173257,0.00009878667,0.00059266767,0.000008080005],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.707253,0.002289481,0.17466484,0.00013729652,0.0095132515,0.002123539,0.034126002,0.0010369573,0.0034086998,0.00021041697,0.007891538,0.05734501],"study_design_scores_gemma":[0.26777923,0.0047436818,0.68636185,0.00022187816,0.00074610015,0.000676856,0.002791137,0.0000307109,0.00018547068,0.000030632225,0.036184512,0.00024795358],"about_ca_topic_score_codex":0.0000575603,"about_ca_topic_score_gemma":0.000010370854,"teacher_disagreement_score":0.511697,"about_ca_system_score_codex":0.00007166316,"about_ca_system_score_gemma":0.00026227842,"threshold_uncertainty_score":0.5202995},"labels":[],"label_agreement":null},{"id":"W4306254394","doi":"10.1093/eurheartj/ehac544.2374","title":"Recurrent atherosclerotic cardiovascular disease events preventable with guideline recommended lipid-lowering treatment following myocardial infarction","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ezetimibe; Guideline; Myocardial infarction; Internal medicine; Population; Cardiology; Statin; Intensive care medicine; Pathology","score_opus":0.038779845342723836,"score_gpt":0.2845484849204867,"score_spread":0.24576863957776285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306254394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98230785,0.006876954,0.00239389,0.0026931053,0.0027184198,0.0017143129,0.000021645985,0.00013022167,0.0011435938],"genre_scores_gemma":[0.9933666,0.000696242,0.0015218991,0.00072348805,0.0027139962,0.00008136884,0.000056933157,0.00014015891,0.0006993247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959966,0.0011660556,0.00055004325,0.00044697506,0.0013087959,0.0005315627],"domain_scores_gemma":[0.9983274,0.000015357393,0.00013311353,0.0007757976,0.00008034581,0.0006680086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031256261,0.0002962993,0.00061928056,0.00015991808,0.0009578656,0.000058781563,0.00012537028,0.000019638132,0.00030883212],"category_scores_gemma":[0.000048926322,0.00023706042,0.0016469321,0.00027227533,0.000013238196,0.00015278718,0.00013481705,0.0005882426,0.000042906773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062621394,0.0046292623,0.22264417,0.00036911917,0.036767684,0.0077025355,0.002471745,0.059127998,0.0019369221,0.000014041056,0.031150367,0.62692404],"study_design_scores_gemma":[0.008309799,0.0029989055,0.096053705,0.0002984422,0.001903249,0.0031427343,0.00026661615,0.00016872048,0.000058192258,0.000007954986,0.88640374,0.00038794972],"about_ca_topic_score_codex":0.000046449335,"about_ca_topic_score_gemma":0.0000013424166,"teacher_disagreement_score":0.85525334,"about_ca_system_score_codex":0.0009605206,"about_ca_system_score_gemma":0.00037223252,"threshold_uncertainty_score":0.96670437},"labels":[],"label_agreement":null},{"id":"W4306318910","doi":"10.1093/eurheartj/ehac544.2375","title":"Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Evolocumab; Medicine; Familial hypercholesterolemia; Placebo; Intima-media thickness; Internal medicine; PCSK9; Cardiology; Alirocumab; Randomized controlled trial; Statin; Lipoprotein; Cholesterol; Carotid arteries; Pathology; LDL receptor","score_opus":0.019839402653493276,"score_gpt":0.24893949316946126,"score_spread":0.229100090515968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306318910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996615,0.0008115828,0.00001312726,0.00045705776,0.0006794309,0.0006183949,0.000019340045,0.000041210762,0.00074483734],"genre_scores_gemma":[0.9972611,0.00016168051,0.0004941151,0.00057761994,0.0012610136,0.000028091335,0.000035135232,0.000077188575,0.00010407346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964215,0.0012080002,0.00044069378,0.00036330023,0.001066912,0.00049956917],"domain_scores_gemma":[0.9989292,0.00004018066,0.00012739863,0.0004283382,0.0001129185,0.00036196192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013635916,0.00025249078,0.00049930566,0.00032663965,0.00039874503,0.000060623617,0.00015817324,0.000033898184,0.00012085346],"category_scores_gemma":[0.000063591724,0.00018363778,0.00025382175,0.00038822333,0.000053113297,0.00013435294,0.00012219719,0.0010193517,0.00004330827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011213996,0.0011935389,0.93864024,0.000052522522,0.00017254132,0.0017977437,0.003348342,0.00050544273,0.0002377806,0.0000015992894,0.0014498938,0.051478952],"study_design_scores_gemma":[0.008424842,0.0029694648,0.9720615,0.000064358595,0.000111011504,0.0033738797,0.00049968757,0.000009485257,0.00005130205,0.000002458596,0.012218386,0.00021362514],"about_ca_topic_score_codex":0.00007945808,"about_ca_topic_score_gemma":0.000012654647,"teacher_disagreement_score":0.051265325,"about_ca_system_score_codex":0.000723912,"about_ca_system_score_gemma":0.00035484636,"threshold_uncertainty_score":0.74885315},"labels":[],"label_agreement":null},{"id":"W4306320159","doi":"10.1093/eurheartj/ehac544.2357","title":"Comparison over 25 years of the burden of familial hypercholesterolemia on hospitalizations for coronary heart disease in a French-Canadian founder population","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Ezetimibe; Cohort; Epidemiology; Population; Internal medicine; Coronary heart disease; Cohort study; Disease; Acute coronary syndrome; Rochester Epidemiology Project; Pediatrics; Cholesterol; Myocardial infarction; Environmental health","score_opus":0.03439451237871762,"score_gpt":0.3036550101544191,"score_spread":0.2692604977757015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306320159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973822,0.00021390548,0.000038563394,0.0013313836,0.0002788818,0.0005193024,0.000050100345,0.000004424877,0.0001811897],"genre_scores_gemma":[0.9987217,0.0000060054517,0.000115947965,0.0007024195,0.0003082738,0.000007298205,0.00002624956,0.000024982382,0.00008712938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855727,0.00038516845,0.00033149248,0.000121127065,0.00043283048,0.00017210809],"domain_scores_gemma":[0.9993707,0.000024488576,0.00009439222,0.00027117983,0.00004923801,0.00019002183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007161137,0.00007233378,0.00022946326,0.000151308,0.00017502875,0.000010126058,0.00009394405,0.000015626005,0.00006897003],"category_scores_gemma":[0.00008065115,0.000063004496,0.00022266875,0.00017039428,0.00002992183,0.000040123705,0.000040099334,0.00029166052,0.0000020127213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013505288,0.00014600213,0.9816449,0.000051277686,0.000040037055,0.00002607658,0.0007993694,0.009511058,0.00016867132,0.00008169243,0.0055191284,0.0018767156],"study_design_scores_gemma":[0.0012177826,0.00033996944,0.9780864,0.00010968953,0.000042709074,0.000056924157,0.00015159776,0.00051984156,0.0000030692975,0.000051651525,0.019365843,0.000054522025],"about_ca_topic_score_codex":0.006922775,"about_ca_topic_score_gemma":0.00036903584,"teacher_disagreement_score":0.013846716,"about_ca_system_score_codex":0.00021413631,"about_ca_system_score_gemma":0.0002821717,"threshold_uncertainty_score":0.99969023},"labels":[],"label_agreement":null},{"id":"W4306320162","doi":"10.1093/eurheartj/ehac544.1386","title":"Lipoprotein(a) and the effect of alirocumab on coronary and non-coronary revascularization following acute coronary syndrome","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Alirocumab; Cardiology; Internal medicine; Hazard ratio; Revascularization; Acute coronary syndrome; Myocardial infarction; Placebo; Confidence interval; Lipoprotein; Cholesterol; Apolipoprotein A1","score_opus":0.009366907916676083,"score_gpt":0.24942450442377226,"score_spread":0.24005759650709618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306320162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156934,0.0050486927,0.00011172775,0.00107208,0.0003291855,0.0012046619,0.0000071938225,0.00002650365,0.0006305988],"genre_scores_gemma":[0.99792415,0.00056776474,0.00020782626,0.0007455581,0.00018905227,0.000026538126,0.00001610128,0.00006869175,0.0002543413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960923,0.001968984,0.00041312628,0.00030987794,0.00092362805,0.00029204684],"domain_scores_gemma":[0.99898285,0.00013201314,0.00016551354,0.00046273577,0.00003441877,0.00022246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004899063,0.00022784663,0.0006650721,0.00013154358,0.0008215612,0.000039857852,0.00012928322,0.000035545912,0.00007438103],"category_scores_gemma":[0.00008069294,0.00015262757,0.0004693113,0.00018106205,0.00012933045,0.00011438211,0.00026299246,0.000851582,0.000008188318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027342997,0.0006621594,0.5890243,0.0017981064,0.012015502,0.057896823,0.0039097844,0.0006115833,0.010991303,0.0002565966,0.00526599,0.29022485],"study_design_scores_gemma":[0.012197453,0.006609947,0.8961735,0.0003136009,0.0007756983,0.08057345,0.00011983349,0.00014724304,0.00018033019,0.000024889925,0.0026990706,0.0001849993],"about_ca_topic_score_codex":0.00002563203,"about_ca_topic_score_gemma":3.8463085e-7,"teacher_disagreement_score":0.30714917,"about_ca_system_score_codex":0.0000858425,"about_ca_system_score_gemma":0.00007730406,"threshold_uncertainty_score":0.6318868},"labels":[],"label_agreement":null},{"id":"W4306320315","doi":"10.1093/eurheartj/ehac544.2348","title":"Potential barriers in lipid-lowering treatment with PCSK9 inhibitors from a healthsystem perspective. Comparative evidence from ten countries","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Family medicine; Discontinuation; Health care; Economic growth; Surgery","score_opus":0.035556382859807695,"score_gpt":0.29860938221499467,"score_spread":0.263052999355187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306320315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846436,0.0105182715,0.00020054297,0.0029240006,0.0005947796,0.0006470752,0.000060403974,0.000045529792,0.00036579446],"genre_scores_gemma":[0.99644375,0.00038151056,0.00041824253,0.00049601326,0.002080743,0.000023610486,0.000010252124,0.00004951555,0.00009637772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964546,0.0012741726,0.0004631906,0.00044099588,0.0009418062,0.00042523927],"domain_scores_gemma":[0.9986929,0.00008014151,0.00018203299,0.00037727758,0.00013415398,0.0005334505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012080971,0.0002542373,0.00068359525,0.00017649152,0.0006934459,0.000099361656,0.000125139,0.000025331383,0.00045312959],"category_scores_gemma":[0.00003973526,0.00019312087,0.00024351137,0.00024702612,0.00007321344,0.00018698776,0.00008651854,0.00076662505,0.000037308233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013651086,0.00092490035,0.7701488,0.00018529024,0.003503453,0.025619537,0.15556316,0.009411651,0.007034683,0.000037204136,0.008517606,0.005402627],"study_design_scores_gemma":[0.017662134,0.01225724,0.6986737,0.0033905387,0.0006736044,0.008071635,0.11230856,0.0006919017,0.0021846439,0.000023724408,0.14304604,0.0010162657],"about_ca_topic_score_codex":0.007517893,"about_ca_topic_score_gemma":0.00028584446,"teacher_disagreement_score":0.13452843,"about_ca_system_score_codex":0.0019400655,"about_ca_system_score_gemma":0.0009502244,"threshold_uncertainty_score":0.99909115},"labels":[],"label_agreement":null},{"id":"W4306321199","doi":"10.1093/eurheartj/ehac544.2356","title":"Awareness of lipid guideline recommendations for high-risk patients amongst primary care physicians in Canada","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Polypharmacy; Guideline; Primary care; Family medicine; Acute coronary syndrome; Statin; Emergency medicine; Internal medicine; Myocardial infarction","score_opus":0.02019068252897728,"score_gpt":0.265287516377926,"score_spread":0.24509683384894876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306321199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524796,0.0004063101,0.00033980765,0.0016969304,0.00090755755,0.0005093508,0.00037747686,0.000008709735,0.0005059054],"genre_scores_gemma":[0.9953919,0.00010389219,0.0016343105,0.0016650875,0.00068470323,0.000014952706,0.0004055547,0.000042158248,0.000057423455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813515,0.0004725703,0.0005333366,0.0001588797,0.00046817085,0.0002319075],"domain_scores_gemma":[0.99910307,0.000030433801,0.0002245891,0.00025545392,0.00027401664,0.00011242758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088381063,0.0000997017,0.00033735702,0.0000952147,0.00032321506,0.000008223721,0.00010463815,0.000009204268,0.00008693879],"category_scores_gemma":[0.000058192876,0.00009532843,0.00015925344,0.00018131762,0.000011550852,0.00004723055,0.000076988836,0.00041298056,0.0000010958807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001899088,0.00025303173,0.7019354,0.00020821199,0.00013199965,0.000048846716,0.0007467507,0.0010915252,0.000065222455,0.0000061756814,0.12368371,0.17163919],"study_design_scores_gemma":[0.0032769192,0.00050563255,0.6877596,0.0001228056,0.000064121705,0.000056602694,0.0014854957,0.000054077726,0.000077070894,0.0000045011725,0.30647907,0.00011410418],"about_ca_topic_score_codex":0.19612825,"about_ca_topic_score_gemma":0.058115575,"teacher_disagreement_score":0.18279536,"about_ca_system_score_codex":0.00089123426,"about_ca_system_score_gemma":0.0015093368,"threshold_uncertainty_score":0.95907134},"labels":[],"label_agreement":null},{"id":"W4307023813","doi":"10.1016/j.cjca.2022.08.068","title":"AWARENESS OF LIPID GUIDELINE RECOMMENDATIONS FOR HIGH-RISK PATIENTS AMONGST PRIMARY CARE PHYSICIANS IN CANADA","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Medicine; Guideline; Polypharmacy; Primary care; Family medicine; Acute coronary syndrome; Statin; Emergency medicine; Internal medicine; Myocardial infarction","score_opus":0.011403968081912607,"score_gpt":0.2356947354503435,"score_spread":0.2242907673684309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307023813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911904,0.0011598212,0.0011011316,0.001912187,0.0020011456,0.00056505675,0.0016098594,0.0000020504754,0.00045835774],"genre_scores_gemma":[0.9975465,0.0000781141,0.00038007955,0.00075097464,0.00072150264,0.00003272532,0.0004575523,0.000020057334,0.000012483349],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984285,0.00024371367,0.0006581951,0.0001367645,0.00023065864,0.0003021651],"domain_scores_gemma":[0.9984584,0.000050693117,0.00035420223,0.00025084167,0.0006242973,0.000261567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005285624,0.00010254789,0.0007545939,0.0002492798,0.00015115742,0.0000025226013,0.00015138299,0.000044221033,0.000021561713],"category_scores_gemma":[0.00011887416,0.00010271332,0.0002510265,0.00020417373,0.00003590182,0.000033388093,0.00001985415,0.00032937928,1.205704e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000138001,0.0000095482355,0.8000641,0.00015619918,0.000424203,0.00007112343,0.00037094753,0.010022527,0.000011418447,0.00003420867,0.0625865,0.12611124],"study_design_scores_gemma":[0.00413386,0.0008588567,0.48807153,0.000080224985,0.00025370403,0.00009516117,0.0029709868,0.000022686341,0.000047089106,0.00004961563,0.5032651,0.00015120769],"about_ca_topic_score_codex":0.9092333,"about_ca_topic_score_gemma":0.9185362,"teacher_disagreement_score":0.44067857,"about_ca_system_score_codex":0.0025189035,"about_ca_system_score_gemma":0.01552791,"threshold_uncertainty_score":0.9900531},"labels":[],"label_agreement":null},{"id":"W4307024057","doi":"10.1016/j.cjca.2022.08.043","title":"HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Life expectancy; Pediatrics; Disease; Population; Atherosclerotic cardiovascular disease; Patient registry; Internal medicine; Cholesterol; Environmental health","score_opus":0.01158186460205414,"score_gpt":0.2114581938402216,"score_spread":0.19987632923816745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307024057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991188,0.0019946988,0.000063360545,0.00140839,0.0012082896,0.00014967938,0.000033322864,0.0000016426374,0.003952623],"genre_scores_gemma":[0.9976449,0.00003939776,0.000037128386,0.0013909693,0.00080794847,0.000008227432,0.000005338717,0.000013881042,0.00005218436],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986296,0.00025226257,0.0003490939,0.00011336798,0.00027847406,0.00037718532],"domain_scores_gemma":[0.9989898,0.000021205818,0.00007771903,0.00022865184,0.00008744881,0.0005951687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068415893,0.00008726751,0.0005626224,0.00026617516,0.0000972416,0.0000041070007,0.00015059108,0.000042090895,0.000057516598],"category_scores_gemma":[0.00007007163,0.000083935454,0.0001985025,0.00018799191,0.000037617123,0.000024242752,0.000017797027,0.0006795926,0.0000013729439],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035630164,0.000006923417,0.72161394,0.00008310125,0.0006874463,0.074943796,0.00051483634,0.02969661,0.00023098329,0.00014592978,0.053784978,0.11793515],"study_design_scores_gemma":[0.0018497041,0.00036547016,0.3362176,0.000017858216,0.00006825023,0.03155404,0.0011006432,0.000011793508,0.000010328169,0.000043397646,0.6286531,0.0001078044],"about_ca_topic_score_codex":0.9525989,"about_ca_topic_score_gemma":0.9738529,"teacher_disagreement_score":0.57486814,"about_ca_system_score_codex":0.0028080316,"about_ca_system_score_gemma":0.026319908,"threshold_uncertainty_score":0.97919995},"labels":[],"label_agreement":null},{"id":"W4307024070","doi":"10.1016/j.cjca.2022.08.025","title":"HIGH-INTENSITY STATINS COMBINED WITH EICOSAPENTAENOIC ACID (EPA) IMPROVES ENDOTHELIAL FUNCTION DURING EXPOSURE TO OXIDIZED LDL","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Rosuvastatin; Eicosapentaenoic acid; Peroxynitrite; Statin; Pharmacology; Bioavailability; Pitavastatin; Nitric oxide; Rosuvastatin Calcium; Endocrinology; Internal medicine; Superoxide; Biochemistry; Chemistry; Fatty acid; Polyunsaturated fatty acid","score_opus":0.007649832991995299,"score_gpt":0.2005947132868329,"score_spread":0.1929448802948376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307024070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944016,0.000478561,0.0011673645,0.0016003449,0.0015136845,0.00048951583,0.00004652346,0.000011429206,0.00029098324],"genre_scores_gemma":[0.99702483,0.000021291291,0.00039365058,0.0008902257,0.0014186297,0.000031070507,0.00001862526,0.00003412224,0.00016757147],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99826115,0.00026340212,0.00039796942,0.000234409,0.00035940154,0.00048367336],"domain_scores_gemma":[0.9982403,0.000020484693,0.00018521909,0.00036727387,0.0002566502,0.0009300668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005989757,0.00017658724,0.0009211245,0.0003786774,0.00035797054,0.000017218594,0.00014394376,0.00007000047,0.00012530228],"category_scores_gemma":[0.00009098548,0.00014693255,0.00034464095,0.00023146084,0.00007431645,0.000057595924,0.000033307035,0.0005932763,0.000006552993],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0692969,0.00010560183,0.082727894,0.0005088598,0.012773343,0.020079324,0.0032434145,0.013991576,0.71731085,0.0011883745,0.012224554,0.06654929],"study_design_scores_gemma":[0.03254665,0.040537655,0.6422472,0.00014559926,0.0018542242,0.03156198,0.0037297513,0.000009354009,0.01975403,0.0002905093,0.22650184,0.0008212329],"about_ca_topic_score_codex":0.0023107359,"about_ca_topic_score_gemma":0.0018207295,"teacher_disagreement_score":0.69755685,"about_ca_system_score_codex":0.00049268774,"about_ca_system_score_gemma":0.0018036138,"threshold_uncertainty_score":0.59917355},"labels":[],"label_agreement":null},{"id":"W4307024187","doi":"10.1016/j.cjca.2022.08.163","title":"GENETIC TESTING FOR FAMILIAL HYPERCHOLESTEROLEMIA IN THE PROVINCE OF QUÉBEC: A SINGLE CENTER RETROSPECTIVE COHORT STUDY","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Genetic testing; PCSK9; Multiplex ligation-dependent probe amplification; Cohort; Apolipoprotein B; LDL receptor; Genetic diagnosis; Family history; Internal medicine; Genetics; Bioinformatics; Gene; Exon; Cholesterol; Biology; Lipoprotein","score_opus":0.020300952079558565,"score_gpt":0.24479667385541476,"score_spread":0.2244957217758562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307024187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966119,0.0005013762,0.00026281097,0.00042000707,0.00024295277,0.0011964717,0.000032065425,0.0000016260427,0.0007308086],"genre_scores_gemma":[0.9988801,0.0000024369306,0.00016081387,0.00027710872,0.0005892475,0.000059209688,0.0000017857302,0.000013437146,0.00001587022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985374,0.0004085895,0.0003959893,0.00014215666,0.00026017238,0.00025565884],"domain_scores_gemma":[0.99913704,0.00007693118,0.00015826902,0.00025935096,0.0002253149,0.00014311007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017278733,0.00008488485,0.0005721892,0.0001769852,0.00011385719,0.0000060362104,0.00018143462,0.000036692425,0.0000039866563],"category_scores_gemma":[0.0004017228,0.000063812666,0.00021837716,0.0001637776,0.000073887386,0.00002074966,0.00001694043,0.0003785945,1.8680494e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008514642,0.00002222183,0.99360514,0.000020196125,0.00018431435,0.00042601675,0.000539115,0.00068967394,0.00012754406,0.000003348674,0.0005240698,0.0037731926],"study_design_scores_gemma":[0.0018498875,0.0036182178,0.9810609,0.000019213392,0.00015768484,0.0026134916,0.0016656468,0.00000988335,0.000004598385,0.000022214597,0.00892541,0.000052816853],"about_ca_topic_score_codex":0.02606991,"about_ca_topic_score_gemma":0.046177346,"teacher_disagreement_score":0.020107435,"about_ca_system_score_codex":0.00075202197,"about_ca_system_score_gemma":0.0029465682,"threshold_uncertainty_score":0.9804156},"labels":[],"label_agreement":null},{"id":"W4307054686","doi":"10.1093/pch/pxac100.010","title":"11 Clinician Management of Childhood Dyslipidemia in the Community Setting","year":2022,"lang":"en","type":"article","venue":"Paediatrics & Child Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Western University; University of Toronto; McMaster University","funders":"","keywords":"Dyslipidemia; Medicine; Family history; Disease; Diabetes mellitus; Pediatrics; Stroke (engine); Gerontology; Family medicine; Internal medicine; Endocrinology","score_opus":0.019596872976633577,"score_gpt":0.29752406549305693,"score_spread":0.27792719251642334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307054686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9424979,0.0119327605,0.0001274191,0.032825265,0.00055854715,0.0034167657,0.000084514046,0.00007629727,0.008480533],"genre_scores_gemma":[0.9823078,0.0018373148,0.0010203343,0.014068726,0.00050643424,0.00011140411,0.00010354138,0.000028787674,0.000015689184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953862,0.001967508,0.00089485245,0.0002486569,0.0009786395,0.00052415556],"domain_scores_gemma":[0.99810207,0.00021729589,0.00037607504,0.0011126549,0.00003587779,0.00015603202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0138311125,0.00016294984,0.0005701764,0.0002154483,0.0009305296,0.00000800704,0.00040491726,0.000053680065,0.00003371705],"category_scores_gemma":[0.0000933973,0.0001305643,0.000299738,0.001121277,0.00003330024,0.000031388066,0.00031006293,0.001851462,0.000004337026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001514161,0.004696502,0.60972434,0.0053831725,0.00037658255,0.000117211304,0.028265378,0.00045692024,5.546398e-7,0.0087384125,0.011983831,0.33010566],"study_design_scores_gemma":[0.0025380948,0.0005816985,0.95410407,0.00012004979,0.000109004475,0.00007024385,0.012903653,0.0000404492,0.0000010898857,0.00034210278,0.029054666,0.0001349018],"about_ca_topic_score_codex":0.002232035,"about_ca_topic_score_gemma":0.00022556145,"teacher_disagreement_score":0.34437966,"about_ca_system_score_codex":0.00029904768,"about_ca_system_score_gemma":0.00036244188,"threshold_uncertainty_score":0.8043784},"labels":[],"label_agreement":null},{"id":"W4307355736","doi":"10.1101/2022.10.20.513093","title":"Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: functional regulation of LDLR levels","year":2022,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Canada Research Chairs; Fondation Leducq","keywords":"PCSK9; Endosome; LDL receptor; Cell biology; Proprotein convertase; Endocytosis; Kexin; Biology; Receptor; Chemistry; Biochemistry; Intracellular; Cholesterol; Lipoprotein","score_opus":0.01815287591727137,"score_gpt":0.23621808799677763,"score_spread":0.21806521207950624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307355736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941687,0.0012921753,0.0027087806,0.00013502201,0.00047509684,0.0009383439,0.00017086798,0.00008473738,0.000026264344],"genre_scores_gemma":[0.99463266,0.0000579941,0.0046731024,0.00007837254,0.00029595708,0.00016094197,0.0000033395004,0.000089151006,0.000008500146],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99750257,0.00019591695,0.00056837476,0.0006744485,0.000811204,0.000247506],"domain_scores_gemma":[0.9972903,0.000026948039,0.00050813454,0.0012407028,0.00070434215,0.00022956551],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007242957,0.00033183477,0.0007389878,0.00036760807,0.0001133396,0.0000224886,0.00012199493,0.0002272372,0.0001626707],"category_scores_gemma":[0.00007294893,0.0003258722,0.00020514707,0.00038832787,0.00016772683,0.00014214395,0.00022700701,0.00065657776,0.0000013121274],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032995484,0.00034955263,0.008288014,0.0017570232,0.0007622756,0.000045555294,0.000032479606,0.000627817,0.9865243,0.0012138839,0.000042028725,0.000027131184],"study_design_scores_gemma":[0.0015333232,0.0005055095,0.5653074,0.0007864675,0.0006030957,7.670942e-7,0.000031294712,0.0003001293,0.428438,0.0000056192484,0.0020685259,0.00041989292],"about_ca_topic_score_codex":0.00026084174,"about_ca_topic_score_gemma":0.0000071869354,"teacher_disagreement_score":0.5580863,"about_ca_system_score_codex":0.00023966872,"about_ca_system_score_gemma":0.0013826863,"threshold_uncertainty_score":0.99991935},"labels":[],"label_agreement":null},{"id":"W4307715479","doi":"10.1097/fjc.0000000000001374","title":"Lipid Lowering in “Very High Risk” Patients Undergoing Coronary Artery Bypass Surgery and Its Projected Reduction in Risk for Recurrent Vascular Events: A Monte Carlo Stepwise Simulation Approach","year":2022,"lang":"en","type":"article","venue":"Journal of Cardiovascular Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Amgen","keywords":"Ezetimibe; Medicine; Cohort; Internal medicine; Adverse effect; Cardiology; Statin; Surgery","score_opus":0.01891886674312631,"score_gpt":0.2689426145097977,"score_spread":0.25002374776667136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307715479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732094,0.020828655,0.0015740937,0.000051121373,0.0021498646,0.002127112,0.000033951914,0.000021003107,0.000004798184],"genre_scores_gemma":[0.98967355,0.008746085,0.00028172936,0.000041505766,0.0008252088,0.0003287132,0.000035038553,0.000062733445,0.000005454128],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99466133,0.002007389,0.0011997056,0.00052237,0.0010939114,0.00051529316],"domain_scores_gemma":[0.99809784,0.0002811362,0.0006995693,0.0003231423,0.0004007205,0.00019758592],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006145541,0.0003091311,0.0014760297,0.00097116973,0.0002211695,0.000015422103,0.00012492592,0.0001562646,0.00001090539],"category_scores_gemma":[0.00031472943,0.00030780645,0.0015670925,0.0006355426,0.00003081333,0.0003661164,0.0001259295,0.0012485025,3.9524343e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005983695,0.0016355371,0.07283145,0.0009896583,0.010421837,0.00032647274,0.0007823004,0.7994745,0.00018730565,9.1585827e-7,0.00019638159,0.107169956],"study_design_scores_gemma":[0.08793203,0.00565506,0.7805922,0.0007444769,0.0137280775,0.0030627607,0.0017231244,0.09350858,0.0005384897,0.00006755545,0.011070508,0.0013771302],"about_ca_topic_score_codex":0.0001613983,"about_ca_topic_score_gemma":0.000010702058,"teacher_disagreement_score":0.70776075,"about_ca_system_score_codex":0.0011828747,"about_ca_system_score_gemma":0.00059868,"threshold_uncertainty_score":0.9999374},"labels":[],"label_agreement":null},{"id":"W4307727543","doi":"10.1016/j.cjca.2022.10.023","title":"Calculated LDL-C: Time to Move On?","year":2022,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Horizon Health Network; Moncton Hospital","funders":"","keywords":"Medicine; Hypertriglyceridemia; Scopus; Canadian Cardiovascular Society; Triglyceride; Library science; Family medicine; MEDLINE; Internal medicine; Cholesterol; Computer science; Law; Political science","score_opus":0.012987543959404678,"score_gpt":0.23402093578660474,"score_spread":0.22103339182720005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307727543","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033730203,0.002136672,0.00014028336,0.9337047,0.0029305469,0.0009703902,0.00032514136,0.000019865472,0.056399416],"genre_scores_gemma":[0.008011325,0.00004846225,0.00009126825,0.95069885,0.030076282,0.000025076431,0.00022570849,0.00013763337,0.010685367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99723935,0.00048559663,0.0005947397,0.00032804918,0.00058905105,0.000763229],"domain_scores_gemma":[0.9974216,0.00006826115,0.00023150732,0.0007511587,0.00034436813,0.001183084],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00090243114,0.00031402937,0.0017552876,0.0010130954,0.00013897587,0.000019713181,0.00033232107,0.0007521991,0.0020762314],"category_scores_gemma":[0.00028205765,0.0002748391,0.0012541296,0.00029302787,0.00008184715,0.000021670498,0.000026876429,0.0035555258,0.0004984165],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070126094,9.38296e-7,0.000057326437,0.000046893765,0.0012893475,0.022885518,0.000034111916,0.0006376864,0.0000069066514,0.000004508739,0.9688528,0.006113803],"study_design_scores_gemma":[0.00072348583,0.0012655352,0.0014075835,0.000100740566,0.00046258338,0.009296502,0.0000125279485,0.0000017655361,0.000005692205,0.000023445347,0.98647225,0.00022791373],"about_ca_topic_score_codex":0.0019585907,"about_ca_topic_score_gemma":0.000067984874,"teacher_disagreement_score":0.04571405,"about_ca_system_score_codex":0.001211634,"about_ca_system_score_gemma":0.0052638245,"threshold_uncertainty_score":0.9999704},"labels":[],"label_agreement":null},{"id":"W4307858346","doi":"10.1093/eurjpc/zwac253","title":"Apolipoprotein B versus non-high-density lipoprotein cholesterol: contradictory results in the same journal","year":2022,"lang":"en","type":"letter","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Apolipoprotein B; Apolipoprotein C2; Cholesterol; High-density lipoprotein; Ldl cholesterol; Internal medicine; Lipoprotein; Very low-density lipoprotein","score_opus":0.025025149093916878,"score_gpt":0.26097973314600764,"score_spread":0.23595458405209077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307858346","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2618207,0.019490741,0.0037269243,0.6591853,0.023005145,0.007708198,0.00049794366,0.00008979256,0.024475241],"genre_scores_gemma":[0.64266855,0.004050722,0.0009070579,0.25566992,0.09387999,0.00007709738,0.00036796,0.0004808758,0.0018978525],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9781598,0.015965788,0.0023124774,0.0006579027,0.0019185533,0.0009855104],"domain_scores_gemma":[0.9949107,0.00043261485,0.0023624846,0.0013871761,0.00063074677,0.00027626482],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.018750075,0.00069748145,0.00263092,0.00075989316,0.00033752748,0.00010040804,0.0013334047,0.00042310468,0.00010805197],"category_scores_gemma":[0.0012221183,0.00049022125,0.002442249,0.00039832253,0.0003743326,0.00016540464,0.00029352214,0.013108953,0.00004819393],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007622592,0.0001533441,0.000073265226,0.00031565415,0.0048370943,0.14609624,0.0015555319,0.000088807086,0.00015994329,0.000007975573,0.76801825,0.071071304],"study_design_scores_gemma":[0.018604934,0.0066476716,0.05619317,0.0006888654,0.001370973,0.032340575,0.0005141103,0.0000011629455,0.00005215241,0.0000914178,0.8830223,0.00047267092],"about_ca_topic_score_codex":0.0002958056,"about_ca_topic_score_gemma":0.000021769474,"teacher_disagreement_score":0.40351537,"about_ca_system_score_codex":0.00067525066,"about_ca_system_score_gemma":0.0008686238,"threshold_uncertainty_score":0.99975497},"labels":[],"label_agreement":null},{"id":"W4308178887","doi":"10.1093/eurheartj/ehac615","title":"Effect of inclisiran on lipids in primary prevention: the ORION-11 trial","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Placebo; Confidence interval; Internal medicine; Clinical endpoint; Apolipoprotein B; PCSK9; Cholesterol; Gastroenterology; Randomized controlled trial; Endocrinology; Lipoprotein; Pathology","score_opus":0.02665512064609833,"score_gpt":0.3069252205063801,"score_spread":0.2802700998602818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308178887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010503,0.00064127205,0.000013430274,0.0012221219,0.000880892,0.0007881168,0.0000017682984,0.0000118501985,0.006335532],"genre_scores_gemma":[0.9963265,0.000054289514,0.000041703363,0.0007033042,0.0023177117,0.000012388455,0.0000044449976,0.000027974014,0.00051170355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938243,0.004717372,0.00038494327,0.00013633062,0.0007522133,0.00018484514],"domain_scores_gemma":[0.9992699,0.00013582081,0.00011885283,0.00035287833,0.000025608075,0.00009691646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011893194,0.00009831619,0.00033931734,0.00011837232,0.00031950555,0.000016177706,0.00012842099,0.000015126883,0.00027340616],"category_scores_gemma":[0.0001633849,0.00006064263,0.00040638458,0.0002356316,0.000029118464,0.00003555336,0.000103114355,0.0009556974,0.00001721774],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16231768,0.002983213,0.06960884,0.0010260362,0.00078698585,0.002776322,0.0031662611,0.0009498618,0.002447478,0.0002868188,0.04748486,0.7061657],"study_design_scores_gemma":[0.112354234,0.041941714,0.29288438,0.00048149313,0.0002103293,0.004625994,0.00018615527,0.00001931604,0.00052977423,0.000028859176,0.5465198,0.00021796116],"about_ca_topic_score_codex":0.000011207147,"about_ca_topic_score_gemma":0.0000011744296,"teacher_disagreement_score":0.7059477,"about_ca_system_score_codex":0.00014032632,"about_ca_system_score_gemma":0.00017314161,"threshold_uncertainty_score":0.41520825},"labels":[],"label_agreement":null},{"id":"W4308184058","doi":"10.1093/eurheartj/ehac594","title":"Inclisiran and cardiovascular events: a patient-level analysis of phase III trials","year":2022,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":214,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma","keywords":"Medicine; Mace; Myocardial infarction; Internal medicine; Placebo; Stroke (engine); Clinical endpoint; Statin; Cardiology; Surrogate endpoint; Randomized controlled trial; Surgery; Percutaneous coronary intervention","score_opus":0.09547442155195424,"score_gpt":0.3419514957216955,"score_spread":0.24647707416974124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308184058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98535997,0.011570041,0.0011946523,0.00025341767,0.00024194297,0.00045638264,0.00008504998,0.000017553939,0.00082099077],"genre_scores_gemma":[0.99794245,0.0004497311,0.0005918494,0.0004909888,0.00038218944,0.0000069139446,0.000025652605,0.00003365536,0.00007657848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99417204,0.0032290723,0.00089173147,0.00026317226,0.0011862195,0.00025774306],"domain_scores_gemma":[0.99863297,0.000064759144,0.0002753711,0.00056698837,0.00013481642,0.000325099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012077332,0.00015091737,0.0014622438,0.0005507263,0.0003985933,0.000021073976,0.000098177385,0.000020323052,0.00058269926],"category_scores_gemma":[0.0003331706,0.00012275926,0.0022218055,0.00078213203,0.000036118436,0.00006920809,0.00017225934,0.00050245214,0.0000035080118],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033732972,0.0021880732,0.030117236,0.00023136708,0.096292816,0.0027323258,0.005682583,0.0023958192,0.004544157,0.00006199912,0.008185259,0.84419507],"study_design_scores_gemma":[0.0520458,0.006935742,0.26271906,0.00021350807,0.037454996,0.009654182,0.0039107935,0.0006984863,0.00059559365,0.00004079192,0.6250471,0.0006839313],"about_ca_topic_score_codex":0.00006604172,"about_ca_topic_score_gemma":0.0000011041525,"teacher_disagreement_score":0.8435111,"about_ca_system_score_codex":0.00006928133,"about_ca_system_score_gemma":0.00013587983,"threshold_uncertainty_score":0.6380148},"labels":[],"label_agreement":null},{"id":"W4308638081","doi":"10.4244/eij-d-22-00735","title":"Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial&amp;nbsp;","year":2022,"lang":"en","type":"article","venue":"EuroIntervention","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Alirocumab; Percutaneous coronary intervention; PCSK9; Internal medicine; Myocardial infarction; Conventional PCI; Statin; Cardiology; Evolocumab; Cholesterol; Apolipoprotein B; Lipoprotein; LDL receptor; Apolipoprotein A1","score_opus":0.015875552086721714,"score_gpt":0.2593631107751104,"score_spread":0.24348755868838867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308638081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754859,0.0005608066,0.0033190332,0.000119505115,0.0007837366,0.019592743,0.000020138534,0.000054155786,0.00006394994],"genre_scores_gemma":[0.99615115,0.00004429692,0.00024105259,0.00004373615,0.0002498424,0.001971199,0.0007631957,0.000056945133,0.0004785622],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966403,0.00061365723,0.0011521982,0.00048185597,0.00080665364,0.0003053204],"domain_scores_gemma":[0.9985967,0.00015507951,0.00062424253,0.00034192362,0.00018413186,0.000097893346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013479897,0.00029123732,0.00094803964,0.0003942773,0.00016588878,0.000025054977,0.00007759067,0.00007346553,0.00005580507],"category_scores_gemma":[0.000080954924,0.0002495452,0.0013272506,0.00029431126,0.000029143364,0.00016370048,0.0000690703,0.0002317304,0.0000027396243],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9609223,0.003576455,0.010544556,0.0009759396,0.0010690908,0.000032983324,0.00042036732,0.00017113611,0.00045255816,0.000020507954,0.000033447443,0.021780657],"study_design_scores_gemma":[0.9164054,0.03600194,0.044949304,0.0006725101,0.0009375849,0.00008883712,0.00011211725,0.00006758654,0.00024521892,0.000021193278,0.00029507605,0.00020323203],"about_ca_topic_score_codex":0.00026805585,"about_ca_topic_score_gemma":0.000073524534,"teacher_disagreement_score":0.044516902,"about_ca_system_score_codex":0.0012644104,"about_ca_system_score_gemma":0.0001725941,"threshold_uncertainty_score":0.9999957},"labels":[],"label_agreement":null},{"id":"W4309196483","doi":"10.1016/j.beem.2022.101720","title":"Genetic testing in dyslipidaemia: An approach based on clinical experience","year":2022,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Endocrinology & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Etiology; Genetic predisposition; Family history; Disease; Biology; Medicine; Internal medicine; Bioinformatics; Genetics","score_opus":0.5080306541374315,"score_gpt":0.585528875134874,"score_spread":0.07749822099744241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309196483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011417221,0.9776348,0.00007606868,0.00059544906,0.0016193128,0.0053642793,0.000028323775,0.00015108162,0.013388969],"genre_scores_gemma":[0.00021832617,0.9658055,0.022667147,0.0017562527,0.005358084,0.0036227738,0.000120426426,0.0002499919,0.00020150826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9478276,0.03674456,0.0053190906,0.0036312235,0.003724531,0.0027530442],"domain_scores_gemma":[0.96254945,0.02862801,0.0012708651,0.0049876445,0.0010140871,0.0015499279],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.035809405,0.00096871646,0.007055121,0.0014092982,0.0006141496,0.00014040589,0.0018059515,0.0015378122,0.000414306],"category_scores_gemma":[0.15969811,0.00080118136,0.002194146,0.003076071,0.001579277,0.00038659514,0.0012731983,0.02204962,0.00034906503],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044677136,0.007929551,0.0005879595,0.0025602921,0.0003772777,0.0038157667,0.0000428469,0.000010549536,1.2818846e-7,0.00027939735,0.00016910408,0.9837804],"study_design_scores_gemma":[0.0034566626,0.0040494725,0.0016802297,0.0015653075,0.00183871,0.001943224,0.00060712086,0.00034148665,1.2573369e-7,0.000021544529,0.9839084,0.0005876841],"about_ca_topic_score_codex":0.0013945269,"about_ca_topic_score_gemma":0.00001990591,"teacher_disagreement_score":0.9837393,"about_ca_system_score_codex":0.00048068678,"about_ca_system_score_gemma":0.008424024,"threshold_uncertainty_score":0.9997584},"labels":[],"label_agreement":null},{"id":"W4309883751","doi":"10.54097/hset.v19i.2693","title":"The Role of High-Density Lipoprotein in Cardiovascular Disease: Benefits, Functions, and Treatments","year":2022,"lang":"en","type":"article","venue":"Highlights in Science Engineering and Technology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"High-density lipoprotein; Lipoprotein; Cholesterol; Disease; Medicine; Reverse cholesterol transport; Atherosclerotic cardiovascular disease; Function (biology); Internal medicine; Arterial wall; Cardiology; Endocrinology; Biology; Cell biology","score_opus":0.004252879449880561,"score_gpt":0.18942668891031647,"score_spread":0.1851738094604359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309883751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620128,0.036709912,0.000020966387,0.00074836257,0.00009997229,0.00033428054,0.000005326743,0.00004628344,0.000022073491],"genre_scores_gemma":[0.9978326,0.0017797877,0.00019623626,0.0000036758786,0.000016452263,0.0001403669,0.000001403956,0.0000074066224,0.000022090608],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99886256,0.00001901227,0.00016597034,0.0003198727,0.00037784982,0.00025475366],"domain_scores_gemma":[0.9993555,0.000016343458,0.00002423368,0.00049876363,0.000031850126,0.000073334944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076390826,0.00009555413,0.0002679514,0.00046367652,0.00024376277,0.000009322366,0.000114518705,0.000042854434,0.0000010019405],"category_scores_gemma":[0.000075950964,0.00006989315,0.00004531338,0.0011501743,0.00023225757,0.000046202993,0.00018052751,0.00019606754,7.695763e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014086002,0.0002913884,0.034760367,0.00014750328,0.00034488708,0.00021765976,0.00025771686,0.010070904,0.005676422,0.18199779,0.000007307444,0.7660872],"study_design_scores_gemma":[0.0043608667,0.0008244513,0.87982666,0.00023052077,0.00028868092,0.00052298204,0.0015566085,0.008748124,0.022980848,0.00367934,0.07645595,0.0005249917],"about_ca_topic_score_codex":0.0010615204,"about_ca_topic_score_gemma":0.000034197925,"teacher_disagreement_score":0.84506625,"about_ca_system_score_codex":0.00011371951,"about_ca_system_score_gemma":0.000089526424,"threshold_uncertainty_score":0.285016},"labels":[],"label_agreement":null},{"id":"W4310294529","doi":"10.1136/heartjnl-2022-321972","title":"Lipid lowering in primary prevention: time to focus on young patients","year":2022,"lang":"en","type":"letter","venue":"Heart","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Primary prevention; Primary (astronomy); Focus (optics); Internal medicine; Intensive care medicine; Pediatrics; Disease","score_opus":0.010902967395213787,"score_gpt":0.24167951102564997,"score_spread":0.23077654363043618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310294529","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13273455,0.00075398845,0.000023635837,0.77871454,0.0024826205,0.0070108655,0.00008505665,0.00024043486,0.077954315],"genre_scores_gemma":[0.0036679583,0.000040540483,0.00033350463,0.94194144,0.008809122,0.0006798368,0.0010160053,0.0001874739,0.04332409],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997739,0.00012274744,0.00032428736,0.0004660488,0.000954147,0.00039374898],"domain_scores_gemma":[0.9990942,0.00001936774,0.00004934069,0.00069603627,0.000038716462,0.000102328886],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00039529722,0.00021716481,0.00060802774,0.00023948337,0.0000644791,0.000015607478,0.00008582871,0.00025508497,0.00234296],"category_scores_gemma":[0.000033308228,0.00021267042,0.00034002445,0.00022610088,0.00000927057,0.000031462583,0.000111745,0.0013546849,0.0010817801],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009638532,0.0001394023,0.0014587743,0.0004211928,0.00005994257,0.0003038878,0.000049487862,0.0000026920711,0.000012092656,2.8543272e-7,0.98561877,0.011837078],"study_design_scores_gemma":[0.0009544431,0.0010432953,0.029686777,0.0004844325,0.00004324051,0.000051842468,0.0000017518514,7.998256e-7,0.000024512688,0.000006220499,0.96752584,0.00017685193],"about_ca_topic_score_codex":0.0001279088,"about_ca_topic_score_gemma":0.00000406953,"teacher_disagreement_score":0.16322693,"about_ca_system_score_codex":0.00062908896,"about_ca_system_score_gemma":0.00020383028,"threshold_uncertainty_score":0.999696},"labels":[],"label_agreement":null},{"id":"W4311275510","doi":"10.1016/j.jacl.2022.12.002","title":"Sex differences in LDL-C response to PCSK9 inhibitors: A real world experience","year":2022,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Evolocumab; PCSK9; Confounding; Context (archaeology); Internal medicine; Gynecology; LDL receptor; Apolipoprotein B; Cholesterol; Lipoprotein","score_opus":0.09722973839030458,"score_gpt":0.41983529243998213,"score_spread":0.32260555404967756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311275510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864612,0.0002065965,0.00006888085,0.00898479,0.003505511,0.00026449494,0.0000025960348,0.000010581223,0.0004953066],"genre_scores_gemma":[0.9897505,0.00010227578,0.00081952545,0.0034318024,0.0048734737,0.000030694326,7.2642325e-7,0.000014164844,0.000976826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99431777,0.0024798536,0.0018661474,0.00027160527,0.0007308936,0.00033370825],"domain_scores_gemma":[0.9972389,0.0013720347,0.0004699838,0.0003714237,0.00011508007,0.00043259127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010282426,0.00012673115,0.0012697967,0.00042721326,0.0000804364,0.000009229649,0.00025330772,0.000102481754,0.00037182108],"category_scores_gemma":[0.0033492493,0.0000970251,0.0005039976,0.0005415238,0.00011775578,0.000056561457,0.00020130257,0.0012868015,0.000010390412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031518932,0.0013828507,0.8764003,0.000045179575,0.00021859966,0.0009748838,0.0033322396,0.000053544703,0.0010053433,0.00013983205,0.009326292,0.07560202],"study_design_scores_gemma":[0.0043970337,0.00743347,0.78256774,0.00010263425,0.000054005024,0.0007685365,0.0017853468,0.000025452813,0.00011058905,0.00017705902,0.20243059,0.00014754398],"about_ca_topic_score_codex":0.0001490935,"about_ca_topic_score_gemma":0.00009323168,"teacher_disagreement_score":0.1931043,"about_ca_system_score_codex":0.00014015057,"about_ca_system_score_gemma":0.0007335927,"threshold_uncertainty_score":0.55905837},"labels":[],"label_agreement":null},{"id":"W4311288485","doi":"10.3390/jcm11237249","title":"Comparison of Current International Guidelines for the Management of Dyslipidemia","year":2022,"lang":"en","type":"review","venue":"Journal of Clinical Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Canadian Cardiovascular Society; Statin; Intensive care medicine; Atherosclerotic cardiovascular disease; Disease; Family medicine; Internal medicine","score_opus":0.6422211402365854,"score_gpt":0.654352368668568,"score_spread":0.012131228431982666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311288485","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000069273306,0.98436123,0.0030517438,0.0032469658,0.007663862,0.0011929951,0.000019350115,0.000003195411,0.00045371152],"genre_scores_gemma":[0.000032929653,0.98935187,0.0021830082,0.00020740736,0.008015167,0.00003694188,0.0000298834,0.00002816622,0.00011462622],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9898707,0.000305917,0.0077156876,0.00019960958,0.0017515366,0.00015649766],"domain_scores_gemma":[0.98969173,0.00240244,0.005982755,0.0005783687,0.001161979,0.00018273962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013880463,0.00023336838,0.0055067292,0.00020377869,0.000037261474,0.0000021941378,0.00060873915,0.0001488246,0.00038458346],"category_scores_gemma":[0.0047462066,0.000108774206,0.0029594537,0.00023965351,0.00019238236,0.00002284639,0.000145817,0.001194581,8.4951193e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019554263,0.00027591392,0.00010523633,0.025643501,0.004193521,0.0000102502245,0.000019458117,0.0000036208978,2.9907426e-8,0.00022414449,0.030469846,0.9388589],"study_design_scores_gemma":[0.0026774146,0.0015253376,0.00016816308,0.040477965,0.0109524485,0.00006805691,0.0001988573,0.000045803663,2.3109949e-7,0.00005062125,0.94376594,0.000069152244],"about_ca_topic_score_codex":0.0000045595943,"about_ca_topic_score_gemma":4.9600834e-7,"teacher_disagreement_score":0.9387898,"about_ca_system_score_codex":0.000084849315,"about_ca_system_score_gemma":0.00056717574,"threshold_uncertainty_score":0.5681995},"labels":[],"label_agreement":null},{"id":"W4311823645","doi":"10.1161/circulationaha.122.063378","title":"Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation","year":2022,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National de la Santé et de la Recherche Médicale; NYU Grossman School of Medicine; University of Glasgow; University of New South Wales; NIHR Oxford Biomedical Research Centre; York University; School of Medicine, Duke University; Rijksuniversiteit Groningen; Uppsala Universitet; University of Oxford; Imperial College London; National Institute for Health and Care Research; Medical Research Council; Kompetenznetz Vorhofflimmern; Steno Diabetes Center Aarhus; McMaster University; Sorbonne Université; Karolinska Institutet; School of Public Health, Imperial College London; Institut for Klinisk Medicin, Aarhus Universitet; National University of Singapore; British Heart Foundation; Universitair Medisch Centrum Groningen; Université de Lorraine; Hamilton Health Sciences; Aarhus Universitet","keywords":"Medicine; Randomized controlled trial; Cardiology; Internal medicine","score_opus":0.04987275761524101,"score_gpt":0.3047279044471778,"score_spread":0.2548551468319368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311823645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70900464,0.018123146,0.03011297,0.20237727,0.0027662143,0.032591973,0.0026012955,0.00015573068,0.002266736],"genre_scores_gemma":[0.99593425,0.0008752331,0.000260284,0.0011950539,0.0011515381,0.0003867702,0.0001597904,0.00002085968,0.000016231223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909067,0.0074931793,0.0007549348,0.0002472511,0.00042283515,0.0001750658],"domain_scores_gemma":[0.9944879,0.004049249,0.0007569437,0.00044788004,0.0002210331,0.00003699626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0199311,0.000132809,0.0017381954,0.000035388937,0.00060747436,0.000015301688,0.000085260835,0.000030895186,0.0000059878466],"category_scores_gemma":[0.0017292417,0.00007070887,0.001304842,0.00033974386,0.0005242658,0.000029081813,0.00006846707,0.0002258993,4.379678e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1222396,0.00031895688,0.38809493,0.0006743536,0.04353962,0.0000029549433,0.013747499,0.05253423,0.013370365,0.020353228,0.24672121,0.09840306],"study_design_scores_gemma":[0.114420705,0.0002142536,0.71213716,0.000053596996,0.0021518846,0.00003195134,0.01116116,0.005347162,0.000096998534,0.0005356616,0.1536409,0.0002085432],"about_ca_topic_score_codex":0.0014211504,"about_ca_topic_score_gemma":0.00002956213,"teacher_disagreement_score":0.32404226,"about_ca_system_score_codex":0.00017397075,"about_ca_system_score_gemma":0.00013210303,"threshold_uncertainty_score":0.69077617},"labels":[],"label_agreement":null},{"id":"W4312032664","doi":"10.21037/atm-2022-70","title":"Should we test for SLCO1B1 genotype before prescribing statins?—a discussion of clinical trial results","year":2022,"lang":"en","type":"letter","venue":"Annals of Translational Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vetenskapsrådet; European Commission; European Federation of Pharmaceutical Industries and Associations; Robert Bosch Stiftung; McGill University","keywords":"SLCO1B1; Medicine; Test (biology); Clinical trial; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Genotype; Internal medicine; Statin; Bioinformatics; Pharmacogenetics; Biology; Genetics; Gene","score_opus":0.3008368744295148,"score_gpt":0.4507267663092328,"score_spread":0.14988989187971802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312032664","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013139346,0.0033465468,0.0006812224,0.9853791,0.0013100881,0.004018648,0.002834584,0.000035242745,0.0010806242],"genre_scores_gemma":[0.09950386,0.008189247,0.012442165,0.69296587,0.115475476,0.0012899027,0.057637084,0.000693674,0.011802716],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929682,0.0003186174,0.0030776463,0.0006839784,0.0025185845,0.00043297012],"domain_scores_gemma":[0.99548084,0.0016524841,0.0011303083,0.00082745886,0.0007191449,0.0001897471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004771573,0.00038842222,0.0022242675,0.000330353,0.00011487567,0.0000038859735,0.00027005665,0.00069583027,0.00041741674],"category_scores_gemma":[0.0029823405,0.00023532973,0.001273163,0.00030316188,0.0002987959,0.00007008947,0.000036415102,0.0016612727,0.0000013313904],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054470208,0.00045100707,0.00018322378,0.00375063,0.0010568894,0.000067631336,0.0007577239,0.000018372148,0.000049172064,0.00009657879,0.8101382,0.12896034],"study_design_scores_gemma":[0.057468824,0.013679743,0.002146031,0.0017593935,0.00093628635,0.00001848544,0.00006896382,0.0001171135,0.00008184952,0.0012348886,0.9222709,0.00021755454],"about_ca_topic_score_codex":0.00018427712,"about_ca_topic_score_gemma":0.000020215452,"teacher_disagreement_score":0.29241323,"about_ca_system_score_codex":0.000018956573,"about_ca_system_score_gemma":0.0008617607,"threshold_uncertainty_score":0.9596468},"labels":[],"label_agreement":null},{"id":"W4312087517","doi":"10.1002/alz.065988","title":"LDLR, VLDLR and APOBR in the pathophysiology of sporadic Alzheimer’s disease","year":2022,"lang":"en","type":"article","venue":"Alzheimer s & Dementia","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"","keywords":"Apolipoprotein E; Internal medicine; Pathophysiology; Apolipoprotein B; Receptor; Disease; Pathological; Endocrinology; LDL receptor; Psychology; Cholesterol; Biology; Medicine; Lipoprotein","score_opus":0.02377600977750977,"score_gpt":0.2671916094611973,"score_spread":0.24341559968368753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312087517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5589647,0.43724158,0.000014333435,0.0021430068,0.0001906639,0.0010033192,0.0000348768,0.000019976778,0.00038748214],"genre_scores_gemma":[0.9966654,0.0005608677,0.0001629632,0.0022249555,0.000107570064,0.00018281493,0.000073265175,0.000019672963,0.00000244485],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983868,0.00028972578,0.00031189417,0.00029636544,0.0004460205,0.00026916593],"domain_scores_gemma":[0.9991248,0.000031830372,0.000097380915,0.0005981783,0.00002797517,0.000119831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007707607,0.00013904221,0.0003323454,0.00009640951,0.00014151489,0.000006499744,0.00015935175,0.000030939074,0.00032662041],"category_scores_gemma":[0.0000127103785,0.00010462238,0.00016755814,0.00025770668,0.00010165189,0.00004271352,0.00015152525,0.00024242172,0.000005837456],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022423198,0.0026275655,0.11755485,0.00018341368,0.029919546,0.0015591067,0.004586135,0.00013884048,0.0026497962,0.009036607,0.013207434,0.8162944],"study_design_scores_gemma":[0.0034172575,0.00077872345,0.8714464,0.000025441368,0.031155108,0.000086748376,0.0011506989,0.00021004373,0.0005047504,0.0021538103,0.08873565,0.000335377],"about_ca_topic_score_codex":0.00038336214,"about_ca_topic_score_gemma":0.000011867504,"teacher_disagreement_score":0.81595904,"about_ca_system_score_codex":0.0000048660077,"about_ca_system_score_gemma":0.00013454766,"threshold_uncertainty_score":0.42663768},"labels":[],"label_agreement":null},{"id":"W4312115155","doi":"10.1007/s10557-022-07413-0","title":"Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials","year":2022,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma","keywords":"Medicine; Placebo; Adverse effect; Post-hoc analysis; Internal medicine; Confidence interval; Randomized controlled trial; Dosing; Clinical trial; Lipid profile; Cholesterol; Pathology","score_opus":0.00802894109880252,"score_gpt":0.24997182522052372,"score_spread":0.2419428841217212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312115155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85450286,0.13927929,0.00010567294,0.00021364394,0.000093040275,0.005612577,0.00015627606,0.000013937821,0.000022693186],"genre_scores_gemma":[0.98413634,0.015105083,0.000040614912,0.00014961475,0.00008039745,0.00027749626,0.0001404538,0.000041308434,0.000028711387],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99272704,0.0034582468,0.0013318728,0.0006101339,0.0015673414,0.00030535532],"domain_scores_gemma":[0.9970051,0.0006429639,0.0005453933,0.0012111851,0.00033703865,0.0002582941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011589528,0.00039450216,0.0067130383,0.000514763,0.00029355098,0.000029869656,0.00014844982,0.00009340155,0.00008483943],"category_scores_gemma":[0.0005860933,0.00021624284,0.0041087805,0.001130789,0.0003457447,0.00008005431,0.00014301513,0.00025116024,1.0511855e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67542547,0.0012891592,0.019107997,0.0002826594,0.11890548,0.000027632612,0.0017572487,0.0007507978,0.000074293064,0.0002959373,0.000008782623,0.18207458],"study_design_scores_gemma":[0.862152,0.0009108144,0.101627305,0.00015710024,0.029482145,0.000008906446,0.00038460272,0.00030225975,0.000045700486,0.000031071522,0.004581262,0.00031683975],"about_ca_topic_score_codex":0.0005494213,"about_ca_topic_score_gemma":0.000008505768,"teacher_disagreement_score":0.18672656,"about_ca_system_score_codex":0.00006581159,"about_ca_system_score_gemma":0.0002626574,"threshold_uncertainty_score":0.8818127},"labels":[],"label_agreement":null},{"id":"W4312225867","doi":"10.1016/j.cjca.2022.12.025","title":"Comparison of Three Methods for LDLC Calculation for Cardiovascular Disease Risk Categorisation in Three Distinct Patient Populations","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Dyslipidemia; Population; Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Demography; Internal medicine; Disease; Cholesterol; Environmental health","score_opus":0.07616571886060036,"score_gpt":0.35805632368785184,"score_spread":0.2818906048272515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312225867","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3012287,0.00791633,0.6879675,0.0003080848,0.000840613,0.0014639731,0.000224342,0.000004014169,0.000046431727],"genre_scores_gemma":[0.98777884,0.000014088354,0.011287971,0.000023770637,0.00052409427,0.0002072747,0.00013526142,0.000026223779,0.0000024683093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978643,0.00051828026,0.0007993389,0.00021441876,0.00028694674,0.00031668742],"domain_scores_gemma":[0.99815214,0.00014841229,0.00040688194,0.00043593414,0.0004259802,0.0004306599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00285506,0.00013576595,0.0010394276,0.00042600906,0.00026115697,0.0000067815276,0.00011167968,0.000084664534,0.000007192951],"category_scores_gemma":[0.0008966113,0.00012956808,0.0015426787,0.00024441123,0.000064376356,0.00005111502,0.000016759213,0.00029983203,1.5358081e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041622648,0.000014355553,0.557447,0.00012862333,0.0012384172,0.000021833772,0.00024701882,0.25832227,0.000016064247,0.00081993546,0.0004464184,0.1808818],"study_design_scores_gemma":[0.0032543133,0.0011721868,0.8851697,0.00003466689,0.0024682367,0.00013800953,0.00027122314,0.013442382,0.000023339726,0.008585879,0.085247636,0.00019242962],"about_ca_topic_score_codex":0.0066787875,"about_ca_topic_score_gemma":0.0069847265,"teacher_disagreement_score":0.68655014,"about_ca_system_score_codex":0.0006149026,"about_ca_system_score_gemma":0.0015002756,"threshold_uncertainty_score":0.9999358},"labels":[],"label_agreement":null},{"id":"W4312745174","doi":"10.1093/eurheartj/ehab724.2026","title":"Efficacy and safety of inclisiran in patients with established cerebrovascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised clinical trials","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Post-hoc analysis; Stroke (engine); Internal medicine; Placebo; PCSK9; Statin; Cardiology; Surgery; Cholesterol; Pathology; Lipoprotein","score_opus":0.033469052113161014,"score_gpt":0.3383774207872246,"score_spread":0.30490836867406357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312745174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531174,0.002642927,0.00012047064,0.0006840948,0.00016635408,0.0009473802,0.000057983216,0.0000075929443,0.00006143713],"genre_scores_gemma":[0.99778014,0.0011848194,0.0003098249,0.0002516538,0.0003198482,0.0000020961122,0.00006265362,0.000036642625,0.000052302767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913711,0.0053571635,0.0017055349,0.000390684,0.00091603934,0.00025949208],"domain_scores_gemma":[0.99683136,0.00063877105,0.00061413023,0.00074204727,0.0006405773,0.0005330969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011792452,0.00022092345,0.0018038753,0.00028229647,0.00017342683,0.000058431862,0.00011640847,0.00006338641,0.00020208041],"category_scores_gemma":[0.004621869,0.00012952475,0.00097600446,0.0009911332,0.00017825663,0.00012767166,0.00012976155,0.00047573927,0.0000011093381],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05618789,0.0020101373,0.88696563,0.00024457747,0.0058506113,0.00019491995,0.0003774994,0.00010261318,0.00016501237,0.000012940941,0.0003054459,0.04758272],"study_design_scores_gemma":[0.12340378,0.0007854922,0.86614966,0.00045720921,0.004414083,0.00005224861,0.00007683097,0.000053262153,0.00003624041,0.0000019033124,0.004445286,0.00012401304],"about_ca_topic_score_codex":0.000028176504,"about_ca_topic_score_gemma":0.000024591178,"teacher_disagreement_score":0.06721589,"about_ca_system_score_codex":0.000043813317,"about_ca_system_score_gemma":0.0005184807,"threshold_uncertainty_score":0.55331427},"labels":[],"label_agreement":null},{"id":"W4312764190","doi":"10.1161/atvb.42.suppl_1.215","title":"Abstract 215: Enhanced Atherosclerosis, Inflammation And Oxidized Phospholipid Reactivity In Female Transgenic Mice Expressing Human Lp(a)","year":2022,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas University; Western University; Robarts Clinical Trials","funders":"","keywords":"Apolipoprotein B; Internal medicine; Endocrinology; Inflammation; Chemistry; Cholesterol; Genetically modified mouse; Lipoprotein; Oil Red O; Apolipoprotein E; PCSK9; Molecular biology; Transgene; Medicine; Biology; LDL receptor; Biochemistry; Adipose tissue; Gene","score_opus":0.03775211846590625,"score_gpt":0.2946589265914596,"score_spread":0.25690680812555333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312764190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979261,0.0004607835,0.00014772563,0.00030489435,0.00014000344,0.00082977384,0.000021070036,0.0000639909,0.00010565552],"genre_scores_gemma":[0.995214,0.0036735947,0.00029602015,0.0002252227,0.00015295726,0.00031860315,0.000072488605,0.000044218225,0.000002888932],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976438,0.00035238394,0.0005231449,0.0007271715,0.0002742567,0.00047919076],"domain_scores_gemma":[0.9990614,0.00005030425,0.00017238896,0.0005085445,0.000040798357,0.00016654354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012055098,0.00030459312,0.0008446739,0.00015973083,0.0005450395,0.00004772155,0.00010825437,0.00018009872,0.00013700491],"category_scores_gemma":[0.00002393044,0.00029405503,0.0002865147,0.00023669026,0.00017034204,0.00016641537,0.00014030075,0.00041139012,0.0000025513684],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020350344,0.00018116059,0.025366435,0.00012545405,0.00017330401,9.983146e-8,0.0012057842,0.000002851096,0.9691328,0.000059218633,0.0000060562506,0.0037264954],"study_design_scores_gemma":[0.0039038756,0.0004174992,0.96062946,0.00015160306,0.00013697405,0.000002294046,0.0005695695,0.000032794673,0.032430224,0.000038777205,0.0013847557,0.00030219465],"about_ca_topic_score_codex":0.000871967,"about_ca_topic_score_gemma":0.00018066607,"teacher_disagreement_score":0.93670255,"about_ca_system_score_codex":0.00012321031,"about_ca_system_score_gemma":0.000060405564,"threshold_uncertainty_score":0.9999512},"labels":[],"label_agreement":null},{"id":"W4313171308","doi":"10.1161/atvb.42.suppl_1.410","title":"Abstract 410: Lipoprotein(a) And Apolipoprotein(a) Inhibit Lysis Of Human Thrombi Formed From Whole Blood Under Conditions Of Flow","year":2022,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lipoprotein(a); Protease; Fibrinolysis; Apolipoprotein B; Lysis; Fibrinogen; Biochemistry; Molecular biology; Whole blood; Fibrin; In vivo; Chemistry; Plasmin; Kringle domain; Recombinant DNA; Lipoprotein; Biology; Enzyme; Immunology; Internal medicine; Medicine; Gene","score_opus":0.031846519502096,"score_gpt":0.28877798324822385,"score_spread":0.25693146374612785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313171308","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967402,0.0007999565,0.00013605083,0.0005720427,0.0000811232,0.00097476447,0.0005462318,0.000042024916,0.000107570406],"genre_scores_gemma":[0.99702656,0.0009311893,0.00082122185,0.0003435792,0.00011361369,0.00027175143,0.00044055373,0.000047447236,0.000004064667],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9975096,0.00022730697,0.0007625056,0.0006560783,0.00042360462,0.00042089119],"domain_scores_gemma":[0.99841297,0.000060224553,0.0003446209,0.00084807683,0.00012118834,0.00021293614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006633417,0.00032435654,0.001304961,0.0002216176,0.00047717695,0.000018954657,0.0001522763,0.00021233449,0.0005820298],"category_scores_gemma":[0.000029311077,0.00029777994,0.0005461084,0.00029445006,0.0005011493,0.00008058434,0.00030314713,0.0003223777,0.0000026849987],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014068256,0.000816148,0.03206572,0.0002923687,0.002500163,4.1580643e-7,0.00062715285,0.000012728844,0.96047866,0.0010549687,0.000048535243,0.002089094],"study_design_scores_gemma":[0.0038199218,0.001522002,0.97740865,0.00016505954,0.0010909373,0.0000048092065,0.00096701784,0.00004765045,0.012644812,0.0017350132,0.00029677816,0.00029732764],"about_ca_topic_score_codex":0.004201983,"about_ca_topic_score_gemma":0.00024118705,"teacher_disagreement_score":0.94783384,"about_ca_system_score_codex":0.000044618315,"about_ca_system_score_gemma":0.000089075846,"threshold_uncertainty_score":0.9999474},"labels":[],"label_agreement":null},{"id":"W4313304290","doi":"10.1136/bmjopen-2021-060172","title":"Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data","year":2022,"lang":"en","type":"article","venue":"BMJ Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of Maryland","keywords":"Medicine; Evolocumab; Placebo; Internal medicine; Clinical trial; Myocardial infarction; Disease; PCSK9; Cardiology; Alternative medicine; Pathology","score_opus":0.1302853567261814,"score_gpt":0.3771575657031397,"score_spread":0.24687220897695827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313304290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786491,0.0010848651,0.0000825816,0.00044600075,0.0001756003,0.018516378,0.0005602184,0.000016826447,0.00046843206],"genre_scores_gemma":[0.99564976,0.000015672475,0.00031799756,0.0002521775,0.00014531772,0.0016295371,0.0019147112,0.000045034656,0.000029799688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98721474,0.0022440196,0.0007492567,0.0011454211,0.008283186,0.00036336845],"domain_scores_gemma":[0.9650533,0.0000984085,0.00019047303,0.034433216,0.00008569385,0.0001388742],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.036408357,0.0002640436,0.0016166503,0.00025339084,0.00016607443,0.000046401517,0.0027213055,0.000056321922,0.00003877024],"category_scores_gemma":[0.0015104571,0.00017777967,0.00073004107,0.000993128,0.0000702545,0.00031076476,0.0022473603,0.00046213542,0.0000013543307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036043953,0.0020018616,0.9040731,0.0004786319,0.01099231,0.0007306007,0.00020176514,0.020896109,9.509621e-8,0.00004341538,0.00057017046,0.02396799],"study_design_scores_gemma":[0.059541658,0.00041350472,0.92369395,0.00017612215,0.0031709448,0.0000029486548,0.00021756272,0.0021630235,5.30747e-7,0.00001041304,0.0103617115,0.00024763294],"about_ca_topic_score_codex":0.01025822,"about_ca_topic_score_gemma":0.00034427593,"teacher_disagreement_score":0.0348979,"about_ca_system_score_codex":0.0003037481,"about_ca_system_score_gemma":0.0011036746,"threshold_uncertainty_score":0.9963325},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"reproducibility","study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["metaresearch"],"domain":"evaluation","study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4313381922","doi":"10.4049/jimmunol.198.supp.216.12","title":"PCSK9 regulates LDL-dependent uptake of bacterial lipids by HepG2 cells through LDL receptor","year":2017,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"PCSK9; LDL receptor; Lipoteichoic acid; Antibody; Lipoprotein; Lipopolysaccharide; Receptor; Flow cytometry; Chemistry; Biology; Molecular biology; Biochemistry; Endocrinology; Immunology; Cholesterol; Bacteria","score_opus":0.015488347521034545,"score_gpt":0.2612835228842583,"score_spread":0.2457951753632238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313381922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862359,0.007243546,0.000115179195,0.0028926644,0.0025157179,0.00025075674,0.000015465283,0.0000082870865,0.0007224434],"genre_scores_gemma":[0.989385,0.0072650253,0.0007636016,0.00015993079,0.0013441694,0.0000022973045,0.0000052170312,0.000029830078,0.0010449098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998215,0.00026062064,0.0007292139,0.00011565411,0.0003840685,0.0002954064],"domain_scores_gemma":[0.9974801,0.00005985326,0.0010327804,0.0010633805,0.00029591366,0.000067982124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016762774,0.00016220481,0.00075850077,0.00004777441,0.00022706515,0.000022098926,0.00055491854,0.0001963192,0.00046573015],"category_scores_gemma":[0.00019865886,0.00009673555,0.00034946817,0.000039474242,0.0002906332,0.00015745798,0.00012621583,0.0004984318,0.000032077573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021442194,0.00016973748,0.000072683244,0.000056069588,0.0012368511,0.000016863587,0.00084787444,0.0000023840876,0.96483576,0.00007482054,0.006758503,0.02378424],"study_design_scores_gemma":[0.006028846,0.0026663102,0.010633636,0.00028977793,0.0005643592,0.0014415383,0.0007845424,0.0000023283712,0.79437834,0.00027879287,0.1827679,0.00016360397],"about_ca_topic_score_codex":0.0003119156,"about_ca_topic_score_gemma":0.0000074251893,"teacher_disagreement_score":0.1760094,"about_ca_system_score_codex":0.00007682064,"about_ca_system_score_gemma":0.00021766969,"threshold_uncertainty_score":0.5099419},"labels":[],"label_agreement":null},{"id":"W4313454138","doi":"10.1111/dom.14965","title":"Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the <scp>VERTIS CV</scp> population with type 2 diabetes and atherosclerotic cardiovascular disease","year":2023,"lang":"en","type":"letter","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"Pfizer; American Diabetes Association","keywords":"Medicine; Type 2 diabetes; Residual risk; Internal medicine; Atherosclerotic cardiovascular disease; Population; Diabetes mellitus; Type 2 Diabetes Mellitus; Insulin resistance; Post-hoc analysis; Endocrinology; Obesity; Disease; Environmental health","score_opus":0.014742287592752942,"score_gpt":0.2366771745231051,"score_spread":0.22193488693035215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313454138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9060393,0.08091571,0.00015784385,0.0055621276,0.00074451166,0.0060179774,0.0004544072,0.00010227426,0.0000058720084],"genre_scores_gemma":[0.91947407,0.029330919,0.0013889358,0.022446316,0.017814811,0.0039318297,0.0048156017,0.00046156364,0.00033595267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949347,0.0008388165,0.0005649556,0.0013871295,0.0013072786,0.00096714153],"domain_scores_gemma":[0.99712926,0.0003213075,0.0001990786,0.0017456369,0.00034613427,0.00025857493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042087426,0.00065108406,0.0020167204,0.00025072292,0.00052783976,0.00016706594,0.00021774367,0.00066749606,0.0000017813129],"category_scores_gemma":[0.00082853285,0.0004690103,0.0016656022,0.0004196831,0.00022105694,0.0001533235,0.00009993773,0.0011091763,0.000003211673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009766689,0.0019046294,0.33500633,0.060759354,0.11405152,0.0006752596,0.0054399045,0.0054994486,0.0003422448,0.0002770499,0.24049713,0.23457047],"study_design_scores_gemma":[0.0038579805,0.00027538984,0.75309426,0.00038329815,0.014361552,0.0000132774985,0.00012474411,0.00023656256,0.000096020645,0.0010240235,0.22620896,0.00032393407],"about_ca_topic_score_codex":0.00067527423,"about_ca_topic_score_gemma":0.000016613953,"teacher_disagreement_score":0.41808793,"about_ca_system_score_codex":0.000086291366,"about_ca_system_score_gemma":0.00017833612,"threshold_uncertainty_score":0.9997762},"labels":[],"label_agreement":null},{"id":"W4313454417","doi":"10.1016/j.molmet.2022.101662","title":"Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: Functional regulation of LDLR levels","year":2022,"lang":"en","type":"article","venue":"Molecular Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; LDL receptor; Endosome; Cell biology; Proprotein convertase; Endocytosis; Chemistry; Biology; Receptor; Biochemistry; Intracellular; Cholesterol","score_opus":0.01398518937076206,"score_gpt":0.24337139073225464,"score_spread":0.22938620136149257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313454417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847258,0.003515821,0.010187227,0.00026696597,0.00020554611,0.0005024719,0.000036286332,0.00002628282,0.0005336442],"genre_scores_gemma":[0.9964301,0.000013070524,0.0028937757,0.0002708004,0.000092889546,0.00007661775,0.00007723352,0.000038922357,0.000106614774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980428,0.0002500253,0.00035361046,0.00032583604,0.00084626104,0.00018144639],"domain_scores_gemma":[0.998866,0.00001205982,0.00018807655,0.0005578101,0.00024013927,0.00013586319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048077348,0.0001629321,0.00046802792,0.00024676096,0.00011595489,0.0000071620902,0.0000661645,0.00004196595,0.0001827807],"category_scores_gemma":[0.000030875133,0.00014926851,0.00018984404,0.00035821713,0.00010691763,0.000109861314,0.00008510083,0.000251551,8.167035e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037529264,0.00029611072,0.00038626898,0.00016275502,0.0004852963,0.000062062085,0.00035949668,0.0016693171,0.9774411,0.008940129,0.00004434099,0.009777884],"study_design_scores_gemma":[0.005270702,0.0008541957,0.20059928,0.00010625356,0.001204167,0.00098096,0.0008385551,0.00073553144,0.766375,0.001123603,0.021498915,0.0004128335],"about_ca_topic_score_codex":0.00028093305,"about_ca_topic_score_gemma":0.000009686558,"teacher_disagreement_score":0.21106605,"about_ca_system_score_codex":0.000044759767,"about_ca_system_score_gemma":0.000285398,"threshold_uncertainty_score":0.6086993},"labels":[],"label_agreement":null},{"id":"W4313546106","doi":"10.1097/mol.0000000000000865","title":"The clinical utility of polygenic risk scores for combined hyperlipidemia","year":2022,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Hyperlipidemia; Medicine; Familial hypercholesterolemia; Disease; Polygenic risk score; Multifactorial Inheritance; Diabetes mellitus; Risk assessment; Internal medicine; Cholesterol; Genetics; Endocrinology; Biology","score_opus":0.2676519221913802,"score_gpt":0.48400219630844915,"score_spread":0.21635027411706897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313546106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022139797,0.9078324,0.000116161966,0.000098614786,0.08790962,0.0037729149,0.00017855561,0.00002697652,0.000042654545],"genre_scores_gemma":[0.000012343094,0.9833157,0.00009800072,0.000017475908,0.014743732,0.0012307263,0.0005074016,0.000050731156,0.000023878865],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99291736,0.0030050895,0.0024353066,0.000712529,0.00040241337,0.00052732637],"domain_scores_gemma":[0.9932345,0.003949945,0.0011115135,0.0014423644,0.00009339349,0.00016824892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008111221,0.00037971145,0.0035564872,0.0001947491,0.0002019686,0.0000071502204,0.00046780793,0.00048004312,0.00013428903],"category_scores_gemma":[0.0037926573,0.000245058,0.0026386764,0.00040143848,0.0003886417,0.000021307684,0.0002876166,0.0018594099,0.000010073002],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022986786,0.00025774713,0.002251647,0.02275571,0.00032123705,3.7871853e-8,0.000013578754,1.2174574e-7,3.305905e-9,0.0004922557,0.025335567,0.9483422],"study_design_scores_gemma":[0.0018497758,0.00077258056,0.0022722401,0.0033000077,0.0006936465,0.000030321435,0.000019127896,0.000028199776,1.3496294e-8,0.0002612351,0.99059296,0.00017991468],"about_ca_topic_score_codex":0.000060393228,"about_ca_topic_score_gemma":0.000009338837,"teacher_disagreement_score":0.96525735,"about_ca_system_score_codex":0.00012473161,"about_ca_system_score_gemma":0.0016064747,"threshold_uncertainty_score":0.9993176},"labels":[],"label_agreement":null},{"id":"W4313554841","doi":"10.1016/s2213-8587(22)00353-9","title":"Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":308,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"NIHR Imperial Biomedical Research Centre; Novartis Pharma; National Institute for Health and Care Research; Novartis","keywords":"Medicine; PCSK9; Clinical endpoint; Placebo; Statin; Population; Dosing; Internal medicine; Cholesterol; Adverse effect; Surrogate endpoint; Clinical trial; Lipoprotein; Pathology","score_opus":0.025977539394577646,"score_gpt":0.26660450488717047,"score_spread":0.24062696549259283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313554841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462914,0.0012927512,0.0000025961074,0.0009880787,0.00021348239,0.0025935923,0.00023957557,0.000026584528,0.0000142030485],"genre_scores_gemma":[0.99742717,0.0019192962,0.000031827218,0.00019405808,0.00024319014,0.000048086757,0.00010307644,0.00002568579,0.0000076018064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99725807,0.0008356487,0.00049800024,0.00042482626,0.00043406285,0.0005494226],"domain_scores_gemma":[0.9974441,0.00052855746,0.00025565142,0.0016014451,0.000115890165,0.00005434964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015824581,0.00019755027,0.0010598145,0.00006103545,0.00015656256,0.000017181952,0.0004001532,0.00009427122,0.0000026674684],"category_scores_gemma":[0.0004861345,0.000091721384,0.000102193975,0.00041271438,0.00035026652,0.000055487875,0.000521134,0.0004401051,0.0000016745458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030525453,0.00030243502,0.9072991,0.00010562662,0.0016677438,0.000012376325,0.00061897817,0.00005682179,0.00028035117,0.0000642715,0.000099061304,0.058967754],"study_design_scores_gemma":[0.12633753,0.000831778,0.8710552,0.00025681933,0.0004296385,0.0000023215298,0.000035535482,0.000012937003,0.0006098959,0.00007787469,0.00026322438,0.00008726164],"about_ca_topic_score_codex":0.0017069324,"about_ca_topic_score_gemma":0.00013821044,"teacher_disagreement_score":0.09581208,"about_ca_system_score_codex":0.000028895009,"about_ca_system_score_gemma":0.000059970076,"threshold_uncertainty_score":0.37402895},"labels":[],"label_agreement":null},{"id":"W4313648897","doi":"10.3390/jcm12020476","title":"High- vs. Low-Intensity Statin Therapy and Changes in Coronary Artery Calcification Density after One Year","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Atorvastatin; Statin; Pravastatin; Internal medicine; Randomized controlled trial; Rosuvastatin; Agatston score; Cardiology; Calcification; Coronary artery disease; Gastroenterology; Cholesterol; Coronary artery calcium","score_opus":0.08481116458986805,"score_gpt":0.37165654504952966,"score_spread":0.2868453804596616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313648897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96627825,0.0008431389,0.0000885705,0.031868733,0.0005949727,0.00028141344,0.0000021045312,0.00001589692,0.000026925069],"genre_scores_gemma":[0.98155564,0.012657185,0.0004499523,0.0031246645,0.0021124268,0.0000051453153,0.0000074319305,0.000015579495,0.00007194903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977998,0.00021288749,0.0009771663,0.00019051172,0.0006223398,0.00019728689],"domain_scores_gemma":[0.9984711,0.00031523255,0.00031993326,0.0002721842,0.0003213014,0.00030025365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040548937,0.00011460968,0.0010604371,0.00019291442,0.000024032288,0.000004508264,0.000056797653,0.00014236118,0.00008669658],"category_scores_gemma":[0.0010218923,0.00007582396,0.00013369299,0.00024641125,0.00017890125,0.00005131763,0.000027201993,0.0006112279,0.000014958657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01322957,0.0005576329,0.6391774,0.00029836138,0.00047515615,0.0028411269,0.00078394316,0.000001556815,0.0012631306,0.000042717616,0.0036153344,0.33771408],"study_design_scores_gemma":[0.00658641,0.0025125917,0.9879662,0.00070730184,0.0000886526,0.00032586648,0.00024304977,0.000035332545,0.00012639255,0.0002612707,0.0010810244,0.00006592566],"about_ca_topic_score_codex":0.00008072372,"about_ca_topic_score_gemma":0.00006214877,"teacher_disagreement_score":0.3487888,"about_ca_system_score_codex":0.000036194262,"about_ca_system_score_gemma":0.000115806564,"threshold_uncertainty_score":0.30920115},"labels":[],"label_agreement":null},{"id":"W4313815834","doi":"10.1503/cmaj.220673","title":"Achievement of treatment targets among patients with type 2 diabetes in 2015 and 2020 in Canadian primary care","year":2023,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"University of Alberta; Diabetes Action Research and Education Foundation","keywords":"Medicine; Blood pressure; Diabetes mellitus; Logistic regression; Type 2 diabetes; Guideline; Angiotensin Receptor Blockers; Primary care; Internal medicine; Medical record; Endocrinology; Angiotensin-converting enzyme; Family medicine","score_opus":0.00382806179151752,"score_gpt":0.20836707697583567,"score_spread":0.20453901518431816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313815834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951376,0.0007788837,1.0180956e-7,0.0032176785,0.00013428436,0.0003021157,0.00003309642,0.0000037227708,0.0003925733],"genre_scores_gemma":[0.99831164,0.00044143325,0.000017959965,0.0008628091,0.00015761207,0.000010229403,0.0001322799,0.000011604164,0.00005444202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983856,0.00009345077,0.00027045328,0.00012090567,0.0006571246,0.00047244865],"domain_scores_gemma":[0.9980698,0.000023508293,0.00007715977,0.000081777114,0.00019914994,0.0015485974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007913117,0.00008905499,0.00029690785,0.0003419743,0.00005805067,0.000011358572,0.000042895164,0.00015977286,0.00009924997],"category_scores_gemma":[0.00020204444,0.00006995102,0.000040874158,0.00041882825,0.000022375929,0.00004673666,0.0000061323894,0.00029275817,0.0000061957503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000008243378,0.000016910382,0.98078954,0.00003785088,0.00007694484,0.00020160172,0.0004426595,0.00000587707,5.3435866e-7,0.0000015831836,0.0014063873,0.017011855],"study_design_scores_gemma":[0.0022714373,0.0003296556,0.9809273,0.00019029819,0.000023059743,0.000003423268,0.00032501816,0.000042773623,0.0000028339198,0.000003557679,0.015816875,0.000063759486],"about_ca_topic_score_codex":0.4637614,"about_ca_topic_score_gemma":0.9604975,"teacher_disagreement_score":0.49673614,"about_ca_system_score_codex":0.00492609,"about_ca_system_score_gemma":0.006700181,"threshold_uncertainty_score":0.99893093},"labels":[],"label_agreement":null},{"id":"W4313827809","doi":"10.1161/circulationaha.122.061010","title":"Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry","year":2023,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health; Esperion Therapeutics; Novo Nordisk Fonden; Amarin Corporation; Regeneron Pharmaceuticals; Aarhus Universitetshospital; Novo Nordisk; Sanofi; Aarhus Universitet; Steno Diabetes Center Aarhus; American Heart Association; Aetna Foundation; AstraZeneca; Amgen","keywords":"Medicine; Cardiology; Internal medicine; Coronary heart disease; Coronary atherosclerosis; Cholesterol; Atherosclerotic cardiovascular disease; Disease; Coronary artery disease; Lipoprotein","score_opus":0.02234801938184753,"score_gpt":0.23652736237722163,"score_spread":0.2141793429953741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313827809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960382,0.00035413503,0.00022524314,0.00025942756,0.000055442546,0.0029923674,0.000015274714,0.00005519323,0.0000047084304],"genre_scores_gemma":[0.9993232,0.00005647029,0.000016404945,0.000182438,0.000059034777,0.00020103338,0.00004982997,0.00006083301,0.000050767027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682117,0.0003540901,0.00041825086,0.00055063446,0.0014755687,0.00038031576],"domain_scores_gemma":[0.9978431,0.00006290624,0.00022808759,0.0013968812,0.0002966975,0.00017232295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011827175,0.00026201233,0.00061875064,0.00010743328,0.0001398098,0.000017859627,0.00015525344,0.00013020133,0.000007052056],"category_scores_gemma":[0.0001924535,0.00017892338,0.00032964334,0.00077262154,0.00012299692,0.00023963924,0.000059029513,0.00026070065,0.000027412161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006461853,0.00024120983,0.9942652,0.00037535705,0.0005110315,0.000008332356,0.0003786185,0.0013445958,0.00015259994,5.1487865e-7,0.000011799511,0.002064564],"study_design_scores_gemma":[0.004244493,0.0002689222,0.98906976,0.005058456,0.0005181664,0.000005327568,0.00004688651,0.00034730847,0.00023219411,0.000008437299,0.000007830564,0.0001922286],"about_ca_topic_score_codex":0.0004987495,"about_ca_topic_score_gemma":0.00007434657,"teacher_disagreement_score":0.005195442,"about_ca_system_score_codex":0.00025021262,"about_ca_system_score_gemma":0.00021921804,"threshold_uncertainty_score":0.7296283},"labels":[],"label_agreement":null},{"id":"W4315798354","doi":"10.1016/j.ihj.2023.01.004","title":"Prior statin use and the incidence of in-hospital arrhythmia in acute coronary syndrome: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Indian Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Acute coronary syndrome; Internal medicine; Atrial fibrillation; Incidence (geometry); Clopidogrel; Meta-analysis; Aspirin; Myocardial infarction; Cardiology","score_opus":0.061216591825693174,"score_gpt":0.34996066573379264,"score_spread":0.2887440739080995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4315798354","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032165237,0.9906752,0.0000033333833,0.0008630907,0.000032261236,0.005139337,0.00006339837,0.0000060879984,7.4629736e-7],"genre_scores_gemma":[0.0012220772,0.99782014,0.00021343389,0.0002417516,0.000028293369,0.00034358646,0.000009809992,0.000039812272,0.0000810709],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9946455,0.0017832725,0.002173391,0.00034516733,0.0007266487,0.00032602588],"domain_scores_gemma":[0.9973488,0.00067562045,0.0009439177,0.0006724725,0.00011887912,0.00024031234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068641156,0.00037603496,0.011487389,0.00075419224,0.00007589402,0.00007464096,0.00014249333,0.00017871961,0.000036675883],"category_scores_gemma":[0.00086735823,0.00018794864,0.0024936467,0.0014614622,0.00014513897,0.00015596708,0.00009958031,0.0011599214,0.000008735838],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001179756,0.00002613008,0.00025371954,0.88150144,0.108749315,0.006462794,0.0004173013,3.618427e-7,5.388184e-9,0.00000641386,0.000031408115,0.0025393479],"study_design_scores_gemma":[0.00074892276,0.00019884467,0.0040012496,0.18859845,0.756406,0.048545633,0.000080601334,0.0000023865239,1.4751776e-8,0.000018415363,0.0011804182,0.00021906126],"about_ca_topic_score_codex":0.00027243886,"about_ca_topic_score_gemma":0.00012392156,"teacher_disagreement_score":0.692903,"about_ca_system_score_codex":0.0001419882,"about_ca_system_score_gemma":0.0006521471,"threshold_uncertainty_score":0.78525496},"labels":[],"label_agreement":null},{"id":"W4316193340","doi":"10.1016/j.ijcrp.2023.200168","title":"Ethnicity based differences in statin use and hypercholesterolemia control among patients with premature coronary artery disease-results of I-PAD study","year":2023,"lang":"en","type":"article","venue":"International Journal of Cardiology Cardiovascular Risk and Prevention","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Isfahan University of Medical Sciences; Ministry of Health and Medical Education","keywords":"Rosuvastatin; Medicine; Odds ratio; Confounding; Statin; Simvastatin; Internal medicine; Coronary artery disease; Lovastatin; Logistic regression; Confidence interval; Population; Cholesterol; Environmental health","score_opus":0.016342171750539994,"score_gpt":0.2575896648361032,"score_spread":0.2412474930855632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316193340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404263,0.0012207378,0.0035553654,0.00005394912,0.00019403298,0.00079432747,0.00012183048,0.000010570315,0.0000065519193],"genre_scores_gemma":[0.9986051,0.0010244015,0.00011004295,0.000019205796,0.0001458325,0.000020386993,0.000054908243,0.000013843864,0.0000063241664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970023,0.001116242,0.00058906485,0.000264334,0.0008734139,0.00015466759],"domain_scores_gemma":[0.9984861,0.00017234485,0.00039894105,0.00026350524,0.0005418626,0.00013726778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021744561,0.00016543195,0.00087050046,0.0003251692,0.000037484933,0.00002375231,0.00009507096,0.000101376514,0.0000010495748],"category_scores_gemma":[0.00036051834,0.00011798382,0.0005471959,0.00013636377,0.00012443992,0.00022443623,0.00003956326,0.00035522573,2.8218892e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035048104,0.00010858828,0.96920496,0.00005254921,0.004644515,0.00043558094,0.00015985462,0.0023562717,0.0000074775876,9.929602e-7,0.000012359433,0.019512057],"study_design_scores_gemma":[0.017033307,0.00097453117,0.97964,0.00032522297,0.0013270881,0.00009931758,0.00016847963,0.00021202126,0.000005283619,0.00005837323,0.000057248042,0.000099104436],"about_ca_topic_score_codex":0.00009742324,"about_ca_topic_score_gemma":0.000028004359,"teacher_disagreement_score":0.019412953,"about_ca_system_score_codex":0.000046809535,"about_ca_system_score_gemma":0.00010606712,"threshold_uncertainty_score":0.48112407},"labels":[],"label_agreement":null},{"id":"W4316661199","doi":"10.1016/j.jacc.2022.10.030","title":"PCSK9 Inhibition During the Inflammatory Stage of SARS-CoV-2 Infection","year":2023,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Idorsia Pharmaceuticals; US WorldMeds; Regeneron Pharmaceuticals; Bayer HealthCare; Medicure; Sanofi; AstraZeneca; Amgen; Pfizer; Daiichi Sankyo Europe; Bristol-Myers Squibb","keywords":"Medicine; Clinical endpoint; Placebo; PCSK9; Internal medicine; Gastroenterology; Adverse effect; Randomized controlled trial; Lipoprotein; Pathology; Cholesterol","score_opus":0.01807810961091906,"score_gpt":0.2826034236069169,"score_spread":0.2645253139959979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316661199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975059,0.00016132921,0.000083936866,0.0010739436,0.00035384743,0.00028211574,0.000025405614,0.000010830948,0.0005026651],"genre_scores_gemma":[0.99862117,0.0004989148,0.000035760357,0.00013392243,0.0005472081,0.000005522905,5.753141e-7,0.000014863489,0.00014206534],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99830073,0.00044749433,0.00056142523,0.00008880707,0.00042701236,0.00017455284],"domain_scores_gemma":[0.9982529,0.00008271902,0.00092493696,0.00041139263,0.00029221384,0.0000357844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014189474,0.000097350945,0.0007714812,0.00020540856,0.00008081892,0.0000018730187,0.0001124382,0.000050529132,0.0000022975864],"category_scores_gemma":[0.00023978118,0.000054284643,0.0007565255,0.00068404345,0.00038286357,0.000048192014,0.00008281653,0.00031016616,0.0000022495542],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020924616,0.00006614583,0.2712229,0.0009502585,0.0029607967,0.0006741219,0.00026478816,0.0041479208,0.70704854,0.0004287506,0.006429112,0.0037142427],"study_design_scores_gemma":[0.0016202452,0.0008377221,0.875664,0.00017983676,0.0002747799,0.0025062242,0.0006145207,0.000031434563,0.09855881,0.000104208266,0.01952488,0.00008335926],"about_ca_topic_score_codex":0.00007222635,"about_ca_topic_score_gemma":0.000011671154,"teacher_disagreement_score":0.6084897,"about_ca_system_score_codex":0.000102905,"about_ca_system_score_gemma":0.00026838866,"threshold_uncertainty_score":0.22136635},"labels":[],"label_agreement":null},{"id":"W4317423838","doi":"10.1007/s40119-022-00300-7","title":"Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9i","year":2023,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary; Amgen (Canada)","funders":"Amgen Canada; Government of Alberta; Alberta Precision Laboratories; Amgen","keywords":"Ezetimibe; Medicine; Statin; Internal medicine; Myocardial infarction; Cohort; Retrospective cohort study; Evolocumab; Guideline; Cardiology; Cholesterol; Lipoprotein; Pathology","score_opus":0.04897385325442376,"score_gpt":0.3544296291000235,"score_spread":0.30545577584559974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317423838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672717,0.0006201647,0.00006750422,0.00058534404,0.00006339772,0.0017600476,0.0000061327673,0.000030061683,0.00014018962],"genre_scores_gemma":[0.9924527,0.006970455,0.000029179299,0.0001267101,0.00014189217,0.00020871699,0.00004283208,0.000012617695,0.000014912625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987605,0.0002539709,0.00035453975,0.0002664087,0.00016542905,0.00019913762],"domain_scores_gemma":[0.9991775,0.00007076515,0.00010619793,0.00042138848,0.00017341088,0.000050722338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010487476,0.0001561082,0.00050731277,0.00013968669,0.00009297779,0.000007147316,0.00004859823,0.00005834339,0.0000022543193],"category_scores_gemma":[0.00002800147,0.000078811514,0.00018459423,0.0004139492,0.00009688859,0.000056012585,0.000018944536,0.00013718763,0.0000012694505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011632883,0.000118919656,0.95345545,0.000005510592,0.0019253198,0.00001793503,0.0007985527,0.0004941938,0.0004799897,0.000020066896,0.000074092764,0.041446675],"study_design_scores_gemma":[0.003304558,0.0060556713,0.9892453,0.00004946563,0.00016851969,0.000021621614,0.00067727204,0.00017908456,0.000075742275,0.000032478427,0.00011757882,0.000072711766],"about_ca_topic_score_codex":0.0022111183,"about_ca_topic_score_gemma":0.00013020527,"teacher_disagreement_score":0.041373964,"about_ca_system_score_codex":0.00016221359,"about_ca_system_score_gemma":0.00015810678,"threshold_uncertainty_score":0.33425644},"labels":[],"label_agreement":null},{"id":"W4317435625","doi":"10.1101/2023.01.18.23284717","title":"Impact of statin withdrawal on perceived and objective muscle function","year":2023,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Statin; Visual analogue scale; Medicine; Physical therapy; Cohort; Internal medicine; Physical medicine and rehabilitation","score_opus":0.025577931473217363,"score_gpt":0.3039897020243804,"score_spread":0.27841177055116306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317435625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975503,0.00022716598,0.00027273918,0.000108522705,0.00030484825,0.0008471678,0.000058050075,0.00008199034,0.00054920156],"genre_scores_gemma":[0.998767,0.00027857666,0.00011927692,0.00004103229,0.00030945946,0.00006049364,0.00006797646,0.000049984785,0.00030619642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984991,0.00012636895,0.0002599605,0.00044782754,0.0004594038,0.0002073639],"domain_scores_gemma":[0.99889326,0.000048925227,0.00013938297,0.0006080812,0.000155563,0.00015477196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005653437,0.0002203714,0.00061339483,0.00017412264,0.000044541575,0.000011861119,0.000052227006,0.00020049838,0.000056220782],"category_scores_gemma":[0.00016285223,0.00016375301,0.0003968775,0.00012610844,0.00006425756,0.000019905016,0.00011032749,0.0005498144,0.000021923297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036982535,0.0008725194,0.8183943,0.005424798,0.0064920587,0.0003093016,0.0104693845,0.0014079504,0.015927263,0.00010683704,0.0013711768,0.13552618],"study_design_scores_gemma":[0.00096621824,0.0013077096,0.99615014,0.00044469035,0.00023663306,0.000009441133,0.0001838017,0.00017075364,0.00010622076,0.00024257599,0.00005516514,0.00012664427],"about_ca_topic_score_codex":0.0031772042,"about_ca_topic_score_gemma":0.00008534379,"teacher_disagreement_score":0.17775588,"about_ca_system_score_codex":0.00015388083,"about_ca_system_score_gemma":0.000359338,"threshold_uncertainty_score":0.66776544},"labels":[],"label_agreement":null},{"id":"W4317660745","doi":"10.1016/j.ajpc.2022.100403","title":"EFFICACY AND SAFETY OF INCLISIRAN BY BASELINE BODY MASS INDEX: A POST HOC POOLED ANALYSIS OF THE ORION-9, ORION-10 AND ORION-11 PHASE III RANDOMIZED CONTROLLED TRIALS","year":2023,"lang":"en","type":"article","venue":"American Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Body mass index; Placebo; Post-hoc analysis; Medicine; Dosing; Adverse effect; Internal medicine; Dyslipidemia; Randomized controlled trial; Obesity; Pathology","score_opus":0.009984804300904617,"score_gpt":0.3106337832131645,"score_spread":0.3006489789122599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317660745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98263437,0.005615087,0.007993414,0.0010491167,0.00023353955,0.0022357209,0.00018346269,0.000010371993,0.000044907632],"genre_scores_gemma":[0.9934101,0.005771472,0.00015226778,0.0001410452,0.0003001552,0.00003558599,0.0000568407,0.00002261963,0.00010989827],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9876481,0.008346196,0.0027484954,0.00032154523,0.00063176005,0.0003038813],"domain_scores_gemma":[0.99010813,0.004710471,0.003432465,0.0004667818,0.0010395191,0.00024263059],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02278906,0.00029557917,0.010969301,0.000732274,0.00010206539,0.000009844529,0.00017559182,0.0001272986,0.000065115666],"category_scores_gemma":[0.008933551,0.00016227632,0.0034743482,0.0014407196,0.0009313466,0.00006190545,0.00010198552,0.00034634105,4.6710926e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77305895,0.0003381365,0.008423067,0.00013250162,0.12325822,0.00011942028,0.0007397651,0.00031255384,0.020698057,0.000099500365,0.00061070704,0.07220913],"study_design_scores_gemma":[0.8871772,0.0044746017,0.033140026,0.0003885132,0.069087535,0.00026372954,0.0021189095,0.0008845583,0.000560888,0.00010003366,0.0015118059,0.00029216634],"about_ca_topic_score_codex":0.00023983803,"about_ca_topic_score_gemma":0.000008521786,"teacher_disagreement_score":0.114118285,"about_ca_system_score_codex":0.00006534817,"about_ca_system_score_gemma":0.00041228437,"threshold_uncertainty_score":0.9994146},"labels":[],"label_agreement":null},{"id":"W4318263103","doi":"10.2147/vhrm.s394134","title":"Elevated Lp(a) Levels Correlate with Severe and Multiple Coronary Artery Stenotic Lesions","year":2023,"lang":"en","type":"article","venue":"Vascular Health and Risk Management","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Coronary artery disease; Lipoprotein(a); Stenosis; Risk factor; Coronary arteries; Artery; Logistic regression; Cholesterol; Lipoprotein","score_opus":0.018674864920282724,"score_gpt":0.24680573218995366,"score_spread":0.22813086726967094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318263103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766841,0.01672701,0.0020423196,0.00079441024,0.0001570837,0.0029010614,0.000040769595,0.0002976798,0.0003556],"genre_scores_gemma":[0.8631118,0.13217545,0.002047512,0.0014336854,0.00010257028,0.000091733855,0.00015669472,0.00006695093,0.00081363093],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99780196,0.00018353315,0.000334557,0.00054331735,0.000535496,0.0006011515],"domain_scores_gemma":[0.9985464,0.00004379694,0.000105246654,0.00060266105,0.000050531387,0.0006513657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010390104,0.00024521127,0.0005205417,0.00023335588,0.00050481403,0.000030156389,0.00005648169,0.00008485098,0.000016970396],"category_scores_gemma":[0.000023989012,0.00017757759,0.00012545488,0.00046443928,0.000072679555,0.00006896866,0.00012147872,0.0002879544,0.000046800924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045681422,0.00022210165,0.12861879,0.0041081216,0.0030654646,0.0011413086,0.0010884799,0.0004513334,0.000004036382,0.00053813134,0.0022651937,0.8580402],"study_design_scores_gemma":[0.008411835,0.0010575056,0.92319405,0.00063349534,0.0006209556,0.00046512362,0.001940645,0.00397848,0.0000031132067,0.00014748669,0.05920016,0.00034712846],"about_ca_topic_score_codex":0.0005586329,"about_ca_topic_score_gemma":0.00009412185,"teacher_disagreement_score":0.8576931,"about_ca_system_score_codex":0.000075514195,"about_ca_system_score_gemma":0.00013953407,"threshold_uncertainty_score":0.7241404},"labels":[],"label_agreement":null},{"id":"W4318753551","doi":"10.1080/14017431.2023.2166101","title":"Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial","year":2023,"lang":"en","type":"article","venue":"Scandinavian Cardiovascular Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Kowa Company; Novo Nordisk; Sanofi; McMaster University; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Post-hoc analysis; Post hoc; Physical therapy; Gerontology; Internal medicine","score_opus":0.03725881310067861,"score_gpt":0.2768449524964483,"score_spread":0.2395861393957697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318753551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9312788,0.06540184,0.00049615547,0.00038915718,0.000570229,0.0014412942,0.00013721135,0.000081236685,0.00020403166],"genre_scores_gemma":[0.9722235,0.025555024,0.00015352674,0.00012746933,0.0015514549,0.000120252385,0.000093276656,0.0000650737,0.00011038995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937125,0.0018083603,0.00083360873,0.0009127922,0.0018332326,0.0008995199],"domain_scores_gemma":[0.99669117,0.00026498685,0.0002046845,0.0020800072,0.00019464208,0.0005645367],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0056921225,0.0005672531,0.0029467575,0.00080887624,0.0007397941,0.00028423883,0.00030950684,0.00028801427,0.00008103008],"category_scores_gemma":[0.00037989806,0.00033409466,0.00975746,0.0023620003,0.0001880454,0.00018435884,0.00011910353,0.0009755345,0.000045363555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033103789,0.00013823182,0.73136616,0.000034228735,0.14207327,0.0015963981,0.0019705326,0.00031590284,0.000005228475,0.0000076775095,0.000112156726,0.11906984],"study_design_scores_gemma":[0.048605517,0.00068546867,0.9141076,0.00007930109,0.02689807,0.000479905,0.0019905877,0.000092927454,0.000007719337,0.00013886529,0.0065360772,0.00037795916],"about_ca_topic_score_codex":0.006469325,"about_ca_topic_score_gemma":0.00037559756,"teacher_disagreement_score":0.18274146,"about_ca_system_score_codex":0.00043958874,"about_ca_system_score_gemma":0.00034560604,"threshold_uncertainty_score":0.9999111},"labels":[],"label_agreement":null},{"id":"W4318823074","doi":"10.21203/rs.3.rs-2524735/v1","title":"International Practice Patterns of Dyslipidemia Management in Patients with Chronic Kidney Disease under Nephrology Care: Is it time to review guideline recommendations?","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Ezetimibe; Nephrology; Kidney disease; Internal medicine; Dyslipidemia; Guideline; Medical prescription; Statin; Lipid profile; Disease; Cholesterol; Pathology; Pharmacology","score_opus":0.05693461076094145,"score_gpt":0.43145907577510056,"score_spread":0.3745244650141591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318823074","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056403875,0.0107055055,0.0021787474,0.9515212,0.00065668114,0.022175552,0.0028219435,0.00011777144,0.004182171],"genre_scores_gemma":[0.14800179,0.32984194,0.03263682,0.2959027,0.007826138,0.021279683,0.12564592,0.001390038,0.037474964],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99486446,0.00079197745,0.00087457366,0.0008089073,0.0021405844,0.00051951513],"domain_scores_gemma":[0.9954613,0.00014366709,0.00021793043,0.0014741642,0.0021337736,0.00056920346],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0033299376,0.00025266345,0.000681822,0.0006722286,0.000060904524,0.000026891585,0.00041118314,0.00015334768,0.0026508672],"category_scores_gemma":[0.001248984,0.00021482982,0.00022436777,0.00055414555,0.00004158751,0.00008480941,0.0013091695,0.001060896,0.00045415614],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015699081,0.00079205824,0.014683933,0.046040058,0.0021107104,0.00016010643,0.0003390838,0.00044456517,0.000001208372,0.00009363744,0.8472042,0.08656051],"study_design_scores_gemma":[0.0027054045,0.00057392026,0.07280633,0.027880782,0.00033631266,0.0000015168226,0.00024140469,0.00013203314,0.0000020343084,0.000038307175,0.89504796,0.00023401104],"about_ca_topic_score_codex":0.00080289703,"about_ca_topic_score_gemma":0.00006785938,"teacher_disagreement_score":0.65561855,"about_ca_system_score_codex":0.0017318482,"about_ca_system_score_gemma":0.0014197162,"threshold_uncertainty_score":0.99826086},"labels":[],"label_agreement":null},{"id":"W4318827072","doi":"10.14744/anatoljcardiol.2022.2012","title":"How Did the Updated 2019 European Society of Cardiology/European Atherosclerosis Society Risk Categorization for Patients with Diabetes Affect the Risk Perception and Lipid Goals? A Simulated Analysis of Real-life Data from EPHESUS Study","year":2023,"lang":"en","type":"article","venue":"The Anatolian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Diabetes mellitus; Internal medicine; Observational study; Cardiology; Canadian Cardiovascular Society; National Cholesterol Education Program; Intensive care medicine; Endocrinology; Metabolic syndrome; Myocardial infarction","score_opus":0.02530576885009905,"score_gpt":0.2649290395885037,"score_spread":0.23962327073840467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318827072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936313,0.00040057057,0.003268028,0.0006585634,0.00012087633,0.0010842446,0.00079981436,0.000020675618,0.000015951186],"genre_scores_gemma":[0.993771,0.0048104604,0.0000535374,0.00008452291,0.00055480236,0.0000050372028,0.00066567224,0.00004730674,0.0000076227384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99383855,0.004392105,0.00063682196,0.00036094562,0.00046081355,0.0003107586],"domain_scores_gemma":[0.99619585,0.0005969134,0.0011561824,0.0013655021,0.00058057596,0.00010497333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007028101,0.00024623572,0.001357898,0.000094125855,0.00035325668,0.000032815988,0.00057523407,0.00009432353,0.000001908135],"category_scores_gemma":[0.00035412866,0.00011156992,0.001054451,0.0008581921,0.00041163474,0.000109279405,0.0002291002,0.00045783698,0.0000011452984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029088336,0.000031988562,0.9591133,0.000029033143,0.025508663,0.0000017481061,0.0022068762,0.007862956,0.00037827087,0.000001519619,0.0021856464,0.0023891097],"study_design_scores_gemma":[0.0029973604,0.0010811387,0.9687068,0.000031082942,0.0153559605,0.0000028064205,0.0053396043,0.0060337144,0.000009670905,0.00001051784,0.00032286876,0.00010849406],"about_ca_topic_score_codex":0.00022439871,"about_ca_topic_score_gemma":0.000013787081,"teacher_disagreement_score":0.010152702,"about_ca_system_score_codex":0.00004132298,"about_ca_system_score_gemma":0.00008073169,"threshold_uncertainty_score":0.45496893},"labels":[],"label_agreement":null},{"id":"W4318946162","doi":"10.21203/rs.3.rs-2521836/v1","title":"Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health","keywords":"PCSK9; Sepsis; Internal medicine; Immunology; Lipoprotein; Biology; Medicine; LDL receptor; Endocrinology; Cholesterol","score_opus":0.051038007618579365,"score_gpt":0.3859241596385129,"score_spread":0.33488615201993355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318946162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99039716,0.0020128235,0.000032507996,0.0016268204,0.00026118834,0.005427353,0.000125661,0.000042193293,0.000074292286],"genre_scores_gemma":[0.9973992,0.0010986186,0.00005240443,0.00016456407,0.00034179378,0.0007397404,0.000067336485,0.000063804095,0.00007252416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909076,0.0026975845,0.00067109196,0.0007693548,0.004271176,0.0006831652],"domain_scores_gemma":[0.9945397,0.0025585105,0.00024184879,0.001677327,0.00075984356,0.00022278047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008654761,0.0003106024,0.0008391199,0.0013724901,0.00011042008,0.00003285714,0.00052411994,0.00050158607,0.000020243642],"category_scores_gemma":[0.0069219153,0.0002268912,0.00047885842,0.0027547095,0.00012706681,0.000043769614,0.00075943774,0.002102616,0.00012555966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028983416,0.0031225884,0.8824902,0.046454713,0.0010977035,0.0033472348,0.012814155,0.0017796407,0.014345581,0.0001216853,0.0029827994,0.0024602693],"study_design_scores_gemma":[0.001984843,0.002884536,0.9834535,0.0032903554,0.00012101583,0.000011044336,0.0016764998,0.000009636993,0.005956011,0.00012463222,0.00029886153,0.00018907015],"about_ca_topic_score_codex":0.003227198,"about_ca_topic_score_gemma":0.00011760057,"teacher_disagreement_score":0.10096328,"about_ca_system_score_codex":0.00058166654,"about_ca_system_score_gemma":0.0010548802,"threshold_uncertainty_score":0.92523545},"labels":[],"label_agreement":null},{"id":"W4319059273","doi":"10.1080/14737159.2023.2176753","title":"How reliable are polygenic risk scores for risk prediction in patients with heart disease?","year":2023,"lang":"en","type":"editorial","venue":"Expert Review of Molecular Diagnostics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Polygenic risk score; Disease; Framingham Risk Score; Medicine; Internal medicine; Biology; Genetics; Genotype; Single-nucleotide polymorphism; Gene","score_opus":0.005721560381645779,"score_gpt":0.2607384818280829,"score_spread":0.2550169214464371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319059273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020647736,0.70752496,0.0015893254,0.00079333916,0.2741955,0.008695205,0.0050141173,0.00011395396,0.000008850405],"genre_scores_gemma":[0.00044642584,0.8290972,0.0018977133,0.00037174494,0.16071527,0.0018769832,0.005215952,0.00028215157,0.00009653231],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99579144,0.0002720932,0.0007455738,0.00075529265,0.0019368281,0.0004987536],"domain_scores_gemma":[0.9957637,0.0007348415,0.0007662541,0.0014310504,0.0009565955,0.00034752846],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00097464625,0.00050076173,0.001737694,0.0001918568,0.00008607815,0.00003030788,0.00020408574,0.00043584994,0.000007054093],"category_scores_gemma":[0.026099293,0.00038989054,0.00077755324,0.00044546774,0.000075847915,0.000062088846,0.00008474778,0.0007621027,0.000008996461],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002628046,0.000299675,0.03074483,0.020110233,0.00031978104,0.000036361213,0.0000124371945,0.000009966885,5.990894e-7,0.000001757857,0.9458879,0.0023136458],"study_design_scores_gemma":[0.0036377918,0.0011239077,0.035479195,0.07326453,0.002070922,5.5237956e-7,0.000011583901,0.0000122268575,0.000033570806,0.000028243567,0.8839399,0.00039752634],"about_ca_topic_score_codex":0.00036459832,"about_ca_topic_score_gemma":0.000024370482,"teacher_disagreement_score":0.12157229,"about_ca_system_score_codex":0.00023223899,"about_ca_system_score_gemma":0.0007448677,"threshold_uncertainty_score":0.9998553},"labels":[],"label_agreement":null},{"id":"W4319962792","doi":"10.1016/j.cjco.2023.02.002","title":"Awareness Among Primary Care Physicians in Canada of Guideline Recommendations for Lowering LDL-Cholesterol in High-Risk Patients","year":2023,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Respiratory Research Network; Canadian Heart Research Centre; University of Toronto; McMaster University; Western University","funders":"Canadian Institutes of Health Research; Amgen Canada; Heart and Stroke Foundation of Canada","keywords":"Medicine; Guideline; Statin; Polypharmacy; Diabetes mellitus; Acute coronary syndrome; Internal medicine; Primary care; Emergency medicine; Family medicine; Endocrinology; Myocardial infarction","score_opus":0.019198145187951203,"score_gpt":0.2944987893706976,"score_spread":0.2753006441827464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319962792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970061,0.000044849345,0.000123332,0.00040961246,0.00022731427,0.0017680207,0.00023031172,0.000009706955,0.0001807133],"genre_scores_gemma":[0.9976245,0.00006578094,0.00032074878,0.0003671522,0.000057442467,0.0002591046,0.0012324858,0.000024352114,0.000048428094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988894,0.000043809996,0.00043210995,0.00021759352,0.00020148179,0.00021563914],"domain_scores_gemma":[0.9992966,0.000030810374,0.00010691033,0.00036781232,0.00014473793,0.00005312966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036015824,0.00009191606,0.00045397863,0.000094472496,0.000045146568,0.000010161859,0.00016236393,0.000036690224,0.0000066276352],"category_scores_gemma":[0.000058611804,0.000089987865,0.00005676614,0.00034205025,0.000010315327,0.00010334498,0.0001365244,0.00010864832,0.000001197818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048184334,0.000053967848,0.83117026,0.0003457103,0.00003997997,0.0000074660625,0.00050028367,0.000509869,0.000014192494,0.0000021344536,0.0022791794,0.16502875],"study_design_scores_gemma":[0.0040675495,0.000080705984,0.9896546,0.0005677549,0.00003198491,2.792271e-7,0.0012319279,0.00022731608,0.00033785024,0.000011986292,0.0036902204,0.00009782654],"about_ca_topic_score_codex":0.9330348,"about_ca_topic_score_gemma":0.9246197,"teacher_disagreement_score":0.16493092,"about_ca_system_score_codex":0.00059447513,"about_ca_system_score_gemma":0.0009313527,"threshold_uncertainty_score":0.36695987},"labels":[],"label_agreement":null},{"id":"W4320036799","doi":"10.51731/cjht.2023.572","title":"Design, Rationale, and Preliminary Results of the Canadian Homozygous Familial Hypercholesterolemia Registry: 2008 to 2022 Update","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Familial hypercholesterolemia; Medicine; Patient registry; Orphan drug; Disease; Atherosclerotic cardiovascular disease; Disease registry; Apheresis; Pediatrics; Intensive care medicine; Cholesterol; Family medicine; Internal medicine; Bioinformatics","score_opus":0.0310804090823588,"score_gpt":0.2634483542726371,"score_spread":0.23236794519027829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320036799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58020145,0.03609777,0.00024540751,0.37923583,0.0008473968,0.0025908505,0.0004520695,0.000112220296,0.0002169905],"genre_scores_gemma":[0.99574256,0.0012593362,0.00084413687,0.0017953026,0.00004139294,0.000019501285,0.000009879282,0.000019643883,0.0002682682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981692,0.00013891765,0.00061921636,0.00018794522,0.0003562798,0.00052848173],"domain_scores_gemma":[0.9984536,0.000044358392,0.0002789799,0.00057870586,0.00026185965,0.0003824629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019452006,0.00013250858,0.0004342441,0.00078456564,0.00044387134,0.000023531755,0.00032240408,0.00018993611,0.000003561726],"category_scores_gemma":[0.0011628164,0.000097411925,0.00009868429,0.0008685022,0.00023265032,0.00005819968,0.000040836097,0.00054960116,0.000005470491],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005236384,0.000019683923,0.003639427,0.0005682957,0.00021067778,0.001487726,0.0014058886,0.0005424531,0.00018975974,0.00027265414,0.19400924,0.7971305],"study_design_scores_gemma":[0.0029662403,0.0028906388,0.21259597,0.0012230563,0.00008549373,0.004816581,0.0040009115,0.00007692321,0.0010011131,0.0010587602,0.7689798,0.00030454522],"about_ca_topic_score_codex":0.27300775,"about_ca_topic_score_gemma":0.42997447,"teacher_disagreement_score":0.796826,"about_ca_system_score_codex":0.00061282096,"about_ca_system_score_gemma":0.011932406,"threshold_uncertainty_score":0.99366903},"labels":[],"label_agreement":null},{"id":"W4320482468","doi":"10.1007/s11136-023-03362-9","title":"Statin withdrawal and health-related quality of life in a primary cardiovascular prevention cohort","year":2023,"lang":"en","type":"article","venue":"Quality of Life Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Statin; Medicine; Quality of life (healthcare); Internal medicine; Physical therapy; Post-hoc analysis; SF-36; Cohort; Cohort study; Health related quality of life; Disease","score_opus":0.21866288215594964,"score_gpt":0.45001645637304327,"score_spread":0.23135357421709363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320482468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845722,0.009852623,0.00012613296,0.0024690276,0.000043495795,0.002186001,0.000034100933,0.000049488728,0.00066694815],"genre_scores_gemma":[0.99641854,0.0025372736,0.0003705975,0.00009245681,0.00007907717,0.00009837994,0.00012426419,0.000028874516,0.0002505213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9883267,0.0052233813,0.0019556892,0.0005396102,0.0033292188,0.0006253878],"domain_scores_gemma":[0.99719113,0.0004363928,0.00030365144,0.0010492301,0.0005226208,0.00049699045],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07376666,0.0001561111,0.0018835221,0.0005078426,0.00010935017,0.00001205505,0.00014175936,0.00019226497,0.00003187982],"category_scores_gemma":[0.0028984537,0.00014566789,0.00051419286,0.0015537939,0.0003609515,0.00009093539,0.00018236604,0.0006827426,0.000013412127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014429506,0.0006850406,0.92908114,0.01959089,0.0023247337,0.00001980842,0.0024368165,0.000063451975,0.0007109548,0.0011697591,0.00112178,0.041352693],"study_design_scores_gemma":[0.004086962,0.00048379158,0.9926427,0.00041466337,0.000026651167,0.0000036750484,0.0012980069,0.000062357874,0.00007281408,0.0005217125,0.0002704586,0.00011618285],"about_ca_topic_score_codex":0.051642306,"about_ca_topic_score_gemma":0.00053504884,"teacher_disagreement_score":0.07086821,"about_ca_system_score_codex":0.00024654163,"about_ca_system_score_gemma":0.002642576,"threshold_uncertainty_score":0.9546729},"labels":[],"label_agreement":null},{"id":"W4320880537","doi":"10.1101/2023.02.14.23285912","title":"Efficacy and safety of bempedoic acid in women with hypercholesterolemia: Pooled analyses from phase 3 trials","year":2023,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"Esperion Therapeutics; Ministero della Salute","keywords":"Placebo; Apolipoprotein B; Internal medicine; Medicine; Familial hypercholesterolemia; Statin; Atherosclerotic cardiovascular disease; Cholesterol; Lipoprotein; Endocrinology; Gastroenterology; Disease","score_opus":0.09969325216831984,"score_gpt":0.3834297289606272,"score_spread":0.2837364767923074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320880537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933217,0.003395361,0.00039555508,0.00060338643,0.0001557469,0.0017673611,0.00022989785,0.000072653704,0.000058313937],"genre_scores_gemma":[0.99602985,0.002251927,0.0006374153,0.000152929,0.00038933914,0.00022300033,0.00018339675,0.000070668226,0.000061478655],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99633175,0.00069796114,0.0011497773,0.00076025905,0.00067468424,0.00038554092],"domain_scores_gemma":[0.99766976,0.00031448857,0.000410755,0.001210564,0.000104174826,0.00029026897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039101774,0.00037574826,0.0027844699,0.00038456658,0.000034826808,0.000024933479,0.0001802414,0.00038157063,0.00006595368],"category_scores_gemma":[0.0008340372,0.00026390536,0.00026628564,0.00035041757,0.0001157351,0.000036238493,0.0002702922,0.0008531476,0.000008420534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0935933,0.0044603446,0.1576046,0.01008524,0.026140606,0.0030396658,0.016227849,0.00097343494,0.24930191,0.000017843073,0.00026576986,0.43828943],"study_design_scores_gemma":[0.055651575,0.0015059931,0.9138562,0.0045296596,0.003004908,0.000032393575,0.00083088805,0.000083869054,0.018463654,0.0002545752,0.0011812064,0.000605061],"about_ca_topic_score_codex":0.0012957908,"about_ca_topic_score_gemma":0.00012287845,"teacher_disagreement_score":0.75625163,"about_ca_system_score_codex":0.00015360069,"about_ca_system_score_gemma":0.000422443,"threshold_uncertainty_score":0.99998134},"labels":[],"label_agreement":null},{"id":"W4321481609","doi":"10.1101/2023.02.21.529381","title":"CETP inhibitor evacetrapib enters mouse brain tissue","year":2023,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; Université de Montréal; McGill University","funders":"Fonds de Recherche du Québec - Santé; Natural Sciences and Engineering Research Council of Canada; Alzheimer Society; Canadian Institutes of Health Research; Canada First Research Excellence Fund; Weston Brain Institute; McGill University","keywords":"Cholesterylester transfer protein; Genetically modified mouse; Cholesterol; Endocrinology; Medicine; Internal medicine; Blood–brain barrier; Transgene; Lipoprotein; Pharmacology; Chemistry; Central nervous system; Biochemistry","score_opus":0.020069308687516697,"score_gpt":0.25919458420431324,"score_spread":0.23912527551679655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321481609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807366,0.0032206925,0.0014948908,0.0052068615,0.003560754,0.003362095,0.0004305601,0.0019621956,0.000025363262],"genre_scores_gemma":[0.98907197,0.00089420524,0.0031825658,0.0018129537,0.0036637362,0.00059585733,0.0000030396545,0.0005079432,0.0002677476],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9950324,0.0002524033,0.00084632233,0.0015785008,0.0012564588,0.0010338736],"domain_scores_gemma":[0.9951157,0.00006978808,0.00035894432,0.0030656958,0.0005338391,0.0008560371],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017706575,0.0008231092,0.0013833112,0.000565483,0.0001924988,0.00018715141,0.00047843836,0.0010021824,0.00009923377],"category_scores_gemma":[0.00057323405,0.00084161403,0.0006458695,0.00073545525,0.00014294845,0.00011694474,0.0006377947,0.0016304678,0.00078156055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017710568,0.00050141837,0.005285682,0.0054424824,0.0018363992,0.0012569429,0.000048132883,0.000049720056,0.94825846,0.00026659828,0.036827683,0.00004934922],"study_design_scores_gemma":[0.0038498915,0.00040176607,0.083662815,0.0024094887,0.00069395616,3.1659104e-7,0.000017151855,0.00014504128,0.742165,0.0000024967858,0.16482475,0.0018272683],"about_ca_topic_score_codex":0.000361959,"about_ca_topic_score_gemma":0.0000087275475,"teacher_disagreement_score":0.20609343,"about_ca_system_score_codex":0.00066865917,"about_ca_system_score_gemma":0.0013246373,"threshold_uncertainty_score":0.9999964},"labels":[],"label_agreement":null},{"id":"W4321766570","doi":"10.26787/nydha-2686-6838-2023-25-1-127-131","title":"ONE-YEAR OUTCOMES IN PATIENTS WITH CORONARY HEART DISEASE WITH PROGRESSIVE ATHEROSCLEROSIS","year":2023,"lang":"en","type":"article","venue":"Medical & pharmaceutical journal Pulse","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Cardiology; Angina; Coronary artery disease; Canadian Cardiovascular Society; Amputation; Inclusion and exclusion criteria; Stroke (engine); Thrombosis; Artery; Surgery; Myocardial infarction","score_opus":0.029182860483596175,"score_gpt":0.33149087774807645,"score_spread":0.30230801726448026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321766570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795331,0.00027890116,0.00004596669,0.018873516,0.0001339793,0.00095423806,0.000013830514,0.00008898675,0.00007749776],"genre_scores_gemma":[0.9935547,0.00019993036,0.00021372834,0.005464536,0.00032733305,0.00007134612,0.000028457076,0.00006008723,0.00007986796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950833,0.00023915098,0.00045695432,0.0003678517,0.0030782192,0.00077454967],"domain_scores_gemma":[0.9967983,0.00009567693,0.000076332406,0.00032347813,0.00018326497,0.002522978],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010156251,0.00025506993,0.0006587457,0.00017955099,0.00014709566,0.00004367253,0.00017549211,0.00012174631,0.0009748035],"category_scores_gemma":[0.0003265158,0.00015381038,0.00019948305,0.0005737553,0.00028502216,0.00014495321,0.00008848024,0.0013441105,0.00013987912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029098955,0.0013948618,0.9694693,0.00013870862,0.00028895415,0.0013256174,0.000056263372,0.000005452608,0.0000059231215,0.000020903071,0.00035560058,0.024028486],"study_design_scores_gemma":[0.014127913,0.0010533968,0.9817635,0.0008374115,0.000266807,0.00008518657,0.00004889267,0.000107423126,0.00002032471,0.00005165951,0.0014304563,0.00020707362],"about_ca_topic_score_codex":0.000009368316,"about_ca_topic_score_gemma":0.0000023577995,"teacher_disagreement_score":0.023821412,"about_ca_system_score_codex":0.00016130427,"about_ca_system_score_gemma":0.00060117483,"threshold_uncertainty_score":0.9999384},"labels":[],"label_agreement":null},{"id":"W4321785678","doi":"10.1002/14651858.cd014857","title":"Simvastatin for lowering lipids","year":2023,"lang":"en","type":"article","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Simvastatin; Placebo; Adverse effect; Medicine; Intervention (counseling); Protocol (science); Physical therapy; Internal medicine; Pharmacology; Intensive care medicine; Alternative medicine; Pathology; Nursing","score_opus":0.08897737448287793,"score_gpt":0.3696635367545418,"score_spread":0.2806861622716639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321785678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04363,0.7700542,0.1056881,0.0010626403,0.002286357,0.07206358,0.0012122291,0.00060760387,0.0033952487],"genre_scores_gemma":[0.25259018,0.64805156,0.054840043,0.001756009,0.004345799,0.023516769,0.007104612,0.0005375149,0.007257543],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99742323,0.00017965281,0.0013603681,0.0002746698,0.00049148424,0.00027057112],"domain_scores_gemma":[0.9975267,0.00031515054,0.0003947075,0.0014388902,0.00017686738,0.00014766803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063387393,0.00018442252,0.0020128905,0.00013582276,0.00005408803,0.000011211571,0.000142395,0.000044822384,0.000054977278],"category_scores_gemma":[0.0033463046,0.0001225696,0.000606193,0.00046122327,0.000028945859,0.00007323226,0.000053286218,0.00007899539,0.00030289334],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021643435,0.000037307163,0.000014008714,0.9891311,0.000113609574,0.00001615641,0.00014168271,0.0000014990597,0.0026580265,0.00017115154,0.005719889,0.0019739163],"study_design_scores_gemma":[0.0034138479,0.00045042604,0.00015843869,0.96382236,0.0018301953,0.00026296976,0.000762297,0.0014343126,0.0043932,0.00003924683,0.02299692,0.000435767],"about_ca_topic_score_codex":0.000023937342,"about_ca_topic_score_gemma":0.000003283288,"teacher_disagreement_score":0.20896016,"about_ca_system_score_codex":0.00003215209,"about_ca_system_score_gemma":0.000079265155,"threshold_uncertainty_score":0.49982432},"labels":[],"label_agreement":null},{"id":"W4322616668","doi":"10.1097/mol.0000000000000869","title":"DNA testing in dyslipidemia: attitudes and complexities","year":2023,"lang":"en","type":"article","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Dyslipidemia; Library science; Family medicine; Dna testing; Medicine; Gerontology; Medical education; History; Genealogy; Pathology; Computer science","score_opus":0.18277033727828781,"score_gpt":0.4025362438840048,"score_spread":0.21976590660571696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322616668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9547732,0.010476337,0.00007997942,0.0027615202,0.029863747,0.0009261591,0.00000971176,0.00022537241,0.0008839983],"genre_scores_gemma":[0.9776011,0.0029160017,0.00078520324,0.00022883379,0.017998943,0.00022585521,0.00014110765,0.000042553158,0.00006041323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865264,0.00016316498,0.00035651916,0.00030547517,0.00015934638,0.0003628583],"domain_scores_gemma":[0.9993497,0.00025338554,0.000049590526,0.0002233383,0.00003690315,0.00008705611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000950989,0.00012398075,0.00043761075,0.0003489866,0.000043707412,0.000007899413,0.000057125253,0.0001064896,0.000017489983],"category_scores_gemma":[0.0005495327,0.00011407629,0.00005206984,0.0005484779,0.000122065874,0.000049758506,0.00010554018,0.00036084835,0.000037169135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047856473,0.00010757237,0.9222181,0.0023838696,0.000021912872,0.000001311369,0.00042920653,0.00003765338,0.00015338269,0.0043980796,0.010974988,0.05922606],"study_design_scores_gemma":[0.001630282,0.000145462,0.9451742,0.0008515529,0.0000055994465,0.000050929964,0.00018197249,0.00047529917,0.0000057798225,0.0010211691,0.050339323,0.00011842833],"about_ca_topic_score_codex":0.00009697318,"about_ca_topic_score_gemma":0.00004177555,"teacher_disagreement_score":0.05910763,"about_ca_system_score_codex":0.00006514873,"about_ca_system_score_gemma":0.000097521515,"threshold_uncertainty_score":0.4651896},"labels":[],"label_agreement":null},{"id":"W4322618020","doi":"10.1714/3980.39627","title":"Position paper ANMCO: Gestione dell’ipercolesterolemia nei pazienti con sindrome coronarica acuta","year":2023,"lang":"en","type":"article","venue":"Giornale italiano di cardiologia","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Cardiology; Reimbursement; Coronary heart disease; Intensive care medicine; Ldl cholesterol; Risk factor; Adverse effect; Disease; Cholesterol; Health care; Myocardial infarction","score_opus":0.0189392644803117,"score_gpt":0.2615985283097952,"score_spread":0.2426592638294835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322618020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886048,0.0018624108,0.0007363852,0.0018454388,0.000823949,0.0011443296,0.0001337039,0.00058372814,0.0042652455],"genre_scores_gemma":[0.9939507,0.0008127331,0.00021002798,0.0014874934,0.0007391656,0.00016236458,0.00069235836,0.00006986138,0.0018752469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968633,0.0002739699,0.0005468311,0.00073727855,0.0007719629,0.00080667983],"domain_scores_gemma":[0.99815595,0.000055528802,0.00013276763,0.0010270727,0.00024145379,0.0003872311],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00094640127,0.00037907017,0.000930893,0.0002206218,0.00029068178,0.00007269555,0.0001989516,0.0004247495,0.00011159633],"category_scores_gemma":[0.00012756798,0.0003238716,0.0007922564,0.0007246168,0.00018637408,0.0002477431,0.00014639132,0.00045073836,0.0011369797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022495235,0.00092785916,0.45065266,0.0020486047,0.0077372584,0.016171284,0.0013034021,0.0027898871,0.20638874,0.0017173674,0.13018343,0.17783],"study_design_scores_gemma":[0.0024849274,0.00082240836,0.95443344,0.00026473252,0.000655455,0.002982277,0.00026068257,0.0001729372,0.0007038763,0.00022271038,0.036475074,0.000521484],"about_ca_topic_score_codex":0.00014151295,"about_ca_topic_score_gemma":0.000006942055,"teacher_disagreement_score":0.5037808,"about_ca_system_score_codex":0.00030360467,"about_ca_system_score_gemma":0.00019460611,"threshold_uncertainty_score":0.9999213},"labels":[],"label_agreement":null},{"id":"W4323058544","doi":"10.1007/978-3-031-24575-6_10","title":"Molecular Mechanisms of Lipoprotein(a) Pathogenicity: Tantalizing Clues and Unanswered Questions","year":2023,"lang":"en","type":"book-chapter","venue":"Contemporary cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lipoprotein(a); Proinflammatory cytokine; In vivo; Lipoprotein; In vitro; Apolipoprotein B; Fibrinolysis; Inflammation; Disease; Immunology; Biology; Medicine; Cell biology; Cholesterol; Pathology; Biochemistry; Internal medicine; Genetics","score_opus":0.03365385578057635,"score_gpt":0.2611534397081494,"score_spread":0.22749958392757308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323058544","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060416185,0.07761116,0.018203331,0.0012787434,0.001614296,0.0057654693,0.0011258491,0.000736721,0.88762283],"genre_scores_gemma":[0.9446329,0.005542275,0.0009139712,0.0006516946,0.00082414475,0.00014455868,0.0007446163,0.0003801396,0.046165686],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99744666,0.00017264883,0.0007750176,0.00077998464,0.00048018666,0.0003455149],"domain_scores_gemma":[0.9980328,0.000068783804,0.00025567668,0.0011167639,0.00026076462,0.00026518904],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090491667,0.00050310465,0.0022752264,0.00035002222,0.00008171174,0.000010873022,0.00014414887,0.00096175226,0.00001752489],"category_scores_gemma":[0.00011943518,0.00047612868,0.0009761242,0.00007822303,0.00032179616,0.000049418442,0.00022646073,0.00060806563,0.00003247444],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047293527,0.000047191395,0.00015299922,0.002778746,0.007826085,0.010445502,0.00017494652,0.000015659905,0.028574176,0.92468774,0.001928998,0.022895027],"study_design_scores_gemma":[0.012604027,0.007466135,0.004003215,0.009427827,0.007309246,0.010542064,0.00056622835,0.00011829372,0.01920121,0.5090928,0.4152673,0.004401652],"about_ca_topic_score_codex":0.00022822352,"about_ca_topic_score_gemma":0.0000095076875,"teacher_disagreement_score":0.9385913,"about_ca_system_score_codex":0.00007720763,"about_ca_system_score_gemma":0.0006073863,"threshold_uncertainty_score":0.99976903},"labels":[],"label_agreement":null},{"id":"W4323294184","doi":"10.1007/s11547-023-01610-z","title":"Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study","year":2023,"lang":"en","type":"article","venue":"La radiologia medica","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sapienza Università di Roma","keywords":"Asymptomatic; Medicine; Radiology; Coronary artery disease; Angiography; SSS*; Internal medicine; Cardiology","score_opus":0.024609433920642403,"score_gpt":0.3178136928411024,"score_spread":0.29320425892046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323294184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950322,0.0018791078,0.000041319247,0.00007358527,0.00046996443,0.002247334,0.000030052897,0.00014899446,0.00007747555],"genre_scores_gemma":[0.9989115,0.000273901,0.00008473397,0.00009596158,0.00021395962,0.00026413827,0.00012210941,0.00003121025,0.000002485333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943221,0.002806167,0.0010439153,0.00068748195,0.00064997264,0.0004903389],"domain_scores_gemma":[0.9973142,0.001443146,0.00014181394,0.0006584097,0.000057481906,0.00038493643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068415063,0.0002611288,0.0013032989,0.0007976412,0.00004537507,0.0000061186474,0.00023459567,0.00029724406,0.000008644377],"category_scores_gemma":[0.00057514926,0.00021194808,0.000703534,0.001684525,0.00043772394,0.00006934366,0.0001531451,0.00083895464,0.000006496726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027594804,0.0013068178,0.9780687,0.00065619673,0.00047441624,0.0044823475,0.0002917436,0.0001262147,0.000054852524,0.00000398127,0.00006233869,0.011712897],"study_design_scores_gemma":[0.009920759,0.0016653787,0.9856064,0.0012048035,0.00019134233,0.00010627261,0.0004234667,0.00065325096,0.0000033080125,0.000048509948,0.000016477394,0.00016003268],"about_ca_topic_score_codex":0.00030575113,"about_ca_topic_score_gemma":0.000049029743,"teacher_disagreement_score":0.011552864,"about_ca_system_score_codex":0.000046542395,"about_ca_system_score_gemma":0.00030661654,"threshold_uncertainty_score":0.8642992},"labels":[],"label_agreement":null},{"id":"W4323306865","doi":"10.1016/s0140-6736(23)00454-3","title":"Inflammation contributes to cardiovascular risk in patients receiving statin therapy","year":2023,"lang":"en","type":"letter","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Life expectancy; Statin; Myocardial infarction; Inflammation; Stroke (engine); Disease; Internal medicine; Cause of death; Atherosclerotic cardiovascular disease; Intensive care medicine; Physical therapy; Population","score_opus":0.025315451883988337,"score_gpt":0.26305514692542903,"score_spread":0.23773969504144069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323306865","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39177775,0.004043246,0.00030041675,0.5970982,0.00096149126,0.004765142,0.00022537367,0.0002510822,0.00057730696],"genre_scores_gemma":[0.062086172,0.015815841,0.000613145,0.86572385,0.049610935,0.0015919328,0.002560055,0.0004601248,0.001537915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99712056,0.0006401579,0.00040817825,0.00038943219,0.00088899,0.0005526627],"domain_scores_gemma":[0.997828,0.00015842837,0.00013261185,0.0016709,0.00016211963,0.00004796072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026633528,0.00026227548,0.0013440924,0.00018996898,0.000095293755,0.00005062197,0.00027425776,0.0003456536,0.000012853675],"category_scores_gemma":[0.00053584354,0.00017117136,0.0004898192,0.00049193314,0.000028775714,0.000035707322,0.00006991701,0.0015550044,0.00018411787],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022646217,0.000014308681,0.03631166,0.00033585366,0.0016969409,0.000086272405,0.0005819133,0.00013898216,0.0000035414755,0.0000035408223,0.7321567,0.22844385],"study_design_scores_gemma":[0.0032693443,0.00009378415,0.27936512,0.00034133808,0.00013126907,0.0000013164996,0.000014435065,0.000009905572,0.00003620429,0.00012283077,0.7164756,0.00013885701],"about_ca_topic_score_codex":0.0012950891,"about_ca_topic_score_gemma":0.00006300777,"teacher_disagreement_score":0.3296916,"about_ca_system_score_codex":0.00022427215,"about_ca_system_score_gemma":0.000104650724,"threshold_uncertainty_score":0.6980165},"labels":[],"label_agreement":null},{"id":"W4323347380","doi":"10.1093/eurheartj/ehad144","title":"Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"National Institute for Health and Care Research; Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Hazard ratio; Placebo; PCSK9; Internal medicine; Mace; Statin; Acute coronary syndrome; Atorvastatin; Confidence interval; Cholesterol; Myocardial infarction; Lipoprotein; Percutaneous coronary intervention; LDL receptor","score_opus":0.024710441051771146,"score_gpt":0.25850592121438265,"score_spread":0.2337954801626115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323347380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942703,0.0015206495,0.00016419831,0.0021674102,0.0005339491,0.0010363401,0.00014789267,0.00010832549,0.000050920666],"genre_scores_gemma":[0.9971285,0.0007707996,0.0000644297,0.0005654323,0.00044074832,0.000029932145,0.00003433037,0.00010899251,0.0008568583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99522424,0.0019375837,0.00051956315,0.00044267197,0.0013192861,0.00055664266],"domain_scores_gemma":[0.99848473,0.000076175034,0.00021582471,0.0006911611,0.00014116995,0.0003909151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039826776,0.00033736456,0.00087140343,0.0001255421,0.0005769565,0.0001683308,0.00013752627,0.00008146624,0.000049251565],"category_scores_gemma":[0.00012256125,0.00020798523,0.00076817774,0.00036103788,0.0001494326,0.00022076596,0.00005642272,0.0010890838,0.000064478976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.070228875,0.0022510563,0.5689658,0.0007779487,0.102210216,0.06828177,0.0146279605,0.0010649447,0.0012225686,0.0000034991779,0.07950809,0.0908573],"study_design_scores_gemma":[0.029613387,0.0012802879,0.9502216,0.00032610737,0.0014464203,0.010501139,0.00042386106,0.000010073965,0.000028439466,0.0000035540438,0.005900925,0.00024419493],"about_ca_topic_score_codex":0.000025242547,"about_ca_topic_score_gemma":0.000004466992,"teacher_disagreement_score":0.38125584,"about_ca_system_score_codex":0.000108589986,"about_ca_system_score_gemma":0.00013854823,"threshold_uncertainty_score":0.8481391},"labels":[],"label_agreement":null},{"id":"W4323352135","doi":"10.1093/eurheartj/ehad155","title":"Transient very low LDL-C levels: a legacy effect for cardiovascular prevention?","year":2023,"lang":"en","type":"letter","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Ezetimibe; Cardiology; Internal medicine; Cardiovascular health; Coronary heart disease; Ldl cholesterol; Cholesterol; Disease","score_opus":0.05664451391738268,"score_gpt":0.30859680397603784,"score_spread":0.25195229005865516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323352135","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031045161,0.061673466,0.04090871,0.81336725,0.023415081,0.018995374,0.00042050763,0.0015453029,0.008629158],"genre_scores_gemma":[0.018132355,0.0034893635,0.0061131236,0.63165456,0.29314008,0.00052372454,0.0012240789,0.0031689908,0.042553708],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932812,0.0021903429,0.0008321787,0.0007651467,0.0018434533,0.0010876786],"domain_scores_gemma":[0.9976034,0.00017886268,0.00020664612,0.0013120018,0.0002911796,0.0004078949],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007964673,0.0006188749,0.0017908858,0.00043688162,0.00046352085,0.00028798106,0.00028958503,0.00038328927,0.00011008813],"category_scores_gemma":[0.00029572996,0.00050225115,0.008742362,0.00030708345,0.00007152165,0.00018649545,0.0000669864,0.0037611069,0.00061096955],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117539734,0.000046803005,0.00003158812,0.0024742377,0.0052803485,0.0073644673,0.000087177,0.00004128155,0.000035824836,8.22168e-7,0.9563397,0.028180206],"study_design_scores_gemma":[0.004412227,0.0015850995,0.0038668062,0.0023193448,0.0025842853,0.009051917,0.00001725252,0.000013355494,0.00005809335,0.000016047825,0.9756196,0.00045594116],"about_ca_topic_score_codex":0.000015065742,"about_ca_topic_score_gemma":8.786346e-7,"teacher_disagreement_score":0.269725,"about_ca_system_score_codex":0.00028921728,"about_ca_system_score_gemma":0.00058735936,"threshold_uncertainty_score":0.9997429},"labels":[],"label_agreement":null},{"id":"W4324304841","doi":"10.1007/s40119-023-00310-z","title":"Correction to: Guideline LDL-C Threshold Achievement in Acute Myocardial Infarction Patients: A Real-World Evidence Study Demonstrating the Impact of Treatment Intensification with PCSK9i","year":2023,"lang":"en","type":"erratum","venue":"Cardiology and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary; Amgen (Canada)","funders":"","keywords":"Medicine; Guideline; Myocardial infarction; Intensive care medicine; Internal medicine; Cardiology; Pathology","score_opus":0.04057259202886799,"score_gpt":0.3490907356350811,"score_spread":0.3085181436062131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324304841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98380476,0.0021959078,0.00018894914,0.00075547583,0.0060175313,0.005946357,0.000034372337,0.000068790694,0.0009878377],"genre_scores_gemma":[0.97426075,0.021734307,0.000027037822,0.00023465768,0.0012640754,0.00067696057,0.0003657728,0.000053215037,0.0013832363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977283,0.00044545057,0.00065203593,0.0005580649,0.00031617383,0.00030000554],"domain_scores_gemma":[0.9983491,0.00011804635,0.00028357812,0.0007298512,0.00042246524,0.00009697692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012907847,0.00036843648,0.0011623378,0.00031998055,0.00013951633,0.000016649616,0.00009204555,0.00021567401,0.0000030423605],"category_scores_gemma":[0.000099385885,0.0002008207,0.00038802755,0.0005736006,0.00010313745,0.000058776794,0.000036861144,0.0005836738,0.0000022683553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049184114,0.0004365112,0.796558,0.000043488428,0.010647729,0.00005758659,0.0019379725,0.0012037242,0.00013894938,0.000006850099,0.07230761,0.11174317],"study_design_scores_gemma":[0.0028352907,0.014561762,0.9773266,0.00046426058,0.0006187426,0.000045278128,0.0006562414,0.00018279895,0.000015128171,0.000011518188,0.0030845804,0.00019781463],"about_ca_topic_score_codex":0.00959817,"about_ca_topic_score_gemma":0.0012764744,"teacher_disagreement_score":0.18076858,"about_ca_system_score_codex":0.0006215342,"about_ca_system_score_gemma":0.0005891794,"threshold_uncertainty_score":0.996997},"labels":[],"label_agreement":null},{"id":"W4324364583","doi":"10.1016/j.atherosclerosis.2023.03.007","title":"Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population","year":2023,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Science and Technology Program of Hubei Province; Zhongnan Hospital of Wuhan University; National Natural Science Foundation of China; European Atherosclerosis Society; Wuhan University; American College of Cardiology Foundation; American Heart Association; Canadian Cardiovascular Society; Chinese Chemical Society; Accident Compensation Corporation; National Science Foundation","keywords":"Lipoprotein(a); Medicine; Logistic regression; Internal medicine; Population; Lipoprotein; Distribution (mathematics); Cardiology; Gastroenterology; Cholesterol; Mathematics","score_opus":0.011603572891701063,"score_gpt":0.24307262868273807,"score_spread":0.23146905579103702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324364583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969638,0.00009151859,0.000040500847,0.0018173093,0.000049599163,0.0008576074,0.00002281514,0.00007778546,0.00007907048],"genre_scores_gemma":[0.9989243,0.00021982007,0.00001927923,0.0002039736,0.00016454945,0.00018664257,0.00019256238,0.000017548515,0.0000713269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987829,0.00012005566,0.00016863685,0.0002104818,0.00048475724,0.0002331694],"domain_scores_gemma":[0.99954426,0.000035277015,0.00007725267,0.00023921511,0.000052206313,0.000051793384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001043372,0.00011963709,0.00022380763,0.000048495538,0.00012131172,0.00003665666,0.000045607736,0.00009120735,0.0000054814777],"category_scores_gemma":[0.00011874625,0.00007124885,0.00006839237,0.00072524894,0.000009727431,0.000099044766,0.00001719519,0.00016002334,0.000023111996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003718188,0.00005234919,0.99147224,0.00008253275,0.000041475814,0.0000037007471,0.0008110921,0.000012719886,0.0024296665,0.000106499894,0.00008268937,0.004867877],"study_design_scores_gemma":[0.0009906685,0.00017683813,0.99779886,0.00009591458,0.000041942134,0.000011526319,0.00014090663,0.0002527395,0.00021124569,0.00004493758,0.00015192176,0.000082473314],"about_ca_topic_score_codex":0.0008425215,"about_ca_topic_score_gemma":0.00023418039,"teacher_disagreement_score":0.0063266708,"about_ca_system_score_codex":0.00014754418,"about_ca_system_score_gemma":0.000020780135,"threshold_uncertainty_score":0.29054436},"labels":[],"label_agreement":null},{"id":"W4327588098","doi":"10.1177/15598276231163129","title":"Evaluating Statin Knowledge-Perceptions and Receptivity Following a Comprehensive Lifestyle Modification Program","year":2023,"lang":"en","type":"article","venue":"American Journal of Lifestyle Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Toronto Rehabilitation Institute; University of Toronto; University of Ottawa; University Health Network","funders":"","keywords":"Medicine; McNemar's test; Receptivity; Statin; Lifestyle modification; Physical therapy; Perception; Family medicine; Disease; Internal medicine","score_opus":0.0699934794267469,"score_gpt":0.4248705422857222,"score_spread":0.3548770628589753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327588098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908158,0.0012123471,0.0010044551,0.0055844453,0.00031931864,0.0006672727,0.0000028914696,0.00011383354,0.0002796443],"genre_scores_gemma":[0.9888769,0.0011556168,0.00797071,0.00037358995,0.0012982854,0.00004796756,0.000023677849,0.000043369615,0.00020991062],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99704176,0.0005884942,0.00080674957,0.00028786005,0.00089488673,0.0003802669],"domain_scores_gemma":[0.9974881,0.00047721717,0.0005628719,0.0003701205,0.00060182967,0.00049986644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031412304,0.0002216615,0.0010032331,0.00043719582,0.00019763215,0.000017707063,0.00010711298,0.000053452488,0.000029947261],"category_scores_gemma":[0.0009991869,0.00016548716,0.00026655968,0.0012903189,0.00043111228,0.00013358943,0.000047752048,0.0004923856,0.000027973183],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016801589,0.00023636186,0.019382585,0.00017915324,0.00046098247,0.00013140951,0.0056495587,0.0000599527,0.0090183625,0.000025443136,0.0014427669,0.9632454],"study_design_scores_gemma":[0.008642766,0.02060838,0.8963993,0.002725685,0.0017661486,0.0022285674,0.040271107,0.007338412,0.00014317864,0.00012844667,0.019257806,0.0004901626],"about_ca_topic_score_codex":0.00015551485,"about_ca_topic_score_gemma":0.00000825811,"teacher_disagreement_score":0.96275526,"about_ca_system_score_codex":0.00012005739,"about_ca_system_score_gemma":0.0003594477,"threshold_uncertainty_score":0.67483705},"labels":[],"label_agreement":null},{"id":"W4353016809","doi":"10.1007/s40256-023-00576-7","title":"Disparities in PCSK9 Initiation Among US Veterans with Peripheral Arterial Disease or Cerebrovascular Disease","year":2023,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Veterans Affairs; Coronary artery disease; Internal medicine; Logistic regression; Odds ratio; Arterial disease; Cardiology; Vascular disease","score_opus":0.009363041760313886,"score_gpt":0.23838409481404813,"score_spread":0.22902105305373424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353016809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942368,0.002336614,0.0015327513,0.0006810838,0.00033386287,0.0006938536,0.00002438406,0.00007439712,0.00008621313],"genre_scores_gemma":[0.9958703,0.0018028198,0.0003103267,0.0005199025,0.0012173599,0.00007788052,0.00004786142,0.000097456425,0.000056071425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99539566,0.00060179434,0.0007798287,0.0004529915,0.002113663,0.0006560601],"domain_scores_gemma":[0.9972441,0.0000755318,0.0003047174,0.0010159239,0.000355434,0.0010042683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016667462,0.00038635853,0.0015676758,0.0005403166,0.00012696402,0.00009404166,0.00022228912,0.000051926774,0.000044353972],"category_scores_gemma":[0.00024852247,0.00027802543,0.0023196528,0.0013130623,0.00044632878,0.0004454765,0.00005365795,0.00048472758,0.000011394906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021974897,0.00079116935,0.67434055,0.0017327903,0.020445928,0.022576693,0.003624775,0.038691178,0.00005831168,0.000063945576,0.0005081158,0.21519163],"study_design_scores_gemma":[0.00814516,0.0008815666,0.97177565,0.0008217816,0.002743028,0.0004206909,0.0013072288,0.0004557022,0.000031435913,0.000027563949,0.012937495,0.0004526982],"about_ca_topic_score_codex":0.001128758,"about_ca_topic_score_gemma":0.000031633925,"teacher_disagreement_score":0.2974351,"about_ca_system_score_codex":0.0002814274,"about_ca_system_score_gemma":0.0010003505,"threshold_uncertainty_score":0.9999672},"labels":[],"label_agreement":null},{"id":"W4353094265","doi":"10.1016/j.jacl.2023.03.008","title":"Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University; McGill University; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre; Université de Montréal; Montreal Clinical Research Institute","funders":"Institut de Recherche Clinique De Montréal","keywords":"Medicine; Metabolic syndrome; Familial hypercholesterolemia; Internal medicine; Cardiology; Pediatrics; Cholesterol; Obesity","score_opus":0.07117254390978822,"score_gpt":0.37475913103348096,"score_spread":0.30358658712369274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353094265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081844,0.005496502,0.00012294146,0.00041948757,0.0026973109,0.00028798665,0.000010006231,0.000026309966,0.00012103903],"genre_scores_gemma":[0.9771107,0.018146636,0.0003229565,0.0004376887,0.0039167083,0.0000066031484,0.0000035905564,0.000022697988,0.00003242877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99541914,0.0014029056,0.0017911928,0.0003207385,0.00068973703,0.00037630982],"domain_scores_gemma":[0.997964,0.00046832132,0.00039104847,0.0005763253,0.00016670559,0.00043354896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0142484335,0.00016610029,0.0022806248,0.00029188802,0.000042043648,0.000010074496,0.0001420248,0.0003961459,0.000013659098],"category_scores_gemma":[0.003264327,0.00012353653,0.0013329687,0.00039657278,0.00021302994,0.00010199953,0.000101139995,0.0013705281,0.000025297695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031009514,0.00013870433,0.8873109,0.0000971575,0.001693393,0.0008024421,0.00006819168,0.00008371371,0.000015569072,0.000027908656,0.00023629174,0.10921563],"study_design_scores_gemma":[0.005772696,0.0010124781,0.9604778,0.00009121131,0.0010308631,0.002300363,0.00006190925,0.00005949184,0.0000058020128,0.00033681246,0.028759358,0.00009119516],"about_ca_topic_score_codex":0.00018095391,"about_ca_topic_score_gemma":0.00003276333,"teacher_disagreement_score":0.10912444,"about_ca_system_score_codex":0.000024572635,"about_ca_system_score_gemma":0.0003324142,"threshold_uncertainty_score":0.5954339},"labels":[],"label_agreement":null},{"id":"W4360808423","doi":"10.1161/circgen.122.003887","title":"Genetic Identification of Homozygous Familial Hypercholesterolemia by Long-Read Sequencing Among Patients With Clinically Diagnosed Heterozygous Familial Hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Circulation Genomic and Precision Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Western University; Robarts Clinical Trials; St. Paul's Hospital","funders":"","keywords":"PCSK9; Familial hypercholesterolemia; Medicine; LDL receptor; Apolipoprotein B; Internal medicine; Genetic testing; Lipoprotein; Lipoprotein(a); Genetic disorder; Bioinformatics; Cholesterol; Disease; Biology","score_opus":0.018276738977824683,"score_gpt":0.26730903718018517,"score_spread":0.2490322982023605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360808423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99145246,0.00056486984,0.0057307715,0.0001203229,0.00034908717,0.0015617673,0.000049212736,0.0001040431,0.00006745293],"genre_scores_gemma":[0.99758065,0.0007939713,0.00019924223,0.00029774028,0.00038726322,0.00006432549,0.00049000676,0.00006595736,0.000120846256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961916,0.00024417893,0.0014180485,0.0007408408,0.0010228332,0.00038248193],"domain_scores_gemma":[0.99775916,0.00023912359,0.0004593661,0.00081716175,0.00036758796,0.00035762353],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014026582,0.00032250103,0.0008300298,0.00031056185,0.00017331244,0.000026300808,0.00016651164,0.00027943714,0.00003447682],"category_scores_gemma":[0.00032905882,0.0002509891,0.00014670155,0.00045470012,0.0003445052,0.00014598867,0.000074539756,0.00033970474,0.000029835963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005525371,0.000086932945,0.8023803,0.000259224,0.0001369578,0.00005095324,0.0011517114,0.00057242,0.021452086,0.0000013316611,0.00024412686,0.1731114],"study_design_scores_gemma":[0.0067130164,0.0008420377,0.98930746,0.00046618722,0.0003143474,0.000048844446,0.0002446494,0.0015471899,0.00009207035,0.000041578558,0.00015849857,0.00022411474],"about_ca_topic_score_codex":0.00030811297,"about_ca_topic_score_gemma":0.000018162535,"teacher_disagreement_score":0.18692714,"about_ca_system_score_codex":0.00020123752,"about_ca_system_score_gemma":0.00014862618,"threshold_uncertainty_score":0.9999942},"labels":[],"label_agreement":null},{"id":"W4360989139","doi":"10.1002/14651858.cd014858","title":"Lovastatin for lowering lipids","year":2023,"lang":"en","type":"article","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Lovastatin; Adverse effect; Placebo; Medicine; Intervention (counseling); Pharmacology; Intensive care medicine; Internal medicine; Cholesterol; Alternative medicine; Pathology; Psychiatry","score_opus":0.08963039066157305,"score_gpt":0.3684164940122861,"score_spread":0.2787861033507131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360989139","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04263308,0.76393044,0.119462416,0.0009828472,0.0022335022,0.0658874,0.0010608865,0.00052996085,0.00327948],"genre_scores_gemma":[0.19955553,0.6932358,0.0640994,0.001710601,0.0043547763,0.021574127,0.0067830817,0.00054377643,0.008142921],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99738646,0.00017764945,0.0013805252,0.00027961732,0.0005015071,0.00027425346],"domain_scores_gemma":[0.9975091,0.0002795673,0.0003973887,0.00149461,0.00017262493,0.00014668818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066075833,0.00018636465,0.0020440533,0.00014378392,0.00005094018,0.000011309373,0.00014499853,0.00004538471,0.000060720886],"category_scores_gemma":[0.0030699875,0.00012480022,0.0006303456,0.0004812091,0.00003024206,0.00007405149,0.000053752927,0.00008077625,0.00036528264],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002285975,0.000037312282,0.000017173446,0.988766,0.0001232024,0.000017112121,0.00014455021,0.0000011655271,0.00250707,0.00017973635,0.0061138826,0.0020699492],"study_design_scores_gemma":[0.0034547788,0.00042943936,0.00021008315,0.96493775,0.0018232834,0.0003218153,0.00072589,0.0011045515,0.004347766,0.000036969894,0.02217991,0.0004277544],"about_ca_topic_score_codex":0.00002533158,"about_ca_topic_score_gemma":0.0000032426292,"teacher_disagreement_score":0.15692244,"about_ca_system_score_codex":0.000033282635,"about_ca_system_score_gemma":0.00008328637,"threshold_uncertainty_score":0.50892055},"labels":[],"label_agreement":null},{"id":"W4360991797","doi":"10.21203/rs.3.rs-2633131/v1","title":"Genome-wide association study of lipids in Greenlandic Inuit shows independent PCSK9 association and reveals a unique genetic architecture","year":2023,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Association (psychology); Genetic architecture; PCSK9; Genetic association; Genome-wide association study; Genetics; Biology; Evolutionary biology; Gene; Single-nucleotide polymorphism; Genotype; Psychology; LDL receptor; Cholesterol; Lipoprotein","score_opus":0.04263365763903863,"score_gpt":0.3511898779273478,"score_spread":0.30855622028830915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360991797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99026316,0.0013135562,0.00006474708,0.0012276376,0.00012635531,0.006702889,0.00013106968,0.00006296615,0.00010760773],"genre_scores_gemma":[0.9949018,0.0014212263,0.00011637446,0.000047477177,0.00052529346,0.00076012895,0.00012369733,0.0000795043,0.0020245046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9900186,0.0035895116,0.0008653673,0.00085885334,0.0038563313,0.00081133423],"domain_scores_gemma":[0.9962972,0.0010999477,0.00043380732,0.0009952099,0.00089121,0.00028265317],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.015151439,0.00030113256,0.0011620064,0.001289327,0.00013410629,0.00007767402,0.00025888396,0.00089589803,0.00004244753],"category_scores_gemma":[0.0052853236,0.00027941793,0.0002519653,0.0008968509,0.00003076933,0.000033180884,0.0009072808,0.0038596715,0.000014455985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013821103,0.00042374845,0.982521,0.003150243,0.0006176015,0.00014160981,0.0081838695,0.00034161974,0.00015738241,0.000002143045,0.00014558132,0.0041770125],"study_design_scores_gemma":[0.0022569743,0.0010172246,0.9919017,0.001080743,0.00012543464,0.0000039410015,0.0019572428,0.000048484526,0.000026581127,0.0011509196,0.00023055756,0.00020019854],"about_ca_topic_score_codex":0.008454736,"about_ca_topic_score_gemma":0.01649554,"teacher_disagreement_score":0.009866116,"about_ca_system_score_codex":0.004070465,"about_ca_system_score_gemma":0.0011416745,"threshold_uncertainty_score":0.9999658},"labels":[],"label_agreement":null},{"id":"W4361263473","doi":"10.1093/ehjopen/oead032","title":"Impact of C-reactive protein levels on lipoprotein(a)-associated aortic stenosis incidence and progression","year":2023,"lang":"en","type":"article","venue":"European Heart Journal Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université Laval; St. Boniface Hospital; University of Ottawa; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Canadian Institutes of Health Research; Université Laval","keywords":"Medicine; Hazard ratio; Internal medicine; Lipoprotein(a); C-reactive protein; Stenosis; Coronary artery disease; Biomarker; Cardiology; Incidence (geometry); Gastroenterology; Aortic valve stenosis; Lipoprotein; Confidence interval; Inflammation; Cholesterol","score_opus":0.07391289252276796,"score_gpt":0.3876409860446956,"score_spread":0.31372809352192765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361263473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508595,0.0001306001,0.000007934227,0.0009086323,0.000056869354,0.0019891579,0.000010843559,0.00004824869,0.0017617667],"genre_scores_gemma":[0.9986864,0.000042075073,0.00030241124,0.00016828737,0.00018164728,0.000024247902,0.00000574087,0.00006251632,0.0005267302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971212,0.0008381909,0.0005207509,0.00030611389,0.00080861273,0.00040509718],"domain_scores_gemma":[0.9984721,0.000053399064,0.00032704312,0.0004402923,0.0002831923,0.0004239517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030722367,0.00021039182,0.0006100109,0.00021296841,0.00024919142,0.0001424387,0.00022935882,0.000057990397,0.00007052731],"category_scores_gemma":[0.000798701,0.00014248131,0.00031609094,0.00054030214,0.00006786896,0.0002871444,0.00029298506,0.00060146255,0.00012550976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040691365,0.0020783287,0.42587972,0.0005343539,0.0031731545,0.0037007625,0.0031475415,0.00007507817,0.1883815,0.000069424554,0.010376554,0.35851446],"study_design_scores_gemma":[0.002020754,0.0037802744,0.98724276,0.0022463019,0.000065670625,0.00027977306,0.0000996219,0.000033357177,0.0035927345,0.00005766666,0.00042589917,0.00015517017],"about_ca_topic_score_codex":0.0003298934,"about_ca_topic_score_gemma":0.0000040140358,"teacher_disagreement_score":0.56136304,"about_ca_system_score_codex":0.00019480906,"about_ca_system_score_gemma":0.00033759337,"threshold_uncertainty_score":0.58102196},"labels":[],"label_agreement":null},{"id":"W4361295234","doi":"10.1136/bmjopen-2022-065551","title":"Risk factors for cardiovascular events in patients with heterozygous familial hypercholesterolaemia: protocol for a systematic review","year":2023,"lang":"en","type":"review","venue":"BMJ Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; MEDLINE; CINAHL; Cochrane Library; Observational study; Systematic review; Meta-analysis; Randomized controlled trial; Family medicine; Protocol (science); Pediatrics; Alternative medicine; Internal medicine; Pathology; Psychological intervention; Psychiatry","score_opus":0.1319408487708177,"score_gpt":0.4354416551667357,"score_spread":0.30350080639591803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361295234","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000064227247,0.31255648,0.00011803705,0.0000052202577,0.00007040291,0.6868699,0.0003185991,0.000040498548,0.000014387726],"genre_scores_gemma":[2.9119929e-7,0.29895535,0.000308477,0.00007063894,0.00014856263,0.6996284,0.0004979727,0.00021871783,0.00017158201],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9937062,0.0011171169,0.0021342074,0.0010771422,0.0012793199,0.00068597344],"domain_scores_gemma":[0.9952606,0.00026114864,0.001072414,0.0028008495,0.00033970064,0.00026529157],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006404055,0.00084302324,0.010445789,0.00023527014,0.00013780562,0.000058762882,0.00080981356,0.0004543026,0.0000033636777],"category_scores_gemma":[0.0016355936,0.0004914204,0.004620593,0.00053123554,0.00002430354,0.00015476743,0.00032695296,0.0005139749,0.00003396285],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022693997,0.00016284575,0.00018622482,0.96490496,0.0046789977,0.000011368282,0.000022392038,8.785588e-7,3.805903e-10,0.0000010257455,0.00019784326,0.029606497],"study_design_scores_gemma":[0.008355936,0.0010068386,0.00021496667,0.838087,0.013938826,0.000030198089,0.000012462375,0.0000017287921,2.9762335e-8,0.000005047493,0.13782716,0.0005197735],"about_ca_topic_score_codex":0.00038690557,"about_ca_topic_score_gemma":0.000040586026,"teacher_disagreement_score":0.13762932,"about_ca_system_score_codex":0.0005624595,"about_ca_system_score_gemma":0.001074687,"threshold_uncertainty_score":0.9997538},"labels":[],"label_agreement":null},{"id":"W4362078409","doi":"10.1093/clinchem/hvad012","title":"The Present and Future of Lipid Testing in Cardiovascular Risk Assessment","year":2023,"lang":"en","type":"review","venue":"Clinical Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of Alberta; Brampton Civic Hospital","funders":"","keywords":"Dyslipidemia; Apolipoprotein B; Medicine; Lipoprotein; Cholesterol; Risk assessment; Internal medicine; Disease; Computer science","score_opus":0.10755284360948095,"score_gpt":0.4262994631131742,"score_spread":0.3187466195036932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362078409","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034806159,0.9968947,0.0000024728406,0.00012537444,0.00026183404,0.0009285726,0.000024417559,0.000035334346,0.0013791915],"genre_scores_gemma":[0.000027310714,0.99200606,0.00019789391,0.00000755338,0.007317535,0.00014336116,0.000032165648,0.000056265166,0.00021187264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996618,0.00039919716,0.0014886591,0.00058098615,0.000607484,0.00030571283],"domain_scores_gemma":[0.9963666,0.0013958935,0.00045229404,0.0014484997,0.000121040684,0.00021566631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058354065,0.0002935204,0.0030084916,0.000022537517,0.00007967435,0.00002012629,0.0002093568,0.0006300754,0.0000056842027],"category_scores_gemma":[0.0012925199,0.00017472576,0.0022100392,0.00037567818,0.00018406355,0.000012824807,0.00023985228,0.0017674987,0.0000042720058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004577938,0.00004875513,0.00096636225,0.035384867,0.0014482529,0.0000509299,0.0000023128057,3.5241538e-7,3.6501646e-8,0.000001602569,0.0002242884,0.9618677],"study_design_scores_gemma":[0.0005812946,0.000047352936,0.0012015877,0.008339025,0.0023068453,0.000068836525,0.000035934394,0.000012517979,0.0000011084172,0.000013923162,0.98724204,0.00014955811],"about_ca_topic_score_codex":0.000044549943,"about_ca_topic_score_gemma":9.2864684e-7,"teacher_disagreement_score":0.98701775,"about_ca_system_score_codex":0.0000887969,"about_ca_system_score_gemma":0.00086813566,"threshold_uncertainty_score":0.76790005},"labels":[],"label_agreement":null},{"id":"W4362580886","doi":"10.1016/j.atherosclerosis.2023.03.020","title":"Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol: Analysis of pooled data from four phase 3 clinical trials","year":2023,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Esperion Therapeutics; Allergan; HLS Therapeutics; Servier; Amarin Corporation; Mylan; Ionis Pharmaceuticals; Abbott Vascular; Regeneron Pharmaceuticals; Novo Nordisk; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Valeant Pharmaceuticals International; Daiichi Sankyo Europe; Kowa Company; Sanofi; NIHR Imperial Biomedical Research Centre; Ministry of Health; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"C-reactive protein; Statin; Internal medicine; Medicine; Placebo; Gastroenterology; Cholesterol; Lipoprotein; Inflammation; Pathology","score_opus":0.18348068345721338,"score_gpt":0.40824912684456366,"score_spread":0.22476844338735028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362580886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931377,0.00013770124,0.0015451583,0.0008576966,0.00019870621,0.0023768758,0.0015401545,0.00019143995,0.000014525485],"genre_scores_gemma":[0.9968457,0.00031077865,0.0007189353,0.0003286532,0.00050888374,0.00009508323,0.0010660717,0.000071226226,0.000054647873],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99325955,0.0022850176,0.0015653983,0.0013476282,0.0010119359,0.0005304639],"domain_scores_gemma":[0.9947648,0.0007921079,0.0007833649,0.0029193005,0.00024948685,0.00049095333],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013632209,0.00042587763,0.0031586047,0.00039846372,0.00016064021,0.000062646606,0.00028169848,0.0004246757,0.00008031261],"category_scores_gemma":[0.00353785,0.00035613583,0.0010535817,0.0015995477,0.0002956378,0.0002762613,0.0004793262,0.0005538554,0.000059514245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027144437,0.0019259462,0.04243526,0.0002789332,0.024035165,0.00011909764,0.0006493399,0.000009064428,0.7426558,0.000021313639,0.00041218803,0.18474342],"study_design_scores_gemma":[0.011200802,0.0007220758,0.9015287,0.00042995138,0.011142867,0.0000043342266,0.0002732484,0.0036341418,0.070478685,0.000072319555,0.00011302632,0.00039985025],"about_ca_topic_score_codex":0.014082613,"about_ca_topic_score_gemma":0.0012593011,"teacher_disagreement_score":0.8590934,"about_ca_system_score_codex":0.00007666426,"about_ca_system_score_gemma":0.00020947069,"threshold_uncertainty_score":0.9998891},"labels":[],"label_agreement":null},{"id":"W4362614789","doi":"10.1186/s12913-023-09304-y","title":"Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"BMC Health Services Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Ted Rogers Centre for Heart Research; Hospital for Sick Children","funders":"National Heart, Lung, and Blood Institute","keywords":"Health informatics; Stakeholder; Cascade; Thematic analysis; Health administration; Computer science; Process management; Medicine; Public health; Nursing; Qualitative research","score_opus":0.24546424192553828,"score_gpt":0.4494284441384743,"score_spread":0.20396420221293604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362614789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859443,0.0036466536,0.002292261,0.0014524388,0.000037095597,0.0060193255,0.00003018335,0.00033812632,0.00023962301],"genre_scores_gemma":[0.72403795,0.0009778119,0.27034682,0.0014000142,0.00024622376,0.0024752652,0.00021791573,0.000084283325,0.00021373028],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966921,0.0007010664,0.00042457745,0.00048922456,0.0007224554,0.00097055576],"domain_scores_gemma":[0.99693006,0.00085604907,0.00005939731,0.00065854465,0.00094215485,0.0005537696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034326157,0.00016106732,0.0004458765,0.00031521823,0.000826777,0.00020715914,0.00018644033,0.00010921873,0.0000011703473],"category_scores_gemma":[0.00011521546,0.00015025106,0.0000752302,0.0011526601,0.00007800986,0.00019689502,0.00028616984,0.00048010817,0.000030681007],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012778512,0.00025771913,0.008465116,0.054466363,0.00019709473,0.00007863732,0.052385844,0.0030118132,0.014375746,0.00023837437,0.00021483547,0.8650306],"study_design_scores_gemma":[0.010151663,0.009050724,0.48367405,0.008654967,0.00009230755,0.00048500721,0.31147677,0.120933376,0.0013663212,0.0010504596,0.052191976,0.0008723816],"about_ca_topic_score_codex":0.003075746,"about_ca_topic_score_gemma":0.0006317928,"teacher_disagreement_score":0.8641582,"about_ca_system_score_codex":0.0001862435,"about_ca_system_score_gemma":0.0013543125,"threshold_uncertainty_score":0.63589835},"labels":[],"label_agreement":null},{"id":"W4362647558","doi":"10.4103/jrms.jrms_1060_21","title":"Comparison of the effect of 40 and 80 mg/day doses of atorvastatin on changes in lipid profiles among acute coronary syndrome patients: A randomized clinical trial study","year":2023,"lang":"en","type":"article","venue":"Journal of Research in Medical Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Sabzevar University of Medical Sciences","keywords":"Medicine; Atorvastatin; Internal medicine; Triglyceride; Acute coronary syndrome; Creatine kinase; Randomized controlled trial; Gastroenterology; Lipid profile; High-density lipoprotein; Lipoprotein; Cholesterol; Blood lipids; Endocrinology; Myocardial infarction","score_opus":0.13107446140601936,"score_gpt":0.50980547513572,"score_spread":0.3787310137297007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362647558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955846,0.0003028607,0.0000012867049,0.0013050964,0.00031832777,0.0024635189,0.0000030681842,0.0000022224617,0.000019027364],"genre_scores_gemma":[0.99914724,0.00064232247,0.00003246245,0.000010473894,0.00011496928,0.000042346015,5.1289175e-7,0.0000045614615,0.0000051278903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9850227,0.007946074,0.0013994101,0.00019927534,0.0051214998,0.00031101328],"domain_scores_gemma":[0.99110764,0.0077200606,0.00055013347,0.00018873821,0.000191432,0.0002419987],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.096578896,0.00009469142,0.0016223415,0.00057843316,0.0000660556,0.000009508001,0.0004061192,0.000103743565,0.000023961564],"category_scores_gemma":[0.018862342,0.000042562217,0.00025438445,0.0015303548,0.0024193667,0.000063459775,0.00019134006,0.00090347795,3.7268822e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09055593,0.0009813289,0.8807195,0.00026976794,0.00015528002,0.00013319135,0.0007112931,0.0000049626956,0.000021290649,0.000003951004,0.00008804848,0.026355483],"study_design_scores_gemma":[0.22294642,0.030486783,0.74220085,0.0020464074,0.0000604511,0.000014689954,0.0014306227,0.00040917587,0.0003354331,0.000026512726,0.000007381058,0.000035266272],"about_ca_topic_score_codex":0.00023337045,"about_ca_topic_score_gemma":0.00011916579,"teacher_disagreement_score":0.13851862,"about_ca_system_score_codex":0.000040879706,"about_ca_system_score_gemma":0.0005882619,"threshold_uncertainty_score":0.9894022},"labels":[],"label_agreement":null},{"id":"W4362652318","doi":"10.33590/emjrespir/10311855","title":"Established Statin Use Reduces Mortality From Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"EMJ Respiratory","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Community-acquired pneumonia; Confidence interval; Odds ratio; Pneumonia; Internal medicine; Meta-analysis; Statin; Sepsis","score_opus":0.3029711371864703,"score_gpt":0.41756209762206326,"score_spread":0.11459096043559297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362652318","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020127122,0.99145603,0.000014031698,0.000050627164,0.0000562124,0.0070928084,0.00090173044,0.000112332,0.000114933624],"genre_scores_gemma":[0.000022006583,0.9948264,0.00017994565,0.0020579717,0.00011565758,0.0017629098,0.00055045605,0.00011661043,0.0003680474],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9847332,0.010019236,0.0025848353,0.0008225793,0.0013920349,0.0004481027],"domain_scores_gemma":[0.99209756,0.0005772362,0.0015137314,0.0046059126,0.00053143856,0.0006741482],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.01026427,0.0009315566,0.022132177,0.00043665385,0.0002291413,0.0001950273,0.00047673495,0.0004732577,0.00028693097],"category_scores_gemma":[0.0017959815,0.00059147767,0.0057113403,0.001476259,0.00017236857,0.00026643358,0.00028730364,0.0010649232,0.000070696085],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002859267,0.00008469309,0.0000024593485,0.7266761,0.26886544,0.00014100151,0.00009300063,8.130468e-8,1.9394417e-7,0.000001886436,0.0006866755,0.0034456297],"study_design_scores_gemma":[0.0001814656,0.0000836565,0.000025262543,0.041325733,0.76269305,0.000038652743,0.000057289777,3.9093558e-7,3.2853436e-7,0.00000559747,0.1952113,0.00037728366],"about_ca_topic_score_codex":0.0020036488,"about_ca_topic_score_gemma":0.00022753674,"teacher_disagreement_score":0.68535036,"about_ca_system_score_codex":0.00030166426,"about_ca_system_score_gemma":0.0011256572,"threshold_uncertainty_score":0.99965364},"labels":[],"label_agreement":null},{"id":"W4362657617","doi":"10.1002/prp2.1080","title":"The <scp>N‐Acetylgalactosamine</scp>‐conjugated small interfering <scp>RNA</scp> inclisiran can be coadministered safely with atorvastatin in cynomolgus monkeys resulting in additive low‐density lipoprotein cholesterol reductions","year":2023,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"Medicines Company","keywords":"Atorvastatin; Pharmacology; Lipoprotein; Low-density lipoprotein; Chemistry; Cholesterol; Medicine; Biochemistry","score_opus":0.06344599065991437,"score_gpt":0.36785617125325687,"score_spread":0.3044101805933425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881655,0.00075301697,0.000019817218,0.004535217,0.0002457643,0.004008715,0.00010801075,0.00023251824,0.0019314676],"genre_scores_gemma":[0.99436355,0.0014190811,0.00014949306,0.00020304706,0.00070825295,0.0014580163,0.00009063314,0.00012354195,0.0014844175],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9918941,0.0025999718,0.00085869513,0.0013792011,0.0011619165,0.0021060721],"domain_scores_gemma":[0.99468225,0.0026866083,0.00024963496,0.0007897026,0.0009766223,0.00061519496],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0053190812,0.0005282102,0.0009811396,0.001292429,0.00096652366,0.00015987309,0.0005546513,0.00029163112,0.000018496108],"category_scores_gemma":[0.004157956,0.0004281523,0.00023824644,0.003111424,0.0013154007,0.00024050202,0.0005764338,0.003434822,0.00004286079],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044814744,0.0041801725,0.045260124,0.0015283521,0.0054378873,0.009855865,0.3580092,0.00068626425,0.49531823,0.00048014708,0.011228059,0.06353424],"study_design_scores_gemma":[0.01810159,0.003690186,0.4286134,0.0011706975,0.0002197739,0.00051246496,0.29976204,0.0019100298,0.24065496,0.0001513225,0.0049177925,0.00029574224],"about_ca_topic_score_codex":0.010962609,"about_ca_topic_score_gemma":0.017264642,"teacher_disagreement_score":0.38335326,"about_ca_system_score_codex":0.0014397441,"about_ca_system_score_gemma":0.0012090979,"threshold_uncertainty_score":0.999817},"labels":[],"label_agreement":null},{"id":"W4365443994","doi":"10.1007/s10557-023-07452-1","title":"Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction","year":2023,"lang":"en","type":"article","venue":"Cardiovascular Drugs and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; University of Toronto","funders":"Amgen","keywords":"Medicine; Myocardial infarction; Guideline; Cholesterol; Internal medicine; Cardiology; Disease; Atherosclerotic cardiovascular disease; Ldl cholesterol; Intensive care medicine; Pathology","score_opus":0.02048169665640739,"score_gpt":0.25906553650527003,"score_spread":0.23858383984886264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365443994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92174053,0.06751022,0.004987625,0.0006444138,0.0010940037,0.0033835405,0.000022007085,0.0004758667,0.00014179466],"genre_scores_gemma":[0.9339267,0.06278812,0.00034806677,0.00062971684,0.0011497941,0.00056242215,0.00023959682,0.00023396577,0.00012160875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994327,0.00050969486,0.0007328329,0.0012941041,0.0021947185,0.0009416624],"domain_scores_gemma":[0.99659705,0.00003035517,0.00012648008,0.0022637502,0.00026578293,0.0007165962],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003352555,0.00072641467,0.0016794641,0.00035204663,0.00049075513,0.00012177081,0.00023581115,0.00022056511,0.000024569175],"category_scores_gemma":[0.000042056698,0.00057275983,0.0053141206,0.00090990117,0.00007740071,0.00029920012,0.000118816846,0.00048318368,0.000040285497],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010913102,0.0002447694,0.006242315,0.0001825331,0.046534743,0.00023473507,0.0005773695,0.0022877504,0.00045156872,0.00000850309,0.00021770455,0.9419267],"study_design_scores_gemma":[0.053160448,0.0017782707,0.31208494,0.0014185768,0.0062421924,0.00037558933,0.00072089944,0.0009441261,0.001111589,0.0001939891,0.6196446,0.0023247977],"about_ca_topic_score_codex":0.00024696655,"about_ca_topic_score_gemma":0.0000019017472,"teacher_disagreement_score":0.9396019,"about_ca_system_score_codex":0.00015688353,"about_ca_system_score_gemma":0.00027471248,"threshold_uncertainty_score":0.9996724},"labels":[],"label_agreement":null},{"id":"W4366588956","doi":"10.2147/ceor.s377935","title":"Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada","year":2023,"lang":"en","type":"article","venue":"ClinicoEconomics and Outcomes Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Montreal Heart Institute; St. Michael's Hospital; Robarts Clinical Trials; Université de Montréal","funders":"HLS Therapeutics; Amryt Pharma; Sanofi; Kowa Company; Regeneron Pharmaceuticals; Novo Nordisk; Servier; Amgen; Pfizer; Esperion Therapeutics; Ultragenyx Pharmaceutical; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Bioinformatics; Biology","score_opus":0.10892320106107337,"score_gpt":0.413451090303862,"score_spread":0.3045278892427886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366588956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952282,0.0015396227,0.000021459924,0.0003402059,0.0002793981,0.0024759544,0.000057632195,0.0000019779839,0.000055582896],"genre_scores_gemma":[0.99453133,0.0051432834,0.000020187874,0.000012047077,0.000044062977,0.00017230092,0.000006727563,0.0000143687,0.00005570916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982171,0.00046041046,0.0005066129,0.00021945522,0.00035646427,0.0002399547],"domain_scores_gemma":[0.99723643,0.0016148194,0.00013913913,0.0007542888,0.00019772742,0.0000575949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010310459,0.00008315237,0.00065540685,0.000097789925,0.00007422894,0.0000023617597,0.00018371663,0.00006857456,0.0000037049015],"category_scores_gemma":[0.00079406245,0.000049140643,0.00054280576,0.00026308864,0.00013522869,0.000021395224,0.00014507766,0.00031997784,5.66695e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004283032,0.000062728046,0.90553457,0.0014535683,0.0015966775,8.8846616e-7,0.00018962736,0.0017003873,0.00033515503,0.00008443458,0.00015871381,0.08845498],"study_design_scores_gemma":[0.0023157366,0.00008530341,0.9873102,0.00013113275,0.00013011662,0.0000029933562,0.0009208299,0.0009542906,0.0052216714,0.00015513325,0.0027250263,0.000047589583],"about_ca_topic_score_codex":0.34629172,"about_ca_topic_score_gemma":0.04621579,"teacher_disagreement_score":0.30007592,"about_ca_system_score_codex":0.00024507425,"about_ca_system_score_gemma":0.0012849256,"threshold_uncertainty_score":0.9711883},"labels":[],"label_agreement":null},{"id":"W4366822127","doi":"10.1007/978-3-031-26163-3_2","title":"Statins and Hemostasis: Therapeutic Potential Based on Clinical Evidence","year":2023,"lang":"en","type":"review","venue":"Advances in experimental medicine and biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hemostasis; Medicine; Dyslipidemia; Hyperlipidemia; Pharmacology; Internal medicine; Diabetes mellitus; Disease; Endocrinology","score_opus":0.25006142005019755,"score_gpt":0.5345764905345848,"score_spread":0.28451507048438723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366822127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035182925,0.99737734,0.000053485106,0.0003642951,0.0005670817,0.0011048629,0.0000100065035,0.000036761827,0.00013432791],"genre_scores_gemma":[0.0037377013,0.9935693,0.00018970796,0.0015166916,0.000679143,0.00017925575,0.00007202607,0.000036074034,0.000020093887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975694,0.00045417188,0.000797466,0.0006789768,0.00018766719,0.00031232816],"domain_scores_gemma":[0.99864316,0.00060294307,0.00019379056,0.00035882063,0.000021387763,0.00017990051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009540374,0.00034804668,0.002094141,0.00021453957,0.000055859433,0.0000047264575,0.000088628025,0.00029967594,0.000030642892],"category_scores_gemma":[0.00022032009,0.00020655,0.00020833832,0.00022958711,0.0005705581,0.000051093335,0.00006816626,0.0004880468,0.000008223368],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120584045,0.00008725616,0.00016096896,0.0037911395,0.00009413298,0.00009145577,0.00003697497,1.2916544e-7,0.000006945658,0.00009496561,0.000029310484,0.99548614],"study_design_scores_gemma":[0.0025613492,0.008503514,0.000109123255,0.034010567,0.00060073525,0.00021507323,0.00053150445,0.0000434154,0.00001081895,0.0001012707,0.95299536,0.0003172528],"about_ca_topic_score_codex":0.00006459024,"about_ca_topic_score_gemma":0.0000080623195,"teacher_disagreement_score":0.99516886,"about_ca_system_score_codex":0.00006417887,"about_ca_system_score_gemma":0.00015374486,"threshold_uncertainty_score":0.84228647},"labels":[],"label_agreement":null},{"id":"W4367040774","doi":"10.1016/j.cjca.2023.04.018","title":"Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Toronto; Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Hazard ratio; Internal medicine; Cardiology; Acute coronary syndrome; Revascularization; Quartile; Placebo; Proportional hazards model; Post-hoc analysis; Confidence interval; Myocardial infarction; Lipoprotein; Cholesterol","score_opus":0.00584398903345867,"score_gpt":0.22666200793410832,"score_spread":0.22081801890064964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367040774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398345,0.0026744786,0.00023584953,0.0016272959,0.00035764245,0.00057818525,0.000013239675,0.000006583209,0.0005232506],"genre_scores_gemma":[0.9988334,0.00047028015,0.000019229685,0.00021072294,0.00033242936,0.000024321738,0.00000793256,0.000018705472,0.00008298441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985819,0.00048389338,0.0003146061,0.00012532293,0.00024589815,0.00024840917],"domain_scores_gemma":[0.99901503,0.00010384138,0.00012386435,0.0003296373,0.00011213309,0.0003154655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018828886,0.000119048826,0.0008203118,0.00027720243,0.00007017621,0.000007987731,0.0000879996,0.00013454704,0.000010931753],"category_scores_gemma":[0.00023243442,0.000070539325,0.0004572508,0.00023021117,0.0002523625,0.000035788595,0.000013953667,0.0002808284,0.000009703501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02356228,0.000013795991,0.4669834,0.0029823952,0.033730768,0.05958054,0.002139012,0.0041023996,0.00107477,0.0030398658,0.0161916,0.38659915],"study_design_scores_gemma":[0.009404068,0.004320759,0.94411933,0.0003684892,0.0016215872,0.022994032,0.00005184104,0.000033025557,0.00031095048,0.00026615532,0.016362224,0.00014751834],"about_ca_topic_score_codex":0.00063641235,"about_ca_topic_score_gemma":0.00011363191,"teacher_disagreement_score":0.47713593,"about_ca_system_score_codex":0.0000766145,"about_ca_system_score_gemma":0.00037897675,"threshold_uncertainty_score":0.28765103},"labels":[],"label_agreement":null},{"id":"W4367042630","doi":"10.1016/j.jacadv.2023.100309","title":"Homozygous Familial Hypercholesterolemia in Canada","year":2023,"lang":"en","type":"article","venue":"JACC Advances","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Toronto; Western University; Université de Montréal; Hospital for Sick Children; Université du Québec à Chicoutimi; University of Ottawa; McGill University Health Centre; Providence Health Care Research Institute; University of British Columbia; Queen Elizabeth II Health Sciences Centre; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Familial hypercholesterolemia; Ezetimibe; Medicine; Interquartile range; Internal medicine; Population; PCSK9; Gastroenterology; Plasmapheresis; Dyslipidemia; Pediatrics; Lipoprotein; Cholesterol; Disease; LDL receptor; Immunology","score_opus":0.011745686635025348,"score_gpt":0.2602204025706649,"score_spread":0.24847471593563958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367042630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994326,0.0019512291,0.000017317747,0.00065167074,0.00035096097,0.00025500226,0.000008248308,0.000055785884,0.0023838184],"genre_scores_gemma":[0.99707425,0.0011962833,0.00015861218,0.0007432327,0.00028617884,0.000042977048,0.000016236374,0.000015207958,0.00046699797],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99897146,0.000027408056,0.00017062819,0.0001956247,0.0003460595,0.00028880904],"domain_scores_gemma":[0.99955744,0.000025105897,0.00002248493,0.0002655547,0.00002439805,0.00010500098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017627167,0.000087728804,0.00025112162,0.00006956763,0.000035168938,0.000005015976,0.00006171801,0.000031616073,0.000019001003],"category_scores_gemma":[0.00004739333,0.00007285154,0.000058622165,0.00036404672,0.000015275557,0.000074820295,0.000026293286,0.00015583218,0.00004414927],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011578139,0.000035907873,0.12991136,0.00033877385,0.000043940498,0.0029491459,0.00021744917,0.0005037529,0.0003916734,0.000036829908,0.0028729483,0.86258245],"study_design_scores_gemma":[0.0023415114,0.00011551136,0.72049904,0.00016736338,0.000027743008,0.00025389012,0.0016516435,0.00026843918,0.0005442382,0.00025968222,0.2736424,0.00022858437],"about_ca_topic_score_codex":0.6199442,"about_ca_topic_score_gemma":0.85193676,"teacher_disagreement_score":0.86235386,"about_ca_system_score_codex":0.00030114816,"about_ca_system_score_gemma":0.0008082174,"threshold_uncertainty_score":0.3825866},"labels":[],"label_agreement":null},{"id":"W4367171991","doi":"10.1016/j.cjca.2023.02.053","title":"Perception of Cardiovascular Risk in Familial Hypercholesterolemia According to Sex","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Perception; Internal medicine; Cardiology; Cholesterol; Neuroscience","score_opus":0.020490930211405693,"score_gpt":0.2599110287278966,"score_spread":0.23942009851649093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367171991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952341,0.0009577142,0.0015736532,0.00028843578,0.00055112917,0.0002810952,0.000020843774,0.000008218957,0.0010848589],"genre_scores_gemma":[0.9975109,0.0006854831,0.0002065326,0.00012694552,0.0014050085,0.000007032745,0.0000060613847,0.000024131536,0.00002786982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981639,0.00035943187,0.0005252621,0.00019402672,0.00031746397,0.00043991712],"domain_scores_gemma":[0.9985604,0.000037173053,0.000098313016,0.0004362729,0.00022250561,0.00064528687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026543967,0.00013050842,0.0010862467,0.0009905387,0.00005356948,0.000007597067,0.00014937064,0.00018639551,0.0000057820175],"category_scores_gemma":[0.0004031315,0.0001186699,0.0008946494,0.00058044225,0.000069421025,0.00005837958,0.000019985177,0.0004569308,0.000026193871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012868563,0.0000029563384,0.65216607,0.00011783547,0.0014084291,0.0011773026,0.0010035771,0.04421401,0.0011610346,0.000011056845,0.0013818181,0.2972272],"study_design_scores_gemma":[0.0021237605,0.0005852366,0.9112982,0.00017652473,0.0004452493,0.0011115734,0.0044791806,0.00003358386,0.000078200006,0.000055158405,0.079461604,0.00015169564],"about_ca_topic_score_codex":0.010723093,"about_ca_topic_score_gemma":0.00091125164,"teacher_disagreement_score":0.2970755,"about_ca_system_score_codex":0.00035046073,"about_ca_system_score_gemma":0.0009841695,"threshold_uncertainty_score":0.99586457},"labels":[],"label_agreement":null},{"id":"W4367173826","doi":"10.1097/mca.0000000000001233","title":"Lipoprotein(a) is associated with premature coronary artery disease: a meta-analysis","year":2023,"lang":"en","type":"review","venue":"Coronary Artery Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Coronary artery disease; Cardiology; Lipoprotein(a); Meta-analysis; Internal medicine; Lipoprotein; Cholesterol","score_opus":0.07409806145032584,"score_gpt":0.3176411745276486,"score_spread":0.2435431130773228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367173826","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002444035,0.98484945,0.00005846704,0.0006569989,0.00021218968,0.007632477,0.0054206676,0.000744493,0.000180853],"genre_scores_gemma":[0.0022900072,0.96300566,0.000058553233,0.0017306296,0.0007473486,0.0049165823,0.0125858905,0.0005339172,0.014131433],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9906051,0.0012122166,0.001689484,0.0024766764,0.0026786965,0.001337798],"domain_scores_gemma":[0.99067354,0.00028692733,0.0009548467,0.004565574,0.0003668862,0.003152205],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0010434489,0.0018945014,0.010016313,0.00096486066,0.00041575392,0.00015871055,0.00067189476,0.00065292866,0.0020949417],"category_scores_gemma":[0.00023209103,0.0012961375,0.015700331,0.0028681946,0.00027917264,0.00033532523,0.00032207096,0.0013896124,0.00073491],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096662354,0.0013737009,0.00031627648,0.04193586,0.74393624,0.042632762,0.00007812889,0.000014284361,5.2052513e-8,0.000021000542,0.0085028475,0.16022222],"study_design_scores_gemma":[0.0010015797,0.00027934063,0.014288569,0.0051437495,0.7406572,0.00040480602,0.00001928892,0.00004949937,4.4135895e-8,0.00006565503,0.23690061,0.0011896354],"about_ca_topic_score_codex":0.000020553773,"about_ca_topic_score_gemma":0.00003614545,"teacher_disagreement_score":0.22839777,"about_ca_system_score_codex":0.0005168247,"about_ca_system_score_gemma":0.0030744413,"threshold_uncertainty_score":0.9993799},"labels":[],"label_agreement":null},{"id":"W4367297383","doi":"10.1016/j.atherosclerosis.2023.04.012","title":"Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society","year":2023,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Western University; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Agence Nationale de la Recherche; British Heart Foundation","keywords":"Lipoprotein(a); Statement (logic); Medicine; Risk factor; Epidemiology; Atherosclerotic cardiovascular disease; Lipoprotein; Disease; Internal medicine; Intensive care medicine; Family medicine; Cholesterol; Political science","score_opus":0.11792832882608495,"score_gpt":0.3354251128855815,"score_spread":0.21749678405949657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367297383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00870344,0.98013824,0.000016259859,0.0025825293,0.00046015062,0.006347549,0.00075675943,0.00020416036,0.00079092005],"genre_scores_gemma":[0.00140761,0.99477935,0.00014958257,0.00053263654,0.00032469377,0.0006379931,0.000025040039,0.00025410042,0.0018890201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937716,0.0025970389,0.0011980964,0.00077104353,0.0011175001,0.0005447222],"domain_scores_gemma":[0.99583733,0.0007093624,0.00077915395,0.0023176605,0.00015342451,0.00020309686],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047854963,0.0006628328,0.0017725645,0.000092744944,0.00061821745,0.00007079504,0.0004886285,0.00027671628,0.000056086526],"category_scores_gemma":[0.00047267237,0.00033997252,0.0022239948,0.0008100046,0.0005674071,0.000022511196,0.00042322325,0.0009806922,0.00009899357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051636416,0.000512005,0.00016318409,0.019461662,0.0045828014,0.000007691108,0.0012198909,0.0000028046632,0.00048500136,0.0014189838,0.016095644,0.9559987],"study_design_scores_gemma":[0.000995597,0.00053764187,0.008678482,0.04377741,0.0034520626,0.000038175163,0.00039379444,0.0000054672655,0.00012578921,0.00007743286,0.94133836,0.00057977077],"about_ca_topic_score_codex":0.00071285653,"about_ca_topic_score_gemma":0.000044082608,"teacher_disagreement_score":0.95541894,"about_ca_system_score_codex":0.0003132363,"about_ca_system_score_gemma":0.0005105535,"threshold_uncertainty_score":0.9999052},"labels":[],"label_agreement":null},{"id":"W4367668438","doi":"10.1093/eurheartj/ehad197","title":"2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":331,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi; Western University","funders":"Esperion Therapeutics; Silence Therapeutics; GlaxoSmithKline; HLS Therapeutics; Swedish Orphan Biovitrum; Servier; Daiichi-Sankyo; Amryt Pharma; Astellas Pharma; Regeneron Pharmaceuticals; Mylan; Ionis Pharmaceuticals; AstraZeneca; Amarin Corporation; REGENXBIO; Danone; Alexion Pharmaceuticals; Kowa Company; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Ironwood Pharmaceuticals, Incorporated; Medpace; Ultragenyx Pharmaceutical","keywords":"Medicine; Familial hypercholesterolemia; Genetic testing; Statement (logic); Lipoprotein(a); Intensive care medicine; Family medicine; Physical therapy; Pediatrics; Internal medicine; Lipoprotein; Cholesterol","score_opus":0.10122813798906802,"score_gpt":0.3599020968927974,"score_spread":0.25867395890372935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367668438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889686,0.00034448248,0.000039156123,0.0054073497,0.00072930456,0.00045322045,0.000031867625,0.00013857384,0.0038874617],"genre_scores_gemma":[0.9599555,0.011155546,0.0021564886,0.0130707,0.00552638,0.0000044497533,0.000039619346,0.00026354843,0.007827778],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99597996,0.0014285169,0.00077109947,0.00052669225,0.00072520744,0.0005685316],"domain_scores_gemma":[0.9982353,0.00009596308,0.00017395597,0.00058171526,0.00007905378,0.0008340206],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0043528033,0.0003052319,0.0005309538,0.00008936738,0.00040821638,0.00012514912,0.00012846713,0.0000615075,0.00004684477],"category_scores_gemma":[0.00013523878,0.00023394672,0.0006089841,0.00021511472,0.00011225038,0.0000491048,0.000114909155,0.00094409223,0.001984176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009264585,0.0007809251,0.06455153,0.00009676618,0.0016374378,0.0040792455,0.0007730869,0.00009222431,0.0015717433,0.00001740819,0.68923223,0.23624092],"study_design_scores_gemma":[0.006588146,0.0025127875,0.8182342,0.0004427622,0.00017813985,0.0009541886,0.00014199564,0.000045463432,0.00005144898,0.0000070310284,0.17063253,0.00021130491],"about_ca_topic_score_codex":0.00002429771,"about_ca_topic_score_gemma":0.0000026712146,"teacher_disagreement_score":0.7536827,"about_ca_system_score_codex":0.00015954563,"about_ca_system_score_gemma":0.00016856716,"threshold_uncertainty_score":0.9987929},"labels":[],"label_agreement":null},{"id":"W4367857310","doi":"10.2196/47911","title":"Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolemia Using the Familial Hypercholesterolemia Case Ascertainment Tool (FAMCAT): Protocol for a Mixed Methods Evaluation Study","year":2023,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council","keywords":"Familial hypercholesterolemia; Medicine; Coronary artery disease; Protocol (science); Identification (biology); Pediatrics; Internal medicine; Cholesterol; Alternative medicine; Pathology","score_opus":0.21503970848291418,"score_gpt":0.5499584868773535,"score_spread":0.3349187783944393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367857310","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48704934,0.000003100572,0.00022911352,0.00013009664,0.00001675191,0.51248634,0.00004318688,0.00003806599,0.0000039728616],"genre_scores_gemma":[0.32679927,3.09766e-7,0.0005313865,0.000022306427,0.00020243945,0.6722612,0.000047346697,0.000064642125,0.0000710904],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.98843765,0.0054756803,0.0013937621,0.0010357026,0.0027373445,0.0009198386],"domain_scores_gemma":[0.9961885,0.00040046772,0.00030510194,0.0018407936,0.00095377746,0.00031133438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02426353,0.0003659611,0.00068697066,0.0005144866,0.00043404812,0.00017412378,0.00043045342,0.00025183804,0.000014730337],"category_scores_gemma":[0.000950785,0.0002746401,0.0003247472,0.0012976904,0.00020970487,0.00034559617,0.00029868097,0.001040844,0.000008450553],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029483432,0.009491197,0.07175249,0.014508427,0.00070694974,0.0013430105,0.014482102,0.0027822175,0.50224555,0.000021623448,0.0040941616,0.34908888],"study_design_scores_gemma":[0.043915693,0.0075170645,0.8204165,0.0074995374,0.00030758514,0.00050603744,0.010292941,0.08863266,0.015554081,0.00041730376,0.0040423344,0.0008982426],"about_ca_topic_score_codex":0.0003391379,"about_ca_topic_score_gemma":0.000026111771,"teacher_disagreement_score":0.748664,"about_ca_system_score_codex":0.0008432282,"about_ca_system_score_gemma":0.0011799041,"threshold_uncertainty_score":0.99997056},"labels":[],"label_agreement":null},{"id":"W4376641825","doi":"10.46747/cfp.6905337","title":"Risk of muscle symptoms while taking statins","year":2023,"lang":"en","type":"article","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Université du Québec; Seven Oaks General Hospital; University of Manitoba","funders":"","keywords":"Medicine; Muscle cramp; Placebo; Muscle weakness; Statin; Weakness; Physical therapy; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Internal medicine; Bioinformatics; Alternative medicine; Surgery; Pathology","score_opus":0.020151981140066832,"score_gpt":0.2457274702414866,"score_spread":0.22557548910141978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376641825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9159274,0.0004207443,0.000033808847,0.00019209752,0.00021435313,0.0004171101,0.00026277042,0.0000888755,0.08244281],"genre_scores_gemma":[0.99021626,0.000097782344,0.00008417578,0.008854248,0.00037877518,0.000024988318,0.00009615922,0.000043026295,0.00020458446],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987005,0.000054414984,0.0002049553,0.00023959146,0.0003143679,0.00048617658],"domain_scores_gemma":[0.9987347,0.000024112958,0.00011140142,0.00055216724,0.00010227241,0.0004753433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028968646,0.00012965396,0.00034338745,0.00024973668,0.00013367269,0.0000115647,0.00009674131,0.00006688723,0.0000068845798],"category_scores_gemma":[0.00003182584,0.00012719701,0.00022807404,0.0007559289,0.000055484845,0.000053064545,0.000017017075,0.00018322092,0.00019029788],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000161951,0.000054755124,0.0046258494,0.00030488687,0.00055827585,0.0001983969,0.00070175645,0.00017208882,0.005899482,0.0012391373,0.0217946,0.96443456],"study_design_scores_gemma":[0.0009891846,0.00020371118,0.82908213,0.0002120331,0.00020598783,0.000001310158,0.0015936944,0.0005828178,0.00080863846,0.00025681398,0.16581938,0.00024429325],"about_ca_topic_score_codex":0.08494964,"about_ca_topic_score_gemma":0.011671867,"teacher_disagreement_score":0.9641903,"about_ca_system_score_codex":0.00018361317,"about_ca_system_score_gemma":0.00076890195,"threshold_uncertainty_score":0.9211438},"labels":[],"label_agreement":null},{"id":"W4376641941","doi":"10.46747/cfp.6905e108","title":"Risque de symptômes musculaires avec la prise de statines","year":2023,"lang":"fr","type":"article","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Musée de la Civilisation; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Seven Oaks General Hospital; University of Winnipeg","funders":"","keywords":"Medicine; Gynecology","score_opus":0.012949200919510706,"score_gpt":0.24943786306857654,"score_spread":0.23648866214906583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376641941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75369865,0.063982055,0.00033489522,0.010132789,0.0027647426,0.0016721592,0.00082114316,0.000422207,0.16617139],"genre_scores_gemma":[0.85990304,0.0067016273,0.0008390783,0.103554934,0.010525374,0.00033330987,0.00036632855,0.00039612912,0.017380191],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961067,0.00049913075,0.00035553757,0.0005257621,0.00045196892,0.0020608993],"domain_scores_gemma":[0.99666536,0.00014270455,0.00008469083,0.00086722797,0.00014115067,0.0020988965],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011915051,0.00040231267,0.0006425035,0.000401095,0.00034410873,0.00010400531,0.00027098047,0.00034439686,0.000018354627],"category_scores_gemma":[0.00012368076,0.0004458043,0.0005137844,0.0010798663,0.00027072255,0.00014639607,0.000044193665,0.000552908,0.00095576525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022990853,0.00009699063,0.0015191947,0.0016249227,0.00086363027,0.0043461574,0.0032952437,0.00085134775,0.001056539,0.0063764267,0.20112115,0.7788254],"study_design_scores_gemma":[0.0011261589,0.00014559974,0.18920629,0.0015555227,0.00045367816,0.00003308574,0.0035002697,0.0038002005,0.0003112414,0.0017288785,0.7975806,0.0005584839],"about_ca_topic_score_codex":0.33449656,"about_ca_topic_score_gemma":0.058383048,"teacher_disagreement_score":0.7782669,"about_ca_system_score_codex":0.0020079932,"about_ca_system_score_gemma":0.00776886,"threshold_uncertainty_score":0.9998221},"labels":[],"label_agreement":null},{"id":"W4377103945","doi":"10.3390/jcm12103543","title":"Lipoprotein(a) Does Not Predict Thrombotic Events and In-Hospital Outcomes in Patients with COVID-19","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"Fondazione Cassa di Risparmio di Perugia","keywords":"Medicine; Procalcitonin; Internal medicine; Proinflammatory cytokine; White blood cell; Pulmonary embolism; Thrombosis; Intensive care unit; Acute coronary syndrome; Lipoprotein(a); Deep vein; D-dimer; Gastroenterology; Lipoprotein; Inflammation; Cholesterol; Sepsis; Myocardial infarction","score_opus":0.03481659998750239,"score_gpt":0.378447385204196,"score_spread":0.34363078521669366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377103945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97066325,0.00017783267,0.000046502184,0.027339134,0.0008728234,0.00080579513,0.000004687977,0.000019770097,0.00007021918],"genre_scores_gemma":[0.99581575,0.000809051,0.00022830734,0.0022228037,0.0007957241,0.000009462001,0.000006017563,0.000025233436,0.000087667504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99587476,0.0002524226,0.0018673702,0.00028276173,0.0013891335,0.00033352003],"domain_scores_gemma":[0.99746925,0.00069243414,0.000564815,0.00034092262,0.00018719405,0.00074541755],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0050608893,0.00019755095,0.0017287417,0.00039652325,0.000034964793,0.000005155652,0.0001330438,0.00017524067,0.00005136298],"category_scores_gemma":[0.008543564,0.0000961145,0.00021126516,0.00046490514,0.00022105563,0.00012540956,0.000058675174,0.00087087665,0.0000053404324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014381668,0.00059142377,0.9834828,0.0002836028,0.00022387363,0.0004677408,0.0002276489,0.000009626279,0.0000020154107,0.00000807811,0.00024520035,0.013019858],"study_design_scores_gemma":[0.026335882,0.0070601767,0.96401286,0.0010715055,0.00017290309,0.000027186576,0.00023436957,0.000024845687,0.0000035594244,0.00026611268,0.0006861672,0.00010441801],"about_ca_topic_score_codex":0.0001836431,"about_ca_topic_score_gemma":0.00008762269,"teacher_disagreement_score":0.025152499,"about_ca_system_score_codex":0.000103953826,"about_ca_system_score_gemma":0.00042204902,"threshold_uncertainty_score":0.9998079},"labels":[],"label_agreement":null},{"id":"W4377220804","doi":"10.1080/14779072.2023.2215982","title":"Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management","year":2023,"lang":"en","type":"review","venue":"Expert Review of Cardiovascular Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Statin; Intensive care medicine; Physical therapy; Internal medicine","score_opus":0.0662136209571721,"score_gpt":0.41747334043264284,"score_spread":0.35125971947547074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377220804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003314839,0.9805437,0.004751544,0.00005606112,0.00031116983,0.013682418,0.00007146781,0.00013971468,0.00044062562],"genre_scores_gemma":[9.963303e-7,0.98973554,0.002792786,0.00025231374,0.00041977552,0.0055467146,0.00077304296,0.00021954546,0.00025928335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99457777,0.0009675663,0.0015644393,0.00091579487,0.0014580906,0.0005163297],"domain_scores_gemma":[0.99682885,0.00011985754,0.000608626,0.001880375,0.00036474055,0.00019754792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004635701,0.0007474364,0.0067791482,0.00024309408,0.00012986708,0.000055650333,0.0002786707,0.0003189903,0.00003676284],"category_scores_gemma":[0.000056004577,0.0005465703,0.008798149,0.0006582703,0.00008720502,0.00010573168,0.00010096522,0.0003126864,0.000008014572],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000050889585,0.00009701389,1.315538e-7,0.23397249,0.025040433,0.00002877106,0.000025747473,5.263131e-7,1.2378337e-7,0.00029006207,0.0013008988,0.73923874],"study_design_scores_gemma":[0.0015994807,0.00034555182,0.000024983296,0.18792376,0.006283033,0.000043714615,0.000062982785,0.0000020991529,4.7081156e-7,0.000079366764,0.80325514,0.0003794042],"about_ca_topic_score_codex":0.00005446786,"about_ca_topic_score_gemma":0.0000016164514,"teacher_disagreement_score":0.80195427,"about_ca_system_score_codex":0.00030736276,"about_ca_system_score_gemma":0.00074388686,"threshold_uncertainty_score":0.9996986},"labels":[],"label_agreement":null},{"id":"W4377942915","doi":"10.3389/fcvm.2023.1130162","title":"Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages","year":2023,"lang":"en","type":"article","venue":"Frontiers in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Sigrid Juséliuksen Säätiö; Sydäntutkimussäätiö; Novo Nordisk; Novo Nordisk Fonden; Academy of Finland; Aarne Koskelon Säätiö; Jenny ja Antti Wihurin Rahasto; Foundation for Cardiovascular Research; Heart and Stroke Foundation of Canada","keywords":"Cell biology; Signal transduction; Macrophage; Cancer research; Chemistry; Immunology; Medicine; Biology; Biochemistry; In vitro","score_opus":0.020605010060480895,"score_gpt":0.27082969878577995,"score_spread":0.25022468872529907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377942915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623134,0.031193366,0.0022164527,0.0012335844,0.0005604314,0.0015170018,0.0000043993273,0.00016099095,0.00080038095],"genre_scores_gemma":[0.9957122,0.0014563384,0.0010790764,0.00025823334,0.0009837876,0.00019614646,0.00008955187,0.000069623966,0.00015505],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99652725,0.00030774286,0.00060624426,0.00073641277,0.0011998155,0.00062253996],"domain_scores_gemma":[0.99866927,0.000041134455,0.000084806175,0.0008695767,0.00009055973,0.00024466822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0038295663,0.00033217086,0.0014758033,0.0012256757,0.00013404313,0.000018443006,0.00013231783,0.00027397188,0.000020671972],"category_scores_gemma":[0.0003559815,0.00028909591,0.0004107409,0.0017429657,0.00022180537,0.00015967556,0.00008381044,0.00063790806,0.000006262315],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004747948,0.00025152697,0.118541,0.0036000132,0.0048647854,0.006377988,0.006245715,0.0018055417,0.061190657,0.00021552225,0.007908033,0.78852445],"study_design_scores_gemma":[0.026830122,0.0012033633,0.8784226,0.005300739,0.0013319128,0.00055261725,0.01226273,0.0013193281,0.04092879,0.0020528105,0.028454449,0.001340507],"about_ca_topic_score_codex":0.0031964446,"about_ca_topic_score_gemma":0.000037658996,"teacher_disagreement_score":0.78718394,"about_ca_system_score_codex":0.0002782915,"about_ca_system_score_gemma":0.00010415781,"threshold_uncertainty_score":0.99995613},"labels":[],"label_agreement":null},{"id":"W4378171958","doi":"10.1093/ehjqcco/qcad030","title":"Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus","year":2023,"lang":"en","type":"article","venue":"European Heart Journal - Quality of Care and Clinical Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Impact; McMaster University; Population Health Research Institute","funders":"","keywords":"Diabetes mellitus; Internal medicine; Heart failure; Medicine; Cardiology; Cholesterol; Endocrinology","score_opus":0.1560002135333883,"score_gpt":0.4244251032834887,"score_spread":0.26842488975010037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378171958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960793,0.0013053018,0.000007465648,0.0022329162,0.000046632027,0.00023681347,0.000019532159,0.000017332097,0.00005469446],"genre_scores_gemma":[0.9981771,0.00077277975,0.0006233204,0.00022263445,0.00015244044,0.0000011499701,0.0000062062886,0.000020955422,0.000023419976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569,0.0019943216,0.0013153788,0.00023156914,0.0004835028,0.00028524688],"domain_scores_gemma":[0.9970034,0.0018646595,0.00031938162,0.0003274515,0.00014350995,0.00034161579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007926634,0.00013844726,0.0010907012,0.00011597966,0.000093524795,0.000020458116,0.0000572152,0.000075824726,0.00000392263],"category_scores_gemma":[0.0022771212,0.00009116602,0.00039851063,0.00020363812,0.0002063125,0.00008367494,0.000057408197,0.0006446061,0.0000063858924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008460528,0.00003807599,0.99351305,0.00034162268,0.00019745428,0.000010319322,0.00046250233,0.0000018119417,0.0000054164743,0.000012246659,0.00006838882,0.005264512],"study_design_scores_gemma":[0.0024726873,0.0010428869,0.9933406,0.00043411145,0.00028309342,0.000010241837,0.000993844,0.0000014854105,0.000026577198,0.00006345145,0.0012336189,0.00009738313],"about_ca_topic_score_codex":0.00009613259,"about_ca_topic_score_gemma":0.00013743945,"teacher_disagreement_score":0.0056495126,"about_ca_system_score_codex":0.000013658156,"about_ca_system_score_gemma":0.000081497514,"threshold_uncertainty_score":0.3717642},"labels":[],"label_agreement":null},{"id":"W4378172817","doi":"10.1097/01.npr.0000000000000059","title":"Pharmacotherapeutics for dyslipidemia management","year":2023,"lang":"en","type":"article","venue":"The Nurse Practitioner","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Petro-Canada; Alberta Children's Hospital; Mount Royal University","funders":"","keywords":"Dyslipidemia; Ezetimibe; Medicine; Bile acid; Pharmacology; Internal medicine; Statin; Intensive care medicine; Disease","score_opus":0.03975199163942374,"score_gpt":0.3627420784639716,"score_spread":0.3229900868245479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378172817","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17846419,0.0030088015,0.052652776,0.43528318,0.007625309,0.019006083,0.00015368397,0.002724149,0.30108184],"genre_scores_gemma":[0.8394899,0.002381456,0.0065346826,0.03622955,0.0059902132,0.002835847,0.00035478052,0.00020014224,0.10598346],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99924076,0.000047098154,0.00012492418,0.00013669072,0.00024836985,0.00020215345],"domain_scores_gemma":[0.99943256,0.000066877445,0.00004411431,0.0003453717,0.00005273287,0.000058353406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007765167,0.00007560447,0.00012500073,0.00005416094,0.00016123781,0.0000138108435,0.000057472378,0.00003521204,0.00014594098],"category_scores_gemma":[0.00002053617,0.000047966518,0.00015310959,0.00022196533,0.000024073264,0.00005901514,0.00000796194,0.00011716855,0.000463746],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095617847,0.00036921256,0.00036364014,0.0008128131,0.002639274,0.00007112446,0.0010566704,0.00026270567,0.004901904,0.039699502,0.47573802,0.47312897],"study_design_scores_gemma":[0.0016210234,0.000057773243,0.004688587,0.000034148834,0.0004677332,0.00003365705,0.00060899433,0.0006732176,0.0013909496,0.0012976209,0.9890455,0.00008078197],"about_ca_topic_score_codex":0.000007823012,"about_ca_topic_score_gemma":7.6653566e-7,"teacher_disagreement_score":0.6610257,"about_ca_system_score_codex":0.000047240952,"about_ca_system_score_gemma":0.000033398235,"threshold_uncertainty_score":0.59606713},"labels":[],"label_agreement":null},{"id":"W4378195092","doi":"10.1016/j.jacl.2023.05.101","title":"Dietary recommendations for dysbetalipoproteinemia: A need for better evidence","year":2023,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Dysfunctional family; Disease; Atherosclerotic cardiovascular disease; Bioinformatics; Intensive care medicine; Internal medicine; Psychiatry; Biology","score_opus":0.5330082096861793,"score_gpt":0.5598871365897444,"score_spread":0.02687892690356508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378195092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009265748,0.9643257,0.004076324,0.017438183,0.00997359,0.004011288,0.000109656765,0.000034142402,0.000021828844],"genre_scores_gemma":[8.978642e-7,0.9304909,0.026944418,0.0020011244,0.03914136,0.0004999707,0.00010633168,0.00011688117,0.0006981231],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992528,0.0008642145,0.0051938626,0.00048495966,0.0004167482,0.00051216636],"domain_scores_gemma":[0.98556864,0.009352277,0.003068373,0.00073829683,0.0008269129,0.00044547685],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011975929,0.00040694792,0.0069671157,0.000375183,0.00010872553,0.00002134641,0.00040359396,0.0012356241,0.00005710872],"category_scores_gemma":[0.017393576,0.0002732347,0.0077591543,0.00032235758,0.00013989002,0.00011232545,0.00009965803,0.0017293115,0.0000428288],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036863907,0.00013129413,0.000011157317,0.023708584,0.0023067906,0.000013963102,0.000006908275,1.6271572e-7,2.5180339e-7,0.000030654795,0.09368073,0.87974083],"study_design_scores_gemma":[0.002170936,0.0038000355,0.000030468309,0.025609301,0.008039057,0.0006718603,0.000012589443,0.0000069807297,3.18121e-7,0.00055843085,0.9588843,0.0002157182],"about_ca_topic_score_codex":0.000011933158,"about_ca_topic_score_gemma":0.000008393646,"teacher_disagreement_score":0.8795251,"about_ca_system_score_codex":0.00011115232,"about_ca_system_score_gemma":0.002040351,"threshold_uncertainty_score":0.999972},"labels":[],"label_agreement":null},{"id":"W4378231919","doi":"10.1186/s12944-023-01833-z","title":"International practice patterns of dyslipidemia management in patients with chronic kidney disease under nephrology care: is it time to review guideline recommendations?","year":2023,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Nephrology; Ezetimibe; Kidney disease; Internal medicine; Dyslipidemia; Lipidology; Guideline; Statin; Medical prescription; Clinical chemistry; Clinical nutrition; Gastroenterology; Disease; Pathology; Pharmacology","score_opus":0.017090723789086073,"score_gpt":0.3413904282946743,"score_spread":0.32429970450558826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378231919","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03856662,0.014680475,0.0004896798,0.93690294,0.0005261842,0.007187149,0.0008327313,0.00007734731,0.0007368941],"genre_scores_gemma":[0.110843696,0.051024426,0.0027443473,0.8260377,0.00085043843,0.0010312819,0.006305871,0.000084195235,0.0010780116],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978616,0.0002562392,0.0007270119,0.00039370995,0.00042628337,0.00033515226],"domain_scores_gemma":[0.997713,0.000057073587,0.0001573971,0.00046084388,0.00015903552,0.0014526319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000875915,0.00015046388,0.0003935856,0.0002672057,0.000048160033,0.0000072055936,0.00009023568,0.00003265387,0.00045972905],"category_scores_gemma":[0.0006412139,0.00012957012,0.000067876885,0.00043122345,0.000019791982,0.00010513216,0.00010702441,0.00016350343,0.000055252334],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045215655,0.0009205723,0.2878531,0.03138739,0.00028583274,0.00007065795,0.000614818,0.00019364191,2.5533126e-7,0.00030143032,0.47623008,0.19762066],"study_design_scores_gemma":[0.004537373,0.00040115952,0.2532671,0.0050142966,0.00012780851,7.31865e-7,0.00020053398,0.00024068645,8.205159e-8,0.000032131018,0.7360307,0.00014741012],"about_ca_topic_score_codex":0.00023955181,"about_ca_topic_score_gemma":0.000019932719,"teacher_disagreement_score":0.25980058,"about_ca_system_score_codex":0.00035541493,"about_ca_system_score_gemma":0.00093822274,"threshold_uncertainty_score":0.5283716},"labels":[],"label_agreement":null},{"id":"W4378373513","doi":"10.1016/j.jacadv.2023.100315","title":"Estimating the Prevalence of Hypercholesterolemia in Indigenous Populations","year":2023,"lang":"en","type":"article","venue":"JACC Advances","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Toronto; University of British Columbia","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC; Amgen","keywords":"Indigenous; Familial hypercholesterolemia; Geography; Biology; Medicine; Internal medicine; Ecology; Cholesterol","score_opus":0.03190581078072457,"score_gpt":0.33849369246845906,"score_spread":0.3065878816877345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378373513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590516,0.0025560984,0.00033210727,0.00036885738,0.00011900673,0.00038913693,0.000005126563,0.000038189813,0.00028632794],"genre_scores_gemma":[0.9959237,0.00029826156,0.0033020605,0.000082344,0.00011634935,0.00004525899,0.000004848629,0.000008336439,0.00021885817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992717,0.000038886432,0.00019624043,0.00011738974,0.00022555198,0.00015022724],"domain_scores_gemma":[0.9995724,0.00003632319,0.000055289125,0.00027751687,0.000029860334,0.00002863381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043277926,0.000054352437,0.00015147116,0.00006643817,0.000063151005,0.000004200038,0.000073669544,0.000026828182,0.000008520121],"category_scores_gemma":[0.00012546605,0.000035256096,0.000059025235,0.00038491582,0.00003375314,0.00008464155,0.000025645173,0.0001108777,0.000011994676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027271431,0.00005421212,0.5667382,0.0019368808,0.000021823736,0.000024535073,0.0030545224,0.008004101,0.0004627564,0.00010014281,0.000033235374,0.41954234],"study_design_scores_gemma":[0.00035269084,0.00006345971,0.9958278,0.0002678283,0.000030169886,0.000023858562,0.00021774886,0.0011046861,0.00020833901,0.00093371613,0.0009209558,0.000048775484],"about_ca_topic_score_codex":0.00011932858,"about_ca_topic_score_gemma":0.000052860145,"teacher_disagreement_score":0.42908958,"about_ca_system_score_codex":0.000025248037,"about_ca_system_score_gemma":0.000052201423,"threshold_uncertainty_score":0.14377019},"labels":[],"label_agreement":null},{"id":"W4378627691","doi":"10.1503/cmaj.230093","title":"Statin initiation and risk of incident kidney disease in patients with diabetes","year":2023,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Diabetes mellitus; Medicine; Kidney disease; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Statin; Disease; Bioinformatics; Internal medicine; Intensive care medicine; Computer science; Endocrinology; Biology","score_opus":0.004105327223099043,"score_gpt":0.21249229975305658,"score_spread":0.20838697252995755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378627691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956759,0.00006877917,0.000008047125,0.003834814,0.000088457215,0.00017864202,0.00007405716,0.0000067919264,0.00006448447],"genre_scores_gemma":[0.9979428,0.00023763183,0.000033712517,0.0014991126,0.00018721586,0.000006628088,0.00006414649,0.000009092439,0.00001966684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998046,0.00016713097,0.000271505,0.00008940239,0.0011776998,0.00024829461],"domain_scores_gemma":[0.9976947,0.000059331003,0.00016808594,0.00007251386,0.00025054894,0.001754856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017358594,0.000060502636,0.00019294012,0.00024144529,0.00007190058,0.000014690237,0.00003357183,0.000089232395,0.00016432529],"category_scores_gemma":[0.003560317,0.00004776526,0.000043932298,0.00031088683,0.000020260673,0.00006891418,0.0000075834137,0.0003635291,0.000008194424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019003455,0.000019311443,0.9841873,0.00003464745,0.00008272465,0.000052854954,0.00014244266,0.000004229715,2.1941212e-7,0.000007948802,0.0023219327,0.013127387],"study_design_scores_gemma":[0.0023900939,0.00009530006,0.99419767,0.00018579038,0.000060634677,0.0000012664858,0.000066625005,0.00021727392,0.0000018922059,0.00005712373,0.0026778094,0.00004853559],"about_ca_topic_score_codex":0.0024095494,"about_ca_topic_score_gemma":0.0054328525,"teacher_disagreement_score":0.013078851,"about_ca_system_score_codex":0.00040817048,"about_ca_system_score_gemma":0.002468696,"threshold_uncertainty_score":0.4379361},"labels":[],"label_agreement":null},{"id":"W4378647153","doi":"10.1016/j.cjcpc.2023.05.006","title":"Exploring Barriers and Facilitators to Indirect Cascade Screening for Familial Hypercholesteraemia in a Paediatric/Parent Population","year":2023,"lang":"en","type":"article","venue":"CJC Pediatric and Congenital Heart Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children; McMaster University; University of Toronto","funders":"Hospital for Sick Children; University of Toronto","keywords":"Worry; Attendance; Medicine; Familial hypercholesterolemia; Population; Newborn screening; Family medicine; Public health; Nursing; Psychiatry; Pediatrics; Environmental health; Cholesterol","score_opus":0.059380952326660574,"score_gpt":0.2925533673416606,"score_spread":0.23317241501500002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378647153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952962,0.0026473843,0.00007327375,0.00031404945,0.00016396423,0.0012408595,0.00016677404,0.00009004158,0.00000744762],"genre_scores_gemma":[0.9976072,0.00055590423,0.00018709825,0.00027163047,0.0006961622,0.00052710564,0.00008489953,0.000027036001,0.00004302017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851453,0.00005881088,0.0002818392,0.00043403023,0.00030130032,0.00040949928],"domain_scores_gemma":[0.998605,0.00007158896,0.000022931166,0.00018316122,0.0000525078,0.001064793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004076472,0.00018018585,0.0003558559,0.0004187747,0.00016131622,0.000033031636,0.00003290691,0.00006260119,0.0000032126918],"category_scores_gemma":[0.0003957351,0.00017406928,0.00012096962,0.0006926002,0.0000212116,0.00019024128,0.000067058034,0.00013943984,0.0000075294083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005264107,0.00001668442,0.9506244,0.0003903145,0.000023226028,0.00005364167,0.0006181994,0.000027645872,0.00001621045,0.000005589001,0.00017815828,0.0475195],"study_design_scores_gemma":[0.0017967834,0.00015717353,0.9957167,0.000024268567,0.00020942165,0.000010183818,0.00082455814,0.00049593527,0.000004179352,0.000028068614,0.0005339015,0.00019883021],"about_ca_topic_score_codex":0.00032389842,"about_ca_topic_score_gemma":0.00002889984,"teacher_disagreement_score":0.04732067,"about_ca_system_score_codex":0.00006130058,"about_ca_system_score_gemma":0.00013913475,"threshold_uncertainty_score":0.7098339},"labels":[],"label_agreement":null},{"id":"W4378840415","doi":"10.1016/j.atherosclerosis.2023.05.019","title":"High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific manner","year":2023,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"Canadian Institutes of Health Research; National Institutes of Health; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada; American Heart Association","keywords":"Genetically modified mouse; Transgene; Lipoprotein; Medicine; Biology; Internal medicine; Cholesterol; Genetics; Gene","score_opus":0.028170850678149707,"score_gpt":0.2529976688697337,"score_spread":0.22482681819158398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378840415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953688,0.0011242344,0.000058901795,0.0011545119,0.00015655262,0.00175645,0.0000848497,0.00013696535,0.000158726],"genre_scores_gemma":[0.9925485,0.004510882,0.0010316729,0.00017693602,0.00016476557,0.0003531921,0.000021668153,0.0001176838,0.001074664],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9966409,0.00036346092,0.0007401947,0.0008190997,0.00064588635,0.0007904193],"domain_scores_gemma":[0.9986802,0.000108322994,0.0001411806,0.00078959827,0.000069340065,0.00021137141],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022093856,0.00041498718,0.0010888968,0.0004521281,0.00012131283,0.000041242376,0.0002035326,0.0003675298,0.000099494624],"category_scores_gemma":[0.000054365584,0.00037201744,0.00028599656,0.0014632372,0.00014627658,0.00017185543,0.00008672933,0.00068344385,0.000032794935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004649556,0.00082627614,0.04809102,0.0016502896,0.0003896007,0.000028259805,0.010313257,0.00038066716,0.82881236,0.0007689262,0.00057031563,0.107704066],"study_design_scores_gemma":[0.0056907753,0.00040984253,0.88744247,0.0011230416,0.00006060423,0.000017136002,0.00054010766,0.000112178765,0.1024413,0.0002658032,0.0014849058,0.00041181213],"about_ca_topic_score_codex":0.0050722416,"about_ca_topic_score_gemma":0.001104037,"teacher_disagreement_score":0.8393515,"about_ca_system_score_codex":0.00015927426,"about_ca_system_score_gemma":0.00010376032,"threshold_uncertainty_score":0.99987316},"labels":[],"label_agreement":null},{"id":"W4379380894","doi":"10.1016/j.jtcvs.2023.05.028","title":"Novel therapies to achieve the recommended low-density lipoprotein cholesterol concentration (LDL-C) targets for patients after coronary artery bypass grafting","year":2023,"lang":"en","type":"editorial","venue":"Journal of Thoracic and Cardiovascular Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Institutes of Health; American College of Cardiology Foundation; U.S. Department of Veterans Affairs","keywords":"Medicine; Bypass grafting; Artery; Ldl cholesterol; Medical therapy; Internal medicine; Cholesterol; Cardiology; Intensive care medicine; Surgery","score_opus":0.015541528140128746,"score_gpt":0.27204235595381404,"score_spread":0.2565008278136853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379380894","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30113935,0.027746042,0.010739759,0.0018983209,0.653319,0.004648317,0.00039441185,0.00009897421,0.000015815001],"genre_scores_gemma":[0.37110937,0.01131169,0.0012084172,0.0009568359,0.6137331,0.0006319053,0.000490751,0.00038426215,0.00017365512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99408424,0.000627514,0.0013874216,0.0006480845,0.0025478508,0.00070490275],"domain_scores_gemma":[0.99494153,0.0012335043,0.00074944546,0.0010216155,0.0016099206,0.00044397006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008573846,0.000625072,0.0025073271,0.00027804292,0.00033309727,0.0001871411,0.00023718542,0.0007450403,0.000006105948],"category_scores_gemma":[0.0019092128,0.00043344093,0.004238706,0.00032082756,0.000089462344,0.00026783757,0.00014358011,0.0013089336,0.0000071930654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006700028,0.0003641029,0.0011706698,0.0020915628,0.019712094,0.0003631148,0.0009554389,0.00003150551,0.00005673592,6.3088413e-7,0.30773482,0.6608193],"study_design_scores_gemma":[0.0056300783,0.0019198294,0.07088291,0.0058963713,0.009182488,0.00060849404,0.00071942445,0.0000384533,0.00043459274,0.000104351835,0.90305126,0.0015317707],"about_ca_topic_score_codex":0.0001301312,"about_ca_topic_score_gemma":0.00002531856,"teacher_disagreement_score":0.6592875,"about_ca_system_score_codex":0.00023941405,"about_ca_system_score_gemma":0.0006626562,"threshold_uncertainty_score":0.9998117},"labels":[],"label_agreement":null},{"id":"W4380365330","doi":"10.5206/uwomj.v90i2.14870","title":"Cardiovascular disease in South Asian Canadians: using risk factors to target primary and secondary prevention","year":2023,"lang":"en","type":"article","venue":"University of Western Ontario Medical Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Disease; Diabetes mellitus; Family history; Ethnic group; Incidence (geometry); Primary prevention; Medical prescription; Obesity; Environmental health; Gerontology; Internal medicine; Endocrinology","score_opus":0.014334211110919787,"score_gpt":0.2175148769919173,"score_spread":0.2031806658809975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380365330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958787,0.00041768805,0.002808066,0.0003224895,0.00011543123,0.00026126037,0.000020835616,0.000014259014,0.00016129487],"genre_scores_gemma":[0.9983319,0.00020519168,0.0007430343,0.00011491994,0.00012819162,1.4806457e-7,0.000028427026,0.000013494072,0.0004347011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825555,0.00015751748,0.00020055147,0.00021706005,0.00088811934,0.00028121553],"domain_scores_gemma":[0.99834245,0.00001264555,0.00007394141,0.00022652817,0.00005398471,0.0012904309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010348184,0.0001135999,0.0004411283,0.00033319942,0.00014522216,0.000012205794,0.000110576126,0.00010659722,0.00019550913],"category_scores_gemma":[0.00007634314,0.00011162921,0.00034351271,0.00020275633,0.000066222055,0.00011613777,0.00008355239,0.0006126373,0.000004166865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001793166,0.00005036866,0.95784086,0.00014047636,0.00068348995,0.004771264,0.009919686,0.00030678484,0.000003916652,0.0000014173805,0.00004926146,0.026053132],"study_design_scores_gemma":[0.002016173,0.00011764466,0.98228586,0.00044618142,0.00038054227,0.00018697757,0.0024014078,0.00010056112,0.000001487602,0.000022706314,0.011931395,0.00010906088],"about_ca_topic_score_codex":0.22827956,"about_ca_topic_score_gemma":0.14050068,"teacher_disagreement_score":0.08777888,"about_ca_system_score_codex":0.00061885256,"about_ca_system_score_gemma":0.0028325643,"threshold_uncertainty_score":0.8751829},"labels":[],"label_agreement":null},{"id":"W4380591442","doi":"10.1371/journal.pone.0281178","title":"Impact of statin withdrawal on perceived and objective muscle function","year":2023,"lang":"en","type":"article","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research","keywords":"Statin; Medicine; Visual analogue scale; Physical therapy; Cohort; Internal medicine; Physical medicine and rehabilitation","score_opus":0.03121905946395589,"score_gpt":0.26851053642571643,"score_spread":0.23729147696176053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380591442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998333,0.000062929284,0.000014593219,0.000083486324,0.000013379087,0.00039490504,0.0000146629945,0.000055956858,0.001027091],"genre_scores_gemma":[0.9993197,0.0001149776,0.00014867858,0.000045503515,0.0001126851,0.000019750285,0.000022403292,0.000014828993,0.00020152808],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9992546,0.00003796668,0.00010088578,0.0001450964,0.00032924765,0.00013220578],"domain_scores_gemma":[0.9995791,0.000026644673,0.000032811597,0.00019141931,0.00008432418,0.00008570718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018307204,0.00007016495,0.0002476645,0.000086078486,0.00003679051,0.000004036666,0.000014159701,0.000039354833,0.00006012223],"category_scores_gemma":[0.00008031189,0.000053129606,0.00008777094,0.00018567599,0.00002704569,0.000029675033,0.0000119873475,0.00010369031,0.000034130382],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045452793,0.0057660732,0.23308297,0.0025350635,0.008849748,0.00011487762,0.011693148,0.00005875888,0.6271377,0.0002139952,0.000993883,0.10500851],"study_design_scores_gemma":[0.0011939454,0.0024146505,0.9941528,0.00018858664,0.00019318309,0.0000020181067,0.00025492426,0.00018674262,0.0012876171,0.000070368464,0.0000053043073,0.00004985918],"about_ca_topic_score_codex":0.0005945621,"about_ca_topic_score_gemma":0.000016718772,"teacher_disagreement_score":0.76106983,"about_ca_system_score_codex":0.0000576742,"about_ca_system_score_gemma":0.00007782408,"threshold_uncertainty_score":0.21665624},"labels":[],"label_agreement":null},{"id":"W4380677035","doi":"10.1038/s41569-023-00892-0","title":"International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Health and Medical Research Council; Medical Research Council","keywords":"Medicine; Familial hypercholesterolemia; Intensive care medicine; Genetic testing; Health care; Risk stratification; Clinical Practice; Coronary artery disease; Family medicine; Internal medicine; Cholesterol","score_opus":0.08836692091211877,"score_gpt":0.4295761413243015,"score_spread":0.3412092204121827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380677035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009628822,0.991249,0.00008803635,0.00027019216,0.0008350835,0.0057601156,0.0002745309,0.000016911777,0.0014964502],"genre_scores_gemma":[0.000016735625,0.991672,0.0024642004,0.00065824535,0.0025832825,0.0019124531,0.00056948175,0.000073261064,0.000050357306],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99583656,0.0011738477,0.0014034552,0.000637087,0.00047811892,0.00047092178],"domain_scores_gemma":[0.99701256,0.00073274446,0.000810231,0.0010124515,0.00037770218,0.000054303997],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005839832,0.00042600554,0.00392204,0.00011054269,0.00008423483,0.000017221282,0.00057072565,0.0011393736,0.0000044557482],"category_scores_gemma":[0.0019288351,0.00025572325,0.004132788,0.0004884904,0.00007415763,0.00006212609,0.00016702326,0.0017719483,0.00002117845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010409813,0.000021500831,0.00003545876,0.03956367,0.00085285417,0.00000828812,0.00031241606,2.4789816e-7,0.000001745112,0.000081010614,0.0028618956,0.9562505],"study_design_scores_gemma":[0.0005932916,0.00013377766,0.0000544607,0.015955573,0.0029765442,0.000279029,0.000539244,4.8327115e-7,2.6947743e-7,0.0000035568737,0.97928935,0.00017441524],"about_ca_topic_score_codex":0.000035907284,"about_ca_topic_score_gemma":0.000015348958,"teacher_disagreement_score":0.97642744,"about_ca_system_score_codex":0.00030407525,"about_ca_system_score_gemma":0.00046150645,"threshold_uncertainty_score":0.9999895},"labels":[],"label_agreement":null},{"id":"W4380786116","doi":"10.1161/circ.146.suppl_1.13821","title":"Abstract 13821: Genetic Identification of Homozygous Familial Hypercholesterolemia by Long-Read Sequencing Among Patients With Clinically Diagnosed Heterozygous Familial Hypercholesterolemia","year":2022,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Familial hypercholesterolemia; Medicine; PCSK9; Internal medicine; LDL receptor; Apolipoprotein B; Genetic testing; Myocardial infarction; Cohort; Diabetes mellitus; Genetic disorder; Unstable angina; Cardiology; Disease; Cholesterol; Lipoprotein; Endocrinology","score_opus":0.014410307838652889,"score_gpt":0.24937589200410412,"score_spread":0.23496558416545124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380786116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545443,0.00018718811,0.0018824978,0.000035045607,0.0003357867,0.0017918973,0.00013151258,0.00009473928,0.000086913016],"genre_scores_gemma":[0.99810684,0.000036257836,0.00016089783,0.00024101144,0.00021289564,0.00022998771,0.00090271916,0.00008408447,0.000025337138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958451,0.00026635712,0.0012822467,0.00072726695,0.0014552724,0.00042380695],"domain_scores_gemma":[0.9977759,0.00007860357,0.00061061495,0.0009754822,0.00032927433,0.00023012052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00087521994,0.00031095953,0.0006253497,0.00018994568,0.0003005739,0.000045658453,0.00022452747,0.0001924551,0.000053944215],"category_scores_gemma":[0.000117203774,0.00030455383,0.00029744825,0.00035503614,0.00015189279,0.00024139656,0.00008459099,0.0005798405,0.000013888895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004502013,0.0004405317,0.93095845,0.00024621605,0.00015999109,0.00007853228,0.000560685,0.004411755,0.015461441,0.0000011231594,0.000043463515,0.04718758],"study_design_scores_gemma":[0.004444932,0.0005301493,0.9930979,0.00010994604,0.00026553456,0.000053103515,0.00018832581,0.00064040784,0.00031619024,0.000012651212,0.000060298767,0.0002805423],"about_ca_topic_score_codex":0.00074629055,"about_ca_topic_score_gemma":0.000039368955,"teacher_disagreement_score":0.06213944,"about_ca_system_score_codex":0.000673514,"about_ca_system_score_gemma":0.0002764196,"threshold_uncertainty_score":0.99994063},"labels":[],"label_agreement":null},{"id":"W4380793496","doi":"10.1161/circ.146.suppl_1.10476","title":"Abstract 10476: Impact of C-Reactive Protein Levels on Lipoprotein(a)-Associated Coronary Artery Disease and Aortic Stenosis Risk in Apparently Healthy Individuals","year":2022,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Montreal Heart Institute; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Lipoprotein(a); Hazard ratio; Coronary artery disease; Internal medicine; C-reactive protein; Stenosis; Cardiology; Biomarker; Lipoprotein; Prospective cohort study; Gastroenterology; Inflammation; Cholesterol; Confidence interval","score_opus":0.027348860516766355,"score_gpt":0.289078027311815,"score_spread":0.26172916679504865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380793496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958809,0.0003611855,0.00003611761,0.00013220352,0.000046992292,0.0031199665,0.0003145513,0.000040472172,0.000067618945],"genre_scores_gemma":[0.9990914,0.000015698643,0.000019880892,0.0000867766,0.000060558676,0.0004543284,0.0002295112,0.000035279292,0.0000065651516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975507,0.00036998754,0.00053304026,0.00041432056,0.0008066737,0.00032524441],"domain_scores_gemma":[0.9987358,0.00006452919,0.00043174552,0.0004237566,0.000083735584,0.00026046936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008864533,0.00020644999,0.0005050681,0.00030142476,0.00018404725,0.000014359125,0.000063186555,0.0000830767,0.000105788145],"category_scores_gemma":[0.00023726594,0.00019680383,0.00026147673,0.00040834447,0.000044700657,0.00013328742,0.000048816535,0.00046352381,0.0000038369317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086097856,0.00094949454,0.965503,0.00022886106,0.00044660614,0.000046525514,0.00052841625,0.0015299307,0.002434875,0.0000208515,0.00001367362,0.027436797],"study_design_scores_gemma":[0.0028867004,0.0007293676,0.99460644,0.00019648594,0.00015228466,0.000008821251,0.00018418452,0.0005545573,0.00009412226,0.00041524117,0.0000043369223,0.00016747821],"about_ca_topic_score_codex":0.0019337474,"about_ca_topic_score_gemma":0.000021790866,"teacher_disagreement_score":0.029103428,"about_ca_system_score_codex":0.0008841336,"about_ca_system_score_gemma":0.00046787458,"threshold_uncertainty_score":0.8025427},"labels":[],"label_agreement":null},{"id":"W4380793535","doi":"10.1161/circ.146.suppl_1.10291","title":"Abstract 10291: Elevated C-Reactive Protein Level Amplifies the Association of Lipoprotein(a) With Cardiovascular Risk and Risk Reduction With Alirocumab After Acute Coronary Syndrome","year":2022,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sanofi (Canada)","funders":"","keywords":"Medicine; Internal medicine; Acute coronary syndrome; Alirocumab; C-reactive protein; Cardiology; Rosuvastatin; Hazard ratio; Lipoprotein(a); Quartile; Unstable angina; Myocardial infarction; Lipoprotein; Cholesterol; Inflammation; Confidence interval; Apolipoprotein A1","score_opus":0.010675482214543574,"score_gpt":0.21397772632282458,"score_spread":0.20330224410828102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380793535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349946,0.0011978552,0.0018686876,0.00012599112,0.000054787746,0.0029810872,0.00015063646,0.000055906898,0.00006558946],"genre_scores_gemma":[0.9982565,0.00010946416,0.00034826965,0.0000186857,0.00008363839,0.00093143765,0.00013975496,0.000050816176,0.00006141249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970919,0.00040699946,0.00034000174,0.00046490753,0.0014251111,0.00027108646],"domain_scores_gemma":[0.99831116,0.000034978697,0.0005505161,0.00071266043,0.0003076713,0.00008300792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016886909,0.00023243825,0.0005252156,0.0001306876,0.0004815769,0.00002938381,0.00006984474,0.00011228204,0.000031643147],"category_scores_gemma":[0.000057790334,0.00016232955,0.00025340967,0.00045543752,0.00009095667,0.00022854439,0.000045911318,0.000597293,0.0000026373923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007999285,0.00063177734,0.856429,0.0007659037,0.0263298,0.00039490606,0.0038880012,0.01207227,0.011283554,0.000105857616,0.000038071877,0.08006158],"study_design_scores_gemma":[0.0025396645,0.00053072325,0.99077106,0.00010474778,0.0023807986,0.0009158778,0.00070393557,0.00012092424,0.001248968,0.00011713958,0.00035476923,0.00021142293],"about_ca_topic_score_codex":0.002798334,"about_ca_topic_score_gemma":0.000048727667,"teacher_disagreement_score":0.13434203,"about_ca_system_score_codex":0.00054278254,"about_ca_system_score_gemma":0.00020308085,"threshold_uncertainty_score":0.6619607},"labels":[],"label_agreement":null},{"id":"W4380794364","doi":"10.1161/circ.146.suppl_1.11904","title":"Abstract 11904: Lipoprotein(a) Integrates Monocyte-Mediated Thrombosis and Inflammation in Atherosclerotic Cardiovascular Disease","year":2022,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Inflammation; Monocyte; Medicine; Tissue factor; Lipoprotein(a); CD14; Immunology; Internal medicine; Lipoprotein; Thrombosis; Receptor; Cholesterol; Coagulation","score_opus":0.032331120066225814,"score_gpt":0.25694441439230953,"score_spread":0.2246132943260837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380794364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943167,0.0028633478,0.00042895525,0.0004710045,0.00010437723,0.0015206789,0.00001706053,0.00008571988,0.00019214288],"genre_scores_gemma":[0.9986863,0.00027673427,0.00008698369,0.00008038046,0.00016408083,0.0003969348,0.00026805166,0.000034697186,0.0000058176297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981645,0.00015488241,0.00034770308,0.00039760032,0.00069600774,0.00023931325],"domain_scores_gemma":[0.9990923,0.000030575164,0.000085683016,0.0005485779,0.00006651596,0.00017639405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009862647,0.00016835576,0.00038406317,0.00021784434,0.00019078344,0.000031778494,0.000058581427,0.00006544365,0.00010901032],"category_scores_gemma":[0.00013586614,0.00016933818,0.0002728918,0.00042239032,0.000039155293,0.00017828075,0.000055765275,0.00030850316,0.000014113429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037847974,0.00042841025,0.6800347,0.0014352048,0.001427543,0.00013854529,0.0022096436,0.04698398,0.023506796,0.0007045007,0.000046840323,0.24270535],"study_design_scores_gemma":[0.0015426627,0.000038385446,0.98866075,0.00008405738,0.00017874013,0.000011660808,0.00025209735,0.007404462,0.00018705343,0.00029556718,0.001175347,0.0001691877],"about_ca_topic_score_codex":0.00089735736,"about_ca_topic_score_gemma":0.00002129513,"teacher_disagreement_score":0.30862606,"about_ca_system_score_codex":0.0003590517,"about_ca_system_score_gemma":0.00014354053,"threshold_uncertainty_score":0.690541},"labels":[],"label_agreement":null},{"id":"W4380794552","doi":"10.1161/circ.146.suppl_1.12552","title":"Abstract 12552: Causal Effect of Exposure to Elevated Lipoprotein(a) Levels on the Blood Transcriptome : A Mendelian Randomization Study","year":2022,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Mendelian randomization; Genome-wide association study; Transcriptome; Medicine; Gene; Genetics; Single-nucleotide polymorphism; Biology; Gene expression; Genotype; Genetic variants","score_opus":0.021865268493029343,"score_gpt":0.26873282661866277,"score_spread":0.24686755812563344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380794552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260867,0.000110506386,0.00048599602,0.00036710248,0.00016128177,0.0059872004,0.000025271815,0.000058694266,0.00019530827],"genre_scores_gemma":[0.9988822,0.0000019065295,0.000013779916,0.00016958971,0.00014249282,0.0006867743,0.000036200996,0.000032848286,0.000034207176],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99751383,0.00057613757,0.00041543305,0.00030587282,0.0009894636,0.00019923877],"domain_scores_gemma":[0.9990119,0.00009639724,0.00012679947,0.0005694102,0.00010271638,0.00009279383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020521032,0.0001685533,0.00044306667,0.00017547444,0.0002497519,0.000015040798,0.00009718383,0.000052628955,0.00030291788],"category_scores_gemma":[0.0001833563,0.00011972135,0.00022782556,0.00057399453,0.000014122553,0.000048187212,0.000020787835,0.00026368306,0.000008081009],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009192559,0.0023875488,0.05426755,0.0007268309,0.0021636942,0.000105737374,0.007176144,0.041537132,0.82801044,0.00037893138,0.00013051015,0.05392292],"study_design_scores_gemma":[0.018619698,0.0038745727,0.95935935,0.000075845885,0.0006382787,0.00003313427,0.00052390207,0.00022324582,0.016269326,0.000028761087,0.00017444324,0.00017947378],"about_ca_topic_score_codex":0.000236953,"about_ca_topic_score_gemma":0.000014256852,"teacher_disagreement_score":0.90509176,"about_ca_system_score_codex":0.00011029655,"about_ca_system_score_gemma":0.00008484458,"threshold_uncertainty_score":0.4882095},"labels":[],"label_agreement":null},{"id":"W4381166389","doi":"10.3389/fcvm.2023.1206551","title":"Regional differences in physicians’ behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study","year":2023,"lang":"en","type":"article","venue":"Frontiers in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; PCSK9; Internal medicine; Demography; Total cholesterol; Lipoprotein; Cholesterol","score_opus":0.0258008758292133,"score_gpt":0.2478189999651999,"score_spread":0.2220181241359866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381166389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827539,0.014675978,0.00012163969,0.00038678173,0.0002459161,0.0017737516,0.000003714777,0.000020394926,0.000017966979],"genre_scores_gemma":[0.9985749,0.00095936266,0.000058740883,0.000090287154,0.00015109981,0.000115095245,0.0000075084276,0.000027696167,0.000015297603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966037,0.0004444642,0.0006002194,0.0004547722,0.0015822907,0.00031452838],"domain_scores_gemma":[0.99823,0.00006920673,0.00019991396,0.0012204874,0.00020402188,0.00007641006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021562316,0.00027717365,0.0018196318,0.0004204305,0.00008878467,0.0000059308686,0.00025378406,0.00010047618,0.0000023754762],"category_scores_gemma":[0.00013294957,0.00013250276,0.00062481244,0.0020273507,0.0006358024,0.00006359031,0.000092927,0.0004333823,1.3411494e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023008176,0.00017948447,0.9726657,0.00011847201,0.0022499608,0.00005739662,0.010273584,0.000056961242,0.00016366612,0.0000020072157,0.000116904404,0.013885769],"study_design_scores_gemma":[0.004167885,0.00044617435,0.94741553,0.00052303873,0.0012619686,0.000020228123,0.04537866,0.0000951749,0.0004142069,0.000018172468,0.00013356918,0.0001253819],"about_ca_topic_score_codex":0.004727523,"about_ca_topic_score_gemma":0.0002497673,"teacher_disagreement_score":0.035105076,"about_ca_system_score_codex":0.00009842732,"about_ca_system_score_gemma":0.0001244257,"threshold_uncertainty_score":0.7146632},"labels":[],"label_agreement":null},{"id":"W4381249868","doi":"10.2196/46533","title":"A Web-Based Application for Risk Stratification and Optimization in Patients With Cardiovascular Disease: Pilot Study","year":2023,"lang":"en","type":"article","venue":"JMIR Cardio","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Cambridge Cardiac Care Centre; University of Ottawa","funders":"","keywords":"Medicine; Psychological intervention; Aspirin; Disease; Residual risk; Comorbidity; Framingham Risk Score; Ramipril; Intensive care medicine; Statin; Physical therapy; Internal medicine; Blood pressure","score_opus":0.013816413085635672,"score_gpt":0.25293773201592573,"score_spread":0.23912131893029007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381249868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580128,0.00031347276,0.03095873,0.000079886704,0.000037179532,0.010346051,0.00006360285,0.0001498737,0.00003838893],"genre_scores_gemma":[0.9942674,0.00004822152,0.00072617136,0.000022968474,0.000112115966,0.0042858217,0.00048419772,0.000040049836,0.000013025673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983396,0.00014086832,0.00022456735,0.000472112,0.0006155209,0.00020735442],"domain_scores_gemma":[0.99874943,0.0000255602,0.00006677207,0.0008061673,0.00020915944,0.00014291132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008977875,0.00015050493,0.0003887177,0.00017995769,0.00010648541,0.00002428001,0.000044893,0.000037561807,0.0000012518004],"category_scores_gemma":[0.000055556706,0.00012619025,0.00016497662,0.00054071186,0.000026160917,0.00007419076,0.000013644097,0.00010041351,0.0000040996397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017318139,0.0008630585,0.80489576,0.00041296592,0.00087077246,0.000008716317,0.00012357089,0.15115844,0.00001068353,0.000017879844,0.000075933174,0.039830387],"study_design_scores_gemma":[0.010240975,0.0014020104,0.9560424,0.000040885814,0.0006091411,4.888865e-7,0.00009192242,0.030513529,0.0000051519664,0.000008855684,0.00089715753,0.0001474502],"about_ca_topic_score_codex":0.00012558016,"about_ca_topic_score_gemma":0.00001671796,"teacher_disagreement_score":0.15114665,"about_ca_system_score_codex":0.00009786522,"about_ca_system_score_gemma":0.00016680868,"threshold_uncertainty_score":0.51458895},"labels":[],"label_agreement":null},{"id":"W4381337400","doi":"10.2337/db23-992-p","title":"992-P: Coronary Artery Calcium Scoring to Improve Statin Use in Adults with Type 2 Diabetes Not on Statin Therapy—Anticipated Cost Utility","year":2023,"lang":"en","type":"article","venue":"Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Diabetes mellitus; Quality-adjusted life year; Population; Stroke (engine); Cost–utility analysis; Internal medicine; Coronary artery disease; Physical therapy; Cost effectiveness","score_opus":0.04650061359558948,"score_gpt":0.29163652948998825,"score_spread":0.24513591589439876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381337400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967647,0.00020401161,0.000008205607,0.00030064114,0.00023779325,0.0020739357,0.00014137376,0.000199424,0.000069875015],"genre_scores_gemma":[0.9973096,0.0000773514,0.00019117589,0.0015814628,0.00010096156,0.00033131306,0.00022893559,0.00007155187,0.00010760183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742806,0.00016402212,0.00038622002,0.0006068432,0.00056190765,0.0008529694],"domain_scores_gemma":[0.99852324,0.00024677202,0.00007699998,0.00070791465,0.00018387375,0.00026120665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007790578,0.0002973885,0.00061206,0.00025620722,0.00008232159,0.0000459441,0.00010785857,0.00010061586,0.00005092158],"category_scores_gemma":[0.00029619658,0.000228893,0.0001015206,0.00088895974,0.00006270843,0.0001343464,0.00005690551,0.0003335408,0.00013206035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001694513,0.0003612097,0.7708614,0.00054002414,0.0003156225,0.00017172849,0.001288553,0.00008990654,0.023880616,0.000011075204,0.00038631057,0.20039907],"study_design_scores_gemma":[0.0033327565,0.0021025466,0.9312636,0.0008083995,0.00003588404,7.949559e-7,0.00031719258,0.0018092671,0.059374236,0.000011508421,0.0006544097,0.00028939423],"about_ca_topic_score_codex":0.00041196155,"about_ca_topic_score_gemma":0.00008751911,"teacher_disagreement_score":0.20010968,"about_ca_system_score_codex":0.00010423624,"about_ca_system_score_gemma":0.00016458417,"threshold_uncertainty_score":0.9333986},"labels":[],"label_agreement":null},{"id":"W4381377543","doi":"10.2337/db23-408-p","title":"408-P: Associations between Apolipoprotein B (apoB): Apolipoprotein A1 (apoA1) Ratio and Metabolic and Kidney Disease in Youth with Type 1 Diabetes","year":2023,"lang":"en","type":"article","venue":"Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Apolipoprotein B; Renal function; Internal medicine; Endocrinology; Apolipoprotein A1; Creatinine; Medicine; Albuminuria; Lipoprotein; Kidney disease; Diabetes mellitus; Chemistry; Cholesterol","score_opus":0.01714876661546078,"score_gpt":0.24949561940446485,"score_spread":0.23234685278900408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381377543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99192125,0.0036380163,0.000009852341,0.0019314081,0.000073818206,0.0015930238,0.0004926687,0.00021023916,0.0001297548],"genre_scores_gemma":[0.9964917,0.00047826435,0.0002878175,0.0006574268,0.0005552461,0.00022654007,0.0010153113,0.00008009156,0.00020764374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732524,0.00020057577,0.00042952923,0.00060926285,0.00060512125,0.00083026977],"domain_scores_gemma":[0.99817604,0.000105845,0.00013389176,0.0005775051,0.00013500881,0.00087173795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010028918,0.00035618883,0.00092234206,0.0004188355,0.00021535993,0.00009706957,0.00010404946,0.00016395311,0.000023964256],"category_scores_gemma":[0.00075939944,0.00029106598,0.00012104796,0.0011102222,0.00016544289,0.00022386711,0.00011680434,0.00035287775,0.000028824243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032787993,0.00006601287,0.9856856,0.00033108285,0.00045723183,0.00001351891,0.00068779825,0.000007333935,0.0011979513,0.00021812008,0.00020799128,0.011094593],"study_design_scores_gemma":[0.002543384,0.0002669879,0.9864199,0.00036989225,0.0006008853,5.200865e-7,0.00016077374,0.0004065561,0.0069277547,0.0004592068,0.0014133044,0.00043081894],"about_ca_topic_score_codex":0.0009829261,"about_ca_topic_score_gemma":0.000045251356,"teacher_disagreement_score":0.010663775,"about_ca_system_score_codex":0.00006961319,"about_ca_system_score_gemma":0.00033031334,"threshold_uncertainty_score":0.99995416},"labels":[],"label_agreement":null},{"id":"W4381431693","doi":"10.1016/j.cjcpc.2023.06.002","title":"Cascade Screening in Familial Hypercholesterolemia: Achieving Buy-In and Turning Patients Into Partners","year":2023,"lang":"en","type":"editorial","venue":"CJC Pediatric and Congenital Heart Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Stollery Children's Hospital; University of Alberta","funders":"","keywords":"Familial hypercholesterolemia; Cascade; Medicine; Business; Internal medicine; Engineering; Cholesterol; Chemical engineering","score_opus":0.010965750176301673,"score_gpt":0.28118212986202556,"score_spread":0.2702163796857239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381431693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91642714,0.0112407645,0.000004129991,0.00010463841,0.071185574,0.0008106527,0.00013065943,0.000066070126,0.000030383291],"genre_scores_gemma":[0.75176764,0.0031653163,0.00006593186,0.00013826952,0.24390803,0.00015156246,0.00053619244,0.00010921591,0.00015787242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678046,0.00018337037,0.00059959304,0.00085416966,0.0009253258,0.00065710663],"domain_scores_gemma":[0.9981825,0.00035779865,0.000093604,0.0003613327,0.00013471095,0.00087009213],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006437904,0.0004461642,0.0009336766,0.0005068125,0.00015434266,0.00007598007,0.00009166973,0.0005965528,0.0000033944345],"category_scores_gemma":[0.0013929901,0.0004340461,0.00018796799,0.00052350835,0.00009546484,0.00017385367,0.0002313122,0.0013590062,0.000012782082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011377318,0.00017802256,0.920028,0.0024606383,0.00008036536,0.000803915,0.00063505286,0.000005735015,0.000002832956,7.942284e-7,0.051549807,0.023117106],"study_design_scores_gemma":[0.0074317106,0.00029829232,0.95732284,0.00044113473,0.00064053026,0.000005936549,0.00035857898,0.000104644154,3.0280776e-7,0.000018451756,0.032764938,0.0006126446],"about_ca_topic_score_codex":0.0013734755,"about_ca_topic_score_gemma":0.00022850717,"teacher_disagreement_score":0.17272246,"about_ca_system_score_codex":0.00013982238,"about_ca_system_score_gemma":0.0006439259,"threshold_uncertainty_score":0.9998111},"labels":[],"label_agreement":null},{"id":"W4381853615","doi":"10.1016/j.numecd.2023.06.014","title":"Relationship between lifestyle habits and cardiovascular risk factors in familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Nutrition Metabolism and Cardiovascular Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Gerontology; Environmental health; Demography; Internal medicine; Cholesterol; Sociology","score_opus":0.02268232980507117,"score_gpt":0.25545824693619384,"score_spread":0.23277591713112267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381853615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85480917,0.1429257,0.00019013238,0.00008754264,0.00016377041,0.001175762,0.0003552695,0.0002258604,0.00006682774],"genre_scores_gemma":[0.9719948,0.02590102,0.00015498012,0.00005813259,0.0011018795,0.00026244618,0.00043105887,0.000070825605,0.00002482153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99591315,0.00081337214,0.0005166852,0.0009376759,0.0012388078,0.0005803333],"domain_scores_gemma":[0.99781454,0.00020343655,0.000059682545,0.0011572022,0.0001269986,0.0006381328],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016406183,0.00041535735,0.0016153586,0.00060289487,0.0003371892,0.00008564052,0.00010641959,0.0002980264,0.0000068076665],"category_scores_gemma":[0.0006160196,0.00038151804,0.0019846258,0.0009884808,0.00018556027,0.00032054845,0.0001192791,0.0004885249,0.000023452654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005945396,0.00010571725,0.97141516,0.0007729408,0.0018463907,0.00010315949,0.00020435828,0.0000883171,0.000012453624,0.000078199984,0.0001387617,0.025175074],"study_design_scores_gemma":[0.0059170905,0.000059210008,0.96392953,0.00017064187,0.004932411,0.000049232058,0.00062652776,0.000020678772,0.00006897131,0.00040989398,0.023447448,0.000368363],"about_ca_topic_score_codex":0.0007404322,"about_ca_topic_score_gemma":0.000010112082,"teacher_disagreement_score":0.1171857,"about_ca_system_score_codex":0.0000415286,"about_ca_system_score_gemma":0.00010487922,"threshold_uncertainty_score":0.9998637},"labels":[],"label_agreement":null},{"id":"W4381892635","doi":"10.2337/db23-189-lb","title":"189-LB: LDL Cholesterol Reduction and Cardiovascular Outcomes in High-Risk Primary Prevention Patients","year":2023,"lang":"en","type":"article","venue":"Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Hazard ratio; Population; Diabetes mellitus; Myocardial infarction; Stroke (engine); Adverse effect; Guideline; Primary prevention; Cholesterol; Clinical trial; Physical therapy; Disease; Confidence interval; Endocrinology","score_opus":0.009036125210003165,"score_gpt":0.23034019715280662,"score_spread":0.22130407194280347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381892635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973961,0.0011033815,0.000010496532,0.0001210205,0.0002882726,0.00084383396,0.000009988925,0.00011027215,0.00011661595],"genre_scores_gemma":[0.9984198,0.00073378906,0.000113185444,0.00007582488,0.00015821238,0.00013393762,0.000157842,0.00002904549,0.00017832429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984763,0.00015765068,0.00025640216,0.00034343314,0.00046901897,0.00029718783],"domain_scores_gemma":[0.9992995,0.000018585484,0.000055215787,0.00047469002,0.000054434397,0.00009757687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085068925,0.00014317012,0.0005353304,0.00020727151,0.0000695976,0.00001979311,0.00004188789,0.000100198034,0.000005936462],"category_scores_gemma":[0.000078065386,0.00012290555,0.0003032446,0.00031518107,0.000034794994,0.00016398152,0.00005298028,0.00017829299,0.00003268689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009832337,0.00009763079,0.7783654,0.00025551938,0.00045051062,0.0000034075297,0.00013282963,0.000035370595,0.000118040516,0.000008642038,0.00006869931,0.22045414],"study_design_scores_gemma":[0.00273701,0.00018986031,0.9948067,0.00011557948,0.00024262644,0.0000014393836,0.00006452521,0.000029298531,0.0006181877,0.00023189887,0.00084584684,0.00011699553],"about_ca_topic_score_codex":0.00035298502,"about_ca_topic_score_gemma":0.0000066030775,"teacher_disagreement_score":0.22033715,"about_ca_system_score_codex":0.00007226873,"about_ca_system_score_gemma":0.000034725806,"threshold_uncertainty_score":0.5011943},"labels":[],"label_agreement":null},{"id":"W4382050264","doi":"10.22374/cjgim.v18i1.662","title":"Évaluation de l’application des lignes directrices de dyslipidémie de la Société canadienne de cardiologie publiées en 2021 quant au dosage de la lipoprotéine (a) au CHUS en 2021","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of General Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"Université de Sherbrooke","keywords":"Medicine; Dyslipidemia; Medical prescription; Internal medicine; Obesity; Pharmacology","score_opus":0.024103734109161595,"score_gpt":0.3178451744344348,"score_spread":0.29374144032527316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382050264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767332,0.0048299506,0.0073947622,0.0067322114,0.00049351127,0.00035337152,0.000021211308,0.00002320674,0.003418576],"genre_scores_gemma":[0.98210967,0.0029496746,0.0027982353,0.0007041321,0.010386208,0.000076166165,0.000034148597,0.000053249903,0.00088852434],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957186,0.0015053642,0.00067737995,0.00029639454,0.00045517093,0.0013470759],"domain_scores_gemma":[0.99610496,0.0006445913,0.00030976813,0.00035252306,0.00033483692,0.0022533508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014058331,0.00029211992,0.0007716938,0.0007141423,0.00026191014,0.00006890292,0.0003999204,0.00034741362,0.00014065346],"category_scores_gemma":[0.0044988673,0.00023778167,0.00030925756,0.00057905726,0.00036222086,0.00014316791,0.000031968746,0.00082178914,0.0000065792487],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00030365193,0.000060114642,0.26510647,0.00039150368,0.0015329873,0.004701704,0.017270528,0.003203057,0.062675215,0.0005971855,0.011022887,0.6331347],"study_design_scores_gemma":[0.0040837503,0.0015588156,0.9128497,0.001674614,0.0011654674,0.011327942,0.0053295232,0.007857301,0.0090187965,0.003921874,0.040741503,0.0004706971],"about_ca_topic_score_codex":0.53709424,"about_ca_topic_score_gemma":0.23079076,"teacher_disagreement_score":0.6477433,"about_ca_system_score_codex":0.007910717,"about_ca_system_score_gemma":0.013804541,"threshold_uncertainty_score":0.9958977},"labels":[],"label_agreement":null},{"id":"W4382137049","doi":"10.1186/s13054-023-04535-1","title":"Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1","year":2023,"lang":"en","type":"article","venue":"Critical Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"National Institute of General Medical Sciences; National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases; Cincinnati Children’s Research Foundation","keywords":"PCSK9; Medicine; Sepsis; Internal medicine; Endothelial dysfunction; Confounding; Lipoprotein; Immunology; LDL receptor; Oncology; Endocrinology; Cholesterol","score_opus":0.017669283977053897,"score_gpt":0.3174560023815264,"score_spread":0.29978671840447246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382137049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631184,0.0011576926,0.000023528077,0.0013203326,0.00018758191,0.00082560163,0.000037012298,0.000031796073,0.00010460953],"genre_scores_gemma":[0.9986456,0.000041453706,0.00003342909,0.0010107611,0.00014229666,0.00008662916,0.000015871097,0.00001812515,0.00000585673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790764,0.00035631377,0.0002941163,0.00026889876,0.0008868343,0.00028622558],"domain_scores_gemma":[0.99808925,0.0010608523,0.000038686172,0.00045348713,0.00023720115,0.00012052169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007089318,0.00013312616,0.0003430151,0.00022522434,0.000051352356,0.000008405977,0.000119901684,0.00013439007,0.000011889093],"category_scores_gemma":[0.0039965096,0.00009669513,0.00019246382,0.001270504,0.000073303156,0.000038631257,0.0000616364,0.00026220427,0.000058477486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012397232,0.0013020262,0.8956845,0.016808363,0.0002301084,0.0033763119,0.022157716,0.00015220635,0.041590665,0.0012723178,0.0012884882,0.003740101],"study_design_scores_gemma":[0.0014946288,0.0018229667,0.9779315,0.0003331681,0.00018855248,0.000015555483,0.0052437023,0.0000026757245,0.012597592,0.00004538816,0.00021399427,0.00011025517],"about_ca_topic_score_codex":0.00014918139,"about_ca_topic_score_gemma":0.000012142146,"teacher_disagreement_score":0.082247056,"about_ca_system_score_codex":0.0001141348,"about_ca_system_score_gemma":0.00012702894,"threshold_uncertainty_score":0.4784484},"labels":[],"label_agreement":null},{"id":"W4382181832","doi":"10.1097/ms9.0000000000000797","title":"Prevalence of hypercholesterolaemia in outpatient children aged 9–11 years","year":2023,"lang":"en","type":"article","venue":"Annals of Medicine and Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Dyslipidemia; Body mass index; Family history; Outpatient clinic; Internal medicine; Cross-sectional study; Pediatrics; Disease; Observational study; Lipid profile; Blood lipids; Cholesterol; Pathology","score_opus":0.07397568766333772,"score_gpt":0.32213496397198116,"score_spread":0.24815927630864343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382181832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934324,0.0034431373,0.0000017708076,0.0027135867,0.00006604411,0.00024630874,0.0000061686014,0.000016216081,0.00007434034],"genre_scores_gemma":[0.9887286,0.010063474,0.000009579185,0.0009539647,0.000114373535,0.000008889198,0.00001907415,0.000010578359,0.000091487906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986886,0.00007751436,0.00044211262,0.00017004981,0.00042204914,0.00019970376],"domain_scores_gemma":[0.99928355,0.00014618722,0.00009677855,0.00028915145,0.00007258955,0.00011174051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021018637,0.00008628728,0.0005719924,0.00034517224,0.000011563769,0.000001055659,0.00004109277,0.00007077086,0.000023967947],"category_scores_gemma":[0.00037666503,0.000067033296,0.00012555382,0.00037801714,0.00013469896,0.000039545594,0.00002793855,0.00011791581,0.0000022449242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006543134,0.00005347568,0.9552099,0.00085905875,0.00005131163,0.00004292362,0.0006970276,0.0000014190393,0.0002515163,0.000010475683,0.008571458,0.034186006],"study_design_scores_gemma":[0.0006915497,0.00018409938,0.9967858,0.0011564455,0.000035022076,0.000021321935,0.00014660263,0.000004333666,0.0004988166,0.00003229714,0.00039592595,0.0000477662],"about_ca_topic_score_codex":0.00061304634,"about_ca_topic_score_gemma":0.000013646647,"teacher_disagreement_score":0.04157592,"about_ca_system_score_codex":0.0000042840416,"about_ca_system_score_gemma":0.00006891204,"threshold_uncertainty_score":0.27335384},"labels":[],"label_agreement":null},{"id":"W4382344170","doi":"10.1161/strokeaha.123.042621","title":"More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL &lt;70 mg/dL After a Stroke","year":2023,"lang":"en","type":"article","venue":"Stroke","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Interquartile range; Stroke (engine); Internal medicine; Ezetimibe; Cholesterol; Myocardial infarction; Cardiology; Statin","score_opus":0.007268739059564913,"score_gpt":0.2349034352663626,"score_spread":0.2276346962067977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382344170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971288,0.00016808542,0.0000339707,0.0006984336,0.00025732868,0.001190775,0.00008104519,0.00007907062,0.00036249356],"genre_scores_gemma":[0.99764675,0.000070324335,0.00023983844,0.00017936487,0.0002984588,0.00023533555,0.00014622351,0.00004808666,0.0011356169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978409,0.00008924114,0.00032806324,0.00045509916,0.00075068517,0.0005360102],"domain_scores_gemma":[0.99912184,0.000006180276,0.000059878603,0.00056070485,0.00007317539,0.00017823037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003864553,0.00022154083,0.00043528297,0.00036254563,0.000041484844,0.000021525035,0.00008268182,0.00013271687,0.000054656797],"category_scores_gemma":[0.00002280206,0.00017673774,0.00015270534,0.00038345574,0.000052728297,0.00013448777,0.00005510418,0.0003926797,0.000062215135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011339063,0.00033147843,0.98774606,0.00021818714,0.0001175585,0.00009598062,0.0017350034,0.00017352859,0.00034790728,0.0000045781494,0.00027167232,0.007824148],"study_design_scores_gemma":[0.0052975095,0.0004994454,0.98965555,0.00025863503,0.000042435287,0.000011901303,0.00074409595,0.00008440043,0.00030670868,0.0000051748984,0.0029242658,0.00016986819],"about_ca_topic_score_codex":0.0006364791,"about_ca_topic_score_gemma":0.00027711317,"teacher_disagreement_score":0.00765428,"about_ca_system_score_codex":0.00026920091,"about_ca_system_score_gemma":0.00012034707,"threshold_uncertainty_score":0.7207156},"labels":[],"label_agreement":null},{"id":"W4382929792","doi":"10.1016/j.phrs.2023.106843","title":"Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor","year":2023,"lang":"en","type":"review","venue":"Pharmacological Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Oesterreichische Nationalbank; Heart and Stroke Foundation of Canada","keywords":"Lipoprotein(a); Medicine; Mendelian randomization; Lipoprotein; Internal medicine; Risk factor; Population; Disease; Atherosclerotic cardiovascular disease; Cardiology; Endocrinology; Cholesterol; Gene; Genetics; Biology; Genotype; Genetic variants","score_opus":0.2892836146462406,"score_gpt":0.5301903918802375,"score_spread":0.24090677723399695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382929792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058205426,0.985208,0.00006119068,0.00019768153,0.0002520118,0.0069221994,0.000059124388,0.0002833512,0.0011959407],"genre_scores_gemma":[0.00075343833,0.99275845,0.00041669534,0.00010231034,0.0022390294,0.0017949252,0.000042114847,0.00014832837,0.0017447001],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99195147,0.0018773447,0.0009014136,0.0013509701,0.0022455954,0.0016732013],"domain_scores_gemma":[0.9958473,0.001483345,0.00017230559,0.00053000933,0.0003812199,0.0015858415],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008859056,0.00054683466,0.0025515822,0.00070280995,0.0006783986,0.00016623676,0.00040987923,0.00058763166,0.00063799415],"category_scores_gemma":[0.0070540737,0.00037684044,0.0008665003,0.0017357743,0.00017111766,0.00006953327,0.001335437,0.0044253594,0.0017055963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008411659,0.00008825485,0.000015044098,0.017203938,0.0010806101,0.00097168225,0.00010273181,4.2064627e-7,0.00013959309,0.00002632728,0.0011587281,0.97912854],"study_design_scores_gemma":[0.0006788384,0.00088913273,0.00009893902,0.0077414294,0.0011593397,0.00014340905,0.00009034249,0.000016376516,0.00016864247,0.0000650334,0.9885118,0.00043670484],"about_ca_topic_score_codex":0.0020271982,"about_ca_topic_score_gemma":0.00004098908,"teacher_disagreement_score":0.9873531,"about_ca_system_score_codex":0.00066278584,"about_ca_system_score_gemma":0.0012506258,"threshold_uncertainty_score":0.99986833},"labels":[],"label_agreement":null},{"id":"W4383314163","doi":"10.21203/rs.3.rs-3105862/v1","title":"Association of LDL-cholesterol subtractions with cardiovascular disorders: A systematic review","year":2023,"lang":"en","type":"review","venue":"Research Square","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Systematic review; Scopus; Web of science; MEDLINE; Biomarker; Disease; Internal medicine","score_opus":0.09303388458307635,"score_gpt":0.42503317074830943,"score_spread":0.3319992861652331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383314163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000017314892,0.9828945,0.000049591024,0.00021554281,0.000060724185,0.016127193,0.000085505504,0.00010275154,0.0004624754],"genre_scores_gemma":[0.0000109778675,0.99291337,0.000028070332,0.000017634677,0.00024807264,0.004305915,0.0002408983,0.00016162741,0.0020734654],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9895029,0.0030696848,0.0012264174,0.0006447434,0.004828753,0.0007275001],"domain_scores_gemma":[0.9948016,0.000709536,0.000531534,0.0025410806,0.0011242612,0.00029198432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012969621,0.00040829004,0.006247246,0.00067543314,0.00017833117,0.000044944754,0.0002760095,0.00043572066,0.000032127286],"category_scores_gemma":[0.0029335718,0.0002637817,0.0036578842,0.0027166747,0.00006999812,0.00009201511,0.00010853565,0.001548536,0.00034173156],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000040860336,0.00009386786,0.000011193634,0.93634075,0.008317069,0.000038433263,0.000022078493,4.9548674e-7,1.3588185e-8,0.000012280913,0.00071896217,0.054440767],"study_design_scores_gemma":[0.0002870635,0.00022777755,0.000024718587,0.647516,0.012539814,0.00008768057,0.00006302568,7.02393e-7,9.1510806e-8,0.0000036274291,0.3391023,0.00014721493],"about_ca_topic_score_codex":0.0005380984,"about_ca_topic_score_gemma":0.00015054812,"teacher_disagreement_score":0.33838332,"about_ca_system_score_codex":0.0010990828,"about_ca_system_score_gemma":0.0014886718,"threshold_uncertainty_score":0.99998146},"labels":[],"label_agreement":null},{"id":"W4383370678","doi":"10.1186/s12886-023-03065-2","title":"Correction: Effect of alirocumab on cataracts in patients with acute coronary syndromes","year":2023,"lang":"en","type":"erratum","venue":"BMC Ophthalmology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"","keywords":"Medicine; Cataracts; Alirocumab; Acute coronary syndrome; MEDLINE; Internal medicine; Intensive care medicine; Cardiology; Ophthalmology; Myocardial infarction","score_opus":0.015822180214031766,"score_gpt":0.28688784562468883,"score_spread":0.2710656654106571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383370678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97035104,0.00047956823,0.0000015154728,0.000034493856,0.021414269,0.0017801936,0.00006788893,0.000058492347,0.0058125453],"genre_scores_gemma":[0.88636273,0.0001667619,0.000048967384,0.000067378154,0.0008160496,0.0003112267,0.0036601415,0.00021343495,0.108353294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997309,0.00038718313,0.00046605914,0.0006588539,0.0007086568,0.00047019418],"domain_scores_gemma":[0.99826384,0.00022176719,0.000285283,0.00096373836,0.00011966221,0.00014573184],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004640094,0.00044390003,0.0017421407,0.000457837,0.000047671863,0.0000052483633,0.00016650053,0.000801057,0.000108043],"category_scores_gemma":[0.00018193865,0.00032483035,0.0003318807,0.00043212736,0.00011342658,0.0000370648,0.00008250857,0.0011070048,0.00012624435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009624561,0.00067721825,0.7563858,0.0035949764,0.0018456903,0.0070785633,0.00006888211,0.000024927886,8.19464e-7,0.0000053781578,0.21794243,0.0027507432],"study_design_scores_gemma":[0.004705644,0.015055702,0.9702333,0.0014615263,0.0005682559,0.0044601853,0.000009601219,0.000009568417,0.000014785242,0.0000046140863,0.0032036207,0.00027317996],"about_ca_topic_score_codex":0.0008124213,"about_ca_topic_score_gemma":0.000039917202,"teacher_disagreement_score":0.21473882,"about_ca_system_score_codex":0.0002593314,"about_ca_system_score_gemma":0.0006763578,"threshold_uncertainty_score":0.99992037},"labels":[],"label_agreement":null},{"id":"W4383875510","doi":"10.1016/j.cmet.2023.06.011","title":"Inflammation and cholesterol at the crossroads of vascular risk","year":2023,"lang":"en","type":"letter","venue":"Cell Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"University of Toronto","keywords":"Inflammation; Residual risk; Cholesterol; Medicine; Internal medicine; Cardiology","score_opus":0.011099473480790972,"score_gpt":0.23336354520408034,"score_spread":0.22226407172328938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383875510","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81238306,0.04962026,0.00013920211,0.13111156,0.0017465045,0.0029204078,0.00013233455,0.00015590472,0.0017907949],"genre_scores_gemma":[0.052259583,0.15784189,0.0011437949,0.5256338,0.1052639,0.001593084,0.0033059756,0.0015884023,0.15136959],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976746,0.00029143176,0.00044887656,0.0004122397,0.0008356182,0.00033723647],"domain_scores_gemma":[0.9980932,0.00007435135,0.00033916798,0.0012763462,0.00013739268,0.00007956487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011619466,0.00029063295,0.00085985655,0.00013494956,0.0001617317,0.00003385153,0.00014737064,0.0005932078,0.00005474124],"category_scores_gemma":[0.00009010583,0.0001851599,0.0005671218,0.0002059817,0.00017674493,0.000044148277,0.00016148077,0.0012420394,0.00012136584],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007234301,0.0000423123,0.0014282751,0.0069255824,0.0023348557,0.00021569528,0.0018123358,0.000030148896,0.004016159,0.000020540725,0.84246063,0.14064114],"study_design_scores_gemma":[0.0012763841,0.000028035969,0.033787187,0.00009533169,0.0016001279,0.000026081192,0.000021297288,0.000014611563,0.005619684,0.000053225576,0.9573165,0.00016150576],"about_ca_topic_score_codex":0.00075424183,"about_ca_topic_score_gemma":0.000019777877,"teacher_disagreement_score":0.76012343,"about_ca_system_score_codex":0.000038476697,"about_ca_system_score_gemma":0.00009968305,"threshold_uncertainty_score":0.75506014},"labels":[],"label_agreement":null},{"id":"W4384497844","doi":"10.3389/fgene.2023.1248435","title":"Editorial: Rare dyslipidemias","year":2023,"lang":"en","type":"editorial","venue":"Frontiers in Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Javna Agencija za Raziskovalno Dejavnost RS; Ministero della Salute","keywords":"Medicine","score_opus":0.010082524601057904,"score_gpt":0.2727869356260614,"score_spread":0.26270441102500347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384497844","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003464568,0.010142493,0.0006227054,0.00013717354,0.98725384,0.0008846171,0.00017514791,0.00017799235,0.0005713723],"genre_scores_gemma":[0.0000037521045,0.014440494,0.006378183,0.000050257706,0.9748029,0.00011896042,0.0009415404,0.0002360824,0.0030277986],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954104,0.00015936913,0.00069782,0.0007524588,0.0022433437,0.0007366526],"domain_scores_gemma":[0.9976316,0.00018009808,0.00018530949,0.0013161507,0.0003649036,0.00032193304],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013597313,0.0004507277,0.0014110139,0.00040607862,0.000065455126,0.000038632003,0.00033656522,0.0025771225,0.000014546542],"category_scores_gemma":[0.002273353,0.0004409154,0.0004993927,0.0005409452,0.00008692154,0.000026362472,0.00015580177,0.0020776282,0.00009685219],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009710017,0.00003780112,0.00051626813,0.0007408924,0.0002698939,0.000090837195,0.00007367142,0.000025231766,0.0000017061916,7.8125515e-7,0.98730946,0.010836363],"study_design_scores_gemma":[0.0018323614,0.00020293448,0.00013890638,0.0004869357,0.00030860578,0.0000016895387,0.00010124063,0.000065827684,0.000016526415,0.00015226868,0.99631244,0.00038028785],"about_ca_topic_score_codex":0.00015492343,"about_ca_topic_score_gemma":0.00004010212,"teacher_disagreement_score":0.012450922,"about_ca_system_score_codex":0.00061785895,"about_ca_system_score_gemma":0.001651013,"threshold_uncertainty_score":0.99980426},"labels":[],"label_agreement":null},{"id":"W4384743216","doi":"10.1016/j.cjca.2023.07.018","title":"Lipoprotein(a): Solving the Puzzle, Deciphering the Riddle, Unraveling the Enigma","year":2023,"lang":"en","type":"editorial","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Alirocumab; Internal medicine; Lipoprotein; Cardiology; Atherosclerotic cardiovascular disease; Lipoprotein(a); Acute coronary syndrome; Revascularization; Disease; Cholesterol; Myocardial infarction","score_opus":0.017337709048451895,"score_gpt":0.2549477845033826,"score_spread":0.23761007545493074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384743216","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00076666154,0.021421036,0.001956998,0.009534521,0.96109945,0.0011202596,0.00007780671,0.000027740098,0.00399552],"genre_scores_gemma":[0.034516927,0.0027579917,0.00006163496,0.0003858079,0.9612953,0.00006271267,0.000025961013,0.00015251464,0.00074113806],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99539983,0.0009333959,0.0010154383,0.0003629189,0.0011967651,0.001091645],"domain_scores_gemma":[0.9940665,0.0020190005,0.00064687105,0.0015120239,0.0010436841,0.00071194186],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007983678,0.00044583896,0.0014837855,0.0002613269,0.0012676247,0.00016902493,0.0013161281,0.00093562953,0.000022732194],"category_scores_gemma":[0.007158262,0.00020664663,0.0016692248,0.00049779785,0.0005620526,0.000061011215,0.0001054558,0.0044834404,0.000045601202],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053726442,8.4157665e-7,0.000063038075,0.00010082592,0.0018890454,0.0008480822,0.00041871128,0.001156491,0.000007614298,0.00005584962,0.9739312,0.021474563],"study_design_scores_gemma":[0.00065757136,0.00018491733,0.00091879716,0.0004647149,0.00095850695,0.0011850293,0.0007820807,0.000017601793,0.000010171357,0.00017348012,0.9944393,0.00020784438],"about_ca_topic_score_codex":0.015608835,"about_ca_topic_score_gemma":0.023455007,"teacher_disagreement_score":0.033750266,"about_ca_system_score_codex":0.00062576664,"about_ca_system_score_gemma":0.008686576,"threshold_uncertainty_score":0.9978133},"labels":[],"label_agreement":null},{"id":"W4384820193","doi":"10.1007/s40261-023-01287-2","title":"Elevations in Creatine Kinase are Not Related to the Choice or Dose of Statins in Patients Taking Colchicine 0.5 mg Daily: Insights from the LoDoCo2 Trial","year":2023,"lang":"en","type":"letter","venue":"Clinical Drug Investigation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Medical Research Council; ZonMw; Teva Pharmaceutical Industries","keywords":"Medicine; Colchicine; Creatine kinase; Pharmacotherapy; Pharmacology; Simvastatin; Internal medicine; Intensive care medicine","score_opus":0.09666996585426156,"score_gpt":0.36331875718599727,"score_spread":0.2666487913317357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384820193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7309256,0.000059538568,0.0000058264204,0.2634858,0.0008035216,0.004455324,0.00017717417,0.000042619227,0.000044609642],"genre_scores_gemma":[0.54993874,0.00017310613,0.00037156368,0.43513542,0.0063120048,0.00091053965,0.005828911,0.0001738352,0.0011558919],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9930363,0.0020532683,0.0026282226,0.0007452736,0.0011735529,0.00036334],"domain_scores_gemma":[0.99143183,0.0053215274,0.0013741187,0.0013293697,0.00037274076,0.00017042273],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0026202695,0.00036101573,0.001257969,0.00027230443,0.00014380887,0.000035824443,0.0003852364,0.0007156039,0.000045763813],"category_scores_gemma":[0.023360822,0.00020462155,0.0003361856,0.0016969346,0.0002660925,0.000094366216,0.00015153915,0.0031856855,0.000056340054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018746186,0.0014205072,0.3046698,0.0011238133,0.0010509552,0.00039486313,0.010317724,0.0006659016,0.000051433704,0.00014853265,0.64410365,0.017306656],"study_design_scores_gemma":[0.037005633,0.00073796563,0.91120267,0.0028281726,0.00032581342,5.8590217e-7,0.00022352865,0.0004632729,0.000027556724,0.0004616631,0.0464634,0.0002597337],"about_ca_topic_score_codex":0.008002385,"about_ca_topic_score_gemma":0.008453857,"teacher_disagreement_score":0.6065329,"about_ca_system_score_codex":0.00025323586,"about_ca_system_score_gemma":0.000761438,"threshold_uncertainty_score":0.999114},"labels":[],"label_agreement":null},{"id":"W4384926342","doi":"10.1172/jci165370","title":"Cell-free, high-density lipoprotein–specific phospholipid efflux assay predicts incident cardiovascular disease","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Investigation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"NIH Clinical Center; Department of Medicine, Georgetown University; National Institutes of Health; NHLBI Division of Intramural Research; McGill University; McGill University Health Centre; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; Hjärt-Lungfonden; Karolinska Institutet; Georgetown University; George Washington University; AstraZeneca","keywords":"Phospholipid; Disease; Cholesterol; Tangier disease; High-density lipoprotein; Lipoprotein; Efflux; Reverse cholesterol transport; Cell; Chemistry; ABCA1; Medicine; Biochemistry; Internal medicine; Membrane","score_opus":0.053473355394074606,"score_gpt":0.31273144003463843,"score_spread":0.2592580846405638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384926342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98785716,0.0035069445,0.0015845167,0.0034468991,0.002441585,0.0008280892,0.000012171023,0.000117043215,0.00020559588],"genre_scores_gemma":[0.9854586,0.0039923466,0.0023189748,0.00091996114,0.0068649515,0.000022106466,0.000053558208,0.000060374714,0.0003091279],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9931599,0.000956333,0.0022479724,0.00047520705,0.0027360031,0.00042461706],"domain_scores_gemma":[0.99455017,0.00037180033,0.00094467617,0.0015666871,0.0009238589,0.0016427861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013908844,0.00028121046,0.0014379093,0.00026586873,0.00016235646,0.00006359956,0.00034349094,0.00032254038,0.000059605052],"category_scores_gemma":[0.005858817,0.00022523686,0.0022454888,0.00076182437,0.00026277287,0.00029242306,0.00017063244,0.0011667132,0.00016854472],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046208138,0.0021572232,0.250556,0.0033977674,0.009402745,0.0071524335,0.0010288749,0.0066271606,0.0025037513,0.0011413522,0.29649037,0.41492152],"study_design_scores_gemma":[0.0071930666,0.0007833671,0.9480981,0.00059704215,0.0014270941,0.00014254716,0.000075884804,0.0005125084,0.004916863,0.0036736657,0.03230335,0.00027647585],"about_ca_topic_score_codex":0.0003301389,"about_ca_topic_score_gemma":0.00000437414,"teacher_disagreement_score":0.69754213,"about_ca_system_score_codex":0.00017736426,"about_ca_system_score_gemma":0.0010762713,"threshold_uncertainty_score":0.9184892},"labels":[],"label_agreement":null},{"id":"W4384945376","doi":"10.1016/j.jcct.2023.05.125","title":"Is There Gender Difference In Statin Prescription?","year":2023,"lang":"en","type":"article","venue":"Journal of cardiovascular computed tomography","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Coronary artery disease; Coronary angiography; Incidence (geometry); Medical prescription; Internal medicine; Cardiology; CAD; Statin; Angiography; Radiology; Myocardial infarction","score_opus":0.02782037771747172,"score_gpt":0.26429227958083235,"score_spread":0.23647190186336062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384945376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9454571,0.04246183,0.010001074,0.00031681373,0.00058152573,0.00054015237,0.000009553801,0.000087823355,0.00054410886],"genre_scores_gemma":[0.9940007,0.0032184198,0.0018212112,0.00025619607,0.0005922987,0.000011992885,0.000009150674,0.000042697968,0.000047330628],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965642,0.00032753852,0.0007256335,0.00030255792,0.0016494333,0.00043061152],"domain_scores_gemma":[0.9982675,0.000041161606,0.00018847927,0.00077763444,0.00044835877,0.0002769064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019740579,0.00023882957,0.00108798,0.0011950035,0.00006682572,0.000044881486,0.00022328606,0.00014870428,0.000029114719],"category_scores_gemma":[0.000042542182,0.0001895453,0.0034294801,0.0021995069,0.00006115738,0.00012172819,0.00006689105,0.00059399474,0.000018616338],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011381553,0.0013262485,0.39863408,0.0033434816,0.060895484,0.013005501,0.0068263626,0.016727598,0.001340123,0.00056135195,0.018764859,0.47743675],"study_design_scores_gemma":[0.0052998234,0.0003131853,0.9617527,0.0004008626,0.00080415775,0.00089208636,0.0003440875,0.0010259883,0.00038388968,0.0006420514,0.027903054,0.00023808984],"about_ca_topic_score_codex":0.00008118007,"about_ca_topic_score_gemma":0.0000023358803,"teacher_disagreement_score":0.56311864,"about_ca_system_score_codex":0.000068270296,"about_ca_system_score_gemma":0.00020599127,"threshold_uncertainty_score":0.77294326},"labels":[],"label_agreement":null},{"id":"W4385230700","doi":"10.1161/jaha.123.030405","title":"Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol","year":2023,"lang":"en","type":"review","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Apolipoprotein B; Ldl cholesterol; Cholesterol; Internal medicine; Standardization","score_opus":0.02723333980626674,"score_gpt":0.33796091303826514,"score_spread":0.3107275732319984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385230700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029468713,0.96485317,0.00060945546,0.001462108,0.00083305227,0.0025622672,0.00010616806,0.00003445997,0.00007060628],"genre_scores_gemma":[0.003650357,0.99444044,0.0002930331,0.00025677885,0.0009511735,0.0000197763,0.0000066973125,0.00007672079,0.0003050278],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99621433,0.00071118976,0.0012726665,0.00019614374,0.0013402124,0.0002654295],"domain_scores_gemma":[0.9953783,0.00018240607,0.00333286,0.00046670006,0.0004878733,0.0001518571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032798715,0.00026158013,0.003262332,0.00030175922,0.00009435718,0.000040953208,0.00016570365,0.00018505835,0.0000032043824],"category_scores_gemma":[0.0008238121,0.0001680089,0.0014673551,0.00081103476,0.000079730395,0.00011027843,0.00008570831,0.00070860126,0.0000071258246],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055972785,0.00008961883,0.0043885354,0.009286016,0.0021447937,0.000006116795,0.00016456505,0.00001511383,0.000042725398,0.0000029058815,0.0021680961,0.9816355],"study_design_scores_gemma":[0.0014755453,0.00113734,0.039944857,0.024266161,0.005361604,0.000474329,0.00012576781,0.000009962911,0.00006879701,0.000040916122,0.92679685,0.00029788326],"about_ca_topic_score_codex":0.0003086496,"about_ca_topic_score_gemma":0.000022278411,"teacher_disagreement_score":0.98133767,"about_ca_system_score_codex":0.00085922267,"about_ca_system_score_gemma":0.000742237,"threshold_uncertainty_score":0.6851204},"labels":[],"label_agreement":null},{"id":"W4385326828","doi":"10.1016/j.pcad.2023.07.006","title":"Lipoprotein(a) in clinical practice: A guide for the clinician","year":2023,"lang":"en","type":"review","venue":"Progress in Cardiovascular Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lipoprotein(a); Atherosclerotic cardiovascular disease; Disease; Epidemiology; Risk factor; Lipoprotein; Intensive care medicine; Genetic epidemiology; Concomitant; Bioinformatics; Internal medicine; Cholesterol","score_opus":0.10232902979038129,"score_gpt":0.4677233243285376,"score_spread":0.3653942945381563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385326828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000036215633,0.9804389,0.00014121275,0.00041436218,0.0009760875,0.017417094,0.00019285908,0.00021576525,0.00020012549],"genre_scores_gemma":[0.000014740049,0.9764474,0.0013307947,0.00022862064,0.0042165066,0.01692489,0.00029134072,0.00034181518,0.00020390183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98962134,0.0021298656,0.0033726988,0.0017603998,0.0019708765,0.0011448355],"domain_scores_gemma":[0.9915321,0.002814793,0.00065291877,0.0041700676,0.0003671433,0.00046301153],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.014603484,0.0008840218,0.007353308,0.00055799435,0.00017521648,0.00013315829,0.0008014229,0.00091104576,0.00001041919],"category_scores_gemma":[0.008369253,0.0005833906,0.015998758,0.0017227037,0.000413946,0.00015671272,0.0003978082,0.0016204403,0.00010377029],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013974535,0.000518517,0.00070122955,0.03778935,0.012451541,0.0011975312,0.000018009972,0.0000059204294,1.15893566e-10,0.00005205063,0.001449876,0.9456762],"study_design_scores_gemma":[0.0027884496,0.00022797428,0.0032673934,0.023470955,0.026221713,0.0002442069,0.00011160741,0.000035906636,2.017455e-8,0.00005121977,0.9430152,0.00056535314],"about_ca_topic_score_codex":0.00031255567,"about_ca_topic_score_gemma":0.00010069352,"teacher_disagreement_score":0.94511086,"about_ca_system_score_codex":0.00044547685,"about_ca_system_score_gemma":0.0026788553,"threshold_uncertainty_score":0.99998367},"labels":[],"label_agreement":null},{"id":"W4385337529","doi":"10.1016/j.atherosclerosis.2023.117192","title":"Evaluation of the efficacy and safety of bempedoic acid in women and men: Pooled analyses from phase 3 trials","year":2023,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"Esperion Therapeutics; Ministero della Salute","keywords":"Medicine; Placebo; Internal medicine; Apolipoprotein B; Statin; Atherosclerotic cardiovascular disease; Cholesterol; Familial hypercholesterolemia; Endocrinology; Lipoprotein; Gastroenterology; Disease","score_opus":0.13788346869342513,"score_gpt":0.39684265422226217,"score_spread":0.258959185528837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385337529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970002,0.0015956794,0.000014026356,0.0003006546,0.000035732264,0.0009203213,0.00005639133,0.0000117330355,0.00006523984],"genre_scores_gemma":[0.99839383,0.0013633275,0.00004607277,0.000054094853,0.00004932361,0.000059383205,0.000010603794,0.000011840514,0.000011527704],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978657,0.00069851376,0.00047317505,0.00019113522,0.00063274836,0.00013878042],"domain_scores_gemma":[0.999081,0.00020828746,0.00018036464,0.0003674313,0.000101852915,0.00006105063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064574913,0.00009405,0.00063966395,0.00008569828,0.000038838385,0.0000060832936,0.000050571056,0.00006666783,0.00006104169],"category_scores_gemma":[0.001037465,0.000059536284,0.0001205205,0.00043903282,0.000072461335,0.000034611207,0.00004857506,0.00007055068,0.0000011121676],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067550025,0.0002605766,0.0086656045,0.000098299315,0.00089496543,3.4877905e-7,0.0052020154,0.000036010715,0.7799718,0.000008888902,0.000059281374,0.20412673],"study_design_scores_gemma":[0.019978177,0.00028087953,0.9038087,0.0002865995,0.0010498135,5.25406e-7,0.0010147465,0.0007190112,0.072483115,0.00024530716,0.000060081733,0.00007302803],"about_ca_topic_score_codex":0.0005858913,"about_ca_topic_score_gemma":0.000023345288,"teacher_disagreement_score":0.8951431,"about_ca_system_score_codex":0.000060916736,"about_ca_system_score_gemma":0.00010966066,"threshold_uncertainty_score":0.24278192},"labels":[],"label_agreement":null},{"id":"W4385378074","doi":"10.1016/j.hlc.2023.06.393","title":"Inter-Individual Variability in LDL-C Reductions With Inclisiran—Pooled Data From ORION-10 and ORION-11","year":2023,"lang":"en","type":"article","venue":"Heart Lung and Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Interquartile range; Placebo; Medicine; Pooled analysis; Internal medicine; Gastroenterology; Ldl cholesterol; Cholesterol; Confidence interval","score_opus":0.040410087759146146,"score_gpt":0.3032638088301344,"score_spread":0.26285372107098826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385378074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99619985,0.00029390186,0.0010715945,0.0015315354,0.00011482501,0.0005434385,0.00006196444,0.000085778855,0.000097128854],"genre_scores_gemma":[0.99805075,0.000060213246,0.00039106258,0.00009382318,0.00030227166,0.000025532318,0.0010050526,0.000015737909,0.00005557442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865943,0.0001709875,0.0002340504,0.00046874632,0.00028794797,0.00017884815],"domain_scores_gemma":[0.9990547,0.00008786311,0.000037094065,0.00064737856,0.00005573107,0.000117244505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013960047,0.00011092463,0.00027152273,0.000120184224,0.00013642864,0.00004073122,0.000044633034,0.00010149288,0.00006143098],"category_scores_gemma":[0.00015163787,0.00009432199,0.000030675994,0.00038171635,0.00005434142,0.00019915933,0.000087032764,0.00016802087,0.000010941884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018839356,0.00014868843,0.9590044,0.00033401634,0.00027525902,0.000027849099,0.0014430475,0.00008997277,0.00068926305,0.00020238117,0.0017475215,0.035849176],"study_design_scores_gemma":[0.0014299395,0.00006210229,0.98217314,0.00017120833,0.0002066431,0.000067478766,0.0002741618,0.010659648,0.000017811795,0.00038959522,0.004434323,0.000113918526],"about_ca_topic_score_codex":0.0018873027,"about_ca_topic_score_gemma":0.0003982683,"teacher_disagreement_score":0.035735257,"about_ca_system_score_codex":0.000052393585,"about_ca_system_score_gemma":0.00011939582,"threshold_uncertainty_score":0.38463393},"labels":[],"label_agreement":null},{"id":"W4385378164","doi":"10.1016/j.hlc.2023.06.408","title":"Pooled Safety Analysis of Inclisiran in 3,576 Patients With Approximately 10,000 Person Years of Exposure From Seven Trials","year":2023,"lang":"en","type":"article","venue":"Heart Lung and Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Pooled analysis; Clinical trial; PCSK9; Internal medicine; Meta-analysis; Cholesterol","score_opus":0.025549309748728103,"score_gpt":0.27681110012322035,"score_spread":0.25126179037449226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385378164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988732,0.00031428123,0.00007466775,0.000046345074,0.0000202696,0.0005014861,0.00008836682,0.000018061912,0.000063318024],"genre_scores_gemma":[0.9991798,0.000029552084,0.00010171799,0.000020031119,0.000032484157,0.000010263615,0.00060075,0.000010345691,0.000015071713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987371,0.00019476366,0.0003852377,0.00018885228,0.00038182896,0.0001122161],"domain_scores_gemma":[0.99943256,0.00007771669,0.00012785703,0.00022685587,0.000082619306,0.000052411888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010836328,0.00007473596,0.00071083487,0.00030397635,0.000024549701,0.0000049933424,0.000018869316,0.00008318828,0.000061419654],"category_scores_gemma":[0.00009836107,0.000063142514,0.00017104899,0.0008695406,0.000020129613,0.000048418227,0.000008465526,0.000061610175,0.0000012521225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000508881,0.00007870928,0.9805497,0.0001643328,0.0009436396,0.0000024244375,0.0017832193,0.0012253781,0.00065755873,0.000008272457,0.000018092182,0.0140597895],"study_design_scores_gemma":[0.0026374592,0.00011424645,0.99206424,0.00012294391,0.0011466878,4.2441212e-7,0.00030778453,0.003418829,0.00006078631,0.000009928487,0.000057230092,0.00005945538],"about_ca_topic_score_codex":0.0013815523,"about_ca_topic_score_gemma":0.00006821389,"teacher_disagreement_score":0.014000334,"about_ca_system_score_codex":0.00003458382,"about_ca_system_score_gemma":0.000040577444,"threshold_uncertainty_score":0.25748768},"labels":[],"label_agreement":null},{"id":"W4385378265","doi":"10.1016/j.hlc.2023.06.409","title":"Pooled Safety and Efficacy of Inclisiran in Patients With Statin Intolerance (ORION-10 and ORION-11)","year":2023,"lang":"en","type":"article","venue":"Heart Lung and Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Tolerability; Placebo; Medicine; myalgia; Statin; Adverse effect; Internal medicine; Clinical endpoint; Surrogate endpoint; Clinical trial; Gastroenterology","score_opus":0.007663772853429656,"score_gpt":0.24971695405608008,"score_spread":0.24205318120265043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385378265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986152,0.00044282616,0.00009345266,0.00023662589,0.000024258283,0.0005170407,0.000005536237,0.000022975579,0.000042091768],"genre_scores_gemma":[0.9996044,0.00010101983,0.00010284619,0.000052907802,0.000034436416,0.0000063882794,0.000063666164,0.000010823123,0.000023495026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991836,0.00005455535,0.00020827688,0.00019729006,0.0002321659,0.00012411972],"domain_scores_gemma":[0.99963343,0.000041436713,0.000044893175,0.00013925883,0.0000640679,0.0000769298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003602954,0.00008106082,0.00025784268,0.00010013597,0.000066216635,0.000009351321,0.0000093652425,0.000053785574,0.0000068215295],"category_scores_gemma":[0.000041993142,0.00006685601,0.000021714746,0.0002478729,0.000037443482,0.00006781472,0.000014989066,0.00007289688,0.0000010134871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003539096,0.000043655014,0.9687262,0.00031645666,0.000029862269,0.0000020182995,0.00065539085,0.00008924536,0.00010763591,0.00005992209,0.000016400529,0.029599315],"study_design_scores_gemma":[0.0046865945,0.00016532022,0.99231774,0.00023809307,0.000043313674,0.000005123227,0.000060288727,0.0019315348,0.00001650758,0.00002422036,0.00044167598,0.00006959325],"about_ca_topic_score_codex":0.000265239,"about_ca_topic_score_gemma":0.000047634072,"teacher_disagreement_score":0.02952972,"about_ca_system_score_codex":0.00002502451,"about_ca_system_score_gemma":0.000037442067,"threshold_uncertainty_score":0.2726309},"labels":[],"label_agreement":null},{"id":"W4385383685","doi":"10.1016/j.hlc.2023.06.348","title":"Baseline Triglycerides and Non-HDL-C and apoB Goal Attainment in the ORION-10 and ORION-11 Trials","year":2023,"lang":"en","type":"article","venue":"Heart Lung and Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Placebo; Quartile; Apolipoprotein B; Internal medicine; Medicine; Statin; Logistic regression; Gastroenterology; Cholesterol; Endocrinology; Confidence interval; Pathology","score_opus":0.031212746132827592,"score_gpt":0.3192350790929732,"score_spread":0.2880223329601456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385383685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216104,0.0032527344,0.00018968584,0.0033266027,0.00006800329,0.0009169179,0.000006047868,0.000027605503,0.000051373554],"genre_scores_gemma":[0.99758124,0.0014803509,0.000074585485,0.00034295264,0.0003386981,0.00005308567,0.000045764446,0.000012046987,0.0000712678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986912,0.0002646756,0.00031361182,0.0002737195,0.00027815998,0.0001786602],"domain_scores_gemma":[0.9993959,0.00023130955,0.00004971285,0.00018614506,0.00003317738,0.0001037228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040350016,0.000118285156,0.00039642552,0.00010897807,0.00016504363,0.000052414398,0.000014471074,0.00008781584,0.000015104537],"category_scores_gemma":[0.00021537778,0.000081035876,0.000054436565,0.0002153239,0.0000483515,0.00007460369,0.000022763563,0.000104263556,0.0000025927513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085259724,0.00018716717,0.7168205,0.0022177983,0.00028884964,0.000109534194,0.0057359757,0.000122241,0.006990229,0.0006277358,0.0053985505,0.26064885],"study_design_scores_gemma":[0.0032092414,0.00013609664,0.9750085,0.00015321966,0.0001461079,0.00017063497,0.0006644495,0.009497584,0.000057750258,0.00017975864,0.010658523,0.000118154836],"about_ca_topic_score_codex":0.0004221054,"about_ca_topic_score_gemma":0.000060861592,"teacher_disagreement_score":0.2605307,"about_ca_system_score_codex":0.000028146931,"about_ca_system_score_gemma":0.00004775116,"threshold_uncertainty_score":0.33045474},"labels":[],"label_agreement":null},{"id":"W4385472772","doi":"10.1016/j.amjcard.2023.07.029","title":"Major Adverse Cardiovascular Events After Colchicine Administration Before Percutaneous Coronary Intervention: Follow-Up of the Colchicine-PCI Trial","year":2023,"lang":"en","type":"article","venue":"The American Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Office of Research and Development; School of Medicine, New York University; York University; American Heart Association; U.S. Department of Veterans Affairs","keywords":"Conventional PCI; Medicine; Percutaneous coronary intervention; Restenosis; Placebo; Internal medicine; Adverse effect; Cardiology; Colchicine; Myocardial infarction; Hazard ratio; Acute coronary syndrome; Stent; Pathology","score_opus":0.013385782141690492,"score_gpt":0.27562925689363565,"score_spread":0.26224347475194515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385472772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993914,0.0011370056,0.00027436123,0.0018246545,0.0015997523,0.0010478955,0.00002482655,0.00002006052,0.00015740976],"genre_scores_gemma":[0.9971403,0.00035315863,0.00005796659,0.00029525708,0.0017838702,0.000036277375,0.000011320313,0.00003501691,0.0002868193],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9963447,0.0012450487,0.0009238029,0.00022739304,0.0009176823,0.00034141523],"domain_scores_gemma":[0.9976605,0.00011021114,0.0007152094,0.0009617147,0.00040394676,0.00014840192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027326723,0.00022640452,0.0015893374,0.00015543222,0.0001269179,0.0000047994945,0.00034604775,0.000089223926,0.00002926554],"category_scores_gemma":[0.0002696987,0.0001240351,0.0032718976,0.00063308753,0.0004963611,0.000052717125,0.00011352937,0.0005357397,0.000012545533],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.513564,0.00051179784,0.108331084,0.00094823353,0.05331235,0.010968352,0.0038072453,0.003574966,0.0028177262,0.00018885262,0.005294126,0.29668128],"study_design_scores_gemma":[0.076386996,0.03216615,0.7655651,0.0007726871,0.009581433,0.08798729,0.005807628,0.000057933463,0.00028995372,0.00041766177,0.020556001,0.000411177],"about_ca_topic_score_codex":0.00008302807,"about_ca_topic_score_gemma":0.000022534497,"teacher_disagreement_score":0.657234,"about_ca_system_score_codex":0.00012620396,"about_ca_system_score_gemma":0.00042362028,"threshold_uncertainty_score":0.5058004},"labels":[],"label_agreement":null},{"id":"W4385512546","doi":"10.33393/jcb.2018.2094","title":"Effect of statins on oxidative DNA damage in diabetic polyneuropathy","year":2018,"lang":"en","type":"article","venue":"Journal of Circulating Biomarkers","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Oxidative phosphorylation; Polyneuropathy; Oxidative damage; Medicine; Diabetes mellitus; Oxidative stress; Internal medicine; Chemistry; Endocrinology; Biochemistry","score_opus":0.010035006146698531,"score_gpt":0.2889960711975483,"score_spread":0.2789610650508497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385512546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99750507,0.00014197893,0.00011096212,0.00013122213,0.00021512041,0.00030065555,0.00000309318,0.0000070820192,0.0015847911],"genre_scores_gemma":[0.9992346,0.0000117603495,0.0003445524,0.00011512903,0.00025969496,0.0000017562165,0.000001492934,0.00002345429,0.000007540656],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978382,0.00052568986,0.0006342378,0.00014628677,0.0006235119,0.00023205834],"domain_scores_gemma":[0.9986078,0.00026987994,0.0005107607,0.00027766605,0.00018671743,0.00014713855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028262818,0.00014376685,0.0005895556,0.00035178612,0.00004313868,0.00000981045,0.0000893335,0.00006660807,0.00003289109],"category_scores_gemma":[0.0010267515,0.00010463311,0.00031007838,0.00040560844,0.00012763203,0.000072226256,0.000019804489,0.00024659306,0.000004498357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035316225,0.00041418953,0.25022537,0.0012856598,0.0011748774,0.001051216,0.0019635144,0.000042252163,0.5681252,0.00004158714,0.00026548252,0.17187907],"study_design_scores_gemma":[0.006398848,0.011404175,0.7888906,0.0018663675,0.00027671925,0.00033602832,0.0002522934,0.00049882906,0.18974075,0.00003307132,0.00013611917,0.00016617644],"about_ca_topic_score_codex":0.000049338694,"about_ca_topic_score_gemma":0.000004408503,"teacher_disagreement_score":0.53866524,"about_ca_system_score_codex":0.000120146615,"about_ca_system_score_gemma":0.00015201893,"threshold_uncertainty_score":0.42668143},"labels":[],"label_agreement":null},{"id":"W4385638734","doi":"10.1016/j.numecd.2023.07.036","title":"Prevalence and predictive role of hypertriglyceridemia in statin-treated patients at very high risk: Insights from the START study","year":2023,"lang":"en","type":"article","venue":"Nutrition Metabolism and Cardiovascular Diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"Menarini Group","keywords":"Hypertriglyceridemia; Medicine; Hazard ratio; Internal medicine; Statin; Cohort; Confidence interval; Proportional hazards model; Cohort study; Triglyceride; Cholesterol","score_opus":0.006310176764829685,"score_gpt":0.21039634315438568,"score_spread":0.204086166389556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385638734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8678968,0.12855113,0.0000055012374,0.000017188418,0.00007181557,0.0020249598,0.0013714142,0.000050078193,0.000011088826],"genre_scores_gemma":[0.9582098,0.040745012,0.0000234841,0.00003412215,0.00020096009,0.0003577468,0.000395322,0.000025880774,0.000007670524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718446,0.0007450317,0.00037748207,0.0005447642,0.00091169664,0.00023659303],"domain_scores_gemma":[0.99865943,0.00015303832,0.00009332631,0.0007080151,0.00018521267,0.00020098119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040301288,0.00022915324,0.0008484944,0.00014865026,0.00018468505,0.0000225121,0.00008270547,0.00008545441,0.000012270799],"category_scores_gemma":[0.0002126706,0.00016026432,0.000423709,0.00048297225,0.00013531742,0.00015542046,0.0001306395,0.00016664361,0.0000041742974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085124734,0.0007408197,0.9814546,0.00032878868,0.002030987,0.000037643178,0.00077298936,0.00003951881,0.000053033637,0.00001074387,0.00014001619,0.013539616],"study_design_scores_gemma":[0.008813504,0.0002303535,0.98348194,0.00018393683,0.0035041345,0.0000028923698,0.0015028882,0.00007247833,0.0002551553,0.00031136305,0.0014923114,0.00014901868],"about_ca_topic_score_codex":0.0025542395,"about_ca_topic_score_gemma":0.000038504364,"teacher_disagreement_score":0.09031298,"about_ca_system_score_codex":0.000036488073,"about_ca_system_score_gemma":0.000051189487,"threshold_uncertainty_score":0.6535389},"labels":[],"label_agreement":null},{"id":"W4385663852","doi":"10.33696/cardiology.4.041","title":"Guidelines Oriented Approach to Lipid (GOAL) Lowering Quality Improvement International Program","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; University of Toronto","funders":"","keywords":"Ezetimibe; Medicine; Internal medicine; Statin; Atherosclerotic cardiovascular disease; Clinical endpoint; Familial hypercholesterolemia; Conventional PCI; Coronary artery disease; Evolocumab; Cardiology; Gastroenterology; Lipoprotein; Clinical trial; Disease; Cholesterol; Myocardial infarction","score_opus":0.16090920198493974,"score_gpt":0.4952902281289376,"score_spread":0.33438102614399784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385663852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969932,0.0001534907,0.012221962,0.006430513,0.0059500104,0.00080627925,0.000008644347,0.000098039665,0.004399063],"genre_scores_gemma":[0.9612302,0.00094767584,0.01676406,0.0025672768,0.017901469,0.000065019834,0.00003042736,0.000035826684,0.00045802293],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958385,0.00026511218,0.0024445402,0.00030556292,0.0008158829,0.0003304002],"domain_scores_gemma":[0.9971512,0.00017867913,0.00050647947,0.00043157936,0.0012882495,0.00044384506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010385411,0.0001478421,0.0013593547,0.00018952074,0.00004231725,0.000014058776,0.00022480347,0.00021625099,0.000011690052],"category_scores_gemma":[0.005562187,0.000104270395,0.0013478389,0.00032438705,0.00006837128,0.000054371976,0.0001656538,0.0005964309,0.00003332433],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014258685,0.00045839287,0.1027817,0.00015627114,0.002532555,0.00034759505,0.00007187875,0.0007012656,0.00048895937,0.00024496915,0.021028116,0.8697624],"study_design_scores_gemma":[0.004660657,0.0034533867,0.38031784,0.000103716455,0.00024382348,0.0008667594,0.00035059205,0.00030903355,0.00008124005,0.00006635503,0.6093597,0.00018693099],"about_ca_topic_score_codex":0.000019398698,"about_ca_topic_score_gemma":0.0000011871534,"teacher_disagreement_score":0.8695755,"about_ca_system_score_codex":0.00008844985,"about_ca_system_score_gemma":0.00030937145,"threshold_uncertainty_score":0.6658859},"labels":[],"label_agreement":null},{"id":"W4386053111","doi":"10.9778/cmajo.20220108","title":"Genetic testing for familial hypercholesterolemia in Quebec, Canada: a single-centre retrospective cohort study","year":2023,"lang":"en","type":"article","venue":"CMAJ Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"","keywords":"Familial hypercholesterolemia; Medicine; LDL receptor; PCSK9; Apolipoprotein B; Cohort; Genetic testing; Retrospective cohort study; Internal medicine; Pediatrics; Cholesterol; Lipoprotein","score_opus":0.0382346007790937,"score_gpt":0.2850428035515995,"score_spread":0.2468082027725058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386053111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99089754,0.00005301391,0.000013826478,0.0004943289,0.00018754565,0.0071570845,0.000018037947,0.000042228487,0.0011364091],"genre_scores_gemma":[0.99622816,0.0000024041447,0.0003808074,0.00033466297,0.00027235015,0.00048935995,0.000024249764,0.000038111873,0.002229909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834055,0.00008538371,0.00029771496,0.00045124828,0.00043233862,0.00039274734],"domain_scores_gemma":[0.99909806,0.000061881154,0.000052818756,0.0004897562,0.00015314981,0.00014433643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007512401,0.00014353525,0.00052707683,0.000070701826,0.00009940699,0.00005825141,0.00019637191,0.000057121943,0.000013535511],"category_scores_gemma":[0.00047549602,0.00013055466,0.00006243643,0.0005000564,0.000017733471,0.000062249186,0.00017845041,0.00016744003,0.000010531187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006946189,0.00012855549,0.9831719,0.000056739103,0.000092176124,0.00019422286,0.00044883054,0.000020507467,0.00023514876,0.0000021650762,0.0020688127,0.013511523],"study_design_scores_gemma":[0.0031495057,0.00027402551,0.9927062,0.0001150457,0.000090317924,0.00000819235,0.0015956863,0.00015230475,0.000042657608,0.000012997992,0.0017209173,0.00013214444],"about_ca_topic_score_codex":0.96461606,"about_ca_topic_score_gemma":0.9918189,"teacher_disagreement_score":0.027202858,"about_ca_system_score_codex":0.0011371288,"about_ca_system_score_gemma":0.0012895789,"threshold_uncertainty_score":0.5323865},"labels":[],"label_agreement":null},{"id":"W4386090741","doi":"10.1093/eurheartj/ehad472","title":"Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"Esperion Therapeutics; Mylan; Amryt Pharma; Amarin Corporation; Regeneron Pharmaceuticals; European Society of Cardiology; Daiichi Sankyo Europe; Silence Therapeutics; European Commission; Sanofi; AstraZeneca; Servier; National Heart, Lung, and Blood Institute; Pfizer; Amgen","keywords":"Medicine; Disease; Polycystic ovary; Atherosclerotic cardiovascular disease; Diabetes mellitus; Internal medicine; Pregnancy; Menopause; Obesity; Endocrinology; Insulin resistance","score_opus":0.06812005930300254,"score_gpt":0.2757782448173607,"score_spread":0.20765818551435816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386090741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070615,0.0021533198,0.00072796224,0.0045347107,0.00051886047,0.0005597265,0.000024709023,0.00019945113,0.00057510776],"genre_scores_gemma":[0.98491746,0.0038032187,0.0004522771,0.00401781,0.005907807,0.000016353433,0.000013601745,0.00016620992,0.0007052729],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99617124,0.0015684824,0.00033588387,0.00045060323,0.0008850371,0.0005887723],"domain_scores_gemma":[0.99787503,0.00006596078,0.000065294604,0.0009106476,0.0000985289,0.0009845286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057275,0.00024687606,0.0004250908,0.00005822113,0.00068877754,0.00021708944,0.00018426418,0.00003276915,0.000056874553],"category_scores_gemma":[0.00018280209,0.00016864022,0.0009046708,0.00041601213,0.000079649704,0.00010583496,0.00020330738,0.0006197556,0.0007205348],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045763954,0.00036819652,0.13324328,0.00040803023,0.008442476,0.0008694638,0.023017421,0.0013591908,0.02278217,0.000017954124,0.31503442,0.49399975],"study_design_scores_gemma":[0.00093416625,0.00012073596,0.6952705,0.00020087624,0.00019606706,0.00013005002,0.0005219982,0.000052629384,0.000020178304,0.000007769056,0.30240238,0.00014270205],"about_ca_topic_score_codex":0.00006344517,"about_ca_topic_score_gemma":0.000001939595,"teacher_disagreement_score":0.56202716,"about_ca_system_score_codex":0.00015993461,"about_ca_system_score_gemma":0.000094274925,"threshold_uncertainty_score":0.9261258},"labels":[],"label_agreement":null},{"id":"W4386191894","doi":"10.1161/circulationaha.123.066398","title":"Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests","year":2023,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; St. Michael's Hospital; Sanofi (Canada)","funders":"Sanofi","keywords":"Medicine; Mace; Internal medicine; Lipoprotein; Alirocumab; Lipoprotein(a); PCSK9; Body mass index; Acute coronary syndrome; Endocrinology; Cardiology; Cholesterol; Apolipoprotein A1; Myocardial infarction; LDL receptor; Percutaneous coronary intervention","score_opus":0.021817980068797208,"score_gpt":0.2950229316344272,"score_spread":0.27320495156563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386191894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887622,0.0015147125,0.007167623,0.00017369416,0.00019025072,0.0018269753,0.000037672587,0.00016271447,0.00016412801],"genre_scores_gemma":[0.99853736,0.000068506786,0.00073370995,0.00005149731,0.00011547203,0.00026004124,0.00015224394,0.000037981248,0.000043178738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977773,0.00015281395,0.0005423809,0.00037836307,0.0008386992,0.00031043217],"domain_scores_gemma":[0.9986177,0.000042176336,0.00014200596,0.0007944869,0.00020088683,0.0002027293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008173227,0.0001653543,0.00060350203,0.00018922593,0.00014535121,0.000014539319,0.000064160835,0.00013705072,0.000041404095],"category_scores_gemma":[0.00018904915,0.00016417495,0.000579741,0.0008728805,0.000036168894,0.00010554145,0.00004978221,0.00022537285,0.00015309297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103139784,0.00011584751,0.90751255,0.00027960594,0.0017809159,0.00018895505,0.0013663503,0.018010154,0.002529347,0.00008331311,0.00015144884,0.067878366],"study_design_scores_gemma":[0.0009355748,0.0001631907,0.98953027,0.00024543115,0.0008059319,0.00015512026,0.00016060904,0.0063520744,0.00057768065,0.00007914845,0.00083651074,0.00015847567],"about_ca_topic_score_codex":0.00029910362,"about_ca_topic_score_gemma":0.000019339133,"teacher_disagreement_score":0.0820177,"about_ca_system_score_codex":0.00016632194,"about_ca_system_score_gemma":0.0001363448,"threshold_uncertainty_score":0.66948605},"labels":[],"label_agreement":null},{"id":"W4386209549","doi":"10.1093/eurheartj/ehad539","title":"Recommendations for statin management in primary prevention: disparities among international risk scores","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia","funders":"","keywords":"Medicine; Framingham Risk Score; Concordance; Statin; Risk assessment; Population; Cohort; Risk factor; Residual risk; Internal medicine; Demography; Environmental health; Disease","score_opus":0.05574851049146582,"score_gpt":0.3355118594207942,"score_spread":0.27976334892932836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386209549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9531238,0.00045050064,0.0073781805,0.015358875,0.001592896,0.0013572769,0.00005599952,0.00013422579,0.020548234],"genre_scores_gemma":[0.91643935,0.009437429,0.045844223,0.0020199148,0.0037441237,0.00014649835,0.00054056913,0.00014198526,0.021685915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987848,0.00025246394,0.0003180989,0.00014422236,0.0002941772,0.00020626126],"domain_scores_gemma":[0.99955535,0.000036978254,0.00008822269,0.00015436573,0.00006015212,0.000104927465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021854776,0.00007869885,0.00015510563,0.00024112323,0.0001705733,0.00006675007,0.000078323625,0.000014285826,0.00010807451],"category_scores_gemma":[0.00006824689,0.00007033475,0.00018842697,0.00016467499,0.00002406111,0.00013013622,0.00006123651,0.0002573592,0.00005752437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002455527,0.00026301236,0.456132,0.00031266463,0.00066861697,0.00044211335,0.0005596069,0.00020336088,0.000026038264,0.00052856805,0.21902654,0.32159194],"study_design_scores_gemma":[0.0015753579,0.00010842244,0.85541886,0.00027089,0.00004053009,0.00010186041,0.00021762162,0.00011928608,0.0000071564064,0.00031392643,0.14176285,0.00006323933],"about_ca_topic_score_codex":0.000015954853,"about_ca_topic_score_gemma":0.000011377619,"teacher_disagreement_score":0.39928687,"about_ca_system_score_codex":0.00010147111,"about_ca_system_score_gemma":0.000043802025,"threshold_uncertainty_score":0.28681675},"labels":[],"label_agreement":null},{"id":"W4386221732","doi":"10.1503/cmaj.230048","title":"Apolipoprotein B in cardiovascular risk assessment","year":2023,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Western University","funders":"","keywords":"Dyslipidemia; Guideline; Apolipoprotein B; Cholesterol; Medicine; Ldl cholesterol; High-density lipoprotein; Internal medicine; Lipoprotein; Endocrinology; Bioinformatics; Biology; Pathology; Obesity","score_opus":0.008803408640405868,"score_gpt":0.2601064654655902,"score_spread":0.25130305682518433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386221732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92761475,0.002475359,0.00044053784,0.052287433,0.0017146259,0.0009980348,0.00004237803,0.00013456088,0.014292324],"genre_scores_gemma":[0.98811924,0.0027180335,0.00030696025,0.004398966,0.003713428,0.000054890897,0.00002835066,0.00004163647,0.00061850366],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.994899,0.00047045172,0.00049715035,0.00022821501,0.003131011,0.0007741706],"domain_scores_gemma":[0.9971737,0.00006172649,0.00012248306,0.00030863585,0.0002879331,0.002045512],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010442518,0.00013460092,0.00053006434,0.0005428271,0.00023776884,0.00006002006,0.00013887274,0.00042672144,0.0010065564],"category_scores_gemma":[0.0021712608,0.00012069134,0.0005796947,0.0009340897,0.0000225286,0.000089129244,0.00002018328,0.0017768055,0.00038824018],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011376497,0.000049587627,0.43930003,0.000060201775,0.0014733868,0.0064554075,0.00023747518,0.00013065156,0.00000477474,0.00020246943,0.048703056,0.5033716],"study_design_scores_gemma":[0.0020561535,0.000056993013,0.55650735,0.0001102547,0.00009122571,0.0004818366,0.00027117864,0.0006020375,0.0000058293135,0.00019235074,0.43950078,0.00012400631],"about_ca_topic_score_codex":0.031875454,"about_ca_topic_score_gemma":0.02604684,"teacher_disagreement_score":0.50324756,"about_ca_system_score_codex":0.0025005387,"about_ca_system_score_gemma":0.0060698055,"threshold_uncertainty_score":0.99990666},"labels":[],"label_agreement":null},{"id":"W4386241392","doi":"10.1016/j.atherosclerosis.2023.06.716","title":"Resolving conflicting LDLR variants in ClinVar - Progress of the ClinGen familial hypercholesterolemia variant curation expert panel","year":2023,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Genomics","funders":"","keywords":"Familial hypercholesterolemia; LDL receptor; Genetics; Computational biology; Medicine; Biology; Endocrinology; Cholesterol; Lipoprotein","score_opus":0.07477839750548873,"score_gpt":0.32003259558106995,"score_spread":0.24525419807558121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386241392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969164,0.00038527636,0.00012839993,0.00093970104,0.00038232925,0.0009355268,0.000011963156,0.000096157506,0.00020420659],"genre_scores_gemma":[0.9976012,0.0006581803,0.00061732857,0.00050624995,0.0003462886,0.00012082256,0.00001292021,0.000049227547,0.000087788525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775136,0.00024442075,0.0006032561,0.0003817807,0.00057778927,0.00044139795],"domain_scores_gemma":[0.99879885,0.000078662684,0.00017735477,0.000744875,0.00009737849,0.00010286949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017279817,0.00017883607,0.00044622153,0.00010430458,0.00014980214,0.000027579586,0.0001975091,0.00018799386,0.000013633436],"category_scores_gemma":[0.00025840462,0.000128883,0.00025439038,0.0006812161,0.00009783436,0.00013195607,0.00012986394,0.00030928606,0.000019780065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043696872,0.00068583083,0.54708415,0.0007977138,0.00047671088,0.00006353299,0.023539139,0.00020565682,0.29709852,0.0005807684,0.0005197797,0.1285112],"study_design_scores_gemma":[0.002477531,0.00016485047,0.98507065,0.0012645253,0.00007863869,0.000019168134,0.00094399677,0.0024464128,0.0060706483,0.000048803187,0.0012329232,0.00018187778],"about_ca_topic_score_codex":0.00096458785,"about_ca_topic_score_gemma":0.00007547693,"teacher_disagreement_score":0.43798646,"about_ca_system_score_codex":0.00010354536,"about_ca_system_score_gemma":0.00015415502,"threshold_uncertainty_score":0.5255696},"labels":[],"label_agreement":null},{"id":"W4386244201","doi":"10.1016/j.atherosclerosis.2023.06.798","title":"Meta-analysis of randomized controlled trials evaluating the association between magnitude and duration of apolipoprotein-B lowering and cardiovascular risk reduction among different lipid-lowering therapies","year":2023,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Medicine; Internal medicine; Randomized controlled trial; Apolipoprotein B; Reduction (mathematics); Meta-analysis; Cardiology; Cholesterol; Mathematics","score_opus":0.09832831200094357,"score_gpt":0.32533317114286975,"score_spread":0.2270048591419262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386244201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862488,0.008326018,0.0012098826,0.00022403875,0.00009956292,0.0037842537,0.0000341463,0.00005133779,0.000021979387],"genre_scores_gemma":[0.9914373,0.0072970595,0.00012728179,0.000008115509,0.00021262561,0.000757947,0.000021726863,0.000030378164,0.000107545435],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9934472,0.0028943645,0.0018046023,0.00038473983,0.0012247523,0.00024434313],"domain_scores_gemma":[0.9952016,0.0021734682,0.0016369342,0.0005950732,0.00031628023,0.00007663761],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03774157,0.00027383992,0.0080884565,0.00035524875,0.00018651724,0.00005718894,0.00007102811,0.000159827,0.000024073308],"category_scores_gemma":[0.004418516,0.00014792936,0.006446009,0.0006888234,0.00013641127,0.00010000719,0.000059859463,0.00019713037,4.804926e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004610794,0.000044600496,0.0369166,0.00021116619,0.919487,1.8778891e-7,0.0032742803,0.00075325824,0.022083452,0.000013765868,0.000003062021,0.01260185],"study_design_scores_gemma":[0.054879557,0.00016116154,0.2870343,0.000060298986,0.64872456,4.954025e-7,0.000511526,0.0017870032,0.0066291774,0.000068974085,0.0000027211108,0.00014024015],"about_ca_topic_score_codex":0.0018894515,"about_ca_topic_score_gemma":0.000032845317,"teacher_disagreement_score":0.27076244,"about_ca_system_score_codex":0.00007872515,"about_ca_system_score_gemma":0.000037649337,"threshold_uncertainty_score":0.9908475},"labels":[],"label_agreement":null},{"id":"W4386244235","doi":"10.1016/j.atherosclerosis.2023.06.805","title":"ARO-ANG3, an investigational RNAI therapeutic, decreases serum LDL-cholesterol, apolipoprotein B, and angiopoietin-like protein 3 in patients with homozygous familial hypercholesterolaemia","year":2023,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Université de Montréal; Université du Québec à Chicoutimi; Université Laval","funders":"","keywords":"Apolipoprotein B; Ldl cholesterol; Cholesterol; PCSK9; Medicine; RNA interference; Angiopoietin 2; Pharmacology; Internal medicine; LDL receptor; Chemistry; Lipoprotein; Biochemistry; Gene; RNA","score_opus":0.018046624412312556,"score_gpt":0.23527619352125193,"score_spread":0.21722956910893937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386244235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961961,0.00012225677,0.000028285485,0.0008018859,0.000077931174,0.0024082428,0.000063366504,0.00025183923,0.000050102186],"genre_scores_gemma":[0.99618167,0.00006486135,0.000842994,0.0017068825,0.00021087534,0.0005133406,0.00017521442,0.00012771913,0.00017645708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967645,0.00026016447,0.00047298823,0.0008000856,0.0009782437,0.00072406547],"domain_scores_gemma":[0.9982892,0.000033372373,0.00013448512,0.0008463582,0.00015933409,0.00053724245],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006564518,0.00043889435,0.00062844215,0.00028969493,0.00021897034,0.00010541978,0.00018928284,0.00025387356,0.000025204337],"category_scores_gemma":[0.00005524839,0.00035676273,0.00015461,0.00072770804,0.00026410923,0.0003777509,0.000104518476,0.00040958464,0.00004780194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061294105,0.00067679206,0.94766814,0.00023198032,0.00022112363,0.000022444889,0.0009974958,0.000014999237,0.007864604,0.00008685742,0.000069921516,0.041532718],"study_design_scores_gemma":[0.0065150796,0.0015115796,0.9886081,0.00047537527,0.00010410782,0.00001920798,0.000210551,0.00007783411,0.0015280861,0.00014621181,0.00042368117,0.00038016986],"about_ca_topic_score_codex":0.0015619084,"about_ca_topic_score_gemma":0.00040977157,"teacher_disagreement_score":0.041152548,"about_ca_system_score_codex":0.00014515789,"about_ca_system_score_gemma":0.00020409664,"threshold_uncertainty_score":0.9998884},"labels":[],"label_agreement":null},{"id":"W4386247816","doi":"10.1016/j.atherosclerosis.2023.06.965","title":"Familial hypercholesterolemia in Canada: Investigating management patterns and clinical outcomes from the FH Canada registry","year":2023,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Université du Québec à Chicoutimi; Montreal Clinical Research Institute; McGill University Health Centre; Université de Montréal; Université Laval; St. Paul's Hospital; Hospital for Sick Children; University of British Columbia; Providence Health Care","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Patient registry; Gerontology; Pediatrics; Internal medicine; Cholesterol","score_opus":0.047327044157522195,"score_gpt":0.27335782118838636,"score_spread":0.22603077703086416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386247816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422777,0.000068617024,0.0000054283964,0.0047855717,0.00030451757,0.0003961309,0.00008376968,0.000026881298,0.00010131688],"genre_scores_gemma":[0.9920458,0.00054331316,0.00008634813,0.006952273,0.00016308503,0.00004263761,0.00003468918,0.000026267377,0.000105557716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822044,0.00014032554,0.0004205392,0.00035355706,0.0005315858,0.0003335616],"domain_scores_gemma":[0.99889463,0.00021087003,0.00007130373,0.00061159773,0.000019043853,0.00019255279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056171353,0.00015655093,0.0003871463,0.000018790859,0.00010063512,0.000020922884,0.00015042958,0.00006259824,0.000011899653],"category_scores_gemma":[0.000106810985,0.000108689856,0.000091525675,0.00018003433,0.000045884397,0.000026865173,0.0001377916,0.00032456397,0.0000032990783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004760445,0.000008057583,0.9819263,0.000036315374,0.00013268707,0.000035547822,0.00007904206,0.000004509402,0.000017940098,0.000005208681,0.0019859977,0.015763635],"study_design_scores_gemma":[0.0011610788,0.000016621656,0.9953248,0.00022038976,0.00008121401,0.0000019188428,0.0015481702,0.000088561064,0.000013463348,0.000010828864,0.0014270904,0.00010586579],"about_ca_topic_score_codex":0.9994981,"about_ca_topic_score_gemma":0.99961525,"teacher_disagreement_score":0.015657768,"about_ca_system_score_codex":0.00045575228,"about_ca_system_score_gemma":0.0010170124,"threshold_uncertainty_score":0.44322434},"labels":[],"label_agreement":null},{"id":"W4386247835","doi":"10.1016/j.atherosclerosis.2023.06.926","title":"Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolemia: Data from three pooled open-label studies","year":2023,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Evolocumab; Familial hypercholesterolemia; Medicine; Open label; PCSK9; Internal medicine; Pediatrics; Clinical trial; Apolipoprotein B; Cholesterol; LDL receptor; Lipoprotein","score_opus":0.1291053804011446,"score_gpt":0.3348264310014908,"score_spread":0.20572105060034618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386247835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503636,0.001566188,0.000014557554,0.00046323254,0.00021012682,0.0020536315,0.00044689217,0.00013460142,0.000074411895],"genre_scores_gemma":[0.9944185,0.0028118177,0.0006924822,0.00037010948,0.00028598984,0.00038830657,0.00081264303,0.00008299895,0.0001371612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974105,0.00012792135,0.00040775945,0.0008732868,0.00065574155,0.0005248096],"domain_scores_gemma":[0.99744624,0.000112567075,0.00010084115,0.002051375,0.000114732036,0.00017427152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004897908,0.00034140632,0.00088413403,0.00015400595,0.00015285447,0.00006306839,0.0005391961,0.0001480715,0.000018378552],"category_scores_gemma":[0.00009983501,0.00023299895,0.00007727192,0.0008095115,0.00008037392,0.00027491746,0.0006928315,0.00022074486,0.00020967488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005642678,0.0015923845,0.90533155,0.00006751833,0.0012083735,0.00006597422,0.0008779107,0.000010215822,0.00022493435,0.0000038331814,0.001110481,0.08894253],"study_design_scores_gemma":[0.024138527,0.0016818533,0.97166395,0.00023361115,0.00061108795,0.0000022625295,0.00044292287,0.00017932312,0.000052856205,0.00005174963,0.0006756267,0.00026620226],"about_ca_topic_score_codex":0.004705374,"about_ca_topic_score_gemma":0.004556982,"teacher_disagreement_score":0.088676326,"about_ca_system_score_codex":0.0003910393,"about_ca_system_score_gemma":0.00019927847,"threshold_uncertainty_score":0.95014215},"labels":[],"label_agreement":null},{"id":"W4386305489","doi":"10.1017/s0266462323000296","title":"Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults","year":2023,"lang":"en","type":"review","venue":"International Journal of Technology Assessment in Health Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Ezetimibe; Medicine; PCSK9; Statin; Context (archaeology); Myocardial infarction; Guideline; Cost effectiveness; Stroke (engine); Quality-adjusted life year; Internal medicine; Cholesterol; Lipoprotein","score_opus":0.04075540256384868,"score_gpt":0.43237473110025143,"score_spread":0.39161932853640274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386305489","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03869541,0.95173424,0.0009853736,0.0004681509,0.0009809263,0.0064587994,0.0006485644,0.000024030953,0.000004496858],"genre_scores_gemma":[0.09666811,0.898121,0.003845216,0.000025121446,0.00020485754,0.0007628659,0.0003017771,0.00006622201,0.000004799272],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959279,0.0004575506,0.0020731038,0.0003909957,0.00086843147,0.00028206845],"domain_scores_gemma":[0.9968918,0.0003619487,0.0012902869,0.00039369482,0.00087714044,0.0001851267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029519734,0.00030559886,0.0027992874,0.0025975013,0.00002990725,0.000008343862,0.00033691662,0.00031346103,0.0000057772186],"category_scores_gemma":[0.00078078406,0.00023839598,0.0009820871,0.00079828635,0.000062695624,0.000099841505,0.00017902073,0.00086106936,3.282205e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009777359,0.00023705234,0.0013511386,0.08335583,0.0018607251,0.00023455851,0.00013799117,0.00029521476,6.368252e-7,0.00019071107,0.000009569572,0.9113488],"study_design_scores_gemma":[0.029508892,0.009538666,0.052570414,0.71342313,0.0028522462,0.00080508523,0.0040998245,0.0001117986,0.00003584194,0.0012607315,0.18480216,0.0009912191],"about_ca_topic_score_codex":0.00039887632,"about_ca_topic_score_gemma":0.00010098039,"teacher_disagreement_score":0.9103576,"about_ca_system_score_codex":0.0015390745,"about_ca_system_score_gemma":0.0038833828,"threshold_uncertainty_score":0.9721506},"labels":[],"label_agreement":null},{"id":"W4386575151","doi":"10.1016/j.athplu.2023.09.001","title":"Lipoprotein(a), Interleukin-6 inhibitors, and atherosclerotic cardiovascular disease: Is there an association?","year":2023,"lang":"en","type":"review","venue":"Atherosclerosis Plus","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Esperion Therapeutics; Bausch Health; Servier; Mylan; Daiichi Sankyo Europe; Silence Therapeutics; Sanofi; Kowa Company; Novo Nordisk; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Gilead Sciences; NIHR Imperial Biomedical Research Centre; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Atherosclerotic cardiovascular disease; Medicine; Disease; Lipoprotein; Internal medicine; Immunology; Cholesterol","score_opus":0.06400184077770718,"score_gpt":0.3106759516495359,"score_spread":0.2466741108718287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386575151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017089783,0.99133795,0.00003557322,0.00019700089,0.0006440878,0.004997339,0.00032089432,0.0006058666,0.00015232309],"genre_scores_gemma":[0.0004886026,0.9917684,0.00014056922,0.00038413823,0.0020877894,0.0013153924,0.00029299827,0.0006303461,0.0028917508],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99281263,0.000797853,0.0013207883,0.0018617419,0.0021069413,0.0011000506],"domain_scores_gemma":[0.99463516,0.00015088255,0.0006206615,0.0032145826,0.00024209892,0.0011365889],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024926763,0.0012290799,0.004874091,0.0003407461,0.00038746136,0.000293924,0.00046348138,0.0010962823,0.000121783065],"category_scores_gemma":[0.00029284434,0.0009993736,0.0042247297,0.0009294345,0.00013682379,0.00024518196,0.0003693301,0.0012362499,0.0006775447],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026887361,0.00019645363,0.00018364546,0.030313449,0.009700344,0.00006748207,0.0004198611,0.0000027720755,0.0000023344492,0.000048719605,0.001780473,0.95725757],"study_design_scores_gemma":[0.0015279906,0.00029203334,0.0018177711,0.02879493,0.011329579,0.000042981304,0.00007900151,0.000030508025,0.00000421382,0.000046218374,0.9550294,0.0010053505],"about_ca_topic_score_codex":0.0011038366,"about_ca_topic_score_gemma":0.00003236262,"teacher_disagreement_score":0.9562522,"about_ca_system_score_codex":0.0016872345,"about_ca_system_score_gemma":0.0010624224,"threshold_uncertainty_score":0.99924564},"labels":[],"label_agreement":null},{"id":"W4386579070","doi":"10.1097/01.eem.0000666300.55111.7f","title":"Special Report","year":2020,"lang":"en","type":"article","venue":"Emergency Medicine News","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.053630918592722995,"score_gpt":0.3249821141071529,"score_spread":0.2713511955144299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386579070","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08393062,0.0034210947,0.0018540325,0.1329456,0.009747696,0.0012507783,0.00000320516,0.00028374206,0.76656324],"genre_scores_gemma":[0.27484322,0.007702016,0.0016882409,0.021184893,0.6464062,0.00012909637,0.00029603604,0.00022041779,0.047529902],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997855,0.000042714655,0.00066615024,0.00039859812,0.00075235957,0.00028514088],"domain_scores_gemma":[0.99862283,0.0000063388334,0.0001159639,0.00053275103,0.00012250026,0.00059958315],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003601129,0.00017190028,0.0005437837,0.000049964237,0.000064375556,0.0000012139728,0.000090965004,0.00007794053,0.021188416],"category_scores_gemma":[0.0007511477,0.00012454756,0.00025409443,0.0004310738,0.00004855458,0.000044746444,0.00003480932,0.00026176733,0.00031889937],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008955735,0.0000369668,0.0103488965,0.00016404124,0.00011319727,0.0007849827,0.00076059834,7.75307e-7,0.0007754509,0.00019218487,0.96486396,0.021869395],"study_design_scores_gemma":[0.0012586963,0.0005437246,0.014066483,0.000043507185,0.00016366782,0.0003373064,0.00031583014,0.000019337656,0.00013960835,0.00005608175,0.9829357,0.0001200474],"about_ca_topic_score_codex":0.00043386756,"about_ca_topic_score_gemma":0.000028770852,"teacher_disagreement_score":0.7190333,"about_ca_system_score_codex":0.000031629446,"about_ca_system_score_gemma":0.00014000284,"threshold_uncertainty_score":0.97970635},"labels":[],"label_agreement":null},{"id":"W4386660575","doi":"10.1093/eurheartj/ehab724.2568","title":"Cardiovascular benefits outweigh risks in patients with atrial fibrillation in REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial)","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Amarin Pharma; Amarin Corporation","keywords":"Medicine; Internal medicine; Atrial fibrillation; Myocardial infarction; Stroke (engine); Cardiology; Clinical endpoint; Unstable angina; Hazard ratio; Adverse effect; Angina; Randomized controlled trial; Confidence interval","score_opus":0.044521242781136394,"score_gpt":0.29077919733187274,"score_spread":0.24625795455073635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386660575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98540723,0.011961206,0.00028615262,0.0001842131,0.00059808145,0.0013170171,0.0000064309897,0.000017317363,0.00022232022],"genre_scores_gemma":[0.9963468,0.0012988325,0.0007360006,0.000019268677,0.0014325046,0.0000045646334,0.000055841523,0.0000748861,0.00003134798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99440783,0.0019420845,0.000942712,0.00052224426,0.0017731531,0.00041198113],"domain_scores_gemma":[0.99814504,0.000019864183,0.00026949483,0.0008144915,0.0005227745,0.00022831804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042742817,0.00027818503,0.0011238926,0.00036292002,0.00010525367,0.00003947541,0.00009066099,0.00009672862,0.000041878844],"category_scores_gemma":[0.00016983769,0.00022264844,0.0019248443,0.00066384126,0.000039070717,0.00024850853,0.000055823497,0.00066097366,0.0000122303745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040702734,0.001008613,0.5660016,0.00057219196,0.0101358425,0.00094109174,0.00095992896,0.13373084,0.000046086163,0.000010345724,0.00010450896,0.24578623],"study_design_scores_gemma":[0.09290689,0.0022066934,0.89533716,0.001886227,0.001031394,0.00092345034,0.00022570207,0.000029673187,0.00034755425,0.0000055061582,0.0048378115,0.00026193625],"about_ca_topic_score_codex":0.00032021603,"about_ca_topic_score_gemma":0.000025300831,"teacher_disagreement_score":0.3293356,"about_ca_system_score_codex":0.00033165474,"about_ca_system_score_gemma":0.000318285,"threshold_uncertainty_score":0.90793395},"labels":[],"label_agreement":null},{"id":"W4386660822","doi":"10.1093/eurheartj/ehab724.2025","title":"Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials","year":2021,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Post-hoc analysis; Mace; Internal medicine; PCSK9; Population; Placebo; Statin; Coronary artery disease; Gemfibrozil; Incidence (geometry); Adverse effect; Cardiology; Cholesterol; Lipoprotein; Myocardial infarction; Pathology; Conventional PCI; LDL receptor","score_opus":0.016227627908505987,"score_gpt":0.2840360089765328,"score_spread":0.26780838106802685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386660822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999244,0.0075130654,0.00009467596,0.0007946352,0.000098513075,0.0013765069,0.00005377888,0.000006372295,0.00007001839],"genre_scores_gemma":[0.99831504,0.0009769636,0.0001412805,0.00021711021,0.00020707604,0.0000038406242,0.000039368282,0.000030761403,0.00006855737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938515,0.0034716898,0.0012726187,0.00029091738,0.00087382784,0.0002394763],"domain_scores_gemma":[0.99746704,0.0004645213,0.0005724203,0.0005545613,0.0005483825,0.0003930864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006556349,0.00021884197,0.0022691314,0.0003174973,0.00017839076,0.000044275548,0.000087531655,0.000042069718,0.00017900967],"category_scores_gemma":[0.0027556175,0.00011892151,0.0010066185,0.0007691826,0.00011715166,0.00008629244,0.000080484315,0.00029175406,8.278e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41963392,0.0035299012,0.49296948,0.00047929224,0.024121558,0.00064603717,0.0012784139,0.0003570836,0.0022131207,0.000046851877,0.00028847752,0.05443584],"study_design_scores_gemma":[0.29716867,0.00063867145,0.69338995,0.00042432648,0.0062974994,0.000050510243,0.00007490128,0.00005834675,0.000081751175,0.0000016816938,0.0017030175,0.000110665],"about_ca_topic_score_codex":0.00002646098,"about_ca_topic_score_gemma":0.000016231492,"teacher_disagreement_score":0.20042048,"about_ca_system_score_codex":0.000045999375,"about_ca_system_score_gemma":0.0003997023,"threshold_uncertainty_score":0.48494783},"labels":[],"label_agreement":null},{"id":"W4386705352","doi":"10.1001/jamacardio.2023.2921","title":"Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Novo Nordisk; Kowa Company; Esperion Therapeutics; Regeneron Pharmaceuticals; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Refractory (planetary science); Term (time); Safety profile; Intensive care medicine; Internal medicine; Adverse effect","score_opus":0.011012250709825104,"score_gpt":0.2525470643555331,"score_spread":0.24153481364570797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386705352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978468,0.00040915597,0.000017177392,0.00015407184,0.0000821204,0.0005626115,0.000014256593,0.00003706961,0.0008767563],"genre_scores_gemma":[0.99910015,0.00038078782,0.000056517674,0.00013286353,0.00015224304,0.000020905185,0.00008766591,0.000021585287,0.00004725593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987662,0.00017566896,0.00026597077,0.00028690125,0.00023620517,0.00026907038],"domain_scores_gemma":[0.9992135,0.00007509943,0.000060131253,0.00046439626,0.00008870731,0.0000981616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055538915,0.00012528252,0.0006881355,0.00016399627,0.000026165879,0.000003933766,0.000055966208,0.00018159144,0.0000048986326],"category_scores_gemma":[0.00010965998,0.00009276044,0.00009455144,0.00024068801,0.000111092195,0.000052462663,0.00006486585,0.00026845816,0.000015226648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018586802,0.000057303496,0.8682159,0.00024194366,0.00023361716,0.00014387524,0.0003003949,0.000021791475,0.00014961984,0.000020112771,0.00018099908,0.12857573],"study_design_scores_gemma":[0.008501857,0.00087890046,0.98668325,0.00015184798,0.000073847696,0.000052132917,0.00006202221,0.0000028351114,0.000022521106,0.000005016119,0.0034799136,0.00008588454],"about_ca_topic_score_codex":0.000028710823,"about_ca_topic_score_gemma":0.0000058508444,"teacher_disagreement_score":0.12848984,"about_ca_system_score_codex":0.00007327613,"about_ca_system_score_gemma":0.000080826314,"threshold_uncertainty_score":0.3782661},"labels":[],"label_agreement":null},{"id":"W4386817746","doi":"10.1002/14651858.cd013673.pub2","title":"Pravastatin for lowering lipids","year":2023,"lang":"en","type":"review","venue":"Cochrane Database of Systematic Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pravastatin; Medicine; Placebo; Adverse effect; Randomized controlled trial; Meta-analysis; Internal medicine; Clinical trial; Cholesterol; Alternative medicine; Pathology","score_opus":0.18338064111186447,"score_gpt":0.42524569769298926,"score_spread":0.24186505658112478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386817746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.5484824e-7,0.95780665,0.004146777,0.000009948243,0.00053695275,0.03636947,0.00089126534,0.00007571412,0.00016307873],"genre_scores_gemma":[6.5942466e-8,0.9830466,0.0032439146,0.000029085102,0.0007204535,0.009558322,0.002423828,0.0001852585,0.00079250365],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9923637,0.0007799304,0.0048281136,0.00069823227,0.0008699255,0.00046009957],"domain_scores_gemma":[0.992438,0.000997389,0.0025316451,0.0034760514,0.0002858388,0.00027104595],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.011570278,0.00071273063,0.015326947,0.00033968667,0.00007059277,0.000028474322,0.000420891,0.00024702982,0.000051230214],"category_scores_gemma":[0.0069717625,0.0004377652,0.0038211634,0.00070264045,0.000051997686,0.00007851756,0.00014205548,0.0003366671,0.0005870702],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000048650936,0.000044211683,2.8267207e-8,0.87870884,0.00068081846,0.000025317933,0.000029851972,2.3654952e-8,0.0000013384802,0.00006648124,0.0024264369,0.11801178],"study_design_scores_gemma":[0.00028479475,0.00007743293,2.5806823e-8,0.56909245,0.006963608,0.000183041,0.000021090764,0.000003926476,0.0000014165307,0.0000013902892,0.4231787,0.00019214246],"about_ca_topic_score_codex":0.000029328752,"about_ca_topic_score_gemma":0.000004694668,"teacher_disagreement_score":0.42075226,"about_ca_system_score_codex":0.00013560837,"about_ca_system_score_gemma":0.00058971776,"threshold_uncertainty_score":0.9998074},"labels":[],"label_agreement":null},{"id":"W4386844974","doi":"10.9778/cmajo.20220163","title":"Evaluating the prevalence of lipid assessments in children in Alberta, Canada","year":2023,"lang":"en","type":"article","venue":"CMAJ Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Alberta Health; University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Pediatrics; Familial hypercholesterolemia; Demography; Cholesterol; Internal medicine","score_opus":0.04814329243885692,"score_gpt":0.38316880784158697,"score_spread":0.33502551540273007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386844974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937663,0.00011384973,9.765812e-7,0.0011667629,0.00006629013,0.0015848923,0.0000059363692,0.0000034007176,0.0032915974],"genre_scores_gemma":[0.9967712,0.00007964626,0.00008115271,0.00034261134,0.000061252846,0.00012099884,0.000011879512,0.00001004663,0.0025211722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988124,0.00015037911,0.0002392179,0.00017825988,0.0004270346,0.00019274645],"domain_scores_gemma":[0.99935067,0.00006802156,0.00005502993,0.0004523437,0.000029953464,0.000043994354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018067157,0.000064943066,0.00022896391,0.000042587137,0.000030819017,0.000010887944,0.0002761978,0.000027941926,0.00009798347],"category_scores_gemma":[0.00021269242,0.0000447631,0.00003582847,0.00041521987,0.000014788101,0.000052948064,0.00019365358,0.00014387899,0.000007997927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030310692,0.000028644385,0.9678546,0.00021575663,0.000045565954,0.0000069730027,0.0002044844,0.00013250075,0.000059257814,0.00003980982,0.000572392,0.030809673],"study_design_scores_gemma":[0.0010386496,0.000088258756,0.99728745,0.00024997373,0.000022308788,0.000008337763,0.0000799872,0.0006251186,0.00013768571,0.00002347596,0.0003911406,0.00004758233],"about_ca_topic_score_codex":0.9588635,"about_ca_topic_score_gemma":0.7699991,"teacher_disagreement_score":0.18886437,"about_ca_system_score_codex":0.00013200208,"about_ca_system_score_gemma":0.0012443902,"threshold_uncertainty_score":0.2341978},"labels":[],"label_agreement":null},{"id":"W4386878555","doi":"10.1093/ehjcvp/pvad054","title":"Cardiovascular preventive actions","year":2023,"lang":"en","type":"editorial","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.04662562444257853,"score_gpt":0.345710432397644,"score_spread":0.2990848079550655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386878555","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045683281,0.15140393,0.0022982052,0.00032972358,0.8363756,0.0022993484,0.0002403971,0.00085412676,0.0057418556],"genre_scores_gemma":[0.00053019443,0.12743713,0.0006680806,0.0003811294,0.8641813,0.00011417639,0.00034013478,0.001340345,0.0050075487],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9815748,0.005311439,0.0016974534,0.001847696,0.0077589653,0.0018096607],"domain_scores_gemma":[0.9919627,0.0004470854,0.000450395,0.0038121312,0.0016932319,0.0016344762],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.016331417,0.0014903902,0.004394326,0.0009885471,0.0011144116,0.00049361604,0.00086387637,0.00085280545,0.00040225504],"category_scores_gemma":[0.0009716375,0.001350766,0.028264917,0.0012972474,0.000231939,0.0003957389,0.0002534206,0.0068852548,0.0027111757],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024632277,0.00019165326,0.000011150382,0.0005781069,0.073490664,0.005182417,0.00017235664,0.0005877664,0.00026854078,0.0000012854634,0.8562747,0.06299498],"study_design_scores_gemma":[0.007943484,0.00046040208,0.00037760352,0.0010624377,0.010949441,0.003136605,0.00007850303,0.000015355863,0.0003665023,0.000014314933,0.974398,0.0011973185],"about_ca_topic_score_codex":0.0001688966,"about_ca_topic_score_gemma":0.000002064088,"teacher_disagreement_score":0.11812328,"about_ca_system_score_codex":0.0010007774,"about_ca_system_score_gemma":0.0018345972,"threshold_uncertainty_score":0.9997845},"labels":[],"label_agreement":null},{"id":"W4386898511","doi":"10.1016/j.clinbiochem.2023.110649","title":"Treatment target achievement in patients with familial hypercholesterolemia: A real-world descriptive study","year":2023,"lang":"en","type":"article","venue":"Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Descriptive statistics; Descriptive research; Internal medicine; Statistics; Mathematics; Cholesterol","score_opus":0.04029482527604323,"score_gpt":0.3394552395106911,"score_spread":0.2991604142346479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386898511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738353,0.000027877915,0.0000024129697,0.00028711735,0.000119756616,0.0013258196,0.000028613287,0.00009120295,0.0007336644],"genre_scores_gemma":[0.9977335,0.00007258381,0.00016973268,0.00016890129,0.00032120437,0.00017459564,0.00021726634,0.000029952784,0.001112315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978045,0.00009563319,0.00059853715,0.0006391491,0.0004901457,0.0003720355],"domain_scores_gemma":[0.9987386,0.00005274951,0.00008310646,0.0007529594,0.00008779932,0.00028482475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006169812,0.0002290529,0.0006342747,0.000072707095,0.000052106952,0.000012586394,0.000096266485,0.0001420392,0.000017000848],"category_scores_gemma":[0.00008437311,0.0001592113,0.00022032527,0.0004418881,0.000088552115,0.000026556536,0.00007681427,0.0003454487,0.000053757693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010738103,0.004157337,0.98678654,0.000052476564,0.00027410677,0.0001581332,0.00017837102,0.0000021135527,0.000076936114,5.8848514e-7,0.00019698379,0.007042608],"study_design_scores_gemma":[0.014046028,0.0034685764,0.97966105,0.000084706815,0.00014316155,0.0000012500054,0.00084031944,0.000009473247,0.00091070385,0.0000041631943,0.00067432993,0.00015622601],"about_ca_topic_score_codex":0.00039708934,"about_ca_topic_score_gemma":0.000089858084,"teacher_disagreement_score":0.012972218,"about_ca_system_score_codex":0.00041329357,"about_ca_system_score_gemma":0.00027596226,"threshold_uncertainty_score":0.64924484},"labels":[],"label_agreement":null},{"id":"W4387007469","doi":"10.1139/cjpp-2023-0223","title":"Role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in diabetic complications","year":2023,"lang":"en","type":"review","venue":"Canadian Journal of Physiology and Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute","keywords":"PCSK9; Kexin; Medicine; Proprotein convertase; Dyslipidemia; Diabetes mellitus; Internal medicine; Type 2 diabetes; Endocrinology; LDL receptor; Lipoprotein; Cholesterol","score_opus":0.04645766913533737,"score_gpt":0.34680596044496836,"score_spread":0.300348291309631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387007469","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020777583,0.9776252,5.6452416e-7,0.00017207583,0.0003766406,0.00090342487,0.00006622221,0.000004054827,0.000074216485],"genre_scores_gemma":[0.030366912,0.9687959,0.000031842836,0.0002361608,0.0003678125,0.00004700811,0.0000639285,0.000036114758,0.000054314605],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981807,0.00042627516,0.00075272325,0.00021045879,0.00008421248,0.00034565167],"domain_scores_gemma":[0.9985183,0.00012964912,0.00044140522,0.0002058307,0.00021057409,0.00049423054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005350799,0.0002087568,0.0018946718,0.0006043268,0.000056378674,0.0000029035168,0.00016761331,0.0003421856,0.00034035635],"category_scores_gemma":[0.00006922465,0.00016756327,0.0003148856,0.00036005676,0.0002966991,0.000027569435,0.000020606953,0.00078599603,0.000023963268],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025246572,0.00028411185,0.00053580955,0.07648214,0.0040670205,0.00095546455,0.0006368688,0.000012065243,0.01744334,0.00059644744,0.0033174409,0.89541686],"study_design_scores_gemma":[0.001687264,0.00086651475,0.0026941863,0.0046400605,0.0021876106,0.0008700745,0.00005728375,0.000013877931,0.00089157047,0.00076375366,0.98505723,0.0002705796],"about_ca_topic_score_codex":0.0019558736,"about_ca_topic_score_gemma":0.001407269,"teacher_disagreement_score":0.98173976,"about_ca_system_score_codex":0.00012614287,"about_ca_system_score_gemma":0.0041909344,"threshold_uncertainty_score":0.7434538},"labels":[],"label_agreement":null},{"id":"W4387078302","doi":"10.1161/circgen.123.004137","title":"Contribution of Lipoprotein(a) to Polygenic Risk Prediction of Coronary Artery Disease: A Prospective UK Biobank Analysis","year":2023,"lang":"en","type":"article","venue":"Circulation Genomic and Precision Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Coronary artery disease; Internal medicine; Medicine; CAD; Cardiology; Hazard ratio; Lipoprotein(a); Biobank; Myocardial infarction; Proportional hazards model; Lipoprotein; Cholesterol; Confidence interval; Bioinformatics; Biology","score_opus":0.01441832865128997,"score_gpt":0.2639913202273062,"score_spread":0.24957299157601623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387078302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96769696,0.0029989157,0.0267798,0.00039648177,0.00016404742,0.0016862232,0.00016197446,0.000054536962,0.000061063656],"genre_scores_gemma":[0.99796796,0.0010316082,0.00014763145,0.000057890673,0.0002616107,0.00006245592,0.00039610767,0.000015621494,0.000059129296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979184,0.00013836786,0.0007058985,0.0004067226,0.0006363872,0.00019419182],"domain_scores_gemma":[0.9983425,0.00012696517,0.00028941347,0.0005308373,0.00039924486,0.0003110526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014473591,0.00015746377,0.0007039332,0.00074292824,0.00009934195,0.0000040296986,0.00005714495,0.0001044485,0.00014073716],"category_scores_gemma":[0.00069673214,0.00012684082,0.00024501188,0.00157251,0.00011227324,0.0000480167,0.000046103094,0.00012346494,0.0000109502025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013312586,0.00006425696,0.9054954,0.00016582922,0.0014481257,0.000012837066,0.0008244914,0.0017057864,0.023800539,0.00016679776,0.00018110484,0.064803585],"study_design_scores_gemma":[0.0023829758,0.0004754909,0.98679507,0.00021456691,0.002164125,0.000013669802,0.00015673446,0.006449788,0.00030538253,0.00077038223,0.00018605053,0.00008573847],"about_ca_topic_score_codex":0.000205225,"about_ca_topic_score_gemma":0.000010713612,"teacher_disagreement_score":0.08129971,"about_ca_system_score_codex":0.00011018833,"about_ca_system_score_gemma":0.00011217464,"threshold_uncertainty_score":0.51724184},"labels":[],"label_agreement":null},{"id":"W4387128991","doi":"10.1007/s12325-023-02666-z","title":"Efficacy and Safety of Single-Pill Combination of Rosuvastatin and Ezetimibe in Chinese Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Treatment (ROZEL): A Randomized, Double-Blind, Double Dummy, Active-Controlled Phase 3 Clinical Trial","year":2023,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Rosuvastatin; Statin; Double blind; Ezetimibe; Randomized controlled trial; Internal medicine; Pill; Simvastatin; Single blind; Atorvastatin; Rheumatology; Pharmacology; Alternative medicine; Placebo","score_opus":0.0329011302102163,"score_gpt":0.36149323518587934,"score_spread":0.32859210497566305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387128991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821041,0.0038941877,0.00010220014,0.00017894413,0.0000966147,0.013460685,0.00004005514,0.000022123057,0.000101086],"genre_scores_gemma":[0.98403525,0.014388357,0.00031179708,0.000065108434,0.000039033228,0.0008785813,0.00022215418,0.00003251305,0.000027209102],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9966347,0.00071736606,0.001461916,0.00042973514,0.0004807404,0.0002755428],"domain_scores_gemma":[0.99739116,0.0014266826,0.00062936224,0.00029177777,0.00014553615,0.000115465635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002261549,0.0003063756,0.0029239275,0.00026310302,0.000041324594,0.000013307673,0.00006720032,0.00012202773,0.000006166714],"category_scores_gemma":[0.0001816598,0.00018550616,0.00023445569,0.0004034761,0.0002807874,0.0002298053,0.000021241216,0.00019778512,3.2537335e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79951984,0.0047662393,0.005030103,0.00007772977,0.00042918246,0.0000069199173,0.00077677506,0.000046172845,0.00023863143,0.000016978302,9.577436e-7,0.18909049],"study_design_scores_gemma":[0.9774889,0.011445425,0.009791143,0.00018290321,0.0001459255,0.0000018446318,0.00009354905,0.00018190283,0.00032674332,0.0000922983,0.000096815245,0.0001525735],"about_ca_topic_score_codex":0.00018995441,"about_ca_topic_score_gemma":0.00008081223,"teacher_disagreement_score":0.18893792,"about_ca_system_score_codex":0.00011571163,"about_ca_system_score_gemma":0.0001399291,"threshold_uncertainty_score":0.7564722},"labels":[],"label_agreement":null},{"id":"W4387159199","doi":"10.1016/j.cjco.2023.09.018","title":"Lipoprotein(a) in Familial Hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Familial hypercholesterolemia; Lipoprotein(a); Apolipoprotein B; Internal medicine; Lipoprotein; Endocrinology; Medicine; Cholesterol","score_opus":0.035281618794260436,"score_gpt":0.32411248363760264,"score_spread":0.2888308648433422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387159199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679905,0.00017605031,0.00001552751,0.0018408794,0.00017537805,0.0015548075,0.000005093727,0.00009198779,0.028149756],"genre_scores_gemma":[0.99366874,0.00014586755,0.00033582235,0.0011735366,0.00035735764,0.00022996166,0.000038583657,0.000031737563,0.0040183985],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987887,0.000064558175,0.00021242994,0.00029530574,0.00031811415,0.00032088385],"domain_scores_gemma":[0.99915636,0.000012894401,0.000023429646,0.00062875455,0.000032673164,0.00014590654],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009778673,0.0001060543,0.00041605977,0.00012627438,0.000051606035,0.000048099566,0.00024828783,0.00009612204,0.00009034091],"category_scores_gemma":[0.00008225411,0.000090710884,0.00010046085,0.00053292315,0.000026676766,0.00011859848,0.00027946586,0.00022931435,0.0009249558],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056083174,0.0002225195,0.03198409,0.00037554288,0.00015384074,0.0016361293,0.0010150139,0.00003535633,0.0055945204,0.00069533713,0.009453188,0.9482736],"study_design_scores_gemma":[0.0072058425,0.0003622946,0.8319984,0.00035685825,0.000042953263,0.00014238624,0.00047549186,0.00018162625,0.0016728619,0.000516069,0.15678145,0.00026377346],"about_ca_topic_score_codex":0.002358342,"about_ca_topic_score_gemma":0.00024721332,"teacher_disagreement_score":0.94800985,"about_ca_system_score_codex":0.00008128329,"about_ca_system_score_gemma":0.0001753284,"threshold_uncertainty_score":0.99985296},"labels":[],"label_agreement":null},{"id":"W4387246785","doi":"10.1016/j.jacc.2023.07.018","title":"Performance of the ACC/AHA Pooled Cohort Cardiovascular Risk Equations in Clinical Practice","year":2023,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; U.S. Department of Veterans Affairs","keywords":"Medicine; Cohort; Internal medicine; Myocardial infarction; Atherosclerosis Risk in Communities; Atherosclerotic cardiovascular disease; Rochester Epidemiology Project; Framingham Risk Score; Epidemiology; Retrospective cohort study; Statin; Cardiology; Disease","score_opus":0.021644449613939562,"score_gpt":0.3198363350275148,"score_spread":0.2981918854135752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387246785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382484,0.0011323262,0.00019558362,0.002473835,0.0007705208,0.0006111479,0.00003422797,0.00000672184,0.00095079077],"genre_scores_gemma":[0.99341726,0.005162547,0.00043105616,0.00025988652,0.0006321112,0.000011236661,7.1168347e-7,0.00001919852,0.00006601661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99502164,0.0022791447,0.001287519,0.00017967251,0.0009665953,0.0002654406],"domain_scores_gemma":[0.9956497,0.00085727515,0.001600726,0.0011462979,0.00065278914,0.00009320496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009667105,0.00013675075,0.001795401,0.00018825267,0.00009154208,0.0000022002605,0.0004483701,0.000095439435,0.0000026764687],"category_scores_gemma":[0.005675875,0.00007613299,0.002535591,0.0015343963,0.00059395324,0.000077317214,0.00018168772,0.0008061672,0.00000346491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011661014,0.000098342156,0.95098853,0.000100766614,0.008939101,0.0001844012,0.00008713593,0.018019093,0.00020918518,0.00008060639,0.0026223566,0.017504394],"study_design_scores_gemma":[0.0017134841,0.00079889136,0.9748486,0.00012415533,0.0024896213,0.0012008572,0.0005845767,0.00045208048,0.00015757531,0.0000310133,0.017523097,0.00007600339],"about_ca_topic_score_codex":0.00017672345,"about_ca_topic_score_gemma":0.000008164449,"teacher_disagreement_score":0.023860129,"about_ca_system_score_codex":0.00011313124,"about_ca_system_score_gemma":0.0009420132,"threshold_uncertainty_score":0.6794963},"labels":[],"label_agreement":null},{"id":"W4387253116","doi":"10.1161/atvb.43.suppl_1.116","title":"Abstract 116: Variation In Lipoprotein (a) Level Reduction With Potent Lipid Lowering: An Analysis Of The Cholesterol Reduction And Residual Risk In Diabetes Study","year":2023,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Berger (Canada); Western University","funders":"","keywords":"Internal medicine; Medicine; Lipoprotein(a); Apolipoprotein B; Endocrinology; Ezetimibe; Type 2 diabetes; Statin; Atorvastatin; Evolocumab; Lipoprotein; Diabetes mellitus; Cholesterol; Apolipoprotein A1","score_opus":0.03891762288104753,"score_gpt":0.28732123598946807,"score_spread":0.24840361310842055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387253116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984282,0.00004210986,0.000027572258,0.00029653823,0.000091567614,0.0010655562,0.00001779956,0.000026822696,0.0000038209105],"genre_scores_gemma":[0.9985262,0.001093416,0.00007490952,0.000023832183,0.000090952184,0.00013108576,0.000039145838,0.000019564393,9.0237853e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981012,0.00036275078,0.0004567339,0.00055806065,0.000241133,0.000280146],"domain_scores_gemma":[0.9990915,0.0000180976,0.0001895309,0.00056137,0.00006212802,0.00007737226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016482456,0.00019217913,0.00067911204,0.000497283,0.00012065186,0.000026510537,0.0000747442,0.00015131045,0.000003993221],"category_scores_gemma":[0.000036436504,0.00013288346,0.00014364687,0.0011424432,0.00012888113,0.00013575182,0.00006615179,0.00022596323,7.3430436e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024198218,0.0004580266,0.87391293,0.00006403477,0.0011561156,1.13925495e-7,0.0022092902,0.00027489194,0.11673731,0.0000065444588,0.0000012177784,0.0051553287],"study_design_scores_gemma":[0.001872223,0.00090610865,0.9934953,0.0001194174,0.00091759197,6.7024376e-7,0.0014858114,0.0003789981,0.0006712587,0.000011583211,0.0000051007487,0.00013593644],"about_ca_topic_score_codex":0.004218626,"about_ca_topic_score_gemma":0.0018887386,"teacher_disagreement_score":0.11958238,"about_ca_system_score_codex":0.000060642353,"about_ca_system_score_gemma":0.000036706915,"threshold_uncertainty_score":0.63773286},"labels":[],"label_agreement":null},{"id":"W4387337615","doi":"10.1016/j.cjca.2023.06.355","title":"SEX DIFFERENCES IN THE PRESENTATION, TREATMENT AND OUTCOMES OF PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEREMIA","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Disease; Internal medicine; Pediatrics; Endocrinology; Cholesterol","score_opus":0.021940818974786096,"score_gpt":0.2545642890968763,"score_spread":0.2326234701220902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387337615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985759,0.00021855863,0.000021012445,0.00054796855,0.00008808746,0.00022885895,0.000017709634,0.0000014827425,0.00030038282],"genre_scores_gemma":[0.9996006,0.00010452668,0.000017331593,0.000087507455,0.00013951966,0.0000058296946,0.000006986829,0.0000052325026,0.000032459215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928075,0.00015566236,0.00020087355,0.00007202077,0.00013441162,0.00015628923],"domain_scores_gemma":[0.9994971,0.000063675536,0.000064541244,0.0001379237,0.000090043315,0.00014669301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028360728,0.00007077816,0.00045469523,0.0001825794,0.000034272816,0.000005865408,0.00005823252,0.00004691777,0.00000143784],"category_scores_gemma":[0.00005143881,0.000035677447,0.00009279509,0.00012624796,0.00010224873,0.00002537757,0.000003361985,0.000094584946,5.773938e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032631553,0.0000031982086,0.98576,0.000013313383,0.00019641191,0.00013735164,0.00082707155,0.000024092311,0.0000018599645,0.00000956857,0.00011854168,0.012875988],"study_design_scores_gemma":[0.0017671204,0.00070651254,0.99468404,0.00001794143,0.00009795752,0.00017603811,0.0008877163,0.0000012843958,0.000005402116,0.00003127979,0.0015922193,0.000032516564],"about_ca_topic_score_codex":0.0027598403,"about_ca_topic_score_gemma":0.002998825,"teacher_disagreement_score":0.012843472,"about_ca_system_score_codex":0.00006138108,"about_ca_system_score_gemma":0.00046319386,"threshold_uncertainty_score":0.41720715},"labels":[],"label_agreement":null},{"id":"W4387337837","doi":"10.1016/j.cjca.2023.06.307","title":"FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA: INVESTIGATING MANAGEMENT PATTERNS AND CLINICAL OUTCOMES FROM THE FH CANADA REGISTRY","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Patient registry; Disease; Internal medicine; Cholesterol","score_opus":0.03649906864490028,"score_gpt":0.2701960487962239,"score_spread":0.23369698015132362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387337837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990304,0.00035602148,0.000021633443,0.007680593,0.0009960998,0.00017008447,0.00007665096,0.0000025019444,0.000392435],"genre_scores_gemma":[0.9949143,0.00027592486,0.00003838877,0.003837163,0.0008696042,0.0000036991296,0.0000144490205,0.000013547814,0.000032954424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982986,0.0002946073,0.0005724318,0.00017411988,0.00027896228,0.00038130916],"domain_scores_gemma":[0.9985803,0.00021499216,0.00012761266,0.00033600524,0.00006453181,0.0006765706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010038944,0.00012017057,0.00064431,0.00007743855,0.000078289864,0.000011685888,0.00017777641,0.000083158004,0.0000044789026],"category_scores_gemma":[0.00032149162,0.000084492895,0.0001459867,0.00013260319,0.000085672,0.000023232074,0.000031488475,0.0005775228,7.252164e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000070710116,2.8402246e-7,0.970904,0.00001908031,0.00034525807,0.0025640351,0.00003602511,0.000121586585,7.344064e-7,0.000007853738,0.011585614,0.014408437],"study_design_scores_gemma":[0.0009637736,0.0000306089,0.96440136,0.00010530496,0.00011845379,0.0002505798,0.0014447364,0.000013737594,7.155165e-7,0.000027576347,0.032571714,0.00007141485],"about_ca_topic_score_codex":0.9995056,"about_ca_topic_score_gemma":0.9999401,"teacher_disagreement_score":0.020986099,"about_ca_system_score_codex":0.00090482616,"about_ca_system_score_gemma":0.013305779,"threshold_uncertainty_score":0.9922879},"labels":[],"label_agreement":null},{"id":"W4387429392","doi":"10.1007/s40119-023-00334-5","title":"Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study","year":2023,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Université Laval; Centre hospitalier universitaire de Québec; Amgen (Canada)","funders":"Amgen Canada; Amgen","keywords":"Evolocumab; Medicine; Hyperlipidemia; Internal medicine; Diabetes mellitus; Endocrinology; Total cholesterol; Cholesterol","score_opus":0.017380496165767822,"score_gpt":0.2911795570283895,"score_spread":0.2737990608626217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387429392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99707144,0.0014593904,0.000015603728,0.00019516288,0.0001213828,0.0010088035,0.000022719078,0.00005455394,0.000050949155],"genre_scores_gemma":[0.9953391,0.0033940438,0.000016446518,0.00063876144,0.00022755178,0.000109662644,0.00014220476,0.000019535024,0.000112685746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981772,0.00050441717,0.00027100687,0.0004567125,0.00028647453,0.0003042263],"domain_scores_gemma":[0.9985561,0.00036846538,0.00006831837,0.00078731275,0.00013270947,0.00008710598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076949946,0.00019339997,0.00090760156,0.00014681781,0.00023297885,0.000024937874,0.000105445244,0.0001308923,0.000008568272],"category_scores_gemma":[0.0000552203,0.0001046212,0.00019282693,0.0010770774,0.00019883763,0.00008283376,0.000051183997,0.0002933327,0.000010753628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010383882,0.00005011913,0.9847308,0.0000051926568,0.0039771204,0.00006872936,0.006405005,0.00009625775,0.0000020725608,0.000023226616,0.00015026728,0.0034528165],"study_design_scores_gemma":[0.005556429,0.0005944293,0.9863366,0.000017409642,0.0003817453,0.0000010871165,0.001990308,0.0000311897,0.000004431313,0.00009046534,0.0048740515,0.000121836645],"about_ca_topic_score_codex":0.010124477,"about_ca_topic_score_gemma":0.004567833,"teacher_disagreement_score":0.005556643,"about_ca_system_score_codex":0.00006476283,"about_ca_system_score_gemma":0.000076144606,"threshold_uncertainty_score":0.9964672},"labels":[],"label_agreement":null},{"id":"W4387516210","doi":"10.2174/0127724328258172230926070748","title":"The Association between Statins Intake and Risk of Post Stroke Pneumonia:A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Current Reviews in Clinical and Experimental Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Meta-analysis; Medicine; Publication bias; Funnel plot; Cochrane Library; Stroke (engine); Odds ratio; Internal medicine; Observational study; Cohort study; Pneumonia; Subgroup analysis; Checklist; Statin; Physical therapy; Psychology","score_opus":0.22599617081920156,"score_gpt":0.5180327889677376,"score_spread":0.2920366181485361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387516210","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003044351,0.99182534,0.0000016154411,0.00014313769,0.00021389536,0.007144132,0.00034634964,0.000012150687,0.000008956803],"genre_scores_gemma":[0.000061007428,0.99795234,0.000021547006,0.0001766709,0.00014659067,0.0014090466,0.00009534238,0.00002630317,0.00011114952],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9897999,0.00492601,0.0039959685,0.00062908453,0.00034499142,0.0003040196],"domain_scores_gemma":[0.9943972,0.0024781646,0.0023567148,0.00043448116,0.000085250635,0.00024814272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011763858,0.00045120943,0.0138687445,0.0001572507,0.00011345503,0.000020983918,0.0001610361,0.00024871816,0.000035754216],"category_scores_gemma":[0.0011991364,0.00022876765,0.0032827854,0.00047292025,0.00022069608,0.000038949755,0.00026331743,0.0010382349,0.000014209408],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006800204,0.00013326637,0.0006030569,0.78328836,0.11823934,0.00000352165,0.000033635526,9.760912e-9,2.9319744e-7,0.000008038002,0.0001933694,0.09749028],"study_design_scores_gemma":[0.00044278573,0.00020247049,0.0001513008,0.02085589,0.8012798,0.000009013074,0.000022928225,0.0000014063963,8.5065807e-7,0.0000037161628,0.17685457,0.00017527117],"about_ca_topic_score_codex":0.00005297386,"about_ca_topic_score_gemma":0.000019052877,"teacher_disagreement_score":0.7624325,"about_ca_system_score_codex":0.000097811804,"about_ca_system_score_gemma":0.00010272987,"threshold_uncertainty_score":0.94803965},"labels":[],"label_agreement":null},{"id":"W4387557738","doi":"10.1016/j.jacadv.2023.100648","title":"The Long-Term Efficacy and Safety of Evinacumab in Patients With Homozygous Familial Hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"JACC Advances","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Regeneron Pharmaceuticals","keywords":"Familial hypercholesterolemia; Medicine; LDL receptor; Internal medicine; Adverse effect; PCSK9; Gastroenterology; Endocrinology; Lipoprotein; Cholesterol","score_opus":0.00793164021826354,"score_gpt":0.26318192930660483,"score_spread":0.2552502890883413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387557738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661386,0.00230109,0.000020357676,0.00014237763,0.00007644847,0.00063939573,0.0000064509672,0.000026699008,0.00017334572],"genre_scores_gemma":[0.9971329,0.002533842,0.00006720668,0.000046232697,0.00006953704,0.000022854045,0.000018674198,0.000014090886,0.00009468982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902326,0.000046161433,0.00020831847,0.00018457921,0.00032987754,0.00020777776],"domain_scores_gemma":[0.9994388,0.000077987024,0.0000573812,0.0003095012,0.00005536786,0.00006093175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027296654,0.00009854049,0.0002689225,0.000052108273,0.000080422134,0.000008416252,0.00006601563,0.000038147948,0.000001722416],"category_scores_gemma":[0.00005937438,0.000055231045,0.00004410295,0.0002454229,0.000100250356,0.00008670183,0.000041635467,0.00012862183,0.0000053646754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010902389,0.000066039844,0.5729728,0.0001647262,0.000038205933,0.000025549263,0.00015402838,0.000017150578,0.000013034127,0.000010913334,0.000011097719,0.42543623],"study_design_scores_gemma":[0.004734068,0.00046626583,0.99292094,0.00022598868,0.00003017535,0.0000092555365,0.000082594444,0.0000046412974,0.00004797309,0.000016045175,0.0013986975,0.000063344],"about_ca_topic_score_codex":0.000023104538,"about_ca_topic_score_gemma":0.00009266436,"teacher_disagreement_score":0.4253729,"about_ca_system_score_codex":0.00003483499,"about_ca_system_score_gemma":0.000046595913,"threshold_uncertainty_score":0.22522567},"labels":[],"label_agreement":null},{"id":"W4387582013","doi":"10.58931/cdet.2023.1315","title":"Lipoprotein (a) in Cardiovascular Risk Assessment and Management in Diabetes Mellitus","year":2023,"lang":"en","type":"article","venue":"Canadian Diabetes & Endocrinology Today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Lipoprotein(a); Risk factor; Diabetes mellitus; Internal medicine; Disease; Type 2 Diabetes Mellitus; Coronary heart disease; Stroke (engine); Atherosclerotic cardiovascular disease; Family history; Risk assessment; Lipoprotein; Cardiology; Endocrinology; Cholesterol","score_opus":0.011954599788277743,"score_gpt":0.2558774691362255,"score_spread":0.24392286934794777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387582013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97248745,0.019468868,0.0000038653984,0.002122916,0.00026095883,0.0017558016,0.000034640027,0.000110378205,0.0037551478],"genre_scores_gemma":[0.9871913,0.010331014,0.00045993796,0.0007306901,0.00013548872,0.00085434376,0.000067428526,0.000058243724,0.00017155493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996015,0.00036005108,0.00046423142,0.0008074396,0.00038845377,0.001964783],"domain_scores_gemma":[0.99817777,0.00006887904,0.00005479771,0.001030614,0.000047769252,0.000620148],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013317069,0.00033049966,0.0009934341,0.0015211287,0.00012778716,0.000033643628,0.00018263781,0.00019640732,0.000054461336],"category_scores_gemma":[0.00008665748,0.00033637122,0.00030997914,0.0010813578,0.00015597777,0.0000959847,0.00012656063,0.0006373752,0.00008612731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000548514,0.000036294197,0.64884967,0.0003421085,0.0009115565,0.0016534566,0.00009659665,0.000111223824,0.000030881616,0.00076448347,0.00035740485,0.34684086],"study_design_scores_gemma":[0.0025218332,0.00013340892,0.9377946,0.00017514988,0.00022369696,0.000012103029,0.00019742218,0.00038327643,0.00030219136,0.00063677825,0.05730467,0.00031482504],"about_ca_topic_score_codex":0.05751078,"about_ca_topic_score_gemma":0.07240077,"teacher_disagreement_score":0.34652603,"about_ca_system_score_codex":0.0007515935,"about_ca_system_score_gemma":0.00034904815,"threshold_uncertainty_score":0.9999088},"labels":[],"label_agreement":null},{"id":"W4387610369","doi":"10.46747/cfp.6910675","title":"PEER simplified lipid guideline 2023 update","year":2023,"lang":"en","type":"article","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; University of British Columbia; Canadian Patient Safety Institute; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; University of Manitoba; Centre Intégré de Santé et Services Sociaux de la Gaspésie; University of Northern British Columbia; University of Alberta; Université Laval; University of Saskatchewan; College of Family Physicians of Canada; NOSM University; Élisabeth Bruyère Hospital; Doug Bragg Enterprises (Canada); Memorial University of Newfoundland; University of Alberta Hospital","funders":"","keywords":"Medicine; Ezetimibe; Guideline; Docosahexaenoic acid; Lipidology; Psychological intervention; Eicosapentaenoic acid; Statin; Intensive care medicine; Internal medicine; Nursing; Polyunsaturated fatty acid; Fatty acid; Clinical chemistry; Pathology; Biochemistry","score_opus":0.024637673008154327,"score_gpt":0.27162205657042193,"score_spread":0.2469843835622676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387610369","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19024399,0.0019615353,0.0002256818,0.071514726,0.0028594057,0.0023735273,0.00080793357,0.00088940916,0.7291238],"genre_scores_gemma":[0.38377804,0.00027992687,0.00045223592,0.580637,0.007825596,0.00013830219,0.0028009925,0.00022622861,0.023861695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977819,0.000040960273,0.00032549014,0.00040203638,0.00062389305,0.0008257593],"domain_scores_gemma":[0.997743,0.000011855612,0.000047214817,0.0008589455,0.00030263327,0.0010363124],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00059202407,0.00021507876,0.00042867666,0.00032446985,0.00019685896,0.000037674945,0.00016121277,0.00012406599,0.000026518312],"category_scores_gemma":[0.000048782993,0.00020819198,0.00029985592,0.0010292613,0.00005050417,0.00007398556,0.00003302865,0.0002601097,0.0038875123],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010959267,0.000012745481,0.00003979619,0.000039450057,0.00012901708,0.0002246999,0.00003111954,0.000030913794,0.000956371,0.00061907724,0.87232274,0.12558311],"study_design_scores_gemma":[0.0006940922,0.000060844533,0.011702106,0.00004189159,0.000074873875,0.0000036107438,0.00040687562,0.00034287467,0.00016885973,0.00025756125,0.98602146,0.00022495486],"about_ca_topic_score_codex":0.034528993,"about_ca_topic_score_gemma":0.009928688,"teacher_disagreement_score":0.7052621,"about_ca_system_score_codex":0.00028924563,"about_ca_system_score_gemma":0.0011660893,"threshold_uncertainty_score":0.9968881},"labels":[],"label_agreement":null},{"id":"W4387610407","doi":"10.46747/cfp.6910e189","title":"Lignes directrices simplifiées de PEER sur les lipides : actualisation 2023","year":2023,"lang":"fr","type":"article","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Canadian Patient Safety Institute; Centre Intégré de Santé et Services Sociaux de la Gaspésie; Université Laval; British Columbia Institute of Technology; Élisabeth Bruyère Hospital; Doug Bragg Enterprises (Canada); Memorial University of Newfoundland; Musée de la Civilisation; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; University of Manitoba; University of Alberta; University of Saskatchewan; College of Family Physicians of Canada; NOSM University","funders":"Ministry of Education, India","keywords":"Humanities; Political science; Medicine; Philosophy","score_opus":0.034905407989668756,"score_gpt":0.26547904585539595,"score_spread":0.23057363786572718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387610407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7186629,0.11959646,0.000097462755,0.03444879,0.0072736195,0.0017785062,0.0012488276,0.0004896263,0.11640378],"genre_scores_gemma":[0.89113384,0.006884543,0.000093681,0.04577931,0.016757889,0.00017228494,0.0007599328,0.00022240095,0.038196113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99626905,0.00029488327,0.0004026344,0.00057515956,0.0007357473,0.0017225464],"domain_scores_gemma":[0.9971268,0.00022569246,0.00011857856,0.0007354305,0.00040552966,0.0013879603],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012931261,0.00041024486,0.0006640617,0.0005678972,0.0005333796,0.000151189,0.00026159012,0.00036247657,0.000036124235],"category_scores_gemma":[0.0003252967,0.00044329464,0.00046466812,0.0016103518,0.00018088202,0.0002885149,0.000037298745,0.00042348707,0.0017622769],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015225275,0.00005108169,0.00093718665,0.0007418035,0.0004798499,0.00030687902,0.0011196703,0.00014951242,0.002590372,0.0019411941,0.25132334,0.74034387],"study_design_scores_gemma":[0.00056304113,0.00013700801,0.115964636,0.00070926925,0.00035393826,0.000005035391,0.0048293495,0.0009872641,0.00087590853,0.0006263905,0.87447107,0.00047710046],"about_ca_topic_score_codex":0.44504797,"about_ca_topic_score_gemma":0.11954879,"teacher_disagreement_score":0.7398668,"about_ca_system_score_codex":0.0012504162,"about_ca_system_score_gemma":0.0031657566,"threshold_uncertainty_score":0.9998019},"labels":[],"label_agreement":null},{"id":"W4387610417","doi":"10.46747/cfp.6910664","title":"Canadian dyslipidemia guidelines for family doctors","year":2023,"lang":"en","type":"editorial","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Quarter (Canadian coin); Medicine; Family medicine; Internal medicine; Geography","score_opus":0.04422513419235939,"score_gpt":0.31742967514911813,"score_spread":0.2732045409567587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387610417","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024187275,0.0045302375,0.000027089416,0.0036257925,0.9486906,0.0029611553,0.008923744,0.0002693518,0.030730164],"genre_scores_gemma":[0.000065431544,0.0005170679,0.00039525007,0.07500295,0.90794265,0.00061142363,0.008224366,0.00055789686,0.0066829403],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99361336,0.00009649192,0.001066614,0.0013513186,0.0013458292,0.002526404],"domain_scores_gemma":[0.990379,0.00036063668,0.00024930498,0.0018799248,0.0025568586,0.004574294],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013212116,0.0009568823,0.00196757,0.0013067989,0.0005910839,0.00015182856,0.0006514192,0.0019622366,0.0000050989916],"category_scores_gemma":[0.0017679639,0.0009783941,0.0013807951,0.00095435634,0.00010819381,0.00011448906,0.000043081684,0.0014185114,0.0006425145],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000021993796,0.000008885388,0.000004396561,0.00051675853,0.00058027956,0.00017657252,0.000023860557,0.000009791358,0.00003219243,0.000073474934,0.96414894,0.034402847],"study_design_scores_gemma":[0.0012334492,0.0002057641,0.00034049168,0.0008433389,0.0006473299,6.0106004e-7,0.00034181497,0.000060957114,0.0000071854734,0.0001689833,0.99523443,0.000915669],"about_ca_topic_score_codex":0.9523998,"about_ca_topic_score_gemma":0.94970745,"teacher_disagreement_score":0.071377166,"about_ca_system_score_codex":0.005919217,"about_ca_system_score_gemma":0.043300603,"threshold_uncertainty_score":0.99933344},"labels":[],"label_agreement":null},{"id":"W4387610418","doi":"10.46747/cfp.6910701","title":"Lipid-lowering therapies for cardiovascular disease prevention and management in primary care","year":2023,"lang":"en","type":"review","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McMaster University; Doug Bragg Enterprises (Canada); University of Manitoba; Élisabeth Bruyère Hospital; University of British Columbia; College of Family Physicians of Canada; University of Alberta; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal","funders":"","keywords":"Medicine; Ezetimibe; Systematic review; Internal medicine; Adverse effect; Relative risk; Mace; Interquartile range; Statin; Cochrane Library; Randomized controlled trial; Meta-analysis; Intensive care medicine; MEDLINE; Confidence interval; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.04146573268927007,"score_gpt":0.2897232964264115,"score_spread":0.24825756373714142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387610418","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004518472,0.990041,0.000040225215,0.000021039112,0.0002830606,0.005969059,0.00020206432,0.000055090375,0.0033432737],"genre_scores_gemma":[0.00001811012,0.99444675,0.0001262527,0.0014458837,0.0007558451,0.001796624,0.0010123622,0.00015784502,0.00024033361],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793303,0.00008504143,0.00038502942,0.0006795337,0.00034789843,0.00056948874],"domain_scores_gemma":[0.9983444,0.00001802765,0.00007397657,0.0009364427,0.00005375845,0.0005733755],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035239838,0.00040930486,0.0017536448,0.0005254793,0.00012630249,0.000044472185,0.00013399436,0.00016406142,2.5718074e-7],"category_scores_gemma":[0.0000050502813,0.000388291,0.0020215516,0.0004370213,0.0000393675,0.000059522747,0.000046888963,0.00023136046,0.000016052067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000066710945,0.000011186332,0.0000011737092,0.09318034,0.0025887403,0.00015370167,0.0000348163,0.0000027122608,4.529947e-8,0.000069668036,0.00019139594,0.90375954],"study_design_scores_gemma":[0.00066572224,0.000049252365,0.0007092839,0.022834413,0.0044045714,0.0000014224951,0.00026314872,0.0000018599617,3.946903e-8,0.00005037263,0.9706748,0.00034512868],"about_ca_topic_score_codex":0.0033525177,"about_ca_topic_score_gemma":0.0018115683,"teacher_disagreement_score":0.97048336,"about_ca_system_score_codex":0.0012534178,"about_ca_system_score_gemma":0.0013962177,"threshold_uncertainty_score":0.9998569},"labels":[],"label_agreement":null},{"id":"W4387610431","doi":"10.46747/cfp.6910696","title":"Influenza vaccination for the prevention of cardiovascular events","year":2023,"lang":"en","type":"article","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of Alberta Hospital; University of Alberta; University of British Columbia","funders":"","keywords":"Vaccination; Medicine; Acute coronary syndrome; Placebo; Immunology; Intensive care medicine; Internal medicine; Myocardial infarction; Alternative medicine; Pathology","score_opus":0.0340111172716645,"score_gpt":0.2828792428835154,"score_spread":0.2488681256118509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387610431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91652054,0.03072332,0.0059967623,0.0025126692,0.0017683984,0.011594128,0.000323401,0.00027404874,0.03028675],"genre_scores_gemma":[0.9890916,0.00032150504,0.00008562702,0.009051396,0.0006497188,0.00032440026,0.00011544294,0.000046469864,0.00031385658],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989743,0.000041797353,0.00018535153,0.00018209798,0.00032234078,0.00029408338],"domain_scores_gemma":[0.99900806,0.000028165272,0.000049753922,0.000579141,0.00017172896,0.00016312597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006088649,0.00009831789,0.00028261874,0.0001596277,0.00014692769,0.000006863554,0.000100010475,0.00006329638,0.0000012904186],"category_scores_gemma":[0.000031313066,0.00007838321,0.00065371353,0.00052650494,0.00001427893,0.000057548787,0.000011259888,0.00008148698,0.00003233815],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034893204,0.000030880827,0.00020969605,0.00039480758,0.0019491239,0.000006620509,0.00012971321,0.0009887182,0.00047427788,0.00094893423,0.008241194,0.98659116],"study_design_scores_gemma":[0.002138804,0.00021763724,0.2613584,0.00015178238,0.0009372513,0.000001312312,0.0007062211,0.0011587767,0.00091705495,0.0013264101,0.73090494,0.0001813883],"about_ca_topic_score_codex":0.008496803,"about_ca_topic_score_gemma":0.0010880253,"teacher_disagreement_score":0.9864097,"about_ca_system_score_codex":0.0001653976,"about_ca_system_score_gemma":0.00052600796,"threshold_uncertainty_score":0.9981057},"labels":[],"label_agreement":null},{"id":"W4387674133","doi":"10.1097/ebp.0000000000001990","title":"Do statins increase the risk for the development of diabetes?","year":2023,"lang":"en","type":"article","venue":"Evidence-Based Practice","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Indigenous Peoples' Health","funders":"","keywords":"Diabetes mellitus; Medicine; Endocrinology","score_opus":0.05885665126636922,"score_gpt":0.349678763239018,"score_spread":0.29082211197264873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387674133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8849391,0.014092483,0.018619617,0.07512558,0.0005344222,0.005649563,0.000057816265,0.00018651964,0.00079489226],"genre_scores_gemma":[0.98163694,0.0010580572,0.012858523,0.0030340545,0.00037611308,0.00076478824,0.00001618056,0.000032922828,0.00022239378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977918,0.00052959786,0.00038026736,0.0002328589,0.0007655901,0.000299843],"domain_scores_gemma":[0.98663944,0.011720876,0.0003353419,0.00082231045,0.00037780582,0.00010422426],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010766982,0.00012674797,0.00024258626,0.000060708586,0.0004326955,0.000038492344,0.00020087915,0.00005051963,0.00005253409],"category_scores_gemma":[0.019761855,0.00006453377,0.00020872572,0.0005601161,0.00008752967,0.00022971438,0.00005349035,0.0002851342,0.00007287025],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025451644,0.0004570889,0.02632716,0.0021759346,0.0023765664,0.00003024273,0.0055223093,0.0011736102,0.0011788523,0.0006654255,0.025160803,0.9323868],"study_design_scores_gemma":[0.003077721,0.00071872026,0.15388227,0.0013607774,0.0024552306,0.000010606088,0.005273925,0.0050526285,0.01034183,0.00016392027,0.8173649,0.00029747462],"about_ca_topic_score_codex":0.00036497865,"about_ca_topic_score_gemma":0.000036291563,"teacher_disagreement_score":0.9320894,"about_ca_system_score_codex":0.000077420904,"about_ca_system_score_gemma":0.0013919321,"threshold_uncertainty_score":0.9884951},"labels":[],"label_agreement":null},{"id":"W4387729057","doi":"10.23736/s0031-0808.23.04999-6","title":"Establishing a multi-specialty consensus in the clinical need for hypercholesterolemia management and its implication for patients access to innovative therapies","year":2023,"lang":"en","type":"article","venue":"Panminerva Medica","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Specialty; Concordance; Likert scale; Consensus conference; Health care; Canadian Cardiovascular Society; Health professionals; Family medicine; MEDLINE; Intensive care medicine; Psychology; Internal medicine; Political science","score_opus":0.12037690174962375,"score_gpt":0.41182356651098245,"score_spread":0.2914466647613587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387729057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974622,0.00015706707,0.0012446074,0.017281462,0.00030545794,0.006174664,0.000056241282,0.000049370054,0.00010914233],"genre_scores_gemma":[0.98868936,0.00027066146,0.0028887778,0.0047319783,0.00061684655,0.0024543437,0.0002021865,0.000031252064,0.00011460874],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983477,0.00011290617,0.0004906611,0.0003589081,0.00037431423,0.00031548872],"domain_scores_gemma":[0.99859685,0.0005635642,0.0000964636,0.00032589078,0.00029000972,0.00012724793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027643905,0.00013249715,0.00035500867,0.00017181024,0.000104389284,0.000054407785,0.00019680348,0.00009459101,0.0000020255325],"category_scores_gemma":[0.0015703614,0.000087875334,0.0000878897,0.00072838913,0.000042745858,0.00007046394,0.00010240008,0.00016180467,0.000003927377],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011723987,0.0007036129,0.122508444,0.0014230108,0.0004812184,0.000019631045,0.007226157,0.0000032405833,0.00018969845,0.0010281713,0.042650513,0.8225939],"study_design_scores_gemma":[0.0072465767,0.0004287976,0.9162955,0.00017959691,0.000081025624,0.0000028937088,0.0017938919,0.0004875799,0.000034877492,0.00011471592,0.07321221,0.00012232845],"about_ca_topic_score_codex":0.000047225087,"about_ca_topic_score_gemma":0.00006650078,"teacher_disagreement_score":0.82247156,"about_ca_system_score_codex":0.00004378196,"about_ca_system_score_gemma":0.00007108114,"threshold_uncertainty_score":0.3583452},"labels":[],"label_agreement":null},{"id":"W4387747952","doi":"10.1016/j.atherosclerosis.2023.117354","title":"Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials","year":2023,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharmaceuticals UK Limited; Novartis Pharma; Novartis","keywords":"Medicine; Myocardial infarction; Placebo; Internal medicine; Post-hoc analysis; Adverse effect; Confidence interval; Cardiology; Pathology","score_opus":0.022149575772875674,"score_gpt":0.2808909723953394,"score_spread":0.2587413966224637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387747952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969881,0.00011216997,0.000019197387,0.00053799525,0.00013315179,0.0020363997,0.00009799226,0.000043244607,0.000031741787],"genre_scores_gemma":[0.9990451,0.00020042947,0.00005061557,0.0002661748,0.00011537442,0.00012781016,0.00009601219,0.000030650528,0.00006786109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99743253,0.0005012828,0.0007054046,0.00035808847,0.0007286198,0.00027408867],"domain_scores_gemma":[0.99843824,0.00022924601,0.00029842983,0.00066836877,0.00023204146,0.00013368049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024104083,0.00020733877,0.0013472912,0.0003899225,0.00014241117,0.00002684888,0.000104858176,0.00012960884,0.00010398014],"category_scores_gemma":[0.0005982072,0.000121550605,0.0006898414,0.0025399427,0.00010002955,0.000083140185,0.00007366134,0.00014791604,0.000005765093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026245607,0.001119507,0.87299275,0.00019754442,0.011517654,0.0000036274091,0.003170982,0.00011581631,0.004413116,0.000028793671,0.00024698186,0.07994763],"study_design_scores_gemma":[0.08217078,0.00075450493,0.91126937,0.00013701124,0.004425238,5.391396e-7,0.00016192642,0.000095861404,0.0003035808,0.0000040492055,0.0005457373,0.00013139659],"about_ca_topic_score_codex":0.0007125402,"about_ca_topic_score_gemma":0.00020071497,"teacher_disagreement_score":0.07981623,"about_ca_system_score_codex":0.00008112972,"about_ca_system_score_gemma":0.00015470528,"threshold_uncertainty_score":0.49566898},"labels":[],"label_agreement":null},{"id":"W4387756258","doi":"10.4103/0028-3886.388115","title":"Effects of Serum Cholesterol on Severity of Stroke and Dosage of Statins on Functional Outcome in Acute Ischemic Stroke","year":2023,"lang":"en","type":"article","venue":"Neurology India","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Stroke (engine); Hyperlipidemia; Atorvastatin; Internal medicine; Statin; Cholesterol; Neuroprotection; Cerebral infarction; Gastroenterology; Diabetes mellitus; Ischemia; Endocrinology","score_opus":0.011657015411501033,"score_gpt":0.2609188651077938,"score_spread":0.24926184969629275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387756258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99855036,0.000028900242,0.0000039870706,0.00034074025,0.00015154983,0.0004387156,0.00017657966,0.00001602091,0.00029314595],"genre_scores_gemma":[0.9990694,0.000054914988,0.00001364674,0.000663519,0.000031870117,0.000018172663,0.000013960046,0.00001363888,0.00012085979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885404,0.00012441953,0.0003079732,0.00022033467,0.0002987322,0.00019448924],"domain_scores_gemma":[0.99933916,0.00017999597,0.00013058487,0.00025825197,0.000029982146,0.00006200519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030200835,0.00011304854,0.0004987749,0.00023835225,0.000014844285,9.991545e-7,0.000048883907,0.00014961702,0.000015294787],"category_scores_gemma":[0.00008134504,0.000098170916,0.00010877131,0.00015495993,0.00008730855,0.000022546756,0.000041254538,0.00037533054,0.000006024271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011402844,0.00021590064,0.95220596,0.0008427249,0.00022565536,0.00014555521,0.00022433796,0.000024960224,0.03974777,0.000027640499,0.00015562426,0.005043579],"study_design_scores_gemma":[0.0032672815,0.002201641,0.9532516,0.000035219626,0.00007556723,0.000022711212,0.0000120635,0.00002238292,0.04095377,0.0000043227537,0.000110207766,0.000043213837],"about_ca_topic_score_codex":0.00006231185,"about_ca_topic_score_gemma":0.000014032317,"teacher_disagreement_score":0.005000365,"about_ca_system_score_codex":0.000010578713,"about_ca_system_score_gemma":0.000053308908,"threshold_uncertainty_score":0.40032938},"labels":[],"label_agreement":null},{"id":"W4387765608","doi":"10.1093/eurjpc/zwad332","title":"Evolocumab in paediatric heterozygous familial hypercholesterolaemia: cognitive function during 80 weeks of open-label extension treatment","year":2023,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université du Québec à Chicoutimi; Université Laval; Université de Montréal; Centre hospitalier universitaire de Québec","funders":"Esperion Therapeutics; Amryt Pharma; Eli Lilly and Company; AstraZeneca; Biolab Farmacêutica; PTC Therapeutics; Sanofi; Kowa Company; Universidade de São Paulo; Regeneron Pharmaceuticals; Novo Nordisk; Amgen","keywords":"Medicine; Evolocumab; Placebo; Randomization; Randomized controlled trial; Internal medicine; Audiology; Cholesterol; Lipoprotein","score_opus":0.04289188693882718,"score_gpt":0.30608124739177256,"score_spread":0.2631893604529454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387765608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933038,0.003582777,0.00062198844,0.0000890081,0.0006116018,0.00068210304,0.0000152283765,0.000016992799,0.0010765328],"genre_scores_gemma":[0.99651843,0.0021988265,0.00009749414,0.000050549508,0.0008381802,0.000010503739,0.000018592098,0.000042466265,0.0002249691],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99602705,0.002228179,0.00079330656,0.00031616338,0.0003110208,0.00032429319],"domain_scores_gemma":[0.9986616,0.00009716216,0.00040520274,0.00028630538,0.0003998499,0.00014992573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026980338,0.00020496326,0.0010428401,0.000494619,0.00006369442,0.000012569909,0.00016504133,0.00007856909,0.000008449011],"category_scores_gemma":[0.0003152846,0.00015992761,0.0004050999,0.00043193818,0.00008292134,0.00015522807,0.00019479268,0.0004140696,0.000039959938],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023567742,0.002018011,0.11971984,0.0007967908,0.0076884264,0.04617995,0.0029864516,0.0009695648,0.11264385,0.000020208152,0.0011565256,0.68225265],"study_design_scores_gemma":[0.021882476,0.007650602,0.9640905,0.00048435509,0.0008523317,0.002847859,0.0007263699,0.000014423184,0.0008630598,0.000032056698,0.00040463125,0.00015129097],"about_ca_topic_score_codex":0.000018915558,"about_ca_topic_score_gemma":0.000003030961,"teacher_disagreement_score":0.8443707,"about_ca_system_score_codex":0.00017779978,"about_ca_system_score_gemma":0.00015465647,"threshold_uncertainty_score":0.65216583},"labels":[],"label_agreement":null},{"id":"W4387783720","doi":"10.1016/j.jacl.2023.10.007","title":"Sex differences in the perception of cardiovascular risk in familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of British Columbia; McGill University Health Centre; Providence Health Care Research Institute; Canadian Heart Research Centre; Providence Health Care","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Atherosclerotic cardiovascular disease; Myocardial infarction; Disease; Male gender; Cholesterol; Demography","score_opus":0.09393370917370486,"score_gpt":0.3804061041598035,"score_spread":0.28647239498609867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387783720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966486,0.0006672988,0.000110556735,0.00104477,0.0011297489,0.00022674717,0.0000027025992,0.000005558157,0.00016398467],"genre_scores_gemma":[0.9885677,0.0074998834,0.00017219054,0.00033533006,0.0033894274,0.0000051917054,0.0000018797818,0.000009025549,0.00001933595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994979,0.0023690208,0.0016089113,0.00017733128,0.00063352415,0.00023221427],"domain_scores_gemma":[0.9981289,0.0008833398,0.00036682704,0.0004199714,0.000110880275,0.00009006324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015805129,0.00010444472,0.0014291714,0.0002542073,0.00002203878,0.0000048153297,0.00021740363,0.00027448556,0.000015789685],"category_scores_gemma":[0.0022069337,0.000060333972,0.0011524346,0.0003897992,0.00016369722,0.000050196355,0.000040051604,0.0011977494,0.000012729453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044999286,0.00023244874,0.826306,0.000072551695,0.0003540461,0.000089521745,0.00074044574,0.00013437112,0.00005403552,0.000010869425,0.00028790432,0.17126784],"study_design_scores_gemma":[0.0036981388,0.0012451224,0.98835075,0.00010738772,0.00023219132,0.00018763487,0.0015760222,0.00010066769,0.000003675222,0.0002405142,0.004206994,0.000050894945],"about_ca_topic_score_codex":0.00029993703,"about_ca_topic_score_gemma":0.00005339579,"teacher_disagreement_score":0.17121693,"about_ca_system_score_codex":0.000030568255,"about_ca_system_score_gemma":0.00020557322,"threshold_uncertainty_score":0.5477774},"labels":[],"label_agreement":null},{"id":"W4387801059","doi":"10.1016/j.jacl.2023.10.008","title":"Comparison of the burden of familial hypercholesterolemia between two cohorts of French Canadians hospitalized 25 years apart for coronary heart disease","year":2023,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de Chicoutimi; Université de Montréal; Université du Québec à Chicoutimi","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Familial hypercholesterolemia; Cohort; Internal medicine; Coronary heart disease; Cohort study; Population; Disease; Pediatrics; Cholesterol","score_opus":0.08296627937137133,"score_gpt":0.42355261912419123,"score_spread":0.34058633975281993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387801059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935855,0.00029459764,0.000059181697,0.0035227526,0.0018099251,0.00055487716,0.00011816617,0.0000053273898,0.000049672286],"genre_scores_gemma":[0.9956165,0.00007093373,0.00036241,0.00033603364,0.003488912,0.000005314106,0.00001502479,0.000018817967,0.00008604233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964763,0.00047813365,0.0020975831,0.00016868162,0.0005221849,0.0002571467],"domain_scores_gemma":[0.99694395,0.000878737,0.0009550788,0.0004700641,0.000380422,0.00037173953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028339385,0.00011575358,0.0018987876,0.0001175442,0.00002769805,0.0000020125954,0.00024410852,0.0001887301,0.000019154428],"category_scores_gemma":[0.001764614,0.000081507,0.0010891607,0.00019691871,0.0003671687,0.000031337768,0.0000687373,0.00044749054,0.00000212377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006644951,0.00015872241,0.9799216,0.00022442048,0.0004556881,0.0000084255225,0.0002220519,0.00014056075,0.00022458003,0.000020357034,0.01287821,0.0050808946],"study_design_scores_gemma":[0.0045118546,0.0017996922,0.97929937,0.0002493858,0.0007167677,0.000021671425,0.00013261396,0.000080208316,0.00006183282,0.00023146963,0.012832582,0.00006256131],"about_ca_topic_score_codex":0.0017830663,"about_ca_topic_score_gemma":0.00012065854,"teacher_disagreement_score":0.0050183334,"about_ca_system_score_codex":0.000033243567,"about_ca_system_score_gemma":0.0010461491,"threshold_uncertainty_score":0.3323759},"labels":[],"label_agreement":null},{"id":"W4387823501","doi":"10.1210/clinem/dgad625","title":"High Lipoprotein(a) May Explain One-Quarter of Clinical Familial Hypercholesterolemia Diagnoses in Danish Lipid Clinics","year":2023,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Danish; Familial hypercholesterolemia; Quarter (Canadian coin); Medical diagnosis; Medicine; Internal medicine; Cholesterol; History; Pathology; Philosophy","score_opus":0.07988070915513015,"score_gpt":0.4016563566574727,"score_spread":0.32177564750234255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387823501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98180884,0.0027244047,0.00008909701,0.009866451,0.0044089127,0.00077559275,0.000019086478,0.000051925235,0.00025566484],"genre_scores_gemma":[0.9500321,0.036314767,0.0013924842,0.0030190947,0.0089846635,0.000026041505,0.000009786685,0.000063496045,0.00015754793],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9859148,0.0042612944,0.0071157846,0.0005059454,0.0012729267,0.0009292469],"domain_scores_gemma":[0.99015796,0.0052926554,0.0020735208,0.0014197049,0.00054392824,0.0005122412],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.017369157,0.0003871049,0.004187348,0.0004138685,0.000097439864,0.000015988258,0.0008694123,0.0006425015,0.000104117375],"category_scores_gemma":[0.010377763,0.00025412263,0.0019943793,0.00066479197,0.00089522783,0.00019830908,0.00030373893,0.0037603972,0.000113605645],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01056115,0.0036078792,0.16972011,0.00030045616,0.0029977183,0.0016551414,0.0008392687,0.00014920339,0.00050644105,0.0026256556,0.0069025937,0.80013436],"study_design_scores_gemma":[0.01585569,0.0023609246,0.9250206,0.00040459918,0.0012725943,0.0005974998,0.0006744135,0.00003479915,0.0006597599,0.0013393114,0.05153438,0.00024544421],"about_ca_topic_score_codex":0.00034285866,"about_ca_topic_score_gemma":0.000086879016,"teacher_disagreement_score":0.79988897,"about_ca_system_score_codex":0.00002897835,"about_ca_system_score_gemma":0.0007996903,"threshold_uncertainty_score":0.9999911},"labels":[],"label_agreement":null},{"id":"W4387965947","doi":"10.1056/nejmoa2309995","title":"Simvastatin in Critically Ill Patients with Covid-19","year":2023,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; NIHR Imperial Biomedical Research Centre; Health Research Council of New Zealand; Medical Research Council; FP7 Health; University of Pittsburgh; National University Health System; Medical Center, University of Pittsburgh; Minderoo Foundation; European Commission; Office of Health and Medical Research; National Health and Medical Research Council; Wellcome Trust; Canadian Institutes of Health Research; National Institute of General Medical Sciences; National Institute for Health and Care Research","keywords":"Interquartile range; Medicine; Simvastatin; Odds ratio; Hazard ratio; Confidence interval; Internal medicine","score_opus":0.019584170042455468,"score_gpt":0.3020634654590752,"score_spread":0.28247929541661976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387965947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9312602,0.00058469304,0.0022912757,0.06424961,0.00032034007,0.00034519215,0.0000033840988,0.00002851281,0.0009167869],"genre_scores_gemma":[0.9806243,0.00033551772,0.0010280815,0.015223625,0.0024682232,0.0000024091712,0.000019968533,0.000025185895,0.00027268103],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980035,0.00011471767,0.00050374144,0.00012803657,0.0009850265,0.00026499183],"domain_scores_gemma":[0.99789655,0.0002312655,0.00012516858,0.00019078163,0.000745029,0.0008112306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018151372,0.00012135811,0.0005633349,0.00035373267,0.0000335973,0.000004879473,0.000077108525,0.000050860497,0.00018949353],"category_scores_gemma":[0.005112946,0.00006793672,0.00007371588,0.0005120694,0.000079528436,0.000058415542,0.000014246829,0.00037525623,0.000009581956],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005224725,0.0003405302,0.38791814,0.00073075166,0.0003881227,0.006956943,0.004408054,0.00026982828,0.0001914576,0.00032070468,0.051148146,0.5421026],"study_design_scores_gemma":[0.21519081,0.007118354,0.5245123,0.0012526279,0.00031257578,0.0013249165,0.0011844564,0.000065408516,0.000029521958,0.00088193326,0.24793743,0.00018970548],"about_ca_topic_score_codex":0.00029328722,"about_ca_topic_score_gemma":0.000086232765,"teacher_disagreement_score":0.5419129,"about_ca_system_score_codex":0.000107201,"about_ca_system_score_gemma":0.0006579351,"threshold_uncertainty_score":0.61210436},"labels":[],"label_agreement":null},{"id":"W4387966609","doi":"10.1161/jaha.123.030757","title":"Validating the SMART2 Score in a Racially Diverse High‐Risk Nationwide Cohort of Patients Receiving Coronary Artery Bypass Grafting","year":2023,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Myocardial infarction; Cohort; Coronary artery disease; Kidney disease; Cardiology; Adverse effect; Framingham Risk Score; Stroke (engine); Surgery; Disease","score_opus":0.012425013491316906,"score_gpt":0.26015295757517287,"score_spread":0.24772794408385596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387966609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730426,0.000027574959,0.000023216937,0.0018056664,0.00038733688,0.00039044203,0.00000979167,0.000011941915,0.00003977868],"genre_scores_gemma":[0.99883485,0.00015610816,0.00021673087,0.00040322958,0.00031617843,0.000006477838,0.00000536371,0.00001534531,0.000045709974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971407,0.0007623116,0.0006448586,0.00010823488,0.0011230028,0.00022090379],"domain_scores_gemma":[0.9972819,0.00048474988,0.001515596,0.00021870065,0.00044728912,0.000051735333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050422163,0.00009279875,0.00052945386,0.0001558797,0.00018862604,0.000018952232,0.00012444894,0.000041657615,0.0000043890113],"category_scores_gemma":[0.0034469473,0.00005916162,0.0003650047,0.00089656987,0.000042335796,0.00013355758,0.000069259375,0.00042978898,0.0000041705553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007161407,0.000050432664,0.98716676,0.000014622246,0.00029374336,0.0000048753272,0.0005735636,0.00028055615,0.00027799487,0.0000018737994,0.0006220378,0.01064193],"study_design_scores_gemma":[0.0009356383,0.00018029788,0.9972599,0.00016097186,0.00020499346,0.000012624109,0.00061819656,0.00020523241,0.00015353308,0.000058631318,0.0001556284,0.000054358716],"about_ca_topic_score_codex":0.00074386236,"about_ca_topic_score_gemma":0.0001302045,"teacher_disagreement_score":0.010587571,"about_ca_system_score_codex":0.00055292173,"about_ca_system_score_gemma":0.00021733943,"threshold_uncertainty_score":0.4126567},"labels":[],"label_agreement":null},{"id":"W4388126987","doi":"10.1097/mol.0000000000000908","title":"Cardiovascular disease prevention in heterozygous familial hypercholesterolemia: how important is a healthy diet in the era of long-lasting cholesterol-lowering drug therapies?","year":2023,"lang":"en","type":"article","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Disease; Dieting; Familial hypercholesterolemia; Cholesterol; Internal medicine; Obesity","score_opus":0.06271050825196377,"score_gpt":0.34313769968821184,"score_spread":0.28042719143624806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388126987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701869,0.016329546,0.00019391616,0.003631503,0.007969773,0.0016182238,0.000019324088,0.000045770914,0.0000050253875],"genre_scores_gemma":[0.9851885,0.010992053,0.000024156794,0.0002366952,0.0029831266,0.00041879926,0.00011347066,0.000038245922,0.0000049795394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963455,0.0008282832,0.0008759963,0.00063869177,0.0006647044,0.0006467806],"domain_scores_gemma":[0.9985708,0.00011557742,0.00019087007,0.0009209952,0.000057548168,0.00014423409],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031847416,0.00028356793,0.00088801526,0.00042395786,0.00006099669,0.000022053226,0.00024467913,0.00015000322,0.000005803852],"category_scores_gemma":[0.00017865613,0.00022623768,0.00053766416,0.0008896426,0.00010689357,0.0001467703,0.0001265445,0.0010050312,0.00000481128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014494868,0.0008888053,0.8627991,0.004532673,0.00026259382,0.000025704578,0.008352704,0.0005130355,0.000075928816,0.000019951329,0.0010458543,0.12003414],"study_design_scores_gemma":[0.006412144,0.00061096123,0.9793505,0.0024394756,0.000067232846,0.00006168244,0.0010228732,0.00095441146,0.000011325006,0.00010494436,0.008712117,0.00025230614],"about_ca_topic_score_codex":0.00034917495,"about_ca_topic_score_gemma":0.00013896161,"teacher_disagreement_score":0.11978184,"about_ca_system_score_codex":0.00016575375,"about_ca_system_score_gemma":0.00023275688,"threshold_uncertainty_score":0.9225705},"labels":[],"label_agreement":null},{"id":"W4388127851","doi":"10.1186/s12872-023-03578-0","title":"Association of LDL-cholesterol subfractions with cardiovascular disorders: a systematic review","year":2023,"lang":"en","type":"review","venue":"BMC Cardiovascular Disorders","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Angiology; Systematic review; Biomarker; Disease; Internal medicine; MEDLINE; Bioinformatics","score_opus":0.02958806177975842,"score_gpt":0.29384271230668774,"score_spread":0.2642546505269293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388127851","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000033445197,0.97442466,0.0041421056,0.000072719995,0.00040963475,0.019699616,0.0001345132,0.00042763294,0.0006857693],"genre_scores_gemma":[0.000018307264,0.9914759,0.00026371246,0.00007305726,0.00037923097,0.005765839,0.0005665149,0.0005686131,0.0008888194],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9863346,0.0028795502,0.0027667186,0.001780274,0.0050726375,0.0011662202],"domain_scores_gemma":[0.99015653,0.00045953455,0.0015452958,0.006813077,0.00056529476,0.0004602818],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.008236464,0.0015248447,0.017287925,0.00082700676,0.00026496017,0.000080483966,0.0006374251,0.001012454,0.00002975155],"category_scores_gemma":[0.0017016137,0.0011522211,0.032681756,0.0030935525,0.00015210298,0.0002403512,0.00020629143,0.0013300239,0.00032603208],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010728128,0.00014981613,0.000050759176,0.8174625,0.09058049,0.000020627307,0.00003151177,0.0001019588,7.629698e-9,0.000009146611,0.00036982718,0.091212615],"study_design_scores_gemma":[0.0013153771,0.0001331588,0.000047850153,0.3868739,0.16260064,0.00023208818,0.000092028815,0.0000049010387,9.381961e-8,0.000007861053,0.44798824,0.0007038661],"about_ca_topic_score_codex":0.0010647367,"about_ca_topic_score_gemma":0.00067800895,"teacher_disagreement_score":0.44761842,"about_ca_system_score_codex":0.0010921977,"about_ca_system_score_gemma":0.0016331444,"threshold_uncertainty_score":0.99975},"labels":[],"label_agreement":null},{"id":"W4388200585","doi":"10.58931/cpct.2023.1319","title":"Practical Implementation of Lipid Lowering for Cardiovascular Risk Reduction in Primary Care","year":2023,"lang":"en","type":"article","venue":"Canadian Primary Care Today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Ezetimibe; Dyslipidemia; Guideline; Medicine; Statin; Adverse effect; Primary care; Secondary prevention; Intensive care medicine; Internal medicine; Disease; Family medicine; Pathology","score_opus":0.01689260470439179,"score_gpt":0.28775228853442125,"score_spread":0.27085968383002945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388200585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776427,0.009009448,0.00061475264,0.00094858033,0.0012467947,0.0044325273,0.0006451601,0.00013996515,0.0053200684],"genre_scores_gemma":[0.9937619,0.00090636604,0.001751797,0.00022138658,0.00072979263,0.00030240125,0.0022021485,0.00006834164,0.00005585118],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980319,0.00010512221,0.00040954424,0.0004365551,0.00047641402,0.0005404523],"domain_scores_gemma":[0.9985194,0.00003366282,0.000089026405,0.00065948605,0.0003165972,0.0003818126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007801963,0.00018232637,0.00058374746,0.0004888214,0.00012582786,0.000015500891,0.000076334625,0.00016694577,0.000028242248],"category_scores_gemma":[0.00007345302,0.0001951372,0.0006992153,0.0005677944,0.000042649215,0.00014607853,0.00003146415,0.00026081043,0.000011383372],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027012167,0.000033251523,0.029794564,0.010003404,0.0014744168,0.0003740143,0.0075681983,0.0004075249,0.0010353535,0.000113301125,0.00717039,0.9417555],"study_design_scores_gemma":[0.009368235,0.0009234191,0.69541764,0.0007218845,0.0017102172,0.00028140613,0.0332853,0.000021430353,0.0076583643,0.0000496165,0.2497334,0.0008290498],"about_ca_topic_score_codex":0.06926137,"about_ca_topic_score_gemma":0.027269648,"teacher_disagreement_score":0.94092643,"about_ca_system_score_codex":0.003051369,"about_ca_system_score_gemma":0.0040389746,"threshold_uncertainty_score":0.9904801},"labels":[],"label_agreement":null},{"id":"W4388272530","doi":"10.1016/j.jcjd.2023.10.310","title":"FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA: INVESTIGATING MANAGEMENT PATTERNS AND CLINICAL OUTCOMES FROM THE FH CANADA REGISTRY","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Diabetes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Patient registry; Family medicine; Gerontology; Pediatrics; Internal medicine; Cholesterol","score_opus":0.02821728382972705,"score_gpt":0.2530901267443469,"score_spread":0.22487284291461984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388272530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104327,0.0005107115,5.546426e-7,0.007601642,0.0005274765,0.00015732601,0.00008281952,0.00000257212,0.000073614676],"genre_scores_gemma":[0.99409276,0.000065506596,0.000043832082,0.0054369643,0.00029783638,0.0000032948979,0.00001203388,0.000014724724,0.00003304114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984614,0.00012431348,0.00052289705,0.00014546959,0.00036598733,0.00037991503],"domain_scores_gemma":[0.9985551,0.0002079638,0.00013159489,0.00027901583,0.00005319953,0.0007731292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076649635,0.000115524854,0.00041248475,0.00007177199,0.00008550728,0.000026395293,0.0001680786,0.00004748433,0.0000130283315],"category_scores_gemma":[0.00032034804,0.000080907324,0.0000934325,0.00015771009,0.00005381141,0.00003762799,0.000025023128,0.00044848962,6.4735656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[8.308002e-7,0.0000015614637,0.9787591,0.00003825874,0.00019330908,0.0003735235,0.00005392683,0.0000096044605,0.0000012111494,0.0000031713782,0.004590883,0.015974626],"study_design_scores_gemma":[0.00080713816,0.000024997156,0.99383503,0.00033687777,0.00009365005,0.0000062068107,0.0014739884,0.000038855265,0.0000045194934,0.00002650275,0.0032757213,0.000076482684],"about_ca_topic_score_codex":0.9993282,"about_ca_topic_score_gemma":0.9999746,"teacher_disagreement_score":0.015898144,"about_ca_system_score_codex":0.0007551191,"about_ca_system_score_gemma":0.010325385,"threshold_uncertainty_score":0.99528515},"labels":[],"label_agreement":null},{"id":"W4388339770","doi":"10.1016/j.jcjo.2023.10.007","title":"Lack of association between Lp(a) and retinal vein occlusion in a single institution and US national database","year":2023,"lang":"en","type":"article","venue":"Canadian Journal of Ophthalmology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Eye Institute; National Institutes of Health; Cleveland Eye Bank Foundation; Research to Prevent Blindness","keywords":"Medicine; Odds ratio; Occlusion; Retrospective cohort study; Database; Retinal Vein; Internal medicine; Cohort","score_opus":0.06043503500535941,"score_gpt":0.3226481661356231,"score_spread":0.2622131311302637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388339770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968386,0.000473573,0.000009014492,0.0010143353,0.00010289004,0.00009860257,0.00003641922,0.0000013695371,0.0014251664],"genre_scores_gemma":[0.9995075,0.000028436174,0.0001720331,0.00003236047,0.00016014466,5.9952754e-7,0.000026660282,0.0000050288313,0.000067247296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916416,0.00009541044,0.00027604468,0.000087354325,0.000219099,0.00015795327],"domain_scores_gemma":[0.99929196,0.000057442678,0.00016134225,0.0000614427,0.00019556776,0.00023222392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014142155,0.00005343567,0.0002592084,0.00041487854,0.00004783562,0.0000062482823,0.00003162685,0.00009974824,0.000029463505],"category_scores_gemma":[0.000719231,0.000051278326,0.000038635717,0.00024034323,0.00005970825,0.00007709077,0.000014348959,0.00017652278,0.0000014951456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003897742,0.0000124932485,0.99398315,0.00009116402,0.00006074556,0.004002359,0.00015329907,0.000011098179,0.0005674983,0.00013549508,0.00021127364,0.00073242513],"study_design_scores_gemma":[0.001011554,0.00037673593,0.97942466,0.00014700141,0.000038466173,0.017876644,0.000057726844,0.000028591556,0.00014494352,0.00025342868,0.0005973154,0.000042958076],"about_ca_topic_score_codex":0.003738595,"about_ca_topic_score_gemma":0.00047389453,"teacher_disagreement_score":0.014558537,"about_ca_system_score_codex":0.0003161525,"about_ca_system_score_gemma":0.0010041953,"threshold_uncertainty_score":0.56516623},"labels":[],"label_agreement":null},{"id":"W4388419480","doi":"10.1161/circ.148.suppl_1.12542","title":"Abstract 12542: Effectiveness of Icosapent Ethyl on First and Total Cardiovascular Events in the Metabolic Syndrome: REDUCE-IT MetSyn","year":2023,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Myocardial infarction; Clinical endpoint; Unstable angina; Stroke (engine); Cardiology; Placebo; Number needed to treat; Metabolic syndrome; Acute coronary syndrome; Relative risk; Randomized controlled trial; Confidence interval; Obesity","score_opus":0.026422811338873933,"score_gpt":0.2843372147215436,"score_spread":0.2579144033826697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388419480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99528146,0.002618825,0.00005117149,0.00026354808,0.00014708683,0.0013064462,0.0000043605482,0.000028420494,0.0002986896],"genre_scores_gemma":[0.9992899,0.00040172023,0.000008385945,0.000030349604,0.00007524211,0.00012088267,0.00004983907,0.000019952353,0.0000037490177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982045,0.0003077171,0.000267407,0.00029777468,0.0007211651,0.00020141104],"domain_scores_gemma":[0.9990902,0.00015986862,0.00006094811,0.00057616853,0.000053195494,0.00005961715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033646843,0.00013671296,0.00051952293,0.00019431225,0.000087533845,0.000007868011,0.000063580344,0.00010216832,0.000008294901],"category_scores_gemma":[0.00016402097,0.00010128889,0.0003875916,0.00056086876,0.000030333389,0.00006982666,0.000023022976,0.00018840536,0.000023419194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013446964,0.0018892299,0.57979935,0.0133367935,0.010201289,0.0013230223,0.0067412416,0.06660107,0.013354419,0.0031740998,0.00013533763,0.30209947],"study_design_scores_gemma":[0.0014984433,0.000061788065,0.9959748,0.00039861212,0.00025710446,0.00017262345,0.00012872984,0.00019410881,0.0006516346,0.00011784341,0.0004525728,0.00009176997],"about_ca_topic_score_codex":0.00037528673,"about_ca_topic_score_gemma":0.000009381232,"teacher_disagreement_score":0.41617545,"about_ca_system_score_codex":0.00006551733,"about_ca_system_score_gemma":0.000049713024,"threshold_uncertainty_score":0.4130441},"labels":[],"label_agreement":null},{"id":"W4388424080","doi":"10.1097/hpc.0000000000000340","title":"Serious Adverse Events of Inclisiran in Patients With Hypercholesterolemia, a Meta-Analysis of ORION Trials","year":2023,"lang":"en","type":"review","venue":"Critical Pathways in Cardiology A Journal of Evidence-Based Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital","funders":"","keywords":"Adverse effect; Medicine; Meta-analysis; Internal medicine; Clinical trial; Incidence (geometry); Systematic review; Odds ratio; Publication bias; MEDLINE; Intensive care medicine","score_opus":0.4631216580404801,"score_gpt":0.459859186455917,"score_spread":0.003262471584563109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388424080","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012132236,0.9843214,0.00048404257,0.0004572489,0.00038547767,0.002040144,0.00015171361,0.000009502534,0.000018191919],"genre_scores_gemma":[0.14238532,0.85620433,0.00038144688,0.00024792866,0.00048868085,0.00011902626,0.00009166748,0.000077954806,0.0000036707709],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9838438,0.006540174,0.006391924,0.0006199734,0.0020400335,0.0005640789],"domain_scores_gemma":[0.98545444,0.009133478,0.0023686828,0.0011301561,0.0014843958,0.00042882247],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.026825372,0.000665124,0.026400963,0.003861493,0.000030413672,0.0000021468963,0.0004678012,0.00088312424,0.000064113454],"category_scores_gemma":[0.03140205,0.00033966106,0.0070820516,0.0032120678,0.0007365811,0.0001582763,0.00008667632,0.0018668866,0.0000022605593],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010206602,0.0018553899,0.03963291,0.14524673,0.4602957,0.007483965,0.00062264845,0.0017442901,0.00002160978,0.00019048875,0.00009589716,0.33260378],"study_design_scores_gemma":[0.010913907,0.01004113,0.019137135,0.104932904,0.8499774,0.00023474416,0.0001843783,0.000011607596,0.0000051860357,0.00013280673,0.003980335,0.00044847812],"about_ca_topic_score_codex":0.00012143327,"about_ca_topic_score_gemma":0.000029961077,"teacher_disagreement_score":0.3896817,"about_ca_system_score_codex":0.0004704192,"about_ca_system_score_gemma":0.0021776196,"threshold_uncertainty_score":0.9999055},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4388443829","doi":"","title":"Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin.","year":2007,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Amlodipine; Pill; Medicine; Psychological intervention; Reduction (mathematics); Disease; Internal medicine; Cardiology; Pharmacology; Mathematics; Blood pressure","score_opus":0.13233557779442967,"score_gpt":0.4734960369891913,"score_spread":0.3411604591947616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388443829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9411643,0.023303362,0.0318842,0.00030642905,0.0006505021,0.002366897,0.00015899054,0.00004162415,0.00012369305],"genre_scores_gemma":[0.99565715,0.0030962706,0.0005198101,0.00008481631,0.0003691582,0.000097467746,0.000056354675,0.000065106884,0.000053882835],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99547654,0.0006402614,0.0015547844,0.0005430122,0.0012566438,0.00052876247],"domain_scores_gemma":[0.9954578,0.00022665279,0.0012980535,0.0013315233,0.00095835945,0.000727562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0052441903,0.0003743366,0.0013415655,0.000663934,0.00055027317,0.00032427924,0.00080047717,0.000104392784,0.00033846544],"category_scores_gemma":[0.0015817492,0.00027587544,0.0017243976,0.0010327094,0.00013028522,0.00059108133,0.00049799675,0.00057575235,0.0000029437747],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036978293,0.0036842423,0.40603298,0.0016859262,0.0121133365,0.0000780568,0.0030727875,0.0026000496,0.12130121,0.00013192643,0.0021192557,0.4434824],"study_design_scores_gemma":[0.0034203094,0.00024219546,0.9488626,0.0017956619,0.003303215,0.000035059613,0.00076896424,0.00025321532,0.036246724,0.0021969753,0.0024338781,0.00044117722],"about_ca_topic_score_codex":0.009303268,"about_ca_topic_score_gemma":0.00045670755,"teacher_disagreement_score":0.54282963,"about_ca_system_score_codex":0.00046888168,"about_ca_system_score_gemma":0.00019049167,"threshold_uncertainty_score":0.99996936},"labels":[],"label_agreement":null},{"id":"W4388452540","doi":"10.1097/hco.0000000000001100","title":"Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care","year":2023,"lang":"en","type":"article","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Apolipoprotein B; Medicine; Primary care; Lipoprotein; Intensive care medicine; Clinical Practice; Cholesterol; Internal medicine; Family medicine","score_opus":0.03397528938236208,"score_gpt":0.3150815274790885,"score_spread":0.2811062380967264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388452540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96091527,0.013632322,0.008494523,0.00070182316,0.006260589,0.0093029775,0.00017911861,0.00043644488,0.000076937446],"genre_scores_gemma":[0.9861869,0.004527395,0.0005015235,0.00012521392,0.005118491,0.0025594851,0.0007782687,0.0001606601,0.000042025837],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99399805,0.00059022545,0.0010586077,0.0018759127,0.000995254,0.0014819286],"domain_scores_gemma":[0.9963572,0.00010644983,0.00023170901,0.0022007618,0.000508581,0.00059531786],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024981224,0.0008132706,0.0026817927,0.0007402156,0.00037480908,0.000079631856,0.00035501248,0.00077128416,0.0000064754404],"category_scores_gemma":[0.00035750156,0.0007864255,0.0018504198,0.000885986,0.00035710703,0.00021268115,0.0004883865,0.0011320465,0.00010594567],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075782376,0.0001787097,0.007963873,0.010845798,0.001699456,0.00008817496,0.0010796654,0.00064171146,0.0010885035,0.00021054762,0.001643237,0.9738025],"study_design_scores_gemma":[0.022409763,0.0018651682,0.8728369,0.0032921834,0.0008449255,0.00091862737,0.0012779906,0.0004709013,0.008991856,0.0010361532,0.08414248,0.0019130916],"about_ca_topic_score_codex":0.0048739235,"about_ca_topic_score_gemma":0.00022295328,"teacher_disagreement_score":0.97188944,"about_ca_system_score_codex":0.0004260849,"about_ca_system_score_gemma":0.0003565331,"threshold_uncertainty_score":0.9994587},"labels":[],"label_agreement":null},{"id":"W4388467129","doi":"10.15829/1560-4071-2023-5587","title":"Incidence of familial hypercholesterolemia in patients with early manifestations of coronary artery disease: data from a Russian multicenter study and meta-analysis","year":2023,"lang":"en","type":"article","venue":"Russian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; PCSK9; Internal medicine; Coronary artery disease; Apolipoprotein B; Proband; Incidence (geometry); LDL receptor; Lipoprotein; Gastroenterology; Cardiology; Cholesterol; Genetics; Gene","score_opus":0.045974933793508276,"score_gpt":0.3022325002633035,"score_spread":0.25625756646979525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388467129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99798346,0.0005603893,0.00032464377,0.00023008714,0.00004317993,0.0004574636,0.00037258587,0.000004343502,0.000023869368],"genre_scores_gemma":[0.9993282,0.00006837616,0.0003704799,0.000040114704,0.000066577006,0.0000077295745,0.000098240715,0.000013763089,0.0000065158993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977677,0.0005085307,0.00074305054,0.0002672513,0.000536311,0.00017718552],"domain_scores_gemma":[0.998489,0.000094341376,0.00036216737,0.00076094357,0.000104344566,0.00018917563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008615428,0.00014390003,0.001605116,0.00043757173,0.00002578398,0.0000064327387,0.00020797292,0.000057615995,0.000013565429],"category_scores_gemma":[0.00006471738,0.00009410376,0.00042239472,0.00040118402,0.00011590628,0.00017413565,0.00011212345,0.00023633809,0.000001379876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001084487,0.00013361756,0.9538476,0.00003927699,0.042843703,0.0010804258,0.0004449789,0.00018028326,0.0000107672295,0.0000033211516,0.00000753461,0.00032403562],"study_design_scores_gemma":[0.003184992,0.0007782052,0.9206054,0.000023032895,0.07481556,0.00003819213,0.0004020419,0.000058620768,0.0000014186071,0.000018475026,0.000007913283,0.0000661056],"about_ca_topic_score_codex":0.00016439459,"about_ca_topic_score_gemma":0.000084627296,"teacher_disagreement_score":0.033242118,"about_ca_system_score_codex":0.000026882462,"about_ca_system_score_gemma":0.00015428383,"threshold_uncertainty_score":0.38374397},"labels":[],"label_agreement":null},{"id":"W4388499266","doi":"10.1161/circulationaha.123.066822","title":"Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease","year":2023,"lang":"en","type":"review","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Kowa Company; Heart and Stroke Foundation of Canada","keywords":"Medicine; Calcification; Aortic valve stenosis; Lipoprotein; LDL receptor; Stenosis; valvular heart disease; Internal medicine; Receptor; Major facilitator superfamily; Cardiology; Endocrinology; Pharmacology; Transporter; Biochemistry; Biology; Cholesterol; Gene","score_opus":0.06654615407056962,"score_gpt":0.3329621386943851,"score_spread":0.2664159846238155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388499266","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08129018,0.91353875,0.00026214414,0.0002096388,0.00016924935,0.004269501,0.00006890564,0.00014652619,0.000045124896],"genre_scores_gemma":[0.08509245,0.9107026,0.0002969068,0.000088184686,0.00058191514,0.0011470539,0.0019244612,0.00012457937,0.000041886695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99699455,0.00037208412,0.0009201578,0.0007644015,0.0005944712,0.0003543344],"domain_scores_gemma":[0.9987147,0.00006643262,0.00019921164,0.00060821493,0.000104436775,0.00030699273],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015126796,0.00037801667,0.0014207454,0.00048594485,0.00014440255,0.000056300996,0.00004975498,0.00036888348,0.000010071866],"category_scores_gemma":[0.00030374373,0.00035518274,0.0004642276,0.0006600372,0.00006665993,0.00016500229,0.00003712005,0.0004178663,0.00007254719],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064683736,0.00009196412,0.0007245156,0.03855301,0.00021863346,0.00013547324,0.00039484812,0.000009534944,0.00010704089,0.0004482878,0.000058378,0.95919365],"study_design_scores_gemma":[0.004121056,0.00025172264,0.26155654,0.071393564,0.0029356473,0.000358802,0.0008559524,0.00028079364,0.000010911433,0.0021491859,0.6545126,0.0015732324],"about_ca_topic_score_codex":0.00026625485,"about_ca_topic_score_gemma":0.000016452135,"teacher_disagreement_score":0.9576204,"about_ca_system_score_codex":0.00045504307,"about_ca_system_score_gemma":0.0005404774,"threshold_uncertainty_score":0.99989},"labels":[],"label_agreement":null},{"id":"W4388595310","doi":"10.1093/eurheartj/ehad655.1309","title":"Eicosapentaenoic acid, arachidonic acid, and triglyceride levels mediate most of the benefit of icosapent ethyl in REDUCE-IT","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Amarin Corporation","keywords":"Mace; Medicine; Eicosapentaenoic acid; Biomarker; Proportional hazards model; Internal medicine; Oncology; Fatty acid; Polyunsaturated fatty acid; Biochemistry","score_opus":0.056523586181578545,"score_gpt":0.31399095206847805,"score_spread":0.2574673658868995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388595310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914433,0.0028392302,0.000010502205,0.0038202133,0.0003805142,0.00040734012,0.000015334159,0.000017453849,0.0010661249],"genre_scores_gemma":[0.99680346,0.0017799325,0.00015466462,0.00054905703,0.0004354674,0.0000030907274,0.0000039922015,0.000046650326,0.00022369162],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974325,0.0004884158,0.0007353415,0.00023541003,0.0007254825,0.00038285297],"domain_scores_gemma":[0.99883074,0.000051377567,0.000258993,0.00051323813,0.00010214372,0.0002435274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032153362,0.00017632963,0.00056485384,0.00023931726,0.00012833708,0.000022645589,0.00019905828,0.000050711944,0.00011104083],"category_scores_gemma":[0.00021654557,0.00011944908,0.00031988355,0.0006478773,0.00011613275,0.000087642984,0.00017742919,0.0007152714,0.00004218191],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014267564,0.0007978727,0.23102991,0.001466645,0.0011373891,0.0015962255,0.006764442,0.00035329963,0.45204127,0.0002529735,0.008942249,0.29419094],"study_design_scores_gemma":[0.0033098578,0.00035880387,0.9584406,0.00071655674,0.000098770644,0.0014900308,0.00034448272,0.000050198192,0.027058067,0.00007130211,0.00793359,0.00012772111],"about_ca_topic_score_codex":0.0000365439,"about_ca_topic_score_gemma":0.000023498449,"teacher_disagreement_score":0.72741073,"about_ca_system_score_codex":0.00006820279,"about_ca_system_score_gemma":0.00025199325,"threshold_uncertainty_score":0.48709923},"labels":[],"label_agreement":null},{"id":"W4388600335","doi":"10.1093/eurheartj/ehad655.2519","title":"Dyslipidaemia and its management in patients with type 2 diabetes across the Middle East and Africa: the PACT-MEA study","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Internal medicine; Observational study; Body mass index; Creatinine; Albuminuria; Epidemiology; Renal function; Endocrinology","score_opus":0.05535663942405812,"score_gpt":0.26751697502466204,"score_spread":0.21216033560060393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388600335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664617,0.0010103548,5.6234853e-7,0.0007408935,0.000109272645,0.0006524282,0.000001724815,0.000016612945,0.00082198397],"genre_scores_gemma":[0.9990617,0.00014476427,0.000013240065,0.00022354693,0.00022872306,0.000004516338,0.0000011241946,0.000025219071,0.00029714598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860966,0.0003763925,0.00016234373,0.0001546493,0.0003947112,0.00030222765],"domain_scores_gemma":[0.9995234,0.000027089862,0.00004403985,0.00023022652,0.000058725884,0.00011654046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021764934,0.00010421782,0.00017171494,0.00004631756,0.00035189345,0.00009497495,0.000073443545,0.000011164698,0.000007990204],"category_scores_gemma":[0.000037705307,0.00004820884,0.00003478983,0.00030971394,0.00004033777,0.000057806377,0.0001330035,0.00034145347,0.000033380922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014584813,0.00016268155,0.96908766,0.00007576224,0.0003357831,0.00021259475,0.011235782,0.000012127248,0.000014782079,0.0000068708,0.00163549,0.01707462],"study_design_scores_gemma":[0.0019390088,0.0005655518,0.9832924,0.000111638416,0.00005519536,0.000035226712,0.004999632,0.000021265763,0.0000020690184,0.0000021823716,0.008915532,0.000060287213],"about_ca_topic_score_codex":0.0000019402623,"about_ca_topic_score_gemma":0.000004605325,"teacher_disagreement_score":0.017014334,"about_ca_system_score_codex":0.000021227681,"about_ca_system_score_gemma":0.000014654921,"threshold_uncertainty_score":0.27065155},"labels":[],"label_agreement":null},{"id":"W4388600458","doi":"10.1093/eurheartj/ehad655.2809","title":"Efficacy and safety of alirocumab in children and adolescents with heterozygous familial hypercholesterolaemia inadequately controlled with statins","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi","keywords":"Alirocumab; Medicine; PCSK9; Placebo; Dosing; Statin; Internal medicine; Clinical endpoint; Familial hypercholesterolemia; Clinical trial; Pharmacology; Gastroenterology; Cholesterol; Apolipoprotein B; Lipoprotein; LDL receptor","score_opus":0.016207229683731873,"score_gpt":0.26118386453328263,"score_spread":0.24497663484955076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388600458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983295,0.00038078497,0.00006936875,0.0002803821,0.000024360836,0.0007682823,0.000006301686,0.000026327918,0.00011465937],"genre_scores_gemma":[0.9986566,0.0005526651,0.00029441403,0.00024085162,0.00016987226,0.000002426439,0.000005618916,0.000045717923,0.000031882824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982293,0.0004224558,0.0003709054,0.00023008768,0.0004396969,0.00030754312],"domain_scores_gemma":[0.9993218,0.00002388735,0.000109805034,0.00020361834,0.00006579235,0.0002750908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011868657,0.00016971736,0.00059415493,0.00018828314,0.000106652005,0.000038389753,0.00005243009,0.000030874966,0.0000029518371],"category_scores_gemma":[0.000050955183,0.000108223125,0.00006199809,0.00020424293,0.00010273137,0.000085559404,0.000044621407,0.00047497454,0.0000055619635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015386328,0.00018360274,0.95733196,0.00016661106,0.0003349195,0.0008614249,0.0009541133,0.00008411962,0.0007254303,0.000003789777,0.00009319421,0.023874493],"study_design_scores_gemma":[0.04368153,0.0015776742,0.94807994,0.0009963984,0.000089249785,0.005158291,0.00009885472,0.000023549881,0.000030588682,0.0000013708825,0.0001549506,0.000107597065],"about_ca_topic_score_codex":0.0000579476,"about_ca_topic_score_gemma":0.000017092529,"teacher_disagreement_score":0.0282952,"about_ca_system_score_codex":0.000034217177,"about_ca_system_score_gemma":0.00009807141,"threshold_uncertainty_score":0.44132107},"labels":[],"label_agreement":null},{"id":"W4388600465","doi":"10.1093/eurheartj/ehad655.1447","title":"Two of a kind: mass and molar immunoassay-based lipoprotein (a) concentrations are similarly prognostic for MACE risk and predictive of alirocumab benefit in ODYSSEY OUTCOMES","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Sanofi (Canada)","funders":"Sanofi","keywords":"Medicine; Mace; Internal medicine; Unstable angina; Myocardial infarction; Body mass index; Cardiology; Percutaneous coronary intervention","score_opus":0.025262657475946488,"score_gpt":0.29594604781083744,"score_spread":0.27068339033489097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388600465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379295,0.001628899,0.002231065,0.0007713727,0.000071721835,0.0012285477,0.00017159281,0.000022871407,0.00008098186],"genre_scores_gemma":[0.99648523,0.00038236973,0.0027873225,0.000110658766,0.00012114151,0.000021926136,0.000015906466,0.000039534083,0.000035920842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830693,0.00032082078,0.00050077226,0.00021223126,0.00038292585,0.0002763044],"domain_scores_gemma":[0.9989298,0.00015365676,0.00028224924,0.00024033876,0.0002151187,0.00017885007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019310979,0.00015327815,0.00052971096,0.00021337035,0.00013346868,0.000030577405,0.00006253268,0.000041805626,0.000008247733],"category_scores_gemma":[0.0005628849,0.000127092,0.00018150777,0.00022914776,0.00009243982,0.00009522095,0.000032906522,0.0003543001,0.0000014733874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003500327,0.00010272641,0.9913377,0.00039600275,0.00020391487,0.00011139886,0.0005031809,0.0005702529,0.0026133216,0.000035295223,0.00012665786,0.0036494837],"study_design_scores_gemma":[0.0057547404,0.00085570576,0.9878369,0.0006677784,0.00019993573,0.000110365174,0.00050114346,0.0021481635,0.0010411061,0.0001279622,0.0006489056,0.00010729451],"about_ca_topic_score_codex":0.00008436501,"about_ca_topic_score_gemma":0.00003678468,"teacher_disagreement_score":0.005404708,"about_ca_system_score_codex":0.000036434092,"about_ca_system_score_gemma":0.00013878879,"threshold_uncertainty_score":0.5182662},"labels":[],"label_agreement":null},{"id":"W4388679314","doi":"10.1016/j.jacadv.2023.100696","title":"Longitudinal Control of Lipid Levels in Patients With Premature Coronary Artery Disease","year":2023,"lang":"en","type":"article","venue":"JACC Advances","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); University of British Columbia","funders":"Canadian Institutes of Health Research; HLS Therapeutics; Ultragenyx Pharmaceutical; Amgen","keywords":"Medicine; Mace; Internal medicine; Myocardial infarction; Cardiology; Hazard ratio; Unstable angina; Coronary artery disease; Acute coronary syndrome; Cohort; Diabetes mellitus; Percutaneous coronary intervention; Confidence interval; Endocrinology","score_opus":0.011273165217138828,"score_gpt":0.25447670687227564,"score_spread":0.2432035416551368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388679314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674207,0.0016882267,0.00021270227,0.0002341553,0.000115678624,0.00076075894,0.000061211234,0.00004307382,0.00014215123],"genre_scores_gemma":[0.9992888,0.0000949373,0.00013860324,0.000118651624,0.00014669541,0.00005023706,0.00003770559,0.000015094113,0.00010925224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893755,0.00003561168,0.00019315776,0.0002102333,0.00041622514,0.00020722242],"domain_scores_gemma":[0.99940205,0.000032001106,0.00006987859,0.00028958372,0.00008205942,0.00012445921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015218732,0.00010837521,0.00035387222,0.00008567442,0.00002653789,0.0000038063508,0.00005083387,0.000035998604,0.00002898224],"category_scores_gemma":[0.000046216912,0.00007396023,0.00008784227,0.00026410946,0.000045527762,0.000148195,0.000016435759,0.0001150282,0.000010774059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001260643,0.0001612566,0.9773669,0.00044211003,0.00007888292,0.00009484394,0.000059829137,0.00015807468,0.000010763259,0.000016715016,0.00007714882,0.020272803],"study_design_scores_gemma":[0.0044762455,0.0003385019,0.99338245,0.00030827257,0.000057630074,0.0000043334403,0.000051526673,0.00004538169,0.000025332689,0.000070842965,0.0011573287,0.00008214587],"about_ca_topic_score_codex":0.000006048389,"about_ca_topic_score_gemma":0.000010980103,"teacher_disagreement_score":0.020190656,"about_ca_system_score_codex":0.000029284547,"about_ca_system_score_gemma":0.00008900648,"threshold_uncertainty_score":0.30160108},"labels":[],"label_agreement":null},{"id":"W4388682386","doi":"10.1016/j.cjca.2023.11.012","title":"Reply to Logan et al.—Explaining the TG Cutoff in the 2021 Lipid Guidelines for When Clinicians Should Rely on Non-HDL-C or ApoB","year":2023,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Alberta; St. Paul's Hospital; McGill University; University of British Columbia","funders":"","keywords":"Medicine; Apolipoprotein B; Guideline; Triglyceride; Cholesterol; Cutoff; Internal medicine; Lipoprotein; Endocrinology; Pathology","score_opus":0.1669426091663032,"score_gpt":0.38799403694421136,"score_spread":0.22105142777790815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388682386","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042319356,0.0008620893,0.0011564251,0.9899674,0.0034331,0.001631959,0.00016134816,0.00000914528,0.0023553194],"genre_scores_gemma":[0.0011116572,0.0006535309,0.0005018978,0.95732164,0.037617996,0.00013718565,0.00011800928,0.00013324007,0.0024048453],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951842,0.0010490064,0.0015014476,0.0005254427,0.00065290375,0.0010869907],"domain_scores_gemma":[0.9953718,0.0013151463,0.00050130475,0.0013502304,0.0010006407,0.00046086233],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010126759,0.00043177963,0.0018968801,0.000775812,0.00025003141,0.000074488176,0.00086481386,0.0007517257,0.00002428932],"category_scores_gemma":[0.006264306,0.00023255781,0.0013776402,0.0004198776,0.00014501208,0.000049021102,0.000041518233,0.0038640485,0.000041996864],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021440026,0.0000016353272,0.000121928184,0.00006608187,0.0006598025,0.0057411105,0.00066445494,0.00042911054,0.0000011685021,0.00002477732,0.97938925,0.012686256],"study_design_scores_gemma":[0.0011817078,0.0016944376,0.0010400919,0.00070514437,0.00039585432,0.0027231833,0.0011614275,0.000009101412,0.000002064298,0.00012225845,0.99072343,0.00024128967],"about_ca_topic_score_codex":0.010325982,"about_ca_topic_score_gemma":0.013877752,"teacher_disagreement_score":0.034184895,"about_ca_system_score_codex":0.0003990922,"about_ca_system_score_gemma":0.005833434,"threshold_uncertainty_score":0.9998026},"labels":[],"label_agreement":null},{"id":"W4388732954","doi":"10.1186/s13024-023-00671-y","title":"Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia","year":2023,"lang":"en","type":"review","venue":"Molecular Neurodegeneration","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia Hospital; University of British Columbia","funders":"Cure Alzheimer's Fund","keywords":"Cholesterylester transfer protein; Dementia; Lipoprotein; Internal medicine; Endocrinology; Vascular dementia; Medicine; Apolipoprotein E; Cholesterol; Cognitive decline; Bioinformatics; Disease; Biology","score_opus":0.022875887460140725,"score_gpt":0.3081298216250106,"score_spread":0.2852539341648699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388732954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18340325,0.7998261,0.0066975583,0.00037164416,0.00004146704,0.009488645,0.00013329067,0.000029232491,0.00000881718],"genre_scores_gemma":[0.078539796,0.91667867,0.0002208311,0.0005599838,0.00021924164,0.003219541,0.00041231053,0.00012429336,0.000025357629],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971905,0.0007134289,0.00065208867,0.0005819724,0.00055720855,0.00030481847],"domain_scores_gemma":[0.99915254,0.000025228306,0.000082493425,0.00045755284,0.00014355089,0.00013861444],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092332833,0.00037824837,0.0011294744,0.00025181434,0.000101015474,0.00007721924,0.000091966416,0.00021092137,0.0000036139509],"category_scores_gemma":[0.00009386532,0.000270728,0.00039990954,0.0004450091,0.00006287347,0.000058865935,0.000060957533,0.00035902002,0.0000030062495],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011008861,0.00051139866,0.000037210317,0.02547353,0.001722914,0.0004047023,0.0014026683,0.00006520528,0.0036596134,0.0006710909,0.000022785885,0.9659188],"study_design_scores_gemma":[0.035223674,0.016315958,0.013792928,0.15536843,0.052627925,0.0031149834,0.0013436328,0.0016568238,0.03452022,0.00026859413,0.6788975,0.0068693096],"about_ca_topic_score_codex":0.00009421784,"about_ca_topic_score_gemma":0.00016471143,"teacher_disagreement_score":0.95904946,"about_ca_system_score_codex":0.0000595182,"about_ca_system_score_gemma":0.00019082581,"threshold_uncertainty_score":0.9999745},"labels":[],"label_agreement":null},{"id":"W4388784714","doi":"10.1016/j.cjco.2023.11.015","title":"Consideration and Application of Lipoprotein(a) in the Risk Assessment of Atherosclerotic Cardiovascular Disease Risk in Adults","year":2023,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of British Columbia; University of Alberta","funders":"","keywords":"Atherosclerotic cardiovascular disease; Disease; Medicine; Risk assessment; Lipoprotein(a); Cardiology; Internal medicine; Intensive care medicine; Lipoprotein; Cholesterol; Computer science; Computer security","score_opus":0.01781228851661266,"score_gpt":0.30028883763582254,"score_spread":0.2824765491192099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388784714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338377,0.000948449,0.0010037118,0.00024788195,0.00001849899,0.004017777,0.00002577403,0.000009466117,0.0003446704],"genre_scores_gemma":[0.997363,0.0015955882,0.00039251806,0.000036440968,0.000037326576,0.0005265783,0.000030337056,0.000011989211,0.0000062377403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998437,0.00041637616,0.000329085,0.00025987608,0.00042839372,0.00012931103],"domain_scores_gemma":[0.99886274,0.00006505116,0.00012961139,0.0008152442,0.000068817506,0.000058525828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003333305,0.000088166824,0.0004534458,0.00009648212,0.000047326957,0.00001746446,0.00012551248,0.000048596652,0.000004280829],"category_scores_gemma":[0.0002349073,0.00006338756,0.00014089262,0.00041617305,0.00005613452,0.00008222085,0.00008754257,0.00016615272,0.0000026582998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035806635,0.00036752198,0.7217508,0.0012362106,0.00052774855,0.000042406682,0.0020429874,0.0038077089,0.0002174364,0.0010231333,0.00004945401,0.26857653],"study_design_scores_gemma":[0.002818154,0.00010363517,0.98686075,0.0002608961,0.00017976027,0.0000032207442,0.00048277524,0.008304303,0.000111420166,0.0006199373,0.0001933902,0.00006176876],"about_ca_topic_score_codex":0.012056393,"about_ca_topic_score_gemma":0.00044399765,"teacher_disagreement_score":0.26851475,"about_ca_system_score_codex":0.000038571037,"about_ca_system_score_gemma":0.00014446015,"threshold_uncertainty_score":0.9945224},"labels":[],"label_agreement":null},{"id":"W4388892089","doi":"10.1093/eurheartj/ehad655.2495","title":"Contribution of Lipoprotein(a) to polygenic risk of coronary artery disease: A prospective UK Biobank analysis","year":2023,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Coronary artery disease; Internal medicine; Cardiology; Hazard ratio; CAD; Lipoprotein(a); Myocardial infarction; Biobank; Proportional hazards model; Lipoprotein; Cholesterol; Confidence interval; Bioinformatics","score_opus":0.01655231198946332,"score_gpt":0.2797225213966069,"score_spread":0.2631702094071436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388892089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949263,0.0014927331,0.0016160223,0.000682444,0.00014526841,0.00069535285,0.00008621455,0.000046224297,0.00030946467],"genre_scores_gemma":[0.99836206,0.0003986195,0.00033371223,0.00012727575,0.0005048283,0.0000075867874,0.00002655579,0.00003003975,0.00020934208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975659,0.0005706596,0.0005438769,0.0002517249,0.0007357747,0.0003320543],"domain_scores_gemma":[0.998233,0.00003559784,0.00024729193,0.00051983475,0.0004318429,0.00053239847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024370512,0.00014991574,0.00062449044,0.00056994724,0.00014155972,0.000016930018,0.00010042604,0.000031574655,0.00014573384],"category_scores_gemma":[0.00046218678,0.00012167877,0.0009135381,0.001599702,0.00006194532,0.000054934153,0.00007249955,0.00033295405,0.00013462822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012936522,0.00019300445,0.97520894,0.000094331124,0.004228615,0.00074644916,0.00034751155,0.00032213418,0.0051459176,0.00005003756,0.0024365392,0.009932864],"study_design_scores_gemma":[0.001343378,0.00066352804,0.9930886,0.00016405803,0.0016042334,0.00027249748,0.00007092666,0.00010556622,0.0010275039,0.00005235034,0.0015001436,0.0001072122],"about_ca_topic_score_codex":0.000047005633,"about_ca_topic_score_gemma":0.000009294859,"teacher_disagreement_score":0.01787966,"about_ca_system_score_codex":0.00009065291,"about_ca_system_score_gemma":0.00019380571,"threshold_uncertainty_score":0.49619162},"labels":[],"label_agreement":null},{"id":"W4389026537","doi":"10.1096/fasebj.30.1_supplement.682.10","title":"Metabolomics Analysis of Serum and Urine After Bean Consumption by Patients with Peripheral Arterial Disease","year":2016,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Saint-Boniface; St. Boniface Hospital; University of Manitoba","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Medicine; Diabetes mellitus; Urine; Risk factor; Population; Internal medicine; Myocardial infarction; Hyperlipidemia; Kidney disease; Type 2 diabetes; Surgery; Physiology; Gastroenterology; Endocrinology","score_opus":0.006214018094778552,"score_gpt":0.21698334086264237,"score_spread":0.2107693227678638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389026537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767184,0.0007212616,0.0007473285,0.00044827393,0.00006067856,0.00015756491,0.00018251673,0.0000045399343,0.0000060011084],"genre_scores_gemma":[0.9991885,0.0003426393,0.00007833177,0.00015099505,0.00014368046,0.0000043541563,0.000010168685,0.000009017985,0.000072327544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991869,0.00008681523,0.00018147143,0.000098526136,0.000308076,0.0001382413],"domain_scores_gemma":[0.9993675,0.000011144886,0.00010454856,0.00021791503,0.0000907007,0.00020820352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002842078,0.000086353364,0.0002768083,0.00006400627,0.000065278036,0.000015675949,0.00003838846,0.000021792985,0.00032286436],"category_scores_gemma":[0.00001484579,0.00003662608,0.00015335329,0.000084333326,0.00009782997,0.000073078045,0.000016457772,0.00007868248,0.0000012710549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026479024,0.00011178324,0.9770282,0.00002794213,0.0022830304,0.000015575852,0.00011704991,0.000002867331,0.0028740047,0.0000068537674,0.00006005361,0.014824751],"study_design_scores_gemma":[0.003498438,0.00016235345,0.9918444,0.000047320125,0.0032821218,0.000020303141,0.000016858587,0.000025339652,0.0007833028,0.000009842059,0.00024954643,0.000060136157],"about_ca_topic_score_codex":0.000007825737,"about_ca_topic_score_gemma":0.0000073416154,"teacher_disagreement_score":0.014816252,"about_ca_system_score_codex":0.00003208358,"about_ca_system_score_gemma":0.0000473409,"threshold_uncertainty_score":0.35351384},"labels":[],"label_agreement":null},{"id":"W4389045874","doi":"10.1016/j.atherosclerosis.2023.117353","title":"Assessment of ethnic inequalities in diagnostic coding of familial hypercholesterolaemia (FH): A cross-sectional database study in Lambeth, South London","year":2023,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"Guy's and St Thomas' NHS Foundation Trust; King's College London; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Cross-sectional study; Ethnic group; Medicine; Coding (social sciences); Inequality; Statistics; Sociology; Anthropology; Mathematics; Pathology","score_opus":0.1096178129649174,"score_gpt":0.3771985942860137,"score_spread":0.2675807813210963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389045874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99830556,0.00013320701,0.00006819578,0.000023949578,0.00015608688,0.0010669356,0.0001311236,0.000039603354,0.00007533661],"genre_scores_gemma":[0.9989829,0.0004042977,0.00013790418,0.0000568928,0.00008523037,0.00019888871,0.00006085264,0.00003428376,0.00003876138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972654,0.00032658494,0.0008886593,0.00039048694,0.0007865806,0.0003423111],"domain_scores_gemma":[0.9985681,0.00049604074,0.00017073254,0.00057912996,0.000101524274,0.00008447584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029966054,0.00017942263,0.0006633233,0.0003596969,0.000038269558,0.000013325769,0.00013415152,0.00012015889,0.000022137523],"category_scores_gemma":[0.00067024666,0.00016590841,0.00018026007,0.0009827,0.00009866781,0.000116413474,0.0001406231,0.00037500673,0.000006269033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000683031,0.00053087366,0.98416823,0.0004276094,0.0000686119,0.000013847099,0.002873939,0.00015788058,0.011010312,0.000053188433,0.000004207283,0.0006229772],"study_design_scores_gemma":[0.0047469563,0.0004966241,0.9900965,0.00050829846,0.0000429763,0.000002319833,0.0028580357,0.00018115688,0.0009286683,0.000014740981,0.000003848805,0.0001198428],"about_ca_topic_score_codex":0.004119299,"about_ca_topic_score_gemma":0.000940494,"teacher_disagreement_score":0.010081643,"about_ca_system_score_codex":0.00018072277,"about_ca_system_score_gemma":0.00021587919,"threshold_uncertainty_score":0.67655486},"labels":[],"label_agreement":null},{"id":"W4389149394","doi":"10.3389/fendo.2023.1218968","title":"A bibliometric analysis of PCSK9 inhibitors from 2007 to 2022","year":2023,"lang":"en","type":"article","venue":"Frontiers in Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Key Research and Development Program of Hunan Province of China; Natural Science Foundation of Hunan Province; China Postdoctoral Science Foundation; National Natural Science Foundation of China; Health Commission of Hunan Province","keywords":"PCSK9; Medicine; Internal medicine; Cholesterol; LDL receptor","score_opus":0.016185149421587688,"score_gpt":0.28662311544951335,"score_spread":0.2704379660279257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389149394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899701,0.0038602962,0.0025314484,0.00065919966,0.0015372139,0.0004063196,0.000084587584,0.000079735175,0.0008711159],"genre_scores_gemma":[0.9920072,0.0018610359,0.0044062273,0.00047717954,0.00029230132,0.00008972317,0.00017415656,0.00002705581,0.00066510105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981112,0.00010291317,0.0004284616,0.000397567,0.00042048324,0.00053938874],"domain_scores_gemma":[0.99900717,0.000053012525,0.00007199989,0.0006219858,0.00007949967,0.000166325],"candidate_categories":["bibliometrics"],"consensus_categories":["bibliometrics"],"category_scores_codex":[0.00034021423,0.00013238798,0.00092387584,0.136174,0.000026091046,0.0000046025716,0.00014713121,0.00010751323,0.00021599256],"category_scores_gemma":[0.00029952693,0.00012582159,0.00036638396,0.2199627,0.000059362872,0.00003376409,0.0001185408,0.00022406693,0.00005133089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012546749,0.00008250168,0.7553979,0.000040951316,0.002253308,0.0003120302,0.00018933286,0.00023975442,0.00035843777,0.000029274019,0.05130702,0.18966404],"study_design_scores_gemma":[0.001117284,0.00018451894,0.92416966,0.000018816803,0.0006613175,0.0000066927687,0.0005118925,0.0004968433,0.0013082211,0.00010331867,0.07130377,0.00011766161],"about_ca_topic_score_codex":0.0020926422,"about_ca_topic_score_gemma":0.00009529697,"teacher_disagreement_score":0.18954638,"about_ca_system_score_codex":0.00012534486,"about_ca_system_score_gemma":0.00008532606,"threshold_uncertainty_score":0.87361676},"labels":[{"model":"gemma","categories":["bibliometrics"],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["bibliometrics"],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4389180571","doi":"10.1161/atvbaha.123.319957","title":"Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial Hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University Health Centre; Western University; McGill University; Centre Hospitalier de l’Université de Montréal; Université de Montréal; Centre hospitalier universitaire de Québec; Montreal Clinical Research Institute","funders":"Institut de Recherche Clinique De Montréal","keywords":"Medicine; Hazard ratio; Internal medicine; Familial hypercholesterolemia; Diabetes mellitus; Proportional hazards model; Atherosclerotic cardiovascular disease; Framingham Risk Score; Relative risk; Confidence interval; Cholesterol; Endocrinology; Disease","score_opus":0.03823966015724557,"score_gpt":0.27281306155175206,"score_spread":0.2345734013945065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389180571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658084,0.0017461748,0.000047091544,0.0001702993,0.0002127665,0.0009350929,0.0001236246,0.00016330511,0.000020819256],"genre_scores_gemma":[0.9538199,0.04504663,0.00014474995,0.00037994268,0.00023984913,0.00019505605,0.00010402339,0.000068118934,0.0000017735995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962759,0.0008315174,0.0005680969,0.0010702952,0.00038488297,0.000869331],"domain_scores_gemma":[0.99820465,0.000095904215,0.00016911022,0.0010769346,0.000077647994,0.0003757249],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019504635,0.00046224863,0.0015297498,0.00035163472,0.00030156574,0.00006024164,0.00015119286,0.0004211829,0.000014168434],"category_scores_gemma":[0.00019079486,0.00039172935,0.0007751427,0.00049159233,0.00031432166,0.0001232257,0.0002927873,0.0005016842,0.000035435736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000104061755,0.00009755512,0.9800595,0.00021875756,0.0014257397,0.000002096966,0.00028252322,0.000008164833,0.008038998,0.0000055775276,0.000040671606,0.009810017],"study_design_scores_gemma":[0.004536352,0.0005078212,0.99119055,0.00031053313,0.0008355065,0.000003439433,0.00031203986,0.00030270682,0.00014818853,0.000059608974,0.0014099708,0.000383259],"about_ca_topic_score_codex":0.002160809,"about_ca_topic_score_gemma":0.00025747067,"teacher_disagreement_score":0.043300457,"about_ca_system_score_codex":0.00007704641,"about_ca_system_score_gemma":0.00004479713,"threshold_uncertainty_score":0.99985343},"labels":[],"label_agreement":null},{"id":"W4389303227","doi":"10.1016/j.jacc.2023.10.007","title":"Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials","year":2023,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Discontinuation; Adverse effect; Tolerability; Incidence (geometry); Internal medicine; Placebo; Population; Creatinine; Post-hoc analysis; Hazard ratio; Confidence interval","score_opus":0.08911593254610639,"score_gpt":0.41227359672290115,"score_spread":0.32315766417679476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389303227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651134,0.0006157475,0.00014053602,0.0015875765,0.0002170405,0.0007154352,0.00014721045,0.0000019985698,0.00006311226],"genre_scores_gemma":[0.9968364,0.0022956892,0.00045973866,0.00006215223,0.00031012105,0.000006554244,0.0000014126123,0.000009035172,0.000018845443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99573207,0.0017351665,0.0020292033,0.00012740627,0.00023087497,0.00014526081],"domain_scores_gemma":[0.996352,0.0015012829,0.0014254686,0.00039697957,0.00024218984,0.00008206629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009693372,0.00009805236,0.0034772174,0.00014896072,0.000019017658,6.2081494e-7,0.00011111504,0.000076773504,9.425747e-7],"category_scores_gemma":[0.0020877267,0.00005526908,0.0013477462,0.00033911748,0.00048713436,0.000018259772,0.000043368684,0.00010944708,9.339267e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021591661,0.00034226725,0.787896,0.0004454364,0.0029664196,0.00007609523,0.00025031832,0.00058442564,0.0051615196,0.00012037451,0.00049553695,0.18006995],"study_design_scores_gemma":[0.008882086,0.008501022,0.9729412,0.000134039,0.00061389426,0.00034609006,0.0006913669,0.000042630098,0.0008410341,0.00021708645,0.006736041,0.000053516913],"about_ca_topic_score_codex":0.000052595165,"about_ca_topic_score_gemma":0.000011478365,"teacher_disagreement_score":0.1850452,"about_ca_system_score_codex":0.00008180182,"about_ca_system_score_gemma":0.00038092482,"threshold_uncertainty_score":0.33595487},"labels":[],"label_agreement":null},{"id":"W4389303714","doi":"10.1503/cmaj.230048-f","title":"L’apolipoprotéine B dans l’évaluation du risque cardiovasculaire","year":2023,"lang":"fr","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Western University","funders":"","keywords":"Medicine; Gynecology; Humanities; Philosophy","score_opus":0.014660596093096112,"score_gpt":0.24748195820377283,"score_spread":0.23282136211067672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389303714","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25923395,0.058146656,0.0026512267,0.564852,0.048603874,0.0026955558,0.00039702439,0.00040431105,0.0630154],"genre_scores_gemma":[0.7393436,0.06384745,0.00026723737,0.018499324,0.14305702,0.0001874862,0.00040852118,0.00030577814,0.034083616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98887897,0.0015561141,0.001089528,0.00044995855,0.0060423445,0.00198306],"domain_scores_gemma":[0.991956,0.00021663487,0.0003372939,0.0005144174,0.0011823039,0.005793364],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.021358976,0.0003673385,0.00092100666,0.0006325696,0.0010038813,0.00018791616,0.0003535193,0.0014866105,0.0063129473],"category_scores_gemma":[0.007605039,0.00036957936,0.0012117476,0.0016866823,0.00013103233,0.0002778111,0.000050161838,0.0025298188,0.004659489],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000012607849,0.000057957343,0.0354506,0.00021856063,0.002373761,0.0068027936,0.0015506826,0.00032997722,0.000008787334,0.0007081049,0.3526465,0.5998397],"study_design_scores_gemma":[0.0028927906,0.00014008886,0.138972,0.0007788312,0.0006639936,0.0037341241,0.0017002553,0.005265678,0.000024813811,0.0003102844,0.8451684,0.0003487489],"about_ca_topic_score_codex":0.070111446,"about_ca_topic_score_gemma":0.06877546,"teacher_disagreement_score":0.59949094,"about_ca_system_score_codex":0.0095967315,"about_ca_system_score_gemma":0.019209014,"threshold_uncertainty_score":0.9998756},"labels":[],"label_agreement":null},{"id":"W4389304068","doi":"10.1016/s2213-8587(23)00352-2","title":"New clarity for managing statin intolerance in diabetes","year":2023,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Statin; Diabetes mellitus; Dyslipidemia; Internal medicine; Ezetimibe; Scopus; MEDLINE; Disease; Intensive care medicine; Physical therapy; Endocrinology","score_opus":0.04077186506000876,"score_gpt":0.30051341303082385,"score_spread":0.2597415479708151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389304068","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.045544848,0.004917103,0.00014197784,0.9443425,0.001342465,0.002431192,0.00017363256,0.00037640665,0.00072988356],"genre_scores_gemma":[0.008874382,0.0021104165,0.0026769175,0.9540109,0.025709817,0.0016034483,0.0010312527,0.00030038835,0.0036824683],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99496514,0.00033156117,0.00057143107,0.0007595023,0.00041280442,0.0029595937],"domain_scores_gemma":[0.99740505,0.0006902463,0.00020562434,0.0015234856,0.00008021228,0.00009537415],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0010210375,0.00047631713,0.002000423,0.00028720897,0.00011903425,0.000042813288,0.0005993056,0.00050777313,0.0000484497],"category_scores_gemma":[0.0002698291,0.00035727854,0.00045301122,0.00037842395,0.00014854639,0.000052029245,0.00021300199,0.0029636617,0.00008862049],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000438833,0.00001758263,0.015629573,0.002164578,0.00062447775,0.00024528595,0.00011975965,0.000010802459,0.000061866354,0.00034223564,0.9013021,0.079437844],"study_design_scores_gemma":[0.0032920358,0.00027181715,0.027336586,0.0005480799,0.00033458165,0.000013100395,0.000028539082,0.00019979084,0.00038719093,0.011905057,0.9552561,0.0004271212],"about_ca_topic_score_codex":0.00053731824,"about_ca_topic_score_gemma":0.00013115963,"teacher_disagreement_score":0.079010725,"about_ca_system_score_codex":0.00018327801,"about_ca_system_score_gemma":0.00024177475,"threshold_uncertainty_score":0.99988794},"labels":[],"label_agreement":null},{"id":"W4389581259","doi":"10.1016/j.atherosclerosis.2023.117425","title":"Differential effect of atorvastatin and pravastatin on thoracic spine attenuation: A sub-analysis of a randomized clinical trial","year":2023,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Pfizer","keywords":"Atorvastatin; Pravastatin; Medicine; Attenuation; Randomized controlled trial; Differential (mechanical device); Internal medicine; Physics; Cholesterol","score_opus":0.048641258901757745,"score_gpt":0.37721035836572103,"score_spread":0.3285690994639633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389581259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962869,0.00009988201,0.0011053004,0.00018944338,0.00014862965,0.0020551095,0.00003409288,0.000045847963,0.000034762532],"genre_scores_gemma":[0.9986459,0.0006078115,0.00017917839,0.000047862257,0.0001672401,0.00018808426,0.00008024062,0.000027557156,0.00005614937],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960233,0.0015856517,0.0011077953,0.00036653152,0.0007056807,0.00021101485],"domain_scores_gemma":[0.99748206,0.0012853913,0.00046409966,0.000515887,0.000118708245,0.0001338804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005830123,0.00019492376,0.0025814683,0.00032534456,0.00004681151,0.000011448621,0.00006510015,0.00013039302,0.00006736246],"category_scores_gemma":[0.00169851,0.0001325316,0.0016022549,0.0010568681,0.00020207609,0.00002743158,0.000044158256,0.00017002088,0.000009341521],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7169376,0.0008674643,0.044797763,0.001173518,0.023687975,0.0000083052,0.0009559607,0.000043267202,0.027494002,0.00024276541,0.00019224474,0.18359914],"study_design_scores_gemma":[0.6322435,0.0050811647,0.32248855,0.00035987346,0.018145733,0.0000010639882,0.000057102516,0.0034573828,0.017917218,0.00002041254,0.000026304526,0.00020164571],"about_ca_topic_score_codex":0.0001169723,"about_ca_topic_score_gemma":0.000010308882,"teacher_disagreement_score":0.2776908,"about_ca_system_score_codex":0.000018109085,"about_ca_system_score_gemma":0.000059596445,"threshold_uncertainty_score":0.5404481},"labels":[],"label_agreement":null},{"id":"W4389773975","doi":"10.1093/ehjqcco/qcad071","title":"Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study","year":2023,"lang":"en","type":"article","venue":"European Heart Journal - Quality of Care and Clinical Outcomes","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Impact; St Joseph's Health Care; McMaster University; Population Health Research Institute","funders":"","keywords":"Prospective cohort study; Medicine; Cohort study; Cohort; Cholesterol; Environmental health; Internal medicine","score_opus":0.07912729866219478,"score_gpt":0.43691518734342727,"score_spread":0.35778788868123246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389773975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998122,0.00061644794,0.000032594482,0.00019549641,0.000090399655,0.00067634345,0.000075275864,0.000029433711,0.00016205256],"genre_scores_gemma":[0.99752927,0.0017156554,0.00026238066,0.00018459518,0.00021824217,0.0000025851214,0.000025124176,0.00001935963,0.000042764306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943118,0.0027803027,0.0014689903,0.0003926395,0.00088103826,0.00016523988],"domain_scores_gemma":[0.99748605,0.00058723136,0.0005632225,0.00059260556,0.00044449914,0.00032640368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0091978265,0.00016413249,0.0015453189,0.0001597266,0.00013251835,0.00003933599,0.000088505025,0.00007411923,0.0000128472075],"category_scores_gemma":[0.0017297022,0.00011251491,0.0009524273,0.00034074354,0.00013696316,0.00011068039,0.00008794771,0.000559946,0.0000026152268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015936796,0.00025683956,0.9867632,0.00009147826,0.007020593,0.000032664986,0.0017929386,0.0000041017274,0.000006609374,0.0000058885907,0.000013664396,0.0038526764],"study_design_scores_gemma":[0.0022432622,0.0013091733,0.98656076,0.000075314274,0.0047461744,0.000009666271,0.0047800643,0.000016185753,0.000008887639,0.000060548682,0.0000825171,0.00010742608],"about_ca_topic_score_codex":0.0014417579,"about_ca_topic_score_gemma":0.0009343084,"teacher_disagreement_score":0.007468124,"about_ca_system_score_codex":0.000019353016,"about_ca_system_score_gemma":0.0000736418,"threshold_uncertainty_score":0.45882246},"labels":[],"label_agreement":null},{"id":"W4389944120","doi":"10.1161/circ.148.suppl_1.13567","title":"Abstract 13567: Comparison of Change in Lipoprotein(a) Mass and Molar Concentrations by Alirocumab and Risk of Subsequent Cardiovascular Events in ODYSSEY OUTCOMES","year":2023,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Mace; Internal medicine; Myocardial infarction; Lipoprotein(a); Hazard ratio; Alirocumab; Cardiology; Lipoprotein; Cholesterol; Percutaneous coronary intervention; Confidence interval","score_opus":0.04982609493009167,"score_gpt":0.312630086937339,"score_spread":0.26280399200724736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389944120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171627,0.0065676398,0.00022922976,0.00009980815,0.000046835827,0.0012601133,0.000027024427,0.000018595134,0.000034464607],"genre_scores_gemma":[0.99839056,0.0013043552,0.00006684519,0.000010315568,0.00002883462,0.00008007828,0.00010135402,0.000015670632,0.0000019722381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849737,0.00012303784,0.0004895358,0.00024912143,0.0004538087,0.00018710067],"domain_scores_gemma":[0.9993414,0.00003771012,0.00015831967,0.00032262204,0.00006476289,0.00007515101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094410556,0.00012328863,0.0006387588,0.00019732618,0.000033127664,0.00000436218,0.000034276705,0.00012290377,0.0000045994016],"category_scores_gemma":[0.000105820865,0.00011914626,0.0001585201,0.0003560422,0.00004366049,0.00011859679,0.000018383285,0.00014843249,0.000001295396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021831196,0.000067493165,0.97828627,0.00040414114,0.00022581981,0.0000065903487,0.0008373736,0.00051990454,0.0024624513,0.000038963575,0.0000026630855,0.017126497],"study_design_scores_gemma":[0.0021339522,0.000035777568,0.99201626,0.00018139489,0.00014161321,0.000003940481,0.00027193295,0.0035119765,0.0014448463,0.000117636955,0.00004826907,0.00009239845],"about_ca_topic_score_codex":0.0066795857,"about_ca_topic_score_gemma":0.0003596074,"teacher_disagreement_score":0.017034099,"about_ca_system_score_codex":0.00008034028,"about_ca_system_score_gemma":0.000042083222,"threshold_uncertainty_score":0.99993503},"labels":[],"label_agreement":null},{"id":"W4389944226","doi":"10.1161/circ.148.suppl_1.13043","title":"Abstract 13043: LDL-C, Lp(a) and Hs-CRP Each Predict Future Cardiovascular Events After ACS on High-Intensity Statin Therapy. An Analysis of the ODYSSEY OUTCOMES Trial","year":2023,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sanofi (Canada)","funders":"","keywords":"Medicine; Internal medicine; Rosuvastatin; Mace; Cardiology; Myocardial infarction; Atorvastatin; C-reactive protein; Statin; Acute coronary syndrome; Hypertriglyceridemia; Unstable angina; Diabetes mellitus; Cholesterol; Endocrinology; Percutaneous coronary intervention; Triglyceride; Inflammation","score_opus":0.02264914111456466,"score_gpt":0.276431047607763,"score_spread":0.2537819064931983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389944226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99695027,0.0005205983,0.00009392256,0.00041526963,0.0005440005,0.0013225221,0.000053608223,0.00007252092,0.000027304965],"genre_scores_gemma":[0.99862844,0.00022326541,0.000026120832,0.0002078186,0.00057709735,0.00006139763,0.00022828922,0.00002839115,0.000019186018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997598,0.00021792375,0.00040190388,0.00042610939,0.0011203206,0.00023572471],"domain_scores_gemma":[0.99834895,0.00004118339,0.00014839119,0.0011507868,0.00019178781,0.00011888609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013318283,0.00020313844,0.0008425559,0.00025600987,0.00012225214,0.000019486119,0.000090057845,0.00017961243,0.000028745644],"category_scores_gemma":[0.00009516321,0.00013346356,0.0009894613,0.0007993017,0.00004366747,0.000106558946,0.000031695246,0.00022695764,0.0000053884746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051380275,0.00027961264,0.91438746,0.00017520547,0.0117032565,0.00003069742,0.0011484129,0.0047250492,0.00051213044,0.000045020515,0.00006500126,0.0617901],"study_design_scores_gemma":[0.008743054,0.00013395633,0.9876901,0.00003894093,0.0018879328,0.0000035935677,0.00018386893,0.00074823404,0.00012290778,0.00005162279,0.0002741315,0.00012169411],"about_ca_topic_score_codex":0.0005894047,"about_ca_topic_score_gemma":0.00005426319,"teacher_disagreement_score":0.07330258,"about_ca_system_score_codex":0.00008627002,"about_ca_system_score_gemma":0.00007922698,"threshold_uncertainty_score":0.5442486},"labels":[],"label_agreement":null},{"id":"W4389949468","doi":"10.1016/j.jacadv.2023.100756","title":"Coronary Atherosclerosis","year":2023,"lang":"en","type":"editorial","venue":"JACC Advances","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cardiology; Medicine; Coronary atherosclerosis; Internal medicine; Coronary heart disease","score_opus":0.015281212266224434,"score_gpt":0.3024333367977256,"score_spread":0.2871521245315012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389949468","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038612686,0.011461667,0.000057538717,0.00017344306,0.98487693,0.0005471211,0.00016436473,0.00036431712,0.0019684923],"genre_scores_gemma":[0.00013026247,0.03203501,0.0005050276,0.000087643224,0.9563592,0.00017700445,0.00056349905,0.00014805066,0.009994315],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728894,0.000053077492,0.0003322375,0.00055416726,0.0013472255,0.00042433987],"domain_scores_gemma":[0.9983411,0.00033936038,0.00015053501,0.0007810093,0.00019272888,0.00019527435],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045021332,0.00031066677,0.00084266166,0.000096465534,0.00010988887,0.000024610192,0.00017113765,0.0006201817,0.000098832206],"category_scores_gemma":[0.0007458538,0.00025139406,0.0004885131,0.00024461077,0.00006704477,0.00010637639,0.00008867977,0.00077337236,0.0005598715],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006846833,0.00003721467,0.00011615896,0.0006889127,0.00018131007,0.00005567373,0.00002803216,0.000002162039,0.000013515272,0.000004261935,0.9371688,0.061635494],"study_design_scores_gemma":[0.00092646823,0.00027983732,0.0012578486,0.00057030935,0.00021770876,0.0000050579756,0.000057405847,0.0000021318754,0.00003408506,0.00011196717,0.9962939,0.00024326978],"about_ca_topic_score_codex":0.00011547931,"about_ca_topic_score_gemma":0.000037724683,"teacher_disagreement_score":0.061392225,"about_ca_system_score_codex":0.00016823562,"about_ca_system_score_gemma":0.0004480522,"threshold_uncertainty_score":0.9999938},"labels":[],"label_agreement":null},{"id":"W4389957014","doi":"10.1161/circ.148.suppl_1.17091","title":"Abstract 17091: ARO-APOC3, an Investigational RNAi Therapeutic, Silences APOC3 and Reduces Atherosclerosis-Associated Lipoproteins in Patients With Mixed Dyslipidemia: MUIR Study Results","year":2023,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada); Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Apolipoprotein B; Cholesterol; Endocrinology; Placebo; Triglyceride; Very low-density lipoprotein; Hypertriglyceridemia; Lipoprotein; Obesity; Pathology","score_opus":0.0352706165480623,"score_gpt":0.27111961102876453,"score_spread":0.23584899448070223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389957014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971788,0.00008229834,0.000007066601,0.0003248598,0.00013311226,0.0020136416,0.000028272447,0.0001480665,0.00008391641],"genre_scores_gemma":[0.99893266,0.000020195012,0.00007356123,0.000114541726,0.00016831166,0.00013101641,0.0005087626,0.000038117567,0.000012809349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752337,0.00025455735,0.0005440451,0.00056029006,0.00078747445,0.0003302392],"domain_scores_gemma":[0.9988791,0.00007921932,0.00025744984,0.0004052979,0.00018997466,0.00018900295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015930191,0.00022603967,0.00041918343,0.00023131739,0.00020596967,0.000056567038,0.00008398284,0.00018317493,0.00000950712],"category_scores_gemma":[0.000249887,0.0001854641,0.00006810593,0.00073825585,0.00009530268,0.0003280515,0.000025402971,0.00029194143,0.000011257406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022929204,0.0006880789,0.97746366,0.00005476062,0.0001773356,0.000004351414,0.0020817285,0.00033018188,0.0018928914,0.000021198033,0.000028516182,0.017028023],"study_design_scores_gemma":[0.005938469,0.0005319227,0.99085736,0.00024442602,0.000084833526,9.1126157e-7,0.0009520994,0.0006701649,0.000262413,0.00023949567,0.000014090135,0.00020381137],"about_ca_topic_score_codex":0.0006914257,"about_ca_topic_score_gemma":0.00038352213,"teacher_disagreement_score":0.016824212,"about_ca_system_score_codex":0.00016581963,"about_ca_system_score_gemma":0.0001710955,"threshold_uncertainty_score":0.7563007},"labels":[],"label_agreement":null},{"id":"W4389957057","doi":"10.1161/circ.148.suppl_1.16133","title":"Abstract 16133: Lipoprotein(a) Screening Practices in a Large US Healthcare Dataset","year":2023,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atherosclerotic cardiovascular disease; Lipoprotein(a); Internal medicine; Hyperlipidemia; Demographics; Familial hypercholesterolemia; Risk factor; Diabetes mellitus; Retrospective cohort study; Cohort; Lipoprotein; Disease; Demography; Cholesterol; Endocrinology","score_opus":0.07323815844185738,"score_gpt":0.36104908695111254,"score_spread":0.28781092850925516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389957057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935332,0.0007780229,0.00044466965,0.0031864329,0.00013132987,0.0011350478,0.00022160218,0.00017006876,0.00039961282],"genre_scores_gemma":[0.99362963,0.000118902055,0.00031452227,0.0005567912,0.00040406335,0.00007783113,0.004855972,0.000028364337,0.000013925543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982712,0.00008908322,0.00033604034,0.00036558532,0.0005473356,0.00039071488],"domain_scores_gemma":[0.9989256,0.000043425865,0.00023486323,0.00057617936,0.00007081601,0.00014908033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016599755,0.0001252005,0.00027815238,0.0002558088,0.0001228902,0.00003280541,0.00006548928,0.00013880453,0.00006961998],"category_scores_gemma":[0.00042944102,0.0001236823,0.000099670106,0.00072087144,0.000013822141,0.00028692826,0.00003946513,0.00031874137,0.00019187742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023575415,0.0002213738,0.8123714,0.0018495356,0.00015862299,0.0006618507,0.0006070073,0.00068782596,0.0020277486,0.00047857803,0.002220934,0.17847937],"study_design_scores_gemma":[0.0012730551,0.000030140409,0.9761419,0.00022056627,0.000029638353,0.000044845572,0.00021505437,0.002531274,0.00007201261,0.000080434176,0.019243272,0.00011775392],"about_ca_topic_score_codex":0.0038833956,"about_ca_topic_score_gemma":0.0008062818,"teacher_disagreement_score":0.17836162,"about_ca_system_score_codex":0.00010438135,"about_ca_system_score_gemma":0.00015078728,"threshold_uncertainty_score":0.5870558},"labels":[],"label_agreement":null},{"id":"W4389966265","doi":"10.1186/s13195-023-01360-0","title":"Statins and cognitive decline in patients with Alzheimer’s and mixed dementia: a longitudinal registry-based cohort study","year":2023,"lang":"en","type":"article","venue":"Alzheimer s Research & Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Medicinska Forskningsrådet; Karolinska Institutet","keywords":"Medicine; Simvastatin; Dementia; Statin; Atorvastatin; Cohort; Internal medicine; Cognitive decline; Cohort study; Rosuvastatin; Physical therapy; Gerontology; Disease","score_opus":0.09119846079507639,"score_gpt":0.3842397506228643,"score_spread":0.29304128982778793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389966265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98237145,0.011590162,0.000026179385,0.0007008219,0.000028062152,0.005123457,0.000026200025,0.00005163306,0.000082025894],"genre_scores_gemma":[0.99797064,0.00086758786,0.00016144743,0.00018666232,0.00006416965,0.00055769755,0.0001285505,0.000050276692,0.000012972257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99615127,0.0005838501,0.00031102094,0.00068381894,0.0016085572,0.000661511],"domain_scores_gemma":[0.9983415,0.00025434952,0.000061888786,0.00049510517,0.0005334994,0.00031365306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031823514,0.00022980165,0.0005068633,0.00040656855,0.00023763369,0.000070182,0.00010300677,0.00008220392,0.000035922825],"category_scores_gemma":[0.00010577346,0.000170217,0.000055368597,0.0009876714,0.00030940797,0.00009899491,0.000116887546,0.0005079839,0.000014241425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025410259,0.000816544,0.9289668,0.000020150559,0.005580728,0.0001708699,0.00037064485,0.0000013432982,0.000007807428,0.0000038717735,0.0001937974,0.061326403],"study_design_scores_gemma":[0.015789723,0.004181171,0.97760946,0.00009769792,0.0006725811,0.0000047424405,0.00066105294,0.00008444421,0.00018926115,0.000020750545,0.0005168846,0.00017221173],"about_ca_topic_score_codex":0.0022897294,"about_ca_topic_score_gemma":0.00086583936,"teacher_disagreement_score":0.061154194,"about_ca_system_score_codex":0.000023124516,"about_ca_system_score_gemma":0.00031488074,"threshold_uncertainty_score":0.69412476},"labels":[],"label_agreement":null},{"id":"W4390046987","doi":"10.1371/journal.pone.0295857","title":"Intolerance upon statin rechallenge: A systematic review and meta-analysis of randomized controlled trials","year":2023,"lang":"en","type":"review","venue":"PLoS ONE","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"College of Family Physicians of Canada; University of Alberta","funders":"Imperial College London; Cleveland Clinic","keywords":"Medicine; myalgia; Statin; Internal medicine; Placebo; Meta-analysis; Randomized controlled trial; Discontinuation; Relative risk; Physical therapy; MEDLINE; Publication bias; Confidence interval; Alternative medicine; Pathology","score_opus":0.34828179518256575,"score_gpt":0.4088727321570236,"score_spread":0.06059093697445783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390046987","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.9308555e-7,0.9455443,0.000048130827,0.00035571834,0.0000147590545,0.053699363,0.00017603219,0.000059728292,0.00010128554],"genre_scores_gemma":[0.0000016452068,0.97705984,0.0007537119,0.00017379047,0.000065463515,0.020672252,0.00014769324,0.000078517674,0.0010470931],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97343665,0.016092729,0.008030498,0.0006098011,0.0015581085,0.0002722188],"domain_scores_gemma":[0.9836396,0.008511894,0.005538355,0.0015809973,0.0005354572,0.00019367613],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.065405495,0.00065253087,0.20217659,0.0007838095,0.000037465743,0.000022585233,0.00017132357,0.00030288938,0.0002705997],"category_scores_gemma":[0.037915774,0.00031052902,0.03144719,0.0013442165,0.00005331298,0.000029159568,0.0000564025,0.0004371043,0.000027979304],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087016996,0.00012299277,1.3645978e-9,0.50917554,0.48923418,0.0000066318903,0.000016838829,2.2991854e-8,5.9898944e-8,0.000027306345,0.0000053068484,0.00054098305],"study_design_scores_gemma":[0.036829084,0.000043719385,6.000328e-9,0.28511667,0.6776485,0.000003927581,0.0000059454974,0.000011921143,2.6862148e-7,0.000014453886,0.000178676,0.00014686093],"about_ca_topic_score_codex":0.000056420045,"about_ca_topic_score_gemma":0.000015450965,"teacher_disagreement_score":0.22405885,"about_ca_system_score_codex":0.000074328185,"about_ca_system_score_gemma":0.0003334123,"threshold_uncertainty_score":0.9999347},"labels":[],"label_agreement":null},{"id":"W4390292287","doi":"10.1161/atvbaha.123.319482","title":"A Century of Milestones and Breakthroughs Related to Low- and High-Density Lipoproteins","year":2023,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; HLS Therapeutics; National Institutes of Health; Pfizer; Amgen","keywords":"Gerontology; Library science; Medicine; Computer science","score_opus":0.01859928410982292,"score_gpt":0.2765365258961178,"score_spread":0.2579372417862949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390292287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967942,0.0005528368,0.00007158813,0.001557356,0.00013738635,0.00074824714,0.000027311857,0.00008802261,0.000023029179],"genre_scores_gemma":[0.978699,0.020027826,0.00063165353,0.0004512592,0.000061734056,0.000051142328,0.000041376126,0.000030430925,0.000005522358],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99834836,0.00014282519,0.00037813224,0.00057968614,0.0001746981,0.00037628817],"domain_scores_gemma":[0.9990208,0.000040239218,0.000080392936,0.0004967438,0.0000852052,0.00027661366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005846875,0.00023810731,0.0008496611,0.00017532427,0.0001645381,0.00001901293,0.000057948706,0.00024546977,0.000020207317],"category_scores_gemma":[0.00005658163,0.00019521937,0.00016883064,0.00037591928,0.00028030126,0.000058236423,0.00021795284,0.00014286475,0.000014391623],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055043914,0.00036874835,0.3369068,0.0015490818,0.0022618794,0.0000028559718,0.00363119,0.0000018263966,0.59054375,0.003837285,0.0002595633,0.06058197],"study_design_scores_gemma":[0.0015479174,0.00071397715,0.99405664,0.00028976257,0.00021558838,0.000009246564,0.00026873327,0.000025455942,0.0011528523,0.00015949781,0.001360106,0.00020022014],"about_ca_topic_score_codex":0.0015617218,"about_ca_topic_score_gemma":0.000085031555,"teacher_disagreement_score":0.65714985,"about_ca_system_score_codex":0.000018122033,"about_ca_system_score_gemma":0.000031168456,"threshold_uncertainty_score":0.7960815},"labels":[],"label_agreement":null},{"id":"W4390399052","doi":"10.1016/j.ahj.2023.12.004","title":"Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial","year":2023,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Amgen","keywords":"Evolocumab; Medicine; Internal medicine; Stroke (engine); Myocardial infarction; Cardiology; Clinical endpoint; PCSK9; Population; Randomized controlled trial; Apolipoprotein B; Cholesterol; Lipoprotein; Apolipoprotein A1","score_opus":0.013220321592103752,"score_gpt":0.2639724303145022,"score_spread":0.25075210872239845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390399052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720114,0.00027946162,0.0001731601,0.00010825324,0.0003399024,0.0018613166,0.00001945894,0.0000094168345,0.000007885499],"genre_scores_gemma":[0.99867076,0.00043643807,0.00036291577,0.00004275507,0.00037585196,0.00004507053,0.0000041159387,0.000021842257,0.000040266612],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654573,0.0014122044,0.00048712877,0.00019511087,0.0011195866,0.00024025083],"domain_scores_gemma":[0.9988286,0.00021750088,0.00028206193,0.00041794885,0.00013278467,0.00012109221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030194276,0.00014326595,0.0009163172,0.00018470752,0.00015313391,0.000010185759,0.00006593843,0.000057840713,0.000018811941],"category_scores_gemma":[0.00078059325,0.00008508883,0.0005832849,0.00050956313,0.0002091292,0.00006590368,0.000060662973,0.00032875672,0.0000037335853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03369729,0.00007003434,0.9187028,0.00007846143,0.0014455374,0.000008449591,0.00023365051,0.0015054252,0.00038903035,7.5734295e-7,0.00037459654,0.043493975],"study_design_scores_gemma":[0.03587389,0.005872195,0.95522726,0.000096618176,0.0005319759,0.000104673985,0.00006706151,0.00013739598,0.0009542181,0.0000051461893,0.0010397016,0.00008988983],"about_ca_topic_score_codex":0.00077478774,"about_ca_topic_score_gemma":0.00001123501,"teacher_disagreement_score":0.043404084,"about_ca_system_score_codex":0.00015040523,"about_ca_system_score_gemma":0.000268181,"threshold_uncertainty_score":0.34698218},"labels":[],"label_agreement":null},{"id":"W4390739000","doi":"10.1016/j.jacl.2023.12.005","title":"Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada); University of British Columbia","funders":"Esperion Therapeutics; Ministry of Health","keywords":"Medicine; Familial hypercholesterolemia; Clinical trial; Internal medicine; Pooled analysis; Pediatrics; Cholesterol; Meta-analysis","score_opus":0.2269201333166373,"score_gpt":0.48440037491288873,"score_spread":0.25748024159625144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390739000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993934,0.001573379,0.0010211926,0.00041454667,0.0017213895,0.0005445318,0.0007717335,0.000006734797,0.00001249029],"genre_scores_gemma":[0.9944714,0.0012293219,0.0018810024,0.00038288283,0.0017640099,0.0000018817045,0.00024263942,0.000023210905,0.0000037085554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9881208,0.0034255877,0.006911008,0.0005419805,0.0007458116,0.00025482933],"domain_scores_gemma":[0.9907926,0.0055934526,0.0018570512,0.0010023636,0.0003798565,0.0003747166],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01548546,0.00022225778,0.004875182,0.0004962688,0.00001995137,0.000011787539,0.0003172635,0.000499498,0.00007138594],"category_scores_gemma":[0.010978184,0.00013965229,0.001090698,0.000542025,0.00036898276,0.00015517224,0.00020378876,0.0012660065,0.000001966841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045079127,0.0039770235,0.4855011,0.00015010004,0.014074227,0.000086027736,0.00016004391,0.000021499764,0.00015742099,0.0000050389303,0.00034968706,0.45043868],"study_design_scores_gemma":[0.044075705,0.01206079,0.9284773,0.0005669073,0.012086182,0.000024547997,0.00005763649,0.00042497623,0.000036108337,0.00002268813,0.0020363352,0.00013081143],"about_ca_topic_score_codex":0.00009405742,"about_ca_topic_score_gemma":0.00007188977,"teacher_disagreement_score":0.45030788,"about_ca_system_score_codex":0.000031202024,"about_ca_system_score_gemma":0.00056723814,"threshold_uncertainty_score":0.9973528},"labels":[],"label_agreement":null},{"id":"W4390860012","doi":"10.1016/j.jacl.2024.01.003","title":"Sex differences in the presentation, treatment and outcomes of patients with homozygous familial hypercholesterolemia","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Heart Institute; Dalhousie University; Western University; University of Toronto; Queen Elizabeth II Health Sciences Centre; BC Innovation Council; Université du Québec à Chicoutimi; Hospital for Sick Children; University of British Columbia; Université Laval; Providence Health Care Research Institute; University of Ottawa; McGill University Health Centre; Providence Health Care; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Familial hypercholesterolemia; Presentation (obstetrics); Pediatrics; Internal medicine; Obstetrics; Cholesterol","score_opus":0.057059282639016634,"score_gpt":0.3810474081197081,"score_spread":0.32398812548069145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390860012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966358,0.0005787248,0.00005337967,0.0018304364,0.00058881147,0.00023383727,0.0000046856358,0.0000027906062,0.00007153701],"genre_scores_gemma":[0.99799997,0.00058972975,0.00019811538,0.0003389552,0.00081130106,0.000004312459,0.0000019151646,0.0000058236405,0.000049886192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983378,0.0004093102,0.00077166955,0.00011310763,0.00026516564,0.00010296562],"domain_scores_gemma":[0.998699,0.00083308626,0.00016409712,0.00014755942,0.000085836065,0.000070405215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011240946,0.000082879415,0.00072992,0.00007664216,0.000015030128,0.000009619559,0.00006476029,0.00008864653,0.000007477864],"category_scores_gemma":[0.0002573697,0.000034341923,0.000196467,0.000075251286,0.00013682744,0.00004528497,0.000012195398,0.0002748038,7.9142353e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038471428,0.00034447404,0.9343101,0.000050205585,0.0003002908,0.000030031377,0.00048170812,8.5449756e-7,0.000001979069,0.000029686567,0.00008376661,0.06398219],"study_design_scores_gemma":[0.003332779,0.0043677827,0.98970896,0.00006826616,0.00023309191,0.00012408759,0.00023239736,0.000009680343,0.000003760849,0.00010070247,0.0017877083,0.000030799918],"about_ca_topic_score_codex":0.000052367737,"about_ca_topic_score_gemma":0.0000366604,"teacher_disagreement_score":0.06395139,"about_ca_system_score_codex":0.00001659297,"about_ca_system_score_gemma":0.00016524819,"threshold_uncertainty_score":0.1400423},"labels":[],"label_agreement":null},{"id":"W4391324086","doi":"10.1007/s40119-024-00349-6","title":"Real-World Risk of Recurrent Cardiovascular Events in Atherosclerotic Cardiovascular Disease Patients with LDL-C Above Guideline-Recommended Threshold: A Retrospective Observational Study","year":2024,"lang":"en","type":"article","venue":"Cardiology and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital; Amgen (Canada)","funders":"Amgen Canada; Alberta Precision Laboratories; Government of Alberta","keywords":"Medicine; Internal medicine; Myocardial infarction; Ezetimibe; Unstable angina; Cardiology; Statin; Population; Stroke (engine); Guideline; Acute coronary syndrome; Coronary artery disease; Diabetes mellitus; Endocrinology","score_opus":0.03969821616150351,"score_gpt":0.29880981830710146,"score_spread":0.2591116021455979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391324086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96095246,0.034763623,0.00032292368,0.000096397125,0.00041344555,0.0030837713,0.00010694697,0.00006811441,0.0001922894],"genre_scores_gemma":[0.98704934,0.011802797,0.0001387619,0.000073442585,0.00036710422,0.00034272735,0.00013512537,0.00006268249,0.000028029997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964001,0.00072751153,0.0006575574,0.0009235095,0.00088530424,0.0004059816],"domain_scores_gemma":[0.99802667,0.000069573915,0.00009538694,0.0012408681,0.00034510717,0.00022241591],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025763966,0.0003880608,0.0016268932,0.0002982027,0.00011117979,0.000012268431,0.00012691444,0.00013635687,0.000016992111],"category_scores_gemma":[0.00007407687,0.00028023554,0.0013283081,0.0006397617,0.0001177831,0.00011411803,0.000059980277,0.0005266058,0.0000035050907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009989325,0.00033819713,0.9603925,0.00011677395,0.017518902,0.00011914179,0.0003157825,0.0008348621,0.000002904425,0.00012032671,0.00006508398,0.019176587],"study_design_scores_gemma":[0.007480405,0.001107406,0.98454267,0.00023338135,0.0016914988,0.000011141097,0.00010712202,0.00015477258,0.000007188715,0.00048348267,0.003909073,0.00027189017],"about_ca_topic_score_codex":0.0006588142,"about_ca_topic_score_gemma":0.000041770545,"teacher_disagreement_score":0.02609684,"about_ca_system_score_codex":0.0002206751,"about_ca_system_score_gemma":0.00027751207,"threshold_uncertainty_score":0.99996495},"labels":[],"label_agreement":null},{"id":"W4391385796","doi":"10.2196/50415","title":"Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study","year":2024,"lang":"en","type":"article","venue":"JMIR Public Health and Surveillance","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; Impact","funders":"McMaster University","keywords":"Kidney disease; Renal function; Prospective cohort study; Medicine; Environmental health; Cohort study; Cohort; Internal medicine","score_opus":0.02656346206242217,"score_gpt":0.31164701321055316,"score_spread":0.285083551148131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391385796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9214671,0.061586507,0.0013963188,0.009714267,0.00019107052,0.005107035,0.00017691146,0.00027269826,0.000088094515],"genre_scores_gemma":[0.9957738,0.00085291406,0.00004480733,0.00059017964,0.0012815995,0.0009361374,0.00031284484,0.000037465208,0.00017028175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671286,0.0005682283,0.00048974843,0.00088795816,0.000739142,0.00060205365],"domain_scores_gemma":[0.9969671,0.00026690136,0.00011176453,0.0005755005,0.00009003238,0.001988741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035867055,0.00024509686,0.0006005393,0.00026041875,0.00041235215,0.00018395286,0.000072075796,0.00012437814,0.00004591437],"category_scores_gemma":[0.0010194763,0.0002026723,0.00009755522,0.00078483205,0.000082515144,0.0003271883,0.00008235025,0.0005957109,0.000016657734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010081849,0.00009176395,0.9630131,0.0008688614,0.00020104516,0.000022594957,0.00053039595,4.3275435e-8,8.338374e-7,0.00020417938,0.0010943401,0.033872012],"study_design_scores_gemma":[0.0011434645,0.0008218177,0.95502204,0.0002747692,0.000029686042,0.00000935754,0.00010261005,0.00008105259,2.420364e-7,0.00012075912,0.042218182,0.00017603624],"about_ca_topic_score_codex":0.00069682347,"about_ca_topic_score_gemma":0.00020703046,"teacher_disagreement_score":0.074306674,"about_ca_system_score_codex":0.00039771787,"about_ca_system_score_gemma":0.003413253,"threshold_uncertainty_score":0.82647365},"labels":[],"label_agreement":null},{"id":"W4391399988","doi":"10.1002/cjce.25201","title":"Optimization and modelling of pravastatin recovery from aqueous solutions using reactive extraction methodology","year":2024,"lang":"en","type":"article","venue":"The Canadian Journal of Chemical Engineering","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"Niğde Üniversitesi","keywords":"Pravastatin; Extraction (chemistry); Response surface methodology; Aqueous solution; Box–Behnken design; Chromatography; Aqueous two-phase system; Solvent; Chemistry; Mathematics; Materials science; Biological system; Organic chemistry; Cholesterol","score_opus":0.0696920172871635,"score_gpt":0.27424721577369005,"score_spread":0.20455519848652653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391399988","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4016397,0.0045649633,0.5933457,0.00023543285,0.00013747251,0.000054196058,0.000005506323,0.000004318815,0.000012743575],"genre_scores_gemma":[0.902417,0.000056249773,0.09725028,0.000015388245,0.00024215017,6.951492e-7,0.0000027428662,0.000013197933,0.0000023111998],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99947494,0.000032643835,0.00020810204,0.00006324064,0.00010199279,0.000119077624],"domain_scores_gemma":[0.9994794,0.00015377495,0.000056552723,0.000074733405,0.00008067577,0.0001548237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055614184,0.000057140467,0.00018694709,0.00011385497,0.000029342626,0.000015519641,0.000027845314,0.00006578848,0.000009171126],"category_scores_gemma":[0.00017664833,0.000044596803,0.00008389334,0.000101572594,0.000026130674,0.00008050436,0.0000042869806,0.00029999568,1.117006e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018818022,0.0000025181316,0.0000028794916,0.000063545456,0.00020963025,0.00004314081,0.0003303405,0.8920918,0.102458335,0.00010231868,0.000006636049,0.004670043],"study_design_scores_gemma":[0.00015271429,0.000033956054,0.000010565306,0.00037237746,0.00025873922,0.00089028286,0.000047482325,0.96516293,0.032629337,0.00028240454,0.00010846275,0.000050728904],"about_ca_topic_score_codex":0.0071906894,"about_ca_topic_score_gemma":0.000055012115,"teacher_disagreement_score":0.5007773,"about_ca_system_score_codex":0.00019609755,"about_ca_system_score_gemma":0.00048485468,"threshold_uncertainty_score":0.9994205},"labels":[],"label_agreement":null},{"id":"W4391530349","doi":"10.1001/jamapediatrics.2023.6477","title":"Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia","year":2024,"lang":"en","type":"article","venue":"JAMA Pediatrics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"National Center for Advancing Translational Sciences; Sanofi","keywords":"Alirocumab; Medicine; Dosing; Placebo; Familial hypercholesterolemia; Internal medicine; Pediatrics; Clinical endpoint; Randomized controlled trial; Apolipoprotein B; Cholesterol","score_opus":0.007092869066038907,"score_gpt":0.2324196781927528,"score_spread":0.2253268091267139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391530349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338335,0.0036077183,0.00016474894,0.0003611523,0.0005246386,0.00070420693,0.000029035496,0.00016329458,0.0010618272],"genre_scores_gemma":[0.9944468,0.0011621981,0.000463467,0.0005265119,0.0030270352,0.000051213934,0.000075308846,0.00006892409,0.00017852815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977157,0.00006483678,0.0003736275,0.0004947601,0.0008888885,0.00046220096],"domain_scores_gemma":[0.9990715,0.000059141537,0.00004303292,0.0004698815,0.000118066404,0.00023841525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004024134,0.00023785885,0.00038691793,0.0004728493,0.00004707348,0.0000976539,0.000110688845,0.00022874873,0.000020448135],"category_scores_gemma":[0.00008967747,0.00017915308,0.0001783262,0.0010437595,0.000023286017,0.0002270854,0.00005795489,0.0006404859,0.00012307259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025027397,0.00026574123,0.912407,0.0013963077,0.00003711209,0.0005898154,0.00032061385,0.000020099078,0.0000026938596,0.00002988365,0.0023103105,0.08237018],"study_design_scores_gemma":[0.0043118545,0.0005998449,0.9843483,0.00006479049,0.00036492344,0.000053383163,0.00003314267,0.000082690654,0.0000066407065,0.000027808652,0.009840719,0.00026591806],"about_ca_topic_score_codex":0.0001405361,"about_ca_topic_score_gemma":0.000035269633,"teacher_disagreement_score":0.08210426,"about_ca_system_score_codex":0.00024096332,"about_ca_system_score_gemma":0.0003581859,"threshold_uncertainty_score":0.7305651},"labels":[],"label_agreement":null},{"id":"W4391544126","doi":"10.1021/acsptsci.3c00261","title":"Microbial Features Linked to Medication Strategies in Cardiometabolic Disease Management","year":2024,"lang":"en","type":"article","venue":"ACS Pharmacology & Translational Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Libin Cardiovascular Institute of Alberta; Alberta Cancer Foundation; University of Calgary","funders":"Fundação para a Ciência e a Tecnologia; Partenariat Canadien Contre Le Cancer; Alberta Health Services; European Commission; Health Canada; Alberta Health; Canadian Institutes of Health Research; Alberta Cancer Foundation; Mitacs","keywords":"Disease; Intensive care medicine; Medicine; Medication adherence; Disease management; Environmental health; Internal medicine","score_opus":0.01396230538032845,"score_gpt":0.338737761400374,"score_spread":0.32477545602004554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391544126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583199,0.0063279364,0.0023529788,0.026749078,0.0012561232,0.0014182478,0.00002422134,0.00010989131,0.0034416325],"genre_scores_gemma":[0.9963289,0.00033199607,0.0009938721,0.0016335407,0.0004345866,0.0001234686,0.000023989449,0.000008595572,0.00012104671],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983997,0.000047259862,0.00018964574,0.00042809217,0.0006320754,0.0003032366],"domain_scores_gemma":[0.999477,0.00002570122,0.000012829499,0.00014725285,0.00006124879,0.00027591776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092815165,0.00010499092,0.00016919567,0.00050151313,0.0001111842,0.000051154275,0.0001692664,0.000039662504,0.00008379568],"category_scores_gemma":[0.000007972483,0.000090074005,0.000088592664,0.0013562181,0.00021799459,0.0002490968,0.000027099266,0.0001861402,0.000042604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007995502,0.00044446846,0.0030276803,0.001214566,0.0006779969,0.001169457,0.0030862137,0.006470347,0.54133594,0.06329958,0.006211413,0.37226278],"study_design_scores_gemma":[0.0013513123,0.000052517287,0.93607086,0.00011110935,0.0003652526,0.000054046213,0.00009856721,0.0005496046,0.0021181237,0.0009966784,0.05804707,0.00018486571],"about_ca_topic_score_codex":0.000048879654,"about_ca_topic_score_gemma":0.000016424596,"teacher_disagreement_score":0.9330432,"about_ca_system_score_codex":0.00009542029,"about_ca_system_score_gemma":0.00089395884,"threshold_uncertainty_score":0.36731115},"labels":[],"label_agreement":null},{"id":"W4391649503","doi":"10.1016/j.cjca.2024.01.023","title":"Canadian Society of Clinical Chemists Harmonized Pediatric Lipid Reporting Recommendations for Clinical Laboratories","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Calgary Laboratory Services; University of British Columbia; Hospital for Sick Children; Royal Columbian Hospital; University of Calgary; Children's Hospital of Eastern Ontario; University of Toronto; Canadian Electricity Association; University of Ottawa; Brampton Civic Hospital; St. Michael's Hospital; University of Alberta","funders":"Hospital for Sick Children; University of Toronto; Dalhousie University; BC Children's Hospital; University of Alberta; University of Calgary; Canadian Society of Clinical Chemists","keywords":"Medicine; Dyslipidemia; Guideline; Percentile; Family medicine; Medical education; Internal medicine; Pathology","score_opus":0.11651108150322302,"score_gpt":0.4179791085417776,"score_spread":0.3014680270385546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391649503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8373956,0.044494692,0.009755668,0.07471762,0.025246128,0.0018034049,0.0008401178,0.000060691193,0.0056860656],"genre_scores_gemma":[0.96921796,0.0045286226,0.005736027,0.00088553503,0.019325241,0.0000135644,0.000051165895,0.000040733437,0.00020112559],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99609476,0.00022090643,0.002823473,0.0002554339,0.0001637656,0.00044167746],"domain_scores_gemma":[0.99584234,0.00036914903,0.0008730317,0.00033259176,0.0009977443,0.0015851659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008957567,0.00013727733,0.0013666432,0.00020959407,0.00012182382,0.000026142166,0.00013171318,0.0003983636,0.000026332322],"category_scores_gemma":[0.004546459,0.000118901335,0.0018672146,0.00036146943,0.00014048789,0.00006809524,0.000009250209,0.0007498955,0.000002669491],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007861243,0.0000070699907,0.40923116,0.0006573458,0.002236337,0.00042401772,0.00023361108,0.000012633253,0.00002013,0.0002933985,0.49858573,0.08821996],"study_design_scores_gemma":[0.0011252904,0.00034112032,0.03498361,0.00011560388,0.0007219871,0.000769641,0.00021956884,0.000032118965,0.000038595415,0.00009508001,0.9614425,0.000114901755],"about_ca_topic_score_codex":0.016880207,"about_ca_topic_score_gemma":0.01775379,"teacher_disagreement_score":0.46285674,"about_ca_system_score_codex":0.0003091648,"about_ca_system_score_gemma":0.027294435,"threshold_uncertainty_score":0.99070317},"labels":[],"label_agreement":null},{"id":"W4391836696","doi":"10.1016/j.jclinepi.2024.111284","title":"Effect of statin use for the primary prevention of cardiovascular disease among older adults: a cautionary tale concerning target trials emulation","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Epidemiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McGill University Health Centre; Institut universitaire de cardiologie et de pneumologie de Québec; Université de Sherbrooke; Université Laval; Université de Montréal; McGill University; University of Manitoba; Institut National de Santé Publique du Québec; Centre hospitalier de l'Université Laval","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Medicine; Hazard ratio; Myocardial infarction; Marginal structural model; Statin; Internal medicine; Proportional hazards model; Population; Confounding; Clinical endpoint; Stroke (engine); Randomized controlled trial; Confidence interval","score_opus":0.15512423426970928,"score_gpt":0.4709958376543819,"score_spread":0.31587160338467263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391836696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79377955,0.047423556,0.1552837,0.00075992127,0.0009769853,0.0017100701,0.00004881648,0.000009928017,0.0000074583213],"genre_scores_gemma":[0.9901639,0.0041631837,0.0037506428,0.00016463829,0.0015961872,0.000051773262,0.000048589634,0.000022300783,0.00003878195],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9845798,0.010026127,0.004509869,0.00024773699,0.0004384874,0.00019795398],"domain_scores_gemma":[0.9463378,0.05062475,0.002036117,0.0004065666,0.00038690344,0.00020782476],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.09398855,0.00014659841,0.0036654337,0.00009955081,0.000042264768,0.0000047031463,0.00009809121,0.00021966426,0.000029880666],"category_scores_gemma":[0.09697308,0.000078700905,0.0055461642,0.00012372031,0.00023739682,0.00015122037,0.00003094745,0.00051302,7.0711184e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01933269,0.0004295434,0.25306934,0.009993005,0.019673465,0.00011935891,0.00020687531,0.02679105,0.000044780823,0.0006275919,0.0022830414,0.66742927],"study_design_scores_gemma":[0.009944824,0.0051308763,0.93631107,0.0040061767,0.009309402,0.00007902939,0.00004772288,0.023856224,0.00008795924,0.0013623943,0.009736919,0.00012741491],"about_ca_topic_score_codex":0.00008311962,"about_ca_topic_score_gemma":6.9531103e-7,"teacher_disagreement_score":0.6832417,"about_ca_system_score_codex":0.000055189368,"about_ca_system_score_gemma":0.0005631901,"threshold_uncertainty_score":0.93292946},"labels":[],"label_agreement":null},{"id":"W4391850535","doi":"10.1016/j.atherosclerosis.2024.117472","title":"Estimating potential cardiovascular health benefits of improved population level control of LDL cholesterol through a twice-yearly siRNA-based approach: A simulation study of a health-system level intervention","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"NIHR Imperial Biomedical Research Centre; Novartis Pharma; National Institute for Health and Care Research; Imperial College London; Novartis","keywords":"Medicine; Placebo; Population; Absolute risk reduction; Internal medicine; Dosing; Demography; Confidence interval; Environmental health; Pathology","score_opus":0.07994188852619412,"score_gpt":0.30887199171795104,"score_spread":0.22893010319175694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391850535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5948238,0.0024672933,0.39960793,0.00007793539,0.00019155556,0.0026152122,0.00014109892,0.00007139841,0.0000038357766],"genre_scores_gemma":[0.99219453,0.000016614578,0.0072068884,0.000059807295,0.00017046637,0.00017085345,0.000091881215,0.00008376464,0.0000051761626],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9952489,0.00074339646,0.0018621844,0.00061319955,0.0011493837,0.00038294788],"domain_scores_gemma":[0.9976628,0.00006420106,0.0008982327,0.00091022317,0.00034232126,0.00012224512],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032359315,0.00031910112,0.0017220114,0.00024422622,0.00012829344,0.000032645417,0.00013896487,0.00016437568,0.0000032307557],"category_scores_gemma":[0.00007960696,0.00028752716,0.0012149962,0.00055338454,0.00004722851,0.0002228718,0.000042069936,0.00024850896,0.0000010769836],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071101845,0.0036638838,0.0128534,0.025740068,0.00499831,0.000001668437,0.00877149,0.5976438,0.0037640631,0.00011878663,0.0000063313637,0.34172717],"study_design_scores_gemma":[0.012995711,0.004658926,0.3675425,0.005203171,0.0010929317,0.00001103507,0.002365451,0.60541636,0.00044278943,0.000007791037,0.000009204688,0.00025415438],"about_ca_topic_score_codex":0.026952835,"about_ca_topic_score_gemma":0.00008269806,"teacher_disagreement_score":0.3973708,"about_ca_system_score_codex":0.00035589674,"about_ca_system_score_gemma":0.00025605303,"threshold_uncertainty_score":0.9999577},"labels":[],"label_agreement":null},{"id":"W4391917445","doi":"10.1101/2024.02.17.24302569","title":"No clear evidence for relationships of Apolipoprotein E genotype with measures of common infections in three UK cohorts","year":2024,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University College London; UK Dementia Research Institute; National Institute for Health and Care Research; British Heart Foundation; Weston Brain Institute; Wellcome Trust; Open Philanthropy Project; Brain Research UK; Medical Research Council; Alzheimer's Association","keywords":"Genotype; Apolipoprotein E; Biology; Psychology; Medicine; Genetics; Demography; Internal medicine; Sociology; Gene","score_opus":0.10274379381753648,"score_gpt":0.3245753460236878,"score_spread":0.22183155220615133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391917445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98449224,0.008209081,0.0017930882,0.00038844947,0.00029350526,0.0037051896,0.00003965292,0.00005218311,0.0010266323],"genre_scores_gemma":[0.99661666,0.00044222383,0.0019356749,0.000020020676,0.00025792723,0.00052537565,0.000024899462,0.000058390982,0.00011882645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977662,0.00018168717,0.000697891,0.00045523912,0.00066092995,0.00023805232],"domain_scores_gemma":[0.9977934,0.00020920309,0.00027458448,0.0011247551,0.0004886608,0.00010944586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024760617,0.0002424819,0.0009821098,0.00034381868,0.00005531023,0.000011833655,0.000149735,0.00033750548,0.000024430703],"category_scores_gemma":[0.0009779098,0.00019199948,0.00036424468,0.00037934355,0.00013100299,0.000029098072,0.00019510102,0.0011054971,0.000011012809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011048319,0.00029915554,0.9746639,0.013288051,0.0009553415,0.000031451844,0.00046914752,0.001035961,0.0010600752,0.0019179186,0.00012342658,0.0050507532],"study_design_scores_gemma":[0.001777891,0.0018846581,0.9580516,0.017969178,0.0016725537,0.00008347423,0.00006401628,0.0008908399,0.0044105113,0.011178633,0.001552231,0.0004643779],"about_ca_topic_score_codex":0.00581182,"about_ca_topic_score_gemma":0.007706689,"teacher_disagreement_score":0.01661225,"about_ca_system_score_codex":0.00014486867,"about_ca_system_score_gemma":0.000774405,"threshold_uncertainty_score":0.8785772},"labels":[],"label_agreement":null},{"id":"W4391946872","doi":"10.53555/sfs.v9i1.2106","title":"The Audit Of Using Of Statins Following A Diagnosis Of Acute Coronary Syndrome (ACS) In The Royal Alexandra Hospital","year":2022,"lang":"en","type":"article","venue":"Journal of Survey in Fisheries Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Acute coronary syndrome; Medicine; Audit; Cardiology; Internal medicine; Emergency medicine; Myocardial infarction; Management","score_opus":0.0778564907617796,"score_gpt":0.2897470012911279,"score_spread":0.21189051052934832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391946872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730676,0.0014122543,0.000010177249,0.0005967222,0.00035607416,0.00022206338,0.00003645031,9.509452e-7,0.000058541755],"genre_scores_gemma":[0.9993901,0.00028513317,0.00024664783,0.000036148234,0.000016113103,0.000008456483,0.0000011073198,0.0000050190883,0.000011234828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969267,0.0007446116,0.000745199,0.0001040494,0.0012827594,0.00019666135],"domain_scores_gemma":[0.9984031,0.00066038134,0.00059996155,0.00018277283,0.00011930872,0.000034523215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010949916,0.00008272145,0.00050121604,0.00013719064,0.00018583919,0.000017930923,0.0004265685,0.000024147912,0.000033816646],"category_scores_gemma":[0.0004408565,0.000046502966,0.00023500387,0.0008485728,0.00045375843,0.00017394635,0.000103249185,0.0002719152,3.263572e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011729838,0.0001582612,0.9954055,0.000037757487,0.00014064848,0.00017687927,0.0022936645,0.0004972994,0.00006005979,0.0000066868383,0.00012431461,0.0009816169],"study_design_scores_gemma":[0.00064115104,0.0019634115,0.9887161,0.00014841282,0.00006629351,0.00019407024,0.007905296,0.000056452318,0.00012982092,0.00004347767,0.00008595542,0.000049523864],"about_ca_topic_score_codex":0.0036284276,"about_ca_topic_score_gemma":0.00045403987,"teacher_disagreement_score":0.01050906,"about_ca_system_score_codex":0.0000775997,"about_ca_system_score_gemma":0.0006011962,"threshold_uncertainty_score":0.5485121},"labels":[],"label_agreement":null},{"id":"W4392151404","doi":"10.3138/canlivj-2023-0028","title":"Impact of statins in the liver: A bane or a boon?","year":2024,"lang":"en","type":"review","venue":"Canadian Liver Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Cholestasis; Liver injury; Liver disease; Adverse effect; Pharmacology; Internal medicine","score_opus":0.07100561881999856,"score_gpt":0.37188146302121183,"score_spread":0.30087584420121327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392151404","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021039505,0.99747646,0.0000034828518,0.00008788809,0.0001866025,0.0009483414,0.00023742682,0.0000047157023,0.000844663],"genre_scores_gemma":[0.00040039496,0.9978186,0.00006701163,0.0001793475,0.00096796284,0.000023328897,0.000025960346,0.00005282139,0.00046458506],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997792,0.00036859096,0.0006300966,0.0002159015,0.00047786455,0.0005155209],"domain_scores_gemma":[0.9983587,0.00006767103,0.00020134302,0.00047916363,0.000104614075,0.00078845385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013566134,0.00031193046,0.0015202536,0.00078035344,0.00008081027,0.000073929594,0.00029234402,0.00022536283,0.0008285836],"category_scores_gemma":[0.00011901941,0.00014636386,0.0016772181,0.00065273966,0.00005418862,0.0000518995,0.000018432323,0.0016895912,0.000090775706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000128729025,0.000026526117,0.000018497596,0.010423305,0.0010372454,0.01438929,0.00068240514,2.3768447e-7,1.329123e-8,0.000028347687,0.018516582,0.9548647],"study_design_scores_gemma":[0.00033941536,0.00050602964,0.0006368432,0.018815866,0.0026384231,0.027975583,0.00011658958,0.000005574408,1.2472587e-8,0.000007306869,0.94880474,0.00015359157],"about_ca_topic_score_codex":0.13790406,"about_ca_topic_score_gemma":0.10469664,"teacher_disagreement_score":0.9547111,"about_ca_system_score_codex":0.0016285634,"about_ca_system_score_gemma":0.019614503,"threshold_uncertainty_score":0.9859434},"labels":[],"label_agreement":null},{"id":"W4392241122","doi":"10.1097/crd.0000000000000667","title":"Lipoprotein(a): A Review of Risk Factors, Measurements, and Novel Treatment Modalities","year":2024,"lang":"en","type":"review","venue":"Cardiology in Review","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mendelian randomization; Lipoprotein(a); Atherosclerotic cardiovascular disease; Observational study; Modalities; Disease; Therapeutic modalities; Lipoprotein; Internal medicine; Bioinformatics; Intensive care medicine; Cholesterol; Genetics; Gene","score_opus":0.13282236450093116,"score_gpt":0.38184218466983544,"score_spread":0.24901982016890428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392241122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002943742,0.99061275,0.000020095613,0.000103746694,0.0003008563,0.0077197175,0.00038473686,0.000043941778,0.0008112227],"genre_scores_gemma":[0.00000306491,0.997151,0.00013154466,0.00024183744,0.00035320583,0.0015339933,0.00039791802,0.00009241129,0.00009499889],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950858,0.0011482041,0.001929266,0.00089242007,0.00049604475,0.00044827966],"domain_scores_gemma":[0.9973815,0.00014649167,0.00060049625,0.001502625,0.00015990224,0.00020896648],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003107292,0.0008654407,0.012136923,0.00025262055,0.000038329123,0.0000074108602,0.00017893373,0.0004794353,0.00003625548],"category_scores_gemma":[0.0007972157,0.0005069675,0.0034023107,0.0005778968,0.00017764761,0.000033004002,0.00012015719,0.00072614994,0.000029802815],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016330213,0.00002247756,0.000017184373,0.525325,0.0015893081,0.00004739546,0.000007933636,2.1667619e-8,2.8451648e-8,0.000035615707,0.00041169397,0.4725417],"study_design_scores_gemma":[0.00022124856,0.00013186145,0.000020431984,0.4531983,0.018295942,0.000682848,0.000003856244,5.8136592e-8,1.6100854e-7,0.000009042355,0.527248,0.00018820133],"about_ca_topic_score_codex":0.00042879375,"about_ca_topic_score_gemma":0.000008143162,"teacher_disagreement_score":0.52683634,"about_ca_system_score_codex":0.000512295,"about_ca_system_score_gemma":0.0009144148,"threshold_uncertainty_score":0.9997382},"labels":[],"label_agreement":null},{"id":"W4392360729","doi":"10.1016/j.cjca.2024.02.019","title":"Increased Lp(a) Workload Volumes Reflect Uptake of the 2021 Canadian Cardiovascular Society Guidelines for Management of Dyslipidemia","year":2024,"lang":"en","type":"letter","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Calgary Laboratory Services; University of Alberta; University of Calgary","funders":"University of Calgary","keywords":"Medicine; Dyslipidemia; Workload; Intensive care medicine; Environmental health; Internal medicine; Gerontology; Obesity; Management","score_opus":0.04501964339006637,"score_gpt":0.29400019688351864,"score_spread":0.24898055349345227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392360729","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048676985,0.29420292,0.0024898779,0.66800994,0.01193492,0.004546206,0.0022396126,0.000018708202,0.01169012],"genre_scores_gemma":[0.1696376,0.022842553,0.022115646,0.61310554,0.16045958,0.00050758553,0.0009379129,0.0011683471,0.009225248],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954557,0.00041767093,0.0017810691,0.0004996958,0.00083196885,0.0010138958],"domain_scores_gemma":[0.9946578,0.00008853203,0.0006157342,0.0015983372,0.002207292,0.00083228253],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0039709485,0.00049457815,0.0030955959,0.0005698085,0.0001663702,0.000024708683,0.0007122218,0.0013072636,0.00003899262],"category_scores_gemma":[0.0004543883,0.00036159065,0.0084065655,0.0005692862,0.00037456362,0.00004076197,0.00005156842,0.0019257817,0.000005613548],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025467738,0.0000010090582,0.00040097578,0.002124417,0.020128077,0.00092651584,0.00005728408,0.0004571743,0.0000076573815,0.000021909964,0.947044,0.028805519],"study_design_scores_gemma":[0.0011034288,0.0001908145,0.0020850415,0.0025095749,0.0073748855,0.0008564125,0.00020675894,0.000021808437,0.000029503812,0.00015354091,0.9852035,0.00026470041],"about_ca_topic_score_codex":0.099716194,"about_ca_topic_score_gemma":0.039274324,"teacher_disagreement_score":0.2713604,"about_ca_system_score_codex":0.0012188213,"about_ca_system_score_gemma":0.013250639,"threshold_uncertainty_score":0.9999893},"labels":[],"label_agreement":null},{"id":"W4392372877","doi":"10.20944/preprints202402.1255.v1","title":"Development of New Resolvin D1 Analogues for Osteoarthritis Therapy: Acellular and Computational Approaches to Study Their Antioxidant Activities","year":2024,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Osteoarthritis; Antioxidant; Medicine; Computer science; Pharmacology; Chemistry; Biochemistry; Alternative medicine; Pathology","score_opus":0.2566158705237651,"score_gpt":0.3408251583449034,"score_spread":0.08420928782113829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392372877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98616594,0.005604401,0.0022122962,0.0004674684,0.00019597023,0.0050270474,0.000059310245,0.000090553935,0.00017698327],"genre_scores_gemma":[0.98421454,0.00019695277,0.0141789885,0.00006112668,0.00026373577,0.0006639532,0.00009764426,0.00006404432,0.00025898602],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974638,0.00012275504,0.00064007164,0.0009530461,0.00053329056,0.00028701645],"domain_scores_gemma":[0.9986592,0.000063303116,0.00016656047,0.00078116904,0.000103142236,0.00022664749],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014868121,0.0003743675,0.00093761843,0.00024671498,0.00015891867,0.000025146961,0.00018860877,0.00018946044,0.0000345124],"category_scores_gemma":[0.000056804296,0.00031651603,0.00031498913,0.00014991392,0.00006286359,0.00003083766,0.0014605551,0.00045345523,0.000013683228],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001968643,0.0022733547,0.13120557,0.0063052317,0.008566123,0.000077987774,0.1711249,0.0010139879,0.014710209,0.0006559379,0.000075311254,0.66202277],"study_design_scores_gemma":[0.0054306625,0.000873326,0.83663505,0.0019780903,0.0004906844,0.0000665104,0.011474988,0.0003130393,0.12601404,0.0051272665,0.0106815295,0.0009148202],"about_ca_topic_score_codex":0.00015377006,"about_ca_topic_score_gemma":0.000048619768,"teacher_disagreement_score":0.7054295,"about_ca_system_score_codex":0.00010159661,"about_ca_system_score_gemma":0.00090655533,"threshold_uncertainty_score":0.9999287},"labels":[],"label_agreement":null},{"id":"W4392446659","doi":"10.1159/000536392","title":"Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III","year":2024,"lang":"en","type":"article","venue":"Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cape Breton Regional Hospital; Windsor Regional Hospital; University of Alberta Hospital; Misericordia Community Hospital; Oakville-Trafalgar Memorial Hospital; Alberta Hospital Edmonton; Occupational and Environmental Medical Association of Canada; University of Toronto; Moncton Hospital; St. Michael's Hospital; Centre hospitalier universitaire de Québec; Canadian Heart Research Centre","funders":"Sanofi","keywords":"Acute coronary syndrome; Dyslipidemia; Medicine; Internal medicine; Cardiology; Intensive care medicine; Myocardial infarction; Obesity","score_opus":0.012814778923246586,"score_gpt":0.26818209746728106,"score_spread":0.2553673185440345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392446659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807991,0.010438036,0.0013565852,0.0014519345,0.0015264449,0.0015183383,0.00022221624,0.00038606435,0.0023013186],"genre_scores_gemma":[0.9902876,0.0029186506,0.0013329601,0.003333526,0.00048900786,0.00029943552,0.00069769827,0.000110307665,0.0005308173],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9965668,0.0005219173,0.00055111246,0.0011100807,0.00049725,0.0007528467],"domain_scores_gemma":[0.99779963,0.00024167036,0.00012226983,0.0013985286,0.00012997704,0.00030794038],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036747314,0.00049197435,0.0015833526,0.00020614392,0.00031929076,0.000044464483,0.00039683285,0.0002083709,0.00004549144],"category_scores_gemma":[0.000023125114,0.0003428595,0.0008497767,0.000773947,0.0005100924,0.00016354637,0.00039120126,0.0009622171,0.00024710174],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034711827,0.00023881799,0.0899512,0.00095392764,0.1662333,0.5733413,0.0061335815,0.00086305256,0.002013363,0.0034069854,0.017221062,0.13617222],"study_design_scores_gemma":[0.0013797752,0.0016074829,0.94613856,0.00022529942,0.004192416,0.029709792,0.0010080467,0.0001552756,0.0000141519695,0.00017171908,0.014928933,0.00046856198],"about_ca_topic_score_codex":0.00043659302,"about_ca_topic_score_gemma":0.00006183817,"teacher_disagreement_score":0.85618734,"about_ca_system_score_codex":0.00044533354,"about_ca_system_score_gemma":0.00023799024,"threshold_uncertainty_score":0.99990237},"labels":[],"label_agreement":null},{"id":"W4392506974","doi":"10.1016/bs.acc.2024.02.004","title":"Advances in familial hypercholesterolemia","year":2024,"lang":"en","type":"article","venue":"Advances in clinical chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Clinical Research Institute","funders":"","keywords":"Familial hypercholesterolemia; Guideline; Medicine; Risk stratification; Atherosclerotic cardiovascular disease; Disease; Intensive care medicine; Clinical trial; Precision medicine; Internal medicine; Pathology; Cholesterol","score_opus":0.023980846893208882,"score_gpt":0.3991943561336079,"score_spread":0.375213509240399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392506974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8162581,0.1517267,0.00012393409,0.00051456224,0.0006851038,0.0002659491,0.000008059132,0.00010406463,0.030313542],"genre_scores_gemma":[0.92966276,0.06776248,0.0005600169,0.0004153833,0.0011399739,0.00005001036,0.000016497243,0.00002525935,0.0003676196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979261,0.000051503066,0.0007829784,0.0005712993,0.00033842708,0.0003296477],"domain_scores_gemma":[0.99903613,0.00027522718,0.000040357874,0.00046020947,0.000026966456,0.00016110139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010438706,0.00016661851,0.0005279323,0.000038199574,0.000016776035,0.000015882146,0.00013237551,0.00023897648,0.00005826484],"category_scores_gemma":[0.00047535377,0.00014086376,0.00027536793,0.00031074215,0.00014730857,0.00029374033,0.000055242755,0.0009920202,0.000038307448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019585059,0.00020157671,0.09342413,0.0020440652,0.000017676457,0.00062004366,0.000038857244,0.0000632189,0.0004345153,0.00004664551,0.000043233722,0.9028702],"study_design_scores_gemma":[0.004912298,0.00029313186,0.04374225,0.003705507,0.0000781589,0.00023206469,0.00031194164,0.00056529784,0.00376583,0.003062027,0.93880725,0.0005242237],"about_ca_topic_score_codex":0.000013574193,"about_ca_topic_score_gemma":0.00003801417,"teacher_disagreement_score":0.93876404,"about_ca_system_score_codex":0.00011813404,"about_ca_system_score_gemma":0.0001925199,"threshold_uncertainty_score":0.57442576},"labels":[],"label_agreement":null},{"id":"W4392604238","doi":"10.1101/2024.03.06.24303892","title":"Publication bias in pharmacogenetics of statin-associated muscle symptoms, an umbrella review with a meta-epidemiological study","year":2024,"lang":"en","type":"review","venue":"medRxiv","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Centre National de la Recherche Scientifique","keywords":"Funnel plot; SLCO1B1; Publication bias; Statin; Meta-analysis; Medicine; Odds ratio; Internal medicine; Pharmacogenetics; Pharmacology; Genotype; Genetics; Biology","score_opus":0.28214524288905907,"score_gpt":0.446024021149999,"score_spread":0.16387877826093994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392604238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00442172,0.989319,0.000008324915,0.00018713214,0.00007425309,0.005708708,0.00006928199,0.00007752977,0.00013401391],"genre_scores_gemma":[0.0012093995,0.9964302,0.00015021533,0.00037794167,0.00010784372,0.0011391884,0.0003615931,0.00009132605,0.00013228442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99272776,0.0032315275,0.0019596557,0.00083472085,0.00085290195,0.00039343484],"domain_scores_gemma":[0.9971945,0.00023963994,0.00083188683,0.0011249154,0.00034486546,0.00026414552],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010177835,0.00060285244,0.006521556,0.00030221918,0.000029516528,0.000018882587,0.0002902698,0.00025763173,0.00014530399],"category_scores_gemma":[0.0014082058,0.00030857197,0.0013312773,0.0016941173,0.0000633499,0.000044005486,0.00008745251,0.0008660162,0.0000339825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012261172,0.0014180273,0.0020390386,0.13668312,0.00996319,0.00018209053,0.00008143046,6.010021e-7,4.953041e-7,0.000020551483,0.00065751624,0.8489417],"study_design_scores_gemma":[0.00089842506,0.0015843911,0.0039322483,0.043617785,0.09362678,0.00008617698,0.000026617332,0.000016427268,5.882396e-7,0.000006495144,0.8557896,0.00041444684],"about_ca_topic_score_codex":0.0002053888,"about_ca_topic_score_gemma":0.000073624105,"teacher_disagreement_score":0.8551321,"about_ca_system_score_codex":0.00017350467,"about_ca_system_score_gemma":0.00069929135,"threshold_uncertainty_score":0.99993664},"labels":[{"model":"gemma","categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"domain":"methods","study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch","metaepi_narrow","metaepi_broad"],"domain":"methods","study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4392723803","doi":"10.1016/j.jlr.2024.100530","title":"Apolipoprotein A1 and high-density lipoprotein limit low-density lipoprotein transcytosis by binding SR-B1","year":2024,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Toronto Metropolitan University; University of Toronto; St. Michael's Hospital","funders":"Division of Mathematical Sciences; RIKEN; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Consortium canadien en neurodégénérescence associée au vieillissement","keywords":"Transcytosis; Apolipoprotein B; Lipoprotein; High-density lipoprotein; Apolipoprotein C2; Chemistry; Low-density lipoprotein receptor-related protein 8; Low-density lipoprotein; Cholesterol; Very low-density lipoprotein; Biochemistry; Receptor; Endocytosis","score_opus":0.03596427515586947,"score_gpt":0.3309292852489316,"score_spread":0.29496501009306214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392723803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96978116,0.01297998,0.0010644888,0.0127667505,0.0007721596,0.0019776593,0.00005123635,0.00011401435,0.0004925807],"genre_scores_gemma":[0.9856871,0.0049207686,0.0015737871,0.00018565591,0.0051824143,0.00006695185,0.000017069504,0.00014578164,0.0022204737],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9911599,0.0010525142,0.0013587641,0.0008664027,0.0041631563,0.0013992527],"domain_scores_gemma":[0.995913,0.00033366252,0.00025402656,0.0009684271,0.0011930146,0.001337855],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011988649,0.00051740295,0.0015034898,0.001378479,0.0006117493,0.00045778838,0.00046686747,0.00056406995,0.00025713365],"category_scores_gemma":[0.00088707573,0.00040543143,0.0008834097,0.0015498454,0.0004927262,0.0005493999,0.00025342483,0.003968275,0.00014125],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001882436,0.0006981544,0.00041315888,0.0043841703,0.0016329952,0.0025427237,0.0010481807,0.000003504821,0.32057306,0.0004899001,0.013304167,0.65302753],"study_design_scores_gemma":[0.008706803,0.0074012545,0.013616345,0.009094405,0.0008437538,0.008024213,0.0014224261,0.00044364735,0.8563573,0.0013695707,0.09138105,0.0013392484],"about_ca_topic_score_codex":0.0046469765,"about_ca_topic_score_gemma":0.00018698756,"teacher_disagreement_score":0.6516883,"about_ca_system_score_codex":0.0007132857,"about_ca_system_score_gemma":0.0012315904,"threshold_uncertainty_score":0.9998398},"labels":[],"label_agreement":null},{"id":"W4392881602","doi":"10.7759/cureus.56255","title":"An Update on Dyslipidemia Management and Medications: A Review","year":2024,"lang":"en","type":"review","venue":"Cureus","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Medicine; Intensive care medicine; Disease; Disease management; Psychological intervention; Clinical trial; Internal medicine; Psychiatry","score_opus":0.0456171975181794,"score_gpt":0.4013804698043977,"score_spread":0.3557632722862183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392881602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.271627e-8,0.9917665,0.000027438817,0.0007889718,0.00031643055,0.0026812523,0.000025134395,0.00010128488,0.0042928583],"genre_scores_gemma":[2.2350432e-7,0.9941714,0.00046580023,0.0026734378,0.0007675233,0.000689028,0.00034173147,0.000066489585,0.0008243801],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980553,0.00016586493,0.0005355791,0.00058069924,0.00044469358,0.00021787669],"domain_scores_gemma":[0.99813974,0.000016806864,0.00012107474,0.0013997264,0.000031801977,0.00029086546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010995939,0.00032905256,0.0017421459,0.000106574975,0.00004856656,0.000021987427,0.00015930884,0.00019087824,0.0001381132],"category_scores_gemma":[0.000036914622,0.00020656019,0.0005015297,0.00028346106,0.000035974597,0.00003375205,0.00007129626,0.0004747795,0.00056659256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[6.8754025e-7,0.000026734502,7.988037e-8,0.23481092,0.0006838442,0.00007241301,0.0000034659538,2.0574638e-9,1.5440921e-9,0.0016195908,0.030050648,0.73273164],"study_design_scores_gemma":[0.00009234295,0.00008304721,0.0000023899179,0.19053143,0.011924586,0.00014881298,0.0000037201205,8.256098e-7,1.1165939e-8,0.00006472972,0.797008,0.0001401052],"about_ca_topic_score_codex":0.000012695819,"about_ca_topic_score_gemma":0.0000028139427,"teacher_disagreement_score":0.76695734,"about_ca_system_score_codex":0.00016684951,"about_ca_system_score_gemma":0.00019093062,"threshold_uncertainty_score":0.842328},"labels":[],"label_agreement":null},{"id":"W4392902278","doi":"10.46747/cfp.7003187","title":"Prevalence and management of dyslipidemia in primary care practices in Canada","year":2024,"lang":"en","type":"article","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Manitoba; Queen's University; Kingston Health Sciences Centre","funders":"","keywords":"Dyslipidemia; Medicine; Body mass index; Internal medicine; Retrospective cohort study; Primary care; Cohort; Medical record; Obesity; Framingham Risk Score; Framingham Heart Study; Pediatrics; Demography; Family medicine; Disease","score_opus":0.01488426093849069,"score_gpt":0.24673554844936144,"score_spread":0.23185128751087075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392902278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88454646,0.04385446,9.3768466e-7,0.00040058864,0.00015754664,0.0006319059,0.00004632509,0.000007508941,0.070354246],"genre_scores_gemma":[0.99210405,0.0011399587,0.00008894661,0.0064623067,0.00007198304,0.000034833407,0.00001747656,0.000015966823,0.00006445708],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990055,0.000039029128,0.00019478642,0.00026139632,0.00022368378,0.0002756092],"domain_scores_gemma":[0.9994452,0.000019866622,0.00004281447,0.00026112335,0.000024669213,0.0002063195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017694072,0.000100739104,0.0002492171,0.00015856506,0.000017449296,0.000010082228,0.000063942585,0.000035189823,9.3341606e-7],"category_scores_gemma":[0.0000044445824,0.00010008174,0.000037683898,0.0003384929,0.000023174523,0.00008390378,0.000017747216,0.00018289601,0.000001921004],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047795762,0.00003315016,0.10026586,0.048295103,0.00031284688,0.0038932895,0.00083956023,0.00005540174,0.00030879106,0.0013861354,0.0030726118,0.84148943],"study_design_scores_gemma":[0.0003859956,0.000033364668,0.9691209,0.0028961664,0.0000749123,0.0000018670348,0.0023137094,0.00007880975,0.00003521415,0.0000231171,0.024915695,0.000120215314],"about_ca_topic_score_codex":0.9773404,"about_ca_topic_score_gemma":0.9876837,"teacher_disagreement_score":0.86885506,"about_ca_system_score_codex":0.0020856238,"about_ca_system_score_gemma":0.0043906486,"threshold_uncertainty_score":0.7788822},"labels":[],"label_agreement":null},{"id":"W4392909117","doi":"10.1136/bmj-2023-076774","title":"Statins, risk, and personalised care","year":2024,"lang":"en","type":"article","venue":"BMJ","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Focus (optics); Population; Medicine; Computer science; Environmental health","score_opus":0.013745205974383801,"score_gpt":0.30524642720947975,"score_spread":0.291501221235096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392909117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91964704,0.06256676,0.0003435678,0.0031410863,0.00027197157,0.00075959205,0.000055645316,0.00014169491,0.013072641],"genre_scores_gemma":[0.9964371,0.00055954244,0.0010533768,0.00030182922,0.00065367034,0.000027786104,0.000019450927,0.000014500558,0.00093279505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99948144,0.00003185391,0.00007572063,0.00013508782,0.00018149987,0.00009438656],"domain_scores_gemma":[0.9997149,0.000014480826,0.000008904739,0.00015188339,0.000027572421,0.00008223977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002361697,0.000050998024,0.00011332827,0.0000280921,0.0000388194,0.000019599493,0.00001227455,0.000031145242,0.00006384474],"category_scores_gemma":[0.00004151401,0.000037623086,0.00007813691,0.00006150004,0.000016325854,0.000020733543,0.000010798378,0.00011322084,0.000037289625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069436464,0.000018092687,0.0109368,0.0026469985,0.0003296214,0.0006057918,0.0079308655,0.0000012701769,0.00019339661,0.0008454085,0.040717416,0.9357049],"study_design_scores_gemma":[0.0013121872,0.000266689,0.09456198,0.0004394892,0.00033411078,0.0003594737,0.0050268224,0.00045598552,0.0003090758,0.00009445761,0.896678,0.00016177256],"about_ca_topic_score_codex":0.00039594356,"about_ca_topic_score_gemma":0.000021498974,"teacher_disagreement_score":0.9355431,"about_ca_system_score_codex":0.00002720123,"about_ca_system_score_gemma":0.000113603106,"threshold_uncertainty_score":0.15342249},"labels":[],"label_agreement":null},{"id":"W4392954115","doi":"10.1093/eurjpc/zwae110","title":"Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES","year":2024,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Alberta; St. Michael's Hospital; Sanofi (Canada)","funders":"Sanofi","keywords":"Medicine; Alirocumab; Molar; Internal medicine; Lipoprotein(a); Cardiology; Lipoprotein; Cholesterol; Dentistry","score_opus":0.03827302767896107,"score_gpt":0.318008986907904,"score_spread":0.27973595922894295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392954115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88292664,0.11320801,0.00272693,0.00010925352,0.00018353442,0.00059685117,0.000033870594,0.0000048895345,0.0002100007],"genre_scores_gemma":[0.9880105,0.011421337,0.00036455406,0.000015347709,0.00013153582,0.000008874872,0.000007724018,0.00002567058,0.000014448429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598557,0.0022708874,0.0009208176,0.00025014373,0.00035420997,0.00021840059],"domain_scores_gemma":[0.99908674,0.0000834036,0.0002981714,0.00026358353,0.00014846632,0.000119615834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039151204,0.00017482766,0.0014502592,0.00027268066,0.000021925538,0.0000055920455,0.00009248805,0.00006732521,0.000004874529],"category_scores_gemma":[0.00020595564,0.00014041278,0.00057185616,0.0002018419,0.0001370193,0.000114473456,0.000059230482,0.00047370535,8.7567554e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014531675,0.00009057199,0.94524086,0.0005635996,0.003520194,0.0005878808,0.0015798324,0.00010432463,0.0023271271,0.00006552686,0.000043041757,0.045731716],"study_design_scores_gemma":[0.0029686207,0.0007627332,0.99039024,0.0008352461,0.0008553456,0.00032561377,0.00046031602,0.000087747074,0.0012234511,0.0000835676,0.0018847198,0.00012239747],"about_ca_topic_score_codex":0.00021396605,"about_ca_topic_score_gemma":0.00001859822,"teacher_disagreement_score":0.105083846,"about_ca_system_score_codex":0.00007326798,"about_ca_system_score_gemma":0.00007922715,"threshold_uncertainty_score":0.5725867},"labels":[],"label_agreement":null},{"id":"W4392967090","doi":"10.20944/preprints202403.1047.v1","title":"Insights Into PCSK9-LDLR Regulation and Trafficking Via the Differential Functions of MHC-I Proteins HFE and HLA-C","year":2024,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Grand Équipement National De Calcul Intensif; Canada Research Chairs; Fondation Leducq","keywords":"Human leukocyte antigen; LDL receptor; Major histocompatibility complex; Chemistry; Biology; Cell biology; Computational biology; Genetics; Antigen; Biochemistry; Cholesterol; Lipoprotein","score_opus":0.050930792162524725,"score_gpt":0.3044386039908431,"score_spread":0.2535078118283184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392967090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98885703,0.0035130763,0.0019029083,0.0010664205,0.0005859695,0.0025915902,0.000006995338,0.0001375033,0.0013384875],"genre_scores_gemma":[0.9976558,0.00041121405,0.00013254088,0.000050749084,0.00066251785,0.00033796494,0.000052170206,0.000057918474,0.00063910574],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974523,0.00020518649,0.0006039681,0.0009068816,0.0005957882,0.00023585946],"domain_scores_gemma":[0.9980324,0.00004525926,0.00023544181,0.0013305903,0.00017760918,0.00017872236],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005791169,0.00035700915,0.0007065727,0.00021768706,0.00020531774,0.000036706104,0.00015165587,0.00039323198,0.00011418103],"category_scores_gemma":[0.00011709299,0.0002528178,0.0003323145,0.00018491068,0.0002405961,0.000052181844,0.0013078804,0.001142872,0.000043318152],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001806303,0.0017257076,0.2005587,0.042874254,0.010821591,0.00015586584,0.05504138,0.0010567254,0.33151865,0.008927088,0.00025183306,0.3452619],"study_design_scores_gemma":[0.001393229,0.0001523937,0.9514483,0.002006262,0.0016762223,0.00011197514,0.0004398584,0.0029689022,0.023481356,0.010478419,0.005354459,0.0004886266],"about_ca_topic_score_codex":0.0010295493,"about_ca_topic_score_gemma":0.00014896915,"teacher_disagreement_score":0.7508896,"about_ca_system_score_codex":0.00011579098,"about_ca_system_score_gemma":0.00024248303,"threshold_uncertainty_score":0.99999243},"labels":[],"label_agreement":null},{"id":"W4393078238","doi":"10.31083/j.jin2303062","title":"The Impact of PCSK9 Gene Polymorphisms on Ischemic Stroke: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Journal of Integrative Neuroscience","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Shanxi Provincial Key Research and Development Project","keywords":"PCSK9; Single-nucleotide polymorphism; Meta-analysis; Odds ratio; Publication bias; Allele; Internal medicine; Kexin; Genotype; Medicine; Oncology; Confidence interval; Case-control study; Bioinformatics; Genetics; Biology; Cholesterol; Gene; LDL receptor; Lipoprotein","score_opus":0.08381814462737144,"score_gpt":0.40165776668368186,"score_spread":0.31783962205631044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393078238","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014846988,0.9977973,0.00012364787,0.00023655691,0.000098320976,0.0015170635,0.00009422853,0.0000042811666,0.000113734524],"genre_scores_gemma":[0.0003012334,0.998317,0.000047642367,0.0002561924,0.000052920495,0.000052674008,0.0000012201367,0.000023691568,0.0009474471],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9956651,0.0007716278,0.0018304387,0.0003564829,0.0011387324,0.00023763166],"domain_scores_gemma":[0.99597424,0.00032523085,0.0022131118,0.0007872759,0.00046759867,0.00023251245],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0033184008,0.00049857196,0.0094617475,0.00050449756,0.000089773304,0.000077745826,0.00047299959,0.00009424265,0.000015480324],"category_scores_gemma":[0.0018488852,0.00015348854,0.011881627,0.0017152253,0.00025202462,0.00008425218,0.000068371635,0.0011034298,0.0000036915083],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028126036,0.00015479988,7.933631e-7,0.726305,0.26221916,0.00034793298,0.000102632854,0.000002631905,0.00016750068,0.000097046825,0.0019466538,0.008627704],"study_design_scores_gemma":[0.000066449255,0.0010461309,0.0000029613227,0.061775755,0.92672706,0.0026015562,0.000017159544,0.000008833436,0.000038235947,0.000003318522,0.007588553,0.0001239851],"about_ca_topic_score_codex":0.000029215424,"about_ca_topic_score_gemma":0.0000019663037,"teacher_disagreement_score":0.66452926,"about_ca_system_score_codex":0.00019551098,"about_ca_system_score_gemma":0.0010409245,"threshold_uncertainty_score":0.99801415},"labels":[],"label_agreement":null},{"id":"W4393166184","doi":"10.1016/j.jacc.2024.02.016","title":"Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl","year":2024,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Esperion Therapeutics; Amarin Corporation; Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Lipoprotein(a); Reduction (mathematics); Internal medicine; Cardiology; Lipoprotein; Cholesterol","score_opus":0.011488806508474088,"score_gpt":0.24833038105614988,"score_spread":0.2368415745476758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393166184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692958,0.025686372,0.0018762728,0.0014372481,0.00051747833,0.0005335584,0.00004843442,0.000016358908,0.00058845815],"genre_scores_gemma":[0.99375683,0.003057398,0.001657972,0.0000779973,0.0013248392,0.000010731902,4.0249228e-7,0.000032910855,0.000080911326],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99770844,0.0005886459,0.0004938216,0.00025530372,0.0007126064,0.00024118593],"domain_scores_gemma":[0.99842256,0.0000688574,0.00038678024,0.0006608576,0.00030835834,0.00015256838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001967488,0.00018681552,0.0014304481,0.00020119997,0.00009099148,0.000010049678,0.00015466014,0.00007505418,0.000003920917],"category_scores_gemma":[0.00013420139,0.00010371139,0.0012881272,0.000573673,0.00055928575,0.00007103128,0.00006987021,0.000628691,0.0000010493394],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008312704,0.00044958823,0.047492053,0.0034340497,0.17420308,0.01333578,0.00094118726,0.01006908,0.035772413,0.0018376887,0.010664048,0.69348836],"study_design_scores_gemma":[0.010981786,0.018829431,0.3741441,0.0026899055,0.035398163,0.30349928,0.0046422863,0.00015375561,0.03023152,0.0014041351,0.21705997,0.000965674],"about_ca_topic_score_codex":0.00010545768,"about_ca_topic_score_gemma":0.000002373842,"teacher_disagreement_score":0.69252264,"about_ca_system_score_codex":0.00007095155,"about_ca_system_score_gemma":0.00054535805,"threshold_uncertainty_score":0.4229228},"labels":[],"label_agreement":null},{"id":"W4393176895","doi":"10.1016/j.jacc.2024.01.032","title":"Reply","year":2024,"lang":"en","type":"letter","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis","keywords":"Medicine","score_opus":0.01345223628162267,"score_gpt":0.2681916458548626,"score_spread":0.2547394095732399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393176895","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011097812,0.006217378,0.00008846692,0.9743889,0.0030303856,0.00042675942,0.00016353512,0.000012660604,0.004574083],"genre_scores_gemma":[0.048641287,0.0018465414,0.00075941184,0.9078514,0.035222866,0.000010346825,0.0000061236883,0.00012109455,0.0055409195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971449,0.0005603599,0.0008928846,0.00022610859,0.0008618193,0.00031392567],"domain_scores_gemma":[0.99694353,0.00014308922,0.0013207352,0.0010545104,0.0004538259,0.00008428077],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011273482,0.0002465892,0.0026569255,0.00029736842,0.00003767953,0.0000045091806,0.00043918026,0.0002457948,0.000011213008],"category_scores_gemma":[0.00027895693,0.00013755666,0.0030750325,0.0005016748,0.00056729995,0.000020318566,0.00013849522,0.0027136842,0.000010186872],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016305396,0.000005263985,0.00029184678,0.0003606807,0.0029072054,0.0068988563,0.000007715249,0.000011714473,0.000068148256,0.000014370842,0.9880424,0.0012287586],"study_design_scores_gemma":[0.00042955476,0.0010372754,0.0014179078,0.00041290832,0.0018430048,0.03413554,0.00006202983,0.0000014649017,0.00008342301,0.00022977646,0.9602366,0.00011048041],"about_ca_topic_score_codex":0.000036121673,"about_ca_topic_score_gemma":4.852208e-7,"teacher_disagreement_score":0.06653751,"about_ca_system_score_codex":0.00020755276,"about_ca_system_score_gemma":0.0012588162,"threshold_uncertainty_score":0.9995871},"labels":[],"label_agreement":null},{"id":"W4393253427","doi":"10.4103/jrms.jrms_318_23","title":"First Iranian guidelines for the diagnosis, management, and treatment of hyperlipidemia in adults","year":2024,"lang":"en","type":"article","venue":"Journal of Research in Medical Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McMaster University; Impact","funders":"","keywords":"Medicine; Guideline; Ezetimibe; Hyperlipidemia; Internal medicine; Pharmacotherapy; Fibrate; Population; Atorvastatin; Hypertriglyceridemia; Statin; Diabetes mellitus; Physical therapy; Intensive care medicine; Triglyceride; Cholesterol; Endocrinology; Pathology","score_opus":0.23849256414450076,"score_gpt":0.5000037180602467,"score_spread":0.2615111539157459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393253427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7248337,0.09508045,0.00014935664,0.17840746,0.0003004289,0.00091393414,0.0000022036375,0.0000034325433,0.0003089979],"genre_scores_gemma":[0.83776593,0.15847291,0.0025970081,0.00017833286,0.00084440556,0.00008251036,2.0679512e-7,0.0000049723785,0.000053703636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732584,0.000117128126,0.00045517605,0.00013895494,0.0017092535,0.00025363732],"domain_scores_gemma":[0.998398,0.001138207,0.000037884074,0.00009888707,0.00014357171,0.00018342212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013730169,0.00005232919,0.0002497062,0.00035529988,0.00007963532,0.000025423864,0.0001827478,0.0000477313,0.000032232558],"category_scores_gemma":[0.0015870418,0.000022879412,0.00010638075,0.00075883494,0.00046563463,0.000064904045,0.00003535308,0.00021077688,5.4620955e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016185603,0.00017394152,0.062455703,0.0009955757,0.00008262605,0.0005849387,0.00043626173,0.000019248511,0.0000023883406,0.0006690952,0.003647941,0.9307704],"study_design_scores_gemma":[0.009827211,0.0105559975,0.31251097,0.028562233,0.00012460176,0.0008625074,0.007957421,0.027403774,0.00019395413,0.004286598,0.5975488,0.00016595161],"about_ca_topic_score_codex":0.00066591206,"about_ca_topic_score_gemma":0.0006604509,"teacher_disagreement_score":0.93060446,"about_ca_system_score_codex":0.00009760601,"about_ca_system_score_gemma":0.00038440042,"threshold_uncertainty_score":0.475863},"labels":[],"label_agreement":null},{"id":"W4393265812","doi":"10.1161/atvbaha.123.320268","title":"Evolocumab Treatment in Pediatric Patients With Homozygous Familial Hypercholesterolemia: Pooled Data From Three Open-Label Studies","year":2024,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Western University","funders":"Amgen","keywords":"Evolocumab; Medicine; PCSK9; Adverse effect; Ezetimibe; Familial hypercholesterolemia; Internal medicine; Alirocumab; Incidence (geometry); Clinical endpoint; Gastroenterology; Pediatrics; Clinical trial; Statin; Lipoprotein; Cholesterol; LDL receptor","score_opus":0.11388470242284413,"score_gpt":0.35220884847489276,"score_spread":0.23832414605204863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393265812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907795,0.0064922487,0.00009091812,0.0005218701,0.00030027292,0.0014444554,0.00026832396,0.00006960682,0.000032774486],"genre_scores_gemma":[0.9748242,0.022778947,0.00081299583,0.00034801586,0.00032523795,0.00021782923,0.0006366129,0.000052800733,0.0000033657388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974581,0.00019638406,0.0004459446,0.0011842245,0.00025295405,0.00046238862],"domain_scores_gemma":[0.9981869,0.00008990717,0.000060853257,0.0014128339,0.000082657156,0.00016685361],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045870087,0.00039492612,0.0011230431,0.00016653002,0.00014354772,0.00011882566,0.00033852772,0.0002219353,0.000021296897],"category_scores_gemma":[0.00003436069,0.00025507566,0.00010955373,0.0003156395,0.00015957962,0.0002748175,0.0005554006,0.00022919149,0.00003189076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055129378,0.0010973063,0.9758677,0.00019305867,0.0028593184,0.0000048032834,0.0005247904,4.315353e-7,0.000791018,0.000043155767,0.00016924083,0.018394044],"study_design_scores_gemma":[0.00927696,0.0022314056,0.98482007,0.0002678985,0.0014946505,0.0000014600872,0.00012996847,0.0001485008,0.0000073244855,0.000074287076,0.0012622287,0.00028522252],"about_ca_topic_score_codex":0.0017590862,"about_ca_topic_score_gemma":0.0030432153,"teacher_disagreement_score":0.018108822,"about_ca_system_score_codex":0.00017928831,"about_ca_system_score_gemma":0.0001665821,"threshold_uncertainty_score":0.99999017},"labels":[],"label_agreement":null},{"id":"W4393386912","doi":"10.1016/j.jacl.2024.03.001","title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","year":2024,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lipoprotein(a); Epidemiology; Risk factor; Lipoprotein; Internal medicine; Risk assessment; Cholesterol","score_opus":0.27786265928669474,"score_gpt":0.5351723513316866,"score_spread":0.2573096920449919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393386912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072418427,0.9613988,0.00017112125,0.01387229,0.020645658,0.0029685576,0.00007023143,0.000013196521,0.00013600747],"genre_scores_gemma":[0.000050185645,0.9807871,0.004641339,0.0028271633,0.0109051615,0.000037630653,0.000020573252,0.000079110294,0.0006517675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97993803,0.0064428286,0.010630851,0.00081920903,0.0016081183,0.0005609395],"domain_scores_gemma":[0.9857802,0.006551783,0.004382564,0.0017598959,0.00090350193,0.00062206335],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.055179723,0.00047024185,0.006850725,0.0007438616,0.00006133682,0.00009717734,0.00067996007,0.0009492902,0.00006417636],"category_scores_gemma":[0.033029236,0.00024093968,0.0045107454,0.0010264353,0.00040720336,0.00015631579,0.00034115647,0.005082128,0.00047498097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011686764,0.0010270083,0.000019312967,0.0032970933,0.0016886033,0.00029967993,0.000033185297,0.000005501262,9.759839e-8,0.000266606,0.10633925,0.88585496],"study_design_scores_gemma":[0.0016714067,0.005019125,0.00024424164,0.014681575,0.0047921315,0.0006821619,0.00001765483,0.0000042507577,4.0344264e-7,0.00006583443,0.9726337,0.00018751793],"about_ca_topic_score_codex":0.000076950964,"about_ca_topic_score_gemma":0.00006302006,"teacher_disagreement_score":0.88566744,"about_ca_system_score_codex":0.00019129894,"about_ca_system_score_gemma":0.0047412184,"threshold_uncertainty_score":0.9972132},"labels":[],"label_agreement":null},{"id":"W4393977327","doi":"10.1097/mca.0000000000001361","title":"Remnant cholesterol and risk of major adverse cardiovascular events: a systematic review and dose–response meta-analysis of cohort studies","year":2024,"lang":"en","type":"review","venue":"Coronary Artery Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Mace; Medicine; Quartile; Hazard ratio; Internal medicine; Meta-analysis; Confidence interval; Cholesterol; Cohort study; Myocardial infarction","score_opus":0.05614071262623204,"score_gpt":0.3379506351295948,"score_spread":0.28180992250336273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393977327","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015304687,0.9888997,0.000007977775,0.00004077999,0.00005940267,0.008192664,0.0012366654,0.00002930611,0.0000030018014],"genre_scores_gemma":[0.001296225,0.9964908,0.00002399484,0.00008668402,0.000030822735,0.0016585838,0.00013447762,0.00006881631,0.00020961603],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99278504,0.0030494665,0.0019979968,0.00093507697,0.0009601089,0.00027228633],"domain_scores_gemma":[0.9956279,0.00028798616,0.0008154542,0.002531734,0.00024662275,0.00049033394],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.005125105,0.0007201773,0.017474305,0.00056832907,0.00006479561,0.000008434887,0.00016257656,0.0001368584,0.000026061049],"category_scores_gemma":[0.00068183424,0.00042219678,0.013031228,0.00080734707,0.00020097931,0.00009236417,0.00023720239,0.00031061124,0.000009772236],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006339908,0.00005532757,0.0000666219,0.51750076,0.4786171,0.0002686036,0.000026164384,5.232569e-7,1.47785535e-8,0.000001046727,0.0000195781,0.0033808493],"study_design_scores_gemma":[0.00034961945,0.000114432165,0.0027096446,0.15192434,0.83978677,0.00027000523,0.00004659675,0.0000038917074,2.4535433e-8,0.0000043899604,0.0045360723,0.000254194],"about_ca_topic_score_codex":0.000025030464,"about_ca_topic_score_gemma":0.0000029436949,"teacher_disagreement_score":0.36557642,"about_ca_system_score_codex":0.00010959043,"about_ca_system_score_gemma":0.00040058486,"threshold_uncertainty_score":0.999823},"labels":[],"label_agreement":null},{"id":"W4394014650","doi":"10.1016/j.jacc.2024.03.396","title":"Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI","year":2024,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University Health Network; University of Alberta; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; Esperion Therapeutics; Kowa Company; Novo Nordisk; National Institutes of Health; Amarin Corporation; CSL Behring; Pfizer","keywords":"Medicine; Internal medicine; Myocardial infarction; Placebo; Incidence (geometry); Randomized controlled trial; Gastroenterology; Clinical endpoint; Surgery; Cardiology; Pathology","score_opus":0.010219784224047531,"score_gpt":0.29879652538707824,"score_spread":0.2885767411630307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394014650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959365,0.0013871209,0.00004104195,0.00046771433,0.0006482566,0.00052571297,0.00007528352,0.0000045667334,0.00091380527],"genre_scores_gemma":[0.9990985,0.000433823,0.00008906009,0.000031116768,0.00026810245,0.00000955552,0.000001869904,0.000017910861,0.000050078965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99740654,0.0008716736,0.0008771963,0.00016254626,0.0004740233,0.00020801368],"domain_scores_gemma":[0.99835557,0.00020345607,0.00073493423,0.00046842408,0.0001560058,0.000081613674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023015917,0.00016392983,0.0017529387,0.00037945088,0.000022050484,8.752341e-7,0.0002489086,0.000079938385,0.000006430658],"category_scores_gemma":[0.00021233213,0.000100871854,0.0011304873,0.0006643106,0.0003786318,0.00003216667,0.000062243744,0.00048477403,8.8332854e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0321558,0.0008255886,0.21534884,0.009567112,0.03492035,0.0029421442,0.000590581,0.0014848803,0.53143996,0.0015573225,0.017113857,0.1520536],"study_design_scores_gemma":[0.016246213,0.06038646,0.19112296,0.014357624,0.0072608916,0.01304903,0.0006226878,0.00012386643,0.67345864,0.00058983755,0.021986336,0.00079545827],"about_ca_topic_score_codex":0.00024283999,"about_ca_topic_score_gemma":0.000017287797,"teacher_disagreement_score":0.15125814,"about_ca_system_score_codex":0.00014071898,"about_ca_system_score_gemma":0.00037808187,"threshold_uncertainty_score":0.4113435},"labels":[],"label_agreement":null},{"id":"W4394075776","doi":"10.6084/m9.figshare.22625119","title":"Additional file 1 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"dataset","venue":"Open MIND","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cascade; Computer science; Familial hypercholesterolemia; Medicine; Engineering; Internal medicine; Cholesterol","score_opus":0.163058618754115,"score_gpt":0.35888283355060213,"score_spread":0.19582421479648712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394075776","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023398954,0.000102354425,0.000038246606,0.00005352826,0.00002102294,0.0029786187,0.9964118,0.0000059483655,0.00015448254],"genre_scores_gemma":[0.0000016704429,0.00002047941,0.23609577,0.000042062733,0.00006173866,0.0016647436,0.7619022,0.000018707824,0.00019261891],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860007,0.00011243367,0.00038292777,0.00039555223,0.00026902911,0.00023998308],"domain_scores_gemma":[0.99727434,0.0014325511,0.00017802641,0.00058237585,0.00039277508,0.00013992074],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026725695,0.00020618406,0.00060527393,0.00009924244,0.00015777623,0.0001596082,0.00023669384,0.00018190015,0.0061246124],"category_scores_gemma":[0.00084917224,0.00020029781,0.00010734612,0.0001938974,0.000080726604,0.00013817515,0.00035863492,0.00029931607,0.00012458865],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078525125,0.00004318088,9.9763966e-8,0.00038652628,0.00013843096,0.000023512577,0.00010252212,0.000042663043,0.000082283485,7.66717e-8,0.8933027,0.10579951],"study_design_scores_gemma":[0.00071108947,0.00058131944,0.00016667394,0.0026925057,0.00017496287,0.00013108544,0.001632554,0.00008625942,0.000043467797,0.0000083311415,0.99359465,0.00017712232],"about_ca_topic_score_codex":0.00089322816,"about_ca_topic_score_gemma":0.00025481475,"teacher_disagreement_score":0.23605752,"about_ca_system_score_codex":0.000056271012,"about_ca_system_score_gemma":0.00079554797,"threshold_uncertainty_score":0.99478394},"labels":[],"label_agreement":null},{"id":"W4394104832","doi":"10.6084/m9.figshare.5129197","title":"Supplementary Material for: Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis","year":2016,"lang":"en","type":"dataset","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PCSK9; Sepsis; Medicine; Plasma levels; Intensive care medicine; Plasma concentration; Internal medicine; LDL receptor; Cholesterol; Lipoprotein","score_opus":0.021660075171034073,"score_gpt":0.2564856118092375,"score_spread":0.23482553663820344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394104832","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044294585,0.000050341365,2.2689792e-7,0.00019282987,0.000047289963,0.002218426,0.9531716,0.000021673,0.0000029997796],"genre_scores_gemma":[0.015694562,0.000019365356,0.00012924774,0.00010348051,0.00029013603,0.0010624812,0.98261154,0.000052102183,0.000037111382],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798656,0.0001309342,0.0004910899,0.00043145785,0.0005685953,0.00039135644],"domain_scores_gemma":[0.99843884,0.000098963385,0.00051661517,0.0006009096,0.00020520484,0.00013946593],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027723896,0.00036231827,0.0009385317,0.00009496008,0.00022181636,0.000037377427,0.00022408803,0.0002456286,0.025089143],"category_scores_gemma":[0.00038570774,0.00020891619,0.00017222425,0.00010543664,0.0000352123,0.00004853535,0.00017499835,0.00021804609,0.000011813235],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021086014,0.00004603975,0.000016097727,0.0030545893,0.002692539,0.000046089554,0.000094244424,6.871652e-8,0.000490098,1.0602557e-7,0.99108016,0.00037136546],"study_design_scores_gemma":[0.019639254,0.0002112789,0.010740139,0.018435923,0.001156304,0.00009436557,0.00008544275,0.000001295683,0.112746954,0.0000017383843,0.8363709,0.0005164031],"about_ca_topic_score_codex":0.00013643244,"about_ca_topic_score_gemma":0.00041237322,"teacher_disagreement_score":0.15470926,"about_ca_system_score_codex":0.00017250112,"about_ca_system_score_gemma":0.00052960374,"threshold_uncertainty_score":0.97580206},"labels":[],"label_agreement":null},{"id":"W4394230136","doi":"10.6084/m9.figshare.7678271","title":"Behavior of Ultrasensitive C-Reactive Protein in Myocardial Revascularization with and without Cardiopulmonary Bypass","year":2019,"lang":"en","type":"dataset","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cardiopulmonary bypass; Cardiology; Internal medicine; Myocardial revascularization; Revascularization; Medicine; Myocardial infarction","score_opus":0.020083380143408193,"score_gpt":0.2660159304971202,"score_spread":0.245932550353712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394230136","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005598049,0.00071293063,6.2297545e-7,0.000014487867,0.000032351985,0.0049853898,0.98853785,0.000015793024,0.00010252297],"genre_scores_gemma":[0.017570091,0.000032243828,0.000049450708,0.000056362507,0.0002532482,0.0010521533,0.9808985,0.00005154185,0.000036415593],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977797,0.00018774187,0.000354255,0.00060572,0.000783121,0.00028944027],"domain_scores_gemma":[0.998328,0.000028011715,0.00028216708,0.0008920569,0.0003260417,0.00014378075],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018816943,0.00037636416,0.0012569552,0.00023680297,0.000033752935,0.00001666904,0.00008871324,0.00048971246,0.0011022206],"category_scores_gemma":[0.0003150389,0.00030869874,0.00027729402,0.0002678527,0.000026897078,0.000098029115,0.00007870364,0.0006706269,0.000076665885],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013082727,0.00039536378,0.001720587,0.010097613,0.0015198395,0.0011425345,0.00010101288,0.00001099719,0.000333904,4.875181e-7,0.9807288,0.002640586],"study_design_scores_gemma":[0.008611167,0.002369917,0.14177272,0.046879392,0.0030144297,0.0015648634,0.00025763182,0.00001759424,0.0031909929,0.0000017528946,0.7909289,0.0013906662],"about_ca_topic_score_codex":0.0006113989,"about_ca_topic_score_gemma":0.00007024858,"teacher_disagreement_score":0.18979992,"about_ca_system_score_codex":0.00014559952,"about_ca_system_score_gemma":0.00055549305,"threshold_uncertainty_score":0.9999365},"labels":[],"label_agreement":null},{"id":"W4394232602","doi":"10.6084/m9.figshare.22625125","title":"Additional file 3 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"dataset","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cascade; Computer science; Familial hypercholesterolemia; Engineering; Medicine; Internal medicine; Cholesterol","score_opus":0.15698858079469794,"score_gpt":0.3286369102389231,"score_spread":0.17164832944422517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394232602","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000032829764,0.0002455408,0.0000025837894,0.000025978708,0.000011512721,0.0019020842,0.99768984,0.00008160402,0.000037569793],"genre_scores_gemma":[5.8884524e-7,0.000010357625,0.02908247,0.00011776649,0.0001329844,0.0080492655,0.96250546,0.00003224546,0.000068884336],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986917,0.00007967704,0.00032641608,0.00034040012,0.00030517176,0.00025665382],"domain_scores_gemma":[0.9964668,0.002069374,0.00017204901,0.0005261465,0.00062226446,0.0001433358],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000063644315,0.00022177184,0.0005156719,0.00011403569,0.00013895237,0.00006866464,0.0001369999,0.00022397828,0.088485934],"category_scores_gemma":[0.0039916085,0.00022126672,0.00015428789,0.00021032532,0.0000187221,0.0000886988,0.00019813655,0.00035049234,0.0003257676],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029778499,0.000025948468,2.055871e-8,0.0038112446,0.00010707017,0.00002666458,0.0000397519,0.000048885315,0.0000116590645,4.562801e-8,0.9833285,0.012570423],"study_design_scores_gemma":[0.0004074438,0.00039232505,0.00023550756,0.01692084,0.000075344156,0.00011041609,0.0004807512,0.00011973892,0.000009994749,0.0000054620837,0.98106456,0.00017760851],"about_ca_topic_score_codex":0.00016317995,"about_ca_topic_score_gemma":0.000060683058,"teacher_disagreement_score":0.088160165,"about_ca_system_score_codex":0.00005939981,"about_ca_system_score_gemma":0.0006278369,"threshold_uncertainty_score":0.9123473},"labels":[],"label_agreement":null},{"id":"W4394348862","doi":"10.6084/m9.figshare.19606714","title":"Additional file 1 of The correlation between lipoprotein(a) elevations and the risk of recurrent cardiovascular events in CAD patients with different LDL-C levels","year":2022,"lang":"en","type":"dataset","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"CAD; Internal medicine; Medicine; Cardiology; Correlation; Mathematics; Engineering; Engineering drawing","score_opus":0.018579251691940104,"score_gpt":0.22450952231860508,"score_spread":0.20593027062666497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394348862","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003734747,0.0005123653,4.3834797e-7,0.000017531214,0.000042169184,0.002672101,0.99636054,0.0000053400504,0.000016047145],"genre_scores_gemma":[0.0009946954,0.000032486907,0.000008373336,0.000019060337,0.00012868382,0.0032872495,0.99547786,0.000021484298,0.000030127307],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969935,0.00054535206,0.0004862198,0.00032642952,0.0014646888,0.00018383053],"domain_scores_gemma":[0.99728066,0.0007442251,0.0006346979,0.0010353564,0.0002413087,0.00006375429],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022251002,0.00024946214,0.0008103289,0.000119738375,0.00016097316,0.0000051687884,0.0002030153,0.00016836957,0.8250034],"category_scores_gemma":[0.002849804,0.00013578612,0.0005805273,0.00034365154,0.000041757776,0.00003918145,0.00025865604,0.0008275629,0.000012354779],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006667518,0.00009621415,0.00037450166,0.00065008877,0.00088053435,0.0000010527541,0.000023533968,0.00002498166,2.3788191e-9,2.5167026e-7,0.9944595,0.0034226296],"study_design_scores_gemma":[0.00156443,0.00010506589,0.3956589,0.003420298,0.00042249507,0.0000026542114,0.000009837104,0.000006149731,5.8401736e-7,0.000007845082,0.59871054,0.000091188165],"about_ca_topic_score_codex":0.00046919775,"about_ca_topic_score_gemma":0.00016654463,"teacher_disagreement_score":0.82499105,"about_ca_system_score_codex":0.00013779268,"about_ca_system_score_gemma":0.00031243314,"threshold_uncertainty_score":0.5537197},"labels":[],"label_agreement":null},{"id":"W4394369675","doi":"10.6084/m9.figshare.14068007","title":"Additional file 2 of Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians","year":2021,"lang":"en","type":"dataset","venue":"Open MIND","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Dyslipidemia; Subclinical infection; Polygenic risk score; Diabetes mellitus; Medicine; Internal medicine; Bioinformatics; Biology; Genetics; Gene; Endocrinology; Genotype; Single-nucleotide polymorphism","score_opus":0.048875138518829735,"score_gpt":0.3175056562305992,"score_spread":0.26863051771176943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394369675","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027531956,0.00097611465,0.0007238116,0.000050097085,0.000030356094,0.0051470757,0.99029315,0.0000021605417,0.000024057905],"genre_scores_gemma":[0.0001516487,0.0004690001,0.06648893,0.00004696169,0.00041771104,0.00644738,0.92588645,0.000037942842,0.00005397166],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967589,0.0001845386,0.0014607888,0.0008922447,0.00038532595,0.00031820755],"domain_scores_gemma":[0.9950392,0.0026457715,0.0007079914,0.00086205726,0.0004186282,0.00032631992],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015329891,0.00030895,0.0017584711,0.00010269407,0.00026077576,0.000044628603,0.00033901437,0.00045167655,0.009504945],"category_scores_gemma":[0.0017950509,0.00029246073,0.0009816859,0.00016620217,0.00041447562,0.00006186474,0.00026899955,0.00034935112,0.000009448627],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041877913,0.00039597275,0.0011067489,0.00074260664,0.0032985741,2.3880963e-7,0.000024735831,0.000001407359,0.0000039481392,5.5847715e-7,0.90218806,0.09219525],"study_design_scores_gemma":[0.001375113,0.00017707652,0.22180931,0.00062934705,0.0014920466,0.0000035268658,0.000071161936,0.000011893895,0.000012976852,0.0000054464294,0.77420765,0.00020444077],"about_ca_topic_score_codex":0.000038021502,"about_ca_topic_score_gemma":0.00036182144,"teacher_disagreement_score":0.22070256,"about_ca_system_score_codex":0.00004895291,"about_ca_system_score_gemma":0.0013283205,"threshold_uncertainty_score":0.99995273},"labels":[],"label_agreement":null},{"id":"W4394394071","doi":"10.6084/m9.figshare.22625122","title":"Additional file 2 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"dataset","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cascade; Computer science; Engineering","score_opus":0.15495800636126691,"score_gpt":0.328497920625209,"score_spread":0.17353991426394208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394394071","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000032365701,0.0002480886,0.0000025139777,0.000025962308,0.000011467134,0.0018983654,0.9976905,0.00008167133,0.000038183527],"genre_scores_gemma":[5.733765e-7,0.000010484184,0.028811557,0.00011792973,0.00013347366,0.008050763,0.9627752,0.00003222088,0.00006781976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998692,0.00007972704,0.00032641584,0.0003402957,0.00030503405,0.00025657986],"domain_scores_gemma":[0.99648434,0.002058643,0.00017226177,0.0005259383,0.00061547314,0.0001433283],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006332864,0.00022173318,0.0005157443,0.00011399975,0.0001389744,0.00006867127,0.0001370105,0.0002239986,0.088976175],"category_scores_gemma":[0.0039450987,0.00022125142,0.00015426816,0.00021024128,0.000018720511,0.000088690795,0.00019825221,0.00035048398,0.0003188385],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029442941,0.000025954165,1.9886764e-8,0.0037813247,0.00010716708,0.00002706315,0.0000397857,0.00004910578,0.000011231524,4.6718952e-8,0.98319894,0.01272989],"study_design_scores_gemma":[0.00040527753,0.0003935924,0.00023354353,0.016779609,0.00007588057,0.000111887006,0.00047895155,0.00011895359,0.000009738259,0.0000054982534,0.9812096,0.00017751401],"about_ca_topic_score_codex":0.00016296002,"about_ca_topic_score_gemma":0.00006062704,"teacher_disagreement_score":0.08865734,"about_ca_system_score_codex":0.000059181886,"about_ca_system_score_gemma":0.00062472414,"threshold_uncertainty_score":0.9118566},"labels":[],"label_agreement":null},{"id":"W4394676333","doi":"10.1016/j.jacl.2024.04.122","title":"Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; Sanofi (Canada); University of Alberta; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Alirocumab; Acute coronary syndrome; Internal medicine; Cardiology; Lipoprotein; Cholesterol; Myocardial infarction","score_opus":0.04398494660573627,"score_gpt":0.3833615390995042,"score_spread":0.33937659249376795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394676333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747918,0.010562585,0.00046443078,0.009317084,0.0036293904,0.0011341092,0.0000123793725,0.00003813924,0.000050037233],"genre_scores_gemma":[0.9924031,0.0009188347,0.0011812864,0.0026987474,0.002410225,0.00005134235,0.0000026223777,0.000050715054,0.00028316223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99506915,0.0008789232,0.0020562394,0.0006449044,0.00097602146,0.00037473586],"domain_scores_gemma":[0.99637944,0.001578325,0.00029004586,0.0010513484,0.0001813989,0.0005194198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00851776,0.0003252737,0.002793771,0.0001566856,0.00010717203,0.00009508348,0.00021174549,0.00028801768,0.0000403924],"category_scores_gemma":[0.002162816,0.0001774224,0.0015349416,0.0001951867,0.00017730249,0.00016513997,0.00034508473,0.0012111564,0.000013875334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053145667,0.0001964166,0.8649956,0.000059142865,0.013873671,0.01379282,0.00037427066,0.0000015165201,0.0000054129227,0.000007062604,0.0006955622,0.105467044],"study_design_scores_gemma":[0.0027672094,0.002192403,0.9485388,0.00019312336,0.003867829,0.02311773,0.001038676,0.00000737914,0.0000022605045,0.00019091848,0.017905593,0.00017807509],"about_ca_topic_score_codex":0.00033718938,"about_ca_topic_score_gemma":0.000048692113,"teacher_disagreement_score":0.10528897,"about_ca_system_score_codex":0.000042338757,"about_ca_system_score_gemma":0.0003176987,"threshold_uncertainty_score":0.7235075},"labels":[],"label_agreement":null},{"id":"W4394857026","doi":"10.1210/clinem/dgae259","title":"Prevalence of Dysbetalipoproteinemia in the UK Biobank According to Different Diagnostic Criteria","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; McGill University; University of British Columbia; Université de Montréal; Montreal Clinical Research Institute","funders":"Institut de Recherche Clinique De Montréal","keywords":"Biobank; Cohort; Context (archaeology); Population; Disease; Medicine; Dyslipidemia; Gold standard (test); Genotype; Internal medicine; Physical therapy; Bioinformatics; Biology; Genetics; Environmental health","score_opus":0.050496457034310535,"score_gpt":0.4010260893733489,"score_spread":0.35052963233903833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394857026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95125103,0.03461422,0.00047954646,0.011107127,0.0017150646,0.00067801715,0.00000758512,0.000013116249,0.00013426921],"genre_scores_gemma":[0.9818339,0.014043235,0.00027412598,0.0014626763,0.0022869608,0.000022428954,5.925017e-7,0.000020422334,0.0000556813],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99543977,0.0013682472,0.0018568854,0.00022482399,0.0006801406,0.00043012007],"domain_scores_gemma":[0.9957527,0.002815586,0.00033767792,0.00073985435,0.00018387183,0.00017029798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050192107,0.00020883932,0.0012639906,0.0002261085,0.00005235903,0.000021689895,0.00063028524,0.00012094574,0.00012004207],"category_scores_gemma":[0.0045618694,0.00009424844,0.00073759403,0.0003723347,0.0002502879,0.000071518894,0.00014216831,0.0013344147,0.000018239565],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004660563,0.0022270856,0.19225524,0.004275651,0.0040308353,0.0039098803,0.0049763564,0.00012894158,0.0133481715,0.013580896,0.0063491636,0.7502572],"study_design_scores_gemma":[0.002420414,0.0012979634,0.97147113,0.0011913218,0.0020868862,0.0028068242,0.0004682083,0.000043391898,0.0024123513,0.0014470115,0.0141976075,0.00015686374],"about_ca_topic_score_codex":0.00015203962,"about_ca_topic_score_gemma":0.000012920899,"teacher_disagreement_score":0.77921593,"about_ca_system_score_codex":0.000024324429,"about_ca_system_score_gemma":0.00022878213,"threshold_uncertainty_score":0.5797442},"labels":[],"label_agreement":null},{"id":"W4394858753","doi":"10.46747/cfp.7004245","title":"Top studies of 2023 relevant to primary care","year":2024,"lang":"en","type":"review","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Élisabeth Bruyère Hospital; University of Manitoba; St. Paul's Hospital; College of Family Physicians of Canada","funders":"","keywords":"Medicine; Irritable bowel syndrome; Medical prescription; Intensive care medicine; Primary care; Internal medicine; Family medicine; Nursing","score_opus":0.052994565274090306,"score_gpt":0.328251566332853,"score_spread":0.2752570010587627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394858753","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019414958,0.9456758,6.9184773e-7,0.00011068211,0.00084073364,0.0019280703,0.00062685314,0.000035865443,0.050761916],"genre_scores_gemma":[0.0000080665395,0.9848496,0.000091256465,0.011855269,0.0013750854,0.00021174113,0.00036953975,0.00012639619,0.0011131002],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977172,0.00008052482,0.00057798345,0.0006022767,0.00045189913,0.00057011726],"domain_scores_gemma":[0.99773705,0.00002705858,0.00010787191,0.0010952833,0.00025744457,0.00077528815],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021212098,0.00047799334,0.0030994006,0.00059345353,0.00007671321,0.000018443454,0.0002146582,0.00023876061,0.0000011880106],"category_scores_gemma":[0.00002351418,0.0003701963,0.0013207494,0.0009529036,0.00007011911,0.000026814703,0.000080778445,0.0005102172,0.00050176715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018240917,0.0000065067143,1.06665105e-7,0.10308795,0.0011233259,0.00023767448,0.0001337403,1.369607e-7,0.0000014368014,0.000096180156,0.030875206,0.8644359],"study_design_scores_gemma":[0.00010323715,0.00015150335,0.000017014345,0.050898872,0.0035563626,0.0000066473513,0.0009405527,6.713691e-8,0.0000011458526,0.000017604096,0.9440099,0.00029709563],"about_ca_topic_score_codex":0.011082967,"about_ca_topic_score_gemma":0.0051585115,"teacher_disagreement_score":0.9131347,"about_ca_system_score_codex":0.0022093854,"about_ca_system_score_gemma":0.0064230226,"threshold_uncertainty_score":0.999875},"labels":[],"label_agreement":null},{"id":"W4394922115","doi":"10.51731/cjht.2024.872","title":"Evinacumab (Evkeeza)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Drug; Pharmacology; Political science","score_opus":0.023581426086268297,"score_gpt":0.29115975924483933,"score_spread":0.26757833315857105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394922115","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0732361,0.8010696,0.0010905563,0.12135615,0.0012213272,0.00040927352,0.000011504911,0.00030857412,0.001296919],"genre_scores_gemma":[0.99552214,0.0028015978,0.000772406,0.00065276626,0.00006683058,0.0000046110945,0.0000014600249,0.000020760255,0.00015741796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99865216,0.00003931966,0.00047360084,0.00013736602,0.00025102473,0.0004465193],"domain_scores_gemma":[0.99923015,0.000021645666,0.00009974978,0.00033817423,0.00013499249,0.00017531017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012564062,0.00010994875,0.00045696608,0.0007564286,0.00014123783,0.00004734306,0.00016141847,0.00014409324,0.00004360077],"category_scores_gemma":[0.0003201433,0.00008156299,0.0002389538,0.00046624037,0.00012573242,0.0000937939,0.000011111732,0.0006372136,0.000029892966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005220697,0.000005222735,0.00038499644,0.00054648705,0.00009831768,0.0011125314,0.00011091912,0.0000011696674,0.000011250501,0.0025017655,0.010599011,0.98462313],"study_design_scores_gemma":[0.000283668,0.0006224117,0.003386565,0.0012347167,0.00004258902,0.0047288053,0.0011866733,0.000016209468,0.00024018032,0.002116091,0.9860547,0.000087363886],"about_ca_topic_score_codex":0.0037676576,"about_ca_topic_score_gemma":0.0009729429,"teacher_disagreement_score":0.98453575,"about_ca_system_score_codex":0.0006533197,"about_ca_system_score_gemma":0.008455487,"threshold_uncertainty_score":0.9971657},"labels":[],"label_agreement":null},{"id":"W4394951018","doi":"10.1097/mol.0000000000000938","title":"Familial hypercholesterolemia-Plus: is the metabolic syndrome changing the clinical picture of familial hypercholesterolemia?","year":2024,"lang":"en","type":"article","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Metabolic syndrome; Internal medicine; Pediatrics; Cholesterol; Obesity","score_opus":0.08524654804661012,"score_gpt":0.3885538529782374,"score_spread":0.3033073049316273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394951018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83711874,0.06022995,0.00078674516,0.007458093,0.09193208,0.0021372298,0.00007819029,0.00011715285,0.00014182758],"genre_scores_gemma":[0.9524722,0.01492066,0.000093310126,0.001902133,0.03000165,0.00035605335,0.000073959396,0.000073033174,0.00010700136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960669,0.00092547236,0.0010785135,0.00067642174,0.00060132,0.00065134914],"domain_scores_gemma":[0.9980557,0.0004305367,0.00012993348,0.0011308942,0.00009984743,0.00015311627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032917736,0.00033565128,0.0010394491,0.00032047337,0.00013461482,0.00003696081,0.00047088394,0.0003747938,0.000053220636],"category_scores_gemma":[0.00023233458,0.00018581253,0.00074000115,0.00072817045,0.00048501955,0.000105695144,0.00029106502,0.0017737371,0.000078292076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009402774,0.000938895,0.047040906,0.0057941717,0.0016476315,0.000016120675,0.01883151,0.00014699493,0.00066813733,0.009613435,0.042678382,0.87168354],"study_design_scores_gemma":[0.0026477596,0.0006110974,0.09601736,0.0015000765,0.00030843943,0.000965839,0.0015158277,0.0008762163,0.000030809006,0.0003097376,0.8949442,0.00027266698],"about_ca_topic_score_codex":0.000059051647,"about_ca_topic_score_gemma":0.0000064319665,"teacher_disagreement_score":0.87141085,"about_ca_system_score_codex":0.000086285785,"about_ca_system_score_gemma":0.00044584853,"threshold_uncertainty_score":0.7706104},"labels":[],"label_agreement":null},{"id":"W4395039859","doi":"10.1161/circ.134.suppl_1.12183","title":"Abstract 12183: <i>SLCO1B1</i> Genotype-Guided Statin Therapy Lowers LDL Cholesterol in Patients With Statin-Intolerance- A Randomized Controlled Trial","year":2016,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dillon Consulting","funders":"","keywords":"Medicine; Statin; Randomized controlled trial; SLCO1B1; Ldl cholesterol; Internal medicine; Ezetimibe; Cholesterol; Cardiology; Pharmacogenetics; Genotype","score_opus":0.013156189774154134,"score_gpt":0.25399838115631507,"score_spread":0.24084219138216093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395039859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98467904,0.00021134471,0.002715594,0.00030471274,0.0002605387,0.011149296,0.000009271286,0.00005959042,0.00061063416],"genre_scores_gemma":[0.9982279,0.00009446515,0.00021180356,0.0003970593,0.00023347014,0.00069100625,0.000056557736,0.000045590514,0.000042161195],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99722004,0.00033243676,0.000889008,0.00039923118,0.0008179618,0.0003413474],"domain_scores_gemma":[0.9984888,0.00021908474,0.00039589836,0.0004731484,0.00028001814,0.00014306753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015921097,0.00025910317,0.0014573924,0.00016207059,0.00006599506,0.000030381743,0.00006617658,0.00012818501,0.00013199642],"category_scores_gemma":[0.00027954418,0.00014223917,0.00038552642,0.0001774694,0.00007827016,0.00019021577,0.0000072246107,0.00015113247,0.000026058626],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9048487,0.00037168676,0.035563603,0.00004726277,0.00040236008,0.0000065885006,0.00038680332,0.00007753365,0.0006598439,0.000025133244,0.000029353496,0.057581134],"study_design_scores_gemma":[0.6584465,0.00019208701,0.34070337,0.00016177437,0.00007572746,0.0000012339787,0.000011912932,0.000057094567,0.00008686261,0.00005246564,0.000080761856,0.00013022142],"about_ca_topic_score_codex":0.00021140436,"about_ca_topic_score_gemma":0.00002433138,"teacher_disagreement_score":0.30513978,"about_ca_system_score_codex":0.00020718791,"about_ca_system_score_gemma":0.000252292,"threshold_uncertainty_score":0.58003443},"labels":[],"label_agreement":null},{"id":"W4395039911","doi":"10.1161/circ.128.suppl_22.a18274","title":"Abstract 18274: Under Use of Statins and LDL-C Control Among People With a Framingham 10-Year Coronary Heart Disease Risk &gt; 20%","year":2013,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Framingham Risk Score; Coronary heart disease; Internal medicine; Atherosclerotic cardiovascular disease; Cardiology; Ldl cholesterol; Disease; Framingham Heart Study; Statin; Cholesterol","score_opus":0.011007139095363576,"score_gpt":0.22385116266986044,"score_spread":0.21284402357449686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395039911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949166,0.00029072366,0.0032014593,0.00023944494,0.000024407154,0.0011781942,0.000047942234,0.000035040277,0.000066151464],"genre_scores_gemma":[0.99918807,0.000027559377,0.00033791186,0.00015462603,0.00007624128,0.000056110162,0.00008167138,0.00002567347,0.00005215499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894214,0.00006248285,0.00022167356,0.00023326337,0.00036606836,0.00017437627],"domain_scores_gemma":[0.9990215,0.0000717992,0.00012735064,0.00035716282,0.00018424359,0.00023795948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019126359,0.00011835655,0.00028749875,0.000061338265,0.000078191355,0.000030568077,0.000020605632,0.000065577355,0.00024869127],"category_scores_gemma":[0.00008483375,0.0000962044,0.00008199069,0.00010119112,0.000071198134,0.0002702173,0.000009444177,0.000120676494,0.000016689715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001664219,0.00008638611,0.9949507,0.00017286731,0.00012166035,0.0000053199665,0.00013925125,0.0013020881,0.00060134515,0.000038821287,0.00019722029,0.0022179037],"study_design_scores_gemma":[0.002157344,0.0000955022,0.9933485,0.000099868885,0.00022090432,0.000010234036,0.00010241089,0.0035751418,0.000014262312,0.00011761691,0.00015335887,0.00010488249],"about_ca_topic_score_codex":0.001803264,"about_ca_topic_score_gemma":0.00009747362,"teacher_disagreement_score":0.0042714146,"about_ca_system_score_codex":0.000044674543,"about_ca_system_score_gemma":0.00011911609,"threshold_uncertainty_score":0.39231014},"labels":[],"label_agreement":null},{"id":"W4395109358","doi":"10.1093/ehjcvp/pvae025","title":"Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation","year":2024,"lang":"en","type":"review","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; Sanofi (Canada); University of Alberta; St. Michael's Hospital","funders":"Duke Clinical Research Institute; American Regent; St. Jude Medical; Esperion Therapeutics; Idorsia Pharmaceuticals; Servier; MyoKardia; Novo Nordisk; Daiichi-Sankyo; Regado Biosciences; Belvoir Media Group; AstraZeneca; Amarin Corporation; National Institutes of Health; Regeneron Pharmaceuticals; Boston VA Research Institute; Boston Scientific Corporation; Pfizer; York University; Eli Lilly and Company; Cleveland Clinic; Bristol-Myers Squibb; CSL Behring; University of Toronto; Heart and Stroke Foundation of Canada; HLS Therapeutics; GlaxoSmithKline; Amgen; Sanofi; American Heart Association","keywords":"Alirocumab; PCSK9; Medicine; Internal medicine; LDL receptor; Cholesterol; Total cholesterol","score_opus":0.05757911266128796,"score_gpt":0.325943084739561,"score_spread":0.26836397207827306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395109358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051106154,0.989333,0.00010304546,0.000066466004,0.0026887092,0.0020579672,0.0001412683,0.00005638572,0.0004425589],"genre_scores_gemma":[0.0017456833,0.9929359,0.00039661958,0.0003636975,0.0040166494,0.000020452955,0.000061697545,0.00035706806,0.00010221532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901062,0.0040047043,0.002304168,0.0007017525,0.0024428358,0.00044031546],"domain_scores_gemma":[0.9963755,0.00010618038,0.00086064904,0.0018849978,0.0004088742,0.0003637933],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0024109865,0.0007205987,0.004044986,0.00037159625,0.00018390418,0.00007192237,0.0005415866,0.00024264949,0.000102440106],"category_scores_gemma":[0.00008997823,0.00046579482,0.013975248,0.0010355047,0.00016601947,0.00016262804,0.0001886668,0.0019481058,0.0000921587],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009831423,0.00012638995,0.000012366861,0.0064173127,0.018470982,0.00035259887,0.000522346,0.000029429715,0.0003163012,0.000008212195,0.002385844,0.9712599],"study_design_scores_gemma":[0.0020146822,0.00018242095,0.00036336484,0.020793516,0.011197223,0.0012245738,0.000037626727,0.000004503357,0.00044417553,0.00001566123,0.963338,0.00038423683],"about_ca_topic_score_codex":0.00010737139,"about_ca_topic_score_gemma":9.464284e-7,"teacher_disagreement_score":0.9708757,"about_ca_system_score_codex":0.00031996248,"about_ca_system_score_gemma":0.0008438577,"threshold_uncertainty_score":0.9997794},"labels":[],"label_agreement":null},{"id":"W4395663253","doi":"10.1016/j.jacl.2024.04.132","title":"High carrier frequency for abetalipoproteinemia and evidence of a founder variant in a French-Canadian population","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Montreal Heart Institute; Université de Montréal; Montreal Clinical Research Institute; Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Institut de Recherche Clinique De Montréal","keywords":"Medicine; Population; Environmental health","score_opus":0.07466491111625129,"score_gpt":0.3998574967821571,"score_spread":0.3251925856659058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395663253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97329086,0.013289484,0.0022566172,0.0072381776,0.0032474021,0.0006063466,0.000010805812,0.000006611568,0.000053695574],"genre_scores_gemma":[0.98731637,0.0006476459,0.008076431,0.0004615806,0.0034326338,0.000011510114,0.000002839844,0.000014953802,0.00003601744],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975179,0.0002553439,0.0015336679,0.00021189507,0.00025081544,0.00023037402],"domain_scores_gemma":[0.9981832,0.000738307,0.00030163705,0.00022010565,0.00023192819,0.00032482317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049278177,0.00010685083,0.0009541162,0.00029862375,0.000023696866,0.000012639146,0.00007831786,0.0003006227,0.000057892816],"category_scores_gemma":[0.003357974,0.00007864394,0.00040117578,0.00019211539,0.00009332966,0.00013510123,0.000015348063,0.00051450974,0.0000012290703],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023890773,0.0004508016,0.3416737,0.0076894066,0.002500137,0.0014306051,0.00077868043,0.000083518484,0.0012383953,0.031240556,0.0038394714,0.60668564],"study_design_scores_gemma":[0.0037399798,0.00448254,0.95188856,0.0033153587,0.00061338523,0.0020352465,0.00004181899,0.00045180667,0.000029196408,0.026996423,0.0062329797,0.00017271779],"about_ca_topic_score_codex":0.043966115,"about_ca_topic_score_gemma":0.019186985,"teacher_disagreement_score":0.6102148,"about_ca_system_score_codex":0.00009879181,"about_ca_system_score_gemma":0.0012228945,"threshold_uncertainty_score":0.9987103},"labels":[],"label_agreement":null},{"id":"W4396520356","doi":"10.1016/j.jns.2024.123023","title":"Effect of lipid-lowering therapy on carotid plaque burden in older adults","year":2024,"lang":"en","type":"article","venue":"Journal of the Neurological Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cardiology; Internal medicine","score_opus":0.013691226322357142,"score_gpt":0.2880985234875175,"score_spread":0.2744072971651604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396520356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228084,0.0011269439,0.0000039059837,0.0052985265,0.0006634571,0.00027042904,3.6909833e-7,0.000006785596,0.0003487609],"genre_scores_gemma":[0.9986467,0.00042300485,0.0000135797,0.00043079167,0.00046724203,0.000002667468,2.133614e-8,0.0000035127448,0.000012476439],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99854904,0.00026120126,0.00026003813,0.0001430186,0.00062741473,0.00015926636],"domain_scores_gemma":[0.99943334,0.00027000395,0.00008535183,0.00012317045,0.00002428125,0.00006387417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024075166,0.000081042504,0.00029391175,0.00009060282,0.000046131478,0.000020230822,0.00024253747,0.00005415769,0.00003106532],"category_scores_gemma":[0.00024746874,0.000030624462,0.00030984025,0.00037582105,0.00013277879,0.000051297455,0.000034709592,0.0004135893,0.0000017672005],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008551882,0.000731554,0.26472792,0.0012453274,0.0003007644,0.001701269,0.0027560908,0.007995593,0.02965628,0.00035811617,0.001089589,0.6808856],"study_design_scores_gemma":[0.0052020457,0.05329076,0.869655,0.0030216207,0.00008887544,0.002072191,0.00006844736,0.001690445,0.059472844,0.00022337421,0.0050056856,0.00020870252],"about_ca_topic_score_codex":0.000033800054,"about_ca_topic_score_gemma":0.0000017986571,"teacher_disagreement_score":0.68067694,"about_ca_system_score_codex":0.00001617993,"about_ca_system_score_gemma":0.000071484785,"threshold_uncertainty_score":0.17968628},"labels":[],"label_agreement":null},{"id":"W4396639677","doi":"10.1016/j.ahj.2024.05.002","title":"Obicetrapib on top of maximally tolerated lipid‐modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN","year":2024,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Tolerability; Ezetimibe; Cholesterylester transfer protein; Internal medicine; Placebo; Population; Clinical endpoint; Apolipoprotein B; Adverse effect; Lipoprotein; PCSK9; Cholesterol; Endocrinology; Pharmacology; Randomized controlled trial; LDL receptor; Pathology","score_opus":0.054159887735997676,"score_gpt":0.29700856169478035,"score_spread":0.24284867395878268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396639677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867699,0.010649136,0.0013610772,0.00040674326,0.000039964034,0.0007258819,0.000028529059,0.0000124038515,0.0000063420944],"genre_scores_gemma":[0.9925127,0.0044280863,0.0026708643,0.00012824764,0.000141274,0.000050631425,0.0000032901187,0.00003009785,0.000034830187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852365,0.00019610905,0.0003380156,0.00025108716,0.0004256208,0.0002655181],"domain_scores_gemma":[0.9991697,0.00017983477,0.0000940031,0.00022906813,0.00010161582,0.0002257879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089448225,0.00014755939,0.0006721124,0.00015524897,0.00009842221,0.00002939196,0.000033898566,0.00003068795,0.000023000359],"category_scores_gemma":[0.000087328415,0.0000956835,0.00020604317,0.0002768264,0.00021878975,0.000066456494,0.000014804442,0.00019047868,5.142341e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017239118,0.0007609901,0.621674,0.004008052,0.010865803,0.00040641337,0.0071062497,0.005739865,0.020134516,0.00034604414,0.0003627343,0.31135625],"study_design_scores_gemma":[0.00524529,0.005597469,0.9725129,0.0022068322,0.0012711289,0.0005766078,0.0010215966,0.003522287,0.0030755503,0.00007269938,0.0045991396,0.00029850553],"about_ca_topic_score_codex":0.0005519922,"about_ca_topic_score_gemma":0.00005271222,"teacher_disagreement_score":0.35083893,"about_ca_system_score_codex":0.000057967438,"about_ca_system_score_gemma":0.00031510615,"threshold_uncertainty_score":0.39018598},"labels":[],"label_agreement":null},{"id":"W4396759629","doi":"10.59236/sc.v1i2.42","title":"AcT: Intravenous Tenecteplase Compared to Alteplase for Acute Ischaemic Stroke in Canada","year":2024,"lang":"en","type":"article","venue":"Stroke Clinician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tenecteplase; Ischaemic stroke; Medicine; Fibrinolytic agent; Stroke (engine); Acute stroke; Cardiology; Internal medicine; Thrombolysis; Tissue plasminogen activator; Ischemia; Myocardial infarction","score_opus":0.01910081326013078,"score_gpt":0.3158128624002574,"score_spread":0.2967120491401266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396759629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876801,0.0010322542,0.0007275399,0.0035864885,0.0017467162,0.0021529857,0.001273852,0.00009836533,0.0017017168],"genre_scores_gemma":[0.99268436,0.0001471781,0.0013805361,0.003112478,0.0009241472,0.00022218277,0.00013404638,0.00006924816,0.0013258181],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975001,0.000057205645,0.00066206197,0.0006017304,0.00046993885,0.00070892717],"domain_scores_gemma":[0.998479,0.00020045147,0.000055596945,0.0006363209,0.00008647928,0.00054212735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062372885,0.00026076072,0.0008128236,0.00024174282,0.000077720884,0.000037589896,0.00016618025,0.000117499214,0.000067152054],"category_scores_gemma":[0.00013534194,0.0002347892,0.00033875034,0.0002934346,0.000027187523,0.000060949384,0.000053634987,0.00048833014,0.000049593637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005671999,0.0007720693,0.03637209,0.002535822,0.005771011,0.009550969,0.0024492696,0.0007577858,0.008223057,0.00093012885,0.0769616,0.8500042],"study_design_scores_gemma":[0.014294156,0.0039865454,0.06767723,0.0022813554,0.00233051,0.0007145044,0.0035154729,0.008912,0.012258271,0.00015929631,0.882276,0.0015946621],"about_ca_topic_score_codex":0.46746156,"about_ca_topic_score_gemma":0.8149581,"teacher_disagreement_score":0.84840953,"about_ca_system_score_codex":0.00089836866,"about_ca_system_score_gemma":0.004351824,"threshold_uncertainty_score":0.9574426},"labels":[],"label_agreement":null},{"id":"W4396801928","doi":"10.51731/cjht.2024.890","title":"Inclisiran (Leqvio)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Internal medicine; Atherosclerotic cardiovascular disease; Clinical trial; Cause of death; Drug; Adverse effect; Disease; Cholesterol; Quality of life (healthcare); Pharmacology","score_opus":0.023971632236052604,"score_gpt":0.29090637191898483,"score_spread":0.26693473968293224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396801928","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.119800694,0.76287293,0.0010740254,0.11262494,0.0013912847,0.00043870177,0.000014649669,0.00034142245,0.0014413717],"genre_scores_gemma":[0.9964597,0.001799407,0.0007296682,0.0008078417,0.00006928128,0.000003727287,0.0000016754587,0.000020195082,0.00010849137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986639,0.000041506944,0.0004912468,0.00013606621,0.00024071446,0.00042653727],"domain_scores_gemma":[0.99925315,0.000023224016,0.00009401679,0.0003288878,0.00012302911,0.00017767705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014182995,0.000106493964,0.00043213664,0.0007897817,0.00014635055,0.00004642626,0.0001611495,0.00014732432,0.00003838092],"category_scores_gemma":[0.00031164178,0.00007894559,0.00022051457,0.00048373052,0.00012962073,0.000092020186,0.000012484481,0.0006558307,0.000024451703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004461117,0.000005020464,0.00058564695,0.00042763527,0.000086968466,0.00093980314,0.00014621225,0.0000011052203,0.000011263536,0.0021945934,0.0052722166,0.9903251],"study_design_scores_gemma":[0.00031207292,0.00064306066,0.00480167,0.0010665419,0.000035817007,0.0034604657,0.001267857,0.000013741696,0.00022124001,0.0026227136,0.9854685,0.000086310654],"about_ca_topic_score_codex":0.0050401306,"about_ca_topic_score_gemma":0.0013874854,"teacher_disagreement_score":0.9902388,"about_ca_system_score_codex":0.000506767,"about_ca_system_score_gemma":0.006937589,"threshold_uncertainty_score":0.99869215},"labels":[],"label_agreement":null},{"id":"W4397005841","doi":"10.3390/cells13100857","title":"Insights into PCSK9-LDLR Regulation and Trafficking via the Differential Functions of MHC-I Proteins HFE and HLA-C","year":2024,"lang":"en","type":"article","venue":"Cells","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"LDL receptor; Cell biology; Biology; Major histocompatibility complex; MHC class I; Extracellular; Human leukocyte antigen; Immune system; HLA-G; Chemistry; Biochemistry; Cholesterol; Genetics; Lipoprotein; Antigen","score_opus":0.009654143893492699,"score_gpt":0.22819156324282236,"score_spread":0.21853741934932966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397005841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982322,0.005981694,0.009655165,0.00045338346,0.00030293775,0.00070612674,0.000001553658,0.000045840996,0.0005313078],"genre_scores_gemma":[0.9986507,0.00017074405,0.00012581414,0.00004103477,0.0003938738,0.00002686821,0.000009168725,0.000015659887,0.0005661009],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99927217,0.000049846924,0.00017058881,0.00019781904,0.00020944611,0.00010012938],"domain_scores_gemma":[0.9995948,0.000030967927,0.000029895085,0.00023556114,0.0000386137,0.0000701638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013646088,0.00009357766,0.00018849185,0.00007052512,0.00011212467,0.000031898107,0.00002599628,0.000070016846,0.000033046694],"category_scores_gemma":[0.000009906582,0.000057548685,0.000084424624,0.00013853148,0.0000889093,0.00005680605,0.000029006647,0.00014188827,0.000006253456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001235316,0.00014926051,0.000260622,0.0028467348,0.000534375,0.000027902008,0.008040767,0.000037895334,0.49408573,0.0020497325,0.0009449449,0.49089852],"study_design_scores_gemma":[0.0067286636,0.0023730441,0.23201314,0.003313799,0.0032621494,0.0004052905,0.0027733105,0.04653501,0.40432197,0.0061399606,0.29102325,0.0011103981],"about_ca_topic_score_codex":0.00014755121,"about_ca_topic_score_gemma":0.000041758554,"teacher_disagreement_score":0.48978812,"about_ca_system_score_codex":0.000024836105,"about_ca_system_score_gemma":0.00005282626,"threshold_uncertainty_score":0.23467672},"labels":[],"label_agreement":null},{"id":"W4397024469","doi":"10.1093/cvr/cvae109","title":"Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial","year":2024,"lang":"en","type":"article","venue":"Cardiovascular Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novartis Pharma","keywords":"Term (time); Medicine; Internal medicine; Administration (probate law); Cardiology; Political science","score_opus":0.06905751732315384,"score_gpt":0.3841613007582386,"score_spread":0.31510378343508477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397024469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94869477,0.042620126,0.0005192393,0.0012104047,0.001274877,0.003427315,0.000017757762,0.0001740691,0.002061445],"genre_scores_gemma":[0.9926565,0.0028418172,0.00006324697,0.0001125934,0.0028194585,0.00028609773,0.00007924288,0.0000887931,0.001052218],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933013,0.0012264069,0.0004399665,0.0009840357,0.0032612162,0.0007871042],"domain_scores_gemma":[0.9967695,0.00015247021,0.000026623864,0.002134397,0.00039025594,0.00052678946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011076771,0.00029032663,0.0007129661,0.0003433194,0.0006132353,0.0005167635,0.00028459253,0.00027448093,0.00009593731],"category_scores_gemma":[0.00045185845,0.00019401721,0.0016224722,0.00090253976,0.00037318093,0.00034636277,0.00018253732,0.0012111346,0.00007149994],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015729208,0.00035014347,0.0004885344,0.0015800087,0.009569744,0.004449079,0.001530622,0.000014989773,0.0013079742,0.0032087257,0.003312632,0.95845836],"study_design_scores_gemma":[0.12853937,0.013553253,0.08512277,0.0016730144,0.005157271,0.006503052,0.0041090157,0.0021376838,0.0028977592,0.002305178,0.7462181,0.0017835328],"about_ca_topic_score_codex":0.00056047144,"about_ca_topic_score_gemma":0.00006907264,"teacher_disagreement_score":0.9566748,"about_ca_system_score_codex":0.00026200878,"about_ca_system_score_gemma":0.0010034338,"threshold_uncertainty_score":0.7911792},"labels":[],"label_agreement":null},{"id":"W4397046409","doi":"10.1681/asn.20223311s1869a","title":"Differential Expression of Renal and Hepatic PCSK9 During Development of Hypercholesterolemia in the Puromycin Aminonucleoside Nephrosis Rat Model of Nephrotic Syndrome","year":2022,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Nephrosis; Puromycin; Nephrotic syndrome; Internal medicine; Endocrinology; Medicine; Biology; Protein biosynthesis; Biochemistry","score_opus":0.016946137632187077,"score_gpt":0.2443382203914126,"score_spread":0.2273920827592255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397046409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812406,0.00026738082,0.0004079413,0.00085904123,0.00003119512,0.0002989737,0.0000062194185,0.0000017957141,0.0000033747026],"genre_scores_gemma":[0.99486285,0.00017809849,0.004234599,0.00065858394,0.000032711,0.00001086235,9.134383e-7,0.000014966058,0.000006434333],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99748,0.00044950575,0.0009715672,0.00013730967,0.00075275643,0.00020886103],"domain_scores_gemma":[0.9979228,0.000097713324,0.0014407997,0.00037684388,0.00010427277,0.000057609977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008611544,0.00014012132,0.0009974644,0.000096323245,0.00010366803,0.0000025489126,0.00033930672,0.000047126297,0.000013231459],"category_scores_gemma":[0.000024542876,0.000086995446,0.00052097574,0.00029277772,0.0005009698,0.000046455287,0.00028026613,0.00048405316,3.847456e-8],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063089124,0.0002873267,0.010106633,0.0003630306,0.00028343734,0.000007412321,0.005536369,0.0014442669,0.97951394,0.0000023538792,0.00011143294,0.0017129325],"study_design_scores_gemma":[0.004455817,0.0019779124,0.895642,0.00043331733,0.0005562094,0.001567183,0.0055583403,0.0020520983,0.0873757,0.000081717095,0.00015407648,0.00014562282],"about_ca_topic_score_codex":0.000109447865,"about_ca_topic_score_gemma":0.0000062871222,"teacher_disagreement_score":0.8921382,"about_ca_system_score_codex":0.00009690896,"about_ca_system_score_gemma":0.00028549045,"threshold_uncertainty_score":0.35475713},"labels":[],"label_agreement":null},{"id":"W4398778186","doi":"10.31083/j.rcm2505190","title":"Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease","year":2024,"lang":"en","type":"review","venue":"Reviews in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Amgen (Canada); Université Laval; St. Michael's Hospital; Western University; University of Toronto; Centre hospitalier universitaire de Québec","funders":"Amgen Canada; Amgen","keywords":"Medicine; Evolocumab; Ldl cholesterol; Cardiology; Atherosclerotic cardiovascular disease; Internal medicine; PCSK9; Disease; Reduction (mathematics); Cholesterol; LDL receptor; Total cholesterol; Lipoprotein","score_opus":0.06626814034301874,"score_gpt":0.35606466693950006,"score_spread":0.2897965265964813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398778186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008990566,0.9812447,0.0007880578,0.00010766728,0.00059783785,0.017086813,0.00006841791,0.000019424073,0.000078117984],"genre_scores_gemma":[0.000058491776,0.99643266,0.00027040244,0.00005406,0.0008124928,0.001996836,0.0001720222,0.00013918466,0.000063819636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99177265,0.0015749286,0.0036736508,0.0010250289,0.0015644815,0.00038928448],"domain_scores_gemma":[0.9937645,0.00018834547,0.0010782138,0.004329907,0.00040691244,0.00023208918],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.018095275,0.0007866842,0.013185829,0.00047563377,0.000047876052,0.0000054949137,0.00037264836,0.0003433039,0.000028883953],"category_scores_gemma":[0.001486471,0.00044284784,0.014264754,0.0012871563,0.0005261643,0.00008184894,0.00015785187,0.0007946101,0.000003836351],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013287289,0.0000375941,7.956975e-7,0.4623731,0.007368389,0.0000048191137,0.000028168604,0.0000018154842,6.3468855e-7,0.000020957357,0.0002960717,0.52985436],"study_design_scores_gemma":[0.0009080374,0.00021100603,0.00003343732,0.40009725,0.07172414,0.00024083123,0.000017775965,0.0000039049132,0.0000016579352,0.000024322966,0.5265783,0.0001593227],"about_ca_topic_score_codex":0.00016970326,"about_ca_topic_score_gemma":0.0000018028014,"teacher_disagreement_score":0.52969503,"about_ca_system_score_codex":0.00021095511,"about_ca_system_score_gemma":0.00086347474,"threshold_uncertainty_score":0.99980235},"labels":[],"label_agreement":null},{"id":"W4399063016","doi":"10.1001/jamaneurol.2024.1433","title":"Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia","year":2024,"lang":"en","type":"article","venue":"JAMA Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"National Institute for Health and Care Research","keywords":"Medicine; Atorvastatin; Stroke (engine); Placebo; Internal medicine; Statin; Randomized controlled trial; Clinical trial","score_opus":0.013229508341377101,"score_gpt":0.2829075150665954,"score_spread":0.2696780067252183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399063016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97145164,0.00095164194,0.0001282228,0.02471887,0.00067113497,0.00041357745,0.000025043215,0.000117005766,0.0015228629],"genre_scores_gemma":[0.97604233,0.00030795604,0.00020466559,0.021618795,0.00066765735,0.00006564053,0.00004527459,0.000044536268,0.0010031619],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99856424,0.00010550461,0.00027877305,0.00041842824,0.00021545815,0.00041759503],"domain_scores_gemma":[0.99928063,0.000105205785,0.000027774622,0.00034625534,0.00009251161,0.00014759647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002771495,0.00015160385,0.0004009872,0.00016550111,0.000023749779,0.000022465612,0.00007734924,0.00026573418,0.00026193616],"category_scores_gemma":[0.00020643487,0.00010934327,0.00015600833,0.00030438538,0.00005804793,0.00007866677,0.000067064684,0.0009262882,0.0002230013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02607794,0.00055342587,0.032286655,0.0023522489,0.0036093765,0.17891446,0.0076477434,0.00011349019,0.035905253,0.0036495805,0.29165235,0.4172375],"study_design_scores_gemma":[0.02497818,0.01533422,0.20760651,0.00044031002,0.0015260915,0.024027796,0.00076479407,0.025724245,0.02459433,0.0020174824,0.6716186,0.0013674706],"about_ca_topic_score_codex":0.00039002264,"about_ca_topic_score_gemma":0.00012927431,"teacher_disagreement_score":0.41587,"about_ca_system_score_codex":0.00003630284,"about_ca_system_score_gemma":0.00030688246,"threshold_uncertainty_score":0.44588894},"labels":[],"label_agreement":null},{"id":"W4399139648","doi":"10.1093/pch/pxae018","title":"Childhood dyslipidemia: Clinician management practices in the primary care setting","year":2024,"lang":"en","type":"article","venue":"Paediatrics & Child Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Centre for Global Health Research; University of Toronto; SickKids Foundation; Hospital for Sick Children; Public Health Ontario; McMaster University","funders":"","keywords":"Dyslipidemia; Medicine; Family medicine; Descriptive statistics; Medical record; Primary care; Descriptive research; Pediatrics; Disease; Internal medicine","score_opus":0.01667083700702931,"score_gpt":0.31512167955906545,"score_spread":0.29845084255203613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399139648","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.103997,0.57239234,0.00042717307,0.17633404,0.003336081,0.009255552,0.00009347394,0.0006596179,0.13350469],"genre_scores_gemma":[0.90514725,0.039721675,0.0036772396,0.043502454,0.0072830496,0.00018874485,0.00030929313,0.000093025075,0.00007727652],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99635524,0.00050237856,0.00080560654,0.00064814184,0.0009767208,0.0007119308],"domain_scores_gemma":[0.998239,0.00032854013,0.00032338893,0.00082018034,0.00005238239,0.00023654844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057649314,0.00025094408,0.00053202925,0.00035059385,0.0003314492,0.00009273904,0.0002480763,0.00015710025,0.0000112579255],"category_scores_gemma":[0.00022034072,0.00017394622,0.00035264678,0.0011268788,0.000027365419,0.00014431146,0.00010569647,0.0015458524,0.00007645729],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049171493,0.00041872635,0.04692468,0.016530061,0.0002875444,0.0005379062,0.0145257255,0.000021657408,2.0738544e-7,0.0032079532,0.012510696,0.90498567],"study_design_scores_gemma":[0.0017255519,0.0004274929,0.7006795,0.0012921476,0.0003931239,0.0002369729,0.007529546,0.000059027705,8.40756e-7,0.00023978806,0.28712654,0.00028948943],"about_ca_topic_score_codex":0.0003484848,"about_ca_topic_score_gemma":0.00012431797,"teacher_disagreement_score":0.90469617,"about_ca_system_score_codex":0.00055502716,"about_ca_system_score_gemma":0.00094521535,"threshold_uncertainty_score":0.70933205},"labels":[],"label_agreement":null},{"id":"W4399250824","doi":"10.1093/ehjcvp/pvae043","title":"Does LDL-C determination method affect statin prescribing for primary prevention? A register-based study in Southern Denmark","year":2024,"lang":"en","type":"article","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Affect (linguistics); Statin; Medicine; Primary prevention; Register (sociolinguistics); Internal medicine; Psychology; Disease","score_opus":0.053366149448841396,"score_gpt":0.3819393901106707,"score_spread":0.3285732406618293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399250824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6453207,0.027714906,0.31675997,0.0007169222,0.001503195,0.007146767,0.000037955844,0.00024448783,0.0005550712],"genre_scores_gemma":[0.94837695,0.0009576311,0.041562237,0.0014598725,0.004601039,0.0004230127,0.000036287158,0.00053515664,0.0020478093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99205667,0.0045198533,0.000856179,0.0007609851,0.0012287786,0.00057753426],"domain_scores_gemma":[0.9983656,0.00022745742,0.00012818618,0.0007555771,0.00021765126,0.0003055181],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.015042021,0.00041523285,0.0010115067,0.00053223793,0.00025590355,0.0003123456,0.00020568416,0.00006785268,0.00010043666],"category_scores_gemma":[0.00009222515,0.00028150354,0.002957387,0.00047543953,0.00003189304,0.00027029874,0.00003618701,0.0007949869,0.000041644453],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013212922,0.0010975078,0.008174165,0.0021488955,0.0073655555,0.0035202506,0.0042801453,0.001684396,0.014542874,0.0000032686867,0.0007943416,0.95506734],"study_design_scores_gemma":[0.08274584,0.009103686,0.13135946,0.008116953,0.010981378,0.0070983213,0.004726724,0.013605278,0.014018682,0.0002756956,0.7147772,0.0031908127],"about_ca_topic_score_codex":0.000045539986,"about_ca_topic_score_gemma":0.000009958632,"teacher_disagreement_score":0.9518765,"about_ca_system_score_codex":0.00038702754,"about_ca_system_score_gemma":0.0004219843,"threshold_uncertainty_score":0.9999637},"labels":[],"label_agreement":null},{"id":"W4399304861","doi":"10.1016/j.jacc.2024.04.008","title":"ApoB Is Ready for Prime Time","year":2024,"lang":"en","type":"editorial","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Prime time; Prime (order theory); Combinatorics; Advertising","score_opus":0.011834474777053095,"score_gpt":0.29786592687495017,"score_spread":0.2860314520978971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399304861","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045111403,0.009829705,0.0004040413,0.006550386,0.9697574,0.0018160144,0.003712931,0.000026418375,0.0033919925],"genre_scores_gemma":[0.0039988523,0.0017822697,0.0010675472,0.0003913837,0.9846571,0.000027589207,0.000028253105,0.00012041199,0.007926571],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968785,0.00034499197,0.0010013347,0.00029227627,0.0011272044,0.0003556683],"domain_scores_gemma":[0.99549794,0.0005977397,0.0015595859,0.00091733516,0.0012627383,0.00016465098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020311722,0.00030741247,0.003335649,0.00026090856,0.00005940771,0.0000070445144,0.00050548674,0.00041801782,0.000011866021],"category_scores_gemma":[0.0012302176,0.00018387786,0.0029703018,0.00037416985,0.00043556665,0.00002749115,0.00014115531,0.0012155194,0.000016238153],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010956922,0.00001883283,0.00001779649,0.00039642307,0.003992117,0.00018612423,0.000016959219,0.000006412967,0.0003427313,0.00001647572,0.99206114,0.0018492814],"study_design_scores_gemma":[0.0012608347,0.0026487133,0.000081341605,0.00045194864,0.0030433463,0.0014721841,0.00005868258,0.00000799339,0.00028103567,0.00020892818,0.9903308,0.00015415362],"about_ca_topic_score_codex":0.00003214234,"about_ca_topic_score_gemma":9.288838e-7,"teacher_disagreement_score":0.01489975,"about_ca_system_score_codex":0.00031320844,"about_ca_system_score_gemma":0.0031465134,"threshold_uncertainty_score":0.7498321},"labels":[],"label_agreement":null},{"id":"W4399386116","doi":"10.1161/atvbaha.124.321058","title":"One-Year Effects of High-Intensity Statin on Bioactive Lipids: Findings From the JUPITER Trial","year":2024,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Pfizer; National Heart, Lung, and Blood Institute; Esperion Therapeutics; University of Toronto; Kowa Company; Amarin Corporation; Fondation Leducq; Bristol-Myers Squibb; AstraZeneca; Novo Nordisk; American Heart Association","keywords":"Rosuvastatin; Statin; Rosuvastatin Calcium; Medicine; Internal medicine; Placebo; Cholesterol; Randomized controlled trial; Pharmacology; Endocrinology; Pathology","score_opus":0.028344396917137443,"score_gpt":0.27901684767932144,"score_spread":0.25067245076218403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399386116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519026,0.00041540098,0.00035002382,0.0018721685,0.0009445155,0.0010681278,0.00006875193,0.000058446487,0.000032318654],"genre_scores_gemma":[0.9947081,0.0030137377,0.0003032148,0.0011670694,0.000624213,0.00008278073,0.000065290864,0.000032478238,0.000003111134],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99828404,0.00027028256,0.0003348592,0.0005615359,0.00024854805,0.00030073847],"domain_scores_gemma":[0.9987886,0.0003526876,0.000059837457,0.00061220204,0.000073659045,0.0001130238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000517673,0.00023295125,0.0008435669,0.00008262962,0.0001245594,0.00004559843,0.000104531464,0.00021535612,0.00006336616],"category_scores_gemma":[0.00010832726,0.00014889248,0.00048359032,0.00018293996,0.0002475501,0.00005495246,0.00008791898,0.00029093336,0.00003772297],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005951932,0.003143945,0.09639359,0.002534616,0.02997701,0.000003915526,0.011157569,0.0000018122798,0.76906,0.019502595,0.006183782,0.05608919],"study_design_scores_gemma":[0.010782052,0.002902206,0.9762087,0.0007075813,0.00078877126,3.962456e-7,0.00014874407,0.000018713556,0.006235287,0.000343116,0.001683615,0.00018082502],"about_ca_topic_score_codex":0.00137366,"about_ca_topic_score_gemma":0.000028943317,"teacher_disagreement_score":0.8798151,"about_ca_system_score_codex":0.000047355625,"about_ca_system_score_gemma":0.000055581735,"threshold_uncertainty_score":0.6071659},"labels":[],"label_agreement":null},{"id":"W4399457398","doi":"10.1016/j.cjco.2024.06.001","title":"Rapid DNA Diagnosis of Familial Hypercholesterolemia Due to the LDLR 15.8-Kilobase Deletion","year":2024,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Familial hypercholesterolemia; LDL receptor; DNA; Genetics; Medicine; Biology; Internal medicine; Cholesterol; Lipoprotein","score_opus":0.025645968001125622,"score_gpt":0.299846282894635,"score_spread":0.2742003148935094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399457398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777001,0.0033835203,0.00039476232,0.011179992,0.00053135684,0.0020820962,0.00004668996,0.000045255987,0.00463619],"genre_scores_gemma":[0.9945534,0.0004501307,0.00034142862,0.0031035338,0.00069486286,0.0003601276,0.000028742816,0.000028250284,0.00043955166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878156,0.000116472635,0.00024514605,0.00028805042,0.00036681897,0.00020194489],"domain_scores_gemma":[0.99900943,0.000050629897,0.000024374467,0.00068659516,0.000074304524,0.0001546583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010576064,0.000117233016,0.0003872778,0.00006143747,0.000070991875,0.00007755897,0.00028278027,0.00007134756,0.00022572209],"category_scores_gemma":[0.000108334454,0.00007381719,0.0001893375,0.00029489788,0.000033872973,0.000097934935,0.00021043108,0.00018129451,0.0002662386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027234675,0.00014691518,0.001437523,0.00052496657,0.00033404442,0.0002795516,0.001021769,0.000014599958,0.0020794377,0.00050416566,0.059530165,0.9338545],"study_design_scores_gemma":[0.0015959571,0.00074903254,0.05036319,0.00097312656,0.00036616676,0.00025648187,0.00038910634,0.00012272567,0.01467413,0.00010801501,0.93019694,0.00020513327],"about_ca_topic_score_codex":0.0011470106,"about_ca_topic_score_gemma":0.00012516072,"teacher_disagreement_score":0.93364936,"about_ca_system_score_codex":0.00007782016,"about_ca_system_score_gemma":0.00019297047,"threshold_uncertainty_score":0.34220475},"labels":[],"label_agreement":null},{"id":"W4399484036","doi":"10.1161/circulationaha.124.069221","title":"Letter by Andreotti et al Regarding Article, “Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance”","year":2024,"lang":"en","type":"letter","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Medicine; Statin; Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ldl cholesterol; Cardiology; Cholesterol","score_opus":0.007282387802067995,"score_gpt":0.2112417428860895,"score_spread":0.2039593550840215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9743099,0.0016476482,0.0014914926,0.019756448,0.00034721754,0.00211275,0.00016074133,0.00008526446,0.000088503824],"genre_scores_gemma":[0.9603832,0.00013447003,0.000059412996,0.03582667,0.00087199063,0.000114587936,0.0024594343,0.000115370174,0.0000348907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964691,0.00038718802,0.00066820113,0.00069512625,0.0014891824,0.00029119517],"domain_scores_gemma":[0.9984445,0.000040475326,0.00041353225,0.0007197756,0.00026713146,0.00011460043],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073104823,0.00038563268,0.000904032,0.0002204748,0.00008167772,0.000058825597,0.000070086346,0.00042028693,0.000007676926],"category_scores_gemma":[0.000052200397,0.00032314425,0.00037330386,0.00021809108,0.00009796403,0.0003789772,0.000040888874,0.0010819652,0.00000892982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014751991,0.000047303303,0.7869401,0.0017462372,0.0045251353,0.000088456254,0.00072945777,0.00040940772,0.00007731924,0.0000021167837,0.19522622,0.01006072],"study_design_scores_gemma":[0.006268149,0.00026263378,0.8393397,0.0021379413,0.0019131516,0.000024174595,0.00002364134,0.00040422814,0.00052751,0.000054090895,0.14858513,0.0004597048],"about_ca_topic_score_codex":0.0015786882,"about_ca_topic_score_gemma":0.000010380959,"teacher_disagreement_score":0.052399553,"about_ca_system_score_codex":0.00015297298,"about_ca_system_score_gemma":0.00013034679,"threshold_uncertainty_score":0.99992204},"labels":[],"label_agreement":null},{"id":"W4399484851","doi":"10.1093/eurheartj/ehae325","title":"Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"Regeneron Pharmaceuticals","keywords":"Medicine; Familial hypercholesterolemia; Genetic disorder; Pediatrics; Ldl cholesterol; Internal medicine; Disease; Cholesterol","score_opus":0.02924699224822403,"score_gpt":0.3049574927204163,"score_spread":0.27571050047219225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399484851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97940576,0.014324627,0.00024295539,0.0016779933,0.00052870566,0.000290887,0.0000030942476,0.000069220725,0.0034567355],"genre_scores_gemma":[0.99353844,0.00305569,0.00021861057,0.0006414187,0.0019496586,0.0000010920577,0.000004250075,0.00006156557,0.000529281],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981725,0.00041385388,0.00038109318,0.00028951658,0.00038726,0.00035574345],"domain_scores_gemma":[0.99925494,0.00004507263,0.0000268938,0.0002860108,0.000039177743,0.000347876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001929021,0.00016823469,0.00036912624,0.00019948403,0.00013328933,0.00016499544,0.00007523884,0.000053676133,0.00006416019],"category_scores_gemma":[0.00007947851,0.00013025625,0.00022303886,0.00019234473,0.000058491067,0.00014741503,0.00007052747,0.0011310524,0.00016852235],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072225643,0.00026919696,0.10651354,0.0007647011,0.00028859774,0.0430701,0.0014471824,0.00001632093,0.0017216036,0.0000574304,0.002619116,0.84251],"study_design_scores_gemma":[0.0021969317,0.00035966278,0.9050499,0.0010227017,0.00007017784,0.041470394,0.00002965513,0.000027730193,0.000022314038,0.0000037165166,0.04962076,0.00012603385],"about_ca_topic_score_codex":0.0000112042235,"about_ca_topic_score_gemma":0.000006503346,"teacher_disagreement_score":0.8423839,"about_ca_system_score_codex":0.00014133136,"about_ca_system_score_gemma":0.00015927815,"threshold_uncertainty_score":0.53116953},"labels":[],"label_agreement":null},{"id":"W4399671319","doi":"10.1093/eurheartj/ehae191","title":"Eight reasons why lipoprotein(a) should be measured in everyone at least once in a lifetime","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Lipoprotein(a); Lipoprotein; Internal medicine; Cholesterol","score_opus":0.06590672830087252,"score_gpt":0.3095423985452887,"score_spread":0.24363567024441618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399671319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8590538,0.06719518,0.0005741159,0.040571455,0.0014264652,0.0015715354,0.00002048405,0.0002412367,0.029345755],"genre_scores_gemma":[0.9880273,0.0010374639,0.000997938,0.003473666,0.002473966,0.000013301394,0.000009959001,0.00013838592,0.0038280361],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99626774,0.0009639286,0.0006011267,0.00045829266,0.0010745473,0.0006343422],"domain_scores_gemma":[0.9987851,0.000047832855,0.00006214426,0.00051415904,0.00008379311,0.00050701696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044833003,0.00026441627,0.00057224836,0.00044989178,0.00015020974,0.00013027969,0.00015410721,0.00009243873,0.00041365385],"category_scores_gemma":[0.0002896047,0.00021860299,0.0004165181,0.00069839985,0.00006216823,0.00021379016,0.00011561362,0.001559538,0.000419801],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003276239,0.0018811122,0.14411497,0.0025638195,0.0014998411,0.110874474,0.008681411,0.00054521253,0.05059329,0.0003699896,0.49991608,0.17568357],"study_design_scores_gemma":[0.002352332,0.0003894931,0.27978572,0.0032003773,0.000077851284,0.013331254,0.00010214795,0.00023841187,0.000539465,0.000020235198,0.6996414,0.00032131525],"about_ca_topic_score_codex":0.00027575556,"about_ca_topic_score_gemma":0.00029241433,"teacher_disagreement_score":0.19972533,"about_ca_system_score_codex":0.00055251014,"about_ca_system_score_gemma":0.00037279856,"threshold_uncertainty_score":0.8914371},"labels":[],"label_agreement":null},{"id":"W4399718027","doi":"10.1161/jaha.123.033654","title":"Genetics and Pathophysiological Mechanisms of Lipoprotein(a)‐Associated Cardiovascular Risk","year":2024,"lang":"en","type":"review","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Novartis Pharmaceuticals Corporation","keywords":"Pathophysiology; Medicine; Genetics; Bioinformatics; Biology; Internal medicine","score_opus":0.021426245221425236,"score_gpt":0.29684060554465774,"score_spread":0.2754143603232325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399718027","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008759987,0.98968595,0.000095514486,0.00012031241,0.00043938198,0.000810745,0.000058884532,0.000014413956,0.0000147982655],"genre_scores_gemma":[0.0051940926,0.99317974,0.00073551846,0.000090167625,0.0006576845,0.000015152584,0.000004232709,0.000053333908,0.00007006741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99530494,0.0016907738,0.0010988993,0.00025254505,0.0013779775,0.0002748727],"domain_scores_gemma":[0.99634,0.0001930101,0.0023760966,0.00053615356,0.00041146638,0.00014330706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004388,0.0003079619,0.0046407613,0.00017598257,0.00008849354,0.000027079563,0.00017289058,0.00029103292,0.0000031876316],"category_scores_gemma":[0.0014944694,0.00016969471,0.0055337716,0.0007151618,0.00008440656,0.000031388285,0.000129444,0.0012185184,0.0000055155474],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028712037,0.00012320971,0.00043390444,0.004627467,0.013303148,0.000030602056,0.00005802872,0.000008228095,0.000038021695,0.00001424827,0.0008842104,0.9804502],"study_design_scores_gemma":[0.001306975,0.0030757433,0.016680224,0.021800445,0.08183523,0.0009302197,0.00013227997,0.00004439799,0.00007669177,0.0017452484,0.871728,0.00064455945],"about_ca_topic_score_codex":0.00018764433,"about_ca_topic_score_gemma":0.0000030370531,"teacher_disagreement_score":0.97980565,"about_ca_system_score_codex":0.00076992816,"about_ca_system_score_gemma":0.0005870868,"threshold_uncertainty_score":0.69199497},"labels":[],"label_agreement":null},{"id":"W4399726013","doi":"10.46747/cfp.7006371","title":"Repeat lipid testing","year":2024,"lang":"en","type":"letter","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.02922382802546592,"score_gpt":0.23964686555202727,"score_spread":0.21042303752656136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399726013","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038060726,0.0066585564,0.00000456407,0.4491673,0.0020518336,0.00097242714,0.0002712151,0.00025459199,0.5402389],"genre_scores_gemma":[0.00038989919,0.000041811265,0.00019404331,0.95027095,0.04039262,0.00007754469,0.0006696061,0.00024251653,0.007721019],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703497,0.00006482611,0.00035299966,0.0008316913,0.00063397334,0.0010815292],"domain_scores_gemma":[0.9976484,0.00003831656,0.000076920376,0.0013896677,0.00018701794,0.00065966544],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022277779,0.0004891095,0.00086985715,0.00047282057,0.00016780567,0.00011456809,0.00022062138,0.0007714184,0.0000069393955],"category_scores_gemma":[0.00003904655,0.00046501023,0.00063489936,0.00065173686,0.000080364356,0.00005245775,0.000037669597,0.0028544753,0.001549857],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001467695,0.0000040230675,0.0000046429286,0.0008573826,0.00027484575,0.005260628,0.000017169777,4.8216395e-7,0.000049001075,0.000016915434,0.91413116,0.07938226],"study_design_scores_gemma":[0.00020702845,0.0001037594,0.00029284687,0.0013070091,0.0005144094,0.00004824287,0.00004226563,0.000027209235,0.000018471961,0.00013299295,0.99686337,0.0004423774],"about_ca_topic_score_codex":0.06469323,"about_ca_topic_score_gemma":0.0026011297,"teacher_disagreement_score":0.53251785,"about_ca_system_score_codex":0.0011345638,"about_ca_system_score_gemma":0.003834564,"threshold_uncertainty_score":0.9997802},"labels":[],"label_agreement":null},{"id":"W4399726021","doi":"10.46747/cfp.7006371_1","title":"Response","year":2024,"lang":"en","type":"letter","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.01853814632298167,"score_gpt":0.2423268398118902,"score_spread":0.22378869348890854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399726021","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007971115,0.007424929,0.0000030121857,0.8095594,0.0013328511,0.00076253555,0.0003778936,0.0001388258,0.17960346],"genre_scores_gemma":[0.00046775688,0.00005242748,0.000040769435,0.9690922,0.013108892,0.000076007746,0.0005544518,0.00020467148,0.016402844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974391,0.00015405644,0.00025957997,0.0006453286,0.00060008105,0.00090184674],"domain_scores_gemma":[0.99789697,0.000033607168,0.00004517468,0.0012944358,0.00010690226,0.00062290387],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037818932,0.0004061653,0.00072810106,0.0005796645,0.000111898225,0.00008364487,0.00019294761,0.0008208205,0.00001148788],"category_scores_gemma":[0.000017368864,0.00038282768,0.0007279744,0.0004326477,0.00008247221,0.00003814145,0.000025147032,0.002445931,0.0031001496],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029277608,0.0000039679535,4.9312706e-7,0.00038523253,0.0003226156,0.009502963,0.000022025479,1.5137216e-7,0.00006802176,0.000023374034,0.97126216,0.018379692],"study_design_scores_gemma":[0.00025230946,0.00012283731,0.0003580482,0.00058671465,0.00037228208,0.000028448088,0.00004319413,0.0000056044555,0.00002364585,0.00015802837,0.9976834,0.00036549245],"about_ca_topic_score_codex":0.02722371,"about_ca_topic_score_gemma":0.0017516414,"teacher_disagreement_score":0.1632006,"about_ca_system_score_codex":0.001247587,"about_ca_system_score_gemma":0.005367382,"threshold_uncertainty_score":0.9998624},"labels":[],"label_agreement":null},{"id":"W4399882750","doi":"10.1016/j.cjco.2024.06.006","title":"Prevention and Management of Cardiovascular Disease in Primary Care: A Comment on the PEER Simplified Lipid Guideline","year":2024,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Fraser Institute; McMaster University; Population Health Research Institute; University of Calgary; Western University; University of Toronto; St. Michael's Hospital; St. Paul's Hospital; University of Victoria; Université de Montréal; Fraser Health; University of Alberta; Université Laval; McGill University Health Centre; West Fraser (Canada); University of British Columbia; Montreal Heart Institute; Centre hospitalier universitaire de Québec","funders":"Esperion Therapeutics; HLS Therapeutics; Idorsia Pharmaceuticals; International Sweeteners Association; Institute for the Advancement of Food and Nutrition Sciences; Almond Board of California; International Nut and Dried Fruit Council; Servier; Novo Nordisk; AstraZeneca; Amarin Corporation; Sanofi; Government of Canada; Ultragenyx Pharmaceutical; United Soybean Board; Dairy Farmers of Canada; National Honey Board; Danone; U.S. Department of Agriculture; Regeneron Pharmaceuticals; General Mills; Kowa Company; Pfizer; Amgen; Physicians Committee for Responsible Medicine; Eli Lilly and Company","keywords":"Guideline; Dyslipidemia; Medicine; Audit; Concordance; Family medicine; Disease; Pathology; Business; Internal medicine","score_opus":0.02751099206691609,"score_gpt":0.3081257296193419,"score_spread":0.28061473755242583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399882750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5520184,0.17832145,0.004160472,0.13200934,0.0012553915,0.032119274,0.00014765549,0.0001766596,0.09979135],"genre_scores_gemma":[0.99047387,0.0036546187,0.0006709039,0.003051087,0.00021198537,0.00047336562,0.00018545827,0.000035001252,0.001243743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986522,0.00010883221,0.00026922865,0.00027728753,0.0005589392,0.00013351408],"domain_scores_gemma":[0.99905074,0.000015873062,0.000021818634,0.00076173025,0.00006190648,0.000087929155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015926479,0.000103639424,0.00035056425,0.000051036113,0.000039391092,0.00004688432,0.0001362787,0.000029396606,0.000028339313],"category_scores_gemma":[0.000014220211,0.00006664314,0.00024456202,0.00015596914,0.000025969275,0.000050089155,0.0002531167,0.0001136185,0.000008421148],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089124555,0.00045011906,0.0006930246,0.010746536,0.006043762,0.00079508324,0.0010367245,0.0006891377,0.000031516378,0.012188866,0.04659973,0.91983426],"study_design_scores_gemma":[0.0022203226,0.00020871911,0.017087912,0.0021044472,0.0010177328,0.000008511075,0.00045859418,0.00028371924,0.00010207056,0.00025562878,0.9761282,0.00012414959],"about_ca_topic_score_codex":0.00045999727,"about_ca_topic_score_gemma":0.000004652548,"teacher_disagreement_score":0.9295285,"about_ca_system_score_codex":0.00013798827,"about_ca_system_score_gemma":0.00010675401,"threshold_uncertainty_score":0.27176282},"labels":[],"label_agreement":null},{"id":"W4399924783","doi":"","title":"Lipid Management: Guidelines From the Canadian PEER Group for Primary Care.","year":2024,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Primary care; Primary (astronomy); Family medicine","score_opus":0.03423485400521613,"score_gpt":0.2596579761216428,"score_spread":0.22542312211642668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399924783","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052525777,0.2201142,0.0041217483,0.2982113,0.013971705,0.033528477,0.001503718,0.0010291688,0.3749939],"genre_scores_gemma":[0.90049696,0.0012805723,0.0048765675,0.031838328,0.015243589,0.015532035,0.0018497522,0.0001577584,0.028724438],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987324,0.000022148066,0.00018492878,0.0002657924,0.0004050475,0.0003897071],"domain_scores_gemma":[0.999107,0.000032320757,0.000013388085,0.0004527775,0.0001490101,0.00024547783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077665935,0.00010648481,0.00017783605,0.000065859436,0.00014361204,0.000091309514,0.000115288494,0.000065770255,0.000018559906],"category_scores_gemma":[0.000066359804,0.00006737245,0.0002371387,0.00014406732,0.000023404264,0.000043733082,0.0000305009,0.00011784856,0.00002161903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017778753,0.000005018802,0.000299665,0.000419811,0.00036212982,0.000043427204,0.00014174689,0.0000011194827,5.588823e-7,0.0012392033,0.0900282,0.9074413],"study_design_scores_gemma":[0.00042320095,0.00001015533,0.13401972,0.00005700519,0.00027884016,0.000006200654,0.00015069271,0.000022351966,0.000008457971,0.00019057929,0.8647604,0.00007236667],"about_ca_topic_score_codex":0.07637293,"about_ca_topic_score_gemma":0.07761875,"teacher_disagreement_score":0.90736896,"about_ca_system_score_codex":0.0003701289,"about_ca_system_score_gemma":0.00016559423,"threshold_uncertainty_score":0.9392123},"labels":[],"label_agreement":null},{"id":"W4400035659","doi":"10.17615/ddy9-8209","title":"Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial","year":2024,"lang":"en","type":"article","venue":"UNC Libraries","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; American Regent; Agency for Healthcare Research and Quality; Regeneron Pharmaceuticals; National Institutes of Health; GlaxoSmithKline; HLS Therapeutics; Daiichi Sankyo Europe; Servier; Novo Nordisk; Verily Life Sciences; Duke Clinical Research Institute; MannKind Corporation; Zafgen; Boston Scientific Corporation; Pfizer; York University; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; CSL Behring; Heart and Stroke Foundation of Canada; Esperion Therapeutics; University of Toronto; Amylin Pharmaceuticals; Amgen; Sanofi; American Heart Association","keywords":"Type 2 diabetes; Adverse effect; Medicine; Physical medicine and rehabilitation; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.015340570433344861,"score_gpt":0.23124880862438618,"score_spread":0.21590823819104132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400035659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844475,0.011285813,0.000018778781,0.001006247,0.0006802479,0.0010839418,0.000021149503,0.00015697618,0.001299382],"genre_scores_gemma":[0.99591255,0.00005012853,0.0009288794,0.00078373036,0.001619755,0.00008922782,0.00011308456,0.00004436473,0.00045829345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852985,0.00013596429,0.00027012403,0.0003125446,0.00049802073,0.00025347172],"domain_scores_gemma":[0.9991432,0.00025201117,0.000042724958,0.00043796533,0.00002555496,0.00009855637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027105803,0.00016798536,0.00033425022,0.00009602393,0.000099650744,0.00006416182,0.00013092645,0.000113881164,0.0001014968],"category_scores_gemma":[0.00016321892,0.000090994974,0.00012129738,0.00047927696,0.00007453053,0.00036424623,0.000082143575,0.00036122967,0.00004579512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012355406,0.00060786103,0.9111315,0.0010130454,0.004122649,0.000406978,0.022190083,0.000030356641,0.00021103371,0.023941588,0.0069531575,0.017036326],"study_design_scores_gemma":[0.092723906,0.005827984,0.65210307,0.0070029036,0.0019906228,0.000029907807,0.006747647,0.00074278325,0.004410099,0.046478044,0.18084112,0.0011019241],"about_ca_topic_score_codex":0.00026699557,"about_ca_topic_score_gemma":0.000085988475,"teacher_disagreement_score":0.25902846,"about_ca_system_score_codex":0.000037217356,"about_ca_system_score_gemma":0.0005228227,"threshold_uncertainty_score":0.37106675},"labels":[],"label_agreement":null},{"id":"W4400184186","doi":"10.1016/j.jacc.2024.04.048","title":"Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs","year":2024,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Esperion Therapeutics","keywords":"Medicine; Internal medicine; Myocardial infarction; Cardiology; Placebo; Statin; Clinical endpoint; Stroke (engine); Pravastatin; Regimen; Adverse effect; Coronary artery disease; Cholesterol; Randomized controlled trial","score_opus":0.016535554910121892,"score_gpt":0.2784250827062098,"score_spread":0.26188952779608793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400184186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94952416,0.04760092,0.00045850937,0.00085766905,0.00035820436,0.00030676866,0.00010448851,0.000006374222,0.00078288006],"genre_scores_gemma":[0.99569494,0.0025974696,0.0010701655,0.0000901364,0.00047691938,0.000004232232,8.104573e-7,0.00001704556,0.00004828936],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99796075,0.00046248094,0.0006137791,0.00016930308,0.0005996283,0.00019406655],"domain_scores_gemma":[0.9984864,0.00015550778,0.00040484444,0.00046518893,0.00037211724,0.00011594607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013662162,0.000152419,0.0020660758,0.00019462354,0.00004198401,0.000003909362,0.0001657977,0.00005258004,0.0000036884055],"category_scores_gemma":[0.0000974909,0.00009303116,0.0014458392,0.0005126708,0.0006100103,0.00005031021,0.00008471928,0.0003429064,8.290308e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012762037,0.0006486838,0.07516092,0.010000666,0.22600976,0.00464887,0.0136635285,0.02763114,0.066555955,0.017231034,0.05676477,0.48892266],"study_design_scores_gemma":[0.012388994,0.016528092,0.53517133,0.0040754853,0.019358223,0.049599074,0.024094047,0.0005872144,0.07293321,0.0019132717,0.2622062,0.0011448513],"about_ca_topic_score_codex":0.00004838684,"about_ca_topic_score_gemma":0.0000020038208,"teacher_disagreement_score":0.4877778,"about_ca_system_score_codex":0.00006704254,"about_ca_system_score_gemma":0.00046233824,"threshold_uncertainty_score":0.37937003},"labels":[],"label_agreement":null},{"id":"W4400258283","doi":"10.1016/j.jacl.2024.06.005","title":"What's next for lipoprotein(a)? A National Lipid Association report from an Expert Panel Discussion","year":2024,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Association (psychology); Lipoprotein(a); Family medicine; Lipoprotein; Internal medicine; Cholesterol; Epistemology","score_opus":0.28352666396005166,"score_gpt":0.5182416227121824,"score_spread":0.23471495875213078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400258283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048863545,0.9557641,0.00044862443,0.0072573293,0.034780685,0.0015262723,0.00005041854,0.000038968614,0.0000847144],"genre_scores_gemma":[0.000011873647,0.87476164,0.0028462098,0.0011924249,0.11914509,0.00013257809,0.00041565328,0.00010666512,0.0013878681],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9897092,0.001517055,0.0058932886,0.0007815488,0.0016353645,0.00046351546],"domain_scores_gemma":[0.9905626,0.0019180767,0.004836264,0.0007293807,0.0013119531,0.0006417347],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.014854177,0.00051192235,0.0062505547,0.00035340144,0.00009093271,0.00023193976,0.0003618513,0.0021072351,0.00013801253],"category_scores_gemma":[0.013302309,0.00027106685,0.0058881547,0.00026539614,0.00008152073,0.0007482956,0.00011621869,0.0025023506,0.00007045527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002768899,0.00042794537,0.00001454441,0.0030112485,0.0026518449,0.00017661962,0.000054571992,2.3887597e-7,8.71563e-7,0.00003432985,0.0409162,0.9524347],"study_design_scores_gemma":[0.0015483386,0.0016319127,0.000102491045,0.014870767,0.004861203,0.002379633,0.000096195385,0.000016848036,4.916598e-7,0.0009261303,0.9732852,0.00028077047],"about_ca_topic_score_codex":0.000045005443,"about_ca_topic_score_gemma":0.000020160052,"teacher_disagreement_score":0.9521539,"about_ca_system_score_codex":0.0006322218,"about_ca_system_score_gemma":0.0044322335,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W4400314389","doi":"10.1161/circresaha.124.324793","title":"Combined Lipid Disturbances: More Than the Sum of Their Parts?","year":2024,"lang":"en","type":"article","venue":"Circulation Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Chemistry; Biology; Computational biology","score_opus":0.07861268919333317,"score_gpt":0.37190545790880847,"score_spread":0.29329276871547527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400314389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780947,0.0064029647,0.00044280177,0.008829144,0.0002538937,0.0011126407,0.000011986262,0.00006910199,0.0047827824],"genre_scores_gemma":[0.9984824,0.0002211265,0.000010314564,0.00006172146,0.0004918157,0.000078384226,0.00003614283,0.000018984842,0.00059910305],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981621,0.000220509,0.00020553915,0.00022463658,0.0009276684,0.0002595629],"domain_scores_gemma":[0.99879616,0.00019009449,0.000020069036,0.0006289753,0.0002730376,0.00009165814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022879522,0.00007687446,0.00019751693,0.00012190571,0.000148343,0.00005182433,0.00011713711,0.00006556852,0.00010143271],"category_scores_gemma":[0.00013415294,0.000043264776,0.000201024,0.00067154976,0.00021316484,0.000062869636,0.00004656565,0.0003714425,0.000037774786],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086039794,0.0009184775,0.3857303,0.011050314,0.0027119936,0.0002328005,0.020944793,0.0011782176,0.013886504,0.0777895,0.039181046,0.44551566],"study_design_scores_gemma":[0.000854949,0.00023205907,0.92428744,0.0006147787,0.000060023733,0.00003308591,0.0017460485,0.014578693,0.0018624235,0.0018631435,0.053744584,0.00012278749],"about_ca_topic_score_codex":0.00029581564,"about_ca_topic_score_gemma":0.000017845805,"teacher_disagreement_score":0.5385571,"about_ca_system_score_codex":0.00007320021,"about_ca_system_score_gemma":0.0002679219,"threshold_uncertainty_score":0.17642863},"labels":[],"label_agreement":null},{"id":"W4400433616","doi":"10.1093/eurheartj/ehae417","title":"Sex differences in treatment of familial hypercholesterolaemia: a meta-analysis","year":2024,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; University of British Columbia; University of Toronto; Providence Health Care","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Odds ratio; Internal medicine; Meta-analysis; Confidence interval; Randomized controlled trial; Cochrane Library; Adverse effect","score_opus":0.279632763951582,"score_gpt":0.39950484546807324,"score_spread":0.11987208151649126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400433616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00060063106,0.99730015,0.000015146974,0.00010850516,0.00016830141,0.0005832362,0.000041594165,0.000018027018,0.0011644067],"genre_scores_gemma":[0.001062261,0.99561894,0.00019623808,0.00005395059,0.0009163489,0.00002038545,0.00002057248,0.000074712014,0.0020366036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995502,0.001873967,0.0011948195,0.0004352366,0.00066560484,0.00032838873],"domain_scores_gemma":[0.99867356,0.000064220505,0.00026117338,0.0006539164,0.00005627538,0.00029086572],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0018848397,0.00047368513,0.0072384286,0.00094962603,0.000050660856,0.000070953785,0.00014909149,0.00012667607,0.0001627257],"category_scores_gemma":[0.000030429712,0.0002446834,0.010916365,0.0008316229,0.000048750015,0.00003873445,0.00005058668,0.0008567739,0.00015480124],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001592091,0.00034240115,0.00034781964,0.007260241,0.31475872,0.0027872168,0.00039943503,0.0000010483309,5.46997e-7,0.0000029331657,0.00037641395,0.6737073],"study_design_scores_gemma":[0.00026073548,0.00039255252,0.0005703101,0.0008775533,0.411469,0.0018549728,0.00001818413,0.0000013931909,2.6398774e-7,0.0000012529222,0.58443314,0.00012063814],"about_ca_topic_score_codex":0.00005539135,"about_ca_topic_score_gemma":0.000014017539,"teacher_disagreement_score":0.67358667,"about_ca_system_score_codex":0.0002391811,"about_ca_system_score_gemma":0.00038160864,"threshold_uncertainty_score":0.99898905},"labels":[],"label_agreement":null},{"id":"W4400492740","doi":"10.1080/14796678.2024.2367860","title":"Emerging therapies for refractory hypercholesterolemia: a narrative review","year":2024,"lang":"en","type":"review","venue":"Future Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Narrative review; Refractory (planetary science); Intensive care medicine; Internal medicine","score_opus":0.038970752598976775,"score_gpt":0.37855967700938453,"score_spread":0.3395889244104078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400492740","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000011779758,0.98909765,0.000108200155,0.0017541291,0.0032734,0.0045904093,0.00013149167,0.0001472574,0.00089630194],"genre_scores_gemma":[0.0000011062007,0.97700334,0.0002815326,0.0017490588,0.017101474,0.0023053568,0.00065233256,0.00016055902,0.0007452545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968961,0.0006004709,0.00080398354,0.00089444785,0.00028449477,0.00052053935],"domain_scores_gemma":[0.99813294,0.00009870106,0.00022761835,0.0011579454,0.00020281701,0.00017995003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012948824,0.0006922525,0.0062139276,0.00020666573,0.00011619508,0.000016292537,0.00020940388,0.0009828144,0.000027098033],"category_scores_gemma":[0.00012543965,0.00042240217,0.0043619266,0.00032690668,0.00008602024,0.000038032147,0.00008469556,0.0014275721,0.000095855234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000097265065,0.0000064302835,2.1546434e-7,0.19762367,0.002923018,0.000121343146,0.00017704949,1.8892e-8,2.1665332e-7,0.00007450536,0.06862492,0.7304389],"study_design_scores_gemma":[0.00026929218,0.0002757712,0.0000015668014,0.06919771,0.012356919,0.0023772507,0.00022504888,8.675807e-8,4.225682e-8,0.000024124722,0.91495454,0.00031761997],"about_ca_topic_score_codex":0.0000034107688,"about_ca_topic_score_gemma":0.000001719874,"teacher_disagreement_score":0.8463296,"about_ca_system_score_codex":0.00028264007,"about_ca_system_score_gemma":0.0007930718,"threshold_uncertainty_score":0.9998228},"labels":[],"label_agreement":null},{"id":"W4400650121","doi":"10.1093/eurjcn/zvae099","title":"Need of education and training of healthcare professionals on the PCSK9 inhibitors in cardiovascular disease","year":2024,"lang":"en","type":"article","venue":"European Journal of Cardiovascular Nursing","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Health professionals; PCSK9; Training (meteorology); Health care; Cardiovascular health; Medical education; Intensive care medicine; Physical therapy; Family medicine; Internal medicine; Cholesterol","score_opus":0.025583971756930023,"score_gpt":0.2917076246787448,"score_spread":0.2661236529218148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400650121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6493849,0.34355184,0.000828114,0.0030402697,0.001131385,0.00064155523,0.0000051789334,0.000014822475,0.001401922],"genre_scores_gemma":[0.9970624,0.0014475276,0.0003392707,0.00010947877,0.0009523054,0.0000042780775,0.0000034692935,0.000062228784,0.000019071924],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995373,0.0017499139,0.00090392126,0.00028315955,0.0014380192,0.0002519962],"domain_scores_gemma":[0.9983547,0.0000942028,0.00020103932,0.0007376403,0.00034134832,0.00027111932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00816686,0.00020987145,0.0010304291,0.00048381375,0.00007295376,0.000026471851,0.00013969789,0.000047390677,0.0000044125577],"category_scores_gemma":[0.00034010847,0.00014095848,0.0023396616,0.0005559647,0.00016037749,0.00012985273,0.000027903527,0.00060066703,0.0000014841072],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024621323,0.00023034225,0.0002642688,0.0015286863,0.00416068,0.0005086948,0.005169817,0.0011257213,0.00026309153,0.00062842836,0.00022392228,0.9856501],"study_design_scores_gemma":[0.016038954,0.005036279,0.31354436,0.26961127,0.025371507,0.009947964,0.080571495,0.0012918776,0.011316485,0.002050477,0.26318514,0.002034178],"about_ca_topic_score_codex":0.00003564287,"about_ca_topic_score_gemma":2.363089e-7,"teacher_disagreement_score":0.98361593,"about_ca_system_score_codex":0.00015057724,"about_ca_system_score_gemma":0.00095063704,"threshold_uncertainty_score":0.574812},"labels":[],"label_agreement":null},{"id":"W4400773698","doi":"10.1186/s12933-024-02348-2","title":"Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) Registry","year":2024,"lang":"en","type":"article","venue":"Cardiovascular Diabetology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; St. Jude Medical; Idorsia Pharmaceuticals; Duke Clinical Research Institute; Eisai; Pfizer; Moderna; Belvoir Media Group; MyoKardia; Novo Nordisk; Medicines Company; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; Assistance publique-Hôpitaux de Paris; National Institutes of Health; Regeneron Pharmaceuticals; Boston Scientific Corporation; Brigham and Women's Hospital; Bristol-Myers Squibb; Cleveland Clinic; Alnylam Pharmaceuticals; HLS Therapeutics; GlaxoSmithKline; CSL Behring; Eli Lilly and Company; Amgen; Sanofi; American Heart Association","keywords":"Medicine; Internal medicine; Lipoprotein(a); Diabetes mellitus; Myocardial infarction; Coronary artery disease; Angiology; Risk factor; Confounding; Kidney disease; Cardiology; Lipoprotein; Endocrinology; Cholesterol","score_opus":0.006516603475260805,"score_gpt":0.2152496248693636,"score_spread":0.2087330213941028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400773698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80331206,0.19014296,0.0019598412,0.00020619525,0.0006276822,0.0026012848,0.00009989733,0.00034111633,0.0007089835],"genre_scores_gemma":[0.990901,0.005612434,0.0007815197,0.00023435599,0.0012872114,0.0006270974,0.00009986987,0.00023005845,0.00022647214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932207,0.001102371,0.0006366959,0.0017684827,0.001947869,0.0013238906],"domain_scores_gemma":[0.9950634,0.000116882184,0.00013848853,0.003679003,0.00038670094,0.0006154835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021278004,0.00083879556,0.0025494248,0.0002762041,0.0004889537,0.00025840875,0.0003881536,0.0006003668,0.00006307351],"category_scores_gemma":[0.00030959188,0.0005326675,0.00359023,0.00069568225,0.0010110075,0.00028265323,0.00019622616,0.0013373111,0.000081695965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015962814,0.00011988914,0.5617829,0.0017279874,0.07368461,0.00050571474,0.00045812473,0.000360204,0.000057997422,0.00031836936,0.00027015028,0.36055443],"study_design_scores_gemma":[0.005782366,0.0007291084,0.793188,0.00066127855,0.0135928625,0.00037173385,0.00013569747,0.0006534104,0.001552272,0.00039065725,0.18170571,0.0012369306],"about_ca_topic_score_codex":0.0011466077,"about_ca_topic_score_gemma":0.000028608792,"teacher_disagreement_score":0.3593175,"about_ca_system_score_codex":0.00022442329,"about_ca_system_score_gemma":0.00038697047,"threshold_uncertainty_score":0.99971247},"labels":[],"label_agreement":null},{"id":"W4400982322","doi":"10.1111/jgs.19093","title":"Discontinuation versus continuation of statins: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of the American Geriatrics Society","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Bruyère; Queen's University; Women's College Hospital; Trillium Health Centre; University of Toronto; University of British Columbia; Institut du Savoir Montfort","funders":"","keywords":"Medicine; Discontinuation; Continuation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; MEDLINE; Intensive care medicine; Internal medicine; Statin","score_opus":0.03560724728600886,"score_gpt":0.36633296901056905,"score_spread":0.3307257217245602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400982322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044904467,0.9961763,0.00023802633,0.00031321257,0.00080922875,0.0023378725,0.000031530646,0.000009878842,0.00003902289],"genre_scores_gemma":[0.000031420852,0.9979232,0.001020555,0.0001789624,0.0006043242,0.000043445114,0.000010434461,0.000052938725,0.00013470516],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9955277,0.00063421525,0.0022286163,0.00018506423,0.0012351415,0.00018927622],"domain_scores_gemma":[0.9913206,0.00024297393,0.0070515843,0.00071875035,0.00056280295,0.00010325572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036406987,0.0003072824,0.0051360005,0.00009992678,0.00004786489,0.000027049891,0.00033069635,0.000097811775,0.000005087608],"category_scores_gemma":[0.0011852934,0.0001520562,0.006637632,0.001509299,0.00011699959,0.00006434602,0.00008888022,0.00074028457,0.000006806397],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015152714,0.000050382438,6.7389e-7,0.8840538,0.0028740095,0.000005114997,0.00014750913,2.5414897e-7,5.027226e-7,0.0000146518,0.0053877574,0.107450165],"study_design_scores_gemma":[0.00060426054,0.0005910434,0.0000068563013,0.7848005,0.08809622,0.000352788,0.00032900606,0.000008939531,6.9340376e-7,0.000010949291,0.12499999,0.00019873297],"about_ca_topic_score_codex":0.00003052611,"about_ca_topic_score_gemma":8.3617306e-7,"teacher_disagreement_score":0.11961224,"about_ca_system_score_codex":0.0005180482,"about_ca_system_score_gemma":0.0014936001,"threshold_uncertainty_score":0.669423},"labels":[],"label_agreement":null},{"id":"W4401057693","doi":"10.1093/qjmed/hcae144","title":"Statin intolerance and the drucebo effect","year":2024,"lang":"en","type":"article","venue":"QJM","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Statin; Medicine; Atherosclerotic cardiovascular disease; Internal medicine; Exercise intolerance; Disease; Risk factor; Cardiology; Physical therapy","score_opus":0.004339644949734757,"score_gpt":0.2600578891900644,"score_spread":0.25571824424032963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401057693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9397766,0.042892586,0.0007678976,0.005631706,0.00032306576,0.000779505,0.000002686722,0.00009793909,0.009728006],"genre_scores_gemma":[0.9977746,0.00027299448,0.00011472159,0.0005473132,0.00029991745,0.000042475713,0.000001779864,0.000009491566,0.00093673094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995228,0.000069054135,0.000066516375,0.000109433255,0.00014328075,0.00008893752],"domain_scores_gemma":[0.99968225,0.00008121987,0.0000058833334,0.00017916437,0.000009717321,0.00004175916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006902921,0.000050898874,0.00014954513,0.000015573689,0.00003644793,0.000024517645,0.000020328996,0.000021392205,0.000029502407],"category_scores_gemma":[0.000042762877,0.000024832116,0.000077042125,0.0000726801,0.00005494525,0.000018069515,0.000012651978,0.0001237549,0.000047255857],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023237188,0.000008242068,0.000655164,0.0011063766,0.00021123921,0.00011373658,0.0012084898,0.000001179391,0.0002781905,0.0066416007,0.004245397,0.98529804],"study_design_scores_gemma":[0.01325624,0.0009284624,0.056876887,0.0014752524,0.0007303939,0.00085268094,0.00025553437,0.0056125685,0.006074505,0.0030480076,0.9105592,0.00033028738],"about_ca_topic_score_codex":0.00014354743,"about_ca_topic_score_gemma":0.0000061965443,"teacher_disagreement_score":0.9849677,"about_ca_system_score_codex":0.000012605964,"about_ca_system_score_gemma":0.00003175982,"threshold_uncertainty_score":0.10126243},"labels":[],"label_agreement":null},{"id":"W4401071338","doi":"10.1016/j.jacadv.2024.101090","title":"Reply","year":2024,"lang":"en","type":"article","venue":"JACC Advances","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Philosophy","score_opus":0.011718389284526246,"score_gpt":0.3036058501993265,"score_spread":0.2918874609148003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401071338","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16298997,0.582954,0.009179226,0.019788262,0.0033012358,0.0011364112,0.0000122014735,0.0013117613,0.21932691],"genre_scores_gemma":[0.9717192,0.0061005913,0.0048601427,0.0039457097,0.0023461687,0.000057403005,0.00001144405,0.000035618395,0.010923737],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994123,0.000010233378,0.00009373477,0.0001722623,0.00019044866,0.0001210015],"domain_scores_gemma":[0.9996539,0.000015284328,0.00000810553,0.00023684897,0.000020480886,0.000065394896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016970428,0.000055597367,0.00013071588,0.00003680982,0.000028501221,0.000017022621,0.00002578302,0.000020452439,0.00012234079],"category_scores_gemma":[0.00003273336,0.00003865255,0.00012221342,0.00013826437,0.000017769009,0.00010900408,0.000010850329,0.00009659068,0.00018480554],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023654544,0.000018323391,0.0004966715,0.0005609892,0.00007508539,0.0002562466,0.000096509764,0.0000036522997,0.0002586292,0.0018353951,0.0067109377,0.9896639],"study_design_scores_gemma":[0.00014682981,0.00007707374,0.0015460044,0.00013585517,0.000034113455,0.00014267197,0.00005843643,0.000058648482,0.0010611344,0.0011142784,0.99557567,0.00004928153],"about_ca_topic_score_codex":0.000024603074,"about_ca_topic_score_gemma":0.0000020476305,"teacher_disagreement_score":0.9896146,"about_ca_system_score_codex":0.000026919302,"about_ca_system_score_gemma":0.00006517672,"threshold_uncertainty_score":0.2375363},"labels":[],"label_agreement":null},{"id":"W4401076354","doi":"10.1001/jama.2024.12537","title":"Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations","year":2024,"lang":"en","type":"article","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Myocardial infarction; Atherosclerotic cardiovascular disease; Cohort; Framingham Risk Score; Internal medicine; Stroke (engine); Statin; Canadian Cardiovascular Society; Atherosclerosis Risk in Communities; Generalized estimating equation; Disease; Physical therapy","score_opus":0.020514348000608616,"score_gpt":0.2819586382899924,"score_spread":0.26144429028938376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401076354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557417,0.0338896,0.0010338052,0.007082042,0.000050853363,0.0019517775,0.000023423627,0.000068247704,0.00015854929],"genre_scores_gemma":[0.9920122,0.006700609,0.00024488766,0.00043817435,0.0002582737,0.00023653568,0.00001434678,0.000022045557,0.000072938004],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986623,0.0002729387,0.00012711731,0.00033722466,0.0004040709,0.00019634124],"domain_scores_gemma":[0.9991357,0.00010884163,0.000025092624,0.00053627987,0.00013474074,0.000059365073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012693714,0.00012626607,0.00032465483,0.00007801598,0.00008106174,0.00005464027,0.000042921078,0.000064518084,0.000010683618],"category_scores_gemma":[0.00013654913,0.000064156455,0.00014680949,0.00038720827,0.0000692237,0.000056214467,0.000021457836,0.00030163975,0.0000041648877],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020863512,0.000120894794,0.0042109704,0.00036176277,0.0018388033,0.00019847891,0.005128183,0.000040008625,0.0002840334,0.00013716382,0.0005463707,0.9869247],"study_design_scores_gemma":[0.008677388,0.0017559909,0.82916033,0.0010067637,0.0012590472,0.0003853046,0.0037558305,0.0048815915,0.0051039127,0.00037988456,0.14312325,0.0005107066],"about_ca_topic_score_codex":0.0027536284,"about_ca_topic_score_gemma":0.0008204496,"teacher_disagreement_score":0.986414,"about_ca_system_score_codex":0.00005636842,"about_ca_system_score_gemma":0.00020025145,"threshold_uncertainty_score":0.41626808},"labels":[],"label_agreement":null},{"id":"W4401226305","doi":"10.1016/j.mayocp.2024.03.025","title":"Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease","year":2024,"lang":"en","type":"article","venue":"Mayo Clinic Proceedings","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Genentech; Esperion Therapeutics; Amgen; Singulex; Daiichi Sankyo Europe; Silence Therapeutics; Sanofi; Kowa Company; Novo Nordisk; Medicines Company; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Pfizer; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Atherosclerotic cardiovascular disease; Disease; Cardiology; Internal medicine","score_opus":0.008967706649121469,"score_gpt":0.23817512053078124,"score_spread":0.22920741388165977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401226305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916578,0.0056729927,0.000043407403,0.000108971464,0.00016539091,0.0016359984,0.0000044474396,0.00009957227,0.0006114086],"genre_scores_gemma":[0.99900967,0.00019363116,0.00015967088,0.00013728741,0.00018102277,0.00010289098,0.000007657684,0.0000566897,0.00015146438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979689,0.0000205553,0.00039815233,0.00048561796,0.00081825873,0.00030849292],"domain_scores_gemma":[0.999218,0.000048894133,0.00005074241,0.0002989087,0.0001481049,0.00023538209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008304091,0.00019818197,0.00066324964,0.00018722384,0.000029463064,0.000025275413,0.000099453464,0.00009579742,0.000021023796],"category_scores_gemma":[0.0002338403,0.00014357487,0.0005155733,0.000549358,0.00008106739,0.00013465808,0.000055578512,0.0003065038,0.000035070698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017672378,0.0013536316,0.8526511,0.02975455,0.0033252402,0.0002529161,0.0013231845,0.000007968658,0.000120598444,0.00040934436,0.0004360581,0.10859817],"study_design_scores_gemma":[0.0050758333,0.0009632989,0.9847869,0.0032994722,0.0010798497,0.000003939448,0.000041976808,0.000081682316,0.0002575446,0.00012008527,0.0040861624,0.00020321683],"about_ca_topic_score_codex":0.00006525127,"about_ca_topic_score_gemma":6.198161e-7,"teacher_disagreement_score":0.13213584,"about_ca_system_score_codex":0.00009585069,"about_ca_system_score_gemma":0.00017281609,"threshold_uncertainty_score":0.58548135},"labels":[],"label_agreement":null},{"id":"W4401334321","doi":"10.1016/j.cjca.2024.04.017","title":"Dyslipidemia and the Current State of Cardiovascular Disease: Epidemiology, Risk Factors, and Effect of Lipid Lowering","year":2024,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"McMaster University; Population Health Research Institute; Hamilton Health Sciences; St. Paul's Hospital; University of British Columbia","funders":"Novartis Pharmaceuticals Canada; Novartis; Amgen","keywords":"Medicine; Dyslipidemia; Epidemiology; Atherosclerotic cardiovascular disease; Disease; Socioeconomic status; Environmental health; Risk factor; Cause of death; Gerontology; Internal medicine; Intensive care medicine; Population","score_opus":0.031237756627941492,"score_gpt":0.31760831117650556,"score_spread":0.2863705545485641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401334321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040643485,0.99249816,0.00035373584,0.00006474361,0.0015411832,0.0010981761,0.0003246469,0.0000045520983,0.00005045601],"genre_scores_gemma":[0.024846919,0.9734019,0.000014470212,0.0000078837065,0.0016275173,0.000021411333,0.00001932163,0.000054503987,0.0000060745137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937032,0.0035112486,0.0016193929,0.0003961551,0.00027278689,0.0004972012],"domain_scores_gemma":[0.9955166,0.0014281382,0.00092755386,0.0008163516,0.00018977991,0.0011215956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010667592,0.0005089103,0.008962741,0.0005296243,0.000080425394,0.000009481993,0.00022459128,0.00023855102,0.0000018719223],"category_scores_gemma":[0.0033596305,0.000254246,0.0048156283,0.00023256683,0.0010576142,0.0000352365,0.00007225978,0.0016946337,0.000001045851],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083764535,8.729171e-7,0.0035841796,0.02809421,0.01411347,0.00011602995,0.000041145842,0.00012692665,2.2348141e-8,0.000022396136,0.0005281335,0.95328885],"study_design_scores_gemma":[0.0010783913,0.00036504204,0.0027355275,0.010289361,0.03445178,0.0008101842,0.0000045422266,0.0000054687425,4.135924e-7,0.00011844449,0.9499607,0.0001801523],"about_ca_topic_score_codex":0.001478357,"about_ca_topic_score_gemma":0.00006788685,"teacher_disagreement_score":0.95310867,"about_ca_system_score_codex":0.00019246152,"about_ca_system_score_gemma":0.0025711833,"threshold_uncertainty_score":0.999991},"labels":[],"label_agreement":null},{"id":"W4401334474","doi":"10.1016/j.cjca.2024.04.023","title":"What Guidelines Say About Risk Reduction: Major Data on the Link Between Lipid Lowering and Outcomes","year":2024,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"Western University; McGill University; University of Alberta; McGill University Health Centre","funders":"","keywords":"Medicine; Dyslipidemia; Apolipoprotein B; Atherosclerotic cardiovascular disease; Guideline; Intensive care medicine; Etiology; Mendelian randomization; Disease; Internal medicine; Cholesterol; Pathology; Genetic variants; Genetics","score_opus":0.11223262635273525,"score_gpt":0.37465256178873907,"score_spread":0.26241993543600384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401334474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005580007,0.9795079,0.00008860593,0.013039012,0.0061250087,0.0005839243,0.00025370574,0.000009227401,0.000336786],"genre_scores_gemma":[0.00014608061,0.9550269,0.00008379856,0.00025494365,0.04400376,0.000010952424,0.00008095903,0.000069721405,0.00032285778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714,0.00048917084,0.0011856452,0.00044319054,0.00030819327,0.00043381794],"domain_scores_gemma":[0.99675494,0.00020069274,0.00048455028,0.0015064806,0.00028058,0.00077274797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037872077,0.00040584023,0.0033133964,0.00047354162,0.00018666244,0.00015001294,0.00055455096,0.0004752617,0.000017081014],"category_scores_gemma":[0.0010565391,0.00021569019,0.0012097561,0.00023030744,0.00019937752,0.00013121475,0.000097714066,0.0018069864,0.000034460016],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000035615803,2.1940771e-7,0.0001144198,0.0018671928,0.0035853083,0.00030018773,0.000023191693,0.0000024051697,1.4205498e-8,0.000023764955,0.028313028,0.9657667],"study_design_scores_gemma":[0.00020293873,0.0001463832,0.00028829268,0.012019916,0.008739865,0.0054965103,0.000082413535,4.508267e-7,9.256094e-8,0.000050009465,0.9727979,0.00017523006],"about_ca_topic_score_codex":0.0008877289,"about_ca_topic_score_gemma":0.00034022305,"teacher_disagreement_score":0.9655915,"about_ca_system_score_codex":0.00026803353,"about_ca_system_score_gemma":0.0037493103,"threshold_uncertainty_score":0.8795591},"labels":[],"label_agreement":null},{"id":"W4401334780","doi":"10.1016/j.cjca.2024.04.003","title":"Traditional and Novel Markers: Target of Treatment vs Marker of Risk","year":2024,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Victoria; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; University of British Columbia","funders":"Novartis Pharmaceuticals Canada","keywords":"Medicine; Kexin; Apolipoprotein B; PCSK9; Lipoprotein; Internal medicine; Cholesterol; Risk factor; Endocrinology; Lipid profile; Risk assessment; Lipoprotein(a); Bioinformatics; LDL receptor; Biology","score_opus":0.046398119652690126,"score_gpt":0.2853873165380231,"score_spread":0.23898919688533293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401334780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015458235,0.9954492,0.00026793458,0.00008090415,0.000663892,0.0003933867,0.0014116445,0.0000018509515,0.0015766032],"genre_scores_gemma":[0.002910349,0.9946997,0.00052751316,0.00001754841,0.0016529736,0.000010771113,0.00006643841,0.000038955503,0.00007575487],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981202,0.000282434,0.0009340219,0.00020368611,0.00019423266,0.0002654435],"domain_scores_gemma":[0.9981908,0.00013657798,0.0005384242,0.00030326186,0.0002000874,0.0006308392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009930894,0.00027740287,0.00358919,0.00062423164,0.000030459163,0.0000061991377,0.00010004068,0.00035645787,0.00004690757],"category_scores_gemma":[0.00016459177,0.00016834223,0.0020119895,0.00017370108,0.00023705074,0.000025060312,0.0000069536113,0.0004741337,0.0000023919092],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011930474,0.0000133067315,0.00057275145,0.016022887,0.0145496875,0.00074280665,0.000085404245,0.000015657943,8.92971e-7,0.00037735174,0.0058870637,0.9616129],"study_design_scores_gemma":[0.0007504151,0.0010925133,0.0015505635,0.0053798906,0.008511393,0.008355767,0.000034433862,0.0000010154553,5.406504e-7,0.000122069345,0.9740839,0.00011749266],"about_ca_topic_score_codex":0.0014449953,"about_ca_topic_score_gemma":0.00021937702,"teacher_disagreement_score":0.96819687,"about_ca_system_score_codex":0.0005038968,"about_ca_system_score_gemma":0.0076633575,"threshold_uncertainty_score":0.9979623},"labels":[],"label_agreement":null},{"id":"W4401334868","doi":"10.1016/j.cjca.2024.05.010","title":"Care Gaps and System Issues With Delivering Cardiovascular Risk Reduction and Lipid-Lowering Therapy in Secondary Prevention","year":2024,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; St. Michael's Hospital; Canadian VIGOUR Centre; University of Alberta; Université de Montréal; Montreal Heart Institute","funders":"Chi Sigma Iota; Canadian Institutes of Health Research; American Regent; Esperion Therapeutics; AstraZeneca; Allergan; HLS Therapeutics; Duke Clinical Research Institute; Eisai; Novo Nordisk; Novartis Pharmaceuticals Canada; Daiichi-Sankyo; Bayer; Servier; Pfizer; York University; Moderna; Seqirus; Regeneron Pharmaceuticals; Boston Scientific Corporation; Cleveland Clinic; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; University of Toronto; Heart and Stroke Foundation of Canada; Sanofi; Amgen","keywords":"Medicine; Secondary prevention; Reduction (mathematics); Intensive care medicine; Internal medicine","score_opus":0.019586445325838787,"score_gpt":0.27652437662511054,"score_spread":0.2569379312992717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401334868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070308778,0.9908745,0.00014273106,0.000015856585,0.0007113278,0.00081554486,0.000026215312,0.000011266752,0.0003716568],"genre_scores_gemma":[0.02815614,0.96911293,0.00011478527,0.0000032239438,0.002480984,0.0000303079,0.000021559965,0.0000649202,0.0000151498325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797904,0.00048339818,0.0006117202,0.00037758696,0.00021416497,0.0003340774],"domain_scores_gemma":[0.99874765,0.000015350986,0.00023173011,0.00036978134,0.00018055575,0.00045494223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012712909,0.0003375485,0.0029006447,0.0007674382,0.000093615316,0.000047275775,0.000079079524,0.0003809682,0.0000017311432],"category_scores_gemma":[0.00002706947,0.00024135897,0.0010139836,0.00023207485,0.00010730055,0.00008404923,0.000017795159,0.0010664237,0.0000013485953],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022763887,5.38948e-7,0.000117479394,0.019872434,0.0037715684,0.0010915019,0.00031145543,0.000042171436,3.091186e-7,0.000005851384,0.00003705029,0.97472686],"study_design_scores_gemma":[0.00085374765,0.00063370366,0.00044734625,0.025673803,0.004909422,0.030445488,0.0010163045,6.767917e-7,0.0000012496514,0.000003408558,0.93579406,0.00022077572],"about_ca_topic_score_codex":0.004336841,"about_ca_topic_score_gemma":0.000985988,"teacher_disagreement_score":0.9745061,"about_ca_system_score_codex":0.00066688133,"about_ca_system_score_gemma":0.0024615722,"threshold_uncertainty_score":0.9842333},"labels":[],"label_agreement":null},{"id":"W4401336595","doi":"10.1016/j.cjca.2024.05.004","title":"Medications for Lipid Control: Statins vs Newer Drugs","year":2024,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia; BC Children's Hospital; University of Ottawa","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Novartis Pharmaceuticals Canada; Novartis; Amgen","keywords":"Medicine; Ezetimibe; PCSK9; Statin; Intensive care medicine; Adverse effect; Internal medicine; Pharmacology; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.03016082196983487,"score_gpt":0.3305414814846103,"score_spread":0.30038065951477544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401336595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000011029714,0.9852673,0.005353296,0.0019029799,0.0029878796,0.0012113585,0.000519074,0.000010296906,0.0027467527],"genre_scores_gemma":[0.00018863613,0.9852562,0.00031866488,0.00053998164,0.012808521,0.000115392344,0.00011175862,0.000090135334,0.00057072315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975579,0.00030446614,0.0010601938,0.00027240682,0.00026316952,0.000541867],"domain_scores_gemma":[0.99696445,0.00020291243,0.00040997154,0.0005159102,0.00049469277,0.0014120827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001750195,0.0003212801,0.0037903658,0.00073983,0.00010114383,0.000028207785,0.00025540302,0.0005150884,0.000032627664],"category_scores_gemma":[0.00035575792,0.00022345809,0.003010308,0.00025200096,0.00015975746,0.000033184035,0.0000094315365,0.0009522543,0.000049827668],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017662964,0.0000014919259,0.0000043714845,0.0092001045,0.0068594133,0.0003032429,0.00007225357,0.0000051473626,4.0669494e-8,0.00069752475,0.13162391,0.8512148],"study_design_scores_gemma":[0.00085897313,0.00036833566,0.0000124945855,0.0047758934,0.017004823,0.004075897,0.0000403572,0.0000015927498,2.8011195e-8,0.000097999015,0.97259945,0.00016415452],"about_ca_topic_score_codex":0.0004800556,"about_ca_topic_score_gemma":0.00039173677,"teacher_disagreement_score":0.8510507,"about_ca_system_score_codex":0.0005814435,"about_ca_system_score_gemma":0.019647574,"threshold_uncertainty_score":0.9859101},"labels":[],"label_agreement":null},{"id":"W4401580032","doi":"10.1080/14796678.2024.2388478","title":"Risk of cardiovascular outcomes with bempedoic acid in high-risk statin intolerant patients: a systematic review and meta analysis","year":2024,"lang":"en","type":"review","venue":"Future Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Regina","funders":"","keywords":"Medicine; Mace; Internal medicine; Statin; myalgia; Incidence (geometry); Adverse effect; Placebo; Meta-analysis; Randomized controlled trial; Relative risk; Myopathy; Myocardial infarction; Confidence interval; Percutaneous coronary intervention; Pathology","score_opus":0.014438105112499187,"score_gpt":0.2817017303064137,"score_spread":0.2672636251939145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401580032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010416268,0.990538,0.00023868003,0.00006188433,0.00020051192,0.007655893,0.0011299163,0.000047954738,0.000022983728],"genre_scores_gemma":[0.0003248566,0.9963875,0.00038625157,0.00014030588,0.00023834892,0.0018372916,0.000544908,0.000110088724,0.000030475649],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99124146,0.004135652,0.0020437627,0.0012127437,0.00086109893,0.0005052814],"domain_scores_gemma":[0.99551135,0.00018929841,0.0010063909,0.0027368965,0.0003346811,0.00022137286],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0036780483,0.0010285119,0.035422936,0.0009369755,0.00005664793,0.000017671216,0.00025899347,0.0006475561,0.00001645721],"category_scores_gemma":[0.0004127277,0.00051001605,0.012670451,0.0019989698,0.00014077793,0.000046772104,0.00015422309,0.0013906783,0.000013574796],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006278013,0.00001828497,0.00031324802,0.5318447,0.46141112,0.00013585888,0.000039550083,0.000008351379,7.431842e-10,0.000008888414,0.0000488031,0.00616497],"study_design_scores_gemma":[0.0005879392,0.00030303237,0.00046233236,0.034457542,0.91944724,0.00019366165,0.00004777865,7.9005866e-7,3.1448128e-8,0.000005307659,0.044086188,0.0004081344],"about_ca_topic_score_codex":0.00087880314,"about_ca_topic_score_gemma":0.000120568606,"teacher_disagreement_score":0.4973871,"about_ca_system_score_codex":0.00019382755,"about_ca_system_score_gemma":0.00032935833,"threshold_uncertainty_score":0.9997351},"labels":[],"label_agreement":null},{"id":"W4401599565","doi":"10.1016/j.atherosclerosis.2024.118445","title":"Sex differences in the treatment of familial hypercholesterolemia: A systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Familial hypercholesterolemia; Meta-analysis; Medicine; Internal medicine; Cholesterol","score_opus":0.1659502058727956,"score_gpt":0.3584442360929887,"score_spread":0.1924940302201931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401599565","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012362383,0.994134,0.0000034027978,0.00016923566,0.000018381323,0.005374848,0.000122021316,0.000016344837,0.00003814721],"genre_scores_gemma":[0.0005781334,0.99582326,0.00002377758,0.0002832111,0.000038772192,0.0028110011,0.000030316183,0.000037972535,0.00037355564],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99655414,0.0009815122,0.0011906909,0.00051922543,0.0005323774,0.000222067],"domain_scores_gemma":[0.9981152,0.0001844774,0.00030809172,0.0012811376,0.000033687007,0.00007742309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001221349,0.00052496983,0.01331112,0.00023169561,0.00003463327,0.00003694687,0.00019704438,0.00021601001,0.000025949363],"category_scores_gemma":[0.000031620722,0.00020361574,0.0062234113,0.001019368,0.00006853997,0.000021309163,0.000029789982,0.00024019601,0.000015954289],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[5.930349e-7,0.00014234181,0.000008524722,0.8318058,0.16070662,0.000005551687,0.0003534356,7.960967e-9,6.5725054e-8,0.0000075525127,0.000011394331,0.006958095],"study_design_scores_gemma":[0.00012663852,0.00025870575,0.000037762282,0.055580493,0.9371207,0.00003114232,0.000071549446,6.700147e-7,1.4159698e-7,0.0000024081512,0.0066321525,0.00013765055],"about_ca_topic_score_codex":0.00038621132,"about_ca_topic_score_gemma":0.000060158723,"teacher_disagreement_score":0.77641404,"about_ca_system_score_codex":0.00011197527,"about_ca_system_score_gemma":0.000097409706,"threshold_uncertainty_score":0.9099215},"labels":[],"label_agreement":null},{"id":"W4401599708","doi":"10.1016/j.atherosclerosis.2024.118447","title":"Real-life experience of canadian patients with homozygous familial hypercholesterolemia following nine years of participation in evinacumab clinical trials: The Canada ELIPSE-OLE study","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec; Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Gerontology; Clinical trial; Pediatrics; Internal medicine; Cholesterol","score_opus":0.08237635807565215,"score_gpt":0.3683410727878977,"score_spread":0.28596471471224555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401599708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979033,0.00023686704,0.000005906261,0.00013982698,0.00031637974,0.0012807857,0.000034087734,0.000012686709,0.00007014339],"genre_scores_gemma":[0.99941796,0.0001280358,0.00003539383,0.00013710326,0.00009056539,0.00013086783,0.0000102622,0.000029323908,0.000020472004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971629,0.00060729455,0.0009459169,0.0003073185,0.0006922431,0.0002843246],"domain_scores_gemma":[0.9987312,0.0002676723,0.00013293,0.0005493404,0.00008664235,0.00023223941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002805878,0.00013800229,0.00074507896,0.0001444203,0.000049208502,0.000015944535,0.00013619266,0.00007902167,0.0000157455],"category_scores_gemma":[0.0006998797,0.00009218259,0.00021429277,0.0006761497,0.00006493806,0.0000682052,0.00002603789,0.00022721355,0.0000013155268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017306063,0.0003357172,0.9706864,0.00006582894,0.00031793962,0.000021639193,0.004925082,0.000029775694,0.00021195074,0.000009558233,0.00014710422,0.02307597],"study_design_scores_gemma":[0.0024772466,0.0006996275,0.9930222,0.00036055484,0.00025552028,6.319344e-7,0.0026211154,0.00007300514,0.00008307807,7.3420244e-7,0.000317525,0.00008878478],"about_ca_topic_score_codex":0.9656363,"about_ca_topic_score_gemma":0.94178325,"teacher_disagreement_score":0.023853015,"about_ca_system_score_codex":0.00023787694,"about_ca_system_score_gemma":0.0016828987,"threshold_uncertainty_score":0.37590972},"labels":[],"label_agreement":null},{"id":"W4401599762","doi":"10.1016/j.atherosclerosis.2024.118378","title":"Clinical expression of familial hypercholesterolemia (FH) in two populations carrying identical by descent FH-causing gene variants","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Familial hypercholesterolemia; Genetics; Gene; Biology; Cholesterol; Endocrinology","score_opus":0.0807795786072937,"score_gpt":0.3825702808613516,"score_spread":0.3017907022540579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401599762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919095,0.0013187273,0.0052992012,0.00021962091,0.0006110274,0.00046361238,0.000029480147,0.000069243906,0.000079555866],"genre_scores_gemma":[0.9955869,0.00045237507,0.0032022435,0.00021136523,0.0003860602,0.000027629287,0.000033909193,0.000053267897,0.000046266396],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99751484,0.00024612612,0.0008700665,0.0004843832,0.0005341972,0.00035037345],"domain_scores_gemma":[0.99908787,0.00006762035,0.00007106544,0.0005120511,0.00005699466,0.00020439054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012577743,0.0001861241,0.00055108947,0.000114324954,0.00007941199,0.000044200155,0.00008567853,0.00016467737,0.000036093392],"category_scores_gemma":[0.00012722047,0.00016004808,0.00036438697,0.00031691283,0.00008075905,0.0001383639,0.00009159025,0.00043700886,0.000018471306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008610911,0.00041733033,0.25554457,0.00030054784,0.000100917096,0.00003380133,0.00056158175,0.000031586038,0.71258336,0.0000976146,0.0005071273,0.02973546],"study_design_scores_gemma":[0.0036284893,0.00021680309,0.95610076,0.0032422454,0.00036885278,0.000049166927,0.00018107086,0.0022831685,0.032855686,0.000115457304,0.0006540119,0.00030430485],"about_ca_topic_score_codex":0.0011100087,"about_ca_topic_score_gemma":0.000056191784,"teacher_disagreement_score":0.70055616,"about_ca_system_score_codex":0.00016203472,"about_ca_system_score_gemma":0.00012599061,"threshold_uncertainty_score":0.6526571},"labels":[],"label_agreement":null},{"id":"W4401599921","doi":"10.1016/j.atherosclerosis.2024.118341","title":"Whole-exome sequencing in familial hypercholesterolemia reveals newly identified variants associated with cardiovascular-event free survival","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Familial hypercholesterolemia; Exome sequencing; Exome; Event (particle physics); Medicine; Genetics; Cardiovascular event; Computational biology; Biology; Internal medicine; Mutation; Cholesterol; Gene; Disease","score_opus":0.03517360677513891,"score_gpt":0.2578073142194436,"score_spread":0.22263370744430466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401599921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926558,0.0027539376,0.0012507974,0.00046985658,0.00068032375,0.0010902398,0.000098817036,0.0002985961,0.00070162665],"genre_scores_gemma":[0.9972919,0.0003467679,0.0002929364,0.00036853008,0.00045093833,0.00015772005,0.00007476128,0.00014876956,0.00086767215],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9955631,0.00045026478,0.00066005375,0.0009544456,0.0015750857,0.00079704117],"domain_scores_gemma":[0.9977392,0.00010710332,0.00007952538,0.0016303614,0.00014290775,0.00030091757],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033073274,0.00043045759,0.0011616278,0.00025580553,0.00013389924,0.00017985911,0.00030129033,0.00033124737,0.00003864612],"category_scores_gemma":[0.00029155126,0.00035330147,0.00087126216,0.0010254182,0.000095248106,0.00028546422,0.00013806351,0.0007130769,0.00009133286],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012745633,0.0015621701,0.23248279,0.0050406554,0.030202247,0.005003972,0.016266653,0.006459186,0.5616682,0.0012104822,0.0036831123,0.13514598],"study_design_scores_gemma":[0.007672665,0.00051965355,0.98025995,0.004973239,0.0013091404,0.000117763884,0.00056841224,0.000813374,0.0009313892,0.00031751892,0.001816055,0.0007008403],"about_ca_topic_score_codex":0.0029254612,"about_ca_topic_score_gemma":0.0007125123,"teacher_disagreement_score":0.74777716,"about_ca_system_score_codex":0.0013576221,"about_ca_system_score_gemma":0.0005684564,"threshold_uncertainty_score":0.9998919},"labels":[],"label_agreement":null},{"id":"W4401600549","doi":"10.1016/j.atherosclerosis.2024.117991","title":"Novel caffeine derivatives mitigate hyperlipidemia by reducing PCSK9 expression and secretion","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"PCSK9; Hyperlipidemia; Caffeine; Secretion; Pharmacology; Medicine; Endocrinology; Chemistry; LDL receptor; Cholesterol; Lipoprotein; Diabetes mellitus","score_opus":0.02085898359752434,"score_gpt":0.2610192561684038,"score_spread":0.2401602725708795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401600549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843965,0.00732237,0.005794077,0.0011940381,0.00021136056,0.00038839979,0.000028483206,0.00019437428,0.0004703785],"genre_scores_gemma":[0.9942554,0.001311315,0.003012158,0.0004060867,0.00036179417,0.000060172737,0.0000442103,0.0000555866,0.00049323315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987111,0.000050074,0.00023894968,0.0004418002,0.0002947823,0.0002632956],"domain_scores_gemma":[0.999372,0.00005121614,0.000038853676,0.00031472495,0.000034796867,0.00018841309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043458957,0.0001832413,0.0003265736,0.000059876525,0.00012976276,0.0000619207,0.000045488632,0.0001340993,0.000058452424],"category_scores_gemma":[0.00006259001,0.00014310886,0.00014238527,0.000193588,0.000077447694,0.0001511617,0.00004794886,0.00022144357,0.00001543226],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016183465,0.000035084668,0.0006788139,0.0002875424,0.000073535244,0.0000017456036,0.0005537799,0.0000014815362,0.9742157,0.00010272971,0.0016474314,0.022385988],"study_design_scores_gemma":[0.0031440037,0.00063840614,0.055701718,0.006431421,0.00043842712,0.00019014056,0.000726001,0.0026922352,0.8418625,0.00013547509,0.08734173,0.0006979506],"about_ca_topic_score_codex":0.00038221528,"about_ca_topic_score_gemma":0.000002275907,"teacher_disagreement_score":0.1323532,"about_ca_system_score_codex":0.00007488908,"about_ca_system_score_gemma":0.000054106717,"threshold_uncertainty_score":0.583581},"labels":[],"label_agreement":null},{"id":"W4401601179","doi":"10.1016/j.atherosclerosis.2024.117909","title":"25-year comparison of coronary lesions anatomy and burden in two cohorts of French Canadians with familial hypercholesterolemia","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Familial hypercholesterolemia; Medicine; Coronary anatomy; Internal medicine; Cardiology; Coronary angiography; Cholesterol; Myocardial infarction","score_opus":0.01933587083277758,"score_gpt":0.2925495095478847,"score_spread":0.2732136387151071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401601179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968213,0.0017707179,0.000055375804,0.00023408086,0.000054548305,0.00043268647,0.000049802893,0.0000220341,0.00055944506],"genre_scores_gemma":[0.99888986,0.00025124347,0.0006193822,0.000053942214,0.000060280363,0.00002006245,0.000012112216,0.000028986848,0.00006409839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988521,0.000054061977,0.00030742562,0.00026253628,0.00031386883,0.00021002917],"domain_scores_gemma":[0.99939275,0.000037531394,0.000043878612,0.0003260871,0.00005061867,0.00014915787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024622562,0.00013296,0.0005271825,0.00013657965,0.0000280923,0.000008937525,0.000061724895,0.000071830116,0.00002507587],"category_scores_gemma":[0.0000095514615,0.00010560902,0.00008664366,0.00028404404,0.00013521762,0.000050055336,0.000029152174,0.00020994525,0.0000027178455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053003216,0.00009728281,0.9601039,0.00040634556,0.00019498097,0.000023943425,0.0024552154,0.000037774396,0.0073026596,0.00021163515,0.00019516292,0.028918097],"study_design_scores_gemma":[0.0016408633,0.0004778748,0.993117,0.0011634969,0.00017395044,0.00002530778,0.0010474956,0.000483599,0.0010821314,0.0000204547,0.00065308396,0.00011479571],"about_ca_topic_score_codex":0.07683154,"about_ca_topic_score_gemma":0.014854052,"teacher_disagreement_score":0.06197749,"about_ca_system_score_codex":0.00008066427,"about_ca_system_score_gemma":0.00024300847,"threshold_uncertainty_score":0.9293159},"labels":[],"label_agreement":null},{"id":"W4401601782","doi":"10.1016/j.atherosclerosis.2024.117785","title":"Is lipoprotein(a) a risk factor for atherosclerotic disease or not?","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Science North","funders":"","keywords":"Atherosclerotic cardiovascular disease; Risk factor; Lipoprotein(a); Medicine; Factor (programming language); Internal medicine; Cardiology; Disease; Lipoprotein; Cholesterol; Computer science","score_opus":0.05651432997617881,"score_gpt":0.3091101123256656,"score_spread":0.25259578234948676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401601782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97265214,0.0035293063,0.010766579,0.0038443797,0.00090750953,0.005038874,0.002195115,0.0008829215,0.00018318178],"genre_scores_gemma":[0.9868779,0.001742401,0.0023600676,0.0022625357,0.0011321986,0.0010034393,0.000020989026,0.00020690431,0.0043935557],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971841,0.000083270854,0.00045695924,0.00088707823,0.00071025325,0.0006783507],"domain_scores_gemma":[0.9978484,0.00015606047,0.00008452659,0.0011291069,0.00012900976,0.0006529004],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005255974,0.00041203166,0.0006265457,0.0001406934,0.0002720752,0.00018180111,0.00018508158,0.00019686384,0.001146231],"category_scores_gemma":[0.0002860527,0.0002896294,0.0011325768,0.00044316665,0.00009659274,0.00017749493,0.00006545415,0.00035101085,0.00037860867],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037574954,0.00075393624,0.008283184,0.005970432,0.002722087,0.00007273823,0.0036148215,0.000010465275,0.020135446,0.0009417969,0.007283045,0.9464545],"study_design_scores_gemma":[0.0070418166,0.0025228604,0.71972644,0.0036123192,0.0028573724,0.000043304877,0.00023249128,0.0058277436,0.021564903,0.00067604065,0.2344218,0.0014728712],"about_ca_topic_score_codex":0.0002784346,"about_ca_topic_score_gemma":0.000023918103,"teacher_disagreement_score":0.9449817,"about_ca_system_score_codex":0.00019762207,"about_ca_system_score_gemma":0.0004343497,"threshold_uncertainty_score":0.9999556},"labels":[],"label_agreement":null},{"id":"W4401602242","doi":"10.1016/j.atherosclerosis.2024.118492","title":"Plozasiran (ARO-APOC3), decreases APOC3 and triglycerides (TG) in patients with mixed dyslipidemia: MUIR final results","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Dyslipidemia; Medicine; Internal medicine; Endocrinology; Obesity","score_opus":0.020534481807793235,"score_gpt":0.24017108989521266,"score_spread":0.21963660808741942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401602242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99585676,0.0017009109,0.000051567375,0.0006515439,0.00019669723,0.0008846991,0.00007124564,0.00015470007,0.0004318503],"genre_scores_gemma":[0.997539,0.0004661027,0.0008909181,0.00037099243,0.00023847767,0.000096525204,0.00007604166,0.000073561816,0.0002483868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768394,0.00012524409,0.0004823798,0.0006670931,0.00057085353,0.0004704905],"domain_scores_gemma":[0.9988585,0.00014206597,0.00007037538,0.0005566322,0.00007943028,0.00029297362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066261727,0.00030820278,0.00061166,0.00018777927,0.00010431549,0.00007876784,0.00009102813,0.00018332046,0.00003268802],"category_scores_gemma":[0.00020650885,0.00022155562,0.0001842468,0.00050677836,0.00013094218,0.0001781256,0.00005353434,0.00035398293,0.00003769585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063869455,0.0014378686,0.6749245,0.001842915,0.0011313367,0.00011598709,0.002207184,0.00003133403,0.0014694792,0.0003559913,0.0048431377,0.3052533],"study_design_scores_gemma":[0.010053254,0.0013265797,0.9772905,0.0017908094,0.00026769226,0.000014734388,0.00015861886,0.00012635767,0.0010279163,0.000054007003,0.007559681,0.00032984524],"about_ca_topic_score_codex":0.0008226812,"about_ca_topic_score_gemma":0.00019778099,"teacher_disagreement_score":0.30492347,"about_ca_system_score_codex":0.00014585708,"about_ca_system_score_gemma":0.00016989569,"threshold_uncertainty_score":0.9034776},"labels":[],"label_agreement":null},{"id":"W4401602254","doi":"10.1016/j.atherosclerosis.2024.118490","title":"Efficacy of evinacumab by low-density lipoprotein receptor genotype and function in patients with homozygous familial hypercholesterolaemia: A subanalysis from the ELIPSE open-label extension study","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Genotype; LDL receptor; Open label; Medicine; Extension (predicate logic); Low-density lipoprotein; Internal medicine; Lipoprotein; Genetics; Biology; Cholesterol; Adverse effect; Computer science; Gene","score_opus":0.019183771794673288,"score_gpt":0.2513692066630655,"score_spread":0.23218543486839222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401602254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949348,0.0017796797,0.00010616959,0.0002008404,0.0001129655,0.0027540147,0.000058935846,0.000044869637,0.000007713755],"genre_scores_gemma":[0.9989404,0.00023950181,0.00017537273,0.00022701152,0.000104459104,0.0001119061,0.00009666618,0.000057763893,0.00004688215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976387,0.00029837943,0.00042566098,0.0006996902,0.0006714604,0.00026609123],"domain_scores_gemma":[0.99861544,0.00010518756,0.000097401724,0.00089608546,0.000164619,0.00012123861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082582753,0.00026645663,0.00067541824,0.00008171749,0.0001421744,0.00010811523,0.00018659532,0.00014360818,0.000023224853],"category_scores_gemma":[0.00008960559,0.00016494401,0.0001019783,0.000598756,0.00008894384,0.0001834772,0.00017510625,0.00039324243,0.000020291098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009900119,0.007973243,0.5852557,0.00027734798,0.0022190325,0.000020737494,0.0041334364,0.000008798963,0.03892453,0.0000064696032,0.0011201494,0.35016045],"study_design_scores_gemma":[0.011581643,0.002431183,0.98328394,0.0005800473,0.00085670064,0.0000013477216,0.00033562622,0.00007533611,0.00052266574,0.000006847794,0.0001439325,0.00018076056],"about_ca_topic_score_codex":0.012335145,"about_ca_topic_score_gemma":0.0008607237,"teacher_disagreement_score":0.39802822,"about_ca_system_score_codex":0.00015083699,"about_ca_system_score_gemma":0.000094117124,"threshold_uncertainty_score":0.9942418},"labels":[],"label_agreement":null},{"id":"W4401602274","doi":"10.1016/j.atherosclerosis.2024.118516","title":"Compassionate use of evinacumab for the treatment of homozygous familial hypercholesterolaemia (HoFH) in children under 5 years of age: Clinical experience","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Pediatrics; Internal medicine; Cholesterol","score_opus":0.10005168185282606,"score_gpt":0.36019502489997185,"score_spread":0.2601433430471458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401602274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645615,0.0018366419,0.00030937517,0.0001033141,0.00016189183,0.00104762,0.00006428651,0.000015449858,0.0000052621367],"genre_scores_gemma":[0.9955972,0.003460729,0.0005491136,0.000071311566,0.00009049145,0.00012122695,0.000012319625,0.000026690359,0.00007091703],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986257,0.000094101124,0.0005592217,0.0002538392,0.00029508292,0.00017203328],"domain_scores_gemma":[0.9989336,0.0003231547,0.00008691872,0.00054130226,0.000054301272,0.000060694954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036384538,0.00012212586,0.00056784356,0.000061854844,0.000023964767,0.000010246652,0.00010531979,0.00010800133,0.000009272778],"category_scores_gemma":[0.000052222877,0.00007850934,0.0005044208,0.000198894,0.00022113901,0.00005583791,0.000026395595,0.000102073864,0.0000018758312],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011052607,0.0032407283,0.37604043,0.00053193484,0.0017435846,0.000014357368,0.00744662,0.0002499187,0.020507667,0.00046142703,0.00030205754,0.588356],"study_design_scores_gemma":[0.0021756275,0.0011052556,0.9923541,0.0003795843,0.0002080569,0.000009173757,0.00020268011,0.00020830074,0.0019345477,0.00001702397,0.001337856,0.0000677866],"about_ca_topic_score_codex":0.0014085629,"about_ca_topic_score_gemma":0.00004788268,"teacher_disagreement_score":0.6163137,"about_ca_system_score_codex":0.000076341006,"about_ca_system_score_gemma":0.00010634805,"threshold_uncertainty_score":0.3201518},"labels":[],"label_agreement":null},{"id":"W4401626622","doi":"10.1016/j.cjco.2024.08.005","title":"Genetic Testing for Familial Hypercholesterolemia: The Current State of Its Implementation in Canada","year":2024,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Provincial Health Services Authority; University of Alberta; University of British Columbia","funders":"University of Alberta; National Lipid Association","keywords":"Familial hypercholesterolemia; Current (fluid); Genetic testing; State (computer science); Genetics; Medicine; Biology; Computer science; Engineering; Internal medicine; Cholesterol; Programming language; Electrical engineering","score_opus":0.04446467093174294,"score_gpt":0.35220245037055115,"score_spread":0.3077377794388082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401626622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930736,0.003927635,0.00013182135,0.00042433487,0.00024057555,0.0019858158,0.000055988043,0.0000043808654,0.0001558698],"genre_scores_gemma":[0.99912447,0.00009476511,0.0002925925,0.00014581748,0.000107821055,0.00018239123,0.000013200788,0.0000110518295,0.000027875894],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99931085,0.000033842567,0.00021306427,0.00013154866,0.00017148444,0.00013920212],"domain_scores_gemma":[0.99967414,0.00004882253,0.000025068754,0.0001603452,0.000053207303,0.000038400103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041739747,0.000054254448,0.00016873529,0.000022435011,0.00002771252,0.000023208397,0.00010296555,0.0000067923834,0.0000058465084],"category_scores_gemma":[0.000036518417,0.000036278518,0.00003329803,0.00012944979,0.0000063313814,0.000039447306,0.00005849507,0.00010008196,0.0000013695528],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001705364,0.0000061997353,0.0048696427,0.00041688184,0.000025718098,0.000009088068,0.00017551753,0.00003960022,0.0004948832,0.00000822402,0.00044907295,0.99348813],"study_design_scores_gemma":[0.0029800767,0.0003215111,0.9338753,0.00092119904,0.00016756348,0.000043124357,0.0005260687,0.003896875,0.0034496759,0.00028794096,0.053370025,0.00016064185],"about_ca_topic_score_codex":0.4943928,"about_ca_topic_score_gemma":0.6371032,"teacher_disagreement_score":0.9933275,"about_ca_system_score_codex":0.00021450549,"about_ca_system_score_gemma":0.001973189,"threshold_uncertainty_score":0.5089741},"labels":[],"label_agreement":null},{"id":"W4401686345","doi":"10.1093/ehjcvp/pvae058","title":"Management of dyslipidaemia in patients with comorbidities: facing the challenge","year":2024,"lang":"en","type":"review","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Medicine; Kidney disease; Ezetimibe; Intensive care medicine; Internal medicine; Dialysis; Diabetes mellitus; Dyslipidemia; PCSK9; Statin; Renal replacement therapy; Alirocumab; Clinical trial; Cholesterol; Disease; Endocrinology; Lipoprotein; LDL receptor","score_opus":0.05612760648022262,"score_gpt":0.340625694163217,"score_spread":0.28449808768299434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401686345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032442942,0.99281275,0.00008748406,0.00011348795,0.0007441641,0.0027162647,0.000027494701,0.00005315753,0.003120765],"genre_scores_gemma":[0.0009874521,0.99652123,0.00018231235,0.00017431636,0.0015313292,0.000054587967,0.000027532802,0.00034336135,0.00017787378],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99335235,0.0021207756,0.0013173514,0.0006566312,0.0019311062,0.000621786],"domain_scores_gemma":[0.99770325,0.000043522166,0.0003196919,0.0014335219,0.00022274781,0.00027729006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0052201003,0.00075190683,0.0033194283,0.00046380254,0.0001742666,0.000102943624,0.0004491541,0.00011478999,0.000096898046],"category_scores_gemma":[0.00000840567,0.00040630647,0.005545863,0.0007466912,0.00011853386,0.0001097639,0.00012456132,0.002191271,0.00010882264],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000809009,0.00017144658,0.000031292806,0.025828421,0.023902884,0.0018637992,0.00024957125,0.00002991229,1.7247447e-7,0.000014291808,0.0010726617,0.94675463],"study_design_scores_gemma":[0.003424954,0.00029654166,0.00040281695,0.035914935,0.009063077,0.0010463335,0.00006890875,0.0000016615538,0.00000161064,0.0000030883373,0.94938904,0.00038702926],"about_ca_topic_score_codex":0.000015639485,"about_ca_topic_score_gemma":3.850941e-7,"teacher_disagreement_score":0.9483164,"about_ca_system_score_codex":0.00036613416,"about_ca_system_score_gemma":0.00025554094,"threshold_uncertainty_score":0.9998389},"labels":[],"label_agreement":null},{"id":"W4401699428","doi":"10.1016/j.jacc.2024.05.058","title":"The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering","year":2024,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"Amgen","keywords":"Medicine; Lipoprotein(a); Pharmacology; Lipoprotein; Internal medicine; Traditional medicine; Cholesterol","score_opus":0.008407574914251844,"score_gpt":0.26624233711382095,"score_spread":0.2578347621995691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401699428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97948605,0.01362911,0.00024867963,0.0033487047,0.001319494,0.0006665072,0.000015631653,0.000009629083,0.0012762008],"genre_scores_gemma":[0.99502593,0.00355205,0.00011859035,0.00011688289,0.00092481606,0.000013568931,1.9641868e-7,0.000023119313,0.00022483067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983113,0.00032003317,0.00051691965,0.00013624069,0.00048759856,0.00022789987],"domain_scores_gemma":[0.99822366,0.00048941316,0.0004295549,0.00060096924,0.00016425671,0.00009213313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008314865,0.00015609682,0.0011083146,0.00012214354,0.00008033378,0.000004999095,0.00022288269,0.000049061546,0.0000016187702],"category_scores_gemma":[0.000254716,0.00007106117,0.001335309,0.0003811331,0.00040218382,0.000023025093,0.000050959043,0.00028524396,0.0000018085668],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059124203,0.00029834718,0.004845137,0.0016854218,0.017541863,0.004138183,0.00036610957,0.0012721036,0.041045822,0.002470442,0.008010202,0.91241395],"study_design_scores_gemma":[0.008246927,0.049391743,0.15973729,0.004836384,0.0051027597,0.017506199,0.0014948901,0.0001807292,0.20813853,0.0011847225,0.5436414,0.00053843914],"about_ca_topic_score_codex":0.00004997794,"about_ca_topic_score_gemma":0.0000052816276,"teacher_disagreement_score":0.9118755,"about_ca_system_score_codex":0.00019222019,"about_ca_system_score_gemma":0.00043616767,"threshold_uncertainty_score":0.28977904},"labels":[],"label_agreement":null},{"id":"W4401945048","doi":"10.1101/2024.08.27.24312680","title":"PCSK9 inhibition in myeloid cells enhances cardioprotection beyond its LDL cholesterol-lowering effects","year":2024,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"PCSK9; Cardioprotection; Ldl cholesterol; LDL receptor; Cholesterol; Chemistry; Internal medicine; Pharmacology; Medicine; Endocrinology; Lipoprotein; Ischemia","score_opus":0.010722004564930105,"score_gpt":0.25502893566871726,"score_spread":0.24430693110378715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401945048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794765,0.009454031,0.0005137357,0.0004619677,0.0038157625,0.002990383,0.000015720127,0.0002726766,0.0029991926],"genre_scores_gemma":[0.9951024,0.0010854413,0.00012520864,0.00021342299,0.0019660813,0.00088958937,0.000048459537,0.00011276976,0.0004565928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967001,0.00020701601,0.0006163023,0.001081825,0.0008669145,0.00052785577],"domain_scores_gemma":[0.9985586,0.000033306886,0.00015392042,0.0009167033,0.00011406845,0.00022340595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015487314,0.0005030791,0.0011018028,0.00051625835,0.00007555552,0.000102627724,0.00010596508,0.00063838175,0.000024518302],"category_scores_gemma":[0.00009085635,0.0004613529,0.00066301954,0.00041713746,0.000046322093,0.00008142867,0.00048533798,0.0021080815,0.0002633666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029984405,0.0003464713,0.0021348882,0.0554401,0.0012070477,0.0028327166,0.0019890778,0.0012971427,0.83478373,0.000055663204,0.0002477162,0.09936562],"study_design_scores_gemma":[0.0014060544,0.00029400236,0.018650826,0.007752611,0.0004446335,0.00022675638,0.000048445476,0.000277887,0.9669504,0.0006982886,0.0026798043,0.00057024974],"about_ca_topic_score_codex":0.0004656682,"about_ca_topic_score_gemma":0.00012926104,"teacher_disagreement_score":0.13216673,"about_ca_system_score_codex":0.0004481501,"about_ca_system_score_gemma":0.00026347136,"threshold_uncertainty_score":0.9997838},"labels":[],"label_agreement":null},{"id":"W4402024925","doi":"10.1177/03000605241271876","title":"Elderly patients with very high plasma lipoprotein(a) concentrations and few cardiovascular consequences: a case series","year":2024,"lang":"en","type":"article","venue":"Journal of International Medical Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Series (stratigraphy); Lipoprotein; Lipoprotein(a); Internal medicine; Plasma lipoprotein; Cardiology; Gerontology; Endocrinology; Cholesterol","score_opus":0.028008686250690834,"score_gpt":0.3354237188781287,"score_spread":0.30741503262743786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402024925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803275,0.006984442,0.00073672185,0.010186348,0.0005841557,0.00043282856,0.000021865875,0.000016797263,0.00070936355],"genre_scores_gemma":[0.99490595,0.0028061073,0.000929825,0.00010204628,0.0010305898,0.000023869086,0.000010702861,0.000019248499,0.00017166113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99402255,0.0002514016,0.0004544713,0.00023164472,0.0047563105,0.0002836323],"domain_scores_gemma":[0.99720937,0.0003091434,0.00005748269,0.00020668525,0.0016239439,0.00059336785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00330026,0.000120461205,0.000386832,0.0003499081,0.00013173663,0.00015203767,0.00015928179,0.00013457001,0.00035208356],"category_scores_gemma":[0.0020594401,0.000076281496,0.00024242555,0.000318434,0.00057467126,0.0003158116,0.000063922496,0.0011155866,0.00001125073],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028560904,0.00069013,0.0184692,0.0014416735,0.014966477,0.19649117,0.0010262919,0.00004341121,0.0001337371,0.016697595,0.0037779622,0.7434063],"study_design_scores_gemma":[0.01919948,0.01494923,0.023726612,0.0134260645,0.0012913917,0.41188997,0.002733,0.00138256,0.002768987,0.0029147083,0.50501573,0.0007022881],"about_ca_topic_score_codex":0.00059052336,"about_ca_topic_score_gemma":0.000074718075,"teacher_disagreement_score":0.742704,"about_ca_system_score_codex":0.00025213507,"about_ca_system_score_gemma":0.0019104461,"threshold_uncertainty_score":0.48467305},"labels":[],"label_agreement":null},{"id":"W4402122986","doi":"10.1016/j.jacc.2024.06.035","title":"Triglyceride Levels, Alirocumab Treatment, and Cardiovascular Outcomes After an Acute Coronary Syndrome","year":2024,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals","keywords":"Alirocumab; Medicine; Mace; Internal medicine; Triglyceride; Placebo; Acute coronary syndrome; PCSK9; Post-hoc analysis; Atorvastatin; Endocrinology; Gastroenterology; Cholesterol; Cardiology; Lipoprotein; Percutaneous coronary intervention; Myocardial infarction","score_opus":0.016748497127076163,"score_gpt":0.28261291374566,"score_spread":0.26586441661858384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402122986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98131514,0.015757564,0.00027054685,0.0013070682,0.00059372606,0.00040433355,0.00019740769,0.000017648552,0.00013657169],"genre_scores_gemma":[0.9959552,0.0025289592,0.00056104216,0.00025993233,0.00034153834,0.000018261559,0.0000014361037,0.000040062787,0.00029354892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979175,0.0004855372,0.0005673928,0.00027228356,0.00047210284,0.00028519644],"domain_scores_gemma":[0.9985175,0.00009150161,0.00022179434,0.0008113378,0.00014413476,0.00021374352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081328,0.00024817785,0.002227418,0.00021507136,0.00006203388,0.000010314645,0.00017741736,0.00008161512,0.0000119302085],"category_scores_gemma":[0.000046997673,0.00013689847,0.0022587944,0.00033928058,0.00044092472,0.00011978098,0.00007502376,0.00027627326,0.0000020741372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008314503,0.00036848136,0.5755626,0.0008324986,0.17868054,0.088472605,0.000602208,0.00060027937,0.0033245804,0.0004390656,0.0030602175,0.13974242],"study_design_scores_gemma":[0.0027375456,0.0052360664,0.8117263,0.00015830627,0.0064316895,0.13986911,0.00043946918,0.000022025759,0.00019292928,0.00014228647,0.03284519,0.0001991074],"about_ca_topic_score_codex":0.00006432456,"about_ca_topic_score_gemma":0.000003816589,"teacher_disagreement_score":0.23616366,"about_ca_system_score_codex":0.00018583916,"about_ca_system_score_gemma":0.0005144094,"threshold_uncertainty_score":0.55825573},"labels":[],"label_agreement":null},{"id":"W4402135000","doi":"10.1093/eurheartj/ehae614","title":"Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Canadian VIGOUR Centre; Alberta Hospital Edmonton; Health Sciences Centre; University Health Network; St. Michael's Hospital","funders":"American Regent; Genentech; U.S. Food and Drug Administration; Sanofi Australia; MicroPort; Idorsia Pharmaceuticals; Novo Nordisk; Akebia Therapeutics; Bristol-Myers Squibb; Cleveland Clinic; CryoLife; Janssen Scientific Affairs; AstraZeneca; Amarin Corporation; XBiotech; ReCor Medical; Intarcia Therapeutics; National Institutes of Health; Regeneron Pharmaceuticals; Boston Scientific Corporation; Daiichi Sankyo Europe; Servier; Gilead Sciences; Duke Clinical Research Institute; FibroGen; Esperion Therapeutics; Alnylam Pharmaceuticals; Kowa Company; Sanofi; HLS Therapeutics; Conselho Nacional de Desenvolvimento Científico e Tecnológico; GlaxoSmithKline; Amgen; York University; Moderna; Pfizer; CSL Behring; Jewish General Hospital; Bayer Corporation; Daiichi-Sankyo; AtriCure; Eli Lilly and Company","keywords":"Medicine; Myocardial infarction; Ldl cholesterol; Internal medicine; Apolipoprotein B; Cholesterol; Cardiology; Baseline (sea)","score_opus":0.047342478717684544,"score_gpt":0.31886668135499585,"score_spread":0.2715242026373113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402135000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97805375,0.003022086,0.0019231512,0.012755537,0.0017680103,0.0016512313,0.000015989035,0.00009643593,0.0007138396],"genre_scores_gemma":[0.99114317,0.0005884204,0.00061051094,0.0026183538,0.004560601,0.000037964815,0.000004276885,0.000088884575,0.00034783856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996212,0.0012273823,0.0006425499,0.00045397962,0.00095292885,0.0005111286],"domain_scores_gemma":[0.9985928,0.000093175324,0.00005157219,0.0007133032,0.00009893532,0.0004502362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008009381,0.00029158595,0.00075240416,0.00043948882,0.0005343558,0.00030453707,0.00015542546,0.000077567296,0.000036450554],"category_scores_gemma":[0.0004742386,0.00018726493,0.0009834577,0.00049831433,0.000059195747,0.00024230688,0.0002678959,0.0012640287,0.000080868944],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007282775,0.00049744826,0.03786519,0.00034776714,0.011787613,0.00436212,0.0067783357,0.0009974957,0.006890249,0.00016108672,0.013699854,0.90933007],"study_design_scores_gemma":[0.027735934,0.002035759,0.42049253,0.0010778005,0.0013535256,0.010422514,0.00093876664,0.00036340067,0.00017700267,0.000047750764,0.5348045,0.0005505118],"about_ca_topic_score_codex":0.00020873912,"about_ca_topic_score_gemma":0.000017849181,"teacher_disagreement_score":0.90877956,"about_ca_system_score_codex":0.00013722203,"about_ca_system_score_gemma":0.0002368381,"threshold_uncertainty_score":0.7636442},"labels":[],"label_agreement":null},{"id":"W4402145696","doi":"10.1016/j.jacc.2024.08.001","title":"ApoA-I Infusions and Burden of Ischemic Events After Acute Myocardial Infarction","year":2024,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University Health Network; Alberta Hospital Edmonton; Health Sciences Centre; St. Michael's Hospital; University of Alberta Hospital","funders":"CSL Behring","keywords":"Medicine; Myocardial infarction; Internal medicine; Placebo; Stroke (engine); Relative risk; Cardiology; Rate ratio; Confidence interval","score_opus":0.0066449528008632455,"score_gpt":0.26210162673137166,"score_spread":0.2554566739305084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402145696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927795,0.0028807044,0.0001864057,0.0026688431,0.00057760614,0.00021356271,0.00006101709,0.000004963092,0.00062740035],"genre_scores_gemma":[0.99629307,0.0021502338,0.00033631286,0.0001507813,0.00092832505,0.000005936205,6.8616595e-7,0.000014408638,0.00012023601],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987317,0.00020108298,0.00045599957,0.00011292834,0.00035384574,0.00014449283],"domain_scores_gemma":[0.9990485,0.00006872866,0.00030265556,0.00029071525,0.00019863115,0.00009079615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006042245,0.00010484282,0.0008982631,0.00017273823,0.00002823607,0.000002056684,0.000104611565,0.00006114967,0.000006966531],"category_scores_gemma":[0.000093202856,0.000064360676,0.00074876717,0.0003483247,0.00028894577,0.000048524198,0.00009890493,0.0003052046,9.116057e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015360272,0.00020035224,0.23218691,0.0021729374,0.062331624,0.0031438223,0.0019886126,0.0013740439,0.46523753,0.0005799498,0.09042323,0.12500073],"study_design_scores_gemma":[0.0039854585,0.0043430873,0.6607495,0.0012860225,0.006954713,0.034429546,0.0015446877,0.00016967733,0.0046580033,0.00046602468,0.28107437,0.0003388733],"about_ca_topic_score_codex":0.00004798387,"about_ca_topic_score_gemma":8.216682e-7,"teacher_disagreement_score":0.4605795,"about_ca_system_score_codex":0.000061166196,"about_ca_system_score_gemma":0.00035023288,"threshold_uncertainty_score":0.26245522},"labels":[],"label_agreement":null},{"id":"W4402236805","doi":"10.22541/au.172544148.87628271/v1","title":"Improvement in muscle function after 2 months of statin withdrawal is not influenced by treatment intensity in patients with statin-associated muscle symptoms","year":2024,"lang":"en","type":"preprint","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Université Laval","funders":"","keywords":"Statin; Medicine; Intensity (physics); Physical medicine and rehabilitation; Internal medicine; Cardiology; Physical therapy; Physics","score_opus":0.004934235020424031,"score_gpt":0.2233026717421903,"score_spread":0.21836843672176626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402236805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507374,0.00021644341,0.000052251547,0.00018460555,0.00020802206,0.0035874667,0.00045202608,0.00006272193,0.00016272253],"genre_scores_gemma":[0.9974988,0.000054410768,0.00021013951,0.00063873304,0.000029464505,0.0006869727,0.00051949813,0.000062582636,0.0002993968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677527,0.000084659616,0.0008820384,0.00085832324,0.0009426344,0.00045704917],"domain_scores_gemma":[0.998418,0.000020131252,0.00028064847,0.0007382683,0.0003772507,0.00016571519],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004386694,0.0004821881,0.0011466577,0.00029871086,0.000022970149,0.000029525445,0.00007849255,0.00031399136,0.00012200179],"category_scores_gemma":[0.00002808944,0.00034444645,0.0002513295,0.00033718033,0.00006079158,0.000058839516,0.0002483432,0.00063557626,0.000009180029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00861787,0.006172135,0.6865038,0.0026895662,0.0031182123,0.000115899136,0.010066943,0.00034669266,0.00097348914,0.000008960846,0.00055732444,0.28082907],"study_design_scores_gemma":[0.009039054,0.004500368,0.9819147,0.0012304449,0.00040708808,2.7792663e-7,0.000515338,0.00039414837,0.0014534104,0.00006270149,0.0001343536,0.00034814526],"about_ca_topic_score_codex":0.04374049,"about_ca_topic_score_gemma":0.0052290536,"teacher_disagreement_score":0.29541084,"about_ca_system_score_codex":0.0016770338,"about_ca_system_score_gemma":0.00050479337,"threshold_uncertainty_score":0.99990076},"labels":[],"label_agreement":null},{"id":"W4402280397","doi":"10.1016/j.jacl.2024.08.013","title":"Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; McGill University Health Centre","funders":"Genentech; Esperion Therapeutics; National Institutes of Health; HLS Therapeutics; Novo Nordisk; National Institute for Health and Care Research; Amarin Corporation; Ionis Pharmaceuticals; American Heart Association; Pharmavite; Amryt Pharma; U.S. Department of Veterans Affairs; Alnylam Pharmaceuticals; Gilead Sciences; Eli Lilly and Company; AstraZeneca; Pfizer; Amgen; Sanofi; Regeneron Pharmaceuticals","keywords":"Apolipoprotein B; Medicine; Dyslipidemia; Lipoprotein; Internal medicine; Population; Cholesterol; Endocrinology; Disease; Environmental health","score_opus":0.06827878713381341,"score_gpt":0.41151399817231343,"score_spread":0.3432352110385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402280397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774137,0.0128153125,0.00012487518,0.0050886553,0.0031527646,0.00084250665,0.00004381926,0.000009945676,0.00050840294],"genre_scores_gemma":[0.9649046,0.018202178,0.0025041974,0.001191095,0.013126957,0.000021519967,0.000010877267,0.000024363653,0.000014209523],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9838237,0.008157974,0.0055968068,0.00044078383,0.0016653923,0.00031529806],"domain_scores_gemma":[0.98907846,0.007973223,0.0015145646,0.0007074944,0.00055535446,0.00017091168],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.060396586,0.00019600753,0.0020877877,0.00015933765,0.00003655354,0.00001578849,0.0004905447,0.00065053283,0.000042692143],"category_scores_gemma":[0.00891422,0.000111375324,0.0027629393,0.00042294475,0.00034635243,0.00007839116,0.0000979781,0.0024113182,0.000009403211],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004260067,0.0027834133,0.48676136,0.00022354422,0.008314285,0.00014077533,0.0009203847,0.00019292312,0.000008308772,0.00086327037,0.005651567,0.4898801],"study_design_scores_gemma":[0.008168414,0.0022444827,0.8946531,0.0010452566,0.00093617005,0.000079411366,0.001624775,0.0007304174,0.000009631528,0.0023744507,0.08800574,0.00012816931],"about_ca_topic_score_codex":0.0010540914,"about_ca_topic_score_gemma":0.00021290666,"teacher_disagreement_score":0.48975194,"about_ca_system_score_codex":0.0001197831,"about_ca_system_score_gemma":0.0006886786,"threshold_uncertainty_score":0.99989015},"labels":[],"label_agreement":null},{"id":"W4402316898","doi":"10.1002/phar.4609","title":"Real‐world effectiveness of monoclonal antibody inhibitors of <scp>PCSK</scp>9 in patients with heterozygous familial hypercholesterolemia: A retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Richmond Hospital; Vancouver Coastal Health; Surrey Memorial Hospital; Fraser Health","funders":"","keywords":"PCSK9; Evolocumab; Familial hypercholesterolemia; Medicine; Ezetimibe; Internal medicine; Gastroenterology; Apolipoprotein B; Statin; Retrospective cohort study; Alirocumab; LDL receptor; Endocrinology; Lipoprotein; Tolerability; Cholesterol; Adverse effect; Apolipoprotein A1","score_opus":0.009131234260714891,"score_gpt":0.3193168435823711,"score_spread":0.31018560932165623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402316898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99201745,0.00494274,0.000016067705,0.00005782491,0.0005073185,0.0023268948,0.00001559934,0.000018685472,0.00009743598],"genre_scores_gemma":[0.99372864,0.005558441,0.000016228547,0.00017560831,0.00038786384,0.000035729336,0.0000048005177,0.000057419413,0.000035292738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962494,0.0015926529,0.0008255126,0.00029921706,0.00072219153,0.00031105135],"domain_scores_gemma":[0.99843585,0.0004366795,0.00041773941,0.00021708288,0.000356358,0.00013625695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042238194,0.00032254565,0.0011518314,0.0005427249,0.00011258478,0.000014590106,0.0002172558,0.00007549683,0.000032421347],"category_scores_gemma":[0.00000784337,0.00019349469,0.00025956088,0.00049593835,0.0003181454,0.00019382256,0.000032577005,0.0009235287,4.6130538e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058987504,0.0019420703,0.7722383,0.00022712443,0.0028301997,0.00008958192,0.003336569,0.000046996152,0.21114375,0.0000075349694,0.00014918736,0.0020899414],"study_design_scores_gemma":[0.021501832,0.0050855107,0.8961651,0.0003352881,0.0006445911,0.000057021996,0.00025529822,0.000022264743,0.07558111,0.00007722858,0.00018039207,0.00009437754],"about_ca_topic_score_codex":0.0003568641,"about_ca_topic_score_gemma":0.000022380582,"teacher_disagreement_score":0.13556263,"about_ca_system_score_codex":0.00017111047,"about_ca_system_score_gemma":0.0001878057,"threshold_uncertainty_score":0.78904843},"labels":[],"label_agreement":null},{"id":"W4402383749","doi":"10.20944/preprints202409.0522.v1","title":"Clinical Expression of Familial Hypercholesterolemia in Patients from France and French Canada Carrying Identical by Descent Pathogenic LDLR Gene Variants: a Proof-of-Concept Study","year":2024,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; LDL receptor; Gene; Genetics; Expression (computer science); Medicine; Biology; Internal medicine; Cholesterol; Lipoprotein; Computer science","score_opus":0.04974241041722643,"score_gpt":0.33096862699827495,"score_spread":0.2812262165810485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402383749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926815,0.002714586,0.00009771703,0.0000410715,0.0010039392,0.0030279288,0.00037561925,0.000023268707,0.00003436941],"genre_scores_gemma":[0.9989117,0.000119039636,0.00026242388,0.00006638806,0.00024286218,0.00017860506,0.0001298082,0.00005666238,0.00003250628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99438375,0.0006337366,0.0019017181,0.0014691004,0.0012201079,0.00039160775],"domain_scores_gemma":[0.99734503,0.000090493,0.00040997606,0.0015998182,0.0002343922,0.00032031426],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00147363,0.00042060338,0.0015821265,0.00010948136,0.000038712904,0.000011192845,0.00035538734,0.0004795457,0.000051116185],"category_scores_gemma":[0.0004775699,0.00038152531,0.00032433722,0.00015662672,0.00012714467,0.0000416036,0.0020455346,0.0017067262,0.0000040765794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017099715,0.0011985262,0.9837587,0.0007916887,0.0003602959,0.00007874375,0.0011913802,0.000026868347,0.0046072695,3.5202518e-7,0.000025937525,0.007789266],"study_design_scores_gemma":[0.0035691906,0.00018603406,0.97152734,0.0020337035,0.00042210604,0.0000032144578,0.00018614056,0.000075169686,0.021621104,0.0000651909,0.000043777218,0.00026702392],"about_ca_topic_score_codex":0.27536044,"about_ca_topic_score_gemma":0.012357577,"teacher_disagreement_score":0.26300284,"about_ca_system_score_codex":0.0002998711,"about_ca_system_score_gemma":0.0013113696,"threshold_uncertainty_score":0.9998637},"labels":[],"label_agreement":null},{"id":"W4402392922","doi":"10.4081/monaldi.2024.2972","title":"Lipid-lowering therapy in patients with coronary heart disease: an Italian real-life survey. Results from the Survey on Risk FactOrs and CardiovascuLar secondary prEvention and drug strategieS (SOFOCLES) in Italy","year":2024,"lang":"en","type":"article","venue":"Monaldi Archives for Chest Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cargill (Canada)","funders":"Sanofi","keywords":"Medicine; Rosuvastatin; Ezetimibe; Atorvastatin; Internal medicine; Population; Diabetes mellitus; Observational study; Statin; Cardiology; Lipid profile; Cholesterol; Endocrinology","score_opus":0.019568807089700914,"score_gpt":0.25679795635547703,"score_spread":0.23722914926577612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402392922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854392,0.0063426546,0.000064707296,0.00014035235,0.00007092498,0.001835905,0.0060499758,0.000044092354,0.000012231192],"genre_scores_gemma":[0.9934639,0.0014193119,0.000043692322,0.000064633496,0.00009953128,0.00011145115,0.0047220266,0.000059230173,0.000016246395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730027,0.0008087569,0.0003504996,0.0007723791,0.0004465857,0.00032153336],"domain_scores_gemma":[0.99808973,0.000628813,0.00004694448,0.0006630696,0.000028969385,0.00054244883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011869895,0.000310818,0.00048440028,0.00012670482,0.00014061113,0.0001214184,0.00009596488,0.000040330473,0.0000031865286],"category_scores_gemma":[0.0002050358,0.0002036009,0.0002545594,0.0001682884,0.00017080911,0.00028075455,0.000047559493,0.0002953939,4.7146614e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010585814,0.00033848424,0.96753716,0.00021872607,0.00045285487,0.000039426566,0.0010623864,0.00026941518,0.0000030786457,0.000007791933,0.000028403289,0.019456428],"study_design_scores_gemma":[0.004344708,0.0005169824,0.9932275,0.00043212256,0.00015214393,3.914057e-7,0.0003156492,0.00032279154,0.000004605883,0.00025825432,0.00018628081,0.00023857555],"about_ca_topic_score_codex":0.011992805,"about_ca_topic_score_gemma":0.0029921418,"teacher_disagreement_score":0.025690302,"about_ca_system_score_codex":0.000036487017,"about_ca_system_score_gemma":0.00048587174,"threshold_uncertainty_score":0.9945864},"labels":[],"label_agreement":null},{"id":"W4402393922","doi":"10.1093/eurjpc/zwae286","title":"Cardiovascular risk estimation: can a risk prediction model derived in one country be used in another?","year":2024,"lang":"en","type":"letter","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Medicine; Estimation; Risk model; Econometrics; Risk analysis (engineering)","score_opus":0.025708860119792076,"score_gpt":0.2472773020663412,"score_spread":0.22156844194654912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402393922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40179923,0.14917226,0.29697722,0.12230636,0.0073204357,0.008397733,0.0035892406,0.0003057191,0.0101318],"genre_scores_gemma":[0.85155296,0.0394692,0.009552277,0.07033462,0.026100866,0.00013501324,0.00097637286,0.0009382484,0.0009404334],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9890505,0.0069023254,0.0016324105,0.0007079831,0.0011101738,0.0005965999],"domain_scores_gemma":[0.99755806,0.00012717982,0.0008684441,0.00095111516,0.00035810767,0.0001370707],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00874558,0.0005264225,0.0026478493,0.00093808206,0.00006864749,0.000038328028,0.00031519457,0.000517561,0.000017407709],"category_scores_gemma":[0.0005814163,0.00047007858,0.0022861378,0.00046561076,0.00017605661,0.00011407709,0.00012430103,0.0058570267,0.000019738509],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014573039,0.00037938362,0.023101412,0.004596819,0.055754676,0.13163398,0.005326449,0.31697717,0.00031483773,0.0000162687,0.36724335,0.09319834],"study_design_scores_gemma":[0.02690789,0.0037923849,0.19129552,0.011363424,0.026320271,0.012581236,0.0005383704,0.015995136,0.00014589295,0.0012794344,0.7077035,0.0020769692],"about_ca_topic_score_codex":0.000194472,"about_ca_topic_score_gemma":0.000032936776,"teacher_disagreement_score":0.44975373,"about_ca_system_score_codex":0.0007601841,"about_ca_system_score_gemma":0.00076505303,"threshold_uncertainty_score":0.9997751},"labels":[],"label_agreement":null},{"id":"W4402574457","doi":"10.1080/14656566.2024.2406270","title":"Expanding therapeutic options: overview of novel pharmacotherapies for dyslipidemia","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Dyslipidemia; Intensive care medicine; Pharmacology; Internal medicine; Disease","score_opus":0.27724691296550846,"score_gpt":0.5227339994316352,"score_spread":0.24548708646612677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402574457","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000010773964,0.9876484,0.0020493707,0.0005010086,0.0037310184,0.005407215,0.00026956658,0.00022401613,0.00016830317],"genre_scores_gemma":[0.0000034105374,0.9870427,0.0016935399,0.0029271669,0.004471845,0.0028184608,0.00022942148,0.00039337834,0.00042002913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961598,0.00023880751,0.001356717,0.00093145116,0.0007423974,0.00057084026],"domain_scores_gemma":[0.99797577,0.0002738639,0.00049647584,0.0008493834,0.00014283559,0.00026170237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011032769,0.0009321112,0.0033247417,0.0006140929,0.00013731743,0.000050134862,0.00034565077,0.0004223373,0.0003745595],"category_scores_gemma":[0.000018669407,0.0006464611,0.0033558272,0.0006221929,0.000095371695,0.00010026393,0.00003618855,0.0006785831,0.00004153733],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000197349,0.0004818241,1.07486045e-7,0.030559568,0.0037233992,0.0000026160928,0.00024725706,0.0000011969577,0.00074465293,0.0017162954,0.014304739,0.948021],"study_design_scores_gemma":[0.0038300643,0.00048804234,1.7667985e-7,0.032715056,0.0006652024,0.00007356626,0.00003398778,0.00008271637,0.0006724531,0.000044061555,0.9608496,0.0005451027],"about_ca_topic_score_codex":0.000019281979,"about_ca_topic_score_gemma":1.7247528e-7,"teacher_disagreement_score":0.9474759,"about_ca_system_score_codex":0.00035349448,"about_ca_system_score_gemma":0.00064231496,"threshold_uncertainty_score":0.9995987},"labels":[],"label_agreement":null},{"id":"W4402636542","doi":"10.1101/2024.09.16.24313777","title":"Statin uses and skeletal muscle-related phenotypes: insights from epidemiological and Mendelian randomization analyses","year":2024,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Mendelian randomization; Mendelian inheritance; Phenotype; Epidemiology; Genetics; Statin; Biology; Computational biology; Bioinformatics; Medicine; Evolutionary biology; Internal medicine; Gene; Genetic variants; Genotype","score_opus":0.0457792940112316,"score_gpt":0.3283628221758904,"score_spread":0.2825835281646588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402636542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942735,0.053440984,0.001087022,0.0007465481,0.0003558009,0.0009752543,0.000069349335,0.00015156527,0.00043844437],"genre_scores_gemma":[0.9889529,0.0077397414,0.0019496933,0.0003418956,0.00039199946,0.000076964854,0.000405881,0.00004547769,0.00009548675],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972668,0.0006040772,0.0006754166,0.00085882697,0.000361265,0.00023357273],"domain_scores_gemma":[0.9986852,0.0003067666,0.0001737434,0.0005163087,0.000091956004,0.00022601687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008175529,0.00037314705,0.0013268687,0.00021701101,0.000082954226,0.00005990215,0.000075734504,0.00041999787,0.00006869717],"category_scores_gemma":[0.0007316583,0.00024401337,0.00031198762,0.00018823754,0.00015698616,0.00003463682,0.00038122278,0.00085996406,0.000015713373],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047708754,0.0016361276,0.096378975,0.023191938,0.045110285,0.004471074,0.0239469,0.0031773483,0.038953207,0.010750809,0.0057803607,0.7418321],"study_design_scores_gemma":[0.031512056,0.0010006728,0.7286827,0.006133296,0.014368579,0.00018479183,0.0015861004,0.050408635,0.0015760211,0.13698985,0.024921658,0.0026356461],"about_ca_topic_score_codex":0.0017410918,"about_ca_topic_score_gemma":0.00007854059,"teacher_disagreement_score":0.7391965,"about_ca_system_score_codex":0.00005034643,"about_ca_system_score_gemma":0.00016609146,"threshold_uncertainty_score":0.99505764},"labels":[],"label_agreement":null},{"id":"W4402674819","doi":"10.1007/s40256-024-00682-0","title":"Efficacy of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients with Heterozygous Familial Hypercholesterolemia: A Meta-analysis","year":2024,"lang":"en","type":"review","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surrey Place Centre; University of British Columbia; University of British Columbia Hospital; St. Paul's Hospital","funders":"","keywords":"Kexin; Proprotein convertase; Medicine; Subtilisin; Familial hypercholesterolemia; Meta-analysis; PCSK9; Pharmacotherapy; Pharmacology; Internal medicine; Oncology; Cholesterol; LDL receptor; Lipoprotein; Enzyme; Biochemistry","score_opus":0.026719737743964984,"score_gpt":0.29411280833595066,"score_spread":0.2673930705919857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402674819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033921096,0.9631618,0.00006699328,0.000026698708,0.00021960007,0.0024721324,0.00007230785,0.000021856229,0.000037489364],"genre_scores_gemma":[0.073256254,0.92518145,0.00057008705,0.00006303052,0.00046844242,0.00008600114,0.00010947207,0.00023086881,0.000034412642],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9909145,0.0015601318,0.0026976198,0.00088099943,0.0033306475,0.00061610655],"domain_scores_gemma":[0.99469316,0.00013761743,0.0016209015,0.0020580254,0.0009993744,0.0004909049],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0033069085,0.0010072768,0.017153746,0.0021121318,0.000042148862,0.00005303288,0.00047746827,0.00032468553,0.00002110508],"category_scores_gemma":[0.00020848404,0.00059359544,0.027156014,0.003923651,0.0004624827,0.00014916391,0.00013240808,0.0018819598,0.000016770851],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045977806,0.00028951193,0.00010715633,0.005424594,0.46721298,0.0004956893,0.00021050307,0.000113267495,1.041529e-7,6.248683e-7,0.000023447563,0.52566236],"study_design_scores_gemma":[0.0031932616,0.0022309618,0.00038122947,0.003569138,0.8044482,0.00036528034,0.00012315827,0.0000017385784,0.000006864539,0.0000010097392,0.1851612,0.0005179911],"about_ca_topic_score_codex":0.00076616765,"about_ca_topic_score_gemma":0.00001095238,"teacher_disagreement_score":0.52514434,"about_ca_system_score_codex":0.00048443556,"about_ca_system_score_gemma":0.0016425905,"threshold_uncertainty_score":0.99965155},"labels":[],"label_agreement":null},{"id":"W4402682380","doi":"10.1042/bcj20240037","title":"Lipoprotein(a) and cardiovascular disease","year":2024,"lang":"en","type":"review","venue":"Biochemical Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Lipoprotein(a); Lipoprotein; Apolipoprotein B; Disease; Plasma lipoprotein; Atherosclerotic cardiovascular disease; Medicine; Catabolism; Internal medicine; Lipoprotein particle; Endocrinology; Biology; Bioinformatics; Cholesterol; Very low-density lipoprotein; Metabolism","score_opus":0.0397109313235692,"score_gpt":0.3222192728203939,"score_spread":0.28250834149682474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402682380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028394503,0.99807054,0.00006179971,0.00012402568,0.0004227235,0.0009203584,0.00002922334,0.00006566981,0.0002772462],"genre_scores_gemma":[0.00002910873,0.9939422,0.0003574231,0.00007169379,0.005061311,0.00007420743,0.000041650022,0.00011705149,0.00030534258],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971589,0.00013978711,0.00064415555,0.00062184513,0.0010020792,0.00043325155],"domain_scores_gemma":[0.99754995,0.000017817061,0.0001017436,0.0008882933,0.000089844056,0.0013523734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00093473785,0.000508847,0.002448147,0.00022137669,0.00010082521,0.00015152224,0.00015584413,0.00042214702,0.000053285054],"category_scores_gemma":[0.00017327708,0.00032047287,0.004588448,0.00028164696,0.00010981111,0.000038807422,0.00016761133,0.0016912143,0.00013452432],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000140967,0.00003173953,3.7187937e-7,0.03909343,0.0043770396,0.0018049991,0.000004609204,1.9005071e-8,0.00000121007,0.000023792169,0.0054566595,0.94919205],"study_design_scores_gemma":[0.00031843974,0.000053417127,0.0000023114105,0.028083943,0.022999328,0.012710478,0.000004394094,0.0000016743792,0.0000034813136,0.00008009083,0.9354383,0.0003041571],"about_ca_topic_score_codex":0.000011244136,"about_ca_topic_score_gemma":4.0388507e-8,"teacher_disagreement_score":0.9488879,"about_ca_system_score_codex":0.00017626911,"about_ca_system_score_gemma":0.0010530786,"threshold_uncertainty_score":0.9999247},"labels":[],"label_agreement":null},{"id":"W4402733242","doi":"10.1016/j.jacc.2024.07.033","title":"Are Triglyceride-Rich Lipoprotein ApoB Particles Really 4 Times More Atherogenic Than LDL ApoB Particles?","year":2024,"lang":"en","type":"editorial","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Apolipoprotein B; Triglyceride; Lipoprotein(a); Lipoprotein; Internal medicine; Cholesterol","score_opus":0.01198981165611974,"score_gpt":0.2788954846815512,"score_spread":0.26690567302543144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402733242","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6718102,0.021521693,0.00010249037,0.006911475,0.29616633,0.0018137918,0.00094805425,0.000075657736,0.0006503256],"genre_scores_gemma":[0.43674004,0.0040771463,0.0006846437,0.00031134044,0.55653054,0.000077754536,0.000013466895,0.00021492172,0.0013501465],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938285,0.0011246774,0.0016889516,0.0005494385,0.0020671636,0.00074128923],"domain_scores_gemma":[0.9929895,0.0005256864,0.0034367524,0.0015354713,0.0011160371,0.00039657514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00266172,0.0005848772,0.0041136025,0.0003375536,0.00013675189,0.000026468259,0.00085125724,0.00055106706,0.000020241276],"category_scores_gemma":[0.0021395383,0.00036572645,0.0031934946,0.0010175812,0.00094760145,0.00007445722,0.00031562327,0.002012584,0.000022789682],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002941525,0.0000994649,0.0013619064,0.0007542317,0.0072181188,0.0020889651,0.0000966237,0.00020383215,0.00087749935,0.00004195238,0.9798149,0.0045010066],"study_design_scores_gemma":[0.0037769536,0.0035584418,0.005513412,0.0019280444,0.0064037903,0.004125669,0.0016525337,0.000047612102,0.0024630204,0.0007594563,0.96914905,0.000622008],"about_ca_topic_score_codex":0.00020750471,"about_ca_topic_score_gemma":0.0000446669,"teacher_disagreement_score":0.2603642,"about_ca_system_score_codex":0.000446517,"about_ca_system_score_gemma":0.0025021557,"threshold_uncertainty_score":0.9998795},"labels":[],"label_agreement":null},{"id":"W4402810661","doi":"10.3389/fneur.2024.1436010","title":"Cognitive function in dyslipidemia patients: exploring the impact of statins","year":2024,"lang":"en","type":"article","venue":"Frontiers in Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Cognition; Dyslipidemia; Medicine; Montreal Cognitive Assessment; Statin; Effects of sleep deprivation on cognitive performance; Cohort; Cognitive decline; Dementia; Gerontology; Physical therapy; Psychology; Internal medicine; Psychiatry; Cognitive impairment; Disease","score_opus":0.021319487417731903,"score_gpt":0.28266240310960045,"score_spread":0.2613429156918685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402810661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449986,0.0013361985,0.0016413381,0.0002584448,0.0014297072,0.00048541246,0.000010641361,0.000019396943,0.00031897513],"genre_scores_gemma":[0.99920917,0.00019544613,0.000051816332,0.00028955657,0.00012667704,0.000082928906,0.000015226881,0.000016311616,0.0000128521415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989869,0.00020619702,0.00024636468,0.00020709838,0.00013992036,0.00021354246],"domain_scores_gemma":[0.99964994,0.00008202856,0.000031827356,0.00016058204,0.000037202557,0.0000383981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003983836,0.00008962554,0.00028648492,0.00023584833,0.00001559338,0.000004059482,0.000040509003,0.00006298592,0.000014458138],"category_scores_gemma":[0.00018654378,0.000058481153,0.00014170958,0.00035534974,0.000060936003,0.000075183794,0.000022593058,0.00042524538,0.0000033911847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012310543,0.00011965214,0.82877684,0.00014947641,0.00021607953,0.000082566585,0.0011139776,0.00022468693,0.000028803004,0.000045876146,0.0029555073,0.16505545],"study_design_scores_gemma":[0.0013172503,0.0014059294,0.99414223,0.0000836879,0.000058330603,0.0000076078504,0.0001971505,0.001566853,0.000032445878,0.0003272125,0.0008117217,0.000049581617],"about_ca_topic_score_codex":0.00043325117,"about_ca_topic_score_gemma":0.00003397283,"teacher_disagreement_score":0.16536537,"about_ca_system_score_codex":0.000059511935,"about_ca_system_score_gemma":0.00010830036,"threshold_uncertainty_score":0.23847923},"labels":[],"label_agreement":null},{"id":"W4402862462","doi":"10.3390/jcm13195725","title":"Clinical Expression of Familial Hypercholesterolemia in Patients from France and French Canada Carrying Identical-by-Descent Pathogenic LDLR Gene Variants: A Proof-of-Concept Study","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Familial hypercholesterolemia; LDL receptor; Medicine; Apolipoprotein B; Population; Gene; Genotype; Internal medicine; Cholesterol; Founder effect; Gastroenterology; Genetics; Endocrinology; Lipoprotein; Biology; Haplotype","score_opus":0.030093833460787266,"score_gpt":0.35609335734753506,"score_spread":0.3259995238867478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402862462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856037,0.010272507,0.0006548275,0.0005482673,0.0021488476,0.00070991856,0.00003918066,0.000004737039,0.000018016153],"genre_scores_gemma":[0.9968648,0.0006191738,0.00049934076,0.00036333638,0.0015986732,0.0000048961742,0.000009899688,0.00002501732,0.0000148919335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99245965,0.0007511557,0.004534713,0.0004209069,0.0015762608,0.0002573195],"domain_scores_gemma":[0.9969248,0.0009275216,0.0007943237,0.00044366167,0.00040097782,0.000508685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048856703,0.00021591916,0.002126903,0.00012056956,0.000025275822,0.000007073306,0.00019706004,0.0002325466,0.00004089878],"category_scores_gemma":[0.0034418432,0.00013930553,0.00032864627,0.00025318254,0.00023871013,0.000099967176,0.00008972648,0.0012695617,2.866964e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006132686,0.0013788505,0.8364239,0.00030092886,0.00038427935,0.00041886052,0.00048676753,0.000003295461,0.0010034147,6.317857e-7,0.0009553466,0.15803047],"study_design_scores_gemma":[0.014127396,0.00534276,0.97345454,0.0046988856,0.00064572424,0.000027470454,0.0003355087,0.000094836956,0.00059252157,0.00004057597,0.0005260937,0.000113668575],"about_ca_topic_score_codex":0.024642676,"about_ca_topic_score_gemma":0.002218215,"teacher_disagreement_score":0.1579168,"about_ca_system_score_codex":0.0000867445,"about_ca_system_score_gemma":0.0010824457,"threshold_uncertainty_score":0.9818523},"labels":[],"label_agreement":null},{"id":"W4403048080","doi":"10.1016/j.athplu.2024.08.002","title":"Using cardiovascular and imaging biomarkers to identify patients with familial hypercholesterolaemia","year":2024,"lang":"en","type":"article","venue":"Atherosclerosis Plus","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.027722401070241345,"score_gpt":0.2871142390337179,"score_spread":0.2593918379634766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403048080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045306,0.0036974587,0.0041213892,0.00019010276,0.00031503834,0.000905734,0.000019682144,0.00014393443,0.00015359263],"genre_scores_gemma":[0.9965586,0.00012297423,0.0022878984,0.00063270994,0.00023212023,0.00003730207,0.000013516949,0.00008827524,0.000026571388],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980062,0.00007235436,0.00022627549,0.00060614716,0.00069768843,0.00039128622],"domain_scores_gemma":[0.9989463,0.000017615279,0.000020657277,0.0006092109,0.00009887804,0.0003073467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005182742,0.00024417098,0.00046803747,0.00016302243,0.0001382463,0.00016427918,0.000077463395,0.000076570155,0.000009631084],"category_scores_gemma":[0.00002571446,0.00018860743,0.00032532855,0.00038347568,0.00007419207,0.00019403745,0.00009072853,0.00018784206,0.000030043198],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000718796,0.0002495382,0.45022574,0.0022350638,0.0085318,0.0002449302,0.0037053924,0.00038043773,0.051406007,0.00006464285,0.0010698802,0.48116776],"study_design_scores_gemma":[0.0036737712,0.0002213514,0.9806733,0.001478995,0.0012940073,0.0001070246,0.00023744834,0.0012626888,0.00067351415,0.000008431073,0.009934751,0.00043468078],"about_ca_topic_score_codex":0.0008855213,"about_ca_topic_score_gemma":0.000010683813,"teacher_disagreement_score":0.5304476,"about_ca_system_score_codex":0.00028231167,"about_ca_system_score_gemma":0.00013611332,"threshold_uncertainty_score":0.7691188},"labels":[],"label_agreement":null},{"id":"W4403075695","doi":"10.53738/revmed.2024.20.889.1772","title":"Symptômes musculaires associés aux statines : performances et qualité de vie","year":2024,"lang":"fr","type":"article","venue":"Revue Médicale Suisse","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; Centre hospitalier de l'Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine","score_opus":0.028256185849007243,"score_gpt":0.3495882008970388,"score_spread":0.32133201504803155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403075695","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24124904,0.7083975,0.0007570879,0.039101105,0.0034976911,0.00066842034,0.00011642954,0.000304695,0.00590805],"genre_scores_gemma":[0.7005267,0.14470863,0.0019490686,0.0037658724,0.0124915205,0.00024133649,0.00016245338,0.00023806914,0.13591632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958745,0.00068219827,0.0007611849,0.0006960173,0.00080702687,0.0011790282],"domain_scores_gemma":[0.99776065,0.0004463124,0.000100000754,0.00079978566,0.00015383525,0.00073938514],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003846494,0.0004385196,0.0009204561,0.000187621,0.00023940614,0.00021489858,0.00024487142,0.00042814322,0.001140511],"category_scores_gemma":[0.0007571843,0.0003870193,0.0008900486,0.00061550085,0.00029874832,0.00031268143,0.00011854205,0.0009671235,0.00073576736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059056118,0.00037659958,0.007404801,0.022262095,0.0013191146,0.0017854766,0.00601102,0.00008043732,0.0002401826,0.022947343,0.01909928,0.9184146],"study_design_scores_gemma":[0.0009110148,0.00045881124,0.019117111,0.011573732,0.0009109378,0.0007633163,0.0017715875,0.0062558046,0.00035710612,0.0013111354,0.9560316,0.0005378015],"about_ca_topic_score_codex":0.0023045249,"about_ca_topic_score_gemma":0.00023360799,"teacher_disagreement_score":0.9369324,"about_ca_system_score_codex":0.00047723728,"about_ca_system_score_gemma":0.0024135318,"threshold_uncertainty_score":0.9998582},"labels":[],"label_agreement":null},{"id":"W4403115981","doi":"10.1016/s2213-8587(24)00221-3","title":"Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Key Research and Development Program of China; Fundação para a Ciência e a Tecnologia; Esperion Therapeutics; Silence Therapeutics; Servier; Health Systems Research Institute; National Natural Science Foundation of China; HLS Therapeutics; Imperial College London; Amryt Pharma; Ultragenyx Pharmaceutical; Medpace; Alexion Pharmaceuticals; Javna Agencija za Raziskovalno Dejavnost RS; AstraZeneca; Amarin Corporation; Novo Nordisk; Abbott Laboratories; National Institute for Health and Care Research; Medical Research Council; Teva Pharmaceutical Industries; Sanofi; European Atherosclerosis Society; Bayer Vital; Bristol-Myers Squibb; Eli Lilly and Company; Amgen; Pfizer; Chulalongkorn University; Universidad de Sevilla; Kowa Company; Regeneron Pharmaceuticals","keywords":"Medicine; Cross-sectional study; Type 2 diabetes; Diabetes mellitus; Medication adherence; Body mass index; Internal medicine; Pediatrics; Environmental health; Endocrinology; Pathology","score_opus":0.013872151055652185,"score_gpt":0.27606482593131165,"score_spread":0.26219267487565945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403115981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964905,0.0019902606,0.0000046792634,0.00049669767,0.00016019707,0.0007199349,0.000019751362,0.000046956186,0.000071017246],"genre_scores_gemma":[0.9988812,0.00043507316,0.00007317182,0.00011881586,0.0002707011,0.000114343246,0.000010582607,0.00002027832,0.00007583883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829966,0.00015035148,0.0003455527,0.00031842067,0.00039444145,0.0004915728],"domain_scores_gemma":[0.99909276,0.00022650542,0.0001199632,0.00038640728,0.00012837294,0.000045989425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085918384,0.00014324993,0.0005545552,0.00012695309,0.0000389549,0.000017150525,0.00013184705,0.00006803007,0.000010237401],"category_scores_gemma":[0.00014050143,0.000088895715,0.00004509813,0.0002885636,0.00018496913,0.00007872525,0.00006146586,0.00036986507,0.0000012781528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028839638,0.000103527236,0.99365616,0.0013356522,0.0004122583,0.000024868968,0.00057322124,0.000024643308,0.000882243,0.000020755724,0.00001584733,0.0026624426],"study_design_scores_gemma":[0.0024745301,0.0012645161,0.9940815,0.00047790087,0.00016441949,0.000020588433,0.00007951365,0.00009144793,0.001100077,0.00002503054,0.00013848691,0.00008198189],"about_ca_topic_score_codex":0.00012821771,"about_ca_topic_score_gemma":0.00029515754,"teacher_disagreement_score":0.0025804609,"about_ca_system_score_codex":0.00009006789,"about_ca_system_score_gemma":0.00008975294,"threshold_uncertainty_score":0.3625062},"labels":[],"label_agreement":null},{"id":"W4403122104","doi":"10.1016/j.ajpc.2024.100801","title":"LONG-TERM EFFICACY OF EVINACUMAB IN PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM SUBGROUP ANALYSES","year":2024,"lang":"en","type":"article","venue":"American Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Familial hypercholesterolemia; Term (time); Medicine; Subgroup analysis; Internal medicine; Pediatrics; Oncology; Physics; Cholesterol; Meta-analysis","score_opus":0.01630444322117124,"score_gpt":0.30889945503973826,"score_spread":0.292595011818567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403122104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995081,0.002530416,0.001485444,0.0000871126,0.000256348,0.00034845926,0.00008475484,0.000010458789,0.00011601082],"genre_scores_gemma":[0.9984926,0.00039303472,0.00048717984,0.000055562676,0.00045367755,0.00000491549,0.00006650941,0.000028298222,0.000018244242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741656,0.0006425981,0.00083989115,0.00033836663,0.000480201,0.00028239322],"domain_scores_gemma":[0.99840957,0.00026544422,0.0004178323,0.0004080625,0.0003459084,0.00015319021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007544748,0.00020704474,0.001513087,0.00035822048,0.000020725884,0.000010287627,0.00015784198,0.00008396003,0.000006383637],"category_scores_gemma":[0.0002121944,0.00014120687,0.000644906,0.0004860525,0.00036549216,0.00010443099,0.000049270522,0.0005546367,0.0000044407107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009421805,0.00036396162,0.724555,0.00012747644,0.004896219,0.0027066076,0.000845414,0.00018191486,0.00070721545,0.000004363576,0.00010182168,0.2560882],"study_design_scores_gemma":[0.00641129,0.0045333295,0.98619294,0.0009043523,0.0009786099,0.00035331247,0.00022031805,0.0000030339695,0.00017096162,0.000010980214,0.000098600955,0.0001222839],"about_ca_topic_score_codex":0.00028847513,"about_ca_topic_score_gemma":0.000021245864,"teacher_disagreement_score":0.26163793,"about_ca_system_score_codex":0.00019525466,"about_ca_system_score_gemma":0.00032241456,"threshold_uncertainty_score":0.57582486},"labels":[],"label_agreement":null},{"id":"W4403203697","doi":"10.1016/j.cjca.2024.08.211","title":"LIPOPROTEIN(A) DISTRIBUTION IN AORTIC STENOSIS PATIENTS SEEN AT A SPECIALISED VALVE CLINIC: ARE LP(A) REDUCING AGENTS THE ULTIMATE SOLUTION?","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Stenosis; Lipoprotein(a); Internal medicine; Cardiology; Aortic valve; Aortic valve stenosis; Lipoprotein; Surgery; Cholesterol","score_opus":0.025251383379625066,"score_gpt":0.28165866671514816,"score_spread":0.2564072833355231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403203697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890552,0.002845382,0.000688823,0.0032506941,0.0020588622,0.00072846224,0.00015595424,0.000013010447,0.0012035659],"genre_scores_gemma":[0.99704045,0.00030552517,0.00002948147,0.00023830577,0.0021506483,0.00001961459,0.00006967388,0.000026879095,0.000119424265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977497,0.00039402492,0.00070941215,0.0002560077,0.0003532246,0.0005376614],"domain_scores_gemma":[0.99852926,0.00006511086,0.00021647221,0.0003685625,0.00028212316,0.0005384842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015505886,0.00017373583,0.00070638006,0.0002403529,0.00019520312,0.000041708103,0.0001597792,0.00019685914,0.000066815206],"category_scores_gemma":[0.0004663763,0.0001239636,0.00080112414,0.0003478743,0.00014191258,0.00009118065,0.00002869965,0.00057555106,0.000049588794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005668363,0.000040070325,0.7457194,0.00078730815,0.003949079,0.0030113298,0.0019549737,0.0014532633,0.00013124321,0.00011269332,0.11543569,0.12683815],"study_design_scores_gemma":[0.0013730165,0.00030149394,0.92734104,0.000596811,0.00042950112,0.0003521721,0.00016322148,0.00014290832,0.00004288464,0.00009376516,0.069024816,0.00013837393],"about_ca_topic_score_codex":0.003963986,"about_ca_topic_score_gemma":0.0018147529,"teacher_disagreement_score":0.18162167,"about_ca_system_score_codex":0.0015670804,"about_ca_system_score_gemma":0.0012935324,"threshold_uncertainty_score":0.5992387},"labels":[],"label_agreement":null},{"id":"W4403226978","doi":"10.1016/j.cjca.2024.08.049","title":"CHARACTERIZATION OF PATIENTS SUB-OPTIMALLY TREATED FOR DYSLIPIDEMIA MANAGEMENT IN SECONDARY PREVENTION FOLLOWING THE PUBLICATION OF THE 2021 CCS DYSLIPIDEMIA GUIDELINES","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Secondary prevention; Characterization (materials science); Intensive care medicine; Primary prevention; Internal medicine; Nanotechnology","score_opus":0.020625456762175618,"score_gpt":0.28043479378645847,"score_spread":0.2598093370242828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403226978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98737234,0.0013325192,0.0043440666,0.0037961195,0.001177158,0.0010912205,0.00005466465,0.0000030011845,0.00082890945],"genre_scores_gemma":[0.9986234,0.00012599463,0.00022506918,0.00018377362,0.0005798636,0.000030702187,0.000094912546,0.000015839136,0.000120498786],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99841,0.00023857281,0.0008443449,0.00013070676,0.00018625378,0.00019013052],"domain_scores_gemma":[0.9987151,0.00004788573,0.0002998336,0.0002733257,0.0005593665,0.00010448422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001967354,0.00009662271,0.00046447583,0.0002810876,0.000049754013,0.000011963441,0.00014850793,0.000115427596,0.000009609885],"category_scores_gemma":[0.00038544906,0.000059858114,0.0005744528,0.00034696521,0.000048863818,0.000104711115,0.000014122101,0.00019680487,5.542869e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031589932,0.000027604035,0.15539365,0.0014548135,0.004438434,0.000047942394,0.0005382023,0.0008650609,0.010409512,0.0015496529,0.016248701,0.8087105],"study_design_scores_gemma":[0.0021406438,0.0003636648,0.88245684,0.00082604354,0.0009132106,0.00003958855,0.00013590857,0.00029858484,0.0016923306,0.00027180894,0.11074845,0.000112904556],"about_ca_topic_score_codex":0.00015490898,"about_ca_topic_score_gemma":0.00039318533,"teacher_disagreement_score":0.8085976,"about_ca_system_score_codex":0.0002142312,"about_ca_system_score_gemma":0.001025798,"threshold_uncertainty_score":0.2440943},"labels":[],"label_agreement":null},{"id":"W4403227159","doi":"10.1016/j.cjca.2024.08.050","title":"CYP2C19 LOSS-OF-FUNCTION POLYMORPHISMS AND RISK FOR ADVERSE CARDIOVASCULAR EVENTS AFTER SUCCESSFUL CORONARY ANGIOPLASTY","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Angioplasty; Internal medicine; Cardiology; Adverse effect","score_opus":0.009175353459705679,"score_gpt":0.22599793688828845,"score_spread":0.21682258342858277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403227159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91992223,0.063205585,0.013830686,0.00024629282,0.0019203036,0.00046330475,0.00016392097,0.000009440149,0.00023824238],"genre_scores_gemma":[0.9960363,0.0016613667,0.00027703086,0.00007319948,0.0018203978,0.000021612566,0.000012802186,0.0000337356,0.0000635693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985568,0.00017630594,0.00042891374,0.00023751293,0.0002456663,0.00035478116],"domain_scores_gemma":[0.9986391,0.00006220263,0.000102787024,0.0003261513,0.00026324857,0.0006064942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012284627,0.00016825875,0.000866424,0.00039812605,0.00007312495,0.00000882314,0.000074280266,0.0002071735,0.00002390522],"category_scores_gemma":[0.000116467934,0.00013880848,0.0014128436,0.00016258756,0.0001541166,0.00011726227,0.000012870893,0.00031300806,0.000004280402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015203495,0.000007963253,0.8219273,0.0009451498,0.01872775,0.003901319,0.00031314022,0.001185331,0.00009635428,0.00022936595,0.003071717,0.14807422],"study_design_scores_gemma":[0.0022170779,0.0011333533,0.677731,0.00031278498,0.003968172,0.008237303,0.00012786684,0.000036240486,0.00005440523,0.0003776632,0.30562142,0.00018275353],"about_ca_topic_score_codex":0.0017184981,"about_ca_topic_score_gemma":0.00043514854,"teacher_disagreement_score":0.3025497,"about_ca_system_score_codex":0.00017508244,"about_ca_system_score_gemma":0.0014134069,"threshold_uncertainty_score":0.56604457},"labels":[],"label_agreement":null},{"id":"W4403227272","doi":"10.1016/j.cjca.2024.08.070","title":"KNOWLEDGE TO ACTION: IMPLEMENTATION OF A KNOWLEDGE TRANSLATION STRATEGY TO IDENTIFY AND TREAT FAMILIAL HYPERCHOLESTEROLEMIA","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Knowledge translation; Translation (biology); Action (physics); Familial hypercholesterolemia; Knowledge management; Internal medicine; Cholesterol; Genetics","score_opus":0.07818673853006136,"score_gpt":0.3916256407235202,"score_spread":0.3134389021934588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403227272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847189,0.007057267,0.0039502955,0.00083519565,0.00070304616,0.0003694647,0.000034023917,0.000006362007,0.0023254177],"genre_scores_gemma":[0.99809945,0.00013300103,0.00012961512,0.00006485249,0.0014748768,0.000008556268,0.0000068761956,0.000015726879,0.0000670743],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990159,0.00013837828,0.00037372424,0.00015534471,0.00010234669,0.00021428654],"domain_scores_gemma":[0.99892634,0.00003473328,0.000035919173,0.00013374939,0.00021620793,0.0006530534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059993175,0.00010423248,0.00044797474,0.00053408573,0.000044965993,0.00002321727,0.00005306151,0.00010202576,0.000019387997],"category_scores_gemma":[0.000024124362,0.00009164835,0.00021057611,0.0002588542,0.0000373605,0.00008727785,0.0000055718065,0.00018064171,0.000012789149],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008253972,0.0000025478025,0.0039555347,0.0003152695,0.00034121601,0.00011466475,0.0027538245,0.000117400035,0.009790779,0.0001097378,0.00358161,0.97883487],"study_design_scores_gemma":[0.002787421,0.0037386087,0.57906985,0.000540349,0.0010133636,0.00411543,0.0046001575,0.000029666042,0.0036207112,0.00014848662,0.40006587,0.00027008055],"about_ca_topic_score_codex":0.001667515,"about_ca_topic_score_gemma":0.012417011,"teacher_disagreement_score":0.9785648,"about_ca_system_score_codex":0.00022368366,"about_ca_system_score_gemma":0.0016805867,"threshold_uncertainty_score":0.69289833},"labels":[],"label_agreement":null},{"id":"W4403378644","doi":"10.1177/03000605241289294","title":"Reduced lipoprotein (a) in patients with severe hypertriglyceridaemia","year":2024,"lang":"en","type":"article","venue":"Journal of International Medical Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Academic Medical Organization of Southwestern Ontario; Heart and Stroke Foundation of Canada","keywords":"Medicine; Apolipoprotein B; Lipoprotein(a); Internal medicine; Lipoprotein; Cholesterol; Endocrinology; Gastroenterology; High-density lipoprotein","score_opus":0.02603530737985612,"score_gpt":0.3681779996217832,"score_spread":0.3421426922419271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403378644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980125,0.0013043678,0.00011233788,0.012431344,0.0005278118,0.0003006737,0.0000033394076,0.000009831818,0.005185312],"genre_scores_gemma":[0.99709404,0.0004273265,0.00047006313,0.0001743037,0.0012850518,0.000010814771,0.000006036044,0.000020491021,0.0005119052],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99306464,0.00016041817,0.00047606573,0.00017432266,0.0058468077,0.00027775066],"domain_scores_gemma":[0.9980789,0.00021688157,0.000049927363,0.00016086941,0.0010779809,0.00041545127],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0042497213,0.00008661051,0.00028398525,0.0007123293,0.000030459936,0.000054285298,0.00026261064,0.00012756564,0.0009514135],"category_scores_gemma":[0.002798195,0.00005233341,0.00014578845,0.0005269782,0.00009903402,0.00016603174,0.00006844361,0.0016550333,0.00003716657],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004803873,0.00091048394,0.0510335,0.00047988983,0.0011708656,0.006994875,0.00028691217,0.000011514901,0.0003205688,0.001150701,0.009447658,0.92338914],"study_design_scores_gemma":[0.015275996,0.0051790723,0.7554918,0.014316722,0.00008490566,0.00425796,0.0002946833,0.0013307282,0.0012485442,0.00078151136,0.20142835,0.00030971912],"about_ca_topic_score_codex":0.00013878473,"about_ca_topic_score_gemma":0.000014755418,"teacher_disagreement_score":0.92307943,"about_ca_system_score_codex":0.0005236129,"about_ca_system_score_gemma":0.0018289138,"threshold_uncertainty_score":0.99996185},"labels":[],"label_agreement":null},{"id":"W4403460684","doi":"10.1016/s2213-8587(24)00277-8","title":"Lomitapide for the treatment of homozygous familial hypercholesterolaemia in children","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia","funders":"","keywords":"Medicine; Familial hypercholesterolemia; MEDLINE; Intensive care medicine; Pediatrics; Internal medicine; Cholesterol","score_opus":0.028896982794405685,"score_gpt":0.2845322833172575,"score_spread":0.2556353005228518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403460684","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51688164,0.035051007,0.000006679509,0.4433909,0.00075193367,0.003249891,0.00038542252,0.000075474425,0.00020701905],"genre_scores_gemma":[0.24978457,0.029818118,0.00027902698,0.6675246,0.044380672,0.0047763647,0.001036124,0.00032793204,0.0020726412],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99712306,0.00021864109,0.00046131885,0.000497363,0.00027279812,0.0014268105],"domain_scores_gemma":[0.9977118,0.00052772247,0.00011774393,0.0015548554,0.00005145093,0.000036459656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039618602,0.00039252377,0.0016033055,0.000150082,0.00007023448,0.00001986998,0.00043272882,0.00037501738,0.0000147453975],"category_scores_gemma":[0.00005193548,0.00019461945,0.0006983653,0.00015348253,0.00028305012,0.00001730159,0.0000734279,0.0011509294,0.000030670773],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033630177,0.0003082273,0.052517828,0.0017242831,0.008244372,0.00059376954,0.0007418262,0.000020085537,0.00021055863,0.00020518497,0.6625068,0.27259076],"study_design_scores_gemma":[0.0038798805,0.0012529484,0.04762488,0.000176554,0.0017043678,0.00033541836,0.000026037502,0.000030506302,0.00060118485,0.0005151861,0.9436339,0.00021909532],"about_ca_topic_score_codex":0.00053340057,"about_ca_topic_score_gemma":0.00005984458,"teacher_disagreement_score":0.28112713,"about_ca_system_score_codex":0.00021388041,"about_ca_system_score_gemma":0.00015170369,"threshold_uncertainty_score":0.7936351},"labels":[],"label_agreement":null},{"id":"W4403467407","doi":"10.1016/j.jacadv.2024.101316","title":"Preventive Lipid-Lowering Therapy and Interactions With Health Care in Patients Who Develop Premature Coronary Artery Disease","year":2024,"lang":"en","type":"article","venue":"JACC Advances","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Providence Health Care; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Coronary artery disease; Disease; Cardiology; Internal medicine; Intensive care medicine; Physical therapy","score_opus":0.007501274033872032,"score_gpt":0.2791017269767437,"score_spread":0.27160045294287166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403467407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9203769,0.07714036,0.00019628013,0.0006718559,0.000280058,0.0010477605,0.000024799354,0.000059325805,0.00020268073],"genre_scores_gemma":[0.9945023,0.0038802123,0.0006700802,0.00039803566,0.00017554064,0.00011223939,0.00005673859,0.00002416868,0.00018070354],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99909216,0.000043823035,0.00016719062,0.00029472576,0.00021540499,0.00018667743],"domain_scores_gemma":[0.9995467,0.000023633327,0.000036291454,0.00017673965,0.000066706045,0.00014991434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008827758,0.00013217528,0.00024948726,0.00008703559,0.00007029456,0.000026621621,0.000030644554,0.000024491437,0.00001164546],"category_scores_gemma":[0.000014696289,0.00009155546,0.000050356095,0.00021146517,0.00002710797,0.00031269816,0.000021547352,0.00020879526,0.0000020982418],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011930928,0.00013976218,0.12073957,0.0017465558,0.00017172511,0.00010856968,0.00514323,0.000015081857,0.0000026846385,0.000024878185,0.00020631264,0.87050855],"study_design_scores_gemma":[0.0015485752,0.0006873021,0.9413386,0.0028629191,0.000029254268,0.000032659198,0.0013909143,0.000025168947,0.000035591336,0.000038150796,0.05185363,0.00015724603],"about_ca_topic_score_codex":0.000016936903,"about_ca_topic_score_gemma":0.00014306208,"teacher_disagreement_score":0.8703513,"about_ca_system_score_codex":0.00014316571,"about_ca_system_score_gemma":0.0003031594,"threshold_uncertainty_score":0.37335235},"labels":[],"label_agreement":null},{"id":"W4403489838","doi":"10.1111/jgh.16768","title":"Circulating lipoprotein(a) in patients with nonalcoholic fatty liver disease: a systematic review and meta‐analysis","year":2024,"lang":"en","type":"review","venue":"Journal of Gastroenterology and Hepatology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Universitat de Barcelona; Sapienza Università di Roma; Sun Yat-sen University","keywords":"Medicine; Nonalcoholic fatty liver disease; Internal medicine; Meta-analysis; Gastroenterology; Fatty liver; Cochrane Library; Confidence interval; Subgroup analysis; Publication bias; Confounding; Nephelometry; Disease; Immunology","score_opus":0.02985696371755712,"score_gpt":0.3023224012057062,"score_spread":0.27246543748814905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403489838","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019030335,0.9955605,0.00007474375,0.0003514973,0.000036819354,0.0020335836,0.000029802628,0.0000068741847,0.0000030927652],"genre_scores_gemma":[0.005285174,0.99335766,0.00019247961,0.0008970494,0.000049574606,0.0001463697,0.000026649663,0.000034741464,0.0000103198145],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9964163,0.0009555556,0.0015147886,0.00041367934,0.00033845392,0.0003612254],"domain_scores_gemma":[0.9979691,0.00006781788,0.0010655526,0.00040046405,0.00017888297,0.00031819646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012292394,0.00045184692,0.010972978,0.0008124875,0.00004342045,0.000016822298,0.00011673425,0.00023062824,0.000030673207],"category_scores_gemma":[0.00009227069,0.00024589995,0.0019364972,0.0003847865,0.00014065593,0.00006549738,0.000090885325,0.0009364273,0.0000026975392],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015424973,0.000101495825,0.011790854,0.8232546,0.16220982,0.0014892869,0.000017397708,1.6630617e-7,1.4026353e-9,0.000012237649,0.000012336443,0.0009575864],"study_design_scores_gemma":[0.00074294826,0.00093043444,0.0044808756,0.06478522,0.923037,0.005076743,0.0000025824545,0.000006047186,1.9003177e-9,0.0000061345263,0.0008137722,0.00011824235],"about_ca_topic_score_codex":0.000025482112,"about_ca_topic_score_gemma":0.00008964193,"teacher_disagreement_score":0.7608272,"about_ca_system_score_codex":0.00008059262,"about_ca_system_score_gemma":0.00019675113,"threshold_uncertainty_score":0.99999934},"labels":[],"label_agreement":null},{"id":"W4403497958","doi":"10.21203/rs.3.rs-5224358/v1","title":"Management of Children with Heterozygous Familial Hypercholesterolemia Worldwide: A Meta-Analysis.","year":2024,"lang":"en","type":"preprint","venue":"Research Square","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Gedeon Richter; Mylan; Amarin Corporation; Daiichi-Sankyo; Teva Pharmaceutical Industries; Novo Nordisk; Valeant Pharmaceuticals International; Regeneron Pharmaceuticals; Esperion Therapeutics; Ultragenyx Pharmaceutical; AstraZeneca; Amgen","keywords":"Familial hypercholesterolemia; Meta-analysis; Medicine; Heterozygote advantage; Pediatrics; Genetics; Internal medicine; Cholesterol; Biology; Allele","score_opus":0.08591335771611851,"score_gpt":0.39214287942778453,"score_spread":0.306229521711666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403497958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9288728,0.051941883,0.00044323562,0.0023392362,0.00012223431,0.008397119,0.00059325225,0.00020264086,0.007087591],"genre_scores_gemma":[0.99218917,0.0013628002,0.0016241154,0.00006709299,0.00029542,0.0010272918,0.00040280793,0.00010545005,0.0029258349],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99254966,0.00066110946,0.0006780291,0.0013111711,0.0039974363,0.00080257346],"domain_scores_gemma":[0.9957955,0.000051974304,0.00012166029,0.0029828711,0.0006411332,0.0004068972],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0036379395,0.0004706479,0.0025998305,0.0014549276,0.000100581434,0.00011586827,0.00047492885,0.00032886432,0.00024229934],"category_scores_gemma":[0.000022929882,0.0003060151,0.0037630238,0.0019068437,0.00023437354,0.000028715524,0.001934103,0.0027920578,0.000088976274],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005004603,0.00047440658,0.0042875083,0.01600687,0.9572429,0.0016920962,0.0003665041,0.0010377993,0.000020277765,0.00033844818,0.00071172125,0.017321],"study_design_scores_gemma":[0.0026358906,0.0015510678,0.18889327,0.0021712861,0.79892206,0.00020749123,0.0006216307,0.00027199122,0.00059029396,0.0010151742,0.0022586233,0.00086119084],"about_ca_topic_score_codex":0.0020619514,"about_ca_topic_score_gemma":0.00021667432,"teacher_disagreement_score":0.18460576,"about_ca_system_score_codex":0.00032177154,"about_ca_system_score_gemma":0.00048880506,"threshold_uncertainty_score":0.9999392},"labels":[],"label_agreement":null},{"id":"W4403591944","doi":"10.1016/j.atherosclerosis.2024.118624","title":"Publication bias in pharmacogenetics of statin-associated muscle symptoms: A meta-epidemiological study","year":2024,"lang":"en","type":"review","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Association Nationale de la Recherche et de la Technologie","keywords":"Pharmacogenetics; Medicine; Statin; Epidemiology; Meta-analysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Publication bias; Internal medicine; Pharmacology; Genetics; Genotype; Biology","score_opus":0.3292323609253614,"score_gpt":0.4284963298699932,"score_spread":0.0992639689446318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403591944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013112382,0.98219115,0.000011101438,0.0000875447,0.00014805369,0.004044984,0.000182017,0.00010345751,0.000119329816],"genre_scores_gemma":[0.012237863,0.985398,0.00013202614,0.00015199656,0.000117614436,0.0014673298,0.00019815456,0.00011197392,0.00018502762],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945064,0.0016324772,0.0019376845,0.00078079815,0.000698766,0.00044385708],"domain_scores_gemma":[0.99762446,0.0003505246,0.0007243029,0.000898396,0.00021504617,0.00018728433],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0049328455,0.00061479374,0.0054194788,0.00036550994,0.000038915365,0.00003431655,0.00026340445,0.00043875046,0.00017151005],"category_scores_gemma":[0.0011257209,0.00036741624,0.0026371882,0.0014592651,0.00006915321,0.000042555926,0.00014918965,0.00074520765,0.00007515602],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000835024,0.0020007407,0.0015406238,0.012320447,0.015207515,0.000012883946,0.00037449607,0.0000012325121,0.000007282215,0.000031816904,0.00086314813,0.96763146],"study_design_scores_gemma":[0.0026348087,0.0019194708,0.02248095,0.013602552,0.12497164,0.000016744701,0.00020526031,0.00005645525,0.00000636995,0.000041767995,0.8331925,0.00087143184],"about_ca_topic_score_codex":0.0005224644,"about_ca_topic_score_gemma":0.000045276876,"teacher_disagreement_score":0.96676004,"about_ca_system_score_codex":0.0003293108,"about_ca_system_score_gemma":0.00040649294,"threshold_uncertainty_score":0.99987775},"labels":[{"model":"gemma","categories":["metaresearch","metaepi_broad"],"domain":"reporting","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch","metaepi_narrow","metaepi_broad"],"domain":"methods","study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4403663865","doi":"10.1101/2024.10.21.619523","title":"Structural analyses of apolipoprotein A-IV polymorphisms Q360H and T347S elucidate the inhibitory effect against thrombosis","year":2024,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Canadian Armed Forces; St. Michael's Hospital; Royal Canadian Navy; York University; University of Toronto","funders":"","keywords":"Apolipoprotein B; Inhibitory postsynaptic potential; Thrombosis; Genetics; Apolipoprotein E; Polymorphism (computer science); Internal medicine; Biology; Medicine; Gene; Genotype; Cholesterol","score_opus":0.02128300082413767,"score_gpt":0.2720147646378564,"score_spread":0.25073176381371876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403663865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708984,0.024503237,0.00004240677,0.0006223225,0.0010661713,0.0023343887,0.00022076535,0.00028472702,0.00002759359],"genre_scores_gemma":[0.9958756,0.0011709128,0.00060271204,0.00032878952,0.0015254802,0.0002913383,0.0000014124586,0.00019733731,0.0000064096716],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99571085,0.00043330336,0.0008824291,0.0012392718,0.0010498835,0.00068426115],"domain_scores_gemma":[0.99619496,0.00009299311,0.00046909615,0.0024739818,0.0003536035,0.00041538215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016608038,0.00084974704,0.001699092,0.00043395994,0.00022965179,0.0001738493,0.00041033435,0.0006717529,0.000028362818],"category_scores_gemma":[0.00023954669,0.00058287557,0.00079830224,0.0007202228,0.0004623407,0.00008567794,0.0010158852,0.001670595,0.000026029431],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001226224,0.000057076875,0.004001915,0.0057144784,0.0028600774,0.00013113827,0.00004304576,0.00003203076,0.9864043,0.0002562273,0.00023702726,0.00014007816],"study_design_scores_gemma":[0.0013719215,0.00032220382,0.16121788,0.002896338,0.0026697991,4.3456464e-7,0.000009897624,0.0005188043,0.82942647,0.000010922189,0.00072201603,0.00083333295],"about_ca_topic_score_codex":0.0010488018,"about_ca_topic_score_gemma":0.0000067781534,"teacher_disagreement_score":0.15721597,"about_ca_system_score_codex":0.00027816353,"about_ca_system_score_gemma":0.00086709,"threshold_uncertainty_score":0.9996623},"labels":[],"label_agreement":null},{"id":"W4403802598","doi":"10.1093/eurheartj/ehae666.1048","title":"Dual pathway inhibition in patients with atherosclerosis with and without heart failure: insights from the XATOA Registry","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Heart failure; Dual (grammatical number); Cardiology; Internal medicine; Intensive care medicine","score_opus":0.0150488588012183,"score_gpt":0.22345374194478865,"score_spread":0.20840488314357034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403802598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953855,0.0013177871,0.000109887376,0.0023728872,0.00009998687,0.00036509684,0.000011067027,0.000044839886,0.00029289673],"genre_scores_gemma":[0.9971233,0.00006223883,0.00086284144,0.0010070128,0.0007895163,0.0000042603915,0.000016099299,0.000065176086,0.00006952463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982375,0.00038850325,0.00024693363,0.00029819732,0.0005915575,0.00023728899],"domain_scores_gemma":[0.9992921,0.00003057752,0.000055852073,0.00033017763,0.000077575765,0.00021371404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005711981,0.00018446516,0.00028352079,0.00007324265,0.00020160094,0.00021223367,0.00003529008,0.000040824285,0.00003212902],"category_scores_gemma":[0.000024596498,0.000094121,0.00008693217,0.00022589682,0.000102508624,0.00019107717,0.000035773777,0.00077547145,0.000031086776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005312145,0.00018165262,0.9856711,0.00009895153,0.00027621767,0.0004112413,0.002041222,0.000011454809,0.0014540388,0.000044844477,0.0053102123,0.00396787],"study_design_scores_gemma":[0.0027717673,0.0007717874,0.9409137,0.0018715004,0.0000671683,0.00091559195,0.00021970393,0.000011525159,0.00027133775,0.000011890141,0.052030206,0.0001438648],"about_ca_topic_score_codex":0.000066868306,"about_ca_topic_score_gemma":0.000062641826,"teacher_disagreement_score":0.046719994,"about_ca_system_score_codex":0.00006600905,"about_ca_system_score_gemma":0.00015701528,"threshold_uncertainty_score":0.3838143},"labels":[],"label_agreement":null},{"id":"W4403806362","doi":"10.1093/eurheartj/ehae666.1606","title":"Relation of apolipoprotein C3 to risk of major adverse cardiovascular events and death after acute coronary syndrome on a background of optimized statin treatment","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Scarborough Hospital; University of Toronto; Sanofi (Canada)","funders":"","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Adverse effect; Statin; Cardiology; Apolipoprotein B; Cholesterol; Myocardial infarction","score_opus":0.025295346716552536,"score_gpt":0.28414348333915135,"score_spread":0.2588481366225988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403806362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249864,0.0050862734,0.00104867,0.00009962524,0.00015498085,0.00082314736,0.00007155323,0.000015154349,0.00020196507],"genre_scores_gemma":[0.99002826,0.0013562881,0.008136023,0.000037648384,0.00011373685,0.000012266678,0.000007838184,0.00005294067,0.0002550172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976095,0.0006827927,0.00056964497,0.00026214513,0.00066175545,0.00021413802],"domain_scores_gemma":[0.9990029,0.000043478507,0.0001348703,0.00045053053,0.00010530141,0.0002629731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016578146,0.00019266755,0.00073453586,0.00025507598,0.000053881056,0.000009311909,0.00005134832,0.000044282337,0.00007799252],"category_scores_gemma":[0.000031869167,0.00014233521,0.00078125956,0.00017714521,0.000032781343,0.000088681074,0.000043727392,0.00025904123,0.000024201663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03880724,0.006321021,0.39077285,0.00972676,0.13516636,0.047531046,0.016487993,0.01573863,0.017879922,0.0005584675,0.0015854349,0.31942427],"study_design_scores_gemma":[0.0044476837,0.004426307,0.9792225,0.0016191268,0.002112337,0.004715458,0.00014915976,0.00009556155,0.00077488646,0.00002393162,0.0022705232,0.00014252236],"about_ca_topic_score_codex":0.00018266278,"about_ca_topic_score_gemma":0.0000016913613,"teacher_disagreement_score":0.58844966,"about_ca_system_score_codex":0.00013990042,"about_ca_system_score_gemma":0.00013986052,"threshold_uncertainty_score":0.5804261},"labels":[],"label_agreement":null},{"id":"W4403806851","doi":"10.1093/eurheartj/ehae666.1331","title":"Lower rate of ischemic events with PCSK9 inhibition in patients with atherosclerotic cardiovascular disease but without prior ischemic events","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi","keywords":"Medicine; PCSK9; Disease; Cardiology; Internal medicine; Atherosclerotic cardiovascular disease; Cholesterol; Lipoprotein; LDL receptor","score_opus":0.014460857049587746,"score_gpt":0.23584745839580218,"score_spread":0.22138660134621443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403806851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952904,0.00233403,0.00043360633,0.00015395058,0.00020411123,0.00092123414,0.000015425532,0.000049156188,0.00059807324],"genre_scores_gemma":[0.99841917,0.00012221994,0.00042852934,0.00020942271,0.00040650155,0.000011517539,0.000021338235,0.00013475222,0.00024653648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709016,0.00048191656,0.00049609,0.000457441,0.0010311704,0.00044324555],"domain_scores_gemma":[0.9985543,0.000015831687,0.00011668063,0.0006355952,0.0002071716,0.00047040707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016996023,0.00030513463,0.00061284716,0.00022226234,0.000099961326,0.000038686427,0.000083704654,0.00004699647,0.000056154593],"category_scores_gemma":[0.00005791762,0.00020804562,0.00051265,0.0003781705,0.00006531582,0.0002713831,0.00005469589,0.00072266406,0.00007454915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004565268,0.0011852381,0.9714422,0.0018698912,0.0032734608,0.0026155852,0.0005300783,0.0008140564,0.0037041092,0.000004272966,0.0014840254,0.008511767],"study_design_scores_gemma":[0.008656585,0.0010571042,0.96312547,0.007216656,0.00083234766,0.00061418826,0.00004387794,0.00007533247,0.0011359728,0.000004097982,0.01688033,0.0003580189],"about_ca_topic_score_codex":0.000022775272,"about_ca_topic_score_gemma":0.0000012323324,"teacher_disagreement_score":0.015396304,"about_ca_system_score_codex":0.00018173008,"about_ca_system_score_gemma":0.00037233255,"threshold_uncertainty_score":0.8483854},"labels":[],"label_agreement":null},{"id":"W4403819152","doi":"10.1093/eurheartj/ehae666.3296","title":"Plasma statin concentrations do not correlate with statin-induced myalgia","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; myalgia; Statin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Internal medicine; Cardiology; Pharmacology","score_opus":0.03480111695267445,"score_gpt":0.2944128172221384,"score_spread":0.25961170026946395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403819152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812839,0.001034252,0.0024858203,0.0028885927,0.0007756039,0.0003994724,0.000019209905,0.00014200808,0.010971157],"genre_scores_gemma":[0.99340355,0.00018363386,0.0031024076,0.0006925423,0.0010000027,0.0000032545618,0.000011438875,0.00008026865,0.001522871],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979741,0.00037992673,0.00036175846,0.00026030318,0.0006427736,0.00038116443],"domain_scores_gemma":[0.9990093,0.000049638595,0.00006548314,0.0002880483,0.00013805224,0.00044945418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012524396,0.00017665468,0.000286167,0.00010776883,0.00027084062,0.0002789276,0.00006980999,0.000032326334,0.00043784996],"category_scores_gemma":[0.000063608735,0.00012288398,0.00019374555,0.00023026737,0.000046909245,0.00015507231,0.00002303367,0.0009609812,0.00063611905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002626025,0.00080786296,0.022185396,0.0020354537,0.0050329766,0.057707828,0.01924938,0.0010669939,0.06690704,0.0050311103,0.18447933,0.6328706],"study_design_scores_gemma":[0.008596114,0.004629799,0.36754534,0.0039042563,0.0006865172,0.052349675,0.0016981463,0.0030487375,0.003994662,0.000052024054,0.5526342,0.0008605155],"about_ca_topic_score_codex":0.000017639913,"about_ca_topic_score_gemma":0.000003030688,"teacher_disagreement_score":0.6320101,"about_ca_system_score_codex":0.00009796136,"about_ca_system_score_gemma":0.0005372167,"threshold_uncertainty_score":0.81762356},"labels":[],"label_agreement":null},{"id":"W4403822480","doi":"10.1093/eurheartj/ehae666.2860","title":"Association of lipid target achievement and cardiovascular outcomes following statin initiation: a population-based cohort study","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto; Institute for Clinical Evaluative Sciences; University Health Network; University of British Columbia","funders":"","keywords":"Medicine; Statin; Cohort; Internal medicine; Cohort study; Population; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Environmental health","score_opus":0.021378584798976707,"score_gpt":0.29219406549979127,"score_spread":0.27081548070081457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403822480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934962,0.0021283745,0.0015019462,0.0010259656,0.00055728486,0.0007394972,0.0000068678014,0.00005079373,0.0004930795],"genre_scores_gemma":[0.99754846,0.000040961815,0.0014266708,0.00024175885,0.00051556446,0.000007778497,0.000018513667,0.000039756324,0.00016055202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971053,0.0008068037,0.00048280336,0.00022922664,0.0011773468,0.00019853357],"domain_scores_gemma":[0.9993029,0.00007020721,0.00009310278,0.00027233612,0.00010868904,0.00015271877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006797934,0.00013768378,0.0005389749,0.00017275849,0.00016213363,0.00009665539,0.00004078811,0.000029704075,0.000058109716],"category_scores_gemma":[0.00026116622,0.00011078937,0.0006564718,0.00018768715,0.000006487837,0.00012098481,0.000024855302,0.00033432225,0.000012409206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008873559,0.00010214446,0.99441534,0.00009626078,0.0025336165,0.0001852899,0.00027738512,0.00017635431,0.000023308774,0.000004763584,0.00042748335,0.0017491519],"study_design_scores_gemma":[0.0014156962,0.00031658143,0.99062365,0.00016853618,0.0007228292,0.00004639334,0.00020056283,0.00015803587,0.00001999182,0.0000059243207,0.0062248227,0.000096966694],"about_ca_topic_score_codex":0.00006058662,"about_ca_topic_score_gemma":0.0000030895071,"teacher_disagreement_score":0.006536768,"about_ca_system_score_codex":0.00017728566,"about_ca_system_score_gemma":0.00013747365,"threshold_uncertainty_score":0.45178592},"labels":[],"label_agreement":null},{"id":"W4403822648","doi":"10.1093/eurheartj/ehae666.2861","title":"Combination of moderate-intensity statins and ezetimibe versus high-intensity statins alone for primary prevention of cardiovascular events","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre; McGill University Health Centre","funders":"","keywords":"Medicine; Ezetimibe; Intensity (physics); Internal medicine; Statin; Primary prevention; Cardiology; Pharmacology; Disease","score_opus":0.04103060423884917,"score_gpt":0.29683712510695914,"score_spread":0.25580652086810995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403822648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9681415,0.0037662939,0.025906835,0.00042908333,0.00075922866,0.0006809757,0.000042073258,0.00003263336,0.00024137556],"genre_scores_gemma":[0.99240524,0.00096376357,0.0060158535,0.000075714626,0.0003063902,0.0000035586966,0.000053652595,0.000045777662,0.00013005747],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980629,0.00033577014,0.0004983251,0.00025634078,0.00062546,0.000221215],"domain_scores_gemma":[0.9986941,0.000057694877,0.00013352185,0.00030207357,0.0006407461,0.00017181957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026378718,0.00015290537,0.0007565323,0.00014956902,0.00012272585,0.000027115699,0.00005197016,0.000043744545,0.000012299467],"category_scores_gemma":[0.00015175078,0.00013251104,0.0006134904,0.00013488773,0.00006058403,0.00015108907,0.000054048225,0.00031942848,0.0000039478223],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046126425,0.0049379766,0.017773733,0.02966842,0.048115075,0.0024212005,0.00972544,0.0052957083,0.04366063,0.0024425744,0.028202439,0.76163036],"study_design_scores_gemma":[0.028925216,0.01114304,0.895095,0.004105444,0.004941184,0.0038232275,0.00078759453,0.0053411117,0.020679025,0.0014273279,0.023014534,0.0007173221],"about_ca_topic_score_codex":0.0000737706,"about_ca_topic_score_gemma":0.0000023449363,"teacher_disagreement_score":0.87732124,"about_ca_system_score_codex":0.00010624215,"about_ca_system_score_gemma":0.00020129129,"threshold_uncertainty_score":0.5403643},"labels":[],"label_agreement":null},{"id":"W4403822670","doi":"10.1093/eurheartj/ehae666.2831","title":"Remnant cholesterol, clinical characteristics and mortality in 41.767 patients from LIPIDOGRAM 2004-2015 studies - the factor analysis for mixed data cluster analysis","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International","keywords":"Medicine; Cluster (spacecraft); Internal medicine; Cholesterol","score_opus":0.16624816365885114,"score_gpt":0.4207576198839697,"score_spread":0.25450945622511856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403822670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893173,0.0051482753,0.0019242538,0.0017089477,0.0008500421,0.0004678158,0.0005429814,0.000025341802,0.000015051677],"genre_scores_gemma":[0.9935442,0.002288394,0.00058071606,0.0009426159,0.002141906,0.000005075794,0.00037674958,0.00003644092,0.0000838766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963024,0.0012044401,0.0010545627,0.00056382205,0.0005474733,0.00032729676],"domain_scores_gemma":[0.99790746,0.00031200572,0.00018584746,0.0011118836,0.0001974193,0.00028537217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005677038,0.000214551,0.0010455898,0.0003045527,0.00017899707,0.00025486265,0.00023656595,0.00006050906,0.0000288009],"category_scores_gemma":[0.0006896769,0.00012573773,0.00075686246,0.0007304183,0.000112707035,0.00018590169,0.00026785998,0.0006861072,0.000015575944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008469717,0.00012830732,0.9566426,0.000063251755,0.013661432,0.000068760295,0.00034772247,0.000006024782,0.0000031292068,5.510277e-7,0.0045735748,0.02441991],"study_design_scores_gemma":[0.0010811862,0.00018113211,0.9398857,0.00012732089,0.008476536,0.000020834885,0.00010928752,0.0024345303,8.7974547e-7,0.000006296797,0.0475523,0.00012399133],"about_ca_topic_score_codex":0.00008367227,"about_ca_topic_score_gemma":0.00028186885,"teacher_disagreement_score":0.042978726,"about_ca_system_score_codex":0.00006570287,"about_ca_system_score_gemma":0.00008903784,"threshold_uncertainty_score":0.5127436},"labels":[],"label_agreement":null},{"id":"W4403855498","doi":"10.31083/j.rcm2510383","title":"Erratum: Leiter et al. Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease. Reviews in Cardiovascular Medicine. 2024; 25: 190","year":2024,"lang":"en","type":"erratum","venue":"Reviews in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Amgen (Canada); Université Laval; St. Michael's Hospital; Western University; University of Toronto; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Evolocumab; Atherosclerotic cardiovascular disease; Ldl cholesterol; Disease; Internal medicine; Cardiology; Cholesterol; Total cholesterol","score_opus":0.03990600599668128,"score_gpt":0.32120144261165307,"score_spread":0.2812954366149718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403855498","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082726314,0.9636458,0.0013450498,0.0029037097,0.00857883,0.021250453,0.00010437309,0.000037923863,0.0020511055],"genre_scores_gemma":[0.00078325026,0.98794943,0.00035340828,0.0012631406,0.0025419784,0.0032554187,0.0007600477,0.00031001,0.0027833292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9810571,0.004718178,0.0064013903,0.0024498536,0.004419007,0.00095449295],"domain_scores_gemma":[0.9881989,0.00027178688,0.0016669806,0.008482732,0.0009132341,0.00046638772],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.05277673,0.0016501943,0.017855264,0.0012620604,0.000097240365,0.000016389147,0.000844892,0.00083275774,0.00014001627],"category_scores_gemma":[0.0041815005,0.0010620197,0.015957786,0.0026346212,0.0011794863,0.00025953524,0.00035661898,0.0031494382,0.00000957106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117671836,0.00015530133,0.000045503086,0.30662474,0.017712912,0.0000627861,0.00035901842,0.000056866986,0.00003446781,0.000043057593,0.30679253,0.36799514],"study_design_scores_gemma":[0.0038091398,0.0005846287,0.0021276893,0.29107618,0.031616364,0.00032685653,0.00012039711,0.000040743027,0.000008116356,0.0000980352,0.6696887,0.00050313375],"about_ca_topic_score_codex":0.0015625972,"about_ca_topic_score_gemma":0.000051457642,"teacher_disagreement_score":0.367492,"about_ca_system_score_codex":0.00052316237,"about_ca_system_score_gemma":0.0012594786,"threshold_uncertainty_score":0.9996245},"labels":[],"label_agreement":null},{"id":"W4403940463","doi":"10.7759/cureus.72776","title":"Effect of Increased Level of Lipoprotein(a) on Cardiovascular Outcomes in Patients With Ischemic Heart Disease: A Systematic Review and Meta-Analysis","year":2024,"lang":"en","type":"review","venue":"Cureus","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mace; Lipoprotein(a); Meta-analysis; Internal medicine; Myocardial infarction; Cardiology; Disease; Prospective cohort study; Lipoprotein; Cholesterol; Conventional PCI","score_opus":0.0579533773267352,"score_gpt":0.33758382759913336,"score_spread":0.27963045027239813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403940463","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015997389,0.9866103,0.0000069994417,0.000024581319,0.000018455821,0.012592065,0.0005413714,0.000019136012,0.000027114307],"genre_scores_gemma":[0.0020088395,0.9954343,0.000049132872,0.00007826835,0.00001830201,0.0020099601,0.00022344914,0.00008630066,0.00009148406],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99471724,0.0013793365,0.0014591991,0.0007223171,0.0014563804,0.00026555496],"domain_scores_gemma":[0.9962889,0.00019875378,0.0005100359,0.0025887,0.00016359634,0.0002500463],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.0031994625,0.00073348754,0.023815501,0.00044393938,0.000019167963,0.000010850192,0.00018315358,0.00020258372,0.000028607246],"category_scores_gemma":[0.00065279944,0.00035215978,0.010667196,0.0011753886,0.00006758896,0.00003883966,0.00008635859,0.00041147816,0.000008522032],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024036439,0.0000878874,0.000073729534,0.69514626,0.30353513,0.000018202229,0.0000037110437,2.78901e-7,7.592618e-9,0.0000022193817,0.00002620619,0.0010823586],"study_design_scores_gemma":[0.0005969403,0.00048621726,0.00020130082,0.15837707,0.8372463,0.000008278697,8.237463e-7,3.6254502e-7,0.0000011713695,4.1828014e-7,0.0028543812,0.00022672825],"about_ca_topic_score_codex":0.0005402553,"about_ca_topic_score_gemma":0.000011679967,"teacher_disagreement_score":0.53676915,"about_ca_system_score_codex":0.0001481311,"about_ca_system_score_gemma":0.00026882527,"threshold_uncertainty_score":0.999893},"labels":[],"label_agreement":null},{"id":"W4404109847","doi":"10.1016/j.jacl.2024.10.008","title":"Extreme LDL-C concentration is associated with increased cardiovascular disease in women with homozygous familial hypercholesterolemia","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada); McGill University Health Centre; University of Ottawa; University of Toronto; Western University; Queen Elizabeth II Health Sciences Centre; Université Laval; University of British Columbia; Montreal Heart Institute; Montreal Clinical Research Institute; Hospital for Sick Children; Université du Québec à Chicoutimi; McMaster University; Providence Health Care; Providence Health Care Research Institute","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Internal medicine; Disease; Ldl cholesterol; Cardiology; Endocrinology; Gastroenterology; Cholesterol","score_opus":0.049798382642746546,"score_gpt":0.3232022719678083,"score_spread":0.27340388932506177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404109847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280244,0.0038137736,0.0005925514,0.0012830064,0.00091199164,0.00040873783,0.000013685587,0.00003123864,0.00014257692],"genre_scores_gemma":[0.99343354,0.00096446014,0.00024695092,0.0018789792,0.003361223,0.000019148216,0.000009203763,0.00003926158,0.00004722666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99607193,0.00091529486,0.001273097,0.0003851023,0.0009157293,0.00043886394],"domain_scores_gemma":[0.9978402,0.0004396781,0.00026540214,0.00046654648,0.00032684012,0.00066132576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004921272,0.00021701556,0.0015343882,0.00014566944,0.000038406833,0.0000350599,0.00012717141,0.00026975415,0.000058492762],"category_scores_gemma":[0.0010526523,0.00013645287,0.00063982414,0.00036183733,0.00022121168,0.00016739611,0.000024940915,0.0011455283,0.000009733572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051196136,0.002943438,0.5602352,0.0010852762,0.024296973,0.026745442,0.0020704204,0.001132331,0.00032702772,0.00011357944,0.0041449745,0.32570916],"study_design_scores_gemma":[0.018788068,0.0069898088,0.9216772,0.0020100465,0.0023328762,0.0019915043,0.0002129173,0.00074577285,0.000021982449,0.00015947357,0.04473481,0.0003355488],"about_ca_topic_score_codex":0.00010438513,"about_ca_topic_score_gemma":0.000022076078,"teacher_disagreement_score":0.36144197,"about_ca_system_score_codex":0.0002772323,"about_ca_system_score_gemma":0.0017737091,"threshold_uncertainty_score":0.5564387},"labels":[],"label_agreement":null},{"id":"W4404120986","doi":"10.24908/qap.v1i2.17347","title":"Gene-Based Targeting for Treatment of Hypercholesterolemia and Prevention of Atherosclerotic Cardiovascular Disease","year":2024,"lang":"en","type":"article","venue":"Qapsule Queen s Undergraduate Health Sciences Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Atherosclerotic cardiovascular disease; Disease; Medicine; Familial hypercholesterolemia; Genetic enhancement; Gene; Internal medicine; Cholesterol; Biology; Genetics","score_opus":0.043381077670330316,"score_gpt":0.32699505950248225,"score_spread":0.2836139818321519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404120986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8738827,0.06322956,0.0509644,0.00971422,0.00039026132,0.0017257129,0.000027738932,0.000037896625,0.00002749046],"genre_scores_gemma":[0.97914165,0.0075549018,0.01280295,0.00010750451,0.00027123487,0.00004042277,0.000009542733,0.000022728873,0.000049082388],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976186,0.00022828368,0.0006550309,0.00036027542,0.0007525446,0.0003852437],"domain_scores_gemma":[0.9988915,0.00006288436,0.00019854079,0.00025823282,0.00014781835,0.0004410475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027244813,0.00016884806,0.0006525484,0.00023809266,0.0002956717,0.00005637895,0.00007939323,0.00004721009,0.000003294864],"category_scores_gemma":[0.000052199925,0.000119018616,0.0007242381,0.00033617584,0.00021545298,0.00014018877,0.0000124044755,0.000092146955,6.006085e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006402446,0.0008863527,0.01630396,0.0125305075,0.002584463,0.00009140892,0.0013091547,0.00927164,0.0032741982,0.0015233799,0.00038163707,0.95120305],"study_design_scores_gemma":[0.078724824,0.12586258,0.29154134,0.04208482,0.01621623,0.003796917,0.004814439,0.17933208,0.07058343,0.07579607,0.1071954,0.004051867],"about_ca_topic_score_codex":0.00024754726,"about_ca_topic_score_gemma":0.0000030780527,"teacher_disagreement_score":0.9471512,"about_ca_system_score_codex":0.00022915594,"about_ca_system_score_gemma":0.0020792682,"threshold_uncertainty_score":0.48534384},"labels":[],"label_agreement":null},{"id":"W4404160305","doi":"10.1111/bcp.16329","title":"SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin‐induced rhabdomyolysis: A case report","year":2024,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"Canadian Institutes of Health Research","keywords":"Rhabdomyolysis; SLCO1B1; Rosuvastatin; Medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Internal medicine; Pharmacology; Statin; Pharmacogenetics; Biology; Genetics; Genotype","score_opus":0.06418015889348433,"score_gpt":0.41483230422504325,"score_spread":0.3506521453315589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404160305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938235,0.0028225726,0.00018470644,0.0010150927,0.0010735065,0.00048283295,0.000007821504,0.0000137671,0.00057615014],"genre_scores_gemma":[0.9963258,0.00046151195,0.0017301154,0.00031583838,0.0010841966,0.00002146403,0.000001944204,0.000025580897,0.000033545217],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9959818,0.0005384305,0.0023513297,0.00030274567,0.00051516964,0.00031049375],"domain_scores_gemma":[0.9979331,0.00035983516,0.0007878063,0.0001611134,0.00042803763,0.00033010473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031396416,0.00012575297,0.001121597,0.0001681249,0.000035254037,0.000029046634,0.000090370304,0.00013822684,0.0001551019],"category_scores_gemma":[0.00072463596,0.00010965429,0.00047378073,0.00043409324,0.00012364905,0.00016124325,0.0000496367,0.0011766927,0.0000017348248],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048109115,0.00063112116,0.00424411,0.00035262486,0.00094118284,0.7770691,0.00016526773,0.00003207786,0.0005117549,0.0000013714337,0.0015319363,0.2140384],"study_design_scores_gemma":[0.0054855812,0.0018031432,0.0534999,0.0013338311,0.0008861711,0.9332346,0.0006132306,0.000548499,0.0005592991,0.00006444616,0.001820781,0.000150534],"about_ca_topic_score_codex":0.0007164228,"about_ca_topic_score_gemma":0.00009284843,"teacher_disagreement_score":0.21388787,"about_ca_system_score_codex":0.000049223396,"about_ca_system_score_gemma":0.0011046444,"threshold_uncertainty_score":0.51122093},"labels":[],"label_agreement":null},{"id":"W4404297418","doi":"10.1093/eurjpc/zwae369","title":"Evolocumab treatment reduces carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia","year":2024,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Evolocumab; Medicine; Alirocumab; Placebo; Randomized controlled trial; Internal medicine; Intima-media thickness; PCSK9; Gastroenterology; Post-hoc analysis; Randomization; Clinical endpoint; Cholesterol; Apolipoprotein B; Carotid arteries; Lipoprotein; Pathology","score_opus":0.011713303082949923,"score_gpt":0.2435340673358941,"score_spread":0.23182076425294418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404297418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896684,0.0065754615,0.00065026147,0.00013752675,0.0012376112,0.0005371368,0.000021235111,0.00002668246,0.0011456355],"genre_scores_gemma":[0.9963391,0.0010854718,0.00049375003,0.00007058193,0.0018434488,0.0000099762965,0.000023578015,0.00006129003,0.00007282646],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99629605,0.0018495908,0.00066743244,0.0003671992,0.00045191203,0.00036781048],"domain_scores_gemma":[0.9988674,0.00010640891,0.00017866469,0.00032421286,0.0003110957,0.00021220012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001717528,0.00027666238,0.0009361389,0.00043647393,0.000043570595,0.000031189145,0.00016113702,0.00007622621,0.000012847547],"category_scores_gemma":[0.00015423493,0.00017713384,0.00056793104,0.00032075288,0.00012929573,0.00015858731,0.00006329556,0.00062421727,0.000035978333],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031103678,0.00074121257,0.37923774,0.00060560374,0.004299043,0.023212258,0.0060541835,0.00060683215,0.001627114,0.000023847966,0.0012624118,0.5792194],"study_design_scores_gemma":[0.0074091484,0.0050962595,0.977519,0.00067772187,0.0008448524,0.0030089964,0.00032425256,0.0000054998427,0.00022076552,0.00001923348,0.004625723,0.00024856618],"about_ca_topic_score_codex":0.000012962838,"about_ca_topic_score_gemma":0.0000041198,"teacher_disagreement_score":0.5982812,"about_ca_system_score_codex":0.00037883082,"about_ca_system_score_gemma":0.00034086185,"threshold_uncertainty_score":0.7223308},"labels":[],"label_agreement":null},{"id":"W4404359865","doi":"10.1161/circ.150.suppl_1.4142200","title":"Abstract 4142200: An Economic Evaluation of Non-HDL-Cholesterol and Apolipoprotein B as Treatment Targets for Lipid-Lowering Therapy in Primary Prevention","year":2024,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Apolipoprotein B; Ldl cholesterol; Primary prevention; Cholesterol; Internal medicine; Disease","score_opus":0.04149131386363672,"score_gpt":0.34380860500875404,"score_spread":0.3023172911451173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404359865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352807,0.002040188,0.0010478991,0.00007082178,0.00014533891,0.0028798734,0.0000055706887,0.000025326135,0.00025691878],"genre_scores_gemma":[0.998665,0.00026122216,0.00019121516,0.00001925035,0.00030212835,0.00036851197,0.0001572048,0.000023914523,0.000011582242],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99904996,0.000041517236,0.0002955622,0.00027718596,0.0002124578,0.00012332607],"domain_scores_gemma":[0.99958926,0.000015062591,0.00006766213,0.00021906482,0.00005373797,0.000055219603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010715335,0.000110979454,0.00023431239,0.00015041041,0.000031019856,0.000025216677,0.00001929507,0.00008937839,0.000026375195],"category_scores_gemma":[0.000011644057,0.00010160838,0.00012031742,0.00005443583,0.000013383066,0.00023104102,0.0000043181453,0.000049575723,0.0000040187742],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011480998,0.000120633136,0.0046516834,0.0003655582,0.000104844214,0.0000010660056,0.0004677605,0.0013240626,0.028314523,0.000026734406,0.0000013831051,0.9645069],"study_design_scores_gemma":[0.0036481842,0.0005598622,0.9574118,0.0003078904,0.00012897556,0.000014184387,0.000042010433,0.026420532,0.010497236,0.00067082344,0.00019515894,0.00010334341],"about_ca_topic_score_codex":0.0007000099,"about_ca_topic_score_gemma":0.0000982085,"teacher_disagreement_score":0.96440357,"about_ca_system_score_codex":0.0005731439,"about_ca_system_score_gemma":0.0003068388,"threshold_uncertainty_score":0.41434693},"labels":[],"label_agreement":null},{"id":"W4404360991","doi":"10.1016/j.metabol.2024.156064","title":"PCSK9 in metabolism and diseases","year":2024,"lang":"en","type":"review","venue":"Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"Labex Immuno-Oncology; Institut Gustave-Roussy; Institut National Du Cancer; National Heart, Lung, and Blood Institute; Institut Universitaire de France; Ligue Contre le Cancer; Fondation pour la Recherche Médicale; Agence Nationale de la Recherche; Université de Paris; Seerave Foundation; Association pour la Recherche sur le Cancer; European Commission; Centre National de la Recherche Scientifique; Equipex","keywords":"PCSK9; LDL receptor; Hyperlipidemia; Cholesterol; Lipid metabolism; Internal medicine; Endocrinology; Biology; Medicine; Lipoprotein; Diabetes mellitus","score_opus":0.033237927048289255,"score_gpt":0.33934560520972273,"score_spread":0.30610767816143347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404360991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004548364,0.9961506,0.000004794211,0.00010912418,0.0010133776,0.0015843452,0.00013351254,0.00010868905,0.0008500772],"genre_scores_gemma":[0.000017675977,0.9954657,0.00017207497,0.0001848014,0.0021443171,0.00038435892,0.00011328166,0.00013379789,0.001384013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973032,0.0002489966,0.00070159236,0.0007536324,0.0005298749,0.0004627028],"domain_scores_gemma":[0.99859047,0.000036778343,0.00010796156,0.0008536332,0.000039783703,0.00037140085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005841006,0.00057612744,0.0042282264,0.0006101501,0.000041942232,0.00007085223,0.00013637656,0.00035518582,0.000070008195],"category_scores_gemma":[0.00011410581,0.00037468344,0.0012931734,0.00072216976,0.000075652344,0.000070609385,0.00017063344,0.00081863045,0.00022413814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000048984984,0.000045491557,0.0000019165866,0.033553205,0.0005330086,0.00027958996,0.00003909379,1.5340214e-8,9.0458904e-8,0.0015966601,0.0006318234,0.96331424],"study_design_scores_gemma":[0.0005155754,0.000010143936,0.0004428273,0.008457623,0.015413692,0.00032297894,0.000010552372,0.0000014903353,2.7204584e-7,0.00022613928,0.9742795,0.00031916352],"about_ca_topic_score_codex":0.00018387623,"about_ca_topic_score_gemma":0.000009851145,"teacher_disagreement_score":0.9736477,"about_ca_system_score_codex":0.000059715465,"about_ca_system_score_gemma":0.00056753296,"threshold_uncertainty_score":0.99987054},"labels":[],"label_agreement":null},{"id":"W4404370476","doi":"10.1210/clinem/dgae804","title":"Dysbetalipoproteinemia: Focus on a Neglected Lipid Disorder","year":2024,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Focus (optics); Neuroscience; Psychology; Cognitive science; Psychoanalysis; Physics; Optics","score_opus":0.03307948452161444,"score_gpt":0.36387174674685674,"score_spread":0.3307922622252423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404370476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.879646,0.056217525,0.0015242411,0.054002844,0.0044031367,0.0007259387,0.000006101373,0.0001202951,0.0033539215],"genre_scores_gemma":[0.9742287,0.012667272,0.00048407642,0.00274392,0.009088013,0.000013409187,0.0000018083459,0.000055490593,0.0007173289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956476,0.0010339408,0.0017203978,0.00027928376,0.0007697232,0.0005490723],"domain_scores_gemma":[0.99737275,0.0008618429,0.00037181037,0.00078071083,0.00029524247,0.0003176639],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00226821,0.0002690576,0.0014801546,0.00024157697,0.00011055614,0.000027524142,0.00036160543,0.0002477858,0.00024100379],"category_scores_gemma":[0.0015504243,0.00013870762,0.0013344805,0.00033376258,0.00033029806,0.00009829967,0.000085897445,0.0027034527,0.00017015976],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002562637,0.00061231677,0.0004539905,0.00014948993,0.0031932488,0.0013339563,0.00019045328,0.000031549014,0.0009948051,0.017769765,0.006691125,0.96601665],"study_design_scores_gemma":[0.00680784,0.002621692,0.07414569,0.00041261376,0.003217313,0.008132974,0.000119000244,0.00012413903,0.0018617108,0.0043270797,0.8979729,0.00025704884],"about_ca_topic_score_codex":0.00012345292,"about_ca_topic_score_gemma":0.000013794126,"teacher_disagreement_score":0.96575963,"about_ca_system_score_codex":0.000030347595,"about_ca_system_score_gemma":0.0005632451,"threshold_uncertainty_score":0.9995974},"labels":[],"label_agreement":null},{"id":"W4404379091","doi":"10.1007/s11883-024-01258-8","title":"The Emerging Potential of Apolipoprotein C-III Inhibition for ASCVD Prevention: A State-of-the-Art Review","year":2024,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Angiology; Medicine; Apolipoprotein B; Internal medicine; Cholesterol","score_opus":0.05239979319096735,"score_gpt":0.36649050036404995,"score_spread":0.31409070717308263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404379091","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000108530454,0.98602617,0.0006142298,0.00017676066,0.002647565,0.010268456,0.000062798106,0.000048334892,0.000047171594],"genre_scores_gemma":[0.00019352743,0.9955541,0.00007845828,0.000019018946,0.00058347586,0.0022532814,0.00019550418,0.00012309232,0.0009995404],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99460095,0.0003028462,0.0027815343,0.00070125546,0.001171688,0.00044173753],"domain_scores_gemma":[0.9952491,0.0000433714,0.0023779979,0.0018050424,0.00038864752,0.00013582208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029578006,0.00054139487,0.002635424,0.00011667694,0.00022146179,0.000037733556,0.000196059,0.00018378989,0.000024877243],"category_scores_gemma":[0.00025933428,0.00029187565,0.0050309356,0.00069463206,0.00016711405,0.0000633979,0.00021647202,0.0005975327,0.000009320727],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000069013386,0.00010543194,0.0000014728396,0.18440568,0.00049529626,0.000003866798,0.0000229764,2.3821552e-7,0.000013591696,0.000022965816,0.005773074,0.8091485],"study_design_scores_gemma":[0.00021865439,0.00010147165,0.000011380539,0.26096797,0.0059842193,0.00020928767,0.000004170201,0.0000022488023,0.000078930825,0.00017961547,0.7320537,0.00018837013],"about_ca_topic_score_codex":0.000021105649,"about_ca_topic_score_gemma":0.000006822709,"teacher_disagreement_score":0.80896014,"about_ca_system_score_codex":0.0001985179,"about_ca_system_score_gemma":0.0010706194,"threshold_uncertainty_score":0.9999533},"labels":[],"label_agreement":null},{"id":"W4404511701","doi":"10.1186/s41043-024-00679-0","title":"Efficacy, side effects, adherence, affordability, and procurement of dietary supplements for treating hypercholesterolemia: a narrative review","year":2024,"lang":"en","type":"review","venue":"Journal of Health Population and Nutrition","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Red yeast rice; Medicine; Traditional medicine; Ingredient; Cholesterol; Narrative review; Food science; Biotechnology; Alternative medicine; Biology; Internal medicine; Intensive care medicine","score_opus":0.07693467031700926,"score_gpt":0.4331112527395706,"score_spread":0.35617658242256134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404511701","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016586527,0.9908225,0.00006959293,0.000862537,0.00014501814,0.0063868333,0.00004427556,0.0000074727786,0.0000031219304],"genre_scores_gemma":[0.0019377088,0.9953665,0.0016725649,0.00019484482,0.00029355643,0.00021174499,0.00029101345,0.000025458317,0.0000065879317],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969307,0.0004375198,0.0017986015,0.00024127317,0.00040776943,0.00018410492],"domain_scores_gemma":[0.99804384,0.00013858464,0.001280878,0.00015623965,0.00020917461,0.00017129035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002400536,0.00024733113,0.0024542215,0.00023124652,0.00010275438,0.0000145625945,0.00003719051,0.00014156757,0.0000019256943],"category_scores_gemma":[0.00022665088,0.00016538131,0.000549733,0.00018291373,0.000024797926,0.00008951657,0.000022763526,0.0003670371,2.0301142e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054333297,0.00013036943,0.000026004765,0.43412924,0.00015337706,0.0000020683108,0.00009897076,2.223304e-8,4.9077715e-7,0.0000062541167,0.00046312794,0.56493574],"study_design_scores_gemma":[0.0039864043,0.006674899,0.0012305221,0.6808198,0.004885773,0.0005519568,0.00013893729,0.000008669657,0.000001647633,0.00019673102,0.30131245,0.00019223474],"about_ca_topic_score_codex":0.000054319353,"about_ca_topic_score_gemma":0.000010359791,"teacher_disagreement_score":0.5647435,"about_ca_system_score_codex":0.00023935385,"about_ca_system_score_gemma":0.00031295602,"threshold_uncertainty_score":0.6744054},"labels":[],"label_agreement":null},{"id":"W4404531825","doi":"10.1093/eurheartj/ehae781","title":"Olpasiran lowering of lipoprotein(a) according to baseline levels: insights from the OCEAN(a)-DOSE study","year":2024,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Amgen","keywords":"Medicine; Baseline (sea); Lipoprotein(a); Internal medicine; Lipoprotein; Cholesterol; Oceanography","score_opus":0.0611509240667414,"score_gpt":0.31938220119121674,"score_spread":0.25823127712447536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404531825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859116,0.006290367,0.0024696542,0.0021882677,0.00096235384,0.000886287,0.0000122936935,0.00008867061,0.0011905277],"genre_scores_gemma":[0.99335366,0.0000870459,0.0007293405,0.0010592367,0.004502923,0.0000028370175,0.0000028683194,0.00009090194,0.00017118407],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971998,0.00062508235,0.00061869575,0.0003610749,0.00087383785,0.0003215513],"domain_scores_gemma":[0.99855965,0.00014746867,0.00007498801,0.0006878552,0.00015091542,0.00037910548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003203441,0.0002266035,0.00048520265,0.00018180009,0.00027340144,0.00017660199,0.00024183706,0.00003169494,0.00015110342],"category_scores_gemma":[0.00035470232,0.00013954238,0.00040885314,0.00048561185,0.000033894987,0.00015146623,0.00016896178,0.00086234673,0.00016864468],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014213518,0.0018250081,0.064672835,0.00073640887,0.0045535793,0.016480194,0.031184195,0.0005446711,0.06489105,0.00010529705,0.02905232,0.7845331],"study_design_scores_gemma":[0.004303096,0.003150555,0.7352004,0.004825845,0.00078185246,0.0030651435,0.01004419,0.0004027392,0.006242607,0.00008738759,0.23126863,0.0006275728],"about_ca_topic_score_codex":0.00015071443,"about_ca_topic_score_gemma":0.000014080343,"teacher_disagreement_score":0.7839055,"about_ca_system_score_codex":0.00008294784,"about_ca_system_score_gemma":0.0001963804,"threshold_uncertainty_score":0.5690373},"labels":[],"label_agreement":null},{"id":"W4404565237","doi":"10.1016/j.acvd.2024.11.001","title":"Estimation of the proportion of cardiovascular disease cases in France attributable to high concentrations of low-density lipoprotein cholesterol","year":2024,"lang":"en","type":"article","venue":"Archives of cardiovascular diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Cholesterol; Estimation; Atherosclerotic cardiovascular disease; Internal medicine; Cardiology; Ldl cholesterol; Disease; Environmental health","score_opus":0.00834597925702589,"score_gpt":0.23550768818866816,"score_spread":0.22716170893164228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404565237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9184622,0.06166147,0.016617496,0.00011595025,0.00015053665,0.0024947762,0.0004287088,0.00003260931,0.00003624306],"genre_scores_gemma":[0.99783665,0.0012235205,0.00052383094,0.000016760698,0.00010562891,0.00015882637,0.00008054173,0.0000358373,0.00001839122],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963667,0.00037580015,0.00085678586,0.0005037716,0.0016011337,0.0002958526],"domain_scores_gemma":[0.99739534,0.00010747221,0.00016794818,0.0018626968,0.00021704104,0.00024947742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061685016,0.00025246883,0.0013887826,0.00026283137,0.0000566864,0.000011893944,0.00022033817,0.000064653344,0.000007850112],"category_scores_gemma":[0.00060973957,0.0001964725,0.0032732189,0.0007704689,0.0003678954,0.00015946862,0.00012758953,0.0001659818,0.0000014654285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006797573,0.00119801,0.03966515,0.023895904,0.01590182,0.00022670956,0.0008178946,0.45416003,0.0032733332,0.001114835,0.000027703443,0.45903885],"study_design_scores_gemma":[0.0021223878,0.00028610145,0.8844524,0.0058607566,0.006328589,0.00004238364,0.00010254425,0.003903934,0.09511182,0.000509594,0.00099462,0.00028486853],"about_ca_topic_score_codex":0.0031780638,"about_ca_topic_score_gemma":0.000014790898,"teacher_disagreement_score":0.84478724,"about_ca_system_score_codex":0.000046270157,"about_ca_system_score_gemma":0.0006363156,"threshold_uncertainty_score":0.80119157},"labels":[],"label_agreement":null},{"id":"W4404610964","doi":"10.1007/s11883-024-01252-0","title":"Lp(a): A Rapidly Evolving Therapeutic Landscape","year":2024,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Angiology; Computational biology; Internal medicine; Biology","score_opus":0.08074497484966937,"score_gpt":0.3650660884991479,"score_spread":0.28432111364947854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404610964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004620379,0.9914733,0.00007053305,0.00003586704,0.004287616,0.0026959463,0.000023305338,0.00043406995,0.0009331211],"genre_scores_gemma":[0.00042977982,0.9952277,0.00006039582,0.000049530026,0.0022376366,0.0007041043,0.0002630553,0.00032020366,0.00070760964],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99487734,0.00020563485,0.0016464503,0.001385727,0.0011392863,0.0007455457],"domain_scores_gemma":[0.99655855,0.000047761772,0.0006736973,0.0021303515,0.00015919801,0.0004304277],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013009416,0.00096696167,0.0036305846,0.00040134066,0.00015066258,0.00020287854,0.00018666442,0.00052597054,0.00036005912],"category_scores_gemma":[0.00010292282,0.0006458572,0.0038206836,0.00083310116,0.000078262245,0.00009045606,0.0001866341,0.0013684944,0.00042867337],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002295188,0.0001444542,0.0000986717,0.048909202,0.000988463,0.0001798757,0.00008277301,4.5200924e-8,0.00000163703,0.000011660276,0.006225092,0.94335586],"study_design_scores_gemma":[0.00019864792,0.00009614165,0.00014887363,0.06257704,0.008618001,0.0017672181,0.00001024633,0.0000062710405,0.0000011323107,0.000029566896,0.926001,0.00054587534],"about_ca_topic_score_codex":0.000017249873,"about_ca_topic_score_gemma":0.0000015553653,"teacher_disagreement_score":0.94280994,"about_ca_system_score_codex":0.0003560116,"about_ca_system_score_gemma":0.0012321952,"threshold_uncertainty_score":0.9995993},"labels":[],"label_agreement":null},{"id":"W4404618993","doi":"10.54254/2753-8818/62/20241479","title":"Therapeutic effects of Alirocumab on atherosclerosis: mechanisms and clinical applications","year":2024,"lang":"en","type":"article","venue":"Theoretical and Natural Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"","keywords":"Alirocumab; PCSK9; Kexin; LDL receptor; Medicine; Atherosclerotic cardiovascular disease; Familial hypercholesterolemia; Clinical trial; Evolocumab; Proprotein convertase; Low-density lipoprotein; Pharmacology; Lipoprotein; Cholesterol; Internal medicine; Disease","score_opus":0.007770192295311833,"score_gpt":0.3059876886966965,"score_spread":0.2982174964013847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404618993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98185307,0.0089499885,0.0053041033,0.0018204732,0.00024781836,0.0008225449,0.0000021072437,0.00007167858,0.0009282118],"genre_scores_gemma":[0.9980848,0.0008345787,0.00048564954,0.00047764904,0.000070556416,0.000016938986,3.9238915e-7,0.0000052930695,0.000024185303],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9990787,0.000040008264,0.0001326418,0.00027811818,0.00031646242,0.00015407281],"domain_scores_gemma":[0.9994329,0.00019276926,0.00001306108,0.0001796112,0.00003138097,0.00015026677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084064767,0.00007229251,0.00018146659,0.000043579625,0.0000845826,0.00002585122,0.000065924774,0.000048692982,0.000008943754],"category_scores_gemma":[0.00006803364,0.000040670704,0.000071465576,0.00025504123,0.0014328866,0.0000388748,0.000045363846,0.00018812112,0.000005365217],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023620825,0.000030484265,0.000038788203,0.00012872479,0.000017734814,0.000001508163,0.00002705833,1.4443378e-8,0.01083868,0.8039355,0.0000013495447,0.18495652],"study_design_scores_gemma":[0.0026192968,0.0047544935,0.16926494,0.0017932632,0.0007756903,0.00023705003,0.00011881407,0.006382891,0.09905513,0.7125274,0.0019739687,0.0004970628],"about_ca_topic_score_codex":0.000004898052,"about_ca_topic_score_gemma":1.7731125e-7,"teacher_disagreement_score":0.18445946,"about_ca_system_score_codex":0.000013128868,"about_ca_system_score_gemma":0.00006482502,"threshold_uncertainty_score":0.527953},"labels":[],"label_agreement":null},{"id":"W4404727045","doi":"10.1016/j.jtha.2024.11.006","title":"Guidelines and guidance: what is the path forward for the ISTH?","year":2024,"lang":"en","type":"editorial","venue":"Journal of Thrombosis and Haemostasis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Thrombosis; Path (computing); Medicine; Internal medicine; Computer science","score_opus":0.05886990993237717,"score_gpt":0.37123319278454703,"score_spread":0.31236328285216985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404727045","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006609908,0.5073184,0.00041884006,0.09033133,0.399862,0.0010737932,0.00027333733,0.000012723802,0.00004858439],"genre_scores_gemma":[0.00032258424,0.46244487,0.001188086,0.0025013755,0.53297424,0.000041653406,0.000014142572,0.00007266855,0.0004403755],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970684,0.00007322491,0.0009738311,0.0003205261,0.0012637697,0.00030021835],"domain_scores_gemma":[0.9965684,0.0007349497,0.00055800553,0.00057809986,0.0013765242,0.00018404453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035315317,0.00034830027,0.0011751007,0.00009762081,0.00037423513,0.0005499672,0.0002550384,0.00043250836,0.000029706487],"category_scores_gemma":[0.00076624635,0.0001526811,0.001005222,0.00014808499,0.00017645607,0.00019922346,0.00013668968,0.00091184885,0.0000022664758],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011656702,0.00001874251,0.0000108,0.00088545604,0.0020196284,0.000009320756,0.00042900004,4.2062192e-7,0.000005431516,0.000023950883,0.8618923,0.1345884],"study_design_scores_gemma":[0.0013195683,0.00055513816,0.00014646663,0.0028332653,0.00477966,0.00013390947,0.0015428591,0.000058968282,0.000060334958,0.00047783914,0.9879239,0.00016806714],"about_ca_topic_score_codex":0.00011888892,"about_ca_topic_score_gemma":0.000016203532,"teacher_disagreement_score":0.13442035,"about_ca_system_score_codex":0.000091214904,"about_ca_system_score_gemma":0.0005645284,"threshold_uncertainty_score":0.62261546},"labels":[],"label_agreement":null},{"id":"W4404727703","doi":"10.1080/17512433.2024.2433603","title":"Risk of new onset diabetes mellitus with pitavastatin as compared to atorvastatin and rosuvastatin: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Expert Review of Clinical Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pitavastatin; Rosuvastatin; Medicine; Atorvastatin; Meta-analysis; Type 2 Diabetes Mellitus; Statin; Diabetes mellitus; Internal medicine; Pharmacology; Endocrinology","score_opus":0.1150498640106041,"score_gpt":0.5001066843340876,"score_spread":0.38505682032348343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404727703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019557678,0.9861447,0.000073053765,0.0013737758,0.0001606907,0.011793466,0.00037449878,0.00003170338,0.000028528217],"genre_scores_gemma":[0.000008119697,0.98364705,0.0041721766,0.010040196,0.00019310461,0.0015136303,0.000119773795,0.00009034866,0.0002156165],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98597234,0.005061382,0.0065075685,0.001185509,0.00082281674,0.0004503837],"domain_scores_gemma":[0.9916094,0.0026055805,0.003175977,0.001216645,0.0004217114,0.0009707017],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.008677251,0.00090689113,0.037603647,0.00032780322,0.000043482643,0.000015495225,0.00031450856,0.00024546988,0.0007376918],"category_scores_gemma":[0.0024165758,0.00047907705,0.006532253,0.001484963,0.00030346884,0.000046527,0.00023003652,0.0009105379,0.000049607694],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019329816,0.00011503304,0.0000041385065,0.7332219,0.2152568,0.000027996168,0.00005111279,7.12707e-8,4.8903203e-8,0.0000041768376,0.016238973,0.035060424],"study_design_scores_gemma":[0.0003536541,0.0005460681,0.000004474162,0.22505438,0.58341956,0.00006453249,0.0000100861835,0.00000187339,6.8807634e-7,0.000004167322,0.19030364,0.00023687072],"about_ca_topic_score_codex":0.00019319162,"about_ca_topic_score_gemma":0.000011969537,"teacher_disagreement_score":0.5081675,"about_ca_system_score_codex":0.000044193814,"about_ca_system_score_gemma":0.001120058,"threshold_uncertainty_score":0.9997661},"labels":[],"label_agreement":null},{"id":"W4405018482","doi":"10.1016/j.jacl.2024.11.008","title":"Variation in lipoprotein(a) response to potent lipid lowering: The role of apolipoprotein (a) isoform size","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; York University; American Heart Association","keywords":"Medicine; Gene isoform; Apolipoprotein B; Lipoprotein(a); Variation (astronomy); Internal medicine; Lipoprotein; Endocrinology; Cholesterol; Genetics; Biology; Gene","score_opus":0.02845290030042194,"score_gpt":0.3635471249868875,"score_spread":0.33509422468646555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405018482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663903,0.0024743804,0.001485844,0.02407663,0.003888243,0.00097065064,0.0000053937383,0.000024137882,0.0006844279],"genre_scores_gemma":[0.9881947,0.0003682635,0.0021706647,0.001199853,0.007775851,0.00002478814,5.7117444e-7,0.00003450157,0.00023083082],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9950617,0.00094159966,0.0025173812,0.00030797668,0.0007779099,0.00039346312],"domain_scores_gemma":[0.99608827,0.0020909477,0.00052146,0.000623826,0.0003367954,0.00033871483],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.016583154,0.00019347068,0.0012514428,0.0003184463,0.000042467236,0.000024359992,0.00029884608,0.00036511416,0.00011340091],"category_scores_gemma":[0.010708235,0.00012001746,0.0009478002,0.00057185267,0.00012926717,0.0001126753,0.000115328745,0.0012856545,0.000039560608],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034448367,0.0013112876,0.004951345,0.00057605107,0.0012944741,0.0003101499,0.0019579527,0.00029489765,0.044208057,0.00224926,0.0014178283,0.90698034],"study_design_scores_gemma":[0.004726551,0.010965643,0.6083895,0.0013947,0.00042660334,0.0015938606,0.00042383847,0.00042952297,0.0043420005,0.0042356425,0.36278397,0.00028817265],"about_ca_topic_score_codex":0.0002496383,"about_ca_topic_score_gemma":0.00004693375,"teacher_disagreement_score":0.90669215,"about_ca_system_score_codex":0.00013384169,"about_ca_system_score_gemma":0.0010443727,"threshold_uncertainty_score":0.997625},"labels":[],"label_agreement":null},{"id":"W4405110646","doi":"10.3389/fneur.2024.1476005","title":"Association of white matter hyperintensities with lipoprotein (a) levels: insights from a cohort study","year":2024,"lang":"en","type":"article","venue":"Frontiers in Neurology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Hyperintensity; Association (psychology); Medicine; Cohort; Cohort study; Internal medicine; White matter; Cardiology; Psychology; Magnetic resonance imaging; Radiology","score_opus":0.007309125805695682,"score_gpt":0.22010031528555699,"score_spread":0.2127911894798613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405110646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925432,0.0012367831,0.0011739801,0.002060327,0.00094427,0.0011736854,0.000012649713,0.00005079505,0.0008043101],"genre_scores_gemma":[0.9970548,0.000035142537,0.000774475,0.0009852627,0.00020628191,0.000116504845,0.00001117342,0.00003404266,0.0007823094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845344,0.00023285301,0.00029782034,0.00040484683,0.00039351592,0.00021752615],"domain_scores_gemma":[0.9993759,0.00003137446,0.0000669333,0.0003870601,0.00008443808,0.00005428534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029887524,0.00014783633,0.000622135,0.0002452225,0.000034381665,0.000011620828,0.00006796702,0.00014606352,0.000060345126],"category_scores_gemma":[0.000034599114,0.000114423856,0.00009625954,0.0002502573,0.000051369025,0.00006690765,0.00004929694,0.0004030963,0.000013719505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038588306,0.000114471426,0.9922173,0.000087576744,0.000655263,0.00045629242,0.001576295,0.000015808148,0.00006601512,0.0000060032417,0.0033319897,0.0010871195],"study_design_scores_gemma":[0.0011994832,0.00094579096,0.99179363,0.000059778842,0.00025074155,0.000039745348,0.0004354537,0.00034996308,0.000110126784,0.00014476324,0.0045711366,0.00009939389],"about_ca_topic_score_codex":0.0009845549,"about_ca_topic_score_gemma":0.00029643747,"teacher_disagreement_score":0.004511608,"about_ca_system_score_codex":0.000088326575,"about_ca_system_score_gemma":0.00009855669,"threshold_uncertainty_score":0.46660694},"labels":[],"label_agreement":null},{"id":"W4405273033","doi":"10.1210/endrev/bnae031","title":"The Biology and Clinical Implications of PCSK7","year":2024,"lang":"en","type":"review","venue":"Endocrine Reviews","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Biology; Disease; Bioinformatics; Proprotein convertase; Kexin; Population; Medicine; Computational biology; LDL receptor; Lipoprotein; Internal medicine; Cholesterol; Endocrinology","score_opus":0.14402103284034493,"score_gpt":0.5091755854199085,"score_spread":0.36515455257956353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405273033","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.0714696e-7,0.9937106,0.000020337191,0.0013319254,0.00030286066,0.002702274,0.000026474954,0.000022136004,0.0018830801],"genre_scores_gemma":[9.027134e-7,0.99736685,0.0002373775,0.00007718063,0.00090586365,0.0004110605,0.00005956749,0.000035450754,0.0009057488],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99714875,0.00054813595,0.0015934708,0.00038960233,0.00009250588,0.0002275116],"domain_scores_gemma":[0.99797875,0.00025061957,0.00036088083,0.0012229272,0.000049730254,0.00013709176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018227191,0.00026295384,0.0032071488,0.000065303895,0.00006121093,0.000011702025,0.0001633348,0.00011307747,0.000015757369],"category_scores_gemma":[0.0005476057,0.000114712915,0.0019754905,0.00028800746,0.0001678559,0.0000097265565,0.00015536534,0.000584803,0.00016176651],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[9.2307573e-7,0.000016525853,0.000008217446,0.030613136,0.00035187227,0.000003462918,0.0000011631803,1.0486146e-10,2.5818954e-8,0.004039028,0.005741234,0.9592244],"study_design_scores_gemma":[0.000103970866,0.00010371666,0.000019784617,0.010207257,0.0049306685,0.0006129939,0.0000010229661,1.0844437e-7,4.8449248e-8,0.00019501973,0.9837377,0.00008770965],"about_ca_topic_score_codex":0.000030986368,"about_ca_topic_score_gemma":0.000010152726,"teacher_disagreement_score":0.97799647,"about_ca_system_score_codex":0.000032661123,"about_ca_system_score_gemma":0.00029837858,"threshold_uncertainty_score":0.4677857},"labels":[],"label_agreement":null},{"id":"W4405323691","doi":"10.51731/cjht.2024.1040","title":"Evolocumab (Repatha)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Evolocumab; Medicine; Reimbursement; Statin; Hyperlipidemia; Internal medicine; Discontinuation; Physical therapy; Endocrinology; Cholesterol; Lipoprotein; Diabetes mellitus; Health care","score_opus":0.019935744332750752,"score_gpt":0.28352586770971805,"score_spread":0.2635901233769673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405323691","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11171389,0.7905327,0.0010446603,0.09346696,0.0012985879,0.00039834343,0.000012576029,0.0003427641,0.0011895087],"genre_scores_gemma":[0.9960039,0.0023288885,0.0008724484,0.00057248725,0.000063459884,0.0000048092916,0.0000014516728,0.000020010732,0.00013251077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864334,0.0000392817,0.00047298963,0.00013940076,0.00026508557,0.00043989945],"domain_scores_gemma":[0.99920344,0.000020429146,0.000100454796,0.00036639304,0.00013827842,0.0001710117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013232254,0.00010760897,0.00043609596,0.0007592315,0.0001330489,0.000040478328,0.00015570364,0.00014971955,0.00004102949],"category_scores_gemma":[0.0003507163,0.00008020286,0.0002366477,0.0004437017,0.00012608503,0.000089766734,0.000011177613,0.0006246139,0.000027998256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000570578,0.0000056927615,0.00060622924,0.0004723893,0.00010222938,0.0014091303,0.00013799076,0.0000014516411,0.000011708674,0.00219524,0.009982746,0.9850695],"study_design_scores_gemma":[0.00033412362,0.0007345942,0.004512384,0.0011444081,0.000045494424,0.0059785964,0.0014420879,0.000028846243,0.00027112878,0.0027215641,0.9826871,0.000099678975],"about_ca_topic_score_codex":0.0046845903,"about_ca_topic_score_gemma":0.001031792,"teacher_disagreement_score":0.9849698,"about_ca_system_score_codex":0.000631657,"about_ca_system_score_gemma":0.008452052,"threshold_uncertainty_score":0.9971691},"labels":[],"label_agreement":null},{"id":"W4405338813","doi":"10.1016/j.jlr.2024.100728","title":"The role of high-density lipoproteins in sepsis","year":2024,"lang":"en","type":"review","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Sepsis; High-density lipoprotein; Chemistry; Medicine; Cholesterol; Internal medicine; Biochemistry","score_opus":0.08054764858350474,"score_gpt":0.4269574471275339,"score_spread":0.3464097985440292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405338813","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007577624,0.9960233,0.0000024003718,0.0006532621,0.000510192,0.001176194,0.000008858022,0.000005726277,0.00086232205],"genre_scores_gemma":[0.0012525939,0.9940978,0.0001176774,0.00000867069,0.0035732975,0.00003523581,0.0000028349812,0.00006291846,0.00084894354],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9934052,0.0013470807,0.0015494584,0.0002674022,0.0028581072,0.00057274755],"domain_scores_gemma":[0.99703,0.00045543813,0.00046759952,0.0008895254,0.00086412014,0.00029331434],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.015272689,0.0002550522,0.002587666,0.0010629551,0.00012663093,0.000067566434,0.0005436239,0.0003864176,0.000039055423],"category_scores_gemma":[0.0010145957,0.00012546567,0.0017639638,0.0015080067,0.00021452435,0.000056047124,0.00028369855,0.0043400126,0.00006381076],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076779725,0.00011043554,0.0000102103295,0.01696478,0.00079824746,0.00031451596,0.00006617363,1.973599e-7,0.000006704409,0.00025295856,0.0019378313,0.9794612],"study_design_scores_gemma":[0.000353203,0.0005635702,0.00006926683,0.030713702,0.0006406566,0.00092752086,0.00016113013,0.0000021213045,0.000059515372,0.00054196565,0.96587425,0.00009311419],"about_ca_topic_score_codex":0.00087690115,"about_ca_topic_score_gemma":0.00010905399,"teacher_disagreement_score":0.97936803,"about_ca_system_score_codex":0.0005569837,"about_ca_system_score_gemma":0.003457076,"threshold_uncertainty_score":0.997957},"labels":[],"label_agreement":null},{"id":"W4405414154","doi":"10.1016/j.jacl.2024.12.003","title":"Exploring the impact of insurance switching on the cost-effectiveness of population genetic screening for familial hypercholesterolemia to US payers","year":2024,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; U.S. Department of Health and Human Services; Muscular Dystrophy Canada; National Institutes of Health; Bristol-Myers Squibb; AstraZeneca","keywords":"Medicine; Population; Actuarial science; Quality-adjusted life year; Life insurance; Cost effectiveness; Quality of life (healthcare); Genetic testing; Environmental health; Business; Risk analysis (engineering)","score_opus":0.2655037146005769,"score_gpt":0.4585594530722698,"score_spread":0.19305573847169288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405414154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855533,0.00027426172,0.010722665,0.0007489108,0.0018232177,0.00084914,0.000008208033,0.0000054320985,0.000014822033],"genre_scores_gemma":[0.99596804,0.00017823534,0.0007238995,0.00022502989,0.0028507966,0.00003159335,0.0000012062678,0.000019409657,0.0000017812553],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973031,0.000917537,0.0011204605,0.00015484438,0.0003229168,0.00018113785],"domain_scores_gemma":[0.9949774,0.0040698033,0.0003363925,0.00029117445,0.00021354153,0.00011166237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076132305,0.00011212123,0.00079409167,0.000107442786,0.000050742798,0.000009762195,0.00015267644,0.00009162788,0.0000028072668],"category_scores_gemma":[0.0028587552,0.00005251064,0.0010037754,0.00017594454,0.00005241666,0.00007056324,0.000030938347,0.00059880695,9.039457e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008502471,0.00017184977,0.3111411,0.0005483358,0.0012289635,0.000011466966,0.00035273857,0.016421016,0.0064630355,0.0001851563,0.00008865142,0.65488523],"study_design_scores_gemma":[0.00131583,0.0034212254,0.9923346,0.0010778656,0.00015140916,0.00010303376,0.00006362588,0.00060338096,0.000336443,0.00015973039,0.00038534906,0.00004750243],"about_ca_topic_score_codex":0.00021920302,"about_ca_topic_score_gemma":0.0000074030154,"teacher_disagreement_score":0.68119353,"about_ca_system_score_codex":0.000057422516,"about_ca_system_score_gemma":0.00016618012,"threshold_uncertainty_score":0.34224033},"labels":[],"label_agreement":null},{"id":"W4405641897","doi":"10.51731/cjht.2024.1050","title":"Inclisiran (Leqvio)","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Familial hypercholesterolemia; Drug; Syringe; Disease; Intensive care medicine; Family medicine; Internal medicine; Cholesterol; Pharmacology; Political science; Psychiatry","score_opus":0.023971632236052604,"score_gpt":0.29090637191898483,"score_spread":0.26693473968293224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405641897","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.119800694,0.76287293,0.0010740254,0.11262494,0.0013912847,0.00043870177,0.000014649669,0.00034142245,0.0014413717],"genre_scores_gemma":[0.9964597,0.001799407,0.0007296682,0.0008078417,0.00006928128,0.000003727287,0.0000016754587,0.000020195082,0.00010849137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986639,0.000041506944,0.0004912468,0.00013606621,0.00024071446,0.00042653727],"domain_scores_gemma":[0.99925315,0.000023224016,0.00009401679,0.0003288878,0.00012302911,0.00017767705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014182995,0.000106493964,0.00043213664,0.0007897817,0.00014635055,0.00004642626,0.0001611495,0.00014732432,0.00003838092],"category_scores_gemma":[0.00031164178,0.00007894559,0.00022051457,0.00048373052,0.00012962073,0.000092020186,0.000012484481,0.0006558307,0.000024451703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004461117,0.000005020464,0.00058564695,0.00042763527,0.000086968466,0.00093980314,0.00014621225,0.0000011052203,0.000011263536,0.0021945934,0.0052722166,0.9903251],"study_design_scores_gemma":[0.00031207292,0.00064306066,0.00480167,0.0010665419,0.000035817007,0.0034604657,0.001267857,0.000013741696,0.00022124001,0.0026227136,0.9854685,0.000086310654],"about_ca_topic_score_codex":0.0050401306,"about_ca_topic_score_gemma":0.0013874854,"teacher_disagreement_score":0.9902388,"about_ca_system_score_codex":0.000506767,"about_ca_system_score_gemma":0.006937589,"threshold_uncertainty_score":0.99869215},"labels":[],"label_agreement":null},{"id":"W4405694336","doi":"10.1080/14656566.2024.2444986","title":"Advances in the pharmacological management of hyperlipidemia through the use of combination therapies","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Pharmacotherapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Hyperlipidemia; Combination therapy; Intensive care medicine; Ezetimibe; Disease; Pharmacology; Internal medicine; Statin; Diabetes mellitus","score_opus":0.184755032120173,"score_gpt":0.4709485409633059,"score_spread":0.2861935088431329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405694336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020932235,0.99331856,0.00008028601,0.0014221566,0.0011097161,0.0033316573,0.000019407198,0.00003198919,0.0006653218],"genre_scores_gemma":[0.00014730326,0.99590284,0.00026402838,0.0021970351,0.0004993572,0.0008268239,0.000043000713,0.00005354894,0.000066042165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969047,0.0008592883,0.00083495246,0.00038748427,0.000776687,0.00023692193],"domain_scores_gemma":[0.99872595,0.000314119,0.0003270102,0.0005446141,0.000053462507,0.00003485826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087397214,0.00039034738,0.0013252912,0.00012671434,0.000060872888,0.00002077242,0.00037608406,0.0001539862,0.00011075666],"category_scores_gemma":[0.00000762965,0.00016581206,0.0009096121,0.00058787747,0.00015192508,0.00012225815,0.00003687167,0.0005848373,0.000010374934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012607675,0.00043241616,7.160289e-7,0.0062026223,0.00087152276,0.000012519587,0.00097394106,0.0000035375751,0.00001017536,0.0037718583,0.0056537623,0.98194087],"study_design_scores_gemma":[0.0012888423,0.0003136166,0.000005515042,0.008285163,0.00025378517,0.000026384847,0.00022589402,0.00001920068,0.000061319006,0.000113928836,0.9892555,0.00015083342],"about_ca_topic_score_codex":0.00003398102,"about_ca_topic_score_gemma":3.2205855e-7,"teacher_disagreement_score":0.98360175,"about_ca_system_score_codex":0.000099140496,"about_ca_system_score_gemma":0.000087491055,"threshold_uncertainty_score":0.676162},"labels":[],"label_agreement":null},{"id":"W4405736455","doi":"10.1056/evide2400391","title":"Low LDL, High Reassurance? Evolocumab’s Long-Term Cognitive Safety Profile","year":2024,"lang":"en","type":"editorial","venue":"NEJM Evidence","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Evolocumab; Term (time); Cognition; Psychology; Medicine; Internal medicine; Psychiatry; Physics; Apolipoprotein B","score_opus":0.015228552246161136,"score_gpt":0.3101656921532363,"score_spread":0.29493713990707515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405736455","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0049920287,0.06575035,0.00037600938,0.0009872908,0.92067426,0.0037906358,0.0008264549,0.00048459164,0.0021183877],"genre_scores_gemma":[0.04124144,0.016893841,0.00017364784,0.00025176816,0.923127,0.00059438037,0.0011956489,0.00023576661,0.016286518],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99302214,0.00030580448,0.00087069423,0.001590757,0.0033568006,0.0008538263],"domain_scores_gemma":[0.99544436,0.0008922296,0.000308241,0.0015907433,0.0012808585,0.00048354355],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0018225546,0.0007555102,0.0017088936,0.00022692389,0.00019160472,0.00015367725,0.00042117885,0.0014815038,0.0008298698],"category_scores_gemma":[0.0045488607,0.0006283423,0.00088052335,0.0005646882,0.00024147013,0.0003279192,0.00024505088,0.0028211647,0.0021560183],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011152965,0.00009892734,0.00021274091,0.009796101,0.0007639857,0.0017789763,0.000121465964,4.097425e-7,0.000029715364,0.000012520944,0.9256286,0.06044128],"study_design_scores_gemma":[0.005563737,0.002645211,0.033836722,0.16738372,0.0063687577,0.00047707837,0.00008962094,0.000028150811,0.0016147834,0.00013695649,0.7795638,0.002291486],"about_ca_topic_score_codex":0.0012129906,"about_ca_topic_score_gemma":0.00012012027,"teacher_disagreement_score":0.15758762,"about_ca_system_score_codex":0.000796094,"about_ca_system_score_gemma":0.0035826245,"threshold_uncertainty_score":0.9998148},"labels":[],"label_agreement":null},{"id":"W4405842856","doi":"10.1038/s41598-024-81628-z","title":"Association of higher potency statin use with risk of osteoporosis and fractures in patients with stroke in a Korean nationwide cohort study","year":2024,"lang":"en","type":"article","venue":"Scientific Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Korea Health Industry Development Institute; Ministry of Food and Drug Safety; Sungkyunkwan University","keywords":"Medicine; Osteoporosis; Statin; Stroke (engine); Cohort; Internal medicine; Cohort study; Stroke risk; Ischemic stroke; Bioinformatics; Biology; Ischemia","score_opus":0.004643396102243897,"score_gpt":0.23751926178715863,"score_spread":0.23287586568491472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405842856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799037,0.0001465743,0.0000111845575,0.000029517816,0.0002828294,0.001402584,0.000019059617,0.0000121967405,0.00010567088],"genre_scores_gemma":[0.99869674,0.0000084074945,0.00030637544,0.0000050251033,0.000010554538,0.000031072486,0.000047444977,0.0000124281605,0.00088194077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976276,0.000107690954,0.000491971,0.00042371277,0.0012053325,0.00014368938],"domain_scores_gemma":[0.99886286,0.00004741301,0.00033767062,0.00040004757,0.00029960874,0.000052374035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002592794,0.00009616733,0.00033967383,0.00032902326,0.000034392728,0.00005142288,0.00002203757,0.000047878097,0.000018291292],"category_scores_gemma":[0.00020685229,0.00006286441,0.000040862567,0.0005990424,0.00005270238,0.00016937674,0.000017030974,0.00014836149,2.049148e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006946053,0.00033531355,0.9956357,0.00010681828,0.00018693462,0.000101873775,0.001257095,0.000047487316,0.000052203126,0.0000012244999,0.00008688947,0.0021190061],"study_design_scores_gemma":[0.0009910251,0.00037869692,0.99728745,0.00021309606,0.00019666282,0.00000433521,0.0002491874,0.000016021511,0.00044020187,0.000040483967,0.00012008892,0.00006276402],"about_ca_topic_score_codex":0.0036067253,"about_ca_topic_score_gemma":0.0025499188,"teacher_disagreement_score":0.0023859416,"about_ca_system_score_codex":0.00011413121,"about_ca_system_score_gemma":0.00020129618,"threshold_uncertainty_score":0.54523134},"labels":[],"label_agreement":null},{"id":"W4406048986","doi":"10.2139/ssrn.5070657","title":"Neuronal PCSK9 Regulates Cognitive Performances via the Modulation of ApoER2 Synaptic Localization","year":2025,"lang":"en","type":"preprint","venue":"SSRN Electronic Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PCSK9; Neuroscience; Synaptic plasticity; Synapse; Biology; Hippocampal formation; Neuron; LDL receptor; Receptor; Lipoprotein; Cholesterol; Endocrinology; Biochemistry","score_opus":0.009234306958206763,"score_gpt":0.2562910762406995,"score_spread":0.24705676928249276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406048986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8058814,0.016789997,0.17372565,0.0011897169,0.00057697087,0.0012170306,0.000013413184,0.00003876197,0.0005670574],"genre_scores_gemma":[0.98891604,0.009722117,0.000043173903,0.00013406451,0.00066291814,0.000025821195,0.00008154597,0.00002229704,0.00039202135],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99723107,0.00024712054,0.00056165084,0.00029160373,0.0007038491,0.00096472027],"domain_scores_gemma":[0.9985499,0.00006049971,0.0004568064,0.0003638083,0.00050195574,0.00006704931],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0023122553,0.00024592123,0.00052648626,0.00019688219,0.0002373267,0.00002967984,0.00019476932,0.0002368064,0.000021099042],"category_scores_gemma":[0.00012052649,0.00016698352,0.0004529076,0.00023061741,0.00011212733,0.00007653894,0.00012675383,0.002947098,0.0000034846812],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022898994,0.00062662055,0.013237153,0.0036375292,0.014148243,0.000019187035,0.0016160894,0.06168487,0.0005872,0.02620533,0.00010963706,0.8758382],"study_design_scores_gemma":[0.009927557,0.004651969,0.114554584,0.008401686,0.009275805,0.0046107764,0.0049693943,0.46235487,0.0053539006,0.372766,0.0016253103,0.0015081369],"about_ca_topic_score_codex":0.00019984269,"about_ca_topic_score_gemma":0.00011948538,"teacher_disagreement_score":0.8743301,"about_ca_system_score_codex":0.0006147635,"about_ca_system_score_gemma":0.0048590214,"threshold_uncertainty_score":0.9993532},"labels":[],"label_agreement":null},{"id":"W4406052930","doi":"","title":"Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib","year":2012,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cholesterylester transfer protein; Dyslipidemia; Chemistry; Pharmacology; Medicine; Biochemistry; Internal medicine; Cholesterol; Disease","score_opus":0.2129342448833568,"score_gpt":0.5224248735224852,"score_spread":0.30949062863912846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406052930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679498,0.018779026,0.0022811436,0.0012031889,0.0010376867,0.0046994854,0.000059715916,0.0000686008,0.0039213537],"genre_scores_gemma":[0.9935809,0.0011713284,0.0004162331,0.0011211081,0.0024490522,0.0005646784,0.000020397107,0.00014066247,0.0005356537],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957732,0.00031116357,0.0011900582,0.0005578606,0.001240447,0.0009273024],"domain_scores_gemma":[0.9973254,0.00017804926,0.0003396644,0.0009729603,0.00032892442,0.0008549934],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0037784795,0.0004982096,0.0014731633,0.00073199696,0.00026550284,0.00039266696,0.00096071174,0.00033089682,0.0016806043],"category_scores_gemma":[0.0003069948,0.0003914088,0.00089798565,0.00068830187,0.00011789574,0.001840173,0.00020484197,0.00080601283,0.000031390136],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003819946,0.0030369884,0.3204639,0.002723804,0.0023609383,0.00007739383,0.0009801293,0.000034601897,0.24966687,0.0010836388,0.048237503,0.3675143],"study_design_scores_gemma":[0.006774202,0.00024305028,0.5009759,0.0031080723,0.00072468206,0.00010766167,0.00013232167,0.000013626718,0.3898412,0.0017278971,0.09535301,0.0009983819],"about_ca_topic_score_codex":0.00031820472,"about_ca_topic_score_gemma":0.000020058083,"teacher_disagreement_score":0.3665159,"about_ca_system_score_codex":0.00021773564,"about_ca_system_score_gemma":0.00024872788,"threshold_uncertainty_score":0.9998538},"labels":[],"label_agreement":null},{"id":"W4406053094","doi":"10.18103/mra.v12i12.6160","title":"A Personalized Medicine Approach is Best for Patients with Homozygous Familial Hypercholesterolemia","year":2024,"lang":"en","type":"article","venue":"Medical Research Archives","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute","keywords":"Familial hypercholesterolemia; Personalized medicine; Medicine; Openness to experience; Health care; Multidisciplinary approach; Disease; Psychology; Bioinformatics; Cholesterol; Internal medicine; Social psychology; Sociology; Social science","score_opus":0.04893374373716055,"score_gpt":0.3713875329031772,"score_spread":0.3224537891660167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406053094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8571631,0.021634448,0.04054263,0.032525912,0.0005004186,0.008584405,0.00023657938,0.00036996076,0.038442574],"genre_scores_gemma":[0.97252667,0.0037966669,0.006800749,0.0020198019,0.003993242,0.0015645835,0.000506204,0.00018704665,0.0086050555],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99343586,0.00034921092,0.0003555913,0.0007735217,0.0041422057,0.000943611],"domain_scores_gemma":[0.99705505,0.00091819407,0.000020304942,0.0005853181,0.00021138167,0.0012097566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023206417,0.00024192294,0.00062392285,0.00043503434,0.00026293314,0.00005069452,0.00030669378,0.00015493596,0.00034508365],"category_scores_gemma":[0.0016515129,0.00013996224,0.00026457547,0.0005079562,0.0016245272,0.0000738145,0.00013486968,0.0012499826,0.000051819658],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002892272,0.0010505038,0.0031642313,0.004182639,0.0007455452,0.00047993456,0.006024881,2.505052e-7,0.00013850794,0.0017169546,0.013430401,0.9661739],"study_design_scores_gemma":[0.02226248,0.013423385,0.017023066,0.0067034373,0.00040619416,0.0005415662,0.0023987715,0.0074882046,0.000089603964,0.0020913593,0.9270209,0.00055104983],"about_ca_topic_score_codex":0.00023781642,"about_ca_topic_score_gemma":0.000010434139,"teacher_disagreement_score":0.96562284,"about_ca_system_score_codex":0.00008816217,"about_ca_system_score_gemma":0.0011988647,"threshold_uncertainty_score":0.5985638},"labels":[],"label_agreement":null},{"id":"W4406124533","doi":"10.3390/jcm14020305","title":"25-Year Comparison of Coronary Lesions Anatomy in Two Cohorts of French Canadians with Familial Hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Cohort; Coronary atherosclerosis; Coronary angiography; Internal medicine; Cardiology; Incidence (geometry); Familial hypercholesterolemia; Angiography; Artery; Referral; Coronary artery disease; Myocardial infarction; Cholesterol","score_opus":0.043292667320935105,"score_gpt":0.4295931586036692,"score_spread":0.3863004912827341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406124533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970574,0.0019626445,0.00035955966,0.0036985134,0.00046660012,0.00033764594,0.0000057428783,0.0000036103863,0.0034599272],"genre_scores_gemma":[0.9970568,0.000463456,0.001166167,0.00074388465,0.00046353418,0.000001821112,0.000003678342,0.000011565325,0.000089122375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961394,0.00025712073,0.0024251363,0.000172216,0.0007948475,0.00021125024],"domain_scores_gemma":[0.99756056,0.0004721223,0.000716682,0.0003945728,0.0004925104,0.00036356197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002835262,0.00013981678,0.002114373,0.00036159513,0.000020989051,0.0000014183615,0.00016440988,0.00013435747,0.00005157694],"category_scores_gemma":[0.00095612154,0.00008799529,0.0002724793,0.00044922548,0.00039124125,0.00004433235,0.000027498869,0.00094666966,6.551658e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089658634,0.0004309921,0.94305027,0.00022819429,0.00035231776,0.0002506804,0.00019098546,0.000030260506,0.00009548459,0.00012342508,0.0020288134,0.052321978],"study_design_scores_gemma":[0.013477109,0.0036997804,0.974242,0.0038114013,0.00055929285,0.00013620456,0.0009461926,0.00009251644,0.000086539905,0.00010068995,0.0027843763,0.00006391715],"about_ca_topic_score_codex":0.0077785267,"about_ca_topic_score_gemma":0.005229838,"teacher_disagreement_score":0.05225806,"about_ca_system_score_codex":0.000082207094,"about_ca_system_score_gemma":0.0015015207,"threshold_uncertainty_score":0.99882877},"labels":[],"label_agreement":null},{"id":"W4406165086","doi":"10.1101/2025.01.07.25320160","title":"Lack of evidence for obesity paradox in patients with cardiovascular diseases: A UK BioBank cohort study","year":2025,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"National Natural Science Foundation of China","keywords":"Biobank; Cohort; Obesity; Medicine; Cohort study; Environmental health; Internal medicine; Bioinformatics; Biology","score_opus":0.06757678681108935,"score_gpt":0.33658367988980525,"score_spread":0.2690068930787159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406165086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786276,0.0063489205,0.0009156119,0.000060354512,0.00030494368,0.013470623,0.00017196452,0.000043113778,0.000056854133],"genre_scores_gemma":[0.99730784,0.00041913128,0.0003901642,0.00006490245,0.00014255755,0.0014522632,0.00010395571,0.000034019977,0.000085191336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598116,0.0003522997,0.00070391677,0.0010647391,0.0015104437,0.0003874433],"domain_scores_gemma":[0.9961051,0.000112315975,0.00022145738,0.002792489,0.0005687567,0.00019991824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021663867,0.00040960344,0.0022452795,0.00026911544,0.000054740194,0.000017475639,0.00033833028,0.00022589376,0.000013785736],"category_scores_gemma":[0.00061869965,0.0002842992,0.001157549,0.00040557692,0.00008692463,0.0000430505,0.00036829594,0.00046694113,0.0000022574136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008472553,0.0013045586,0.9873684,0.004076471,0.0034146067,0.000035845853,0.00015244697,0.00022032844,2.7766086e-7,0.000004867894,0.000042848907,0.0025320714],"study_design_scores_gemma":[0.0047440855,0.0007400908,0.987128,0.0028718414,0.003835025,9.463739e-7,0.00005618349,0.000039309143,0.00002274287,0.000042853222,0.00025097557,0.00026794663],"about_ca_topic_score_codex":0.0018638687,"about_ca_topic_score_gemma":0.00011984556,"teacher_disagreement_score":0.0186802,"about_ca_system_score_codex":0.0002591225,"about_ca_system_score_gemma":0.00087546575,"threshold_uncertainty_score":0.9999609},"labels":[],"label_agreement":null},{"id":"W4406212852","doi":"10.1016/j.phrs.2024.107575","title":"GWAS of CRP response to statins further supports the role of APOE in statin response: A GIST consortium study","year":2025,"lang":"en","type":"review","venue":"Pharmacological Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"NIHR Barts Biomedical Research Centre, Queen Mary University of London; National Heart, Lung, and Blood Institute; National Institute for Health and Care Research; Barts Charity; AstraZeneca","keywords":"Genome-wide association study; Statin; Medicine; Inflammatory response; Oncology; Internal medicine; Inflammation; Biology; Genetics; Single-nucleotide polymorphism; Genotype","score_opus":0.14426831469709872,"score_gpt":0.5329206861434667,"score_spread":0.38865237144636794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406212852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09308181,0.8901539,0.0000064824853,0.0011309541,0.000085332074,0.014346745,0.0002745598,0.000025268444,0.00089497794],"genre_scores_gemma":[0.119457655,0.87466526,0.000107665226,0.0001600911,0.00010807573,0.0028615436,0.00002220997,0.00005471246,0.0025627785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97468024,0.019508604,0.00163501,0.00079968217,0.0024397487,0.0009367329],"domain_scores_gemma":[0.98732424,0.01015995,0.0002818616,0.0010736439,0.00074628246,0.0004140512],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03774336,0.0003868698,0.0027773874,0.0010410442,0.00011563818,0.000022527825,0.00072062056,0.0002778399,0.0010183846],"category_scores_gemma":[0.010937167,0.00022151017,0.00064260385,0.00274897,0.00046298426,0.000027014607,0.0007028822,0.0020840478,0.00004197161],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035805896,0.0037593236,0.00048529208,0.012653003,0.0011311934,0.0011274391,0.0021592241,0.0000046641426,0.00090868794,0.00003905563,0.002567353,0.9393589],"study_design_scores_gemma":[0.0026814009,0.005076958,0.004302897,0.00461053,0.00080380257,0.000028060977,0.003244384,0.000005203716,0.00029455707,0.00005365703,0.97865736,0.0002411916],"about_ca_topic_score_codex":0.00060984166,"about_ca_topic_score_gemma":0.000052707048,"teacher_disagreement_score":0.97609,"about_ca_system_score_codex":0.00045892913,"about_ca_system_score_gemma":0.0055776387,"threshold_uncertainty_score":0.9998948},"labels":[],"label_agreement":null},{"id":"W4406336518","doi":"10.1093/eurheartj/ehae791","title":"Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry","year":2025,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"NIHR Clinical Research Network North West London; NIHR Imperial Biomedical Research Centre; MPN Stichting; Ministerio de Universidades; Wyższa Szkoła Informatyki i Zarzadzania z siedziba w Rzeszowie; Ministry of Higher Education, Malaysia; Department of Health and Social Care; Universiti Teknologi MARA; Ministry of Higher Education; National Institute for Health and Care Research; Universidad de Sevilla","keywords":"Medicine; Overweight; Odds ratio; Body mass index; Obesity; Confidence interval; Internal medicine; Coronary artery disease; Population; Pediatrics; Environmental health","score_opus":0.031820698864063975,"score_gpt":0.3057024532608731,"score_spread":0.2738817543968091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406336518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94084847,0.052943815,0.000113700684,0.0040020975,0.00047500696,0.000472176,0.00000513442,0.000025538338,0.0011140347],"genre_scores_gemma":[0.99048966,0.006247505,0.00014171014,0.001744424,0.00095106574,0.0000052345267,0.000002993032,0.000023917128,0.000393485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975992,0.00096657407,0.00034093816,0.0002929712,0.0005306401,0.0002697195],"domain_scores_gemma":[0.99886245,0.00004313639,0.000051382085,0.0006461459,0.000179946,0.00021696313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00248221,0.00017213053,0.00045017406,0.00012500476,0.0003669674,0.00013133473,0.000107458436,0.00004050634,0.0000036793192],"category_scores_gemma":[0.00032383058,0.000114772934,0.00032693404,0.00030145605,0.00013594455,0.00013524934,0.00013182349,0.00064199715,0.000009771339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014381697,0.0006684016,0.86033297,0.0017037952,0.006160425,0.010368724,0.004126788,0.0012514996,0.0007629812,0.0004097702,0.04153821,0.07123827],"study_design_scores_gemma":[0.0026023425,0.00014021157,0.8885525,0.00067740143,0.00048293345,0.0011051986,0.0010167888,0.00007881038,0.000039334784,0.000101231104,0.10505416,0.00014909588],"about_ca_topic_score_codex":0.000041062634,"about_ca_topic_score_gemma":0.000015453621,"teacher_disagreement_score":0.07108918,"about_ca_system_score_codex":0.00013900758,"about_ca_system_score_gemma":0.00026510112,"threshold_uncertainty_score":0.46803042},"labels":[],"label_agreement":null},{"id":"W4406382888","doi":"10.1016/s0029-7437(07)70173-8","title":"10.1016/s0029-7437(07)70173-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Anastrozole; Spare part; Internal medicine; Psychology; Medicine; Business; Tamoxifen; Marketing","score_opus":0.007688465496087548,"score_gpt":0.2030550216136844,"score_spread":0.19536655611759687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406382888","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017023879,0.0004474768,0.0000035228404,0.00083801773,4.4315496e-7,0.000533888,0.000008249043,0.00017715071,0.99628884],"genre_scores_gemma":[0.00030872787,0.0000026014297,0.00032371806,0.0002477398,0.0007015758,0.000039722574,0.000022497361,0.000037935086,0.99831545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872136,0.000044447956,0.00020247042,0.00027889115,0.0004031519,0.0003496951],"domain_scores_gemma":[0.9988883,0.000013405925,0.000020415113,0.0006693145,0.000061372586,0.00034720244],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032846615,0.00015068968,0.00034728143,0.00006475213,0.0000770025,0.000019251098,0.000103628394,0.00009001132,0.9975614],"category_scores_gemma":[0.000036499332,0.0001290169,0.00021654821,0.00019803207,0.000025794589,0.000048741094,0.00002616834,0.00016598345,0.9965879],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010849361,0.000041590374,1.7835914e-7,0.00002849967,0.00005989352,0.00002506195,0.000011224609,0.000005657434,0.000023259245,5.220896e-7,0.48097312,0.5187225],"study_design_scores_gemma":[0.0008241644,0.00035061312,0.00022910898,0.00005755588,0.000085804415,0.00012046384,0.0000014470747,0.000036318514,0.0001535835,0.0000046749246,0.9979892,0.0001470863],"about_ca_topic_score_codex":0.00011387212,"about_ca_topic_score_gemma":2.3075083e-7,"teacher_disagreement_score":0.51857543,"about_ca_system_score_codex":0.00006594034,"about_ca_system_score_gemma":0.00009318701,"threshold_uncertainty_score":0.52611566},"labels":[],"label_agreement":null},{"id":"W4406384252","doi":"10.1016/s1558-0164(13)70013-0","title":"10.1016/s1558-0164(13)70013-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Disease; Cardiology; Internal medicine; Endocrinology","score_opus":0.006222944434236709,"score_gpt":0.1929621493198773,"score_spread":0.18673920488564058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406384252","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031654616,0.00045109322,0.0000027689755,0.00082593167,0.0000021975604,0.0005386237,0.000008179917,0.00015640206,0.9948493],"genre_scores_gemma":[0.0005770447,0.0000026690473,0.00019441568,0.00027857537,0.0006196103,0.000040334966,0.000024354564,0.000038988655,0.998224],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987078,0.000045353336,0.00020522522,0.00027991776,0.00040777272,0.00035395983],"domain_scores_gemma":[0.9988942,0.000013553822,0.000020545347,0.00065110036,0.000060926206,0.00035964328],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032404592,0.0001519468,0.00034854095,0.00007135374,0.000074023446,0.000018754508,0.000101997706,0.00008912263,0.9961058],"category_scores_gemma":[0.00003517572,0.00012919023,0.00021545446,0.00022876289,0.000025937972,0.000048501006,0.000025998123,0.00016576583,0.9978589],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001701032,0.000081352664,1.0715269e-7,0.000042159238,0.00009132634,0.000047526766,0.00001856845,0.000011250729,0.00004118924,6.958606e-7,0.3850979,0.6143978],"study_design_scores_gemma":[0.0008538737,0.00034795114,0.00033214883,0.00005559875,0.000084737665,0.00011596691,0.0000015624968,0.000046424044,0.00014623816,0.0000035553946,0.99786323,0.00014870595],"about_ca_topic_score_codex":0.0001830232,"about_ca_topic_score_gemma":4.4324725e-7,"teacher_disagreement_score":0.6142491,"about_ca_system_score_codex":0.00006600742,"about_ca_system_score_gemma":0.00009756866,"threshold_uncertainty_score":0.5268225},"labels":[],"label_agreement":null},{"id":"W4406388554","doi":"10.1016/s1634-6939(18)66059-4","title":"10.1016/s1634-6939(18)66059-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.008489472486617265,"score_gpt":0.20331461664744688,"score_spread":0.1948251441608296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406388554","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022500164,0.00046484658,0.0000026788507,0.00074854837,0.0000022816992,0.00052954856,0.000007949662,0.00015249853,0.9958416],"genre_scores_gemma":[0.00055755134,0.0000025207419,0.00022186215,0.0002890418,0.00060632324,0.000039613813,0.00002447922,0.000038025915,0.99822056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871886,0.00004590582,0.00020384829,0.00027845483,0.00040204282,0.00035086204],"domain_scores_gemma":[0.9988946,0.000014054627,0.000019489575,0.000656264,0.000062470914,0.00035317542],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003267101,0.00015085668,0.00034645014,0.00007004147,0.000074485426,0.000018059824,0.00010101527,0.00009016655,0.99734914],"category_scores_gemma":[0.000036077025,0.00012914423,0.0002129847,0.00023354054,0.0000260235,0.000048297,0.000025805339,0.00016538736,0.9925838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011176624,0.0000568132,3.2950484e-7,0.000030098043,0.00006999495,0.000034372773,0.000011644886,0.0000071324857,0.000031657088,5.059264e-7,0.26420578,0.7354399],"study_design_scores_gemma":[0.00085486734,0.00035214124,0.00027357522,0.000055438668,0.00008834158,0.00011543386,0.000001486992,0.000041045965,0.00017008082,0.0000034969014,0.99789685,0.00014726706],"about_ca_topic_score_codex":0.00013653994,"about_ca_topic_score_gemma":2.4175893e-7,"teacher_disagreement_score":0.7352927,"about_ca_system_score_codex":0.00006586937,"about_ca_system_score_gemma":0.00009853343,"threshold_uncertainty_score":0.52663493},"labels":[],"label_agreement":null},{"id":"W4406395619","doi":"10.1016/s0029-7437(09)70091-6","title":"10.1016/s0029-7437(09)70091-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gerontology; Internal medicine; Psychology","score_opus":0.0074346085152426685,"score_gpt":0.20164652140040584,"score_spread":0.19421191288516318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406395619","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022449982,0.00044073508,0.0000030553283,0.00077222794,4.2112586e-7,0.0005376814,0.000007961773,0.00018021566,0.9958127],"genre_scores_gemma":[0.0003147607,0.0000024841274,0.00025157485,0.00020590417,0.00062873913,0.000037137455,0.00002296697,0.00003803524,0.9984984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987187,0.000044947265,0.00020373684,0.00027856263,0.00040455352,0.00034949978],"domain_scores_gemma":[0.9988953,0.000013268856,0.000020038626,0.0006557486,0.000059970323,0.0003556889],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003251555,0.00015086346,0.00034668992,0.000069862275,0.00007624224,0.000018992381,0.00010083543,0.00009011912,0.9966006],"category_scores_gemma":[0.000034518736,0.0001290232,0.0002160746,0.00022777593,0.000025962536,0.00004717104,0.000025473553,0.00016589239,0.9945512],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109446984,0.000050777162,2.1200175e-7,0.000027574106,0.000058212318,0.000022393277,0.000013171343,0.0000062727177,0.000028155117,5.769052e-7,0.41972053,0.5799627],"study_design_scores_gemma":[0.0008252652,0.0003578927,0.00025094836,0.000056788773,0.000084209954,0.00011299801,0.0000016228674,0.000046815352,0.00016032982,0.00000346783,0.99795246,0.00014720677],"about_ca_topic_score_codex":0.00012120757,"about_ca_topic_score_gemma":2.5269972e-7,"teacher_disagreement_score":0.57981545,"about_ca_system_score_codex":0.00006659683,"about_ca_system_score_gemma":0.000091852766,"threshold_uncertainty_score":0.52614135},"labels":[],"label_agreement":null},{"id":"W4406412793","doi":"10.1016/j.acvd.2024.10.056","title":"Sex differences in management of LDL-cholesterol in patients with chronic coronary syndrome","year":2025,"lang":"en","type":"article","venue":"Archives of cardiovascular diseases","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Medicine; Ldl cholesterol; Acute coronary syndrome; Internal medicine; Cholesterol; Cardiology; Coronary heart disease; Myocardial infarction","score_opus":0.005009552353330945,"score_gpt":0.209574595331669,"score_spread":0.20456504297833805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406412793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796944,0.017590428,0.00040862407,0.000022690368,0.000035277273,0.0012770293,0.000028881223,0.000015108384,0.0009275066],"genre_scores_gemma":[0.9978396,0.0017066995,0.00019896838,0.000016388025,0.000009028447,0.00010619107,0.000041626135,0.0000162901,0.00006514971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981285,0.00017758973,0.00039776013,0.00037552143,0.000649289,0.00027138667],"domain_scores_gemma":[0.998865,0.000042032698,0.00006388637,0.0009077863,0.000028239736,0.00009306575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016463386,0.00019116432,0.0010412539,0.00036990622,0.000021252054,0.0000049045116,0.00016439338,0.000037081703,0.0000068455706],"category_scores_gemma":[0.000010482378,0.00015222728,0.0007044894,0.00034682313,0.00018315237,0.000060969054,0.00011772498,0.0001176341,7.768242e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040077645,0.00059062906,0.8824614,0.0036862057,0.004085271,0.00015649424,0.000068282585,0.00041613032,0.0000020522007,0.000087105705,0.0000018915597,0.108043715],"study_design_scores_gemma":[0.0073778043,0.00041609714,0.9876933,0.002969773,0.0010062492,0.0000062585723,0.00010198802,0.000033062868,0.000052589123,0.00012383545,0.00009576537,0.00012328857],"about_ca_topic_score_codex":0.00025596964,"about_ca_topic_score_gemma":0.00001574958,"teacher_disagreement_score":0.10792042,"about_ca_system_score_codex":0.00005772547,"about_ca_system_score_gemma":0.00015595603,"threshold_uncertainty_score":0.6207648},"labels":[],"label_agreement":null},{"id":"W4406413116","doi":"10.1016/s1558-0164(06)70093-1","title":"10.1016/s1558-0164(06)70093-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Internal medicine; Intensive care medicine","score_opus":0.006409542782910065,"score_gpt":0.19467812162514816,"score_spread":0.1882685788422381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406413116","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026296938,0.00046771893,0.0000029074204,0.0008645616,0.0000015452305,0.0005349909,0.0000088024735,0.00015634867,0.99533343],"genre_scores_gemma":[0.00053081714,0.0000025551035,0.00024365474,0.00027716925,0.000612304,0.000038366605,0.000030364548,0.0000382959,0.99822646],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987099,0.000045942423,0.00020512418,0.0002797837,0.00040824435,0.00035098914],"domain_scores_gemma":[0.99888426,0.00001363642,0.000020583386,0.0006649582,0.00006002058,0.00035656695],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000325808,0.00015167038,0.00034873953,0.00007171367,0.00007366373,0.000018567627,0.00010332018,0.00008791873,0.995228],"category_scores_gemma":[0.000035533103,0.00012916744,0.00021803334,0.00022767836,0.000025461788,0.000049056875,0.000025786027,0.00016565519,0.9982372],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001486494,0.00008481824,1.13390435e-7,0.000044359418,0.000094474126,0.000046649788,0.000019262941,0.000009232245,0.00005676965,9.727204e-7,0.52166116,0.4778335],"study_design_scores_gemma":[0.0008252538,0.00031877763,0.00028615608,0.000056427798,0.000084605024,0.00011418179,0.0000015644264,0.000037198137,0.00018318316,0.0000037061632,0.9979405,0.00014849412],"about_ca_topic_score_codex":0.00010043696,"about_ca_topic_score_gemma":1.9401557e-7,"teacher_disagreement_score":0.477685,"about_ca_system_score_codex":0.00006667404,"about_ca_system_score_gemma":0.00009837171,"threshold_uncertainty_score":0.5267295},"labels":[],"label_agreement":null},{"id":"W4406418447","doi":"10.1016/s0029-7437(08)70347-1","title":"10.1016/s0029-7437(08)70347-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dementia; Gerontology; Cholesterol; Medicine; Psychology; Internal medicine; Disease","score_opus":0.00773383823219501,"score_gpt":0.2025217970395593,"score_spread":0.1947879588073643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406418447","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020742235,0.00047287965,0.0000030332546,0.00080992904,4.433301e-7,0.0005381189,0.000008614768,0.00018071209,0.9959121],"genre_scores_gemma":[0.00039388073,0.0000026771345,0.00026658672,0.00025507828,0.0006341984,0.000039804403,0.000023683919,0.0000384107,0.9983457],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871254,0.000045146695,0.00020495581,0.0002795432,0.00040606447,0.00035174168],"domain_scores_gemma":[0.99888927,0.000013817413,0.000020125453,0.0006585269,0.000061429186,0.0003568279],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003290194,0.0001514345,0.0003484717,0.00007057367,0.00007534652,0.000018659894,0.00010135593,0.00009037794,0.9972054],"category_scores_gemma":[0.000036189136,0.00012959048,0.00021695517,0.00023027141,0.00002541445,0.00004839518,0.000025922727,0.00016690345,0.99522954],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001105972,0.000054901484,2.1680863e-7,0.000028754579,0.00006109405,0.00002359101,0.000012244319,0.000006125612,0.000028356015,5.7768256e-7,0.50491166,0.49476185],"study_design_scores_gemma":[0.0008515804,0.00035258668,0.000222743,0.000055934812,0.000083766136,0.00011390646,0.0000015308186,0.000044726945,0.0001706292,0.0000035761566,0.99795127,0.00014774142],"about_ca_topic_score_codex":0.000103834354,"about_ca_topic_score_gemma":2.4641255e-7,"teacher_disagreement_score":0.49461412,"about_ca_system_score_codex":0.00006739915,"about_ca_system_score_gemma":0.000095079624,"threshold_uncertainty_score":0.52845466},"labels":[],"label_agreement":null},{"id":"W4406422418","doi":"10.1016/j.ccol.2023.02.006","title":"10.1016/j.ccol.2023.02.006","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Ldl cholesterol; Cholesterol; Medicine; Internal medicine","score_opus":0.006375342258095621,"score_gpt":0.19705923855311094,"score_spread":0.1906838962950153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406422418","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032036495,0.00044800877,0.0000014662564,0.0007566683,0.0000024663054,0.0005913587,0.000009590877,0.00012513038,0.99486166],"genre_scores_gemma":[0.0004871758,0.000001880196,0.00016928217,0.00026881014,0.0006356006,0.00004985858,0.000024558592,0.000032536926,0.9983303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988049,0.00004118297,0.00018823473,0.00025643045,0.0003885472,0.00032064845],"domain_scores_gemma":[0.99901664,0.000012831092,0.000018008097,0.00058756577,0.00005724701,0.0003076973],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003134019,0.00013539229,0.0003207419,0.00006692224,0.000068266214,0.000017459572,0.00009072332,0.000086114094,0.9955249],"category_scores_gemma":[0.0000312236,0.00011705091,0.00019870102,0.00024562972,0.00002179614,0.000041869338,0.000024349485,0.00015367552,0.99323064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011924789,0.000056054345,4.107969e-7,0.00003234525,0.00006623257,0.000032066586,0.0000093006165,0.000009203564,0.000035763616,5.3828154e-7,0.23776919,0.76186967],"study_design_scores_gemma":[0.00075437676,0.00034291987,0.0003635309,0.000052140953,0.000080772435,0.00008225792,0.0000014054981,0.000043360727,0.00016552006,0.000002629732,0.9979782,0.00013287729],"about_ca_topic_score_codex":0.00016654635,"about_ca_topic_score_gemma":3.4755448e-7,"teacher_disagreement_score":0.76173675,"about_ca_system_score_codex":0.00006448841,"about_ca_system_score_gemma":0.000097967924,"threshold_uncertainty_score":0.47731978},"labels":[],"label_agreement":null},{"id":"W4406423075","doi":"10.1016/s1544-8800(09)70066-1","title":"10.1016/s1544-8800(09)70066-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Jupiter (rocket family); Medicine; Stroke (engine); Cardiology; Internal medicine; Astronomy; Physics","score_opus":0.006494120320741631,"score_gpt":0.19493722260744334,"score_spread":0.18844310228670172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406423075","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002742057,0.00045263144,0.0000028117302,0.00084746355,0.0000022602496,0.00054313627,0.000008465707,0.00015397539,0.9952472],"genre_scores_gemma":[0.00038256744,0.0000024004248,0.00023590667,0.0001889218,0.0006240137,0.00003977307,0.000023639455,0.000038254184,0.9984645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871176,0.000045386427,0.00020465234,0.00027842584,0.0004084366,0.00035132776],"domain_scores_gemma":[0.99889904,0.000013605156,0.000020107429,0.00065332785,0.000061481354,0.00035242122],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00031693108,0.00015113597,0.00034829744,0.00006998093,0.00007478286,0.000018593122,0.00010040989,0.00009022087,0.9954165],"category_scores_gemma":[0.000033369382,0.00012924484,0.00021703189,0.00022819261,0.000025840094,0.000048020334,0.000025504269,0.00016525181,0.99403983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001375555,0.00006068718,2.647081e-7,0.000032494107,0.000067415414,0.00003492796,0.000013721307,0.000007750406,0.000034823486,6.864069e-7,0.14714058,0.8524691],"study_design_scores_gemma":[0.00083633995,0.00034958567,0.00038134324,0.00005525139,0.00008570251,0.000110815454,0.0000015079156,0.000040273546,0.00018194933,0.0000034268376,0.99780643,0.00014736119],"about_ca_topic_score_codex":0.00018555277,"about_ca_topic_score_gemma":3.7391226e-7,"teacher_disagreement_score":0.85232174,"about_ca_system_score_codex":0.00006767148,"about_ca_system_score_gemma":0.00010139441,"threshold_uncertainty_score":0.52704513},"labels":[],"label_agreement":null},{"id":"W4406423079","doi":"10.1016/s1553-3212(10)70045-5","title":"10.1016/s1553-3212(10)70045-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Stroke (engine); Stroke risk; Medicine; Physical medicine and rehabilitation; Pediatrics; Ischemic stroke; Internal medicine; Engineering","score_opus":0.006688113749333514,"score_gpt":0.1952160077855447,"score_spread":0.1885278940362112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406423079","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019859793,0.00049017207,0.0000022016534,0.0008374522,0.0000022209404,0.0005352656,0.000009075731,0.00016142825,0.9959762],"genre_scores_gemma":[0.00038139717,0.0000022985316,0.00021361803,0.00024398381,0.0006464858,0.000041154213,0.000029216124,0.000040597424,0.9984012],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864584,0.00004930053,0.00021536497,0.0002931769,0.0004286064,0.00036769386],"domain_scores_gemma":[0.99883235,0.000014661813,0.000022307724,0.0006935152,0.00007080195,0.00036634988],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00034944626,0.00016057401,0.00036610395,0.00007354525,0.000079636506,0.000019877558,0.0001083316,0.00009697398,0.9976722],"category_scores_gemma":[0.000043270324,0.00013748466,0.00023095681,0.00023451017,0.000027720607,0.00005050374,0.000028014181,0.00016147037,0.99569213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017079445,0.00006472058,1.4897445e-7,0.000036073285,0.00007330994,0.000036481717,0.000013690273,0.0000076205556,0.000030346398,5.982531e-7,0.27489105,0.7246752],"study_design_scores_gemma":[0.0008985339,0.00040192145,0.00020155036,0.000058227397,0.00009227819,0.00009984346,0.0000015344318,0.000043945358,0.00018038524,0.0000033594126,0.9978623,0.00015611538],"about_ca_topic_score_codex":0.000114331524,"about_ca_topic_score_gemma":3.141107e-7,"teacher_disagreement_score":0.7245191,"about_ca_system_score_codex":0.000074968586,"about_ca_system_score_gemma":0.00011201781,"threshold_uncertainty_score":0.5606462},"labels":[],"label_agreement":null},{"id":"W4406423261","doi":"10.1016/s1553-3212(09)70091-3","title":"10.1016/s1553-3212(09)70091-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Jupiter (rocket family); Stroke (engine); Medicine; Stroke risk; Internal medicine; Cardiology; Ischemic stroke; Physics; Astronomy; Aerospace engineering; Engineering","score_opus":0.006480395697605966,"score_gpt":0.19499310466797656,"score_spread":0.1885127089703706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406423261","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029314037,0.00045962838,0.0000025510426,0.00084178994,0.0000022390966,0.00054675527,0.000007944185,0.00015479978,0.9950529],"genre_scores_gemma":[0.00039608745,0.000002627124,0.0002077143,0.00023247159,0.0006348021,0.000037201586,0.000024085162,0.000037720325,0.9984273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99872124,0.00004423831,0.00020334938,0.00027747624,0.00040648453,0.00034719767],"domain_scores_gemma":[0.9988993,0.000013416269,0.000020141155,0.0006539611,0.000059508016,0.00035367475],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032057526,0.00015010464,0.00034760332,0.00007153646,0.00007438582,0.000018624027,0.00009895526,0.0000885115,0.995481],"category_scores_gemma":[0.00003223765,0.00012874283,0.00021912326,0.00023023516,0.00002546412,0.00004641875,0.000025938685,0.00016424744,0.9938855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014987827,0.000060291342,2.432895e-7,0.000033020486,0.00006813798,0.0000359412,0.000016910446,0.000008340314,0.00003091183,6.4049584e-7,0.15993538,0.8396603],"study_design_scores_gemma":[0.00087526103,0.00034253087,0.0003209515,0.000056466324,0.00008502537,0.00011458055,0.0000016391414,0.000044720677,0.0001617288,0.0000033760407,0.9978468,0.00014691068],"about_ca_topic_score_codex":0.00013690825,"about_ca_topic_score_gemma":3.0066585e-7,"teacher_disagreement_score":0.8395134,"about_ca_system_score_codex":0.00006996962,"about_ca_system_score_gemma":0.000094521296,"threshold_uncertainty_score":0.524998},"labels":[],"label_agreement":null},{"id":"W4406450126","doi":"10.1016/s1541-9800(10)70287-8","title":"10.1016/s1541-9800(10)70287-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Simvastatin; Medicine; Pharmacology","score_opus":0.006768908647931686,"score_gpt":0.19554976486972356,"score_spread":0.18878085622179186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406450126","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020162924,0.0004914244,0.0000020828782,0.0008295432,0.0000021811818,0.0005340504,0.0000093687795,0.0001569952,0.9959581],"genre_scores_gemma":[0.00036426526,0.000002337157,0.00021196772,0.00023772819,0.000644191,0.00004222206,0.000030409055,0.000040636623,0.99842626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998641,0.000049981525,0.0002167802,0.00029476458,0.0004290224,0.00036845682],"domain_scores_gemma":[0.9988265,0.000015112366,0.000022190063,0.00069566397,0.00007224411,0.0003682921],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00035104548,0.00016088066,0.000367219,0.00007383379,0.00007929012,0.000020024618,0.00010858704,0.000096840355,0.99815714],"category_scores_gemma":[0.000043320975,0.00013767702,0.00022873383,0.00023784883,0.000027722836,0.00005065037,0.00002820671,0.00015970237,0.995617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016444657,0.000062575346,1.5658068e-7,0.000034149318,0.0000717623,0.000035034842,0.000013080449,0.000006628246,0.00003014072,5.506249e-7,0.29140356,0.7081779],"study_design_scores_gemma":[0.00091519207,0.00040015674,0.00020188626,0.00005765625,0.00009243121,0.00009827366,0.0000015300774,0.00004686947,0.00018272942,0.0000034051425,0.9978435,0.00015635075],"about_ca_topic_score_codex":0.00011543283,"about_ca_topic_score_gemma":2.9432258e-7,"teacher_disagreement_score":0.7080216,"about_ca_system_score_codex":0.00007368963,"about_ca_system_score_gemma":0.000108437955,"threshold_uncertainty_score":0.5614306},"labels":[],"label_agreement":null},{"id":"W4406451839","doi":"10.1016/s1166-4568(19)30140-8","title":"10.1016/s1166-4568(19)30140-8","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.0073025375472531495,"score_gpt":0.20048242553045803,"score_spread":0.19317988798320487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406451839","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021821193,0.0005650745,0.0000031336272,0.0010021264,0.0000021505834,0.0005499733,0.000008438786,0.00016490789,0.9955221],"genre_scores_gemma":[0.00040234046,0.0000030646004,0.0002451208,0.00038541688,0.0006104588,0.00004147037,0.000025031595,0.000037359412,0.9982497],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987066,0.000048915383,0.00020372456,0.00028246414,0.00040902372,0.00034931127],"domain_scores_gemma":[0.9987997,0.000015378908,0.00002020957,0.00065938616,0.00005670462,0.0004486685],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00035583976,0.00015024724,0.00034497908,0.000073295654,0.000081182305,0.000017961811,0.000101529644,0.00009021494,0.9957531],"category_scores_gemma":[0.000046666584,0.00012853413,0.00021548955,0.0002303646,0.000026705675,0.000043035092,0.000025863827,0.00016399508,0.99186033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001396778,0.000057868376,3.289404e-7,0.0000368451,0.00006664379,0.00004054487,0.000015190852,0.00000967623,0.000025541565,7.345657e-7,0.21973789,0.7798691],"study_design_scores_gemma":[0.0008735001,0.0003346195,0.00025808119,0.000047490717,0.00007415463,0.0001333715,0.0000016441302,0.000042070522,0.00012700658,0.0000042489964,0.99795705,0.00014677428],"about_ca_topic_score_codex":0.00016915573,"about_ca_topic_score_gemma":2.9771414e-7,"teacher_disagreement_score":0.7797223,"about_ca_system_score_codex":0.00007640378,"about_ca_system_score_gemma":0.000119380245,"threshold_uncertainty_score":0.524147},"labels":[],"label_agreement":null},{"id":"W4406452332","doi":"10.1016/s1155-1941(19)30044-7","title":"10.1016/s1155-1941(19)30044-7","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.007374838983657469,"score_gpt":0.20133630975273978,"score_spread":0.19396147076908232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406452332","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021214455,0.00051915756,0.0000031165453,0.0011066709,0.0000022558604,0.000558928,0.000009673862,0.00016964911,0.9955091],"genre_scores_gemma":[0.00039766595,0.0000025272384,0.00025867834,0.00039830385,0.0005933902,0.00004095486,0.000027816375,0.00003736659,0.9982433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987173,0.000047827838,0.00020360683,0.00028190707,0.0004001484,0.00034921945],"domain_scores_gemma":[0.9988049,0.000015182677,0.00002008523,0.0006562512,0.00005690793,0.0004466435],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00034799462,0.00014987407,0.00034312656,0.000072562696,0.00008185169,0.000018246372,0.000101591446,0.00009041139,0.9956187],"category_scores_gemma":[0.000048579554,0.00012852238,0.00021837094,0.00023817905,0.0000271335,0.00004544064,0.000025817686,0.00016555605,0.9920201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014596798,0.0000610271,2.995536e-7,0.000039202416,0.00007008533,0.00004178683,0.000016408916,0.00001078074,0.000028039156,7.311157e-7,0.21753222,0.7820535],"study_design_scores_gemma":[0.000899787,0.00033271077,0.00022038401,0.000049985712,0.000084685395,0.00013615776,0.0000016698588,0.000037674832,0.00011673614,0.000004107483,0.9979693,0.00014679506],"about_ca_topic_score_codex":0.00017239603,"about_ca_topic_score_gemma":3.0723274e-7,"teacher_disagreement_score":0.78190666,"about_ca_system_score_codex":0.00008155437,"about_ca_system_score_gemma":0.00012719752,"threshold_uncertainty_score":0.52409905},"labels":[],"label_agreement":null},{"id":"W4406452405","doi":"10.1016/s1097-8690(13)70017-9","title":"10.1016/s1097-8690(13)70017-9","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Environmental science","score_opus":0.006718917990476295,"score_gpt":0.19585305554036128,"score_spread":0.18913413754988498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406452405","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003612633,0.0004562106,0.000002559294,0.0010384097,0.0000023005246,0.0005349556,0.000008048777,0.0001542646,0.99419063],"genre_scores_gemma":[0.00046265716,0.00000261746,0.0002194974,0.00027432482,0.000636415,0.0000397537,0.000024322015,0.000038013455,0.9983024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998713,0.00004507922,0.00020353298,0.00027944602,0.00040598793,0.00035293572],"domain_scores_gemma":[0.9988803,0.000013458243,0.000020435817,0.000667919,0.000060760616,0.00035707004],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032888944,0.0001510035,0.00034821438,0.00006963011,0.000076882505,0.000019074845,0.00010282441,0.00008879553,0.99554175],"category_scores_gemma":[0.000035732304,0.00012905031,0.00021198914,0.00022120107,0.00002689575,0.000049536673,0.000025970778,0.00016346027,0.993381],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013715122,0.00006139015,2.856287e-7,0.00003284855,0.0000696602,0.00003795955,0.00001539703,0.00000717605,0.000029377969,4.5254635e-7,0.20770638,0.79190195],"study_design_scores_gemma":[0.00086063123,0.0003564371,0.0002938354,0.000056138248,0.00008598418,0.00011548521,0.0000015273407,0.000045924055,0.00016054507,0.0000038618396,0.9978723,0.00014732097],"about_ca_topic_score_codex":0.00017756266,"about_ca_topic_score_gemma":5.172722e-7,"teacher_disagreement_score":0.7917546,"about_ca_system_score_codex":0.00006261213,"about_ca_system_score_gemma":0.000096366246,"threshold_uncertainty_score":0.5262519},"labels":[],"label_agreement":null},{"id":"W4406455815","doi":"10.1016/j.yend.2014.03.002","title":"10.1016/j.yend.2014.03.002","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Metabolic syndrome; Internal medicine; Intervention (counseling); Cardiology; Endocrinology; Obesity; Psychiatry","score_opus":0.006468586237348254,"score_gpt":0.19569242052624422,"score_spread":0.18922383428889597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406455815","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018983049,0.0005555433,0.0000018512492,0.00081234286,0.000002255465,0.00047205866,0.000007921612,0.00014428266,0.99610543],"genre_scores_gemma":[0.00043686686,0.0000036107845,0.00022501753,0.00025222788,0.0006090788,0.000033238844,0.000021025447,0.00003557909,0.99838334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99880457,0.000043730157,0.00018538699,0.00026176454,0.00037844173,0.00032613674],"domain_scores_gemma":[0.9989476,0.000012604572,0.000018702842,0.0006331287,0.00005464473,0.00033331246],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003123142,0.00013823807,0.00032074965,0.00006569228,0.000066710134,0.000016704178,0.000093934344,0.00008199104,0.99694145],"category_scores_gemma":[0.000029014083,0.000116946314,0.00019804762,0.00016860038,0.000023455488,0.000044459117,0.000022887043,0.00014991968,0.99648184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010387152,0.00005031756,2.5371554e-7,0.000026908529,0.000059274786,0.000027591386,0.000011260624,0.000005126209,0.000029294357,6.38745e-7,0.27578476,0.7239007],"study_design_scores_gemma":[0.000780198,0.0003192717,0.00023391668,0.0000443562,0.00007662968,0.00010651043,0.0000012599631,0.00003727614,0.00017192271,0.0000029536136,0.99809206,0.00013367445],"about_ca_topic_score_codex":0.00011891366,"about_ca_topic_score_gemma":2.3776468e-7,"teacher_disagreement_score":0.72376704,"about_ca_system_score_codex":0.00005716342,"about_ca_system_score_gemma":0.00008156193,"threshold_uncertainty_score":0.47689322},"labels":[],"label_agreement":null},{"id":"W4406456171","doi":"10.1016/s0029-7437(05)70393-1","title":"10.1016/s0029-7437(05)70393-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Simvastatin; Medicine; Atorvastatin; Pharmacology; Statin; Internal medicine","score_opus":0.007527198927181777,"score_gpt":0.20202165628938348,"score_spread":0.1944944573622017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406456171","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018409506,0.0004495037,0.0000030979365,0.0010045174,5.20684e-7,0.00053370016,0.00000866455,0.00017959454,0.9959794],"genre_scores_gemma":[0.0003267817,0.0000024761785,0.00027641834,0.00030451582,0.00063764007,0.000039816052,0.000023845922,0.000038212685,0.9983503],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987158,0.00004626443,0.00020662928,0.00027668945,0.0004006108,0.00035400066],"domain_scores_gemma":[0.99889237,0.000014047311,0.000020423067,0.0006520767,0.00006056373,0.00036053412],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003391351,0.00015116522,0.0003514911,0.00007028538,0.00007492966,0.000018290117,0.000100846744,0.000087343426,0.9965748],"category_scores_gemma":[0.00003749232,0.00012889974,0.00021823448,0.0002276208,0.000025581592,0.000048295973,0.000025665122,0.00016508657,0.9943591],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098687575,0.00004884947,1.5164143e-7,0.000025632731,0.000053011532,0.000027066502,0.000010239625,0.000005537274,0.000023603972,5.3496683e-7,0.5269219,0.4727848],"study_design_scores_gemma":[0.0008384309,0.00033965238,0.00018358185,0.000056015575,0.000084814485,0.0001519584,0.0000014210522,0.000045167268,0.00016633957,0.0000036774072,0.99798244,0.00014652457],"about_ca_topic_score_codex":0.0001224451,"about_ca_topic_score_gemma":2.7358595e-7,"teacher_disagreement_score":0.47263825,"about_ca_system_score_codex":0.00006848535,"about_ca_system_score_gemma":0.0000939841,"threshold_uncertainty_score":0.5256379},"labels":[],"label_agreement":null},{"id":"W4406457256","doi":"10.1016/s1544-8800(08)70170-2","title":"10.1016/s1544-8800(08)70170-2","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Cardiology; Internal medicine; Stroke (engine); Engineering; Aerospace engineering","score_opus":0.006764626869559519,"score_gpt":0.19659348221701267,"score_spread":0.18982885534745314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406457256","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028570201,0.00043368296,0.0000027826918,0.00085241924,0.0000022087372,0.0005396293,0.000007827685,0.00015236325,0.99515206],"genre_scores_gemma":[0.0005913655,0.0000025717704,0.0002372292,0.00024292193,0.0006188808,0.000039235572,0.00002263463,0.000038022394,0.99820715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987075,0.000045589517,0.00021083171,0.00027864263,0.00040651512,0.00035093937],"domain_scores_gemma":[0.9988829,0.000013481197,0.000021355543,0.0006670148,0.00006128328,0.00035395977],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032929349,0.00015097027,0.00034835993,0.000069618276,0.00007759472,0.000019071724,0.00010256631,0.000090414636,0.99580806],"category_scores_gemma":[0.00003612102,0.00012918249,0.00022521977,0.00021641076,0.00002673549,0.00004869505,0.000025957128,0.00016628011,0.9949701],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013894358,0.000061037055,2.5163223e-7,0.00003423723,0.00006988876,0.00003760311,0.00001426422,0.0000075616263,0.00004167428,6.6594305e-7,0.18657714,0.8130167],"study_design_scores_gemma":[0.00085762225,0.00034464127,0.00034684662,0.000057091147,0.00008563365,0.000114812894,0.0000014430941,0.00004245739,0.00018788029,0.0000033330573,0.997811,0.00014721413],"about_ca_topic_score_codex":0.00016355967,"about_ca_topic_score_gemma":3.5084508e-7,"teacher_disagreement_score":0.8128695,"about_ca_system_score_codex":0.00006742672,"about_ca_system_score_gemma":0.00010186138,"threshold_uncertainty_score":0.5267909},"labels":[],"label_agreement":null},{"id":"W4406466025","doi":"10.1016/s1553-3212(07)70275-3","title":"10.1016/s1553-3212(07)70275-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Peripheral neuropathy; Medicine; Peripheral; Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.006556326800626876,"score_gpt":0.1954203044405118,"score_spread":0.18886397763988494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406466025","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024776065,0.00048467424,0.0000030798615,0.00084387755,0.000002349342,0.0005371515,0.000008262649,0.0001567038,0.9954863],"genre_scores_gemma":[0.0005186143,0.000002654488,0.00022852872,0.00029074555,0.0006347334,0.000039841056,0.000023767652,0.000038612423,0.99822253],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871117,0.000045456472,0.00020481473,0.0002793506,0.0004062487,0.00035294652],"domain_scores_gemma":[0.99888754,0.000013572125,0.000020386842,0.0006580101,0.000062304294,0.00035819891],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032984148,0.00015166649,0.00035014492,0.000066856206,0.00007499049,0.000018577497,0.00010180082,0.00009041119,0.9968898],"category_scores_gemma":[0.000036008907,0.00012940225,0.00021526554,0.00020866767,0.000025760752,0.00004837305,0.000026012263,0.00016668375,0.9961547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013970098,0.0000648451,2.5859399e-7,0.00003480326,0.0000737201,0.000039936698,0.000015314967,0.000007609501,0.000032392236,8.0334985e-7,0.19286045,0.80673015],"study_design_scores_gemma":[0.000830125,0.00034962295,0.00026809255,0.000055533023,0.00008325146,0.00011724796,0.0000015850109,0.000039251678,0.00016377936,0.0000037089853,0.9979402,0.00014764573],"about_ca_topic_score_codex":0.00012601238,"about_ca_topic_score_gemma":2.6252727e-7,"teacher_disagreement_score":0.8065825,"about_ca_system_score_codex":0.000068627356,"about_ca_system_score_gemma":0.00010391826,"threshold_uncertainty_score":0.5276871},"labels":[],"label_agreement":null},{"id":"W4406466354","doi":"10.1016/s1553-3212(07)70055-9","title":"10.1016/s1553-3212(07)70055-9","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Simvastatin; Parkinson's disease; Medicine; Neuroscience; Psychology; Internal medicine; Disease","score_opus":0.006540421112026324,"score_gpt":0.19559294228681273,"score_spread":0.1890525211747864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406466354","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027140905,0.0004947601,0.0000026511625,0.0009019511,0.0000023025862,0.0005329474,0.000008059588,0.00015572183,0.9951875],"genre_scores_gemma":[0.0006032841,0.0000027209467,0.00023224052,0.00030283822,0.00063587073,0.00003975902,0.000023600269,0.000038377475,0.9981213],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870867,0.000045042245,0.00020411964,0.00027846714,0.0004091899,0.0003545076],"domain_scores_gemma":[0.9988913,0.00001340694,0.00001970653,0.0006562215,0.000060138413,0.00035924098],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003296552,0.00015094201,0.00034772052,0.00006656864,0.000074447424,0.000018476721,0.00010082245,0.000090132045,0.9968637],"category_scores_gemma":[0.00003579819,0.00012918533,0.00021922425,0.00020270061,0.000025279935,0.00004919801,0.000025837791,0.00016558348,0.99624574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013663794,0.00006301249,2.3541257e-7,0.00003262949,0.00007243539,0.00003960018,0.00001550111,0.000007706412,0.00003740275,6.479534e-7,0.19172913,0.8078651],"study_design_scores_gemma":[0.0008266348,0.00034383958,0.0003139335,0.000054195654,0.00008448229,0.00011478249,0.0000016069174,0.000038918195,0.00015941757,0.000003260524,0.99791163,0.00014730102],"about_ca_topic_score_codex":0.00012057125,"about_ca_topic_score_gemma":2.451013e-7,"teacher_disagreement_score":0.80771774,"about_ca_system_score_codex":0.00006935761,"about_ca_system_score_gemma":0.00010205057,"threshold_uncertainty_score":0.5268025},"labels":[],"label_agreement":null},{"id":"W4406474034","doi":"10.1016/s1541-9800(06)71136-x","title":"10.1016/s1541-9800(06)71136-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Diabetes mellitus; Medicine; Internal medicine; Pharmacology; Endocrinology","score_opus":0.006546285656117256,"score_gpt":0.19527949522158117,"score_spread":0.1887332095654639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406474034","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026228128,0.00050097116,0.0000026986534,0.0009117174,0.0000015649867,0.00053616194,0.000008177384,0.00015471166,0.9952612],"genre_scores_gemma":[0.0005306018,0.0000027928977,0.00022319515,0.00028536905,0.0006185933,0.000039704486,0.000032118183,0.000038450908,0.99822915],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870366,0.000047134017,0.00020435924,0.00028016092,0.0004099348,0.00035473699],"domain_scores_gemma":[0.9988782,0.000013727345,0.000019608939,0.0006615647,0.00006166922,0.00036524242],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003344548,0.00015132493,0.00034833918,0.00006960353,0.00007463479,0.000018444463,0.0001010606,0.0000911819,0.995481],"category_scores_gemma":[0.000037145073,0.00012940296,0.00021692576,0.00022477868,0.000025775513,0.000048260405,0.000025460069,0.00016907664,0.99489546],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111130976,0.00006426783,3.7240315e-7,0.000035629637,0.0000738765,0.00003577973,0.00001574246,0.0000088802735,0.000029550267,7.3334644e-7,0.2516999,0.74792415],"study_design_scores_gemma":[0.00086385873,0.00030805694,0.00028872912,0.000056737652,0.000083518935,0.000110968125,0.0000016386757,0.00004556241,0.00012218049,0.0000037633388,0.9979673,0.00014767871],"about_ca_topic_score_codex":0.00010152773,"about_ca_topic_score_gemma":2.3093585e-7,"teacher_disagreement_score":0.74777645,"about_ca_system_score_codex":0.00006740144,"about_ca_system_score_gemma":0.000100034034,"threshold_uncertainty_score":0.52768993},"labels":[],"label_agreement":null},{"id":"W4406476824","doi":"10.1016/j.yend.2013.04.009","title":"10.1016/j.yend.2013.04.009","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Apolipoprotein B; Placebo; Internal medicine; Double blind; Randomized controlled trial; Gastroenterology; Cholesterol; Alternative medicine; Pathology","score_opus":0.007282459503468757,"score_gpt":0.19956787457286965,"score_spread":0.1922854150694009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406476824","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025915375,0.00059283106,0.0000018988355,0.0013366084,0.0000022266738,0.00049783644,0.000007561571,0.0001520999,0.9948174],"genre_scores_gemma":[0.00048338648,0.000004146213,0.00021620597,0.0002615371,0.0005841062,0.000019035104,0.000021619682,0.000034621586,0.99837536],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988087,0.00004162561,0.00018633172,0.0002564909,0.0003785285,0.0003283203],"domain_scores_gemma":[0.9989588,0.000011939513,0.000018601824,0.0006256752,0.000055567896,0.00032937687],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00029658555,0.00013887971,0.00032099275,0.00006603979,0.00006592703,0.000016918826,0.00009539971,0.00008234531,0.9951148],"category_scores_gemma":[0.000026519154,0.000117620446,0.00019722118,0.0001977334,0.00002259921,0.000047411955,0.000022854618,0.00015056331,0.99248934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010555875,0.000051837902,1.7118944e-7,0.000025806066,0.00005829167,0.000027796923,0.000011522562,0.000009799581,0.000025972622,5.726339e-7,0.22646107,0.7732216],"study_design_scores_gemma":[0.0007572786,0.00033106987,0.00020512468,0.000050003327,0.00007429186,0.000104922336,0.0000013769487,0.000048201426,0.00013746037,0.000003424762,0.9981524,0.00013448941],"about_ca_topic_score_codex":0.00020446096,"about_ca_topic_score_gemma":3.4644518e-7,"teacher_disagreement_score":0.7730871,"about_ca_system_score_codex":0.000055700133,"about_ca_system_score_gemma":0.00008129185,"threshold_uncertainty_score":0.47964227},"labels":[],"label_agreement":null},{"id":"W4406487469","doi":"10.1210/clinem/dgaf031","title":"Longitudinal Association of Statin Treatment With Insulin Sensitivity and Beta-Cell Function in the PROMISE Cohort","year":2025,"lang":"en","type":"article","venue":"The Journal of Clinical Endocrinology & Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Western University; University of Toronto","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Cohort; Internal medicine; Insulin sensitivity; BETA (programming language); Statin; Insulin; Association (psychology); Oncology; Insulin resistance; Psychology; Computer science","score_opus":0.027101458089751375,"score_gpt":0.33502435879554315,"score_spread":0.30792290070579176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406487469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878472,0.004297843,0.00033942703,0.0064544696,0.0001942573,0.00054217764,0.0000030499612,0.0000038963976,0.0003176792],"genre_scores_gemma":[0.9918306,0.0069930083,0.00022417992,0.0005254854,0.00027893682,0.000008228585,0.0000014230937,0.0000056235745,0.0001325522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99658924,0.0018151336,0.00089791894,0.00012755425,0.00037189067,0.00019826076],"domain_scores_gemma":[0.9976059,0.001130427,0.00067120173,0.00027677676,0.00026389162,0.000051799834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005929142,0.000117437514,0.00094813836,0.000094456955,0.000056080396,0.0000059699255,0.00006458427,0.00009051134,0.0000054537363],"category_scores_gemma":[0.00039171544,0.000051994426,0.00022587077,0.00018550135,0.00013950624,0.000048922662,0.000021645792,0.00059497514,9.335638e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004458845,0.0012180518,0.89634025,0.00006863289,0.001956733,0.00013433605,0.00037348564,0.000035541525,0.00027604753,0.00057670654,0.00017520401,0.09438616],"study_design_scores_gemma":[0.0074972585,0.0012762308,0.9815503,0.00004292974,0.0025638596,0.00022970492,0.00022854196,0.000022418899,0.0005866583,0.00015413715,0.0058091553,0.000038829436],"about_ca_topic_score_codex":0.00029007922,"about_ca_topic_score_gemma":0.00017474547,"teacher_disagreement_score":0.09434733,"about_ca_system_score_codex":0.000049974784,"about_ca_system_score_gemma":0.00034815675,"threshold_uncertainty_score":0.25849038},"labels":[],"label_agreement":null},{"id":"W4406500301","doi":"10.1016/s0029-7437(06)72521-6","title":"10.1016/s0029-7437(06)72521-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Environmental health; Business","score_opus":0.007435645226341162,"score_gpt":0.20145948550834045,"score_spread":0.1940238402819993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406500301","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025100661,0.0004540474,0.0000029069977,0.00086246966,2.1781554e-7,0.00053304917,0.000008513366,0.00018024546,0.99544847],"genre_scores_gemma":[0.00048304183,0.0000024628273,0.00024468073,0.00025754556,0.00061978353,0.000039846305,0.000030129373,0.000038365197,0.99828416],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987155,0.00004505612,0.00020534851,0.00027813925,0.00040508015,0.0003508637],"domain_scores_gemma":[0.9988958,0.000014288473,0.000020175798,0.0006536131,0.000060873055,0.00035519776],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033225524,0.00015086218,0.00034938173,0.000071220216,0.000075411845,0.000018998391,0.000099263445,0.00009008963,0.9964366],"category_scores_gemma":[0.000036663372,0.00012915484,0.00021891137,0.00023103473,0.000025899368,0.000048036774,0.000025696334,0.00016582433,0.99530923],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089037,0.00005437838,3.2462754e-7,0.000029161305,0.00006187289,0.000021534794,0.000012523077,0.0000059061263,0.00002797636,6.8246516e-7,0.62676,0.37293658],"study_design_scores_gemma":[0.00080240174,0.00029812497,0.00027665112,0.00005719096,0.00008374394,0.000112733345,0.0000015831936,0.000043355692,0.00014863127,0.000003931165,0.99802434,0.00014732123],"about_ca_topic_score_codex":0.0000945258,"about_ca_topic_score_gemma":1.9999727e-7,"teacher_disagreement_score":0.37278926,"about_ca_system_score_codex":0.00006688367,"about_ca_system_score_gemma":0.00009595864,"threshold_uncertainty_score":0.52667814},"labels":[],"label_agreement":null},{"id":"W4406518725","doi":"10.1016/j.yend.2014.03.006","title":"10.1016/j.yend.2014.03.006","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Risk factor; Disease; Cholesterol; Internal medicine; Vascular disease; Lipoprotein; Cardiology","score_opus":0.006158646930115099,"score_gpt":0.19747120502070117,"score_spread":0.1913125580905861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406518725","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020536857,0.0005212208,0.0000019750673,0.0007733371,0.0000022857876,0.00047415978,0.000008338619,0.00014446437,0.99602056],"genre_scores_gemma":[0.00045639195,0.0000030495337,0.0002218078,0.00024825183,0.00064479135,0.000033368782,0.000024890198,0.000035543104,0.9983319],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99880844,0.000043306092,0.00018619857,0.00026057486,0.00037667464,0.00032478903],"domain_scores_gemma":[0.99896795,0.000012469602,0.000018805507,0.000625245,0.00005496753,0.0003205903],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000316685,0.0001379221,0.00031910907,0.00006557864,0.000066361856,0.00001674147,0.00009264717,0.00008174407,0.99590826],"category_scores_gemma":[0.000027509415,0.000116672825,0.0001974762,0.00016726885,0.000023424212,0.000043886837,0.000022622093,0.00014734954,0.995967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104295315,0.00005000861,2.8905706e-7,0.000026902344,0.00005788707,0.000025895928,0.000009961573,0.0000059289646,0.000032351287,6.61572e-7,0.28791878,0.7117671],"study_design_scores_gemma":[0.0007606284,0.0003096161,0.0002693608,0.000043557673,0.00007766906,0.00010210188,0.0000011849104,0.000033774217,0.00018440743,0.0000031929217,0.99808115,0.00013336075],"about_ca_topic_score_codex":0.00014586368,"about_ca_topic_score_gemma":2.7493647e-7,"teacher_disagreement_score":0.7116337,"about_ca_system_score_codex":0.00005770241,"about_ca_system_score_gemma":0.00008804134,"threshold_uncertainty_score":0.47577798},"labels":[],"label_agreement":null},{"id":"W4406519272","doi":"10.1016/j.yend.2013.03.037","title":"10.1016/j.yend.2013.03.037","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Primary prevention; Statin; Jupiter (rocket family); Intensive care medicine; Internal medicine; Endocrinology; Disease; Astronomy","score_opus":0.007459501149388414,"score_gpt":0.1999589399203345,"score_spread":0.19249943877094608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406519272","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023701694,0.0005674951,0.0000017858106,0.0012561482,0.0000024229664,0.0005141733,0.000007748737,0.00014665026,0.9951334],"genre_scores_gemma":[0.00045313084,0.0000034321693,0.00024423294,0.0002600686,0.00061307487,0.00003707201,0.0000234385,0.000036466477,0.9983291],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987642,0.000043909564,0.00019369982,0.00026688047,0.00039028082,0.0003410407],"domain_scores_gemma":[0.99892217,0.000012442669,0.000019317902,0.00063714606,0.000059382994,0.00034952912],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030963132,0.00014448263,0.00033133783,0.00006833713,0.000070907474,0.000017407807,0.00009745473,0.00008557533,0.9956323],"category_scores_gemma":[0.000027747763,0.0001223211,0.00020228962,0.00020835003,0.00002471062,0.00004863122,0.000024212193,0.00015643015,0.9947941],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114589006,0.00005615202,2.2499049e-7,0.00002904545,0.00006517838,0.000029465078,0.000012728106,0.000007294598,0.00002826015,6.764488e-7,0.2235884,0.776068],"study_design_scores_gemma":[0.0007851522,0.0003313283,0.00022678905,0.00005122166,0.00007859733,0.00008917754,0.0000013864911,0.00004540123,0.0001432215,0.0000032388034,0.99810445,0.0001400308],"about_ca_topic_score_codex":0.00016854478,"about_ca_topic_score_gemma":4.624204e-7,"teacher_disagreement_score":0.77592796,"about_ca_system_score_codex":0.00005919113,"about_ca_system_score_gemma":0.00008648336,"threshold_uncertainty_score":0.49881095},"labels":[],"label_agreement":null},{"id":"W4406545205","doi":"10.1016/s1544-8800(12)70283-x","title":"10.1016/s1544-8800(12)70283-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Diabetes mellitus; Medicine; Internal medicine; Cardiology; Endocrinology","score_opus":0.006961457455191008,"score_gpt":0.1929847394807035,"score_spread":0.1860232820255125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406545205","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019113652,0.00038289904,0.0000032386347,0.0008738912,0.0000022850174,0.000543968,0.000007672636,0.00015322771,0.99612147],"genre_scores_gemma":[0.0005070693,0.0000024910753,0.00020745989,0.00024923548,0.0006092265,0.00003920765,0.000022612157,0.000038315244,0.9983244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987174,0.000045442714,0.00020384022,0.00027721628,0.00040492028,0.00035114374],"domain_scores_gemma":[0.9989054,0.000013406678,0.000020002506,0.00065306015,0.00005251081,0.00035557614],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000313157,0.00015092414,0.00034739738,0.00006905354,0.000074527605,0.000018333483,0.000099949124,0.000089157635,0.9955948],"category_scores_gemma":[0.000032451855,0.00012904804,0.00021444667,0.00018005012,0.000028330249,0.000047883947,0.000025619789,0.00016451838,0.9925339],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015472206,0.00006273944,2.8396423e-7,0.000034397417,0.00007209588,0.00003653941,0.000014602807,0.000009933306,0.000031081316,5.728567e-7,0.1759447,0.8236383],"study_design_scores_gemma":[0.0008430361,0.00037133571,0.00045248496,0.00005566099,0.00008538415,0.00010966675,0.0000013639618,0.0000448272,0.00016031331,0.0000034033005,0.9977254,0.00014706817],"about_ca_topic_score_codex":0.00017245808,"about_ca_topic_score_gemma":5.3658783e-7,"teacher_disagreement_score":0.8234913,"about_ca_system_score_codex":0.00006802723,"about_ca_system_score_gemma":0.00010003278,"threshold_uncertainty_score":0.5262427},"labels":[],"label_agreement":null},{"id":"W4406545388","doi":"10.1016/s1553-3212(09)70127-x","title":"10.1016/s1553-3212(09)70127-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dementia; Block (permutation group theory); Statin; Medicine; Psychology; Neuroscience; Internal medicine; Disease; Mathematics; Combinatorics","score_opus":0.0065861410619832235,"score_gpt":0.19543629281774172,"score_spread":0.1888501517557585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406545388","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028525896,0.00050778623,0.0000024050971,0.00087495276,0.0000022591796,0.00053586153,0.000008105218,0.00015350623,0.99506253],"genre_scores_gemma":[0.00043965055,0.0000027150143,0.00020221011,0.00022970085,0.0006398522,0.000037764123,0.000023515697,0.00003809731,0.9983865],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987254,0.000041927426,0.00020244546,0.00027476661,0.0004057923,0.0003496597],"domain_scores_gemma":[0.9989115,0.000013553986,0.000020094325,0.00063668017,0.00006172347,0.0003564525],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000323443,0.0001498761,0.0003455858,0.00007131839,0.00007472678,0.000018362723,0.00009825193,0.000088278095,0.99560755],"category_scores_gemma":[0.000033599976,0.00012867905,0.0002158363,0.00023893018,0.000025328864,0.000048831014,0.000024858711,0.00016356615,0.993911],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014889071,0.00006332035,2.7713872e-7,0.00003576954,0.00006955261,0.000035359782,0.000016080216,0.0000071885706,0.000028693084,6.927263e-7,0.17447667,0.8251175],"study_design_scores_gemma":[0.00086421316,0.00032367354,0.0003199461,0.000055317836,0.00008591771,0.00011974852,0.0000015848434,0.000039892053,0.00018648284,0.0000035823023,0.9978529,0.00014673942],"about_ca_topic_score_codex":0.00012221494,"about_ca_topic_score_gemma":2.8217636e-7,"teacher_disagreement_score":0.8249708,"about_ca_system_score_codex":0.00006971285,"about_ca_system_score_gemma":0.00009972838,"threshold_uncertainty_score":0.5247379},"labels":[],"label_agreement":null},{"id":"W4406545541","doi":"10.1016/s1544-8800(12)70024-6","title":"10.1016/s1544-8800(12)70024-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cardiology; Internal medicine; Medicine","score_opus":0.0069671489959564365,"score_gpt":0.19276728500455106,"score_spread":0.18580013600859463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406545541","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021037506,0.00040092162,0.0000026362209,0.00082370645,0.0000022776746,0.00053693645,0.00000775725,0.00015335242,0.99596864],"genre_scores_gemma":[0.00046992133,0.000002530339,0.00023163593,0.00025015738,0.00062200485,0.000039053433,0.000021094527,0.00003855402,0.99832505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987202,0.00004454737,0.0002029513,0.00027782624,0.00040489848,0.00034951957],"domain_scores_gemma":[0.9989117,0.000013550677,0.000019530687,0.0006495975,0.000051741434,0.0003538725],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030975844,0.00015076666,0.00034521383,0.000069642534,0.000073139134,0.000018717259,0.00009927423,0.00008895102,0.99592084],"category_scores_gemma":[0.00003276103,0.00012862496,0.00021429507,0.0001814844,0.000025644651,0.000047466197,0.000025714871,0.0001655775,0.99285585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014286868,0.000059280876,3.1345255e-7,0.00003354441,0.00007002451,0.000036326426,0.000014081051,0.0000073059778,0.000031646898,6.242821e-7,0.19022441,0.8093796],"study_design_scores_gemma":[0.0008230308,0.00036954263,0.00044130668,0.000056513323,0.00008674768,0.000114218405,0.0000013991231,0.000043153555,0.00015102825,0.0000033677577,0.99776304,0.00014662482],"about_ca_topic_score_codex":0.00016967357,"about_ca_topic_score_gemma":5.3781946e-7,"teacher_disagreement_score":0.80923295,"about_ca_system_score_codex":0.00006774828,"about_ca_system_score_gemma":0.000096556825,"threshold_uncertainty_score":0.52451736},"labels":[],"label_agreement":null},{"id":"W4406545660","doi":"10.1016/s1544-8800(11)70381-5","title":"10.1016/s1544-8800(11)70381-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Test (biology); Medicine; Internal medicine; Geology","score_opus":0.0064100648798339965,"score_gpt":0.19453340579899653,"score_spread":0.18812334091916252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406545660","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043602153,0.0004158319,0.0000027677731,0.0009843014,0.000002378566,0.000539748,0.000007926893,0.00015466959,0.9935322],"genre_scores_gemma":[0.0005354869,0.0000021405406,0.00025514938,0.00024150284,0.0006222732,0.00003988339,0.000021843096,0.00003821381,0.9982435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987203,0.00004608019,0.00020313695,0.00027730002,0.0004053623,0.00034780652],"domain_scores_gemma":[0.99889284,0.000014980852,0.000019933883,0.0006633285,0.00005984796,0.00034909332],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032153857,0.00014979187,0.0003440865,0.00006807968,0.000074767086,0.000018289487,0.00010252656,0.00008985153,0.99560785],"category_scores_gemma":[0.00003540724,0.0001281524,0.00021403773,0.00021919899,0.000026613165,0.000046337154,0.000026205105,0.000142226,0.9916405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010798182,0.00006424042,5.467467e-7,0.000035421424,0.000058509428,0.000036557572,0.000015130541,0.000008410364,0.000029261766,8.1117963e-7,0.1943615,0.80528164],"study_design_scores_gemma":[0.0008659469,0.00029309196,0.00044253457,0.00005513503,0.00008715969,0.00011328123,0.0000014648331,0.000041418836,0.00016744967,0.0000030203003,0.9977834,0.00014604986],"about_ca_topic_score_codex":0.00024240035,"about_ca_topic_score_gemma":7.6340393e-7,"teacher_disagreement_score":0.8051356,"about_ca_system_score_codex":0.00006737898,"about_ca_system_score_gemma":0.000100178535,"threshold_uncertainty_score":0.52259034},"labels":[],"label_agreement":null},{"id":"W4406545773","doi":"10.1016/s1544-8800(06)70516-4","title":"10.1016/s1544-8800(06)70516-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Fish oil; Statin; Cardiology; Internal medicine; Fish <Actinopterygii>; Medicine; Environmental science; Fishery; Biology","score_opus":0.00658123553934441,"score_gpt":0.19545324220403731,"score_spread":0.1888720066646929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406545773","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031836268,0.00045182492,0.0000026750092,0.0009131093,0.0000015789518,0.0005409782,0.000008314702,0.00015449096,0.9947434],"genre_scores_gemma":[0.0005605622,0.000002576509,0.00023729619,0.00025293988,0.00060613244,0.000038186077,0.000030489657,0.000037865713,0.998234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870974,0.000045641373,0.00020419022,0.000278108,0.00040845337,0.0003538723],"domain_scores_gemma":[0.9988878,0.000013727834,0.000019631474,0.0006533282,0.00006120409,0.0003643444],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00031940613,0.0001510341,0.00034803513,0.00007016567,0.00007454173,0.00001855208,0.00010033471,0.000090714995,0.994943],"category_scores_gemma":[0.00003546315,0.00012806752,0.0002169348,0.0002282936,0.000025754984,0.000048069858,0.000025406654,0.00016668535,0.994828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011137057,0.000061448896,3.756498e-7,0.000033940476,0.00007004526,0.00003451128,0.000014085555,0.00000815732,0.0000344861,6.745905e-7,0.23513718,0.7644937],"study_design_scores_gemma":[0.00082598877,0.00030995428,0.0004535458,0.000056110617,0.00008570631,0.000111783054,0.0000015307324,0.000044221455,0.00015253107,0.0000033509941,0.997808,0.00014727376],"about_ca_topic_score_codex":0.00014998279,"about_ca_topic_score_gemma":2.9235028e-7,"teacher_disagreement_score":0.7643465,"about_ca_system_score_codex":0.000068204004,"about_ca_system_score_gemma":0.00010244044,"threshold_uncertainty_score":0.52224416},"labels":[],"label_agreement":null},{"id":"W4406545812","doi":"10.1016/s1544-8800(06)70849-1","title":"10.1016/s1544-8800(06)70849-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Statin; Diabetes mellitus; Medicine; Cardiology; Internal medicine; Endocrinology","score_opus":0.006546073296319825,"score_gpt":0.19516605094189926,"score_spread":0.18861997764557945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406545812","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030109163,0.00046208297,0.0000028374668,0.0009783371,0.0000015837778,0.0005477815,0.000008649612,0.00015712346,0.99483067],"genre_scores_gemma":[0.00053197896,0.000002591097,0.000236398,0.00026374837,0.00061297795,0.000039969116,0.00003026887,0.000038890004,0.99824315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869007,0.00004706685,0.00020662135,0.00028197342,0.00041634616,0.0003579169],"domain_scores_gemma":[0.9988697,0.000013912341,0.00001975516,0.0006658938,0.000062540326,0.00036815222],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003286809,0.00015294923,0.0003547204,0.00007138085,0.000075577846,0.000018837072,0.000101888225,0.000091749534,0.9946561],"category_scores_gemma":[0.00003602044,0.00013095209,0.00022549523,0.00023177202,0.000026183881,0.00004885489,0.000026153784,0.00016860358,0.9950316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011228647,0.000062076535,3.3065194e-7,0.000034240256,0.00007288885,0.00003469175,0.000013867759,0.000008122922,0.000034641114,7.0053346e-7,0.24471645,0.7549097],"study_design_scores_gemma":[0.0008420863,0.00030977506,0.0004212638,0.000056401565,0.00008910232,0.000115414085,0.0000015115804,0.000041775125,0.00015486452,0.000003296824,0.9978153,0.00014922726],"about_ca_topic_score_codex":0.00015969899,"about_ca_topic_score_gemma":2.9636783e-7,"teacher_disagreement_score":0.75476044,"about_ca_system_score_codex":0.000069076545,"about_ca_system_score_gemma":0.00010430473,"threshold_uncertainty_score":0.5340071},"labels":[],"label_agreement":null},{"id":"W4406545845","doi":"10.1016/s1544-8800(07)70040-4","title":"10.1016/s1544-8800(07)70040-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Sepsis; Internal medicine; Emergency medicine; Oncology; Cardiology","score_opus":0.0065935044830773655,"score_gpt":0.19578879363656534,"score_spread":0.189195289153488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406545845","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002765918,0.00047418784,0.0000027495241,0.0008792511,0.000002241797,0.0005385421,0.000008002916,0.00015751197,0.9951716],"genre_scores_gemma":[0.0005230728,0.0000024828196,0.00024112163,0.00025107653,0.0006149425,0.0000392958,0.000022241888,0.00003834378,0.9982674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987139,0.000045189274,0.00020383313,0.0002785277,0.0004072873,0.00035125873],"domain_scores_gemma":[0.9988948,0.000013450176,0.000019920984,0.00065396464,0.000061279316,0.00035656634],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003158459,0.00015104354,0.00034823146,0.000066180524,0.000074777025,0.000018542718,0.000100584584,0.000090230445,0.9966671],"category_scores_gemma":[0.00003403876,0.00012920488,0.00022016618,0.00020505597,0.000025908272,0.000048281785,0.000025624506,0.00016584978,0.9960839],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001430801,0.00006343624,2.596874e-7,0.00003450427,0.00007198314,0.000039495015,0.000013897755,0.000008234138,0.000030937215,7.088511e-7,0.16200222,0.83759123],"study_design_scores_gemma":[0.0008396463,0.0003560172,0.0003775699,0.000056674813,0.00008656058,0.000119127355,0.0000014506971,0.00003942388,0.00015727257,0.0000037253687,0.9978152,0.00014732612],"about_ca_topic_score_codex":0.00016852473,"about_ca_topic_score_gemma":3.0120486e-7,"teacher_disagreement_score":0.83744395,"about_ca_system_score_codex":0.000069526286,"about_ca_system_score_gemma":0.00010419878,"threshold_uncertainty_score":0.52688223},"labels":[],"label_agreement":null},{"id":"W4406551188","doi":"10.1016/s1544-8800(05)70356-0","title":"10.1016/s1544-8800(05)70356-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"FLAGS register; Medicine; Internal medicine; Cardiology; Computer science","score_opus":0.0066606518197373675,"score_gpt":0.19601318948538266,"score_spread":0.18935253766564528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406551188","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002653823,0.00041796968,0.0000027388733,0.0009863001,0.0000026128607,0.00053993316,0.00000827094,0.0001550576,0.9952333],"genre_scores_gemma":[0.00047733626,0.000002432854,0.00024119118,0.00029241413,0.00062254607,0.000039307663,0.000024752375,0.000038342852,0.9982617],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987116,0.000045572626,0.00020373428,0.00027779597,0.00040701876,0.00035429138],"domain_scores_gemma":[0.99889296,0.000013534721,0.000020030799,0.0006531335,0.00006101001,0.00035930504],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00031648355,0.00015113296,0.00034806938,0.000070235335,0.00007482735,0.000018567478,0.00010060681,0.000090083166,0.9950297],"category_scores_gemma":[0.000033985256,0.00012904267,0.00021691331,0.00022805097,0.000025866746,0.000048368427,0.000025778587,0.00016498673,0.99306715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013240108,0.000059371374,1.8578316e-7,0.000031345964,0.000065032196,0.00004263357,0.000013328564,0.000007172152,0.000032280575,6.709483e-7,0.2235533,0.77606225],"study_design_scores_gemma":[0.0008524223,0.00038765607,0.0003325125,0.000055701756,0.0000856587,0.00014378286,0.0000015043292,0.00004130976,0.00016655026,0.000003511179,0.99778265,0.00014676579],"about_ca_topic_score_codex":0.00017040412,"about_ca_topic_score_gemma":3.5530266e-7,"teacher_disagreement_score":0.7759155,"about_ca_system_score_codex":0.000068994595,"about_ca_system_score_gemma":0.000100283505,"threshold_uncertainty_score":0.5262208},"labels":[],"label_agreement":null},{"id":"W4406551253","doi":"10.1016/s1544-8800(05)70272-4","title":"10.1016/s1544-8800(05)70272-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Cardiology; Internal medicine","score_opus":0.006632878392659796,"score_gpt":0.1958261420051284,"score_spread":0.1891932636124686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406551253","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002724141,0.00041915188,0.0000027775702,0.0009879556,0.000002656974,0.00053948903,0.000008216576,0.00015464735,0.99516094],"genre_scores_gemma":[0.00048663825,0.0000024050373,0.00024360392,0.00028831192,0.0006169878,0.000038556715,0.000023221213,0.000038345406,0.9982619],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987109,0.000045588207,0.00020395915,0.00027802805,0.0004071425,0.00035438233],"domain_scores_gemma":[0.9988922,0.000013529729,0.000020056536,0.0006537993,0.000061049264,0.00035937098],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00031668224,0.00015121666,0.0003483034,0.000070227805,0.00007426029,0.000018563062,0.00010080379,0.00009014985,0.9953804],"category_scores_gemma":[0.000033929355,0.00012910702,0.00021685935,0.0002278757,0.000025859938,0.00004864848,0.000025789885,0.00016554013,0.9928166],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013320654,0.000059795624,1.9250236e-7,0.000030973406,0.00006524218,0.000042649674,0.000013414361,0.0000070686797,0.00003278583,6.933345e-7,0.21769996,0.781914],"study_design_scores_gemma":[0.000858887,0.0003917033,0.00033865104,0.00005568044,0.00008552818,0.00014524197,0.0000015297403,0.000041417537,0.00017535001,0.0000035477274,0.9977556,0.0001468563],"about_ca_topic_score_codex":0.0001718405,"about_ca_topic_score_gemma":3.6267957e-7,"teacher_disagreement_score":0.78176713,"about_ca_system_score_codex":0.00006896218,"about_ca_system_score_gemma":0.00010254339,"threshold_uncertainty_score":0.5264832},"labels":[],"label_agreement":null},{"id":"W4406551927","doi":"10.1016/s1544-8800(13)70006-x","title":"10.1016/s1544-8800(13)70006-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"PCSK9; Medicine; Antibody; Phase (matter); Internal medicine; Immunology; Chemistry; LDL receptor; Cholesterol","score_opus":0.006144112940338042,"score_gpt":0.1927599092616643,"score_spread":0.18661579632132627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406551927","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034649123,0.00048299038,0.0000028940985,0.00084859336,0.000002227875,0.0005374347,0.000008742113,0.00015604995,0.99449617],"genre_scores_gemma":[0.00064353686,0.0000025246807,0.00018475641,0.00025060738,0.0006266105,0.000039955874,0.00002477805,0.00003884362,0.9981884],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870336,0.000048305832,0.00020580439,0.0002800319,0.0004102772,0.0003522313],"domain_scores_gemma":[0.998891,0.000014279202,0.000020084672,0.0006586835,0.00006113095,0.0003548486],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032736326,0.00015234388,0.000360892,0.00007065743,0.00007480788,0.000021220945,0.00010146763,0.00009074685,0.99609715],"category_scores_gemma":[0.00003398473,0.00013032333,0.00021812132,0.00022931091,0.000026226822,0.000054092245,0.000025013807,0.00016752075,0.9934827],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001482585,0.00006330006,3.3818407e-7,0.000033548346,0.00007100245,0.000036112666,0.000014279676,0.000011054382,0.000032345622,5.6583445e-7,0.16616814,0.83342105],"study_design_scores_gemma":[0.0008488728,0.00034837952,0.00046550998,0.000054405937,0.00008654629,0.000110908935,0.0000015203383,0.000047739355,0.00017801765,0.0000034487493,0.99770606,0.00014859487],"about_ca_topic_score_codex":0.00024717842,"about_ca_topic_score_gemma":5.6688884e-7,"teacher_disagreement_score":0.83327246,"about_ca_system_score_codex":0.000066035194,"about_ca_system_score_gemma":0.00010142835,"threshold_uncertainty_score":0.5314431},"labels":[],"label_agreement":null},{"id":"W4406553604","doi":"10.1016/s1558-0164(09)70225-1","title":"10.1016/s1558-0164(09)70225-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pitavastatin; Medicine; Statin; Block (permutation group theory); Hydroxymethylglutaryl-CoA Reductase Inhibitors; Internal medicine","score_opus":0.006481984740612867,"score_gpt":0.19477502929993085,"score_spread":0.18829304455931797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406553604","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002775579,0.00045877116,0.000002786185,0.0008232981,0.0000023646426,0.0005403798,0.000008845061,0.00015491314,0.99523306],"genre_scores_gemma":[0.00035695572,0.0000025502168,0.00022699483,0.00021469344,0.0006393421,0.000041106774,0.000024528657,0.000038788596,0.99845505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870104,0.000046682508,0.00020521418,0.0002805183,0.00041512918,0.0003514101],"domain_scores_gemma":[0.99889344,0.00001361854,0.00002071288,0.0006565483,0.000060408132,0.00035525777],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033459082,0.00015134293,0.00034868455,0.00007174668,0.000076962126,0.000018279425,0.00010249174,0.00008747596,0.99616605],"category_scores_gemma":[0.000035250192,0.00012910835,0.00021933531,0.00022969823,0.00002577204,0.000048042602,0.000025927811,0.00016753541,0.99784386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016833488,0.00007434052,8.175189e-8,0.000039416136,0.00008549177,0.000044716253,0.000018270808,0.000008390772,0.00004838208,9.0511384e-7,0.30859312,0.69091856],"study_design_scores_gemma":[0.0008365526,0.00036095452,0.00024035781,0.0000530711,0.00008402137,0.00009801232,0.0000017204235,0.00003899377,0.00018812681,0.000003455331,0.99794614,0.00014858584],"about_ca_topic_score_codex":0.00012553553,"about_ca_topic_score_gemma":2.7641767e-7,"teacher_disagreement_score":0.69077,"about_ca_system_score_codex":0.00007168327,"about_ca_system_score_gemma":0.00010248692,"threshold_uncertainty_score":0.52648854},"labels":[],"label_agreement":null},{"id":"W4406553638","doi":"10.1016/s1558-0164(09)70286-x","title":"10.1016/s1558-0164(09)70286-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine","score_opus":0.006526669244103423,"score_gpt":0.1951034891472905,"score_spread":0.1885768199031871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406553638","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025662666,0.00047772695,0.0000030472436,0.0008646959,0.000002261264,0.0005380294,0.000008134419,0.00015577907,0.99538404],"genre_scores_gemma":[0.00034577507,0.0000027142296,0.00023906742,0.00021492141,0.00062346394,0.00003958483,0.000022753216,0.000038866034,0.99847287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869955,0.000046625133,0.0002058686,0.0002838515,0.00041117772,0.00035295423],"domain_scores_gemma":[0.998882,0.0000138129735,0.000020658515,0.0006638959,0.00006147625,0.00035816373],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003364441,0.00015219241,0.00035005325,0.00007167378,0.0000748673,0.00001856561,0.00010195836,0.00008944018,0.9959561],"category_scores_gemma":[0.000036299603,0.00012956036,0.00021885989,0.00022962021,0.000026075042,0.000047981965,0.000025454277,0.00016816611,0.997963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016867556,0.00007448305,8.194438e-8,0.000041265677,0.000085445936,0.000045114608,0.000017766586,0.000008674604,0.000046778623,9.087267e-7,0.2915542,0.7079566],"study_design_scores_gemma":[0.000842373,0.00035172954,0.00023817545,0.000058636466,0.00008485149,0.000095675736,0.0000016018374,0.000042284642,0.00018900295,0.0000036556664,0.99794304,0.0001489923],"about_ca_topic_score_codex":0.00012381272,"about_ca_topic_score_gemma":2.7920575e-7,"teacher_disagreement_score":0.7078076,"about_ca_system_score_codex":0.00006824606,"about_ca_system_score_gemma":0.00010193095,"threshold_uncertainty_score":0.5283318},"labels":[],"label_agreement":null},{"id":"W4406554020","doi":"10.1016/s1558-0164(12)70153-0","title":"10.1016/s1558-0164(12)70153-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Internal medicine","score_opus":0.007025858039069299,"score_gpt":0.1933360329938925,"score_spread":0.1863101749548232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406554020","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019230775,0.0003788463,0.0000027864116,0.00079081726,0.0000021972178,0.00053734425,0.000008116636,0.00015415075,0.99620265],"genre_scores_gemma":[0.00042643407,0.0000024968085,0.00022869658,0.00028390283,0.00062374165,0.000038917176,0.000024662153,0.0000386742,0.9983325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987051,0.00004575379,0.00020527579,0.0002790296,0.0004136853,0.00035114953],"domain_scores_gemma":[0.99889916,0.000013341774,0.000020545887,0.0006524055,0.000053026095,0.00036149658],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033164673,0.00015162847,0.00034977883,0.00007064508,0.00007320252,0.000018377246,0.00010079039,0.00008845928,0.9957951],"category_scores_gemma":[0.000035332843,0.0001290656,0.00021362734,0.00018213798,0.000025831823,0.000047859587,0.000025829198,0.00016443607,0.9975111],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001921332,0.00007947076,1.0658083e-7,0.000042111704,0.00009216153,0.000048484493,0.000019481533,0.0000083584255,0.000045220477,8.030683e-7,0.39525744,0.6042142],"study_design_scores_gemma":[0.0008441182,0.00037453457,0.00031846424,0.000055990975,0.00008390137,0.00011551884,0.0000014916984,0.000037337377,0.0001624053,0.0000035485145,0.9978543,0.00014837418],"about_ca_topic_score_codex":0.00012615012,"about_ca_topic_score_gemma":4.1169037e-7,"teacher_disagreement_score":0.60406584,"about_ca_system_score_codex":0.00006974427,"about_ca_system_score_gemma":0.00010145456,"threshold_uncertainty_score":0.5263142},"labels":[],"label_agreement":null},{"id":"W4406554054","doi":"10.1016/s1558-0164(12)70316-4","title":"10.1016/s1558-0164(12)70316-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Endocrinology","score_opus":0.006937070840123361,"score_gpt":0.19297022051676124,"score_spread":0.1860331496766379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406554054","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019237075,0.00039013062,0.0000028002469,0.00076648424,0.0000022453692,0.00053688785,0.000008010405,0.0001542599,0.99621546],"genre_scores_gemma":[0.0004456619,0.0000025869138,0.00023466385,0.00028270207,0.0006110978,0.00003909787,0.000023677338,0.000038677277,0.99832183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987073,0.0000453774,0.00020510095,0.00028003595,0.00040963435,0.0003525336],"domain_scores_gemma":[0.99890465,0.000013407199,0.000020538873,0.0006555654,0.00005242183,0.00035344317],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032832398,0.00015194026,0.0003486132,0.000070823124,0.00007440158,0.000018422406,0.00010111185,0.00008835736,0.99593604],"category_scores_gemma":[0.000035072364,0.0001293035,0.00021573524,0.00018097932,0.00002582911,0.00004772621,0.000025876496,0.00016442557,0.99736243],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018906963,0.00007874696,1.0171253e-7,0.000041594456,0.00009257566,0.000048082886,0.000018725983,0.000008448081,0.00004659941,8.4391934e-7,0.3949522,0.604523],"study_design_scores_gemma":[0.00084024895,0.00037244015,0.00029760646,0.000056290133,0.00008601375,0.00011440044,0.0000014507748,0.00003781999,0.00017030693,0.0000037298275,0.99787104,0.0001486515],"about_ca_topic_score_codex":0.00012636164,"about_ca_topic_score_gemma":4.147927e-7,"teacher_disagreement_score":0.60437435,"about_ca_system_score_codex":0.00006951406,"about_ca_system_score_gemma":0.000098010125,"threshold_uncertainty_score":0.5272844},"labels":[],"label_agreement":null},{"id":"W4406554276","doi":"10.1016/s1558-0164(12)70142-6","title":"10.1016/s1558-0164(12)70142-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"myalgia; Medicine; Dosing; Statin; Intensive care medicine; Physical therapy; Pharmacology; Internal medicine","score_opus":0.006773350151227526,"score_gpt":0.1922047645813965,"score_spread":0.18543141443016897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406554276","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013662002,0.00034544777,0.0000029244056,0.0008686185,0.000002331701,0.000523069,0.000008036458,0.00015272491,0.9967306],"genre_scores_gemma":[0.00042632627,0.0000027235203,0.00026893313,0.00033788133,0.0006012432,0.000039226983,0.000023781042,0.000038537575,0.99826133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871314,0.000046028665,0.0002078387,0.00027946362,0.0004075565,0.00034598858],"domain_scores_gemma":[0.9989066,0.0000144288915,0.000020826234,0.00065205764,0.00005164448,0.0003544207],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033728834,0.00015055557,0.00034915833,0.00006658825,0.00007353555,0.000018031316,0.00009992754,0.00008947509,0.99576575],"category_scores_gemma":[0.00003601293,0.0001281765,0.00022163527,0.00017680661,0.000025928115,0.00004670157,0.000025586343,0.00016568435,0.9975585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001901728,0.00007974762,8.211525e-8,0.00003905145,0.00008881578,0.000042379677,0.000021697437,0.000007928073,0.000034255892,8.095465e-7,0.41699007,0.582505],"study_design_scores_gemma":[0.00085293286,0.00041784334,0.000251204,0.000046685516,0.000082688945,0.00010657321,0.0000020474067,0.000042144857,0.00014198039,0.0000029006974,0.99790585,0.00014716675],"about_ca_topic_score_codex":0.00009035137,"about_ca_topic_score_gemma":3.2818986e-7,"teacher_disagreement_score":0.5823578,"about_ca_system_score_codex":0.00006214729,"about_ca_system_score_gemma":0.00009903304,"threshold_uncertainty_score":0.5226886},"labels":[],"label_agreement":null},{"id":"W4406554325","doi":"10.1016/s1558-0164(12)70167-0","title":"10.1016/s1558-0164(12)70167-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Primary prevention; Primary (astronomy); Internal medicine; Disease","score_opus":0.006855460067212232,"score_gpt":0.1921991302330502,"score_spread":0.18534367016583797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406554325","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019143764,0.00037550312,0.0000029599441,0.0008059587,0.0000021824403,0.00054141413,0.000008297011,0.0001571912,0.9961921],"genre_scores_gemma":[0.0004747012,0.0000025107195,0.00022639798,0.0002742991,0.00063067337,0.00004019786,0.000023202627,0.000039688694,0.99828833],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986829,0.000048688038,0.00020646238,0.0002855785,0.00041701496,0.0003593535],"domain_scores_gemma":[0.9988842,0.000015058669,0.000021045513,0.00066264655,0.000051374293,0.0003656832],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003449597,0.00015465987,0.0003541121,0.00007150109,0.00007564197,0.000019462337,0.00010336856,0.00009024754,0.99621385],"category_scores_gemma":[0.000038091006,0.00013084993,0.0002187111,0.00018228343,0.00002673018,0.000051038507,0.000026255739,0.00016837913,0.99784136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020345302,0.00008257644,1.0128055e-7,0.000043863456,0.00009364363,0.000050320617,0.000019385601,0.000008174821,0.000044392822,9.29754e-7,0.39417338,0.6052798],"study_design_scores_gemma":[0.00084881287,0.00037762706,0.00031211614,0.000059579394,0.00008501268,0.00011371012,0.0000014414818,0.00003448796,0.00016626615,0.0000037707619,0.99784565,0.00015153959],"about_ca_topic_score_codex":0.00012051845,"about_ca_topic_score_gemma":4.4473907e-7,"teacher_disagreement_score":0.6051282,"about_ca_system_score_codex":0.000070498485,"about_ca_system_score_gemma":0.000102664424,"threshold_uncertainty_score":0.53359056},"labels":[],"label_agreement":null},{"id":"W4406554845","doi":"10.1016/s1634-6939(17)80522-6","title":"10.1016/s1634-6939(17)80522-6","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.006440121260486525,"score_gpt":0.1947758709015738,"score_spread":0.1883357496410873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406554845","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016273382,0.0004654725,0.0000026462976,0.00089079986,0.0000020220575,0.0005331293,0.000008368871,0.00015465346,0.9963156],"genre_scores_gemma":[0.00030873646,0.000002305894,0.00024355527,0.00034322476,0.0006186786,0.000034030116,0.000025839125,0.00003679692,0.99838686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987148,0.000042361607,0.00020404492,0.0002785955,0.00040790584,0.00035230996],"domain_scores_gemma":[0.9988929,0.000013788061,0.000019985247,0.0006564246,0.0000600823,0.00035684466],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032689027,0.00015115924,0.00034738646,0.00006977226,0.00007491537,0.000018411678,0.00010045909,0.000090443886,0.9964322],"category_scores_gemma":[0.000032618897,0.00012915986,0.00021642593,0.00022699055,0.000026289968,0.000047690082,0.00002565253,0.00016634924,0.9909659],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012401635,0.00005764425,2.1385054e-7,0.000026325242,0.000065973014,0.000033763365,0.0000129964665,0.000007936547,0.000027787277,4.9084815e-7,0.28308347,0.7165594],"study_design_scores_gemma":[0.0008525052,0.00035499976,0.00022823267,0.000055267577,0.00008660828,0.00011384549,0.0000014471057,0.000041254807,0.00014766573,0.0000032735245,0.9979675,0.00014741426],"about_ca_topic_score_codex":0.000114885195,"about_ca_topic_score_gemma":2.951058e-7,"teacher_disagreement_score":0.71641195,"about_ca_system_score_codex":0.00006681233,"about_ca_system_score_gemma":0.00009642768,"threshold_uncertainty_score":0.52669865},"labels":[],"label_agreement":null},{"id":"W4406555555","doi":"10.1016/s1634-6939(23)44394-3","title":"10.1016/s1634-6939(23)44394-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Psychology","score_opus":0.0064303574939604865,"score_gpt":0.1945311015887611,"score_spread":0.18810074409480063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406555555","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029620423,0.000560424,0.000002702449,0.00084856554,0.000002268446,0.0005446084,0.000008675471,0.00015656634,0.9949142],"genre_scores_gemma":[0.00059702294,0.000002217924,0.00023042929,0.00030735182,0.0006209198,0.00003956072,0.000031597403,0.000038462495,0.99813247],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987073,0.000045936937,0.00020472186,0.0002794701,0.00040978476,0.00035278028],"domain_scores_gemma":[0.99889076,0.000013579766,0.000020077843,0.00065715465,0.000060917366,0.00035751803],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003283429,0.00015145204,0.00034823408,0.00007075565,0.00007567546,0.000016918724,0.00010215686,0.00009041653,0.9945958],"category_scores_gemma":[0.00003487874,0.00012947318,0.00021674027,0.00020014109,0.000034094468,0.000048273076,0.000025834239,0.0001651774,0.994163],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014632747,0.000065467866,2.5607162e-7,0.000035254478,0.00007616175,0.000038827155,0.000022960507,0.000007877882,0.00003564123,9.774757e-7,0.19771239,0.8018578],"study_design_scores_gemma":[0.000847539,0.00035078565,0.0002443889,0.000055946413,0.00008752955,0.00009984653,0.0000017164986,0.000041696712,0.00017200765,0.000004737323,0.9979461,0.00014774267],"about_ca_topic_score_codex":0.000101574624,"about_ca_topic_score_gemma":2.2335246e-7,"teacher_disagreement_score":0.8017101,"about_ca_system_score_codex":0.00006658233,"about_ca_system_score_gemma":0.00009765461,"threshold_uncertainty_score":0.5279763},"labels":[],"label_agreement":null},{"id":"W4406556981","doi":"10.1016/s1877-7848(21)45592-9","title":"10.1016/s1877-7848(21)45592-9","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.006282261582033936,"score_gpt":0.19387112814970753,"score_spread":0.1875888665676736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406556981","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002534454,0.0004749769,0.0000029881726,0.00096296286,0.000002267197,0.0005404063,0.00000832541,0.00015699993,0.9953166],"genre_scores_gemma":[0.00054808747,0.0000026165935,0.00025579726,0.00029508778,0.0006202611,0.000039787705,0.000022925307,0.00003843593,0.998177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987031,0.000046506004,0.00020512703,0.00028095453,0.00041064448,0.00035363267],"domain_scores_gemma":[0.99888176,0.0000137683555,0.00002014114,0.0006630797,0.00006176096,0.00035949136],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033302067,0.00015168203,0.00034946986,0.000070857364,0.00007541323,0.000018697843,0.0001018002,0.00009081562,0.99540174],"category_scores_gemma":[0.00003579679,0.00012962142,0.00021718626,0.00023195532,0.00002649267,0.000048821603,0.000026605145,0.00016424934,0.99258715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015564592,0.000062377905,2.757637e-7,0.000033839282,0.00007091006,0.00003870176,0.000014261171,0.000008040503,0.000037316735,5.9981153e-7,0.1892656,0.81031245],"study_design_scores_gemma":[0.00083590444,0.0003766235,0.00027632568,0.000055777975,0.0000849737,0.00011874618,0.0000015292707,0.000043347518,0.00017912839,0.0000036416363,0.99787605,0.0001479497],"about_ca_topic_score_codex":0.00012297486,"about_ca_topic_score_gemma":2.8466744e-7,"teacher_disagreement_score":0.8101645,"about_ca_system_score_codex":0.00006810506,"about_ca_system_score_gemma":0.000098819364,"threshold_uncertainty_score":0.5285808},"labels":[],"label_agreement":null},{"id":"W4406557055","doi":"10.1016/s1876-1143(12)70065-4","title":"10.1016/s1876-1143(12)70065-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Infliximab; Medicine; Internal medicine; Tumor necrosis factor alpha","score_opus":0.006784562829969286,"score_gpt":0.1922850000162998,"score_spread":0.18550043718633052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406557055","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021100524,0.00038925908,0.000002754939,0.00078145135,0.0000022488346,0.0005419647,0.000008020049,0.00015447217,0.99600977],"genre_scores_gemma":[0.0004553097,0.0000024694746,0.00023584998,0.00029997618,0.00062532315,0.00003865177,0.000024516732,0.000038274426,0.99827963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987104,0.00004643804,0.00020494297,0.00027796338,0.0004083017,0.00035194287],"domain_scores_gemma":[0.99890745,0.0000138596915,0.000020098882,0.0006544488,0.00005189113,0.0003522366],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033349928,0.00015098364,0.00034692086,0.00006998548,0.00007475549,0.000018636938,0.00010025111,0.00009054204,0.9955631],"category_scores_gemma":[0.00003394273,0.00012917549,0.00021390297,0.00018236734,0.000025790348,0.00004830622,0.000026964613,0.00016396282,0.99177974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014615472,0.000061530365,3.480552e-7,0.000032665255,0.00006992403,0.00003564386,0.000014381888,0.000007756388,0.00003282066,6.192958e-7,0.14718117,0.852417],"study_design_scores_gemma":[0.00084859814,0.0003647919,0.00030620594,0.000055623957,0.00008599151,0.00011045717,0.0000014079444,0.00003899918,0.00016760592,0.0000034321893,0.99786955,0.00014732766],"about_ca_topic_score_codex":0.00013454817,"about_ca_topic_score_gemma":4.617631e-7,"teacher_disagreement_score":0.85226965,"about_ca_system_score_codex":0.00006706326,"about_ca_system_score_gemma":0.00009797191,"threshold_uncertainty_score":0.5267623},"labels":[],"label_agreement":null},{"id":"W4406561359","doi":"10.1016/j.ccol.2015.05.010","title":"10.1016/j.ccol.2015.05.010","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Pharmacology; Medicine; Chemistry","score_opus":0.006268118773155686,"score_gpt":0.20537019450147911,"score_spread":0.19910207572832342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406561359","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025697972,0.00041641493,0.0000019476577,0.0012692467,0.0000030476297,0.0006095743,0.000007881613,0.00014488742,0.9949772],"genre_scores_gemma":[0.00046537994,0.0000018371353,0.00022650564,0.00031725987,0.0006143004,0.000045640914,0.000020893682,0.000035775727,0.9982724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987947,0.000041139825,0.0001879436,0.00025469888,0.00039717072,0.00032439927],"domain_scores_gemma":[0.99894047,0.000012351647,0.000018836514,0.00062388665,0.00006375485,0.0003406785],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033601205,0.00013821328,0.0003252533,0.00006591343,0.00006662961,0.000017507366,0.00009420652,0.00009173876,0.9946458],"category_scores_gemma":[0.00003293767,0.000118046766,0.00019311816,0.00021130822,0.000023749933,0.00004595267,0.000024054778,0.00016686023,0.99077994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011991724,0.000052392403,2.3958466e-7,0.000025432399,0.00005881918,0.000033964203,0.0000108805325,0.000005571436,0.000036420322,5.1129194e-7,0.28748846,0.7121674],"study_design_scores_gemma":[0.0008260622,0.0003993463,0.00022396678,0.000048182166,0.00008282581,0.00012512863,0.0000013234331,0.000038345013,0.00020719947,0.0000029136527,0.9979093,0.00013541158],"about_ca_topic_score_codex":0.00012968924,"about_ca_topic_score_gemma":3.0309005e-7,"teacher_disagreement_score":0.71203196,"about_ca_system_score_codex":0.00006265447,"about_ca_system_score_gemma":0.0001036449,"threshold_uncertainty_score":0.48138076},"labels":[],"label_agreement":null},{"id":"W4406561400","doi":"10.1016/j.ccol.2015.05.015","title":"10.1016/j.ccol.2015.05.015","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Heart failure; Medicine; Cardiology; Intensive care medicine; Internal medicine; Chemistry","score_opus":0.006967998924005741,"score_gpt":0.20774029476598707,"score_spread":0.20077229584198134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406561400","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021595652,0.00048351547,0.0000020318619,0.0012430823,0.000002851439,0.0006122897,0.000008148993,0.00014652686,0.995342],"genre_scores_gemma":[0.0004498233,0.0000018601968,0.00021596515,0.0003112917,0.00060684455,0.000046219753,0.00002208085,0.000035985413,0.9983099],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99876845,0.000043892018,0.00019033776,0.00025581254,0.00041491384,0.0003265663],"domain_scores_gemma":[0.9989259,0.000011999671,0.00001902384,0.0006187319,0.00006856908,0.0003557486],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00035572686,0.00013949905,0.00033084478,0.00006649524,0.00006393144,0.000017475897,0.00009421685,0.00008761164,0.9938399],"category_scores_gemma":[0.000033669006,0.00011917039,0.00018925834,0.00021858346,0.0000232846,0.000047765152,0.000024613779,0.00015347665,0.99087757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120271514,0.000051610896,2.2524173e-7,0.000024672005,0.00005890926,0.000033875538,0.000011162178,0.0000065867,0.000026591426,4.7654078e-7,0.32134193,0.6783237],"study_design_scores_gemma":[0.0008585461,0.00041914886,0.00019350507,0.000050267838,0.00008448479,0.00012369831,0.0000014964679,0.000041539166,0.00017199836,0.0000030233505,0.99791557,0.00013670255],"about_ca_topic_score_codex":0.00012720496,"about_ca_topic_score_gemma":2.7290397e-7,"teacher_disagreement_score":0.67818695,"about_ca_system_score_codex":0.000070708375,"about_ca_system_score_gemma":0.000111032474,"threshold_uncertainty_score":0.48596275},"labels":[],"label_agreement":null},{"id":"W4406561494","doi":"10.1016/j.ccol.2015.05.018","title":"10.1016/j.ccol.2015.05.018","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Diabetes mellitus; Medicine; Internal medicine; Cardiology; Endocrinology","score_opus":0.006626627449697001,"score_gpt":0.20693908344885104,"score_spread":0.20031245599915404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406561494","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025107644,0.0004204445,0.0000020206062,0.0011512239,0.000002939396,0.0006063491,0.000007682475,0.00014455448,0.995154],"genre_scores_gemma":[0.00051601505,0.000001853005,0.00021781321,0.00031751994,0.0006140673,0.000045626188,0.00002038148,0.00003560796,0.9982311],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987803,0.00005546968,0.00018814126,0.0002558366,0.00039559946,0.00032465768],"domain_scores_gemma":[0.9989473,0.000014733088,0.000018816616,0.0006180662,0.00006436435,0.00033670364],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00041021814,0.00013785034,0.00032325793,0.00006552014,0.00008100129,0.000017278791,0.0000934721,0.000086696906,0.9943741],"category_scores_gemma":[0.000039780418,0.0001177177,0.00019121803,0.00021412646,0.000024331184,0.000046373272,0.000024100866,0.00018000885,0.9912582],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001246889,0.00005357543,2.2037455e-7,0.00002551963,0.000060248014,0.00003152397,0.000012676647,0.000005092226,0.000028260145,4.7360552e-7,0.31259835,0.68705934],"study_design_scores_gemma":[0.0008389876,0.00044560837,0.00020502682,0.000051758478,0.00008336373,0.0001219145,0.000001636152,0.000037557875,0.00018929594,0.000003093105,0.99788684,0.00013492609],"about_ca_topic_score_codex":0.00012235738,"about_ca_topic_score_gemma":2.572063e-7,"teacher_disagreement_score":0.68692446,"about_ca_system_score_codex":0.000066132554,"about_ca_system_score_gemma":0.00010143168,"threshold_uncertainty_score":0.48003885},"labels":[],"label_agreement":null},{"id":"W4406572234","doi":"10.1016/j.ccol.2023.02.007","title":"10.1016/j.ccol.2023.02.007","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Medicine; Intensive care medicine; Internal medicine; Obesity","score_opus":0.006601622687576974,"score_gpt":0.1980871219839686,"score_spread":0.19148549929639164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406572234","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004647006,0.00045184305,0.0000015036201,0.00073336856,0.0000025419697,0.00059166824,0.0000086527325,0.00012416806,0.99343926],"genre_scores_gemma":[0.00049673615,0.0000019976758,0.00017856095,0.0002943923,0.00061516726,0.000046519435,0.00002174224,0.000032156015,0.9983127],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879205,0.000040586223,0.0001891019,0.00025647928,0.0003951689,0.00032658645],"domain_scores_gemma":[0.9989939,0.0000135384735,0.00001797831,0.00059048436,0.00005830124,0.00032583106],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00034499934,0.00013509979,0.0003192218,0.000068371184,0.00006783192,0.000016055308,0.00009135976,0.0000882697,0.99604946],"category_scores_gemma":[0.0000341148,0.000116914685,0.0001981021,0.00024981648,0.000022188939,0.000041835257,0.00002431316,0.00015815349,0.9934064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013558903,0.000058352765,6.2685746e-7,0.00003368809,0.00007040349,0.000037992035,0.000010036108,0.00000717677,0.000041293035,5.976777e-7,0.20185132,0.7977529],"study_design_scores_gemma":[0.0007481888,0.0003602832,0.0005129104,0.000053005806,0.000078421435,0.00008681709,0.0000014864147,0.000030639716,0.00016057899,0.0000021010944,0.9978329,0.00013268647],"about_ca_topic_score_codex":0.0001674461,"about_ca_topic_score_gemma":3.0535318e-7,"teacher_disagreement_score":0.79762024,"about_ca_system_score_codex":0.00006618207,"about_ca_system_score_gemma":0.00009845773,"threshold_uncertainty_score":0.47676423},"labels":[],"label_agreement":null},{"id":"W4406575699","doi":"10.1016/s1553-3212(11)70013-9","title":"10.1016/s1553-3212(11)70013-9","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Statin; Cohort; Internal medicine; Cardiology","score_opus":0.006348319151619025,"score_gpt":0.1940167276569811,"score_spread":0.1876684085053621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406575699","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043625776,0.00039333018,0.0000027531198,0.0009664772,0.0000024329065,0.00054830435,0.000007687608,0.00015699465,0.9935594],"genre_scores_gemma":[0.0005328573,0.000002249382,0.0002552226,0.00027415942,0.0006424113,0.000041518153,0.000024027966,0.000038598057,0.998189],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987084,0.000046575693,0.00020397766,0.00027851443,0.00040934634,0.00035316963],"domain_scores_gemma":[0.9988899,0.000014615133,0.00002028088,0.000659311,0.000061413346,0.00035448445],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033815706,0.00015048504,0.00034549806,0.00006935448,0.0000751005,0.000018655242,0.0001036202,0.00009072166,0.9957244],"category_scores_gemma":[0.000036463658,0.0001286962,0.00021105185,0.00022720135,0.000026446636,0.00004710259,0.000026541331,0.00014446216,0.99207956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010306938,0.00006711713,5.6050226e-7,0.000036210637,0.00006014196,0.000038286802,0.000017076232,0.000008644379,0.000028976205,8.7124806e-7,0.23264994,0.7669891],"study_design_scores_gemma":[0.0008213108,0.00028123564,0.00034172292,0.000054474356,0.00008309464,0.00011069145,0.0000018313044,0.000044824286,0.00015405576,0.0000029093328,0.99795705,0.00014679358],"about_ca_topic_score_codex":0.00021648988,"about_ca_topic_score_gemma":7.0993394e-7,"teacher_disagreement_score":0.7668423,"about_ca_system_score_codex":0.00006652623,"about_ca_system_score_gemma":0.00009329868,"threshold_uncertainty_score":0.5248079},"labels":[],"label_agreement":null},{"id":"W4406577057","doi":"10.1016/s1544-8800(12)70001-5","title":"10.1016/s1544-8800(12)70001-5","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Saturn; Medicine; Internal medicine; Cardiology; Physics; Astrophysics; Planet","score_opus":0.006890158758470455,"score_gpt":0.19288538567529132,"score_spread":0.18599522691682085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406577057","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018968092,0.0003727562,0.0000035297514,0.00078618916,0.0000021769158,0.00054531725,0.000008595267,0.00015494134,0.9962297],"genre_scores_gemma":[0.0004550097,0.0000026425223,0.000230621,0.00026432268,0.0006193652,0.000039496164,0.000024593215,0.000039036084,0.99832493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870855,0.000045301415,0.00020370881,0.00027759722,0.0004107277,0.00035412807],"domain_scores_gemma":[0.99890065,0.000013322219,0.00001983007,0.00065526203,0.000051702704,0.00035923664],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030586953,0.00015161275,0.00034698957,0.00006824211,0.00007460518,0.000018585279,0.00010104423,0.000089578105,0.9961013],"category_scores_gemma":[0.000030597585,0.00012977282,0.00020854225,0.0001780011,0.000025748677,0.000048242386,0.000024680057,0.0001647241,0.9929432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015347342,0.00006737622,2.625312e-7,0.000031968975,0.00007056616,0.00003638234,0.000014085958,0.000009754399,0.000033524662,6.196746e-7,0.18159443,0.81798756],"study_design_scores_gemma":[0.0008734857,0.00037382817,0.00038368703,0.000054781838,0.000087927445,0.000116699346,0.0000014372613,0.000039614533,0.00015418869,0.000003291722,0.9977631,0.00014795292],"about_ca_topic_score_codex":0.00016616825,"about_ca_topic_score_gemma":5.090067e-7,"teacher_disagreement_score":0.8178396,"about_ca_system_score_codex":0.00006793609,"about_ca_system_score_gemma":0.00009782483,"threshold_uncertainty_score":0.52919817},"labels":[],"label_agreement":null},{"id":"W4406577262","doi":"10.1016/s1544-8800(10)70046-4","title":"10.1016/s1544-8800(10)70046-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Genotype; Cardiology; Internal medicine; Medicine; Genetics; Biology; Gene","score_opus":0.006777892446850423,"score_gpt":0.1957726308146703,"score_spread":0.18899473836781988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406577262","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021287845,0.00048169307,0.0000022620795,0.0008538998,0.0000021829114,0.0005352235,0.000008937584,0.00015993681,0.9958271],"genre_scores_gemma":[0.00037698142,0.000002207674,0.00021802068,0.00021286025,0.0006503675,0.00004161696,0.00002863504,0.000040521947,0.99842876],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986527,0.00004894482,0.00021484641,0.00029233916,0.0004252003,0.00036596644],"domain_scores_gemma":[0.99882954,0.0000150612395,0.000021915961,0.00069549354,0.00007164878,0.00036634566],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032942355,0.00016023648,0.00036645634,0.00007292535,0.0000785317,0.000019752979,0.00010920053,0.00009648881,0.9977678],"category_scores_gemma":[0.00004170363,0.00013720532,0.0002323182,0.00023646155,0.000027511353,0.000050967305,0.000028579323,0.00015855033,0.9956154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001830931,0.00006222097,1.4535655e-7,0.00003391805,0.00007164795,0.000035101995,0.000012435267,0.000007746287,0.000027323815,5.4632557e-7,0.27145556,0.72811025],"study_design_scores_gemma":[0.0009030506,0.00039692433,0.00029706044,0.000056862074,0.00009319075,0.00009930528,0.0000014523685,0.000045222267,0.00016245023,0.000003345372,0.99778545,0.00015571056],"about_ca_topic_score_codex":0.00015337735,"about_ca_topic_score_gemma":3.4923178e-7,"teacher_disagreement_score":0.72795457,"about_ca_system_score_codex":0.00007344731,"about_ca_system_score_gemma":0.00011092674,"threshold_uncertainty_score":0.5595071},"labels":[],"label_agreement":null},{"id":"W4406577655","doi":"10.1016/s1544-8800(09)70030-2","title":"10.1016/s1544-8800(09)70030-2","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Fenofibrate; Dyslipidemia; Medicine; Statin; Internal medicine; Cardiology; Disease","score_opus":0.006798755173350296,"score_gpt":0.1962890478165754,"score_spread":0.18949029264322512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406577655","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002432645,0.00045527384,0.0000031075851,0.0008220777,0.0000022399872,0.0005501159,0.0000075869884,0.00014999225,0.995577],"genre_scores_gemma":[0.00034447096,0.0000025541897,0.0002540499,0.00019237492,0.00059792254,0.000039415827,0.000022388549,0.000038685284,0.99850816],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871445,0.000047340192,0.00020344426,0.0002780157,0.0004060872,0.00035064877],"domain_scores_gemma":[0.9988968,0.000013443523,0.000020024647,0.00065388344,0.00006269546,0.0003531816],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003230378,0.00015100025,0.00034898942,0.00006937007,0.00007549146,0.000018492716,0.000099988385,0.00009016579,0.9953066],"category_scores_gemma":[0.000035368324,0.0001291314,0.00021150924,0.00023398266,0.000025911111,0.000047960224,0.00002542021,0.00016542498,0.99389744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001424151,0.00006048315,2.4593015e-7,0.000032403066,0.00006873788,0.000035559773,0.00001386033,0.0000072912617,0.000033816028,7.080018e-7,0.14413428,0.8554702],"study_design_scores_gemma":[0.0008432462,0.0003586455,0.0003570549,0.00005485185,0.00008565316,0.00011181288,0.0000015065092,0.000041263498,0.00018544105,0.0000033992117,0.99780995,0.0001472008],"about_ca_topic_score_codex":0.0001684968,"about_ca_topic_score_gemma":3.4134771e-7,"teacher_disagreement_score":0.855323,"about_ca_system_score_codex":0.00006802307,"about_ca_system_score_gemma":0.00010288065,"threshold_uncertainty_score":0.52658254},"labels":[],"label_agreement":null},{"id":"W4406577660","doi":"10.1016/s1544-8800(09)70082-x","title":"10.1016/s1544-8800(09)70082-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Jupiter (rocket family); Statin; Medicine; Cardiology; Internal medicine; Environmental science; Astronomy; Physics","score_opus":0.006641435024770161,"score_gpt":0.19524175153381867,"score_spread":0.18860031650904852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406577660","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002744759,0.00045809464,0.0000027948174,0.0008612251,0.000002275013,0.0005426513,0.0000081571325,0.00015422559,0.99522585],"genre_scores_gemma":[0.00037547213,0.0000026398677,0.00023803365,0.00018882664,0.00062134414,0.000039614584,0.00002279032,0.00003842696,0.99847287],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870896,0.00004583193,0.0002045218,0.00027886566,0.00041000973,0.00035179002],"domain_scores_gemma":[0.9988913,0.0000136889885,0.000020094687,0.0006557784,0.000061782965,0.00035737938],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00031415233,0.00015132071,0.0003497343,0.000069998285,0.000075926735,0.000018267276,0.00010079906,0.000090351765,0.99516296],"category_scores_gemma":[0.000034160163,0.000129394,0.00021774526,0.00022962471,0.00002621869,0.000048214355,0.0000258079,0.00016633332,0.9940601],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013996089,0.00006098451,2.5888397e-7,0.00003281518,0.00006895619,0.000037026355,0.000014569849,0.000007708042,0.000034636036,6.8047456e-7,0.13990746,0.85969496],"study_design_scores_gemma":[0.00083726546,0.0003533422,0.00037702487,0.000055456516,0.0000846773,0.00011807224,0.0000015308754,0.000041930973,0.00017600378,0.000003384295,0.9978038,0.00014749817],"about_ca_topic_score_codex":0.00017471673,"about_ca_topic_score_gemma":3.5503908e-7,"teacher_disagreement_score":0.85954744,"about_ca_system_score_codex":0.00006763666,"about_ca_system_score_gemma":0.000102532176,"threshold_uncertainty_score":0.5276534},"labels":[],"label_agreement":null},{"id":"W4406577983","doi":"10.1016/s1544-8800(09)70169-1","title":"10.1016/s1544-8800(09)70169-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Statin; Medicine; Cardiology; Internal medicine; Ldl cholesterol; Cholesterol","score_opus":0.006546061111263807,"score_gpt":0.19515491183014316,"score_spread":0.18860885071887937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406577983","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026098886,0.00045266008,0.0000029346056,0.00087804324,0.000002262017,0.00054556166,0.000008448298,0.00015406878,0.9953461],"genre_scores_gemma":[0.00036774567,0.0000025369873,0.00023468294,0.00018920262,0.0006289074,0.000039270297,0.000022240985,0.000038708404,0.9984767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986994,0.00004632778,0.00020644355,0.00028146917,0.00041105459,0.00035526574],"domain_scores_gemma":[0.9988852,0.000014003285,0.000020330614,0.00065859436,0.00006210808,0.00035973877],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032036772,0.00015273462,0.00035118504,0.00007068334,0.000075383155,0.000018571902,0.00010174153,0.000090957175,0.9957573],"category_scores_gemma":[0.000034432385,0.00012960628,0.00021920232,0.00022787637,0.000026283566,0.00004894079,0.000026016682,0.00016543108,0.9948621],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014196275,0.00006092721,2.2581956e-7,0.000032850345,0.00006937737,0.000036013553,0.000013931376,0.0000070786605,0.000036364017,6.991098e-7,0.15291665,0.8466839],"study_design_scores_gemma":[0.0008498633,0.00035594933,0.00035902255,0.000058017853,0.00008570255,0.00011220456,0.000001503104,0.00003860252,0.00018429778,0.0000035120631,0.9978024,0.00014894643],"about_ca_topic_score_codex":0.00017119436,"about_ca_topic_score_gemma":3.464476e-7,"teacher_disagreement_score":0.84653497,"about_ca_system_score_codex":0.00006896518,"about_ca_system_score_gemma":0.000104516745,"threshold_uncertainty_score":0.5285191},"labels":[],"label_agreement":null},{"id":"W4406578072","doi":"10.1016/s1544-8800(08)70224-0","title":"10.1016/s1544-8800(08)70224-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Prehypertension; Blood pressure; Medicine; Cardiology; Internal medicine","score_opus":0.006498587033868557,"score_gpt":0.19480721573352716,"score_spread":0.18830862869965861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406578072","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029623725,0.00046140075,0.000002645914,0.0008472542,0.0000022398924,0.00054439146,0.000008333901,0.00015377374,0.9950176],"genre_scores_gemma":[0.0005144853,0.0000024177652,0.00023272395,0.0002466625,0.0006029577,0.00004080159,0.000023601644,0.000038374674,0.998298],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986989,0.000046619836,0.00021248078,0.00027862182,0.0004125587,0.00035085046],"domain_scores_gemma":[0.9988979,0.000013563779,0.000021085998,0.000652565,0.000060378472,0.00035452045],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033183364,0.00015054259,0.00034633698,0.00007043563,0.00007642071,0.000018362942,0.00010028683,0.00008871217,0.99648654],"category_scores_gemma":[0.00003508486,0.00012910133,0.00022530055,0.00023087361,0.000025839452,0.000048104677,0.000025885984,0.00016808535,0.9947809],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014280294,0.00006341904,2.7229007e-7,0.00003417182,0.000069347916,0.000036686488,0.00001416106,0.000008159107,0.000037244816,6.88744e-7,0.16955988,0.8300332],"study_design_scores_gemma":[0.0008658242,0.00035491923,0.0003575828,0.000054246026,0.0000843507,0.000114565344,0.0000015175516,0.000042246145,0.00019822839,0.0000033277943,0.997776,0.000147245],"about_ca_topic_score_codex":0.00015006034,"about_ca_topic_score_gemma":3.2618777e-7,"teacher_disagreement_score":0.8298859,"about_ca_system_score_codex":0.000068926005,"about_ca_system_score_gemma":0.0001013811,"threshold_uncertainty_score":0.52645993},"labels":[],"label_agreement":null},{"id":"W4406578356","doi":"10.1016/s1544-8800(07)70200-2","title":"10.1016/s1544-8800(07)70200-2","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Medicine; Internal medicine","score_opus":0.006713213810871444,"score_gpt":0.1959122597124856,"score_spread":0.18919904590161415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406578356","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027120141,0.00045387982,0.0000025433915,0.00083550037,0.000001986412,0.0005310375,0.000009743043,0.00015224259,0.99530107],"genre_scores_gemma":[0.00045104232,0.000002654707,0.00024810812,0.000255185,0.0006106993,0.000037245485,0.000027459544,0.00003775147,0.9983299],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987216,0.00004481853,0.00020354152,0.00027509686,0.0004029125,0.00035204546],"domain_scores_gemma":[0.9989121,0.000012852611,0.000019868077,0.000635906,0.00006108238,0.00035816693],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030674937,0.00015024003,0.00034487204,0.000064616484,0.00007319166,0.000018071647,0.00009949638,0.00008963352,0.99684024],"category_scores_gemma":[0.000033435725,0.00012887725,0.00021189536,0.00020940808,0.000025520827,0.00004665029,0.000024076244,0.00016355554,0.9957524],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014969356,0.00006601848,3.3860226e-7,0.000033490447,0.00007093229,0.000042048017,0.000013172553,0.000008410107,0.000026718528,7.3001877e-7,0.13676241,0.86282605],"study_design_scores_gemma":[0.0008353549,0.00034961902,0.0004566214,0.000053409494,0.00008371867,0.00012296319,0.0000012890944,0.000041310323,0.0001514687,0.0000031294367,0.99775445,0.00014664498],"about_ca_topic_score_codex":0.00024692263,"about_ca_topic_score_gemma":4.5372553e-7,"teacher_disagreement_score":0.8626794,"about_ca_system_score_codex":0.000067870475,"about_ca_system_score_gemma":0.000096553085,"threshold_uncertainty_score":0.5255462},"labels":[],"label_agreement":null},{"id":"W4406578688","doi":"10.1016/s1544-8800(06)70519-x","title":"10.1016/s1544-8800(06)70519-x","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Medicine; Internal medicine; Cardiology","score_opus":0.0065566103500640785,"score_gpt":0.19528378164028773,"score_spread":0.18872717129022365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406578688","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036175225,0.0004575292,0.0000026583898,0.00085170806,0.0000015606744,0.0005397499,0.000008290495,0.00015449208,0.99436647],"genre_scores_gemma":[0.00058612187,0.0000025672082,0.00023682852,0.00025310318,0.0006056602,0.00003810237,0.000030105533,0.00003796359,0.99820954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871033,0.00004611633,0.00020428117,0.00027754498,0.00040831623,0.00035342056],"domain_scores_gemma":[0.9988892,0.00001371498,0.000019652747,0.0006516764,0.00006205459,0.00036370452],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032124578,0.00015092085,0.00034751845,0.00007010188,0.00007450088,0.000018804907,0.000100413694,0.0000906094,0.9948349],"category_scores_gemma":[0.00003593251,0.00012916155,0.00021681155,0.00022814004,0.000025397785,0.0000485925,0.000025412532,0.00016651516,0.9948734],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011144699,0.00006140628,4.489368e-7,0.000034362936,0.000070087524,0.000034556106,0.000014170289,0.000008373906,0.000032246146,6.2871965e-7,0.23530339,0.7643289],"study_design_scores_gemma":[0.00081085856,0.00029968293,0.0005089652,0.00005589184,0.0000853638,0.00011170505,0.0000015022108,0.000036922,0.00014282568,0.0000032544583,0.9977958,0.0001472225],"about_ca_topic_score_codex":0.00014170735,"about_ca_topic_score_gemma":3.1279373e-7,"teacher_disagreement_score":0.7641817,"about_ca_system_score_codex":0.00006670595,"about_ca_system_score_gemma":0.00010215117,"threshold_uncertainty_score":0.5267055},"labels":[],"label_agreement":null},{"id":"W4406578728","doi":"10.1016/s1544-8800(06)70537-1","title":"10.1016/s1544-8800(06)70537-1","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Gerontology; Internal medicine","score_opus":0.006810576680480278,"score_gpt":0.196283162028906,"score_spread":0.18947258534842573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406578728","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00325484,0.00046383476,0.000002602596,0.00090478105,0.0000015857195,0.00054171955,0.000008531126,0.0001544203,0.9946677],"genre_scores_gemma":[0.00058482453,0.000002609446,0.00023222719,0.00025587695,0.0006155674,0.00003830259,0.000030725263,0.000037957918,0.9982019],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987105,0.000045886212,0.000203943,0.00027782843,0.0004083316,0.00035350036],"domain_scores_gemma":[0.99888974,0.000013698075,0.00001918242,0.0006524377,0.00006089336,0.00036404654],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003190916,0.00015092861,0.00034766344,0.00007005553,0.00007450911,0.000018539831,0.000100347876,0.000090659276,0.99489635],"category_scores_gemma":[0.000035418463,0.00012918051,0.00021678665,0.00022520167,0.00002579749,0.000048791113,0.000025417447,0.00016592344,0.9950144],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112021306,0.000061621315,3.6124203e-7,0.0000343565,0.00007025162,0.000034613095,0.0000135915725,0.000008250346,0.000036788493,7.315831e-7,0.24636897,0.7532584],"study_design_scores_gemma":[0.0008260643,0.00030604916,0.000445558,0.0000558462,0.00008565349,0.000110582565,0.0000014796158,0.000043431,0.0001630284,0.0000032968685,0.9978118,0.00014720912],"about_ca_topic_score_codex":0.00014074003,"about_ca_topic_score_gemma":2.777837e-7,"teacher_disagreement_score":0.75311124,"about_ca_system_score_codex":0.0000671966,"about_ca_system_score_gemma":0.00010236311,"threshold_uncertainty_score":0.5267829},"labels":[],"label_agreement":null},{"id":"W4406579117","doi":"10.1016/s1541-9800(07)70524-0","title":"10.1016/s1541-9800(07)70524-0","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Rosiglitazone; Business; Medicine; Internal medicine","score_opus":0.006641575528467137,"score_gpt":0.1959408085691034,"score_spread":0.18929923304063626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406579117","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018113123,0.00042575938,0.0000020416633,0.001025844,0.0000022159375,0.0005335162,0.000008297273,0.00015292622,0.9960381],"genre_scores_gemma":[0.0005205543,0.0000026671496,0.00023454182,0.00023212431,0.00061914657,0.000036821253,0.000024221288,0.0000379923,0.9982919],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987106,0.000045785004,0.00020426507,0.00027918513,0.00040835282,0.00035184794],"domain_scores_gemma":[0.9988915,0.000013331587,0.000020033172,0.0006573582,0.000060817634,0.00035699533],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00032641526,0.00015125237,0.0003482327,0.00006719387,0.00007485597,0.00001854007,0.00010068707,0.00009031669,0.99735737],"category_scores_gemma":[0.00003484953,0.00012939014,0.0002167309,0.00020721318,0.000025859752,0.000048245714,0.000025468386,0.00016591774,0.9964258],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013359576,0.00006181184,3.1358317e-7,0.000033219956,0.000070727176,0.000038243317,0.000014195655,0.00000582823,0.000024831697,6.4176663e-7,0.20861796,0.79099864],"study_design_scores_gemma":[0.0008340257,0.00035047365,0.00026485568,0.00005565333,0.00008567961,0.00011734871,0.0000019219135,0.000042015807,0.00013707932,0.0000039592073,0.9979594,0.0001476167],"about_ca_topic_score_codex":0.00011044417,"about_ca_topic_score_gemma":1.9489508e-7,"teacher_disagreement_score":0.790851,"about_ca_system_score_codex":0.00006641713,"about_ca_system_score_gemma":0.000097529366,"threshold_uncertainty_score":0.52763766},"labels":[],"label_agreement":null},{"id":"W4406579761","doi":"10.1016/s1541-9800(11)70136-3","title":"10.1016/s1541-9800(11)70136-3","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Cholesterol; Business; Medicine; Internal medicine","score_opus":0.006364472132041915,"score_gpt":0.1940352166165057,"score_spread":0.18767074448446378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406579761","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037999516,0.0004084911,0.0000025086554,0.0009888681,0.000002402207,0.0005480438,0.000007757923,0.0001545755,0.9940874],"genre_scores_gemma":[0.0005719161,0.000002169664,0.00025739567,0.00027773235,0.0006245619,0.00004150912,0.000023727544,0.000038396036,0.99816257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987106,0.000046722238,0.00020471514,0.0002789453,0.000408766,0.00035026247],"domain_scores_gemma":[0.9988889,0.000014750075,0.000020012469,0.00066410436,0.00006104442,0.0003511726],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033480185,0.00015060692,0.00034634344,0.00006923054,0.00007474291,0.00001858889,0.000103081264,0.00009047309,0.99615824],"category_scores_gemma":[0.000035775196,0.00012876105,0.00021387417,0.00022597068,0.000026689198,0.000047183716,0.000026355805,0.00014259927,0.9918996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010320474,0.000065184264,5.5810875e-7,0.00003605471,0.000059607,0.000036741054,0.000015052996,0.00000859922,0.00002916169,8.9751853e-7,0.22269686,0.7769481],"study_design_scores_gemma":[0.00083927216,0.0002866567,0.00032830526,0.000056122833,0.00008398058,0.000107658896,0.0000015811122,0.00004558356,0.0001635707,0.0000035531411,0.99793684,0.0001468636],"about_ca_topic_score_codex":0.00018968096,"about_ca_topic_score_gemma":6.091802e-7,"teacher_disagreement_score":0.7768012,"about_ca_system_score_codex":0.00006709678,"about_ca_system_score_gemma":0.00009291045,"threshold_uncertainty_score":0.52507234},"labels":[],"label_agreement":null},{"id":"W4406588328","doi":"10.1016/s1541-9800(06)71373-4","title":"10.1016/s1541-9800(06)71373-4","year":2000,"lang":"en","type":"article","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Outbreak; Virology; Medicine; Business","score_opus":0.0065192289395225615,"score_gpt":0.19506068502097024,"score_spread":0.18854145608144768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406588328","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028775397,0.0004715175,0.0000026591401,0.00087449193,0.0000015898455,0.00054068264,0.000008625042,0.00015488683,0.995068],"genre_scores_gemma":[0.0005440054,0.0000025697236,0.00022386026,0.00029289923,0.0006128764,0.000039830895,0.000031846434,0.00003848598,0.99821365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99870145,0.000046259065,0.00020523816,0.00027984602,0.00041140168,0.00035580315],"domain_scores_gemma":[0.99888015,0.000013592559,0.000019687766,0.0006589483,0.00006174067,0.0003658895],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003346542,0.00015159781,0.0003494962,0.000070742055,0.00007516261,0.000018635366,0.00010128095,0.000090908594,0.99551094],"category_scores_gemma":[0.000036483427,0.00012959748,0.0002173191,0.00023121912,0.000025919635,0.000048367965,0.000025983762,0.00016750107,0.99481165],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107554624,0.00006356992,3.599602e-7,0.0000349839,0.000071734765,0.00003539435,0.000015219921,0.000008325592,0.00003551375,7.2338753e-7,0.25694203,0.7426846],"study_design_scores_gemma":[0.0008510606,0.00030724815,0.0002796196,0.000056798537,0.00008603913,0.00011153065,0.0000015275969,0.00004877679,0.00016391404,0.0000037965083,0.9979418,0.00014788685],"about_ca_topic_score_codex":0.00010499762,"about_ca_topic_score_gemma":2.2605423e-7,"teacher_disagreement_score":0.7425367,"about_ca_system_score_codex":0.00006841949,"about_ca_system_score_gemma":0.000101295125,"threshold_uncertainty_score":0.52848315},"labels":[],"label_agreement":null},{"id":"W4406615635","doi":"10.1093/eurheartj/ehae810","title":"Obesity in familial hypercholesterolaemia: when precision medicine should meet precision population health","year":2025,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centres Intégré Universitaires de Santé et de Services Sociaux; Institut universitaire de cardiologie et de pneumologie de Québec; Université Laval; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Precision medicine; Obesity; Population; Family medicine; Physical therapy; Environmental health; Internal medicine; Pathology","score_opus":0.05812027429944321,"score_gpt":0.3502252225123625,"score_spread":0.29210494821291927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406615635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9653607,0.005051217,0.003665013,0.018236816,0.001065916,0.0009529698,0.0000028159172,0.00007380382,0.0055907485],"genre_scores_gemma":[0.98743266,0.0009878543,0.00206781,0.007340298,0.0014634266,0.0000033983486,0.000020847734,0.000041328574,0.00064235786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569273,0.0015290583,0.0009256493,0.0004020915,0.0009464786,0.0005040109],"domain_scores_gemma":[0.9986735,0.00008313938,0.0001614433,0.0005707897,0.00011555139,0.0003955697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0080670575,0.00022664442,0.0007298316,0.00051002577,0.00033152886,0.000050984603,0.0001687642,0.00010283443,0.00007969954],"category_scores_gemma":[0.00044727654,0.00017076421,0.0002358761,0.0003801444,0.00004500095,0.00020445447,0.00011345792,0.0010396343,0.000027015469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010032913,0.00050567294,0.5664775,0.00038736878,0.00012114567,0.00036781587,0.0016394436,0.00014830577,0.001078189,0.0002612995,0.07671678,0.3512932],"study_design_scores_gemma":[0.0037048296,0.0007082907,0.94404924,0.0021867212,0.000042027907,0.000712814,0.00013145045,0.00008965859,0.000029229926,0.0005772591,0.047651853,0.00011664116],"about_ca_topic_score_codex":0.00044561268,"about_ca_topic_score_gemma":0.000114195784,"teacher_disagreement_score":0.37757173,"about_ca_system_score_codex":0.00049237564,"about_ca_system_score_gemma":0.00026490146,"threshold_uncertainty_score":0.69635624},"labels":[],"label_agreement":null},{"id":"W4406645032","doi":"10.1016/b978-84-9022-110-5.00009-9","title":"10.1016/b978-84-9022-110-5.00009-9","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Materials science","score_opus":0.009612514253133824,"score_gpt":0.19358859407425405,"score_spread":0.18397607982112021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406645032","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019675324,0.0030755007,0.0000018685722,0.00052983494,0.000009153056,0.001416669,0.00009344141,0.0002527506,0.99461883],"genre_scores_gemma":[0.0000020176503,0.000016280119,0.00013761631,0.00038974787,0.002097637,0.00005482308,0.00026306658,0.000231101,0.9968077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715775,0.000032142594,0.00053339853,0.00073102163,0.0009861653,0.00055950705],"domain_scores_gemma":[0.9974982,0.000028182798,0.00012063224,0.0015554541,0.00015556451,0.0006419427],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00040517718,0.0005863631,0.0012393409,0.00029605784,0.000110777444,0.000037253016,0.0002469585,0.0006069472,0.99649763],"category_scores_gemma":[0.000028515342,0.0005374932,0.0008368329,0.00007669694,0.00007367421,0.00004991753,0.000101978614,0.00072552264,0.9941057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022216525,0.000033800865,6.9109616e-9,0.00014172205,0.00040415055,0.00018671105,0.000008480543,0.0000024471187,0.0000031945572,0.00006620305,0.22566962,0.7732615],"study_design_scores_gemma":[0.00091497554,0.0005965569,0.000003866377,0.00056311704,0.000555627,0.0002722075,3.29907e-7,0.0000055938563,0.000016759988,0.00010963798,0.99642915,0.0005321849],"about_ca_topic_score_codex":0.00009507583,"about_ca_topic_score_gemma":6.1925823e-7,"teacher_disagreement_score":0.7727293,"about_ca_system_score_codex":0.00023753704,"about_ca_system_score_gemma":0.00037008026,"threshold_uncertainty_score":0.99970764},"labels":[],"label_agreement":null},{"id":"W4406645976","doi":"10.1016/b978-84-8086-683-5.50013-5","title":"10.1016/b978-84-8086-683-5.50013-5","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Type 2 Diabetes Mellitus; Medicine; Internal medicine; Diabetes mellitus; Type 2 diabetes; Endocrinology","score_opus":0.009832401470630836,"score_gpt":0.19373840963956898,"score_spread":0.18390600816893815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406645976","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000022074205,0.0026997232,0.0000018641805,0.00045676797,0.000009302188,0.0014000974,0.00011921007,0.0002419891,0.99506885],"genre_scores_gemma":[0.0000018188181,0.000016248072,0.00013541387,0.00031310096,0.0021202357,0.000054797703,0.00032231212,0.00022319559,0.9968129],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972348,0.000031434403,0.00052709726,0.0007061034,0.00095281465,0.0005476997],"domain_scores_gemma":[0.99753374,0.000028169443,0.000119812496,0.0015144309,0.0001620728,0.000641753],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00039345465,0.000576805,0.0012188251,0.00029216884,0.00010622426,0.000037351154,0.00023792841,0.0006025349,0.9966667],"category_scores_gemma":[0.000029578747,0.0005261932,0.0008195876,0.00007241178,0.00007582677,0.000047021513,0.00009820564,0.0007272634,0.99418473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020878461,0.000032805285,7.9008355e-9,0.00014337774,0.00041024567,0.000168132,0.0000089429805,0.0000021252697,0.0000035406822,0.00004759026,0.22266342,0.77631104],"study_design_scores_gemma":[0.0008857117,0.00055343873,0.000004641932,0.0005715334,0.00056927034,0.00026821927,4.3264023e-7,0.0000051288525,0.000016917784,0.0001068182,0.99649644,0.00052145927],"about_ca_topic_score_codex":0.00009389823,"about_ca_topic_score_gemma":6.495316e-7,"teacher_disagreement_score":0.77578956,"about_ca_system_score_codex":0.00022613109,"about_ca_system_score_gemma":0.00038111143,"threshold_uncertainty_score":0.99971896},"labels":[],"label_agreement":null},{"id":"W4406648992","doi":"10.1016/b978-2-294-73068-9.00506-5","title":"10.1016/b978-2-294-73068-9.00506-5","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Chemistry; Pharmacology; Medicine","score_opus":0.009811814534007236,"score_gpt":0.19443437363529842,"score_spread":0.1846225591012912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406648992","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000019076783,0.00244735,0.0000017251245,0.00047541573,0.0000073747156,0.0013017913,0.000084503015,0.00023183596,0.9954481],"genre_scores_gemma":[0.0000016320118,0.00001190976,0.00014161646,0.00030670094,0.002186719,0.000043499702,0.00024260393,0.00021391672,0.9968514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974238,0.00002890716,0.00048171755,0.000673454,0.0008850731,0.00050702004],"domain_scores_gemma":[0.9976921,0.000025847223,0.000107388434,0.0014238657,0.00013813574,0.0006126827],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00037410745,0.00053807645,0.001153375,0.0002738153,0.00009742268,0.000031962736,0.00021635831,0.0005612697,0.9963686],"category_scores_gemma":[0.000025762627,0.0004925926,0.00077808637,0.000064915424,0.000066047854,0.000043791435,0.000092599956,0.0006724718,0.9944217],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019712096,0.000031006806,6.4843673e-9,0.00013189738,0.0003904045,0.00018793016,0.00000730505,0.0000019799145,0.0000034148998,0.0000434306,0.17813107,0.82087445],"study_design_scores_gemma":[0.000828717,0.00054042257,0.0000032090081,0.0005355399,0.00050654315,0.00027595143,3.474698e-7,0.000004590713,0.000018202141,0.00010085459,0.9966994,0.0004862337],"about_ca_topic_score_codex":0.00006786346,"about_ca_topic_score_gemma":6.158581e-7,"teacher_disagreement_score":0.8203882,"about_ca_system_score_codex":0.00022331074,"about_ca_system_score_gemma":0.00035020104,"threshold_uncertainty_score":0.9997526},"labels":[],"label_agreement":null},{"id":"W4406650335","doi":"10.1016/b978-2-294-73068-9.00562-4","title":"10.1016/b978-2-294-73068-9.00562-4","year":2000,"lang":"en","type":"book-chapter","venue":"Time to knit","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.009779063435132875,"score_gpt":0.1941605910609263,"score_spread":0.18438152762579343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406650335","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000022540908,0.002313995,0.0000014398266,0.00046088803,0.0000075388084,0.0013049922,0.00008185329,0.0002315771,0.99559546],"genre_scores_gemma":[0.0000015452756,0.000012075503,0.00013937919,0.00030387664,0.0022223466,0.000044059765,0.0002326272,0.00021502415,0.9968291],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99743545,0.000028282646,0.00048238417,0.0006750453,0.00087254524,0.00050627475],"domain_scores_gemma":[0.99767745,0.000026459891,0.00010913662,0.0014246394,0.00014415271,0.0006181373],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00036735387,0.00053934817,0.0011497381,0.00027674402,0.00009572381,0.000031602965,0.000219357,0.00057405967,0.9965107],"category_scores_gemma":[0.000027607517,0.0004938902,0.0007757485,0.0000649373,0.00006657421,0.00004385225,0.000091257294,0.0006807575,0.9946249],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019135777,0.000029644596,6.280331e-9,0.0001302545,0.0003930261,0.00019080407,0.000007428397,0.0000019470917,0.000004385424,0.000040633946,0.1881368,0.8108737],"study_design_scores_gemma":[0.00083497557,0.00052912935,0.0000029393896,0.00054482894,0.00052864634,0.00024389407,3.421281e-7,0.0000046926307,0.000022343298,0.00010152939,0.996698,0.0004886518],"about_ca_topic_score_codex":0.000056274723,"about_ca_topic_score_gemma":4.928026e-7,"teacher_disagreement_score":0.81038505,"about_ca_system_score_codex":0.00022608881,"about_ca_system_score_gemma":0.00036668498,"threshold_uncertainty_score":0.99975127},"labels":[],"label_agreement":null},{"id":"W4406711945","doi":"10.1002/lipd.12432","title":"Regression of carotid atherosclerosis in high‐risk individuals with proprotein convertase subtilisin/kexin type 9 inhibitors","year":2025,"lang":"en","type":"article","venue":"Lipids","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dr. Everett Chalmers Regional Hospital; Western University","funders":"Scheme for Promotion of Academic and Research Collaboration; Heart and Stroke Foundation of Canada","keywords":"PCSK9; Medicine; Kexin; Internal medicine; Lipidology; Proprotein convertase; Cardiology; Clinical chemistry; Cholesterol; Gastroenterology; Lipoprotein; LDL receptor","score_opus":0.008919188755771752,"score_gpt":0.2476759699924237,"score_spread":0.23875678123665195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406711945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674976,0.00050163525,0.000060312766,0.00040752094,0.00028225707,0.0014107028,0.000023446637,0.00004812962,0.0005162559],"genre_scores_gemma":[0.9974952,0.00023188407,0.0011866005,0.00017869778,0.00017964386,0.00008474372,0.000031859512,0.00002832854,0.0005830391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819094,0.00019146691,0.00043436248,0.00036887173,0.00051690615,0.00029746472],"domain_scores_gemma":[0.9988231,0.000036584384,0.00015743921,0.00071212824,0.00015602083,0.00011473048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007795204,0.00021681681,0.0006604477,0.00025818756,0.000060363487,0.000012431068,0.00010712514,0.00019463443,0.000050606614],"category_scores_gemma":[0.00017074715,0.00014151276,0.00013150889,0.0007709111,0.0001142587,0.00006950838,0.00006458092,0.0003626325,0.000009646625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031360416,0.00027942605,0.98345757,0.000629731,0.00018062133,0.0000049981672,0.00042494352,0.000011116914,0.004167121,0.00022125953,0.00067907217,0.009630524],"study_design_scores_gemma":[0.00609431,0.0010798634,0.79396105,0.0032412312,0.0002449814,0.0000074687696,0.00032615077,0.00002022355,0.19110653,0.0001015729,0.0035938136,0.00022279937],"about_ca_topic_score_codex":0.0040520686,"about_ca_topic_score_gemma":0.00020932888,"teacher_disagreement_score":0.18949653,"about_ca_system_score_codex":0.0001033327,"about_ca_system_score_gemma":0.00038484257,"threshold_uncertainty_score":0.61255425},"labels":[],"label_agreement":null},{"id":"W4406788773","doi":"10.1016/s2213-8587(24)00347-4","title":"Protein-binding therapy: a new approach to lower cholesterol","year":2025,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cholesterol; MEDLINE; Internal medicine; Biochemistry","score_opus":0.040997041786902784,"score_gpt":0.2831626981905293,"score_spread":0.24216565640362653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406788773","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047545366,0.0026601527,0.00015312903,0.92243564,0.0009366866,0.005231617,0.00007136212,0.00035346096,0.020612556],"genre_scores_gemma":[0.0043455795,0.0004441304,0.0010789046,0.9437542,0.02056246,0.0014223355,0.00028119131,0.0001326304,0.027978584],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949474,0.0004112478,0.0004675438,0.0009748838,0.00059563,0.0026033064],"domain_scores_gemma":[0.9967323,0.000108747365,0.0001625679,0.0027301405,0.00009514639,0.00017112246],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00062307296,0.0006189925,0.0019829152,0.000313249,0.00017326346,0.00007592681,0.0009163265,0.0006320289,0.00011730023],"category_scores_gemma":[0.00012212755,0.0004037561,0.00058813934,0.0004276439,0.00013454344,0.000040471667,0.0003110606,0.0032657636,0.0003084518],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009583242,0.00006710111,0.0003958852,0.0006314557,0.0012335747,0.00012578447,0.00011324199,0.0000020030363,0.00041390012,0.00013233317,0.9465995,0.050189376],"study_design_scores_gemma":[0.0024613284,0.00030834335,0.0009139259,0.00038771617,0.00026688934,0.00008397329,0.000012643216,0.0000051475313,0.0012994092,0.0001893142,0.9937092,0.00036209638],"about_ca_topic_score_codex":0.00021480033,"about_ca_topic_score_gemma":0.000004041034,"teacher_disagreement_score":0.04982728,"about_ca_system_score_codex":0.00018304124,"about_ca_system_score_gemma":0.00046769413,"threshold_uncertainty_score":0.99984145},"labels":[],"label_agreement":null},{"id":"W4406901829","doi":"10.1007/s40291-024-00768-0","title":"Molecular Therapeutics in Development to Treat Hyperlipoproteinemia","year":2025,"lang":"en","type":"review","venue":"Molecular Diagnosis & Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Academic Medical Organization of Southwestern Ontario; Heart and Stroke Foundation of Canada","keywords":"Molecular medicine; Medicine; Human genetics; Pharmacology; Intensive care medicine; Internal medicine; Biology","score_opus":0.039645864724661806,"score_gpt":0.3430746492664283,"score_spread":0.30342878454176647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406901829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026317977,0.9869196,0.0004537283,0.00052980875,0.00017100786,0.008106337,0.00002042815,0.00012751232,0.0010398146],"genre_scores_gemma":[0.0002040961,0.98305374,0.0019257665,0.005044237,0.00012791375,0.008965643,0.0002190024,0.00023221328,0.00022738674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949752,0.0005243319,0.0012405294,0.0012957791,0.0010351002,0.00092905684],"domain_scores_gemma":[0.99715704,0.00011115363,0.00020226344,0.0019718953,0.00015559468,0.00040207207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074672065,0.0011343024,0.00370566,0.0010163352,0.000097439755,0.00007735609,0.00054779346,0.00078414025,0.000079267396],"category_scores_gemma":[0.000074690484,0.00092200696,0.0016700039,0.0017978529,0.000045446228,0.000036124617,0.0001604714,0.0008172517,0.00015952697],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004181384,0.0004755375,0.000039146806,0.009387288,0.00089293893,0.0010510577,0.00012170672,0.000005913208,0.00006591882,0.00003865619,0.00011411055,0.9877659],"study_design_scores_gemma":[0.001609043,0.00029782567,0.00007905947,0.021967085,0.0009052437,0.000082274215,0.000011143374,4.1211956e-7,0.0037152949,0.00001379672,0.97051877,0.00080007256],"about_ca_topic_score_codex":0.00021632518,"about_ca_topic_score_gemma":0.000023213557,"teacher_disagreement_score":0.98696584,"about_ca_system_score_codex":0.0008407455,"about_ca_system_score_gemma":0.0020780147,"threshold_uncertainty_score":0.99932307},"labels":[],"label_agreement":null},{"id":"W4406999825","doi":"10.1016/j.athoracsur.2025.01.013","title":"Emerging Implications of Elevated Lipoprotein(a) Levels in Coronary Artery Bypass Graft Surgery","year":2025,"lang":"en","type":"review","venue":"The Annals of Thoracic Surgery","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; St Joseph's Health Centre; Western University; St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Artery; Coronary artery bypass surgery; Cardiology; Narrative review; Internal medicine; Narrative; Surgery; Intensive care medicine","score_opus":0.17777745533153433,"score_gpt":0.43027556152075985,"score_spread":0.2524981061892255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406999825","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039831996,0.99118,0.00006229913,0.0016890701,0.00034172516,0.0021499167,0.00022582841,0.00006058879,0.00030739585],"genre_scores_gemma":[0.009766063,0.98842734,0.000037919657,0.00029540833,0.0002569,0.00047789715,0.00032496403,0.000084468666,0.0003290107],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9939769,0.0013620979,0.002614129,0.00059677823,0.0007566659,0.0006934427],"domain_scores_gemma":[0.99215806,0.0034083636,0.00136313,0.0024120687,0.0004862069,0.00017220047],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008035706,0.00058221264,0.005480036,0.0014344038,0.00010191322,0.000014563405,0.0003989367,0.00045852325,0.00009456549],"category_scores_gemma":[0.0014111078,0.00041516643,0.003571766,0.0025523629,0.00019532315,0.00010709037,0.00019078262,0.0007392152,0.000014028535],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007803266,0.00019632133,0.00037245886,0.04862942,0.0012480152,0.00005681678,0.000029265175,0.0000011233701,0.0000071702316,0.000030044443,0.0032777793,0.94607353],"study_design_scores_gemma":[0.00019383765,0.00008467517,0.016187394,0.19068687,0.0039683464,0.0007935919,0.00012011344,0.000005917203,0.000964328,0.0007790767,0.78505695,0.0011589035],"about_ca_topic_score_codex":0.00034772567,"about_ca_topic_score_gemma":0.000024665058,"teacher_disagreement_score":0.94491464,"about_ca_system_score_codex":0.00007055656,"about_ca_system_score_gemma":0.0026876566,"threshold_uncertainty_score":0.99983},"labels":[],"label_agreement":null},{"id":"W4407028321","doi":"10.1016/j.jacl.2025.01.004","title":"Polygenic risk score for coronary artery disease predicts atherosclerotic cardiovascular disease in familial hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia; Université de Sherbrooke; McGill University Health Centre; Montreal Clinical Research Institute","funders":"Canadian Institutes of Health Research; Heart And Stroke Foundation Of Quebec; Heart and Stroke Foundation of Canada","keywords":"Medicine; Familial hypercholesterolemia; Internal medicine; Coronary artery disease; Atherosclerotic cardiovascular disease; Cardiology; Framingham Risk Score; Disease; Cholesterol","score_opus":0.05548483528757916,"score_gpt":0.34802454131983135,"score_spread":0.2925397060322522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407028321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785277,0.010469424,0.003299737,0.0017368007,0.0046534655,0.0011963437,0.000053638843,0.000020880903,0.0000420097],"genre_scores_gemma":[0.9875348,0.0038088295,0.0005959688,0.0021239107,0.0057016704,0.00005181147,0.000014181375,0.00003494341,0.00013383667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952587,0.0011001418,0.002095884,0.0004760695,0.00058650156,0.00048270184],"domain_scores_gemma":[0.9965731,0.0008071729,0.00043457598,0.0009659939,0.0003055098,0.0009136321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053645046,0.0002542795,0.0018150312,0.0002791595,0.000080211976,0.000014907342,0.00027303165,0.00030820924,0.000014415018],"category_scores_gemma":[0.0050001917,0.00019932892,0.0031452617,0.00022675285,0.00025413686,0.00011414225,0.00009195353,0.0011148513,0.000007967311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011772419,0.0008510771,0.8885989,0.00045468684,0.0024550443,0.00030693147,0.000030512032,0.000573486,0.000021903808,0.00005995501,0.0009167367,0.093958326],"study_design_scores_gemma":[0.014155652,0.0012220271,0.96441424,0.0006331222,0.0029460571,0.00008863727,0.000028005605,0.00044487254,0.000002085939,0.0010250114,0.014899937,0.0001403589],"about_ca_topic_score_codex":0.000028717977,"about_ca_topic_score_gemma":0.000011519942,"teacher_disagreement_score":0.093817964,"about_ca_system_score_codex":0.00012189695,"about_ca_system_score_gemma":0.0018226171,"threshold_uncertainty_score":0.81283975},"labels":[],"label_agreement":null},{"id":"W4407151615","doi":"10.1016/j.exger.2025.112698","title":"Statin is associated with higher cortical thickness in early Alzheimer's disease","year":2025,"lang":"en","type":"article","venue":"Experimental Gerontology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health; Alzheimer's Disease Neuroimaging Initiative; U.S. Department of Defense; National Institute on Aging; Eli Lilly and Company; Roche Canada","keywords":"Statin; Medicine; Cuneus; Posterior cingulate; Internal medicine; Dementia; Cardiology; Neuroprotection; Alzheimer's Disease Neuroimaging Initiative; Neuroscience; Cortex (anatomy); Disease; Cognition; Psychology; Precuneus; Psychiatry","score_opus":0.030787583983176613,"score_gpt":0.3285720573408049,"score_spread":0.2977844733576283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407151615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837655,0.0087490305,0.00007341388,0.0019399673,0.00022634403,0.0005950506,0.000007793051,0.000058188474,0.004584734],"genre_scores_gemma":[0.99572307,0.000009573358,0.00020627172,0.0029502437,0.000045836,0.00015312513,0.000025610474,0.000017647108,0.00086861436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860483,0.00017296613,0.0002467823,0.00034897865,0.00026114445,0.00036527426],"domain_scores_gemma":[0.9993513,0.00004008051,0.000041672374,0.00033669255,0.000041231924,0.0001890194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001711255,0.00016270526,0.00044224825,0.00007833717,0.00006263633,0.000011160231,0.00007012344,0.00012288,0.0003644039],"category_scores_gemma":[0.000025386033,0.0001306522,0.000094983,0.00017923473,0.00014596184,0.00005086078,0.000043348056,0.00025387687,0.000021891809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011736548,0.007205588,0.9048201,0.00021382484,0.0040109656,0.005789465,0.010059861,0.0000068225145,0.0071386364,0.025699586,0.01086274,0.0124558695],"study_design_scores_gemma":[0.005837713,0.0005804609,0.98537177,0.0001487321,0.0002270133,0.000019868154,0.0005108227,0.00003552097,0.0050328453,0.00007060012,0.0019733347,0.00019132985],"about_ca_topic_score_codex":0.00091661233,"about_ca_topic_score_gemma":0.00008636652,"teacher_disagreement_score":0.08055166,"about_ca_system_score_codex":0.00017932408,"about_ca_system_score_gemma":0.00022947414,"threshold_uncertainty_score":0.5327842},"labels":[],"label_agreement":null},{"id":"W4407199550","doi":"10.2337/dc24-2110","title":"Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial","year":2025,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital; Sanofi (Canada)","funders":"American Regent; St. Jude Medical; Silence Therapeutics; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Servier; Assistance publique-Hôpitaux de Paris; Genentech; University of Oxford; Belvoir Media Group; Novo Nordisk; MyoKardia; Medicines Company; AstraZeneca; Amarin Corporation; Ironwood Pharmaceuticals, Incorporated; National Institutes of Health; Regeneron Pharmaceuticals; Boston Scientific Corporation; Duke Clinical Research Institute; Eisai; Cytokinetics; Bristol-Myers Squibb; Cleveland Clinic; Brigham and Women's Hospital; York University; Moderna; Pfizer; Roche Diagnostics; Heart and Stroke Foundation of Canada; Netherlands Heart Institute; HLS Therapeutics; GlaxoSmithKline; CSL Behring; Eli Lilly and Company; Edwards Lifesciences; Amgen; Sanofi; American Heart Association; Esperion Therapeutics; Alnylam Pharmaceuticals; Patient-Centered Outcomes Research Institute; Sanofi Australia; University of Toronto; U.S. Department of Veterans Affairs","keywords":"Alirocumab; Medicine; Internal medicine; PCSK9; Endocrinology; Diabetes mellitus; Lipoprotein; Insulin resistance; Post-hoc analysis; Nod; Placebo; Odds ratio; Statin; Cholesterol; LDL receptor; Apolipoprotein A1","score_opus":0.008600064441508935,"score_gpt":0.26825764600844176,"score_spread":0.2596575815669328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407199550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98674995,0.007390644,0.0000055804867,0.0013155492,0.00017574604,0.0040353816,0.00013511299,0.000037819373,0.0001541908],"genre_scores_gemma":[0.99845207,0.0002607151,0.00009811263,0.00063868746,0.000050361592,0.00035747612,0.000034124867,0.00003062285,0.000077826444],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99775684,0.000533004,0.00053238694,0.0003753605,0.0004693044,0.00033309386],"domain_scores_gemma":[0.99776804,0.00033393156,0.00036650724,0.00094985316,0.00045360657,0.00012805079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009537648,0.00031589574,0.0018745909,0.00026140097,0.00011477629,0.000024104915,0.00020235116,0.00015439556,0.000009315826],"category_scores_gemma":[0.0008512981,0.00015638184,0.0006155438,0.0005700772,0.0002450151,0.0000513624,0.00017396292,0.00024499447,0.000001312547],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08360084,0.00022400416,0.8157549,0.0025486276,0.008816956,0.0000025349207,0.005508017,0.00004284059,0.009803018,0.00007355208,0.00006239859,0.07356233],"study_design_scores_gemma":[0.45482305,0.0018016759,0.38630158,0.0016493694,0.0030940576,9.2840355e-7,0.002940801,0.000033760687,0.14870818,0.0001058967,0.00025239852,0.00028832201],"about_ca_topic_score_codex":0.0005795733,"about_ca_topic_score_gemma":0.00032729656,"teacher_disagreement_score":0.4294533,"about_ca_system_score_codex":0.000056125034,"about_ca_system_score_gemma":0.00014291368,"threshold_uncertainty_score":0.6377066},"labels":[],"label_agreement":null},{"id":"W4407265883","doi":"10.1093/eurjpc/zwaf067","title":"Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome","year":2025,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital; Sanofi (Canada)","funders":"Sanofi-Aventis Deutschland; Regeneron Pharmaceuticals; Sanofi","keywords":"Mace; Medicine; Internal medicine; Alirocumab; Acute coronary syndrome; Cardiology; Statin; Hypertriglyceridemia; Proportional hazards model; Atorvastatin; Apolipoprotein B; Endocrinology; Cholesterol; Percutaneous coronary intervention; Myocardial infarction; Triglyceride; Apolipoprotein A1","score_opus":0.00990008961696877,"score_gpt":0.24762307344924292,"score_spread":0.23772298383227414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407265883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853597,0.012058794,0.00089594047,0.000056449837,0.00019255483,0.0009663109,0.000051477917,0.0000051013994,0.00041363668],"genre_scores_gemma":[0.9714513,0.02696772,0.0013287048,0.000049951137,0.000051299838,0.000017714017,0.000010058384,0.000025992445,0.00009727388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955767,0.0028202964,0.0007112731,0.00032058355,0.0003144551,0.00025671214],"domain_scores_gemma":[0.9988416,0.00006262805,0.00031311752,0.0003903108,0.00023994451,0.00015242586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020741033,0.0002431964,0.001391003,0.00031438237,0.0000412127,0.0000053482063,0.00008098247,0.00006246031,0.0000092598475],"category_scores_gemma":[0.00015186564,0.00018058317,0.0006234598,0.00014144203,0.00007816331,0.000055023487,0.00009869248,0.00031239633,0.0000019606714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067972364,0.00052010926,0.74982196,0.00020046745,0.024292592,0.00417456,0.00034973086,0.00051034795,0.000023266006,0.000016666496,0.000044581815,0.21324848],"study_design_scores_gemma":[0.013881219,0.00463444,0.9757869,0.0005327781,0.0024437143,0.00051444536,0.00005040454,0.0000043694727,0.000086423854,0.00006322674,0.0018856882,0.00011638093],"about_ca_topic_score_codex":0.000045431476,"about_ca_topic_score_gemma":0.000001141943,"teacher_disagreement_score":0.22596493,"about_ca_system_score_codex":0.00018285825,"about_ca_system_score_gemma":0.00011497053,"threshold_uncertainty_score":0.7363968},"labels":[],"label_agreement":null},{"id":"W4407374752","doi":"10.3390/ijms26041484","title":"Low-Dose Docetaxel Is Effective in Reducing Atherogenic Lipids and Atherosclerosis","year":2025,"lang":"en","type":"article","venue":"International Journal of Molecular Sciences","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McGill University Health Centre","funders":"Canadian Institutes of Health Research; McGill University Health Centre","keywords":"Cholesterol; Dyslipidemia; Lipoprotein; High-density lipoprotein; Endocrinology; Internal medicine; Docetaxel; Medicine; Blood lipids; Pharmacology; Chemistry; Chemotherapy; Diabetes mellitus","score_opus":0.010267944388610251,"score_gpt":0.3010202895235996,"score_spread":0.2907523451349894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407374752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99187595,0.003013201,0.0012266288,0.002614812,0.00040857753,0.00016342134,0.0000011575088,0.0000037483849,0.00069250306],"genre_scores_gemma":[0.99699223,0.0005471465,0.0011356757,0.0011740586,0.00010254678,0.0000047538774,1.9684386e-7,0.0000042864585,0.000039088092],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986826,0.00007396583,0.00029403652,0.00016990058,0.0006511763,0.0001283139],"domain_scores_gemma":[0.9994437,0.000039425515,0.00012396347,0.00009716143,0.00022981579,0.00006591398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001202896,0.00008175752,0.00022083602,0.00035307722,0.0000432665,0.00005795222,0.00020984907,0.00004308242,0.000013628467],"category_scores_gemma":[0.00014768691,0.00006229447,0.00017901667,0.00030509615,0.0001370653,0.0001220746,0.00005865997,0.00016207295,0.0000014707149],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000485406,0.000671875,0.08280555,0.00017191167,0.0015742964,0.000489336,0.0030754076,0.0005900835,0.3277027,0.0029572358,0.00022653531,0.5792497],"study_design_scores_gemma":[0.009078842,0.0013919459,0.5263301,0.004411494,0.00025065397,0.0012829223,0.0010871534,0.0014718942,0.44857597,0.0035505872,0.0022343101,0.00033409562],"about_ca_topic_score_codex":0.000091110225,"about_ca_topic_score_gemma":0.0000043458917,"teacher_disagreement_score":0.57891554,"about_ca_system_score_codex":0.000105550665,"about_ca_system_score_gemma":0.00026274112,"threshold_uncertainty_score":0.25402948},"labels":[],"label_agreement":null},{"id":"W4407375835","doi":"10.1080/14796678.2025.2461425","title":"Evinacumab for children with homozygous familial hypercholesterolemia: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Future Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Silence Therapeutics; Ultragenyx Pharmaceutical; Regeneron Pharmaceuticals; Esperion Therapeutics; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Plain language; Pediatrics; Internal medicine; Cardiology; Cholesterol; Linguistics","score_opus":0.005115613997138777,"score_gpt":0.25241614621039105,"score_spread":0.24730053221325227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407375835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707723,0.013141421,0.0054956744,0.002445523,0.0008992487,0.0023420174,0.00014476849,0.00016887095,0.0045901285],"genre_scores_gemma":[0.98565054,0.00042996014,0.0017702384,0.003562644,0.006397719,0.00043208332,0.0004748655,0.000049339855,0.0012326065],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986066,0.00013070912,0.00020927275,0.0004560761,0.0001716383,0.00042569244],"domain_scores_gemma":[0.9989825,0.00004311135,0.00004030431,0.0007154386,0.00010553313,0.00011313464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039090362,0.00022710524,0.0008333501,0.0001273373,0.00012174586,0.000010627927,0.00012936382,0.0003421735,0.000004979815],"category_scores_gemma":[0.000050783052,0.00016097902,0.0004018906,0.00018895222,0.0000889675,0.000032186614,0.000050777246,0.00038290533,0.000007044862],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075043426,0.00027927026,0.19036832,0.0018676813,0.011354406,0.0019793406,0.001454431,0.00012898778,0.0031538957,0.0035006157,0.1701985,0.6082102],"study_design_scores_gemma":[0.015696261,0.0021122177,0.6521653,0.00031943707,0.0019134732,0.005745089,0.0016424544,0.000014805347,0.0005238325,0.0000924603,0.31923082,0.00054384134],"about_ca_topic_score_codex":0.000090341986,"about_ca_topic_score_gemma":0.00005533901,"teacher_disagreement_score":0.6076664,"about_ca_system_score_codex":0.00011727392,"about_ca_system_score_gemma":0.00029343306,"threshold_uncertainty_score":0.65645343},"labels":[],"label_agreement":null},{"id":"W4407392403","doi":"10.1001/jamacardio.2024.5433","title":"Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers","year":2025,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Placebo; Internal medicine; Apolipoprotein B; Randomized controlled trial; Gastroenterology; C-reactive protein; Lipoprotein(a); Inflammation; Randomization; Clinical endpoint; Clinical trial; Cholesterol; Pathology","score_opus":0.007228263054587478,"score_gpt":0.24633224251867564,"score_spread":0.23910397946408815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407392403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95874524,0.021906245,0.0008026262,0.0013568704,0.0008530498,0.0008717823,0.000007849693,0.0001358952,0.015320414],"genre_scores_gemma":[0.9955544,0.0017965051,0.00023046894,0.0012888006,0.0005246809,0.00009764736,0.000015564035,0.000018482004,0.00047347898],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99852175,0.00024809747,0.00033560893,0.0003863205,0.00017142778,0.000336774],"domain_scores_gemma":[0.998998,0.000075915166,0.000056518882,0.00061476725,0.00011096212,0.0001438798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096790784,0.00017717535,0.0008305452,0.00017243013,0.00008870447,0.000017536742,0.00007836899,0.00033425144,0.000010778115],"category_scores_gemma":[0.00021066927,0.00014765846,0.00031577103,0.00021114109,0.0001567193,0.000046223064,0.00008511694,0.0002540986,0.000022228924],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004573491,0.00009669887,0.39786845,0.008166562,0.014919249,0.00208817,0.00057557825,0.000035902765,0.09013465,0.014666295,0.067970105,0.39890486],"study_design_scores_gemma":[0.017284058,0.00032497259,0.5083011,0.00091837364,0.0012792626,0.0055790497,0.0009030591,0.000096092626,0.004112044,0.00044714913,0.46023968,0.0005152125],"about_ca_topic_score_codex":0.00011541196,"about_ca_topic_score_gemma":0.000003671678,"teacher_disagreement_score":0.39838964,"about_ca_system_score_codex":0.00011155464,"about_ca_system_score_gemma":0.00026614455,"threshold_uncertainty_score":0.6021337},"labels":[],"label_agreement":null},{"id":"W4407707201","doi":"10.1007/s12170-025-00760-1","title":"Lipoprotein(a) as a Causal Risk Factor for Cardiovascular Disease","year":2025,"lang":"en","type":"review","venue":"Current Cardiovascular Risk Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Medicine; Atherosclerotic cardiovascular disease; Lipoprotein(a); Risk factor; Disease; Internal medicine; Cardiology; Cholesterol; Lipoprotein","score_opus":0.03991134023534787,"score_gpt":0.3368358871422346,"score_spread":0.29692454690688674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407707201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038077655,0.9470399,0.019022536,0.000009542789,0.006330439,0.023806373,0.0028061506,0.00063571916,0.0003112692],"genre_scores_gemma":[0.00011463284,0.9820105,0.00077710685,0.000019738802,0.005459636,0.008815419,0.0017282324,0.00055785436,0.00051687576],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9826394,0.0022633444,0.0034485164,0.004744341,0.0048633483,0.002041092],"domain_scores_gemma":[0.9811824,0.00034098874,0.0018041377,0.013406944,0.0011271569,0.0021383741],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.007379084,0.0026793755,0.014410227,0.001181444,0.00092367537,0.00025582968,0.00063252234,0.0013297806,0.00009810019],"category_scores_gemma":[0.006434045,0.0022232146,0.08817468,0.0016156028,0.00033875092,0.0002269222,0.0005870616,0.0031175206,0.00013178831],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006880504,0.0002442529,0.00006279228,0.09956128,0.076390766,0.0026758001,0.000026889575,0.000077831035,8.145803e-9,0.000023526547,0.000612985,0.82025504],"study_design_scores_gemma":[0.0015877053,0.00016355302,0.000110478606,0.026851427,0.1750497,0.00195177,0.00000916709,0.000009168624,0.0000016782284,0.00020495542,0.7924619,0.0015985119],"about_ca_topic_score_codex":0.0010403666,"about_ca_topic_score_gemma":0.000007145193,"teacher_disagreement_score":0.81865656,"about_ca_system_score_codex":0.0012664909,"about_ca_system_score_gemma":0.007964691,"threshold_uncertainty_score":0.9999667},"labels":[],"label_agreement":null},{"id":"W4407753432","doi":"10.3390/jcm14041371","title":"Triglycerides/High-Density Lipoprotein Ratio and Coronary Artery Disease: Results from a Large Single-Center Study","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Coronary artery disease; Internal medicine; Center (category theory); Cardiology; Single Center; High-density lipoprotein; Cholesterol","score_opus":0.04785367802950002,"score_gpt":0.36559872010232813,"score_spread":0.3177450420728281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407753432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97691447,0.0024433061,0.0011195311,0.016355677,0.0016596962,0.0011035551,0.000034426965,0.000022300192,0.00034703227],"genre_scores_gemma":[0.9910719,0.0006310114,0.00036324162,0.0037355756,0.0037593234,0.0000075079947,0.000024969799,0.000018475244,0.00038799486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950298,0.0006114319,0.0026580896,0.00041533046,0.0010071942,0.00027812383],"domain_scores_gemma":[0.9963033,0.00086849806,0.0009418909,0.0006857154,0.00046686138,0.00073372235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005588774,0.00023162334,0.0017461427,0.00018453553,0.00010244014,0.000019074861,0.00014261542,0.00015682596,0.0000820541],"category_scores_gemma":[0.007846031,0.00014839804,0.00038633135,0.00023813178,0.00019823379,0.00011563094,0.000101341444,0.0009289665,0.0000051388174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06743082,0.011469259,0.5059218,0.00036467405,0.004434895,0.011512571,0.0008106675,0.0000018221779,0.0003600824,0.000098745084,0.018199936,0.37939477],"study_design_scores_gemma":[0.053865172,0.005634976,0.9274937,0.0017334725,0.0013638053,0.00021665239,0.00054021395,0.000047863556,0.000028455901,0.00044397227,0.008514876,0.00011683599],"about_ca_topic_score_codex":0.00024442468,"about_ca_topic_score_gemma":0.00009136163,"teacher_disagreement_score":0.42157194,"about_ca_system_score_codex":0.0000708728,"about_ca_system_score_gemma":0.0004629701,"threshold_uncertainty_score":0.93929994},"labels":[],"label_agreement":null},{"id":"W4407786190","doi":"10.1097/mol.0000000000000977","title":"Leveraging drug-target Mendelian randomization for tailored lipoprotein-lipid lowering","year":2025,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Mendelian randomization; PCSK9; Lipoprotein; Medicine; Drug; Pharmacology; Lipoprotein lipase; Cholesterylester transfer protein; Bioinformatics; Proprotein convertase; Kexin; Cholesterol; Genetic variants; Biology; Internal medicine; LDL receptor; Genetics; Gene; Genotype","score_opus":0.08425527938219267,"score_gpt":0.3927712487079301,"score_spread":0.30851596932573744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407786190","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[7.158104e-7,0.8900926,0.027570289,0.00023478782,0.074278,0.0074928794,0.000042735883,0.00010940529,0.00017860428],"genre_scores_gemma":[0.000004393069,0.9660364,0.0010241773,0.000047831596,0.02725207,0.0033825154,0.0019284516,0.00009416575,0.0002300368],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955894,0.00056262396,0.0016186393,0.0010706125,0.00038009018,0.0007786548],"domain_scores_gemma":[0.997756,0.00040295202,0.00051563437,0.00092933094,0.0001911583,0.00020493151],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019993798,0.0006861692,0.0040303543,0.0010816533,0.00014395913,0.000033947716,0.00029874948,0.00053772517,0.000070066635],"category_scores_gemma":[0.0008077741,0.000599041,0.001526065,0.0007691095,0.00007559097,0.0000874985,0.00017205051,0.0009084497,0.000026832338],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020389321,0.00012624508,0.000009505892,0.13501,0.00023133581,2.0499327e-7,0.00008029812,0.00002017105,1.9959393e-7,0.00023738928,0.013417616,0.8506631],"study_design_scores_gemma":[0.006970979,0.00009562311,0.000003901598,0.051929135,0.00046989744,0.000044314987,0.000022731918,0.00010404462,0.0000015134873,0.00010788081,0.93982375,0.00042626142],"about_ca_topic_score_codex":0.00004461461,"about_ca_topic_score_gemma":0.000003131044,"teacher_disagreement_score":0.9264061,"about_ca_system_score_codex":0.0004918247,"about_ca_system_score_gemma":0.0014191357,"threshold_uncertainty_score":0.9996461},"labels":[],"label_agreement":null},{"id":"W4407802558","doi":"10.1093/eurjpc/zwaf092","title":"High remnant cholesterol and atherosclerotic cardiovascular disease in healthy women and men aged 70–100","year":2025,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Gentofte Hospital; County Foundation","keywords":"Medicine; Atherosclerotic cardiovascular disease; Cholesterol; Internal medicine; Disease; Ldl cholesterol; Cardiology","score_opus":0.012974692499773786,"score_gpt":0.24838659396473,"score_spread":0.23541190146495622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407802558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97255385,0.023499684,0.001592009,0.0005654916,0.00024899704,0.00058292993,0.00000624397,0.000010915119,0.00093988876],"genre_scores_gemma":[0.99197596,0.0068631102,0.00021020346,0.0004255926,0.0003352935,0.000011621885,0.0000025731074,0.000028789655,0.00014684054],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956159,0.0027595973,0.00062383467,0.00035410194,0.0002749198,0.0003716275],"domain_scores_gemma":[0.9988033,0.000056089008,0.00017510785,0.00045206764,0.0001354711,0.0003779491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005099768,0.00020308385,0.0011606993,0.00028202363,0.00007565893,0.00001975537,0.0001133595,0.000048876176,0.0000055035457],"category_scores_gemma":[0.00024523996,0.00016196983,0.00043915602,0.00018404162,0.00016215436,0.00008175473,0.00013272076,0.00048363156,0.0000026830537],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00977115,0.0004874185,0.28755173,0.0029666394,0.020389317,0.01530913,0.004409104,0.0012641603,0.0025604905,0.00040585324,0.0011234118,0.6537616],"study_design_scores_gemma":[0.007271685,0.00095725205,0.98421675,0.00050175074,0.00047975566,0.0004566107,0.00024602705,0.0000077725745,0.000019976262,0.00022881507,0.005485967,0.00012762703],"about_ca_topic_score_codex":0.000027597738,"about_ca_topic_score_gemma":0.0000010231572,"teacher_disagreement_score":0.69666505,"about_ca_system_score_codex":0.0001677749,"about_ca_system_score_gemma":0.00019093725,"threshold_uncertainty_score":0.6604938},"labels":[],"label_agreement":null},{"id":"W4407911249","doi":"10.1093/eurjpc/zwaf048","title":"Reappraisal of statin primary prevention trials: implications for identification of the statin-eligible primary prevention patient","year":2025,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Statin; Dyslipidemia; Primary prevention; Randomized controlled trial; Framingham Risk Score; Internal medicine; Cohort; Clinical trial; Physical therapy; Disease","score_opus":0.04260923833761186,"score_gpt":0.35917014389983637,"score_spread":0.3165609055622245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407911249","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4819089,0.0061304984,0.4992824,0.0009013387,0.0011445496,0.0037195585,0.00019318744,0.000015914458,0.006703667],"genre_scores_gemma":[0.9912717,0.000957354,0.0064978115,0.00010312713,0.00029565458,0.000059903654,0.00009788441,0.00003172073,0.0006848979],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99244785,0.0043813093,0.0024070453,0.00024851962,0.00032263767,0.00019261721],"domain_scores_gemma":[0.9948797,0.00039185636,0.0028253505,0.00058255525,0.0012566521,0.000063876745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009731116,0.00016125638,0.0011503401,0.00023916479,0.00009198197,0.000009272828,0.00024385708,0.00006280027,0.0000069792864],"category_scores_gemma":[0.001859914,0.000115166935,0.0014872709,0.00032822587,0.00014350121,0.00010968399,0.00010179752,0.00024077589,0.0000010626417],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027600515,0.0009520036,0.008341331,0.0027332366,0.0056357705,0.000010139448,0.0009823915,0.00069415563,0.2207802,0.0039258664,0.009492793,0.74369204],"study_design_scores_gemma":[0.006120815,0.0025760664,0.94609094,0.0013118669,0.0027796235,0.00015859508,0.00046266447,0.0000092986775,0.018184666,0.0038926657,0.018250095,0.0001627028],"about_ca_topic_score_codex":0.0000032905239,"about_ca_topic_score_gemma":7.2541303e-7,"teacher_disagreement_score":0.9377496,"about_ca_system_score_codex":0.000100301244,"about_ca_system_score_gemma":0.0007387542,"threshold_uncertainty_score":0.46963713},"labels":[],"label_agreement":null},{"id":"W4407983857","doi":"10.21037/cdt-24-162","title":"Elevated lipoprotein(a) and cardiovascular outcomes in prediabetes and diabetes: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Cardiovascular Diagnosis and Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prediabetes; Medicine; Meta-analysis; Diabetes mellitus; Internal medicine; Type 2 diabetes; Endocrinology","score_opus":0.048968709802436186,"score_gpt":0.3093239028994624,"score_spread":0.2603551930970262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407983857","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029970237,0.984043,0.000020979063,0.00017206321,0.00004975638,0.015123539,0.00017466825,0.00008239664,0.000033910535],"genre_scores_gemma":[0.0002095334,0.9849677,0.0001572065,0.0006920654,0.00006672287,0.013604097,0.000098830715,0.00012369026,0.00008016031],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9916827,0.0024376442,0.0018064672,0.0020941503,0.0011979436,0.00078111206],"domain_scores_gemma":[0.9949852,0.0007105544,0.00035898256,0.0032296472,0.00022456062,0.0004910147],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.006739728,0.0015023324,0.033259165,0.0010786481,0.00019774052,0.0002073665,0.00023590676,0.00071624975,0.000026646185],"category_scores_gemma":[0.0006917342,0.00096927956,0.017265659,0.0017519494,0.00025472458,0.00016198009,0.0002744895,0.00073413516,0.0000019003384],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014541656,0.000050150156,0.00026386502,0.43013528,0.43887475,0.000037190042,0.000019769024,4.4434412e-7,1.1822132e-8,0.000007405373,0.000010398695,0.1305993],"study_design_scores_gemma":[0.0012371653,0.00013747453,0.0003578981,0.052995645,0.84823745,0.00007316586,0.000018194192,0.0000028967845,0.0000015663825,0.000018191404,0.09614399,0.00077634474],"about_ca_topic_score_codex":0.00031021956,"about_ca_topic_score_gemma":0.000015650889,"teacher_disagreement_score":0.40936273,"about_ca_system_score_codex":0.00009502973,"about_ca_system_score_gemma":0.00021205228,"threshold_uncertainty_score":0.99977255},"labels":[],"label_agreement":null},{"id":"W4408284633","doi":"10.1016/j.jbc.2025.108392","title":"Structural analyses of apolipoprotein A-IV polymorphisms Q360H and T347S elucidate the inhibitory effect against thrombosis","year":2025,"lang":"en","type":"article","venue":"Journal of Biological Chemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; Canadian Blood Services; Canadian Armed Forces; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; York University; Canadian Blood Services; Canadian Armed Forces; Natural Sciences and Engineering Research Council of Canada; Acorda Therapeutics; Heart and Stroke Foundation of Canada","keywords":"Inhibitory postsynaptic potential; Thrombosis; Apolipoprotein B; Chemistry; Genetics; Pharmacology; Biology; Medicine; Biochemistry; Internal medicine; Cholesterol","score_opus":0.029628716607118053,"score_gpt":0.3155664091117736,"score_spread":0.2859376925046555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408284633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004275,0.008023849,0.00003398294,0.0008464159,0.00008394371,0.00018949964,0.0000065212657,0.000009733178,0.00076328416],"genre_scores_gemma":[0.99828714,0.00072316156,0.00014957278,0.00033520046,0.00043689527,0.0000044286226,0.000004922766,0.000006174602,0.000052493317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862415,0.00012974032,0.00055483944,0.00017467896,0.00031204734,0.00020456008],"domain_scores_gemma":[0.99896103,0.00012499475,0.00033616868,0.00030707315,0.0001387906,0.0001319459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084540545,0.00017927815,0.0007503534,0.000045953984,0.0000880261,0.000015362084,0.00016244545,0.00021342222,0.00004291487],"category_scores_gemma":[0.00037861173,0.000083812454,0.0004837344,0.00020840974,0.00030422866,0.000035866036,0.000089984955,0.00048613286,4.6832628e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028826288,0.00003775624,0.011230862,0.00033215372,0.00061685225,0.000029580933,0.000022524322,0.000005196032,0.97160226,0.000008356589,0.00016557069,0.015660642],"study_design_scores_gemma":[0.001452951,0.0003829417,0.083806105,0.00035367842,0.0003176967,0.00018840795,0.0000980066,0.000023829918,0.9127492,0.00013046995,0.0003995152,0.0000972191],"about_ca_topic_score_codex":0.00004087148,"about_ca_topic_score_gemma":3.910725e-7,"teacher_disagreement_score":0.07257524,"about_ca_system_score_codex":0.00005760567,"about_ca_system_score_gemma":0.00012562121,"threshold_uncertainty_score":0.34177727},"labels":[],"label_agreement":null},{"id":"W4408389186","doi":"10.1016/j.cjca.2025.02.037","title":"Obesity and Public Health—Dare We Have Hope?","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Obesity; Public health; Environmental health; Family medicine; Internal medicine; Nursing","score_opus":0.02286482601469947,"score_gpt":0.26569361839617966,"score_spread":0.2428287923814802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408389186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48671162,0.14726922,0.014271033,0.31240013,0.0026142355,0.0009837517,0.000057213638,0.00002444169,0.03566835],"genre_scores_gemma":[0.9936494,0.0018046092,0.0001602833,0.003147201,0.0008031592,0.0000025571653,0.0000035729918,0.000009008347,0.00042021114],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987356,0.0002365566,0.00033618367,0.00013812238,0.0001243768,0.00042916246],"domain_scores_gemma":[0.9981408,0.00002759869,0.000102087564,0.00026135295,0.00027928504,0.0011888448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011305567,0.000102662685,0.0007386489,0.00041049038,0.0001532085,0.000022097292,0.000091287846,0.00013317255,0.0000146685215],"category_scores_gemma":[0.00025942485,0.000085945394,0.00026122024,0.000148852,0.00014307437,0.00005119244,0.000014473568,0.00038092292,0.0000026441248],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059339618,0.000008182348,0.4493685,0.00053606316,0.0016952496,0.0011318672,0.0005289233,0.00003146127,0.000031240805,0.0033948454,0.14374825,0.39946607],"study_design_scores_gemma":[0.0008965012,0.00022662338,0.22060782,0.00011355493,0.000064820706,0.0019290503,0.00045950335,0.0000026650862,0.0000069012954,0.0002898161,0.7753465,0.000056251833],"about_ca_topic_score_codex":0.0035487532,"about_ca_topic_score_gemma":0.004532635,"teacher_disagreement_score":0.63159823,"about_ca_system_score_codex":0.00032898228,"about_ca_system_score_gemma":0.0068989443,"threshold_uncertainty_score":0.998731},"labels":[],"label_agreement":null},{"id":"W4408412759","doi":"10.1161/jaha.124.038955","title":"Impact of Lipoprotein(a) on Valvular and Cardiovascular Outcomes in Patients With Calcific Aortic Valve Stenosis","year":2025,"lang":"en","type":"article","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Hazard ratio; Myocardial infarction; Lipoprotein(a); Aortic valve replacement; Stroke (engine); Aortic valve stenosis; Stenosis; Heart failure; Proportional hazards model; Aortic valve; Risk factor; Lipoprotein; Confidence interval; Cholesterol","score_opus":0.006612505625629691,"score_gpt":0.2693261025824803,"score_spread":0.2627135969568506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408412759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998543,0.0002976156,0.000031635722,0.00051699416,0.00008191369,0.00048071714,0.0000046259493,0.000003827446,0.000039642553],"genre_scores_gemma":[0.9994677,0.00006975577,0.00016481195,0.00020396111,0.00004455367,0.000004985832,5.750962e-7,0.000011666902,0.000032042946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997968,0.00033408965,0.00042429782,0.00012305706,0.0009662151,0.00018430098],"domain_scores_gemma":[0.9986731,0.00009535249,0.00044975558,0.00036950316,0.00034384834,0.000068449815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013697427,0.00012134723,0.0011130453,0.0002135819,0.000049326773,0.000012123483,0.0000687097,0.0000464529,0.0000020057191],"category_scores_gemma":[0.00051320164,0.00006751836,0.0013111149,0.00053429534,0.00004494928,0.000061575396,0.00002372978,0.00029045247,4.9430525e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024357146,0.00022056591,0.986337,0.000031949832,0.0032140587,0.0000010880464,0.00007568944,0.00021991617,0.000038332182,0.0000018818328,0.00009390835,0.009522031],"study_design_scores_gemma":[0.0022557501,0.0014230203,0.9951136,0.00024370023,0.0006422395,0.0000028215156,0.00006334394,0.000012353609,0.000107496555,0.000018476741,0.00005894908,0.000058217833],"about_ca_topic_score_codex":0.0013024104,"about_ca_topic_score_gemma":0.000007905367,"teacher_disagreement_score":0.009463813,"about_ca_system_score_codex":0.00068532676,"about_ca_system_score_gemma":0.00024561788,"threshold_uncertainty_score":0.2753319},"labels":[],"label_agreement":null},{"id":"W4408504822","doi":"10.1002/psp4.70017","title":"Comparison of Model‐Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged &lt; 5 Years With Homozygous Familial Hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Dosing; Pharmacokinetics; Population; Lipoprotein; Gastroenterology; Body weight; Internal medicine; Pediatrics; Cholesterol","score_opus":0.03740819570575227,"score_gpt":0.3463627957102121,"score_spread":0.30895460000445985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408504822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97508246,0.020429384,0.00057457935,0.00012757206,0.0005535372,0.0029114678,0.0000859966,0.00009825401,0.00013675915],"genre_scores_gemma":[0.99531776,0.0033610936,0.00032345724,0.00042844168,0.00020886427,0.0001467061,0.000056332017,0.000056738674,0.000100608515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996534,0.00047067244,0.0010488881,0.000716483,0.0006086162,0.00062133605],"domain_scores_gemma":[0.99845254,0.00025753642,0.00029595618,0.00037971121,0.00023799796,0.00037626718],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010817139,0.00042431254,0.0016043321,0.0016678046,0.000100957164,0.000036714617,0.00025977514,0.00025865858,0.000012174499],"category_scores_gemma":[0.00007204695,0.0003906436,0.00013296788,0.0025348985,0.00028469483,0.000118445045,0.00021300667,0.0008996421,0.0000013739993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002862392,0.0023632005,0.8242208,0.0027414039,0.0027178912,0.0002605904,0.00094316574,0.006994361,0.116528764,0.000044522003,0.0034252044,0.0368977],"study_design_scores_gemma":[0.051218096,0.0009432277,0.8693805,0.00046980506,0.002967593,0.0005218791,0.0001703515,0.062751815,0.009646817,0.000004226508,0.0013746531,0.0005510581],"about_ca_topic_score_codex":0.00024030179,"about_ca_topic_score_gemma":0.000004630564,"teacher_disagreement_score":0.10688195,"about_ca_system_score_codex":0.0002233299,"about_ca_system_score_gemma":0.00031405487,"threshold_uncertainty_score":0.99985456},"labels":[],"label_agreement":null},{"id":"W4408546881","doi":"10.1186/s12944-025-02506-9","title":"Evaluation of the hypercholesterolemia care cascade and compliance with NCEP-ATP III guidelines in Iran based on the WHO STEPS survey","year":2025,"lang":"en","type":"article","venue":"Lipids in Health and Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Lipidology; Clinical chemistry; Clinical nutrition; Compliance (psychology); Cascade; Medicine; Internal medicine; Chemistry; Psychology","score_opus":0.09074766031979815,"score_gpt":0.37399134823383196,"score_spread":0.2832436879140338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408546881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755871,0.011248711,0.00004412196,0.011041636,0.000081268656,0.0017612797,0.00004354493,0.0000065597837,0.00018574465],"genre_scores_gemma":[0.9887713,0.00028259883,0.000042961947,0.010698224,0.000055970755,0.000101786165,0.00001516551,0.000007637473,0.000024339632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759066,0.0010402686,0.00036229508,0.00025044076,0.0005609068,0.00019545236],"domain_scores_gemma":[0.99881333,0.00015095292,0.00007526068,0.0005014059,0.00021946924,0.00023959347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034755352,0.00011566871,0.00030316546,0.00007578136,0.0001194726,0.000010742833,0.00006932064,0.000042297503,0.0000030290744],"category_scores_gemma":[0.001073292,0.00006211267,0.000040371102,0.0003318911,0.0000978177,0.000025032215,0.000026339716,0.000213083,1.4149308e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011490136,0.00007308324,0.926038,0.0021020137,0.000015125302,0.0000017977885,0.0009387646,0.0007660959,0.0000022992806,0.000059918562,0.00026117713,0.06859268],"study_design_scores_gemma":[0.003967187,0.00013713156,0.98186576,0.0028294395,0.000050298597,8.58332e-7,0.0009092055,0.0096365465,0.000006813922,0.000046642734,0.00049293536,0.00005720732],"about_ca_topic_score_codex":0.0047946665,"about_ca_topic_score_gemma":0.0030002096,"teacher_disagreement_score":0.06853548,"about_ca_system_score_codex":0.00012774406,"about_ca_system_score_gemma":0.0015443276,"threshold_uncertainty_score":0.7248134},"labels":[],"label_agreement":null},{"id":"W4408607306","doi":"10.1038/s41746-025-01557-7","title":"Credibility assessment of a mechanistic model of atherosclerosis to predict cardiovascular outcomes under lipid-lowering therapy","year":2025,"lang":"en","type":"article","venue":"npj Digital Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Novartis Pharma","keywords":"Credibility; Medicine; Internal medicine; Political science","score_opus":0.04198192115583864,"score_gpt":0.3190774672488459,"score_spread":0.27709554609300724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408607306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79910433,0.0010243458,0.18988976,0.0010466031,0.00031919006,0.0015549901,0.00006421043,0.000078597055,0.006917989],"genre_scores_gemma":[0.99748677,0.0003595402,0.0011014531,0.0005636305,0.00012731315,0.0000864247,0.00001933535,0.00003302777,0.0002224785],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99703455,0.000045383455,0.00079616497,0.0004911061,0.0013041574,0.00032865457],"domain_scores_gemma":[0.9977378,0.00010584004,0.00011816864,0.0014407051,0.00035036603,0.00024711195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011641968,0.0002866177,0.0016248543,0.00024871813,0.000046955105,0.000010822089,0.00019712035,0.00012842215,0.000029232797],"category_scores_gemma":[0.00041888628,0.00020148224,0.0007593491,0.00050405896,0.00015827872,0.00009159179,0.000113851675,0.00020137941,0.0000012976906],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015739999,0.004318975,0.2444498,0.0082652,0.025461063,0.000029194405,0.0017291603,0.025306033,0.08651907,0.018456766,0.001034063,0.58285666],"study_design_scores_gemma":[0.027517233,0.0070406157,0.8958363,0.009221548,0.003275175,0.000028682936,0.0016420641,0.021572027,0.02185728,0.008172359,0.0028376437,0.0009990728],"about_ca_topic_score_codex":0.00023674764,"about_ca_topic_score_gemma":0.0000043146247,"teacher_disagreement_score":0.6513865,"about_ca_system_score_codex":0.00018370873,"about_ca_system_score_gemma":0.00040152372,"threshold_uncertainty_score":0.8216207},"labels":[],"label_agreement":null},{"id":"W4408721768","doi":"10.1016/j.jacadv.2025.101662","title":"Lipoprotein (a) Distribution in Aortic Stenosis Patients","year":2025,"lang":"en","type":"article","venue":"JACC Advances","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"University of Ottawa Heart Institute Foundation","keywords":"Cardiology; Stenosis; Internal medicine; Medicine","score_opus":0.006258282372256751,"score_gpt":0.2741296414010259,"score_spread":0.2678713590287692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408721768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041086,0.0028469765,0.0017551146,0.0007160923,0.00025082842,0.0008393023,0.000014394329,0.00004873687,0.0031176968],"genre_scores_gemma":[0.9981584,0.0005333075,0.00032983403,0.00030427735,0.00007662505,0.00012133672,0.00007750321,0.0000069890325,0.00039170336],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990187,0.000039730974,0.00024269044,0.00022483213,0.00025521943,0.00021878586],"domain_scores_gemma":[0.99951667,0.000017164552,0.0000447946,0.00028464594,0.00007872441,0.000058002384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019125936,0.00009807843,0.00026528942,0.00007264283,0.000051213985,0.000009975221,0.000053360403,0.00005992755,0.000020247579],"category_scores_gemma":[0.0001633543,0.000080912396,0.00010372502,0.0004013355,0.000027192504,0.00012670121,0.00002991631,0.0001356313,0.00001553632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109104774,0.0002337251,0.29842928,0.00030324844,0.000035570596,0.0000071571667,0.000029796598,0.000010881957,0.0000398525,0.00033350548,0.0002465865,0.7002213],"study_design_scores_gemma":[0.0020725208,0.00015240154,0.9514754,0.0003390828,0.000047437767,6.8600923e-7,0.000085538595,0.000058206024,0.0018304589,0.0009745354,0.042862,0.00010172825],"about_ca_topic_score_codex":0.00020438984,"about_ca_topic_score_gemma":0.00003725445,"teacher_disagreement_score":0.70011955,"about_ca_system_score_codex":0.0001651737,"about_ca_system_score_gemma":0.000076245706,"threshold_uncertainty_score":0.32995117},"labels":[],"label_agreement":null},{"id":"W4408773262","doi":"10.58931/cct.2025.114","title":"PCSK9 Targeted Therapy to Lower Cholesterol and Reduce Cardiovascular Events","year":2025,"lang":"en","type":"article","venue":"Canadian Cardiology Today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Women's College Hospital; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Evolocumab; Alirocumab; PCSK9; Ezetimibe; Proprotein convertase; Medicine; Kexin; Statin; Disease; Clinical trial; Cholesterol; Internal medicine; Pharmacology; Lipoprotein; LDL receptor","score_opus":0.01286534570143037,"score_gpt":0.25676341455751994,"score_spread":0.24389806885608958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408773262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.955299,0.021746708,0.00041748595,0.0063956548,0.0014247822,0.0017752761,0.000047567253,0.00007478487,0.012818732],"genre_scores_gemma":[0.9881116,0.00073424744,0.00015375567,0.008850693,0.0004948338,0.0001636046,0.000030778276,0.0000342296,0.0014262574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979688,0.00024365276,0.0002557972,0.00062892976,0.00022672718,0.0006761132],"domain_scores_gemma":[0.9977491,0.000021168828,0.000021407006,0.0011403437,0.00015165933,0.0009163466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083380047,0.00025453902,0.0009293598,0.00040227536,0.00018292709,0.00001626302,0.00014487916,0.00031394817,0.000035851324],"category_scores_gemma":[0.0001213854,0.00023118546,0.0006003595,0.00040313957,0.000084838786,0.000041740546,0.000043310647,0.0003100547,0.000052955427],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047163203,0.00005572468,0.099168755,0.00027375825,0.014642124,0.0016730196,0.0004973399,0.00031106317,0.0023914806,0.00064359524,0.042703986,0.8371675],"study_design_scores_gemma":[0.0016860698,0.00016372261,0.33949673,0.00006964216,0.00020430113,0.0002518065,0.000052063537,0.0000033397916,0.00048235388,0.00006206482,0.65733993,0.00018800274],"about_ca_topic_score_codex":0.026363485,"about_ca_topic_score_gemma":0.003697226,"teacher_disagreement_score":0.8369795,"about_ca_system_score_codex":0.00035664573,"about_ca_system_score_gemma":0.0010447144,"threshold_uncertainty_score":0.98012006},"labels":[],"label_agreement":null},{"id":"W4408783695","doi":"10.3390/biom15040468","title":"Oral and Non-Oral Cholesterol-Lowering Drugs with PCSK9 and Other Biomolecules as Targets: Present Status and Future Prospects","year":2025,"lang":"en","type":"review","venue":"Biomolecules","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Cholesterol; PCSK9; Pharmacology; Oral administration; Cholesterol lowering; Oral route; Intensive care medicine; Lipoprotein; Internal medicine; LDL receptor","score_opus":0.011285282331851294,"score_gpt":0.2989672186923574,"score_spread":0.2876819363605061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408783695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028944192,0.99278396,0.000116490126,0.00034440655,0.00013656467,0.0027459948,0.00010305879,0.000080209764,0.00079487433],"genre_scores_gemma":[0.00079531065,0.9965803,0.0011097473,0.00033021043,0.0004209861,0.00022992698,0.00008432473,0.00012002351,0.0003291433],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972622,0.0001275265,0.00046634316,0.0009994853,0.00050143816,0.0006430272],"domain_scores_gemma":[0.99853903,0.000027353894,0.00020292886,0.0006664456,0.000082060025,0.00048219113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030907113,0.0007519581,0.0019878978,0.00032423213,0.0001593311,0.00018622854,0.00011205344,0.0003971617,0.000011244703],"category_scores_gemma":[0.000021558219,0.00050308974,0.00025639357,0.00038621202,0.00046798264,0.00008372863,0.00024384756,0.00037971526,0.000004797754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091239235,0.000089306704,0.00024338225,0.037929066,0.00096638367,0.0002063827,0.00024283213,1.826681e-8,0.000019530771,0.00025824562,0.00011278911,0.95984083],"study_design_scores_gemma":[0.0019580584,0.00059146556,0.000472511,0.012577825,0.0016372355,0.00052080676,0.00024869706,0.0000020044856,0.00014977652,0.000019005027,0.98125005,0.0005725689],"about_ca_topic_score_codex":0.0011449731,"about_ca_topic_score_gemma":0.00009650948,"teacher_disagreement_score":0.9811373,"about_ca_system_score_codex":0.00008603621,"about_ca_system_score_gemma":0.0004944227,"threshold_uncertainty_score":0.9997421},"labels":[],"label_agreement":null},{"id":"W4408786154","doi":"10.1097/mol.0000000000000982","title":"The need for national and international registries of patients with elevated lipoprotein(a)","year":2025,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"Medicine; Lipoprotein(a); Atherosclerotic cardiovascular disease; Intensive care medicine; Risk factor; Population; Disease; Internal medicine; Lipoprotein; Environmental health; Cholesterol","score_opus":0.07618104060977081,"score_gpt":0.39464269333054897,"score_spread":0.31846165272077814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408786154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007185587,0.98292595,0.00020021445,0.0002493891,0.012927282,0.0033533238,0.00022079049,0.000011389473,0.000104474326],"genre_scores_gemma":[0.000007093221,0.99422807,0.00014058768,0.00001216809,0.0030575392,0.0010379432,0.0012999461,0.000016068441,0.00020058955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984547,0.00014383337,0.0005970256,0.0003034626,0.00031611236,0.00018485035],"domain_scores_gemma":[0.998455,0.00041736983,0.00035807808,0.0002605776,0.0004645634,0.000044425706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060795154,0.00020558429,0.0009691463,0.00024538144,0.00006288641,0.000011775954,0.0001512515,0.00018516277,0.000011237094],"category_scores_gemma":[0.00073222624,0.00012357181,0.00022043467,0.00025460921,0.00016687858,0.000029675355,0.00007544567,0.00028978684,9.5227944e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021698994,0.0001076323,0.00031025385,0.03130266,0.0002756461,1.0437212e-8,0.000012338699,1.6837839e-7,1.0701617e-8,0.0039644614,0.012810824,0.950999],"study_design_scores_gemma":[0.001689814,0.00019845022,0.0009235852,0.0117083825,0.000109257024,0.000005798059,0.000006788602,0.0000035032454,7.7077296e-8,0.00015568572,0.9851008,0.00009786141],"about_ca_topic_score_codex":0.0000061491905,"about_ca_topic_score_gemma":0.0000045039505,"teacher_disagreement_score":0.97229,"about_ca_system_score_codex":0.00011490169,"about_ca_system_score_gemma":0.00087663316,"threshold_uncertainty_score":0.5039112},"labels":[],"label_agreement":null},{"id":"W4408786589","doi":"10.1016/j.metop.2025.100362","title":"PCSK9-promoted LDLR degradation: Recruitment or prevention of essential cofactors?","year":2025,"lang":"en","type":"editorial","venue":"Metabolism Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"PCSK9; LDL receptor; Degradation (telecommunications); Cofactor; Biology; Biochemistry; Cholesterol; Computer science; Enzyme; Telecommunications; Lipoprotein","score_opus":0.05827966953247607,"score_gpt":0.3795345834026222,"score_spread":0.32125491387014615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408786589","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001832556,0.0074756374,0.0015603292,0.00043182453,0.9686119,0.013600688,0.00060757867,0.000094867864,0.005784643],"genre_scores_gemma":[0.000712717,0.004342988,0.0059470707,0.000114662165,0.8650115,0.0017537103,0.0071323686,0.00014577017,0.114839174],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956403,0.000469623,0.0010043882,0.000761221,0.0017492583,0.0003752507],"domain_scores_gemma":[0.996825,0.000121457284,0.00059554004,0.001511788,0.00075085345,0.0001953782],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019289326,0.00044448645,0.002062674,0.00026299155,0.00012667633,0.00012232107,0.0006734796,0.0008745391,0.0011112501],"category_scores_gemma":[0.0009772871,0.00033385542,0.00065887446,0.00055867125,0.000061021598,0.0002068126,0.0005183034,0.00074083783,0.000027332275],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012750779,0.0004889608,0.000008419145,0.001689687,0.0021433765,0.00003579521,0.00011428173,8.0145554e-7,0.00015946852,0.00016409629,0.88981223,0.10410781],"study_design_scores_gemma":[0.0049464772,0.00028011162,0.0005421317,0.0011164668,0.003108919,0.0000059088325,0.00003990606,0.0000039180077,0.003976082,0.00009859446,0.9855975,0.00028398985],"about_ca_topic_score_codex":0.0025601063,"about_ca_topic_score_gemma":0.00019787194,"teacher_disagreement_score":0.10905453,"about_ca_system_score_codex":0.00017085539,"about_ca_system_score_gemma":0.0039533577,"threshold_uncertainty_score":0.99991137},"labels":[],"label_agreement":null},{"id":"W4408931634","doi":"10.2196/58837","title":"Pharmacist-Initiated Team-Based Intervention for Optimizing Guideline-Directed Lipid Therapy of Hospitalized Patients With Acute Coronary Syndrome: Pilot Study Using a Stepped-Wedge Cluster Design","year":2025,"lang":"en","type":"article","venue":"JMIR Cardio","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Pharmacist; Acute coronary syndrome; Guideline; Physical therapy; Clinical pharmacy; Outpatient clinic; Population; Internal medicine; Emergency medicine; Pharmacy; Family medicine; Myocardial infarction","score_opus":0.05090394036668436,"score_gpt":0.34570581558663965,"score_spread":0.29480187521995527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408931634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9084885,0.00042222886,0.075917035,0.000034310706,0.00035068893,0.01447077,0.00006891539,0.0001856728,0.00006189109],"genre_scores_gemma":[0.986133,0.000028112227,0.012215035,0.00030398928,0.00007034754,0.0008811729,0.0002251776,0.00007837425,0.00006482324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971706,0.00051246077,0.0008310125,0.00051378465,0.0005911741,0.00038095177],"domain_scores_gemma":[0.997955,0.00006821863,0.00028532764,0.0006524911,0.00091564265,0.00012328704],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010628862,0.000351731,0.0010946636,0.00030401757,0.00014293139,0.000029799281,0.00014564014,0.00008531405,0.000017798035],"category_scores_gemma":[0.00004056812,0.00027852555,0.000547622,0.00053553714,0.00005712402,0.00012890938,0.00005181651,0.00019082724,0.0000014776966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27902862,0.037937347,0.5114782,0.0046372334,0.0720377,0.00078164774,0.0021407981,0.013573863,0.0075851902,0.000006245197,0.013731533,0.057061642],"study_design_scores_gemma":[0.4187225,0.06743674,0.44006562,0.0038165937,0.008221655,0.00023707507,0.0007911443,0.050368313,0.0068664663,0.00001380529,0.0018257865,0.0016342837],"about_ca_topic_score_codex":0.00013006302,"about_ca_topic_score_gemma":0.0000024310984,"teacher_disagreement_score":0.13969389,"about_ca_system_score_codex":0.00026774473,"about_ca_system_score_gemma":0.00039017812,"threshold_uncertainty_score":0.9999667},"labels":[],"label_agreement":null},{"id":"W4408964957","doi":"10.1016/s0735-1097(25)03163-8","title":"ALLIED HEALTH PROFESSIONAL OPTIMIZATION OF DYSLIPIDEMIA TREATMENT: TOWARD OPTIMAL CARDIOVASCULAR RISK REDUCTION","year":2025,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Rheumatology Association","funders":"","keywords":"Medicine; Dyslipidemia; Reduction (mathematics); Intensive care medicine; Environmental health; Internal medicine; Disease","score_opus":0.013940775030188486,"score_gpt":0.29257272808787116,"score_spread":0.2786319530576827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408964957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93511444,0.012887824,0.039951183,0.0073641646,0.0022898444,0.0015023283,0.00013909076,0.000017133358,0.00073398],"genre_scores_gemma":[0.9858108,0.0041962448,0.008995331,0.0001362464,0.00064683036,0.000014027422,0.000004534248,0.00001848851,0.000177508],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9966774,0.0012958404,0.0010175237,0.00020614873,0.00055186416,0.00025124388],"domain_scores_gemma":[0.99700963,0.00008979816,0.0015680162,0.00065922894,0.0005556572,0.00011766784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002021528,0.00018337455,0.0022224043,0.00027442785,0.000111327434,0.0000018423235,0.00020087067,0.00009721567,0.0000047795234],"category_scores_gemma":[0.000287849,0.000113772556,0.0021008288,0.0006985107,0.00038957273,0.000050004805,0.000063484345,0.0003372829,2.8428175e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005541157,0.00046793857,0.020491965,0.00066669553,0.02632071,0.000079032034,0.00035103626,0.8649438,0.0012462368,0.0005275229,0.010043636,0.06932027],"study_design_scores_gemma":[0.057659667,0.044015482,0.5487102,0.005687183,0.03438357,0.016107315,0.023619028,0.010277624,0.03528751,0.0011941568,0.22125228,0.0018059354],"about_ca_topic_score_codex":0.00013322312,"about_ca_topic_score_gemma":0.0000011981895,"teacher_disagreement_score":0.8546662,"about_ca_system_score_codex":0.0004409136,"about_ca_system_score_gemma":0.0020007137,"threshold_uncertainty_score":0.46395102},"labels":[],"label_agreement":null},{"id":"W4409094219","doi":"10.1016/s0140-6736(25)00055-8","title":"The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma","year":2025,"lang":"en","type":"review","venue":"The Lancet","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"Cardiovascular Research Institute of Vermont, Larner College of Medicine, University of Vermont; NIHR Imperial Biomedical Research Centre; Fundación Interhospitalaria para la Investigación Cardiovascular; School of Medicine, Duke University; Società Italiana di Cardiologia; NIHR Barts Biomedical Research Centre, Queen Mary University of London; Queen Mary University of London; Duke-NUS Medical School; Royal College of Surgeons in Ireland; Faculty of Medicine and Health, University of Sydney; Queensland University of Technology; National Institute on Aging","keywords":"Atheroma; Medicine; Cardiology; Internal medicine; Commission; Coronary artery disease; Ischemia; Myocardial ischaemia; Business; Finance","score_opus":0.06538178271844193,"score_gpt":0.3445956088093701,"score_spread":0.2792138260909282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409094219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020101805,0.981619,0.00004998588,0.010663305,0.0006635347,0.0018991183,0.00022651881,0.0001420914,0.0045354445],"genre_scores_gemma":[0.00013957871,0.98377556,0.00018015825,0.0045286044,0.008704435,0.00023895496,0.00020142723,0.00006233248,0.0021689357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971518,0.00069545384,0.00045637018,0.00048288712,0.0006814513,0.0005320692],"domain_scores_gemma":[0.9955919,0.00074182835,0.00018436257,0.0032065196,0.000042801566,0.00023261519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016730849,0.00040539165,0.0025284463,0.000054687538,0.00049287005,0.00008822047,0.00084535195,0.00020914096,0.00004208685],"category_scores_gemma":[0.00037690104,0.00018909143,0.0006999078,0.00025513652,0.000057442616,0.00002530848,0.0003102287,0.0012399611,0.00013569715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025654133,0.000022402626,0.00003905497,0.0067496947,0.00048250653,0.00013535398,0.00015067148,0.0000010990899,4.798546e-7,0.00038233458,0.06651154,0.9252683],"study_design_scores_gemma":[0.00055516144,0.00006225725,0.0012977078,0.052726783,0.00094362954,0.000028571918,0.000018778015,0.0000067632186,4.482704e-7,0.0005612085,0.94360787,0.00019083748],"about_ca_topic_score_codex":0.000072039424,"about_ca_topic_score_gemma":0.000016881388,"teacher_disagreement_score":0.9250775,"about_ca_system_score_codex":0.00021032414,"about_ca_system_score_gemma":0.0005020686,"threshold_uncertainty_score":0.7710925},"labels":[],"label_agreement":null},{"id":"W4409218809","doi":"10.1161/circulationaha.124.071269","title":"Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES","year":2025,"lang":"en","type":"letter","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University Health Network; Sanofi (Canada)","funders":"","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Statin; Cardiology; Lipoprotein; C-reactive protein; Cholesterol; High-density lipoprotein; Inflammation; Myocardial infarction","score_opus":0.010174118630695339,"score_gpt":0.2391255758159482,"score_spread":0.22895145718525287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409218809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828177,0.00033132735,0.0013906523,0.008506473,0.00024495006,0.006351652,0.00031331537,0.000037516198,0.0000063791376],"genre_scores_gemma":[0.9926031,0.00005083042,0.00039811892,0.0057720505,0.00025970713,0.00023785791,0.00057321676,0.00006654558,0.000038542228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99477065,0.0011122336,0.0009200329,0.0010908701,0.0017355263,0.000370693],"domain_scores_gemma":[0.9960198,0.00009899921,0.00080267474,0.002089038,0.0008399393,0.00014957043],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015204647,0.00063869776,0.0028215856,0.00074191665,0.00014234748,0.000024063578,0.00014787095,0.00095304754,0.000008404355],"category_scores_gemma":[0.0001262482,0.0004919981,0.0011274641,0.00082464825,0.00013333521,0.0002409379,0.00015346463,0.00111366,6.983547e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012876486,0.0020029733,0.7707111,0.009498366,0.10714423,0.001077769,0.0046876105,0.0048038876,0.017111052,0.00021262716,0.00027532797,0.06959857],"study_design_scores_gemma":[0.0023057694,0.00052419095,0.98621607,0.00103471,0.006354868,0.00008177023,0.000075745076,0.0002358556,0.0026048166,0.00012649472,0.00007491038,0.00036480458],"about_ca_topic_score_codex":0.008566474,"about_ca_topic_score_gemma":0.00026900365,"teacher_disagreement_score":0.21550496,"about_ca_system_score_codex":0.00030179406,"about_ca_system_score_gemma":0.00023774376,"threshold_uncertainty_score":0.9997532},"labels":[],"label_agreement":null},{"id":"W4409252942","doi":"10.1016/j.atherosclerosis.2025.119189","title":"Why has the “Lp(a) receptor” proven so elusive?","year":2025,"lang":"en","type":"editorial","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Computational biology; Biology","score_opus":0.016470840801698992,"score_gpt":0.2613772169760262,"score_spread":0.24490637617432723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409252942","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008017334,0.0060885083,0.0002444877,0.01782483,0.9666183,0.0034553958,0.00045072314,0.0003257745,0.004190236],"genre_scores_gemma":[0.00054353033,0.0058423732,0.00035155407,0.004912421,0.9725509,0.00074038707,0.0005566377,0.0001938598,0.014308314],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99573284,0.00027564316,0.0005756103,0.00088152464,0.0018567855,0.00067761564],"domain_scores_gemma":[0.9963902,0.0003946035,0.00027714073,0.0021976316,0.00052218104,0.0002182076],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012163363,0.0005877146,0.0011917684,0.0001185649,0.00072343333,0.00028223466,0.0005843444,0.0013073046,0.00028807524],"category_scores_gemma":[0.0010263999,0.00038718188,0.0011260775,0.00046466663,0.00033477126,0.00006979283,0.00027340208,0.0017259719,0.00020461988],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007882769,0.00010636073,0.00004153545,0.00053271744,0.00071029435,0.00000253894,0.0002740858,6.0343007e-7,0.0003819031,0.000031702144,0.9868673,0.010972111],"study_design_scores_gemma":[0.0015038043,0.00029587062,0.00026575362,0.0012877528,0.00078788394,0.0000018453624,0.000079467696,0.0000039458023,0.00053534925,0.000040331513,0.9948496,0.0003484024],"about_ca_topic_score_codex":0.003025128,"about_ca_topic_score_gemma":0.00017412698,"teacher_disagreement_score":0.01291241,"about_ca_system_score_codex":0.00042993555,"about_ca_system_score_gemma":0.0022759768,"threshold_uncertainty_score":0.9999892},"labels":[],"label_agreement":null},{"id":"W4409293083","doi":"10.26434/chemrxiv-2025-x10p3","title":"Orthogonal investigation at single-particle and ensemble levels uncovers lipoprotein-extracellular vesicle binding","year":2025,"lang":"en","type":"preprint","venue":"ChemRxiv","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"Ministero dell'Università e della Ricerca; Università degli Studi di Brescia; Ministero della Salute; Consorzio Interuniversitario Nazionale per la Scienza e Tecnologia dei Materiali","keywords":"Extracellular vesicles; Extracellular; Particle (ecology); Extracellular vesicle; Lipoprotein; Vesicle; Chemistry; Biophysics; Physics; Microvesicles; Cell biology; Biochemistry; Cholesterol; Biology; Membrane","score_opus":0.04411464793552803,"score_gpt":0.2642105521060182,"score_spread":0.22009590417049016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409293083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908746,0.0045344573,0.00041215087,0.0009703217,0.00031217586,0.0010877036,0.000013128761,0.00012706337,0.0016683888],"genre_scores_gemma":[0.99214286,0.00013579818,0.0022817247,0.00028461395,0.00039471398,0.00009415727,0.00010123428,0.000038979797,0.0045259465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977735,0.000084303705,0.00044249173,0.00074578024,0.0005383564,0.00041552357],"domain_scores_gemma":[0.9984782,0.00004534445,0.00018460624,0.0008125138,0.00013086143,0.0003484913],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007776775,0.00033228192,0.0006237471,0.0001071534,0.00018840669,0.00006464713,0.00010684439,0.0004115527,0.00006408637],"category_scores_gemma":[0.00017731656,0.00032774254,0.00029206942,0.00023200862,0.00013541455,0.00007486003,0.00045148487,0.0005616974,0.000042405794],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023264468,0.00021236323,0.022967767,0.005169546,0.0008466511,0.00019415625,0.0010608254,0.00013183334,0.9248939,0.0012195224,0.00077016564,0.042300627],"study_design_scores_gemma":[0.0017148785,0.00012676054,0.010830778,0.0012304863,0.0004647978,0.00007257908,0.00011222216,0.0005940466,0.97894794,0.00084288645,0.004628342,0.00043426218],"about_ca_topic_score_codex":0.00020448361,"about_ca_topic_score_gemma":0.000034069348,"teacher_disagreement_score":0.054054063,"about_ca_system_score_codex":0.0005111942,"about_ca_system_score_gemma":0.0004885361,"threshold_uncertainty_score":0.99991745},"labels":[],"label_agreement":null},{"id":"W4409370771","doi":"10.1016/j.jvsvi.2025.100231","title":"Lipid management in patients newly referred to a vascular surgery outpatient clinic","year":2025,"lang":"en","type":"article","venue":"JVS-Vascular Insights","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Vascular surgery; Outpatient clinic; Surgery; Internal medicine; Cardiac surgery","score_opus":0.01966981702658597,"score_gpt":0.27293766337477243,"score_spread":0.25326784634818644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409370771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97916305,0.0028285151,0.0009321007,0.0004836363,0.0015414953,0.004140882,0.000004277237,0.00016172192,0.010744309],"genre_scores_gemma":[0.9883422,0.0015810826,0.0017038897,0.0051795747,0.00036392975,0.000642292,0.00018119627,0.00009353996,0.0019122708],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952797,0.00038017018,0.0011518885,0.0010448785,0.0013936973,0.00074966066],"domain_scores_gemma":[0.9970131,0.000068280715,0.00012527939,0.0020942097,0.00027134936,0.00042780448],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012686697,0.00045479566,0.0012800597,0.0011674992,0.00015242424,0.000053205207,0.00025696956,0.0003036188,0.00008841911],"category_scores_gemma":[0.00022756377,0.000391949,0.0013284779,0.0015966995,0.000045103392,0.00013717939,0.0002763604,0.00045720072,0.0004203658],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027242596,0.010791932,0.18748674,0.0059831333,0.012754044,0.0010707303,0.0035770726,0.00051098457,0.00006393365,0.0026449698,0.0578498,0.7145424],"study_design_scores_gemma":[0.00631202,0.00037481694,0.544033,0.0010175215,0.0005344814,0.0000019143324,0.0001632498,0.000055742,0.00013322363,0.00016018038,0.44674814,0.00046574988],"about_ca_topic_score_codex":0.00036603518,"about_ca_topic_score_gemma":0.0001299604,"teacher_disagreement_score":0.71407664,"about_ca_system_score_codex":0.0005627172,"about_ca_system_score_gemma":0.0002604928,"threshold_uncertainty_score":0.99985325},"labels":[],"label_agreement":null},{"id":"W4409429407","doi":"10.1016/j.ajpc.2025.100993","title":"Implementation strategies for improving the care of familial hypercholesterolaemia from the International Atherosclerosis Society: next steps in implementation science and practice","year":2025,"lang":"en","type":"article","venue":"American Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; National Heart, Lung, and Blood Institute; William Raveis Charitable Fund; Sanofi; National Health and Medical Research Council; Amgen","keywords":"Medicine; Engineering ethics; Sociology; Engineering","score_opus":0.025785841513084898,"score_gpt":0.3701206961930936,"score_spread":0.34433485468000874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409429407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545593,0.0007891426,0.01055821,0.0023086471,0.00022492874,0.0005689074,0.000031712498,0.0000017774166,0.000060722625],"genre_scores_gemma":[0.9962817,0.0004100879,0.002159854,0.0009155845,0.00018542538,0.000033681972,0.000007387426,0.000005010721,0.0000012850834],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99873155,0.00030136888,0.000373744,0.00014963526,0.00030456192,0.00013914601],"domain_scores_gemma":[0.99808264,0.00045628444,0.0004228385,0.00014561892,0.00086681294,0.000025798729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025465935,0.00007531151,0.00030447752,0.00006146732,0.00010463211,0.000039277194,0.00017842822,0.000021785054,0.0000023835175],"category_scores_gemma":[0.0002706334,0.00004619548,0.0001886792,0.00022014568,0.00046398313,0.0002854086,0.00007413696,0.00016234958,4.7610786e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045529963,0.000018937732,0.06937661,0.00003937794,0.0008046757,0.0000015968749,0.010295675,0.000028474029,0.071140796,0.00035320432,0.00015046672,0.84733486],"study_design_scores_gemma":[0.0019426018,0.0005564768,0.55614674,0.0000513359,0.00036904452,0.000035217978,0.43836722,0.000019486506,0.0013417681,0.00013573901,0.0009940336,0.000040339015],"about_ca_topic_score_codex":0.0016371377,"about_ca_topic_score_gemma":0.00013546589,"teacher_disagreement_score":0.84729457,"about_ca_system_score_codex":0.00023305223,"about_ca_system_score_gemma":0.0009863713,"threshold_uncertainty_score":0.24748735},"labels":[],"label_agreement":null},{"id":"W4409435947","doi":"10.1097/mol.0000000000000972","title":"Translating genetics into clinical practice plus nonmainstream thoughts on lipoprotein(a)","year":2025,"lang":"en","type":"article","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Clinical Practice; Genetics; Medicine; Psychology; Biology; Family medicine","score_opus":0.0809607691739147,"score_gpt":0.4492049131426863,"score_spread":0.3682441439687716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409435947","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14819965,0.122867316,0.064350076,0.06369196,0.5515736,0.012414197,0.00003264001,0.0007267017,0.03614387],"genre_scores_gemma":[0.65289265,0.04353211,0.05568549,0.0063580414,0.23932399,0.0011102069,0.00038384332,0.00020169438,0.00051197805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679404,0.0007360744,0.0009769283,0.00065310573,0.0003937757,0.0004460649],"domain_scores_gemma":[0.9982824,0.000445661,0.00017484413,0.0007712477,0.00015152736,0.00017434168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020265176,0.00024899901,0.000750709,0.00028943407,0.000110648965,0.000016907105,0.00016948995,0.00035197288,0.000015930458],"category_scores_gemma":[0.0013093414,0.00022178586,0.00032547908,0.000495618,0.00015403317,0.00007256853,0.000079244826,0.0010784714,0.000052154235],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081105396,0.0008556017,0.0062532676,0.0011303899,0.00015421749,0.0000018310766,0.0005128083,0.00010893376,0.000018947376,0.0041846354,0.0077786115,0.9781897],"study_design_scores_gemma":[0.005744653,0.0009473762,0.016169917,0.0013489274,0.000096143776,0.000052548974,0.00025155267,0.0009797434,0.00004299751,0.00080684,0.9733326,0.00022672414],"about_ca_topic_score_codex":0.00007937104,"about_ca_topic_score_gemma":0.000027663942,"teacher_disagreement_score":0.977963,"about_ca_system_score_codex":0.0002109398,"about_ca_system_score_gemma":0.00074489455,"threshold_uncertainty_score":0.90441644},"labels":[],"label_agreement":null},{"id":"W4409523417","doi":"10.1093/eurjpc/zwaf214","title":"Efficacy and safety of inclisiran based on background lipid-lowering treatment","year":2025,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novartis Pharma; Esperion Therapeutics; Amgen; Singulex; Daiichi Sankyo Europe; Sanofi; Kowa Company; Medicines Company; Novo Nordisk; Genentech; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Medicine; Intensive care medicine","score_opus":0.020827360517514836,"score_gpt":0.29124124904543114,"score_spread":0.2704138885279163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409523417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94881445,0.0032197125,0.01559468,0.000410935,0.0005269316,0.00047603142,0.000008352898,0.000010025634,0.030938897],"genre_scores_gemma":[0.9978987,0.00072776485,0.0005162256,0.00018898166,0.00042914692,0.0000011950357,0.0000034627978,0.00001653866,0.00021796106],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99795467,0.0010129398,0.000530751,0.00017510525,0.00016623923,0.00016031854],"domain_scores_gemma":[0.9990458,0.0001490441,0.00022808998,0.00029787607,0.00017094177,0.00010824031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017614574,0.00014471517,0.0007865881,0.00020350447,0.00005304816,0.0000056397507,0.000080046266,0.000036137204,0.000014856084],"category_scores_gemma":[0.00015042457,0.0001042614,0.00047471758,0.00012310487,0.00010091403,0.000027959393,0.00004314384,0.00020070345,0.0000031493078],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0122510595,0.00072087516,0.018021379,0.00060269824,0.006946976,0.002597022,0.00049023697,0.001783464,0.008150692,0.00048097852,0.00082420564,0.94713044],"study_design_scores_gemma":[0.023186622,0.010236231,0.8825517,0.0016770425,0.0012801673,0.0005530187,0.00021475942,0.000032712058,0.002516415,0.000029407702,0.07754366,0.00017823197],"about_ca_topic_score_codex":0.0000035329701,"about_ca_topic_score_gemma":3.7752076e-7,"teacher_disagreement_score":0.94695216,"about_ca_system_score_codex":0.00010802275,"about_ca_system_score_gemma":0.00015648935,"threshold_uncertainty_score":0.42516565},"labels":[],"label_agreement":null},{"id":"W4409593491","doi":"10.1016/j.ijcard.2025.133290","title":"LDL-cholesterol levels and lipid lowering therapy in secondary prevention. Baseline data from the BRING-UP prospective registry","year":2025,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Medicine; Baseline (sea); Prospective cohort study; Ldl cholesterol; Cholesterol; Internal medicine; Secondary prevention; Cardiology","score_opus":0.040015392286790956,"score_gpt":0.34423394491154014,"score_spread":0.3042185526247492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409593491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9536592,0.0074877893,0.027702024,0.0070396536,0.0020693988,0.00034331248,0.00009143599,0.000008293484,0.0015989166],"genre_scores_gemma":[0.99489695,0.0015149226,0.0002382104,0.0010653383,0.002032786,0.0000048388706,0.00003821301,0.000008139261,0.00020061152],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99879247,0.00017942577,0.00042621838,0.0002063316,0.00028556937,0.000110008135],"domain_scores_gemma":[0.99893075,0.00016480232,0.00017000233,0.00040723215,0.0002848112,0.00004239203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014428173,0.000096033946,0.00038372527,0.00010634188,0.00002750446,0.000029154882,0.00037685593,0.00008034531,0.00002716454],"category_scores_gemma":[0.00034197484,0.00006578433,0.00015033215,0.000066308974,0.00007606217,0.00014114464,0.0001678174,0.00046316165,0.0000014476007],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021468534,0.00010256994,0.43565217,0.000044961376,0.0058425954,0.00056996633,0.00036939065,0.00015310576,0.0032815773,0.00021250917,0.005275788,0.5463485],"study_design_scores_gemma":[0.0048377197,0.00015564785,0.9426839,0.00038608155,0.00008005231,0.0011167412,0.00016176382,0.00005679034,0.0004817914,0.0009057517,0.049069047,0.00006473829],"about_ca_topic_score_codex":0.00011794134,"about_ca_topic_score_gemma":0.000046005218,"teacher_disagreement_score":0.5462838,"about_ca_system_score_codex":0.000097304226,"about_ca_system_score_gemma":0.0003701663,"threshold_uncertainty_score":0.26826072},"labels":[],"label_agreement":null},{"id":"W4409594648","doi":"10.1016/j.clinbiochem.2025.110929","title":"Lp(a): A Clinical Review","year":2025,"lang":"es","type":"review","venue":"Clinical Biochemistry","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; McGill University Health Centre","funders":"","keywords":"Medicine","score_opus":0.08670013191371166,"score_gpt":0.4849724561747972,"score_spread":0.3982723242610855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409594648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047735877,0.9691423,0.000029708135,0.00232024,0.00379259,0.00368927,0.0002607357,0.00016714525,0.020550234],"genre_scores_gemma":[0.000022801132,0.9572751,0.00035924825,0.011955929,0.013973816,0.00031882446,0.0010915558,0.00012220826,0.014880526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9828077,0.0022881054,0.009248342,0.003140442,0.0013384602,0.0011769246],"domain_scores_gemma":[0.9855075,0.0035832552,0.0020083706,0.006427908,0.0006537323,0.0018192667],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.01750489,0.0014184227,0.01287497,0.00008835552,0.00018733465,0.00006756501,0.0013551805,0.004278307,0.0013271099],"category_scores_gemma":[0.031576924,0.0011060609,0.015204396,0.0010609219,0.0010324816,0.000038964074,0.00090814766,0.005908421,0.0024507882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027963368,0.0005489886,0.0003203786,0.34033984,0.0016196619,0.00017206694,3.7766458e-7,1.7872257e-9,1.748355e-7,0.00001160404,0.099744245,0.5572147],"study_design_scores_gemma":[0.0011248939,0.00024052351,0.00012403214,0.35416737,0.011121809,0.00011699373,0.0000038418557,5.083206e-7,0.000008083156,0.000008438637,0.632492,0.0005914693],"about_ca_topic_score_codex":0.000025132178,"about_ca_topic_score_gemma":5.9778534e-7,"teacher_disagreement_score":0.5566232,"about_ca_system_score_codex":0.00027070823,"about_ca_system_score_gemma":0.010142136,"threshold_uncertainty_score":0.9998566},"labels":[],"label_agreement":null},{"id":"W4409617126","doi":"10.14740/jocmr6196","title":"Lipoprotein(a)-Lowering Drugs: A Mini Review","year":2025,"lang":"de","type":"review","venue":"Journal of Clinical Medicine Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Lipoprotein(a); Pharmacology; Lipoprotein; Internal medicine; Cholesterol","score_opus":0.26065555919239913,"score_gpt":0.5837657085233805,"score_spread":0.32311014933098137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409617126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019724203,0.9411877,0.00012620383,0.029724894,0.008156301,0.0064958427,0.000018690307,0.000025844467,0.014244791],"genre_scores_gemma":[0.00003752581,0.93711185,0.00039692092,0.003021622,0.053303443,0.00016259613,0.000039974624,0.00016453999,0.005761551],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.95073026,0.0137370555,0.018501863,0.001547376,0.013127508,0.002355929],"domain_scores_gemma":[0.9549388,0.021463368,0.0060617276,0.004177907,0.009392631,0.0039655645],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.20516118,0.0012817527,0.021831444,0.002532063,0.0004241015,0.00007172969,0.0027451895,0.001974998,0.002735748],"category_scores_gemma":[0.17163266,0.0007811797,0.00867403,0.0050915377,0.0019943733,0.00020877262,0.0010054766,0.021039722,0.00096234155],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030622937,0.00047095123,0.00002932181,0.27586442,0.003623009,0.0017873237,0.0000550258,5.6941712e-8,1.9222524e-7,0.000036535825,0.10482685,0.6130001],"study_design_scores_gemma":[0.0031362362,0.0042960155,0.000041472376,0.45750058,0.007683741,0.0004128541,0.00012525963,0.0000014359613,0.0000014144806,0.0000828942,0.5264464,0.00027169922],"about_ca_topic_score_codex":0.0003033339,"about_ca_topic_score_gemma":0.0000068225086,"teacher_disagreement_score":0.61272836,"about_ca_system_score_codex":0.0008579727,"about_ca_system_score_gemma":0.022880921,"threshold_uncertainty_score":0.99999344},"labels":[],"label_agreement":null},{"id":"W4409736153","doi":"10.1093/eurjpc/zwaf258","title":"Inflammation mediates residual cardiovascular risk in statin-treated patients with coronary disease","year":2025,"lang":"en","type":"letter","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Cegep Edouard Montpetit; Montreal Heart Institute","funders":"Orionin Tutkimussäätiö; Sigrid Juséliuksen Säätiö","keywords":"Medicine; Residual risk; Inflammation; Statin; Cardiology; Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Disease; Atherosclerotic cardiovascular disease; Coronary disease; Coronary heart disease","score_opus":0.007751713298020671,"score_gpt":0.2184571497857174,"score_spread":0.21070543648769674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409736153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9084273,0.031120231,0.0032454021,0.043924503,0.0019350566,0.005133483,0.00095983094,0.00009247485,0.00516171],"genre_scores_gemma":[0.86680067,0.019113757,0.0028807702,0.06312334,0.03672851,0.00013604843,0.007292285,0.00076629204,0.0031583493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9889655,0.007768123,0.0011701811,0.00052475795,0.0010853027,0.00048611077],"domain_scores_gemma":[0.9967063,0.00019706396,0.0009582283,0.00084359816,0.001078809,0.00021598303],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0033316524,0.00048191738,0.0020343,0.00066711527,0.000076867516,0.000021295264,0.00028480875,0.00022798443,0.00002291954],"category_scores_gemma":[0.0007987273,0.00035526924,0.0014334116,0.0003022045,0.00017545788,0.00012586222,0.00012354298,0.0027060797,0.000017550306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041387696,0.0001428082,0.5108083,0.0017469568,0.026673073,0.09622126,0.0003097546,0.0013552613,0.0000044873527,0.0000027977908,0.25162086,0.10697565],"study_design_scores_gemma":[0.006506112,0.001007021,0.75585127,0.001333884,0.0042081918,0.00018943788,0.000029388686,0.0000012977539,0.000008203482,0.000027270502,0.23055932,0.00027857922],"about_ca_topic_score_codex":0.000028583472,"about_ca_topic_score_gemma":0.0000021969495,"teacher_disagreement_score":0.24504298,"about_ca_system_score_codex":0.00028897243,"about_ca_system_score_gemma":0.0006660648,"threshold_uncertainty_score":0.9998899},"labels":[],"label_agreement":null},{"id":"W4409838725","doi":"10.1016/j.atherosclerosis.2025.119211","title":"Interleukin-6 modifies Lipoprotein(a) and oxidized phospholipids associated cardiovascular disease risk in a secondary prevention cohort","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institutes of Health; National Heart, Lung, and Blood Institute; Foundation for the National Institutes of Health","keywords":"Internal medicine; Medicine; Lipoprotein(a); Apolipoprotein B; Myocardial infarction; Clinical endpoint; Gastroenterology; Cardiology; Lipoprotein; Cohort; Endocrinology; Cholesterol; Randomized controlled trial","score_opus":0.012086750319102332,"score_gpt":0.24496426074608174,"score_spread":0.2328775104269794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409838725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98512644,0.010532873,0.0007024156,0.00024016728,0.00019616385,0.0019452687,0.000037469574,0.00013000544,0.0010891715],"genre_scores_gemma":[0.99291104,0.0050276085,0.00027534747,0.00027695892,0.00007854321,0.0005338881,0.00004485405,0.00004291889,0.000808861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997496,0.00037657804,0.00048432147,0.00068529614,0.00053670985,0.00042105623],"domain_scores_gemma":[0.998528,0.00004516627,0.000109267414,0.0009808878,0.000108458895,0.0002282106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018438011,0.0002945582,0.0008975603,0.00020749409,0.00016353073,0.000059610928,0.00011335522,0.00020705156,0.000048880218],"category_scores_gemma":[0.00039671393,0.000273625,0.00079171325,0.0005373705,0.000113806935,0.00013911376,0.00012223644,0.0004782503,0.0000097406655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011138347,0.0012283318,0.61262214,0.0011526854,0.009723814,0.000048553553,0.00085027923,0.00009787912,0.0033910254,0.00037310144,0.0005899868,0.36880836],"study_design_scores_gemma":[0.00619472,0.0001474063,0.9857061,0.0010046304,0.0014159075,0.0000030740528,0.00013167715,0.00033746913,0.0016798823,0.0006497867,0.002476715,0.00025263272],"about_ca_topic_score_codex":0.004449862,"about_ca_topic_score_gemma":0.00019532623,"teacher_disagreement_score":0.37308395,"about_ca_system_score_codex":0.00030952788,"about_ca_system_score_gemma":0.00029625636,"threshold_uncertainty_score":0.99997157},"labels":[],"label_agreement":null},{"id":"W4409865374","doi":"10.1503/cmaj.241713","title":"Clinical significance of low-density lipoprotein cholesterol percentage reduction and attained levels after percutaneous coronary intervention","year":2025,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"National Health Insurance Service","keywords":"Percutaneous coronary intervention; Medicine; Clinical significance; Reduction (mathematics); Cholesterol; Internal medicine; Low-density lipoprotein; Cardiology; Myocardial infarction; Mathematics","score_opus":0.010246044075450747,"score_gpt":0.2841947643043845,"score_spread":0.27394872022893374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409865374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891445,0.0005648874,0.00042344318,0.008387243,0.0007726996,0.0004404479,0.000017526252,0.00001326234,0.00023596645],"genre_scores_gemma":[0.9954997,0.00030143335,0.000153744,0.0023960855,0.00088640355,0.0000114227305,0.000007907147,0.000011815939,0.0007314989],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99732125,0.00044015856,0.00077837124,0.00023914163,0.0009108632,0.00031022148],"domain_scores_gemma":[0.9981941,0.000054846765,0.00022991699,0.00018691404,0.00041227884,0.00092192146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033202877,0.00012531903,0.00045590513,0.00017629542,0.00014040273,0.0000340758,0.00008239929,0.0004352935,0.0006098472],"category_scores_gemma":[0.00093976554,0.00011606543,0.0003042127,0.00015293088,0.00010127652,0.00009031185,0.000023469922,0.00096893,0.000010398719],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003172068,0.00019974813,0.1580557,0.000401806,0.0006328831,0.0011129791,0.00031317535,0.0000012595963,0.00032881068,0.000035392593,0.0031831474,0.8354179],"study_design_scores_gemma":[0.0021893736,0.00024493926,0.9861147,0.0008539429,0.0001473983,0.0029033711,0.00054405036,0.00010510368,0.00008216817,0.000073052506,0.0066329,0.000109037624],"about_ca_topic_score_codex":0.0051593115,"about_ca_topic_score_gemma":0.0076400484,"teacher_disagreement_score":0.83530885,"about_ca_system_score_codex":0.0008627094,"about_ca_system_score_gemma":0.0017903396,"threshold_uncertainty_score":0.77993697},"labels":[],"label_agreement":null},{"id":"W4410068287","doi":"10.1016/j.atherosclerosis.2025.119218","title":"The Brussels International Declaration on Lipoprotein(a) Testing and Management","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Daiichi Sankyo Europe; Abbott Diagnostics; Genentech; Seqirus; Imperial College London; HLS Therapeutics; Novo Nordisk; Swedish Orphan Biovitrum; Amgen; Siemens Healthineers; InfraRedx; Amryt Pharma; Daiichi-Sankyo; Medicines Company; AstraZeneca; Amarin Corporation; Regeneron Pharmaceuticals; Ultragenyx Pharmaceutical; European Federation of Pharmaceutical Industries and Associations; Silence Therapeutics; Kowa Company; PTC Therapeutics; Sanofi; Anthera; Esperion Therapeutics; Eli Lilly and Company; CSL Behring","keywords":"Declaration; Business; Political science; Law","score_opus":0.031222753934641433,"score_gpt":0.27537453408113827,"score_spread":0.24415178014649683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410068287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9077037,0.0006632563,0.0019896305,0.011481835,0.0005628719,0.0016208094,0.0000033213862,0.00013295215,0.07584161],"genre_scores_gemma":[0.9924996,0.001672965,0.0021673264,0.0016641137,0.00013980386,0.00015930823,0.0000028032366,0.000012274564,0.0016818224],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99920315,0.000032265205,0.00015282887,0.00020140952,0.00026640133,0.00014396684],"domain_scores_gemma":[0.9994707,0.000073437695,0.000036707992,0.00031686577,0.00005923033,0.000043063472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041962398,0.0000891657,0.000112826354,0.000055842993,0.00026727986,0.00007125155,0.00007766033,0.00004348545,0.000005216402],"category_scores_gemma":[0.00010351597,0.00005972237,0.00006421891,0.00018838042,0.00003895022,0.000034957757,0.000055394863,0.00010099064,0.000013766505],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079298516,0.0000810525,0.012965607,0.000098009376,0.00036565907,0.0000028118545,0.000069571906,0.000008537834,0.0016681486,0.015205925,0.0008983996,0.968557],"study_design_scores_gemma":[0.0015680231,0.0001823544,0.9249796,0.0005760587,0.00012436096,0.0000068157656,0.00013198022,0.0004936427,0.0031296765,0.00087686675,0.06781888,0.000111697016],"about_ca_topic_score_codex":0.0001461268,"about_ca_topic_score_gemma":0.000014918675,"teacher_disagreement_score":0.9684453,"about_ca_system_score_codex":0.000065721026,"about_ca_system_score_gemma":0.000023484352,"threshold_uncertainty_score":0.24354075},"labels":[],"label_agreement":null},{"id":"W4410083737","doi":"10.1016/j.jlr.2025.100820","title":"Lipoprotein (a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic cardiovascular disease","year":2025,"lang":"en","type":"article","venue":"Journal of Lipid Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institutes of Health; Novo Nordisk; National Heart, Lung, and Blood Institute; Intercept Pharmaceuticals; U.S. Department of Veterans Affairs; Regeneron Pharmaceuticals; Eli Lilly and Company; A. Alfred Taubman Medical Research Institute; Amgen","keywords":"Inflammation; Monocyte; Atherosclerotic cardiovascular disease; Thrombosis; Disease; Medicine; Lipoprotein(a); Lipoprotein; Cholesterol; Immunology; Cardiology; Internal medicine","score_opus":0.07018852396199927,"score_gpt":0.36724302036061757,"score_spread":0.2970544963986183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410083737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98273647,0.010515693,0.0003694823,0.0047276714,0.00016056241,0.0009411662,0.0000030155284,0.000012139188,0.00053377624],"genre_scores_gemma":[0.990694,0.0080601,0.00037367217,0.000057034307,0.0006097294,0.00004278128,0.0000038957023,0.00001952669,0.00013929748],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99675626,0.00065720757,0.0006095811,0.00023384603,0.001361788,0.00038130666],"domain_scores_gemma":[0.9981565,0.00018258338,0.000091526315,0.0004993085,0.0007380933,0.0003319874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006932499,0.0001410416,0.0006592767,0.0009776923,0.00010853119,0.00006743913,0.00015431544,0.00012465288,0.000024917827],"category_scores_gemma":[0.0016786761,0.00010386067,0.0004118161,0.0010487103,0.00015509466,0.0001903441,0.00009546594,0.001018189,0.00000908925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004345714,0.001401668,0.29850236,0.007088986,0.008717156,0.0009387893,0.0024846457,0.0010802741,0.05460585,0.0017846534,0.003143733,0.6159062],"study_design_scores_gemma":[0.006806131,0.0007229484,0.95023525,0.0036806515,0.00036501364,0.00005817799,0.0011499142,0.0014830154,0.0070605655,0.0009986047,0.027226835,0.00021288237],"about_ca_topic_score_codex":0.0003399815,"about_ca_topic_score_gemma":0.000022083937,"teacher_disagreement_score":0.6517329,"about_ca_system_score_codex":0.00031918183,"about_ca_system_score_gemma":0.0008493354,"threshold_uncertainty_score":0.44235814},"labels":[],"label_agreement":null},{"id":"W4410105393","doi":"10.1093/eurheartj/ehaf204","title":"ApoB and Lp(a): core measures to assess cardiovascular risk","year":2025,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Core (optical fiber); Internal medicine; Cardiology","score_opus":0.07373768819717796,"score_gpt":0.3206608591782003,"score_spread":0.24692317098102234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410105393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9237787,0.027907899,0.014253698,0.0024099539,0.000912204,0.00074075186,0.000007443304,0.00010248979,0.029886827],"genre_scores_gemma":[0.9896952,0.0021938111,0.0033045462,0.0024078302,0.0014434555,0.000004238392,0.0000017418674,0.000047991558,0.0009011865],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977523,0.00064722414,0.00030201604,0.0002974762,0.0006597375,0.0003412189],"domain_scores_gemma":[0.9986156,0.000032706324,0.00004746442,0.00060035393,0.00020832884,0.0004955273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044327583,0.00017198628,0.00052655843,0.00020533662,0.00038006727,0.00010904528,0.00010198396,0.00004240256,0.000030724048],"category_scores_gemma":[0.00043254264,0.00013567453,0.00059399504,0.00027575693,0.00004365444,0.00006258165,0.00009854484,0.0006719134,0.00008033712],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037768038,0.00017212157,0.25693315,0.00038856218,0.0051077865,0.0022206097,0.0006442088,0.00031711746,0.0018432572,0.00028129193,0.08368214,0.64803207],"study_design_scores_gemma":[0.0011194645,0.00016318832,0.44193193,0.00024558374,0.0003631542,0.0018463298,0.000095753734,0.000011093781,0.00019613982,0.000031066287,0.55388856,0.00010773695],"about_ca_topic_score_codex":0.000050735216,"about_ca_topic_score_gemma":0.000003797995,"teacher_disagreement_score":0.6479243,"about_ca_system_score_codex":0.000074874784,"about_ca_system_score_gemma":0.00019105508,"threshold_uncertainty_score":0.5532647},"labels":[],"label_agreement":null},{"id":"W4410159198","doi":"10.14740/cr2063","title":"Lipid-Lowering Therapy in Post-Acute Coronary Syndrome Patients: An Observational Study","year":2025,"lang":"en","type":"article","venue":"Cardiology Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Observational study; Cardiology; Acute coronary syndrome; Internal medicine; Myocardial infarction","score_opus":0.15473054413390305,"score_gpt":0.43210412903509776,"score_spread":0.2773735849011947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410159198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510515,0.0007381702,0.000020555151,0.00061245245,0.00028630745,0.002144374,0.000012675848,0.000039177747,0.0010411514],"genre_scores_gemma":[0.9981191,0.0003041746,0.000042889926,0.00046587252,0.00014346628,0.0003977627,0.00013113659,0.000019811661,0.0003757953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971541,0.0008701085,0.00031131718,0.000502919,0.0006229373,0.00053859554],"domain_scores_gemma":[0.99823076,0.0001271434,0.000019755076,0.00079357397,0.00069234124,0.00013640789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029448797,0.00013699112,0.000670367,0.0004414233,0.00017075017,0.00001650984,0.00021547367,0.00016902202,0.000040935534],"category_scores_gemma":[0.00023831763,0.00011610945,0.00015777542,0.00069843564,0.00014629532,0.00010641174,0.000159888,0.0007149484,0.000022573073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006825757,0.00047434896,0.9757161,0.000032583575,0.0007591334,0.00080591626,0.00020948108,0.000019263518,0.0003053091,0.00005609424,0.00023821837,0.020700965],"study_design_scores_gemma":[0.0035942022,0.0037962757,0.99025214,0.0000378538,0.00002684108,0.00011373444,0.00059801625,0.000016212303,0.00002113408,0.000048104146,0.0014089793,0.00008652484],"about_ca_topic_score_codex":0.00023811492,"about_ca_topic_score_gemma":0.000028335517,"teacher_disagreement_score":0.02061444,"about_ca_system_score_codex":0.00025493442,"about_ca_system_score_gemma":0.0006404724,"threshold_uncertainty_score":0.47348058},"labels":[],"label_agreement":null},{"id":"W4410159348","doi":"10.1186/s12982-025-00589-4","title":"Dyslipidemia and its associated factors in Ethiopia: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Discover Public Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Meta-analysis; Medicine; Systematic review; Internal medicine; MEDLINE; Obesity; Biology; Biochemistry","score_opus":0.13387148451258976,"score_gpt":0.39917687488442954,"score_spread":0.26530539037183976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410159348","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007692839,0.9855692,0.000019970264,0.0046639075,0.000044721623,0.009116388,0.0003787844,0.0000457661,0.00015359887],"genre_scores_gemma":[0.00009104298,0.99173254,0.000010518683,0.0051198206,0.000025713272,0.0009786353,0.0006979015,0.00004580874,0.0012980443],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9913072,0.0036867112,0.0024641408,0.0009721933,0.00079651084,0.00077323924],"domain_scores_gemma":[0.99633,0.00056280475,0.0011574543,0.0010930868,0.0001572101,0.00069942157],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.010053735,0.00072958827,0.02246916,0.0010351762,0.00011213257,0.00008747846,0.0001967687,0.0005316206,0.00007303841],"category_scores_gemma":[0.0038965782,0.0004362918,0.0034626601,0.0031919968,0.000037149293,0.00018139134,0.00016798888,0.001141714,0.000005011492],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[3.1337547e-7,0.000057509165,0.000025354459,0.89252687,0.10485422,0.0000071759587,0.00007824334,1.7900444e-8,4.211915e-10,0.00027161662,0.00012468698,0.0020540126],"study_design_scores_gemma":[0.00029939844,0.00006540181,0.0001376149,0.13275243,0.80886734,0.000020146505,0.000049013117,0.0000022948063,5.232345e-9,0.000005601878,0.057438128,0.00036260733],"about_ca_topic_score_codex":0.0009825742,"about_ca_topic_score_gemma":0.000565915,"teacher_disagreement_score":0.75977445,"about_ca_system_score_codex":0.0007633353,"about_ca_system_score_gemma":0.0061135637,"threshold_uncertainty_score":0.9998089},"labels":[],"label_agreement":null},{"id":"W4410253637","doi":"10.1093/cvr/cvaf078","title":"RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study","year":2025,"lang":"en","type":"article","venue":"Cardiovascular Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"Fonds de Recherche du Québec - Santé; Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Canadian Institutes of Health Research; Université Laval","keywords":"Mendelian randomization; PCSK9; Drug; Medicine; Disease; RNA interference; Pharmacology; Internal medicine; Biology; RNA; Cholesterol; Genetics; Gene; Genetic variants; LDL receptor","score_opus":0.06622341481445325,"score_gpt":0.3879013057004192,"score_spread":0.32167789088596593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410253637","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21712838,0.13641153,0.61525214,0.0012817377,0.001215146,0.026654676,0.000075683834,0.00017431613,0.0018063848],"genre_scores_gemma":[0.9952658,0.0012330316,0.0004999591,0.000026862024,0.00036545034,0.0020559868,0.00020627414,0.00005543193,0.00029121226],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9929703,0.002075784,0.00067659334,0.0008872781,0.002745025,0.00064505177],"domain_scores_gemma":[0.99437046,0.00048723113,0.00008435034,0.0029869406,0.0018427927,0.00022819971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016406406,0.0003049963,0.0012677317,0.00064053916,0.00055043236,0.00008410959,0.0003354979,0.00013365576,0.000024755984],"category_scores_gemma":[0.0016338708,0.0002280997,0.004454547,0.0016702205,0.00027437232,0.00013623692,0.00018219238,0.000537878,0.000008395765],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065338895,0.0052653076,0.0029055811,0.013123492,0.18568097,0.00038408884,0.001559005,0.13261311,0.002845108,0.0021461027,0.0031652418,0.5849731],"study_design_scores_gemma":[0.39870527,0.0067797294,0.02638376,0.00759816,0.06383236,0.000038110244,0.013577399,0.07883588,0.070875935,0.002556397,0.32845512,0.002361883],"about_ca_topic_score_codex":0.00052468874,"about_ca_topic_score_gemma":0.000013766048,"teacher_disagreement_score":0.7781374,"about_ca_system_score_codex":0.00033595486,"about_ca_system_score_gemma":0.0012466647,"threshold_uncertainty_score":0.9301636},"labels":[],"label_agreement":null},{"id":"W4410302993","doi":"10.1016/j.jacc.2025.04.005","title":"Homozygous Familial Hypercholesterolemia Is a Life-Limiting Condition","year":2025,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia; Providence Health Care","funders":"National Heart, Lung, and Blood Institute; Nederlandse Organisatie voor Wetenschappelijk Onderzoek","keywords":"Medicine; Familial hypercholesterolemia; Limiting; Internal medicine; Pediatrics; Cardiology; Cholesterol","score_opus":0.011390668015898442,"score_gpt":0.2792092176587585,"score_spread":0.26781854964286006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410302993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98870605,0.0008883464,0.0009523881,0.0057405746,0.00056339,0.00025720327,0.00004860625,0.000006900545,0.0028365157],"genre_scores_gemma":[0.99416274,0.0003450098,0.00044889867,0.0040833633,0.0007474121,0.0000046641376,7.4281695e-7,0.000011563133,0.00019561489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835634,0.00035965414,0.0005936092,0.00013039542,0.00035122948,0.00020879852],"domain_scores_gemma":[0.9983841,0.000110449284,0.00059420336,0.00043222168,0.00037378233,0.000105244864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078668614,0.00012166733,0.0011582444,0.00018626727,0.000081541715,0.000003449226,0.00021327626,0.000070150214,0.00000499161],"category_scores_gemma":[0.00039599522,0.00007982161,0.00091355527,0.0004465624,0.00037046042,0.000037678095,0.00007730888,0.0004010489,0.0000015569882],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012393881,0.00053726434,0.45040187,0.0017682689,0.023098359,0.005506414,0.0007535662,0.0021332072,0.07945507,0.0029845124,0.25743932,0.16352828],"study_design_scores_gemma":[0.010101769,0.003900305,0.8026063,0.0011343381,0.0033790732,0.027166331,0.0045721293,0.000113006055,0.00651917,0.0011503943,0.13899215,0.0003650304],"about_ca_topic_score_codex":0.00002981118,"about_ca_topic_score_gemma":0.0000017277339,"teacher_disagreement_score":0.3522044,"about_ca_system_score_codex":0.00012364954,"about_ca_system_score_gemma":0.0007905953,"threshold_uncertainty_score":0.3255031},"labels":[],"label_agreement":null},{"id":"W4410434278","doi":"10.5937/scriptamed56-57087","title":"Lipoprotein(a) and cardiovascular disease: Evidence, recommendations and emerging therapies","year":2025,"lang":"en","type":"article","venue":"Scripta Medica","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Atherosclerotic cardiovascular disease; Lipoprotein(a); Intensive care medicine; Lipoprotein; Cardiology; Internal medicine; Cholesterol","score_opus":0.025253146364598793,"score_gpt":0.2959975218570302,"score_spread":0.2707443754924314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410434278","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050724294,0.86146975,0.0046188943,0.07588173,0.0015693904,0.0016735569,0.000012753357,0.00019521182,0.0038544408],"genre_scores_gemma":[0.8864086,0.1031306,0.0027318238,0.0035137183,0.000559099,0.00026575508,0.00002185885,0.00003310151,0.0033354277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837345,0.0001381893,0.00025199002,0.00044363015,0.00052840024,0.0002643449],"domain_scores_gemma":[0.99871665,0.000029241826,0.000032038497,0.0007872306,0.00008951673,0.00034532533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013414503,0.00016151513,0.0004314224,0.00017195127,0.0002633929,0.00004267909,0.00007606904,0.000076804514,0.000107693435],"category_scores_gemma":[0.0005829114,0.0001309758,0.00022195169,0.00029746752,0.00017914863,0.00013905467,0.00010261244,0.0002404657,0.000004147786],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058849695,0.00003348986,0.0034442435,0.00058318087,0.001619567,0.000041747247,0.00032982888,1.9666832e-7,0.00007651671,0.0012538509,0.015225308,0.97733325],"study_design_scores_gemma":[0.0014127124,0.00008474283,0.07430302,0.0024022267,0.0014030619,0.000049115137,0.0009073985,0.00018076759,0.000077240744,0.0009780392,0.91801655,0.00018512383],"about_ca_topic_score_codex":0.00043028546,"about_ca_topic_score_gemma":0.000012567792,"teacher_disagreement_score":0.9771481,"about_ca_system_score_codex":0.000030324403,"about_ca_system_score_gemma":0.00025437938,"threshold_uncertainty_score":0.53410375},"labels":[],"label_agreement":null},{"id":"W4410438290","doi":"10.3389/fcvm.2025.1461416","title":"Treatment adherence, persistence, and effectiveness of fixed dose combination versus free combination therapy of rosuvastatin–ezetimibe as a lipid-lowering therapy","year":2025,"lang":"en","type":"article","venue":"Frontiers in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"Sanofi","keywords":"Ezetimibe; Medicine; Rosuvastatin; Fixed-dose combination; Internal medicine; Combination therapy; Dyslipidemia; Statin; Discontinuation; Propensity score matching; Incidence (geometry); Logistic regression; Persistence (discontinuity); Mathematics","score_opus":0.020982722429172627,"score_gpt":0.27848755248157714,"score_spread":0.2575048300524045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410438290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87104976,0.11526562,0.0065128407,0.0002821167,0.0015936292,0.0028004877,0.000008946518,0.00004047352,0.0024461134],"genre_scores_gemma":[0.9799661,0.01870092,0.00086551777,0.000041733718,0.00007849102,0.00020836256,0.000052126117,0.000028155526,0.000058564703],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99725926,0.00051483815,0.0005715511,0.0005037226,0.00086785917,0.00028277517],"domain_scores_gemma":[0.99814034,0.00019783403,0.00016034454,0.0010518344,0.0003394494,0.000110179026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020886215,0.00031518406,0.0017535742,0.0006119955,0.0000721433,0.000007204224,0.00016223943,0.00018264465,0.000012179372],"category_scores_gemma":[0.00033269392,0.00024714117,0.00070348073,0.0008767741,0.00035516894,0.000093386625,0.00004333572,0.00018911429,3.869837e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016291358,0.0016589105,0.10133077,0.0026842128,0.01642728,0.00011306732,0.003341743,0.00018624404,0.005907585,0.0010448758,0.0003495843,0.8506644],"study_design_scores_gemma":[0.206001,0.017425766,0.72321093,0.0040672077,0.0016578955,0.00006203816,0.0040599103,0.00094557647,0.033450607,0.0013511482,0.0072189956,0.00054890383],"about_ca_topic_score_codex":0.0011081721,"about_ca_topic_score_gemma":0.000007029117,"teacher_disagreement_score":0.8501155,"about_ca_system_score_codex":0.00032842814,"about_ca_system_score_gemma":0.0002815288,"threshold_uncertainty_score":0.9999981},"labels":[],"label_agreement":null},{"id":"W4410482972","doi":"10.1093/eurjpc/zwaf236.255","title":"Statin intolerance in a real word setting of Italian cardiology centers: data from the BRING-UP Prevention study","year":2025,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"Daiichi Sankyo Europe; Heart Care Foundation of India; Amgen","keywords":"Medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Statin; Cardiology; Internal medicine; Emergency medicine; Medical emergency; Intensive care medicine","score_opus":0.044318537182965696,"score_gpt":0.3390177636626083,"score_spread":0.2946992264796426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410482972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98019594,0.0030160428,0.011756339,0.00040200877,0.0008860323,0.0008425341,0.00005313888,0.000008724287,0.0028392696],"genre_scores_gemma":[0.9979051,0.00061200064,0.00050218793,0.0000978233,0.0006550467,0.000004026341,0.000046189904,0.000021700394,0.00015594832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99143183,0.006505103,0.0011206442,0.00038039638,0.00028566344,0.00027636168],"domain_scores_gemma":[0.9978443,0.00023782285,0.00059626356,0.0009741543,0.00027803655,0.000069464426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072225817,0.00018142731,0.0011509344,0.00016918553,0.000053744865,0.000012222865,0.0005984757,0.000048058835,0.000010308305],"category_scores_gemma":[0.00065163965,0.00013129486,0.0004183351,0.0002985627,0.00012076897,0.00011655782,0.00042181916,0.00060859625,0.0000048599472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001462396,0.00023941796,0.8514628,0.0001452985,0.0051195216,0.0015804489,0.0028344733,0.0003678401,0.0008813394,0.000026166092,0.0033713533,0.13250896],"study_design_scores_gemma":[0.004445264,0.0007448922,0.9856389,0.00079919526,0.00059066404,0.00018848717,0.004673405,0.000026204041,0.00003764049,0.000101495745,0.0026633404,0.00009048997],"about_ca_topic_score_codex":0.00021427819,"about_ca_topic_score_gemma":0.00010904112,"teacher_disagreement_score":0.13417614,"about_ca_system_score_codex":0.00009104997,"about_ca_system_score_gemma":0.00024389035,"threshold_uncertainty_score":0.5354049},"labels":[],"label_agreement":null},{"id":"W4410525430","doi":"10.1161/circulationaha.124.073233","title":"Efficacy and Safety of Inclisiran in Adolescents With Genetically Confirmed Homozygous Familial Hypercholesterolemia: Results From the Double-Blind, Placebo-Controlled Part of the ORION-13 Randomized Trial","year":2025,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Novartis Pharma","keywords":"Familial hypercholesterolemia; Medicine; PCSK9; Placebo; Internal medicine; Statin; Hyperlipidemia; Compound heterozygosity; Randomized controlled trial; Alirocumab; Gastroenterology; Lipoprotein; LDL receptor; Endocrinology; Cholesterol; Diabetes mellitus; Mutation; Pathology; Genetics","score_opus":0.0194826513401305,"score_gpt":0.26956708477812275,"score_spread":0.25008443343799225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410525430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988821,0.00052772375,0.00042904724,0.0006354132,0.00022831284,0.009059078,0.000015168936,0.000010255399,0.0002739421],"genre_scores_gemma":[0.9993618,0.00009384432,0.000026180891,0.00014997386,0.00019154667,0.00012436675,0.00003135273,0.000010846251,0.000010083854],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99748933,0.00067254266,0.00092969096,0.00027968266,0.00047650453,0.00015225778],"domain_scores_gemma":[0.9985011,0.0004099928,0.00028174956,0.0006041433,0.00015397398,0.000048999416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002009043,0.0001487389,0.0009939142,0.000068648245,0.000080022015,0.0000134080765,0.00011091435,0.00016172818,0.0000021236365],"category_scores_gemma":[0.0006597722,0.000076736884,0.00023548666,0.00026574917,0.00023260126,0.00002981495,0.000043125845,0.00025954298,3.800746e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9865847,0.00016394057,0.0057295254,0.00007156215,0.0002758708,0.0000019930412,0.000444373,0.00040389595,0.00036900092,0.00005918742,0.0000030201095,0.0058929236],"study_design_scores_gemma":[0.78523654,0.0000820446,0.21237288,0.00092986855,0.00054828625,0.0000029649786,0.000057782494,0.0005328441,0.00011756607,0.000041147112,0.00002482496,0.000053227544],"about_ca_topic_score_codex":0.0010477483,"about_ca_topic_score_gemma":0.00029237202,"teacher_disagreement_score":0.20664336,"about_ca_system_score_codex":0.000053229593,"about_ca_system_score_gemma":0.00031659973,"threshold_uncertainty_score":0.31292394},"labels":[],"label_agreement":null},{"id":"W4410599567","doi":"10.3390/ijtm5020018","title":"Socioeconomic Disparities and Other Factors in Dyslipidemia: Insights from NHANES 2017–2020 Data","year":2025,"lang":"en","type":"article","venue":"International Journal of Translational Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"Baylor University","keywords":"Dyslipidemia; Socioeconomic status; National Health and Nutrition Examination Survey; Medicine; Environmental health; Gerontology; Internal medicine; Obesity; Population","score_opus":0.035842227361966655,"score_gpt":0.33623068104168774,"score_spread":0.3003884536797211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410599567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95155716,0.010518058,0.0021676295,0.033694237,0.0010842184,0.00014834802,0.00010692446,0.0000071015575,0.0007162993],"genre_scores_gemma":[0.9956024,0.0005680179,0.00055519247,0.0014711546,0.0015921202,0.0000015668685,0.00014702775,0.000009020922,0.00005346563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984275,0.000059742204,0.0006882639,0.00018865646,0.00054121006,0.00009463964],"domain_scores_gemma":[0.9989995,0.00036461363,0.00017822783,0.0001912651,0.00017183508,0.0000945803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000449606,0.00012357888,0.00047274987,0.00030523827,0.000028491411,0.000013735154,0.00028008744,0.00009720849,0.00014211156],"category_scores_gemma":[0.00017813817,0.0000889179,0.00008473292,0.00006563946,0.00013246354,0.00022560422,0.00003565394,0.00033186126,0.000002138767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057604746,0.00012721689,0.9688318,0.00009924723,0.0020641573,0.00018075577,0.0011808767,0.000051445597,0.0009703489,0.0038799874,0.0038334827,0.018204642],"study_design_scores_gemma":[0.004645475,0.000080677826,0.9615089,0.00086348434,0.0002173476,0.00008837202,0.0003385226,0.00031461613,0.00012844945,0.009349323,0.02237585,0.00008895492],"about_ca_topic_score_codex":0.0006518949,"about_ca_topic_score_gemma":0.00021824264,"teacher_disagreement_score":0.04404525,"about_ca_system_score_codex":0.00007233434,"about_ca_system_score_gemma":0.00020805746,"threshold_uncertainty_score":0.36259666},"labels":[],"label_agreement":null},{"id":"W4410790698","doi":"10.1016/j.cjcpc.2025.05.003","title":"Developing a Knowledge Translation Intervention to Improve the Detection and Management of Pediatric Dyslipidemias in British Columbia","year":2025,"lang":"en","type":"article","venue":"CJC Pediatric and Congenital Heart Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia; Michael Smith Health Research BC; BC Children's Hospital","keywords":"Intervention (counseling); Knowledge translation; Medicine; Computer science; Knowledge management; Nursing","score_opus":0.01555977167776449,"score_gpt":0.2763663341876066,"score_spread":0.2608065625098421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410790698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701269,0.026479661,0.0016930429,0.00022010655,0.00015264306,0.0012012768,0.000012319976,0.000017706643,0.00009631503],"genre_scores_gemma":[0.9969637,0.0021586963,0.00016753214,0.00011543436,0.0002025821,0.00015840313,0.000005080742,0.000007847345,0.00022074251],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991075,0.00006841718,0.0002954238,0.0002457372,0.00012761583,0.00015531185],"domain_scores_gemma":[0.99958,0.00003690409,0.00003233329,0.00014000454,0.00007505593,0.0001356884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038958242,0.00007459565,0.00020415233,0.000109392306,0.00009552062,0.000046631387,0.000030562496,0.00004890081,0.000004408917],"category_scores_gemma":[0.000043309064,0.000087605804,0.000085918655,0.0005980511,0.000022683485,0.0000635704,0.000049567512,0.00009378461,0.000001582325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020773741,0.00015054685,0.35172573,0.0040096813,0.00007685604,0.000022260689,0.00014047908,6.951251e-7,0.000014582451,0.0000370419,0.00014316931,0.64347124],"study_design_scores_gemma":[0.0018345289,0.00009359102,0.99617857,0.00008826426,0.0006244599,0.0000062663635,0.00027367118,0.00015200656,0.000005334358,0.00016642442,0.0004860523,0.000090852394],"about_ca_topic_score_codex":0.0016574379,"about_ca_topic_score_gemma":0.0042107264,"teacher_disagreement_score":0.6444528,"about_ca_system_score_codex":0.00005361878,"about_ca_system_score_gemma":0.000112864465,"threshold_uncertainty_score":0.3572461},"labels":[],"label_agreement":null},{"id":"W4410839950","doi":"10.1016/j.cdnut.2025.106507","title":"The Use of PCSK9 Inhibitor Is Associated With More Adaptative Eating Behaviors Among Adults With Heterozygous Familial Hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"Current Developments in Nutrition","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; Université Laval","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Canadian Foundation for Dietetic Research","keywords":"PCSK9; Familial hypercholesterolemia; LDL receptor; Medicine; Psychology; Internal medicine; Cholesterol; Lipoprotein","score_opus":0.028098899376018508,"score_gpt":0.2847225400428969,"score_spread":0.25662364066687837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410839950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973523,0.0005936951,0.00017720665,0.00006623213,0.00017876462,0.0015521137,0.00002815247,0.00002827282,0.000023282235],"genre_scores_gemma":[0.9978506,0.00039240727,0.0010734452,0.00007562702,0.000034180313,0.00036956315,0.00014471702,0.00001890319,0.000040554987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830836,0.000107492415,0.00043214575,0.00030774175,0.0005608453,0.00028340667],"domain_scores_gemma":[0.9991618,0.000066385546,0.00016614833,0.00023205813,0.0003053466,0.000068253474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024984777,0.00019348429,0.00035621712,0.0001652902,0.00015014393,0.000029685576,0.00007601676,0.00009418701,0.0000012172661],"category_scores_gemma":[0.00008454742,0.00012852185,0.00006779119,0.00052047306,0.00014251778,0.00016237116,0.000039368842,0.00033653117,5.7167966e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017301422,0.0011413323,0.78880376,0.0010035839,0.0003337141,0.00004871284,0.0045550754,0.000015544838,0.00019923119,0.000010184952,0.000314297,0.2018444],"study_design_scores_gemma":[0.009393028,0.00035380173,0.96142036,0.022495518,0.00013608372,0.000010245728,0.0016043133,0.00012224265,0.0029002684,0.0000074900404,0.0013463305,0.00021029582],"about_ca_topic_score_codex":0.00013711298,"about_ca_topic_score_gemma":0.00023176258,"teacher_disagreement_score":0.20163411,"about_ca_system_score_codex":0.00035231575,"about_ca_system_score_gemma":0.00025160806,"threshold_uncertainty_score":0.5240969},"labels":[],"label_agreement":null},{"id":"W4410871301","doi":"10.1111/dom.16469","title":"Why, how and in whom should we measure levels of lipoprotein(a): A review of the latest evidence and clinical implications","year":2025,"lang":"en","type":"review","venue":"Diabetes Obesity and Metabolism","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Eli Lilly Canada; National Institutes of Health; Ionis Pharmaceuticals; Regeneron Pharmaceuticals; Novartis; Novo Nordisk; Esperion Therapeutics; Arrowhead Pharmaceuticals; Merck; NewAmsterdam Pharma; Boehringer Ingelheim; Amgen; Eli Lilly and Company; 89bio","keywords":"Medicine; Disease; Atherosclerotic cardiovascular disease; Lipoprotein(a); Statin; Guideline; Intensive care medicine; Familial hypercholesterolemia; Risk factor; PCSK9; Epidemiology; Narrative review; Bioinformatics; Internal medicine; Lipoprotein; Pathology; Cholesterol; LDL receptor","score_opus":0.10622161136636724,"score_gpt":0.37055368627367347,"score_spread":0.26433207490730626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410871301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020734612,0.9894079,0.000006607617,0.005067542,0.00009874032,0.003157324,0.000150484,0.000009835969,0.00002809851],"genre_scores_gemma":[0.0017497364,0.9969058,0.00017559463,0.00080734753,0.00012544947,0.00014972893,0.000008274784,0.000018779085,0.00005927029],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711585,0.0008311438,0.00091125997,0.0005190388,0.00036878514,0.00025394114],"domain_scores_gemma":[0.9976284,0.0005233319,0.00048542925,0.0009655852,0.00023137797,0.0001658969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032745942,0.0003365421,0.003707966,0.00014357429,0.000093706854,0.000025245565,0.0002066592,0.00039802605,0.000004966868],"category_scores_gemma":[0.0022903932,0.00020702732,0.00069284166,0.0006223212,0.00039378874,0.00009479844,0.00028308158,0.00067982473,2.4656438e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000020990724,0.000077780984,0.0036282865,0.2571289,0.00026602228,6.441521e-7,0.00001676658,4.450227e-9,0.0000019679594,0.00014971403,0.000167922,0.7385599],"study_design_scores_gemma":[0.0004041481,0.000037290374,0.14888757,0.35367158,0.005052078,0.000012185232,0.0000039992638,5.2827545e-7,0.0000106994,0.00013301299,0.49161214,0.00017476894],"about_ca_topic_score_codex":0.00012924493,"about_ca_topic_score_gemma":0.000066924724,"teacher_disagreement_score":0.73838514,"about_ca_system_score_codex":0.000017456576,"about_ca_system_score_gemma":0.00063811487,"threshold_uncertainty_score":0.8442329},"labels":[],"label_agreement":null},{"id":"W4410948573","doi":"10.38109/2225-1685-2025-2-6-34","title":"Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)","year":2025,"lang":"en","type":"article","venue":"Eurasian heart journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Public Health Agency of Canada; American Heart Association","keywords":"Dyslipidemia; Medicine; Internal medicine; Coronary atherosclerosis; Coronary heart disease; Disease","score_opus":0.0951150631828377,"score_gpt":0.3754632220465284,"score_spread":0.2803481588636907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410948573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8479704,0.018386578,0.051765576,0.07228038,0.0026093777,0.006440052,0.00024377492,0.000033010638,0.00027084383],"genre_scores_gemma":[0.98295784,0.012457591,0.0027142747,0.0002874779,0.0008345312,0.00028430726,0.000009980756,0.000020429716,0.00043354463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844754,0.00017554083,0.0006781637,0.00018036884,0.00032959576,0.00018880537],"domain_scores_gemma":[0.9977181,0.00088229356,0.00045654326,0.00018161914,0.0007035014,0.000057959784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023593968,0.00014332707,0.0005614429,0.000069829664,0.0003409091,0.000018878703,0.00005928111,0.00014270384,0.0000064649503],"category_scores_gemma":[0.0007883546,0.00008460437,0.0007011087,0.00017142294,0.000095650576,0.00006171435,0.00001750116,0.00012349743,1.037022e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000461039,0.000278222,0.67721957,0.0005178111,0.0049031815,1.1841853e-7,0.001474454,0.00046259537,0.007069686,0.00037669577,0.035696503,0.27154014],"study_design_scores_gemma":[0.0038624946,0.0012795215,0.9569445,0.0005230686,0.0013134308,0.00002420715,0.0012248928,0.0028474652,0.0045360546,0.0002277525,0.027124254,0.00009232136],"about_ca_topic_score_codex":0.0000719093,"about_ca_topic_score_gemma":0.00003995821,"teacher_disagreement_score":0.279725,"about_ca_system_score_codex":0.00022485021,"about_ca_system_score_gemma":0.00024922314,"threshold_uncertainty_score":0.34500661},"labels":[],"label_agreement":null},{"id":"W4411119170","doi":"10.1016/j.japh.2025.102445","title":"Patterns and determinants of statin prescribing and discontinuation in individuals aged 80 and older: A 10-year population-based cohort study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Pharmacists Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Rimouski; Institut National de Santé Publique du Québec; Université Laval","funders":"Fonds de Recherche du Québec - Santé; Réseau québécois de recherche sur le vieillissement","keywords":"Medicine; Discontinuation; Cohort; Statin; Cohort study; Population; Gerontology; Family medicine; Demography; Internal medicine; Environmental health","score_opus":0.010477156177278915,"score_gpt":0.3162109204152602,"score_spread":0.3057337642379813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411119170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989061,0.00011528254,0.000037608745,0.00024710468,0.000045704484,0.00062739896,0.000012459015,0.0000024909125,0.0000058541086],"genre_scores_gemma":[0.99958664,0.000117049596,0.00010226779,0.00011462149,0.000026831809,0.00000787486,0.0000024570315,0.00000599154,0.000036243477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986066,0.00035784784,0.0004395789,0.00010281332,0.00039903886,0.00009410562],"domain_scores_gemma":[0.9986759,0.00012577423,0.00096508657,0.000090213856,0.000103386825,0.000039678303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001860564,0.00007442043,0.0004142867,0.0001429996,0.000052047442,0.00002396479,0.000038209848,0.000019339897,0.0000029414027],"category_scores_gemma":[0.00038075936,0.000054054693,0.000055104643,0.00018461248,0.0000176215,0.000088223445,0.000027510774,0.00014142739,2.9671552e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069813286,0.000119649216,0.97671324,0.00005703593,0.00014901365,0.0000027265921,0.00053292775,0.0000070308142,0.0001969749,4.6612888e-7,0.00002988916,0.02212126],"study_design_scores_gemma":[0.0030519597,0.00017409824,0.9952453,0.00019144407,0.0003154002,0.00000638876,0.00036998294,0.0002881012,0.00029395055,0.000016362406,0.000004025927,0.000043022337],"about_ca_topic_score_codex":0.00054153707,"about_ca_topic_score_gemma":0.0000837215,"teacher_disagreement_score":0.022078238,"about_ca_system_score_codex":0.00015663762,"about_ca_system_score_gemma":0.000070869086,"threshold_uncertainty_score":0.22042865},"labels":[],"label_agreement":null},{"id":"W4411139941","doi":"10.1016/j.jacl.2025.05.016","title":"Age and effect of intensive statin in acute mild ischemic stroke or transient ischemic attack: Subgroup analysis of the INSPIRES trial","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Hazard ratio; Proportional hazards model; Stroke (engine); Statin; Internal medicine; Logistic regression; Physical therapy; Confidence interval","score_opus":0.04793367315366384,"score_gpt":0.4119252579801245,"score_spread":0.36399158482646066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411139941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954727,0.00082199246,0.00011299713,0.0016944312,0.0011699985,0.0005199145,0.000018909452,0.000002425398,0.00018658949],"genre_scores_gemma":[0.9970303,0.0010357685,0.0002607134,0.0010029573,0.00047682752,0.000005727823,0.0000033525992,0.000008113592,0.0001762157],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9959679,0.0010043001,0.0022637565,0.00020616502,0.00036073994,0.00019711218],"domain_scores_gemma":[0.996009,0.002167683,0.00093670737,0.00037344656,0.00040130358,0.00011185156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004334914,0.00014895694,0.0025778557,0.0003699695,0.000019232546,0.00000338299,0.00018206453,0.00027922232,0.00002558912],"category_scores_gemma":[0.005440105,0.000077855446,0.0014192318,0.0006621408,0.00034865976,0.000036256257,0.00006806645,0.00086265383,1.9850374e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.473825,0.0013846355,0.35828707,0.0016599626,0.039127942,0.00028347774,0.0011987791,0.00016570248,0.035513975,0.000034470217,0.025183072,0.0633359],"study_design_scores_gemma":[0.16263404,0.0180824,0.76140386,0.0012234019,0.025321307,0.000118765485,0.0005156576,0.0003761379,0.0135601135,0.000012258359,0.016537689,0.00021434501],"about_ca_topic_score_codex":0.000083307896,"about_ca_topic_score_gemma":0.00015794163,"teacher_disagreement_score":0.40311682,"about_ca_system_score_codex":0.0000331466,"about_ca_system_score_gemma":0.00041661077,"threshold_uncertainty_score":0.6512707},"labels":[],"label_agreement":null},{"id":"W4411272824","doi":"10.1093/eurjpc/zwaf342","title":"Rationale for the routine screening of Lipoprotein(a) in cardiovascular risk assessment","year":2025,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Providence Health Care; Centre for Advancing Health Outcomes; Western University; McGill University Health Centre; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Lipoprotein(a); Risk assessment; Atherosclerotic cardiovascular disease; Ldl cholesterol; Intensive care medicine; Lipoprotein; Internal medicine; Cholesterol; Disease","score_opus":0.019699005925413307,"score_gpt":0.29548086747978525,"score_spread":0.27578186155437195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411272824","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.107641295,0.030388229,0.85322905,0.00088668946,0.000520362,0.0017671414,0.000019747016,0.0000074306145,0.005540034],"genre_scores_gemma":[0.9883111,0.0013419881,0.0093284445,0.00011263785,0.0006639396,0.000025792195,0.0000058481146,0.000019892746,0.00019035173],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9963463,0.0021198422,0.00078633695,0.0001936465,0.00034546095,0.00020840281],"domain_scores_gemma":[0.9981462,0.00027976648,0.00041214927,0.00046898136,0.00063678203,0.000056138702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011109233,0.00013646804,0.00095069635,0.00021103685,0.00008863877,0.0000085898855,0.00020314631,0.00004234592,0.000008207121],"category_scores_gemma":[0.00084059674,0.000091147755,0.0016512542,0.000248858,0.00010697361,0.00005601203,0.00008157907,0.00045498053,8.570845e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001607722,0.00021156837,0.0683084,0.0006080568,0.02462674,0.00057563686,0.00048165518,0.023041295,0.0011725061,0.0017953529,0.0020216862,0.8755494],"study_design_scores_gemma":[0.007687955,0.0008370345,0.92903143,0.000559317,0.0020494899,0.0002885594,0.00060452695,0.00024090428,0.0006034787,0.00030854,0.057674374,0.000114382754],"about_ca_topic_score_codex":0.000028300186,"about_ca_topic_score_gemma":0.0000027448964,"teacher_disagreement_score":0.88066983,"about_ca_system_score_codex":0.000073789146,"about_ca_system_score_gemma":0.00027218153,"threshold_uncertainty_score":0.38502607},"labels":[],"label_agreement":null},{"id":"W4411523842","doi":"10.2337/dc25-0942","title":"Cardiovascular Outcomes and Efficacy of the PCSK9 Inhibitor Evolocumab in Individuals With Type 1 Diabetes: Insights From the FOURIER Trial","year":2025,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Division of Diabetes, Endocrinology, and Metabolic Diseases; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Evolocumab; Internal medicine; PCSK9; Diabetes mellitus; Unstable angina; Hazard ratio; Type 2 diabetes; Population; Clinical endpoint; Placebo; Type 1 diabetes; Randomized controlled trial; Myocardial infarction; Cardiology; Cholesterol; Endocrinology; Lipoprotein; Confidence interval","score_opus":0.008529580317728047,"score_gpt":0.23417559908225222,"score_spread":0.22564601876452417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411523842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663287,0.030593513,0.0000012501396,0.0004349909,0.00041253687,0.0018901238,0.000039411258,0.000022324391,0.00027719728],"genre_scores_gemma":[0.99874485,0.00007493498,0.00008536601,0.0006715814,0.00023358755,0.00010452226,0.000034720975,0.000023824972,0.000026590084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795103,0.00031065155,0.0003418963,0.00036245765,0.00074632996,0.00028764503],"domain_scores_gemma":[0.9979558,0.00031546064,0.00008221341,0.0014122985,0.0001665718,0.00006768475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042839994,0.00022503143,0.0008787145,0.000091723625,0.00011773915,0.000030351728,0.00021032401,0.00015596618,0.0000066401935],"category_scores_gemma":[0.0005049748,0.00010795485,0.00046662195,0.0005927347,0.0001798333,0.00005413549,0.00015633482,0.00033447088,0.0000032272335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027236546,0.00006432722,0.97300607,0.00018070526,0.001967729,0.000002587445,0.0014749564,0.000014457018,0.000042341,0.00003778672,0.00016308599,0.022773566],"study_design_scores_gemma":[0.031070635,0.00029185548,0.9506015,0.0006925655,0.0010826903,2.2511323e-7,0.0011098867,0.000009623873,0.0026212083,0.000077138924,0.012295397,0.00014722784],"about_ca_topic_score_codex":0.0001722971,"about_ca_topic_score_gemma":0.00007393588,"teacher_disagreement_score":0.03241622,"about_ca_system_score_codex":0.00007422922,"about_ca_system_score_gemma":0.0002983971,"threshold_uncertainty_score":0.44022712},"labels":[],"label_agreement":null},{"id":"W4411535590","doi":"10.1080/14796678.2025.2513805","title":"Long-term safety and effectiveness of evinacumab in people with homozygous familial hypercholesterolemia: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Future Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec à Chicoutimi","funders":"Servier; Novo Nordisk; Argenx; Amryt Pharma; Fresenius Medical Care North America; Amarin Corporation; Mylan; Ionis Pharmaceuticals; Abbott Laboratories; Regeneron Pharmaceuticals; Esperion Therapeutics; Ultragenyx Pharmaceutical; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Amgen; Vifor Pharma; Pfizer; Daiichi Sankyo Europe; Silence Therapeutics; Kowa Company; Sanofi","keywords":"Medicine; Familial hypercholesterolemia; Term (time); Plain language; Pediatrics; Internal medicine; Intensive care medicine; Linguistics; Cholesterol","score_opus":0.003289234119944993,"score_gpt":0.24306042863471466,"score_spread":0.23977119451476966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411535590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98573226,0.010823612,0.00084955903,0.00018024431,0.00026274603,0.00089637254,0.000027032054,0.000027282807,0.0012009103],"genre_scores_gemma":[0.9981687,0.0009754912,0.00007498325,0.00015932525,0.00039600357,0.000060679766,0.00008797246,0.000016854194,0.000059966478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984753,0.00051992066,0.00023123433,0.0003583563,0.00014770511,0.00026749558],"domain_scores_gemma":[0.9992211,0.00013109729,0.00004106314,0.0004708552,0.000065465,0.000070415714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008135104,0.00018048396,0.001083765,0.0001663363,0.00003986473,0.000003977599,0.000073926676,0.00027144564,0.0000020348043],"category_scores_gemma":[0.000045382072,0.00013283138,0.00015406446,0.00027915533,0.00010839362,0.00003252749,0.00007038548,0.00037423693,0.0000010558914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050361627,0.000057699763,0.96147496,0.0028508932,0.00057147664,0.0013189908,0.0004881663,0.000035070425,0.0017792871,0.00020390145,0.000051608622,0.026131779],"study_design_scores_gemma":[0.0050022425,0.00044757512,0.99134934,0.0006004835,0.00020396487,0.0010574312,0.00039247618,0.0000027562655,0.00024064389,0.000006372229,0.0005886979,0.00010801795],"about_ca_topic_score_codex":0.0002198352,"about_ca_topic_score_gemma":0.0005035731,"teacher_disagreement_score":0.029874373,"about_ca_system_score_codex":0.0001316916,"about_ca_system_score_gemma":0.00020935487,"threshold_uncertainty_score":0.5416706},"labels":[],"label_agreement":null},{"id":"W4411539495","doi":"10.1161/atv.45.suppl_1.tu0035","title":"Abstract Tu0035: Lipoprotein(a) Induces a Proglycolytic and Proinflammatory Response in Coronary Artery and Aortic Valve Endothelial Cells, with Altered Metabolism and Reactive Oxygen Species Generation.","year":2025,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Proinflammatory cytokine; CD36; Transcriptome; Gene expression; Biology; Internal medicine; Inflammation; Endocrinology; Medicine; Receptor; Gene; Biochemistry","score_opus":0.026015498275938957,"score_gpt":0.2616050532546531,"score_spread":0.23558955497871414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411539495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552053,0.0019237201,0.00004694134,0.0006619728,0.00009323147,0.0016502779,0.000025657106,0.000033147513,0.000044538934],"genre_scores_gemma":[0.9923969,0.006124383,0.0006193343,0.00036370807,0.00015098345,0.0002858776,0.000019884355,0.000027301556,0.0000116432475],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99803543,0.00029815946,0.00041245503,0.00071516883,0.00016774215,0.00037106243],"domain_scores_gemma":[0.9991821,0.00007617387,0.00011410039,0.00038527587,0.000071505034,0.00017081565],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008377279,0.0003292842,0.00081875134,0.00023917652,0.00020992418,0.00008116376,0.000054066568,0.00021861416,0.000011133862],"category_scores_gemma":[0.0000482851,0.00025190623,0.0001118522,0.00015917857,0.0004216947,0.00016791104,0.000105301704,0.00025508928,0.0000010137853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000345517,0.00017996461,0.042266335,0.00032009635,0.0011542458,0.0000027688454,0.0011816329,5.6877724e-7,0.94804907,0.00019684035,0.000018733577,0.0062842006],"study_design_scores_gemma":[0.0035394982,0.00066897814,0.9886905,0.0002868243,0.00037176223,0.000020997233,0.00044964795,0.00007698839,0.0049191494,0.00004972535,0.0006728693,0.00025308674],"about_ca_topic_score_codex":0.00026786598,"about_ca_topic_score_gemma":0.0001555113,"teacher_disagreement_score":0.9464241,"about_ca_system_score_codex":0.000048710113,"about_ca_system_score_gemma":0.00016749038,"threshold_uncertainty_score":0.9999933},"labels":[],"label_agreement":null},{"id":"W4411577041","doi":"10.1192/bja.2025.10112","title":"Neuroprotective effects of statins and cyclodextrins: review and potential role in dementia treatment","year":2025,"lang":"en","type":"article","venue":"BJPsych Advances","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Olds College","funders":"","keywords":"Neuroprotection; Dementia; Medicine; Pharmacology; Neuroscience; Internal medicine; Psychology; Disease","score_opus":0.003424739951179396,"score_gpt":0.2744114627059716,"score_spread":0.2709867227547922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411577041","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3642793,0.63185537,0.0005766433,0.00042589114,0.00006606454,0.0020507989,0.0000043765,0.000013079836,0.0007284397],"genre_scores_gemma":[0.75924444,0.23913862,0.0010089691,0.00031469163,0.00002242215,0.00018754414,0.000002633243,0.0000071831446,0.00007347516],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99926746,0.00007340941,0.00018952813,0.00022842373,0.00011162332,0.00012955502],"domain_scores_gemma":[0.99966115,0.00002502721,0.00005307085,0.00017895352,0.000032206393,0.000049594295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012257748,0.00010591552,0.00040154633,0.000073409385,0.00003058421,0.000004156705,0.000022221735,0.000024544703,0.0000037375294],"category_scores_gemma":[0.000046649508,0.00007998447,0.00005611364,0.00015958949,0.00004214453,0.000056454275,0.000019539104,0.00006175498,4.3538262e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012868222,0.0002162034,0.010066928,0.0075879176,0.00026234376,0.00003635614,0.00008369724,0.0000034494683,0.0015413837,0.0001759409,0.000016607315,0.9798805],"study_design_scores_gemma":[0.015318974,0.0036065772,0.8731745,0.009403231,0.0027463357,0.00011445163,0.00033715458,0.00007758857,0.01538943,0.0029889296,0.0764546,0.0003882454],"about_ca_topic_score_codex":0.00016939014,"about_ca_topic_score_gemma":0.000050879135,"teacher_disagreement_score":0.97949225,"about_ca_system_score_codex":0.00002271732,"about_ca_system_score_gemma":0.0000478779,"threshold_uncertainty_score":0.3261672},"labels":[],"label_agreement":null},{"id":"W4411696424","doi":"10.1016/j.ymthe.2025.06.004","title":"RNA interference targeting lipoprotein(a): A “big hit” against “little a”?","year":2025,"lang":"en","type":"editorial","venue":"Molecular Therapy","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"RNA interference; Interference (communication); RNA; Computational biology; Biology; Chemistry; Cell biology; Genetics; Computer science; Gene; Telecommunications","score_opus":0.010116603623303976,"score_gpt":0.2677052357986912,"score_spread":0.25758863217538724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411696424","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005614848,0.10406965,0.008661128,0.0013710981,0.85799235,0.0038655533,0.0001631234,0.0004923249,0.017769942],"genre_scores_gemma":[0.009412032,0.035429157,0.0019382505,0.0025095083,0.94081473,0.000751805,0.002031624,0.0003461695,0.0067667007],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952255,0.00035133248,0.00076640997,0.0011421287,0.0017068456,0.00080777064],"domain_scores_gemma":[0.9968367,0.000111815025,0.00028981725,0.0018265593,0.0006177722,0.00031730416],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011522222,0.00076962326,0.001495525,0.0003249756,0.00018218489,0.00012075398,0.00054640207,0.0013428912,0.0001004924],"category_scores_gemma":[0.0007290868,0.0006727978,0.0011942158,0.0004805462,0.000105541396,0.00004612856,0.0001873289,0.0019798742,0.00008527154],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004986106,0.00020324485,0.0000028190093,0.0010853518,0.001340303,0.0006333453,0.0001388037,0.0000055426467,0.010236457,0.000038764705,0.51945287,0.46636388],"study_design_scores_gemma":[0.0031636574,0.0004867782,0.000007297279,0.0013848159,0.00016268784,0.0000058222577,0.00003617002,0.000019750956,0.022818184,0.00010579385,0.97124696,0.00056211377],"about_ca_topic_score_codex":0.00070864934,"about_ca_topic_score_gemma":0.000013126831,"teacher_disagreement_score":0.46580178,"about_ca_system_score_codex":0.00036363714,"about_ca_system_score_gemma":0.0018830992,"threshold_uncertainty_score":0.99995357},"labels":[],"label_agreement":null},{"id":"W4411698506","doi":"10.1007/s40256-025-00740-1","title":"A Drug–Drug Interaction Study Evaluating the Pharmacokinetic Consequences of Obicetrapib Therapy on Atorvastatin or Rosuvastatin Levels in Healthy Volunteers","year":2025,"lang":"en","type":"article","venue":"American Journal of Cardiovascular Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Rosuvastatin; Atorvastatin; Medicine; Drug; Pharmacotherapy; Pharmacokinetics; Pharmacology; Rosuvastatin Calcium; Drug interaction; Drug-drug interaction; Internal medicine","score_opus":0.0394081592109647,"score_gpt":0.37937407008664825,"score_spread":0.33996591087568356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411698506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678696,0.008900757,0.00043165713,0.0016208217,0.00047595124,0.0015779139,0.000007660429,0.000015098713,0.00018317702],"genre_scores_gemma":[0.9959569,0.0019501863,0.000616214,0.0010926473,0.00022049941,0.00006620632,0.000001313493,0.00003537143,0.0000606537],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9932232,0.0026484202,0.0014077169,0.00038054917,0.0019324297,0.00040769673],"domain_scores_gemma":[0.9969114,0.0007503834,0.00076379953,0.00075649685,0.0006553831,0.00016251145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00897794,0.0003192767,0.0017074601,0.0006294619,0.00012662497,0.000035078952,0.00033021334,0.0000305821,0.000038888636],"category_scores_gemma":[0.0004833909,0.00019640784,0.0015111759,0.0015097377,0.00040986983,0.00013421179,0.00004038994,0.0008599286,0.0000025885768],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010854106,0.00090196007,0.00543427,0.00023169952,0.010381292,0.00021404565,0.015504631,0.008490006,0.001627974,0.000015512973,0.00019096397,0.9461535],"study_design_scores_gemma":[0.090883136,0.06469784,0.350007,0.007344922,0.009588761,0.002449104,0.43148062,0.0026089423,0.020819157,0.00020291006,0.018213581,0.0017040448],"about_ca_topic_score_codex":0.0033039586,"about_ca_topic_score_gemma":0.000050776507,"teacher_disagreement_score":0.9444495,"about_ca_system_score_codex":0.00033778316,"about_ca_system_score_gemma":0.0015766363,"threshold_uncertainty_score":0.8009279},"labels":[],"label_agreement":null},{"id":"W4411721398","doi":"10.1093/eurjpc/zwaf352","title":"Proposal of a familial hypercholesterolemia paediatric diagnostic score (FH-PeDS)","year":2025,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sociedade Portuguesa de Cardiologia; NextGenerationEU; Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona; Javna Agencija za Raziskovalno Dejavnost RS; University College London; British Heart Foundation; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Silence Therapeutics; European Commission; Sanofi; Esperion Therapeutics; Ultragenyx Pharmaceutical; AstraZeneca; Indian National Science Academy; Amgen","keywords":"Medicine; Cohort; Population; Cohort study; Pediatrics; Internal medicine","score_opus":0.011913812320703,"score_gpt":0.26153140862431157,"score_spread":0.24961759630360858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411721398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685635,0.0095147975,0.010675763,0.00051866745,0.001060604,0.0005499986,0.000012475838,0.0000143904335,0.009089777],"genre_scores_gemma":[0.9957726,0.0012032528,0.0010958669,0.00023343806,0.0013513351,0.0000037985967,0.0000053654453,0.000026803236,0.00030756713],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9962959,0.0020315815,0.0008473686,0.00022377064,0.00032871313,0.00027264512],"domain_scores_gemma":[0.99829066,0.00021139081,0.00039113074,0.00038176676,0.0005731096,0.000151952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028761865,0.0001813411,0.0009950539,0.00033726628,0.000047737944,0.000008007858,0.00022695033,0.00006784356,0.000014159769],"category_scores_gemma":[0.0014503448,0.00013845229,0.0008836502,0.00030775947,0.00017583421,0.000070309514,0.00012972984,0.00060157845,0.00001679494],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028874713,0.00069808436,0.38785675,0.0023609805,0.008515963,0.012346609,0.0010444316,0.00044304912,0.024880208,0.0014021093,0.019949552,0.53761476],"study_design_scores_gemma":[0.006222888,0.002493431,0.9693527,0.0010003615,0.0017889938,0.002197144,0.00026173366,0.0000037585155,0.001521405,0.00040773416,0.014567281,0.0001825538],"about_ca_topic_score_codex":0.0000054248103,"about_ca_topic_score_gemma":7.888942e-7,"teacher_disagreement_score":0.58149594,"about_ca_system_score_codex":0.00007686528,"about_ca_system_score_gemma":0.00061318924,"threshold_uncertainty_score":0.564592},"labels":[],"label_agreement":null},{"id":"W4412008660","doi":"10.1161/circgen.124.004937","title":"Importance of Clinical, Laboratory, and Genetic Risk Factors for Incident CAD","year":2025,"lang":"en","type":"article","venue":"Circulation Genomic and Precision Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"National Center for Advancing Translational Sciences; National Human Genome Research Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Internal medicine; CRFS; Myocardial infarction; Dyslipidemia; Coronary artery disease; Cardiology; Diabetes mellitus; Familial hypercholesterolemia; Disease; Cholesterol; Endocrinology","score_opus":0.03290294306854185,"score_gpt":0.3488639086240414,"score_spread":0.3159609655554995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412008660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97466594,0.011335642,0.012375929,0.0003255355,0.00027298924,0.00087111315,0.00001949744,0.000012853728,0.00012048982],"genre_scores_gemma":[0.9936931,0.004481886,0.0011850665,0.00030096684,0.00022577957,0.000015316242,0.000022039334,0.000010148032,0.000065706394],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853605,0.00009320873,0.00076431356,0.0003006152,0.00019596057,0.00010984583],"domain_scores_gemma":[0.99870485,0.00035984386,0.000268778,0.0003370569,0.00019176799,0.00013772419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013382224,0.00011040847,0.0005713202,0.00011460491,0.0000880459,0.0000045875927,0.000038629616,0.00010796427,0.00002539714],"category_scores_gemma":[0.0011083146,0.00008013402,0.000081555416,0.00014096376,0.00013193683,0.000025686984,0.000027159234,0.000116693445,5.1136044e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011350478,0.000019278425,0.8972444,0.00021435389,0.00010863337,0.0000013966734,0.00020216059,0.000020500733,0.0012138879,0.00008066433,0.0004156462,0.10036555],"study_design_scores_gemma":[0.0026488535,0.00021730892,0.9886502,0.00017186553,0.00031944155,0.0000049921964,0.00017881002,0.000899424,0.00008771388,0.0006795799,0.0060798996,0.000061910265],"about_ca_topic_score_codex":0.00011361138,"about_ca_topic_score_gemma":0.000009299934,"teacher_disagreement_score":0.10030364,"about_ca_system_score_codex":0.000027959093,"about_ca_system_score_gemma":0.00015729909,"threshold_uncertainty_score":0.32677704},"labels":[],"label_agreement":null},{"id":"W4412080117","doi":"10.1101/2025.07.07.25330740","title":"Medication Exposure and Neurodegenerative Disease Risk Across National Biobanks","year":2025,"lang":"en","type":"preprint","venue":"medRxiv","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"National Institute on Aging; National Institutes of Health; Amazon Web Services; U.S. Department of Health and Human Services","keywords":"Biobank; Disease; Environmental health; Medicine; Bioinformatics; Biology; Pathology","score_opus":0.019982522091233062,"score_gpt":0.311717973972699,"score_spread":0.29173545188146593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412080117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823559,0.009331985,0.0017020406,0.0031914853,0.00071409583,0.0010358006,0.00074753613,0.0000927139,0.00082845066],"genre_scores_gemma":[0.9924292,0.0037268423,0.0005024796,0.000897444,0.0009497284,0.0002541554,0.000378271,0.000020288735,0.0008415931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766487,0.00023390741,0.00033186734,0.0006933747,0.00084697735,0.00022903396],"domain_scores_gemma":[0.9984176,0.000049827908,0.00016891288,0.0006870693,0.0003416825,0.00033489705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011645104,0.00024621695,0.00043820837,0.00009661134,0.00017886263,0.000040658448,0.00012246308,0.0002416098,0.000028024617],"category_scores_gemma":[0.0007845195,0.00020617833,0.00023849914,0.00012840277,0.000118681724,0.00003391987,0.0003293562,0.0007542925,0.000008438619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053236884,0.00047637188,0.81096184,0.004657841,0.0015639736,0.00018254724,0.0021457933,0.00029665613,0.0002059849,0.0016243838,0.0037083172,0.17364392],"study_design_scores_gemma":[0.0011273429,0.000059395934,0.98376155,0.00037482538,0.00037503394,0.0000118103935,0.00004428757,0.0013215964,0.00026548008,0.0011172784,0.011324283,0.00021711168],"about_ca_topic_score_codex":0.00014595353,"about_ca_topic_score_gemma":0.00002982555,"teacher_disagreement_score":0.1734268,"about_ca_system_score_codex":0.00009856474,"about_ca_system_score_gemma":0.0009226812,"threshold_uncertainty_score":0.8407708},"labels":[],"label_agreement":null},{"id":"W4412084917","doi":"10.1016/j.cjco.2025.06.021","title":"Implementing Dyslipidemia Guidelines into Clinical Practice Following an Acute Coronary Syndrome: Challenges and Opportunities for Improvement","year":2025,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk; Sanofi; Canadian Cardiovascular Society; Novartis; HLS Therapeutics; Pfizer; Amgen","keywords":"Dyslipidemia; Acute coronary syndrome; Medicine; Clinical Practice; Intensive care medicine; Cardiology; Internal medicine; Physical therapy; Myocardial infarction; Obesity","score_opus":0.18152954771857377,"score_gpt":0.47139707766403555,"score_spread":0.2898675299454618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412084917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8292333,0.03612855,0.0031631629,0.108961865,0.0017236657,0.008903768,0.000032640775,0.00015284479,0.011700213],"genre_scores_gemma":[0.76483154,0.032406967,0.15572792,0.03851352,0.001108376,0.0017951583,0.00025594837,0.00012358067,0.005236961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977973,0.00015623168,0.0008347158,0.0005024484,0.00032618438,0.0003830848],"domain_scores_gemma":[0.9983436,0.00022496894,0.00016997084,0.0006359032,0.00040937084,0.00021617947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009741875,0.00018015702,0.0007826537,0.00006856091,0.00029694603,0.00009300794,0.0002396989,0.00011980094,0.000011940683],"category_scores_gemma":[0.0010648719,0.00015325379,0.00022365959,0.00005058819,0.0000391134,0.0005327135,0.00066574913,0.00017513167,0.0000012640706],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026207918,0.000113318245,0.00040296596,0.00038187826,0.0018399023,0.0002454672,0.000225477,1.3335963e-7,0.000100278034,0.002769273,0.0038642695,0.98979497],"study_design_scores_gemma":[0.0075406767,0.003058964,0.011153205,0.00072490785,0.002510952,0.0002887223,0.017607313,0.00026902382,0.00011668854,0.0014941386,0.9548863,0.0003490822],"about_ca_topic_score_codex":0.00024237281,"about_ca_topic_score_gemma":0.00009180027,"teacher_disagreement_score":0.98944587,"about_ca_system_score_codex":0.00008499077,"about_ca_system_score_gemma":0.00060143264,"threshold_uncertainty_score":0.6249508},"labels":[],"label_agreement":null},{"id":"W4412100973","doi":"10.1093/eurjpc/zwaf392","title":"Family history of premature atherosclerotic cardiovascular disease and lipoprotein(a) levels: a multicohort analysis","year":2025,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Heart, Lung, and Blood Institute; National Institutes of Health; Baylor College of Medicine","keywords":"Medicine; Atherosclerotic cardiovascular disease; Cohort; Family history; Internal medicine; Cohort study; Disease; Lipoprotein(a); Cardiology; Lipoprotein; Cholesterol","score_opus":0.02352934108963734,"score_gpt":0.2506538764322063,"score_spread":0.227124535342569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412100973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73155046,0.20512292,0.05433214,0.00015203671,0.00073368824,0.0010197051,0.000025952102,0.00002387672,0.0070392615],"genre_scores_gemma":[0.9950506,0.0020689857,0.0013516617,0.00016030465,0.00033647777,0.000007240151,0.000005133515,0.000029975312,0.0009896237],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99592716,0.00216391,0.0008018282,0.00036309956,0.00048795025,0.00025606237],"domain_scores_gemma":[0.9978744,0.00006046392,0.00037732066,0.0008103701,0.0006066304,0.00027082828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038062963,0.00023612387,0.0017475707,0.0005317682,0.000041031737,0.0000070523242,0.00019137115,0.000073078554,0.0000140891525],"category_scores_gemma":[0.0004919307,0.00018997528,0.0027712164,0.0003819741,0.00026946262,0.00007347936,0.00012484338,0.0004501113,0.0000025147513],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004041399,0.00080380455,0.11912228,0.0048510837,0.43732065,0.009298243,0.002301499,0.0066307164,0.02545021,0.0005904327,0.0056425645,0.38394713],"study_design_scores_gemma":[0.0025617478,0.00036829326,0.94569665,0.00051268045,0.02229377,0.00016397896,0.0001270949,0.00005542205,0.00008508233,0.000048399324,0.027929684,0.00015722288],"about_ca_topic_score_codex":0.000025133233,"about_ca_topic_score_gemma":6.513854e-7,"teacher_disagreement_score":0.8265743,"about_ca_system_score_codex":0.00023617214,"about_ca_system_score_gemma":0.00048466973,"threshold_uncertainty_score":0.7746967},"labels":[],"label_agreement":null},{"id":"W4412123218","doi":"10.2196/76850","title":"Lipid Profile and Apolipoprotein B Serum Levels in the Vietnamese Population With Newly Diagnosed Elevated Low-Density Lipoprotein Cholesterol and Association With the Single-Nucleotide Variant rs676210: Cross-Sectional Study","year":2025,"lang":"en","type":"article","venue":"JMIR Cardio","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Vietnamese; Single-nucleotide polymorphism; Cross-sectional study; Apolipoprotein B; Preprint; Lipid profile; Medicine; Population; Internal medicine; Genetics; Biology; Genotype; Environmental health; Gene; Cholesterol; Pathology; Computer science","score_opus":0.01212393654430716,"score_gpt":0.2645631569127759,"score_spread":0.2524392203684687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412123218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902674,0.00014640966,0.00015785528,0.0016075597,0.00009984716,0.0074218777,0.000031703694,0.00007299558,0.00019434832],"genre_scores_gemma":[0.99748397,0.000010310032,0.00010924078,0.0006170628,0.00042538767,0.0010047484,0.000025198153,0.000035990317,0.0002881067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675804,0.0006804498,0.00042712718,0.00061982166,0.0010864893,0.00042806802],"domain_scores_gemma":[0.9985729,0.00011705619,0.00022192221,0.0007232337,0.0002645549,0.00010033224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027138172,0.00032182774,0.00060391927,0.00015046082,0.00044712535,0.0002989944,0.0001294461,0.00019735776,0.0000067991646],"category_scores_gemma":[0.00013185438,0.00018019052,0.0001225382,0.0006897455,0.00009775127,0.00022524223,0.00008166181,0.00065178773,0.000002951316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061637297,0.00040121624,0.9769224,0.00023372918,0.00058655004,0.00011283582,0.0016607067,0.000060871855,0.00036989123,0.000033434684,0.000058285135,0.018943684],"study_design_scores_gemma":[0.0065933806,0.0007847692,0.990258,0.00020891514,0.00020235866,0.00014142532,0.0010081446,0.00009540583,0.0002621102,0.0000237966,0.00021805774,0.00020363145],"about_ca_topic_score_codex":0.005409208,"about_ca_topic_score_gemma":0.0038045032,"teacher_disagreement_score":0.018740052,"about_ca_system_score_codex":0.000400352,"about_ca_system_score_gemma":0.00018605775,"threshold_uncertainty_score":0.8177141},"labels":[],"label_agreement":null},{"id":"W4412388960","doi":"10.1161/jaha.124.040361","title":"Role of Lipoprotein(a) in Atherosclerotic Cardiovascular Disease in South Asian Individuals","year":2025,"lang":"en","type":"review","venue":"Journal of the American Heart Association","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Atherosclerotic cardiovascular disease; Disease; Cardiology; Lipoprotein(a); Internal medicine; Lipoprotein; Cholesterol","score_opus":0.01602521610473692,"score_gpt":0.2874033071403741,"score_spread":0.2713780910356372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412388960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016641071,0.9812312,0.0000059986965,0.00024454633,0.00016546372,0.0015993188,0.00003313331,0.0000056739145,0.000073562944],"genre_scores_gemma":[0.041369185,0.9577039,0.00018851028,0.0001123655,0.00043270315,0.000057614783,0.0000050046633,0.000043111348,0.00008763692],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9948256,0.0017295763,0.0013727839,0.00023453365,0.0015106857,0.00032682312],"domain_scores_gemma":[0.99696314,0.00015827353,0.0017821747,0.0007528114,0.0001950124,0.00014858144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046914793,0.00026932676,0.004408708,0.0006099477,0.000037576323,0.000018134553,0.0002724819,0.00016615314,0.0000045193733],"category_scores_gemma":[0.0018404385,0.00018422038,0.004175088,0.0015621923,0.00005007384,0.0000654334,0.000086979155,0.000977436,0.0000032478617],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045497636,0.00024725962,0.11466314,0.007408558,0.0030988536,0.000017148674,0.00048245394,0.0000946119,0.0000024767787,0.0000053610847,0.00006422577,0.87387043],"study_design_scores_gemma":[0.0020027193,0.00034721007,0.56070054,0.06356254,0.0090372,0.000045916393,0.00044296792,0.00000952043,0.0000070113097,0.00012352581,0.363326,0.00039480758],"about_ca_topic_score_codex":0.0005836755,"about_ca_topic_score_gemma":0.000020438987,"teacher_disagreement_score":0.8734756,"about_ca_system_score_codex":0.0014641341,"about_ca_system_score_gemma":0.0019934608,"threshold_uncertainty_score":0.7512289},"labels":[],"label_agreement":null},{"id":"W4412391937","doi":"10.1016/j.jaccas.2025.103953","title":"Apparent Nonresponse to PCSK9 Inhibition in a Patient With Heterozygous Familial Hypercholesterolemia Due to PCSK9 Gene Duplication","year":2025,"lang":"en","type":"article","venue":"JACC Case Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia Hospital; University of Saskatchewan; University of British Columbia","funders":"","keywords":"PCSK9; Ezetimibe; Evolocumab; Kexin; Familial hypercholesterolemia; Internal medicine; Endocrinology; Medicine; LDL receptor; Alirocumab; Gene duplication; Proprotein convertase; Cholesterol; Lipoprotein; Biology; Genetics; Gene","score_opus":0.010847724774419686,"score_gpt":0.27060777019411114,"score_spread":0.25976004541969144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412391937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199224,0.00015675215,0.0032011333,0.0010895004,0.0001972497,0.0028233142,0.0000112563075,0.000070656,0.00045790928],"genre_scores_gemma":[0.9949622,0.00000631829,0.0012032832,0.0026001034,0.00014163468,0.00086138386,0.00007297707,0.000028912526,0.0001231776],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9976546,0.0001216121,0.0006877594,0.00067665655,0.0005041464,0.0003552136],"domain_scores_gemma":[0.9982588,0.00002605655,0.000121312514,0.0010508779,0.0001991936,0.00034370867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007734151,0.00022690537,0.00049113366,0.0004094419,0.00008615023,0.000034083318,0.000021065576,0.00012490628,0.00001008213],"category_scores_gemma":[0.0001708743,0.00019279422,0.00013662003,0.00064539333,0.000018223092,0.00006721197,0.00008652258,0.00020992818,0.000014191264],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035724412,0.00084968045,0.00507395,0.0003725912,0.00015760113,0.73275346,0.0020932034,0.0012841331,0.028748041,0.000008999463,0.00093447464,0.2241514],"study_design_scores_gemma":[0.0039830413,0.0026382168,0.12093125,0.0018495062,0.00032450657,0.73117375,0.00088035566,0.00016510519,0.09581486,0.00004555249,0.04143877,0.00075508887],"about_ca_topic_score_codex":0.002211702,"about_ca_topic_score_gemma":0.0011339454,"teacher_disagreement_score":0.22339632,"about_ca_system_score_codex":0.0005663056,"about_ca_system_score_gemma":0.00037606753,"threshold_uncertainty_score":0.78619206},"labels":[],"label_agreement":null},{"id":"W4412414116","doi":"10.3389/fphar.2025.1554631","title":"Systemic evaluation of inclisiran on the risk of new-onset diabetes and hyperglycemia compared to evolocumab and atorvastatin","year":2025,"lang":"en","type":"article","venue":"Frontiers in Pharmacology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Natural Science Foundation of Fujian Province","keywords":"Medicine; Adverse Event Reporting System; Atorvastatin; Evolocumab; Adverse effect; Internal medicine; Type 2 diabetes; Diabetes mellitus; Glycemic; Dyslipidemia; Alogliptin; Pharmacology; Endocrinology; Insulin; Sitagliptin; Cholesterol; Apolipoprotein B","score_opus":0.017166450214644025,"score_gpt":0.31206683877442715,"score_spread":0.2949003885597831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412414116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990888,0.006324115,0.00026001126,0.00062739087,0.0004965888,0.0012402841,0.000018245548,0.0000063564676,0.00013900056],"genre_scores_gemma":[0.99840516,0.00032568938,0.00065166515,0.0004761504,0.000037838934,0.00006580361,0.0000043156188,0.0000064302703,0.000026968208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859124,0.0005429627,0.0002923675,0.0001819273,0.00024867457,0.00014283933],"domain_scores_gemma":[0.9994057,0.00013084317,0.00010089669,0.00019080176,0.0001060315,0.00006571605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018254251,0.00009075767,0.0004529474,0.00020172799,0.000036884627,0.0000024909318,0.000061900166,0.0000635912,0.00001498848],"category_scores_gemma":[0.00022850685,0.0000663383,0.000046177214,0.0002380394,0.000093623086,0.000017043447,0.00004460445,0.00015495055,3.995561e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012844616,0.00010586133,0.8481916,0.00057570194,0.0009138248,0.0000017583089,0.0017892303,0.0004405132,0.0061288266,0.00005874494,0.048832357,0.091677085],"study_design_scores_gemma":[0.022281,0.0011408682,0.9032733,0.0008829864,0.0030644706,0.000015929647,0.0037956566,0.029316613,0.032296475,0.0015753349,0.002122911,0.00023444487],"about_ca_topic_score_codex":0.0001806714,"about_ca_topic_score_gemma":0.0000107908945,"teacher_disagreement_score":0.09144264,"about_ca_system_score_codex":0.000103218794,"about_ca_system_score_gemma":0.00024060355,"threshold_uncertainty_score":0.27051973},"labels":[],"label_agreement":null},{"id":"W4412492495","doi":"10.1038/s41569-025-01194-3","title":"Lipoprotein(a) in coronary artery disease","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Coronary artery disease; Cardiology; Internal medicine; Lipoprotein(a); Disease; Lipoprotein; Atherosclerotic cardiovascular disease; Cholesterol","score_opus":0.027982447324424287,"score_gpt":0.3534646118952286,"score_spread":0.3254821645708043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412492495","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.579417e-7,0.9837041,0.000041289,0.00020001674,0.001232563,0.009500012,0.00008290413,0.00007686644,0.0051613185],"genre_scores_gemma":[0.000007698747,0.99200225,0.00026715067,0.0011200164,0.0020954742,0.002544716,0.00081775413,0.000080836304,0.0010641128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99390197,0.0020825716,0.001577948,0.0012730396,0.00042434523,0.0007401118],"domain_scores_gemma":[0.9964398,0.00019682567,0.00037421647,0.0024636756,0.000095567884,0.0004298762],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002234003,0.00091077876,0.010665513,0.0006615465,0.0000630387,0.000013719594,0.00039576727,0.0023908154,0.000050911225],"category_scores_gemma":[0.0011326773,0.0006297415,0.0051563624,0.0010535194,0.000106400585,0.00004730178,0.00021709347,0.0041459333,0.00022697989],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002979879,0.00003183924,0.00004252656,0.1298426,0.00048084633,0.002306793,0.0000020400037,1.32339e-7,2.181779e-8,0.00020906782,0.004436364,0.86261797],"study_design_scores_gemma":[0.00051035977,0.0000729534,0.00049416814,0.07463043,0.0038811543,0.0018429656,0.0000012946064,2.2072805e-7,1.945698e-8,0.00006508526,0.91808707,0.00041427623],"about_ca_topic_score_codex":0.000010227987,"about_ca_topic_score_gemma":0.000009265064,"teacher_disagreement_score":0.9136507,"about_ca_system_score_codex":0.0004997667,"about_ca_system_score_gemma":0.0026091083,"threshold_uncertainty_score":0.9996154},"labels":[],"label_agreement":null},{"id":"W4412494302","doi":"10.1016/j.jcct.2025.05.210","title":"Assessing The Predictive Value Of Lipoprotein(a) And C-reactive Protein For Detecting Subclinical Atherosclerosis","year":2025,"lang":"en","type":"article","venue":"Journal of cardiovascular computed tomography","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Predictive value; Subclinical infection; C-reactive protein; Internal medicine; Cardiology; Lipoprotein(a); Predictive value of tests; Lipoprotein; Cholesterol; Inflammation","score_opus":0.019608852097070098,"score_gpt":0.29573619204236384,"score_spread":0.27612733994529376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412494302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.722393,0.01738125,0.25748584,0.0003420053,0.00030131885,0.001913413,0.0000056279823,0.000025588937,0.0001519873],"genre_scores_gemma":[0.98337805,0.00017605643,0.015667103,0.00010538898,0.00056488346,0.0000682868,0.0000016782398,0.00003314915,0.0000053820518],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99678475,0.0005501535,0.0010121507,0.00034499416,0.0009826135,0.0003253289],"domain_scores_gemma":[0.9969483,0.00038745702,0.00058864127,0.00072180043,0.001188888,0.00016490617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005163022,0.0002663057,0.0014433959,0.0004907213,0.00025260303,0.000086240536,0.00022935784,0.00021797644,8.375546e-7],"category_scores_gemma":[0.00058442017,0.00017976457,0.0040929094,0.0009898634,0.00026476078,0.00023209686,0.00009868982,0.00068191905,9.870226e-8],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002853102,0.0012000259,0.024673445,0.0044798343,0.11105706,0.00010284576,0.0013522214,0.0052879583,0.014125946,0.0018750394,0.0001871216,0.8328054],"study_design_scores_gemma":[0.03494615,0.0067008557,0.7712812,0.012139098,0.0247101,0.0014979477,0.0036084382,0.011673648,0.110695824,0.0046431236,0.017111234,0.000992408],"about_ca_topic_score_codex":0.00009727201,"about_ca_topic_score_gemma":0.0000012460896,"teacher_disagreement_score":0.831813,"about_ca_system_score_codex":0.00007181076,"about_ca_system_score_gemma":0.00039492836,"threshold_uncertainty_score":0.73305863},"labels":[],"label_agreement":null},{"id":"W4412522050","doi":"10.1080/03007995.2025.2536607","title":"Diagnostic accuracy of cardiovascular and imaging biomarkers to identify index patients with familial hypercholesterolaemia","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Internal medicine; Cohort; Intima-media thickness; Population; Cardiology; Carotid arteries","score_opus":0.03401270397466517,"score_gpt":0.40080789210865436,"score_spread":0.3667951881339892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412522050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96685773,0.02773785,0.0023251122,0.0013068565,0.00036661787,0.0012616109,0.00001078361,0.000015267538,0.000118184966],"genre_scores_gemma":[0.9900993,0.009458486,0.000038051585,0.000101634505,0.00017443483,0.000073043855,0.0000391664,0.000011307292,0.000004550369],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99664694,0.00022583624,0.0002713971,0.00041148512,0.0020397396,0.00040459033],"domain_scores_gemma":[0.9979438,0.0005225253,0.000024632802,0.0004140573,0.00041179406,0.0006831989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021949613,0.00012741816,0.00040582626,0.0003484365,0.00012307304,0.000034524353,0.00011917753,0.000080780395,0.000010429286],"category_scores_gemma":[0.006009766,0.000090873786,0.000101228565,0.000506135,0.00033595867,0.0000885132,0.0002673196,0.00049955765,0.0000026202306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002811878,0.00014732577,0.2958635,0.0010857659,0.00024903202,0.000010735658,0.00006264046,3.1818738e-7,0.000008949259,0.00003691409,0.0009710206,0.7012826],"study_design_scores_gemma":[0.0042125774,0.0003273723,0.9421557,0.0033275527,0.000058568203,0.000008747251,0.00010658907,0.00008919868,0.000050585637,0.00006853878,0.049504686,0.00008988576],"about_ca_topic_score_codex":0.00041405985,"about_ca_topic_score_gemma":0.0000074894383,"teacher_disagreement_score":0.70119274,"about_ca_system_score_codex":0.000066302935,"about_ca_system_score_gemma":0.00046426317,"threshold_uncertainty_score":0.71946853},"labels":[],"label_agreement":null},{"id":"W4412529724","doi":"10.1016/j.atherosclerosis.2025.120458","title":"Characterization of lipoprotein (a) testing in Alberta, Canada: a retrospective cohort study","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; Libin Cardiovascular Institute of Alberta; Novartis (Canada)","funders":"Novartis Pharmaceuticals Canada; Novartis","keywords":"Medicine; Retrospective cohort study; Lipoprotein(a); Internal medicine; Lipoprotein; Cholesterol","score_opus":0.012470846618477744,"score_gpt":0.23530484128702145,"score_spread":0.2228339946685437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412529724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551076,0.000018196233,0.00006731316,0.00029835195,0.00009967231,0.0020154836,0.000007309419,0.000017400027,0.0019655307],"genre_scores_gemma":[0.99898463,0.000018912568,0.000101507416,0.00020371437,0.00004401604,0.00021519359,0.000010589675,0.000017632681,0.00040379842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986118,0.00008313521,0.0003795796,0.00031013796,0.0004058989,0.00020944988],"domain_scores_gemma":[0.9991673,0.000038412098,0.00010799412,0.00045968252,0.00017267939,0.000053918222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000519547,0.0001320904,0.00053390255,0.00011489069,0.000052486987,0.000008010714,0.00007358948,0.00006276557,0.000018534136],"category_scores_gemma":[0.0003308755,0.00012211905,0.000070269925,0.0008912504,0.000023442088,0.000044693723,0.0000404782,0.0001597204,0.0000013146383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026884898,0.00024651026,0.97130954,0.00006878697,0.00012967996,0.0000024650653,0.00017722805,0.0000014548646,0.024004925,0.00005147497,0.000009287652,0.0039717336],"study_design_scores_gemma":[0.0011891616,0.00019132243,0.9898775,0.0003084688,0.00009545914,0.0000011539422,0.00011370929,0.00006463217,0.007975772,0.000009533915,0.00008913387,0.00008412023],"about_ca_topic_score_codex":0.94011945,"about_ca_topic_score_gemma":0.7557685,"teacher_disagreement_score":0.18435095,"about_ca_system_score_codex":0.00048481912,"about_ca_system_score_gemma":0.0006694318,"threshold_uncertainty_score":0.49798703},"labels":[],"label_agreement":null},{"id":"W4412605406","doi":"10.1016/j.jacadv.2025.101864","title":"Cholesterol Levels and Cardiovascular Outcomes Following Statin Initiation for Primary Prevention","year":2025,"lang":"en","type":"article","venue":"JACC Advances","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University Health Network; University of Toronto; Women's College Hospital; Western University; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research","keywords":"Primary prevention; Medicine; Statin; Cholesterol; Internal medicine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Cardiology; Disease","score_opus":0.021790381622874,"score_gpt":0.32964442831864954,"score_spread":0.30785404669577554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412605406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8210743,0.022469738,0.1512839,0.0005858353,0.00043511132,0.0020817814,0.000016080361,0.00008313489,0.0019701102],"genre_scores_gemma":[0.98424155,0.00041606487,0.013103909,0.0008696963,0.00011777169,0.0003337336,0.0000445948,0.00001869598,0.0008539719],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990043,0.000054196564,0.00023510918,0.0002668083,0.00026989315,0.00016967328],"domain_scores_gemma":[0.9994836,0.00006098441,0.00004818077,0.0002967364,0.00006202663,0.000048478807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000622397,0.00011673284,0.00046442007,0.00008470435,0.0001127772,0.000023295524,0.000035954065,0.00005782379,0.0000028549057],"category_scores_gemma":[0.00014226652,0.00009718754,0.00047786656,0.00011149708,0.000016981794,0.0002717707,0.00002460863,0.00007550391,0.0000010319916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046775433,0.000062846666,0.07970105,0.001381558,0.0013204823,0.0000045280935,0.00013746634,0.000044183656,0.00023845043,0.00025869042,0.00004658683,0.9167574],"study_design_scores_gemma":[0.0055400534,0.00020549698,0.9400867,0.00043328686,0.0009302508,0.0000073815645,0.0003489474,0.000032657685,0.0014855887,0.0027478982,0.047999486,0.00018221965],"about_ca_topic_score_codex":0.000014576318,"about_ca_topic_score_gemma":0.000007950044,"teacher_disagreement_score":0.91657513,"about_ca_system_score_codex":0.00005388672,"about_ca_system_score_gemma":0.00009950591,"threshold_uncertainty_score":0.3963193},"labels":[],"label_agreement":null},{"id":"W4412784601","doi":"10.46747/cfp.710708450_2","title":"Correction","year":2025,"lang":"en","type":"erratum","venue":"Canadian Family Physician","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science; Data science; Information retrieval; World Wide Web","score_opus":0.011434103159309953,"score_gpt":0.23582088681419405,"score_spread":0.2243867836548841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412784601","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002240055,0.0088294875,0.000024568375,0.0007066632,0.068353266,0.00067917997,0.0001265749,0.00008299782,0.9211749],"genre_scores_gemma":[0.00033174755,0.00082883943,0.000025917465,0.18183179,0.010340255,0.00007720368,0.001988791,0.00008465285,0.8044908],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981408,0.00005072692,0.00024912308,0.0005179538,0.00041126873,0.000630138],"domain_scores_gemma":[0.9979483,0.000010651729,0.000078150384,0.0010152754,0.00020617807,0.00074143417],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001455199,0.0003462513,0.0007819593,0.00051010685,0.0002015486,0.000042987544,0.00015501808,0.0006338418,0.0000091299735],"category_scores_gemma":[0.00002783418,0.00035961682,0.0005617755,0.0005369508,0.00005084585,0.000041358504,0.000020759862,0.001352477,0.00026184815],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054833154,0.000013379142,0.0000022151942,0.0002489238,0.00021656035,0.0000958838,0.0000083505965,5.924606e-7,0.000005736742,0.00006501574,0.8358432,0.16349465],"study_design_scores_gemma":[0.0003037879,0.00007773298,0.0028010309,0.0012018182,0.00036309805,0.0000040157893,0.00010543576,0.00007441313,0.000011395694,0.00004794683,0.99472624,0.00028307096],"about_ca_topic_score_codex":0.121605545,"about_ca_topic_score_gemma":0.04230976,"teacher_disagreement_score":0.18112513,"about_ca_system_score_codex":0.0014431095,"about_ca_system_score_gemma":0.010690039,"threshold_uncertainty_score":0.99988556},"labels":[],"label_agreement":null},{"id":"W4412825410","doi":"10.1097/mol.0000000000001000","title":"The complex pro-atherosclerotic role of lipoprotein(a): a multiplicity of cellular targets","year":2025,"lang":"en","type":"article","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Lipoprotein(a); Lipoprotein; Pathogenesis; Medicine; Tissue factor; Lysophosphatidic acid; LRP1; Immunology; Receptor; Bioinformatics; Coagulation; Biology; Internal medicine; LDL receptor; Cholesterol","score_opus":0.04779694898818871,"score_gpt":0.33742595776430456,"score_spread":0.28962900877611586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412825410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7316294,0.16083258,0.018488914,0.0055763833,0.06506109,0.014911783,0.000089808615,0.00019729779,0.0032127667],"genre_scores_gemma":[0.99618006,0.0014553635,0.00040598662,0.000033109365,0.0016405988,0.00020449996,0.00003096078,0.000015057832,0.000034351124],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817646,0.00029162955,0.00066922494,0.000279689,0.0002677011,0.00031531096],"domain_scores_gemma":[0.9987656,0.00013397084,0.00020708358,0.0006614801,0.0001691314,0.00006272787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091315707,0.0001540456,0.00061386975,0.00015884564,0.000074271964,0.0000040045484,0.00020098076,0.00012777763,0.000025560497],"category_scores_gemma":[0.0002866512,0.00011064329,0.00024370466,0.00037066935,0.00027594776,0.000024978506,0.00012523214,0.00031261262,0.0000048744973],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017162481,0.0034278897,0.13290939,0.011681027,0.00072118617,2.7493448e-7,0.0019935532,0.00013129214,0.13776782,0.06133294,0.010639667,0.63767874],"study_design_scores_gemma":[0.008068359,0.0010030309,0.4106168,0.0024361124,0.00011784002,0.000013275189,0.0007574848,0.0034847008,0.019492399,0.005249477,0.5484221,0.00033844434],"about_ca_topic_score_codex":0.00029022055,"about_ca_topic_score_gemma":0.000016825687,"teacher_disagreement_score":0.63734025,"about_ca_system_score_codex":0.000059162656,"about_ca_system_score_gemma":0.00022150227,"threshold_uncertainty_score":0.45119026},"labels":[],"label_agreement":null},{"id":"W4412954503","doi":"10.5830/cvja-2025-005","title":"Identification of genetic risk variants in PCSK9 gene and its association with myocardial infarction in Pakistani Pashtun population","year":2025,"lang":"en","type":"article","venue":"Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"PCSK9; Myocardial infarction; Identification (biology); Genetic variants; Internal medicine; Population; Gene; Association (psychology); Medicine; Genetic association; Cardiology; Genetics; Biology; Genotype; Single-nucleotide polymorphism; Cholesterol; Environmental health; Psychology; LDL receptor","score_opus":0.008337352181251256,"score_gpt":0.21464534864555332,"score_spread":0.20630799646430206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412954503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85491794,0.12341552,0.02010198,0.00007101481,0.00044441276,0.0008770233,0.000047194764,0.000013335284,0.00011157182],"genre_scores_gemma":[0.99298185,0.004857826,0.0014397857,0.000015621103,0.00058004085,0.000016638645,0.000004684536,0.00007635362,0.000027209866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99028164,0.0019135793,0.0032982787,0.0005363661,0.0033347826,0.0006353689],"domain_scores_gemma":[0.99361694,0.00015389979,0.0027108216,0.0009925908,0.0021943147,0.0003314614],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.015806511,0.0005108719,0.0031793849,0.0019727084,0.00014355956,0.00009049573,0.0003624984,0.0004996107,0.000008145929],"category_scores_gemma":[0.0015851558,0.00042516532,0.004976156,0.00211467,0.00008751806,0.00040411658,0.00008535775,0.0014357949,0.0000047567364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003968785,0.000953491,0.7251696,0.0016734974,0.091184065,0.0020405839,0.02192058,0.09272372,0.0037687395,0.00004776491,0.000053544216,0.05649561],"study_design_scores_gemma":[0.021914871,0.0009034981,0.93766147,0.002071577,0.019393934,0.002275217,0.010504958,0.0005031847,0.00100145,0.00047727962,0.0025767128,0.00071583997],"about_ca_topic_score_codex":0.00012639731,"about_ca_topic_score_gemma":0.0000047038084,"teacher_disagreement_score":0.21249186,"about_ca_system_score_codex":0.0010186584,"about_ca_system_score_gemma":0.00065028993,"threshold_uncertainty_score":0.99982},"labels":[],"label_agreement":null},{"id":"W4412980075","doi":"10.1016/j.cpcardiol.2025.103146","title":"Metabolic syndrome, ischemic heart disease, and heart failure: insights from the Colombian Heart Failure Registry (RECOLFACA)","year":2025,"lang":"en","type":"article","venue":"Current Problems in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cytodiagnostics (Canada)","funders":"","keywords":"Medicine; Heart failure; Cardiology; Metabolic syndrome; Internal medicine; Disease; Obesity","score_opus":0.015635507319915063,"score_gpt":0.2665702622025682,"score_spread":0.2509347548826531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412980075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7882131,0.18261448,0.00021134678,0.024161654,0.0012689809,0.0028815973,0.00009885885,0.00012355129,0.00042645854],"genre_scores_gemma":[0.99449724,0.0016505735,0.00041630387,0.0019024165,0.0005143955,0.0006789189,0.00019419272,0.000038111943,0.000107873435],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968295,0.00059838337,0.000625533,0.0009388915,0.00037625173,0.00063143455],"domain_scores_gemma":[0.9979165,0.0002068113,0.00009271149,0.001337692,0.00012077801,0.00032546997],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069270603,0.0003954319,0.001488961,0.00018272678,0.00022145103,0.000050565362,0.0002492088,0.00033114513,0.000022672164],"category_scores_gemma":[0.00026578354,0.0002942124,0.00046343746,0.00060300174,0.0003800617,0.000115107185,0.00026285692,0.0011384735,0.000032065615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015705518,0.00023064243,0.58789015,0.0011873593,0.0011469629,0.00007593324,0.00021959552,0.00012766954,0.0034841504,0.0018139089,0.40049016,0.0031763816],"study_design_scores_gemma":[0.0014523702,0.00006493375,0.34444442,0.00048081597,0.0002913718,0.00021260274,0.000088458284,0.000013958842,0.00009019092,0.0009875746,0.65167934,0.00019394455],"about_ca_topic_score_codex":0.00035299856,"about_ca_topic_score_gemma":0.00019997927,"teacher_disagreement_score":0.25118917,"about_ca_system_score_codex":0.00012256221,"about_ca_system_score_gemma":0.0006114677,"threshold_uncertainty_score":0.999951},"labels":[],"label_agreement":null},{"id":"W4413038049","doi":"10.1161/atvbaha.125.322137","title":"Lp(a) as a Risk Factor for Peripheral Artery Disease: Context Is Everything","year":2025,"lang":"en","type":"review","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cardiology; Risk factor; Internal medicine; Thrombosis; Claudication; Coronary artery disease; Context (archaeology); Proinflammatory cytokine; Restenosis; Lipoprotein(a); Intermittent claudication; Disease; Vascular disease; Arterial disease; Surgery; Inflammation; Lipoprotein; Stent; Cholesterol","score_opus":0.05798000490381442,"score_gpt":0.35193305530022045,"score_spread":0.293953050396406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413038049","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004887213,0.98769844,0.0007859066,0.00029198412,0.0005898588,0.0039468454,0.0016479314,0.00010603152,0.000045784833],"genre_scores_gemma":[0.0051104426,0.9907377,0.0002813341,0.0017481181,0.0005653968,0.0010545489,0.00033674372,0.00010247377,0.00006325267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99624205,0.0005101857,0.0009107465,0.0013300686,0.00026669304,0.00074027904],"domain_scores_gemma":[0.9974515,0.0002256955,0.00037255554,0.0013063126,0.00015299731,0.0004909531],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005908052,0.0008424712,0.004058335,0.0002455509,0.00043093233,0.000106850355,0.00022970793,0.0007542788,0.00024942006],"category_scores_gemma":[0.00021198836,0.0006348436,0.0035575302,0.00024339944,0.0002079436,0.00008774617,0.0001841209,0.000508371,0.000030465313],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012742707,0.0001614764,0.0016499049,0.026062181,0.005697931,5.1582515e-7,0.0002972699,2.5951561e-8,0.000017600474,0.00017540863,0.0004790743,0.9654459],"study_design_scores_gemma":[0.0016063381,0.00055140676,0.049782313,0.012913783,0.0071042036,0.000004818217,0.00006488771,0.000009088527,8.352719e-7,0.000057117715,0.9272649,0.00064026663],"about_ca_topic_score_codex":0.00014720771,"about_ca_topic_score_gemma":0.000023132257,"teacher_disagreement_score":0.9648056,"about_ca_system_score_codex":0.00016991507,"about_ca_system_score_gemma":0.0006800638,"threshold_uncertainty_score":0.9996103},"labels":[],"label_agreement":null},{"id":"W4413094101","doi":"10.1016/j.cjca.2025.08.003","title":"International Validation of Risk Scores for Familial Hypercholesterolemia","year":2025,"lang":"en","type":"editorial","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ezetimibe; Medicine; Familial hypercholesterolemia; PCSK9; Atherosclerotic cardiovascular disease; Internal medicine; LDL receptor; Statin; Cholesterol; Disease; Oncology; Lipoprotein","score_opus":0.011497934055781664,"score_gpt":0.2758036801386706,"score_spread":0.264305746082889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413094101","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009384073,0.0018536554,0.0073634065,0.00035359908,0.9752825,0.0005118082,0.0021756524,0.00000480047,0.0030705377],"genre_scores_gemma":[0.06693181,0.0014471639,0.00065533747,0.000049196165,0.93013436,0.00001503216,0.0005415928,0.000031261134,0.00019424982],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816006,0.00019966008,0.000729692,0.00019975318,0.00044404104,0.00026681542],"domain_scores_gemma":[0.99649596,0.00038636316,0.0005528332,0.00032711786,0.0018853641,0.00035235344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014673395,0.00018237846,0.001222355,0.00066792325,0.000058015714,0.000015829582,0.00028788438,0.00078945945,0.000009368079],"category_scores_gemma":[0.004310939,0.00016219451,0.0009925857,0.00009077586,0.00012012349,0.000047258116,0.000015783702,0.0008487312,0.0000011353101],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034085644,0.000002316735,0.0026679197,0.000258689,0.0016261357,0.000050587663,0.00005998416,0.00030576144,0.000026893982,0.000022042726,0.9733252,0.021313598],"study_design_scores_gemma":[0.0022669302,0.00036687212,0.002449073,0.00040775823,0.0010380332,0.00008915753,0.00004080521,0.000002743069,0.000117445226,0.00014507078,0.9929755,0.000100636724],"about_ca_topic_score_codex":0.0027667894,"about_ca_topic_score_gemma":0.00071079086,"teacher_disagreement_score":0.05754773,"about_ca_system_score_codex":0.0004452165,"about_ca_system_score_gemma":0.00865508,"threshold_uncertainty_score":0.99696493},"labels":[],"label_agreement":null},{"id":"W4413110707","doi":"10.1093/eurheartj/ehaf517","title":"Cardiovascular biomarkers for risk stratification in primary prevention","year":2025,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"Deutsche Forschungsgemeinschaft","keywords":"Medicine; Risk stratification; Primary prevention; Stratification (seeds); Primary (astronomy); Risk assessment; Intensive care medicine; Internal medicine; Disease","score_opus":0.027058508755228104,"score_gpt":0.29826167729661146,"score_spread":0.2712031685413834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413110707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8516207,0.019433677,0.09155966,0.0020830664,0.0009301219,0.0025415102,0.000009281116,0.00008073547,0.031741276],"genre_scores_gemma":[0.9864569,0.0013856604,0.00997243,0.00043188725,0.0007770533,0.000024374382,0.000028699384,0.00003724407,0.000885768],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983173,0.0006092731,0.00035815698,0.00020839665,0.00028663527,0.00022024108],"domain_scores_gemma":[0.99931115,0.000026246971,0.000074775715,0.00038393712,0.00010400419,0.00009990695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005021995,0.000098897435,0.00029995482,0.00021305993,0.00016029774,0.000044820787,0.00006266259,0.000037875085,0.00001230941],"category_scores_gemma":[0.00015923979,0.00008675375,0.0006959806,0.00023848243,0.00002243451,0.0000856708,0.000017135513,0.0003039001,0.000013576984],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058122486,0.0003451158,0.06955984,0.00066335016,0.002521682,0.00012718551,0.0001803542,0.00024272258,0.003240321,0.00019016887,0.011693749,0.9106543],"study_design_scores_gemma":[0.0030958732,0.00020315219,0.8470094,0.00035963382,0.00031984245,0.00029045803,0.00007995743,0.00006402164,0.00036124827,0.00022018066,0.14790328,0.0000929508],"about_ca_topic_score_codex":0.000016029226,"about_ca_topic_score_gemma":0.0000029150203,"teacher_disagreement_score":0.9105613,"about_ca_system_score_codex":0.00016655696,"about_ca_system_score_gemma":0.00027631447,"threshold_uncertainty_score":0.35377154},"labels":[],"label_agreement":null},{"id":"W4413114276","doi":"10.1007/s11883-025-01325-8","title":"Polygenic Modulation of Monogenic Diseases: Familial Hypercholesterolemia as the Exemplar","year":2025,"lang":"en","type":"review","venue":"Current Atherosclerosis Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; University of British Columbia Hospital","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Penetrance; Phenotype; Coronary artery disease; Disease; Bioinformatics; Internal medicine; Genetics; Cholesterol; Biology; Gene","score_opus":0.04471786072185518,"score_gpt":0.34769980697322556,"score_spread":0.30298194625137037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413114276","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075282217,0.98677576,0.000077767494,0.000028343014,0.0016766876,0.003619668,0.00008910448,0.00008443876,0.00012000336],"genre_scores_gemma":[0.008110591,0.9897322,0.000022550572,0.000049612874,0.00067849754,0.00062242645,0.00044489568,0.00009255644,0.00024667315],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99543995,0.00036195817,0.0017812982,0.0009033795,0.0010569143,0.00045649774],"domain_scores_gemma":[0.995836,0.00010016855,0.0010585395,0.0025570374,0.00019462605,0.00025362024],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072491047,0.0006474371,0.0027211732,0.00023718998,0.00017537177,0.00004271466,0.00027424845,0.0003895432,0.000041379168],"category_scores_gemma":[0.00027503964,0.00041382358,0.003058737,0.00065297436,0.00013791841,0.00007743043,0.00020880204,0.000667815,0.000025846371],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011960013,0.00023473875,0.0005996096,0.022772532,0.0005404001,0.000013723835,0.0000678969,0.0000015615718,0.000016150463,0.000011019531,0.00031507664,0.97541535],"study_design_scores_gemma":[0.00049617497,0.00011854021,0.008166318,0.03861615,0.0070303106,0.00024558016,0.000016393973,0.0000067606184,0.000008150942,0.00005613751,0.9448304,0.00040908126],"about_ca_topic_score_codex":0.00011653099,"about_ca_topic_score_gemma":0.0000027147414,"teacher_disagreement_score":0.9750062,"about_ca_system_score_codex":0.0003132714,"about_ca_system_score_gemma":0.0016804937,"threshold_uncertainty_score":0.9998314},"labels":[],"label_agreement":null},{"id":"W4413149501","doi":"10.1016/j.jacl.2025.08.009","title":"Extreme lipoprotein(a) is a cardiovascular risk equivalent in heterozygous familial hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; Montreal Clinical Research Institute","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Lipoprotein(a); Internal medicine; Cardiology; Lipoprotein; Cholesterol","score_opus":0.08472779856806323,"score_gpt":0.3850927413615161,"score_spread":0.3003649427934529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413149501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97580886,0.009925466,0.003662691,0.003131873,0.0053360243,0.00067449117,0.000007822652,0.000022242919,0.0014305344],"genre_scores_gemma":[0.978457,0.007105651,0.0025803077,0.004523513,0.0069539426,0.000019216679,0.0000020590287,0.000033248176,0.00032510766],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9935418,0.0016044473,0.002951043,0.00049528305,0.00086410105,0.00054336275],"domain_scores_gemma":[0.99699634,0.00047080705,0.000658393,0.0010795348,0.0004163355,0.00037859697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010046301,0.00027907587,0.0027062963,0.00044945808,0.000065442255,0.000019308292,0.0003392642,0.00064619264,0.000072518575],"category_scores_gemma":[0.0030733447,0.0002154438,0.0033287671,0.0004033755,0.00022803109,0.0001064273,0.00015922553,0.0022457587,0.0000314884],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035779863,0.0010547806,0.2093775,0.0003893317,0.0039978903,0.0006018757,0.00018884131,0.00013413269,0.00018559553,0.000082022416,0.0045731473,0.7758369],"study_design_scores_gemma":[0.020623602,0.00339262,0.642638,0.0009346295,0.001927073,0.0012853395,0.00016545795,0.0001494893,0.0002736489,0.0013251519,0.32697606,0.0003089077],"about_ca_topic_score_codex":0.00037691835,"about_ca_topic_score_gemma":0.00005972515,"teacher_disagreement_score":0.775528,"about_ca_system_score_codex":0.00016407603,"about_ca_system_score_gemma":0.0008543509,"threshold_uncertainty_score":0.9756829},"labels":[],"label_agreement":null},{"id":"W4413260690","doi":"10.1016/j.hlc.2025.06.839","title":"The Functionality of High-Density Lipoprotein Cholesterol is Impaired in Patients With Diabetes That Require Minor Amputations","year":2025,"lang":"en","type":"article","venue":"Heart Lung and Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Medicine; Diabetes mellitus; Minor (academic); Cholesterol; Internal medicine; Endocrinology; Humanities","score_opus":0.00828539356275674,"score_gpt":0.23350796649163366,"score_spread":0.22522257292887693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413260690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679995,0.0003416911,0.00045891988,0.0015263854,0.000054418313,0.0007547395,0.0000064037413,0.000016320879,0.000041164018],"genre_scores_gemma":[0.99950296,0.0000072809767,0.00006343706,0.00026417544,0.000029599323,0.000039537706,0.000031108084,0.0000059780677,0.000055929955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991499,0.0000780261,0.00018568644,0.00017928582,0.00027792167,0.00012915833],"domain_scores_gemma":[0.99947613,0.00003674804,0.0000581822,0.00025340173,0.00013462189,0.00004090109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034989664,0.00007958691,0.00020216074,0.000061723505,0.00015769049,0.0000173785,0.000018269171,0.000060517254,0.000004537078],"category_scores_gemma":[0.000030857962,0.000054993634,0.000058900823,0.00019917572,0.00005630279,0.000094906645,0.0000131561665,0.00008834094,6.920272e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008634626,0.000065621425,0.972146,0.00017838903,0.00007239647,1.568322e-7,0.0001004576,0.000026622492,0.00005097303,0.00010865118,0.000052751166,0.027111655],"study_design_scores_gemma":[0.0015436555,0.00007144458,0.9967905,0.0001716594,0.00006640489,7.102427e-7,0.000041717052,0.0003731708,0.0003333114,0.0004350065,0.00012204018,0.000050378752],"about_ca_topic_score_codex":0.0012308818,"about_ca_topic_score_gemma":0.0002095775,"teacher_disagreement_score":0.027061276,"about_ca_system_score_codex":0.000060055678,"about_ca_system_score_gemma":0.00007456609,"threshold_uncertainty_score":0.22425753},"labels":[],"label_agreement":null},{"id":"W4413268482","doi":"10.1016/j.atherosclerosis.2025.119908","title":"Treating hyperlipidemia by targeting IP3R1 to lower PCSK9 expression and secretion","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Thrombosis and Atherosclerosis Research Institute; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"PCSK9; Secretion; Hyperlipidemia; Medicine; Internal medicine; LDL receptor; Endocrinology; Cholesterol; Lipoprotein; Diabetes mellitus","score_opus":0.009720985142402883,"score_gpt":0.25592225467588864,"score_spread":0.24620126953348576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413268482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909602,0.0012359845,0.0037159019,0.0014203603,0.00016932255,0.00050775707,0.0000068726945,0.000094534036,0.0018891061],"genre_scores_gemma":[0.99272454,0.00023686569,0.003467336,0.0020579912,0.00017661389,0.00007870989,0.000018783383,0.000026874353,0.0012122933],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988104,0.00007134026,0.00024969951,0.00036492242,0.00023228842,0.00027132884],"domain_scores_gemma":[0.9993516,0.000047419035,0.00004689775,0.00032240708,0.00006053286,0.00017115126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005044056,0.00015469639,0.00032653485,0.000060268903,0.00019026744,0.000031688454,0.00005167487,0.00012609446,0.000050512703],"category_scores_gemma":[0.00019344466,0.00012710739,0.00012093831,0.00022836476,0.000025421496,0.00006687541,0.000068542126,0.00015383314,0.000015757467],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072880415,0.00007048284,0.027474258,0.0001485243,0.00005908104,9.789255e-7,0.0003265017,0.0000048302672,0.9020435,0.000053183794,0.010665708,0.059080057],"study_design_scores_gemma":[0.008076106,0.0012696247,0.2713831,0.0055633266,0.00060798303,0.000015948488,0.0018743377,0.0010102091,0.45097867,0.00019931945,0.2579761,0.001045259],"about_ca_topic_score_codex":0.00024296119,"about_ca_topic_score_gemma":0.0000034411203,"teacher_disagreement_score":0.45106485,"about_ca_system_score_codex":0.000085846885,"about_ca_system_score_gemma":0.000036996178,"threshold_uncertainty_score":0.51832885},"labels":[],"label_agreement":null},{"id":"W4413268910","doi":"10.1016/j.atherosclerosis.2025.119878","title":"Expanded clinical experience of children with homozygous familial hypercholesterolaemia (HOFH) under 5 years of age treated with evinacumab through compassionate use programs","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Compassionate Use; Pediatrics; Medicine; Psychology; Internal medicine; Clinical trial","score_opus":0.054823557729954224,"score_gpt":0.32049178588945126,"score_spread":0.26566822815949703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413268910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976265,0.00015586501,0.00069966057,0.00005377843,0.000043654636,0.0012169366,0.000015630367,0.00007312752,0.00011484223],"genre_scores_gemma":[0.9963165,0.00031107335,0.0026909318,0.00026862367,0.000038507605,0.00011333697,0.000037293234,0.000041984575,0.00018175135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787396,0.00016861888,0.000580961,0.00048384917,0.0005712885,0.000321313],"domain_scores_gemma":[0.9985097,0.00006420822,0.00020221094,0.0009224364,0.0001765425,0.00012488046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027214506,0.00024391567,0.00093250856,0.00006580765,0.000068143425,0.00002488424,0.00018264381,0.00018297567,0.000010512408],"category_scores_gemma":[0.00003344906,0.00016607004,0.00027727475,0.0005205798,0.0005565584,0.00015637651,0.000067745474,0.0002766599,0.00000206772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015655328,0.0013422531,0.94834113,0.00013143892,0.0010263348,0.000019000061,0.0011458461,0.000017453138,0.003394793,0.000099701465,0.000047984824,0.04286852],"study_design_scores_gemma":[0.006419269,0.0016711658,0.98637813,0.0011631101,0.0003768659,0.00003314131,0.00044810926,0.0000089375535,0.0031857248,0.00000845801,0.00014213136,0.00016495686],"about_ca_topic_score_codex":0.0029789952,"about_ca_topic_score_gemma":0.00013196217,"teacher_disagreement_score":0.042703565,"about_ca_system_score_codex":0.000067983296,"about_ca_system_score_gemma":0.00019937128,"threshold_uncertainty_score":0.67721397},"labels":[],"label_agreement":null},{"id":"W4413269048","doi":"10.1016/j.atherosclerosis.2025.119967","title":"Contemporary experience of aortic stenosis in the Canadian homozygous familial hypercholesterolemia registry","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; University of Toronto; Western University; Centre hospitalier de l'Université Laval; Montreal Clinical Research Institute; University of British Columbia; Hospital for Sick Children; Université du Québec à Chicoutimi; Université de Montréal; Université Laval; McMaster University; University of British Columbia Hospital; University of Ottawa; McGill University Health Centre; McGill University","funders":"","keywords":"Familial hypercholesterolemia; Stenosis; Medicine; Cardiology; Internal medicine; Cholesterol","score_opus":0.034364789070752855,"score_gpt":0.28147224457291614,"score_spread":0.2471074555021633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413269048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870558,0.0005476734,0.000025421296,0.0016317548,0.0001202761,0.00063762564,0.00001420583,0.000017828459,0.009949451],"genre_scores_gemma":[0.99615216,0.00013051333,0.00008452142,0.0031274047,0.00004971686,0.00014300641,0.000006135077,0.000014189196,0.00029232676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985817,0.00013049692,0.00036702646,0.0002675956,0.00035665496,0.00029652283],"domain_scores_gemma":[0.9988239,0.00004361197,0.0000631843,0.0008793962,0.000069053815,0.00012084661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053255825,0.0001419469,0.0003756375,0.00013597083,0.00012379434,0.000026768008,0.00026234426,0.0001444193,0.00001271286],"category_scores_gemma":[0.00008797189,0.00010268048,0.0001893657,0.00049672724,0.0001670363,0.000058524274,0.000030104244,0.00026416723,0.0000059121217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011761867,0.00027998202,0.9430326,0.00039253873,0.00017534444,0.000059772028,0.008447129,0.000004783868,0.009256264,0.00031102827,0.0027675484,0.035155345],"study_design_scores_gemma":[0.0013162626,0.00012056274,0.9895856,0.0004425334,0.00005342623,0.000009555696,0.0025906428,0.000024154073,0.0017213073,0.000029496934,0.00399903,0.00010742521],"about_ca_topic_score_codex":0.3756109,"about_ca_topic_score_gemma":0.036985625,"teacher_disagreement_score":0.33862525,"about_ca_system_score_codex":0.00019456919,"about_ca_system_score_gemma":0.000783713,"threshold_uncertainty_score":0.9805869},"labels":[],"label_agreement":null},{"id":"W4413269115","doi":"10.1016/j.atherosclerosis.2025.119614","title":"Baseline characteristics and response to evinacumab in women and men with homozygous familial hypercholesterolemia in the ELIPSE OLE study","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Familial hypercholesterolemia; Baseline (sea); Medicine; Internal medicine; Demography; Gerontology; Political science; Cholesterol; Sociology","score_opus":0.011670834339058658,"score_gpt":0.2603802616113048,"score_spread":0.24870942727224613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413269115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99624044,0.00017720587,0.000033009343,0.0018304621,0.000019934147,0.001582395,0.000012294447,0.000017540186,0.000086751366],"genre_scores_gemma":[0.9967442,0.00021613509,0.000109180466,0.0023236263,0.000042807667,0.00038240102,0.0000021222252,0.000019394085,0.00016011155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982752,0.00049433234,0.0002808971,0.0003636047,0.00028176207,0.00030417473],"domain_scores_gemma":[0.99915534,0.00013874617,0.00003120888,0.0005227639,0.00004375266,0.00010818081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002829971,0.00017432703,0.00044151937,0.00016723493,0.00007559494,0.000051193863,0.000098741315,0.000066456596,0.000003652215],"category_scores_gemma":[0.00018320778,0.00011359733,0.000027278411,0.00044259045,0.000051849547,0.00005150438,0.00007983527,0.0002467186,0.0000025028348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011199946,0.0014157874,0.8042891,0.00021523678,0.00016277221,0.00016380027,0.046728216,0.000004011887,0.008879237,0.000013073294,0.00017902344,0.1267498],"study_design_scores_gemma":[0.0049073836,0.0013262824,0.9845399,0.0002781662,0.00004837786,0.00001993069,0.00771385,0.000039649054,0.000033864788,0.0000074343347,0.00097503915,0.000110074514],"about_ca_topic_score_codex":0.0006846173,"about_ca_topic_score_gemma":0.0002982596,"teacher_disagreement_score":0.18025085,"about_ca_system_score_codex":0.00017144174,"about_ca_system_score_gemma":0.00011173689,"threshold_uncertainty_score":0.46323648},"labels":[],"label_agreement":null},{"id":"W4413269147","doi":"10.1016/j.atherosclerosis.2025.119634","title":"Effect of pitavastatin on the plasma lipidome in adolescents with combined dyslipidemia","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pitavastatin; Lipidome; Dyslipidemia; Medicine; Chemistry; Internal medicine; Statin; Obesity; Lipid metabolism","score_opus":0.008780401152630764,"score_gpt":0.2502922648556004,"score_spread":0.24151186370296965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413269147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966797,0.00007377925,0.00004117621,0.0009500672,0.000109525696,0.0011653932,0.0000034823397,0.00002947899,0.00094735436],"genre_scores_gemma":[0.99884355,0.00003698739,0.000038328744,0.0007541656,0.00004286199,0.00012064257,0.0000021276237,0.000022439077,0.0001388903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852616,0.00031698777,0.0002841233,0.00024852285,0.0003686217,0.0002555983],"domain_scores_gemma":[0.9990172,0.00018111941,0.0000815062,0.00061482505,0.000044477074,0.00006090782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012031994,0.00017837876,0.0005264001,0.000111817666,0.00005668023,0.0000094325615,0.00012420482,0.0000858882,0.00001538174],"category_scores_gemma":[0.00018927074,0.00009596564,0.0001673032,0.0005225989,0.000086369226,0.000023749673,0.000032823602,0.0002840338,0.000017468059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055628386,0.0007944717,0.92025954,0.0024895892,0.00047484902,0.000006833327,0.00054932706,0.00011405059,0.014430894,0.0012468315,0.001046443,0.053024326],"study_design_scores_gemma":[0.011821323,0.0046261027,0.9218091,0.007915619,0.00021260515,0.0000018249372,0.00012189924,0.00030587602,0.05271089,0.000025314026,0.0002855664,0.00016387703],"about_ca_topic_score_codex":0.00022221838,"about_ca_topic_score_gemma":0.000042282038,"teacher_disagreement_score":0.052860446,"about_ca_system_score_codex":0.00008902743,"about_ca_system_score_gemma":0.000080128724,"threshold_uncertainty_score":0.3913365},"labels":[],"label_agreement":null},{"id":"W4413345705","doi":"10.1001/jamacardio.2025.2725","title":"Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US","year":2025,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Atherosclerotic cardiovascular disease; Disease; Statin; Internal medicine; Risk assessment; Cardiology","score_opus":0.016646473362507904,"score_gpt":0.2970258327422532,"score_spread":0.2803793593797453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413345705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804954,0.004868638,0.0068561463,0.002246304,0.00036957755,0.0020091324,0.00003545992,0.000060901035,0.0030584668],"genre_scores_gemma":[0.99473655,0.0006020327,0.00030602523,0.0033760131,0.0005019036,0.00038765237,0.000017541486,0.000020205169,0.000052086794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964554,0.0014356474,0.00041221152,0.00068140274,0.00047801415,0.00053733314],"domain_scores_gemma":[0.9972575,0.00021212797,0.000045471414,0.002156272,0.00012210164,0.00020654159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046499944,0.00022575224,0.000993669,0.00019013988,0.00014791336,0.000037182315,0.0002712022,0.00016473615,0.0000067777505],"category_scores_gemma":[0.0016702466,0.00015622326,0.0011184404,0.0006998712,0.00008994834,0.000053516796,0.00013378976,0.000584674,0.00004514899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006327032,0.00009560714,0.8185145,0.00035047845,0.002216698,0.000535556,0.0004295501,0.00883417,0.00009800701,0.0007091074,0.0015378527,0.16604574],"study_design_scores_gemma":[0.0019911479,0.00011420403,0.9360527,0.000101502425,0.00076107687,0.000045621488,0.00058287237,0.00012729729,0.00002796309,0.0005920884,0.059449878,0.00015368253],"about_ca_topic_score_codex":0.0018383261,"about_ca_topic_score_gemma":0.000037647394,"teacher_disagreement_score":0.16589205,"about_ca_system_score_codex":0.00023130608,"about_ca_system_score_gemma":0.00033456128,"threshold_uncertainty_score":0.63706},"labels":[],"label_agreement":null},{"id":"W4413365353","doi":"10.1016/j.atherosclerosis.2025.120447","title":"Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill Genome Centre","funders":"National Health and Medical Research Council; Medical Research Council; Esperion Therapeutics; Monash University; National Heart Foundation of Australia; InfraRedx; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Eli Lilly and Company; UK Research and Innovation; AstraZeneca; CSL Behring; Silence Therapeutics; Sanofi; Amgen; Pfizer; Anthera","keywords":"Primary prevention; Medicine; Disease; Environmental health; Internal medicine","score_opus":0.02762668364703805,"score_gpt":0.29019038778555034,"score_spread":0.26256370413851227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413365353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94194907,0.0066829138,0.046895564,0.00022821051,0.000118867996,0.00396073,0.000051344312,0.00004068663,0.000072605035],"genre_scores_gemma":[0.99719006,0.0005120067,0.0006118993,0.00011331756,0.00006431866,0.0013979925,0.000025513196,0.00002115114,0.000063767875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982955,0.00023450708,0.0003857996,0.00037031926,0.0004519776,0.00026190164],"domain_scores_gemma":[0.99800557,0.0005910177,0.000099776,0.0009798898,0.00024776498,0.00007600128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002339386,0.00016528077,0.0008440278,0.0002204279,0.00012965669,0.000019947462,0.0001319943,0.00008130387,0.0000066537245],"category_scores_gemma":[0.00037929544,0.00012049054,0.0012205121,0.001568767,0.00008288175,0.00006250948,0.0000564596,0.00011806171,0.0000011989996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006580218,0.0002895676,0.9122747,0.0034287656,0.015831126,0.0000033498827,0.00010159312,0.015355786,0.00056659855,0.0005836561,0.00000975549,0.050897084],"study_design_scores_gemma":[0.0027762947,0.00012191004,0.98410517,0.00087126845,0.008816961,3.4569348e-7,0.000029442026,0.0013614171,0.0005012082,0.00015137478,0.0011605022,0.00010409794],"about_ca_topic_score_codex":0.002183338,"about_ca_topic_score_gemma":0.000038912094,"teacher_disagreement_score":0.07183048,"about_ca_system_score_codex":0.0002673705,"about_ca_system_score_gemma":0.0003129562,"threshold_uncertainty_score":0.49134618},"labels":[],"label_agreement":null},{"id":"W4413384258","doi":"10.1016/j.jaccas.2025.104648","title":"Multimodal Therapy Achieves Secondary Prevention LDL-C Targets in LDL-Receptor Null Homozygous Familial Hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"JACC Case Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Familial hypercholesterolemia; LDL receptor; Ldl cholesterol; Null (SQL); Medicine; Internal medicine; Cholesterol; Lipoprotein; Computer science","score_opus":0.011913900799256593,"score_gpt":0.2885000191053702,"score_spread":0.2765861183061136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413384258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894211,0.0044412306,0.00040435503,0.0004174071,0.00092541607,0.0016861001,0.000013892352,0.00011490362,0.0025755668],"genre_scores_gemma":[0.99494463,0.0004892658,0.0010524561,0.00065261865,0.00045820072,0.00021285977,0.00011321517,0.000041403902,0.002035373],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99746317,0.00019430224,0.00082308456,0.0006563777,0.00042692982,0.0004361351],"domain_scores_gemma":[0.9985512,0.00003329774,0.00018409098,0.00092114916,0.00012058107,0.0001896791],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011409026,0.00028898547,0.00067184295,0.000273783,0.00011881318,0.000038179292,0.00004784634,0.00028642316,0.00018284927],"category_scores_gemma":[0.00011818578,0.00025211507,0.00044824707,0.00032572134,0.00005750124,0.00016346946,0.00006683395,0.00057498703,0.000018698998],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073252653,0.0012220618,0.022347586,0.00059999956,0.000503493,0.16694011,0.0007900047,0.000035371882,0.008593771,0.000020066824,0.0027655005,0.7954495],"study_design_scores_gemma":[0.018620234,0.001575894,0.419944,0.0016250961,0.00046478063,0.2597031,0.0014876459,0.00040666314,0.021707715,0.0007032517,0.27243033,0.0013313115],"about_ca_topic_score_codex":0.002329097,"about_ca_topic_score_gemma":0.0005098312,"teacher_disagreement_score":0.79411817,"about_ca_system_score_codex":0.00027038518,"about_ca_system_score_gemma":0.0007325988,"threshold_uncertainty_score":0.9999931},"labels":[],"label_agreement":null},{"id":"W4413439009","doi":"10.1016/j.jecr.2025.100199","title":"Massive tissue deposition of cholesterol leading to multi-organ failure in cholestatic hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical and Translational Endocrinology Case Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Rehabilitation Institute; University of Toronto; Western University","funders":"Canadian Institutes of Health Research","keywords":"Deposition (geology); Cholesterol; Medicine; Internal medicine; Biology","score_opus":0.03603902063733039,"score_gpt":0.3842645537246939,"score_spread":0.34822553308736354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413439009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855232,0.00059124513,0.007987287,0.0052404273,0.00021470612,0.00034126572,0.0000035043877,0.0000053657964,0.000092984854],"genre_scores_gemma":[0.99174106,0.00013361206,0.007470761,0.0004758379,0.0001209185,0.0000062397166,0.0000041026406,0.000008643557,0.00003884558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736935,0.00016640374,0.0018080919,0.00022191633,0.00025219424,0.00018206127],"domain_scores_gemma":[0.9988061,0.00019149689,0.00039511133,0.00017504471,0.0002532279,0.00017900315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083635363,0.00012094491,0.00081428787,0.0003193077,0.0000381487,0.000007936863,0.0000278827,0.0001419411,0.000007954587],"category_scores_gemma":[0.00031550496,0.00009852648,0.0002196643,0.00018779557,0.00011248944,0.000108298605,0.000016035272,0.0005291164,7.368061e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006472556,0.00070277543,0.6516771,0.0005671841,0.0005752885,0.10172783,0.0004108254,0.00043886073,0.0033965826,0.0002596262,0.00003917667,0.23955753],"study_design_scores_gemma":[0.0059828144,0.00063246326,0.7955321,0.0008402212,0.00038994782,0.19152762,0.00016822605,0.000066532746,0.002942737,0.00038765196,0.0014178945,0.00011178078],"about_ca_topic_score_codex":0.00005692342,"about_ca_topic_score_gemma":0.000178292,"teacher_disagreement_score":0.23944575,"about_ca_system_score_codex":0.000017064891,"about_ca_system_score_gemma":0.00029613147,"threshold_uncertainty_score":0.40177932},"labels":[],"label_agreement":null},{"id":"W4413451555","doi":"10.1016/j.cjca.2025.07.042","title":"Canadian and French Risk Scores Are Valid in Identifying Cardiovascular Disease in Australian Patients With Familial Hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"Esperion Therapeutics; Regeneron Pharmaceuticals; Novo Nordisk; Sanofi; University of Western Australia; AstraZeneca; National Health and Medical Research Council; Amgen","keywords":"Medicine; Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Disease; Pediatrics; Internal medicine; Gerontology; Cholesterol","score_opus":0.013777252667105113,"score_gpt":0.23928208636882237,"score_spread":0.22550483370171726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413451555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939653,0.0041087586,0.00008546676,0.0006591921,0.00036810516,0.00042635316,0.00007497113,0.000002820526,0.000308999],"genre_scores_gemma":[0.99908304,0.00029088545,0.0000672873,0.00021004652,0.00026298722,0.000011091093,0.000013868693,0.000017871715,0.000042914122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802876,0.0003713874,0.00045191773,0.0002950645,0.00026165106,0.0005912144],"domain_scores_gemma":[0.9978357,0.000024831785,0.000098417935,0.00043081405,0.00022377656,0.0013864882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009918181,0.00019356533,0.000934836,0.001269253,0.00009973616,0.000034103603,0.00014148247,0.00017604223,0.000004112838],"category_scores_gemma":[0.00026815842,0.00016726519,0.00032741888,0.00039970435,0.00013665803,0.00010482709,0.000013542245,0.00066966127,0.0000013522124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062965984,0.0000030604303,0.98753023,0.000098471304,0.0005414619,0.0017057278,0.000108328466,0.0024272893,8.838204e-7,0.000006572101,0.00032638278,0.007188599],"study_design_scores_gemma":[0.0032921375,0.00009815012,0.9782827,0.0006114589,0.00044494696,0.00008732804,0.00016546571,0.000006145918,0.0000022083375,0.00008213752,0.016792217,0.00013509719],"about_ca_topic_score_codex":0.60055745,"about_ca_topic_score_gemma":0.74952006,"teacher_disagreement_score":0.14896259,"about_ca_system_score_codex":0.0009740842,"about_ca_system_score_gemma":0.004139187,"threshold_uncertainty_score":0.73427397},"labels":[],"label_agreement":null},{"id":"W4413733540","doi":"10.15829/1560-4071-2025-6416","title":"Bioequivalence study of Rosuvastatin in healthy volunteers after a single dose on an empty stomach","year":2025,"lang":"en","type":"article","venue":"Russian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"IONICS Mass Spectrometry (Canada)","funders":"","keywords":"Medicine; Rosuvastatin; Bioequivalence; Stomach; Internal medicine; Pharmacokinetics","score_opus":0.020250861030566933,"score_gpt":0.3234005622108908,"score_spread":0.30314970118032386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413733540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952173,0.00153582,0.0005111115,0.00075797667,0.00038705757,0.00050979183,0.0000054634993,0.000007921752,0.0010675339],"genre_scores_gemma":[0.9987741,0.00010537533,0.0003218808,0.00046110607,0.00027921438,0.000014508841,0.0000013154853,0.000014784208,0.000027686234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746203,0.0007625917,0.00082397356,0.0002441732,0.0003911245,0.0003161247],"domain_scores_gemma":[0.9989083,0.000055200104,0.00022790724,0.0004921367,0.0001275605,0.00018893226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016967743,0.00016056767,0.0011204623,0.00056133134,0.00003135623,0.000006856596,0.00014716886,0.000120841425,0.000012083532],"category_scores_gemma":[0.00011423275,0.00012251303,0.0003190483,0.00038155695,0.00009204878,0.0000721579,0.000032557684,0.0004899479,0.000001987569],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04054902,0.004484527,0.8181093,0.001125221,0.0026825897,0.006027145,0.006909922,0.0024888513,0.0030854614,0.0007345931,0.00043793663,0.11336547],"study_design_scores_gemma":[0.00896047,0.023136545,0.96282893,0.00043323913,0.0002625922,0.0006210506,0.002382804,0.000032465257,0.00018007087,0.00012952392,0.00090462016,0.00012770858],"about_ca_topic_score_codex":0.00015693213,"about_ca_topic_score_gemma":0.00006483165,"teacher_disagreement_score":0.14471965,"about_ca_system_score_codex":0.00020017738,"about_ca_system_score_gemma":0.000454139,"threshold_uncertainty_score":0.49959365},"labels":[],"label_agreement":null},{"id":"W4413853467","doi":"10.1093/eurjpc/zwaf555","title":"SCORE2 charts assign a different risk category than the underlying model in a large portion of Polish primary care patients","year":2025,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Bio-Rad Laboratories","keywords":"Medicine; Primary care; Risk model; Family medicine; Risk analysis (engineering)","score_opus":0.018684213733665033,"score_gpt":0.26794078759066364,"score_spread":0.24925657385699862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413853467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96343374,0.004466616,0.023430906,0.00009440309,0.0003400558,0.00056982285,0.000032310407,0.000006530694,0.0076256054],"genre_scores_gemma":[0.99868405,0.00077404646,0.00008434453,0.00016101045,0.00015100317,0.000005386643,0.000022874588,0.000020556028,0.00009672984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963289,0.002198605,0.0007152062,0.00019034743,0.00030669424,0.00026026688],"domain_scores_gemma":[0.9985445,0.000046939855,0.0005597924,0.00033877435,0.0004316609,0.00007831417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002087344,0.00015580755,0.0007652863,0.00023950313,0.00007683242,0.000007257114,0.00017085273,0.00005110867,0.0000024487583],"category_scores_gemma":[0.00017688503,0.0000996453,0.0006103122,0.00015834045,0.00007763481,0.000061455336,0.000115803385,0.00054792274,0.0000012865482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013903977,0.00056205434,0.86102283,0.0011352019,0.0028497607,0.0005611914,0.006234896,0.001833525,0.0012186421,0.0006032007,0.0011438236,0.1214445],"study_design_scores_gemma":[0.0035705569,0.000490748,0.9932208,0.0005657278,0.0004266754,0.000047094218,0.0008998696,0.000059715774,0.00009749934,0.00022784734,0.0003159403,0.00007754699],"about_ca_topic_score_codex":0.000015935879,"about_ca_topic_score_gemma":0.000009061967,"teacher_disagreement_score":0.13219798,"about_ca_system_score_codex":0.00020747546,"about_ca_system_score_gemma":0.00026939396,"threshold_uncertainty_score":0.40634173},"labels":[],"label_agreement":null},{"id":"W4413859311","doi":"10.1093/cvr/cvaf142","title":"Vascular regenerative deficiencies in people with elevated lipoprotein(a): the Lp(a)-VRCE CardioLink-16 translational study","year":2025,"lang":"en","type":"article","venue":"Cardiovascular Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Stephen's University; North York General Hospital; Canada Research Chairs; Western University; St. Michael's Hospital","funders":"","keywords":"Lipoprotein(a); Medicine; Lipoprotein; Internal medicine; Cardiology; Endocrinology; Bioinformatics; Biology; Cholesterol","score_opus":0.04019133641791063,"score_gpt":0.335641811328285,"score_spread":0.2954504749103744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413859311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9289145,0.04338043,0.007078009,0.0014049174,0.00014268141,0.009344099,0.000012004776,0.00011694185,0.0096064545],"genre_scores_gemma":[0.99597955,0.0007316886,0.00022771591,0.00012683397,0.00034960717,0.0016124855,0.000037027694,0.00006586532,0.00086924055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98976636,0.0028764822,0.00061378843,0.0011940638,0.0043978784,0.0011514156],"domain_scores_gemma":[0.9950579,0.00024978054,0.00004581018,0.0030295285,0.0013871384,0.00022988243],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0147689795,0.00042048568,0.0014064481,0.00081486057,0.0008553116,0.00015183374,0.0005539183,0.00023563804,0.00003666865],"category_scores_gemma":[0.00050605275,0.00026906576,0.0015017705,0.004743371,0.0004769344,0.00015110918,0.00020641761,0.0016604316,0.000035471618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059501813,0.0066432166,0.40087152,0.0041653262,0.08972741,0.0040310216,0.029478686,0.05045002,0.002808717,0.015648495,0.0034316124,0.38679382],"study_design_scores_gemma":[0.021742541,0.0020746405,0.8633433,0.0009531122,0.002546148,0.00046833188,0.023563528,0.0012306558,0.0060029305,0.00058656634,0.07638544,0.0011028034],"about_ca_topic_score_codex":0.005900884,"about_ca_topic_score_gemma":0.00192984,"teacher_disagreement_score":0.4624718,"about_ca_system_score_codex":0.0006367538,"about_ca_system_score_gemma":0.001872766,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W4413893866","doi":"10.4081/cardio.2025.80","title":"Lipoprotein(a): what clinicians need to know","year":2025,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Need to know; Medicine; Intensive care medicine; Computer science; Computer security","score_opus":0.011634917237357392,"score_gpt":0.3144226758901416,"score_spread":0.30278775865278423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413893866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49051675,0.053803083,0.028456362,0.084235065,0.010188563,0.006024554,0.00009024721,0.000774364,0.32591102],"genre_scores_gemma":[0.97514474,0.001612859,0.0013028808,0.018691098,0.0015087962,0.0001844609,0.000034733435,0.000018748666,0.0015016561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808604,0.00020202424,0.0003759904,0.00051996205,0.00025901294,0.0005569615],"domain_scores_gemma":[0.9984962,0.000028781376,0.000039474213,0.00096561195,0.00019130108,0.00027866903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070038985,0.0002110462,0.0009397965,0.000099588775,0.000098101766,0.00003611075,0.00016871202,0.00030955215,0.000031177733],"category_scores_gemma":[0.00026834945,0.00018424254,0.00060476916,0.000644612,0.000082197155,0.00007384746,0.00015449332,0.00023626456,0.00035363698],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006900779,0.000066411034,0.016404906,0.00020205625,0.0011488032,0.00044263928,0.000044284523,0.00011873982,0.00021374346,0.0071095917,0.12616307,0.84739566],"study_design_scores_gemma":[0.0019309191,0.0005992181,0.07649563,0.00025481018,0.00035032752,0.00044458374,0.00055898185,0.000010779251,0.0002115726,0.0013697186,0.91754764,0.00022578354],"about_ca_topic_score_codex":0.00040752275,"about_ca_topic_score_gemma":0.000061533465,"teacher_disagreement_score":0.8471699,"about_ca_system_score_codex":0.0002969609,"about_ca_system_score_gemma":0.0003856137,"threshold_uncertainty_score":0.7513193},"labels":[],"label_agreement":null},{"id":"W4413954137","doi":"10.1177/20480040251371770","title":"Neuro-cognitive profile of adult statin users at a large tertiary care hospital in Delhi, India","year":2025,"lang":"en","type":"article","venue":"JRSM Cardiovascular Disease","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tertiary care; New delhi; Tertiary level; Medicine; Cognition; Family medicine; Psychology; Psychiatry; Mathematics education; Pathology","score_opus":0.003710364066286481,"score_gpt":0.2315537001222589,"score_spread":0.22784333605597243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413954137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690823,0.025108835,0.0004239792,0.00019856286,0.00027431114,0.00312924,0.0005404201,0.0000859186,0.0011564384],"genre_scores_gemma":[0.99705946,0.000593017,0.00018699263,0.0008302394,0.0001362198,0.000548388,0.00046420176,0.000060349557,0.00012111861],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965877,0.00034395585,0.0005463114,0.00080564705,0.0010860238,0.00063037523],"domain_scores_gemma":[0.9975564,0.000057606114,0.000093598464,0.0013252405,0.00051632576,0.00045083588],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045625912,0.00035951802,0.0009911888,0.00037103365,0.000113330825,0.000018251621,0.00015820564,0.00015776893,0.00004937888],"category_scores_gemma":[0.00065566046,0.00033747265,0.0022804756,0.00069455657,0.00010832397,0.00012825779,0.00023267047,0.00034540298,0.000030542895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012049425,0.0010406678,0.9204521,0.007006637,0.0076663783,0.003542871,0.0035920811,0.00013094467,0.00006906687,0.0001697333,0.0011520144,0.05397256],"study_design_scores_gemma":[0.0100371605,0.000121933976,0.97831506,0.0011283801,0.0028712992,0.000013673167,0.0027056944,0.0001743517,0.0011117397,0.000024877283,0.0031209367,0.00037487934],"about_ca_topic_score_codex":0.00044409026,"about_ca_topic_score_gemma":0.00003183506,"teacher_disagreement_score":0.057862975,"about_ca_system_score_codex":0.0003250098,"about_ca_system_score_gemma":0.00074321625,"threshold_uncertainty_score":0.99990773},"labels":[],"label_agreement":null},{"id":"W4413970793","doi":"10.1016/j.jacc.2025.08.043","title":"Lipoprotein(a) Levels and Time to Cardiovascular Benefit With Alirocumab in Patients With Recent Acute Coronary Syndrome","year":2025,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Alirocumab; Cardiology; Internal medicine; Intensive care medicine; Lipoprotein; Cholesterol","score_opus":0.005910957936600971,"score_gpt":0.22433303452125258,"score_spread":0.21842207658465163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413970793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500823,0.001137976,0.00029537125,0.0019386103,0.000084449865,0.0010705825,0.000059023227,0.0000057254206,0.00040004746],"genre_scores_gemma":[0.997386,0.0001848769,0.001441681,0.00064293435,0.000055861194,0.00001906391,0.000001441648,0.000024372697,0.0002438094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798924,0.00026704484,0.00050760974,0.0002563824,0.0006794925,0.0003002383],"domain_scores_gemma":[0.9982535,0.000047681497,0.0003433125,0.0007086473,0.000491607,0.00015525526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077309296,0.00021262154,0.0019287772,0.00029435023,0.000060510574,0.0000044669787,0.00022734585,0.00005847493,0.000007636021],"category_scores_gemma":[0.00006309702,0.0001216402,0.00043535352,0.00091368414,0.00028846643,0.000056845387,0.00012868016,0.00032881615,0.0000014995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025158899,0.00038667853,0.79185915,0.00040035433,0.039803844,0.0044683157,0.00012136692,0.005613781,0.0004261762,0.00013543236,0.0020293791,0.1295966],"study_design_scores_gemma":[0.0049605174,0.004953835,0.9739934,0.00043397688,0.0012330515,0.004134014,0.00007953439,0.0000030576819,0.00011701355,0.00003830729,0.0099174315,0.00013586054],"about_ca_topic_score_codex":0.000057066452,"about_ca_topic_score_gemma":0.0000063269244,"teacher_disagreement_score":0.18213423,"about_ca_system_score_codex":0.00022325639,"about_ca_system_score_gemma":0.0004620568,"threshold_uncertainty_score":0.49603435},"labels":[],"label_agreement":null},{"id":"W4413999541","doi":"10.3389/fendo.2025.1687649","title":"Editorial: Endocrinology, lipids, and disease: unraveling the links","year":2025,"lang":"en","type":"editorial","venue":"Frontiers in Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Disease; Medicine; Endocrinology; Bioinformatics; Internal medicine; Computational biology; Physiology; Biology","score_opus":0.006590630300199,"score_gpt":0.26198026613824316,"score_spread":0.25538963583804414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413999541","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006362331,0.046634424,0.0007482443,0.0044366526,0.94549143,0.0013511009,0.00017892364,0.00013991293,0.0009556584],"genre_scores_gemma":[0.00019704756,0.03721343,0.000983209,0.0005360542,0.95766276,0.0003819647,0.00041451372,0.00007797541,0.0025330216],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995338,0.00047057946,0.00077381387,0.0011575329,0.00091172056,0.0013483418],"domain_scores_gemma":[0.9970805,0.00049248524,0.00021324588,0.0015455136,0.00030392635,0.0003643397],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0005846071,0.0006193709,0.0016819275,0.0006303437,0.00023304882,0.00004895236,0.000526176,0.001831964,0.00001567267],"category_scores_gemma":[0.003804113,0.00047554748,0.00042349074,0.00036268216,0.0006125048,0.000056869467,0.0004963551,0.0055751386,0.000008066899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045061007,0.00006880054,0.0019280114,0.0007133438,0.0005675681,0.00027563144,0.000060723618,0.0000040271743,0.0000013108507,0.0002719012,0.9679243,0.027733766],"study_design_scores_gemma":[0.0030370846,0.00017065433,0.00070413854,0.00040101595,0.0007075502,0.000036930236,0.00017376721,0.00003111761,0.0000076362885,0.0012691161,0.9931076,0.0003533802],"about_ca_topic_score_codex":0.0006715064,"about_ca_topic_score_gemma":0.00005658192,"teacher_disagreement_score":0.027380385,"about_ca_system_score_codex":0.0003985578,"about_ca_system_score_gemma":0.0024311426,"threshold_uncertainty_score":0.9997696},"labels":[],"label_agreement":null},{"id":"W4414013033","doi":"10.1016/j.lpmfor.2025.100712","title":"Évaluation du risque cardiovasculaire lié aux lipides : quels éléments privilégier ?","year":2025,"lang":"fr","type":"article","venue":"La Presse Médicale Formation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fédération des Maisons D'Hébergement pour Femmes","funders":"","keywords":"Medicine","score_opus":0.022690332452547656,"score_gpt":0.28142188837997567,"score_spread":0.258731555927428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414013033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27249116,0.25615406,0.22452888,0.026397645,0.00987078,0.007857454,0.00013874292,0.0006385747,0.2019227],"genre_scores_gemma":[0.94350296,0.033649188,0.0015353985,0.0014970431,0.0032293913,0.0006643358,0.000401263,0.00007185468,0.015448553],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951772,0.0012693971,0.0009720542,0.00050066604,0.0013104466,0.00077020563],"domain_scores_gemma":[0.9976797,0.00017596758,0.00022611443,0.0011272132,0.0004476456,0.0003433361],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042563854,0.000395258,0.00081271905,0.0002652388,0.00044446698,0.00017277508,0.000243445,0.00062977924,0.000517642],"category_scores_gemma":[0.0009304979,0.00038049906,0.0008294223,0.00060553494,0.00021802366,0.00083414844,0.00019507484,0.000606709,0.0002640134],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011089603,0.00048187794,0.0018847658,0.004800705,0.0013981925,0.00004219257,0.0015850856,0.0010467306,0.00018109634,0.008274968,0.022645835,0.95754766],"study_design_scores_gemma":[0.0042557805,0.00014994231,0.052486937,0.003913918,0.0020521476,0.0001143574,0.00043643374,0.032849915,0.005306799,0.0019235293,0.89608806,0.00042217263],"about_ca_topic_score_codex":0.0011254834,"about_ca_topic_score_gemma":0.00007792747,"teacher_disagreement_score":0.9571255,"about_ca_system_score_codex":0.0006779541,"about_ca_system_score_gemma":0.0010758871,"threshold_uncertainty_score":0.9998647},"labels":[],"label_agreement":null},{"id":"W4414104862","doi":"10.1016/j.cjco.2025.09.003","title":"Spectrum of DNA Variants in Southwestern Ontario Patients with Familial Hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"CJC Open","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Familial hypercholesterolemia; DNA; Genetic variants; Genetic variation; Genetic diversity; Allele; Genome; Diversity (politics)","score_opus":0.011441990071120012,"score_gpt":0.2526655476976169,"score_spread":0.2412235576264969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414104862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98373073,0.000026165424,0.000056415134,0.00017729666,0.00011113861,0.0011835463,0.000008907364,0.000007665767,0.014698143],"genre_scores_gemma":[0.99718595,0.000003545971,0.0002482,0.0004477002,0.00003081292,0.000028639255,0.000026291018,0.000012155508,0.002016719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989898,0.000045576617,0.00025254238,0.00025326147,0.0002549901,0.00020378166],"domain_scores_gemma":[0.99928194,0.000008598506,0.000050122675,0.00053975603,0.000049121758,0.00007043758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029253677,0.00011236466,0.00050402986,0.000093730414,0.000027307004,0.000023557892,0.00020798946,0.00007073433,0.000071422655],"category_scores_gemma":[0.000014633376,0.000084773055,0.00006087771,0.00018833284,0.000031205283,0.000099308054,0.00016408962,0.00018810187,0.00001366972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006546803,0.00024720115,0.9915872,0.000090373906,0.000114815935,0.00002775733,0.00055387244,0.0000027855765,0.00005877773,0.00007700883,0.00005648247,0.006529042],"study_design_scores_gemma":[0.0075987447,0.00029161034,0.9894188,0.0004394063,0.00006875968,0.0000038586554,0.00007090941,0.0000024942333,0.00026147673,0.00007071141,0.0016958528,0.00007737447],"about_ca_topic_score_codex":0.053830486,"about_ca_topic_score_gemma":0.089548424,"teacher_disagreement_score":0.03571794,"about_ca_system_score_codex":0.00019722607,"about_ca_system_score_gemma":0.0006128038,"threshold_uncertainty_score":0.9524701},"labels":[],"label_agreement":null},{"id":"W4414439546","doi":"10.1016/j.ajpc.2025.101190","title":"BASELINE CHARACTERISTICS AND RESPONSE TO EVINACUMAB IN WOMEN AND MEN WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN THE ELIPSE OLE STUDY","year":2025,"lang":"en","type":"article","venue":"American Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Familial hypercholesterolemia; Clinical endpoint; Cohort; Primary prevention; Lipoprotein(a); Lipoprotein; Atherosclerotic cardiovascular disease","score_opus":0.006191064000567,"score_gpt":0.2784234874468793,"score_spread":0.27223242344631227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414439546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970016,0.00044089556,0.0004874124,0.0012389931,0.000034972818,0.0007075465,0.00000613159,0.0000024725646,0.000079977195],"genre_scores_gemma":[0.99835074,0.00027542337,0.00019167725,0.00097487454,0.00010337934,0.000052655458,7.1806363e-7,0.00000908522,0.00004147384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966842,0.0022604028,0.00040724527,0.00020905286,0.00019820512,0.00024092438],"domain_scores_gemma":[0.99908906,0.00027102084,0.00013724923,0.00025343115,0.00014259141,0.00010663068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004958601,0.0001343141,0.00092525873,0.00030514383,0.000034048793,0.000012411649,0.00010171592,0.000033788514,0.0000011220353],"category_scores_gemma":[0.000429948,0.00008369316,0.00006462766,0.00037842453,0.00018066156,0.00004144316,0.00006251763,0.00038748124,3.6503778e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028004406,0.0003544186,0.61085355,0.00006109891,0.0008134164,0.0034441685,0.016970415,0.00002022355,0.0009092078,0.000005842056,0.000125558,0.33843768],"study_design_scores_gemma":[0.0036536974,0.0063167186,0.9622737,0.00016819437,0.00012424168,0.0013504474,0.024955876,0.0000049512814,0.000004677744,0.000018605364,0.0010560212,0.00007285151],"about_ca_topic_score_codex":0.00011097662,"about_ca_topic_score_gemma":0.000026526406,"teacher_disagreement_score":0.35142016,"about_ca_system_score_codex":0.00018000574,"about_ca_system_score_gemma":0.00025574927,"threshold_uncertainty_score":0.3412908},"labels":[],"label_agreement":null},{"id":"W4414439823","doi":"10.1016/j.ajpc.2025.101131","title":"SAFETY AND EFFICACY OF OBICETRAPIB IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA","year":2025,"lang":"en","type":"article","venue":"American Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tolerability; Placebo; Familial hypercholesterolemia; Clinical endpoint; Adverse effect; Clinical trial; Apolipoprotein B","score_opus":0.004208194437454932,"score_gpt":0.24810938835387336,"score_spread":0.24390119391641843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414439823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965857,0.0005830853,0.001921982,0.00010683803,0.00010508132,0.00031042937,0.00000659922,0.0000028017396,0.00037744982],"genre_scores_gemma":[0.9988754,0.0002803761,0.00056108885,0.00017972098,0.00007120567,0.0000023041346,0.000003212625,0.000008945978,0.00001777433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985672,0.0003954927,0.0004898682,0.00016312454,0.0002006345,0.00018363765],"domain_scores_gemma":[0.9990636,0.00009452441,0.00028768336,0.00020742012,0.00026203925,0.00008473363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005786317,0.00011945679,0.0010915707,0.00024015135,0.0000198672,0.0000024392093,0.00007524173,0.000050246992,0.000002052323],"category_scores_gemma":[0.00010530396,0.00008569688,0.00022623151,0.00026784398,0.0003581132,0.000043233526,0.00003713246,0.00030157462,2.7334855e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004685641,0.000124804,0.7859264,0.00006165493,0.0010207257,0.00006029317,0.00017696786,0.000056067976,0.00016517259,0.000019625168,0.000017018598,0.2076856],"study_design_scores_gemma":[0.007745945,0.003328262,0.9872971,0.00030112633,0.0002653873,0.0001271032,0.0002542964,0.0000010116245,0.00006716793,0.000014594068,0.00053615245,0.00006184593],"about_ca_topic_score_codex":0.00005643072,"about_ca_topic_score_gemma":0.00000442443,"teacher_disagreement_score":0.20762375,"about_ca_system_score_codex":0.0000901845,"about_ca_system_score_gemma":0.00018599888,"threshold_uncertainty_score":0.34946176},"labels":[],"label_agreement":null},{"id":"W4414516593","doi":"10.1161/atvbaha.124.322336","title":"Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy","year":2025,"lang":"en","type":"article","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; St. Michael's Hospital","funders":"","keywords":"PCSK9; Cardiovascular event; Mace; Apolipoprotein B; Multiplex; Lipoprotein(a); Disease; Acute coronary syndrome","score_opus":0.03666562005713214,"score_gpt":0.2768323941298696,"score_spread":0.24016677407273745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414516593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96803045,0.024282606,0.0039032982,0.00023458232,0.0006283613,0.002424515,0.00030832566,0.00015492874,0.000032910353],"genre_scores_gemma":[0.9718829,0.025508199,0.00046940087,0.0007052907,0.0003339239,0.00045494197,0.00054847,0.000081210404,0.000015670897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99552417,0.0004284243,0.0010165276,0.0015789433,0.00066637376,0.0007855477],"domain_scores_gemma":[0.9975179,0.000055522814,0.0001639398,0.0016451769,0.00025828672,0.0003591883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011805405,0.00069217285,0.002175913,0.00026724857,0.00052865915,0.00013702967,0.00020492754,0.00062093104,0.000029791263],"category_scores_gemma":[0.00009964088,0.00058862066,0.0020070865,0.00036907208,0.0002557728,0.00023634583,0.0002910807,0.00043028896,0.0000074342074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059597503,0.0005822796,0.7416941,0.00047843982,0.023386104,6.123962e-7,0.0005468023,0.000009515821,0.12014725,0.00009911129,0.0003276122,0.1126686],"study_design_scores_gemma":[0.008069795,0.0004933186,0.9655908,0.00031332325,0.001611087,9.921946e-7,0.00018785798,0.00019625478,0.002982646,0.000114935305,0.019943198,0.0004958019],"about_ca_topic_score_codex":0.0052054725,"about_ca_topic_score_gemma":0.000044733148,"teacher_disagreement_score":0.22389673,"about_ca_system_score_codex":0.00014023512,"about_ca_system_score_gemma":0.000062390114,"threshold_uncertainty_score":0.9996565},"labels":[],"label_agreement":null},{"id":"W4414518231","doi":"10.1016/j.jacl.2025.09.029","title":"Implementation strategies to optimize the use of nonstatin add-on lipid-lowering therapies in individuals with dyslipidemia: A systematic review","year":2025,"lang":"en","type":"review","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"Merck","keywords":"Health care; Healthcare system; MEDLINE; Disease; Precision medicine","score_opus":0.18304526005787433,"score_gpt":0.49081854047386564,"score_spread":0.3077732804159913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414518231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000086758686,0.99167025,0.0008386789,0.0012156105,0.0009073513,0.005196192,0.000031135383,0.000007684501,0.00004636165],"genre_scores_gemma":[0.00003100182,0.99112374,0.004696421,0.0025579615,0.001274724,0.00023023,0.000012838128,0.00003519648,0.0000378684],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98787904,0.0041227587,0.0065625077,0.00033980873,0.00075843115,0.0003374683],"domain_scores_gemma":[0.98592895,0.008292483,0.0043144748,0.0008552628,0.0004250062,0.00018382825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01346501,0.00042312054,0.009538798,0.00045992032,0.000041806023,0.000035399084,0.00041165575,0.00039911713,0.00006172281],"category_scores_gemma":[0.006211823,0.00019919206,0.0017705181,0.00069053343,0.00012691812,0.00012390332,0.00009190534,0.0016567662,0.0000052576606],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001564404,0.00016916805,0.00011395377,0.7129814,0.002504064,0.0000269704,0.00011222173,0.0000327372,4.455757e-8,0.00016627656,0.0028731253,0.28086358],"study_design_scores_gemma":[0.0015382477,0.0025649113,0.00017293784,0.75856674,0.0078106658,0.00035676363,0.00028652363,0.0000010084393,2.1040997e-7,0.000011206105,0.22851594,0.00017482525],"about_ca_topic_score_codex":0.000036493457,"about_ca_topic_score_gemma":0.00008091511,"teacher_disagreement_score":0.28068876,"about_ca_system_score_codex":0.000105919615,"about_ca_system_score_gemma":0.0027374297,"threshold_uncertainty_score":0.8122816},"labels":[],"label_agreement":null},{"id":"W4414714155","doi":"10.1016/j.cjca.2025.08.170","title":"P259 FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA: SEX DIFFERENCES IN DIAGNOSIS, MANAGEMENT AND OUTCOMES FROM THE FH CANADA REGISTRY","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Atherosclerotic cardiovascular disease; Disease; Genetic disorder; Patient registry; Epidemiology","score_opus":0.012863237970280252,"score_gpt":0.2181042730949429,"score_spread":0.20524103512466266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414714155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98343736,0.0053840904,0.000021963971,0.00886602,0.0006435045,0.0002219,0.000044940894,8.737464e-7,0.0013793237],"genre_scores_gemma":[0.9958406,0.00075961195,0.000020605346,0.0030553339,0.00021191553,0.000015628117,0.0000042241145,0.000006144404,0.000085927306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986655,0.00022159387,0.00040674038,0.00016620764,0.00020431301,0.0003356472],"domain_scores_gemma":[0.99913573,0.00016283724,0.000072289266,0.00029081377,0.000044107892,0.00029419234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040539773,0.00012954701,0.00071876834,0.00013390576,0.000055229368,0.0000121952335,0.0001939655,0.00007645882,0.0000056785143],"category_scores_gemma":[0.00011989956,0.000089183464,0.00008461947,0.00014236165,0.00007121813,0.000022178401,0.000023740913,0.00044199766,1.0647801e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015228857,8.734695e-7,0.9742423,0.000025930882,0.0002487556,0.0014154239,0.000047446312,0.000050762676,5.563183e-7,0.000029902118,0.0087168515,0.01520594],"study_design_scores_gemma":[0.0011000587,0.000019944471,0.9464081,0.00016526783,0.00008650776,0.000081453916,0.0014393292,0.0000034282045,0.0000027739727,0.00006069752,0.05056619,0.000066268054],"about_ca_topic_score_codex":0.9995472,"about_ca_topic_score_gemma":0.9999614,"teacher_disagreement_score":0.041849338,"about_ca_system_score_codex":0.0016336978,"about_ca_system_score_gemma":0.01309641,"threshold_uncertainty_score":0.9924984},"labels":[],"label_agreement":null},{"id":"W4414714227","doi":"10.1016/j.cjca.2025.08.177","title":"P266 PHASE 1 RESULTS FROM THE ADVANCING CARDIAC CARE UNIT-BASED RAPID ASSESSMENT AND TREATMENT OF HYPERCHOLESTEROLEMIA (ACCURATE) STUDY","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Acute coronary syndrome; Disease; Genetic testing; Clinical trial; Atherosclerotic cardiovascular disease","score_opus":0.02873880907679542,"score_gpt":0.3349624220680372,"score_spread":0.3062236129912418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414714227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839339,0.011377669,0.00051715533,0.0013210401,0.0006165253,0.000757147,0.00027102703,0.0000040832347,0.0012014117],"genre_scores_gemma":[0.9984153,0.00045259978,0.00020894114,0.00023180722,0.0006047336,0.000014883737,0.000043874985,0.000012821723,0.000015031637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805,0.0006764869,0.00058170286,0.00021246485,0.00018943139,0.0002899513],"domain_scores_gemma":[0.9981829,0.0002646181,0.00019292985,0.00055955397,0.00039942606,0.00040060177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008723225,0.00017411557,0.0010225784,0.00020865422,0.00014098384,0.000017228736,0.00011515535,0.00010432008,0.000003984674],"category_scores_gemma":[0.00013930946,0.0001126644,0.00038138853,0.00017441234,0.00012659848,0.000037130645,0.000010668947,0.00025344617,3.485709e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014537413,0.00008073455,0.5044703,0.00008788039,0.0052414727,0.00096042204,0.0041219625,0.001885911,0.0007007617,0.000031212574,0.0017665594,0.47919908],"study_design_scores_gemma":[0.02583464,0.0060206847,0.747663,0.00031985392,0.002494503,0.000090446694,0.021261455,0.000029474046,0.0004201062,0.000015313743,0.19568242,0.00016809127],"about_ca_topic_score_codex":0.010582746,"about_ca_topic_score_gemma":0.0043452214,"teacher_disagreement_score":0.479031,"about_ca_system_score_codex":0.0005148245,"about_ca_system_score_gemma":0.004476807,"threshold_uncertainty_score":0.9960059},"labels":[],"label_agreement":null},{"id":"W4414714341","doi":"10.1016/j.cjca.2025.08.054","title":"P052 SECULAR TRENDS IN THE DETECTION AND MANAGEMENT OF PEDIATRIC DYSLIPIDEMIAS IN BRITISH COLUMBIA (2000-2021)","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Secular variation; MEDLINE; Epidemiology; Risk assessment","score_opus":0.008140221892746506,"score_gpt":0.23229695144859613,"score_spread":0.22415672955584962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414714341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981587,0.0126916915,0.00038077802,0.00054420275,0.0003470815,0.00020900935,0.0000051608167,0.0000010961663,0.004233959],"genre_scores_gemma":[0.9971807,0.0020389468,0.00005095064,0.00018701714,0.00040459976,0.000007725994,0.0000016858168,0.0000052545893,0.00012309768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988899,0.000257222,0.00038769358,0.000116278905,0.00012271303,0.00022618759],"domain_scores_gemma":[0.99950933,0.000025772497,0.00008197999,0.00017735292,0.00007185132,0.00013368855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015166308,0.00005566082,0.0004643675,0.00043474746,0.000039410803,0.000018755933,0.0000865702,0.00011303965,0.000013831587],"category_scores_gemma":[0.0000525978,0.000062974636,0.0001688644,0.00063565,0.00005606624,0.000027918497,0.000009127607,0.00030181173,2.4526383e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030949595,0.0000066768453,0.5439016,0.0002858808,0.00038644628,0.002608763,0.00018968908,0.000208984,0.000012086251,0.00004254464,0.004249997,0.44807637],"study_design_scores_gemma":[0.0014661574,0.00014421764,0.9651012,0.000110179,0.00022642325,0.0010796143,0.00048536726,0.000007640897,0.0000025324823,0.00012294119,0.031206239,0.00004751101],"about_ca_topic_score_codex":0.05566791,"about_ca_topic_score_gemma":0.3609611,"teacher_disagreement_score":0.44802886,"about_ca_system_score_codex":0.00021920478,"about_ca_system_score_gemma":0.00049975154,"threshold_uncertainty_score":0.9506205},"labels":[],"label_agreement":null},{"id":"W4414714402","doi":"10.1016/j.cjca.2025.08.218","title":"P073 PREVALENCE AND PREDICTORS OF LP(A) MEASUREMENT IN YOUNGER PATIENTS FOLLOWING ST-ELEVATION MYOCARDIAL INFARCTION","year":2025,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Myocardial infarction; Atherosclerotic cardiovascular disease; Cohort; Risk stratification; Disease; Cohort study","score_opus":0.01235962873830567,"score_gpt":0.2326891731363548,"score_spread":0.2203295443980491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414714402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936242,0.0028030376,0.0005019132,0.00032193356,0.001210692,0.0003392203,0.000008669312,0.0000021559963,0.001188196],"genre_scores_gemma":[0.99926734,0.0002252224,0.00003514738,0.00012949981,0.00031555584,0.0000059067866,0.0000035516052,0.000006239053,0.000011565773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876106,0.00018503114,0.00042844465,0.000118513126,0.0003091473,0.00019778541],"domain_scores_gemma":[0.9990887,0.000018467243,0.00012534147,0.00015204343,0.00041238838,0.00020307122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013957722,0.00008570864,0.0004873697,0.00044634257,0.000039005885,0.0000056099516,0.000053416225,0.00011746642,0.0000023332236],"category_scores_gemma":[0.00049616775,0.0000776013,0.00022968848,0.00019317717,0.00005764312,0.00009210403,0.000008313751,0.00020539657,2.1774278e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006243255,0.0000031941456,0.99076563,0.00013608737,0.0005169349,0.000017747809,0.000088548775,0.00011740239,0.00011915796,0.000048711223,0.00045623488,0.007667893],"study_design_scores_gemma":[0.0017577064,0.0002755538,0.98640126,0.000320204,0.00029054418,0.000031391613,0.000052725925,0.0000039666843,0.000041618543,0.00007577467,0.010700668,0.000048605925],"about_ca_topic_score_codex":0.0009997168,"about_ca_topic_score_gemma":0.0004964449,"teacher_disagreement_score":0.010244434,"about_ca_system_score_codex":0.0004268661,"about_ca_system_score_gemma":0.0014592522,"threshold_uncertainty_score":0.3164489},"labels":[],"label_agreement":null},{"id":"W4414717540","doi":"10.1016/j.lanwpc.2025.101696","title":"Trends of lipid-lowering drug utilization, treatment intensity and LDL-C target attainment in adults with diabetes and non-dialysis chronic kidney disease in Hong Kong","year":2025,"lang":"en","type":"article","venue":"The Lancet Regional Health - Western Pacific","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Chinese University of Hong Kong","keywords":"Diabetes mellitus; Kidney disease; Drug; Intensity (physics); Population; Disease","score_opus":0.018773676483022445,"score_gpt":0.2812812479438388,"score_spread":0.2625075714608164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414717540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739467,0.0074285427,0.00006389026,0.017686712,0.000050933948,0.0006993938,0.00002469498,0.000016519141,0.00008264378],"genre_scores_gemma":[0.9937614,0.0049431473,0.000057294175,0.00074735144,0.00017268387,0.000094955605,0.00007788759,0.000012519089,0.00013275754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998503,0.00012416067,0.0003663186,0.00036572252,0.00026003685,0.00038070866],"domain_scores_gemma":[0.9990779,0.00005101536,0.00012255915,0.00044631286,0.00004835407,0.00025386093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060889806,0.00019340792,0.0007788027,0.00024065543,0.000090365254,0.000013289793,0.000060690996,0.00003950819,0.0000031012214],"category_scores_gemma":[0.000017384284,0.00012508848,0.000069646725,0.00044842754,0.0001412508,0.00005843736,0.000036853082,0.00015005944,3.264844e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090732606,0.00014316877,0.97639215,0.001816063,0.00010115538,0.000012617168,0.0019401583,0.00005387552,0.000006193513,0.000025744304,0.00017020333,0.018431338],"study_design_scores_gemma":[0.0049364218,0.00032467622,0.98860145,0.003094712,0.00005585285,0.000004224609,0.0004887761,0.001054429,0.0000496259,0.000036529385,0.0012483539,0.00010496252],"about_ca_topic_score_codex":0.0008639192,"about_ca_topic_score_gemma":0.0010929389,"teacher_disagreement_score":0.019814733,"about_ca_system_score_codex":0.0004439904,"about_ca_system_score_gemma":0.00053956395,"threshold_uncertainty_score":0.510096},"labels":[],"label_agreement":null},{"id":"W4414788525","doi":"10.1177/25424823251385903","title":"Statins, cholesterol and cognition at the time of Alzheimer's disease diagnosis: A cross-sectional study from the Swedish registry for cognitive/dementia disorders","year":2025,"lang":"en","type":"article","venue":"Journal of Alzheimer s Disease Reports","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"Demensfonden; NextGenerationEU; Emil och Wera Cornells Stiftelse; Parkinsonfonden; Forskningsrådet om Hälsa, Arbetsliv och Välfärd; Vetenskapsrådet; Gun och Bertil Stohnes Stiftelse; Hjärnfonden; Stiftelsen för Gamla Tjänarinnor; Stockholms Läns Landsting; Karolinska Institutet","keywords":"Cognition; Disease; Cognitive decline; Longitudinal study; Simvastatin; Cholesterol; Atherosclerotic cardiovascular disease","score_opus":0.020296500077823246,"score_gpt":0.3167052604572956,"score_spread":0.29640876037947234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414788525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9255766,0.069514826,0.000106782376,0.001579868,0.0003543327,0.0024550185,0.000355166,0.000012604112,0.000044778986],"genre_scores_gemma":[0.9976831,0.0007348062,0.000025099549,0.000663211,0.0003778173,0.00031145112,0.0001473226,0.000027883712,0.000029296529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707896,0.00022466926,0.0011518383,0.00037087206,0.00094287767,0.00023081231],"domain_scores_gemma":[0.9970761,0.00030270856,0.0010798662,0.0005262939,0.0006278336,0.00038719055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014168089,0.00023087207,0.0004953436,0.00008190464,0.00036939475,0.000093520284,0.00009495275,0.00005195151,0.00008912639],"category_scores_gemma":[0.00063803664,0.00014069257,0.0006204326,0.00015616372,0.00028070653,0.00018707429,0.000105176056,0.00024400797,0.0000013180185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018340073,0.0011374146,0.97539365,0.00008476783,0.01161803,0.00030048893,0.00014365352,0.000013164484,0.000018370849,0.0000024195128,0.0021562942,0.007297717],"study_design_scores_gemma":[0.0033129244,0.0002736987,0.96972233,0.0004667968,0.024133483,0.00008414267,0.00036114056,0.000024534456,0.00015035017,0.00050587987,0.00084056077,0.00012412886],"about_ca_topic_score_codex":0.00016469814,"about_ca_topic_score_gemma":0.000035153043,"teacher_disagreement_score":0.07210649,"about_ca_system_score_codex":0.000032683816,"about_ca_system_score_gemma":0.0006852559,"threshold_uncertainty_score":0.57372767},"labels":[],"label_agreement":null},{"id":"W4414966768","doi":"10.1093/pch/pxaf040","title":"Current practices, attitudes and barriers to paediatric lipid screening and management amongst Family Physicians and Paediatricians in British Columbia","year":2025,"lang":"en","type":"article","venue":"Paediatrics & Child Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Psychological intervention; Clinical Practice; Odds; Knowledge translation; MEDLINE; Alternative medicine","score_opus":0.00974351864462595,"score_gpt":0.2747650085890186,"score_spread":0.2650214899443926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414966768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8035356,0.18357912,0.00082837144,0.007091636,0.00055444456,0.0036417057,0.0000850949,0.000119564706,0.0005644594],"genre_scores_gemma":[0.70296127,0.28370377,0.0033209394,0.008542636,0.0011294617,0.00017467905,0.000037979058,0.000053959997,0.00007532109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966291,0.00023638348,0.0007062359,0.0009837699,0.000600578,0.00084390445],"domain_scores_gemma":[0.99804765,0.00014336486,0.0003470254,0.0004339554,0.00009654963,0.0009314535],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018528489,0.0002756564,0.00085013383,0.0005388032,0.0006702772,0.00031344758,0.00012308483,0.00014367315,0.000004479781],"category_scores_gemma":[0.0004043675,0.00039302465,0.0001221111,0.0017340963,0.000085422835,0.00019029745,0.0003144674,0.00071887544,0.0000019437364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002497502,0.00011084172,0.5871969,0.0024796247,0.00007241496,0.00004149767,0.00026814986,0.000004458056,3.2357514e-7,0.000041852614,0.0048299916,0.40492895],"study_design_scores_gemma":[0.0027984343,0.00026428202,0.95351756,0.0007491731,0.00026731016,0.000046484543,0.0010281808,0.00007680663,1.9461072e-7,0.00003667346,0.04091346,0.000301435],"about_ca_topic_score_codex":0.025678605,"about_ca_topic_score_gemma":0.03307867,"teacher_disagreement_score":0.40462753,"about_ca_system_score_codex":0.00022240376,"about_ca_system_score_gemma":0.0004412366,"threshold_uncertainty_score":0.9998522},"labels":[],"label_agreement":null},{"id":"W4415008749","doi":"10.3390/children12101364","title":"Screening for Familial Hypercholesterolemia in Childhood: An Overview of Current Practices Around the World","year":2025,"lang":"en","type":"review","venue":"Children","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Disease; Atherosclerotic cardiovascular disease; Developed country; Cause of death; Genetic testing; Genetic diagnosis","score_opus":0.15923492795021807,"score_gpt":0.44379879095224034,"score_spread":0.2845638630020223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415008749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000539122,0.99335057,0.00005335564,0.000084307016,0.00024217238,0.0053492095,0.00015461973,0.000024796258,0.0002018378],"genre_scores_gemma":[0.000080530546,0.99681365,0.0003280945,0.00017503025,0.0013972594,0.00041565878,0.0006316922,0.00005109867,0.0001069793],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974209,0.00040216162,0.0008465402,0.0005562918,0.0004284375,0.00034569137],"domain_scores_gemma":[0.9976054,0.00027698796,0.00076718366,0.0011707393,0.000066991124,0.00011272775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015267004,0.00039638954,0.0022062538,0.0003362402,0.000091202455,0.00003713057,0.00040719454,0.00018829839,0.000008002574],"category_scores_gemma":[0.00032542847,0.00024597728,0.0011066602,0.0006350564,0.000058611615,0.00011556571,0.00012588335,0.0008998806,0.0000026908733],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017773673,0.00018091063,0.00044911756,0.024692917,0.00037080102,0.0000012054558,0.00004796007,9.028928e-7,2.781551e-8,0.00011122653,0.00017410067,0.97395307],"study_design_scores_gemma":[0.0013005927,0.00013490077,0.014248948,0.072579704,0.0032817305,0.00007174541,0.00002519086,0.0000029965336,6.885009e-7,0.000029961471,0.9080726,0.00025097778],"about_ca_topic_score_codex":0.0002669601,"about_ca_topic_score_gemma":0.0002693046,"teacher_disagreement_score":0.9737021,"about_ca_system_score_codex":0.00009941662,"about_ca_system_score_gemma":0.0009401512,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W4415103943","doi":"10.1016/j.jacl.2025.09.024","title":"JCL Roundtable: Novel therapies in lipid management","year":2025,"lang":"en","type":"article","venue":"Journal of clinical lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cholesterylester transfer protein; Chylomicron; Atherosclerotic cardiovascular disease; Apolipoprotein B; Lipoprotein; Adverse effect","score_opus":0.07530817419162966,"score_gpt":0.4257603828759231,"score_spread":0.35045220868429344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415103943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85408264,0.00785488,0.030800989,0.054241434,0.024946973,0.0009992048,0.0000031510765,0.000035981586,0.027034722],"genre_scores_gemma":[0.9413917,0.007636506,0.01585709,0.014607608,0.009956764,0.000013771111,0.0000023393966,0.000026508947,0.010507678],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973266,0.00027454272,0.0016523044,0.00018636009,0.0003002559,0.00025995166],"domain_scores_gemma":[0.9985669,0.0004051128,0.00036063205,0.00035912177,0.00017646048,0.00013172814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049519204,0.00011667473,0.001109843,0.00028646277,0.00002920488,0.000017237586,0.00017065518,0.00022685525,0.000060459646],"category_scores_gemma":[0.0007091191,0.00008298353,0.0005537752,0.00031513642,0.00008008076,0.000109225984,0.00006924858,0.0007723422,0.000008996226],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005131351,0.0036789502,0.20920497,0.00082952465,0.0040314863,0.00038446535,0.00015751035,0.000071569266,0.00032183493,0.030637221,0.02976401,0.7157871],"study_design_scores_gemma":[0.009142283,0.00090575987,0.34099287,0.0003884207,0.00025611403,0.00031200078,0.000164229,0.000023404446,0.000026514357,0.0012614209,0.64644414,0.00008280962],"about_ca_topic_score_codex":0.000030068219,"about_ca_topic_score_gemma":0.00002703424,"teacher_disagreement_score":0.7157043,"about_ca_system_score_codex":0.000094451774,"about_ca_system_score_gemma":0.0003320541,"threshold_uncertainty_score":0.33839703},"labels":[],"label_agreement":null},{"id":"W4415146929","doi":"10.1111/cge.70064","title":"<scp>ApoE</scp> Polymorphism Analysis in Health and Disease of South Asian Populations: A Systematic Review and Meta‐Analysis","year":2025,"lang":"en","type":"review","venue":"Clinical Genetics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; South asia; Public health; Meta-analysis; Apolipoprotein E; Ethnic group; Genetic association; Mental health; Genotype","score_opus":0.13916865348474558,"score_gpt":0.43790048438969226,"score_spread":0.2987318309049467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415146929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009543343,0.9942463,0.0004447775,0.00036606638,0.000032478976,0.0046046865,0.00024880157,0.000015681519,0.000031639738],"genre_scores_gemma":[0.00009633441,0.9962974,0.0011662279,0.0012739627,0.00005155593,0.00028977668,0.00032034604,0.000030692467,0.00047370803],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9917492,0.0022980105,0.00425846,0.0008379446,0.0005268144,0.0003295405],"domain_scores_gemma":[0.9947372,0.0006670265,0.0015700547,0.0018007996,0.00014043799,0.0010844484],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0040815524,0.00047627735,0.017564798,0.001005895,0.00005713358,0.000021941023,0.00018129217,0.00032464595,0.000012466966],"category_scores_gemma":[0.004345498,0.0003302299,0.006575885,0.0036737889,0.00013725905,0.00001580865,0.0001570714,0.0004916479,0.0000023290604],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001223877,0.00009269436,0.00085613236,0.8419887,0.1479108,0.000011399509,0.00002812069,0.0000016893036,1.3875036e-10,0.000038427963,0.000027693923,0.009043142],"study_design_scores_gemma":[0.00024503347,0.00009125891,0.0010880358,0.069760606,0.9230352,0.000005403841,0.0000327791,0.000037530408,1.4034943e-9,0.000036843598,0.0055654347,0.00010188805],"about_ca_topic_score_codex":0.00007728245,"about_ca_topic_score_gemma":0.00005653265,"teacher_disagreement_score":0.7751244,"about_ca_system_score_codex":0.000054268952,"about_ca_system_score_gemma":0.0013909535,"threshold_uncertainty_score":0.999915},"labels":[],"label_agreement":null},{"id":"W4415267843","doi":"10.33393/grhta.2025.3503","title":"Estimation of patients potentially eligible for icosapent ethyl therapy in Italy through a review of literature data","year":2025,"lang":"it","type":"review","venue":"Global & Regional Health Technology Assessment","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Hypertriglyceridemia; Reimbursement; Medical prescription; Residual risk; Estimation; Triglyceride; Primary care; Clinical Practice","score_opus":0.053666433711674795,"score_gpt":0.4474086683705294,"score_spread":0.3937422346588546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415267843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006476212,0.9577154,0.007601828,0.014821641,0.0005858283,0.015440146,0.0035333594,0.00005563293,0.000181397],"genre_scores_gemma":[0.0005876516,0.95739055,0.023225082,0.0030576678,0.000101864556,0.0010569812,0.014509671,0.000039443137,0.000031080046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913488,0.00071989524,0.003845732,0.0015374993,0.0015849477,0.0009631388],"domain_scores_gemma":[0.9921535,0.00019086816,0.002959065,0.0033851913,0.0011379252,0.0001734311],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003707796,0.00084827485,0.0055104294,0.0005238437,0.00015479502,0.000015393573,0.0014737198,0.0013506823,0.000022728891],"category_scores_gemma":[0.00047827832,0.00070022757,0.0010507695,0.0033426406,0.00028551414,0.00020472052,0.0006206392,0.0011947525,0.0000038935354],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011166791,0.0011714429,0.00019111639,0.3231099,0.00062085636,0.000007630059,0.000012171905,0.0000031556108,6.1680595e-8,0.011130287,0.0057492736,0.65789247],"study_design_scores_gemma":[0.0036526439,0.0025113272,0.001361166,0.45997655,0.0007589619,0.000045541557,0.00004323892,0.00006271485,0.0000012185418,0.0020865188,0.5291417,0.0003583861],"about_ca_topic_score_codex":0.00046008994,"about_ca_topic_score_gemma":0.000034639335,"teacher_disagreement_score":0.65753406,"about_ca_system_score_codex":0.00183222,"about_ca_system_score_gemma":0.013080124,"threshold_uncertainty_score":0.99994576},"labels":[],"label_agreement":null},{"id":"W4415449915","doi":"10.1210/jendso/bvaf149.803","title":"SAT-248 A Case Series of Heterozygous Familial Hypercholesteremia With PCSK9 Inhibitor Failure","year":2025,"lang":"en","type":"article","venue":"Journal of the Endocrine Society","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Evolocumab; Alirocumab; Ezetimibe; PCSK9; Familial hypercholesterolemia; Monoclonal; Statin; Dyslipidemia","score_opus":0.008194193182728052,"score_gpt":0.2508145392283521,"score_spread":0.24262034604562407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415449915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99235797,0.000962436,0.00019750049,0.005595388,0.00036183055,0.0003106046,0.000009715297,0.000010976423,0.00019360514],"genre_scores_gemma":[0.9939795,0.00013298023,0.0035736389,0.0008900462,0.00064015196,0.0000042372344,8.592828e-7,0.000017497894,0.00076107675],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99858826,0.00009068611,0.0004698079,0.00012461284,0.0005053389,0.00022126194],"domain_scores_gemma":[0.9988194,0.000030758794,0.00026641774,0.00043841868,0.00034225298,0.00010273538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003796046,0.0001563241,0.0005441957,0.000041281273,0.000121575846,0.00001642154,0.00014523993,0.0000604136,0.000009009277],"category_scores_gemma":[0.00007186307,0.00008411172,0.0009521882,0.0002797396,0.00014896411,0.00011808929,0.00009599854,0.0005981479,6.8985514e-7],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011676099,0.0038639507,0.25944832,0.016744144,0.028185787,0.034582432,0.021300826,0.000973779,0.19279894,0.0010284517,0.2727507,0.15664656],"study_design_scores_gemma":[0.029608173,0.0043454543,0.045425776,0.0052073644,0.004263303,0.49634674,0.021970952,0.000063490756,0.18373296,0.00039301472,0.2079681,0.00067466917],"about_ca_topic_score_codex":0.00009815237,"about_ca_topic_score_gemma":0.000058296602,"teacher_disagreement_score":0.4617643,"about_ca_system_score_codex":0.00014025634,"about_ca_system_score_gemma":0.0004583376,"threshold_uncertainty_score":0.34299767},"labels":[],"label_agreement":null},{"id":"W4415450658","doi":"10.1016/s2213-8587(25)00286-4","title":"Recent advances in research and care of familial hypercholesterolaemia","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Universidad de Sevilla","keywords":"Familial hypercholesterolemia; Risk stratification; Clinical Practice; Ldl cholesterol; Atherosclerotic cardiovascular disease; Cardiovascular health","score_opus":0.1133343352357879,"score_gpt":0.4203352713989604,"score_spread":0.3070009361631725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415450658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003784747,0.9913606,2.6542503e-7,0.00042954736,0.00021792062,0.0015245234,0.00006132319,0.000022933176,0.002598122],"genre_scores_gemma":[0.00039602726,0.9983918,0.0000449887,0.00013284983,0.00049041904,0.00037858722,0.000064541535,0.000024516656,0.00007624946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99671125,0.00085000065,0.0005118368,0.00045292155,0.00033004853,0.0011439614],"domain_scores_gemma":[0.9980808,0.0005230058,0.00010651255,0.0010450748,0.00018013158,0.00006450279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011007168,0.00025561143,0.002897739,0.00035297865,0.000065152446,0.000009067666,0.00035321468,0.0002226427,0.000009259938],"category_scores_gemma":[0.00031918057,0.00015680277,0.00021409614,0.0005449144,0.00039391193,0.00003283702,0.00032349443,0.0013297205,0.000005403629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023700051,0.000025913672,0.0009572839,0.03627433,0.00011801825,0.000022326782,0.00008245149,1.0974148e-7,9.539744e-7,0.00028793656,0.000090989866,0.962116],"study_design_scores_gemma":[0.0008238851,0.0002567161,0.0007287978,0.01081647,0.00028274333,0.000032724205,0.00014588573,1.9621902e-7,0.0000134766415,0.00016159768,0.98663354,0.00010396023],"about_ca_topic_score_codex":0.000038753205,"about_ca_topic_score_gemma":0.000077262885,"teacher_disagreement_score":0.9865426,"about_ca_system_score_codex":0.00016048244,"about_ca_system_score_gemma":0.0004661285,"threshold_uncertainty_score":0.63942313},"labels":[],"label_agreement":null},{"id":"W4415451133","doi":"10.1210/jendso/bvaf149.805","title":"SAT-250 Impact of Lipoprotein(a) on the Clinical Diagnosis of Familial Hypercholesterolaemia in Chinese","year":2025,"lang":"en","type":"article","venue":"Journal of the Endocrine Society","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Schulich School of Medicine and Dentistry; Robarts Research Institute; Schulich School of Medicine and Dentistry, Western University; University of Toronto","keywords":"Cohort; Genetic diagnosis; Clinical diagnosis; Cohort study; Chinese population; Population; Family history; Risk factor","score_opus":0.023834525613551816,"score_gpt":0.37214639285132195,"score_spread":0.34831186723777013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415451133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99131966,0.0009899946,0.000019777859,0.006432882,0.00039481593,0.00050893944,0.000010132865,0.0000037172151,0.00032006195],"genre_scores_gemma":[0.9965343,0.0016207484,0.0002325054,0.0009602635,0.0005291909,0.000010944771,5.943037e-7,0.000013269395,0.00009820723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975751,0.00037316154,0.0010512968,0.00013233708,0.0006456246,0.00022247303],"domain_scores_gemma":[0.998076,0.00042345384,0.000510778,0.0006676815,0.00023765533,0.00008443585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023837115,0.00016266965,0.0008376985,0.00006121935,0.00005440508,0.000007514124,0.00036632473,0.00008819003,0.000025388254],"category_scores_gemma":[0.0011988926,0.00007051729,0.0031510505,0.0004958454,0.0001728988,0.00005363007,0.00013205221,0.0010716793,8.994306e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006719485,0.00084004906,0.96360856,0.00023816158,0.0015954218,0.00001862549,0.00044899157,0.00015388776,0.0011694349,0.000068110836,0.0068793045,0.024307486],"study_design_scores_gemma":[0.0034979573,0.0007524582,0.991391,0.0007109398,0.00017404204,0.00007599513,0.00022855055,0.00004359941,0.0017548094,0.0002914781,0.0010242015,0.000054948065],"about_ca_topic_score_codex":0.0005210716,"about_ca_topic_score_gemma":0.000026352458,"teacher_disagreement_score":0.027782444,"about_ca_system_score_codex":0.0001869602,"about_ca_system_score_gemma":0.0005595388,"threshold_uncertainty_score":0.46559727},"labels":[],"label_agreement":null},{"id":"W4415623458","doi":"10.1016/j.ijcard.2025.133996","title":"Prevalence and distribution of lipoprotein(a) levels in a multiethnic population in Dubai: Implications for cardiovascular risk stratification","year":2025,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Mohammed Bin Rashid University of Medicine and Health Sciences","keywords":"Cohort; Cohort study; Population; Quarter (Canadian coin); Risk stratification; Distribution (mathematics); Epidemiology; Risk assessment","score_opus":0.024693494036248934,"score_gpt":0.33240592972778094,"score_spread":0.307712435691532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415623458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9094759,0.0049156314,0.08356706,0.0008909689,0.0002704315,0.0007171601,0.000092163864,0.000004176075,0.00006651367],"genre_scores_gemma":[0.99735826,0.0013271096,0.0009796459,0.000021376452,0.0001914025,0.00006013077,0.000045597415,0.0000055801606,0.000010894639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985963,0.00019335655,0.000691793,0.00017281194,0.00023084186,0.00011491501],"domain_scores_gemma":[0.99871385,0.00013505356,0.00027312423,0.00022052281,0.00062108424,0.000036375575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016477891,0.000086382126,0.0004923358,0.00029972682,0.00002063863,0.000007207102,0.000116720075,0.00012404831,9.627848e-7],"category_scores_gemma":[0.0009817244,0.00007946154,0.00043693616,0.00017263739,0.00004961784,0.00010107527,0.000024021196,0.00019935382,1.416125e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039679257,0.00006506773,0.85155505,0.00021966675,0.0011607646,0.0000071493273,0.00009094844,0.0037639465,0.0011109443,0.002924947,0.000028299763,0.13867639],"study_design_scores_gemma":[0.0023630161,0.00012272192,0.99228024,0.000264449,0.00021482068,0.0001249908,0.000046117977,0.00016793785,0.00028167974,0.0036995937,0.00038264907,0.00005180543],"about_ca_topic_score_codex":0.00027502654,"about_ca_topic_score_gemma":0.000045528817,"teacher_disagreement_score":0.14072514,"about_ca_system_score_codex":0.00022958893,"about_ca_system_score_gemma":0.00016357578,"threshold_uncertainty_score":0.32403478},"labels":[],"label_agreement":null},{"id":"W4415652668","doi":"10.14740/jocmr6363","title":"Clinical Effects of the Concurrent Ingestion of Rosuvastatin and Magnesium Oxide: A Multicenter, Randomized, Parallel-Group Trial","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Medicine Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Ingestion; Magnesium; Rosuvastatin Calcium; Clinical trial; Reduction (mathematics)","score_opus":0.10499609021946872,"score_gpt":0.5193902731671262,"score_spread":0.41439418294765745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415652668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9716836,0.011560773,0.0018302073,0.009150252,0.0025042926,0.0030204053,0.0000011902644,0.000004110894,0.0002451523],"genre_scores_gemma":[0.98777074,0.009454487,0.00074591604,0.00025966536,0.0015785823,0.000026024702,0.0000010294337,0.000011949877,0.00015162968],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9861324,0.0069896793,0.004298235,0.00025539286,0.0020268136,0.00029749877],"domain_scores_gemma":[0.976676,0.01966451,0.001310568,0.00051209127,0.0014607612,0.00037609186],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05933085,0.00014691497,0.0029029453,0.00029064424,0.000062873856,0.000006951831,0.00026829378,0.000247558,0.000018109618],"category_scores_gemma":[0.08944317,0.00007204111,0.0011078812,0.00047335058,0.0021155223,0.0000487989,0.0001753777,0.0020650658,6.572186e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6732303,0.0019870154,0.0326394,0.004033595,0.001033895,0.00007582345,0.00015336624,0.0000017966581,0.00023714207,0.00088548136,0.0023666464,0.28335553],"study_design_scores_gemma":[0.8758945,0.008936368,0.10437893,0.0059828437,0.001174893,0.00003887743,0.00020557476,0.00032619984,0.0002727812,0.0005292468,0.0021973215,0.000062454004],"about_ca_topic_score_codex":0.00015209428,"about_ca_topic_score_gemma":0.000009255236,"teacher_disagreement_score":0.2832931,"about_ca_system_score_codex":0.000039426555,"about_ca_system_score_gemma":0.0008732237,"threshold_uncertainty_score":0.96861684},"labels":[],"label_agreement":null},{"id":"W4415708527","doi":"10.1126/science.ady7186","title":"The functional landscape of coding variation in the familial hypercholesterolemia gene <i>LDLR</i>","year":2025,"lang":"en","type":"article","venue":"Science","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Familial hypercholesterolemia; Missense mutation; Hyperlipidemia; Gene; Phenotype; Disease; Limiting; LDL receptor; Multifactorial Inheritance","score_opus":0.014436180826105633,"score_gpt":0.264623044738005,"score_spread":0.25018686391189937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415708527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991508,0.000333856,0.0017493685,0.0027089906,0.00030332324,0.00022842082,0.0000012705967,0.0000059911927,0.0031607766],"genre_scores_gemma":[0.99884677,0.00004868866,0.00008593669,0.0008431784,0.000079792604,0.000011897313,0.0000011304469,0.0000012357777,0.00008136213],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991295,0.000043271404,0.00012161728,0.00012444059,0.0004545571,0.00012662543],"domain_scores_gemma":[0.99955285,0.00005217918,0.000024726618,0.0002768833,0.000074725474,0.000018630704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024228783,0.00003532269,0.00007429337,0.00006250105,0.00019947416,0.000022640086,0.00014747854,0.000019464977,0.0000030371677],"category_scores_gemma":[0.00013291955,0.000017900495,0.000041650772,0.00066870666,0.00013882811,0.000053609867,0.000030542793,0.00009936878,0.00000174554],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005394674,0.0003383635,0.20233622,0.00025185838,0.00010094967,0.000019897654,0.0046882597,0.00069717475,0.4836353,0.055225194,0.0024148428,0.24975248],"study_design_scores_gemma":[0.00046098503,0.000031000716,0.9930791,0.000026309142,0.000014143636,0.000010296244,0.00023441097,0.0004951723,0.002180839,0.00024551875,0.0032008898,0.000021320417],"about_ca_topic_score_codex":0.00005651787,"about_ca_topic_score_gemma":0.00002468201,"teacher_disagreement_score":0.7907429,"about_ca_system_score_codex":0.000035932688,"about_ca_system_score_gemma":0.00030865177,"threshold_uncertainty_score":0.15342142},"labels":[],"label_agreement":null},{"id":"W4415747944","doi":"10.1016/j.jtha.2025.10.009","title":"Lipoprotein(a) prolongs ex vivo plasma clot lysis times through effects on clot formation rate and fibrin structure","year":2025,"lang":"en","type":"article","venue":"Journal of Thrombosis and Haemostasis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Clot formation; Fibrin; Antifibrinolytic; Ex vivo; Lysis; Thrombosis; Fibrinolysis","score_opus":0.018620482806014898,"score_gpt":0.2951338451399949,"score_spread":0.27651336233398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415747944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98788786,0.0029467887,0.00037983773,0.006948704,0.00021982566,0.00076469703,0.000017714412,0.000020458256,0.0008141361],"genre_scores_gemma":[0.9910107,0.004752921,0.0023768016,0.0013441986,0.00034038952,0.000010366253,0.0000064061705,0.000023359504,0.0001348297],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99831,0.0001711189,0.0005478088,0.00024623878,0.00045398422,0.00027081306],"domain_scores_gemma":[0.99885964,0.000114058595,0.0003502725,0.00030433654,0.00020796838,0.00016372088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064013165,0.00025637788,0.0009029375,0.00018961882,0.0003297991,0.00016328447,0.000084462845,0.00018460865,0.000042362397],"category_scores_gemma":[0.00014882165,0.00018055973,0.0002922336,0.0002881742,0.00007175652,0.00035211188,0.000062622916,0.00037834726,0.0000023015223],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037680403,0.00048539203,0.005687744,0.007870032,0.006451427,0.00016909964,0.0029500742,0.00008017716,0.031976845,0.0021923422,0.03635994,0.9020089],"study_design_scores_gemma":[0.017705558,0.00626071,0.16180392,0.0059041223,0.004762393,0.0009951795,0.0010893896,0.0007270446,0.73307806,0.0047886684,0.062120628,0.0007643572],"about_ca_topic_score_codex":0.00012797707,"about_ca_topic_score_gemma":0.000024449144,"teacher_disagreement_score":0.9012445,"about_ca_system_score_codex":0.00009991775,"about_ca_system_score_gemma":0.00011014957,"threshold_uncertainty_score":0.7363012},"labels":[],"label_agreement":null},{"id":"W4415775040","doi":"10.7759/cureus.95956","title":"Comparison of Cardiovascular Risk Estimation and Statin Prescribing in Primary Care: A Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"Cureus","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Western University","funders":"","keywords":"Retrospective cohort study; Statin; Medical record; Cohort study; Risk assessment; Clinical Practice; Primary care; Estimation; Risk management","score_opus":0.013420060482776018,"score_gpt":0.30064612407321223,"score_spread":0.28722606359043623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415775040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658443,0.026664166,0.0028391993,0.000012626368,0.000086154,0.0022353544,0.00000954612,0.000026522386,0.002282162],"genre_scores_gemma":[0.99782825,0.00041050246,0.0015759189,0.00001317785,0.000028040738,0.00009513946,0.000022067918,0.0000107580045,0.000016141197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985533,0.00018626159,0.00034431575,0.00031542504,0.00045355535,0.00014716665],"domain_scores_gemma":[0.99914485,0.000026555588,0.000079673715,0.00055460323,0.0001473417,0.00004697136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095517153,0.00011533167,0.0008017921,0.00009876603,0.00005706869,0.0000101894575,0.000047377845,0.0000654663,0.0000027770761],"category_scores_gemma":[0.00018737468,0.0001055418,0.00015490243,0.0002681524,0.00003952233,0.00005822789,0.000058225687,0.0002309163,5.5009394e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063759646,0.00023532868,0.95824724,0.0004352565,0.0010409416,0.000009472327,0.002530618,0.00038590253,0.000017494165,0.000038733688,0.000028622075,0.036966633],"study_design_scores_gemma":[0.0022358126,0.0003392129,0.992319,0.00019837487,0.00094896613,0.0000022692818,0.0023081566,0.0011010943,0.00026029782,0.000055046596,0.00015545262,0.00007630895],"about_ca_topic_score_codex":0.0047901766,"about_ca_topic_score_gemma":0.00019263978,"teacher_disagreement_score":0.036890324,"about_ca_system_score_codex":0.00042613767,"about_ca_system_score_gemma":0.000158008,"threshold_uncertainty_score":0.7241346},"labels":[],"label_agreement":null},{"id":"W4415790197","doi":"10.1161/circ.152.suppl_3.4360415","title":"Abstract 4360415: Small, Dense LDL-C and Conventional LDL-C Similarly Predict Cardiovascular Risk and Benefit of Alirocumab in Statin-Treated Patients With Recent Acute Coronary Syndrome","year":2025,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Alirocumab; Mace; Acute coronary syndrome; Placebo; Rosuvastatin; Myocardial infarction","score_opus":0.008825624189272381,"score_gpt":0.21928591753897542,"score_spread":0.21046029334970304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415790197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405503,0.0036772075,0.00064464705,0.000041802763,0.00005276816,0.0012946643,0.00012287732,0.000026563364,0.0000844347],"genre_scores_gemma":[0.9978109,0.0013538804,0.0003094376,0.00004385375,0.0000134544825,0.000043255834,0.00038632433,0.000021264079,0.000017613866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984085,0.000067310415,0.0004219801,0.00040280257,0.00049075147,0.00020868353],"domain_scores_gemma":[0.99904054,0.000036291698,0.00014701721,0.00038055104,0.00028464897,0.00011096218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046019326,0.00019009497,0.00054559606,0.00020237484,0.00008396986,0.000018159657,0.000037727536,0.00014011636,0.000026319141],"category_scores_gemma":[0.0000456902,0.00016841207,0.00014227038,0.00029126927,0.000082015395,0.00013593037,0.0000330815,0.00018909824,0.0000011097133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003480768,0.0001562699,0.9535627,0.00042748256,0.0013181888,0.0000748214,0.00008180561,0.00040670508,0.000045396784,0.000040783238,0.0000065762288,0.043531235],"study_design_scores_gemma":[0.006877706,0.0001949746,0.99048036,0.00048428724,0.0010309649,0.0000719722,0.000037630412,0.00031179172,0.000052365573,0.00015395985,0.00016860968,0.00013538948],"about_ca_topic_score_codex":0.00043198987,"about_ca_topic_score_gemma":0.00004888485,"teacher_disagreement_score":0.043395843,"about_ca_system_score_codex":0.00014346461,"about_ca_system_score_gemma":0.0001153268,"threshold_uncertainty_score":0.6867644},"labels":[],"label_agreement":null},{"id":"W4415790295","doi":"10.1161/circ.152.suppl_3.4370601","title":"Abstract 4370601: Efficacy of Icosapent Ethyl for Cardiovascular Risk Reduction by Aspirin Use in REDUCE-IT","year":2025,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Aspirin; Clinical endpoint; Placebo; Myocardial infarction; Clinical trial; Eicosapentaenoic acid","score_opus":0.032153218723274736,"score_gpt":0.3040444437649645,"score_spread":0.2718912250416897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415790295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98497456,0.0033118546,0.008791837,0.0002666855,0.0003109396,0.0019700336,0.000017520902,0.000036296602,0.0003202421],"genre_scores_gemma":[0.9985549,0.0003382626,0.0005336997,0.000046113335,0.00016742725,0.000100139616,0.00018588673,0.000021034593,0.00005256098],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99840474,0.0001051451,0.0005111009,0.0003830316,0.00038240175,0.00021360515],"domain_scores_gemma":[0.99886876,0.00006590871,0.00013816137,0.00068099174,0.00017939712,0.00006680698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013759031,0.00014066439,0.0004886892,0.0002215282,0.000066397086,0.000017039603,0.000054773554,0.00018052135,0.000012270896],"category_scores_gemma":[0.00038736028,0.000142201,0.0007850875,0.00038351666,0.000036242844,0.00013337383,0.000014590816,0.00020563131,0.0000042085244],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011937383,0.0013332043,0.08705945,0.002957474,0.003941219,0.000013180757,0.0007981156,0.022867545,0.062339343,0.00066387776,0.003533133,0.8132997],"study_design_scores_gemma":[0.005171941,0.00006069994,0.9678822,0.00047494436,0.00072158594,0.000010345895,0.000113160466,0.0005673739,0.012033929,0.00024262832,0.012563937,0.00015722099],"about_ca_topic_score_codex":0.0014502471,"about_ca_topic_score_gemma":0.000016739343,"teacher_disagreement_score":0.8808228,"about_ca_system_score_codex":0.00025734762,"about_ca_system_score_gemma":0.00018318191,"threshold_uncertainty_score":0.57987887},"labels":[],"label_agreement":null},{"id":"W4415792964","doi":"10.1016/j.mayocp.2025.09.014","title":"Can Physical Fitness Lower the Risk of Statin-Related Diabetes: Time to Prescribe Exercise?","year":2025,"lang":"en","type":"editorial","venue":"Mayo Clinic Proceedings","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Misericordia Community Hospital; Covenant Health","funders":"","keywords":"Physical fitness; Physical activity; MEDLINE; Risk assessment; Physical exercise","score_opus":0.006719472508442428,"score_gpt":0.271133717373829,"score_spread":0.2644142448653866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415792964","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23904195,0.0029485612,0.000009804143,0.005077948,0.7134981,0.012180777,0.0027807434,0.0006280244,0.02383405],"genre_scores_gemma":[0.022756016,0.0017833431,0.0003099931,0.00074467115,0.8417697,0.0013860605,0.0006904818,0.00039169355,0.13016805],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99516016,0.00007069339,0.0011372323,0.0009856366,0.0019138528,0.0007324238],"domain_scores_gemma":[0.9959622,0.00076280127,0.0006940786,0.0008780545,0.0013553218,0.00034752494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025776285,0.00060009863,0.0022004314,0.00020428187,0.00017779606,0.00006274169,0.00067027827,0.0009644781,0.00030399425],"category_scores_gemma":[0.0051820586,0.00040574116,0.0011240715,0.0008031271,0.00021736036,0.00006694428,0.00037303873,0.0022861175,0.00027606808],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033791846,0.0002915174,0.00016193475,0.002057774,0.0010269259,0.000006062933,0.00086854957,0.0000011928815,0.000032210533,0.000007224985,0.983882,0.0113266865],"study_design_scores_gemma":[0.0031258948,0.0014673155,0.000985452,0.0054340255,0.00483946,0.0000014609809,0.00021980057,0.00017039076,0.00037168467,0.0005043206,0.98227704,0.0006031479],"about_ca_topic_score_codex":0.00032964922,"about_ca_topic_score_gemma":0.0000037031382,"teacher_disagreement_score":0.21628594,"about_ca_system_score_codex":0.00019646874,"about_ca_system_score_gemma":0.0013280336,"threshold_uncertainty_score":0.9998394},"labels":[],"label_agreement":null},{"id":"W4415794328","doi":"10.1161/circ.152.suppl_3.4369873","title":"Abstract 4369873: <i>LPA</i> -Targeted siRNAs Lower Lp(a) by Over 90%: A Meta-Analysis of Olpasiran, Lepodisiran, and Zerlasiran","year":2025,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"","keywords":"Adverse effect; Small interfering RNA; Apolipoprotein B; Confidence interval; Clinical trial; Relative risk; Meta-analysis; Disease","score_opus":0.02648920046918938,"score_gpt":0.2879977393573365,"score_spread":0.2615085388881471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415794328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742239,0.015858456,0.0043327464,0.0007097378,0.00013115126,0.0008464368,0.00007709566,0.00006546931,0.0037550027],"genre_scores_gemma":[0.99857575,0.00011531539,0.00012036889,0.0006685118,0.000048304188,0.00002617638,0.00020470838,0.000020251571,0.00022060696],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9980528,0.00008140592,0.0006064883,0.0004519781,0.00056930666,0.00023805579],"domain_scores_gemma":[0.9987097,0.00006958144,0.0002001945,0.0006982516,0.00019607651,0.0001262227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006765584,0.00022166607,0.001271333,0.0003929808,0.000089491725,0.00002780609,0.00006743039,0.00018681464,0.0003211483],"category_scores_gemma":[0.00009444443,0.0001859821,0.0014350457,0.001102927,0.000072123614,0.00012866581,0.00002408526,0.00017582905,0.00000447065],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008630017,0.001436939,0.23995008,0.0026208898,0.56060016,0.00008060188,0.000977324,0.0030889183,0.14398101,0.0029374943,0.0056307283,0.03783288],"study_design_scores_gemma":[0.0016012172,0.000041639276,0.85240185,0.000025434112,0.13629186,0.000004850281,0.000043040232,0.0013907995,0.0021799686,0.00015512259,0.005666991,0.00019720593],"about_ca_topic_score_codex":0.00056538475,"about_ca_topic_score_gemma":0.00006600269,"teacher_disagreement_score":0.6124518,"about_ca_system_score_codex":0.00006682887,"about_ca_system_score_gemma":0.00010438663,"threshold_uncertainty_score":0.758413},"labels":[],"label_agreement":null},{"id":"W4415923520","doi":"10.1097/mol.0000000000001016","title":"Evolving guidelines on lipoprotein(a)","year":2025,"lang":"en","type":"review","venue":"Current Opinion in Lipidology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Clinical trial; MEDLINE; Consensus conference; Clinical Practice; Evidence-based medicine","score_opus":0.21348289434231443,"score_gpt":0.4779162488700973,"score_spread":0.2644333545277829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415923520","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.7205772e-7,0.9101591,0.00014498853,0.00038130942,0.0851405,0.0026580573,0.000028610066,0.00009382938,0.0013934218],"genre_scores_gemma":[1.3319334e-7,0.9549794,0.00040197858,0.00013930108,0.04277502,0.0008514533,0.0004238209,0.00005802656,0.00037086566],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99585605,0.0005544034,0.0015392527,0.00095830177,0.00048578175,0.0006062061],"domain_scores_gemma":[0.9976416,0.00025412094,0.0003566476,0.0013228881,0.00023942276,0.00018530445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012974455,0.0006222432,0.0035046462,0.0010303395,0.00007345087,0.00002044585,0.00031249158,0.0007196121,0.00015630947],"category_scores_gemma":[0.001806447,0.0004854422,0.0012938961,0.00081080303,0.000076088574,0.000042097803,0.00020346159,0.0014300584,0.00021916033],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000144604655,0.00011876113,0.000008277956,0.09572895,0.00009746668,4.5799118e-7,0.000008004645,7.5871947e-7,1.2091013e-8,0.0007859774,0.086356826,0.81688005],"study_design_scores_gemma":[0.000659101,0.00020034418,0.000024946905,0.14573884,0.00024138606,0.0000829091,0.000004688107,0.0000075161133,4.692708e-8,0.0000718225,0.8526824,0.00028597616],"about_ca_topic_score_codex":0.000058299436,"about_ca_topic_score_gemma":0.0000033517185,"teacher_disagreement_score":0.81659406,"about_ca_system_score_codex":0.00039080228,"about_ca_system_score_gemma":0.0016339974,"threshold_uncertainty_score":0.99975973},"labels":[],"label_agreement":null},{"id":"W4415929160","doi":"10.1001/jamacardio.2025.4105","title":"Small-Interfering RNA Olpasiran and Apolipoprotein B Particles","year":2025,"lang":"en","type":"article","venue":"JAMA Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Apolipoprotein B; RNA; Randomized controlled trial; Clinical trial; Triglycerides blood","score_opus":0.02139024292275338,"score_gpt":0.26409177518804666,"score_spread":0.24270153226529328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415929160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96946555,0.0044808122,0.005923906,0.0036996747,0.0002806159,0.0005688356,0.0000035606406,0.00010291498,0.015474144],"genre_scores_gemma":[0.9962503,0.00037791318,0.0008544794,0.0014174496,0.0005578354,0.00008679906,0.000005419031,0.000015414284,0.00043441867],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99881065,0.0001420916,0.0002443516,0.00033776928,0.00010933316,0.00035580236],"domain_scores_gemma":[0.99923027,0.000042517277,0.000033035074,0.00049093465,0.00006751747,0.00013574387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005621894,0.00014692078,0.0006267427,0.000115210634,0.00008856406,0.000024872901,0.000070439346,0.00018899137,0.00001123907],"category_scores_gemma":[0.00017090561,0.00012313017,0.0002260927,0.00015257995,0.00011891255,0.000037781643,0.00011132672,0.00026803528,0.000014347267],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007172772,0.00003812736,0.035779074,0.00092296745,0.0016349828,0.0004738287,0.0003207735,0.000056116343,0.023394113,0.010595216,0.0018302376,0.9242373],"study_design_scores_gemma":[0.013658642,0.0010132494,0.6977132,0.0007921704,0.0010965501,0.0021912511,0.0011761229,0.0010080776,0.043301053,0.003841443,0.23350888,0.00069933006],"about_ca_topic_score_codex":0.0004014617,"about_ca_topic_score_gemma":0.00003170393,"teacher_disagreement_score":0.92353797,"about_ca_system_score_codex":0.00008000422,"about_ca_system_score_gemma":0.00012735506,"threshold_uncertainty_score":0.50211024},"labels":[],"label_agreement":null},{"id":"W4415975115","doi":"10.1101/2025.11.04.25339533","title":"Electronic health record (EHR)-detectable statin intolerance phenotypes: Prevalence and validation in real-world general practice","year":2025,"lang":"","type":"preprint","venue":"medRxiv","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kensington Health","funders":"National Health and Medical Research Council; Medical Research Council; University of New South Wales; Nvidia","keywords":"Statin; Electronic health record; Myopathy; Health records; Judgement; Exercise intolerance; General practice; Clinical Practice","score_opus":0.01892454047930494,"score_gpt":0.3215827644692017,"score_spread":0.3026582239898968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415975115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89804506,0.06701286,0.0068576136,0.008932459,0.0022765987,0.009218247,0.00011942721,0.00021293179,0.007324807],"genre_scores_gemma":[0.61057913,0.36264953,0.010379402,0.0024990742,0.001587552,0.0011338458,0.00015626528,0.00014015599,0.010875016],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9883327,0.0033907534,0.0023881805,0.00246863,0.001427903,0.0019918212],"domain_scores_gemma":[0.99450076,0.00056843343,0.001443911,0.0023315754,0.0005694856,0.0005858371],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.011257136,0.0009676245,0.0023204566,0.0008254858,0.00037329918,0.00016224013,0.00053204957,0.00048954145,0.00021249456],"category_scores_gemma":[0.0015342461,0.0010161523,0.00035795968,0.0016512611,0.00017055015,0.00047569833,0.0005561464,0.0035211274,0.000037048547],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033585583,0.0012936807,0.20220132,0.047284734,0.0015442435,0.00014178024,0.0065760836,0.0018177131,0.00043073395,0.004227193,0.0005148251,0.7306091],"study_design_scores_gemma":[0.018288668,0.005270354,0.56738865,0.03679687,0.0031585551,0.00022190878,0.0013953832,0.023383196,0.005251339,0.0058717686,0.328417,0.004556292],"about_ca_topic_score_codex":0.044598002,"about_ca_topic_score_gemma":0.009490171,"teacher_disagreement_score":0.7260528,"about_ca_system_score_codex":0.002631051,"about_ca_system_score_gemma":0.0073197368,"threshold_uncertainty_score":0.9992289},"labels":[],"label_agreement":null},{"id":"W4416040060","doi":"10.1056/nejmoa2514428","title":"Evolocumab in Patients without a Previous Myocardial Infarction or Stroke","year":2025,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Amgen","keywords":"Evolocumab; Myocardial infarction; Diabetes mellitus; Stroke (engine); PCSK9; Placebo","score_opus":0.010382065649242676,"score_gpt":0.28170219469319524,"score_spread":0.2713201290439526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416040060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98687816,0.0025840024,0.0007753977,0.005239299,0.0012550213,0.0004885804,0.0000012084337,0.000008997925,0.0027693065],"genre_scores_gemma":[0.99360085,0.00092671055,0.00030118693,0.00090877304,0.0030432555,0.0000027090082,0.000004259172,0.000011019937,0.0012012294],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981107,0.0001446526,0.0006549462,0.0001296507,0.00075895776,0.00020109663],"domain_scores_gemma":[0.9989994,0.00006003303,0.00020119495,0.00024956712,0.0002689399,0.00022085862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014848381,0.00013489136,0.00074313954,0.00041568762,0.00003202736,0.000006037542,0.0000791015,0.0000902044,0.00011468679],"category_scores_gemma":[0.0009033237,0.00007752708,0.00014115342,0.00031145546,0.000046941776,0.0000778268,0.000019082248,0.00047308707,0.0000025676563],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005798679,0.0001345526,0.37893584,0.00011616856,0.0003942337,0.0001017931,0.00043947477,0.000014881087,0.00008414867,0.000020098381,0.004064265,0.6098958],"study_design_scores_gemma":[0.17390038,0.0043048933,0.689398,0.0018654934,0.0005968599,0.00045433687,0.00014391611,0.000027137037,0.00006357372,0.00014623358,0.12900272,0.00009649311],"about_ca_topic_score_codex":0.00026869823,"about_ca_topic_score_gemma":0.000068611174,"teacher_disagreement_score":0.6097994,"about_ca_system_score_codex":0.00017901878,"about_ca_system_score_gemma":0.00063979253,"threshold_uncertainty_score":0.31614628},"labels":[],"label_agreement":null},{"id":"W4416054854","doi":"10.1001/jama.2025.20620","title":"Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"JAMA","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"Institut de Cardiologie de Montréal; Pfizer; Esperion Therapeutics; Amgen","keywords":"Familial hypercholesterolemia; PCSK9; Ldl cholesterol; Heterozygote advantage; LDL receptor; Proprotein convertase; Cholesterol","score_opus":0.0069561193506765115,"score_gpt":0.2474121746888795,"score_spread":0.240456055338203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416054854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964307,0.00047432978,0.00008692641,0.00083405897,0.00006214051,0.0006740092,0.000009195604,0.000022475457,0.0014061696],"genre_scores_gemma":[0.99833125,0.00012475773,0.000540495,0.000722005,0.00012354541,0.000021139158,0.00001172236,0.0000126833165,0.000112407026],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989847,0.00006429428,0.00027940384,0.00024132615,0.00023232655,0.00019796423],"domain_scores_gemma":[0.9994521,0.000033263386,0.000039329378,0.000319596,0.000070056274,0.000085636966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028497181,0.0001222115,0.00041902304,0.00012024215,0.00002720067,0.000009326469,0.000047353667,0.00011057769,0.0000046967034],"category_scores_gemma":[0.00007549938,0.00009146616,0.00006461313,0.00021393829,0.000072569026,0.000056060493,0.000044198507,0.00023756997,0.000001978727],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014154147,0.0003908105,0.09947563,0.0016372073,0.0002300626,0.0002144563,0.0013681415,0.000021175285,0.0033395428,0.00017425352,0.00027474767,0.8787198],"study_design_scores_gemma":[0.028811121,0.00071298325,0.9588799,0.0023110774,0.00007945106,0.00008030458,0.00028477336,0.000054155746,0.004003003,0.000015537293,0.004651139,0.00011654931],"about_ca_topic_score_codex":0.0010022142,"about_ca_topic_score_gemma":0.00028993262,"teacher_disagreement_score":0.8786033,"about_ca_system_score_codex":0.00006211205,"about_ca_system_score_gemma":0.00012391905,"threshold_uncertainty_score":0.37298816},"labels":[],"label_agreement":null},{"id":"W4416239555","doi":"10.1146/annurev-med-050124-025051","title":"Lipoprotein(a): An Underappreciated Inherited Risk Factor for Atherosclerosis, Aortic Stenosis, and Abdominal Aortic Aneurysm","year":2025,"lang":"en","type":"article","venue":"Annual Review of Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Abdominal aortic aneurysm; Risk factor; Stenosis; Pathophysiology; Aortic aneurysm; Clinical trial","score_opus":0.02173259196679341,"score_gpt":0.326688197233365,"score_spread":0.3049556052665716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416239555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69505274,0.28604594,0.0024350844,0.008733574,0.00036823773,0.0065918057,0.00029573648,0.0001204406,0.00035642748],"genre_scores_gemma":[0.7368361,0.2554138,0.000889506,0.00585522,0.00036894385,0.00026678608,0.00008330203,0.000047722744,0.0002386339],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971896,0.00028787347,0.0010222362,0.0005243309,0.00058210787,0.0003938594],"domain_scores_gemma":[0.997797,0.00016076938,0.0003614164,0.0008026459,0.0005553512,0.0003227754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016728224,0.00032760165,0.0015611202,0.00017341817,0.00013036394,0.000007731472,0.00015320929,0.00015831064,0.00012678596],"category_scores_gemma":[0.0015449759,0.00022934937,0.00027091734,0.0005651832,0.00029162422,0.00011628846,0.000050504408,0.00030883498,0.0000022353263],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003355574,0.0002922188,0.0031942334,0.0318458,0.00054693106,0.0000070602096,0.0004681678,1.6379377e-7,0.0022552237,0.00013077908,0.001786928,0.95913696],"study_design_scores_gemma":[0.018773915,0.009561993,0.8186743,0.09338941,0.006292938,0.00010301752,0.0013995969,0.00033092423,0.002292005,0.0006036033,0.047820434,0.00075781223],"about_ca_topic_score_codex":0.00063763716,"about_ca_topic_score_gemma":0.000021154827,"teacher_disagreement_score":0.95837915,"about_ca_system_score_codex":0.00006521927,"about_ca_system_score_gemma":0.00022981293,"threshold_uncertainty_score":0.93525964},"labels":[],"label_agreement":null},{"id":"W4416276238","doi":"10.3389/fcvm.2025.1612095","title":"Effectiveness of combining PCSK9 inhibitors with statins on major adverse cardiovascular events and lipid levels in patients after percutaneous coronary intervention: a systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Frontiers in Cardiovascular Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PCSK9; Adverse effect; Evolocumab; Alirocumab; Percutaneous coronary intervention; Coronary artery disease; Dyslipidemia","score_opus":0.010229761416756473,"score_gpt":0.24865649907191575,"score_spread":0.2384267376551593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416276238","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28493184,0.7014034,0.0055882684,0.00012488982,0.00025161152,0.007527707,0.00004512599,0.000029026232,0.00009817191],"genre_scores_gemma":[0.99562263,0.0026635316,0.0005971881,0.00025235768,0.00002227983,0.00068623526,0.000067591805,0.000043124357,0.000045066463],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9938674,0.0021530744,0.0012180207,0.00091357774,0.0014575449,0.00039036814],"domain_scores_gemma":[0.99767107,0.00014449093,0.00020780538,0.0015066019,0.00028362786,0.00018643096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006457717,0.000519025,0.008224652,0.0011000272,0.000056011846,0.000006494065,0.0001362456,0.0001746425,0.000017026783],"category_scores_gemma":[0.00037415815,0.00035706547,0.0032521551,0.0016013022,0.00023771482,0.0001084548,0.000105735264,0.00043745124,6.0928977e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096823863,0.00033714378,0.1189665,0.34298593,0.5339636,0.00062972086,0.00044324825,0.00032983505,0.000001658687,0.000007928036,0.000020432151,0.0013457808],"study_design_scores_gemma":[0.009132559,0.00091760996,0.36192566,0.03997758,0.5869172,0.00011965759,0.00059374666,0.00003111518,0.00001596686,0.00001838463,0.00004712357,0.00030335385],"about_ca_topic_score_codex":0.00054383057,"about_ca_topic_score_gemma":0.00002488061,"teacher_disagreement_score":0.7106908,"about_ca_system_score_codex":0.00031989292,"about_ca_system_score_gemma":0.000088783825,"threshold_uncertainty_score":0.9998881},"labels":[],"label_agreement":null},{"id":"W4416347310","doi":"10.18203/2394-6040.ijcmph20253757","title":"Association between elevated lipoprotein(a) levels and cardiovascular risk","year":2025,"lang":"","type":"article","venue":"International Journal of Community Medicine and Public Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Confounding; Meta-analysis; Observational study; Stroke (engine); Myocardial infarction; Disease; Cochrane Library; Risk factor","score_opus":0.07105335724929779,"score_gpt":0.35543108993515116,"score_spread":0.28437773268585337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416347310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6526422,0.11458191,0.013424667,0.21352804,0.0027100744,0.000949689,0.00013372065,0.000031624397,0.001998087],"genre_scores_gemma":[0.9098618,0.08077076,0.00024270486,0.0055060503,0.0032658374,0.000006747426,0.000043999116,0.000029159526,0.0002729161],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9875002,0.006350258,0.0023638543,0.0002576317,0.0028099813,0.00071810605],"domain_scores_gemma":[0.9910046,0.0016442868,0.0019515189,0.0008502692,0.003448162,0.001101202],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.039715778,0.0004228158,0.0022543194,0.0013761839,0.0008447407,0.00017235434,0.00069416646,0.00041720923,0.00012244197],"category_scores_gemma":[0.010013538,0.00035189837,0.00059020845,0.0007371409,0.00034277092,0.00047006746,0.0003644864,0.004074583,0.0000027901342],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012581305,0.00028825502,0.10589474,0.0007975522,0.024205666,0.000031967193,0.0058276895,0.0000035188796,0.000010007001,0.00047313646,0.0064464896,0.85589516],"study_design_scores_gemma":[0.011887305,0.0022411968,0.5358353,0.0037464062,0.0022150737,0.0003135023,0.011433142,0.000055183857,0.000024959467,0.0018816917,0.4300899,0.00027631343],"about_ca_topic_score_codex":0.021523977,"about_ca_topic_score_gemma":0.00023033722,"teacher_disagreement_score":0.85561883,"about_ca_system_score_codex":0.0012043103,"about_ca_system_score_gemma":0.003318284,"threshold_uncertainty_score":0.9998933},"labels":[],"label_agreement":null},{"id":"W4416425577","doi":"10.1016/j.atherosclerosis.2025.120590","title":"Imputation of untreated LDL-C in treated subjects with homozygous familial hypercholesterolaemia: An international collaboration","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Western University; Robarts Clinical Trials; McGill University Health Centre; University of British Columbia","funders":"HLS Therapeutics; Novo Nordisk; Daiichi-Sankyo; Amryt Pharma; Daiichi Sankyo Europe; Silence Therapeutics; University of British Columbia; PTC Therapeutics; Sanofi; Kowa Company; Ionis Pharmaceuticals; Regeneron Pharmaceuticals; Amgen; Pfizer; Esperion Therapeutics; Ultragenyx Pharmaceutical; AstraZeneca; Eli Lilly and Company","keywords":"Imputation (statistics); Missing data; Medical record; MEDLINE","score_opus":0.011454493020405118,"score_gpt":0.2720644157014938,"score_spread":0.2606099226810887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416425577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975894,0.00005251324,0.0003704011,0.0002811711,0.0000886723,0.00062597624,0.000021530135,0.000053150554,0.0009172028],"genre_scores_gemma":[0.9986833,0.0001356005,0.0005788357,0.00021110252,0.000047591187,0.000064783104,0.0001306409,0.000019043626,0.00012915481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888515,0.000093352515,0.00029042046,0.0002750842,0.00029478324,0.00016118167],"domain_scores_gemma":[0.9992421,0.000019782317,0.00007894664,0.0003224581,0.00027609593,0.000060593473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002360216,0.00013526026,0.000318349,0.00022964393,0.000039121067,0.000025684676,0.000077923105,0.00012982746,0.000011413976],"category_scores_gemma":[0.00003868523,0.00011035968,0.00006165137,0.00077100744,0.000049302136,0.00020441566,0.00001521125,0.00012130959,0.0000027490132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016870127,0.0009184389,0.85289186,0.00017072249,0.00040068082,0.000025939731,0.0015824547,0.0004559507,0.08765774,0.00025525983,0.000041286665,0.053912662],"study_design_scores_gemma":[0.005830299,0.00069765,0.96992296,0.00032660927,0.00012851674,0.000011759329,0.00049529626,0.00084633345,0.021509303,0.00002475955,0.00010013524,0.0001063661],"about_ca_topic_score_codex":0.0020796373,"about_ca_topic_score_gemma":0.0010402361,"teacher_disagreement_score":0.11703112,"about_ca_system_score_codex":0.00020922998,"about_ca_system_score_gemma":0.00021348566,"threshold_uncertainty_score":0.45003372},"labels":[],"label_agreement":null},{"id":"W4416513105","doi":"10.1016/j.jare.2025.11.044","title":"Identification and evaluation of a lipid-lowering small compound as a PCSK9 inhibitor","year":2025,"lang":"en","type":"article","venue":"Journal of Advanced Research","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Major Science and Technology Projects of China; Excellent Youth Foundation of Heilongjiang Province of China; National Natural Science Foundation of China","keywords":"Identification (biology); PCSK9; Proprotein convertase; Kexin; Ezetimibe","score_opus":0.07545460376912196,"score_gpt":0.438557250139737,"score_spread":0.36310264637061507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416513105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116004,0.0050103734,0.00068041374,0.0010616295,0.00020066922,0.00051714777,6.406256e-7,0.0000031413383,0.0013659614],"genre_scores_gemma":[0.9979979,0.00073601893,0.00066982675,0.00002325936,0.00024505143,0.000010994042,8.5922494e-7,0.0000069169982,0.00030917698],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977018,0.0002477262,0.00044755408,0.0001174074,0.0013312659,0.00015424324],"domain_scores_gemma":[0.9969991,0.00011004318,0.00015639709,0.00022414021,0.0024116857,0.00009866673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008572941,0.00005463592,0.00026605817,0.00043244506,0.00008333932,0.000022375609,0.000070509144,0.000051433533,0.000012098389],"category_scores_gemma":[0.0013517055,0.00004394385,0.000103780854,0.00041769713,0.00007624131,0.000108722896,0.000044686447,0.0003919813,0.0000017416512],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009790091,0.00022011384,0.00082982023,0.0008335874,0.00025440392,0.000020649766,0.00039738446,0.00027554968,0.49337876,0.00024945548,0.00027673665,0.5022845],"study_design_scores_gemma":[0.022055812,0.0033262414,0.13089597,0.0064349263,0.00068564765,0.0009490036,0.0056434325,0.00245149,0.78438836,0.009162624,0.03374995,0.0002565571],"about_ca_topic_score_codex":0.000022903443,"about_ca_topic_score_gemma":0.000008903916,"teacher_disagreement_score":0.502028,"about_ca_system_score_codex":0.00020580603,"about_ca_system_score_gemma":0.0007682251,"threshold_uncertainty_score":0.29712275},"labels":[],"label_agreement":null},{"id":"W4416526623","doi":"10.1038/s41467-025-66522-0","title":"Cryo-electron microscopy reveals sequential binding and activation of Ryanodine Receptors by statin triplets","year":2025,"lang":"en","type":"article","venue":"Nature Communications","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"RYR1; Ryanodine receptor; Statin; Atorvastatin; Protein subunit; Binding site; Transmembrane protein; Transmembrane domain","score_opus":0.014460127085684138,"score_gpt":0.3427905159312079,"score_spread":0.3283303888455238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416526623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96037954,0.021806689,0.00088996993,0.012667413,0.00017270328,0.0010868732,0.00006487886,0.00006391652,0.0028680412],"genre_scores_gemma":[0.9874177,0.003214795,0.0076752356,0.0004792837,0.000028558577,0.00003846659,0.00042214553,0.000012535803,0.00071130274],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999073,0.00017048405,0.00027718552,0.00015930367,0.00017544953,0.00014452754],"domain_scores_gemma":[0.9985289,0.00011507954,0.00012276987,0.0010055248,0.00017518112,0.00005255492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004884332,0.00009895477,0.00027983406,0.00015683762,0.00018873418,0.000014395908,0.0001917473,0.00022545547,0.000013400708],"category_scores_gemma":[0.00027808218,0.00009229856,0.00008029676,0.0004633798,0.00008904591,0.000064435706,0.000102383405,0.0006577575,0.0000012081811],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011525795,0.00018452642,0.004554384,0.00025251118,0.00021141293,2.1398061e-7,0.00020676233,3.450344e-7,0.94447327,0.004033309,0.034829307,0.011138697],"study_design_scores_gemma":[0.0038114,0.0002979042,0.017729962,0.00086733844,0.0004289073,0.000014312793,0.000323295,0.00009103202,0.5988965,0.0004381006,0.37683022,0.00027103414],"about_ca_topic_score_codex":0.000112061956,"about_ca_topic_score_gemma":0.000026835638,"teacher_disagreement_score":0.3455768,"about_ca_system_score_codex":0.00012338083,"about_ca_system_score_gemma":0.00016767014,"threshold_uncertainty_score":0.3763826},"labels":[],"label_agreement":null},{"id":"W4416869732","doi":"10.1159/000549181","title":"Association between Lipid Accumulation Product and Cardiometabolic Multimorbidity in Adults Aged 50 Years and Older: Findings from the English Longitudinal Study of Ageing","year":2025,"lang":"en","type":"article","venue":"Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Longitudinal study; Ageing; Product (mathematics); Multimorbidity; Healthy ageing; Inclusion (mineral); Longitudinal data; Risk factor","score_opus":0.030480749142848027,"score_gpt":0.3062411212917248,"score_spread":0.2757603721488768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416869732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961105,0.0021623604,0.000058163376,0.00012666524,0.00030795546,0.0011452337,0.000019351695,0.000020943899,0.000048845966],"genre_scores_gemma":[0.99860746,0.0003670288,0.00004620291,0.000030244622,0.00085008173,0.000040471296,0.00003567229,0.000008782122,0.000014073696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846023,0.00048187087,0.00029541104,0.00037043102,0.0002035454,0.00018851452],"domain_scores_gemma":[0.99912983,0.00028235177,0.00008891098,0.0003459392,0.00011333941,0.00003964687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001479173,0.00011427661,0.0007469087,0.00013724258,0.0000680324,0.000012058664,0.000057849535,0.00012902511,0.0000016666529],"category_scores_gemma":[0.0010048372,0.000092828035,0.00009996901,0.00028857854,0.000045299854,0.000056285324,0.000090575326,0.00028828759,3.4893307e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048898648,0.000021918393,0.98252565,0.000059169855,0.0006925729,0.000011418792,0.002372902,0.000017259865,0.00006709303,0.0000027103922,0.00008632628,0.0140940575],"study_design_scores_gemma":[0.0032484287,0.00008792148,0.994427,0.00009264176,0.0005234883,0.0000023553703,0.0010425647,0.000011188089,0.000041004594,0.000010366751,0.0004456572,0.00006734761],"about_ca_topic_score_codex":0.0035722074,"about_ca_topic_score_gemma":0.00025980858,"teacher_disagreement_score":0.01402671,"about_ca_system_score_codex":0.00008725624,"about_ca_system_score_gemma":0.000048507663,"threshold_uncertainty_score":0.5400133},"labels":[],"label_agreement":null},{"id":"W4417279605","doi":"10.24265/horizmed.2025.v25n4.03","title":"Evaluación del riesgo cardiovascular mediante un nuevo score en una cohorte con hipercolesterolemia familiar del noroccidente de Colombia","year":2025,"lang":"es","type":"article","venue":"Horizonte Médico (Lima)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risk stratification; Myocardial infarction; Ldl cholesterol","score_opus":0.011502609093375077,"score_gpt":0.2792588851400092,"score_spread":0.2677562760466341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417279605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.855997,0.12148536,0.0064527993,0.0015714583,0.0028040684,0.005043798,0.00038703438,0.00044661883,0.0058118543],"genre_scores_gemma":[0.94689506,0.04327343,0.0007882699,0.0027210491,0.0025231338,0.00076519983,0.0003198454,0.00033463977,0.0023793606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98713213,0.0021976999,0.002060548,0.0024082588,0.0034038706,0.0027975137],"domain_scores_gemma":[0.99221146,0.0004000354,0.0004711619,0.004228388,0.0012147418,0.0014742204],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0067187306,0.0016392268,0.003823204,0.0006908982,0.00093690265,0.00035548778,0.0013084594,0.0016191499,0.00019474445],"category_scores_gemma":[0.0011982599,0.0016464979,0.0035233614,0.0016485545,0.00078323984,0.00045255944,0.00073615566,0.0024202275,0.00039505176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003812561,0.0018595757,0.43922055,0.012220024,0.044654988,0.007946701,0.0036136773,0.00050724216,0.016559394,0.0051234444,0.026022619,0.43845922],"study_design_scores_gemma":[0.039852902,0.004163209,0.6216637,0.020786094,0.030381504,0.0018276242,0.006897675,0.0047780173,0.017744334,0.00095725944,0.2466928,0.0042549106],"about_ca_topic_score_codex":0.0059681814,"about_ca_topic_score_gemma":0.0003700673,"teacher_disagreement_score":0.4342043,"about_ca_system_score_codex":0.002480885,"about_ca_system_score_gemma":0.0037113493,"threshold_uncertainty_score":0.9998812},"labels":[],"label_agreement":null},{"id":"W4417335347","doi":"10.1016/j.ahj.2025.107327","title":"A multicenter trial to test pitavastatin calcium in youth with combined dyslipidemia of obesity: Design, implementation, challenges, and responses","year":2025,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Dyslipidemia; Pitavastatin; Multicenter study; Multicenter trial; Calcium; Clinical trial; Triglycerides blood","score_opus":0.05207570577707606,"score_gpt":0.35855471382435994,"score_spread":0.3064790080472839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417335347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99159515,0.0007239323,0.0019536354,0.004531241,0.000061141254,0.0010838171,0.000009612774,0.000009735152,0.00003172788],"genre_scores_gemma":[0.9899184,0.00030863678,0.008503907,0.001093058,0.00010816348,0.000026616186,0.0000023031073,0.000013558275,0.000025358686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983425,0.00041689482,0.0004666227,0.00019493884,0.00031281667,0.00026623558],"domain_scores_gemma":[0.9989951,0.00029441333,0.00013000058,0.00020713909,0.00016204678,0.00021125564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00152986,0.00012497437,0.0005959629,0.00029429243,0.000064870044,0.000014741935,0.0000464074,0.000025322448,0.000011505508],"category_scores_gemma":[0.0003145533,0.00009512028,0.00007860424,0.00030751218,0.000083244246,0.000049715545,0.000027149526,0.00024015181,0.0000011376957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19565791,0.002699893,0.5262484,0.00046923623,0.0011024954,0.00026678314,0.020383637,0.000037407208,0.005159742,0.00011715021,0.0021156992,0.24574164],"study_design_scores_gemma":[0.06771188,0.017379439,0.88029325,0.00073339423,0.00029385072,0.00016082787,0.029756205,0.000036068013,0.0021982864,0.00003168192,0.0011873737,0.00021772346],"about_ca_topic_score_codex":0.0008599238,"about_ca_topic_score_gemma":0.00022199359,"teacher_disagreement_score":0.35404485,"about_ca_system_score_codex":0.00009822438,"about_ca_system_score_gemma":0.000518839,"threshold_uncertainty_score":0.38788927},"labels":[],"label_agreement":null},{"id":"W4417358375","doi":"10.5334/gh.1506","title":"Global Guidance for Dyslipidaemia Management in Adults: A Scoping Review","year":2025,"lang":"en","type":"article","venue":"Global Heart","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"World Health Organization","keywords":"Scope (computer science); Best practice; Primary care; Scope of practice; Primary prevention; MEDLINE; Global health","score_opus":0.011968922460664137,"score_gpt":0.34975588380145434,"score_spread":0.3377869613407902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417358375","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035986826,0.7332178,0.011229105,0.021608472,0.0017071766,0.024369558,0.00014549901,0.00033025973,0.17140532],"genre_scores_gemma":[0.5214561,0.12634687,0.12658778,0.211018,0.002418097,0.0081817,0.0002880409,0.00009930265,0.0036040987],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99857664,0.000045544573,0.00039649478,0.00035147846,0.000260532,0.00036929845],"domain_scores_gemma":[0.9993064,0.000008803518,0.000034048662,0.00047876054,0.000076477154,0.000095524345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006328258,0.00013359342,0.00049587083,0.000026982385,0.000050337378,0.000010343007,0.000083229985,0.00006374603,0.000018962606],"category_scores_gemma":[0.00008400928,0.00012294881,0.00024203636,0.00064507825,0.000021014786,0.000039527626,0.00006565557,0.000056614717,0.000030188856],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009243708,0.00035032938,0.07539469,0.26124296,0.0004082744,0.00013321333,0.000013490789,0.000016531809,0.0000021647145,0.020199113,0.15952219,0.4817927],"study_design_scores_gemma":[0.008240337,0.000266909,0.18695222,0.61747986,0.00036380926,0.00011076454,0.000072561015,0.00013122347,0.000018345501,0.0012817213,0.18473041,0.00035182355],"about_ca_topic_score_codex":0.0002448733,"about_ca_topic_score_gemma":0.00024351545,"teacher_disagreement_score":0.60687095,"about_ca_system_score_codex":0.0005427676,"about_ca_system_score_gemma":0.0002417796,"threshold_uncertainty_score":0.50137067},"labels":[],"label_agreement":null},{"id":"W4417482274","doi":"10.1016/j.jval.2025.09.2859","title":"RWD109 Integrating Mendelian Randomization With Real-World Evidence: Cost-Effectiveness of Lipoprotein Testing for Primary Prevention of Cardiovascular Disease in High-Income Countries","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre","funders":"","keywords":"Mendelian randomization; Primary prevention; Disease; Primary care; Mendelian inheritance; Leverage (statistics); Atherosclerotic cardiovascular disease","score_opus":0.03510096090607259,"score_gpt":0.3224504170256981,"score_spread":0.2873494561196255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9170009,0.020626202,0.044817146,0.00039636757,0.00016705401,0.016731888,0.000032039054,0.000049836894,0.00017860216],"genre_scores_gemma":[0.98762614,0.0021734426,0.008776971,0.000037112535,0.00006477352,0.0012308155,0.00004323958,0.00002815734,0.00001932273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962378,0.0013186091,0.0010565149,0.00043086795,0.00061918277,0.00033698406],"domain_scores_gemma":[0.9975247,0.0009739626,0.00036498802,0.0005979346,0.00042082253,0.00011763084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009976342,0.0002013058,0.0013667081,0.00066624174,0.00007456308,0.000008260878,0.00009503266,0.00007628579,0.0000014422894],"category_scores_gemma":[0.0014644625,0.00016686648,0.00028009154,0.0015358492,0.00007479294,0.00015651641,0.000034353412,0.0002186985,1.4633973e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022457737,0.00055176386,0.43988732,0.13372311,0.0011596036,0.000030972344,0.00045641983,0.19824995,0.00026093476,0.0053323708,0.000004180129,0.19788563],"study_design_scores_gemma":[0.030762525,0.001742081,0.83123773,0.11950725,0.0006945659,0.000005655518,0.00015743152,0.011166512,0.0025145507,0.0016739606,0.00022516403,0.00031253666],"about_ca_topic_score_codex":0.066391535,"about_ca_topic_score_gemma":0.00059642916,"teacher_disagreement_score":0.39135045,"about_ca_system_score_codex":0.0008880565,"about_ca_system_score_gemma":0.0028645096,"threshold_uncertainty_score":0.9398254},"labels":[],"label_agreement":null},{"id":"W4417488450","doi":"10.1016/j.ajpc.2025.101386","title":"Optimizing low-density lipoprotein cholesterol (LDL-C) management – a US physician survey of barriers and burdens","year":2025,"lang":"en","type":"article","venue":"American Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Merck Sharp and Dohme; Merck","keywords":"Ldl cholesterol; Cholesterol; MEDLINE; Disease management; Lipoprotein(a); Association (psychology)","score_opus":0.006685597482052897,"score_gpt":0.26396978845069574,"score_spread":0.25728419096864286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417488450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98343587,0.0012816574,0.013275973,0.00021738694,0.00021018987,0.00047709426,0.000011587649,0.000007475503,0.0010827946],"genre_scores_gemma":[0.99673903,0.00073737226,0.0017240403,0.00053348276,0.00014129911,0.000009944977,0.000004274212,0.000015566378,0.000094963136],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976929,0.00092023873,0.0005591883,0.00026263326,0.00028063238,0.0002844103],"domain_scores_gemma":[0.9983359,0.00007551116,0.00051622704,0.00037892486,0.0004958256,0.0001976025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018598452,0.0001844158,0.0014128912,0.0002605452,0.000065251304,0.000008701353,0.00013458959,0.00006120732,0.0000040662744],"category_scores_gemma":[0.00017073558,0.0001575546,0.00045750805,0.00038916705,0.00047670692,0.000055208693,0.0001206084,0.00033070365,9.2279964e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023103885,0.0001802968,0.1215463,0.0008488584,0.013831086,0.0006884983,0.0007980516,0.00037661602,0.002826664,0.00015163489,0.0005346189,0.85590696],"study_design_scores_gemma":[0.0026755114,0.0011742464,0.9903835,0.0006391657,0.0008339571,0.00027953356,0.0015989174,0.000018031553,0.0014993728,0.00007682493,0.0006814988,0.00013943115],"about_ca_topic_score_codex":0.001008558,"about_ca_topic_score_gemma":0.000036195153,"teacher_disagreement_score":0.86883724,"about_ca_system_score_codex":0.00010154742,"about_ca_system_score_gemma":0.00020374237,"threshold_uncertainty_score":0.642489},"labels":[],"label_agreement":null},{"id":"W44836796","doi":"10.1016/j.ajpath.2012.04.003","title":"Plaque Attack","year":2012,"lang":"en","type":"article","venue":"American Journal Of Pathology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer security; Business; Computer science","score_opus":0.019921184444916525,"score_gpt":0.3092790892126482,"score_spread":0.28935790476773166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W44836796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933316,0.001482891,0.0018227915,0.001189194,0.0002945037,0.000061954706,9.144298e-7,0.000007025343,0.0018091168],"genre_scores_gemma":[0.99148536,0.00026017462,0.0054048356,0.0015323277,0.0012462819,0.0000014073861,6.990503e-7,0.000012613156,0.00005633169],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990713,0.0001414916,0.0002660389,0.000058686466,0.00020107416,0.0002614316],"domain_scores_gemma":[0.999162,0.000026548212,0.00024630225,0.00019426818,0.00010398151,0.0002668923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008052863,0.000071106115,0.0004510228,0.00009412574,0.000022987238,0.0000021474086,0.000055655295,0.000033745306,0.00006769129],"category_scores_gemma":[0.00007422446,0.000050833776,0.00022361772,0.00013075283,0.00015392473,0.000060414408,0.000015086112,0.00025236173,0.00003994402],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005962052,0.0005616817,0.22699974,0.00006735354,0.000540502,0.003423988,0.00203991,0.000009152037,0.007665705,0.00090893335,0.0053940844,0.7517927],"study_design_scores_gemma":[0.003115597,0.006723345,0.6015789,0.00010226387,0.0005045347,0.15866664,0.0021294556,0.000005760057,0.0021483381,0.00007147823,0.22469872,0.00025496114],"about_ca_topic_score_codex":0.00001079251,"about_ca_topic_score_gemma":4.395507e-7,"teacher_disagreement_score":0.7515378,"about_ca_system_score_codex":0.000042891003,"about_ca_system_score_gemma":0.00010519665,"threshold_uncertainty_score":0.20729412},"labels":[],"label_agreement":null},{"id":"W45374862","doi":"","title":"Abstract 14020: Patients With Diabetes in Addition to Manifest Cardiovascular Disease are More Likely to Achieve LDL-Cholesterol-Target in Clinical Practice in Europe and Canada: Results of the Dyslipidemia International Study","year":2011,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dyslipidemia; Diabetes mellitus; Ldl cholesterol; Atherosclerotic cardiovascular disease; Disease; Cholesterol; Internal medicine; Type 2 diabetes; Intensive care medicine; Endocrinology","score_opus":0.021441184505870684,"score_gpt":0.2656670886159681,"score_spread":0.24422590411009742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W45374862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971338,0.00006164851,0.000015150555,0.0005956197,0.00015453139,0.001837905,0.00007737882,0.000005950876,0.000118016476],"genre_scores_gemma":[0.9991889,0.000006087499,0.0001302154,0.00043202736,0.00009173867,0.00006461036,0.00006707777,0.000017687638,0.0000016658568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977751,0.0003053033,0.0006326685,0.00039435326,0.0007219397,0.00017066573],"domain_scores_gemma":[0.9987836,0.00008192907,0.00018326992,0.0005011287,0.00028239895,0.00016768063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014945373,0.0001278803,0.0003453241,0.0001367178,0.000024648141,0.000009430507,0.000095767886,0.00005211144,0.00000362413],"category_scores_gemma":[0.0020447383,0.00009857936,0.00006629139,0.0003505237,0.000021432195,0.00017210681,0.000058689213,0.00025179557,0.0000012012131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077665807,0.0005084814,0.98903626,0.000044226992,0.00012442686,0.000054403863,0.0006370264,0.0020633205,0.0000024540122,0.0000017027686,0.000032539516,0.00671847],"study_design_scores_gemma":[0.0033738322,0.00013800766,0.99521846,0.00035586592,0.000086221924,0.0000010636905,0.00031788708,0.000099839075,0.0000043050995,0.00000331114,0.00030242655,0.00009878509],"about_ca_topic_score_codex":0.0708002,"about_ca_topic_score_gemma":0.10402671,"teacher_disagreement_score":0.033226512,"about_ca_system_score_codex":0.00020806634,"about_ca_system_score_gemma":0.00026133336,"threshold_uncertainty_score":0.93538743},"labels":[],"label_agreement":null},{"id":"W51603664","doi":"10.1161/circ.114.suppl_18.ii_899","title":"Abstract 4164: Decreased Skeletal Muscle Mitochondrial DNA in Patients on High-Dose Simvastatin Therapy","year":2006,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Simvastatin; Skeletal muscle; Mitochondrial DNA; Internal medicine; Cardiology; Endocrinology; Pharmacology; Biochemistry; Gene","score_opus":0.011604915850700876,"score_gpt":0.24178667221786462,"score_spread":0.23018175636716376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W51603664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976784,0.000078784404,0.000099736935,0.00008315196,0.00026853872,0.00095337507,0.000010754689,0.000048145794,0.0007791205],"genre_scores_gemma":[0.99827003,0.000007582151,0.00016987023,0.00017190452,0.0006435544,0.000035210443,0.0006648038,0.000027521695,0.000009507336],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986224,0.000059402922,0.00031096028,0.00027609893,0.00050588726,0.0002252594],"domain_scores_gemma":[0.99940777,0.000029469818,0.0000896992,0.0003242831,0.00006556104,0.0000832453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017190089,0.00013971192,0.00023904268,0.00012443506,0.000056939385,0.000018209166,0.000037573027,0.00010817408,0.000113189104],"category_scores_gemma":[0.00004116922,0.00012552839,0.00012542764,0.00016558192,0.00001924723,0.00008456373,0.0000051563343,0.0001419578,0.00005759768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012708554,0.0037508614,0.31219602,0.00019749456,0.00013301204,0.000086524546,0.0002440683,0.003004459,0.04118814,0.00085894094,0.00090496335,0.63616467],"study_design_scores_gemma":[0.007958487,0.00013174006,0.9897632,0.00004820646,0.000014152273,0.0000010364586,0.000008031843,0.0001270126,0.0004724583,0.0002152818,0.0011397104,0.00012069437],"about_ca_topic_score_codex":0.0019055032,"about_ca_topic_score_gemma":0.00006385206,"teacher_disagreement_score":0.6775672,"about_ca_system_score_codex":0.00016222328,"about_ca_system_score_gemma":0.000082183156,"threshold_uncertainty_score":0.51188993},"labels":[],"label_agreement":null},{"id":"W55408654","doi":"10.1016/s0828-282x(08)70616-0","title":"Book review","year":2008,"lang":"en","type":"article","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Dyslipidemia; Medicine; Hyperlipidemia; Clinical phenotype; Pathology; Phenotype; Disease; Genetics; Endocrinology","score_opus":0.019789188442790075,"score_gpt":0.2513699111625744,"score_spread":0.23158072271978433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W55408654","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00299315,0.96730834,0.0007605623,0.008540097,0.0004887474,0.0002047976,0.0000036038423,0.00000432702,0.019696392],"genre_scores_gemma":[0.43518502,0.4360625,0.00036789564,0.11777901,0.0071727578,0.000008564434,0.000008680106,0.000043196873,0.0033723689],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913144,0.00010225506,0.00029888377,0.00007663076,0.00014629179,0.00024451403],"domain_scores_gemma":[0.99862665,0.000011741939,0.00008801179,0.00024896316,0.00025269418,0.00077194924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047993244,0.000074622796,0.00067570875,0.00012731383,0.000071109935,0.0000016125167,0.00007820474,0.00007526638,0.00021344246],"category_scores_gemma":[0.0001765575,0.000057853285,0.00048678616,0.00009702087,0.00010993428,0.000039409926,0.0000034836116,0.00025989176,0.000034358316],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008737997,5.354819e-7,0.002563626,0.00015922458,0.00021443487,0.0026555073,0.000017225992,0.000011266788,0.000008065365,0.000018143232,0.9879923,0.006350962],"study_design_scores_gemma":[0.00042294123,0.00018926029,0.01583782,0.00033715996,0.00014357497,0.040309604,0.0000045942156,2.3221273e-7,0.000017630306,0.0000066731595,0.94268227,0.00004827098],"about_ca_topic_score_codex":0.00032266,"about_ca_topic_score_gemma":0.000045460594,"teacher_disagreement_score":0.5312458,"about_ca_system_score_codex":0.00011898423,"about_ca_system_score_gemma":0.0028741527,"threshold_uncertainty_score":0.50986236},"labels":[],"label_agreement":null},{"id":"W580892585","doi":"","title":"家族性高コレステロール血症familial hypercholesterolemia (FH)診療ガイドライン (代謝) -- (臨床分野での進歩)","year":2009,"lang":"ja","type":"article","venue":"Canadian parliamentary review","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Internal medicine; Medicine; Endocrinology; Cholesterol","score_opus":0.02132454168306089,"score_gpt":0.27396453795668513,"score_spread":0.2526399962736242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W580892585","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02108315,0.9086698,0.000013835716,0.042709485,0.0019502661,0.0052541364,0.00050411624,0.0001055183,0.019709645],"genre_scores_gemma":[0.17551668,0.56961334,0.00025706153,0.24726672,0.0037018592,0.00011116193,0.0005945913,0.00012800109,0.0028105848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932689,0.00059316517,0.0015133519,0.0012986886,0.0011593363,0.0021665727],"domain_scores_gemma":[0.99253404,0.000037771653,0.0002741204,0.0025629767,0.00021073318,0.0043803332],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0018522599,0.0009696463,0.0023929093,0.0003468464,0.00043302344,0.00011226472,0.0006881717,0.00043829385,0.004286948],"category_scores_gemma":[0.0001373278,0.0009327577,0.0012900777,0.0008796474,0.00017789911,0.00031978253,0.00005355634,0.0012493051,0.0028610167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004079707,0.00014115928,0.0010611265,0.0063201287,0.0005231395,0.0014112525,0.00017672671,9.296235e-7,0.00006959691,0.00007239206,0.30709732,0.68308544],"study_design_scores_gemma":[0.0020742915,0.0010623496,0.011651845,0.025806068,0.002392156,0.00063947414,0.00029264457,0.000014633464,0.000042004373,0.00003106731,0.955081,0.0009124655],"about_ca_topic_score_codex":0.20241483,"about_ca_topic_score_gemma":0.09274426,"teacher_disagreement_score":0.68217295,"about_ca_system_score_codex":0.0026113102,"about_ca_system_score_gemma":0.0037798993,"threshold_uncertainty_score":0.9993123},"labels":[],"label_agreement":null},{"id":"W598675542","doi":"10.71781/4931","title":"Interventions visant à améliorer la détection et le traitement de l’ostéoporose en soins de première ligne","year":2011,"lang":"fr","type":"dissertation","venue":"Open MIND","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Osteoporosis Canada","keywords":"Medicine; Gynecology","score_opus":0.03795776915268524,"score_gpt":0.3635493792845296,"score_spread":0.32559161013184434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W598675542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9087272,0.0060264813,0.0056818477,0.00056593225,0.0013227072,0.004098011,0.00015623112,0.000012246073,0.073409334],"genre_scores_gemma":[0.93650615,0.0018166185,0.010538896,0.00010499,0.0009006086,0.0006855797,0.0017106647,0.0001453144,0.047591154],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964597,0.00094001205,0.0008117863,0.00067821256,0.00044117152,0.0006691189],"domain_scores_gemma":[0.9982638,0.0000794421,0.0003773607,0.0006879888,0.000166232,0.0004251738],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004167717,0.0004344187,0.00077417144,0.00021347472,0.00027313182,0.000228343,0.00042907466,0.0006706632,0.0038280035],"category_scores_gemma":[0.00020953834,0.00043366625,0.0008917774,0.0002393055,0.000067296656,0.00031952435,0.00013915228,0.00082346663,0.00038635876],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057398854,0.0026624885,0.00092997536,0.0028340083,0.001387722,0.00025179022,0.031637993,0.00007171984,0.008830558,0.0017864669,0.0006031701,0.9484301],"study_design_scores_gemma":[0.017021695,0.0038344467,0.17186882,0.033050504,0.0077831363,0.0013105554,0.09095825,0.00085514993,0.14458825,0.0006326036,0.5258776,0.002218987],"about_ca_topic_score_codex":0.0122927055,"about_ca_topic_score_gemma":0.012037052,"teacher_disagreement_score":0.94621116,"about_ca_system_score_codex":0.00049259147,"about_ca_system_score_gemma":0.002866007,"threshold_uncertainty_score":0.99981153},"labels":[],"label_agreement":null},{"id":"W612116504","doi":"10.71781/4771","title":"L'impact de l'adhésion aux statines sur les maladies cérébrovasculaires en prévention primaire dans un contexte réel d'utilisation","year":2008,"lang":"en","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Diabetes mellitus; Observational study; Statin; Regimen; Cohort; Rate ratio; Pediatrics; Confidence interval; Endocrinology","score_opus":0.00781808014360623,"score_gpt":0.20985116702426257,"score_spread":0.20203308688065635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W612116504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96821404,0.025697222,0.00065420015,0.00015029669,0.0004664458,0.0010166331,0.00005883929,0.00021079449,0.0035315405],"genre_scores_gemma":[0.97210807,0.0055959816,0.0005416978,0.000039672657,0.0003661227,0.00006808301,0.0020720954,0.00007159536,0.019136667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967516,0.0003191644,0.00054068107,0.0006775166,0.0011825901,0.00052844215],"domain_scores_gemma":[0.9978339,0.00007124736,0.00043193024,0.0006123934,0.00064926385,0.00040124753],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00042541663,0.0005562004,0.00077035616,0.00035733264,0.0046359655,0.00004122082,0.00021937018,0.0006362856,0.00006126298],"category_scores_gemma":[0.00019844186,0.0005429781,0.0011202327,0.0002938166,0.00019566325,0.00035779466,0.00006623995,0.00056395377,0.000016502332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012603154,0.0025086466,0.43042105,0.0074819475,0.010800845,0.012889704,0.21037559,0.004831328,0.09047317,0.004783994,0.0030113598,0.2098192],"study_design_scores_gemma":[0.0027659528,0.00034591803,0.95925486,0.0011512457,0.0010935193,0.0027500896,0.017385615,0.00062210596,0.009806844,0.00011334394,0.004177573,0.00053291075],"about_ca_topic_score_codex":0.08712097,"about_ca_topic_score_gemma":0.014396723,"teacher_disagreement_score":0.5288338,"about_ca_system_score_codex":0.006660981,"about_ca_system_score_gemma":0.004098614,"threshold_uncertainty_score":0.99970216},"labels":[],"label_agreement":null},{"id":"W644300461","doi":"10.1097/hco.0000000000000184","title":"New worldwide lipid guidelines","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nice; Excellence; Atherosclerotic cardiovascular disease; Population; Risk assessment; Health care; Framingham Risk Score; Disease; Family medicine; Environmental health; Internal medicine","score_opus":0.27156874526635566,"score_gpt":0.47661151550544384,"score_spread":0.20504277023908818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W644300461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[1.7907921e-7,0.9769895,0.0007790584,0.00020858928,0.01860473,0.0018885669,0.000025991158,0.0000827847,0.0014205861],"genre_scores_gemma":[1.5415515e-7,0.9720737,0.00053268886,0.000037954072,0.0257011,0.00027216022,0.00076397124,0.0000798997,0.0005384229],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99600124,0.00059673225,0.0014162442,0.0008109548,0.0005101141,0.00066471996],"domain_scores_gemma":[0.997543,0.000077422046,0.00029864337,0.0012551708,0.00032607748,0.0004997293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019744877,0.0005717607,0.0050572045,0.00056073756,0.000034829613,0.000016080878,0.00029010733,0.0006198604,0.00004696128],"category_scores_gemma":[0.00046999796,0.0004304051,0.0018129818,0.0006389269,0.00005760599,0.000044294917,0.0002303527,0.00094163447,0.0002760128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007388268,0.00001085015,0.000035846482,0.01673549,0.00018572829,0.000013373186,0.000007406256,0.0000016471799,3.7041863e-9,0.00016988858,0.23358326,0.7492491],"study_design_scores_gemma":[0.00094501453,0.000101886355,0.00002346492,0.020507567,0.00051877834,0.00091415877,0.000009691169,0.0000012576382,1.5710597e-8,0.000069487025,0.97656465,0.0003440067],"about_ca_topic_score_codex":0.0000800616,"about_ca_topic_score_gemma":0.0000018684866,"teacher_disagreement_score":0.7489051,"about_ca_system_score_codex":0.00048000313,"about_ca_system_score_gemma":0.0033665693,"threshold_uncertainty_score":0.99981475},"labels":[],"label_agreement":null},{"id":"W6890161294","doi":"10.3389/fphar.2022.1003370.s002","title":"Presentation1_The association between statin use and osteoarthritis-related outcomes: An updated systematic review and meta-analysis.pdf","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Statin; Observational study; Meta-analysis; Population; Systematic review; MEDLINE; Atorvastatin; Risk assessment","score_opus":0.06801038071654189,"score_gpt":0.3178787201586604,"score_spread":0.24986833944211853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6890161294","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.091652505,0.20807596,0.000010671161,0.0062863934,0.00005814544,0.024352467,0.6685638,0.0004748222,0.00052529614],"genre_scores_gemma":[0.41558492,0.0002780502,0.00017734394,0.004875624,0.000040849503,0.0038438232,0.56704676,0.00007303971,0.008079605],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99754053,0.00085746136,0.0005169678,0.00029134308,0.000621612,0.00017210664],"domain_scores_gemma":[0.9987162,0.00016120037,0.00035007918,0.00044399945,0.00017508763,0.00015348586],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074258074,0.0001529842,0.0016555347,0.00010951049,0.00019113558,0.00006976601,0.000065605105,0.000053810123,0.07402894],"category_scores_gemma":[0.0008544033,0.00011702758,0.00044424945,0.0004990468,0.000003420403,0.00021506213,0.000086498854,0.00022237796,0.000090141155],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002688493,0.00025115858,0.023290092,0.25239885,0.64143044,0.00017533841,0.0016114075,0.0000501734,0.000009791743,0.000026226855,0.0803566,0.0003730184],"study_design_scores_gemma":[0.001594896,0.0003395605,0.0751314,0.0017627681,0.9173636,0.00005581952,0.00032496202,0.00007913502,0.00001097522,0.000020075531,0.0029792802,0.00033757056],"about_ca_topic_score_codex":0.00009309669,"about_ca_topic_score_gemma":0.000028580871,"teacher_disagreement_score":0.32393244,"about_ca_system_score_codex":0.000098085686,"about_ca_system_score_gemma":0.000047515066,"threshold_uncertainty_score":0.92681754},"labels":[],"label_agreement":null},{"id":"W6901744931","doi":"10.6084/m9.figshare.10117160.v1","title":"MOESM1 of Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis","year":2019,"lang":"en","type":"article","venue":"Open MIND","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Statin; Heart failure; Cohort study; Risk assessment; Prospective cohort study","score_opus":0.06369387609481085,"score_gpt":0.37066218649341687,"score_spread":0.306968310398606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901744931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929838,0.0033272326,0.0000037979955,0.0007572987,0.0000062808253,0.0028416156,0.000050525046,2.9359754e-7,0.000029138424],"genre_scores_gemma":[0.9945768,0.00048008145,0.003748964,0.00033504656,0.0000023093837,0.000033685574,0.000023390541,0.000006816288,0.00079287007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823624,0.00042316518,0.0008011892,0.00017547426,0.0002883824,0.00007552287],"domain_scores_gemma":[0.9987977,0.0002397026,0.00040121074,0.00035264896,0.00015882056,0.000049931783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029585816,0.000074668314,0.002785148,0.00006331144,0.000006785922,0.000014340992,0.000045146196,0.00005796741,0.0002183312],"category_scores_gemma":[0.0009227016,0.000046340538,0.00044571524,0.00019490883,0.000011865974,0.000108926644,0.00005177437,0.00007738501,0.0000058126157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009097452,0.00011958383,0.9454419,0.018563237,0.035669655,4.4126364e-7,0.000084829204,3.661e-7,0.000001438992,0.000001528966,0.00003826232,0.00006968528],"study_design_scores_gemma":[0.0016954934,0.00025204994,0.6257486,0.0013427655,0.37055168,9.91062e-7,0.00013536675,0.000015577936,0.000017825723,0.000002166227,0.00015818802,0.00007934709],"about_ca_topic_score_codex":0.00044670125,"about_ca_topic_score_gemma":0.00033047152,"teacher_disagreement_score":0.33488202,"about_ca_system_score_codex":0.000022689164,"about_ca_system_score_gemma":0.00003843527,"threshold_uncertainty_score":0.23905736},"labels":[],"label_agreement":null},{"id":"W6901844563","doi":"10.60692/kvt67-12840","title":"Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta","funders":"","keywords":"Alirocumab; Mace; Acute coronary syndrome; Placebo; Statin; Hazard ratio; Propensity score matching; Clinical trial","score_opus":0.04942660450104167,"score_gpt":0.27798657811383204,"score_spread":0.22855997361279037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901844563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885679,0.00001959671,0.009670252,0.00008835276,0.00019543082,0.0011347396,0.00017942904,0.000045302284,0.00009900515],"genre_scores_gemma":[0.99830616,0.0000027023423,0.0011783962,0.0003022331,0.000059452585,0.000039218347,0.000031107134,0.000016113097,0.00006465042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997453,0.00016491549,0.0013644849,0.00023754919,0.00054671266,0.00023338442],"domain_scores_gemma":[0.9982446,0.000014317227,0.00035559066,0.00074552494,0.0003943057,0.00024568103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010189305,0.00019673983,0.00092950126,0.00015019551,0.00005976398,0.000028554712,0.00008489604,0.00019116014,0.000011282994],"category_scores_gemma":[0.00006539539,0.00016299766,0.0002587124,0.00023919412,0.00004835518,0.0002834805,0.00017799174,0.00018254867,0.00005258008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004628061,0.00005266173,0.9309386,0.007618899,0.0015916453,0.0002619694,0.019808669,0.000018853605,0.000110083434,0.000025108098,0.00001583485,0.03492963],"study_design_scores_gemma":[0.0046644825,0.00030527596,0.98704445,0.0015651289,0.00023021168,0.0013203179,0.0027464759,0.00004717221,0.0019030559,1.8212714e-7,0.00003093655,0.00014229634],"about_ca_topic_score_codex":0.00005766529,"about_ca_topic_score_gemma":0.0000014293666,"teacher_disagreement_score":0.05610588,"about_ca_system_score_codex":0.00007691988,"about_ca_system_score_gemma":0.0001441473,"threshold_uncertainty_score":0.6646852},"labels":[],"label_agreement":null},{"id":"W6901928062","doi":"10.6084/m9.figshare.25876066.v1","title":"Additional file 1 of Strategies aiming to improve statin therapy adherence in older adults: a systematic review","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Université Laval; Université de Sherbrooke; Centre hospitalier universitaire de Québec","funders":"","keywords":"MEDLINE; Disease; Clinical trial; Risk assessment; Statin","score_opus":0.024350328288670387,"score_gpt":0.2953789087895792,"score_spread":0.2710285805009088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901928062","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022999464,0.036181226,0.0000010939805,0.000050826384,0.000012605313,0.0022221983,0.96078473,0.00003589431,0.00068841426],"genre_scores_gemma":[0.0035649226,0.00025952043,0.00037382607,0.0009339412,0.00013528399,0.014084981,0.9801552,0.000030500263,0.00046177572],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989596,0.000050108047,0.00033009864,0.00020615883,0.00031092495,0.0001431018],"domain_scores_gemma":[0.99919456,0.00028035245,0.000060184157,0.00026870318,0.00012676777,0.00006941553],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000085187996,0.0001052807,0.00043279203,0.00006510119,0.000013082106,0.00002182462,0.000068564994,0.000041175415,0.9433577],"category_scores_gemma":[0.001410086,0.00007637132,0.00015300607,0.00028851882,0.0000027189872,0.000081542545,0.000020462869,0.00012829555,0.00088973704],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005165942,0.000015402,2.2424123e-8,0.32263747,0.000029795154,0.000027719354,0.0001229411,1.9543056e-7,0.0000021287751,0.000001890276,0.6729291,0.00422815],"study_design_scores_gemma":[0.00018909022,0.0001639995,0.00015213962,0.9574819,0.000018394274,0.000021194473,0.00035375977,0.00007753238,0.000026222513,0.0000054108896,0.041429948,0.000080382066],"about_ca_topic_score_codex":0.000027552362,"about_ca_topic_score_gemma":0.000014661094,"teacher_disagreement_score":0.942468,"about_ca_system_score_codex":0.000044430886,"about_ca_system_score_gemma":0.00042017366,"threshold_uncertainty_score":0.9998882},"labels":[],"label_agreement":null},{"id":"W6901944761","doi":"10.6084/m9.figshare.22625152.v1","title":"Additional file 10 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cascade; Familial hypercholesterolemia; Key (lock); Triglycerides blood","score_opus":0.1634249307961576,"score_gpt":0.325189430894413,"score_spread":0.16176450009825538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6901944761","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035243335,0.00017209686,0.000019248284,0.0000860295,0.000005134327,0.0012575561,0.9941185,0.00014927267,0.0006677999],"genre_scores_gemma":[0.0061874744,0.0000035540975,0.082283825,0.00013901835,0.00008437696,0.004577604,0.90633726,0.000027513683,0.00035939587],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99924856,0.00004341122,0.00017521248,0.0001780742,0.00017208868,0.00018264695],"domain_scores_gemma":[0.99831986,0.0008841573,0.000055945606,0.00022524933,0.00042109273,0.00009368941],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005772657,0.000093493145,0.00021419227,0.00006249986,0.000113633316,0.00003554016,0.000055638608,0.000061238454,0.052282516],"category_scores_gemma":[0.0017166989,0.00009143865,0.00007638455,0.00022750052,0.000011603688,0.00009658645,0.00008280609,0.000104072285,0.00011157597],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042458247,0.000021230328,0.0000013939771,0.0011223664,0.00005312035,0.000013987402,0.00036374803,0.00026179318,0.00066561403,0.0000014447587,0.9114415,0.08601133],"study_design_scores_gemma":[0.0016216625,0.0010830035,0.015913945,0.012028517,0.0000628563,0.00020019311,0.0046072975,0.00688874,0.00080401235,0.000082749044,0.9564056,0.00030143955],"about_ca_topic_score_codex":0.000018927383,"about_ca_topic_score_gemma":0.0000066439825,"teacher_disagreement_score":0.087781295,"about_ca_system_score_codex":0.000025972733,"about_ca_system_score_gemma":0.00021810213,"threshold_uncertainty_score":0.94858384},"labels":[],"label_agreement":null},{"id":"W6902119760","doi":"10.6084/m9.figshare.5572897","title":"Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review","year":2017,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mace; Myocardial infarction; Stroke (engine); Observational study; Incidence (geometry); Systematic review; Disease; Meta-analysis; Secondary prevention; Mortality rate","score_opus":0.029576308439222695,"score_gpt":0.2653104087097926,"score_spread":0.2357341002705699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902119760","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014190793,0.92982006,0.0000036777756,0.00035210166,0.0001680687,0.017950319,0.03652079,0.00022653176,0.0007676271],"genre_scores_gemma":[0.84940106,0.031216344,0.00013071412,0.0010719755,0.0014175023,0.006773683,0.10885313,0.00040784653,0.00072775205],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99530256,0.00042410006,0.00058162457,0.00096296734,0.0021091918,0.00061956013],"domain_scores_gemma":[0.99167526,0.00003595429,0.0002688749,0.0063708546,0.0007633485,0.00088573096],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040471376,0.00055386085,0.0022405607,0.0001790117,0.00033874335,0.00021196679,0.00051442103,0.000109777415,0.0011743427],"category_scores_gemma":[0.0011300957,0.00040196048,0.0023418583,0.0004152596,0.00003543334,0.00032670412,0.00022949037,0.0004772086,0.00032367566],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039587563,0.0003043329,0.009464351,0.9625465,0.010968169,0.003947053,0.00015628262,0.0005400581,3.8831683e-7,0.000012689451,0.007592348,0.00407192],"study_design_scores_gemma":[0.0028454615,0.00006479228,0.39696515,0.5776258,0.0031208682,0.000011742532,0.0000072437424,0.000058001515,7.129018e-7,0.0000028716177,0.01890056,0.00039680183],"about_ca_topic_score_codex":0.00018124151,"about_ca_topic_score_gemma":0.000010495661,"teacher_disagreement_score":0.89860374,"about_ca_system_score_codex":0.0002744049,"about_ca_system_score_gemma":0.00033796448,"threshold_uncertainty_score":0.99984324},"labels":[],"label_agreement":null},{"id":"W6902146029","doi":"10.6084/m9.figshare.22625140","title":"Additional file 8 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cascade; Familial hypercholesterolemia; Key (lock); Triglycerides blood","score_opus":0.1631401995175904,"score_gpt":0.3228361730074607,"score_spread":0.1596959734898703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902146029","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017640323,0.00012012296,0.000016351194,0.00006782853,0.000004212035,0.0010623833,0.9963738,0.00012587686,0.00046544502],"genre_scores_gemma":[0.0035034358,0.0000026146522,0.08337557,0.00012809658,0.00006417384,0.0046742195,0.9080847,0.000021109752,0.00014611012],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992807,0.000040566527,0.00016698358,0.0001709394,0.00016403843,0.00017678208],"domain_scores_gemma":[0.99815273,0.0011155535,0.000054118438,0.00021448804,0.00037224733,0.00009083684],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004832479,0.00008922164,0.00020582123,0.000060548646,0.000109869085,0.000033524717,0.000052451207,0.000057645175,0.06531276],"category_scores_gemma":[0.0019223384,0.00008724774,0.000073438736,0.00022617931,0.000010970582,0.000092466915,0.0000795959,0.00010657697,0.00008483147],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026038377,0.000016455022,0.0000011941574,0.0009110806,0.00004264306,0.000012044074,0.00031043764,0.00022198384,0.00051148585,0.0000010572654,0.9211167,0.076828845],"study_design_scores_gemma":[0.0012606038,0.0008551152,0.017829884,0.0130391605,0.000050302413,0.00020166655,0.0045748423,0.005887494,0.00059887284,0.00006674552,0.95537025,0.00026504337],"about_ca_topic_score_codex":0.000018276376,"about_ca_topic_score_gemma":0.0000062667455,"teacher_disagreement_score":0.088289075,"about_ca_system_score_codex":0.000024695166,"about_ca_system_score_gemma":0.00021851806,"threshold_uncertainty_score":0.9355417},"labels":[],"label_agreement":null},{"id":"W6902181786","doi":"10.6084/m9.figshare.26723837","title":"Additional file 4 of Strategies aiming to improve statin therapy adherence in older adults: a systematic review","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Université Laval; Université de Sherbrooke; Centre hospitalier universitaire de Québec","funders":"","keywords":"MEDLINE; Disease; Clinical trial; Risk assessment; Statin","score_opus":0.02407272306186635,"score_gpt":0.2953670760426278,"score_spread":0.27129435298076143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902181786","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023094097,0.03656902,0.0000011100059,0.000050512757,0.000012627055,0.0022268197,0.96038914,0.000035938112,0.00069173955],"genre_scores_gemma":[0.0037444106,0.00026602083,0.00037264192,0.00094255,0.00013669167,0.013917116,0.9801321,0.000030759686,0.00045767747],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989594,0.00005004673,0.00033039565,0.0002060814,0.0003109739,0.00014310771],"domain_scores_gemma":[0.99919844,0.00027817042,0.000060204617,0.00026840434,0.00012535336,0.00006941118],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008522148,0.00010527233,0.00043295606,0.00006511082,0.000013088147,0.000021887845,0.00006857327,0.0000411754,0.9408042],"category_scores_gemma":[0.0013876148,0.00007636581,0.00015300843,0.00028835775,0.0000027197514,0.00008162613,0.000020455063,0.00012826174,0.0008800476],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000052709097,0.000015430434,2.2555353e-8,0.3250526,0.000029822115,0.000028254435,0.00012331072,1.9279453e-7,0.000002101898,0.0000019574413,0.67043954,0.004301526],"study_design_scores_gemma":[0.00019128417,0.00016697429,0.00015201382,0.95845604,0.000018373978,0.000021230117,0.00035329146,0.000078019264,0.000026257574,0.0000054936872,0.04045055,0.0000804593],"about_ca_topic_score_codex":0.000027624905,"about_ca_topic_score_gemma":0.00001484058,"teacher_disagreement_score":0.9399241,"about_ca_system_score_codex":0.000044435666,"about_ca_system_score_gemma":0.00041866783,"threshold_uncertainty_score":0.9998979},"labels":[],"label_agreement":null},{"id":"W6902337114","doi":"10.6084/m9.figshare.5572897.v2","title":"Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mace; Myocardial infarction; Stroke (engine); Observational study; Incidence (geometry); Systematic review; Disease; Meta-analysis; Secondary prevention; Mortality rate","score_opus":0.024069108466013733,"score_gpt":0.25483069975046624,"score_spread":0.2307615912844525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902337114","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015843099,0.932643,0.000008211654,0.00021226717,0.00017631159,0.018381296,0.031724993,0.00032657545,0.00068427547],"genre_scores_gemma":[0.80219454,0.022542424,0.0002483988,0.0025850602,0.0032030435,0.007597551,0.16035442,0.00054503686,0.00072953926],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9950432,0.0005587548,0.00062772125,0.0009804801,0.0021370684,0.00065275567],"domain_scores_gemma":[0.9942118,0.000041629886,0.00015353214,0.0035704614,0.0011430165,0.0008795463],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038486157,0.0005512054,0.0020604916,0.00024226496,0.00015083814,0.00008096241,0.00029346766,0.00010845223,0.0023864363],"category_scores_gemma":[0.0006224184,0.00039819363,0.0020056267,0.0013332085,0.000040980798,0.00020510759,0.00014523529,0.00040874488,0.0006487513],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006037024,0.00039039736,0.004266593,0.9588019,0.012477021,0.0023307288,0.00033427755,0.0003028252,7.618768e-7,0.000013636104,0.016767466,0.0037106492],"study_design_scores_gemma":[0.0033216458,0.00019789425,0.20115077,0.7466463,0.004021089,0.00001931229,0.000014959706,0.00009537299,0.0000020456512,0.0000035741252,0.04398491,0.00054212054],"about_ca_topic_score_codex":0.00009969455,"about_ca_topic_score_gemma":0.0000093851495,"teacher_disagreement_score":0.9101005,"about_ca_system_score_codex":0.00030709922,"about_ca_system_score_gemma":0.00035736477,"threshold_uncertainty_score":0.999847},"labels":[],"label_agreement":null},{"id":"W6902795405","doi":"10.7916/d8bv7f51","title":"Residual macrovascular risk in 2013: what have we learned?","year":2014,"lang":"en","type":"article","venue":"Columbia Academic Commons (Columbia University)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"H. Lundbeck A/S; Servier; Astellas Pharma; Novo Nordisk; International Atherosclerosis Society; Québec Consortium for Drug Discovery; Anthera; Regeneron Pharmaceuticals; Amarin Corporation; Boston Scientific Corporation; Genentech; Valeant Pharmaceuticals International; Daiichi Sankyo Europe; Kowa Company; Halozyme; Sanofi; GlaxoSmithKline; Eli Lilly and Company; AstraZeneca; Amylin Pharmaceuticals; Amgen; Pfizer","keywords":"Evolocumab; Atherosclerotic cardiovascular disease; Residual risk; Triglycerides blood; Disease","score_opus":0.018189756913602202,"score_gpt":0.23510628862065325,"score_spread":0.21691653170705105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6902795405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766678,0.0034529753,0.00037475684,0.0038014525,0.00035721206,0.0016653214,0.000031780506,0.00027684873,0.013371803],"genre_scores_gemma":[0.92128307,0.024982598,0.00045261867,0.0005232694,0.0005698717,0.000016582891,0.0000631555,0.00010673511,0.0520021],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99574083,0.0009775672,0.00054108497,0.0009699628,0.0008116098,0.0009589573],"domain_scores_gemma":[0.9971844,0.00019993834,0.0002517932,0.0015607906,0.00017400474,0.00062907947],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001915644,0.00029569145,0.0010215102,0.00044141093,0.0005244119,0.00023374638,0.00066758995,0.0008070424,0.00053960754],"category_scores_gemma":[0.00029789432,0.00050217746,0.00058410317,0.0011556838,0.00031815557,0.0006683682,0.00045780579,0.0026283474,0.00017406553],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026785917,0.00032464016,0.7552279,0.00033483078,0.0005488088,0.0005368082,0.00071612664,0.00014048637,0.00013452274,0.00023017565,0.07561021,0.16592759],"study_design_scores_gemma":[0.006806091,0.00031393228,0.23408453,0.0007735821,0.0005802772,0.00012765486,0.0023654925,0.0007856027,0.00003563629,0.00072243967,0.75279015,0.0006146127],"about_ca_topic_score_codex":0.077565946,"about_ca_topic_score_gemma":0.30463335,"teacher_disagreement_score":0.67717993,"about_ca_system_score_codex":0.0006235918,"about_ca_system_score_gemma":0.00037901138,"threshold_uncertainty_score":0.999743},"labels":[],"label_agreement":null},{"id":"W6904398562","doi":"10.1371/journal.pgph.0003406.s005","title":"Hypercholesterolemia diagnosis codes.","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primary care; Pandemic; Health care; Confidence interval; Primary health care; Depression (economics); Telehealth; Coronavirus disease 2019 (COVID-19)","score_opus":0.04064178948524947,"score_gpt":0.29944064165461565,"score_spread":0.25879885216936616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6904398562","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.105456136,0.16859971,0.000031431748,0.012014931,0.001276078,0.0047994796,0.5825159,0.0037216407,0.12158471],"genre_scores_gemma":[0.9392589,0.00016044728,0.0001305299,0.0021602323,0.0013184077,0.0010787022,0.054405913,0.0000631385,0.0014237363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99924666,0.000016562479,0.00010387585,0.00021163152,0.0002460781,0.00017517144],"domain_scores_gemma":[0.99946743,0.00003650545,0.000008092849,0.00030839752,0.00004254238,0.00013704789],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00006408833,0.00008938426,0.00016783758,0.000052314164,0.00003251291,0.000051435607,0.000051361378,0.000079116966,0.10967952],"category_scores_gemma":[0.00018172771,0.000070270245,0.00019717429,0.0001562371,0.0000029462988,0.00005986527,0.00003601396,0.0001923675,0.007332785],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005139714,0.000021954613,0.00020865427,0.0014992306,0.00009532409,0.00039691277,0.00007234448,0.0000010758112,0.000033252316,0.000016495766,0.8289812,0.16866842],"study_design_scores_gemma":[0.00019431002,0.00005861524,0.008355182,0.0042353203,0.000042625757,0.00016524065,0.000011305574,0.00008749297,0.0010148862,0.000011688693,0.9857412,0.00008214493],"about_ca_topic_score_codex":0.00001574723,"about_ca_topic_score_gemma":0.0000036942022,"teacher_disagreement_score":0.83380276,"about_ca_system_score_codex":0.00006154255,"about_ca_system_score_gemma":0.00012776718,"threshold_uncertainty_score":0.9934401},"labels":[],"label_agreement":null},{"id":"W6920286755","doi":"10.60692/a0az9-har25","title":"Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: ODYSSEY OUTCOMES","year":2024,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; Sanofi (Canada); University of Alberta","funders":"","keywords":"Alirocumab; Placebo; Adverse effect; Acute coronary syndrome; Unstable angina; Mace; PCSK9; Angina","score_opus":0.016542324980808307,"score_gpt":0.23290364041293452,"score_spread":0.21636131543212622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920286755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903156,0.0006440266,0.00541261,0.0003472214,0.0004552147,0.001813856,0.000092079645,0.00041361386,0.0005057486],"genre_scores_gemma":[0.99787086,0.000008454827,0.00053406425,0.0006230901,0.000080037426,0.0004431802,0.000017074353,0.000041218704,0.0003820033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761456,0.00007734101,0.00066357024,0.00040585521,0.00083013,0.00040856015],"domain_scores_gemma":[0.99862474,0.000011338894,0.0000629651,0.0008256807,0.00010146435,0.00037379115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009315862,0.00037249963,0.0010330717,0.00045608883,0.00014750696,0.000361402,0.000085207874,0.00018480753,0.000012224293],"category_scores_gemma":[0.000023589371,0.00026579795,0.00046102036,0.0002729078,0.000036837162,0.00072007906,0.00017789974,0.00020946594,0.00025854332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014234796,0.0000036303866,0.92160326,0.005073648,0.0055325134,0.0009206723,0.023225462,0.00001076641,0.0000014115618,0.000077681005,0.000057060097,0.043351546],"study_design_scores_gemma":[0.001697365,0.00018121909,0.9792481,0.0008520561,0.0010191432,0.005621677,0.008701982,0.00024342902,0.000050993032,0.0000014808263,0.0019918394,0.000390694],"about_ca_topic_score_codex":0.00008245368,"about_ca_topic_score_gemma":4.7742526e-7,"teacher_disagreement_score":0.057644863,"about_ca_system_score_codex":0.00014740558,"about_ca_system_score_gemma":0.00007235263,"threshold_uncertainty_score":0.99997944},"labels":[],"label_agreement":null},{"id":"W6920358677","doi":"10.60692/bh5t6-hsn43","title":"Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol","year":2021,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta","funders":"","keywords":"Alirocumab; Mace; Acute coronary syndrome; Placebo; Statin; Hazard ratio; Propensity score matching; Clinical trial","score_opus":0.04942660450104167,"score_gpt":0.27798657811383204,"score_spread":0.22855997361279037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920358677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885679,0.00001959671,0.009670252,0.00008835276,0.00019543082,0.0011347396,0.00017942904,0.000045302284,0.00009900515],"genre_scores_gemma":[0.99830616,0.0000027023423,0.0011783962,0.0003022331,0.000059452585,0.000039218347,0.000031107134,0.000016113097,0.00006465042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997453,0.00016491549,0.0013644849,0.00023754919,0.00054671266,0.00023338442],"domain_scores_gemma":[0.9982446,0.000014317227,0.00035559066,0.00074552494,0.0003943057,0.00024568103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010189305,0.00019673983,0.00092950126,0.00015019551,0.00005976398,0.000028554712,0.00008489604,0.00019116014,0.000011282994],"category_scores_gemma":[0.00006539539,0.00016299766,0.0002587124,0.00023919412,0.00004835518,0.0002834805,0.00017799174,0.00018254867,0.00005258008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004628061,0.00005266173,0.9309386,0.007618899,0.0015916453,0.0002619694,0.019808669,0.000018853605,0.000110083434,0.000025108098,0.00001583485,0.03492963],"study_design_scores_gemma":[0.0046644825,0.00030527596,0.98704445,0.0015651289,0.00023021168,0.0013203179,0.0027464759,0.00004717221,0.0019030559,1.8212714e-7,0.00003093655,0.00014229634],"about_ca_topic_score_codex":0.00005766529,"about_ca_topic_score_gemma":0.0000014293666,"teacher_disagreement_score":0.05610588,"about_ca_system_score_codex":0.00007691988,"about_ca_system_score_gemma":0.0001441473,"threshold_uncertainty_score":0.6646852},"labels":[],"label_agreement":null},{"id":"W6920372483","doi":"10.60692/9hswd-g0736","title":"Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: ODYSSEY OUTCOMES","year":2024,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; Sanofi (Canada); University of Alberta","funders":"","keywords":"Alirocumab; Placebo; Adverse effect; Acute coronary syndrome; Unstable angina; Mace; PCSK9; Angina","score_opus":0.016542324980808307,"score_gpt":0.23290364041293452,"score_spread":0.21636131543212622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920372483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903156,0.0006440266,0.00541261,0.0003472214,0.0004552147,0.001813856,0.000092079645,0.00041361386,0.0005057486],"genre_scores_gemma":[0.99787086,0.000008454827,0.00053406425,0.0006230901,0.000080037426,0.0004431802,0.000017074353,0.000041218704,0.0003820033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761456,0.00007734101,0.00066357024,0.00040585521,0.00083013,0.00040856015],"domain_scores_gemma":[0.99862474,0.000011338894,0.0000629651,0.0008256807,0.00010146435,0.00037379115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009315862,0.00037249963,0.0010330717,0.00045608883,0.00014750696,0.000361402,0.000085207874,0.00018480753,0.000012224293],"category_scores_gemma":[0.000023589371,0.00026579795,0.00046102036,0.0002729078,0.000036837162,0.00072007906,0.00017789974,0.00020946594,0.00025854332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014234796,0.0000036303866,0.92160326,0.005073648,0.0055325134,0.0009206723,0.023225462,0.00001076641,0.0000014115618,0.000077681005,0.000057060097,0.043351546],"study_design_scores_gemma":[0.001697365,0.00018121909,0.9792481,0.0008520561,0.0010191432,0.005621677,0.008701982,0.00024342902,0.000050993032,0.0000014808263,0.0019918394,0.000390694],"about_ca_topic_score_codex":0.00008245368,"about_ca_topic_score_gemma":4.7742526e-7,"teacher_disagreement_score":0.057644863,"about_ca_system_score_codex":0.00014740558,"about_ca_system_score_gemma":0.00007235263,"threshold_uncertainty_score":0.99997944},"labels":[],"label_agreement":null},{"id":"W6920554806","doi":"10.60692/hcjck-sdr63","title":"Predictors of the Common Adverse Drug Reactions of Statins","year":2012,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Atorvastatin; Incidence (geometry); Statin; Drug reaction; Drug; Adverse effect; myalgia","score_opus":0.02102299026854193,"score_gpt":0.2239167108344362,"score_spread":0.20289372056589428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920554806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926761,0.000008771547,0.0005412691,0.000032369593,0.00043415857,0.0005667238,0.00008719791,0.00003632922,0.00561711],"genre_scores_gemma":[0.9996217,3.2718654e-7,0.00007736712,0.000040416675,0.00009350667,0.000023022698,0.000009741208,0.000005311801,0.00012858983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988074,0.00007039454,0.0005528802,0.000037371865,0.00039861538,0.00013339649],"domain_scores_gemma":[0.998933,0.0000045799115,0.00036883523,0.00047354214,0.00013969462,0.00008032155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005767427,0.00007370462,0.00023670039,0.00008640078,0.00005511971,0.0000032369348,0.000058853886,0.00004677417,0.000011664611],"category_scores_gemma":[0.000019974068,0.00004420139,0.00017304892,0.00017264653,0.00003308395,0.0002739066,0.000027887465,0.00008014011,0.00003350093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039710638,0.0000065174586,0.93876344,0.0016204403,0.00013907465,1.2331967e-7,0.05880448,0.000030632982,0.000006429514,0.00020163399,0.0001372308,0.0002502989],"study_design_scores_gemma":[0.0010403735,0.000034123354,0.966119,0.00040546205,0.0001615625,0.00005403671,0.025531273,0.000105760104,0.003969519,1.5781235e-7,0.0025200024,0.000058766593],"about_ca_topic_score_codex":0.00010530563,"about_ca_topic_score_gemma":3.7667914e-7,"teacher_disagreement_score":0.033273205,"about_ca_system_score_codex":0.000068506204,"about_ca_system_score_gemma":0.000054945085,"threshold_uncertainty_score":0.18024804},"labels":[],"label_agreement":null},{"id":"W6920600915","doi":"10.6084/m9.figshare.10117160","title":"MOESM1 of Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis","year":2019,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort; Statin; Heart failure; Cohort study; Risk assessment; Prospective cohort study","score_opus":0.061210322366711735,"score_gpt":0.33687479051575364,"score_spread":0.2756644681490419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920600915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7710889,0.061446134,0.0000018210851,0.0027371063,0.000025021502,0.013457893,0.15116154,0.00003163204,0.00004994501],"genre_scores_gemma":[0.98887134,0.00035850276,0.00047760137,0.0014283959,0.0000073187734,0.00022217359,0.008142642,0.000017690474,0.00047436278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984674,0.00029588898,0.0006791977,0.00015137903,0.0003251577,0.000080985315],"domain_scores_gemma":[0.99864817,0.00034072532,0.0003876536,0.000318646,0.00025408293,0.000050722247],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067955104,0.000080755046,0.0023726993,0.00007400354,0.000005947008,0.0000058872074,0.000026598278,0.00007172284,0.0037826302],"category_scores_gemma":[0.0043223207,0.000051601375,0.0006464761,0.00021346891,0.0000026979508,0.00007108106,0.000029412631,0.00009267558,0.00001391482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000052649148,0.00011252182,0.67922944,0.2716991,0.04471614,7.5713194e-7,0.00005100792,6.9491074e-7,3.7427998e-7,0.0000014368885,0.004173899,0.000009329024],"study_design_scores_gemma":[0.0009506587,0.00016784269,0.8218756,0.008626008,0.167935,8.24684e-7,0.000034451434,0.000020406625,0.000004753157,0.0000013957772,0.00030342405,0.00007965607],"about_ca_topic_score_codex":0.00008291701,"about_ca_topic_score_gemma":0.00007947128,"teacher_disagreement_score":0.2630731,"about_ca_system_score_codex":0.000023992741,"about_ca_system_score_gemma":0.0000293274,"threshold_uncertainty_score":0.99712807},"labels":[],"label_agreement":null},{"id":"W6920711415","doi":"10.6084/m9.figshare.22625137.v1","title":"Additional file 7 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cascade; Familial hypercholesterolemia; Key (lock); Triglycerides blood","score_opus":0.16321148957847828,"score_gpt":0.32286740282698057,"score_spread":0.15965591324850228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920711415","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017565776,0.00011999418,0.00001633153,0.000067728186,0.000004211676,0.001062003,0.9963846,0.00012669082,0.00046186356],"genre_scores_gemma":[0.0034741785,0.0000026420605,0.08307624,0.00012769244,0.00006400563,0.004655858,0.90843415,0.000021077038,0.00014416412],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928063,0.000040556024,0.00016698668,0.00017096207,0.00016407369,0.00017679184],"domain_scores_gemma":[0.99815375,0.0011145548,0.0000541151,0.00021449795,0.00037221794,0.0000908433],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000048323232,0.00008922423,0.00020582277,0.000060565813,0.000109875014,0.000033529283,0.000052457937,0.00005764603,0.064419426],"category_scores_gemma":[0.0019021502,0.000087251996,0.00007343936,0.00022631258,0.000010971583,0.000092482245,0.00007961504,0.00010658016,0.000084325686],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026166048,0.00001654004,0.0000012075536,0.00092353305,0.00004285555,0.00001210409,0.0003120521,0.00022300892,0.00051967415,0.0000010663384,0.92135054,0.07657128],"study_design_scores_gemma":[0.0012582293,0.00085314765,0.01775017,0.013134389,0.000050201343,0.00020119884,0.004564298,0.0058709704,0.00059204677,0.00006658948,0.9553942,0.0002645205],"about_ca_topic_score_codex":0.00001831068,"about_ca_topic_score_gemma":0.000006273974,"teacher_disagreement_score":0.08795046,"about_ca_system_score_codex":0.000024696394,"about_ca_system_score_gemma":0.00021849493,"threshold_uncertainty_score":0.9364358},"labels":[],"label_agreement":null},{"id":"W6920795787","doi":"10.60692/ydgc6-51p03","title":"The panorama of familial hypercholesterolemia in Latin America: a systematic review","year":2016,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Latin Americans; Ethnic group; Indigenous; PCSK9; Systematic review; Mutation","score_opus":0.02290007746452074,"score_gpt":0.2289132151051972,"score_spread":0.20601313764067644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6920795787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797894,0.0016168228,0.0069678943,0.0011194192,0.00033975203,0.0071017193,0.000072001436,0.00015519939,0.0028378041],"genre_scores_gemma":[0.9990585,0.000057361372,0.00005055254,0.00040672612,0.00004001869,0.00026135833,0.0000029081743,0.000007943851,0.00011465241],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99786144,0.00020280297,0.0011487006,0.00009583271,0.00049002277,0.00020120692],"domain_scores_gemma":[0.99859905,0.000021900005,0.00041164778,0.0007100993,0.00018378376,0.000073501324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011908002,0.00012855156,0.0007020278,0.00010023516,0.000049802376,0.000021261658,0.00011651786,0.00006318019,0.000004031351],"category_scores_gemma":[0.00016876837,0.00005598939,0.00018418817,0.0002453911,0.000041054704,0.00017889109,0.000032243144,0.00007453387,0.00025843113],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020566524,0.000007992328,0.07312044,0.8980561,0.0003276022,0.000013186649,0.018572716,0.0000025319684,0.00002016126,0.00022066188,0.00015599882,0.009296956],"study_design_scores_gemma":[0.008643046,0.00045064246,0.20388085,0.7611748,0.0009913866,0.00045837578,0.0218475,0.00029196037,0.00048710033,0.0000019734748,0.0012441325,0.00052823935],"about_ca_topic_score_codex":0.000023956856,"about_ca_topic_score_gemma":3.8745335e-7,"teacher_disagreement_score":0.13688129,"about_ca_system_score_codex":0.00014818602,"about_ca_system_score_gemma":0.000074679614,"threshold_uncertainty_score":0.33216953},"labels":[],"label_agreement":null},{"id":"W6921008745","doi":"10.6084/m9.figshare.10086296.v1","title":"Additional file 2: of Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9","year":2019,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Danish Agency for Science and Higher Education; Medical Research Council; Canadian Institutes of Health Research; Forsknings- og Innovationsstyrelsen; National Institutes of Health; Vincent Fairfax Family Foundation; Novo Nordisk Foundation Center for Basic Metabolic Research; Helsefonden; Universitair Medisch Centrum Groningen; Augustinus Fonden; Region Hovedstaden; Novo Nordisk; Hjärt-Lungfonden; Centers for Disease Control and Prevention; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Institut National de la Santé et de la Recherche Médicale; NIH Clinical Center; National Stroke Foundation; University of Oxford; European Commission; UK-India Education and Research Initiative; Sundhed og Sygdom, Det Frie Forskningsråd; National Institute of Neurological Disorders and Stroke; British Heart Foundation; Hjerteforeningen; Diabetesforeningen; Vetenskapsrådet; Pfizer; Västra Götalandsregionen; Heart and Stroke Foundation of Canada; Copenhagen Graduate School for Nanoscience and Nanotechnology; Canadian Stroke Network; Hunter Medical Research Institute; National Health and Medical Research Council; AstraZeneca; U.S. Department of Veterans Affairs; Office of Research and Development; Johns Hopkins University","keywords":"Genetic variants; PCSK9; Genetic association; Genome-wide association study; Association (psychology); Genetic variation; Genotype","score_opus":0.012932169526026471,"score_gpt":0.22950260567833833,"score_spread":0.21657043615231186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921008745","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027167743,0.000057652185,0.0000010227632,0.000017252743,0.00001148719,0.0002479535,0.9706091,0.000007934127,0.0018798359],"genre_scores_gemma":[0.26424032,0.0000017472813,0.00016723572,0.00013961391,0.00005588251,0.00016695297,0.7348104,0.000011055062,0.00040675537],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9990278,0.000030478903,0.00026712407,0.00015560935,0.0003825242,0.00013644977],"domain_scores_gemma":[0.9989187,0.00041583084,0.00020233083,0.00027437354,0.00014152168,0.000047242942],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006799734,0.00007048037,0.00038866472,0.00020756104,0.000008883851,0.000004256393,0.000055841454,0.000082710256,0.9643151],"category_scores_gemma":[0.0018205025,0.000069895264,0.00023680825,0.00051157887,0.0000017423696,0.000043489687,0.000029812183,0.00009339209,0.000397547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020423155,0.0001120448,0.01583928,0.0005829386,0.0011329745,0.000009282305,0.00008812039,0.00040364734,0.000054513486,2.2703075e-7,0.97646683,0.005289692],"study_design_scores_gemma":[0.00041312395,0.000051828407,0.92722535,0.0015185155,0.00012833078,9.4357057e-7,0.000015927884,0.0004876029,0.000075069795,0.000001947451,0.07002385,0.000057528883],"about_ca_topic_score_codex":0.000043171218,"about_ca_topic_score_gemma":0.000042456428,"teacher_disagreement_score":0.96391755,"about_ca_system_score_codex":0.00011568887,"about_ca_system_score_gemma":0.000112783426,"threshold_uncertainty_score":0.5109795},"labels":[],"label_agreement":null},{"id":"W6921019286","doi":"10.6084/m9.figshare.5768613.v1","title":"Additional file 3: of Ezetimibe prescriptions in older Canadian adults after an acute myocardial infarction: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Medical prescription; Cohort study; Cohort; Retrospective cohort study; MEDLINE","score_opus":0.010551092214414477,"score_gpt":0.24753477769349394,"score_spread":0.23698368547907947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921019286","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032081943,0.000011741208,1.4069349e-7,0.00005167798,0.000042258147,0.0014678936,0.96528786,0.000026402135,0.0010300676],"genre_scores_gemma":[0.44967192,1.2831603e-7,0.00009495403,0.00031733298,0.00037834755,0.002939374,0.54649603,0.000013248694,0.000088655375],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9987896,0.00007230071,0.00023665513,0.0002787466,0.00039582216,0.0002268711],"domain_scores_gemma":[0.9988581,0.000050589075,0.000056159784,0.00044233198,0.0003271138,0.0002657002],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000056915404,0.00011929573,0.00024766437,0.00021182501,0.00008025042,0.00001435243,0.00006391216,0.00010247746,0.9748449],"category_scores_gemma":[0.00040819537,0.000116589516,0.00013121295,0.00028089999,0.000009852849,0.000112425776,0.000016078193,0.00014019718,0.00045798125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008532479,0.00016877486,0.030839615,0.00004802264,0.00012578507,0.000036962047,0.00013616162,0.0000047845197,1.7118658e-7,1.5235024e-7,0.9675281,0.0010261287],"study_design_scores_gemma":[0.0007826331,0.0003577386,0.8864119,0.0010014506,0.00004376447,0.000011457234,0.000050154136,0.00027155376,0.0000013257677,0.0000010547236,0.110967875,0.00009911471],"about_ca_topic_score_codex":0.03430504,"about_ca_topic_score_gemma":0.1675946,"teacher_disagreement_score":0.97438693,"about_ca_system_score_codex":0.00018186172,"about_ca_system_score_gemma":0.00080019946,"threshold_uncertainty_score":0.9721256},"labels":[],"label_agreement":null},{"id":"W6921039145","doi":"10.6084/m9.figshare.26723834.v1","title":"Additional file 3 of Strategies aiming to improve statin therapy adherence in older adults: a systematic review","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Université Laval; Université de Sherbrooke; Centre hospitalier universitaire de Québec","funders":"","keywords":"MEDLINE; Disease; Clinical trial; Risk assessment; Statin","score_opus":0.023868486528709487,"score_gpt":0.2948949617011562,"score_spread":0.2710264751724467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921039145","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023206234,0.036411326,0.0000011017714,0.000050597377,0.000012749958,0.0022238481,0.9605478,0.000035870384,0.0006935006],"genre_scores_gemma":[0.0036417516,0.0002660893,0.0003722873,0.0009416445,0.0001382791,0.013919547,0.9802134,0.00003077613,0.00047621017],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99895954,0.000050054055,0.000330263,0.00020605819,0.0003109957,0.00014308945],"domain_scores_gemma":[0.9991965,0.00027757627,0.000060194387,0.00026825065,0.00012801861,0.000069408474],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008514481,0.00010526412,0.00043284148,0.00006507688,0.000013080848,0.000021874792,0.00006851674,0.000041171497,0.94184947],"category_scores_gemma":[0.001409663,0.00007634954,0.00015299514,0.00028839908,0.0000027192036,0.00008161275,0.000020446321,0.00012826621,0.00090062065],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005194394,0.000015375208,2.2431125e-8,0.3258071,0.000029731591,0.000028059787,0.00012279989,1.952642e-7,0.0000021321616,0.0000018747894,0.66969526,0.0042922962],"study_design_scores_gemma":[0.00019185757,0.00016360168,0.0001509827,0.9566468,0.00001819365,0.000020955145,0.00035157937,0.00007760381,0.000026837037,0.0000054239126,0.042265818,0.00008032264],"about_ca_topic_score_codex":0.000027902517,"about_ca_topic_score_gemma":0.00001477261,"teacher_disagreement_score":0.94094884,"about_ca_system_score_codex":0.000044628163,"about_ca_system_score_gemma":0.00042043353,"threshold_uncertainty_score":0.9998773},"labels":[],"label_agreement":null},{"id":"W6921039459","doi":"10.6084/m9.figshare.5572897.v1","title":"Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review","year":2017,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Mace; Myocardial infarction; Observational study; Stroke (engine); Incidence (geometry); Systematic review; Disease; Meta-analysis; Secondary prevention; Atherosclerotic cardiovascular disease","score_opus":0.029576308439222695,"score_gpt":0.2653104087097926,"score_spread":0.2357341002705699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921039459","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014190793,0.92982006,0.0000036777756,0.00035210166,0.0001680687,0.017950319,0.03652079,0.00022653176,0.0007676271],"genre_scores_gemma":[0.84940106,0.031216344,0.00013071412,0.0010719755,0.0014175023,0.006773683,0.10885313,0.00040784653,0.00072775205],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99530256,0.00042410006,0.00058162457,0.00096296734,0.0021091918,0.00061956013],"domain_scores_gemma":[0.99167526,0.00003595429,0.0002688749,0.0063708546,0.0007633485,0.00088573096],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040471376,0.00055386085,0.0022405607,0.0001790117,0.00033874335,0.00021196679,0.00051442103,0.000109777415,0.0011743427],"category_scores_gemma":[0.0011300957,0.00040196048,0.0023418583,0.0004152596,0.00003543334,0.00032670412,0.00022949037,0.0004772086,0.00032367566],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039587563,0.0003043329,0.009464351,0.9625465,0.010968169,0.003947053,0.00015628262,0.0005400581,3.8831683e-7,0.000012689451,0.007592348,0.00407192],"study_design_scores_gemma":[0.0028454615,0.00006479228,0.39696515,0.5776258,0.0031208682,0.000011742532,0.0000072437424,0.000058001515,7.129018e-7,0.0000028716177,0.01890056,0.00039680183],"about_ca_topic_score_codex":0.00018124151,"about_ca_topic_score_gemma":0.000010495661,"teacher_disagreement_score":0.89860374,"about_ca_system_score_codex":0.0002744049,"about_ca_system_score_gemma":0.00033796448,"threshold_uncertainty_score":0.99984324},"labels":[],"label_agreement":null},{"id":"W6921046233","doi":"10.6084/m9.figshare.22625143","title":"Additional file 9 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cascade; Familial hypercholesterolemia; Key (lock); Triglycerides blood","score_opus":0.16312709879292422,"score_gpt":0.32284605002169564,"score_spread":0.15971895122877142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921046233","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017564208,0.00012011036,0.000016366766,0.000067832356,0.000004212304,0.0010621111,0.9963833,0.00012672004,0.00046289418],"genre_scores_gemma":[0.0034929214,0.0000026462185,0.08328424,0.00012810856,0.00006419179,0.004641985,0.9082197,0.000021127546,0.00014507187],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992807,0.000040564963,0.00016698263,0.00017092002,0.00016405966,0.00017676695],"domain_scores_gemma":[0.99815303,0.0011153822,0.00005411173,0.00021442577,0.00037222533,0.00009082493],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000048315014,0.000089211135,0.000205789,0.00006056267,0.000109875094,0.000033518118,0.00005241395,0.00005763584,0.06504103],"category_scores_gemma":[0.0019222419,0.00008723759,0.000073437,0.00022630073,0.000010970334,0.00009247876,0.00007957457,0.00010653935,0.00008448313],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002607958,0.000016482101,0.0000012052284,0.00091245334,0.000042702977,0.00001206085,0.00031092434,0.00022230296,0.0005162561,0.0000010445395,0.9227848,0.07515371],"study_design_scores_gemma":[0.0012586282,0.00085252756,0.017945852,0.013023387,0.000050237748,0.00020141687,0.0045705256,0.005880663,0.00059036276,0.000066680244,0.955295,0.00026468365],"about_ca_topic_score_codex":0.000017932603,"about_ca_topic_score_gemma":0.0000062572203,"teacher_disagreement_score":0.08816362,"about_ca_system_score_codex":0.00002469015,"about_ca_system_score_gemma":0.00021839538,"threshold_uncertainty_score":0.93581367},"labels":[],"label_agreement":null},{"id":"W6921084618","doi":"10.6084/m9.figshare.22625137","title":"Additional file 7 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cascade; Familial hypercholesterolemia; Key (lock); Triglycerides blood","score_opus":0.16321148957847828,"score_gpt":0.32286740282698057,"score_spread":0.15965591324850228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921084618","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017565776,0.00011999418,0.00001633153,0.000067728186,0.000004211676,0.001062003,0.9963846,0.00012669082,0.00046186356],"genre_scores_gemma":[0.0034741785,0.0000026420605,0.08307624,0.00012769244,0.00006400563,0.004655858,0.90843415,0.000021077038,0.00014416412],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928063,0.000040556024,0.00016698668,0.00017096207,0.00016407369,0.00017679184],"domain_scores_gemma":[0.99815375,0.0011145548,0.0000541151,0.00021449795,0.00037221794,0.0000908433],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000048323232,0.00008922423,0.00020582277,0.000060565813,0.000109875014,0.000033529283,0.000052457937,0.00005764603,0.064419426],"category_scores_gemma":[0.0019021502,0.000087251996,0.00007343936,0.00022631258,0.000010971583,0.000092482245,0.00007961504,0.00010658016,0.000084325686],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026166048,0.00001654004,0.0000012075536,0.00092353305,0.00004285555,0.00001210409,0.0003120521,0.00022300892,0.00051967415,0.0000010663384,0.92135054,0.07657128],"study_design_scores_gemma":[0.0012582293,0.00085314765,0.01775017,0.013134389,0.000050201343,0.00020119884,0.004564298,0.0058709704,0.00059204677,0.00006658948,0.9553942,0.0002645205],"about_ca_topic_score_codex":0.00001831068,"about_ca_topic_score_gemma":0.000006273974,"teacher_disagreement_score":0.08795046,"about_ca_system_score_codex":0.000024696394,"about_ca_system_score_gemma":0.00021849493,"threshold_uncertainty_score":0.9364358},"labels":[],"label_agreement":null},{"id":"W6921084719","doi":"10.6084/m9.figshare.22625131","title":"Additional file 5 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Outreach; Familial hypercholesterolemia; Proband; Primer (cosmetics); Cascade","score_opus":0.16312091101295934,"score_gpt":0.32283487658227616,"score_spread":0.15971396556931683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921084719","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017572084,0.00011990535,0.000016310061,0.0000677068,0.000004211113,0.0010621753,0.9963839,0.00012669305,0.00046186688],"genre_scores_gemma":[0.0034932117,0.0000026420014,0.083248146,0.00012792798,0.00006411643,0.004668738,0.9082297,0.000021113228,0.00014440471],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992807,0.000040565603,0.00016698382,0.00017094404,0.00016407145,0.00017675966],"domain_scores_gemma":[0.9981531,0.001115297,0.000054116874,0.00021448763,0.00037216023,0.000090834124],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004832415,0.000089217836,0.00020582038,0.000060561644,0.00010987244,0.000033511933,0.000052452175,0.00005764749,0.06527928],"category_scores_gemma":[0.0019221432,0.00008724346,0.00007344341,0.00022631086,0.0000109699495,0.00009247078,0.000079608886,0.000106570944,0.000084149106],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026026906,0.000016448987,0.0000012020147,0.00091050216,0.00004261515,0.000012036576,0.00030992474,0.00022143521,0.000515528,0.0000010632531,0.9221874,0.075755835],"study_design_scores_gemma":[0.0012655671,0.00085674634,0.01822211,0.013084349,0.000050494284,0.00020241937,0.004594125,0.0058661983,0.0005930033,0.00006665572,0.95493233,0.00026602575],"about_ca_topic_score_codex":0.00001829938,"about_ca_topic_score_gemma":0.00000627115,"teacher_disagreement_score":0.08815422,"about_ca_system_score_codex":0.000024692126,"about_ca_system_score_gemma":0.00021842477,"threshold_uncertainty_score":0.9355752},"labels":[],"label_agreement":null},{"id":"W6921112065","doi":"10.6084/m9.figshare.26723837.v1","title":"Additional file 4 of Strategies aiming to improve statin therapy adherence in older adults: a systematic review","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Université Laval; Université de Sherbrooke; Centre hospitalier universitaire de Québec","funders":"","keywords":"MEDLINE; Disease; Clinical trial; Risk assessment; Statin","score_opus":0.02407272306186635,"score_gpt":0.2953670760426278,"score_spread":0.27129435298076143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921112065","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023094097,0.03656902,0.0000011100059,0.000050512757,0.000012627055,0.0022268197,0.96038914,0.000035938112,0.00069173955],"genre_scores_gemma":[0.0037444106,0.00026602083,0.00037264192,0.00094255,0.00013669167,0.013917116,0.9801321,0.000030759686,0.00045767747],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989594,0.00005004673,0.00033039565,0.0002060814,0.0003109739,0.00014310771],"domain_scores_gemma":[0.99919844,0.00027817042,0.000060204617,0.00026840434,0.00012535336,0.00006941118],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008522148,0.00010527233,0.00043295606,0.00006511082,0.000013088147,0.000021887845,0.00006857327,0.0000411754,0.9408042],"category_scores_gemma":[0.0013876148,0.00007636581,0.00015300843,0.00028835775,0.0000027197514,0.00008162613,0.000020455063,0.00012826174,0.0008800476],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000052709097,0.000015430434,2.2555353e-8,0.3250526,0.000029822115,0.000028254435,0.00012331072,1.9279453e-7,0.000002101898,0.0000019574413,0.67043954,0.004301526],"study_design_scores_gemma":[0.00019128417,0.00016697429,0.00015201382,0.95845604,0.000018373978,0.000021230117,0.00035329146,0.000078019264,0.000026257574,0.0000054936872,0.04045055,0.0000804593],"about_ca_topic_score_codex":0.000027624905,"about_ca_topic_score_gemma":0.00001484058,"teacher_disagreement_score":0.9399241,"about_ca_system_score_codex":0.000044435666,"about_ca_system_score_gemma":0.00041866783,"threshold_uncertainty_score":0.9998979},"labels":[],"label_agreement":null},{"id":"W6921148207","doi":"10.6084/m9.figshare.19881416.v1","title":"Additional file 3 of A cross-sectional study evaluating cardiovascular risk and statin prescribing in the Canadian Primary Care Sentinel Surveillance Network database","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Queen's University; University of Alberta; University of Calgary","funders":"","keywords":"Primary care; Statin; Medical record; MEDLINE; Risk assessment; Patient data","score_opus":0.04986823936698049,"score_gpt":0.29268868126344,"score_spread":0.24282044189645952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921148207","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035944037,0.0017911667,1.7095962e-7,0.000005443298,0.000022750339,0.0011814965,0.96026045,0.0000120408395,0.0007824395],"genre_scores_gemma":[0.2493431,0.0000018818673,0.00015947159,0.00011534246,0.00025441992,0.0024312846,0.74765486,0.000016000666,0.00002365022],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99724543,0.0006915834,0.00028331927,0.00034241617,0.001154015,0.0002832632],"domain_scores_gemma":[0.99848974,0.0005537786,0.00011181519,0.00050876744,0.00023508431,0.00010082904],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001083187,0.00011912057,0.00028687573,0.0000775394,0.0006188306,0.000042904438,0.0001272994,0.000034108583,0.59926623],"category_scores_gemma":[0.0018828574,0.000104425155,0.0001970612,0.00035429947,0.000013130739,0.00006093758,0.00016030823,0.00046920916,0.000013864376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049035916,0.00008817386,0.10561188,0.0005290078,0.00030656814,0.00016173045,0.000703061,0.0032847773,2.3668366e-7,4.5160144e-7,0.885743,0.003522079],"study_design_scores_gemma":[0.0008023402,0.00013925858,0.8491848,0.0002806813,0.000025562438,0.00006994307,0.0007311599,0.0003221523,1.3301404e-7,0.000001729679,0.14835185,0.000090401925],"about_ca_topic_score_codex":0.02593814,"about_ca_topic_score_gemma":0.03333414,"teacher_disagreement_score":0.7435729,"about_ca_system_score_codex":0.0002800497,"about_ca_system_score_gemma":0.0011884501,"threshold_uncertainty_score":0.98430496},"labels":[],"label_agreement":null},{"id":"W6921187739","doi":"10.6084/m9.figshare.5768634.v1","title":"Additional file 4: of Ezetimibe prescriptions in older Canadian adults after an acute myocardial infarction: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Medical prescription; Cohort study; Cohort; Retrospective cohort study; Inclusion (mineral); MEDLINE","score_opus":0.010515646555519837,"score_gpt":0.2474537661385773,"score_spread":0.23693811958305747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921187739","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031834047,0.00001171836,1.4067369e-7,0.00005245243,0.00004227098,0.0014679716,0.9655383,0.000026408763,0.00102668],"genre_scores_gemma":[0.44830164,1.2870436e-7,0.00009517219,0.00032071533,0.00037911366,0.002945805,0.5478548,0.000013278931,0.000089381305],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99878955,0.00007238865,0.000236637,0.0002787418,0.00039582106,0.00022687513],"domain_scores_gemma":[0.9988583,0.0000506104,0.000056156787,0.00044213282,0.0003271206,0.0002657046],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000056967518,0.00011929288,0.0002476572,0.00021189752,0.00008025612,0.000014352586,0.00006386425,0.000102476784,0.9751166],"category_scores_gemma":[0.00040507704,0.00011658859,0.00013121676,0.00027853248,0.000009853153,0.000112402995,0.000016071304,0.00014020457,0.0004645638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085188614,0.00016842381,0.030111467,0.00004794457,0.00012558103,0.000037085785,0.00013622714,0.000004777873,1.7124493e-7,1.4926694e-7,0.9682501,0.0010329089],"study_design_scores_gemma":[0.00078146416,0.00035730985,0.88550866,0.0009947722,0.00004372372,0.0000114413415,0.00005016548,0.00027333852,0.0000013242219,0.0000010645406,0.11187772,0.00009902661],"about_ca_topic_score_codex":0.034064308,"about_ca_topic_score_gemma":0.16503562,"teacher_disagreement_score":0.97465205,"about_ca_system_score_codex":0.0001818777,"about_ca_system_score_gemma":0.00080008735,"threshold_uncertainty_score":0.97236794},"labels":[],"label_agreement":null},{"id":"W6921220398","doi":"10.6084/m9.figshare.22625128","title":"Additional file 4 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Outreach; Familial hypercholesterolemia; Network packet; Cascade; Throughput","score_opus":0.16415120690745577,"score_gpt":0.3231163491751616,"score_spread":0.1589651422677058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921220398","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017476901,0.00011997512,0.00001635047,0.00006730285,0.000004208207,0.0010617324,0.99639374,0.00012660355,0.0004623758],"genre_scores_gemma":[0.0035246161,0.0000026399377,0.08318188,0.00012774023,0.000064054904,0.0046650977,0.90826964,0.000021092466,0.00014321395],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928075,0.000040531468,0.00016698918,0.0001709222,0.00016406174,0.00017676408],"domain_scores_gemma":[0.99815464,0.0011167129,0.000054119453,0.00021452665,0.00036916597,0.00009082505],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000048299833,0.00008920901,0.00020578507,0.000060564078,0.000109867375,0.000033526736,0.000052471907,0.000057644695,0.065295786],"category_scores_gemma":[0.0019144589,0.00008724184,0.0000734335,0.0002262379,0.000010969896,0.00009247092,0.000079604855,0.000106558415,0.00008471855],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026496722,0.00001648453,0.0000012088727,0.00091228244,0.000042710202,0.000012064074,0.0003107842,0.00021921181,0.0005128413,0.0000010650631,0.92213064,0.07581418],"study_design_scores_gemma":[0.0012588318,0.0008631735,0.017821584,0.012997526,0.000050177514,0.00020120216,0.0045646527,0.0058729025,0.0005849651,0.0000666151,0.95545393,0.00026441648],"about_ca_topic_score_codex":0.000018134699,"about_ca_topic_score_gemma":0.000006248704,"teacher_disagreement_score":0.0881241,"about_ca_system_score_codex":0.00002468673,"about_ca_system_score_gemma":0.00021817963,"threshold_uncertainty_score":0.9355587},"labels":[],"label_agreement":null},{"id":"W6921238352","doi":"10.6084/m9.figshare.5768634","title":"Additional file 4: of Ezetimibe prescriptions in older Canadian adults after an acute myocardial infarction: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Medical prescription; Cohort study; Cohort; Retrospective cohort study; Inclusion (mineral); MEDLINE","score_opus":0.010515646555519837,"score_gpt":0.2474537661385773,"score_spread":0.23693811958305747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6921238352","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031834047,0.00001171836,1.4067369e-7,0.00005245243,0.00004227098,0.0014679716,0.9655383,0.000026408763,0.00102668],"genre_scores_gemma":[0.44830164,1.2870436e-7,0.00009517219,0.00032071533,0.00037911366,0.002945805,0.5478548,0.000013278931,0.000089381305],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99878955,0.00007238865,0.000236637,0.0002787418,0.00039582106,0.00022687513],"domain_scores_gemma":[0.9988583,0.0000506104,0.000056156787,0.00044213282,0.0003271206,0.0002657046],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000056967518,0.00011929288,0.0002476572,0.00021189752,0.00008025612,0.000014352586,0.00006386425,0.000102476784,0.9751166],"category_scores_gemma":[0.00040507704,0.00011658859,0.00013121676,0.00027853248,0.000009853153,0.000112402995,0.000016071304,0.00014020457,0.0004645638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085188614,0.00016842381,0.030111467,0.00004794457,0.00012558103,0.000037085785,0.00013622714,0.000004777873,1.7124493e-7,1.4926694e-7,0.9682501,0.0010329089],"study_design_scores_gemma":[0.00078146416,0.00035730985,0.88550866,0.0009947722,0.00004372372,0.0000114413415,0.00005016548,0.00027333852,0.0000013242219,0.0000010645406,0.11187772,0.00009902661],"about_ca_topic_score_codex":0.034064308,"about_ca_topic_score_gemma":0.16503562,"teacher_disagreement_score":0.97465205,"about_ca_system_score_codex":0.0001818777,"about_ca_system_score_gemma":0.00080008735,"threshold_uncertainty_score":0.97236794},"labels":[],"label_agreement":null},{"id":"W6930246878","doi":"10.5281/zenodo.11106375","title":"Global climate change below 2°C avoids large end century increases in burned area in Canada","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Carleton University; Environment and Climate Change Canada","funders":"","keywords":"Climate change; Climate model; Global warming; Global change; Greenhouse gas; Land use; General Circulation Model; Projection (relational algebra)","score_opus":0.024181703977498976,"score_gpt":0.24749776454128977,"score_spread":0.2233160605637908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930246878","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007038499,0.012686922,0.000024970885,0.00075768185,0.00033686587,0.0023444467,0.004475521,0.0007269473,0.97160816],"genre_scores_gemma":[0.9042187,0.023127386,0.00015833284,0.0022106885,0.002729497,0.0000021906385,0.014522058,0.020804487,0.032226667],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99738836,0.00031744264,0.0003198613,0.00058496883,0.00070297206,0.00068640674],"domain_scores_gemma":[0.9988946,0.000006150953,0.00008928149,0.0006178316,0.00010387653,0.00028826282],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00075705384,0.00026216623,0.00047808167,0.0004112134,0.00019038838,0.00014079345,0.00038095028,0.00016336473,0.01850153],"category_scores_gemma":[0.00021137003,0.0002568116,0.000098501914,0.0009821465,0.000047591555,0.000056178207,0.00076913706,0.00047601716,0.0021413667],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001760624,0.00033790627,0.00052397,0.0024613342,0.00021380834,0.002118231,0.0003065497,0.0000014025414,0.000010242436,0.0018883722,0.8953604,0.096601725],"study_design_scores_gemma":[0.0012190536,0.000094849835,0.005730182,0.001088017,0.000046397836,0.00020994362,0.00033138157,0.00004298082,0.000002026686,0.000020934936,0.9909901,0.00022413263],"about_ca_topic_score_codex":0.4692041,"about_ca_topic_score_gemma":0.13788053,"teacher_disagreement_score":0.9393815,"about_ca_system_score_codex":0.0016455281,"about_ca_system_score_gemma":0.00008341105,"threshold_uncertainty_score":0.99998844},"labels":[],"label_agreement":null},{"id":"W6930265267","doi":"10.5281/zenodo.11830155","title":"Winterberg stadtplan pdf","year":2024,"lang":"de","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clipping (morphology); Tone (literature); Quarter (Canadian coin)","score_opus":0.02487477741092345,"score_gpt":0.25464818914468396,"score_spread":0.2297734117337605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930265267","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017201752,0.01612117,0.0011191936,0.0012156639,0.0012920955,0.0016853352,0.00072510366,0.0012907033,0.97637874],"genre_scores_gemma":[0.010474067,0.0060197525,0.0002046358,0.0006949943,0.0070093307,1.7137278e-7,0.008648303,0.024279036,0.9426697],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99532866,0.00069493,0.00059452635,0.0012029066,0.0012554799,0.00092352106],"domain_scores_gemma":[0.9969105,0.000015007535,0.00020335271,0.0016561836,0.0005327328,0.00068220386],"candidate_categories":["metaepi_narrow","scholarly_communication","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0017010128,0.0005233893,0.0007362076,0.0007042896,0.001139695,0.0011940344,0.0011282119,0.00041626373,0.43672246],"category_scores_gemma":[0.00052151346,0.0005070251,0.00045080954,0.00081087905,0.0002885301,0.00010319583,0.001646684,0.0013411662,0.76907927],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010535259,0.00017153926,6.329027e-7,0.0019317479,0.0013474373,0.00038060694,0.00082133664,0.0000020643256,0.0001682169,0.0012704466,0.876091,0.11770959],"study_design_scores_gemma":[0.0010569611,0.00067619124,0.00004281839,0.0014848353,0.0005855771,0.00040518728,0.00041058252,0.000058169117,0.00007493954,0.000107417305,0.9946333,0.0004639753],"about_ca_topic_score_codex":0.00012111838,"about_ca_topic_score_gemma":0.0000012059658,"teacher_disagreement_score":0.33235684,"about_ca_system_score_codex":0.0005607055,"about_ca_system_score_gemma":0.000027202957,"threshold_uncertainty_score":0.9998428},"labels":[],"label_agreement":null},{"id":"W6930378266","doi":"10.5281/zenodo.13848188","title":"FIGURE 5 in Chironomidae (Diptera: Insecta) of Alaska, USA, with descriptions of new species and a checklist","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trent University","funders":"","keywords":"Checklist; Chironomidae; Scale (ratio); Taxonomy (biology)","score_opus":0.02925162935737343,"score_gpt":0.23972091098883716,"score_spread":0.21046928163146372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930378266","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018982287,0.003121609,0.000240081,0.00033335475,0.000057013774,0.00092527166,0.0002695241,0.00015130924,0.97591954],"genre_scores_gemma":[0.18410403,0.0015035963,0.0007449262,0.00005879636,0.00045087835,1.0942738e-7,0.00085330993,0.004765436,0.8075189],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988624,0.00008249052,0.00024045799,0.00031714648,0.00031346545,0.00018403759],"domain_scores_gemma":[0.9992027,0.000003488122,0.000112535934,0.0004332914,0.000108281194,0.00013967387],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002670311,0.00015418662,0.00039745474,0.00045956418,0.00007976977,0.000071139046,0.00018549,0.00011032764,0.017739115],"category_scores_gemma":[0.00008416648,0.00013289343,0.00007497519,0.00040008765,0.00017725478,0.000040605948,0.00024976832,0.00029385596,0.0008257255],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016707504,0.00016817823,0.00015203452,0.002627649,0.000394571,0.00004807243,0.0015735023,0.0000029867897,0.0009083252,0.0011264591,0.967921,0.02491013],"study_design_scores_gemma":[0.0009244748,0.000375241,0.0109506855,0.0009941068,0.00008956155,0.000095385294,0.00017029316,0.00000583713,0.00010180214,0.000017131466,0.98616123,0.00011426215],"about_ca_topic_score_codex":0.00069929694,"about_ca_topic_score_gemma":0.00002982437,"teacher_disagreement_score":0.16840063,"about_ca_system_score_codex":0.00007957151,"about_ca_system_score_gemma":0.00002370739,"threshold_uncertainty_score":0.99995226},"labels":[],"label_agreement":null},{"id":"W6930688068","doi":"10.5281/zenodo.14244949","title":"Figure 15 in Osteology of the two-fingered oviraptorid Oksoko avarsan (Theropoda: Oviraptorosauria)","year":2024,"lang":"en","type":"other","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ontario Museum","funders":"","keywords":"Dorsum; Vertebra; Osteology; Thoracic vertebrae; Dorsal fin","score_opus":0.02369592210100048,"score_gpt":0.26016890634925716,"score_spread":0.2364729842482567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6930688068","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032441497,0.004473469,0.000118355165,0.0011625971,0.0007509167,0.0019427013,0.0003351583,0.00071690214,0.98725575],"genre_scores_gemma":[0.24120902,0.0015771342,0.00040077628,0.00082871283,0.003469543,8.336386e-7,0.0020735902,0.02522811,0.7252123],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741787,0.000522602,0.00039567967,0.0005835184,0.0006711551,0.00040919878],"domain_scores_gemma":[0.9982076,0.000010720994,0.00019990308,0.0012439567,0.00019297692,0.00014480505],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008585895,0.00026293346,0.00054316205,0.0004663556,0.00024262634,0.00009884107,0.0007293395,0.00026678081,0.028885588],"category_scores_gemma":[0.00033191688,0.00020809598,0.00026937667,0.0007648763,0.00026595723,0.00003695307,0.00084711734,0.00077424775,0.006350798],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013958695,0.00017644574,0.000016297958,0.001322995,0.00040577175,0.00008079742,0.00070593046,0.0000034468758,0.0025560688,0.0018206147,0.951053,0.04171902],"study_design_scores_gemma":[0.0011860592,0.00028297532,0.00026305692,0.0006892457,0.00011370018,0.0001350499,0.00011031253,0.000015212141,0.0002480835,0.00008522389,0.99669266,0.0001784408],"about_ca_topic_score_codex":0.00037977396,"about_ca_topic_score_gemma":0.000010067158,"teacher_disagreement_score":0.26204348,"about_ca_system_score_codex":0.00021081342,"about_ca_system_score_gemma":0.000028630804,"threshold_uncertainty_score":0.99442285},"labels":[],"label_agreement":null},{"id":"W6938982852","doi":"10.60692/ac1jc-hw045","title":"Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome","year":2023,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta","funders":"","keywords":"Alirocumab; Acute coronary syndrome; Revascularization; Hazard ratio; Quartile; Post-hoc analysis; Confidence interval","score_opus":0.009524021599656296,"score_gpt":0.21094294012172024,"score_spread":0.20141891852206395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6938982852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606895,0.000027198526,0.0009054623,0.00013834007,0.00014950277,0.0020677375,0.000032448927,0.00014877251,0.00046161114],"genre_scores_gemma":[0.99920416,0.0000033985993,0.000021378675,0.0001304742,0.000043744843,0.0004169626,0.00004291187,0.000013938067,0.00012302937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998461,0.00019518331,0.0004538892,0.00013029239,0.0005825875,0.00017702345],"domain_scores_gemma":[0.9991049,0.000015332591,0.00016958332,0.00055517856,0.00008044503,0.00007453842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013803707,0.00015626042,0.00047413682,0.00020800032,0.00009241766,0.000036474583,0.00006020115,0.00010751764,0.000008446122],"category_scores_gemma":[0.00003317068,0.000085919884,0.00021274656,0.00033144586,0.00005996368,0.00018763151,0.00004952218,0.00010901426,0.00027144063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03353281,0.000017134216,0.7189009,0.045151662,0.008745642,0.00091513153,0.13065343,0.0005088987,0.000023706363,0.0019361934,0.00045335715,0.059161123],"study_design_scores_gemma":[0.014283865,0.0011812242,0.9761696,0.0012844885,0.00074634055,0.0016276309,0.0012173478,0.0020789003,0.001011351,0.000001946314,0.00019297565,0.0002043696],"about_ca_topic_score_codex":0.0000206713,"about_ca_topic_score_gemma":6.4552346e-8,"teacher_disagreement_score":0.25726864,"about_ca_system_score_codex":0.00005471742,"about_ca_system_score_gemma":0.000022908072,"threshold_uncertainty_score":0.35037112},"labels":[],"label_agreement":null},{"id":"W6939371815","doi":"10.6084/m9.figshare.22625140.v1","title":"Additional file 8 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cascade; Familial hypercholesterolemia; Key (lock); Triglycerides blood","score_opus":0.1631401995175904,"score_gpt":0.3228361730074607,"score_spread":0.1596959734898703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939371815","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017640323,0.00012012296,0.000016351194,0.00006782853,0.000004212035,0.0010623833,0.9963738,0.00012587686,0.00046544502],"genre_scores_gemma":[0.0035034358,0.0000026146522,0.08337557,0.00012809658,0.00006417384,0.0046742195,0.9080847,0.000021109752,0.00014611012],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992807,0.000040566527,0.00016698358,0.0001709394,0.00016403843,0.00017678208],"domain_scores_gemma":[0.99815273,0.0011155535,0.000054118438,0.00021448804,0.00037224733,0.00009083684],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00004832479,0.00008922164,0.00020582123,0.000060548646,0.000109869085,0.000033524717,0.000052451207,0.000057645175,0.06531276],"category_scores_gemma":[0.0019223384,0.00008724774,0.000073438736,0.00022617931,0.000010970582,0.000092466915,0.0000795959,0.00010657697,0.00008483147],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026038377,0.000016455022,0.0000011941574,0.0009110806,0.00004264306,0.000012044074,0.00031043764,0.00022198384,0.00051148585,0.0000010572654,0.9211167,0.076828845],"study_design_scores_gemma":[0.0012606038,0.0008551152,0.017829884,0.0130391605,0.000050302413,0.00020166655,0.0045748423,0.005887494,0.00059887284,0.00006674552,0.95537025,0.00026504337],"about_ca_topic_score_codex":0.000018276376,"about_ca_topic_score_gemma":0.0000062667455,"teacher_disagreement_score":0.088289075,"about_ca_system_score_codex":0.000024695166,"about_ca_system_score_gemma":0.00021851806,"threshold_uncertainty_score":0.9355417},"labels":[],"label_agreement":null},{"id":"W6939428111","doi":"10.60692/vaznq-20628","title":"Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts","year":2001,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Asian Indian; Coronary heart disease; Triglyceride; Cholesterol; Indian subcontinent; Apolipoprotein B; Immigration; High-density lipoprotein; Mongoloid","score_opus":0.04773144865589375,"score_gpt":0.2589575467155247,"score_spread":0.21122609805963094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939428111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944706,0.000034214216,0.0028428384,0.000016901768,0.00007038981,0.001400388,0.00010602585,0.0000148571835,0.0010437848],"genre_scores_gemma":[0.9997666,0.0000020581779,0.000027345715,0.00004635114,0.000038912724,0.00009112895,0.000010952212,0.0000073075134,0.000009352387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887127,0.00009200705,0.00039942793,0.00009976532,0.00040326384,0.00013428324],"domain_scores_gemma":[0.9993336,0.00000636064,0.00020850792,0.0001965963,0.00018475426,0.00007018026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019782558,0.00010877135,0.00027135288,0.00020589134,0.000047791444,0.000029108043,0.00002625018,0.00009610519,0.000009545732],"category_scores_gemma":[0.000041461844,0.00007426306,0.000067435285,0.00009113767,0.000019624453,0.00020373202,0.000012491577,0.000062518084,0.0000045442634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006704109,0.0000030253577,0.90683913,0.00038004812,0.00010157915,3.279479e-7,0.0829657,0.000024436478,8.428724e-7,0.0000136186345,0.0000026530195,0.0096015725],"study_design_scores_gemma":[0.004003708,0.0001327993,0.9534884,0.00027456472,0.00015840863,0.000076225355,0.03622334,0.0049168826,0.00019546102,0.0000034453128,0.0004276477,0.000099101424],"about_ca_topic_score_codex":0.00021156302,"about_ca_topic_score_gemma":0.000023540253,"teacher_disagreement_score":0.04674236,"about_ca_system_score_codex":0.00011214027,"about_ca_system_score_gemma":0.000068044166,"threshold_uncertainty_score":0.30283597},"labels":[],"label_agreement":null},{"id":"W6939538373","doi":"10.6084/m9.figshare.19881416","title":"Additional file 3 of A cross-sectional study evaluating cardiovascular risk and statin prescribing in the Canadian Primary Care Sentinel Surveillance Network database","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Queen's University; University of Alberta; University of Calgary","funders":"","keywords":"Primary care; Statin; Medical record; MEDLINE; Risk assessment; Patient data","score_opus":0.04986823936698049,"score_gpt":0.29268868126344,"score_spread":0.24282044189645952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939538373","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035944037,0.0017911667,1.7095962e-7,0.000005443298,0.000022750339,0.0011814965,0.96026045,0.0000120408395,0.0007824395],"genre_scores_gemma":[0.2493431,0.0000018818673,0.00015947159,0.00011534246,0.00025441992,0.0024312846,0.74765486,0.000016000666,0.00002365022],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99724543,0.0006915834,0.00028331927,0.00034241617,0.001154015,0.0002832632],"domain_scores_gemma":[0.99848974,0.0005537786,0.00011181519,0.00050876744,0.00023508431,0.00010082904],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001083187,0.00011912057,0.00028687573,0.0000775394,0.0006188306,0.000042904438,0.0001272994,0.000034108583,0.59926623],"category_scores_gemma":[0.0018828574,0.000104425155,0.0001970612,0.00035429947,0.000013130739,0.00006093758,0.00016030823,0.00046920916,0.000013864376],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049035916,0.00008817386,0.10561188,0.0005290078,0.00030656814,0.00016173045,0.000703061,0.0032847773,2.3668366e-7,4.5160144e-7,0.885743,0.003522079],"study_design_scores_gemma":[0.0008023402,0.00013925858,0.8491848,0.0002806813,0.000025562438,0.00006994307,0.0007311599,0.0003221523,1.3301404e-7,0.000001729679,0.14835185,0.000090401925],"about_ca_topic_score_codex":0.02593814,"about_ca_topic_score_gemma":0.03333414,"teacher_disagreement_score":0.7435729,"about_ca_system_score_codex":0.0002800497,"about_ca_system_score_gemma":0.0011884501,"threshold_uncertainty_score":0.98430496},"labels":[],"label_agreement":null},{"id":"W6939721484","doi":"10.6084/m9.figshare.5768646.v1","title":"Additional file 5: of Ezetimibe prescriptions in older Canadian adults after an acute myocardial infarction: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Medical prescription; Cohort study; Cohort; Myocardial infarction; Retrospective cohort study","score_opus":0.010523378397382844,"score_gpt":0.24744820226591516,"score_spread":0.2369248238685323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939721484","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03148445,0.000011653435,1.3693432e-7,0.000051751642,0.000042235195,0.001466953,0.96589667,0.000026419943,0.0010197295],"genre_scores_gemma":[0.44761708,1.2886365e-7,0.000095294134,0.0003179711,0.0003795974,0.0029496318,0.54853636,0.000013311252,0.00009060355],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99878985,0.000072320254,0.00023660492,0.00027869162,0.0003957429,0.0002268106],"domain_scores_gemma":[0.99885976,0.00005056966,0.000056157856,0.00043915558,0.00032866996,0.00026565779],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000056923924,0.00011928121,0.00024762002,0.00021181969,0.00008015632,0.000014207684,0.00006364694,0.00010248306,0.97503006],"category_scores_gemma":[0.00040726084,0.00011658104,0.00013119951,0.00028087277,0.000009841224,0.000112761416,0.000016082497,0.00014018458,0.0004575813],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008841006,0.0001688726,0.029289972,0.000048042213,0.00012586481,0.000037146317,0.00013737616,0.0000047122458,1.6598361e-7,1.4781475e-7,0.96904814,0.0010511508],"study_design_scores_gemma":[0.0007811659,0.00036822687,0.88427526,0.0009984047,0.000043665743,0.000011430864,0.00005080113,0.00027235498,0.0000012957885,0.0000010465286,0.11309742,0.000098898054],"about_ca_topic_score_codex":0.033639614,"about_ca_topic_score_gemma":0.16822456,"teacher_disagreement_score":0.9745725,"about_ca_system_score_codex":0.00018182385,"about_ca_system_score_gemma":0.00079971744,"threshold_uncertainty_score":0.9727955},"labels":[],"label_agreement":null},{"id":"W6939801418","doi":"10.6084/m9.figshare.19881413","title":"Additional file 2 of A cross-sectional study evaluating cardiovascular risk and statin prescribing in the Canadian Primary Care Sentinel Surveillance Network database","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Queen's University; University of Alberta; University of Calgary","funders":"","keywords":"Checklist; Primary care; Observational study; Statin; Electronic health record; MEDLINE; Health records; Primary health care","score_opus":0.04912821864259781,"score_gpt":0.2925468227117814,"score_spread":0.2434186040691836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939801418","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03550199,0.0018096054,1.666971e-7,0.000005442994,0.000022677728,0.0011799556,0.9606732,0.000012056684,0.00079488615],"genre_scores_gemma":[0.24551255,0.0000019078375,0.00015838785,0.00011575564,0.00025588158,0.0024372397,0.7514789,0.000016025546,0.000023358944],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99724567,0.0006919916,0.000283319,0.00034231722,0.0011535248,0.00028318627],"domain_scores_gemma":[0.9984949,0.00055106566,0.000111944406,0.0005085734,0.00023266506,0.0001008232],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010781332,0.00011910101,0.00028691368,0.00007751639,0.000618923,0.000042908337,0.00012730868,0.000034111497,0.60063624],"category_scores_gemma":[0.0018621524,0.00010441836,0.00019703749,0.0003541662,0.000013129691,0.0000609324,0.00016039633,0.00046919863,0.000013586481],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048100763,0.00008743813,0.101653785,0.0005205943,0.00030420627,0.00016260322,0.00069760834,0.0032704978,2.2654997e-7,4.5781235e-7,0.8897204,0.0035341328],"study_design_scores_gemma":[0.00079705333,0.00013945965,0.84712535,0.00027799566,0.00002569275,0.000070707145,0.00072742277,0.00031965305,1.295911e-7,0.0000017376874,0.15042461,0.00009021268],"about_ca_topic_score_codex":0.025906073,"about_ca_topic_score_gemma":0.03330613,"teacher_disagreement_score":0.74547154,"about_ca_system_score_codex":0.00027908248,"about_ca_system_score_gemma":0.001182905,"threshold_uncertainty_score":0.9843335},"labels":[],"label_agreement":null},{"id":"W6939814901","doi":"10.6084/m9.figshare.22625143.v1","title":"Additional file 9 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cascade; Familial hypercholesterolemia; Key (lock); Triglycerides blood","score_opus":0.16312709879292422,"score_gpt":0.32284605002169564,"score_spread":0.15971895122877142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939814901","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017564208,0.00012011036,0.000016366766,0.000067832356,0.000004212304,0.0010621111,0.9963833,0.00012672004,0.00046289418],"genre_scores_gemma":[0.0034929214,0.0000026462185,0.08328424,0.00012810856,0.00006419179,0.004641985,0.9082197,0.000021127546,0.00014507187],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992807,0.000040564963,0.00016698263,0.00017092002,0.00016405966,0.00017676695],"domain_scores_gemma":[0.99815303,0.0011153822,0.00005411173,0.00021442577,0.00037222533,0.00009082493],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000048315014,0.000089211135,0.000205789,0.00006056267,0.000109875094,0.000033518118,0.00005241395,0.00005763584,0.06504103],"category_scores_gemma":[0.0019222419,0.00008723759,0.000073437,0.00022630073,0.000010970334,0.00009247876,0.00007957457,0.00010653935,0.00008448313],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002607958,0.000016482101,0.0000012052284,0.00091245334,0.000042702977,0.00001206085,0.00031092434,0.00022230296,0.0005162561,0.0000010445395,0.9227848,0.07515371],"study_design_scores_gemma":[0.0012586282,0.00085252756,0.017945852,0.013023387,0.000050237748,0.00020141687,0.0045705256,0.005880663,0.00059036276,0.000066680244,0.955295,0.00026468365],"about_ca_topic_score_codex":0.000017932603,"about_ca_topic_score_gemma":0.0000062572203,"teacher_disagreement_score":0.08816362,"about_ca_system_score_codex":0.00002469015,"about_ca_system_score_gemma":0.00021839538,"threshold_uncertainty_score":0.93581367},"labels":[],"label_agreement":null},{"id":"W6939839862","doi":"10.6084/m9.figshare.28283403.v1","title":"Additional file 1 of Cardiovascular disease essential medicines listing by countries: changes over time and association with health outcomes","year":2025,"lang":"en","type":"article","venue":"Open MIND","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Disease; Association (psychology); Listing (finance); Alternative medicine; MEDLINE; Health care","score_opus":0.00897776134047969,"score_gpt":0.2712012793183737,"score_spread":0.262223517977894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6939839862","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07867795,0.013468419,0.00019415523,0.021092787,0.00023841267,0.005494417,0.8692209,0.000023598037,0.011589343],"genre_scores_gemma":[0.11689417,0.0030560335,0.02347887,0.017768497,0.003565716,0.0036244048,0.61214346,0.00030888474,0.21915995],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868286,0.00007328406,0.00019485682,0.00026067256,0.0006095784,0.00017872431],"domain_scores_gemma":[0.9989984,0.00029458242,0.0001442448,0.00028058683,0.00014098488,0.00014117645],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005278305,0.00011545306,0.00056788453,0.00005707883,0.000109588786,0.000033311328,0.0000668731,0.000052772477,0.14264432],"category_scores_gemma":[0.0005070841,0.000086363354,0.000109169705,0.00014234497,0.000052560925,0.000072150775,0.00006265865,0.00008687065,0.000017740422],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010433929,0.00006171369,0.0016824647,0.00020711252,0.0017710018,0.0000114837,0.00009730522,0.000002507159,0.0000033845047,0.0000020711325,0.9652403,0.030816332],"study_design_scores_gemma":[0.0014855218,0.00011518653,0.02417554,0.000995899,0.00047645153,0.0000042438987,0.00008176673,0.000077689525,0.000046096608,0.0000027906667,0.97244966,0.00008917762],"about_ca_topic_score_codex":0.0005287657,"about_ca_topic_score_gemma":0.000060773593,"teacher_disagreement_score":0.25707743,"about_ca_system_score_codex":0.000116563366,"about_ca_system_score_gemma":0.00064182444,"threshold_uncertainty_score":0.8581394},"labels":[],"label_agreement":null},{"id":"W6957953578","doi":"10.60692/v9q94-4r927","title":"Predictors of the Common Adverse Drug Reactions of Statins","year":2012,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Atorvastatin; Incidence (geometry); Statin; Drug reaction; Drug; Adverse effect; myalgia","score_opus":0.02102299026854193,"score_gpt":0.2239167108344362,"score_spread":0.20289372056589428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6957953578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926761,0.000008771547,0.0005412691,0.000032369593,0.00043415857,0.0005667238,0.00008719791,0.00003632922,0.00561711],"genre_scores_gemma":[0.9996217,3.2718654e-7,0.00007736712,0.000040416675,0.00009350667,0.000023022698,0.000009741208,0.000005311801,0.00012858983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988074,0.00007039454,0.0005528802,0.000037371865,0.00039861538,0.00013339649],"domain_scores_gemma":[0.998933,0.0000045799115,0.00036883523,0.00047354214,0.00013969462,0.00008032155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005767427,0.00007370462,0.00023670039,0.00008640078,0.00005511971,0.0000032369348,0.000058853886,0.00004677417,0.000011664611],"category_scores_gemma":[0.000019974068,0.00004420139,0.00017304892,0.00017264653,0.00003308395,0.0002739066,0.000027887465,0.00008014011,0.00003350093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039710638,0.0000065174586,0.93876344,0.0016204403,0.00013907465,1.2331967e-7,0.05880448,0.000030632982,0.000006429514,0.00020163399,0.0001372308,0.0002502989],"study_design_scores_gemma":[0.0010403735,0.000034123354,0.966119,0.00040546205,0.0001615625,0.00005403671,0.025531273,0.000105760104,0.003969519,1.5781235e-7,0.0025200024,0.000058766593],"about_ca_topic_score_codex":0.00010530563,"about_ca_topic_score_gemma":3.7667914e-7,"teacher_disagreement_score":0.033273205,"about_ca_system_score_codex":0.000068506204,"about_ca_system_score_gemma":0.000054945085,"threshold_uncertainty_score":0.18024804},"labels":[],"label_agreement":null},{"id":"W6958029955","doi":"10.6084/m9.figshare.14228222.v1","title":"Additional file 1 of A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Cirrhosis; MEDLINE; Disease; Population; Risk assessment","score_opus":0.03203398083052025,"score_gpt":0.27934484001974946,"score_spread":0.2473108591892292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958029955","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045090823,0.0319906,2.4826159e-7,0.000067382556,0.0000070544293,0.0011791335,0.9659241,0.000008929426,0.0007774589],"genre_scores_gemma":[0.0024603996,0.0022324547,0.0005590223,0.0006374003,0.00004824986,0.002461463,0.991312,0.000026290529,0.0002627039],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99850273,0.00015945567,0.00048157442,0.000197569,0.0005375545,0.000121101475],"domain_scores_gemma":[0.99855524,0.00048206575,0.00015061475,0.0004674151,0.0002753315,0.00006930231],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014522376,0.000116983756,0.0011234017,0.00005753713,0.000015576612,0.000003093427,0.000049005175,0.00004554214,0.8225105],"category_scores_gemma":[0.0060312375,0.0000916283,0.00046663554,0.00021367954,0.000008292074,0.000023905155,0.000043089207,0.000112908056,0.000060104707],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006193247,0.00006020076,0.000008635395,0.3963772,0.00046937002,0.000044158907,0.000018926974,0.0000017484452,0.0000022605025,0.0000017570633,0.6022082,0.0008013177],"study_design_scores_gemma":[0.0009890608,0.000096850985,0.01267562,0.86748093,0.00053238985,0.000074147334,0.00007174266,0.000025839157,0.00046079664,0.0000029691294,0.11744819,0.00014144673],"about_ca_topic_score_codex":0.00000981208,"about_ca_topic_score_gemma":0.0000031209179,"teacher_disagreement_score":0.82245034,"about_ca_system_score_codex":0.00003387056,"about_ca_system_score_gemma":0.0002093423,"threshold_uncertainty_score":0.72203904},"labels":[],"label_agreement":null},{"id":"W6958370066","doi":"10.6084/m9.figshare.25876333","title":"Additional file 2 of Strategies aiming to improve statin therapy adherence in older adults: a systematic review","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Université Laval; Université de Sherbrooke; Centre hospitalier universitaire de Québec","funders":"","keywords":"MEDLINE; Disease; Clinical trial; Risk assessment; Statin","score_opus":0.023432492844239573,"score_gpt":0.29473024476002274,"score_spread":0.27129775191578315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958370066","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022838687,0.036817733,0.0000010684778,0.00005055982,0.000012693024,0.0022189054,0.96013415,0.000035902205,0.0007061554],"genre_scores_gemma":[0.0034942357,0.00026661332,0.0003640319,0.0009322091,0.0001372444,0.013761599,0.9805511,0.00003039463,0.00046257782],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989598,0.000050089202,0.0003302627,0.00020598745,0.00031083866,0.0001430433],"domain_scores_gemma":[0.9991998,0.00027595708,0.000060276343,0.0002681258,0.00012645267,0.00006940286],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008467242,0.00010524358,0.0004329095,0.00006505393,0.0000130831695,0.000021877157,0.00006852268,0.000041175677,0.9422199],"category_scores_gemma":[0.00139125,0.00007634363,0.00015297325,0.00028827015,0.0000027189456,0.000081604514,0.000020459678,0.00012826279,0.0008792254],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000051283037,0.00001537707,2.1609708e-8,0.3241331,0.000029757999,0.000028525952,0.00012290142,1.9622541e-7,0.0000020446134,0.0000019247768,0.67130786,0.0043531684],"study_design_scores_gemma":[0.00019077955,0.00016424774,0.00014962399,0.95573467,0.000018344736,0.00002127483,0.00035022295,0.00007706004,0.00002607626,0.000005465929,0.043181907,0.00008030143],"about_ca_topic_score_codex":0.000027860437,"about_ca_topic_score_gemma":0.000014757351,"teacher_disagreement_score":0.9413407,"about_ca_system_score_codex":0.000044444998,"about_ca_system_score_gemma":0.00041810132,"threshold_uncertainty_score":0.99989873},"labels":[],"label_agreement":null},{"id":"W6958507219","doi":"10.6084/m9.figshare.22625134.v1","title":"Additional file 6 of Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia","year":2023,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Outreach; Cascade; Network packet; Familial hypercholesterolemia; Proband","score_opus":0.16312791917475128,"score_gpt":0.32280271518932435,"score_spread":0.15967479601457307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958507219","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017459186,0.000120308236,0.0000163529,0.000067782086,0.000004212577,0.0010639218,0.9963869,0.00012671227,0.00046788092],"genre_scores_gemma":[0.0035006097,0.0000026417547,0.0833381,0.00012810204,0.0000642076,0.0046806377,0.908119,0.000021142787,0.00014551925],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928063,0.000040567375,0.0001669875,0.0001709471,0.00016407213,0.0001767777],"domain_scores_gemma":[0.99815285,0.0011154782,0.00005411832,0.00021449148,0.00037224303,0.00009083928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000048325874,0.00008921886,0.00020581813,0.000060560436,0.00010985352,0.000033528202,0.000052456748,0.000057644596,0.064772956],"category_scores_gemma":[0.001922229,0.00008724738,0.00007343795,0.00022632346,0.000010970611,0.00009247885,0.00007961249,0.00010657904,0.00008433373],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000262155,0.00001656483,0.0000012017988,0.00091266015,0.000042717114,0.000012059545,0.00031156983,0.00021883698,0.0005159456,0.0000010749744,0.9220617,0.07587946],"study_design_scores_gemma":[0.001253153,0.0008478859,0.017909717,0.012942111,0.0000499725,0.00020017022,0.0045537134,0.0057704705,0.0005827103,0.00006631304,0.9555605,0.0002633054],"about_ca_topic_score_codex":0.000018488236,"about_ca_topic_score_gemma":0.000006380151,"teacher_disagreement_score":0.08826787,"about_ca_system_score_codex":0.000024660494,"about_ca_system_score_gemma":0.00021846128,"threshold_uncertainty_score":0.93608195},"labels":[],"label_agreement":null},{"id":"W6958509975","doi":"10.6084/m9.figshare.14314369.v1","title":"Additional file 1 of Associations between essential medicines and health outcomes for cardiovascular disease","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Athabasca University","funders":"","keywords":"Disease; MEDLINE; Essential hypertension; Health care; Public health","score_opus":0.048451898972864886,"score_gpt":0.30707179823070035,"score_spread":0.25861989925783546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958509975","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029519428,0.0022696576,0.0000122766705,0.0013863519,0.000018826328,0.00046157255,0.99566513,0.000023843366,0.0001328261],"genre_scores_gemma":[0.002049454,0.0000144686055,0.0008557826,0.0004935254,0.00061751937,0.0007884814,0.9948436,0.000017084989,0.0003200861],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988823,0.000042768657,0.00023041792,0.00022028836,0.0004520927,0.00017211752],"domain_scores_gemma":[0.9985369,0.00047563858,0.00009371736,0.000318245,0.00032596246,0.0002495552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010073783,0.00009444895,0.00053561764,0.00003907977,0.00010091158,0.000008461154,0.000033248598,0.00005248686,0.7658941],"category_scores_gemma":[0.0043718438,0.000083064435,0.0006926009,0.00011568337,0.000008605295,0.000037794885,0.00003848491,0.0000753746,0.000033669778],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000026524576,0.00002696939,0.0002791985,0.00062516105,0.0009378389,0.0000099141835,0.0000137039315,0.000001023043,1.2103969e-7,0.000004340637,0.9918719,0.006227156],"study_design_scores_gemma":[0.00060119777,0.000033643388,0.3053971,0.0012339675,0.00019919037,0.0000053409553,0.0000210219,0.000009778192,0.000008310067,0.00003458055,0.69239354,0.00006232898],"about_ca_topic_score_codex":0.000021539898,"about_ca_topic_score_gemma":0.000008138664,"teacher_disagreement_score":0.76586044,"about_ca_system_score_codex":0.000044973352,"about_ca_system_score_gemma":0.0008697487,"threshold_uncertainty_score":0.5233821},"labels":[],"label_agreement":null},{"id":"W6958528800","doi":"10.6084/m9.figshare.26723834","title":"Additional file 3 of Strategies aiming to improve statin therapy adherence in older adults: a systematic review","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health and Social Services Centre University Institute of Geriatrics of Sherbrooke; Université Laval; Université de Sherbrooke; Centre hospitalier universitaire de Québec","funders":"","keywords":"MEDLINE; Disease; Clinical trial; Risk assessment; Statin","score_opus":0.023868486528709487,"score_gpt":0.2948949617011562,"score_spread":0.2710264751724467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958528800","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023206234,0.036411326,0.0000011017714,0.000050597377,0.000012749958,0.0022238481,0.9605478,0.000035870384,0.0006935006],"genre_scores_gemma":[0.0036417516,0.0002660893,0.0003722873,0.0009416445,0.0001382791,0.013919547,0.9802134,0.00003077613,0.00047621017],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99895954,0.000050054055,0.000330263,0.00020605819,0.0003109957,0.00014308945],"domain_scores_gemma":[0.9991965,0.00027757627,0.000060194387,0.00026825065,0.00012801861,0.000069408474],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00008514481,0.00010526412,0.00043284148,0.00006507688,0.000013080848,0.000021874792,0.00006851674,0.000041171497,0.94184947],"category_scores_gemma":[0.001409663,0.00007634954,0.00015299514,0.00028839908,0.0000027192036,0.00008161275,0.000020446321,0.00012826621,0.00090062065],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005194394,0.000015375208,2.2431125e-8,0.3258071,0.000029731591,0.000028059787,0.00012279989,1.952642e-7,0.0000021321616,0.0000018747894,0.66969526,0.0042922962],"study_design_scores_gemma":[0.00019185757,0.00016360168,0.0001509827,0.9566468,0.00001819365,0.000020955145,0.00035157937,0.00007760381,0.000026837037,0.0000054239126,0.042265818,0.00008032264],"about_ca_topic_score_codex":0.000027902517,"about_ca_topic_score_gemma":0.00001477261,"teacher_disagreement_score":0.94094884,"about_ca_system_score_codex":0.000044628163,"about_ca_system_score_gemma":0.00042043353,"threshold_uncertainty_score":0.9998773},"labels":[],"label_agreement":null},{"id":"W6958697511","doi":"10.6084/m9.figshare.26586972","title":"Additional file 1 of Spatiotemporal analysis of the effect of global development indicators on child mortality","year":2024,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Sanitation; Per capita; Population; Open defecation; Table (database); Health indicator; Trend analysis; Mortality rate; Child mortality","score_opus":0.012688604668146615,"score_gpt":0.2699408746194249,"score_spread":0.25725226995127826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6958697511","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033772036,0.00013614817,2.0040179e-7,0.00001719308,0.000014340326,0.00024881572,0.9632459,0.000010581409,0.0025547803],"genre_scores_gemma":[0.5361211,2.4140382e-7,0.000020914966,0.000017580167,0.00003101229,0.00011771367,0.4636682,0.000003501583,0.000019792196],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9989772,0.00005310514,0.0002293667,0.0001324683,0.00053222955,0.00007566179],"domain_scores_gemma":[0.99937475,0.00014958165,0.000110865054,0.00027979346,0.00004212565,0.000042887434],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008484423,0.00007625947,0.00031931492,0.000081401624,0.00002253363,0.0000024437072,0.00007217734,0.00005701154,0.8465094],"category_scores_gemma":[0.00063992763,0.000046413632,0.00044777966,0.0009546974,0.000011696673,0.000014053601,0.000038589373,0.000086198066,0.00004617523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018672314,0.000036494508,0.003160212,0.0013326348,0.002452576,0.000004812246,0.000025245383,0.000014948963,5.6595644e-7,0.0000061853825,0.9817792,0.011168415],"study_design_scores_gemma":[0.00011824547,0.00010964734,0.83450645,0.004137259,0.0003347007,0.0000020012612,0.000003308666,0.00005411796,0.001613262,9.050916e-7,0.15908085,0.000039259878],"about_ca_topic_score_codex":0.00003261043,"about_ca_topic_score_gemma":0.000028622368,"teacher_disagreement_score":0.8464632,"about_ca_system_score_codex":0.000066826025,"about_ca_system_score_gemma":0.00029922946,"threshold_uncertainty_score":0.1892693},"labels":[],"label_agreement":null},{"id":"W6959035559","doi":"10.6084/m9.figshare.5768595","title":"Additional file 2: of Ezetimibe prescriptions in older Canadian adults after an acute myocardial infarction: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Ezetimibe; Cohort study; Cohort; Retrospective cohort study; MEDLINE; Epidemiology","score_opus":0.01045699323016245,"score_gpt":0.2473832260370716,"score_spread":0.23692623280690916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6959035559","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032380607,0.00001168918,1.3881326e-7,0.0000520294,0.000042174088,0.0014642868,0.9650118,0.000026361573,0.0010109184],"genre_scores_gemma":[0.4532605,1.2777507e-7,0.00009371011,0.0003156225,0.00037466214,0.0028943522,0.5429603,0.000013191202,0.00008755152],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9987902,0.00007228846,0.00023653157,0.00027862543,0.00039556497,0.00022679169],"domain_scores_gemma":[0.99885696,0.00005244369,0.00005611749,0.0004419373,0.00032691442,0.00026561847],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000056913053,0.000119269294,0.00024753806,0.0002118404,0.0000802365,0.000014349867,0.00006386619,0.000102442566,0.9755307],"category_scores_gemma":[0.00042866325,0.000116567346,0.00013116594,0.0002809284,0.000009851176,0.00011241907,0.000016066397,0.00014017767,0.0004558894],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008606919,0.00016901427,0.030237481,0.000047277957,0.0001267204,0.000037449932,0.0001371399,0.0000047526355,1.7272555e-7,1.4828906e-7,0.9680651,0.0010886802],"study_design_scores_gemma":[0.0007860534,0.00035665717,0.89129347,0.0010436053,0.000043963442,0.000011630154,0.0000500577,0.00027200844,0.0000013656323,0.0000010661666,0.10604053,0.00009962647],"about_ca_topic_score_codex":0.033386037,"about_ca_topic_score_gemma":0.16495903,"teacher_disagreement_score":0.9750748,"about_ca_system_score_codex":0.0001816908,"about_ca_system_score_gemma":0.0007998941,"threshold_uncertainty_score":0.9730507},"labels":[],"label_agreement":null},{"id":"W6962623641","doi":"10.17863/cam.72847","title":"Sex-Specific Associations of Genetically Predicted Circulating Lp(a) (Lipoprotein(a)) and Hepatic LPA Gene Expression Levels With Cardiovascular Outcomes: Mendelian Randomization and Observational Analyses.","year":2021,"lang":"en","type":"article","venue":"Apollo (University of Cambridge)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Mendelian randomization; Disease; Gene expression; Gene; Single-nucleotide polymorphism; Risk factor; Genetic association","score_opus":0.05709074062165187,"score_gpt":0.2624988588548291,"score_spread":0.20540811823317723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6962623641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9204266,0.0021827638,0.07620476,0.00026121066,0.00002289386,0.00055603683,0.000104887964,0.00002514562,0.00021571484],"genre_scores_gemma":[0.9753752,0.000538292,0.023648592,0.00004399174,0.000040118204,0.0000020536938,0.00019198399,0.00001798082,0.0001418294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980791,0.0002172622,0.00029479468,0.00037452605,0.00085006794,0.00018423745],"domain_scores_gemma":[0.9985436,0.0000836373,0.00020334011,0.00047829634,0.0005308881,0.00016019499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056943676,0.00016184947,0.00088842324,0.00013631179,0.0002025492,0.000013513636,0.0000596178,0.00012276099,0.00002183294],"category_scores_gemma":[0.00011901005,0.00015896131,0.00031716016,0.00041107103,0.00012849599,0.00014249432,0.00007689302,0.00012406881,3.8613408e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093313365,0.0005993358,0.5673604,0.0019777964,0.014619359,0.000472851,0.0034409186,0.003754634,0.35158357,0.0010630607,0.00021857252,0.053976376],"study_design_scores_gemma":[0.010496727,0.00011874537,0.96879244,0.00021875363,0.0012341364,0.000079410536,0.0009767131,0.0025732059,0.015069653,0.000020136815,0.00022340607,0.0001966704],"about_ca_topic_score_codex":0.0007594123,"about_ca_topic_score_gemma":0.000046038127,"teacher_disagreement_score":0.40143204,"about_ca_system_score_codex":0.00008084457,"about_ca_system_score_gemma":0.00026627918,"threshold_uncertainty_score":0.6482254},"labels":[],"label_agreement":null},{"id":"W6965085740","doi":"10.3389/fphar.2022.1003370.s004","title":"Presentation3_The association between statin use and osteoarthritis-related outcomes: An updated systematic review and meta-analysis.pdf","year":2022,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Statin; Observational study; Meta-analysis; Population; Systematic review; MEDLINE; Atorvastatin; Risk assessment","score_opus":0.06801038071654189,"score_gpt":0.3178787201586604,"score_spread":0.24986833944211853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6965085740","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0889778,0.21333194,0.0000103913235,0.0062885457,0.00005788199,0.024241501,0.66609305,0.00047228468,0.0005266165],"genre_scores_gemma":[0.42113453,0.00027022086,0.00017382775,0.0048061404,0.00004040589,0.00380217,0.5618738,0.00007223887,0.007826655],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99754125,0.0008571161,0.000516832,0.00029127317,0.00062149006,0.00017204307],"domain_scores_gemma":[0.9987162,0.00016139122,0.00034981396,0.0004439107,0.0001752695,0.00015342893],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074212754,0.00015295953,0.0016555609,0.00010898422,0.00019200928,0.000069728405,0.00006556409,0.000054810956,0.07550436],"category_scores_gemma":[0.0008546178,0.00011700874,0.00044427664,0.0004975487,0.0000034328775,0.00021498764,0.000086491265,0.00022233768,0.00009024559],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002688974,0.00025063736,0.023298956,0.2521815,0.6419828,0.00017604756,0.0016120864,0.00004990932,0.0000099804765,0.000026871347,0.0800171,0.00036726356],"study_design_scores_gemma":[0.0016168542,0.00034135184,0.071889535,0.0017769329,0.9205561,0.00005645589,0.00033580232,0.00007881999,0.000011098912,0.000020685286,0.0029770562,0.00033930494],"about_ca_topic_score_codex":0.00009277202,"about_ca_topic_score_gemma":0.000028566668,"teacher_disagreement_score":0.33215672,"about_ca_system_score_codex":0.0000978484,"about_ca_system_score_gemma":0.00004753675,"threshold_uncertainty_score":0.9253408},"labels":[],"label_agreement":null},{"id":"W6976736818","doi":"10.60692/r45h9-6ac94","title":"The panorama of familial hypercholesterolemia in Latin America: a systematic review","year":2016,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Latin Americans; Ethnic group; Indigenous; PCSK9; Systematic review; Mutation","score_opus":0.02290007746452074,"score_gpt":0.2289132151051972,"score_spread":0.20601313764067644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976736818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797894,0.0016168228,0.0069678943,0.0011194192,0.00033975203,0.0071017193,0.000072001436,0.00015519939,0.0028378041],"genre_scores_gemma":[0.9990585,0.000057361372,0.00005055254,0.00040672612,0.00004001869,0.00026135833,0.0000029081743,0.000007943851,0.00011465241],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99786144,0.00020280297,0.0011487006,0.00009583271,0.00049002277,0.00020120692],"domain_scores_gemma":[0.99859905,0.000021900005,0.00041164778,0.0007100993,0.00018378376,0.000073501324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011908002,0.00012855156,0.0007020278,0.00010023516,0.000049802376,0.000021261658,0.00011651786,0.00006318019,0.000004031351],"category_scores_gemma":[0.00016876837,0.00005598939,0.00018418817,0.0002453911,0.000041054704,0.00017889109,0.000032243144,0.00007453387,0.00025843113],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020566524,0.000007992328,0.07312044,0.8980561,0.0003276022,0.000013186649,0.018572716,0.0000025319684,0.00002016126,0.00022066188,0.00015599882,0.009296956],"study_design_scores_gemma":[0.008643046,0.00045064246,0.20388085,0.7611748,0.0009913866,0.00045837578,0.0218475,0.00029196037,0.00048710033,0.0000019734748,0.0012441325,0.00052823935],"about_ca_topic_score_codex":0.000023956856,"about_ca_topic_score_gemma":3.8745335e-7,"teacher_disagreement_score":0.13688129,"about_ca_system_score_codex":0.00014818602,"about_ca_system_score_gemma":0.000074679614,"threshold_uncertainty_score":0.33216953},"labels":[],"label_agreement":null},{"id":"W6976900703","doi":"10.6084/m9.figshare.28283403","title":"Additional file 1 of Cardiovascular disease essential medicines listing by countries: changes over time and association with health outcomes","year":2025,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Disease; Association (psychology); Listing (finance); Alternative medicine; MEDLINE; Health care","score_opus":0.007993863643418017,"score_gpt":0.24159044843730698,"score_spread":0.23359658479388895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976900703","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018549385,0.004021596,0.0000018144239,0.001345963,0.000016222035,0.00044842804,0.9935659,0.000038933245,0.00037561313],"genre_scores_gemma":[0.0013709465,0.000052328553,0.00007614379,0.0016538824,0.00024049134,0.00052297424,0.9934332,0.000017625152,0.0026324072],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986796,0.00005278162,0.00016639562,0.00022474506,0.00068574597,0.00019074781],"domain_scores_gemma":[0.99882084,0.00042490062,0.00013953628,0.00025576548,0.00021557708,0.00014339291],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013072613,0.0001240572,0.00048368744,0.00006507516,0.00009730489,0.000014598456,0.000039571645,0.00006408699,0.71553737],"category_scores_gemma":[0.0022319518,0.00009512675,0.00015368307,0.00015267963,0.000012785293,0.00004695989,0.000035161233,0.000102248465,0.00004309193],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002505261,0.00002269605,0.00020894136,0.0010333873,0.00086051103,0.000007772056,0.000023871718,0.0000018267843,3.950386e-7,7.913566e-7,0.9958351,0.0019796002],"study_design_scores_gemma":[0.0008026762,0.00007195802,0.03217779,0.005716646,0.00019647366,0.0000033902486,0.000021097907,0.000094434254,0.000012811773,0.00000170021,0.9608168,0.00008424526],"about_ca_topic_score_codex":0.00010697527,"about_ca_topic_score_gemma":0.000015094238,"teacher_disagreement_score":0.7154943,"about_ca_system_score_codex":0.00012272746,"about_ca_system_score_gemma":0.00050081284,"threshold_uncertainty_score":0.3879156},"labels":[],"label_agreement":null},{"id":"W6976920461","doi":"10.6084/m9.figshare.14314369","title":"Additional file 1 of Associations between essential medicines and health outcomes for cardiovascular disease","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Athabasca University","funders":"","keywords":"Disease; MEDLINE; Essential hypertension; Health care; Public health","score_opus":0.048451898972864886,"score_gpt":0.30707179823070035,"score_spread":0.25861989925783546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976920461","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029519428,0.0022696576,0.0000122766705,0.0013863519,0.000018826328,0.00046157255,0.99566513,0.000023843366,0.0001328261],"genre_scores_gemma":[0.002049454,0.0000144686055,0.0008557826,0.0004935254,0.00061751937,0.0007884814,0.9948436,0.000017084989,0.0003200861],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988823,0.000042768657,0.00023041792,0.00022028836,0.0004520927,0.00017211752],"domain_scores_gemma":[0.9985369,0.00047563858,0.00009371736,0.000318245,0.00032596246,0.0002495552],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010073783,0.00009444895,0.00053561764,0.00003907977,0.00010091158,0.000008461154,0.000033248598,0.00005248686,0.7658941],"category_scores_gemma":[0.0043718438,0.000083064435,0.0006926009,0.00011568337,0.000008605295,0.000037794885,0.00003848491,0.0000753746,0.000033669778],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000026524576,0.00002696939,0.0002791985,0.00062516105,0.0009378389,0.0000099141835,0.0000137039315,0.000001023043,1.2103969e-7,0.000004340637,0.9918719,0.006227156],"study_design_scores_gemma":[0.00060119777,0.000033643388,0.3053971,0.0012339675,0.00019919037,0.0000053409553,0.0000210219,0.000009778192,0.000008310067,0.00003458055,0.69239354,0.00006232898],"about_ca_topic_score_codex":0.000021539898,"about_ca_topic_score_gemma":0.000008138664,"teacher_disagreement_score":0.76586044,"about_ca_system_score_codex":0.000044973352,"about_ca_system_score_gemma":0.0008697487,"threshold_uncertainty_score":0.5233821},"labels":[],"label_agreement":null},{"id":"W6976929228","doi":"10.6084/m9.figshare.14228225","title":"Additional file 2 of A systematic review on pharmacokinetics, cardiovascular outcomes and safety profiles of statins in cirrhosis","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Cirrhosis; MEDLINE; Disease; Risk assessment; Clinical trial","score_opus":0.030925763084483877,"score_gpt":0.27876615202620303,"score_spread":0.24784038894171914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6976929228","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044789413,0.032493442,2.429125e-7,0.00006703916,0.000007096748,0.0011771576,0.9654059,0.0000089282985,0.00079540093],"genre_scores_gemma":[0.0024153842,0.0022872728,0.00054555497,0.0006361728,0.000048873768,0.0024091396,0.99136835,0.000026201425,0.00026305605],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9985029,0.00015940114,0.0004817921,0.00019741962,0.00053741893,0.000121056466],"domain_scores_gemma":[0.99856347,0.00047518994,0.00015082529,0.00046650384,0.00027471033,0.000069291134],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014442412,0.000116946234,0.0011236789,0.000057499135,0.000015577763,0.0000031001996,0.00004897766,0.000045542405,0.8196919],"category_scores_gemma":[0.0059582465,0.00009159809,0.00046654453,0.000213512,0.000008291959,0.000023921679,0.000043083095,0.00011288184,0.00005945793],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006168378,0.0000602703,0.000008371621,0.39920297,0.00047007142,0.000045445442,0.000018971208,0.0000017595303,0.000002184799,0.0000017909097,0.5993569,0.0008251177],"study_design_scores_gemma":[0.0009984005,0.00009711161,0.012502408,0.8630923,0.00053178275,0.000074500625,0.00007118305,0.000025729645,0.0004590605,0.0000030005208,0.12200302,0.00014150311],"about_ca_topic_score_codex":0.000009911825,"about_ca_topic_score_gemma":0.0000031395505,"teacher_disagreement_score":0.8196324,"about_ca_system_score_codex":0.000033880347,"about_ca_system_score_gemma":0.00020840274,"threshold_uncertainty_score":0.7133008},"labels":[],"label_agreement":null},{"id":"W6977111263","doi":"10.6084/m9.figshare.5768613","title":"Additional file 3: of Ezetimibe prescriptions in older Canadian adults after an acute myocardial infarction: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Medical prescription; Cohort study; Cohort; Retrospective cohort study; MEDLINE","score_opus":0.010551092214414477,"score_gpt":0.24753477769349394,"score_spread":0.23698368547907947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977111263","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032081943,0.000011741208,1.4069349e-7,0.00005167798,0.000042258147,0.0014678936,0.96528786,0.000026402135,0.0010300676],"genre_scores_gemma":[0.44967192,1.2831603e-7,0.00009495403,0.00031733298,0.00037834755,0.002939374,0.54649603,0.000013248694,0.000088655375],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9987896,0.00007230071,0.00023665513,0.0002787466,0.00039582216,0.0002268711],"domain_scores_gemma":[0.9988581,0.000050589075,0.000056159784,0.00044233198,0.0003271138,0.0002657002],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000056915404,0.00011929573,0.00024766437,0.00021182501,0.00008025042,0.00001435243,0.00006391216,0.00010247746,0.9748449],"category_scores_gemma":[0.00040819537,0.000116589516,0.00013121295,0.00028089999,0.000009852849,0.000112425776,0.000016078193,0.00014019718,0.00045798125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008532479,0.00016877486,0.030839615,0.00004802264,0.00012578507,0.000036962047,0.00013616162,0.0000047845197,1.7118658e-7,1.5235024e-7,0.9675281,0.0010261287],"study_design_scores_gemma":[0.0007826331,0.0003577386,0.8864119,0.0010014506,0.00004376447,0.000011457234,0.000050154136,0.00027155376,0.0000013257677,0.0000010547236,0.110967875,0.00009911471],"about_ca_topic_score_codex":0.03430504,"about_ca_topic_score_gemma":0.1675946,"teacher_disagreement_score":0.97438693,"about_ca_system_score_codex":0.00018186172,"about_ca_system_score_gemma":0.00080019946,"threshold_uncertainty_score":0.9721256},"labels":[],"label_agreement":null},{"id":"W6977142495","doi":"10.6084/m9.figshare.14437715.v3","title":"Additional file of Gene discovery for the bark beetle-vectored fungal tree pathogen Grosmannia clavigera","year":2021,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Bark (sound); Pathogen; Fungal pathogen; Tree (set theory); Gene","score_opus":0.026049790798242198,"score_gpt":0.25080196426287477,"score_spread":0.22475217346463255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977142495","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009078449,0.0015071613,0.0000101076985,0.00012868148,0.000044474637,0.0004967471,0.99652195,0.000020907979,0.0011791795],"genre_scores_gemma":[0.0022014005,0.000008365013,0.00089474826,0.0005145921,0.0011348116,0.0022148686,0.9900611,0.000028677145,0.0029414431],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989497,0.000037485257,0.00019865067,0.00023613301,0.00036638146,0.00021165024],"domain_scores_gemma":[0.9983803,0.0007028409,0.00007915749,0.000480593,0.0002699439,0.00008714435],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000050252318,0.000118444455,0.00026851206,0.000022277653,0.000108599925,0.000024927827,0.00009515177,0.000088299515,0.9318097],"category_scores_gemma":[0.0018965484,0.000083984625,0.00048498638,0.00014748254,0.000010059226,0.0000717967,0.00004837323,0.00012733109,0.00022300857],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003815447,0.00004858541,0.0000018212705,0.00026229623,0.00015301004,0.000057113244,0.000023526356,0.0000019817808,0.0005343411,0.000006065082,0.99216574,0.0067073344],"study_design_scores_gemma":[0.00057471724,0.00009461368,0.027913835,0.0010699787,0.000062274325,0.00011878852,0.000057686113,0.000060003433,0.0020113266,0.000014642957,0.9679228,0.00009933897],"about_ca_topic_score_codex":0.000005800843,"about_ca_topic_score_gemma":0.000019086017,"teacher_disagreement_score":0.93158674,"about_ca_system_score_codex":0.00004023177,"about_ca_system_score_gemma":0.00053767575,"threshold_uncertainty_score":0.34247935},"labels":[],"label_agreement":null},{"id":"W6977187029","doi":"10.6084/m9.figshare.5768586.v1","title":"Additional file 1: of Ezetimibe prescriptions in older Canadian adults after an acute myocardial infarction: a population-based cohort study","year":2018,"lang":"en","type":"article","venue":"Figshare","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Checklist; Medical prescription; Cohort study; Ezetimibe; Cohort; Retrospective cohort study","score_opus":0.010789529458726787,"score_gpt":0.24725799389176611,"score_spread":0.23646846443303932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6977187029","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032090493,0.0000117408035,1.4056887e-7,0.00005215822,0.000042260282,0.0014675608,0.96528375,0.00002641291,0.0010255035],"genre_scores_gemma":[0.4489122,1.2861624e-7,0.00009512222,0.0003179387,0.000379405,0.0029439623,0.54724926,0.000013270919,0.00008872085],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99878967,0.0000722994,0.00023664224,0.00027873117,0.00039581727,0.00022686925],"domain_scores_gemma":[0.99885833,0.000050590563,0.00005615611,0.00044213422,0.00032709158,0.00026569748],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005692707,0.00011929258,0.00024764135,0.00021183425,0.0000802377,0.00001435308,0.00006388579,0.00010247775,0.97485715],"category_scores_gemma":[0.00040804222,0.00011658798,0.00013121158,0.00028097516,0.000009851898,0.00011242494,0.000016071972,0.0001401956,0.00045779278],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008554241,0.00016861205,0.030228492,0.000047893947,0.00012566533,0.000037109774,0.00013602796,0.0000047799335,1.7173899e-7,1.4867196e-7,0.9681287,0.0010368554],"study_design_scores_gemma":[0.0007831013,0.0003571368,0.8861037,0.0009962925,0.00004373816,0.00001132472,0.00005008593,0.0002735038,0.0000013133739,0.0000010621505,0.11127969,0.00009907439],"about_ca_topic_score_codex":0.0344412,"about_ca_topic_score_gemma":0.16596071,"teacher_disagreement_score":0.9743994,"about_ca_system_score_codex":0.00018298368,"about_ca_system_score_gemma":0.0008002515,"threshold_uncertainty_score":0.97198856},"labels":[],"label_agreement":null},{"id":"W6980901828","doi":"","title":"CSI Compressco LP Announces Fourth Quarter And Full Year 2017 Results","year":2018,"lang":"en","type":"other","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Work (physics)","score_opus":0.017934982114831542,"score_gpt":0.26888577908794015,"score_spread":0.2509507969731086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6980901828","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026103493,0.0036167155,0.00015218162,0.0005717244,0.00040985574,0.00068111566,0.000092159404,0.00016501268,0.9940502],"genre_scores_gemma":[0.00084956427,0.0020787257,0.0031869656,0.000443527,0.0038838645,0.000019021678,0.00014013756,0.0001921191,0.9892061],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985714,0.00005290666,0.00022058435,0.0004465373,0.00044032422,0.00026825024],"domain_scores_gemma":[0.99875337,0.000012205959,0.00011758403,0.000856657,0.00006349924,0.00019670915],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00033086276,0.00023940777,0.0005894985,0.00012290155,0.000045540266,0.00003281135,0.000092118404,0.00031265093,0.0012919133],"category_scores_gemma":[0.000023791392,0.00016511802,0.00015385528,0.000055912144,0.00013380461,0.000024111709,0.00004590365,0.00016779525,0.00080444687],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013031145,0.000028386188,0.00006928267,0.00025585588,0.00026189804,0.000034280623,0.000055728684,1.2949969e-8,0.000007293286,0.000055454566,0.995806,0.003295491],"study_design_scores_gemma":[0.0020856583,0.00046849565,0.0010012789,0.00047136217,0.00013838669,0.00008524859,0.00008666988,0.000008427443,0.000007779129,0.00001643587,0.9954348,0.0001954498],"about_ca_topic_score_codex":0.0013267831,"about_ca_topic_score_gemma":0.0007403085,"teacher_disagreement_score":0.0048441254,"about_ca_system_score_codex":0.000018547027,"about_ca_system_score_gemma":0.00008547991,"threshold_uncertainty_score":0.99997354},"labels":[],"label_agreement":null},{"id":"W6981263385","doi":"","title":"DTE Energy reports strong second quarter 2020 results; continues progress in environmental goals - Earnings News (EARNINGS) News","year":2020,"lang":"en","type":"other","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Earnings; Quarter (Canadian coin); Energy (signal processing); Work (physics)","score_opus":0.006940604658776478,"score_gpt":0.230688660767939,"score_spread":0.22374805610916254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981263385","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011344096,0.016311241,0.00021990732,0.0032844595,0.00076569704,0.0030863534,0.00015564672,0.00064425403,0.96418834],"genre_scores_gemma":[0.047141172,0.0014959015,0.0014746984,0.0016107988,0.003277953,0.00025255975,0.001329655,0.000831778,0.94258547],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956291,0.00027110995,0.001146913,0.0013465167,0.0009105593,0.0006958412],"domain_scores_gemma":[0.9974896,0.000024415343,0.00086982705,0.0011012527,0.000014249976,0.00050070795],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005055399,0.00065116474,0.0016174484,0.00023634931,0.000053062206,0.00006557296,0.00015854773,0.00065233035,0.008732636],"category_scores_gemma":[0.00006595728,0.0005520258,0.0005576366,0.00019966914,0.00014650487,0.000082138824,0.0001421725,0.0008730246,0.00013693848],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028731988,0.00017717498,0.04684111,0.0004045252,0.0007267552,0.0038966746,0.00055710634,9.2357794e-7,0.000092580856,0.000018749566,0.90257615,0.044420935],"study_design_scores_gemma":[0.0027564035,0.00048320167,0.013564376,0.0005319547,0.00016549324,0.00032013422,0.0007025225,0.000012839346,0.00012427953,0.000002957165,0.9808139,0.0005219367],"about_ca_topic_score_codex":0.004708559,"about_ca_topic_score_gemma":0.0029699113,"teacher_disagreement_score":0.07823776,"about_ca_system_score_codex":0.0001630319,"about_ca_system_score_gemma":0.00020292761,"threshold_uncertainty_score":0.9996931},"labels":[],"label_agreement":null},{"id":"W6981865335","doi":"","title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","year":2002,"lang":"en","type":"article","venue":"RePub (Erasmus University, Rotterdam)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novartis Pharma","keywords":"Myocardial infarction; Conventional PCI; Placebo; Angina; Discontinuation","score_opus":0.013430070178817598,"score_gpt":0.24786632766998165,"score_spread":0.23443625749116406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6981865335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797635,0.001159016,0.0024791253,0.00054831913,0.0009768971,0.01310521,0.000031729334,0.00008303871,0.0018531564],"genre_scores_gemma":[0.990977,0.00048212789,0.000902418,0.000043674652,0.0003091432,0.000111813795,0.00006686183,0.000034040815,0.00707292],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971079,0.00070178736,0.0007480971,0.0004479458,0.0006383806,0.0003558546],"domain_scores_gemma":[0.99826616,0.0003793784,0.00042495978,0.0005183987,0.00023045667,0.0001806358],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016273316,0.00026870513,0.0022675586,0.0002761778,0.00024878574,0.000018426601,0.00017132737,0.00017010642,0.00039229015],"category_scores_gemma":[0.0003353114,0.00024641422,0.00458999,0.00023738071,0.000069422924,0.00017963344,0.00009254204,0.0001862976,0.0000093016615],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.974785,0.0011456207,0.00070709566,0.0006980921,0.005310011,0.00030316727,0.0006790745,0.000024650972,0.00021101677,0.00010522723,0.0009306778,0.01510037],"study_design_scores_gemma":[0.9894283,0.0014567303,0.00037278887,0.00053014385,0.0030891881,0.00013664951,0.00055295543,0.00068470824,0.000074314885,0.0000814113,0.003346612,0.0002461872],"about_ca_topic_score_codex":0.00021310002,"about_ca_topic_score_gemma":0.00002447105,"teacher_disagreement_score":0.0148541825,"about_ca_system_score_codex":0.0002655112,"about_ca_system_score_gemma":0.00007733611,"threshold_uncertainty_score":0.9999988},"labels":[],"label_agreement":null},{"id":"W6990738739","doi":"","title":"Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials.","year":2017,"lang":"en","type":"article","venue":"Prodinra (INRA Bordeaux-Aquitaine)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Alirocumab; Pooled analysis; Statin; Evolocumab; PCSK9; Meta-analysis","score_opus":0.1677035256669517,"score_gpt":0.49783172541268655,"score_spread":0.3301281997457348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6990738739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921705,0.0017000131,0.0012214727,0.0011932438,0.0003321857,0.0022940978,0.0000873679,0.000052405096,0.00094871083],"genre_scores_gemma":[0.9947558,0.0006348887,0.0033433584,0.00025088497,0.00057300983,0.000048953294,0.00010541833,0.000059270595,0.00022844043],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99461573,0.0006809493,0.002308475,0.000879126,0.00092771294,0.0005879775],"domain_scores_gemma":[0.9940662,0.00069154875,0.0013405009,0.0023240314,0.0009746753,0.00060307316],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011149433,0.00040208094,0.0033610833,0.00058912765,0.00029009025,0.000110169196,0.00044583852,0.00026361234,0.00012790324],"category_scores_gemma":[0.012703517,0.0003253922,0.0009950829,0.0010415536,0.00028649566,0.00022571211,0.00035305994,0.00039693606,0.000013354964],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016699102,0.0033690706,0.07624633,0.0016899558,0.021495482,0.00014119122,0.0013859135,0.00007720762,0.0142987985,0.0023768866,0.00081250846,0.8614076],"study_design_scores_gemma":[0.07721483,0.011906936,0.8251244,0.0012833648,0.05070613,0.00006424928,0.0033812413,0.0044549336,0.0070887776,0.00036941713,0.016774682,0.0016310829],"about_ca_topic_score_codex":0.0011779452,"about_ca_topic_score_gemma":0.00009559934,"teacher_disagreement_score":0.8597765,"about_ca_system_score_codex":0.00008030348,"about_ca_system_score_gemma":0.00054432545,"threshold_uncertainty_score":0.99991983},"labels":[],"label_agreement":null},{"id":"W6991067667","doi":"","title":"Étude des mécanismes impliqués dans l’athéroprotection en réponse à un traitement avec le MPE-298, un azapeptide macrocyclique ligand du CD36/SR-B2, chez les souris déficientes en apolipoprotéines E hypercholestérolémiques","year":2023,"lang":"fr","type":"dissertation","venue":"Papyrus : Institutional Repository (Université de Montréal)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds de recherche du Québec – Nature et technologies; Université de Montréal; Centre in Green Chemistry and Catalysis; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Agrégation; Animal model; Prostate disease","score_opus":0.005780399973388046,"score_gpt":0.19471876587611062,"score_spread":0.18893836590272256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6991067667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.958864,0.030165538,0.0035996912,0.001125126,0.0012264132,0.002617288,0.00016166728,0.0005403655,0.0016999256],"genre_scores_gemma":[0.96470195,0.016355706,0.0021952353,0.000160378,0.0018884118,0.0005496146,0.00086506613,0.00022236472,0.0130612785],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9930294,0.0011981507,0.0012035924,0.0015580907,0.001624158,0.0013865903],"domain_scores_gemma":[0.9963888,0.0003089271,0.00068786246,0.00095529517,0.00072521844,0.0009339132],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0019018428,0.0012455004,0.0013826446,0.00078484014,0.009853057,0.0001692704,0.00068592385,0.0013233705,0.00006596611],"category_scores_gemma":[0.0003932984,0.0013347635,0.0013710067,0.0008517682,0.0007483444,0.00050786976,0.00033932077,0.0014238439,0.00009648524],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00335957,0.0017052423,0.03088865,0.0034583712,0.004645214,0.009118172,0.25557554,0.0032854818,0.56005126,0.0076343296,0.00021032275,0.12006786],"study_design_scores_gemma":[0.004135477,0.00082548155,0.5060607,0.0023343167,0.0019999514,0.0056669586,0.1277315,0.0010248064,0.33718404,0.0006621352,0.010945052,0.0014295591],"about_ca_topic_score_codex":0.2335555,"about_ca_topic_score_gemma":0.041773584,"teacher_disagreement_score":0.47517207,"about_ca_system_score_codex":0.0093829,"about_ca_system_score_gemma":0.003584073,"threshold_uncertainty_score":0.9999731},"labels":[],"label_agreement":null},{"id":"W6995975196","doi":"","title":"Quantifying the use of the 'statin' antilipemic drugs in Nova Scotia, Canada and Queensland, Australia","year":2004,"lang":"en","type":"article","venue":"Queensland's institutional digital repository (The University of Queensland)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nova (rocket); Statistical analysis; Nova scotia; Context (archaeology)","score_opus":0.03361312116026786,"score_gpt":0.2340352075935169,"score_spread":0.20042208643324905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6995975196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964994,0.00020907386,0.00022482073,0.0010815525,0.00028921542,0.0005854667,0.00009653864,0.0000132673185,0.0010006308],"genre_scores_gemma":[0.9989721,0.000033139288,0.00015942646,0.00011289557,0.000077133,5.008516e-7,0.0000230996,0.00001052722,0.0006111484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981312,0.00010544245,0.0003936404,0.00030838355,0.00077280105,0.0002884915],"domain_scores_gemma":[0.99871415,0.00015234602,0.00023799705,0.0005730373,0.00020816029,0.00011433324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023506948,0.00021779026,0.0004154721,0.00007935398,0.00037235266,0.00004148286,0.0002679084,0.00011307387,0.000009241075],"category_scores_gemma":[0.00011085093,0.00013129435,0.00023921145,0.00032645857,0.0009422645,0.0002895028,0.0001362303,0.00040344123,0.0000035386518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006128136,0.00018925156,0.9849672,0.00036135854,0.00040327685,0.00030016017,0.0015627994,0.0044094073,0.0004965185,0.0040910114,0.0012816512,0.0013245537],"study_design_scores_gemma":[0.002387172,0.00009307971,0.9857681,0.0006560997,0.00015282384,0.0005485083,0.00085340405,0.00010008117,0.00088423386,0.000093985735,0.008262813,0.00019970122],"about_ca_topic_score_codex":0.7206474,"about_ca_topic_score_gemma":0.41758153,"teacher_disagreement_score":0.30306587,"about_ca_system_score_codex":0.00029732814,"about_ca_system_score_gemma":0.0015753988,"threshold_uncertainty_score":0.59304607},"labels":[],"label_agreement":null},{"id":"W6997116526","doi":"","title":"Use and misuse of ezetimibe: analysis of utilization and cost in Saskatchewan, a Canadian jurisdiction with broad access","year":2013,"lang":"en","type":"article","venue":"eScholarship@McGill (McGill)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ezetimibe; Formulary; Jurisdiction; Acute coronary syndrome; Statin; Beijing","score_opus":0.03212785162566132,"score_gpt":0.26797087169994344,"score_spread":0.23584302007428212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W6997116526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997545,0.0003485334,0.0000028451514,0.00004880134,0.000024634477,0.0010492977,0.0002110097,0.00002062487,0.0007492313],"genre_scores_gemma":[0.9984445,0.00064359925,0.00044869405,0.00020131607,0.0000071709214,0.00006245811,0.00007680271,0.00003251187,0.000082928505],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998173,0.00016922376,0.00048704157,0.0004264617,0.00041726368,0.0003270291],"domain_scores_gemma":[0.9983852,0.00006190868,0.00019501818,0.0004914865,0.00041592808,0.00045044895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005883763,0.00021366581,0.0007029356,0.00090563775,0.00014496155,0.000041467545,0.00009071819,0.00018964574,0.0000703715],"category_scores_gemma":[0.00017784497,0.00018663584,0.00012005148,0.0014765075,0.000109964014,0.00077741244,0.000053136806,0.00027744283,0.0000015285872],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004986533,0.00040295324,0.40041748,0.001100553,0.0030887818,0.000080377606,0.00013213263,0.0002326286,0.012022138,0.0015177722,0.000006343226,0.5805002],"study_design_scores_gemma":[0.0022068622,0.000260699,0.980269,0.00029089607,0.0014910484,0.00004400302,0.00042130466,0.0007253343,0.011615248,0.00012648763,0.0022887874,0.00026032154],"about_ca_topic_score_codex":0.3982059,"about_ca_topic_score_gemma":0.44517186,"teacher_disagreement_score":0.58023983,"about_ca_system_score_codex":0.00025381928,"about_ca_system_score_gemma":0.00013553069,"threshold_uncertainty_score":0.76107883},"labels":[],"label_agreement":null},{"id":"W7006181300","doi":"","title":"A study of PCSK9 in glucose and insulin homeostasis","year":2021,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Glucose homeostasis; Insulin; Homeostasis; Diabetes mellitus","score_opus":0.01941612641666511,"score_gpt":0.2697743030585213,"score_spread":0.25035817664185617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7006181300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745067,0.012266362,1.8657026e-8,0.000011929493,0.000400115,0.0021907971,0.0002643009,0.00006484183,0.010294943],"genre_scores_gemma":[0.99370706,0.003984325,0.00019641811,0.00011952849,0.00004960114,0.00024814915,0.0006005769,0.00016119551,0.0009331321],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99521536,0.00056239724,0.0012241276,0.001149144,0.0012825024,0.00056648796],"domain_scores_gemma":[0.9973273,0.000103456376,0.0004419031,0.0012255016,0.0005071223,0.00039469067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015208648,0.00063073717,0.001898177,0.0007008562,0.00027065547,0.00003264325,0.00022205662,0.0007119094,0.00010194935],"category_scores_gemma":[0.00084262935,0.00063158217,0.00043882534,0.0011092479,0.000039045713,0.00022200959,0.00013692632,0.001635541,0.00001876442],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001189479,0.0034977142,0.0011418812,0.0036097108,0.0013561365,0.0019207996,0.00024183051,0.0000040329564,0.0074968454,0.0017030472,0.0000013040037,0.9778372],"study_design_scores_gemma":[0.05720386,0.008677632,0.56643933,0.012382237,0.006582316,0.0011131527,0.08032947,0.000019158973,0.21461847,0.0032630747,0.04441186,0.0049594403],"about_ca_topic_score_codex":0.0036930218,"about_ca_topic_score_gemma":0.009593349,"teacher_disagreement_score":0.9728778,"about_ca_system_score_codex":0.00043010295,"about_ca_system_score_gemma":0.0002036466,"threshold_uncertainty_score":0.9996135},"labels":[],"label_agreement":null},{"id":"W7024173078","doi":"","title":"A putative role for PCSK9 in synaptic remodelling and plasticity in response to brain injury: implications for Alzheimer's disease","year":2011,"lang":"en","type":"other","venue":"Library and Archives Canada (Government of Canada)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"PCSK9; Hippocampal formation; Downregulation and upregulation; Regulator; LDL receptor; Neuroplasticity; Hippocampus; Gene expression; Receptor","score_opus":0.010066899266983498,"score_gpt":0.2093100988970037,"score_spread":0.19924319963002018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7024173078","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25844902,0.0442176,0.029468585,0.13897578,0.0008562374,0.05172461,0.048928678,0.0002038446,0.42717564],"genre_scores_gemma":[0.96370924,0.00023402757,0.00899777,0.0032788205,0.00015113044,0.00070959266,0.00006867162,0.00026249193,0.02258826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986924,0.00006932221,0.00024457034,0.0003324708,0.00039217356,0.00026904137],"domain_scores_gemma":[0.9989527,0.00035529886,0.000100705525,0.00019330272,9.3048345e-7,0.0003970945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000033986576,0.00018610452,0.0004267973,0.000098013355,0.00004772342,0.00000653539,0.00007837815,0.000046815385,0.0000074002337],"category_scores_gemma":[0.000033746353,0.00018129946,0.000043728447,0.000073403964,0.00004037107,0.000050689418,0.00005254966,0.00010327652,1.3113081e-9],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2570353,0.0012705077,0.06536575,0.016050609,0.0066943737,0.0005540252,0.0044064387,0.0009113835,0.023501778,0.24943249,0.06893787,0.30583948],"study_design_scores_gemma":[0.009926444,0.0023031835,0.36064854,0.0058172913,0.001123461,0.00002443713,0.004505399,0.011632597,0.006402124,0.016287211,0.579299,0.0020303216],"about_ca_topic_score_codex":0.007415371,"about_ca_topic_score_gemma":0.040579945,"teacher_disagreement_score":0.7052602,"about_ca_system_score_codex":0.000016180706,"about_ca_system_score_gemma":0.0022290966,"threshold_uncertainty_score":0.9991943},"labels":[],"label_agreement":null},{"id":"W7036839650","doi":"","title":"Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada","year":2023,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Placebo; Coronary heart disease; Myocardial infarction; Formulary; Probabilistic logic; Clinical endpoint; Residual risk; Pharmacy; Disease","score_opus":0.1905288083506102,"score_gpt":0.49173416804346654,"score_spread":0.30120535969285633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7036839650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704836,0.024668915,0.00023885345,0.00008724546,0.00068002427,0.0035958043,0.000094008145,0.000005716239,0.00014585057],"genre_scores_gemma":[0.9834747,0.016046446,0.000027051505,0.000018525909,0.00010297618,0.0002555549,0.000010453856,0.000036203102,0.000028111834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962363,0.0008898609,0.00091594964,0.0003031683,0.001353527,0.00030117107],"domain_scores_gemma":[0.9968795,0.0005468489,0.0008610266,0.001082473,0.0005211356,0.000109012144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072672684,0.0002082352,0.0012921586,0.00028800443,0.00011843885,0.000016847946,0.001078154,0.00008950418,0.00011740058],"category_scores_gemma":[0.0007398923,0.0001301423,0.0010114518,0.0014205065,0.00010800995,0.00023511708,0.0003708406,0.00040038637,4.1914078e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014730028,0.0002905186,0.78419584,0.0034942245,0.0061839386,0.000011155906,0.0003329463,0.013098115,0.11242691,0.000013676305,0.0037502532,0.074729435],"study_design_scores_gemma":[0.0016192974,0.000016034275,0.8026856,0.0012376732,0.0007000573,0.000016162458,0.00030287754,0.00011155504,0.19057414,0.00017792585,0.0024516212,0.00010704374],"about_ca_topic_score_codex":0.5844842,"about_ca_topic_score_gemma":0.021886002,"teacher_disagreement_score":0.5625982,"about_ca_system_score_codex":0.0003999619,"about_ca_system_score_gemma":0.0014852689,"threshold_uncertainty_score":0.995962},"labels":[],"label_agreement":null},{"id":"W7037153033","doi":"","title":"Dyslipidemia in women: etiology and management","year":2014,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Ezetimibe; Statin; Lipoprotein; Cholesterol; Etiology; Fibrate","score_opus":0.13612520871277092,"score_gpt":0.5192032093836504,"score_spread":0.3830780006708795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7037153033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707721,0.012508598,0.00041718123,0.0007194278,0.00032248787,0.000852252,0.0000035643834,0.000022742794,0.0143816415],"genre_scores_gemma":[0.9691101,0.027077613,0.0004681695,0.0025925417,0.00031169804,0.00012453055,0.000004517282,0.000035931975,0.000274903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975899,0.0003827709,0.0006821144,0.0004079598,0.00048834505,0.00044895094],"domain_scores_gemma":[0.9985845,0.000111586836,0.00029061764,0.0005705107,0.00009847704,0.00034430536],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0039222394,0.000215109,0.0010059741,0.0006544422,0.0000946644,0.00016376753,0.0006042877,0.0001249443,0.0019334697],"category_scores_gemma":[0.00020358022,0.00017923034,0.00013649423,0.0005212785,0.00010279864,0.00043319786,0.00055501884,0.00038665303,0.000012506046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007206003,0.0003261656,0.6154729,0.001227729,0.0006729647,0.0001548927,0.00032724376,0.000042259308,0.005972361,0.0009922874,0.019796785,0.35429376],"study_design_scores_gemma":[0.0018496884,0.00003435659,0.91126156,0.00049657724,0.00007307228,0.000042658306,0.00010218146,0.000046361227,0.0006123553,0.003163506,0.08212076,0.00019693974],"about_ca_topic_score_codex":0.00043032644,"about_ca_topic_score_gemma":0.00003452932,"teacher_disagreement_score":0.35409683,"about_ca_system_score_codex":0.00016461409,"about_ca_system_score_gemma":0.00006594194,"threshold_uncertainty_score":0.9989789},"labels":[],"label_agreement":null},{"id":"W7042890260","doi":"","title":"Rapid increase in statins newly dispended to Ontario seniors between 1994 and 2000","year":2003,"lang":"en","type":"article","venue":"Queensland's institutional digital repository (The University of Queensland)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Statin; Age groups; Mortality rate; Myocardial infarction; Sudden cardiac death; Diabetes mellitus","score_opus":0.010944944843921743,"score_gpt":0.20647654090316722,"score_spread":0.19553159605924547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7042890260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9534203,0.00019117241,0.00081149803,0.00023456037,0.00008967322,0.000616205,0.00006820934,0.000030350784,0.044538025],"genre_scores_gemma":[0.99581146,0.000032730943,0.00078797597,0.00010033158,0.00008297675,0.0000013733949,0.00006537797,0.000011473343,0.0031062888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983565,0.00011696239,0.00030993414,0.00037980624,0.00053379766,0.00030299922],"domain_scores_gemma":[0.9989634,0.00009411614,0.00010063904,0.00038631854,0.00009580154,0.0003597372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029058877,0.00021545659,0.00047231655,0.00018061994,0.0003145485,0.00003935409,0.00013055485,0.00012360382,0.000049730992],"category_scores_gemma":[0.00008584398,0.00018010648,0.00019371556,0.0002432443,0.00032468975,0.00027563554,0.00007220958,0.00031188165,0.000018486078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096722145,0.0003009125,0.9772431,0.00014804977,0.00043230606,0.0010164855,0.003357573,0.00025927293,0.000111606205,0.0036259054,0.0010453737,0.011492167],"study_design_scores_gemma":[0.0033626205,0.00036498584,0.82770985,0.00022797054,0.0001552938,0.0004597455,0.00068803673,0.000015725984,0.00020833027,0.00023030581,0.16629241,0.00028471323],"about_ca_topic_score_codex":0.038514346,"about_ca_topic_score_gemma":0.008499228,"teacher_disagreement_score":0.16524704,"about_ca_system_score_codex":0.000489144,"about_ca_system_score_gemma":0.0013956467,"threshold_uncertainty_score":0.9678883},"labels":[],"label_agreement":null},{"id":"W7046347124","doi":"","title":"A discordance analysis of apolipoprotein A-I and high-density lipoprotein-cholesterol in UK Biobank","year":2024,"lang":"en","type":"dissertation","venue":"eScholarship@McGill (McGill)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biobank; Apolipoprotein B; Apolipoprotein E; Disease; Epidemiology","score_opus":0.010770854435362935,"score_gpt":0.2518799557436292,"score_spread":0.24110910130826627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7046347124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98858964,0.0036534348,0.0000010053382,0.00006307617,0.0006298814,0.0025229813,0.00089488085,0.0001534219,0.0034916808],"genre_scores_gemma":[0.9936153,0.0012680107,0.0005661972,0.0001963551,0.00011951917,0.00041377512,0.0012796386,0.00022571818,0.0023154374],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9933921,0.00040192824,0.0017055776,0.0019201331,0.001664677,0.0009155483],"domain_scores_gemma":[0.9964451,0.00008810166,0.0006834082,0.0018851127,0.00033578047,0.0005624483],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018788916,0.0010493943,0.0031410789,0.002335377,0.00031635704,0.000084027124,0.00038677626,0.0010959674,0.00010821342],"category_scores_gemma":[0.00047945083,0.0009896716,0.0013436561,0.0033225848,0.0001449404,0.00029976905,0.00020315505,0.0023400204,0.00005758301],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002356204,0.00075607747,0.0010975789,0.009386491,0.011385865,0.0010243433,0.00010601225,0.000032593543,0.055792313,0.013362637,0.0000047214253,0.90469515],"study_design_scores_gemma":[0.008116592,0.0020376914,0.6564707,0.011623562,0.02921552,0.0002959767,0.0013122235,0.00031001322,0.26295307,0.017256917,0.006621148,0.003786541],"about_ca_topic_score_codex":0.047154166,"about_ca_topic_score_gemma":0.059957888,"teacher_disagreement_score":0.90090865,"about_ca_system_score_codex":0.00074564264,"about_ca_system_score_gemma":0.0001831963,"threshold_uncertainty_score":0.9999616},"labels":[],"label_agreement":null},{"id":"W7072674446","doi":"","title":"World Heart Federation Cholesterol Roadmap: The Portuguese case","year":2024,"lang":"en","type":"article","venue":"Repositório Comum (Repositório Científico de Acesso Aberto de Portugal)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Portuguese; Referral; Atherosclerotic cardiovascular disease; Balanced scorecard; Cholesterol; Government (linguistics); Blood cholesterol; Disease; Canadian Cardiovascular Society","score_opus":0.014111658708300032,"score_gpt":0.28316077317369936,"score_spread":0.2690491144653993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7072674446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9085423,0.052564286,0.005690587,0.012581707,0.0019065436,0.003015522,0.000024999126,0.0011490813,0.014524986],"genre_scores_gemma":[0.97906154,0.0007070185,0.000954808,0.004610062,0.0014337597,0.00040118923,0.00009548849,0.0001960643,0.012540052],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99353856,0.00051143265,0.0014167958,0.0014362811,0.0015928969,0.0015040245],"domain_scores_gemma":[0.99558294,0.00020870897,0.00030147014,0.0024464075,0.00039262092,0.0010678825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032642824,0.0007505349,0.0010209467,0.0005482433,0.0010615265,0.00090591377,0.00038753005,0.00039023237,0.00012352531],"category_scores_gemma":[0.00018407503,0.00056700327,0.0011031232,0.001518802,0.00018754644,0.0006121985,0.0002506458,0.0014322344,0.00014538258],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015331814,0.0036081437,0.12227761,0.0067981095,0.0067792996,0.29877785,0.019150594,0.0010677164,0.108356066,0.00786919,0.09100943,0.33277282],"study_design_scores_gemma":[0.0028447942,0.0007497869,0.08338594,0.0019065132,0.0025752136,0.48783627,0.00092533225,0.015831016,0.03725466,0.0002500689,0.36488253,0.0015578639],"about_ca_topic_score_codex":0.0023601912,"about_ca_topic_score_gemma":0.0019478666,"teacher_disagreement_score":0.33121496,"about_ca_system_score_codex":0.001238337,"about_ca_system_score_gemma":0.0014033758,"threshold_uncertainty_score":0.99967813},"labels":[],"label_agreement":null},{"id":"W7092115238","doi":"","title":"ApoB Testing in Dyslipidemia Management: Knowledge and Practices of Healthcare Providers in Saudi Arabia","year":2025,"lang":"en","type":"article","venue":"DOAJ (DOAJ: Directory of Open Access Journals)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Dyslipidemia; Pharmacy; Health care; Christian ministry; Clinical pharmacy; Pharmacist; MEDLINE; Ambulatory care","score_opus":0.22415989310706746,"score_gpt":0.5607867885518568,"score_spread":0.33662689544478935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7092115238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8735165,0.10679614,0.00005470588,0.0018227624,0.0002522052,0.0020161357,0.000006777666,0.000020888187,0.015513875],"genre_scores_gemma":[0.9830446,0.015139147,0.00092728663,0.00042178234,0.000097008946,0.000096965145,0.0000048523157,0.000029425162,0.00023889476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968538,0.0005179615,0.0012174506,0.0004990911,0.00050198595,0.00040969718],"domain_scores_gemma":[0.9973933,0.00047793373,0.0010866679,0.00054246985,0.0003024844,0.00019714287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004384594,0.0002498696,0.0011901046,0.0014532363,0.00010179307,0.00019503263,0.0006515895,0.00013744825,0.0001367647],"category_scores_gemma":[0.0016575108,0.00022646954,0.00013697168,0.0022299609,0.00010400051,0.0011308104,0.00061767176,0.000650629,0.0000015046253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028175346,0.00028163014,0.8188153,0.0053528924,0.00023392,0.00008275792,0.00025099868,0.000025703923,0.0018647106,0.00017559406,0.0019780605,0.17065671],"study_design_scores_gemma":[0.001962458,0.00002648622,0.9811728,0.0067085144,0.00015018714,0.000017221091,0.00048284678,0.0001337895,0.0013500996,0.0016851635,0.006123715,0.00018670432],"about_ca_topic_score_codex":0.009409121,"about_ca_topic_score_gemma":0.0015184863,"teacher_disagreement_score":0.17047001,"about_ca_system_score_codex":0.00022971223,"about_ca_system_score_gemma":0.0004997123,"threshold_uncertainty_score":0.9971873},"labels":[],"label_agreement":null},{"id":"W7093636301","doi":"","title":"Creating knowledge for e-cigarette regulatory policy.","year":2020,"lang":"en","type":"report","venue":"The International Islamic University Malaysia Repository (The International Islamic University Malaysia)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"General partnership; Unit (ring theory); Public policy; Health policy; Public health; Tobacco control","score_opus":0.019126653892848063,"score_gpt":0.25478539129639793,"score_spread":0.23565873740354987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7093636301","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28687644,0.00045104415,0.0024462387,0.037387937,0.007957737,0.0035820305,0.00108649,0.00057283737,0.65963924],"genre_scores_gemma":[0.754209,0.00085563445,0.00031340632,0.0006395748,0.007204738,0.000008848079,0.0008567414,0.00014510025,0.23576698],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933664,0.00036395708,0.0008404877,0.0014834058,0.0031892338,0.00075646746],"domain_scores_gemma":[0.9935502,0.00050644064,0.0012427953,0.0016527707,0.0028454885,0.00020232842],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015072024,0.000893941,0.0011831429,0.0009644811,0.0011924043,0.00023212367,0.0038837187,0.0007271212,0.0002226068],"category_scores_gemma":[0.00047578468,0.00079549034,0.0021862546,0.00073209463,0.00070449495,0.0004732337,0.0015664352,0.0018191014,0.00010949537],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013029426,0.0029099633,0.008684177,0.003190722,0.07481947,0.007567846,0.014480952,0.010847819,0.0278637,0.27201262,0.54438066,0.020212658],"study_design_scores_gemma":[0.0048040976,0.00034285974,0.0065253833,0.0011082932,0.00353042,0.0026030175,0.0038112714,0.029224252,0.0013135112,0.00079044374,0.9446433,0.0013031521],"about_ca_topic_score_codex":0.004473962,"about_ca_topic_score_gemma":0.00020490364,"teacher_disagreement_score":0.46733254,"about_ca_system_score_codex":0.008236539,"about_ca_system_score_gemma":0.0055411872,"threshold_uncertainty_score":0.9994496},"labels":[],"label_agreement":null},{"id":"W7095192323","doi":"","title":"RESEARCH ARTICLE Cardiovascular Disease Rates, Outcomes, and Quality of Care in Ontario Métis: A Population-Based Cohort Study","year":2016,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cohort study; Research article; Disease; Original research; Cohort; MEDLINE","score_opus":0.05462195016676993,"score_gpt":0.36170882605499705,"score_spread":0.30708687588822714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7095192323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530923,0.0015405976,0.00012405543,0.00024675677,0.000030299627,0.0024587037,0.000007769451,0.000024610876,0.00025796556],"genre_scores_gemma":[0.9993118,0.00002074323,0.00011875296,0.00004700216,0.000022300515,0.00016732933,0.000012423025,0.000016186932,0.00028347276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99669486,0.0007081656,0.00047225348,0.0004416774,0.0013400322,0.00034302162],"domain_scores_gemma":[0.9980892,0.00013369277,0.000037082522,0.0011413004,0.00030748363,0.00029127186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047308784,0.00012825172,0.00072570314,0.00017009887,0.0000725609,0.000011837817,0.000064319735,0.000056674642,0.0001002577],"category_scores_gemma":[0.00034839916,0.000078226214,0.00030172718,0.0002500784,0.00005835918,0.00006779991,0.000058419217,0.00017839615,0.0000059768804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003383826,0.0003069196,0.994198,0.00016519181,0.00041513325,0.00003545425,0.00020888481,0.000015883597,0.000019117366,0.00013992895,0.0000047246,0.0041523264],"study_design_scores_gemma":[0.0055817724,0.00025525322,0.9928167,0.00010184509,0.00016628056,7.810125e-7,0.0006834863,0.000008079257,0.00007467912,0.00003213588,0.00017588491,0.00010310234],"about_ca_topic_score_codex":0.59775186,"about_ca_topic_score_gemma":0.3436697,"teacher_disagreement_score":0.2540821,"about_ca_system_score_codex":0.0005352115,"about_ca_system_score_gemma":0.0006472729,"threshold_uncertainty_score":0.6683066},"labels":[],"label_agreement":null},{"id":"W7095883824","doi":"","title":"Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 25","year":2005,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lipoprotein; Disease; Lipoprotein(a); Angina; Risk factor; Cholesterol; Atherosclerotic cardiovascular disease; Cohort","score_opus":0.01927031645751336,"score_gpt":0.2617949207573877,"score_spread":0.24252460429987432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7095883824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868302,0.0055740685,0.00044220817,0.0029127565,0.00013771714,0.0036963662,0.0001353189,0.000055718243,0.00021565739],"genre_scores_gemma":[0.99659634,0.0013878065,0.00016269674,0.00045719012,0.0008260524,0.00013347021,0.00011801051,0.000041735057,0.00027671864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964852,0.00079606625,0.00058821775,0.0007989222,0.0009443034,0.00038731773],"domain_scores_gemma":[0.99486095,0.00019626983,0.00013603554,0.004434781,0.00012129854,0.0002506571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002865568,0.00032392005,0.0010326222,0.0000698581,0.0002666306,0.00006643739,0.00042809008,0.0001183331,0.00015252852],"category_scores_gemma":[0.00032788957,0.00017908312,0.00064269337,0.00031127574,0.0003206367,0.00028440318,0.0004548073,0.00058442185,0.000048311213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032936784,0.0021166953,0.9211696,0.0003000455,0.009948539,0.00009159651,0.0033361006,0.000056989105,0.0009869107,0.00004308528,0.0086927125,0.049964063],"study_design_scores_gemma":[0.011902972,0.00008686837,0.9809025,0.00016189818,0.002141321,0.000012788751,0.0012479757,0.00030953283,0.00046250844,0.000017374223,0.0025351378,0.00021909983],"about_ca_topic_score_codex":0.1921778,"about_ca_topic_score_gemma":0.09039171,"teacher_disagreement_score":0.10178609,"about_ca_system_score_codex":0.00010166622,"about_ca_system_score_gemma":0.000292074,"threshold_uncertainty_score":0.9262063},"labels":[],"label_agreement":null},{"id":"W7096238819","doi":"","title":"for the Canadian Cardiovascular Outcomes Research Team","year":2015,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Coronary artery disease; Risk factor; Epidemiology; MEDLINE; Atherosclerotic cardiovascular disease; Cardiovascular health","score_opus":0.15513932574567393,"score_gpt":0.3927264983912133,"score_spread":0.23758717264553939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7096238819","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04912697,0.044059176,0.008274042,0.09516287,0.0021412726,0.016788907,0.000045403707,0.00031474722,0.7840866],"genre_scores_gemma":[0.9851334,0.00007066562,0.0011295527,0.0017204754,0.00070203806,0.00033468814,0.000009072021,0.000029162125,0.010870918],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793404,0.00010317699,0.00013100183,0.00020947357,0.0011084907,0.00051381113],"domain_scores_gemma":[0.9974769,0.00009517946,0.000007768234,0.001133308,0.0006200756,0.00066681486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070771687,0.0000858079,0.0003214457,0.0001193308,0.00036137443,0.000041390605,0.00013988529,0.00008961354,0.000030031388],"category_scores_gemma":[0.00071912934,0.000044629116,0.0005853544,0.0002295031,0.00008163675,0.000031238746,0.000029986986,0.00024667,0.00010483941],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016133371,0.0001245635,0.050593473,0.0002803,0.007988427,0.00011224779,0.0017576658,0.00016323364,0.00000853808,0.016586566,0.5779814,0.34424224],"study_design_scores_gemma":[0.0014192491,0.00013336114,0.013729254,0.000008439405,0.00015650579,0.000050158662,0.0011013027,0.000157538,0.000079036276,0.00028926475,0.9828071,0.00006877114],"about_ca_topic_score_codex":0.58895236,"about_ca_topic_score_gemma":0.28663075,"teacher_disagreement_score":0.9360064,"about_ca_system_score_codex":0.0004090983,"about_ca_system_score_gemma":0.0021508664,"threshold_uncertainty_score":0.72638637},"labels":[],"label_agreement":null},{"id":"W7096365030","doi":"","title":"ORIGINAL INVESTIGATION Statin Use and Survival Outcomes in Elderly Patients With Heart Failure","year":2015,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heart failure; Stroke (engine); Statin; Confidence interval; Cohort; Cohort study; Relative risk; Coronary heart disease","score_opus":0.027525781752919913,"score_gpt":0.2620081635938916,"score_spread":0.2344823818409717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7096365030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785525,0.000017327351,0.00013332104,0.0014228134,0.00003758216,0.00042364825,0.0000034728475,0.000026101334,0.00008045987],"genre_scores_gemma":[0.9909938,0.0000018679538,0.00828945,0.00042549276,0.000028673428,0.000012344006,0.000029699675,0.000011165662,0.0002074919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991068,0.000048923688,0.00013466153,0.00015868113,0.0004055694,0.00014533098],"domain_scores_gemma":[0.9994235,0.000020148844,0.000023688219,0.00017473877,0.00013337325,0.00022457201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030485782,0.00008967111,0.00025328793,0.00006126272,0.000018590017,0.000025548647,0.000015972992,0.000041043622,0.000011088662],"category_scores_gemma":[0.00008275874,0.000056690136,0.000023270455,0.00011446361,0.000034175533,0.00018784404,0.000010584365,0.000104461586,0.0000070490564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005903174,0.000039674745,0.99851257,0.000026143012,0.000019970135,0.0000033961803,0.00014175438,0.000001988369,0.0000063763955,0.00012440195,0.00045640496,0.0006082787],"study_design_scores_gemma":[0.0041836808,0.0006333095,0.9903789,0.000032677108,0.000021078466,0.000004562961,0.00023391831,0.000015188694,0.00006878222,0.00004852068,0.0043011727,0.00007816681],"about_ca_topic_score_codex":0.0029732534,"about_ca_topic_score_gemma":0.0016246589,"teacher_disagreement_score":0.008156129,"about_ca_system_score_codex":0.000047281268,"about_ca_system_score_gemma":0.00017027756,"threshold_uncertainty_score":0.44946894},"labels":[],"label_agreement":null},{"id":"W7096395225","doi":"","title":"Competing interests:","year":2016,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Myocardial infarction; Statin; Placebo; Randomized controlled trial; Psychological intervention; Absolute risk reduction; Cholesterol; Cholesterol lowering","score_opus":0.018854503496260222,"score_gpt":0.27566447275443645,"score_spread":0.25680996925817623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7096395225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83083165,0.00024275419,0.010527341,0.0073343404,0.0001291772,0.00021264466,6.992703e-7,0.00014144315,0.15057993],"genre_scores_gemma":[0.99503845,0.000033176548,0.0012474166,0.00078070554,0.00022734173,0.000003853393,3.9695377e-7,0.000006204395,0.0026624515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996178,0.000012499462,0.000074919924,0.00008284527,0.000111569076,0.000100355144],"domain_scores_gemma":[0.9996743,0.000013423825,0.0000094849665,0.00020404453,0.00002697776,0.00007172153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017067022,0.000034862118,0.000098886936,0.000018531446,0.000016018514,0.0000027247393,0.000020707399,0.000018989516,0.0006498459],"category_scores_gemma":[0.000045985907,0.000016091619,0.00007594961,0.00003044722,0.000014551618,0.0000200958,0.000016581462,0.0000269798,0.0002634409],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005408571,0.000056526653,0.02557231,0.00008179659,0.00011944714,0.000057163958,0.000080288824,2.5924294e-8,0.015884012,0.0073786597,0.002761498,0.9479542],"study_design_scores_gemma":[0.008411524,0.0007100114,0.17826767,0.0012363141,0.00011851891,0.000850619,0.00075490447,0.000029745155,0.05861398,0.00068463275,0.7499547,0.00036736822],"about_ca_topic_score_codex":0.00004198886,"about_ca_topic_score_gemma":0.000007904703,"teacher_disagreement_score":0.94758683,"about_ca_system_score_codex":0.000026590373,"about_ca_system_score_gemma":0.00002527454,"threshold_uncertainty_score":0.71153575},"labels":[],"label_agreement":null},{"id":"W7096899581","doi":"","title":"Canadian Cardiovascular Outcomes Research Team. Regional","year":2004,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"MEDLINE; Outcomes research; Quality (philosophy); Government (linguistics); Disease","score_opus":0.05712164451983672,"score_gpt":0.34158922820193044,"score_spread":0.28446758368209374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7096899581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5037675,0.010950449,0.0009623764,0.05205971,0.00044021176,0.0029056964,0.000011456383,0.00028386025,0.42861873],"genre_scores_gemma":[0.9906718,0.00023647136,0.0016626588,0.0023736318,0.00041418447,0.00005635577,0.000016755068,0.0000312492,0.0045368965],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973123,0.00008658252,0.00017605156,0.00033857906,0.0014273117,0.0006591886],"domain_scores_gemma":[0.9977837,0.00001693545,0.000008744877,0.0010963792,0.0002879284,0.0008062886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020785576,0.00012193598,0.00042994134,0.00032227888,0.0002476583,0.000023699522,0.00011462377,0.00012951059,0.00017598557],"category_scores_gemma":[0.00012106325,0.00009014316,0.0007247854,0.00040031387,0.00007741433,0.000053250056,0.000029596236,0.00040349504,0.00046832216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032478612,0.0012951388,0.25200742,0.0014578627,0.024122493,0.0074499245,0.0040774704,0.0014370611,0.00047503898,0.1834879,0.15326026,0.37060463],"study_design_scores_gemma":[0.0034571104,0.00020417242,0.1369261,0.00008239911,0.00014740875,0.0006349896,0.00068119395,0.0000051679303,0.00044078685,0.0018216346,0.85536057,0.0002384692],"about_ca_topic_score_codex":0.7125893,"about_ca_topic_score_gemma":0.13627967,"teacher_disagreement_score":0.70210034,"about_ca_system_score_codex":0.0009830314,"about_ca_system_score_gemma":0.0025041508,"threshold_uncertainty_score":0.87948096},"labels":[],"label_agreement":null},{"id":"W7097338055","doi":"","title":"All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association. Commentary","year":2009,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); MEDLINE; Action (physics)","score_opus":0.01362765431459747,"score_gpt":0.2879057580997265,"score_spread":0.27427810378512907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7097338055","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23129448,0.0001572801,0.000003300669,0.75281733,0.008660862,0.0010118379,0.000041918927,0.0000066703133,0.0060063214],"genre_scores_gemma":[0.9595093,0.000040775973,0.000019296907,0.035717115,0.004419725,0.000008334677,0.000005489344,0.0000056126714,0.00027433067],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9979706,0.00027966753,0.0002874909,0.000120891105,0.0011516183,0.0001897334],"domain_scores_gemma":[0.999063,0.000094353505,0.000091185335,0.0005202805,0.00008019396,0.00015096852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018252587,0.00007164781,0.00021210097,0.000030250001,0.000110494235,0.000009336401,0.00021316492,0.00018759936,0.00018767673],"category_scores_gemma":[0.00036794238,0.00003150472,0.00013232381,0.00016234304,0.00007209495,0.000028234786,0.000067261135,0.00043759577,0.0000018378611],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021664922,0.000052304164,0.24463198,0.00001729383,0.00010603017,0.0000015785097,0.0005467358,0.0000019949923,0.000015874524,0.00020201097,0.7532605,0.0011420414],"study_design_scores_gemma":[0.0009771984,0.000027457165,0.8730686,0.00008397929,0.00005465159,0.000006205451,0.00016580186,0.000026970587,0.00018794481,0.00011477367,0.12524883,0.000037621692],"about_ca_topic_score_codex":0.40348965,"about_ca_topic_score_gemma":0.16763172,"teacher_disagreement_score":0.72821486,"about_ca_system_score_codex":0.00014187046,"about_ca_system_score_gemma":0.0005152515,"threshold_uncertainty_score":0.8475568},"labels":[],"label_agreement":null},{"id":"W7097372532","doi":"","title":"Université de Montréal","year":2016,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Arterial disease; MEDLINE","score_opus":0.0056676233323541035,"score_gpt":0.1951123952825721,"score_spread":0.189444771950218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7097372532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88640213,0.0006623016,0.0044378,0.008374664,0.000028739974,0.00012032151,0.0000010928349,0.000071442075,0.09990153],"genre_scores_gemma":[0.9504494,0.0002744986,0.00061019254,0.00056899723,0.000091120506,0.0000011860086,3.6510124e-7,0.000004522633,0.047999714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997197,0.0000081686485,0.000030210245,0.000058267255,0.00008853128,0.00009513944],"domain_scores_gemma":[0.9997289,0.00000496292,0.0000049972427,0.00015395807,0.000014833098,0.00009233817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000834266,0.000025621235,0.00006284129,0.000013120906,0.000025960995,6.7079407e-7,0.000014490488,0.000022289214,0.0005579945],"category_scores_gemma":[0.000008300771,0.000013009518,0.00006562526,0.000023443334,0.000008821864,0.000012400213,0.000016304843,0.00001418333,0.00016662951],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026306437,0.00006976497,0.052312944,0.000046592024,0.00022552785,0.00040824214,0.00016244635,2.9630155e-7,0.03703952,0.008150016,0.05127831,0.8500433],"study_design_scores_gemma":[0.0028057604,0.00014077769,0.1901773,0.000036263566,0.000057443354,0.00038440115,0.00006570484,0.000007073907,0.02522865,0.00011450519,0.78091127,0.000070817296],"about_ca_topic_score_codex":0.0006548569,"about_ca_topic_score_gemma":0.000105540086,"teacher_disagreement_score":0.8499724,"about_ca_system_score_codex":0.00016109909,"about_ca_system_score_gemma":0.000037213467,"threshold_uncertainty_score":0.6109649},"labels":[],"label_agreement":null},{"id":"W7099795501","doi":"","title":"United","year":2016,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hypertriglyceridemia; Ldl cholesterol; Cholesterol; Apolipoprotein B; Lipoprotein; Very low-density lipoprotein","score_opus":0.018800345138415345,"score_gpt":0.2648590866990857,"score_spread":0.24605874156067037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7099795501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8179486,0.00015844828,0.011724149,0.013886031,0.00009331389,0.00025501134,0.0000011760975,0.0001680697,0.15576524],"genre_scores_gemma":[0.98047626,0.000052590112,0.0005680341,0.0015331763,0.00014562375,0.00000409528,0.0000011481765,0.0000050094177,0.017214062],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997119,0.000007919879,0.00004357673,0.00005715017,0.00010378475,0.00007570417],"domain_scores_gemma":[0.99969673,0.0000057836746,0.000004556568,0.0001944075,0.00002895293,0.000069565285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009625796,0.00002495524,0.00006371109,0.000034045795,0.00001109685,0.0000011832534,0.000012195574,0.000018990288,0.0007038926],"category_scores_gemma":[0.000022943643,0.000010748912,0.000053526983,0.00007513825,0.000010047397,0.000012944608,0.000006159133,0.000015604699,0.00027962736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006820691,0.000072230425,0.013546101,0.000051521347,0.00015517816,0.00006311904,0.000026195497,4.425675e-8,0.013619013,0.024480669,0.017503329,0.9304144],"study_design_scores_gemma":[0.0018851311,0.00012891363,0.049231954,0.000052550582,0.00002879087,0.000103198516,0.000017797789,0.000004015109,0.011910449,0.00019917543,0.93638104,0.00005700146],"about_ca_topic_score_codex":0.00005672059,"about_ca_topic_score_gemma":0.000001940216,"teacher_disagreement_score":0.9303574,"about_ca_system_score_codex":0.000014900506,"about_ca_system_score_gemma":0.000025543804,"threshold_uncertainty_score":0.77071303},"labels":[],"label_agreement":null},{"id":"W7101003527","doi":"","title":"ORIGINAL RESEARCH Cardiovascular Risk According to Plasma Apolipoprotein and Lipid Profiles in a Canadian First Nation","year":2011,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Original research; Apolipoprotein B; Risk factor; Research article; Cholesterol; First nation; Epidemiology; Triglycerides blood","score_opus":0.08793419309789544,"score_gpt":0.30181943239438364,"score_spread":0.2138852392964882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7101003527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980696,0.0006433879,0.00022727378,0.00062918075,0.00010917606,0.002297729,0.000010024912,0.000044834575,0.015342393],"genre_scores_gemma":[0.9944982,0.00033412062,0.003941473,0.00009539059,0.00049540185,0.0003552647,0.000009985148,0.00003365234,0.00023650427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973674,0.00021667278,0.0002671799,0.00051016285,0.0007998862,0.00083874096],"domain_scores_gemma":[0.9982037,0.0000318315,0.000023841212,0.00064213906,0.00022471942,0.000873745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004218368,0.00016675687,0.00044327753,0.00091788097,0.00028694764,0.000038110753,0.000114746224,0.00015628699,0.00011008011],"category_scores_gemma":[0.0004804589,0.0001425044,0.00018328028,0.0008086602,0.0000602506,0.000119491735,0.00006799363,0.00049918477,0.00010417053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006081077,0.00016826522,0.7160179,0.00080821075,0.00091127673,0.0005572293,0.004560724,0.000031949723,0.0001624455,0.0047802767,0.00074326305,0.27065036],"study_design_scores_gemma":[0.0061862716,0.0018981966,0.4869647,0.0009304161,0.000312293,0.00043498795,0.005646165,0.0012665999,0.010746412,0.00048849685,0.48418418,0.00094127015],"about_ca_topic_score_codex":0.94882405,"about_ca_topic_score_gemma":0.69677454,"teacher_disagreement_score":0.4834409,"about_ca_system_score_codex":0.0005861317,"about_ca_system_score_gemma":0.00079846394,"threshold_uncertainty_score":0.58111614},"labels":[],"label_agreement":null},{"id":"W7101250685","doi":"","title":"Statin use in Canadians: trends, determinants and persistence","year":2007,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Statin; Comorbidity; Medical prescription; Diabetes mellitus; Population; Persistence (discontinuity); Disease; Type 2 diabetes","score_opus":0.032544063399778216,"score_gpt":0.2780667028360889,"score_spread":0.2455226394363107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7101250685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950111,0.00033895762,0.00009037387,0.0002117321,0.000026653574,0.00010886673,0.0000027016501,0.000010795393,0.0041988264],"genre_scores_gemma":[0.99474216,0.000065274224,0.0015505744,0.0008058005,0.00003406202,0.0000025761206,0.0000020887694,0.000006451412,0.002791028],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99936736,0.0000126677905,0.00012556331,0.00013850597,0.00013278215,0.00022314537],"domain_scores_gemma":[0.9995846,0.000020047662,0.0000127639905,0.00016500533,0.000018888042,0.00019868097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003915906,0.000056605408,0.00014835129,0.00012601602,0.000023209617,0.000008705088,0.000017895554,0.000037726382,0.000055352273],"category_scores_gemma":[0.000042079293,0.00004490687,0.000037056943,0.00014277227,0.000023813349,0.000056388068,0.000007567716,0.000070352995,0.0000029145579],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046395664,0.000027146722,0.40389603,0.000057511064,0.00001635576,0.00065649475,0.0005431344,2.3393379e-7,0.00009426738,0.00006904239,0.00026712127,0.59432626],"study_design_scores_gemma":[0.0008308957,0.00009304384,0.98954666,0.00004762911,0.000016107764,0.00015978815,0.0008956675,0.000060082108,0.0002671877,0.000003555621,0.008012823,0.00006654275],"about_ca_topic_score_codex":0.07624249,"about_ca_topic_score_gemma":0.26146272,"teacher_disagreement_score":0.59425974,"about_ca_system_score_codex":0.00006043733,"about_ca_system_score_gemma":0.00006833261,"threshold_uncertainty_score":0.9299089},"labels":[],"label_agreement":null},{"id":"W7103572747","doi":"","title":"Évolution des lignes directrices sur le traitement de la dyslipidémie: Les données pourraient vous libérer","year":2014,"lang":"en","type":"article","venue":"PubMed Central","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronary heart disease; Context (archaeology); Coronary disease","score_opus":0.01830886517561238,"score_gpt":0.2255687234476529,"score_spread":0.20725985827204052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7103572747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98790914,0.003195291,0.0029990003,0.0008069479,0.00036004224,0.00065110746,0.0000054588513,0.00015826205,0.003914777],"genre_scores_gemma":[0.9956934,0.00062179455,0.0010276315,0.00024162083,0.001789152,0.00021939752,0.000016542657,0.000032490352,0.00035799228],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974195,0.00029622516,0.0002605028,0.0003037282,0.00044083563,0.001279205],"domain_scores_gemma":[0.99890447,0.000083310464,0.000074290416,0.00029663558,0.000060481747,0.00058081903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001756946,0.00018909805,0.00033851218,0.00009369516,0.00020437465,0.00006705255,0.000104224746,0.0001315516,0.000026910273],"category_scores_gemma":[0.00034419636,0.00015517096,0.00026773402,0.00015447705,0.00015535468,0.00012887835,0.000028602952,0.00017869631,0.0000074393784],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014997185,0.0006988331,0.13796526,0.00054018444,0.00029089605,0.000020520114,0.0011484313,0.00015939474,0.0017988625,0.0020590895,0.001301036,0.85386753],"study_design_scores_gemma":[0.001927307,0.000100845005,0.9097909,0.0000693544,0.00014772413,0.00008687726,0.00013334394,0.00041496873,0.006869037,0.0002592082,0.0800207,0.00017977771],"about_ca_topic_score_codex":0.0022305252,"about_ca_topic_score_gemma":0.00023769264,"teacher_disagreement_score":0.85368776,"about_ca_system_score_codex":0.00044359654,"about_ca_system_score_gemma":0.0002902798,"threshold_uncertainty_score":0.6327688},"labels":[],"label_agreement":null},{"id":"W7104566397","doi":"10.1681/asn.2025t5z50rj1","title":"Association of Statin Therapy with Adverse Clinical Outcomes Among Patients on Dialysis: A Province-Wide Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"Journal of the American Society of Nephrology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Retrospective cohort study; Adverse effect; Cohort study; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Statin; MEDLINE","score_opus":0.01042671749286155,"score_gpt":0.29836848585506254,"score_spread":0.287941768362201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7104566397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965181,0.000022980716,0.00008294911,0.0023179813,0.00009139101,0.0008901717,0.000005068064,0.0000045713673,0.00006682478],"genre_scores_gemma":[0.9943616,0.00028152487,0.00046576647,0.0046564024,0.000075642645,0.0000094302295,7.9868005e-7,0.000010264241,0.000138599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974048,0.0006425804,0.000801501,0.0001622013,0.0008251574,0.00016373348],"domain_scores_gemma":[0.9959161,0.00034481438,0.00262087,0.0003777426,0.0006865558,0.00005386297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021862888,0.00012453737,0.0013330833,0.00005598537,0.000056884914,0.0000025477102,0.00016398916,0.00006660196,0.00000569242],"category_scores_gemma":[0.00037622006,0.00006783416,0.0010707286,0.00036834067,0.0003530063,0.00004106212,0.000039762115,0.00047783204,2.2826526e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012697164,0.0013433212,0.9828715,0.0000135077835,0.008254815,0.0000018643065,0.00054582313,0.000019863248,0.000019041301,0.0000017313446,0.003223431,0.0024353927],"study_design_scores_gemma":[0.005101993,0.0069685197,0.98488474,0.000044129578,0.0009287369,9.839879e-7,0.0016015506,0.0000090554595,0.000026051119,0.000019733916,0.0003668534,0.000047672333],"about_ca_topic_score_codex":0.00070935977,"about_ca_topic_score_gemma":0.0001041359,"teacher_disagreement_score":0.0073260786,"about_ca_system_score_codex":0.00032575993,"about_ca_system_score_gemma":0.00042249012,"threshold_uncertainty_score":0.27661967},"labels":[],"label_agreement":null},{"id":"W7113636517","doi":"","title":"Proposal of a Familial Hypercholesterolemia Pediatric Diagnostic Score (FH-PeDS)","year":2025,"lang":"en","type":"article","venue":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Genetic testing; Cohort; Diagnostic test; Genetic diagnosis; Predictive power; Portuguese; Population","score_opus":0.04608115004386836,"score_gpt":0.3743764778103501,"score_spread":0.32829532776648174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7113636517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740221,0.012569103,0.00057908223,0.0036130073,0.0003064236,0.0033257676,0.000119152246,0.00013527101,0.00533009],"genre_scores_gemma":[0.9912947,0.0035560222,0.0016466699,0.000058457186,0.00020039415,0.00070926896,0.000046222478,0.00001792852,0.0024703294],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9959936,0.00006386369,0.0004752311,0.0007501348,0.0018352552,0.0008819188],"domain_scores_gemma":[0.9967996,0.00039923526,0.00010003101,0.00040104764,0.0021256653,0.00017445887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063061374,0.00018128111,0.00039781275,0.0037564689,0.00060305564,0.000043020867,0.00045381673,0.00027636468,0.000007295154],"category_scores_gemma":[0.007955378,0.00015272337,0.0001106874,0.0059979367,0.0017730482,0.0002544794,0.00029670823,0.0006238285,0.000003969077],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061843666,0.0021669033,0.27480257,0.0043734545,0.0003683388,0.000105937615,0.00034905353,0.00000211672,0.04082121,0.17462727,0.026851386,0.4749133],"study_design_scores_gemma":[0.025279814,0.020398764,0.3726465,0.0037435433,0.000941551,0.0015980789,0.0031934308,0.0030145482,0.12672676,0.38121825,0.05867056,0.0025681977],"about_ca_topic_score_codex":0.00013513834,"about_ca_topic_score_gemma":0.0000113257065,"teacher_disagreement_score":0.4723451,"about_ca_system_score_codex":0.00030891527,"about_ca_system_score_gemma":0.0061623557,"threshold_uncertainty_score":0.9994718},"labels":[],"label_agreement":null},{"id":"W7115809647","doi":"","title":"The NLRP3 Inflammasome Contributes to Statin Myopathy","year":2016,"lang":"en","type":"dissertation","venue":"MacSphere (McMaster University)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Inflammasome; Fluvastatin; Myopathy; Statin; Prenylation; Atorvastatin; Protein kinase B; Ubiquitin","score_opus":0.00750134549493122,"score_gpt":0.21675189112013965,"score_spread":0.20925054562520842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7115809647","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06359305,0.002404318,0.00088301353,0.002572483,0.0014739672,0.0028372358,0.000111896275,0.00020584051,0.92591816],"genre_scores_gemma":[0.0152495075,0.00051136373,0.00014462856,0.00037817346,0.00040412133,0.000011578056,0.00016254015,0.000071800554,0.98306626],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801046,0.00014286727,0.0002924498,0.00049611373,0.000518663,0.00053942273],"domain_scores_gemma":[0.99838835,0.00010403944,0.00017127958,0.000694148,0.0003341295,0.0003080693],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031826043,0.00035312824,0.00059183117,0.00018706467,0.00040530588,0.00007224975,0.00034106683,0.00031393205,0.008196349],"category_scores_gemma":[0.00009299818,0.00024175351,0.0004018072,0.0004859279,0.000053695254,0.00009190179,0.00008578608,0.000380092,0.00037239754],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014861857,0.000038875507,0.00070412335,0.00030866067,0.000645541,0.00033391925,0.00032081007,0.0000011956467,0.0007100293,0.0026935867,0.00359533,0.98916173],"study_design_scores_gemma":[0.0022872323,0.00022447694,0.009941671,0.0006177922,0.0003936555,0.000009962482,0.0026640967,0.0000020664475,0.0013736314,0.00011958437,0.982078,0.0002877855],"about_ca_topic_score_codex":0.00020731593,"about_ca_topic_score_gemma":0.0011278513,"teacher_disagreement_score":0.98887396,"about_ca_system_score_codex":0.00039365917,"about_ca_system_score_gemma":0.00047157437,"threshold_uncertainty_score":0.9927103},"labels":[],"label_agreement":null},{"id":"W7116048439","doi":"10.1016/j.eclinm.2025.103712","title":"Comparing rosuvastatin and atorvastatin on cardiovascular and kidney outcomes in patients with diabetes across chronic kidney disease stages: an emulated target trial in China","year":2025,"lang":"en","type":"article","venue":"EClinicalMedicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Chinese University of Hong Kong; Hospital Authority","keywords":"Rosuvastatin; Kidney disease; Atorvastatin; Diabetes mellitus; Rosuvastatin Calcium; Kidney","score_opus":0.014149263865203205,"score_gpt":0.3075981822204842,"score_spread":0.293448918355281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116048439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941083,0.0013210282,0.000074236705,0.001553876,0.00024815675,0.00251387,0.0000761566,0.000057731773,0.00004660002],"genre_scores_gemma":[0.9967678,0.0001534206,0.00031730323,0.0020577703,0.00018600446,0.00011211649,0.00030843352,0.000042617405,0.000054518667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964071,0.00040458216,0.0009611766,0.0008515239,0.0007429712,0.00063265295],"domain_scores_gemma":[0.9976192,0.000200851,0.00013180244,0.00089193234,0.000076188895,0.0010799959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022893907,0.00038327533,0.0018223451,0.00024422514,0.00010875609,0.000034383524,0.000111965455,0.00014265504,0.00002304288],"category_scores_gemma":[0.002281932,0.00027351195,0.00020076211,0.00046029084,0.0002703073,0.00013057597,0.000110312554,0.00066984945,0.0000015204964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009807916,0.00084851775,0.9814218,0.0006596651,0.0005558113,0.00007380864,0.00028477435,0.00011778133,0.0000023719847,0.000017240221,0.000092491115,0.0061178165],"study_design_scores_gemma":[0.14816438,0.0025104498,0.84518147,0.0016049606,0.00023275455,3.9570278e-7,0.00005436133,0.0012523481,0.0000066315,0.00004024896,0.00073640473,0.00021559754],"about_ca_topic_score_codex":0.00041534562,"about_ca_topic_score_gemma":0.00006570444,"teacher_disagreement_score":0.13835646,"about_ca_system_score_codex":0.00018465429,"about_ca_system_score_gemma":0.00057314755,"threshold_uncertainty_score":0.9999717},"labels":[],"label_agreement":null},{"id":"W7116656716","doi":"10.1016/j.atherosclerosis.2025.120627","title":"Evinacumab in patients aged 5–17 years with homozygous familial hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec; Louisiana-Pacific (Canada)","funders":"Regeneron Pharmaceuticals","keywords":"Familial hypercholesterolemia; Lipoprotein(a); Lipoprotein; Ldl cholesterol","score_opus":0.009594380498738321,"score_gpt":0.2342926044971297,"score_spread":0.22469822399839137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116656716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971218,0.00014826981,0.0000577804,0.00018261191,0.00010808923,0.0007464066,0.000008456137,0.00006327863,0.0015633004],"genre_scores_gemma":[0.99719995,0.00010404354,0.00038042004,0.00133292,0.000057298486,0.00008501198,0.000018927361,0.000031513766,0.0007899264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858075,0.00007538706,0.0002526085,0.00035889327,0.00039198183,0.0003403655],"domain_scores_gemma":[0.9991587,0.000018196843,0.000042759268,0.00061904924,0.000060828854,0.000100463054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026847745,0.00017487281,0.0004212643,0.00013944262,0.000061731116,0.000024704908,0.000114890485,0.00012929924,0.000024738472],"category_scores_gemma":[0.000030881398,0.00014339053,0.00014416754,0.00042852605,0.00006267046,0.00007055639,0.00005081781,0.00028531183,0.000027222188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004536858,0.00051300705,0.92703897,0.00012386963,0.00015884641,0.000021918999,0.0004614222,0.0000108105405,0.0008243726,0.000028732038,0.0012430752,0.069121286],"study_design_scores_gemma":[0.0064084027,0.00043393142,0.99010795,0.00048354012,0.00009087069,0.0000031360955,0.00008015339,0.0000053110566,0.00022046629,0.000011802838,0.0020243698,0.0001300806],"about_ca_topic_score_codex":0.0006390295,"about_ca_topic_score_gemma":0.00019025007,"teacher_disagreement_score":0.0689912,"about_ca_system_score_codex":0.0002178137,"about_ca_system_score_gemma":0.00013452704,"threshold_uncertainty_score":0.5847296},"labels":[],"label_agreement":null},{"id":"W7117130172","doi":"10.1016/j.athplu.2025.10.016","title":"Lomitapide in paediatric patients with homozygous familial hypercholesterolaemia (HoFH) – Analysis of long-term (104-week) safety and efficacy from the APH-19 study","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis Plus","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Langara College","funders":"","keywords":"Disease; MEDLINE; Clinical trial; Ldl cholesterol; Familial hypercholesterolemia","score_opus":0.013996510864854803,"score_gpt":0.2518155349864326,"score_spread":0.2378190241215778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117130172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996287,0.0011123323,0.00024483138,0.00013376094,0.00009308266,0.0019415792,0.00008711578,0.000033901255,0.00006641959],"genre_scores_gemma":[0.99863404,0.0005030092,0.00006677521,0.0004987719,0.00007785186,0.000056322584,0.000090060756,0.00003057606,0.000042619842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974406,0.0003662445,0.00062665256,0.0005961048,0.0006241169,0.0003462885],"domain_scores_gemma":[0.99812984,0.00034551392,0.0001667661,0.0010914967,0.000121181045,0.00014518628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007708787,0.00028980192,0.0011138454,0.00032035314,0.00014674854,0.000038271493,0.00023435507,0.00014156217,0.000016796921],"category_scores_gemma":[0.00014772447,0.00018645894,0.0003078995,0.0017441637,0.00012945528,0.000077535544,0.00016434492,0.00036033508,0.0000032786934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009913549,0.0011267263,0.96892446,0.00005109828,0.0021098831,0.000010007512,0.001668012,0.00013264042,0.000050663813,0.0000026206903,0.000016028489,0.02491653],"study_design_scores_gemma":[0.012526737,0.0005843889,0.98210794,0.00015318397,0.0038931738,7.8307573e-7,0.0004504506,0.00008104787,0.000016321865,0.0000018262006,0.000025076304,0.00015906004],"about_ca_topic_score_codex":0.0047486695,"about_ca_topic_score_gemma":0.0027722882,"teacher_disagreement_score":0.02475747,"about_ca_system_score_codex":0.00023683326,"about_ca_system_score_gemma":0.0001845992,"threshold_uncertainty_score":0.76035756},"labels":[],"label_agreement":null},{"id":"W7117368553","doi":"10.1093/eurjpc/zwaf783","title":"Prediction of inclisiran efficacy in patients with established atherosclerotic cardiovascular disease: the SIRIUS <i>in-silico</i> modelling of cardiovascular outcomes","year":2025,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"Novartis Pharma","keywords":"Sirius; Outcome (game theory); MEDLINE; Cardiovascular health; Atherosclerotic cardiovascular disease; Clinical trial","score_opus":0.02254514430828092,"score_gpt":0.22487911643127362,"score_spread":0.2023339721229927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117368553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585397,0.017098056,0.021977957,0.00006846593,0.00030623726,0.0011953228,0.000025308367,0.000008668925,0.0007802782],"genre_scores_gemma":[0.9985845,0.0009090348,0.00026559527,0.000038349237,0.00012278969,0.000008102906,0.000011592647,0.000039009527,0.000021012649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942083,0.0029673616,0.0012419322,0.00035779955,0.00089986133,0.0003247529],"domain_scores_gemma":[0.99752665,0.00014725022,0.00040415852,0.0011402814,0.0006610642,0.00012057257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058395974,0.00026524605,0.0019939805,0.00046162636,0.000048402588,0.0000087733915,0.00032328686,0.00006662875,0.0000026312107],"category_scores_gemma":[0.00039439645,0.00016989729,0.0023188922,0.00059685984,0.00023745342,0.00012786331,0.00011647177,0.0005548219,7.9026233e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014834144,0.0005419797,0.52946335,0.00050667446,0.01578048,0.0003212698,0.00039740704,0.4214981,0.000036699865,0.000051794283,0.000031794763,0.029887047],"study_design_scores_gemma":[0.010944254,0.00065443694,0.982708,0.0011054333,0.002706623,0.000021727035,0.00010606114,0.00013387509,0.000052533698,0.000034471188,0.0014203552,0.00011226197],"about_ca_topic_score_codex":0.00005844063,"about_ca_topic_score_gemma":0.0000011780045,"teacher_disagreement_score":0.4532446,"about_ca_system_score_codex":0.000129069,"about_ca_system_score_gemma":0.000259812,"threshold_uncertainty_score":0.692821},"labels":[],"label_agreement":null},{"id":"W7117371402","doi":"10.1016/j.atherosclerosis.2025.120625","title":"Systematic identification of familial hypercholesterolaemia: An updated systematic review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Atherosclerosis","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"National Institute for Health and Care Research; National Institute on Handicapped Research","keywords":"Identification (biology); Systematic review; Scalability; MEDLINE","score_opus":0.036341190966155186,"score_gpt":0.30290957326200824,"score_spread":0.26656838229585306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117371402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6709677,0.29686832,0.008447334,0.0026998192,0.00014066741,0.020096134,0.00017637435,0.0002722413,0.0003314306],"genre_scores_gemma":[0.99476147,0.0022349355,0.00015822715,0.0015253604,0.000008218677,0.00056937616,0.000050471455,0.000018444294,0.0006734866],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9971651,0.0005881558,0.0012832513,0.00037451,0.00042593924,0.00016307674],"domain_scores_gemma":[0.9977425,0.00004565424,0.0003992159,0.001438499,0.00027060043,0.00010353953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024301982,0.00020216106,0.0036331266,0.0002140391,0.00007314497,0.000034953984,0.00014904827,0.000110594934,0.000034067227],"category_scores_gemma":[0.00017959786,0.00013462557,0.0011618602,0.0009843861,0.00005284341,0.00011801853,0.000038279737,0.00011574999,0.000008516243],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005384946,0.00011128919,0.00019873386,0.8775521,0.11819882,4.9123634e-7,0.000114545066,0.000001987663,0.003619817,0.00016089567,0.000030959858,0.00000499116],"study_design_scores_gemma":[0.00033324014,0.000060115162,0.006195876,0.01241737,0.97950315,0.000006248905,0.00015817632,0.000115547045,0.0010838278,0.000015826607,0.0000012244619,0.00010936372],"about_ca_topic_score_codex":0.0001729348,"about_ca_topic_score_gemma":0.000020239428,"teacher_disagreement_score":0.8651347,"about_ca_system_score_codex":0.000052332998,"about_ca_system_score_gemma":0.00004641404,"threshold_uncertainty_score":0.54898715},"labels":[],"label_agreement":null},{"id":"W7117558999","doi":"10.7326/annals-25-00662","title":"Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk","year":2025,"lang":"en","type":"article","venue":"Annals of Internal Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Type 2 diabetes; Baseline (sea); Diabetes mellitus; Type 2 Diabetes Mellitus; Cardiovascular event; MEDLINE; Disease; Statin","score_opus":0.018673694855185906,"score_gpt":0.3246075368788811,"score_spread":0.3059338420236952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117558999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974428,0.019906292,0.0032247417,0.0009255965,0.00021821013,0.00057352823,0.000013083946,0.00000981711,0.00070075353],"genre_scores_gemma":[0.9949869,0.003987702,0.00024068142,0.0006229549,0.00011018849,0.000013366486,0.0000044424282,0.000012078466,0.000021668222],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99831975,0.00029718853,0.0005340387,0.00025196784,0.00038689125,0.00021016024],"domain_scores_gemma":[0.9986033,0.00034938575,0.00010119404,0.00040857907,0.0004110594,0.00012652506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041455273,0.00014140087,0.0010568912,0.00037828716,0.000019782177,0.000001943912,0.000089564724,0.000060184884,0.000016938084],"category_scores_gemma":[0.0025302304,0.00010441651,0.00020624849,0.0005357275,0.000095189374,0.000036127694,0.00007702234,0.00020342959,9.930628e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026569432,0.00014187099,0.46072954,0.0036062556,0.002730511,0.000045929213,0.0004184639,0.00019688217,0.006231057,0.00023376124,0.00038014344,0.5226286],"study_design_scores_gemma":[0.005067804,0.002239541,0.9080337,0.0139854755,0.0005069701,0.000010797328,0.00070836383,0.00024784787,0.06319018,0.0002968262,0.0055633453,0.00014914316],"about_ca_topic_score_codex":0.0030069156,"about_ca_topic_score_gemma":0.000025565725,"teacher_disagreement_score":0.5224795,"about_ca_system_score_codex":0.000026407082,"about_ca_system_score_gemma":0.00008018207,"threshold_uncertainty_score":0.45455772},"labels":[],"label_agreement":null},{"id":"W7117578364","doi":"10.1016/j.ajpc.2025.101402","title":"Trends in lipoprotein(a) testing and impact on clinical care: A contemporary systemwide analysis","year":2025,"lang":"en","type":"article","venue":"American Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Feinstein Institutes for Medical Research","keywords":"Risk assessment; MEDLINE; Test (biology); Risk-based testing; Disease","score_opus":0.030376648851427407,"score_gpt":0.37881332459000866,"score_spread":0.3484366757385813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117578364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884086,0.004855833,0.0013966413,0.000284074,0.00016419408,0.0002659601,0.000008904885,0.000009083424,0.00460671],"genre_scores_gemma":[0.99846107,0.00019799295,0.00070296024,0.00026410786,0.0003000726,0.000011693435,0.000004935112,0.000011263221,0.00004590712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675006,0.0015178252,0.0009491192,0.00029885108,0.00023527863,0.00024883976],"domain_scores_gemma":[0.99804753,0.0004862953,0.0005797036,0.0003468927,0.00035288074,0.00018668546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025698545,0.00018564289,0.0022779005,0.0013451937,0.00003785882,0.0000100926245,0.000099173405,0.000092710616,0.000004121314],"category_scores_gemma":[0.00075433776,0.00013129224,0.0013966116,0.0019296308,0.00027848387,0.000045849756,0.000047776837,0.00057254615,7.6719016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064000144,0.000041041483,0.64555824,0.000041319774,0.00554581,0.00045092328,0.00008855792,0.0001259464,0.00002351089,0.0000134358625,0.00010519888,0.347366],"study_design_scores_gemma":[0.0020682493,0.0046638595,0.98926353,0.00039088583,0.0015980912,0.0003518957,0.0010983039,0.000030143752,0.000016389511,0.000029247023,0.0003911908,0.000098205615],"about_ca_topic_score_codex":0.000913326,"about_ca_topic_score_gemma":0.00001678024,"teacher_disagreement_score":0.34726778,"about_ca_system_score_codex":0.00021640224,"about_ca_system_score_gemma":0.0004761964,"threshold_uncertainty_score":0.53539425},"labels":[],"label_agreement":null},{"id":"W7118253775","doi":"10.1093/ije/dyaf223","title":"Human genetics suggests differing causal pathways from HMGCR inhibition to coronary artery disease and type 2 diabetes","year":2025,"lang":"en","type":"article","venue":"International Journal of Epidemiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Queen's University Belfast; Queen's University; Wellcome Trust; British Heart Foundation; Department of Health, Northern Ireland","keywords":"Type 2 diabetes; Coronary artery disease; Atherosclerotic cardiovascular disease; Disease; Statin; Workflow; Human genetics; Diabetes mellitus; Coronary heart disease","score_opus":0.03514509009995791,"score_gpt":0.3302770558806273,"score_spread":0.29513196578066936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7118253775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879587,0.004360279,0.0013375124,0.005206181,0.0009130391,0.00012589691,0.000023551625,0.000008793052,0.00006600885],"genre_scores_gemma":[0.9921868,0.0005219697,0.0011258925,0.0051675993,0.000909182,0.0000044537455,0.000043576285,0.000008831517,0.00003169633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998751,0.00019584976,0.00054347643,0.00016536354,0.00018219612,0.00016213344],"domain_scores_gemma":[0.9988934,0.00026936346,0.00016074312,0.00014598103,0.00029552422,0.000235005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007748461,0.00010076226,0.0004086186,0.00018493329,0.000037637234,0.000008403085,0.000085641484,0.00007246373,0.000037960483],"category_scores_gemma":[0.0010031282,0.00008304254,0.00013022478,0.00005058057,0.000055501325,0.00004473416,0.00008433654,0.00020790778,0.000003942011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048220498,0.00014316567,0.9308478,0.000052932694,0.0012150852,0.00064685644,0.00008717247,0.00016347226,0.020693237,0.00192874,0.0025771575,0.04116216],"study_design_scores_gemma":[0.00091876957,0.00029441528,0.9872306,0.00036184755,0.0001283374,0.000092284135,0.000017668674,0.00014966667,0.00039102396,0.008350371,0.0019989905,0.00006602953],"about_ca_topic_score_codex":0.00003245433,"about_ca_topic_score_gemma":0.000011009962,"teacher_disagreement_score":0.05638278,"about_ca_system_score_codex":0.00010851695,"about_ca_system_score_gemma":0.00011867108,"threshold_uncertainty_score":0.33863768},"labels":[],"label_agreement":null},{"id":"W7126928920","doi":"","title":"High lipoprotein(a) may explain one quarter of clinical familial hypercholesterolemia diagnoses in Danish lipid clinics","year":2024,"lang":"en","type":"article","venue":"VBN Forskningsportal (Aalborg Universitet)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Sanofi; AstraZeneca; Amgen","keywords":"Danish; Familial hypercholesterolemia; Medical diagnosis; Quarter (Canadian coin); Disease","score_opus":0.025814407693750974,"score_gpt":0.3047678542743691,"score_spread":0.2789534465806181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7126928920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993082,0.0009317733,0.00015703234,0.00059918256,0.0009634959,0.0009168916,0.000068674395,0.00018045276,0.003100488],"genre_scores_gemma":[0.99447614,0.00090804795,0.001501534,0.00037094974,0.0012429866,0.000015982674,0.00019043131,0.00007780249,0.0012161355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961867,0.0001764364,0.0013316807,0.0008528664,0.0008636456,0.0005887149],"domain_scores_gemma":[0.99805975,0.00028859553,0.0002470074,0.00082804577,0.00016394843,0.000412629],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016027804,0.0003714466,0.0013209375,0.0004928164,0.00008095172,0.00003843577,0.00028148267,0.00051471527,0.00033851803],"category_scores_gemma":[0.00028076916,0.00036102877,0.000842627,0.00079573307,0.00024721771,0.00039723373,0.00014067022,0.0010384549,0.000108516695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00420731,0.003542246,0.58808345,0.003865839,0.0028188608,0.010515724,0.005998333,0.00011129763,0.0017929879,0.01699802,0.013044401,0.34902155],"study_design_scores_gemma":[0.019131288,0.0066491757,0.7291874,0.0083425,0.0021185195,0.00036510336,0.010528606,0.0009021379,0.0039727804,0.0006199083,0.21626751,0.0019150676],"about_ca_topic_score_codex":0.002368082,"about_ca_topic_score_gemma":0.00036356508,"teacher_disagreement_score":0.3471065,"about_ca_system_score_codex":0.00016881757,"about_ca_system_score_gemma":0.00059184374,"threshold_uncertainty_score":0.9998842},"labels":[],"label_agreement":null},{"id":"W7127574261","doi":"10.1093/eurheartj/ehaf784.4619","title":"Vascular regenerative cell content in people with elevated lipoprotein(a): primary results of the Lp(a)-VRCE study","year":2025,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Progenitor cell; Peripheral blood mononuclear cell; Diabetes mellitus; Aldehyde dehydrogenase; Flow cytometry; Cell; Vascular disease; Stem cell; Creatinine","score_opus":0.024926688968229152,"score_gpt":0.25550609437204597,"score_spread":0.23057940540381683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7127574261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98436004,0.0015439712,0.00013130094,0.0013850282,0.00017171848,0.0016466174,0.000004219286,0.000019021492,0.010738071],"genre_scores_gemma":[0.9956083,0.00011935021,0.00044163514,0.0008025491,0.00022688118,0.00001045855,0.000003263349,0.00003351498,0.0027539935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964653,0.0015339807,0.00064319925,0.00030352973,0.00074974925,0.00030419085],"domain_scores_gemma":[0.99851537,0.000037237936,0.00020502576,0.0007936058,0.0003128361,0.00013592181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032866916,0.0001933426,0.00057202665,0.00016066738,0.00019470474,0.000035363424,0.00019282318,0.000035857614,0.000014355447],"category_scores_gemma":[0.00015276817,0.00011114789,0.0002834345,0.00063210184,0.000063310436,0.000054106935,0.00011518701,0.00078485324,0.000008800147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009096921,0.007536075,0.86420304,0.0012462,0.0030721508,0.002205768,0.014095201,0.0012500255,0.058214284,0.00011008904,0.01973755,0.01923273],"study_design_scores_gemma":[0.010473847,0.0012237614,0.96915776,0.00067726715,0.00016604507,0.00023587272,0.0011689649,0.000015030849,0.006864753,0.0000027524504,0.009894519,0.000119409386],"about_ca_topic_score_codex":0.00046960378,"about_ca_topic_score_gemma":0.00018508808,"teacher_disagreement_score":0.10495477,"about_ca_system_score_codex":0.00016691367,"about_ca_system_score_gemma":0.0005127975,"threshold_uncertainty_score":0.45324793},"labels":[],"label_agreement":null},{"id":"W7127625573","doi":"10.1093/eurheartj/ehaf784.2068","title":"Elevated lipoprotein(a) identifies patients with acute coronary syndrome who derive earlier and greater cardiovascular benefit of alirocumab, particularly for limb events","year":2025,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mace; Hazard ratio; Acute coronary syndrome; Placebo; Alirocumab; Confidence interval; Myocardial infarction; Randomization","score_opus":0.013395355608935023,"score_gpt":0.24431606843655743,"score_spread":0.23092071282762242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7127625573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99425274,0.0025538835,0.0012220017,0.00026901907,0.00018344227,0.0013325165,0.000027027098,0.000029987816,0.0001294085],"genre_scores_gemma":[0.99696153,0.000272022,0.0011483936,0.00034546468,0.00010890405,0.00002990042,0.000024349789,0.000067760055,0.0010416447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976709,0.00026252161,0.0005123757,0.00038827915,0.0007270419,0.00043892005],"domain_scores_gemma":[0.9984422,0.000023245295,0.00014639781,0.0005830087,0.0005299985,0.00027516708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010837202,0.0002708546,0.0008324106,0.00021047829,0.0002886376,0.00006945558,0.0001198765,0.00006275528,0.000024386023],"category_scores_gemma":[0.000058155754,0.00020151363,0.0006300646,0.00022133335,0.00009611011,0.00021611356,0.0001003994,0.00032664507,0.000009188697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045894296,0.0006889971,0.92822295,0.0017120278,0.02983762,0.0026139205,0.00094645185,0.00011303957,0.0014466443,0.00006134022,0.0026636668,0.027103914],"study_design_scores_gemma":[0.0060035,0.0016477495,0.9812766,0.00094981055,0.0016271671,0.002103834,0.000055673496,0.000013310194,0.001191118,0.00005092476,0.0048767063,0.00020362434],"about_ca_topic_score_codex":0.00003395365,"about_ca_topic_score_gemma":0.0000020674313,"teacher_disagreement_score":0.053053636,"about_ca_system_score_codex":0.00007234326,"about_ca_system_score_gemma":0.00014405094,"threshold_uncertainty_score":0.8217487},"labels":[],"label_agreement":null},{"id":"W7127891376","doi":"10.1093/eurheartj/ehaf784.3710","title":"Design and initial results of the Canadian lipoprotein(a) registry","year":2025,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of British Columbia","funders":"","keywords":"Ezetimibe; Observational study; Disease registry; Risk factor; Patient registry; Disease; Atherosclerotic cardiovascular disease","score_opus":0.038936719989812255,"score_gpt":0.2944920884872352,"score_spread":0.25555536849742294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7127891376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61550516,0.0076719057,0.004081391,0.06436055,0.0021670668,0.002536389,0.000028068083,0.00006534195,0.3035841],"genre_scores_gemma":[0.9945701,0.000080730584,0.0018638453,0.0016297625,0.00048355362,0.0000010886396,8.0006805e-7,0.000014433148,0.0013556966],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99854267,0.0005708009,0.00027518484,0.0001273856,0.0002750763,0.00020891489],"domain_scores_gemma":[0.99912393,0.000026538553,0.00007914674,0.00040240743,0.00011617028,0.00025179252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024084074,0.000083181694,0.0001950441,0.000102469494,0.00034943147,0.000044591943,0.00010158622,0.000039304243,0.000013268147],"category_scores_gemma":[0.00035572005,0.000054729495,0.00013215971,0.00017618325,0.00009821178,0.000032714048,0.00004198794,0.00049600477,0.0000063392745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003502116,0.00034378708,0.028760176,0.0011514084,0.0017993356,0.0040460895,0.0029839836,0.00032802913,0.009432062,0.0018400886,0.42465717,0.5211558],"study_design_scores_gemma":[0.004281779,0.00036894958,0.5275288,0.0011776626,0.00015475153,0.0049469224,0.000109143315,0.00006301168,0.0052577304,0.00016359468,0.45580313,0.00014451423],"about_ca_topic_score_codex":0.0071946215,"about_ca_topic_score_gemma":0.0020736074,"teacher_disagreement_score":0.52101123,"about_ca_system_score_codex":0.0000796361,"about_ca_system_score_gemma":0.0011143574,"threshold_uncertainty_score":0.99941653},"labels":[],"label_agreement":null},{"id":"W7128022003","doi":"10.1093/eurheartj/ehaf784.3504","title":"Age and risk scores for detecting coronary artery calcification in heterozygous familial hypercholesterolemia","year":2025,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Framingham Risk Score; Receiver operating characteristic; Logistic regression; Coronary artery disease; Risk assessment; Atherosclerotic cardiovascular disease; Intima-media thickness; Odds ratio","score_opus":0.03397648583010049,"score_gpt":0.30041957329681535,"score_spread":0.26644308746671486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7128022003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474,0.0013167701,0.0024036919,0.00034395035,0.00024873525,0.00042339487,0.0000038059438,0.000023741108,0.00049591507],"genre_scores_gemma":[0.9968125,0.00055128697,0.001478294,0.00048150402,0.0005162867,0.0000073340557,0.0000034178431,0.000023688255,0.00012566574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871856,0.00037094293,0.00031453586,0.00020452592,0.00015647174,0.00023498866],"domain_scores_gemma":[0.9994863,0.000060071434,0.000062381514,0.00021466102,0.000049801714,0.00012678446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014294191,0.00010784123,0.00024800666,0.00016722447,0.00021385899,0.000058747766,0.000050679242,0.00003810712,0.0000029110486],"category_scores_gemma":[0.00017709154,0.00009285135,0.00013435712,0.000096717435,0.0000388397,0.00007360219,0.00003318166,0.00048503283,0.000005523639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006453827,0.000099876655,0.51052016,0.00023248285,0.00015888619,0.0013743233,0.00065849297,0.00003944204,0.010438599,0.000010013761,0.0007468523,0.4750755],"study_design_scores_gemma":[0.002437523,0.00027819112,0.9862819,0.00033365915,0.0000659512,0.0029445635,0.00015633936,0.00016964642,0.00020768397,0.00004102473,0.007005459,0.00007806714],"about_ca_topic_score_codex":0.000029562967,"about_ca_topic_score_gemma":0.000028456734,"teacher_disagreement_score":0.47576174,"about_ca_system_score_codex":0.0000756336,"about_ca_system_score_gemma":0.00006868839,"threshold_uncertainty_score":0.3786368},"labels":[],"label_agreement":null},{"id":"W7128038288","doi":"10.1093/eurheartj/ehaf784.4300","title":"Icosapent ethyl reduces cardiovascular risk across apolipoprotein b and fasting triglyceride rich lipoprotein levels","year":2025,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"Apolipoprotein B; Quartile; Triglyceride; Residual risk; Diabetes mellitus; Lipoprotein; Mace; Cholesterol","score_opus":0.03734938871757588,"score_gpt":0.3173394321000992,"score_spread":0.2799900433825233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7128038288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602768,0.026398633,0.004123999,0.0017635063,0.0006377701,0.0011153204,0.000021238584,0.00013505043,0.0055277008],"genre_scores_gemma":[0.9901252,0.0016893161,0.003901303,0.0006439039,0.0023104316,0.000021766242,0.0000041345343,0.000095570336,0.0012083771],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99489856,0.0015648326,0.00084112096,0.00069035817,0.0010649104,0.0009401917],"domain_scores_gemma":[0.9978278,0.00007816324,0.00024152295,0.0009509753,0.00028701822,0.00061450276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008402796,0.00042849733,0.0010703213,0.00025628766,0.0012215729,0.0003366707,0.00023610787,0.00012804741,0.00008365005],"category_scores_gemma":[0.0009738381,0.00035497086,0.0010478458,0.0005609999,0.0001754983,0.00021540381,0.0002916848,0.0017697497,0.0000975662],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004606703,0.00018357438,0.010613536,0.00045576663,0.0029922507,0.0012100216,0.0012406381,0.00020579074,0.004587827,0.00003905944,0.0020443345,0.9759665],"study_design_scores_gemma":[0.008181062,0.00087449106,0.7089757,0.0019082954,0.0010256687,0.007715602,0.0011887143,0.00016849523,0.015464526,0.00014160696,0.25360936,0.00074653665],"about_ca_topic_score_codex":0.0003626482,"about_ca_topic_score_gemma":0.000010566932,"teacher_disagreement_score":0.97521996,"about_ca_system_score_codex":0.00019725577,"about_ca_system_score_gemma":0.00035766762,"threshold_uncertainty_score":0.9998902},"labels":[],"label_agreement":null},{"id":"W7128046363","doi":"10.1093/eurheartj/ehaf784.2021","title":"Lp(a) measurement in younger patients following ST-elevation myocardial infarction: insights from a contemporary regional registry","year":2025,"lang":"en","type":"article","venue":"European Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; Vancouver General Hospital","funders":"","keywords":"Myocardial infarction; Coronary artery disease; Disease; Clinical endpoint; Retrospective cohort study; Risk stratification; Arterial disease; Risk assessment; Primary care","score_opus":0.054774357517760934,"score_gpt":0.28202362704544903,"score_spread":0.2272492695276881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7128046363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751829,0.004487467,0.00043956478,0.0029817352,0.0015596814,0.000525409,0.0000040116097,0.000041955474,0.014777313],"genre_scores_gemma":[0.9947206,0.00009108621,0.00025954508,0.0033845687,0.0013278531,0.0000067049914,0.000041587977,0.000027264583,0.00014082716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971473,0.0006695973,0.00054121675,0.00028542063,0.0011357387,0.00022071146],"domain_scores_gemma":[0.99902004,0.000023143075,0.00013032988,0.00036466608,0.00027770575,0.00018410769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014204509,0.00016829272,0.0003784776,0.00024198371,0.00021147395,0.000072137685,0.00008970659,0.00006442816,0.000021871536],"category_scores_gemma":[0.00022329102,0.00014721353,0.00041069044,0.0002855288,0.00002802716,0.00025390123,0.00004615953,0.0006437637,0.000028416878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092379696,0.0005382511,0.8893464,0.00009584888,0.0013983326,0.00080584805,0.0006810996,0.000027261844,0.00196044,0.00015925242,0.09096134,0.013102112],"study_design_scores_gemma":[0.003863595,0.000119774966,0.7947661,0.0007043489,0.000059263948,0.00004608974,0.00010576443,0.000010779841,0.000029115849,0.00010363345,0.2000862,0.000105286264],"about_ca_topic_score_codex":0.00011992408,"about_ca_topic_score_gemma":0.000008110815,"teacher_disagreement_score":0.10912487,"about_ca_system_score_codex":0.00041693135,"about_ca_system_score_gemma":0.00058569945,"threshold_uncertainty_score":0.6003194},"labels":[],"label_agreement":null},{"id":"W7132982148","doi":"","title":"Evaluación de señales en farmacovigilancia : Lovastatina y mareo","year":2015,"lang":"es","type":"article","venue":"Repositorio - Universidad de Ciencias Aplicadas y Ambientales UDCA.","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Subject (documents); MEDLINE; Clinical Practice; Qualitative analysis","score_opus":0.0164935126946413,"score_gpt":0.3071959593555834,"score_spread":0.29070244666094214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132982148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648348,0.006840357,0.0020339494,0.00076533214,0.0014843048,0.0015010176,0.000102427075,0.00032011376,0.022117706],"genre_scores_gemma":[0.9883569,0.0009417021,0.0024720156,0.00053658115,0.0032226683,0.00003861607,0.00007587302,0.00013735308,0.004218329],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99231714,0.00096236257,0.00088419334,0.0014012998,0.0025117905,0.0019232187],"domain_scores_gemma":[0.99456674,0.0002194041,0.00051126187,0.0016679633,0.00071455614,0.0023200563],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031721953,0.00082195416,0.0012003345,0.00052059157,0.0006462832,0.00035260225,0.0008873991,0.000727983,0.00006381351],"category_scores_gemma":[0.0004415728,0.0008584063,0.0008930555,0.0014305857,0.00047305753,0.0005032651,0.0005189255,0.0011263762,0.00031379465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004279811,0.0046799444,0.56905776,0.0048356904,0.0046919715,0.025554242,0.041422132,0.0017538834,0.1397366,0.02211882,0.05792319,0.12394595],"study_design_scores_gemma":[0.01347423,0.0037610484,0.25681153,0.002625142,0.0043623545,0.017898872,0.03929722,0.0033065472,0.062463015,0.00039949204,0.5924264,0.00317414],"about_ca_topic_score_codex":0.003011111,"about_ca_topic_score_gemma":0.00004550865,"teacher_disagreement_score":0.5345032,"about_ca_system_score_codex":0.007373644,"about_ca_system_score_gemma":0.0051124273,"threshold_uncertainty_score":0.99938667},"labels":[],"label_agreement":null},{"id":"W7135442912","doi":"","title":"Allocating funds for the Cariovascular Disease Prevention in light ofthe NCEP ATP III Guidelines","year":2005,"lang":"en","type":"article","venue":"Research Portal (King's College London)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"","keywords":"Disease prevention; Disease; MEDLINE; Primary prevention; Government (linguistics)","score_opus":0.07579842182500492,"score_gpt":0.3953954499675561,"score_spread":0.3195970281425512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7135442912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7398187,0.1027687,0.005614822,0.10954661,0.00085011014,0.026105748,0.00015582537,0.0003768993,0.01476258],"genre_scores_gemma":[0.9839405,0.0015109696,0.0015611835,0.00064232794,0.0023416409,0.0015509733,0.00007450771,0.00008272023,0.0082952],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948879,0.00033601615,0.0008796091,0.0006789157,0.0021454678,0.0010721212],"domain_scores_gemma":[0.9967842,0.0002683121,0.00012534331,0.0013168928,0.001034268,0.00047096168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008301719,0.00027259815,0.00059106655,0.00034934524,0.0006092178,0.00007667697,0.0003894788,0.00016127976,0.00019032034],"category_scores_gemma":[0.0016432261,0.0001921656,0.0007819721,0.0010823308,0.0001445928,0.00023115322,0.00019729561,0.00068808265,0.000030351594],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074585574,0.0040586097,0.02280991,0.0062530525,0.005297155,0.0033529804,0.0049059275,0.005009316,0.0037533261,0.036590297,0.08414308,0.8163678],"study_design_scores_gemma":[0.009917375,0.00060539314,0.016236931,0.0013469964,0.0003823378,0.00015243438,0.002528584,0.020026274,0.0012218433,0.0005488174,0.9465337,0.00049935665],"about_ca_topic_score_codex":0.0013905243,"about_ca_topic_score_gemma":0.0025228832,"teacher_disagreement_score":0.8623906,"about_ca_system_score_codex":0.00028097443,"about_ca_system_score_gemma":0.0013936567,"threshold_uncertainty_score":0.7836285},"labels":[],"label_agreement":null},{"id":"W71535241","doi":"","title":"Efficacy and cost of HMG-CoA reductase inhibitors in the treatment of patients with primary hyperlipidemia.","year":2000,"lang":"en","type":"article","venue":"PubMed","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Simvastatin; Pravastatin; Medicine; Hyperlipidemia; Cerivastatin; Atorvastatin; Cholesterol; Internal medicine; Reductase; Fluvastatin; Statin; HMG-CoA reductase; Confidence interval; Randomized controlled trial; Pharmacology; Endocrinology; Urology; Biochemistry; Chemistry; Enzyme","score_opus":0.012316005379878266,"score_gpt":0.21535322128951848,"score_spread":0.20303721590964022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W71535241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456936,0.0011882668,3.511907e-7,0.00022441104,0.000021956885,0.0026668431,0.000012958657,0.000005519591,0.0013103349],"genre_scores_gemma":[0.9987472,0.0004326066,0.000044742486,0.00011249827,0.00006993891,0.00048718863,0.000030588715,0.000009181692,0.00006603235],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991099,0.000072311654,0.00022023352,0.00014081567,0.00028084434,0.00017589152],"domain_scores_gemma":[0.9994943,0.000038839396,0.000052840336,0.00030570093,0.000030248617,0.000078072975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002898749,0.00008821892,0.00031667316,0.000046459652,0.000017896888,0.0000026679709,0.000033676268,0.000038500584,0.000008382873],"category_scores_gemma":[0.000020584836,0.000046741934,0.00005860897,0.00015876126,0.000076898476,0.00002822895,0.000004092982,0.00005382635,5.145015e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006602376,0.0010627077,0.07580581,0.000085722735,0.00007664136,0.000006184338,0.00051031343,0.000006335493,0.0000063056555,0.000003503251,0.00007718743,0.92169905],"study_design_scores_gemma":[0.0068417904,0.00045698645,0.98233926,0.00003085458,0.00010556476,0.000004141722,0.00004608645,9.193051e-7,0.0004594142,0.0000021366618,0.009667529,0.00004529956],"about_ca_topic_score_codex":0.00024586244,"about_ca_topic_score_gemma":0.000009993224,"teacher_disagreement_score":0.92165375,"about_ca_system_score_codex":0.000067995104,"about_ca_system_score_gemma":0.000040931052,"threshold_uncertainty_score":0.19060807},"labels":[],"label_agreement":null},{"id":"W7162132917","doi":"10.82308/5987","title":"Barriers to Care in Familial Hypercholesterolemia","year":2022,"lang":"en","type":"dissertation","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Familial hypercholesterolemia; Genetic testing; PCSK9; Genetic diagnosis; Cohort; Geneticist; Disease; Atherosclerotic cardiovascular disease; Apolipoprotein B","score_opus":0.007925650760785259,"score_gpt":0.28641717166251845,"score_spread":0.2784915209017332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7162132917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9323769,0.0018353112,0.0000019381143,0.00013601253,0.00085499726,0.0013505804,0.000023080185,0.000050736344,0.0633704],"genre_scores_gemma":[0.97180015,0.00019298952,0.0002422094,0.0029907972,0.00046061148,0.00057863106,0.0021366647,0.00009091014,0.021507064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835914,0.00006650687,0.0002704593,0.00040852747,0.0006254264,0.00026991955],"domain_scores_gemma":[0.9989514,0.000006229144,0.000029428666,0.00051093596,0.000072758034,0.00042928912],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022448025,0.00019813719,0.0005095827,0.00028112033,0.000082551,0.000011384304,0.000105534724,0.0002077861,0.0018197999],"category_scores_gemma":[0.000093888455,0.00018422768,0.00025985928,0.00027688034,0.0000047881367,0.000021670516,0.000027154229,0.0005840583,0.000044694963],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004551255,0.00012227622,0.026918616,0.0061863516,0.0005364048,0.0011898046,0.060942188,0.00013913572,0.0019410845,0.0002703583,0.0071146414,0.8900879],"study_design_scores_gemma":[0.004857574,0.0015311638,0.24051042,0.00061120174,0.00035976985,0.00005268619,0.1910073,0.000005428215,0.0012438768,0.000013763813,0.55901927,0.0007875566],"about_ca_topic_score_codex":0.0026491405,"about_ca_topic_score_gemma":0.006292691,"teacher_disagreement_score":0.88930035,"about_ca_system_score_codex":0.00050352304,"about_ca_system_score_gemma":0.0010607544,"threshold_uncertainty_score":0.9990927},"labels":[],"label_agreement":null},{"id":"W7671174","doi":"","title":"弾性表面波センサを用いた懸濁液試料(ペイント)の濃度測定","year":2003,"lang":"en","type":"article","venue":"Revista Panamericana De Salud Publica-pan American Journal of Public Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geology","score_opus":0.03184649506663645,"score_gpt":0.3117972191286265,"score_spread":0.27995072406199006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7671174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7398447,0.028406154,0.095866136,0.1160204,0.0009154545,0.00279768,0.000096387026,0.00043789885,0.015615231],"genre_scores_gemma":[0.9539303,0.004768335,0.023496242,0.016246796,0.0010241413,0.000033260494,0.000026477124,0.00016825726,0.00030619276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9892446,0.0031157252,0.0024540871,0.00071538414,0.0021186313,0.002351581],"domain_scores_gemma":[0.9890052,0.00024221728,0.002918749,0.0016235271,0.0013500064,0.0048602964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013711608,0.00061646855,0.0030101924,0.0011697686,0.0003294327,0.00031196725,0.0006873601,0.00013281236,0.00043758226],"category_scores_gemma":[0.0035961887,0.00052020815,0.0012728577,0.004115717,0.0008632782,0.00052733027,0.00007304668,0.0015366189,0.000045328023],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073158226,0.0006847486,0.023009336,0.00036606382,0.000966107,0.0001941962,0.00072501705,0.0000040578225,0.00006190441,0.011155898,0.011254049,0.9515055],"study_design_scores_gemma":[0.0020794694,0.004288062,0.07817218,0.0002528764,0.00018100289,0.006399619,0.0062859305,0.000037009042,0.000013548076,0.00006813883,0.90167296,0.0005492149],"about_ca_topic_score_codex":0.0020846878,"about_ca_topic_score_gemma":0.000030282576,"teacher_disagreement_score":0.9509562,"about_ca_system_score_codex":0.0023985885,"about_ca_system_score_gemma":0.017771075,"threshold_uncertainty_score":0.9997249},"labels":[],"label_agreement":null},{"id":"W77103575","doi":"10.1096/fasebj.21.5.a341-d","title":"Effects of FBCx® on lipid lowering in LDLr‐KO mice","year":2007,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nexus Clinical Research (Canada)","funders":"","keywords":"Internal medicine; Endocrinology; LDL receptor; Triglyceride; Blood lipids; Chemistry; Cholesterol; Hyperlipidemia; Receptor; Medicine; Lipoprotein","score_opus":0.009275292471186417,"score_gpt":0.2565313984274729,"score_spread":0.2472561059562865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W77103575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950368,0.0012007463,0.00088664127,0.000318958,0.0003388073,0.0002446495,3.4003915e-7,0.000008000849,0.0019650615],"genre_scores_gemma":[0.99809885,0.00028586533,0.00012614619,0.00045245624,0.00091254024,0.0000014986502,3.424791e-7,0.00001331422,0.000108988315],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989476,0.00006351046,0.0002568535,0.000081496815,0.00039517795,0.00025531257],"domain_scores_gemma":[0.999398,0.00014028559,0.00008901156,0.00020563549,0.00004218796,0.00012487202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021430177,0.00008433959,0.00024594238,0.00011449867,0.000062468804,0.000007803372,0.00009222629,0.00004947674,0.000022528237],"category_scores_gemma":[0.00014507792,0.000050859388,0.00018207423,0.00015960501,0.000030874508,0.000030132771,0.000018123212,0.0004950511,0.000015239807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019934548,0.00059261516,0.008705637,0.0008111391,0.00039280002,0.0018885967,0.0019355507,0.00014969849,0.6941941,0.00021801227,0.0004734788,0.28864494],"study_design_scores_gemma":[0.0041269343,0.00076754356,0.14097679,0.0011091469,0.00011865269,0.0014243934,0.00026321821,0.000025464553,0.84905905,0.00007456625,0.0019427518,0.0001115038],"about_ca_topic_score_codex":0.000076602904,"about_ca_topic_score_gemma":0.00001494288,"teacher_disagreement_score":0.28853342,"about_ca_system_score_codex":0.000090003035,"about_ca_system_score_gemma":0.000077461926,"threshold_uncertainty_score":0.21507782},"labels":[],"label_agreement":null},{"id":"W79096564","doi":"10.1007/978-1-4615-1321-6_8","title":"Advances in Lipid-Lowering Therapy in Atherosclerosis","year":2001,"lang":"en","type":"review","venue":"Advances in experimental medicine and biology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Chemistry; Medicine","score_opus":0.07159513683192596,"score_gpt":0.4198043372443062,"score_spread":0.34820920041238024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W79096564","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038975182,0.99205416,0.000009072152,0.0000780596,0.0005385927,0.0012895394,0.0000030330816,0.000021262978,0.002108767],"genre_scores_gemma":[0.006073168,0.9922293,0.00010297727,0.00033170328,0.0006689696,0.00047761053,0.000056361954,0.00004097508,0.000018971381],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975339,0.00019937548,0.00089521747,0.000702416,0.0001555142,0.00051357626],"domain_scores_gemma":[0.99919593,0.00012974054,0.00018200329,0.00035915137,0.000013444578,0.00011971532],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052773807,0.0004707074,0.0026742287,0.00050083554,0.00003022461,0.000003592778,0.00014476656,0.00035355723,0.00007587123],"category_scores_gemma":[0.000056227018,0.00030536187,0.00018787255,0.0006575687,0.00031512856,0.00016627458,0.00007040376,0.00054610515,0.0000036191266],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006769514,0.00016379663,0.0024508033,0.0016011429,0.000019070721,0.00004481281,0.00024182095,3.0397098e-7,0.00006808833,0.000055123437,0.0000027610952,0.99528456],"study_design_scores_gemma":[0.0032697394,0.0016235564,0.00014479735,0.016847514,0.000029198156,0.00014408451,0.0006504712,0.0000011614259,0.000055214714,0.0000527428,0.97689736,0.0002841648],"about_ca_topic_score_codex":0.000338519,"about_ca_topic_score_gemma":0.00024151009,"teacher_disagreement_score":0.9950004,"about_ca_system_score_codex":0.00024326079,"about_ca_system_score_gemma":0.00007853491,"threshold_uncertainty_score":0.99993986},"labels":[],"label_agreement":null},{"id":"W799814716","doi":"10.1016/j.cjca.2015.07.006","title":"Evidence, Guidelines, and Gut Checks: Musings on Entering the Post-Statin Era of Lipid Management","year":2015,"lang":"en","type":"review","venue":"Canadian Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":true,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Dyslipidemia; Statin; Guideline; Kexin; Proprotein convertase; Subtilisin; Intensive care medicine; Disease; Internal medicine; Cholesterol; Lipoprotein; Pathology; LDL receptor","score_opus":0.12340585071447172,"score_gpt":0.3550409877960899,"score_spread":0.23163513708161818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W799814716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018561678,0.99462306,0.00011770847,0.0012044361,0.00082348404,0.0007077107,0.00003360548,0.0000028709665,0.00230149],"genre_scores_gemma":[0.000679181,0.9953855,0.00042097634,0.0006122431,0.002731212,0.000013848197,0.000010897045,0.000038896156,0.00010723588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99748504,0.00043167442,0.0011248431,0.00022651802,0.00037396137,0.0003579672],"domain_scores_gemma":[0.9972653,0.00008860316,0.00064416765,0.00055163255,0.00081398996,0.00063634466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032470191,0.00028737518,0.0025570309,0.00039186107,0.00006925653,0.000020418154,0.00027656165,0.0002292191,0.000011642065],"category_scores_gemma":[0.00054211094,0.00017182861,0.0009247038,0.00019294702,0.00016835703,0.00004384918,0.000043332922,0.0007886586,0.000004382089],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025089243,0.0000011077159,0.000025974214,0.0046541956,0.0012559494,0.00048624288,0.00006637725,0.000014691464,3.3434e-7,0.000050166676,0.010482934,0.9829369],"study_design_scores_gemma":[0.00039162586,0.00049926975,0.00024127666,0.023693379,0.0019117151,0.0048621786,0.00011594521,7.3895666e-7,1.7681307e-7,0.000011508906,0.96815,0.00012215182],"about_ca_topic_score_codex":0.0011415508,"about_ca_topic_score_gemma":0.00021482343,"teacher_disagreement_score":0.9828148,"about_ca_system_score_codex":0.00036545494,"about_ca_system_score_gemma":0.0033478863,"threshold_uncertainty_score":0.7006967},"labels":[],"label_agreement":null},{"id":"W803523995","doi":"10.1096/fasebj.23.1_supplement.311.2","title":"Simvastatin Increases Endothelial Nitric Oxide Synthase Expression in Cultured Endothelial Cells Preconditioned with Steady Laminar Flow","year":2009,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Heart Institute","funders":"","keywords":"Enos; Simvastatin; Nitric oxide synthase; Reductase; Chemistry; Statin; HMG-CoA reductase; Hydroxymethylglutaryl-CoA reductase; Internal medicine; Nitric oxide; Endothelium; Endocrinology; Biology; Pharmacology; Medicine; Biochemistry; Enzyme","score_opus":0.010411398033025914,"score_gpt":0.23825764779196185,"score_spread":0.22784624975893594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W803523995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99573785,0.0005555547,0.0018266753,0.00033669404,0.00008000717,0.00074675883,0.00012844667,0.000043044714,0.00054494524],"genre_scores_gemma":[0.9930747,0.0003054326,0.0045395205,0.00056924624,0.00093597383,0.000024156678,0.000030410267,0.000029921614,0.0004905993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975785,0.00046990838,0.0004550255,0.00025114542,0.000778131,0.0004672815],"domain_scores_gemma":[0.99880505,0.000110224835,0.00022837214,0.00042065166,0.00012352596,0.00031218585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010354168,0.00026083278,0.00048618118,0.00019616919,0.00030843157,0.000074181014,0.00018206115,0.000095921394,0.00022270699],"category_scores_gemma":[0.00010030592,0.00014287903,0.00023444576,0.0002672235,0.00006949245,0.00019336015,0.000020437254,0.0007040439,0.000034864956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027823243,0.0007605285,0.0006007076,0.000056251272,0.0001574943,0.0014177344,0.00065930473,0.0006725824,0.9745207,0.00001436843,0.0008557042,0.01750232],"study_design_scores_gemma":[0.013794946,0.001465589,0.014845674,0.0010734902,0.00042385462,0.005910066,0.0017007069,0.00040240074,0.9586743,0.00028528715,0.0010298066,0.0003938406],"about_ca_topic_score_codex":0.00013704995,"about_ca_topic_score_gemma":0.000023390947,"teacher_disagreement_score":0.01710848,"about_ca_system_score_codex":0.00015791832,"about_ca_system_score_gemma":0.00030673324,"threshold_uncertainty_score":0.58264375},"labels":[],"label_agreement":null},{"id":"W87703995","doi":"10.2165/00044011-200828100-00003","title":"Evaluation of a New Formulation of Fenofibric Acid, ABT-335, Co-Administered with Statins","year":2008,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Medicine; Atorvastatin; Combination therapy; Rosuvastatin; Fenofibrate; Rosuvastatin Calcium; Simvastatin; Statin; Pharmacotherapy; Internal medicine; Pharmacology; Clinical endpoint; Clinical trial; Fibrate; Randomized controlled trial; Gastroenterology","score_opus":0.2015735245686092,"score_gpt":0.40608301158157345,"score_spread":0.20450948701296426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W87703995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99532974,0.00025785126,0.0017247912,0.00056929485,0.00007411443,0.0011063658,0.000009248368,0.000028461214,0.0009001189],"genre_scores_gemma":[0.9920637,0.00007913547,0.0070435954,0.00023963711,0.00022672328,0.000020510934,0.00016415594,0.000019827045,0.00014274279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967354,0.0004049711,0.0009876419,0.0002655415,0.0014608796,0.0001455554],"domain_scores_gemma":[0.99774486,0.00011953103,0.0005563613,0.00047226262,0.0008418835,0.00026510053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003559136,0.00012456834,0.0005163919,0.00009841576,0.0000580282,0.000003866913,0.000059338327,0.00015972201,0.00004190073],"category_scores_gemma":[0.0011937721,0.00009916547,0.00019619694,0.00032258977,0.00022377801,0.0001500003,0.000013574828,0.00020939078,0.000010383914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020344283,0.000979573,0.5965438,0.0014660847,0.0012748396,0.000018329052,0.009023709,0.0007457176,0.01028042,0.0014545802,0.005659563,0.37051895],"study_design_scores_gemma":[0.008434727,0.0016504949,0.9401158,0.00040753555,0.00088292756,0.000051794104,0.00019978391,0.0069927266,0.038699765,0.0018912146,0.0005060986,0.0001671131],"about_ca_topic_score_codex":0.00025889426,"about_ca_topic_score_gemma":0.000043973283,"teacher_disagreement_score":0.37035182,"about_ca_system_score_codex":0.00007977495,"about_ca_system_score_gemma":0.002047275,"threshold_uncertainty_score":0.40438503},"labels":[],"label_agreement":null},{"id":"W87776635","doi":"10.1096/fasebj.22.1_supplement.1040.4","title":"Statins Induce Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9","year":2008,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"PCSK9; Kexin; Proprotein convertase; Sterol regulatory element-binding protein; LDL receptor; Endocrinology; Internal medicine; HMG-CoA reductase; Cholesterol; Chemistry; Simvastatin; Familial hypercholesterolemia; Statin; Reductase; Lipoprotein; Biology; Medicine; Sterol; Biochemistry; Enzyme","score_opus":0.052418107846937095,"score_gpt":0.2786927339702285,"score_spread":0.22627462612329138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W87776635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99686337,0.0007053323,0.00024080437,0.00070150703,0.00021374453,0.00047268963,0.000022256603,0.000017250291,0.0007630709],"genre_scores_gemma":[0.99740785,0.00023940126,0.000783328,0.00028957007,0.00041783656,0.0000047355215,0.000004030675,0.000023455963,0.00082979415],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982979,0.00018736396,0.00039370058,0.00013068307,0.0007030005,0.00028734782],"domain_scores_gemma":[0.9987872,0.000039241535,0.0002017903,0.0004369124,0.00030947107,0.00022533156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010371449,0.0001371526,0.00037405136,0.000081124665,0.0002509366,0.000011582892,0.00015325018,0.000077053635,0.00038789],"category_scores_gemma":[0.00020534932,0.000080438986,0.00020606905,0.00020276838,0.000169371,0.00007898151,0.00003200507,0.00059862895,0.000050942235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036231827,0.0010747325,0.023118576,0.00068340276,0.002063685,0.0037924289,0.011095087,0.00012133475,0.8090181,0.00070889754,0.006879047,0.13782153],"study_design_scores_gemma":[0.0056047733,0.0015449852,0.07644714,0.00032305781,0.00025554508,0.0163977,0.0009179042,0.0002153044,0.8942529,0.00021158309,0.003578487,0.00025061006],"about_ca_topic_score_codex":0.00017255096,"about_ca_topic_score_gemma":0.000010543395,"teacher_disagreement_score":0.13757092,"about_ca_system_score_codex":0.000070284266,"about_ca_system_score_gemma":0.0008581325,"threshold_uncertainty_score":0.42471236},"labels":[],"label_agreement":null},{"id":"W92472783","doi":"","title":"Abstract 15400: The Effect of Statins on the Risk of First Non-Fatal Myocardial Infarction: A Population-Based Observational Study Using the PGRx Information System","year":2012,"lang":"en","type":"article","venue":"","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Rosuvastatin; Myocardial infarction; Statin; Internal medicine; Observational study; Odds ratio; Population; Propensity score matching; Logistic regression; Physical therapy","score_opus":0.032260659116987486,"score_gpt":0.2822094782747582,"score_spread":0.24994881915777067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W92472783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953311,0.000025806265,0.0008811253,0.0003104151,0.00024410995,0.0025877042,0.00004388856,0.000017716664,0.0005581171],"genre_scores_gemma":[0.99932873,0.0000020798132,0.000059251168,0.00012278209,0.00032979416,0.00009429761,0.000049755465,0.000009584103,0.0000037363538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998036,0.00030231403,0.0005056209,0.0000803139,0.0009124684,0.00016326222],"domain_scores_gemma":[0.99814695,0.00067771197,0.00038354952,0.0005809829,0.00016436519,0.000046423364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033244267,0.00013585143,0.00030032036,0.000056667777,0.000346616,0.000018310906,0.00010167313,0.000052626263,0.000037807014],"category_scores_gemma":[0.00027082206,0.000054450888,0.00027174718,0.00025656365,0.000042239775,0.00019366034,0.00002221502,0.00021360708,0.0000062673025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030383596,0.00007922317,0.99001294,0.00033303114,0.00048424263,2.0099515e-7,0.0013821094,0.0060015526,0.000015532563,0.0002554164,0.00007559509,0.0010563018],"study_design_scores_gemma":[0.0013404603,0.0004199761,0.98818153,0.00010406161,0.00031310317,0.0000056198305,0.0024510722,0.0066484637,0.0002973321,0.0000012346073,0.0001816405,0.000055506116],"about_ca_topic_score_codex":0.0079217125,"about_ca_topic_score_gemma":0.00008322155,"teacher_disagreement_score":0.007838491,"about_ca_system_score_codex":0.00012755704,"about_ca_system_score_gemma":0.000097192154,"threshold_uncertainty_score":0.99868464},"labels":[],"label_agreement":null},{"id":"W93908262","doi":"10.1016/j.ahj.2015.01.008","title":"The effect of an apolipoprotein A-I–containing high-density lipoprotein–mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia","year":2015,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Familial hypercholesterolemia; Apolipoprotein B; Internal medicine; Magnetic resonance imaging; Lipoprotein; Cardiology; Residual risk; Cholesterol; Endocrinology; Gastroenterology; Radiology","score_opus":0.010789926043636208,"score_gpt":0.25155195268100594,"score_spread":0.24076202663736973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W93908262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778384,0.00009749664,0.000029123428,0.0005355245,0.00015500438,0.0013142716,0.000004569162,0.000036192945,0.000043948436],"genre_scores_gemma":[0.9984629,0.000014025269,0.00042247647,0.000529193,0.0004251555,0.000060224687,0.0000071274276,0.00006073499,0.000018172912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956744,0.0012342097,0.000613509,0.0003890003,0.0013629128,0.0007259773],"domain_scores_gemma":[0.99779826,0.00014620717,0.00028953454,0.0007494413,0.00031497804,0.0007015873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028519465,0.00032914348,0.0010166942,0.00013907181,0.0002659627,0.00007377658,0.0002073105,0.00009081544,0.000007070012],"category_scores_gemma":[0.0002662475,0.00019690364,0.00020007785,0.00041190186,0.00039830102,0.00018972992,0.000053955286,0.0010292527,0.000019199693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013771369,0.00077206205,0.6615795,0.000108647306,0.00032943086,0.00027622122,0.0012043368,0.00032285377,0.0010446395,0.000012287583,0.00007657614,0.3205021],"study_design_scores_gemma":[0.011418589,0.035352793,0.9448515,0.00034449142,0.00017734556,0.0010294523,0.000577494,0.00009975938,0.005617754,0.0000247387,0.0002131392,0.0002929429],"about_ca_topic_score_codex":0.013004849,"about_ca_topic_score_gemma":0.0005762469,"teacher_disagreement_score":0.32020915,"about_ca_system_score_codex":0.000332376,"about_ca_system_score_gemma":0.00029407273,"threshold_uncertainty_score":0.99356765},"labels":[],"label_agreement":null},{"id":"W949789291","doi":"10.1096/fasebj.29.1_supplement.743.12","title":"Dietary high oleic canola oil supplemented with DHA oil attenuates plasma PCSK9 levels in humans","year":2015,"lang":"en","type":"article","venue":"The FASEB Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Canola; PCSK9; Cholesterol; Chemistry; Food science; Oleic acid; Animal science; LDL receptor; Biology; Biochemistry; Lipoprotein","score_opus":0.04147079767988207,"score_gpt":0.27051615391102113,"score_spread":0.22904535623113906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W949789291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99162376,0.00094709644,0.00003057209,0.0056987144,0.00024042351,0.00010124063,0.00003181062,0.000026998454,0.0012993874],"genre_scores_gemma":[0.99587125,0.00024028207,0.00037890446,0.0006651617,0.0008145266,0.000017272578,0.000028916676,0.00003721817,0.0019464688],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99779934,0.00023528456,0.00038671886,0.00020143224,0.00086601084,0.0005112199],"domain_scores_gemma":[0.99879813,0.00003333004,0.00013876935,0.00046772725,0.00018333388,0.0003787281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016407797,0.00021023567,0.000443471,0.0001365539,0.00020193664,0.000050439503,0.00020824393,0.00006874842,0.00021525864],"category_scores_gemma":[0.00005076139,0.00011741152,0.00014988249,0.00024201076,0.000095575844,0.00011706982,0.00005138736,0.0007419276,0.000046650315],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070051146,0.0019071258,0.24339154,0.0010350185,0.0051855496,0.011894432,0.019334042,0.003016711,0.059347194,0.0004028121,0.025436874,0.6220436],"study_design_scores_gemma":[0.1263124,0.010915346,0.5165469,0.00631424,0.0037125957,0.031765983,0.032084875,0.0014587882,0.16215463,0.0009750538,0.104736656,0.0030225373],"about_ca_topic_score_codex":0.0021877878,"about_ca_topic_score_gemma":0.0015407464,"teacher_disagreement_score":0.61902106,"about_ca_system_score_codex":0.00027175236,"about_ca_system_score_gemma":0.000638582,"threshold_uncertainty_score":0.47879028},"labels":[],"label_agreement":null},{"id":"W972520836","doi":"","title":"Abstract 20999: Determinants of Reaching Guideline-Recommended LDL-Cholesterol Targets in Secondary Prevention in Europe and Canada: Results of the Dyslipidemia International Study","year":2010,"lang":"en","type":"article","venue":"Circulation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dyslipidemia; Medicine; Statin; Guideline; Diabetes mellitus; Internal medicine; Atherosclerotic cardiovascular disease; Disease; Ldl cholesterol; Cholesterol; Physical therapy; Endocrinology; Pathology","score_opus":0.018867998815087005,"score_gpt":0.2959389618804178,"score_spread":0.2770709630653308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W972520836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834293,0.000034861627,0.000016637854,0.00030205553,0.00031138983,0.0006274785,0.000013553285,0.0000031864254,0.00034793396],"genre_scores_gemma":[0.999721,0.0000049336877,0.000098191056,0.000055906123,0.00007205667,0.000007666215,0.000023557177,0.000008359828,0.0000083468185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986267,0.00010556934,0.00071887206,0.0001724004,0.00028564397,0.00009083386],"domain_scores_gemma":[0.9992679,0.000030422629,0.0002672328,0.0002717994,0.00013023194,0.00003245053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016051169,0.00007356949,0.00022257288,0.0000894566,0.000021209169,0.000004256047,0.000068825124,0.00005476036,0.000008584116],"category_scores_gemma":[0.00045297528,0.00005909864,0.000037626007,0.0001119883,0.000013642836,0.00008683784,0.000035227124,0.0002841724,1.2243534e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065297914,0.00012515437,0.9268389,0.00006372639,0.000026959517,0.0000060429134,0.00039397346,0.000082867664,0.005658229,0.0000029517994,0.000043933454,0.066692],"study_design_scores_gemma":[0.0026182812,0.00002594192,0.99538136,0.00013986358,0.00001775892,0.000009812456,0.00012043215,0.00069525774,0.0007199085,0.00001912528,0.0002076155,0.000044658365],"about_ca_topic_score_codex":0.15176715,"about_ca_topic_score_gemma":0.6123241,"teacher_disagreement_score":0.46055695,"about_ca_system_score_codex":0.000080494865,"about_ca_system_score_gemma":0.00034784264,"threshold_uncertainty_score":0.8538813},"labels":[],"label_agreement":null},{"id":"W97785587","doi":"10.1016/j.jacc.2013.07.051","title":"Low Levels of High-Density Lipoprotein Cholesterol and Increased Risk of Cardiovascular Events in Stable Ischemic Heart Disease Patients","year":2013,"lang":"en","type":"article","venue":"Journal of the American College of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of British Columbia; McMaster University Medical Centre","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research; U.S. Department of Veterans Affairs","keywords":"Medicine; Internal medicine; Quartile; Myocardial infarction; Post-hoc analysis; Cholesterol; Cardiology; Statin; Population; Stroke (engine); Lipoprotein; Endocrinology; Confidence interval","score_opus":0.006734656363457016,"score_gpt":0.21729053548411015,"score_spread":0.21055587912065313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W97785587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972925,0.0011390916,0.00012815169,0.00021506783,0.000113612055,0.0009175359,0.00016861153,0.0000025980657,0.000022824564],"genre_scores_gemma":[0.99891967,0.00036784986,0.00044137868,0.00009514211,0.00012987164,0.000013418405,0.0000014703887,0.000020695974,0.000010535214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969527,0.0009785484,0.0008756559,0.00020435466,0.00073109753,0.00025764524],"domain_scores_gemma":[0.99717134,0.00009481955,0.0010778788,0.00077976275,0.00065137376,0.00022481829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014261657,0.0001834966,0.002171159,0.00020052769,0.000035161953,0.0000014952691,0.0002062398,0.00007326236,0.0000055177616],"category_scores_gemma":[0.0005793813,0.0001253588,0.0010176002,0.0003774793,0.00039568965,0.000093718096,0.00013748388,0.00034573962,6.360492e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015770637,0.00028354776,0.974734,0.0005657288,0.0034087484,0.00003571339,0.000044537992,0.00083508843,0.00650507,0.000004491259,0.00040048288,0.011605545],"study_design_scores_gemma":[0.0039545735,0.00075985305,0.98515135,0.00030754146,0.0008129768,0.0001353126,0.00010581952,0.000013691524,0.008352295,0.00012163241,0.00019029072,0.00009468502],"about_ca_topic_score_codex":0.005996261,"about_ca_topic_score_gemma":0.000015214073,"teacher_disagreement_score":0.01151086,"about_ca_system_score_codex":0.00009688986,"about_ca_system_score_gemma":0.0003631285,"threshold_uncertainty_score":0.9064593},"labels":[],"label_agreement":null},{"id":"W97805238","doi":"10.1093/pch/14.7.450","title":"A case report of prenatal exposure to rosuvastatin and telmisartan","year":2009,"lang":"en","type":"article","venue":"Paediatrics & Child Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Telmisartan; Rosuvastatin; Polymicrogyria; Microcephaly; Oligohydramnios; Pregnancy; Pediatrics; Hyperlipidemia; Obstetrics; Internal medicine; Fetus; Endocrinology; Magnetic resonance imaging; Blood pressure","score_opus":0.011095167478552154,"score_gpt":0.27144925180656804,"score_spread":0.2603540843280159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W97805238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97491693,0.010090122,0.00089953415,0.010966962,0.00014669675,0.0015597992,0.000055877517,0.00007267036,0.0012913806],"genre_scores_gemma":[0.9882912,0.0007533918,0.0068636183,0.0032765747,0.00068545935,0.000012475006,0.00003516692,0.00002071174,0.000061405684],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99795353,0.000077980614,0.00065911084,0.00039202961,0.0005047542,0.00041261988],"domain_scores_gemma":[0.9982938,0.0000336183,0.00022178085,0.0006051999,0.00012884024,0.00071673497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013365856,0.00016844776,0.00059131684,0.00019564769,0.00015451667,0.000011543777,0.00004807558,0.000086885986,0.000010323604],"category_scores_gemma":[0.0002816665,0.00014601387,0.00014834768,0.00046698473,0.000022366221,0.000047001882,0.000032628122,0.00028264028,0.0000037309176],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004358699,0.0010368205,0.043488298,0.0034157382,0.00019862207,0.061811075,0.007745575,0.000040649327,0.000042639385,0.0013526933,0.00814496,0.87228703],"study_design_scores_gemma":[0.008718305,0.012890407,0.3904428,0.00068781426,0.00041237965,0.5588065,0.0013226599,0.00007683208,0.0006922998,0.00041074175,0.024664387,0.00087494106],"about_ca_topic_score_codex":0.0005843217,"about_ca_topic_score_gemma":0.000057559235,"teacher_disagreement_score":0.8714121,"about_ca_system_score_codex":0.00008325544,"about_ca_system_score_gemma":0.00047714257,"threshold_uncertainty_score":0.5954273},"labels":[],"label_agreement":null}]}